Citrus Sinensis ID: 003836
Local Sequence Feature Prediction
| Prediction and (Method) | Result |
|---|
Close Homologs for Annotation Transfer
Close Homologs in SWISS-PROT Database Detected by BLAST 
Original result of BLAST against SWISS-PROT Database
ID ![]() | Alignment graph ![]() | Length ![]() |
Definition ![]() |
RBH(Q2H) ![]() |
RBH(H2Q) ![]() |
Q cover ![]() |
H cover ![]() |
Identity ![]() |
E-value ![]() |
| Query | 792 | 2.2.26 [Sep-21-2011] | |||||||
| Q39202 | 832 | G-type lectin S-receptor- | yes | no | 0.962 | 0.915 | 0.466 | 0.0 | |
| Q9FLV4 | 872 | G-type lectin S-receptor- | no | no | 0.945 | 0.858 | 0.334 | 1e-109 | |
| Q9XID3 | 829 | G-type lectin S-receptor- | no | no | 0.904 | 0.863 | 0.345 | 1e-107 | |
| Q8RWZ5 | 821 | G-type lectin S-receptor- | no | no | 0.926 | 0.894 | 0.322 | 7e-91 | |
| P17801 | 817 | Putative receptor protein | N/A | no | 0.909 | 0.881 | 0.336 | 3e-89 | |
| Q39203 | 797 | G-type lectin S-receptor- | no | no | 0.861 | 0.855 | 0.323 | 6e-84 | |
| O64477 | 828 | G-type lectin S-receptor- | no | no | 0.877 | 0.839 | 0.315 | 5e-81 | |
| O81906 | 849 | G-type lectin S-receptor- | no | no | 0.926 | 0.864 | 0.288 | 7e-72 | |
| O64783 | 814 | G-type lectin S-receptor- | no | no | 0.920 | 0.895 | 0.286 | 6e-69 | |
| Q9SXB3 | 820 | G-type lectin S-receptor- | no | no | 0.917 | 0.886 | 0.293 | 2e-68 |
| >sp|Q39202|RLK1_ARATH G-type lectin S-receptor-like serine/threonine-protein kinase RLK1 OS=Arabidopsis thaliana GN=RLK1 PE=2 SV=2 | Back alignment and function desciption |
|---|
Score = 693 bits (1788), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 384/824 (46%), Positives = 509/824 (61%), Gaps = 62/824 (7%)
Query: 3 FHLLSLLFLLLLPCLTAAQSNGTISIGQQLTAAESTE---PWLSPSKDFALGFHQLDSKD 59
HL+ +L L + NG++ +G+ LTA+ES + W SPS DFA GF ++ D
Sbjct: 9 IHLVLILQLQTFFVFSQNIRNGSVPVGESLTASESQQISSSWRSPSGDFAFGFRKIQPND 68
Query: 60 LFLPAIWYYKIPSKTIVWYASAVNPA----PRGSKLRLTANRGLVLEDPEGREIWKSEIS 115
F +IW+ KI KTIVW+A AVN P GSK+ LTA+ GLV+ DP G+E+W++ +S
Sbjct: 69 GFTLSIWFDKISDKTIVWHAQAVNTTTGLVPNGSKVTLTADGGLVIADPRGQELWRA-LS 127
Query: 116 TGQAAFGVLYDTGNFLIVNTNSER----LWQSFDHPTDTLLPTQTMERGGVVSSRRKDTY 171
G + G D GNF++ SE LW SF++PTDTLLP Q +E G +SSRR +T
Sbjct: 128 GGSVSRGRFTDDGNFVLFRDGSEDSDEVLWSSFENPTDTLLPNQNIEVGRNLSSRRTETS 187
Query: 172 FSRGRFQFRLLEDGNAVLNTINLESGFA---YDAYFWSNTFDTNRSNAGYRVVFNESGQL 228
F +GRF RL +DGN L+++N E+ Y Y+ SNT D N N G ++VFN+SG++
Sbjct: 188 FKKGRFSLRLEDDGNLQLHSLNAETASESDIYSQYYESNTNDPN--NPGIQLVFNQSGEI 245
Query: 229 YVLRENKQRASLV---PETVSAKENYLRATLNFDGVFIFYSHPKNNS--TGDAIWSVSDV 283
YVL+ N R + P+ A Y+ G + PK G + +
Sbjct: 246 YVLQRNNSRFVVKDRDPDFSIAAPFYIST-----GFLLSTIIPKEARRIVGGCLLGLCR- 299
Query: 284 LPENICINNDIRKGLGSGICGFNSICSISGAKRPICQCPKGFSLLDPDDAYGSCKPDF-I 342
+N+C +D LG+ CG+N+ICS+ KRP C+CP+ F L DP + YG C PDF +
Sbjct: 300 --DNMCSPDD---ALGNMACGYNNICSLGNNKRPKCECPERFVLKDPSNEYGDCLPDFEM 354
Query: 343 LGCEEDGKKSGED--LYYIEELRNTDWPTSDYEQISPYGKDECVSSCLKDCQCSAAVL-- 398
C + + + D LY L T+WP DYE + Y ++ C +SCL DC C+A +
Sbjct: 355 QTCRPENQTANSDVNLYEFITLEKTNWPFGDYESYANYDEERCKASCLSDCLCAAVIFGT 414
Query: 399 -RDDTCWKKKLPLSYGKTDRDETGTTFIKIRK-----VPSGGK--KKVDVLIPVVSVLFG 450
RD CWKKK PLS+G+ TFIK+R VP G KK+D LI SVL G
Sbjct: 415 NRDLKCWKKKFPLSHGERSPRGDSDTFIKVRNRSIADVPVTGNRAKKLDWLIIACSVLLG 474
Query: 451 SSALINLLLVSACCLGFLVVNRKKFMRPHQEDQG-------VSYMNLRCFTYKELVEVTR 503
+SA + + C K M+ D G + +NLR FTY EL E TR
Sbjct: 475 TSAFV---IFDTSCSYRKTKKSKNMMKNQARDIGRTTATTTANELNLRVFTYGELAEATR 531
Query: 504 GFKEELGRGAFGTVYKGFVNM--GSSNHVAVKKLNSVFQDSEKEFKAEVNGIGQTHHKNL 561
F EELGRGAFG VYKG++ + GS VAVKKL+ + D+EKEFK EV IGQ HHKNL
Sbjct: 532 DFTEELGRGAFGIVYKGYLEVAGGSEVTVAVKKLDRLDLDNEKEFKNEVKVIGQIHHKNL 591
Query: 562 VRLLGYCDEGQNRLLVYEFMSNGTVASFLFGDSKPNWKLRTEIAMGIAGGLFYLHEECCT 621
VRL+G+C+EGQ++++VYEF+ GT+A+FLF +P+W+ R IA+ IA G+ YLHEEC
Sbjct: 592 VRLIGFCNEGQSQMIVYEFLPQGTLANFLFRRPRPSWEDRKNIAVAIARGILYLHEECSE 651
Query: 622 QIIHCDIKPQNILLDDHYNARISDFGLAKLLTLDQSHTNTAIRGTKGYVAPEWFRNMPIT 681
QIIHCDIKPQNILLD++Y RISDFGLAKLL ++Q++T T IRGTKGYVAPEWFRN PIT
Sbjct: 652 QIIHCDIKPQNILLDEYYTPRISDFGLAKLLLMNQTYTLTNIRGTKGYVAPEWFRNSPIT 711
Query: 682 VKVDVYSYGVLLLEIICLRRNIDNEISKVDKAILTDWAYDRYQERTLEALVENDLEAMNN 741
KVDVYSYGV+LLEI+C ++ +D E D IL +WAYD +++ LE L E+D EAMN+
Sbjct: 712 SKVDVYSYGVMLLEIVCCKKAVDLE----DNVILINWAYDCFRQGRLEDLTEDDSEAMND 767
Query: 742 VTMLHRFVMVAFWCIQEDPSHRPTMRKVTQMLEGVVEVPIPPCP 785
+ + R+V +A WCIQE+ RP MR VTQMLEGV++V PP P
Sbjct: 768 METVERYVKIAIWCIQEEHGMRPNMRNVTQMLEGVIQVFDPPNP 811
|
Arabidopsis thaliana (taxid: 3702) EC: 2EC: .EC: 7EC: .EC: 1EC: 1EC: .EC: 1 |
| >sp|Q9FLV4|Y5248_ARATH G-type lectin S-receptor-like serine/threonine-protein kinase At5g24080 OS=Arabidopsis thaliana GN=At5g24080 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 397 bits (1021), Expect = e-109, Method: Compositional matrix adjust.
Identities = 280/836 (33%), Positives = 426/836 (50%), Gaps = 87/836 (10%)
Query: 9 LFLLLLPCLTAAQSNGTISIGQQLTAAESTEPWLSPSKDFALGFHQLDSKDLFLPAIWYY 68
LF L + + I +G +L A+E W+S + FA+GF + D FL +IW+
Sbjct: 13 LFSFFCFFLVSLATEPHIGLGSKLKASEPNRAWVSANGTFAIGFTRFKPTDRFLLSIWFA 72
Query: 69 KIPSK-TIVWYASAVNPAPRGSKLRLTANRGLVLEDPEGREIWKSEISTGQAAFGVLYDT 127
++P TIVW + +P + + L L A LVL D + +W S S V+ ++
Sbjct: 73 QLPGDPTIVWSPNRNSPVTKEAVLELEATGNLVLSD-QNTVVWTSNTSNHGVESAVMSES 131
Query: 128 GNFLIVNTN---SERLWQSFDHPTDTLLPTQTMERGGVVSSRRKDTYFSRGRFQFRLLED 184
GNFL++ T +WQSF P+DTLLP Q + ++S + G + ++L+
Sbjct: 132 GNFLLLGTEVTAGPTIWQSFSQPSDTLLPNQPLTVSLELTSNPSPS--RHGHYSLKMLQQ 189
Query: 185 GNAV----LNTINLESGFAYDAYFWSNTFDTNRS---------NAGYRVVFNES--GQLY 229
++ INL+ Y +WS +N + +++V+ ES G +Y
Sbjct: 190 HTSLSLGLTYNINLDPHANYS--YWSGPDISNVTGDVTAVLDDTGSFKIVYGESSIGAVY 247
Query: 230 VLR----ENKQRASLVPETVSAKENYLRATLNFDGVFIFYSHPKNNSTGDAIWSVSDVLP 285
V + +N+ + ++ R L +G Y N+ G + W +P
Sbjct: 248 VYKNPVDDNRNYNNSSNLGLTKNPVLRRLVLENNGNLRLYRW-DNDMNGSSQW-----VP 301
Query: 286 ENICINN--DIRKGLGSGICGFNSICSISGAKRPI-CQC-PKGFSLLDPDDA-YGSCKPD 340
E ++N DI +GICG N +C++ K+ C C P L D ++A S
Sbjct: 302 EWAAVSNPCDI-----AGICG-NGVCNLDRTKKNADCLCLPGSVKLPDQENAKLCSDNSS 355
Query: 341 FILGCEEDGKKSGEDLYYIEELRNTDWPTSD---YEQISPYGK-DECVSSCLKDCQCSAA 396
+ CE + ++G + I ++ T++ S+ E IS +C CL DC+C A+
Sbjct: 356 LVQECESNINRNGS--FKISTVQETNYYFSERSVIENISDISNVRKCGEMCLSDCKCVAS 413
Query: 397 V--LRDDT--CWKKKLPLSYGKTDRDETGTTFIKIRKV---------------PSGGKKK 437
V L D+ CW K L++G RD T F+K R S G ++
Sbjct: 414 VYGLDDEKPYCWILK-SLNFGGF-RDPGSTLFVKTRANESYPSNSNNNDSKSRKSHGLRQ 471
Query: 438 VDVLIPVVSVLFGSSALINLLLVSACCLGFLVVNRKKFMRPHQEDQGVSYMNLRCFTYKE 497
++IP+V + AL+ +LL + ++RK+ ++ ++ + + FTY++
Sbjct: 472 KVLVIPIVVGMLVLVALLGMLL-------YYNLDRKRTLKRAAKNSLILCDSPVSFTYRD 524
Query: 498 LVEVTRGFKEELGRGAFGTVYKGFVNMGSSNHVAVKKLNSVFQDSEKEFKAEVNGIGQTH 557
L T F + LG G FGTVYKG V VAVK+L+ E+EF EVN IG H
Sbjct: 525 LQNCTNNFSQLLGSGGFGTVYKGTV--AGETLVAVKRLDRALSHGEREFITEVNTIGSMH 582
Query: 558 HKNLVRLLGYCDEGQNRLLVYEFMSNGTVASFLFGDSKP----NWKLRTEIAMGIAGGLF 613
H NLVRL GYC E +RLLVYE+M NG++ ++F + +W+ R EIA+ A G+
Sbjct: 583 HMNLVRLCGYCSEDSHRLLVYEYMINGSLDKWIFSSEQTANLLDWRTRFEIAVATAQGIA 642
Query: 614 YLHEECCTQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLDQSHTNTAIRGTKGYVAPE 673
Y HE+C +IIHCDIKP+NILLDD++ ++SDFGLAK++ + SH T IRGT+GY+APE
Sbjct: 643 YFHEQCRNRIIHCDIKPENILLDDNFCPKVSDFGLAKMMGREHSHVVTMIRGTRGYLAPE 702
Query: 674 WFRNMPITVKVDVYSYGVLLLEIICLRRNIDNEISKVDKAILTDWAYDRYQERTLEALVE 733
W N PITVK DVYSYG+LLLEI+ RRN+D D WAY T V+
Sbjct: 703 WVSNRPITVKADVYSYGMLLLEIVGGRRNLDMSYDAED-FFYPGWAYKELTNGTSLKAVD 761
Query: 734 NDLEAMNNVTMLHRFVMVAFWCIQEDPSHRPTMRKVTQMLEGVV-EVPIPPCPWTL 788
L+ + + + + VAFWCIQ++ S RP+M +V ++LEG E+ +PP P T+
Sbjct: 762 KRLQGVAEEEEVVKALKVAFWCIQDEVSMRPSMGEVVKLLEGTSDEINLPPMPQTI 817
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9XID3|Y1343_ARATH G-type lectin S-receptor-like serine/threonine-protein kinase At1g34300 OS=Arabidopsis thaliana GN=At1g34300 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 388 bits (997), Expect = e-107, Method: Compositional matrix adjust.
Identities = 277/802 (34%), Positives = 409/802 (50%), Gaps = 86/802 (10%)
Query: 25 TISIGQQLTAAESTEPWLSPSKDFALGFHQLDSKDLFLPAIWYY-KIPSKTIVWYASAVN 83
TI +G + A+ S + W SP+ F++ F S + FL A+ + +P +W A V+
Sbjct: 26 TIPLGSVIYASGSNQNWPSPNSTFSVSFVPSPSPNSFLAAVSFAGSVP----IWSAGTVD 81
Query: 84 PAPRGSKLRLTANRGLVLEDPEGREIWKSEISTGQAAFGVLYDTGNFLIVNTNSERLWQS 143
RGS LRL + L L + G +W S+ G + DTG F+++N S +W S
Sbjct: 82 S--RGS-LRLHTSGSLRLTNGSGTTVWDSKTDRLGVTSGSIEDTGEFILLNNRSVPVWSS 138
Query: 144 FDHPTDTLLPTQTMERGGVVSSRRKDTYFSRGRFQFRLLEDGNAVLNTINLESGFAYDAY 203
FD+PTDT++ +Q G ++ S G + F+L GN L + A
Sbjct: 139 FDNPTDTIVQSQNFTAGKILRS---------GLYSFQLERSGNLTLR-------WNTSAI 182
Query: 204 FWSNTFDTNRSNAGY--RVVFNESGQLYVLRENK-QRASLVPETVSAKENYLR-ATLNFD 259
+W++ +++ S+ R+ +G + + N A +V N R L+ D
Sbjct: 183 YWNHGLNSSFSSNLSSPRLSLQTNGVVSIFESNLLGGAEIVYSGDYGDSNTFRFLKLDDD 242
Query: 260 G-VFIFYSHPKNNSTGDAIWSVSDVLPENICINNDIRKGLGSGICGFNSICSISGAKRPI 318
G + I+ S +N+ +A WS D + L G CG ICS + PI
Sbjct: 243 GNLRIYSSASRNSGPVNAHWSAVD-------------QCLVYGYCGNFGICSYNDTN-PI 288
Query: 319 CQCP-KGFSLLDPDDAYGSCKPDFILGCEEDGKKSGEDLYYIEELRNTDWPTSDYEQISP 377
C CP + F +D +D CK L + G + DL + D P S+
Sbjct: 289 CSCPSRNFDFVDVNDRRKGCKRKVELS-DCSGNTTMLDLVHTRLFTYEDDPNSESFFA-- 345
Query: 378 YGKDECVSSCLKDCQCSAAVLRDD---TCWKKKLPLSY--GKTDRDETGTTFIKI----- 427
G C ++CL C A+V D CW+K P S+ G T+++K+
Sbjct: 346 -GSSPCRANCLSSVLCLASVSMSDGSGNCWQKH-PGSFFTGYQWPSVPSTSYVKVCGPVV 403
Query: 428 ----RKVPSG--GKKKVDVLIPVVSVLFGSSALI--NLLLVSACCLG---FLVVNRKKFM 476
+ G KV + I V+V+ G L+ + L CC F ++ +
Sbjct: 404 ANTLERATKGDDNNSKVHLWIVAVAVIAGLLGLVAVEIGLWWCCCRKNPRFGTLSSHYTL 463
Query: 477 RPHQEDQGVSYMNLRCFTYKELVEVTRGFKEELGRGAFGTVYKGFVNMGSSNHVAVKKLN 536
+ V FTYKEL T+ FKE+LG G FGTVY+G + + VAVK+L
Sbjct: 464 LEYASGAPVQ------FTYKELQRCTKSFKEKLGAGGFGTVYRGVLT--NRTVVAVKQLE 515
Query: 537 SVFQDSEKEFKAEVNGIGQTHHKNLVRLLGYCDEGQNRLLVYEFMSNGTVASFLFGDSKP 596
+ Q EK+F+ EV I THH NLVRL+G+C +G++RLLVYEFM NG++ +FLF
Sbjct: 516 GIEQ-GEKQFRMEVATISSTHHLNLVRLIGFCSQGRHRLLVYEFMRNGSLDNFLFTTDSA 574
Query: 597 ---NWKLRTEIAMGIAGGLFYLHEECCTQIIHCDIKPQNILLDDHYNARISDFGLAKLLT 653
W+ R IA+G A G+ YLHEEC I+HCDIKP+NIL+DD++ A++SDFGLAKLL
Sbjct: 575 KFLTWEYRFNIALGTAKGITYLHEECRDCIVHCDIKPENILVDDNFAAKVSDFGLAKLLN 634
Query: 654 -LDQSHTNTAIRGTKGYVAPEWFRNMPITVKVDVYSYGVLLLEIICLRRNIDNEISKVDK 712
D + +++RGT+GY+APEW N+PIT K DVYSYG++LLE++ +RN D K +
Sbjct: 635 PKDNRYNMSSVRGTRGYLAPEWLANLPITSKSDVYSYGMVLLELVSGKRNFDVS-EKTNH 693
Query: 713 AILTDWAYDRYQERTLEALVENDLEAMNNVTM--LHRFVMVAFWCIQEDPSHRPTMRKVT 770
+ WAY+ +++ +A+++ L V M + R V +FWCIQE P RPTM KV
Sbjct: 694 KKFSIWAYEEFEKGNTKAILDTRLSEDQTVDMEQVMRMVKTSFWCIQEQPLQRPTMGKVV 753
Query: 771 QMLEGVVEVPIPPCPWTLNITS 792
QMLEG+ E+ P CP T++ S
Sbjct: 754 QMLEGITEIKNPLCPKTISEVS 775
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q8RWZ5|SD25_ARATH G-type lectin S-receptor-like serine/threonine-protein kinase SD2-5 OS=Arabidopsis thaliana GN=SD25 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 335 bits (860), Expect = 7e-91, Method: Compositional matrix adjust.
Identities = 265/822 (32%), Positives = 408/822 (49%), Gaps = 88/822 (10%)
Query: 5 LLSLLFLLLLPCLTAAQSNGTISIG---QQLTAAESTEPWL-SPSKDFALGF-HQLDSKD 59
+++ L L P S G+I+ G Q+ + +L S + F GF DS
Sbjct: 8 IVTCLVFLPDPLRAGVASIGSITPGFGGSQMNYINNDGIFLESNNSAFGFGFVTTQDSVT 67
Query: 60 LFLPAIWYYKIPSKTIVWYASAVNPAPRGSKLRLTANRGLVLEDPEGREIWKSEISTGQA 119
LF +I + S ++W A+ +P K N +V+E G E+W+ + S A
Sbjct: 68 LFTLSIIHKS--STKLIWSANRASPVSNSDKFVFDDNGNVVME---GTEVWRLDNSGKNA 122
Query: 120 AFGVLYDTGNFLIVNTNSERLWQSFDHPTDTLLPTQTMERGGVVSSRRKDTYFSRGRFQF 179
+ L D+GN ++V+ + +W+SFDHPTDTL+ Q + G ++S S +
Sbjct: 123 SRIELRDSGNLVVVSVDGTSIWESFDHPTDTLITNQAFKEGMKLTSSP-----SSSNMTY 177
Query: 180 RL-LEDGNAVLNTINLESGFAYDAYFWSNTFDTNRSNAGYRVVFNESGQLY-------VL 231
L ++ G+ VL+ +L +WS +NA R++ + G +
Sbjct: 178 ALEIKSGDMVLSVNSLTP-----QVYWS------MANARERIINKDGGVVTSSSLLGNSW 226
Query: 232 RENKQRASLVPETVSA--KENYLR--ATLNFDGVFIFYSHPKNNSTGDAIWSVSDVLPEN 287
R Q+ L+ + V + K++ A L +GV F + S D+ S +P +
Sbjct: 227 RFFDQKQVLLWQFVFSDNKDDNTTWIAVLGNNGVISFSNLGSGASAADS----STKIPSD 282
Query: 288 ICINNDIRKGLGSGICGFNSICSISGAKRPICQCPKGFSLLDPDDAYGSCKPDFILGCEE 347
+C + CG +C SG+K +C C G S D CK C++
Sbjct: 283 LCGTPE--------PCGPYYVC--SGSK--VCGCVSGLSRARSD-----CKTGITSPCKK 325
Query: 348 DGKKSGEDLYYIEELRNTDWPTSDYEQISPYGK----DECVSSCLKDCQCSAAVLRDDT- 402
+ L + D+ Y P+ K D C C +C C ++ +
Sbjct: 326 TKDNATLPLQLVSAGDGVDYFALGYAP--PFSKKTDLDSCKEFCHNNCSCLGLFFQNSSG 383
Query: 403 -CWKKKLPLSYGKTDRDETG-TTFIKIRKVPSGGKKKVDVLIPVVSVLFGSSALINLLLV 460
C+ S+ + +G ++IKI SGG + + + ++
Sbjct: 384 NCFLFDYIGSFKTSGNGGSGFVSYIKIASTGSGGGDNGEDDGKHFPYVVIIVVVTVFIIA 443
Query: 461 SACCLGFLVVNRKKFM-----RPHQED---QGVSYMNLRCFTYKELVEVTRGFKEELGRG 512
+ F + RKK + +ED + +S M +R F YK+L T F +LG+G
Sbjct: 444 VLIFVAFRIHKRKKMILEAPQESSEEDNFLENLSGMPIR-FAYKDLQSATNNFSVKLGQG 502
Query: 513 AFGTVYKGFVNMGSSNHVAVKKLNSVFQDSEKEFKAEVNGIGQTHHKNLVRLLGYCDEGQ 572
FG+VY+G + GS +AVKKL + Q +KEF+AEV+ IG HH +LVRL G+C EG
Sbjct: 503 GFGSVYEGTLPDGS--RLAVKKLEGIGQ-GKKEFRAEVSIIGSIHHLHLVRLRGFCAEGA 559
Query: 573 NRLLVYEFMSNGTVASFLF----GDSKPNWKLRTEIAMGIAGGLFYLHEECCTQIIHCDI 628
+RLL YEF+S G++ ++F GD +W R IA+G A GL YLHE+C +I+HCDI
Sbjct: 560 HRLLAYEFLSKGSLERWIFRKKDGDVLLDWDTRFNIALGTAKGLAYLHEDCDARIVHCDI 619
Query: 629 KPQNILLDDHYNARISDFGLAKLLTLDQSHTNTAIRGTKGYVAPEWFRNMPITVKVDVYS 688
KP+NILLDD++NA++SDFGLAKL+T +QSH T +RGT+GY+APEW N I+ K DVYS
Sbjct: 620 KPENILLDDNFNAKVSDFGLAKLMTREQSHVFTTMRGTRGYLAPEWITNYAISEKSDVYS 679
Query: 689 YGVLLLEIICLRRNID-NEISKVDKAILTDWAYDRYQERTLEALVENDLEAMNNV-TMLH 746
YG++LLE+I R+N D +E S +K +A+ + +E L +V+ ++ ++ +
Sbjct: 680 YGMVLLELIGGRKNYDPSETS--EKCHFPSFAFKKMEEGKLMDIVDGKMKNVDVTDERVQ 737
Query: 747 RFVMVAFWCIQEDPSHRPTMRKVTQMLEGVVEVPIPPCPWTL 788
R + A WCIQED RP+M KV QMLEGV V PP T+
Sbjct: 738 RAMKTALWCIQEDMQTRPSMSKVVQMLEGVFPVVQPPSSSTM 779
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|P17801|KPRO_MAIZE Putative receptor protein kinase ZmPK1 OS=Zea mays GN=PK1 PE=2 SV=2 | Back alignment and function description |
|---|
Score = 330 bits (846), Expect = 3e-89, Method: Compositional matrix adjust.
Identities = 283/841 (33%), Positives = 409/841 (48%), Gaps = 121/841 (14%)
Query: 9 LFLLLLPCLTAAQSNGTISIGQQLTAAESTEPWLSPSKD--FALGFHQLDSKDLFLPAIW 66
F+ L P AA S + +G L ES E S D F+ GF+++ + F ++W
Sbjct: 17 FFIALFP--RAASSRDILPLGSSL-VVESYESSTLQSSDGTFSSGFYEVYTH-AFTFSVW 72
Query: 67 YYKIPS-----KTIVWYASAVNPA-PRGSKLRLTANRGLVLEDPEGREIWKSEISTGQAA 120
Y K + KTIVW A+ P R S L L + +VL D +G +W+++ G
Sbjct: 73 YSKTEAAAANNKTIVWSANPDRPVHARRSALTLQKDGNMVLTDYDGAAVWRAD---GNNF 129
Query: 121 FGV----LYDTGNFLIVNTNSERLWQSFDHPTDTLLPTQTMERGGVVSSRRKDTYFSR-- 174
GV L DTGN +I ++ +WQSFD PTDT LPTQ + ++R T SR
Sbjct: 130 TGVQRARLLDTGNLVIEDSGGNTVWQSFDSPTDTFLPTQLI----TAATRLVPTTQSRSP 185
Query: 175 GRFQFRLLEDGNAVLNTINLESGFAYDAYFWSNTFDTNRSNAGYRVVFNESGQLYVLREN 234
G + FR + +VL+ I + D Y W + D N G R +N S +L +L ++
Sbjct: 186 GNYIFRFSD--LSVLSLIYHVPQVS-DIY-WPDP-DQNLYQDG-RNQYN-STRLGMLTDS 238
Query: 235 KQRAS--------LVPETVSAKENYLRATLNFDGVFIFYSHPKNNSTGDAIWSVSDVLPE 286
AS LV V R TL+ DG YS N+S G WSVS V
Sbjct: 239 GVLASSDFADGQALVASDVGPGVKR-RLTLDPDGNLRLYS--MNDSDGS--WSVSMVAMT 293
Query: 287 NICINNDIRKGLGSGICGFNSICSISGAKRPICQCPKGFSLLDPDDAYGSCKPDFILGCE 346
C +I G+CG N IC S P C CP G++ +P + C C+
Sbjct: 294 QPC---NIH-----GLCGPNGICHYS--PTPTCSCPPGYATRNPGNWTEGCMAIVNTTCD 343
Query: 347 EDGKKSGEDLYYIEELRNTDWPTSDYEQISPYGKDECVSSCLKDCQCSAAVLRDDT--CW 404
K+S + ++ L NTD+ SD + + C C+ DC C ++ T C+
Sbjct: 344 RYDKRS---MRFVR-LPNTDFWGSDQQHLLSVSLRTCRDICISDCTCKGFQYQEGTGSCY 399
Query: 405 KKKLPLSYGKTDRDETGTTFIKIRKVPSGGKKKVDVLIPVVSVL---------------- 448
K S + T ++K+ P+G + LIP V
Sbjct: 400 PKAYLFSGRTYPTSDVRTIYLKL---PTGVSVS-NALIPRSDVFDSVPRRLDCDRMNKSI 455
Query: 449 --------------------FGSSALINLLLVSACCLGFLVVNRKKFMRPHQ---EDQGV 485
+G A ++ VS + V +++ +RP + ++G
Sbjct: 456 REPFPDVHKTGGGESKWFYFYGFIAAFFVVEVSFISFAWFFVLKRE-LRPSELWASEKGY 514
Query: 486 SYM--NLRCFTYKELVEVTRGFKEELGRGAFGTVYKGFVNMGSSNHVAVKKLNSVFQDSE 543
M N R ++Y+ELV+ TR FK ELGRG GTVYKG + HVAVKKL +V Q E
Sbjct: 515 KAMTSNFRRYSYRELVKATRKFKVELGRGESGTVYKGVLE--DDRHVAVKKLENVRQGKE 572
Query: 544 KEFKAEVNGIGQTHHKNLVRLLGYCDEGQNRLLVYEFMSNGTVASFLF---GDSKPNWKL 600
F+AE++ IG+ +H NLVR+ G+C EG +RLLV E++ NG++A+ LF G+ +W+
Sbjct: 573 V-FQAELSVIGRINHMNLVRIWGFCSEGSHRLLVSEYVENGSLANILFSEGGNILLDWEG 631
Query: 601 RTEIAMGIAGGLFYLHEECCTQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLDQSHTN 660
R IA+G+A GL YLH EC +IHCD+KP+NILLD + +I+DFGL KLL S N
Sbjct: 632 RFNIALGVAKGLAYLHHECLEWVIHCDVKPENILLDQAFEPKITDFGLVKLLNRGGSTQN 691
Query: 661 TA-IRGTKGYVAPEWFRNMPITVKVDVYSYGVLLLEIICLRR------NIDNEISKVDKA 713
+ +RGT GY+APEW ++PIT KVDVYSYGV+LLE++ R D S + K
Sbjct: 692 VSHVRGTLGYIAPEWVSSLPITAKVDVYSYGVVLLELLTGTRVSELVGGTDEVHSMLRKL 751
Query: 714 ILTDWAYDRYQERT-LEALVENDLEAMNNVTMLHRFVMVAFWCIQEDPSHRPTMRKVTQM 772
+ A +E++ ++ +++ L N + +A C++ED S RPTM Q
Sbjct: 752 VRMLSAKLEGEEQSWIDGYLDSKLNRPVNYVQARTLIKLAVSCLEEDRSKRPTMEHAVQT 811
Query: 773 L 773
L
Sbjct: 812 L 812
|
Probable receptor. Interaction with a ligand in the extracellular domain triggers the protein kinase activity of the cytoplasmic domain. Zea mays (taxid: 4577) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q39203|SD22_ARATH G-type lectin S-receptor-like serine/threonine-protein kinase SD2-2 OS=Arabidopsis thaliana GN=SD22 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 312 bits (800), Expect = 6e-84, Method: Compositional matrix adjust.
Identities = 242/747 (32%), Positives = 359/747 (48%), Gaps = 65/747 (8%)
Query: 48 FALGFHQL--DSKDLFLPAIWYYKIPSKTIVWYASAVNPA--PRGSKLRLTANRGLVLED 103
F LGF S + +L I Y +P+ T VW A+ + P P S L LT+ L++ +
Sbjct: 40 FRLGFFSTTNGSSNWYL-GISYASMPTPTHVWVANRIRPVSDPDSSTLELTSTGYLIVSN 98
Query: 104 PEGREIWKSEISTGQAAFGVLYDTGNFLIVNTNSERLWQSFDHPTDTLLPTQTMERGGVV 163
+W+++ F +TGN +++N + +WQSFD+PTDT LP + +
Sbjct: 99 LRDGVVWQTDNKQPGTDF-RFSETGNLILINDDGSPVWQSFDNPTDTWLPGMNVTGLTAM 157
Query: 164 SSRRKDTYFSRGRFQFRLLEDGNAVLNTINLESGFAYDAYFWSNTFDTNRSNAGY-RVVF 222
+S R S G + RL N + + +WS T + G +
Sbjct: 158 TSWRSLFDPSPGFYSLRLSPSFN------EFQLVYKGTTPYWSTGNWTGEAFVGVPEMTI 211
Query: 223 NESGQLYVLRENKQRAS---LVPETVSAKENYL-RATLNFDGVFIFYSHPKNNSTGDAIW 278
+ + + AS +VP S E L R + +G Y+ + + W
Sbjct: 212 PYIYRFHFVNPYTPTASFWYIVPPLDSVSEPRLTRFMVGANGQLKQYTWDPQTQSWNMFW 271
Query: 279 SVSDVLPENIC-INNDIRKGLGSGICGFNSICSISGAKRPICQCPKGFSLLDPDDAYGSC 337
+ PE+ C + N +CG CS S +P C C +GF + D A+ S
Sbjct: 272 ----LQPEDPCRVYN---------LCGQLGFCS-SELLKP-CACIRGFRPRN-DAAWRS- 314
Query: 338 KPDFILGCEEDGKKSGEDLYYIEELRNTDWPTSDYEQISPYGKDECVSSCLKDCQCSAAV 397
D+ GC + SGE E + + + K C +CL + C
Sbjct: 315 -DDYSDGCRRENGDSGEKSDTFEAVGDLRYDGDVKMSRLQVSKSSCAKTCLGNSSCVGFY 373
Query: 398 LRDDTCWKKKLPLSYGKTDRDETGTTFIKIRKVPSGGKKKVDVLIPVVSVLFGSSALINL 457
++ + K L L ++ G K + +L VV GS +++
Sbjct: 374 HKEKSNLCKIL-LESPNNLKNSKGNI-----------SKSIIILCSVV----GSISVLGF 417
Query: 458 LLVSACCLGFLVVNRKKFMRPHQEDQGVSYMNLRCFTYKELVEVTRGFKEELGRGAFGTV 517
L+ L L +RK+ Q++ G + +NL+ F++KEL T GF +++G G FG V
Sbjct: 418 TLLVPLIL--LKRSRKRKKTRKQDEDGFAVLNLKVFSFKELQSATNGFSDKVGHGGFGAV 475
Query: 518 YKGFVNMGSSNHVAVKKLNSVFQDSEKEFKAEVNGIGQTHHKNLVRLLGYCDEGQNRLLV 577
+KG + GSS VAVK+L E EF+AEV IG H NLVRL G+C E +RLLV
Sbjct: 476 FKGTLP-GSSTFVAVKRLERP-GSGESEFRAEVCTIGNIQHVNLVRLRGFCSENLHRLLV 533
Query: 578 YEFMSNGTVASFLFGDSKP--NWKLRTEIAMGIAGGLFYLHEECCTQIIHCDIKPQNILL 635
Y++M G+++S+L S +W+ R IA+G A G+ YLHE C IIHCDIKP+NILL
Sbjct: 534 YDYMPQGSLSSYLSRTSPKLLSWETRFRIALGTAKGIAYLHEGCRDCIIHCDIKPENILL 593
Query: 636 DDHYNARISDFGLAKLLTLDQSHTNTAIRGTKGYVAPEWFRNMPITVKVDVYSYGVLLLE 695
D YNA++SDFGLAKLL D S +RGT GYVAPEW +PIT K DVYS+G+ LLE
Sbjct: 594 DSDYNAKVSDFGLAKLLGRDFSRVLATMRGTWGYVAPEWISGLPITTKADVYSFGMTLLE 653
Query: 696 IICLRRNI-------DNEISKVDKAILTDWAYDRYQERTLEALVENDLEAMNNVTMLHRF 748
+I RRN+ + ++ +K WA + ++++V++ L N + R
Sbjct: 654 LIGGRRNVIVNSDTLGEKETEPEKWFFPPWAAREIIQGNVDSVVDSRLNGEYNTEEVTRM 713
Query: 749 VMVAFWCIQEDPSHRPTMRKVTQMLEG 775
VA WCIQ++ RP M V +MLEG
Sbjct: 714 ATVAIWCIQDNEEIRPAMGTVVKMLEG 740
|
Serine/threonine-protein kinase. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|O64477|Y2913_ARATH G-type lectin S-receptor-like serine/threonine-protein kinase At2g19130 OS=Arabidopsis thaliana GN=At2g19130 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 303 bits (775), Expect = 5e-81, Method: Compositional matrix adjust.
Identities = 249/789 (31%), Positives = 379/789 (48%), Gaps = 94/789 (11%)
Query: 42 LSPSKDFALGFHQLDSKDLFLPAIWYYKIPSKTIVWYASAVNP-APRGSKLRLTANRGLV 100
+S + +GF + S F +WY ++ S+TI+W A+ + + S + +N L+
Sbjct: 39 VSSDGTYEMGFFKPGSSSNFYIGMWYKQL-SQTILWVANRDKAVSDKNSSVFKISNGNLI 97
Query: 101 LEDPEGRE-IWKSEI---STGQAAFGVLYDTGNFLIVNTNSER----LWQSFDHPTDTLL 152
L D + +W + + S+ A VL D GN ++ S LWQSFDHP DT L
Sbjct: 98 LLDGNYQTPVWSTGLNSTSSVSALEAVLQDDGNLVLRTGGSSLSANVLWQSFDHPGDTWL 157
Query: 153 PTQTMERGGVVSSRRKDTYFSRGRFQFRLLEDGNAVLNTINLESGFAYDAY------FWS 206
P GV K T S+ ++ LED + L ++ L+ AY +WS
Sbjct: 158 P-------GVKIRLDKRTGKSQRLTSWKSLEDPSPGLFSLELDESTAYKILWNGSNEYWS 210
Query: 207 N--------TFDT---NRSNAGYRVVFNESGQLYVLRENKQRASLVPETVSAKENYLRAT 255
+ FD+ R N Y F + S ++ + N R
Sbjct: 211 SGPWNPQSRIFDSVPEMRLNYIYNFSFF----------SNTTDSYFTYSIYNQLNVSRFV 260
Query: 256 LNFDGVFIFYSHPKNNSTGDAIWSVSDVLPENICINNDIRKGLGS-GICGFNSICSISGA 314
++ G ++ + N + WS P C + + GS GIC S
Sbjct: 261 MDVSGQIKQFTWLEGNKAWNLFWS----QPRQQC---QVYRYCGSFGIC--------SDK 305
Query: 315 KRPICQCPKGFSLLDPDDAYGSCKPDFILGC--EEDGKKSGEDLYYIEELRNTDWPTSDY 372
P C+CP+GF + D D+ GC + + + S D+ L N +
Sbjct: 306 SEPFCRCPQGFRPMSQKDWD---LKDYSAGCVRKTELQCSRGDINQFFRLPNMKL-ADNS 361
Query: 373 EQISPYGKDECVSSCLKDCQCSAAVLRDDT----CWKKKLPLSYGKTDRDETGTTF---I 425
E ++ C S+C DC C A + + W K + D + G F +
Sbjct: 362 EVLTRTSLSICASACQGDCSCKAYAYDEGSSKCLVWSKDVLNLQQLEDENSEGNIFYLRL 421
Query: 426 KIRKVPS-GGKKKVDVLIPVVSVLFGSSALINLLLVSACCLGFLVVNRKKFMRPHQEDQG 484
VP+ G K + + + GS + ++++ + ++ R++ ++ G
Sbjct: 422 AASDVPNVGASGKSNNKGLIFGAVLGS---LGVIVLVLLVVILILRYRRRKRMRGEKGDG 478
Query: 485 VSYMNLRCFTYKELVEVTRGFKEELGRGAFGTVYKGFVNMGSSNHVAVKKLNSVFQDSEK 544
L F+Y+EL T+ F ++LG G FG+V+KG + S+ +AVK+L + Q EK
Sbjct: 479 T----LSAFSYRELQNATKNFSDKLGGGGFGSVFKG--ALPDSSDIAVKRLEGISQ-GEK 531
Query: 545 EFKAEVNGIGQTHHKNLVRLLGYCDEGQNRLLVYEFMSNGTVASFLFGDSKP-----NWK 599
+F+ EV IG H NLVRL G+C EG +LLVY++M NG++ S LF + WK
Sbjct: 532 QFRTEVVTIGTIQHVNLVRLRGFCSEGSKKLLVYDYMPNGSLDSHLFLNQVEEKIVLGWK 591
Query: 600 LRTEIAMGIAGGLFYLHEECCTQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLDQSHT 659
LR +IA+G A GL YLH+EC IIHCDIKP+NILLD + +++DFGLAKL+ D S
Sbjct: 592 LRFQIALGTARGLAYLHDECRDCIIHCDIKPENILLDSQFCPKVADFGLAKLVGRDFSRV 651
Query: 660 NTAIRGTKGYVAPEWFRNMPITVKVDVYSYGVLLLEIICLRRNID-NEISKVDKAILTDW 718
T +RGT+GY+APEW + IT K DVYSYG++L E++ RRN + +E KV W
Sbjct: 652 LTTMRGTRGYLAPEWISGVAITAKADVYSYGMMLFELVSGRRNTEQSENEKV--RFFPSW 709
Query: 719 AYD-RYQERTLEALVENDLEA-MNNVTMLHRFVMVAFWCIQEDPSHRPTMRKVTQMLEGV 776
A ++ + +LV+ LE ++ + R VA WCIQ++ SHRP M +V Q+LEGV
Sbjct: 710 AATILTKDGDIRSLVDPRLEGDAVDIEEVTRACKVACWCIQDEESHRPAMSQVVQILEGV 769
Query: 777 VEVPIPPCP 785
+EV PP P
Sbjct: 770 LEVNPPPFP 778
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|O81906|B120_ARATH G-type lectin S-receptor-like serine/threonine-protein kinase B120 OS=Arabidopsis thaliana GN=B120 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 272 bits (696), Expect = 7e-72, Method: Compositional matrix adjust.
Identities = 240/832 (28%), Positives = 373/832 (44%), Gaps = 98/832 (11%)
Query: 2 AFHLLSLLFLLLLPCLTAAQSNGTISIGQQLTAAESTEPWLSPSKDFALGFHQLDSKDLF 61
+ +L L+ L AA TI G+ L + +P +SP K F LGF S
Sbjct: 8 SLYLSLFLYFFLYESSMAAN---TIRRGESLRDGINHKPLVSPQKTFELGFFSPGSSTHR 64
Query: 62 LPAIWYYKIPSKTIVWYASAVNPAPRGSKLRLTANRG-LVLEDPEGREIWKSEISTGQA- 119
IWY I K +VW A+ P S + + +N G LVL D + +W S I +
Sbjct: 65 FLGIWYGNIEDKAVVWVANRATPISDQSGVLMISNDGNLVLLDGKNITVWSSNIESSTTN 124
Query: 120 ---AFGVLYDTGNFLIVNTNSER-LWQSFDHPTDTLLPT-------QTMERGGVVSSRRK 168
++DTGNF++ T+++R +W+SF+HPTDT LP QT + V S R
Sbjct: 125 NNNRVVSIHDTGNFVLSETDTDRPIWESFNHPTDTFLPQMRVRVNPQTGDNHAFV-SWRS 183
Query: 169 DTYFSRGRFQFRLLEDGNAVLNTINLESGFAYDAYFWSNTFDTNRSNA--------GYRV 220
+T S G + + G + + + W++ T N G+++
Sbjct: 184 ETDPSPGNYSLGVDPSGAPEIVLWEGNKTRKWRSGQWNSAIFTGIPNMSLLTNYLYGFKL 243
Query: 221 VF--NESGQLYVLRENKQRASLVPETVSAKENYLRATLNFDGVFIFYSHPKNNSTGDAIW 278
+E+G +Y + VP S LR + ++G + N T W
Sbjct: 244 SSPPDETGSVYF--------TYVPSDPSV---LLRFKVLYNGT---EEELRWNETLKK-W 288
Query: 279 SVSDVLPENICINNDIRKGLGSGICGFNSICSISGAKRPICQCPKGFSLLDPDDAYGSCK 338
+ P++ C + + GIC IC C G+ + + C+
Sbjct: 289 TKFQSEPDSEC--DQYNRCGKFGICDMK-------GSNGICSCIHGYEQVSVGNWSRGCR 339
Query: 339 PDFILGCEEDGKKSGEDLYYIEELRNTDWPTSDYEQISPYGKDECVSSCLKDCQCSAAVL 398
L CE + ++ ++ ++ D+ ++ + P ++C CL++C C+A L
Sbjct: 340 RRTPLKCERNISVGEDEFLTLKSVKLPDFEIPEHNLVDP---EDCRERCLRNCSCNAYSL 396
Query: 399 RDD---TCWKKKLPLSYGKTDRDETGTTFIKIR----KVPSGGKKKVDVLIPVV--SVLF 449
W + L + E G + + IR +V K K+ V++ V+ +L
Sbjct: 397 VGGIGCMIWNQDLV----DLQQFEAGGSSLHIRLADSEVGENRKTKIAVIVAVLVGVILI 452
Query: 450 GSSALINLLL-----VSACCLG------FLVVNRKKFMRPHQ----------EDQGVSYM 488
G AL+ VS G +V + K E + V+
Sbjct: 453 GIFALLLWRFKRKKDVSGAYCGKNTDTSVVVADLTKSKETTSAFSGSVDIMIEGKAVNTS 512
Query: 489 NLRCFTYKELVEVTRGF--KEELGRGAFGTVYKGFVNMGSSNHVAVKKLNSVFQDSEKEF 546
L F+ + T F + ELGRG FG VYKG + G +AVK+L+ EF
Sbjct: 513 ELPVFSLNAIAIATNDFCKENELGRGGFGPVYKGVLEDG--REIAVKRLSGKSGQGVDEF 570
Query: 547 KAEVNGIGQTHHKNLVRLLGYCDEGQNRLLVYEFMSNGTVASFLFGDSKP---NWKLRTE 603
K E+ I + H+NLVRLLG C EG+ ++LVYE+M N ++ FLF ++K +WKLR
Sbjct: 571 KNEIILIAKLQHRNLVRLLGCCFEGEEKMLVYEYMPNKSLDFFLFDETKQALIDWKLRFS 630
Query: 604 IAMGIAGGLFYLHEECCTQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLDQSHTNTA- 662
I GIA GL YLH + +IIH D+K N+LLD N +ISDFG+A++ +Q+ NT
Sbjct: 631 IIEGIARGLLYLHRDSRLRIIHRDLKVSNVLLDAEMNPKISDFGMARIFGGNQNEANTVR 690
Query: 663 IRGTKGYVAPEWFRNMPITVKVDVYSYGVLLLEIICLRRNIDNEISKVDKAILTDWAYDR 722
+ GT GY++PE+ +VK DVYS+GVLLLEI+ +RN + + L +A+
Sbjct: 691 VVGTYGYMSPEYAMEGLFSVKSDVYSFGVLLLEIVSGKRN--TSLRSSEHGSLIGYAWYL 748
Query: 723 YQERTLEALVENDLEAMNNVTMLHRFVMVAFWCIQEDPSHRPTMRKVTQMLE 774
Y E LV+ + + R + VA C+Q+ + RP M V MLE
Sbjct: 749 YTHGRSEELVDPKIRVTCSKREALRCIHVAMLCVQDSAAERPNMASVLLMLE 800
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|O64783|Y1137_ARATH G-type lectin S-receptor-like serine/threonine-protein kinase At1g61370 OS=Arabidopsis thaliana GN=At1g61370 PE=3 SV=2 | Back alignment and function description |
|---|
Score = 262 bits (670), Expect = 6e-69, Method: Compositional matrix adjust.
Identities = 236/824 (28%), Positives = 384/824 (46%), Gaps = 95/824 (11%)
Query: 7 SLLFLLLL--PCLTAAQSNGT-ISIGQQLTAAESTEPWLSPSKDFALGFHQLDSKDLFLP 63
SLLFLL++ C AA + + +SIGQ L+ SP+ + LGF ++
Sbjct: 11 SLLFLLIIFPSCAFAAITRASPLSIGQTLS---------SPNGTYELGFFSPNNSRNQYV 61
Query: 64 AIWYYKIPSKTIVWYASAVNPAPR-GSKLRLTANRGLVLEDPEGREIWK-SEISTGQAAF 121
IW+ I + +VW A+ P + L + +N L+L + E +W E +
Sbjct: 62 GIWFKNITPRVVVWVANRDKPVTNNAANLTINSNGSLILVEREQNVVWSIGETFSSNELR 121
Query: 122 GVLYDTGNFLIVNTNSER-LWQSFDHPTDTLLPTQTM------ERGGVVSSRRKDTYFSR 174
L + GN ++++ SER LW+SF+H DT+L ++ + V+SS + T S
Sbjct: 122 AELLENGNLVLIDGVSERNLWESFEHLGDTMLLESSVMYDVPNNKKRVLSSWKNPTDPSP 181
Query: 175 GRFQFRLLEDGNAVLNTINLESGFAYDAY--FWSNTFDTNRSNAGYRVVFNESGQLYVLR 232
G F A L T GF +W R RV F ++
Sbjct: 182 GEFV--------AELTTQVPPQGFIMRGSRPYW-------RGGPWARVRFTGIPEMDGSH 226
Query: 233 ENKQRASLVPETVSAKENYLRATLNFDGVFIFYSHPKNNSTGDAIWS-----VSDV-LPE 286
+K S + V+A L +L + Y+ + + IW+ V+D+ P
Sbjct: 227 VSKFDIS---QDVAAGTGSLTYSLERRNSNLSYTTLTSAGSLKIIWNNGSGWVTDLEAPV 283
Query: 287 NICINNDIRKGLGSGICGFNSICSISGAKRPICQCPKGFSLLDPDDAY------GSCKPD 340
+ C D+ CG +C S P C+C KGF + D+ + G C
Sbjct: 284 SSC---DVYN-----TCGPFGLCIRSNP--PKCECLKGF-VPKSDEEWNKRNWTGGCMRR 332
Query: 341 FILGCEEDGKKSGE----DLYYIEELRNTDWPTSDYEQISPYGKDECVSSCLKDCQCSA- 395
L C+ + + + D++ I + N P YE +S +++C CL +C C+A
Sbjct: 333 TNLSCDVNSSATAQANNGDIFDI--VANVK-PPDFYEYLSLINEEDCQQRCLGNCSCTAF 389
Query: 396 AVLRDDTC--WKKKLPLSYGKTDRDETGTTFIKIRKVPSGGKKKVDVLIP-VVSVLFGSS 452
+ + C W ++L ET + I++ G +V +++ +VS+ S
Sbjct: 390 SYIEQIGCLVWNRELVDVMQFVAGGETLS--IRLASSELAGSNRVKIIVASIVSI----S 443
Query: 453 ALINLLLVSACCLGFLVVNRKKFMRPHQEDQGVSYMNLR-----CFTYKELVEVTRGFKE 507
+ L+ S + P + Q L+ F + ++ +T F
Sbjct: 444 VFMILVFASYWYWRYKAKQNDSNPIPLETSQDAWREQLKPQDVNFFDMQTILTITNNFSM 503
Query: 508 E--LGRGAFGTVYKGFVNMGSSNHVAVKKLNSVFQDSEKEFKAEVNGIGQTHHKNLVRLL 565
E LG+G FG VYKG N+ +A+K+L+S +EF E+ I + H+NLVRLL
Sbjct: 504 ENKLGQGGFGPVYKG--NLQDGKEIAIKRLSSTSGQGLEEFMNEIILISKLQHRNLVRLL 561
Query: 566 GYCDEGQNRLLVYEFMSNGTVASFLFGDSKP---NWKLRTEIAMGIAGGLFYLHEECCTQ 622
G C EG+ +LL+YEFM+N ++ +F+F +K +W R EI GIA GL YLH + C +
Sbjct: 562 GCCIEGEEKLLIYEFMANKSLNTFIFDSTKKLELDWPKRFEIIQGIACGLLYLHRDSCLR 621
Query: 623 IIHCDIKPQNILLDDHYNARISDFGLAKLLTLDQSHTNT-AIRGTKGYVAPEWFRNMPIT 681
++H D+K NILLD+ N +ISDFGLA++ Q NT + GT GY++PE+ +
Sbjct: 622 VVHRDMKVSNILLDEEMNPKISDFGLARMFQGTQHQANTRRVVGTLGYMSPEYAWTGMFS 681
Query: 682 VKVDVYSYGVLLLEIICLRRNIDNEISKVDKAILTDWAYDRYQERTLEALVENDLEAMNN 741
K D+Y++GVLLLEII +R I + K +L ++A+D + E L++ D+ + +
Sbjct: 682 EKSDIYAFGVLLLEIITGKRISSFTIGEEGKTLL-EFAWDSWCESGGSDLLDQDISSSGS 740
Query: 742 VTMLHRFVMVAFWCIQEDPSHRPTMRKVTQMLEGVVEVPIPPCP 785
+ + R V + CIQ+ RP + +V ML +++P P P
Sbjct: 741 ESEVARCVQIGLLCIQQQAGDRPNIAQVMSMLTTTMDLPKPKQP 784
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9SXB3|Y1112_ARATH G-type lectin S-receptor-like serine/threonine-protein kinase At1g11280 OS=Arabidopsis thaliana GN=At1g11280 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 261 bits (666), Expect = 2e-68, Method: Compositional matrix adjust.
Identities = 242/825 (29%), Positives = 368/825 (44%), Gaps = 98/825 (11%)
Query: 8 LLFLLLLPCLTAAQSNGTISIGQQLTAAESTEPWLSPSKDFALGFHQLDSKDLFLPAIWY 67
L L L C AA I+I LT ++ SP + LGF ++ IW+
Sbjct: 17 LWLSLFLSCGYAA-----ITISSPLTLGQTLS---SPGGFYELGFFSPNNSQNQYVGIWF 68
Query: 68 YKIPSKTIVWYASAVNPAPRG-SKLRLTANRGLVLEDPEGREIWKSE-ISTGQAAFGVLY 125
KI + +VW A+ P + L ++ N L+L D +W + S L
Sbjct: 69 KKITPRVVVWVANREKPITTPVANLTISRNGSLILLDSSKNVVWSTRRPSISNKCHAKLL 128
Query: 126 DTGNFLIVNTNSERL-WQSFDHPTDTLLPTQTME------RGGVVSSRRKDTYFSRGRFQ 178
DTGN +IV+ SE L WQSF++P DT+LP ++ V+SS + T S G F
Sbjct: 129 DTGNLVIVDDVSENLLWQSFENPGDTMLPYSSLMYNLATGEKRVLSSWKSHTDPSPGDFV 188
Query: 179 FRLLEDGNAVLNTINLESGFAYDAYFWSNTFDTNRS--NAGYRVVFNES---GQLYVLRE 233
RL A + T+ S + W+ T T + Y F+ S G L
Sbjct: 189 VRLTPQVPAQIVTMRGSSVYKRSGP-WAKTGFTGVPLMDESYTSPFSLSQDVGNGTGLFS 247
Query: 234 NKQRASLVPETVSAKENYLRATLNFDGVFIFYSHPKNNSTGDAIWSVSDVLPENICINND 293
QR+S + + E YL+ T ++G TG W + + P N+C D
Sbjct: 248 YLQRSSELTRVIITSEGYLK-TFRYNG------------TG---WVLDFITPANLC---D 288
Query: 294 IRKGLGSGICGFNSICSISGAKRPICQCPKGF-----SLLDPDDAYGSCKPDFILGCEED 348
+ G CG +C S + C+C KGF + C L C+ +
Sbjct: 289 LY-----GACGPFGLCVTSNPTK--CKCMKGFVPKYKEEWKRGNMTSGCMRRTELSCQAN 341
Query: 349 ----GKKSGEDLYYIEELRNTDWPTSDYEQISPYGKDECVSSCLKDCQCSA-AVLRDDTC 403
+ G D++Y L N P YE S D+C CL +C CSA A + C
Sbjct: 342 LSTKTQGKGVDVFY--RLANVK-PPDLYEYASFVDADQCHQGCLSNCSCSAFAYITGIGC 398
Query: 404 --WKKKLPLSYGKTDRDETGTTFIKIRKVPS--GGKKKVDVLIPVVSV------LFGSSA 453
W +L T R G F+ IR S G ++ +++ +S+ FGS
Sbjct: 399 LLWNHELI----DTIRYSVGGEFLSIRLASSELAGSRRTKIIVGSISLSIFVILAFGSYK 454
Query: 454 LINLLLVSACCLGFLVVNR-----KKFMRPHQEDQGVSYMNLRCFTYKELVEVTRGF--K 506
+ N K + P QE G+++ F + T F
Sbjct: 455 YWRYRAKQNVGPTWAFFNNSQDSWKNGLEP-QEISGLTF-----FEMNTIRAATNNFNVS 508
Query: 507 EELGRGAFGTVYKGFVNMGSSNHVAVKKLNSVFQDSEKEFKAEVNGIGQTHHKNLVRLLG 566
+LG+G FG VYKG + +AVK+L+S +EF E+ I + H+NLVRLLG
Sbjct: 509 NKLGQGGFGPVYKG--TLSDKKDIAVKRLSSSSGQGTEEFMNEIKLISKLQHRNLVRLLG 566
Query: 567 YCDEGQNRLLVYEFMSNGTVASFLFGDS---KPNWKLRTEIAMGIAGGLFYLHEECCTQI 623
C +G+ +LL+YEF+ N ++ +FLF + + +W R I G++ GL YLH + C ++
Sbjct: 567 CCIDGEEKLLIYEFLVNKSLDTFLFDLTLKLQIDWPKRFNIIQGVSRGLLYLHRDSCMRV 626
Query: 624 IHCDIKPQNILLDDHYNARISDFGLAKLLTLDQSHTNT-AIRGTKGYVAPEWFRNMPITV 682
IH D+K NILLDD N +ISDFGLA++ Q NT + GT GY++PE+ +
Sbjct: 627 IHRDLKVSNILLDDKMNPKISDFGLARMFQGTQHQDNTRKVVGTLGYMSPEYAWTGMFSE 686
Query: 683 KVDVYSYGVLLLEIICLRRNIDNEISKVDKAILTDWAYDRYQERTLEALVENDLEAMNNV 742
K D+Y++GVLLLEII ++ I + + L A++ + E L++ D+ + +
Sbjct: 687 KSDIYAFGVLLLEIISGKK-ISSFCCGEEGKTLLGHAWECWLETGGVDLLDEDISSSCSP 745
Query: 743 TMLH--RFVMVAFWCIQEDPSHRPTMRKVTQMLEGVVEVPIPPCP 785
+ R V + CIQ+ RP + +V M+ ++P P P
Sbjct: 746 VEVEVARCVQIGLLCIQQQAVDRPNIAQVVTMMTSATDLPRPKQP 790
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
Close Homologs in the Non-Redundant Database Detected by BLAST 
Original result of BLAST against Nonredundant Database
GI ![]() | Alignment Graph ![]() | Length ![]() |
Definition ![]() |
Q cover ![]() |
H cover ![]() |
Identity ![]() |
E-value ![]() |
| Query | 792 | ||||||
| 224099309 | 801 | predicted protein [Populus trichocarpa] | 0.972 | 0.961 | 0.581 | 0.0 | |
| 224057535 | 775 | predicted protein [Populus trichocarpa] | 0.963 | 0.984 | 0.572 | 0.0 | |
| 255544746 | 800 | ATP binding protein, putative [Ricinus c | 0.949 | 0.94 | 0.585 | 0.0 | |
| 224053032 | 752 | predicted protein [Populus trichocarpa] | 0.935 | 0.985 | 0.575 | 0.0 | |
| 356575025 | 800 | PREDICTED: G-type lectin S-receptor-like | 0.960 | 0.951 | 0.551 | 0.0 | |
| 224103119 | 799 | predicted protein [Populus trichocarpa] | 0.982 | 0.973 | 0.558 | 0.0 | |
| 109676362 | 2037 | CCHC-type integrase [Populus trichocarpa | 0.933 | 0.362 | 0.582 | 0.0 | |
| 224073224 | 699 | predicted protein [Populus trichocarpa] | 0.862 | 0.977 | 0.560 | 0.0 | |
| 224143661 | 691 | predicted protein [Populus trichocarpa] | 0.863 | 0.989 | 0.568 | 0.0 | |
| 356555135 | 815 | PREDICTED: G-type lectin S-receptor-like | 0.987 | 0.959 | 0.544 | 0.0 |
| >gi|224099309|ref|XP_002334494.1| predicted protein [Populus trichocarpa] gi|222872794|gb|EEF09925.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 911 bits (2355), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 459/789 (58%), Positives = 569/789 (72%), Gaps = 19/789 (2%)
Query: 1 MAFHLLSLLF--LLLLPCLTAAQSNGTISIGQQLTAAESTEPWLSPSKDFALGFHQL-DS 57
MAF +L L F L++LP +Q+ G I++G L+ +E+T WLSPS DFA GFH L +
Sbjct: 1 MAFPILHLSFSLLIMLPPFAVSQTGGNITVGASLSTSENTS-WLSPSGDFAFGFHPLYGN 59
Query: 58 KDLFLPAIWYYKIPSKTIVWYASAVNPAPRGSKLRLTANRGLVLEDPEGREIWKSEISTG 117
K LFL AIWY KIP KTIVWYA+ PAP GSK LTANRG+ L DP+GRE+W+SE G
Sbjct: 60 KYLFLLAIWYDKIPEKTIVWYANGDKPAPTGSKAVLTANRGISLTDPQGRELWRSETIIG 119
Query: 118 QAAFGVLYDTGNFLIVNTNSERLWQSFDHPTDTLLPTQTMERGGVVSSRRKDTYFSRGRF 177
A+G + D GNF++ + S++LW+SF +P DTLLP+Q ++RG +SSR+ + FS GRF
Sbjct: 120 VVAYGAMTDKGNFVLQDRVSDKLWESFKNPADTLLPSQVLDRGMTLSSRQSENNFSMGRF 179
Query: 178 QFRLLEDGNAVLNTINLESGFAYDAYFWSNT-FDTNRSNAGYRVVFNESGQLYVLRENKQ 236
Q +L +DGN L TINL S + + Y+ S T + S+ GY+VVFNESG LY+LREN Q
Sbjct: 180 QLKLTDDGNLELATINLPSDYTNEPYYKSGTDGGLDSSSPGYQVVFNESGYLYILRENDQ 239
Query: 237 RASLVPE-TVSAKENYLRATLNFDGVFIFYSHPKNNSTGDAIWSVSDVLPENICINNDIR 295
SL T S + Y RATLNFDG+F Y HPK STG+ W+ P+NIC + +
Sbjct: 240 IFSLTQRVTASTGDFYRRATLNFDGLFTQYYHPKA-STGNERWTPIWSQPDNICQASFVS 298
Query: 296 KGLGSGICGFNSICSISGAKRPICQCPKGFSLLDPDDAYGSCKPDFILGCEEDGKKSGED 355
G SG CGFNS+C ++ +RPIC+CP G+SLLDP D YGSC+P++ CEED ED
Sbjct: 299 SG--SGTCGFNSVCRLNSDRRPICECPGGYSLLDPSDQYGSCRPNYTQSCEEDEVAPVED 356
Query: 356 LYYIEELRNTDWPTSDYEQISPYGKDECVSSCLKDCQCSAAVLRD-DTCWKKKLPLSYGK 414
LY EEL NTDWPTSDY + P+ +++C SCL DC C+ A+ R D CWKKKLPLS G+
Sbjct: 357 LYDFEELTNTDWPTSDYALLKPFTEEKCRQSCLNDCMCAVAIFRSGDMCWKKKLPLSNGR 416
Query: 415 TDRDETGTTFIKIRKVP--------SGGKKKVDVLIPVVSVLFGSSALINLLLVSACCLG 466
+ G +K+R+ KK D LI V SV G S +N LLV A +
Sbjct: 417 VQTNLDGKALLKVRRSNVNPRSPYFPNNKKDRDGLILVGSVFLGCSVFVNFLLVCAIFMC 476
Query: 467 FLVVNRKKFMRPHQEDQGVSYMNLRCFTYKELVEVTRGFKEELGRGAFGTVYKGFVNMGS 526
F + R++ R Q+D V NLRCFTY+EL E T GFKEELGRGAFG VYKG V++GS
Sbjct: 477 FFFIYRRRTKRIPQKDGAVE-TNLRCFTYQELAEATEGFKEELGRGAFGVVYKGVVHIGS 535
Query: 527 SNHVAVKKLNSVFQDSEKEFKAEVNGIGQTHHKNLVRLLGYCDEGQNRLLVYEFMSNGTV 586
S VAVKKLN+V +D +EFK EVN IGQTHHKNLVRLLG+C+EG RLLVYEFMSNG++
Sbjct: 536 SIVVAVKKLNNVAEDRVREFKTEVNVIGQTHHKNLVRLLGFCEEGDQRLLVYEFMSNGSL 595
Query: 587 ASFLFGDSKPNWKLRTEIAMGIAGGLFYLHEECCTQIIHCDIKPQNILLDDHYNARISDF 646
+SF+F D+KP WK+R +IA G+A GL YLHEEC QIIHCDIKPQNILLD++YNARISDF
Sbjct: 596 SSFIFQDAKPGWKIRIQIAFGVARGLLYLHEECSNQIIHCDIKPQNILLDEYYNARISDF 655
Query: 647 GLAKLLTLDQSHTNTAIRGTKGYVAPEWFRNMPITVKVDVYSYGVLLLEIICLRRNIDNE 706
GLAKLL LDQS T+TAIRGTKGYVAPEWFRN+P+TVKVDVYSYGVLLLEIIC RRN+D++
Sbjct: 656 GLAKLLLLDQSQTHTAIRGTKGYVAPEWFRNLPVTVKVDVYSYGVLLLEIICCRRNVDSK 715
Query: 707 ISKVDKAILTDWAYDRYQERTLEALVENDLEAMNNVTMLHRFVMVAFWCIQEDPSHRPTM 766
+ ++AILTDWAYD Y+E TL+ALV +D A++++ L RF+M+AFWCIQEDPS RPTM
Sbjct: 716 ATIEEQAILTDWAYDCYREGTLDALVGSDTGALDDIEKLERFLMIAFWCIQEDPSLRPTM 775
Query: 767 RKVTQMLEG 775
RKVTQMLEG
Sbjct: 776 RKVTQMLEG 784
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224057535|ref|XP_002299255.1| predicted protein [Populus trichocarpa] gi|222846513|gb|EEE84060.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 908 bits (2346), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 460/804 (57%), Positives = 567/804 (70%), Gaps = 41/804 (5%)
Query: 1 MAFHLLSLL--FLLLLPCLTAAQSNGTISIGQQLTAAESTEPWLSPSKDFALGFHQLDSK 58
MAF L +L F LL P AQ NG ++G LTA + WLSP++DFA GF QLD K
Sbjct: 1 MAFDLPCILYFFFLLFPSSLVAQRNGNATVGDSLTAGDEATLWLSPAEDFAFGFRQLDKK 60
Query: 59 DLFLPAIWYYKIPSKTIVWYASAVNPAPRGSKLRLTANRGLVLEDPEGREIWKSEISTGQ 118
DL+L AIWY KIP KTIVWYA+ PAP+ S ++LTA G+VL +P+G EIWKS G+
Sbjct: 61 DLYLLAIWYNKIPDKTIVWYANGDRPAPKKSTVKLTAELGVVLNNPQGGEIWKSGPGNGE 120
Query: 119 AAFGVLYDTGNFLIVNTNSERLWQSFDHPTDTLLPTQTMERGGVVSSRRKDTYFSRGRFQ 178
AA+G + DTGNFL+ N N E+LWQSF+ TDTLLPTQ ME+GG++SSR +T FS+GRFQ
Sbjct: 121 AAYGFMNDTGNFLVANANGEKLWQSFELLTDTLLPTQIMEKGGILSSRLSETNFSQGRFQ 180
Query: 179 FRLLEDGNAVLNTINLESGFAYDAYFWSNTFDTNRSNAGYRVVFNESGQLYVLRENKQRA 238
FRL+ DGNAVLNTINL +GF Y+AYFWS T D+N SNAGY+VVFNESG LYVLR N R
Sbjct: 181 FRLIPDGNAVLNTINLPTGFPYEAYFWSKTVDSNSSNAGYQVVFNESGYLYVLRANNTRE 240
Query: 239 SL-VPETVSAKENYLRATLNFDGVFIFYSHPKNNSTGDAIWSVSDVLPENICINNDIRKG 297
+L + V A ENY RATL+FDGVF+ YSHPK NS G+ WSV +PENIC + +G
Sbjct: 241 ALTLGRVVPATENYHRATLHFDGVFVLYSHPK-NSPGNENWSVVRTMPENICT---VVRG 296
Query: 298 L-GSGICGFNSICSISGAKRPICQCPKGFSLLDPDDAYGSCKPDFILG-CEEDGKKSGED 355
L GSG CG+N +C+IS KR IC+CP+ FSLLDPDD YG CKPDF C E+ + ED
Sbjct: 297 LKGSGPCGYNGVCTISTDKRAICRCPQRFSLLDPDDPYGGCKPDFPTQVCAEEVPNAPED 356
Query: 356 LYYIEELRNTDWPTSDYEQISPYGKDECVSSCLKDCQCSAAVLRDDTCWKKKLPLSYGKT 415
Y + L N DWP SDYE +PY ++C +CL+D C+ V + TCWKK+LPLS G+
Sbjct: 357 -YELVPLTNIDWPESDYEMYTPYNIEDCKKACLQDFFCNVIVFGEGTCWKKRLPLSNGRQ 415
Query: 416 DRDETGTTFIKIRK-------VPSGGKKKVDVLIPVVSVLFGSSALINLLLVSACCLGFL 468
G +F+K+RK P KK + VVSVL G S N +LV F
Sbjct: 416 GESVNGASFMKVRKGNYTLPGPPPIPKKN----LLVVSVLLGGSVFFNFVLVGVVSFAFF 471
Query: 469 VVNRKKFMRPHQEDQGVSYMNLRCFTYKELVEVTRGFKEELGRGAFGTVYKGFVNMGSSN 528
+ KF R Q ++ V NLRCF+YKEL+E T GFKEELGRGAFG VYKG +GS
Sbjct: 472 FIYHNKFTRTPQVERAVQ-SNLRCFSYKELMEATNGFKEELGRGAFGIVYKGLTQIGSGV 530
Query: 529 HVAVKKLNSVFQDSEKEFKAEVNGIGQTHHKNLVRLLGYCDEGQNRLLVYEFMSNGTVAS 588
VA+KK++ ++S+KEFK EV+ ++G+CDEGQ+R+LVYEF+SNG +AS
Sbjct: 531 PVAIKKVDRFVKESDKEFKTEVD------------VIGFCDEGQHRMLVYEFLSNGALAS 578
Query: 589 FLFGDSKPNWKLRTEIAMGIAGGLFYLHEECCTQIIHCDIKPQNILLDDHYNARISDFGL 648
FLFGD K +W RT+IA GIA GL YLH+EC TQIIHCDIKPQNILLD+HY+ARI+DFGL
Sbjct: 579 FLFGDVKLSWNQRTQIAFGIARGLLYLHDECSTQIIHCDIKPQNILLDEHYDARIADFGL 638
Query: 649 AKLLTLDQSHTNTAIRGTKGYVAPEWFRNMPITVKVDVYSYGVLLLEIICLRRNIDNEIS 708
AKL N +GTKGYVAPEWFRNM ITVKVDVY++GVLLLEIIC RR++D E+
Sbjct: 639 AKLF------RNPQHKGTKGYVAPEWFRNMLITVKVDVYNFGVLLLEIICCRRSVDTEVG 692
Query: 709 KVDKAILTDWAYDRYQERTLEALVENDLEAMNNVTMLHRFVMVAFWCIQEDPSHRPTMRK 768
+ ++AILTDWAYD YQE + ALVE+D EA+N++ L RFVMVA WCIQEDP+ RPTM+
Sbjct: 693 E-ERAILTDWAYDCYQEGMMHALVESDEEALNDMKKLERFVMVAIWCIQEDPNLRPTMKM 751
Query: 769 VTQMLEGVVEVPIPPCPWTLNITS 792
V MLEG+++VP+PPCP +I S
Sbjct: 752 VMLMLEGIIQVPVPPCPSPFSIAS 775
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|255544746|ref|XP_002513434.1| ATP binding protein, putative [Ricinus communis] gi|223547342|gb|EEF48837.1| ATP binding protein, putative [Ricinus communis] | Back alignment and taxonomy information |
|---|
Score = 900 bits (2326), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 454/775 (58%), Positives = 557/775 (71%), Gaps = 23/775 (2%)
Query: 20 AQSNGTISIGQQLTAAESTEPWLSPSKDFALGFHQLDSKDLFLPAIWYYKIPSKTIVWYA 79
AQ+ TI +G L AA+ E WLSPS DFA GF QL++K+L+L AI Y KI KTIVWYA
Sbjct: 23 AQNGDTIIVGDFLAAADPAESWLSPSGDFAFGFRQLENKNLYLLAICYNKISDKTIVWYA 82
Query: 80 SAVNPAPRGSKLRLTANRGLVLEDPEGREIWKSEISTGQAAFGVLYDTGNFLIVNTNSER 139
+ +PAP GSK+ LTA+RGLVL P+G+EIWKS I+ G AA G++ DTGNF IVNT E+
Sbjct: 83 NGDDPAPTGSKVELTADRGLVLTSPQGKEIWKSGINIGDAARGMMNDTGNFRIVNTGGEK 142
Query: 140 LWQSFDHPTDTLLPTQTMERGG-VVSSRRKDTYFSRGRFQFRLLEDGNAVLNTINLESGF 198
LWQ+FD P DTLLP Q +ERGG ++SSR ++T FSRGRFQFRL+ DGN VLN NL +G
Sbjct: 143 LWQTFDDPKDTLLPGQALERGGKILSSRLRETNFSRGRFQFRLIPDGNGVLNANNLRTGD 202
Query: 199 AYDAYFWSNTFDTNRSNAGYRVVFNESGQLYVLRENKQRASLVPE-TVSAKENYLRATLN 257
AYDAY+W+NT D N SNAG R+VFNESG LY LR + +R + PE V E Y R TLN
Sbjct: 203 AYDAYYWTNTVDANLSNAGLRIVFNESGYLYTLRASNKRELITPERVVPTTEYYHRVTLN 262
Query: 258 FDGVFIFYSHPKNNSTGDAIWSVSDVLPENICINNDIRKGLGSGICGFNSICSISGAKRP 317
FDGV YSHPKN ST + WS+ PENIC + +G+G CGFNS+C ++ +R
Sbjct: 263 FDGVLTQYSHPKN-STDNGNWSIIFSAPENICF---LITDIGTGPCGFNSVCQLNADQRA 318
Query: 318 ICQCPKGFSLLDPDDAYGSCKPDFILGCEEDGKKSGEDLYYIEELRNTDWPTSDYEQISP 377
IC+CP FS +DP D Y CKPDF ED + + Y EL NTDWPTSDYE+
Sbjct: 319 ICRCPPRFSSVDPGDDYAGCKPDFSTQFCEDAPSTSPEDYDFLELTNTDWPTSDYERYDS 378
Query: 378 YGKDECVSSCLKDCQCSAAVLRDDTCWKKKLPLSYGKTDRDETGTTFIKIRKVPSGG--- 434
Y +EC +C++DC C+ V R +CWKKKLPLS G+ G FIK+RK G
Sbjct: 379 YNIEECQKACIQDCFCNVVVFRG-SCWKKKLPLSNGRQSEKVNGRAFIKVRKDDYMGRGL 437
Query: 435 --------KKKVDVLIPVVSVLFGSSALINLLLVSACCLGFLVVNRKKFMRPHQEDQGVS 486
K+ D L+ V+SVL GSS IN +L+ FL KK Q ++
Sbjct: 438 PPRPFPNAKEDQDSLVLVISVLLGSSVFINFILIGLVTFCFLFFYHKKSTGIPQGEKS-- 495
Query: 487 YMNLRCFTYKELVEVTRGFKEELGRGAFGTVYKGFVNMGSSNHVAVKKLNSVFQDSEKEF 546
NLRCF+YKELVE T+GFKEELGRG+FG VYKG + MG++ VAVKKL+ V + EKE+
Sbjct: 496 --NLRCFSYKELVEATKGFKEELGRGSFGIVYKGLIEMGTTVPVAVKKLDRVVEYGEKEY 553
Query: 547 KAEVNGIGQTHHKNLVRLLGYCDEGQNRLLVYEFMSNGTVASFLFGDSKPNWKLRTEIAM 606
KAEV IGQTHHKNLV+LLG+CDEGQ +LLVYE +SNGT+A+FLFGD+K +WK RT+IA
Sbjct: 554 KAEVKAIGQTHHKNLVQLLGFCDEGQQKLLVYELLSNGTLANFLFGDTKLSWKQRTQIAF 613
Query: 607 GIAGGLFYLHEECCTQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLDQSHTNTAIRGT 666
GIA GL YLHEEC TQIIHCDIKPQNIL+D++Y+A+ISDFGLAKLL LDQS T T IRGT
Sbjct: 614 GIARGLVYLHEECNTQIIHCDIKPQNILVDEYYDAKISDFGLAKLLLLDQSQTFTTIRGT 673
Query: 667 KGYVAPEWFRNMPITVKVDVYSYGVLLLEIICLRRNIDNEISKVDKAILTDWAYDRYQER 726
KGYVAPEWFRN+PITVKVD YS+GVLLLEIIC RR++D EIS ++AILTDWAYD Y E
Sbjct: 674 KGYVAPEWFRNVPITVKVDAYSFGVLLLEIICSRRSVDTEISG-ERAILTDWAYDCYMEG 732
Query: 727 TLEALVENDLEAMNNVTMLHRFVMVAFWCIQEDPSHRPTMRKVTQMLEGVVEVPI 781
++ LVEND EA++++ + RF+MVA WCIQEDP+ RPTM+ V MLEG+++V +
Sbjct: 733 RIDDLVENDEEALSDLKKVERFLMVAIWCIQEDPTLRPTMKTVILMLEGIIQVAV 787
|
Source: Ricinus communis Species: Ricinus communis Genus: Ricinus Family: Euphorbiaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224053032|ref|XP_002297673.1| predicted protein [Populus trichocarpa] gi|222844931|gb|EEE82478.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 894 bits (2309), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 449/780 (57%), Positives = 555/780 (71%), Gaps = 39/780 (5%)
Query: 23 NGTISIGQQLTAAESTEPWLSPSKDFALGFHQLDSKDLFLPAIWYYKIPSKTIVWYASAV 82
NG ++G LTA + WLSP++DFA GF QLD KDL+L AIWY KIP KTIVWYA+
Sbjct: 2 NGNATVGDSLTAGDEATLWLSPAEDFAFGFRQLDKKDLYLLAIWYNKIPDKTIVWYANGD 61
Query: 83 NPAPRGSKLRLTANRGLVLEDPEGREIWKSEISTGQAAFGVLYDTGNFLIVNTNSERLWQ 142
PAP+ S ++LTA G+VL +P+G EIWKS G+AA+G + DTGNFL+ N N E+LWQ
Sbjct: 62 RPAPKKSTVKLTAELGVVLNNPQGGEIWKSGPGNGEAAYGFMNDTGNFLVANANGEKLWQ 121
Query: 143 SFDHPTDTLLPTQTMERGGVVSSRRKDTYFSRGRFQFRLLEDGNAVLNTINLESGFAYDA 202
SF+ TDTLLPTQ ME+GG++SSR +T FS+GRFQFRL+ DGNAVLNTINL +GF Y+A
Sbjct: 122 SFELLTDTLLPTQIMEKGGILSSRLSETNFSQGRFQFRLIPDGNAVLNTINLPTGFPYEA 181
Query: 203 YFWSNTFDTNRSNAGYRVVFNESGQLYVLRENKQRASL-VPETVSAKENYLRATLNFDGV 261
YFWS T D+N SNAGY+VVFNESG LYVLR N R +L + V A ENY RATL+FDGV
Sbjct: 182 YFWSKTVDSNSSNAGYQVVFNESGYLYVLRANNTREALTLGRVVPATENYHRATLHFDGV 241
Query: 262 FIFYSHPKNNSTGDAIWSVSDVLPENICINNDIRKGL-GSGICGFNSICSISGAKRPICQ 320
F+ YSHPK NS G+ WSV +PENIC + +GL GSG CG+N +C+IS KR IC+
Sbjct: 242 FVLYSHPK-NSPGNENWSVVRTMPENICT---VVRGLKGSGPCGYNGVCTISTDKRAICR 297
Query: 321 CPKGFSLLDPDDAYGSCKPDFILG-CEEDGKKSGEDLYYIEELRNTDWPTSDYEQISPYG 379
CP+ FSLLDPDD YG CKPDF C E+ + ED Y + L N DWP SDYE +PY
Sbjct: 298 CPQRFSLLDPDDPYGGCKPDFPTQVCAEEVPNAPED-YELVPLTNIDWPESDYEMYTPYN 356
Query: 380 KDECVSSCLKDCQCSAAVLRDDTCWKKKLPLSYGKTDRDETGTTFIKIRK-------VPS 432
++C +CL+D C+ V + TCWKK+LPLS G+ G +F+K+RK P
Sbjct: 357 IEDCKKACLQDFFCNVIVFGEGTCWKKRLPLSNGRQGESVNGASFMKVRKGNYTLPGPPP 416
Query: 433 GGKKKVDVLIPVVSVLFGSSALINLLLVSACCLGFLVVNRKKFMRPHQEDQGVSYMNLRC 492
KK + VVSVL G S N +LV F + KF R Q ++ V NLRC
Sbjct: 417 IPKKN----LLVVSVLLGGSVFFNFVLVGVVSFAFFFIYHNKFTRTPQVERAVQ-SNLRC 471
Query: 493 FTYKELVEVTRGFKEELGRGAFGTVYKGFVNMGSSNHVAVKKLNSVFQDSEKEFKAEVNG 552
F+YKEL+E T GFKEELGRGAFG VYKG +GS VA+KK++ ++S+KEFK EV+
Sbjct: 472 FSYKELMEATNGFKEELGRGAFGIVYKGLTQIGSGVPVAIKKVDRFVKESDKEFKTEVD- 530
Query: 553 IGQTHHKNLVRLLGYCDEGQNRLLVYEFMSNGTVASFLFGDSKPNWKLRTEIAMGIAGGL 612
++G+CDEGQ+R+LVYEF+SNG +ASFLFGD K +W RT+IA GIA GL
Sbjct: 531 -----------VIGFCDEGQHRMLVYEFLSNGALASFLFGDVKLSWNQRTQIAFGIARGL 579
Query: 613 FYLHEECCTQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLDQSHTNTAIRGTKGYVAP 672
YLH+EC TQIIHCDIKPQNILLD+HY+ARI+DFGLAKL N +GTKGYVAP
Sbjct: 580 LYLHDECSTQIIHCDIKPQNILLDEHYDARIADFGLAKLF------RNPQHKGTKGYVAP 633
Query: 673 EWFRNMPITVKVDVYSYGVLLLEIICLRRNIDNEISKVDKAILTDWAYDRYQERTLEALV 732
EWFRNM ITVKVDVY++GVLLLEIIC RR++D E+ + ++AILTDWAYD YQE + ALV
Sbjct: 634 EWFRNMLITVKVDVYNFGVLLLEIICCRRSVDTEVGE-ERAILTDWAYDCYQEGMMHALV 692
Query: 733 ENDLEAMNNVTMLHRFVMVAFWCIQEDPSHRPTMRKVTQMLEGVVEVPIPPCPWTLNITS 792
E+D EA+N++ L RFVMVA WCIQEDP+ RPTM+ V MLEG+++VP+PPCP +I S
Sbjct: 693 ESDEEALNDMKKLERFVMVAIWCIQEDPNLRPTMKMVMLMLEGIIQVPVPPCPSPFSIAS 752
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|356575025|ref|XP_003555643.1| PREDICTED: G-type lectin S-receptor-like serine/threonine-protein kinase RLK1-like [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 875 bits (2260), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 437/793 (55%), Positives = 562/793 (70%), Gaps = 32/793 (4%)
Query: 8 LLFLLLLPCLTAAQSNGTISIGQQLTAAESTEPWLSPSKDFALGFHQLDSKDLFLPAIWY 67
LL LL LP ++A +SIG+ L A + WLSPS+DFA GFHQLD+ DL+L AI Y
Sbjct: 14 LLPLLQLPYVSATN----VSIGETLVAGNGGKRWLSPSEDFAFGFHQLDN-DLYLLAISY 68
Query: 68 YKIPSKTIVWYASAVNPAPRGSKLRLTANRGLVLEDPEGREIWKSEISTGQAAFGVLYDT 127
IP + +WYA+ NPAP+GSKL L GLVL+ P+G E+W S++ +G ++G++ DT
Sbjct: 69 QNIPRDSFIWYANGDNPAPKGSKLELNQYTGLVLKSPQGVELWTSQLISGTISYGLMNDT 128
Query: 128 GNFLIVNTNSERLWQSFDHPTDTLLPTQTMERGGVVSSRRKDTYFSRGRFQFRLLEDGNA 187
GNF +++ NS+ LW SF +PTDTL+PTQ ME G +SSR+K+ FSRGRFQFRLL DGNA
Sbjct: 129 GNFQLLDENSQVLWDSFSNPTDTLVPTQIMEVKGTLSSRQKEANFSRGRFQFRLLPDGNA 188
Query: 188 VLNTINLESGFAYDAYFWSNTFD-TNRSNAGYRVVFNESGQLYVLRENKQRASLV--PET 244
VLN INL + + YDA++ S T+D TN +N+G++V+F+ SG LY+L+ + ++ + +
Sbjct: 189 VLNPINLPTNYTYDAHYISATYDSTNTTNSGFQVIFDNSG-LYILKRSGEKVYITNPKDA 247
Query: 245 VSAKENYLRATLNFDGVFIFYSHPKNNSTGDAIWSVSDVLPENICINNDIRKGLGSGICG 304
+S Y RAT+NFDG F ++PKN ++ + W+V LP+NIC+N G GSG+CG
Sbjct: 248 LSTDSYYYRATINFDGTFTISNYPKNPASNPS-WTVMKTLPDNICMNLLGNTG-GSGVCG 305
Query: 305 FNSICSISGAKRPICQCPKGFSLLDPDDAYGSCKPDFILGCEEDGKKSGEDLYYIEELRN 364
FNSIC++ +RP C CP+G+S LD D YGSCKP+ LGC G+ DLY+++E+ N
Sbjct: 306 FNSICTLKADQRPKCSCPEGYSPLDSRDEYGSCKPNLELGCGSSGQSLQGDLYFMKEMAN 365
Query: 365 TDWPTSDYEQISPYGKDECVSSCLKDCQCSAAVLRDDTCWKKKLPLSYGKTDRDETGTTF 424
TDWP SDYE PY ++C +SCL+DC C+ ++ RDD+C+KKKLPLS G+ DR + F
Sbjct: 366 TDWPVSDYELYKPYNSEDCKTSCLQDCLCAVSIFRDDSCYKKKLPLSNGRRDRAVGASAF 425
Query: 425 IKIRK-----VPSGG-------KKKVDVLIPVVSVLFGSSALINLLLVSACCLGFLVVNR 472
IK+ K P KK D LI V+SVL G S NL VSA +GF
Sbjct: 426 IKLMKNGVSLSPPNPFIEEKKYKKDQDTLITVISVLLGGSVFFNL--VSAVWVGFYFYYN 483
Query: 473 KKFMRPHQEDQGVSYMNLRCFTYKELVEVTRGFKEELGRGAFGTVYKGFVNMGSSNHVAV 532
KK ++ + NL FT+ ELV+ T FKEELGRG+ G VYKG N+ + +AV
Sbjct: 484 KK----SSTNKTATESNLCSFTFAELVQATDNFKEELGRGSCGIVYKGTTNLAT---IAV 536
Query: 533 KKLNSVFQDSEKEFKAEVNGIGQTHHKNLVRLLGYCDEGQNRLLVYEFMSNGTVASFLFG 592
KKL+ V +D +KEFK EVN IGQTHHK+LVRLLGYCDE Q+R+LVYEF+SNGT+A+FLFG
Sbjct: 537 KKLDKVLKDCDKEFKTEVNVIGQTHHKSLVRLLGYCDEEQHRILVYEFLSNGTLANFLFG 596
Query: 593 DSKPNWKLRTEIAMGIAGGLFYLHEECCTQIIHCDIKPQNILLDDHYNARISDFGLAKLL 652
D KPNW R +IA GIA GL YLHEECCTQIIHCDIKPQNILLD+ YNARISDFGL+KLL
Sbjct: 597 DFKPNWNQRVQIAFGIARGLVYLHEECCTQIIHCDIKPQNILLDEQYNARISDFGLSKLL 656
Query: 653 TLDQSHTNTAIRGTKGYVAPEWFRNMPITVKVDVYSYGVLLLEIICLRRNIDNEISKVDK 712
+++SHT T IRGTKGYVAP+WFR+ PIT KVDVYS+GVLLLEIIC RRN+D E+ +K
Sbjct: 657 KINESHTETGIRGTKGYVAPDWFRSAPITTKVDVYSFGVLLLEIICCRRNVDGEVGNEEK 716
Query: 713 AILTDWAYDRYQERTLEALVENDLEAMNNVTMLHRFVMVAFWCIQEDPSHRPTMRKVTQM 772
AILTDWAYD Y+ ++ L+END EA+++ L RFVMVA WC+QEDPS RP M+KV M
Sbjct: 717 AILTDWAYDCYRAGRIDILLENDDEAIDDTNRLERFVMVAIWCLQEDPSLRPPMKKVMLM 776
Query: 773 LEGVVEVPIPPCP 785
LEG+ V IPP P
Sbjct: 777 LEGIAPVTIPPSP 789
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224103119|ref|XP_002334088.1| predicted protein [Populus trichocarpa] gi|222839594|gb|EEE77931.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 870 bits (2249), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 446/799 (55%), Positives = 560/799 (70%), Gaps = 21/799 (2%)
Query: 1 MAFHLLSLLF--LLLLPCLTAAQSNGTISIGQQLTAAESTEPWLSPSKDFALGFHQL-DS 57
MAF +L L F L++LP +Q+ G I++G L+ +++T WLSPS DFA GF+QL +
Sbjct: 1 MAFPILHLSFSLLIMLPPFAVSQTGGNITVGASLSTSDNTS-WLSPSGDFAFGFYQLYGN 59
Query: 58 KDLFLPAIWYYKIPSKTIVWYASAVNPAPRGSKLRLTANRGLVLEDPEGREIWKSEISTG 117
KDLFL AIWY KIP KTIVWYA+ PAP GSK LTANRG+ L DP+GRE+W+SE G
Sbjct: 60 KDLFLLAIWYDKIPDKTIVWYANGDKPAPTGSKAVLTANRGISLTDPQGRELWRSETIIG 119
Query: 118 QAAFGVLYDTGNFLIVNTNSERLWQSFDHPTDTLLPTQTMERGGVVSSRRKDTYFSRGRF 177
A+G + DTGNF++ + S++LW+SF +P DTLLP+Q ++RG +SSR+ +T FS GRF
Sbjct: 120 DVAYGAMTDTGNFVLRDRVSDKLWESFKNPADTLLPSQVLDRGMTLSSRQSETNFSMGRF 179
Query: 178 QFRLLEDGNAVLNTINLESGFAYDAYFWSNT-FDTNRSNAGYRVVFNESGQLYVLRENKQ 236
Q +L +DGN VL TINL S + + Y+ S T + S+ GY+VVFNESG LY+LR+N Q
Sbjct: 180 QLKLRDDGNLVLATINLPSDYTNEPYYKSGTDGGLDSSSPGYQVVFNESGYLYILRKNDQ 239
Query: 237 RASLVPE-TVSAKENYLRATLNFDGVFIFYSHPKNNSTGDAIWSVSDVLPENICINNDIR 295
SL T S + Y RATLNFDGVF Y HPK STG+ W+ P+NIC + +
Sbjct: 240 IFSLTQRVTASTGDFYHRATLNFDGVFTQYYHPKA-STGNERWTPIWSQPDNICQASSVS 298
Query: 296 KGLGSGICGFNSICSISGAKRPICQCPKGFSLLDPDDAYGSCKPDFILGCEEDGKKSGED 355
G SG CGFNS+C ++ RPIC+CP G+SLLDP D YGSC+P++ CEED ED
Sbjct: 299 AG--SGTCGFNSVCRLNSDGRPICECPGGYSLLDPSDQYGSCRPNYTQSCEEDEVAPVED 356
Query: 356 LYYIEELRNTDWPTSDYEQISPYGKDECVSSCLKDCQCSAAVLRD-DTCWKKKLPLSYGK 414
LY EEL NTDWPTSDY + P+ +++C SCL DC C+ A+ R D CWKKKLPLS G+
Sbjct: 357 LYDFEELTNTDWPTSDYALLQPFTEEKCRQSCLNDCMCAVAIFRSGDMCWKKKLPLSNGR 416
Query: 415 TDRDETGTTFIKIRKVP--------SGGKKKVDVLIPVVSVLFGSSALINLLLVSACCLG 466
+K+R+ KK D LI V SV G S +N LLV A C+G
Sbjct: 417 VQTIVDAKALLKVRRSNVNPRSPYFPNNKKDRDGLILVGSVFLGCSVFVNFLLVCAICMG 476
Query: 467 FLVVNRKKFMRPHQEDQGVSYMNLRCFTYKELVEVTRGFKEELGRGAFGTVYKGFVNMGS 526
F + R++ R Q+D V NLRCFTY+EL E T GFKEELGRGAFG VY+G V++GS
Sbjct: 477 FFFIYRRRTKRIPQKDGAVE-TNLRCFTYQELAEATEGFKEELGRGAFGVVYRGVVHIGS 535
Query: 527 SNHVAVKKLNSVFQDSEKEFKAEVNGIGQTHHKNLVRLLGYCDEGQNRLLVYEFMSNGTV 586
S VAVKKLN+V +D +EFK EVN IGQTHHKNLVRLLG+C+EG RLLVYEFMSNG++
Sbjct: 536 SIVVAVKKLNNVAEDRVREFKTEVNVIGQTHHKNLVRLLGFCEEGDQRLLVYEFMSNGSL 595
Query: 587 ASFLFGDSKPNWKLRTEIAMGIAGGLFYLHEECCTQIIHCDIKPQNILLDDHYNARISDF 646
+SF+F D+KP WK+R +IA G+A GL YLHE+ +QIIHCDIKPQNILLD+ NARISDF
Sbjct: 596 SSFIFQDAKPGWKIRIQIAFGVARGLLYLHED--SQIIHCDIKPQNILLDESLNARISDF 653
Query: 647 GLAKLLTLDQSHTNTAIRGTKGYVAPEWFRNMPITVKVDVYSYGVLLLEIICLRRNIDNE 706
GLAKLL DQ+ T TAIRGTKGYVAPEWF+N+P+T KVD YS+G+LLLE++C R+N +
Sbjct: 654 GLAKLLKTDQTKTTTAIRGTKGYVAPEWFKNLPVTTKVDTYSFGILLLELVCCRKNFEIN 713
Query: 707 ISKVDKAILTDWAYDRYQERTLEALVENDLEAMNNVTMLHRFVMVAFWCIQEDPSHRPTM 766
+ + +L DWA D +E L LVE D EAM ++ + RFVMVA WCIQEDPS RP M
Sbjct: 714 AMQEHQIVLADWACDCLKEGKLNLLVEEDEEAMEDMKRVERFVMVAIWCIQEDPSLRPGM 773
Query: 767 RKVTQMLEGVVEVPIPPCP 785
+KV QMLEG V+V +PP P
Sbjct: 774 KKVVQMLEGGVQVSVPPDP 792
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|109676362|gb|ABG37663.1| CCHC-type integrase [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 870 bits (2248), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 443/761 (58%), Positives = 538/761 (70%), Gaps = 22/761 (2%)
Query: 9 LFLLLLPCLTAAQSNGTISIGQQLTAAESTEPWLSPSKDFALGFHQLDSKDLFLPAIWYY 68
L ++LL + AQ+NG + G +TA + + W S S +FA GF QL++KD FL +IWY
Sbjct: 43 LTMVLLQLMAVAQTNGRVPTGASITATDDSPSWPSASGEFAFGFRQLENKDYFLLSIWYE 102
Query: 69 KIPSKTIVWYASAVNP-----APRGSKLRLTANRGLVLEDPEGREIWKSEISTGQA-AFG 122
KIP KT+VWYA +P PRGSKL LT +RGL+L DP+G +IW S I G A + G
Sbjct: 103 KIPEKTVVWYAIGEDPTDDPAVPRGSKLELTDDRGLLLADPQGNQIWSSGIPPGAAVSSG 162
Query: 123 VLYDTGNFLIVNTNSERLWQSFDHPTDTLLPTQTMERGGVVSSRRKDTYFSRGRFQFRLL 182
V+ DTGNF++ N NS RLW+SF++PTDTLLPTQ ME GGVVSSRR +T FS GRFQ RLL
Sbjct: 163 VMNDTGNFVLQNRNSFRLWESFNNPTDTLLPTQIMEVGGVVSSRRTETNFSLGRFQLRLL 222
Query: 183 EDGNAVLNTINLESGFAYDAYFWSNTFD-TNRSNAGYRVVFNESGQLYVLRENKQRASLV 241
++GN VLN +NL + F YD Y+ S T D +N SN+GYR++FNESG +Y+LR N L
Sbjct: 223 DNGNLVLNYMNLPTKFVYDDYYSSETSDASNSSNSGYRLIFNESGYMYILRRNGLIEDLT 282
Query: 242 PETVSAKENYLRATLNFDGVFIFYSHPKNNSTGDAIWSVSDVLPENICINNDIRKGLGSG 301
+ + Y RATLNFDGVF Y +PK S+G+ WS P++IC+N + LGSG
Sbjct: 283 KTALPTIDFYHRATLNFDGVFTQYFYPKA-SSGNRSWSSVWSKPDDICVN--MGADLGSG 339
Query: 302 ICGFNSICSISGAKRPICQCPKGFSLLDPDDAYGSCKPDFILGCEEDGKKSGEDLYYIEE 361
CG+NSIC++ KRP C+CP+GFSLLD +D YGSC PDF L C +DG S ED Y E
Sbjct: 340 ACGYNSICNLKADKRPECKCPQGFSLLDQNDKYGSCIPDFELSCRDDGLNSTEDQYDFVE 399
Query: 362 LRNTDWPTSDYEQISPYGKDECVSSCLKDCQCSAAVLRDDTCWKKKLPLSYGKTDRDETG 421
L N DWPTSDYE+ P +DEC SCL DC CS A+ RD CWKKKLPLS G+ D G
Sbjct: 400 LINVDWPTSDYERYKPINEDECRKSCLNDCLCSVAIFRDG-CWKKKLPLSNGRFDIGMNG 458
Query: 422 TTFIKIRK--VP--------SGGKKKVDVLIPVVSVLFGSSALINLLLVSACCLGFLVVN 471
F+K K VP G KKK D+ SV+ G+S +N +LV A CL +
Sbjct: 459 KAFLKFPKGYVPLDRPPPQLPGEKKKPDIKFITGSVVLGTSVFVNFVLVGAFCLTSSFIY 518
Query: 472 RKKFMRPHQEDQGVSYMNLRCFTYKELVEVTRGFKEELGRGAFGTVYKGFVNMGSSNHVA 531
RKK + + G+ NLR FTYKEL E T FK+E+GRG FG VYKG + GS+ VA
Sbjct: 519 RKKTEKVKEGGSGLE-TNLRYFTYKELAEATNDFKDEVGRGGFGVVYKGTIQAGSTRVVA 577
Query: 532 VKKLNSVFQDSEKEFKAEVNGIGQTHHKNLVRLLGYCDEGQNRLLVYEFMSNGTVASFLF 591
VKKL+ V QD EKEFK EV IGQTHHKNLVRLLG+CDEGQNRLLVYEF+SNGT+A+FLF
Sbjct: 578 VKKLDKVVQDGEKEFKTEVQVIGQTHHKNLVRLLGFCDEGQNRLLVYEFLSNGTLANFLF 637
Query: 592 GDSKPNWKLRTEIAMGIAGGLFYLHEECCTQIIHCDIKPQNILLDDHYNARISDFGLAKL 651
G SKPNWK RT+IA GIA GL YLHEEC TQIIHCDIKPQNILLD++YNARISDFGLAKL
Sbjct: 638 GCSKPNWKQRTQIAFGIARGLLYLHEECGTQIIHCDIKPQNILLDNYYNARISDFGLAKL 697
Query: 652 LTLDQSHTNTAIRGTKGYVAPEWFRNMPITVKVDVYSYGVLLLEIICLRRNIDNEISKVD 711
L +DQS T TAIRGTKGYVAPEWFRN PITVKVDVYS+GV+LLEIIC RRN+D EI +V+
Sbjct: 698 LVMDQSKTQTAIRGTKGYVAPEWFRNRPITVKVDVYSFGVMLLEIICCRRNVDLEIGEVE 757
Query: 712 KAILTDWAYDRYQERTLEALVENDLEAMNNVTMLHRFVMVA 752
+LTDWAYD Y + +L+ L+ +D EA N+++ L R + A
Sbjct: 758 NPVLTDWAYDCYMDGSLDVLIGDDTEAKNDISTLERLLKPA 798
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224073224|ref|XP_002304031.1| predicted protein [Populus trichocarpa] gi|222841463|gb|EEE79010.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 842 bits (2176), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 435/776 (56%), Positives = 521/776 (67%), Gaps = 93/776 (11%)
Query: 17 LTAAQSNGTISIGQQLTAAESTEPWLSPSKDFALGFHQLDSKDLFLPAIWYYKIPSKTIV 76
+ AQ+NG + +G +TA + + WLS S +FA GF QL++KD FL +IWY KIP KT+V
Sbjct: 1 MAVAQTNGRVPVGASITATDDSPSWLSASGEFAFGFRQLENKDYFLLSIWYEKIPEKTVV 60
Query: 77 WYASAVNP-----APRGSKLRLTANRGLVLEDPEGREIWKSEISTGQAAFGVLYDTGNFL 131
WYA +P PRGSK+ LT +RGL+L DP+G IW S I G + GV+ DTGNF+
Sbjct: 61 WYAIGEDPTDDPAVPRGSKVELTDDRGLLLADPQGNLIWTSRILLGAVSSGVMNDTGNFV 120
Query: 132 IVNTNSERLWQSFDHPTDTLLPTQTMERGGVVSSRRKDTYFSRGRFQFRLLEDGNAVLNT 191
+ N NSERLW+SF++PTDTLLPTQ ME GGVVSSRR +T FS GRFQ RLL++GN VLN+
Sbjct: 121 LQNRNSERLWESFNNPTDTLLPTQIMEAGGVVSSRRTETNFSLGRFQLRLLDNGNLVLNS 180
Query: 192 INLESGFAYDAYFWSNTFD-TNRSNAGYRVVFNESGQLYVLRENKQRASLVPETVSAKEN 250
+NL + FAYD Y+ S T D +N SN GYR++FNESG Y+L S + +SA +
Sbjct: 181 MNLSTKFAYDDYYRSGTSDASNSSNTGYRLLFNESG--YILWRPPPSPSSL---ISADIH 235
Query: 251 YLRATLNFDGVFIFYSHPKNNSTGDAIWSVSDVLPENICINNDIRKGLGSGICGFNSICS 310
Y+++ WS P++IC+N + LGSG CG+NSIC+
Sbjct: 236 YIQS-----------------------WSSVWSKPDDICVN--MGADLGSGACGYNSICN 270
Query: 311 ISGAKRPICQCPKGFSLLDPDDAYGSCKPDFILGCEEDGKKSGEDLYYIEELRNTDWPTS 370
+ KRP C+CP+GFSLLD +D YGSC PDF L C +DG S ED Y EL N DWPTS
Sbjct: 271 LKADKRPECKCPQGFSLLDQNDKYGSCIPDFELSCRDDGLNSTEDQYDFVELINVDWPTS 330
Query: 371 DYEQISPYGKDECVSSCLKDCQCSAAVLRDDTCWKKKLPLSYGKTDRDETGTTFIKIRKV 430
DYE+ P +DEC SCL DC CS A+ RD CWKKKLPLS G+ D G F+K
Sbjct: 331 DYERYKPINEDECRKSCLNDCLCSVAIFRD-GCWKKKLPLSNGRFDIGMNGKAFLKF--- 386
Query: 431 PSGGKKKVDVLIPVVSVLFGSSALINLLLVSACCLGFLVVNRKKFMRPHQEDQGVSYMNL 490
P G Y NL
Sbjct: 387 PKG-----------------------------------------------------YTNL 393
Query: 491 RCFTYKELVEVTRGFKEELGRGAFGTVYKGFVNMGSSNHVAVKKLNSVFQDSEKEFKAEV 550
R FTYKEL E T FK+E+GRG FG VYKG + GS+ VAVKKL+ V QD EKEFK EV
Sbjct: 394 RYFTYKELAEATNDFKDEVGRGGFGVVYKGTIQAGSTRVVAVKKLDKVVQDGEKEFKTEV 453
Query: 551 NGIGQTHHKNLVRLLGYCDEGQNRLLVYEFMSNGTVASFLFGDSKPNWKLRTEIAMGIAG 610
IGQTHHKNLVRLLG+CDEGQNRLLVYEF+SNGT+A+FLFG SKPNWK RT+IA GIA
Sbjct: 454 QVIGQTHHKNLVRLLGFCDEGQNRLLVYEFLSNGTLANFLFGCSKPNWKQRTQIAFGIAR 513
Query: 611 GLFYLHEECCTQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLDQSHTNTAIRGTKGYV 670
GL YLHEEC TQIIHCDIKPQNILLD++YNARISDFGLAKLL +DQS T TAIRGTKGYV
Sbjct: 514 GLLYLHEECGTQIIHCDIKPQNILLDNYYNARISDFGLAKLLVMDQSKTQTAIRGTKGYV 573
Query: 671 APEWFRNMPITVKVDVYSYGVLLLEIICLRRNIDNEISKVDKAILTDWAYDRYQERTLEA 730
APEWFRN PITVKVDVYS+GV+LLEIIC RRN+D EI +V+ +LTDWAYD Y + +L+
Sbjct: 574 APEWFRNRPITVKVDVYSFGVMLLEIICCRRNVDLEIGEVENPVLTDWAYDCYMDGSLDV 633
Query: 731 LVENDLEAMNNVTMLHRFVMVAFWCIQEDPSHRPTMRKVTQMLEGVVEVPIPPCPW 786
L+ +D EA N+++ L R + V WCIQEDPS RPTMRKVTQMLEGVVEVP P P+
Sbjct: 634 LIGDDTEAKNDISTLERLLKVGIWCIQEDPSLRPTMRKVTQMLEGVVEVPAAPNPF 689
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224143661|ref|XP_002336066.1| predicted protein [Populus trichocarpa] gi|222869874|gb|EEF07005.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 842 bits (2175), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 435/765 (56%), Positives = 510/765 (66%), Gaps = 81/765 (10%)
Query: 23 NGTISIGQQLTAAESTEPWLSPSKDFALGFHQLDSKDLFLPAIWYYKIPSKTIVWYASAV 82
NG++ +G +TA + WLS S +FA GF L+ KD FL +IWY KIP KTIVWYA+
Sbjct: 1 NGSMPVGAFITATDDAPSWLSSSGEFAFGFQPLEYKDHFLLSIWYAKIPEKTIVWYANGD 60
Query: 83 NPAPRGSKLRLTANRGLVLEDPEGREIWKSEISTGQAAFGVLYDTGNFLIVNTNSERLWQ 142
NPAPR SK+ L + GLVL DP+G IW S G + GV+ DTGNF++ N+NS RLW+
Sbjct: 61 NPAPRESKVELRGDSGLVLTDPQGNLIWSSGSLLGTVSSGVMNDTGNFVLQNSNSFRLWE 120
Query: 143 SFDHPTDTLLPTQTMERGGVVSSRRKDTYFSRGRFQFRLLEDGNAVLNTINLESGFAYDA 202
SF +PTDTLLPTQ ME GGVVSSRR +T FS GRFQ RLL++GN VLN +NL + F YD
Sbjct: 121 SFSNPTDTLLPTQIMEVGGVVSSRRTETNFSLGRFQLRLLDNGNLVLNYMNLPTKFVYDD 180
Query: 203 YFWSNTFD-TNRSNAGYRVVFNESGQLYVLRENKQRASLVPETVSAKENYLRATLNFDGV 261
Y+ S T D +N SN+GYR++FNESG +Y+LR N L + + Y RATLNFD
Sbjct: 181 YYSSETSDASNSSNSGYRLIFNESGYMYILRRNGLIEDLTKTALPTIDFYHRATLNFDA- 239
Query: 262 FIFYSHPKNNSTGDAIWSVSDVLPENICINNDIRKGLGSGICGFNSICSISGAKRPICQC 321
LGSG CG+NSIC++ KRP C+C
Sbjct: 240 -----------------------------------DLGSGACGYNSICNLKADKRPECKC 264
Query: 322 PKGFSLLDPDDAYGSCKPDFILGCEEDGKKSGEDLYYIEELRNTDWPTSDYEQISPYGKD 381
P+GFSLLD +D YGSC PDF L C +DG S ED Y EL N DWPTSDYE+ P +D
Sbjct: 265 PQGFSLLDQNDKYGSCIPDFELSCRDDGLNSTEDQYDFVELINVDWPTSDYERYKPINED 324
Query: 382 ECVSSCLKDCQCSAAVLRDDTCWKKKLPLSYGKTDRDETGTTFIKIRKVPSGGKKKVDVL 441
EC SCL DC CS A+ RD CWKKKLPLS G+ D G F+K P G K +
Sbjct: 325 ECRKSCLNDCLCSVAIFRD-GCWKKKLPLSNGRFDIGMNGKAFLKF---PKGYKTE---- 376
Query: 442 IPVVSVLFGSSALINLLLVSACCLGFLVVNRKKFMRPHQEDQGVSYMNLRCFTYKELVEV 501
V G S L NLR FTYKEL E
Sbjct: 377 ----KVKEGGSGL--------------------------------ETNLRYFTYKELAEA 400
Query: 502 TRGFKEELGRGAFGTVYKGFVNMGSSNHVAVKKLNSVFQDSEKEFKAEVNGIGQTHHKNL 561
T FK+E+GRG FG VYKG + GS+ VAVKKL+ V QD EKEFK EV IGQTHHKNL
Sbjct: 401 TNDFKDEVGRGGFGVVYKGTIQAGSTRVVAVKKLDKVVQDGEKEFKTEVQVIGQTHHKNL 460
Query: 562 VRLLGYCDEGQNRLLVYEFMSNGTVASFLFGDSKPNWKLRTEIAMGIAGGLFYLHEECCT 621
VRLLG+CDEGQNRLLVYEF+SNGT+A+FLFG SKPNWK RT+IA GIA GL YLHEEC T
Sbjct: 461 VRLLGFCDEGQNRLLVYEFLSNGTLANFLFGCSKPNWKQRTQIAFGIARGLLYLHEECGT 520
Query: 622 QIIHCDIKPQNILLDDHYNARISDFGLAKLLTLDQSHTNTAIRGTKGYVAPEWFRNMPIT 681
QIIHCDIKPQNILLD++YNARISDFGLAKLL +DQS T TAIRGTKGYVAPEWFRN PIT
Sbjct: 521 QIIHCDIKPQNILLDNYYNARISDFGLAKLLVMDQSKTQTAIRGTKGYVAPEWFRNRPIT 580
Query: 682 VKVDVYSYGVLLLEIICLRRNIDNEISKVDKAILTDWAYDRYQERTLEALVENDLEAMNN 741
VKVDVYS+GV+LLEIIC RRN+D EI +V+ +LTDWAYD Y + +L+ L+ +D EA N+
Sbjct: 581 VKVDVYSFGVMLLEIICCRRNVDLEIGEVENPVLTDWAYDCYMDGSLDVLIGDDTEAKND 640
Query: 742 VTMLHRFVMVAFWCIQEDPSHRPTMRKVTQMLEGVVEVPIPPCPW 786
++ L R + V WCIQEDPS RPTMRKVTQMLEGVVEVP P P+
Sbjct: 641 ISTLERLLKVGIWCIQEDPSLRPTMRKVTQMLEGVVEVPAAPNPF 685
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|356555135|ref|XP_003545892.1| PREDICTED: G-type lectin S-receptor-like serine/threonine-protein kinase RLK1-like [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 834 bits (2154), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 441/810 (54%), Positives = 557/810 (68%), Gaps = 28/810 (3%)
Query: 1 MAFHLLSLLFL--LLLPCL---TAAQSNGTISIGQQLTAAESTEPWL--SPSKDFALGFH 53
MA LL LFL +LLP AQ+ I+IG TA ST PWL SPS DFA GF
Sbjct: 1 MASPLLPFLFLSMVLLPFQHINVMAQTKSNIAIGDSHTAGASTSPWLVSSPSGDFAFGFL 60
Query: 54 QL-DSKDLFLPAIWYYKIPSKTIVWYASAVNPAPRGSKLRLTANRGLVL-EDPEGREIWK 111
L D+ D F+ IWY KI KTIVW+A+ PAP+GSK+ LTA+ GLVL P G ++WK
Sbjct: 61 PLEDTPDHFMLCIWYAKIQDKTIVWFANRDKPAPKGSKVVLTADDGLVLITAPNGNQLWK 120
Query: 112 SEISTGQAAFGVLYDTGNFLIVNTNSERLWQSFDHPTDTLLPTQTMERGGVVSSRRKDTY 171
+ T + + GVL +TGNF++ + +S +W+SF DTLLP QTMERG +SS+ + Y
Sbjct: 121 TGGLTVRVSSGVLNNTGNFVLQDGDSNTVWESFKDYRDTLLPYQTMERGQKLSSKLRRNY 180
Query: 172 FSRGRFQFRLLEDGNAVLNTINLESGFAYDAYFWSNTFDTNRSNAGYRVVFNESGQLYVL 231
F++GRF DGN V+++INL SG+A + Y+ S T ++N S+AG ++VF+ SG +YVL
Sbjct: 181 FNKGRFVLFFQNDGNLVMHSINLPSGYANEHYYESGTVESNISSAGTQLVFDGSGDMYVL 240
Query: 232 RENKQRASLVPETVSAKEN----YLRATLNFDGVFIFYSHPKNNSTGDAIWSVSDVLPEN 287
REN ++ +L A YLRATL+FDGVF Y HPK S+G W+ P+N
Sbjct: 241 RENNEKYNLSRGGSGASSTTQFFYLRATLDFDGVFTLYQHPKG-SSGTGGWTPVWSHPDN 299
Query: 288 ICINNDIRKGLGSGICGFNSICSISGAKRPICQCPKGFSLLDPDDAYGSCKPDFILGCEE 347
IC D GSG+CG+NSICS+ KRP C+CPK +SL+DP+D GSCKPDF+ C
Sbjct: 300 IC--KDYVASAGSGVCGYNSICSLRDDKRPNCKCPKWYSLVDPNDPNGSCKPDFVQACAV 357
Query: 348 DGKKSGEDLYYIEELRNTDWPTSDYEQISPYGKDECVSSCLKDCQCSAAVLR-DDTCWKK 406
D + +DLY E L +TDWP SDY P+ +++C SC++DC CS A+ R D+CWKK
Sbjct: 358 DELSNRKDLYDFEVLIDTDWPQSDYVLQRPFNEEQCRQSCMEDCMCSVAIFRLGDSCWKK 417
Query: 407 KLPLSYGKTDRDETGT-TFIKIRK------VPSG-GKKKVDVLIPVVSVLFGSSALINLL 458
KLPLS G+ D G F+K+RK VP+ K + I V SVL GSSA +NL+
Sbjct: 418 KLPLSNGRVDATLNGAKAFMKVRKDNSSLIVPTIIVNKNRNTSILVGSVLLGSSAFLNLI 477
Query: 459 LVSACCLGFLVVNR-KKFMRPHQEDQGVSYMNLRCFTYKELVEVTRGFKEELGRGAFGTV 517
L+ A CL V R KK +R + NLRCFTYKEL + T GF + LG+GAFG V
Sbjct: 478 LLGAICLSTSYVFRYKKKLRSIGRSDTIVETNLRCFTYKELEKATDGFDKVLGKGAFGIV 537
Query: 518 YKGFVNMGSSNHVAVKKLNS-VFQDSEKEFKAEVNGIGQTHHKNLVRLLGYCDEGQNRLL 576
Y+G +NMGS VAVK+LN+ + +D KEFK E+N IG THHKNLVR+LG+C+ + RLL
Sbjct: 538 YEGVINMGSDTRVAVKRLNTFLLEDVHKEFKNELNAIGLTHHKNLVRILGFCETEEKRLL 597
Query: 577 VYEFMSNGTVASFLFGD-SKPNWKLRTEIAMGIAGGLFYLHEECCTQIIHCDIKPQNILL 635
VYE+MSNGT+AS LF KP+W+LR +IA+G+A GL YLHEEC TQIIHCDIKPQNILL
Sbjct: 598 VYEYMSNGTLASLLFNILEKPSWELRLQIAIGVARGLLYLHEECSTQIIHCDIKPQNILL 657
Query: 636 DDHYNARISDFGLAKLLTLDQSHTNTAIRGTKGYVAPEWFRNMPITVKVDVYSYGVLLLE 695
DD+YNARISDFGLAKLL ++QS TNTAIRGTKGYVA EWF+NMPIT KVDVYSYGVLLLE
Sbjct: 658 DDYYNARISDFGLAKLLNMNQSRTNTAIRGTKGYVALEWFKNMPITAKVDVYSYGVLLLE 717
Query: 696 IICLRRNIDNEISKVDKAILTDWAYDRYQERTLEALVENDLEAMNNVTMLHRFVMVAFWC 755
I+ R++++ E +KAIL +WAYD Y ERTL ALVE D EA++++ L + VM+A WC
Sbjct: 718 IVSCRKSVEFETEDKEKAILAEWAYDCYTERTLHALVEGDKEALDDMKNLEKLVMIALWC 777
Query: 756 IQEDPSHRPTMRKVTQMLEGVVEVPIPPCP 785
+QEDP RPTMR VTQMLEGVVEV +PPCP
Sbjct: 778 VQEDPDLRPTMRNVTQMLEGVVEVKVPPCP 807
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
Prediction of Gene Ontology (GO) Terms
Close Homologs with Gene Ontology terms Detected by BLAST 
Original result of BLAST against Gene Ontology (AMIGO)
ID ![]() |
Alignment graph ![]() |
Length ![]() |
Definition ![]() |
Q cover ![]() |
H cover ![]() |
Identity ![]() |
E-value ![]() |
| Query | 792 | ||||||
| TAIR|locus:2026155 | 829 | AT1G34300 [Arabidopsis thalian | 0.835 | 0.798 | 0.359 | 5e-99 | |
| TAIR|locus:2116525 | 821 | SD2-5 "S-domain-2 5" [Arabidop | 0.897 | 0.866 | 0.335 | 2.5e-90 | |
| TAIR|locus:2059103 | 828 | AT2G19130 [Arabidopsis thalian | 0.887 | 0.849 | 0.331 | 3.3e-86 | |
| TAIR|locus:2141176 | 849 | B120 [Arabidopsis thaliana (ta | 0.366 | 0.341 | 0.403 | 9.2e-73 | |
| TAIR|locus:2197649 | 821 | AT1G61360 [Arabidopsis thalian | 0.604 | 0.583 | 0.315 | 3.7e-72 | |
| TAIR|locus:2197734 | 814 | AT1G61370 [Arabidopsis thalian | 0.590 | 0.574 | 0.309 | 2.3e-70 | |
| TAIR|locus:2197714 | 792 | AT1G61440 [Arabidopsis thalian | 0.609 | 0.609 | 0.319 | 8.6e-67 | |
| TAIR|locus:2200908 | 842 | AT1G61610 [Arabidopsis thalian | 0.377 | 0.355 | 0.389 | 4.7e-66 | |
| TAIR|locus:2197729 | 805 | SD1-29 "S-domain-1 29" [Arabid | 0.608 | 0.598 | 0.314 | 5.2e-66 | |
| TAIR|locus:2200923 | 802 | AT1G61550 [Arabidopsis thalian | 0.597 | 0.589 | 0.319 | 7.3e-64 |
| TAIR|locus:2026155 AT1G34300 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 983 (351.1 bits), Expect = 5.0e-99, P = 5.0e-99
Identities = 265/737 (35%), Positives = 378/737 (51%)
Query: 87 RGSKLRLTANRGLVLEDPEGREIWKSEISTGQAAFGVLYDTGNFLIVNTNSERLWQSFDH 146
RGS LRL + L L + G +W S+ G + DTG F+++N S +W SFD+
Sbjct: 83 RGS-LRLHTSGSLRLTNGSGTTVWDSKTDRLGVTSGSIEDTGEFILLNNRSVPVWSSFDN 141
Query: 147 PTDTLLPTQTMERGGVVSSRRKDTYFSRGRFQFRLLEDGNAVLNTINLESGFAYDAYFWS 206
PTDT++ +Q G ++ S G + F+L GN T+ + Y + +
Sbjct: 142 PTDTIVQSQNFTAGKILRS---------GLYSFQLERSGNL---TLRWNTSAIYWNHGLN 189
Query: 207 NTFDTNRSNAGYRVVFNESGQLYVLRENKQR-ASLVPETVSAKENYLR-ATLNFDGVFIF 264
++F +N S+ R+ +G + + N A +V N R L+ DG
Sbjct: 190 SSFSSNLSSP--RLSLQTNGVVSIFESNLLGGAEIVYSGDYGDSNTFRFLKLDDDGNLRI 247
Query: 265 YSHPKNNSTG-DAIWSVSDVLPENICINNDIRKGLGSGICGFNSICSISGAKRPICQCP- 322
YS NS +A WS D C L G CG ICS + PIC CP
Sbjct: 248 YSSASRNSGPVNAHWSAVDQ-----C--------LVYGYCGNFGICSYNDTN-PICSCPS 293
Query: 323 KGFSLLDPDDAYGSCKPDFILGCEEDGKKSGEDLYYIEELRNTDWPTSDYEQISPYGKDE 382
+ F +D +D CK L + G + DL + D P S E G
Sbjct: 294 RNFDFVDVNDRRKGCKRKVELS-DCSGNTTMLDLVHTRLFTYEDDPNS--ESFFA-GSSP 349
Query: 383 CVSSCLKDCQCSAAVLRDD---TCWKKKLPLSY--GKTDRDETGTTFIKI---------R 428
C ++CL C A+V D CW+K P S+ G T+++K+
Sbjct: 350 CRANCLSSVLCLASVSMSDGSGNCWQKH-PGSFFTGYQWPSVPSTSYVKVCGPVVANTLE 408
Query: 429 KVPSG--GKKKVDVLIPVVSVLFGSSALI--NLLLVSACCLG---FLVVNRKKFMRPHQE 481
+ G KV + I V+V+ G L+ + L CC F ++ + +
Sbjct: 409 RATKGDDNNSKVHLWIVAVAVIAGLLGLVAVEIGLWWCCCRKNPRFGTLSSHYTLLEYAS 468
Query: 482 DQGVSYMNLRCFTYKELVEVTRGFKEELGRGAFGTVYKGFVNMGSSNHVAVKKLNSVFQD 541
V FTYKEL T+ FKE+LG G FGTVY+G + + VAVK+L + Q
Sbjct: 469 GAPVQ------FTYKELQRCTKSFKEKLGAGGFGTVYRGVLT--NRTVVAVKQLEGIEQ- 519
Query: 542 SEKEFKAEVNGIGQTHHKNLVRLLGYCDEGQNRLLVYEFMSNGTVASFLFG-DSKP--NW 598
EK+F+ EV I THH NLVRL+G+C +G++RLLVYEFM NG++ +FLF DS W
Sbjct: 520 GEKQFRMEVATISSTHHLNLVRLIGFCSQGRHRLLVYEFMRNGSLDNFLFTTDSAKFLTW 579
Query: 599 KLRTEIAMGIAGGLFYLHEECCTQIIHCDIKPQNILLDDHYNARISDFGLAKLLT-LDQS 657
+ R IA+G A G+ YLHEEC I+HCDIKP+NIL+DD++ A++SDFGLAKLL D
Sbjct: 580 EYRFNIALGTAKGITYLHEECRDCIVHCDIKPENILVDDNFAAKVSDFGLAKLLNPKDNR 639
Query: 658 HTNTAIRGTKGYVAPEWFRNMPITVKVDVYSYGVLLLEIICLRRNIDNEISKVDKAILTD 717
+ +++RGT+GY+APEW N+PIT K DVYSYG++LLE++ +RN D K + +
Sbjct: 640 YNMSSVRGTRGYLAPEWLANLPITSKSDVYSYGMVLLELVSGKRNFDVS-EKTNHKKFSI 698
Query: 718 WAYDRYQERTLEALVENDLEAMNNVTM--LHRFVMVAFWCIQEDPSHRPTMRKVTQMLEG 775
WAY+ +++ +A+++ L V M + R V +FWCIQE P RPTM KV QMLEG
Sbjct: 699 WAYEEFEKGNTKAILDTRLSEDQTVDMEQVMRMVKTSFWCIQEQPLQRPTMGKVVQMLEG 758
Query: 776 VVEVPIPPCPWTLNITS 792
+ E+ P CP T++ S
Sbjct: 759 ITEIKNPLCPKTISEVS 775
|
|
| TAIR|locus:2116525 SD2-5 "S-domain-2 5" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 901 (322.2 bits), Expect = 2.5e-90, P = 2.5e-90
Identities = 266/794 (33%), Positives = 404/794 (50%)
Query: 29 GQQLTAAESTEPWLSPSKDFALGFHQLDSKD-LFLPAIWYYKIPSKTIVWYASAVNPAPR 87
G Q+ + +L S + A GF + ++D + L + S ++W A+ +P
Sbjct: 35 GSQMNYINNDGIFLE-SNNSAFGFGFVTTQDSVTLFTLSIIHKSSTKLIWSANRASPVSN 93
Query: 88 GSKLRLTANRGLVLEDPEGREIWKSEISTGQAAFGVLYDTGNFLIVNTNSERLWQSFDHP 147
K N +V+E G E+W+ + S A+ L D+GN ++V+ + +W+SFDHP
Sbjct: 94 SDKFVFDDNGNVVME---GTEVWRLDNSGKNASRIELRDSGNLVVVSVDGTSIWESFDHP 150
Query: 148 TDTLLPTQTMERGGVVSSRRKDTYFSRGRFQFRL-LEDGNAVLNTINLESGFAYDAYFWS 206
TDTL+ Q + G ++S S + L ++ G+ VL+ +L +WS
Sbjct: 151 TDTLITNQAFKEGMKLTSSP-----SSSNMTYALEIKSGDMVLSVNSLTP-----QVYWS 200
Query: 207 NTFDTNRS-NAGYRVVFNES--GQLYVLRENKQRASLVPETVSA--KENYLR--ATLNFD 259
R N VV + S G + + KQ L+ + V + K++ A L +
Sbjct: 201 MANARERIINKDGGVVTSSSLLGNSWRFFDQKQ--VLLWQFVFSDNKDDNTTWIAVLGNN 258
Query: 260 GVFIFYSHPKNNSTGDAIWSVSDVLPENICINNDIRKGLGSGICGFNSICSISGAKRPIC 319
GV F + S D+ S +P ++C G CG +CS G+K +C
Sbjct: 259 GVISFSNLGSGASAADS----STKIPSDLC-------GTPEP-CGPYYVCS--GSK--VC 302
Query: 320 QCPKGFSLLDPDDAYGSCKPDFILGCEEDGKKSGEDLYYIEELRNTDWPTSDYEQISPYG 379
C G S D CK C++ + L + D+ Y P+
Sbjct: 303 GCVSGLSRARSD-----CKTGITSPCKKTKDNATLPLQLVSAGDGVDYFALGYAP--PFS 355
Query: 380 K----DECVSSCLKDCQCSAAVLRDDT--CWKKKLPLSYGKTDRDETG-TTFIKIRKVPS 432
K D C C +C C ++ + C+ S+ + +G ++IKI S
Sbjct: 356 KKTDLDSCKEFCHNNCSCLGLFFQNSSGNCFLFDYIGSFKTSGNGGSGFVSYIKIASTGS 415
Query: 433 GGKKKVD---VLIPVVSVLFGSSALINLLLVSACCLGFLVVNRKKFM--RPHQ---ED-- 482
GG + P V ++ + I +L+ + F + RKK + P + ED
Sbjct: 416 GGGDNGEDDGKHFPYVVIIVVVTVFIIAVLIF---VAFRIHKRKKMILEAPQESSEEDNF 472
Query: 483 -QGVSYMNLRCFTYKELVEVTRGFKEELGRGAFGTVYKGFVNMGSSNHVAVKKLNSVFQD 541
+ +S M +R F YK+L T F +LG+G FG+VY+G + GS +AVKKL + Q
Sbjct: 473 LENLSGMPIR-FAYKDLQSATNNFSVKLGQGGFGSVYEGTLPDGS--RLAVKKLEGIGQ- 528
Query: 542 SEKEFKAEVNGIGQTHHKNLVRLLGYCDEGQNRLLVYEFMSNGTVASFLF----GDSKPN 597
+KEF+AEV+ IG HH +LVRL G+C EG +RLL YEF+S G++ ++F GD +
Sbjct: 529 GKKEFRAEVSIIGSIHHLHLVRLRGFCAEGAHRLLAYEFLSKGSLERWIFRKKDGDVLLD 588
Query: 598 WKLRTEIAMGIAGGLFYLHEECCTQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLDQS 657
W R IA+G A GL YLHE+C +I+HCDIKP+NILLDD++NA++SDFGLAKL+T +QS
Sbjct: 589 WDTRFNIALGTAKGLAYLHEDCDARIVHCDIKPENILLDDNFNAKVSDFGLAKLMTREQS 648
Query: 658 HTNTAIRGTKGYVAPEWFRNMPITVKVDVYSYGVLLLEIICLRRNID-NEISKVDKAILT 716
H T +RGT+GY+APEW N I+ K DVYSYG++LLE+I R+N D +E S +K
Sbjct: 649 HVFTTMRGTRGYLAPEWITNYAISEKSDVYSYGMVLLELIGGRKNYDPSETS--EKCHFP 706
Query: 717 DWAYDRYQERTLEALVENDLEAMNNVT--MLHRFVMVAFWCIQEDPSHRPTMRKVTQMLE 774
+A+ + +E L +V+ ++ ++ VT + R + A WCIQED RP+M KV QMLE
Sbjct: 707 SFAFKKMEEGKLMDIVDGKMKNVD-VTDERVQRAMKTALWCIQEDMQTRPSMSKVVQMLE 765
Query: 775 GVVEVPIPPCPWTL 788
GV V PP T+
Sbjct: 766 GVFPVVQPPSSSTM 779
|
|
| TAIR|locus:2059103 AT2G19130 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 862 (308.5 bits), Expect = 3.3e-86, P = 3.3e-86
Identities = 259/781 (33%), Positives = 389/781 (49%)
Query: 42 LSPSKDFALGFHQLDSKDLFLPAIWYYKIPSKTIVWYASAVNP-APRGSKLRLTANRGLV 100
+S + +GF + S F +WY ++ S+TI+W A+ + + S + +N L+
Sbjct: 39 VSSDGTYEMGFFKPGSSSNFYIGMWYKQL-SQTILWVANRDKAVSDKNSSVFKISNGNLI 97
Query: 101 LEDPEGRE-IWKSEI-STGQ--AAFGVLYDTGNFLIVNTNSERL-----WQSFDHPTDTL 151
L D + +W + + ST A VL D GN L++ T L WQSFDHP DT
Sbjct: 98 LLDGNYQTPVWSTGLNSTSSVSALEAVLQDDGN-LVLRTGGSSLSANVLWQSFDHPGDTW 156
Query: 152 LPTQTMERGGVVSSRRKDTYFSRGRFQFRLLEDGNAVLNTINLESGFAYDAYFW--SNTF 209
LP GV K T S+ ++ LED + L ++ L+ AY W SN +
Sbjct: 157 LP-------GVKIRLDKRTGKSQRLTSWKSLEDPSPGLFSLELDESTAYKI-LWNGSNEY 208
Query: 210 -DTNRSNAGYRVVFNESGQL---YVLREN---KQRASLVPETVSAKENYLRATLNFDGVF 262
+ N R+ F+ ++ Y+ + S ++ + N R ++ G
Sbjct: 209 WSSGPWNPQSRI-FDSVPEMRLNYIYNFSFFSNTTDSYFTYSIYNQLNVSRFVMDVSGQI 267
Query: 263 IFYSHPKNNSTGDAIWSVSDVLPENICINNDIRKGLGSGICGFNSICSISGAKRPICQCP 322
++ + N + WS P C + + CG ICS P C+CP
Sbjct: 268 KQFTWLEGNKAWNLFWSQ----PRQQC---QVYR-----YCGSFGICS--DKSEPFCRCP 313
Query: 323 KGFSLLDPDDAYGSCKPDFILGC--EEDGKKSGEDLYYIEELRNTDWPTSDYEQISPYGK 380
+GF + D K D+ GC + + + S D+ L N + E ++
Sbjct: 314 QGFRPMSQKD--WDLK-DYSAGCVRKTELQCSRGDINQFFRLPNMKLADNS-EVLTRTSL 369
Query: 381 DECVSSCLKDCQCSAAVLRDDT--C--WKKK-LPLSYGKTDRDETGTTFIKIRK--VPS- 432
C S+C DC C A + + C W K L L + + E ++++ VP+
Sbjct: 370 SICASACQGDCSCKAYAYDEGSSKCLVWSKDVLNLQQLEDENSEGNIFYLRLAASDVPNV 429
Query: 433 GGKKKVDVLIPVVSVLFGSSALINLLLVSACCLGFLVVNRKKFMRPHQEDQGVSYMNLRC 492
G K + + + GS +I L+L+ + L R+K MR + D G L
Sbjct: 430 GASGKSNNKGLIFGAVLGSLGVIVLVLLVVILI--LRYRRRKRMRGEKGD-GT----LSA 482
Query: 493 FTYKELVEVTRGFKEELGRGAFGTVYKGFVNMGSSNHVAVKKLNSVFQDSEKEFKAEVNG 552
F+Y+EL T+ F ++LG G FG+V+KG + S+ +AVK+L + Q EK+F+ EV
Sbjct: 483 FSYRELQNATKNFSDKLGGGGFGSVFKGA--LPDSSDIAVKRLEGISQ-GEKQFRTEVVT 539
Query: 553 IGQTHHKNLVRLLGYCDEGQNRLLVYEFMSNGTVASFLFGDSKPN-----WKLRTEIAMG 607
IG H NLVRL G+C EG +LLVY++M NG++ S LF + WKLR +IA+G
Sbjct: 540 IGTIQHVNLVRLRGFCSEGSKKLLVYDYMPNGSLDSHLFLNQVEEKIVLGWKLRFQIALG 599
Query: 608 IAGGLFYLHEECCTQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLDQSHTNTAIRGTK 667
A GL YLH+EC IIHCDIKP+NILLD + +++DFGLAKL+ D S T +RGT+
Sbjct: 600 TARGLAYLHDECRDCIIHCDIKPENILLDSQFCPKVADFGLAKLVGRDFSRVLTTMRGTR 659
Query: 668 GYVAPEWFRNMPITVKVDVYSYGVLLLEIICLRRNID-NEISKVDKAILTDWAYDRY-QE 725
GY+APEW + IT K DVYSYG++L E++ RRN + +E KV WA ++
Sbjct: 660 GYLAPEWISGVAITAKADVYSYGMMLFELVSGRRNTEQSENEKV--RFFPSWAATILTKD 717
Query: 726 RTLEALVENDLEA-MNNVTMLHRFVMVAFWCIQEDPSHRPTMRKVTQMLEGVVEVPIPPC 784
+ +LV+ LE ++ + R VA WCIQ++ SHRP M +V Q+LEGV+EV PP
Sbjct: 718 GDIRSLVDPRLEGDAVDIEEVTRACKVACWCIQDEESHRPAMSQVVQILEGVLEVNPPPF 777
Query: 785 P 785
P
Sbjct: 778 P 778
|
|
| TAIR|locus:2141176 B120 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 511 (184.9 bits), Expect = 9.2e-73, Sum P(3) = 9.2e-73
Identities = 121/300 (40%), Positives = 170/300 (56%)
Query: 481 EDQGVSYMNLRCFTYKELVEVTRGF-KE-ELGRGAFGTVYKGFVNMGSSNHVAVKKLNSV 538
E + V+ L F+ + T F KE ELGRG FG VYKG + G +AVK+L+
Sbjct: 505 EGKAVNTSELPVFSLNAIAIATNDFCKENELGRGGFGPVYKGVLEDG--REIAVKRLSGK 562
Query: 539 FQDSEKEFKAEVNGIGQTHHKNLVRLLGYCDEGQNRLLVYEFMSNGTVASFLFGDSKP-- 596
EFK E+ I + H+NLVRLLG C EG+ ++LVYE+M N ++ FLF ++K
Sbjct: 563 SGQGVDEFKNEIILIAKLQHRNLVRLLGCCFEGEEKMLVYEYMPNKSLDFFLFDETKQAL 622
Query: 597 -NWKLRTEIAMGIAGGLFYLHEECCTQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLD 655
+WKLR I GIA GL YLH + +IIH D+K N+LLD N +ISDFG+A++ +
Sbjct: 623 IDWKLRFSIIEGIARGLLYLHRDSRLRIIHRDLKVSNVLLDAEMNPKISDFGMARIFGGN 682
Query: 656 QSHTNTA-IRGTKGYVAPEWFRNMPITVKVDVYSYGVLLLEIICLRRNIDNEISKVDKAI 714
Q+ NT + GT GY++PE+ +VK DVYS+GVLLLEI+ +RN + +
Sbjct: 683 QNEANTVRVVGTYGYMSPEYAMEGLFSVKSDVYSFGVLLLEIVSGKRN--TSLRSSEHGS 740
Query: 715 LTDWAYDRYQERTLEALVENDLEAMNNVTMLHRFVMVAFWCIQEDPSHRPTMRKVTQMLE 774
L +A+ Y E LV+ + + R + VA C+Q+ + RP M V MLE
Sbjct: 741 LIGYAWYLYTHGRSEELVDPKIRVTCSKREALRCIHVAMLCVQDSAAERPNMASVLLMLE 800
|
|
| TAIR|locus:2197649 AT1G61360 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 581 (209.6 bits), Expect = 3.7e-72, Sum P(2) = 3.7e-72
Identities = 164/520 (31%), Positives = 262/520 (50%)
Query: 301 GICGFNSICSISGAKRPICQCPKGFS-LLDPDDAYGS----CKPDFILGCEEDG--KKSG 353
G CG +C SG P+CQC KGF D + G+ C L C+ + + G
Sbjct: 284 GRCGPFGLCVRSGT--PMCQCLKGFEPKSDEEWRSGNWSRGCVRRTNLSCQGNSSVETQG 341
Query: 354 ED---LYYIEELRNTDWPTSDYEQISPYGKDECVSSCLKDCQCSA-AVLRDDTC--WKKK 407
+D Y++ ++ P YE S +++C CL++C C+A + + C W ++
Sbjct: 342 KDRDVFYHVSNIK----PPDSYELASFSNEEQCHQGCLRNCSCTAFSYVSGIGCLVWNQE 397
Query: 408 LPLSYGKTDRDETGTTFIKIRKVPSGGKKKVDVLIPVVSVLFGSSALINLLLVSACCL-- 465
L + ET + +++ G+K++ ++ V+ L S LI +L+ C
Sbjct: 398 LLDTVKFIGGGETLS--LRLAHSELTGRKRIKII--TVATLSLSVCLILVLVACGCWRYR 453
Query: 466 ----GFLVVNRKKFMRPHQED-QGVSYMNLRCFTYKELVEVTRGFK--EELGRGAFGTVY 518
G +V++ + D Q L F +L T F +LG+G FGTVY
Sbjct: 454 VKQNGSSLVSKDNVEGAWKSDLQSQDVSGLNFFEIHDLQTATNNFSVLNKLGQGGFGTVY 513
Query: 519 KGFVNMGSSNHVAVKKLNSVFQDSEKEFKAEVNGIGQTHHKNLVRLLGYCDEGQNRLLVY 578
KG + G +AVK+L S +EF E+ I + H+NL+RLLG C +G+ +LLVY
Sbjct: 514 KGKLQDGKE--IAVKRLTSSSVQGTEEFMNEIKLISKLQHRNLLRLLGCCIDGEEKLLVY 571
Query: 579 EFMSNGTVASFLFGDSKP---NWKLRTEIAMGIAGGLFYLHEECCTQIIHCDIKPQNILL 635
E+M N ++ F+F K +W R I GIA GL YLH + +++H D+K NILL
Sbjct: 572 EYMVNKSLDIFIFDLKKKLEIDWATRFNIIQGIARGLLYLHRDSFLRVVHRDLKVSNILL 631
Query: 636 DDHYNARISDFGLAKLLTLDQSHTNT-AIRGTKGYVAPEWFRNMPITVKVDVYSYGVLLL 694
D+ N +ISDFGLA+L +Q +T ++ GT GY++PE+ + K D+YS+GVL+L
Sbjct: 632 DEKMNPKISDFGLARLFHGNQHQDSTGSVVGTLGYMSPEYAWTGTFSEKSDIYSFGVLML 691
Query: 695 EIICLRRNIDNEISKVDKAILTDWAYDRYQERTLEALVENDLEAMNNVTMLH--RFVMVA 752
EII + K +K +L+ +A+D + E L++ DL+ ++V + R V +
Sbjct: 692 EIITGKEISSFSYGKDNKNLLS-YAWDSWSENGGVNLLDQDLDDSDSVNSVEAGRCVHIG 750
Query: 753 FWCIQEDPSHRPTMRKVTQMLEGVVEVPIPPCPWTLNITS 792
C+Q RP +++V ML ++P P P + TS
Sbjct: 751 LLCVQHQAIDRPNIKQVMSMLTSTTDLPKPTQPMFVLETS 790
|
|
| TAIR|locus:2197734 AT1G61370 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 584 (210.6 bits), Expect = 2.3e-70, Sum P(2) = 2.3e-70
Identities = 157/508 (30%), Positives = 257/508 (50%)
Query: 303 CGFNSICSISGAKRPICQCPKGFSLLDPDDAY------GSCKPDFILGCEEDGKKSGE-- 354
CG +C S P C+C KGF + D+ + G C L C+ + + +
Sbjct: 292 CGPFGLCIRSNP--PKCECLKGF-VPKSDEEWNKRNWTGGCMRRTNLSCDVNSSATAQAN 348
Query: 355 --DLYYIEELRNTDWPTSDYEQISPYGKDECVSSCLKDCQCSA-AVLRDDTC--WKKKLP 409
D++ I + N P YE +S +++C CL +C C+A + + C W ++L
Sbjct: 349 NGDIFDI--VANVK-PPDFYEYLSLINEEDCQQRCLGNCSCTAFSYIEQIGCLVWNRELV 405
Query: 410 LSYGKTDRDETGTTFIKIRKVPSGGKKKVDVLIP-VVSVLFGSSALINLLLVSACCLGFL 468
ET + I++ G +V +++ +VS+ S + L+ S +
Sbjct: 406 DVMQFVAGGETLS--IRLASSELAGSNRVKIIVASIVSI----SVFMILVFASYWYWRYK 459
Query: 469 VVNRKKFMRPHQEDQG-----VSYMNLRCFTYKELVEVTRGFKEE--LGRGAFGTVYKGF 521
P + Q + ++ F + ++ +T F E LG+G FG VYKG
Sbjct: 460 AKQNDSNPIPLETSQDAWREQLKPQDVNFFDMQTILTITNNFSMENKLGQGGFGPVYKG- 518
Query: 522 VNMGSSNHVAVKKLNSVFQDSEKEFKAEVNGIGQTHHKNLVRLLGYCDEGQNRLLVYEFM 581
N+ +A+K+L+S +EF E+ I + H+NLVRLLG C EG+ +LL+YEFM
Sbjct: 519 -NLQDGKEIAIKRLSSTSGQGLEEFMNEIILISKLQHRNLVRLLGCCIEGEEKLLIYEFM 577
Query: 582 SNGTVASFLFGDSKP---NWKLRTEIAMGIAGGLFYLHEECCTQIIHCDIKPQNILLDDH 638
+N ++ +F+F +K +W R EI GIA GL YLH + C +++H D+K NILLD+
Sbjct: 578 ANKSLNTFIFDSTKKLELDWPKRFEIIQGIACGLLYLHRDSCLRVVHRDMKVSNILLDEE 637
Query: 639 YNARISDFGLAKLLTLDQSHTNTA-IRGTKGYVAPEWFRNMPITVKVDVYSYGVLLLEII 697
N +ISDFGLA++ Q NT + GT GY++PE+ + K D+Y++GVLLLEII
Sbjct: 638 MNPKISDFGLARMFQGTQHQANTRRVVGTLGYMSPEYAWTGMFSEKSDIYAFGVLLLEII 697
Query: 698 CLRRNIDNEISKVDKAILTDWAYDRYQERTLEALVENDLEAMNNVTMLHRFVMVAFWCIQ 757
+R I + K +L ++A+D + E L++ D+ + + + + R V + CIQ
Sbjct: 698 TGKRISSFTIGEEGKTLL-EFAWDSWCESGGSDLLDQDISSSGSESEVARCVQIGLLCIQ 756
Query: 758 EDPSHRPTMRKVTQMLEGVVEVPIPPCP 785
+ RP + +V ML +++P P P
Sbjct: 757 QQAGDRPNIAQVMSMLTTTMDLPKPKQP 784
|
|
| TAIR|locus:2197714 AT1G61440 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 566 (204.3 bits), Expect = 8.6e-67, Sum P(2) = 8.6e-67
Identities = 167/523 (31%), Positives = 252/523 (48%)
Query: 278 WSVSDVLPENICINNDIRKGLGSGICGFNSICSISGAKRPICQCPKGFSLLDPDD-AYGS 336
W S P N C DI G+CG C IS P C+C KGF ++ G+
Sbjct: 264 WKSSYEGPANSC---DIY-----GVCGPFGFCVISDP--PKCKCFKGFVPKSIEEWKRGN 313
Query: 337 ----CKPDFILGCEEDGKKSGEDLYYIEELRNTDWPTSDYEQISPYGKDECVSSCLKDCQ 392
C L C+ G +G+D + N P YE + + C SCL +C
Sbjct: 314 WTSGCARRTELHCQ--GNSTGKDANVFHTVPNIK-PPDFYEYANSVDAEGCYQSCLHNCS 370
Query: 393 CSA-AVLRDDTC--WKKKLPLSYGKTDRDETGTTFIKIRKVPSGGKKKVDVLIPVVSVLF 449
C A A + C W K L T + G + IR S ++DV ++++
Sbjct: 371 CLAFAYIPGIGCLMWSKDLM----DTMQFSAGGEILSIRLAHS----ELDVHKRKMTIVA 422
Query: 450 GSSALINLLLVSACCLGFLVVNRKKFMRPHQED-QGVSYMNLRCFTYKELVEVTRGFK-- 506
+ +L +++ GF NR K + D Q L F + T F
Sbjct: 423 STVSLTLFVILGFATFGFWR-NRVKHHDAWRNDLQSQDVPGLEFFEMNTIQTATSNFSLS 481
Query: 507 EELGRGAFGTVYKGFVNMGSSNHVAVKKLNSVFQDSEKEFKAEVNGIGQTHHKNLVRLLG 566
+LG G FG+VYKG + G +AVK+L+S + ++EF E+ I + H+NLVR+LG
Sbjct: 482 NKLGHGGFGSVYKGKLQDG--REIAVKRLSSSSEQGKQEFMNEIVLISKLQHRNLVRVLG 539
Query: 567 YCDEGQNRLLVYEFMSNGTVASFLFGDSKP---NWKLRTEIAMGIAGGLFYLHEECCTQI 623
C EG+ +LL+YEFM N ++ +F+FG K +W R +I GI GL YLH + ++
Sbjct: 540 CCVEGKEKLLIYEFMKNKSLDTFVFGSRKRLELDWPKRFDIIQGIVRGLLYLHRDSRLRV 599
Query: 624 IHCDIKPQNILLDDHYNARISDFGLAKLLTLDQSHTNTA-IRGTKGYVAPEWFRNMPITV 682
IH D+K NILLD+ N +ISDFGLA+L Q T + GT GY++PE+ +
Sbjct: 600 IHRDLKVSNILLDEKMNPKISDFGLARLFQGSQYQDKTRRVVGTLGYMSPEYAWTGVFSE 659
Query: 683 KVDVYSYGVLLLEIICLRRNIDNEISKVDKAILTDWAYDRYQERTLEALVENDLEAMNNV 742
K D+YS+GVLLLEII + + KA+L + ++ + E L++ L+ ++
Sbjct: 660 KSDIYSFGVLLLEIISGEKISRFSYGEEGKALLA-YVWECWCETRGVNLLDQALDDSSHP 718
Query: 743 TMLHRFVMVAFWCIQEDPSHRPTMRKVTQMLEGVVEVPIPPCP 785
+ R V + C+Q P+ RP ++ ML ++P+P P
Sbjct: 719 AEVGRCVQIGLLCVQHQPADRPNTLELLSMLTTTSDLPLPKQP 761
|
|
| TAIR|locus:2200908 AT1G61610 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 524 (189.5 bits), Expect = 4.7e-66, Sum P(3) = 4.7e-66
Identities = 121/311 (38%), Positives = 175/311 (56%)
Query: 482 DQGVSYMNLRCFTYKELVEVTRGFKEE--LGRGAFGTVYKGFVNMGSSNHVAVKKLNSVF 539
DQ V +L F++ + T F EE LG+G FGTVYKG N +AVK+L+
Sbjct: 503 DQ-VDTPDLPIFSFDSVASATGDFAEENKLGQGGFGTVYKG--NFSEGREIAVKRLSGKS 559
Query: 540 QDSEKEFKAEVNGIGQTHHKNLVRLLGYCDEGQNRLLVYEFMSNGTVASFLFGDSKP--- 596
+ +EFK E+ I + H+NLVRLLG C E ++L+YE+M N ++ FLF +SK
Sbjct: 560 KQGLEEFKNEILLIAKLQHRNLVRLLGCCIEDNEKMLLYEYMPNKSLDRFLFDESKQGSL 619
Query: 597 NWKLRTEIAMGIAGGLFYLHEECCTQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLDQ 656
+W+ R E+ GIA GL YLH + +IIH D+K NILLD N +ISDFG+A++ Q
Sbjct: 620 DWRKRWEVIGGIARGLLYLHRDSRLKIIHRDLKASNILLDTEMNPKISDFGMARIFNYRQ 679
Query: 657 SHTNTA-IRGTKGYVAPEWFRNMPITVKVDVYSYGVLLLEIICLRRNIDNEISKVDKAIL 715
H NT + GT GY+APE+ + K DVYS+GVL+LEI+ R+N+ D L
Sbjct: 680 DHANTIRVVGTYGYMAPEYAMEGIFSEKSDVYSFGVLILEIVSGRKNVS--FRGTDHGSL 737
Query: 716 TDWAYDRYQERTLEALVENDLEAMNNVTMLHRFVMVAFWCIQEDPSHRPTMRKVTQMLEG 775
+A+ + + + +++ ++ +VT R + V C Q+ HRP M V MLE
Sbjct: 738 IGYAWHLWSQGKTKEMIDPIVKDTRDVTEAMRCIHVGMLCTQDSVIHRPNMGSVLLMLES 797
Query: 776 VV-EVPIPPCP 785
++P P P
Sbjct: 798 QTSQLPPPRQP 808
|
|
| TAIR|locus:2197729 SD1-29 "S-domain-1 29" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 555 (200.4 bits), Expect = 5.2e-66, Sum P(2) = 5.2e-66
Identities = 166/528 (31%), Positives = 249/528 (47%)
Query: 278 WSVSDVLPENICINNDIRKGLGSGICGFNSICSISGAKRPICQCPKGFSLLDPDDAYGS- 336
W + LPEN C D+ G CG +C S P C+C KGF + D+ +G
Sbjct: 270 WKLHLSLPENPC---DLY-----GRCGPYGLCVRSDP--PKCECLKGF-VPKSDEEWGKG 318
Query: 337 -----CKPDFILGCEEDG--KKSGED--LYYIEELRNTDWPTSDYEQISPY-GKDECVSS 386
C L C+ K G+D ++Y R TD T D Q + + ++C
Sbjct: 319 NWTSGCVRRTKLSCQAKSSMKTQGKDTDIFY----RMTDVKTPDLHQFASFLNAEQCYQG 374
Query: 387 CLKDCQCSA-AVLRDDTC--WKKKLPLSYGKTDRDETGTTFIKIRKVPSGGKKKVDVLIP 443
CL +C C+A A + C W +L + E FI++ G + +++
Sbjct: 375 CLGNCSCTAFAYISGIGCLVWNGELADTVQFLSSGEF--LFIRLASSELAGSSRRKIIVG 432
Query: 444 VVSVLFGSSALINLLLVSACCLGFLVVNRKKFMRPHQEDQGVSYMNLRCFTYKELVEVTR 503
L ++ +L+ +A L + + E Q VS +N F + T
Sbjct: 433 TTVSL----SIFLILVFAAIMLWRYRAKQNDAWKNGFERQDVSGVNF--FEMHTIRTATN 486
Query: 504 GFK--EELGRGAFGTVYKGFVNMGSSNHVAVKKLNSVFQDSEKEFKAEVNGIGQTHHKNL 561
F +LG+G FG VYKG + + VK+L S +EF E+ I + H+NL
Sbjct: 487 NFSPSNKLGQGGFGPVYKG--KLVDGKEIGVKRLASSSGQGTEEFMNEITLISKLQHRNL 544
Query: 562 VRLLGYCDEGQNRLLVYEFMSNGTVASFLFGDS---KPNWKLRTEIAMGIAGGLFYLHEE 618
VRLLGYC +G+ +LL+YEFM N ++ F+F + +W R I GIA GL YLH +
Sbjct: 545 VRLLGYCIDGEEKLLIYEFMVNKSLDIFIFDPCLKFELDWPKRFNIIQGIARGLLYLHRD 604
Query: 619 CCTQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLDQSHTNTA-IRGTKGYVAPEWFRN 677
++IH D+K NILLDD N +ISDFGLA++ Q NT + GT GY++PE+
Sbjct: 605 SRLRVIHRDLKVSNILLDDRMNPKISDFGLARMFQGTQYQDNTRRVVGTLGYMSPEYAWA 664
Query: 678 MPITVKVDVYSYGVLLLEIICLRRNIDNEISKVDKAILTDWAYDRYQERTLEALVENDLE 737
+ K D+YS+GVL+LEII +R I I + L + +D + E L++ DL
Sbjct: 665 GLFSEKSDIYSFGVLMLEIISGKR-ISRFIYGDESKGLLAYTWDSWCETGGSNLLDRDLT 723
Query: 738 AMNNVTMLHRFVMVAFWCIQEDPSHRPTMRKVTQMLEGVVEVPIPPCP 785
+ R V + C+Q + RP +V ML ++P+P P
Sbjct: 724 DTCQAFEVARCVQIGLLCVQHEAVDRPNTLQVLSMLTSATDLPVPKQP 771
|
|
| TAIR|locus:2200923 AT1G61550 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 546 (197.3 bits), Expect = 7.3e-64, Sum P(2) = 7.3e-64
Identities = 161/504 (31%), Positives = 241/504 (47%)
Query: 301 GICGFNSICSISGAKRPICQCPKGFSLLDPDDAY-----GSCKPDFILGCEEDGKKSGED 355
G+CG +C +S P C+C KGF ++ G C L C+ G +G
Sbjct: 281 GVCGPFGLCVMSIP--PKCKCFKGFVPQFSEEWKRGNWTGGCVRRTELLCQ--GNSTGRH 336
Query: 356 LYYIEELRNTDWPTSDYEQISPYGKDECVSSCLKDCQCSA-AVLRDDTC--WKKKLPLSY 412
+ + N P YE +S +EC SCL +C C A A + C W ++L
Sbjct: 337 VNVFHPVANIK-PPDFYEFVSSGSAEECYQSCLHNCSCLAFAYINGIGCLIWNQELM--- 392
Query: 413 GKTDRDETGTTFIKIRKVPS---GGKKKVDVLIPVVSV-LFGSSALINLLLVSACCLGFL 468
+ G + IR S G ++K ++ +VS+ LF + A
Sbjct: 393 -DVMQFSVGGELLSIRLASSEMGGNQRKKTIIASIVSISLFVTLASAAFGFWRYRLKHNA 451
Query: 469 VVNRKKFMRPHQED-QGVSYMNLRCFTYKELVEVTRGFK--EELGRGAFGTVYKGFVNMG 525
+V++ + D + L F K + T F +LG+G FG VYKG + G
Sbjct: 452 IVSKVSLQGAWRNDLKSEDVSGLYFFEMKTIEIATNNFSLVNKLGQGGFGPVYKGKLQDG 511
Query: 526 SSNHVAVKKLNSVFQDSEKEFKAEVNGIGQTHHKNLVRLLGYCDEGQNRLLVYEFMSNGT 585
+AVK+L+S ++EF E+ I + H NLVR+LG C EG+ RLLVYEFM N +
Sbjct: 512 KE--IAVKRLSSSSGQGKEEFMNEILLISKLQHINLVRILGCCIEGEERLLVYEFMVNKS 569
Query: 586 VASFLFGDSKP---NWKLRTEIAMGIAGGLFYLHEECCTQIIHCDIKPQNILLDDHYNAR 642
+ +F+F K +W R I GIA GL YLH + +IIH D+K NILLDD N +
Sbjct: 570 LDTFIFDSRKRVEIDWPKRFSIIQGIARGLLYLHRDSRLRIIHRDVKVSNILLDDKMNPK 629
Query: 643 ISDFGLAKLLTLDQSHTNTA-IRGTKGYVAPEWFRNMPITVKVDVYSYGVLLLEIICLRR 701
ISDFGLA++ + NT I GT GY++PE+ + K D YS+GVLLLE+I +
Sbjct: 630 ISDFGLARMYEGTKYQDNTRRIVGTLGYMSPEYAWTGVFSEKSDTYSFGVLLLEVISGEK 689
Query: 702 NIDNEISKVDKAILTDWAYDRYQERTLEALVENDLEAMNNVTMLHRFVMVAFWCIQEDPS 761
K K +L +A++ + E ++ D + + + R V + C+Q P+
Sbjct: 690 ISRFSYDKERKNLLA-YAWESWCENGGVGFLDKDATDSCHPSEVGRCVQIGLLCVQHQPA 748
Query: 762 HRPTMRKVTQMLEGVVEVPIPPCP 785
RP ++ ML ++P+P P
Sbjct: 749 DRPNTLELLSMLTTTSDLPLPKEP 772
|
|
Prediction of Enzyme Commission (EC) Number
EC Number Prediction by Annotation Transfer from SWISS-PROT Entries 
Original result of BLAST against SWISS-PROT
ID ![]() | Name ![]() | Annotated EC number ![]() | Identity ![]() | Query coverage ![]() | Hit coverage ![]() | RBH(Q2H) ![]() | RBH(H2Q) ![]() |
| Q39202 | RLK1_ARATH | 2, ., 7, ., 1, 1, ., 1 | 0.4660 | 0.9621 | 0.9158 | yes | no |
EC Number Prediction by Ezypred Server 
Original result from Ezypred Server
Fail to connect to Ezypred Server
Prediction of Functionally Associated Proteins
Functionally Associated Proteins Detected by STRING 
Original result from the STRING server
Fail to connect to STRING server
Conserved Domains and Related Protein Families
Conserved Domains Detected by RPS-BLAST 
Original result of RPS-BLAST against CDD database part I
ID ![]() | Alignment Graph ![]() | Length ![]() |
Definition ![]() |
E-value ![]() |
| Query | 792 | |||
| cd00180 | 215 | cd00180, PKc, Catalytic domain of Protein Kinases | 4e-47 | |
| pfam07714 | 258 | pfam07714, Pkinase_Tyr, Protein tyrosine kinase | 7e-46 | |
| pfam00069 | 260 | pfam00069, Pkinase, Protein kinase domain | 7e-46 | |
| smart00219 | 257 | smart00219, TyrKc, Tyrosine kinase, catalytic doma | 4e-44 | |
| smart00220 | 254 | smart00220, S_TKc, Serine/Threonine protein kinase | 9e-44 | |
| smart00221 | 258 | smart00221, STYKc, Protein kinase; unclassified sp | 3e-43 | |
| cd00192 | 262 | cd00192, PTKc, Catalytic domain of Protein Tyrosin | 1e-39 | |
| cd06606 | 260 | cd06606, STKc_MAPKKK, Catalytic domain of the Prot | 2e-33 | |
| cd05122 | 253 | cd05122, PKc_STE, Catalytic domain of STE family P | 6e-33 | |
| cd08215 | 258 | cd08215, STKc_Nek, Catalytic domain of the Protein | 1e-30 | |
| COG0515 | 384 | COG0515, SPS1, Serine/threonine protein kinase [Ge | 8e-29 | |
| cd05034 | 261 | cd05034, PTKc_Src_like, Catalytic domain of Src ki | 9e-29 | |
| cd05039 | 256 | cd05039, PTKc_Csk_like, Catalytic domain of C-term | 9e-29 | |
| cd06627 | 254 | cd06627, STKc_Cdc7_like, Catalytic domain of Cell | 8e-28 | |
| cd05033 | 266 | cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec | 1e-26 | |
| cd05068 | 261 | cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re | 2e-25 | |
| cd06623 | 264 | cd06623, PKc_MAPKK_plant_like, Catalytic domain of | 8e-25 | |
| cd05041 | 251 | cd05041, PTKc_Fes_like, Catalytic domain of Fes-li | 1e-24 | |
| cd05060 | 257 | cd05060, PTKc_Syk_like, Catalytic domain of Spleen | 1e-24 | |
| cd05038 | 284 | cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai | 6e-24 | |
| cd05032 | 277 | cd05032, PTKc_InsR_like, Catalytic domain of Insul | 1e-23 | |
| cd05148 | 261 | cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro | 1e-23 | |
| cd05067 | 260 | cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro | 3e-23 | |
| cd05048 | 283 | cd05048, PTKc_Ror, Catalytic Domain of the Protein | 6e-23 | |
| cd08217 | 265 | cd08217, STKc_Nek2, Catalytic domain of the Protei | 8e-23 | |
| cd05116 | 257 | cd05116, PTKc_Syk, Catalytic domain of the Protein | 9e-23 | |
| cd05112 | 256 | cd05112, PTKc_Itk, Catalytic domain of the Protein | 1e-22 | |
| cd05052 | 263 | cd05052, PTKc_Abl, Catalytic domain of the Protein | 2e-22 | |
| cd05123 | 250 | cd05123, STKc_AGC, Catalytic domain of AGC family | 5e-22 | |
| cd05059 | 256 | cd05059, PTKc_Tec_like, Catalytic domain of Tec-li | 6e-22 | |
| cd05061 | 288 | cd05061, PTKc_InsR, Catalytic domain of the Protei | 6e-22 | |
| cd05065 | 269 | cd05065, PTKc_EphR_B, Catalytic domain of the Prot | 1e-21 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 2e-21 | |
| cd05057 | 279 | cd05057, PTKc_EGFR_like, Catalytic domain of Epide | 2e-21 | |
| cd06626 | 264 | cd06626, STKc_MEKK4, Catalytic domain of the Prote | 9e-21 | |
| pfam01453 | 109 | pfam01453, B_lectin, D-mannose binding lectin | 1e-20 | |
| cd06612 | 256 | cd06612, STKc_MST1_2, Catalytic domain of the Prot | 1e-20 | |
| cd05083 | 254 | cd05083, PTKc_Chk, Catalytic domain of the Protein | 1e-20 | |
| cd05036 | 277 | cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro | 1e-20 | |
| cd05063 | 268 | cd05063, PTKc_EphR_A2, Catalytic domain of the Pro | 1e-20 | |
| cd05049 | 280 | cd05049, PTKc_Trk, Catalytic domain of the Protein | 2e-20 | |
| cd06632 | 258 | cd06632, STKc_MEKK1_plant, Catalytic domain of the | 2e-20 | |
| cd05062 | 277 | cd05062, PTKc_IGF-1R, Catalytic domain of the Prot | 3e-20 | |
| cd05072 | 261 | cd05072, PTKc_Lyn, Catalytic domain of the Protein | 3e-20 | |
| cd05581 | 280 | cd05581, STKc_PDK1, Catalytic domain of the Protei | 4e-20 | |
| cd06614 | 286 | cd06614, STKc_PAK, Catalytic domain of the Protein | 5e-20 | |
| cd08530 | 256 | cd08530, STKc_CNK2-like, Catalytic domain of the P | 7e-20 | |
| cd00028 | 116 | cd00028, B_lectin, Bulb-type mannose-specific lect | 8e-20 | |
| cd06631 | 265 | cd06631, STKc_YSK4, Catalytic domain of the Protei | 2e-19 | |
| cd08528 | 269 | cd08528, STKc_Nek10, Catalytic domain of the Prote | 2e-19 | |
| cd05578 | 258 | cd05578, STKc_Yank1, Catalytic domain of the Prote | 4e-19 | |
| cd05066 | 267 | cd05066, PTKc_EphR_A, Catalytic domain of the Prot | 5e-19 | |
| cd05055 | 302 | cd05055, PTKc_PDGFR, Catalytic domain of the Prote | 6e-19 | |
| cd08529 | 256 | cd08529, STKc_FA2-like, Catalytic domain of the Pr | 6e-19 | |
| cd06609 | 274 | cd06609, STKc_MST3_like, Catalytic domain of Mamma | 6e-19 | |
| cd05113 | 256 | cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro | 8e-19 | |
| cd07840 | 287 | cd07840, STKc_CDK9_like, Catalytic domain of Cycli | 1e-18 | |
| cd08220 | 256 | cd08220, STKc_Nek8, Catalytic domain of the Protei | 2e-18 | |
| smart00108 | 114 | smart00108, B_lectin, Bulb-type mannose-specific l | 2e-18 | |
| cd05114 | 256 | cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro | 3e-18 | |
| cd05058 | 262 | cd05058, PTKc_Met_Ron, Catalytic domain of the Pro | 3e-18 | |
| cd05035 | 273 | cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li | 4e-18 | |
| cd06608 | 275 | cd06608, STKc_myosinIII_like, Catalytic domain of | 4e-18 | |
| cd06629 | 272 | cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o | 4e-18 | |
| cd05070 | 260 | cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro | 6e-18 | |
| cd06605 | 265 | cd06605, PKc_MAPKK, Catalytic domain of the dual-s | 7e-18 | |
| cd06621 | 287 | cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of | 7e-18 | |
| cd05577 | 277 | cd05577, STKc_GRK, Catalytic domain of the Protein | 9e-18 | |
| cd05053 | 293 | cd05053, PTKc_FGFR, Catalytic domain of the Protei | 1e-17 | |
| cd06628 | 267 | cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o | 1e-17 | |
| cd05071 | 262 | cd05071, PTKc_Src, Catalytic domain of the Protein | 1e-17 | |
| cd07838 | 287 | cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc | 2e-17 | |
| cd05084 | 252 | cd05084, PTKc_Fes, Catalytic domain of the Protein | 2e-17 | |
| cd05115 | 257 | cd05115, PTKc_Zap-70, Catalytic domain of the Prot | 2e-17 | |
| cd05082 | 256 | cd05082, PTKc_Csk, Catalytic domain of the Protein | 2e-17 | |
| cd05085 | 250 | cd05085, PTKc_Fer, Catalytic domain of the Protein | 3e-17 | |
| cd06642 | 277 | cd06642, STKc_STK25-YSK1, Catalytic domain of the | 3e-17 | |
| cd06630 | 268 | cd06630, STKc_MEKK1, Catalytic domain of the Prote | 4e-17 | |
| cd05118 | 283 | cd05118, STKc_CMGC, Catalytic domain of CMGC famil | 4e-17 | |
| cd07829 | 282 | cd07829, STKc_CDK_like, Catalytic domain of Cyclin | 4e-17 | |
| cd05045 | 290 | cd05045, PTKc_RET, Catalytic domain of the Protein | 4e-17 | |
| cd05090 | 283 | cd05090, PTKc_Ror1, Catalytic domain of the Protei | 5e-17 | |
| cd05093 | 288 | cd05093, PTKc_TrkB, Catalytic domain of the Protei | 5e-17 | |
| cd05069 | 260 | cd05069, PTKc_Yes, Catalytic domain of the Protein | 6e-17 | |
| cd05092 | 280 | cd05092, PTKc_TrkA, Catalytic domain of the Protei | 7e-17 | |
| cd08221 | 256 | cd08221, STKc_Nek9, Catalytic domain of the Protei | 8e-17 | |
| cd06625 | 263 | cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ | 1e-16 | |
| cd06640 | 277 | cd06640, STKc_MST4, Catalytic domain of the Protei | 1e-16 | |
| cd05040 | 257 | cd05040, PTKc_Ack_like, Catalytic domain of the Pr | 1e-16 | |
| cd05050 | 288 | cd05050, PTKc_Musk, Catalytic domain of the Protei | 1e-16 | |
| cd05094 | 291 | cd05094, PTKc_TrkC, Catalytic domain of the Protei | 2e-16 | |
| cd05044 | 269 | cd05044, PTKc_c-ros, Catalytic domain of the Prote | 3e-16 | |
| cd05110 | 303 | cd05110, PTKc_HER4, Catalytic domain of the Protei | 5e-16 | |
| cd05607 | 277 | cd05607, STKc_GRK7, Catalytic domain of the Protei | 5e-16 | |
| cd06613 | 262 | cd06613, STKc_MAP4K3_like, Catalytic domain of Mit | 9e-16 | |
| cd05081 | 284 | cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) | 9e-16 | |
| cd05088 | 303 | cd05088, PTKc_Tie2, Catalytic domain of the Protei | 1e-15 | |
| cd06611 | 280 | cd06611, STKc_SLK_like, Catalytic domain of Ste20- | 2e-15 | |
| cd05579 | 265 | cd05579, STKc_MAST_like, Catalytic domain of Micro | 2e-15 | |
| cd06610 | 267 | cd06610, STKc_OSR1_SPAK, Catalytic domain of the P | 2e-15 | |
| cd05608 | 280 | cd05608, STKc_GRK1, Catalytic domain of the Protei | 2e-15 | |
| cd06616 | 288 | cd06616, PKc_MKK4, Catalytic domain of the dual-sp | 2e-15 | |
| cd06641 | 277 | cd06641, STKc_MST3, Catalytic domain of the Protei | 2e-15 | |
| cd05580 | 290 | cd05580, STKc_PKA, Catalytic domain of the Protein | 2e-15 | |
| TIGR03903 | 1266 | TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas | 4e-15 | |
| cd07833 | 288 | cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep | 4e-15 | |
| cd06917 | 277 | cd06917, STKc_NAK1_like, Catalytic domain of Funga | 7e-15 | |
| cd05073 | 260 | cd05073, PTKc_Hck, Catalytic domain of the Protein | 8e-15 | |
| cd05630 | 285 | cd05630, STKc_GRK6, Catalytic domain of the Protei | 1e-14 | |
| cd08224 | 267 | cd08224, STKc_Nek6_Nek7, Catalytic domain of the P | 1e-14 | |
| cd06624 | 268 | cd06624, STKc_ASK, Catalytic domain of the Protein | 1e-14 | |
| PLN00034 | 353 | PLN00034, PLN00034, mitogen-activated protein kina | 1e-14 | |
| cd05111 | 279 | cd05111, PTK_HER3, Pseudokinase domain of the Prot | 1e-14 | |
| cd07841 | 298 | cd07841, STKc_CDK7, Catalytic domain of the Serine | 2e-14 | |
| cd05097 | 295 | cd05097, PTKc_DDR_like, Catalytic domain of Discoi | 2e-14 | |
| cd05572 | 262 | cd05572, STKc_cGK_PKG, Catalytic domain of the Pro | 2e-14 | |
| cd05080 | 283 | cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma | 2e-14 | |
| cd06656 | 297 | cd06656, STKc_PAK3, Catalytic domain of the Protei | 3e-14 | |
| cd05046 | 275 | cd05046, PTK_CCK4, Pseudokinase domain of the Prot | 3e-14 | |
| cd06643 | 282 | cd06643, STKc_SLK, Catalytic domain of the Protein | 4e-14 | |
| cd05042 | 269 | cd05042, PTKc_Aatyk, Catalytic domain of the Prote | 4e-14 | |
| cd07851 | 343 | cd07851, STKc_p38, Catalytic domain of the Serine/ | 4e-14 | |
| cd05074 | 273 | cd05074, PTKc_Tyro3, Catalytic domain of the Prote | 5e-14 | |
| cd05064 | 266 | cd05064, PTKc_EphR_A10, Catalytic domain of the Pr | 5e-14 | |
| cd06647 | 293 | cd06647, STKc_PAK_I, Catalytic domain of the Prote | 6e-14 | |
| cd05108 | 316 | cd05108, PTKc_EGFR, Catalytic domain of the Protei | 7e-14 | |
| cd05611 | 260 | cd05611, STKc_Rim15_like, Catalytic domain of fung | 8e-14 | |
| cd06637 | 272 | cd06637, STKc_TNIK, Catalytic domain of the Protei | 1e-13 | |
| cd07832 | 286 | cd07832, STKc_CCRK, Catalytic domain of the Serine | 1e-13 | |
| cd05075 | 272 | cd05075, PTKc_Axl, Catalytic domain of the Protein | 2e-13 | |
| cd06636 | 282 | cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr | 2e-13 | |
| cd06655 | 296 | cd06655, STKc_PAK2, Catalytic domain of the Protei | 2e-13 | |
| cd05605 | 285 | cd05605, STKc_GRK4_like, Catalytic domain of G pro | 2e-13 | |
| cd06654 | 296 | cd06654, STKc_PAK1, Catalytic domain of the Protei | 2e-13 | |
| cd05109 | 279 | cd05109, PTKc_HER2, Catalytic domain of the Protei | 2e-13 | |
| cd06620 | 284 | cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of | 2e-13 | |
| cd06639 | 291 | cd06639, STKc_myosinIIIB, Catalytic domain of the | 3e-13 | |
| cd08225 | 257 | cd08225, STKc_Nek5, Catalytic domain of the Protei | 3e-13 | |
| cd05089 | 297 | cd05089, PTKc_Tie1, Catalytic domain of the Protei | 3e-13 | |
| cd05100 | 334 | cd05100, PTKc_FGFR3, Catalytic domain of the Prote | 3e-13 | |
| cd06617 | 283 | cd06617, PKc_MKK3_6, Catalytic domain of the dual- | 3e-13 | |
| cd05615 | 323 | cd05615, STKc_cPKC_alpha, Catalytic domain of the | 4e-13 | |
| cd06607 | 307 | cd06607, STKc_TAO, Catalytic domain of the Protein | 5e-13 | |
| cd07852 | 337 | cd07852, STKc_MAPK15, Catalytic domain of the Seri | 7e-13 | |
| cd05631 | 285 | cd05631, STKc_GRK4, Catalytic domain of the Protei | 7e-13 | |
| cd07830 | 283 | cd07830, STKc_MAK_like, Catalytic domain of Male g | 1e-12 | |
| cd06653 | 264 | cd06653, STKc_MEKK3_like_1, Catalytic domain of MA | 1e-12 | |
| cd06658 | 292 | cd06658, STKc_PAK5, Catalytic domain of the Protei | 1e-12 | |
| cd05051 | 296 | cd05051, PTKc_DDR, Catalytic domain of the Protein | 1e-12 | |
| cd05632 | 285 | cd05632, STKc_GRK5, Catalytic domain of the Protei | 1e-12 | |
| cd05570 | 318 | cd05570, STKc_PKC, Catalytic domain of the Protein | 2e-12 | |
| cd07846 | 286 | cd07846, STKc_CDKL2_3, Catalytic domain of the Ser | 2e-12 | |
| cd06633 | 313 | cd06633, STKc_TAO3, Catalytic domain of the Protei | 2e-12 | |
| cd06644 | 292 | cd06644, STKc_STK10_LOK, Catalytic domain of the P | 2e-12 | |
| cd06618 | 296 | cd06618, PKc_MKK7, Catalytic domain of the dual-sp | 2e-12 | |
| cd05087 | 269 | cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of t | 2e-12 | |
| cd05573 | 350 | cd05573, STKc_ROCK_NDR_like, Catalytic domain of R | 2e-12 | |
| cd05612 | 291 | cd05612, STKc_PRKX_like, Catalytic domain of PRKX- | 4e-12 | |
| cd05587 | 324 | cd05587, STKc_cPKC, Catalytic domain of the Protei | 4e-12 | |
| cd05098 | 307 | cd05098, PTKc_FGFR1, Catalytic domain of the Prote | 5e-12 | |
| cd07834 | 330 | cd07834, STKc_MAPK, Catalytic domain of the Serine | 6e-12 | |
| cd06638 | 286 | cd06638, STKc_myosinIIIA, Catalytic domain of the | 6e-12 | |
| PRK13184 | 932 | PRK13184, pknD, serine/threonine-protein kinase; R | 6e-12 | |
| cd05590 | 320 | cd05590, STKc_nPKC_eta, Catalytic domain of the Pr | 6e-12 | |
| cd05091 | 283 | cd05091, PTKc_Ror2, Catalytic domain of the Protei | 7e-12 | |
| cd07861 | 285 | cd07861, STKc_CDK1_euk, Catalytic domain of the Se | 8e-12 | |
| cd05575 | 323 | cd05575, STKc_SGK, Catalytic domain of the Protein | 9e-12 | |
| cd05079 | 284 | cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma | 9e-12 | |
| cd07863 | 288 | cd07863, STKc_CDK4, Catalytic domain of the Serine | 1e-11 | |
| cd05056 | 270 | cd05056, PTKc_FAK, Catalytic domain of the Protein | 1e-11 | |
| cd06657 | 292 | cd06657, STKc_PAK4, Catalytic domain of the Protei | 1e-11 | |
| cd07860 | 284 | cd07860, STKc_CDK2_3, Catalytic domain of the Seri | 1e-11 | |
| cd05047 | 270 | cd05047, PTKc_Tie, Catalytic domain of Tie Protein | 1e-11 | |
| cd06648 | 285 | cd06648, STKc_PAK_II, Catalytic domain of the Prot | 2e-11 | |
| cd05101 | 304 | cd05101, PTKc_FGFR2, Catalytic domain of the Prote | 2e-11 | |
| cd07855 | 334 | cd07855, STKc_ERK5, Catalytic domain of the Serine | 2e-11 | |
| cd07847 | 286 | cd07847, STKc_CDKL1_4, Catalytic domain of the Ser | 2e-11 | |
| cd08218 | 256 | cd08218, STKc_Nek1, Catalytic domain of the Protei | 2e-11 | |
| cd05616 | 323 | cd05616, STKc_cPKC_beta, Catalytic domain of the P | 2e-11 | |
| cd05619 | 316 | cd05619, STKc_nPKC_theta, Catalytic domain of the | 2e-11 | |
| cd07835 | 283 | cd07835, STKc_CDK1_like, Catalytic domain of Cycli | 3e-11 | |
| cd08223 | 257 | cd08223, STKc_Nek4, Catalytic domain of the Protei | 3e-11 | |
| cd06651 | 266 | cd06651, STKc_MEKK3, Catalytic domain of the Prote | 3e-11 | |
| PTZ00283 | 496 | PTZ00283, PTZ00283, serine/threonine protein kinas | 3e-11 | |
| cd08219 | 255 | cd08219, STKc_Nek3, Catalytic domain of the Protei | 4e-11 | |
| cd07862 | 290 | cd07862, STKc_CDK6, Catalytic domain of the Serine | 4e-11 | |
| cd07864 | 302 | cd07864, STKc_CDK12, Catalytic domain of the Serin | 5e-11 | |
| cd07845 | 309 | cd07845, STKc_CDK10, Catalytic domain of the Serin | 5e-11 | |
| cd06622 | 286 | cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of | 5e-11 | |
| cd06652 | 265 | cd06652, STKc_MEKK2, Catalytic domain of the Prote | 5e-11 | |
| cd07856 | 328 | cd07856, STKc_Sty1_Hog1, Catalytic domain of the S | 7e-11 | |
| cd05099 | 314 | cd05099, PTKc_FGFR4, Catalytic domain of the Prote | 8e-11 | |
| cd07880 | 343 | cd07880, STKc_p38gamma_MAPK12, Catalytic domain of | 8e-11 | |
| cd07879 | 342 | cd07879, STKc_p38delta_MAPK13, Catalytic domain of | 8e-11 | |
| cd07850 | 353 | cd07850, STKc_JNK, Catalytic domain of the Serine/ | 9e-11 | |
| cd05582 | 318 | cd05582, STKc_RSK_N, N-terminal catalytic domain o | 1e-10 | |
| cd06635 | 317 | cd06635, STKc_TAO1, Catalytic domain of the Protei | 1e-10 | |
| cd05106 | 374 | cd05106, PTKc_CSF-1R, Catalytic domain of the Prot | 2e-10 | |
| cd07853 | 372 | cd07853, STKc_NLK, Catalytic domain of the Serine/ | 2e-10 | |
| cd07857 | 332 | cd07857, STKc_MPK1, Catalytic domain of the Serine | 2e-10 | |
| PTZ00263 | 329 | PTZ00263, PTZ00263, protein kinase A catalytic sub | 2e-10 | |
| cd05585 | 312 | cd05585, STKc_YPK1_like, Catalytic domain of Yeast | 2e-10 | |
| cd05592 | 316 | cd05592, STKc_nPKC_theta_delta, Catalytic domain o | 2e-10 | |
| cd06634 | 308 | cd06634, STKc_TAO2, Catalytic domain of the Protei | 3e-10 | |
| cd07866 | 311 | cd07866, STKc_BUR1, Catalytic domain of the Serine | 3e-10 | |
| cd05604 | 325 | cd05604, STKc_SGK3, Catalytic domain of the Protei | 3e-10 | |
| cd07877 | 345 | cd07877, STKc_p38alpha_MAPK14, Catalytic domain of | 4e-10 | |
| PLN00009 | 294 | PLN00009, PLN00009, cyclin-dependent kinase A; Pro | 4e-10 | |
| cd07875 | 364 | cd07875, STKc_JNK1, Catalytic domain of the Serine | 5e-10 | |
| cd05043 | 280 | cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Rece | 5e-10 | |
| cd07876 | 359 | cd07876, STKc_JNK2, Catalytic domain of the Serine | 7e-10 | |
| cd05586 | 330 | cd05586, STKc_Sck1_like, Catalytic domain of Suppr | 7e-10 | |
| cd05078 | 258 | cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat | 7e-10 | |
| cd08228 | 267 | cd08228, STKc_Nek6, Catalytic domain of the Protei | 7e-10 | |
| cd05620 | 316 | cd05620, STKc_nPKC_delta, Catalytic domain of the | 8e-10 | |
| cd06659 | 297 | cd06659, STKc_PAK6, Catalytic domain of the Protei | 9e-10 | |
| cd06615 | 308 | cd06615, PKc_MEK, Catalytic domain of the dual-spe | 1e-09 | |
| cd07839 | 284 | cd07839, STKc_CDK5, Catalytic domain of the Serine | 1e-09 | |
| cd06649 | 331 | cd06649, PKc_MEK2, Catalytic domain of the dual-sp | 1e-09 | |
| cd05095 | 296 | cd05095, PTKc_DDR2, Catalytic domain of the Protei | 1e-09 | |
| cd07836 | 284 | cd07836, STKc_Pho85, Catalytic domain of the Serin | 1e-09 | |
| cd07831 | 282 | cd07831, STKc_MOK, Catalytic domain of the Serine/ | 1e-09 | |
| cd05096 | 304 | cd05096, PTKc_DDR1, Catalytic domain of the Protei | 2e-09 | |
| cd07865 | 310 | cd07865, STKc_CDK9, Catalytic domain of the Serine | 2e-09 | |
| cd05603 | 321 | cd05603, STKc_SGK2, Catalytic domain of the Protei | 3e-09 | |
| cd07874 | 355 | cd07874, STKc_JNK3, Catalytic domain of the Serine | 4e-09 | |
| cd05104 | 375 | cd05104, PTKc_Kit, Catalytic domain of the Protein | 4e-09 | |
| cd05610 | 669 | cd05610, STKc_MASTL, Catalytic domain of the Prote | 4e-09 | |
| cd06650 | 333 | cd06650, PKc_MEK1, Catalytic domain of the dual-sp | 4e-09 | |
| cd06619 | 279 | cd06619, PKc_MKK5, Catalytic domain of the dual-sp | 5e-09 | |
| cd05621 | 370 | cd05621, STKc_ROCK2, Catalytic domain of the Prote | 8e-09 | |
| PTZ00426 | 340 | PTZ00426, PTZ00426, cAMP-dependent protein kinase | 1e-08 | |
| cd05602 | 325 | cd05602, STKc_SGK1, Catalytic domain of the Protei | 1e-08 | |
| cd08229 | 267 | cd08229, STKc_Nek7, Catalytic domain of the Protei | 1e-08 | |
| cd05633 | 279 | cd05633, STKc_GRK3, Catalytic domain of the Protei | 1e-08 | |
| cd07858 | 337 | cd07858, STKc_TEY_MAPK_plant, Catalytic domain of | 1e-08 | |
| cd07878 | 343 | cd07878, STKc_p38beta_MAPK11, Catalytic domain of | 2e-08 | |
| cd05606 | 278 | cd05606, STKc_beta_ARK, Catalytic domain of the Pr | 4e-08 | |
| cd05037 | 259 | cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) dom | 4e-08 | |
| cd05617 | 327 | cd05617, STKc_aPKC_zeta, Catalytic domain of the P | 4e-08 | |
| cd05597 | 331 | cd05597, STKc_DMPK_like, Catalytic domain of Myoto | 4e-08 | |
| cd07869 | 303 | cd07869, STKc_PFTAIRE1, Catalytic domain of the Se | 5e-08 | |
| cd05600 | 333 | cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun | 6e-08 | |
| cd05584 | 323 | cd05584, STKc_p70S6K, Catalytic domain of the Prot | 6e-08 | |
| cd07849 | 336 | cd07849, STKc_ERK1_2_like, Catalytic domain of Ext | 6e-08 | |
| cd05624 | 331 | cd05624, STKc_MRCK_beta, Catalytic domain of the P | 7e-08 | |
| cd05102 | 338 | cd05102, PTKc_VEGFR3, Catalytic domain of the Prot | 7e-08 | |
| cd05593 | 328 | cd05593, STKc_PKB_gamma, Catalytic domain of the P | 7e-08 | |
| cd05077 | 262 | cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) do | 7e-08 | |
| cd05618 | 329 | cd05618, STKc_aPKC_iota, Catalytic domain of the P | 7e-08 | |
| cd05591 | 321 | cd05591, STKc_nPKC_epsilon, Catalytic domain of th | 8e-08 | |
| PHA03207 | 392 | PHA03207, PHA03207, serine/threonine kinase US3; P | 1e-07 | |
| cd05594 | 325 | cd05594, STKc_PKB_alpha, Catalytic domain of the P | 1e-07 | |
| cd05599 | 364 | cd05599, STKc_NDR_like, Catalytic domain of Nuclea | 1e-07 | |
| cd08222 | 260 | cd08222, STKc_Nek11, Catalytic domain of the Prote | 1e-07 | |
| cd05583 | 288 | cd05583, STKc_MSK_N, N-terminal catalytic domain o | 2e-07 | |
| cd07842 | 316 | cd07842, STKc_CDK8_like, Catalytic domain of Cycli | 2e-07 | |
| cd05054 | 337 | cd05054, PTKc_VEGFR, Catalytic domain of the Prote | 2e-07 | |
| cd07872 | 309 | cd07872, STKc_PCTAIRE2, Catalytic domain of the Se | 2e-07 | |
| cd05103 | 343 | cd05103, PTKc_VEGFR2, Catalytic domain of the Prot | 2e-07 | |
| cd05589 | 324 | cd05589, STKc_PKN, Catalytic domain of the Protein | 2e-07 | |
| cd05601 | 330 | cd05601, STKc_CRIK, Catalytic domain of the Protei | 2e-07 | |
| cd06646 | 267 | cd06646, STKc_MAP4K5, Catalytic domain of the Prot | 2e-07 | |
| cd07848 | 287 | cd07848, STKc_CDKL5, Catalytic domain of the Serin | 3e-07 | |
| cd05623 | 332 | cd05623, STKc_MRCK_alpha, Catalytic domain of the | 3e-07 | |
| cd07873 | 301 | cd07873, STKc_PCTAIRE1, Catalytic domain of the Se | 3e-07 | |
| cd01098 | 84 | cd01098, PAN_AP_plant, Plant PAN/APPLE-like domain | 3e-07 | |
| cd07859 | 338 | cd07859, STKc_TDY_MAPK_plant, Catalytic domain of | 3e-07 | |
| cd05571 | 323 | cd05571, STKc_PKB, Catalytic domain of the Protein | 3e-07 | |
| PHA03209 | 357 | PHA03209, PHA03209, serine/threonine kinase US3; P | 4e-07 | |
| cd05596 | 370 | cd05596, STKc_ROCK, Catalytic domain of the Protei | 5e-07 | |
| cd06645 | 267 | cd06645, STKc_MAP4K3, Catalytic domain of the Prot | 5e-07 | |
| cd05595 | 323 | cd05595, STKc_PKB_beta, Catalytic domain of the Pr | 6e-07 | |
| cd05588 | 329 | cd05588, STKc_aPKC, Catalytic domain of the Protei | 8e-07 | |
| cd07837 | 295 | cd07837, STKc_CdkB_plant, Catalytic domain of the | 9e-07 | |
| cd07871 | 288 | cd07871, STKc_PCTAIRE3, Catalytic domain of the Se | 1e-06 | |
| cd05614 | 332 | cd05614, STKc_MSK2_N, N-terminal catalytic domain | 1e-06 | |
| cd05086 | 268 | cd05086, PTKc_Aatyk2, Catalytic domain of the Prot | 1e-06 | |
| cd07844 | 291 | cd07844, STKc_PCTAIRE_like, Catalytic domain of PC | 1e-06 | |
| cd05628 | 363 | cd05628, STKc_NDR1, Catalytic domain of the Protei | 3e-06 | |
| PHA03390 | 267 | PHA03390, pk1, serine/threonine-protein kinase 1; | 3e-06 | |
| cd05598 | 376 | cd05598, STKc_LATS, Catalytic domain of the Protei | 4e-06 | |
| cd07870 | 291 | cd07870, STKc_PFTAIRE2, Catalytic domain of the Se | 6e-06 | |
| cd05627 | 360 | cd05627, STKc_NDR2, Catalytic domain of the Protei | 6e-06 | |
| PTZ00036 | 440 | PTZ00036, PTZ00036, glycogen synthase kinase; Prov | 6e-06 | |
| cd05622 | 371 | cd05622, STKc_ROCK1, Catalytic domain of the Prote | 8e-06 | |
| cd05613 | 290 | cd05613, STKc_MSK1_N, N-terminal catalytic domain | 9e-06 | |
| cd05574 | 316 | cd05574, STKc_phototropin_like, Catalytic domain o | 1e-05 | |
| cd05106 | 374 | cd05106, PTKc_CSF-1R, Catalytic domain of the Prot | 4e-05 | |
| PTZ00267 | 478 | PTZ00267, PTZ00267, NIMA-related protein kinase; P | 4e-05 | |
| cd07854 | 342 | cd07854, STKc_MAPK4_6, Catalytic domain of the Ser | 4e-05 | |
| cd05107 | 401 | cd05107, PTKc_PDGFR_beta, Catalytic domain of the | 5e-05 | |
| cd05105 | 400 | cd05105, PTKc_PDGFR_alpha, Catalytic domain of the | 7e-05 | |
| PHA03211 | 461 | PHA03211, PHA03211, serine/threonine kinase US3; P | 1e-04 | |
| PHA02988 | 283 | PHA02988, PHA02988, hypothetical protein; Provisio | 2e-04 | |
| PTZ00024 | 335 | PTZ00024, PTZ00024, cyclin-dependent protein kinas | 2e-04 | |
| cd05104 | 375 | cd05104, PTKc_Kit, Catalytic domain of the Protein | 4e-04 | |
| cd05609 | 305 | cd05609, STKc_MAST, Catalytic domain of the Protei | 4e-04 | |
| cd05625 | 382 | cd05625, STKc_LATS1, Catalytic domain of the Prote | 5e-04 | |
| PTZ00284 | 467 | PTZ00284, PTZ00284, protein kinase; Provisional | 5e-04 | |
| cd07843 | 293 | cd07843, STKc_CDC2L1, Catalytic domain of the Seri | 0.001 | |
| PHA03212 | 391 | PHA03212, PHA03212, serine/threonine kinase US3; P | 0.001 | |
| cd05629 | 377 | cd05629, STKc_NDR_like_fungal, Catalytic domain of | 0.001 | |
| cd05054 | 337 | cd05054, PTKc_VEGFR, Catalytic domain of the Prote | 0.002 | |
| PHA02882 | 294 | PHA02882, PHA02882, putative serine/threonine kina | 0.003 | |
| cd05107 | 401 | cd05107, PTKc_PDGFR_beta, Catalytic domain of the | 0.004 | |
| smart00090 | 237 | smart00090, RIO, RIO-like kinase | 0.004 |
| >gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Score = 166 bits (422), Expect = 4e-47
Identities = 69/201 (34%), Positives = 104/201 (51%), Gaps = 9/201 (4%)
Query: 509 LGRGAFGTVYKGFVNMGSSNHVAVKKLN-SVFQDSEKEFKAEVNGIGQTHHKNLVRLLGY 567
LG G FGTVY + + VA+K + +E E+ + + +H N+V+L G
Sbjct: 1 LGEGGFGTVYLAR-DKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGV 59
Query: 568 CDEGQNRLLVYEFMSNGTVASFLFGDSKP-NWKLRTEIAMGIAGGLFYLHEECCTQIIHC 626
++ + LV E+ G++ L + + I + I GL YLH IIH
Sbjct: 60 FEDENHLYLVMEYCEGGSLKDLLKENEGKLSEDEILRILLQILEGLEYLHSN---GIIHR 116
Query: 627 DIKPQNILLD-DHYNARISDFGLAKLLTLDQSHTNTAIRGTKGYVAPE-WFRNMPITVKV 684
D+KP+NILLD D+ +++DFGL+KLLT D+S T I GT Y+APE + K
Sbjct: 117 DLKPENILLDSDNGKVKLADFGLSKLLTSDKSLLKT-IVGTPAYMAPEVLLGKGYYSEKS 175
Query: 685 DVYSYGVLLLEIICLRRNIDN 705
D++S GV+L E+ L+ I
Sbjct: 176 DIWSLGVILYELPELKDLIRK 196
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215 |
| >gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase | Back alignment and domain information |
|---|
Score = 164 bits (418), Expect = 7e-46
Identities = 87/281 (30%), Positives = 134/281 (47%), Gaps = 37/281 (13%)
Query: 505 FKEELGRGAFGTVYKGFVNMGSSNH---VAVKKLNSVFQDSEK-EFKAEVNGIGQTHHKN 560
++LG GAFG VYKG + VAVK L + E+ EF E + + + H N
Sbjct: 3 LGKKLGEGAFGEVYKGTLKGDGEGTETKVAVKTLKEGASEEEREEFLEEASIMKKLSHPN 62
Query: 561 LVRLLGYCDEGQNRLLVYEFMSNGTVASFL-FGDSKPNWKLRTEIAMGIAGGLFYLHEEC 619
+VRLLG C +G+ +V E+M G + FL K K ++A+ IA G+ YL +
Sbjct: 63 IVRLLGVCTQGEPLYIVTEYMPGGDLLDFLRKHGEKLTLKDLLQMALQIAKGMEYLESKN 122
Query: 620 CTQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLDQSHTNTAIRGTKG---YVAPEWFR 676
+H D+ +N L+ ++ +ISDFGL++ + D + G K ++APE +
Sbjct: 123 F---VHRDLAARNCLVTENLVVKISDFGLSRDIYEDDYYRKR--GGGKLPIKWMAPESLK 177
Query: 677 NMPITVKVDVYSYGVLLLEIICLRR----NIDNEISKVDKAILTDWAYDRYQERTLEALV 732
+ T K DV+S+GVLL EI L + NE +V + + D Y+ L
Sbjct: 178 DGKFTSKSDVWSFGVLLWEIFTLGEQPYPGMSNE--EVLELL-----EDGYR---LPRP- 226
Query: 733 ENDLEAMNNVTMLHRFVMVAFWCIQEDPSHRPTMRKVTQML 773
EN + + + ML C DP RPT ++ + L
Sbjct: 227 ENCPDELYEL-MLQ--------CWAYDPEDRPTFSELVEDL 258
|
Length = 258 |
| >gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain | Back alignment and domain information |
|---|
Score = 164 bits (417), Expect = 7e-46
Identities = 83/275 (30%), Positives = 130/275 (47%), Gaps = 37/275 (13%)
Query: 505 FKEELGRGAFGTVYKGFVNMGSSNHVAVKKLNSVFQDSEKE--FKAEVNGIGQTHHKNLV 562
+LG G+FGTVYK + G+ VAVK L + S+K+ + E+ + + H N+V
Sbjct: 3 LLRKLGSGSFGTVYKA-KHKGTGKIVAVKILKKRSEKSKKDQTARREIRILRRLSHPNIV 61
Query: 563 RLLGYCDEGQNRLLVYEFMSNGTVASFLFGDSKPNWKLRTEIAMGIAGGLFYLHEECCTQ 622
RL+ ++ + LV E+ G + +L + +IA+ I GL YLH
Sbjct: 62 RLIDAFEDKDHLYLVMEYCEGGDLFDYLSRGGPLSEDEAKKIALQILRGLEYLHSN---G 118
Query: 623 IIHCDIKPQNILLDDHYNARISDFGLAKLLTLDQSHTNTAIRGTKGYVAPEW-FRNMPIT 681
IIH D+KP+NILLD++ +I+DFGLAK L S T GT Y+APE
Sbjct: 119 IIHRDLKPENILLDENGVVKIADFGLAKKLLKSSSSLTT-FVGTPWYMAPEVLLGGNGYG 177
Query: 682 VKVDVYSYGVLLLEIICLR-----RNIDNEISKVDKAILTDWAYDRYQER----TLEALV 732
KVDV+S GV+L E++ + NI +++ + + + +D + + L+
Sbjct: 178 PKVDVWSLGVILYELLTGKPPFSGENILDQLQLIRRILGPPLEFDEPKWSSGSEEAKDLI 237
Query: 733 ENDLEAMNNVTMLHRFVMVAFWCIQEDPSHRPTMR 767
+ C+ +DPS RPT
Sbjct: 238 K--------------------KCLNKDPSKRPTAE 252
|
Length = 260 |
| >gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Score = 159 bits (405), Expect = 4e-44
Identities = 83/284 (29%), Positives = 124/284 (43%), Gaps = 44/284 (15%)
Query: 505 FKEELGRGAFGTVYKGFVNMGSSNH---VAVKKLNSVFQDSE-KEFKAEVNGIGQTHHKN 560
++LG GAFG VYKG + VAVK L + + +EF E + + H N
Sbjct: 3 LGKKLGEGAFGEVYKGKLKGKGGKKKVEVAVKTLKEDASEQQIEEFLREARIMRKLDHPN 62
Query: 561 LVRLLGYCDEGQNRLLVYEFMSNGTVASFLFGDSKPNWKLRT--EIAMGIAGGLFYLHEE 618
+V+LLG C E + +V E+M G + S+L ++P L A+ IA G+ YL +
Sbjct: 63 VVKLLGVCTEEEPLYIVMEYMEGGDLLSYL-RKNRPKLSLSDLLSFALQIARGMEYLESK 121
Query: 619 CCTQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLDQSHTNTAIRGTKGYV---APEWF 675
IH D+ +N L+ ++ +ISDFGL++ L RG K + APE
Sbjct: 122 NF---IHRDLAARNCLVGENLVVKISDFGLSRDLY---DDDYYRKRGGKLPIRWMAPESL 175
Query: 676 RNMPITVKVDVYSYGVLLLEIICL----RRNIDNEISKVDKAILTDWAYDRYQERTLEAL 731
+ T K DV+S+GVLL EI L + NE +
Sbjct: 176 KEGKFTSKSDVWSFGVLLWEIFTLGEQPYPGMSNE--------------------EVLEY 215
Query: 732 VEND--LEAMNNVTMLHRFVMVAFWCIQEDPSHRPTMRKVTQML 773
++N L N + C EDP RPT ++ ++L
Sbjct: 216 LKNGYRLPQPPNCP--PELYDLMLQCWAEDPEDRPTFSELVEIL 257
|
Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257 |
| >gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Score = 158 bits (402), Expect = 9e-44
Identities = 69/280 (24%), Positives = 113/280 (40%), Gaps = 43/280 (15%)
Query: 505 FKEELGRGAFGTVYKGFVNMGSSNHVAVKKLNSVFQDSEKE-FKAEVNGIGQTHHKNLVR 563
E+LG G+FG VY + + VA+K + ++E E+ + + H N+VR
Sbjct: 3 ILEKLGEGSFGKVYLA-RDKKTGKLVAIKVIKKKKIKKDRERILREIKILKKLKHPNIVR 61
Query: 564 LLGYCDEGQNRLLVYEFMSNGTVASFLFGDSKPNWKLRTEIAMG-----IAGGLFYLHEE 618
L ++ LV E+ G + L K +L +E I L YLH +
Sbjct: 62 LYDVFEDEDKLYLVMEYCEGGDLFDLL----KKRGRL-SEDEARFYLRQILSALEYLHSK 116
Query: 619 CCTQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLDQSHTNTAIRGTKGYVAPEWFRNM 678
I+H D+KP+NILLD+ + +++DFGLA+ L T + GT Y+APE
Sbjct: 117 ---GIVHRDLKPENILLDEDGHVKLADFGLARQLD-PGEKLTTFV-GTPEYMAPEVLLGK 171
Query: 679 PITVKVDVYSYGVLLLEIICLRR------NIDNEISKVDKAILTDWAYDRYQERTLEALV 732
VD++S GV+L E++ + + K+ K + + L+
Sbjct: 172 GYGKAVDIWSLGVILYELLTGKPPFPGDDQLLELFKKIGKPKPPFPPPEWDISPEAKDLI 231
Query: 733 ENDLEAMNNVTMLHRFVMVAFWCIQEDPSHRPTMRKVTQM 772
+ +DP R T + Q
Sbjct: 232 RK--------------------LLVKDPEKRLTAEEALQH 251
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254 |
| >gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Score = 157 bits (399), Expect = 3e-43
Identities = 82/285 (28%), Positives = 122/285 (42%), Gaps = 45/285 (15%)
Query: 505 FKEELGRGAFGTVYKGFVNMGSSNH---VAVKKL-NSVFQDSEKEFKAEVNGIGQTHHKN 560
++LG GAFG VYKG + VAVK L + +EF E + + H N
Sbjct: 3 LGKKLGEGAFGEVYKGTLKGKGDGKEVEVAVKTLKEDASEQQIEEFLREARIMRKLDHPN 62
Query: 561 LVRLLGYCDEGQNRLLVYEFMSNGTVASFLFGDSKPN---WKLRTEIAMGIAGGLFYLHE 617
+V+LLG C E + ++V E+M G + +L ++P A+ IA G+ YL
Sbjct: 63 IVKLLGVCTEEEPLMIVMEYMPGGDLLDYL-RKNRPKELSLSDLLSFALQIARGMEYLES 121
Query: 618 ECCTQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLDQ----SHTNTAIRGTKGYVAPE 673
+ IH D+ +N L+ ++ +ISDFGL++ L D IR ++APE
Sbjct: 122 KNF---IHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYYKVKGGKLPIR----WMAPE 174
Query: 674 WFRNMPITVKVDVYSYGVLLLEIICL----RRNIDNEISKVDKAILTDWAYDRYQERTLE 729
+ T K DV+S+GVLL EI L + N LE
Sbjct: 175 SLKEGKFTSKSDVWSFGVLLWEIFTLGEEPYPGMSN-------------------AEVLE 215
Query: 730 ALVEND-LEAMNNVTMLHRFVMVAFWCIQEDPSHRPTMRKVTQML 773
L + L N + C EDP RPT ++ ++L
Sbjct: 216 YLKKGYRLPKPPNCP--PELYKLMLQCWAEDPEDRPTFSELVEIL 258
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258 |
| >gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 146 bits (372), Expect = 1e-39
Identities = 86/291 (29%), Positives = 126/291 (43%), Gaps = 52/291 (17%)
Query: 507 EELGRGAFGTVYKGFVNMGSSNH--VAVKKLNSVFQDSE-KEFKAEVNGIGQTHHKNLVR 563
++LG GAFG VYKG + VAVK L + E K+F E + + H N+VR
Sbjct: 1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVR 60
Query: 564 LLGYCDEGQNRLLVYEFMSNGTVASFL---------FGDSKPNWKLRTEIAMGIAGGLFY 614
LLG C E + LV E+M G + +L S + K A+ IA G+ Y
Sbjct: 61 LLGVCTEEEPLYLVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEY 120
Query: 615 LHEECCTQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLDQSHTNTAIRGTKGYV---- 670
L + + +H D+ +N L+ + +ISDFGL++ + D + T G +
Sbjct: 121 LASK---KFVHRDLAARNCLVGEDLVVKISDFGLSRDVYDDDYYRKK----TGGKLPIRW 173
Query: 671 -APEWFRNMPITVKVDVYSYGVLLLEIICLRR----NIDNEISKVDKAILTDWAYDRYQE 725
APE ++ T K DV+S+GVLL EI L + N E
Sbjct: 174 MAPESLKDGIFTSKSDVWSFGVLLWEIFTLGATPYPGLSN-------------------E 214
Query: 726 RTLEALVE-NDLEAMNNVT-MLHRFVMVAFWCIQEDPSHRPTMRKVTQMLE 774
LE L + L L+ ++ C Q DP RPT ++ + LE
Sbjct: 215 EVLEYLRKGYRLPKPEYCPDELYELML---SCWQLDPEDRPTFSELVERLE 262
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262 |
| >gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Score = 129 bits (326), Expect = 2e-33
Identities = 69/221 (31%), Positives = 108/221 (48%), Gaps = 22/221 (9%)
Query: 500 EVTRGFKEELGRGAFGTVYKGFVNMGSSNHVAVKKLNSVFQDSE--KEFKAEVNGIGQTH 557
E TRG E LGRG+FG+VY + + +AVK + E + + E+ +
Sbjct: 1 EWTRG--ELLGRGSFGSVYLAL-DKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQ 57
Query: 558 HKNLVRLLG-YCDEGQNRLLVY-EFMSNGTVASFLFGDSKPNWKLR-TEI---AMGIAGG 611
H N+VR G DE +N L ++ E++S G+++S L K KL I I G
Sbjct: 58 HPNIVRYYGSERDEEKNTLNIFLEYVSGGSLSSLL----KKFGKLPEPVIRKYTRQILEG 113
Query: 612 LFYLHEECCTQIIHCDIKPQNILLDDHYNARISDFGLAKLL-TLDQSHTNTAIRGTKGYV 670
L YLH I+H DIK NIL+D +++DFG AK L ++ ++RGT ++
Sbjct: 114 LAYLHSN---GIVHRDIKGANILVDSDGVVKLADFGCAKRLGDIETGEGTGSVRGTPYWM 170
Query: 671 APEWFRNMPITVKVDVYSYGVLLLEIICLRR---NIDNEIS 708
APE R D++S G ++E+ + + N ++
Sbjct: 171 APEVIRGEEYGRAADIWSLGCTVIEMATGKPPWSELGNPMA 211
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260 |
| >gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Score = 127 bits (321), Expect = 6e-33
Identities = 56/195 (28%), Positives = 91/195 (46%), Gaps = 15/195 (7%)
Query: 506 KEELGRGAFGTVYKGFVNMGSSNHVAVKKLNSVFQDSEKEFKAEVNGIGQTHHKNLVRLL 565
E++G+G FG VYK + VA+K + ++ +++ E+ + + H N+V+
Sbjct: 5 LEKIGKGGFGEVYKARHKR-TGKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIVKYY 63
Query: 566 GYCDEGQNRLLVYEFMSNGTVASFLFGDSKPNWKLRTE-----IAMGIAGGLFYLHEECC 620
G + +V EF S G++ L K + TE + + GL YLH
Sbjct: 64 GSYLKKDELWIVMEFCSGGSLKDLL----KSTNQTLTESQIAYVCKELLKGLEYLHSN-- 117
Query: 621 TQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLDQSHTNTAIRGTKGYVAPEWFRNMPI 680
IIH DIK NILL ++ DFGL+ L+ ++ GT ++APE P
Sbjct: 118 -GIIHRDIKAANILLTSDGEVKLIDFGLSAQLSDTKARNTMV--GTPYWMAPEVINGKPY 174
Query: 681 TVKVDVYSYGVLLLE 695
K D++S G+ +E
Sbjct: 175 DYKADIWSLGITAIE 189
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253 |
| >gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Score = 121 bits (305), Expect = 1e-30
Identities = 55/210 (26%), Positives = 99/210 (47%), Gaps = 27/210 (12%)
Query: 506 KEELGRGAFGTVYKGFVNMGSSNHVAVKKLNSVFQDSEKEFKA---EVNGIGQTHHKNLV 562
+++G+G+FG VY +K+++ + SEKE + EV + + +H N++
Sbjct: 5 IKQIGKGSFGKVYLV-RRKSDGKLYVLKEID-LSNMSEKEREDALNEVKILKKLNHPNII 62
Query: 563 RLLGYCD---EGQNRLLVYEFMSNGTVASFLFGDSKPN--------WKLRTEIAMGIAGG 611
+ Y + E +V E+ G ++ + K ++ +
Sbjct: 63 K---YYESFEEKGKLCIVMEYADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLA---- 115
Query: 612 LFYLHEECCTQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLDQSHTNTAIRGTKGYVA 671
L YLH +I+H DIKPQNI L + ++ DFG++K+L+ T + GT Y++
Sbjct: 116 LKYLHSR---KILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTVDLAKTVV-GTPYYLS 171
Query: 672 PEWFRNMPITVKVDVYSYGVLLLEIICLRR 701
PE +N P K D++S G +L E+ L+
Sbjct: 172 PELCQNKPYNYKSDIWSLGCVLYELCTLKH 201
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258 |
| >gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Score = 119 bits (297), Expect = 8e-29
Identities = 71/280 (25%), Positives = 114/280 (40%), Gaps = 32/280 (11%)
Query: 505 FKEELGRGAFGTVYKGFVNMGSSNHVAVKKLNSVFQDSEKE---FKAEVNGIGQT--HHK 559
+LG G+FG VY VA+K L + KE F E+ I + H
Sbjct: 4 ILRKLGEGSFGEVYLARDRK----LVALKVLAKKLESKSKEVERFLREI-QILASLNHPP 58
Query: 560 NLVRLLGYCDEGQNRLLVYEFMSNGTVASFLFGDSKPNWKLRTE----IAMGIAGGLFYL 615
N+V+L + + + LV E++ G++ L L I I L YL
Sbjct: 59 NIVKLYDFFQDEGSLYLVMEYVDGGSLED-LLKKIGRKGPLSESEALFILAQILSALEYL 117
Query: 616 HEECCTQIIHCDIKPQNILLDDHYN-ARISDFGLAKLLTLDQSHTN-----TAIRGTKGY 669
H + IIH DIKP+NILLD ++ DFGLAKLL S ++ + GT GY
Sbjct: 118 HSKG---IIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGSTSSIPALPSTSVGTPGY 174
Query: 670 VAPEWFRNM---PITVKVDVYSYGVLLLEIICLRRNIDNEISKVDKAILTDWAYDRYQER 726
+APE + + D++S G+ L E++ + E + + +
Sbjct: 175 MAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLKIILELPTPS 234
Query: 727 TLEALVENDLEAMNNVTMLHRFVMVAFWCIQEDPSHRPTM 766
L ++ E ++ + + +DP +R +
Sbjct: 235 LASPLSPSNPELISKA--ASDLLKK---LLAKDPKNRLSS 269
|
Length = 384 |
| >gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 115 bits (291), Expect = 9e-29
Identities = 67/197 (34%), Positives = 98/197 (49%), Gaps = 14/197 (7%)
Query: 506 KEELGRGAFGTVYKGFVNMGSSNHVAVKKLNSVFQDSEKEFKAEVNGIGQTHHKNLVRLL 565
+ +LG G FG V+ G N + VAVK L E F E + + H LV+L
Sbjct: 11 ERKLGAGQFGEVWMGTWN--GTTKVAVKTLKPGTMSPE-AFLQEAQIMKKLRHDKLVQLY 67
Query: 566 GYCDEGQNRLLVYEFMSNGTVASFLFGDSKPNWKLRTEIAMG--IAGGLFYLHEECCTQI 623
C E + +V E+MS G++ FL +L + M IA G+ YL
Sbjct: 68 AVCSEEEPIYIVTEYMSKGSLLDFLKSGEGKKLRLPQLVDMAAQIAEGMAYLESR---NY 124
Query: 624 IHCDIKPQNILLDDHYNARISDFGLAKLLTLDQSHTNTAIRGTK---GYVAPEWFRNMPI 680
IH D+ +NIL+ ++ +I+DFGLA+L+ D+ TA G K + APE
Sbjct: 125 IHRDLAARNILVGENLVCKIADFGLARLIEDDEY---TAREGAKFPIKWTAPEAANYGRF 181
Query: 681 TVKVDVYSYGVLLLEII 697
T+K DV+S+G+LL EI+
Sbjct: 182 TIKSDVWSFGILLTEIV 198
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261 |
| >gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 115 bits (290), Expect = 9e-29
Identities = 73/278 (26%), Positives = 121/278 (43%), Gaps = 41/278 (14%)
Query: 505 FKEELGRGAFGTVYKGFVNMGSSNHVAVKKLNSVFQDSEKEFKAEVNGIGQTHHKNLVRL 564
+G+G FG V G VAVK L + + F AE + + H NLV+L
Sbjct: 10 LGATIGKGEFGDVMLGDY---RGQKVAVKCLKDD-STAAQAFLAEASVMTTLRHPNLVQL 65
Query: 565 LGYCDEGQNRLLVYEFMSNGTVASFL--FGDSKPNWKLRTEIAMGIAGGLFYLHEECCTQ 622
LG +G +V E+M+ G++ +L G + + A+ + G+ YL E+
Sbjct: 66 LGVVLQGNPLYIVTEYMAKGSLVDYLRSRGRAVITLAQQLGFALDVCEGMEYLEEK---N 122
Query: 623 IIHCDIKPQNILLDDHYNARISDFGLAKLLTLDQSHTNTAIRGTKGYVAPEWFRNMPITV 682
+H D+ +N+L+ + A++SDFGLAK + Q ++ T APE R +
Sbjct: 123 FVHRDLAARNVLVSEDLVAKVSDFGLAKEASQGQDSGKLPVKWT----APEALREKKFST 178
Query: 683 KVDVYSYGVLLLEIICLRRN------IDNEISKVDKAILTDWAYDRYQERTLEALVENDL 736
K DV+S+G+LL EI R + + + V+K Y+ E
Sbjct: 179 KSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPHVEKG---------YRMEAPEGCPPEVY 229
Query: 737 EAMNNVTMLHRFVMVAFWCIQEDPSHRPTMRKVTQMLE 774
+ M + C + DP+ RPT +++ + L
Sbjct: 230 KVMKD-------------CWELDPAKRPTFKQLREQLA 254
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256 |
| >gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 112 bits (283), Expect = 8e-28
Identities = 56/199 (28%), Positives = 104/199 (52%), Gaps = 15/199 (7%)
Query: 505 FKEELGRGAFGTVYKGFVNMGSSNHVAVKK--LNSVFQDSEKEFKAEVNGIGQTHHKNLV 562
+ +GRGAFG VYKG +N+ + + VA+K+ L + +++ K E++ + H N+V
Sbjct: 4 LGDLIGRGAFGVVYKG-LNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIV 62
Query: 563 RLLGYCDEGQNRLLVYEFMSNGTVASFLFGDSKPNWKL-RTEIAMGIAG---GLFYLHEE 618
+ +G + + ++ E+ NG++ + K + +A+ + GL YLHE+
Sbjct: 63 KYIGSIETSDSLYIILEYAENGSLRQII----KKFGPFPESLVAVYVYQVLQGLAYLHEQ 118
Query: 619 CCTQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLDQSHTNTAIRGTKGYVAPEWFRNM 678
+IH DIK NIL +++DFG+A L D S + ++ GT ++APE
Sbjct: 119 ---GVIHRDIKAANILTTKDGVVKLADFGVATKLN-DVSKDDASVVGTPYWMAPEVIEMS 174
Query: 679 PITVKVDVYSYGVLLLEII 697
+ D++S G ++E++
Sbjct: 175 GASTASDIWSLGCTVIELL 193
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254 |
| >gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 109 bits (275), Expect = 1e-26
Identities = 73/281 (25%), Positives = 132/281 (46%), Gaps = 40/281 (14%)
Query: 507 EELGRGAFGTVYKGFVNMGSSNH--VAVKKLNSVFQDSEK-EFKAEVNGIGQTHHKNLVR 563
+ +G G FG V +G + + VA+K L + D ++ +F E + +GQ H N++R
Sbjct: 10 KVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNIIR 69
Query: 564 LLGYCDEGQNRLLVYEFMSNGTVASFL-FGDSKPNWKLRTEIAMGIAGGLFYLHEECCTQ 622
L G + + +++ E+M NG++ FL D K + GIA G+ YL E
Sbjct: 70 LEGVVTKSRPVMIITEYMENGSLDKFLRENDGKFTVGQLVGMLRGIASGMKYLSEMN--- 126
Query: 623 IIHCDIKPQNILLDDHYNARISDFGLAKLLTLDQSHTNTA-----IRGTKGYVAPEWFRN 677
+H D+ +NIL++ + ++SDFGL++ L ++ T IR T APE
Sbjct: 127 YVHRDLAARNILVNSNLVCKVSDFGLSRRLEDSEATYTTKGGKIPIRWT----APEAIAY 182
Query: 678 MPITVKVDVYSYGVLLLEIICLRR----NIDNEISKVDKAILTDWAYDRYQERTLEALVE 733
T DV+S+G+++ E++ ++ N+ V KA+ + R
Sbjct: 183 RKFTSASDVWSFGIVMWEVMSYGERPYWDMSNQ--DVIKAVEDGY---RLP--------- 228
Query: 734 NDLEAMNNVTMLHRFVMVAFWCIQEDPSHRPTMRKVTQMLE 774
M+ + L++ ++ C Q+D + RPT ++ L+
Sbjct: 229 ---PPMDCPSALYQLML---DCWQKDRNERPTFSQIVSTLD 263
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 105 bits (265), Expect = 2e-25
Identities = 59/195 (30%), Positives = 98/195 (50%), Gaps = 8/195 (4%)
Query: 505 FKEELGRGAFGTVYKGFVNMGSSNHVAVKKLNSVFQDSEKEFKAEVNGIGQTHHKNLVRL 564
+LG G FG V++G N ++ VAVK L D K+F AE + + H L++L
Sbjct: 10 LLRKLGAGQFGEVWEGLWN--NTTPVAVKTLKPGTMD-PKDFLAEAQIMKKLRHPKLIQL 66
Query: 565 LGYCDEGQNRLLVYEFMSNGTVASFLFGDSKPNWKLRTEIAMG--IAGGLFYLHEECCTQ 622
C + +V E M G++ +L G + KL I M +A G+ YL +
Sbjct: 67 YAVCTLEEPIYIVTELMKYGSLLEYLQGGAGRALKLPQLIDMAAQVASGMAYLEAQ---N 123
Query: 623 IIHCDIKPQNILLDDHYNARISDFGLAKLLTLDQSHTNTAIRGTKGYVAPEWFRNMPITV 682
IH D+ +N+L+ ++ +++DFGLA+++ D + + APE ++
Sbjct: 124 YIHRDLAARNVLVGENNICKVADFGLARVIKEDIYEAREGAKFPIKWTAPEAALYNRFSI 183
Query: 683 KVDVYSYGVLLLEII 697
K DV+S+G+LL EI+
Sbjct: 184 KSDVWSFGILLTEIV 198
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261 |
| >gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Score = 104 bits (261), Expect = 8e-25
Identities = 58/192 (30%), Positives = 94/192 (48%), Gaps = 11/192 (5%)
Query: 508 ELGRGAFGTVYKGFVNMGSSNHVAVKKLNSVFQDS-EKEFKAEVNGIGQTHHKNLVRLLG 566
LG+G+ G VYK + + A+KK++ + K+ E+ + +V+ G
Sbjct: 8 VLGQGSSGVVYKV-RHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPYVVKCYG 66
Query: 567 -YCDEGQNRLLVYEFMSNGTVASFLFGDSKPNWKLR--TEIAMGIAGGLFYLHEECCTQI 623
+ EG+ + V E+M G++A L IA I GL YLH + I
Sbjct: 67 AFYKEGEISI-VLEYMDGGSLADLL--KKVGKIPEPVLAYIARQILKGLDYLHTK--RHI 121
Query: 624 IHCDIKPQNILLDDHYNARISDFGLAKLLTLDQSHTNTAIRGTKGYVAPEWFRNMPITVK 683
IH DIKP N+L++ +I+DFG++K+L NT + GT Y++PE + +
Sbjct: 122 IHRDIKPSNLLINSKGEVKIADFGISKVLENTLDQCNTFV-GTVTYMSPERIQGESYSYA 180
Query: 684 VDVYSYGVLLLE 695
D++S G+ LLE
Sbjct: 181 ADIWSLGLTLLE 192
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264 |
| >gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 103 bits (259), Expect = 1e-24
Identities = 62/197 (31%), Positives = 102/197 (51%), Gaps = 16/197 (8%)
Query: 507 EELGRGAFGTVYKGFVNMGSSNHVAVKKLNS-VFQDSEKEFKAEVNGIGQTHHKNLVRLL 565
E++G+G FG VYKG + + VAVK S + D +++F E + Q H N+V+L+
Sbjct: 1 EKIGKGNFGDVYKGVLKGNTE--VAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKLI 58
Query: 566 GYCDEGQNRLLVYEFMSNGTVASFLFGDSKPNWKLRTEIAMGI--AGGLFYLHEECCTQI 623
G C + Q +V E + G++ +FL K ++ + M + A G+ YL + C
Sbjct: 59 GVCVQKQPIYIVMELVPGGSLLTFLRK-KKNRLTVKKLLQMSLDAAAGMEYLESKNC--- 114
Query: 624 IHCDIKPQNILLDDHYNARISDFGLAKLLTLDQSHTNTAIRGTK----GYVAPEWFRNMP 679
IH D+ +N L+ ++ +ISDFG+++ ++ T G K + APE
Sbjct: 115 IHRDLAARNCLVGENNVLKISDFGMSR---EEEGGIYTVSDGLKQIPIKWTAPEALNYGR 171
Query: 680 ITVKVDVYSYGVLLLEI 696
T + DV+SYG+LL E
Sbjct: 172 YTSESDVWSYGILLWET 188
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251 |
| >gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 103 bits (259), Expect = 1e-24
Identities = 67/195 (34%), Positives = 96/195 (49%), Gaps = 11/195 (5%)
Query: 507 EELGRGAFGTVYKGFVNM--GSSNHVAVKKL-NSVFQDSEKEFKAEVNGIGQTHHKNLVR 563
+ELG G FG+V KG M G VAVK L +KEF E + + Q H +VR
Sbjct: 1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVR 60
Query: 564 LLGYCDEGQNRLLVYEFMSNGTVASFLFGDSKPNWKLRTEIAMGIAGGLFYLHEECCTQI 623
L+G C +G+ +LV E G + +L + E+A +A G+ YL E
Sbjct: 61 LIGVC-KGEPLMLVMELAPLGPLLKYLKKRREIPVSDLKELAHQVAMGMAYL-ESK--HF 116
Query: 624 IHCDIKPQNILLDDHYNARISDFGLAKLLTLDQSHTNTAIRG---TKGYVAPEWFRNMPI 680
+H D+ +N+LL + + A+ISDFG+++ L + G K Y APE
Sbjct: 117 VHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYYRATTAGRWPLKWY-APECINYGKF 175
Query: 681 TVKVDVYSYGVLLLE 695
+ K DV+SYGV L E
Sbjct: 176 SSKSDVWSYGVTLWE 190
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257 |
| >gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 102 bits (256), Expect = 6e-24
Identities = 60/205 (29%), Positives = 101/205 (49%), Gaps = 20/205 (9%)
Query: 505 FKEELGRGAFGTVYKG---FVNMGSSNHVAVKKLN-SVFQDSEKEFKAEVNGIGQTHHKN 560
F ++LG G FG V + + VAVK LN S + +F+ E+ + H+N
Sbjct: 8 FIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHEN 67
Query: 561 LVRLLGYCDE--GQNRLLVYEFMSNGTVASFL-FGDSKPNWKLRTEIAMGIAGGLFYLHE 617
+V+ G C++ G++ L+ E++ +G++ +L + N K + I G+ YL
Sbjct: 68 IVKYKGVCEKPGGRSLRLIMEYLPSGSLRDYLQRHRDQINLKRLLLFSSQICKGMDYLGS 127
Query: 618 ECCTQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLD------QSHTNTAIRGTKGYVA 671
+ + IH D+ +NIL++ +ISDFGLAK+L D + + I + A
Sbjct: 128 Q---RYIHRDLAARNILVESEDLVKISDFGLAKVLPEDKDYYYVKEPGESPIF----WYA 180
Query: 672 PEWFRNMPITVKVDVYSYGVLLLEI 696
PE R + DV+S+GV L E+
Sbjct: 181 PECLRTSKFSSASDVWSFGVTLYEL 205
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284 |
| >gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 101 bits (253), Expect = 1e-23
Identities = 63/213 (29%), Positives = 103/213 (48%), Gaps = 29/213 (13%)
Query: 508 ELGRGAFGTVYKGFVNMGSSNH----VAVKKLNSVFQDSEK-EFKAEVNGIGQTHHKNLV 562
ELG+G+FG VY+G VA+K +N E+ EF E + + + + ++V
Sbjct: 13 ELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKEFNCHHVV 72
Query: 563 RLLGYCDEGQNRLLVYEFMSNGTVASFL-----------FGDSKPNWKLRTEIAMGIAGG 611
RLLG GQ L+V E M+ G + S+L P + ++A IA G
Sbjct: 73 RLLGVVSTGQPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGP-PTLQKFIQMAAEIADG 131
Query: 612 LFYLHEECCTQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLDQSHTNTAIRGTKG--- 668
+ YL + +H D+ +N ++ + +I DFG+ + D T+ +G KG
Sbjct: 132 MAYLAA---KKFVHRDLAARNCMVAEDLTVKIGDFGMTR----DIYETDYYRKGGKGLLP 184
Query: 669 --YVAPEWFRNMPITVKVDVYSYGVLLLEIICL 699
++APE ++ T K DV+S+GV+L E+ L
Sbjct: 185 VRWMAPESLKDGVFTTKSDVWSFGVVLWEMATL 217
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277 |
| >gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Score = 100 bits (251), Expect = 1e-23
Identities = 60/197 (30%), Positives = 99/197 (50%), Gaps = 18/197 (9%)
Query: 507 EELGRGAFGTVYKGFVNMGSSNH--VAVKKLNSVFQDSEKEFKAEVNGIGQTHHKNLVRL 564
+LG G FG V++G N VA+K L S +++F+ EV + + HK+L+ L
Sbjct: 12 RKLGSGYFGEVWEGL----WKNRVRVAIKILKSDDLLKQQDFQKEVQALKRLRHKHLISL 67
Query: 565 LGYCDEGQNRLLVYEFMSNGTVASFLFGDSKPNWKLRTEIAMG--IAGGLFYLHEECCTQ 622
C G+ ++ E M G++ +FL + + I M +A G+ YL E+
Sbjct: 68 FAVCSVGEPVYIITELMEKGSLLAFLRSPEGQVLPVASLIDMACQVAEGMAYLEEQ---N 124
Query: 623 IIHCDIKPQNILLDDHYNARISDFGLAKLLTLD---QSHTNTAIRGTKGYVAPEWFRNMP 679
IH D+ +NIL+ + +++DFGLA+L+ D S + T APE +
Sbjct: 125 SIHRDLAARNILVGEDLVCKVADFGLARLIKEDVYLSSDKKIPYKWT----APEAASHGT 180
Query: 680 ITVKVDVYSYGVLLLEI 696
+ K DV+S+G+LL E+
Sbjct: 181 FSTKSDVWSFGILLYEM 197
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261 |
| >gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Score = 99.5 bits (248), Expect = 3e-23
Identities = 65/200 (32%), Positives = 99/200 (49%), Gaps = 15/200 (7%)
Query: 507 EELGRGAFGTVYKGFVNMGSSNHVAVKKLNSVFQDSEKEFKAEVNGIGQTHHKNLVRLLG 566
++LG G FG V+ G+ N VA+K L E F AE N + Q H LVRL
Sbjct: 12 KKLGAGQFGEVWMGYYN--GHTKVAIKSLKQGSMSPEA-FLAEANLMKQLQHPRLVRLYA 68
Query: 567 YCDEGQNRLLVYEFMSNGTVASFLFGDSKPNWKLRTEIAMG--IAGGLFYLHEECCTQII 624
+ + ++ E+M NG++ FL + I M IA G+ ++ + I
Sbjct: 69 VVTQ-EPIYIITEYMENGSLVDFLKTPEGIKLTINKLIDMAAQIAEGMAFIERK---NYI 124
Query: 625 HCDIKPQNILLDDHYNARISDFGLAKLLTLDQSHTNTAIRGTK---GYVAPEWFRNMPIT 681
H D++ NIL+ + +I+DFGLA+L+ ++ TA G K + APE T
Sbjct: 125 HRDLRAANILVSETLCCKIADFGLARLIEDNEY---TAREGAKFPIKWTAPEAINYGTFT 181
Query: 682 VKVDVYSYGVLLLEIICLRR 701
+K DV+S+G+LL EI+ R
Sbjct: 182 IKSDVWSFGILLTEIVTYGR 201
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260 |
| >gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Score = 99.5 bits (248), Expect = 6e-23
Identities = 65/218 (29%), Positives = 105/218 (48%), Gaps = 33/218 (15%)
Query: 505 FKEELGRGAFGTVYKGFV----NMGSSNHVAVKKL-NSVFQDSEKEFKAEVNGIGQTHHK 559
F EELG GAFG VYKG + S+ VA+K L + ++EF+ E + H
Sbjct: 9 FLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDLQHP 68
Query: 560 NLVRLLGYCDEGQNRLLVYEFMSNGTVASFLFGDS---------------KPNWKLR-TE 603
N+V LLG C + Q +++E++++G + FL +S
Sbjct: 69 NIVCLLGVCTKEQPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLH 128
Query: 604 IAMGIAGGLFYLHEECCTQIIHCDIKPQNILLDDHYNARISDFGLAKLL-TLD----QSH 658
IA+ IA G+ YL +H D+ +N L+ + +ISDFGL++ + + D QS
Sbjct: 129 IAIQIAAGMEYLSSH---HFVHRDLAARNCLVGEGLTVKISDFGLSRDIYSADYYRVQSK 185
Query: 659 TNTAIRGTKGYVAPEWFRNMPITVKVDVYSYGVLLLEI 696
+ +R ++ PE T + D++S+GV+L EI
Sbjct: 186 SLLPVR----WMPPEAILYGKFTTESDIWSFGVVLWEI 219
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283 |
| >gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Score = 98.5 bits (246), Expect = 8e-23
Identities = 78/282 (27%), Positives = 123/282 (43%), Gaps = 55/282 (19%)
Query: 507 EELGRGAFGTVYKGFVNMGSSNHVAVKKLNSVFQDSEKEFK---AEVNGIGQTHHKNLVR 563
E +G+G+FGTV K V S + V K +EKE + +EVN + + H N+VR
Sbjct: 6 ETIGKGSFGTVRK--VRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIVR 63
Query: 564 LLGYCDEGQNR-----LLVYEFMSNGTVASFLFGDSKPN--------WKLRTEIAMGIAG 610
Y D +R +V E+ G +A + K W++ T++ +
Sbjct: 64 ---YYDRIIDRSNQTLYIVMEYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLA--- 117
Query: 611 GLFYLH--EECCTQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLDQSHTNTAIRGTKG 668
L+ H + ++H D+KP NI LD + N ++ DFGLAK+L D S T + GT
Sbjct: 118 -LYECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKILGHDSSFAKTYV-GTPY 175
Query: 669 YVAPEWFRNMPITVKVDVYSYGVLLLEIICLR-----RNIDNEISKVDKAILTDWAYDRY 723
Y++PE +M K D++S G L+ E+ L RN SK+ + Y RY
Sbjct: 176 YMSPEQLNHMSYDEKSDIWSLGCLIYELCALSPPFTARNQLQLASKIKEGKFRRIPY-RY 234
Query: 724 QERTLEALVENDLEAMNNVTMLHRFVMVAFWCIQEDPSHRPT 765
L ++++ + DP RP+
Sbjct: 235 SS-ELNEVIKS--------------------MLNVDPDKRPS 255
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265 |
| >gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Score = 98.1 bits (244), Expect = 9e-23
Identities = 70/194 (36%), Positives = 100/194 (51%), Gaps = 11/194 (5%)
Query: 508 ELGRGAFGTVYKGFVNMGSSNH-VAVKKLNSVFQDS--EKEFKAEVNGIGQTHHKNLVRL 564
ELG G FGTV KG M S VAVK L + D + E E N + Q + +VR+
Sbjct: 2 ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRM 61
Query: 565 LGYCDEGQNRLLVYEFMSNGTVASFLFGDSKPNWKLRTEIAMGIAGGLFYLHEECCTQII 624
+G C E ++ +LV E G + FL + K TE+ ++ G+ YL E T +
Sbjct: 62 IGIC-EAESWMLVMELAELGPLNKFLQKNKHVTEKNITELVHQVSMGMKYLEE---TNFV 117
Query: 625 HCDIKPQNILLDDHYNARISDFGLAKLLTLDQSHTNTAIRG---TKGYVAPEWFRNMPIT 681
H D+ +N+LL + A+ISDFGL+K L D+++ G K Y APE +
Sbjct: 118 HRDLAARNVLLVTQHYAKISDFGLSKALGADENYYKAKTHGKWPVKWY-APECMNYYKFS 176
Query: 682 VKVDVYSYGVLLLE 695
K DV+S+GVL+ E
Sbjct: 177 SKSDVWSFGVLMWE 190
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257 |
| >gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Score = 97.7 bits (243), Expect = 1e-22
Identities = 57/198 (28%), Positives = 101/198 (51%), Gaps = 9/198 (4%)
Query: 500 EVTRGFKEELGRGAFGTVYKGFVNMGSSNHVAVKKLNSVFQDSEKEFKAEVNGIGQTHHK 559
E+T +E+G G FG V+ G+ VA+K + SE++F E + + H
Sbjct: 5 ELT--LVQEIGSGQFGLVWLGY--WLEKRKVAIKTIREGAM-SEEDFIEEAQVMMKLSHP 59
Query: 560 NLVRLLGYCDEGQNRLLVYEFMSNGTVASFLFGD-SKPNWKLRTEIAMGIAGGLFYLHEE 618
LV+L G C E LV+EFM +G ++ +L K + + + + + G+ YL
Sbjct: 60 KLVQLYGVCTERSPICLVFEFMEHGCLSDYLRAQRGKFSQETLLGMCLDVCEGMAYLESS 119
Query: 619 CCTQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLDQSHTNTAIRGTKGYVAPEWFRNM 678
+IH D+ +N L+ ++ ++SDFG+ + + DQ ++T + + +PE F
Sbjct: 120 N---VIHRDLAARNCLVGENQVVKVSDFGMTRFVLDDQYTSSTGTKFPVKWSSPEVFSFS 176
Query: 679 PITVKVDVYSYGVLLLEI 696
+ K DV+S+GVL+ E+
Sbjct: 177 KYSSKSDVWSFGVLMWEV 194
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256 |
| >gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Score = 97.6 bits (243), Expect = 2e-22
Identities = 66/198 (33%), Positives = 105/198 (53%), Gaps = 17/198 (8%)
Query: 506 KEELGRGAFGTVYKGFVNMGSSNHVAVKKLNSVFQDSE--KEFKAEVNGIGQTHHKNLVR 563
K +LG G +G VY+G V S VAVK L +D+ +EF E + + H NLV+
Sbjct: 11 KHKLGGGQYGEVYEG-VWKKYSLTVAVKTLK---EDTMEVEEFLKEAAVMKEIKHPNLVQ 66
Query: 564 LLGYCDEGQNRLLVYEFMSNGTVASFL--FGDSKPNWKLRTEIAMGIAGGLFYLHEECCT 621
LLG C ++ EFM+ G + +L + N + +A I+ + YL ++
Sbjct: 67 LLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKK--- 123
Query: 622 QIIHCDIKPQNILLDDHYNARISDFGLAKLLTLDQSHTNTAIRGTK---GYVAPEWFRNM 678
IH D+ +N L+ +++ +++DFGL++L+T D T TA G K + APE
Sbjct: 124 NFIHRDLAARNCLVGENHLVKVADFGLSRLMTGD---TYTAHAGAKFPIKWTAPESLAYN 180
Query: 679 PITVKVDVYSYGVLLLEI 696
++K DV+++GVLL EI
Sbjct: 181 KFSIKSDVWAFGVLLWEI 198
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263 |
| >gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 95.7 bits (239), Expect = 5e-22
Identities = 67/205 (32%), Positives = 100/205 (48%), Gaps = 32/205 (15%)
Query: 509 LGRGAFGTVYKGFVNMGSSNHV-AVKKLN--SVFQDSEKEF-KAEVNGIGQTHHKNLVRL 564
LG+G+FG V V + + A+K L + + E E E N + + +H +V+L
Sbjct: 1 LGKGSFGKVLL--VRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKL 58
Query: 565 LGYCDEGQNRL-LVYEFMSNGTVASFL-----FGDSKPNWKLRT-----EIAMGIAGGLF 613
Y + + +L LV E+ G + S L F + R EI + +
Sbjct: 59 H-YAFQTEEKLYLVLEYAPGGELFSHLSKEGRFSEE------RARFYAAEIVLALE---- 107
Query: 614 YLHEECCTQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLDQSHTNTAIRGTKGYVAPE 673
YLH II+ D+KP+NILLD + +++DFGLAK L+ + S TNT GT Y+APE
Sbjct: 108 YLHSL---GIIYRDLKPENILLDADGHIKLTDFGLAKELSSEGSRTNTFC-GTPEYLAPE 163
Query: 674 WFRNMPITVKVDVYSYGVLLLEIIC 698
VD +S GVLL E++
Sbjct: 164 VLLGKGYGKAVDWWSLGVLLYEMLT 188
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250 |
| >gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 96.0 bits (239), Expect = 6e-22
Identities = 63/199 (31%), Positives = 98/199 (49%), Gaps = 19/199 (9%)
Query: 505 FKEELGRGAFGTVYKGFVNMGSSNHVAVKKLNSVFQDSEKEFKAEVNGIGQTHHKNLVRL 564
F +ELG G FG V+ G VA+K + SE +F E + + H NLV+L
Sbjct: 8 FLKELGSGQFGVVHLGKWR--GKIDVAIKMIREGAM-SEDDFIEEAKVMMKLSHPNLVQL 64
Query: 565 LGYCDEGQNRLLVYEFMSNGTVASFLFGDSKPNWKLRTEIAMG----IAGGLFYLHEECC 620
G C + + +V E+M+NG + ++L KL TE + + + YL
Sbjct: 65 YGVCTKQRPIFIVTEYMANGCLLNYLRERKG---KLGTEWLLDMCSDVCEAMEYLESNG- 120
Query: 621 TQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLDQSHTNTAIRGTK---GYVAPEWFRN 677
IH D+ +N L+ + ++SDFGLA+ + DQ T+ +GTK + PE F
Sbjct: 121 --FIHRDLAARNCLVGEDNVVKVSDFGLARYVLDDQY---TSSQGTKFPVKWAPPEVFDY 175
Query: 678 MPITVKVDVYSYGVLLLEI 696
+ K DV+S+GVL+ E+
Sbjct: 176 SRFSSKSDVWSFGVLMWEV 194
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256 |
| >gnl|CDD|133192 cd05061, PTKc_InsR, Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Score = 96.6 bits (240), Expect = 6e-22
Identities = 82/293 (27%), Positives = 138/293 (47%), Gaps = 55/293 (18%)
Query: 508 ELGRGAFGTVYKG----FVNMGSSNHVAVKKLNSVFQDSEK-EF--KAEVNGIGQTHHKN 560
ELG+G+FG VY+G + + VAVK +N E+ EF +A V HH
Sbjct: 13 ELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHH-- 70
Query: 561 LVRLLGYCDEGQNRLLVYEFMSNGTVASFLF----------GDSKPNWKLRTEIAMGIAG 610
+VRLLG +GQ L+V E M++G + S+L G P + ++A IA
Sbjct: 71 VVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIAD 130
Query: 611 GLFYLHEECCTQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLDQSHTNTAIRGTKG-- 668
G+ YL+ + + +H D+ +N ++ + +I DFG +T D T+ +G KG
Sbjct: 131 GMAYLNAK---KFVHRDLAARNCMVAHDFTVKIGDFG----MTRDIYETDYYRKGGKGLL 183
Query: 669 ---YVAPEWFRNMPITVKVDVYSYGVLLLEIICLR----RNIDNEISKVDKAILTDWAYD 721
++APE ++ T D++S+GV+L EI L + + NE +V K ++ D
Sbjct: 184 PVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNE--QVLKFVMDGGYLD 241
Query: 722 RYQERTLEALVENDLEAMNNVTMLHRFVMVAFWCIQEDPSHRPTMRKVTQMLE 774
+ +N E + ++ + C Q +P RPT ++ +L+
Sbjct: 242 Q---------PDNCPERVTDLMRM---------CWQFNPKMRPTFLEIVNLLK 276
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein metabolism, ion and amino acid transport, cell cycle and proliferation, cell differentiation, gene transcription, and nitric oxide synthesis. Insulin resistance, caused by abnormalities in InsR signaling, has been described in diabetes, hypertension, cardiovascular disease, metabolic syndrome, heart failure, and female infertility. Length = 288 |
| >gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Score = 95.3 bits (237), Expect = 1e-21
Identities = 79/282 (28%), Positives = 134/282 (47%), Gaps = 31/282 (10%)
Query: 506 KEELGRGAFGTVYKGFVNMGS--SNHVAVKKLNSVFQDSE-KEFKAEVNGIGQTHHKNLV 562
+E +G G FG V +G + + VA+K L S + + + ++F +E + +GQ H N++
Sbjct: 9 EEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNII 68
Query: 563 RLLGYCDEGQNRLLVYEFMSNGTVASFL-FGDSKPNWKLRTEIAMGIAGGLFYLHEECCT 621
L G + + +++ EFM NG + SFL D + + GIA G+ YL E
Sbjct: 69 HLEGVVTKSRPVMIITEFMENGALDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLSE---M 125
Query: 622 QIIHCDIKPQNILLDDHYNARISDFGLAKLLTLDQSH-TNTAIRGTK---GYVAPEWFRN 677
+H D+ +NIL++ + ++SDFGL++ L D S T T+ G K + APE
Sbjct: 126 NYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSSLGGKIPIRWTAPEAIAY 185
Query: 678 MPITVKVDVYSYGVLLLEIICL--RRNIDNEISKVDKAILTDWAYDRYQERTLEALVEND 735
T DV+SYG+++ E++ R D V AI D+
Sbjct: 186 RKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQDVINAIEQDYRLP-------------- 231
Query: 736 LEAMNNVTMLHRFVMVAFWCIQEDPSHRPTMRKVTQMLEGVV 777
M+ T LH+ ++ C Q+D + RP ++ L+ ++
Sbjct: 232 -PPMDCPTALHQLMLD---CWQKDRNARPKFGQIVSTLDKMI 269
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 99.5 bits (248), Expect = 2e-21
Identities = 86/343 (25%), Positives = 153/343 (44%), Gaps = 35/343 (10%)
Query: 448 LFGSSALINLLLVSACCLGFLVVNRKKFM---RPHQED-----QGVSYMNLRCFTYKELV 499
+ + L L+++ GF+ + + + R ED Q + T +++
Sbjct: 630 FYITCTLGAFLVLALVAFGFVFIRGRNNLELKRVENEDGTWELQFFDSKVSKSITINDIL 689
Query: 500 EVTRGFKEE--LGRGAFGTVYKGFVNMGSSNHVAVKKLNSVFQDSEKEFKAEVNGIGQTH 557
KEE + RG G YKG VK++N V +S +E+ +G+
Sbjct: 690 SSL---KEENVISRGKKGASYKGKSIKNGM-QFVVKEINDV--NSIPS--SEIADMGKLQ 741
Query: 558 HKNLVRLLGYCDEGQNRLLVYEFMSNGTVASFLFGDSKPNWKLRTEIAMGIAGGLFYLHE 617
H N+V+L+G C + L++E++ ++ L S W+ R +IA+GIA L +LH
Sbjct: 742 HPNIVKLIGLCRSEKGAYLIHEYIEGKNLSEVLRNLS---WERRRKIAIGIAKALRFLHC 798
Query: 618 ECCTQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLDQSHTNTAIRGTKGYVAPEWFRN 677
C ++ ++ P+ I++D + L LL D ++ YVAPE
Sbjct: 799 RCSPAVVVGNLSPEKIIIDGKDEPHLR-LSLPGLLCTDTKCFISS-----AYVAPETRET 852
Query: 678 MPITVKVDVYSYGVLLLEIICLRRNIDNEISKVDKAILTDWAYDRYQERTLEALVENDLE 737
IT K D+Y +G++L+E++ + D E V +I+ +WA Y + L+ ++ +
Sbjct: 853 KDITEKSDIYGFGLILIELLTGKSPADAE-FGVHGSIV-EWARYCYSDCHLDMWIDPSIR 910
Query: 738 A---MNNVTMLHRFVM-VAFWCIQEDPSHRPTMRKVTQMLEGV 776
+N ++ VM +A C DP+ RP V + LE
Sbjct: 911 GDVSVNQNEIVE--VMNLALHCTATDPTARPCANDVLKTLESA 951
|
Length = 968 |
| >gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 94.8 bits (236), Expect = 2e-21
Identities = 64/205 (31%), Positives = 102/205 (49%), Gaps = 30/205 (14%)
Query: 509 LGRGAFGTVYKG-FVNMGSSNH--VAVKKL-NSVFQDSEKEFKAEVNGIGQTHHKNLVRL 564
LG GAFGTVYKG ++ G VA+K L + KE E + H ++VRL
Sbjct: 15 LGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDHPHVVRL 74
Query: 565 LGYCDEGQNRLLVYEFMSNGTVASFLFG-----DSKP--NWKLRTEIAMGIAGGLFYLHE 617
LG C L+ + M G + ++ S+ NW ++ IA G+ YL E
Sbjct: 75 LGIC-LSSQVQLITQLMPLGCLLDYVRNHKDNIGSQYLLNWCVQ------IAKGMSYLEE 127
Query: 618 ECCTQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLDQSHTN-----TAIRGTKGYVAP 672
+ +++H D+ +N+L+ + +I+DFGLAKLL +D+ + I+ ++A
Sbjct: 128 K---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLDVDEKEYHAEGGKVPIK----WMAL 180
Query: 673 EWFRNMPITVKVDVYSYGVLLLEII 697
E + T K DV+SYGV + E++
Sbjct: 181 ESILHRIYTHKSDVWSYGVTVWELM 205
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279 |
| >gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Score = 92.4 bits (230), Expect = 9e-21
Identities = 63/214 (29%), Positives = 98/214 (45%), Gaps = 25/214 (11%)
Query: 509 LGRGAFGTVYKGFVNMGSSNHVAVKKLNSVFQDSE----KEFKAEVNGIGQTHHKNLVRL 564
+G G FG VY VN+ + +AVK++ QD++ KE E+ + H NLV+
Sbjct: 8 IGGGTFGKVYTA-VNLDTGELMAVKEIR--IQDNDPKTIKEIADEMKVLELLKHPNLVKY 64
Query: 565 LGYCDEGQNRLLVYEFMSNGTVASFLFGDSKPNWKLRTEIAMGIAGGLFYLHEECCTQII 624
G + + E+ S GT+ L + + + + GL YLH I+
Sbjct: 65 YGVEVHREKVYIFMEYCSGGTLEELLEHGRILDEHVIRVYTLQLLEGLAYLHSH---GIV 121
Query: 625 HCDIKPQNILLDDHYNARISDFGLAKLLTLDQSHTNTA------IRGTKGYVAPEWFRNM 678
H DIKP NI LD + ++ DFG A L +++T T + GT Y+APE
Sbjct: 122 HRDIKPANIFLDHNGVIKLGDFGCAVKL---KNNTTTMGEEVQSLAGTPAYMAPEVITGG 178
Query: 679 PITVK---VDVYSYGVLLLEIICLRR---NIDNE 706
D++S G ++LE+ +R +DNE
Sbjct: 179 KGKGHGRAADIWSLGCVVLEMATGKRPWSELDNE 212
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264 |
| >gnl|CDD|216511 pfam01453, B_lectin, D-mannose binding lectin | Back alignment and domain information |
|---|
Score = 87.4 bits (217), Expect = 1e-20
Identities = 40/98 (40%), Positives = 54/98 (55%), Gaps = 2/98 (2%)
Query: 72 SKTIVWYASAVNP-APRGSKLRLTANRGLVLEDPEGREIWKS-EISTGQAAFGVLYDTGN 129
++T+VW A+ +NP L L ++ LVL D GR +W S G VL D GN
Sbjct: 1 NQTVVWVANRLNPLTDSSYTLILQSDGNLVLYDGNGRVVWSSNTSGKGSGCVAVLQDDGN 60
Query: 130 FLIVNTNSERLWQSFDHPTDTLLPTQTMERGGVVSSRR 167
++ + + + LWQSFDHPTDTLLP Q + SRR
Sbjct: 61 LVLYDNSGKVLWQSFDHPTDTLLPGQKDGNVVIGGSRR 98
|
These proteins include mannose-specific lectins from plants as well as bacteriocins from bacteria. Length = 109 |
| >gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Score = 91.9 bits (229), Expect = 1e-20
Identities = 59/201 (29%), Positives = 101/201 (50%), Gaps = 24/201 (11%)
Query: 505 FKEELGRGAFGTVYKGFVNMGSSNHVAVKKLNSVFQDSEKEFKAEVNGIGQTHHKNLVRL 564
E+LG G++G+VYK ++ + VA+K + V +D + E E++ + Q +V+
Sbjct: 7 ILEKLGEGSYGSVYKA-IHKETGQVVAIKVV-PVEEDLQ-EIIKEISILKQCDSPYIVKY 63
Query: 565 LGYCDEGQNRLLVYEFMSNGTVASFLFGDSKPNWKLRT------EIAM---GIAGGLFYL 615
G + + +V E+ G+V+ + K+ EIA GL YL
Sbjct: 64 YGSYFKNTDLWIVMEYCGAGSVSDIM--------KITNKTLTEEEIAAILYQTLKGLEYL 115
Query: 616 HEECCTQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLDQSHTNTAIRGTKGYVAPEWF 675
H + IH DIK NILL++ A+++DFG++ LT + NT I GT ++APE
Sbjct: 116 HSN---KKIHRDIKAGNILLNEEGQAKLADFGVSGQLTDTMAKRNTVI-GTPFWMAPEVI 171
Query: 676 RNMPITVKVDVYSYGVLLLEI 696
+ + K D++S G+ +E+
Sbjct: 172 QEIGYNNKADIWSLGITAIEM 192
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256 |
| >gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Score = 91.9 bits (228), Expect = 1e-20
Identities = 78/282 (27%), Positives = 132/282 (46%), Gaps = 37/282 (13%)
Query: 497 ELVEVTRGFKEELGRGAFGTVYKGFVNMGSSNHVAVKKLNSVFQDSEKEFKAEVNGIGQT 556
L ++T G E +G G FG V +G G VAVK + + + F E + +
Sbjct: 4 NLQKLTLG--EIIGEGEFGAVLQGEY-TGQK--VAVKNIKC--DVTAQAFLEETAVMTKL 56
Query: 557 HHKNLVRLLGYCDEGQNRLLVYEFMSNGTVASFLF--GDSKPNWKLRTEIAMGIAGGLFY 614
HHKNLVRLLG +V E MS G + +FL G + + + ++ +A G+ Y
Sbjct: 57 HHKNLVRLLGVILH-NGLYIVMELMSKGNLVNFLRTRGRALVSVIQLLQFSLDVAEGMEY 115
Query: 615 LHEECCTQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLDQSHTNTAIRGTKGYVAPEW 674
L + +++H D+ +NIL+ + A++SDFGLA++ ++ ++ ++ T APE
Sbjct: 116 LESK---KLVHRDLAARNILVSEDGVAKVSDFGLARVGSMGVDNSKLPVKWT----APEA 168
Query: 675 FRNMPITVKVDVYSYGVLLLEIICLRRNIDNEISKVDKAILTDWAYDRYQERTLEALVEN 734
++ + K DV+SYGVLL E+ R Y + + ++ VE
Sbjct: 169 LKHKKFSSKSDVWSYGVLLWEVFSYGRA----------------PYPKMSLKEVKECVEK 212
Query: 735 D--LEAMNNVTMLHRFVMVAFWCIQEDPSHRPTMRKVTQMLE 774
+E +M + W + +P RP+ K+ + LE
Sbjct: 213 GYRMEPPEGCPADVYVLMTSCW--ETEPKKRPSFHKLREKLE 252
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254 |
| >gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Score = 92.1 bits (229), Expect = 1e-20
Identities = 68/212 (32%), Positives = 100/212 (47%), Gaps = 29/212 (13%)
Query: 509 LGRGAFGTVYKGFV----NMGSSNHVAVKKLNSVF-QDSEKEFKAEVNGIGQTHHKNLVR 563
LG GAFG VY+G VAVK L + E +F E + + +H+N+VR
Sbjct: 14 LGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKFNHQNIVR 73
Query: 564 LLGYCDEGQNRLLVYEFMSNGTVASFLFGDSKPNWKLRTEIAM--------GIAGGLFYL 615
L+G E R ++ E M+ G + SFL +++P + + + M +A G YL
Sbjct: 74 LIGVSFERLPRFILLELMAGGDLKSFL-RENRPRPERPSSLTMKDLLFCARDVAKGCKYL 132
Query: 616 HEECCTQIIHCDIKPQNILLDDHYNAR---ISDFGLAKLLTLDQSHTNTAIRGTKG---- 668
E IH DI +N LL R I+DFG+A+ D + +G +
Sbjct: 133 EEN---HFIHRDIAARNCLLTCKGPGRVAKIADFGMAR----DIYRASYYRKGGRAMLPI 185
Query: 669 -YVAPEWFRNMPITVKVDVYSYGVLLLEIICL 699
++ PE F + T K DV+S+GVLL EI L
Sbjct: 186 KWMPPEAFLDGIFTSKTDVWSFGVLLWEIFSL 217
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277 |
| >gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Score = 92.0 bits (228), Expect = 1e-20
Identities = 57/196 (29%), Positives = 103/196 (52%), Gaps = 11/196 (5%)
Query: 509 LGRGAFGTVYKGFVNMG--SSNHVAVKKLNSVFQDSEK-EFKAEVNGIGQTHHKNLVRLL 565
+G G FG V++G + M VA+K L + + ++ +F +E + +GQ H N++RL
Sbjct: 13 IGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHNIIRLE 72
Query: 566 GYCDEGQNRLLVYEFMSNGTVASFLFGDSKPNWKLRTEIAM--GIAGGLFYLHEECCTQI 623
G + + +++ E+M NG + +L D + + M GIA G+ YL +
Sbjct: 73 GVVTKFKPAMIITEYMENGALDKYL-RDHDGEFSSYQLVGMLRGIAAGMKYLSD---MNY 128
Query: 624 IHCDIKPQNILLDDHYNARISDFGLAKLLTLDQSHTNTAIRGTKG--YVAPEWFRNMPIT 681
+H D+ +NIL++ + ++SDFGL+++L D T T G + APE T
Sbjct: 129 VHRDLAARNILVNSNLECKVSDFGLSRVLEDDPEGTYTTSGGKIPIRWTAPEAIAYRKFT 188
Query: 682 VKVDVYSYGVLLLEII 697
DV+S+G+++ E++
Sbjct: 189 SASDVWSFGIVMWEVM 204
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268 |
| >gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Score = 91.7 bits (228), Expect = 2e-20
Identities = 66/216 (30%), Positives = 101/216 (46%), Gaps = 31/216 (14%)
Query: 505 FKEELGRGAFGTVYKG----FVNMGSSNHVAVKKL-NSVFQDSEKEFKAEVNGIGQTHHK 559
K ELG GAFG V+ G VAVK L + D+ K+F+ E + H+
Sbjct: 9 LKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHE 68
Query: 560 NLVRLLGYCDEGQNRLLVYEFMSNGTVASFL--------FGDSKPNWKLR------TEIA 605
N+V+ G C EG ++V+E+M +G + FL F S + +IA
Sbjct: 69 NIVKFYGVCTEGDPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIA 128
Query: 606 MGIAGGLFYLHEECCTQIIHCDIKPQNILLDDHYNARISDFGLAK-LLTLD----QSHTN 660
+ IA G+ YL + +H D+ +N L+ +I DFG+++ + T D HT
Sbjct: 129 VQIASGMVYLASQ---HFVHRDLATRNCLVGYDLVVKIGDFGMSRDVYTTDYYRVGGHTM 185
Query: 661 TAIRGTKGYVAPEWFRNMPITVKVDVYSYGVLLLEI 696
IR ++ PE T + DV+S+GV+L EI
Sbjct: 186 LPIR----WMPPESIMYRKFTTESDVWSFGVVLWEI 217
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280 |
| >gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 91.3 bits (227), Expect = 2e-20
Identities = 60/202 (29%), Positives = 99/202 (49%), Gaps = 24/202 (11%)
Query: 507 EELGRGAFGTVYKGFVNMGSSNHVAVKKLNSVFQDSE-----KEFKAEVNGIGQTHHKNL 561
E LG G+FG+VY+G N+ + AVK+++ K+ + E+ + + H N+
Sbjct: 6 ELLGSGSFGSVYEGL-NLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNI 64
Query: 562 VRLLGYCDEGQNRLLVYEFMSNGTVASFL--FGD-SKPNWKLRTEIAMGIAGGLFYLHEE 618
V+ LG E N + E + G++A L +G +P +L T I GL YLH+
Sbjct: 65 VQYLGTEREEDNLYIFLELVPGGSLAKLLKKYGSFPEPVIRLYTR---QILLGLEYLHDR 121
Query: 619 CCTQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLDQSHTNTAIRGTKG---YVAPEWF 675
+H DIK NIL+D + +++DFG+AK Q + + KG ++APE
Sbjct: 122 ---NTVHRDIKGANILVDTNGVVKLADFGMAK-----QVVEFSFAKSFKGSPYWMAPEVI 173
Query: 676 RNM-PITVKVDVYSYGVLLLEI 696
+ D++S G +LE+
Sbjct: 174 AQQGGYGLAADIWSLGCTVLEM 195
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258 |
| >gnl|CDD|133193 cd05062, PTKc_IGF-1R, Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 91.2 bits (226), Expect = 3e-20
Identities = 65/212 (30%), Positives = 108/212 (50%), Gaps = 27/212 (12%)
Query: 508 ELGRGAFGTVY----KGFVNMGSSNHVAVKKLNSVFQDSEK-EFKAEVNGIGQTHHKNLV 562
ELG+G+FG VY KG V VA+K +N E+ EF E + + + + ++V
Sbjct: 13 ELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVV 72
Query: 563 RLLGYCDEGQNRLLVYEFMSNGTVASFLF----------GDSKPNWKLRTEIAMGIAGGL 612
RLLG +GQ L++ E M+ G + S+L + P+ K ++A IA G+
Sbjct: 73 RLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGM 132
Query: 613 FYLHEECCTQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLDQSHTNTAIRGTKG---- 668
YL+ + +H D+ +N ++ + + +I DFG +T D T+ +G KG
Sbjct: 133 AYLN---ANKFVHRDLAARNCMVAEDFTVKIGDFG----MTRDIYETDYYRKGGKGLLPV 185
Query: 669 -YVAPEWFRNMPITVKVDVYSYGVLLLEIICL 699
+++PE ++ T DV+S+GV+L EI L
Sbjct: 186 RWMSPESLKDGVFTTYSDVWSFGVVLWEIATL 217
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, where it is frequently overexpressed, IGF-1R is implicated in proliferation, the suppression of apoptosis, invasion, and metastasis. IGF-1R is being developed as a therapeutic target in cancer treatment. Length = 277 |
| >gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Score = 90.9 bits (225), Expect = 3e-20
Identities = 63/196 (32%), Positives = 100/196 (51%), Gaps = 14/196 (7%)
Query: 507 EELGRGAFGTVYKGFVNMGSSNHVAVKKLNSVFQDSEKEFKAEVNGIGQTHHKNLVRLLG 566
++LG G FG V+ G+ N +S VAVK L S + F E N + H LVRL
Sbjct: 12 KKLGAGQFGEVWMGYYN--NSTKVAVKTLKPGTM-SVQAFLEEANLMKTLQHDKLVRLYA 68
Query: 567 YCDEGQNRLLVYEFMSNGTVASFLFGDSKPNWKLRTEI--AMGIAGGLFYLHEECCTQII 624
+ + ++ E+M+ G++ FL D L I + IA G+ Y+ + I
Sbjct: 69 VVTKEEPIYIITEYMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIERK---NYI 125
Query: 625 HCDIKPQNILLDDHYNARISDFGLAKLLTLDQSHTNTAIRGTK---GYVAPEWFRNMPIT 681
H D++ N+L+ + +I+DFGLA+++ ++ TA G K + APE T
Sbjct: 126 HRDLRAANVLVSESLMCKIADFGLARVIEDNEY---TAREGAKFPIKWTAPEAINFGSFT 182
Query: 682 VKVDVYSYGVLLLEII 697
+K DV+S+G+LL EI+
Sbjct: 183 IKSDVWSFGILLYEIV 198
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261 |
| >gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Score = 91.1 bits (227), Expect = 4e-20
Identities = 58/230 (25%), Positives = 97/230 (42%), Gaps = 53/230 (23%)
Query: 505 FKEELGRGAFGTVYKGFVNMGSSNH-VAVK-----------KLNSVFQDSEKEFKAEVNG 552
F + +G G+F TV +N A+K K+ V EKE +NG
Sbjct: 5 FGKIIGEGSFSTVVLAKEK--ETNKEYAIKILDKRQLIKEKKVKYVKI--EKEVLTRLNG 60
Query: 553 IGQTHHKNLVRLLGYCDEGQNRL-LVYEFMSNGTVASFL--FGD-SKPNWKLRT-EIAMG 607
H +++L Y + + L V E+ NG + ++ +G + + EI +
Sbjct: 61 -----HPGIIKLY-YTFQDEENLYFVLEYAPNGELLQYIRKYGSLDEKCTRFYAAEILLA 114
Query: 608 IAGGLFYLHEECCTQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLDQSHTNTAIR--- 664
+ YLH + IIH D+KP+NILLD + +I+DFG AK+L + S +
Sbjct: 115 LE----YLHSK---GIIHRDLKPENILLDKDMHIKITDFGTAKVLDPNSSPESNKGDATN 167
Query: 665 ----------------GTKGYVAPEWFRNMPITVKVDVYSYGVLLLEIIC 698
GT YV+PE P D+++ G ++ +++
Sbjct: 168 IDSQIEKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLT 217
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280 |
| >gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Score = 90.7 bits (226), Expect = 5e-20
Identities = 56/199 (28%), Positives = 97/199 (48%), Gaps = 17/199 (8%)
Query: 505 FKEELGRGAFGTVYKGFVNMGSSNHVAVKKLNSVFQDSEKEFKAEVNGIGQTHHKNLVRL 564
E++G GA G VYK + + VA+KK+ + + +++ E+ + H N+V
Sbjct: 23 NLEKIGEGASGEVYKA-TDRATGKEVAIKKMR-LRKQNKELIINEILIMKDCKHPNIVDY 80
Query: 565 LGYCDEGQNRL-LVYEFMSNGTVASFLFGDSKPNWKLRTE-----IAMGIAGGLFYLHEE 618
+ L +V E+M G++ + N+ E + + GL YLH
Sbjct: 81 YD-SYLVGDELWVVMEYMDGGSLTDII----TQNFVRMNEPQIAYVCREVLQGLEYLHS- 134
Query: 619 CCTQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLDQSHTNTAIRGTKGYVAPEWFRNM 678
+IH DIK NILL + +++DFG A LT ++S N+ + GT ++APE +
Sbjct: 135 --QNVIHRDIKSDNILLSKDGSVKLADFGFAAQLTKEKSKRNS-VVGTPYWMAPEVIKRK 191
Query: 679 PITVKVDVYSYGVLLLEII 697
KVD++S G++ +E+
Sbjct: 192 DYGPKVDIWSLGIMCIEMA 210
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286 |
| >gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Score = 89.4 bits (222), Expect = 7e-20
Identities = 75/278 (26%), Positives = 123/278 (44%), Gaps = 48/278 (17%)
Query: 509 LGRGAFGTVYKGFVNMGSSNHV-AVKKLNSVFQDSEKEFKAEVNGI---GQTHHKNLVR- 563
LG+G++G+VYK V S N A+K+++ + S+KE + VN I +H N++
Sbjct: 8 LGKGSYGSVYK--VKRLSDNQFYALKEVD-LGSMSQKEREDAVNEIRILASVNHPNIISY 64
Query: 564 ----LLGYCDEGQNRL-LVYEFMSNGTVASFLFGDSKPNWKLRTE-----IAMGIAGGLF 613
L G N+L +V E+ G ++ + K KL E I + + GL
Sbjct: 65 KEAFLDG------NKLCIVMEYAPFGDLSKAI-SKRKKKRKLIPEQEIWRIFIQLLRGLQ 117
Query: 614 YLHEECCTQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLDQSHTNTAIRGTKGYVAPE 673
LHE+ +I+H D+K NILL + +I D G++K+L ++ T I GT Y+APE
Sbjct: 118 ALHEQ---KILHRDLKSANILLVANDLVKIGDLGISKVLK--KNMAKTQI-GTPHYMAPE 171
Query: 674 WFRNMPITVKVDVYSYGVLLLEIICLRRNIDNEISKVDKAILTDWAYDRYQERTLEALVE 733
++ P + K D++S G LL E+ + + D Y + Q +
Sbjct: 172 VWKGRPYSYKSDIWSLGCLLYEMATFAPPFEAR-------SMQDLRY-KVQRGKYPPIPP 223
Query: 734 NDLEAMNNVTMLHRFVMVAFWCIQEDPSHRPTMRKVTQ 771
+ + N +Q P RP K+
Sbjct: 224 IYSQDLQNFIR---------SMLQVKPKLRPNCDKILA 252
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256 |
| >gnl|CDD|237995 cd00028, B_lectin, Bulb-type mannose-specific lectin | Back alignment and domain information |
|---|
Score = 85.4 bits (212), Expect = 8e-20
Identities = 39/126 (30%), Positives = 61/126 (48%), Gaps = 11/126 (8%)
Query: 23 NGTISIGQQLTAAESTEPWLSPSKDFALGFHQLDSKDLFLPAIWYYKIPSKTIVWYASAV 82
+ +S GQ L ++ S F LGF +L + I Y S+T+VW A+
Sbjct: 1 SNPLSSGQTLVSSGSL---------FELGFFKLIMQSRDYNLILYKGS-SRTVVWVANRD 50
Query: 83 NPAPRGSKLRLTANRGLVLEDPEGREIWKSEISTGQAAFG-VLYDTGNFLIVNTNSERLW 141
NP+ L L ++ LV+ D G +W S + + VL D GN ++ +++ LW
Sbjct: 51 NPSGSSCTLTLQSDGNLVIYDGSGTVVWSSNTTRVNGNYVLVLLDDGNLVLYDSDGNFLW 110
Query: 142 QSFDHP 147
QSFD+P
Sbjct: 111 QSFDYP 116
|
The domain contains a three-fold internal repeat (beta-prism architecture). The consensus sequence motif QXDXNXVXY is involved in alpha-D-mannose recognition. Lectins are carbohydrate-binding proteins which specifically recognize diverse carbohydrates and mediate a wide variety of biological processes, such as cell-cell and host-pathogen interactions, serum glycoprotein turnover, and innate immune responses. Length = 116 |
| >gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Score = 88.8 bits (220), Expect = 2e-19
Identities = 67/208 (32%), Positives = 107/208 (51%), Gaps = 22/208 (10%)
Query: 502 TRGFKEELGRGAFGTVYKGFVNMGSSNHVAVKK--LNSVFQD-SEKEFKA---EVNGIGQ 555
T+G E LG+GA+GTVY G N G +AVK+ L++ +EKE++ EV+ +
Sbjct: 3 TKG--EVLGKGAYGTVYCGLTNQGQL--IAVKQVELDTSNVLAAEKEYEKLQEEVDLLKS 58
Query: 556 THHKNLVRLLGYCDEGQNRLLVYEFMSNGTVASFL--FGDSKPNWKLRTEIAMGIAGGLF 613
H N+V+ LG C + + EF+ G+++S L FG P + I G+
Sbjct: 59 LKHVNIVQYLGTCLDDNTISIFMEFVPGGSISSILNRFG-PLPEPVFC-KYTKQILDGVA 116
Query: 614 YLHEECCTQIIHCDIKPQNILLDDHYNARISDFGLAKLL---TLDQSHTNT--AIRGTKG 668
YLH C ++H DIK N++L + ++ DFG A+ L L +H+N ++ GT
Sbjct: 117 YLHNNC---VVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVGLHGTHSNMLKSMHGTPY 173
Query: 669 YVAPEWFRNMPITVKVDVYSYGVLLLEI 696
++APE K D++S G + E+
Sbjct: 174 WMAPEVINESGYGRKSDIWSIGCTVFEM 201
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265 |
| >gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Score = 88.3 bits (219), Expect = 2e-19
Identities = 77/288 (26%), Positives = 118/288 (40%), Gaps = 47/288 (16%)
Query: 507 EELGRGAFGTVYKGFVNMGSSNHVAVKKLN-------SVFQDSEKEFK---AEVNGIG-Q 555
E LG GAFG VYK N +A+K++N ++ +K +EV I Q
Sbjct: 6 EHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQ 65
Query: 556 THHKNLVRLLGYCDEGQNRLLVYEFMSNGTVASFLFGDSKPNWKLRTE-----IAMGIAG 610
H N+VR E +V + + + F K + TE I + +
Sbjct: 66 LRHPNIVRYYKTFLENDRLYIVMDLIEGAPLGE-HFNSLKEKKQRFTEERIWNIFVQMVL 124
Query: 611 GLFYLHEECCTQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLDQSHTN---TAIRGTK 667
L YLH+E +I+H D+ P NI+L + I+DFGLAK Q T++ GT
Sbjct: 125 ALRYLHKE--KRIVHRDLTPNNIMLGEDDKVTITDFGLAK-----QKQPESKLTSVVGTI 177
Query: 668 GYVAPEWFRNMPITVKVDVYSYGVLLLEIICLRRNI--DNEISKVDKAILTDWAYDRYQE 725
Y PE +N P K DV+++G +L ++ L+ N +S K
Sbjct: 178 LYSCPEIVKNEPYGEKADVWAFGCILYQMCTLQPPFYSTNMLSLATK------------- 224
Query: 726 RTLEALVENDLEAMNNVTMLHRFVMVAFWCIQEDPSHRPTMRKVTQML 773
+VE E + V C+ D RP + +V+ M+
Sbjct: 225 -----IVEAVYEPLPEGMYSEDVTDVITSCLTPDAEARPDIIQVSAMI 267
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269 |
| >gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Score = 87.8 bits (218), Expect = 4e-19
Identities = 68/233 (29%), Positives = 93/233 (39%), Gaps = 57/233 (24%)
Query: 510 GRGAFGTVYKGFVN------------MGSSNHVAVKKLNSVFQDSEKEFKAEVNGIGQTH 557
G+GAFG V V M V + +V E+ E+N
Sbjct: 9 GKGAFGKVCI--VQKRDTKKMFAMKYMNKQKCVEKGSVRNVLN--ERRILQELN------ 58
Query: 558 HKNLVRL-LGYCDEGQNRLLVYEFMSNGTVASFLFGDSKPNWKLRTEIAMG--------- 607
H LV L + DE +N LV + + L GD LR ++
Sbjct: 59 HPFLVNLWYSFQDE-ENMYLVVDLL--------LGGD------LRYHLSQKVKFSEEQVK 103
Query: 608 -----IAGGLFYLHEECCTQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLDQSHTNTA 662
I L YLH + IIH DIKP NILLD+ + I+DF +A +T D T+T+
Sbjct: 104 FWICEIVLALEYLHSK---GIIHRDIKPDNILLDEQGHVHITDFNIATKVTPDTLTTSTS 160
Query: 663 IRGTKGYVAPEWFRNMPITVKVDVYSYGVLLLEIICLRRNIDNEISKVDKAIL 715
GT GY+APE +V VD +S GV E + +R + I
Sbjct: 161 --GTPGYMAPEVLCRQGYSVAVDWWSLGVTAYECLRGKRPYRGHSRTIRDQIR 211
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258 |
| >gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Score = 87.6 bits (217), Expect = 5e-19
Identities = 74/280 (26%), Positives = 134/280 (47%), Gaps = 35/280 (12%)
Query: 509 LGRGAFGTVYKGFVNMGSSNH--VAVKKLNSVFQDSEK-EFKAEVNGIGQTHHKNLVRLL 565
+G G FG V G + + VA+K L + + + ++ +F +E + +GQ H N++ L
Sbjct: 12 IGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIHLE 71
Query: 566 GYCDEGQNRLLVYEFMSNGTVASFLFGDSKPNWKLRTEIAM-----GIAGGLFYLHEECC 620
G + + ++V E+M NG++ +FL + + T I + GIA G+ YL +
Sbjct: 72 GVVTKSKPVMIVTEYMENGSLDAFL----RKHDGQFTVIQLVGMLRGIASGMKYLSD--- 124
Query: 621 TQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLDQSHTNTAIRGTK---GYVAPEWFRN 677
+H D+ +NIL++ + ++SDFGL+++L D T RG K + APE
Sbjct: 125 MGYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEAAYTT-RGGKIPIRWTAPEAIAY 183
Query: 678 MPITVKVDVYSYGVLLLEIICLRRNIDNEISKVDKAILTDWAYDRYQERTLEALVENDLE 737
T DV+SYG+++ E++ E+S D + Y L A
Sbjct: 184 RKFTSASDVWSYGIVMWEVMSYGERPYWEMSNQDVIKAIEEGY------RLPA------- 230
Query: 738 AMNNVTMLHRFVMVAFWCIQEDPSHRPTMRKVTQMLEGVV 777
M+ LH+ ++ C Q+D + RP ++ +L+ ++
Sbjct: 231 PMDCPAALHQLMLD---CWQKDRNERPKFEQIVSILDKLI 267
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267 |
| >gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 87.9 bits (218), Expect = 6e-19
Identities = 86/311 (27%), Positives = 134/311 (43%), Gaps = 52/311 (16%)
Query: 487 YMNLRCFTYKELVEVTRG---FKEELGRGAFGTVYK----GFVNMGSSNHVAVKKLNSVF 539
Y++ Y E R F + LG GAFG V + G + VAVK L
Sbjct: 18 YIDPTQLPYDLKWEFPRNNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTA 77
Query: 540 QDSEKE-FKAEVNGIGQT-HHKNLVRLLGYCDEGQNRLLVYEFMSNGTVASFLFGDSKPN 597
SE+E +E+ + +H+N+V LLG C G L++ E+ G + +FL K
Sbjct: 78 HSSEREALMSELKIMSHLGNHENIVNLLGACTIGGPILVITEYCCYGDLLNFL--RRKRE 135
Query: 598 WKLRTEIAMG----IAGGLFYLHEECCTQIIHCDIKPQNILLDDHYNARISDFGLAKLLT 653
L E + +A G+ +L + C IH D+ +N+LL +I DFGLA+ +
Sbjct: 136 SFLTLEDLLSFSYQVAKGMAFLASKNC---IHRDLAARNVLLTHGKIVKICDFGLARDIM 192
Query: 654 LDQSHTNTAIRGTK----GYVAPEWFRNMPITVKVDVYSYGVLLLEIICLRRN------I 703
D +N ++G ++APE N T + DV+SYG+LL EI L N +
Sbjct: 193 ND---SNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSNPYPGMPV 249
Query: 704 DNEISKVDKAILTDWAYDRYQERTLEALVENDLEAMNNVTMLHRFVMVAFWCIQEDPSHR 763
D++ K+ K + Y+ E + M C DP R
Sbjct: 250 DSKFYKLIK--------EGYRMAQPEHAPAEIYDIMKT-------------CWDADPLKR 288
Query: 764 PTMRKVTQMLE 774
PT +++ Q++
Sbjct: 289 PTFKQIVQLIG 299
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302 |
| >gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Score = 86.8 bits (215), Expect = 6e-19
Identities = 62/221 (28%), Positives = 110/221 (49%), Gaps = 23/221 (10%)
Query: 506 KEELGRGAFGTVYKGFVNMGSSNHV-AVKKLNSVFQDSEKEFKA--EVNGIGQTHHKNLV 562
++G+G+FG V+K V + V A+K+++ + + +A E + + ++
Sbjct: 5 LNKIGKGSFGVVFK--VVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYII 62
Query: 563 RLLGYCDEGQNRLLVYEFMSNGTVASFL---FGDSKPN---WKLRTEIAMGIAGGLFYLH 616
R + +V E+ NG + L G P W+ +I +G+A +LH
Sbjct: 63 RYYESFLDKGKLNIVMEYAENGDLHKLLKMQRGRPLPEDQVWRFFIQILLGLA----HLH 118
Query: 617 EECCTQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLDQSHTNTAIRGTKGYVAPEWFR 676
+ +I+H DIK N+ LD + N +I D G+AKLL+ + + NT I GT Y++PE
Sbjct: 119 SK---KILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNTNFANT-IVGTPYYLSPELCE 174
Query: 677 NMPITVKVDVYSYGVLLLEIICLRR---NIDNEISKVDKAI 714
+ P K DV++ GV+L E C + + +N+ + + K I
Sbjct: 175 DKPYNEKSDVWALGVVLYE-CCTGKHPFDANNQGALILKII 214
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256 |
| >gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 87.3 bits (217), Expect = 6e-19
Identities = 59/197 (29%), Positives = 97/197 (49%), Gaps = 17/197 (8%)
Query: 507 EELGRGAFGTVYKGFVNMGSSNHVAVKKLNSVFQDSEKE---FKAEVNGIGQTHHKNLVR 563
E +G+G+FG VYK ++ VA+K ++ +++E E + E+ + Q + +
Sbjct: 7 ECIGKGSFGEVYKAIDK-RTNQVVAIKVID--LEEAEDEIEDIQQEIQFLSQCRSPYITK 63
Query: 564 LLGYCDEGQNRLLVYEFMSNGTVASFLFGDSKPNWKLRTEIAM---GIAGGLFYLHEECC 620
G +G ++ E+ G+ L KP T IA + GL YLHEE
Sbjct: 64 YYGSFLKGSKLWIIMEYCGGGSCLDLL----KPGKLDETYIAFILREVLLGLEYLHEE-- 117
Query: 621 TQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLDQSHTNTAIRGTKGYVAPEWFRNMPI 680
IH DIK NILL + + +++DFG++ LT S NT + GT ++APE +
Sbjct: 118 -GKIHRDIKAANILLSEEGDVKLADFGVSGQLTSTMSKRNTFV-GTPFWMAPEVIKQSGY 175
Query: 681 TVKVDVYSYGVLLLEII 697
K D++S G+ +E+
Sbjct: 176 DEKADIWSLGITAIELA 192
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274 |
| >gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Score = 86.5 bits (214), Expect = 8e-19
Identities = 74/271 (27%), Positives = 120/271 (44%), Gaps = 33/271 (12%)
Query: 505 FKEELGRGAFGTVYKGFVNMGSSNHVAVK--KLNSVFQDSEKEFKAEVNGIGQTHHKNLV 562
F +ELG G FG V G VA+K K S+ SE EF E + + H+ LV
Sbjct: 8 FLKELGTGQFGVVKYG--KWRGQYDVAIKMIKEGSM---SEDEFIEEAKVMMKLSHEKLV 62
Query: 563 RLLGYCDEGQNRLLVYEFMSNGTVASFLF-GDSKPNWKLRTEIAMGIAGGLFYLHEECCT 621
+L G C + + +V E+MSNG + ++L + E+ + G+ YL +
Sbjct: 63 QLYGVCTKQRPIYIVTEYMSNGCLLNYLREHGKRFQPSQLLEMCKDVCEGMAYLESK--- 119
Query: 622 QIIHCDIKPQNILLDDHYNARISDFGLAKLLTLDQSHTNTAIRGTKGYV---APEWFRNM 678
Q IH D+ +N L+DD ++SDFGL++ + LD +T++ G+K V PE
Sbjct: 120 QFIHRDLAARNCLVDDQGCVKVSDFGLSRYV-LDDEYTSSV--GSKFPVRWSPPEVLLYS 176
Query: 679 PITVKVDVYSYGVLLLEIICLRRNIDNEISKVDKAILTDWAYDRYQERTLEALVENDLEA 738
+ K DV+++GVL+ E+ L + Y+R+ V L
Sbjct: 177 KFSSKSDVWAFGVLMWEVYSLGKM----------------PYERFNNSETVEKVSQGLRL 220
Query: 739 MNNVTMLHRFVMVAFWCIQEDPSHRPTMRKV 769
+ + + C E RPT +++
Sbjct: 221 YRPHLASEKVYAIMYSCWHEKAEERPTFQQL 251
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256 |
| >gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 86.8 bits (216), Expect = 1e-18
Identities = 66/230 (28%), Positives = 106/230 (46%), Gaps = 45/230 (19%)
Query: 507 EELGRGAFGTVYKGFVNMGSSNHVAVKKLNSVFQDSEKE-----FKAEVNGIGQTHHKNL 561
++G G +G VYK N + VA+KK+ ++EKE E+ + + H N+
Sbjct: 5 AQIGEGTYGQVYKA-RNKKTGELVALKKIRM---ENEKEGFPITAIREIKLLQKLRHPNI 60
Query: 562 VRLLG-YCDEGQNRL-LVYEFMSNGTVASFLFGDSKPNWKLRTE-----IAMGIAGGLFY 614
VRL +G+ + +V+E+M + + L P K TE + GL Y
Sbjct: 61 VRLKEIVTSKGKGSIYMVFEYMDH-DLTGLL---DSPEVKF-TESQIKCYMKQLLEGLQY 115
Query: 615 LHEECCTQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLDQSH--TNTAIRGTKGYVAP 672
LH I+H DIK NIL+++ +++DFGLA+ T S TN I T Y P
Sbjct: 116 LHSN---GILHRDIKGSNILINNDGVLKLADFGLARPYTKRNSADYTNRVI--TLWYRPP 170
Query: 673 EWFRNMPI-------TVKVDVYSYGVLLLEIICLRRNI---DNEISKVDK 712
E + +VD++S G +L E+ L + I E+ +++K
Sbjct: 171 E------LLLGATRYGPEVDMWSVGCILAELF-LGKPIFQGSTELEQLEK 213
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287 |
| >gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Score = 85.7 bits (212), Expect = 2e-18
Identities = 74/275 (26%), Positives = 123/275 (44%), Gaps = 46/275 (16%)
Query: 509 LGRGAFGTVYKGFVNMGSSNHVAVKKLNSVFQDSEKEFKA---EVNGIGQTHHKNLVRLL 565
+GRGAFG V+ V +K++ V Q ++ E A E + H N++
Sbjct: 8 VGRGAFGIVHL-CRRKADQKLVIIKQIP-VEQMTKDERLAAQNECQVLKLLSHPNIIEYY 65
Query: 566 GYCDEGQNRLLVYEFMSNGTVASFL------FGDSKPNWKLRTEIAMGIAGGLFYLHEEC 619
E + ++V E+ GT+A ++ D +I + L ++H +
Sbjct: 66 ENFLEDKALMIVMEYAPGGTLAEYIQKRCNSLLDEDTILHFFVQILLA----LHHVHTK- 120
Query: 620 CTQIIHCDIKPQNILLDDHYN-ARISDFGLAKLLTLDQSHTNTAIRGTKGYVAPEWFRNM 678
I+H D+K QNILLD H +I DFG++K+L+ +S T + GT Y++PE
Sbjct: 121 --LILHRDLKTQNILLDKHKMVVKIGDFGISKILS-SKSKAYTVV-GTPCYISPELCEGK 176
Query: 679 PITVKVDVYSYGVLLLEIICLRRNID--NEISKVDKAILTDWA--YDRYQERTLEALVEN 734
P K D+++ G +L E+ L+R + N + V K + +A DRY L L+ +
Sbjct: 177 PYNQKSDIWALGCVLYELASLKRAFEAANLPALVLKIMSGTFAPISDRYSPD-LRQLILS 235
Query: 735 DLEAMNNVTMLHRFVMVAFWCIQEDPSHRPTMRKV 769
ML+ DPS RP + ++
Sbjct: 236 ---------MLNL-----------DPSKRPQLSQI 250
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256 |
| >gnl|CDD|214519 smart00108, B_lectin, Bulb-type mannose-specific lectin | Back alignment and domain information |
|---|
Score = 81.2 bits (201), Expect = 2e-18
Identities = 38/111 (34%), Positives = 58/111 (52%), Gaps = 3/111 (2%)
Query: 37 STEPWLSPSKDFALGFHQLDSKDLFLPAIWYYKIPSKTIVWYASAVNPAPRGSKLRLTAN 96
S + +S + F LGF L ++ + I Y S+T+VW A+ NP L L ++
Sbjct: 6 SGQTLVSGNSLFELGFFTLIMQNDYN-LILYKSS-SRTVVWVANRDNPVSDSCTLTLQSD 63
Query: 97 RGLVLEDPEGREIWKSEISTGQAAFG-VLYDTGNFLIVNTNSERLWQSFDH 146
LVL D +GR +W S + + VL D GN +I +++ LWQSFD+
Sbjct: 64 GNLVLYDGDGRVVWSSNTTGANGNYVLVLLDDGNLVIYDSDGNFLWQSFDY 114
|
Length = 114 |
| >gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Score = 85.3 bits (211), Expect = 3e-18
Identities = 67/285 (23%), Positives = 121/285 (42%), Gaps = 53/285 (18%)
Query: 505 FKEELGRGAFGTVYKGFVNMGSSNHVAVKKLNSVFQDSEKEFKAEVNGIGQTHHKNLVRL 564
F +ELG G FG V+ G + VA+K +N SE++F E + + H LV+L
Sbjct: 8 FMKELGSGQFGVVHLG--KWRAQIKVAIKAINEGAM-SEEDFIEEAKVMMKLSHPKLVQL 64
Query: 565 LGYCDEGQNRLLVYEFMSNGTVASFLFGDSKPNWKLRTEIAMG----IAGGLFYLHEECC 620
G C + + +V EFM NG + ++L + KL ++ + + G+ YL
Sbjct: 65 YGVCTQQKPLYIVTEFMENGCLLNYL---RQRQGKLSKDMLLSMCQDVCEGMEYLER--- 118
Query: 621 TQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLDQSHTNTAIRGTKGYVAPEWFRNMPI 680
IH D+ +N L+ ++SDFG+ + + D+ +++ + + PE F
Sbjct: 119 NSFIHRDLAARNCLVSSTGVVKVSDFGMTRYVLDDEYTSSSGAKFPVKWSPPEVFNFSKY 178
Query: 681 TVKVDVYSYGVLLLEIICLRRNIDNEISKVDKAILTDWAYDRYQERTLEALVENDLEAMN 740
+ K DV+S+GVL+ E+ + E + +++ E +
Sbjct: 179 SSKSDVWSFGVLMWEV--------------------------FTEGKMPFEKKSNYEVVE 212
Query: 741 NVTMLHRF------------VMVAFWCIQEDPSHRPTMRKVTQML 773
++ R VM + W E P RPT ++ + +
Sbjct: 213 MISRGFRLYRPKLASMTVYEVMYSCW--HEKPEGRPTFAELLRAI 255
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256 |
| >gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Score = 84.8 bits (210), Expect = 3e-18
Identities = 60/198 (30%), Positives = 103/198 (52%), Gaps = 13/198 (6%)
Query: 509 LGRGAFGTVYKGFV--NMGSSNHVAVKKLNSVFQDSE-KEFKAEVNGIGQTHHKNLVRLL 565
+G+G FG VY G + + G H AVK LN + E ++F E + H N++ LL
Sbjct: 3 IGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLSLL 62
Query: 566 GYC--DEGQNRLLVYEFMSNGTVASFLFGDSK-PNWKLRTEIAMGIAGGLFYLHEECCTQ 622
G C EG L+V +M +G + +F+ ++ P K + +A G+ YL + +
Sbjct: 63 GICLPSEGSP-LVVLPYMKHGDLRNFIRSETHNPTVKDLIGFGLQVAKGMEYLASK---K 118
Query: 623 IIHCDIKPQNILLDDHYNARISDFGLAKLL---TLDQSHTNTAIRGTKGYVAPEWFRNMP 679
+H D+ +N +LD+ + +++DFGLA+ + H +T + ++A E +
Sbjct: 119 FVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYSVHNHTGAKLPVKWMALESLQTQK 178
Query: 680 ITVKVDVYSYGVLLLEII 697
T K DV+S+GVLL E++
Sbjct: 179 FTTKSDVWSFGVLLWELM 196
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262 |
| >gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 84.9 bits (210), Expect = 4e-18
Identities = 59/205 (28%), Positives = 98/205 (47%), Gaps = 20/205 (9%)
Query: 509 LGRGAFGTVYKGFVNM--GSSNHVAVK--KLNSVFQDSEKEFKAEVNGIGQTHHKNLVRL 564
LG G FG+V +G ++ GS VAVK KL+ +EF +E + H N+++L
Sbjct: 7 LGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMKL 66
Query: 565 LGYCDEGQNR------LLVYEFMSNGTVASFLF----GDSKPNWKLRT--EIAMGIAGGL 612
+G C E + +++ FM +G + SFL G L+T + + IA G+
Sbjct: 67 IGVCFEASSLQKIPKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGM 126
Query: 613 FYLHEECCTQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLDQSHTNTAI-RGTKGYVA 671
YL IH D+ +N +L + ++DFGL+K + + I + ++A
Sbjct: 127 EYLSNR---NFIHRDLAARNCMLREDMTVCVADFGLSKKIYSGDYYRQGRIAKMPVKWIA 183
Query: 672 PEWFRNMPITVKVDVYSYGVLLLEI 696
E + T K DV+++GV + EI
Sbjct: 184 IESLADRVYTSKSDVWAFGVTMWEI 208
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273 |
| >gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 85.0 bits (211), Expect = 4e-18
Identities = 59/181 (32%), Positives = 89/181 (49%), Gaps = 21/181 (11%)
Query: 506 KEELGRGAFGTVYKGFVNMGSSNHVAVKKLNSVFQDSEKEFKAEVNGIGQ-THHKNLVRL 564
E +G G +G VYK + + VA+K ++ + +D E+E K E N + + ++H N+
Sbjct: 11 VEVIGEGTYGKVYKA-RHKKTGQLVAIKIMDII-EDEEEEIKEEYNILRKYSNHPNIATF 68
Query: 565 LG-------YCDEGQNRL-LVYEFMSNGTVASFLFGDSKPNWKLRTE----IAMGIAGGL 612
G ++ Q L LV E G+V + G K +L+ E I GL
Sbjct: 69 YGAFIKKNPPGNDDQ--LWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGL 126
Query: 613 FYLHEECCTQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLDQSHTNTAIRGTKGYVAP 672
YLHE ++IH DIK QNILL + ++ DFG++ L NT I GT ++AP
Sbjct: 127 AYLHEN---KVIHRDIKGQNILLTKNAEVKLVDFGVSAQLDSTLGRRNTFI-GTPYWMAP 182
Query: 673 E 673
E
Sbjct: 183 E 183
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275 |
| >gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 84.8 bits (210), Expect = 4e-18
Identities = 58/210 (27%), Positives = 109/210 (51%), Gaps = 21/210 (10%)
Query: 507 EELGRGAFGTVYKGFVNMGSSNHVAVKKL----------NSVFQDSEKEFKAEVNGIGQT 556
E +G+G +G VY +N+ + +AVK++ +S +D K ++E+ +
Sbjct: 7 ELIGKGTYGRVYLA-LNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDL 65
Query: 557 HHKNLVRLLGYCDEGQNRLLVY-EFMSNGTVASFLFGDSKPNWKLRTEIAMGIAGGLFYL 615
H N+V+ LG + + L ++ E++ G++ S L + +L + GL YL
Sbjct: 66 DHLNIVQYLG-FETTEEYLSIFLEYVPGGSIGSCLRTYGRFEEQLVRFFTEQVLEGLAYL 124
Query: 616 HEECCTQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLD--QSHTNTAIRGTKGYVAPE 673
H + I+H D+K N+L+D +ISDFG++K + D + N +++G+ ++APE
Sbjct: 125 HSK---GILHRDLKADNLLVDADGICKISDFGISK-KSDDIYDNDQNMSMQGSVFWMAPE 180
Query: 674 WFRN--MPITVKVDVYSYGVLLLEIICLRR 701
+ + KVD++S G ++LE+ RR
Sbjct: 181 VIHSYSQGYSAKVDIWSLGCVVLEMFAGRR 210
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272 |
| >gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Score = 84.3 bits (208), Expect = 6e-18
Identities = 79/273 (28%), Positives = 119/273 (43%), Gaps = 31/273 (11%)
Query: 507 EELGRGAFGTVYKGFVNMGSSNHVAVKKLNSVFQDSEKEFKAEVNGIGQTHHKNLVRLLG 566
++LG G FG V+ G N + VAVK L E F E + + H LV+L
Sbjct: 12 KKLGNGQFGEVWMGTWN--GNTKVAVKTLKPGTMSPES-FLEEAQIMKKLRHDKLVQLYA 68
Query: 567 YCDEGQNRLLVYEFMSNGTVASFLFGDSKPNWKLR--TEIAMGIAGGLFYLHEECCTQII 624
E + +V E+MS G++ FL KL ++A +A G+ Y+ I
Sbjct: 69 VVSE-EPIYIVTEYMSKGSLLDFLKDGEGRALKLPNLVDMAAQVAAGMAYIER---MNYI 124
Query: 625 HCDIKPQNILLDDHYNARISDFGLAKLLTLDQSHTNTAIRGTK---GYVAPEWFRNMPIT 681
H D++ NIL+ D +I+DFGLA+L+ + + TA +G K + APE T
Sbjct: 125 HRDLRSANILVGDGLVCKIADFGLARLI---EDNEYTARQGAKFPIKWTAPEAALYGRFT 181
Query: 682 VKVDVYSYGVLLLEIICLRRNIDNEISKVDKAILTDWAYDRYQERTLEALVENDLEAMNN 741
+K DV+S+G+LL E++ R V + + ER D +
Sbjct: 182 IKSDVWSFGILLTELVTKGR--------VPYPGMNNREVLEQVERGYRMPCPQDCPISLH 233
Query: 742 VTMLHRFVMVAFWCIQEDPSHRPTMRKVTQMLE 774
ML C ++DP RPT + LE
Sbjct: 234 ELMLQ--------CWKKDPEERPTFEYLQSFLE 258
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260 |
| >gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Score = 83.9 bits (208), Expect = 7e-18
Identities = 64/269 (23%), Positives = 116/269 (43%), Gaps = 23/269 (8%)
Query: 508 ELGRGAFGTVYKGFVNMGSSNHVAVKKLNSVFQDSE--KEFKAEVNGIGQTHHKNLVRLL 565
ELG G G V K V + + K + + K+ E++ + + + +V
Sbjct: 8 ELGAGNSGVVSK--VLHRPTGKIMAVKTIRLEINEAIQKQILRELDILHKCNSPYIVGFY 65
Query: 566 GYC-DEGQNRLLVYEFMSNGTVASFLFGDSKP-NWKLRTEIAMGIAGGLFYLHEECCTQI 623
G + G + + E+M G++ L ++ +IA+ + GL YLHE+ +I
Sbjct: 66 GAFYNNGDISICM-EYMDGGSLDKILKEVQGRIPERILGKIAVAVLKGLTYLHEK--HKI 122
Query: 624 IHCDIKPQNILLDDHYNARISDFGLAKLLTLDQSHTNTAIRGTKGYVAPEWFRNMPITVK 683
IH D+KP NIL++ ++ DFG++ L + T GT Y+APE + +VK
Sbjct: 123 IHRDVKPSNILVNSRGQIKLCDFGVSGQLVNSLAKTFV---GTSSYMAPERIQGNDYSVK 179
Query: 684 VDVYSYGVLLLEIICLRRNIDNEISKVDKAILTDWAYDRYQERTLEALVENDLEAMNNVT 743
D++S G+ L+E+ R E + I L+ +V + +
Sbjct: 180 SDIWSLGLSLIELATGRFPYPPE-NDPPDGIF----------ELLQYIVNEPPPRLPSGK 228
Query: 744 MLHRFVMVAFWCIQEDPSHRPTMRKVTQM 772
F C+ +DP RP+ +++ +
Sbjct: 229 FSPDFQDFVNLCLIKDPRERPSYKELLEH 257
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265 |
| >gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 84.4 bits (209), Expect = 7e-18
Identities = 61/214 (28%), Positives = 103/214 (48%), Gaps = 23/214 (10%)
Query: 496 KELVEVTRGFKEELGRGAFGTVYKGFVNMGSSNHVAVKKLNSVFQDSE--KEFKAEVNGI 553
+++VE++R LG GA G+V K + ++ + K + + + K+ E+
Sbjct: 1 EKIVELSR-----LGEGAGGSVTK--CRLKNTGMIFALKTITTDPNPDLQKQILRELEIN 53
Query: 554 GQTHHKNLVRLLG-YCDEGQNRL-LVYEFMSNGTVASFLFGDSKP-----NWKLRTEIAM 606
+V+ G + DE + + + E+ G++ S ++ K K+ +IA
Sbjct: 54 KSCKSPYIVKYYGAFLDESSSSIGIAMEYCEGGSLDS-IYKKVKKRGGRIGEKVLGKIAE 112
Query: 607 GIAGGLFYLHEECCTQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLDQSHTNTAIRGT 666
+ GL YLH +IIH DIKP NILL ++ DFG++ L + T T GT
Sbjct: 113 SVLKGLSYLHSR---KIIHRDIKPSNILLTRKGQVKLCDFGVSGELVNSLAGTFT---GT 166
Query: 667 KGYVAPEWFRNMPITVKVDVYSYGVLLLEIICLR 700
Y+APE + P ++ DV+S G+ LLE+ R
Sbjct: 167 SFYMAPERIQGKPYSITSDVWSLGLTLLEVAQNR 200
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287 |
| >gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Score = 84.1 bits (208), Expect = 9e-18
Identities = 72/231 (31%), Positives = 106/231 (45%), Gaps = 21/231 (9%)
Query: 509 LGRGAFGTVYKGFVNMGSSNHV-AVKKLNSVFQDSEKEFKAEVNG--IGQTHHKNLVRLL 565
LG+G FG V + ++ + A KKL+ K + +N I + + L
Sbjct: 1 LGKGGFGEVCA--CQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSL 58
Query: 566 GYCDEGQNRL-LVYEFMSNGTVASFLFGDSKPNWKLRTEI--AMGIAGGLFYLHEECCTQ 622
Y E ++ L LV M+ G + ++ +P + I A I GL +LH+ +
Sbjct: 59 AYAFETKDDLCLVMTLMNGGDLKYHIYNVGEPGFPEARAIFYAAQIICGLEHLHQR---R 115
Query: 623 IIHCDIKPQNILLDDHYNARISDFGLAKLLTLDQSHTNTAIRGTKGYVAPEWFRNMPITV 682
I++ D+KP+N+LLDDH N RISD GLA + L GT GY+APE +
Sbjct: 116 IVYRDLKPENVLLDDHGNVRISDLGLA--VELKGGKKIKGRAGTPGYMAPEVLQGEVYDF 173
Query: 683 KVDVYSYGVLLLEIICLRRNIDNEISKVDKAILTDWAYDRYQERTLEALVE 733
VD ++ G L E+I R KV+K L + RTLE VE
Sbjct: 174 SVDWFALGCTLYEMIAGRSPFRQRKEKVEKEEL--------KRRTLEMAVE 216
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277 |
| >gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 84.0 bits (208), Expect = 1e-17
Identities = 66/222 (29%), Positives = 101/222 (45%), Gaps = 42/222 (18%)
Query: 509 LGRGAFGTV----YKGFVNMGSSNHVAVKKLNSVFQDSEKEFKAEVNG------IGQTHH 558
LG GAFG V G N ++ VAVK L +EK+ V+ IG+ H
Sbjct: 20 LGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKD--DATEKDLSDLVSEMEMMKMIGK--H 75
Query: 559 KNLVRLLGYCDEGQNRLLVYEFMSNGTVASFLFGDSKPNWKLR----------------T 602
KN++ LLG C + +V E+ ++G + FL P
Sbjct: 76 KNIINLLGVCTQEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLV 135
Query: 603 EIAMGIAGGLFYLHEECCTQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLDQSHTNTA 662
A +A G+ +L + C IH D+ +N+L+ + + +I+DFGLA+ D H +
Sbjct: 136 SFAYQVARGMEFLASKKC---IHRDLAARNVLVTEDHVMKIADFGLAR----DIHHIDYY 188
Query: 663 IRGTKG-----YVAPEWFRNMPITVKVDVYSYGVLLLEIICL 699
+ T G ++APE + T + DV+S+GVLL EI L
Sbjct: 189 RKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTL 230
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293 |
| >gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 83.4 bits (206), Expect = 1e-17
Identities = 65/204 (31%), Positives = 106/204 (51%), Gaps = 20/204 (9%)
Query: 509 LGRGAFGTVYKGFVNMGSSNHVAVKK--LNSVFQDSEKEFKA-------EVNGIGQTHHK 559
+G G+FG+VY G +N S +AVK+ L SV S+ ++ E+ + + H+
Sbjct: 8 IGSGSFGSVYLG-MNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHE 66
Query: 560 NLVRLLGYCDEGQNRLLVY-EFMSNGTVASFLFGDSKPNWKLRTEIAMGIAGGLFYLHEE 618
N+V+ LG + L ++ E++ G+VA+ L L I GL YLH
Sbjct: 67 NIVQYLG-SSLDADHLNIFLEYVPGGSVAALLNNYGAFEETLVRNFVRQILKGLNYLHNR 125
Query: 619 CCTQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLDQSHTNT-----AIRGTKGYVAPE 673
IIH DIK NIL+D+ +ISDFG++K L + T T +++G+ ++APE
Sbjct: 126 ---GIIHRDIKGANILVDNKGGIKISDFGISKKLEANSLSTKTNGARPSLQGSVFWMAPE 182
Query: 674 WFRNMPITVKVDVYSYGVLLLEII 697
+ T K D++S G L++E++
Sbjct: 183 VVKQTSYTRKADIWSLGCLVVEML 206
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267 |
| >gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Score = 83.2 bits (205), Expect = 1e-17
Identities = 61/194 (31%), Positives = 101/194 (52%), Gaps = 15/194 (7%)
Query: 508 ELGRGAFGTVYKGFVNMGSSNHVAVKKLNSVFQDSEKEFKAEVNGIGQTHHKNLVRLLGY 567
+LG+G FG V+ G N + VA+K L E F E + + H+ LV+L
Sbjct: 13 KLGQGCFGEVWMGTWN--GTTRVAIKTLKPGTMSPEA-FLQEAQVMKKLRHEKLVQLYAV 69
Query: 568 CDEGQNRLLVYEFMSNGTVASFLFGDSKPNWKLR--TEIAMGIAGGLFYLHEECCTQIIH 625
E + +V E+MS G++ FL G+ +L ++A IA G+ Y+ +H
Sbjct: 70 VSE-EPIYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVER---MNYVH 125
Query: 626 CDIKPQNILLDDHYNARISDFGLAKLLTLDQSHTNTAIRGTK---GYVAPEWFRNMPITV 682
D++ NIL+ ++ +++DFGLA+L+ + + TA +G K + APE T+
Sbjct: 126 RDLRAANILVGENLVCKVADFGLARLI---EDNEYTARQGAKFPIKWTAPEAALYGRFTI 182
Query: 683 KVDVYSYGVLLLEI 696
K DV+S+G+LL E+
Sbjct: 183 KSDVWSFGILLTEL 196
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262 |
| >gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 83.5 bits (207), Expect = 2e-17
Identities = 76/305 (24%), Positives = 131/305 (42%), Gaps = 72/305 (23%)
Query: 507 EELGRGAFGTVYKGFVNMGSSNHVAVKKLNSVFQDSEKEFKAEVNGIGQT---------- 556
E+G GA+GTVYK ++ + VA+KK+ SE GI +
Sbjct: 5 AEIGEGAYGTVYKA-RDLNTGRFVALKKVR--VPLSE-------EGIPLSTLREIALLKQ 54
Query: 557 ----HHKNLVRLLGYC-----DEGQNRLLVYEFMSNGTVASFLFGDSKPN---WKLRTEI 604
H N+VRLL C D LV+E + +A++L KP ++ ++
Sbjct: 55 LESFEHPNIVRLLDVCHGPRTDRELKLTLVFEHVDQ-DLATYLSKCPKPGLPPETIK-DL 112
Query: 605 AMGIAGGLFYLHEECCTQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLDQSHTNTAIR 664
+ G+ +LH +I+H D+KPQNIL+ +I+DFGLA++ + + + T+ +
Sbjct: 113 MRQLLRGVDFLH---SHRIVHRDLKPQNILVTSDGQVKIADFGLARIYSFEMALTSVVV- 168
Query: 665 GTKGYVAPEWFRNMPITVKVDVYSYGVLLLEIICLRRNI---DNEISKVDKAIL------ 715
T Y APE VD++S G + E+ RR + +E ++DK I
Sbjct: 169 -TLWYRAPEVLLQSSYATPVDMWSVGCIFAELF-RRRPLFRGTSEADQLDK-IFDVIGLP 225
Query: 716 --TDW---------AYDRYQERTLEALV-ENDLEAMNNVTMLHRFVMVAFWCIQEDPSHR 763
+W ++ Y R+ ++ V E E + +L + + +P R
Sbjct: 226 SEEEWPRNVSLPRSSFPSYTPRSFKSFVPEICEEG---LDLLKK-------MLTFNPHKR 275
Query: 764 PTMRK 768
+ +
Sbjct: 276 ISAFE 280
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287 |
| >gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Score = 82.4 bits (203), Expect = 2e-17
Identities = 61/200 (30%), Positives = 96/200 (48%), Gaps = 15/200 (7%)
Query: 507 EELGRGAFGTVYKGFVNMGSSNHVAVKKLNSVFQ-DSEKEFKAEVNGIGQTHHKNLVRLL 565
E +GRG FG V+ G + + VAVK D + +F E + Q H N+VRL+
Sbjct: 1 ERIGRGNFGEVFSGRLR-ADNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLI 59
Query: 566 GYCDEGQNRLLVYEFMSNGTVASFLFGDSKPNWKLRTEIAM--GIAGGLFYLHEECCTQI 623
G C + Q +V E + G +FL + P K++ I M A G+ YL + C
Sbjct: 60 GVCTQKQPIYIVMELVQGGDFLTFLRTEG-PRLKVKELIQMVENAAAGMEYLESKHC--- 115
Query: 624 IHCDIKPQNILLDDHYNARISDFGLAKLLTLDQSHTNTAIRGTK----GYVAPEWFRNMP 679
IH D+ +N L+ + +ISDFG+++ ++ + G K + APE
Sbjct: 116 IHRDLAARNCLVTEKNVLKISDFGMSR---EEEDGVYASTGGMKQIPVKWTAPEALNYGR 172
Query: 680 ITVKVDVYSYGVLLLEIICL 699
+ + DV+S+G+LL E L
Sbjct: 173 YSSESDVWSFGILLWEAFSL 192
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252 |
| >gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Score = 82.7 bits (204), Expect = 2e-17
Identities = 62/197 (31%), Positives = 98/197 (49%), Gaps = 17/197 (8%)
Query: 508 ELGRGAFGTVYKGFVNMGSSN-HVAVKKLNSVFQDSEKEFKAEVNGIGQTHHK----NLV 562
ELG G FG V KG M VA+K L ++EK + E+ + H+ +V
Sbjct: 2 ELGSGNFGCVKKGVYKMRKKQIDVAIKVLK---NENEKSVRDEMMREAEIMHQLDNPYIV 58
Query: 563 RLLGYCDEGQNRLLVYEFMSNGTVASFLFG--DSKPNWKLRTEIAMGIAGGLFYLHEECC 620
R++G C E + +LV E S G + FL G D + E+ ++ G+ YL +
Sbjct: 59 RMIGVC-EAEALMLVMEMASGGPLNKFLSGKKDEITVSNV-VELMHQVSMGMKYLEGK-- 114
Query: 621 TQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLDQSH--TNTAIRGTKGYVAPEWFRNM 678
+H D+ +N+LL + + A+ISDFGL+K L D S+ +A + + APE
Sbjct: 115 -NFVHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYYKARSAGKWPLKWYAPECINFR 173
Query: 679 PITVKVDVYSYGVLLLE 695
+ + DV+SYG+ + E
Sbjct: 174 KFSSRSDVWSYGITMWE 190
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257 |
| >gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Score = 82.3 bits (203), Expect = 2e-17
Identities = 74/277 (26%), Positives = 124/277 (44%), Gaps = 43/277 (15%)
Query: 509 LGRGAFGTV----YKGFVNMGSSNHVAVKKLNSVFQDSEKEFKAEVNGIGQTHHKNLVRL 564
+G+G FG V Y+G N VAVK + + + + F AE + + Q H NLV+L
Sbjct: 14 IGKGEFGDVMLGDYRG-------NKVAVKCIKN--DATAQAFLAEASVMTQLRHSNLVQL 64
Query: 565 LGYCDEGQNRL-LVYEFMSNGTVASFLF--GDSKPNWKLRTEIAMGIAGGLFYLHEECCT 621
LG E + L +V E+M+ G++ +L G S + ++ + + YL
Sbjct: 65 LGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEA---N 121
Query: 622 QIIHCDIKPQNILLDDHYNARISDFGLAKLLTLDQSHTNTAIRGTKGYVAPEWFRNMPIT 681
+H D+ +N+L+ + A++SDFGL K + Q ++ T APE R +
Sbjct: 122 NFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKLPVKWT----APEALREKKFS 177
Query: 682 VKVDVYSYGVLLLEIICLRRNIDNEISKVDKAILTDWAYDRYQERTLEALVEN--DLEAM 739
K DV+S+G+LL EI R Y R + + VE ++A
Sbjct: 178 TKSDVWSFGILLWEIYSFGR----------------VPYPRIPLKDVVPRVEKGYKMDAP 221
Query: 740 NNVTMLHRFVMVAFWCIQEDPSHRPTMRKVTQMLEGV 776
+ + VM W + D + RP+ ++ + LE +
Sbjct: 222 DGCPPVVYDVMKQCWHL--DAATRPSFLQLREQLEHI 256
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256 |
| >gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Score = 82.0 bits (202), Expect = 3e-17
Identities = 61/197 (30%), Positives = 100/197 (50%), Gaps = 11/197 (5%)
Query: 507 EELGRGAFGTVYKGFVNMGSSNHVAVKKLNSVF-QDSEKEFKAEVNGIGQTHHKNLVRLL 565
E LG+G FG V+KG + VAVK Q+ + +F +E + Q H N+V+L+
Sbjct: 1 ELLGKGNFGEVFKG--TLKDKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLI 58
Query: 566 GYCDEGQNRLLVYEFMSNGTVASFLFGDSKPNWKLR--TEIAMGIAGGLFYLHEECCTQI 623
G C + Q +V E + G SFL K K + + A+ A G+ YL + C
Sbjct: 59 GVCTQRQPIYIVMELVPGGDFLSFL-RKKKDELKTKQLVKFALDAAAGMAYLESKNC--- 114
Query: 624 IHCDIKPQNILLDDHYNARISDFGLAKLLTLDQSHTNTAIRGTK-GYVAPEWFRNMPITV 682
IH D+ +N L+ ++ +ISDFG+++ D ++++ ++ + APE +
Sbjct: 115 IHRDLAARNCLVGENNVLKISDFGMSRQED-DGIYSSSGLKQIPIKWTAPEALNYGRYSS 173
Query: 683 KVDVYSYGVLLLEIICL 699
+ DV+SYG+LL E L
Sbjct: 174 ESDVWSYGILLWETFSL 190
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250 |
| >gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Score = 82.4 bits (203), Expect = 3e-17
Identities = 61/194 (31%), Positives = 98/194 (50%), Gaps = 13/194 (6%)
Query: 507 EELGRGAFGTVYKGFVNMGSSNHVAVKKLN-SVFQDSEKEFKAEVNGIGQTHHKNLVRLL 565
E +G+G+FG VYKG N + VA+K ++ +D ++ + E+ + Q + R
Sbjct: 10 ERIGKGSFGEVYKGIDNR-TKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYITRYY 68
Query: 566 GYCDEGQNRLLVYEFMSNGTVASFLFGDSKPNWKLRTEIAM---GIAGGLFYLHEECCTQ 622
G +G ++ E++ G+ L KP T IA I GL YLH E +
Sbjct: 69 GSYLKGTKLWIIMEYLGGGSALDLL----KPGPLEETYIATILREILKGLDYLHSE---R 121
Query: 623 IIHCDIKPQNILLDDHYNARISDFGLAKLLTLDQSHTNTAIRGTKGYVAPEWFRNMPITV 682
IH DIK N+LL + + +++DFG+A LT Q NT + GT ++APE +
Sbjct: 122 KIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNTFV-GTPFWMAPEVIKQSAYDF 180
Query: 683 KVDVYSYGVLLLEI 696
K D++S G+ +E+
Sbjct: 181 KADIWSLGITAIEL 194
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277 |
| >gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 81.8 bits (202), Expect = 4e-17
Identities = 57/204 (27%), Positives = 99/204 (48%), Gaps = 18/204 (8%)
Query: 507 EELGRGAFGTVYKGFVNMGSSNHVAVKKLN------SVFQDSEKEFKAEVNGIGQTHHKN 560
++LG GAF + Y ++ + +AVK++ S ++ + + E+ + + +H +
Sbjct: 6 QQLGTGAFSSCY-QARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPH 64
Query: 561 LVRLLGYCDEGQNRLLVYEFMSNGTVASFL--FGDSKPNWKLRTEIAMGIAGGLFYLHEE 618
++R+LG E + L E+M+ G+V+ L +G K + + GL YLHE
Sbjct: 65 IIRMLGATCEDSHFNLFVEWMAGGSVSHLLSKYGAFKEAVIIN--YTEQLLRGLSYLHEN 122
Query: 619 CCTQIIHCDIKPQNILLDDH-YNARISDFGLAKLLTLDQSHTNT---AIRGTKGYVAPEW 674
QIIH D+K N+L+D RI+DFG A L + + GT ++APE
Sbjct: 123 ---QIIHRDVKGANLLIDSTGQRLRIADFGAAARLAAKGTGAGEFQGQLLGTIAFMAPEV 179
Query: 675 FRNMPITVKVDVYSYGVLLLEIIC 698
R DV+S G +++E+
Sbjct: 180 LRGEQYGRSCDVWSVGCVIIEMAT 203
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268 |
| >gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 82.4 bits (204), Expect = 4e-17
Identities = 50/199 (25%), Positives = 93/199 (46%), Gaps = 12/199 (6%)
Query: 507 EELGRGAFGTVYKGFVNMGSSNHVAVKKLNSVFQDSEKEFKA--EVNGIGQTHHKNLVRL 564
++G G +G VYK + + VA+KK+ F+ A E+ + + +H N+++L
Sbjct: 5 GKIGEGTYGVVYKAR-DKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKL 63
Query: 565 LGYCDEGQNRLLVYEFMSNGTVASFLFGDSK--PNWKLRTEIAMGIAGGLFYLHEECCTQ 622
L + LV+EFM + + + P +++ + + GL + H
Sbjct: 64 LDVFRHKGDLYLVFEFMDT-DLYKLIKDRQRGLPESLIKSYLYQ-LLQGLAFCHSH---G 118
Query: 623 IIHCDIKPQNILLDDHYNARISDFGLAKLLTLDQSHTNTAIRGTKGYVAPEWFRNMPI-T 681
I+H D+KP+N+L++ +++DFGLA+ T T+ Y APE +
Sbjct: 119 ILHRDLKPENLLINTEGVLKLADFGLARSFGSPVR-PYTHYVVTRWYRAPELLLGDKGYS 177
Query: 682 VKVDVYSYGVLLLEIICLR 700
VD++S G + E++ R
Sbjct: 178 TPVDIWSVGCIFAELLSRR 196
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283 |
| >gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 82.1 bits (204), Expect = 4e-17
Identities = 61/238 (25%), Positives = 105/238 (44%), Gaps = 62/238 (26%)
Query: 506 KEELGRGAFGTVYKGFVNMGSSNHVAVKKLNSVFQDSEKEFKAEVNGIGQT--------- 556
E+LG G +G VYK + + VA+KK + D+E+E GI T
Sbjct: 4 LEKLGEGTYGVVYKAR-DKKTGEIVALKK---IRLDNEEE------GIPSTALREISLLK 53
Query: 557 --HHKNLVRLLGYCDEGQNRLLVYEFMSN---------------GTVASFLFGDSKPNWK 599
H N+V+LL + LV+E+ + S ++
Sbjct: 54 ELKHPNIVKLLDVIHTERKLYLVFEYCDMDLKKYLDKRPGPLSPNLIKSIMY-------- 105
Query: 600 LRTEIAMGIAGGLFYLHEECCTQIIHCDIKPQNILLDDHYNARISDFGLAKLLTL-DQSH 658
++ G+A Y H +I+H D+KPQNIL++ +++DFGLA+ + +++
Sbjct: 106 ---QLLRGLA----YCHSH---RILHRDLKPQNILINRDGVLKLADFGLARAFGIPLRTY 155
Query: 659 TNTAIRGTKGYVAPEWFRNMPI-TVKVDVYSYGVLLLEIICLRRNI---DNEISKVDK 712
T+ + T Y APE + VD++S G + E+I + + D+EI ++ K
Sbjct: 156 THEVV--TLWYRAPEILLGSKHYSTAVDIWSVGCIFAEMI-TGKPLFPGDSEIDQLFK 210
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282 |
| >gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Score = 82.3 bits (203), Expect = 4e-17
Identities = 77/302 (25%), Positives = 131/302 (43%), Gaps = 61/302 (20%)
Query: 509 LGRGAFGTVYKGFV----NMGSSNHVAVKKLNSVFQDSE-KEFKAEVNGIGQTHHKNLVR 563
LG G FG V K VAVK L SE ++ +E N + Q +H ++++
Sbjct: 8 LGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQVNHPHVIK 67
Query: 564 LLGYCDEGQNRLLVYEFMSNGTVASFL-----------------------FGDSKP-NWK 599
L G C + LL+ E+ G++ SFL D +
Sbjct: 68 LYGACSQDGPLLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMG 127
Query: 600 LRTEIAMGIAGGLFYLHEECCTQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLDQSHT 659
A I+ G+ YL E +++H D+ +N+L+ + +ISDFGL++ D
Sbjct: 128 DLISFAWQISRGMQYLAE---MKLVHRDLAARNVLVAEGRKMKISDFGLSR----DVYEE 180
Query: 660 NTAIRGTKG-----YVAPEWFRNMPITVKVDVYSYGVLLLEIICLRRNIDNEIS--KVDK 712
++ ++ +KG ++A E + T + DV+S+GVLL EI+ L N I+ ++
Sbjct: 181 DSYVKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIAPERLFN 240
Query: 713 AILTDWAYDRYQERTLEALVENDLEAMNNVTMLHRFVMVAFWCIQEDPSHRPTMRKVTQM 772
+ T + +R EN E M N+ + C +++P RPT +++
Sbjct: 241 LLKTGYRMER---------PENCSEEMYNLMLT---------CWKQEPDKRPTFADISKE 282
Query: 773 LE 774
LE
Sbjct: 283 LE 284
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290 |
| >gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Score = 82.0 bits (202), Expect = 5e-17
Identities = 62/218 (28%), Positives = 107/218 (49%), Gaps = 33/218 (15%)
Query: 505 FKEELGRGAFGTVYKGFVNMGSSNH---VAVKKLNSVFQDSE-KEFKAEVNGIGQTHHKN 560
F EELG AFG +YKG + + +H VA+K L + + EF+ E + + + HH N
Sbjct: 9 FMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAELHHPN 68
Query: 561 LVRLLGYCDEGQNRLLVYEFMSNGTVASFLF---------GDSKPNWKLRT--------E 603
+V LLG + Q +++E+++ G + FL S + +++
Sbjct: 69 IVCLLGVVTQEQPVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLH 128
Query: 604 IAMGIAGGLFYLHEECCTQIIHCDIKPQNILLDDHYNARISDFGLAK-LLTLD----QSH 658
IA+ IA G+ YL +H D+ +NIL+ + + +ISD GL++ + + D Q
Sbjct: 129 IAIQIAAGMEYLSSHF---FVHKDLAARNILIGEQLHVKISDLGLSREIYSADYYRVQPK 185
Query: 659 TNTAIRGTKGYVAPEWFRNMPITVKVDVYSYGVLLLEI 696
+ IR ++ PE + D++S+GV+L EI
Sbjct: 186 SLLPIR----WMPPEAIMYGKFSSDSDIWSFGVVLWEI 219
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. Avian Ror1 was found to be involved in late limb development. Studies in mice reveal that Ror1 is important in the regulation of neurite growth in central neurons, as well as in respiratory development. Loss of Ror1 also enhances the heart and skeletal abnormalities found in Ror2-deficient mice. Length = 283 |
| >gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Score = 82.0 bits (202), Expect = 5e-17
Identities = 62/214 (28%), Positives = 99/214 (46%), Gaps = 29/214 (13%)
Query: 505 FKEELGRGAFGTVYKG-FVNMGSSNH---VAVKKLNSVFQDSEKEFKAEVNGIGQTHHKN 560
K ELG GAFG V+ N+ VAVK L ++ K+F E + H++
Sbjct: 9 LKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEH 68
Query: 561 LVRLLGYCDEGQNRLLVYEFMSNGTVASF---------LFGDSKPNWKLRT----EIAMG 607
+V+ G C EG ++V+E+M +G + F L + +L IA
Sbjct: 69 IVKFYGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQ 128
Query: 608 IAGGLFYLHEECCTQIIHCDIKPQNILLDDHYNARISDFGLAK-LLTLDQ----SHTNTA 662
IA G+ YL + +H D+ +N L+ ++ +I DFG+++ + + D HT
Sbjct: 129 IAAGMVYLASQ---HFVHRDLATRNCLVGENLLVKIGDFGMSRDVYSTDYYRVGGHTMLP 185
Query: 663 IRGTKGYVAPEWFRNMPITVKVDVYSYGVLLLEI 696
IR ++ PE T + DV+S GV+L EI
Sbjct: 186 IR----WMPPESIMYRKFTTESDVWSLGVVLWEI 215
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288 |
| >gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Score = 81.3 bits (200), Expect = 6e-17
Identities = 82/279 (29%), Positives = 127/279 (45%), Gaps = 45/279 (16%)
Query: 508 ELGRGAFGTVYKGFVNMGSSNHVAVKKLNSVFQDSEKEFKAEVNGIGQTHHKNLVRLLGY 567
+LG+G FG V+ G N + VA+K L E F E + + H LV L
Sbjct: 13 KLGQGCFGEVWMGTWN--GTTKVAIKTLKPGTMMPEA-FLQEAQIMKKLRHDKLVPLYAV 69
Query: 568 CDEGQNRLLVYEFMSNGTVASFLF-GDSKPNWKLR--TEIAMGIAGGLFYLHEECCTQII 624
E + +V EFM G++ FL GD K KL ++A IA G+ Y+ I
Sbjct: 70 VSE-EPIYIVTEFMGKGSLLDFLKEGDGK-YLKLPQLVDMAAQIADGMAYIER---MNYI 124
Query: 625 HCDIKPQNILLDDHYNARISDFGLAKLLTLDQSHTNTAIRGTK---GYVAPEWFRNMPIT 681
H D++ NIL+ D+ +I+DFGLA+L+ + + TA +G K + APE T
Sbjct: 125 HRDLRAANILVGDNLVCKIADFGLARLI---EDNEYTARQGAKFPIKWTAPEAALYGRFT 181
Query: 682 VKVDVYSYGVLLLEIICLRR-----NIDNEI-SKVDKAILTDWAYDRYQERTLEALVEND 735
+K DV+S+G+LL E++ R ++ E+ +V++ Y+ + E+
Sbjct: 182 IKSDVWSFGILLTELVTKGRVPYPGMVNREVLEQVERG---------YRMPCPQGCPESL 232
Query: 736 LEAMNNVTMLHRFVMVAFWCIQEDPSHRPTMRKVTQMLE 774
E M C ++DP RPT + LE
Sbjct: 233 HELMKL-------------CWKKDPDERPTFEYIQSFLE 258
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260 |
| >gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Score = 81.6 bits (201), Expect = 7e-17
Identities = 61/217 (28%), Positives = 98/217 (45%), Gaps = 33/217 (15%)
Query: 505 FKEELGRGAFGTVYKGFVNMGSSNH----VAVKKLNSVFQDSEKEFKAEVNGIGQTHHKN 560
K ELG GAFG V+ + VAVK L + + ++F+ E + H++
Sbjct: 9 LKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVLQHQH 68
Query: 561 LVRLLGYCDEGQNRLLVYEFMSNGTVASFLFGDSKPNWKLRTE----------------I 604
+VR G C EG+ L+V+E+M +G + FL P+ K+ I
Sbjct: 69 IVRFYGVCTEGRPLLMVFEYMRHGDLNRFLRSHG-PDAKILAGGEDVAPGQLTLGQMLAI 127
Query: 605 AMGIAGGLFYLHEECCTQIIHCDIKPQNILLDDHYNARISDFGLAK-LLTLDQ----SHT 659
A IA G+ YL +H D+ +N L+ +I DFG+++ + + D T
Sbjct: 128 ASQIASGMVYL---ASLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRT 184
Query: 660 NTAIRGTKGYVAPEWFRNMPITVKVDVYSYGVLLLEI 696
IR ++ PE T + D++S+GV+L EI
Sbjct: 185 MLPIR----WMPPESILYRKFTTESDIWSFGVVLWEI 217
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280 |
| >gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Score = 80.6 bits (199), Expect = 8e-17
Identities = 67/276 (24%), Positives = 121/276 (43%), Gaps = 40/276 (14%)
Query: 509 LGRGAFG--TVYKGFVNMGSSNHVAVKKLNSVFQDSEKEFKAEVNGI---GQTHHKNLVR 563
LG+GAFG T+Y+ + + V K ++ + SEKE + +N I H N++
Sbjct: 8 LGKGAFGEATLYR----RTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIA 63
Query: 564 LLGYCDEGQNRLLVYEFMSNGTVASFLFGDSKPNWKLRTEIAM--GIAGGLFYLHEECCT 621
+ + L+ E+ + GT+ + ++ + I + Y+H+
Sbjct: 64 YYNHFMDDNTLLIEMEYANGGTLYDKIVRQKGQLFEEEMVLWYLFQIVSAVSYIHKA--- 120
Query: 622 QIIHCDIKPQNILLDDHYNARISDFGLAKLLTLDQSHTNTAIRGTKGYVAPEWFRNMPIT 681
I+H DIK NI L ++ DFG++K+L + S T + GT Y++PE + +
Sbjct: 121 GILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEYSMAETVV-GTPYYMSPELCQGVKYN 179
Query: 682 VKVDVYSYGVLLLEIICLRRNID--NEISKVDKAILTDWA--YDRYQERTLEALVENDLE 737
K D+++ G +L E++ L+R D N ++ V K + ++ Y L +LV +
Sbjct: 180 FKSDIWALGCVLYELLTLKRTFDATNPLNLVVKIVQGNYTPVVSVYSSE-LISLVHS--- 235
Query: 738 AMNNVTMLHRFVMVAFWCIQEDPSHRPTMRKVTQML 773
+Q+DP RPT +V
Sbjct: 236 -----------------LLQQDPEKRPTADEVLDQP 254
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256 |
| >gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 80.2 bits (198), Expect = 1e-16
Identities = 57/199 (28%), Positives = 90/199 (45%), Gaps = 17/199 (8%)
Query: 509 LGRGAFGTVYKGFVNMGSSNHVAVKKLNSVFQDSEKEFKAEVNGIGQT-------HHKNL 561
LG+GAFG VY ++ + +AVK++ F E K EVN + H+ +
Sbjct: 10 LGQGAFGRVYL-CYDVDTGRELAVKQVP--FDPDSPETKKEVNALECEIQLLKNLQHERI 66
Query: 562 VRLLGYCDEGQNRLLVYEFMSNGTVASFLFGDSKPNWKLRTEIAMGIAGGLFYLHEECCT 621
V+ G + + + E+M G+V L + + I G+ YLH
Sbjct: 67 VQYYGCLRDDETLSIFMEYMPGGSVKDQLKAYGALTETVTRKYTRQILEGVEYLHSN--- 123
Query: 622 QIIHCDIKPQNILLDDHYNARISDFGLAKLLTLDQSHTNTAIR---GTKGYVAPEWFRNM 678
I+H DIK NIL D N ++ DFG +K L S T ++ GT +++PE
Sbjct: 124 MIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICSSG-TGMKSVTGTPYWMSPEVISGE 182
Query: 679 PITVKVDVYSYGVLLLEII 697
K DV+S G ++E++
Sbjct: 183 GYGRKADVWSVGCTVVEML 201
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263 |
| >gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Score = 80.5 bits (198), Expect = 1e-16
Identities = 55/191 (28%), Positives = 98/191 (51%), Gaps = 7/191 (3%)
Query: 507 EELGRGAFGTVYKGFVNMGSSNHVAVKKLN-SVFQDSEKEFKAEVNGIGQTHHKNLVRLL 565
E +G+G+FG V+KG N + VA+K ++ +D ++ + E+ + Q + +
Sbjct: 10 ERIGKGSFGEVFKGIDNR-TQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYY 68
Query: 566 GYCDEGQNRLLVYEFMSNGTVASFLFGDSKPNWKLRTEIAMGIAGGLFYLHEECCTQIIH 625
G +G ++ E++ G+ L +++ T + I GL YLH E + IH
Sbjct: 69 GSYLKGTKLWIIMEYLGGGSALDLLRAGPFDEFQIATMLKE-ILKGLDYLHSE---KKIH 124
Query: 626 CDIKPQNILLDDHYNARISDFGLAKLLTLDQSHTNTAIRGTKGYVAPEWFRNMPITVKVD 685
DIK N+LL + + +++DFG+A LT Q NT + GT ++APE + K D
Sbjct: 125 RDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNTFV-GTPFWMAPEVIQQSAYDSKAD 183
Query: 686 VYSYGVLLLEI 696
++S G+ +E+
Sbjct: 184 IWSLGITAIEL 194
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277 |
| >gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Score = 79.7 bits (197), Expect = 1e-16
Identities = 58/197 (29%), Positives = 93/197 (47%), Gaps = 11/197 (5%)
Query: 507 EELGRGAFGTVYKGFVNMGSSNH--VAVKKLNS-VFQDSEKEFKAEVNGIGQTHHKNLVR 563
++LG G+FG V +G + VAVK L S D +F E + H+NL+R
Sbjct: 1 KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIR 60
Query: 564 LLGYCDEGQNRLLVYEFMSNGTVASFLFGDSKPNWKLRT--EIAMGIAGGLFYLHEECCT 621
L G ++V E G++ L D+ ++ + T + A+ IA G+ YL +
Sbjct: 61 LYGVVLT-HPLMMVTELAPLGSLLDRLRKDALGHFLISTLCDYAVQIANGMRYLESK--- 116
Query: 622 QIIHCDIKPQNILLDDHYNARISDFGLAKLLTLDQSH--TNTAIRGTKGYVAPEWFRNMP 679
+ IH D+ +NILL +I DFGL + L ++ H ++ + APE R
Sbjct: 117 RFIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHYVMEEHLKVPFAWCAPESLRTRT 176
Query: 680 ITVKVDVYSYGVLLLEI 696
+ DV+ +GV L E+
Sbjct: 177 FSHASDVWMFGVTLWEM 193
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257 |
| >gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Score = 80.6 bits (199), Expect = 1e-16
Identities = 66/233 (28%), Positives = 108/233 (46%), Gaps = 44/233 (18%)
Query: 500 EVTRG---FKEELGRGAFGTVYK----GFVNMGSSNHVAVKKL-NSVFQDSEKEFKAEVN 551
E R + ++G+GAFG V++ G + VAVK L D + +F+ E
Sbjct: 1 EYPRNNIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAA 60
Query: 552 GIGQTHHKNLVRLLGYCDEGQNRLLVYEFMSNGTVASFLFGDSKPNW---------KLRT 602
+ + H N+V+LLG C G+ L++E+M+ G + FL S P R
Sbjct: 61 LMAEFDHPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRHRS-PRAQCSLSHSTSSARK 119
Query: 603 E--------------IAMGIAGGLFYLHEECCTQIIHCDIKPQNILLDDHYNARISDFGL 648
IA +A G+ YL E + +H D+ +N L+ ++ +I+DFGL
Sbjct: 120 CGLNPLPLSCTEQLCIAKQVAAGMAYLSER---KFVHRDLATRNCLVGENMVVKIADFGL 176
Query: 649 A-KLLTLD--QSHTNTA--IRGTKGYVAPEWFRNMPITVKVDVYSYGVLLLEI 696
+ + + D ++ N A IR ++ PE T + DV++YGV+L EI
Sbjct: 177 SRNIYSADYYKASENDAIPIR----WMPPESIFYNRYTTESDVWAYGVVLWEI 225
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288 |
| >gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Score = 80.4 bits (198), Expect = 2e-16
Identities = 63/217 (29%), Positives = 102/217 (47%), Gaps = 32/217 (14%)
Query: 505 FKEELGRGAFGTVYKG-FVNMGSSNH---VAVKKLNSVFQDSEKEFKAEVNGIGQTHHKN 560
K ELG GAFG V+ N+ + VAVK L + K+F+ E + H++
Sbjct: 9 LKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEH 68
Query: 561 LVRLLGYCDEGQNRLLVYEFMSNGTVASFLFG---------DSKP---NWKL----RTEI 604
+V+ G C +G ++V+E+M +G + FL D +P +L I
Sbjct: 69 IVKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHI 128
Query: 605 AMGIAGGLFYLHEECCTQIIHCDIKPQNILLDDHYNARISDFGLAK-LLTLDQ----SHT 659
A IA G+ YL + +H D+ +N L+ + +I DFG+++ + + D HT
Sbjct: 129 ASQIASGMVYLASQ---HFVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDYYRVGGHT 185
Query: 660 NTAIRGTKGYVAPEWFRNMPITVKVDVYSYGVLLLEI 696
IR ++ PE T + DV+S+GV+L EI
Sbjct: 186 MLPIR----WMPPESIMYRKFTTESDVWSFGVILWEI 218
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291 |
| >gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Score = 79.1 bits (195), Expect = 3e-16
Identities = 82/288 (28%), Positives = 129/288 (44%), Gaps = 44/288 (15%)
Query: 509 LGRGAFGTVYKG----FVNMGSS-NHVAVKKLNSVFQDSEK-EFKAEVNGIGQTHHKNLV 562
LG GAFG VY+G + GS VAVK L D EK EF E + + +H N+V
Sbjct: 3 LGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPNIV 62
Query: 563 RLLGYCDEGQNRLLVYEFMSNGTVASFL-------FGDSKPNWKLRTEIAMGIAGGLFYL 615
+LLG C + + ++ E M G + S+L FG K +I + +A G YL
Sbjct: 63 KLLGVCLLNEPQYIIMELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYL 122
Query: 616 HEECCTQIIHCDIKPQNILLDDH-YNAR----ISDFGLAKLLTLDQSHTNTAIRGTK--- 667
+ IH D+ +N L+ + Y+A I DFGLA+ + + G
Sbjct: 123 EQ---MHFIHRDLAARNCLVSEKGYDADRVVKIGDFGLARDIYKSDYYR---KEGEGLLP 176
Query: 668 -GYVAPEWFRNMPITVKVDVYSYGVLLLEIICLRRNIDNEISKVDKAILTDWAYDRYQER 726
++APE + T + DV+S+GVL+ EI+ L + ++ + +L + R
Sbjct: 177 VRWMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQPYPALNNQE--VL---QHVTAGGR 231
Query: 727 TLEALVENDLEAMNNVTMLHRFVMVAFWCIQEDPSHRPTMRKVTQMLE 774
L+ N +M W +DPS RPT ++ ++L+
Sbjct: 232 ---------LQKPENCPDKIYQLMTNCW--AQDPSERPTFDRIQEILQ 268
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269 |
| >gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Score = 79.3 bits (195), Expect = 5e-16
Identities = 68/198 (34%), Positives = 104/198 (52%), Gaps = 16/198 (8%)
Query: 509 LGRGAFGTVYKG-FVNMGSSNH--VAVKKLN-SVFQDSEKEFKAEVNGIGQTHHKNLVRL 564
LG GAFGTVYKG +V G + VA+K LN + + EF E + H +LVRL
Sbjct: 15 LGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVRL 74
Query: 565 LGYCDEGQNRLLVYEFMSNGTVASFLFGDSKPNW--KLRTEIAMGIAGGLFYLHEECCTQ 622
LG C +L V + M +G + ++ + K N +L + IA G+ YL E +
Sbjct: 75 LGVCLSPTIQL-VTQLMPHGCLLDYVH-EHKDNIGSQLLLNWCVQIAKGMMYLEER---R 129
Query: 623 IIHCDIKPQNILLDDHYNARISDFGLAKLLTLDQSHTNTAIRGTK---GYVAPEWFRNMP 679
++H D+ +N+L+ + +I+DFGLA+LL D+ N G K ++A E
Sbjct: 130 LVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKEYNA--DGGKMPIKWMALECIHYRK 187
Query: 680 ITVKVDVYSYGVLLLEII 697
T + DV+SYGV + E++
Sbjct: 188 FTHQSDVWSYGVTIWELM 205
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303 |
| >gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Score = 78.8 bits (194), Expect = 5e-16
Identities = 67/232 (28%), Positives = 103/232 (44%), Gaps = 31/232 (13%)
Query: 509 LGRGAFGTV----YKGFVNMGSSNHVAVKKLNSVFQDS----EKEFKAEVNGIGQTHHKN 560
LG+G FG V K M + + K+L + EKE +VN
Sbjct: 1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSP------- 53
Query: 561 LVRLLGYCDEGQNRL-LVYEFMSNGTVASFLFGDSKPNWKLRTEI--AMGIAGGLFYLHE 617
+ L Y E + L LV M+ G + ++ + ++ I + I G+ +LH
Sbjct: 54 FIVNLAYAFESKTHLCLVMSLMNGGDLKYHIYNVGERGLEMERVIHYSAQITCGILHLHS 113
Query: 618 ECCTQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLDQSHTNTAIRGTKGYVAPEWFRN 677
I++ D+KP+N+LLDD N R+SD GLA + L T T GT GY+APE +
Sbjct: 114 ---MDIVYRDMKPENVLLDDQGNCRLSDLGLA--VELKDGKTITQRAGTNGYMAPEILKE 168
Query: 678 MPITVKVDVYSYGVLLLEIICLRRNIDNEISKVDKAILTDWAYDRYQERTLE 729
P + VD ++ G + E++ R + KV K + + RTLE
Sbjct: 169 EPYSYPVDWFAMGCSIYEMVAGRTPFKDHKEKVAK--------EELKRRTLE 212
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277 |
| >gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 77.7 bits (192), Expect = 9e-16
Identities = 53/204 (25%), Positives = 89/204 (43%), Gaps = 27/204 (13%)
Query: 505 FKEELGRGAFGTVYKGFVNMGSSNHVAVKKLNSVFQDSEKEFKAEVNGIGQTHHKNLVRL 564
+ +G G +G VYK ++ + VA+K + D + + E++ + + H N+V
Sbjct: 7 LIQRIGSGTYGDVYKA-RDIATGELVAIKVIKLEPGDDFEIIQQEISMLKECRHPNIVAY 65
Query: 565 LGYCDEGQNRLLVYEFMSNGTVASFLFGDSKPNWKLRTEIAMG---IA-------GGLFY 614
G +V E+ G++ T + IA GL Y
Sbjct: 66 FGSYLRRDKLWIVMEYCGGGSLQDIY---------QVTRGPLSELQIAYVCRETLKGLAY 116
Query: 615 LHEECCTQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLDQSHTNTAIRGTKGYVAPEW 674
LHE T IH DIK NILL + + +++DFG++ LT + + I GT ++APE
Sbjct: 117 LHE---TGKIHRDIKGANILLTEDGDVKLADFGVSAQLTATIAKRKSFI-GTPYWMAPEV 172
Query: 675 F---RNMPITVKVDVYSYGVLLLE 695
R K D+++ G+ +E
Sbjct: 173 AAVERKGGYDGKCDIWALGITAIE 196
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262 |
| >gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 78.3 bits (193), Expect = 9e-16
Identities = 60/203 (29%), Positives = 97/203 (47%), Gaps = 17/203 (8%)
Query: 505 FKEELGRGAFGTVYKGFVNMGSSNH---VAVKKLNSVFQDSEKEFKAEVNGIGQTHHKNL 561
F ++LG+G FG+V + N VAVKKL + ++F+ E+ + H N+
Sbjct: 8 FIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAEHLRDFEREIEILKSLQHDNI 67
Query: 562 VRLLGYC-DEGQNRL-LVYEFMSNGTVASFLFGDSKPNWKLRTE----IAMGIAGGLFYL 615
V+ G C G+ L LV E++ G++ +L K +L A I G+ YL
Sbjct: 68 VKYKGVCYSAGRRNLRLVMEYLPYGSLRDYL---QKHRERLDHRKLLLYASQICKGMEYL 124
Query: 616 HEECCTQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLDQSHTNTAIRGTKG--YVAPE 673
+ +H D+ +NIL++ +I DFGL K+L D+ + G + APE
Sbjct: 125 GSKRY---VHRDLATRNILVESENRVKIGDFGLTKVLPQDKEYYKVREPGESPIFWYAPE 181
Query: 674 WFRNMPITVKVDVYSYGVLLLEI 696
+V DV+S+GV+L E+
Sbjct: 182 SLTESKFSVASDVWSFGVVLYEL 204
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284 |
| >gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Score = 78.1 bits (192), Expect = 1e-15
Identities = 61/219 (27%), Positives = 103/219 (47%), Gaps = 34/219 (15%)
Query: 505 FKEELGRGAFGTVYKGFVNM-GSSNHVAVKKLNS-VFQDSEKEFKAEVNGIGQT-HHKNL 561
F++ +G G FG V K + G A+K++ +D ++F E+ + + HH N+
Sbjct: 11 FQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNI 70
Query: 562 VRLLGYCDEGQNRLLVYEFMSNGTVASFLFG----DSKPNWKLRTEIA------------ 605
+ LLG C+ L E+ +G + FL ++ P + + A
Sbjct: 71 INLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFA 130
Query: 606 MGIAGGLFYLHEECCTQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLDQSHTNTAIRG 665
+A G+ YL ++ Q IH D+ +NIL+ ++Y A+I+DFGL++ ++
Sbjct: 131 ADVARGMDYLSQK---QFIHRDLAARNILVGENYVAKIADFGLSR-------GQEVYVKK 180
Query: 666 TKGYVAPEWFR----NMPI-TVKVDVYSYGVLLLEIICL 699
T G + W N + T DV+SYGVLL EI+ L
Sbjct: 181 TMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSL 219
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303 |
| >gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 77.5 bits (191), Expect = 2e-15
Identities = 60/203 (29%), Positives = 99/203 (48%), Gaps = 27/203 (13%)
Query: 508 ELGRGAFGTVYKGFVNMGSSNHVAVKKLNSVFQDSEK--EFKAEVNGIGQTHHKNLVRLL 565
ELG GAFG VYK + + A K + + E+ +F E++ + + H N+V L
Sbjct: 12 ELGDGAFGKVYKA-QHKETGLFAAAKIIQ--IESEEELEDFMVEIDILSECKHPNIVGLY 68
Query: 566 -GYCDEGQNRLLVYEFMSNGTVASFLFGDSKPNWKLRTE-----IAMGIAGGLFYLHEEC 619
Y E + +L+ EF G + S + + TE + + L +LH
Sbjct: 69 EAYFYENKLWILI-EFCDGGALDSIMLELERG----LTEPQIRYVCRQMLEALNFLHSH- 122
Query: 620 CTQIIHCDIKPQNILLDDHYNARISDFGL-AKLLTLDQSHTNTAIRGTKGYVAP-----E 673
++IH D+K NILL + +++DFG+ AK + Q +T I GT ++AP E
Sbjct: 123 --KVIHRDLKAGNILLTLDGDVKLADFGVSAKNKSTLQKR-DTFI-GTPYWMAPEVVACE 178
Query: 674 WFRNMPITVKVDVYSYGVLLLEI 696
F++ P K D++S G+ L+E+
Sbjct: 179 TFKDNPYDYKADIWSLGITLIEL 201
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280 |
| >gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Score = 76.9 bits (190), Expect = 2e-15
Identities = 58/204 (28%), Positives = 97/204 (47%), Gaps = 22/204 (10%)
Query: 509 LGRGAFGTVYKGFVNMGSSNHV----AVKKLNSVFQDSEKEFKAEVNGIGQTHHKNLVRL 564
+ +GA+G V+ S+ + +KK + + ++ + E + + Q +V+L
Sbjct: 1 ISKGAYGRVF--LAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKL 58
Query: 565 LGYCDEGQNRL-LVYEFMSNGTVASFL--FGDSKPNWKLRTEIAMGIAGGLFYLHEECCT 621
Y +G+ L LV E++ G +AS L G S R IA I L YLH
Sbjct: 59 Y-YSFQGKKNLYLVMEYLPGGDLASLLENVG-SLDEDVARIYIAE-IVLALEYLHS---N 112
Query: 622 QIIHCDIKPQNILLDDHYNARISDFGLAKL----LTLDQSHTNTAIR---GTKGYVAPEW 674
IIH D+KP NIL+D + + +++DFGL+K+ ++ + + GT Y+APE
Sbjct: 113 GIIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDEKEDKRIVGTPDYIAPEV 172
Query: 675 FRNMPITVKVDVYSYGVLLLEIIC 698
+ VD +S G +L E +
Sbjct: 173 ILGQGHSKTVDWWSLGCILYEFLV 196
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265 |
| >gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Score = 77.0 bits (190), Expect = 2e-15
Identities = 56/203 (27%), Positives = 90/203 (44%), Gaps = 16/203 (7%)
Query: 505 FKEELGRGAFGTVYKGFVNMGSSNHVAVKKLN-SVFQDSEKEFKAEVNGIGQTHHKNLVR 563
E +G GA VY + ++ VA+K+++ Q S E + EV + Q +H N+V+
Sbjct: 5 LIEVIGVGATAVVYAAIC-LPNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPNVVK 63
Query: 564 LLGYCDEGQNRLLVYEFMSNGTVASFLFGDSKPNWKLRTE--IAM---GIAGGLFYLHEE 618
G LV ++S G++ + S E IA + GL YLH
Sbjct: 64 YYTSFVVGDELWLVMPYLSGGSLLDIM--KSSYPRGGLDEAIIATVLKEVLKGLEYLHSN 121
Query: 619 CCTQIIHCDIKPQNILLDDHYNARISDFGLAKLL---TLDQSHTNTAIRGTKGYVAPEWF 675
IH DIK NILL + + +I+DFG++ L GT ++APE
Sbjct: 122 ---GQIHRDIKAGNILLGEDGSVKIADFGVSASLADGGDRTRKVRKTFVGTPCWMAPEVM 178
Query: 676 RNMP-ITVKVDVYSYGVLLLEII 697
+ K D++S+G+ +E+
Sbjct: 179 EQVHGYDFKADIWSFGITAIELA 201
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267 |
| >gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Score = 77.2 bits (190), Expect = 2e-15
Identities = 76/248 (30%), Positives = 114/248 (45%), Gaps = 26/248 (10%)
Query: 509 LGRGAFGTVYKGFVNMGSSNHV-AVKKLNSVFQDSEKEFKA---EVNGIGQTHHKNLVRL 564
LG+G FG V M ++ + A KKLN K ++ E + + H + +V L
Sbjct: 1 LGKGGFGEVSA--CQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSL 58
Query: 565 LGYCDEGQNRL-LVYEFMSNGTVASFLFGDSKPNWKLRTEIAM----GIAGGLFYLHEEC 619
Y + + L LV M+ G + ++ + N A I GL +LH+
Sbjct: 59 -AYAFQTKTDLCLVMTIMNGGDLRYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQR- 116
Query: 620 CTQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLDQSHTNTAIRGTKGYVAPEWFRNMP 679
+II+ D+KP+N+LLD+ N RISD GLA L QS T GT G++APE +
Sbjct: 117 --RIIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQSKTK-GYAGTPGFMAPELLQGEE 173
Query: 680 ITVKVDVYSYGVLLLEIICLR-----RNIDNEISKVDKAILTDWAY--DRYQERT---LE 729
VD ++ GV L E+I R R E ++ + IL D D++ + E
Sbjct: 174 YDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRILNDSVTYPDKFSPASKSFCE 233
Query: 730 ALVENDLE 737
AL+ D E
Sbjct: 234 ALLAKDPE 241
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280 |
| >gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Score = 77.4 bits (191), Expect = 2e-15
Identities = 64/214 (29%), Positives = 103/214 (48%), Gaps = 21/214 (9%)
Query: 493 FTYKELVEVTRGFKEELGRGAFGTVYKGFVNMGSSNHVAVKKLNS-VFQDSEKEFKAEVN 551
FT ++L + E+GRGAFGTV K ++ S +AVK++ S V + +K +++
Sbjct: 1 FTAEDLKD-----LGEIGRGAFGTVNK-MLHKPSGTIMAVKRIRSTVDEKEQKRLLMDLD 54
Query: 552 GIGQTHH-KNLVRLLGYC-DEGQNRLLVYEFMSNGTVASFLFGDSKPNWKLRTEI----A 605
+ ++ +V+ G EG + + E M + + + EI A
Sbjct: 55 VVMRSSDCPYIVKFYGALFREG-DCWICMELMDISLDKFYKYVYEVLKSVIPEEILGKIA 113
Query: 606 MGIAGGLFYLHEECCTQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLDQSHTNTAIRG 665
+ L YL EE +IIH D+KP NILLD + N ++ DFG++ L + T A G
Sbjct: 114 VATVKALNYLKEE--LKIIHRDVKPSNILLDRNGNIKLCDFGISGQLVDSIAKTRDA--G 169
Query: 666 TKGYVAPEW---FRNMPITVKVDVYSYGVLLLEI 696
+ Y+APE V+ DV+S G+ L E+
Sbjct: 170 CRPYMAPERIDPSARDGYDVRSDVWSLGITLYEV 203
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288 |
| >gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Score = 77.0 bits (189), Expect = 2e-15
Identities = 58/194 (29%), Positives = 99/194 (51%), Gaps = 13/194 (6%)
Query: 507 EELGRGAFGTVYKGFVNMGSSNHVAVKKLN-SVFQDSEKEFKAEVNGIGQTHHKNLVRLL 565
E++G+G+FG V+KG N + VA+K ++ +D ++ + E+ + Q + +
Sbjct: 10 EKIGKGSFGEVFKGIDNR-TQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYY 68
Query: 566 GYCDEGQNRLLVYEFMSNGTVASFLFGDSKPNWKLRTEIAM---GIAGGLFYLHEECCTQ 622
G + ++ E++ G+ L +P T+IA I GL YLH E +
Sbjct: 69 GSYLKDTKLWIIMEYLGGGSALDLL----EPGPLDETQIATILREILKGLDYLHSE---K 121
Query: 623 IIHCDIKPQNILLDDHYNARISDFGLAKLLTLDQSHTNTAIRGTKGYVAPEWFRNMPITV 682
IH DIK N+LL +H +++DFG+A LT Q NT + GT ++APE +
Sbjct: 122 KIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNTFV-GTPFWMAPEVIKQSAYDS 180
Query: 683 KVDVYSYGVLLLEI 696
K D++S G+ +E+
Sbjct: 181 KADIWSLGITAIEL 194
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277 |
| >gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 77.2 bits (191), Expect = 2e-15
Identities = 59/201 (29%), Positives = 92/201 (45%), Gaps = 19/201 (9%)
Query: 505 FKEELGRGAFGTV----YKGFVNMGSSNHVAVKKLNS---VFQDSEKEFKAEVNGIGQTH 557
F + LG G+FG V +KG S + A+K L+ V + E +
Sbjct: 5 FIKTLGTGSFGRVMLVRHKG-----SGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIR 59
Query: 558 HKNLVRLLGYCDEGQNRLLVYEFMSNGTVASFLFGDSKPNWKLRTEIAMGIAGGLFYLHE 617
H LV L G + N LV E++ G + S L + + A + L YLH
Sbjct: 60 HPFLVNLYGSFQDDSNLYLVMEYVPGGELFSHLRKSGRFPEPVARFYAAQVVLALEYLHS 119
Query: 618 ECCTQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLDQSHTNTAIRGTKGYVAPEWFRN 677
I++ D+KP+N+LLD +I+DFG AK + + T T + GT Y+APE +
Sbjct: 120 L---DIVYRDLKPENLLLDSDGYIKITDFGFAKRV---KGRTYT-LCGTPEYLAPEIILS 172
Query: 678 MPITVKVDVYSYGVLLLEIIC 698
VD ++ G+L+ E++
Sbjct: 173 KGYGKAVDWWALGILIYEMLA 193
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290 |
| >gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein | Back alignment and domain information |
|---|
Score = 79.9 bits (197), Expect = 4e-15
Identities = 52/187 (27%), Positives = 87/187 (46%), Gaps = 18/187 (9%)
Query: 526 SSNHVAVKKLNSVFQDSEKE---FKAEVNGIGQTHHKNLVRLLGYCDEGQNRLL-VYEFM 581
+ + VA+K L + + E + F+ E + +H N+V LL + L V+E++
Sbjct: 2 TGHEVAIKLLRTDAPEEEHQRARFRRETALCARLYHPNIVALLDSGEAPPGLLFAVFEYV 61
Query: 582 SNGTVASFLFGDSKPNWKLRTEIAMGIAGGLFYLHEECCTQIIHCDIKPQNILL---DDH 638
T+ L D + + + L H + I+H D+KPQNI++
Sbjct: 62 PGRTLREVLAADGALPAGETGRLMLQVLDALACAHNQ---GIVHRDLKPQNIMVSQTGVR 118
Query: 639 YNARISDFGLAKLL-----TLDQSHTNTA-IRGTKGYVAPEWFRNMPITVKVDVYSYGVL 692
+A++ DFG+ LL + T T + GT Y APE R P+T D+Y++G++
Sbjct: 119 PHAKVLDFGIGTLLPGVRDADVATLTRTTEVLGTPTYCAPEQLRGEPVTPNSDLYAWGLI 178
Query: 693 LLEIICL 699
LE CL
Sbjct: 179 FLE--CL 183
|
This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266 |
| >gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 76.2 bits (188), Expect = 4e-15
Identities = 60/211 (28%), Positives = 90/211 (42%), Gaps = 41/211 (19%)
Query: 507 EELGRGAFGTVYKGFVNMGSSNHVAVKKLNSVFQDSEKEFKA--EVNGIGQTHHKNLVRL 564
+G GA+G V K N + VA+KK D + + A EV + Q H+N+V L
Sbjct: 7 GVVGEGAYGVVLKC-RNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHENIVNL 65
Query: 565 LGYCDEGQNRLLVYEFMSNGTVASFLFGDSKPN-----------WKLRTEIAMGIAGGLF 613
LV+E++ T+ L ++ P W+L IA
Sbjct: 66 KEAFRRKGRLYLVFEYVER-TLLELL--EASPGGLPPDAVRSYIWQLLQAIA-------- 114
Query: 614 YLHEECCTQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLDQSHTNTAIRGTKGYVAPE 673
Y H IIH DIKP+NIL+ + ++ DFG A+ L A T YVA
Sbjct: 115 YCHSH---NIIHRDIKPENILVSESGVLKLCDFGFARAL-----RARPASPLTD-YVATR 165
Query: 674 WFRNMPITVK-------VDVYSYGVLLLEII 697
W+R + V VDV++ G ++ E++
Sbjct: 166 WYRAPELLVGDTNYGKPVDVWAIGCIMAELL 196
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288 |
| >gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 75.6 bits (186), Expect = 7e-15
Identities = 56/196 (28%), Positives = 96/196 (48%), Gaps = 11/196 (5%)
Query: 507 EELGRGAFGTVYKGFVNMGSSNHVAVKKLNSVFQDSE-KEFKAEVNGIGQTHH---KNLV 562
E +GRGA+G VY+G ++ + VA+K +N D + + + EV + Q N+
Sbjct: 7 ELIGRGAYGAVYRG-KHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPPNIT 65
Query: 563 RLLGYCDEGQNRLLVYEFMSNGTVASFLFGDSKPNWKLRTEIAMGIAGGLFYLHEECCTQ 622
+ G +G ++ E+ G+V + L K + I + L Y+H+
Sbjct: 66 KYYGSYLKGPRLWIIMEYAEGGSVRT-LMKAGPIAEKYISVIIREVLVALKYIHK---VG 121
Query: 623 IIHCDIKPQNILLDDHYNARISDFGLAKLLTLDQSHTNTAIRGTKGYVAPEWFRN-MPIT 681
+IH DIK NIL+ + N ++ DFG+A LL + S +T + GT ++APE
Sbjct: 122 VIHRDIKAANILVTNTGNVKLCDFGVAALLNQNSSKRSTFV-GTPYWMAPEVITEGKYYD 180
Query: 682 VKVDVYSYGVLLLEII 697
K D++S G+ + E+
Sbjct: 181 TKADIWSLGITIYEMA 196
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277 |
| >gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Score = 75.1 bits (184), Expect = 8e-15
Identities = 63/211 (29%), Positives = 105/211 (49%), Gaps = 17/211 (8%)
Query: 497 ELVEVTRGFKEELGRGAFGTVYKGFVNMGSSNHVAVKKLNSVFQDSEKEFKAEVNGIGQT 556
E+ + +++LG G FG V+ N + V K S+ S + F AE N +
Sbjct: 2 EIPRESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGSM---SVEAFLAEANVMKTL 58
Query: 557 HHKNLVRLLGYCDEGQNRLLVYEFMSNGTVASFLF---GDSKPNWKLRTEIAMGIAGGLF 613
H LV+L + + ++ EFM+ G++ FL G +P KL + + IA G+
Sbjct: 59 QHDKLVKLHAVVTK-EPIYIITEFMAKGSLLDFLKSDEGSKQPLPKL-IDFSAQIAEGMA 116
Query: 614 YLHEECCTQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLDQSHTNTAIRGTK---GYV 670
++ + IH D++ NIL+ +I+DFGLA+++ + + TA G K +
Sbjct: 117 FIEQR---NYIHRDLRAANILVSASLVCKIADFGLARVI---EDNEYTAREGAKFPIKWT 170
Query: 671 APEWFRNMPITVKVDVYSYGVLLLEIICLRR 701
APE T+K DV+S+G+LL+EI+ R
Sbjct: 171 APEAINFGSFTIKSDVWSFGILLMEIVTYGR 201
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260 |
| >gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Score = 75.1 bits (184), Expect = 1e-14
Identities = 65/197 (32%), Positives = 95/197 (48%), Gaps = 17/197 (8%)
Query: 509 LGRGAFGTVYKGFVNMGSSNHVAVKKLNSVFQDSEKEFKAEVNGIGQTH-----HKNLVR 563
LG+G FG V V + A KKL + K+ K E + + + V
Sbjct: 8 LGKGGFGEVCACQVR-ATGKMYACKKLE---KKRIKKRKGESMALNEKQILEKVNSRFVV 63
Query: 564 LLGYCDEGQNRL-LVYEFMSNGTVASFLF--GDSKPNWKLRTEIAMGIAGGLFYLHEECC 620
L Y E ++ L LV M+ G + ++ G++ A I GL LH+E
Sbjct: 64 SLAYAYETKDALCLVLTLMNGGDLKFHIYHMGEAGFEEGRAVFYAAEICCGLEDLHQE-- 121
Query: 621 TQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLDQSHTNTAIRGTKGYVAPEWFRNMPI 680
+I++ D+KP+NILLDDH + RISD GLA + + + T GT GY+APE +N
Sbjct: 122 -RIVYRDLKPENILLDDHGHIRISDLGLA--VHVPEGQTIKGRVGTVGYMAPEVVKNERY 178
Query: 681 TVKVDVYSYGVLLLEII 697
T D ++ G LL E+I
Sbjct: 179 TFSPDWWALGCLLYEMI 195
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285 |
| >gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Score = 74.8 bits (184), Expect = 1e-14
Identities = 72/290 (24%), Positives = 118/290 (40%), Gaps = 50/290 (17%)
Query: 502 TRGFKEE--LGRGAFGTVYKGFVNMGSSNHVAVKKLNSVFQDSEKEFKA----EVNGIGQ 555
FK E +G+G F VYK + + VA+KK+ +F+ + + + E++ + Q
Sbjct: 1 LGNFKIEKKIGKGQFSVVYKA-ICLLDGRVVALKKVQ-IFEMMDAKARQDCLKEIDLLKQ 58
Query: 556 THHKNLVRLLGYCDEGQNRLLVYEFMSNGTVASFLFGDSKPNWKLRTEIA-----MGIAG 610
H N+++ L E +V E G + S + K +L E + +
Sbjct: 59 LDHPNVIKYLASFIENNELNIVLELADAGDL-SRMIKHFKKQKRLIPERTIWKYFVQLCS 117
Query: 611 GLFYLHEECCTQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLDQSHTNTA--IRGTKG 668
L ++H + +I+H DIKP N+ + ++ D GL + + S T A + GT
Sbjct: 118 ALEHMHSK---RIMHRDIKPANVFITATGVVKLGDLGLGRFFS---SKTTAAHSLVGTPY 171
Query: 669 YVAPEWFRNMPITVKVDVYSYGVLLLEIICLRR-------NIDNEISKVDKAILTDWAYD 721
Y++PE K D++S G LL E+ L+ N+ + K++K D
Sbjct: 172 YMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEKCDYPPLPAD 231
Query: 722 RYQERTLEALVENDLEAMNNVTMLHRFVMVAFWCIQEDPSHRPTMRKVTQ 771
Y E L LV CI DP RP + V Q
Sbjct: 232 HYSEE-LRDLVSR--------------------CINPDPEKRPDISYVLQ 260
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Score = 74.5 bits (183), Expect = 1e-14
Identities = 55/194 (28%), Positives = 91/194 (46%), Gaps = 11/194 (5%)
Query: 509 LGRGAFGTVYKGFVNMGSSNHVAVKKLNSVFQDSEKEFKAEVNGIGQTHHKNLVRLLGYC 568
LG+G +G VY ++ + +A+K++ + E+ H+N+V+ LG
Sbjct: 16 LGKGTYGIVYAA-RDLSTQVRIAIKEIPERDSRYVQPLHEEIALHSYLKHRNIVQYLGSD 74
Query: 569 DEGQNRLLVYEFMSNGTVASFL---FGDSKPNWKLRTEIAMGIAGGLFYLHEECCTQIIH 625
E + E + G++++ L +G K N + I GL YLH+ QI+H
Sbjct: 75 SENGFFKIFMEQVPGGSLSALLRSKWGPLKDNEQTIIFYTKQILEGLKYLHDN---QIVH 131
Query: 626 CDIKPQNILLDDHYNA-RISDFGLAKLLTLDQSHTNTAIRGTKGYVAPEWFRNMP--ITV 682
DIK N+L++ + +ISDFG +K L T T GT Y+APE P
Sbjct: 132 RDIKGDNVLVNTYSGVVKISDFGTSKRLAGINPCTET-FTGTLQYMAPEVIDKGPRGYGA 190
Query: 683 KVDVYSYGVLLLEI 696
D++S G ++E+
Sbjct: 191 PADIWSLGCTIVEM 204
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268 |
| >gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Score = 75.6 bits (186), Expect = 1e-14
Identities = 58/212 (27%), Positives = 100/212 (47%), Gaps = 30/212 (14%)
Query: 495 YKELVEVTRGFKEELGRGAFGTVYKGFVNMGSSNHVAVKKLNSVFQDS-EKEFKAEVNGI 553
EL V R +G GA GTVYK ++ + A+K + +D+ ++ E+ +
Sbjct: 73 LSELERVNR-----IGSGAGGTVYK-VIHRPTGRLYALKVIYGNHEDTVRRQICREIEIL 126
Query: 554 GQTHHKNLVRLLGYCDEGQNRLLVYEFMSNGTVASFLFGDSKPNWKLRTEIAMGIAGGLF 613
+H N+V+ D ++ EFM G++ D + ++A I G+
Sbjct: 127 RDVNHPNVVKCHDMFDHNGEIQVLLEFMDGGSLEGTHIADEQ----FLADVARQILSGIA 182
Query: 614 YLHEECCTQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLDQSHTNTAIRGTKGYVAPE 673
YLH I+H DIKP N+L++ N +I+DFG++++L N+++ GT Y++PE
Sbjct: 183 YLHRR---HIVHRDIKPSNLLINSAKNVKIADFGVSRILAQTMDPCNSSV-GTIAYMSPE 238
Query: 674 WFRNMPITVKV----------DVYSYGVLLLE 695
I + D++S GV +LE
Sbjct: 239 -----RINTDLNHGAYDGYAGDIWSLGVSILE 265
|
Length = 353 |
| >gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Score = 74.6 bits (183), Expect = 1e-14
Identities = 62/205 (30%), Positives = 98/205 (47%), Gaps = 30/205 (14%)
Query: 509 LGRGAFGTVYKGF-VNMGSSNH--VAVKKL-NSVFQDSEKEFKAEVNGIGQTHHKNLVRL 564
LG G FGTV+KG + G S VA+K + + + + +E + +G H +VRL
Sbjct: 15 LGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGSLDHAYIVRL 74
Query: 565 LGYCDEGQNRLLVYEFMSNGTVASFLF---GDSKP----NWKLRTEIAMGIAGGLFYLHE 617
LG C G + LV + G++ + P NW ++ IA G++YL E
Sbjct: 75 LGIC-PGASLQLVTQLSPLGSLLDHVRQHRDSLDPQRLLNWCVQ------IAKGMYYLEE 127
Query: 618 ECCTQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLDQ-----SHTNTAIRGTKGYVAP 672
++H ++ +NILL +I+DFG+A LL D S T I+ ++A
Sbjct: 128 HR---MVHRNLAARNILLKSDSIVQIADFGVADLLYPDDKKYFYSEHKTPIK----WMAL 180
Query: 673 EWFRNMPITVKVDVYSYGVLLLEII 697
E T + DV+SYGV + E++
Sbjct: 181 ESILFGRYTHQSDVWSYGVTVWEMM 205
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER3 binds the neuregulin ligands, NRG1 and NRG2. HER3 contains an impaired tyr kinase domain and relies on its heterodimerization partners for activity following ligand binding. The HER2-HER3 heterodimer constitutes a high affinity co-receptor capable of potent mitogenic signaling. HER3 participates in a signaling pathway involved in the proliferation, survival, adhesion, and motility of tumor cells. Length = 279 |
| >gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Score = 74.5 bits (184), Expect = 2e-14
Identities = 62/227 (27%), Positives = 93/227 (40%), Gaps = 43/227 (18%)
Query: 509 LGRGAFGTVYKGFVNMGSSNHVAVKKLNSVFQDSEKEFKAEVNGIGQT-----------H 557
LG G + VYK + VA+KK+ E K +GI T
Sbjct: 8 LGEGTYAVVYKARDKE-TGRIVAIKKIKL------GERKEAKDGINFTALREIKLLQELK 60
Query: 558 HKNLVRLLGYCDEGQNRLLVYEFMS-------NGTVASFLFGDSKPNWKLRTEIAMGIAG 610
H N++ LL N LV+EFM D K +
Sbjct: 61 HPNIIGLLDVFGHKSNINLVFEFMETDLEKVIKDKSIVLTPADIK-------SYMLMTLR 113
Query: 611 GLFYLHEECCTQIIHCDIKPQNILLDDHYNARISDFGLAKLL-TLDQSHTNTAIRGTKGY 669
GL YLH I+H D+KP N+L+ +++DFGLA+ + ++ T+ + T+ Y
Sbjct: 114 GLEYLHSN---WILHRDLKPNNLLIASDGVLKLADFGLARSFGSPNRKMTHQVV--TRWY 168
Query: 670 VAPE-WFRNMPITVKVDVYSYGVLLLEIICLRRNI---DNEISKVDK 712
APE F V VD++S G + E + LR D++I ++ K
Sbjct: 169 RAPELLFGARHYGVGVDMWSVGCIFAE-LLLRVPFLPGDSDIDQLGK 214
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298 |
| >gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 74.6 bits (183), Expect = 2e-14
Identities = 62/226 (27%), Positives = 103/226 (45%), Gaps = 38/226 (16%)
Query: 505 FKEELGRGAFGTVY-------KGFVNMGSS------NHVAVKKLNS-VFQDSEKEFKAEV 550
KE+LG G FG V+ F+ G+ VAVK L + V + + +F E+
Sbjct: 9 LKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDFLKEI 68
Query: 551 NGIGQTHHKNLVRLLGYCDEGQNRLLVYEFMSNGTVASFL----------FGDSKPNWKL 600
+ + + N++RLLG C ++ E+M NG + FL ++ P+ +
Sbjct: 69 KIMSRLKNPNIIRLLGVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSI 128
Query: 601 RTEIAMG--IAGGLFYLHEECCTQIIHCDIKPQNILLDDHYNARISDFGLAK-LLTLD-- 655
+ M IA G+ YL +H D+ +N L+ +HY +I+DFG+++ L + D
Sbjct: 129 ANLLYMAVQIASGMKYL---ASLNFVHRDLATRNCLVGNHYTIKIADFGMSRNLYSGDYY 185
Query: 656 --QSHTNTAIRGTKGYVAPEWFRNMPITVKVDVYSYGVLLLEIICL 699
Q IR ++A E T DV+++GV L E+ L
Sbjct: 186 RIQGRAVLPIR----WMAWESILLGKFTTASDVWAFGVTLWEMFTL 227
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295 |
| >gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 73.8 bits (182), Expect = 2e-14
Identities = 56/193 (29%), Positives = 86/193 (44%), Gaps = 9/193 (4%)
Query: 509 LGRGAFGTVYKGFVNMGSSNHV--AVKKLNSVFQDSEKEFKAEVNGIGQTHHKNLVRLLG 566
LG G FG V V + VKK + V ++ +E + + +H +V+L
Sbjct: 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYR 60
Query: 567 YCDEGQNRLLVYEFMSNGTVASFLFGDSK-PNWKLRTEIAMGIAGGLFYLHEECCTQIIH 625
+ + ++ E+ G + + L + R IA + YLH II+
Sbjct: 61 TFKDKKYIYMLMEYCLGGELWTILRDRGLFDEYTARFYIAC-VVLAFEYLHNR---GIIY 116
Query: 626 CDIKPQNILLDDHYNARISDFGLAKLLTLDQSHTNTAIRGTKGYVAPEWFRNMPITVKVD 685
D+KP+N+LLD + ++ DFG AK L T T GT YVAPE N VD
Sbjct: 117 RDLKPENLLLDSNGYVKLVDFGFAKKLK-SGQKTWTFC-GTPEYVAPEIILNKGYDFSVD 174
Query: 686 VYSYGVLLLEIIC 698
+S G+LL E++
Sbjct: 175 YWSLGILLYELLT 187
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262 |
| >gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 74.2 bits (182), Expect = 2e-14
Identities = 77/288 (26%), Positives = 122/288 (42%), Gaps = 30/288 (10%)
Query: 507 EELGRGAFGTV----YKGFVNMGSSNHVAVKKLNS-VFQDSEKEFKAEVNGIGQTHHKNL 561
LG G FG V Y N G+ VAVK L Q + +K E+N + +H+N+
Sbjct: 10 RVLGEGHFGKVSLYCYDP-ANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENI 68
Query: 562 VRLLGYCDE--GQNRLLVYEFMSNGTVASFLFGDSKPNWKLRTE----IAMGIAGGLFYL 615
V+ G C E G+ L+ E++ G++ +L P KL A I G+ YL
Sbjct: 69 VKYKGCCSEQGGKGLQLIMEYVPLGSLRDYL-----PKHKLNLAQLLLFAQQICEGMAYL 123
Query: 616 HEECCTQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLDQSHTNTAIRGTKG--YVAPE 673
H + IH D+ +N+LLD+ +I DFGLAK + + G + A E
Sbjct: 124 HSQ---HYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAVE 180
Query: 674 WFRNMPITVKVDVYSYGVLLLEIICLRRNIDNEISKVDKAI-LTDWAYDRYQERTLEALV 732
+ + DV+S+GV L E++ + D++ S K + + L L+
Sbjct: 181 CLKENKFSYASDVWSFGVTLYELLT---HCDSKQSPPKKFEEMIGPKQGQMTVVRLIELL 237
Query: 733 END--LEAMNNVTMLHRFVMVAFWCIQEDPSHRPTMRKVTQMLEGVVE 778
E L N +M W + + RPT R + +L+ +
Sbjct: 238 ERGMRLPCPKNCPQEVYILMKNCW--ETEAKFRPTFRSLIPILKEMHH 283
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283 |
| >gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Score = 74.0 bits (181), Expect = 3e-14
Identities = 52/191 (27%), Positives = 98/191 (51%), Gaps = 6/191 (3%)
Query: 507 EELGRGAFGTVYKGFVNMGSSNHVAVKKLNSVFQDSEKEFKAEVNGIGQTHHKNLVRLLG 566
E++G+GA GTVY +++ + VA+K++N Q ++ E+ + + + N+V L
Sbjct: 25 EKIGQGASGTVYTA-IDIATGQEVAIKQMNLQQQPKKELIINEILVMRENKNPNIVNYLD 83
Query: 567 YCDEGQNRLLVYEFMSNGTVASFLFGDSKPNWKLRTEIAMGIAGGLFYLHEECCTQIIHC 626
G +V E+++ G++ + ++ + L +LH Q+IH
Sbjct: 84 SYLVGDELWVVMEYLAGGSLTDVVTETCMDEGQI-AAVCRECLQALDFLHS---NQVIHR 139
Query: 627 DIKPQNILLDDHYNARISDFGLAKLLTLDQSHTNTAIRGTKGYVAPEWFRNMPITVKVDV 686
DIK NILL + +++DFG +T +QS +T + GT ++APE KVD+
Sbjct: 140 DIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMV-GTPYWMAPEVVTRKAYGPKVDI 198
Query: 687 YSYGVLLLEII 697
+S G++ +E++
Sbjct: 199 WSLGIMAIEMV 209
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297 |
| >gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Score = 73.7 bits (181), Expect = 3e-14
Identities = 62/222 (27%), Positives = 100/222 (45%), Gaps = 30/222 (13%)
Query: 493 FTYKELVEVTRGFKEELGRGAFGTVY----KGFVNMGSSNHVAVKKLNSV-FQDSEKEFK 547
F L E+T LGRG FG V+ KG G V VK L ++ + EF+
Sbjct: 2 FPRSNLQEIT-----TLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFR 56
Query: 548 AEVNGIGQTHHKNLVRLLGYCDEGQNRLLVYEFMSNGTVASFLFGDSKPNWKL------- 600
E++ + HKN+VRLLG C E + ++ E+ G + FL + KL
Sbjct: 57 RELDMFRKLSHKNVVRLLGLCREAEPHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLST 116
Query: 601 --RTEIAMGIAGGLFYLHEECCTQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLDQ-- 656
+ + IA G+ +L + +H D+ +N L+ ++S L+K + +
Sbjct: 117 KQKVALCTQIALGMDHLSN---ARFVHRDLAARNCLVSSQREVKVSLLSLSKDVYNSEYY 173
Query: 657 SHTNTAI--RGTKGYVAPEWFRNMPITVKVDVYSYGVLLLEI 696
N I R ++APE + + K DV+S+GVL+ E+
Sbjct: 174 KLRNALIPLR----WLAPEAVQEDDFSTKSDVWSFGVLMWEV 211
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275 |
| >gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Score = 73.5 bits (180), Expect = 4e-14
Identities = 56/195 (28%), Positives = 97/195 (49%), Gaps = 11/195 (5%)
Query: 508 ELGRGAFGTVYKGFVNMGSSNHVAVKKLNSVFQDSEKEFKAEVNGIGQTHHKNLVRLLGY 567
ELG GAFG VYK N + A K +++ ++ +++ E++ + H N+V+LL
Sbjct: 12 ELGDGAFGKVYKA-QNKETGVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDA 70
Query: 568 CDEGQNRLLVYEFMSNGTVASFLFGDSKPNWKLRTEIA-MGIAGGLFYLHEECCTQIIHC 626
N ++ EF + G V + + +P + + + L YLHE +IIH
Sbjct: 71 FYYENNLWILIEFCAGGAVDAVMLELERPLTEPQIRVVCKQTLEALNYLHE---NKIIHR 127
Query: 627 DIKPQNILLDDHYNARISDFGLAKLLTLDQSHTNTAIRGTKGYVAPEWF-----RNMPIT 681
D+K NIL + +++DFG++ T ++ I GT ++APE ++ P
Sbjct: 128 DLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRDSFI-GTPYWMAPEVVMCETSKDRPYD 186
Query: 682 VKVDVYSYGVLLLEI 696
K DV+S G+ L+E+
Sbjct: 187 YKADVWSLGITLIEM 201
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282 |
| >gnl|CDD|133174 cd05042, PTKc_Aatyk, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Score = 73.0 bits (179), Expect = 4e-14
Identities = 59/211 (27%), Positives = 91/211 (43%), Gaps = 30/211 (14%)
Query: 507 EELGRGAFGTVYKGFVNMG-SSNHVAVKKL-NSVFQDSEKEFKAEVNGIGQTHHKNLVRL 564
+E+G G FG V G + G S V VK+L S D + F EV + +H N+++
Sbjct: 1 DEIGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQC 60
Query: 565 LGYCDEGQNRLLVYEFMSNGTVASFL-------FGDSKPNWKLRTEIAMGIAGGLFYLHE 617
LG C E LLV EF G + ++L ++ + R +A +A GL +LH+
Sbjct: 61 LGQCIESIPYLLVLEFCPLGDLKNYLRSNRGMVAQMAQKDVLQR--MACEVASGLLWLHQ 118
Query: 618 ECCTQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLDQSHTNTAIRGTKGYVAPEW--- 674
IH D+ +N L + +I D+GLA L+Q + I V W
Sbjct: 119 ---ADFIHSDLALRNCQLTADLSVKIGDYGLA----LEQYPEDYYITKDCHAVPLRWLAP 171
Query: 675 ---------FRNMPITVKVDVYSYGVLLLEI 696
T K +++S GV + E+
Sbjct: 172 ELVEIRGQDLLPKDQTKKSNIWSLGVTMWEL 202
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kinases based on overall sequence similarity and the phylogenetic tree. However, analysis of catalytic residues suggests that Aatyk proteins may be multispecific kinases, functioning also as serine/threonine kinases. They are involved in neural differentiation, nerve growth factor (NGF) signaling, apoptosis, and spermatogenesis. Length = 269 |
| >gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 73.9 bits (182), Expect = 4e-14
Identities = 58/202 (28%), Positives = 90/202 (44%), Gaps = 25/202 (12%)
Query: 509 LGRGAFGTVYKGFVNMGSSNHVAVKKLNSVFQDSE--KEFKAEVNGIGQTHHKNLVRLLG 566
+G GA+G V F + + VA+KKL+ FQ + K E+ + H+N++ LL
Sbjct: 23 VGSGAYGQVCSAF-DTKTGRKVAIKKLSRPFQSAIHAKRTYRELRLLKHMDHENVIGLLD 81
Query: 567 -YC-----DEGQNRLLVYEFMS---NGTVASFLFGDSKPNWKLRTEIAMGIAGGLFYLHE 617
+ ++ Q+ LV M N V D + + I GL Y+H
Sbjct: 82 VFTPASSLEDFQDVYLVTHLMGADLNNIVKCQKLSDDHIQF-----LVYQILRGLKYIHS 136
Query: 618 ECCTQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLDQSHTNTAIRGTKGYVAPEWFRN 677
IIH D+KP NI +++ +I DFGLA+ T T+ Y APE N
Sbjct: 137 ---AGIIHRDLKPSNIAVNEDCELKILDFGLARHT----DDEMTGYVATRWYRAPEIMLN 189
Query: 678 -MPITVKVDVYSYGVLLLEIIC 698
M VD++S G ++ E++
Sbjct: 190 WMHYNQTVDIWSVGCIMAELLT 211
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343 |
| >gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Score = 73.0 bits (179), Expect = 5e-14
Identities = 58/206 (28%), Positives = 103/206 (50%), Gaps = 20/206 (9%)
Query: 509 LGRGAFGTVYKGFVNM--GSSNHVAVKKLNS-VFQDSE-KEFKAEVNGIGQTHHKNLVRL 564
LG+G FG+V + + GS VAVK L + +F S+ +EF E + + H N+++L
Sbjct: 7 LGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVIKL 66
Query: 565 LGYC--DEGQNRL----LVYEFMSNGTVASFLF----GDSKPNWKLRT--EIAMGIAGGL 612
+G + RL ++ FM +G + +FL G+ L+T + IA G+
Sbjct: 67 IGVSLRSRAKGRLPIPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGM 126
Query: 613 FYLHEECCTQIIHCDIKPQNILLDDHYNARISDFGLA-KLLTLDQSHTNTAIRGTKGYVA 671
YL + IH D+ +N +L+++ ++DFGL+ K+ + D A + ++A
Sbjct: 127 EYLSSK---NFIHRDLAARNCMLNENMTVCVADFGLSKKIYSGDYYRQGCASKLPVKWLA 183
Query: 672 PEWFRNMPITVKVDVYSYGVLLLEII 697
E + T DV+++GV + EI+
Sbjct: 184 LESLADNVYTTHSDVWAFGVTMWEIM 209
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273 |
| >gnl|CDD|133195 cd05064, PTKc_EphR_A10, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Score = 72.6 bits (178), Expect = 5e-14
Identities = 72/278 (25%), Positives = 123/278 (44%), Gaps = 33/278 (11%)
Query: 509 LGRGAFGTVYKGFVNMGSSNH--VAVKKLNSVFQDSEKE-FKAEVNGIGQTHHKNLVRLL 565
LG G FG + +G + + S VA+ L + D ++ F AE +GQ H N+VRL
Sbjct: 13 LGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRGFLAEALTLGQFDHSNIVRLE 72
Query: 566 GYCDEGQNRLLVYEFMSNGTVASFLFGDSKPNWKLRTEIAM----GIAGGLFYLHEECCT 621
G G ++V E+MSNG + SFL K +L M G+A G+ YL E
Sbjct: 73 GVITRGNTMMIVTEYMSNGALDSFL---RKHEGQLVAGQLMGMLPGLASGMKYLSE---M 126
Query: 622 QIIHCDIKPQNILLDDHYNARISDFGLAKLLTLDQSHTNTAIRGTKGYVAPEWFRNMPIT 681
+H + +L++ +IS F + + +T + + + APE + +
Sbjct: 127 GYVHKGLAAHKVLVNSDLVCKISGFRRLQEDKSEAIYTTMSGKSPVLWAAPEAIQYHHFS 186
Query: 682 VKVDVYSYGVLLLEIICL--RRNIDNEISKVDKAILTDWAYDRYQERTLEALVENDLEAM 739
DV+S+G+++ E++ R D V KA+ D ++ L A
Sbjct: 187 SASDVWSFGIVMWEVMSYGERPYWDMSGQDVIKAV-----EDGFR---LPAPR------- 231
Query: 740 NNVTMLHRFVMVAFWCIQEDPSHRPTMRKVTQMLEGVV 777
N +LH+ ++ C Q++ RP ++ +L +V
Sbjct: 232 NCPNLLHQLMLD---CWQKERGERPRFSQIHSILSKMV 266
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). EphA10, which contains an inactive tyr kinase domain, may function to attenuate signals of co-clustered active receptors. EphA10 is mainly expressed in the testis. Ephrin/EphR interaction results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Score = 73.0 bits (179), Expect = 6e-14
Identities = 58/201 (28%), Positives = 100/201 (49%), Gaps = 26/201 (12%)
Query: 507 EELGRGAFGTVYKGFVNMGSSNHVAVKKLNSVFQDSEKEFKAEVNGIGQTHHKNLVRLLG 566
E++G+GA GTVY +++ + VA+K++N Q ++ E+ + + H N+V L
Sbjct: 25 EKIGQGASGTVYTA-IDVATGQEVAIKQMNLQQQPKKELIINEILVMRENKHPNIVNYLD 83
Query: 567 YCDEGQNRLLVYEFMSNGTVASFLFGDSKPNWKLRTEIAMG---IAG-------GLFYLH 616
G +V E+++ G++ + TE M IA L +LH
Sbjct: 84 SYLVGDELWVVMEYLAGGSLTDVV-----------TETCMDEGQIAAVCRECLQALEFLH 132
Query: 617 EECCTQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLDQSHTNTAIRGTKGYVAPEWFR 676
Q+IH DIK NILL + +++DFG +T +QS +T + GT ++APE
Sbjct: 133 SN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMV-GTPYWMAPEVVT 188
Query: 677 NMPITVKVDVYSYGVLLLEII 697
KVD++S G++ +E++
Sbjct: 189 RKAYGPKVDIWSLGIMAIEMV 209
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293 |
| >gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Score = 73.1 bits (179), Expect = 7e-14
Identities = 73/279 (26%), Positives = 115/279 (41%), Gaps = 50/279 (17%)
Query: 509 LGRGAFGTVYKGFVNMGSSN---HVAVKKL-NSVFQDSEKEFKAEVNGIGQTHHKNLVRL 564
LG GAFGTVYKG VA+K+L + + KE E + + ++ RL
Sbjct: 15 LGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRL 74
Query: 565 LGYCDEGQNRLLVYEFMSNGTVASF-------LFGDSKPNWKLRTEIAMGIAGGLFYLHE 617
LG C +L + + M G + + + NW ++ IA G+ YL E
Sbjct: 75 LGICLTSTVQL-ITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQ------IAKGMNYLEE 127
Query: 618 ECCTQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLDQSHTNTAIRGTKGYVAPEWFRN 677
+++H D+ +N+L+ + +I+DFGLAKLL D+ G V +W
Sbjct: 128 R---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGADEK----EYHAEGGKVPIKWMAL 180
Query: 678 MPI-----TVKVDVYSYGVLLLEIICLRRNIDNEISKVDKAILTDWAYDRYQERTLEALV 732
I T + DV+SYGV + E++ YD + +++
Sbjct: 181 ESILHRIYTHQSDVWSYGVTVWELMTFGSK----------------PYDGIPASEISSIL 224
Query: 733 END--LEAMNNVTMLHRFVMVAFWCIQEDPSHRPTMRKV 769
E L T+ +MV W I D RP R++
Sbjct: 225 EKGERLPQPPICTIDVYMIMVKCWMI--DADSRPKFREL 261
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316 |
| >gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 71.7 bits (176), Expect = 8e-14
Identities = 51/199 (25%), Positives = 90/199 (45%), Gaps = 21/199 (10%)
Query: 507 EELGRGAFGTVYKGFVNMGSSNHVAVKKLNSVFQDSEKE---FKAE-VNGIGQTHHKNLV 562
+ + +GAFG+VY + ++ A+K L ++ + KAE + Q +
Sbjct: 2 KPISKGAFGSVYLA-KKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVA 60
Query: 563 RLLGYCDEGQNRLLVYEFMSNGTVASFL--FGDSKPNW--KLRTEIAMGIAGGLFYLHEE 618
+L LV E+++ G AS + G +W + E+ +G+ LH+
Sbjct: 61 KLYYSFQSKDYLYLVMEYLNGGDCASLIKTLGGLPEDWAKQYIAEVVLGVE----DLHQR 116
Query: 619 CCTQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLDQSHTNTAIRGTKGYVAPEWFRNM 678
IIH DIKP+N+L+D + +++DFGL++ N GT Y+APE +
Sbjct: 117 ---GIIHRDIKPENLLIDQTGHLKLTDFGLSRNGLE-----NKKFVGTPDYLAPETILGV 168
Query: 679 PITVKVDVYSYGVLLLEII 697
D +S G ++ E +
Sbjct: 169 GDDKMSDWWSLGCVIFEFL 187
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260 |
| >gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Score = 71.7 bits (175), Expect = 1e-13
Identities = 64/206 (31%), Positives = 100/206 (48%), Gaps = 24/206 (11%)
Query: 507 EELGRGAFGTVYKGFVNMGSSNHVAVKKLNSVFQDSEKEFKAEVNGIGQ-THHKNLVRLL 565
E +G G +G VYKG + +A K+ V D E+E K E+N + + +HH+N+
Sbjct: 12 ELVGNGTYGQVYKG--RHVKTGQLAAIKVMDVTGDEEEEIKQEINMLKKYSHHRNIATYY 69
Query: 566 GYCDEGQ------NRLLVYEFMSNGTVASFLFGDSKPNWKLRTE----IAMGIAGGLFYL 615
G + LV EF G+V L ++K N L+ E I I GL +L
Sbjct: 70 GAFIKKNPPGMDDQLWLVMEFCGAGSVTD-LIKNTKGN-TLKEEWIAYICREILRGLSHL 127
Query: 616 HEECCTQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLDQSHTNTAIRGTKGYVAPEWF 675
H+ ++IH DIK QN+LL ++ ++ DFG++ L NT I GT ++APE
Sbjct: 128 HQH---KVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNTFI-GTPYWMAPEVI 183
Query: 676 R-----NMPITVKVDVYSYGVLLLEI 696
+ K D++S G+ +E+
Sbjct: 184 ACDENPDATYDFKSDLWSLGITAIEM 209
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272 |
| >gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Score = 71.5 bits (176), Expect = 1e-13
Identities = 44/168 (26%), Positives = 80/168 (47%), Gaps = 8/168 (4%)
Query: 509 LGRGAFGTVYKGFVNMGSSNHVAVKKLNS--VFQDSEKEFKAEVNGIGQTHHKNLVRLLG 566
+G GA G V+K + + VA+KK+ + + E+ + H +V+LL
Sbjct: 8 IGEGAHGIVFKA-KDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLD 66
Query: 567 YCDEGQNRLLVYEFMSNGTVASFLFGDSKPNWKLRTE-IAMGIAGGLFYLHEECCTQIIH 625
G +LV E+M ++ L + +P + + + + G+ Y+H I+H
Sbjct: 67 VFPHGSGFVLVMEYMP-SDLSEVLRDEERPLPEAQVKSYMRMLLKGVAYMHAN---GIMH 122
Query: 626 CDIKPQNILLDDHYNARISDFGLAKLLTLDQSHTNTAIRGTKGYVAPE 673
D+KP N+L+ +I+DFGLA+L + ++ + T+ Y APE
Sbjct: 123 RDLKPANLLISADGVLKIADFGLARLFSEEEPRLYSHQVATRWYRAPE 170
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286 |
| >gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Score = 71.2 bits (174), Expect = 2e-13
Identities = 61/205 (29%), Positives = 102/205 (49%), Gaps = 21/205 (10%)
Query: 509 LGRGAFGTVYKGFVNMGSSN-HVAVKKLN-SVFQDSEKE-FKAEVNGIGQTHHKNLVRLL 565
LG G FG+V +G +N S VAVK + ++ SE E F +E + + H N++RL+
Sbjct: 7 LGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLI 66
Query: 566 GYCDEGQNR------LLVYEFMSNGTVASFLF----GDSKPNW---KLRTEIAMGIAGGL 612
G C + +++ FM +G + SFL GD P + ++ + IA G+
Sbjct: 67 GVCLQTVESEGYPSPVVILPFMKHGDLHSFLLYSRLGDC-PQYLPTQMLVKFMTDIASGM 125
Query: 613 FYLHEECCTQIIHCDIKPQNILLDDHYNARISDFGLA-KLLTLDQSHTNTAIRGTKGYVA 671
YL + IH D+ +N +L+++ N ++DFGL+ K+ D + ++A
Sbjct: 126 EYLSSK---SFIHRDLAARNCMLNENMNVCVADFGLSKKIYNGDYYRQGRIAKMPVKWIA 182
Query: 672 PEWFRNMPITVKVDVYSYGVLLLEI 696
E + T K DV+S+GV + EI
Sbjct: 183 IESLADRVYTTKSDVWSFGVTMWEI 207
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transformed cells. Axl signaling is important in many cellular functions such as survival, anti-apoptosis, proliferation, migration, and adhesion. Axl was originally isolated from patients with chronic myelogenous leukemia and a chronic myeloproliferative disorder. Axl is overexpressed in many human cancers including colon, squamous cell, thyroid, breast, and lung carcinomas. Length = 272 |
| >gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Score = 71.6 bits (175), Expect = 2e-13
Identities = 69/217 (31%), Positives = 106/217 (48%), Gaps = 33/217 (15%)
Query: 497 ELVEVTRGFKEELGRGAFGTVYKG-FVNMGSSNHVAVKKLNSVFQDSEKEFKAEVNGIGQ 555
ELVEV +G G +G VYKG V G +A K+ V +D E+E K E+N + +
Sbjct: 19 ELVEV-------VGNGTYGQVYKGRHVKTG---QLAAIKVMDVTEDEEEEIKLEINMLKK 68
Query: 556 -THHKNLVRLLGY----CDEGQNR--LLVYEFMSNGTVASFLFGDSKPNWKLRTE----I 604
+HH+N+ G G + LV EF G+V L ++K N L+ + I
Sbjct: 69 YSHHRNIATYYGAFIKKSPPGHDDQLWLVMEFCGAGSVTD-LVKNTKGN-ALKEDWIAYI 126
Query: 605 AMGIAGGLFYLHEECCTQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLDQSHTNTAIR 664
I GL +LH ++IH DIK QN+LL ++ ++ DFG++ L NT I
Sbjct: 127 CREILRGLAHLHAH---KVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNTFI- 182
Query: 665 GTKGYVAPEWFR-----NMPITVKVDVYSYGVLLLEI 696
GT ++APE + + D++S G+ +E+
Sbjct: 183 GTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEM 219
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282 |
| >gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Score = 71.7 bits (175), Expect = 2e-13
Identities = 50/191 (26%), Positives = 98/191 (51%), Gaps = 6/191 (3%)
Query: 507 EELGRGAFGTVYKGFVNMGSSNHVAVKKLNSVFQDSEKEFKAEVNGIGQTHHKNLVRLLG 566
E++G+GA GTV+ +++ + VA+K++N Q ++ E+ + + + N+V L
Sbjct: 25 EKIGQGASGTVFTA-IDVATGQEVAIKQINLQKQPKKELIINEILVMKELKNPNIVNFLD 83
Query: 567 YCDEGQNRLLVYEFMSNGTVASFLFGDSKPNWKLRTEIAMGIAGGLFYLHEECCTQIIHC 626
G +V E+++ G++ + ++ + L +LH Q+IH
Sbjct: 84 SFLVGDELFVVMEYLAGGSLTDVVTETCMDEAQI-AAVCRECLQALEFLH---ANQVIHR 139
Query: 627 DIKPQNILLDDHYNARISDFGLAKLLTLDQSHTNTAIRGTKGYVAPEWFRNMPITVKVDV 686
DIK N+LL + +++DFG +T +QS +T + GT ++APE KVD+
Sbjct: 140 DIKSDNVLLGMDGSVKLTDFGFCAQITPEQSKRSTMV-GTPYWMAPEVVTRKAYGPKVDI 198
Query: 687 YSYGVLLLEII 697
+S G++ +E++
Sbjct: 199 WSLGIMAIEMV 209
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296 |
| >gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 71.4 bits (175), Expect = 2e-13
Identities = 64/200 (32%), Positives = 92/200 (46%), Gaps = 23/200 (11%)
Query: 509 LGRGAFGTVYKGFVNMGSSNHVAVKKLNSVFQDSEKEFKAEVNGIGQTH-----HKNLVR 563
LG+G FG V V + A KKL + K+ K E + + + V
Sbjct: 8 LGKGGFGEVCACQVR-ATGKMYACKKLE---KKRIKKRKGEAMALNEKQILEKVNSRFVV 63
Query: 564 LLGYCDEGQNRL-LVYEFMSNGTVASFLFGDSKPNWKLRTEI--AMGIAGGLFYLHEECC 620
L Y E ++ L LV M+ G + ++ P + + A I GL LH E
Sbjct: 64 SLAYAYETKDALCLVLTLMNGGDLKFHIYNMGNPGFDEERAVFYAAEITCGLEDLHRE-- 121
Query: 621 TQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLDQSHTNTAIR---GTKGYVAPEWFRN 677
+I++ D+KP+NILLDD+ + RISD GLA + IR GT GY+APE +N
Sbjct: 122 -RIVYRDLKPENILLDDYGHIRISDLGLAV-----EIPEGETIRGRVGTVGYMAPEVVKN 175
Query: 678 MPITVKVDVYSYGVLLLEII 697
T D + G L+ E+I
Sbjct: 176 ERYTFSPDWWGLGCLIYEMI 195
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285 |
| >gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Score = 71.3 bits (174), Expect = 2e-13
Identities = 52/191 (27%), Positives = 98/191 (51%), Gaps = 6/191 (3%)
Query: 507 EELGRGAFGTVYKGFVNMGSSNHVAVKKLNSVFQDSEKEFKAEVNGIGQTHHKNLVRLLG 566
E++G+GA GTVY +++ + VA++++N Q ++ E+ + + + N+V L
Sbjct: 26 EKIGQGASGTVYTA-MDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLD 84
Query: 567 YCDEGQNRLLVYEFMSNGTVASFLFGDSKPNWKLRTEIAMGIAGGLFYLHEECCTQIIHC 626
G +V E+++ G++ + ++ + L +LH Q+IH
Sbjct: 85 SYLVGDELWVVMEYLAGGSLTDVVTETCMDEGQI-AAVCRECLQALEFLHS---NQVIHR 140
Query: 627 DIKPQNILLDDHYNARISDFGLAKLLTLDQSHTNTAIRGTKGYVAPEWFRNMPITVKVDV 686
DIK NILL + +++DFG +T +QS +T + GT ++APE KVD+
Sbjct: 141 DIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMV-GTPYWMAPEVVTRKAYGPKVDI 199
Query: 687 YSYGVLLLEII 697
+S G++ +E+I
Sbjct: 200 WSLGIMAIEMI 210
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296 |
| >gnl|CDD|133240 cd05109, PTKc_HER2, Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Score = 70.8 bits (173), Expect = 2e-13
Identities = 78/290 (26%), Positives = 118/290 (40%), Gaps = 50/290 (17%)
Query: 509 LGRGAFGTVYKGFVNMGSSN---HVAVKKL-NSVFQDSEKEFKAEVNGIGQTHHKNLVRL 564
LG GAFGTVYKG N VA+K L + + KE E + + RL
Sbjct: 15 LGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVCRL 74
Query: 565 LGYCDEGQNRLLVYEFMSNGTVASFLFGDSKP-------NWKLRTEIAMGIAGGLFYLHE 617
LG C +L V + M G + ++ + NW ++ IA G+ YL E
Sbjct: 75 LGICLTSTVQL-VTQLMPYGCLLDYVRENKDRIGSQDLLNWCVQ------IAKGMSYLEE 127
Query: 618 ECCTQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLDQSHTNTAIRGTKGYVAPEWFRN 677
+++H D+ +N+L+ + +I+DFGLA+LL +D+ T G V +W
Sbjct: 128 ---VRLVHRDLAARNVLVKSPNHVKITDFGLARLLDIDE----TEYHADGGKVPIKWMAL 180
Query: 678 MPI-----TVKVDVYSYGVLLLEIICLRRNIDNEISKVDKAILTDWAYDRYQERTLEALV 732
I T + DV+SYGV + E++ YD R + L+
Sbjct: 181 ESILHRRFTHQSDVWSYGVTVWELMTFGAK----------------PYDGIPAREIPDLL 224
Query: 733 E--NDLEAMNNVTMLHRFVMVAFWCIQEDPSHRPTMRKVTQMLEGVVEVP 780
E L T+ +MV W I D RP R++ + P
Sbjct: 225 EKGERLPQPPICTIDVYMIMVKCWMI--DSECRPRFRELVDEFSRMARDP 272
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER2 does not bind to any known EGFR subfamily ligands, but contributes to the kinase activity of all possible heterodimers. It acts as the preferred partner with other ligand-bound EGFR proteins and functions as a signal amplifier, with the HER2-HER3 heterodimer being the most potent pair in mitogenic signaling. HER2 plays an important role in cell development, proliferation, survival and motility. Overexpression of HER2 results in its activation and downstream signaling, even in the absence of ligand. HER2 overexpression, mainly due to gene amplification, has been shown in a variety of human cancers. Its role in breast cancer is especially well-documented. HER2 is up-regulated in about 25% of breast tumors and is associated with increases in tumor aggressiveness, recurrence and mortality. HER2 is a target for monoclonal antibodies and small molecule inhibitors, which are being developed as treatments for cancer. The first humanized antibody approved for clinical use is Trastuzumab (Herceptin), which is being used in combination with other therapies to improve the survival rates of patients with HER2-overexpressing breast cancer. Length = 279 |
| >gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 71.0 bits (174), Expect = 2e-13
Identities = 56/197 (28%), Positives = 90/197 (45%), Gaps = 21/197 (10%)
Query: 508 ELGRGAFGTVYKGFVNMGSSNHVAVKKLNSVFQDSEKEFKAE-VNGIGQTHHKN---LVR 563
+LG G G+V K V + V KK V ++ + + + + H +V
Sbjct: 12 DLGAGNGGSVSK--VKHIPTGTVMAKK--VVHIGAKSSVRKQILRELQIMHECRSPYIVS 67
Query: 564 LLGYCDEGQNRLLVYEFMSNGTVASFLFGDSKPNWKLRTE----IAMGIAGGLFYLHEEC 619
G N + EFM G+ L K + E IA+ + GL YL+
Sbjct: 68 FYGAFLNENNICMCMEFMDCGS----LDRIYKKGGPIPVEILGKIAVAVVEGLTYLYNV- 122
Query: 620 CTQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLDQSHTNTAIRGTKGYVAPEWFRNMP 679
+I+H DIKP NIL++ ++ DFG++ L S +T + GT Y++PE +
Sbjct: 123 -HRIMHRDIKPSNILVNSRGQIKLCDFGVSGELI--NSIADTFV-GTSTYMSPERIQGGK 178
Query: 680 ITVKVDVYSYGVLLLEI 696
TVK DV+S G+ ++E+
Sbjct: 179 YTVKSDVWSLGISIIEL 195
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284 |
| >gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Score = 70.8 bits (173), Expect = 3e-13
Identities = 62/206 (30%), Positives = 98/206 (47%), Gaps = 23/206 (11%)
Query: 507 EELGRGAFGTVYKGFVNMGSSNHVAVKKLNSVFQDSEKEFKAEVNGIGQ-THHKNLVRLL 565
E +G+G +G VYK N + AVK L+ + D ++E +AE N + +H N+V+
Sbjct: 28 ETIGKGTYGKVYK-VTNKKDGSLAAVKILDPI-SDVDEEIEAEYNILQSLPNHPNVVKFY 85
Query: 566 G------YCDEGQNRLLVYEFMSNGTVASFLFGDSKPNWKLR----TEIAMGIAGGLFYL 615
G GQ LV E + G+V + G +L + I G GL +L
Sbjct: 86 GMFYKADKLVGGQ-LWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHL 144
Query: 616 HEECCTQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLDQSHTNTAIRGTKGYVAPEWF 675
H +IIH D+K NILL ++ DFG++ LT + NT++ GT ++APE
Sbjct: 145 HN---NRIIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTRLRRNTSV-GTPFWMAPEVI 200
Query: 676 R-----NMPITVKVDVYSYGVLLLEI 696
+ + DV+S G+ +E+
Sbjct: 201 ACEQQYDYSYDARCDVWSLGITAIEL 226
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291 |
| >gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Score = 70.4 bits (172), Expect = 3e-13
Identities = 60/205 (29%), Positives = 98/205 (47%), Gaps = 26/205 (12%)
Query: 509 LGRGAFGTVY--KGFVNMGSSNHVAVKKLN-SVFQDSEKEF-KAEVNGIGQTHHKNLVRL 564
+G G+FG +Y K + S H +K+++ + EKE K EV + + H N+V
Sbjct: 8 IGEGSFGKIYLAKAKSD---SEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNIVTF 64
Query: 565 LGYCDEGQNRLLVYEFMSNGTVAS-------FLFG-DSKPNWKLRTEIAMGIAGGLFYLH 616
E +V E+ G + LF D +W ++ I+ GL ++H
Sbjct: 65 FASFQENGRLFIVMEYCDGGDLMKRINRQRGVLFSEDQILSWFVQ------ISLGLKHIH 118
Query: 617 EECCTQIIHCDIKPQNILLDDH-YNARISDFGLAKLLTLDQSHTNTAIRGTKGYVAPEWF 675
+ +I+H DIK QNI L + A++ DFG+A+ L T + GT Y++PE
Sbjct: 119 DR---KILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDSMELAYTCV-GTPYYLSPEIC 174
Query: 676 RNMPITVKVDVYSYGVLLLEIICLR 700
+N P K D++S G +L E+ L+
Sbjct: 175 QNRPYNNKTDIWSLGCVLYELCTLK 199
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257 |
| >gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Score = 70.8 bits (173), Expect = 3e-13
Identities = 57/219 (26%), Positives = 104/219 (47%), Gaps = 34/219 (15%)
Query: 505 FKEELGRGAFGTVYKGFVNM-GSSNHVAVKKLNSVFQDSE-KEFKAEVNGIGQT-HHKNL 561
F++ +G G FG V + + G + A+K L +++ ++F E+ + + HH N+
Sbjct: 6 FEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNI 65
Query: 562 VRLLGYCDEGQNRLLVYEFMSNGTVASFLFG----DSKPNW------------KLRTEIA 605
+ LLG C+ + E+ G + FL ++ P + + + A
Sbjct: 66 INLLGACENRGYLYIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFA 125
Query: 606 MGIAGGLFYLHEECCTQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLDQSHTNTAIRG 665
+A G+ YL E+ Q IH D+ +N+L+ ++ ++I+DFGL++ ++
Sbjct: 126 SDVATGMQYLSEK---QFIHRDLAARNVLVGENLASKIADFGLSR-------GEEVYVKK 175
Query: 666 TKGYVAPEWFR----NMPI-TVKVDVYSYGVLLLEIICL 699
T G + W N + T K DV+S+GVLL EI+ L
Sbjct: 176 TMGRLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVSL 214
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297 |
| >gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 71.2 bits (174), Expect = 3e-13
Identities = 61/239 (25%), Positives = 99/239 (41%), Gaps = 36/239 (15%)
Query: 558 HKNLVRLLGYCDEGQNRLLVYEFMSNGTVASFLFGDSKP----------------NWKLR 601
HKN++ LLG C + ++ E+ S G + +L P +K
Sbjct: 77 HKNIINLLGACTQDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDL 136
Query: 602 TEIAMGIAGGLFYLHEECCTQIIHCDIKPQNILLDDHYNARISDFGLAK-LLTLDQSHTN 660
A +A G+ YL + C IH D+ +N+L+ + +I+DFGLA+ + +D
Sbjct: 137 VSCAYQVARGMEYLASQKC---IHRDLAARNVLVTEDNVMKIADFGLARDVHNIDYYKKT 193
Query: 661 TAIRGTKGYVAPEWFRNMPITVKVDVYSYGVLLLEIICLRRNIDNEISKVDKAILTDWAY 720
T R ++APE + T + DV+S+GVLL EI L + Y
Sbjct: 194 TNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGS----------------PY 237
Query: 721 DRYQERTLEALVENDLEAMNNVTMLHRFVMVAFWCIQEDPSHRPTMRKVTQMLEGVVEV 779
L L++ H M+ C PS RPT +++ + L+ V+ V
Sbjct: 238 PGIPVEELFKLLKEGHRMDKPANCTHELYMIMRECWHAVPSQRPTFKQLVEDLDRVLTV 296
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334 |
| >gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Score = 70.5 bits (173), Expect = 3e-13
Identities = 69/283 (24%), Positives = 118/283 (41%), Gaps = 45/283 (15%)
Query: 507 EELGRGAFGTVYKGFVNMGSSNHVAVKKLNSVFQDSE-KEFKAEVNGIGQTHH-KNLVRL 564
EELGRGA+G V K ++ + +AVK++ + E K +++ ++ V
Sbjct: 7 EELGRGAYGVVDK-MRHVPTGTIMAVKRIRATVNSQEQKRLLMDLDISMRSVDCPYTVTF 65
Query: 565 LGYC-DEGQNRLLVYEFMSNGTVASFLFGDSKPNWKLRT------EIAMGIAGGLFYLHE 617
G EG V+ M + F + L +IA+ I L YLH
Sbjct: 66 YGALFREGD----VWICMEVMDTSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLHS 121
Query: 618 ECCTQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLDQSHTNTAIRGTKGYVAPEWFRN 677
+ +IH D+KP N+L++ + ++ DFG++ L + T A G K Y+APE R
Sbjct: 122 K--LSVIHRDVKPSNVLINRNGQVKLCDFGISGYLVDSVAKTIDA--GCKPYMAPE--RI 175
Query: 678 MPIT------VKVDVYSYGVLLLEIICLRRNIDNEISKVDKAILTDWAYDRYQE--RTLE 729
P VK DV+S G+ ++E+ R + YD ++ + L+
Sbjct: 176 NPELNQKGYDVKSDVWSLGITMIELATGR-----------------FPYDSWKTPFQQLK 218
Query: 730 ALVENDLEAMNNVTMLHRFVMVAFWCIQEDPSHRPTMRKVTQM 772
+VE + F C++++ RP ++ Q
Sbjct: 219 QVVEEPSPQLPAEKFSPEFQDFVNKCLKKNYKERPNYPELLQH 261
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283 |
| >gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Score = 70.8 bits (173), Expect = 4e-13
Identities = 62/208 (29%), Positives = 96/208 (46%), Gaps = 11/208 (5%)
Query: 504 GFKEELGRGAFGTVYKGFVNMGSSNHV-AVK--KLNSVFQDSEKEFK-AEVNGIGQTHHK 559
F LG+G+FG V ++ + A+K K + V QD + E E +
Sbjct: 3 NFLMVLGKGSFGKVM--LAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKP 60
Query: 560 NLVRLLGYCDEGQNRL-LVYEFMSNGTVASFLFGDSKPNWKLRTEIAMGIAGGLFYLHEE 618
+ L C + +RL V E+++ G + + K A I+ GLF+LH
Sbjct: 61 PFLTQLHSCFQTVDRLYFVMEYVNGGDLMYHIQQVGKFKEPQAVFYAAEISVGLFFLHRR 120
Query: 619 CCTQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLDQSHTNTAIRGTKGYVAPEWFRNM 678
II+ D+K N++LD + +I+DFG+ K +D T T GT Y+APE
Sbjct: 121 ---GIIYRDLKLDNVMLDSEGHIKIADFGMCKEHMVDGVTTRTFC-GTPDYIAPEIIAYQ 176
Query: 679 PITVKVDVYSYGVLLLEIICLRRNIDNE 706
P VD ++YGVLL E++ + D E
Sbjct: 177 PYGKSVDWWAYGVLLYEMLAGQPPFDGE 204
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323 |
| >gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Score = 70.6 bits (173), Expect = 5e-13
Identities = 66/198 (33%), Positives = 97/198 (48%), Gaps = 21/198 (10%)
Query: 508 ELGRGAFGTVYKGFVNMGSSNHVAVKKLN-SVFQDSEK--EFKAEVNGIGQTHHKNLVRL 564
E+G G+FG VY ++ ++ VA+KK++ S Q +EK + EV + Q H N +
Sbjct: 22 EIGHGSFGAVYFAR-DVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEY 80
Query: 565 LGYCDEGQNRLLVYEFMSNGTVASFLFGDSKPNWKLRTEIA---MGIAGGLFYLHEECCT 621
G LV E+ G+ + L KP ++ EIA G GL YLH
Sbjct: 81 KGCYLREHTAWLVMEYCL-GSASDILEVHKKPLQEV--EIAAICHGALQGLAYLHSHE-- 135
Query: 622 QIIHCDIKPQNILLDDHYNARISDFGLAKLLTLDQSHTNTAIRGTKGYVAPEWFRNM--- 678
IH DIK NILL + +++DFG A L+ S N+ + GT ++APE M
Sbjct: 136 -RIHRDIKAGNILLTEPGTVKLADFGSASLV----SPANSFV-GTPYWMAPEVILAMDEG 189
Query: 679 PITVKVDVYSYGVLLLEI 696
KVDV+S G+ +E+
Sbjct: 190 QYDGKVDVWSLGITCIEL 207
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307 |
| >gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Score = 70.3 bits (173), Expect = 7e-13
Identities = 60/218 (27%), Positives = 110/218 (50%), Gaps = 46/218 (21%)
Query: 506 KEELGRGAFGTVYKGFVNMGSSNHVAVKKLNSVFQ---DSEKEFKAEVNGIGQ-THHKNL 561
++LG+GA+G V+K ++ + VA+KK+ F+ D+++ F+ E+ + + H N+
Sbjct: 12 LQKLGKGAYGIVWKA-IDRRTKEVVALKKIFDAFRNATDAQRTFR-EIMFLQELGDHPNI 69
Query: 562 VRLLGY--CDEGQNRLLVYEFMSNGTVASFLFGDSKPNWKLRTEIAMGI----------- 608
V+LL + ++ LV+E+M ++ + +R I +
Sbjct: 70 VKLLNVIKAENDKDIYLVFEYM-----------ETDLHAVIRANILEDVHKRYIMYQLLK 118
Query: 609 AGGLFYLHEECCTQIIHCDIKPQNILLDDHYNARISDFGLAKLLT-LDQSHTNTAIRGTK 667
A L Y+H +IH D+KP NILL+ +++DFGLA+ L+ L+++ N + T
Sbjct: 119 A--LKYIHS---GNVIHRDLKPSNILLNSDCRVKLADFGLARSLSELEENPENPVL--TD 171
Query: 668 GYVAPEWFRNMPITVK-------VDVYSYGVLLLEIIC 698
YVA W+R I + VD++S G +L E++
Sbjct: 172 -YVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLL 208
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337 |
| >gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Score = 69.6 bits (170), Expect = 7e-13
Identities = 62/202 (30%), Positives = 90/202 (44%), Gaps = 27/202 (13%)
Query: 509 LGRGAFGTVYKGFVNMGSSNHVAVKKLNSVFQDSEKEFKAEVNGIGQTH-----HKNLVR 563
LG+G FG V V + A KKL + K+ K E + + + V
Sbjct: 8 LGKGGFGEVCACQVR-ATGKMYACKKLE---KKRIKKRKGEAMALNEKRILEKVNSRFVV 63
Query: 564 LLGYCDEGQNRL-LVYEFMSNGTVASFLFGDSKPNWKLRTEIAMGIAGGLFYLHEECC-- 620
L Y E ++ L LV M+ G + ++ P + + I FY E CC
Sbjct: 64 SLAYAYETKDALCLVLTIMNGGDLKFHIYNMGNPGFDEQRAI--------FYAAELCCGL 115
Query: 621 -----TQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLDQSHTNTAIRGTKGYVAPEWF 675
+I++ D+KP+NILLDD + RISD GLA + + + T GT GY+APE
Sbjct: 116 EDLQRERIVYRDLKPENILLDDRGHIRISDLGLA--VQIPEGETVRGRVGTVGYMAPEVI 173
Query: 676 RNMPITVKVDVYSYGVLLLEII 697
N T D + G L+ E+I
Sbjct: 174 NNEKYTFSPDWWGLGCLIYEMI 195
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285 |
| >gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 69.1 bits (170), Expect = 1e-12
Identities = 73/319 (22%), Positives = 127/319 (39%), Gaps = 96/319 (30%)
Query: 507 EELGRGAFGTVYKGFVNMGSSNHVAVKKLNSVFQDSE-----KEFKA--EVNGIGQTHHK 559
++LG G FG+VY N + VA+KK+ F E +E K+ ++N H
Sbjct: 5 KQLGDGTFGSVYLA-RNKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLN-----EHP 58
Query: 560 NLVRLLGYCDEGQNRLLVYEFM----------------SNGTVASFLFGDSKPNWKLRTE 603
N+V+L E V+E+M S + S ++ +
Sbjct: 59 NIVKLKEVFRENDELYFVFEYMEGNLYQLMKDRKGKPFSESVIRSIIY-----------Q 107
Query: 604 IAMGIAGGLFYLHEECCTQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLDQSHTNTAI 663
I G+A ++H+ H D+KP+N+L+ +I+DFGLA+ + T
Sbjct: 108 ILQGLA----HIHK---HGFFHRDLKPENLLVSGPEVVKIADFGLAR--EIRSRPPYTDY 158
Query: 664 RGTKGYVAPEW-----FRNMPITVKVDVYSYGVLLLEIICLR-----RNIDNEISKVDK- 712
T+ Y APE + P VD+++ G ++ E+ LR +EI ++ K
Sbjct: 159 VSTRWYRAPEILLRSTSYSSP----VDIWALGCIMAELYTLRPLFPGS---SEIDQLYKI 211
Query: 713 -AIL-----TDW------------AYDRYQERTLEALVEN-DLEAMNNVTMLHRFVMVAF 753
++L DW + ++ +L L+ N EA++ +
Sbjct: 212 CSVLGTPTKQDWPEGYKLASKLGFRFPQFAPTSLHQLIPNASPEAID----------LIK 261
Query: 754 WCIQEDPSHRPTMRKVTQM 772
++ DP RPT + Q
Sbjct: 262 DMLRWDPKKRPTASQALQH 280
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283 |
| >gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 68.5 bits (167), Expect = 1e-12
Identities = 58/199 (29%), Positives = 96/199 (48%), Gaps = 15/199 (7%)
Query: 509 LGRGAFGTVYKGFVNMGSSNHVAVKKL--NSVFQDSEKEFKA---EVNGIGQTHHKNLVR 563
LGRGAFG VY + + + +AVK++ + Q++ KE A E+ + H +V+
Sbjct: 10 LGRGAFGEVYLCY-DADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQ 68
Query: 564 LLGYC--DEGQNRLLVY-EFMSNGTVASFLFGDSKPNWKLRTEIAMGIAGGLFYLHEECC 620
G C D + +L ++ E+M G++ L + I G+ YLH
Sbjct: 69 YYG-CLRDPEEKKLSIFVEYMPGGSIKDQLKAYGALTENVTRRYTRQILQGVSYLHS--- 124
Query: 621 TQIIHCDIKPQNILLDDHYNARISDFGLAK-LLTLDQSHTN-TAIRGTKGYVAPEWFRNM 678
I+H DIK NIL D N ++ DFG +K + T+ S T ++ GT +++PE
Sbjct: 125 NMIVHRDIKGANILRDSAGNVKLGDFGASKRIQTICMSGTGIKSVTGTPYWMSPEVISGE 184
Query: 679 PITVKVDVYSYGVLLLEII 697
K DV+S ++E++
Sbjct: 185 GYGRKADVWSVACTVVEML 203
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264 |
| >gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Score = 68.9 bits (168), Expect = 1e-12
Identities = 50/190 (26%), Positives = 92/190 (48%), Gaps = 6/190 (3%)
Query: 508 ELGRGAFGTVYKGFVNMGSSNHVAVKKLNSVFQDSEKEFKAEVNGIGQTHHKNLVRLLGY 567
++G G+ G V + VAVKK++ Q + EV + HH+N+V +
Sbjct: 29 KIGEGSTGIVCIA-TEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHENVVDMYNS 87
Query: 568 CDEGQNRLLVYEFMSNGTVASFLFGDSKPNWKLRTEIAMGIAGGLFYLHEECCTQIIHCD 627
G +V EF+ G + + ++ N + + + + L YLH + +IH D
Sbjct: 88 YLVGDELWVVMEFLEGGALTD-IVTHTRMNEEQIATVCLSVLRALSYLHNQ---GVIHRD 143
Query: 628 IKPQNILLDDHYNARISDFGLAKLLTLDQSHTNTAIRGTKGYVAPEWFRNMPITVKVDVY 687
IK +ILL ++SDFG ++ + + + GT ++APE +P +VD++
Sbjct: 144 IKSDSILLTSDGRIKLSDFGFCAQVSKEVPKRKSLV-GTPYWMAPEVISRLPYGTEVDIW 202
Query: 688 SYGVLLLEII 697
S G++++E+I
Sbjct: 203 SLGIMVIEMI 212
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292 |
| >gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Score = 68.9 bits (169), Expect = 1e-12
Identities = 63/233 (27%), Positives = 98/233 (42%), Gaps = 47/233 (20%)
Query: 505 FKEELGRGAFGTVY---------------KGFVNMGSSNHVAVKKLN-SVFQDSEKEFKA 548
F E+LG G FG V+ N + VAVK L ++ ++F
Sbjct: 9 FVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNAREDFLK 68
Query: 549 EVNGIGQTHHKNLVRLLGYCDEGQNRLLVYEFMSNGTVASFL----FGDSKPNWKLRT-- 602
EV + + N+ RLLG C ++ E+M NG + FL S ++
Sbjct: 69 EVKILSRLSDPNIARLLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLS 128
Query: 603 -----EIAMGIAGGLFYLHEECCTQIIHCDIKPQNILLDDHYNARISDFGLAK-LLTLDQ 656
+A IA G+ YL +H D+ +N L+ +Y +I+DFG+++ L + D
Sbjct: 129 FSTLLYMATQIASGMRYLES---LNFVHRDLATRNCLVGKNYTIKIADFGMSRNLYSSDY 185
Query: 657 SHTNTAIRGTKGYVAPEWFRNMP--------ITVKVDVYSYGVLLLEIICLRR 701
++G AP R M T K DV+++GV L EI+ L R
Sbjct: 186 YR----VQGR----APLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEILTLCR 230
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296 |
| >gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Score = 68.8 bits (168), Expect = 1e-12
Identities = 60/197 (30%), Positives = 92/197 (46%), Gaps = 17/197 (8%)
Query: 509 LGRGAFGTVYKGFVNMGSSNHVAVKKLNSVFQDSEKEFKAEVNGIGQTH-----HKNLVR 563
LG+G FG V V + A K+L + K+ K E + + + V
Sbjct: 8 LGKGGFGEVCACQVR-ATGKMYACKRLE---KKRIKKRKGESMALNEKQILEKVNSQFVV 63
Query: 564 LLGYCDEGQNRL-LVYEFMSNGTVASFLFGDSKPNWKLRTEI--AMGIAGGLFYLHEECC 620
L Y E ++ L LV M+ G + ++ P ++ + A I GL LH E
Sbjct: 64 NLAYAYETKDALCLVLTIMNGGDLKFHIYNMGNPGFEEERALFYAAEILCGLEDLHRE-- 121
Query: 621 TQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLDQSHTNTAIRGTKGYVAPEWFRNMPI 680
++ D+KP+NILLDD+ + RISD GLA + + + + GT GY+APE N
Sbjct: 122 -NTVYRDLKPENILLDDYGHIRISDLGLA--VKIPEGESIRGRVGTVGYMAPEVLNNQRY 178
Query: 681 TVKVDVYSYGVLLLEII 697
T+ D + G L+ E+I
Sbjct: 179 TLSPDYWGLGCLIYEMI 195
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285 |
| >gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Score = 68.9 bits (169), Expect = 2e-12
Identities = 37/94 (39%), Positives = 51/94 (54%), Gaps = 4/94 (4%)
Query: 605 AMGIAGGLFYLHEECCTQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLDQSHTNTAIR 664
A I GL +LHE II+ D+K N+LLD + +I+DFG+ K L T+T
Sbjct: 102 AAEIVLGLQFLHER---GIIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGGVTTSTFC- 157
Query: 665 GTKGYVAPEWFRNMPITVKVDVYSYGVLLLEIIC 698
GT Y+APE P VD ++ GVLL E++
Sbjct: 158 GTPDYIAPEILSYQPYGPAVDWWALGVLLYEMLA 191
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318 |
| >gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Score = 68.6 bits (168), Expect = 2e-12
Identities = 60/206 (29%), Positives = 95/206 (46%), Gaps = 36/206 (17%)
Query: 509 LGRGAFGTVYKGFVNMGSSNHVAVKKLNSVFQDSE--KEFKA----EVNGIGQTHHKNLV 562
+G G++G V K + + VA+KK F +SE K K E+ + Q H+NLV
Sbjct: 9 VGEGSYGMVMK-CKHKETGQIVAIKK----FLESEDDKMVKKIAMREIRMLKQLRHENLV 63
Query: 563 RLLGYCDEGQNRLLVYEFMSNGTVASFLFGDSKPN---WKLRTEIAMGIAGGLFYLHEEC 619
L+ + LV+EF+ + TV L + PN + I G+ + H
Sbjct: 64 NLIEVFRRKKRLYLVFEFVDH-TVLDDL--EKYPNGLDESRVRKYLFQILRGIEFCHSH- 119
Query: 620 CTQIIHCDIKPQNILLDDHYNARISDFGLAKLLTL-DQSHTNTAIRGTKGYVAPEWFRNM 678
IIH DIKP+NIL+ ++ DFG A+ L + +T+ YVA W+R
Sbjct: 120 --NIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEVYTD--------YVATRWYRAP 169
Query: 679 PITVK-------VDVYSYGVLLLEII 697
+ V VD+++ G L+ E++
Sbjct: 170 ELLVGDTKYGRAVDIWAVGCLVTEML 195
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286 |
| >gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Score = 68.9 bits (168), Expect = 2e-12
Identities = 76/266 (28%), Positives = 114/266 (42%), Gaps = 35/266 (13%)
Query: 508 ELGRGAFGTVYKGFVNMGSSNH-VAVKKLN-SVFQDSEK--EFKAEVNGIGQTHHKNLVR 563
E+G G+FG VY F +N VAVKK++ S Q +EK + EV + Q H N +
Sbjct: 28 EIGHGSFGAVY--FATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIE 85
Query: 564 LLGYCDEGQNRLLVYEFMSNGTVASFLFGDSKPNWKLR-TEIAMGIAGGLFYLHEECCTQ 622
G + LV E+ G+ + L KP ++ I G GL YLH
Sbjct: 86 YKGCYLKEHTAWLVMEYCL-GSASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHN--- 141
Query: 623 IIHCDIKPQNILLDDHYNARISDFGLAKLLTLDQSHTNTAIRGTKGYVAPEWFRNM---P 679
+IH DIK NILL + +++DFG A + S GT ++APE M
Sbjct: 142 MIHRDIKAGNILLTEPGQVKLADFGSASKSSPANSFV-----GTPYWMAPEVILAMDEGQ 196
Query: 680 ITVKVDVYSYGVLLLEIICLRRNIDNEISKVDKAILTDWAYDRYQERTLEALVENDLEAM 739
KVDV+S G I C+ E+++ + ++ L + +ND +
Sbjct: 197 YDGKVDVWSLG-----ITCI------ELAERKPPL-----FNMNAMSALYHIAQNDSPTL 240
Query: 740 NNVTMLHRFVMVAFWCIQEDPSHRPT 765
+ F +C+Q+ P RP
Sbjct: 241 QSNEWTDSFRGFVDYCLQKIPQERPA 266
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313 |
| >gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Score = 68.5 bits (167), Expect = 2e-12
Identities = 55/199 (27%), Positives = 101/199 (50%), Gaps = 19/199 (9%)
Query: 508 ELGRGAFGTVYKGFVNMGSSNHVAVKKLNSVFQDSEKEFKAEVNGIGQTHHKNLVRLLG- 566
ELG GAFG VYK N + A K + + ++ +++ E+ + +H +V+LLG
Sbjct: 19 ELGDGAFGKVYKA-KNKETGALAAAKVIETKSEEELEDYMVEIEILATCNHPYIVKLLGA 77
Query: 567 YCDEGQNRLLVYEFMSNGTVASFLF----GDSKPNWKLRTEIAMGIAGGLFYLHEECCTQ 622
+ +G+ +++ EF G V + + G ++P ++ I + L YLH +
Sbjct: 78 FYWDGKLWIMI-EFCPGGAVDAIMLELDRGLTEPQIQV---ICRQMLEALQYLHSM---K 130
Query: 623 IIHCDIKPQNILLDDHYNARISDFGLAKLLTLDQSHTNTAIRGTKGYVAP-----EWFRN 677
IIH D+K N+LL + +++DFG++ ++ I GT ++AP E ++
Sbjct: 131 IIHRDLKAGNVLLTLDGDIKLADFGVSAKNVKTLQRRDSFI-GTPYWMAPEVVMCETMKD 189
Query: 678 MPITVKVDVYSYGVLLLEI 696
P K D++S G+ L+E+
Sbjct: 190 TPYDYKADIWSLGITLIEM 208
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292 |
| >gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Score = 68.6 bits (168), Expect = 2e-12
Identities = 57/209 (27%), Positives = 97/209 (46%), Gaps = 37/209 (17%)
Query: 507 EELGRGAFGTVYKGFVNMGSSNHV-AVKKL-NSVFQDSEKEFKAEVNGIGQTHH-KNLVR 563
E+G G G VYK + + HV AVK++ + ++ K +++ + ++H +V+
Sbjct: 21 GEIGSGTCGQVYK--MRFKKTGHVMAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVK 78
Query: 564 LLGYCDEGQNRLLVYEFMS----------NGTVASFLFGDSKPNWKLRTEIAMGIAGGLF 613
GY + + E MS G + + G ++ + I L
Sbjct: 79 CYGYFITDSDVFICMELMSTCLDKLLKRIQGPIPEDILG----------KMTVAIVKALH 128
Query: 614 YLHEECCTQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLDQSHTNTAIRGTKGYVAPE 673
YL E+ +IH D+KP NILLD N ++ DFG++ L ++ T +A G Y+APE
Sbjct: 129 YLKEK--HGVIHRDVKPSNILLDASGNVKLCDFGISGRLVDSKAKTRSA--GCAAYMAPE 184
Query: 674 WFRNMPIT------VKVDVYSYGVLLLEI 696
R P ++ DV+S G+ L+E+
Sbjct: 185 --RIDPPDPNPKYDIRADVWSLGISLVEL 211
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296 |
| >gnl|CDD|173646 cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Score = 68.0 bits (166), Expect = 2e-12
Identities = 50/153 (32%), Positives = 72/153 (47%), Gaps = 12/153 (7%)
Query: 507 EELGRGAFGTVYKGFVNMG-SSNHVAVKKL--NSVFQDSEKEFKAEVNGIGQTHHKNLVR 563
+E+G G FG V G VN G + V VK+L ++ Q+ + +F E H NL++
Sbjct: 1 KEIGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQE-QMKFLEEAQPYRSLQHSNLLQ 59
Query: 564 LLGYCDEGQNRLLVYEFMSNGTVASFLFGDSK-----PNWKLRTEIAMGIAGGLFYLHEE 618
LG C E LLV EF G + +L K P+ +A IA GL +LH+
Sbjct: 60 CLGQCTEVTPYLLVMEFCPLGDLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKN 119
Query: 619 CCTQIIHCDIKPQNILLDDHYNARISDFGLAKL 651
IH D+ +N LL +I D+GL+
Sbjct: 120 ---NFIHSDLALRNCLLTADLTVKIGDYGLSHN 149
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells. Aatyk1 has been implicated in neural differentiation, and is a regulator of the Na-K-2Cl cotransporter, a membrane protein involved in cell proliferation and survival, epithelial transport, and blood pressure control. The function of Aatyk3 is still unknown. Length = 269 |
| >gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 68.9 bits (169), Expect = 2e-12
Identities = 57/226 (25%), Positives = 92/226 (40%), Gaps = 47/226 (20%)
Query: 509 LGRGAFGTVYKGFVNMGSSNHV-AVKKLNS---VFQDSEKEFKAEVNGIGQTHHKNLVRL 564
+GRGAFG V+ V + V A+K L + ++ +AE + + +V+L
Sbjct: 9 IGRGAFGEVW--LVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADSPWIVKL 66
Query: 565 LGYCDEGQNRL-LVYEFMSNGTVASFL--FGDSKPNWK--LRTEIAMGIAGGLFYLHEEC 619
Y + + L LV E+M G + + L E+ + + +H+
Sbjct: 67 Y-YSFQDEEHLYLVMEYMPGGDLMNLLIRKDVFPEETARFYIAELVLALD----SVHKLG 121
Query: 620 CTQIIHCDIKPQNILLDDHYNARISDFGLAK-------------LLTLDQSHTNTAIR-- 664
IH DIKP NIL+D + +++DFGL K N +R
Sbjct: 122 F---IHRDIKPDNILIDADGHIKLADFGLCKKMNKAKDREYYLNDSHNLLFRDNVLVRRR 178
Query: 665 -------------GTKGYVAPEWFRNMPITVKVDVYSYGVLLLEII 697
GT Y+APE R P ++ D +S GV+L E++
Sbjct: 179 DHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEML 224
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350 |
| >gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 67.5 bits (165), Expect = 4e-12
Identities = 50/192 (26%), Positives = 94/192 (48%), Gaps = 11/192 (5%)
Query: 509 LGRGAFGTVYKGFVNMGSSNHVAVKKLN---SVFQDSEKEFKAEVNGIGQTHHKNLVRLL 565
+G G FG V+ + + A+K + + E+ E + + H ++RL
Sbjct: 9 VGTGTFGRVHLVRDRISEH-YYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIRLF 67
Query: 566 GYCDEGQNRLLVYEFMSNGTVASFLFGDSKPNWKLRTEIAMGIAGGLFYLHEECCTQIIH 625
+ + ++ E++ G + S+L + + A I L YLH + +I++
Sbjct: 68 WTEHDQRFLYMLMEYVPGGELFSYLRNSGRFSNSTGLFYASEIVCALEYLHSK---EIVY 124
Query: 626 CDIKPQNILLDDHYNARISDFGLAKLLTLDQSHTNTAIRGTKGYVAPEWFRNMPITVKVD 685
D+KP+NILLD + +++DFG AK L D++ T + GT Y+APE ++ VD
Sbjct: 125 RDLKPENILLDKEGHIKLTDFGFAKKLR-DRTWT---LCGTPEYLAPEVIQSKGHNKAVD 180
Query: 686 VYSYGVLLLEII 697
++ G+L+ E++
Sbjct: 181 WWALGILIYEML 192
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291 |
| >gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Score = 67.9 bits (166), Expect = 4e-12
Identities = 58/195 (29%), Positives = 91/195 (46%), Gaps = 13/195 (6%)
Query: 509 LGRGAFGTVYKGFVNMGSSNHVAVK--KLNSVFQDSEKE---FKAEVNGIGQTHHKNLVR 563
LG+G+FG V G+ A+K K + + QD + E + V + +
Sbjct: 8 LGKGSFGKVMLA-ERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPP--FLT 64
Query: 564 LLGYCDEGQNRL-LVYEFMSNGTVASFLFGDSKPNWKLRTEIAMGIAGGLFYLHEECCTQ 622
L C + +RL V E+++ G + + K A IA GLF+LH +
Sbjct: 65 QLHSCFQTMDRLYFVMEYVNGGDLMYHIQQVGKFKEPHAVFYAAEIAIGLFFLHSK---G 121
Query: 623 IIHCDIKPQNILLDDHYNARISDFGLAKLLTLDQSHTNTAIRGTKGYVAPEWFRNMPITV 682
II+ D+K N++LD + +I+DFG+ K T T GT Y+APE P
Sbjct: 122 IIYRDLKLDNVMLDAEGHIKIADFGMCKENIFGGKTTRTFC-GTPDYIAPEIIAYQPYGK 180
Query: 683 KVDVYSYGVLLLEII 697
VD +++GVLL E++
Sbjct: 181 SVDWWAFGVLLYEML 195
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324 |
| >gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Score = 67.3 bits (164), Expect = 5e-12
Identities = 76/303 (25%), Positives = 123/303 (40%), Gaps = 62/303 (20%)
Query: 509 LGRGAFGTVYKGFVNMGSSNH-------VAVKKLNSVFQDSEKEFKAEVNG------IGQ 555
LG G FG V +G VAVK L S +EK+ ++ IG+
Sbjct: 26 LGEGCFGQVVMAEA-IGLDKEKPNRVTKVAVKMLKS--DATEKDLSDLISEMEMMKMIGK 82
Query: 556 THHKNLVRLLGYCDEGQNRLLVYEFMSNGTVASFLFGDSKP----------------NWK 599
HKN++ LLG C + ++ E+ S G + +L P ++K
Sbjct: 83 --HKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFK 140
Query: 600 LRTEIAMGIAGGLFYLHEECCTQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLDQSHT 659
A +A G+ YL + C IH D+ +N+L+ + +I+DFGLA+ D H
Sbjct: 141 DLVSCAYQVARGMEYLASKKC---IHRDLAARNVLVTEDNVMKIADFGLAR----DIHHI 193
Query: 660 NTAIRGTKG-----YVAPEWFRNMPITVKVDVYSYGVLLLEIICLRRNIDNEISKVDKAI 714
+ + T G ++APE + T + DV+S+GVLL EI L +
Sbjct: 194 DYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGS------------ 241
Query: 715 LTDWAYDRYQERTLEALVENDLEAMNNVTMLHRFVMVAFWCIQEDPSHRPTMRKVTQMLE 774
Y L L++ + M+ C PS RPT +++ + L+
Sbjct: 242 ----PYPGVPVEELFKLLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLD 297
Query: 775 GVV 777
++
Sbjct: 298 RIL 300
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307 |
| >gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 67.6 bits (166), Expect = 6e-12
Identities = 60/229 (26%), Positives = 98/229 (42%), Gaps = 68/229 (29%)
Query: 509 LGRGAFGTVYKGFVNMGSSNHVAVKKLNSVFQDSEKEFKA-----EVNGIGQTHHKNLVR 563
+G GA+G V V+ + VA+KK+++VF D A E+ + H+N++
Sbjct: 8 IGSGAYGVVCSA-VDKRTGRKVAIKKISNVFDD---LIDAKRILREIKLLRHLRHENIIG 63
Query: 564 LLGYCD-------EGQNRL-LVYEFM--------------SNGTVASFLFGDSKPNWKLR 601
LL D E N + +V E M ++ + FL+ LR
Sbjct: 64 LL---DILRPPSPEDFNDVYIVTELMETDLHKVIKSPQPLTDDHIQYFLYQ------ILR 114
Query: 602 TEIAMGIAGGLFYLHEECCTQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLDQSHTN- 660
GL YLH +IH D+KP NIL++ + + +I DFGLA+ + D+
Sbjct: 115 ---------GLKYLHS---ANVIHRDLKPSNILVNSNCDLKICDFGLARGVDPDEDEKGF 162
Query: 661 -TAIRGTKGYVAPEWFR-------NMPITVKVDVYSYGVLLLEIICLRR 701
T YV W+R + T +D++S G + E++ R+
Sbjct: 163 LT------EYVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELL-TRK 204
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330 |
| >gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Score = 67.0 bits (163), Expect = 6e-12
Identities = 59/205 (28%), Positives = 98/205 (47%), Gaps = 21/205 (10%)
Query: 507 EELGRGAFGTVYKGFVNMGSSNHVAVKKLNSVFQDSEKEFKAEVNGI-GQTHHKNLVRLL 565
E +G+G +G V+K +N + + AVK L+ + D ++E +AE N + + H N+V+
Sbjct: 24 ETIGKGTYGKVFK-VLNKKNGSKAAVKILDPI-HDIDEEIEAEYNILKALSDHPNVVKFY 81
Query: 566 GY-----CDEGQNRLLVYEFMSNGTVASFLFGDSKPNWKLRTEIAMGIAG----GLFYLH 616
G G LV E + G+V + G K ++ I I GL +LH
Sbjct: 82 GMYYKKDVKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLH 141
Query: 617 EECCTQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLDQSHTNTAIRGTKGYVAPEWFR 676
+ IH D+K NILL ++ DFG++ LT + NT++ GT ++APE
Sbjct: 142 V---NKTIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTRLRRNTSV-GTPFWMAPEVIA 197
Query: 677 -----NMPITVKVDVYSYGVLLLEI 696
+ + DV+S G+ +E+
Sbjct: 198 CEQQLDSTYDARCDVWSLGITAIEL 222
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286 |
| >gnl|CDD|183880 PRK13184, pknD, serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Score = 69.0 bits (169), Expect = 6e-12
Identities = 60/224 (26%), Positives = 92/224 (41%), Gaps = 37/224 (16%)
Query: 509 LGRGAFGTVYKGFVNMGSSNHVAVKKLNSVFQDSE---KEFKAEVNGIGQTHHKNLVRLL 565
+G+G G VY + + S VA+KK+ ++ K F E H +V +
Sbjct: 10 IGKGGMGEVYLAY-DPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVY 68
Query: 566 GYCDEGQNRLLVYEFMSNGTVASFLFGDSKPNWK---LRTEIAMGIAGGLFY--LHEECC 620
C +G ++ T+ S L K W+ L E+A + G F H+ C
Sbjct: 69 SICSDGDPVYYTMPYIEGYTLKSLL----KSVWQKESLSKELAEKTSVGAFLSIFHKICA 124
Query: 621 T-------QIIHCDIKPQNILLDDHYNARISDFGLAK--------LLTLDQSHTNTA--- 662
T ++H D+KP NILL I D+G A LL +D N
Sbjct: 125 TIEYVHSKGVLHRDLKPDNILLGLFGEVVILDWGAAIFKKLEEEDLLDIDVDERNICYSS 184
Query: 663 ------IRGTKGYVAPEWFRNMPITVKVDVYSYGVLLLEIICLR 700
I GT Y+APE +P + D+Y+ GV+L +++ L
Sbjct: 185 MTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTLS 228
|
Length = 932 |
| >gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Score = 67.2 bits (164), Expect = 6e-12
Identities = 60/196 (30%), Positives = 96/196 (48%), Gaps = 13/196 (6%)
Query: 509 LGRGAFGTVYKGFVNMGSSNHV-AVK--KLNSVFQDSEKEFK-AEVNGIGQTHHKNLVRL 564
LG+G+FG V + S + AVK K + + QD + E E + + +
Sbjct: 3 LGKGSFGKVM--LARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQ 60
Query: 565 LGYCDEGQNRLL-VYEFMSNGTVASFLFGDSKPNWKLRTEI-AMGIAGGLFYLHEECCTQ 622
L C + +RL V EF++ G + F S+ + R A I L +LH++
Sbjct: 61 LYCCFQTPDRLFFVMEFVNGGDLM-FHIQKSRRFDEARARFYAAEITSALMFLHDK---G 116
Query: 623 IIHCDIKPQNILLDDHYNARISDFGLAKLLTLDQSHTNTAIRGTKGYVAPEWFRNMPITV 682
II+ D+K N+LLD + +++DFG+ K + T+T GT Y+APE + M
Sbjct: 117 IIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFNGKTTSTFC-GTPDYIAPEILQEMLYGP 175
Query: 683 KVDVYSYGVLLLEIIC 698
VD ++ GVLL E++C
Sbjct: 176 SVDWWAMGVLLYEMLC 191
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320 |
| >gnl|CDD|173647 cd05091, PTKc_Ror2, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Score = 66.6 bits (162), Expect = 7e-12
Identities = 59/219 (26%), Positives = 101/219 (46%), Gaps = 35/219 (15%)
Query: 505 FKEELGRGAFGTVYKGFVNMGS-----SNHVAVKKLNSVFQDS-EKEFKAEVNGIGQTHH 558
F EELG FG VYKG + G+ + VA+K L + +EFK E + H
Sbjct: 9 FMEELGEDRFGKVYKGHL-FGTAPGEQTQAVAIKTLKDKAEGPLREEFKHEAMMRSRLQH 67
Query: 559 KNLVRLLGYCDEGQNRLLVYEFMSNGTVASFLF--------GDSKPNWKLRT-------- 602
N+V LLG + Q +++ + S+ + FL G + + +++
Sbjct: 68 PNIVCLLGVVTKEQPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFV 127
Query: 603 EIAMGIAGGLFYLHEECCTQIIHCDIKPQNILLDDHYNARISDFGLAK-LLTLD----QS 657
I IA G+ +L ++H D+ +N+L+ D N +ISD GL + + D
Sbjct: 128 HIVTQIAAGMEFLSSH---HVVHKDLATRNVLVFDKLNVKISDLGLFREVYAADYYKLMG 184
Query: 658 HTNTAIRGTKGYVAPEWFRNMPITVKVDVYSYGVLLLEI 696
++ IR +++PE ++ D++SYGV+L E+
Sbjct: 185 NSLLPIR----WMSPEAIMYGKFSIDSDIWSYGVVLWEV 219
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror2 plays important roles in skeletal and heart formation. Ror2-deficient mice show widespread bone abnormalities, ventricular defects in the heart, and respiratory dysfunction. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Ror2 is also implicated in neural development. Length = 283 |
| >gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Score = 66.3 bits (162), Expect = 8e-12
Identities = 63/217 (29%), Positives = 114/217 (52%), Gaps = 30/217 (13%)
Query: 507 EELGRGAFGTVYKGFVNMGSSNHVAVKKLNSVFQDSEKE-----FKAEVNGIGQTHHKNL 561
E++G G +G VYKG N + VA+KK+ +SE+E E++ + + H N+
Sbjct: 6 EKIGEGTYGVVYKG-RNKKTGQIVAMKKIR---LESEEEGVPSTAIREISLLKELQHPNI 61
Query: 562 VRLLGYCDEGQNRL-LVYEFMSNGTVASFLFGDSKPNWK-LRTEIAMG----IAGGLFYL 615
V L + ++RL L++EF+S + +L DS P + + E+ I G+ +
Sbjct: 62 VCLQDVLMQ-ESRLYLIFEFLSM-DLKKYL--DSLPKGQYMDAELVKSYLYQILQGILFC 117
Query: 616 HEECCTQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLD-QSHTNTAIRGTKGYVAPEW 674
H +++H D+KPQN+L+D+ +++DFGLA+ + + +T+ + T Y APE
Sbjct: 118 HSR---RVLHRDLKPQNLLIDNKGVIKLADFGLARAFGIPVRVYTHEVV--TLWYRAPEV 172
Query: 675 FRNMP-ITVKVDVYSYGVLLLEIICLRRNI---DNEI 707
P + VD++S G + E+ ++ + D+EI
Sbjct: 173 LLGSPRYSTPVDIWSIGTIFAEMA-TKKPLFHGDSEI 208
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285 |
| >gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Score = 66.7 bits (163), Expect = 9e-12
Identities = 37/93 (39%), Positives = 51/93 (54%), Gaps = 4/93 (4%)
Query: 605 AMGIAGGLFYLHEECCTQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLDQSHTNTAIR 664
A IA L YLH II+ D+KP+NILLD + ++DFGL K ++ S T +
Sbjct: 102 AAEIASALGYLHS---LNIIYRDLKPENILLDSQGHVVLTDFGLCK-EGIEHSKTTSTFC 157
Query: 665 GTKGYVAPEWFRNMPITVKVDVYSYGVLLLEII 697
GT Y+APE R P VD + G +L E++
Sbjct: 158 GTPEYLAPEVLRKQPYDRTVDWWCLGAVLYEML 190
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323 |
| >gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 66.1 bits (161), Expect = 9e-12
Identities = 55/199 (27%), Positives = 95/199 (47%), Gaps = 12/199 (6%)
Query: 508 ELGRGAFGTVYKGFVNMGSSN---HVAVKKLNSVFQDSE-KEFKAEVNGIGQTHHKNLVR 563
+LG G FG V + N VAVK L + + K E+ + +H+N+V+
Sbjct: 11 DLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVK 70
Query: 564 LLGYCDEGQNR--LLVYEFMSNGTVASFLFGD-SKPNWKLRTEIAMGIAGGLFYLHEECC 620
G C E L+ EF+ +G++ +L + +K N K + + A+ I G+ YL
Sbjct: 71 YKGICTEDGGNGIKLIMEFLPSGSLKEYLPRNKNKINLKQQLKYAVQICKGMDYLGSR-- 128
Query: 621 TQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLDQSHTNTA--IRGTKGYVAPEWFRNM 678
Q +H D+ +N+L++ + +I DFGL K + D+ + + + APE
Sbjct: 129 -QYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVKDDLDSPVFWYAPECLIQS 187
Query: 679 PITVKVDVYSYGVLLLEII 697
+ DV+S+GV L E++
Sbjct: 188 KFYIASDVWSFGVTLYELL 206
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284 |
| >gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Score = 66.1 bits (161), Expect = 1e-11
Identities = 58/203 (28%), Positives = 93/203 (45%), Gaps = 23/203 (11%)
Query: 508 ELGRGAFGTVYKGFVNMGSSNHVAVKKLNSVFQDSEKEFK-------AEVNGIGQTHHKN 560
E+G GA+GTVYK + S + VA+K + Q +E A + + H N
Sbjct: 7 EIGVGAYGTVYKA-RDPHSGHFVALKSVR--VQTNEDGLPLSTVREVALLKRLEAFDHPN 63
Query: 561 LVRLLGYC-----DEGQNRLLVYEFMSNGTVASFLFGDSKPNWKLRT--EIAMGIAGGLF 613
+VRL+ C D LV+E + + ++L P T ++ GL
Sbjct: 64 IVRLMDVCATSRTDRETKVTLVFEHVDQ-DLRTYLDKVPPPGLPAETIKDLMRQFLRGLD 122
Query: 614 YLHEECCTQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLDQSHTNTAIRGTKGYVAPE 673
+LH C I+H D+KP+NIL+ +++DFGLA++ + + T + T Y APE
Sbjct: 123 FLHANC---IVHRDLKPENILVTSGGQVKLADFGLARIYSCQMALTPVVV--TLWYRAPE 177
Query: 674 WFRNMPITVKVDVYSYGVLLLEI 696
VD++S G + E+
Sbjct: 178 VLLQSTYATPVDMWSVGCIFAEM 200
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288 |
| >gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Score = 65.5 bits (160), Expect = 1e-11
Identities = 53/198 (26%), Positives = 92/198 (46%), Gaps = 12/198 (6%)
Query: 506 KEELGRGAFGTVYKG-FVNM-GSSNHVAVK--KLNSVFQDSEKEFKAEVNGIGQTHHKNL 561
+G G FG VY+G +++ VAVK K + EK F E + Q H ++
Sbjct: 11 GRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREK-FLQEAYIMRQFDHPHI 69
Query: 562 VRLLGYCDEGQNRLLVYEFMSNGTVASFLFGDSKPNWKLRTEI--AMGIAGGLFYLHEEC 619
V+L+G E +V E G + S+L +K + L + I + ++ L YL
Sbjct: 70 VKLIGVITE-NPVWIVMELAPLGELRSYL-QVNKYSLDLASLILYSYQLSTALAYLES-- 125
Query: 620 CTQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLDQSHTNTAIRGTKGYVAPEWFRNMP 679
+ +H DI +N+L+ ++ DFGL++ L + + + + ++APE
Sbjct: 126 -KRFVHRDIAARNVLVSSPDCVKLGDFGLSRYLEDESYYKASKGKLPIKWMAPESINFRR 184
Query: 680 ITVKVDVYSYGVLLLEII 697
T DV+ +GV + EI+
Sbjct: 185 FTSASDVWMFGVCMWEIL 202
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270 |
| >gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Score = 66.2 bits (161), Expect = 1e-11
Identities = 49/190 (25%), Positives = 91/190 (47%), Gaps = 6/190 (3%)
Query: 508 ELGRGAFGTVYKGFVNMGSSNHVAVKKLNSVFQDSEKEFKAEVNGIGQTHHKNLVRLLGY 567
++G G+ G V V S VAVKK++ Q + EV + H+N+V +
Sbjct: 27 KIGEGSTGIVCIATVK-SSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNS 85
Query: 568 CDEGQNRLLVYEFMSNGTVASFLFGDSKPNWKLRTEIAMGIAGGLFYLHEECCTQIIHCD 627
G +V EF+ G + + ++ N + + + + L LH + +IH D
Sbjct: 86 YLVGDELWVVMEFLEGGALTD-IVTHTRMNEEQIAAVCLAVLKALSVLHAQ---GVIHRD 141
Query: 628 IKPQNILLDDHYNARISDFGLAKLLTLDQSHTNTAIRGTKGYVAPEWFRNMPITVKVDVY 687
IK +ILL ++SDFG ++ + + + GT ++APE +P +VD++
Sbjct: 142 IKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKSLV-GTPYWMAPELISRLPYGPEVDIW 200
Query: 688 SYGVLLLEII 697
S G++++E++
Sbjct: 201 SLGIMVIEMV 210
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292 |
| >gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Score = 66.0 bits (161), Expect = 1e-11
Identities = 61/219 (27%), Positives = 111/219 (50%), Gaps = 29/219 (13%)
Query: 507 EELGRGAFGTVYKGFVNMGSSNHVAVKKLNSVFQDSEKEFKA-----EVNGIGQTHHKNL 561
E++G G +G VYK N + VA+KK+ D+E E E++ + + +H N+
Sbjct: 6 EKIGEGTYGVVYKA-RNKLTGEVVALKKIR---LDTETEGVPSTAIREISLLKELNHPNI 61
Query: 562 VRLLGYCDEGQNRL-LVYEFMSNGTVASFLFGDSKPNWKLRTEIAMG----IAGGLFYLH 616
V+LL +N+L LV+EF+ F D+ P + + + GL + H
Sbjct: 62 VKLLDVI-HTENKLYLVFEFLHQDLKK---FMDASPLSGIPLPLIKSYLFQLLQGLAFCH 117
Query: 617 EECCTQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLD-QSHTNTAIRGTKGYVAPEWF 675
+++H D+KPQN+L++ +++DFGLA+ + +++T+ + T Y APE
Sbjct: 118 SH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVV--TLWYRAPEIL 172
Query: 676 RNMPI-TVKVDVYSYGVLLLEIICLRRNI---DNEISKV 710
+ VD++S G + E++ RR + D+EI ++
Sbjct: 173 LGCKYYSTAVDIWSLGCIFAEMVT-RRALFPGDSEIDQL 210
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284 |
| >gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 65.5 bits (159), Expect = 1e-11
Identities = 60/215 (27%), Positives = 100/215 (46%), Gaps = 34/215 (15%)
Query: 509 LGRGAFGTVYKGFVNM-GSSNHVAVKKLNS-VFQDSEKEFKAEVNGIGQT-HHKNLVRLL 565
+G G FG V K + G A+K++ +D ++F E+ + + HH N++ LL
Sbjct: 3 IGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLL 62
Query: 566 GYCDEGQNRLLVYEFMSNGTVASFLFG----DSKPNW------------KLRTEIAMGIA 609
G C+ L E+ +G + FL ++ P + + A +A
Sbjct: 63 GACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVA 122
Query: 610 GGLFYLHEECCTQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLDQSHTNTAIRGTKGY 669
G+ YL ++ Q IH D+ +NIL+ ++Y A+I+DFGL++ ++ T G
Sbjct: 123 RGMDYLSQK---QFIHRDLAARNILVGENYVAKIADFGLSR-------GQEVYVKKTMGR 172
Query: 670 VAPEWFR----NMPI-TVKVDVYSYGVLLLEIICL 699
+ W N + T DV+SYGVLL EI+ L
Sbjct: 173 LPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSL 207
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270 |
| >gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Score = 65.5 bits (160), Expect = 2e-11
Identities = 47/190 (24%), Positives = 90/190 (47%), Gaps = 6/190 (3%)
Query: 508 ELGRGAFGTVYKGFVNMGSSNHVAVKKLNSVFQDSEKEFKAEVNGIGQTHHKNLVRLLGY 567
++G G+ G V + VAVKK++ Q + EV + H N+V +
Sbjct: 26 KIGEGSTGIVCIATD-KSTGRQVAVKKMDLRKQQRRELLFNEVVIMRDYQHPNIVEMYSS 84
Query: 568 CDEGQNRLLVYEFMSNGTVASFLFGDSKPNWKLRTEIAMGIAGGLFYLHEECCTQIIHCD 627
G +V EF+ G + + ++ N + + + + L +LH + +IH D
Sbjct: 85 YLVGDELWVVMEFLEGGALTD-IVTHTRMNEEQIATVCLAVLKALSFLHAQ---GVIHRD 140
Query: 628 IKPQNILLDDHYNARISDFGLAKLLTLDQSHTNTAIRGTKGYVAPEWFRNMPITVKVDVY 687
IK +ILL ++SDFG ++ + + + GT ++APE +P +VD++
Sbjct: 141 IKSDSILLTSDGRVKLSDFGFCAQVSKEVPRRKSLV-GTPYWMAPEVISRLPYGTEVDIW 199
Query: 688 SYGVLLLEII 697
S G++++E++
Sbjct: 200 SLGIMVIEMV 209
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285 |
| >gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 65.8 bits (160), Expect = 2e-11
Identities = 58/237 (24%), Positives = 101/237 (42%), Gaps = 36/237 (15%)
Query: 558 HKNLVRLLGYCDEGQNRLLVYEFMSNGTVASFLFGDSKPNWKLRTEIA------------ 605
HKN++ LLG C + ++ E+ S G + +L P + +IA
Sbjct: 80 HKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDL 139
Query: 606 ----MGIAGGLFYLHEECCTQIIHCDIKPQNILLDDHYNARISDFGLAK-LLTLDQSHTN 660
+A G+ YL + C IH D+ +N+L+ ++ +I+DFGLA+ + +D
Sbjct: 140 VSCTYQVARGMEYLASQKC---IHRDLAARNVLVTENNVMKIADFGLARDVNNIDYYKKT 196
Query: 661 TAIRGTKGYVAPEWFRNMPITVKVDVYSYGVLLLEIICLRRNIDNEISKVDKAILTDWAY 720
T R ++APE + T + DV+S+GVL+ EI L + Y
Sbjct: 197 TNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGS----------------PY 240
Query: 721 DRYQERTLEALVENDLEAMNNVTMLHRFVMVAFWCIQEDPSHRPTMRKVTQMLEGVV 777
L L++ + M+ C PSHRPT +++ + L+ ++
Sbjct: 241 PGIPVEELFKLLKEGHRMDKPANCTNELYMMMRDCWHAIPSHRPTFKQLVEDLDRIL 297
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304 |
| >gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Score = 65.8 bits (161), Expect = 2e-11
Identities = 55/221 (24%), Positives = 96/221 (43%), Gaps = 44/221 (19%)
Query: 507 EELGRGAFGTVYKGFVNMGSSNHVAVKKLNSVFQ--DSEKEFKAEVNGIGQTHHKNLVRL 564
E +G GA+G V ++ S VA+KK+ F K E+ + H N++ +
Sbjct: 11 ENIGSGAYGVVCSA-IDTRSGKKVAIKKIPHAFDVPTLAKRTLRELKILRHFKHDNIIAI 69
Query: 565 LGYC----DEGQNRLLVYEFM---------SNGT-----VASFLFGDSKPNWKLRTEIAM 606
+ ++ +V + M S+ + FL+ LR
Sbjct: 70 RDILRPPGADFKDVYVVMDLMESDLHHIIHSDQPLTEEHIRYFLYQ------LLR----- 118
Query: 607 GIAGGLFYLHEECCTQIIHCDIKPQNILLDDHYNARISDFGLAKLLT---LDQSHTNTAI 663
GL Y+H +IH D+KP N+L+++ RI DFG+A+ L+ + + T
Sbjct: 119 ----GLKYIHSAN---VIHRDLKPSNLLVNEDCELRIGDFGMARGLSSSPTEHKYFMTEY 171
Query: 664 RGTKGYVAPEWFRNMP-ITVKVDVYSYGVLLLEIICLRRNI 703
T+ Y APE ++P T +D++S G + E++ RR +
Sbjct: 172 VATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEML-GRRQL 211
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334 |
| >gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Score = 65.1 bits (159), Expect = 2e-11
Identities = 58/209 (27%), Positives = 95/209 (45%), Gaps = 36/209 (17%)
Query: 507 EELGRGAFGTVYKGFVNMGSSNHVAVKKLNSVFQDSE------KEFKAEVNGIGQTHHKN 560
++G G++G V+K N + VA+KK F +SE K E+ + Q H N
Sbjct: 7 SKIGEGSYGVVFK-CRNRETGQIVAIKK----FVESEDDPVIKKIALREIRMLKQLKHPN 61
Query: 561 LVRLLGYCDEGQNRLLVYEFMSNGTVASFLFGDSKPNW---KLRTEIAMGIAGGLFYLHE 617
LV L+ + LV+E+ + TV + L + P L +I + + H+
Sbjct: 62 LVNLIEVFRRKRKLHLVFEYCDH-TVLNEL--EKNPRGVPEHLIKKIIWQTLQAVNFCHK 118
Query: 618 ECCTQIIHCDIKPQNILLDDHYNARISDFGLAKLLT-LDQSHTNTAIRGTKGYVAPEWFR 676
C IH D+KP+NIL+ ++ DFG A++LT +T+ YVA W+R
Sbjct: 119 HNC---IHRDVKPENILITKQGQIKLCDFGFARILTGPGDDYTD--------YVATRWYR 167
Query: 677 NMPITV-------KVDVYSYGVLLLEIIC 698
+ V VDV++ G + E++
Sbjct: 168 APELLVGDTQYGPPVDVWAIGCVFAELLT 196
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286 |
| >gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Score = 64.5 bits (157), Expect = 2e-11
Identities = 58/221 (26%), Positives = 101/221 (45%), Gaps = 30/221 (13%)
Query: 507 EELGRGAFGTVYKGFV--NMGSSNHVAVKKLN-SVFQDSEK-EFKAEVNGIGQTHHKNLV 562
+++G G+FG K + + +K++N S E+ E + EV + H N+V
Sbjct: 6 KKIGEGSFG---KAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIV 62
Query: 563 RLLGYCDEGQNRLLVYEFMSNGTV-------ASFLFG-DSKPNWKLRTEIAMGIAGGLFY 614
+ +E N +V ++ G + LF D +W ++ I L +
Sbjct: 63 QYQESFEENGNLYIVMDYCEGGDLYKKINAQRGVLFPEDQILDWFVQ------ICLALKH 116
Query: 615 LHEECCTQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLDQSHTNTAIRGTKGYVAPEW 674
+H+ +I+H DIK QNI L ++ DFG+A++L T I GT Y++PE
Sbjct: 117 VHDR---KILHRDIKSQNIFLTKDGTIKLGDFGIARVLNSTVELARTCI-GTPYYLSPEI 172
Query: 675 FRNMPITVKVDVYSYGVLLLEIICLRR-----NIDNEISKV 710
N P K D+++ G +L E+ L+ N+ N + K+
Sbjct: 173 CENRPYNNKSDIWALGCVLYEMCTLKHAFEAGNMKNLVLKI 213
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256 |
| >gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Score = 65.4 bits (159), Expect = 2e-11
Identities = 60/197 (30%), Positives = 93/197 (47%), Gaps = 9/197 (4%)
Query: 505 FKEELGRGAFGTVYKGFVNMGSSNHVAVK--KLNSVFQDSEKEFK-AEVNGIGQTHHKNL 561
F LG+G+FG V G+ A+K K + V QD + E E + +
Sbjct: 4 FLMVLGKGSFGKVMLA-ERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPF 62
Query: 562 VRLLGYCDEGQNRL-LVYEFMSNGTVASFLFGDSKPNWKLRTEIAMGIAGGLFYLHEECC 620
+ L C + +RL V E+++ G + + + A IA GLF+LH +
Sbjct: 63 LTQLHSCFQTMDRLYFVMEYVNGGDLMYQIQQVGRFKEPHAVFYAAEIAIGLFFLHSK-- 120
Query: 621 TQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLDQSHTNTAIRGTKGYVAPEWFRNMPI 680
II+ D+K N++LD + +I+DFG+ K D T T GT Y+APE P
Sbjct: 121 -GIIYRDLKLDNVMLDSEGHIKIADFGMCKENMWDGVTTKTFC-GTPDYIAPEIIAYQPY 178
Query: 681 TVKVDVYSYGVLLLEII 697
VD +++GVLL E++
Sbjct: 179 GKSVDWWAFGVLLYEML 195
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323 |
| >gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Score = 65.4 bits (159), Expect = 2e-11
Identities = 59/194 (30%), Positives = 92/194 (47%), Gaps = 11/194 (5%)
Query: 509 LGRGAFGTVYKGFVNMGSSNHVAVKKL--NSVFQDSEKE---FKAEVNGIGQTHHKNLVR 563
LG+G+FG V+ + G++ A+K L + V D + E + V + H L
Sbjct: 3 LGKGSFGKVFLAELK-GTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAW-EHPFLTH 60
Query: 564 LLGYCDEGQNRLLVYEFMSNGTVASFLFGDSKPNWKLRTEIAMGIAGGLFYLHEECCTQI 623
L +N V E+++ G + + K + T A I GL +LH + I
Sbjct: 61 LYCTFQTKENLFFVMEYLNGGDLMFHIQSCHKFDLPRATFYAAEIICGLQFLHSK---GI 117
Query: 624 IHCDIKPQNILLDDHYNARISDFGLAKLLTLDQSHTNTAIRGTKGYVAPEWFRNMPITVK 683
++ D+K NILLD + +I+DFG+ K L + T T GT Y+APE
Sbjct: 118 VYRDLKLDNILLDTDGHIKIADFGMCKENMLGDAKTCTFC-GTPDYIAPEILLGQKYNTS 176
Query: 684 VDVYSYGVLLLEII 697
VD +S+GVLL E++
Sbjct: 177 VDWWSFGVLLYEML 190
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316 |
| >gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 64.6 bits (158), Expect = 3e-11
Identities = 60/215 (27%), Positives = 107/215 (49%), Gaps = 27/215 (12%)
Query: 507 EELGRGAFGTVYKGFVNMGSSNHVAVKKLNSVFQDSEKEFKA-----EVNGIGQTHHKNL 561
E++G G +G VYK + + VA+KK+ ++E E E++ + + +H N+
Sbjct: 5 EKIGEGTYGVVYKA-RDKLTGEIVALKKIR---LETEDEGVPSTAIREISLLKELNHPNI 60
Query: 562 VRLLGYCDEGQNRLLVYEFMSNGTVASFLFGDSKPNWKLRTEIAMG----IAGGLFYLHE 617
VRLL LV+EF+ + + ++ DS P L + + G+ Y H
Sbjct: 61 VRLLDVVHSENKLYLVFEFL-DLDLKKYM--DSSPLTGLDPPLIKSYLYQLLQGIAYCHS 117
Query: 618 ECCTQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLD-QSHTNTAIRGTKGYVAPEWFR 676
+++H D+KPQN+L+D +++DFGLA+ + +++T+ + T Y APE
Sbjct: 118 H---RVLHRDLKPQNLLIDREGALKLADFGLARAFGVPVRTYTHEVV--TLWYRAPEILL 172
Query: 677 NMP-ITVKVDVYSYGVLLLEIICLRRNI---DNEI 707
+ VD++S G + E + RR + D+EI
Sbjct: 173 GSRQYSTPVDIWSIGCIFAE-MVNRRPLFPGDSEI 206
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283 |
| >gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Score = 64.2 bits (156), Expect = 3e-11
Identities = 63/207 (30%), Positives = 98/207 (47%), Gaps = 22/207 (10%)
Query: 505 FKEELGRGAFGTVYKGFVNMGS-SNHVAVKKLNSVFQDSEKEFKA---EVNGIGQTHHKN 560
F +G+G++G V V + +KKLN + S +E KA E + Q H N
Sbjct: 4 FVRVVGKGSYGEV--SLVRHRTDGKQYVIKKLN-LRNASRRERKAAEQEAQLLSQLKHPN 60
Query: 561 LVRLLGYCD--EGQNRLL--VYEFMSNGTVASFLFGDSKPNWKLRTEIA---MGIAGGLF 613
+V Y + EG++ LL V F G + L + K ++ + IA L
Sbjct: 61 IV---AYRESWEGEDGLLYIVMGFCEGGDLYHKL-KEQKGKLLPENQVVEWFVQIAMALQ 116
Query: 614 YLHEECCTQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLDQSHTNTAIRGTKGYVAPE 673
YLHE+ I+H D+K QN+ L ++ D G+A++L +T I GT Y++PE
Sbjct: 117 YLHEK---HILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQCDMASTLI-GTPYYMSPE 172
Query: 674 WFRNMPITVKVDVYSYGVLLLEIICLR 700
F N P K DV++ G + E+ L+
Sbjct: 173 LFSNKPYNYKSDVWALGCCVYEMATLK 199
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257 |
| >gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Score = 64.3 bits (156), Expect = 3e-11
Identities = 58/199 (29%), Positives = 97/199 (48%), Gaps = 15/199 (7%)
Query: 509 LGRGAFGTVYKGFVNMGSSNHVAVKKL--NSVFQDSEKEFKA---EVNGIGQTHHKNLVR 563
LG+GAFG VY + ++ + +A K++ + ++ KE A E+ + H+ +V+
Sbjct: 10 LGQGAFGRVYLCY-DVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQ 68
Query: 564 LLGYC--DEGQNRLLVY-EFMSNGTVASFLFGDSKPNWKLRTEIAMGIAGGLFYLHEECC 620
G C D + L ++ E+M G+V L + + I G+ YLH
Sbjct: 69 YYG-CLRDRAEKTLTIFMEYMPGGSVKDQLKAYGALTESVTRKYTRQILEGMSYLHS--- 124
Query: 621 TQIIHCDIKPQNILLDDHYNARISDFGLAK-LLTLDQSHTNT-AIRGTKGYVAPEWFRNM 678
I+H DIK NIL D N ++ DFG +K L T+ S T ++ GT +++PE
Sbjct: 125 NMIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICMSGTGIRSVTGTPYWMSPEVISGE 184
Query: 679 PITVKVDVYSYGVLLLEII 697
K DV+S G ++E++
Sbjct: 185 GYGRKADVWSLGCTVVEML 203
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266 |
| >gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 66.0 bits (161), Expect = 3e-11
Identities = 37/96 (38%), Positives = 51/96 (53%), Gaps = 1/96 (1%)
Query: 612 LFYLHEECCTQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLDQS-HTNTAIRGTKGYV 670
L +H +IH DIK NILL + ++ DFG +K+ S GT YV
Sbjct: 153 LLAVHHVHSKHMIHRDIKSANILLCSNGLVKLGDFGFSKMYAATVSDDVGRTFCGTPYYV 212
Query: 671 APEWFRNMPITVKVDVYSYGVLLLEIICLRRNIDNE 706
APE +R P + K D++S GVLL E++ L+R D E
Sbjct: 213 APEIWRRKPYSKKADMFSLGVLLYELLTLKRPFDGE 248
|
Length = 496 |
| >gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Score = 63.8 bits (155), Expect = 4e-11
Identities = 34/90 (37%), Positives = 55/90 (61%), Gaps = 4/90 (4%)
Query: 611 GLFYLHEECCTQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLDQSHTNTAIRGTKGYV 670
G+ ++HE+ +++H DIK +NI L + ++ DFG A+LLT ++ T + GT YV
Sbjct: 112 GVQHIHEK---RVLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPGAYACTYV-GTPYYV 167
Query: 671 APEWFRNMPITVKVDVYSYGVLLLEIICLR 700
PE + NMP K D++S G +L E+ L+
Sbjct: 168 PPEIWENMPYNNKSDIWSLGCILYELCTLK 197
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255 |
| >gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Score = 64.3 bits (156), Expect = 4e-11
Identities = 58/219 (26%), Positives = 99/219 (45%), Gaps = 23/219 (10%)
Query: 508 ELGRGAFGTVYKGFVNMGSSNHVAVKKLNSVFQDSEKEFK-------AEVNGIGQTHHKN 560
E+G GA+G V+K VA+K++ Q E+ A + + H N
Sbjct: 8 EIGEGAYGKVFKARDLKNGGRFVALKRVR--VQTGEEGMPLSTIREVAVLRHLETFEHPN 65
Query: 561 LVRLLGYC-----DEGQNRLLVYEFMSNGTVASFLFGDSKPNWKLRT--EIAMGIAGGLF 613
+VRL C D LV+E + + ++L +P T ++ + GL
Sbjct: 66 VVRLFDVCTVSRTDRETKLTLVFEHVDQ-DLTTYLDKVPEPGVPTETIKDMMFQLLRGLD 124
Query: 614 YLHEECCTQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLDQSHTNTAIRGTKGYVAPE 673
+LH +++H D+KPQNIL+ +++DFGLA++ + + T+ + T Y APE
Sbjct: 125 FLHSH---RVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMALTSVVV--TLWYRAPE 179
Query: 674 WFRNMPITVKVDVYSYGVLLLEIICLRRNIDNEISKVDK 712
VD++S G + E+ R+ + S VD+
Sbjct: 180 VLLQSSYATPVDLWSVGCIFAEMF-RRKPLFRGSSDVDQ 217
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290 |
| >gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Score = 64.4 bits (157), Expect = 5e-11
Identities = 67/213 (31%), Positives = 103/213 (48%), Gaps = 39/213 (18%)
Query: 508 ELGRGAFGTVYKGFVNMGSSNHVAVKKLNSVFQDSEKE-FKA----EVNGIGQTHHKNLV 562
++G G +G VYK + + VA+KK V D+EKE F E+ + Q +H+N+V
Sbjct: 14 QIGEGTYGQVYKA-RDKDTGELVALKK---VRLDNEKEGFPITAIREIKILRQLNHRNIV 69
Query: 563 RLLGYCDEGQNRL----------LVYEFMSN---GTVASFLFGDSKPNWKLRTEIAMGIA 609
L + Q+ L LV+E+M + G + S L S+ + K +
Sbjct: 70 NLKEIVTDKQDALDFKKDKGAFYLVFEYMDHDLMGLLESGLVHFSEDHIK---SFMKQLL 126
Query: 610 GGLFYLHEECCTQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLDQS--HTNTAIRGTK 667
GL Y H+ +H DIK NILL++ +++DFGLA+L ++S +TN I T
Sbjct: 127 EGLNYCHK---KNFLHRDIKCSNILLNNKGQIKLADFGLARLYNSEESRPYTNKVI--TL 181
Query: 668 GYVAPEWF----RNMPITVKVDVYSYGVLLLEI 696
Y PE R P +DV+S G +L E+
Sbjct: 182 WYRPPELLLGEERYGP---AIDVWSCGCILGEL 211
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302 |
| >gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Score = 64.3 bits (157), Expect = 5e-11
Identities = 63/229 (27%), Positives = 98/229 (42%), Gaps = 49/229 (21%)
Query: 491 RCFTYKELVEVTRGFKEELGRGAFGTVYKGFVNMGSSNHVAVKKLNSVFQDSEKEFKA-- 548
RC + E ++ R +G G +G VY+ + S VA+KK V D+E++
Sbjct: 2 RCRSVTEFEKLNR-----IGEGTYGIVYRA-RDTTSGEIVALKK---VRMDNERDGIPIS 52
Query: 549 ---EVNGIGQTHHKNLVRLL---------------GYCDEGQNRLLVYEFMSNGTVASFL 590
E+ + H N+V L YC++ LL + M F
Sbjct: 53 SLREITLLLNLRHPNIVELKEVVVGKHLDSIFLVMEYCEQDLASLL--DNMP----TPF- 105
Query: 591 FGDSKPNWKLRTEIAMGIAGGLFYLHEECCTQIIHCDIKPQNILLDDHYNARISDFGLAK 650
S+ K + + + GL YLHE IIH D+K N+LL D +I+DFGLA+
Sbjct: 106 ---SESQVKC---LMLQLLRGLQYLHENF---IIHRDLKVSNLLLTDKGCLKIADFGLAR 156
Query: 651 LLTL-DQSHTNTAIRGTKGYVAPE-WFRNMPITVKVDVYSYGVLLLEII 697
L + T + T Y APE T +D+++ G +L E++
Sbjct: 157 TYGLPAKPMTPKVV--TLWYRAPELLLGCTTYTTAIDMWAVGCILAELL 203
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309 |
| >gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 64.1 bits (156), Expect = 5e-11
Identities = 59/207 (28%), Positives = 101/207 (48%), Gaps = 26/207 (12%)
Query: 505 FKEELGRGAFGTVYKGFVNMGSSNHVAVKKLNSVFQDSE-KEFKAEVNGIGQTHHKNLVR 563
+ELG+G +G+VYK + + +A+K++ +S+ + E++ + + +V
Sbjct: 5 VLDELGKGNYGSVYKVL-HRPTGVTMAMKEIRLELDESKFNQIIMELDILHKAVSPYIVD 63
Query: 564 LLG-YCDEGQNRLLVY---EFMSNGTVASFLFGDS----KPNWKLRTEIAMGIAGGLFYL 615
G + EG VY E+M G++ G P LR I + GL +L
Sbjct: 64 FYGAFFIEGA----VYMCMEYMDAGSLDKLYAGGVATEGIPEDVLR-RITYAVVKGLKFL 118
Query: 616 HEECCTQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLDQSHTNTAIRGTKGYVAPEWF 675
EE IIH D+KP N+L++ + ++ DFG++ L + TN G + Y+APE
Sbjct: 119 KEE--HNIIHRDVKPTNVLVNGNGQVKLCDFGVSGNLVASLAKTNI---GCQSYMAPERI 173
Query: 676 R------NMPITVKVDVYSYGVLLLEI 696
+ N TV+ DV+S G+ +LE+
Sbjct: 174 KSGGPNQNPTYTVQSDVWSLGLSILEM 200
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286 |
| >gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Score = 63.5 bits (154), Expect = 5e-11
Identities = 56/201 (27%), Positives = 94/201 (46%), Gaps = 13/201 (6%)
Query: 509 LGRGAFGTVYKGFVNMGSSNHVAVKKL--NSVFQDSEKEFKA---EVNGIGQTHHKNLVR 563
LG+GAFG VY + + + +AVK++ + ++ KE A E+ + H+ +V+
Sbjct: 10 LGQGAFGRVYLCY-DADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQ 68
Query: 564 LLGYCDEGQNRLL--VYEFMSNGTVASFLFGDSKPNWKLRTEIAMGIAGGLFYLHEECCT 621
G + R L E M G++ L + + I G+ YLH
Sbjct: 69 YYGCLRDPMERTLSIFMEHMPGGSIKDQLKSYGALTENVTRKYTRQILEGVSYLHS---N 125
Query: 622 QIIHCDIKPQNILLDDHYNARISDFGLAK-LLTLDQSHTN-TAIRGTKGYVAPEWFRNMP 679
I+H DIK NIL D N ++ DFG +K L T+ S T ++ GT +++PE
Sbjct: 126 MIVHRDIKGANILRDSVGNVKLGDFGASKRLQTICLSGTGMKSVTGTPYWMSPEVISGEG 185
Query: 680 ITVKVDVYSYGVLLLEIICLR 700
K D++S G ++E++ +
Sbjct: 186 YGRKADIWSVGCTVVEMLTEK 206
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265 |
| >gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Score = 64.1 bits (156), Expect = 7e-11
Identities = 56/203 (27%), Positives = 91/203 (44%), Gaps = 34/203 (16%)
Query: 509 LGRGAFGTVYKGFVNMGSSNHVAVKKLNSVFQDS--EKEFKAEVNGIGQTHHKNLVRLLG 566
+G GAFG V + N VA+KK+ F K E+ + H+N++ L
Sbjct: 18 VGMGAFGLVCSARDQLTGQN-VAIKKIMKPFSTPVLAKRTYRELKLLKHLRHENIISL-- 74
Query: 567 YCD----EGQNRLLVYEFMSNGTVASFLFGDSKPNWKLRTEIAM----GIAGGLFYLHEE 618
D ++ V E + + L S+P L + I GL Y+H
Sbjct: 75 -SDIFISPLEDIYFVTELLGT-DLHRLL--TSRP---LEKQFIQYFLYQILRGLKYVHS- 126
Query: 619 CCTQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLDQSHTNTAIRGTKGYVAPE----W 674
++H D+KP NIL++++ + +I DFGLA++ Q T T+ Y APE W
Sbjct: 127 --AGVVHRDLKPSNILINENCDLKICDFGLARI----QDPQMTGYVSTRYYRAPEIMLTW 180
Query: 675 FRNMPITVKVDVYSYGVLLLEII 697
+ V+VD++S G + E++
Sbjct: 181 QK---YDVEVDIWSAGCIFAEML 200
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328 |
| >gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Score = 63.8 bits (155), Expect = 8e-11
Identities = 75/300 (25%), Positives = 127/300 (42%), Gaps = 56/300 (18%)
Query: 509 LGRGAFGTVYK--GF-VNMGSSNH---VAVKKL--NSVFQD-----SEKEFKAEVNGIGQ 555
LG G FG V + + ++ + VAVK L N+ +D SE E +
Sbjct: 20 LGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELMKLIG---- 75
Query: 556 THHKNLVRLLGYCDEGQNRLLVYEFMSNGTVASFLFGDSKPNWKLRTEI----------- 604
HKN++ LLG C + ++ E+ + G + FL P +I
Sbjct: 76 -KHKNIINLLGVCTQEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFK 134
Query: 605 -----AMGIAGGLFYLHEECCTQIIHCDIKPQNILLDDHYNARISDFGLAK-LLTLDQSH 658
A +A G+ YL C IH D+ +N+L+ + +I+DFGLA+ + +D
Sbjct: 135 DLVSCAYQVARGMEYLESRRC---IHRDLAARNVLVTEDNVMKIADFGLARGVHDIDYYK 191
Query: 659 TNTAIRGTKGYVAPEWFRNMPITVKVDVYSYGVLLLEIICLRRNIDNEISKVDKAILTDW 718
+ R ++APE + T + DV+S+G+L+ EI L + I
Sbjct: 192 KTSNGRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFTLGGSPYPGIP---------- 241
Query: 719 AYDRYQERTLEALVE-NDLEAMNNVTMLHRFVMVAFWCIQEDPSHRPTMRKVTQMLEGVV 777
E + L E + ++ +N T H M+ C P+ RPT +++ + L+ V+
Sbjct: 242 -----VEELFKLLREGHRMDKPSNCT--HELYMLMRECWHAVPTQRPTFKQLVEALDKVL 294
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314 |
| >gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 63.8 bits (155), Expect = 8e-11
Identities = 63/215 (29%), Positives = 98/215 (45%), Gaps = 33/215 (15%)
Query: 495 YKELVEVTRGFKEELGRGAFGTVYKGFVNMGSSNHVAVKKLNSVFQDS--EKEFKAEVNG 552
Y++L +V G GA+GTV ++ + VA+KKL FQ K E+
Sbjct: 17 YRDLKQV--------GSGAYGTVCSA-LDRRTGAKVAIKKLYRPFQSELFAKRAYRELRL 67
Query: 553 IGQTHHKNLVRLLGY------CDEGQNRLLVYEFMSNGTVASFLFGDSKPNWKLRTEIAM 606
+ H+N++ LL D + LV FM GT L K + +
Sbjct: 68 LKHMKHENVIGLLDVFTPDLSLDRFHDFYLVMPFM--GTDLGKLMKHEKLSEDRIQFLVY 125
Query: 607 GIAGGLFYLHEECCTQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLDQSHTNTAIRG- 665
+ GL Y+H IIH D+KP N+ +++ +I DFGLA+ T++ + G
Sbjct: 126 QMLKGLKYIH---AAGIIHRDLKPGNLAVNEDCELKILDFGLAR-------QTDSEMTGY 175
Query: 666 --TKGYVAPEWFRN-MPITVKVDVYSYGVLLLEII 697
T+ Y APE N M T VD++S G ++ E++
Sbjct: 176 VVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEML 210
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343 |
| >gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 63.8 bits (155), Expect = 8e-11
Identities = 58/204 (28%), Positives = 95/204 (46%), Gaps = 32/204 (15%)
Query: 509 LGRGAFGTVYKGFVNMGSSNHVAVKKLNSVFQDSE---KEFKAEVNGIGQTHHKNLVRLL 565
+G GA+G+V ++ + VA+KKL+ FQ SE K E+ + H+N++ LL
Sbjct: 23 VGSGAYGSVCSA-IDKRTGEKVAIKKLSRPFQ-SEIFAKRAYRELTLLKHMQHENVIGLL 80
Query: 566 GY------CDEGQNRLLVYEFMSN--GTVASFLFGDSKPNWKLRTEIAMGIAGGLFYLHE 617
DE Q+ LV +M + + K + + + GL Y+H
Sbjct: 81 DVFTSAVSGDEFQDFYLVMPYMQTDLQKIMGHPLSEDKVQYLVYQMLC-----GLKYIHS 135
Query: 618 ECCTQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLDQSHTNTAIRG---TKGYVAPEW 674
IIH D+KP N+ +++ +I DFGLA+ H + + G T+ Y APE
Sbjct: 136 ---AGIIHRDLKPGNLAVNEDCELKILDFGLAR-------HADAEMTGYVVTRWYRAPEV 185
Query: 675 FRN-MPITVKVDVYSYGVLLLEII 697
N M VD++S G ++ E++
Sbjct: 186 ILNWMHYNQTVDIWSVGCIMAEML 209
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342 |
| >gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Score = 64.0 bits (156), Expect = 9e-11
Identities = 59/200 (29%), Positives = 91/200 (45%), Gaps = 21/200 (10%)
Query: 509 LGRGAFGTVYKGFVNMGSSNHVAVKKLNSVFQD--SEKEFKAEVNGIGQTHHKNLVRLLG 566
+G GA G V + + + +VA+KKL+ FQ+ K E+ + +HKN++ LL
Sbjct: 24 IGSGAQGIVCAAY-DTVTGQNVAIKKLSRPFQNVTHAKRAYRELVLMKLVNHKNIIGLLN 82
Query: 567 Y------CDEGQNRLLVYEFMSNG--TVASFLFGDSKPNWKLRTEIAMGIAGGLFYLHEE 618
+E Q+ LV E M V + ++ L + G+ +LH
Sbjct: 83 VFTPQKSLEEFQDVYLVMELMDANLCQVIQMDLDHERMSYLLYQMLC-----GIKHLHS- 136
Query: 619 CCTQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLDQSHTNTAIRGTKGYVAPEWFRNM 678
IIH D+KP NI++ +I DFGLA+ T S T T+ Y APE M
Sbjct: 137 --AGIIHRDLKPSNIVVKSDCTLKILDFGLAR--TAGTSFMMTPYVVTRYYRAPEVILGM 192
Query: 679 PITVKVDVYSYGVLLLEIIC 698
VD++S G ++ E+I
Sbjct: 193 GYKENVDIWSVGCIMGEMIR 212
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353 |
| >gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 63.3 bits (154), Expect = 1e-10
Identities = 57/200 (28%), Positives = 102/200 (51%), Gaps = 22/200 (11%)
Query: 509 LGRGAFGTVYKGFVNMGS-SNHV----AVKKLNSVFQDSEKEFKAEVNGIGQTHHKNLVR 563
LG+G+FG V+ G + + +KK +D + K E + + + +H +V+
Sbjct: 4 LGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRT-KMERDILAEVNHPFIVK 62
Query: 564 LLGYCDEGQNRL-LVYEFMSNGTVASFL-----FGDSKPNWKLRTEIAMGIAGGLFYLHE 617
L Y + + +L L+ +F+ G + + L F + + L E+A+ L +LH
Sbjct: 63 L-HYAFQTEGKLYLILDFLRGGDLFTRLSKEVMFTEEDVKFYL-AELALA----LDHLHS 116
Query: 618 ECCTQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLDQSHTNTAIRGTKGYVAPEWFRN 677
II+ D+KP+NILLD+ + +++DFGL+K ++D + GT Y+APE
Sbjct: 117 ---LGIIYRDLKPENILLDEEGHIKLTDFGLSK-ESIDHEKKAYSFCGTVEYMAPEVVNR 172
Query: 678 MPITVKVDVYSYGVLLLEII 697
T D +S+GVL+ E++
Sbjct: 173 RGHTQSADWWSFGVLMFEML 192
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318 |
| >gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Score = 62.8 bits (152), Expect = 1e-10
Identities = 61/196 (31%), Positives = 93/196 (47%), Gaps = 17/196 (8%)
Query: 508 ELGRGAFGTVYKGFVNMGSSNHVAVKKLN-SVFQDSEK--EFKAEVNGIGQTHHKNLVRL 564
E+G G+FG VY ++ ++ VA+KK++ S Q +EK + EV + + H N +
Sbjct: 32 EIGHGSFGAVYFAR-DVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEY 90
Query: 565 LGYCDEGQNRLLVYEFMSNGTVASFLFGDSKPNWKLR-TEIAMGIAGGLFYLHEECCTQI 623
G LV E+ G+ + L KP ++ I G GL YLH +
Sbjct: 91 KGCYLREHTAWLVMEYCL-GSASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSH---NM 146
Query: 624 IHCDIKPQNILLDDHYNARISDFGLAKLLTLDQSHTNTAIRGTKGYVAPEWFRNM---PI 680
IH DIK NILL + +++DFG A + + S GT ++APE M
Sbjct: 147 IHRDIKAGNILLTEPGQVKLADFGSASIASPANSFV-----GTPYWMAPEVILAMDEGQY 201
Query: 681 TVKVDVYSYGVLLLEI 696
KVDV+S G+ +E+
Sbjct: 202 DGKVDVWSLGITCIEL 217
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317 |
| >gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 63.3 bits (154), Expect = 2e-10
Identities = 48/177 (27%), Positives = 86/177 (48%), Gaps = 37/177 (20%)
Query: 608 IAGGLFYLHEECCTQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLDQSHTNTAIRGTK 667
+A G+ +L + C IH D+ +N+LL D A+I DFGLA+ + D +N ++G
Sbjct: 221 VAQGMDFLASKNC---IHRDVAARNVLLTDGRVAKICDFGLARDIMND---SNYVVKGNA 274
Query: 668 ----GYVAPEWFRNMPITVKVDVYSYGVLLLEIICLRRN------IDNEISKVDKAILTD 717
++APE + TV+ DV+SYG+LL EI L ++ ++++ K+ K
Sbjct: 275 RLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGKSPYPGILVNSKFYKMVK----- 329
Query: 718 WAYDRYQERTLEALVENDLEAMNNVTMLHRFVMVAFWCIQEDPSHRPTMRKVTQMLE 774
YQ + D + +M W + +P+ RPT +++Q+++
Sbjct: 330 ---RGYQ------MSRPDFAPPEIYS-----IMKMCWNL--EPTERPTFSQISQLIQ 370
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374 |
| >gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Score = 63.2 bits (154), Expect = 2e-10
Identities = 61/211 (28%), Positives = 92/211 (43%), Gaps = 41/211 (19%)
Query: 509 LGRGAFGTVYKGFVNMGSSNHVAVKKLNSVFQD--SEKEFKAEVNGIGQTHHKNLVRLL- 565
+G GAFG V+ + VA+KK+ +VFQ+ S K E+ + H N++ L
Sbjct: 8 IGYGAFGVVW-SVTDPRDGKRVALKKMPNVFQNLVSCKRVFRELKMLCFFKHDNVLSALD 66
Query: 566 ----GYCDEGQNRLLVYEFM--------------SNGTVASFLFGDSKPNWKLRTEIAMG 607
+ D + +V E M S+ V FL+
Sbjct: 67 ILQPPHIDPFEEIYVVTELMQSDLHKIIVSPQPLSSDHVKVFLYQ--------------- 111
Query: 608 IAGGLFYLHEECCTQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLDQSHTNTAIRGTK 667
I GL YLH I+H DIKP N+L++ + +I DFGLA++ D+S T T+
Sbjct: 112 ILRGLKYLHS---AGILHRDIKPGNLLVNSNCVLKICDFGLARVEEPDESKHMTQEVVTQ 168
Query: 668 GYVAPEWFRNMP-ITVKVDVYSYGVLLLEII 697
Y APE T VD++S G + E++
Sbjct: 169 YYRAPEILMGSRHYTSAVDIWSVGCIFAELL 199
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372 |
| >gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Score = 62.8 bits (153), Expect = 2e-10
Identities = 56/224 (25%), Positives = 87/224 (38%), Gaps = 60/224 (26%)
Query: 508 ELGRGAFGTVYKG-FVNMGSSNHVAVKKLNSVFQDS--------EKEFKAEVNGIGQTHH 558
ELG+GA+G V VA+KK+ +VF E + G H
Sbjct: 7 ELGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKILAKRALRELKLLRHFRG-----H 61
Query: 559 KNLVRL--LGYCDEGQ-NRLLVY-EFM--------------SNGTVASFLFGDSKPNWKL 600
KN+ L + G N L +Y E M ++ SF++
Sbjct: 62 KNITCLYDMDIVFPGNFNELYLYEELMEADLHQIIRSGQPLTDAHFQSFIYQ-------- 113
Query: 601 RTEIAMGIAGGLFYLHEECCTQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLDQSHTN 660
I GL Y+H ++H D+KP N+L++ +I DFGLA+ + +
Sbjct: 114 -------ILCGLKYIHS---ANVLHRDLKPGNLLVNADCELKICDFGLARGFSENPGENA 163
Query: 661 TAIRGTKGYVAPEWFR-------NMPITVKVDVYSYGVLLLEII 697
+ YVA W+R T +DV+S G +L E++
Sbjct: 164 GFM---TEYVATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELL 204
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332 |
| >gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 62.9 bits (153), Expect = 2e-10
Identities = 59/201 (29%), Positives = 102/201 (50%), Gaps = 23/201 (11%)
Query: 506 KEELGRGAFGTVYKGFVNMGSSNHVAVK--KLNSVFQDSEKEFKAEVNGIGQT-HHKNLV 562
E LG G+FG V + + G+ + A+K K + + + + A+ I H +V
Sbjct: 23 GETLGTGSFGRV-RIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPFIV 81
Query: 563 RLL-GYCDEGQNRL-LVYEFMSNGTVASFLFGDSK-PNWKLR---TEIAMGIAGGLFYLH 616
++ + DE NR+ + EF+ G + + L + PN + E+ + YLH
Sbjct: 82 NMMCSFQDE--NRVYFLLEFVVGGELFTHLRKAGRFPNDVAKFYHAELVLAFE----YLH 135
Query: 617 EECCTQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLDQSHTNTAIRGTKGYVAPEWFR 676
+ II+ D+KP+N+LLD+ + +++DFG AK + D++ T + GT Y+APE +
Sbjct: 136 SK---DIIYRDLKPENLLLDNKGHVKVTDFGFAKKVP-DRTFT---LCGTPEYLAPEVIQ 188
Query: 677 NMPITVKVDVYSYGVLLLEII 697
+ VD ++ GVLL E I
Sbjct: 189 SKGHGKAVDWWTMGVLLYEFI 209
|
Length = 329 |
| >gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 62.6 bits (152), Expect = 2e-10
Identities = 40/107 (37%), Positives = 58/107 (54%), Gaps = 5/107 (4%)
Query: 612 LFYLHEECCTQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLDQSHTNTAIRGTKGYVA 671
L LH+ +I+ D+KP+NILLD + + DFGL KL D TNT GT Y+A
Sbjct: 106 LENLHK---FNVIYRDLKPENILLDYQGHIALCDFGLCKLNMKDDDKTNTFC-GTPEYLA 161
Query: 672 PEWFRNMPITVKVDVYSYGVLLLEIIC-LRRNIDNEISKVDKAILTD 717
PE T VD ++ GVLL E++ L D ++++ + IL +
Sbjct: 162 PELLLGHGYTKAVDWWTLGVLLYEMLTGLPPFYDENVNEMYRKILQE 208
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312 |
| >gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Score = 62.5 bits (152), Expect = 2e-10
Identities = 54/194 (27%), Positives = 91/194 (46%), Gaps = 11/194 (5%)
Query: 509 LGRGAFGTVYKGFVNMGSSNHVAVKKLNS--VFQDSEKE---FKAEVNGIGQTHHKNLVR 563
LG+G+FG V + G++ A+K L V +D + E + V + H L
Sbjct: 3 LGKGSFGKVMLAELK-GTNEFFAIKALKKDVVLEDDDVECTMVERRVLALA-WEHPFLTH 60
Query: 564 LLGYCDEGQNRLLVYEFMSNGTVASFLFGDSKPNWKLRTEIAMGIAGGLFYLHEECCTQI 623
L ++ V E+++ G + + + + A I GL +LH++ I
Sbjct: 61 LFCTFQTKEHLFFVMEYLNGGDLMFHIQSSGRFDEARARFYAAEIICGLQFLHKK---GI 117
Query: 624 IHCDIKPQNILLDDHYNARISDFGLAKLLTLDQSHTNTAIRGTKGYVAPEWFRNMPITVK 683
I+ D+K N+LLD + +I+DFG+ K + +T GT Y+APE +
Sbjct: 118 IYRDLKLDNVLLDKDGHIKIADFGMCKENMNGEGKASTFC-GTPDYIAPEILKGQKYNES 176
Query: 684 VDVYSYGVLLLEII 697
VD +S+GVLL E++
Sbjct: 177 VDWWSFGVLLYEML 190
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316 |
| >gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Score = 62.0 bits (150), Expect = 3e-10
Identities = 59/197 (29%), Positives = 91/197 (46%), Gaps = 19/197 (9%)
Query: 508 ELGRGAFGTVYKGFVNMGSSNHV-AVKKLN-SVFQDSEK--EFKAEVNGIGQTHHKNLVR 563
E+G G+FG VY F ++ V A+KK++ S Q +EK + EV + + H N ++
Sbjct: 22 EIGHGSFGAVY--FARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQ 79
Query: 564 LLGYCDEGQNRLLVYEFMSNGTVASFLFGDSKPNWKLR-TEIAMGIAGGLFYLHEECCTQ 622
G LV E+ G+ + L KP ++ + G GL YLH
Sbjct: 80 YRGCYLREHTAWLVMEYCL-GSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSH---N 135
Query: 623 IIHCDIKPQNILLDDHYNARISDFGLAKLLTLDQSHTNTAIRGTKGYVAPEWFRNM---P 679
+IH D+K NILL + ++ DFG A ++ GT ++APE M
Sbjct: 136 MIHRDVKAGNILLSEPGLVKLGDFGSASIMAPANXFV-----GTPYWMAPEVILAMDEGQ 190
Query: 680 ITVKVDVYSYGVLLLEI 696
KVDV+S G+ +E+
Sbjct: 191 YDGKVDVWSLGITCIEL 207
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308 |
| >gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Score = 61.9 bits (151), Expect = 3e-10
Identities = 65/232 (28%), Positives = 99/232 (42%), Gaps = 54/232 (23%)
Query: 507 EELGRGAFGTVYKGFVNMGSSNHVAVKKLNSVFQDSEKE-FKA----EVNGIGQTHHKNL 561
+LG G FG VYK + + VA+KK+ +EK+ F E+ + + H N+
Sbjct: 14 GKLGEGTFGEVYKA-RQIKTGRVVALKKI---LMHNEKDGFPITALREIKILKKLKHPNV 69
Query: 562 VRLLG----YCDEGQN-RLLVYEFMSNGTVASFLFGD-----SKPNWKLRTE-----IAM 606
V L+ D+ + R VY V ++ D P+ KL TE +
Sbjct: 70 VPLIDMAVERPDKSKRKRGSVY------MVTPYMDHDLSGLLENPSVKL-TESQIKCYML 122
Query: 607 GIAGGLFYLHEECCTQIIHCDIKPQNILLDDHYNARISDFGLAKLLT------------L 654
+ G+ YLH I+H DIK NIL+D+ +I+DFGLA+
Sbjct: 123 QLLEGINYLH---ENHILHRDIKAANILIDNQGILKIADFGLARPYDGPPPNPKGGGGGG 179
Query: 655 DQSHTNTAIRGTKGYVAPEWF---RNMPITVKVDVYSYGVLLLEIICLRRNI 703
+ +TN + T+ Y PE R T VD++ G + E+ RR I
Sbjct: 180 TRKYTNLVV--TRWYRPPELLLGERRY--TTAVDIWGIGCVFAEMF-TRRPI 226
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311 |
| >gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Score = 61.9 bits (150), Expect = 3e-10
Identities = 61/194 (31%), Positives = 93/194 (47%), Gaps = 11/194 (5%)
Query: 509 LGRGAFGTVYKGFVNMGSSNHVAVKKLNS---VFQDSEKEFKAEVNGIGQTHHKNLVRLL 565
+G+G+FG V + + AVK L + + +K AE N + + + L
Sbjct: 3 IGKGSFGKVLLAKRKLDGKCY-AVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGL 61
Query: 566 GYCDEGQNRL-LVYEFMSNGTVASFLFGD-SKPNWKLRTEIAMGIAGGLFYLHEECCTQI 623
Y + +L V +F++ G + L + S P + R A IA L YLH I
Sbjct: 62 HYSFQTTEKLYFVLDFVNGGELFFHLQRERSFPEPRARFYAAE-IASALGYLHS---INI 117
Query: 624 IHCDIKPQNILLDDHYNARISDFGLAKLLTLDQSHTNTAIRGTKGYVAPEWFRNMPITVK 683
++ D+KP+NILLD + ++DFGL K + QS T T GT Y+APE R P
Sbjct: 118 VYRDLKPENILLDSQGHVVLTDFGLCK-EGIAQSDTTTTFCGTPEYLAPEVIRKQPYDNT 176
Query: 684 VDVYSYGVLLLEII 697
VD + G +L E++
Sbjct: 177 VDWWCLGAVLYEML 190
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325 |
| >gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 62.0 bits (150), Expect = 4e-10
Identities = 60/210 (28%), Positives = 92/210 (43%), Gaps = 37/210 (17%)
Query: 509 LGRGAFGTVYKGFVNMGSSNHVAVKKLNSVFQD--SEKEFKAEVNGIGQTHHKNLVRLLG 566
+G GA+G+V F + + VAVKKL+ FQ K E+ + H+N++ LL
Sbjct: 25 VGSGAYGSVCAAF-DTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLD 83
Query: 567 Y------CDEGQNRLLVYEFMS---NGTVASFLFGDSKPNWKLRTEIAMGIAGGLFYLHE 617
+E + LV M N V D + + I GL Y+H
Sbjct: 84 VFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQF-----LIYQILRGLKYIHS 138
Query: 618 ECCTQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLDQSHTNTAIRGTKGYVAPEWFRN 677
IIH D+KP N+ +++ +I DFGLA+ HT+ + GYVA W+R
Sbjct: 139 ---ADIIHRDLKPSNLAVNEDCELKILDFGLAR-------HTDDEM---TGYVATRWYRA 185
Query: 678 -------MPITVKVDVYSYGVLLLEIICLR 700
M VD++S G ++ E++ R
Sbjct: 186 PEIMLNWMHYNQTVDIWSVGCIMAELLTGR 215
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345 |
| >gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Score = 61.4 bits (149), Expect = 4e-10
Identities = 73/295 (24%), Positives = 132/295 (44%), Gaps = 57/295 (19%)
Query: 507 EELGRGAFGTVYKGFVNMGSSNHVAVKKLNSVFQDSEKEFKA--EVNGIGQTHHKNLVRL 564
E++G G +G VYK + ++ +A+KK+ +D A E++ + + H N+VRL
Sbjct: 8 EKIGEGTYGVVYKA-RDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRL 66
Query: 565 LGYCDEGQNRLLVYEFMSNGTVASFLFGDSKPNW----KLRTEIAMGIAGGLFYLHEECC 620
+ LV+E++ + + + DS P++ +L I G+ Y H
Sbjct: 67 QDVVHSEKRLYLVFEYL-DLDLKKHM--DSSPDFAKNPRLIKTYLYQILRGIAYCHSH-- 121
Query: 621 TQIIHCDIKPQNILLDDHYNA-RISDFGLAKLLTLDQSHTNTAIRGTKGYVAPEWFRNMP 679
+++H D+KPQN+L+D NA +++DFGLA+ + +R V W+R
Sbjct: 122 -RVLHRDLKPQNLLIDRRTNALKLADFGLARAFGI-------PVRTFTHEVVTLWYRAPE 173
Query: 680 I-------TVKVDVYSYGVLLLEIICLRRNI--DNEISKVDK----------------AI 714
I + VD++S G + E++ + D+EI ++ K
Sbjct: 174 ILLGSRHYSTPVDIWSVGCIFAEMVNQKPLFPGDSEIDELFKIFRILGTPNEETWPGVTS 233
Query: 715 LTDW--AYDRYQERTLEALVENDLEAMNNVTMLHRFVMVAFWCIQEDPSHRPTMR 767
L D+ A+ ++ + L +V LE V +L + + + DPS R T R
Sbjct: 234 LPDYKSAFPKWPPKDLATVVPT-LEP-AGVDLLSKMLRL-------DPSKRITAR 279
|
Length = 294 |
| >gnl|CDD|143380 cd07875, STKc_JNK1, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Score = 62.0 bits (150), Expect = 5e-10
Identities = 58/200 (29%), Positives = 91/200 (45%), Gaps = 21/200 (10%)
Query: 509 LGRGAFGTVYKGFVNMGSSNHVAVKKLNSVFQDSEKEFKA--EVNGIGQTHHKNLVRLLG 566
+G GA G V + + +VA+KKL+ FQ+ +A E+ + +HKN++ LL
Sbjct: 32 IGSGAQGIVCAAY-DAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLN 90
Query: 567 Y------CDEGQNRLLVYEFMSNG--TVASFLFGDSKPNWKLRTEIAMGIAGGLFYLHEE 618
+E Q+ +V E M V + ++ L + G+ +LH
Sbjct: 91 VFTPQKSLEEFQDVYIVMELMDANLCQVIQMELDHERMSYLLYQMLC-----GIKHLHS- 144
Query: 619 CCTQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLDQSHTNTAIRGTKGYVAPEWFRNM 678
IIH D+KP NI++ +I DFGLA+ T S T T+ Y APE M
Sbjct: 145 --AGIIHRDLKPSNIVVKSDCTLKILDFGLAR--TAGTSFMMTPYVVTRYYRAPEVILGM 200
Query: 679 PITVKVDVYSYGVLLLEIIC 698
VD++S G ++ E+I
Sbjct: 201 GYKENVDIWSVGCIMGEMIK 220
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK1 specifically binds with JAMP (JNK1-associated membrane protein), which regulates the duration of JNK1 activity in response to stimuli. Specific JNK1 substrates include Itch and SG10, which are implicated in Th2 responses and airway inflammation, and microtubule dynamics and axodendritic length, respectively. Mice deficient in Jnk1 are protected against arthritis, obesity, type 2 diabetes, cardiac cell death, and non-alcoholic liver disease, suggesting that JNK1 may play roles in the pathogenesis of these diseases. Length = 364 |
| >gnl|CDD|133175 cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Score = 60.9 bits (148), Expect = 5e-10
Identities = 53/219 (24%), Positives = 89/219 (40%), Gaps = 51/219 (23%)
Query: 512 GAFGTVYKGFVNMGSSNHVAVKKLNSVFQDSEKEF--KAEVNGIGQT------------- 556
G FG ++ G L E+E K + +
Sbjct: 17 GTFGRIFYG-------------ILIDEKPGKEEEVFVKTVKDHASEIQVTLLLQESCLLY 63
Query: 557 --HHKNLVRLLGYCDEGQNRLLV-YEFMSNGTVASFL----FGDSKPNWKLRT----EIA 605
H+N++ +L C E V Y +M+ G + FL G++ L T +A
Sbjct: 64 GLSHQNILPILHVCIEDGEPPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMA 123
Query: 606 MGIAGGLFYLHEECCTQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLDQSHT-----N 660
+ IA G+ YLH+ +IH DI +N ++D+ +I+D L++ L H N
Sbjct: 124 IQIACGMSYLHKR---GVIHKDIAARNCVIDEELQVKITDNALSRDLFPMDYHCLGDNEN 180
Query: 661 TAIRGTKGYVAPEWFRNMPITVKVDVYSYGVLLLEIICL 699
++ ++A E N + DV+S+GVLL E++ L
Sbjct: 181 RPVK----WMALESLVNKEYSSASDVWSFGVLLWELMTL 215
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It acts as a chemorepulsive axon guidance receptor of Wnt glycoproteins and is responsible for the establishment of axon tracts during the development of the central nervous system. In addition, studies in mice reveal that Ryk is essential in skeletal, craniofacial, and cardiac development. Thus, it appears Ryk is involved in signal transduction despite its lack of kinase activity. Ryk may function as an accessory protein that modulates the signals coming from catalytically active partner RTKs such as the Eph receptors. Length = 280 |
| >gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Score = 61.2 bits (148), Expect = 7e-10
Identities = 61/198 (30%), Positives = 93/198 (46%), Gaps = 19/198 (9%)
Query: 509 LGRGAFGTVYKGFVNMGSSNHVAVKKLNSVFQDSEKEFKA--EVNGIGQTHHKNLVRLLG 566
+G GA G V F + N VAVKKL+ FQ+ +A E+ + +HKN++ LL
Sbjct: 29 IGSGAQGIVCAAFDTVLGIN-VAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLLN 87
Query: 567 Y------CDEGQNRLLVYEFM-SNGTVASFLFGDSKPNWKLRTEIAMGIAGGLFYLHEEC 619
+E Q+ LV E M +N + D + L ++ GI +LH
Sbjct: 88 VFTPQKSLEEFQDVYLVMELMDANLCQVIHMELDHERMSYLLYQMLCGIK----HLHS-- 141
Query: 620 CTQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLDQSHTNTAIRGTKGYVAPEWFRNMP 679
IIH D+KP NI++ +I DFGLA+ + T + T+ Y APE M
Sbjct: 142 -AGIIHRDLKPSNIVVKSDCTLKILDFGLARTACTNFMMTPYVV--TRYYRAPEVILGMG 198
Query: 680 ITVKVDVYSYGVLLLEII 697
VD++S G ++ E++
Sbjct: 199 YKENVDIWSVGCIMGELV 216
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359 |
| >gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 61.1 bits (148), Expect = 7e-10
Identities = 61/199 (30%), Positives = 96/199 (48%), Gaps = 16/199 (8%)
Query: 509 LGRGAFGTVYKGFVNMGSSNHV-AVKKLNSVFQDSEKEFK---AEVNGIGQTHHKNLVRL 564
+G+G FG VY+ V + + A+K L+ ++KE E N + +T +
Sbjct: 1 IGKGTFGQVYQ--VRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFI 58
Query: 565 LGYCDEGQ---NRLLVYEFMSNGTVASFLFGDSK-PNWKLRTEIAMGIAGGLFYLHEECC 620
+G Q + LV ++MS G + L + + + + IA + L +LH+
Sbjct: 59 VGLKFSFQTDSDLYLVTDYMSGGELFWHLQKEGRFSEDRAKFYIAELVLA-LEHLHKY-- 115
Query: 621 TQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLDQSHTNTAIRGTKGYVAPE-WFRNMP 679
I++ D+KP+NILLD + + DFGL+K D TNT GT Y+APE
Sbjct: 116 -DIVYRDLKPENILLDATGHIALCDFGLSKANLTDNKTTNTFC-GTTEYLAPEVLLDEKG 173
Query: 680 ITVKVDVYSYGVLLLEIIC 698
T VD +S GVL+ E+ C
Sbjct: 174 YTKHVDFWSLGVLVFEMCC 192
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330 |
| >gnl|CDD|133209 cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 60.2 bits (146), Expect = 7e-10
Identities = 71/290 (24%), Positives = 121/290 (41%), Gaps = 64/290 (22%)
Query: 507 EELGRGAFGTVYKGF---VNMGSSNH---VAVKKLNSVFQDSEKEFKAEVNGIGQTHHKN 560
E LG+G F ++KG V H V +K L+ ++ + F + + Q HK+
Sbjct: 1 ESLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSHRNYSESFFEAASMMSQLSHKH 60
Query: 561 LVRLLGYCDEGQNRLLVYEFMSNGTVASFLFGDSKPN-------WKLRTEIAMGIAGGLF 613
LV G C G ++V E++ G++ ++L K N WKL E+A +A L
Sbjct: 61 LVLNYGVCVCGDESIMVQEYVKFGSLDTYL----KKNKNLINISWKL--EVAKQLAWALH 114
Query: 614 YLHEECCTQIIHCDIKPQNILL----DDHYNA----RISDFG-----LAKLLTLDQSHTN 660
+L ++ + H ++ +N+LL D ++SD G L K + L++
Sbjct: 115 FLEDK---GLTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGISITVLPKEILLERI--- 168
Query: 661 TAIRGTKGYVAPEWFRN-MPITVKVDVYSYGVLLLEIICLRRNIDNEISKVDKAILTDWA 719
+V PE N +++ D +S+G L EI D +S +D +
Sbjct: 169 -------PWVPPECIENPQNLSLAADKWSFGTTLWEIFS---GGDKPLSALDSQKKLQFY 218
Query: 720 YDRYQERTLEALVENDLEAMNNVTMLHRFVMVAFWCIQEDPSHRPTMRKV 769
DR+Q L A +L + N C+ +P RP+ R +
Sbjct: 219 EDRHQ---LPAPKWTELANLINQ------------CMDYEPDFRPSFRAI 253
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 258 |
| >gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Score = 60.0 bits (145), Expect = 7e-10
Identities = 60/286 (20%), Positives = 119/286 (41%), Gaps = 50/286 (17%)
Query: 506 KEELGRGAFGTVYKGFVNMGSSNHVAVKKLNSVFQ----DSEKEFKAEVNGIGQTHHKNL 561
++++GRG F VY+ + VA+KK+ +F+ + ++ E++ + Q +H N+
Sbjct: 7 EKKIGRGQFSEVYRATCLL-DRKPVALKKVQ-IFEMMDAKARQDCVKEIDLLKQLNHPNV 64
Query: 562 VRLLGYCDEGQNRLLVYEFMSNGTVASFLFGDSKPN--------WKLRTEIAMGIAGGLF 613
++ L E +V E G ++ + K WK ++ +
Sbjct: 65 IKYLDSFIEDNELNIVLELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVE---- 120
Query: 614 YLHEECCTQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLDQSHTNTAIRGTKGYVAPE 673
++H +++H DIKP N+ + ++ D GL + + + ++ + GT Y++PE
Sbjct: 121 HMHSR---RVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLV-GTPYYMSPE 176
Query: 674 WFRNMPITVKVDVYSYGVLLLEIICL-------RRNIDNEISKVDKAILTDWAYDRYQER 726
K D++S G LL E+ L + N+ + K+++ + Y E+
Sbjct: 177 RIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLFSLCQKIEQCDYPPLPTEHYSEK 236
Query: 727 TLEALVENDLEAMNNVTMLHRFVMVAFWCIQEDPSHRPTMRKVTQM 772
+L +M CI DP RP + V Q+
Sbjct: 237 L------RELVSM---------------CIYPDPDQRPDIGYVHQI 261
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267 |
| >gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Score = 60.7 bits (147), Expect = 8e-10
Identities = 74/277 (26%), Positives = 120/277 (43%), Gaps = 24/277 (8%)
Query: 509 LGRGAFGTVYKGFVNMGSSNHVAVKKL--NSVFQDSEKEFKAEVNGIGQTHHKN--LVRL 564
LG+G+FG V + G + AVK L + V D + E + +N L L
Sbjct: 3 LGKGSFGKVLLAELK-GKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHL 61
Query: 565 LGYCDEGQNRLLVYEFMSNGTVASFLFGDSKPNWKLRTEIAMGIAGGLFYLHEECCTQII 624
++ V EF++ G + + + + T A I GL +LH + II
Sbjct: 62 YCTFQTKEHLFFVMEFLNGGDLMFHIQDKGRFDLYRATFYAAEIVCGLQFLHSK---GII 118
Query: 625 HCDIKPQNILLDDHYNARISDFGLAKLLTLDQSHTNTAIRGTKGYVAPEWFRNMPITVKV 684
+ D+K N++LD + +I+DFG+ K + +T GT Y+APE + + T V
Sbjct: 119 YRDLKLDNVMLDRDGHIKIADFGMCKENVFGDNRASTFC-GTPDYIAPEILQGLKYTFSV 177
Query: 685 DVYSYGVLLLEIICLRRNI--DNEISKVDKAILTDWAYDRY----QERTLEALVEND--- 735
D +S+GVLL E++ + D+E + + Y R+ + LE L E D
Sbjct: 178 DWWSFGVLLYEMLIGQSPFHGDDEDELFESIRVDTPHYPRWITKESKDILEKLFERDPTR 237
Query: 736 -LEAMNNVTMLHRFVMVAFWCIQE----DPSHRPTMR 767
L + N+ H F W E DP +P ++
Sbjct: 238 RLGVVGNIR-GHPFFKTINWTALEKRELDPPFKPKVK 273
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316 |
| >gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Score = 60.4 bits (146), Expect = 9e-10
Identities = 44/172 (25%), Positives = 82/172 (47%), Gaps = 5/172 (2%)
Query: 526 SSNHVAVKKLNSVFQDSEKEFKAEVNGIGQTHHKNLVRLLGYCDEGQNRLLVYEFMSNGT 585
S VAVK ++ Q + EV + H+N+V + G+ ++ EF+ G
Sbjct: 45 SGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHQNVVEMYKSYLVGEELWVLMEFLQGGA 104
Query: 586 VASFLFGDSKPNWKLRTEIAMGIAGGLFYLHEECCTQIIHCDIKPQNILLDDHYNARISD 645
+ + ++ N + + + L YLH + +IH DIK +ILL ++SD
Sbjct: 105 LTD-IVSQTRLNEEQIATVCESVLQALCYLHSQ---GVIHRDIKSDSILLTLDGRVKLSD 160
Query: 646 FGLAKLLTLDQSHTNTAIRGTKGYVAPEWFRNMPITVKVDVYSYGVLLLEII 697
FG ++ D + + GT ++APE P +VD++S G++++E++
Sbjct: 161 FGFCAQISKDVPKRKSLV-GTPYWMAPEVISRTPYGTEVDIWSLGIMVIEMV 211
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297 |
| >gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Score = 60.5 bits (147), Expect = 1e-09
Identities = 32/94 (34%), Positives = 58/94 (61%), Gaps = 5/94 (5%)
Query: 603 EIAMGIAGGLFYLHEECCTQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLDQSHTNTA 662
+I++ + GL YL E+ +I+H D+KP NIL++ ++ DFG++ L S N+
Sbjct: 103 KISIAVLRGLTYLREK--HKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLI--DSMANSF 158
Query: 663 IRGTKGYVAPEWFRNMPITVKVDVYSYGVLLLEI 696
+ GT+ Y++PE + TV+ D++S G+ L+E+
Sbjct: 159 V-GTRSYMSPERLQGTHYTVQSDIWSLGLSLVEM 191
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308 |
| >gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Score = 59.8 bits (145), Expect = 1e-09
Identities = 52/217 (23%), Positives = 92/217 (42%), Gaps = 56/217 (25%)
Query: 507 EELGRGAFGTVYKGFVNMGSSNHVAVKKLNSVFQDSEKE-----FKAEVNGIGQTHHKNL 561
E++G G +GTV+K N + VA+K+ V D + E E+ + + HKN+
Sbjct: 6 EKIGEGTYGTVFKA-KNRETHEIVALKR---VRLDDDDEGVPSSALREICLLKELKHKNI 61
Query: 562 VRLLGYCDEGQNRLLVYEF---------------MSNGTVASFLFGDSKPNWKLRTEIAM 606
VRL + LV+E+ + V SF+F L+
Sbjct: 62 VRLYDVLHSDKKLTLVFEYCDQDLKKYFDSCNGDIDPEIVKSFMFQ------LLK----- 110
Query: 607 GIAGGLFYLHEECCTQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLDQSHTNTAIRGT 666
GL + H ++H D+KPQN+L++ + +++DFGLA+ + +R
Sbjct: 111 ----GLAFCHSH---NVLHRDLKPQNLLINKNGELKLADFGLARAFGI-------PVRCY 156
Query: 667 KGYVAPEWFRNMPI-------TVKVDVYSYGVLLLEI 696
V W+R + + +D++S G + E+
Sbjct: 157 SAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAEL 193
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284 |
| >gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Score = 60.4 bits (146), Expect = 1e-09
Identities = 40/137 (29%), Positives = 74/137 (54%), Gaps = 5/137 (3%)
Query: 579 EFMSNGTVASFLFGDSKPNWKLRTEIAMGIAGGLFYLHEECCTQIIHCDIKPQNILLDDH 638
E M G++ L + ++ ++++ + GL YL E+ QI+H D+KP NIL++
Sbjct: 83 EHMDGGSLDQVLKEAKRIPEEILGKVSIAVLRGLAYLREK--HQIMHRDVKPSNILVNSR 140
Query: 639 YNARISDFGLAKLLTLDQSHTNTAIRGTKGYVAPEWFRNMPITVKVDVYSYGVLLLEIIC 698
++ DFG++ L S N+ + GT+ Y++PE + +V+ D++S G+ L+E+
Sbjct: 141 GEIKLCDFGVSGQLI--DSMANSFV-GTRSYMSPERLQGTHYSVQSDIWSMGLSLVELAI 197
Query: 699 LRRNIDNEISKVDKAIL 715
R I +K +AI
Sbjct: 198 GRYPIPPPDAKELEAIF 214
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331 |
| >gnl|CDD|173651 cd05095, PTKc_DDR2, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Score = 59.9 bits (145), Expect = 1e-09
Identities = 61/227 (26%), Positives = 97/227 (42%), Gaps = 39/227 (17%)
Query: 505 FKEELGRGAFGTVY------------KGFVNMGSSNH---VAVKKLNS-VFQDSEKEFKA 548
FKE+LG G FG V+ K F S N VAVK L +++ +F
Sbjct: 9 FKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNARNDFLK 68
Query: 549 EVNGIGQTHHKNLVRLLGYCDEGQNRLLVYEFMSNGTVASFLFGDSKPNWKLRTE----- 603
E+ + + N++RLL C ++ E+M NG + FL + +
Sbjct: 69 EIKIMSRLKDPNIIRLLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTIS 128
Query: 604 ------IAMGIAGGLFYLHEECCTQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLDQS 657
+A IA G+ YL +H D+ +N L+ +Y +I+DFG+++ L S
Sbjct: 129 YSTLIFMATQIASGMKYLSS---LNFVHRDLATRNCLVGKNYTIKIADFGMSRNL---YS 182
Query: 658 HTNTAIRGTKGYVAPEWFRNMPI-----TVKVDVYSYGVLLLEIICL 699
I+G + + W I T DV+++GV L EI+ L
Sbjct: 183 GDYYRIQG-RAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEILTL 228
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues with the highest levels found in skeletal muscle, skin, kidney and lung. It is important in cell proliferation and development. Mice, with a deletion of DDR2, suffer from dwarfism and delayed healing of epidermal wounds. DDR2 also contributes to collagen (type I) regulation by inhibiting fibrillogenesis and altering the morphology of collagen fibers. It is also expressed in immature dendritic cells (DCs), where it plays a role in DC activation and function. Length = 296 |
| >gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Score = 59.8 bits (145), Expect = 1e-09
Identities = 59/226 (26%), Positives = 107/226 (47%), Gaps = 50/226 (22%)
Query: 507 EELGRGAFGTVYKGFVNMGSSNHVAVKKLNSVFQDSEKEFKA----EVNGIGQTHHKNLV 562
E+LG G + TVYKG N + VA+K+++ D+E+ + E++ + + H+N+V
Sbjct: 6 EKLGEGTYATVYKG-RNRTTGEIVALKEIH---LDAEEGTPSTAIREISLMKELKHENIV 61
Query: 563 RLLGYCDEGQNRLLVYEFMSN-----------------GTVASFLFGDSKPNWKLRTEIA 605
RL +LV+E+M TV SF + ++
Sbjct: 62 RLHDVIHTENKLMLVFEYMDKDLKKYMDTHGVRGALDPNTVKSFTY-----------QLL 110
Query: 606 MGIAGGLFYLHEECCTQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLD-QSHTNTAIR 664
GIA + HE +++H D+KPQN+L++ +++DFGLA+ + + +N +
Sbjct: 111 KGIA----FCHEN---RVLHRDLKPQNLLINKRGELKLADFGLARAFGIPVNTFSNEVV- 162
Query: 665 GTKGYVAPE-WFRNMPITVKVDVYSYGVLLLEIIC---LRRNIDNE 706
T Y AP+ + + +D++S G ++ E+I L +NE
Sbjct: 163 -TLWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMITGRPLFPGTNNE 207
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284 |
| >gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Score = 59.6 bits (145), Expect = 1e-09
Identities = 53/203 (26%), Positives = 91/203 (44%), Gaps = 24/203 (11%)
Query: 509 LGRGAFGTVYKGFVNMGSSNHVAVKKLNSVFQDSEKEFKAEVNGIGQ-------THHKNL 561
+G G F V K + + + A+K + F+ E +VN + + + H N+
Sbjct: 7 IGEGTFSEVLKA-QSRKTGKYYAIKCMKKHFKSLE-----QVNNLREIQALRRLSPHPNI 60
Query: 562 VRLLGYC-DEGQNRL-LVYEFMSNGTVASFLFGDSKPNWKLRTEIAM-GIAGGLFYLHEE 618
+RL+ D RL LV+E M + + + G +P + R + M + L ++H
Sbjct: 61 LRLIEVLFDRKTGRLALVFELM-DMNLYELIKGRKRPLPEKRVKSYMYQLLKSLDHMHRN 119
Query: 619 CCTQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLDQSHTNTAIRGTKGYVAPEWFRNM 678
I H DIKP+NIL+ D +++DFG + + T T+ Y APE
Sbjct: 120 ---GIFHRDIKPENILIKD-DILKLADFGSCR--GIYSKPPYTEYISTRWYRAPECLLTD 173
Query: 679 PI-TVKVDVYSYGVLLLEIICLR 700
K+D+++ G + EI+ L
Sbjct: 174 GYYGPKMDIWAVGCVFFEILSLF 196
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282 |
| >gnl|CDD|133227 cd05096, PTKc_DDR1, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Score = 59.2 bits (143), Expect = 2e-09
Identities = 61/237 (25%), Positives = 100/237 (42%), Gaps = 47/237 (19%)
Query: 505 FKEELGRGAFGTVYKGFV-------------NM--GSSNHVAVKKLNS-VFQDSEKEFKA 548
FKE+LG G FG V+ V N+ G VAVK L +++ +F
Sbjct: 9 FKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANKNARNDFLK 68
Query: 549 EVNGIGQTHHKNLVRLLGYCDEGQNRLLVYEFMSNGTVASFL-------------FGDSK 595
EV + + N++RLLG C + ++ E+M NG + FL
Sbjct: 69 EVKILSRLKDPNIIRLLGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPP 128
Query: 596 ------PNWKLRTEIAMGIAGGLFYLHEECCTQIIHCDIKPQNILLDDHYNARISDFGLA 649
++ +A+ IA G+ YL +H D+ +N L+ ++ +I+DFG++
Sbjct: 129 AHCLPAISYSSLLHVALQIASGMKYLSS---LNFVHRDLATRNCLVGENLTIKIADFGMS 185
Query: 650 KLLTLD-----QSHTNTAIRGTKGYVAPEWFRNMPITVKVDVYSYGVLLLEIICLRR 701
+ L Q IR ++A E T DV+++GV L EI+ L +
Sbjct: 186 RNLYAGDYYRIQGRAVLPIR----WMAWECILMGKFTTASDVWAFGVTLWEILMLCK 238
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in keratinocytes, colonic mucosa epithelium, lung epithelium, thyroid follicles, and the islets of Langerhans. During embryonic development, it is found in the developing neuroectoderm. DDR1 is a key regulator of cell morphogenesis, differentiation and proliferation. It is important in the development of the mammary gland, the vasculator and the kidney. DDR1 is also found in human leukocytes, where it facilitates cell adhesion, migration, maturation, and cytokine production. Length = 304 |
| >gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Score = 59.3 bits (144), Expect = 2e-09
Identities = 55/186 (29%), Positives = 87/186 (46%), Gaps = 33/186 (17%)
Query: 509 LGRGAFGTVYKGFVNMGSSNHVAVKKLNSVFQDSEKE-FKA----EVNGIGQTHHKNLVR 563
+G+G FG V+K + + VA+KK V ++EKE F E+ + H+N+V
Sbjct: 20 IGQGTFGEVFKA-RHKKTKQIVALKK---VLMENEKEGFPITALREIKILQLLKHENVVN 75
Query: 564 LLGYCD---EGQNR-----LLVYEFMSNGTVASFLFGDSKPNWK-----LRTEIAMGIAG 610
L+ C NR LV+EF + +A L S N K ++ + M +
Sbjct: 76 LIEICRTKATPYNRYKGSFYLVFEFCEH-DLAGLL---SNKNVKFTLSEIKKVMKM-LLN 130
Query: 611 GLFYLHEECCTQIIHCDIKPQNILLDDHYNARISDFGLAK---LLTLDQSHTNTAIRGTK 667
GL+Y+H +I+H D+K NIL+ +++DFGLA+ L + + T T
Sbjct: 131 GLYYIHR---NKILHRDMKAANILITKDGILKLADFGLARAFSLSKNSKPNRYTNRVVTL 187
Query: 668 GYVAPE 673
Y PE
Sbjct: 188 WYRPPE 193
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310 |
| >gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Score = 58.8 bits (142), Expect = 3e-09
Identities = 34/93 (36%), Positives = 50/93 (53%), Gaps = 4/93 (4%)
Query: 605 AMGIAGGLFYLHEECCTQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLDQSHTNTAIR 664
A +A + YLH II+ D+KP+NILLD + ++DFGL K ++ T +
Sbjct: 102 AAEVASAIGYLHSL---NIIYRDLKPENILLDSQGHVVLTDFGLCK-EGVEPEETTSTFC 157
Query: 665 GTKGYVAPEWFRNMPITVKVDVYSYGVLLLEII 697
GT Y+APE R P VD + G +L E++
Sbjct: 158 GTPEYLAPEVLRKEPYDRTVDWWCLGAVLYEML 190
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321 |
| >gnl|CDD|143379 cd07874, STKc_JNK3, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Score = 58.9 bits (142), Expect = 4e-09
Identities = 59/199 (29%), Positives = 91/199 (45%), Gaps = 21/199 (10%)
Query: 509 LGRGAFGTVYKGFVNMGSSNHVAVKKLNSVFQDSEKEFKA--EVNGIGQTHHKNLVRLLG 566
+G GA G V + + N VA+KKL+ FQ+ +A E+ + +HKN++ LL
Sbjct: 25 IGSGAQGIVCAAYDAVLDRN-VAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLN 83
Query: 567 Y------CDEGQNRLLVYEFMSNG--TVASFLFGDSKPNWKLRTEIAMGIAGGLFYLHEE 618
+E Q+ LV E M V + ++ L + G+ +LH
Sbjct: 84 VFTPQKSLEEFQDVYLVMELMDANLCQVIQMELDHERMSYLLYQMLC-----GIKHLHS- 137
Query: 619 CCTQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLDQSHTNTAIRGTKGYVAPEWFRNM 678
IIH D+KP NI++ +I DFGLA+ T S T T+ Y APE M
Sbjct: 138 --AGIIHRDLKPSNIVVKSDCTLKILDFGLAR--TAGTSFMMTPYVVTRYYRAPEVILGM 193
Query: 679 PITVKVDVYSYGVLLLEII 697
VD++S G ++ E++
Sbjct: 194 GYKENVDIWSVGCIMGEMV 212
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, stroke, sciatic axotomy neural death, and neuronal death due to NGF deprivation, oxidative stress, or exposure to beta-amyloid peptide. This suggests that JNK3 may play roles in the pathogenesis of these diseases. Length = 355 |
| >gnl|CDD|133235 cd05104, PTKc_Kit, Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Score = 59.1 bits (143), Expect = 4e-09
Identities = 49/177 (27%), Positives = 80/177 (45%), Gaps = 37/177 (20%)
Query: 608 IAGGLFYLHEECCTQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLDQSHTNTAIRGTK 667
+A G+ +L + C IH D+ +NILL +I DFGLA+ + D +N ++G
Sbjct: 223 VAKGMSFLASKNC---IHRDLAARNILLTHGRITKICDFGLARDIRND---SNYVVKGNA 276
Query: 668 ----GYVAPEWFRNMPITVKVDVYSYGVLLLEIICL------RRNIDNEISKVDKAILTD 717
++APE N T + DV+SYG+LL EI L +D++ K+ K
Sbjct: 277 RLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSSPYPGMPVDSKFYKMIK----- 331
Query: 718 WAYDRYQERTLEALVENDLEAMNNVTMLHRFVMVAFWCIQEDPSHRPTMRKVTQMLE 774
+ Y+ + E + M + C DP RPT +++ Q++E
Sbjct: 332 ---EGYRMLSPECAPSEMYDIMKS-------------CWDADPLKRPTFKQIVQLIE 372
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. Kit signaling is involved in major cellular functions including cell survival, proliferation, differentiation, adhesion, and chemotaxis. Mutations in Kit, which result in constitutive ligand-independent activation, are found in human cancers such as gastrointestinal stromal tumor (GIST) and testicular germ cell tumor (TGCT). The aberrant expression of Kit and/or SCF is associated with other tumor types such as systemic mastocytosis and cancers of the breast, neurons, lung, prostate, colon, and rectum. Although the structure of the human Kit catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 375 |
| >gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Score = 59.5 bits (144), Expect = 4e-09
Identities = 48/152 (31%), Positives = 78/152 (51%), Gaps = 14/152 (9%)
Query: 511 RGAFGTVYKGFVNMGSSNHV--AVKKLNSVFQDSEKEFKAEVNGIGQTHHKNLVRLLGYC 568
RGAFG VY G S + VKK + + ++ + +AE + + + +V L
Sbjct: 14 RGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHLYYSL 73
Query: 569 DEGQNRLLVYEFMSNGTVASFL--FG--DSKPNWKLRTEIAMGIAGGLFYLHEECCTQII 624
N LV E++ G V S L +G D + K +E+A+ L YLH II
Sbjct: 74 QSANNVYLVMEYLIGGDVKSLLHIYGYFDEEMAVKYISEVALA----LDYLHRH---GII 126
Query: 625 HCDIKPQNILLDDHYNARISDFGLAKLLTLDQ 656
H D+KP N+L+ + + +++DFGL+K +TL++
Sbjct: 127 HRDLKPDNMLISNEGHIKLTDFGLSK-VTLNR 157
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669 |
| >gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Score = 58.5 bits (141), Expect = 4e-09
Identities = 34/118 (28%), Positives = 67/118 (56%), Gaps = 5/118 (4%)
Query: 579 EFMSNGTVASFLFGDSKPNWKLRTEIAMGIAGGLFYLHEECCTQIIHCDIKPQNILLDDH 638
E M G++ L + ++ ++++ + GL YL E+ +I+H D+KP NIL++
Sbjct: 83 EHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREK--HKIMHRDVKPSNILVNSR 140
Query: 639 YNARISDFGLAKLLTLDQSHTNTAIRGTKGYVAPEWFRNMPITVKVDVYSYGVLLLEI 696
++ DFG++ L S N+ + GT+ Y++PE + +V+ D++S G+ L+E+
Sbjct: 141 GEIKLCDFGVSGQLI--DSMANSFV-GTRSYMSPERLQGTHYSVQSDIWSMGLSLVEM 195
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333 |
| >gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Score = 57.6 bits (139), Expect = 5e-09
Identities = 65/271 (23%), Positives = 119/271 (43%), Gaps = 39/271 (14%)
Query: 505 FKEELGRGAFGTVYKGFVNMGSSNHVAVKKLN-SVFQDSEKEFKAEVNGIGQTHHKNLVR 563
++E LG G GTVYK + + + +AVK + + + +K+ +E+ + + ++
Sbjct: 5 YQEILGHGNGGTVYKAYH-LLTRRILAVKVIPLDITVELQKQIMSELEILYKCDSPYIIG 63
Query: 564 LLGYCDEGQNRL-LVYEFMSNGTVASFLFGDSKPNWKLRTEIAMGIAGGLFYLHEECCTQ 622
G +NR+ + EFM G++ + P L IA+ + GL YL +
Sbjct: 64 FYGAFFV-ENRISICTEFMDGGSLDVY---RKIPEHVL-GRIAVAVVKGLTYLWS---LK 115
Query: 623 IIHCDIKPQNILLDDHYNARISDFGLAKLLTLDQSHTNTAIRGTKGYVAPEWFRNMPITV 682
I+H D+KP N+L++ ++ DFG++ L S T + GT Y+APE +
Sbjct: 116 ILHRDVKPSNMLVNTRGQVKLCDFGVSTQLV--NSIAKTYV-GTNAYMAPERISGEQYGI 172
Query: 683 KVDVYSYGVLLLEIICLRRNIDNEISKVDKAILTDWAYDRYQE--------RTLEALVEN 734
DV+S G+ +E+ L + Y + Q+ + L+ +V+
Sbjct: 173 HSDVWSLGISFMEL-----------------ALGRFPYPQIQKNQGSLMPLQLLQCIVDE 215
Query: 735 DLEAMNNVTMLHRFVMVAFWCIQEDPSHRPT 765
D + +FV C+++ P RP
Sbjct: 216 DPPVLPVGQFSEKFVHFITQCMRKQPKERPA 246
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279 |
| >gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Score = 58.1 bits (140), Expect = 8e-09
Identities = 59/226 (26%), Positives = 105/226 (46%), Gaps = 35/226 (15%)
Query: 495 YKELVEVTRGFKEE---------LGRGAFGTVYKGFVNMGSSNHVAVKKLNSVFQDSEKE 545
Y+++V R + + +GRGAFG V V SS V KL S F+ ++
Sbjct: 28 YEKIVRKIRKLQMKAEDYDVVKVIGRGAFGEVQ--LVRHKSSQKVYAMKLLSKFEMIKRS 85
Query: 546 ----FKAEVNGIGQTHHKNLVRLLGYCDEGQNRLLVYEFMSNGTVASFLFG-DSKPNW-K 599
F E + + + +V+L + + +V E+M G + + + D W K
Sbjct: 86 DSAFFWEERDIMAFANSPWVVQLFCAFQDDKYLYMVMEYMPGGDLVNLMSNYDVPEKWAK 145
Query: 600 LRT-EIAMGIAGGLFYLHEECCTQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLDQS- 657
T E+ + + +H +IH D+KP N+LLD H + +++DFG + +D++
Sbjct: 146 FYTAEVVLALDA----IHS---MGLIHRDVKPDNMLLDKHGHLKLADFGTC--MKMDETG 196
Query: 658 --HTNTAIRGTKGYVAPEWFRNMP----ITVKVDVYSYGVLLLEII 697
+TA+ GT Y++PE ++ + D +S GV L E++
Sbjct: 197 MVRCDTAV-GTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEML 241
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370 |
| >gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 57.3 bits (138), Expect = 1e-08
Identities = 52/197 (26%), Positives = 88/197 (44%), Gaps = 12/197 (6%)
Query: 505 FKEELGRGAFGTVYKGFVNMGSSNHVAVKKLNS---VFQDSEKEFKAEVNGIGQTHHKNL 561
F LG G+FG V VA+K+ + Q +E + +H
Sbjct: 34 FIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFC 93
Query: 562 VRLLGYCDEGQNRLLVYEFMSNGTVASFLFGDSKPNWKLRTEIAMGIAGGLFYLHEECCT 621
V L G + LV EF+ G +FL + N + ++ A + + E +
Sbjct: 94 VNLYGSFKDESYLYLVLEFVIGGEFFTFL----RRNKRFPNDVGCFYAAQIVLIFEYLQS 149
Query: 622 -QIIHCDIKPQNILLDDHYNARISDFGLAKLLTLDQSHTNTAIRGTKGYVAPEWFRNMPI 680
I++ D+KP+N+LLD +++DFG AK++ + T T + GT Y+APE N+
Sbjct: 150 LNIVYRDLKPENLLLDKDGFIKMTDFGFAKVV---DTRTYT-LCGTPEYIAPEILLNVGH 205
Query: 681 TVKVDVYSYGVLLLEII 697
D ++ G+ + EI+
Sbjct: 206 GKAADWWTLGIFIYEIL 222
|
Length = 340 |
| >gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Score = 57.3 bits (138), Expect = 1e-08
Identities = 34/93 (36%), Positives = 50/93 (53%), Gaps = 4/93 (4%)
Query: 605 AMGIAGGLFYLHEECCTQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLDQSHTNTAIR 664
A IA L YLH I++ D+KP+NILLD + ++DFGL K ++ + T +
Sbjct: 102 AAEIASALGYLHS---LNIVYRDLKPENILLDSQGHIVLTDFGLCK-ENIEHNGTTSTFC 157
Query: 665 GTKGYVAPEWFRNMPITVKVDVYSYGVLLLEII 697
GT Y+APE P VD + G +L E++
Sbjct: 158 GTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEML 190
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325 |
| >gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Score = 56.6 bits (136), Expect = 1e-08
Identities = 62/286 (21%), Positives = 115/286 (40%), Gaps = 50/286 (17%)
Query: 506 KEELGRGAFGTVYKGFVNMGSSNHVAVKKLNSVFQDSEKEFKA----EVNGIGQTHHKNL 561
++++GRG F VY+ + VA+KK+ +F + + +A E++ + Q +H N+
Sbjct: 7 EKKIGRGQFSEVYRATCLLDGVP-VALKKVQ-IFDLMDAKARADCIKEIDLLKQLNHPNV 64
Query: 562 VRLLGYCDEGQNRLLVYEFMSNGTVASFL--------FGDSKPNWKLRTEIAMGIAGGLF 613
++ E +V E G ++ + K WK ++ L
Sbjct: 65 IKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLC----SALE 120
Query: 614 YLHEECCTQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLDQSHTNTAIRGTKGYVAPE 673
++H +++H DIKP N+ + ++ D GL + + + ++ + GT Y++PE
Sbjct: 121 HMHSR---RVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLV-GTPYYMSPE 176
Query: 674 WFRNMPITVKVDVYSYGVLLLEIICL-------RRNIDNEISKVDKAILTDWAYDRYQER 726
K D++S G LL E+ L + N+ + K+++ D Y E
Sbjct: 177 RIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEQCDYPPLPSDHYSEE 236
Query: 727 TLEALVENDLEAMNNVTMLHRFVMVAFWCIQEDPSHRPTMRKVTQM 772
L LV CI DP RP + V +
Sbjct: 237 -LRQLVN--------------------MCINPDPEKRPDITYVYDV 261
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Score = 56.6 bits (136), Expect = 1e-08
Identities = 37/117 (31%), Positives = 61/117 (52%), Gaps = 11/117 (9%)
Query: 605 AMGIAGGLFYLHEECCTQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLDQSHTNTAIR 664
A I GL ++H +++ D+KP NILLD+H + RISD GLA + + H +
Sbjct: 103 ATEIILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHASV--- 156
Query: 665 GTKGYVAPEWF-RNMPITVKVDVYSYGVLLLEII----CLRRNIDNEISKVDKAILT 716
GT GY+APE + D +S G +L +++ R++ + ++D+ LT
Sbjct: 157 GTHGYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLT 213
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279 |
| >gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 57.0 bits (138), Expect = 1e-08
Identities = 54/218 (24%), Positives = 94/218 (43%), Gaps = 56/218 (25%)
Query: 509 LGRGAFGTVYKGFVNMGSSNHVAVKKLNSVFQ---DSEKEFKAEVNGIGQTHHKNLVRLL 565
+GRGA+G V N ++ VA+KK+ + F D+++ + E+ + H+N++ +
Sbjct: 13 IGRGAYGIVCSA-KNSETNEKVAIKKIANAFDNRIDAKRTLR-EIKLLRHLDHENVIAIK 70
Query: 566 GYCDEGQNR-----LLVYEFM---------SNGTVAS-----FLFGDSKPNWKLRTEIAM 606
+VYE M S+ T++ FL+ LR
Sbjct: 71 DIMPPPHREAFNDVYIVYELMDTDLHQIIRSSQTLSDDHCQYFLYQ------LLR----- 119
Query: 607 GIAGGLFYLHEECCTQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLDQSHTNTAIRGT 666
GL Y+H ++H D+KP N+LL+ + + +I DFGLA+ T+
Sbjct: 120 ----GLKYIHS---ANVLHRDLKPSNLLLNANCDLKICDFGLART-------TSEKGDFM 165
Query: 667 KGYVAPEWFRNMPI-------TVKVDVYSYGVLLLEII 697
YV W+R + T +DV+S G + E++
Sbjct: 166 TEYVVTRWYRAPELLLNCSEYTTAIDVWSVGCIFAELL 203
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337 |
| >gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 56.6 bits (136), Expect = 2e-08
Identities = 56/208 (26%), Positives = 90/208 (43%), Gaps = 39/208 (18%)
Query: 509 LGRGAFGTVYKGFVNMGSSNHVAVKKLNSVFQD---SEKEFKAEVNGIGQTHHKNLVRLL 565
+G GA+G+V + + VAVKKL+ FQ + + ++ E+ + H+N++ LL
Sbjct: 23 VGSGAYGSVCSAY-DTRLRQKVAVKKLSRPFQSLIHARRTYR-ELRLLKHMKHENVIGLL 80
Query: 566 GY------CDEGQNRLLVYEFMS---NGTVASFLFGDSKPNWKLRTEIAMGIAGGLFYLH 616
+ LV M N V D + + + GL Y+H
Sbjct: 81 DVFTPATSIENFNEVYLVTNLMGADLNNIVKCQKLSDEHVQF-----LIYQLLRGLKYIH 135
Query: 617 EECCTQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLDQSHTNTAIRGTKGYVAPEWFR 676
IIH D+KP N+ +++ RI DFGLA+ D T GYVA W+R
Sbjct: 136 S---AGIIHRDLKPSNVAVNEDCELRILDFGLAR--QADDEMT--------GYVATRWYR 182
Query: 677 NMPITVK-------VDVYSYGVLLLEII 697
I + VD++S G ++ E++
Sbjct: 183 APEIMLNWMHYNQTVDIWSVGCIMAELL 210
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343 |
| >gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Score = 55.3 bits (133), Expect = 4e-08
Identities = 40/137 (29%), Positives = 69/137 (50%), Gaps = 16/137 (11%)
Query: 611 GLFYLHEECCTQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLDQSHTNTAIRGTKGYV 670
GL ++H +++ D+KP NILLD+H + RISD GLA + + H + GT GY+
Sbjct: 109 GLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHASV---GTHGYM 162
Query: 671 APEWF-RNMPITVKVDVYSYGVLLLEII----CLRRNIDNEISKVDKAILT---DWAYDR 722
APE + + D +S G +L +++ R++ + ++D+ LT +
Sbjct: 163 APEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVELPDSF 222
Query: 723 YQERT--LEALVENDLE 737
E LE L++ D+
Sbjct: 223 SPELRSLLEGLLQRDVN 239
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278 |
| >gnl|CDD|173627 cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 54.8 bits (132), Expect = 4e-08
Identities = 61/216 (28%), Positives = 103/216 (47%), Gaps = 39/216 (18%)
Query: 507 EELGRGAFGTVYKG-------FVNMGSSNHVAV--KKLNSVFQDSEKEFKAEVNGIGQTH 557
E LG+G F +YKG +G V+V K L S +DS F + + Q
Sbjct: 1 EHLGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRDSL-AFFETASLMSQLS 59
Query: 558 HKNLVRLLGYCDEGQNRLLVYEFMSNGTVASFLFGDSKPN-----WKLRTEIAMGIAGGL 612
HK+LV+L G C +N ++V E++ G + FL + N WKL ++A +A L
Sbjct: 60 HKHLVKLYGVCVRDEN-IMVEEYVKFGPLDVFL--HREKNNVSLHWKL--DVAKQLASAL 114
Query: 613 FYLHEECCTQIIHCDIKPQNILLDDHYN-------ARISDFGLAK-LLTLDQSHTNTAIR 664
YL ++ +++H ++ +NIL+ + ++SD G+ +L+ ++
Sbjct: 115 HYLEDK---KLVHGNVCGKNILVARYGLNEGYVPFIKLSDPGIPITVLSREERVERIP-- 169
Query: 665 GTKGYVAPEWFRNMP--ITVKVDVYSYGVLLLEIIC 698
++APE RN +T+ D +S+G LLEI
Sbjct: 170 ----WIAPECIRNGQASLTIAADKWSFGTTLLEICS 201
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 259 |
| >gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Score = 55.4 bits (133), Expect = 4e-08
Identities = 63/260 (24%), Positives = 114/260 (43%), Gaps = 22/260 (8%)
Query: 509 LGRGAFGTVYKGFVNMGSSNHV---AVKKLNSVFQDSEKEF-KAEVNGIGQTHHKNLVRL 564
+GRG++ V V + ++ + V K V D + ++ + E + Q +
Sbjct: 3 IGRGSYAKVL--LVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVG 60
Query: 565 LGYCDEGQNRL-LVYEFMSNGTVASFLFGDSKPNWKLRTEIAMGIAGGLFYLHEECCTQI 623
L C + +RL LV E+++ G + + K + A I L +LHE I
Sbjct: 61 LHSCFQTTSRLFLVIEYVNGGDLMFHMQRQRKLPEEHARFYAAEICIALNFLHER---GI 117
Query: 624 IHCDIKPQNILLDDHYNARISDFGLAKLLTLDQSHTNTAIRGTKGYVAPEWFRNMPITVK 683
I+ D+K N+LLD + +++D+G+ K L T + GT Y+APE R
Sbjct: 118 IYRDLKLDNVLLDADGHIKLTDYGMCKE-GLGPGDTTSTFCGTPNYIAPEILRGEEYGFS 176
Query: 684 VDVYSYGVLLLEIICLRRNIDNEISKVDKAILTDWAYDRYQERTLEALVENDLEAMNNVT 743
VD ++ GVL+ E++ R D I+TD ++ + ++E + ++
Sbjct: 177 VDWWALGVLMFEMMAGRSPFD---------IITDNPDMNTEDYLFQVILEKPIRIPRFLS 227
Query: 744 MLHRFVMVAFWCIQEDPSHR 763
+ V+ F + +DP R
Sbjct: 228 VKASHVLKGF--LNKDPKER 245
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327 |
| >gnl|CDD|173688 cd05597, STKc_DMPK_like, Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 55.6 bits (134), Expect = 4e-08
Identities = 59/188 (31%), Positives = 89/188 (47%), Gaps = 36/188 (19%)
Query: 509 LGRGAFGTVYKGFVNMGSSNHV-AVKKLN--SVFQDSEKE-FKAE----VNG----IGQT 556
+GRGAFG V V M ++ V A+K LN + + +E F+ E VNG I
Sbjct: 9 IGRGAFGEV--AVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDRRWITNL 66
Query: 557 HHKNLVRLLGYCDEGQNRLLVYEFMSNGTVASFL--FGDSKPNWKLR---TEIAMGIAGG 611
H+ + DE N LV ++ G + + L F D P R E+ + I
Sbjct: 67 HY-------AFQDE-NNLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVLAIDS- 117
Query: 612 LFYLHEECCTQIIHCDIKPQNILLDDHYNARISDFG-LAKLLTLDQSHTNTAIRGTKGYV 670
+H+ +H DIKP N+LLD + + R++DFG +LL +N A+ GT Y+
Sbjct: 118 ---VHQ---LGYVHRDIKPDNVLLDKNGHIRLADFGSCLRLLADGTVQSNVAV-GTPDYI 170
Query: 671 APEWFRNM 678
+PE + M
Sbjct: 171 SPEILQAM 178
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, and cardiac conduction defects. The genetic basis for DM1 is the mutational expansion of a CTG repeat in the 3'-UTR of DMPK. DMPK is expressed in skeletal and cardiac muscles, and in central nervous tissues. The functional role of DMPK is not fully understood. It may play a role in the signal transduction and homeostasis of calcium. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKgamma is expressed in heart and skeletal muscles, unlike MRCKalpha and MRCKbeta, which are expressed ubiquitously. Length = 331 |
| >gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 55.1 bits (132), Expect = 5e-08
Identities = 57/201 (28%), Positives = 96/201 (47%), Gaps = 23/201 (11%)
Query: 507 EELGRGAFGTVYKGFVNMGSSNHVAVKKLNSVFQDSE-KEFKA--EVNGIGQTHHKNLVR 563
E+LG G++ TVYKG + + VA+K + Q+ E F A E + + H N+V
Sbjct: 11 EKLGEGSYATVYKGKSKV-NGKLVALKVIR--LQEEEGTPFTAIREASLLKGLKHANIVL 67
Query: 564 LLGYCDEGQNRLLVYEFMSNGTVASFLFGDSKP------NWKLRTEIAMGIAGGLFYLHE 617
L + LV+E++ + D P N KL + GL Y+H+
Sbjct: 68 LHDIIHTKETLTLVFEYVHTDLCQ---YMDKHPGGLHPENVKL---FLFQLLRGLSYIHQ 121
Query: 618 ECCTQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLDQSHTNTAIRGTKGYVAPE-WFR 676
I+H D+KPQN+L+ D +++DFGLA+ ++ SHT + T Y P+
Sbjct: 122 R---YILHRDLKPQNLLISDTGELKLADFGLARAKSV-PSHTYSNEVVTLWYRPPDVLLG 177
Query: 677 NMPITVKVDVYSYGVLLLEII 697
+ + +D++ G + +E+I
Sbjct: 178 STEYSTCLDMWGVGCIFVEMI 198
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303 |
| >gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 55.1 bits (133), Expect = 6e-08
Identities = 52/207 (25%), Positives = 87/207 (42%), Gaps = 35/207 (16%)
Query: 507 EELGRGAFGTVY-------KGFVNMGSSNHVAVKKLNSVFQDSEKEFKAEVNGIGQTHHK 559
++G+G +G V+ V + + KLN V + E + + T +
Sbjct: 7 TQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEV-----RHVLTERDILTTTKSE 61
Query: 560 NLVRLLGYCDEGQNRLLVYEFMSNGTVASFLFGDSKPNWKLRTEIAMGIAGGLFYLHEEC 619
LV+LL + + L E++ G + L L + A FY+ E
Sbjct: 62 WLVKLLYAFQDDEYLYLAMEYVPGGDFRTLL----NNLGVLSEDHAR------FYMAEMF 111
Query: 620 CT-------QIIHCDIKPQNILLDDHYNARISDFGLAK-LLTLDQSHTNTAIRGTKGYVA 671
IH D+KP+N L+D + +++DFGL+K ++T S + G+ Y+A
Sbjct: 112 EAVDALHELGYIHRDLKPENFLIDASGHIKLTDFGLSKGIVTYANS-----VVGSPDYMA 166
Query: 672 PEWFRNMPITVKVDVYSYGVLLLEIIC 698
PE R VD +S G +L E +C
Sbjct: 167 PEVLRGKGYDFTVDYWSLGCMLYEFLC 193
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333 |
| >gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 54.8 bits (132), Expect = 6e-08
Identities = 57/200 (28%), Positives = 95/200 (47%), Gaps = 20/200 (10%)
Query: 509 LGRGAFGTVYKGFVNMGSSNH--VAVKKLNSVF----QDSEKEFKAEVNGIGQTHHKNLV 562
LG+G +G V++ G+ A+K L Q KAE N + H +V
Sbjct: 4 LGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIV 63
Query: 563 RLLGYCDEGQNRLLVYEFMSNGTVASFL-----FGDSKPNWKLRTEIAMGIAGGLFYLHE 617
L+ G L+ E++S G + L F + + L +EI++ + +LH+
Sbjct: 64 DLIYAFQTGGKLYLILEYLSGGELFMHLEREGIFMEDTACFYL-SEISLALE----HLHQ 118
Query: 618 ECCTQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLDQSHTNTAIRGTKGYVAPEWFRN 677
+ II+ D+KP+NILLD + +++DFGL K + + T+T GT Y+APE
Sbjct: 119 Q---GIIYRDLKPENILLDAQGHVKLTDFGLCKESIHEGTVTHTFC-GTIEYMAPEILMR 174
Query: 678 MPITVKVDVYSYGVLLLEII 697
VD +S G L+ +++
Sbjct: 175 SGHGKAVDWWSLGALMYDML 194
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323 |
| >gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 55.0 bits (133), Expect = 6e-08
Identities = 31/94 (32%), Positives = 50/94 (53%), Gaps = 14/94 (14%)
Query: 611 GLFYLHEECCTQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLDQSHTNTAIRGTKGYV 670
GL Y+H ++H D+KP N+LL+ + + +I DFGLA++ + HT YV
Sbjct: 118 GLKYIHS---ANVLHRDLKPSNLLLNTNCDLKICDFGLARIADPEHDHT----GFLTEYV 170
Query: 671 APEWFRNMPI-------TVKVDVYSYGVLLLEII 697
A W+R I T +D++S G +L E++
Sbjct: 171 ATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEML 204
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336 |
| >gnl|CDD|173713 cd05624, STKc_MRCK_beta, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Score = 55.0 bits (132), Expect = 7e-08
Identities = 62/206 (30%), Positives = 100/206 (48%), Gaps = 29/206 (14%)
Query: 509 LGRGAFGTVYKGFVNMGSSNHV-AVKKLN--SVFQDSEKE-FKAE----VNGIGQTHHKN 560
+GRGAFG V V M + + A+K LN + + +E F+ E VNG Q
Sbjct: 9 IGRGAFGEV--AVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDCQ----- 61
Query: 561 LVRLLGYCDEGQNRL-LVYEFMSNGTVASFL--FGDSKPNWKLRTEIA-MGIAGGLFYLH 616
+ L Y + +N L LV ++ G + + L F D P R IA M +A + +H
Sbjct: 62 WITTLHYAFQDENYLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYIAEMVLA--IHSIH 119
Query: 617 EECCTQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLDQSHTNTAIRGTKGYVAPEWFR 676
+ +H DIKP N+LLD + + R++DFG + D + ++ GT Y++PE +
Sbjct: 120 QL---HYVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQDGTVQSSVAVGTPDYISPEILQ 176
Query: 677 NMPITV-----KVDVYSYGVLLLEII 697
M + + D +S GV + E++
Sbjct: 177 AMEDGMGKYGPECDWWSLGVCMYEML 202
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. Length = 331 |
| >gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 55.0 bits (132), Expect = 7e-08
Identities = 50/173 (28%), Positives = 79/173 (45%), Gaps = 31/173 (17%)
Query: 608 IAGGLFYLHEECCTQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLDQSHTNT-AIRGT 666
+A G+ +L C IH D+ +NILL ++ +I DFGLA+ + D + + R
Sbjct: 183 VARGMEFLASRKC---IHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSARLP 239
Query: 667 KGYVAPEWFRNMPITVKVDVYSYGVLLLEIICLRRN------IDNEISKVDKAILTDWAY 720
++APE + T + DV+S+GVLL EI L + I+ E +
Sbjct: 240 LKWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQINEEFCQ----------- 288
Query: 721 DRYQERTLEALVENDLEAMNNVTMLHRFVMVAFWCIQEDPSHRPTMRKVTQML 773
R ++ T + A N T +M+A W Q DP RPT + ++L
Sbjct: 289 -RLKDGT-------RMRAPENATPEIYRIMLACW--QGDPKERPTFSALVEIL 331
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. VEGFR3 preferentially binds the ligands VEGFC and VEGFD. VEGFR3 is essential for lymphatic endothelial cell (EC) development and function. It has been shown to regulate adaptive immunity during corneal transplantation. VEGFR3 is upregulated on blood vascular ECs in pathological conditions such as vascular tumors and the periphery of solid tumors. It plays a role in cancer progression and lymph node metastasis. Missense mutations in the VEGFR3 gene are associated with primary human lymphedema. Length = 338 |
| >gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Score = 54.7 bits (131), Expect = 7e-08
Identities = 58/203 (28%), Positives = 92/203 (45%), Gaps = 12/203 (5%)
Query: 509 LGRGAFGTVYKGFVNMGSSNHVAVKKLNS---VFQDSEKEFKAEVNGIGQTHHKNLVRLL 565
LG+G FG V S + A+K L + +D E + T H L L
Sbjct: 3 LGKGTFGKVIL-VREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSL- 60
Query: 566 GYCDEGQNRL-LVYEFMSNGTVASFLFGDSKPNWKLRTEI-AMGIAGGLFYLHEECCTQI 623
Y + ++RL V E+++ G + F + + RT I L YLH +I
Sbjct: 61 KYSFQTKDRLCFVMEYVNGGELF-FHLSRERVFSEDRTRFYGAEIVSALDYLHS---GKI 116
Query: 624 IHCDIKPQNILLDDHYNARISDFGLAKLLTLDQSHTNTAIRGTKGYVAPEWFRNMPITVK 683
++ D+K +N++LD + +I+DFGL K D + T GT Y+APE +
Sbjct: 117 VYRDLKLENLMLDKDGHIKITDFGLCKEGITDAATMKTFC-GTPEYLAPEVLEDNDYGRA 175
Query: 684 VDVYSYGVLLLEIICLRRNIDNE 706
VD + GV++ E++C R N+
Sbjct: 176 VDWWGLGVVMYEMMCGRLPFYNQ 198
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328 |
| >gnl|CDD|173643 cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 54.2 bits (130), Expect = 7e-08
Identities = 71/288 (24%), Positives = 119/288 (41%), Gaps = 56/288 (19%)
Query: 507 EELGRGAFGTVYKGFVNMGSSNH-----------VAVKKLNSVFQDSEKEFKAEVNGIGQ 555
E LGRG +Y G +N + V +K L+ +D F + + Q
Sbjct: 1 EHLGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSHRDISLAFFETASMMRQ 60
Query: 556 THHKNLVRLLGYCDEGQNRLLVYEFMSNGTVASFLFGDSKP---NWKLRTEIAMGIAGGL 612
HK++V L G C ++V EF+ G + F+ S WK + +A +A L
Sbjct: 61 VSHKHIVLLYGVCVRDVENIMVEEFVEFGPLDLFMHRKSDVLTTPWKFK--VAKQLASAL 118
Query: 613 FYLHEECCTQIIHCDIKPQNILL-----DDHYNA--RISDFGLAKLLTLDQSHTNTAIRG 665
YL ++ ++H ++ +NILL D ++SD G+ + L + I
Sbjct: 119 SYLEDK---DLVHGNVCTKNILLAREGIDGECGPFIKLSDPGIP-ITVLSRQECVERIP- 173
Query: 666 TKGYVAPEWFRNMP-ITVKVDVYSYGVLLLEIICLRRNIDNEISKVDKAILTDWAYDRYQ 724
++APE + +++ D +S+G L E IC + EI DK + +
Sbjct: 174 ---WIAPECVEDSKNLSIAADKWSFGTTLWE-ICY----NGEIPLKDKTLAE-------K 218
Query: 725 ERTLEA---LVENDLEAMNNVTMLHRFVMVAFWCIQEDPSHRPTMRKV 769
ER E LV + + ++ M H C+ DP+ RP R +
Sbjct: 219 ERFYEGQCMLVTPSCKELADL-MTH--------CMNYDPNQRPFFRAI 257
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 262 |
| >gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Score = 54.7 bits (131), Expect = 7e-08
Identities = 51/201 (25%), Positives = 94/201 (46%), Gaps = 11/201 (5%)
Query: 509 LGRGAFGTVYKGFVNMGSSNHV-AVKKLNSVFQDSEKEF---KAEVNGIGQTHHKNLVRL 564
+GRG++ V V + + + A+K + + +++ + E + Q + +
Sbjct: 3 IGRGSYAKVL--LVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVG 60
Query: 565 LGYCDEGQNRLL-VYEFMSNGTVASFLFGDSKPNWKLRTEIAMGIAGGLFYLHEECCTQI 623
L C + ++RL V E+++ G + + K + + I+ L YLHE I
Sbjct: 61 LHSCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHER---GI 117
Query: 624 IHCDIKPQNILLDDHYNARISDFGLAKLLTLDQSHTNTAIRGTKGYVAPEWFRNMPITVK 683
I+ D+K N+LLD + +++D+G+ K L T + GT Y+APE R
Sbjct: 118 IYRDLKLDNVLLDSEGHIKLTDYGMCKE-GLRPGDTTSTFCGTPNYIAPEILRGEDYGFS 176
Query: 684 VDVYSYGVLLLEIICLRRNID 704
VD ++ GVL+ E++ R D
Sbjct: 177 VDWWALGVLMFEMMAGRSPFD 197
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329 |
| >gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Score = 54.5 bits (131), Expect = 8e-08
Identities = 54/196 (27%), Positives = 94/196 (47%), Gaps = 15/196 (7%)
Query: 509 LGRGAFGTVYKGFVNMGSSNHVAVK--KLNSVFQDSEKE---FKAEVNGIGQTHHKNLVR 563
LG+G+FG V + G+ A+K K + + QD + + + + + H +
Sbjct: 3 LGKGSFGKVMLAELK-GTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKH--PFLT 59
Query: 564 LLGYCDEGQNRLL-VYEFMSNGTVASFLFGDSKPNWKLRTEI-AMGIAGGLFYLHEECCT 621
L C + ++RL V E++ NG F S+ + R+ A + L +LH
Sbjct: 60 ALHCCFQTKDRLFFVMEYV-NGGDLMFQIQRSRKFDEPRSRFYAAEVTLALMFLHRH--- 115
Query: 622 QIIHCDIKPQNILLDDHYNARISDFGLAKLLTLDQSHTNTAIRGTKGYVAPEWFRNMPIT 681
+I+ D+K NILLD + +++DFG+ K + T T GT Y+APE + +
Sbjct: 116 GVIYRDLKLDNILLDAEGHCKLADFGMCKE-GILNGVTTTTFCGTPDYIAPEILQELEYG 174
Query: 682 VKVDVYSYGVLLLEII 697
VD ++ GVL+ E++
Sbjct: 175 PSVDWWALGVLMYEMM 190
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321 |
| >gnl|CDD|165473 PHA03207, PHA03207, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 54.5 bits (131), Expect = 1e-07
Identities = 42/159 (26%), Positives = 66/159 (41%), Gaps = 15/159 (9%)
Query: 549 EVNGIGQTHHKNLVRLLGYCDEGQNRLLVYEFMSNGTVASFLFGDSKPNWKLRTEIAM-- 606
E++ + H+ ++ L+ + + V M F + D L I +
Sbjct: 136 EIDILKTISHRAIINLI---HAYRWKSTVCMVMPKYKCDLFTYVDRSGPLPLEQAITIQR 192
Query: 607 GIAGGLFYLHEECCTQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLDQSHTNT----A 662
+ L YLH IIH D+K +NI LD+ NA + DFG A L +H +T
Sbjct: 193 RLLEALAYLHGR---GIIHRDVKTENIFLDEPENAVLGDFGAACKLD---AHPDTPQCYG 246
Query: 663 IRGTKGYVAPEWFRNMPITVKVDVYSYGVLLLEIICLRR 701
GT +PE P K D++S G++L E+
Sbjct: 247 WSGTLETNSPELLALDPYCAKTDIWSAGLVLFEMSVKNV 285
|
Length = 392 |
| >gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Score = 54.3 bits (130), Expect = 1e-07
Identities = 51/196 (26%), Positives = 84/196 (42%), Gaps = 9/196 (4%)
Query: 509 LGRGAFGTVYKGFVNMGSSNH---VAVKKLNSVFQDSEKEFKAEVNGIGQTHHKNLVRLL 565
LG+G FG V V ++ + + K + E N + Q + L
Sbjct: 3 LGKGTFGKVI--LVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTAL 60
Query: 566 GYCDEGQNRL-LVYEFMSNGTVASFLFGDSKPNWKLRTEIAMGIAGGLFYLHEECCTQII 624
Y + +RL V E+ + G + L + + I L YLH E ++
Sbjct: 61 KYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALDYLHSE--KNVV 118
Query: 625 HCDIKPQNILLDDHYNARISDFGLAKLLTLDQSHTNTAIRGTKGYVAPEWFRNMPITVKV 684
+ D+K +N++LD + +I+DFGL K D + T GT Y+APE + V
Sbjct: 119 YRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKTFC-GTPEYLAPEVLEDNDYGRAV 177
Query: 685 DVYSYGVLLLEIICLR 700
D + GV++ E++C R
Sbjct: 178 DWWGLGVVMYEMMCGR 193
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325 |
| >gnl|CDD|173690 cd05599, STKc_NDR_like, Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 54.3 bits (131), Expect = 1e-07
Identities = 61/243 (25%), Positives = 94/243 (38%), Gaps = 72/243 (29%)
Query: 509 LGRGAFGTVYKGFVNMGSSNHV-AVKKLNS---VFQDSEKEFKAEVNGIGQTHHKNLVRL 564
+GRGAFG V V + H+ A+KKL + ++ +AE + + + + +V+L
Sbjct: 9 IGRGAFGEVR--LVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADNPWVVKL 66
Query: 565 LGYC---DEGQNRLLVYEFMSNGTVASFLFGDSKPNWKLRTEIAMGIAGGLFYLHEECCT 621
Y DE L+ E++ G + + L K + E FY+ E
Sbjct: 67 --YYSFQDE-NYLYLIMEYLPGGDMMTLLM---KKD-TFTEEET------RFYI-AETIL 112
Query: 622 QI--------IHCDIKPQNILLDDHYNARISDFGLAKLLTLDQSHTNTAIR--------- 664
I IH DIKP N+LLD + ++SDFGL L +SH R
Sbjct: 113 AIDSIHKLGYIHRDIKPDNLLLDAKGHIKLSDFGLCT--GLKKSHRTEFYRILSHALPSN 170
Query: 665 ------------------------------GTKGYVAPEWFRNMPITVKVDVYSYGVLLL 694
GT Y+APE F + D +S GV++
Sbjct: 171 FLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWSLGVIMY 230
Query: 695 EII 697
E++
Sbjct: 231 EML 233
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplication. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. This subfamily also contains fungal NDR-like kinases. Length = 364 |
| >gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Score = 53.4 bits (128), Expect = 1e-07
Identities = 62/282 (21%), Positives = 119/282 (42%), Gaps = 46/282 (16%)
Query: 506 KEELGRGAFGTVY-------KGFVNMGSSNHVAVKKLNSVFQDSEKEFKAEVNGIGQTHH 558
++ LG+G+FGTVY + + V +LN + + E + + H
Sbjct: 5 QQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNP---NETVQANQEAQLLSKLDH 61
Query: 559 KNLVRLLGYCDEGQNRLLVYEFMSNGTVASFLFGDSKPNWKLRTEIAM-----GIAGGLF 613
+V+ E ++ E+ G + K K +E + + G+
Sbjct: 62 PAIVKFHASFLERDAFCIITEY-CEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVH 120
Query: 614 YLHEECCTQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLDQSHTNTAIRGTKGYVAPE 673
Y+H+ +I+H D+K +NI L ++ +I DFG+++LL + T GT Y++PE
Sbjct: 121 YMHQR---RILHRDLKAKNIFLKNNL-LKIGDFGVSRLL-MGSCDLATTFTGTPYYMSPE 175
Query: 674 WFRNMPITVKVDVYSYGVLLLEIICLRRNID--NEISKVDKAILTDWAY--DRYQERTLE 729
++ K D++S G +L E+ CL + N +S V + + + Y R L
Sbjct: 176 ALKHQGYDSKSDIWSLGCILYEMCCLAHAFEGQNFLSVVLRIVEGPTPSLPETY-SRQLN 234
Query: 730 ALVENDLEAMNNVTMLHRFVMVAFWCIQEDPSHRPTMRKVTQ 771
+++++ L +DPS RP+ ++ +
Sbjct: 235 SIMQSMLN--------------------KDPSLRPSAAEILR 256
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260 |
| >gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Score = 53.3 bits (128), Expect = 2e-07
Identities = 29/77 (37%), Positives = 42/77 (54%), Gaps = 2/77 (2%)
Query: 623 IIHCDIKPQNILLDDHYNARISDFGLAKLLTLDQSHTNTAIRGTKGYVAPEWFRNMPI-- 680
II+ DIK +NILLD + ++DFGL+K ++ + GT Y+APE R
Sbjct: 126 IIYRDIKLENILLDSEGHVVLTDFGLSKEFLAEEEERAYSFCGTIEYMAPEVIRGGSGGH 185
Query: 681 TVKVDVYSYGVLLLEII 697
VD +S GVL E++
Sbjct: 186 DKAVDWWSLGVLTFELL 202
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288 |
| >gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 53.4 bits (129), Expect = 2e-07
Identities = 43/179 (24%), Positives = 66/179 (36%), Gaps = 63/179 (35%)
Query: 510 GRGAFGTVYKGFVNMGSSNHV-AVKKLNSVFQDSEKEFKAEVNGIGQT-----------H 557
GRG +G VYK G A+KK K K + GI Q+
Sbjct: 9 GRGTYGRVYKAKRKNGKDGKEYAIKKF--------KGDKEQYTGISQSACREIALLRELK 60
Query: 558 HKNLVRLLGYCDEGQNRL--LVYEF-------------------MSNGTVASFLFGDSKP 596
H+N+V L+ E ++ L++++ + V S L+
Sbjct: 61 HENVVSLVEVFLEHADKSVYLLFDYAEHDLWQIIKFHRQAKRVSIPPSMVKSLLWQ---- 116
Query: 597 NWKLRTEIAMGIAGGLFYLHEECCTQIIHCDIKPQNILL----DDHYNARISDFGLAKL 651
I G+ YLH ++H D+KP NIL+ + +I D GLA+L
Sbjct: 117 -----------ILNGVHYLHS---NWVLHRDLKPANILVMGEGPERGVVKIGDLGLARL 161
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316 |
| >gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 53.7 bits (129), Expect = 2e-07
Identities = 33/93 (35%), Positives = 50/93 (53%), Gaps = 4/93 (4%)
Query: 608 IAGGLFYLHEECCTQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLDQSHT-NTAIRGT 666
+A G+ +L C IH D+ +NILL ++ +I DFGLA+ + D + R
Sbjct: 182 VARGMEFLASRKC---IHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLP 238
Query: 667 KGYVAPEWFRNMPITVKVDVYSYGVLLLEIICL 699
++APE + T + DV+S+GVLL EI L
Sbjct: 239 LKWMAPESIFDKVYTTQSDVWSFGVLLWEIFSL 271
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337 |
| >gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 53.5 bits (128), Expect = 2e-07
Identities = 50/208 (24%), Positives = 96/208 (46%), Gaps = 39/208 (18%)
Query: 507 EELGRGAFGTVYKGFVNMGSSNHVAVKKLNSVFQDSEK-EFKAEVNGIGQTHHKNLVRLL 565
E+LG G + TV+KG + + N VA+K++ ++ EV+ + H N+V L
Sbjct: 12 EKLGEGTYATVFKGRSKL-TENLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLH 70
Query: 566 GYCDEGQNRLLVYEF---------------MSNGTVASFLFGDSKPNWKLRTEIAMGIAG 610
++ LV+E+ MS V FL+ I
Sbjct: 71 DIVHTDKSLTLVFEYLDKDLKQYMDDCGNIMSMHNVKIFLYQ---------------ILR 115
Query: 611 GLFYLHEECCTQIIHCDIKPQNILLDDHYNARISDFGLAKLLTL-DQSHTNTAIRGTKGY 669
GL Y H +++H D+KPQN+L+++ +++DFGLA+ ++ ++++N + T Y
Sbjct: 116 GLAYCHRR---KVLHRDLKPQNLLINERGELKLADFGLARAKSVPTKTYSNEVV--TLWY 170
Query: 670 VAPE-WFRNMPITVKVDVYSYGVLLLEI 696
P+ + + ++D++ G + E+
Sbjct: 171 RPPDVLLGSSEYSTQIDMWGVGCIFFEM 198
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309 |
| >gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 53.5 bits (128), Expect = 2e-07
Identities = 50/173 (28%), Positives = 76/173 (43%), Gaps = 31/173 (17%)
Query: 608 IAGGLFYLHEECCTQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLDQSHTNTA-IRGT 666
+A G+ +L C IH D+ +NILL ++ +I DFGLA+ + D + R
Sbjct: 188 VAKGMEFLASRKC---IHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLP 244
Query: 667 KGYVAPEWFRNMPITVKVDVYSYGVLLLEIICLRRN------IDNEISKVDKAILTDWAY 720
++APE + T++ DV+S+GVLL EI L + ID E +
Sbjct: 245 LKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCR----------- 293
Query: 721 DRYQERTLEALVENDLEAMNNVTMLHRFVMVAFWCIQEDPSHRPTMRKVTQML 773
R +E T + M TML C +PS RPT ++ + L
Sbjct: 294 -RLKEGTRMRAPDYTTPEMYQ-TMLD--------CWHGEPSQRPTFSELVEHL 336
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343 |
| >gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Score = 53.1 bits (128), Expect = 2e-07
Identities = 61/205 (29%), Positives = 88/205 (42%), Gaps = 32/205 (15%)
Query: 509 LGRGAFGTV----YKGFVNMGSSNHVAVKKLNSVF---QD------SEKEFKAEVNGIGQ 555
LGRG FG V YK + A+K L +D EK N
Sbjct: 7 LGRGHFGKVLLAEYKK-----TGELYAIKALKKGDIIARDEVESLMCEKRIFETANSER- 60
Query: 556 THHKNLVRLLGYCDEGQNRL-LVYEFMSNGTVASFLFGD--SKPNWKLRTEIAMGIAGGL 612
H LV L C + ++ + V E+ + G + + D S+P A + GL
Sbjct: 61 --HPFLVNLFA-CFQTEDHVCFVMEYAAGGDLMMHIHTDVFSEPRAVF---YAACVVLGL 114
Query: 613 FYLHEECCTQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLDQSHTNTAIRGTKGYVAP 672
YLHE +I++ D+K N+LLD +I+DFGL K T+T GT ++AP
Sbjct: 115 QYLHEN---KIVYRDLKLDNLLLDTEGFVKIADFGLCKEGMGFGDRTSTFC-GTPEFLAP 170
Query: 673 EWFRNMPITVKVDVYSYGVLLLEII 697
E T VD + GVL+ E++
Sbjct: 171 EVLTETSYTRAVDWWGLGVLIYEML 195
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324 |
| >gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Score = 53.3 bits (128), Expect = 2e-07
Identities = 56/208 (26%), Positives = 94/208 (45%), Gaps = 26/208 (12%)
Query: 509 LGRGAFGTVYKGFVNMGSSNHV-AVKKLN-SVFQDSEK--EFKAEVNGIGQTHHKNLVRL 564
+GRG FG V V ++ + A+K + SV E F+ E + + ++ + +L
Sbjct: 9 VGRGHFGEVQ--VVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPWIPQL 66
Query: 565 LGYCDEGQNRLLVYEFMSNGTVASFL------FGDSKPNWKLRTEIAMGIAGGLFYLHEE 618
+ N LV E+ G + S L F + + L E+ + I +H+
Sbjct: 67 QYAFQDKDNLYLVMEYQPGGDLLSLLNRYEDQFDEDMAQFYL-AELVLAIHS----VHQ- 120
Query: 619 CCTQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLDQSHTNTAIRGTKGYVAPEWFRNM 678
+H DIKP+N+L+D + +++DFG A LT ++ + GT Y+APE M
Sbjct: 121 --MGYVHRDIKPENVLIDRTGHIKLADFGSAARLTANKMVNSKLPVGTPDYIAPEVLTTM 178
Query: 679 ------PITVKVDVYSYGVLLLEIICLR 700
V+ D +S GV+ E+I R
Sbjct: 179 NGDGKGTYGVECDWWSLGVIAYEMIYGR 206
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330 |
| >gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Score = 52.7 bits (126), Expect = 2e-07
Identities = 61/273 (22%), Positives = 118/273 (43%), Gaps = 35/273 (12%)
Query: 507 EELGRGAFGTVYKGFVNMGSSNHVAVKKLNSVFQDSEKEFKAEVNGIGQTHHKNLVRLLG 566
+ +G G +G VYK N+ + AVK + D + E+ + + H N+V G
Sbjct: 15 QRVGSGTYGDVYKA-RNLHTGELAAVKIIKLEPGDDFSLIQQEIFMVKECKHCNIVAYFG 73
Query: 567 YCDEGQNRLLVYEFMSNGTVASFLFGDSKPNWKLRTE-IAMGIAGGLFYLHEECCTQIIH 625
+ + E+ G++ ++ + P +L+ + GL YLH + +H
Sbjct: 74 SYLSREKLWICMEYCGGGSLQD-IYHVTGPLSELQIAYVCRETLQGLAYLHSK---GKMH 129
Query: 626 CDIKPQNILLDDHYNARISDFGLAKLLTLDQSHTNTAIRGTKGYVAPEWF---RNMPITV 682
DIK NILL D+ + +++DFG+A +T + + I GT ++APE +N
Sbjct: 130 RDIKGANILLTDNGDVKLADFGVAAKITATIAKRKSFI-GTPYWMAPEVAAVEKNGGYNQ 188
Query: 683 KVDVYSYGVLLLEIICLRRNIDNEISKVDKAILTDWAYDRYQERTLEALVENDL------ 736
D+++ G+ +E+ A L +D + R L + +++
Sbjct: 189 LCDIWAVGITAIEL----------------AELQPPMFDLHPMRALFLMSKSNFQPPKLK 232
Query: 737 EAMNNVTMLHRFVMVAFWCIQEDPSHRPTMRKV 769
+ + H FV ++ + ++P RPT ++
Sbjct: 233 DKTKWSSTFHNFVKIS---LTKNPKKRPTAERL 262
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267 |
| >gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Score = 52.7 bits (126), Expect = 3e-07
Identities = 54/195 (27%), Positives = 91/195 (46%), Gaps = 16/195 (8%)
Query: 509 LGRGAFGTVYKGFVNMGSSNHVAVKKLNSVFQDSE--KEFKA----EVNGIGQTHHKNLV 562
+G GA+G V K + + VA+KK F+DSE +E K E+ + +N+V
Sbjct: 9 VGEGAYGVVLK-CRHKETKEIVAIKK----FKDSEENEEVKETTLRELKMLRTLKQENIV 63
Query: 563 RLLGYCDEGQNRLLVYEFMSNGTVASFL-FGDSKPNWKLRTEIAMGIAGGLFYLHEECCT 621
L LV+E++ + + P K+R+ I I + + H+
Sbjct: 64 ELKEAFRRRGKLYLVFEYVEKNMLELLEEMPNGVPPEKVRSYIYQLIKA-IHWCHK---N 119
Query: 622 QIIHCDIKPQNILLDDHYNARISDFGLAKLLTLDQSHTNTAIRGTKGYVAPEWFRNMPIT 681
I+H DIKP+N+L+ + ++ DFG A+ L+ + T T+ Y +PE P
Sbjct: 120 DIVHRDIKPENLLISHNDVLKLCDFGFARNLSEGSNANYTEYVATRWYRSPELLLGAPYG 179
Query: 682 VKVDVYSYGVLLLEI 696
VD++S G +L E+
Sbjct: 180 KAVDMWSVGCILGEL 194
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287 |
| >gnl|CDD|88524 cd05623, STKc_MRCK_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Score = 52.8 bits (126), Expect = 3e-07
Identities = 58/202 (28%), Positives = 97/202 (48%), Gaps = 21/202 (10%)
Query: 509 LGRGAFGTVYKGFVNMGSSNHV-AVKKLN--SVFQDSEKE-FKAEVNGIGQTHHKNLVRL 564
+GRGAFG V V + +++ V A+K LN + + +E F+ E + + ++ + L
Sbjct: 9 IGRGAFGEV--AVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQWITTL 66
Query: 565 LGYCDEGQNRLLVYEFMSNGTVASFL--FGDSKPNWKLRTEIA-MGIA-GGLFYLHEECC 620
+ N LV ++ G + + L F D P R +A M IA + LH
Sbjct: 67 HYAFQDENNLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVIAIDSVHQLH---- 122
Query: 621 TQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLDQSHTNTAIRGTKGYVAPEWFRNMP- 679
+H DIKP NIL+D + + R++DFG L D + ++ GT Y++PE + M
Sbjct: 123 --YVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQSSVAVGTPDYISPEILQAMED 180
Query: 680 ----ITVKVDVYSYGVLLLEII 697
+ D +S GV + E++
Sbjct: 181 GKGKYGPECDWWSLGVCMYEML 202
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathway. Length = 332 |
| >gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 52.7 bits (126), Expect = 3e-07
Identities = 54/206 (26%), Positives = 103/206 (50%), Gaps = 27/206 (13%)
Query: 507 EELGRGAFGTVYKGFVNMGSSNHVAVKKLNSVFQDSEKEFKA------EVNGIGQTHHKN 560
++LG G + TVYKG + + N VA+K++ E E A EV+ + H N
Sbjct: 12 DKLGEGTYATVYKGRSKL-TDNLVALKEIR-----LEHEEGAPCTAIREVSLLKDLKHAN 65
Query: 561 LVRLLGYCDEGQNRLLVYEFMSNGTVASFL--FGDS--KPNWKLRTEIAMGIAGGLFYLH 616
+V L ++ LV+E++ + + +L G+S N KL + GL Y H
Sbjct: 66 IVTLHDIIHTEKSLTLVFEYL-DKDLKQYLDDCGNSINMHNVKL---FLFQLLRGLNYCH 121
Query: 617 EECCTQIIHCDIKPQNILLDDHYNARISDFGLAKLLTL-DQSHTNTAIRGTKGYVAPE-W 674
+++H D+KPQN+L+++ +++DFGLA+ ++ ++++N + T Y P+
Sbjct: 122 RR---KVLHRDLKPQNLLINERGELKLADFGLARAKSIPTKTYSNEVV--TLWYRPPDIL 176
Query: 675 FRNMPITVKVDVYSYGVLLLEIICLR 700
+ + ++D++ G + E+ R
Sbjct: 177 LGSTDYSTQIDMWGVGCIFYEMSTGR 202
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301 |
| >gnl|CDD|238531 cd01098, PAN_AP_plant, Plant PAN/APPLE-like domain; present in plant S-receptor protein kinases and secreted glycoproteins | Back alignment and domain information |
|---|
Score = 48.2 bits (115), Expect = 3e-07
Identities = 19/87 (21%), Positives = 36/87 (41%), Gaps = 8/87 (9%)
Query: 343 LGCEEDGKKSGEDLYYIEELRNTDWPTSDYEQISPYGKDECVSSCLKDCQCSAAVLRDD- 401
L C DG D + +L + P + I+ +EC +CL +C C+A +
Sbjct: 3 LNCGGDG---STDGFL--KLPDVKLPDNAS-AITAISLEECREACLSNCSCTAYAYNNGS 56
Query: 402 -TCWKKKLPLSYGKTDRDETGTTFIKI 427
C L+ ++ GT ++++
Sbjct: 57 GGCLLWNGLLNNLRSLSSGGGTLYLRL 83
|
PAN/APPLE domains fulfill diverse biological functions by mediating protein-protein or protein-carbohydrate interactions. S-receptor protein kinases and S-locus glycoproteins are involved in sporophytic self-incompatibility response in Brassica, one of probably many molecular mechanisms, by which hermaphrodite flowering plants avoid self-fertilization. Length = 84 |
| >gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 52.9 bits (127), Expect = 3e-07
Identities = 58/211 (27%), Positives = 97/211 (45%), Gaps = 34/211 (16%)
Query: 507 EELGRGAFGTVYKGFVNMGSSNHVAVKKLNSVFQ---DSEKEFKAEVNGIGQTHHKNLVR 563
E +G+G++G V ++ + VA+KK+N VF+ D+ + + E+ + H ++V
Sbjct: 6 EVIGKGSYGVVCSA-IDTHTGEKVAIKKINDVFEHVSDATRILR-EIKLLRLLRHPDIVE 63
Query: 564 LLGYC-----DEGQNRLLVYEFMSNGTVASFLFGDSKPNWKLRTE----IAMGIAGGLFY 614
+ E ++ +V+E M S L K N L E + L Y
Sbjct: 64 IKHIMLPPSRREFKDIYVVFELME-----SDLHQVIKANDDLTPEHHQFFLYQLLRALKY 118
Query: 615 LHEECCTQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLDQSHTNTAIRGTKGYVAPEW 674
+H + H D+KP+NIL + +I DFGLA++ D T TAI T YVA W
Sbjct: 119 IHT---ANVFHRDLKPKNILANADCKLKICDFGLARVAFND---TPTAIFWTD-YVATRW 171
Query: 675 FRNMPI--------TVKVDVYSYGVLLLEII 697
+R + T +D++S G + E++
Sbjct: 172 YRAPELCGSFFSKYTPAIDIWSIGCIFAEVL 202
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338 |
| >gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Score = 52.5 bits (126), Expect = 3e-07
Identities = 31/93 (33%), Positives = 49/93 (52%), Gaps = 4/93 (4%)
Query: 608 IAGGLFYLHEECCTQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLDQSHTNTAIRGTK 667
I L YLH +++ D+K +N++LD + +I+DFGL K D + T GT
Sbjct: 104 IVSALGYLHSC---DVVYRDLKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFC-GTP 159
Query: 668 GYVAPEWFRNMPITVKVDVYSYGVLLLEIICLR 700
Y+APE + VD + GV++ E++C R
Sbjct: 160 EYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGR 192
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323 |
| >gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 52.6 bits (126), Expect = 4e-07
Identities = 30/90 (33%), Positives = 45/90 (50%), Gaps = 5/90 (5%)
Query: 608 IAGGLFYLHEECCTQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLDQSHTNTAIRGTK 667
I GL YLH + +IIH D+K +NI ++D I D G A+ + + A GT
Sbjct: 166 ILEGLRYLHAQ---RIIHRDVKTENIFINDVDQVCIGDLGAAQFPVVAPAFLGLA--GTV 220
Query: 668 GYVAPEWFRNMPITVKVDVYSYGVLLLEII 697
APE K D++S G++L E++
Sbjct: 221 ETNAPEVLARDKYNSKADIWSAGIVLFEML 250
|
Length = 357 |
| >gnl|CDD|173687 cd05596, STKc_ROCK, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Score = 52.5 bits (126), Expect = 5e-07
Identities = 57/203 (28%), Positives = 92/203 (45%), Gaps = 26/203 (12%)
Query: 509 LGRGAFGTVYKGFVNMGSSNHVAVKKLNSVFQ---DSEKEFKAEVNGIGQTHHKN---LV 562
+GRGAFG V V SS V KL S F+ S+ F E I H N +V
Sbjct: 51 IGRGAFGEVQ--LVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDI--MAHANSEWIV 106
Query: 563 RLLGYCDEGQNRLLVYEFMSNGTVASFLFG-DSKPNW-KLRT-EIAMGIAGGLFYLHEEC 619
+L + + +V E+M G + + + D W + T E+ + + +H
Sbjct: 107 QLHYAFQDDKYLYMVMEYMPGGDLVNLMSNYDIPEKWARFYTAEVVLALDA----IHS-- 160
Query: 620 CTQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLD-QSHTNTAIRGTKGYVAPEWFRNM 678
IH D+KP N+LLD + +++DFG + + +TA+ GT Y++PE ++
Sbjct: 161 -MGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMDANGMVRCDTAV-GTPDYISPEVLKSQ 218
Query: 679 PITV----KVDVYSYGVLLLEII 697
+ D +S GV L E++
Sbjct: 219 GGDGYYGRECDWWSVGVFLYEML 241
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via interaction with Rho GTPases and is involved in many cellular functions including contraction, adhesion, migration, motility, proliferation, and apoptosis. The ROCK subfamily consists of two isoforms, ROCK1 and ROCK2, which may be functionally redundant in some systems, but exhibit different tissue distributions. Both isoforms are ubiquitously expressed in most tissues, but ROCK2 is more prominent in brain and skeletal muscle while ROCK1 is more pronounced in the liver, testes, and kidney. Studies in knockout mice result in different phenotypes, suggesting that the two isoforms do not compensate for each other during embryonic development. Length = 370 |
| >gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Score = 51.6 bits (123), Expect = 5e-07
Identities = 66/279 (23%), Positives = 120/279 (43%), Gaps = 43/279 (15%)
Query: 507 EELGRGAFGTVYKGF-VNMGSSNHVAVKKLNSVFQDSEKEF---KAEVNGIGQTHHKNLV 562
+ +G G +G VYK VN G + V KL + ++F + E+ + H N+V
Sbjct: 15 QRIGSGTYGDVYKARNVNTGELAAIKVIKL-----EPGEDFAVVQQEIIMMKDCKHSNIV 69
Query: 563 RLLGYCDEGQNRLLVYEFMSNGTVASFLFGDSKPNWKLRTE-IAMGIAGGLFYLHEECCT 621
G + EF G++ ++ + P + + ++ GL+YLH +
Sbjct: 70 AYFGSYLRRDKLWICMEFCGGGSLQD-IYHVTGPLSESQIAYVSRETLQGLYYLHSK--- 125
Query: 622 QIIHCDIKPQNILLDDHYNARISDFGLAKLLTLDQSHTNTAIRGTKGYVAPEWF---RNM 678
+H DIK NILL D+ + +++DFG++ +T + + I GT ++APE R
Sbjct: 126 GKMHRDIKGANILLTDNGHVKLADFGVSAQITATIAKRKSFI-GTPYWMAPEVAAVERKG 184
Query: 679 PITVKVDVYSYGVLLLEIICLRRNIDNEISKVDKAILTDWAYDRYQERTLEALVENDLE- 737
D+++ G+ +E+ A L +D + R L + +++ +
Sbjct: 185 GYNQLCDIWAVGITAIEL----------------AELQPPMFDLHPMRALFLMTKSNFQP 228
Query: 738 -----AMNNVTMLHRFVMVAFWCIQEDPSHRPTMRKVTQ 771
M H FV +A + ++P RPT K+ Q
Sbjct: 229 PKLKDKMKWSNSFHHFVKMA---LTKNPKKRPTAEKLLQ 264
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267 |
| >gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Score = 51.9 bits (124), Expect = 6e-07
Identities = 32/93 (34%), Positives = 49/93 (52%), Gaps = 4/93 (4%)
Query: 608 IAGGLFYLHEECCTQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLDQSHTNTAIRGTK 667
I L YLH +++ DIK +N++LD + +I+DFGL K D + T GT
Sbjct: 104 IVSALEYLHSR---DVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFC-GTP 159
Query: 668 GYVAPEWFRNMPITVKVDVYSYGVLLLEIICLR 700
Y+APE + VD + GV++ E++C R
Sbjct: 160 EYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGR 192
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323 |
| >gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Score = 51.4 bits (123), Expect = 8e-07
Identities = 32/97 (32%), Positives = 51/97 (52%), Gaps = 4/97 (4%)
Query: 608 IAGGLFYLHEECCTQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLDQSHTNTAIRGTK 667
I+ L +LHE II+ D+K N+LLD + +++D+G+ K + T + GT
Sbjct: 105 ISLALNFLHER---GIIYRDLKLDNVLLDAEGHIKLTDYGMCKE-GIRPGDTTSTFCGTP 160
Query: 668 GYVAPEWFRNMPITVKVDVYSYGVLLLEIICLRRNID 704
Y+APE R VD ++ GVL+ E++ R D
Sbjct: 161 NYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFD 197
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions including proliferation, migration, apoptosis, polarity maintenance and cytoskeletal regulation. They also play a critical role in the regulation of glucose metabolism and in the pathogenesis of type 2 diabetes. Length = 329 |
| >gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Score = 51.0 bits (122), Expect = 9e-07
Identities = 53/216 (24%), Positives = 97/216 (44%), Gaps = 41/216 (18%)
Query: 507 EELGRGAFGTVYKGFVNMGSSNHVAVKKLNSVFQDSEKEFKAEVNGIGQT---------- 556
E++G G +G VYK + + VA+KK + ++E GI T
Sbjct: 7 EKIGEGTYGKVYKA-RDKNTGKLVALKKTRL---EMDEE------GIPPTALREISLLQM 56
Query: 557 --HHKNLVRLLGY----CDEGQNRL-LVYEFMSNGTVASFLFGDSK-PNWKLRTEIAMG- 607
+VRLL G+ L LV+E++ + + F+ + + P L +
Sbjct: 57 LSESIYIVRLLDVEHVEEKNGKPSLYLVFEYLDS-DLKKFMDSNGRGPGRPLPAKTIKSF 115
Query: 608 ---IAGGLFYLHEECCTQIIHCDIKPQNILLDDHYNA-RISDFGLAKLLTLD-QSHTNTA 662
+ G+ + H+ ++H D+KPQN+L+D +I+D GL + ++ +S+T+
Sbjct: 116 MYQLLKGVAHCHKH---GVMHRDLKPQNLLVDKQKGLLKIADLGLGRAFSIPVKSYTHEI 172
Query: 663 IRGTKGYVAPE-WFRNMPITVKVDVYSYGVLLLEII 697
+ T Y APE + + VD++S G + E+
Sbjct: 173 V--TLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMS 206
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295 |
| >gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Score = 50.8 bits (121), Expect = 1e-06
Identities = 52/203 (25%), Positives = 100/203 (49%), Gaps = 21/203 (10%)
Query: 507 EELGRGAFGTVYKGFVNMGSSNHVAVKKLNSVFQDSEKEFKA------EVNGIGQTHHKN 560
++LG G + TV+KG + + N VA+K++ E E A EV+ + H N
Sbjct: 11 DKLGEGTYATVFKGRSKL-TENLVALKEIRL-----EHEEGAPCTAIREVSLLKNLKHAN 64
Query: 561 LVRLLGYCDEGQNRLLVYEFMSNGTVASFLFGDSKPNWKLRTEIAM-GIAGGLFYLHEEC 619
+V L + LV+E++ + + +L +I M + GL Y H+
Sbjct: 65 IVTLHDIIHTERCLTLVFEYLDS-DLKQYLDNCGNLMSMHNVKIFMFQLLRGLSYCHKR- 122
Query: 620 CTQIIHCDIKPQNILLDDHYNARISDFGLAKLLTL-DQSHTNTAIRGTKGYVAPE-WFRN 677
+I+H D+KPQN+L+++ +++DFGLA+ ++ ++++N + T Y P+ +
Sbjct: 123 --KILHRDLKPQNLLINEKGELKLADFGLARAKSVPTKTYSNEVV--TLWYRPPDVLLGS 178
Query: 678 MPITVKVDVYSYGVLLLEIICLR 700
+ +D++ G +L E+ R
Sbjct: 179 TEYSTPIDMWGVGCILYEMATGR 201
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288 |
| >gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Score = 51.1 bits (122), Expect = 1e-06
Identities = 56/222 (25%), Positives = 102/222 (45%), Gaps = 29/222 (13%)
Query: 509 LGRGAFGTVY----KGFVNMGSSNHVAVKKLNSVFQ--DSEKEFKAEVNGIGQTHHKNLV 562
LG GA+G V+ + G + V + ++ Q + + + E N + +
Sbjct: 8 LGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPFL 67
Query: 563 RLLGYCDEGQNRL-LVYEFMSNGTVASFLFGDSKPNWKLRTEIAMGIAGG-----LFYLH 616
L Y + + +L L+ +++S G + + L+ + N+ E + G L +LH
Sbjct: 68 VTLHYAFQTEAKLHLILDYVSGGEMFTHLY--QRDNFS---EDEVRFYSGEIILALEHLH 122
Query: 617 EECCTQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLDQSHTNTAIRGTKGYVAPEWFR 676
+ I++ DIK +NILLD + ++DFGL+K ++ + GT Y+APE R
Sbjct: 123 K---LGIVYRDIKLENILLDSEGHVVLTDFGLSKEFLSEEKERTYSFCGTIEYMAPEIIR 179
Query: 677 NMPITVK-VDVYSYGVLLLEIIC--------LRRNIDNEISK 709
K VD +S G+L+ E++ RN +E+S+
Sbjct: 180 GKGGHGKAVDWWSLGILIFELLTGASPFTLEGERNTQSEVSR 221
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332 |
| >gnl|CDD|133217 cd05086, PTKc_Aatyk2, Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 50.3 bits (120), Expect = 1e-06
Identities = 40/151 (26%), Positives = 69/151 (45%), Gaps = 15/151 (9%)
Query: 507 EELGRGAFGTVYKGFVNMGSS-NHVAVKKLNSVFQDSEK-EFKAEVNGIGQTHHKNLVRL 564
+E+G G FG V + + V VK+L + E+ EF + + H N+++
Sbjct: 1 QEIGNGWFGKVLLSEIYTDTGVARVVVKELKANASSKEQNEFLQQGDPYRILQHPNILQC 60
Query: 565 LGYCDEGQNRLLVYEFMSNGTVASFLFGDSKPNWKLRT-------EIAMGIAGGLFYLHE 617
LG C E LLV+E+ G + S+L S+ W R +A IA G+ ++H+
Sbjct: 61 LGQCVEAIPYLLVFEYCELGDLKSYL---SQEQWHRRNSQLLLLQRMACEIAAGVTHMHK 117
Query: 618 ECCTQIIHCDIKPQNILLDDHYNARISDFGL 648
+H D+ +N L ++ D+G+
Sbjct: 118 H---NFLHSDLALRNCFLTSDLTVKVGDYGI 145
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage spermatogenesis. Although it is classified as a tyr kinase based on sequence similarity and the phylogenetic tree, Aatyk2 has been characterized as a serine/threonine kinase. Length = 268 |
| >gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 50.5 bits (121), Expect = 1e-06
Identities = 48/174 (27%), Positives = 79/174 (45%), Gaps = 45/174 (25%)
Query: 494 TYKELVEVTRGFKEELGRGAFGTVYKGFVNMGSSNHVAVKKLNSVFQDSEKEFKA--EVN 551
TYK+L ++LG G++ TVYKG + + VA+K++ + + F A E +
Sbjct: 6 TYKKL--------DKLGEGSYATVYKGRSKL-TGQLVALKEI-RLEHEEGAPFTAIREAS 55
Query: 552 GIGQTHHKNLVRLLGYCDEGQNRLLVYEF---------------MSNGTVASFLFGDSKP 596
+ H N+V L + LV+E+ +S V FLF
Sbjct: 56 LLKDLKHANIVTLHDIIHTKKTLTLVFEYLDTDLKQYMDDCGGGLSMHNVRLFLFQ---- 111
Query: 597 NWKLRTEIAMGIAGGLFYLHEECCTQIIHCDIKPQNILLDDHYNARISDFGLAK 650
LR GL Y H+ +++H D+KPQN+L+ + +++DFGLA+
Sbjct: 112 --LLR---------GLAYCHQR---RVLHRDLKPQNLLISERGELKLADFGLAR 151
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291 |
| >gnl|CDD|173717 cd05628, STKc_NDR1, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Score = 49.7 bits (118), Expect = 3e-06
Identities = 57/229 (24%), Positives = 87/229 (37%), Gaps = 47/229 (20%)
Query: 509 LGRGAFGTVYKGFVNMGSSNHVAVKKLNSVFQDSEKE----FKAEVNGIGQTHHKNLVRL 564
+GRGAFG V V + HV K+ EKE +AE + + + +V++
Sbjct: 9 IGRGAFGEVR--LVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLWVVKM 66
Query: 565 LGYCDEGQNRLLVYEFMSNGTVASFLFGDSKPNWKLRTEIAMGIAGGLFYLHEECCTQII 624
+ N L+ EF+ G + + L K + E IA + + I
Sbjct: 67 FYSFQDKLNLYLIMEFLPGGDMMTLLM---KKDTLTEEETQFYIAETVLAIDSIHQLGFI 123
Query: 625 HCDIKPQNILLDDHYNARISDFGLAKLLTLDQSHTNTAIR-------------------- 664
H DIKP N+LLD + ++SDFGL L ++H R
Sbjct: 124 HRDIKPDNLLLDSKGHVKLSDFGLCT--GLKKAHRTEFYRNLNHSLPSDFTFQNMNSKRK 181
Query: 665 ----------------GTKGYVAPEWFRNMPITVKVDVYSYGVLLLEII 697
GT Y+APE F D +S GV++ E++
Sbjct: 182 AETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEML 230
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, muscle, lung and spleen. It is not an essential protein because mice deficient of NDR1 remain viable and fertile. However, these mice develop T-cell lymphomas and appear to be hypersenstive to carcinogenic treatment. NDR1 appears to act as a tumor suppressor. NDR1 is also called STK38. Length = 363 |
| >gnl|CDD|223069 PHA03390, pk1, serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Score = 49.1 bits (118), Expect = 3e-06
Identities = 29/96 (30%), Positives = 43/96 (44%), Gaps = 9/96 (9%)
Query: 604 IAMGIAGGLFYLHEECCTQIIHCDIKPQNILLDDH-YNARISDFGLAKLLTLDQSHTNTA 662
I + L LH+ IIH DIK +N+L D + D+GL K+ T +
Sbjct: 114 IIRQLVEALNDLHK---HNIIHNDIKLENVLYDRAKDRIYLCDYGLCKI-----IGTPSC 165
Query: 663 IRGTKGYVAPEWFRNMPITVKVDVYSYGVLLLEIIC 698
GT Y +PE + V D ++ GVL E++
Sbjct: 166 YDGTLDYFSPEKIKGHNYDVSFDWWAVGVLTYELLT 201
|
Length = 267 |
| >gnl|CDD|173689 cd05598, STKc_LATS, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Score = 49.8 bits (119), Expect = 4e-06
Identities = 59/245 (24%), Positives = 92/245 (37%), Gaps = 71/245 (28%)
Query: 509 LGRGAFGTVYKGFVNMGSSNHV-AVKKLNS--VFQDSE-KEFKAEVNGIGQTHHKNLVRL 564
+G GAFG V V +N + A+K L V ++ KAE + + + ++ +V+L
Sbjct: 9 IGIGAFGEVC--LVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEWVVKL 66
Query: 565 LGYCDEGQNRLLVYEFMSNGTVASFLFGDSKPNWKLRTEIAMGIAG---GLFYLHEECCT 621
+ N V +++ G + S L I +GI FY+ E C
Sbjct: 67 YYSFQDKDNLYFVMDYIPGGDMMSLL-------------IRLGIFEEDLARFYIAELTCA 113
Query: 622 -------QIIHCDIKPQNILLDDHYNARISDFGL-------------------------- 648
IH DIKP NIL+D + +++DFGL
Sbjct: 114 IESVHKMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQKGDHHRQDSMEP 173
Query: 649 ---------AKLLTLDQSHTNTAIR-------GTKGYVAPEWFRNMPITVKVDVYSYGVL 692
+L L++ R GT Y+APE T D +S GV+
Sbjct: 174 SEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVI 233
Query: 693 LLEII 697
L E++
Sbjct: 234 LYEML 238
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Length = 376 |
| >gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 48.4 bits (115), Expect = 6e-06
Identities = 50/198 (25%), Positives = 93/198 (46%), Gaps = 17/198 (8%)
Query: 507 EELGRGAFGTVYKGFVNMGSSNHVAVKKLNSVFQDSEKEFKA--EVNGIGQTHHKNLVRL 564
E+LG G++ TVYKG + + + K+ S+ + F A E + + H N+V L
Sbjct: 11 EKLGEGSYATVYKGISRI--NGQLVALKVISMKTEEGVPFTAIREASLLKGLKHANIVLL 68
Query: 565 LGYCDEGQNRLLVYEFMSNGTVASFLF----GDSKPNWKLRTEIAMGIAGGLFYLHEECC 620
+ V+E+M +A ++ G N +L + GL Y+H +
Sbjct: 69 HDIIHTKETLTFVFEYMHT-DLAQYMIQHPGGLHPYNVRL---FMFQLLRGLAYIHGQ-- 122
Query: 621 TQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLDQSHTNTAIRGTKGYVAPE-WFRNMP 679
I+H D+KPQN+L+ +++DFGLA+ ++ S T ++ T Y P+
Sbjct: 123 -HILHRDLKPQNLLISYLGELKLADFGLARAKSI-PSQTYSSEVVTLWYRPPDVLLGATD 180
Query: 680 ITVKVDVYSYGVLLLEII 697
+ +D++ G + +E++
Sbjct: 181 YSSALDIWGAGCIFIEML 198
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291 |
| >gnl|CDD|173716 cd05627, STKc_NDR2, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Score = 48.9 bits (116), Expect = 6e-06
Identities = 55/229 (24%), Positives = 87/229 (37%), Gaps = 47/229 (20%)
Query: 509 LGRGAFGTVYKGFVNMGSSNHVAVKKLNSVFQDSEKE----FKAEVNGIGQTHHKNLVRL 564
+GRGAFG V V + H+ K+ EKE +AE + + + +V++
Sbjct: 9 IGRGAFGEVR--LVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGAWVVKM 66
Query: 565 LGYCDEGQNRLLVYEFMSNGTVASFLFGDSKPNWKLRTEIAMGIAGGLFYLHEECCTQII 624
+ +N L+ EF+ G + + L K + IA + + I
Sbjct: 67 FYSFQDKRNLYLIMEFLPGGDMMTLLM---KKDTLSEEATQFYIAETVLAIDAIHQLGFI 123
Query: 625 HCDIKPQNILLDDHYNARISDFGLAKLLTLDQSHTNTAIR-------------------- 664
H DIKP N+LLD + ++SDFGL L ++H R
Sbjct: 124 HRDIKPDNLLLDAKGHVKLSDFGLCT--GLKKAHRTEFYRNLTHNPPSDFSFQNMNSKRK 181
Query: 665 ----------------GTKGYVAPEWFRNMPITVKVDVYSYGVLLLEII 697
GT Y+APE F D +S GV++ E++
Sbjct: 182 AETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEML 230
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regulating neuronal growth and differentiation, as well as in facilitating neurite outgrowth. It is also implicated in fear conditioning as it contributes to the coupling of neuronal morphological changes with fear-memory consolidation. NDR2 is also referred to as STK38-like. Length = 360 |
| >gnl|CDD|173333 PTZ00036, PTZ00036, glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Score = 48.9 bits (116), Expect = 6e-06
Identities = 57/203 (28%), Positives = 99/203 (48%), Gaps = 25/203 (12%)
Query: 509 LGRGAFGTVYKGFVNMGSSNHVAVKKLNSVFQDSEKEFKAEVNGIGQTHHKNLVRLLGYC 568
+G G+FG VY+ + + +S VA+KK V QD + + + E+ + +H N++ L Y
Sbjct: 74 IGNGSFGVVYEA-ICIDTSEKVAIKK---VLQDPQYKNR-ELLIMKNLNHINIIFLKDYY 128
Query: 569 ------DEGQNRLL--VYEFMSNGTVASFLFGDSKPNWKLRTEI----AMGIAGGLFYLH 616
+N L V EF+ TV ++ ++ N L + + + L Y+H
Sbjct: 129 YTECFKKNEKNIFLNVVMEFIPQ-TVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYIH 187
Query: 617 EECCTQIIHCDIKPQNILLDDH-YNARISDFGLAKLLTLDQSHTNTAIRGTKGYVAPE-W 674
+ I H D+KPQN+L+D + + ++ DFG AK L Q + ++ Y APE
Sbjct: 188 SKF---ICHRDLKPQNLLIDPNTHTLKLCDFGSAKNLLAGQRSVSYIC--SRFYRAPELM 242
Query: 675 FRNMPITVKVDVYSYGVLLLEII 697
T +D++S G ++ E+I
Sbjct: 243 LGATNYTTHIDLWSLGCIIAEMI 265
|
Length = 440 |
| >gnl|CDD|173712 cd05622, STKc_ROCK1, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Score = 48.5 bits (115), Expect = 8e-06
Identities = 55/201 (27%), Positives = 88/201 (43%), Gaps = 22/201 (10%)
Query: 509 LGRGAFGTVYKGFVNMGSSNHVAVKKLNSVFQ---DSEKEFKAEVNGIGQTHHKNLVRLL 565
+GRGAFG V V S+ V KL S F+ S+ F E I + V L
Sbjct: 51 IGRGAFGEVQ--LVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQL 108
Query: 566 GYCDEGQNRL-LVYEFMSNGTVASFLFGDSKPNWKLR---TEIAMGIAGGLFYLHEECCT 621
Y + L +V E+M G + + + P R E+ + + +H
Sbjct: 109 FYAFQDDRYLYMVMEYMPGGDLVNLMSNYDVPEKWARFYTAEVVLALDA----IHS---M 161
Query: 622 QIIHCDIKPQNILLDDHYNARISDFGLAKLLTLD-QSHTNTAIRGTKGYVAPEWFRNMP- 679
IH D+KP N+LLD + +++DFG + + +TA+ GT Y++PE ++
Sbjct: 162 GFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTAV-GTPDYISPEVLKSQGG 220
Query: 680 ---ITVKVDVYSYGVLLLEII 697
+ D +S GV L E++
Sbjct: 221 DGYYGRECDWWSVGVFLYEML 241
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, and kidney. It mediates signaling from Rho to the actin cytoskeleton. It is implicated in the development of cardiac fibrosis, cardiomyocyte apoptosis, and hyperglycemia. Mice deficient with ROCK1 display eyelids open at birth (EOB) and omphalocele phenotypes due to the disorganization of actin filaments in the eyelids and the umbilical ring. Length = 371 |
| >gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Score = 48.1 bits (114), Expect = 9e-06
Identities = 29/77 (37%), Positives = 45/77 (58%), Gaps = 2/77 (2%)
Query: 623 IIHCDIKPQNILLDDHYNARISDFGLAKLLTLDQSHTNTAIRGTKGYVAPEWFR--NMPI 680
II+ DIK +NILLD + + ++DFGL+K D+ + GT Y+AP+ R +
Sbjct: 126 IIYRDIKLENILLDSNGHVVLTDFGLSKEFHEDEVERAYSFCGTIEYMAPDIVRGGDGGH 185
Query: 681 TVKVDVYSYGVLLLEII 697
VD +S GVL+ E++
Sbjct: 186 DKAVDWWSMGVLMYELL 202
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290 |
| >gnl|CDD|173665 cd05574, STKc_phototropin_like, Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 48.0 bits (115), Expect = 1e-05
Identities = 57/237 (24%), Positives = 89/237 (37%), Gaps = 63/237 (26%)
Query: 507 EELGRGAFGTVYKGFVNMGSSNHV-AVK-----------KLNSVFQDSEKEFKAEVNGIG 554
+ LG+G G V+ V + + + A+K K+ V +E+E A ++
Sbjct: 7 KLLGKGDVGRVF--LVRLKGTGKLFALKVLDKKEMIKRNKVKRVL--TEQEILATLD--- 59
Query: 555 QTHHKNLVRLLGYCDEGQNRLLVYEFMSNGTVASFLFGDSKPNWKLRTEIAMGIAG---- 610
H L L LV ++ G + L +P L E+A A
Sbjct: 60 ---HPFLPTLYASFQTETYLCLVMDYCPGGELFRLL--QRQPGKCLSEEVARFYAAEVLL 114
Query: 611 GLFYLHEECCTQIIHCDIKPQNILLDDHYNARI--SDFGLAKLLT----------LDQSH 658
L YLH I++ D+KP+NILL H + I SDF L+K S
Sbjct: 115 ALEYLH---LLGIVYRDLKPENILL--HESGHIMLSDFDLSKQSDVEPPPVSKALRKGSR 169
Query: 659 TNTAIR------------------GTKGYVAPEWFRNMPITVKVDVYSYGVLLLEII 697
++ GT+ Y+APE VD ++ G+LL E++
Sbjct: 170 RSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILLYEML 226
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-terminal photosensory domain and a C-terminal catalytic domain. The N-terminal domain contains two LOV (Light, Oxygen or Voltage) domains that binds FMN. Photoexcitation of the LOV domains results in autophosphorylation at multiple sites and activation of the catalytic domain. Neurospora crassa nrc-2 plays a role in growth and development by controlling entry into the conidiation program. Length = 316 |
| >gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 46.4 bits (110), Expect = 4e-05
Identities = 35/105 (33%), Positives = 49/105 (46%), Gaps = 9/105 (8%)
Query: 495 YKELVEVTRG---FKEELGRGAFGTVYK----GFVNMGSSNHVAVKKLNSVFQDSEKE-F 546
Y E E R F + LG GAFG V + G + VAVK L + E+E
Sbjct: 29 YNEKWEFPRDNLQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASAHTDEREAL 88
Query: 547 KAEVNGIGQT-HHKNLVRLLGYCDEGQNRLLVYEFMSNGTVASFL 590
+E+ + HKN+V LLG C G L++ E+ G + +FL
Sbjct: 89 MSELKILSHLGQHKNIVNLLGACTHGGPVLVITEYCCYGDLLNFL 133
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374 |
| >gnl|CDD|140293 PTZ00267, PTZ00267, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 46.5 bits (110), Expect = 4e-05
Identities = 42/161 (26%), Positives = 71/161 (44%), Gaps = 10/161 (6%)
Query: 547 KAEVNGIGQTHHKNLVRLLGYCDEGQNRLLVYEFMSNGTVASFLFGDSKPNWKLRTEIAM 606
++E++ + H +V+ LL+ E+ S G + + K K
Sbjct: 113 RSELHCLAACDHFGIVKHFDDFKSDDKLLLIMEYGSGGDLNKQI----KQRLKEHLPFQE 168
Query: 607 GIAGGLFY-----LHEECCTQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLDQS-HTN 660
G LFY L E +++H D+K NI L ++ DFG +K + S
Sbjct: 169 YEVGLLFYQIVLALDEVHSRKMMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDSVSLDVA 228
Query: 661 TAIRGTKGYVAPEWFRNMPITVKVDVYSYGVLLLEIICLRR 701
++ GT Y+APE + + K D++S GV+L E++ L R
Sbjct: 229 SSFCGTPYYLAPELWERKRYSKKADMWSLGVILYELLTLHR 269
|
Length = 478 |
| >gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Score = 46.3 bits (110), Expect = 4e-05
Identities = 50/215 (23%), Positives = 89/215 (41%), Gaps = 40/215 (18%)
Query: 509 LGRGAFGTVYKGFVNMGSSNHVAVKKLNSVFQDSEKEFKAEVNGIGQTHHKNLVRLLGYC 568
LG G+ G V+ V+ VAVKK+ S K E+ I + H N+V++
Sbjct: 13 LGCGSNGLVFSA-VDSDCDKRVAVKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVYEVL 71
Query: 569 DEGQNRLLVYEFMSNGT-VASFLFGDSKPNWKLRTEIAMG-------------IAGGLFY 614
+ L E + + T + S L + G + GL Y
Sbjct: 72 GPSGSDL--TEDVGSLTELNSVYIVQEYMETDLANVLEQGPLSEEHARLFMYQLLRGLKY 129
Query: 615 LHEECCTQIIHCDIKPQNILLD-DHYNARISDFGLAKLLTLDQSHTNTAIRGTKGY---- 669
+H ++H D+KP N+ ++ + +I DFGLA+++ SH KGY
Sbjct: 130 IHS---ANVLHRDLKPANVFINTEDLVLKIGDFGLARIVDPHYSH--------KGYLSEG 178
Query: 670 VAPEWFRNMPI-------TVKVDVYSYGVLLLEII 697
+ +W+R+ + T +D+++ G + E++
Sbjct: 179 LVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEML 213
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342 |
| >gnl|CDD|133238 cd05107, PTKc_PDGFR_beta, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Score = 46.2 bits (109), Expect = 5e-05
Identities = 31/96 (32%), Positives = 52/96 (54%), Gaps = 10/96 (10%)
Query: 608 IAGGLFYLHEECCTQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLDQSHTNTAIRGTK 667
+A G+ +L + C +H D+ +N+L+ + +I DFGLA+ + D +N +G+
Sbjct: 248 VANGMEFLASKNC---VHRDLAARNVLICEGKLVKICDFGLARDIMRD---SNYISKGST 301
Query: 668 ----GYVAPEWFRNMPITVKVDVYSYGVLLLEIICL 699
++APE N T DV+S+G+LL EI L
Sbjct: 302 FLPLKWMAPESIFNNLYTTLSDVWSFGILLWEIFTL 337
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-DD induce PDGFR beta homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR beta signaling leads to a variety of cellular effects including the stimulation of cell growth and chemotaxis, as well as the inhibition of apoptosis and GAP junctional communication. It is critical in normal angiogenesis as it is involved in the recruitment of pericytes and smooth muscle cells essential for vessel stability. Aberrant PDGFR beta expression is associated with some human cancers. The continuously-active fusion proteins of PDGFR beta with COL1A1 and TEL are associated with dermatofibrosarcoma protuberans (DFSP) and a subset of chronic myelomonocytic leukemia (CMML), respectively. Length = 401 |
| >gnl|CDD|173653 cd05105, PTKc_PDGFR_alpha, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Score = 45.8 bits (108), Expect = 7e-05
Identities = 31/98 (31%), Positives = 50/98 (51%), Gaps = 14/98 (14%)
Query: 608 IAGGLFYLHEECCTQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLDQSHTNTAIRGTK 667
+A G+ +L + C +H D+ +N+LL +I DFGLA+ D H + +
Sbjct: 246 VARGMEFLASKNC---VHRDLAARNVLLAQGKIVKICDFGLAR----DIMHDSNYVSKGS 298
Query: 668 GYVAPEW------FRNMPITVKVDVYSYGVLLLEIICL 699
++ +W F N+ T+ DV+SYG+LL EI L
Sbjct: 299 TFLPVKWMAPESIFDNLYTTLS-DVWSYGILLWEIFSL 335
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-AB, and PDGF-CC induce PDGFR alpha homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR alpha signaling is important in the formation of lung alveoli, intestinal villi, mesenchymal dermis, and hair follicles, as well as in the development of oligodendrocytes, retinal astrocytes, neural crest cells, and testicular cells. Aberrant PDGFR alpha expression is associated with some human cancers. Mutations in PDGFR alpha have been found within a subset of gastrointestinal stromal tumors (GISTs). An active fusion protein FIP1L1-PDGFR alpha, derived from interstitial deletion, is associated with idiopathic hypereosinophilic syndrome (HES) and chronic eosinophilic leukemia (CEL). Length = 400 |
| >gnl|CDD|223009 PHA03211, PHA03211, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 44.9 bits (106), Expect = 1e-04
Identities = 30/95 (31%), Positives = 46/95 (48%), Gaps = 4/95 (4%)
Query: 602 TEIAMGIAGGLFYLHEECCTQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLDQSH-TN 660
T +A + + Y+H IIH DIK +N+L++ + + DFG A S +
Sbjct: 263 TAVARQLLSAIDYIH---GEGIIHRDIKTENVLVNGPEDICLGDFGAACFARGSWSTPFH 319
Query: 661 TAIRGTKGYVAPEWFRNMPITVKVDVYSYGVLLLE 695
I GT APE P T VD++S G+++ E
Sbjct: 320 YGIAGTVDTNAPEVLAGDPYTPSVDIWSAGLVIFE 354
|
Length = 461 |
| >gnl|CDD|165291 PHA02988, PHA02988, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 43.6 bits (103), Expect = 2e-04
Identities = 37/190 (19%), Positives = 85/190 (44%), Gaps = 18/190 (9%)
Query: 517 VYKGFVNMGSSNHVAVKKLNSVFQDSEK---EFKAEVNGIGQTHHKNLVRLLGY----CD 569
+YKG N + V ++ + + + E+ + + N++++ G+ D
Sbjct: 36 IYKGIFN---NKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIVD 92
Query: 570 EGQNRLLVYEFMSNGTVASFLFGDSKPNWKLRTEIAMGIAGGLFYLHEECCTQIIHCDIK 629
+ L+ E+ + G + L + ++K + ++A+ GL+ L++ T + ++
Sbjct: 93 DLPRLSLILEYCTRGYLREVLDKEKDLSFKTKLDMAIDCCKGLYNLYKY--TNKPYKNLT 150
Query: 630 PQNILLDDHYNARISDFGLAKLLTLDQSHTNTAIRGTKGYVAPEWFRNM--PITVKVDVY 687
+ L+ ++Y +I GL K+L+ + Y + + ++ T+K D+Y
Sbjct: 151 SVSFLVTENYKLKIICHGLEKILSSPPFKNVNFM----VYFSYKMLNDIFSEYTIKDDIY 206
Query: 688 SYGVLLLEII 697
S GV+L EI
Sbjct: 207 SLGVVLWEIF 216
|
Length = 283 |
| >gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 44.0 bits (104), Expect = 2e-04
Identities = 43/166 (25%), Positives = 71/166 (42%), Gaps = 39/166 (23%)
Query: 509 LGRGAFGTVYKGFVNMGSSNHVAVKKL-NSVFQDSEKEFKAEVNGIG------------- 554
LG G +G V K + + + VA+KK+ + + + V G
Sbjct: 17 LGEGTYGKVEKAY-DTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMN 75
Query: 555 QTHHKNLVRLLG-YCDEGQ-NRLLVYEFMSNGTVASFLFGDSKP--NWKLR-TE-----I 604
+ H+N++ L+ Y + N LV + M+ D K + K+R TE I
Sbjct: 76 EIKHENIMGLVDVYVEGDFIN--LVMDIMA---------SDLKKVVDRKIRLTESQVKCI 124
Query: 605 AMGIAGGLFYLHEECCTQIIHCDIKPQNILLDDHYNARISDFGLAK 650
+ I GL LH+ +H D+ P NI ++ +I+DFGLA+
Sbjct: 125 LLQILNGLNVLHK---WYFMHRDLSPANIFINSKGICKIADFGLAR 167
|
Length = 335 |
| >gnl|CDD|133235 cd05104, PTKc_Kit, Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Score = 43.3 bits (102), Expect = 4e-04
Identities = 30/92 (32%), Positives = 46/92 (50%), Gaps = 6/92 (6%)
Query: 505 FKEELGRGAFGTVYK----GFVNMGSSNHVAVKKLNSVFQDSEKE-FKAEVNGIGQT-HH 558
F + LG GAFG V + G ++ VAVK L +E+E +E+ + +H
Sbjct: 39 FGKTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNH 98
Query: 559 KNLVRLLGYCDEGQNRLLVYEFMSNGTVASFL 590
N+V LLG C G L++ E+ G + +FL
Sbjct: 99 INIVNLLGACTVGGPTLVITEYCCYGDLLNFL 130
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. Kit signaling is involved in major cellular functions including cell survival, proliferation, differentiation, adhesion, and chemotaxis. Mutations in Kit, which result in constitutive ligand-independent activation, are found in human cancers such as gastrointestinal stromal tumor (GIST) and testicular germ cell tumor (TGCT). The aberrant expression of Kit and/or SCF is associated with other tumor types such as systemic mastocytosis and cancers of the breast, neurons, lung, prostate, colon, and rectum. Although the structure of the human Kit catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 375 |
| >gnl|CDD|173700 cd05609, STKc_MAST, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Score = 42.8 bits (101), Expect = 4e-04
Identities = 31/98 (31%), Positives = 48/98 (48%), Gaps = 17/98 (17%)
Query: 614 YLHEECCTQIIHCDIKPQNILLDDHYNARISDFGLAKL----LT--LDQSHTNTAIR--- 664
YLH I+H D+KP N+L+ + +++DFGL+K+ LT L + H R
Sbjct: 116 YLHN---YGIVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSLTTNLYEGHIEKDTREFL 172
Query: 665 -----GTKGYVAPEWFRNMPITVKVDVYSYGVLLLEII 697
GT Y+APE VD ++ G++L E +
Sbjct: 173 DKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFL 210
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. MAST1, MAST2, and MAST3 bind and phosphorylate the tumor suppressor PTEN, and may contribute to the regulation and stabilization of PTEN. MAST2 is involved in the regulation of the Fc-gamma receptor of the innate immune response in macrophages, and may also be involved in the regulation of the Na+/H+ exchanger NHE3. Length = 305 |
| >gnl|CDD|173714 cd05625, STKc_LATS1, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Score = 42.7 bits (100), Expect = 5e-04
Identities = 42/152 (27%), Positives = 68/152 (44%), Gaps = 25/152 (16%)
Query: 509 LGRGAFGTV-YKGFVNMGSSNHV-AVKKLNSVFQDSEKEFKAEVNGIGQTHHKNLVRLLG 566
LG GAFG V V+ + + ++K + + ++ KAE + + + ++ +VRL
Sbjct: 9 LGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEWVVRLYY 68
Query: 567 YCDEGQNRLLVYEFMSNGTVASFLFGDSKPNWKLRTEIAMGI---AGGLFYLHEECCT-- 621
+ N V +++ G + S L I MGI FY+ E C
Sbjct: 69 SFQDKDNLYFVMDYIPGGDMMSLL-------------IRMGIFPEDLARFYIAELTCAVE 115
Query: 622 -----QIIHCDIKPQNILLDDHYNARISDFGL 648
IH DIKP NIL+D + +++DFGL
Sbjct: 116 SVHKMGFIHRDIKPDNILIDRDGHIKLTDFGL 147
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype and poor prognosis. LATS1 induces G2 arrest and promotes cytokinesis. It may be a component of the mitotic exit network in higher eukaryotes. Length = 382 |
| >gnl|CDD|140307 PTZ00284, PTZ00284, protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 43.0 bits (101), Expect = 5e-04
Identities = 30/110 (27%), Positives = 47/110 (42%), Gaps = 22/110 (20%)
Query: 603 EIAMGIAGGLFYLHEECCTQIIHCDIKPQNILLD----------------DHYNARISDF 646
+I L Y H E ++H D+KP+NIL++ D RI D
Sbjct: 235 QIIFQTGVALDYFHTE--LHLMHTDLKPENILMETSDTVVDPVTNRALPPDPCRVRICDL 292
Query: 647 GLAKLLTLDQSHTNTAIRGTKGYVAPEWFRNMPITVKVDVYSYGVLLLEI 696
G D+ H+ TAI T+ Y +PE + D++S G ++ E+
Sbjct: 293 GGC----CDERHSRTAIVSTRHYRSPEVVLGLGWMYSTDMWSMGCIIYEL 338
|
Length = 467 |
| >gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Score = 41.4 bits (98), Expect = 0.001
Identities = 53/205 (25%), Positives = 91/205 (44%), Gaps = 38/205 (18%)
Query: 512 GAFGTVYKGFVNMGSSNHVAVKKLNSVFQDSEKE-FKA----EVNGIGQTHHKNLVRL-- 564
G +G VY+ + + VA+KKL + EKE F E+N + + H N+V +
Sbjct: 16 GTYGVVYRA-RDKKTGEIVALKKLK---MEKEKEGFPITSLREINILLKLQHPNIVTVKE 71
Query: 565 --LGYCDEGQNRL-LVYEF--------MSNGTVASFLFGDSKPNWKLRTEIAMGIAGGLF 613
+G +++ +V E+ M FL + K L ++ G+A
Sbjct: 72 VVVG---SNLDKIYMVMEYVEHDLKSLMETMK-QPFLQSEVK---CLMLQLLSGVA---- 120
Query: 614 YLHEECCTQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLDQSHTNTAIRGTKGYVAPE 673
+LH+ I+H D+K N+LL++ +I DFGLA+ T + T Y APE
Sbjct: 121 HLHDN---WILHRDLKTSNLLLNNRGILKICDFGLAREYG-SPLKPYTQLVVTLWYRAPE 176
Query: 674 WFRNMPI-TVKVDVYSYGVLLLEII 697
+ +D++S G + E++
Sbjct: 177 LLLGAKEYSTAIDMWSVGCIFAELL 201
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293 |
| >gnl|CDD|165478 PHA03212, PHA03212, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 41.5 bits (97), Expect = 0.001
Identities = 28/83 (33%), Positives = 41/83 (49%), Gaps = 3/83 (3%)
Query: 614 YLHEECCTQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLDQSHTNTAIRGTKGYVAPE 673
YLHE +IIH DIK +NI ++ + + DFG A ++ GT APE
Sbjct: 197 YLHE---NRIIHRDIKAENIFINHPGDVCLGDFGAACFPVDINANKYYGWAGTIATNAPE 253
Query: 674 WFRNMPITVKVDVYSYGVLLLEI 696
P VD++S G++L E+
Sbjct: 254 LLARDPYGPAVDIWSAGIVLFEM 276
|
Length = 391 |
| >gnl|CDD|173718 cd05629, STKc_NDR_like_fungal, Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 41.8 bits (98), Expect = 0.001
Identities = 44/153 (28%), Positives = 70/153 (45%), Gaps = 25/153 (16%)
Query: 509 LGRGAFGTVYKGFVNMGSSNHV-AVKKL--NSVFQ-DSEKEFKAEVNGIGQTHHKNLVRL 564
+G+GAFG V V + + A+K L + +F+ D KAE + + ++ +V L
Sbjct: 9 IGKGAFGEVR--LVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDSPWVVSL 66
Query: 565 LGYCDEGQNRLLVYEFMSNGTVASFLFGDSKPNWKLRTEIAMGIAGGLFYLHEECCTQI- 623
+ Q L+ EF+ G + + L + +E FY+ EC I
Sbjct: 67 YYSFQDAQYLYLIMEFLPGGDLMTMLI-----KYDTFSEDVT-----RFYM-AECVLAIE 115
Query: 624 -------IHCDIKPQNILLDDHYNARISDFGLA 649
IH DIKP NIL+D + ++SDFGL+
Sbjct: 116 AVHKLGFIHRDIKPDNILIDRGGHIKLSDFGLS 148
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of Ace2p activity and cellular morphogenesis) network. CBK1 and Orb6 play similar roles in coordinating cell morphology with cell cycle progression. Ukc1 is involved in morphogenesis, pathogenicity, and pigment formation. Cot1 plays a role in polar tip extension. Length = 377 |
| >gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 41.0 bits (96), Expect = 0.002
Identities = 34/95 (35%), Positives = 45/95 (47%), Gaps = 11/95 (11%)
Query: 505 FKEELGRGAFGTVYK----GFVNMGSSNHVAVKKLNSVFQDSE-KEFKAEV---NGIGQT 556
+ LGRGAFG V + G S VAVK L SE K E+ IG
Sbjct: 11 LGKPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGATASEYKALMTELKILIHIG-- 68
Query: 557 HHKNLVRLLGYCDEGQNRLLV-YEFMSNGTVASFL 590
HH N+V LLG C + L+V E+ G ++++L
Sbjct: 69 HHLNVVNLLGACTKPGGPLMVIVEYCKFGNLSNYL 103
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337 |
| >gnl|CDD|165211 PHA02882, PHA02882, putative serine/threonine kinase; Provisional | Back alignment and domain information |
|---|
Score = 40.3 bits (94), Expect = 0.003
Identities = 31/105 (29%), Positives = 47/105 (44%), Gaps = 9/105 (8%)
Query: 597 NWKLRTEIAMGIAGGLFYLHEECCTQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLDQ 656
N KL I + L Y+HE I H DIKP+NI++D + I D+G+A +
Sbjct: 124 NKKLIKNIMKDMLTTLEYIHEH---GISHGDIKPENIMVDGNNRGYIIDYGIASHFIIHG 180
Query: 657 SHTNTAI------RGTKGYVAPEWFRNMPITVKVDVYSYGVLLLE 695
H + RGT Y + +T + D+ S G +L+
Sbjct: 181 KHIEYSKEQKDLHRGTLYYAGLDAHNGACVTRRGDLESLGYCMLK 225
|
Length = 294 |
| >gnl|CDD|133238 cd05107, PTKc_PDGFR_beta, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Score = 40.0 bits (93), Expect = 0.004
Identities = 30/88 (34%), Positives = 45/88 (51%), Gaps = 6/88 (6%)
Query: 509 LGRGAFGTVYK----GFVNMGSSNHVAVKKLNSVFQDSEKE-FKAEVNGIGQTH-HKNLV 562
LG GAFG V + G + S+ VAVK L S + SEK+ +E+ + H N+V
Sbjct: 45 LGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTARSSEKQALMSELKIMSHLGPHLNIV 104
Query: 563 RLLGYCDEGQNRLLVYEFMSNGTVASFL 590
LLG C +G ++ E+ G + +L
Sbjct: 105 NLLGACTKGGPIYIITEYCRYGDLVDYL 132
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-DD induce PDGFR beta homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR beta signaling leads to a variety of cellular effects including the stimulation of cell growth and chemotaxis, as well as the inhibition of apoptosis and GAP junctional communication. It is critical in normal angiogenesis as it is involved in the recruitment of pericytes and smooth muscle cells essential for vessel stability. Aberrant PDGFR beta expression is associated with some human cancers. The continuously-active fusion proteins of PDGFR beta with COL1A1 and TEL are associated with dermatofibrosarcoma protuberans (DFSP) and a subset of chronic myelomonocytic leukemia (CMML), respectively. Length = 401 |
| >gnl|CDD|214511 smart00090, RIO, RIO-like kinase | Back alignment and domain information |
|---|
Score = 39.6 bits (93), Expect = 0.004
Identities = 35/170 (20%), Positives = 58/170 (34%), Gaps = 40/170 (23%)
Query: 501 VTRGFKEELGR----GAFGTVYKGFVNMGSSNHVAVK--KLN-SVFQDSEK----EFKAE 549
+ RG +G G VY GS AVK + F+ ++ +F+ +
Sbjct: 24 LNRGILSAIGGCISTGKEANVYHALDFDGSGKERAVKIYRTGTLEFKRRDRYVDGDFRFK 83
Query: 550 VNGIGQTH---------HKNLVRLLGY---CDEGQNRLLVYEFMSNGTVASFLFGDSKPN 597
I +NL RL + + N V F+ GD P
Sbjct: 84 YRKINPRKLVRLWAEKEFRNLQRLYEAGVPVPK------PIAWRRNVLVMEFIGGDGLPA 137
Query: 598 WKLR-TEIAMGIAGGLFY--------LHEECCTQIIHCDIKPQNILLDDH 638
+L+ E L+ L++E +++H D+ NIL+ D
Sbjct: 138 PRLKDVEPEEEEEFELYDDILEEMRKLYKEG--ELVHGDLSEYNILVHDG 185
|
Length = 237 |
Conserved Domains Detected by HHsearch 
Original result of HHsearch against CDD database
ID ![]() | Alignment Graph ![]() | Length ![]() |
Definition ![]() |
Probability ![]() |
| Query | 792 | |||
| KOG1187 | 361 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0192 | 362 | consensus Tyrosine kinase specific for activated ( | 100.0 | |
| KOG0581 | 364 | consensus Mitogen-activated protein kinase kinase | 100.0 | |
| KOG0197 | 468 | consensus Tyrosine kinases [Signal transduction me | 100.0 | |
| KOG0615 | 475 | consensus Serine/threonine protein kinase Chk2 and | 100.0 | |
| KOG0595 | 429 | consensus Serine/threonine-protein kinase involved | 100.0 | |
| KOG1026 | 774 | consensus Nerve growth factor receptor TRKA and re | 100.0 | |
| KOG0575 | 592 | consensus Polo-like serine/threonine protein kinas | 100.0 | |
| KOG0196 | 996 | consensus Tyrosine kinase, EPH (ephrin) receptor f | 100.0 | |
| KOG0591 | 375 | consensus NIMA (never in mitosis)-related G2-speci | 100.0 | |
| KOG0198 | 313 | consensus MEKK and related serine/threonine protei | 100.0 | |
| KOG4721 | 904 | consensus Serine/threonine protein kinase, contain | 100.0 | |
| KOG0598 | 357 | consensus Ribosomal protein S6 kinase and related | 100.0 | |
| KOG0593 | 396 | consensus Predicted protein kinase KKIAMRE [Genera | 100.0 | |
| KOG0592 | 604 | consensus 3-phosphoinositide-dependent protein kin | 100.0 | |
| KOG0194 | 474 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| KOG0193 | 678 | consensus Serine/threonine protein kinase RAF [Sig | 100.0 | |
| KOG0600 | 560 | consensus Cdc2-related protein kinase [Cell cycle | 100.0 | |
| cd05102 | 338 | PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi | 100.0 | |
| KOG0578 | 550 | consensus p21-activated serine/threonine protein k | 100.0 | |
| KOG1095 | 1025 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| KOG0661 | 538 | consensus MAPK related serine/threonine protein ki | 100.0 | |
| KOG0659 | 318 | consensus Cdk activating kinase (CAK)/RNA polymera | 100.0 | |
| PHA02988 | 283 | hypothetical protein; Provisional | 100.0 | |
| KOG0583 | 370 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05064 | 266 | PTKc_EphR_A10 Catalytic domain of the Protein Tyro | 100.0 | |
| KOG0582 | 516 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| cd05104 | 375 | PTKc_Kit Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG2345 | 302 | consensus Serine/threonine protein kinase/TGF-beta | 100.0 | |
| KOG0597 | 808 | consensus Serine-threonine protein kinase FUSED [G | 100.0 | |
| PF07714 | 259 | Pkinase_Tyr: Protein tyrosine kinase Protein kinas | 100.0 | |
| KOG0588 | 786 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| cd05106 | 374 | PTKc_CSF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| KOG0201 | 467 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05571 | 323 | STKc_PKB Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07848 | 287 | STKc_CDKL5 Catalytic domain of the Serine/Threonin | 100.0 | |
| KOG0585 | 576 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd05096 | 304 | PTKc_DDR1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG4278 | 1157 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| cd05612 | 291 | STKc_PRKX_like Catalytic domain of PRKX-like Prote | 100.0 | |
| PTZ00426 | 340 | cAMP-dependent protein kinase catalytic subunit; P | 100.0 | |
| KOG0616 | 355 | consensus cAMP-dependent protein kinase catalytic | 100.0 | |
| KOG4257 | 974 | consensus Focal adhesion tyrosine kinase FAK, cont | 100.0 | |
| cd05068 | 261 | PTKc_Frk_like Catalytic domain of Fyn-related kina | 100.0 | |
| cd05631 | 285 | STKc_GRK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05585 | 312 | STKc_YPK1_like Catalytic domain of Yeast Protein K | 100.0 | |
| cd05052 | 263 | PTKc_Abl Catalytic domain of the Protein Tyrosine | 100.0 | |
| PLN00113 | 968 | leucine-rich repeat receptor-like protein kinase; | 100.0 | |
| KOG3653 | 534 | consensus Transforming growth factor beta/activin | 100.0 | |
| cd06649 | 331 | PKc_MEK2 Catalytic domain of the dual-specificity | 100.0 | |
| cd05593 | 328 | STKc_PKB_gamma Catalytic domain of the Protein Ser | 100.0 | |
| cd05600 | 333 | STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- | 100.0 | |
| PTZ00263 | 329 | protein kinase A catalytic subunit; Provisional | 100.0 | |
| cd05048 | 283 | PTKc_Ror Catalytic Domain of the Protein Tyrosine | 100.0 | |
| KOG0611 | 668 | consensus Predicted serine/threonine protein kinas | 100.0 | |
| cd05105 | 400 | PTKc_PDGFR_alpha Catalytic domain of the Protein T | 100.0 | |
| KOG0605 | 550 | consensus NDR and related serine/threonine kinases | 100.0 | |
| cd05114 | 256 | PTKc_Tec_Rlk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05595 | 323 | STKc_PKB_beta Catalytic domain of the Protein Seri | 100.0 | |
| KOG1094 | 807 | consensus Discoidin domain receptor DDR1 [Signal t | 100.0 | |
| cd05033 | 266 | PTKc_EphR Catalytic domain of Ephrin Receptor Prot | 100.0 | |
| cd05049 | 280 | PTKc_Trk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05116 | 257 | PTKc_Syk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05072 | 261 | PTKc_Lyn Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05093 | 288 | PTKc_TrkB Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05148 | 261 | PTKc_Srm_Brk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05054 | 337 | PTKc_VEGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05094 | 291 | PTKc_TrkC Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05584 | 323 | STKc_p70S6K Catalytic domain of the Protein Serine | 100.0 | |
| cd06650 | 333 | PKc_MEK1 Catalytic domain of the dual-specificity | 100.0 | |
| KOG1989 | 738 | consensus ARK protein kinase family [Signal transd | 100.0 | |
| cd05594 | 325 | STKc_PKB_alpha Catalytic domain of the Protein Ser | 100.0 | |
| cd05108 | 316 | PTKc_EGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05573 | 350 | STKc_ROCK_NDR_like Catalytic domain of ROCK- and N | 100.0 | |
| KOG0658 | 364 | consensus Glycogen synthase kinase-3 [Carbohydrate | 100.0 | |
| cd05080 | 283 | PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd05614 | 332 | STKc_MSK2_N N-terminal catalytic domain of the Pro | 100.0 | |
| cd05113 | 256 | PTKc_Btk_Bmx Catalytic domain of the Protein Tyros | 100.0 | |
| cd05090 | 283 | PTKc_Ror1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| PTZ00267 | 478 | NIMA-related protein kinase; Provisional | 100.0 | |
| cd05084 | 252 | PTKc_Fes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05590 | 320 | STKc_nPKC_eta Catalytic domain of the Protein Seri | 100.0 | |
| cd05111 | 279 | PTK_HER3 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd05626 | 381 | STKc_LATS2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05591 | 321 | STKc_nPKC_epsilon Catalytic domain of the Protein | 100.0 | |
| cd05601 | 330 | STKc_CRIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07862 | 290 | STKc_CDK6 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05059 | 256 | PTKc_Tec_like Catalytic domain of Tec-like Protein | 100.0 | |
| cd05060 | 257 | PTKc_Syk_like Catalytic domain of Spleen Tyrosine | 100.0 | |
| cd05592 | 316 | STKc_nPKC_theta_delta Catalytic domain of the Prot | 100.0 | |
| cd05115 | 257 | PTKc_Zap-70 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd07871 | 288 | STKc_PCTAIRE3 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05618 | 329 | STKc_aPKC_iota Catalytic domain of the Protein Ser | 100.0 | |
| cd05063 | 268 | PTKc_EphR_A2 Catalytic domain of the Protein Tyros | 100.0 | |
| cd05092 | 280 | PTKc_TrkA Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05107 | 401 | PTKc_PDGFR_beta Catalytic domain of the Protein Ty | 100.0 | |
| PHA03212 | 391 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05062 | 277 | PTKc_IGF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05089 | 297 | PTKc_Tie1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07859 | 338 | STKc_TDY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| KOG0580 | 281 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| cd05596 | 370 | STKc_ROCK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05091 | 283 | PTKc_Ror2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05035 | 273 | PTKc_Axl_like Catalytic Domain of Axl-like Protein | 100.0 | |
| cd05588 | 329 | STKc_aPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05055 | 302 | PTKc_PDGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| PLN00034 | 353 | mitogen-activated protein kinase kinase; Provision | 100.0 | |
| cd05081 | 284 | PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of | 100.0 | |
| cd05620 | 316 | STKc_nPKC_delta Catalytic domain of the Protein Se | 100.0 | |
| cd05047 | 270 | PTKc_Tie Catalytic domain of Tie Protein Tyrosine | 100.0 | |
| cd05608 | 280 | STKc_GRK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05067 | 260 | PTKc_Lck_Blk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05071 | 262 | PTKc_Src Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05599 | 364 | STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel | 100.0 | |
| cd05570 | 318 | STKc_PKC Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05628 | 363 | STKc_NDR1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05582 | 318 | STKc_RSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| cd05088 | 303 | PTKc_Tie2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05070 | 260 | PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05619 | 316 | STKc_nPKC_theta Catalytic domain of the Protein Se | 100.0 | |
| cd05605 | 285 | STKc_GRK4_like Catalytic domain of G protein-coupl | 100.0 | |
| cd05097 | 295 | PTKc_DDR_like Catalytic domain of Discoidin Domain | 100.0 | |
| cd05053 | 293 | PTKc_FGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05076 | 274 | PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| cd05085 | 250 | PTKc_Fer Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05575 | 323 | STKc_SGK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05065 | 269 | PTKc_EphR_B Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05075 | 272 | PTKc_Axl Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07869 | 303 | STKc_PFTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05040 | 257 | PTKc_Ack_like Catalytic domain of the Protein Tyro | 100.0 | |
| KOG0694 | 694 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05621 | 370 | STKc_ROCK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05109 | 279 | PTKc_HER2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05587 | 324 | STKc_cPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05036 | 277 | PTKc_ALK_LTK Catalytic domain of the Protein Tyros | 100.0 | |
| cd05589 | 324 | STKc_PKN Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05625 | 382 | STKc_LATS1 Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG0660 | 359 | consensus Mitogen-activated protein kinase [Signal | 100.0 | |
| cd05039 | 256 | PTKc_Csk_like Catalytic domain of C-terminal Src k | 100.0 | |
| cd05045 | 290 | PTKc_RET Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0033 | 355 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd05079 | 284 | PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd05101 | 304 | PTKc_FGFR2 Catalytic domain of the Protein Tyrosin | 100.0 | |
| KOG0589 | 426 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd05629 | 377 | STKc_NDR_like_fungal Catalytic domain of Fungal Nu | 100.0 | |
| cd05598 | 376 | STKc_LATS Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05066 | 267 | PTKc_EphR_A Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05069 | 260 | PTKc_Yes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06625 | 263 | STKc_MEKK3_like Catalytic domain of MAP/ERK kinase | 100.0 | |
| cd08228 | 267 | STKc_Nek6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05103 | 343 | PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05038 | 284 | PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P | 100.0 | |
| cd05616 | 323 | STKc_cPKC_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd00192 | 262 | PTKc Catalytic domain of Protein Tyrosine Kinases. | 100.0 | |
| cd05032 | 277 | PTKc_InsR_like Catalytic domain of Insulin Recepto | 100.0 | |
| cd05043 | 280 | PTK_Ryk Pseudokinase domain of Ryk (Receptor relat | 100.0 | |
| cd07853 | 372 | STKc_NLK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05051 | 296 | PTKc_DDR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd08229 | 267 | STKc_Nek7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05077 | 262 | PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| cd06646 | 267 | STKc_MAP4K5 Catalytic domain of the Protein Serine | 100.0 | |
| cd08529 | 256 | STKc_FA2-like Catalytic domain of the Protein Seri | 100.0 | |
| cd05604 | 325 | STKc_SGK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05617 | 327 | STKc_aPKC_zeta Catalytic domain of the Protein Ser | 100.0 | |
| KOG4279 | 1226 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05078 | 258 | PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain | 100.0 | |
| cd05061 | 288 | PTKc_InsR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05058 | 262 | PTKc_Met_Ron Catalytic domain of the Protein Tyros | 100.0 | |
| cd05603 | 321 | STKc_SGK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0663 | 419 | consensus Protein kinase PITSLRE and related kinas | 100.0 | |
| cd05602 | 325 | STKc_SGK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05087 | 269 | PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein | 100.0 | |
| cd05615 | 323 | STKc_cPKC_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd05034 | 261 | PTKc_Src_like Catalytic domain of Src kinase-like | 100.0 | |
| cd06619 | 279 | PKc_MKK5 Catalytic domain of the dual-specificity | 100.0 | |
| cd05073 | 260 | PTKc_Hck Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05056 | 270 | PTKc_FAK Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05098 | 307 | PTKc_FGFR1 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd06615 | 308 | PKc_MEK Catalytic domain of the dual-specificity P | 100.0 | |
| PTZ00283 | 496 | serine/threonine protein kinase; Provisional | 100.0 | |
| KOG0199 | 1039 | consensus ACK and related non-receptor tyrosine ki | 100.0 | |
| cd05095 | 296 | PTKc_DDR2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05050 | 288 | PTKc_Musk Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG1025 | 1177 | consensus Epidermal growth factor receptor EGFR an | 100.0 | |
| cd05046 | 275 | PTK_CCK4 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd05607 | 277 | STKc_GRK7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06620 | 284 | PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr | 100.0 | |
| KOG0599 | 411 | consensus Phosphorylase kinase gamma subunit [Carb | 100.0 | |
| PF00069 | 260 | Pkinase: Protein kinase domain Protein kinase; unc | 100.0 | |
| cd05041 | 251 | PTKc_Fes_like Catalytic domain of Fes-like Protein | 100.0 | |
| cd06624 | 268 | STKc_ASK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05099 | 314 | PTKc_FGFR4 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05082 | 256 | PTKc_Csk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05622 | 371 | STKc_ROCK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG0594 | 323 | consensus Protein kinase PCTAIRE and related kinas | 100.0 | |
| cd08224 | 267 | STKc_Nek6_Nek7 Catalytic domain of the Protein Ser | 100.0 | |
| KOG0032 | 382 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd05112 | 256 | PTKc_Itk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06642 | 277 | STKc_STK25-YSK1 Catalytic domain of the Protein Se | 100.0 | |
| cd05100 | 334 | PTKc_FGFR3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05037 | 259 | PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the | 100.0 | |
| cd05623 | 332 | STKc_MRCK_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd05044 | 269 | PTKc_c-ros Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05627 | 360 | STKc_NDR2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08528 | 269 | STKc_Nek10 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06654 | 296 | STKc_PAK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06645 | 267 | STKc_MAP4K3 Catalytic domain of the Protein Serine | 100.0 | |
| cd06643 | 282 | STKc_SLK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06628 | 267 | STKc_MAPKKK_Byr2_like Catalytic domain of fungal B | 100.0 | |
| cd05597 | 331 | STKc_DMPK_like Catalytic domain of Myotonic Dystro | 100.0 | |
| cd05624 | 331 | STKc_MRCK_beta Catalytic domain of the Protein Ser | 100.0 | |
| PTZ00036 | 440 | glycogen synthase kinase; Provisional | 100.0 | |
| cd06637 | 272 | STKc_TNIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05042 | 269 | PTKc_Aatyk Catalytic domain of the Protein Tyrosin | 100.0 | |
| smart00219 | 258 | TyrKc Tyrosine kinase, catalytic domain. Phosphotr | 100.0 | |
| KOG2052 | 513 | consensus Activin A type IB receptor, serine/threo | 100.0 | |
| cd07868 | 317 | STKc_CDK8 Catalytic domain of the Serine/Threonine | 100.0 | |
| PHA03209 | 357 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd08227 | 327 | PK_STRAD_alpha Pseudokinase domain of STE20-relate | 100.0 | |
| KOG0574 | 502 | consensus STE20-like serine/threonine kinase MST [ | 100.0 | |
| cd05630 | 285 | STKc_GRK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| PRK13184 | 932 | pknD serine/threonine-protein kinase; Reviewed | 100.0 | |
| cd05586 | 330 | STKc_Sck1_like Catalytic domain of Suppressor of l | 100.0 | |
| cd06609 | 274 | STKc_MST3_like Catalytic domain of Mammalian Ste20 | 100.0 | |
| cd06651 | 266 | STKc_MEKK3 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06644 | 292 | STKc_STK10_LOK Catalytic domain of the Protein Ser | 100.0 | |
| cd05057 | 279 | PTKc_EGFR_like Catalytic domain of Epidermal Growt | 100.0 | |
| cd07872 | 309 | STKc_PCTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| KOG0667 | 586 | consensus Dual-specificity tyrosine-phosphorylatio | 100.0 | |
| PHA03207 | 392 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd07873 | 301 | STKc_PCTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| cd07833 | 288 | STKc_CDKL Catalytic domain of Cyclin-Dependent pro | 100.0 | |
| cd06655 | 296 | STKc_PAK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05632 | 285 | STKc_GRK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07863 | 288 | STKc_CDK4 Catalytic domain of the Serine/Threonine | 100.0 | |
| PTZ00284 | 467 | protein kinase; Provisional | 100.0 | |
| cd05086 | 268 | PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05110 | 303 | PTKc_HER4 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07846 | 286 | STKc_CDKL2_3 Catalytic domain of the Serine/Threon | 100.0 | |
| KOG0584 | 632 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd06613 | 262 | STKc_MAP4K3_like Catalytic domain of Mitogen-activ | 100.0 | |
| cd06632 | 258 | STKc_MEKK1_plant Catalytic domain of the Protein S | 100.0 | |
| cd06612 | 256 | STKc_MST1_2 Catalytic domain of the Protein Serine | 100.0 | |
| cd08223 | 257 | STKc_Nek4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05074 | 273 | PTKc_Tyro3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd06656 | 297 | STKc_PAK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| PHA03211 | 461 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd07867 | 317 | STKc_CDC2L6 Catalytic domain of Serine/Threonine K | 100.0 | |
| cd06629 | 272 | STKc_MAPKKK_Bck1_like Catalytic domain of fungal B | 100.0 | |
| cd08219 | 255 | STKc_Nek3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08221 | 256 | STKc_Nek9 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06631 | 265 | STKc_YSK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06640 | 277 | STKc_MST4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05083 | 254 | PTKc_Chk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07841 | 298 | STKc_CDK7 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06622 | 286 | PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS | 100.0 | |
| KOG0610 | 459 | consensus Putative serine/threonine protein kinase | 100.0 | |
| cd06658 | 292 | STKc_PAK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06605 | 265 | PKc_MAPKK Catalytic domain of the dual-specificity | 100.0 | |
| cd07875 | 364 | STKc_JNK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06611 | 280 | STKc_SLK_like Catalytic domain of Ste20-like kinas | 100.0 | |
| cd06626 | 264 | STKc_MEKK4 Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG0579 | 1187 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| cd07847 | 286 | STKc_CDKL1_4 Catalytic domain of the Serine/Threon | 100.0 | |
| cd07874 | 355 | STKc_JNK3 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06652 | 265 | STKc_MEKK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG0577 | 948 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd07876 | 359 | STKc_JNK2 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07861 | 285 | STKc_CDK1_euk Catalytic domain of the Serine/Threo | 100.0 | |
| cd06659 | 297 | STKc_PAK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06630 | 268 | STKc_MEKK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05609 | 305 | STKc_MAST Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05574 | 316 | STKc_phototropin_like Catalytic domain of Phototro | 100.0 | |
| cd07832 | 286 | STKc_CCRK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07878 | 343 | STKc_p38beta_MAPK11 Catalytic domain of the Serine | 100.0 | |
| cd05572 | 262 | STKc_cGK_PKG Catalytic domain of the Protein Serin | 100.0 | |
| cd07839 | 284 | STKc_CDK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06623 | 264 | PKc_MAPKK_plant_like Catalytic domain of Plant dua | 100.0 | |
| cd08218 | 256 | STKc_Nek1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06639 | 291 | STKc_myosinIIIB Catalytic domain of the Protein Se | 100.0 | |
| cd08217 | 265 | STKc_Nek2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05579 | 265 | STKc_MAST_like Catalytic domain of Microtubule-ass | 100.0 | |
| cd08220 | 256 | STKc_Nek8 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06648 | 285 | STKc_PAK_II Catalytic domain of the Protein Serine | 100.0 | |
| cd06641 | 277 | STKc_MST3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05633 | 279 | STKc_GRK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05580 | 290 | STKc_PKA Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06638 | 286 | STKc_myosinIIIA Catalytic domain of the Protein Se | 100.0 | |
| PTZ00266 | 1021 | NIMA-related protein kinase; Provisional | 100.0 | |
| KOG4717 | 864 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd06647 | 293 | STKc_PAK_I Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06610 | 267 | STKc_OSR1_SPAK Catalytic domain of the Protein Ser | 100.0 | |
| cd07860 | 284 | STKc_CDK2_3 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd05578 | 258 | STKc_Yank1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06636 | 282 | STKc_MAP4K4_6 Catalytic domain of the Protein Seri | 100.0 | |
| cd06621 | 287 | PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek | 100.0 | |
| cd06635 | 317 | STKc_TAO1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07840 | 287 | STKc_CDK9_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd06917 | 277 | STKc_NAK1_like Catalytic domain of Fungal Nak1-lik | 100.0 | |
| KOG0607 | 463 | consensus MAP kinase-interacting kinase and relate | 100.0 | |
| cd07843 | 293 | STKc_CDC2L1 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd06607 | 307 | STKc_TAO Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06614 | 286 | STKc_PAK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05122 | 253 | PKc_STE Catalytic domain of STE family Protein Kin | 100.0 | |
| cd07835 | 283 | STKc_CDK1_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| PHA03210 | 501 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd06608 | 275 | STKc_myosinIII_like Catalytic domain of Class III | 100.0 | |
| cd07844 | 291 | STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like | 100.0 | |
| cd08225 | 257 | STKc_Nek5 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0200 | 609 | consensus Fibroblast/platelet-derived growth facto | 100.0 | |
| cd05583 | 288 | STKc_MSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| cd05577 | 277 | STKc_GRK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07831 | 282 | STKc_MOK Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0596 | 677 | consensus Dual specificity; serine/threonine and t | 100.0 | |
| cd05611 | 260 | STKc_Rim15_like Catalytic domain of fungal Rim15-l | 100.0 | |
| cd07842 | 316 | STKc_CDK8_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd06617 | 283 | PKc_MKK3_6 Catalytic domain of the dual-specificit | 100.0 | |
| cd06653 | 264 | STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina | 100.0 | |
| cd07870 | 291 | STKc_PFTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| cd06606 | 260 | STKc_MAPKKK Catalytic domain of the Protein Serine | 100.0 | |
| cd06657 | 292 | STKc_PAK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05613 | 290 | STKc_MSK1_N N-terminal catalytic domain of the Pro | 100.0 | |
| cd07852 | 337 | STKc_MAPK15 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd06616 | 288 | PKc_MKK4 Catalytic domain of the dual-specificity | 100.0 | |
| PHA02882 | 294 | putative serine/threonine kinase; Provisional | 100.0 | |
| cd07850 | 353 | STKc_JNK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd08530 | 256 | STKc_CNK2-like Catalytic domain of the Protein Ser | 100.0 | |
| cd08226 | 328 | PK_STRAD_beta Pseudokinase domain of STE20-related | 100.0 | |
| cd07836 | 284 | STKc_Pho85 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd07855 | 334 | STKc_ERK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07858 | 337 | STKc_TEY_MAPK_plant Catalytic domain of the Serine | 99.98 | |
| cd06627 | 254 | STKc_Cdc7_like Catalytic domain of Cell division c | 99.98 | |
| cd05606 | 278 | STKc_beta_ARK Catalytic domain of the Protein Seri | 99.98 | |
| cd07830 | 283 | STKc_MAK_like Catalytic domain of Male germ cell-A | 99.98 | |
| KOG4645 | 1509 | consensus MAPKKK (MAP kinase kinase kinase) SSK2 a | 99.98 | |
| PHA03390 | 267 | pk1 serine/threonine-protein kinase 1; Provisional | 99.98 | |
| cd07837 | 295 | STKc_CdkB_plant Catalytic domain of the Serine/Thr | 99.98 | |
| cd06634 | 308 | STKc_TAO2 Catalytic domain of the Protein Serine/T | 99.98 | |
| KOG0586 | 596 | consensus Serine/threonine protein kinase [General | 99.98 | |
| cd07879 | 342 | STKc_p38delta_MAPK13 Catalytic domain of the Serin | 99.98 | |
| cd07864 | 302 | STKc_CDK12 Catalytic domain of the Serine/Threonin | 99.98 | |
| cd05118 | 283 | STKc_CMGC Catalytic domain of CMGC family Serine/T | 99.98 | |
| cd08216 | 314 | PK_STRAD Pseudokinase domain of STE20-related kina | 99.98 | |
| cd08215 | 258 | STKc_Nek Catalytic domain of the Protein Serine/Th | 99.98 | |
| cd07834 | 330 | STKc_MAPK Catalytic domain of the Serine/Threonine | 99.98 | |
| KOG0666 | 438 | consensus Cyclin C-dependent kinase CDK8 [Transcri | 99.98 | |
| cd07845 | 309 | STKc_CDK10 Catalytic domain of the Serine/Threonin | 99.98 | |
| PTZ00024 | 335 | cyclin-dependent protein kinase; Provisional | 99.98 | |
| cd07849 | 336 | STKc_ERK1_2_like Catalytic domain of Extracellular | 99.98 | |
| cd05581 | 280 | STKc_PDK1 Catalytic domain of the Protein Serine/T | 99.98 | |
| PLN00009 | 294 | cyclin-dependent kinase A; Provisional | 99.98 | |
| cd07829 | 282 | STKc_CDK_like Catalytic domain of Cyclin-Dependent | 99.98 | |
| cd06633 | 313 | STKc_TAO3 Catalytic domain of the Protein Serine/T | 99.98 | |
| cd07865 | 310 | STKc_CDK9 Catalytic domain of the Serine/Threonine | 99.97 | |
| KOG0983 | 391 | consensus Mitogen-activated protein kinase (MAPK) | 99.97 | |
| KOG0986 | 591 | consensus G protein-coupled receptor kinase [Signa | 99.97 | |
| cd05123 | 250 | STKc_AGC Catalytic domain of AGC family Protein Se | 99.97 | |
| cd06618 | 296 | PKc_MKK7 Catalytic domain of the dual-specificity | 99.97 | |
| cd07838 | 287 | STKc_CDK4_6_like Catalytic domain of Cyclin-Depend | 99.97 | |
| cd08222 | 260 | STKc_Nek11 Catalytic domain of the Protein Serine/ | 99.97 | |
| KOG0690 | 516 | consensus Serine/threonine protein kinase [Signal | 99.97 | |
| cd07866 | 311 | STKc_BUR1 Catalytic domain of the Serine/Threonine | 99.97 | |
| cd07854 | 342 | STKc_MAPK4_6 Catalytic domain of the Serine/Threon | 99.97 | |
| KOG1006 | 361 | consensus Mitogen-activated protein kinase (MAPK) | 99.97 | |
| KOG4236 | 888 | consensus Serine/threonine protein kinase PKC mu/P | 99.97 | |
| KOG0604 | 400 | consensus MAP kinase-activated protein kinase 2 [S | 99.97 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 99.97 | |
| KOG0612 | 1317 | consensus Rho-associated, coiled-coil containing p | 99.97 | |
| cd07856 | 328 | STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre | 99.97 | |
| KOG4250 | 732 | consensus TANK binding protein kinase TBK1 [Signal | 99.97 | |
| cd07857 | 332 | STKc_MPK1 Catalytic domain of the Serine/Threonine | 99.97 | |
| cd05576 | 237 | STKc_RPK118_like Catalytic domain of the Protein S | 99.97 | |
| cd07851 | 343 | STKc_p38 Catalytic domain of the Serine/Threonine | 99.97 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 99.97 | |
| KOG0696 | 683 | consensus Serine/threonine protein kinase [Signal | 99.97 | |
| cd07877 | 345 | STKc_p38alpha_MAPK14 Catalytic domain of the Serin | 99.97 | |
| cd07880 | 343 | STKc_p38gamma_MAPK12 Catalytic domain of the Serin | 99.97 | |
| KOG0671 | 415 | consensus LAMMER dual specificity kinases [Signal | 99.97 | |
| KOG1151 | 775 | consensus Tousled-like protein kinase [Signal tran | 99.97 | |
| KOG1024 | 563 | consensus Receptor-like protein tyrosine kinase RY | 99.97 | |
| cd05610 | 669 | STKc_MASTL Catalytic domain of the Protein Serine/ | 99.97 | |
| smart00220 | 244 | S_TKc Serine/Threonine protein kinases, catalytic | 99.97 | |
| PLN03224 | 507 | probable serine/threonine protein kinase; Provisio | 99.97 | |
| KOG0662 | 292 | consensus Cyclin-dependent kinase CDK5 [Intracellu | 99.97 | |
| PLN03225 | 566 | Serine/threonine-protein kinase SNT7; Provisional | 99.96 | |
| KOG0614 | 732 | consensus cGMP-dependent protein kinase [Signal tr | 99.96 | |
| KOG0669 | 376 | consensus Cyclin T-dependent kinase CDK9 [Cell cyc | 99.96 | |
| KOG0587 | 953 | consensus Traf2- and Nck-interacting kinase and re | 99.96 | |
| KOG0695 | 593 | consensus Serine/threonine protein kinase [Signal | 99.95 | |
| KOG0664 | 449 | consensus Nemo-like MAPK-related serine/threonine | 99.95 | |
| KOG0984 | 282 | consensus Mitogen-activated protein kinase (MAPK) | 99.95 | |
| KOG1027 | 903 | consensus Serine/threonine protein kinase and endo | 99.95 | |
| PF01453 | 114 | B_lectin: D-mannose binding lectin; InterPro: IPR0 | 99.95 | |
| KOG0668 | 338 | consensus Casein kinase II, alpha subunit [Signal | 99.95 | |
| KOG0608 | 1034 | consensus Warts/lats-like serine threonine kinases | 99.95 | |
| cd00180 | 215 | PKc Catalytic domain of Protein Kinases. Protein K | 99.94 | |
| KOG1290 | 590 | consensus Serine/threonine protein kinase [Signal | 99.94 | |
| cd00028 | 116 | B_lectin Bulb-type mannose-specific lectin. The do | 99.94 | |
| KOG0665 | 369 | consensus Jun-N-terminal kinase (JNK) [Signal tran | 99.94 | |
| smart00221 | 225 | STYKc Protein kinase; unclassified specificity. Ph | 99.93 | |
| KOG0670 | 752 | consensus U4/U6-associated splicing factor PRP4 [R | 99.93 | |
| KOG1152 | 772 | consensus Signal transduction serine/threonine kin | 99.93 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 99.93 | |
| smart00108 | 114 | B_lectin Bulb-type mannose-specific lectin. | 99.93 | |
| KOG1167 | 418 | consensus Serine/threonine protein kinase of the C | 99.92 | |
| PLN00181 | 793 | protein SPA1-RELATED; Provisional | 99.91 | |
| KOG1345 | 378 | consensus Serine/threonine kinase [Signal transduc | 99.91 | |
| KOG0195 | 448 | consensus Integrin-linked kinase [Signal transduct | 99.9 | |
| smart00750 | 176 | KIND kinase non-catalytic C-lobe domain. It is an | 99.9 | |
| PRK09188 | 365 | serine/threonine protein kinase; Provisional | 99.88 | |
| KOG1164 | 322 | consensus Casein kinase (serine/threonine/tyrosine | 99.85 | |
| COG0515 | 384 | SPS1 Serine/threonine protein kinase [General func | 99.82 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.82 | |
| KOG1163 | 341 | consensus Casein kinase (serine/threonine/tyrosine | 99.8 | |
| cd05147 | 190 | RIO1_euk RIO kinase family; eukaryotic RIO1, catal | 99.8 | |
| PRK10359 | 232 | lipopolysaccharide core biosynthesis protein; Prov | 99.79 | |
| KOG1023 | 484 | consensus Natriuretic peptide receptor, guanylate | 99.78 | |
| cd05145 | 190 | RIO1_like RIO kinase family; RIO1, RIO3 and simila | 99.78 | |
| KOG1165 | 449 | consensus Casein kinase (serine/threonine/tyrosine | 99.77 | |
| KOG1240 | 1431 | consensus Protein kinase containing WD40 repeats [ | 99.76 | |
| PF00954 | 110 | S_locus_glycop: S-locus glycoprotein family; Inter | 99.75 | |
| PRK12274 | 218 | serine/threonine protein kinase; Provisional | 99.73 | |
| PF14531 | 288 | Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_ | 99.73 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 99.72 | |
| PRK10345 | 210 | hypothetical protein; Provisional | 99.7 | |
| smart00090 | 237 | RIO RIO-like kinase. | 99.7 | |
| PRK14879 | 211 | serine/threonine protein kinase; Provisional | 99.65 | |
| KOG1166 | 974 | consensus Mitotic checkpoint serine/threonine prot | 99.65 | |
| KOG4158 | 598 | consensus BRPK/PTEN-induced protein kinase [Signal | 99.64 | |
| TIGR03724 | 199 | arch_bud32 Kae1-associated kinase Bud32. Members o | 99.64 | |
| KOG1033 | 516 | consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati | 99.64 | |
| cd05144 | 198 | RIO2_C RIO kinase family; RIO2, C-terminal catalyt | 99.62 | |
| PRK09605 | 535 | bifunctional UGMP family protein/serine/threonine | 99.61 | |
| cd05120 | 155 | APH_ChoK_like Aminoglycoside 3'-phosphotransferase | 99.53 | |
| cd05119 | 187 | RIO RIO kinase family, catalytic domain. The RIO k | 99.53 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.52 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.51 | |
| PRK01723 | 239 | 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | 99.48 | |
| KOG1266 | 458 | consensus Protein kinase [Signal transduction mech | 99.37 | |
| TIGR01982 | 437 | UbiB 2-polyprenylphenol 6-hydroxylase. This model | 99.32 | |
| cd05151 | 170 | ChoK Choline Kinase (ChoK). The ChoK subfamily is | 99.18 | |
| cd01098 | 84 | PAN_AP_plant Plant PAN/APPLE-like domain; present | 99.13 | |
| cd05146 | 197 | RIO3_euk RIO kinase family; eukaryotic RIO3, catal | 99.13 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.12 | |
| PRK04750 | 537 | ubiB putative ubiquinone biosynthesis protein UbiB | 99.11 | |
| KOG1243 | 690 | consensus Protein kinase [General function predict | 99.1 | |
| PF08276 | 66 | PAN_2: PAN-like domain; InterPro: IPR013227 PAN do | 99.1 | |
| cd05154 | 223 | ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an | 99.02 | |
| COG3642 | 204 | Mn2+-dependent serine/threonine protein kinase [Si | 98.97 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 98.96 | |
| KOG3741 | 655 | consensus Poly(A) ribonuclease subunit [RNA proces | 98.92 | |
| KOG3087 | 229 | consensus Serine/threonine protein kinase [General | 98.88 | |
| cd00129 | 80 | PAN_APPLE PAN/APPLE-like domain; present in N-term | 98.74 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 98.68 | |
| PRK15123 | 268 | lipopolysaccharide core heptose(I) kinase RfaP; Pr | 98.68 | |
| PF01163 | 188 | RIO1: RIO1 family; InterPro: IPR018934 Protein pho | 98.65 | |
| smart00108 | 114 | B_lectin Bulb-type mannose-specific lectin. | 98.61 | |
| cd00028 | 116 | B_lectin Bulb-type mannose-specific lectin. The do | 98.58 | |
| PF06293 | 206 | Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; | 98.5 | |
| KOG2137 | 700 | consensus Protein kinase [Signal transduction mech | 98.46 | |
| COG0478 | 304 | RIO-like serine/threonine protein kinase fused to | 98.44 | |
| COG4248 | 637 | Uncharacterized protein with protein kinase and he | 98.42 | |
| PRK09902 | 216 | hypothetical protein; Provisional | 98.41 | |
| COG0661 | 517 | AarF Predicted unusual protein kinase [General fun | 98.35 | |
| PF06176 | 229 | WaaY: Lipopolysaccharide core biosynthesis protein | 98.12 | |
| COG1718 | 268 | RIO1 Serine/threonine protein kinase involved in c | 98.09 | |
| TIGR02172 | 226 | Fb_sc_TIGR02172 Fibrobacter succinogenes paralogou | 98.08 | |
| PF01453 | 114 | B_lectin: D-mannose binding lectin; InterPro: IPR0 | 98.06 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 98.03 | |
| PF12260 | 188 | PIP49_C: Protein-kinase domain of FAM69; InterPro: | 97.98 | |
| smart00473 | 78 | PAN_AP divergent subfamily of APPLE domains. Apple | 97.97 | |
| KOG1235 | 538 | consensus Predicted unusual protein kinase [Genera | 97.94 | |
| cd05150 | 244 | APH Aminoglycoside 3'-phosphotransferase (APH). Th | 97.88 | |
| PF01636 | 239 | APH: Phosphotransferase enzyme family This family | 97.79 | |
| COG2112 | 201 | Predicted Ser/Thr protein kinase [Signal transduct | 97.71 | |
| cd05155 | 235 | APH_ChoK_like_1 Uncharacterized bacterial proteins | 97.62 | |
| PLN02876 | 822 | acyl-CoA dehydrogenase | 97.58 | |
| PF10707 | 199 | YrbL-PhoP_reg: PhoP regulatory network protein Yrb | 97.54 | |
| PF13095 | 207 | FTA2: Kinetochore Sim4 complex subunit FTA2 | 97.41 | |
| PRK10593 | 297 | hypothetical protein; Provisional | 97.39 | |
| cd05157 | 235 | ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes. | 97.32 | |
| TIGR02721 | 256 | ycfN_thiK thiamine kinase. Members of this family | 97.3 | |
| cd01100 | 73 | APPLE_Factor_XI_like Subfamily of PAN/APPLE-like d | 97.28 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 97.17 | |
| cd05153 | 296 | HomoserineK_II Homoserine Kinase, type II. Homoser | 97.17 | |
| PRK09550 | 401 | mtnK methylthioribose kinase; Reviewed | 97.16 | |
| TIGR00938 | 307 | thrB_alt homoserine kinase, Neisseria type. Homose | 96.76 | |
| PRK05231 | 319 | homoserine kinase; Provisional | 96.74 | |
| cd05156 | 302 | ChoK_euk Choline Kinase (ChoK) in eukaryotes. The | 96.68 | |
| PF07387 | 308 | Seadorna_VP7: Seadornavirus VP7; InterPro: IPR0099 | 96.1 | |
| PLN02236 | 344 | choline kinase | 95.99 | |
| PF03881 | 288 | Fructosamin_kin: Fructosamine kinase; InterPro: IP | 95.97 | |
| cd05152 | 276 | MPH2' Macrolide 2'-Phosphotransferase (MPH2'). MPH | 95.85 | |
| COG3173 | 321 | Predicted aminoglycoside phosphotransferase [Gener | 95.74 | |
| KOG1826 | 2724 | consensus Ras GTPase activating protein RasGAP/neu | 95.66 | |
| PLN02756 | 418 | S-methyl-5-thioribose kinase | 95.6 | |
| KOG1236 | 565 | consensus Predicted unusual protein kinase [Genera | 95.23 | |
| TIGR02906 | 313 | spore_CotS spore coat protein, CotS family. Member | 94.98 | |
| PF01633 | 211 | Choline_kinase: Choline/ethanolamine kinase; Inter | 94.98 | |
| KOG2268 | 465 | consensus Serine/threonine protein kinase [Signal | 94.96 |
| >KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-54 Score=461.99 Aligned_cols=288 Identities=44% Similarity=0.744 Sum_probs=251.2
Q ss_pred CccccCHHHHHHHHhhhh--hhcCccccceEEEeeecCCCceEEEEEEcccccccchHHHHHHHHHhcccCCCCcccccc
Q 003836 489 NLRCFTYKELVEVTRGFK--EELGRGAFGTVYKGFVNMGSSNHVAVKKLNSVFQDSEKEFKAEVNGIGQTHHKNLVRLLG 566 (792)
Q Consensus 489 ~~~~~~~~el~~~~~~~~--~~lG~G~~g~Vy~g~~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~g 566 (792)
..+.|++.||..+|++|. ..||+|+||+||+|.++.+ ..||||++........++|.+|++++.+++|||||+|+|
T Consensus 61 ~~~~fs~~el~~AT~~Fs~~~~ig~Ggfg~VYkG~l~~~--~~vAVK~~~~~~~~~~~eF~~Ei~~ls~l~H~Nlv~LlG 138 (361)
T KOG1187|consen 61 PLRSFSYDELRKATNNFSESNLIGEGGFGTVYKGVLSDG--TVVAVKRLSSNSGQGEREFLNEVEILSRLRHPNLVKLLG 138 (361)
T ss_pred CcceeeHHHHHHHHhCCchhcceecCCCeEEEEEEECCC--CEEEEEEecCCCCcchhHHHHHHHHHhcCCCcCcccEEE
Confidence 577899999999999998 5899999999999998754 689999887654331566999999999999999999999
Q ss_pred eeccCC-ceEEEEEeccCCCccccccCCC--CCchhHHHHHHHHHHHHHHHHhhccCCCeEecCCCCCcEEEcCCCCeEE
Q 003836 567 YCDEGQ-NRLLVYEFMSNGTVASFLFGDS--KPNWKLRTEIAMGIAGGLFYLHEECCTQIIHCDIKPQNILLDDHYNARI 643 (792)
Q Consensus 567 ~~~~~~-~~~lV~E~~~~gsL~~~l~~~~--~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dikp~NILl~~~~~~kl 643 (792)
||.+.+ +++||||||++|+|.++|+... .++|.+|++||.++|+||+|||+.+.+.||||||||+|||||+++++||
T Consensus 139 yC~e~~~~~~LVYEym~nGsL~d~L~~~~~~~L~W~~R~kIa~g~A~gL~yLH~~~~~~iiHrDiKssNILLD~~~~aKl 218 (361)
T KOG1187|consen 139 YCLEGGEHRLLVYEYMPNGSLEDHLHGKKGEPLDWETRLKIALGAARGLAYLHEGCPPPIIHRDIKSSNILLDEDFNAKL 218 (361)
T ss_pred EEecCCceEEEEEEccCCCCHHHHhCCCCCCCCCHHHHHHHHHHHHHHHHHHccCCCCCEecCCCCHHHeeECCCCCEEc
Confidence 999999 5999999999999999999875 8999999999999999999999999999999999999999999999999
Q ss_pred eecCCCccccCCCCCccccccccCCcccccccccCCCCcccceehHHHHHHHHHhcCcCCCcchhhhhhhhHHHHHHHhh
Q 003836 644 SDFGLAKLLTLDQSHTNTAIRGTKGYVAPEWFRNMPITVKVDVYSYGVLLLEIICLRRNIDNEISKVDKAILTDWAYDRY 723 (792)
Q Consensus 644 ~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DV~S~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~ 723 (792)
+|||+|+..........+...||.+|+|||++..+..+.|+|||||||+|+||+||+++.+.... .....+..|+...+
T Consensus 219 sDFGLa~~~~~~~~~~~~~~~gt~gY~~PEy~~~g~lt~KsDVySFGVvllElitgr~~~d~~~~-~~~~~l~~w~~~~~ 297 (361)
T KOG1187|consen 219 SDFGLAKLGPEGDTSVSTTVMGTFGYLAPEYASTGKLTEKSDVYSFGVVLLELITGRKAVDQSRP-RGELSLVEWAKPLL 297 (361)
T ss_pred cCccCcccCCccccceeeecCCCCccCChhhhccCCcCcccccccchHHHHHHHhCCcccCCCCC-cccccHHHHHHHHH
Confidence 99999976543111111111799999999999999999999999999999999999998876442 22233778888888
Q ss_pred cccchhHhhhchhc-ccCCH-HHHHHHHHHHHHccccCCCCCCCHHhHHHHhccCcCC
Q 003836 724 QERTLEALVENDLE-AMNNV-TMLHRFVMVAFWCIQEDPSHRPTMRKVTQMLEGVVEV 779 (792)
Q Consensus 724 ~~~~~~~~~~~~~~-~~~~~-~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~L~~~~~~ 779 (792)
.++.+.+++|+.+. ..++. +.+.++..++.+|++.+|.+||+|.||+++|+.+...
T Consensus 298 ~~~~~~eiiD~~l~~~~~~~~~~~~~~~~~a~~C~~~~~~~RP~m~~Vv~~L~~~~~~ 355 (361)
T KOG1187|consen 298 EEGKLREIVDPRLKEGEYPDEKEVKKLAELALRCLRPDPKERPTMSQVVKELEGILSL 355 (361)
T ss_pred HCcchhheeCCCccCCCCChHHHHHHHHHHHHHHcCcCCCcCcCHHHHHHHHHhhccc
Confidence 88899999999987 55554 7889999999999999999999999999999766544
|
|
| >KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-46 Score=397.27 Aligned_cols=251 Identities=33% Similarity=0.512 Sum_probs=213.0
Q ss_pred hhhcCccccceEEEeeecCCCceEEEEEEcccccccc--hHHHHHHHHHhcccCCCCcccccceeccCC-ceEEEEEecc
Q 003836 506 KEELGRGAFGTVYKGFVNMGSSNHVAVKKLNSVFQDS--EKEFKAEVNGIGQTHHKNLVRLLGYCDEGQ-NRLLVYEFMS 582 (792)
Q Consensus 506 ~~~lG~G~~g~Vy~g~~~~~~~~~vavK~~~~~~~~~--~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~-~~~lV~E~~~ 582 (792)
.+.||+|+||+||+|.+... ..||||++....... .++|.+|+.+|.+++|||||+++|+|.+.. ...+|||||+
T Consensus 46 ~~~iG~G~~g~V~~~~~~g~--~~vavK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~f~G~~~~~~~~~~iVtEy~~ 123 (362)
T KOG0192|consen 46 EEVLGSGSFGTVYKGKWRGT--DVVAVKIISDPDFDDESRKAFRREASLLSRLRHPNIVQFYGACTSPPGSLCIVTEYMP 123 (362)
T ss_pred hhhcccCCceeEEEEEeCCc--eeEEEEEecchhcChHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCceEEEEEeCC
Confidence 35599999999999988632 239999998654332 569999999999999999999999999988 7999999999
Q ss_pred CCCccccccC--CCCCchhHHHHHHHHHHHHHHHHhhccCCC-eEecCCCCCcEEEcCCC-CeEEeecCCCccccCCCCC
Q 003836 583 NGTVASFLFG--DSKPNWKLRTEIAMGIAGGLFYLHEECCTQ-IIHCDIKPQNILLDDHY-NARISDFGLAKLLTLDQSH 658 (792)
Q Consensus 583 ~gsL~~~l~~--~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~-ivH~dikp~NILl~~~~-~~kl~Dfg~a~~~~~~~~~ 658 (792)
+|+|.++|++ ...+++..+++|+.|||+||.|||++ + ||||||||+|||++.++ ++||+|||+++...... .
T Consensus 124 ~GsL~~~l~~~~~~~l~~~~~l~~aldiArGm~YLH~~---~~iIHrDLK~~NiLv~~~~~~~KI~DFGlsr~~~~~~-~ 199 (362)
T KOG0192|consen 124 GGSLSVLLHKKRKRKLPLKVRLRIALDIARGMEYLHSE---GPIIHRDLKSDNILVDLKGKTLKIADFGLSREKVISK-T 199 (362)
T ss_pred CCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHhcC---CCeeecccChhhEEEcCCCCEEEECCCccceeecccc-c
Confidence 9999999988 57899999999999999999999999 7 99999999999999997 99999999998765432 2
Q ss_pred ccccccccCCcccccccc--cCCCCcccceehHHHHHHHHHhcCcCCCcchhhhhhhhHHHHHHHhhcccchhHhhhchh
Q 003836 659 TNTAIRGTKGYVAPEWFR--NMPITVKVDVYSYGVLLLEIICLRRNIDNEISKVDKAILTDWAYDRYQERTLEALVENDL 736 (792)
Q Consensus 659 ~~~~~~gt~~y~aPE~~~--~~~~~~k~DV~S~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 736 (792)
..+...||+.|||||++. ...|+.|+||||||++||||+||+.||...... . ....++....
T Consensus 200 ~~~~~~GT~~wMAPEv~~~~~~~~~~K~DvySFgIvlWEl~t~~~Pf~~~~~~-~---------------~~~~v~~~~~ 263 (362)
T KOG0192|consen 200 SMTSVAGTYRWMAPEVLRGEKSPYTEKSDVYSFGIVLWELLTGEIPFEDLAPV-Q---------------VASAVVVGGL 263 (362)
T ss_pred cccCCCCCccccChhhhcCCCCcCCccchhhhHHHHHHHHHHCCCCCCCCCHH-H---------------HHHHHHhcCC
Confidence 333467999999999999 669999999999999999999999999876431 1 1122333444
Q ss_pred cccCCHHHHHHHHHHHHHccccCCCCCCCHHhHHHHhccCcC
Q 003836 737 EAMNNVTMLHRFVMVAFWCIQEDPSHRPTMRKVTQMLEGVVE 778 (792)
Q Consensus 737 ~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~L~~~~~ 778 (792)
+...+......+..++.+||+.||+.||++.+|+.+|+.+..
T Consensus 264 Rp~~p~~~~~~l~~l~~~CW~~dp~~RP~f~ei~~~l~~~~~ 305 (362)
T KOG0192|consen 264 RPPIPKECPPHLSSLMERCWLVDPSRRPSFLEIVSRLESIMS 305 (362)
T ss_pred CCCCCccCCHHHHHHHHHhCCCCCCcCCCHHHHHHHHHHHHH
Confidence 555555577889999999999999999999999999987643
|
|
| >KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-45 Score=373.66 Aligned_cols=258 Identities=26% Similarity=0.360 Sum_probs=214.8
Q ss_pred cCHHHHHHHHhhhhhhcCccccceEEEeeecCCCceEEEEEEccc-ccccchHHHHHHHHHhcccCCCCcccccceeccC
Q 003836 493 FTYKELVEVTRGFKEELGRGAFGTVYKGFVNMGSSNHVAVKKLNS-VFQDSEKEFKAEVNGIGQTHHKNLVRLLGYCDEG 571 (792)
Q Consensus 493 ~~~~el~~~~~~~~~~lG~G~~g~Vy~g~~~~~~~~~vavK~~~~-~~~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~ 571 (792)
++..||+. .+.||+|..|+|||+.+ ..+++.+|+|.+.. ......+++.+|++++++.+||+||+++|.|...
T Consensus 76 i~~~dle~-----~~~lG~G~gG~V~kv~H-k~t~~i~AlK~I~~~~~~~~~~Qi~rEl~il~~~~spyIV~~ygaF~~~ 149 (364)
T KOG0581|consen 76 ISLSDLER-----LGVLGSGNGGTVYKVRH-KPTGKIYALKVILLNIDPALQKQILRELEILRSCQSPYIVGFYGAFYSN 149 (364)
T ss_pred cCHHHhhh-----hhhcccCCCcEEEEEEE-cCCCeEEEEEeecccCCHHHHHHHHHHHHHHhhCCCCCeeeEeEEEEeC
Confidence 55566654 35799999999999965 46778999999953 3455678999999999999999999999999988
Q ss_pred C-ceEEEEEeccCCCccccccCCCCCchhHHHHHHHHHHHHHHHHhhccCCCeEecCCCCCcEEEcCCCCeEEeecCCCc
Q 003836 572 Q-NRLLVYEFMSNGTVASFLFGDSKPNWKLRTEIAMGIAGGLFYLHEECCTQIIHCDIKPQNILLDDHYNARISDFGLAK 650 (792)
Q Consensus 572 ~-~~~lV~E~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dikp~NILl~~~~~~kl~Dfg~a~ 650 (792)
. ...|+||||++|||+.++...+++++....+|+.+|++||.|||+. .+||||||||+|||++..|++||+|||.++
T Consensus 150 ~~~isI~mEYMDgGSLd~~~k~~g~i~E~~L~~ia~~VL~GL~YLh~~--~~IIHRDIKPsNlLvNskGeVKicDFGVS~ 227 (364)
T KOG0581|consen 150 GEEISICMEYMDGGSLDDILKRVGRIPEPVLGKIARAVLRGLSYLHEE--RKIIHRDIKPSNLLVNSKGEVKICDFGVSG 227 (364)
T ss_pred CceEEeehhhcCCCCHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhc--cCeeeccCCHHHeeeccCCCEEeccccccH
Confidence 8 5999999999999999998888899999999999999999999973 399999999999999999999999999999
Q ss_pred cccCCCCCccccccccCCcccccccccCCCCcccceehHHHHHHHHHhcCcCCCcchhhhhhhhHHHHHHHhhcccchhH
Q 003836 651 LLTLDQSHTNTAIRGTKGYVAPEWFRNMPITVKVDVYSYGVLLLEIICLRRNIDNEISKVDKAILTDWAYDRYQERTLEA 730 (792)
Q Consensus 651 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DV~S~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 730 (792)
.+... ......||..|||||.+++..|+.++||||||+.++|+.+|+.|+......... |. ..+..
T Consensus 228 ~lvnS---~a~tfvGT~~YMsPERi~g~~Ys~~sDIWSLGLsllE~a~GrfP~~~~~~~~~~-----~~------~Ll~~ 293 (364)
T KOG0581|consen 228 ILVNS---IANTFVGTSAYMSPERISGESYSVKSDIWSLGLSLLELAIGRFPYPPPNPPYLD-----IF------ELLCA 293 (364)
T ss_pred Hhhhh---hcccccccccccChhhhcCCcCCcccceecccHHHHHHhhCCCCCCCcCCCCCC-----HH------HHHHH
Confidence 87644 445677999999999999999999999999999999999999999764111000 00 11233
Q ss_pred hhhchhcccCCHHHHHHHHHHHHHccccCCCCCCCHHhHHHH
Q 003836 731 LVENDLEAMNNVTMLHRFVMVAFWCIQEDPSHRPTMRKVTQM 772 (792)
Q Consensus 731 ~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~ 772 (792)
++++..........++++.+++..||+.||.+||+++|++++
T Consensus 294 Iv~~ppP~lP~~~fS~ef~~FV~~CL~Kdp~~R~s~~qLl~H 335 (364)
T KOG0581|consen 294 IVDEPPPRLPEGEFSPEFRSFVSCCLRKDPSERPSAKQLLQH 335 (364)
T ss_pred HhcCCCCCCCcccCCHHHHHHHHHHhcCCcccCCCHHHHhcC
Confidence 343222222222488899999999999999999999999874
|
|
| >KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-45 Score=387.78 Aligned_cols=259 Identities=29% Similarity=0.411 Sum_probs=222.8
Q ss_pred HHHHhhhhhhcCccccceEEEeeecCCCceEEEEEEcccccccchHHHHHHHHHhcccCCCCcccccceeccCCceEEEE
Q 003836 499 VEVTRGFKEELGRGAFGTVYKGFVNMGSSNHVAVKKLNSVFQDSEKEFKAEVNGIGQTHHKNLVRLLGYCDEGQNRLLVY 578 (792)
Q Consensus 499 ~~~~~~~~~~lG~G~~g~Vy~g~~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~lV~ 578 (792)
......+.+.||+|-||.||+|.++.. ..||+|.++.. ....+.|.+|+++|.+|+|+|||+++|+|..++.++|||
T Consensus 204 ~r~~l~l~~~LG~G~FG~V~~g~~~~~--~~vavk~ik~~-~m~~~~f~~Ea~iMk~L~H~~lV~l~gV~~~~~piyIVt 280 (468)
T KOG0197|consen 204 PREELKLIRELGSGQFGEVWLGKWNGS--TKVAVKTIKEG-SMSPEAFLREAQIMKKLRHEKLVKLYGVCTKQEPIYIVT 280 (468)
T ss_pred cHHHHHHHHHhcCCccceEEEEEEcCC--CcccceEEecc-ccChhHHHHHHHHHHhCcccCeEEEEEEEecCCceEEEE
Confidence 333445678899999999999998743 36999999865 445678999999999999999999999999999999999
Q ss_pred EeccCCCccccccC--CCCCchhHHHHHHHHHHHHHHHHhhccCCCeEecCCCCCcEEEcCCCCeEEeecCCCccccCCC
Q 003836 579 EFMSNGTVASFLFG--DSKPNWKLRTEIAMGIAGGLFYLHEECCTQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLDQ 656 (792)
Q Consensus 579 E~~~~gsL~~~l~~--~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dikp~NILl~~~~~~kl~Dfg~a~~~~~~~ 656 (792)
|||+.|+|.+||.. ...+...+.+.++.|||+||+||+++ ++|||||.++|||++++..+||+|||+||....+.
T Consensus 281 E~m~~GsLl~yLr~~~~~~l~~~~Ll~~a~qIaeGM~YLes~---~~IHRDLAARNiLV~~~~~vKIsDFGLAr~~~d~~ 357 (468)
T KOG0197|consen 281 EYMPKGSLLDYLRTREGGLLNLPQLLDFAAQIAEGMAYLESK---NYIHRDLAARNILVDEDLVVKISDFGLARLIGDDE 357 (468)
T ss_pred EecccCcHHHHhhhcCCCccchHHHHHHHHHHHHHHHHHHhC---CccchhhhhhheeeccCceEEEcccccccccCCCc
Confidence 99999999999986 46789999999999999999999999 99999999999999999999999999999655554
Q ss_pred CCccccccccCCcccccccccCCCCcccceehHHHHHHHHHh-cCcCCCcchhhhhhhhHHHHHHHhhcccchhHhhhch
Q 003836 657 SHTNTAIRGTKGYVAPEWFRNMPITVKVDVYSYGVLLLEIIC-LRRNIDNEISKVDKAILTDWAYDRYQERTLEALVEND 735 (792)
Q Consensus 657 ~~~~~~~~gt~~y~aPE~~~~~~~~~k~DV~S~Gv~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 735 (792)
........-...|.|||.+....|+.|||||||||+||||+| |+.|+.... ...+.+.++..
T Consensus 358 Y~~~~~~kfPIkWtAPEa~~~~~FS~kSDVWSFGVlL~E~fT~G~~py~~ms-----------------n~ev~~~le~G 420 (468)
T KOG0197|consen 358 YTASEGGKFPIKWTAPEALNYGKFSSKSDVWSFGVLLWELFTYGRVPYPGMS-----------------NEEVLELLERG 420 (468)
T ss_pred eeecCCCCCCceecCHHHHhhCCcccccceeehhhhHHHHhccCCCCCCCCC-----------------HHHHHHHHhcc
Confidence 444444445668999999999999999999999999999998 555654432 22345667778
Q ss_pred hcccCCHHHHHHHHHHHHHccccCCCCCCCHHhHHHHhccCcCCC
Q 003836 736 LEAMNNVTMLHRFVMVAFWCIQEDPSHRPTMRKVTQMLEGVVEVP 780 (792)
Q Consensus 736 ~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~L~~~~~~~ 780 (792)
.+...|..++..+.++|..||+.+|++|||++.+...|+.+....
T Consensus 421 yRlp~P~~CP~~vY~lM~~CW~~~P~~RPtF~~L~~~l~~~~~~~ 465 (468)
T KOG0197|consen 421 YRLPRPEGCPDEVYELMKSCWHEDPEDRPTFETLREVLEDFFTST 465 (468)
T ss_pred CcCCCCCCCCHHHHHHHHHHhhCCcccCCCHHHHHHHHHHhhhcc
Confidence 888888899999999999999999999999999999998875543
|
|
| >KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-44 Score=368.07 Aligned_cols=248 Identities=25% Similarity=0.401 Sum_probs=205.6
Q ss_pred hhhhhhcCccccceEEEeeecCCCceEEEEEEccccccc-------chHHHHHHHHHhcccCCCCcccccceeccCCceE
Q 003836 503 RGFKEELGRGAFGTVYKGFVNMGSSNHVAVKKLNSVFQD-------SEKEFKAEVNGIGQTHHKNLVRLLGYCDEGQNRL 575 (792)
Q Consensus 503 ~~~~~~lG~G~~g~Vy~g~~~~~~~~~vavK~~~~~~~~-------~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~ 575 (792)
+-+.+.||+|+||.|-+|. +..+++.||||++++.... .....++|+++|++++|||||++++++...+..|
T Consensus 174 yii~~~LGsGafg~Vkla~-e~~tgk~vAiKIi~krk~~~~s~~~~~~~~v~~EieILkkL~HP~IV~~~d~f~~~ds~Y 252 (475)
T KOG0615|consen 174 YIISKTLGSGAFGLVKLAY-EKKTGKQVAIKIINKRKSTGCSRAIAKTRDVQNEIEILKKLSHPNIVRIKDFFEVPDSSY 252 (475)
T ss_pred eEeeeeecCCceeEEEEEE-EcccCcEEEeeeeehhhcccccccccchhhhHHHHHHHHhcCCCCEEEEeeeeecCCceE
Confidence 3446789999999999995 5677899999999764322 2334679999999999999999999999999999
Q ss_pred EEEEeccCCCccccccCCCCCchhHHHHHHHHHHHHHHHHhhccCCCeEecCCCCCcEEEcCC---CCeEEeecCCCccc
Q 003836 576 LVYEFMSNGTVASFLFGDSKPNWKLRTEIAMGIAGGLFYLHEECCTQIIHCDIKPQNILLDDH---YNARISDFGLAKLL 652 (792)
Q Consensus 576 lV~E~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dikp~NILl~~~---~~~kl~Dfg~a~~~ 652 (792)
||||||++|.|.+++-.++.+.+..-..++.|++.|+.|||++ ||+||||||+|||+..+ ..+||+|||+|+..
T Consensus 253 mVlE~v~GGeLfd~vv~nk~l~ed~~K~~f~Qll~avkYLH~~---GI~HRDiKPeNILl~~~~e~~llKItDFGlAK~~ 329 (475)
T KOG0615|consen 253 MVLEYVEGGELFDKVVANKYLREDLGKLLFKQLLTAVKYLHSQ---GIIHRDIKPENILLSNDAEDCLLKITDFGLAKVS 329 (475)
T ss_pred EEEEEecCccHHHHHHhccccccchhHHHHHHHHHHHHHHHHc---CcccccCCcceEEeccCCcceEEEecccchhhcc
Confidence 9999999999999999999999999999999999999999999 99999999999999866 77999999999986
Q ss_pred cCCCCCccccccccCCcccccccccCC---CCcccceehHHHHHHHHHhcCcCCCcchhhhhhhhHHHHHHHhhcccchh
Q 003836 653 TLDQSHTNTAIRGTKGYVAPEWFRNMP---ITVKVDVYSYGVLLLEIICLRRNIDNEISKVDKAILTDWAYDRYQERTLE 729 (792)
Q Consensus 653 ~~~~~~~~~~~~gt~~y~aPE~~~~~~---~~~k~DV~S~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 729 (792)
. +..-..+.+|||.|.|||++.++. +..|.|+||+||+||-+++|..||.....+.. ..+
T Consensus 330 g--~~sfm~TlCGTpsYvAPEVl~~kg~~~~~~kVDiWSlGcvLfvcLsG~pPFS~~~~~~s---------------l~e 392 (475)
T KOG0615|consen 330 G--EGSFMKTLCGTPSYVAPEVLASKGVEYYPSKVDIWSLGCVLFVCLSGYPPFSEEYTDPS---------------LKE 392 (475)
T ss_pred c--cceehhhhcCCccccChhheecCCeecccchheeeeccceEEEEeccCCCcccccCCcc---------------HHH
Confidence 5 344456789999999999997654 33588999999999999999999976543310 011
Q ss_pred Hhhhchh--cccCCHHHHHHHHHHHHHccccCCCCCCCHHhHHH
Q 003836 730 ALVENDL--EAMNNVTMLHRFVMVAFWCIQEDPSHRPTMRKVTQ 771 (792)
Q Consensus 730 ~~~~~~~--~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~ 771 (792)
++..... .+..-.+.+++..+++.+||..||++|||++|+++
T Consensus 393 QI~~G~y~f~p~~w~~Iseea~dlI~~mL~VdP~~R~s~~eaL~ 436 (475)
T KOG0615|consen 393 QILKGRYAFGPLQWDRISEEALDLINWMLVVDPENRPSADEALN 436 (475)
T ss_pred HHhcCcccccChhhhhhhHHHHHHHHHhhEeCcccCcCHHHHhc
Confidence 1111111 11223456788999999999999999999999987
|
|
| >KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-43 Score=362.77 Aligned_cols=198 Identities=28% Similarity=0.464 Sum_probs=180.2
Q ss_pred hhhhcCccccceEEEeeecCCCceEEEEEEcccc--cccchHHHHHHHHHhcccCCCCcccccceeccCCceEEEEEecc
Q 003836 505 FKEELGRGAFGTVYKGFVNMGSSNHVAVKKLNSV--FQDSEKEFKAEVNGIGQTHHKNLVRLLGYCDEGQNRLLVYEFMS 582 (792)
Q Consensus 505 ~~~~lG~G~~g~Vy~g~~~~~~~~~vavK~~~~~--~~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~lV~E~~~ 582 (792)
+.++||+|+|++||+|++... +..||||.+.+. .....+.+..|+.+|+.++|||||++++++..++..+||||||.
T Consensus 14 ~~~~iG~GsfavVykg~h~~~-~~~VAIK~i~~~~l~~k~~e~L~~Ei~iLkel~H~nIV~l~d~~~~~~~i~lVMEyC~ 92 (429)
T KOG0595|consen 14 LSREIGSGSFAVVYKGRHKKS-GTEVAIKCIAKKKLNKKLVELLLSEIKILKELKHPNIVRLLDCIEDDDFIYLVMEYCN 92 (429)
T ss_pred ehhhccCcceEEEEEeEeccC-CceEEeeeehhhccCHHHHHHHHHHHHHHHhcCCcceeeEEEEEecCCeEEEEEEeCC
Confidence 346699999999999987654 489999999775 55567788999999999999999999999999999999999999
Q ss_pred CCCccccccCCCCCchhHHHHHHHHHHHHHHHHhhccCCCeEecCCCCCcEEEcCC------CCeEEeecCCCccccCCC
Q 003836 583 NGTVASFLFGDSKPNWKLRTEIAMGIAGGLFYLHEECCTQIIHCDIKPQNILLDDH------YNARISDFGLAKLLTLDQ 656 (792)
Q Consensus 583 ~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dikp~NILl~~~------~~~kl~Dfg~a~~~~~~~ 656 (792)
+|+|..|++.++.+++.....++.|||.||++||++ +||||||||.||||+.. -.+||+|||+|+.+. .
T Consensus 93 gGDLs~yi~~~~~l~e~t~r~Fm~QLA~alq~L~~~---~IiHRDLKPQNiLLs~~~~~~~~~~LKIADFGfAR~L~--~ 167 (429)
T KOG0595|consen 93 GGDLSDYIRRRGRLPEATARHFMQQLASALQFLHEN---NIIHRDLKPQNILLSTTARNDTSPVLKIADFGFARFLQ--P 167 (429)
T ss_pred CCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCCcceEEeccCCCCCCCceEEecccchhhhCC--c
Confidence 999999999999999999999999999999999999 99999999999999865 458999999999886 3
Q ss_pred CCccccccccCCcccccccccCCCCcccceehHHHHHHHHHhcCcCCCcchh
Q 003836 657 SHTNTAIRGTKGYVAPEWFRNMPITVKVDVYSYGVLLLEIICLRRNIDNEIS 708 (792)
Q Consensus 657 ~~~~~~~~gt~~y~aPE~~~~~~~~~k~DV~S~Gv~l~el~tg~~p~~~~~~ 708 (792)
.....+.+|++-|||||+++..+|+.|+|+||.|++|||+++|+.||+....
T Consensus 168 ~~~a~tlcGSplYMAPEV~~~~~YdAKADLWSiG~Ilyq~l~g~~Pf~a~t~ 219 (429)
T KOG0595|consen 168 GSMAETLCGSPLYMAPEVIMSQQYDAKADLWSIGTILYQCLTGKPPFDAETP 219 (429)
T ss_pred hhHHHHhhCCccccCHHHHHhccccchhhHHHHHHHHHHHHhCCCCccccCH
Confidence 4445568899999999999999999999999999999999999999986543
|
|
| >KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-44 Score=395.00 Aligned_cols=260 Identities=26% Similarity=0.405 Sum_probs=218.4
Q ss_pred HHHhhhhhhcCccccceEEEeeecC----CCceEEEEEEccccccc-chHHHHHHHHHhcccCCCCcccccceeccCCce
Q 003836 500 EVTRGFKEELGRGAFGTVYKGFVNM----GSSNHVAVKKLNSVFQD-SEKEFKAEVNGIGQTHHKNLVRLLGYCDEGQNR 574 (792)
Q Consensus 500 ~~~~~~~~~lG~G~~g~Vy~g~~~~----~~~~~vavK~~~~~~~~-~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~ 574 (792)
.....+.++||+|+||.||+|.... .....||||.+++.... .+++|++|+++++.++|||||+|+|+|.+++..
T Consensus 485 r~~i~~~~eLGegaFGkVf~a~~~~l~p~~~~~lVAVK~LKd~a~~~~~~dF~REaeLla~l~H~nIVrLlGVC~~~~P~ 564 (774)
T KOG1026|consen 485 RSDIVFKEELGEGAFGKVFLAEAYGLLPGQDEQLVAVKALKDKAENQARQDFRREAELLAELQHPNIVRLLGVCREGDPL 564 (774)
T ss_pred hhheeehhhhcCchhhhhhhhhccCCCCCccceehhHhhhcccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEccCCee
Confidence 3334467889999999999997743 34568999999987665 778999999999999999999999999999999
Q ss_pred EEEEEeccCCCccccccCC----------CC----CchhHHHHHHHHHHHHHHHHhhccCCCeEecCCCCCcEEEcCCCC
Q 003836 575 LLVYEFMSNGTVASFLFGD----------SK----PNWKLRTEIAMGIAGGLFYLHEECCTQIIHCDIKPQNILLDDHYN 640 (792)
Q Consensus 575 ~lV~E~~~~gsL~~~l~~~----------~~----l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dikp~NILl~~~~~ 640 (792)
++|+|||..|+|.+||..+ .. ++..+.+.||.|||.||.||.++ .+|||||..+|+||.++..
T Consensus 565 ~MvFEYm~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs~~---~FVHRDLATRNCLVge~l~ 641 (774)
T KOG1026|consen 565 CMVFEYMDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYLSSH---HFVHRDLATRNCLVGENLV 641 (774)
T ss_pred EEEEEecccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhC---cccccchhhhhceeccceE
Confidence 9999999999999999642 12 77889999999999999999999 9999999999999999999
Q ss_pred eEEeecCCCccccCCCCCccc-cccccCCcccccccccCCCCcccceehHHHHHHHHHh-cCcCCCcchhhhhhhhHHHH
Q 003836 641 ARISDFGLAKLLTLDQSHTNT-AIRGTKGYVAPEWFRNMPITVKVDVYSYGVLLLEIIC-LRRNIDNEISKVDKAILTDW 718 (792)
Q Consensus 641 ~kl~Dfg~a~~~~~~~~~~~~-~~~gt~~y~aPE~~~~~~~~~k~DV~S~Gv~l~el~t-g~~p~~~~~~~~~~~~~~~~ 718 (792)
+||+|||++|.......+... .-.-.++|||||.+..++||.+||||||||+||||++ |+.|+.....+
T Consensus 642 VKIsDfGLsRdiYssDYYk~~~~t~lPIRWMppEsIly~kFTteSDVWs~GVvLWEIFsyG~QPy~glSn~--------- 712 (774)
T KOG1026|consen 642 VKISDFGLSRDIYSSDYYKVRGNTLLPIRWMPPESILYGKFTTESDVWSFGVVLWEIFSYGKQPYYGLSNQ--------- 712 (774)
T ss_pred EEecccccchhhhhhhhhcccCCceeeeecCCHHHhhcCcccchhhhhhhhhhhhhhhccccCcccccchH---------
Confidence 999999999976544433322 2234678999999999999999999999999999997 67777654322
Q ss_pred HHHhhcccchhHhhhchhcccCCHHHHHHHHHHHHHccccCCCCCCCHHhHHHHhccCcCC
Q 003836 719 AYDRYQERTLEALVENDLEAMNNVTMLHRFVMVAFWCIQEDPSHRPTMRKVTQMLEGVVEV 779 (792)
Q Consensus 719 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~L~~~~~~ 779 (792)
.+.+.+..+-....+...+.++..||..||+.+|++||+++||-..|+.....
T Consensus 713 --------EVIe~i~~g~lL~~Pe~CP~~vY~LM~~CW~~~P~~RPsF~eI~~~L~~~~~~ 765 (774)
T KOG1026|consen 713 --------EVIECIRAGQLLSCPENCPTEVYSLMLECWNENPKRRPSFKEIHSRLQAWAQA 765 (774)
T ss_pred --------HHHHHHHcCCcccCCCCCCHHHHHHHHHHhhcCcccCCCHHHHHHHHHHHHhc
Confidence 22223333333667888999999999999999999999999999999886544
|
|
| >KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-43 Score=374.09 Aligned_cols=247 Identities=23% Similarity=0.364 Sum_probs=210.7
Q ss_pred hhhhhhcCccccceEEEeeecCCCceEEEEEEccccc---ccchHHHHHHHHHhcccCCCCcccccceeccCCceEEEEE
Q 003836 503 RGFKEELGRGAFGTVYKGFVNMGSSNHVAVKKLNSVF---QDSEKEFKAEVNGIGQTHHKNLVRLLGYCDEGQNRLLVYE 579 (792)
Q Consensus 503 ~~~~~~lG~G~~g~Vy~g~~~~~~~~~vavK~~~~~~---~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~lV~E 579 (792)
|...+.||+|+|+.||+++. ..+++.||+|++.+.. ....+.+.+||++.++|+|||||+++++|++.+++|||.|
T Consensus 20 Y~~g~~LGkGgFA~cYe~~~-~~tge~~A~KvVpk~~l~k~~~reKv~~EIeIHr~L~HpnIV~f~~~FEDs~nVYivLE 98 (592)
T KOG0575|consen 20 YKRGRFLGKGGFARCYEARD-LDTGEVVAVKVVPKKLLKKPKQREKVLNEIEIHRSLKHPNIVQFYHFFEDSNNVYIVLE 98 (592)
T ss_pred eeeeeeeccCcceEEEEEEE-cCCCcEEEEEEeehHHhcCcchHHHHHHHHHHHHhcCCCcEEeeeeEeecCCceEEEEE
Confidence 33456899999999999975 3567899999997632 3345678999999999999999999999999999999999
Q ss_pred eccCCCccccccCCCCCchhHHHHHHHHHHHHHHHHhhccCCCeEecCCCCCcEEEcCCCCeEEeecCCCccccCCCCCc
Q 003836 580 FMSNGTVASFLFGDSKPNWKLRTEIAMGIAGGLFYLHEECCTQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLDQSHT 659 (792)
Q Consensus 580 ~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dikp~NILl~~~~~~kl~Dfg~a~~~~~~~~~~ 659 (792)
+|++++|.+++.+++.+++.+.+.+..||+.||.|||+. +|+|||||..|++|+++.++||+|||+|..+..+. +.
T Consensus 99 LC~~~sL~el~Krrk~ltEpEary~l~QIv~GlkYLH~~---~IiHRDLKLGNlfL~~~~~VKIgDFGLAt~le~~~-Er 174 (592)
T KOG0575|consen 99 LCHRGSLMELLKRRKPLTEPEARYFLRQIVEGLKYLHSL---GIIHRDLKLGNLFLNENMNVKIGDFGLATQLEYDG-ER 174 (592)
T ss_pred ecCCccHHHHHHhcCCCCcHHHHHHHHHHHHHHHHHHhc---CceecccchhheeecCcCcEEecccceeeeecCcc-cc
Confidence 999999999999889999999999999999999999999 99999999999999999999999999999886543 34
Q ss_pred cccccccCCcccccccccCCCCcccceehHHHHHHHHHhcCcCCCcchhhhhhhhHHHHHHHhhcccchhHhhhchhccc
Q 003836 660 NTAIRGTKGYVAPEWFRNMPITVKVDVYSYGVLLLEIICLRRNIDNEISKVDKAILTDWAYDRYQERTLEALVENDLEAM 739 (792)
Q Consensus 660 ~~~~~gt~~y~aPE~~~~~~~~~k~DV~S~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 739 (792)
..+++|||.|.|||++....++..+||||+||+||-|+.|++||+...-... ...+..... .
T Consensus 175 k~TlCGTPNYIAPEVl~k~gHsfEvDiWSlGcvmYtLL~G~PPFetk~vket----------------y~~Ik~~~Y--~ 236 (592)
T KOG0575|consen 175 KKTLCGTPNYIAPEVLNKSGHSFEVDIWSLGCVMYTLLVGRPPFETKTVKET----------------YNKIKLNEY--S 236 (592)
T ss_pred cceecCCCcccChhHhccCCCCCchhhhhhhhHHHhhhhCCCCcccchHHHH----------------HHHHHhcCc--c
Confidence 4578899999999999999999999999999999999999999976532211 111111111 1
Q ss_pred CCHHHHHHHHHHHHHccccCCCCCCCHHhHHHH
Q 003836 740 NNVTMLHRFVMVAFWCIQEDPSHRPTMRKVTQM 772 (792)
Q Consensus 740 ~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~ 772 (792)
.|...+.+..+||.++|+.||.+|||+++|+..
T Consensus 237 ~P~~ls~~A~dLI~~lL~~~P~~Rpsl~~vL~h 269 (592)
T KOG0575|consen 237 MPSHLSAEAKDLIRKLLRPNPSERPSLDEVLDH 269 (592)
T ss_pred cccccCHHHHHHHHHHhcCCcccCCCHHHHhcC
Confidence 233566788899999999999999999999963
|
|
| >KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-43 Score=381.34 Aligned_cols=271 Identities=25% Similarity=0.459 Sum_probs=233.2
Q ss_pred ccccCHHHHHHHHhhhh-----------hhcCccccceEEEeeecCCC--ceEEEEEEccccccc-chHHHHHHHHHhcc
Q 003836 490 LRCFTYKELVEVTRGFK-----------EELGRGAFGTVYKGFVNMGS--SNHVAVKKLNSVFQD-SEKEFKAEVNGIGQ 555 (792)
Q Consensus 490 ~~~~~~~el~~~~~~~~-----------~~lG~G~~g~Vy~g~~~~~~--~~~vavK~~~~~~~~-~~~~~~~Ei~~l~~ 555 (792)
...++|+|--++...|. ++||.|.||.|++|.+...+ ...||||.++....+ .+.+|+.|+.||.+
T Consensus 607 iDP~TYEDPnqAvreFakEId~s~i~Ie~VIGaGEFGEVc~GrLk~pgkre~~VAIKTLK~GytekqrrdFL~EAsIMGQ 686 (996)
T KOG0196|consen 607 IDPHTYEDPNQAVREFAKEIDPSCVKIEKVIGAGEFGEVCSGRLKLPGKREITVAIKTLKAGYTEKQRRDFLSEASIMGQ 686 (996)
T ss_pred cCCccccCccHHHHHhhhhcChhheEEEEEEecccccceecccccCCCCcceeEEEeeeccCccHHHHhhhhhhhhhccc
Confidence 34578887777776664 45999999999999987544 457999999976554 45689999999999
Q ss_pred cCCCCcccccceeccCCceEEEEEeccCCCccccccCC-CCCchhHHHHHHHHHHHHHHHHhhccCCCeEecCCCCCcEE
Q 003836 556 THHKNLVRLLGYCDEGQNRLLVYEFMSNGTVASFLFGD-SKPNWKLRTEIAMGIAGGLFYLHEECCTQIIHCDIKPQNIL 634 (792)
Q Consensus 556 l~h~niv~l~g~~~~~~~~~lV~E~~~~gsL~~~l~~~-~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dikp~NIL 634 (792)
++||||++|.|+....+..+||.|||+||+|+.||+.+ ..+.+.+...++++||.||+||.+. ++|||||.++|||
T Consensus 687 FdHPNIIrLEGVVTks~PvMIiTEyMENGsLDsFLR~~DGqftviQLVgMLrGIAsGMkYLsdm---~YVHRDLAARNIL 763 (996)
T KOG0196|consen 687 FDHPNIIRLEGVVTKSKPVMIITEYMENGSLDSFLRQNDGQFTVIQLVGMLRGIASGMKYLSDM---NYVHRDLAARNIL 763 (996)
T ss_pred CCCCcEEEEEEEEecCceeEEEhhhhhCCcHHHHHhhcCCceEeehHHHHHHHHHHHhHHHhhc---Cchhhhhhhhhee
Confidence 99999999999999999999999999999999999865 5789999999999999999999998 9999999999999
Q ss_pred EcCCCCeEEeecCCCccccCCCCCccccccc--cCCcccccccccCCCCcccceehHHHHHHHHHh-cCcCCCcchhhhh
Q 003836 635 LDDHYNARISDFGLAKLLTLDQSHTNTAIRG--TKGYVAPEWFRNMPITVKVDVYSYGVLLLEIIC-LRRNIDNEISKVD 711 (792)
Q Consensus 635 l~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~g--t~~y~aPE~~~~~~~~~k~DV~S~Gv~l~el~t-g~~p~~~~~~~~~ 711 (792)
++.+..+|++|||++|.+..+.....+..-| ..+|.|||.+...++|.++||||||++|||+++ |.+|+-+...
T Consensus 764 VNsnLvCKVsDFGLSRvledd~~~~ytt~GGKIPiRWTAPEAIa~RKFTsASDVWSyGIVmWEVmSyGERPYWdmSN--- 840 (996)
T KOG0196|consen 764 VNSNLVCKVSDFGLSRVLEDDPEAAYTTLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSN--- 840 (996)
T ss_pred eccceEEEeccccceeecccCCCccccccCCccceeecChhHhhhcccCchhhccccceEEEEecccCCCcccccch---
Confidence 9999999999999999887665333333322 568999999999999999999999999999885 8888754432
Q ss_pred hhhHHHHHHHhhcccchhHhhhchhcccCCHHHHHHHHHHHHHccccCCCCCCCHHhHHHHhccCcCCC
Q 003836 712 KAILTDWAYDRYQERTLEALVENDLEAMNNVTMLHRFVMVAFWCIQEDPSHRPTMRKVTQMLEGVVEVP 780 (792)
Q Consensus 712 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~L~~~~~~~ 780 (792)
.++..-+++..+...+++++..|.+||+.|||.|-.+||.+.||+.+|++++.-|
T Consensus 841 --------------QdVIkaIe~gyRLPpPmDCP~aL~qLMldCWqkdR~~RP~F~qiV~~lDklIrnP 895 (996)
T KOG0196|consen 841 --------------QDVIKAIEQGYRLPPPMDCPAALYQLMLDCWQKDRNRRPKFAQIVSTLDKLIRNP 895 (996)
T ss_pred --------------HHHHHHHHhccCCCCCCCCcHHHHHHHHHHHHHHhhcCCCHHHHHHHHHHHhcCc
Confidence 3344556677788889999999999999999999999999999999999987543
|
|
| >KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-42 Score=332.93 Aligned_cols=255 Identities=24% Similarity=0.357 Sum_probs=205.1
Q ss_pred HhhhhhhcCccccceEEEeeecCCCceEEEEEEccc--ccccchHHHHHHHHHhcccCCCCcccccc-eeccCCc-eEEE
Q 003836 502 TRGFKEELGRGAFGTVYKGFVNMGSSNHVAVKKLNS--VFQDSEKEFKAEVNGIGQTHHKNLVRLLG-YCDEGQN-RLLV 577 (792)
Q Consensus 502 ~~~~~~~lG~G~~g~Vy~g~~~~~~~~~vavK~~~~--~~~~~~~~~~~Ei~~l~~l~h~niv~l~g-~~~~~~~-~~lV 577 (792)
.+.+.++||+|.||+|||+.. ..++..+|.|.+.- .+....+.+..|+.+|++|+|||||++++ -+.+.++ ++||
T Consensus 20 ~y~Il~~IG~GsFg~vykv~~-~~~g~l~a~K~i~f~~md~k~rq~~v~Ei~lLkQL~HpNIVqYy~~~f~~~~evlniv 98 (375)
T KOG0591|consen 20 DYQILKKIGRGSFGEVYKVQC-LLDGKLVALKKIQFGMMDAKARQDCVKEISLLKQLNHPNIVQYYAHSFIEDNEVLNIV 98 (375)
T ss_pred HHHHHHHHcCCcchheEEeee-ccCcchhhhhhcchhhccHHHHHHHHHHHHHHHhcCCchHHHHHHHhhhccchhhHHH
Confidence 355678999999999999964 45678999998862 23444567899999999999999999999 5566666 7899
Q ss_pred EEeccCCCccccccC----CCCCchhHHHHHHHHHHHHHHHHhhccCC-CeEecCCCCCcEEEcCCCCeEEeecCCCccc
Q 003836 578 YEFMSNGTVASFLFG----DSKPNWKLRTEIAMGIAGGLFYLHEECCT-QIIHCDIKPQNILLDDHYNARISDFGLAKLL 652 (792)
Q Consensus 578 ~E~~~~gsL~~~l~~----~~~l~~~~~~~i~~~ia~gL~yLH~~~~~-~ivH~dikp~NILl~~~~~~kl~Dfg~a~~~ 652 (792)
|||+..|+|...+.. ++.++++.+++++.|+++||..+|.+... -|+||||||.||+|+.+|.+||+|||+++.+
T Consensus 99 mE~c~~GDLsqmIk~~K~qkr~ipE~~Vwk~f~QL~~AL~~cH~~~~r~~VmHRDIKPaNIFl~~~gvvKLGDfGL~r~l 178 (375)
T KOG0591|consen 99 MELCDAGDLSQMIKHFKKQKRLIPEKTVWKYFVQLCRALYHCHSKIPRGTVMHRDIKPANIFLTANGVVKLGDFGLGRFL 178 (375)
T ss_pred HHhhcccCHHHHHHHHHhccccCchHHHHHHHHHHHHHHHHHhccccccceeeccCcchheEEcCCCceeeccchhHhHh
Confidence 999999999998853 46789999999999999999999994322 3999999999999999999999999999998
Q ss_pred cCCCCCccccccccCCcccccccccCCCCcccceehHHHHHHHHHhcCcCCCcchhhhhhhhHHHHHHHhhcccchhHhh
Q 003836 653 TLDQSHTNTAIRGTKGYVAPEWFRNMPITVKVDVYSYGVLLLEIICLRRNIDNEISKVDKAILTDWAYDRYQERTLEALV 732 (792)
Q Consensus 653 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DV~S~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 732 (792)
...... ....+|||.||+||.+.+.+|+.|+||||+||++|||+..+.||....-. . +..-+
T Consensus 179 ~s~~tf-A~S~VGTPyYMSPE~i~~~~Y~~kSDiWslGCllyEMcaL~~PF~g~n~~-------~----------L~~KI 240 (375)
T KOG0591|consen 179 SSKTTF-AHSLVGTPYYMSPERIHESGYNFKSDIWSLGCLLYEMCALQSPFYGDNLL-------S----------LCKKI 240 (375)
T ss_pred cchhHH-HHhhcCCCcccCHHHHhcCCCCcchhHHHHHHHHHHHHhcCCCcccccHH-------H----------HHHHH
Confidence 755443 34567999999999999999999999999999999999999999765110 0 00111
Q ss_pred hc-hhcccCCHHHHHHHHHHHHHccccCCCCCCCHHhHHHHhcc
Q 003836 733 EN-DLEAMNNVTMLHRFVMVAFWCIQEDPSHRPTMRKVTQMLEG 775 (792)
Q Consensus 733 ~~-~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~L~~ 775 (792)
.+ +.....+...+.++..++..|+..||+.||+...+++.+..
T Consensus 241 ~qgd~~~~p~~~YS~~l~~li~~ci~vd~~~RP~t~~~v~di~~ 284 (375)
T KOG0591|consen 241 EQGDYPPLPDEHYSTDLRELINMCIAVDPEQRPDTVPYVQDIQS 284 (375)
T ss_pred HcCCCCCCcHHHhhhHHHHHHHHHccCCcccCCCcchHHHHHHH
Confidence 11 11111225678899999999999999999996555555443
|
|
| >KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-40 Score=343.37 Aligned_cols=252 Identities=26% Similarity=0.399 Sum_probs=203.7
Q ss_pred hhhhhcCccccceEEEeeecCCCceEEEEEEcccccccchHHHHHHHHHhcccCCCCcccccceeccCC--ceEEEEEec
Q 003836 504 GFKEELGRGAFGTVYKGFVNMGSSNHVAVKKLNSVFQDSEKEFKAEVNGIGQTHHKNLVRLLGYCDEGQ--NRLLVYEFM 581 (792)
Q Consensus 504 ~~~~~lG~G~~g~Vy~g~~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~--~~~lV~E~~ 581 (792)
...+.||+|+||+||++.... +++..|||.+........+.+.+|+.+|.+++|||||+++|...... .++++|||+
T Consensus 20 ~~~~~lG~Gs~G~V~l~~~~~-~g~~~AvK~v~~~~~~~~~~l~~Ei~iL~~l~~p~IV~~~G~~~~~~~~~~~i~mEy~ 98 (313)
T KOG0198|consen 20 SKGKLLGRGSFGSVYLATNKK-TGELMAVKSVELEDSPTSESLEREIRILSRLNHPNIVQYYGSSSSRENDEYNIFMEYA 98 (313)
T ss_pred hhhccccCccceEEEEEEecC-CCcceeeeeeecccchhHHHHHHHHHHHHhCCCCCEEeeCCccccccCeeeEeeeecc
Confidence 345789999999999997643 36789999987653333667999999999999999999999854444 688999999
Q ss_pred cCCCccccccCCC-CCchhHHHHHHHHHHHHHHHHhhccCCCeEecCCCCCcEEEcC-CCCeEEeecCCCccccC--CCC
Q 003836 582 SNGTVASFLFGDS-KPNWKLRTEIAMGIAGGLFYLHEECCTQIIHCDIKPQNILLDD-HYNARISDFGLAKLLTL--DQS 657 (792)
Q Consensus 582 ~~gsL~~~l~~~~-~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dikp~NILl~~-~~~~kl~Dfg~a~~~~~--~~~ 657 (792)
++|+|.+++.+.. .+++..+.+++.||++||+|||++ +|+||||||+|||++. ++.+||+|||+++.... ...
T Consensus 99 ~~GsL~~~~~~~g~~l~E~~v~~ytr~iL~GL~ylHs~---g~vH~DiK~~NiLl~~~~~~~KlaDFG~a~~~~~~~~~~ 175 (313)
T KOG0198|consen 99 PGGSLSDLIKRYGGKLPEPLVRRYTRQILEGLAYLHSK---GIVHCDIKPANILLDPSNGDVKLADFGLAKKLESKGTKS 175 (313)
T ss_pred CCCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhC---CEeccCcccceEEEeCCCCeEEeccCccccccccccccc
Confidence 9999999998766 799999999999999999999998 9999999999999999 79999999999997764 222
Q ss_pred CccccccccCCcccccccccC-CCCcccceehHHHHHHHHHhcCcCCCcchhhhhhhhHHHHHHHhhcccchhHhhhchh
Q 003836 658 HTNTAIRGTKGYVAPEWFRNM-PITVKVDVYSYGVLLLEIICLRRNIDNEISKVDKAILTDWAYDRYQERTLEALVENDL 736 (792)
Q Consensus 658 ~~~~~~~gt~~y~aPE~~~~~-~~~~k~DV~S~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 736 (792)
.......||+.|||||++..+ ....++|||||||++.||+||+.||....... .+ +..+.....
T Consensus 176 ~~~~~~~Gtp~~maPEvi~~g~~~~~~sDiWSlGCtVvEM~Tg~~PW~~~~~~~------~~---------~~~ig~~~~ 240 (313)
T KOG0198|consen 176 DSELSVQGTPNYMAPEVIRNGEVARRESDIWSLGCTVVEMLTGKPPWSEFFEEA------EA---------LLLIGREDS 240 (313)
T ss_pred cccccccCCccccCchhhcCCCcCCccchhhhcCCEEEeccCCCCcchhhcchH------HH---------HHHHhccCC
Confidence 334457899999999999863 34459999999999999999999986531100 00 011111112
Q ss_pred cccCCHHHHHHHHHHHHHccccCCCCCCCHHhHHHHhc
Q 003836 737 EAMNNVTMLHRFVMVAFWCIQEDPSHRPTMRKVTQMLE 774 (792)
Q Consensus 737 ~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~L~ 774 (792)
.+..+...+.+..+++..|++.+|++|||++++++..-
T Consensus 241 ~P~ip~~ls~~a~~Fl~~C~~~~p~~Rpta~eLL~hpf 278 (313)
T KOG0198|consen 241 LPEIPDSLSDEAKDFLRKCFKRDPEKRPTAEELLEHPF 278 (313)
T ss_pred CCCCCcccCHHHHHHHHHHhhcCcccCcCHHHHhhChh
Confidence 23455567788899999999999999999999998653
|
|
| >KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-40 Score=349.84 Aligned_cols=250 Identities=30% Similarity=0.473 Sum_probs=213.3
Q ss_pred ccccCHHHHHHHHhhhhhhcCccccceEEEeeecCCCceEEEEEEcccccccchHHHHHHHHHhcccCCCCcccccceec
Q 003836 490 LRCFTYKELVEVTRGFKEELGRGAFGTVYKGFVNMGSSNHVAVKKLNSVFQDSEKEFKAEVNGIGQTHHKNLVRLLGYCD 569 (792)
Q Consensus 490 ~~~~~~~el~~~~~~~~~~lG~G~~g~Vy~g~~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~ 569 (792)
+..+.|++|.+. +-||.|+.|.||+|.++ ++.||||+++.. -+.+|+-|++|+|+||+.+.|+|.
T Consensus 118 ~WeiPFe~IsEL-----eWlGSGaQGAVF~Grl~---netVAVKKV~el-------kETdIKHLRkLkH~NII~FkGVCt 182 (904)
T KOG4721|consen 118 LWEIPFEEISEL-----EWLGSGAQGAVFLGRLH---NETVAVKKVREL-------KETDIKHLRKLKHPNIITFKGVCT 182 (904)
T ss_pred hccCCHHHhhhh-----hhhccCcccceeeeecc---CceehhHHHhhh-------hhhhHHHHHhccCcceeeEeeeec
Confidence 455677777654 34999999999999987 467999998642 245788899999999999999999
Q ss_pred cCCceEEEEEeccCCCccccccCCCCCchhHHHHHHHHHHHHHHHHhhccCCCeEecCCCCCcEEEcCCCCeEEeecCCC
Q 003836 570 EGQNRLLVYEFMSNGTVASFLFGDSKPNWKLRTEIAMGIAGGLFYLHEECCTQIIHCDIKPQNILLDDHYNARISDFGLA 649 (792)
Q Consensus 570 ~~~~~~lV~E~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dikp~NILl~~~~~~kl~Dfg~a 649 (792)
....++||||||+.|.|.++|+....+.......+..+||.||.|||.+ .|||||||.-||||..+..+||+|||-+
T Consensus 183 qsPcyCIiMEfCa~GqL~~VLka~~~itp~llv~Wsk~IA~GM~YLH~h---KIIHRDLKSPNiLIs~~d~VKIsDFGTS 259 (904)
T KOG4721|consen 183 QSPCYCIIMEFCAQGQLYEVLKAGRPITPSLLVDWSKGIAGGMNYLHLH---KIIHRDLKSPNILISYDDVVKISDFGTS 259 (904)
T ss_pred CCceeEEeeeccccccHHHHHhccCccCHHHHHHHHHHhhhhhHHHHHh---hHhhhccCCCceEeeccceEEeccccch
Confidence 9999999999999999999999999999999999999999999999999 9999999999999999999999999999
Q ss_pred ccccCCCCCccccccccCCcccccccccCCCCcccceehHHHHHHHHHhcCcCCCcchhhhhhhhHHHHHHHhhcccchh
Q 003836 650 KLLTLDQSHTNTAIRGTKGYVAPEWFRNMPITVKVDVYSYGVLLLEIICLRRNIDNEISKVDKAILTDWAYDRYQERTLE 729 (792)
Q Consensus 650 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DV~S~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 729 (792)
+..... .....+.||..|||||++++.+.++|.||||||||||||+||..|+.+..+... +.
T Consensus 260 ~e~~~~--STkMSFaGTVaWMAPEvIrnePcsEKVDIwSfGVVLWEmLT~EiPYkdVdssAI----------------Iw 321 (904)
T KOG4721|consen 260 KELSDK--STKMSFAGTVAWMAPEVIRNEPCSEKVDIWSFGVVLWEMLTGEIPYKDVDSSAI----------------IW 321 (904)
T ss_pred Hhhhhh--hhhhhhhhhHhhhCHHHhhcCCcccccceehhHHHHHHHHhcCCCccccchhee----------------EE
Confidence 876533 344567899999999999999999999999999999999999999965433211 11
Q ss_pred HhhhchhcccCCHHHHHHHHHHHHHccccCCCCCCCHHhHHHHhcc
Q 003836 730 ALVENDLEAMNNVTMLHRFVMVAFWCIQEDPSHRPTMRKVTQMLEG 775 (792)
Q Consensus 730 ~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~L~~ 775 (792)
.+=...+....+..+++-+.-|+++||+..|..||++++|+..|+-
T Consensus 322 GVGsNsL~LpvPstcP~GfklL~Kqcw~sKpRNRPSFrqil~HldI 367 (904)
T KOG4721|consen 322 GVGSNSLHLPVPSTCPDGFKLLLKQCWNSKPRNRPSFRQILLHLDI 367 (904)
T ss_pred eccCCcccccCcccCchHHHHHHHHHHhcCCCCCccHHHHHHHHhh
Confidence 1122334444566677788889999999999999999999999864
|
|
| >KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-40 Score=335.11 Aligned_cols=238 Identities=24% Similarity=0.316 Sum_probs=201.5
Q ss_pred hhhhcCccccceEEEeeecCCCceEEEEEEccccc---ccchHHHHHHHHHhcccCCCCcccccceeccCCceEEEEEec
Q 003836 505 FKEELGRGAFGTVYKGFVNMGSSNHVAVKKLNSVF---QDSEKEFKAEVNGIGQTHHKNLVRLLGYCDEGQNRLLVYEFM 581 (792)
Q Consensus 505 ~~~~lG~G~~g~Vy~g~~~~~~~~~vavK~~~~~~---~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~lV~E~~ 581 (792)
+.++||+|+||+||.++.. ++++.+|+|.+++.. ....+...+|..+|.+++||.||+++-.|.+..++|||+||+
T Consensus 29 ~lkviGkG~fGkV~~Vrk~-dt~kiYAmKvl~K~~iv~~~e~~~~~~Er~IL~~v~hPFiv~l~ysFQt~~kLylVld~~ 107 (357)
T KOG0598|consen 29 ILKVIGKGSFGKVFQVRKK-DTGKIYAMKVLKKKKIVEKKEVRHTKAERNILSKIKHPFIVKLIYSFQTEEKLYLVLDYL 107 (357)
T ss_pred eeeeeeccCCceEEEEEEc-ccCceeehhhhhhhHhhhhhhHHHHHHHHHHHHhCCCCcEeeeEEecccCCeEEEEEecc
Confidence 4578999999999999765 778899999998643 334567899999999999999999999999999999999999
Q ss_pred cCCCccccccCCCCCchhHHHHHHHHHHHHHHHHhhccCCCeEecCCCCCcEEEcCCCCeEEeecCCCccccCCCCCccc
Q 003836 582 SNGTVASFLFGDSKPNWKLRTEIAMGIAGGLFYLHEECCTQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLDQSHTNT 661 (792)
Q Consensus 582 ~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dikp~NILl~~~~~~kl~Dfg~a~~~~~~~~~~~~ 661 (792)
.||.|..+|.+...+++....-++..|+.||.|||++ +||||||||+|||||++|+++|+|||+++...... ....
T Consensus 108 ~GGeLf~hL~~eg~F~E~~arfYlaEi~lAL~~LH~~---gIiyRDlKPENILLd~~GHi~LtDFgL~k~~~~~~-~~t~ 183 (357)
T KOG0598|consen 108 NGGELFYHLQREGRFSEDRARFYLAEIVLALGYLHSK---GIIYRDLKPENILLDEQGHIKLTDFGLCKEDLKDG-DATR 183 (357)
T ss_pred CCccHHHHHHhcCCcchhHHHHHHHHHHHHHHHHHhC---CeeeccCCHHHeeecCCCcEEEeccccchhcccCC-Cccc
Confidence 9999999999999999999999999999999999999 99999999999999999999999999999654332 2334
Q ss_pred cccccCCcccccccccCCCCcccceehHHHHHHHHHhcCcCCCcchhhhhhhhHHHHHHHhhcccchhHhhhchhcccCC
Q 003836 662 AIRGTKGYVAPEWFRNMPITVKVDVYSYGVLLLEIICLRRNIDNEISKVDKAILTDWAYDRYQERTLEALVENDLEAMNN 741 (792)
Q Consensus 662 ~~~gt~~y~aPE~~~~~~~~~k~DV~S~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 741 (792)
+++||+.|||||++.+..|+..+|.||+|+++|||++|.+||......... +.+.... ....+
T Consensus 184 tfcGT~eYmAPEil~~~gy~~~vDWWsLGillYeML~G~pPF~~~~~~~~~----------------~~I~~~k-~~~~p 246 (357)
T KOG0598|consen 184 TFCGTPEYMAPEILLGKGYDKAVDWWSLGILLYEMLTGKPPFYAEDVKKMY----------------DKILKGK-LPLPP 246 (357)
T ss_pred cccCCccccChHHHhcCCCCcccchHhHHHHHHHHhhCCCCCcCccHHHHH----------------HHHhcCc-CCCCC
Confidence 578999999999999999999999999999999999999999765432111 1111111 11122
Q ss_pred HHHHHHHHHHHHHccccCCCCCC
Q 003836 742 VTMLHRFVMVAFWCIQEDPSHRP 764 (792)
Q Consensus 742 ~~~~~~l~~l~~~Cl~~~p~~RP 764 (792)
.-...+..+++...|+.||++|.
T Consensus 247 ~~ls~~ardll~~LL~rdp~~RL 269 (357)
T KOG0598|consen 247 GYLSEEARDLLKKLLKRDPRQRL 269 (357)
T ss_pred ccCCHHHHHHHHHHhccCHHHhc
Confidence 23556788899999999999995
|
|
| >KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-40 Score=320.76 Aligned_cols=259 Identities=21% Similarity=0.294 Sum_probs=203.1
Q ss_pred hhcCccccceEEEeeecCCCceEEEEEEcccccc--cchHHHHHHHHHhcccCCCCcccccceeccCCceEEEEEeccCC
Q 003836 507 EELGRGAFGTVYKGFVNMGSSNHVAVKKLNSVFQ--DSEKEFKAEVNGIGQTHHKNLVRLLGYCDEGQNRLLVYEFMSNG 584 (792)
Q Consensus 507 ~~lG~G~~g~Vy~g~~~~~~~~~vavK~~~~~~~--~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~lV~E~~~~g 584 (792)
.++|+|+||.|||++ +..+++.||||++..... ...+-.++||++|++++|+|+|.|+.+|......+||+||++..
T Consensus 8 gkvGEGSYGvV~KCr-nk~TgqIVAIKkF~Esedd~~VkKIAlREIrmLKqLkH~NLVnLiEVFrrkrklhLVFE~~dhT 86 (396)
T KOG0593|consen 8 GKVGEGSYGVVMKCR-NKDTGQIVAIKKFVESEDDPVVKKIALREIRMLKQLKHENLVNLIEVFRRKRKLHLVFEYCDHT 86 (396)
T ss_pred hccccCcceEEEEec-cCCcccEEEEEeeccCCccHHHHHHHHHHHHHHHhcccchHHHHHHHHHhcceeEEEeeecchH
Confidence 469999999999996 457889999999976433 34567899999999999999999999999999999999999985
Q ss_pred CccccccCCCCCchhHHHHHHHHHHHHHHHHhhccCCCeEecCCCCCcEEEcCCCCeEEeecCCCccccCCCCCcccccc
Q 003836 585 TVASFLFGDSKPNWKLRTEIAMGIAGGLFYLHEECCTQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLDQSHTNTAIR 664 (792)
Q Consensus 585 sL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dikp~NILl~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~ 664 (792)
-|+++=+....++.....+++.|+++|+.|+|+. ++|||||||+||||+.++.+||+|||+|+.+.. .....+..+
T Consensus 87 vL~eLe~~p~G~~~~~vk~~l~Q~l~ai~~cHk~---n~IHRDIKPENILit~~gvvKLCDFGFAR~L~~-pgd~YTDYV 162 (396)
T KOG0593|consen 87 VLHELERYPNGVPSELVKKYLYQLLKAIHFCHKN---NCIHRDIKPENILITQNGVVKLCDFGFARTLSA-PGDNYTDYV 162 (396)
T ss_pred HHHHHHhccCCCCHHHHHHHHHHHHHHhhhhhhc---CeecccCChhheEEecCCcEEeccchhhHhhcC-Ccchhhhhh
Confidence 5555544446788999999999999999999999 999999999999999999999999999999875 344445667
Q ss_pred ccCCccccccccc-CCCCcccceehHHHHHHHHHhcCcCCCcchhhhhhhhHHHHHHH--------hhcc-cchhHhhhc
Q 003836 665 GTKGYVAPEWFRN-MPITVKVDVYSYGVLLLEIICLRRNIDNEISKVDKAILTDWAYD--------RYQE-RTLEALVEN 734 (792)
Q Consensus 665 gt~~y~aPE~~~~-~~~~~k~DV~S~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~--------~~~~-~~~~~~~~~ 734 (792)
.|..|+|||.+.+ .+|+...||||.||++.||++|...|...++. ++......... .+.. +....+.-+
T Consensus 163 ATRWYRaPELLvGDtqYG~pVDiWAiGCv~aEl~~G~pL~PG~SDi-DQLy~I~ktLG~L~prhq~iF~~N~~F~Gv~lP 241 (396)
T KOG0593|consen 163 ATRWYRAPELLVGDTQYGKPVDIWAIGCVFAELLTGEPLWPGRSDI-DQLYLIRKTLGNLIPRHQSIFSSNPFFHGVRLP 241 (396)
T ss_pred hhhhccChhhhcccCcCCCcccchhhhHHHHHHhcCCcCCCCcchH-HHHHHHHHHHcccCHHHHHHhccCCceeeeecC
Confidence 8999999999987 79999999999999999999999888655432 22221111111 1111 111111111
Q ss_pred hhcccCC-----HHHHHHHHHHHHHccccCCCCCCCHHhHHH
Q 003836 735 DLEAMNN-----VTMLHRFVMVAFWCIQEDPSHRPTMRKVTQ 771 (792)
Q Consensus 735 ~~~~~~~-----~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~ 771 (792)
......+ +..+.-+++++..||+.||++|++-+|++.
T Consensus 242 ~~~~~epLe~k~p~~s~~~ld~~k~cL~~dP~~R~sc~qll~ 283 (396)
T KOG0593|consen 242 EPEHPEPLERKYPKISNVLLDLLKKCLKMDPDDRLSCEQLLH 283 (396)
T ss_pred CCCCccchhhhcccchHHHHHHHHHHhcCCccccccHHHHhc
Confidence 1111111 234567899999999999999999999885
|
|
| >KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-40 Score=345.71 Aligned_cols=248 Identities=24% Similarity=0.334 Sum_probs=210.3
Q ss_pred hhhhhcCccccceEEEeeecCCCceEEEEEEccccc---ccchHHHHHHHHHhccc-CCCCcccccceeccCCceEEEEE
Q 003836 504 GFKEELGRGAFGTVYKGFVNMGSSNHVAVKKLNSVF---QDSEKEFKAEVNGIGQT-HHKNLVRLLGYCDEGQNRLLVYE 579 (792)
Q Consensus 504 ~~~~~lG~G~~g~Vy~g~~~~~~~~~vavK~~~~~~---~~~~~~~~~Ei~~l~~l-~h~niv~l~g~~~~~~~~~lV~E 579 (792)
.|.+.||+|+|++|+++.. ..+++.+|||++.+.. +...+-+..|-.+|.+| .||.|++|+-.|.+...+|+|+|
T Consensus 76 ~Fg~~lGeGSYStV~~A~~-~~t~keYAiKVl~K~~Iike~KvkYV~~Ek~~l~~L~~hPgivkLy~TFQD~~sLYFvLe 154 (604)
T KOG0592|consen 76 KFGKILGEGSYSTVVLARE-KATGKEYAIKVLDKRYIIKEKKVKYVTREKEALTQLSGHPGIVKLYFTFQDEESLYFVLE 154 (604)
T ss_pred chhheeccccceeEEEeee-cCCCceeeHhhhhHHHHHhhcccchhhHHHHHHHHhhCCCCeEEEEEEeecccceEEEEE
Confidence 4678999999999999964 4578899999997643 33445678899999999 89999999999999999999999
Q ss_pred eccCCCccccccCCCCCchhHHHHHHHHHHHHHHHHhhccCCCeEecCCCCCcEEEcCCCCeEEeecCCCccccCCCCC-
Q 003836 580 FMSNGTVASFLFGDSKPNWKLRTEIAMGIAGGLFYLHEECCTQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLDQSH- 658 (792)
Q Consensus 580 ~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dikp~NILl~~~~~~kl~Dfg~a~~~~~~~~~- 658 (792)
|+++|+|.++|++-+.+++.-...++.+|+.||+|||+. |||||||||+|||||+++++||.|||.|+.+......
T Consensus 155 ~A~nGdll~~i~K~Gsfde~caR~YAAeIldAleylH~~---GIIHRDlKPENILLd~dmhikITDFGsAK~l~~~~~~~ 231 (604)
T KOG0592|consen 155 YAPNGDLLDLIKKYGSFDETCARFYAAEILDALEYLHSN---GIIHRDLKPENILLDKDGHIKITDFGSAKILSPSQKSQ 231 (604)
T ss_pred ecCCCcHHHHHHHhCcchHHHHHHHHHHHHHHHHHHHhc---CceeccCChhheeEcCCCcEEEeeccccccCChhhccc
Confidence 999999999999999999999999999999999999999 9999999999999999999999999999988653322
Q ss_pred ---------cc--ccccccCCcccccccccCCCCcccceehHHHHHHHHHhcCcCCCcchhhhhhhhHHHHHHHhhcccc
Q 003836 659 ---------TN--TAIRGTKGYVAPEWFRNMPITVKVDVYSYGVLLLEIICLRRNIDNEISKVDKAILTDWAYDRYQERT 727 (792)
Q Consensus 659 ---------~~--~~~~gt~~y~aPE~~~~~~~~~k~DV~S~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 727 (792)
.. ..++||..|.+||++.....+..+|+|+|||+||+|+.|+.||....+-..
T Consensus 232 ~~~~~~~~a~s~~~SFVGTAeYVSPElL~~~~~~~~sDiWAlGCilyQmlaG~PPFra~Neyli---------------- 295 (604)
T KOG0592|consen 232 ENPVDPNQASSRRSSFVGTAEYVSPELLNDSPAGPSSDLWALGCILYQMLAGQPPFRAANEYLI---------------- 295 (604)
T ss_pred cCccCcccccCcccceeeeecccCHHHhcCCCCCcccchHHHHHHHHHHhcCCCCCccccHHHH----------------
Confidence 11 447899999999999999999999999999999999999999976533211
Q ss_pred hhHhhhchhcccCCHHHHHHHHHHHHHccccCCCCCCCHHhHHHHh
Q 003836 728 LEALVENDLEAMNNVTMLHRFVMVAFWCIQEDPSHRPTMRKVTQML 773 (792)
Q Consensus 728 ~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~L 773 (792)
.+.+++- .-.++...++.+.+|+.+.|..||.+|++.+||.+..
T Consensus 296 FqkI~~l--~y~fp~~fp~~a~dLv~KLLv~dp~~Rlt~~qIk~Hp 339 (604)
T KOG0592|consen 296 FQKIQAL--DYEFPEGFPEDARDLIKKLLVRDPSDRLTSQQIKAHP 339 (604)
T ss_pred HHHHHHh--cccCCCCCCHHHHHHHHHHHccCccccccHHHHhhCc
Confidence 1111111 1123444557788999999999999999999998863
|
|
| >KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-40 Score=357.86 Aligned_cols=259 Identities=27% Similarity=0.368 Sum_probs=214.1
Q ss_pred hhhhhcCccccceEEEeeecCCCc---eEEEEEEccc---ccccchHHHHHHHHHhcccCCCCcccccceeccCCceEEE
Q 003836 504 GFKEELGRGAFGTVYKGFVNMGSS---NHVAVKKLNS---VFQDSEKEFKAEVNGIGQTHHKNLVRLLGYCDEGQNRLLV 577 (792)
Q Consensus 504 ~~~~~lG~G~~g~Vy~g~~~~~~~---~~vavK~~~~---~~~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~lV 577 (792)
.+.++||+|+||.||+|.+..... ..||||..+. ......++|.+|.+++++++|||||+++|++.....++||
T Consensus 160 ~l~kkLGeGaFGeV~~G~l~~~~~~~~~~VAvK~~k~~~~~~~~~~~e~m~EArvMr~l~H~NVVr~yGVa~~~~Pl~iv 239 (474)
T KOG0194|consen 160 ELGKKLGEGAFGEVFKGKLKLKNGFKVVPVAVKTTKGSSELTKEQIKEFMKEARVMRQLNHPNVVRFYGVAVLEEPLMLV 239 (474)
T ss_pred cccceeecccccEEEEEEEEecCCceeeeeEEEeecccccccHHHHHHHHHHHHHHHhCCCCCEEEEEEEEcCCCccEEE
Confidence 345789999999999999976533 2389999885 3456678999999999999999999999999999999999
Q ss_pred EEeccCCCccccccCCC-CCchhHHHHHHHHHHHHHHHHhhccCCCeEecCCCCCcEEEcCCCCeEEeecCCCccccCCC
Q 003836 578 YEFMSNGTVASFLFGDS-KPNWKLRTEIAMGIAGGLFYLHEECCTQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLDQ 656 (792)
Q Consensus 578 ~E~~~~gsL~~~l~~~~-~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dikp~NILl~~~~~~kl~Dfg~a~~~~~~~ 656 (792)
||+|+||+|+++|...+ .++..++.+++.+.|.||+|||++ ++|||||.++|+|++.+..+||+|||+++......
T Consensus 240 mEl~~gGsL~~~L~k~~~~v~~~ek~~~~~~AA~Gl~YLh~k---~~IHRDIAARNcL~~~~~~vKISDFGLs~~~~~~~ 316 (474)
T KOG0194|consen 240 MELCNGGSLDDYLKKNKKSLPTLEKLRFCYDAARGLEYLHSK---NCIHRDIAARNCLYSKKGVVKISDFGLSRAGSQYV 316 (474)
T ss_pred EEecCCCcHHHHHHhCCCCCCHHHHHHHHHHHHhHHHHHHHC---CCcchhHhHHHheecCCCeEEeCccccccCCccee
Confidence 99999999999998876 599999999999999999999999 99999999999999999999999999998654111
Q ss_pred CCccccccccCCcccccccccCCCCcccceehHHHHHHHHHh-cCcCCCcchhhhhhhhHHHHHHHhhcccchhHhhhch
Q 003836 657 SHTNTAIRGTKGYVAPEWFRNMPITVKVDVYSYGVLLLEIIC-LRRNIDNEISKVDKAILTDWAYDRYQERTLEALVEND 735 (792)
Q Consensus 657 ~~~~~~~~gt~~y~aPE~~~~~~~~~k~DV~S~Gv~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 735 (792)
.. .....-...|+|||.+..+.|+.++|||||||++||+++ |..|+....... ....++...
T Consensus 317 ~~-~~~~klPirWLAPEtl~~~~~s~kTDV~sfGV~~~Eif~~g~~Py~g~~~~~----------------v~~kI~~~~ 379 (474)
T KOG0194|consen 317 MK-KFLKKLPIRWLAPETLNTGIFSFKTDVWSFGVLLWEIFENGAEPYPGMKNYE----------------VKAKIVKNG 379 (474)
T ss_pred ec-cccccCcceecChhhhccCccccccchhheeeeEEeeeccCCCCCCCCCHHH----------------HHHHHHhcC
Confidence 11 111234678999999999999999999999999999998 777886543221 111222344
Q ss_pred hcccCCHHHHHHHHHHHHHccccCCCCCCCHHhHHHHhccCcCCCCC
Q 003836 736 LEAMNNVTMLHRFVMVAFWCIQEDPSHRPTMRKVTQMLEGVVEVPIP 782 (792)
Q Consensus 736 ~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~L~~~~~~~~p 782 (792)
.+...+...+.++..++.+|++.+|++||+|.++.+.|+.+.....+
T Consensus 380 ~r~~~~~~~p~~~~~~~~~c~~~~p~~R~tm~~i~~~l~~~~~~~~~ 426 (474)
T KOG0194|consen 380 YRMPIPSKTPKELAKVMKQCWKKDPEDRPTMSTIKKKLEALEKKKEA 426 (474)
T ss_pred ccCCCCCCCHHHHHHHHHHhccCChhhccCHHHHHHHHHHHHhcccc
Confidence 44555556777888899999999999999999999999887655443
|
|
| >KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-40 Score=348.47 Aligned_cols=253 Identities=27% Similarity=0.410 Sum_probs=203.0
Q ss_pred hhhhcCccccceEEEeeecCCCceEEEEEEcccc--cccchHHHHHHHHHhcccCCCCcccccceeccCCceEEEEEecc
Q 003836 505 FKEELGRGAFGTVYKGFVNMGSSNHVAVKKLNSV--FQDSEKEFKAEVNGIGQTHHKNLVRLLGYCDEGQNRLLVYEFMS 582 (792)
Q Consensus 505 ~~~~lG~G~~g~Vy~g~~~~~~~~~vavK~~~~~--~~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~lV~E~~~ 582 (792)
+.+.||+|.||+||+|.++. .||||+++.. ..+..+.|++|+.++++-+|.||+-+.|+|..+.. .||..+|+
T Consensus 396 l~~rIGsGsFGtV~Rg~whG----dVAVK~Lnv~~pt~~qlqaFKnEVa~lkkTRH~NIlLFMG~~~~p~~-AIiTqwCe 470 (678)
T KOG0193|consen 396 LGERIGSGSFGTVYRGRWHG----DVAVKLLNVDDPTPEQLQAFKNEVAVLKKTRHENILLFMGACMNPPL-AIITQWCE 470 (678)
T ss_pred ccceeccccccceeeccccc----ceEEEEEecCCCCHHHHHHHHHHHHHHhhcchhhheeeehhhcCCce-eeeehhcc
Confidence 45679999999999999873 5999999754 34456789999999999999999999999999888 99999999
Q ss_pred CCCccccccCC-CCCchhHHHHHHHHHHHHHHHHhhccCCCeEecCCCCCcEEEcCCCCeEEeecCCCccccCC-CCCcc
Q 003836 583 NGTVASFLFGD-SKPNWKLRTEIAMGIAGGLFYLHEECCTQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLD-QSHTN 660 (792)
Q Consensus 583 ~gsL~~~l~~~-~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dikp~NILl~~~~~~kl~Dfg~a~~~~~~-~~~~~ 660 (792)
+.+|..+|+-. .+++..+.+.||+|||+||.|||.+ +|||||||..||+|.++++|||.|||++.....- .....
T Consensus 471 GsSLY~hlHv~etkfdm~~~idIAqQiaqGM~YLHAK---~IIHrDLKSnNIFl~~~~kVkIgDFGLatvk~~w~g~~q~ 547 (678)
T KOG0193|consen 471 GSSLYTHLHVQETKFDMNTTIDIAQQIAQGMDYLHAK---NIIHRDLKSNNIFLHEDLKVKIGDFGLATVKTRWSGEQQL 547 (678)
T ss_pred CchhhhhccchhhhhhHHHHHHHHHHHHHhhhhhhhh---hhhhhhccccceEEccCCcEEEecccceeeeeeecccccc
Confidence 99999999865 5788899999999999999999999 9999999999999999999999999999764332 11122
Q ss_pred ccccccCCccccccccc---CCCCcccceehHHHHHHHHHhcCcCCCcchhhhhhhhHHHHHHHhhcccchhHhhhchhc
Q 003836 661 TAIRGTKGYVAPEWFRN---MPITVKVDVYSYGVLLLEIICLRRNIDNEISKVDKAILTDWAYDRYQERTLEALVENDLE 737 (792)
Q Consensus 661 ~~~~gt~~y~aPE~~~~---~~~~~k~DV~S~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 737 (792)
....|..-|||||+++. .+|+..+||||||+++|||+||..|+.... .++.++. ..+.....++..
T Consensus 548 ~qp~gsilwmAPEvIRmqd~nPfS~qSDVYaFGiV~YELltg~lPysi~~--~dqIifm-----VGrG~l~pd~s~---- 616 (678)
T KOG0193|consen 548 EQPHGSLLWMAPEVIRMQDDNPFSFQSDVYAFGIVWYELLTGELPYSIQN--RDQIIFM-----VGRGYLMPDLSK---- 616 (678)
T ss_pred CCCccchhhhcHHHHhhcccCCCCcccchhhhhHHHHHHHhCcCCcCCCC--hhheEEE-----ecccccCccchh----
Confidence 22347788999999863 579999999999999999999999997322 1111110 000000011111
Q ss_pred ccCCHHHHHHHHHHHHHccccCCCCCCCHHhHHHHhccCcC
Q 003836 738 AMNNVTMLHRFVMVAFWCIQEDPSHRPTMRKVTQMLEGVVE 778 (792)
Q Consensus 738 ~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~L~~~~~ 778 (792)
......+++.+|+..||..++++||.+.+|+.+|+.++.
T Consensus 617 --~~s~~pk~mk~Ll~~C~~~~~~eRP~F~~il~~l~~l~~ 655 (678)
T KOG0193|consen 617 --IRSNCPKAMKRLLSDCWKFDREERPLFPQLLSKLEELLP 655 (678)
T ss_pred --hhccCHHHHHHHHHHHHhcCcccCccHHHHHHHHHHhhh
Confidence 122456678889999999999999999999998888765
|
|
| >KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-39 Score=334.15 Aligned_cols=260 Identities=23% Similarity=0.278 Sum_probs=206.4
Q ss_pred hhhcCccccceEEEeeecCCCceEEEEEEccccc--ccchHHHHHHHHHhcccCCCCcccccceeccC--CceEEEEEec
Q 003836 506 KEELGRGAFGTVYKGFVNMGSSNHVAVKKLNSVF--QDSEKEFKAEVNGIGQTHHKNLVRLLGYCDEG--QNRLLVYEFM 581 (792)
Q Consensus 506 ~~~lG~G~~g~Vy~g~~~~~~~~~vavK~~~~~~--~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~--~~~~lV~E~~ 581 (792)
.++||+|.||.|||+.. ..+++.||+|++.... ........+||.+|++|+||||++|.+...+. ..+|||+|||
T Consensus 122 i~kIGeGTyg~VYkAr~-~~tgkivALKKvr~d~~~~~~~~t~~REI~ILr~l~HpNIikL~eivt~~~~~siYlVFeYM 200 (560)
T KOG0600|consen 122 IEKIGEGTYGQVYKARD-LETGKIVALKKVRFDNEKEGFPITAIREIKILRRLDHPNIIKLEEIVTSKLSGSIYLVFEYM 200 (560)
T ss_pred HHHhcCcchhheeEeee-cccCcEEEEEEeecccCCCcchHHHHHHHHHHHhcCCCcccceeeEEEecCCceEEEEEecc
Confidence 46799999999999964 5677899999987543 34456678999999999999999999988766 6899999999
Q ss_pred cCCCccccccCC-CCCchhHHHHHHHHHHHHHHHHhhccCCCeEecCCCCCcEEEcCCCCeEEeecCCCccccCCCCCcc
Q 003836 582 SNGTVASFLFGD-SKPNWKLRTEIAMGIAGGLFYLHEECCTQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLDQSHTN 660 (792)
Q Consensus 582 ~~gsL~~~l~~~-~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dikp~NILl~~~~~~kl~Dfg~a~~~~~~~~~~~ 660 (792)
+. +|.-++... -.+++.++..++.|++.||+|+|++ +|+|||||.+|||||.+|.+||+|||+|+++........
T Consensus 201 dh-DL~GLl~~p~vkft~~qIKc~mkQLl~Gl~~cH~~---gvlHRDIK~SNiLidn~G~LKiaDFGLAr~y~~~~~~~~ 276 (560)
T KOG0600|consen 201 DH-DLSGLLSSPGVKFTEPQIKCYMKQLLEGLEYCHSR---GVLHRDIKGSNILIDNNGVLKIADFGLARFYTPSGSAPY 276 (560)
T ss_pred cc-hhhhhhcCCCcccChHHHHHHHHHHHHHHHHHhhc---CeeeccccccceEEcCCCCEEeccccceeeccCCCCccc
Confidence 98 888888764 4789999999999999999999999 999999999999999999999999999999888777777
Q ss_pred ccccccCCccccccccc-CCCCcccceehHHHHHHHHHhcCcCCCcchhhhhhhhHHHH----HHHhhcccchh--Hhhh
Q 003836 661 TAIRGTKGYVAPEWFRN-MPITVKVDVYSYGVLLLEIICLRRNIDNEISKVDKAILTDW----AYDRYQERTLE--ALVE 733 (792)
Q Consensus 661 ~~~~gt~~y~aPE~~~~-~~~~~k~DV~S~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~----~~~~~~~~~~~--~~~~ 733 (792)
+..+-|..|+|||++.+ ..|+.+.|+||.||||.||++|+..|....+..+...+... ....|...++. ..+.
T Consensus 277 T~rVvTLWYRpPELLLG~t~Yg~aVDlWS~GCIl~El~~gkPI~~G~tEveQl~kIfklcGSP~e~~W~~~kLP~~~~~k 356 (560)
T KOG0600|consen 277 TSRVVTLWYRPPELLLGATSYGTAVDLWSVGCILAELFLGKPILQGRTEVEQLHKIFKLCGSPTEDYWPVSKLPHATIFK 356 (560)
T ss_pred ccceEEeeccChHHhcCCcccccceeehhhhHHHHHHHcCCCCcCCccHHHHHHHHHHHhCCCChhccccccCCcccccC
Confidence 88888999999999876 57999999999999999999999998765543322221110 00111111111 0000
Q ss_pred c------hhcccCCHHHHHHHHHHHHHccccCCCCCCCHHhHHH
Q 003836 734 N------DLEAMNNVTMLHRFVMVAFWCIQEDPSHRPTMRKVTQ 771 (792)
Q Consensus 734 ~------~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~ 771 (792)
+ .+... ....+...++|+..+|..||.+|.|+.++++
T Consensus 357 p~~~y~r~l~E~-~~~~~~~~l~Ll~~lL~ldP~kR~tA~~aL~ 399 (560)
T KOG0600|consen 357 PQQPYKRRLRET-FKDFPASALDLLEKLLSLDPDKRGTASSALQ 399 (560)
T ss_pred CCCcccchHHHH-hccCCHHHHHHHHHHhccCccccccHHHHhc
Confidence 0 01100 1223466788999999999999999999886
|
|
| >cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-39 Score=352.47 Aligned_cols=258 Identities=27% Similarity=0.387 Sum_probs=200.7
Q ss_pred HhhhhhhcCccccceEEEeeec----CCCceEEEEEEcccccc-cchHHHHHHHHHhccc-CCCCcccccceeccCC-ce
Q 003836 502 TRGFKEELGRGAFGTVYKGFVN----MGSSNHVAVKKLNSVFQ-DSEKEFKAEVNGIGQT-HHKNLVRLLGYCDEGQ-NR 574 (792)
Q Consensus 502 ~~~~~~~lG~G~~g~Vy~g~~~----~~~~~~vavK~~~~~~~-~~~~~~~~Ei~~l~~l-~h~niv~l~g~~~~~~-~~ 574 (792)
.+.+.++||+|+||.||+|... ...++.||||++..... ...+.+.+|+.++.++ +||||++++++|...+ ..
T Consensus 8 ~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~ 87 (338)
T cd05102 8 RLRLGKVLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEGATASEHKALMSELKILIHIGNHLNVVNLLGACTKPNGPL 87 (338)
T ss_pred HceeeeEeccCCcceEEEEEEeccCCcccchhhheeccccccchHHHHHHHHHHHHHHHhccCcceeeEEeEecCCCCce
Confidence 3456688999999999999642 23346799999875432 3346789999999999 8999999999887654 57
Q ss_pred EEEEEeccCCCccccccCC-------------------------------------------------------------
Q 003836 575 LLVYEFMSNGTVASFLFGD------------------------------------------------------------- 593 (792)
Q Consensus 575 ~lV~E~~~~gsL~~~l~~~------------------------------------------------------------- 593 (792)
++||||+++|+|.+++...
T Consensus 88 ~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 167 (338)
T cd05102 88 MVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSGSTNPPQETDDLW 167 (338)
T ss_pred EEEEecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCCccccccccccCcccccchhccccc
Confidence 8999999999999888642
Q ss_pred -CCCchhHHHHHHHHHHHHHHHHhhccCCCeEecCCCCCcEEEcCCCCeEEeecCCCccccCCCCCc-cccccccCCccc
Q 003836 594 -SKPNWKLRTEIAMGIAGGLFYLHEECCTQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLDQSHT-NTAIRGTKGYVA 671 (792)
Q Consensus 594 -~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dikp~NILl~~~~~~kl~Dfg~a~~~~~~~~~~-~~~~~gt~~y~a 671 (792)
..+++..+.+++.||++||+|||+. +|+||||||+|||+++++.+||+|||+++......... .....+++.|+|
T Consensus 168 ~~~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrDiKp~Nil~~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~~y~a 244 (338)
T cd05102 168 KSPLTMEDLICYSFQVARGMEFLASR---KCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSARLPLKWMA 244 (338)
T ss_pred cCCCCHHHHHHHHHHHHHHHHHHHHC---CEECCCCccceEEEcCCCcEEEeecccccccccCcchhcccCCCCCccccC
Confidence 2366778889999999999999998 99999999999999999999999999998654332221 223346778999
Q ss_pred ccccccCCCCcccceehHHHHHHHHHh-cCcCCCcchhhhhhhhHHHHHHHhhcccchhHhhhchhcccCCHHHHHHHHH
Q 003836 672 PEWFRNMPITVKVDVYSYGVLLLEIIC-LRRNIDNEISKVDKAILTDWAYDRYQERTLEALVENDLEAMNNVTMLHRFVM 750 (792)
Q Consensus 672 PE~~~~~~~~~k~DV~S~Gv~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 750 (792)
||.+.+..++.++|||||||++|||++ |..||........ + ......+ .....+...+..+.+
T Consensus 245 PE~~~~~~~~~~sDiwslG~il~el~~~g~~pf~~~~~~~~---~----~~~~~~~---------~~~~~~~~~~~~l~~ 308 (338)
T cd05102 245 PESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQINEE---F----CQRLKDG---------TRMRAPENATPEIYR 308 (338)
T ss_pred cHHhhcCCCCcccCHHHHHHHHHHHHhCCCCCCCCCCccHH---H----HHHHhcC---------CCCCCCCCCCHHHHH
Confidence 999999999999999999999999997 9999865322110 0 0000110 011112234567889
Q ss_pred HHHHccccCCCCCCCHHhHHHHhccCcC
Q 003836 751 VAFWCIQEDPSHRPTMRKVTQMLEGVVE 778 (792)
Q Consensus 751 l~~~Cl~~~p~~RPs~~evl~~L~~~~~ 778 (792)
++.+||+.+|++|||+.||+++|+.+++
T Consensus 309 li~~cl~~dp~~RPs~~el~~~l~~~~~ 336 (338)
T cd05102 309 IMLACWQGDPKERPTFSALVEILGDLLQ 336 (338)
T ss_pred HHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence 9999999999999999999999998653
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V |
| >KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-39 Score=342.51 Aligned_cols=244 Identities=25% Similarity=0.363 Sum_probs=209.8
Q ss_pred hhcCccccceEEEeeecCCCceEEEEEEcccccccchHHHHHHHHHhcccCCCCcccccceeccCCceEEEEEeccCCCc
Q 003836 507 EELGRGAFGTVYKGFVNMGSSNHVAVKKLNSVFQDSEKEFKAEVNGIGQTHHKNLVRLLGYCDEGQNRLLVYEFMSNGTV 586 (792)
Q Consensus 507 ~~lG~G~~g~Vy~g~~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~lV~E~~~~gsL 586 (792)
++||+|+.|.||.+. +..+++.||||++........+-+.+|+.+|+..+|+|||.++..+..++++++|||||++|+|
T Consensus 279 ~kigqgaSG~vy~A~-~~~~~~~VaiK~m~l~~Q~~keLilnEi~Vm~~~~H~NiVnfl~Sylv~deLWVVMEym~ggsL 357 (550)
T KOG0578|consen 279 KKIGQGATGGVYVAR-KISTKQEVAIKRMDLRKQPKKELLLNEILVMRDLHHPNIVNFLDSYLVGDELWVVMEYMEGGSL 357 (550)
T ss_pred hhhccccccceeeee-eccCCceEEEEEEEeccCCchhhhHHHHHHHHhccchHHHHHHHHhcccceeEEEEeecCCCch
Confidence 579999999999995 4566788999999887777888899999999999999999999999999999999999999999
Q ss_pred cccccCCCCCchhHHHHHHHHHHHHHHHHhhccCCCeEecCCCCCcEEEcCCCCeEEeecCCCccccCCCCCcccccccc
Q 003836 587 ASFLFGDSKPNWKLRTEIAMGIAGGLFYLHEECCTQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLDQSHTNTAIRGT 666 (792)
Q Consensus 587 ~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dikp~NILl~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~gt 666 (792)
.+.+.. ..+++.++..|++.+++||+|||.+ +|+|||||.+|||++.+|.+||+|||++..+..... .....+||
T Consensus 358 TDvVt~-~~~~E~qIA~Icre~l~aL~fLH~~---gIiHrDIKSDnILL~~~g~vKltDFGFcaqi~~~~~-KR~TmVGT 432 (550)
T KOG0578|consen 358 TDVVTK-TRMTEGQIAAICREILQGLKFLHAR---GIIHRDIKSDNILLTMDGSVKLTDFGFCAQISEEQS-KRSTMVGT 432 (550)
T ss_pred hhhhhc-ccccHHHHHHHHHHHHHHHHHHHhc---ceeeeccccceeEeccCCcEEEeeeeeeeccccccC-ccccccCC
Confidence 998854 4489999999999999999999999 999999999999999999999999999988765554 34456799
Q ss_pred CCcccccccccCCCCcccceehHHHHHHHHHhcCcCCCcchhhhhhhhHHHHHHHhhcccchhHhhh-chhcccCCHHHH
Q 003836 667 KGYVAPEWFRNMPITVKVDVYSYGVLLLEIICLRRNIDNEISKVDKAILTDWAYDRYQERTLEALVE-NDLEAMNNVTML 745 (792)
Q Consensus 667 ~~y~aPE~~~~~~~~~k~DV~S~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~ 745 (792)
|.|||||+.....|+.|.||||||++++||+.|+.||-.+...... ..+.+ ....-..+...+
T Consensus 433 PYWMAPEVvtrk~YG~KVDIWSLGIMaIEMveGEPPYlnE~PlrAl----------------yLIa~ng~P~lk~~~klS 496 (550)
T KOG0578|consen 433 PYWMAPEVVTRKPYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRAL----------------YLIATNGTPKLKNPEKLS 496 (550)
T ss_pred CCccchhhhhhcccCccccchhhhhHHHHHhcCCCCccCCChHHHH----------------HHHhhcCCCCcCCccccC
Confidence 9999999999999999999999999999999999999754321110 00111 112222345677
Q ss_pred HHHHHHHHHccccCCCCCCCHHhHHHH
Q 003836 746 HRFVMVAFWCIQEDPSHRPTMRKVTQM 772 (792)
Q Consensus 746 ~~l~~l~~~Cl~~~p~~RPs~~evl~~ 772 (792)
..+.+++.+||+.|+++||++.|+|+.
T Consensus 497 ~~~kdFL~~cL~~dv~~RasA~eLL~H 523 (550)
T KOG0578|consen 497 PELKDFLDRCLVVDVEQRASAKELLEH 523 (550)
T ss_pred HHHHHHHHHHhhcchhcCCCHHHHhcC
Confidence 889999999999999999999999973
|
|
| >KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-39 Score=375.22 Aligned_cols=254 Identities=27% Similarity=0.411 Sum_probs=209.0
Q ss_pred hhhhcCccccceEEEeeecCCCc----eEEEEEEccccc-ccchHHHHHHHHHhcccCCCCcccccceeccCCceEEEEE
Q 003836 505 FKEELGRGAFGTVYKGFVNMGSS----NHVAVKKLNSVF-QDSEKEFKAEVNGIGQTHHKNLVRLLGYCDEGQNRLLVYE 579 (792)
Q Consensus 505 ~~~~lG~G~~g~Vy~g~~~~~~~----~~vavK~~~~~~-~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~lV~E 579 (792)
+.+.||+|.||.||+|......+ ..||||.+++.. .+.+.+|.+|..+|+.++|||||+++|+|.+....+|++|
T Consensus 696 l~~~lG~G~FG~VY~g~~~~~~~~~~~~~vaiK~l~~~~~~~~~~~Fl~Ea~~m~~f~HpNiv~liGv~l~~~~~~i~le 775 (1025)
T KOG1095|consen 696 LLRVLGKGAFGEVYEGTYSDVPGSVSPIQVAVKSLKRLSSEQEVSDFLKEALLMSKFDHPNIVSLIGVCLDSGPPLILLE 775 (1025)
T ss_pred eeeeeccccccceEEEEEecCCCCccceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCcceeeEEEeecCCCCcEEEeh
Confidence 44579999999999998865443 359999998753 4566789999999999999999999999999999999999
Q ss_pred eccCCCccccccCC-------CCCchhHHHHHHHHHHHHHHHHhhccCCCeEecCCCCCcEEEcCCCCeEEeecCCCccc
Q 003836 580 FMSNGTVASFLFGD-------SKPNWKLRTEIAMGIAGGLFYLHEECCTQIIHCDIKPQNILLDDHYNARISDFGLAKLL 652 (792)
Q Consensus 580 ~~~~gsL~~~l~~~-------~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dikp~NILl~~~~~~kl~Dfg~a~~~ 652 (792)
||++|+|..||++. ..+.....+.++.|||+|+.||+++ ++|||||.++|+||++...+||+|||+|+..
T Consensus 776 yM~gGDL~sflr~~r~~~~~~~~L~~~dLl~~a~dvA~G~~YLe~~---~fvHRDLAaRNCLL~~~r~VKIaDFGlArDi 852 (1025)
T KOG1095|consen 776 YMEGGDLLSFLRESRPAPFQPSNLSMRDLLAFALDVAKGMNYLESK---HFVHRDLAARNCLLDERRVVKIADFGLARDI 852 (1025)
T ss_pred hcccCcHHHHHHhcccccCCCCCCCHHHHHHHHHHHhhhhHHHHhC---CCcCcchhhhheeecccCcEEEcccchhHhh
Confidence 99999999999865 3578889999999999999999999 9999999999999999999999999999954
Q ss_pred cCCCCCccccc-cccCCcccccccccCCCCcccceehHHHHHHHHHh-cCcCCCcchhhhhhhhHHHHHHHhhcccchhH
Q 003836 653 TLDQSHTNTAI-RGTKGYVAPEWFRNMPITVKVDVYSYGVLLLEIIC-LRRNIDNEISKVDKAILTDWAYDRYQERTLEA 730 (792)
Q Consensus 653 ~~~~~~~~~~~-~gt~~y~aPE~~~~~~~~~k~DV~S~Gv~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 730 (792)
...+....... .-...|||||.+..+.|+.|+|||||||+||||+| |..|+........ +..
T Consensus 853 y~~~yyr~~~~a~lPvkWm~PEsl~d~iFtskSDvWsFGVllWEifslG~~PY~~~~n~~v----------------~~~ 916 (1025)
T KOG1095|consen 853 YDKDYYRKHGEAMLPVKWMPPESLKDGIFTSKSDVWSFGVLLWEIFSLGATPYPSRSNFEV----------------LLD 916 (1025)
T ss_pred hhchheeccCccccceecCCHHHHhhcccccccchhhhHHHHHHHHhCCCCCCCCcchHHH----------------HHH
Confidence 43333222211 23458999999999999999999999999999998 5566654322100 111
Q ss_pred hhhchhcccCCHHHHHHHHHHHHHccccCCCCCCCHHhHHHHhccCcC
Q 003836 731 LVENDLEAMNNVTMLHRFVMVAFWCIQEDPSHRPTMRKVTQMLEGVVE 778 (792)
Q Consensus 731 ~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~L~~~~~ 778 (792)
++... +...+..++..+.+||.+||+.+|++||++..|+++++.+..
T Consensus 917 ~~~gg-RL~~P~~CP~~ly~lM~~CW~~~pe~RP~F~~i~~q~~~i~~ 963 (1025)
T KOG1095|consen 917 VLEGG-RLDPPSYCPEKLYQLMLQCWKHDPEDRPSFRTIVEQDPAISN 963 (1025)
T ss_pred HHhCC-ccCCCCCCChHHHHHHHHHccCChhhCccHHHHHhhhhhhhh
Confidence 12222 455577788899999999999999999999999999877654
|
|
| >KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-39 Score=337.95 Aligned_cols=265 Identities=23% Similarity=0.300 Sum_probs=207.3
Q ss_pred HHHhhhhhhcCccccceEEEeeecCCCceEEEEEEcccccccc-hHHHHHHHHHhcccC-CCCcccccceeccCC-ceEE
Q 003836 500 EVTRGFKEELGRGAFGTVYKGFVNMGSSNHVAVKKLNSVFQDS-EKEFKAEVNGIGQTH-HKNLVRLLGYCDEGQ-NRLL 576 (792)
Q Consensus 500 ~~~~~~~~~lG~G~~g~Vy~g~~~~~~~~~vavK~~~~~~~~~-~~~~~~Ei~~l~~l~-h~niv~l~g~~~~~~-~~~l 576 (792)
..+|...++||.|+||.||+|+- ..++..||||++++....- +-.-.+|++.|++|+ ||||+++..++.+.+ .+++
T Consensus 9 m~RY~~i~klGDGTfGsV~la~~-~~~~~~VAIK~MK~Kf~s~ee~~nLREvksL~kln~hpniikL~Evi~d~~~~L~f 87 (538)
T KOG0661|consen 9 MDRYTVIRKLGDGTFGSVYLAKS-KETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNPHPNIIKLKEVIRDNDRILYF 87 (538)
T ss_pred HHHHHHHHHhcCCcceeEEEeee-cCCCceeeHHHHHhhhccHHHHHHHHHHHHHHhcCCCCcchhhHHHhhccCceEee
Confidence 34566778999999999999975 4566789999998754432 233568999999998 999999999999888 9999
Q ss_pred EEEeccCCCccccccCC-CCCchhHHHHHHHHHHHHHHHHhhccCCCeEecCCCCCcEEEcCCCCeEEeecCCCccccCC
Q 003836 577 VYEFMSNGTVASFLFGD-SKPNWKLRTEIAMGIAGGLFYLHEECCTQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLD 655 (792)
Q Consensus 577 V~E~~~~gsL~~~l~~~-~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dikp~NILl~~~~~~kl~Dfg~a~~~~~~ 655 (792)
|||||+. +|.+++.++ +.+++..+..|+.||++||+|+|.+ |++|||+||+|||+..+..+||+|||+||....
T Consensus 88 VfE~Md~-NLYqLmK~R~r~fse~~irnim~QilqGL~hiHk~---GfFHRDlKPENiLi~~~~~iKiaDFGLARev~S- 162 (538)
T KOG0661|consen 88 VFEFMDC-NLYQLMKDRNRLFSESDIRNIMYQILQGLAHIHKH---GFFHRDLKPENILISGNDVIKIADFGLAREVRS- 162 (538)
T ss_pred eHHhhhh-hHHHHHhhcCCcCCHHHHHHHHHHHHHHHHHHHhc---CcccccCChhheEecccceeEeccccccccccc-
Confidence 9999976 899999765 5789999999999999999999999 999999999999999999999999999997643
Q ss_pred CCCccccccccCCccccccc-ccCCCCcccceehHHHHHHHHHhcCcCCCcchhhhhhhhHHHHH----HHhhccc-c--
Q 003836 656 QSHTNTAIRGTKGYVAPEWF-RNMPITVKVDVYSYGVLLLEIICLRRNIDNEISKVDKAILTDWA----YDRYQER-T-- 727 (792)
Q Consensus 656 ~~~~~~~~~gt~~y~aPE~~-~~~~~~~k~DV~S~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~----~~~~~~~-~-- 727 (792)
....+..+.|..|+|||++ +.+-|+.+.|||++|||++||.+.+..|....+..+...+.+.. ...+.++ .
T Consensus 163 -kpPYTeYVSTRWYRAPEvLLrs~~Ys~pvD~wA~GcI~aEl~sLrPLFPG~sE~Dqi~KIc~VLGtP~~~~~~eg~~La 241 (538)
T KOG0661|consen 163 -KPPYTEYVSTRWYRAPEVLLRSGYYSSPVDMWAVGCIMAELYSLRPLFPGASEIDQIYKICEVLGTPDKDSWPEGYNLA 241 (538)
T ss_pred -CCCcchhhhcccccchHHhhhccccCCchHHHHHHHHHHHHHHhcccCCCCcHHHHHHHHHHHhCCCccccchhHHHHH
Confidence 3344566789999999987 56789999999999999999999998886654432222111110 0111110 0
Q ss_pred ------hhHhhhchhcccCCHHHHHHHHHHHHHccccCCCCCCCHHhHHHH
Q 003836 728 ------LEALVENDLEAMNNVTMLHRFVMVAFWCIQEDPSHRPTMRKVTQM 772 (792)
Q Consensus 728 ------~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~ 772 (792)
.....-..+....+ ..+.++++++.+|+++||.+|||++|.+++
T Consensus 242 ~~mnf~~P~~~~~~l~~L~p-~~s~~~~~li~~ll~WDP~kRpTA~~al~~ 291 (538)
T KOG0661|consen 242 SAMNFRFPQVKPSPLKDLLP-NASSEAASLIERLLAWDPDKRPTASQALQH 291 (538)
T ss_pred HHhccCCCcCCCCChHHhCc-ccCHHHHHHHHHHhcCCCccCccHHHHhcC
Confidence 11111111111122 267889999999999999999999999985
|
|
| >KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-38 Score=307.87 Aligned_cols=274 Identities=22% Similarity=0.283 Sum_probs=208.5
Q ss_pred hhhcCccccceEEEeeecCCCceEEEEEEccccc--ccchHHHHHHHHHhcccCCCCcccccceeccCCceEEEEEeccC
Q 003836 506 KEELGRGAFGTVYKGFVNMGSSNHVAVKKLNSVF--QDSEKEFKAEVNGIGQTHHKNLVRLLGYCDEGQNRLLVYEFMSN 583 (792)
Q Consensus 506 ~~~lG~G~~g~Vy~g~~~~~~~~~vavK~~~~~~--~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~lV~E~~~~ 583 (792)
.++||+|.||.||+|.. ..+++.||||+++... ........+||+.|+.++|+||+.++++|.+.+...||+|||+.
T Consensus 7 ~~~lGEG~~gvVyka~d-~~t~~~VAIKKIkl~~~kdGi~~talREIK~Lqel~h~nIi~LiD~F~~~~~l~lVfEfm~t 85 (318)
T KOG0659|consen 7 LEKLGEGTYGVVYKARD-TETGKRVAIKKIKLGNAKDGINRTALREIKLLQELKHPNIIELIDVFPHKSNLSLVFEFMPT 85 (318)
T ss_pred hhhhcCcceEEEEEEEe-cCCCcEEEEEEeeccccccCccHHHHHHHHHHHHccCcchhhhhhhccCCCceEEEEEeccc
Confidence 46799999999999974 4678899999997542 22345789999999999999999999999999999999999987
Q ss_pred CCccccccCC-CCCchhHHHHHHHHHHHHHHHHhhccCCCeEecCCCCCcEEEcCCCCeEEeecCCCccccCCCCCcccc
Q 003836 584 GTVASFLFGD-SKPNWKLRTEIAMGIAGGLFYLHEECCTQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLDQSHTNTA 662 (792)
Q Consensus 584 gsL~~~l~~~-~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dikp~NILl~~~~~~kl~Dfg~a~~~~~~~~~~~~~ 662 (792)
+|+..++++ ..++..++..++.++++||+|||++ .|+||||||.|+|++++|.+||+|||+|+.+....... +.
T Consensus 86 -dLe~vIkd~~i~l~pa~iK~y~~m~LkGl~y~H~~---~IlHRDlKPnNLLis~~g~lKiADFGLAr~f~~p~~~~-~~ 160 (318)
T KOG0659|consen 86 -DLEVVIKDKNIILSPADIKSYMLMTLKGLAYCHSK---WILHRDLKPNNLLISSDGQLKIADFGLARFFGSPNRIQ-TH 160 (318)
T ss_pred -cHHHHhcccccccCHHHHHHHHHHHHHHHHHHHhh---hhhcccCCccceEEcCCCcEEeecccchhccCCCCccc-cc
Confidence 899999876 4678999999999999999999999 99999999999999999999999999999886543332 22
Q ss_pred ccccCCccccccccc-CCCCcccceehHHHHHHHHHhcCcCCCcchhhhhhhhHHHH----HHHhhcc-cchhHhhh---
Q 003836 663 IRGTKGYVAPEWFRN-MPITVKVDVYSYGVLLLEIICLRRNIDNEISKVDKAILTDW----AYDRYQE-RTLEALVE--- 733 (792)
Q Consensus 663 ~~gt~~y~aPE~~~~-~~~~~k~DV~S~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~----~~~~~~~-~~~~~~~~--- 733 (792)
.+-|.-|+|||.+.+ .+|+...||||.||++.||+-|..-|....+..+...+... ..+.|.+ ..+.+..+
T Consensus 161 ~V~TRWYRAPELLfGsr~Yg~~VDmWavGCI~AELllr~P~fpG~sDidQL~~If~~LGTP~~~~WP~~~~lpdY~~~~~ 240 (318)
T KOG0659|consen 161 QVVTRWYRAPELLFGSRQYGTGVDMWAVGCIFAELLLRVPFFPGDSDIDQLSKIFRALGTPTPDQWPEMTSLPDYVKIQQ 240 (318)
T ss_pred ceeeeeccChHHhccchhcCCcchhhhHHHHHHHHHccCCCCCCCchHHHHHHHHHHcCCCCcccCccccccccHHHHhc
Confidence 357899999998865 67999999999999999999887666544332221111110 0001110 00111111
Q ss_pred ---chhcccCCHHHHHHHHHHHHHccccCCCCCCCHHhHHHHhccCcCCCCCCCCCC
Q 003836 734 ---NDLEAMNNVTMLHRFVMVAFWCIQEDPSHRPTMRKVTQMLEGVVEVPIPPCPWT 787 (792)
Q Consensus 734 ---~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~L~~~~~~~~p~~P~~ 787 (792)
+.+.. .-...+.++++++..++..||.+|++++|++++= -....|.|..|+-
T Consensus 241 ~P~~~~~~-lf~aas~d~ldLl~~m~~ynP~~Rita~qaL~~~-yf~~~P~pt~~~~ 295 (318)
T KOG0659|consen 241 FPKPPLNN-LFPAASSDALDLLSKMLTYNPKKRITASQALKHP-YFKSLPLPTPPSK 295 (318)
T ss_pred CCCCcccc-ccccccHHHHHHHHhhhccCchhcccHHHHhcch-hhhcCCCCCChhh
Confidence 11111 2234567779999999999999999999998752 2334555555543
|
|
| >PHA02988 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-38 Score=338.08 Aligned_cols=261 Identities=17% Similarity=0.300 Sum_probs=207.6
Q ss_pred CccccCHHHHHHHHhhhhhhcCccccceEEEeeecCCCceEEEEEEcccccccc---hHHHHHHHHHhcccCCCCccccc
Q 003836 489 NLRCFTYKELVEVTRGFKEELGRGAFGTVYKGFVNMGSSNHVAVKKLNSVFQDS---EKEFKAEVNGIGQTHHKNLVRLL 565 (792)
Q Consensus 489 ~~~~~~~~el~~~~~~~~~~lG~G~~g~Vy~g~~~~~~~~~vavK~~~~~~~~~---~~~~~~Ei~~l~~l~h~niv~l~ 565 (792)
+++.++.+++...+ ...||+|+++.||+|+++ ++.||||+++...... .+.+.+|+.++.+++||||++++
T Consensus 11 ~~~~i~~~~i~~~~---~~~i~~g~~~~v~~~~~~---~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~ 84 (283)
T PHA02988 11 DIKCIESDDIDKYT---SVLIKENDQNSIYKGIFN---NKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIY 84 (283)
T ss_pred cceecCHHHcCCCC---CeEEeeCCceEEEEEEEC---CEEEEEEeccccccccHHHHHHHHHHHHHHHhcCCCCEEEEe
Confidence 34555666653211 136999999999999873 5789999997654333 46788999999999999999999
Q ss_pred ceecc----CCceEEEEEeccCCCccccccCCCCCchhHHHHHHHHHHHHHHHHhhccCCCeEecCCCCCcEEEcCCCCe
Q 003836 566 GYCDE----GQNRLLVYEFMSNGTVASFLFGDSKPNWKLRTEIAMGIAGGLFYLHEECCTQIIHCDIKPQNILLDDHYNA 641 (792)
Q Consensus 566 g~~~~----~~~~~lV~E~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dikp~NILl~~~~~~ 641 (792)
|++.+ ....++||||+++|+|.+++...+.+++....+++.|++.||.|||+. .+++||||||+|||+++++.+
T Consensus 85 g~~~~~~~~~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~i~~~i~~~l~~lH~~--~~~~Hrdlkp~nill~~~~~~ 162 (283)
T PHA02988 85 GFIIDIVDDLPRLSLILEYCTRGYLREVLDKEKDLSFKTKLDMAIDCCKGLYNLYKY--TNKPYKNLTSVSFLVTENYKL 162 (283)
T ss_pred eeEEecccCCCceEEEEEeCCCCcHHHHHhhCCCCChhHHHHHHHHHHHHHHHHHhc--CCCCCCcCChhhEEECCCCcE
Confidence 99876 356889999999999999998888899999999999999999999974 278899999999999999999
Q ss_pred EEeecCCCccccCCCCCccccccccCCccccccccc--CCCCcccceehHHHHHHHHHhcCcCCCcchhhhhhhhHHHHH
Q 003836 642 RISDFGLAKLLTLDQSHTNTAIRGTKGYVAPEWFRN--MPITVKVDVYSYGVLLLEIICLRRNIDNEISKVDKAILTDWA 719 (792)
Q Consensus 642 kl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~k~DV~S~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~ 719 (792)
||+|||+++...... ....++..|+|||++.+ ..++.++|||||||++|||++|+.||........ .
T Consensus 163 kl~dfg~~~~~~~~~----~~~~~~~~y~aPE~~~~~~~~~~~k~Di~SlGvil~el~~g~~Pf~~~~~~~~---~---- 231 (283)
T PHA02988 163 KIICHGLEKILSSPP----FKNVNFMVYFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTGKIPFENLTTKEI---Y---- 231 (283)
T ss_pred EEcccchHhhhcccc----ccccCcccccCHHHhhhccccccchhhhhHHHHHHHHHHHCCCCCCCCCHHHH---H----
Confidence 999999998654322 22357889999999976 6899999999999999999999999975432110 0
Q ss_pred HHhhcccchhHhhhchhcccCCHHHHHHHHHHHHHccccCCCCCCCHHhHHHHhccCc
Q 003836 720 YDRYQERTLEALVENDLEAMNNVTMLHRFVMVAFWCIQEDPSHRPTMRKVTQMLEGVV 777 (792)
Q Consensus 720 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~L~~~~ 777 (792)
..+.........+...+..+.+++.+||+.||++|||++|+++.|+.+.
T Consensus 232 ---------~~i~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ell~~l~~~~ 280 (283)
T PHA02988 232 ---------DLIINKNNSLKLPLDCPLEIKCIVEACTSHDSIKRPNIKEILYNLSLYK 280 (283)
T ss_pred ---------HHHHhcCCCCCCCCcCcHHHHHHHHHHhcCCcccCcCHHHHHHHHHHHH
Confidence 0111111111222245667899999999999999999999999998653
|
|
| >KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-38 Score=344.81 Aligned_cols=246 Identities=23% Similarity=0.346 Sum_probs=204.9
Q ss_pred hhhhhhcCccccceEEEeeecCCCceEEEEEEcccc----cc-cchHHHHHHHHHhcccC-CCCcccccceeccCCceEE
Q 003836 503 RGFKEELGRGAFGTVYKGFVNMGSSNHVAVKKLNSV----FQ-DSEKEFKAEVNGIGQTH-HKNLVRLLGYCDEGQNRLL 576 (792)
Q Consensus 503 ~~~~~~lG~G~~g~Vy~g~~~~~~~~~vavK~~~~~----~~-~~~~~~~~Ei~~l~~l~-h~niv~l~g~~~~~~~~~l 576 (792)
+.+.+.||+|+||+|++|... .+++.||+|++.+. .. ...+.+.+|+.++++++ ||||++++.++....+.++
T Consensus 19 y~~~~~lG~GsfgkV~~a~~~-~t~~~vAiKii~~~~~~~~~~~~~~~i~rEi~~~~~~~~HpnI~~l~ev~~t~~~~~i 97 (370)
T KOG0583|consen 19 YELGRTLGSGSFGKVKLAKHR-LTGEKVAIKIIDRKKVSSKSQKLDELIKREISILRRLRSHPNIIRLLEVFATPTKIYI 97 (370)
T ss_pred eeeeeeecCCCCeeEEEeeec-cCCCeEEEEEechhcccccccccchhhHHHHHHHHHhccCCCEeEEEEEEecCCeEEE
Confidence 445678999999999999654 45589999977653 12 34567789999999998 9999999999999999999
Q ss_pred EEEeccCCCccccccCCCCCchhHHHHHHHHHHHHHHHHhhccCCCeEecCCCCCcEEEcCC-CCeEEeecCCCccccCC
Q 003836 577 VYEFMSNGTVASFLFGDSKPNWKLRTEIAMGIAGGLFYLHEECCTQIIHCDIKPQNILLDDH-YNARISDFGLAKLLTLD 655 (792)
Q Consensus 577 V~E~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dikp~NILl~~~-~~~kl~Dfg~a~~~~~~ 655 (792)
||||+.+|+|.+++.+..++.+....+++.|++.|++|+|+. +|+||||||+|||++.+ +++||+|||++.... .
T Consensus 98 vmEy~~gGdL~~~i~~~g~l~E~~ar~~F~Qlisav~y~H~~---gi~HRDLK~ENilld~~~~~~Kl~DFG~s~~~~-~ 173 (370)
T KOG0583|consen 98 VMEYCSGGDLFDYIVNKGRLKEDEARKYFRQLISAVAYCHSR---GIVHRDLKPENILLDGNEGNLKLSDFGLSAISP-G 173 (370)
T ss_pred EEEecCCccHHHHHHHcCCCChHHHHHHHHHHHHHHHHHHhC---CEeeCCCCHHHEEecCCCCCEEEeccccccccC-C
Confidence 999999999999999888999999999999999999999999 99999999999999999 999999999999874 2
Q ss_pred CCCccccccccCCcccccccccCC-CC-cccceehHHHHHHHHHhcCcCCCcchhhhhhhhHHHHHHHhhcccchhHhhh
Q 003836 656 QSHTNTAIRGTKGYVAPEWFRNMP-IT-VKVDVYSYGVLLLEIICLRRNIDNEISKVDKAILTDWAYDRYQERTLEALVE 733 (792)
Q Consensus 656 ~~~~~~~~~gt~~y~aPE~~~~~~-~~-~k~DV~S~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 733 (792)
........+||+.|+|||++.+.. |+ .++||||+||+||.|++|+.||+....... . .. +..
T Consensus 174 ~~~~l~t~cGsp~Y~aPEvl~~~~~Y~g~~aDvWS~GViLy~ml~G~~PF~d~~~~~l---~-----~k--------i~~ 237 (370)
T KOG0583|consen 174 EDGLLKTFCGSPAYAAPEVLSGKGTYSGKAADVWSLGVILYVLLCGRLPFDDSNVPNL---Y-----RK--------IRK 237 (370)
T ss_pred CCCcccCCCCCcccCCHHHhCCCCCcCCchhhhhhhHHHHHHHHhCCCCCCCccHHHH---H-----HH--------Hhc
Confidence 334455678999999999999877 86 789999999999999999999986321100 0 00 111
Q ss_pred chhcccCCHHH-HHHHHHHHHHccccCCCCCCCHHhHHH
Q 003836 734 NDLEAMNNVTM-LHRFVMVAFWCIQEDPSHRPTMRKVTQ 771 (792)
Q Consensus 734 ~~~~~~~~~~~-~~~l~~l~~~Cl~~~p~~RPs~~evl~ 771 (792)
.. -.++... +.++..++.+||+.+|.+|+++.+|++
T Consensus 238 ~~--~~~p~~~~S~~~~~Li~~mL~~~P~~R~t~~~i~~ 274 (370)
T KOG0583|consen 238 GE--FKIPSYLLSPEARSLIEKMLVPDPSTRITLLEILE 274 (370)
T ss_pred CC--ccCCCCcCCHHHHHHHHHHcCCCcccCCCHHHHhh
Confidence 11 1122223 778899999999999999999999994
|
|
| >cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-38 Score=333.28 Aligned_cols=256 Identities=23% Similarity=0.349 Sum_probs=205.0
Q ss_pred HHhhhhhhcCccccceEEEeeecC--CCceEEEEEEcccccc-cchHHHHHHHHHhcccCCCCcccccceeccCCceEEE
Q 003836 501 VTRGFKEELGRGAFGTVYKGFVNM--GSSNHVAVKKLNSVFQ-DSEKEFKAEVNGIGQTHHKNLVRLLGYCDEGQNRLLV 577 (792)
Q Consensus 501 ~~~~~~~~lG~G~~g~Vy~g~~~~--~~~~~vavK~~~~~~~-~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~lV 577 (792)
....+.+.||+|+||.||+|.+.. ..+..+|+|.++.... .....+.+|+.++++++||||+++++++...+..++|
T Consensus 5 ~~~~~~~~ig~G~fg~V~~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv 84 (266)
T cd05064 5 KSIKIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRGFLAEALTLGQFDHSNIVRLEGVITRGNTMMIV 84 (266)
T ss_pred HHeEEeeeecccCCCeEEEEEEecCCCceeeEEEEecCCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEecCCCcEEE
Confidence 345567889999999999997643 3356899999876432 3346789999999999999999999999999999999
Q ss_pred EEeccCCCccccccCC-CCCchhHHHHHHHHHHHHHHHHhhccCCCeEecCCCCCcEEEcCCCCeEEeecCCCccccCCC
Q 003836 578 YEFMSNGTVASFLFGD-SKPNWKLRTEIAMGIAGGLFYLHEECCTQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLDQ 656 (792)
Q Consensus 578 ~E~~~~gsL~~~l~~~-~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dikp~NILl~~~~~~kl~Dfg~a~~~~~~~ 656 (792)
|||+++|+|.+++... ..+++..++.++.||+.||+|||+. +++||||||+|||++.++.+|++|||.+.......
T Consensus 85 ~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~i~~al~~lH~~---~iiH~dikp~nili~~~~~~~l~dfg~~~~~~~~~ 161 (266)
T cd05064 85 TEYMSNGALDSFLRKHEGQLVAGQLMGMLPGLASGMKYLSEM---GYVHKGLAAHKVLVNSDLVCKISGFRRLQEDKSEA 161 (266)
T ss_pred EEeCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHC---CEeeccccHhhEEEcCCCcEEECCCcccccccccc
Confidence 9999999999999764 5689999999999999999999998 99999999999999999999999999876543222
Q ss_pred CCccccccccCCcccccccccCCCCcccceehHHHHHHHHHh-cCcCCCcchhhhhhhhHHHHHHHhhcccchhHhhhch
Q 003836 657 SHTNTAIRGTKGYVAPEWFRNMPITVKVDVYSYGVLLLEIIC-LRRNIDNEISKVDKAILTDWAYDRYQERTLEALVEND 735 (792)
Q Consensus 657 ~~~~~~~~gt~~y~aPE~~~~~~~~~k~DV~S~Gv~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 735 (792)
........++..|+|||.+.+..++.++|||||||++||+++ |+.||........ + .. +...
T Consensus 162 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~p~~~~~~~~~---~-----~~---------~~~~ 224 (266)
T cd05064 162 IYTTMSGKSPVLWAAPEAIQYHHFSSASDVWSFGIVMWEVMSYGERPYWDMSGQDV---I-----KA---------VEDG 224 (266)
T ss_pred hhcccCCCCceeecCHHHHhhCCccchhHHHHHHHHHHHHhcCCCCCcCcCCHHHH---H-----HH---------HHCC
Confidence 111122335678999999999999999999999999999875 9999865432110 0 00 0111
Q ss_pred hcccCCHHHHHHHHHHHHHccccCCCCCCCHHhHHHHhccC
Q 003836 736 LEAMNNVTMLHRFVMVAFWCIQEDPSHRPTMRKVTQMLEGV 776 (792)
Q Consensus 736 ~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~L~~~ 776 (792)
.....+...+..+.+++.+||+.+|++||++++|++.|+++
T Consensus 225 ~~~~~~~~~~~~~~~li~~c~~~~p~~RP~~~~i~~~l~~~ 265 (266)
T cd05064 225 FRLPAPRNCPNLLHQLMLDCWQKERGERPRFSQIHSILSKM 265 (266)
T ss_pred CCCCCCCCCCHHHHHHHHHHcCCCchhCCCHHHHHHHHHhh
Confidence 11122334556788999999999999999999999999775
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor |
| >KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-38 Score=326.62 Aligned_cols=258 Identities=23% Similarity=0.315 Sum_probs=204.2
Q ss_pred hhhhhhcCccccceEEEeeecCCCceEEEEEEccccc-ccchHHHHHHHHHhcccCCCCcccccceeccCCceEEEEEec
Q 003836 503 RGFKEELGRGAFGTVYKGFVNMGSSNHVAVKKLNSVF-QDSEKEFKAEVNGIGQTHHKNLVRLLGYCDEGQNRLLVYEFM 581 (792)
Q Consensus 503 ~~~~~~lG~G~~g~Vy~g~~~~~~~~~vavK~~~~~~-~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~lV~E~~ 581 (792)
|.+.++||.|..++||+|... ..++.||||++.-.. ....+.+.+|+..+..++||||++++..|..+..+++||.||
T Consensus 28 YeL~e~IG~G~sa~V~~A~c~-p~~e~VAIK~inLEkc~~~ld~l~kE~~~msl~~HPNIv~~~~sFvv~~~LWvVmpfM 106 (516)
T KOG0582|consen 28 YELQEVIGVGASAVVYLARCI-PTNEVVAIKIINLEKCNNDLDALRKEVQTMSLIDHPNIVTYHCSFVVDSELWVVMPFM 106 (516)
T ss_pred eeEEEEEeccceeEeeeeeec-ccCCEEEEEEeehhhhhhhHHHHHHHHHHhhhcCCCCcceEEEEEEecceeEEeehhh
Confidence 456688999999999999654 455899999987433 223688999999999999999999999999999999999999
Q ss_pred cCCCccccccCC--CCCchhHHHHHHHHHHHHHHHHhhccCCCeEecCCCCCcEEEcCCCCeEEeecCCCccccCCCCCc
Q 003836 582 SNGTVASFLFGD--SKPNWKLRTEIAMGIAGGLFYLHEECCTQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLDQSHT 659 (792)
Q Consensus 582 ~~gsL~~~l~~~--~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dikp~NILl~~~~~~kl~Dfg~a~~~~~~~~~~ 659 (792)
.+||+.+.++.. ..+++..+..|.+++++||.|||++ |.||||||+.||||+++|.+||+|||.+..+.......
T Consensus 107 a~GS~ldIik~~~~~Gl~E~~Ia~iLre~LkaL~YLH~~---G~IHRdvKAgnILi~~dG~VkLadFgvsa~l~~~G~R~ 183 (516)
T KOG0582|consen 107 AGGSLLDIIKTYYPDGLEEASIATILREVLKALDYLHQN---GHIHRDVKAGNILIDSDGTVKLADFGVSASLFDSGDRQ 183 (516)
T ss_pred cCCcHHHHHHHHccccccHHHHHHHHHHHHHHHHHHHhc---CceecccccccEEEcCCCcEEEcCceeeeeecccCcee
Confidence 999999999754 5689999999999999999999999 99999999999999999999999999877654332211
Q ss_pred --c-ccccccCCccccccccc--CCCCcccceehHHHHHHHHHhcCcCCCcchhhhhhhhHHHHHHHhhcccchhHhhhc
Q 003836 660 --N-TAIRGTKGYVAPEWFRN--MPITVKVDVYSYGVLLLEIICLRRNIDNEISKVDKAILTDWAYDRYQERTLEALVEN 734 (792)
Q Consensus 660 --~-~~~~gt~~y~aPE~~~~--~~~~~k~DV~S~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 734 (792)
. ....||+.|||||+++. ..|+.|+||||||+...||.+|..||....... .++. .... ........
T Consensus 184 ~~rf~tfvgtp~wmAPEvl~q~~~GYdfKaDIwSfGITA~ELA~G~aPf~k~pPmk--vLl~-----tLqn-~pp~~~t~ 255 (516)
T KOG0582|consen 184 VTRFNTFVGTPCWMAPEVLMQQLHGYDFKADIWSFGITACELAHGHAPFSKYPPMK--VLLL-----TLQN-DPPTLLTS 255 (516)
T ss_pred eEeeccccCcccccChHHhhhcccCccchhhhhhhhHHHHHHhcCCCCcccCChHH--HHHH-----HhcC-CCCCcccc
Confidence 1 34679999999999543 569999999999999999999999997654321 1110 0000 00000011
Q ss_pred hhcccCCHHHHHHHHHHHHHccccCCCCCCCHHhHHHH
Q 003836 735 DLEAMNNVTMLHRFVMVAFWCIQEDPSHRPTMRKVTQM 772 (792)
Q Consensus 735 ~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~ 772 (792)
.+...........+.+++..||+.||.+|||++++++.
T Consensus 256 ~~~~d~~k~~~ksf~e~i~~CL~kDP~kRptAskLlkh 293 (516)
T KOG0582|consen 256 GLDKDEDKKFSKSFREMIALCLVKDPSKRPTASKLLKH 293 (516)
T ss_pred cCChHHhhhhcHHHHHHHHHHhhcCcccCCCHHHHhcc
Confidence 11222223445678899999999999999999999863
|
|
| >cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-38 Score=347.92 Aligned_cols=256 Identities=26% Similarity=0.392 Sum_probs=201.3
Q ss_pred HhhhhhhcCccccceEEEeee----cCCCceEEEEEEccccc-ccchHHHHHHHHHhccc-CCCCcccccceeccCCceE
Q 003836 502 TRGFKEELGRGAFGTVYKGFV----NMGSSNHVAVKKLNSVF-QDSEKEFKAEVNGIGQT-HHKNLVRLLGYCDEGQNRL 575 (792)
Q Consensus 502 ~~~~~~~lG~G~~g~Vy~g~~----~~~~~~~vavK~~~~~~-~~~~~~~~~Ei~~l~~l-~h~niv~l~g~~~~~~~~~ 575 (792)
...+.+.||+|+||.||++.. ..+++..||||+++... ....+.+.+|++++..+ +||||++++++|.+.+..+
T Consensus 36 ~~~~~~~LG~G~fG~V~~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~il~~l~~HpnIv~l~~~~~~~~~~~ 115 (375)
T cd05104 36 RLSFGKTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHINIVNLLGACTVGGPTL 115 (375)
T ss_pred HeehhheecCCccceEEEEEEeccccCccceeEEEEeccCCcCcHHHHHHHHHHHHHHHhcCCcceeeeeeeeccCCcce
Confidence 345678999999999999864 23445689999987533 23456788999999999 8999999999999999999
Q ss_pred EEEEeccCCCccccccCCC-------------------------------------------------------------
Q 003836 576 LVYEFMSNGTVASFLFGDS------------------------------------------------------------- 594 (792)
Q Consensus 576 lV~E~~~~gsL~~~l~~~~------------------------------------------------------------- 594 (792)
+||||+++|+|.+++....
T Consensus 116 lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 195 (375)
T cd05104 116 VITEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNEYMDMKPGVSYVVPTKADKRRSVRSGSYI 195 (375)
T ss_pred eeehhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchhhhhhhhcCCCcccccccccccccccccceec
Confidence 9999999999998885321
Q ss_pred --------------CCchhHHHHHHHHHHHHHHHHhhccCCCeEecCCCCCcEEEcCCCCeEEeecCCCccccCCCCCc-
Q 003836 595 --------------KPNWKLRTEIAMGIAGGLFYLHEECCTQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLDQSHT- 659 (792)
Q Consensus 595 --------------~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dikp~NILl~~~~~~kl~Dfg~a~~~~~~~~~~- 659 (792)
.+++..+.+++.||++||+|||+. +|+||||||+|||+++++.+||+|||+++.........
T Consensus 196 ~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~~~ 272 (375)
T cd05104 196 DQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLASK---NCIHRDLAARNILLTHGRITKICDFGLARDIRNDSNYVV 272 (375)
T ss_pred ccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCchhhEEEECCCcEEEecCccceeccCcccccc
Confidence 367788899999999999999998 99999999999999999999999999998664332211
Q ss_pred cccccccCCcccccccccCCCCcccceehHHHHHHHHHh-cCcCCCcchhhhhhhhHHHHHHHhhcccchhHhhhchhcc
Q 003836 660 NTAIRGTKGYVAPEWFRNMPITVKVDVYSYGVLLLEIIC-LRRNIDNEISKVDKAILTDWAYDRYQERTLEALVENDLEA 738 (792)
Q Consensus 660 ~~~~~gt~~y~aPE~~~~~~~~~k~DV~S~Gv~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 738 (792)
.....++..|+|||.+.+..++.++|||||||++|||++ |..||........ . ...+......
T Consensus 273 ~~~~~~~~~y~aPE~~~~~~~~~~sDi~slG~~l~ellt~g~~p~~~~~~~~~---~-------------~~~~~~~~~~ 336 (375)
T cd05104 273 KGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSSPYPGMPVDSK---F-------------YKMIKEGYRM 336 (375)
T ss_pred cCCCCCCcceeChhHhcCCCCCCCCCHHHHHHHHHHHHhcCCCCCCCCCchHH---H-------------HHHHHhCccC
Confidence 112335678999999999999999999999999999998 7888764322110 0 0011111111
Q ss_pred cCCHHHHHHHHHHHHHccccCCCCCCCHHhHHHHhccC
Q 003836 739 MNNVTMLHRFVMVAFWCIQEDPSHRPTMRKVTQMLEGV 776 (792)
Q Consensus 739 ~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~L~~~ 776 (792)
..+...+.++.+++.+||+.||++||++.||+++|++.
T Consensus 337 ~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~l~~~ 374 (375)
T cd05104 337 LSPECAPSEMYDIMKSCWDADPLKRPTFKQIVQLIEQQ 374 (375)
T ss_pred CCCCCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHhh
Confidence 11122345788999999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce |
| >KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-39 Score=308.31 Aligned_cols=260 Identities=23% Similarity=0.260 Sum_probs=211.6
Q ss_pred HhhhhhhcCccccceEEEeeecCCCceEEEEEEcccccccchHHHHHHHHHhcccCCCCcccccceeccCC-----ceEE
Q 003836 502 TRGFKEELGRGAFGTVYKGFVNMGSSNHVAVKKLNSVFQDSEKEFKAEVNGIGQTHHKNLVRLLGYCDEGQ-----NRLL 576 (792)
Q Consensus 502 ~~~~~~~lG~G~~g~Vy~g~~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~-----~~~l 576 (792)
++.+.+.||+|||+.||+++ ...+++.+|+|++.....+..+..++|++..++++|||+++++++...+. +.||
T Consensus 22 Ryri~~~LgeGGfsfv~LV~-~~s~~~~YAlKkI~c~~~~~~e~~~rEid~~rkf~s~~vl~l~dh~l~~~~D~~~~~yl 100 (302)
T KOG2345|consen 22 RYRIQRLLGEGGFSFVDLVK-GLSTGHLYALKKILCHSQEDIEEALREIDNHRKFNSPNVLRLVDHQLREEKDGKHEAYL 100 (302)
T ss_pred eEEEeeeecCCCceeeeeec-ccCcccchhhheeeccchHHHHHHHHHHHHHHhhCCcchHHHHHHHHHhhccCceeEEE
Confidence 35567889999999999986 44566789999999887888899999999999999999999999985443 4899
Q ss_pred EEEeccCCCccccccCC----CCCchhHHHHHHHHHHHHHHHHhhccCCCeEecCCCCCcEEEcCCCCeEEeecCCCccc
Q 003836 577 VYEFMSNGTVASFLFGD----SKPNWKLRTEIAMGIAGGLFYLHEECCTQIIHCDIKPQNILLDDHYNARISDFGLAKLL 652 (792)
Q Consensus 577 V~E~~~~gsL~~~l~~~----~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dikp~NILl~~~~~~kl~Dfg~a~~~ 652 (792)
+++|...|+|.+.+... ..+++.+++.|+.+|++||++||+. .++++||||||.|||+.+.+.++|.|||.+...
T Consensus 101 l~Pyy~~Gsl~d~i~~~k~kg~~~sE~~iL~if~gic~gL~~lH~~-~~~yAH~DiKP~NILls~~~~~vl~D~GS~~~a 179 (302)
T KOG2345|consen 101 LLPYYKRGSLLDEIERLKIKGNFVSEAQILWIFLGICRGLEALHEK-EPPYAHRDIKPANILLSDSGLPVLMDLGSATQA 179 (302)
T ss_pred EeehhccccHHHHHHHHhhcCCccCHHHHHHHHHHHHHHHHHHhcc-CCcccccCCCcceeEecCCCceEEEeccCcccc
Confidence 99999999999998653 4689999999999999999999998 235999999999999999999999999998765
Q ss_pred cCCCCC--------ccccccccCCcccccccc---cCCCCcccceehHHHHHHHHHhcCcCCCcchhhhhhhhHHHHHHH
Q 003836 653 TLDQSH--------TNTAIRGTKGYVAPEWFR---NMPITVKVDVYSYGVLLLEIICLRRNIDNEISKVDKAILTDWAYD 721 (792)
Q Consensus 653 ~~~~~~--------~~~~~~gt~~y~aPE~~~---~~~~~~k~DV~S~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~ 721 (792)
...-.. .-.....|..|+|||.+. +..+++++|||||||+||+|+.|..||+...+.....
T Consensus 180 ~i~i~~~~~a~~lQe~a~e~Ct~pyRAPELf~vk~~~ti~ertDIWSLGCtLYa~mf~~sPfe~~~~~GgSl-------- 251 (302)
T KOG2345|consen 180 PIQIEGSRQALRLQEWAEERCTIPYRAPELFNVKSHCTITERTDIWSLGCTLYAMMFGESPFERIYQQGGSL-------- 251 (302)
T ss_pred ceEeechHHHHHHHHHHHHhCCCcccCchheecccCcccccccchhhhhHHHHHHHHcCCcchHHhhcCCeE--------
Confidence 422111 112335799999999985 4568999999999999999999999997654422211
Q ss_pred hhcccchhHhhhchhcccCCHHHHHHHHHHHHHccccCCCCCCCHHhHHHHhccCc
Q 003836 722 RYQERTLEALVENDLEAMNNVTMLHRFVMVAFWCIQEDPSHRPTMRKVTQMLEGVV 777 (792)
Q Consensus 722 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~L~~~~ 777 (792)
..++....+........++.+.+++.+||+.||.+||++.+++..++.++
T Consensus 252 ------aLAv~n~q~s~P~~~~yse~l~~lik~mlqvdP~qRP~i~~ll~~~d~Li 301 (302)
T KOG2345|consen 252 ------ALAVQNAQISIPNSSRYSEALHQLIKSMLQVDPNQRPTIPELLSKLDDLI 301 (302)
T ss_pred ------EEeeeccccccCCCCCccHHHHHHHHHHhcCCcccCCCHHHHHHHHHhhc
Confidence 11222223333333347889999999999999999999999999998764
|
|
| >KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-38 Score=335.29 Aligned_cols=246 Identities=27% Similarity=0.405 Sum_probs=210.9
Q ss_pred hhhhhhcCccccceEEEeeecCCCceEEEEEEcccccc--cchHHHHHHHHHhcccCCCCcccccceeccCCceEEEEEe
Q 003836 503 RGFKEELGRGAFGTVYKGFVNMGSSNHVAVKKLNSVFQ--DSEKEFKAEVNGIGQTHHKNLVRLLGYCDEGQNRLLVYEF 580 (792)
Q Consensus 503 ~~~~~~lG~G~~g~Vy~g~~~~~~~~~vavK~~~~~~~--~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~lV~E~ 580 (792)
+.+.+.||+|.||.||||. .+++.+.||+|.+.+..+ ...+.+.+|++++++++|||||.++++|+...+.++|.||
T Consensus 4 yhv~e~iG~Gsfg~VYKgr-rK~t~~~vAik~i~K~gr~~k~l~~l~~ev~i~r~lkHpniv~m~esfEt~~~~~vVte~ 82 (808)
T KOG0597|consen 4 YHVYEMIGEGSFGRVYKGR-RKYTIQVVAIKFIDKSGRNEKELKNLRQEVRILRSLKHPNIVEMLESFETSAHLWVVTEY 82 (808)
T ss_pred hhHHHHhcCCccceeeecc-cccceeEEEEEEehhcCCchHHHHHHHHHHHHHHhcCCcchhhHHHhhcccceEEEEehh
Confidence 3455789999999999996 457788999999876433 3356789999999999999999999999999999999999
Q ss_pred ccCCCccccccCCCCCchhHHHHHHHHHHHHHHHHhhccCCCeEecCCCCCcEEEcCCCCeEEeecCCCccccCCCCCcc
Q 003836 581 MSNGTVASFLFGDSKPNWKLRTEIAMGIAGGLFYLHEECCTQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLDQSHTN 660 (792)
Q Consensus 581 ~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dikp~NILl~~~~~~kl~Dfg~a~~~~~~~~~~~ 660 (792)
+.+ +|..+|..+..+++..+..|+.++..||.|||+. +|+|||+||.||||+..+.+|++|||+|+.+.. .....
T Consensus 83 a~g-~L~~il~~d~~lpEe~v~~~a~~LVsaL~yLhs~---rilhrd~kPqniLl~~~~~~KlcdFg~Ar~m~~-~t~vl 157 (808)
T KOG0597|consen 83 AVG-DLFTILEQDGKLPEEQVRAIAYDLVSALYYLHSN---RILHRDMKPQNILLEKGGTLKLCDFGLARAMST-NTSVL 157 (808)
T ss_pred hhh-hHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhc---CcccccCCcceeeecCCCceeechhhhhhhccc-Cceee
Confidence 988 9999999999999999999999999999999999 999999999999999999999999999998764 33445
Q ss_pred ccccccCCcccccccccCCCCcccceehHHHHHHHHHhcCcCCCcchhhhhhhhHHHHHHHhhcccchhHhhhchhcccC
Q 003836 661 TAIRGTKGYVAPEWFRNMPITVKVDVYSYGVLLLEIICLRRNIDNEISKVDKAILTDWAYDRYQERTLEALVENDLEAMN 740 (792)
Q Consensus 661 ~~~~gt~~y~aPE~~~~~~~~~k~DV~S~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 740 (792)
+.+.|||-|||||...+.+|+..+|.||+||++||+++|+.||....-. . -++.+...... .
T Consensus 158 tsikGtPlYmAPElv~e~pyd~~sDlWslGcilYE~~~G~PPF~a~si~-------~---------Lv~~I~~d~v~--~ 219 (808)
T KOG0597|consen 158 TSIKGTPLYMAPELVEEQPYDHTSDLWSLGCILYELYVGQPPFYARSIT-------Q---------LVKSILKDPVK--P 219 (808)
T ss_pred eeccCcccccCHHHHcCCCccchhhHHHHHHHHHHHhcCCCCchHHHHH-------H---------HHHHHhcCCCC--C
Confidence 6678999999999999999999999999999999999999999643211 0 01112222222 2
Q ss_pred CHHHHHHHHHHHHHccccCCCCCCCHHhHHHH
Q 003836 741 NVTMLHRFVMVAFWCIQEDPSHRPTMRKVTQM 772 (792)
Q Consensus 741 ~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~ 772 (792)
+.+.+..+..++.-.|+.||..|.+-.+++..
T Consensus 220 p~~~S~~f~nfl~gLL~kdP~~RltW~~Ll~H 251 (808)
T KOG0597|consen 220 PSTASSSFVNFLQGLLIKDPAQRLTWTDLLGH 251 (808)
T ss_pred cccccHHHHHHHHHHhhcChhhcccHHHHhcC
Confidence 44778889999999999999999999998864
|
|
| >PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-38 Score=331.94 Aligned_cols=249 Identities=30% Similarity=0.498 Sum_probs=195.9
Q ss_pred hhhhcCccccceEEEeeec---CCCceEEEEEEcccccc-cchHHHHHHHHHhcccCCCCcccccceeccCCceEEEEEe
Q 003836 505 FKEELGRGAFGTVYKGFVN---MGSSNHVAVKKLNSVFQ-DSEKEFKAEVNGIGQTHHKNLVRLLGYCDEGQNRLLVYEF 580 (792)
Q Consensus 505 ~~~~lG~G~~g~Vy~g~~~---~~~~~~vavK~~~~~~~-~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~lV~E~ 580 (792)
+.+.||.|.||.||+|.+. ...+..|+||.++.... ...+.+.+|++.+++++||||++++|++.+.+..++|+||
T Consensus 3 ~~~~ig~G~fg~v~~~~~~~~~~~~~~~V~vk~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~g~~~~~~~~~lv~e~ 82 (259)
T PF07714_consen 3 LIKQIGEGSFGKVYRAEWKQKDNDKNQPVAVKILKPSSSEEEEEEFLNEIQILRKLRHPNIVKLYGFCIENEPLFLVMEY 82 (259)
T ss_dssp EEEEEEEESSEEEEEEEEESTTTSSEEEEEEEEESTTSSHHHHHHHHHHHHHHHTHSBTTBE-EEEEEESSSSEEEEEE-
T ss_pred EeeEEccCCCcEEEEEEEEcccCCCCEEEEEEEeccccccccceeeeecccccccccccccccccccccccccccccccc
Confidence 3467999999999999887 23457899999965433 3468899999999999999999999999988889999999
Q ss_pred ccCCCccccccCC--CCCchhHHHHHHHHHHHHHHHHhhccCCCeEecCCCCCcEEEcCCCCeEEeecCCCccccCCCC-
Q 003836 581 MSNGTVASFLFGD--SKPNWKLRTEIAMGIAGGLFYLHEECCTQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLDQS- 657 (792)
Q Consensus 581 ~~~gsL~~~l~~~--~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dikp~NILl~~~~~~kl~Dfg~a~~~~~~~~- 657 (792)
+++|+|.++|... ..+++.++.+|+.||++||+|||+. +++|+||+++|||+++++.+||+|||+++.......
T Consensus 83 ~~~g~L~~~L~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~---~iiH~~l~~~nill~~~~~~Kl~~f~~~~~~~~~~~~ 159 (259)
T PF07714_consen 83 CPGGSLDDYLKSKNKEPLSEQQRLSIAIQIAEALSYLHSN---NIIHGNLSPSNILLDSNGQVKLSDFGLSRPISEKSKY 159 (259)
T ss_dssp -TTEBHHHHHHHTCTTTSBHHHHHHHHHHHHHHHHHHHHT---TEEEST-SGGGEEEETTTEEEEESTTTGEETTTSSSE
T ss_pred cccccccccccccccccccccccccccccccccccccccc---ccccccccccccccccccccccccccccccccccccc
Confidence 9999999999876 6789999999999999999999998 999999999999999999999999999987632222
Q ss_pred CccccccccCCcccccccccCCCCcccceehHHHHHHHHHh-cCcCCCcchhhhhhhhHHHHHHHhhcccchhHhhhchh
Q 003836 658 HTNTAIRGTKGYVAPEWFRNMPITVKVDVYSYGVLLLEIIC-LRRNIDNEISKVDKAILTDWAYDRYQERTLEALVENDL 736 (792)
Q Consensus 658 ~~~~~~~gt~~y~aPE~~~~~~~~~k~DV~S~Gv~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 736 (792)
...........|+|||.+....++.++||||||+++|||++ |+.|+....... + ...+ ....
T Consensus 160 ~~~~~~~~~~~~~aPE~~~~~~~~~ksDVysfG~~l~ei~~~~~~p~~~~~~~~----~------------~~~~-~~~~ 222 (259)
T PF07714_consen 160 KNDSSQQLPLRYLAPEVLKDGEYTKKSDVYSFGMLLYEILTLGKFPFSDYDNEE----I------------IEKL-KQGQ 222 (259)
T ss_dssp EESTTSESGGGGS-HHHHHHSEESHHHHHHHHHHHHHHHHTTSSGTTTTSCHHH----H------------HHHH-HTTE
T ss_pred cccccccccccccccccccccccccccccccccccccccccccccccccccccc----c------------cccc-cccc
Confidence 22223446778999999999889999999999999999999 678875442110 0 0111 1111
Q ss_pred cccCCHHHHHHHHHHHHHccccCCCCCCCHHhHHHHh
Q 003836 737 EAMNNVTMLHRFVMVAFWCIQEDPSHRPTMRKVTQML 773 (792)
Q Consensus 737 ~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~L 773 (792)
....+...+..+.+++.+||+.+|++||++++|++.|
T Consensus 223 ~~~~~~~~~~~~~~li~~C~~~~p~~RPs~~~i~~~L 259 (259)
T PF07714_consen 223 RLPIPDNCPKDIYSLIQQCWSHDPEKRPSFQEILQEL 259 (259)
T ss_dssp ETTSBTTSBHHHHHHHHHHT-SSGGGS--HHHHHHHH
T ss_pred cceeccchhHHHHHHHHHHcCCChhhCcCHHHHHhcC
Confidence 2222334566788999999999999999999999976
|
Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A .... |
| >KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-38 Score=337.20 Aligned_cols=242 Identities=24% Similarity=0.317 Sum_probs=207.5
Q ss_pred hhhhcCccccceEEEeeecCCCceEEEEEEccccc---ccchHHHHHHHHHhcccCCCCcccccceeccCCceEEEEEec
Q 003836 505 FKEELGRGAFGTVYKGFVNMGSSNHVAVKKLNSVF---QDSEKEFKAEVNGIGQTHHKNLVRLLGYCDEGQNRLLVYEFM 581 (792)
Q Consensus 505 ~~~~lG~G~~g~Vy~g~~~~~~~~~vavK~~~~~~---~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~lV~E~~ 581 (792)
+.+.||.|+-|.|-+|+. ..+++.+|||++.+.. ......+++||.+|+.+.|||+++++++..+..++|||.||+
T Consensus 16 LgkTLG~Gstg~vrlakh-~~TGqlaaiKii~k~~~~s~s~~~~IerEIviMkLi~HpnVl~LydVwe~~~~lylvlEyv 94 (786)
T KOG0588|consen 16 LGKTLGKGSTGCVRLAKH-AETGQLAAIKIIPKRSELSSSQPAGIEREIVIMKLIEHPNVLRLYDVWENKQHLYLVLEYV 94 (786)
T ss_pred ccccccCCCCceehhhhc-ccccceeEEEeeccccccccccccchhhhhHHHHHhcCCCeeeeeeeeccCceEEEEEEec
Confidence 457899999999999975 4678999999997652 223456899999999999999999999999999999999999
Q ss_pred cCCCccccccCCCCCchhHHHHHHHHHHHHHHHHhhccCCCeEecCCCCCcEEEcCCCCeEEeecCCCccccCCCCCccc
Q 003836 582 SNGTVASFLFGDSKPNWKLRTEIAMGIAGGLFYLHEECCTQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLDQSHTNT 661 (792)
Q Consensus 582 ~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dikp~NILl~~~~~~kl~Dfg~a~~~~~~~~~~~~ 661 (792)
++|-|.++|..++.+.+....+++.||..|+.|+|.. +|+||||||+|+|||..+++||+|||+|.+-.. .....
T Consensus 95 ~gGELFdylv~kG~l~e~eaa~ff~QIi~gv~yCH~~---~icHRDLKpENlLLd~~~nIKIADFGMAsLe~~--gklLe 169 (786)
T KOG0588|consen 95 PGGELFDYLVRKGPLPEREAAHFFRQILDGVSYCHAF---NICHRDLKPENLLLDVKNNIKIADFGMASLEVP--GKLLE 169 (786)
T ss_pred CCchhHHHHHhhCCCCCHHHHHHHHHHHHHHHHHhhh---cceeccCCchhhhhhcccCEeeeccceeecccC--Ccccc
Confidence 9999999999999999999999999999999999999 999999999999999999999999999986432 23344
Q ss_pred cccccCCcccccccccCCCC-cccceehHHHHHHHHHhcCcCCCcchhhhhhhhHHHHHHHhhcccchhHhhhchhc--c
Q 003836 662 AIRGTKGYVAPEWFRNMPIT-VKVDVYSYGVLLLEIICLRRNIDNEISKVDKAILTDWAYDRYQERTLEALVENDLE--A 738 (792)
Q Consensus 662 ~~~gt~~y~aPE~~~~~~~~-~k~DV~S~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~ 738 (792)
+.+|+|.|.|||++++.+|+ .++||||.|||||.|+||+.||++..- ..++..-.. -
T Consensus 170 TSCGSPHYA~PEIV~G~pYdG~~sDVWSCGVILfALLtG~LPFdDdNi--------------------r~LLlKV~~G~f 229 (786)
T KOG0588|consen 170 TSCGSPHYAAPEIVSGRPYDGRPSDVWSCGVILFALLTGKLPFDDDNI--------------------RVLLLKVQRGVF 229 (786)
T ss_pred ccCCCcccCCchhhcCCCCCCCccccchhHHHHHHHHhCCCCCCCccH--------------------HHHHHHHHcCcc
Confidence 56899999999999999985 789999999999999999999984311 111111111 1
Q ss_pred cCCHHHHHHHHHHHHHccccCCCCCCCHHhHHHH
Q 003836 739 MNNVTMLHRFVMVAFWCIQEDPSHRPTMRKVTQM 772 (792)
Q Consensus 739 ~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~ 772 (792)
+.+...+.++.+|+.+|+..||+.|.|++||++.
T Consensus 230 ~MPs~Is~eaQdLLr~ml~VDp~~RiT~~eI~kH 263 (786)
T KOG0588|consen 230 EMPSNISSEAQDLLRRMLDVDPSTRITTEEILKH 263 (786)
T ss_pred cCCCcCCHHHHHHHHHHhccCccccccHHHHhhC
Confidence 2245567888999999999999999999999986
|
|
| >cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-38 Score=345.11 Aligned_cols=257 Identities=27% Similarity=0.406 Sum_probs=201.6
Q ss_pred HhhhhhhcCccccceEEEeeec----CCCceEEEEEEccccc-ccchHHHHHHHHHhccc-CCCCcccccceeccCCceE
Q 003836 502 TRGFKEELGRGAFGTVYKGFVN----MGSSNHVAVKKLNSVF-QDSEKEFKAEVNGIGQT-HHKNLVRLLGYCDEGQNRL 575 (792)
Q Consensus 502 ~~~~~~~lG~G~~g~Vy~g~~~----~~~~~~vavK~~~~~~-~~~~~~~~~Ei~~l~~l-~h~niv~l~g~~~~~~~~~ 575 (792)
.+.+.+.||+|+||.||++... ..+...||+|++.... ......+.+|+++++.+ +|+||++++++|.+....+
T Consensus 39 ~~~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~~h~nIv~~~~~~~~~~~~~ 118 (374)
T cd05106 39 NLQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASAHTDEREALMSELKILSHLGQHKNIVNLLGACTHGGPVL 118 (374)
T ss_pred HceehheecCCCcccEEEEEEecCCcccccceeEEEeccCCCCHHHHHHHHHHHHHHHhhccCCceeeEeeEecCCCCeE
Confidence 3456788999999999998742 2234579999997543 33345788999999999 8999999999999999999
Q ss_pred EEEEeccCCCccccccCC--------------------------------------------------------------
Q 003836 576 LVYEFMSNGTVASFLFGD-------------------------------------------------------------- 593 (792)
Q Consensus 576 lV~E~~~~gsL~~~l~~~-------------------------------------------------------------- 593 (792)
+||||+++|+|.++++..
T Consensus 119 lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 198 (374)
T cd05106 119 VITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFSSQGSDTYVEMRPVSSSSSQSSDSK 198 (374)
T ss_pred EeHhhccCCcHHHHHHhhhhhhccccccccccccccccccccchhcccccccccccccccccccccCCcccccccccccc
Confidence 999999999999887532
Q ss_pred --------CCCchhHHHHHHHHHHHHHHHHhhccCCCeEecCCCCCcEEEcCCCCeEEeecCCCccccCCCCCc-ccccc
Q 003836 594 --------SKPNWKLRTEIAMGIAGGLFYLHEECCTQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLDQSHT-NTAIR 664 (792)
Q Consensus 594 --------~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dikp~NILl~~~~~~kl~Dfg~a~~~~~~~~~~-~~~~~ 664 (792)
..+++..+.+++.||+.||+|||+. +|+||||||+|||+++++.+||+|||+++......... .....
T Consensus 199 ~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~---giiHrDLkp~Nil~~~~~~~kL~DfGla~~~~~~~~~~~~~~~~ 275 (374)
T cd05106 199 DEEDTEDSWPLDLDDLLRFSSQVAQGMDFLASK---NCIHRDVAARNVLLTDGRVAKICDFGLARDIMNDSNYVVKGNAR 275 (374)
T ss_pred chhccCCCCCcCHHHHHHHHHHHHHHHHHHHHC---CEEeccCchheEEEeCCCeEEEeeceeeeeccCCcceeeccCCC
Confidence 1357778899999999999999998 99999999999999999999999999998654332211 11233
Q ss_pred ccCCcccccccccCCCCcccceehHHHHHHHHHh-cCcCCCcchhhhhhhhHHHHHHHhhcccchhHhhhchhcccCCHH
Q 003836 665 GTKGYVAPEWFRNMPITVKVDVYSYGVLLLEIIC-LRRNIDNEISKVDKAILTDWAYDRYQERTLEALVENDLEAMNNVT 743 (792)
Q Consensus 665 gt~~y~aPE~~~~~~~~~k~DV~S~Gv~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 743 (792)
++..|+|||++.+..++.++|||||||++|||++ |+.||........ ....+........+..
T Consensus 276 ~~~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt~G~~Pf~~~~~~~~----------------~~~~~~~~~~~~~~~~ 339 (374)
T cd05106 276 LPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGKSPYPGILVNSK----------------FYKMVKRGYQMSRPDF 339 (374)
T ss_pred CccceeCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCccccccHH----------------HHHHHHcccCccCCCC
Confidence 5678999999998899999999999999999997 9999865422110 0011111111111222
Q ss_pred HHHHHHHHHHHccccCCCCCCCHHhHHHHhccCc
Q 003836 744 MLHRFVMVAFWCIQEDPSHRPTMRKVTQMLEGVV 777 (792)
Q Consensus 744 ~~~~l~~l~~~Cl~~~p~~RPs~~evl~~L~~~~ 777 (792)
.+.++.+++.+||+.+|++||++.+|+++|++++
T Consensus 340 ~~~~l~~li~~cl~~dp~~RPs~~~l~~~l~~~~ 373 (374)
T cd05106 340 APPEIYSIMKMCWNLEPTERPTFSQISQLIQRQL 373 (374)
T ss_pred CCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHh
Confidence 3467889999999999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti |
| >KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-39 Score=329.38 Aligned_cols=245 Identities=24% Similarity=0.349 Sum_probs=208.4
Q ss_pred hhhcCccccceEEEeeecCCCceEEEEEEccccc-ccchHHHHHHHHHhcccCCCCcccccceeccCCceEEEEEeccCC
Q 003836 506 KEELGRGAFGTVYKGFVNMGSSNHVAVKKLNSVF-QDSEKEFKAEVNGIGQTHHKNLVRLLGYCDEGQNRLLVYEFMSNG 584 (792)
Q Consensus 506 ~~~lG~G~~g~Vy~g~~~~~~~~~vavK~~~~~~-~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~lV~E~~~~g 584 (792)
.+.||+|.||.||||.. ..+++.||+|++.-.. .+..++++.|+.++..++++||.+++|.+..+..++++||||.+|
T Consensus 18 ~~~IgrGsfG~Vyk~~d-~~t~k~vAiKii~Le~~~deIediqqei~~Ls~~~~~~it~yygsyl~g~~LwiiMey~~gG 96 (467)
T KOG0201|consen 18 LELIGRGSFGEVYKAID-NKTKKVVAIKIIDLEEAEDEIEDIQQEISVLSQCDSPNITEYYGSYLKGTKLWIIMEYCGGG 96 (467)
T ss_pred chhccccccceeeeeee-ccccceEEEEEechhhcchhhHHHHHHHHHHHhcCcchHHhhhhheeecccHHHHHHHhcCc
Confidence 36899999999999964 4667899999997543 445678999999999999999999999999999999999999999
Q ss_pred CccccccCCCCCchhHHHHHHHHHHHHHHHHhhccCCCeEecCCCCCcEEEcCCCCeEEeecCCCccccCCCCCcccccc
Q 003836 585 TVASFLFGDSKPNWKLRTEIAMGIAGGLFYLHEECCTQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLDQSHTNTAIR 664 (792)
Q Consensus 585 sL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dikp~NILl~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~ 664 (792)
++.+.|.....+++..+.-|++++..||.|||.+ +.+|||||+.|||+..+|.+||+|||++-.+....... ..++
T Consensus 97 sv~~lL~~~~~~~E~~i~~ilre~l~~l~ylH~~---~kiHrDIKaanil~s~~g~vkl~DfgVa~ql~~~~~rr-~tfv 172 (467)
T KOG0201|consen 97 SVLDLLKSGNILDEFEIAVILREVLKGLDYLHSE---KKIHRDIKAANILLSESGDVKLADFGVAGQLTNTVKRR-KTFV 172 (467)
T ss_pred chhhhhccCCCCccceeeeehHHHHHHhhhhhhc---ceecccccccceeEeccCcEEEEecceeeeeechhhcc-cccc
Confidence 9999998888788999999999999999999999 99999999999999999999999999998877655554 5677
Q ss_pred ccCCcccccccccCCCCcccceehHHHHHHHHHhcCcCCCcchhhhhhhhHHHHHHHhhcccchhHhhhchhcccCCHHH
Q 003836 665 GTKGYVAPEWFRNMPITVKVDVYSYGVLLLEIICLRRNIDNEISKVDKAILTDWAYDRYQERTLEALVENDLEAMNNVTM 744 (792)
Q Consensus 665 gt~~y~aPE~~~~~~~~~k~DV~S~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 744 (792)
||+.|||||++....|+.|+||||||++.+||.+|..|+...........+ -....+..+...
T Consensus 173 GTPfwMAPEVI~~~~Y~~KADIWSLGITaiEla~GePP~s~~hPmrvlflI-----------------pk~~PP~L~~~~ 235 (467)
T KOG0201|consen 173 GTPFWMAPEVIKQSGYDTKADIWSLGITAIELAKGEPPHSKLHPMRVLFLI-----------------PKSAPPRLDGDF 235 (467)
T ss_pred ccccccchhhhccccccchhhhhhhhHHHHHHhcCCCCCcccCcceEEEec-----------------cCCCCCcccccc
Confidence 999999999999889999999999999999999999998765432111111 111111122245
Q ss_pred HHHHHHHHHHccccCCCCCCCHHhHHHH
Q 003836 745 LHRFVMVAFWCIQEDPSHRPTMRKVTQM 772 (792)
Q Consensus 745 ~~~l~~l~~~Cl~~~p~~RPs~~evl~~ 772 (792)
+..+.+++..||+.||+.||++.++++.
T Consensus 236 S~~~kEFV~~CL~k~P~~RpsA~~LLKh 263 (467)
T KOG0201|consen 236 SPPFKEFVEACLDKNPEFRPSAKELLKH 263 (467)
T ss_pred CHHHHHHHHHHhhcCcccCcCHHHHhhh
Confidence 6678899999999999999999999863
|
|
| >cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-37 Score=336.35 Aligned_cols=243 Identities=23% Similarity=0.274 Sum_probs=199.3
Q ss_pred hhcCccccceEEEeeecCCCceEEEEEEccccc---ccchHHHHHHHHHhcccCCCCcccccceeccCCceEEEEEeccC
Q 003836 507 EELGRGAFGTVYKGFVNMGSSNHVAVKKLNSVF---QDSEKEFKAEVNGIGQTHHKNLVRLLGYCDEGQNRLLVYEFMSN 583 (792)
Q Consensus 507 ~~lG~G~~g~Vy~g~~~~~~~~~vavK~~~~~~---~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~lV~E~~~~ 583 (792)
+.||+|+||.||++... .+++.+|+|++.... ......+.+|+.++++++||||+++++++...+..++||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~-~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~ 79 (323)
T cd05571 1 KLLGKGTFGKVILVREK-ATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTALKYSFQTHDRLCFVMEYANG 79 (323)
T ss_pred CeeeeCCCeEEEEEEEC-CCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCCEEEEEEcCCEEEEEEeCCCC
Confidence 36999999999999754 456789999987532 23345678899999999999999999999999999999999999
Q ss_pred CCccccccCCCCCchhHHHHHHHHHHHHHHHHhhccCCCeEecCCCCCcEEEcCCCCeEEeecCCCccccCCCCCccccc
Q 003836 584 GTVASFLFGDSKPNWKLRTEIAMGIAGGLFYLHEECCTQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLDQSHTNTAI 663 (792)
Q Consensus 584 gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dikp~NILl~~~~~~kl~Dfg~a~~~~~~~~~~~~~~ 663 (792)
|+|.+++.....+++..+..++.||+.||+|||+. +|+||||||+|||++.++.+||+|||+++..... .......
T Consensus 80 ~~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~lH~~---~ivHrDlkp~NIll~~~~~~kl~DfG~a~~~~~~-~~~~~~~ 155 (323)
T cd05571 80 GELFFHLSRERVFSEDRARFYGAEIVSALGYLHSC---DVVYRDLKLENLMLDKDGHIKITDFGLCKEGISD-GATMKTF 155 (323)
T ss_pred CcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhC---CeEeCCCCHHHEEECCCCCEEEeeCCCCcccccC-CCcccce
Confidence 99999998888899999999999999999999998 9999999999999999999999999999753222 1222345
Q ss_pred cccCCcccccccccCCCCcccceehHHHHHHHHHhcCcCCCcchhhhhhhhHHHHHHHhhcccchhHhhhchhcccCCHH
Q 003836 664 RGTKGYVAPEWFRNMPITVKVDVYSYGVLLLEIICLRRNIDNEISKVDKAILTDWAYDRYQERTLEALVENDLEAMNNVT 743 (792)
Q Consensus 664 ~gt~~y~aPE~~~~~~~~~k~DV~S~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 743 (792)
.||+.|+|||.+.+..++.++|||||||++|||++|+.||........ . ..+.... ...+..
T Consensus 156 ~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~---~-------------~~~~~~~--~~~p~~ 217 (323)
T cd05571 156 CGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKL---F-------------ELILMEE--IRFPRT 217 (323)
T ss_pred ecCccccChhhhcCCCCCccccCcccchhhhhhhcCCCCCCCCCHHHH---H-------------HHHHcCC--CCCCCC
Confidence 699999999999999999999999999999999999999965422110 0 0000010 112233
Q ss_pred HHHHHHHHHHHccccCCCCCC-----CHHhHHHH
Q 003836 744 MLHRFVMVAFWCIQEDPSHRP-----TMRKVTQM 772 (792)
Q Consensus 744 ~~~~l~~l~~~Cl~~~p~~RP-----s~~evl~~ 772 (792)
...++.+++.+||+.||++|| ++.++++.
T Consensus 218 ~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~h 251 (323)
T cd05571 218 LSPEAKSLLAGLLKKDPKQRLGGGPEDAKEIMEH 251 (323)
T ss_pred CCHHHHHHHHHHccCCHHHcCCCCCCCHHHHHcC
Confidence 456788999999999999999 78888763
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be |
| >cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-37 Score=328.91 Aligned_cols=264 Identities=19% Similarity=0.216 Sum_probs=201.9
Q ss_pred hhhhhcCccccceEEEeeecCCCceEEEEEEccccc--ccchHHHHHHHHHhcccCCCCcccccceeccCCceEEEEEec
Q 003836 504 GFKEELGRGAFGTVYKGFVNMGSSNHVAVKKLNSVF--QDSEKEFKAEVNGIGQTHHKNLVRLLGYCDEGQNRLLVYEFM 581 (792)
Q Consensus 504 ~~~~~lG~G~~g~Vy~g~~~~~~~~~vavK~~~~~~--~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~lV~E~~ 581 (792)
.+.+.||+|+||.||++... .+++.+|+|++.... ....+.+.+|+.++++++|+||+++++++.+.+..++||||+
T Consensus 4 ~~~~~lg~g~~~~v~~~~~~-~~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 82 (287)
T cd07848 4 EVLGVVGEGAYGVVLKCRHK-ETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQENIVELKEAFRRRGKLYLVFEYV 82 (287)
T ss_pred eEEEEecccCCEEEEEEEEC-CCCcEEEEEEEecccccccchhhHHHHHHHHHhCCCccccchhhhEecCCEEEEEEecC
Confidence 45578999999999999754 456789999987532 233467889999999999999999999999999999999999
Q ss_pred cCCCccccccCCCCCchhHHHHHHHHHHHHHHHHhhccCCCeEecCCCCCcEEEcCCCCeEEeecCCCccccCCCCCccc
Q 003836 582 SNGTVASFLFGDSKPNWKLRTEIAMGIAGGLFYLHEECCTQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLDQSHTNT 661 (792)
Q Consensus 582 ~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dikp~NILl~~~~~~kl~Dfg~a~~~~~~~~~~~~ 661 (792)
+++.+..+......+++..+..++.||+.||.|||+. +|+||||||+|||++.++.+||+|||+++...........
T Consensus 83 ~~~~l~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~---~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~ 159 (287)
T cd07848 83 EKNMLELLEEMPNGVPPEKVRSYIYQLIKAIHWCHKN---DIVHRDIKPENLLISHNDVLKLCDFGFARNLSEGSNANYT 159 (287)
T ss_pred CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCcEEEeeccCccccccccccccc
Confidence 9987776655556788999999999999999999998 9999999999999999999999999999876543333334
Q ss_pred cccccCCcccccccccCCCCcccceehHHHHHHHHHhcCcCCCcchhhhhhhhHHHHH--------HHhhcccchhHhhh
Q 003836 662 AIRGTKGYVAPEWFRNMPITVKVDVYSYGVLLLEIICLRRNIDNEISKVDKAILTDWA--------YDRYQERTLEALVE 733 (792)
Q Consensus 662 ~~~gt~~y~aPE~~~~~~~~~k~DV~S~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~--------~~~~~~~~~~~~~~ 733 (792)
...|++.|+|||.+.+..++.++|||||||++|||++|+.||................ ..............
T Consensus 160 ~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (287)
T cd07848 160 EYVATRWYRSPELLLGAPYGKAVDMWSVGCILGELSDGQPLFPGESEIDQLFTIQKVLGPLPAEQMKLFYSNPRFHGLRF 239 (287)
T ss_pred ccccccccCCcHHHcCCCCCCchhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhCCCCHHHHHhhhccchhccccc
Confidence 4568999999999998889999999999999999999999997543221111110000 00000000000000
Q ss_pred chh------cccCCHHHHHHHHHHHHHccccCCCCCCCHHhHHH
Q 003836 734 NDL------EAMNNVTMLHRFVMVAFWCIQEDPSHRPTMRKVTQ 771 (792)
Q Consensus 734 ~~~------~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~ 771 (792)
+.. ........+..+.+++.+||+.||++|||++|+++
T Consensus 240 ~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~~P~~R~s~~~~l~ 283 (287)
T cd07848 240 PAVNHPQSLERRYLGILSGVLLDLMKNLLKLNPTDRYLTEQCLN 283 (287)
T ss_pred CcccCcccHHHhhhcccCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence 000 00011124567999999999999999999999987
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes |
| >KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-37 Score=321.08 Aligned_cols=254 Identities=23% Similarity=0.303 Sum_probs=203.5
Q ss_pred HhhhhhhcCccccceEEEeeecCCCceEEEEEEccccccc--------------chHHHHHHHHHhcccCCCCcccccce
Q 003836 502 TRGFKEELGRGAFGTVYKGFVNMGSSNHVAVKKLNSVFQD--------------SEKEFKAEVNGIGQTHHKNLVRLLGY 567 (792)
Q Consensus 502 ~~~~~~~lG~G~~g~Vy~g~~~~~~~~~vavK~~~~~~~~--------------~~~~~~~Ei~~l~~l~h~niv~l~g~ 567 (792)
.+.+.++||+|.||.|-+|. +..+++.||||++.+.... ..+...+||.+|++++|+|||+|+.+
T Consensus 98 qy~l~~eiG~G~yGkVkLar-~~~~~~l~AiKil~K~~~~~~~~~~~~~a~~~~~~ekv~~EIailKkl~H~nVV~LiEv 176 (576)
T KOG0585|consen 98 QYELIKEIGSGQYGKVKLAR-DEVDGKLYAIKILPKKELRRQYGFPRQPAMKLMPIEKVRREIAILKKLHHPNVVKLIEV 176 (576)
T ss_pred heehhhhhcCCccceEEEEe-ecCCCcEEEEEeechhhhhhhcccccccccccCcHHHHHHHHHHHHhcCCcCeeEEEEe
Confidence 34556789999999999995 4566789999999753211 12478899999999999999999999
Q ss_pred eccC--CceEEEEEeccCCCccccccCCCCCchhHHHHHHHHHHHHHHHHhhccCCCeEecCCCCCcEEEcCCCCeEEee
Q 003836 568 CDEG--QNRLLVYEFMSNGTVASFLFGDSKPNWKLRTEIAMGIAGGLFYLHEECCTQIIHCDIKPQNILLDDHYNARISD 645 (792)
Q Consensus 568 ~~~~--~~~~lV~E~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dikp~NILl~~~~~~kl~D 645 (792)
..+. +.+|||+|||..|.+...=.....+.+.+.+++++++..||+|||.+ +||||||||+|+||+++|++||+|
T Consensus 177 LDDP~s~~~YlVley~s~G~v~w~p~d~~els~~~Ar~ylrDvv~GLEYLH~Q---giiHRDIKPsNLLl~~~g~VKIsD 253 (576)
T KOG0585|consen 177 LDDPESDKLYLVLEYCSKGEVKWCPPDKPELSEQQARKYLRDVVLGLEYLHYQ---GIIHRDIKPSNLLLSSDGTVKISD 253 (576)
T ss_pred ecCcccCceEEEEEeccCCccccCCCCcccccHHHHHHHHHHHHHHHHHHHhc---CeeccccchhheEEcCCCcEEeec
Confidence 9765 57999999999998877655444589999999999999999999999 999999999999999999999999
Q ss_pred cCCCccccCCCCC----ccccccccCCcccccccccCC----CCcccceehHHHHHHHHHhcCcCCCcchhhhhhhhHHH
Q 003836 646 FGLAKLLTLDQSH----TNTAIRGTKGYVAPEWFRNMP----ITVKVDVYSYGVLLLEIICLRRNIDNEISKVDKAILTD 717 (792)
Q Consensus 646 fg~a~~~~~~~~~----~~~~~~gt~~y~aPE~~~~~~----~~~k~DV~S~Gv~l~el~tg~~p~~~~~~~~~~~~~~~ 717 (792)
||.+..+...... ......|||.|+|||...++. .+.+.||||+||+||-|+.|+.||.......
T Consensus 254 FGVs~~~~~~~~~~~d~~L~~tvGTPAF~APE~c~~~~~~~~~g~a~DiWalGVTLYCllfG~~PF~~~~~~~------- 326 (576)
T KOG0585|consen 254 FGVSNEFPQGSDEGSDDQLSRTVGTPAFFAPELCSGGNSFSYSGFALDIWALGVTLYCLLFGQLPFFDDFELE------- 326 (576)
T ss_pred cceeeecccCCccccHHHHhhcCCCccccchHhhcCCCCccccchhhhhhhhhhhHHHhhhccCCcccchHHH-------
Confidence 9999876322111 122357999999999987632 3578999999999999999999997653321
Q ss_pred HHHHhhcccchhHhhhchhcccCCHHHHHHHHHHHHHccccCCCCCCCHHhHHHHhcc
Q 003836 718 WAYDRYQERTLEALVENDLEAMNNVTMLHRFVMVAFWCIQEDPSHRPTMRKVTQMLEG 775 (792)
Q Consensus 718 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~L~~ 775 (792)
....++...+.-...++..+++.+|+.++|+.||+.|.+..+|....--
T Consensus 327 ---------l~~KIvn~pL~fP~~pe~~e~~kDli~~lL~KdP~~Ri~l~~ik~Hpwv 375 (576)
T KOG0585|consen 327 ---------LFDKIVNDPLEFPENPEINEDLKDLIKRLLEKDPEQRITLPDIKLHPWV 375 (576)
T ss_pred ---------HHHHHhcCcccCCCcccccHHHHHHHHHHhhcChhheeehhhheeccee
Confidence 1123344444444444667889999999999999999999999886543
|
|
| >cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-37 Score=332.86 Aligned_cols=260 Identities=24% Similarity=0.358 Sum_probs=198.6
Q ss_pred hhhhhhcCccccceEEEeeecC---------------CCceEEEEEEccccc-ccchHHHHHHHHHhcccCCCCcccccc
Q 003836 503 RGFKEELGRGAFGTVYKGFVNM---------------GSSNHVAVKKLNSVF-QDSEKEFKAEVNGIGQTHHKNLVRLLG 566 (792)
Q Consensus 503 ~~~~~~lG~G~~g~Vy~g~~~~---------------~~~~~vavK~~~~~~-~~~~~~~~~Ei~~l~~l~h~niv~l~g 566 (792)
+.+.++||+|+||.||++..+. +.+..||+|.+.... .....++.+|++++.+++||||+++++
T Consensus 7 ~~~~~~lg~G~fg~V~~~~~~~~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~ 86 (304)
T cd05096 7 LLFKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANKNARNDFLKEVKILSRLKDPNIIRLLG 86 (304)
T ss_pred CeeeeEecccCCeEEEEEEeccCcccccccccccccCCcceEEEEEEecCCCCHHHHHHHHHHHHHHhhcCCCCeeEEEE
Confidence 4456789999999999997532 234579999987543 334567999999999999999999999
Q ss_pred eeccCCceEEEEEeccCCCccccccCC-------------------CCCchhHHHHHHHHHHHHHHHHhhccCCCeEecC
Q 003836 567 YCDEGQNRLLVYEFMSNGTVASFLFGD-------------------SKPNWKLRTEIAMGIAGGLFYLHEECCTQIIHCD 627 (792)
Q Consensus 567 ~~~~~~~~~lV~E~~~~gsL~~~l~~~-------------------~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~d 627 (792)
++.+.+..++||||+++|+|.+++... ..+++..+.+++.||+.||+|||+. +|+|||
T Consensus 87 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~---~ivH~d 163 (304)
T cd05096 87 VCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSSL---NFVHRD 163 (304)
T ss_pred EEecCCceEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHHC---CccccC
Confidence 999999999999999999999988542 1357788999999999999999998 999999
Q ss_pred CCCCcEEEcCCCCeEEeecCCCccccCCCCC-ccccccccCCcccccccccCCCCcccceehHHHHHHHHHh--cCcCCC
Q 003836 628 IKPQNILLDDHYNARISDFGLAKLLTLDQSH-TNTAIRGTKGYVAPEWFRNMPITVKVDVYSYGVLLLEIIC--LRRNID 704 (792)
Q Consensus 628 ikp~NILl~~~~~~kl~Dfg~a~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~k~DV~S~Gv~l~el~t--g~~p~~ 704 (792)
|||+|||+++++.+||+|||+++........ ......++..|+|||.+....++.++||||||+++|||++ +..||.
T Consensus 164 lkp~Nill~~~~~~kl~DfG~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~p~~ 243 (304)
T cd05096 164 LATRNCLVGENLTIKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAWECILMGKFTTASDVWAFGVTLWEILMLCKEQPYG 243 (304)
T ss_pred cchhheEEcCCccEEECCCccceecccCceeEecCcCCCCccccCHHHHhcCCCCchhhhHHHHHHHHHHHHccCCCCCC
Confidence 9999999999999999999999865433221 1222345788999999988899999999999999999997 455665
Q ss_pred cchhhhhhhhHHHHHHHhhcccchhHhhhchhcccCCHHHHHHHHHHHHHccccCCCCCCCHHhHHHHhcc
Q 003836 705 NEISKVDKAILTDWAYDRYQERTLEALVENDLEAMNNVTMLHRFVMVAFWCIQEDPSHRPTMRKVTQMLEG 775 (792)
Q Consensus 705 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~L~~ 775 (792)
....... + ............ ......+...+..+.+++.+||+.+|++|||++||.+.|++
T Consensus 244 ~~~~~~~---~-~~~~~~~~~~~~------~~~~~~~~~~~~~~~~li~~cl~~~p~~RPs~~~i~~~l~~ 304 (304)
T cd05096 244 ELTDEQV---I-ENAGEFFRDQGR------QVYLFRPPPCPQGLYELMLQCWSRDCRERPSFSDIHAFLTE 304 (304)
T ss_pred cCCHHHH---H-HHHHHHhhhccc------cccccCCCCCCHHHHHHHHHHccCCchhCcCHHHHHHHHhC
Confidence 4322111 0 000000000000 00011122345678999999999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k |
| >KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-38 Score=332.94 Aligned_cols=260 Identities=27% Similarity=0.393 Sum_probs=220.1
Q ss_pred HHHHHHHhhhhhhcCccccceEEEeeecCCCceEEEEEEcccccccchHHHHHHHHHhcccCCCCcccccceeccCCceE
Q 003836 496 KELVEVTRGFKEELGRGAFGTVYKGFVNMGSSNHVAVKKLNSVFQDSEKEFKAEVNGIGQTHHKNLVRLLGYCDEGQNRL 575 (792)
Q Consensus 496 ~el~~~~~~~~~~lG~G~~g~Vy~g~~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~ 575 (792)
.|++......+++||-|-||.||.|.+..-+ ..||||.++.. ....++|+.|..+|+.++|||+|+|+|+|..+...|
T Consensus 262 WEmeRtdItMkhKLGGGQYGeVYeGvWKkys-lTvAVKtLKED-tMeveEFLkEAAvMKeikHpNLVqLLGVCT~EpPFY 339 (1157)
T KOG4278|consen 262 WEMERTDITMKHKLGGGQYGEVYEGVWKKYS-LTVAVKTLKED-TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTHEPPFY 339 (1157)
T ss_pred hhccchheeeeeccCCCcccceeeeeeeccc-eeeehhhhhhc-chhHHHHHHHHHHHHhhcCccHHHHhhhhccCCCeE
Confidence 3444444445689999999999999997654 58999999864 345689999999999999999999999999999999
Q ss_pred EEEEeccCCCccccccCC--CCCchhHHHHHHHHHHHHHHHHhhccCCCeEecCCCCCcEEEcCCCCeEEeecCCCcccc
Q 003836 576 LVYEFMSNGTVASFLFGD--SKPNWKLRTEIAMGIAGGLFYLHEECCTQIIHCDIKPQNILLDDHYNARISDFGLAKLLT 653 (792)
Q Consensus 576 lV~E~~~~gsL~~~l~~~--~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dikp~NILl~~~~~~kl~Dfg~a~~~~ 653 (792)
||.|||.+|+|.+||++- ..++--..+.+|.||+.||.||..+ .+|||||.++|.|+.++..+|++|||+++++.
T Consensus 340 IiTEfM~yGNLLdYLRecnr~ev~avvLlyMAtQIsSaMeYLEkk---nFIHRDLAARNCLVgEnhiVKvADFGLsRlMt 416 (1157)
T KOG4278|consen 340 IITEFMCYGNLLDYLRECNRSEVPAVVLLYMATQISSAMEYLEKK---NFIHRDLAARNCLVGENHIVKVADFGLSRLMT 416 (1157)
T ss_pred EEEecccCccHHHHHHHhchhhcchhHHHHHHHHHHHHHHHHHHh---hhhhhhhhhhhccccccceEEeeccchhhhhc
Confidence 999999999999999764 4566777889999999999999999 99999999999999999999999999999998
Q ss_pred CCCCCccccccccCCcccccccccCCCCcccceehHHHHHHHHHhcC-cCCCcchhhhhhhhHHHHHHHhhcccchhHhh
Q 003836 654 LDQSHTNTAIRGTKGYVAPEWFRNMPITVKVDVYSYGVLLLEIICLR-RNIDNEISKVDKAILTDWAYDRYQERTLEALV 732 (792)
Q Consensus 654 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DV~S~Gv~l~el~tg~-~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 732 (792)
.+.......-.-.+.|.|||.+....|+.|+|||+|||+||||.|-. .|+.. .+. ..+-.++
T Consensus 417 gDTYTAHAGAKFPIKWTAPEsLAyNtFSiKSDVWAFGVLLWEIATYGMsPYPG-idl----------------SqVY~LL 479 (1157)
T KOG4278|consen 417 GDTYTAHAGAKFPIKWTAPESLAYNTFSIKSDVWAFGVLLWEIATYGMSPYPG-IDL----------------SQVYGLL 479 (1157)
T ss_pred CCceecccCccCcccccCcccccccccccchhhHHHHHHHHHHHhcCCCCCCC-ccH----------------HHHHHHH
Confidence 77655444334467899999999999999999999999999999844 44432 111 1234566
Q ss_pred hchhcccCCHHHHHHHHHHHHHccccCCCCCCCHHhHHHHhccCc
Q 003836 733 ENDLEAMNNVTMLHRFVMVAFWCIQEDPSHRPTMRKVTQMLEGVV 777 (792)
Q Consensus 733 ~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~L~~~~ 777 (792)
+...+...+..+++.+++|++.||+++|.+||++.|+-+.+|.+.
T Consensus 480 EkgyRM~~PeGCPpkVYeLMraCW~WsPsDRPsFaeiHqafEtmf 524 (1157)
T KOG4278|consen 480 EKGYRMDGPEGCPPKVYELMRACWNWSPSDRPSFAEIHQAFETMF 524 (1157)
T ss_pred hccccccCCCCCCHHHHHHHHHHhcCCcccCccHHHHHHHHHHHh
Confidence 677777778889999999999999999999999999999886653
|
|
| >cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-37 Score=330.64 Aligned_cols=243 Identities=22% Similarity=0.232 Sum_probs=200.2
Q ss_pred hhhhhcCccccceEEEeeecCCCceEEEEEEccccc---ccchHHHHHHHHHhcccCCCCcccccceeccCCceEEEEEe
Q 003836 504 GFKEELGRGAFGTVYKGFVNMGSSNHVAVKKLNSVF---QDSEKEFKAEVNGIGQTHHKNLVRLLGYCDEGQNRLLVYEF 580 (792)
Q Consensus 504 ~~~~~lG~G~~g~Vy~g~~~~~~~~~vavK~~~~~~---~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~lV~E~ 580 (792)
.+.+.||+|+||.||++... .+++.+|+|++.... ....+.+.+|++++++++||||+++++++.+.+..++||||
T Consensus 4 ~~~~~lg~G~~g~Vy~~~~~-~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~ 82 (291)
T cd05612 4 ERIKTVGTGTFGRVHLVRDR-ISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIRLFWTEHDQRFLYMLMEY 82 (291)
T ss_pred eeeeeeecCCCeEEEEEEEc-CCCCEEEEEEEEHHHHhhhHHHHHHHHHHHHHHhCCCCcHhhhHhhhccCCeEEEEEeC
Confidence 34578999999999999754 456789999986432 22345688999999999999999999999999999999999
Q ss_pred ccCCCccccccCCCCCchhHHHHHHHHHHHHHHHHhhccCCCeEecCCCCCcEEEcCCCCeEEeecCCCccccCCCCCcc
Q 003836 581 MSNGTVASFLFGDSKPNWKLRTEIAMGIAGGLFYLHEECCTQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLDQSHTN 660 (792)
Q Consensus 581 ~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dikp~NILl~~~~~~kl~Dfg~a~~~~~~~~~~~ 660 (792)
+++|+|.+++.....+++.....++.||+.||+|||+. +|+||||||+|||++.++.+||+|||+++..... .
T Consensus 83 ~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~NIli~~~~~~kl~Dfg~~~~~~~~----~ 155 (291)
T cd05612 83 VPGGELFSYLRNSGRFSNSTGLFYASEIVCALEYLHSK---EIVYRDLKPENILLDKEGHIKLTDFGFAKKLRDR----T 155 (291)
T ss_pred CCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCHHHeEECCCCCEEEEecCcchhccCC----c
Confidence 99999999998888899999999999999999999998 9999999999999999999999999999865422 2
Q ss_pred ccccccCCcccccccccCCCCcccceehHHHHHHHHHhcCcCCCcchhhhhhhhHHHHHHHhhcccchhHhhhchhcccC
Q 003836 661 TAIRGTKGYVAPEWFRNMPITVKVDVYSYGVLLLEIICLRRNIDNEISKVDKAILTDWAYDRYQERTLEALVENDLEAMN 740 (792)
Q Consensus 661 ~~~~gt~~y~aPE~~~~~~~~~k~DV~S~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 740 (792)
....|++.|+|||.+.+..++.++|||||||++|||++|+.||........ . ..+.... ...
T Consensus 156 ~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~~---~-------------~~i~~~~--~~~ 217 (291)
T cd05612 156 WTLCGTPEYLAPEVIQSKGHNKAVDWWALGILIYEMLVGYPPFFDDNPFGI---Y-------------EKILAGK--LEF 217 (291)
T ss_pred ccccCChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH---H-------------HHHHhCC--cCC
Confidence 234689999999999998999999999999999999999999975432110 0 0011111 111
Q ss_pred CHHHHHHHHHHHHHccccCCCCCCC-----HHhHHHH
Q 003836 741 NVTMLHRFVMVAFWCIQEDPSHRPT-----MRKVTQM 772 (792)
Q Consensus 741 ~~~~~~~l~~l~~~Cl~~~p~~RPs-----~~evl~~ 772 (792)
+......+.+++.+||+.||.+||+ ++++++.
T Consensus 218 ~~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~h 254 (291)
T cd05612 218 PRHLDLYAKDLIKKLLVVDRTRRLGNMKNGADDVKNH 254 (291)
T ss_pred CccCCHHHHHHHHHHcCCCHHHccCCccCCHHHHhcC
Confidence 2233557889999999999999995 8888865
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt |
| >PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-37 Score=337.60 Aligned_cols=245 Identities=23% Similarity=0.285 Sum_probs=202.1
Q ss_pred hhhhhhcCccccceEEEeeecCCCceEEEEEEccccc---ccchHHHHHHHHHhcccCCCCcccccceeccCCceEEEEE
Q 003836 503 RGFKEELGRGAFGTVYKGFVNMGSSNHVAVKKLNSVF---QDSEKEFKAEVNGIGQTHHKNLVRLLGYCDEGQNRLLVYE 579 (792)
Q Consensus 503 ~~~~~~lG~G~~g~Vy~g~~~~~~~~~vavK~~~~~~---~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~lV~E 579 (792)
+.+.+.||+|+||.||+|.........+|+|++.... ....+.+.+|+.+++.++||||+++++++.+.+..++|||
T Consensus 32 y~~~~~ig~G~~g~Vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lv~E 111 (340)
T PTZ00426 32 FNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFCVNLYGSFKDESYLYLVLE 111 (340)
T ss_pred cEEEEEEeecCCeEEEEEEEECCCCeEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCCcceEEEEEeCCEEEEEEe
Confidence 4556889999999999998665545689999986432 2334678899999999999999999999999999999999
Q ss_pred eccCCCccccccCCCCCchhHHHHHHHHHHHHHHHHhhccCCCeEecCCCCCcEEEcCCCCeEEeecCCCccccCCCCCc
Q 003836 580 FMSNGTVASFLFGDSKPNWKLRTEIAMGIAGGLFYLHEECCTQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLDQSHT 659 (792)
Q Consensus 580 ~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dikp~NILl~~~~~~kl~Dfg~a~~~~~~~~~~ 659 (792)
|+++|+|.+++.....+++..+..++.||+.||.|||+. +|+||||||+|||++.++.+||+|||+++.....
T Consensus 112 y~~~g~L~~~i~~~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDLkp~NILl~~~~~ikL~DFG~a~~~~~~---- 184 (340)
T PTZ00426 112 FVIGGEFFTFLRRNKRFPNDVGCFYAAQIVLIFEYLQSL---NIVYRDLKPENLLLDKDGFIKMTDFGFAKVVDTR---- 184 (340)
T ss_pred CCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC---CeEccCCCHHHEEECCCCCEEEecCCCCeecCCC----
Confidence 999999999998888899999999999999999999998 9999999999999999999999999999865321
Q ss_pred cccccccCCcccccccccCCCCcccceehHHHHHHHHHhcCcCCCcchhhhhhhhHHHHHHHhhcccchhHhhhchhccc
Q 003836 660 NTAIRGTKGYVAPEWFRNMPITVKVDVYSYGVLLLEIICLRRNIDNEISKVDKAILTDWAYDRYQERTLEALVENDLEAM 739 (792)
Q Consensus 660 ~~~~~gt~~y~aPE~~~~~~~~~k~DV~S~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 739 (792)
.....||+.|+|||.+.+..++.++|||||||++|||++|+.||........ ... +..... .
T Consensus 185 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~--------~~~--------i~~~~~--~ 246 (340)
T PTZ00426 185 TYTLCGTPEYIAPEILLNVGHGKAADWWTLGIFIYEILVGCPPFYANEPLLI--------YQK--------ILEGII--Y 246 (340)
T ss_pred cceecCChhhcCHHHHhCCCCCccccccchhhHHHHHhcCCCCCCCCCHHHH--------HHH--------HhcCCC--C
Confidence 2345689999999999988899999999999999999999999975432110 001 111100 1
Q ss_pred CCHHHHHHHHHHHHHccccCCCCCC-----CHHhHHHH
Q 003836 740 NNVTMLHRFVMVAFWCIQEDPSHRP-----TMRKVTQM 772 (792)
Q Consensus 740 ~~~~~~~~l~~l~~~Cl~~~p~~RP-----s~~evl~~ 772 (792)
.+......+.+++.+||+.+|++|+ +++++++.
T Consensus 247 ~p~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~~~h 284 (340)
T PTZ00426 247 FPKFLDNNCKHLMKKLLSHDLTKRYGNLKKGAQNVKEH 284 (340)
T ss_pred CCCCCCHHHHHHHHHHcccCHHHcCCCCCCCHHHHHcC
Confidence 1223345678899999999999995 89988875
|
|
| >KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-37 Score=303.38 Aligned_cols=233 Identities=26% Similarity=0.303 Sum_probs=200.1
Q ss_pred hhhhcCccccceEEEeeecCCCceEEEEEEcccccccc---hHHHHHHHHHhcccCCCCcccccceeccCCceEEEEEec
Q 003836 505 FKEELGRGAFGTVYKGFVNMGSSNHVAVKKLNSVFQDS---EKEFKAEVNGIGQTHHKNLVRLLGYCDEGQNRLLVYEFM 581 (792)
Q Consensus 505 ~~~~lG~G~~g~Vy~g~~~~~~~~~vavK~~~~~~~~~---~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~lV~E~~ 581 (792)
+.+.||.|+||.|.+++.. .++..+|+|++++...-. .+...+|..+|+.+.||.++++.+.|.+.+.++|||||+
T Consensus 48 ~~~tlGtGSFGrV~LVr~k-~~g~yYAmKvL~k~~vVklKQveH~~nEk~vL~~v~~PFlv~l~~t~~d~~~lymvmeyv 126 (355)
T KOG0616|consen 48 RLKTLGTGSFGRVHLVREK-HSGNYYAMKVLDKQKVVKLKQVEHTHNEKRVLKAVSHPFLVKLYGTFKDNSNLYMVMEYV 126 (355)
T ss_pred heeeeccCccceEEEEEEc-cCCceeehhhcCHHHHHHHHHHHHHhhHHHHHhhccCceeEEEEEeeccCCeEEEEEecc
Confidence 3568999999999999765 457899999998754333 345779999999999999999999999999999999999
Q ss_pred cCCCccccccCCCCCchhHHHHHHHHHHHHHHHHhhccCCCeEecCCCCCcEEEcCCCCeEEeecCCCccccCCCCCccc
Q 003836 582 SNGTVASFLFGDSKPNWKLRTEIAMGIAGGLFYLHEECCTQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLDQSHTNT 661 (792)
Q Consensus 582 ~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dikp~NILl~~~~~~kl~Dfg~a~~~~~~~~~~~~ 661 (792)
++|.|..+|++.++++++..+-+|.||+.||+|||+. +|++|||||+|||||.+|.+||.|||.|+.... ..-
T Consensus 127 ~GGElFS~Lrk~~rF~e~~arFYAAeivlAleylH~~---~iiYRDLKPENiLlD~~G~iKitDFGFAK~v~~----rT~ 199 (355)
T KOG0616|consen 127 PGGELFSYLRKSGRFSEPHARFYAAEIVLALEYLHSL---DIIYRDLKPENLLLDQNGHIKITDFGFAKRVSG----RTW 199 (355)
T ss_pred CCccHHHHHHhcCCCCchhHHHHHHHHHHHHHHHHhc---CeeeccCChHHeeeccCCcEEEEeccceEEecC----cEE
Confidence 9999999999999999999999999999999999999 999999999999999999999999999997643 245
Q ss_pred cccccCCcccccccccCCCCcccceehHHHHHHHHHhcCcCCCcchhhhhhhhHHHHHHHhhcccchhHhhhchhcccCC
Q 003836 662 AIRGTKGYVAPEWFRNMPITVKVDVYSYGVLLLEIICLRRNIDNEISKVDKAILTDWAYDRYQERTLEALVENDLEAMNN 741 (792)
Q Consensus 662 ~~~gt~~y~aPE~~~~~~~~~k~DV~S~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 741 (792)
+.+|||.|+|||+++...+..++|.|||||++|||+.|..||....... ..+.++...+. +|
T Consensus 200 TlCGTPeYLAPEii~sk~ynkavDWWalGVLIYEMlaG~pPF~~~~~~~----------------iY~KI~~~~v~--fP 261 (355)
T KOG0616|consen 200 TLCGTPEYLAPEIIQSKGYNKAVDWWALGVLIYEMLAGYPPFYDDNPIQ----------------IYEKILEGKVK--FP 261 (355)
T ss_pred EecCCccccChHHhhcCCCCcchhHHHHHHHHHHHHcCCCCCcCCChHH----------------HHHHHHhCccc--CC
Confidence 6889999999999999999999999999999999999999997643311 11222222222 34
Q ss_pred HHHHHHHHHHHHHccccCCCCC
Q 003836 742 VTMLHRFVMVAFWCIQEDPSHR 763 (792)
Q Consensus 742 ~~~~~~l~~l~~~Cl~~~p~~R 763 (792)
.....++.+|+...|+.|-.+|
T Consensus 262 ~~fs~~~kdLl~~LL~vD~t~R 283 (355)
T KOG0616|consen 262 SYFSSDAKDLLKKLLQVDLTKR 283 (355)
T ss_pred cccCHHHHHHHHHHHhhhhHhh
Confidence 5566778889999999999999
|
|
| >KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-38 Score=331.09 Aligned_cols=254 Identities=24% Similarity=0.361 Sum_probs=218.7
Q ss_pred hhhhhhcCccccceEEEeeecCC---CceEEEEEEccc-ccccchHHHHHHHHHhcccCCCCcccccceeccCCceEEEE
Q 003836 503 RGFKEELGRGAFGTVYKGFVNMG---SSNHVAVKKLNS-VFQDSEKEFKAEVNGIGQTHHKNLVRLLGYCDEGQNRLLVY 578 (792)
Q Consensus 503 ~~~~~~lG~G~~g~Vy~g~~~~~---~~~~vavK~~~~-~~~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~lV~ 578 (792)
..+.+.||+|-||.||+|.+... ..-.||||.++. ...+..+.|..|..+|+.++||||++|+|+|.+. ..+|||
T Consensus 391 Itl~r~iG~GqFGdVy~gvYt~~~kge~iaVAvKtCK~d~t~d~tekflqEa~iMrnfdHphIikLIGv~~e~-P~Wivm 469 (974)
T KOG4257|consen 391 ITLKRLIGEGQFGDVYKGVYTDPEKGERIAVAVKTCKTDCTPDDTEKFLQEASIMRNFDHPHIIKLIGVCVEQ-PMWIVM 469 (974)
T ss_pred ccHHHhhcCCcccceeeeEecccccCcceeeeeehhccCCChhhHHHHHHHHHHHHhCCCcchhheeeeeecc-ceeEEE
Confidence 34567899999999999988543 345799999987 5566678899999999999999999999999764 679999
Q ss_pred EeccCCCccccccCC-CCCchhHHHHHHHHHHHHHHHHhhccCCCeEecCCCCCcEEEcCCCCeEEeecCCCccccCCCC
Q 003836 579 EFMSNGTVASFLFGD-SKPNWKLRTEIAMGIAGGLFYLHEECCTQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLDQS 657 (792)
Q Consensus 579 E~~~~gsL~~~l~~~-~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dikp~NILl~~~~~~kl~Dfg~a~~~~~~~~ 657 (792)
|.++.|.|.+||..+ ..++......++.||+.||+|||++ +.|||||..+|||+....-+||+|||+++.+..+..
T Consensus 470 EL~~~GELr~yLq~nk~sL~l~tL~ly~~Qi~talaYLeSk---rfVHRDIAaRNiLVsSp~CVKLaDFGLSR~~ed~~y 546 (974)
T KOG4257|consen 470 ELAPLGELREYLQQNKDSLPLRTLTLYCYQICTALAYLESK---RFVHRDIAARNILVSSPQCVKLADFGLSRYLEDDAY 546 (974)
T ss_pred ecccchhHHHHHHhccccchHHHHHHHHHHHHHHHHHHHhh---chhhhhhhhhheeecCcceeeecccchhhhccccch
Confidence 999999999999876 4688899999999999999999999 999999999999999999999999999999887766
Q ss_pred CccccccccCCcccccccccCCCCcccceehHHHHHHHHHh-cCcCCCcchhhhhhhhHHHHHHHhhcccchhHhhhchh
Q 003836 658 HTNTAIRGTKGYVAPEWFRNMPITVKVDVYSYGVLLLEIIC-LRRNIDNEISKVDKAILTDWAYDRYQERTLEALVENDL 736 (792)
Q Consensus 658 ~~~~~~~gt~~y~aPE~~~~~~~~~k~DV~S~Gv~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 736 (792)
...+...-.+.|||||.+.-.+|+.++|||-|||++|||+. |.+||.... ..++...++..-
T Consensus 547 YkaS~~kLPIKWmaPESINfRrFTtASDVWMFgVCmWEIl~lGvkPfqgvk-----------------NsDVI~~iEnGe 609 (974)
T KOG4257|consen 547 YKASRGKLPIKWMAPESINFRRFTTASDVWMFGVCMWEILSLGVKPFQGVK-----------------NSDVIGHIENGE 609 (974)
T ss_pred hhccccccceeecCccccchhcccchhhHHHHHHHHHHHHHhcCCcccccc-----------------ccceEEEecCCC
Confidence 66665556778999999999999999999999999999986 788986532 223333455556
Q ss_pred cccCCHHHHHHHHHHHHHccccCCCCCCCHHhHHHHhccCc
Q 003836 737 EAMNNVTMLHRFVMVAFWCIQEDPSHRPTMRKVTQMLEGVV 777 (792)
Q Consensus 737 ~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~L~~~~ 777 (792)
+...++.++..+..++.+||..+|.+||.+.|+...|+.++
T Consensus 610 RlP~P~nCPp~LYslmskcWayeP~kRPrftei~~~lsdv~ 650 (974)
T KOG4257|consen 610 RLPCPPNCPPALYSLMSKCWAYEPSKRPRFTEIKAILSDVL 650 (974)
T ss_pred CCCCCCCCChHHHHHHHHHhccCcccCCcHHHHHHHHHHHH
Confidence 66778889999999999999999999999999998875544
|
|
| >cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-37 Score=321.60 Aligned_cols=254 Identities=26% Similarity=0.419 Sum_probs=204.6
Q ss_pred HHHhhhhhhcCccccceEEEeeecCCCceEEEEEEcccccccchHHHHHHHHHhcccCCCCcccccceeccCCceEEEEE
Q 003836 500 EVTRGFKEELGRGAFGTVYKGFVNMGSSNHVAVKKLNSVFQDSEKEFKAEVNGIGQTHHKNLVRLLGYCDEGQNRLLVYE 579 (792)
Q Consensus 500 ~~~~~~~~~lG~G~~g~Vy~g~~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~lV~E 579 (792)
.....+.+.||+|++|.||+|... .++.||+|.++... ...+++.+|++++++++|+||+++++++...+..++|||
T Consensus 5 ~~~~~~~~~lg~g~~~~v~~~~~~--~~~~v~iK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 81 (261)
T cd05068 5 RTSIQLLRKLGAGQFGEVWEGLWN--NTTPVAVKTLKPGT-MDPKDFLAEAQIMKKLRHPKLIQLYAVCTLEEPIYIVTE 81 (261)
T ss_pred hhheeeEEEecccCCccEEEEEec--CCeEEEEEeeCCCc-ccHHHHHHHHHHHHHCCCCCccceeEEEecCCCeeeeee
Confidence 344556789999999999999754 34679999987543 346789999999999999999999999999999999999
Q ss_pred eccCCCccccccCCC--CCchhHHHHHHHHHHHHHHHHhhccCCCeEecCCCCCcEEEcCCCCeEEeecCCCccccCCCC
Q 003836 580 FMSNGTVASFLFGDS--KPNWKLRTEIAMGIAGGLFYLHEECCTQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLDQS 657 (792)
Q Consensus 580 ~~~~gsL~~~l~~~~--~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dikp~NILl~~~~~~kl~Dfg~a~~~~~~~~ 657 (792)
|+++++|.+++.... .+++..+..++.|++.||.|||+. +|+|+||||+||++++++.+||+|||+++.......
T Consensus 82 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~~ 158 (261)
T cd05068 82 LMKYGSLLEYLQGGAGRALKLPQLIDMAAQVASGMAYLEAQ---NYIHRDLAARNVLVGENNICKVADFGLARVIKEDIY 158 (261)
T ss_pred cccCCcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeeccCCcceEEEcCCCCEEECCcceEEEccCCcc
Confidence 999999999997643 689999999999999999999998 999999999999999999999999999987653222
Q ss_pred CccccccccCCcccccccccCCCCcccceehHHHHHHHHHh-cCcCCCcchhhhhhhhHHHHHHHhhcccchhHhhhchh
Q 003836 658 HTNTAIRGTKGYVAPEWFRNMPITVKVDVYSYGVLLLEIIC-LRRNIDNEISKVDKAILTDWAYDRYQERTLEALVENDL 736 (792)
Q Consensus 658 ~~~~~~~gt~~y~aPE~~~~~~~~~k~DV~S~Gv~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 736 (792)
........+..|+|||.+.+..++.++||||||++++||++ |+.||........ . . .+....
T Consensus 159 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~---~-----~---------~~~~~~ 221 (261)
T cd05068 159 EAREGAKFPIKWTAPEAALYNRFSIKSDVWSFGILLTEIVTYGRMPYPGMTNAEV---L-----Q---------QVDQGY 221 (261)
T ss_pred cccCCCcCceeccCccccccCCCCchhhHHHHHHHHHHHHhcCCCCCCCCCHHHH---H-----H---------HHHcCC
Confidence 21222223458999999998899999999999999999999 8888865322100 0 0 011111
Q ss_pred cccCCHHHHHHHHHHHHHccccCCCCCCCHHhHHHHhccC
Q 003836 737 EAMNNVTMLHRFVMVAFWCIQEDPSHRPTMRKVTQMLEGV 776 (792)
Q Consensus 737 ~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~L~~~ 776 (792)
....+...+..+.+++.+|++.+|++||++.++++.|+.+
T Consensus 222 ~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~l~~~l~~~ 261 (261)
T cd05068 222 RMPCPPGCPKELYDIMLDCWKEDPDDRPTFETLQWKLEDF 261 (261)
T ss_pred CCCCCCcCCHHHHHHHHHHhhcCcccCCCHHHHHHHHhcC
Confidence 1112233456789999999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a |
| >cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-37 Score=326.68 Aligned_cols=248 Identities=25% Similarity=0.297 Sum_probs=198.5
Q ss_pred hhhhcCccccceEEEeeecCCCceEEEEEEccccc---ccchHHHHHHHHHhcccCCCCcccccceeccCCceEEEEEec
Q 003836 505 FKEELGRGAFGTVYKGFVNMGSSNHVAVKKLNSVF---QDSEKEFKAEVNGIGQTHHKNLVRLLGYCDEGQNRLLVYEFM 581 (792)
Q Consensus 505 ~~~~lG~G~~g~Vy~g~~~~~~~~~vavK~~~~~~---~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~lV~E~~ 581 (792)
..+.||+|+||.||++... .+++.||+|++.... ......+.+|+.++.+++|+||+++++++.+.+..++||||+
T Consensus 4 ~~~~lg~G~~g~V~~~~~~-~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~iv~~~~~~~~~~~~~lv~e~~ 82 (285)
T cd05631 4 HYRVLGKGGFGEVCACQVR-ATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSLAYAYETKDALCLVLTIM 82 (285)
T ss_pred EEEEEecCCCEEEEEEEEe-cCCceEEEEEeeHhhhhhhhhHHHHHHHHHHHHhcCCCcEEEEEEEEccCCeEEEEEEec
Confidence 3467999999999999754 456799999986432 223456789999999999999999999999999999999999
Q ss_pred cCCCccccccCC--CCCchhHHHHHHHHHHHHHHHHhhccCCCeEecCCCCCcEEEcCCCCeEEeecCCCccccCCCCCc
Q 003836 582 SNGTVASFLFGD--SKPNWKLRTEIAMGIAGGLFYLHEECCTQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLDQSHT 659 (792)
Q Consensus 582 ~~gsL~~~l~~~--~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dikp~NILl~~~~~~kl~Dfg~a~~~~~~~~~~ 659 (792)
++|+|..++... ..+++..+..++.|++.||+|||+. +|+||||||+|||+++++.+||+|||+++...... .
T Consensus 83 ~~g~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~iiH~dikp~Nill~~~~~~kl~Dfg~~~~~~~~~--~ 157 (285)
T cd05631 83 NGGDLKFHIYNMGNPGFDEQRAIFYAAELCCGLEDLQRE---RIVYRDLKPENILLDDRGHIRISDLGLAVQIPEGE--T 157 (285)
T ss_pred CCCcHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhC---CEEeCCCCHHHEEECCCCCEEEeeCCCcEEcCCCC--e
Confidence 999999887543 4688999999999999999999998 99999999999999999999999999998753222 2
Q ss_pred cccccccCCcccccccccCCCCcccceehHHHHHHHHHhcCcCCCcchhhhhhhhHHHHHHHhhcccchhHhhhchhccc
Q 003836 660 NTAIRGTKGYVAPEWFRNMPITVKVDVYSYGVLLLEIICLRRNIDNEISKVDKAILTDWAYDRYQERTLEALVENDLEAM 739 (792)
Q Consensus 660 ~~~~~gt~~y~aPE~~~~~~~~~k~DV~S~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 739 (792)
.....|++.|+|||.+.+..++.++|||||||++|||++|+.||............. .. +. .....
T Consensus 158 ~~~~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~~~----~~--------~~--~~~~~ 223 (285)
T cd05631 158 VRGRVGTVGYMAPEVINNEKYTFSPDWWGLGCLIYEMIQGQSPFRKRKERVKREEVD----RR--------VK--EDQEE 223 (285)
T ss_pred ecCCCCCCCccCHhhhcCCCCCcccCchhHHHHHHHHHhCCCCCCCCCcchhHHHHH----HH--------hh--ccccc
Confidence 233468999999999999999999999999999999999999997543211100000 00 00 00111
Q ss_pred CCHHHHHHHHHHHHHccccCCCCCCC-----HHhHHHH
Q 003836 740 NNVTMLHRFVMVAFWCIQEDPSHRPT-----MRKVTQM 772 (792)
Q Consensus 740 ~~~~~~~~l~~l~~~Cl~~~p~~RPs-----~~evl~~ 772 (792)
.+...+..+.+|+.+||+.||.+||+ ++++++.
T Consensus 224 ~~~~~s~~~~~li~~~l~~~P~~R~~~~~~~~~~~~~h 261 (285)
T cd05631 224 YSEKFSEDAKSICRMLLTKNPKERLGCRGNGAAGVKQH 261 (285)
T ss_pred CCccCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHhcC
Confidence 23345667889999999999999997 7888863
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i |
| >cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-37 Score=331.62 Aligned_cols=241 Identities=22% Similarity=0.262 Sum_probs=195.6
Q ss_pred cCccccceEEEeeecCCCceEEEEEEcccc---cccchHHHHHHHHHhcccCCCCcccccceeccCCceEEEEEeccCCC
Q 003836 509 LGRGAFGTVYKGFVNMGSSNHVAVKKLNSV---FQDSEKEFKAEVNGIGQTHHKNLVRLLGYCDEGQNRLLVYEFMSNGT 585 (792)
Q Consensus 509 lG~G~~g~Vy~g~~~~~~~~~vavK~~~~~---~~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~lV~E~~~~gs 585 (792)
||+|+||.||++... .+++.+|+|++... .......+.+|+.++++++||||+++++++.+.+..++||||+++|+
T Consensus 1 lg~G~~g~Vy~~~~~-~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~ 79 (312)
T cd05585 1 IGKGSFGKVMQVRKR-DTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKFSFQSPEKLYLVLAFINGGE 79 (312)
T ss_pred CCcCCCeEEEEEEEC-CCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCcEeceeeEEecCCeEEEEEcCCCCCc
Confidence 799999999999754 45678999998653 23345678899999999999999999999999999999999999999
Q ss_pred ccccccCCCCCchhHHHHHHHHHHHHHHHHhhccCCCeEecCCCCCcEEEcCCCCeEEeecCCCccccCCCCCccccccc
Q 003836 586 VASFLFGDSKPNWKLRTEIAMGIAGGLFYLHEECCTQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLDQSHTNTAIRG 665 (792)
Q Consensus 586 L~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dikp~NILl~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~g 665 (792)
|.+++.....+++..+..++.||+.||.|||+. +|+||||||+|||++.++.+||+|||+++...... .......|
T Consensus 80 L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~HrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~-~~~~~~~g 155 (312)
T cd05585 80 LFHHLQREGRFDLSRARFYTAELLCALENLHKF---NVIYRDLKPENILLDYQGHIALCDFGLCKLNMKDD-DKTNTFCG 155 (312)
T ss_pred HHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC---CeEeCCCCHHHeEECCCCcEEEEECcccccCccCC-CccccccC
Confidence 999998878899999999999999999999998 99999999999999999999999999998643222 22234568
Q ss_pred cCCcccccccccCCCCcccceehHHHHHHHHHhcCcCCCcchhhhhhhhHHHHHHHhhcccchhHhhhchhcccCCHHHH
Q 003836 666 TKGYVAPEWFRNMPITVKVDVYSYGVLLLEIICLRRNIDNEISKVDKAILTDWAYDRYQERTLEALVENDLEAMNNVTML 745 (792)
Q Consensus 666 t~~y~aPE~~~~~~~~~k~DV~S~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 745 (792)
|+.|+|||.+.+..++.++|||||||++|||++|+.||........ . ..+.... ...+....
T Consensus 156 t~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~pf~~~~~~~~-------~---------~~~~~~~--~~~~~~~~ 217 (312)
T cd05585 156 TPEYLAPELLLGHGYTKAVDWWTLGVLLYEMLTGLPPFYDENVNEM-------Y---------RKILQEP--LRFPDGFD 217 (312)
T ss_pred CcccCCHHHHcCCCCCCccceechhHHHHHHHhCCCCcCCCCHHHH-------H---------HHHHcCC--CCCCCcCC
Confidence 9999999999999999999999999999999999999965422100 0 0011111 11223345
Q ss_pred HHHHHHHHHccccCCCCCCCHHhHHHH
Q 003836 746 HRFVMVAFWCIQEDPSHRPTMRKVTQM 772 (792)
Q Consensus 746 ~~l~~l~~~Cl~~~p~~RPs~~evl~~ 772 (792)
..+.+++.+||+.||.+||++..+.+.
T Consensus 218 ~~~~~li~~~L~~dp~~R~~~~~~~e~ 244 (312)
T cd05585 218 RDAKDLLIGLLSRDPTRRLGYNGAQEI 244 (312)
T ss_pred HHHHHHHHHHcCCCHHHcCCCCCHHHH
Confidence 678899999999999999865443333
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl |
| >cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-37 Score=321.81 Aligned_cols=252 Identities=27% Similarity=0.397 Sum_probs=203.9
Q ss_pred hhhhhhcCccccceEEEeeecCCCceEEEEEEcccccccchHHHHHHHHHhcccCCCCcccccceeccCCceEEEEEecc
Q 003836 503 RGFKEELGRGAFGTVYKGFVNMGSSNHVAVKKLNSVFQDSEKEFKAEVNGIGQTHHKNLVRLLGYCDEGQNRLLVYEFMS 582 (792)
Q Consensus 503 ~~~~~~lG~G~~g~Vy~g~~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~lV~E~~~ 582 (792)
..+.+.||+|++|.||+|... ..++.+|+|++... ....+++.+|++++++++|+||+++++++...+..++||||++
T Consensus 8 ~~~~~~ig~g~~~~v~~~~~~-~~~~~~~~K~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 85 (263)
T cd05052 8 ITMKHKLGGGQYGEVYEGVWK-KYSLTVAVKTLKED-TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMT 85 (263)
T ss_pred eEEeeecCCcccceEEEEEEe-cCCceEEEEEecCC-chHHHHHHHHHHHHHhCCCCChhheEEEEcCCCCcEEEEEeCC
Confidence 345678999999999999765 34678999998753 3345689999999999999999999999999999999999999
Q ss_pred CCCccccccCC--CCCchhHHHHHHHHHHHHHHHHhhccCCCeEecCCCCCcEEEcCCCCeEEeecCCCccccCCCCCcc
Q 003836 583 NGTVASFLFGD--SKPNWKLRTEIAMGIAGGLFYLHEECCTQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLDQSHTN 660 (792)
Q Consensus 583 ~gsL~~~l~~~--~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dikp~NILl~~~~~~kl~Dfg~a~~~~~~~~~~~ 660 (792)
+++|.+++... ..+++..++.++.|+++||+|||+. +++|+||||+|||+++++.+||+|||+++..........
T Consensus 86 ~~~L~~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~---~i~H~dlkp~nil~~~~~~~kl~df~~~~~~~~~~~~~~ 162 (263)
T cd05052 86 YGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKK---NFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAH 162 (263)
T ss_pred CCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhC---CEeecccCcceEEEcCCCcEEeCCCccccccccceeecc
Confidence 99999998653 4578999999999999999999998 999999999999999999999999999987654322222
Q ss_pred ccccccCCcccccccccCCCCcccceehHHHHHHHHHh-cCcCCCcchhhhhhhhHHHHHHHhhcccchhHhhhchhccc
Q 003836 661 TAIRGTKGYVAPEWFRNMPITVKVDVYSYGVLLLEIIC-LRRNIDNEISKVDKAILTDWAYDRYQERTLEALVENDLEAM 739 (792)
Q Consensus 661 ~~~~gt~~y~aPE~~~~~~~~~k~DV~S~Gv~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 739 (792)
....++..|+|||.+.+..++.++||||||+++|||++ |..|+........ ... +.......
T Consensus 163 ~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~~~--------~~~---------~~~~~~~~ 225 (263)
T cd05052 163 AGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQV--------YEL---------LEKGYRME 225 (263)
T ss_pred CCCCCccccCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHH--------HHH---------HHCCCCCC
Confidence 22234668999999998999999999999999999998 8888864322110 000 11111112
Q ss_pred CCHHHHHHHHHHHHHccccCCCCCCCHHhHHHHhccC
Q 003836 740 NNVTMLHRFVMVAFWCIQEDPSHRPTMRKVTQMLEGV 776 (792)
Q Consensus 740 ~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~L~~~ 776 (792)
.+...+..+.+++.+||+.+|++||++.+++++|+.+
T Consensus 226 ~~~~~~~~~~~li~~cl~~~p~~Rp~~~~l~~~l~~~ 262 (263)
T cd05052 226 RPEGCPPKVYELMRACWQWNPSDRPSFAEIHQAFETM 262 (263)
T ss_pred CCCCCCHHHHHHHHHHccCCcccCCCHHHHHHHHHhh
Confidence 2233456788999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays |
| >PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-36 Score=375.43 Aligned_cols=269 Identities=26% Similarity=0.489 Sum_probs=211.6
Q ss_pred cCHHHHHHHHhhhhhhcCccccceEEEeeecCCCceEEEEEEcccccccchHHHHHHHHHhcccCCCCcccccceeccCC
Q 003836 493 FTYKELVEVTRGFKEELGRGAFGTVYKGFVNMGSSNHVAVKKLNSVFQDSEKEFKAEVNGIGQTHHKNLVRLLGYCDEGQ 572 (792)
Q Consensus 493 ~~~~el~~~~~~~~~~lG~G~~g~Vy~g~~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~ 572 (792)
++++++.... ...+.||+|+||.||+|... .+++.||||++..... ...+|++.+++++|||||+++++|.+.+
T Consensus 683 ~~~~~~~~~~-~~~~~ig~G~~g~Vy~~~~~-~~~~~vavK~~~~~~~----~~~~~~~~l~~l~HpnIv~~~~~~~~~~ 756 (968)
T PLN00113 683 ITINDILSSL-KEENVISRGKKGASYKGKSI-KNGMQFVVKEINDVNS----IPSSEIADMGKLQHPNIVKLIGLCRSEK 756 (968)
T ss_pred hhHHHHHhhC-CcccEEccCCCeeEEEEEEC-CCCcEEEEEEccCCcc----ccHHHHHHHhhCCCCCcceEEEEEEcCC
Confidence 4444444321 22357999999999999763 3467899999875432 2235688999999999999999999999
Q ss_pred ceEEEEEeccCCCccccccCCCCCchhHHHHHHHHHHHHHHHHhhccCCCeEecCCCCCcEEEcCCCCeEEeecCCCccc
Q 003836 573 NRLLVYEFMSNGTVASFLFGDSKPNWKLRTEIAMGIAGGLFYLHEECCTQIIHCDIKPQNILLDDHYNARISDFGLAKLL 652 (792)
Q Consensus 573 ~~~lV~E~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dikp~NILl~~~~~~kl~Dfg~a~~~ 652 (792)
..++||||+++|+|.++++ .++|..+.+|+.||++||+|||+.+..+|+||||||+||+++.++.+++. |+.+...
T Consensus 757 ~~~lv~Ey~~~g~L~~~l~---~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlkp~Nil~~~~~~~~~~-~~~~~~~ 832 (968)
T PLN00113 757 GAYLIHEYIEGKNLSEVLR---NLSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHLR-LSLPGLL 832 (968)
T ss_pred CCEEEEeCCCCCcHHHHHh---cCCHHHHHHHHHHHHHHHHHhccCCCCCeecCCCCHHhEEECCCCceEEE-ecccccc
Confidence 9999999999999999995 38899999999999999999997777799999999999999999998886 6665433
Q ss_pred cCCCCCccccccccCCcccccccccCCCCcccceehHHHHHHHHHhcCcCCCcchhhhhhhhHHHHHHHhhcccchhHhh
Q 003836 653 TLDQSHTNTAIRGTKGYVAPEWFRNMPITVKVDVYSYGVLLLEIICLRRNIDNEISKVDKAILTDWAYDRYQERTLEALV 732 (792)
Q Consensus 653 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DV~S~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 732 (792)
... ....+++.|+|||++.+..++.|+|||||||++|||+||+.|++..... ......|.............+
T Consensus 833 ~~~-----~~~~~t~~y~aPE~~~~~~~~~~sDv~S~Gvvl~el~tg~~p~~~~~~~--~~~~~~~~~~~~~~~~~~~~~ 905 (968)
T PLN00113 833 CTD-----TKCFISSAYVAPETRETKDITEKSDIYGFGLILIELLTGKSPADAEFGV--HGSIVEWARYCYSDCHLDMWI 905 (968)
T ss_pred ccC-----CCccccccccCcccccCCCCCcccchhhHHHHHHHHHhCCCCCCcccCC--CCcHHHHHHHhcCccchhhee
Confidence 211 1235789999999999999999999999999999999999999644322 122334444444344444555
Q ss_pred hchhcc--cCCHHHHHHHHHHHHHccccCCCCCCCHHhHHHHhccCcC
Q 003836 733 ENDLEA--MNNVTMLHRFVMVAFWCIQEDPSHRPTMRKVTQMLEGVVE 778 (792)
Q Consensus 733 ~~~~~~--~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~L~~~~~ 778 (792)
++.+.. ..+.++..++.+++.+||+.+|++||+|+||+++|+++..
T Consensus 906 ~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~L~~~~~ 953 (968)
T PLN00113 906 DPSIRGDVSVNQNEIVEVMNLALHCTATDPTARPCANDVLKTLESASR 953 (968)
T ss_pred CccccCCCCccHHHHHHHHHHHHhhCcCCchhCcCHHHHHHHHHHhhc
Confidence 554433 2345677789999999999999999999999999998765
|
|
| >KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-37 Score=318.12 Aligned_cols=269 Identities=26% Similarity=0.369 Sum_probs=201.4
Q ss_pred hhhhcCccccceEEEeeecCCCceEEEEEEcccccccchHHHHHHHHHhcc--cCCCCcccccceeccCC----ceEEEE
Q 003836 505 FKEELGRGAFGTVYKGFVNMGSSNHVAVKKLNSVFQDSEKEFKAEVNGIGQ--THHKNLVRLLGYCDEGQ----NRLLVY 578 (792)
Q Consensus 505 ~~~~lG~G~~g~Vy~g~~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~--l~h~niv~l~g~~~~~~----~~~lV~ 578 (792)
+.+.||+|+||.||||.++ ++.||||++.. +..+.|++|-++++. ++|+||+++++.-..+. +++||+
T Consensus 214 l~eli~~Grfg~V~KaqL~---~~~VAVKifp~---~~kqs~~~Ek~Iy~lp~m~h~nIl~Fi~~ekr~t~~~~eywLVt 287 (534)
T KOG3653|consen 214 LLELIGRGRFGCVWKAQLD---NRLVAVKIFPE---QEKQSFQNEKNIYSLPGMKHENILQFIGAEKRGTADRMEYWLVT 287 (534)
T ss_pred hHHHhhcCccceeehhhcc---CceeEEEecCH---HHHHHHHhHHHHHhccCccchhHHHhhchhccCCccccceeEEe
Confidence 4578999999999999886 37899999863 445678888887775 68999999999887665 889999
Q ss_pred EeccCCCccccccCCCCCchhHHHHHHHHHHHHHHHHhhcc------CCCeEecCCCCCcEEEcCCCCeEEeecCCCccc
Q 003836 579 EFMSNGTVASFLFGDSKPNWKLRTEIAMGIAGGLFYLHEEC------CTQIIHCDIKPQNILLDDHYNARISDFGLAKLL 652 (792)
Q Consensus 579 E~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~------~~~ivH~dikp~NILl~~~~~~kl~Dfg~a~~~ 652 (792)
||.++|+|.+||.. ..++|....+|+..+++||+|||+.. +++|+|||||.+|||+.+|+++.|+|||+|..+
T Consensus 288 ~fh~kGsL~dyL~~-ntisw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkSkNVLvK~DlTccIaDFGLAl~~ 366 (534)
T KOG3653|consen 288 EFHPKGSLCDYLKA-NTISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLKSKNVLVKNDLTCCIADFGLALRL 366 (534)
T ss_pred eeccCCcHHHHHHh-ccccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCccccccccccceEEccCCcEEeeccceeEEe
Confidence 99999999999965 45799999999999999999999874 357999999999999999999999999999998
Q ss_pred cCCCCCc-cccccccCCcccccccccC-CCC-----cccceehHHHHHHHHHhcCcCCCcchhhhhhhhHHHHHHHhhcc
Q 003836 653 TLDQSHT-NTAIRGTKGYVAPEWFRNM-PIT-----VKVDVYSYGVLLLEIICLRRNIDNEISKVDKAILTDWAYDRYQE 725 (792)
Q Consensus 653 ~~~~~~~-~~~~~gt~~y~aPE~~~~~-~~~-----~k~DV~S~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~ 725 (792)
....... ....+||.+|||||++.+. .+. .+.||||+|.+||||++.-.-++....+..+..+..-.-.+-.-
T Consensus 367 ~p~~~~~d~~~qVGT~RYMAPEvLEgainl~d~~Afkr~DvYamgLVLWEi~SRC~~~~~~~vp~Yqlpfe~evG~hPt~ 446 (534)
T KOG3653|consen 367 EPGKPQGDTHGQVGTRRYMAPEVLEGAINLQDRDAFKRIDVYAMGLVLWEIASRCTDADPGPVPEYQLPFEAEVGNHPTL 446 (534)
T ss_pred cCCCCCcchhhhhhhhhhcCHHHHhhhcccccHHHHHHHHHHHHHHHHHHHHhhcccccCCCCCcccCchhHHhcCCCCH
Confidence 7654433 3347899999999999764 233 46999999999999999765443211111100000000000000
Q ss_pred cchhHh-hhchhcccCCH-----HHHHHHHHHHHHccccCCCCCCCHHhHHHHhccCcCCC
Q 003836 726 RTLEAL-VENDLEAMNNV-----TMLHRFVMVAFWCIQEDPSHRPTMRKVTQMLEGVVEVP 780 (792)
Q Consensus 726 ~~~~~~-~~~~~~~~~~~-----~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~L~~~~~~~ 780 (792)
+.++++ +....++..+. ..+..+.+.+..||..||+.|.|+.=|.+++.++..+.
T Consensus 447 e~mq~~VV~kK~RP~~p~~W~~h~~~~~l~et~EeCWDhDaeARLTA~Cv~eR~~~l~~~~ 507 (534)
T KOG3653|consen 447 EEMQELVVRKKQRPKIPDAWRKHAGMAVLCETIEECWDHDAEARLTAGCVEERMAELMMLW 507 (534)
T ss_pred HHHHHHHHhhccCCCChhhhhcCccHHHHHHHHHHHcCCchhhhhhhHHHHHHHHHHhccC
Confidence 111111 22222222221 34677899999999999999999998888887765544
|
|
| >cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-37 Score=334.28 Aligned_cols=264 Identities=22% Similarity=0.306 Sum_probs=203.2
Q ss_pred hhhhhhcCccccceEEEeeecCCCceEEEEEEccccc-ccchHHHHHHHHHhcccCCCCcccccceeccCCceEEEEEec
Q 003836 503 RGFKEELGRGAFGTVYKGFVNMGSSNHVAVKKLNSVF-QDSEKEFKAEVNGIGQTHHKNLVRLLGYCDEGQNRLLVYEFM 581 (792)
Q Consensus 503 ~~~~~~lG~G~~g~Vy~g~~~~~~~~~vavK~~~~~~-~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~lV~E~~ 581 (792)
+...+.||+|+||.||++... .++..+|+|.+.... ....+.+.+|++++++++|+||+++++++..++..++||||+
T Consensus 7 y~~~~~lg~G~~g~V~~~~~~-~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 85 (331)
T cd06649 7 FERISELGAGNGGVVTKVQHK-PSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHM 85 (331)
T ss_pred ceEEEeecCCCCEEEEEEEEC-CCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEeecC
Confidence 334578999999999999754 456789999987542 233567999999999999999999999999999999999999
Q ss_pred cCCCccccccCCCCCchhHHHHHHHHHHHHHHHHhhccCCCeEecCCCCCcEEEcCCCCeEEeecCCCccccCCCCCccc
Q 003836 582 SNGTVASFLFGDSKPNWKLRTEIAMGIAGGLFYLHEECCTQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLDQSHTNT 661 (792)
Q Consensus 582 ~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dikp~NILl~~~~~~kl~Dfg~a~~~~~~~~~~~~ 661 (792)
++++|.+++.....+++..+..++.|++.||.|||++ .+|+||||||+|||++.++.+||+|||+++..... ...
T Consensus 86 ~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~--~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~---~~~ 160 (331)
T cd06649 86 DGGSLDQVLKEAKRIPEEILGKVSIAVLRGLAYLREK--HQIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS---MAN 160 (331)
T ss_pred CCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhhc--CCEEcCCCChhhEEEcCCCcEEEccCccccccccc---ccc
Confidence 9999999998877889999999999999999999985 26999999999999999999999999999765322 123
Q ss_pred cccccCCcccccccccCCCCcccceehHHHHHHHHHhcCcCCCcchhhhhhhhHHHHHHH--------------------
Q 003836 662 AIRGTKGYVAPEWFRNMPITVKVDVYSYGVLLLEIICLRRNIDNEISKVDKAILTDWAYD-------------------- 721 (792)
Q Consensus 662 ~~~gt~~y~aPE~~~~~~~~~k~DV~S~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~-------------------- 721 (792)
...|++.|+|||.+.+..++.++|||||||++|||++|+.||...........+......
T Consensus 161 ~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (331)
T cd06649 161 SFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVELAIGRYPIPPPDAKELEAIFGRPVVDGEEGEPHSISPRPRPPGRPV 240 (331)
T ss_pred cCCCCcCcCCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhcccccccccCCccccCcccccccccc
Confidence 346899999999999999999999999999999999999999643221110000000000
Q ss_pred ------hhcccchhHhhh----chhcccCCHHHHHHHHHHHHHccccCCCCCCCHHhHHHH
Q 003836 722 ------RYQERTLEALVE----NDLEAMNNVTMLHRFVMVAFWCIQEDPSHRPTMRKVTQM 772 (792)
Q Consensus 722 ------~~~~~~~~~~~~----~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~ 772 (792)
.........+.+ .............++.+++.+||+.||++|||++|+++.
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~~P~~Rpt~~ell~h 301 (331)
T cd06649 241 SGHGMDSRPAMAIFELLDYIVNEPPPKLPNGVFTPDFQEFVNKCLIKNPAERADLKMLMNH 301 (331)
T ss_pred cccccccccchhHHHHHHHHHhCCCcCCCCccccHHHHHHHHHHccCCcccCCCHHHHhcC
Confidence 000000001111 111111112356789999999999999999999999875
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-37 Score=331.82 Aligned_cols=243 Identities=24% Similarity=0.277 Sum_probs=198.9
Q ss_pred hhcCccccceEEEeeecCCCceEEEEEEccccc---ccchHHHHHHHHHhcccCCCCcccccceeccCCceEEEEEeccC
Q 003836 507 EELGRGAFGTVYKGFVNMGSSNHVAVKKLNSVF---QDSEKEFKAEVNGIGQTHHKNLVRLLGYCDEGQNRLLVYEFMSN 583 (792)
Q Consensus 507 ~~lG~G~~g~Vy~g~~~~~~~~~vavK~~~~~~---~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~lV~E~~~~ 583 (792)
+.||+|+||.||++.. ..+++.+|+|++.+.. ......+.+|++++++++||||+++++++...+..++||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~-~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~Ey~~~ 79 (328)
T cd05593 1 KLLGKGTFGKVILVRE-KASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLKYSFQTKDRLCFVMEYVNG 79 (328)
T ss_pred CeeeeCCCEEEEEEEE-CCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCEEEEEEeCCCC
Confidence 3689999999999965 3556899999987532 23446788999999999999999999999999999999999999
Q ss_pred CCccccccCCCCCchhHHHHHHHHHHHHHHHHhhccCCCeEecCCCCCcEEEcCCCCeEEeecCCCccccCCCCCccccc
Q 003836 584 GTVASFLFGDSKPNWKLRTEIAMGIAGGLFYLHEECCTQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLDQSHTNTAI 663 (792)
Q Consensus 584 gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dikp~NILl~~~~~~kl~Dfg~a~~~~~~~~~~~~~~ 663 (792)
|+|..++.....+++..+..++.||+.||+|||+. +|+||||||+|||++.++.+||+|||+++...... ......
T Consensus 80 g~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrDikp~NIll~~~~~~kL~DfG~~~~~~~~~-~~~~~~ 155 (328)
T cd05593 80 GELFFHLSRERVFSEDRTRFYGAEIVSALDYLHSG---KIVYRDLKLENLMLDKDGHIKITDFGLCKEGITDA-ATMKTF 155 (328)
T ss_pred CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC---CeEecccCHHHeEECCCCcEEEecCcCCccCCCcc-cccccc
Confidence 99999998878899999999999999999999998 99999999999999999999999999987543221 122345
Q ss_pred cccCCcccccccccCCCCcccceehHHHHHHHHHhcCcCCCcchhhhhhhhHHHHHHHhhcccchhHhhhchhcccCCHH
Q 003836 664 RGTKGYVAPEWFRNMPITVKVDVYSYGVLLLEIICLRRNIDNEISKVDKAILTDWAYDRYQERTLEALVENDLEAMNNVT 743 (792)
Q Consensus 664 ~gt~~y~aPE~~~~~~~~~k~DV~S~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 743 (792)
.||+.|+|||.+.+..++.++|||||||++|||++|+.||........ . ..+... ....+..
T Consensus 156 ~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~Pf~~~~~~~~---~-------------~~~~~~--~~~~p~~ 217 (328)
T cd05593 156 CGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKL---F-------------ELILME--DIKFPRT 217 (328)
T ss_pred cCCcCccChhhhcCCCCCccCCccccchHHHHHhhCCCCCCCCCHHHH---H-------------HHhccC--CccCCCC
Confidence 689999999999998999999999999999999999999965322110 0 000000 0111223
Q ss_pred HHHHHHHHHHHccccCCCCCC-----CHHhHHHH
Q 003836 744 MLHRFVMVAFWCIQEDPSHRP-----TMRKVTQM 772 (792)
Q Consensus 744 ~~~~l~~l~~~Cl~~~p~~RP-----s~~evl~~ 772 (792)
.+.++.+++.+||+.||++|| ++.|+++.
T Consensus 218 ~~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~h 251 (328)
T cd05593 218 LSADAKSLLSGLLIKDPNKRLGGGPDDAKEIMRH 251 (328)
T ss_pred CCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHhcC
Confidence 456788999999999999997 88888864
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate |
| >cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-37 Score=334.46 Aligned_cols=251 Identities=20% Similarity=0.295 Sum_probs=202.8
Q ss_pred hhhhhcCccccceEEEeeecCCCceEEEEEEccccc---ccchHHHHHHHHHhcccCCCCcccccceeccCCceEEEEEe
Q 003836 504 GFKEELGRGAFGTVYKGFVNMGSSNHVAVKKLNSVF---QDSEKEFKAEVNGIGQTHHKNLVRLLGYCDEGQNRLLVYEF 580 (792)
Q Consensus 504 ~~~~~lG~G~~g~Vy~g~~~~~~~~~vavK~~~~~~---~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~lV~E~ 580 (792)
.+.+.||+|+||.||+|... .+++.||+|++.... ....+.+.+|++++.+++||||+++++++.+.+..++||||
T Consensus 4 ~~~~~ig~G~~g~Vy~~~~~-~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~ 82 (333)
T cd05600 4 QILTQVGQGGYGQVFLAKKK-DTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLLYAFQDDEYLYLAMEY 82 (333)
T ss_pred EEEEEEeecCCeEEEEEEEC-CCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhCCCCCCccEEEEEEcCCEEEEEEeC
Confidence 34578999999999999754 456789999987532 23345788999999999999999999999999999999999
Q ss_pred ccCCCccccccCCCCCchhHHHHHHHHHHHHHHHHhhccCCCeEecCCCCCcEEEcCCCCeEEeecCCCccccCCCCCcc
Q 003836 581 MSNGTVASFLFGDSKPNWKLRTEIAMGIAGGLFYLHEECCTQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLDQSHTN 660 (792)
Q Consensus 581 ~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dikp~NILl~~~~~~kl~Dfg~a~~~~~~~~~~~ 660 (792)
+++|+|.+++.....+++..+..++.||+.||.|||+. +|+||||||+|||++.++.+||+|||+++.... ..
T Consensus 83 ~~g~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~kL~Dfg~a~~~~~----~~ 155 (333)
T cd05600 83 VPGGDFRTLLNNLGVLSEDHARFYMAEMFEAVDALHEL---GYIHRDLKPENFLIDASGHIKLTDFGLSKGIVT----YA 155 (333)
T ss_pred CCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEECCCCCEEEEeCcCCccccc----cc
Confidence 99999999998878889999999999999999999998 999999999999999999999999999986543 22
Q ss_pred ccccccCCcccccccccCCCCcccceehHHHHHHHHHhcCcCCCcchhhhhhhhHHHHHHHhhcccchhHhhhchhcccC
Q 003836 661 TAIRGTKGYVAPEWFRNMPITVKVDVYSYGVLLLEIICLRRNIDNEISKVDKAILTDWAYDRYQERTLEALVENDLEAMN 740 (792)
Q Consensus 661 ~~~~gt~~y~aPE~~~~~~~~~k~DV~S~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 740 (792)
....||+.|+|||.+.+..++.++|||||||++|||++|+.||...........+..+ . ..+........
T Consensus 156 ~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~i~~~-----~-----~~~~~~~~~~~ 225 (333)
T cd05600 156 NSVVGSPDYMAPEVLRGKGYDFTVDYWSLGCMLYEFLCGFPPFSGSTPNETWENLKYW-----K-----ETLQRPVYDDP 225 (333)
T ss_pred CCcccCccccChhHhcCCCCCCccceecchHHHhhhhhCCCCCCCCCHHHHHHHHHhc-----c-----ccccCCCCCcc
Confidence 3456899999999999999999999999999999999999999754322111111000 0 00000000000
Q ss_pred CHHHHHHHHHHHHHccccCCCCCCCHHhHHHH
Q 003836 741 NVTMLHRFVMVAFWCIQEDPSHRPTMRKVTQM 772 (792)
Q Consensus 741 ~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~ 772 (792)
....+.++.+++.+||+.+|.+||+++++++.
T Consensus 226 ~~~~s~~~~~li~~~l~~~~~rr~s~~~ll~h 257 (333)
T cd05600 226 RFNLSDEAWDLITKLINDPSRRFGSLEDIKNH 257 (333)
T ss_pred ccccCHHHHHHHHHHhhChhhhcCCHHHHHhC
Confidence 12345678899999999999999999999975
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. |
| >PTZ00263 protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-37 Score=333.73 Aligned_cols=244 Identities=23% Similarity=0.279 Sum_probs=200.0
Q ss_pred hhhhhhcCccccceEEEeeecCCCceEEEEEEccccc---ccchHHHHHHHHHhcccCCCCcccccceeccCCceEEEEE
Q 003836 503 RGFKEELGRGAFGTVYKGFVNMGSSNHVAVKKLNSVF---QDSEKEFKAEVNGIGQTHHKNLVRLLGYCDEGQNRLLVYE 579 (792)
Q Consensus 503 ~~~~~~lG~G~~g~Vy~g~~~~~~~~~vavK~~~~~~---~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~lV~E 579 (792)
+.+.+.||+|+||.||++... .+++.+|+|++.... ....+.+.+|+.++++++||||+++++++.+++..++|||
T Consensus 20 y~~~~~lg~G~~g~V~~~~~~-~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e 98 (329)
T PTZ00263 20 FEMGETLGTGSFGRVRIAKHK-GTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPFIVNMMCSFQDENRVYFLLE 98 (329)
T ss_pred eEEEEEEEecCCeEEEEEEEC-CCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCcEEEEEEcCCEEEEEEc
Confidence 345678999999999999764 456789999986532 2234578899999999999999999999999999999999
Q ss_pred eccCCCccccccCCCCCchhHHHHHHHHHHHHHHHHhhccCCCeEecCCCCCcEEEcCCCCeEEeecCCCccccCCCCCc
Q 003836 580 FMSNGTVASFLFGDSKPNWKLRTEIAMGIAGGLFYLHEECCTQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLDQSHT 659 (792)
Q Consensus 580 ~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dikp~NILl~~~~~~kl~Dfg~a~~~~~~~~~~ 659 (792)
|+++|+|.+++.....+++.....++.||+.||+|||+. +|+||||||+|||++.++.+||+|||+++.....
T Consensus 99 ~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~---- 171 (329)
T PTZ00263 99 FVVGGELFTHLRKAGRFPNDVAKFYHAELVLAFEYLHSK---DIIYRDLKPENLLLDNKGHVKVTDFGFAKKVPDR---- 171 (329)
T ss_pred CCCCChHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCHHHEEECCCCCEEEeeccCceEcCCC----
Confidence 999999999998888889999999999999999999998 9999999999999999999999999999865322
Q ss_pred cccccccCCcccccccccCCCCcccceehHHHHHHHHHhcCcCCCcchhhhhhhhHHHHHHHhhcccchhHhhhchhccc
Q 003836 660 NTAIRGTKGYVAPEWFRNMPITVKVDVYSYGVLLLEIICLRRNIDNEISKVDKAILTDWAYDRYQERTLEALVENDLEAM 739 (792)
Q Consensus 660 ~~~~~gt~~y~aPE~~~~~~~~~k~DV~S~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 739 (792)
.....||+.|+|||.+.+..++.++|||||||++|||++|+.||........ .. .+..... .
T Consensus 172 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~--------~~--------~i~~~~~--~ 233 (329)
T PTZ00263 172 TFTLCGTPEYLAPEVIQSKGHGKAVDWWTMGVLLYEFIAGYPPFFDDTPFRI--------YE--------KILAGRL--K 233 (329)
T ss_pred cceecCChhhcCHHHHcCCCCCCcceeechHHHHHHHHcCCCCCCCCCHHHH--------HH--------HHhcCCc--C
Confidence 1234689999999999999999999999999999999999999965422100 00 1111111 1
Q ss_pred CCHHHHHHHHHHHHHccccCCCCCCC-----HHhHHHH
Q 003836 740 NNVTMLHRFVMVAFWCIQEDPSHRPT-----MRKVTQM 772 (792)
Q Consensus 740 ~~~~~~~~l~~l~~~Cl~~~p~~RPs-----~~evl~~ 772 (792)
.+.....++.+++.+||+.||.+||+ +++++..
T Consensus 234 ~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~h 271 (329)
T PTZ00263 234 FPNWFDGRARDLVKGLLQTDHTKRLGTLKGGVADVKNH 271 (329)
T ss_pred CCCCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcC
Confidence 12223456789999999999999997 6777754
|
|
| >cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-37 Score=323.99 Aligned_cols=253 Identities=27% Similarity=0.418 Sum_probs=203.7
Q ss_pred hhhhhhcCccccceEEEeeecCC----CceEEEEEEccccc-ccchHHHHHHHHHhcccCCCCcccccceeccCCceEEE
Q 003836 503 RGFKEELGRGAFGTVYKGFVNMG----SSNHVAVKKLNSVF-QDSEKEFKAEVNGIGQTHHKNLVRLLGYCDEGQNRLLV 577 (792)
Q Consensus 503 ~~~~~~lG~G~~g~Vy~g~~~~~----~~~~vavK~~~~~~-~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~lV 577 (792)
..+.+.||+|+||.||+|..... ....+++|.+.... ......+.+|+.++.+++||||+++++++......+++
T Consensus 7 ~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~~~ 86 (283)
T cd05048 7 VRFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDLQHPNIVCLLGVCTKEQPTCML 86 (283)
T ss_pred cchhhcccCccCCcEEEEEEecCCCCcceeeEEEEecccCCCHHHHHHHHHHHHHHHhcCCcccceEEEEEcCCCceEEE
Confidence 34567899999999999976432 22579999987543 23346789999999999999999999999999999999
Q ss_pred EEeccCCCccccccCC----------------CCCchhHHHHHHHHHHHHHHHHhhccCCCeEecCCCCCcEEEcCCCCe
Q 003836 578 YEFMSNGTVASFLFGD----------------SKPNWKLRTEIAMGIAGGLFYLHEECCTQIIHCDIKPQNILLDDHYNA 641 (792)
Q Consensus 578 ~E~~~~gsL~~~l~~~----------------~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dikp~NILl~~~~~~ 641 (792)
|||+++++|.+++... ..+++..+..++.|++.||+|||+. +++|+||||+||++++++.+
T Consensus 87 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH~~---~i~H~dlkp~Nil~~~~~~~ 163 (283)
T cd05048 87 FEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLSSH---HFVHRDLAARNCLVGEGLTV 163 (283)
T ss_pred EecCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccccccceEEEcCCCcE
Confidence 9999999999998653 3467888999999999999999998 99999999999999999999
Q ss_pred EEeecCCCccccCCCC-CccccccccCCcccccccccCCCCcccceehHHHHHHHHHh-cCcCCCcchhhhhhhhHHHHH
Q 003836 642 RISDFGLAKLLTLDQS-HTNTAIRGTKGYVAPEWFRNMPITVKVDVYSYGVLLLEIIC-LRRNIDNEISKVDKAILTDWA 719 (792)
Q Consensus 642 kl~Dfg~a~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~k~DV~S~Gv~l~el~t-g~~p~~~~~~~~~~~~~~~~~ 719 (792)
||+|||+++....... .......+++.|+|||.+.+..++.++|||||||++|||++ |..||........
T Consensus 164 ~L~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDv~slG~il~el~~~g~~p~~~~~~~~~-------- 235 (283)
T cd05048 164 KISDFGLSRDIYSADYYRVQSKSLLPVRWMPPEAILYGKFTTESDIWSFGVVLWEIFSYGLQPYYGFSNQEV-------- 235 (283)
T ss_pred EECCCcceeeccccccccccCCCcccccccCHHHhccCcCchhhhHHHHHHHHHHHHcCCCCCCCCCCHHHH--------
Confidence 9999999986543222 12223346788999999998899999999999999999998 9999865432110
Q ss_pred HHhhcccchhHhhhchhcccCCHHHHHHHHHHHHHccccCCCCCCCHHhHHHHhcc
Q 003836 720 YDRYQERTLEALVENDLEAMNNVTMLHRFVMVAFWCIQEDPSHRPTMRKVTQMLEG 775 (792)
Q Consensus 720 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~L~~ 775 (792)
...+........+...+.++.+++.+||+.+|++||+++||+++|++
T Consensus 236 ---------~~~i~~~~~~~~~~~~~~~~~~l~~~c~~~~p~~Rp~~~~i~~~l~~ 282 (283)
T cd05048 236 ---------IEMIRSRQLLPCPEDCPARVYALMIECWNEIPARRPRFKDIHTRLRS 282 (283)
T ss_pred ---------HHHHHcCCcCCCcccCCHHHHHHHHHHccCChhhCcCHHHHHHHHhc
Confidence 01111111122234556789999999999999999999999999976
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer |
| >KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-37 Score=312.41 Aligned_cols=248 Identities=21% Similarity=0.369 Sum_probs=209.4
Q ss_pred HHHhhhhhhcCccccceEEEeeecCCCceEEEEEEcccccc---cchHHHHHHHHHhcccCCCCcccccceeccCCceEE
Q 003836 500 EVTRGFKEELGRGAFGTVYKGFVNMGSSNHVAVKKLNSVFQ---DSEKEFKAEVNGIGQTHHKNLVRLLGYCDEGQNRLL 576 (792)
Q Consensus 500 ~~~~~~~~~lG~G~~g~Vy~g~~~~~~~~~vavK~~~~~~~---~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~l 576 (792)
+.++.|.+.||+|.||.|-++.. ...++.||||.+++... +..-.+.+||++|..|+||||+.++.+|+..+...|
T Consensus 52 kHRyE~~etLGkGTYGKVk~A~e-~~sgR~VAiKsIrKdkIkdeqDlvhIRREIeIMSsLNHPhII~IyEVFENkdKIvi 130 (668)
T KOG0611|consen 52 KHRYEITETLGKGTYGKVKLAYE-HKSGREVAIKSIRKDKIKDEQDLVHIRREIEIMSSLNHPHIIQIYEVFENKDKIVI 130 (668)
T ss_pred hhHHHHHHHhcCCcccceeehhh-ccCCcEeehhhhhhhhcccHHHHHHHHHHHHHHhhcCCCceeehhhhhcCCceEEE
Confidence 34567889999999999999964 35678999999876433 334568899999999999999999999999999999
Q ss_pred EEEeccCCCccccccCCCCCchhHHHHHHHHHHHHHHHHhhccCCCeEecCCCCCcEEEcCCCCeEEeecCCCccccCCC
Q 003836 577 VYEFMSNGTVASFLFGDSKPNWKLRTEIAMGIAGGLFYLHEECCTQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLDQ 656 (792)
Q Consensus 577 V~E~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dikp~NILl~~~~~~kl~Dfg~a~~~~~~~ 656 (792)
||||..+|.|.+|+...+.+++.....+++||..|+.|+|.. +++|||||.+|||||.|+++||+|||++-.+..+
T Consensus 131 vMEYaS~GeLYDYiSer~~LsErEaRhfFRQIvSAVhYCHkn---rVvHRDLKLENILLD~N~NiKIADFGLSNly~~~- 206 (668)
T KOG0611|consen 131 VMEYASGGELYDYISERGSLSEREARHFFRQIVSAVHYCHKN---RVVHRDLKLENILLDQNNNIKIADFGLSNLYADK- 206 (668)
T ss_pred EEEecCCccHHHHHHHhccccHHHHHHHHHHHHHHHHHHhhc---cceecccchhheeecCCCCeeeeccchhhhhccc-
Confidence 999999999999999999999999999999999999999999 9999999999999999999999999999876533
Q ss_pred CCccccccccCCcccccccccCCCC-cccceehHHHHHHHHHhcCcCCCcchhhhhhhhHHHHHHHhhcccchhHhhhch
Q 003836 657 SHTNTAIRGTKGYVAPEWFRNMPIT-VKVDVYSYGVLLLEIICLRRNIDNEISKVDKAILTDWAYDRYQERTLEALVEND 735 (792)
Q Consensus 657 ~~~~~~~~gt~~y~aPE~~~~~~~~-~k~DV~S~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 735 (792)
.-..+++|++-|.+||++.+.+|. +..|-|||||+||.|+.|..||+...... .. .++....
T Consensus 207 -kfLqTFCGSPLYASPEIvNG~PY~GPEVDsWsLGvLLYtLVyGtMPFDG~Dhk~---lv-------------rQIs~Ga 269 (668)
T KOG0611|consen 207 -KFLQTFCGSPLYASPEIVNGTPYKGPEVDSWSLGVLLYTLVYGTMPFDGRDHKR---LV-------------RQISRGA 269 (668)
T ss_pred -cHHHHhcCCcccCCccccCCCCCCCCccchhhHHHHHHHHhhcccccCCchHHH---HH-------------HHhhccc
Confidence 334568899999999999999885 78999999999999999999998754321 11 1111111
Q ss_pred hcccCCHHHHHHHHHHHHHccccCCCCCCCHHhHHHH
Q 003836 736 LEAMNNVTMLHRFVMVAFWCIQEDPSHRPTMRKVTQM 772 (792)
Q Consensus 736 ~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~ 772 (792)
.. .++.+....-||+|||-.||+.|.|+++|...
T Consensus 270 Yr---EP~~PSdA~gLIRwmLmVNP~RRATieDiAsH 303 (668)
T KOG0611|consen 270 YR---EPETPSDASGLIRWMLMVNPERRATIEDIASH 303 (668)
T ss_pred cc---CCCCCchHHHHHHHHHhcCcccchhHHHHhhh
Confidence 11 22344566779999999999999999999875
|
|
| >cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-37 Score=337.55 Aligned_cols=257 Identities=23% Similarity=0.355 Sum_probs=201.9
Q ss_pred hhhhhhcCccccceEEEeeecC----CCceEEEEEEccccccc-chHHHHHHHHHhcccC-CCCcccccceeccCCceEE
Q 003836 503 RGFKEELGRGAFGTVYKGFVNM----GSSNHVAVKKLNSVFQD-SEKEFKAEVNGIGQTH-HKNLVRLLGYCDEGQNRLL 576 (792)
Q Consensus 503 ~~~~~~lG~G~~g~Vy~g~~~~----~~~~~vavK~~~~~~~~-~~~~~~~Ei~~l~~l~-h~niv~l~g~~~~~~~~~l 576 (792)
..+.+.||+|+||.||+|+... .....||||++...... ..+.+.+|+++++++. ||||++++++|.+....+|
T Consensus 39 ~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~~l~~l~~HpnIv~l~~~~~~~~~~~l 118 (400)
T cd05105 39 LVLGRILGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPTARSSEKQALMSELKIMTHLGPHLNIVNLLGACTKSGPIYI 118 (400)
T ss_pred eehhheecCCCCceEEEEEEcccCCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCCeeeEEEEEccCCceEE
Confidence 3456789999999999997532 22347999999754332 3457999999999996 9999999999999999999
Q ss_pred EEEeccCCCccccccCC---------------------------------------------------------------
Q 003836 577 VYEFMSNGTVASFLFGD--------------------------------------------------------------- 593 (792)
Q Consensus 577 V~E~~~~gsL~~~l~~~--------------------------------------------------------------- 593 (792)
||||+++|+|.++|+..
T Consensus 119 v~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 198 (400)
T cd05105 119 ITEYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSYVILSFENKGDYMDMKQADTTQYVPMLEIKEAS 198 (400)
T ss_pred EEEecCCCcHHHHHHHhhhhhhccccccccccccccCCCcccccccchhhhhhcccccccccccccccccchhhhhhhhh
Confidence 99999999999887532
Q ss_pred ---------------------------------CCCchhHHHHHHHHHHHHHHHHhhccCCCeEecCCCCCcEEEcCCCC
Q 003836 594 ---------------------------------SKPNWKLRTEIAMGIAGGLFYLHEECCTQIIHCDIKPQNILLDDHYN 640 (792)
Q Consensus 594 ---------------------------------~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dikp~NILl~~~~~ 640 (792)
..+++..+.+++.||++||+|||+. +|+|+||||+|||+++++.
T Consensus 199 ~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~---~ivH~dikp~Nill~~~~~ 275 (400)
T cd05105 199 KYSDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLASK---NCVHRDLAARNVLLAQGKI 275 (400)
T ss_pred hhhhcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCChHhEEEeCCCE
Confidence 1356777889999999999999998 9999999999999999999
Q ss_pred eEEeecCCCccccCCCCC-ccccccccCCcccccccccCCCCcccceehHHHHHHHHHh-cCcCCCcchhhhhhhhHHHH
Q 003836 641 ARISDFGLAKLLTLDQSH-TNTAIRGTKGYVAPEWFRNMPITVKVDVYSYGVLLLEIIC-LRRNIDNEISKVDKAILTDW 718 (792)
Q Consensus 641 ~kl~Dfg~a~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~k~DV~S~Gv~l~el~t-g~~p~~~~~~~~~~~~~~~~ 718 (792)
+||+|||+++........ ......+++.|+|||.+.+..++.++|||||||++|||++ |+.||.........
T Consensus 276 ~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwSlGvil~ellt~g~~P~~~~~~~~~~------ 349 (400)
T cd05105 276 VKICDFGLARDIMHDSNYVSKGSTFLPVKWMAPESIFDNLYTTLSDVWSYGILLWEIFSLGGTPYPGMIVDSTF------ 349 (400)
T ss_pred EEEEeCCcceeccccccccccCCcCCCcceEChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCcccchhHHH------
Confidence 999999999865433222 1222346788999999998899999999999999999997 88888654221110
Q ss_pred HHHhhcccchhHhhhchhcccCCHHHHHHHHHHHHHccccCCCCCCCHHhHHHHhccCcC
Q 003836 719 AYDRYQERTLEALVENDLEAMNNVTMLHRFVMVAFWCIQEDPSHRPTMRKVTQMLEGVVE 778 (792)
Q Consensus 719 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~L~~~~~ 778 (792)
... +........+...+.++.+++.+||+.+|++||++.+|.++|+.+.+
T Consensus 350 -~~~---------~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~l~~l~~ 399 (400)
T cd05105 350 -YNK---------IKSGYRMAKPDHATQEVYDIMVKCWNSEPEKRPSFLHLSDIVESLLP 399 (400)
T ss_pred -HHH---------HhcCCCCCCCccCCHHHHHHHHHHCccCHhHCcCHHHHHHHHHHHcC
Confidence 000 01111111223445678999999999999999999999999998654
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF- |
| >KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-37 Score=322.99 Aligned_cols=265 Identities=20% Similarity=0.283 Sum_probs=213.5
Q ss_pred hhhcCccccceEEEeeecCCCceEEEEEEccccc---ccchHHHHHHHHHhcccCCCCcccccceeccCCceEEEEEecc
Q 003836 506 KEELGRGAFGTVYKGFVNMGSSNHVAVKKLNSVF---QDSEKEFKAEVNGIGQTHHKNLVRLLGYCDEGQNRLLVYEFMS 582 (792)
Q Consensus 506 ~~~lG~G~~g~Vy~g~~~~~~~~~vavK~~~~~~---~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~lV~E~~~ 582 (792)
.++||+|+||.||+++- ..++..+|+|++++.. ....+.++.|-.+|...+++.||+|+-.|.+.+.+||||||++
T Consensus 146 Lk~IgkGAfGeVrLarK-k~Tg~iyAmK~LkKS~M~~~~Qv~hV~aERdiL~~~ds~~vVKLyYsFQD~~~LYLiMEylP 224 (550)
T KOG0605|consen 146 LKVIGKGAFGEVRLARK-KDTGEIYAMKILKKSEMLKKNQVEHVRAERDILAEVDSPWVVKLYYSFQDKEYLYLIMEYLP 224 (550)
T ss_pred heeeccccceeEEEEEE-ccCCcEEeeecccHHHHHhhhhHHHHHHHHHHhhhcCCCcEEEEEEEecCCCeeEEEEEecC
Confidence 36799999999999964 5678899999998753 3345678899999999999999999999999999999999999
Q ss_pred CCCccccccCCCCCchhHHHHHHHHHHHHHHHHhhccCCCeEecCCCCCcEEEcCCCCeEEeecCCCccccCC-------
Q 003836 583 NGTVASFLFGDSKPNWKLRTEIAMGIAGGLFYLHEECCTQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLD------- 655 (792)
Q Consensus 583 ~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dikp~NILl~~~~~~kl~Dfg~a~~~~~~------- 655 (792)
||++..+|.....+++......+.+++-||..||+. |||||||||+|+|||..|++||+|||++.-+...
T Consensus 225 GGD~mTLL~~~~~L~e~~arfYiaE~vlAI~~iH~~---gyIHRDIKPdNlLiD~~GHiKLSDFGLs~gl~~~~~~~~~~ 301 (550)
T KOG0605|consen 225 GGDMMTLLMRKDTLTEDWARFYIAETVLAIESIHQL---GYIHRDIKPDNLLIDAKGHIKLSDFGLSTGLDKKHRIESYR 301 (550)
T ss_pred CccHHHHHHhcCcCchHHHHHHHHHHHHHHHHHHHc---CcccccCChhheeecCCCCEeeccccccchhhhhhhhhhhc
Confidence 999999999999999999999999999999999999 9999999999999999999999999999643210
Q ss_pred ---------------CCC-----c-------------------cccccccCCcccccccccCCCCcccceehHHHHHHHH
Q 003836 656 ---------------QSH-----T-------------------NTAIRGTKGYVAPEWFRNMPITVKVDVYSYGVLLLEI 696 (792)
Q Consensus 656 ---------------~~~-----~-------------------~~~~~gt~~y~aPE~~~~~~~~~k~DV~S~Gv~l~el 696 (792)
... . ....+|||-|||||++.+..|+..+|.||||||+|||
T Consensus 302 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~~nrr~~a~StVGTPDYiAPEVll~kgY~~~cDwWSLG~ImyEm 381 (550)
T KOG0605|consen 302 LDEQMQINLSEAKPSDFPKFNTPRSTMSRREQLQTWKRNRRQLAYSTVGTPDYIAPEVLLGKGYGKECDWWSLGCIMYEM 381 (550)
T ss_pred chhhhhhhhccCCCccccccccccchhhHHHHHHHHHhhhhhhhhcccCCccccchHHHhcCCCCccccHHHHHHHHHHH
Confidence 000 0 0123599999999999999999999999999999999
Q ss_pred HhcCcCCCcchhhhhhhhHHHHHHHhhcccchhHhhhchhcccCCHHHHHHHHHHHHHccccCCCCCCC---HHhHHHHh
Q 003836 697 ICLRRNIDNEISKVDKAILTDWAYDRYQERTLEALVENDLEAMNNVTMLHRFVMVAFWCIQEDPSHRPT---MRKVTQML 773 (792)
Q Consensus 697 ~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs---~~evl~~L 773 (792)
+.|-+||..+.....-..+..|-.. +........+.+..+||.+|+. ||++|.- ++||.++-
T Consensus 382 LvGyPPF~s~tp~~T~rkI~nwr~~--------------l~fP~~~~~s~eA~DLI~rll~-d~~~RLG~~G~~EIK~HP 446 (550)
T KOG0605|consen 382 LVGYPPFCSETPQETYRKIVNWRET--------------LKFPEEVDLSDEAKDLITRLLC-DPENRLGSKGAEEIKKHP 446 (550)
T ss_pred HhCCCCCCCCCHHHHHHHHHHHhhh--------------ccCCCcCcccHHHHHHHHHHhc-CHHHhcCcccHHHHhcCC
Confidence 9999999887655443334333211 1111222344788899999999 9999974 67776642
Q ss_pred -------ccCcCCCCCCCCCCCC
Q 003836 774 -------EGVVEVPIPPCPWTLN 789 (792)
Q Consensus 774 -------~~~~~~~~p~~P~~~~ 789 (792)
+.+.+.+.|=.|-..+
T Consensus 447 fF~~v~W~~l~~~~apfvP~v~~ 469 (550)
T KOG0605|consen 447 FFKGVDWDHLREMPAPFVPQVNS 469 (550)
T ss_pred ccccCCcchhhcCCCCCCCCCCC
Confidence 4556666555555443
|
|
| >cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-36 Score=317.85 Aligned_cols=248 Identities=25% Similarity=0.400 Sum_probs=199.2
Q ss_pred hhhhhcCccccceEEEeeecCCCceEEEEEEcccccccchHHHHHHHHHhcccCCCCcccccceeccCCceEEEEEeccC
Q 003836 504 GFKEELGRGAFGTVYKGFVNMGSSNHVAVKKLNSVFQDSEKEFKAEVNGIGQTHHKNLVRLLGYCDEGQNRLLVYEFMSN 583 (792)
Q Consensus 504 ~~~~~lG~G~~g~Vy~g~~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~lV~E~~~~ 583 (792)
.+.+.||+|+||.||++... .+..+|+|.+... .....++.+|+.++++++||||+++++++.+.+..++||||+++
T Consensus 7 ~~~~~lg~G~~~~vy~~~~~--~~~~~a~K~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e~~~~ 83 (256)
T cd05114 7 TFMKELGSGQFGVVHLGKWR--AQIKVAIKAINEG-AMSEEDFIEEAKVMMKLSHPKLVQLYGVCTQQKPLYIVTEFMEN 83 (256)
T ss_pred EEeeEecCCcCceEEEEEec--cCceEEEEecccC-CccHHHHHHHHHHHHHCCCCCceeEEEEEccCCCEEEEEEcCCC
Confidence 34578999999999999764 3457999988643 33457899999999999999999999999999999999999999
Q ss_pred CCccccccCC-CCCchhHHHHHHHHHHHHHHHHhhccCCCeEecCCCCCcEEEcCCCCeEEeecCCCccccCCCCCcccc
Q 003836 584 GTVASFLFGD-SKPNWKLRTEIAMGIAGGLFYLHEECCTQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLDQSHTNTA 662 (792)
Q Consensus 584 gsL~~~l~~~-~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dikp~NILl~~~~~~kl~Dfg~a~~~~~~~~~~~~~ 662 (792)
|+|.+++... ..+++..+..++.|++.||+|||+. +|+|+||||+||++++++.+||+|||.++............
T Consensus 84 ~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~ni~i~~~~~~kl~d~g~~~~~~~~~~~~~~~ 160 (256)
T cd05114 84 GCLLNYLRQRQGKLSKDMLLSMCQDVCEGMEYLERN---SFIHRDLAARNCLVSSTGVVKVSDFGMTRYVLDDEYTSSSG 160 (256)
T ss_pred CcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHC---CccccccCcceEEEcCCCeEEECCCCCccccCCCceeccCC
Confidence 9999998754 4688999999999999999999998 99999999999999999999999999998654333222222
Q ss_pred ccccCCcccccccccCCCCcccceehHHHHHHHHHh-cCcCCCcchhhhhhhhHHHHHHHhhcccchhHhhhchhcccCC
Q 003836 663 IRGTKGYVAPEWFRNMPITVKVDVYSYGVLLLEIIC-LRRNIDNEISKVDKAILTDWAYDRYQERTLEALVENDLEAMNN 741 (792)
Q Consensus 663 ~~gt~~y~aPE~~~~~~~~~k~DV~S~Gv~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 741 (792)
..++..|+|||.+.+..++.++||||||+++|||++ |+.||.......... ..... .....+
T Consensus 161 ~~~~~~y~aPE~~~~~~~~~~~Di~s~G~~l~el~~~g~~p~~~~~~~~~~~--------~i~~~---------~~~~~~ 223 (256)
T cd05114 161 AKFPVKWSPPEVFNFSKYSSKSDVWSFGVLMWEVFTEGKMPFEKKSNYEVVE--------MISRG---------FRLYRP 223 (256)
T ss_pred CCCchhhCChhhcccCccchhhhhHHHHHHHHHHHcCCCCCCCCCCHHHHHH--------HHHCC---------CCCCCC
Confidence 335668999999998899999999999999999999 888886543211100 00000 001111
Q ss_pred HHHHHHHHHHHHHccccCCCCCCCHHhHHHHhc
Q 003836 742 VTMLHRFVMVAFWCIQEDPSHRPTMRKVTQMLE 774 (792)
Q Consensus 742 ~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~L~ 774 (792)
......+.+++.+||+.+|++||+++++++.|.
T Consensus 224 ~~~~~~~~~li~~c~~~~p~~Rps~~~l~~~l~ 256 (256)
T cd05114 224 KLASMTVYEVMYSCWHEKPEGRPTFAELLRAIT 256 (256)
T ss_pred CCCCHHHHHHHHHHccCCcccCcCHHHHHHhhC
Confidence 223457899999999999999999999999873
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h |
| >cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-37 Score=331.10 Aligned_cols=243 Identities=24% Similarity=0.284 Sum_probs=198.1
Q ss_pred hhcCccccceEEEeeecCCCceEEEEEEccccc---ccchHHHHHHHHHhcccCCCCcccccceeccCCceEEEEEeccC
Q 003836 507 EELGRGAFGTVYKGFVNMGSSNHVAVKKLNSVF---QDSEKEFKAEVNGIGQTHHKNLVRLLGYCDEGQNRLLVYEFMSN 583 (792)
Q Consensus 507 ~~lG~G~~g~Vy~g~~~~~~~~~vavK~~~~~~---~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~lV~E~~~~ 583 (792)
+.||+|+||.||++... .+++.||+|++.... ......+.+|++++++++||||+++++++...+..++||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~-~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~~lv~E~~~~ 79 (323)
T cd05595 1 KLLGKGTFGKVILVREK-ATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANG 79 (323)
T ss_pred CeeeeCCCEEEEEEEEC-CCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCcceeeEEecCCEEEEEEeCCCC
Confidence 36899999999999753 456799999987532 23345678899999999999999999999999999999999999
Q ss_pred CCccccccCCCCCchhHHHHHHHHHHHHHHHHhhccCCCeEecCCCCCcEEEcCCCCeEEeecCCCccccCCCCCccccc
Q 003836 584 GTVASFLFGDSKPNWKLRTEIAMGIAGGLFYLHEECCTQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLDQSHTNTAI 663 (792)
Q Consensus 584 gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dikp~NILl~~~~~~kl~Dfg~a~~~~~~~~~~~~~~ 663 (792)
|+|..++.....+++..+..++.||+.||+|||+. +|+||||||+|||++.++.+||+|||+++...... ......
T Consensus 80 ~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~-~~~~~~ 155 (323)
T cd05595 80 GELFFHLSRERVFTEERARFYGAEIVSALEYLHSR---DVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDG-ATMKTF 155 (323)
T ss_pred CcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHEEEcCCCCEEecccHHhccccCCC-Cccccc
Confidence 99999998777899999999999999999999998 99999999999999999999999999987542221 222345
Q ss_pred cccCCcccccccccCCCCcccceehHHHHHHHHHhcCcCCCcchhhhhhhhHHHHHHHhhcccchhHhhhchhcccCCHH
Q 003836 664 RGTKGYVAPEWFRNMPITVKVDVYSYGVLLLEIICLRRNIDNEISKVDKAILTDWAYDRYQERTLEALVENDLEAMNNVT 743 (792)
Q Consensus 664 ~gt~~y~aPE~~~~~~~~~k~DV~S~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 743 (792)
.||+.|+|||.+.+..++.++|||||||++|||++|+.||........ . ..+..... ..+..
T Consensus 156 ~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~---~-------------~~~~~~~~--~~p~~ 217 (323)
T cd05595 156 CGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERL---F-------------ELILMEEI--RFPRT 217 (323)
T ss_pred cCCcCcCCcccccCCCCCchhchhhhHHHHHHHHhCCCCCCCCCHHHH---H-------------HHHhcCCC--CCCCC
Confidence 689999999999999999999999999999999999999965422110 0 00011100 11223
Q ss_pred HHHHHHHHHHHccccCCCCCC-----CHHhHHHH
Q 003836 744 MLHRFVMVAFWCIQEDPSHRP-----TMRKVTQM 772 (792)
Q Consensus 744 ~~~~l~~l~~~Cl~~~p~~RP-----s~~evl~~ 772 (792)
.+..+.+++.+||+.||++|| ++.++++.
T Consensus 218 ~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~l~h 251 (323)
T cd05595 218 LSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEH 251 (323)
T ss_pred CCHHHHHHHHHHccCCHHHhCCCCCCCHHHHHcC
Confidence 456788999999999999998 78888753
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in |
| >KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-37 Score=328.27 Aligned_cols=265 Identities=23% Similarity=0.336 Sum_probs=211.5
Q ss_pred HHHHHHhhhhhhcCccccceEEEeeecCCCceEEEEEEcccccccch-HHHHHHHHHhcccCCCCcccccceeccCCceE
Q 003836 497 ELVEVTRGFKEELGRGAFGTVYKGFVNMGSSNHVAVKKLNSVFQDSE-KEFKAEVNGIGQTHHKNLVRLLGYCDEGQNRL 575 (792)
Q Consensus 497 el~~~~~~~~~~lG~G~~g~Vy~g~~~~~~~~~vavK~~~~~~~~~~-~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~ 575 (792)
|+-...-.|+++||+|-||.|.++..+. ...||||+++....... ++|.+|+++|.+++||||++|+|+|..++.++
T Consensus 534 EfPRs~L~~~ekiGeGqFGEVhLCeveg--~lkVAVK~Lr~~a~~~~r~~F~kEIkiLsqLkhPNIveLvGVC~~DePic 611 (807)
T KOG1094|consen 534 EFPRSRLRFKEKIGEGQFGEVHLCEVEG--PLKVAVKILRPDATKNARNDFLKEIKILSRLKHPNIVELLGVCVQDDPLC 611 (807)
T ss_pred hcchhheehhhhhcCcccceeEEEEecC--ceEEEEeecCcccchhHHHHHHHHHHHHhccCCCCeeEEEeeeecCCchH
Confidence 3333333467899999999999998764 47899999998766554 89999999999999999999999999999999
Q ss_pred EEEEeccCCCccccccCCC--CCchhHHHHHHHHHHHHHHHHhhccCCCeEecCCCCCcEEEcCCCCeEEeecCCCcccc
Q 003836 576 LVYEFMSNGTVASFLFGDS--KPNWKLRTEIAMGIAGGLFYLHEECCTQIIHCDIKPQNILLDDHYNARISDFGLAKLLT 653 (792)
Q Consensus 576 lV~E~~~~gsL~~~l~~~~--~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dikp~NILl~~~~~~kl~Dfg~a~~~~ 653 (792)
+|+|||++|+|.+||..+. ...-..-.+|+.||+.||+||.+. ++|||||.++|+|+|.++++||+|||+++.+.
T Consensus 612 mI~EYmEnGDLnqFl~aheapt~~t~~~vsi~tqiasgmaYLes~---nfVHrd~a~rNcLv~~e~~iKiadfgmsR~ly 688 (807)
T KOG1094|consen 612 MITEYMENGDLNQFLSAHELPTAETAPGVSICTQIASGMAYLESL---NFVHRDLATRNCLVDGEFTIKIADFGMSRNLY 688 (807)
T ss_pred HHHHHHhcCcHHHHHHhccCcccccchhHHHHHHHHHHHHHHHhh---chhhccccccceeecCcccEEecCcccccccc
Confidence 9999999999999998773 335566778999999999999998 99999999999999999999999999999766
Q ss_pred CCCCCcc-ccccccCCcccccccccCCCCcccceehHHHHHHHHHh--cCcCCCcchhhhhhhhHHHHHHHhhcccchhH
Q 003836 654 LDQSHTN-TAIRGTKGYVAPEWFRNMPITVKVDVYSYGVLLLEIIC--LRRNIDNEISKVDKAILTDWAYDRYQERTLEA 730 (792)
Q Consensus 654 ~~~~~~~-~~~~gt~~y~aPE~~~~~~~~~k~DV~S~Gv~l~el~t--g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 730 (792)
....... ...+-.++|||||.+..++++.++|||+|||++||+++ ..+|+......... +-............
T Consensus 689 sg~yy~vqgr~vlpiRwmawEsillgkFttaSDvWafgvTlwE~~~~C~e~Py~~lt~e~vv----en~~~~~~~~~~~~ 764 (807)
T KOG1094|consen 689 SGDYYRVQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEVFMLCREQPYSQLTDEQVV----ENAGEFFRDQGRQV 764 (807)
T ss_pred cCCceeeecceeeeeeehhHHHHHhccccchhhhhhhHHHHHHHHHHHhhCchhhhhHHHHH----HhhhhhcCCCCcce
Confidence 5544432 23445789999999999999999999999999999875 56777554322110 11111111111111
Q ss_pred hhhchhcccCCHHHHHHHHHHHHHccccCCCCCCCHHhHHHHhccC
Q 003836 731 LVENDLEAMNNVTMLHRFVMVAFWCIQEDPSHRPTMRKVTQMLEGV 776 (792)
Q Consensus 731 ~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~L~~~ 776 (792)
....+.-++..+.+++..||..+.++||+++++...|+..
T Consensus 765 ------~l~~P~~cp~~lyelml~Cw~~es~~RPsFe~lh~~lq~~ 804 (807)
T KOG1094|consen 765 ------VLSRPPACPQGLYELMLRCWRRESEQRPSFEQLHLFLQED 804 (807)
T ss_pred ------eccCCCcCcHHHHHHHHHHhchhhhcCCCHHHHHHHHHHh
Confidence 1223445677889999999999999999999999988763
|
|
| >cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-37 Score=320.21 Aligned_cols=255 Identities=25% Similarity=0.411 Sum_probs=204.6
Q ss_pred hhhhhhcCccccceEEEeeecCC--CceEEEEEEccccc-ccchHHHHHHHHHhcccCCCCcccccceeccCCceEEEEE
Q 003836 503 RGFKEELGRGAFGTVYKGFVNMG--SSNHVAVKKLNSVF-QDSEKEFKAEVNGIGQTHHKNLVRLLGYCDEGQNRLLVYE 579 (792)
Q Consensus 503 ~~~~~~lG~G~~g~Vy~g~~~~~--~~~~vavK~~~~~~-~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~lV~E 579 (792)
..+.+.||+|+||.||+|..... +...+|||+++... .....++.+|+.++++++|+||+++++++.+.+..++|||
T Consensus 6 ~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e 85 (266)
T cd05033 6 VTIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNIIRLEGVVTKSRPVMIITE 85 (266)
T ss_pred ceeeeEecCCccceEEEEEEccCCCCcceEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCcceEeEEEecCCceEEEEE
Confidence 34567899999999999987543 34579999987543 3345678999999999999999999999999999999999
Q ss_pred eccCCCccccccCC-CCCchhHHHHHHHHHHHHHHHHhhccCCCeEecCCCCCcEEEcCCCCeEEeecCCCccccCCCCC
Q 003836 580 FMSNGTVASFLFGD-SKPNWKLRTEIAMGIAGGLFYLHEECCTQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLDQSH 658 (792)
Q Consensus 580 ~~~~gsL~~~l~~~-~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dikp~NILl~~~~~~kl~Dfg~a~~~~~~~~~ 658 (792)
|+++++|.+++... ..+++..+.+++.|++.||+|||+. +|+|+||||+|||+++++.+||+|||+++........
T Consensus 86 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~Lh~~---~i~H~di~p~nili~~~~~~~l~dfg~~~~~~~~~~~ 162 (266)
T cd05033 86 YMENGSLDKFLRENDGKFTVGQLVGMLRGIASGMKYLSEM---NYVHRDLAARNILVNSNLVCKVSDFGLSRRLEDSEAT 162 (266)
T ss_pred cCCCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCcceEEEcCCCCEEECccchhhcccccccc
Confidence 99999999999764 4689999999999999999999998 9999999999999999999999999999977522221
Q ss_pred -ccccccccCCcccccccccCCCCcccceehHHHHHHHHHh-cCcCCCcchhhhhhhhHHHHHHHhhcccchhHhhhchh
Q 003836 659 -TNTAIRGTKGYVAPEWFRNMPITVKVDVYSYGVLLLEIIC-LRRNIDNEISKVDKAILTDWAYDRYQERTLEALVENDL 736 (792)
Q Consensus 659 -~~~~~~gt~~y~aPE~~~~~~~~~k~DV~S~Gv~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 736 (792)
......++..|+|||.+.+..++.++||||||+++|||++ |..||........ . .. +....
T Consensus 163 ~~~~~~~~~~~y~~Pe~~~~~~~~~~~Dv~slG~~l~~l~~~g~~p~~~~~~~~~----~----~~---------~~~~~ 225 (266)
T cd05033 163 YTTKGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSYGERPYWDMSNQDV----I----KA---------VEDGY 225 (266)
T ss_pred eeccCCCCCccccChhhhccCCCccccchHHHHHHHHHHHccCCCCCCCCCHHHH----H----HH---------HHcCC
Confidence 1112334678999999998899999999999999999998 8888854322100 0 00 00001
Q ss_pred cccCCHHHHHHHHHHHHHccccCCCCCCCHHhHHHHhccCc
Q 003836 737 EAMNNVTMLHRFVMVAFWCIQEDPSHRPTMRKVTQMLEGVV 777 (792)
Q Consensus 737 ~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~L~~~~ 777 (792)
....+...+..+.+++.+||+.+|++||+++||+++|++++
T Consensus 226 ~~~~~~~~~~~l~~li~~cl~~~p~~Rp~~~ei~~~l~~~~ 266 (266)
T cd05033 226 RLPPPMDCPSALYQLMLDCWQKDRNERPTFSQIVSTLDKMI 266 (266)
T ss_pred CCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhhC
Confidence 11112234567889999999999999999999999998753
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment |
| >cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-36 Score=321.92 Aligned_cols=255 Identities=25% Similarity=0.415 Sum_probs=204.9
Q ss_pred HHhhhhhhcCccccceEEEeeecC----CCceEEEEEEccccccc-chHHHHHHHHHhcccCCCCcccccceeccCCceE
Q 003836 501 VTRGFKEELGRGAFGTVYKGFVNM----GSSNHVAVKKLNSVFQD-SEKEFKAEVNGIGQTHHKNLVRLLGYCDEGQNRL 575 (792)
Q Consensus 501 ~~~~~~~~lG~G~~g~Vy~g~~~~----~~~~~vavK~~~~~~~~-~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~ 575 (792)
..+.+.+.||+|+||.||+|.... ...+.+|+|+++..... ..+.+.+|++++++++|+||+++++++......+
T Consensus 5 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~ 84 (280)
T cd05049 5 DTIVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHENIVKFYGVCTEGDPPI 84 (280)
T ss_pred HHhhHHhhccccCCceEeeeeeccccCcCCcceEEEEeecccCCHHHHHHHHHHHHHHHhcCCCCchheeeEEecCCCeE
Confidence 445667899999999999997642 23468999999765444 4578999999999999999999999999999999
Q ss_pred EEEEeccCCCccccccCC--------------CCCchhHHHHHHHHHHHHHHHHhhccCCCeEecCCCCCcEEEcCCCCe
Q 003836 576 LVYEFMSNGTVASFLFGD--------------SKPNWKLRTEIAMGIAGGLFYLHEECCTQIIHCDIKPQNILLDDHYNA 641 (792)
Q Consensus 576 lV~E~~~~gsL~~~l~~~--------------~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dikp~NILl~~~~~~ 641 (792)
+||||+++++|.+++... ..+++..+..++.||+.||.|||+. +++|+||||+||+++.++.+
T Consensus 85 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~---~i~h~dlkp~nili~~~~~~ 161 (280)
T cd05049 85 MVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLASQ---HFVHRDLATRNCLVGYDLVV 161 (280)
T ss_pred EEEecCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHhhC---CeeccccccceEEEcCCCeE
Confidence 999999999999998643 2467888999999999999999998 99999999999999999999
Q ss_pred EEeecCCCccccCCCC-CccccccccCCcccccccccCCCCcccceehHHHHHHHHHh-cCcCCCcchhhhhhhhHHHHH
Q 003836 642 RISDFGLAKLLTLDQS-HTNTAIRGTKGYVAPEWFRNMPITVKVDVYSYGVLLLEIIC-LRRNIDNEISKVDKAILTDWA 719 (792)
Q Consensus 642 kl~Dfg~a~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~k~DV~S~Gv~l~el~t-g~~p~~~~~~~~~~~~~~~~~ 719 (792)
||+|||+++....... .......+++.|+|||.+.+..++.++||||||+++|||++ |..||........ .
T Consensus 162 kl~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~e~~~~g~~p~~~~~~~~~---~---- 234 (280)
T cd05049 162 KIGDFGMSRDVYTTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQPWYGLSNEEV---I---- 234 (280)
T ss_pred EECCcccceecccCcceecCCCCcccceecChhhhccCCcchhhhHHHHHHHHHHHHhcCCCCCCCCCHHHH---H----
Confidence 9999999976533222 11223345778999999999999999999999999999998 9999864322110 0
Q ss_pred HHhhcccchhHhhhchhcccCCHHHHHHHHHHHHHccccCCCCCCCHHhHHHHhcc
Q 003836 720 YDRYQERTLEALVENDLEAMNNVTMLHRFVMVAFWCIQEDPSHRPTMRKVTQMLEG 775 (792)
Q Consensus 720 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~L~~ 775 (792)
.. + ........+...+..+.+++.+||+.+|++||++.||+++|++
T Consensus 235 -~~--------~-~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~~l~~ 280 (280)
T cd05049 235 -EC--------I-TQGRLLQRPRTCPSEVYDIMLGCWKRDPQQRINIKDIHERLQK 280 (280)
T ss_pred -HH--------H-HcCCcCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHhhC
Confidence 00 0 0111111122345678999999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt |
| >cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-36 Score=317.12 Aligned_cols=247 Identities=28% Similarity=0.385 Sum_probs=199.6
Q ss_pred hcCccccceEEEeeec-CCCceEEEEEEcccccc--cchHHHHHHHHHhcccCCCCcccccceeccCCceEEEEEeccCC
Q 003836 508 ELGRGAFGTVYKGFVN-MGSSNHVAVKKLNSVFQ--DSEKEFKAEVNGIGQTHHKNLVRLLGYCDEGQNRLLVYEFMSNG 584 (792)
Q Consensus 508 ~lG~G~~g~Vy~g~~~-~~~~~~vavK~~~~~~~--~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~lV~E~~~~g 584 (792)
+||+|+||.||+|.+. ..+++.+|+|+++.... ...+++.+|+.++++++|+||+++++++. .+..++||||+++|
T Consensus 2 ~lg~G~~g~v~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-~~~~~lv~e~~~~~ 80 (257)
T cd05116 2 ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMIGICE-AESWMLVMELAELG 80 (257)
T ss_pred cCCCcCCcceEEeEEecCCCceEEEEEEccCCCCcHHHHHHHHHHHHHHHhCCCCCcceEEEEEc-CCCcEEEEecCCCC
Confidence 5899999999999753 34567899999865432 23567899999999999999999999885 45678999999999
Q ss_pred CccccccCCCCCchhHHHHHHHHHHHHHHHHhhccCCCeEecCCCCCcEEEcCCCCeEEeecCCCccccCCCCCc--ccc
Q 003836 585 TVASFLFGDSKPNWKLRTEIAMGIAGGLFYLHEECCTQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLDQSHT--NTA 662 (792)
Q Consensus 585 sL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dikp~NILl~~~~~~kl~Dfg~a~~~~~~~~~~--~~~ 662 (792)
+|.+++.....+++..+.+++.|++.||+|||+. +|+||||||+|||+++++.+||+|||+++......... ...
T Consensus 81 ~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH~~---~i~H~dlkp~nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~ 157 (257)
T cd05116 81 PLNKFLQKNKHVTEKNITELVHQVSMGMKYLEET---NFVHRDLAARNVLLVTQHYAKISDFGLSKALGADENYYKAKTH 157 (257)
T ss_pred cHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---CEeecccchhhEEEcCCCeEEECCCccccccCCCCCeeeecCC
Confidence 9999998777889999999999999999999998 99999999999999999999999999998765433221 122
Q ss_pred ccccCCcccccccccCCCCcccceehHHHHHHHHHh-cCcCCCcchhhhhhhhHHHHHHHhhcccchhHhhhchhcccCC
Q 003836 663 IRGTKGYVAPEWFRNMPITVKVDVYSYGVLLLEIIC-LRRNIDNEISKVDKAILTDWAYDRYQERTLEALVENDLEAMNN 741 (792)
Q Consensus 663 ~~gt~~y~aPE~~~~~~~~~k~DV~S~Gv~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 741 (792)
..++..|+|||.+....++.++||||||+++|||++ |+.||........ ...+........+
T Consensus 158 ~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~-----------------~~~i~~~~~~~~~ 220 (257)
T cd05116 158 GKWPVKWYAPECMNYYKFSSKSDVWSFGVLMWEAFSYGQKPYKGMKGNEV-----------------TQMIESGERMECP 220 (257)
T ss_pred CCCCccccCHhHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHHHH-----------------HHHHHCCCCCCCC
Confidence 234578999999988889999999999999999998 8999865422110 0111111111223
Q ss_pred HHHHHHHHHHHHHccccCCCCCCCHHhHHHHhcc
Q 003836 742 VTMLHRFVMVAFWCIQEDPSHRPTMRKVTQMLEG 775 (792)
Q Consensus 742 ~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~L~~ 775 (792)
...+.++.+++.+||+.+|++||++++|.++|++
T Consensus 221 ~~~~~~l~~li~~~~~~~p~~Rp~~~~i~~~l~~ 254 (257)
T cd05116 221 QRCPPEMYDLMKLCWTYGVDERPGFAVVELRLRN 254 (257)
T ss_pred CCCCHHHHHHHHHHhccCchhCcCHHHHHHHHhc
Confidence 3455778899999999999999999999999976
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio |
| >cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-37 Score=319.20 Aligned_cols=251 Identities=26% Similarity=0.408 Sum_probs=201.9
Q ss_pred hhhhhhcCccccceEEEeeecCCCceEEEEEEcccccccchHHHHHHHHHhcccCCCCcccccceeccCCceEEEEEecc
Q 003836 503 RGFKEELGRGAFGTVYKGFVNMGSSNHVAVKKLNSVFQDSEKEFKAEVNGIGQTHHKNLVRLLGYCDEGQNRLLVYEFMS 582 (792)
Q Consensus 503 ~~~~~~lG~G~~g~Vy~g~~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~lV~E~~~ 582 (792)
..+.++||+|++|.||+|... .+..||+|++... ....+.+.+|+.++++++|+||+++++.+.+.+..++||||++
T Consensus 8 ~~~~~~lg~g~~g~v~~~~~~--~~~~v~iK~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 84 (261)
T cd05072 8 IKLVKKLGAGQFGEVWMGYYN--NSTKVAVKTLKPG-TMSVQAFLEEANLMKTLQHDKLVRLYAVVTKEEPIYIITEYMA 84 (261)
T ss_pred eEEeeecCCcCCceEEEEEec--CCceEEEEEccCC-chhHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCcEEEEecCC
Confidence 345678999999999999754 3457999998653 2345789999999999999999999999999999999999999
Q ss_pred CCCccccccCC--CCCchhHHHHHHHHHHHHHHHHhhccCCCeEecCCCCCcEEEcCCCCeEEeecCCCccccCCCCCcc
Q 003836 583 NGTVASFLFGD--SKPNWKLRTEIAMGIAGGLFYLHEECCTQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLDQSHTN 660 (792)
Q Consensus 583 ~gsL~~~l~~~--~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dikp~NILl~~~~~~kl~Dfg~a~~~~~~~~~~~ 660 (792)
+++|.+++... ..+++..+..++.|++.||+|||+. +++|+||||+||++++++.+||+|||+++..........
T Consensus 85 ~~~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~LH~~---~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~~~~ 161 (261)
T cd05072 85 KGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIERK---NYIHRDLRAANVLVSESLMCKIADFGLARVIEDNEYTAR 161 (261)
T ss_pred CCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccccchhhEEecCCCcEEECCCccceecCCCceecc
Confidence 99999999653 4678889999999999999999998 999999999999999999999999999987654332222
Q ss_pred ccccccCCcccccccccCCCCcccceehHHHHHHHHHh-cCcCCCcchhhhhhhhHHHHHHHhhcccchhHhhhchhccc
Q 003836 661 TAIRGTKGYVAPEWFRNMPITVKVDVYSYGVLLLEIIC-LRRNIDNEISKVDKAILTDWAYDRYQERTLEALVENDLEAM 739 (792)
Q Consensus 661 ~~~~gt~~y~aPE~~~~~~~~~k~DV~S~Gv~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 739 (792)
....++..|+|||.+....++.++||||||+++|||++ |+.||........ . . .... .....
T Consensus 162 ~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~~---~-~----~~~~---------~~~~~ 224 (261)
T cd05072 162 EGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLYEIVTYGKIPYPGMSNSDV---M-S----ALQR---------GYRMP 224 (261)
T ss_pred CCCccceecCCHHHhccCCCChhhhhhhhHHHHHHHHccCCCCCCCCCHHHH---H-H----HHHc---------CCCCC
Confidence 23345678999999998899999999999999999998 8888864322110 0 0 0000 00111
Q ss_pred CCHHHHHHHHHHHHHccccCCCCCCCHHhHHHHhccC
Q 003836 740 NNVTMLHRFVMVAFWCIQEDPSHRPTMRKVTQMLEGV 776 (792)
Q Consensus 740 ~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~L~~~ 776 (792)
.....+..+.+++.+|++.+|++||+++++.+.|+.+
T Consensus 225 ~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~ 261 (261)
T cd05072 225 RMENCPDELYDIMKTCWKEKAEERPTFDYLQSVLDDF 261 (261)
T ss_pred CCCCCCHHHHHHHHHHccCCcccCcCHHHHHHHHhcC
Confidence 1122446788999999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa |
| >cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-37 Score=324.62 Aligned_cols=257 Identities=24% Similarity=0.396 Sum_probs=205.1
Q ss_pred hhhhhhcCccccceEEEeeec----CCCceEEEEEEcccccccchHHHHHHHHHhcccCCCCcccccceeccCCceEEEE
Q 003836 503 RGFKEELGRGAFGTVYKGFVN----MGSSNHVAVKKLNSVFQDSEKEFKAEVNGIGQTHHKNLVRLLGYCDEGQNRLLVY 578 (792)
Q Consensus 503 ~~~~~~lG~G~~g~Vy~g~~~----~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~lV~ 578 (792)
..+.+.||+|+||.||++... ..+...+|+|.+........+.+.+|+.++++++|+||+++++++...+..++||
T Consensus 7 ~~~~~~lg~G~~~~v~~~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 86 (288)
T cd05093 7 IVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPLIMVF 86 (288)
T ss_pred eeeccccCCcCCeeEEeeEeccCCCCCcceEEEEEecCCcCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccEEEE
Confidence 345678999999999999752 2344579999998765566678999999999999999999999999999999999
Q ss_pred EeccCCCccccccCCC-------------CCchhHHHHHHHHHHHHHHHHhhccCCCeEecCCCCCcEEEcCCCCeEEee
Q 003836 579 EFMSNGTVASFLFGDS-------------KPNWKLRTEIAMGIAGGLFYLHEECCTQIIHCDIKPQNILLDDHYNARISD 645 (792)
Q Consensus 579 E~~~~gsL~~~l~~~~-------------~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dikp~NILl~~~~~~kl~D 645 (792)
||+++++|.+++.... .+++..+..++.|++.||+|||+. +++||||||+|||+++++.+||+|
T Consensus 87 e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH~~---~i~H~dlkp~Nili~~~~~~kl~d 163 (288)
T cd05093 87 EYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLASQ---HFVHRDLATRNCLVGENLLVKIGD 163 (288)
T ss_pred EcCCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeecccCcceEEEccCCcEEecc
Confidence 9999999999986432 478999999999999999999998 999999999999999999999999
Q ss_pred cCCCccccCCCCC-ccccccccCCcccccccccCCCCcccceehHHHHHHHHHh-cCcCCCcchhhhhhhhHHHHHHHhh
Q 003836 646 FGLAKLLTLDQSH-TNTAIRGTKGYVAPEWFRNMPITVKVDVYSYGVLLLEIIC-LRRNIDNEISKVDKAILTDWAYDRY 723 (792)
Q Consensus 646 fg~a~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~k~DV~S~Gv~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~ 723 (792)
||+++........ ......++..|+|||.+.+..++.++||||||++++||++ |..||....... .. ...
T Consensus 164 fg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~t~g~~p~~~~~~~~---~~-----~~i 235 (288)
T cd05093 164 FGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNE---VI-----ECI 235 (288)
T ss_pred CCccccccCCceeecCCCCCccccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHH---HH-----HHH
Confidence 9999865432221 1122335778999999998899999999999999999998 888885432211 00 000
Q ss_pred cccchhHhhhchhcccCCHHHHHHHHHHHHHccccCCCCCCCHHhHHHHhccCcCC
Q 003836 724 QERTLEALVENDLEAMNNVTMLHRFVMVAFWCIQEDPSHRPTMRKVTQMLEGVVEV 779 (792)
Q Consensus 724 ~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~L~~~~~~ 779 (792)
..... ...+...+..+.+++.+||+.+|.+|||++|+++.|+++...
T Consensus 236 ~~~~~---------~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~v~~~l~~~~~~ 282 (288)
T cd05093 236 TQGRV---------LQRPRTCPKEVYDLMLGCWQREPHMRLNIKEIHSLLQNLAKA 282 (288)
T ss_pred HcCCc---------CCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHHHh
Confidence 11110 001112345789999999999999999999999999887643
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly |
| >cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-36 Score=316.91 Aligned_cols=252 Identities=24% Similarity=0.416 Sum_probs=207.2
Q ss_pred HhhhhhhcCccccceEEEeeecCCCceEEEEEEcccccccchHHHHHHHHHhcccCCCCcccccceeccCCceEEEEEec
Q 003836 502 TRGFKEELGRGAFGTVYKGFVNMGSSNHVAVKKLNSVFQDSEKEFKAEVNGIGQTHHKNLVRLLGYCDEGQNRLLVYEFM 581 (792)
Q Consensus 502 ~~~~~~~lG~G~~g~Vy~g~~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~lV~E~~ 581 (792)
.+.+.++||.|+||.||+|.... ++.+++|.+..........+.+|+.++++++|+||+++++++.+.+..++||||+
T Consensus 7 ~y~~~~~ig~g~~~~vy~~~~~~--~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~ 84 (261)
T cd05148 7 EFTLERKLGSGYFGEVWEGLWKN--RVRVAIKILKSDDLLKQQDFQKEVQALKRLRHKHLISLFAVCSVGEPVYIITELM 84 (261)
T ss_pred HHHHhhhhccCCCccEEEeEecC--CCcEEEEeccccchhhHHHHHHHHHHHhcCCCcchhheeeeEecCCCeEEEEeec
Confidence 35567899999999999997654 5789999998765556678999999999999999999999999999999999999
Q ss_pred cCCCccccccCC--CCCchhHHHHHHHHHHHHHHHHhhccCCCeEecCCCCCcEEEcCCCCeEEeecCCCccccCCCCCc
Q 003836 582 SNGTVASFLFGD--SKPNWKLRTEIAMGIAGGLFYLHEECCTQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLDQSHT 659 (792)
Q Consensus 582 ~~gsL~~~l~~~--~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dikp~NILl~~~~~~kl~Dfg~a~~~~~~~~~~ 659 (792)
++++|.+++... ..+++..+.+++.||+.||.|||+. +|+|+||||+||++++++.+||+|||.+.........
T Consensus 85 ~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~---~i~h~dl~~~nilv~~~~~~kl~d~g~~~~~~~~~~~- 160 (261)
T cd05148 85 EKGSLLAFLRSPEGQVLPVASLIDMACQVAEGMAYLEEQ---NSIHRDLAARNILVGEDLVCKVADFGLARLIKEDVYL- 160 (261)
T ss_pred ccCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccccCcceEEEcCCceEEEccccchhhcCCcccc-
Confidence 999999999764 4678999999999999999999998 9999999999999999999999999999876432222
Q ss_pred cccccccCCcccccccccCCCCcccceehHHHHHHHHHh-cCcCCCcchhhhhhhhHHHHHHHhhcccchhHhhhchhcc
Q 003836 660 NTAIRGTKGYVAPEWFRNMPITVKVDVYSYGVLLLEIIC-LRRNIDNEISKVDKAILTDWAYDRYQERTLEALVENDLEA 738 (792)
Q Consensus 660 ~~~~~gt~~y~aPE~~~~~~~~~k~DV~S~Gv~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 738 (792)
.....++..|+|||.+....++.++||||||+++++|++ |+.||........ + . .+......
T Consensus 161 ~~~~~~~~~~~~PE~~~~~~~~~~~DiwslG~~l~~l~~~g~~p~~~~~~~~~---~-------------~-~~~~~~~~ 223 (261)
T cd05148 161 SSDKKIPYKWTAPEAASHGTFSTKSDVWSFGILLYEMFTYGQVPYPGMNNHEV---Y-------------D-QITAGYRM 223 (261)
T ss_pred ccCCCCceEecCHHHHccCCCCchhhHHHHHHHHHHHHcCCCCCCCcCCHHHH---H-------------H-HHHhCCcC
Confidence 123345778999999988899999999999999999998 7888865432110 0 0 00111111
Q ss_pred cCCHHHHHHHHHHHHHccccCCCCCCCHHhHHHHhccC
Q 003836 739 MNNVTMLHRFVMVAFWCIQEDPSHRPTMRKVTQMLEGV 776 (792)
Q Consensus 739 ~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~L~~~ 776 (792)
..+...+..+.+++.+||+.+|.+|||++++++.|+.+
T Consensus 224 ~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~l~~~L~~~ 261 (261)
T cd05148 224 PCPAKCPQEIYKIMLECWAAEPEDRPSFKALREELDNI 261 (261)
T ss_pred CCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHhcC
Confidence 22334556788999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom |
| >cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-36 Score=330.63 Aligned_cols=258 Identities=25% Similarity=0.372 Sum_probs=201.6
Q ss_pred HhhhhhhcCccccceEEEeeecC----CCceEEEEEEcccccc-cchHHHHHHHHHhccc-CCCCcccccceecc-CCce
Q 003836 502 TRGFKEELGRGAFGTVYKGFVNM----GSSNHVAVKKLNSVFQ-DSEKEFKAEVNGIGQT-HHKNLVRLLGYCDE-GQNR 574 (792)
Q Consensus 502 ~~~~~~~lG~G~~g~Vy~g~~~~----~~~~~vavK~~~~~~~-~~~~~~~~Ei~~l~~l-~h~niv~l~g~~~~-~~~~ 574 (792)
.+.+.+.||+|+||.||+|.... .+++.||+|++..... ...+.+..|+.++.++ +|+||++++++|.. +...
T Consensus 8 ~~~i~~~lG~G~fg~Vy~a~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~~~~l~~h~niv~~~~~~~~~~~~~ 87 (337)
T cd05054 8 RLKLGKPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGATASEYKALMTELKILIHIGHHLNVVNLLGACTKPGGPL 87 (337)
T ss_pred HhhhhcccccCcCceEEeccccccccccccceeeeeeccCCCCHHHHHHHHHHHHHHHhhccCcchhheeeeEecCCCCE
Confidence 45667899999999999996421 2346899999875432 2345688899999999 89999999998864 4578
Q ss_pred EEEEEeccCCCccccccCC-------------------------------------------------------------
Q 003836 575 LLVYEFMSNGTVASFLFGD------------------------------------------------------------- 593 (792)
Q Consensus 575 ~lV~E~~~~gsL~~~l~~~------------------------------------------------------------- 593 (792)
+++|||+++++|.+++...
T Consensus 88 ~~v~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 167 (337)
T cd05054 88 MVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSLSDVEEDEEGDELYK 167 (337)
T ss_pred EEEEecCCCCCHHHHHHhccccccccccccccccccccccccccccccCCccccccccccccCcchhhcccchhhhHHhh
Confidence 8999999999999887532
Q ss_pred CCCchhHHHHHHHHHHHHHHHHhhccCCCeEecCCCCCcEEEcCCCCeEEeecCCCccccCCCCCc-cccccccCCcccc
Q 003836 594 SKPNWKLRTEIAMGIAGGLFYLHEECCTQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLDQSHT-NTAIRGTKGYVAP 672 (792)
Q Consensus 594 ~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dikp~NILl~~~~~~kl~Dfg~a~~~~~~~~~~-~~~~~gt~~y~aP 672 (792)
..+++..+..++.||+.||+|||+. +|+||||||+|||+++++.+||+|||+++.+....... .....++..|+||
T Consensus 168 ~~l~~~~~~~~~~qi~~aL~~lH~~---~ivHrDikp~Nill~~~~~vkL~DfG~a~~~~~~~~~~~~~~~~~~~~y~aP 244 (337)
T cd05054 168 EPLTLEDLISYSFQVARGMEFLASR---KCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAP 244 (337)
T ss_pred cCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCcceEEEeCCCcEEEeccccchhcccCcchhhccCCCCCccccCc
Confidence 2568889999999999999999998 99999999999999999999999999998764332221 2234467789999
Q ss_pred cccccCCCCcccceehHHHHHHHHHh-cCcCCCcchhhhhhhhHHHHHHHhhcccchhHhhhchhcccCCHHHHHHHHHH
Q 003836 673 EWFRNMPITVKVDVYSYGVLLLEIIC-LRRNIDNEISKVDKAILTDWAYDRYQERTLEALVENDLEAMNNVTMLHRFVMV 751 (792)
Q Consensus 673 E~~~~~~~~~k~DV~S~Gv~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 751 (792)
|++.+..++.++|||||||++|||++ |..||........ + ...+........+.....++.++
T Consensus 245 E~~~~~~~~~~~Di~SlGv~l~el~t~g~~p~~~~~~~~~---~-------------~~~~~~~~~~~~~~~~~~~~~~l 308 (337)
T cd05054 245 ESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQIDEE---F-------------CRRLKEGTRMRAPEYATPEIYSI 308 (337)
T ss_pred HHhcCCCCCccccHHHHHHHHHHHHHcCCCCCCCCCccHH---H-------------HHHHhccCCCCCCccCCHHHHHH
Confidence 99999999999999999999999998 9988864321100 0 00011111111222345678999
Q ss_pred HHHccccCCCCCCCHHhHHHHhccCcC
Q 003836 752 AFWCIQEDPSHRPTMRKVTQMLEGVVE 778 (792)
Q Consensus 752 ~~~Cl~~~p~~RPs~~evl~~L~~~~~ 778 (792)
+.+||+.+|++||++.||+++|+.+++
T Consensus 309 ~~~cl~~~p~~RPs~~ell~~l~~~~~ 335 (337)
T cd05054 309 MLDCWHNNPEDRPTFSELVEILGDLLQ 335 (337)
T ss_pred HHHHccCChhhCcCHHHHHHHHHHHHh
Confidence 999999999999999999999998754
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto |
| >cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-36 Score=323.62 Aligned_cols=254 Identities=23% Similarity=0.391 Sum_probs=204.8
Q ss_pred hhhhcCccccceEEEeeecC----CCceEEEEEEcccccccchHHHHHHHHHhcccCCCCcccccceeccCCceEEEEEe
Q 003836 505 FKEELGRGAFGTVYKGFVNM----GSSNHVAVKKLNSVFQDSEKEFKAEVNGIGQTHHKNLVRLLGYCDEGQNRLLVYEF 580 (792)
Q Consensus 505 ~~~~lG~G~~g~Vy~g~~~~----~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~lV~E~ 580 (792)
+.+.||+|+||.||+++... .+...+++|.+........+.+.+|++++++++|+||+++++++...+..++||||
T Consensus 9 ~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 88 (291)
T cd05094 9 LKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVKFYGVCGDGDPLIMVFEY 88 (291)
T ss_pred EeeeecccCCCeEEEeEeeccCCCCcceeeEEEecCCccHHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCceEEEEec
Confidence 45789999999999997532 23457899998776555667899999999999999999999999999999999999
Q ss_pred ccCCCccccccCC----------------CCCchhHHHHHHHHHHHHHHHHhhccCCCeEecCCCCCcEEEcCCCCeEEe
Q 003836 581 MSNGTVASFLFGD----------------SKPNWKLRTEIAMGIAGGLFYLHEECCTQIIHCDIKPQNILLDDHYNARIS 644 (792)
Q Consensus 581 ~~~gsL~~~l~~~----------------~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dikp~NILl~~~~~~kl~ 644 (792)
+++++|.+++... ..+++..+..++.||+.||+|||++ +|+||||||+|||++.++.+||+
T Consensus 89 ~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~---~i~H~dlkp~Nil~~~~~~~~l~ 165 (291)
T cd05094 89 MKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLASQ---HFVHRDLATRNCLVGANLLVKIG 165 (291)
T ss_pred CCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHHHhC---CeeecccCcceEEEccCCcEEEC
Confidence 9999999998643 2378899999999999999999998 99999999999999999999999
Q ss_pred ecCCCccccCCCC-CccccccccCCcccccccccCCCCcccceehHHHHHHHHHh-cCcCCCcchhhhhhhhHHHHHHHh
Q 003836 645 DFGLAKLLTLDQS-HTNTAIRGTKGYVAPEWFRNMPITVKVDVYSYGVLLLEIIC-LRRNIDNEISKVDKAILTDWAYDR 722 (792)
Q Consensus 645 Dfg~a~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~k~DV~S~Gv~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~ 722 (792)
|||+++....... .......++..|+|||.+.+..++.++||||||+++|||++ |+.||........ . ..
T Consensus 166 dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~---~-----~~ 237 (291)
T cd05094 166 DFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQLSNTEV---I-----EC 237 (291)
T ss_pred CCCcccccCCCceeecCCCCCcceeecChHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHH---H-----HH
Confidence 9999976543221 11223446788999999999999999999999999999999 9998855432110 0 00
Q ss_pred hcccchhHhhhchhcccCCHHHHHHHHHHHHHccccCCCCCCCHHhHHHHhccCcC
Q 003836 723 YQERTLEALVENDLEAMNNVTMLHRFVMVAFWCIQEDPSHRPTMRKVTQMLEGVVE 778 (792)
Q Consensus 723 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~L~~~~~ 778 (792)
..... ....+...+..+.+++.+||+.+|++||++++|+++|+.+..
T Consensus 238 ~~~~~---------~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~v~~~l~~~~~ 284 (291)
T cd05094 238 ITQGR---------VLERPRVCPKEVYDIMLGCWQREPQQRLNIKEIYKILHALGK 284 (291)
T ss_pred HhCCC---------CCCCCccCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHHh
Confidence 11111 111122345678899999999999999999999999998754
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n |
| >cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-36 Score=327.64 Aligned_cols=244 Identities=24% Similarity=0.289 Sum_probs=198.2
Q ss_pred hhcCccccceEEEeeecC--CCceEEEEEEccccc----ccchHHHHHHHHHhcccCCCCcccccceeccCCceEEEEEe
Q 003836 507 EELGRGAFGTVYKGFVNM--GSSNHVAVKKLNSVF----QDSEKEFKAEVNGIGQTHHKNLVRLLGYCDEGQNRLLVYEF 580 (792)
Q Consensus 507 ~~lG~G~~g~Vy~g~~~~--~~~~~vavK~~~~~~----~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~lV~E~ 580 (792)
+.||+|+||.||++.... ..++.+|+|+++... ......+.+|+.++++++||||+++++++..++..++||||
T Consensus 2 ~~lg~G~~g~V~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~e~ 81 (323)
T cd05584 2 KVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIVDLIYAFQTGGKLYLILEY 81 (323)
T ss_pred ceeeecCCeEEEEEEEcccCCCCCEEEEEEEEHHHHHhhhhhHHHHHHHHHHHHhCCCCchhceeeEEecCCeEEEEEeC
Confidence 579999999999987532 356789999987532 22345678999999999999999999999999999999999
Q ss_pred ccCCCccccccCCCCCchhHHHHHHHHHHHHHHHHhhccCCCeEecCCCCCcEEEcCCCCeEEeecCCCccccCCCCCcc
Q 003836 581 MSNGTVASFLFGDSKPNWKLRTEIAMGIAGGLFYLHEECCTQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLDQSHTN 660 (792)
Q Consensus 581 ~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dikp~NILl~~~~~~kl~Dfg~a~~~~~~~~~~~ 660 (792)
+++++|.+++.....+.+..+..++.||+.||+|||+. +|+||||||+|||++.++.+||+|||+++...... ...
T Consensus 82 ~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~-~~~ 157 (323)
T cd05584 82 LSGGELFMHLEREGIFMEDTACFYLSEISLALEHLHQQ---GIIYRDLKPENILLDAQGHVKLTDFGLCKESIHEG-TVT 157 (323)
T ss_pred CCCchHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEECCCCCEEEeeCcCCeecccCC-Ccc
Confidence 99999999998878888899999999999999999998 99999999999999999999999999987543222 222
Q ss_pred ccccccCCcccccccccCCCCcccceehHHHHHHHHHhcCcCCCcchhhhhhhhHHHHHHHhhcccchhHhhhchhcccC
Q 003836 661 TAIRGTKGYVAPEWFRNMPITVKVDVYSYGVLLLEIICLRRNIDNEISKVDKAILTDWAYDRYQERTLEALVENDLEAMN 740 (792)
Q Consensus 661 ~~~~gt~~y~aPE~~~~~~~~~k~DV~S~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 740 (792)
....|++.|+|||.+.+..++.++|||||||++|||++|+.||........ ...+..... ..
T Consensus 158 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~pf~~~~~~~~----------------~~~~~~~~~--~~ 219 (323)
T cd05584 158 HTFCGTIEYMAPEILMRSGHGKAVDWWSLGALMYDMLTGAPPFTAENRKKT----------------IDKILKGKL--NL 219 (323)
T ss_pred cccCCCccccChhhccCCCCCCcceecccHHHHHHHhcCCCCCCCCCHHHH----------------HHHHHcCCC--CC
Confidence 345689999999999988899999999999999999999999975432110 011111111 11
Q ss_pred CHHHHHHHHHHHHHccccCCCCCC-----CHHhHHHH
Q 003836 741 NVTMLHRFVMVAFWCIQEDPSHRP-----TMRKVTQM 772 (792)
Q Consensus 741 ~~~~~~~l~~l~~~Cl~~~p~~RP-----s~~evl~~ 772 (792)
+......+.+++.+||+.+|++|| +++++++.
T Consensus 220 ~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~l~~h 256 (323)
T cd05584 220 PPYLTPEARDLLKKLLKRNPSSRLGAGPGDAAEVQSH 256 (323)
T ss_pred CCCCCHHHHHHHHHHcccCHhHcCCCCCCCHHHHhcC
Confidence 223456788999999999999999 78888763
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in |
| >cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-36 Score=330.39 Aligned_cols=267 Identities=21% Similarity=0.293 Sum_probs=202.9
Q ss_pred HHHhhhhhhcCccccceEEEeeecCCCceEEEEEEccccc-ccchHHHHHHHHHhcccCCCCcccccceeccCCceEEEE
Q 003836 500 EVTRGFKEELGRGAFGTVYKGFVNMGSSNHVAVKKLNSVF-QDSEKEFKAEVNGIGQTHHKNLVRLLGYCDEGQNRLLVY 578 (792)
Q Consensus 500 ~~~~~~~~~lG~G~~g~Vy~g~~~~~~~~~vavK~~~~~~-~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~lV~ 578 (792)
...+.+.++||+|+||.||++... .++..+|+|++.... ......+.+|++++++++|+||++++++|.+.+..++||
T Consensus 4 ~~~y~~~~~lg~g~~g~V~~~~~~-~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 82 (333)
T cd06650 4 DDDFEKISELGAGNGGVVFKVSHK-PSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICM 82 (333)
T ss_pred hhhhheeccccCCCCEEEEEEEEC-CCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCcccceeEEEEECCEEEEEE
Confidence 344556788999999999999754 456789999886542 234467899999999999999999999999999999999
Q ss_pred EeccCCCccccccCCCCCchhHHHHHHHHHHHHHHHHhhccCCCeEecCCCCCcEEEcCCCCeEEeecCCCccccCCCCC
Q 003836 579 EFMSNGTVASFLFGDSKPNWKLRTEIAMGIAGGLFYLHEECCTQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLDQSH 658 (792)
Q Consensus 579 E~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dikp~NILl~~~~~~kl~Dfg~a~~~~~~~~~ 658 (792)
||+++|+|.+++.....+++.....++.|++.||.|||+. .+|+|+||||+|||+++++.+||+|||++......
T Consensus 83 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~l~~~l~~lH~~--~~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~--- 157 (333)
T cd06650 83 EHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREK--HKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS--- 157 (333)
T ss_pred ecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhc--CCEEecCCChhhEEEcCCCCEEEeeCCcchhhhhh---
Confidence 9999999999998877889999999999999999999974 26999999999999999999999999999765322
Q ss_pred ccccccccCCcccccccccCCCCcccceehHHHHHHHHHhcCcCCCcchhhhhhhhHHH-----HHHHh-----------
Q 003836 659 TNTAIRGTKGYVAPEWFRNMPITVKVDVYSYGVLLLEIICLRRNIDNEISKVDKAILTD-----WAYDR----------- 722 (792)
Q Consensus 659 ~~~~~~gt~~y~aPE~~~~~~~~~k~DV~S~Gv~l~el~tg~~p~~~~~~~~~~~~~~~-----~~~~~----------- 722 (792)
......|+..|+|||.+.+..++.++|||||||++|||++|+.||...........+.. .....
T Consensus 158 ~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (333)
T cd06650 158 MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAIGRYPIPPPDAKELELMFGCPVEGDPAESETSPRPRPPGRP 237 (333)
T ss_pred ccccCCCCccccCHHHhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcchhHHHHHhcCcccCCccccccCcccCCccch
Confidence 12234689999999999988999999999999999999999999965432111000000 00000
Q ss_pred ---hc-----ccchhHhhhchhc---ccC-CHHHHHHHHHHHHHccccCCCCCCCHHhHHHH
Q 003836 723 ---YQ-----ERTLEALVENDLE---AMN-NVTMLHRFVMVAFWCIQEDPSHRPTMRKVTQM 772 (792)
Q Consensus 723 ---~~-----~~~~~~~~~~~~~---~~~-~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~ 772 (792)
.. ......+.+.... ... ......++.+++.+||+.||++|||++|+++.
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~P~~Rpt~~ell~h 299 (333)
T cd06650 238 LSSYGPDSRPPMAIFELLDYIVNEPPPKLPSGVFGAEFQDFVNKCLIKNPAERADLKQLMVH 299 (333)
T ss_pred hhhhcccccccccHHHHHHHHhcCCCccCCCCCcCHHHHHHHHHhccCCcccCcCHHHHhhC
Confidence 00 0000001111000 000 11234678899999999999999999999763
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst |
| >KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-37 Score=343.72 Aligned_cols=256 Identities=21% Similarity=0.311 Sum_probs=210.6
Q ss_pred hhhhcCccccceEEEeeecCCCceEEEEEEcccccccchHHHHHHHHHhcccC-CCCcccccc-eecc------CCceEE
Q 003836 505 FKEELGRGAFGTVYKGFVNMGSSNHVAVKKLNSVFQDSEKEFKAEVNGIGQTH-HKNLVRLLG-YCDE------GQNRLL 576 (792)
Q Consensus 505 ~~~~lG~G~~g~Vy~g~~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~-h~niv~l~g-~~~~------~~~~~l 576 (792)
+.+.|.+|||+.||.+....+ +..+|+|++-..++...+.+++||++|++|. |+|||.+++ .... .-+.+|
T Consensus 41 V~~vLAEGGFa~VYla~~~~~-~~~~AlKrm~~~de~~L~~v~~EI~~MK~L~gh~nIV~yidss~~~~~~~~~~~Evll 119 (738)
T KOG1989|consen 41 VEKVLAEGGFAQVYLAQDVKG-GKKYALKRMYVNDEEALNAVKREIDIMKLLSGHKNIVSYIDSSAINRSSNNGVWEVLL 119 (738)
T ss_pred EEEEEccCCcEEEEEEEecCC-CceeeeeeeecCCHHHHHHHHHHHHHHHHhcCCCceeeEeccccccccCCCceeEEEe
Confidence 346799999999999987644 3789999998777788889999999999997 999999999 3321 236789
Q ss_pred EEEeccCCCccccccCC--CCCchhHHHHHHHHHHHHHHHHhhccCCCeEecCCCCCcEEEcCCCCeEEeecCCCccccC
Q 003836 577 VYEFMSNGTVASFLFGD--SKPNWKLRTEIAMGIAGGLFYLHEECCTQIIHCDIKPQNILLDDHYNARISDFGLAKLLTL 654 (792)
Q Consensus 577 V~E~~~~gsL~~~l~~~--~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dikp~NILl~~~~~~kl~Dfg~a~~~~~ 654 (792)
+||||++|+|-+++..+ ..+++.++++|+.|+++|+++||.. .++|||||||.+||||+.+++.||||||.|.-...
T Consensus 120 LmEyC~gg~Lvd~mn~Rlq~~lte~eVLkIf~dv~~AVa~mH~~-~pPiIHRDLKiENvLls~~g~~KLCDFGSatt~~~ 198 (738)
T KOG1989|consen 120 LMEYCKGGSLVDFMNTRLQTRLTEDEVLKIFYDVCEAVAAMHYL-KPPIIHRDLKIENVLLSADGNYKLCDFGSATTKIL 198 (738)
T ss_pred ehhhccCCcHHHHHHHHHhccCChHHHHHHHHHHHHHHHHHhcC-CCccchhhhhhhheEEcCCCCEEeCcccccccccC
Confidence 99999999999999754 4699999999999999999999986 56799999999999999999999999999875433
Q ss_pred CCC-Cc-------cccccccCCccccccc---ccCCCCcccceehHHHHHHHHHhcCcCCCcchhhhhhhhHHHHHHHhh
Q 003836 655 DQS-HT-------NTAIRGTKGYVAPEWF---RNMPITVKVDVYSYGVLLLEIICLRRNIDNEISKVDKAILTDWAYDRY 723 (792)
Q Consensus 655 ~~~-~~-------~~~~~gt~~y~aPE~~---~~~~~~~k~DV~S~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~ 723 (792)
... .. .-...-|+-|+|||++ .+.++++|+|||+|||+||-|+....||+....
T Consensus 199 ~~~~~~e~~~ve~eI~k~TTp~YRsPEMIDlysg~pI~eKsDIWALGclLYkLCy~t~PFe~sg~--------------- 263 (738)
T KOG1989|consen 199 SPTSAQEVNYVEEEIEKYTTPQYRSPEMIDLYSGLPIGEKSDIWALGCLLYKLCYFTTPFEESGK--------------- 263 (738)
T ss_pred CCccHHHHHHHHHHHHhhCCccccChHHHhhhcCCCCcchhHHHHHHHHHHHHHHhCCCcCcCcc---------------
Confidence 221 11 1112368999999987 578899999999999999999999999975422
Q ss_pred cccchhHhhhchhcccCCHHHHHHHHHHHHHccccCCCCCCCHHhHHHHhccCcCCCCC
Q 003836 724 QERTLEALVENDLEAMNNVTMLHRFVMVAFWCIQEDPSHRPTMRKVTQMLEGVVEVPIP 782 (792)
Q Consensus 724 ~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~L~~~~~~~~p 782 (792)
.+++.....-.....++..+.+||..||+.||.+||++-||++.+.++...+.|
T Consensus 264 -----laIlng~Y~~P~~p~ys~~l~~LI~~mL~~nP~~RPnI~Qv~~~~~~l~~~~~~ 317 (738)
T KOG1989|consen 264 -----LAILNGNYSFPPFPNYSDRLKDLIRTMLQPNPDERPNIYQVLEEIFELANKPCP 317 (738)
T ss_pred -----eeEEeccccCCCCccHHHHHHHHHHHHhccCcccCCCHHHHHHHHHHHhcCCCC
Confidence 223334444444467889999999999999999999999999999887655444
|
|
| >cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-37 Score=329.83 Aligned_cols=243 Identities=23% Similarity=0.263 Sum_probs=197.5
Q ss_pred hhcCccccceEEEeeecCCCceEEEEEEccccc---ccchHHHHHHHHHhcccCCCCcccccceeccCCceEEEEEeccC
Q 003836 507 EELGRGAFGTVYKGFVNMGSSNHVAVKKLNSVF---QDSEKEFKAEVNGIGQTHHKNLVRLLGYCDEGQNRLLVYEFMSN 583 (792)
Q Consensus 507 ~~lG~G~~g~Vy~g~~~~~~~~~vavK~~~~~~---~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~lV~E~~~~ 583 (792)
+.||+|+||.||++... .+++.+|+|++.... ......+.+|++++++++||||+++++++...+..++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~-~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~ 79 (325)
T cd05594 1 KLLGKGTFGKVILVKEK-ATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANG 79 (325)
T ss_pred CeeeeCCCEEEEEEEEC-CCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCCceEEEEEcCCEEEEEEeCCCC
Confidence 36899999999999653 456799999987532 22345678899999999999999999999999999999999999
Q ss_pred CCccccccCCCCCchhHHHHHHHHHHHHHHHHhh-ccCCCeEecCCCCCcEEEcCCCCeEEeecCCCccccCCCCCcccc
Q 003836 584 GTVASFLFGDSKPNWKLRTEIAMGIAGGLFYLHE-ECCTQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLDQSHTNTA 662 (792)
Q Consensus 584 gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~-~~~~~ivH~dikp~NILl~~~~~~kl~Dfg~a~~~~~~~~~~~~~ 662 (792)
|+|..++.....+++..+..++.||+.||+|||+ . +|+||||||+|||++.++.+||+|||+++...... .....
T Consensus 80 ~~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~~---~ivHrDikp~NIll~~~~~~kL~Dfg~~~~~~~~~-~~~~~ 155 (325)
T cd05594 80 GELFFHLSRERVFSEDRARFYGAEIVSALDYLHSEK---NVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDG-ATMKT 155 (325)
T ss_pred CcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcC---CEEecCCCCCeEEECCCCCEEEecCCCCeecCCCC-ccccc
Confidence 9999999887889999999999999999999997 6 99999999999999999999999999987543222 12234
Q ss_pred ccccCCcccccccccCCCCcccceehHHHHHHHHHhcCcCCCcchhhhhhhhHHHHHHHhhcccchhHhhhchhcccCCH
Q 003836 663 IRGTKGYVAPEWFRNMPITVKVDVYSYGVLLLEIICLRRNIDNEISKVDKAILTDWAYDRYQERTLEALVENDLEAMNNV 742 (792)
Q Consensus 663 ~~gt~~y~aPE~~~~~~~~~k~DV~S~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 742 (792)
..||+.|+|||.+.+..++.++|||||||++|||++|+.||.......... .+.... ...+.
T Consensus 156 ~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tG~~Pf~~~~~~~~~~----------------~i~~~~--~~~p~ 217 (325)
T cd05594 156 FCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFE----------------LILMEE--IRFPR 217 (325)
T ss_pred ccCCcccCCHHHHccCCCCCccccccccceeeeeccCCCCCCCCCHHHHHH----------------HHhcCC--CCCCC
Confidence 568999999999999999999999999999999999999996542211000 000000 01122
Q ss_pred HHHHHHHHHHHHccccCCCCCC-----CHHhHHHH
Q 003836 743 TMLHRFVMVAFWCIQEDPSHRP-----TMRKVTQM 772 (792)
Q Consensus 743 ~~~~~l~~l~~~Cl~~~p~~RP-----s~~evl~~ 772 (792)
....++.+++.+||+.||++|+ ++.++++.
T Consensus 218 ~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~h 252 (325)
T cd05594 218 TLSPEAKSLLSGLLKKDPKQRLGGGPDDAKEIMQH 252 (325)
T ss_pred CCCHHHHHHHHHHhhcCHHHhCCCCCCCHHHHhcC
Confidence 3456788999999999999996 89998864
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien |
| >cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-36 Score=326.92 Aligned_cols=255 Identities=25% Similarity=0.353 Sum_probs=200.6
Q ss_pred HhhhhhhcCccccceEEEeeecCCC---ceEEEEEEccccc-ccchHHHHHHHHHhcccCCCCcccccceeccCCceEEE
Q 003836 502 TRGFKEELGRGAFGTVYKGFVNMGS---SNHVAVKKLNSVF-QDSEKEFKAEVNGIGQTHHKNLVRLLGYCDEGQNRLLV 577 (792)
Q Consensus 502 ~~~~~~~lG~G~~g~Vy~g~~~~~~---~~~vavK~~~~~~-~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~lV 577 (792)
.+...+.||+|+||.||+|.+.... ...||+|+++... ....+++.+|+.+++.++|+||++++|+|... ..++|
T Consensus 8 ~f~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~g~~~~~-~~~~v 86 (316)
T cd05108 8 EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQLI 86 (316)
T ss_pred hceeeeeeecCCCceEEEEEEecCCCccceeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEcCC-Cceee
Confidence 3445578999999999999764322 2358999987543 34457899999999999999999999999765 56799
Q ss_pred EEeccCCCccccccCC-CCCchhHHHHHHHHHHHHHHHHhhccCCCeEecCCCCCcEEEcCCCCeEEeecCCCccccCCC
Q 003836 578 YEFMSNGTVASFLFGD-SKPNWKLRTEIAMGIAGGLFYLHEECCTQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLDQ 656 (792)
Q Consensus 578 ~E~~~~gsL~~~l~~~-~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dikp~NILl~~~~~~kl~Dfg~a~~~~~~~ 656 (792)
+||+++|+|.+++... ..+++..+++++.||+.||+|||+. +|+||||||+|||+++++.+||+|||+++......
T Consensus 87 ~e~~~~g~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~LH~~---~iiH~dlkp~Nill~~~~~~kl~DfG~a~~~~~~~ 163 (316)
T cd05108 87 TQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEER---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGADE 163 (316)
T ss_pred eecCCCCCHHHHHHhccccCCHHHHHHHHHHHHHHHHHHHhc---CeeccccchhheEecCCCcEEEccccccccccCCC
Confidence 9999999999999765 4678899999999999999999998 99999999999999999999999999998765433
Q ss_pred CCcc-ccccccCCcccccccccCCCCcccceehHHHHHHHHHh-cCcCCCcchhhhhhhhHHHHHHHhhcccchhHhhhc
Q 003836 657 SHTN-TAIRGTKGYVAPEWFRNMPITVKVDVYSYGVLLLEIIC-LRRNIDNEISKVDKAILTDWAYDRYQERTLEALVEN 734 (792)
Q Consensus 657 ~~~~-~~~~gt~~y~aPE~~~~~~~~~k~DV~S~Gv~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 734 (792)
.... ....++..|+|||.+.+..++.++||||||+++|||++ |+.||........ ...+..
T Consensus 164 ~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slGv~l~el~t~g~~p~~~~~~~~~-----------------~~~~~~ 226 (316)
T cd05108 164 KEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEI-----------------SSILEK 226 (316)
T ss_pred cceeccCCccceeecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCHHHH-----------------HHHHhC
Confidence 2211 12234678999999999999999999999999999998 8999865322110 001111
Q ss_pred hhcccCCHHHHHHHHHHHHHccccCCCCCCCHHhHHHHhccCc
Q 003836 735 DLEAMNNVTMLHRFVMVAFWCIQEDPSHRPTMRKVTQMLEGVV 777 (792)
Q Consensus 735 ~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~L~~~~ 777 (792)
......+......+.+++.+||+.+|++||++.+++..|..+.
T Consensus 227 ~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~l~~~l~~~~ 269 (316)
T cd05108 227 GERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMA 269 (316)
T ss_pred CCCCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHH
Confidence 1111112223456789999999999999999999999987654
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor |
| >cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-37 Score=333.82 Aligned_cols=250 Identities=22% Similarity=0.325 Sum_probs=202.7
Q ss_pred hhhhhcCccccceEEEeeecCCCceEEEEEEccccc---ccchHHHHHHHHHhcccCCCCcccccceeccCCceEEEEEe
Q 003836 504 GFKEELGRGAFGTVYKGFVNMGSSNHVAVKKLNSVF---QDSEKEFKAEVNGIGQTHHKNLVRLLGYCDEGQNRLLVYEF 580 (792)
Q Consensus 504 ~~~~~lG~G~~g~Vy~g~~~~~~~~~vavK~~~~~~---~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~lV~E~ 580 (792)
.+.+.||+|+||+||++... .+++.||+|++.... ......+.+|++++..++|+||+++++++.+++..++||||
T Consensus 4 ~~~~~lg~G~~g~Vy~~~~~-~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~ 82 (350)
T cd05573 4 EVIKVIGRGAFGEVWLVRDK-DTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADSPWIVKLYYSFQDEEHLYLVMEY 82 (350)
T ss_pred eEEEEEEeCCcEEEEEEEEC-CCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhcCCCCccchhhheecCCeEEEEEcC
Confidence 34578999999999999754 456799999987532 23456789999999999999999999999999999999999
Q ss_pred ccCCCccccccCCCCCchhHHHHHHHHHHHHHHHHhhccCCCeEecCCCCCcEEEcCCCCeEEeecCCCccccCCC----
Q 003836 581 MSNGTVASFLFGDSKPNWKLRTEIAMGIAGGLFYLHEECCTQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLDQ---- 656 (792)
Q Consensus 581 ~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dikp~NILl~~~~~~kl~Dfg~a~~~~~~~---- 656 (792)
+++++|.+++.....+++..+..++.||+.||+|||+. +|+||||||+|||++.++.+||+|||+++......
T Consensus 83 ~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~---giiH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~ 159 (350)
T cd05573 83 MPGGDLMNLLIRKDVFPEETARFYIAELVLALDSVHKL---GFIHRDIKPDNILIDADGHIKLADFGLCKKMNKAKDREY 159 (350)
T ss_pred CCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHeEECCCCCEEeecCCCCccCcccCcccc
Confidence 99999999998878899999999999999999999998 99999999999999999999999999998765433
Q ss_pred ------------------------CCccccccccCCcccccccccCCCCcccceehHHHHHHHHHhcCcCCCcchhhhhh
Q 003836 657 ------------------------SHTNTAIRGTKGYVAPEWFRNMPITVKVDVYSYGVLLLEIICLRRNIDNEISKVDK 712 (792)
Q Consensus 657 ------------------------~~~~~~~~gt~~y~aPE~~~~~~~~~k~DV~S~Gv~l~el~tg~~p~~~~~~~~~~ 712 (792)
........||+.|+|||.+.+..++.++|||||||++|||++|+.||.........
T Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~~~~~~~ 239 (350)
T cd05573 160 YLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYGFPPFYSDTLQETY 239 (350)
T ss_pred cccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCceeeEecchhhhhhccCCCCCCCCCHHHHH
Confidence 11223356899999999999999999999999999999999999999764322111
Q ss_pred hhHHHHHHHhhcccchhHhhhchhcccCCHHHHHHHHHHHHHccccCCCCCCC-HHhHHHH
Q 003836 713 AILTDWAYDRYQERTLEALVENDLEAMNNVTMLHRFVMVAFWCIQEDPSHRPT-MRKVTQM 772 (792)
Q Consensus 713 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs-~~evl~~ 772 (792)
..+..+ . ...........+.++.+++..|++ +|.+||+ ++|+++.
T Consensus 240 ~~i~~~-----~---------~~~~~p~~~~~~~~~~~li~~ll~-dp~~R~~s~~~ll~h 285 (350)
T cd05573 240 NKIINW-----K---------ESLRFPPDPPVSPEAIDLICRLLC-DPEDRLGSFEEIKSH 285 (350)
T ss_pred HHHhcc-----C---------CcccCCCCCCCCHHHHHHHHHHcc-ChhhcCCCHHHHhcC
Confidence 000000 0 111111111145678889999998 9999999 9999975
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the |
| >KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-37 Score=314.67 Aligned_cols=256 Identities=23% Similarity=0.283 Sum_probs=194.4
Q ss_pred hhhcCccccceEEEeeecCCCceEEEEEEcccccccchHHHHHHHHHhcccCCCCcccccceeccCC-----ceEEEEEe
Q 003836 506 KEELGRGAFGTVYKGFVNMGSSNHVAVKKLNSVFQDSEKEFKAEVNGIGQTHHKNLVRLLGYCDEGQ-----NRLLVYEF 580 (792)
Q Consensus 506 ~~~lG~G~~g~Vy~g~~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~-----~~~lV~E~ 580 (792)
.+++|.|+||.||+|++... ++.||||++-... +.-.+|+.+|++++|||||+|+-+|.... ...|||||
T Consensus 29 ~~liG~GsFg~Vyq~~~~e~-~~~vAIKKv~~d~----r~knrEl~im~~l~HpNIV~L~~~f~~~~~~d~~~lnlVley 103 (364)
T KOG0658|consen 29 VRLIGSGSFGVVYQAKLRET-EEEVAIKKVLQDK----RYKNRELQIMRKLDHPNIVRLLYFFSSSTESDEVYLNLVLEY 103 (364)
T ss_pred eEEEeecccceEEEEEEcCC-CceeEEEEecCCC----CcCcHHHHHHHhcCCcCeeeEEEEEEecCCCchhHHHHHHHh
Confidence 35799999999999988644 6899999985432 23457999999999999999999884322 33489999
Q ss_pred ccCCCccccccC----CCCCchhHHHHHHHHHHHHHHHHhhccCCCeEecCCCCCcEEEcCC-CCeEEeecCCCccccCC
Q 003836 581 MSNGTVASFLFG----DSKPNWKLRTEIAMGIAGGLFYLHEECCTQIIHCDIKPQNILLDDH-YNARISDFGLAKLLTLD 655 (792)
Q Consensus 581 ~~~gsL~~~l~~----~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dikp~NILl~~~-~~~kl~Dfg~a~~~~~~ 655 (792)
||. +|.++++. +..++...+.-+..||++||+|||+. +|+||||||.|+|+|.+ |.+||||||.|+.+...
T Consensus 104 mP~-tL~~~~r~~~~~~~~mp~~~iKLYt~Qlfrgl~yLh~~---~IcHRDIKPqNlLvD~~tg~LKicDFGSAK~L~~~ 179 (364)
T KOG0658|consen 104 MPE-TLYRVIRHYTRANQRMPLLEIKLYTYQLFRGLAYLHSH---GICHRDIKPQNLLVDPDTGVLKICDFGSAKVLVKG 179 (364)
T ss_pred chH-HHHHHHHHHhhcCCCCceeeeHHHHHHHHHHHHHHHhc---CcccCCCChheEEEcCCCCeEEeccCCcceeeccC
Confidence 998 88888864 46778888888999999999999998 99999999999999966 99999999999988654
Q ss_pred CCCccccccccCCccccccccc-CCCCcccceehHHHHHHHHHhcCcCCCcchhhhhhhhHHHHHH----H-------hh
Q 003836 656 QSHTNTAIRGTKGYVAPEWFRN-MPITVKVDVYSYGVLLLEIICLRRNIDNEISKVDKAILTDWAY----D-------RY 723 (792)
Q Consensus 656 ~~~~~~~~~gt~~y~aPE~~~~-~~~~~k~DV~S~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~----~-------~~ 723 (792)
+.. .....|..|+|||.+.+ ..|+.+.||||.||++.||+-|+.-|...........+....- + ..
T Consensus 180 epn--iSYicSRyYRaPELifga~~Yt~~IDiWSaGCV~aELl~g~plFpG~s~~dQL~eIik~lG~Pt~e~I~~mn~~y 257 (364)
T KOG0658|consen 180 EPN--ISYICSRYYRAPELIFGATEYTTSIDIWSAGCVMAELLKGQPLFPGDSSVDQLVEIIKVLGTPTREDIKSMNPNY 257 (364)
T ss_pred CCc--eeEEEeccccCHHHHcCccccCceeEEhhhhHHHHHHhcCCcccCCCCHHHHHHHHHHHhCCCCHHHHhhcCccc
Confidence 433 45567899999999876 6799999999999999999999999877544322221111000 0 00
Q ss_pred cccchhHhhhchhcccCCHHHHHHHHHHHHHccccCCCCCCCHHhHHHH
Q 003836 724 QERTLEALVENDLEAMNNVTMLHRFVMVAFWCIQEDPSHRPTMRKVTQM 772 (792)
Q Consensus 724 ~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~ 772 (792)
.+....++...............+.++++.++|+.+|.+|.++.|++.+
T Consensus 258 ~~~~~p~ik~~~~~~~~~~~~~~d~~dll~~~L~Y~P~~R~~~~~~l~h 306 (364)
T KOG0658|consen 258 TEFKFPQIKAHPWHKVFFKRLPPDALDLLSKLLQYSPSKRLSALEALAH 306 (364)
T ss_pred ccccCcccccccceeecccCCCHHHHHHHHHHhccChhhcCCHHHHhcc
Confidence 0111111111111111233456788999999999999999999998864
|
|
| >cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-36 Score=320.16 Aligned_cols=268 Identities=26% Similarity=0.360 Sum_probs=204.4
Q ss_pred hhhhhcCccccceEEEeee---cCCCceEEEEEEccccc-ccchHHHHHHHHHhcccCCCCcccccceeccC--CceEEE
Q 003836 504 GFKEELGRGAFGTVYKGFV---NMGSSNHVAVKKLNSVF-QDSEKEFKAEVNGIGQTHHKNLVRLLGYCDEG--QNRLLV 577 (792)
Q Consensus 504 ~~~~~lG~G~~g~Vy~g~~---~~~~~~~vavK~~~~~~-~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~--~~~~lV 577 (792)
.+.+.||+|+||+||++.. ...+++.+|+|.+.... ......+.+|++++++++||||+++++++... ...++|
T Consensus 7 ~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv 86 (283)
T cd05080 7 KKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENIVKYKGCCSEQGGKGLQLI 86 (283)
T ss_pred eeceecccCCCcEEEEeeEccccCCCCceEEEEEeccccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCceEEEE
Confidence 4557899999999988653 23456789999987543 23456789999999999999999999988653 457899
Q ss_pred EEeccCCCccccccCCCCCchhHHHHHHHHHHHHHHHHhhccCCCeEecCCCCCcEEEcCCCCeEEeecCCCccccCCCC
Q 003836 578 YEFMSNGTVASFLFGDSKPNWKLRTEIAMGIAGGLFYLHEECCTQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLDQS 657 (792)
Q Consensus 578 ~E~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dikp~NILl~~~~~~kl~Dfg~a~~~~~~~~ 657 (792)
|||+++++|.+++... .+++..+..++.|+++||.|||+. +|+|+||||+|||+++++.+||+|||+++.......
T Consensus 87 ~e~~~~~~l~~~~~~~-~l~~~~~~~i~~~l~~~l~~lH~~---~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~ 162 (283)
T cd05080 87 MEYVPLGSLRDYLPKH-KLNLAQLLLFAQQICEGMAYLHSQ---HYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHE 162 (283)
T ss_pred ecCCCCCCHHHHHHHc-CCCHHHHHHHHHHHHHHHHHHHHC---CeeccccChheEEEcCCCcEEEeecccccccCCcch
Confidence 9999999999998654 589999999999999999999998 999999999999999999999999999987643322
Q ss_pred Cc--cccccccCCcccccccccCCCCcccceehHHHHHHHHHhcCcCCCcchhhhhhhhHHHHHHHhhcccchhHhhhch
Q 003836 658 HT--NTAIRGTKGYVAPEWFRNMPITVKVDVYSYGVLLLEIICLRRNIDNEISKVDKAILTDWAYDRYQERTLEALVEND 735 (792)
Q Consensus 658 ~~--~~~~~gt~~y~aPE~~~~~~~~~k~DV~S~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 735 (792)
.. .....++..|+|||.+.+..++.++||||||++++||++|..|+........... ...........+...++..
T Consensus 163 ~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~ 240 (283)
T cd05080 163 YYRVREDGDSPVFWYAVECLKENKFSYASDVWSFGVTLYELLTHCDSKQSPPKKFEEMI--GPKQGQMTVVRLIELLERG 240 (283)
T ss_pred hhccCCCCCCCceeeCHhHhcccCCCcccccHHHHHHHHHHHhCCCCCCCCcchhhhhh--cccccccchhhhhhhhhcC
Confidence 11 1122356679999999888999999999999999999999999854332111100 0000001111122222222
Q ss_pred hcccCCHHHHHHHHHHHHHccccCCCCCCCHHhHHHHhccCc
Q 003836 736 LEAMNNVTMLHRFVMVAFWCIQEDPSHRPTMRKVTQMLEGVV 777 (792)
Q Consensus 736 ~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~L~~~~ 777 (792)
.....+...+..+.+++.+||+.+|++|||+++|+++|+.+.
T Consensus 241 ~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~i~~~l~~~~ 282 (283)
T cd05080 241 MRLPCPKNCPQEVYILMKNCWETEAKFRPTFRSLIPILKEMH 282 (283)
T ss_pred CCCCCCCCCCHHHHHHHHHHhccChhhCCCHHHHHHHHHHhh
Confidence 222233345678899999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign |
| >cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-36 Score=328.70 Aligned_cols=252 Identities=21% Similarity=0.245 Sum_probs=199.7
Q ss_pred hhhhhcCccccceEEEeeecC--CCceEEEEEEccccc----ccchHHHHHHHHHhccc-CCCCcccccceeccCCceEE
Q 003836 504 GFKEELGRGAFGTVYKGFVNM--GSSNHVAVKKLNSVF----QDSEKEFKAEVNGIGQT-HHKNLVRLLGYCDEGQNRLL 576 (792)
Q Consensus 504 ~~~~~lG~G~~g~Vy~g~~~~--~~~~~vavK~~~~~~----~~~~~~~~~Ei~~l~~l-~h~niv~l~g~~~~~~~~~l 576 (792)
.+.+.||+|+||.||++.... .+++.+|+|++.+.. ....+.+.+|+.++.++ +|+||+++++++.+.+..++
T Consensus 3 ~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~l 82 (332)
T cd05614 3 ELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPFLVTLHYAFQTEAKLHL 82 (332)
T ss_pred eEEEEEeecCCEEEEEEEEcccCCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHHhccCCCCcccEEEEEecCCEEEE
Confidence 345789999999999986532 356789999986532 22345678899999999 59999999999999999999
Q ss_pred EEEeccCCCccccccCCCCCchhHHHHHHHHHHHHHHHHhhccCCCeEecCCCCCcEEEcCCCCeEEeecCCCccccCCC
Q 003836 577 VYEFMSNGTVASFLFGDSKPNWKLRTEIAMGIAGGLFYLHEECCTQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLDQ 656 (792)
Q Consensus 577 V~E~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dikp~NILl~~~~~~kl~Dfg~a~~~~~~~ 656 (792)
||||+++|+|.+++.....+++..+..++.||+.||+|||+. +|+||||||+|||++.++.+||+|||+++......
T Consensus 83 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivHrDlkp~Nili~~~~~~kl~DfG~~~~~~~~~ 159 (332)
T cd05614 83 ILDYVSGGEMFTHLYQRDNFSEDEVRFYSGEIILALEHLHKL---GIVYRDIKLENILLDSEGHVVLTDFGLSKEFLSEE 159 (332)
T ss_pred EEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC---CcEecCCCHHHeEECCCCCEEEeeCcCCccccccC
Confidence 999999999999998878899999999999999999999998 99999999999999999999999999998764443
Q ss_pred CCccccccccCCcccccccccC-CCCcccceehHHHHHHHHHhcCcCCCcchhhhhhhhHHHHHHHhhcccchhHhhhch
Q 003836 657 SHTNTAIRGTKGYVAPEWFRNM-PITVKVDVYSYGVLLLEIICLRRNIDNEISKVDKAILTDWAYDRYQERTLEALVEND 735 (792)
Q Consensus 657 ~~~~~~~~gt~~y~aPE~~~~~-~~~~k~DV~S~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 735 (792)
........||+.|+|||.+.+. .++.++|||||||++|||++|+.||...........+. . .+..
T Consensus 160 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~----~--------~~~~-- 225 (332)
T cd05614 160 KERTYSFCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTGASPFTLEGERNTQSEVS----R--------RILK-- 225 (332)
T ss_pred CCccccccCCccccCHHHhcCCCCCCCccccccchhhhhhhhcCCCCCCCCCCCCCHHHHH----H--------HHhc--
Confidence 3333446799999999999765 47899999999999999999999996432211110000 0 0000
Q ss_pred hcccCCHHHHHHHHHHHHHccccCCCCCC-----CHHhHHHH
Q 003836 736 LEAMNNVTMLHRFVMVAFWCIQEDPSHRP-----TMRKVTQM 772 (792)
Q Consensus 736 ~~~~~~~~~~~~l~~l~~~Cl~~~p~~RP-----s~~evl~~ 772 (792)
.....+......+.+++.+||+.||++|| +++++++.
T Consensus 226 ~~~~~~~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~h 267 (332)
T cd05614 226 CDPPFPSFIGPEAQDLLHKLLRKDPKKRLGAGPQGASEIKEH 267 (332)
T ss_pred CCCCCCCCCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHHcC
Confidence 01112223456778999999999999999 67777754
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-36 Score=315.64 Aligned_cols=249 Identities=26% Similarity=0.405 Sum_probs=200.1
Q ss_pred hhhhhhcCccccceEEEeeecCCCceEEEEEEcccccccchHHHHHHHHHhcccCCCCcccccceeccCCceEEEEEecc
Q 003836 503 RGFKEELGRGAFGTVYKGFVNMGSSNHVAVKKLNSVFQDSEKEFKAEVNGIGQTHHKNLVRLLGYCDEGQNRLLVYEFMS 582 (792)
Q Consensus 503 ~~~~~~lG~G~~g~Vy~g~~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~lV~E~~~ 582 (792)
+.+.+.||+|+||+||++.... ...+|+|.+... .....++.+|+.++++++||||+++++++.+....++||||++
T Consensus 6 ~~~~~~lg~G~~~~vy~~~~~~--~~~~aik~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 82 (256)
T cd05113 6 LTFLKELGTGQFGVVKYGKWRG--QYDVAIKMIKEG-SMSEDEFIEEAKVMMKLSHEKLVQLYGVCTKQRPIYIVTEYMS 82 (256)
T ss_pred eEEeeEecCcccceEEEEEecC--CCcEEEEEcCCC-cccHHHHHHHHHHHhcCCCCCeeeEEEEEccCCCcEEEEEcCC
Confidence 3456789999999999997543 346999988754 2345779999999999999999999999999999999999999
Q ss_pred CCCccccccCC-CCCchhHHHHHHHHHHHHHHHHhhccCCCeEecCCCCCcEEEcCCCCeEEeecCCCccccCCCCCccc
Q 003836 583 NGTVASFLFGD-SKPNWKLRTEIAMGIAGGLFYLHEECCTQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLDQSHTNT 661 (792)
Q Consensus 583 ~gsL~~~l~~~-~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dikp~NILl~~~~~~kl~Dfg~a~~~~~~~~~~~~ 661 (792)
+|+|.+++... ..+++..+.+++.||+.||+|||+. +++|+||||+||++++++.+||+|||.++...........
T Consensus 83 ~~~l~~~i~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~nili~~~~~~kl~d~g~~~~~~~~~~~~~~ 159 (256)
T cd05113 83 NGCLLNYLREHGKRFQPSQLLEMCKDVCEGMAYLESK---QFIHRDLAARNCLVDDQGCVKVSDFGLSRYVLDDEYTSSV 159 (256)
T ss_pred CCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccccCcceEEEcCCCCEEECCCccceecCCCceeecC
Confidence 99999999764 4689999999999999999999998 9999999999999999999999999999866443322222
Q ss_pred cccccCCcccccccccCCCCcccceehHHHHHHHHHh-cCcCCCcchhhhhhhhHHHHHHHhhcccchhHhhhchhcccC
Q 003836 662 AIRGTKGYVAPEWFRNMPITVKVDVYSYGVLLLEIIC-LRRNIDNEISKVDKAILTDWAYDRYQERTLEALVENDLEAMN 740 (792)
Q Consensus 662 ~~~gt~~y~aPE~~~~~~~~~k~DV~S~Gv~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 740 (792)
...++..|+|||.+.+..++.++||||||+++|||++ |+.||......... ... ........
T Consensus 160 ~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~~~~--------~~~---------~~~~~~~~ 222 (256)
T cd05113 160 GSKFPVRWSPPEVLLYSKFSSKSDVWAFGVLMWEVYSLGKMPYERFNNSETV--------EKV---------SQGLRLYR 222 (256)
T ss_pred CCccChhhCCHHHHhcCcccchhHHHHHHHHHHHHhcCCCCCcCcCCHHHHH--------HHH---------hcCCCCCC
Confidence 2335678999999998889999999999999999998 88888643221100 000 00011111
Q ss_pred CHHHHHHHHHHHHHccccCCCCCCCHHhHHHHhc
Q 003836 741 NVTMLHRFVMVAFWCIQEDPSHRPTMRKVTQMLE 774 (792)
Q Consensus 741 ~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~L~ 774 (792)
+...+..+.+++.+||+.+|.+||++.+|++.|+
T Consensus 223 ~~~~~~~~~~li~~cl~~~p~~Rp~~~~ll~~~~ 256 (256)
T cd05113 223 PHLASEKVYAIMYSCWHEKAEERPTFQQLLSSIE 256 (256)
T ss_pred CCCCCHHHHHHHHHHcCCCcccCCCHHHHHHhhC
Confidence 2223567899999999999999999999998874
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds |
| >cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-36 Score=320.12 Aligned_cols=253 Identities=27% Similarity=0.411 Sum_probs=199.9
Q ss_pred hhhhhhcCccccceEEEeeec---CCCceEEEEEEccccc-ccchHHHHHHHHHhcccCCCCcccccceeccCCceEEEE
Q 003836 503 RGFKEELGRGAFGTVYKGFVN---MGSSNHVAVKKLNSVF-QDSEKEFKAEVNGIGQTHHKNLVRLLGYCDEGQNRLLVY 578 (792)
Q Consensus 503 ~~~~~~lG~G~~g~Vy~g~~~---~~~~~~vavK~~~~~~-~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~lV~ 578 (792)
..+.+.||+|+||.||+|... ....+.+++|.+.... ......+.+|++++++++|+||+++++++..+...++||
T Consensus 7 ~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 86 (283)
T cd05090 7 VRFMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAELHHPNIVCLLGVVTQEQPVCMLF 86 (283)
T ss_pred ceeeeeccccCCcceEEEEEecCCCCCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCCeeeEEEEEecCCceEEEE
Confidence 345678999999999999752 2345789999997533 233467899999999999999999999999999999999
Q ss_pred EeccCCCccccccCC-----------------CCCchhHHHHHHHHHHHHHHHHhhccCCCeEecCCCCCcEEEcCCCCe
Q 003836 579 EFMSNGTVASFLFGD-----------------SKPNWKLRTEIAMGIAGGLFYLHEECCTQIIHCDIKPQNILLDDHYNA 641 (792)
Q Consensus 579 E~~~~gsL~~~l~~~-----------------~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dikp~NILl~~~~~~ 641 (792)
||+++++|.+++... ..+++.....++.|++.||+|||+. +|+|+||||+|||+++++.+
T Consensus 87 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~---~i~H~dlkp~nili~~~~~~ 163 (283)
T cd05090 87 EYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLSSH---FFVHKDLAARNILIGEQLHV 163 (283)
T ss_pred EcCCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHhc---CeehhccccceEEEcCCCcE
Confidence 999999999988522 2467888999999999999999998 99999999999999999999
Q ss_pred EEeecCCCccccCCCC-CccccccccCCcccccccccCCCCcccceehHHHHHHHHHh-cCcCCCcchhhhhhhhHHHHH
Q 003836 642 RISDFGLAKLLTLDQS-HTNTAIRGTKGYVAPEWFRNMPITVKVDVYSYGVLLLEIIC-LRRNIDNEISKVDKAILTDWA 719 (792)
Q Consensus 642 kl~Dfg~a~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~k~DV~S~Gv~l~el~t-g~~p~~~~~~~~~~~~~~~~~ 719 (792)
||+|||+++....... .......++..|+|||.+.+..++.++||||||+++|||++ |..||........ . .
T Consensus 164 kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~g~~p~~~~~~~~~---~-~-- 237 (283)
T cd05090 164 KISDLGLSREIYSADYYRVQPKSLLPIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFSFGLQPYYGFSNQEV---I-E-- 237 (283)
T ss_pred EeccccccccccCCcceecccCCCccceecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCHHHH---H-H--
Confidence 9999999987643322 12223345678999999988889999999999999999998 8888854321100 0 0
Q ss_pred HHhhcccchhHhhhchhcccCCHHHHHHHHHHHHHccccCCCCCCCHHhHHHHhcc
Q 003836 720 YDRYQERTLEALVENDLEAMNNVTMLHRFVMVAFWCIQEDPSHRPTMRKVTQMLEG 775 (792)
Q Consensus 720 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~L~~ 775 (792)
.+........+.....++.+++.+||+.+|++||++.+|.++|.+
T Consensus 238 -----------~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~~ 282 (283)
T cd05090 238 -----------MVRKRQLLPCSEDCPPRMYSLMTECWQEGPSRRPRFKDIHTRLRS 282 (283)
T ss_pred -----------HHHcCCcCCCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHHhhc
Confidence 000000111122345678889999999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >PTZ00267 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-36 Score=343.99 Aligned_cols=249 Identities=18% Similarity=0.239 Sum_probs=201.2
Q ss_pred hhhhhhcCccccceEEEeeecCCCceEEEEEEcccccccchHHHHHHHHHhcccCCCCcccccceeccCCceEEEEEecc
Q 003836 503 RGFKEELGRGAFGTVYKGFVNMGSSNHVAVKKLNSVFQDSEKEFKAEVNGIGQTHHKNLVRLLGYCDEGQNRLLVYEFMS 582 (792)
Q Consensus 503 ~~~~~~lG~G~~g~Vy~g~~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~lV~E~~~ 582 (792)
+.+.+.||+|++|.||++......++.||+|++..........+.+|+.++++++||||+++++++...+..+|||||++
T Consensus 69 y~~~~~lg~G~~g~vy~a~~~~~~~~~vv~K~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~~lv~E~~~ 148 (478)
T PTZ00267 69 YVLTTLVGRNPTTAAFVATRGSDPKEKVVAKFVMLNDERQAAYARSELHCLAACDHFGIVKHFDDFKSDDKLLLIMEYGS 148 (478)
T ss_pred EEEEEEEEeCCCcEEEEEEEcCCCCeEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEECCEEEEEEECCC
Confidence 44567899999999999976544367888888765544455678899999999999999999999999999999999999
Q ss_pred CCCccccccC----CCCCchhHHHHHHHHHHHHHHHHhhccCCCeEecCCCCCcEEEcCCCCeEEeecCCCccccCCCC-
Q 003836 583 NGTVASFLFG----DSKPNWKLRTEIAMGIAGGLFYLHEECCTQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLDQS- 657 (792)
Q Consensus 583 ~gsL~~~l~~----~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dikp~NILl~~~~~~kl~Dfg~a~~~~~~~~- 657 (792)
+|+|.+++.. ...+++..+..++.||+.||.|||+. +|+||||||+|||++.++.+||+|||+++.......
T Consensus 149 gg~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~---~ivHrDlkp~NIll~~~~~~kL~DFgla~~~~~~~~~ 225 (478)
T PTZ00267 149 GGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVHSR---KMMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDSVSL 225 (478)
T ss_pred CCCHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhC---CEEECCcCHHhEEECCCCcEEEEeCcCceecCCcccc
Confidence 9999988753 24578889999999999999999998 999999999999999999999999999987643322
Q ss_pred CccccccccCCcccccccccCCCCcccceehHHHHHHHHHhcCcCCCcchhhhhhhhHHHHHHHhhcccchhHhhhchhc
Q 003836 658 HTNTAIRGTKGYVAPEWFRNMPITVKVDVYSYGVLLLEIICLRRNIDNEISKVDKAILTDWAYDRYQERTLEALVENDLE 737 (792)
Q Consensus 658 ~~~~~~~gt~~y~aPE~~~~~~~~~k~DV~S~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 737 (792)
.......||+.|+|||.+.+..++.++|||||||++|||++|+.||....... .+ ..+.....
T Consensus 226 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~Pf~~~~~~~---~~-------------~~~~~~~~- 288 (478)
T PTZ00267 226 DVASSFCGTPYYLAPELWERKRYSKKADMWSLGVILYELLTLHRPFKGPSQRE---IM-------------QQVLYGKY- 288 (478)
T ss_pred ccccccCCCccccCHhHhCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCHHH---HH-------------HHHHhCCC-
Confidence 12334569999999999999999999999999999999999999996532210 00 01111100
Q ss_pred ccCCHHHHHHHHHHHHHccccCCCCCCCHHhHHH
Q 003836 738 AMNNVTMLHRFVMVAFWCIQEDPSHRPTMRKVTQ 771 (792)
Q Consensus 738 ~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~ 771 (792)
...+...+..+.+++..||+.+|++||+++++++
T Consensus 289 ~~~~~~~s~~~~~li~~~L~~dP~~Rps~~~~l~ 322 (478)
T PTZ00267 289 DPFPCPVSSGMKALLDPLLSKNPALRPTTQQLLH 322 (478)
T ss_pred CCCCccCCHHHHHHHHHHhccChhhCcCHHHHHh
Confidence 1112234567889999999999999999999874
|
|
| >cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-36 Score=312.58 Aligned_cols=247 Identities=26% Similarity=0.389 Sum_probs=197.8
Q ss_pred hhcCccccceEEEeeecCCCceEEEEEEccccc-ccchHHHHHHHHHhcccCCCCcccccceeccCCceEEEEEeccCCC
Q 003836 507 EELGRGAFGTVYKGFVNMGSSNHVAVKKLNSVF-QDSEKEFKAEVNGIGQTHHKNLVRLLGYCDEGQNRLLVYEFMSNGT 585 (792)
Q Consensus 507 ~~lG~G~~g~Vy~g~~~~~~~~~vavK~~~~~~-~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~lV~E~~~~gs 585 (792)
+.||+|+||.||+|... .+++.+|+|.+.... .+....+.+|++++++++|+||+++++++......++||||+++++
T Consensus 1 ~~lg~g~~g~vy~~~~~-~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~ 79 (252)
T cd05084 1 ERIGRGNFGEVFSGRLR-ADNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGGD 79 (252)
T ss_pred CccCcccCccEEEEEEe-cCCceEEEEecCccCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEcCCCCeEEEEeeccCCc
Confidence 46999999999999764 346789999876533 3345679999999999999999999999999999999999999999
Q ss_pred ccccccCC-CCCchhHHHHHHHHHHHHHHHHhhccCCCeEecCCCCCcEEEcCCCCeEEeecCCCccccCCCCCcc-ccc
Q 003836 586 VASFLFGD-SKPNWKLRTEIAMGIAGGLFYLHEECCTQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLDQSHTN-TAI 663 (792)
Q Consensus 586 L~~~l~~~-~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dikp~NILl~~~~~~kl~Dfg~a~~~~~~~~~~~-~~~ 663 (792)
|.+++... ..+++..+..++.|++.||.|||+. +|+|+||||+|||++.++.+||+|||+++.......... ...
T Consensus 80 L~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~---~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~ 156 (252)
T cd05084 80 FLTFLRTEGPRLKVKELIQMVENAAAGMEYLESK---HCIHRDLAARNCLVTEKNVLKISDFGMSREEEDGVYASTGGMK 156 (252)
T ss_pred HHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhC---CccccccchheEEEcCCCcEEECccccCcccccccccccCCCC
Confidence 99999654 4688999999999999999999998 999999999999999999999999999876532211111 111
Q ss_pred cccCCcccccccccCCCCcccceehHHHHHHHHHh-cCcCCCcchhhhhhhhHHHHHHHhhcccchhHhhhchhcccCCH
Q 003836 664 RGTKGYVAPEWFRNMPITVKVDVYSYGVLLLEIIC-LRRNIDNEISKVDKAILTDWAYDRYQERTLEALVENDLEAMNNV 742 (792)
Q Consensus 664 ~gt~~y~aPE~~~~~~~~~k~DV~S~Gv~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 742 (792)
..+..|+|||.+.+..++.++||||||+++|||++ |..|+........ ...+........+.
T Consensus 157 ~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~e~~~~~~~p~~~~~~~~~-----------------~~~~~~~~~~~~~~ 219 (252)
T cd05084 157 QIPVKWTAPEALNYGRYSSESDVWSFGILLWEAFSLGAVPYANLSNQQT-----------------REAIEQGVRLPCPE 219 (252)
T ss_pred CCceeecCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccCHHHH-----------------HHHHHcCCCCCCcc
Confidence 23457999999999899999999999999999998 7888754322110 00111111112233
Q ss_pred HHHHHHHHHHHHccccCCCCCCCHHhHHHHhc
Q 003836 743 TMLHRFVMVAFWCIQEDPSHRPTMRKVTQMLE 774 (792)
Q Consensus 743 ~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~L~ 774 (792)
..+..+.+++.+||+.+|++|||+++|+++|+
T Consensus 220 ~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~ 251 (252)
T cd05084 220 LCPDAVYRLMERCWEYDPGQRPSFSTVHQELQ 251 (252)
T ss_pred cCCHHHHHHHHHHcCCChhhCcCHHHHHHHHh
Confidence 34567889999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular |
| >cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-36 Score=325.80 Aligned_cols=237 Identities=25% Similarity=0.358 Sum_probs=192.9
Q ss_pred hhcCccccceEEEeeecCCCceEEEEEEccccc---ccchHHHHHHHHHhccc-CCCCcccccceeccCCceEEEEEecc
Q 003836 507 EELGRGAFGTVYKGFVNMGSSNHVAVKKLNSVF---QDSEKEFKAEVNGIGQT-HHKNLVRLLGYCDEGQNRLLVYEFMS 582 (792)
Q Consensus 507 ~~lG~G~~g~Vy~g~~~~~~~~~vavK~~~~~~---~~~~~~~~~Ei~~l~~l-~h~niv~l~g~~~~~~~~~lV~E~~~ 582 (792)
+.||+|+||+||+++.. .+++.||+|++.+.. ....+.+..|+.++..+ +||||+++++++.+.+..++||||++
T Consensus 1 ~~lg~G~~g~V~~~~~~-~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~~~iv~Ey~~ 79 (320)
T cd05590 1 RVLGKGSFGKVMLARLK-ESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLYCCFQTPDRLFFVMEFVN 79 (320)
T ss_pred CeeeeCCCeEEEEEEEc-CCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhccCCCchhceeeEEEcCCEEEEEEcCCC
Confidence 36899999999999754 456789999987532 23445677888888876 69999999999999999999999999
Q ss_pred CCCccccccCCCCCchhHHHHHHHHHHHHHHHHhhccCCCeEecCCCCCcEEEcCCCCeEEeecCCCccccCCCCCcccc
Q 003836 583 NGTVASFLFGDSKPNWKLRTEIAMGIAGGLFYLHEECCTQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLDQSHTNTA 662 (792)
Q Consensus 583 ~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dikp~NILl~~~~~~kl~Dfg~a~~~~~~~~~~~~~ 662 (792)
+|+|.+++.....+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++...... .....
T Consensus 80 ~g~L~~~i~~~~~l~~~~~~~~~~ql~~~L~~lH~~---~ivH~dlkp~NIli~~~~~~kL~DfG~~~~~~~~~-~~~~~ 155 (320)
T cd05590 80 GGDLMFHIQKSRRFDEARARFYAAEITSALMFLHDK---GIIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFNG-KTTST 155 (320)
T ss_pred CchHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC---CeEeCCCCHHHeEECCCCcEEEeeCCCCeecCcCC-Ccccc
Confidence 999999998878899999999999999999999998 99999999999999999999999999987543222 22234
Q ss_pred ccccCCcccccccccCCCCcccceehHHHHHHHHHhcCcCCCcchhhhhhhhHHHHHHHhhcccchhHhhhchhcccCCH
Q 003836 663 IRGTKGYVAPEWFRNMPITVKVDVYSYGVLLLEIICLRRNIDNEISKVDKAILTDWAYDRYQERTLEALVENDLEAMNNV 742 (792)
Q Consensus 663 ~~gt~~y~aPE~~~~~~~~~k~DV~S~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 742 (792)
..||+.|+|||.+.+..++.++|||||||++|||++|+.||........ . ..+.... ...+.
T Consensus 156 ~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~---~-------------~~i~~~~--~~~~~ 217 (320)
T cd05590 156 FCGTPDYIAPEILQEMLYGPSVDWWAMGVLLYEMLCGHAPFEAENEDDL---F-------------EAILNDE--VVYPT 217 (320)
T ss_pred cccCccccCHHHHcCCCCCCccchhhhHHHHHHHhhCCCCCCCCCHHHH---H-------------HHHhcCC--CCCCC
Confidence 5689999999999999999999999999999999999999975432110 0 0011100 01122
Q ss_pred HHHHHHHHHHHHccccCCCCCCCH
Q 003836 743 TMLHRFVMVAFWCIQEDPSHRPTM 766 (792)
Q Consensus 743 ~~~~~l~~l~~~Cl~~~p~~RPs~ 766 (792)
....++.+++.+||+.||.+||++
T Consensus 218 ~~~~~~~~li~~~L~~dP~~R~~~ 241 (320)
T cd05590 218 WLSQDAVDILKAFMTKNPTMRLGS 241 (320)
T ss_pred CCCHHHHHHHHHHcccCHHHCCCC
Confidence 345678899999999999999998
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal |
| >cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-36 Score=317.32 Aligned_cols=253 Identities=25% Similarity=0.331 Sum_probs=197.5
Q ss_pred hhhhcCccccceEEEeeecCCCc---eEEEEEEcccccc-cchHHHHHHHHHhcccCCCCcccccceeccCCceEEEEEe
Q 003836 505 FKEELGRGAFGTVYKGFVNMGSS---NHVAVKKLNSVFQ-DSEKEFKAEVNGIGQTHHKNLVRLLGYCDEGQNRLLVYEF 580 (792)
Q Consensus 505 ~~~~lG~G~~g~Vy~g~~~~~~~---~~vavK~~~~~~~-~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~lV~E~ 580 (792)
+.+.||+|+||+||+|....... ..+++|++..... ....++..|+..+++++|+||+++++++.. ...++++||
T Consensus 11 ~~~~lg~G~~~~vy~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~l~~l~h~~iv~~~~~~~~-~~~~~i~e~ 89 (279)
T cd05111 11 KLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGSLDHAYIVRLLGICPG-ASLQLVTQL 89 (279)
T ss_pred eccccCccCCcceEEEEEcCCCCceeeEEEEeecccccchHHHHHHHHHHHHHhcCCCCCcceEEEEECC-CccEEEEEe
Confidence 45789999999999997643222 2578888764322 234678888889999999999999999864 457789999
Q ss_pred ccCCCccccccCC-CCCchhHHHHHHHHHHHHHHHHhhccCCCeEecCCCCCcEEEcCCCCeEEeecCCCccccCCCC-C
Q 003836 581 MSNGTVASFLFGD-SKPNWKLRTEIAMGIAGGLFYLHEECCTQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLDQS-H 658 (792)
Q Consensus 581 ~~~gsL~~~l~~~-~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dikp~NILl~~~~~~kl~Dfg~a~~~~~~~~-~ 658 (792)
+++|+|.+++... ..+++..+..++.||+.||+|||+. +++|+||||+|||+++++.+||+|||+++....... .
T Consensus 90 ~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~iiH~dlkp~nili~~~~~~kl~Dfg~~~~~~~~~~~~ 166 (279)
T cd05111 90 SPLGSLLDHVRQHRDSLDPQRLLNWCVQIAKGMYYLEEH---RMVHRNLAARNILLKSDSIVQIADFGVADLLYPDDKKY 166 (279)
T ss_pred CCCCcHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHC---CEeccccCcceEEEcCCCcEEEcCCccceeccCCCccc
Confidence 9999999999764 5689999999999999999999998 999999999999999999999999999987643322 1
Q ss_pred ccccccccCCcccccccccCCCCcccceehHHHHHHHHHh-cCcCCCcchhhhhhhhHHHHHHHhhcccchhHhhhchhc
Q 003836 659 TNTAIRGTKGYVAPEWFRNMPITVKVDVYSYGVLLLEIIC-LRRNIDNEISKVDKAILTDWAYDRYQERTLEALVENDLE 737 (792)
Q Consensus 659 ~~~~~~gt~~y~aPE~~~~~~~~~k~DV~S~Gv~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 737 (792)
......++..|+|||.+.+..++.++||||||+++|||++ |+.||........ .. ++.....
T Consensus 167 ~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~~~----~~-------------~~~~~~~ 229 (279)
T cd05111 167 FYSEHKTPIKWMALESILFGRYTHQSDVWSYGVTVWEMMSYGAEPYAGMRPHEV----PD-------------LLEKGER 229 (279)
T ss_pred ccCCCCCcccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHH----HH-------------HHHCCCc
Confidence 2233456788999999998899999999999999999998 9988865422110 00 0111001
Q ss_pred ccCCHHHHHHHHHHHHHccccCCCCCCCHHhHHHHhccCcC
Q 003836 738 AMNNVTMLHRFVMVAFWCIQEDPSHRPTMRKVTQMLEGVVE 778 (792)
Q Consensus 738 ~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~L~~~~~ 778 (792)
...+......+.+++.+||..+|++|||+.|+++.|+.+.+
T Consensus 230 ~~~~~~~~~~~~~li~~c~~~~p~~Rps~~el~~~l~~~~~ 270 (279)
T cd05111 230 LAQPQICTIDVYMVMVKCWMIDENVRPTFKELANEFTRMAR 270 (279)
T ss_pred CCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHh
Confidence 11111223467789999999999999999999999988664
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r |
| >cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-36 Score=333.89 Aligned_cols=250 Identities=23% Similarity=0.295 Sum_probs=196.3
Q ss_pred hhhhcCccccceEEEeeecCCCceEEEEEEccccc---ccchHHHHHHHHHhcccCCCCcccccceeccCCceEEEEEec
Q 003836 505 FKEELGRGAFGTVYKGFVNMGSSNHVAVKKLNSVF---QDSEKEFKAEVNGIGQTHHKNLVRLLGYCDEGQNRLLVYEFM 581 (792)
Q Consensus 505 ~~~~lG~G~~g~Vy~g~~~~~~~~~vavK~~~~~~---~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~lV~E~~ 581 (792)
+.+.||+|+||+||+|... .+++.+|+|++.... ......+.+|++++++++|+||+++++++.+.+..++||||+
T Consensus 5 ~~~~LG~G~~g~Vy~~~~~-~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~lv~E~~ 83 (381)
T cd05626 5 KIKTLGIGAFGEVCLACKV-DTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVMDYI 83 (381)
T ss_pred EEEEEeecCCEEEEEEEEC-CCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhcCCCCeeeeEEEEecCCEEEEEEecC
Confidence 3568999999999999754 567899999987532 233467899999999999999999999999999999999999
Q ss_pred cCCCccccccCCCCCchhHHHHHHHHHHHHHHHHhhccCCCeEecCCCCCcEEEcCCCCeEEeecCCCccccCCCC----
Q 003836 582 SNGTVASFLFGDSKPNWKLRTEIAMGIAGGLFYLHEECCTQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLDQS---- 657 (792)
Q Consensus 582 ~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dikp~NILl~~~~~~kl~Dfg~a~~~~~~~~---- 657 (792)
++|+|.+++.....+++.....++.||+.||.|||+. +|+||||||+|||++.++.+||+|||+++.+.....
T Consensus 84 ~gg~L~~~l~~~~~~~e~~~~~~~~qi~~aL~~LH~~---givHrDlKp~Nili~~~~~~kL~DFGl~~~~~~~~~~~~~ 160 (381)
T cd05626 84 PGGDMMSLLIRMEVFPEVLARFYIAELTLAIESVHKM---GFIHRDIKPDNILIDLDGHIKLTDFGLCTGFRWTHNSKYY 160 (381)
T ss_pred CCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC---CeeecCCcHHHEEECCCCCEEEeeCcCCcccccccccccc
Confidence 9999999998878889999999999999999999998 999999999999999999999999999864321100
Q ss_pred ------------------------------------------CccccccccCCcccccccccCCCCcccceehHHHHHHH
Q 003836 658 ------------------------------------------HTNTAIRGTKGYVAPEWFRNMPITVKVDVYSYGVLLLE 695 (792)
Q Consensus 658 ------------------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~k~DV~S~Gv~l~e 695 (792)
.......||+.|+|||.+.+..++.++|||||||++||
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlG~il~e 240 (381)
T cd05626 161 QKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQLCDWWSVGVILFE 240 (381)
T ss_pred cccccccccccCcccccccccccccccccchhhccccccccccccccccCCccccCHHHHcCCCCCCccceeehhhHHHH
Confidence 00123469999999999998899999999999999999
Q ss_pred HHhcCcCCCcchhhhhhhhHHHHHHHhhcccchhHhhhchhcccCCHHHHHHHHHHHHH--ccccCCCCCCCHHhHHHH
Q 003836 696 IICLRRNIDNEISKVDKAILTDWAYDRYQERTLEALVENDLEAMNNVTMLHRFVMVAFW--CIQEDPSHRPTMRKVTQM 772 (792)
Q Consensus 696 l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~--Cl~~~p~~RPs~~evl~~ 772 (792)
|++|+.||..............+ ............+.++.+++.+ |+..+|..||+++|+++.
T Consensus 241 lltG~~Pf~~~~~~~~~~~i~~~--------------~~~~~~~~~~~~s~~~~dli~~ll~~~~~~~~R~~~~~~l~h 305 (381)
T cd05626 241 MLVGQPPFLAPTPTETQLKVINW--------------ENTLHIPPQVKLSPEAVDLITKLCCSAEERLGRNGADDIKAH 305 (381)
T ss_pred HHhCCCCCcCCCHHHHHHHHHcc--------------ccccCCCCCCCCCHHHHHHHHHHccCcccccCCCCHHHHhcC
Confidence 99999999754322111100000 0001111111234566677766 566777779999999875
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po |
| >cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-36 Score=325.51 Aligned_cols=243 Identities=23% Similarity=0.336 Sum_probs=197.1
Q ss_pred hhcCccccceEEEeeecCCCceEEEEEEccccc---ccchHHHHHHHHHhccc-CCCCcccccceeccCCceEEEEEecc
Q 003836 507 EELGRGAFGTVYKGFVNMGSSNHVAVKKLNSVF---QDSEKEFKAEVNGIGQT-HHKNLVRLLGYCDEGQNRLLVYEFMS 582 (792)
Q Consensus 507 ~~lG~G~~g~Vy~g~~~~~~~~~vavK~~~~~~---~~~~~~~~~Ei~~l~~l-~h~niv~l~g~~~~~~~~~lV~E~~~ 582 (792)
+.||+|+||.||+|... .+++.+|+|++.... ......+..|.+++..+ +||||+++++++.+.+..++||||++
T Consensus 1 ~~lG~G~~g~Vy~~~~~-~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~hp~i~~~~~~~~~~~~~~lv~E~~~ 79 (321)
T cd05591 1 KVLGKGSFGKVMLAELK-GTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTALHCCFQTKDRLFFVMEYVN 79 (321)
T ss_pred CccccCCCeEEEEEEEC-CCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCeEEEEEeCCC
Confidence 36999999999999754 456789999987532 23345677888888866 79999999999999999999999999
Q ss_pred CCCccccccCCCCCchhHHHHHHHHHHHHHHHHhhccCCCeEecCCCCCcEEEcCCCCeEEeecCCCccccCCCCCcccc
Q 003836 583 NGTVASFLFGDSKPNWKLRTEIAMGIAGGLFYLHEECCTQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLDQSHTNTA 662 (792)
Q Consensus 583 ~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dikp~NILl~~~~~~kl~Dfg~a~~~~~~~~~~~~~ 662 (792)
+|+|..++.....+++..+..++.||+.||.|||+. +|+||||||+|||++.++.+||+|||+++...... .....
T Consensus 80 ~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDikp~Nill~~~~~~kL~Dfg~~~~~~~~~-~~~~~ 155 (321)
T cd05591 80 GGDLMFQIQRSRKFDEPRSRFYAAEVTLALMFLHRH---GVIYRDLKLDNILLDAEGHCKLADFGMCKEGILNG-VTTTT 155 (321)
T ss_pred CCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHeEECCCCCEEEeecccceecccCC-ccccc
Confidence 999999998878899999999999999999999998 99999999999999999999999999987643222 22234
Q ss_pred ccccCCcccccccccCCCCcccceehHHHHHHHHHhcCcCCCcchhhhhhhhHHHHHHHhhcccchhHhhhchhcccCCH
Q 003836 663 IRGTKGYVAPEWFRNMPITVKVDVYSYGVLLLEIICLRRNIDNEISKVDKAILTDWAYDRYQERTLEALVENDLEAMNNV 742 (792)
Q Consensus 663 ~~gt~~y~aPE~~~~~~~~~k~DV~S~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 742 (792)
..||+.|+|||++.+..++.++|||||||++|||++|+.||........ . ..+..... ..+.
T Consensus 156 ~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~Pf~~~~~~~~---~-------------~~i~~~~~--~~p~ 217 (321)
T cd05591 156 FCGTPDYIAPEILQELEYGPSVDWWALGVLMYEMMAGQPPFEADNEDDL---F-------------ESILHDDV--LYPV 217 (321)
T ss_pred cccCccccCHHHHcCCCCCCccceechhHHHHHHhcCCCCCCCCCHHHH---H-------------HHHHcCCC--CCCC
Confidence 5689999999999999999999999999999999999999975432211 0 00111100 1122
Q ss_pred HHHHHHHHHHHHccccCCCCCC-------CHHhHHHH
Q 003836 743 TMLHRFVMVAFWCIQEDPSHRP-------TMRKVTQM 772 (792)
Q Consensus 743 ~~~~~l~~l~~~Cl~~~p~~RP-------s~~evl~~ 772 (792)
....++.+++..||+.+|++|| +++++++.
T Consensus 218 ~~~~~~~~ll~~~L~~dp~~R~~~~~~~~~~~~~~~h 254 (321)
T cd05591 218 WLSKEAVSILKAFMTKNPNKRLGCVASQGGEDAIKQH 254 (321)
T ss_pred CCCHHHHHHHHHHhccCHHHcCCCCCCCCCHHHHhcC
Confidence 2346788999999999999999 78888754
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to |
| >cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-37 Score=331.67 Aligned_cols=250 Identities=21% Similarity=0.251 Sum_probs=200.5
Q ss_pred hhhhhcCccccceEEEeeecCCCceEEEEEEccccc---ccchHHHHHHHHHhcccCCCCcccccceeccCCceEEEEEe
Q 003836 504 GFKEELGRGAFGTVYKGFVNMGSSNHVAVKKLNSVF---QDSEKEFKAEVNGIGQTHHKNLVRLLGYCDEGQNRLLVYEF 580 (792)
Q Consensus 504 ~~~~~lG~G~~g~Vy~g~~~~~~~~~vavK~~~~~~---~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~lV~E~ 580 (792)
.+.+.||+|+||+||++... .+++.+|+|+++... ....+.+.+|+.++++++|+||+++++++.+.+..++||||
T Consensus 4 ~~~~~lg~G~~g~Vy~~~~~-~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~~~~i~~~~~~~~~~~~~~lv~e~ 82 (330)
T cd05601 4 DVKSLVGRGHFGEVQVVREK-ATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPWIPQLQYAFQDKDNLYLVMEY 82 (330)
T ss_pred eEEEEEEeccCEEEEEEEEC-CCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceeeEEecCCeEEEEECC
Confidence 35578999999999999754 456799999987542 23456788999999999999999999999999999999999
Q ss_pred ccCCCccccccCC-CCCchhHHHHHHHHHHHHHHHHhhccCCCeEecCCCCCcEEEcCCCCeEEeecCCCccccCCCCCc
Q 003836 581 MSNGTVASFLFGD-SKPNWKLRTEIAMGIAGGLFYLHEECCTQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLDQSHT 659 (792)
Q Consensus 581 ~~~gsL~~~l~~~-~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dikp~NILl~~~~~~kl~Dfg~a~~~~~~~~~~ 659 (792)
+++|+|.+++... ..+++..+..++.||+.||.|||+. +|+||||||+|||++.++.+||+|||+++.........
T Consensus 83 ~~~~~L~~~l~~~~~~l~~~~~~~~~~qi~~aL~~lH~~---~i~H~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~ 159 (330)
T cd05601 83 QPGGDLLSLLNRYEDQFDEDMAQFYLAELVLAIHSVHQM---GYVHRDIKPENVLIDRTGHIKLADFGSAARLTANKMVN 159 (330)
T ss_pred CCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---CeEcccCchHheEECCCCCEEeccCCCCeECCCCCcee
Confidence 9999999999776 6789999999999999999999998 99999999999999999999999999998765443333
Q ss_pred cccccccCCcccccccc------cCCCCcccceehHHHHHHHHHhcCcCCCcchhhhhhhhHHHHHHHhhcccchhHhhh
Q 003836 660 NTAIRGTKGYVAPEWFR------NMPITVKVDVYSYGVLLLEIICLRRNIDNEISKVDKAILTDWAYDRYQERTLEALVE 733 (792)
Q Consensus 660 ~~~~~gt~~y~aPE~~~------~~~~~~k~DV~S~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 733 (792)
.....||+.|+|||++. ...++.++|||||||++|||++|+.||...........+ ... .
T Consensus 160 ~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~i-------~~~-------~ 225 (330)
T cd05601 160 SKLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGTSAKTYNNI-------MNF-------Q 225 (330)
T ss_pred eecccCCccccCHHHhccccccccCCCCCcceeecccceeeeeccCCCCCCCCCHHHHHHHH-------HcC-------C
Confidence 33456899999999986 456789999999999999999999999754322110000 000 0
Q ss_pred chhcccCCHHHHHHHHHHHHHccccCCCCCCCHHhHHHH
Q 003836 734 NDLEAMNNVTMLHRFVMVAFWCIQEDPSHRPTMRKVTQM 772 (792)
Q Consensus 734 ~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~ 772 (792)
...........+..+.+++..||+ +|.+||+++++++.
T Consensus 226 ~~~~~~~~~~~~~~~~~li~~ll~-~p~~R~t~~~l~~h 263 (330)
T cd05601 226 RFLKFPEDPKVSSDFLDLIQSLLC-GQKERLGYEGLCCH 263 (330)
T ss_pred CccCCCCCCCCCHHHHHHHHHHcc-ChhhCCCHHHHhCC
Confidence 001111112345678889999998 99999999999864
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor |
| >cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-36 Score=320.60 Aligned_cols=263 Identities=21% Similarity=0.298 Sum_probs=192.9
Q ss_pred hhhhhhcCccccceEEEeeecCCCceEEEEEEcccccc--cchHHHHHHHHHhccc---CCCCcccccceec-----cCC
Q 003836 503 RGFKEELGRGAFGTVYKGFVNMGSSNHVAVKKLNSVFQ--DSEKEFKAEVNGIGQT---HHKNLVRLLGYCD-----EGQ 572 (792)
Q Consensus 503 ~~~~~~lG~G~~g~Vy~g~~~~~~~~~vavK~~~~~~~--~~~~~~~~Ei~~l~~l---~h~niv~l~g~~~-----~~~ 572 (792)
+.+.+.||+|+||.||++.....+++.||+|+++.... .....+.+|+.+++++ +||||++++++|. ...
T Consensus 3 Y~~~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~hpniv~~~~~~~~~~~~~~~ 82 (290)
T cd07862 3 YECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDRET 82 (290)
T ss_pred cceeeEeccCCCeEEEEEEEcCCCCeEEEEEEEecccCCCCchHHHHHHHHHHHhhcccCCCCcceEEEEEecccCCCCC
Confidence 34567899999999999976444567899998865322 2234566777776665 6999999999884 345
Q ss_pred ceEEEEEeccCCCccccccCC--CCCchhHHHHHHHHHHHHHHHHhhccCCCeEecCCCCCcEEEcCCCCeEEeecCCCc
Q 003836 573 NRLLVYEFMSNGTVASFLFGD--SKPNWKLRTEIAMGIAGGLFYLHEECCTQIIHCDIKPQNILLDDHYNARISDFGLAK 650 (792)
Q Consensus 573 ~~~lV~E~~~~gsL~~~l~~~--~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dikp~NILl~~~~~~kl~Dfg~a~ 650 (792)
..++||||++ ++|.+++... ..+++..+..++.||+.||+|||+. +|+||||||+|||++.++.+||+|||+++
T Consensus 83 ~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~---~iiH~dlkp~Nil~~~~~~~kl~Dfg~~~ 158 (290)
T cd07862 83 KLTLVFEHVD-QDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLADFGLAR 158 (290)
T ss_pred cEEEEEccCC-CCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCHHHEEEcCCCCEEEccccceE
Confidence 6899999997 5898888653 4578999999999999999999998 99999999999999999999999999998
Q ss_pred cccCCCCCccccccccCCcccccccccCCCCcccceehHHHHHHHHHhcCcCCCcchhhhhhhhHHHHHH----Hhhccc
Q 003836 651 LLTLDQSHTNTAIRGTKGYVAPEWFRNMPITVKVDVYSYGVLLLEIICLRRNIDNEISKVDKAILTDWAY----DRYQER 726 (792)
Q Consensus 651 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DV~S~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~----~~~~~~ 726 (792)
..... .......|++.|+|||.+.+..++.++|||||||++|||++|+.||...........+..... ..+...
T Consensus 159 ~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~~~~~~~~i~~~~~~~~~~~~~~~ 236 (290)
T cd07862 159 IYSFQ--MALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPRD 236 (290)
T ss_pred eccCC--cccccccccccccChHHHhCCCCCCccchHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHHhCCCChhhchhh
Confidence 65432 223345689999999999888999999999999999999999999976543221111111000 000000
Q ss_pred -ch-hHhhhchhc---ccCCHHHHHHHHHHHHHccccCCCCCCCHHhHHH
Q 003836 727 -TL-EALVENDLE---AMNNVTMLHRFVMVAFWCIQEDPSHRPTMRKVTQ 771 (792)
Q Consensus 727 -~~-~~~~~~~~~---~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~ 771 (792)
.+ ......... ..........+.+++.+||+.+|++|||+.|+++
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~ 286 (290)
T cd07862 237 VALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALS 286 (290)
T ss_pred hcccchhccCCCCCCHHHHccCCCHHHHHHHHHHhccCchhcCCHHHHhc
Confidence 00 000000000 0001123456789999999999999999999986
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla |
| >cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-36 Score=313.68 Aligned_cols=249 Identities=26% Similarity=0.412 Sum_probs=199.6
Q ss_pred hhhhhhcCccccceEEEeeecCCCceEEEEEEcccccccchHHHHHHHHHhcccCCCCcccccceeccCCceEEEEEecc
Q 003836 503 RGFKEELGRGAFGTVYKGFVNMGSSNHVAVKKLNSVFQDSEKEFKAEVNGIGQTHHKNLVRLLGYCDEGQNRLLVYEFMS 582 (792)
Q Consensus 503 ~~~~~~lG~G~~g~Vy~g~~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~lV~E~~~ 582 (792)
..+.+.||+|+||.||++... ....+|+|++... .....++.+|++++++++|+||+++++++.+.+..++||||++
T Consensus 6 ~~~~~~lg~G~~~~v~~~~~~--~~~~~~iK~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~ 82 (256)
T cd05059 6 LTFLKELGSGQFGVVHLGKWR--GKIDVAIKMIREG-AMSEDDFIEEAKVMMKLSHPNLVQLYGVCTKQRPIFIVTEYMA 82 (256)
T ss_pred cchhhhhccCCCceEEEeEec--CCccEEEEEeccC-CCCHHHHHHHHHHHHhCCCCCEEEEEEEEcCCCceEEEEecCC
Confidence 346688999999999999754 3457999998643 2234678899999999999999999999999999999999999
Q ss_pred CCCccccccCC-CCCchhHHHHHHHHHHHHHHHHhhccCCCeEecCCCCCcEEEcCCCCeEEeecCCCccccCCCCCccc
Q 003836 583 NGTVASFLFGD-SKPNWKLRTEIAMGIAGGLFYLHEECCTQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLDQSHTNT 661 (792)
Q Consensus 583 ~gsL~~~l~~~-~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dikp~NILl~~~~~~kl~Dfg~a~~~~~~~~~~~~ 661 (792)
+++|.+++... ..+++..+..++.||+.||+|||+. +++|+||||+||++++++.+||+|||+++...........
T Consensus 83 ~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dl~p~ni~i~~~~~~kl~dfg~~~~~~~~~~~~~~ 159 (256)
T cd05059 83 NGCLLNYLRERKGKLGTEWLLDMCSDVCEAMEYLESN---GFIHRDLAARNCLVGEDNVVKVSDFGLARYVLDDQYTSSQ 159 (256)
T ss_pred CCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHC---CcccccccHhhEEECCCCcEEECCcccceecccccccccC
Confidence 99999999754 4678999999999999999999998 9999999999999999999999999999865432222222
Q ss_pred cccccCCcccccccccCCCCcccceehHHHHHHHHHh-cCcCCCcchhhhhhhhHHHHHHHhhcccchhHhhhchhcccC
Q 003836 662 AIRGTKGYVAPEWFRNMPITVKVDVYSYGVLLLEIIC-LRRNIDNEISKVDKAILTDWAYDRYQERTLEALVENDLEAMN 740 (792)
Q Consensus 662 ~~~gt~~y~aPE~~~~~~~~~k~DV~S~Gv~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 740 (792)
...++..|+|||.+.+..++.++||||||+++|||++ |+.||........ . .. +........
T Consensus 160 ~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~---~-----~~---------~~~~~~~~~ 222 (256)
T cd05059 160 GTKFPVKWAPPEVFDYSRFSSKSDVWSFGVLMWEVFSEGKMPYERFSNSEV---V-----ES---------VSAGYRLYR 222 (256)
T ss_pred CCCCCccccCHHHhccCCCCchhhHHHHHHHHHHHhccCCCCCCCCCHHHH---H-----HH---------HHcCCcCCC
Confidence 2224567999999999999999999999999999999 7888864322110 0 00 011111112
Q ss_pred CHHHHHHHHHHHHHccccCCCCCCCHHhHHHHhc
Q 003836 741 NVTMLHRFVMVAFWCIQEDPSHRPTMRKVTQMLE 774 (792)
Q Consensus 741 ~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~L~ 774 (792)
+...+.++.+++.+||+.+|++|||++|+++.|.
T Consensus 223 ~~~~~~~~~~li~~cl~~~p~~Rpt~~~~l~~l~ 256 (256)
T cd05059 223 PKLAPTEVYTIMYSCWHEKPEDRPAFKKLLSQLT 256 (256)
T ss_pred CCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHhC
Confidence 2235667899999999999999999999999873
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows |
| >cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-36 Score=312.20 Aligned_cols=250 Identities=29% Similarity=0.404 Sum_probs=201.1
Q ss_pred hhcCccccceEEEeeecCCC--ceEEEEEEcccccc-cchHHHHHHHHHhcccCCCCcccccceeccCCceEEEEEeccC
Q 003836 507 EELGRGAFGTVYKGFVNMGS--SNHVAVKKLNSVFQ-DSEKEFKAEVNGIGQTHHKNLVRLLGYCDEGQNRLLVYEFMSN 583 (792)
Q Consensus 507 ~~lG~G~~g~Vy~g~~~~~~--~~~vavK~~~~~~~-~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~lV~E~~~~ 583 (792)
++||+|+||.||+|+....+ ...+|+|.+..... ...+++.+|+.++++++|+||+++++++. .+..++||||+++
T Consensus 1 ~~ig~G~~g~v~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~~v~e~~~~ 79 (257)
T cd05060 1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVRLIGVCK-GEPLMLVMELAPL 79 (257)
T ss_pred CccCccCceeEEEeEeeccCCCcceEEEEecccccchHHHHHHHHHHHHHHhcCCCCeeeEEEEEc-CCceEEEEEeCCC
Confidence 46999999999999764433 36899999876543 34568999999999999999999999876 4568999999999
Q ss_pred CCccccccCCCCCchhHHHHHHHHHHHHHHHHhhccCCCeEecCCCCCcEEEcCCCCeEEeecCCCccccCCCCCcc--c
Q 003836 584 GTVASFLFGDSKPNWKLRTEIAMGIAGGLFYLHEECCTQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLDQSHTN--T 661 (792)
Q Consensus 584 gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dikp~NILl~~~~~~kl~Dfg~a~~~~~~~~~~~--~ 661 (792)
++|.+++.....+++..+..++.|++.||+|||+. +++|+||||+|||++.++.+||+|||+++.......... .
T Consensus 80 ~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lh~~---~i~H~di~p~nili~~~~~~kl~df~~~~~~~~~~~~~~~~~ 156 (257)
T cd05060 80 GPLLKYLKKRREIPVSDLKELAHQVAMGMAYLESK---HFVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYYRATT 156 (257)
T ss_pred CcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHhhc---CeeccCcccceEEEcCCCcEEeccccccceeecCCccccccc
Confidence 99999998877899999999999999999999998 999999999999999999999999999987644332211 1
Q ss_pred cccccCCcccccccccCCCCcccceehHHHHHHHHHh-cCcCCCcchhhhhhhhHHHHHHHhhcccchhHhhhchhcccC
Q 003836 662 AIRGTKGYVAPEWFRNMPITVKVDVYSYGVLLLEIIC-LRRNIDNEISKVDKAILTDWAYDRYQERTLEALVENDLEAMN 740 (792)
Q Consensus 662 ~~~gt~~y~aPE~~~~~~~~~k~DV~S~Gv~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 740 (792)
...++..|+|||.+.+..++.++||||||+++|||++ |+.||....... +... +........
T Consensus 157 ~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~~g~~p~~~~~~~~----~~~~-------------~~~~~~~~~ 219 (257)
T cd05060 157 AGRWPLKWYAPECINYGKFSSKSDVWSYGVTLWEAFSYGAKPYGEMKGAE----VIAM-------------LESGERLPR 219 (257)
T ss_pred CccccccccCHHHhcCCCCCccchHHHHHHHHHHHHcCCCCCcccCCHHH----HHHH-------------HHcCCcCCC
Confidence 1224568999999998899999999999999999998 899986542210 0000 000011112
Q ss_pred CHHHHHHHHHHHHHccccCCCCCCCHHhHHHHhccCc
Q 003836 741 NVTMLHRFVMVAFWCIQEDPSHRPTMRKVTQMLEGVV 777 (792)
Q Consensus 741 ~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~L~~~~ 777 (792)
+...+..+.+++.+||+.+|++||++.++++.|+++.
T Consensus 220 ~~~~~~~l~~li~~cl~~~p~~Rp~~~~l~~~l~~~~ 256 (257)
T cd05060 220 PEECPQEIYSIMLSCWKYRPEDRPTFSELESTFRRDP 256 (257)
T ss_pred CCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHhcc
Confidence 2334567889999999999999999999999998763
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi |
| >cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-36 Score=324.16 Aligned_cols=242 Identities=23% Similarity=0.335 Sum_probs=193.3
Q ss_pred hhcCccccceEEEeeecCCCceEEEEEEccccc---ccchHHHHHHHHHhcc-cCCCCcccccceeccCCceEEEEEecc
Q 003836 507 EELGRGAFGTVYKGFVNMGSSNHVAVKKLNSVF---QDSEKEFKAEVNGIGQ-THHKNLVRLLGYCDEGQNRLLVYEFMS 582 (792)
Q Consensus 507 ~~lG~G~~g~Vy~g~~~~~~~~~vavK~~~~~~---~~~~~~~~~Ei~~l~~-l~h~niv~l~g~~~~~~~~~lV~E~~~ 582 (792)
+.||+|+||.||+|... ++++.||+|+++... ....+.+..|..++.. .+||||+++++++...+..++||||++
T Consensus 1 ~~lG~G~~g~Vy~~~~~-~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~ 79 (316)
T cd05592 1 KVLGKGSFGKVMLAELK-GTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHLFCTFQTKEHLFFVMEYLN 79 (316)
T ss_pred CeeeeCCCeEEEEEEEC-CCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCC
Confidence 36999999999999764 456789999987532 2233455667777765 489999999999999999999999999
Q ss_pred CCCccccccCCCCCchhHHHHHHHHHHHHHHHHhhccCCCeEecCCCCCcEEEcCCCCeEEeecCCCccccCCCCCcccc
Q 003836 583 NGTVASFLFGDSKPNWKLRTEIAMGIAGGLFYLHEECCTQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLDQSHTNTA 662 (792)
Q Consensus 583 ~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dikp~NILl~~~~~~kl~Dfg~a~~~~~~~~~~~~~ 662 (792)
+|+|..++.....+++..+..++.||+.||+|||+. +|+||||||+|||++.++.+||+|||+++...... .....
T Consensus 80 gg~L~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~---~ivH~dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~-~~~~~ 155 (316)
T cd05592 80 GGDLMFHIQSSGRFDEARARFYAAEIICGLQFLHKK---GIIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGE-GKAST 155 (316)
T ss_pred CCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC---CEEeCCCCHHHeEECCCCCEEEccCcCCeECCCCC-Ccccc
Confidence 999999998777899999999999999999999998 99999999999999999999999999998643322 22234
Q ss_pred ccccCCcccccccccCCCCcccceehHHHHHHHHHhcCcCCCcchhhhhhhhHHHHHHHhhcccchhHhhhchhcccCCH
Q 003836 663 IRGTKGYVAPEWFRNMPITVKVDVYSYGVLLLEIICLRRNIDNEISKVDKAILTDWAYDRYQERTLEALVENDLEAMNNV 742 (792)
Q Consensus 663 ~~gt~~y~aPE~~~~~~~~~k~DV~S~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 742 (792)
..||+.|+|||.+.+..++.++|||||||++|||++|+.||....... ... .+... ....+.
T Consensus 156 ~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~G~~Pf~~~~~~~---~~~-------------~i~~~--~~~~~~ 217 (316)
T cd05592 156 FCGTPDYIAPEILKGQKYNESVDWWSFGVLLYEMLIGQSPFHGEDEDE---LFD-------------SILND--RPHFPR 217 (316)
T ss_pred ccCCccccCHHHHcCCCCCCcccchhHHHHHHHHHhCCCCCCCCCHHH---HHH-------------HHHcC--CCCCCC
Confidence 568999999999999899999999999999999999999997543211 000 00000 111222
Q ss_pred HHHHHHHHHHHHccccCCCCCCCHH-hHHH
Q 003836 743 TMLHRFVMVAFWCIQEDPSHRPTMR-KVTQ 771 (792)
Q Consensus 743 ~~~~~l~~l~~~Cl~~~p~~RPs~~-evl~ 771 (792)
....++.+++.+||+.+|++||++. ++++
T Consensus 218 ~~~~~~~~ll~~~l~~~P~~R~~~~~~l~~ 247 (316)
T cd05592 218 WISKEAKDCLSKLFERDPTKRLGVDGDIRQ 247 (316)
T ss_pred CCCHHHHHHHHHHccCCHHHcCCChHHHHc
Confidence 3456678899999999999999975 5543
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp |
| >cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-36 Score=311.91 Aligned_cols=248 Identities=26% Similarity=0.371 Sum_probs=197.8
Q ss_pred hcCccccceEEEeeecC-CCceEEEEEEcccccc-cchHHHHHHHHHhcccCCCCcccccceeccCCceEEEEEeccCCC
Q 003836 508 ELGRGAFGTVYKGFVNM-GSSNHVAVKKLNSVFQ-DSEKEFKAEVNGIGQTHHKNLVRLLGYCDEGQNRLLVYEFMSNGT 585 (792)
Q Consensus 508 ~lG~G~~g~Vy~g~~~~-~~~~~vavK~~~~~~~-~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~lV~E~~~~gs 585 (792)
.||+|+||.||+|.+.. ..+..||+|++..... ...+.+.+|+.++++++|+||+++++++. ....++||||+++++
T Consensus 2 ~ig~G~~g~v~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~-~~~~~lv~e~~~~~~ 80 (257)
T cd05115 2 ELGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMIGVCE-AEALMLVMEMASGGP 80 (257)
T ss_pred ccCCCCcccEEEEEEecCCCceeEEEEEcccccChHHHHHHHHHHHHHHhcCCCCeEEEEEEEc-CCCeEEEEEeCCCCC
Confidence 48999999999997653 2345799999876432 33467999999999999999999999885 457899999999999
Q ss_pred ccccccC-CCCCchhHHHHHHHHHHHHHHHHhhccCCCeEecCCCCCcEEEcCCCCeEEeecCCCccccCCCCCcc--cc
Q 003836 586 VASFLFG-DSKPNWKLRTEIAMGIAGGLFYLHEECCTQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLDQSHTN--TA 662 (792)
Q Consensus 586 L~~~l~~-~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dikp~NILl~~~~~~kl~Dfg~a~~~~~~~~~~~--~~ 662 (792)
|.+++.. ...+++..+.+++.||+.||+|||++ +++|+||||+|||++.++.+||+|||+++.......... ..
T Consensus 81 L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~ 157 (257)
T cd05115 81 LNKFLSGKKDEITVSNVVELMHQVSMGMKYLEGK---NFVHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYYKARSA 157 (257)
T ss_pred HHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhc---CeeecccchheEEEcCCCcEEeccCCccccccCCccceeccCC
Confidence 9999975 35789999999999999999999998 999999999999999999999999999986544332211 11
Q ss_pred ccccCCcccccccccCCCCcccceehHHHHHHHHHh-cCcCCCcchhhhhhhhHHHHHHHhhcccchhHhhhchhcccCC
Q 003836 663 IRGTKGYVAPEWFRNMPITVKVDVYSYGVLLLEIIC-LRRNIDNEISKVDKAILTDWAYDRYQERTLEALVENDLEAMNN 741 (792)
Q Consensus 663 ~~gt~~y~aPE~~~~~~~~~k~DV~S~Gv~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 741 (792)
..++..|+|||.+....++.++||||||+++||+++ |+.||........ ...+........+
T Consensus 158 ~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~-----------------~~~~~~~~~~~~~ 220 (257)
T cd05115 158 GKWPLKWYAPECINFRKFSSRSDVWSYGITMWEAFSYGQKPYKKMKGPEV-----------------MSFIEQGKRLDCP 220 (257)
T ss_pred CCCCcccCCHHHHccCCCCchhhHHHHHHHHHHHhcCCCCCcCcCCHHHH-----------------HHHHHCCCCCCCC
Confidence 223578999999988889999999999999999996 9999865432110 0111111112223
Q ss_pred HHHHHHHHHHHHHccccCCCCCCCHHhHHHHhccC
Q 003836 742 VTMLHRFVMVAFWCIQEDPSHRPTMRKVTQMLEGV 776 (792)
Q Consensus 742 ~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~L~~~ 776 (792)
...+.++.+++.+||+.+|++||++.+|.+.|+..
T Consensus 221 ~~~~~~l~~li~~c~~~~~~~Rp~~~~i~~~l~~~ 255 (257)
T cd05115 221 AECPPEMYALMKDCWIYKWEDRPNFAKVEERMRTY 255 (257)
T ss_pred CCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHhhh
Confidence 34567888999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho |
| >cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-36 Score=320.87 Aligned_cols=263 Identities=19% Similarity=0.268 Sum_probs=197.1
Q ss_pred hhhhhhcCccccceEEEeeecCCCceEEEEEEccccc-ccchHHHHHHHHHhcccCCCCcccccceeccCCceEEEEEec
Q 003836 503 RGFKEELGRGAFGTVYKGFVNMGSSNHVAVKKLNSVF-QDSEKEFKAEVNGIGQTHHKNLVRLLGYCDEGQNRLLVYEFM 581 (792)
Q Consensus 503 ~~~~~~lG~G~~g~Vy~g~~~~~~~~~vavK~~~~~~-~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~lV~E~~ 581 (792)
+.+.++||+|+||+||+|... .+++.||+|+++... ......+.+|++++++++||||+++++++......++||||+
T Consensus 7 y~~~~~lg~G~~g~Vy~~~~~-~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~ 85 (288)
T cd07871 7 YVKLDKLGEGTYATVFKGRSK-LTENLVALKEIRLEHEEGAPCTAIREVSLLKNLKHANIVTLHDIIHTERCLTLVFEYL 85 (288)
T ss_pred ceEeeEEecCCCEEEEEEEEC-CCCCEEEEEEecccccCCcchhHHHHHHHHHhCCCCCEeeEEEEEcCCCeEEEEEeCC
Confidence 344578999999999999754 456789999986533 233457889999999999999999999999999999999999
Q ss_pred cCCCccccccCC-CCCchhHHHHHHHHHHHHHHHHhhccCCCeEecCCCCCcEEEcCCCCeEEeecCCCccccCCCCCcc
Q 003836 582 SNGTVASFLFGD-SKPNWKLRTEIAMGIAGGLFYLHEECCTQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLDQSHTN 660 (792)
Q Consensus 582 ~~gsL~~~l~~~-~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dikp~NILl~~~~~~kl~Dfg~a~~~~~~~~~~~ 660 (792)
++ +|.+++... ..+++..+..++.||+.||+|||+. +|+||||||+|||+++++.+||+|||+++...... ...
T Consensus 86 ~~-~l~~~l~~~~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~dlkp~Nil~~~~~~~kl~DfG~~~~~~~~~-~~~ 160 (288)
T cd07871 86 DS-DLKQYLDNCGNLMSMHNVKIFMFQLLRGLSYCHKR---KILHRDLKPQNLLINEKGELKLADFGLARAKSVPT-KTY 160 (288)
T ss_pred Cc-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEECCCCCEEECcCcceeeccCCC-ccc
Confidence 85 898888654 4578899999999999999999998 99999999999999999999999999997653222 122
Q ss_pred ccccccCCccccccccc-CCCCcccceehHHHHHHHHHhcCcCCCcchhhhhhhhHHHH----HHHhhcc----cchhHh
Q 003836 661 TAIRGTKGYVAPEWFRN-MPITVKVDVYSYGVLLLEIICLRRNIDNEISKVDKAILTDW----AYDRYQE----RTLEAL 731 (792)
Q Consensus 661 ~~~~gt~~y~aPE~~~~-~~~~~k~DV~S~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~----~~~~~~~----~~~~~~ 731 (792)
....+++.|+|||.+.+ ..++.++|||||||++|||++|+.||............... ....+.. ......
T Consensus 161 ~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (288)
T cd07871 161 SNEVVTLWYRPPDVLLGSTEYSTPIDMWGVGCILYEMATGRPMFPGSTVKEELHLIFRLLGTPTEETWPGITSNEEFRSY 240 (288)
T ss_pred cCceecccccChHHhcCCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHHhhccccchhhhcc
Confidence 33457899999998865 56899999999999999999999999654332211111000 0000000 000111
Q ss_pred hhchhccc----CCHHHHHHHHHHHHHccccCCCCCCCHHhHHH
Q 003836 732 VENDLEAM----NNVTMLHRFVMVAFWCIQEDPSHRPTMRKVTQ 771 (792)
Q Consensus 732 ~~~~~~~~----~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~ 771 (792)
..+..... .......++.+++.+||+.||.+|||++|+++
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dp~~R~t~~~~l~ 284 (288)
T cd07871 241 LFPQYRAQPLINHAPRLDTDGIDLLSSLLLYETKSRISAEAALR 284 (288)
T ss_pred ccCccCCCchHHhCCCCCHHHHHHHHHhcCcCcccCCCHHHHhc
Confidence 11110000 01123456789999999999999999999986
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament |
| >cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-36 Score=326.55 Aligned_cols=250 Identities=22% Similarity=0.301 Sum_probs=196.3
Q ss_pred hhcCccccceEEEeeecCCCceEEEEEEccccc---ccchHHHHHHHHHhccc-CCCCcccccceeccCCceEEEEEecc
Q 003836 507 EELGRGAFGTVYKGFVNMGSSNHVAVKKLNSVF---QDSEKEFKAEVNGIGQT-HHKNLVRLLGYCDEGQNRLLVYEFMS 582 (792)
Q Consensus 507 ~~lG~G~~g~Vy~g~~~~~~~~~vavK~~~~~~---~~~~~~~~~Ei~~l~~l-~h~niv~l~g~~~~~~~~~lV~E~~~ 582 (792)
+.||+|+||.||++... .+++.+|+|++++.. ....+.+.+|+.++.++ +||||+++++++...+..++||||++
T Consensus 1 ~~lG~G~~g~V~~~~~~-~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E~~~ 79 (329)
T cd05618 1 RVIGRGSYAKVLLVRLK-KTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVN 79 (329)
T ss_pred CeeeeCCCeEEEEEEEC-CCCCEEEEEEEEhhHhcchhHHHHHHHHHHHHHhcCCCCcCCceeeEEEeCCEEEEEEeCCC
Confidence 36999999999999754 456789999987532 22345678899888776 89999999999999999999999999
Q ss_pred CCCccccccCCCCCchhHHHHHHHHHHHHHHHHhhccCCCeEecCCCCCcEEEcCCCCeEEeecCCCccccCCCCCcccc
Q 003836 583 NGTVASFLFGDSKPNWKLRTEIAMGIAGGLFYLHEECCTQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLDQSHTNTA 662 (792)
Q Consensus 583 ~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dikp~NILl~~~~~~kl~Dfg~a~~~~~~~~~~~~~ 662 (792)
+|+|..++.....+++..+..++.||+.||+|||+. +|+||||||+|||++.++.+||+|||+++...... .....
T Consensus 80 ~~~L~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~---~ivH~Dikp~Nili~~~~~~kL~DfG~~~~~~~~~-~~~~~ 155 (329)
T cd05618 80 GGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHER---GIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPG-DTTST 155 (329)
T ss_pred CCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCHHHEEECCCCCEEEeeCCccccccCCC-Ccccc
Confidence 999999988778899999999999999999999998 99999999999999999999999999997543222 22234
Q ss_pred ccccCCcccccccccCCCCcccceehHHHHHHHHHhcCcCCCcchhhhh-hhhHHHHHHHhhcccchhHhhhchhcccCC
Q 003836 663 IRGTKGYVAPEWFRNMPITVKVDVYSYGVLLLEIICLRRNIDNEISKVD-KAILTDWAYDRYQERTLEALVENDLEAMNN 741 (792)
Q Consensus 663 ~~gt~~y~aPE~~~~~~~~~k~DV~S~Gv~l~el~tg~~p~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 741 (792)
..||+.|+|||++.+..++.++|||||||++|||++|+.||........ ......+.... +.... ...+
T Consensus 156 ~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~--------i~~~~--~~~p 225 (329)
T cd05618 156 FCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQV--------ILEKQ--IRIP 225 (329)
T ss_pred ccCCccccCHHHHcCCCCCCccceecccHHHHHHhhCCCCCccCCCcCCcccccHHHHHHH--------HhcCC--CCCC
Confidence 5689999999999999999999999999999999999999953211100 00000111111 11111 1123
Q ss_pred HHHHHHHHHHHHHccccCCCCCCC------HHhHHH
Q 003836 742 VTMLHRFVMVAFWCIQEDPSHRPT------MRKVTQ 771 (792)
Q Consensus 742 ~~~~~~l~~l~~~Cl~~~p~~RPs------~~evl~ 771 (792)
......+.+++.+||+.||++||+ +.++++
T Consensus 226 ~~~~~~~~~ll~~~L~~dP~~R~~~~~~~~~~~i~~ 261 (329)
T cd05618 226 RSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQG 261 (329)
T ss_pred CCCCHHHHHHHHHHhcCCHHHcCCCCCCCCHHHHhc
Confidence 344567889999999999999998 466654
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o |
| >cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-36 Score=316.11 Aligned_cols=254 Identities=24% Similarity=0.439 Sum_probs=202.9
Q ss_pred hhhhhcCccccceEEEeeecCCC--ceEEEEEEccccc-ccchHHHHHHHHHhcccCCCCcccccceeccCCceEEEEEe
Q 003836 504 GFKEELGRGAFGTVYKGFVNMGS--SNHVAVKKLNSVF-QDSEKEFKAEVNGIGQTHHKNLVRLLGYCDEGQNRLLVYEF 580 (792)
Q Consensus 504 ~~~~~lG~G~~g~Vy~g~~~~~~--~~~vavK~~~~~~-~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~lV~E~ 580 (792)
...+.||+|+||.||+|...... ...+++|++.... ....+++.+|++++++++|+||+++++++.+.+..++||||
T Consensus 8 ~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 87 (268)
T cd05063 8 TKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHNIIRLEGVVTKFKPAMIITEY 87 (268)
T ss_pred eEeeEecCCCCccEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCCCeeEEEEEEccCCCcEEEEEc
Confidence 34578999999999999875332 2479999987543 33456789999999999999999999999999999999999
Q ss_pred ccCCCccccccCC-CCCchhHHHHHHHHHHHHHHHHhhccCCCeEecCCCCCcEEEcCCCCeEEeecCCCccccCCCCCc
Q 003836 581 MSNGTVASFLFGD-SKPNWKLRTEIAMGIAGGLFYLHEECCTQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLDQSHT 659 (792)
Q Consensus 581 ~~~gsL~~~l~~~-~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dikp~NILl~~~~~~kl~Dfg~a~~~~~~~~~~ 659 (792)
+++++|.+++... ..+++..+..++.|++.||+|||+. +++|+||||+||++++++.+||+|||++..........
T Consensus 88 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~---~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~~~~~ 164 (268)
T cd05063 88 MENGALDKYLRDHDGEFSSYQLVGMLRGIAAGMKYLSDM---NYVHRDLAARNILVNSNLECKVSDFGLSRVLEDDPEGT 164 (268)
T ss_pred CCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccccchhhEEEcCCCcEEECCCccceecccccccc
Confidence 9999999999764 5689999999999999999999998 99999999999999999999999999998764332222
Q ss_pred cc--cccccCCcccccccccCCCCcccceehHHHHHHHHHh-cCcCCCcchhhhhhhhHHHHHHHhhcccchhHhhhchh
Q 003836 660 NT--AIRGTKGYVAPEWFRNMPITVKVDVYSYGVLLLEIIC-LRRNIDNEISKVDKAILTDWAYDRYQERTLEALVENDL 736 (792)
Q Consensus 660 ~~--~~~gt~~y~aPE~~~~~~~~~k~DV~S~Gv~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 736 (792)
.. ....+..|+|||.+....++.++||||||+++|||++ |+.||........ . .. +....
T Consensus 165 ~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~il~ell~~g~~p~~~~~~~~~---~-----~~---------i~~~~ 227 (268)
T cd05063 165 YTTSGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSFGERPYWDMSNHEV---M-----KA---------INDGF 227 (268)
T ss_pred eeccCCCcCceecCHHHhhcCCcChHhHHHHHHHHHHHHHhCCCCCCCcCCHHHH---H-----HH---------HhcCC
Confidence 11 1223457999999998889999999999999999997 9999864322100 0 00 00111
Q ss_pred cccCCHHHHHHHHHHHHHccccCCCCCCCHHhHHHHhccCc
Q 003836 737 EAMNNVTMLHRFVMVAFWCIQEDPSHRPTMRKVTQMLEGVV 777 (792)
Q Consensus 737 ~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~L~~~~ 777 (792)
........+..+.+++.+||+.+|++||++.+|++.|++++
T Consensus 228 ~~~~~~~~~~~~~~li~~c~~~~p~~Rp~~~~i~~~l~~~~ 268 (268)
T cd05063 228 RLPAPMDCPSAVYQLMLQCWQQDRARRPRFVDIVNLLDKLL 268 (268)
T ss_pred CCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhhC
Confidence 11112234567889999999999999999999999998763
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored |
| >cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-36 Score=317.56 Aligned_cols=252 Identities=25% Similarity=0.386 Sum_probs=202.1
Q ss_pred hhhhhcCccccceEEEeee----cCCCceEEEEEEcccccccchHHHHHHHHHhcccCCCCcccccceeccCCceEEEEE
Q 003836 504 GFKEELGRGAFGTVYKGFV----NMGSSNHVAVKKLNSVFQDSEKEFKAEVNGIGQTHHKNLVRLLGYCDEGQNRLLVYE 579 (792)
Q Consensus 504 ~~~~~lG~G~~g~Vy~g~~----~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~lV~E 579 (792)
.+.++||+|+||.||++.. +...+..+++|.+........+.+.+|++++++++|+||+++++++.+....++|||
T Consensus 8 ~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 87 (280)
T cd05092 8 VLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVLQHQHIVRFYGVCTEGRPLLMVFE 87 (280)
T ss_pred eeccccCCccCCeEEEeEEecCCCCCCceEEEEEecCcCCHHHHHHHHHHHHHHhcCCCCCCceEEEEEecCCceEEEEe
Confidence 3467899999999999864 233456899999887666667789999999999999999999999999999999999
Q ss_pred eccCCCccccccCC---------------CCCchhHHHHHHHHHHHHHHHHhhccCCCeEecCCCCCcEEEcCCCCeEEe
Q 003836 580 FMSNGTVASFLFGD---------------SKPNWKLRTEIAMGIAGGLFYLHEECCTQIIHCDIKPQNILLDDHYNARIS 644 (792)
Q Consensus 580 ~~~~gsL~~~l~~~---------------~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dikp~NILl~~~~~~kl~ 644 (792)
|+++++|.+++... ..+++..+..++.||+.||+|||+. +++|+||||+|||+++++.+||+
T Consensus 88 ~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~---~i~H~dlkp~nil~~~~~~~kL~ 164 (280)
T cd05092 88 YMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLASL---HFVHRDLATRNCLVGQGLVVKIG 164 (280)
T ss_pred cCCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHHC---CeecccccHhhEEEcCCCCEEEC
Confidence 99999999998653 2478899999999999999999998 99999999999999999999999
Q ss_pred ecCCCccccCCCCC-ccccccccCCcccccccccCCCCcccceehHHHHHHHHHh-cCcCCCcchhhhhhhhHHHHHHHh
Q 003836 645 DFGLAKLLTLDQSH-TNTAIRGTKGYVAPEWFRNMPITVKVDVYSYGVLLLEIIC-LRRNIDNEISKVDKAILTDWAYDR 722 (792)
Q Consensus 645 Dfg~a~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~k~DV~S~Gv~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~ 722 (792)
|||+++........ ......+++.|+|||.+.+..++.++|||||||++|||++ |+.||.........
T Consensus 165 dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~---------- 234 (280)
T cd05092 165 DFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQPWYQLSNTEAI---------- 234 (280)
T ss_pred CCCceeEcCCCceeecCCCccccccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCccCCHHHHH----------
Confidence 99999765432211 1122335678999999999999999999999999999998 88888543221110
Q ss_pred hcccchhHhhhchhcccCCHHHHHHHHHHHHHccccCCCCCCCHHhHHHHhcc
Q 003836 723 YQERTLEALVENDLEAMNNVTMLHRFVMVAFWCIQEDPSHRPTMRKVTQMLEG 775 (792)
Q Consensus 723 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~L~~ 775 (792)
.... .......+...+..+.+++.+||+.+|.+||+++||++.|++
T Consensus 235 ------~~~~-~~~~~~~~~~~~~~~~~li~~cl~~~P~~Rp~~~~l~~~l~~ 280 (280)
T cd05092 235 ------ECIT-QGRELERPRTCPPEVYAIMQGCWQREPQQRMVIKDIHSRLQA 280 (280)
T ss_pred ------HHHH-cCccCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHhC
Confidence 0000 101111122345668899999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory |
| >cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-36 Score=332.17 Aligned_cols=256 Identities=22% Similarity=0.340 Sum_probs=200.9
Q ss_pred hhhhhhcCccccceEEEeeecC----CCceEEEEEEccccccc-chHHHHHHHHHhcccC-CCCcccccceeccCCceEE
Q 003836 503 RGFKEELGRGAFGTVYKGFVNM----GSSNHVAVKKLNSVFQD-SEKEFKAEVNGIGQTH-HKNLVRLLGYCDEGQNRLL 576 (792)
Q Consensus 503 ~~~~~~lG~G~~g~Vy~g~~~~----~~~~~vavK~~~~~~~~-~~~~~~~Ei~~l~~l~-h~niv~l~g~~~~~~~~~l 576 (792)
..+.+.||+|+||.||+|.... ...+.||+|+++..... ..+.+.+|++++.++. ||||++++++|...+..++
T Consensus 39 ~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~~H~niv~~~~~~~~~~~~~i 118 (401)
T cd05107 39 LVLGRTLGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTARSSEKQALMSELKIMSHLGPHLNIVNLLGACTKGGPIYI 118 (401)
T ss_pred eehhhhccCCCceeEEEEEEcCCCCCCCceEEEEEecCCCCChhHHHHHHHHHHHHHhcCCCCCeEEEEEEEccCCCcEE
Confidence 3345789999999999997642 23468999999764333 2357889999999997 9999999999999999999
Q ss_pred EEEeccCCCccccccCCC--------------------------------------------------------------
Q 003836 577 VYEFMSNGTVASFLFGDS-------------------------------------------------------------- 594 (792)
Q Consensus 577 V~E~~~~gsL~~~l~~~~-------------------------------------------------------------- 594 (792)
|+||+++|+|.++++...
T Consensus 119 v~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 198 (401)
T cd05107 119 ITEYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQRKSHVSLGSESDGGYMDMSKDESADYVPMQDMKGT 198 (401)
T ss_pred EEeccCCCcHHHHHHhccccchhhhcccccccccccccccccccccccchhhhhccCccccccCCccccCccchhcchhh
Confidence 999999999999885421
Q ss_pred ------------------------------------CCchhHHHHHHHHHHHHHHHHhhccCCCeEecCCCCCcEEEcCC
Q 003836 595 ------------------------------------KPNWKLRTEIAMGIAGGLFYLHEECCTQIIHCDIKPQNILLDDH 638 (792)
Q Consensus 595 ------------------------------------~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dikp~NILl~~~ 638 (792)
.+++..+..++.||+.||+|||+. +|+||||||+|||++++
T Consensus 199 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrdlkp~NiLl~~~ 275 (401)
T cd05107 199 VKYADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLASK---NCVHRDLAARNVLICEG 275 (401)
T ss_pred hhhhhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcC---CcCcccCCcceEEEeCC
Confidence 245667788999999999999998 99999999999999999
Q ss_pred CCeEEeecCCCccccCCCCC-ccccccccCCcccccccccCCCCcccceehHHHHHHHHHh-cCcCCCcchhhhhhhhHH
Q 003836 639 YNARISDFGLAKLLTLDQSH-TNTAIRGTKGYVAPEWFRNMPITVKVDVYSYGVLLLEIIC-LRRNIDNEISKVDKAILT 716 (792)
Q Consensus 639 ~~~kl~Dfg~a~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~k~DV~S~Gv~l~el~t-g~~p~~~~~~~~~~~~~~ 716 (792)
+.+||+|||+++........ ......+++.|+|||.+.+..++.++||||||+++|||++ |+.||........ .
T Consensus 276 ~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGvil~e~l~~g~~P~~~~~~~~~---~- 351 (401)
T cd05107 276 KLVKICDFGLARDIMRDSNYISKGSTFLPLKWMAPESIFNNLYTTLSDVWSFGILLWEIFTLGGTPYPELPMNEQ---F- 351 (401)
T ss_pred CEEEEEecCcceecccccccccCCCcCCCCceeChHHhcCCCCCcHhHHHHHHHHHHHHHHcCCCCCCCCCchHH---H-
Confidence 99999999999865432221 1222346788999999998889999999999999999998 8888854321110 0
Q ss_pred HHHHHhhcccchhHhhhchhcccCCHHHHHHHHHHHHHccccCCCCCCCHHhHHHHhccCc
Q 003836 717 DWAYDRYQERTLEALVENDLEAMNNVTMLHRFVMVAFWCIQEDPSHRPTMRKVTQMLEGVV 777 (792)
Q Consensus 717 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~L~~~~ 777 (792)
...+........+...+.++.+++.+||+.+|.+||+++||++.|++++
T Consensus 352 ------------~~~~~~~~~~~~p~~~~~~l~~li~~cl~~~P~~RPs~~ell~~L~~~~ 400 (401)
T cd05107 352 ------------YNAIKRGYRMAKPAHASDEIYEIMQKCWEEKFEIRPDFSQLVHLVGDLL 400 (401)
T ss_pred ------------HHHHHcCCCCCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHh
Confidence 0111111111122234567899999999999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D |
| >PHA03212 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-36 Score=331.95 Aligned_cols=258 Identities=19% Similarity=0.229 Sum_probs=196.3
Q ss_pred hhhhhhcCccccceEEEeeecCCCceEEEEEEcccccccchHHHHHHHHHhcccCCCCcccccceeccCCceEEEEEecc
Q 003836 503 RGFKEELGRGAFGTVYKGFVNMGSSNHVAVKKLNSVFQDSEKEFKAEVNGIGQTHHKNLVRLLGYCDEGQNRLLVYEFMS 582 (792)
Q Consensus 503 ~~~~~~lG~G~~g~Vy~g~~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~lV~E~~~ 582 (792)
+.+.++||+|+||.||++.. ..+++.||+|+.. ...+.+|++++++++||||+++++++......++|+|++.
T Consensus 94 y~~~~~lg~G~~g~V~~~~d-~~~~~~vaiK~~~------~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~lv~e~~~ 166 (391)
T PHA03212 94 FSILETFTPGAEGFAFACID-NKTCEHVVIKAGQ------RGGTATEAHILRAINHPSIIQLKGTFTYNKFTCLILPRYK 166 (391)
T ss_pred cEEEEEEcCCCCeEEEEEEE-CCCCCEEEEechh------hhhhHHHHHHHHhCCCCCCCCEeEEEEECCeeEEEEecCC
Confidence 44567899999999999965 4567789999753 2457899999999999999999999999999999999996
Q ss_pred CCCccccccCCCCCchhHHHHHHHHHHHHHHHHhhccCCCeEecCCCCCcEEEcCCCCeEEeecCCCccccCCCCCcccc
Q 003836 583 NGTVASFLFGDSKPNWKLRTEIAMGIAGGLFYLHEECCTQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLDQSHTNTA 662 (792)
Q Consensus 583 ~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dikp~NILl~~~~~~kl~Dfg~a~~~~~~~~~~~~~ 662 (792)
++|..++.....+++..++.++.||+.||+|||+. +|+||||||+|||++.++.+||+|||+++............
T Consensus 167 -~~L~~~l~~~~~l~~~~~~~i~~qi~~aL~ylH~~---~IvHrDiKP~NIll~~~~~vkL~DFG~a~~~~~~~~~~~~~ 242 (391)
T PHA03212 167 -TDLYCYLAAKRNIAICDILAIERSVLRAIQYLHEN---RIIHRDIKAENIFINHPGDVCLGDFGAACFPVDINANKYYG 242 (391)
T ss_pred -CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCChHhEEEcCCCCEEEEeCCccccccccccccccc
Confidence 68888887777889999999999999999999998 99999999999999999999999999997643322233334
Q ss_pred ccccCCcccccccccCCCCcccceehHHHHHHHHHhcCcCCCcchhhh----hhhhHHHHHHH------hhc---ccchh
Q 003836 663 IRGTKGYVAPEWFRNMPITVKVDVYSYGVLLLEIICLRRNIDNEISKV----DKAILTDWAYD------RYQ---ERTLE 729 (792)
Q Consensus 663 ~~gt~~y~aPE~~~~~~~~~k~DV~S~Gv~l~el~tg~~p~~~~~~~~----~~~~~~~~~~~------~~~---~~~~~ 729 (792)
..||+.|+|||++.+..++.++|||||||++|||++|+.|+....... ....+...... .+. ...+.
T Consensus 243 ~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~l~~i~~~~g~~p~~~~~~~~~~~~ 322 (391)
T PHA03212 243 WAGTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCHDSLFEKDGLDGDCDSDRQIKLIIRRSGTHPNEFPIDAQANLD 322 (391)
T ss_pred ccCccCCCChhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCcCCcccccccCchhHHHHHHHHHhcCChhhcCcchhHHHH
Confidence 579999999999999999999999999999999999998874321100 00000000000 000 00001
Q ss_pred Hhh----hchhcc-------cCCHHHHHHHHHHHHHccccCCCCCCCHHhHHH
Q 003836 730 ALV----ENDLEA-------MNNVTMLHRFVMVAFWCIQEDPSHRPTMRKVTQ 771 (792)
Q Consensus 730 ~~~----~~~~~~-------~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~ 771 (792)
.+. ...... ......+.++.+++.+||+.||++|||++|+++
T Consensus 323 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~mL~~dP~~Rpta~elL~ 375 (391)
T PHA03212 323 EIYIGLAKKSSRKPGSRPLWTNLYELPIDLEYLICKMLAFDAHHRPSAEALLD 375 (391)
T ss_pred HHHHHHHhccCCCCCCCCCHHHHhhhhhhHHHHHHHHhcCChhhCCCHHHHhc
Confidence 000 000000 001134567889999999999999999999986
|
|
| >cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-36 Score=318.07 Aligned_cols=254 Identities=24% Similarity=0.390 Sum_probs=198.3
Q ss_pred HhhhhhhcCccccceEEEeeec----CCCceEEEEEEccccc-ccchHHHHHHHHHhcccCCCCcccccceeccCCceEE
Q 003836 502 TRGFKEELGRGAFGTVYKGFVN----MGSSNHVAVKKLNSVF-QDSEKEFKAEVNGIGQTHHKNLVRLLGYCDEGQNRLL 576 (792)
Q Consensus 502 ~~~~~~~lG~G~~g~Vy~g~~~----~~~~~~vavK~~~~~~-~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~l 576 (792)
.+.+.+.||+|+||.||+|... ...+..+|+|++.... .....++.+|+.+++.++|+||+++++++.+....++
T Consensus 7 ~~~~~~~ig~G~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~l 86 (277)
T cd05062 7 KITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPTLV 86 (277)
T ss_pred HceeeeeeccccCCeEEEEEeccCCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCeEE
Confidence 3455678999999999998653 2334679999986432 2334578999999999999999999999999999999
Q ss_pred EEEeccCCCccccccCC----------CCCchhHHHHHHHHHHHHHHHHhhccCCCeEecCCCCCcEEEcCCCCeEEeec
Q 003836 577 VYEFMSNGTVASFLFGD----------SKPNWKLRTEIAMGIAGGLFYLHEECCTQIIHCDIKPQNILLDDHYNARISDF 646 (792)
Q Consensus 577 V~E~~~~gsL~~~l~~~----------~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dikp~NILl~~~~~~kl~Df 646 (792)
||||+++++|.+++... ..+++..+..++.|++.||+|||+. +++|+||||+|||+++++.+||+||
T Consensus 87 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~---~~vH~dlkp~Nil~~~~~~~~l~df 163 (277)
T cd05062 87 IMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDF 163 (277)
T ss_pred EEecCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCcchheEEEcCCCCEEECCC
Confidence 99999999999998642 2356788899999999999999998 9999999999999999999999999
Q ss_pred CCCccccCCCCC-ccccccccCCcccccccccCCCCcccceehHHHHHHHHHh-cCcCCCcchhhhhhhhHHHHHHHhhc
Q 003836 647 GLAKLLTLDQSH-TNTAIRGTKGYVAPEWFRNMPITVKVDVYSYGVLLLEIIC-LRRNIDNEISKVDKAILTDWAYDRYQ 724 (792)
Q Consensus 647 g~a~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~k~DV~S~Gv~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~ 724 (792)
|+++........ ......+++.|+|||.+.+..++.++|||||||++|||++ |..||........ . ....
T Consensus 164 g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~p~~~~~~~~~---~-----~~~~ 235 (277)
T cd05062 164 GMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGMSNEQV---L-----RFVM 235 (277)
T ss_pred CCccccCCcceeecCCCCccCHhhcChhHhhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHH---H-----HHHH
Confidence 999765432221 1112335778999999998899999999999999999999 6778754322110 0 0000
Q ss_pred ccchhHhhhchhcccCCHHHHHHHHHHHHHccccCCCCCCCHHhHHHHhcc
Q 003836 725 ERTLEALVENDLEAMNNVTMLHRFVMVAFWCIQEDPSHRPTMRKVTQMLEG 775 (792)
Q Consensus 725 ~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~L~~ 775 (792)
+.. ....+...+..+.+++.+||+.+|++|||+.|++++|++
T Consensus 236 ~~~---------~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~~ 277 (277)
T cd05062 236 EGG---------LLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKE 277 (277)
T ss_pred cCC---------cCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHhhC
Confidence 000 001122344578899999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh |
| >cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-36 Score=321.21 Aligned_cols=257 Identities=24% Similarity=0.392 Sum_probs=201.4
Q ss_pred hhhhhcCccccceEEEeeecCCC-ceEEEEEEccccc-ccchHHHHHHHHHhccc-CCCCcccccceeccCCceEEEEEe
Q 003836 504 GFKEELGRGAFGTVYKGFVNMGS-SNHVAVKKLNSVF-QDSEKEFKAEVNGIGQT-HHKNLVRLLGYCDEGQNRLLVYEF 580 (792)
Q Consensus 504 ~~~~~lG~G~~g~Vy~g~~~~~~-~~~vavK~~~~~~-~~~~~~~~~Ei~~l~~l-~h~niv~l~g~~~~~~~~~lV~E~ 580 (792)
.+.+.||+|+||.||+|...... ...+++|.++... ....+.+.+|++++.++ +||||+++++++.+....++|+||
T Consensus 5 ~~~~~lg~g~~g~v~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv~e~ 84 (297)
T cd05089 5 KFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNIINLLGACENRGYLYIAIEY 84 (297)
T ss_pred eeeeeecCCCcceEEEEEecCCCCcceeEEEEccccCCHHHHHHHHHHHHHHHhhcCCCchhheEEEEccCCcceEEEEe
Confidence 45678999999999999775432 2357888887532 33456789999999999 799999999999999999999999
Q ss_pred ccCCCccccccCC----------------CCCchhHHHHHHHHHHHHHHHHhhccCCCeEecCCCCCcEEEcCCCCeEEe
Q 003836 581 MSNGTVASFLFGD----------------SKPNWKLRTEIAMGIAGGLFYLHEECCTQIIHCDIKPQNILLDDHYNARIS 644 (792)
Q Consensus 581 ~~~gsL~~~l~~~----------------~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dikp~NILl~~~~~~kl~ 644 (792)
+++++|.+++... ..+++..+..++.|++.||+|||+. +|+||||||+|||+++++.+||+
T Consensus 85 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~---~ivH~dlkp~Nill~~~~~~kl~ 161 (297)
T cd05089 85 APYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLSEK---QFIHRDLAARNVLVGENLASKIA 161 (297)
T ss_pred cCCCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCcCCcceEEECCCCeEEEC
Confidence 9999999998643 2477889999999999999999998 99999999999999999999999
Q ss_pred ecCCCccccCCCCCccccccccCCcccccccccCCCCcccceehHHHHHHHHHh-cCcCCCcchhhhhhhhHHHHHHHhh
Q 003836 645 DFGLAKLLTLDQSHTNTAIRGTKGYVAPEWFRNMPITVKVDVYSYGVLLLEIIC-LRRNIDNEISKVDKAILTDWAYDRY 723 (792)
Q Consensus 645 Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DV~S~Gv~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~ 723 (792)
|||++...... ........+..|+|||.+....++.++|||||||++|||++ |+.||........ . ..
T Consensus 162 dfg~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~el~t~g~~pf~~~~~~~~---~-----~~- 230 (297)
T cd05089 162 DFGLSRGEEVY--VKKTMGRLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVSLGGTPYCGMTCAEL---Y-----EK- 230 (297)
T ss_pred CcCCCccccce--eccCCCCcCccccCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHH---H-----HH-
Confidence 99998643211 11111223557999999988889999999999999999997 9999865432110 0 00
Q ss_pred cccchhHhhhchhcccCCHHHHHHHHHHHHHccccCCCCCCCHHhHHHHhccCcCCCCC
Q 003836 724 QERTLEALVENDLEAMNNVTMLHRFVMVAFWCIQEDPSHRPTMRKVTQMLEGVVEVPIP 782 (792)
Q Consensus 724 ~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~L~~~~~~~~p 782 (792)
+........+...+..+.+++.+||+.+|.+||+++++++.|+.+++...+
T Consensus 231 --------~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~~~~~~~ 281 (297)
T cd05089 231 --------LPQGYRMEKPRNCDDEVYELMRQCWRDRPYERPPFAQISVQLSRMLEARKA 281 (297)
T ss_pred --------HhcCCCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhhcc
Confidence 111111112223456788999999999999999999999999888765443
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. |
| >cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-36 Score=327.44 Aligned_cols=264 Identities=20% Similarity=0.296 Sum_probs=196.2
Q ss_pred hhhhhcCccccceEEEeeecCCCceEEEEEEccccc--ccchHHHHHHHHHhcccCCCCcccccceeccC-----CceEE
Q 003836 504 GFKEELGRGAFGTVYKGFVNMGSSNHVAVKKLNSVF--QDSEKEFKAEVNGIGQTHHKNLVRLLGYCDEG-----QNRLL 576 (792)
Q Consensus 504 ~~~~~lG~G~~g~Vy~g~~~~~~~~~vavK~~~~~~--~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~-----~~~~l 576 (792)
.+.++||+|+||.||+|.. ..+++.||||++.... ......+.+|++++++++||||+++++++... ...++
T Consensus 3 ~i~~~lg~G~~g~V~~~~~-~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~l 81 (338)
T cd07859 3 KIQEVIGKGSYGVVCSAID-THTGEKVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIYV 81 (338)
T ss_pred EEEEEEeecCCeEEEEEEE-CCCCCEEEEEEechhhccchhHHHHHHHHHHHHhCCCCCEeeecceEeccCCCCCceEEE
Confidence 4557899999999999975 3556799999987532 23345788999999999999999999988543 34799
Q ss_pred EEEeccCCCccccccCCCCCchhHHHHHHHHHHHHHHHHhhccCCCeEecCCCCCcEEEcCCCCeEEeecCCCccccCCC
Q 003836 577 VYEFMSNGTVASFLFGDSKPNWKLRTEIAMGIAGGLFYLHEECCTQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLDQ 656 (792)
Q Consensus 577 V~E~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dikp~NILl~~~~~~kl~Dfg~a~~~~~~~ 656 (792)
||||+. ++|.+++.....+++..+..++.||++||.|||+. +|+||||||+|||++.++.+||+|||+++......
T Consensus 82 v~e~~~-~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~ 157 (338)
T cd07859 82 VFELME-SDLHQVIKANDDLTPEHHQFFLYQLLRALKYIHTA---NVFHRDLKPKNILANADCKLKICDFGLARVAFNDT 157 (338)
T ss_pred EEecCC-CCHHHHHHhcccCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEECCCCcEEEccCcccccccccc
Confidence 999996 68999988777899999999999999999999998 99999999999999999999999999998653322
Q ss_pred CC--ccccccccCCccccccccc--CCCCcccceehHHHHHHHHHhcCcCCCcchhhhhhhhHHHH-------HHHhhcc
Q 003836 657 SH--TNTAIRGTKGYVAPEWFRN--MPITVKVDVYSYGVLLLEIICLRRNIDNEISKVDKAILTDW-------AYDRYQE 725 (792)
Q Consensus 657 ~~--~~~~~~gt~~y~aPE~~~~--~~~~~k~DV~S~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~-------~~~~~~~ 725 (792)
.. ......||+.|+|||++.+ ..++.++|||||||++|||++|+.||............... .......
T Consensus 158 ~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DvwSlGvvl~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~i~~ 237 (338)
T cd07859 158 PTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLITDLLGTPSPETISRVRN 237 (338)
T ss_pred CccccccCCCCCCCcCCHHHHhccccccCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHhhh
Confidence 21 1233568999999999875 67899999999999999999999999654321110000000 0000000
Q ss_pred cchhHhhhchhccc-C-----CHHHHHHHHHHHHHccccCCCCCCCHHhHHHH
Q 003836 726 RTLEALVENDLEAM-N-----NVTMLHRFVMVAFWCIQEDPSHRPTMRKVTQM 772 (792)
Q Consensus 726 ~~~~~~~~~~~~~~-~-----~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~ 772 (792)
......+....... . .......+.+++.+||+.+|++|||++|+++.
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~e~l~h 290 (338)
T cd07859 238 EKARRYLSSMRKKQPVPFSQKFPNADPLALRLLERLLAFDPKDRPTAEEALAD 290 (338)
T ss_pred hhHHHHHHhhcccCCCchHHhcCCCChHHHHHHHHHcCcCcccCCCHHHHhcC
Confidence 11111111000000 0 01124567899999999999999999999974
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos |
| >KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-36 Score=289.71 Aligned_cols=242 Identities=25% Similarity=0.349 Sum_probs=206.2
Q ss_pred hhhhcCccccceEEEeeecCCCceEEEEEEccccc---ccchHHHHHHHHHhcccCCCCcccccceeccCCceEEEEEec
Q 003836 505 FKEELGRGAFGTVYKGFVNMGSSNHVAVKKLNSVF---QDSEKEFKAEVNGIGQTHHKNLVRLLGYCDEGQNRLLVYEFM 581 (792)
Q Consensus 505 ~~~~lG~G~~g~Vy~g~~~~~~~~~vavK~~~~~~---~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~lV~E~~ 581 (792)
+.+.||+|.||.||.|..+ .+...||+|++.+.. ...+.++.+|+++-..|+||||++++++|.+....||++||.
T Consensus 26 igr~LgkgkFG~vYlarek-ks~~IvalKVlfKsqi~~~~v~~qlrREiEIqs~L~hpnilrlY~~fhd~~riyLilEya 104 (281)
T KOG0580|consen 26 IGRPLGKGKFGNVYLAREK-KSLFIVALKVLFKSQILKTQVEHQLRREIEIQSHLRHPNILRLYGYFHDSKRIYLILEYA 104 (281)
T ss_pred ccccccCCccccEeEeeec-cCCcEEEEeeeeHHHHHHhcchhhhhheeEeecccCCccHHhhhhheeccceeEEEEEec
Confidence 4578999999999999754 456789999987642 334578999999999999999999999999999999999999
Q ss_pred cCCCcccccc--CCCCCchhHHHHHHHHHHHHHHHHhhccCCCeEecCCCCCcEEEcCCCCeEEeecCCCccccCCCCCc
Q 003836 582 SNGTVASFLF--GDSKPNWKLRTEIAMGIAGGLFYLHEECCTQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLDQSHT 659 (792)
Q Consensus 582 ~~gsL~~~l~--~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dikp~NILl~~~~~~kl~Dfg~a~~~~~~~~~~ 659 (792)
++|+|...|. ....+++.....++.|+|.||.|+|.+ +++||||||+|+|++..+..||+|||-+.... ...
T Consensus 105 ~~gel~k~L~~~~~~~f~e~~~a~Yi~q~A~Al~y~h~k---~VIhRdiKpenlLlg~~~~lkiAdfGwsV~~p---~~k 178 (281)
T KOG0580|consen 105 PRGELYKDLQEGRMKRFDEQRAATYIKQLANALLYCHLK---RVIHRDIKPENLLLGSAGELKIADFGWSVHAP---SNK 178 (281)
T ss_pred CCchHHHHHHhcccccccccchhHHHHHHHHHHHHhccC---CcccCCCCHHHhccCCCCCeeccCCCceeecC---CCC
Confidence 9999999998 456789999999999999999999998 99999999999999999999999999987543 344
Q ss_pred cccccccCCcccccccccCCCCcccceehHHHHHHHHHhcCcCCCcchhhhhhhhHHHHHHHhhcccchhHhhhchhccc
Q 003836 660 NTAIRGTKGYVAPEWFRNMPITVKVDVYSYGVLLLEIICLRRNIDNEISKVDKAILTDWAYDRYQERTLEALVENDLEAM 739 (792)
Q Consensus 660 ~~~~~gt~~y~aPE~~~~~~~~~k~DV~S~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 739 (792)
..+.+||.-|.+||...+..++.+.|+|++|++.||++.|..||.......- ...+..-++ .
T Consensus 179 R~tlcgt~dyl~pEmv~~~~hd~~Vd~w~lgvl~yeflvg~ppFes~~~~et----------------YkrI~k~~~--~ 240 (281)
T KOG0580|consen 179 RKTLCGTLDYLPPEMVEGRGHDKFVDLWSLGVLCYEFLVGLPPFESQSHSET----------------YKRIRKVDL--K 240 (281)
T ss_pred ceeeecccccCCHhhcCCCCccchhhHHHHHHHHHHHHhcCCchhhhhhHHH----------------HHHHHHccc--c
Confidence 4567899999999999999999999999999999999999999986642211 111111111 1
Q ss_pred CCHHHHHHHHHHHHHccccCCCCCCCHHhHHH
Q 003836 740 NNVTMLHRFVMVAFWCIQEDPSHRPTMRKVTQ 771 (792)
Q Consensus 740 ~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~ 771 (792)
++...+..+.+++.+|+..+|.+|.+..|++.
T Consensus 241 ~p~~is~~a~dlI~~ll~~~p~~r~~l~~v~~ 272 (281)
T KOG0580|consen 241 FPSTISGGAADLISRLLVKNPIERLALTEVMD 272 (281)
T ss_pred CCcccChhHHHHHHHHhccCccccccHHHHhh
Confidence 23456678889999999999999999999987
|
|
| >cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-36 Score=330.87 Aligned_cols=249 Identities=19% Similarity=0.246 Sum_probs=198.8
Q ss_pred hhhhhhcCccccceEEEeeecCCCceEEEEEEccccc---ccchHHHHHHHHHhcccCCCCcccccceeccCCceEEEEE
Q 003836 503 RGFKEELGRGAFGTVYKGFVNMGSSNHVAVKKLNSVF---QDSEKEFKAEVNGIGQTHHKNLVRLLGYCDEGQNRLLVYE 579 (792)
Q Consensus 503 ~~~~~~lG~G~~g~Vy~g~~~~~~~~~vavK~~~~~~---~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~lV~E 579 (792)
+.+.+.||+|+||.||++... .+++.+|+|++.+.. ......+.+|+.+++.++||||+++++++.+++..++|||
T Consensus 45 y~~~~~lg~G~~g~Vy~~~~~-~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~h~~iv~~~~~~~~~~~~~lv~E 123 (370)
T cd05596 45 FDVIKVIGRGAFGEVQLVRHK-SSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHANSEWIVQLHYAFQDDKYLYMVME 123 (370)
T ss_pred cEEEEEEeeCCCEEEEEEEEC-CCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEEEEEEc
Confidence 345578999999999999754 456789999986432 2334567899999999999999999999999999999999
Q ss_pred eccCCCccccccCCCCCchhHHHHHHHHHHHHHHHHhhccCCCeEecCCCCCcEEEcCCCCeEEeecCCCccccCCCCCc
Q 003836 580 FMSNGTVASFLFGDSKPNWKLRTEIAMGIAGGLFYLHEECCTQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLDQSHT 659 (792)
Q Consensus 580 ~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dikp~NILl~~~~~~kl~Dfg~a~~~~~~~~~~ 659 (792)
|+++|+|.+++... .+++.....++.||+.||+|||+. +|+||||||+|||++.++.+||+|||+++.........
T Consensus 124 y~~gg~L~~~l~~~-~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrDLkp~NILl~~~~~~kL~DfG~~~~~~~~~~~~ 199 (370)
T cd05596 124 YMPGGDLVNLMSNY-DIPEKWARFYTAEVVLALDAIHSM---GFIHRDVKPDNMLLDKSGHLKLADFGTCMKMDANGMVR 199 (370)
T ss_pred CCCCCcHHHHHHhc-CCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHEEEcCCCCEEEEeccceeeccCCCccc
Confidence 99999999988653 577888899999999999999998 99999999999999999999999999998765433323
Q ss_pred cccccccCCcccccccccC----CCCcccceehHHHHHHHHHhcCcCCCcchhhhhhhhHHHHHHHhhcccchhHhhhch
Q 003836 660 NTAIRGTKGYVAPEWFRNM----PITVKVDVYSYGVLLLEIICLRRNIDNEISKVDKAILTDWAYDRYQERTLEALVEND 735 (792)
Q Consensus 660 ~~~~~gt~~y~aPE~~~~~----~~~~k~DV~S~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 735 (792)
.....||+.|+|||.+.+. .++.++|||||||++|||++|+.||........ ...+....
T Consensus 200 ~~~~~gt~~y~aPE~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~----------------~~~i~~~~ 263 (370)
T cd05596 200 CDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGT----------------YSKIMDHK 263 (370)
T ss_pred CCCCCCCcCeECHHHhccCCCCCCCCCceeeeehhHHHHHHHhCCCCcCCCCHHHH----------------HHHHHcCC
Confidence 3345699999999998653 478999999999999999999999975432111 01111110
Q ss_pred --hcccCCHHHHHHHHHHHHHccccCCCC--CCCHHhHHHH
Q 003836 736 --LEAMNNVTMLHRFVMVAFWCIQEDPSH--RPTMRKVTQM 772 (792)
Q Consensus 736 --~~~~~~~~~~~~l~~l~~~Cl~~~p~~--RPs~~evl~~ 772 (792)
+........+.++.+++..||+.+|.+ ||+++|+++.
T Consensus 264 ~~~~~~~~~~~s~~~~~li~~~L~~~p~r~~R~s~~ell~h 304 (370)
T cd05596 264 NSLTFPDDIEISKQAKDLICAFLTDREVRLGRNGVDEIKSH 304 (370)
T ss_pred CcCCCCCcCCCCHHHHHHHHHHccChhhccCCCCHHHHhcC
Confidence 111111234677889999999999987 9999999865
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in |
| >cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-36 Score=316.62 Aligned_cols=255 Identities=25% Similarity=0.330 Sum_probs=201.2
Q ss_pred HHhhhhhhcCccccceEEEeeecC----CCceEEEEEEccccccc-chHHHHHHHHHhcccCCCCcccccceeccCCceE
Q 003836 501 VTRGFKEELGRGAFGTVYKGFVNM----GSSNHVAVKKLNSVFQD-SEKEFKAEVNGIGQTHHKNLVRLLGYCDEGQNRL 575 (792)
Q Consensus 501 ~~~~~~~~lG~G~~g~Vy~g~~~~----~~~~~vavK~~~~~~~~-~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~ 575 (792)
..+.+.++||+|+||.||+|.... ..++.||+|+++..... ....+.+|+.++.+++||||+++++++.+....+
T Consensus 5 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~ 84 (283)
T cd05091 5 STVRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHEAMMRSRLQHPNIVCLLGVVTKEQPLS 84 (283)
T ss_pred HHHHHHHHhCCCCCCeEEEEEEecCCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEcCCCceE
Confidence 345667899999999999997642 23468999999754332 2456889999999999999999999999999999
Q ss_pred EEEEeccCCCccccccCC----------------CCCchhHHHHHHHHHHHHHHHHhhccCCCeEecCCCCCcEEEcCCC
Q 003836 576 LVYEFMSNGTVASFLFGD----------------SKPNWKLRTEIAMGIAGGLFYLHEECCTQIIHCDIKPQNILLDDHY 639 (792)
Q Consensus 576 lV~E~~~~gsL~~~l~~~----------------~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dikp~NILl~~~~ 639 (792)
+++||+++++|.+++... ..+++..+.+++.|++.||.|||+. +|+||||||+|||+++++
T Consensus 85 ~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH~~---gi~H~dlkp~Nil~~~~~ 161 (283)
T cd05091 85 MIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLSSH---HVVHKDLATRNVLVFDKL 161 (283)
T ss_pred EEEEcCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHc---CccccccchhheEecCCC
Confidence 999999999999998421 2467888899999999999999998 999999999999999999
Q ss_pred CeEEeecCCCccccCCCCC-ccccccccCCcccccccccCCCCcccceehHHHHHHHHHh-cCcCCCcchhhhhhhhHHH
Q 003836 640 NARISDFGLAKLLTLDQSH-TNTAIRGTKGYVAPEWFRNMPITVKVDVYSYGVLLLEIIC-LRRNIDNEISKVDKAILTD 717 (792)
Q Consensus 640 ~~kl~Dfg~a~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~k~DV~S~Gv~l~el~t-g~~p~~~~~~~~~~~~~~~ 717 (792)
.+||+|||+++........ ......+++.|+|||.+.+..++.++||||||+++|||++ |..||........
T Consensus 162 ~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~------ 235 (283)
T cd05091 162 NVKISDLGLFREVYAADYYKLMGNSLLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQDV------ 235 (283)
T ss_pred ceEecccccccccccchheeeccCccCCccccCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCHHHH------
Confidence 9999999998865432221 1222345778999999988889999999999999999998 7777754322100
Q ss_pred HHHHhhcccchhHhhhchhcccCCHHHHHHHHHHHHHccccCCCCCCCHHhHHHHhcc
Q 003836 718 WAYDRYQERTLEALVENDLEAMNNVTMLHRFVMVAFWCIQEDPSHRPTMRKVTQMLEG 775 (792)
Q Consensus 718 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~L~~ 775 (792)
...+... .....+...+..+.+++..||+.+|++||++.+|++.|+.
T Consensus 236 ----------~~~i~~~-~~~~~~~~~~~~~~~li~~cl~~~p~~RP~~~~i~~~l~~ 282 (283)
T cd05091 236 ----------IEMIRNR-QVLPCPDDCPAWVYTLMLECWNEFPSRRPRFKDIHSRLRT 282 (283)
T ss_pred ----------HHHHHcC-CcCCCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHHhhC
Confidence 0011111 1111233456678899999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-36 Score=313.56 Aligned_cols=252 Identities=26% Similarity=0.411 Sum_probs=199.2
Q ss_pred hhhhcCccccceEEEeeecCC--CceEEEEEEccccc--ccchHHHHHHHHHhcccCCCCcccccceeccCCc------e
Q 003836 505 FKEELGRGAFGTVYKGFVNMG--SSNHVAVKKLNSVF--QDSEKEFKAEVNGIGQTHHKNLVRLLGYCDEGQN------R 574 (792)
Q Consensus 505 ~~~~lG~G~~g~Vy~g~~~~~--~~~~vavK~~~~~~--~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~------~ 574 (792)
+.+.||+|+||.||+|+.... ....+|+|+++... ......+.+|++.++.++|+||+++++++.+.+. .
T Consensus 3 ~~~~lg~G~~g~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~ 82 (273)
T cd05035 3 LGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMKLIGVCFEASSLQKIPKP 82 (273)
T ss_pred cccccCcCCCceEEEEEEecCCCCcceEEEEEeccCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEeeeccCCccccCccc
Confidence 457899999999999987543 34689999987532 2334678999999999999999999998866554 7
Q ss_pred EEEEEeccCCCccccccCC------CCCchhHHHHHHHHHHHHHHHHhhccCCCeEecCCCCCcEEEcCCCCeEEeecCC
Q 003836 575 LLVYEFMSNGTVASFLFGD------SKPNWKLRTEIAMGIAGGLFYLHEECCTQIIHCDIKPQNILLDDHYNARISDFGL 648 (792)
Q Consensus 575 ~lV~E~~~~gsL~~~l~~~------~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dikp~NILl~~~~~~kl~Dfg~ 648 (792)
++|+||+++|+|..++... ..+++.....++.|++.||+|||+. +++||||||+||++++++.+||+|||+
T Consensus 83 ~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~aL~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~dfg~ 159 (273)
T cd05035 83 MVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLSNR---NFIHRDLAARNCMLREDMTVCVADFGL 159 (273)
T ss_pred EEEEeccCCCCHHHHHHHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhC---CeeccccchheEEECCCCeEEECCccc
Confidence 8999999999999988432 3578899999999999999999998 999999999999999999999999999
Q ss_pred CccccCCCCCc-cccccccCCcccccccccCCCCcccceehHHHHHHHHHh-cCcCCCcchhhhhhhhHHHHHHHhhccc
Q 003836 649 AKLLTLDQSHT-NTAIRGTKGYVAPEWFRNMPITVKVDVYSYGVLLLEIIC-LRRNIDNEISKVDKAILTDWAYDRYQER 726 (792)
Q Consensus 649 a~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~k~DV~S~Gv~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 726 (792)
++......... .....++..|+|||.+....++.++||||||+++|||++ |..||....... ..
T Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~SlG~il~el~~~g~~p~~~~~~~~---~~----------- 225 (273)
T cd05035 160 SKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGQTPYPGVENHE---IY----------- 225 (273)
T ss_pred eeeccccccccccccccCCccccCHhhcccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCHHH---HH-----------
Confidence 98764333221 112234678999999988899999999999999999999 788875432110 00
Q ss_pred chhHhhhchhcccCCHHHHHHHHHHHHHccccCCCCCCCHHhHHHHhccC
Q 003836 727 TLEALVENDLEAMNNVTMLHRFVMVAFWCIQEDPSHRPTMRKVTQMLEGV 776 (792)
Q Consensus 727 ~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~L~~~ 776 (792)
..+. .......+...+..+.+++.+||+.||.+||++.|+++.|+++
T Consensus 226 --~~~~-~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~e~~~~l~~~ 272 (273)
T cd05035 226 --DYLR-HGNRLKQPEDCLDELYDLMYSCWRADPKDRPTFTKLREVLENI 272 (273)
T ss_pred --HHHH-cCCCCCCCcCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence 0001 1111112334566889999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu |
| >cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-36 Score=325.53 Aligned_cols=250 Identities=22% Similarity=0.309 Sum_probs=197.3
Q ss_pred hhcCccccceEEEeeecCCCceEEEEEEccccc---ccchHHHHHHHHHhccc-CCCCcccccceeccCCceEEEEEecc
Q 003836 507 EELGRGAFGTVYKGFVNMGSSNHVAVKKLNSVF---QDSEKEFKAEVNGIGQT-HHKNLVRLLGYCDEGQNRLLVYEFMS 582 (792)
Q Consensus 507 ~~lG~G~~g~Vy~g~~~~~~~~~vavK~~~~~~---~~~~~~~~~Ei~~l~~l-~h~niv~l~g~~~~~~~~~lV~E~~~ 582 (792)
+.||+|+||.||++... .+++.||+|++++.. ....+.+.+|+.++.++ +||||+++++++.+.+..++||||++
T Consensus 1 ~~lG~G~~g~V~~~~~~-~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~il~~~~~hp~Iv~~~~~~~~~~~~~lv~e~~~ 79 (329)
T cd05588 1 RVIGRGSYAKVLLVELK-KTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLHSCFQTESRLFFVIEFVS 79 (329)
T ss_pred CeEeeCCCeEEEEEEEC-CCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCCCCceEEEEEcCCEEEEEEeCCC
Confidence 36899999999999754 456789999997532 22345688899999988 79999999999999999999999999
Q ss_pred CCCccccccCCCCCchhHHHHHHHHHHHHHHHHhhccCCCeEecCCCCCcEEEcCCCCeEEeecCCCccccCCCCCcccc
Q 003836 583 NGTVASFLFGDSKPNWKLRTEIAMGIAGGLFYLHEECCTQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLDQSHTNTA 662 (792)
Q Consensus 583 ~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dikp~NILl~~~~~~kl~Dfg~a~~~~~~~~~~~~~ 662 (792)
+|+|..++.....+++..+..++.||+.||.|||+. +|+||||||+|||++.++.+||+|||+++..... ......
T Consensus 80 ~g~L~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~-~~~~~~ 155 (329)
T cd05588 80 GGDLMFHMQRQRKLPEEHARFYSAEISLALNFLHER---GIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIRP-GDTTST 155 (329)
T ss_pred CCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHeEECCCCCEEECcCccccccccC-CCcccc
Confidence 999999998778899999999999999999999998 9999999999999999999999999998753221 222234
Q ss_pred ccccCCcccccccccCCCCcccceehHHHHHHHHHhcCcCCCcchhhhh-hhhHHHHHHHhhcccchhHhhhchhcccCC
Q 003836 663 IRGTKGYVAPEWFRNMPITVKVDVYSYGVLLLEIICLRRNIDNEISKVD-KAILTDWAYDRYQERTLEALVENDLEAMNN 741 (792)
Q Consensus 663 ~~gt~~y~aPE~~~~~~~~~k~DV~S~Gv~l~el~tg~~p~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 741 (792)
..||+.|+|||++.+..++.++|||||||++|||++|+.||+....... ......+... .+..... ..+
T Consensus 156 ~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~--------~~~~~~~--~~p 225 (329)
T cd05588 156 FCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGMSDNPDQNTEDYLFQ--------VILEKQI--RIP 225 (329)
T ss_pred ccCCccccCHHHHcCCCCCCccceechHHHHHHHHHCCCCcccccccccccccchHHHHH--------HHHcCCC--CCC
Confidence 5689999999999999999999999999999999999999964221110 0000011111 1111111 112
Q ss_pred HHHHHHHHHHHHHccccCCCCCCC------HHhHHH
Q 003836 742 VTMLHRFVMVAFWCIQEDPSHRPT------MRKVTQ 771 (792)
Q Consensus 742 ~~~~~~l~~l~~~Cl~~~p~~RPs------~~evl~ 771 (792)
...+.++.+++.+||+.||.+||+ ++++++
T Consensus 226 ~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~i~~ 261 (329)
T cd05588 226 RSLSVKASSVLKGFLNKDPKERLGCHPQTGFRDIKS 261 (329)
T ss_pred CCCCHHHHHHHHHHhccCHHHcCCCCCCCCHHHHhc
Confidence 234567889999999999999997 667764
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl |
| >cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-36 Score=320.39 Aligned_cols=255 Identities=26% Similarity=0.375 Sum_probs=203.2
Q ss_pred hhhhhhcCccccceEEEeeec----CCCceEEEEEEccccc-ccchHHHHHHHHHhccc-CCCCcccccceeccCCceEE
Q 003836 503 RGFKEELGRGAFGTVYKGFVN----MGSSNHVAVKKLNSVF-QDSEKEFKAEVNGIGQT-HHKNLVRLLGYCDEGQNRLL 576 (792)
Q Consensus 503 ~~~~~~lG~G~~g~Vy~g~~~----~~~~~~vavK~~~~~~-~~~~~~~~~Ei~~l~~l-~h~niv~l~g~~~~~~~~~l 576 (792)
..+.+.||+|+||.||++... ......+|+|+++... ....+.+.+|+.+++++ +|+||+++++++...+..++
T Consensus 37 ~~~~~~ig~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~l 116 (302)
T cd05055 37 LSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSHLGNHENIVNLLGACTIGGPILV 116 (302)
T ss_pred eEEcceeeccCCeeEEEEEEecCCCCCceeEEEEEecCccCChHHHHHHHHHHHHHHhccCCCCcceEEEEEecCCceEE
Confidence 445678999999999998642 2344579999987543 23346789999999999 79999999999999999999
Q ss_pred EEEeccCCCccccccCCC--CCchhHHHHHHHHHHHHHHHHhhccCCCeEecCCCCCcEEEcCCCCeEEeecCCCccccC
Q 003836 577 VYEFMSNGTVASFLFGDS--KPNWKLRTEIAMGIAGGLFYLHEECCTQIIHCDIKPQNILLDDHYNARISDFGLAKLLTL 654 (792)
Q Consensus 577 V~E~~~~gsL~~~l~~~~--~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dikp~NILl~~~~~~kl~Dfg~a~~~~~ 654 (792)
||||+++|+|.+++.... .+++.++..++.||+.||+|||+. +|+|+||||+|||++.++.+||+|||+++....
T Consensus 117 v~e~~~~~~L~~~i~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~~l~dfg~~~~~~~ 193 (302)
T cd05055 117 ITEYCCYGDLLNFLRRKRESFLTLEDLLSFSYQVAKGMAFLASK---NCIHRDLAARNVLLTHGKIVKICDFGLARDIMN 193 (302)
T ss_pred EEEcCCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHC---CeehhhhccceEEEcCCCeEEECCCcccccccC
Confidence 999999999999997543 379999999999999999999998 999999999999999999999999999986643
Q ss_pred CCCC-ccccccccCCcccccccccCCCCcccceehHHHHHHHHHh-cCcCCCcchhhhhhhhHHHHHHHhhcccchhHhh
Q 003836 655 DQSH-TNTAIRGTKGYVAPEWFRNMPITVKVDVYSYGVLLLEIIC-LRRNIDNEISKVDKAILTDWAYDRYQERTLEALV 732 (792)
Q Consensus 655 ~~~~-~~~~~~gt~~y~aPE~~~~~~~~~k~DV~S~Gv~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 732 (792)
.... ......++..|+|||.+.+..++.++|||||||++|||++ |..||......... ...+
T Consensus 194 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~t~g~~p~~~~~~~~~~----------------~~~~ 257 (302)
T cd05055 194 DSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSNPYPGMPVDSKF----------------YKLI 257 (302)
T ss_pred CCceeecCCCCcccccCCHhhhccCCCCcHhHHHHHHHHHHHHHhCCCCCcCCCCchHHH----------------HHHH
Confidence 3221 1122345778999999999999999999999999999998 88888654321110 0011
Q ss_pred hchhcccCCHHHHHHHHHHHHHccccCCCCCCCHHhHHHHhccC
Q 003836 733 ENDLEAMNNVTMLHRFVMVAFWCIQEDPSHRPTMRKVTQMLEGV 776 (792)
Q Consensus 733 ~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~L~~~ 776 (792)
........+.....++.+++.+||+.+|++||++.|+++.|+++
T Consensus 258 ~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ell~~l~~~ 301 (302)
T cd05055 258 KEGYRMAQPEHAPAEIYDIMKTCWDADPLKRPTFKQIVQLIGKQ 301 (302)
T ss_pred HcCCcCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHhh
Confidence 11111111223356789999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept |
| >PLN00034 mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=325.39 Aligned_cols=245 Identities=24% Similarity=0.350 Sum_probs=192.0
Q ss_pred hhhhcCccccceEEEeeecCCCceEEEEEEcccccc-cchHHHHHHHHHhcccCCCCcccccceeccCCceEEEEEeccC
Q 003836 505 FKEELGRGAFGTVYKGFVNMGSSNHVAVKKLNSVFQ-DSEKEFKAEVNGIGQTHHKNLVRLLGYCDEGQNRLLVYEFMSN 583 (792)
Q Consensus 505 ~~~~lG~G~~g~Vy~g~~~~~~~~~vavK~~~~~~~-~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~lV~E~~~~ 583 (792)
+.++||+|+||+||++... .+++.||||++..... ...+.+.+|++++++++|+||+++++++.+.+..++||||+++
T Consensus 78 ~~~~lg~G~~g~V~~~~~~-~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~ 156 (353)
T PLN00034 78 RVNRIGSGAGGTVYKVIHR-PTGRLYALKVIYGNHEDTVRRQICREIEILRDVNHPNVVKCHDMFDHNGEIQVLLEFMDG 156 (353)
T ss_pred hhhhccCCCCeEEEEEEEC-CCCCEEEEEEEecCCcHHHHHHHHHHHHHHHhCCCCCcceeeeEeccCCeEEEEEecCCC
Confidence 3568999999999999754 4567899999865432 3356789999999999999999999999999999999999999
Q ss_pred CCccccccCCCCCchhHHHHHHHHHHHHHHHHhhccCCCeEecCCCCCcEEEcCCCCeEEeecCCCccccCCCCCccccc
Q 003836 584 GTVASFLFGDSKPNWKLRTEIAMGIAGGLFYLHEECCTQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLDQSHTNTAI 663 (792)
Q Consensus 584 gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dikp~NILl~~~~~~kl~Dfg~a~~~~~~~~~~~~~~ 663 (792)
|+|.... ...+..+..++.||+.||+|||+. +|+||||||+|||+++++.+||+|||+++....... .....
T Consensus 157 ~~L~~~~----~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~~~~kL~DfG~~~~~~~~~~-~~~~~ 228 (353)
T PLN00034 157 GSLEGTH----IADEQFLADVARQILSGIAYLHRR---HIVHRDIKPSNLLINSAKNVKIADFGVSRILAQTMD-PCNSS 228 (353)
T ss_pred Ccccccc----cCCHHHHHHHHHHHHHHHHHHHHC---CEeecCCCHHHEEEcCCCCEEEcccccceecccccc-ccccc
Confidence 9987643 346777889999999999999998 999999999999999999999999999987643221 22334
Q ss_pred cccCCccccccccc-----CCCCcccceehHHHHHHHHHhcCcCCCcchhhhhhhhHHHHHHHhhcccchhHhhhchhcc
Q 003836 664 RGTKGYVAPEWFRN-----MPITVKVDVYSYGVLLLEIICLRRNIDNEISKVDKAILTDWAYDRYQERTLEALVENDLEA 738 (792)
Q Consensus 664 ~gt~~y~aPE~~~~-----~~~~~k~DV~S~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 738 (792)
.||..|+|||.+.. ...+.++|||||||++|||++|+.||.............. +......
T Consensus 229 ~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~~~~--------------~~~~~~~ 294 (353)
T PLN00034 229 VGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGVGRQGDWASLMCA--------------ICMSQPP 294 (353)
T ss_pred ccCccccCccccccccccCcCCCcchhHHHHHHHHHHHHhCCCCCCCCCCccHHHHHHH--------------HhccCCC
Confidence 68999999998743 2345689999999999999999999973221111000000 0000111
Q ss_pred cCCHHHHHHHHHHHHHccccCCCCCCCHHhHHHH
Q 003836 739 MNNVTMLHRFVMVAFWCIQEDPSHRPTMRKVTQM 772 (792)
Q Consensus 739 ~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~ 772 (792)
..+.....++.+++.+||+.||++||++.|+++.
T Consensus 295 ~~~~~~~~~l~~li~~~l~~~P~~Rpt~~ell~h 328 (353)
T PLN00034 295 EAPATASREFRHFISCCLQREPAKRWSAMQLLQH 328 (353)
T ss_pred CCCCccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 1223445678999999999999999999999986
|
|
| >cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-36 Score=318.51 Aligned_cols=269 Identities=25% Similarity=0.382 Sum_probs=202.6
Q ss_pred hhhhhcCccccceEEEeee---cCCCceEEEEEEcccccccchHHHHHHHHHhcccCCCCcccccceecc--CCceEEEE
Q 003836 504 GFKEELGRGAFGTVYKGFV---NMGSSNHVAVKKLNSVFQDSEKEFKAEVNGIGQTHHKNLVRLLGYCDE--GQNRLLVY 578 (792)
Q Consensus 504 ~~~~~lG~G~~g~Vy~g~~---~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~--~~~~~lV~ 578 (792)
.+.+.||+|+||.||++.. ....++.||+|++........+.+.+|++++++++|+||+++++++.. ....++|+
T Consensus 7 ~~~~~lg~g~~g~v~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~ 86 (284)
T cd05081 7 KFIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLRLVM 86 (284)
T ss_pred eeeeeccCCCCceEEEEEecCCcCCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEccCCCCceEEEE
Confidence 4457899999999999875 334567899999887655666789999999999999999999998743 34688999
Q ss_pred EeccCCCccccccCC-CCCchhHHHHHHHHHHHHHHHHhhccCCCeEecCCCCCcEEEcCCCCeEEeecCCCccccCCCC
Q 003836 579 EFMSNGTVASFLFGD-SKPNWKLRTEIAMGIAGGLFYLHEECCTQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLDQS 657 (792)
Q Consensus 579 E~~~~gsL~~~l~~~-~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dikp~NILl~~~~~~kl~Dfg~a~~~~~~~~ 657 (792)
||+++++|.+++... ..+++..+..++.|++.||+|||+. +|+|+||||+|||+++++.+||+|||+++.......
T Consensus 87 e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~l~~aL~~LH~~---~i~H~dlkp~nili~~~~~~~l~dfg~~~~~~~~~~ 163 (284)
T cd05081 87 EYLPYGSLRDYLQKHRERLDHRKLLLYASQICKGMEYLGSK---RYVHRDLATRNILVESENRVKIGDFGLTKVLPQDKE 163 (284)
T ss_pred EecCCCCHHHHHHhcCcCCCHHHHHHHHHHHHHHHHHHHHC---CceeccCCHhhEEECCCCeEEECCCcccccccCCCc
Confidence 999999999999764 4689999999999999999999998 999999999999999999999999999987643322
Q ss_pred Cc--cccccccCCcccccccccCCCCcccceehHHHHHHHHHhcCcCCCcchhhhhhhhHHHHHHHhhcccchhHhhhch
Q 003836 658 HT--NTAIRGTKGYVAPEWFRNMPITVKVDVYSYGVLLLEIICLRRNIDNEISKVDKAILTDWAYDRYQERTLEALVEND 735 (792)
Q Consensus 658 ~~--~~~~~gt~~y~aPE~~~~~~~~~k~DV~S~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 735 (792)
.. .....++..|+|||.+.+..++.++||||||++++||++|..++.............. .........+...+...
T Consensus 164 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~ 242 (284)
T cd05081 164 YYKVREPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYSDKSCSPPAEFMRMMGND-KQGQMIVYHLIELLKNN 242 (284)
T ss_pred ceeecCCCCCceEeeCHHHhccCCcChHHHHHHHHHHHHHHhhcCCcCCCcchhhhhhcccc-cccccchHHHHHHHhcC
Confidence 11 1112234569999999988999999999999999999998776543221100000000 00000000011122222
Q ss_pred hcccCCHHHHHHHHHHHHHccccCCCCCCCHHhHHHHhccC
Q 003836 736 LEAMNNVTMLHRFVMVAFWCIQEDPSHRPTMRKVTQMLEGV 776 (792)
Q Consensus 736 ~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~L~~~ 776 (792)
.....+...+.++.+++.+||+.+|++|||+.||++.|+.+
T Consensus 243 ~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~~ 283 (284)
T cd05081 243 GRLPAPPGCPAEIYAIMKECWNNDPSQRPSFSELALQVEAI 283 (284)
T ss_pred CcCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHhc
Confidence 22222233456789999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th |
| >cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-36 Score=322.81 Aligned_cols=241 Identities=23% Similarity=0.335 Sum_probs=193.8
Q ss_pred hhcCccccceEEEeeecCCCceEEEEEEccccc---ccchHHHHHHHHHhccc-CCCCcccccceeccCCceEEEEEecc
Q 003836 507 EELGRGAFGTVYKGFVNMGSSNHVAVKKLNSVF---QDSEKEFKAEVNGIGQT-HHKNLVRLLGYCDEGQNRLLVYEFMS 582 (792)
Q Consensus 507 ~~lG~G~~g~Vy~g~~~~~~~~~vavK~~~~~~---~~~~~~~~~Ei~~l~~l-~h~niv~l~g~~~~~~~~~lV~E~~~ 582 (792)
+.||+|+||.||++... .+++.||+|+++... ......+..|.+++... +|+||+++++++.+.+..++||||++
T Consensus 1 ~~lg~G~~g~V~~~~~~-~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E~~~ 79 (316)
T cd05620 1 KVLGKGSFGKVLLAELK-GKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLYCTFQTKEHLFFVMEFLN 79 (316)
T ss_pred CeeeeCCCeEEEEEEEC-CCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCCccCeeEEEEeCCEEEEEECCCC
Confidence 36999999999999754 456789999987532 23345667788887754 89999999999999999999999999
Q ss_pred CCCccccccCCCCCchhHHHHHHHHHHHHHHHHhhccCCCeEecCCCCCcEEEcCCCCeEEeecCCCccccCCCCCcccc
Q 003836 583 NGTVASFLFGDSKPNWKLRTEIAMGIAGGLFYLHEECCTQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLDQSHTNTA 662 (792)
Q Consensus 583 ~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dikp~NILl~~~~~~kl~Dfg~a~~~~~~~~~~~~~ 662 (792)
+|+|..++.....+++..+..++.||+.||+|||+. +|+||||||+|||++.++.+||+|||+++..... ......
T Consensus 80 ~g~L~~~i~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivHrDlkp~Nil~~~~~~~kl~Dfg~~~~~~~~-~~~~~~ 155 (316)
T cd05620 80 GGDLMFHIQDKGRFDLYRATFYAAEIVCGLQFLHSK---GIIYRDLKLDNVMLDRDGHIKIADFGMCKENVFG-DNRAST 155 (316)
T ss_pred CCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHeEECCCCCEEeCccCCCeecccC-CCceec
Confidence 999999998777889999999999999999999998 9999999999999999999999999998753221 122334
Q ss_pred ccccCCcccccccccCCCCcccceehHHHHHHHHHhcCcCCCcchhhhhhhhHHHHHHHhhcccchhHhhhchhcccCCH
Q 003836 663 IRGTKGYVAPEWFRNMPITVKVDVYSYGVLLLEIICLRRNIDNEISKVDKAILTDWAYDRYQERTLEALVENDLEAMNNV 742 (792)
Q Consensus 663 ~~gt~~y~aPE~~~~~~~~~k~DV~S~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 742 (792)
..||+.|+|||.+.+..++.++|||||||++|||++|+.||........ . . .+... ....+.
T Consensus 156 ~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~Pf~~~~~~~~---~-----~--------~~~~~--~~~~~~ 217 (316)
T cd05620 156 FCGTPDYIAPEILQGLKYTFSVDWWSFGVLLYEMLIGQSPFHGDDEDEL---F-----E--------SIRVD--TPHYPR 217 (316)
T ss_pred cCCCcCccCHHHHcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHHH---H-----H--------HHHhC--CCCCCC
Confidence 5689999999999999999999999999999999999999965432110 0 0 00000 011122
Q ss_pred HHHHHHHHHHHHccccCCCCCCCHH-hHH
Q 003836 743 TMLHRFVMVAFWCIQEDPSHRPTMR-KVT 770 (792)
Q Consensus 743 ~~~~~l~~l~~~Cl~~~p~~RPs~~-evl 770 (792)
....++.+++.+||+.||++||++. +++
T Consensus 218 ~~~~~~~~li~~~l~~dP~~R~~~~~~~~ 246 (316)
T cd05620 218 WITKESKDILEKLFERDPTRRLGVVGNIR 246 (316)
T ss_pred CCCHHHHHHHHHHccCCHHHcCCChHHHH
Confidence 2456778899999999999999984 665
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I |
| >cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-36 Score=313.63 Aligned_cols=249 Identities=25% Similarity=0.405 Sum_probs=196.1
Q ss_pred hhcCccccceEEEeeecCCC-ceEEEEEEccccc-ccchHHHHHHHHHhccc-CCCCcccccceeccCCceEEEEEeccC
Q 003836 507 EELGRGAFGTVYKGFVNMGS-SNHVAVKKLNSVF-QDSEKEFKAEVNGIGQT-HHKNLVRLLGYCDEGQNRLLVYEFMSN 583 (792)
Q Consensus 507 ~~lG~G~~g~Vy~g~~~~~~-~~~vavK~~~~~~-~~~~~~~~~Ei~~l~~l-~h~niv~l~g~~~~~~~~~lV~E~~~~ 583 (792)
+.||+|+||.||+|.+.... ...+++|.++... ....+.+.+|++++.++ +||||+++++++...+..++||||+++
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~ 80 (270)
T cd05047 1 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPH 80 (270)
T ss_pred CcCCCCCCceEEEEEEcCCCCeeEEEEEEccccCCHHHHHHHHHHHHHHHhhccCCCeeeEEEEEecCCCceEEEEeCCC
Confidence 36899999999999875432 2457889887532 34456889999999999 899999999999999999999999999
Q ss_pred CCccccccCCC----------------CCchhHHHHHHHHHHHHHHHHhhccCCCeEecCCCCCcEEEcCCCCeEEeecC
Q 003836 584 GTVASFLFGDS----------------KPNWKLRTEIAMGIAGGLFYLHEECCTQIIHCDIKPQNILLDDHYNARISDFG 647 (792)
Q Consensus 584 gsL~~~l~~~~----------------~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dikp~NILl~~~~~~kl~Dfg 647 (792)
|+|.+++.... .+++..+..++.|++.||+|||+. +++|+||||+|||+++++.+||+|||
T Consensus 81 ~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH~~---~i~H~dikp~nili~~~~~~kl~dfg 157 (270)
T cd05047 81 GNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQK---QFIHRDLAARNILVGENYVAKIADFG 157 (270)
T ss_pred CcHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHHHC---CEeecccccceEEEcCCCeEEECCCC
Confidence 99999986432 467889999999999999999998 99999999999999999999999999
Q ss_pred CCccccCCCCCccccccccCCcccccccccCCCCcccceehHHHHHHHHHh-cCcCCCcchhhhhhhhHHHHHHHhhccc
Q 003836 648 LAKLLTLDQSHTNTAIRGTKGYVAPEWFRNMPITVKVDVYSYGVLLLEIIC-LRRNIDNEISKVDKAILTDWAYDRYQER 726 (792)
Q Consensus 648 ~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DV~S~Gv~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 726 (792)
+++..... ........+..|+|||.+....++.++||||||++++||++ |+.||........ . ..
T Consensus 158 l~~~~~~~--~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~~~---~-----~~---- 223 (270)
T cd05047 158 LSRGQEVY--VKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAEL---Y-----EK---- 223 (270)
T ss_pred Cccccchh--hhccCCCCccccCChHHHccCCCCchhhHHHHHHHHHHHHcCCCCCccccCHHHH---H-----HH----
Confidence 98632211 11111223567999999988889999999999999999997 9999864322100 0 00
Q ss_pred chhHhhhchhcccCCHHHHHHHHHHHHHccccCCCCCCCHHhHHHHhccCc
Q 003836 727 TLEALVENDLEAMNNVTMLHRFVMVAFWCIQEDPSHRPTMRKVTQMLEGVV 777 (792)
Q Consensus 727 ~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~L~~~~ 777 (792)
+........+......+.+++.+||+.+|.+|||+.++++.|+.++
T Consensus 224 -----~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~l~~~~ 269 (270)
T cd05047 224 -----LPQGYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRML 269 (270)
T ss_pred -----HhCCCCCCCCCcCCHHHHHHHHHHcccChhhCCCHHHHHHHHHHhh
Confidence 0011111112233457889999999999999999999999998865
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l |
| >cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-35 Score=314.44 Aligned_cols=245 Identities=26% Similarity=0.326 Sum_probs=195.2
Q ss_pred cCccccceEEEeeecCCCceEEEEEEcccccc---cchHHHHHHHHHhcccCCCCcccccceeccCCceEEEEEeccCCC
Q 003836 509 LGRGAFGTVYKGFVNMGSSNHVAVKKLNSVFQ---DSEKEFKAEVNGIGQTHHKNLVRLLGYCDEGQNRLLVYEFMSNGT 585 (792)
Q Consensus 509 lG~G~~g~Vy~g~~~~~~~~~vavK~~~~~~~---~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~lV~E~~~~gs 585 (792)
||+|+||+||++... .+++.+|+|++..... ...+.+..|++++++++|+||+++.+++......++||||+++|+
T Consensus 1 lg~G~~g~Vy~~~~~-~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~g~ 79 (280)
T cd05608 1 LGKGGFGEVSACQMR-ATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAYAFQTKTDLCLVMTIMNGGD 79 (280)
T ss_pred CCCCCceeEEEEEEc-cCCcEEEEEeeeHHHHhhhHHHHHHHHHHHHHHhCCCCcEeeeeEEEcCCCeEEEEEeCCCCCC
Confidence 799999999999654 4567899999865322 223567889999999999999999999999999999999999999
Q ss_pred ccccccC----CCCCchhHHHHHHHHHHHHHHHHhhccCCCeEecCCCCCcEEEcCCCCeEEeecCCCccccCCCCCccc
Q 003836 586 VASFLFG----DSKPNWKLRTEIAMGIAGGLFYLHEECCTQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLDQSHTNT 661 (792)
Q Consensus 586 L~~~l~~----~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dikp~NILl~~~~~~kl~Dfg~a~~~~~~~~~~~~ 661 (792)
|..++.. ...+++..+..++.||+.||+|||+. +|+||||||+|||+++++.+||+|||+++....... ...
T Consensus 80 L~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~-~~~ 155 (280)
T cd05608 80 LRYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQR---RIIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQS-KTK 155 (280)
T ss_pred HHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEeeCccceecCCCCc-ccc
Confidence 9887743 34688999999999999999999998 999999999999999999999999999986543322 223
Q ss_pred cccccCCcccccccccCCCCcccceehHHHHHHHHHhcCcCCCcchhhhhhhhHHHHHHHhhcccchhHhhhchhcccCC
Q 003836 662 AIRGTKGYVAPEWFRNMPITVKVDVYSYGVLLLEIICLRRNIDNEISKVDKAILTDWAYDRYQERTLEALVENDLEAMNN 741 (792)
Q Consensus 662 ~~~gt~~y~aPE~~~~~~~~~k~DV~S~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 741 (792)
...|++.|+|||.+.+..++.++||||||+++|||++|+.||............ ...+.... ...+
T Consensus 156 ~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~------------~~~~~~~~--~~~~ 221 (280)
T cd05608 156 GYAGTPGFMAPELLQGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKEL------------KQRILNDS--VTYP 221 (280)
T ss_pred ccCCCcCccCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCcchhHHHH------------HHhhcccC--CCCc
Confidence 346899999999999999999999999999999999999999654321110000 00011110 1122
Q ss_pred HHHHHHHHHHHHHccccCCCCCC-----CHHhHHHH
Q 003836 742 VTMLHRFVMVAFWCIQEDPSHRP-----TMRKVTQM 772 (792)
Q Consensus 742 ~~~~~~l~~l~~~Cl~~~p~~RP-----s~~evl~~ 772 (792)
...+..+.+++.+||+.+|++|| +++++++.
T Consensus 222 ~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~~l~h 257 (280)
T cd05608 222 DKFSPASKSFCEALLAKDPEKRLGFRDGNCDGLRTH 257 (280)
T ss_pred ccCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHhcC
Confidence 34567788999999999999999 67778764
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g |
| >cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-36 Score=311.39 Aligned_cols=254 Identities=28% Similarity=0.415 Sum_probs=203.6
Q ss_pred HHHHHhhhhhhcCccccceEEEeeecCCCceEEEEEEcccccccchHHHHHHHHHhcccCCCCcccccceeccCCceEEE
Q 003836 498 LVEVTRGFKEELGRGAFGTVYKGFVNMGSSNHVAVKKLNSVFQDSEKEFKAEVNGIGQTHHKNLVRLLGYCDEGQNRLLV 577 (792)
Q Consensus 498 l~~~~~~~~~~lG~G~~g~Vy~g~~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~lV 577 (792)
+....+++.++||+|+||.||+|... .++.+|+|.+.... .....+.+|+.++++++|+||+++++++. .+..++|
T Consensus 3 ~~~~~~~~~~~ig~G~~g~v~~~~~~--~~~~~a~K~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v 78 (260)
T cd05067 3 VPRETLKLVKKLGAGQFGEVWMGYYN--GHTKVAIKSLKQGS-MSPEAFLAEANLMKQLQHPRLVRLYAVVT-QEPIYII 78 (260)
T ss_pred cchHHceeeeeeccCccceEEeeecC--CCceEEEEEecCCC-CcHHHHHHHHHHHHhcCCcCeeeEEEEEc-cCCcEEE
Confidence 34556677889999999999999754 34679999987543 34568999999999999999999999874 4568999
Q ss_pred EEeccCCCccccccCC--CCCchhHHHHHHHHHHHHHHHHhhccCCCeEecCCCCCcEEEcCCCCeEEeecCCCccccCC
Q 003836 578 YEFMSNGTVASFLFGD--SKPNWKLRTEIAMGIAGGLFYLHEECCTQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLD 655 (792)
Q Consensus 578 ~E~~~~gsL~~~l~~~--~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dikp~NILl~~~~~~kl~Dfg~a~~~~~~ 655 (792)
|||+++++|.+++... ..+++.++..++.|++.||+|||+. +++|+||||+||++++++.++|+|||++......
T Consensus 79 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~---~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~ 155 (260)
T cd05067 79 TEYMENGSLVDFLKTPEGIKLTINKLIDMAAQIAEGMAFIERK---NYIHRDLRAANILVSETLCCKIADFGLARLIEDN 155 (260)
T ss_pred EEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcC---CeecccccHHhEEEcCCCCEEEccCcceeecCCC
Confidence 9999999999998653 4678899999999999999999998 9999999999999999999999999999876533
Q ss_pred CCCccccccccCCcccccccccCCCCcccceehHHHHHHHHHh-cCcCCCcchhhhhhhhHHHHHHHhhcccchhHhhhc
Q 003836 656 QSHTNTAIRGTKGYVAPEWFRNMPITVKVDVYSYGVLLLEIIC-LRRNIDNEISKVDKAILTDWAYDRYQERTLEALVEN 734 (792)
Q Consensus 656 ~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DV~S~Gv~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 734 (792)
.........++..|+|||.+....++.++||||||++++||++ |+.||......... ..+..
T Consensus 156 ~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~-----------------~~~~~ 218 (260)
T cd05067 156 EYTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTYGRIPYPGMTNPEVI-----------------QNLER 218 (260)
T ss_pred CcccccCCcccccccCHHHhccCCcCcccchHHHHHHHHHHHhCCCCCCCCCChHHHH-----------------HHHHc
Confidence 3322233345778999999988889999999999999999999 99998644321100 00111
Q ss_pred hhcccCCHHHHHHHHHHHHHccccCCCCCCCHHhHHHHhcc
Q 003836 735 DLEAMNNVTMLHRFVMVAFWCIQEDPSHRPTMRKVTQMLEG 775 (792)
Q Consensus 735 ~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~L~~ 775 (792)
......+...+.++.+++.+||+.+|++||+++++++.|+.
T Consensus 219 ~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~ 259 (260)
T cd05067 219 GYRMPRPDNCPEELYELMRLCWKEKPEERPTFEYLRSVLED 259 (260)
T ss_pred CCCCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHhhc
Confidence 11111222345678999999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr |
| >cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-35 Score=311.65 Aligned_cols=251 Identities=27% Similarity=0.425 Sum_probs=200.7
Q ss_pred HhhhhhhcCccccceEEEeeecCCCceEEEEEEcccccccchHHHHHHHHHhcccCCCCcccccceeccCCceEEEEEec
Q 003836 502 TRGFKEELGRGAFGTVYKGFVNMGSSNHVAVKKLNSVFQDSEKEFKAEVNGIGQTHHKNLVRLLGYCDEGQNRLLVYEFM 581 (792)
Q Consensus 502 ~~~~~~~lG~G~~g~Vy~g~~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~lV~E~~ 581 (792)
.+.+.++||+|+||.||+|.... + ..||+|+++... ...+++.+|++++++++|+||+++++++.+ ...++||||+
T Consensus 7 ~~~~~~~lg~g~~~~v~~~~~~~-~-~~valK~~~~~~-~~~~~~~~E~~~l~~l~~~~i~~~~~~~~~-~~~~lv~e~~ 82 (262)
T cd05071 7 SLRLEVKLGQGCFGEVWMGTWNG-T-TRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEYM 82 (262)
T ss_pred HeeEeeecCCCCCCcEEEEEecC-C-ceEEEEecccCc-cCHHHHHHHHHHHHhCCCCCcceEEEEECC-CCcEEEEEcC
Confidence 35667889999999999997643 2 469999997532 345679999999999999999999998754 5578999999
Q ss_pred cCCCccccccCC--CCCchhHHHHHHHHHHHHHHHHhhccCCCeEecCCCCCcEEEcCCCCeEEeecCCCccccCCCCCc
Q 003836 582 SNGTVASFLFGD--SKPNWKLRTEIAMGIAGGLFYLHEECCTQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLDQSHT 659 (792)
Q Consensus 582 ~~gsL~~~l~~~--~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dikp~NILl~~~~~~kl~Dfg~a~~~~~~~~~~ 659 (792)
++|+|.+++... ..+++..+..++.|+++||+|||+. +++|+||||+||++++++.+||+|||.++.........
T Consensus 83 ~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~~---~i~H~dl~p~Nill~~~~~~~L~dfg~~~~~~~~~~~~ 159 (262)
T cd05071 83 SKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERM---NYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTA 159 (262)
T ss_pred CCCcHHHHHhhccccCCCHHHHHHHHHHHHHHHHHHHHC---CccccccCcccEEEcCCCcEEeccCCceeecccccccc
Confidence 999999999753 4578999999999999999999998 99999999999999999999999999998765433222
Q ss_pred cccccccCCcccccccccCCCCcccceehHHHHHHHHHh-cCcCCCcchhhhhhhhHHHHHHHhhcccchhHhhhchhcc
Q 003836 660 NTAIRGTKGYVAPEWFRNMPITVKVDVYSYGVLLLEIIC-LRRNIDNEISKVDKAILTDWAYDRYQERTLEALVENDLEA 738 (792)
Q Consensus 660 ~~~~~gt~~y~aPE~~~~~~~~~k~DV~S~Gv~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 738 (792)
.....++..|+|||.+.+..++.++||||||+++|||++ |+.||........ . .. +......
T Consensus 160 ~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~ellt~g~~p~~~~~~~~~---~-----~~---------~~~~~~~ 222 (262)
T cd05071 160 RQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREV---L-----DQ---------VERGYRM 222 (262)
T ss_pred ccCCcccceecCHhHhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCChHHH---H-----HH---------HhcCCCC
Confidence 223346778999999988899999999999999999999 7778764422110 0 00 0001111
Q ss_pred cCCHHHHHHHHHHHHHccccCCCCCCCHHhHHHHhccC
Q 003836 739 MNNVTMLHRFVMVAFWCIQEDPSHRPTMRKVTQMLEGV 776 (792)
Q Consensus 739 ~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~L~~~ 776 (792)
..+...+..+.+++.+|++.+|++||++.++++.|+..
T Consensus 223 ~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~~~~~l~~~ 260 (262)
T cd05071 223 PCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDY 260 (262)
T ss_pred CCccccCHHHHHHHHHHccCCcccCCCHHHHHHHHHHh
Confidence 12334566788999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo |
| >cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-36 Score=331.51 Aligned_cols=249 Identities=20% Similarity=0.266 Sum_probs=197.6
Q ss_pred hhhhcCccccceEEEeeecCCCceEEEEEEccccc---ccchHHHHHHHHHhcccCCCCcccccceeccCCceEEEEEec
Q 003836 505 FKEELGRGAFGTVYKGFVNMGSSNHVAVKKLNSVF---QDSEKEFKAEVNGIGQTHHKNLVRLLGYCDEGQNRLLVYEFM 581 (792)
Q Consensus 505 ~~~~lG~G~~g~Vy~g~~~~~~~~~vavK~~~~~~---~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~lV~E~~ 581 (792)
+.+.||+|+||+||++... .+++.||||++.... ......+.+|+.+++.++|+||+++++++.+++..++||||+
T Consensus 5 ~~~~lG~G~~g~V~~~~~~-~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~E~~ 83 (364)
T cd05599 5 SIKVIGRGAFGEVRLVQKK-DTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADNPWVVKLYYSFQDENYLYLIMEYL 83 (364)
T ss_pred EEEEEEecCCEEEEEEEEC-CCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCeEEEEECCC
Confidence 4578999999999999754 456789999997532 233456889999999999999999999999999999999999
Q ss_pred cCCCccccccCCCCCchhHHHHHHHHHHHHHHHHhhccCCCeEecCCCCCcEEEcCCCCeEEeecCCCccccCCCCC---
Q 003836 582 SNGTVASFLFGDSKPNWKLRTEIAMGIAGGLFYLHEECCTQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLDQSH--- 658 (792)
Q Consensus 582 ~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dikp~NILl~~~~~~kl~Dfg~a~~~~~~~~~--- 658 (792)
++|+|.+++.....+++..+..++.||+.||+|||+. +|+||||||+|||++.++.+||+|||+++.+......
T Consensus 84 ~~g~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~---~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~ 160 (364)
T cd05599 84 PGGDMMTLLMKKDTFTEEETRFYIAETILAIDSIHKL---GYIHRDIKPDNLLLDAKGHIKLSDFGLCTGLKKSHRTEFY 160 (364)
T ss_pred CCcHHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCCHHHeEECCCCCEEEeecccceecccccccccc
Confidence 9999999998878899999999999999999999998 9999999999999999999999999998765322110
Q ss_pred ----------------------------------ccccccccCCcccccccccCCCCcccceehHHHHHHHHHhcCcCCC
Q 003836 659 ----------------------------------TNTAIRGTKGYVAPEWFRNMPITVKVDVYSYGVLLLEIICLRRNID 704 (792)
Q Consensus 659 ----------------------------------~~~~~~gt~~y~aPE~~~~~~~~~k~DV~S~Gv~l~el~tg~~p~~ 704 (792)
......||+.|+|||++....++.++|||||||++|||++|+.||.
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~G~~Pf~ 240 (364)
T cd05599 161 RILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWSLGVIMYEMLVGYPPFC 240 (364)
T ss_pred ccccccccccccccccccccccccccchhhcccccccccccCccccCHHHHcCCCCCCeeeeecchhHHHHhhcCCCCCC
Confidence 0112458999999999999999999999999999999999999997
Q ss_pred cchhhhhhhhHHHHHHHhhcccchhHhhhchhcccCCHHHHHHHHHHHHHccccCCCCCCC---HHhHHHH
Q 003836 705 NEISKVDKAILTDWAYDRYQERTLEALVENDLEAMNNVTMLHRFVMVAFWCIQEDPSHRPT---MRKVTQM 772 (792)
Q Consensus 705 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs---~~evl~~ 772 (792)
..........+.. +. ..+........++.+.+++.+|+. +|.+|++ ++|+++.
T Consensus 241 ~~~~~~~~~~i~~-----~~---------~~~~~~~~~~~s~~~~~li~~ll~-~p~~R~~~~~~~~ll~h 296 (364)
T cd05599 241 SDNPQETYRKIIN-----WK---------ETLQFPDEVPLSPEAKDLIKRLCC-EAERRLGNNGVNEIKSH 296 (364)
T ss_pred CCCHHHHHHHHHc-----CC---------CccCCCCCCCCCHHHHHHHHHHcc-CHhhcCCCCCHHHHhcC
Confidence 5432211000000 00 000000111234567788888996 8999998 8888764
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica |
| >cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-36 Score=322.52 Aligned_cols=243 Identities=24% Similarity=0.333 Sum_probs=197.4
Q ss_pred hhcCccccceEEEeeecCCCceEEEEEEccccc---ccchHHHHHHHHHhccc-CCCCcccccceeccCCceEEEEEecc
Q 003836 507 EELGRGAFGTVYKGFVNMGSSNHVAVKKLNSVF---QDSEKEFKAEVNGIGQT-HHKNLVRLLGYCDEGQNRLLVYEFMS 582 (792)
Q Consensus 507 ~~lG~G~~g~Vy~g~~~~~~~~~vavK~~~~~~---~~~~~~~~~Ei~~l~~l-~h~niv~l~g~~~~~~~~~lV~E~~~ 582 (792)
+.||+|+||+||++... .+++.+|+|++++.. ......+.+|+++++.+ +||||+++++++...+..++||||++
T Consensus 1 ~~lG~G~~g~V~~~~~~-~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~h~~i~~~~~~~~~~~~~~lv~e~~~ 79 (318)
T cd05570 1 KVLGKGSFGKVLLAELK-GTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQLHSCFQTKDRLFFVMEYVN 79 (318)
T ss_pred CeeeeCCCeEEEEEEEC-CCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCC
Confidence 36999999999999764 456789999987532 23345677888888887 79999999999999999999999999
Q ss_pred CCCccccccCCCCCchhHHHHHHHHHHHHHHHHhhccCCCeEecCCCCCcEEEcCCCCeEEeecCCCccccCCCCCcccc
Q 003836 583 NGTVASFLFGDSKPNWKLRTEIAMGIAGGLFYLHEECCTQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLDQSHTNTA 662 (792)
Q Consensus 583 ~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dikp~NILl~~~~~~kl~Dfg~a~~~~~~~~~~~~~ 662 (792)
+|+|..++.....+++..+..++.||+.||+|||+. +|+||||||+|||+++++.+||+|||+++....... ....
T Consensus 80 ~~~L~~~~~~~~~l~~~~~~~~~~qi~~~l~~LH~~---~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~-~~~~ 155 (318)
T cd05570 80 GGDLMFHIQRSGRFDEPRARFYAAEIVLGLQFLHER---GIIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGGV-TTST 155 (318)
T ss_pred CCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhC---CeEccCCCHHHeEECCCCcEEecccCCCeecCcCCC-cccc
Confidence 999999998877899999999999999999999998 999999999999999999999999999875322221 2233
Q ss_pred ccccCCcccccccccCCCCcccceehHHHHHHHHHhcCcCCCcchhhhhhhhHHHHHHHhhcccchhHhhhchhcccCCH
Q 003836 663 IRGTKGYVAPEWFRNMPITVKVDVYSYGVLLLEIICLRRNIDNEISKVDKAILTDWAYDRYQERTLEALVENDLEAMNNV 742 (792)
Q Consensus 663 ~~gt~~y~aPE~~~~~~~~~k~DV~S~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 742 (792)
..|++.|+|||.+.+..++.++|||||||++|||++|+.||........ . . .+.... ...+.
T Consensus 156 ~~g~~~y~aPE~~~~~~~~~~~DiwslGvil~~l~~G~~pf~~~~~~~~---~-----~--------~i~~~~--~~~~~ 217 (318)
T cd05570 156 FCGTPDYIAPEILSYQPYGPAVDWWALGVLLYEMLAGQSPFEGDDEDEL---F-----Q--------SILEDE--VRYPR 217 (318)
T ss_pred eecCccccCHHHhcCCCCCcchhhhhHHHHHHHHhhCCCCCCCCCHHHH---H-----H--------HHHcCC--CCCCC
Confidence 4689999999999999999999999999999999999999965432110 0 0 000000 11122
Q ss_pred HHHHHHHHHHHHccccCCCCCCCH-----HhHHHH
Q 003836 743 TMLHRFVMVAFWCIQEDPSHRPTM-----RKVTQM 772 (792)
Q Consensus 743 ~~~~~l~~l~~~Cl~~~p~~RPs~-----~evl~~ 772 (792)
..+..+.+++.+||+.||.+||++ .++++.
T Consensus 218 ~~~~~~~~li~~~l~~dP~~R~s~~~~~~~~ll~~ 252 (318)
T cd05570 218 WLSKEAKSILKSFLTKNPEKRLGCLPTGEQDIKGH 252 (318)
T ss_pred cCCHHHHHHHHHHccCCHHHcCCCCCCCHHHHhcC
Confidence 345678899999999999999999 887753
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re |
| >cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-36 Score=329.07 Aligned_cols=198 Identities=25% Similarity=0.322 Sum_probs=172.5
Q ss_pred hhhhcCccccceEEEeeecCCCceEEEEEEccccc---ccchHHHHHHHHHhcccCCCCcccccceeccCCceEEEEEec
Q 003836 505 FKEELGRGAFGTVYKGFVNMGSSNHVAVKKLNSVF---QDSEKEFKAEVNGIGQTHHKNLVRLLGYCDEGQNRLLVYEFM 581 (792)
Q Consensus 505 ~~~~lG~G~~g~Vy~g~~~~~~~~~vavK~~~~~~---~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~lV~E~~ 581 (792)
+.+.||+|+||+||++... .+++.+|+|++.+.. ......+.+|+.++.+++|+||+++++.+.+....++||||+
T Consensus 5 ~~~~LG~G~~g~V~~~~~~-~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~~~~~~iv~~~~~~~~~~~~~lv~E~~ 83 (363)
T cd05628 5 SLKVIGRGAFGEVRLVQKK-DTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLWVVKMFYSFQDKLNLYLIMEFL 83 (363)
T ss_pred EeEEEEeCCCEEEEEEEEC-CCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHhCCCCCcceEEEEEecCCeEEEEEcCC
Confidence 4578999999999999653 456799999987532 223456888999999999999999999999999999999999
Q ss_pred cCCCccccccCCCCCchhHHHHHHHHHHHHHHHHhhccCCCeEecCCCCCcEEEcCCCCeEEeecCCCccccCCCC----
Q 003836 582 SNGTVASFLFGDSKPNWKLRTEIAMGIAGGLFYLHEECCTQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLDQS---- 657 (792)
Q Consensus 582 ~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dikp~NILl~~~~~~kl~Dfg~a~~~~~~~~---- 657 (792)
++|+|.+++.....+++..+..++.||+.||+|||+. +|+||||||+|||++.++.+||+|||+++.......
T Consensus 84 ~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~---givHrDlKp~NILi~~~~~vkL~DFGla~~~~~~~~~~~~ 160 (363)
T cd05628 84 PGGDMMTLLMKKDTLTEEETQFYIAETVLAIDSIHQL---GFIHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKAHRTEFY 160 (363)
T ss_pred CCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC---CeEecCCCHHHeEECCCCCEEEeeccCccccccccccccc
Confidence 9999999998888899999999999999999999998 999999999999999999999999999976432110
Q ss_pred ------------------------------CccccccccCCcccccccccCCCCcccceehHHHHHHHHHhcCcCCCcc
Q 003836 658 ------------------------------HTNTAIRGTKGYVAPEWFRNMPITVKVDVYSYGVLLLEIICLRRNIDNE 706 (792)
Q Consensus 658 ------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~k~DV~S~Gv~l~el~tg~~p~~~~ 706 (792)
.......||+.|+|||++.+..++.++|||||||++|||++|+.||...
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DvwSlGvil~ell~G~~Pf~~~ 239 (363)
T cd05628 161 RNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPPFCSE 239 (363)
T ss_pred ccccccccccccccccccccccchhhhccccccccccCCccccCHHHHcCCCCCCchhhhhhHHHHHHHHhCCCCCCCC
Confidence 0012346999999999999999999999999999999999999999754
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus |
| >cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-36 Score=326.69 Aligned_cols=240 Identities=22% Similarity=0.243 Sum_probs=195.3
Q ss_pred hhcCccccceEEEeeec--CCCceEEEEEEcccccc--cchHHHHHHHHHhcccCCCCcccccceeccCCceEEEEEecc
Q 003836 507 EELGRGAFGTVYKGFVN--MGSSNHVAVKKLNSVFQ--DSEKEFKAEVNGIGQTHHKNLVRLLGYCDEGQNRLLVYEFMS 582 (792)
Q Consensus 507 ~~lG~G~~g~Vy~g~~~--~~~~~~vavK~~~~~~~--~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~lV~E~~~ 582 (792)
+.||+|+||.||++... ...++.+|+|++..... .....+.+|++++++++||||+++++++.+.+..++||||++
T Consensus 2 ~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~ 81 (318)
T cd05582 2 KVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNHPFIVKLHYAFQTEGKLYLILDFLR 81 (318)
T ss_pred ceeeeCCCEEEEEEEEeccCCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhCCCCCcccEEEEEEcCCEEEEEEcCCC
Confidence 46999999999998642 24567899999875322 234567889999999999999999999999999999999999
Q ss_pred CCCccccccCCCCCchhHHHHHHHHHHHHHHHHhhccCCCeEecCCCCCcEEEcCCCCeEEeecCCCccccCCCCCcccc
Q 003836 583 NGTVASFLFGDSKPNWKLRTEIAMGIAGGLFYLHEECCTQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLDQSHTNTA 662 (792)
Q Consensus 583 ~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dikp~NILl~~~~~~kl~Dfg~a~~~~~~~~~~~~~ 662 (792)
+|+|.+++.....+++..+..++.||+.||+|||+. +|+||||||+|||+++++.+||+|||+++...... .....
T Consensus 82 ~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~-~~~~~ 157 (318)
T cd05582 82 GGDLFTRLSKEVMFTEEDVKFYLAELALALDHLHSL---GIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHE-KKAYS 157 (318)
T ss_pred CCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCCHHHeEECCCCcEEEeeccCCcccCCCC-Cceec
Confidence 999999998777899999999999999999999998 99999999999999999999999999998654322 22234
Q ss_pred ccccCCcccccccccCCCCcccceehHHHHHHHHHhcCcCCCcchhhhhhhhHHHHHHHhhcccchhHhhhchhcccCCH
Q 003836 663 IRGTKGYVAPEWFRNMPITVKVDVYSYGVLLLEIICLRRNIDNEISKVDKAILTDWAYDRYQERTLEALVENDLEAMNNV 742 (792)
Q Consensus 663 ~~gt~~y~aPE~~~~~~~~~k~DV~S~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 742 (792)
..|++.|+|||.+.+..++.++|||||||++|||++|+.||........ . ..+.... ...+.
T Consensus 158 ~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~---~-------------~~i~~~~--~~~p~ 219 (318)
T cd05582 158 FCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGSLPFQGKDRKET---M-------------TMILKAK--LGMPQ 219 (318)
T ss_pred ccCChhhcCHHHHcCCCCCCccceeccceEeeeeccCCCCCCCCCHHHH---H-------------HHHHcCC--CCCCC
Confidence 5689999999999988899999999999999999999999975422110 0 0011111 01122
Q ss_pred HHHHHHHHHHHHccccCCCCCCCHHh
Q 003836 743 TMLHRFVMVAFWCIQEDPSHRPTMRK 768 (792)
Q Consensus 743 ~~~~~l~~l~~~Cl~~~p~~RPs~~e 768 (792)
.....+.+++.+||+.||++||++.+
T Consensus 220 ~~~~~~~~li~~~l~~~P~~R~~a~~ 245 (318)
T cd05582 220 FLSPEAQSLLRALFKRNPANRLGAGP 245 (318)
T ss_pred CCCHHHHHHHHHHhhcCHhHcCCCCC
Confidence 34567789999999999999999655
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate |
| >cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-36 Score=321.58 Aligned_cols=253 Identities=26% Similarity=0.406 Sum_probs=197.9
Q ss_pred hhhhhhcCccccceEEEeeecCC-CceEEEEEEccccc-ccchHHHHHHHHHhccc-CCCCcccccceeccCCceEEEEE
Q 003836 503 RGFKEELGRGAFGTVYKGFVNMG-SSNHVAVKKLNSVF-QDSEKEFKAEVNGIGQT-HHKNLVRLLGYCDEGQNRLLVYE 579 (792)
Q Consensus 503 ~~~~~~lG~G~~g~Vy~g~~~~~-~~~~vavK~~~~~~-~~~~~~~~~Ei~~l~~l-~h~niv~l~g~~~~~~~~~lV~E 579 (792)
+.+.+.||+|+||.||+|..... ....+++|++.... ......+.+|++++.++ +|+||+++++++.+.+..++|||
T Consensus 9 ~~~~~~lg~G~~g~V~~a~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~Ei~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e 88 (303)
T cd05088 9 IKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIE 88 (303)
T ss_pred ceeeeeecCCCCceEEEEEEccCCceeeEEEEEecccCCHHHHHHHHHHHHHHHHhcCCCCcceEEEEECCCCCceEEEE
Confidence 44567899999999999986532 23457888876532 33456789999999999 89999999999999999999999
Q ss_pred eccCCCccccccCC----------------CCCchhHHHHHHHHHHHHHHHHhhccCCCeEecCCCCCcEEEcCCCCeEE
Q 003836 580 FMSNGTVASFLFGD----------------SKPNWKLRTEIAMGIAGGLFYLHEECCTQIIHCDIKPQNILLDDHYNARI 643 (792)
Q Consensus 580 ~~~~gsL~~~l~~~----------------~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dikp~NILl~~~~~~kl 643 (792)
|+++++|.+++... ..+++..++.++.||+.||+|||+. +|+||||||+|||+++++.+||
T Consensus 89 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~---gi~H~dlkp~Nili~~~~~~kl 165 (303)
T cd05088 89 YAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQK---QFIHRDLAARNILVGENYVAKI 165 (303)
T ss_pred eCCCCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHHHhC---CccccccchheEEecCCCcEEe
Confidence 99999999998643 2467889999999999999999998 9999999999999999999999
Q ss_pred eecCCCccccCCCCCccccccccCCcccccccccCCCCcccceehHHHHHHHHHh-cCcCCCcchhhhhhhhHHHHHHHh
Q 003836 644 SDFGLAKLLTLDQSHTNTAIRGTKGYVAPEWFRNMPITVKVDVYSYGVLLLEIIC-LRRNIDNEISKVDKAILTDWAYDR 722 (792)
Q Consensus 644 ~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DV~S~Gv~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~ 722 (792)
+|||+++...... ......++..|+|||.+.+..++.++|||||||+++||+| |..||........ . ..
T Consensus 166 ~dfg~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~---~-----~~ 235 (303)
T cd05088 166 ADFGLSRGQEVYV--KKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAEL---Y-----EK 235 (303)
T ss_pred CccccCcccchhh--hcccCCCcccccCHHHHhccCCcccccchhhhhHHHHHHhcCCCCcccCChHHH---H-----HH
Confidence 9999986432111 1111224567999999988889999999999999999998 9999864322110 0 00
Q ss_pred hcccchhHhhhchhcccCCHHHHHHHHHHHHHccccCCCCCCCHHhHHHHhccCc
Q 003836 723 YQERTLEALVENDLEAMNNVTMLHRFVMVAFWCIQEDPSHRPTMRKVTQMLEGVV 777 (792)
Q Consensus 723 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~L~~~~ 777 (792)
+........+...+..+.+++.+||+.+|++||++++++++|+.+.
T Consensus 236 ---------~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~l~~~~ 281 (303)
T cd05088 236 ---------LPQGYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRML 281 (303)
T ss_pred ---------HhcCCcCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHH
Confidence 0011111112223457889999999999999999999999987653
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A |
| >cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-35 Score=310.71 Aligned_cols=250 Identities=28% Similarity=0.425 Sum_probs=199.8
Q ss_pred HhhhhhhcCccccceEEEeeecCCCceEEEEEEcccccccchHHHHHHHHHhcccCCCCcccccceeccCCceEEEEEec
Q 003836 502 TRGFKEELGRGAFGTVYKGFVNMGSSNHVAVKKLNSVFQDSEKEFKAEVNGIGQTHHKNLVRLLGYCDEGQNRLLVYEFM 581 (792)
Q Consensus 502 ~~~~~~~lG~G~~g~Vy~g~~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~lV~E~~ 581 (792)
.+.+.++||+|+||.||++... .+..+|+|++..... ..+.+.+|+.++++++|+|++++++++.+ ...+++|||+
T Consensus 7 ~~~~~~~ig~g~~~~v~~~~~~--~~~~~~~k~~~~~~~-~~~~~~~E~~~l~~l~~~~i~~~~~~~~~-~~~~lv~e~~ 82 (260)
T cd05070 7 SLQLIKKLGNGQFGEVWMGTWN--GNTKVAVKTLKPGTM-SPESFLEEAQIMKKLRHDKLVQLYAVVSE-EPIYIVTEYM 82 (260)
T ss_pred HhhhhheeccccCceEEEEEec--CCceeEEEEecCCCC-CHHHHHHHHHHHHhcCCCceEEEEeEECC-CCcEEEEEec
Confidence 3556788999999999999754 345699999876433 35679999999999999999999998854 5688999999
Q ss_pred cCCCccccccCC--CCCchhHHHHHHHHHHHHHHHHhhccCCCeEecCCCCCcEEEcCCCCeEEeecCCCccccCCCCCc
Q 003836 582 SNGTVASFLFGD--SKPNWKLRTEIAMGIAGGLFYLHEECCTQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLDQSHT 659 (792)
Q Consensus 582 ~~gsL~~~l~~~--~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dikp~NILl~~~~~~kl~Dfg~a~~~~~~~~~~ 659 (792)
++++|.+++... ..+++..+.+++.|++.||+|||+. +|+|+||||+||++++++.+||+|||++..........
T Consensus 83 ~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~---~i~H~di~p~Nili~~~~~~~l~dfg~~~~~~~~~~~~ 159 (260)
T cd05070 83 SKGSLLDFLKDGEGRALKLPNLVDMAAQVAAGMAYIERM---NYIHRDLRSANILVGDGLVCKIADFGLARLIEDNEYTA 159 (260)
T ss_pred CCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCccceEEEeCCceEEeCCceeeeeccCccccc
Confidence 999999998753 4578999999999999999999998 99999999999999999999999999998764433222
Q ss_pred cccccccCCcccccccccCCCCcccceehHHHHHHHHHh-cCcCCCcchhhhhhhhHHHHHHHhhcccchhHhhhchhcc
Q 003836 660 NTAIRGTKGYVAPEWFRNMPITVKVDVYSYGVLLLEIIC-LRRNIDNEISKVDKAILTDWAYDRYQERTLEALVENDLEA 738 (792)
Q Consensus 660 ~~~~~gt~~y~aPE~~~~~~~~~k~DV~S~Gv~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 738 (792)
.....++..|+|||.+.+..++.++||||||+++|||++ |..||....... .. . .+......
T Consensus 160 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~~---~~-~-------------~~~~~~~~ 222 (260)
T cd05070 160 RQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMNNRE---VL-E-------------QVERGYRM 222 (260)
T ss_pred ccCCCCCccccChHHHhcCCCcchhhhHHHHHHHHHHHhcCCCCCCCCCHHH---HH-H-------------HHHcCCCC
Confidence 222335678999999988899999999999999999999 888886432110 00 0 01111111
Q ss_pred cCCHHHHHHHHHHHHHccccCCCCCCCHHhHHHHhcc
Q 003836 739 MNNVTMLHRFVMVAFWCIQEDPSHRPTMRKVTQMLEG 775 (792)
Q Consensus 739 ~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~L~~ 775 (792)
..+...+..+.+++.+|++.+|++|||++++.+.|+.
T Consensus 223 ~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~ 259 (260)
T cd05070 223 PCPQDCPISLHELMLQCWKKDPEERPTFEYLQSFLED 259 (260)
T ss_pred CCCCcCCHHHHHHHHHHcccCcccCcCHHHHHHHHhc
Confidence 2233445678999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r |
| >cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-36 Score=321.27 Aligned_cols=242 Identities=24% Similarity=0.343 Sum_probs=194.0
Q ss_pred hhcCccccceEEEeeecCCCceEEEEEEccccc---ccchHHHHHHHHHhcc-cCCCCcccccceeccCCceEEEEEecc
Q 003836 507 EELGRGAFGTVYKGFVNMGSSNHVAVKKLNSVF---QDSEKEFKAEVNGIGQ-THHKNLVRLLGYCDEGQNRLLVYEFMS 582 (792)
Q Consensus 507 ~~lG~G~~g~Vy~g~~~~~~~~~vavK~~~~~~---~~~~~~~~~Ei~~l~~-l~h~niv~l~g~~~~~~~~~lV~E~~~ 582 (792)
+.||+|+||.||+|... .+++.||+|+++... ......+..|..++.. ++||||+++++++.+.+..++||||++
T Consensus 1 ~~lG~G~~g~Vy~~~~~-~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~ey~~ 79 (316)
T cd05619 1 KMLGKGSFGKVFLAELK-GTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHLYCTFQTKENLFFVMEYLN 79 (316)
T ss_pred CeeeeCCCEEEEEEEEC-CCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCcCcceEEEEEeCCEEEEEEeCCC
Confidence 36999999999999754 456789999987532 2334556778888876 489999999999999999999999999
Q ss_pred CCCccccccCCCCCchhHHHHHHHHHHHHHHHHhhccCCCeEecCCCCCcEEEcCCCCeEEeecCCCccccCCCCCcccc
Q 003836 583 NGTVASFLFGDSKPNWKLRTEIAMGIAGGLFYLHEECCTQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLDQSHTNTA 662 (792)
Q Consensus 583 ~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dikp~NILl~~~~~~kl~Dfg~a~~~~~~~~~~~~~ 662 (792)
+|+|.+++.....+++.....++.||+.||.|||+. +|+||||||+|||++.++.+||+|||+++...... .....
T Consensus 80 ~g~L~~~l~~~~~~~~~~~~~~~~qi~~al~~LH~~---~ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~~~~~-~~~~~ 155 (316)
T cd05619 80 GGDLMFHIQSCHKFDLPRATFYAAEIICGLQFLHSK---GIVYRDLKLDNILLDTDGHIKIADFGMCKENMLGD-AKTCT 155 (316)
T ss_pred CCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhC---CeEeCCCCHHHEEECCCCCEEEccCCcceECCCCC-Cceee
Confidence 999999998777889999999999999999999998 99999999999999999999999999987532221 12234
Q ss_pred ccccCCcccccccccCCCCcccceehHHHHHHHHHhcCcCCCcchhhhhhhhHHHHHHHhhcccchhHhhhchhcccCCH
Q 003836 663 IRGTKGYVAPEWFRNMPITVKVDVYSYGVLLLEIICLRRNIDNEISKVDKAILTDWAYDRYQERTLEALVENDLEAMNNV 742 (792)
Q Consensus 663 ~~gt~~y~aPE~~~~~~~~~k~DV~S~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 742 (792)
..||+.|+|||.+.+..++.++|||||||++|||++|+.||....... .... +... ....+.
T Consensus 156 ~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~~~---~~~~-------------i~~~--~~~~~~ 217 (316)
T cd05619 156 FCGTPDYIAPEILLGQKYNTSVDWWSFGVLLYEMLIGQSPFHGHDEEE---LFQS-------------IRMD--NPCYPR 217 (316)
T ss_pred ecCCccccCHHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCCCHHH---HHHH-------------HHhC--CCCCCc
Confidence 568999999999999899999999999999999999999996542210 0000 0000 011122
Q ss_pred HHHHHHHHHHHHccccCCCCCCCHH-hHHH
Q 003836 743 TMLHRFVMVAFWCIQEDPSHRPTMR-KVTQ 771 (792)
Q Consensus 743 ~~~~~l~~l~~~Cl~~~p~~RPs~~-evl~ 771 (792)
....++.+++.+||+.+|++||++. ++.+
T Consensus 218 ~~~~~~~~li~~~l~~~P~~R~~~~~~l~~ 247 (316)
T cd05619 218 WLTREAKDILVKLFVREPERRLGVKGDIRQ 247 (316)
T ss_pred cCCHHHHHHHHHHhccCHhhcCCChHHHHc
Confidence 3445678999999999999999997 6654
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in |
| >cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-35 Score=314.63 Aligned_cols=249 Identities=27% Similarity=0.301 Sum_probs=198.9
Q ss_pred hhhhhcCccccceEEEeeecCCCceEEEEEEccccc---ccchHHHHHHHHHhcccCCCCcccccceeccCCceEEEEEe
Q 003836 504 GFKEELGRGAFGTVYKGFVNMGSSNHVAVKKLNSVF---QDSEKEFKAEVNGIGQTHHKNLVRLLGYCDEGQNRLLVYEF 580 (792)
Q Consensus 504 ~~~~~lG~G~~g~Vy~g~~~~~~~~~vavK~~~~~~---~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~lV~E~ 580 (792)
...+.||+|+||+||++... .+++.||+|++.... ......+.+|+.++++++|+||+++++.+..++..++||||
T Consensus 3 ~~~~~lg~G~~g~V~~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 81 (285)
T cd05605 3 RHYRVLGKGGFGEVCACQVR-ATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLTL 81 (285)
T ss_pred eEEEEEecCCCeEEEEEEEc-CCCceEEEEEEehhhhhhhhhHHHHHHHHHHHHhcCCCCEeeeeeeecCCCeEEEEEec
Confidence 34578999999999999753 456799999986532 22235678899999999999999999999999999999999
Q ss_pred ccCCCccccccCC--CCCchhHHHHHHHHHHHHHHHHhhccCCCeEecCCCCCcEEEcCCCCeEEeecCCCccccCCCCC
Q 003836 581 MSNGTVASFLFGD--SKPNWKLRTEIAMGIAGGLFYLHEECCTQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLDQSH 658 (792)
Q Consensus 581 ~~~gsL~~~l~~~--~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dikp~NILl~~~~~~kl~Dfg~a~~~~~~~~~ 658 (792)
+++|+|.+++... ..+++..+..++.|++.||.|||+. +|+|+||||+||++++++.++|+|||+++......
T Consensus 82 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~-- 156 (285)
T cd05605 82 MNGGDLKFHIYNMGNPGFDEERAVFYAAEITCGLEDLHRE---RIVYRDLKPENILLDDYGHIRISDLGLAVEIPEGE-- 156 (285)
T ss_pred cCCCcHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHHC---CcEecCCCHHHEEECCCCCEEEeeCCCceecCCCC--
Confidence 9999999888643 4688999999999999999999998 99999999999999999999999999998654222
Q ss_pred ccccccccCCcccccccccCCCCcccceehHHHHHHHHHhcCcCCCcchhhhhhhhHHHHHHHhhcccchhHhhhchhcc
Q 003836 659 TNTAIRGTKGYVAPEWFRNMPITVKVDVYSYGVLLLEIICLRRNIDNEISKVDKAILTDWAYDRYQERTLEALVENDLEA 738 (792)
Q Consensus 659 ~~~~~~gt~~y~aPE~~~~~~~~~k~DV~S~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 738 (792)
......|++.|+|||.+.+..++.++|||||||++|||++|+.||........... +...+.. ...
T Consensus 157 ~~~~~~~~~~y~aPE~~~~~~~~~~~Diws~G~~l~el~~g~~pf~~~~~~~~~~~-------------~~~~~~~-~~~ 222 (285)
T cd05605 157 TIRGRVGTVGYMAPEVVKNERYTFSPDWWGLGCLIYEMIEGKSPFRQRKEKVKREE-------------VERRVKE-DQE 222 (285)
T ss_pred ccccccCCCCccCcHHhcCCCCCccccchhHHHHHHHHHHCCCCCCCCchhhHHHH-------------HHHHhhh-ccc
Confidence 12234689999999999988999999999999999999999999975432111000 0000110 111
Q ss_pred cCCHHHHHHHHHHHHHccccCCCCCC-----CHHhHHHH
Q 003836 739 MNNVTMLHRFVMVAFWCIQEDPSHRP-----TMRKVTQM 772 (792)
Q Consensus 739 ~~~~~~~~~l~~l~~~Cl~~~p~~RP-----s~~evl~~ 772 (792)
..+...+..+.+++..||+.||++|| +++++++.
T Consensus 223 ~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~~ 261 (285)
T cd05605 223 EYSEKFSEAARSICRQLLTKDPGFRLGCRGEGAEEVKAH 261 (285)
T ss_pred ccCcccCHHHHHHHHHHccCCHHHhcCCCCCCHHHHhcC
Confidence 22334567788999999999999999 88888654
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, |
| >cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-36 Score=317.67 Aligned_cols=261 Identities=23% Similarity=0.335 Sum_probs=198.3
Q ss_pred HHhhhhhhcCccccceEEEeeecC-------------CCceEEEEEEccccc-ccchHHHHHHHHHhcccCCCCcccccc
Q 003836 501 VTRGFKEELGRGAFGTVYKGFVNM-------------GSSNHVAVKKLNSVF-QDSEKEFKAEVNGIGQTHHKNLVRLLG 566 (792)
Q Consensus 501 ~~~~~~~~lG~G~~g~Vy~g~~~~-------------~~~~~vavK~~~~~~-~~~~~~~~~Ei~~l~~l~h~niv~l~g 566 (792)
..+.+.++||+|+||.||++.... +....||+|+++... ......+.+|++++++++|+||+++++
T Consensus 5 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~ 84 (295)
T cd05097 5 QQLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDFLKEIKIMSRLKNPNIIRLLG 84 (295)
T ss_pred HhCeehhccCCCCCceEEecccccchhhccccCcccCCCceEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCcCeEEE
Confidence 345567889999999999986532 122458999987542 334567999999999999999999999
Q ss_pred eeccCCceEEEEEeccCCCccccccCC------------CCCchhHHHHHHHHHHHHHHHHhhccCCCeEecCCCCCcEE
Q 003836 567 YCDEGQNRLLVYEFMSNGTVASFLFGD------------SKPNWKLRTEIAMGIAGGLFYLHEECCTQIIHCDIKPQNIL 634 (792)
Q Consensus 567 ~~~~~~~~~lV~E~~~~gsL~~~l~~~------------~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dikp~NIL 634 (792)
++...+..++||||+++++|.+++... ..+++..+++++.|++.||+|||+. +++|+||||+||+
T Consensus 85 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~---~i~H~dlkp~Nil 161 (295)
T cd05097 85 VCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLASL---NFVHRDLATRNCL 161 (295)
T ss_pred EEcCCCccEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHHHHHhc---CeeccccChhhEE
Confidence 999999999999999999999988543 1357888999999999999999998 9999999999999
Q ss_pred EcCCCCeEEeecCCCccccCCCCCc-cccccccCCcccccccccCCCCcccceehHHHHHHHHHh--cCcCCCcchhhhh
Q 003836 635 LDDHYNARISDFGLAKLLTLDQSHT-NTAIRGTKGYVAPEWFRNMPITVKVDVYSYGVLLLEIIC--LRRNIDNEISKVD 711 (792)
Q Consensus 635 l~~~~~~kl~Dfg~a~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~k~DV~S~Gv~l~el~t--g~~p~~~~~~~~~ 711 (792)
+++++.+||+|||+++......... .....++..|+|||.+.+..++.++||||||++++||++ +..||........
T Consensus 162 l~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~~l~el~~~~~~~p~~~~~~~~~ 241 (295)
T cd05097 162 VGNHYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEMFTLCKEQPYSLLSDEQV 241 (295)
T ss_pred EcCCCcEEecccccccccccCcceeccCcCcCceeecChhhhccCCcCchhhHHHHHHHHHHHHHcCCCCCCcccChHHH
Confidence 9999999999999998654322111 122335678999999998899999999999999999998 5566654322111
Q ss_pred hhhHHHHHHHhhcccchhHhhhchhcccCCHHHHHHHHHHHHHccccCCCCCCCHHhHHHHhc
Q 003836 712 KAILTDWAYDRYQERTLEALVENDLEAMNNVTMLHRFVMVAFWCIQEDPSHRPTMRKVTQMLE 774 (792)
Q Consensus 712 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~L~ 774 (792)
...... ...... .......+...+..+.+++.+||+.+|++||++++|++.|+
T Consensus 242 ~~~~~~----~~~~~~------~~~~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~i~~~l~ 294 (295)
T cd05097 242 IENTGE----FFRNQG------RQIYLSQTPLCPSPVFKLMMRCWSRDIKDRPTFNKIHHFLR 294 (295)
T ss_pred HHHHHH----hhhhcc------ccccCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHh
Confidence 000000 000000 00000111223467899999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including |
| >cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-36 Score=317.74 Aligned_cols=255 Identities=26% Similarity=0.357 Sum_probs=202.4
Q ss_pred hhhhhhcCccccceEEEeeecC----CCceEEEEEEccccc-ccchHHHHHHHHHhccc-CCCCcccccceeccCCceEE
Q 003836 503 RGFKEELGRGAFGTVYKGFVNM----GSSNHVAVKKLNSVF-QDSEKEFKAEVNGIGQT-HHKNLVRLLGYCDEGQNRLL 576 (792)
Q Consensus 503 ~~~~~~lG~G~~g~Vy~g~~~~----~~~~~vavK~~~~~~-~~~~~~~~~Ei~~l~~l-~h~niv~l~g~~~~~~~~~l 576 (792)
+.+.+.||+|+||.||++.... .....+|+|++.... .....++.+|+.++.++ +|+||+++++++..++..++
T Consensus 14 ~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~l 93 (293)
T cd05053 14 LTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGVCTQEGPLYV 93 (293)
T ss_pred eEEeeEecccccccEEEEEEecCCCCCCceeEEEEEccCCCCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEcCCCCeEE
Confidence 3445789999999999997642 234689999987532 23345688999999999 89999999999999999999
Q ss_pred EEEeccCCCccccccC----------------CCCCchhHHHHHHHHHHHHHHHHhhccCCCeEecCCCCCcEEEcCCCC
Q 003836 577 VYEFMSNGTVASFLFG----------------DSKPNWKLRTEIAMGIAGGLFYLHEECCTQIIHCDIKPQNILLDDHYN 640 (792)
Q Consensus 577 V~E~~~~gsL~~~l~~----------------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dikp~NILl~~~~~ 640 (792)
||||+++|+|.+++.. ...+++..+++++.|++.||+|||+. +|+|+||||+|||+++++.
T Consensus 94 i~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~---~ivH~dlkp~Nil~~~~~~ 170 (293)
T cd05053 94 VVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLASK---KCIHRDLAARNVLVTEDHV 170 (293)
T ss_pred EEEeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHC---CccccccceeeEEEcCCCe
Confidence 9999999999999853 24578899999999999999999998 9999999999999999999
Q ss_pred eEEeecCCCccccCCCCCc-cccccccCCcccccccccCCCCcccceehHHHHHHHHHh-cCcCCCcchhhhhhhhHHHH
Q 003836 641 ARISDFGLAKLLTLDQSHT-NTAIRGTKGYVAPEWFRNMPITVKVDVYSYGVLLLEIIC-LRRNIDNEISKVDKAILTDW 718 (792)
Q Consensus 641 ~kl~Dfg~a~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~k~DV~S~Gv~l~el~t-g~~p~~~~~~~~~~~~~~~~ 718 (792)
+||+|||+++......... .....++..|+|||.+.+..++.++|||||||++|||++ |..||........
T Consensus 171 ~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~------- 243 (293)
T cd05053 171 MKIADFGLARDIHHIDYYRKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVEEL------- 243 (293)
T ss_pred EEeCccccccccccccceeccCCCCCCccccCHHHhccCCcCcccceeehhhHHHHHhcCCCCCCCCCCHHHH-------
Confidence 9999999998764332211 122335678999999988899999999999999999998 8888754321110
Q ss_pred HHHhhcccchhHhhhchhcccCCHHHHHHHHHHHHHccccCCCCCCCHHhHHHHhccCc
Q 003836 719 AYDRYQERTLEALVENDLEAMNNVTMLHRFVMVAFWCIQEDPSHRPTMRKVTQMLEGVV 777 (792)
Q Consensus 719 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~L~~~~ 777 (792)
...+........+......+.+++.+||+.+|.+|||+.|+++.|++++
T Consensus 244 ----------~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~eil~~l~~~~ 292 (293)
T cd05053 244 ----------FKLLKEGYRMEKPQNCTQELYHLMRDCWHEVPSQRPTFKQLVEDLDRML 292 (293)
T ss_pred ----------HHHHHcCCcCCCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHHHHHhh
Confidence 0011111111223344567889999999999999999999999998865
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, |
| >cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-36 Score=314.24 Aligned_cols=240 Identities=22% Similarity=0.349 Sum_probs=189.7
Q ss_pred hcCccccceEEEeeecC-----------------------CCceEEEEEEcccccccchHHHHHHHHHhcccCCCCcccc
Q 003836 508 ELGRGAFGTVYKGFVNM-----------------------GSSNHVAVKKLNSVFQDSEKEFKAEVNGIGQTHHKNLVRL 564 (792)
Q Consensus 508 ~lG~G~~g~Vy~g~~~~-----------------------~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l 564 (792)
.||+|+||.||+|.+.. +....|++|++..........+.+|+.++++++|+||+++
T Consensus 2 ~lG~G~~~~vy~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~~~~l~h~niv~~ 81 (274)
T cd05076 2 HLGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDPSHRDIALAFFETASLMSQVSHIHLAFV 81 (274)
T ss_pred CcCcccccceecceeEeccCCCCcccccccccccccccCCCeeeeEEEEecChHHHHHHHHHHHHHHHHhcCCCCCeeeE
Confidence 59999999999997531 1224689999876545555678899999999999999999
Q ss_pred cceeccCCceEEEEEeccCCCccccccC-CCCCchhHHHHHHHHHHHHHHHHhhccCCCeEecCCCCCcEEEcCCC----
Q 003836 565 LGYCDEGQNRLLVYEFMSNGTVASFLFG-DSKPNWKLRTEIAMGIAGGLFYLHEECCTQIIHCDIKPQNILLDDHY---- 639 (792)
Q Consensus 565 ~g~~~~~~~~~lV~E~~~~gsL~~~l~~-~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dikp~NILl~~~~---- 639 (792)
+++|.+....++||||+++|+|..++.. ...+++..+.+++.||++||+|||++ +|+||||||+|||++..+
T Consensus 82 ~~~~~~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~iiH~dlkp~Nill~~~~~~~~ 158 (274)
T cd05076 82 HGVCVRGSENIMVEEFVEHGPLDVCLRKEKGRVPVAWKITVAQQLASALSYLEDK---NLVHGNVCAKNILLARLGLAEG 158 (274)
T ss_pred EEEEEeCCceEEEEecCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcC---CccCCCCCcccEEEeccCcccC
Confidence 9999999999999999999999999865 45688999999999999999999998 999999999999998644
Q ss_pred ---CeEEeecCCCccccCCCCCccccccccCCccccccccc-CCCCcccceehHHHHHHHHH-hcCcCCCcchhhhhhhh
Q 003836 640 ---NARISDFGLAKLLTLDQSHTNTAIRGTKGYVAPEWFRN-MPITVKVDVYSYGVLLLEII-CLRRNIDNEISKVDKAI 714 (792)
Q Consensus 640 ---~~kl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~k~DV~S~Gv~l~el~-tg~~p~~~~~~~~~~~~ 714 (792)
.+|++|||++...... ....++..|+|||.+.+ ..++.++||||||+++|||+ +|+.||..........
T Consensus 159 ~~~~~kl~d~g~~~~~~~~-----~~~~~~~~~~aPe~~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~- 232 (274)
T cd05076 159 TSPFIKLSDPGVSFTALSR-----EERVERIPWIAPECVPGGNSLSTAADKWSFGTTLLEICFDGEVPLKERTPSEKER- 232 (274)
T ss_pred ccceeeecCCccccccccc-----cccccCCcccCchhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCccccChHHHHH-
Confidence 3799999998654322 12246788999998865 56899999999999999995 6888886542211100
Q ss_pred HHHHHHHhhcccchhHhhhchhcccCCHHHHHHHHHHHHHccccCCCCCCCHHhHHHHhc
Q 003836 715 LTDWAYDRYQERTLEALVENDLEAMNNVTMLHRFVMVAFWCIQEDPSHRPTMRKVTQMLE 774 (792)
Q Consensus 715 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~L~ 774 (792)
. ..... ..+.....++.+++.+||+.+|++||++.+|++.|+
T Consensus 233 ---~-------------~~~~~--~~~~~~~~~~~~li~~cl~~~p~~Rps~~~il~~L~ 274 (274)
T cd05076 233 ---F-------------YEKKH--RLPEPSCKELATLISQCLTYEPTQRPSFRTILRDLT 274 (274)
T ss_pred ---H-------------HHhcc--CCCCCCChHHHHHHHHHcccChhhCcCHHHHHHhhC
Confidence 0 00000 011112346889999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt |
| >cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-35 Score=308.28 Aligned_cols=246 Identities=26% Similarity=0.386 Sum_probs=198.1
Q ss_pred hhcCccccceEEEeeecCCCceEEEEEEcccccc-cchHHHHHHHHHhcccCCCCcccccceeccCCceEEEEEeccCCC
Q 003836 507 EELGRGAFGTVYKGFVNMGSSNHVAVKKLNSVFQ-DSEKEFKAEVNGIGQTHHKNLVRLLGYCDEGQNRLLVYEFMSNGT 585 (792)
Q Consensus 507 ~~lG~G~~g~Vy~g~~~~~~~~~vavK~~~~~~~-~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~lV~E~~~~gs 585 (792)
+.||+|+||.||+|... ++..+|+|++..... .....+.+|++++++++|+||+++++++......++||||+++++
T Consensus 1 ~~ig~g~~g~vy~~~~~--~~~~~a~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~ 78 (250)
T cd05085 1 ELLGKGNFGEVFKGTLK--DKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGVCTQRQPIYIVMELVPGGD 78 (250)
T ss_pred CccCCCCCceEEEEEec--CCcEEEEEecCCcCCHHHHHHHHHHHHHHHhCCCCCcCeEEEEEecCCccEEEEECCCCCc
Confidence 36899999999999754 356899999876433 334578999999999999999999999999999999999999999
Q ss_pred ccccccCC-CCCchhHHHHHHHHHHHHHHHHhhccCCCeEecCCCCCcEEEcCCCCeEEeecCCCccccCCCCCcccccc
Q 003836 586 VASFLFGD-SKPNWKLRTEIAMGIAGGLFYLHEECCTQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLDQSHTNTAIR 664 (792)
Q Consensus 586 L~~~l~~~-~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dikp~NILl~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~ 664 (792)
|.+++... ..+++..+..++.|++.||.|||+. +++|+||||+||++++++.+||+|||++...............
T Consensus 79 L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~~~ 155 (250)
T cd05085 79 FLSFLRKKKDELKTKQLVKFALDAAAGMAYLESK---NCIHRDLAARNCLVGENNVLKISDFGMSRQEDDGIYSSSGLKQ 155 (250)
T ss_pred HHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeecccChheEEEcCCCeEEECCCccceeccccccccCCCCC
Confidence 99998654 4578999999999999999999998 9999999999999999999999999999764432222222233
Q ss_pred ccCCcccccccccCCCCcccceehHHHHHHHHHh-cCcCCCcchhhhhhhhHHHHHHHhhcccchhHhhhchhcccCCHH
Q 003836 665 GTKGYVAPEWFRNMPITVKVDVYSYGVLLLEIIC-LRRNIDNEISKVDKAILTDWAYDRYQERTLEALVENDLEAMNNVT 743 (792)
Q Consensus 665 gt~~y~aPE~~~~~~~~~k~DV~S~Gv~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 743 (792)
++..|+|||.+....++.++||||||+++||+++ |..||......... ... ........+..
T Consensus 156 ~~~~y~aPE~~~~~~~~~~~Di~slG~ll~~~~~~g~~p~~~~~~~~~~--------~~~---------~~~~~~~~~~~ 218 (250)
T cd05085 156 IPIKWTAPEALNYGRYSSESDVWSYGILLWETFSLGVCPYPGMTNQQAR--------EQV---------EKGYRMSCPQK 218 (250)
T ss_pred CcccccCHHHhccCCCCchhHHHHHHHHHHHHhcCCCCCCCCCCHHHHH--------HHH---------HcCCCCCCCCC
Confidence 4678999999998899999999999999999998 88898654221100 000 00111112223
Q ss_pred HHHHHHHHHHHccccCCCCCCCHHhHHHHhc
Q 003836 744 MLHRFVMVAFWCIQEDPSHRPTMRKVTQMLE 774 (792)
Q Consensus 744 ~~~~l~~l~~~Cl~~~p~~RPs~~evl~~L~ 774 (792)
.+..+.+++.+|++.+|++||++.|+++.|.
T Consensus 219 ~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~ 249 (250)
T cd05085 219 CPDDVYKVMQRCWDYKPENRPKFSELQKELA 249 (250)
T ss_pred CCHHHHHHHHHHcccCcccCCCHHHHHHHhc
Confidence 4568899999999999999999999999885
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c |
| >cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-36 Score=322.12 Aligned_cols=238 Identities=26% Similarity=0.301 Sum_probs=190.7
Q ss_pred hhcCccccceEEEeeecCCCceEEEEEEccccc---ccchHHHHHHHH-HhcccCCCCcccccceeccCCceEEEEEecc
Q 003836 507 EELGRGAFGTVYKGFVNMGSSNHVAVKKLNSVF---QDSEKEFKAEVN-GIGQTHHKNLVRLLGYCDEGQNRLLVYEFMS 582 (792)
Q Consensus 507 ~~lG~G~~g~Vy~g~~~~~~~~~vavK~~~~~~---~~~~~~~~~Ei~-~l~~l~h~niv~l~g~~~~~~~~~lV~E~~~ 582 (792)
+.||+|+||+||++... .+++.||+|++.... ....+++.+|.. +++.++||||+++++.+.+.+..++||||++
T Consensus 1 ~~lg~G~~g~V~~~~~~-~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~~l~hp~iv~~~~~~~~~~~~~lv~e~~~ 79 (323)
T cd05575 1 KVIGKGSFGKVLLAKHK-ADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTADKLYFVLDYVN 79 (323)
T ss_pred CeeeeCCCeEEEEEEEC-CCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhhCCCCCCCCeeEEEEeCCEEEEEEcCCC
Confidence 36999999999999754 456799999986532 122344555554 5678999999999999999999999999999
Q ss_pred CCCccccccCCCCCchhHHHHHHHHHHHHHHHHhhccCCCeEecCCCCCcEEEcCCCCeEEeecCCCccccCCCCCcccc
Q 003836 583 NGTVASFLFGDSKPNWKLRTEIAMGIAGGLFYLHEECCTQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLDQSHTNTA 662 (792)
Q Consensus 583 ~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dikp~NILl~~~~~~kl~Dfg~a~~~~~~~~~~~~~ 662 (792)
+|+|.+++.....+++..+..++.||+.||.|||+. +|+||||||+|||++.++.+||+|||+++..... ......
T Consensus 80 ~g~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~---givH~dikp~NIll~~~~~~kl~Dfg~~~~~~~~-~~~~~~ 155 (323)
T cd05575 80 GGELFFHLQRERSFPEPRARFYAAEIASALGYLHSL---NIIYRDLKPENILLDSQGHVVLTDFGLCKEGIEH-SKTTST 155 (323)
T ss_pred CCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---CeEeCCCCHHHeEECCCCcEEEeccCCCcccccC-CCcccc
Confidence 999999998878889999999999999999999998 9999999999999999999999999998754322 222334
Q ss_pred ccccCCcccccccccCCCCcccceehHHHHHHHHHhcCcCCCcchhhhhhhhHHHHHHHhhcccchhHhhhchhcccCCH
Q 003836 663 IRGTKGYVAPEWFRNMPITVKVDVYSYGVLLLEIICLRRNIDNEISKVDKAILTDWAYDRYQERTLEALVENDLEAMNNV 742 (792)
Q Consensus 663 ~~gt~~y~aPE~~~~~~~~~k~DV~S~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 742 (792)
..||+.|+|||.+.+..++.++|||||||++|||++|+.||........ ...+..... ....
T Consensus 156 ~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~----------------~~~i~~~~~--~~~~ 217 (323)
T cd05575 156 FCGTPEYLAPEVLRKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRDTAEM----------------YDNILNKPL--RLKP 217 (323)
T ss_pred ccCChhhcChhhhcCCCCCccccccccchhhhhhhcCCCCCCCCCHHHH----------------HHHHHcCCC--CCCC
Confidence 5689999999999999999999999999999999999999965422100 001111111 1112
Q ss_pred HHHHHHHHHHHHccccCCCCCCCHH
Q 003836 743 TMLHRFVMVAFWCIQEDPSHRPTMR 767 (792)
Q Consensus 743 ~~~~~l~~l~~~Cl~~~p~~RPs~~ 767 (792)
..+..+.+++.+||+.+|.+||++.
T Consensus 218 ~~~~~~~~li~~~l~~~p~~R~~~~ 242 (323)
T cd05575 218 NISVSARHLLEGLLQKDRTKRLGAK 242 (323)
T ss_pred CCCHHHHHHHHHHhhcCHHhCCCCC
Confidence 2356788999999999999999985
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr |
| >cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-35 Score=312.89 Aligned_cols=254 Identities=27% Similarity=0.443 Sum_probs=201.9
Q ss_pred hhhhhhcCccccceEEEeeecCCC--ceEEEEEEccccc-ccchHHHHHHHHHhcccCCCCcccccceeccCCceEEEEE
Q 003836 503 RGFKEELGRGAFGTVYKGFVNMGS--SNHVAVKKLNSVF-QDSEKEFKAEVNGIGQTHHKNLVRLLGYCDEGQNRLLVYE 579 (792)
Q Consensus 503 ~~~~~~lG~G~~g~Vy~g~~~~~~--~~~vavK~~~~~~-~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~lV~E 579 (792)
..+.+.||+|+||.||+|...... ...||+|.+.... ....++|.+|+.++++++||||+++++++.++...++|||
T Consensus 6 ~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e 85 (269)
T cd05065 6 VKIEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSRPVMIITE 85 (269)
T ss_pred eEEEeEecCCCCCeEEEEEEecCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCcCcceEEEEECCCCceEEEEe
Confidence 456678999999999999875432 2479999987542 3345689999999999999999999999999999999999
Q ss_pred eccCCCccccccCC-CCCchhHHHHHHHHHHHHHHHHhhccCCCeEecCCCCCcEEEcCCCCeEEeecCCCccccCCCCC
Q 003836 580 FMSNGTVASFLFGD-SKPNWKLRTEIAMGIAGGLFYLHEECCTQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLDQSH 658 (792)
Q Consensus 580 ~~~~gsL~~~l~~~-~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dikp~NILl~~~~~~kl~Dfg~a~~~~~~~~~ 658 (792)
|+++++|.+++... ..+++..+..++.|++.||+|||+. +++|+||||+||+++.++.+||+|||+++........
T Consensus 86 ~~~~~~L~~~l~~~~~~~~~~~~~~i~~~l~~al~~lH~~---g~~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~~~~ 162 (269)
T cd05065 86 FMENGALDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLSEM---NYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSD 162 (269)
T ss_pred cCCCCcHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHC---CEeecccChheEEEcCCCcEEECCCccccccccCccc
Confidence 99999999999754 5678999999999999999999998 9999999999999999999999999998865433221
Q ss_pred cc-c-ccc--ccCCcccccccccCCCCcccceehHHHHHHHHHh-cCcCCCcchhhhhhhhHHHHHHHhhcccchhHhhh
Q 003836 659 TN-T-AIR--GTKGYVAPEWFRNMPITVKVDVYSYGVLLLEIIC-LRRNIDNEISKVDKAILTDWAYDRYQERTLEALVE 733 (792)
Q Consensus 659 ~~-~-~~~--gt~~y~aPE~~~~~~~~~k~DV~S~Gv~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 733 (792)
.. . ... .+..|+|||.+....++.++||||||+++||+++ |..||....... ..... .
T Consensus 163 ~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~e~l~~g~~p~~~~~~~~----~~~~i-------------~ 225 (269)
T cd05065 163 PTYTSSLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQD----VINAI-------------E 225 (269)
T ss_pred cccccccCCCcceeecCHhHhccCcccchhhhhhhHHHHHHHhcCCCCCCCCCCHHH----HHHHH-------------H
Confidence 11 1 111 2457999999999999999999999999999886 999986532210 00000 0
Q ss_pred chhcccCCHHHHHHHHHHHHHccccCCCCCCCHHhHHHHhccC
Q 003836 734 NDLEAMNNVTMLHRFVMVAFWCIQEDPSHRPTMRKVTQMLEGV 776 (792)
Q Consensus 734 ~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~L~~~ 776 (792)
.......+.+.+..+.+++.+||+.+|++||++++|+++|+++
T Consensus 226 ~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~ 268 (269)
T cd05065 226 QDYRLPPPMDCPTALHQLMLDCWQKDRNARPKFGQIVSTLDKM 268 (269)
T ss_pred cCCcCCCcccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence 1111111223456678999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr |
| >cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-35 Score=312.32 Aligned_cols=252 Identities=25% Similarity=0.401 Sum_probs=195.8
Q ss_pred hhhhcCccccceEEEeeecCCCc-eEEEEEEcccc--cccchHHHHHHHHHhcccCCCCcccccceeccC------CceE
Q 003836 505 FKEELGRGAFGTVYKGFVNMGSS-NHVAVKKLNSV--FQDSEKEFKAEVNGIGQTHHKNLVRLLGYCDEG------QNRL 575 (792)
Q Consensus 505 ~~~~lG~G~~g~Vy~g~~~~~~~-~~vavK~~~~~--~~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~------~~~~ 575 (792)
+.++||+|+||.||+|....... ..+|+|.++.. .....+.+.+|++++++++|+||+++++++... ...+
T Consensus 3 i~~~ig~G~~g~V~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~ 82 (272)
T cd05075 3 LGKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLIGVCLQTVESEGYPSPV 82 (272)
T ss_pred cccccCcccCceEEEeEEccCCCeeeEEEEecccCcCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEccCCcccCCCCcE
Confidence 45789999999999998754332 36899988653 233456789999999999999999999987432 2468
Q ss_pred EEEEeccCCCccccccC------CCCCchhHHHHHHHHHHHHHHHHhhccCCCeEecCCCCCcEEEcCCCCeEEeecCCC
Q 003836 576 LVYEFMSNGTVASFLFG------DSKPNWKLRTEIAMGIAGGLFYLHEECCTQIIHCDIKPQNILLDDHYNARISDFGLA 649 (792)
Q Consensus 576 lV~E~~~~gsL~~~l~~------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dikp~NILl~~~~~~kl~Dfg~a 649 (792)
+||||+++|+|.+++.. ...+++.....++.||+.||+|||+. +|+||||||+|||+++++.+||+|||++
T Consensus 83 ~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~Dfg~~ 159 (272)
T cd05075 83 VILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYLSSK---SFIHRDLAARNCMLNENMNVCVADFGLS 159 (272)
T ss_pred EEEEeCCCCcHHHHHHHhcccCCcccCCHHHHHHHHHHHHHHHHHHHHC---CeeccccchhheEEcCCCCEEECCCCcc
Confidence 99999999999988732 23478999999999999999999998 9999999999999999999999999999
Q ss_pred ccccCCCCC-ccccccccCCcccccccccCCCCcccceehHHHHHHHHHh-cCcCCCcchhhhhhhhHHHHHHHhhcccc
Q 003836 650 KLLTLDQSH-TNTAIRGTKGYVAPEWFRNMPITVKVDVYSYGVLLLEIIC-LRRNIDNEISKVDKAILTDWAYDRYQERT 727 (792)
Q Consensus 650 ~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~k~DV~S~Gv~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 727 (792)
+........ ......+++.|+|||.+.+..++.++||||||+++|||++ |+.||....... . ........
T Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~---~-----~~~~~~~~ 231 (272)
T cd05075 160 KKIYNGDYYRQGRIAKMPVKWIAIESLADRVYTTKSDVWSFGVTMWEIATRGQTPYPGVENSE---I-----YDYLRQGN 231 (272)
T ss_pred cccCcccceecCCcccCCcccCCHHHccCCCcChHHHHHHHHHHHHHHHcCCCCCCCCCCHHH---H-----HHHHHcCC
Confidence 876433221 1122345678999999999999999999999999999999 788885432210 0 00011110
Q ss_pred hhHhhhchhcccCCHHHHHHHHHHHHHccccCCCCCCCHHhHHHHhccC
Q 003836 728 LEALVENDLEAMNNVTMLHRFVMVAFWCIQEDPSHRPTMRKVTQMLEGV 776 (792)
Q Consensus 728 ~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~L~~~ 776 (792)
....+...+..+.+++.+||+.+|++|||+++|++.|+.+
T Consensus 232 ---------~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~l~~~ 271 (272)
T cd05075 232 ---------RLKQPPDCLDGLYSLMSSCWLLNPKDRPSFETLRCELEKA 271 (272)
T ss_pred ---------CCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence 0111223456688999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor |
| >cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-36 Score=319.42 Aligned_cols=263 Identities=21% Similarity=0.263 Sum_probs=194.1
Q ss_pred hhhhhhcCccccceEEEeeecCCCceEEEEEEcccccc-cchHHHHHHHHHhcccCCCCcccccceeccCCceEEEEEec
Q 003836 503 RGFKEELGRGAFGTVYKGFVNMGSSNHVAVKKLNSVFQ-DSEKEFKAEVNGIGQTHHKNLVRLLGYCDEGQNRLLVYEFM 581 (792)
Q Consensus 503 ~~~~~~lG~G~~g~Vy~g~~~~~~~~~vavK~~~~~~~-~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~lV~E~~ 581 (792)
+.+.+.||+|+||.||+|... .+++.+|+|++..... .....+.+|+.++++++||||+++++++.+....++||||+
T Consensus 7 y~~~~~lg~G~~g~V~~~~~~-~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~ 85 (303)
T cd07869 7 YEKLEKLGEGSYATVYKGKSK-VNGKLVALKVIRLQEEEGTPFTAIREASLLKGLKHANIVLLHDIIHTKETLTLVFEYV 85 (303)
T ss_pred ceEeeeEEecCCEEEEEEEEC-CCCCEEEEEEeccccccccchhHHHHHHHHhhCCCCCcCeEEEEEecCCeEEEEEECC
Confidence 345678999999999999754 4567899999875432 23456789999999999999999999999999999999999
Q ss_pred cCCCccccccCC-CCCchhHHHHHHHHHHHHHHHHhhccCCCeEecCCCCCcEEEcCCCCeEEeecCCCccccCCCCCcc
Q 003836 582 SNGTVASFLFGD-SKPNWKLRTEIAMGIAGGLFYLHEECCTQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLDQSHTN 660 (792)
Q Consensus 582 ~~gsL~~~l~~~-~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dikp~NILl~~~~~~kl~Dfg~a~~~~~~~~~~~ 660 (792)
+ ++|.+++... ..+++..+..++.||+.||+|||+. +|+||||||+|||+++++.+||+|||+++...... ...
T Consensus 86 ~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~-~~~ 160 (303)
T cd07869 86 H-TDLCQYMDKHPGGLHPENVKLFLFQLLRGLSYIHQR---YILHRDLKPQNLLISDTGELKLADFGLARAKSVPS-HTY 160 (303)
T ss_pred C-cCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEECCCCcceeccCCC-ccC
Confidence 6 5777777554 5678899999999999999999998 99999999999999999999999999997543222 222
Q ss_pred ccccccCCccccccccc-CCCCcccceehHHHHHHHHHhcCcCCCcchhhhhhhhHHHHHH-----Hhhccc-chhHhhh
Q 003836 661 TAIRGTKGYVAPEWFRN-MPITVKVDVYSYGVLLLEIICLRRNIDNEISKVDKAILTDWAY-----DRYQER-TLEALVE 733 (792)
Q Consensus 661 ~~~~gt~~y~aPE~~~~-~~~~~k~DV~S~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~-----~~~~~~-~~~~~~~ 733 (792)
....+++.|+|||.+.+ ..++.++|||||||++|||++|+.||................. ..+... ....+..
T Consensus 161 ~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (303)
T cd07869 161 SNEVVTLWYRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQGVAAFPGMKDIQDQLERIFLVLGTPNEDTWPGVHSLPHFKP 240 (303)
T ss_pred CCCcccCCCCChHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHHHHHhCCCChhhccchhhcccccc
Confidence 33457899999998865 4588999999999999999999999975432111100000000 000000 0000000
Q ss_pred chhcccC---------CHHHHHHHHHHHHHccccCCCCCCCHHhHHH
Q 003836 734 NDLEAMN---------NVTMLHRFVMVAFWCIQEDPSHRPTMRKVTQ 771 (792)
Q Consensus 734 ~~~~~~~---------~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~ 771 (792)
....... ....+..+.+++.+||+.||++|||++|+++
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dp~~R~s~~~~l~ 287 (303)
T cd07869 241 ERFTLYSPKNLRQAWNKLSYVNHAEDLASKLLQCFPKNRLSAQAALS 287 (303)
T ss_pred ccccccCCccHHHHhhccCCChHHHHHHHHHhccCchhccCHHHHhc
Confidence 0000000 0012356789999999999999999999987
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an |
| >cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-35 Score=308.78 Aligned_cols=248 Identities=26% Similarity=0.365 Sum_probs=200.7
Q ss_pred hhcCccccceEEEeeecCCCc--eEEEEEEcccccc-cchHHHHHHHHHhcccCCCCcccccceeccCCceEEEEEeccC
Q 003836 507 EELGRGAFGTVYKGFVNMGSS--NHVAVKKLNSVFQ-DSEKEFKAEVNGIGQTHHKNLVRLLGYCDEGQNRLLVYEFMSN 583 (792)
Q Consensus 507 ~~lG~G~~g~Vy~g~~~~~~~--~~vavK~~~~~~~-~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~lV~E~~~~ 583 (792)
+.||+|++|.||+|.+....+ ..+|+|.+..... ...+.+.+|+.++++++|+||+++++.+.+ ...++|+||+++
T Consensus 1 ~~ig~g~~~~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~v~e~~~~ 79 (257)
T cd05040 1 KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIRLYGVVLT-HPLMMVTELAPL 79 (257)
T ss_pred CcCCccCcccEEeeeEecCCCCceEEEEeecCCcccHHHHHHHHHHHHHHhhcCCCCccceeEEEcC-CeEEEEEEecCC
Confidence 468999999999998754233 3699999987655 566789999999999999999999999988 889999999999
Q ss_pred CCccccccCCC--CCchhHHHHHHHHHHHHHHHHhhccCCCeEecCCCCCcEEEcCCCCeEEeecCCCccccCCCCC--c
Q 003836 584 GTVASFLFGDS--KPNWKLRTEIAMGIAGGLFYLHEECCTQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLDQSH--T 659 (792)
Q Consensus 584 gsL~~~l~~~~--~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dikp~NILl~~~~~~kl~Dfg~a~~~~~~~~~--~ 659 (792)
++|.+++.... .+++.....++.|++.||+|||+. +++|+||||+||+++.++.+||+|||+++........ .
T Consensus 80 ~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~---~i~H~di~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~ 156 (257)
T cd05040 80 GSLLDRLRKDALGHFLISTLCDYAVQIANGMRYLESK---RFIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHYVM 156 (257)
T ss_pred CcHHHHHHhcccccCcHHHHHHHHHHHHHHHHHHHhC---CccccccCcccEEEecCCEEEeccccccccccccccceec
Confidence 99999997653 689999999999999999999998 9999999999999999999999999999876543221 1
Q ss_pred cccccccCCcccccccccCCCCcccceehHHHHHHHHHh-cCcCCCcchhhhhhhhHHHHHHHhhcccchhHhhhchhcc
Q 003836 660 NTAIRGTKGYVAPEWFRNMPITVKVDVYSYGVLLLEIIC-LRRNIDNEISKVDKAILTDWAYDRYQERTLEALVENDLEA 738 (792)
Q Consensus 660 ~~~~~gt~~y~aPE~~~~~~~~~k~DV~S~Gv~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 738 (792)
.....++..|+|||.+.+..++.++||||||+++|||++ |+.||........ .... .......
T Consensus 157 ~~~~~~~~~y~~pE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~---~~~~-------------~~~~~~~ 220 (257)
T cd05040 157 EEHLKVPFAWCAPESLRTRTFSHASDVWMFGVTLWEMFTYGEEPWAGLSGSQI---LKKI-------------DKEGERL 220 (257)
T ss_pred ccCCCCCceecCHHHhcccCcCchhhhHHHHHHHHHHHhCCCCCCCCCCHHHH---HHHH-------------HhcCCcC
Confidence 123456789999999998899999999999999999999 9999864322110 0000 0000011
Q ss_pred cCCHHHHHHHHHHHHHccccCCCCCCCHHhHHHHhc
Q 003836 739 MNNVTMLHRFVMVAFWCIQEDPSHRPTMRKVTQMLE 774 (792)
Q Consensus 739 ~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~L~ 774 (792)
..+...+..+.+++.+||+.+|++||++.++++.|.
T Consensus 221 ~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~ 256 (257)
T cd05040 221 ERPEACPQDIYNVMLQCWAHNPADRPTFAALREFLP 256 (257)
T ss_pred CCCccCCHHHHHHHHHHCCCCcccCCCHHHHHHHhc
Confidence 112234567889999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and |
| >KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-36 Score=322.87 Aligned_cols=236 Identities=24% Similarity=0.318 Sum_probs=200.5
Q ss_pred hhhhcCccccceEEEeeecCCCceEEEEEEccccc---ccchHHHHHHHHHhccc-CCCCcccccceeccCCceEEEEEe
Q 003836 505 FKEELGRGAFGTVYKGFVNMGSSNHVAVKKLNSVF---QDSEKEFKAEVNGIGQT-HHKNLVRLLGYCDEGQNRLLVYEF 580 (792)
Q Consensus 505 ~~~~lG~G~~g~Vy~g~~~~~~~~~vavK~~~~~~---~~~~~~~~~Ei~~l~~l-~h~niv~l~g~~~~~~~~~lV~E~ 580 (792)
|.++||+|.||+|+++.+. ++++.+|||.+++.. .+..+..+.|.+++... +||.|+.|+.+|...+++++||||
T Consensus 372 ~l~vLGkGsFGkV~lae~k-~~~e~yAIK~LKK~~Il~~d~Ve~~~~EkrI~~la~~HPFL~~L~~~fQT~~~l~fvmey 450 (694)
T KOG0694|consen 372 LLAVLGRGSFGKVLLAELK-GTNEYYAIKVLKKGDILQRDEVESLMCEKRIFELANRHPFLVNLFSCFQTKEHLFFVMEY 450 (694)
T ss_pred EEEEeccCcCceEEEEEEc-CCCcEEEEEEeeccceeccccHHHHHHHHHHHHHhccCCeEeecccccccCCeEEEEEEe
Confidence 4578999999999999875 556799999998753 45567788888888877 599999999999999999999999
Q ss_pred ccCCCccccccCCCCCchhHHHHHHHHHHHHHHHHhhccCCCeEecCCCCCcEEEcCCCCeEEeecCCCccccCCCCCcc
Q 003836 581 MSNGTVASFLFGDSKPNWKLRTEIAMGIAGGLFYLHEECCTQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLDQSHTN 660 (792)
Q Consensus 581 ~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dikp~NILl~~~~~~kl~Dfg~a~~~~~~~~~~~ 660 (792)
+.||++..+. ....+++....-++..|+.||.|||++ +||+||||.+|||||.+|.+||+|||+++..... ....
T Consensus 451 ~~Ggdm~~~~-~~~~F~e~rarfyaAev~l~L~fLH~~---~IIYRDlKLdNiLLD~eGh~kiADFGlcKe~m~~-g~~T 525 (694)
T KOG0694|consen 451 VAGGDLMHHI-HTDVFSEPRARFYAAEVVLGLQFLHEN---GIIYRDLKLDNLLLDTEGHVKIADFGLCKEGMGQ-GDRT 525 (694)
T ss_pred cCCCcEEEEE-ecccccHHHHHHHHHHHHHHHHHHHhc---CceeeecchhheEEcccCcEEecccccccccCCC-CCcc
Confidence 9999944433 446789999999999999999999999 9999999999999999999999999999975433 3355
Q ss_pred ccccccCCcccccccccCCCCcccceehHHHHHHHHHhcCcCCCcchhhhhhhhHHHHHHHhhcccchhHhhhchh--cc
Q 003836 661 TAIRGTKGYVAPEWFRNMPITVKVDVYSYGVLLLEIICLRRNIDNEISKVDKAILTDWAYDRYQERTLEALVENDL--EA 738 (792)
Q Consensus 661 ~~~~gt~~y~aPE~~~~~~~~~k~DV~S~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~ 738 (792)
.+++|||.|||||++.+..|+.+.|.|||||+||||+.|..||..+.++.. .+..+ +.
T Consensus 526 sTfCGTpey~aPEil~e~~Yt~aVDWW~lGVLlyeML~Gq~PF~gddEee~--------------------FdsI~~d~~ 585 (694)
T KOG0694|consen 526 STFCGTPEFLAPEVLTEQSYTRAVDWWGLGVLLYEMLVGESPFPGDDEEEV--------------------FDSIVNDEV 585 (694)
T ss_pred ccccCChhhcChhhhccCcccchhhHHHHHHHHHHHHcCCCCCCCCCHHHH--------------------HHHHhcCCC
Confidence 678999999999999999999999999999999999999999986543311 12211 22
Q ss_pred cCCHHHHHHHHHHHHHccccCCCCCCCH
Q 003836 739 MNNVTMLHRFVMVAFWCIQEDPSHRPTM 766 (792)
Q Consensus 739 ~~~~~~~~~l~~l~~~Cl~~~p~~RPs~ 766 (792)
.++...+.+.+.++.++|..+|++|.-+
T Consensus 586 ~yP~~ls~ea~~il~~ll~k~p~kRLG~ 613 (694)
T KOG0694|consen 586 RYPRFLSKEAIAIMRRLLRKNPEKRLGS 613 (694)
T ss_pred CCCCcccHHHHHHHHHHhccCcccccCC
Confidence 3566778899999999999999999866
|
|
| >cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-36 Score=328.00 Aligned_cols=249 Identities=20% Similarity=0.261 Sum_probs=196.8
Q ss_pred hhhhhhcCccccceEEEeeecCCCceEEEEEEccccc---ccchHHHHHHHHHhcccCCCCcccccceeccCCceEEEEE
Q 003836 503 RGFKEELGRGAFGTVYKGFVNMGSSNHVAVKKLNSVF---QDSEKEFKAEVNGIGQTHHKNLVRLLGYCDEGQNRLLVYE 579 (792)
Q Consensus 503 ~~~~~~lG~G~~g~Vy~g~~~~~~~~~vavK~~~~~~---~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~lV~E 579 (792)
+.+.+.||+|+||.||++... .+++.+|+|++.+.. ....+.+.+|+.+++.++||||+++++++.+++..++|||
T Consensus 45 y~~~~~lG~G~fg~Vy~~~~~-~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~~~~lv~E 123 (370)
T cd05621 45 YDVVKVIGRGAFGEVQLVRHK-SSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFCAFQDDKYLYMVME 123 (370)
T ss_pred CeEEEEEEecCCeEEEEEEEC-CCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEEc
Confidence 445578999999999999754 456789999986422 2234568899999999999999999999999999999999
Q ss_pred eccCCCccccccCCCCCchhHHHHHHHHHHHHHHHHhhccCCCeEecCCCCCcEEEcCCCCeEEeecCCCccccCCCCCc
Q 003836 580 FMSNGTVASFLFGDSKPNWKLRTEIAMGIAGGLFYLHEECCTQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLDQSHT 659 (792)
Q Consensus 580 ~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dikp~NILl~~~~~~kl~Dfg~a~~~~~~~~~~ 659 (792)
|+++|+|.+++... .+++..+..++.||+.||+|||+. +|+||||||+|||+++++.+||+|||+++.........
T Consensus 124 y~~gg~L~~~l~~~-~~~~~~~~~~~~qil~aL~~LH~~---~IvHrDLKp~NILl~~~~~~kL~DFG~a~~~~~~~~~~ 199 (370)
T cd05621 124 YMPGGDLVNLMSNY-DVPEKWAKFYTAEVVLALDAIHSM---GLIHRDVKPDNMLLDKHGHLKLADFGTCMKMDETGMVR 199 (370)
T ss_pred CCCCCcHHHHHHhc-CCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHEEECCCCCEEEEecccceecccCCcee
Confidence 99999999998654 578889999999999999999998 99999999999999999999999999998764333323
Q ss_pred cccccccCCcccccccccC----CCCcccceehHHHHHHHHHhcCcCCCcchhhhhhhhHHHHHHHhhcccchhHhhhch
Q 003836 660 NTAIRGTKGYVAPEWFRNM----PITVKVDVYSYGVLLLEIICLRRNIDNEISKVDKAILTDWAYDRYQERTLEALVEND 735 (792)
Q Consensus 660 ~~~~~gt~~y~aPE~~~~~----~~~~k~DV~S~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 735 (792)
.....||+.|+|||.+... .++.++|||||||++|||++|+.||........ ...+++..
T Consensus 200 ~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~DiwSlG~ilyell~G~~Pf~~~~~~~~----------------~~~i~~~~ 263 (370)
T cd05621 200 CDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYADSLVGT----------------YSKIMDHK 263 (370)
T ss_pred cccCCCCcccCCHHHHhccCCCCCCCcccCEEeehHHHHHHHhCCCCCCCCCHHHH----------------HHHHHhCC
Confidence 3455799999999998654 378999999999999999999999975432111 11111111
Q ss_pred --hcccCCHHHHHHHHHHHHHccccCCCC--CCCHHhHHHH
Q 003836 736 --LEAMNNVTMLHRFVMVAFWCIQEDPSH--RPTMRKVTQM 772 (792)
Q Consensus 736 --~~~~~~~~~~~~l~~l~~~Cl~~~p~~--RPs~~evl~~ 772 (792)
+........+..+.+++..||+.++.+ ||+++|+++.
T Consensus 264 ~~~~~p~~~~~s~~~~~li~~~L~~~~~r~~R~~~~e~l~h 304 (370)
T cd05621 264 NSLNFPEDVEISKHAKNLICAFLTDREVRLGRNGVEEIKQH 304 (370)
T ss_pred cccCCCCcccCCHHHHHHHHHHccCchhccCCCCHHHHhcC
Confidence 111112234567788889999855543 8899999886
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found |
| >cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-35 Score=313.96 Aligned_cols=256 Identities=26% Similarity=0.378 Sum_probs=201.8
Q ss_pred hhhhhcCccccceEEEeeecCCCc---eEEEEEEccccc-ccchHHHHHHHHHhcccCCCCcccccceeccCCceEEEEE
Q 003836 504 GFKEELGRGAFGTVYKGFVNMGSS---NHVAVKKLNSVF-QDSEKEFKAEVNGIGQTHHKNLVRLLGYCDEGQNRLLVYE 579 (792)
Q Consensus 504 ~~~~~lG~G~~g~Vy~g~~~~~~~---~~vavK~~~~~~-~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~lV~E 579 (792)
.+.+.||+|+||+||+|.....+. ..||+|++.... ....+++.+|+.++++++|+||+++++++... ..++++|
T Consensus 10 ~~~~~lg~G~~g~vy~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-~~~l~~~ 88 (279)
T cd05109 10 KKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVCRLLGICLTS-TVQLVTQ 88 (279)
T ss_pred eeeeecCCCCCceEEEEEEecCCCccceEEEEEEecCCCCHHHHHHHHHHHHHHHhcCCCCCceEEEEEcCC-CcEEEEE
Confidence 345789999999999997543222 258999987533 33456789999999999999999999999754 5779999
Q ss_pred eccCCCccccccCC-CCCchhHHHHHHHHHHHHHHHHhhccCCCeEecCCCCCcEEEcCCCCeEEeecCCCccccCCCCC
Q 003836 580 FMSNGTVASFLFGD-SKPNWKLRTEIAMGIAGGLFYLHEECCTQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLDQSH 658 (792)
Q Consensus 580 ~~~~gsL~~~l~~~-~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dikp~NILl~~~~~~kl~Dfg~a~~~~~~~~~ 658 (792)
|+++|+|.+++... ..+++..+..++.||+.||+|||+. +|+||||||+|||+++++.+||+|||+++........
T Consensus 89 ~~~~g~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~lH~~---~iiH~dlkp~Nil~~~~~~~kL~dfG~~~~~~~~~~~ 165 (279)
T cd05109 89 LMPYGCLLDYVRENKDRIGSQDLLNWCVQIAKGMSYLEEV---RLVHRDLAARNVLVKSPNHVKITDFGLARLLDIDETE 165 (279)
T ss_pred cCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccccccceEEEcCCCcEEECCCCceeecccccce
Confidence 99999999999764 5689999999999999999999998 9999999999999999999999999999876543222
Q ss_pred c-cccccccCCcccccccccCCCCcccceehHHHHHHHHHh-cCcCCCcchhhhhhhhHHHHHHHhhcccchhHhhhchh
Q 003836 659 T-NTAIRGTKGYVAPEWFRNMPITVKVDVYSYGVLLLEIIC-LRRNIDNEISKVDKAILTDWAYDRYQERTLEALVENDL 736 (792)
Q Consensus 659 ~-~~~~~gt~~y~aPE~~~~~~~~~k~DV~S~Gv~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 736 (792)
. .....+++.|+|||.+.+..++.++||||||+++|||++ |..||....... +.. .+....
T Consensus 166 ~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~----~~~-------------~~~~~~ 228 (279)
T cd05109 166 YHADGGKVPIKWMALESILHRRFTHQSDVWSYGVTVWELMTFGAKPYDGIPARE----IPD-------------LLEKGE 228 (279)
T ss_pred eecCCCccchhhCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHHH----HHH-------------HHHCCC
Confidence 1 112234678999999998899999999999999999998 888886432211 101 111111
Q ss_pred cccCCHHHHHHHHHHHHHccccCCCCCCCHHhHHHHhccCcCCC
Q 003836 737 EAMNNVTMLHRFVMVAFWCIQEDPSHRPTMRKVTQMLEGVVEVP 780 (792)
Q Consensus 737 ~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~L~~~~~~~ 780 (792)
....+...+..+.+++.+||+.||++||++.++++.|+.+...|
T Consensus 229 ~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~l~~~l~~~~~~~ 272 (279)
T cd05109 229 RLPQPPICTIDVYMIMVKCWMIDSECRPRFRELVDEFSRMARDP 272 (279)
T ss_pred cCCCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhhcCC
Confidence 11112234567889999999999999999999999998876655
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve |
| >cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-36 Score=322.71 Aligned_cols=245 Identities=25% Similarity=0.343 Sum_probs=196.5
Q ss_pred hhhhhcCccccceEEEeeecCCCceEEEEEEccccc---ccchHHHHHHHHHhcccCC-CCcccccceeccCCceEEEEE
Q 003836 504 GFKEELGRGAFGTVYKGFVNMGSSNHVAVKKLNSVF---QDSEKEFKAEVNGIGQTHH-KNLVRLLGYCDEGQNRLLVYE 579 (792)
Q Consensus 504 ~~~~~lG~G~~g~Vy~g~~~~~~~~~vavK~~~~~~---~~~~~~~~~Ei~~l~~l~h-~niv~l~g~~~~~~~~~lV~E 579 (792)
.+.+.||+|+||.||+|... ++++.||+|++.... ....+.+..|++++..++| ++|+++++++.+.+..++|||
T Consensus 3 ~~~~~lg~G~~g~Vy~~~~~-~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E 81 (324)
T cd05587 3 NFLMVLGKGSFGKVMLAERK-GTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVME 81 (324)
T ss_pred eEEEEEeeccCeEEEEEEEC-CCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCEEEEEEc
Confidence 35578999999999999754 456789999987532 2344667889999999865 568889999999999999999
Q ss_pred eccCCCccccccCCCCCchhHHHHHHHHHHHHHHHHhhccCCCeEecCCCCCcEEEcCCCCeEEeecCCCccccCCCCCc
Q 003836 580 FMSNGTVASFLFGDSKPNWKLRTEIAMGIAGGLFYLHEECCTQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLDQSHT 659 (792)
Q Consensus 580 ~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dikp~NILl~~~~~~kl~Dfg~a~~~~~~~~~~ 659 (792)
|+++|+|.+++.....+++..+..++.||+.||+|||+. +|+||||||+|||++.++.+||+|||+++...... ..
T Consensus 82 ~~~~g~L~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~dlkp~Nill~~~~~~kL~Dfg~~~~~~~~~-~~ 157 (324)
T cd05587 82 YVNGGDLMYHIQQVGKFKEPHAVFYAAEIAIGLFFLHSK---GIIYRDLKLDNVMLDAEGHIKIADFGMCKENIFGG-KT 157 (324)
T ss_pred CCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHeEEcCCCCEEEeecCcceecCCCC-Cc
Confidence 999999999998878889999999999999999999998 99999999999999999999999999987532211 12
Q ss_pred cccccccCCcccccccccCCCCcccceehHHHHHHHHHhcCcCCCcchhhhhhhhHHHHHHHhhcccchhHhhhchhccc
Q 003836 660 NTAIRGTKGYVAPEWFRNMPITVKVDVYSYGVLLLEIICLRRNIDNEISKVDKAILTDWAYDRYQERTLEALVENDLEAM 739 (792)
Q Consensus 660 ~~~~~gt~~y~aPE~~~~~~~~~k~DV~S~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 739 (792)
.....||+.|+|||++.+..++.++|||||||++|||++|+.||........ . ..+... ...
T Consensus 158 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~~~~---~-------------~~i~~~--~~~ 219 (324)
T cd05587 158 TRTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDEL---F-------------QSIMEH--NVS 219 (324)
T ss_pred eeeecCCccccChhhhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHHH---H-------------HHHHcC--CCC
Confidence 2345689999999999999999999999999999999999999975432110 0 001111 111
Q ss_pred CCHHHHHHHHHHHHHccccCCCCCCCH-----HhHHH
Q 003836 740 NNVTMLHRFVMVAFWCIQEDPSHRPTM-----RKVTQ 771 (792)
Q Consensus 740 ~~~~~~~~l~~l~~~Cl~~~p~~RPs~-----~evl~ 771 (792)
.+...+.++.+++.+||+.+|.+||+. +++++
T Consensus 220 ~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~~~~ 256 (324)
T cd05587 220 YPKSLSKEAVSICKGLLTKHPAKRLGCGPTGERDIRE 256 (324)
T ss_pred CCCCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhc
Confidence 222345678899999999999999986 55554
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory |
| >cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-36 Score=314.67 Aligned_cols=251 Identities=28% Similarity=0.356 Sum_probs=198.6
Q ss_pred hhhhhcCccccceEEEeeecCC----CceEEEEEEccccc-ccchHHHHHHHHHhcccCCCCcccccceeccCCceEEEE
Q 003836 504 GFKEELGRGAFGTVYKGFVNMG----SSNHVAVKKLNSVF-QDSEKEFKAEVNGIGQTHHKNLVRLLGYCDEGQNRLLVY 578 (792)
Q Consensus 504 ~~~~~lG~G~~g~Vy~g~~~~~----~~~~vavK~~~~~~-~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~lV~ 578 (792)
.+.+.||+|++|.||+|..... ....|++|.+.... ...+..+.+|+.++++++|+||+++++++.+.+..++||
T Consensus 9 ~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 88 (277)
T cd05036 9 TLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKFNHQNIVRLIGVSFERLPRFILL 88 (277)
T ss_pred EeeeECCCCCCCcEEEEEEecCCCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCcEEEE
Confidence 3457899999999999987531 45689999886443 334567999999999999999999999999999999999
Q ss_pred EeccCCCccccccCCC-------CCchhHHHHHHHHHHHHHHHHhhccCCCeEecCCCCCcEEEcCCC---CeEEeecCC
Q 003836 579 EFMSNGTVASFLFGDS-------KPNWKLRTEIAMGIAGGLFYLHEECCTQIIHCDIKPQNILLDDHY---NARISDFGL 648 (792)
Q Consensus 579 E~~~~gsL~~~l~~~~-------~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dikp~NILl~~~~---~~kl~Dfg~ 648 (792)
||+++++|.+++.... .+++..+.+++.||+.||+|||+. +++|+||||+|||++.++ .+||+|||+
T Consensus 89 e~~~g~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~---~ivH~dlkp~nil~~~~~~~~~~kl~dfg~ 165 (277)
T cd05036 89 ELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLEEN---HFIHRDIAARNCLLTCKGPGRVAKIADFGM 165 (277)
T ss_pred ecCCCCCHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHC---CEeecccchheEEEeccCCCcceEeccCcc
Confidence 9999999999986542 478899999999999999999998 999999999999998764 599999999
Q ss_pred CccccCCCCCc-cccccccCCcccccccccCCCCcccceehHHHHHHHHHh-cCcCCCcchhhhhhhhHHHHHHHhhccc
Q 003836 649 AKLLTLDQSHT-NTAIRGTKGYVAPEWFRNMPITVKVDVYSYGVLLLEIIC-LRRNIDNEISKVDKAILTDWAYDRYQER 726 (792)
Q Consensus 649 a~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~k~DV~S~Gv~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 726 (792)
++......... ......+..|+|||.+.+..++.++|||||||++|||++ |+.||........
T Consensus 166 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~~g~~pf~~~~~~~~--------------- 230 (277)
T cd05036 166 ARDIYRASYYRKGGRAMLPIKWMPPEAFLDGIFTSKTDVWSFGVLLWEIFSLGYMPYPGRTNQEV--------------- 230 (277)
T ss_pred ccccCCccceecCCCCCccHhhCCHHHHhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHH---------------
Confidence 98763222111 112223568999999999999999999999999999997 8888865432110
Q ss_pred chhHhhhchhcccCCHHHHHHHHHHHHHccccCCCCCCCHHhHHHHhc
Q 003836 727 TLEALVENDLEAMNNVTMLHRFVMVAFWCIQEDPSHRPTMRKVTQMLE 774 (792)
Q Consensus 727 ~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~L~ 774 (792)
...+........+...+..+.+++.+||+.+|++||++.+|++.|+
T Consensus 231 --~~~~~~~~~~~~~~~~~~~~~~~i~~cl~~~p~~Rps~~~vl~~l~ 276 (277)
T cd05036 231 --MEFVTGGGRLDPPKGCPGPVYRIMTDCWQHTPEDRPNFATILERIQ 276 (277)
T ss_pred --HHHHHcCCcCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHhh
Confidence 0011111111223344567889999999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well |
| >cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=321.61 Aligned_cols=244 Identities=23% Similarity=0.294 Sum_probs=193.1
Q ss_pred hhhhcCccccceEEEeeecCCCceEEEEEEccccc---ccchHHHHHHHHHh---cccCCCCcccccceeccCCceEEEE
Q 003836 505 FKEELGRGAFGTVYKGFVNMGSSNHVAVKKLNSVF---QDSEKEFKAEVNGI---GQTHHKNLVRLLGYCDEGQNRLLVY 578 (792)
Q Consensus 505 ~~~~lG~G~~g~Vy~g~~~~~~~~~vavK~~~~~~---~~~~~~~~~Ei~~l---~~l~h~niv~l~g~~~~~~~~~lV~ 578 (792)
+.+.||+|+||.||++... .+++.||||+++... ....+.+.+|++++ ++++||||+++++++.+.+..++||
T Consensus 3 i~~~lg~G~~g~Vy~~~~~-~~~~~~aiK~~~~~~~~~~~~~~~l~~e~~~~~~~~~l~hp~i~~~~~~~~~~~~~~lv~ 81 (324)
T cd05589 3 CLAVLGRGHFGKVLLAEYK-KTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVNLFACFQTEDHVCFVM 81 (324)
T ss_pred EEEEEeecCCEEEEEEEEC-CCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccccCCCChhceeeEEEcCCEEEEEE
Confidence 4578999999999999754 456789999987532 22334566676554 5678999999999999999999999
Q ss_pred EeccCCCccccccCCCCCchhHHHHHHHHHHHHHHHHhhccCCCeEecCCCCCcEEEcCCCCeEEeecCCCccccCCCCC
Q 003836 579 EFMSNGTVASFLFGDSKPNWKLRTEIAMGIAGGLFYLHEECCTQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLDQSH 658 (792)
Q Consensus 579 E~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dikp~NILl~~~~~~kl~Dfg~a~~~~~~~~~ 658 (792)
||+++++|..++.. ..+++..+..++.||+.||.|||+. +|+||||||+|||++.++.+||+|||+++...... .
T Consensus 82 E~~~~~~L~~~~~~-~~l~~~~~~~~~~qi~~al~~lH~~---~ivHrdlkp~Nill~~~~~~kL~Dfg~~~~~~~~~-~ 156 (324)
T cd05589 82 EYAAGGDLMMHIHT-DVFSEPRAVFYAACVVLGLQYLHEN---KIVYRDLKLDNLLLDTEGFVKIADFGLCKEGMGFG-D 156 (324)
T ss_pred cCCCCCcHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHHhC---CeEecCCCHHHeEECCCCcEEeCcccCCccCCCCC-C
Confidence 99999999988854 4689999999999999999999998 99999999999999999999999999987543222 2
Q ss_pred ccccccccCCcccccccccCCCCcccceehHHHHHHHHHhcCcCCCcchhhhhhhhHHHHHHHhhcccchhHhhhchhcc
Q 003836 659 TNTAIRGTKGYVAPEWFRNMPITVKVDVYSYGVLLLEIICLRRNIDNEISKVDKAILTDWAYDRYQERTLEALVENDLEA 738 (792)
Q Consensus 659 ~~~~~~gt~~y~aPE~~~~~~~~~k~DV~S~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 738 (792)
......|++.|+|||.+.+..++.++|||||||++|||++|+.||........ . ..+.... .
T Consensus 157 ~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~G~~pf~~~~~~~~---~-------------~~i~~~~--~ 218 (324)
T cd05589 157 RTSTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIYEMLVGESPFPGDDEEEV---F-------------DSIVNDE--V 218 (324)
T ss_pred cccccccCccccCHhHhcCCCCCcccchhhHHHHHHHHHhCCCCCCCCCHHHH---H-------------HHHHhCC--C
Confidence 22345689999999999999999999999999999999999999965432110 0 0011111 1
Q ss_pred cCCHHHHHHHHHHHHHccccCCCCCC-----CHHhHHHH
Q 003836 739 MNNVTMLHRFVMVAFWCIQEDPSHRP-----TMRKVTQM 772 (792)
Q Consensus 739 ~~~~~~~~~l~~l~~~Cl~~~p~~RP-----s~~evl~~ 772 (792)
..+...+..+.+++.+||+.||.+|| ++.++++.
T Consensus 219 ~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~l~~~ 257 (324)
T cd05589 219 RYPRFLSREAISIMRRLLRRNPERRLGSGEKDAEDVKKQ 257 (324)
T ss_pred CCCCCCCHHHHHHHHHHhhcCHhHcCCCCCCCHHHHhhC
Confidence 12223456788999999999999999 56666653
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved |
| >cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-36 Score=331.09 Aligned_cols=249 Identities=21% Similarity=0.269 Sum_probs=193.4
Q ss_pred hhhhcCccccceEEEeeecCCCceEEEEEEccccc---ccchHHHHHHHHHhcccCCCCcccccceeccCCceEEEEEec
Q 003836 505 FKEELGRGAFGTVYKGFVNMGSSNHVAVKKLNSVF---QDSEKEFKAEVNGIGQTHHKNLVRLLGYCDEGQNRLLVYEFM 581 (792)
Q Consensus 505 ~~~~lG~G~~g~Vy~g~~~~~~~~~vavK~~~~~~---~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~lV~E~~ 581 (792)
+.++||+|+||+||++... .+++.+|+|++.+.. ......+.+|++++++++|+||+++++.+.+++..++||||+
T Consensus 5 ~~~~LG~G~~g~Vy~a~~~-~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~~~h~~iv~~~~~~~~~~~~~lv~E~~ 83 (382)
T cd05625 5 KIKTLGIGAFGEVCLARKV-DTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVMDYI 83 (382)
T ss_pred EEEEEEeCCCEEEEEEEEC-CCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhCCCCcCCeEEEEEEeCCEEEEEEeCC
Confidence 3568999999999999754 456789999987532 233457889999999999999999999999999999999999
Q ss_pred cCCCccccccCCCCCchhHHHHHHHHHHHHHHHHhhccCCCeEecCCCCCcEEEcCCCCeEEeecCCCccccCCC-----
Q 003836 582 SNGTVASFLFGDSKPNWKLRTEIAMGIAGGLFYLHEECCTQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLDQ----- 656 (792)
Q Consensus 582 ~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dikp~NILl~~~~~~kl~Dfg~a~~~~~~~----- 656 (792)
++|+|.+++.+...+++.....++.||+.||+|||+. +|+||||||+|||++.++.+||+|||+++.+....
T Consensus 84 ~gg~L~~~l~~~~~~~e~~~~~~~~qi~~al~~lH~~---~ivHrDlKp~NILl~~~g~~kL~DFGla~~~~~~~~~~~~ 160 (382)
T cd05625 84 PGGDMMSLLIRMGIFPEDLARFYIAELTCAVESVHKM---GFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYY 160 (382)
T ss_pred CCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCCEEEeECCCCcccccccccccc
Confidence 9999999998777888999999999999999999998 99999999999999999999999999975432100
Q ss_pred -----------------------------------------CCccccccccCCcccccccccCCCCcccceehHHHHHHH
Q 003836 657 -----------------------------------------SHTNTAIRGTKGYVAPEWFRNMPITVKVDVYSYGVLLLE 695 (792)
Q Consensus 657 -----------------------------------------~~~~~~~~gt~~y~aPE~~~~~~~~~k~DV~S~Gv~l~e 695 (792)
........||+.|+|||++.+..++.++|||||||++||
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGvil~e 240 (382)
T cd05625 161 QSGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILYE 240 (382)
T ss_pred ccccccccccccccccccccccccccccccchhhhhccccccccccccccCcccCCHHHhcCCCCCCeeeEEechHHHHH
Confidence 000123468999999999999999999999999999999
Q ss_pred HHhcCcCCCcchhhhhhhhHHHHHHHhhcccchhHhhhchhcccCCHHHHHHHHHHHHHccccCCCCCCC---HHhHHHH
Q 003836 696 IICLRRNIDNEISKVDKAILTDWAYDRYQERTLEALVENDLEAMNNVTMLHRFVMVAFWCIQEDPSHRPT---MRKVTQM 772 (792)
Q Consensus 696 l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs---~~evl~~ 772 (792)
|++|+.||.............. + ............+.++.+++.+++ .+|.+|++ ++|+++.
T Consensus 241 lltG~~Pf~~~~~~~~~~~i~~-----~---------~~~~~~p~~~~~s~~~~~li~~l~-~~p~~R~~~~~~~ei~~h 305 (382)
T cd05625 241 MLVGQPPFLAQTPLETQMKVIN-----W---------QTSLHIPPQAKLSPEASDLIIKLC-RGPEDRLGKNGADEIKAH 305 (382)
T ss_pred HHhCCCCCCCCCHHHHHHHHHc-----c---------CCCcCCCCcccCCHHHHHHHHHHc-cCHhHcCCCCCHHHHhcC
Confidence 9999999975432211100000 0 000111111223455666676665 49999997 7777653
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an |
| >KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-36 Score=303.61 Aligned_cols=270 Identities=23% Similarity=0.289 Sum_probs=206.3
Q ss_pred hhhcCccccceEEEeeecCCCceEEEEEEccccc--ccchHHHHHHHHHhcccCCCCcccccceecc-----CCceEEEE
Q 003836 506 KEELGRGAFGTVYKGFVNMGSSNHVAVKKLNSVF--QDSEKEFKAEVNGIGQTHHKNLVRLLGYCDE-----GQNRLLVY 578 (792)
Q Consensus 506 ~~~lG~G~~g~Vy~g~~~~~~~~~vavK~~~~~~--~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~-----~~~~~lV~ 578 (792)
.+.||+|+||.|.++.. ..+++.||||++.... ....++..+|+++|+.++|+||+.+++.+.- -+..|+|+
T Consensus 27 ~~~iG~GAyGvVcsA~~-~~t~~~VAIKKi~~~F~~~~~akRtlRElklLr~~~HeNIi~l~di~~p~~~~~f~DvYiV~ 105 (359)
T KOG0660|consen 27 IEPIGRGAYGVVCSAKD-KRTGEKVAIKKILNPFENQIDAKRTLRELKLLRHLRHENIIGLLDIFRPPSRDKFNDVYLVF 105 (359)
T ss_pred cccccCcceeeEEEEEE-cCCCCEeehhhhhhhhhchHHHHHHHHHHHHHHHhcCCCcceEEeecccccccccceeEEeh
Confidence 35799999999999965 4567899999998543 3456788999999999999999999998854 35689999
Q ss_pred EeccCCCccccccCCCCCchhHHHHHHHHHHHHHHHHhhccCCCeEecCCCCCcEEEcCCCCeEEeecCCCccccCCC-C
Q 003836 579 EFMSNGTVASFLFGDSKPNWKLRTEIAMGIAGGLFYLHEECCTQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLDQ-S 657 (792)
Q Consensus 579 E~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dikp~NILl~~~~~~kl~Dfg~a~~~~~~~-~ 657 (792)
|+|+ .+|...++..+.++......+..||++||+|+|+. +|+||||||+|+|++.+..+||+|||+|+...... .
T Consensus 106 elMe-tDL~~iik~~~~L~d~H~q~f~YQiLrgLKyiHSA---nViHRDLKPsNll~n~~c~lKI~DFGLAR~~~~~~~~ 181 (359)
T KOG0660|consen 106 ELME-TDLHQIIKSQQDLTDDHAQYFLYQILRGLKYIHSA---NVIHRDLKPSNLLLNADCDLKICDFGLARYLDKFFED 181 (359)
T ss_pred hHHh-hHHHHHHHcCccccHHHHHHHHHHHHHhcchhhcc---cccccccchhheeeccCCCEEeccccceeeccccCcc
Confidence 9994 59999998888899999999999999999999999 99999999999999999999999999999875431 2
Q ss_pred CccccccccCCccccccccc-CCCCcccceehHHHHHHHHHhcCcCCCcchhhhhhhhHHHH-------HHHhhcccchh
Q 003836 658 HTNTAIRGTKGYVAPEWFRN-MPITVKVDVYSYGVLLLEIICLRRNIDNEISKVDKAILTDW-------AYDRYQERTLE 729 (792)
Q Consensus 658 ~~~~~~~gt~~y~aPE~~~~-~~~~~k~DV~S~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~-------~~~~~~~~~~~ 729 (792)
...+..+-|..|+|||++.. ..||.+.||||.|||+.||++|+..|.......+...+... ...........
T Consensus 182 ~~mTeYVaTRWYRAPElll~~~~Yt~aiDiWSvGCI~AEmL~gkplFpG~d~v~Ql~lI~~~lGtP~~e~l~~i~s~~ar 261 (359)
T KOG0660|consen 182 GFMTEYVATRWYRAPELLLNSSEYTKAIDIWSVGCILAEMLTGKPLFPGKDYVHQLQLILELLGTPSEEDLQKIRSEKAR 261 (359)
T ss_pred cchhcceeeeeecCHHHHhccccccchhhhhhhhHHHHHHHcCCCCCCCCchHHHHHHHHHhcCCCCHHHHHHhccHHHH
Confidence 22355678999999999864 68999999999999999999999988654332221111111 11111111122
Q ss_pred Hhhhchhc-ccCC-----HHHHHHHHHHHHHccccCCCCCCCHHhHHHH--hccCcCCC
Q 003836 730 ALVENDLE-AMNN-----VTMLHRFVMVAFWCIQEDPSHRPTMRKVTQM--LEGVVEVP 780 (792)
Q Consensus 730 ~~~~~~~~-~~~~-----~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~--L~~~~~~~ 780 (792)
..+.+... ...+ +......++++.+||..||.+|+|++|.++. |+..-+..
T Consensus 262 ~yi~slp~~p~~~f~~~fp~a~p~AidLlekmL~fdP~kRita~eAL~hPYl~~~hdp~ 320 (359)
T KOG0660|consen 262 PYIKSLPQIPKQPFSSIFPNANPLAIDLLEKMLVFDPKKRITAEEALAHPYLAPYHDPE 320 (359)
T ss_pred HHHHhCCCCCCCCHHHHcCCCCHHHHHHHHHHhccCccccCCHHHHhcChhhhhhcCCc
Confidence 22221110 0001 1345678999999999999999999999974 44444433
|
|
| >cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-35 Score=309.34 Aligned_cols=246 Identities=28% Similarity=0.417 Sum_probs=202.2
Q ss_pred hhhhhhcCccccceEEEeeecCCCceEEEEEEcccccccchHHHHHHHHHhcccCCCCcccccceeccCCceEEEEEecc
Q 003836 503 RGFKEELGRGAFGTVYKGFVNMGSSNHVAVKKLNSVFQDSEKEFKAEVNGIGQTHHKNLVRLLGYCDEGQNRLLVYEFMS 582 (792)
Q Consensus 503 ~~~~~~lG~G~~g~Vy~g~~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~lV~E~~~ 582 (792)
..+.+.||+|++|.||++... ++.+|+|.+..... ..+++.+|+.++++++|+||+++++++.+....++||||++
T Consensus 8 ~~~~~~ig~g~~g~v~~~~~~---~~~v~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~ 83 (256)
T cd05039 8 LKLGATIGKGEFGDVMLGDYR---GQKVAVKCLKDDST-AAQAFLAEASVMTTLRHPNLVQLLGVVLQGNPLYIVTEYMA 83 (256)
T ss_pred ccceeeeecCCCceEEEEEec---CcEEEEEEeccchh-HHHHHHHHHHHHHhcCCcceeeeEEEEcCCCCeEEEEEecC
Confidence 445678999999999999753 56899999976543 56789999999999999999999999999999999999999
Q ss_pred CCCccccccCCC--CCchhHHHHHHHHHHHHHHHHhhccCCCeEecCCCCCcEEEcCCCCeEEeecCCCccccCCCCCcc
Q 003836 583 NGTVASFLFGDS--KPNWKLRTEIAMGIAGGLFYLHEECCTQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLDQSHTN 660 (792)
Q Consensus 583 ~gsL~~~l~~~~--~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dikp~NILl~~~~~~kl~Dfg~a~~~~~~~~~~~ 660 (792)
+++|.+++.... .+++..+..++.|++.||.|||+. +++|+||||+||++++++.+||+|||.++.......
T Consensus 84 ~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~---~i~H~di~p~Nili~~~~~~~l~d~g~~~~~~~~~~--- 157 (256)
T cd05039 84 KGSLVDYLRSRGRAVITLAQQLGFALDVCEGMEYLEEK---NFVHRDLAARNVLVSEDLVAKVSDFGLAKEASQGQD--- 157 (256)
T ss_pred CCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhC---CccchhcccceEEEeCCCCEEEcccccccccccccc---
Confidence 999999997654 689999999999999999999998 999999999999999999999999999987632211
Q ss_pred ccccccCCcccccccccCCCCcccceehHHHHHHHHHh-cCcCCCcchhhhhhhhHHHHHHHhhcccchhHhhhchhccc
Q 003836 661 TAIRGTKGYVAPEWFRNMPITVKVDVYSYGVLLLEIIC-LRRNIDNEISKVDKAILTDWAYDRYQERTLEALVENDLEAM 739 (792)
Q Consensus 661 ~~~~gt~~y~aPE~~~~~~~~~k~DV~S~Gv~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 739 (792)
....+..|+|||.+....++.++||||||++++|+++ |+.||....... +. .. +.......
T Consensus 158 -~~~~~~~~~ape~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~----~~----~~---------~~~~~~~~ 219 (256)
T cd05039 158 -SGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKD----VV----PH---------VEKGYRME 219 (256)
T ss_pred -cCCCcccccCchhhcCCcCCcHHHHHHHHHHHHHHHhcCCCCCCCCCHHH----HH----HH---------HhcCCCCC
Confidence 2234568999999988899999999999999999997 888886442211 00 00 00111111
Q ss_pred CCHHHHHHHHHHHHHccccCCCCCCCHHhHHHHhccC
Q 003836 740 NNVTMLHRFVMVAFWCIQEDPSHRPTMRKVTQMLEGV 776 (792)
Q Consensus 740 ~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~L~~~ 776 (792)
.+...+..+.+++.+||+.+|++||+++|++++|+.+
T Consensus 220 ~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~~ 256 (256)
T cd05039 220 APEGCPPEVYKVMKDCWELDPAKRPTFKQLREQLALI 256 (256)
T ss_pred CccCCCHHHHHHHHHHhccChhhCcCHHHHHHHHhcC
Confidence 2223457788999999999999999999999999763
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk |
| >cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-35 Score=316.62 Aligned_cols=253 Identities=26% Similarity=0.384 Sum_probs=200.5
Q ss_pred hhhhcCccccceEEEeeecC----CCceEEEEEEcccccc-cchHHHHHHHHHhcccCCCCcccccceeccCCceEEEEE
Q 003836 505 FKEELGRGAFGTVYKGFVNM----GSSNHVAVKKLNSVFQ-DSEKEFKAEVNGIGQTHHKNLVRLLGYCDEGQNRLLVYE 579 (792)
Q Consensus 505 ~~~~lG~G~~g~Vy~g~~~~----~~~~~vavK~~~~~~~-~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~lV~E 579 (792)
+.+.||+|+||.||+|.... .....+++|.+..... ....++.+|+.++++++||||+++++.+...+..++|+|
T Consensus 4 ~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 83 (290)
T cd05045 4 LGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQVNHPHVIKLYGACSQDGPLLLIVE 83 (290)
T ss_pred ccccccCcCCcceEEEEEecCCCCCcceeEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCCcEEEEE
Confidence 45789999999999997532 1224688998875432 234678999999999999999999999999999999999
Q ss_pred eccCCCccccccCC------------------------CCCchhHHHHHHHHHHHHHHHHhhccCCCeEecCCCCCcEEE
Q 003836 580 FMSNGTVASFLFGD------------------------SKPNWKLRTEIAMGIAGGLFYLHEECCTQIIHCDIKPQNILL 635 (792)
Q Consensus 580 ~~~~gsL~~~l~~~------------------------~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dikp~NILl 635 (792)
|+++++|.+++... ..+++..++.++.|++.||+|||+. +|+||||||+|||+
T Consensus 84 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~---~ivH~dikp~nill 160 (290)
T cd05045 84 YAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLAEM---KLVHRDLAARNVLV 160 (290)
T ss_pred ecCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHHHHHHHHHHHC---CeehhhhhhheEEE
Confidence 99999999987532 2467888999999999999999998 99999999999999
Q ss_pred cCCCCeEEeecCCCccccCCCCCc-cccccccCCcccccccccCCCCcccceehHHHHHHHHHh-cCcCCCcchhhhhhh
Q 003836 636 DDHYNARISDFGLAKLLTLDQSHT-NTAIRGTKGYVAPEWFRNMPITVKVDVYSYGVLLLEIIC-LRRNIDNEISKVDKA 713 (792)
Q Consensus 636 ~~~~~~kl~Dfg~a~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~k~DV~S~Gv~l~el~t-g~~p~~~~~~~~~~~ 713 (792)
++++.+||+|||+++......... .....++..|+|||.+.+..++.++||||||++++||++ |+.||.......
T Consensus 161 ~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~--- 237 (290)
T cd05045 161 AEGRKMKISDFGLSRDVYEEDSYVKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIAPER--- 237 (290)
T ss_pred cCCCcEEeccccccccccCccchhcccCCCCCccccCHHHHccCCcchHhHHHHHHHHHHHHHhcCCCCCCCCCHHH---
Confidence 999999999999998654332211 122345678999999988889999999999999999998 888885432110
Q ss_pred hHHHHHHHhhcccchhHhhhchhcccCCHHHHHHHHHHHHHccccCCCCCCCHHhHHHHhccCc
Q 003836 714 ILTDWAYDRYQERTLEALVENDLEAMNNVTMLHRFVMVAFWCIQEDPSHRPTMRKVTQMLEGVV 777 (792)
Q Consensus 714 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~L~~~~ 777 (792)
+...+........+...+.++.+++.+||+.+|++||++.|+++.|++++
T Consensus 238 --------------~~~~~~~~~~~~~~~~~~~~~~~~i~~cl~~~P~~Rp~~~~i~~~l~~~~ 287 (290)
T cd05045 238 --------------LFNLLKTGYRMERPENCSEEMYNLMLTCWKQEPDKRPTFADISKELEKMM 287 (290)
T ss_pred --------------HHHHHhCCCCCCCCCCCCHHHHHHHHHHccCCcccCCCHHHHHHHHHHHH
Confidence 00111111112222334567889999999999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi |
| >KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-37 Score=292.79 Aligned_cols=248 Identities=23% Similarity=0.330 Sum_probs=201.5
Q ss_pred HhhhhhhcCccccceEEEeeecCCCceEEEEEEccc--ccccchHHHHHHHHHhcccCCCCcccccceeccCCceEEEEE
Q 003836 502 TRGFKEELGRGAFGTVYKGFVNMGSSNHVAVKKLNS--VFQDSEKEFKAEVNGIGQTHHKNLVRLLGYCDEGQNRLLVYE 579 (792)
Q Consensus 502 ~~~~~~~lG~G~~g~Vy~g~~~~~~~~~vavK~~~~--~~~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~lV~E 579 (792)
.+.+.++||+|.|+.||+. ++..+++.+|+|++.. ......+++.+|+++-+.|+||||++|.....+....+||+|
T Consensus 12 ~y~l~e~igkG~FSvVrRc-~~~~tg~~fa~kiin~~k~~~~~~e~l~rEarIC~~LqHP~IvrL~~ti~~~~~~ylvFe 90 (355)
T KOG0033|consen 12 NYDVKEELGKGAFSVVRRC-VHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVFD 90 (355)
T ss_pred hhhHHHHHccCchHHHHHH-HhccchHHHHHHHhhhhhhccccHHHHHHHHHHHHhcCCCcEeehhhhhcccceeEEEEe
Confidence 3556789999999999998 4667788888888753 334467889999999999999999999999999999999999
Q ss_pred eccCCCccccccCCCCCchhHHHHHHHHHHHHHHHHhhccCCCeEecCCCCCcEEEcC---CCCeEEeecCCCccccCCC
Q 003836 580 FMSNGTVASFLFGDSKPNWKLRTEIAMGIAGGLFYLHEECCTQIIHCDIKPQNILLDD---HYNARISDFGLAKLLTLDQ 656 (792)
Q Consensus 580 ~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dikp~NILl~~---~~~~kl~Dfg~a~~~~~~~ 656 (792)
+|.+++|..-+-.+...++...-..++||+.+|.|.|.. +|||||+||.|+||.. .--+||+|||+|..+. .
T Consensus 91 ~m~G~dl~~eIV~R~~ySEa~aSH~~rQiLeal~yCH~n---~IvHRDvkP~nllLASK~~~A~vKL~~FGvAi~l~--~ 165 (355)
T KOG0033|consen 91 LVTGGELFEDIVAREFYSEADASHCIQQILEALAYCHSN---GIVHRDLKPENLLLASKAKGAAVKLADFGLAIEVN--D 165 (355)
T ss_pred cccchHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHhc---CceeccCChhheeeeeccCCCceeecccceEEEeC--C
Confidence 999999977665555567778888999999999999999 9999999999999963 3458999999999876 2
Q ss_pred CCccccccccCCcccccccccCCCCcccceehHHHHHHHHHhcCcCCCcchhhhhhhhHHHHHHHhhcccchhHhhhchh
Q 003836 657 SHTNTAIRGTKGYVAPEWFRNMPITVKVDVYSYGVLLLEIICLRRNIDNEISKVDKAILTDWAYDRYQERTLEALVENDL 736 (792)
Q Consensus 657 ~~~~~~~~gt~~y~aPE~~~~~~~~~k~DV~S~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 736 (792)
........|||+|||||++...+|+..+|||+-||+||-|+.|..||..+.... ..++++....
T Consensus 166 g~~~~G~~GtP~fmaPEvvrkdpy~kpvDiW~cGViLfiLL~G~~PF~~~~~~r----------------lye~I~~g~y 229 (355)
T KOG0033|consen 166 GEAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHR----------------LYEQIKAGAY 229 (355)
T ss_pred ccccccccCCCcccCHHHhhcCCCCCcchhhhhhHHHHHHHhCCCCCCCccHHH----------------HHHHHhcccc
Confidence 333345679999999999999999999999999999999999999997643211 1111111111
Q ss_pred c--ccCCHHHHHHHHHHHHHccccCCCCCCCHHhHHH
Q 003836 737 E--AMNNVTMLHRFVMVAFWCIQEDPSHRPTMRKVTQ 771 (792)
Q Consensus 737 ~--~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~ 771 (792)
. ...=....++..+|+.+||..||.+|.|+.|.++
T Consensus 230 d~~~~~w~~is~~Ak~LvrrML~~dP~kRIta~EAL~ 266 (355)
T KOG0033|consen 230 DYPSPEWDTVTPEAKSLIRRMLTVNPKKRITADEALK 266 (355)
T ss_pred CCCCcccCcCCHHHHHHHHHHhccChhhhccHHHHhC
Confidence 1 1111234567789999999999999999999886
|
|
| >cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=315.31 Aligned_cols=270 Identities=24% Similarity=0.358 Sum_probs=203.4
Q ss_pred HhhhhhhcCccccceEEEeeec---CCCceEEEEEEccccc-ccchHHHHHHHHHhcccCCCCcccccceeccC--CceE
Q 003836 502 TRGFKEELGRGAFGTVYKGFVN---MGSSNHVAVKKLNSVF-QDSEKEFKAEVNGIGQTHHKNLVRLLGYCDEG--QNRL 575 (792)
Q Consensus 502 ~~~~~~~lG~G~~g~Vy~g~~~---~~~~~~vavK~~~~~~-~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~--~~~~ 575 (792)
++...++||+|+||.||++..+ ..+++.+|+|.++... ......+.+|++++++++|+||+++++++... ...+
T Consensus 5 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 84 (284)
T cd05079 5 FLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGIK 84 (284)
T ss_pred hhhhceecCCCCceeEEEEEEccCCCCccceEEEEEcCccccHHHHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCCceE
Confidence 3445578999999999998753 3456789999987543 33346799999999999999999999998765 5688
Q ss_pred EEEEeccCCCccccccCC-CCCchhHHHHHHHHHHHHHHHHhhccCCCeEecCCCCCcEEEcCCCCeEEeecCCCccccC
Q 003836 576 LVYEFMSNGTVASFLFGD-SKPNWKLRTEIAMGIAGGLFYLHEECCTQIIHCDIKPQNILLDDHYNARISDFGLAKLLTL 654 (792)
Q Consensus 576 lV~E~~~~gsL~~~l~~~-~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dikp~NILl~~~~~~kl~Dfg~a~~~~~ 654 (792)
+||||+++++|.+++.+. ..+++..+..++.||+.||+|||+. +++||||||+||+++.++.+||+|||+++....
T Consensus 85 lv~e~~~g~~L~~~l~~~~~~~~~~~~~~i~~~i~~aL~~lH~~---gi~H~dlkp~Nil~~~~~~~~l~dfg~~~~~~~ 161 (284)
T cd05079 85 LIMEFLPSGSLKEYLPRNKNKINLKQQLKYAVQICKGMDYLGSR---QYVHRDLAARNVLVESEHQVKIGDFGLTKAIET 161 (284)
T ss_pred EEEEccCCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecccchheEEEcCCCCEEECCCcccccccc
Confidence 999999999999999654 4689999999999999999999998 999999999999999999999999999987654
Q ss_pred CCCC--ccccccccCCcccccccccCCCCcccceehHHHHHHHHHhcCcCCCcchhhhhhhhHHHHHHHhhcccchhHhh
Q 003836 655 DQSH--TNTAIRGTKGYVAPEWFRNMPITVKVDVYSYGVLLLEIICLRRNIDNEISKVDKAILTDWAYDRYQERTLEALV 732 (792)
Q Consensus 655 ~~~~--~~~~~~gt~~y~aPE~~~~~~~~~k~DV~S~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 732 (792)
.... ......++..|+|||.+.+..++.++||||||+++|||++++.|............... ............+
T Consensus 162 ~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~ellt~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~ 239 (284)
T cd05079 162 DKEYYTVKDDLDSPVFWYAPECLIQSKFYIASDVWSFGVTLYELLTYCDSESSPMTLFLKMIGPT--HGQMTVTRLVRVL 239 (284)
T ss_pred CccceeecCCCCCCccccCHHHhccCCCCccccchhhhhhhhhhhcCCCCCccccchhhhhcccc--cccccHHHHHHHH
Confidence 3321 11234467789999999888999999999999999999998776533211100000000 0000000000111
Q ss_pred hchhcccCCHHHHHHHHHHHHHccccCCCCCCCHHhHHHHhccC
Q 003836 733 ENDLEAMNNVTMLHRFVMVAFWCIQEDPSHRPTMRKVTQMLEGV 776 (792)
Q Consensus 733 ~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~L~~~ 776 (792)
........+...+..+.+++.+||+.+|++||+++++++.|+.+
T Consensus 240 ~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~~~ 283 (284)
T cd05079 240 EEGKRLPRPPNCPEEVYQLMRKCWEFQPSKRTTFQNLIEGFEAI 283 (284)
T ss_pred HcCccCCCCCCCCHHHHHHHHHHccCCcccCcCHHHHHHHHHhh
Confidence 11111112233567899999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a |
| >cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-36 Score=319.02 Aligned_cols=262 Identities=24% Similarity=0.344 Sum_probs=205.4
Q ss_pred HHHhhhhhhcCccccceEEEeeec------CCCceEEEEEEccccc-ccchHHHHHHHHHhccc-CCCCcccccceeccC
Q 003836 500 EVTRGFKEELGRGAFGTVYKGFVN------MGSSNHVAVKKLNSVF-QDSEKEFKAEVNGIGQT-HHKNLVRLLGYCDEG 571 (792)
Q Consensus 500 ~~~~~~~~~lG~G~~g~Vy~g~~~------~~~~~~vavK~~~~~~-~~~~~~~~~Ei~~l~~l-~h~niv~l~g~~~~~ 571 (792)
...+.+.+.||+|+||.||++... ......+|+|.+.... .....++.+|+.+++++ +|+||+++++++...
T Consensus 14 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~ 93 (304)
T cd05101 14 RDKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQD 93 (304)
T ss_pred HHHeeecceeeccCCceEEEEEEeccCCCCCCcceeEEeeecccccchHHHHHHHHHHHHHHhhccCCCchheeEEEecC
Confidence 344456688999999999999642 1223579999987532 33456789999999999 899999999999999
Q ss_pred CceEEEEEeccCCCccccccCC----------------CCCchhHHHHHHHHHHHHHHHHhhccCCCeEecCCCCCcEEE
Q 003836 572 QNRLLVYEFMSNGTVASFLFGD----------------SKPNWKLRTEIAMGIAGGLFYLHEECCTQIIHCDIKPQNILL 635 (792)
Q Consensus 572 ~~~~lV~E~~~~gsL~~~l~~~----------------~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dikp~NILl 635 (792)
...++||||+++|+|.+++... ..+++..+..++.||++||.|||+. +|+||||||+|||+
T Consensus 94 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~---givH~dlkp~Nili 170 (304)
T cd05101 94 GPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLASQ---KCIHRDLAARNVLV 170 (304)
T ss_pred CceEEEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHHHHC---CeeecccccceEEE
Confidence 9999999999999999998653 2467788999999999999999998 99999999999999
Q ss_pred cCCCCeEEeecCCCccccCCCCCc-cccccccCCcccccccccCCCCcccceehHHHHHHHHHh-cCcCCCcchhhhhhh
Q 003836 636 DDHYNARISDFGLAKLLTLDQSHT-NTAIRGTKGYVAPEWFRNMPITVKVDVYSYGVLLLEIIC-LRRNIDNEISKVDKA 713 (792)
Q Consensus 636 ~~~~~~kl~Dfg~a~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~k~DV~S~Gv~l~el~t-g~~p~~~~~~~~~~~ 713 (792)
++++.+||+|||+++......... .....+++.|+|||.+.+..++.++||||||+++|||++ |..|+........
T Consensus 171 ~~~~~~kl~D~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~-- 248 (304)
T cd05101 171 TENNVMKIADFGLARDVNNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEEL-- 248 (304)
T ss_pred cCCCcEEECCCccceecccccccccccCCCCCceeeCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCCHHHH--
Confidence 999999999999998764332221 222345678999999998889999999999999999998 6777754321100
Q ss_pred hHHHHHHHhhcccchhHhhhchhcccCCHHHHHHHHHHHHHccccCCCCCCCHHhHHHHhccCcCCCC
Q 003836 714 ILTDWAYDRYQERTLEALVENDLEAMNNVTMLHRFVMVAFWCIQEDPSHRPTMRKVTQMLEGVVEVPI 781 (792)
Q Consensus 714 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~L~~~~~~~~ 781 (792)
. . .+........+...+..+.+++.+||+.+|++||++.|+++.|++++.+..
T Consensus 249 -----~-~---------~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~e~l~~l~~~~~~~~ 301 (304)
T cd05101 249 -----F-K---------LLKEGHRMDKPANCTNELYMMMRDCWHAIPSHRPTFKQLVEDLDRILTLTT 301 (304)
T ss_pred -----H-H---------HHHcCCcCCCCCCCCHHHHHHHHHHcccChhhCCCHHHHHHHHHHHHHhhh
Confidence 0 0 011111111122345678899999999999999999999999998876654
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >KOG0589 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-36 Score=318.49 Aligned_cols=248 Identities=22% Similarity=0.325 Sum_probs=207.6
Q ss_pred hhhhhhcCccccceEEEeeecCCCceEEEEEEcccc--cccchHHHHHHHHHhcccCCCCcccccceeccCCc-eEEEEE
Q 003836 503 RGFKEELGRGAFGTVYKGFVNMGSSNHVAVKKLNSV--FQDSEKEFKAEVNGIGQTHHKNLVRLLGYCDEGQN-RLLVYE 579 (792)
Q Consensus 503 ~~~~~~lG~G~~g~Vy~g~~~~~~~~~vavK~~~~~--~~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~-~~lV~E 579 (792)
|...+++|+|+||.++..... .+...+++|++.-. ........++|+.++++++|||||.+.+.+.+++. .+|||+
T Consensus 6 Ye~~~~iG~GafG~a~lvrhk-~~~~~~vlK~I~l~~~t~~~r~~A~~E~~lis~~~hP~iv~y~ds~~~~~~~l~Ivm~ 84 (426)
T KOG0589|consen 6 YEVLRQVGRGAFGSALLVRHK-SDDKLYVLKKINLEKLTEPERRSAIQEMDLLSKLLHPNIVEYKDSFEEDGQLLCIVME 84 (426)
T ss_pred hhhhhhcCccccchhhhhhhc-cCCceEEEEEEeccccCchhhHHHHHHHHHHHhccCCCeeeeccchhcCCceEEEEEe
Confidence 455688999999999998654 44568999987643 23334578999999999999999999999999988 899999
Q ss_pred eccCCCccccccCCC--CCchhHHHHHHHHHHHHHHHHhhccCCCeEecCCCCCcEEEcCCCCeEEeecCCCccccCCCC
Q 003836 580 FMSNGTVASFLFGDS--KPNWKLRTEIAMGIAGGLFYLHEECCTQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLDQS 657 (792)
Q Consensus 580 ~~~~gsL~~~l~~~~--~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dikp~NILl~~~~~~kl~Dfg~a~~~~~~~~ 657 (792)
|++||+|.+.+...+ .++++.+.+++.|++.|+.|||++ .|+|||||+.||+++.+..+||.|||+|+.+..+..
T Consensus 85 Y~eGg~l~~~i~~~k~~~f~E~~i~~~~~Q~~~av~ylH~~---~iLHRDlK~~Nifltk~~~VkLgDfGlaK~l~~~~~ 161 (426)
T KOG0589|consen 85 YCEGGDLAQLIKEQKGVLFPEERILKWFVQILLAVNYLHEN---RVLHRDLKCANIFLTKDKKVKLGDFGLAKILNPEDS 161 (426)
T ss_pred ecCCCCHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHhh---hhhcccchhhhhhccccCceeecchhhhhhcCCchh
Confidence 999999999997653 578999999999999999999988 999999999999999999999999999999875542
Q ss_pred CccccccccCCcccccccccCCCCcccceehHHHHHHHHHhcCcCCCcchhhhhhhhHHHHHHHhhcccchhHhhhchhc
Q 003836 658 HTNTAIRGTKGYVAPEWFRNMPITVKVDVYSYGVLLLEIICLRRNIDNEISKVDKAILTDWAYDRYQERTLEALVENDLE 737 (792)
Q Consensus 658 ~~~~~~~gt~~y~aPE~~~~~~~~~k~DV~S~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 737 (792)
....+.||+.||.||.+.+.+|..|+|||||||++|||++-+.+|.......- +..+. +...
T Consensus 162 -~a~tvvGTp~YmcPEil~d~pYn~KSDiWsLGC~~yEm~~lk~aF~a~~m~~L----------------i~ki~-~~~~ 223 (426)
T KOG0589|consen 162 -LASTVVGTPYYMCPEILSDIPYNEKSDIWSLGCCLYEMCTLKPAFKASNMSEL----------------ILKIN-RGLY 223 (426)
T ss_pred -hhheecCCCcccCHHHhCCCCCCccCcchhhcchHHHHHhcccccCccchHHH----------------HHHHh-hccC
Confidence 34457799999999999999999999999999999999999999975432210 00111 1112
Q ss_pred ccCCHHHHHHHHHHHHHccccCCCCCCCHHhHHHH
Q 003836 738 AMNNVTMLHRFVMVAFWCIQEDPSHRPTMRKVTQM 772 (792)
Q Consensus 738 ~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~ 772 (792)
...+...+.++..++..|++.+|..||++.+++.+
T Consensus 224 ~Plp~~ys~el~~lv~~~l~~~P~~RPsa~~LL~~ 258 (426)
T KOG0589|consen 224 SPLPSMYSSELRSLVKSMLRKNPEHRPSALELLRR 258 (426)
T ss_pred CCCCccccHHHHHHHHHHhhcCCccCCCHHHHhhC
Confidence 33455678889999999999999999999999875
|
|
| >cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-36 Score=329.92 Aligned_cols=249 Identities=22% Similarity=0.271 Sum_probs=195.3
Q ss_pred hhhhcCccccceEEEeeecCCCceEEEEEEccccc---ccchHHHHHHHHHhcccCCCCcccccceeccCCceEEEEEec
Q 003836 505 FKEELGRGAFGTVYKGFVNMGSSNHVAVKKLNSVF---QDSEKEFKAEVNGIGQTHHKNLVRLLGYCDEGQNRLLVYEFM 581 (792)
Q Consensus 505 ~~~~lG~G~~g~Vy~g~~~~~~~~~vavK~~~~~~---~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~lV~E~~ 581 (792)
+.+.||+|+||+||++... .+++.||||++.+.. ....+.+.+|++++++++||||+++++++.+....++||||+
T Consensus 5 ~~~~lG~G~~g~Vy~~~~~-~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~E~~ 83 (377)
T cd05629 5 TVKVIGKGAFGEVRLVQKK-DTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDSPWVVSLYYSFQDAQYLYLIMEFL 83 (377)
T ss_pred EeEEEeecCCEEEEEEEEC-CCCCEEEEEEEEHHHHHHhHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCeeEEEEeCC
Confidence 4578999999999999654 456789999986532 233467889999999999999999999999999999999999
Q ss_pred cCCCccccccCCCCCchhHHHHHHHHHHHHHHHHhhccCCCeEecCCCCCcEEEcCCCCeEEeecCCCccccCCCCC---
Q 003836 582 SNGTVASFLFGDSKPNWKLRTEIAMGIAGGLFYLHEECCTQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLDQSH--- 658 (792)
Q Consensus 582 ~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dikp~NILl~~~~~~kl~Dfg~a~~~~~~~~~--- 658 (792)
++|+|.+++.....+++.....++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++.+......
T Consensus 84 ~gg~L~~~l~~~~~~~~~~~~~~~~ql~~aL~~LH~~---givHrDlkp~NIll~~~~~~kl~DfGla~~~~~~~~~~~~ 160 (377)
T cd05629 84 PGGDLMTMLIKYDTFSEDVTRFYMAECVLAIEAVHKL---GFIHRDIKPDNILIDRGGHIKLSDFGLSTGFHKQHDSAYY 160 (377)
T ss_pred CCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHEEECCCCCEEEeecccccccccccccccc
Confidence 9999999998878889999999999999999999998 9999999999999999999999999999643211000
Q ss_pred -------------------------------------------ccccccccCCcccccccccCCCCcccceehHHHHHHH
Q 003836 659 -------------------------------------------TNTAIRGTKGYVAPEWFRNMPITVKVDVYSYGVLLLE 695 (792)
Q Consensus 659 -------------------------------------------~~~~~~gt~~y~aPE~~~~~~~~~k~DV~S~Gv~l~e 695 (792)
......||+.|+|||.+.+..++.++|||||||++||
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~e 240 (377)
T cd05629 161 QKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGYGQECDWWSLGAIMFE 240 (377)
T ss_pred cccccccccccccccccccccccccccccchhhhhhhhhcccccccccCCCccccCHHHHccCCCCCceeeEecchhhhh
Confidence 0012458999999999999999999999999999999
Q ss_pred HHhcCcCCCcchhhhhhhhHHHHHHHhhcccchhHhhhchhcccCCHHHHHHHHHHHHHccccCCCCC---CCHHhHHHH
Q 003836 696 IICLRRNIDNEISKVDKAILTDWAYDRYQERTLEALVENDLEAMNNVTMLHRFVMVAFWCIQEDPSHR---PTMRKVTQM 772 (792)
Q Consensus 696 l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~R---Ps~~evl~~ 772 (792)
|++|+.||...........+..+ . ..+........+.++.+++.+||+ +|.+| |++.|+++.
T Consensus 241 lltG~~Pf~~~~~~~~~~~i~~~-----~---------~~~~~p~~~~~s~~~~dli~~lL~-~~~~r~~r~~~~~~l~h 305 (377)
T cd05629 241 CLIGWPPFCSENSHETYRKIINW-----R---------ETLYFPDDIHLSVEAEDLIRRLIT-NAENRLGRGGAHEIKSH 305 (377)
T ss_pred hhcCCCCCCCCCHHHHHHHHHcc-----C---------CccCCCCCCCCCHHHHHHHHHHhc-CHhhcCCCCCHHHHhcC
Confidence 99999999654321110000000 0 000000111234567889999997 67765 599998875
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of |
| >cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-36 Score=331.57 Aligned_cols=250 Identities=20% Similarity=0.259 Sum_probs=195.7
Q ss_pred hhhhhcCccccceEEEeeecCCCceEEEEEEccccc---ccchHHHHHHHHHhcccCCCCcccccceeccCCceEEEEEe
Q 003836 504 GFKEELGRGAFGTVYKGFVNMGSSNHVAVKKLNSVF---QDSEKEFKAEVNGIGQTHHKNLVRLLGYCDEGQNRLLVYEF 580 (792)
Q Consensus 504 ~~~~~lG~G~~g~Vy~g~~~~~~~~~vavK~~~~~~---~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~lV~E~ 580 (792)
.+.+.||+|+||.||++... .+++.+|+|++.+.. ......+.+|++++++++|+||+++++.+.+++..++||||
T Consensus 4 ~~~~~lG~G~~g~V~~a~~~-~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~E~ 82 (376)
T cd05598 4 VKIKTIGIGAFGEVCLVRKV-DTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVMDY 82 (376)
T ss_pred eEEEEEEeCCCeEEEEEEEC-CCCCEEEEEEEcHHHHHhhhhHHHHHHHHHHHHhCCCCCcceEEEEEEcCCEEEEEEeC
Confidence 34578999999999999754 457899999986532 22346688999999999999999999999999999999999
Q ss_pred ccCCCccccccCCCCCchhHHHHHHHHHHHHHHHHhhccCCCeEecCCCCCcEEEcCCCCeEEeecCCCccccCCC----
Q 003836 581 MSNGTVASFLFGDSKPNWKLRTEIAMGIAGGLFYLHEECCTQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLDQ---- 656 (792)
Q Consensus 581 ~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dikp~NILl~~~~~~kl~Dfg~a~~~~~~~---- 656 (792)
+++|+|.+++.....+++.....++.||+.||+|||+. +|+||||||+|||++.++.+||+|||++..+....
T Consensus 83 ~~~g~L~~~i~~~~~~~~~~~~~~~~qi~~al~~lH~~---~ivHrDlkp~Nill~~~~~ikL~DFG~a~~~~~~~~~~~ 159 (376)
T cd05598 83 IPGGDMMSLLIRLGIFEEDLARFYIAELTCAIESVHKM---GFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKY 159 (376)
T ss_pred CCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---CeEeCCCCHHHEEECCCCCEEEEeCCCCccccccccccc
Confidence 99999999998878888999999999999999999998 99999999999999999999999999985331100
Q ss_pred --------------------------------------CCccccccccCCcccccccccCCCCcccceehHHHHHHHHHh
Q 003836 657 --------------------------------------SHTNTAIRGTKGYVAPEWFRNMPITVKVDVYSYGVLLLEIIC 698 (792)
Q Consensus 657 --------------------------------------~~~~~~~~gt~~y~aPE~~~~~~~~~k~DV~S~Gv~l~el~t 698 (792)
........||+.|+|||++.+..++.++|||||||++|||++
T Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyell~ 239 (376)
T cd05598 160 YQKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILYEMLV 239 (376)
T ss_pred cccccccccccccccccccccccccccchhhhhhhhcccccccccCCCccccCHHHHcCCCCCcceeeeeccceeeehhh
Confidence 000123469999999999999999999999999999999999
Q ss_pred cCcCCCcchhhhhhhhHHHHHHHhhcccchhHhhhchhcccCCHHHHHHHHHHHHHccccCCCCCC---CHHhHHHH
Q 003836 699 LRRNIDNEISKVDKAILTDWAYDRYQERTLEALVENDLEAMNNVTMLHRFVMVAFWCIQEDPSHRP---TMRKVTQM 772 (792)
Q Consensus 699 g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RP---s~~evl~~ 772 (792)
|+.||...........+.. +. ...........+..+.+++.+|+ .+|.+|+ ++.|+++.
T Consensus 240 G~~Pf~~~~~~~~~~~i~~-----~~---------~~~~~~~~~~~s~~~~~li~~l~-~~p~~R~~~~t~~ell~h 301 (376)
T cd05598 240 GQPPFLADTPAETQLKVIN-----WE---------TTLHIPSQAKLSREASDLILRLC-CGAEDRLGKNGADEIKAH 301 (376)
T ss_pred CCCCCCCCCHHHHHHHHhc-----cC---------ccccCCCCCCCCHHHHHHHHHHh-cCHhhcCCCCCHHHHhCC
Confidence 9999975432211110000 00 00001111123455667777766 4999999 88988865
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. |
| >cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-35 Score=311.35 Aligned_cols=254 Identities=24% Similarity=0.410 Sum_probs=202.2
Q ss_pred hhhhhhcCccccceEEEeeecCC--CceEEEEEEccccc-ccchHHHHHHHHHhcccCCCCcccccceeccCCceEEEEE
Q 003836 503 RGFKEELGRGAFGTVYKGFVNMG--SSNHVAVKKLNSVF-QDSEKEFKAEVNGIGQTHHKNLVRLLGYCDEGQNRLLVYE 579 (792)
Q Consensus 503 ~~~~~~lG~G~~g~Vy~g~~~~~--~~~~vavK~~~~~~-~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~lV~E 579 (792)
+.+.+.||+|+||.||+|..... ....+|+|.++... ....+.+.+|+.++++++||||+++++++.+++..++|||
T Consensus 6 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 85 (267)
T cd05066 6 IKIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSKPVMIVTE 85 (267)
T ss_pred eEeeeeecccCCCceEEEEEecCCCCceEEEEEECCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccEEEEE
Confidence 34567899999999999976432 23479999987533 2345688999999999999999999999999999999999
Q ss_pred eccCCCccccccCC-CCCchhHHHHHHHHHHHHHHHHhhccCCCeEecCCCCCcEEEcCCCCeEEeecCCCccccCCCCC
Q 003836 580 FMSNGTVASFLFGD-SKPNWKLRTEIAMGIAGGLFYLHEECCTQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLDQSH 658 (792)
Q Consensus 580 ~~~~gsL~~~l~~~-~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dikp~NILl~~~~~~kl~Dfg~a~~~~~~~~~ 658 (792)
|+++++|.+++... ..+++.++..++.|++.||+|||+. +++|+||||+|||++.++.+||+|||+++........
T Consensus 86 ~~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~---~i~h~dlkp~nili~~~~~~~l~dfg~~~~~~~~~~~ 162 (267)
T cd05066 86 YMENGSLDAFLRKHDGQFTVIQLVGMLRGIASGMKYLSDM---GYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEA 162 (267)
T ss_pred cCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC---CEeehhhchhcEEECCCCeEEeCCCCcccccccccce
Confidence 99999999999765 4678999999999999999999998 9999999999999999999999999999876543322
Q ss_pred ccc--cccccCCcccccccccCCCCcccceehHHHHHHHHHh-cCcCCCcchhhhhhhhHHHHHHHhhcccchhHhhhch
Q 003836 659 TNT--AIRGTKGYVAPEWFRNMPITVKVDVYSYGVLLLEIIC-LRRNIDNEISKVDKAILTDWAYDRYQERTLEALVEND 735 (792)
Q Consensus 659 ~~~--~~~gt~~y~aPE~~~~~~~~~k~DV~S~Gv~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 735 (792)
... ...++..|+|||.+.+..++.++||||||+++||+++ |+.||........ . .... ..
T Consensus 163 ~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~ell~~g~~p~~~~~~~~~---~-----~~~~---------~~ 225 (267)
T cd05066 163 AYTTRGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWEMSNQDV---I-----KAIE---------EG 225 (267)
T ss_pred eeecCCCccceeecCHhHhccCccCchhhhHHHHHHHHHHhcCCCCCcccCCHHHH---H-----HHHh---------CC
Confidence 211 1223568999999998899999999999999999886 9999865322110 0 0000 00
Q ss_pred hcccCCHHHHHHHHHHHHHccccCCCCCCCHHhHHHHhccC
Q 003836 736 LEAMNNVTMLHRFVMVAFWCIQEDPSHRPTMRKVTQMLEGV 776 (792)
Q Consensus 736 ~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~L~~~ 776 (792)
.....+...+..+.+++.+|++.+|.+||+|.++++.|+++
T Consensus 226 ~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~ 266 (267)
T cd05066 226 YRLPAPMDCPAALHQLMLDCWQKDRNERPKFEQIVSILDKL 266 (267)
T ss_pred CcCCCCCCCCHHHHHHHHHHcccCchhCCCHHHHHHHHHhh
Confidence 11111223456788999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul |
| >cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-35 Score=308.53 Aligned_cols=249 Identities=28% Similarity=0.417 Sum_probs=198.7
Q ss_pred hhhhhhcCccccceEEEeeecCCCceEEEEEEcccccccchHHHHHHHHHhcccCCCCcccccceeccCCceEEEEEecc
Q 003836 503 RGFKEELGRGAFGTVYKGFVNMGSSNHVAVKKLNSVFQDSEKEFKAEVNGIGQTHHKNLVRLLGYCDEGQNRLLVYEFMS 582 (792)
Q Consensus 503 ~~~~~~lG~G~~g~Vy~g~~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~lV~E~~~ 582 (792)
+.+.+.||+|++|.||++.... ...+|+|++.... ...+.+.+|++++++++|+|++++++++.. +..++||||++
T Consensus 8 ~~~~~~ig~g~~~~v~~~~~~~--~~~~~lK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-~~~~~v~e~~~ 83 (260)
T cd05069 8 LRLDVKLGQGCFGEVWMGTWNG--TTKVAIKTLKPGT-MMPEAFLQEAQIMKKLRHDKLVPLYAVVSE-EPIYIVTEFMG 83 (260)
T ss_pred eeeeeeecCcCCCeEEEEEEcC--CceEEEEEcccCC-ccHHHHHHHHHHHHhCCCCCeeeEEEEEcC-CCcEEEEEcCC
Confidence 4556789999999999997643 2469999886532 345678999999999999999999998854 56789999999
Q ss_pred CCCccccccCC--CCCchhHHHHHHHHHHHHHHHHhhccCCCeEecCCCCCcEEEcCCCCeEEeecCCCccccCCCCCcc
Q 003836 583 NGTVASFLFGD--SKPNWKLRTEIAMGIAGGLFYLHEECCTQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLDQSHTN 660 (792)
Q Consensus 583 ~gsL~~~l~~~--~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dikp~NILl~~~~~~kl~Dfg~a~~~~~~~~~~~ 660 (792)
+++|.+++... ..+++..+..++.|++.||+|||+. +++|+||||+||++++++.+||+|||+++..........
T Consensus 84 ~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~---~i~H~dl~~~Nill~~~~~~~l~dfg~~~~~~~~~~~~~ 160 (260)
T cd05069 84 KGSLLDFLKEGDGKYLKLPQLVDMAAQIADGMAYIERM---NYIHRDLRAANILVGDNLVCKIADFGLARLIEDNEYTAR 160 (260)
T ss_pred CCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhC---CEeecccCcceEEEcCCCeEEECCCccceEccCCccccc
Confidence 99999999754 3478999999999999999999998 999999999999999999999999999987643332222
Q ss_pred ccccccCCcccccccccCCCCcccceehHHHHHHHHHh-cCcCCCcchhhhhhhhHHHHHHHhhcccchhHhhhchhccc
Q 003836 661 TAIRGTKGYVAPEWFRNMPITVKVDVYSYGVLLLEIIC-LRRNIDNEISKVDKAILTDWAYDRYQERTLEALVENDLEAM 739 (792)
Q Consensus 661 ~~~~gt~~y~aPE~~~~~~~~~k~DV~S~Gv~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 739 (792)
....++..|+|||.+.+..++.++||||||+++|||++ |+.||........ . . . +.......
T Consensus 161 ~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~---~-~----~---------~~~~~~~~ 223 (260)
T cd05069 161 QGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMVNREV---L-E----Q---------VERGYRMP 223 (260)
T ss_pred CCCccchhhCCHHHhccCCcChHHHHHHHHHHHHHHHhCCCCCCCCCCHHHH---H-H----H---------HHcCCCCC
Confidence 23345778999999988899999999999999999999 8888865432110 0 0 0 00011111
Q ss_pred CCHHHHHHHHHHHHHccccCCCCCCCHHhHHHHhcc
Q 003836 740 NNVTMLHRFVMVAFWCIQEDPSHRPTMRKVTQMLEG 775 (792)
Q Consensus 740 ~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~L~~ 775 (792)
.+...+..+.+++.+||+.+|++||++++|++.|+.
T Consensus 224 ~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~ 259 (260)
T cd05069 224 CPQGCPESLHELMKLCWKKDPDERPTFEYIQSFLED 259 (260)
T ss_pred CCcccCHHHHHHHHHHccCCcccCcCHHHHHHHHhc
Confidence 223455678899999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an |
| >cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-35 Score=309.32 Aligned_cols=248 Identities=22% Similarity=0.284 Sum_probs=200.9
Q ss_pred hhhhcCccccceEEEeeecCCCceEEEEEEcccccc-----cchHHHHHHHHHhcccCCCCcccccceeccCCceEEEEE
Q 003836 505 FKEELGRGAFGTVYKGFVNMGSSNHVAVKKLNSVFQ-----DSEKEFKAEVNGIGQTHHKNLVRLLGYCDEGQNRLLVYE 579 (792)
Q Consensus 505 ~~~~lG~G~~g~Vy~g~~~~~~~~~vavK~~~~~~~-----~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~lV~E 579 (792)
..+.||+|++|.||++... .+++.+++|.+..... ...+.+.+|++++++++||||+++++++.+.+..++|+|
T Consensus 6 ~~~~lg~g~~~~vy~~~~~-~~~~~~~lk~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e 84 (263)
T cd06625 6 RGKLLGQGAFGRVYLCYDV-DTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQYYGCLRDDETLSIFME 84 (263)
T ss_pred ccceecCCCceEEEEEEEc-CCCcEEEEEEEeecccchhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEccCCeEEEEEE
Confidence 4578999999999999653 4567899998764321 123568899999999999999999999999999999999
Q ss_pred eccCCCccccccCCCCCchhHHHHHHHHHHHHHHHHhhccCCCeEecCCCCCcEEEcCCCCeEEeecCCCccccCCCCCc
Q 003836 580 FMSNGTVASFLFGDSKPNWKLRTEIAMGIAGGLFYLHEECCTQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLDQSHT 659 (792)
Q Consensus 580 ~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dikp~NILl~~~~~~kl~Dfg~a~~~~~~~~~~ 659 (792)
|+++++|.+++.....+++....+++.|++.||.|||+. +|+|+||+|+||++++++.++|+|||+++.........
T Consensus 85 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~---~i~H~dl~p~nilv~~~~~~~l~dfg~~~~~~~~~~~~ 161 (263)
T cd06625 85 YMPGGSVKDQLKAYGALTETVTRKYTRQILEGVEYLHSN---MIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICSSG 161 (263)
T ss_pred ECCCCcHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEeecccceecccccccc
Confidence 999999999998777889999999999999999999998 99999999999999999999999999998654322221
Q ss_pred c--ccccccCCcccccccccCCCCcccceehHHHHHHHHHhcCcCCCcchhhhhhhhHHHHHHHhhcccchhHhhhchhc
Q 003836 660 N--TAIRGTKGYVAPEWFRNMPITVKVDVYSYGVLLLEIICLRRNIDNEISKVDKAILTDWAYDRYQERTLEALVENDLE 737 (792)
Q Consensus 660 ~--~~~~gt~~y~aPE~~~~~~~~~k~DV~S~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 737 (792)
. ....++..|+|||.+.+..++.++||||||+++|||++|+.||......... .........
T Consensus 162 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~----------------~~~~~~~~~ 225 (263)
T cd06625 162 TGMKSVTGTPYWMSPEVISGEGYGRKADVWSVGCTVVEMLTEKPPWAEFEAMAAI----------------FKIATQPTN 225 (263)
T ss_pred ccccCCCcCccccCcceeccCCCCchhhhHHHHHHHHHHHhCCCCccccchHHHH----------------HHHhccCCC
Confidence 1 2345788999999999988999999999999999999999998653221100 000111111
Q ss_pred ccCCHHHHHHHHHHHHHccccCCCCCCCHHhHHHH
Q 003836 738 AMNNVTMLHRFVMVAFWCIQEDPSHRPTMRKVTQM 772 (792)
Q Consensus 738 ~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~ 772 (792)
...+......+.+++.+||+.+|.+||++.|+++.
T Consensus 226 ~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~ 260 (263)
T cd06625 226 PQLPSHVSPDARNFLRRTFVENAKKRPSAEELLRH 260 (263)
T ss_pred CCCCccCCHHHHHHHHHHhhcCcccCCCHHHHhhC
Confidence 22233455678899999999999999999999873
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t |
| >cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-35 Score=310.97 Aligned_cols=254 Identities=20% Similarity=0.354 Sum_probs=202.4
Q ss_pred hhhhhcCccccceEEEeeecCCCceEEEEEEccccc---ccchHHHHHHHHHhcccCCCCcccccceeccCCceEEEEEe
Q 003836 504 GFKEELGRGAFGTVYKGFVNMGSSNHVAVKKLNSVF---QDSEKEFKAEVNGIGQTHHKNLVRLLGYCDEGQNRLLVYEF 580 (792)
Q Consensus 504 ~~~~~lG~G~~g~Vy~g~~~~~~~~~vavK~~~~~~---~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~lV~E~ 580 (792)
.+.++||+|+||.||+|... .+++.+|||++.... ......+.+|++++++++||||+++++++.+.+..++|+||
T Consensus 5 ~i~~~l~~g~~~~v~~~~~~-~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 83 (267)
T cd08228 5 QIEKKIGRGQFSEVYRATCL-LDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNVIKYLDSFIEDNELNIVLEL 83 (267)
T ss_pred eeeeeeccCCCeeEEEEEEe-CCCCEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCcceeeeeeeEEECCeEEEEEEe
Confidence 35578999999999999754 356789999875422 23345788999999999999999999999999999999999
Q ss_pred ccCCCccccccC----CCCCchhHHHHHHHHHHHHHHHHhhccCCCeEecCCCCCcEEEcCCCCeEEeecCCCccccCCC
Q 003836 581 MSNGTVASFLFG----DSKPNWKLRTEIAMGIAGGLFYLHEECCTQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLDQ 656 (792)
Q Consensus 581 ~~~gsL~~~l~~----~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dikp~NILl~~~~~~kl~Dfg~a~~~~~~~ 656 (792)
+++++|.+++.. ...+++..+..++.||++||+|||+. +++|+||||+||+++.++.++|+|||+++......
T Consensus 84 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~dl~~~nil~~~~~~~~l~d~g~~~~~~~~~ 160 (267)
T cd08228 84 ADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMHSR---RVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKT 160 (267)
T ss_pred cCCCcHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhC---CeeCCCCCHHHEEEcCCCCEEECccccceeccchh
Confidence 999999988753 24578889999999999999999998 99999999999999999999999999998764322
Q ss_pred CCccccccccCCcccccccccCCCCcccceehHHHHHHHHHhcCcCCCcchhhhhhhhHHHHHHHhhcccchhHhhhchh
Q 003836 657 SHTNTAIRGTKGYVAPEWFRNMPITVKVDVYSYGVLLLEIICLRRNIDNEISKVDKAILTDWAYDRYQERTLEALVENDL 736 (792)
Q Consensus 657 ~~~~~~~~gt~~y~aPE~~~~~~~~~k~DV~S~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 736 (792)
. ......+++.|+|||.+.+..++.++||||||+++|||++|+.||......... +. .. +.....
T Consensus 161 ~-~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~~-----~~-~~--------~~~~~~ 225 (267)
T cd08228 161 T-AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLFS-----LC-QK--------IEQCDY 225 (267)
T ss_pred H-HHhcCCCCccccChhhhccCCCCchhhHHHHHHHHHHHhcCCCCCccccccHHH-----HH-HH--------HhcCCC
Confidence 1 112345788999999998888999999999999999999999998643221110 00 00 000001
Q ss_pred cccCCHHHHHHHHHHHHHccccCCCCCCCHHhHHHHhccC
Q 003836 737 EAMNNVTMLHRFVMVAFWCIQEDPSHRPTMRKVTQMLEGV 776 (792)
Q Consensus 737 ~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~L~~~ 776 (792)
...........+.+++.+||+.+|++||++.+|++.|+.+
T Consensus 226 ~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~vl~~~~~~ 265 (267)
T cd08228 226 PPLPTEHYSEKLRELVSMCIYPDPDQRPDIGYVHQIAKQM 265 (267)
T ss_pred CCCChhhcCHHHHHHHHHHCCCCcccCcCHHHHHHHHHHh
Confidence 1111223456789999999999999999999999999875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase |
| >cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-35 Score=322.78 Aligned_cols=259 Identities=25% Similarity=0.359 Sum_probs=198.5
Q ss_pred HHhhhhhhcCccccceEEEeeec----CCCceEEEEEEccccc-ccchHHHHHHHHHhccc-CCCCcccccceeccC-Cc
Q 003836 501 VTRGFKEELGRGAFGTVYKGFVN----MGSSNHVAVKKLNSVF-QDSEKEFKAEVNGIGQT-HHKNLVRLLGYCDEG-QN 573 (792)
Q Consensus 501 ~~~~~~~~lG~G~~g~Vy~g~~~----~~~~~~vavK~~~~~~-~~~~~~~~~Ei~~l~~l-~h~niv~l~g~~~~~-~~ 573 (792)
..+.+.+.||+|+||.||+|... ..+++.||||+++... ......+.+|+.++.++ +|+||+++++++... ..
T Consensus 7 ~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~ 86 (343)
T cd05103 7 DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGP 86 (343)
T ss_pred hHhcccccccCCccceEEEEeeccCCccccceeEEEEEeccCCChHHHHHHHHHHHHHHhccCCccHhhhcceeecCCCc
Confidence 34567789999999999999642 2345789999997533 23345788999999999 789999999988654 56
Q ss_pred eEEEEEeccCCCccccccCC------------------------------------------------------------
Q 003836 574 RLLVYEFMSNGTVASFLFGD------------------------------------------------------------ 593 (792)
Q Consensus 574 ~~lV~E~~~~gsL~~~l~~~------------------------------------------------------------ 593 (792)
.++||||+++|+|.+++...
T Consensus 87 ~~lv~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 166 (343)
T cd05103 87 LMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITSSQSSASSGFVEEKSLSDVEEEEA 166 (343)
T ss_pred eEEEEeccCCCcHHHHHHhcCCccccccccccccccccccccchhhhhhhhccccccccccccccccCCCccccchhhhh
Confidence 78999999999999887532
Q ss_pred -------CCCchhHHHHHHHHHHHHHHHHhhccCCCeEecCCCCCcEEEcCCCCeEEeecCCCccccCCCCC-ccccccc
Q 003836 594 -------SKPNWKLRTEIAMGIAGGLFYLHEECCTQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLDQSH-TNTAIRG 665 (792)
Q Consensus 594 -------~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dikp~NILl~~~~~~kl~Dfg~a~~~~~~~~~-~~~~~~g 665 (792)
..+++..+.+++.||++||+|||+. +|+||||||+|||+++++.+||+|||+++........ ......+
T Consensus 167 ~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~---~i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~ 243 (343)
T cd05103 167 EQEDLYKKVLTLEDLICYSFQVAKGMEFLASR---KCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARL 243 (343)
T ss_pred hhhhhhhccCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCccCeEEEcCCCcEEEEecccccccccCcchhhcCCCCC
Confidence 1256777889999999999999998 9999999999999999999999999999875432221 1122345
Q ss_pred cCCcccccccccCCCCcccceehHHHHHHHHHh-cCcCCCcchhhhhhhhHHHHHHHhhcccchhHhhhchhcccCCHHH
Q 003836 666 TKGYVAPEWFRNMPITVKVDVYSYGVLLLEIIC-LRRNIDNEISKVDKAILTDWAYDRYQERTLEALVENDLEAMNNVTM 744 (792)
Q Consensus 666 t~~y~aPE~~~~~~~~~k~DV~S~Gv~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 744 (792)
+..|+|||.+.+..++.++||||||+++|||++ |..|+........ . .. .+........+...
T Consensus 244 ~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~---~----~~---------~~~~~~~~~~~~~~ 307 (343)
T cd05103 244 PLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEE---F----CR---------RLKEGTRMRAPDYT 307 (343)
T ss_pred CcceECcHHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCccccHH---H----HH---------HHhccCCCCCCCCC
Confidence 678999999988899999999999999999997 8888754321110 0 00 00011111111123
Q ss_pred HHHHHHHHHHccccCCCCCCCHHhHHHHhccCcC
Q 003836 745 LHRFVMVAFWCIQEDPSHRPTMRKVTQMLEGVVE 778 (792)
Q Consensus 745 ~~~l~~l~~~Cl~~~p~~RPs~~evl~~L~~~~~ 778 (792)
..++.+++..||+.+|++||++.||++.|+.+.+
T Consensus 308 ~~~~~~~~~~cl~~~p~~Rps~~eil~~l~~~~~ 341 (343)
T cd05103 308 TPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQ 341 (343)
T ss_pred CHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence 4568899999999999999999999999988654
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp |
| >cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-35 Score=314.20 Aligned_cols=269 Identities=25% Similarity=0.386 Sum_probs=207.5
Q ss_pred hhhhhhcCccccceEEEeeec---CCCceEEEEEEccccccc-chHHHHHHHHHhcccCCCCcccccceecc--CCceEE
Q 003836 503 RGFKEELGRGAFGTVYKGFVN---MGSSNHVAVKKLNSVFQD-SEKEFKAEVNGIGQTHHKNLVRLLGYCDE--GQNRLL 576 (792)
Q Consensus 503 ~~~~~~lG~G~~g~Vy~g~~~---~~~~~~vavK~~~~~~~~-~~~~~~~Ei~~l~~l~h~niv~l~g~~~~--~~~~~l 576 (792)
..+.+.||+|+||.||++.+. .++++.+|||++...... ..+.+.+|++++++++|+||+++++++.. ....++
T Consensus 6 ~~~~~~ig~g~~~~v~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~ei~~l~~l~~~~i~~~~~~~~~~~~~~~~l 85 (284)
T cd05038 6 LKFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHENIVKYKGVCEKPGGRSLRL 85 (284)
T ss_pred chhheeeccCCCeeEEEeeecCCCCCCceEEEEEEeccccchHHHHHHHHHHHHHHhCCCCChheEEeeeecCCCCceEE
Confidence 345578999999999999864 234678999999865443 46789999999999999999999999877 567899
Q ss_pred EEEeccCCCccccccCCC-CCchhHHHHHHHHHHHHHHHHhhccCCCeEecCCCCCcEEEcCCCCeEEeecCCCccccCC
Q 003836 577 VYEFMSNGTVASFLFGDS-KPNWKLRTEIAMGIAGGLFYLHEECCTQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLD 655 (792)
Q Consensus 577 V~E~~~~gsL~~~l~~~~-~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dikp~NILl~~~~~~kl~Dfg~a~~~~~~ 655 (792)
||||+++++|.+++.... .+++..+..++.|++.||+|||+. +++|+||||+||+++.++.+||+|||++......
T Consensus 86 v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~l~~aL~~lH~~---~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~ 162 (284)
T cd05038 86 IMEYLPSGSLRDYLQRHRDQINLKRLLLFSSQICKGMDYLGSQ---RYIHRDLAARNILVESEDLVKISDFGLAKVLPED 162 (284)
T ss_pred EEecCCCCCHHHHHHhCccccCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHhEEEcCCCCEEEcccccccccccC
Confidence 999999999999997654 689999999999999999999998 9999999999999999999999999999876532
Q ss_pred CCCc--cccccccCCcccccccccCCCCcccceehHHHHHHHHHhcCcCCCcchhhhhhhhHHHHHHHhhcccchhHhhh
Q 003836 656 QSHT--NTAIRGTKGYVAPEWFRNMPITVKVDVYSYGVLLLEIICLRRNIDNEISKVDKAILTDWAYDRYQERTLEALVE 733 (792)
Q Consensus 656 ~~~~--~~~~~gt~~y~aPE~~~~~~~~~k~DV~S~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 733 (792)
.... .....++..|+|||.+.+..++.++||||||++++||++|+.|+............. .........+...+.
T Consensus 163 ~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~ 240 (284)
T cd05038 163 KDYYYVKEPGESPIFWYAPECLRTSKFSSASDVWSFGVTLYELFTYGDPSQSPPAEFLRMIGI--AQGQMIVTRLLELLK 240 (284)
T ss_pred CcceeccCCCCCcccccCcHHHccCCCCcccchHHHhhhhheeeccCCCcccccchhcccccc--ccccccHHHHHHHHH
Confidence 2211 112234567999999988899999999999999999999999886532221100000 000000011112222
Q ss_pred chhcccCCHHHHHHHHHHHHHccccCCCCCCCHHhHHHHhccC
Q 003836 734 NDLEAMNNVTMLHRFVMVAFWCIQEDPSHRPTMRKVTQMLEGV 776 (792)
Q Consensus 734 ~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~L~~~ 776 (792)
.......+...+.++.+++.+||+.+|++||++.||+++|+++
T Consensus 241 ~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~i 283 (284)
T cd05038 241 EGERLPRPPSCPDEVYDLMKLCWEAEPQDRPSFADLILIVDRL 283 (284)
T ss_pred cCCcCCCCccCCHHHHHHHHHHhccChhhCCCHHHHHHHHhhc
Confidence 2222222333456789999999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut |
| >cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=321.23 Aligned_cols=240 Identities=25% Similarity=0.337 Sum_probs=194.1
Q ss_pred hhhhhcCccccceEEEeeecCCCceEEEEEEccccc---ccchHHHHHHHHHhccc-CCCCcccccceeccCCceEEEEE
Q 003836 504 GFKEELGRGAFGTVYKGFVNMGSSNHVAVKKLNSVF---QDSEKEFKAEVNGIGQT-HHKNLVRLLGYCDEGQNRLLVYE 579 (792)
Q Consensus 504 ~~~~~lG~G~~g~Vy~g~~~~~~~~~vavK~~~~~~---~~~~~~~~~Ei~~l~~l-~h~niv~l~g~~~~~~~~~lV~E 579 (792)
.+.+.||+|+||.||++... .+++.+|+|++.+.. ....+.+..|..++..+ +|++|+++++++.+.+..++|||
T Consensus 3 ~~~~~lg~G~~g~Vy~~~~~-~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E 81 (323)
T cd05616 3 NFLMVLGKGSFGKVMLAERK-GTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQLHSCFQTMDRLYFVME 81 (323)
T ss_pred eEEEEEeeCCCeEEEEEEEC-CCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCeEeeEEEEEecCCEEEEEEc
Confidence 34578999999999999754 556789999987532 22334567788888777 68999999999999999999999
Q ss_pred eccCCCccccccCCCCCchhHHHHHHHHHHHHHHHHhhccCCCeEecCCCCCcEEEcCCCCeEEeecCCCccccCCCCCc
Q 003836 580 FMSNGTVASFLFGDSKPNWKLRTEIAMGIAGGLFYLHEECCTQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLDQSHT 659 (792)
Q Consensus 580 ~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dikp~NILl~~~~~~kl~Dfg~a~~~~~~~~~~ 659 (792)
|+++|+|.+++.....+++..+..++.||+.||+|||+. +|+||||||+|||+++++.+||+|||+++...... ..
T Consensus 82 ~~~~g~L~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~Nill~~~~~~kL~DfG~~~~~~~~~-~~ 157 (323)
T cd05616 82 YVNGGDLMYQIQQVGRFKEPHAVFYAAEIAIGLFFLHSK---GIIYRDLKLDNVMLDSEGHIKIADFGMCKENMWDG-VT 157 (323)
T ss_pred CCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC---CEEecCCCHHHeEECCCCcEEEccCCCceecCCCC-Cc
Confidence 999999999998777899999999999999999999998 99999999999999999999999999997543221 12
Q ss_pred cccccccCCcccccccccCCCCcccceehHHHHHHHHHhcCcCCCcchhhhhhhhHHHHHHHhhcccchhHhhhchhccc
Q 003836 660 NTAIRGTKGYVAPEWFRNMPITVKVDVYSYGVLLLEIICLRRNIDNEISKVDKAILTDWAYDRYQERTLEALVENDLEAM 739 (792)
Q Consensus 660 ~~~~~gt~~y~aPE~~~~~~~~~k~DV~S~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 739 (792)
.....||+.|+|||.+.+..++.++|||||||++|||++|+.||........ . ..+.... ..
T Consensus 158 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~---~-------------~~i~~~~--~~ 219 (323)
T cd05616 158 TKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDEL---F-------------QSIMEHN--VA 219 (323)
T ss_pred cccCCCChhhcCHHHhcCCCCCCccchhchhHHHHHHHhCCCCCCCCCHHHH---H-------------HHHHhCC--CC
Confidence 2345689999999999999999999999999999999999999975432111 0 0111111 11
Q ss_pred CCHHHHHHHHHHHHHccccCCCCCCCH
Q 003836 740 NNVTMLHRFVMVAFWCIQEDPSHRPTM 766 (792)
Q Consensus 740 ~~~~~~~~l~~l~~~Cl~~~p~~RPs~ 766 (792)
.+...+.++.+++.+||+.+|++|++.
T Consensus 220 ~p~~~s~~~~~li~~~l~~~p~~R~~~ 246 (323)
T cd05616 220 YPKSMSKEAVAICKGLMTKHPGKRLGC 246 (323)
T ss_pred CCCcCCHHHHHHHHHHcccCHHhcCCC
Confidence 223455678899999999999999985
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and |
| >cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-35 Score=306.63 Aligned_cols=248 Identities=31% Similarity=0.449 Sum_probs=204.0
Q ss_pred hhcCccccceEEEeeecCC--CceEEEEEEcccccccc-hHHHHHHHHHhcccCCCCcccccceeccCCceEEEEEeccC
Q 003836 507 EELGRGAFGTVYKGFVNMG--SSNHVAVKKLNSVFQDS-EKEFKAEVNGIGQTHHKNLVRLLGYCDEGQNRLLVYEFMSN 583 (792)
Q Consensus 507 ~~lG~G~~g~Vy~g~~~~~--~~~~vavK~~~~~~~~~-~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~lV~E~~~~ 583 (792)
+.||+|+||.||++..... .+..+++|.+....... .+.+.+|++.+++++|+||+++++++......++||||+++
T Consensus 1 ~~ig~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (262)
T cd00192 1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVRLLGVCTEEEPLYLVLEYMEG 80 (262)
T ss_pred CccccCCceEEEEEEEecCCCCCceEEeEeeccccchhHHHHHHHHHHHHhhcCCCChheeeeeecCCCceEEEEEeccC
Confidence 4699999999999977532 25689999998654433 67899999999999999999999999999999999999999
Q ss_pred CCccccccCC---------CCCchhHHHHHHHHHHHHHHHHhhccCCCeEecCCCCCcEEEcCCCCeEEeecCCCccccC
Q 003836 584 GTVASFLFGD---------SKPNWKLRTEIAMGIAGGLFYLHEECCTQIIHCDIKPQNILLDDHYNARISDFGLAKLLTL 654 (792)
Q Consensus 584 gsL~~~l~~~---------~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dikp~NILl~~~~~~kl~Dfg~a~~~~~ 654 (792)
++|.+++... ..+++..+.+++.|+++||+|||+. +++|+||+|+||++++++.+||+|||.++....
T Consensus 81 ~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~---~i~H~di~p~nili~~~~~~~l~dfg~~~~~~~ 157 (262)
T cd00192 81 GDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLASK---KFVHRDLAARNCLVGEDLVVKISDFGLSRDVYD 157 (262)
T ss_pred CcHHHHHhhccccccccccccCCHHHHHHHHHHHHHHHHHHHcC---CcccCccCcceEEECCCCcEEEccccccccccc
Confidence 9999999875 6789999999999999999999998 999999999999999999999999999987654
Q ss_pred CCC-CccccccccCCcccccccccCCCCcccceehHHHHHHHHHh-cCcCCCcchhhhhhhhHHHHHHHhhcccchhHhh
Q 003836 655 DQS-HTNTAIRGTKGYVAPEWFRNMPITVKVDVYSYGVLLLEIIC-LRRNIDNEISKVDKAILTDWAYDRYQERTLEALV 732 (792)
Q Consensus 655 ~~~-~~~~~~~gt~~y~aPE~~~~~~~~~k~DV~S~Gv~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 732 (792)
... .......++..|+|||.+....++.++||||||++++||++ |..||........ ... +
T Consensus 158 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~--------~~~---------~ 220 (262)
T cd00192 158 DDYYRKKTGGKLPIRWMAPESLKDGIFTSKSDVWSFGVLLWEIFTLGATPYPGLSNEEV--------LEY---------L 220 (262)
T ss_pred ccccccccCCCcCccccCHHHhccCCcchhhccHHHHHHHHHHHhcCCCCCCCCCHHHH--------HHH---------H
Confidence 332 22233457889999999988899999999999999999999 5888865421100 000 0
Q ss_pred hchhcccCCHHHHHHHHHHHHHccccCCCCCCCHHhHHHHhc
Q 003836 733 ENDLEAMNNVTMLHRFVMVAFWCIQEDPSHRPTMRKVTQMLE 774 (792)
Q Consensus 733 ~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~L~ 774 (792)
........+...+.++.+++.+||+.+|++|||+.|+++.|+
T Consensus 221 ~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~l~ 262 (262)
T cd00192 221 RKGYRLPKPEYCPDELYELMLSCWQLDPEDRPTFSELVERLE 262 (262)
T ss_pred HcCCCCCCCccCChHHHHHHHHHccCCcccCcCHHHHHHhhC
Confidence 011112223344678899999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan |
| >cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-35 Score=312.48 Aligned_cols=254 Identities=26% Similarity=0.405 Sum_probs=201.5
Q ss_pred HhhhhhhcCccccceEEEeeecC----CCceEEEEEEccccc-ccchHHHHHHHHHhcccCCCCcccccceeccCCceEE
Q 003836 502 TRGFKEELGRGAFGTVYKGFVNM----GSSNHVAVKKLNSVF-QDSEKEFKAEVNGIGQTHHKNLVRLLGYCDEGQNRLL 576 (792)
Q Consensus 502 ~~~~~~~lG~G~~g~Vy~g~~~~----~~~~~vavK~~~~~~-~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~l 576 (792)
...+.+.||+|+||.||+|.... .....+|+|.+.... ......+.+|+.++.+++|+||+++++++......++
T Consensus 7 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~ 86 (277)
T cd05032 7 KITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKEFNCHHVVRLLGVVSTGQPTLV 86 (277)
T ss_pred HeeEEeEecCCCCceEEEEEEeccCCCCcceeEEEEecCCccCHHHHHHHHHHHHHHHhCCCCceeEEEEEEcCCCCcEE
Confidence 34456789999999999997642 234689999987543 2334578899999999999999999999999999999
Q ss_pred EEEeccCCCccccccCC----------CCCchhHHHHHHHHHHHHHHHHhhccCCCeEecCCCCCcEEEcCCCCeEEeec
Q 003836 577 VYEFMSNGTVASFLFGD----------SKPNWKLRTEIAMGIAGGLFYLHEECCTQIIHCDIKPQNILLDDHYNARISDF 646 (792)
Q Consensus 577 V~E~~~~gsL~~~l~~~----------~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dikp~NILl~~~~~~kl~Df 646 (792)
||||+++|+|.+++... ..+++..+..++.||+.||.|||+. +|+|+||||+|||++.++.+||+||
T Consensus 87 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~di~p~nill~~~~~~kl~df 163 (277)
T cd05032 87 VMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLAAK---KFVHRDLAARNCMVAEDLTVKIGDF 163 (277)
T ss_pred EEecCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHHHhC---CccccccChheEEEcCCCCEEECCc
Confidence 99999999999998642 2367889999999999999999998 9999999999999999999999999
Q ss_pred CCCccccCCCCC-ccccccccCCcccccccccCCCCcccceehHHHHHHHHHh-cCcCCCcchhhhhhhhHHHHHHHhhc
Q 003836 647 GLAKLLTLDQSH-TNTAIRGTKGYVAPEWFRNMPITVKVDVYSYGVLLLEIIC-LRRNIDNEISKVDKAILTDWAYDRYQ 724 (792)
Q Consensus 647 g~a~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~k~DV~S~Gv~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~ 724 (792)
|+++........ ......++..|+|||.+.+..++.++||||||+++||+++ |+.||........ . ..
T Consensus 164 g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~---~-~~------ 233 (277)
T cd05032 164 GMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTKSDVWSFGVVLWEMATLAEQPYQGLSNEEV---L-KF------ 233 (277)
T ss_pred ccchhhccCcccccCCCCCccccccCHHHHhcCCCCcccchHHHHHHHHHhhccCCCCCccCCHHHH---H-HH------
Confidence 999865433221 2223346788999999988889999999999999999998 8888854322110 0 00
Q ss_pred ccchhHhhhchhcccCCHHHHHHHHHHHHHccccCCCCCCCHHhHHHHhcc
Q 003836 725 ERTLEALVENDLEAMNNVTMLHRFVMVAFWCIQEDPSHRPTMRKVTQMLEG 775 (792)
Q Consensus 725 ~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~L~~ 775 (792)
+........+...+..+.+++.+||+.+|++|||+.++++.|++
T Consensus 234 -------~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~ 277 (277)
T cd05032 234 -------VIDGGHLDLPENCPDKLLELMRMCWQYNPKMRPTFLEIVSSLKD 277 (277)
T ss_pred -------HhcCCCCCCCCCCCHHHHHHHHHHcCCChhhCCCHHHHHHHhcC
Confidence 00111111122336788899999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological |
| >cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-35 Score=313.38 Aligned_cols=257 Identities=23% Similarity=0.338 Sum_probs=203.5
Q ss_pred HHhhhhhhcCccccceEEEeeecC---CCceEEEEEEccccc-ccchHHHHHHHHHhcccCCCCcccccceecc-CCceE
Q 003836 501 VTRGFKEELGRGAFGTVYKGFVNM---GSSNHVAVKKLNSVF-QDSEKEFKAEVNGIGQTHHKNLVRLLGYCDE-GQNRL 575 (792)
Q Consensus 501 ~~~~~~~~lG~G~~g~Vy~g~~~~---~~~~~vavK~~~~~~-~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~-~~~~~ 575 (792)
..+.+.+.||+|+||.||+|.... ..+..|++|++.... ....+.+.+|+.++++++|+||+++++++.+ ....+
T Consensus 6 ~~~~~~~~i~~g~~g~V~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~ 85 (280)
T cd05043 6 DRVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTLLLQESCLLYGLSHQNILPILHVCIEDGEPPF 85 (280)
T ss_pred hheEEeeeecccCCceEEEEEEecCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCCCCE
Confidence 344556889999999999998764 235789999987543 2335678899999999999999999998766 56789
Q ss_pred EEEEeccCCCccccccCC--------CCCchhHHHHHHHHHHHHHHHHhhccCCCeEecCCCCCcEEEcCCCCeEEeecC
Q 003836 576 LVYEFMSNGTVASFLFGD--------SKPNWKLRTEIAMGIAGGLFYLHEECCTQIIHCDIKPQNILLDDHYNARISDFG 647 (792)
Q Consensus 576 lV~E~~~~gsL~~~l~~~--------~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dikp~NILl~~~~~~kl~Dfg 647 (792)
+++||+++++|.+++... ..+++..+..++.||+.||+|||+. +++|+||||+||++++++.+||+|||
T Consensus 86 ~~~~~~~~~~L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~---~i~H~di~p~nil~~~~~~~kl~d~g 162 (280)
T cd05043 86 VLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLHKR---GVIHKDIAARNCVIDEELQVKITDNA 162 (280)
T ss_pred EEEEcCCCCcHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHHC---CEeecccCHhhEEEcCCCcEEECCCC
Confidence 999999999999998643 3578999999999999999999998 99999999999999999999999999
Q ss_pred CCccccCCCCC-ccccccccCCcccccccccCCCCcccceehHHHHHHHHHh-cCcCCCcchhhhhhhhHHHHHHHhhcc
Q 003836 648 LAKLLTLDQSH-TNTAIRGTKGYVAPEWFRNMPITVKVDVYSYGVLLLEIIC-LRRNIDNEISKVDKAILTDWAYDRYQE 725 (792)
Q Consensus 648 ~a~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~k~DV~S~Gv~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~ 725 (792)
+++.+...... ......++..|+|||.+.+..++.++||||||+++||+++ |+.||....... +..+
T Consensus 163 ~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~----~~~~------- 231 (280)
T cd05043 163 LSRDLFPMDYHCLGDNENRPVKWMALESLVNKEYSSASDVWSFGVLLWELMTLGQTPYVEIDPFE----MAAY------- 231 (280)
T ss_pred CcccccCCceEEeCCCCCcchhccCHHHHhcCCCCchhhHHHhHHHHHHHhcCCCCCcCcCCHHH----HHHH-------
Confidence 99866433322 1222345778999999998889999999999999999999 999986532211 0000
Q ss_pred cchhHhhhchhcccCCHHHHHHHHHHHHHccccCCCCCCCHHhHHHHhccCc
Q 003836 726 RTLEALVENDLEAMNNVTMLHRFVMVAFWCIQEDPSHRPTMRKVTQMLEGVV 777 (792)
Q Consensus 726 ~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~L~~~~ 777 (792)
+............+..+.+++.+||+.+|++|||+.++++.|+.+.
T Consensus 232 ------~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~~~~ 277 (280)
T cd05043 232 ------LKDGYRLAQPINCPDELFAVMACCWALDPEERPSFSQLVQCLTDFH 277 (280)
T ss_pred ------HHcCCCCCCCCcCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHH
Confidence 0011111112223567889999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It |
| >cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-35 Score=326.68 Aligned_cols=263 Identities=24% Similarity=0.293 Sum_probs=198.8
Q ss_pred hhhhcCccccceEEEeeecCCCceEEEEEEccccc--ccchHHHHHHHHHhcccCCCCcccccceeccCC-----ceEEE
Q 003836 505 FKEELGRGAFGTVYKGFVNMGSSNHVAVKKLNSVF--QDSEKEFKAEVNGIGQTHHKNLVRLLGYCDEGQ-----NRLLV 577 (792)
Q Consensus 505 ~~~~lG~G~~g~Vy~g~~~~~~~~~vavK~~~~~~--~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~-----~~~lV 577 (792)
..+.||+|+||.||++... .+++.||+|++.... ....+++.+|+++++.++|+||+++++++.... ..++|
T Consensus 4 ~~~~lg~G~~g~V~~~~~~-~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv 82 (372)
T cd07853 4 PDRPIGYGAFGVVWSVTDP-RDGKRVALKKMPNVFQNLVSCKRVFRELKMLCFFKHDNVLSALDILQPPHIDPFEEIYVV 82 (372)
T ss_pred ccceeeeCCCEEEEEEEEC-CCCCEEEEEeccccccchHHHHHHHHHHHHHHhCCCCCcCCHhheecCCCccccceEEEE
Confidence 3468999999999999753 456789999986532 234467899999999999999999999998776 78999
Q ss_pred EEeccCCCccccccCCCCCchhHHHHHHHHHHHHHHHHhhccCCCeEecCCCCCcEEEcCCCCeEEeecCCCccccCCCC
Q 003836 578 YEFMSNGTVASFLFGDSKPNWKLRTEIAMGIAGGLFYLHEECCTQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLDQS 657 (792)
Q Consensus 578 ~E~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dikp~NILl~~~~~~kl~Dfg~a~~~~~~~~ 657 (792)
+||+. ++|.+++.....+++..+..++.||+.||.|||+. +|+||||||+|||++.++.+||+|||+++.......
T Consensus 83 ~e~~~-~~l~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~---~ivH~dlkp~Nili~~~~~~kL~Dfg~a~~~~~~~~ 158 (372)
T cd07853 83 TELMQ-SDLHKIIVSPQPLSSDHVKVFLYQILRGLKYLHSA---GILHRDIKPGNLLVNSNCVLKICDFGLARVEEPDES 158 (372)
T ss_pred eeccc-cCHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCChHHEEECCCCCEEeccccceeecccCcc
Confidence 99997 57888887777899999999999999999999998 999999999999999999999999999987654433
Q ss_pred CccccccccCCcccccccccC-CCCcccceehHHHHHHHHHhcCcCCCcchhhhhhhhHHHHHH----Hhh---cccchh
Q 003836 658 HTNTAIRGTKGYVAPEWFRNM-PITVKVDVYSYGVLLLEIICLRRNIDNEISKVDKAILTDWAY----DRY---QERTLE 729 (792)
Q Consensus 658 ~~~~~~~gt~~y~aPE~~~~~-~~~~k~DV~S~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~----~~~---~~~~~~ 729 (792)
.......+++.|+|||.+.+. .++.++|||||||++|||++|+.||...........+..... ..+ .+....
T Consensus 159 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~ 238 (372)
T cd07853 159 KHMTQEVVTQYYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRRILFQAQSPIQQLDLITDLLGTPSLEAMRSACEGARA 238 (372)
T ss_pred ccCCCCCcCCCcCCHHHHcCCCCCCcHHHHHhHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHcCCCCHHHHHHhhHHHHH
Confidence 333445678999999998764 579999999999999999999999975432211111100000 000 000000
Q ss_pred Hhhhchhcc-------cCCHHHHHHHHHHHHHccccCCCCCCCHHhHHHH
Q 003836 730 ALVENDLEA-------MNNVTMLHRFVMVAFWCIQEDPSHRPTMRKVTQM 772 (792)
Q Consensus 730 ~~~~~~~~~-------~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~ 772 (792)
.+....... .......+++.+++.+||+.||++|||++|+++.
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~h 288 (372)
T cd07853 239 HILRGPHKPPSLPVLYTLSSQATHEAVHLLCRMLVFDPDKRISAADALAH 288 (372)
T ss_pred HHHhCCCCCCchHHhcccCCCCCHHHHHHHHHhCCCChhhCcCHHHHhcC
Confidence 000000000 0111235678899999999999999999999974
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription |
| >cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-35 Score=315.69 Aligned_cols=260 Identities=24% Similarity=0.356 Sum_probs=201.6
Q ss_pred hhhhhhcCccccceEEEeeecCCC---------------ceEEEEEEccccc-ccchHHHHHHHHHhcccCCCCcccccc
Q 003836 503 RGFKEELGRGAFGTVYKGFVNMGS---------------SNHVAVKKLNSVF-QDSEKEFKAEVNGIGQTHHKNLVRLLG 566 (792)
Q Consensus 503 ~~~~~~lG~G~~g~Vy~g~~~~~~---------------~~~vavK~~~~~~-~~~~~~~~~Ei~~l~~l~h~niv~l~g 566 (792)
+.+.++||+|+||.||++...... ...||+|++.... ....+.+.+|++++++++|+||+++++
T Consensus 7 ~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~ 86 (296)
T cd05051 7 LNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNAREDFLKEVKILSRLSDPNIARLLG 86 (296)
T ss_pred CcccccccCCCCccEEEEEeccCCcccccccccccccCCceeEEEEEecCccCHHHHHHHHHHHHHHHhcCCCCEeEEEE
Confidence 456688999999999998764322 2468999987543 234568899999999999999999999
Q ss_pred eeccCCceEEEEEeccCCCccccccCCC-----------CCchhHHHHHHHHHHHHHHHHhhccCCCeEecCCCCCcEEE
Q 003836 567 YCDEGQNRLLVYEFMSNGTVASFLFGDS-----------KPNWKLRTEIAMGIAGGLFYLHEECCTQIIHCDIKPQNILL 635 (792)
Q Consensus 567 ~~~~~~~~~lV~E~~~~gsL~~~l~~~~-----------~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dikp~NILl 635 (792)
++..+...++|+||+++++|.+++.... .+++..+..++.|++.||+|||+. +|+|+||||+||++
T Consensus 87 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~---~i~H~dlkp~Nili 163 (296)
T cd05051 87 VCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLESL---NFVHRDLATRNCLV 163 (296)
T ss_pred EEecCCCcEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHHHHHHHHc---Cccccccchhceee
Confidence 9999999999999999999999987654 688999999999999999999998 99999999999999
Q ss_pred cCCCCeEEeecCCCccccCCCCC-ccccccccCCcccccccccCCCCcccceehHHHHHHHHHh--cCcCCCcchhhhhh
Q 003836 636 DDHYNARISDFGLAKLLTLDQSH-TNTAIRGTKGYVAPEWFRNMPITVKVDVYSYGVLLLEIIC--LRRNIDNEISKVDK 712 (792)
Q Consensus 636 ~~~~~~kl~Dfg~a~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~k~DV~S~Gv~l~el~t--g~~p~~~~~~~~~~ 712 (792)
++++.++|+|||+++........ ......+++.|+|||.+....++.++||||||+++|||++ +..|+.......
T Consensus 164 ~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~p~~~~~~~~-- 241 (296)
T cd05051 164 GKNYTIKIADFGMSRNLYSSDYYRVQGRAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEILTLCREQPYEHLTDQQ-- 241 (296)
T ss_pred cCCCceEEccccceeecccCcceeecCcCCCCceecCHHHhhcCCCCccchhhhhHHHHHHHHhcCCCCCCCCcChHH--
Confidence 99999999999999865432221 1223346778999999988899999999999999999998 566765432111
Q ss_pred hhHHHHHHHhhcccchhHhhhchhcccCCHHHHHHHHHHHHHccccCCCCCCCHHhHHHHhcc
Q 003836 713 AILTDWAYDRYQERTLEALVENDLEAMNNVTMLHRFVMVAFWCIQEDPSHRPTMRKVTQMLEG 775 (792)
Q Consensus 713 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~L~~ 775 (792)
.+ ......+.... .......+...+.++.+++.+||+.+|.+|||+.||++.|+.
T Consensus 242 -~~-~~~~~~~~~~~------~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rpt~~el~~~L~~ 296 (296)
T cd05051 242 -VI-ENAGHFFRDDG------RQIYLPRPPNCPKDIYELMLECWRRDEEDRPTFREIHLFLQR 296 (296)
T ss_pred -HH-HHHHhcccccc------ccccCCCccCCCHHHHHHHHHHhccChhcCCCHHHHHHHhcC
Confidence 01 00000000000 000011122344678999999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke |
| >cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-35 Score=308.56 Aligned_cols=255 Identities=20% Similarity=0.340 Sum_probs=203.8
Q ss_pred hhhhhhcCccccceEEEeeecCCCceEEEEEEccccc---ccchHHHHHHHHHhcccCCCCcccccceeccCCceEEEEE
Q 003836 503 RGFKEELGRGAFGTVYKGFVNMGSSNHVAVKKLNSVF---QDSEKEFKAEVNGIGQTHHKNLVRLLGYCDEGQNRLLVYE 579 (792)
Q Consensus 503 ~~~~~~lG~G~~g~Vy~g~~~~~~~~~vavK~~~~~~---~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~lV~E 579 (792)
+.+.+.||+|++|.||++... .+++.++||.+.... .....++.+|+.++++++|+||+++++++.+++..+++||
T Consensus 4 y~~~~~ig~g~~g~v~~~~~~-~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~e 82 (267)
T cd08229 4 FRIEKKIGRGQFSEVYRATCL-LDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVLE 82 (267)
T ss_pred hhhhhhhcccCCeEEEEEeec-CCCceEEEEeeeehhhhhHHHHHHHHHHHHHHHHccCCchhhhhheeEeCCeEEEEEE
Confidence 445678999999999999754 346789999876432 2234678899999999999999999999999999999999
Q ss_pred eccCCCccccccC----CCCCchhHHHHHHHHHHHHHHHHhhccCCCeEecCCCCCcEEEcCCCCeEEeecCCCccccCC
Q 003836 580 FMSNGTVASFLFG----DSKPNWKLRTEIAMGIAGGLFYLHEECCTQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLD 655 (792)
Q Consensus 580 ~~~~gsL~~~l~~----~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dikp~NILl~~~~~~kl~Dfg~a~~~~~~ 655 (792)
|+++++|.+++.. ...+++..+..++.||++||.|||+. +++|+||||+||+++.++.++|+|||++......
T Consensus 83 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~ 159 (267)
T cd08229 83 LADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMHSR---RVMHRDIKPANVFITATGVVKLGDLGLGRFFSSK 159 (267)
T ss_pred ecCCCCHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCCEEECcchhhhccccC
Confidence 9999999998863 34578999999999999999999998 9999999999999999999999999998866433
Q ss_pred CCCccccccccCCcccccccccCCCCcccceehHHHHHHHHHhcCcCCCcchhhhhhhhHHHHHHHhhcccchhHhhhch
Q 003836 656 QSHTNTAIRGTKGYVAPEWFRNMPITVKVDVYSYGVLLLEIICLRRNIDNEISKVDKAILTDWAYDRYQERTLEALVEND 735 (792)
Q Consensus 656 ~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DV~S~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 735 (792)
.. ......++..|+|||.+.+..++.++||||||+++|||++|..||......... . ...+....
T Consensus 160 ~~-~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~--~------------~~~~~~~~ 224 (267)
T cd08229 160 TT-AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYS--L------------CKKIEQCD 224 (267)
T ss_pred Cc-ccccccCCcCccCHHHhcCCCccchhhHHHHHHHHHHHHhCCCCcccccchHHH--H------------hhhhhcCC
Confidence 22 122345888999999999889999999999999999999999998643221000 0 00000111
Q ss_pred hcccCCHHHHHHHHHHHHHccccCCCCCCCHHhHHHHhccC
Q 003836 736 LEAMNNVTMLHRFVMVAFWCIQEDPSHRPTMRKVTQMLEGV 776 (792)
Q Consensus 736 ~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~L~~~ 776 (792)
............+.+++.+||+.+|.+||||.+|+++++++
T Consensus 225 ~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~i~~~~~~~ 265 (267)
T cd08229 225 YPPLPSDHYSEELRQLVNMCINPDPEKRPDITYVYDVAKRM 265 (267)
T ss_pred CCCCCcccccHHHHHHHHHhcCCCcccCCCHHHHHHHHhhh
Confidence 11111223566788999999999999999999999999875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. |
| >cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-35 Score=308.13 Aligned_cols=241 Identities=22% Similarity=0.364 Sum_probs=191.0
Q ss_pred hhcCccccceEEEeeecCC-----------CceEEEEEEcccccccchHHHHHHHHHhcccCCCCcccccceeccCCceE
Q 003836 507 EELGRGAFGTVYKGFVNMG-----------SSNHVAVKKLNSVFQDSEKEFKAEVNGIGQTHHKNLVRLLGYCDEGQNRL 575 (792)
Q Consensus 507 ~~lG~G~~g~Vy~g~~~~~-----------~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~ 575 (792)
+.||+|+||.||+|+.... ....+++|.+..........+.+|+.+++.++||||+++++++......+
T Consensus 1 ~~lg~G~~~~vy~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~l~~l~hp~iv~~~~~~~~~~~~~ 80 (262)
T cd05077 1 EHLGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSHRDISLAFFETASMMRQVSHKHIVLLYGVCVRDVENI 80 (262)
T ss_pred CccccCCcceEeeeecccCCCccccccchhhceeEEEeecChhhhhHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCCE
Confidence 4689999999999986422 12358999887665555668899999999999999999999999999999
Q ss_pred EEEEeccCCCccccccCC-CCCchhHHHHHHHHHHHHHHHHhhccCCCeEecCCCCCcEEEcCCCC-------eEEeecC
Q 003836 576 LVYEFMSNGTVASFLFGD-SKPNWKLRTEIAMGIAGGLFYLHEECCTQIIHCDIKPQNILLDDHYN-------ARISDFG 647 (792)
Q Consensus 576 lV~E~~~~gsL~~~l~~~-~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dikp~NILl~~~~~-------~kl~Dfg 647 (792)
+||||+++|+|..++... ..+++..+.+++.||++||+|||++ +|+||||||+|||++.++. +|++|||
T Consensus 81 lv~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~dlkp~Nill~~~~~~~~~~~~~~l~d~g 157 (262)
T cd05077 81 MVEEFVEFGPLDLFMHRKSDVLTTPWKFKVAKQLASALSYLEDK---DLVHGNVCTKNILLAREGIDGECGPFIKLSDPG 157 (262)
T ss_pred EEEecccCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhC---CeECCCCCcccEEEecCCccCCCCceeEeCCCC
Confidence 999999999999998754 5689999999999999999999998 9999999999999987664 8999999
Q ss_pred CCccccCCCCCccccccccCCcccccccc-cCCCCcccceehHHHHHHHHH-hcCcCCCcchhhhhhhhHHHHHHHhhcc
Q 003836 648 LAKLLTLDQSHTNTAIRGTKGYVAPEWFR-NMPITVKVDVYSYGVLLLEII-CLRRNIDNEISKVDKAILTDWAYDRYQE 725 (792)
Q Consensus 648 ~a~~~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~k~DV~S~Gv~l~el~-tg~~p~~~~~~~~~~~~~~~~~~~~~~~ 725 (792)
++...... ....++..|+|||.+. ...++.++|||||||++|||+ +|+.|+.........
T Consensus 158 ~~~~~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~------------- 219 (262)
T cd05077 158 IPITVLSR-----QECVERIPWIAPECVEDSKNLSIAADKWSFGTTLWEICYNGEIPLKDKTLAEKE------------- 219 (262)
T ss_pred CCccccCc-----ccccccccccChhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCcchhHHH-------------
Confidence 98755322 1234678899999886 467899999999999999998 577776543211000
Q ss_pred cchhHhhhchhcccCCHHHHHHHHHHHHHccccCCCCCCCHHhHHHHhc
Q 003836 726 RTLEALVENDLEAMNNVTMLHRFVMVAFWCIQEDPSHRPTMRKVTQMLE 774 (792)
Q Consensus 726 ~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~L~ 774 (792)
.+...... ........+.+++.+||+.||.+||++.+|++.++
T Consensus 220 ----~~~~~~~~--~~~~~~~~~~~li~~cl~~dp~~Rp~~~~il~~~~ 262 (262)
T cd05077 220 ----RFYEGQCM--LVTPSCKELADLMTHCMNYDPNQRPFFRAIMRDIN 262 (262)
T ss_pred ----HHHhcCcc--CCCCChHHHHHHHHHHcCCChhhCcCHHHHHHhcC
Confidence 00000000 01112356789999999999999999999998763
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom |
| >cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-35 Score=310.61 Aligned_cols=253 Identities=21% Similarity=0.288 Sum_probs=201.3
Q ss_pred hhhhhhcCccccceEEEeeecCCCceEEEEEEcccccccchHHHHHHHHHhcccCCCCcccccceeccCCceEEEEEecc
Q 003836 503 RGFKEELGRGAFGTVYKGFVNMGSSNHVAVKKLNSVFQDSEKEFKAEVNGIGQTHHKNLVRLLGYCDEGQNRLLVYEFMS 582 (792)
Q Consensus 503 ~~~~~~lG~G~~g~Vy~g~~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~lV~E~~~ 582 (792)
+.+.+.||+|+||.||+|+.. .+++.+|+|++..........+.+|+.++++++|+||+++++.+...+..++|+||++
T Consensus 11 y~~~~~lg~g~~g~vy~~~~~-~~~~~~aik~~~~~~~~~~~~~~~e~~~l~~~~h~~ii~~~~~~~~~~~~~iv~e~~~ 89 (267)
T cd06646 11 YELIQRVGSGTYGDVYKARNL-HTGELAAVKIIKLEPGDDFSLIQQEIFMVKECKHCNIVAYFGSYLSREKLWICMEYCG 89 (267)
T ss_pred cchhheeecCCCeEEEEEEEC-CCCeEEEEEEEecCccchHHHHHHHHHHHHhcCCCCeeeeeEEEEeCCEEEEEEeCCC
Confidence 455678999999999999753 4567899999876555556678899999999999999999999999999999999999
Q ss_pred CCCccccccCCCCCchhHHHHHHHHHHHHHHHHhhccCCCeEecCCCCCcEEEcCCCCeEEeecCCCccccCCCCCcccc
Q 003836 583 NGTVASFLFGDSKPNWKLRTEIAMGIAGGLFYLHEECCTQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLDQSHTNTA 662 (792)
Q Consensus 583 ~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dikp~NILl~~~~~~kl~Dfg~a~~~~~~~~~~~~~ 662 (792)
+++|.+++.....+++..+..++.|++.||.|||+. +|+|+||+|+||+++.++.+||+|||+++....... ....
T Consensus 90 ~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~~~-~~~~ 165 (267)
T cd06646 90 GGSLQDIYHVTGPLSELQIAYVCRETLQGLAYLHSK---GKMHRDIKGANILLTDNGDVKLADFGVAAKITATIA-KRKS 165 (267)
T ss_pred CCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEECCCCCEEECcCccceeeccccc-ccCc
Confidence 999999998777889999999999999999999998 999999999999999999999999999986642221 1223
Q ss_pred ccccCCcccccccc---cCCCCcccceehHHHHHHHHHhcCcCCCcchhhhhhhhHHHHHHHhhcccchhHhhhchhccc
Q 003836 663 IRGTKGYVAPEWFR---NMPITVKVDVYSYGVLLLEIICLRRNIDNEISKVDKAILTDWAYDRYQERTLEALVENDLEAM 739 (792)
Q Consensus 663 ~~gt~~y~aPE~~~---~~~~~~k~DV~S~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 739 (792)
..+++.|+|||.+. ...++.++|||||||++|||++|+.|+........... ..... +..+...
T Consensus 166 ~~~~~~y~~PE~~~~~~~~~~~~~~Dvws~G~il~el~~g~~p~~~~~~~~~~~~--------~~~~~---~~~~~~~-- 232 (267)
T cd06646 166 FIGTPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFL--------MSKSN---FQPPKLK-- 232 (267)
T ss_pred cccCccccCHhHcccccCCCCcchhhHHHHHHHHHHHHhCCCCccccchhhhhee--------eecCC---CCCCCCc--
Confidence 45788999999884 44578899999999999999999999854321110000 00000 0000000
Q ss_pred CCHHHHHHHHHHHHHccccCCCCCCCHHhHHHHh
Q 003836 740 NNVTMLHRFVMVAFWCIQEDPSHRPTMRKVTQML 773 (792)
Q Consensus 740 ~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~L 773 (792)
.....+..+.+++.+||+.+|++||++++|++.|
T Consensus 233 ~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~l 266 (267)
T cd06646 233 DKTKWSSTFHNFVKISLTKNPKKRPTAERLLTHL 266 (267)
T ss_pred cccccCHHHHHHHHHHhhCChhhCcCHHHHhcCC
Confidence 1122456788999999999999999999998754
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-35 Score=306.59 Aligned_cols=246 Identities=23% Similarity=0.323 Sum_probs=201.6
Q ss_pred hhhhcCccccceEEEeeecCCCceEEEEEEcccc--cccchHHHHHHHHHhcccCCCCcccccceeccCCceEEEEEecc
Q 003836 505 FKEELGRGAFGTVYKGFVNMGSSNHVAVKKLNSV--FQDSEKEFKAEVNGIGQTHHKNLVRLLGYCDEGQNRLLVYEFMS 582 (792)
Q Consensus 505 ~~~~lG~G~~g~Vy~g~~~~~~~~~vavK~~~~~--~~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~lV~E~~~ 582 (792)
+.+.||+|++|.||++... .+++.+++|.+... .......+.+|++++++++|+||+++++++.+.+..++||||++
T Consensus 4 ~~~~l~~g~~~~v~~~~~~-~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 82 (256)
T cd08529 4 ILNKIGKGSFGVVFKVVRK-ADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYIIRYYESFLDKGKLNIVMEYAE 82 (256)
T ss_pred EeEEecCCCCeEEEEEEEc-CCCcEEEEEEeehhhCCHHHHHHHHHHHHHHHhcCCCCeehheeeeccCCEEEEEEEeCC
Confidence 4578999999999999764 45678999987642 33456788999999999999999999999999999999999999
Q ss_pred CCCccccccCC--CCCchhHHHHHHHHHHHHHHHHhhccCCCeEecCCCCCcEEEcCCCCeEEeecCCCccccCCCCCcc
Q 003836 583 NGTVASFLFGD--SKPNWKLRTEIAMGIAGGLFYLHEECCTQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLDQSHTN 660 (792)
Q Consensus 583 ~gsL~~~l~~~--~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dikp~NILl~~~~~~kl~Dfg~a~~~~~~~~~~~ 660 (792)
+++|.+++... ..+++..+.+++.|++.||.|||+. +++|+||||+||++++++.+||+|||+++....... ..
T Consensus 83 ~~~L~~~l~~~~~~~~~~~~~~~i~~~l~~al~~lH~~---~i~h~dl~~~nili~~~~~~~l~df~~~~~~~~~~~-~~ 158 (256)
T cd08529 83 NGDLHKLLKMQRGRPLPEDQVWRFFIQILLGLAHLHSK---KILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNTN-FA 158 (256)
T ss_pred CCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCcceEEEeCCCCEEEcccccceeccCccc-hh
Confidence 99999999764 5678899999999999999999998 999999999999999999999999999987654322 22
Q ss_pred ccccccCCcccccccccCCCCcccceehHHHHHHHHHhcCcCCCcchhhhhhhhHHHHHHHhhcccchhHhhhchhcccC
Q 003836 661 TAIRGTKGYVAPEWFRNMPITVKVDVYSYGVLLLEIICLRRNIDNEISKVDKAILTDWAYDRYQERTLEALVENDLEAMN 740 (792)
Q Consensus 661 ~~~~gt~~y~aPE~~~~~~~~~k~DV~S~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 740 (792)
....+++.|+|||++.+..++.++||||||++++||++|+.||........ . ..+... .....
T Consensus 159 ~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~---~-------------~~~~~~-~~~~~ 221 (256)
T cd08529 159 NTIVGTPYYLSPELCEDKPYNEKSDVWALGVVLYECCTGKHPFDANNQGAL---I-------------LKIIRG-VFPPV 221 (256)
T ss_pred hccccCccccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHHH---H-------------HHHHcC-CCCCC
Confidence 334578899999999999999999999999999999999999965432110 0 001111 11112
Q ss_pred CHHHHHHHHHHHHHccccCCCCCCCHHhHHHH
Q 003836 741 NVTMLHRFVMVAFWCIQEDPSHRPTMRKVTQM 772 (792)
Q Consensus 741 ~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~ 772 (792)
+......+.+++.+||+.+|++||++.++++.
T Consensus 222 ~~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~~ 253 (256)
T cd08529 222 SQMYSQQLAQLIDQCLTKDYRQRPDTFQLLRN 253 (256)
T ss_pred ccccCHHHHHHHHHHccCCcccCcCHHHHhhC
Confidence 22455678999999999999999999999873
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc |
| >cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=321.57 Aligned_cols=241 Identities=25% Similarity=0.278 Sum_probs=191.9
Q ss_pred hhcCccccceEEEeeecCCCceEEEEEEccccc---ccchHHHHHHHH-HhcccCCCCcccccceeccCCceEEEEEecc
Q 003836 507 EELGRGAFGTVYKGFVNMGSSNHVAVKKLNSVF---QDSEKEFKAEVN-GIGQTHHKNLVRLLGYCDEGQNRLLVYEFMS 582 (792)
Q Consensus 507 ~~lG~G~~g~Vy~g~~~~~~~~~vavK~~~~~~---~~~~~~~~~Ei~-~l~~l~h~niv~l~g~~~~~~~~~lV~E~~~ 582 (792)
+.||+|+||.||++... .+++.+|+|++.... .....++..|.. +++.++||||+++++.+...+..++||||++
T Consensus 1 ~~lG~G~~g~V~~~~~~-~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~hp~iv~~~~~~~~~~~~~lv~e~~~ 79 (325)
T cd05604 1 KVIGKGSFGKVLLAKRK-LDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTTEKLYFVLDFVN 79 (325)
T ss_pred CceeeCCCeEEEEEEEC-CCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHHhCCCCCCccEEEEEecCCEEEEEEcCCC
Confidence 36999999999999753 456799999986532 223345556655 4677999999999999999999999999999
Q ss_pred CCCccccccCCCCCchhHHHHHHHHHHHHHHHHhhccCCCeEecCCCCCcEEEcCCCCeEEeecCCCccccCCCCCcccc
Q 003836 583 NGTVASFLFGDSKPNWKLRTEIAMGIAGGLFYLHEECCTQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLDQSHTNTA 662 (792)
Q Consensus 583 ~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dikp~NILl~~~~~~kl~Dfg~a~~~~~~~~~~~~~ 662 (792)
+|+|..++.....+++..+..++.||+.||+|||+. +|+||||||+|||+++++.+||+|||+++..... ......
T Consensus 80 ~~~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~~---givH~Dlkp~NIll~~~~~~kL~DfG~~~~~~~~-~~~~~~ 155 (325)
T cd05604 80 GGELFFHLQRERSFPEPRARFYAAEIASALGYLHSI---NIVYRDLKPENILLDSQGHVVLTDFGLCKEGIAQ-SDTTTT 155 (325)
T ss_pred CCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCHHHeEECCCCCEEEeecCCcccCCCC-CCCccc
Confidence 999999998878899999999999999999999998 9999999999999999999999999998754222 122334
Q ss_pred ccccCCcccccccccCCCCcccceehHHHHHHHHHhcCcCCCcchhhhhhhhHHHHHHHhhcccchhHhhhchhcccCCH
Q 003836 663 IRGTKGYVAPEWFRNMPITVKVDVYSYGVLLLEIICLRRNIDNEISKVDKAILTDWAYDRYQERTLEALVENDLEAMNNV 742 (792)
Q Consensus 663 ~~gt~~y~aPE~~~~~~~~~k~DV~S~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 742 (792)
..||+.|+|||.+.+..++.++|||||||++|||++|+.||........ . ..+..... ....
T Consensus 156 ~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~~~~---~-------------~~~~~~~~--~~~~ 217 (325)
T cd05604 156 FCGTPEYLAPEVIRKQPYDNTVDWWCLGAVLYEMLYGLPPFYCRDVAEM---Y-------------DNILHKPL--VLRP 217 (325)
T ss_pred ccCChhhCCHHHHcCCCCCCcCccccccceehhhhcCCCCCCCCCHHHH---H-------------HHHHcCCc--cCCC
Confidence 5689999999999999999999999999999999999999965422110 0 00111111 0112
Q ss_pred HHHHHHHHHHHHccccCCCCCCCHHhHH
Q 003836 743 TMLHRFVMVAFWCIQEDPSHRPTMRKVT 770 (792)
Q Consensus 743 ~~~~~l~~l~~~Cl~~~p~~RPs~~evl 770 (792)
..+..+.+++.+||+.+|.+||++.+.+
T Consensus 218 ~~~~~~~~ll~~ll~~~p~~R~~~~~~~ 245 (325)
T cd05604 218 GASLTAWSILEELLEKDRQRRLGAKEDF 245 (325)
T ss_pred CCCHHHHHHHHHHhccCHHhcCCCCCCH
Confidence 2445678899999999999999886433
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, |
| >cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-35 Score=319.96 Aligned_cols=249 Identities=22% Similarity=0.297 Sum_probs=196.3
Q ss_pred hhcCccccceEEEeeecCCCceEEEEEEccccc---ccchHHHHHHHHHhccc-CCCCcccccceeccCCceEEEEEecc
Q 003836 507 EELGRGAFGTVYKGFVNMGSSNHVAVKKLNSVF---QDSEKEFKAEVNGIGQT-HHKNLVRLLGYCDEGQNRLLVYEFMS 582 (792)
Q Consensus 507 ~~lG~G~~g~Vy~g~~~~~~~~~vavK~~~~~~---~~~~~~~~~Ei~~l~~l-~h~niv~l~g~~~~~~~~~lV~E~~~ 582 (792)
+.||+|+||.||++... .+++.+|+|++++.. ....+.+.+|+.++.++ +|+||+++++++.+.+..++||||++
T Consensus 1 ~~lG~G~~g~V~~~~~~-~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~ 79 (327)
T cd05617 1 RVIGRGSYAKVLLVRLK-KNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLHSCFQTTSRLFLVIEYVN 79 (327)
T ss_pred CeeeeCCCeEEEEEEEC-CCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhhcCCCCEeeEEEEEEeCCEEEEEEeCCC
Confidence 36999999999999764 456789999997542 22345688999999888 69999999999999999999999999
Q ss_pred CCCccccccCCCCCchhHHHHHHHHHHHHHHHHhhccCCCeEecCCCCCcEEEcCCCCeEEeecCCCccccCCCCCcccc
Q 003836 583 NGTVASFLFGDSKPNWKLRTEIAMGIAGGLFYLHEECCTQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLDQSHTNTA 662 (792)
Q Consensus 583 ~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dikp~NILl~~~~~~kl~Dfg~a~~~~~~~~~~~~~ 662 (792)
+|+|..++.....+++..+..++.||+.||+|||++ +|+||||||+|||++.++.+||+|||+++...... .....
T Consensus 80 ~~~L~~~~~~~~~l~~~~~~~~~~qi~~al~~lH~~---~ivHrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~-~~~~~ 155 (327)
T cd05617 80 GGDLMFHMQRQRKLPEEHARFYAAEICIALNFLHER---GIIYRDLKLDNVLLDADGHIKLTDYGMCKEGLGPG-DTTST 155 (327)
T ss_pred CCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHEEEeCCCCEEEeccccceeccCCC-Cceec
Confidence 999999988777899999999999999999999998 99999999999999999999999999987532211 22234
Q ss_pred ccccCCcccccccccCCCCcccceehHHHHHHHHHhcCcCCCcchhhhhhhhHHHHHHHhhcccchhHhhhchhcccCCH
Q 003836 663 IRGTKGYVAPEWFRNMPITVKVDVYSYGVLLLEIICLRRNIDNEISKVDKAILTDWAYDRYQERTLEALVENDLEAMNNV 742 (792)
Q Consensus 663 ~~gt~~y~aPE~~~~~~~~~k~DV~S~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 742 (792)
..||+.|+|||.+.+..++.++|||||||++|||++|+.||........... ...... .+..... ..+.
T Consensus 156 ~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~ell~g~~pf~~~~~~~~~~~-~~~~~~--------~~~~~~~--~~p~ 224 (327)
T cd05617 156 FCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIITDNPDMNT-EDYLFQ--------VILEKPI--RIPR 224 (327)
T ss_pred ccCCcccCCHHHHCCCCCCchheeehhHHHHHHHHhCCCCCCccCCCccccc-HHHHHH--------HHHhCCC--CCCC
Confidence 5689999999999999999999999999999999999999964322111000 000111 1111111 1222
Q ss_pred HHHHHHHHHHHHccccCCCCCCCH------HhHHH
Q 003836 743 TMLHRFVMVAFWCIQEDPSHRPTM------RKVTQ 771 (792)
Q Consensus 743 ~~~~~l~~l~~~Cl~~~p~~RPs~------~evl~ 771 (792)
..+..+.+++.+||+.||++||++ +++++
T Consensus 225 ~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~i~~ 259 (327)
T cd05617 225 FLSVKASHVLKGFLNKDPKERLGCQPQTGFSDIKS 259 (327)
T ss_pred CCCHHHHHHHHHHhccCHHHcCCCCCCCCHHHHHc
Confidence 345667899999999999999984 56654
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways |
| >KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-36 Score=320.98 Aligned_cols=244 Identities=26% Similarity=0.343 Sum_probs=207.0
Q ss_pred hcCccccceEEEeeecCCCceEEEEEEcccccccchHHHHHHHHHhcccCCCCcccccceeccCCceEEEEEeccCCCcc
Q 003836 508 ELGRGAFGTVYKGFVNMGSSNHVAVKKLNSVFQDSEKEFKAEVNGIGQTHHKNLVRLLGYCDEGQNRLLVYEFMSNGTVA 587 (792)
Q Consensus 508 ~lG~G~~g~Vy~g~~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~lV~E~~~~gsL~ 587 (792)
+||+|.||+||-|.. ..+...+|||.+........+.+.+||.+.++++|.|||+++|.|.++...-+.||.++||||.
T Consensus 582 VLGKGTYG~VYA~RD-~~tqvrIaIKEIpekdsr~~QPLhEEIaLH~~LrHkNIVrYLGs~senGf~kIFMEqVPGGSLS 660 (1226)
T KOG4279|consen 582 VLGKGTYGTVYAARD-MDTQVRIAIKEIPEKDSREVQPLHEEIALHSTLRHKNIVRYLGSVSENGFFKIFMEQVPGGSLS 660 (1226)
T ss_pred EeecCceeEEEeecc-ccceeEEEeeecccccchhhccHHHHHHHHHHHhhHhHHHHhhccCCCCeEEEEeecCCCCcHH
Confidence 599999999999964 4667889999998877777788999999999999999999999999999999999999999999
Q ss_pred ccccCC-CCC--chhHHHHHHHHHHHHHHHHhhccCCCeEecCCCCCcEEEcC-CCCeEEeecCCCccccCCCCCccccc
Q 003836 588 SFLFGD-SKP--NWKLRTEIAMGIAGGLFYLHEECCTQIIHCDIKPQNILLDD-HYNARISDFGLAKLLTLDQSHTNTAI 663 (792)
Q Consensus 588 ~~l~~~-~~l--~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dikp~NILl~~-~~~~kl~Dfg~a~~~~~~~~~~~~~~ 663 (792)
++|+.. +++ ++.++-...+||++||.|||+. .|||||||-.|+|++. .|.+||+|||-++.+..-. ....++
T Consensus 661 sLLrskWGPlKDNEstm~fYtkQILeGLkYLHen---~IVHRDIKGDNVLvNTySGvlKISDFGTsKRLAgin-P~TETF 736 (1226)
T KOG4279|consen 661 SLLRSKWGPLKDNESTMNFYTKQILEGLKYLHEN---KIVHRDIKGDNVLVNTYSGVLKISDFGTSKRLAGIN-PCTETF 736 (1226)
T ss_pred HHHHhccCCCccchhHHHHHHHHHHHHhhhhhhc---ceeeccccCCcEEEeeccceEEecccccchhhccCC-cccccc
Confidence 999865 566 7888899999999999999999 9999999999999974 6899999999999875322 233446
Q ss_pred cccCCcccccccccC--CCCcccceehHHHHHHHHHhcCcCCCcchhhhhhhhHHHHHHHhhcccchhHhhhchhcccCC
Q 003836 664 RGTKGYVAPEWFRNM--PITVKVDVYSYGVLLLEIICLRRNIDNEISKVDKAILTDWAYDRYQERTLEALVENDLEAMNN 741 (792)
Q Consensus 664 ~gt~~y~aPE~~~~~--~~~~k~DV~S~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 741 (792)
-||..|||||++..+ .|+.++|||||||.+.||.||++||....+... . +-.+=.-...+..+
T Consensus 737 TGTLQYMAPEvIDqG~RGYG~aADIWS~GCT~vEMATGrPPF~ElgspqA----------A-----MFkVGmyKvHP~iP 801 (1226)
T KOG4279|consen 737 TGTLQYMAPEVIDQGPRGYGKAADIWSFGCTMVEMATGRPPFVELGSPQA----------A-----MFKVGMYKVHPPIP 801 (1226)
T ss_pred ccchhhhChHhhccCCcCCCchhhhhhccceeEeeccCCCCeeecCChhH----------h-----hhhhcceecCCCCc
Confidence 699999999999765 488999999999999999999999965433210 0 00111122345677
Q ss_pred HHHHHHHHHHHHHccccCCCCCCCHHhHHH
Q 003836 742 VTMLHRFVMVAFWCIQEDPSHRPTMRKVTQ 771 (792)
Q Consensus 742 ~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~ 771 (792)
.+.+.+...++.+|+.++|.+||+++++++
T Consensus 802 eelsaeak~FilrcFepd~~~R~sA~~LL~ 831 (1226)
T KOG4279|consen 802 EELSAEAKNFILRCFEPDPCDRPSAKDLLQ 831 (1226)
T ss_pred HHHHHHHHHHHHHHcCCCcccCccHHHhcc
Confidence 888999999999999999999999999986
|
|
| >cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=310.85 Aligned_cols=241 Identities=22% Similarity=0.380 Sum_probs=191.2
Q ss_pred hhcCccccceEEEeeecCCC------ceEEEEEEcccccccchHHHHHHHHHhcccCCCCcccccceeccCCceEEEEEe
Q 003836 507 EELGRGAFGTVYKGFVNMGS------SNHVAVKKLNSVFQDSEKEFKAEVNGIGQTHHKNLVRLLGYCDEGQNRLLVYEF 580 (792)
Q Consensus 507 ~~lG~G~~g~Vy~g~~~~~~------~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~lV~E~ 580 (792)
+.||+|+||.||+|...... ...+++|.+........+.+.+|+.++++++||||+++++++..+...++||||
T Consensus 1 ~~lg~G~~~~Vy~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~ 80 (258)
T cd05078 1 ESLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSHRNYSESFFEAASMMSQLSHKHLVLNYGVCVCGDESIMVQEY 80 (258)
T ss_pred CCCCcccchhheeeeecccccccccccchhhHHhhcchhHHHHHHHHHHHHHHHhCCCCChhheeeEEEeCCCcEEEEec
Confidence 46999999999999764321 235888888765555567889999999999999999999999999999999999
Q ss_pred ccCCCccccccCC-CCCchhHHHHHHHHHHHHHHHHhhccCCCeEecCCCCCcEEEcCCCC--------eEEeecCCCcc
Q 003836 581 MSNGTVASFLFGD-SKPNWKLRTEIAMGIAGGLFYLHEECCTQIIHCDIKPQNILLDDHYN--------ARISDFGLAKL 651 (792)
Q Consensus 581 ~~~gsL~~~l~~~-~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dikp~NILl~~~~~--------~kl~Dfg~a~~ 651 (792)
+++|+|.+++... ..+++..++.++.||+.||+|||+. +|+||||||+|||++.++. ++++|||++..
T Consensus 81 ~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~iiH~dlkp~nili~~~~~~~~~~~~~~~l~d~g~~~~ 157 (258)
T cd05078 81 VKFGSLDTYLKKNKNLINISWKLEVAKQLAWALHFLEDK---GLTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGISIT 157 (258)
T ss_pred CCCCcHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCccceEEEecccccccCCCceEEecccccccc
Confidence 9999999999765 4579999999999999999999998 9999999999999987765 59999999875
Q ss_pred ccCCCCCccccccccCCcccccccccC-CCCcccceehHHHHHHHHHhcC-cCCCcchhhhhhhhHHHHHHHhhcccchh
Q 003836 652 LTLDQSHTNTAIRGTKGYVAPEWFRNM-PITVKVDVYSYGVLLLEIICLR-RNIDNEISKVDKAILTDWAYDRYQERTLE 729 (792)
Q Consensus 652 ~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~k~DV~S~Gv~l~el~tg~-~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 729 (792)
.... ....+++.|+|||.+.+. .++.++||||||+++|||++|. .|+.........
T Consensus 158 ~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~~~~~~~~~~~~~----------------- 215 (258)
T cd05078 158 VLPK-----EILLERIPWVPPECIENPQNLSLAADKWSFGTTLWEIFSGGDKPLSALDSQKKL----------------- 215 (258)
T ss_pred cCCc-----hhccccCCccCchhccCCCCCCchhhHHHHHHHHHHHHcCCCCChhhccHHHHH-----------------
Confidence 4321 224578899999999874 5799999999999999999995 444322111000
Q ss_pred HhhhchhcccCCHHHHHHHHHHHHHccccCCCCCCCHHhHHHHhc
Q 003836 730 ALVENDLEAMNNVTMLHRFVMVAFWCIQEDPSHRPTMRKVTQMLE 774 (792)
Q Consensus 730 ~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~L~ 774 (792)
.+... ....+.....++.+++.+||+.+|++|||++++++.|+
T Consensus 216 ~~~~~--~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~l~ 258 (258)
T cd05078 216 QFYED--RHQLPAPKWTELANLINQCMDYEPDFRPSFRAIIRDLN 258 (258)
T ss_pred HHHHc--cccCCCCCcHHHHHHHHHHhccChhhCCCHHHHHHhcC
Confidence 00000 01112223457889999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity |
| >cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-35 Score=312.51 Aligned_cols=256 Identities=25% Similarity=0.406 Sum_probs=199.2
Q ss_pred HhhhhhhcCccccceEEEeeecC----CCceEEEEEEcccccc-cchHHHHHHHHHhcccCCCCcccccceeccCCceEE
Q 003836 502 TRGFKEELGRGAFGTVYKGFVNM----GSSNHVAVKKLNSVFQ-DSEKEFKAEVNGIGQTHHKNLVRLLGYCDEGQNRLL 576 (792)
Q Consensus 502 ~~~~~~~lG~G~~g~Vy~g~~~~----~~~~~vavK~~~~~~~-~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~l 576 (792)
.+.+.+.||+|+||.||+|.... ..+..||+|.+..... .....+.+|+.++++++|+||+++++++.+....++
T Consensus 7 ~~~i~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l 86 (288)
T cd05061 7 KITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVRLLGVVSKGQPTLV 86 (288)
T ss_pred HceeeeeecCCCCcEEEEEEEeccCCCCcceEEEEEECCCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCcEE
Confidence 34556889999999999986532 2345799998865432 234568899999999999999999999999999999
Q ss_pred EEEeccCCCccccccCC----------CCCchhHHHHHHHHHHHHHHHHhhccCCCeEecCCCCCcEEEcCCCCeEEeec
Q 003836 577 VYEFMSNGTVASFLFGD----------SKPNWKLRTEIAMGIAGGLFYLHEECCTQIIHCDIKPQNILLDDHYNARISDF 646 (792)
Q Consensus 577 V~E~~~~gsL~~~l~~~----------~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dikp~NILl~~~~~~kl~Df 646 (792)
||||+++|+|.+++... ....+..+.+++.|++.||.|||+. +|+||||||+|||+++++.+||+||
T Consensus 87 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~---~i~H~dikp~nili~~~~~~~L~Df 163 (288)
T cd05061 87 VMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNAK---KFVHRDLAARNCMVAHDFTVKIGDF 163 (288)
T ss_pred EEeCCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhC---CCcCCCCChheEEEcCCCcEEECcC
Confidence 99999999999999642 2345677889999999999999998 9999999999999999999999999
Q ss_pred CCCccccCCCCC-ccccccccCCcccccccccCCCCcccceehHHHHHHHHHh-cCcCCCcchhhhhhhhHHHHHHHhhc
Q 003836 647 GLAKLLTLDQSH-TNTAIRGTKGYVAPEWFRNMPITVKVDVYSYGVLLLEIIC-LRRNIDNEISKVDKAILTDWAYDRYQ 724 (792)
Q Consensus 647 g~a~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~k~DV~S~Gv~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~ 724 (792)
|+++........ ......++..|+|||.+.+..++.++|||||||++|||++ |..||....... ..
T Consensus 164 g~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~DvwslG~~l~el~~~~~~p~~~~~~~~---~~--------- 231 (288)
T cd05061 164 GMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQ---VL--------- 231 (288)
T ss_pred CccccccccccccccCCCcccccccCHHHhccCCCChHhHHHHHHHHHHHHHhCCCCCCCCCCHHH---HH---------
Confidence 999865432221 1122235678999999998899999999999999999998 677875432110 00
Q ss_pred ccchhHhhhchhcccCCHHHHHHHHHHHHHccccCCCCCCCHHhHHHHhccCc
Q 003836 725 ERTLEALVENDLEAMNNVTMLHRFVMVAFWCIQEDPSHRPTMRKVTQMLEGVV 777 (792)
Q Consensus 725 ~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~L~~~~ 777 (792)
..+.+.. ....+......+.+++.+||+.+|++|||+.++++.|++.+
T Consensus 232 ----~~~~~~~-~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~~~ 279 (288)
T cd05061 232 ----KFVMDGG-YLDQPDNCPERVTDLMRMCWQFNPKMRPTFLEIVNLLKDDL 279 (288)
T ss_pred ----HHHHcCC-CCCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHhhc
Confidence 0011110 01112233467899999999999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta |
| >cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-35 Score=307.32 Aligned_cols=251 Identities=26% Similarity=0.436 Sum_probs=193.5
Q ss_pred hhcCccccceEEEeeecC--CCceEEEEEEccccc-ccchHHHHHHHHHhcccCCCCcccccceec-cCCceEEEEEecc
Q 003836 507 EELGRGAFGTVYKGFVNM--GSSNHVAVKKLNSVF-QDSEKEFKAEVNGIGQTHHKNLVRLLGYCD-EGQNRLLVYEFMS 582 (792)
Q Consensus 507 ~~lG~G~~g~Vy~g~~~~--~~~~~vavK~~~~~~-~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~-~~~~~~lV~E~~~ 582 (792)
+.||+|+||.||+|.... .....+|+|++.... ....+.+.+|+.+++.++||||+++++++. .+...++|+||++
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~~~ 80 (262)
T cd05058 1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLSLLGICLPSEGSPLVVLPYMK 80 (262)
T ss_pred CcccccCCceEEEEEEecCCCceEEEEEEecCccCCHHHHHHHHHHHHHHccCCCCCcceEEEEeecCCCCcEEEEecCC
Confidence 368999999999997632 234679999986432 234567889999999999999999999875 4556789999999
Q ss_pred CCCccccccCC-CCCchhHHHHHHHHHHHHHHHHhhccCCCeEecCCCCCcEEEcCCCCeEEeecCCCccccCCCCC---
Q 003836 583 NGTVASFLFGD-SKPNWKLRTEIAMGIAGGLFYLHEECCTQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLDQSH--- 658 (792)
Q Consensus 583 ~gsL~~~l~~~-~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dikp~NILl~~~~~~kl~Dfg~a~~~~~~~~~--- 658 (792)
+|+|.+++... ..+.+..+..++.||+.||+|||+. +++||||||+|||+++++.+||+|||+++........
T Consensus 81 ~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlk~~nili~~~~~~kl~dfg~~~~~~~~~~~~~~ 157 (262)
T cd05058 81 HGDLRNFIRSETHNPTVKDLIGFGLQVAKGMEYLASK---KFVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYSVH 157 (262)
T ss_pred CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhC---CccccccCcceEEEcCCCcEEECCccccccccCCcceeec
Confidence 99999999764 4567788899999999999999998 9999999999999999999999999999865432211
Q ss_pred ccccccccCCcccccccccCCCCcccceehHHHHHHHHHhcCc-CCCcchhhhhhhhHHHHHHHhhcccchhHhhhchhc
Q 003836 659 TNTAIRGTKGYVAPEWFRNMPITVKVDVYSYGVLLLEIICLRR-NIDNEISKVDKAILTDWAYDRYQERTLEALVENDLE 737 (792)
Q Consensus 659 ~~~~~~gt~~y~aPE~~~~~~~~~k~DV~S~Gv~l~el~tg~~-p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 737 (792)
......++..|+|||.+....++.++||||||+++|||++|+. |+...... . +... +.....
T Consensus 158 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~~-~---~~~~-------------~~~~~~ 220 (262)
T cd05058 158 NHTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVDSF-D---ITVY-------------LLQGRR 220 (262)
T ss_pred ccccCcCCccccChhHhccCccchHHHHHHHHHHHHHHHcCCCCCCCCCCHH-H---HHHH-------------HhcCCC
Confidence 1122345678999999988899999999999999999999655 44332111 0 0000 000001
Q ss_pred ccCCHHHHHHHHHHHHHccccCCCCCCCHHhHHHHhccCc
Q 003836 738 AMNNVTMLHRFVMVAFWCIQEDPSHRPTMRKVTQMLEGVV 777 (792)
Q Consensus 738 ~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~L~~~~ 777 (792)
...+...+..+.+++.+||+.+|++||++.||++.|+++.
T Consensus 221 ~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~il~~l~~~~ 260 (262)
T cd05058 221 LLQPEYCPDPLYEVMLSCWHPKPEMRPTFSELVSRIEQIF 260 (262)
T ss_pred CCCCCcCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHh
Confidence 1111223457889999999999999999999999998753
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca |
| >cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-35 Score=319.66 Aligned_cols=238 Identities=23% Similarity=0.266 Sum_probs=190.3
Q ss_pred hhcCccccceEEEeeecCCCceEEEEEEccccc---ccchHHHHHHHH-HhcccCCCCcccccceeccCCceEEEEEecc
Q 003836 507 EELGRGAFGTVYKGFVNMGSSNHVAVKKLNSVF---QDSEKEFKAEVN-GIGQTHHKNLVRLLGYCDEGQNRLLVYEFMS 582 (792)
Q Consensus 507 ~~lG~G~~g~Vy~g~~~~~~~~~vavK~~~~~~---~~~~~~~~~Ei~-~l~~l~h~niv~l~g~~~~~~~~~lV~E~~~ 582 (792)
++||+|+||.||++... .+++.+|+|++.+.. .....++.+|.. +++.++||||+++++++.+.+..++||||++
T Consensus 1 ~~lg~G~~g~Vy~~~~~-~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~~~ 79 (321)
T cd05603 1 KVIGKGSFGKVLLAKRK-SDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLHYSFQTAEKLYFVLDYVN 79 (321)
T ss_pred CeeeeCCCEEEEEEEEC-CCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHHhCCCCCccceeeEEEcCCEEEEEEcCCC
Confidence 36999999999999754 456789999986532 222344555554 5788999999999999999999999999999
Q ss_pred CCCccccccCCCCCchhHHHHHHHHHHHHHHHHhhccCCCeEecCCCCCcEEEcCCCCeEEeecCCCccccCCCCCcccc
Q 003836 583 NGTVASFLFGDSKPNWKLRTEIAMGIAGGLFYLHEECCTQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLDQSHTNTA 662 (792)
Q Consensus 583 ~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dikp~NILl~~~~~~kl~Dfg~a~~~~~~~~~~~~~ 662 (792)
+|+|..++.....+.+..+..++.||+.||.|||+. +|+||||||+|||++.++.+||+|||+++...... .....
T Consensus 80 ~~~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~lH~~---~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~-~~~~~ 155 (321)
T cd05603 80 GGELFFHLQRERCFLEPRARFYAAEVASAIGYLHSL---NIIYRDLKPENILLDSQGHVVLTDFGLCKEGVEPE-ETTST 155 (321)
T ss_pred CCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCCHHHeEECCCCCEEEccCCCCccCCCCC-Ccccc
Confidence 999999988777888999999999999999999998 99999999999999999999999999987542222 22234
Q ss_pred ccccCCcccccccccCCCCcccceehHHHHHHHHHhcCcCCCcchhhhhhhhHHHHHHHhhcccchhHhhhchhcccCCH
Q 003836 663 IRGTKGYVAPEWFRNMPITVKVDVYSYGVLLLEIICLRRNIDNEISKVDKAILTDWAYDRYQERTLEALVENDLEAMNNV 742 (792)
Q Consensus 663 ~~gt~~y~aPE~~~~~~~~~k~DV~S~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 742 (792)
..||+.|+|||.+.+..++.++|||||||++|||++|+.||........ . ..+.... ...+.
T Consensus 156 ~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~---~-------------~~i~~~~--~~~~~ 217 (321)
T cd05603 156 FCGTPEYLAPEVLRKEPYDRTVDWWCLGAVLYEMLYGLPPFYSRDVSQM---Y-------------DNILHKP--LQLPG 217 (321)
T ss_pred ccCCcccCCHHHhcCCCCCCcCcccccchhhhhhhcCCCCCCCCCHHHH---H-------------HHHhcCC--CCCCC
Confidence 5689999999999998999999999999999999999999965421100 0 0111111 11222
Q ss_pred HHHHHHHHHHHHccccCCCCCCCHH
Q 003836 743 TMLHRFVMVAFWCIQEDPSHRPTMR 767 (792)
Q Consensus 743 ~~~~~l~~l~~~Cl~~~p~~RPs~~ 767 (792)
.....+.+++.+||+.+|.+||+..
T Consensus 218 ~~~~~~~~li~~~l~~~p~~R~~~~ 242 (321)
T cd05603 218 GKTVAACDLLVGLLHKDQRRRLGAK 242 (321)
T ss_pred CCCHHHHHHHHHHccCCHhhcCCCC
Confidence 3456788999999999999999764
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. |
| >KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-35 Score=293.56 Aligned_cols=260 Identities=20% Similarity=0.213 Sum_probs=198.5
Q ss_pred hhcCccccceEEEeeecCCCceEEEEEEccccccc--chHHHHHHHHHhcccCCCCcccccceecc--CCceEEEEEecc
Q 003836 507 EELGRGAFGTVYKGFVNMGSSNHVAVKKLNSVFQD--SEKEFKAEVNGIGQTHHKNLVRLLGYCDE--GQNRLLVYEFMS 582 (792)
Q Consensus 507 ~~lG~G~~g~Vy~g~~~~~~~~~vavK~~~~~~~~--~~~~~~~Ei~~l~~l~h~niv~l~g~~~~--~~~~~lV~E~~~ 582 (792)
+.|++|+||.||+|+. ..+.+.||+|+++..... ---.-.+||.+|.+++|||||.+..+... -+..|||||||+
T Consensus 82 nrI~EGtyGiVYRakd-k~t~eIVALKr~kmekek~GFPItsLREIniLl~~~H~NIV~vkEVVvG~~~d~iy~VMe~~E 160 (419)
T KOG0663|consen 82 NRIEEGTYGVVYRAKD-KKTDEIVALKRLKMEKEKEGFPITSLREINILLKARHPNIVEVKEVVVGSNMDKIYIVMEYVE 160 (419)
T ss_pred hhcccCcceeEEEecc-CCcceeEEeeecccccccCCCcchhHHHHHHHHhcCCCCeeeeEEEEeccccceeeeeHHHHH
Confidence 5699999999999974 456789999999754211 12356899999999999999999887754 457999999998
Q ss_pred CCCccccccCCC-CCchhHHHHHHHHHHHHHHHHhhccCCCeEecCCCCCcEEEcCCCCeEEeecCCCccccCCCCCccc
Q 003836 583 NGTVASFLFGDS-KPNWKLRTEIAMGIAGGLFYLHEECCTQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLDQSHTNT 661 (792)
Q Consensus 583 ~gsL~~~l~~~~-~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dikp~NILl~~~~~~kl~Dfg~a~~~~~~~~~~~~ 661 (792)
. +|..++...+ ++...+..-+..|+++|++|||+. .|+|||||++|+|++..|.+||+|||+||.+... ....+
T Consensus 161 h-DLksl~d~m~q~F~~~evK~L~~QlL~glk~lH~~---wilHRDLK~SNLLm~~~G~lKiaDFGLAR~ygsp-~k~~T 235 (419)
T KOG0663|consen 161 H-DLKSLMETMKQPFLPGEVKTLMLQLLRGLKHLHDN---WILHRDLKTSNLLLSHKGILKIADFGLAREYGSP-LKPYT 235 (419)
T ss_pred h-hHHHHHHhccCCCchHHHHHHHHHHHHHHHHHhhc---eeEecccchhheeeccCCcEEecccchhhhhcCC-cccCc
Confidence 8 8999998764 788999999999999999999999 9999999999999999999999999999988654 33445
Q ss_pred cccccCCccccccccc-CCCCcccceehHHHHHHHHHhcCcCCCcchhhhhhhh---HHHHHHHh-h---cccc------
Q 003836 662 AIRGTKGYVAPEWFRN-MPITVKVDVYSYGVLLLEIICLRRNIDNEISKVDKAI---LTDWAYDR-Y---QERT------ 727 (792)
Q Consensus 662 ~~~gt~~y~aPE~~~~-~~~~~k~DV~S~Gv~l~el~tg~~p~~~~~~~~~~~~---~~~~~~~~-~---~~~~------ 727 (792)
..+-|..|+|||.+.+ ..|+...|+||+|||+.|+++++..|....+..+... +...+.+. | .+-.
T Consensus 236 ~lVVTLWYRaPELLLG~~tyst~iDMWSvGCI~aE~l~~kPlf~G~sE~dQl~~If~llGtPte~iwpg~~~lp~~k~~~ 315 (419)
T KOG0663|consen 236 PLVVTLWYRAPELLLGAKTYSTAVDMWSVGCIFAELLTQKPLFPGKSEIDQLDKIFKLLGTPSEAIWPGYSELPAVKKMT 315 (419)
T ss_pred ceEEEeeecCHHHhcCCcccCcchhhhhHHHHHHHHHhcCCCCCCCchHHHHHHHHHHhCCCccccCCCccccchhhccc
Confidence 6677999999999876 5799999999999999999999988866544322111 11111000 0 0000
Q ss_pred hhHhhhchhcccCCHH-HHHHHHHHHHHccccCCCCCCCHHhHHHH
Q 003836 728 LEALVENDLEAMNNVT-MLHRFVMVAFWCIQEDPSHRPTMRKVTQM 772 (792)
Q Consensus 728 ~~~~~~~~~~~~~~~~-~~~~l~~l~~~Cl~~~p~~RPs~~evl~~ 772 (792)
........++..+... ..+.-.+++...|..||.+|.|++|.++.
T Consensus 316 f~~~pyn~lr~kF~~~~lse~g~~Lln~llt~dP~kR~tA~~~L~h 361 (419)
T KOG0663|consen 316 FSEHPYNNLRKKFGALSLSEQGFDLLNKLLTYDPGKRITAEDGLKH 361 (419)
T ss_pred cCCCCchhhhhhccccccchhHHHHHHHHhccCccccccHHHhhcc
Confidence 0011111122222211 34677889999999999999999988864
|
|
| >cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-35 Score=320.33 Aligned_cols=241 Identities=24% Similarity=0.282 Sum_probs=191.5
Q ss_pred hhcCccccceEEEeeecCCCceEEEEEEccccc---ccchHHHHHHHH-HhcccCCCCcccccceeccCCceEEEEEecc
Q 003836 507 EELGRGAFGTVYKGFVNMGSSNHVAVKKLNSVF---QDSEKEFKAEVN-GIGQTHHKNLVRLLGYCDEGQNRLLVYEFMS 582 (792)
Q Consensus 507 ~~lG~G~~g~Vy~g~~~~~~~~~vavK~~~~~~---~~~~~~~~~Ei~-~l~~l~h~niv~l~g~~~~~~~~~lV~E~~~ 582 (792)
+.||+|+||+||++... .+++.+|+|++.... .....++..|.. +++.++|+||+++++++.+.+..++||||++
T Consensus 1 ~~lg~G~fg~V~~~~~~-~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~Iv~~~~~~~~~~~~~lv~e~~~ 79 (325)
T cd05602 1 KVIGKGSFGKVLLARHK-AEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFVLDYIN 79 (325)
T ss_pred CeeeeCCCeEEEEEEEC-CCCCEEEEEEEEHHHHHhhhHHHHHHHHHHHHHHhCCCCCCCceeEEEEcCCeEEEEEeCCC
Confidence 36999999999999754 456789999987532 122334444544 5678899999999999999999999999999
Q ss_pred CCCccccccCCCCCchhHHHHHHHHHHHHHHHHhhccCCCeEecCCCCCcEEEcCCCCeEEeecCCCccccCCCCCcccc
Q 003836 583 NGTVASFLFGDSKPNWKLRTEIAMGIAGGLFYLHEECCTQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLDQSHTNTA 662 (792)
Q Consensus 583 ~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dikp~NILl~~~~~~kl~Dfg~a~~~~~~~~~~~~~ 662 (792)
+|+|.+++.....+.+.....++.||++||.|||+. +|+||||||+|||++.++.+||+|||+++...... .....
T Consensus 80 ~~~L~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~---giiHrDlkp~Nili~~~~~~kl~DfG~a~~~~~~~-~~~~~ 155 (325)
T cd05602 80 GGELFYHLQRERCFLEPRARFYAAEIASALGYLHSL---NIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHN-GTTST 155 (325)
T ss_pred CCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHeEECCCCCEEEccCCCCcccccCC-CCccc
Confidence 999999998877788889999999999999999998 99999999999999999999999999997543222 22334
Q ss_pred ccccCCcccccccccCCCCcccceehHHHHHHHHHhcCcCCCcchhhhhhhhHHHHHHHhhcccchhHhhhchhcccCCH
Q 003836 663 IRGTKGYVAPEWFRNMPITVKVDVYSYGVLLLEIICLRRNIDNEISKVDKAILTDWAYDRYQERTLEALVENDLEAMNNV 742 (792)
Q Consensus 663 ~~gt~~y~aPE~~~~~~~~~k~DV~S~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 742 (792)
..||+.|+|||++.+..++.++|||||||++|||++|+.||........ . ..+..... ....
T Consensus 156 ~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~---~-------------~~i~~~~~--~~~~ 217 (325)
T cd05602 156 FCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEM---Y-------------DNILNKPL--QLKP 217 (325)
T ss_pred ccCCccccCHHHHcCCCCCCccccccccHHHHHHhcCCCCCCCCCHHHH---H-------------HHHHhCCc--CCCC
Confidence 5689999999999999999999999999999999999999965432111 0 00111111 1122
Q ss_pred HHHHHHHHHHHHccccCCCCCCCHHhHH
Q 003836 743 TMLHRFVMVAFWCIQEDPSHRPTMRKVT 770 (792)
Q Consensus 743 ~~~~~l~~l~~~Cl~~~p~~RPs~~evl 770 (792)
.....+.+++.+||+.+|.+||++.+.+
T Consensus 218 ~~~~~~~~li~~~l~~~p~~R~~~~~~~ 245 (325)
T cd05602 218 NITNSARHLLEGLLQKDRTKRLGAKDDF 245 (325)
T ss_pred CCCHHHHHHHHHHcccCHHHCCCCCCCH
Confidence 3456788999999999999999987544
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt |
| >cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-35 Score=307.85 Aligned_cols=252 Identities=27% Similarity=0.390 Sum_probs=191.1
Q ss_pred hhcCccccceEEEeeecC-CCceEEEEEEcccccc-cchHHHHHHHHHhcccCCCCcccccceeccCCceEEEEEeccCC
Q 003836 507 EELGRGAFGTVYKGFVNM-GSSNHVAVKKLNSVFQ-DSEKEFKAEVNGIGQTHHKNLVRLLGYCDEGQNRLLVYEFMSNG 584 (792)
Q Consensus 507 ~~lG~G~~g~Vy~g~~~~-~~~~~vavK~~~~~~~-~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~lV~E~~~~g 584 (792)
+.||+|+||.||+|.... .....+++|+++.... .....+.+|+.++++++||||+++++++.+....++||||+++|
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g 80 (269)
T cd05087 1 KEIGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQCLGQCTEVTPYLLVMEFCPLG 80 (269)
T ss_pred CcccccCCceEEEEEEcCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCCcEEEEECCCCC
Confidence 358999999999997643 3446799999875432 33457899999999999999999999999999999999999999
Q ss_pred CccccccCC-----CCCchhHHHHHHHHHHHHHHHHhhccCCCeEecCCCCCcEEEcCCCCeEEeecCCCccccCCCCC-
Q 003836 585 TVASFLFGD-----SKPNWKLRTEIAMGIAGGLFYLHEECCTQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLDQSH- 658 (792)
Q Consensus 585 sL~~~l~~~-----~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dikp~NILl~~~~~~kl~Dfg~a~~~~~~~~~- 658 (792)
+|.+++... ...++..+.+++.|++.||+|||+. +++|+||||+||+++.++.+||+|||+++........
T Consensus 81 ~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~---~i~H~dlkp~nil~~~~~~~kL~dfg~~~~~~~~~~~~ 157 (269)
T cd05087 81 DLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKN---NFIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYYV 157 (269)
T ss_pred cHHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHC---CEeccccCcceEEEcCCCcEEECCccccccccCcceee
Confidence 999998643 2356778889999999999999998 9999999999999999999999999999754332211
Q ss_pred ccccccccCCcccccccccC-------CCCcccceehHHHHHHHHHh-cCcCCCcchhhhhhhhHHHHHHHhhcccchhH
Q 003836 659 TNTAIRGTKGYVAPEWFRNM-------PITVKVDVYSYGVLLLEIIC-LRRNIDNEISKVDKAILTDWAYDRYQERTLEA 730 (792)
Q Consensus 659 ~~~~~~gt~~y~aPE~~~~~-------~~~~k~DV~S~Gv~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 730 (792)
......++..|+|||++.+. .++.++||||||+++|||++ |+.||......... ... ... ....
T Consensus 158 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~~~----~~~---~~~-~~~~ 229 (269)
T cd05087 158 TPDQLWVPLRWIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPYRHLSDEQVL----TYT---VRE-QQLK 229 (269)
T ss_pred cCCCcCCcccccCHhHhccccccccccCCCccchhHHHHHHHHHHHhCCCCCCCCCChHHHH----HHH---hhc-ccCC
Confidence 12234567889999998642 36889999999999999996 99998653221110 000 000 0001
Q ss_pred hhhchhcccCCHHHHHHHHHHHHHccccCCCCCCCHHhHHHHhc
Q 003836 731 LVENDLEAMNNVTMLHRFVMVAFWCIQEDPSHRPTMRKVTQMLE 774 (792)
Q Consensus 731 ~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~L~ 774 (792)
+..+.. .....+.+.+++..|+ .+|++|||++||+..|+
T Consensus 230 ~~~~~~----~~~~~~~~~~l~~~c~-~~P~~Rpt~~~l~~~l~ 268 (269)
T cd05087 230 LPKPRL----KLPLSDRWYEVMQFCW-LQPEQRPSAEEVHLLLS 268 (269)
T ss_pred CCCCcc----CCCCChHHHHHHHHHh-cCcccCCCHHHHHHHhc
Confidence 111111 1123445777888998 58999999999999885
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells |
| >cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-35 Score=318.50 Aligned_cols=240 Identities=26% Similarity=0.350 Sum_probs=193.9
Q ss_pred hhhhhcCccccceEEEeeecCCCceEEEEEEccccc---ccchHHHHHHHHHhcccC-CCCcccccceeccCCceEEEEE
Q 003836 504 GFKEELGRGAFGTVYKGFVNMGSSNHVAVKKLNSVF---QDSEKEFKAEVNGIGQTH-HKNLVRLLGYCDEGQNRLLVYE 579 (792)
Q Consensus 504 ~~~~~lG~G~~g~Vy~g~~~~~~~~~vavK~~~~~~---~~~~~~~~~Ei~~l~~l~-h~niv~l~g~~~~~~~~~lV~E 579 (792)
++.+.||+|+||.||++... .+++.||+|++.+.. ....+.+..|+.+++.+. |++|+++++++.+.+..++|||
T Consensus 3 ~~~~~lg~G~~g~Vy~~~~~-~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E 81 (323)
T cd05615 3 NFLMVLGKGSFGKVMLAERK-GTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQLHSCFQTVDRLYFVME 81 (323)
T ss_pred eEEEEEEecCCeEEEEEEEC-CCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCchhheeeEEecCCEEEEEEc
Confidence 45678999999999999753 456789999987532 233456788888888875 6778889999999999999999
Q ss_pred eccCCCccccccCCCCCchhHHHHHHHHHHHHHHHHhhccCCCeEecCCCCCcEEEcCCCCeEEeecCCCccccCCCCCc
Q 003836 580 FMSNGTVASFLFGDSKPNWKLRTEIAMGIAGGLFYLHEECCTQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLDQSHT 659 (792)
Q Consensus 580 ~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dikp~NILl~~~~~~kl~Dfg~a~~~~~~~~~~ 659 (792)
|+++|+|.+++.....+++..+..++.||+.||+|||+. +|+||||||+|||++.++.+||+|||+++...... ..
T Consensus 82 y~~~g~L~~~i~~~~~l~~~~~~~i~~qi~~al~~lH~~---~ivHrDikp~Nill~~~~~ikL~Dfg~~~~~~~~~-~~ 157 (323)
T cd05615 82 YVNGGDLMYHIQQVGKFKEPQAVFYAAEISVGLFFLHRR---GIIYRDLKLDNVMLDSEGHIKIADFGMCKEHMVDG-VT 157 (323)
T ss_pred CCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHeEECCCCCEEEeccccccccCCCC-cc
Confidence 999999999998878899999999999999999999998 99999999999999999999999999987543222 12
Q ss_pred cccccccCCcccccccccCCCCcccceehHHHHHHHHHhcCcCCCcchhhhhhhhHHHHHHHhhcccchhHhhhchhccc
Q 003836 660 NTAIRGTKGYVAPEWFRNMPITVKVDVYSYGVLLLEIICLRRNIDNEISKVDKAILTDWAYDRYQERTLEALVENDLEAM 739 (792)
Q Consensus 660 ~~~~~gt~~y~aPE~~~~~~~~~k~DV~S~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 739 (792)
.....||+.|+|||.+.+..++.++|||||||++|||++|+.||........ ...+..... .
T Consensus 158 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~~~~----------------~~~i~~~~~--~ 219 (323)
T cd05615 158 TRTFCGTPDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQPPFDGEDEDEL----------------FQSIMEHNV--S 219 (323)
T ss_pred ccCccCCccccCHHHHcCCCCCCccchhhhHHHHHHHHhCCCCCCCCCHHHH----------------HHHHHhCCC--C
Confidence 2345689999999999998999999999999999999999999975432110 011111111 1
Q ss_pred CCHHHHHHHHHHHHHccccCCCCCCCH
Q 003836 740 NNVTMLHRFVMVAFWCIQEDPSHRPTM 766 (792)
Q Consensus 740 ~~~~~~~~l~~l~~~Cl~~~p~~RPs~ 766 (792)
.+...+.++.+++.+||+.+|.+|++.
T Consensus 220 ~p~~~~~~~~~li~~~l~~~p~~R~~~ 246 (323)
T cd05615 220 YPKSLSKEAVSICKGLMTKHPSKRLGC 246 (323)
T ss_pred CCccCCHHHHHHHHHHcccCHhhCCCC
Confidence 222345678899999999999999985
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a |
| >cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-35 Score=307.56 Aligned_cols=251 Identities=29% Similarity=0.464 Sum_probs=202.3
Q ss_pred HhhhhhhcCccccceEEEeeecCCCceEEEEEEcccccccchHHHHHHHHHhcccCCCCcccccceeccCCceEEEEEec
Q 003836 502 TRGFKEELGRGAFGTVYKGFVNMGSSNHVAVKKLNSVFQDSEKEFKAEVNGIGQTHHKNLVRLLGYCDEGQNRLLVYEFM 581 (792)
Q Consensus 502 ~~~~~~~lG~G~~g~Vy~g~~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~lV~E~~ 581 (792)
.+.+.++||+|++|.||++..+ ..+.++||.+... ....+++.+|+.++++++|+||+++++++......++||||+
T Consensus 7 ~~~i~~~ig~g~~~~v~~~~~~--~~~~~~vK~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~ 83 (261)
T cd05034 7 SLKLERKLGAGQFGEVWMGTWN--GTTKVAVKTLKPG-TMSPEAFLQEAQIMKKLRHDKLVQLYAVCSEEEPIYIVTEYM 83 (261)
T ss_pred heeeeeeeccCcceEEEEEEEc--CCceEEEEEecCC-ccCHHHHHHHHHHHhhCCCCCEeeeeeeeecCCceEEEEecc
Confidence 3445678999999999999754 3467999998754 334578999999999999999999999999989999999999
Q ss_pred cCCCccccccCC--CCCchhHHHHHHHHHHHHHHHHhhccCCCeEecCCCCCcEEEcCCCCeEEeecCCCccccCCCCCc
Q 003836 582 SNGTVASFLFGD--SKPNWKLRTEIAMGIAGGLFYLHEECCTQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLDQSHT 659 (792)
Q Consensus 582 ~~gsL~~~l~~~--~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dikp~NILl~~~~~~kl~Dfg~a~~~~~~~~~~ 659 (792)
++++|.+++... ..+++..+..++.|++.||.|||+. +++|+||||+||++++++.+||+|||+++.........
T Consensus 84 ~~~~L~~~i~~~~~~~~~~~~~~~~~~~i~~al~~lh~~---~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~~~ 160 (261)
T cd05034 84 SKGSLLDFLKSGEGKKLRLPQLVDMAAQIAEGMAYLESR---NYIHRDLAARNILVGENLVCKIADFGLARLIEDDEYTA 160 (261)
T ss_pred CCCCHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCcchheEEEcCCCCEEECccccceeccchhhhh
Confidence 999999999764 3689999999999999999999998 99999999999999999999999999998765322222
Q ss_pred cccccccCCcccccccccCCCCcccceehHHHHHHHHHh-cCcCCCcchhhhhhhhHHHHHHHhhcccchhHhhhchhcc
Q 003836 660 NTAIRGTKGYVAPEWFRNMPITVKVDVYSYGVLLLEIIC-LRRNIDNEISKVDKAILTDWAYDRYQERTLEALVENDLEA 738 (792)
Q Consensus 660 ~~~~~gt~~y~aPE~~~~~~~~~k~DV~S~Gv~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 738 (792)
......+..|+|||.+.+..++.++||||||++++|+++ |+.||....... .+.. + ......
T Consensus 161 ~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~---~~~~-------------~-~~~~~~ 223 (261)
T cd05034 161 REGAKFPIKWTAPEAANYGRFTIKSDVWSFGILLTEIVTYGRVPYPGMTNRE---VLEQ-------------V-ERGYRM 223 (261)
T ss_pred hhccCCCccccCHHHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHHH---HHHH-------------H-HcCCCC
Confidence 222334668999999998889999999999999999998 898885432210 0000 0 011111
Q ss_pred cCCHHHHHHHHHHHHHccccCCCCCCCHHhHHHHhcc
Q 003836 739 MNNVTMLHRFVMVAFWCIQEDPSHRPTMRKVTQMLEG 775 (792)
Q Consensus 739 ~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~L~~ 775 (792)
..+...+.++.+++.+||+.+|++||+++++.+.|+.
T Consensus 224 ~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~~l~~ 260 (261)
T cd05034 224 PRPPNCPEELYDLMLQCWDKDPEERPTFEYLQSFLED 260 (261)
T ss_pred CCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHHhc
Confidence 1122235678899999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t |
| >cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-35 Score=309.74 Aligned_cols=249 Identities=23% Similarity=0.369 Sum_probs=196.1
Q ss_pred hhhhhcCccccceEEEeeecCCCceEEEEEEcccc-cccchHHHHHHHHHhcccCCCCcccccceeccCCceEEEEEecc
Q 003836 504 GFKEELGRGAFGTVYKGFVNMGSSNHVAVKKLNSV-FQDSEKEFKAEVNGIGQTHHKNLVRLLGYCDEGQNRLLVYEFMS 582 (792)
Q Consensus 504 ~~~~~lG~G~~g~Vy~g~~~~~~~~~vavK~~~~~-~~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~lV~E~~~ 582 (792)
.+.+.||+|+||.||+|... .+++.+|+|++... .....+.+.+|++++++++||||+++++++...+..++||||++
T Consensus 4 ~~~~~lg~g~~~~v~~~~~~-~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~ 82 (279)
T cd06619 4 QYQEILGHGNGGTVYKAYHL-LTRRILAVKVIPLDITVELQKQIMSELEILYKCDSPYIIGFYGAFFVENRISICTEFMD 82 (279)
T ss_pred hheeeeccCCCeEEEEEEEc-CCCcEEEEEEEecCCChHHHHHHHHHHHHHHhCCCCCeeeEEEEEEECCEEEEEEecCC
Confidence 34578999999999999654 45678999998653 23345679999999999999999999999999999999999999
Q ss_pred CCCccccccCCCCCchhHHHHHHHHHHHHHHHHhhccCCCeEecCCCCCcEEEcCCCCeEEeecCCCccccCCCCCcccc
Q 003836 583 NGTVASFLFGDSKPNWKLRTEIAMGIAGGLFYLHEECCTQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLDQSHTNTA 662 (792)
Q Consensus 583 ~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dikp~NILl~~~~~~kl~Dfg~a~~~~~~~~~~~~~ 662 (792)
+++|..+. .+++..+..++.|++.||.|||+. +|+|+||||+|||++.++.+||+|||++...... ....
T Consensus 83 ~~~l~~~~----~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nill~~~~~~~l~dfg~~~~~~~~---~~~~ 152 (279)
T cd06619 83 GGSLDVYR----KIPEHVLGRIAVAVVKGLTYLWSL---KILHRDVKPSNMLVNTRGQVKLCDFGVSTQLVNS---IAKT 152 (279)
T ss_pred CCChHHhh----cCCHHHHHHHHHHHHHHHHHHHHC---CEeeCCCCHHHEEECCCCCEEEeeCCcceecccc---cccC
Confidence 99997653 467888899999999999999998 9999999999999999999999999999865322 2233
Q ss_pred ccccCCcccccccccCCCCcccceehHHHHHHHHHhcCcCCCcchhhhhhhhHHHHHHHhhcccchhHhhhchhcccCCH
Q 003836 663 IRGTKGYVAPEWFRNMPITVKVDVYSYGVLLLEIICLRRNIDNEISKVDKAILTDWAYDRYQERTLEALVENDLEAMNNV 742 (792)
Q Consensus 663 ~~gt~~y~aPE~~~~~~~~~k~DV~S~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 742 (792)
..++..|+|||.+.+..++.++||||||+++|||++|+.||............... ...+.+.........
T Consensus 153 ~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~---------~~~~~~~~~~~~~~~ 223 (279)
T cd06619 153 YVGTNAYMAPERISGEQYGIHSDVWSLGISFMELALGRFPYPQIQKNQGSLMPLQL---------LQCIVDEDPPVLPVG 223 (279)
T ss_pred CCCChhhcCceeecCCCCCCcchHHHHHHHHHHHHhCCCCchhhcccccccchHHH---------HHHHhccCCCCCCCC
Confidence 46899999999999989999999999999999999999998653221111000000 011111111111112
Q ss_pred HHHHHHHHHHHHccccCCCCCCCHHhHHHH
Q 003836 743 TMLHRFVMVAFWCIQEDPSHRPTMRKVTQM 772 (792)
Q Consensus 743 ~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~ 772 (792)
....++.+++.+||+.+|++||+++|+++.
T Consensus 224 ~~~~~~~~li~~~l~~~P~~Rp~~~eil~~ 253 (279)
T cd06619 224 QFSEKFVHFITQCMRKQPKERPAPENLMDH 253 (279)
T ss_pred cCCHHHHHHHHHHhhCChhhCCCHHHHhcC
Confidence 244578899999999999999999999873
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p |
| >cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-35 Score=306.81 Aligned_cols=251 Identities=26% Similarity=0.415 Sum_probs=200.3
Q ss_pred HHhhhhhhcCccccceEEEeeecCCCceEEEEEEcccccccchHHHHHHHHHhcccCCCCcccccceeccCCceEEEEEe
Q 003836 501 VTRGFKEELGRGAFGTVYKGFVNMGSSNHVAVKKLNSVFQDSEKEFKAEVNGIGQTHHKNLVRLLGYCDEGQNRLLVYEF 580 (792)
Q Consensus 501 ~~~~~~~~lG~G~~g~Vy~g~~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~lV~E~ 580 (792)
..+.+.++||+|+||.||++... .+..+++|.+... ....+.+.+|+.++++++|+||+++.+++.+ ...+++|||
T Consensus 6 ~~~~~~~~lg~g~~~~vy~~~~~--~~~~~~iK~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~~~~~v~e~ 81 (260)
T cd05073 6 ESLKLEKKLGAGQFGEVWMATYN--KHTKVAVKTMKPG-SMSVEAFLAEANVMKTLQHDKLVKLHAVVTK-EPIYIITEF 81 (260)
T ss_pred cceeEEeEecCccceEEEEEEec--CCccEEEEecCCC-hhHHHHHHHHHHHHHhcCCCCcceEEEEEcC-CCeEEEEEe
Confidence 34556788999999999999754 3346999988753 2345678999999999999999999999887 778999999
Q ss_pred ccCCCccccccCC--CCCchhHHHHHHHHHHHHHHHHhhccCCCeEecCCCCCcEEEcCCCCeEEeecCCCccccCCCCC
Q 003836 581 MSNGTVASFLFGD--SKPNWKLRTEIAMGIAGGLFYLHEECCTQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLDQSH 658 (792)
Q Consensus 581 ~~~gsL~~~l~~~--~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dikp~NILl~~~~~~kl~Dfg~a~~~~~~~~~ 658 (792)
+++++|.+++... ..+++..+..++.|++.||.|||+. +++|+||||+||+++.++.+||+|||.++........
T Consensus 82 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~~---~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~ 158 (260)
T cd05073 82 MAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQR---NYIHRDLRAANILVSASLVCKIADFGLARVIEDNEYT 158 (260)
T ss_pred CCCCcHHHHHHhCCccccCHHHHHHHHHHHHHHHHHHHhC---CccccccCcceEEEcCCCcEEECCCcceeeccCCCcc
Confidence 9999999999753 4578889999999999999999998 9999999999999999999999999999876433322
Q ss_pred ccccccccCCcccccccccCCCCcccceehHHHHHHHHHh-cCcCCCcchhhhhhhhHHHHHHHhhcccchhHhhhchhc
Q 003836 659 TNTAIRGTKGYVAPEWFRNMPITVKVDVYSYGVLLLEIIC-LRRNIDNEISKVDKAILTDWAYDRYQERTLEALVENDLE 737 (792)
Q Consensus 659 ~~~~~~gt~~y~aPE~~~~~~~~~k~DV~S~Gv~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 737 (792)
......++..|+|||.+....++.++||||||++++++++ |+.||......... . . +.....
T Consensus 159 ~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~~~----~----~---------~~~~~~ 221 (260)
T cd05073 159 AREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVI----R----A---------LERGYR 221 (260)
T ss_pred cccCCcccccccCHhHhccCCcCccccchHHHHHHHHHHhcCCCCCCCCCHHHHH----H----H---------HhCCCC
Confidence 2223345678999999998889999999999999999999 88888643221100 0 0 011111
Q ss_pred ccCCHHHHHHHHHHHHHccccCCCCCCCHHhHHHHhcc
Q 003836 738 AMNNVTMLHRFVMVAFWCIQEDPSHRPTMRKVTQMLEG 775 (792)
Q Consensus 738 ~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~L~~ 775 (792)
.......+..+.+++.+|++.+|++||++.+++++|+.
T Consensus 222 ~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~~L~~ 259 (260)
T cd05073 222 MPRPENCPEELYNIMMRCWKNRPEERPTFEYIQSVLDD 259 (260)
T ss_pred CCCcccCCHHHHHHHHHHcccCcccCcCHHHHHHHHhc
Confidence 11122345678899999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa |
| >cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-35 Score=309.55 Aligned_cols=255 Identities=22% Similarity=0.302 Sum_probs=202.6
Q ss_pred HhhhhhhcCccccceEEEeeecCC--CceEEEEEEccccc-ccchHHHHHHHHHhcccCCCCcccccceeccCCceEEEE
Q 003836 502 TRGFKEELGRGAFGTVYKGFVNMG--SSNHVAVKKLNSVF-QDSEKEFKAEVNGIGQTHHKNLVRLLGYCDEGQNRLLVY 578 (792)
Q Consensus 502 ~~~~~~~lG~G~~g~Vy~g~~~~~--~~~~vavK~~~~~~-~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~lV~ 578 (792)
...+.+.||+|+||.||+|..... ....+++|+..... ....+.+.+|+.++++++|+||+++++++.+ ...++||
T Consensus 7 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~-~~~~lv~ 85 (270)
T cd05056 7 DITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIVKLIGVITE-NPVWIVM 85 (270)
T ss_pred hceeeeeeCCccceeEEEEEEecCCCCCcceEEEecCCcCCHHHHHHHHHHHHHHHhCCCCchhceeEEEcC-CCcEEEE
Confidence 344567899999999999976432 23578999887654 3445689999999999999999999999875 4578999
Q ss_pred EeccCCCccccccCC-CCCchhHHHHHHHHHHHHHHHHhhccCCCeEecCCCCCcEEEcCCCCeEEeecCCCccccCCCC
Q 003836 579 EFMSNGTVASFLFGD-SKPNWKLRTEIAMGIAGGLFYLHEECCTQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLDQS 657 (792)
Q Consensus 579 E~~~~gsL~~~l~~~-~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dikp~NILl~~~~~~kl~Dfg~a~~~~~~~~ 657 (792)
||+++|+|.+++... ..+++..+..++.|++.||+|||+. +++|+||||+|||++.++.+||+|||+++.......
T Consensus 86 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~l~~~l~~lH~~---~~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~ 162 (270)
T cd05056 86 ELAPLGELRSYLQVNKYSLDLASLILYSYQLSTALAYLESK---RFVHRDIAARNVLVSSPDCVKLGDFGLSRYLEDESY 162 (270)
T ss_pred EcCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccccChheEEEecCCCeEEccCceeeecccccc
Confidence 999999999999764 4589999999999999999999998 999999999999999999999999999987654432
Q ss_pred CccccccccCCcccccccccCCCCcccceehHHHHHHHHHh-cCcCCCcchhhhhhhhHHHHHHHhhcccchhHhhhchh
Q 003836 658 HTNTAIRGTKGYVAPEWFRNMPITVKVDVYSYGVLLLEIIC-LRRNIDNEISKVDKAILTDWAYDRYQERTLEALVENDL 736 (792)
Q Consensus 658 ~~~~~~~gt~~y~aPE~~~~~~~~~k~DV~S~Gv~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 736 (792)
.......++..|+|||.+....++.++||||||++++|+++ |..||.......... .... ..
T Consensus 163 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~~~~~--------~~~~---------~~ 225 (270)
T cd05056 163 YKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMLGVKPFQGVKNNDVIG--------RIEN---------GE 225 (270)
T ss_pred eecCCCCccccccChhhhccCCCCchhhhHHHHHHHHHHHHcCCCCCCCCCHHHHHH--------HHHc---------CC
Confidence 22223334568999999988889999999999999999986 999986543221100 0000 00
Q ss_pred cccCCHHHHHHHHHHHHHccccCCCCCCCHHhHHHHhccCc
Q 003836 737 EAMNNVTMLHRFVMVAFWCIQEDPSHRPTMRKVTQMLEGVV 777 (792)
Q Consensus 737 ~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~L~~~~ 777 (792)
....+...+..+.+++.+|+..+|++|||+.++++.|+++.
T Consensus 226 ~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~~~~l~~~~ 266 (270)
T cd05056 226 RLPMPPNCPPTLYSLMTKCWAYDPSKRPRFTELKAQLSDIL 266 (270)
T ss_pred cCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHH
Confidence 11112234567889999999999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions |
| >cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-35 Score=316.94 Aligned_cols=258 Identities=26% Similarity=0.353 Sum_probs=202.0
Q ss_pred HHhhhhhhcCccccceEEEeeecC------CCceEEEEEEccccc-ccchHHHHHHHHHhccc-CCCCcccccceeccCC
Q 003836 501 VTRGFKEELGRGAFGTVYKGFVNM------GSSNHVAVKKLNSVF-QDSEKEFKAEVNGIGQT-HHKNLVRLLGYCDEGQ 572 (792)
Q Consensus 501 ~~~~~~~~lG~G~~g~Vy~g~~~~------~~~~~vavK~~~~~~-~~~~~~~~~Ei~~l~~l-~h~niv~l~g~~~~~~ 572 (792)
..+.+.+.||+|+||.||++.... .....+|+|.+.... .....++.+|+++++++ +|+||+++++++.+.+
T Consensus 18 ~~~~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~ 97 (307)
T cd05098 18 DRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDG 97 (307)
T ss_pred HHeEEeeeeccCCCeeEEEeEEeccCCcccCccceEEEEeccCCCChHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecCC
Confidence 345567899999999999986532 122469999987532 33446788999999999 7999999999999999
Q ss_pred ceEEEEEeccCCCccccccCC----------------CCCchhHHHHHHHHHHHHHHHHhhccCCCeEecCCCCCcEEEc
Q 003836 573 NRLLVYEFMSNGTVASFLFGD----------------SKPNWKLRTEIAMGIAGGLFYLHEECCTQIIHCDIKPQNILLD 636 (792)
Q Consensus 573 ~~~lV~E~~~~gsL~~~l~~~----------------~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dikp~NILl~ 636 (792)
..++||||+++|+|.+++... ..+++.++++++.|++.||+|||+. +++|+||||+|||++
T Consensus 98 ~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~---gi~H~dlkp~Nill~ 174 (307)
T cd05098 98 PLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLASK---KCIHRDLAARNVLVT 174 (307)
T ss_pred ceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHC---CcccccccHHheEEc
Confidence 999999999999999999653 2478889999999999999999998 999999999999999
Q ss_pred CCCCeEEeecCCCccccCCCCCc-cccccccCCcccccccccCCCCcccceehHHHHHHHHHh-cCcCCCcchhhhhhhh
Q 003836 637 DHYNARISDFGLAKLLTLDQSHT-NTAIRGTKGYVAPEWFRNMPITVKVDVYSYGVLLLEIIC-LRRNIDNEISKVDKAI 714 (792)
Q Consensus 637 ~~~~~kl~Dfg~a~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~k~DV~S~Gv~l~el~t-g~~p~~~~~~~~~~~~ 714 (792)
.++.+||+|||.++......... .....+++.|+|||.+.+..++.++|||||||++|||++ |+.||.......
T Consensus 175 ~~~~~kL~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~~g~~p~~~~~~~~---- 250 (307)
T cd05098 175 EDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEE---- 250 (307)
T ss_pred CCCcEEECCCcccccccccchhhccccCCCccceeChHHhccCCCCcHHHHHHHHHHHHHHHcCCCCCCCcCCHHH----
Confidence 99999999999997654322111 112234568999999998889999999999999999998 777775432110
Q ss_pred HHHHHHHhhcccchhHhhhchhcccCCHHHHHHHHHHHHHccccCCCCCCCHHhHHHHhccCcC
Q 003836 715 LTDWAYDRYQERTLEALVENDLEAMNNVTMLHRFVMVAFWCIQEDPSHRPTMRKVTQMLEGVVE 778 (792)
Q Consensus 715 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~L~~~~~ 778 (792)
+...+........+...+.++.+++.+||+.+|++||++.+|++.|+.+++
T Consensus 251 -------------~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~evl~~l~~~~~ 301 (307)
T cd05098 251 -------------LFKLLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILA 301 (307)
T ss_pred -------------HHHHHHcCCCCCCCCcCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHHH
Confidence 000111111112223345688899999999999999999999999988654
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-35 Score=314.72 Aligned_cols=262 Identities=22% Similarity=0.315 Sum_probs=200.1
Q ss_pred hhhhhcCccccceEEEeeecCCCceEEEEEEccccc-ccchHHHHHHHHHhcccCCCCcccccceeccCCceEEEEEecc
Q 003836 504 GFKEELGRGAFGTVYKGFVNMGSSNHVAVKKLNSVF-QDSEKEFKAEVNGIGQTHHKNLVRLLGYCDEGQNRLLVYEFMS 582 (792)
Q Consensus 504 ~~~~~lG~G~~g~Vy~g~~~~~~~~~vavK~~~~~~-~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~lV~E~~~ 582 (792)
.+.+.||+|+||.||++... .++..+|+|.+.... .....++.+|++++.+++||||+++++++.+++..++||||++
T Consensus 4 ~~~~~lg~G~~g~v~~~~~~-~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ey~~ 82 (308)
T cd06615 4 EKLGELGAGNGGVVTKVLHR-PSGLIMARKLIHLEIKPAIRNQIIRELKVLHECNSPYIVGFYGAFYSDGEISICMEHMD 82 (308)
T ss_pred eEEeeccCCCCeEEEEEEEc-CCCeEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCEEEEEeeccC
Confidence 34578999999999999754 456789999886532 2334678899999999999999999999999999999999999
Q ss_pred CCCccccccCCCCCchhHHHHHHHHHHHHHHHHhhccCCCeEecCCCCCcEEEcCCCCeEEeecCCCccccCCCCCcccc
Q 003836 583 NGTVASFLFGDSKPNWKLRTEIAMGIAGGLFYLHEECCTQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLDQSHTNTA 662 (792)
Q Consensus 583 ~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dikp~NILl~~~~~~kl~Dfg~a~~~~~~~~~~~~~ 662 (792)
+++|.+++.....+++..+..++.||++||.|||+. .+++|+||||+|||++.++.+||+|||++...... ....
T Consensus 83 ~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~--~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~---~~~~ 157 (308)
T cd06615 83 GGSLDQVLKKAGRIPENILGKISIAVLRGLTYLREK--HKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS---MANS 157 (308)
T ss_pred CCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhh--CCEEECCCChHHEEEecCCcEEEccCCCccccccc---cccc
Confidence 999999998878889999999999999999999973 28999999999999999999999999998755322 1223
Q ss_pred ccccCCcccccccccCCCCcccceehHHHHHHHHHhcCcCCCcchhhhhhhhHHHHHHHhhcc-----------------
Q 003836 663 IRGTKGYVAPEWFRNMPITVKVDVYSYGVLLLEIICLRRNIDNEISKVDKAILTDWAYDRYQE----------------- 725 (792)
Q Consensus 663 ~~gt~~y~aPE~~~~~~~~~k~DV~S~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~----------------- 725 (792)
..+++.|+|||.+.+..++.++||||||+++|||++|+.||...........+.. .......
T Consensus 158 ~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~ 236 (308)
T cd06615 158 FVGTRSYMSPERLQGTHYTVQSDIWSLGLSLVEMAIGRYPIPPPDAKELEAMFGR-PVSEGEAKESHRPVSGHPPDSPRP 236 (308)
T ss_pred CCCCcCccChhHhcCCCCCccchHHHHHHHHHHHHhCCCCCCCcchhhHHHhhcC-ccccccccCCcccccCCCCCccch
Confidence 4688999999999888899999999999999999999999864322111000000 0000000
Q ss_pred cchhHhhhchh---cccC-CHHHHHHHHHHHHHccccCCCCCCCHHhHHHH
Q 003836 726 RTLEALVENDL---EAMN-NVTMLHRFVMVAFWCIQEDPSHRPTMRKVTQM 772 (792)
Q Consensus 726 ~~~~~~~~~~~---~~~~-~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~ 772 (792)
....++.+... .... ......++.+++.+||+.+|++||+++||++.
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~ 287 (308)
T cd06615 237 MAIFELLDYIVNEPPPKLPSGAFSDEFQDFVDKCLKKNPKERADLKELTKH 287 (308)
T ss_pred hhHHHHHHHHhcCCCccCcCcccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 00000111000 0000 11245578899999999999999999999985
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down |
| >PTZ00283 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-35 Score=335.11 Aligned_cols=250 Identities=24% Similarity=0.292 Sum_probs=198.8
Q ss_pred HhhhhhhcCccccceEEEeeecCCCceEEEEEEcccc--cccchHHHHHHHHHhcccCCCCcccccceeccCC-------
Q 003836 502 TRGFKEELGRGAFGTVYKGFVNMGSSNHVAVKKLNSV--FQDSEKEFKAEVNGIGQTHHKNLVRLLGYCDEGQ------- 572 (792)
Q Consensus 502 ~~~~~~~lG~G~~g~Vy~g~~~~~~~~~vavK~~~~~--~~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~------- 572 (792)
.+.+.+.||+|+||+||++... .+++.||||++... .......+.+|+..+..++|+||++++..+....
T Consensus 33 rY~i~~~LG~G~fG~Vy~a~~~-~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~~~h~~iv~~~~~~~~~~~~~~~~~ 111 (496)
T PTZ00283 33 KYWISRVLGSGATGTVLCAKRV-SDGEPFAVKVVDMEGMSEADKNRAQAEVCCLLNCDFFSIVKCHEDFAKKDPRNPENV 111 (496)
T ss_pred CEEEEEEEecCCCEEEEEEEEc-CCCCEEEEEEEecccCCHHHHHHHHHHHHHHhcCCCCcEEEeecceecccccCcccc
Confidence 3456688999999999999753 45679999998653 2334567889999999999999999988774332
Q ss_pred -ceEEEEEeccCCCccccccCC----CCCchhHHHHHHHHHHHHHHHHhhccCCCeEecCCCCCcEEEcCCCCeEEeecC
Q 003836 573 -NRLLVYEFMSNGTVASFLFGD----SKPNWKLRTEIAMGIAGGLFYLHEECCTQIIHCDIKPQNILLDDHYNARISDFG 647 (792)
Q Consensus 573 -~~~lV~E~~~~gsL~~~l~~~----~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dikp~NILl~~~~~~kl~Dfg 647 (792)
..++||||+++|+|.+++... ..+++..+..++.|++.||.|||+. +|+||||||+|||++.++.+||+|||
T Consensus 112 ~~i~lV~Ey~~~gsL~~~l~~~~~~~~~l~e~~~~~i~~qll~aL~~lH~~---~IiHrDLKP~NILl~~~~~vkL~DFG 188 (496)
T PTZ00283 112 LMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAVHHVHSK---HMIHRDIKSANILLCSNGLVKLGDFG 188 (496)
T ss_pred eEEEEEEeCCCCCcHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEEeCCCCEEEEecc
Confidence 367999999999999988643 4678889999999999999999998 99999999999999999999999999
Q ss_pred CCccccCCCC-CccccccccCCcccccccccCCCCcccceehHHHHHHHHHhcCcCCCcchhhhhhhhHHHHHHHhhccc
Q 003836 648 LAKLLTLDQS-HTNTAIRGTKGYVAPEWFRNMPITVKVDVYSYGVLLLEIICLRRNIDNEISKVDKAILTDWAYDRYQER 726 (792)
Q Consensus 648 ~a~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~k~DV~S~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 726 (792)
+++....... .......||+.|+|||.+.+..++.++|||||||++|||++|+.||........ .
T Consensus 189 ls~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~k~DVwSlGvilyeLltG~~Pf~~~~~~~~-------~------- 254 (496)
T PTZ00283 189 FSKMYAATVSDDVGRTFCGTPYYVAPEIWRRKPYSKKADMFSLGVLLYELLTLKRPFDGENMEEV-------M------- 254 (496)
T ss_pred cCeeccccccccccccccCCcceeCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHH-------H-------
Confidence 9987653322 223346799999999999999999999999999999999999999965422100 0
Q ss_pred chhHhhhchhcccCCHHHHHHHHHHHHHccccCCCCCCCHHhHHHH
Q 003836 727 TLEALVENDLEAMNNVTMLHRFVMVAFWCIQEDPSHRPTMRKVTQM 772 (792)
Q Consensus 727 ~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~ 772 (792)
....... ....+...+.++.+++.+||+.+|.+||++.+++++
T Consensus 255 --~~~~~~~-~~~~~~~~~~~l~~li~~~L~~dP~~RPs~~ell~~ 297 (496)
T PTZ00283 255 --HKTLAGR-YDPLPPSISPEMQEIVTALLSSDPKRRPSSSKLLNM 297 (496)
T ss_pred --HHHhcCC-CCCCCCCCCHHHHHHHHHHcccChhhCcCHHHHHhC
Confidence 0001000 111223445678899999999999999999999864
|
|
| >KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-36 Score=321.35 Aligned_cols=247 Identities=24% Similarity=0.320 Sum_probs=208.1
Q ss_pred hhhhcCccccceEEEeeecCCCc--eEEEEEEccccccc-chHHHHHHHHHhcccCCCCcccccceeccCCceEEEEEec
Q 003836 505 FKEELGRGAFGTVYKGFVNMGSS--NHVAVKKLNSVFQD-SEKEFKAEVNGIGQTHHKNLVRLLGYCDEGQNRLLVYEFM 581 (792)
Q Consensus 505 ~~~~lG~G~~g~Vy~g~~~~~~~--~~vavK~~~~~~~~-~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~lV~E~~ 581 (792)
+.|+||+|.||.|++|.+...++ ..||||.++..... ...+|.+|+.+|.+|+|+|+++|||+..+ ....+|+|.+
T Consensus 114 l~e~LG~GsFgvV~rg~Wt~psgk~V~VAVKclr~d~l~~~mddflrEas~M~~L~H~hliRLyGvVl~-qp~mMV~ELa 192 (1039)
T KOG0199|consen 114 LYELLGEGSFGVVKRGTWTQPSGKHVNVAVKCLRDDSLNAIMDDFLREASHMLKLQHPHLIRLYGVVLD-QPAMMVFELA 192 (1039)
T ss_pred HHHHhcCcceeeEeeccccCCCCcEEeEEEEeccCCccchhHHHHHHHHHHHHhccCcceeEEeeeecc-chhhHHhhhc
Confidence 45789999999999999876444 57999999865443 67899999999999999999999999988 7889999999
Q ss_pred cCCCccccccCC--CCCchhHHHHHHHHHHHHHHHHhhccCCCeEecCCCCCcEEEcCCCCeEEeecCCCccccCCCCCc
Q 003836 582 SNGTVASFLFGD--SKPNWKLRTEIAMGIAGGLFYLHEECCTQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLDQSHT 659 (792)
Q Consensus 582 ~~gsL~~~l~~~--~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dikp~NILl~~~~~~kl~Dfg~a~~~~~~~~~~ 659 (792)
+.|||.+.|++. ..+-......++.|||.||.||..+ +.|||||.++|+||-....+||+|||+.+-+...+...
T Consensus 193 plGSLldrLrka~~~~llv~~Lcdya~QiA~aM~YLesk---rlvHRDLAARNlllasprtVKI~DFGLmRaLg~ned~Y 269 (1039)
T KOG0199|consen 193 PLGSLLDRLRKAKKAILLVSRLCDYAMQIAKAMQYLESK---RLVHRDLAARNLLLASPRTVKICDFGLMRALGENEDMY 269 (1039)
T ss_pred ccchHHHHHhhccccceeHHHHHHHHHHHHHHHHHHhhh---hhhhhhhhhhhheecccceeeeecccceeccCCCCcce
Confidence 999999999873 3567788889999999999999999 99999999999999999999999999999887665544
Q ss_pred ccc--ccccCCcccccccccCCCCcccceehHHHHHHHHHh-cCcCCCcchhhhhhhhHHHHHHHhhcccchhHhhhchh
Q 003836 660 NTA--IRGTKGYVAPEWFRNMPITVKVDVYSYGVLLLEIIC-LRRNIDNEISKVDKAILTDWAYDRYQERTLEALVENDL 736 (792)
Q Consensus 660 ~~~--~~gt~~y~aPE~~~~~~~~~k~DV~S~Gv~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 736 (792)
... ..-...|.|||.+....|+.++|||+|||.||||+| |+.||-.... ..+...+|..-
T Consensus 270 vm~p~rkvPfAWCaPEsLrh~kFShaSDvWmyGVTiWEMFtyGEePW~G~~g-----------------~qIL~~iD~~e 332 (1039)
T KOG0199|consen 270 VMAPQRKVPFAWCAPESLRHRKFSHASDVWMYGVTIWEMFTYGEEPWVGCRG-----------------IQILKNIDAGE 332 (1039)
T ss_pred EecCCCcCcccccCHhHhccccccccchhhhhhhhHHhhhccCCCCCCCCCH-----------------HHHHHhccccc
Confidence 221 234568999999999999999999999999999998 4566643211 12233444445
Q ss_pred cccCCHHHHHHHHHHHHHccccCCCCCCCHHhHHHH
Q 003836 737 EAMNNVTMLHRFVMVAFWCIQEDPSHRPTMRKVTQM 772 (792)
Q Consensus 737 ~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~ 772 (792)
+...+..++++++++++.||..+|++|||+..|.+.
T Consensus 333 rLpRPk~csedIY~imk~cWah~paDRptFsair~~ 368 (1039)
T KOG0199|consen 333 RLPRPKYCSEDIYQIMKNCWAHNPADRPTFSAIRED 368 (1039)
T ss_pred cCCCCCCChHHHHHHHHHhccCCccccccHHHHHHh
Confidence 555677889999999999999999999999999743
|
|
| >cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-35 Score=311.91 Aligned_cols=260 Identities=22% Similarity=0.328 Sum_probs=198.1
Q ss_pred hhhhhhcCccccceEEEeeec---------------CCCceEEEEEEccccc-ccchHHHHHHHHHhcccCCCCcccccc
Q 003836 503 RGFKEELGRGAFGTVYKGFVN---------------MGSSNHVAVKKLNSVF-QDSEKEFKAEVNGIGQTHHKNLVRLLG 566 (792)
Q Consensus 503 ~~~~~~lG~G~~g~Vy~g~~~---------------~~~~~~vavK~~~~~~-~~~~~~~~~Ei~~l~~l~h~niv~l~g 566 (792)
+.+.+.||+|+||.||++... .++...+|+|++.... .....++.+|+.++++++|+||+++++
T Consensus 7 ~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~~~ 86 (296)
T cd05095 7 LTFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNARNDFLKEIKIMSRLKDPNIIRLLA 86 (296)
T ss_pred ceeeeeccCCCCCeEEecccccccccccccccccCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceEEE
Confidence 456678999999999997532 2234579999987542 334568999999999999999999999
Q ss_pred eeccCCceEEEEEeccCCCccccccCCC-----------CCchhHHHHHHHHHHHHHHHHhhccCCCeEecCCCCCcEEE
Q 003836 567 YCDEGQNRLLVYEFMSNGTVASFLFGDS-----------KPNWKLRTEIAMGIAGGLFYLHEECCTQIIHCDIKPQNILL 635 (792)
Q Consensus 567 ~~~~~~~~~lV~E~~~~gsL~~~l~~~~-----------~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dikp~NILl 635 (792)
++...+..++||||+++++|.+++.... .+++..+.+++.||+.||+|||+. +++|+||||+|||+
T Consensus 87 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~---~i~H~dlkp~Nili 163 (296)
T cd05095 87 VCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSSL---NFVHRDLATRNCLV 163 (296)
T ss_pred EEecCCccEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHHHHHHHHHC---CeecccCChheEEE
Confidence 9999999999999999999999986532 356778999999999999999998 99999999999999
Q ss_pred cCCCCeEEeecCCCccccCCCCCc-cccccccCCcccccccccCCCCcccceehHHHHHHHHHh--cCcCCCcchhhhhh
Q 003836 636 DDHYNARISDFGLAKLLTLDQSHT-NTAIRGTKGYVAPEWFRNMPITVKVDVYSYGVLLLEIIC--LRRNIDNEISKVDK 712 (792)
Q Consensus 636 ~~~~~~kl~Dfg~a~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~k~DV~S~Gv~l~el~t--g~~p~~~~~~~~~~ 712 (792)
++++.+||+|||+++.+....... .....+++.|+|||......++.++|||||||++|||++ |..||.........
T Consensus 164 ~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~DiwSlG~~l~el~~~~~~~p~~~~~~~~~~ 243 (296)
T cd05095 164 GKNYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEILTLCKEQPYSQLSDEQVI 243 (296)
T ss_pred cCCCCEEeccCcccccccCCcceeccCcCcCccccCCHHHHhcCCccchhhhhHHHHHHHHHHHhCCCCCccccChHHHH
Confidence 999999999999998654322211 112234678999999888889999999999999999998 66777543221110
Q ss_pred hhHHHHHHHhhcccchhHhhhchhcccCCHHHHHHHHHHHHHccccCCCCCCCHHhHHHHhcc
Q 003836 713 AILTDWAYDRYQERTLEALVENDLEAMNNVTMLHRFVMVAFWCIQEDPSHRPTMRKVTQMLEG 775 (792)
Q Consensus 713 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~L~~ 775 (792)
.....+ +..... ......+...+..+.+++.+||+.+|.+||++.||.+.|+.
T Consensus 244 ~~~~~~----~~~~~~------~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~~ 296 (296)
T cd05095 244 ENTGEF----FRDQGR------QVYLPKPALCPDSLYKLMLSCWRRNAKERPSFQEIHATLLE 296 (296)
T ss_pred HHHHHH----Hhhccc------cccCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHHhC
Confidence 000000 000000 00001122244678899999999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit |
| >cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-35 Score=311.86 Aligned_cols=253 Identities=24% Similarity=0.370 Sum_probs=199.3
Q ss_pred hhhhhhcCccccceEEEeeecC----CCceEEEEEEcccccc-cchHHHHHHHHHhcccCCCCcccccceeccCCceEEE
Q 003836 503 RGFKEELGRGAFGTVYKGFVNM----GSSNHVAVKKLNSVFQ-DSEKEFKAEVNGIGQTHHKNLVRLLGYCDEGQNRLLV 577 (792)
Q Consensus 503 ~~~~~~lG~G~~g~Vy~g~~~~----~~~~~vavK~~~~~~~-~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~lV 577 (792)
+.+.+.||+|+||.||++.... .+...+|+|++..... ...+++.+|+.++++++||||+++++++.++...++|
T Consensus 7 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~ei~~l~~l~h~~iv~~~~~~~~~~~~~lv 86 (288)
T cd05050 7 IEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDHPNIVKLLGVCAVGKPMCLL 86 (288)
T ss_pred ceecccccccccccEEEEEEcccCCCCcceeEEEEecCCCcCHHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCccEEE
Confidence 3445789999999999997532 2457899999875432 3456799999999999999999999999999999999
Q ss_pred EEeccCCCccccccCC----------------------CCCchhHHHHHHHHHHHHHHHHhhccCCCeEecCCCCCcEEE
Q 003836 578 YEFMSNGTVASFLFGD----------------------SKPNWKLRTEIAMGIAGGLFYLHEECCTQIIHCDIKPQNILL 635 (792)
Q Consensus 578 ~E~~~~gsL~~~l~~~----------------------~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dikp~NILl 635 (792)
|||+++|+|.+++... ..+++..++.++.|++.||+|||+. +++||||||+|||+
T Consensus 87 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~lH~~---~i~H~dl~p~nil~ 163 (288)
T cd05050 87 FEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSER---KFVHRDLATRNCLV 163 (288)
T ss_pred EecCCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhC---CeecccccHhheEe
Confidence 9999999999998642 1367788899999999999999998 99999999999999
Q ss_pred cCCCCeEEeecCCCccccCCCCC-ccccccccCCcccccccccCCCCcccceehHHHHHHHHHh-cCcCCCcchhhhhhh
Q 003836 636 DDHYNARISDFGLAKLLTLDQSH-TNTAIRGTKGYVAPEWFRNMPITVKVDVYSYGVLLLEIIC-LRRNIDNEISKVDKA 713 (792)
Q Consensus 636 ~~~~~~kl~Dfg~a~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~k~DV~S~Gv~l~el~t-g~~p~~~~~~~~~~~ 713 (792)
++++.+||+|||+++........ .......+..|+|||.+.+..++.++|||||||++|||++ |..||.......
T Consensus 164 ~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~~~~p~~~~~~~~--- 240 (288)
T cd05050 164 GENMVVKIADFGLSRNIYSADYYKASENDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGMQPYYGMAHEE--- 240 (288)
T ss_pred cCCCceEECccccceecccCccccccCCCccChhhcCHHHHhcCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCHHH---
Confidence 99999999999998865433221 1122234668999999998899999999999999999998 777875432210
Q ss_pred hHHHHHHHhhcccchhHhhhchhcccCCHHHHHHHHHHHHHccccCCCCCCCHHhHHHHhcc
Q 003836 714 ILTDWAYDRYQERTLEALVENDLEAMNNVTMLHRFVMVAFWCIQEDPSHRPTMRKVTQMLEG 775 (792)
Q Consensus 714 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~L~~ 775 (792)
.. ....... . ...+...+.++.+++.+||+.+|++|||+.|+++.|++
T Consensus 241 ----~~-~~~~~~~--------~-~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~el~~~l~~ 288 (288)
T cd05050 241 ----VI-YYVRDGN--------V-LSCPDNCPLELYNLMRLCWSKLPSDRPSFASINRILQR 288 (288)
T ss_pred ----HH-HHHhcCC--------C-CCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHhhC
Confidence 00 0001111 0 11122345678999999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M |
| >KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-36 Score=324.88 Aligned_cols=251 Identities=27% Similarity=0.386 Sum_probs=212.3
Q ss_pred hhhcCccccceEEEeeecCCC---ceEEEEEEccccc-ccchHHHHHHHHHhcccCCCCcccccceeccCCceEEEEEec
Q 003836 506 KEELGRGAFGTVYKGFVNMGS---SNHVAVKKLNSVF-QDSEKEFKAEVNGIGQTHHKNLVRLLGYCDEGQNRLLVYEFM 581 (792)
Q Consensus 506 ~~~lG~G~~g~Vy~g~~~~~~---~~~vavK~~~~~~-~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~lV~E~~ 581 (792)
.++||+|+||+||||.+--.. .-+||+|++.... .+..+++.+|+-+|.+++||||++|+|+|.... ..||.+||
T Consensus 701 ~kvLGsgAfGtV~kGiw~Pege~vKipVaiKvl~~~t~~~~s~e~LdeAl~masldHpnl~RLLgvc~~s~-~qlvtq~m 779 (1177)
T KOG1025|consen 701 DKVLGSGAFGTVYKGIWIPEGENVKIPVAIKVLIEFTSPKASIELLDEALRMASLDHPNLLRLLGVCMLST-LQLVTQLM 779 (1177)
T ss_pred hceeccccceeEEeeeEecCCceecceeEEEEeeccCCchhhHHHHHHHHHHhcCCCchHHHHhhhcccch-HHHHHHhc
Confidence 467999999999999874322 2379999886543 445689999999999999999999999998877 88999999
Q ss_pred cCCCccccccCC-CCCchhHHHHHHHHHHHHHHHHhhccCCCeEecCCCCCcEEEcCCCCeEEeecCCCccccCCCCCcc
Q 003836 582 SNGTVASFLFGD-SKPNWKLRTEIAMGIAGGLFYLHEECCTQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLDQSHTN 660 (792)
Q Consensus 582 ~~gsL~~~l~~~-~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dikp~NILl~~~~~~kl~Dfg~a~~~~~~~~~~~ 660 (792)
+.|+|.+|++.+ ..+..+..+.|..|||+||.|||++ +++||||.++|||+.+-..+||.|||+++.+..+.....
T Consensus 780 P~G~LlDyvr~hr~~igsq~lLnw~~QIAkgM~YLe~q---rlVHrdLaaRNVLVksP~hvkitdfgla~ll~~d~~ey~ 856 (1177)
T KOG1025|consen 780 PLGCLLDYVREHRDNIGSQDLLNWCYQIAKGMKYLEEQ---RLVHRDLAARNVLVKSPNHVKITDFGLAKLLAPDEKEYS 856 (1177)
T ss_pred ccchHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHhc---chhhhhhhhhheeecCCCeEEEEecchhhccCccccccc
Confidence 999999999765 5788899999999999999999998 999999999999999999999999999999887765544
Q ss_pred cc-ccccCCcccccccccCCCCcccceehHHHHHHHHHh-cCcCCCcchhhhhhhhHHHHHHHhhcccchhHhhhchhcc
Q 003836 661 TA-IRGTKGYVAPEWFRNMPITVKVDVYSYGVLLLEIIC-LRRNIDNEISKVDKAILTDWAYDRYQERTLEALVENDLEA 738 (792)
Q Consensus 661 ~~-~~gt~~y~aPE~~~~~~~~~k~DV~S~Gv~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 738 (792)
.. ..-.+.|||-|.++...|+.++|||||||.+||++| |..|++.... +.+.+++....+.
T Consensus 857 ~~~gK~pikwmale~i~~~~~thqSDVWsfGVtiWElmTFGa~Py~gi~~-----------------~eI~dlle~geRL 919 (1177)
T KOG1025|consen 857 APGGKVPIKWMALESIRIRKYTHQSDVWSFGVTIWELMTFGAKPYDGIPA-----------------EEIPDLLEKGERL 919 (1177)
T ss_pred ccccccCcHHHHHHHhhccCCCchhhhhhhhhhHHHHHhcCCCccCCCCH-----------------HHhhHHHhccccC
Confidence 33 334668999999999999999999999999999998 6677765432 2334445555556
Q ss_pred cCCHHHHHHHHHHHHHccccCCCCCCCHHhHHHHhccCc
Q 003836 739 MNNVTMLHRFVMVAFWCIQEDPSHRPTMRKVTQMLEGVV 777 (792)
Q Consensus 739 ~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~L~~~~ 777 (792)
..++....++..++.+||-.|+..||+++++...+.++.
T Consensus 920 sqPpiCtiDVy~~mvkCwmid~~~rp~fkel~~~fs~~a 958 (1177)
T KOG1025|consen 920 SQPPICTIDVYMVMVKCWMIDADSRPTFKELAEEFSRMA 958 (1177)
T ss_pred CCCCCccHHHHHHHHHHhccCcccCccHHHHHHHHHHHh
Confidence 667788899999999999999999999999998876654
|
|
| >cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-35 Score=308.80 Aligned_cols=251 Identities=25% Similarity=0.377 Sum_probs=200.4
Q ss_pred hhhcCccccceEEEeeecC----CCceEEEEEEccccccc-chHHHHHHHHHhcccCCCCcccccceeccCCceEEEEEe
Q 003836 506 KEELGRGAFGTVYKGFVNM----GSSNHVAVKKLNSVFQD-SEKEFKAEVNGIGQTHHKNLVRLLGYCDEGQNRLLVYEF 580 (792)
Q Consensus 506 ~~~lG~G~~g~Vy~g~~~~----~~~~~vavK~~~~~~~~-~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~lV~E~ 580 (792)
.+.||+|+||.||+|.... ...+.+++|.+...... ..+++.+|++++++++|+||+++++++.+.+..++||||
T Consensus 10 ~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 89 (275)
T cd05046 10 ITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRKLSHKNVVRLLGLCREAEPHYMILEY 89 (275)
T ss_pred eeeecccceeEEEEEEeccCCcCCCcceEEEEccCCccchHHHHHHHHHHHHHHhcCCcceeeeEEEECCCCcceEEEEe
Confidence 4679999999999998642 23467999988764333 457899999999999999999999999999999999999
Q ss_pred ccCCCccccccCCC---------CCchhHHHHHHHHHHHHHHHHhhccCCCeEecCCCCCcEEEcCCCCeEEeecCCCcc
Q 003836 581 MSNGTVASFLFGDS---------KPNWKLRTEIAMGIAGGLFYLHEECCTQIIHCDIKPQNILLDDHYNARISDFGLAKL 651 (792)
Q Consensus 581 ~~~gsL~~~l~~~~---------~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dikp~NILl~~~~~~kl~Dfg~a~~ 651 (792)
+++|+|.+++.... .+++..+..++.|++.||+|||+. +|+|+||||+|||++.++.++|+|||+++.
T Consensus 90 ~~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~---~i~H~dlkp~Nili~~~~~~~l~~~~~~~~ 166 (275)
T cd05046 90 TDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLSNA---RFVHRDLAARNCLVSSQREVKVSLLSLSKD 166 (275)
T ss_pred cCCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHHHhhhc---CcccCcCccceEEEeCCCcEEEcccccccc
Confidence 99999999997654 689999999999999999999998 999999999999999999999999999876
Q ss_pred ccCCCCCccccccccCCcccccccccCCCCcccceehHHHHHHHHHh-cCcCCCcchhhhhhhhHHHHHHHhhcccchhH
Q 003836 652 LTLDQSHTNTAIRGTKGYVAPEWFRNMPITVKVDVYSYGVLLLEIIC-LRRNIDNEISKVDKAILTDWAYDRYQERTLEA 730 (792)
Q Consensus 652 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DV~S~Gv~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 730 (792)
.............++..|+|||.+.+...+.++||||||+++++|++ |..||....... .. .....
T Consensus 167 ~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~~~~~p~~~~~~~~---~~-----~~~~~----- 233 (275)
T cd05046 167 VYNSEYYKLRNALIPLRWLAPEAVQEDDFSTKSDVWSFGVLMWEVFTQGELPFYGLSDEE---VL-----NRLQA----- 233 (275)
T ss_pred cCcccccccCCceeEEeecChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCccccchHH---HH-----HHHHc-----
Confidence 54333323333456778999999988889999999999999999999 777875432110 00 00000
Q ss_pred hhhchhcccCCHHHHHHHHHHHHHccccCCCCCCCHHhHHHHhcc
Q 003836 731 LVENDLEAMNNVTMLHRFVMVAFWCIQEDPSHRPTMRKVTQMLEG 775 (792)
Q Consensus 731 ~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~L~~ 775 (792)
.......+...+..+.+++.+||+.+|++||++.|++++|++
T Consensus 234 ---~~~~~~~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~~l~~l~~ 275 (275)
T cd05046 234 ---GKLELPVPEGCPSRLYKLMTRCWAVNPKDRPSFSELVSALGE 275 (275)
T ss_pred ---CCcCCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHhcC
Confidence 011111122344678899999999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s |
| >cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-35 Score=308.99 Aligned_cols=244 Identities=26% Similarity=0.373 Sum_probs=192.4
Q ss_pred cCccccceEEEeeecCCCceEEEEEEccccc---ccchHHHHHHHHHhcccCCCCcccccceeccCCceEEEEEeccCCC
Q 003836 509 LGRGAFGTVYKGFVNMGSSNHVAVKKLNSVF---QDSEKEFKAEVNGIGQTHHKNLVRLLGYCDEGQNRLLVYEFMSNGT 585 (792)
Q Consensus 509 lG~G~~g~Vy~g~~~~~~~~~vavK~~~~~~---~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~lV~E~~~~gs 585 (792)
||+|+||.||++... .+++.+|+|++.... ....+.+..|++++++++||||+++++++.++...++||||+++++
T Consensus 1 lg~G~~g~Vy~~~~~-~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~il~~l~hp~i~~~~~~~~~~~~~~lv~e~~~g~~ 79 (277)
T cd05607 1 LGKGGFGEVCAVQVK-NTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAYAFESKTHLCLVMSLMNGGD 79 (277)
T ss_pred CCCCCceEEEEEEEc-cCCcEEEEEEEcHHHhhcchhhHHHHHHHHHHHhcCCCcEEEEEEEEecCCeEEEEEecCCCCC
Confidence 799999999999754 456799999986422 1234456679999999999999999999999999999999999999
Q ss_pred ccccccCC--CCCchhHHHHHHHHHHHHHHHHhhccCCCeEecCCCCCcEEEcCCCCeEEeecCCCccccCCCCCccccc
Q 003836 586 VASFLFGD--SKPNWKLRTEIAMGIAGGLFYLHEECCTQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLDQSHTNTAI 663 (792)
Q Consensus 586 L~~~l~~~--~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dikp~NILl~~~~~~kl~Dfg~a~~~~~~~~~~~~~~ 663 (792)
|.+++... ..+++..+..++.||+.||+|||+. +|+||||||+|||++.++.+||+|||++....... .....
T Consensus 80 L~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~dikp~Nili~~~~~~~l~Dfg~~~~~~~~~--~~~~~ 154 (277)
T cd05607 80 LKYHIYNVGERGLEMERVIHYSAQITCGILHLHSM---DIVYRDMKPENVLLDDQGNCRLSDLGLAVELKDGK--TITQR 154 (277)
T ss_pred HHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHC---CEEEccCChHhEEEcCCCCEEEeeceeeeecCCCc--eeecc
Confidence 99888544 3578889999999999999999998 99999999999999999999999999998654322 22234
Q ss_pred cccCCcccccccccCCCCcccceehHHHHHHHHHhcCcCCCcchhhhhhhhHHHHHHHhhcccchhHhhhchhcccCCHH
Q 003836 664 RGTKGYVAPEWFRNMPITVKVDVYSYGVLLLEIICLRRNIDNEISKVDKAILTDWAYDRYQERTLEALVENDLEAMNNVT 743 (792)
Q Consensus 664 ~gt~~y~aPE~~~~~~~~~k~DV~S~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 743 (792)
.|+..|+|||++.+..++.++|||||||++|||++|+.||............ .. ........ .....
T Consensus 155 ~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~g~~p~~~~~~~~~~~~~---~~---------~~~~~~~~-~~~~~ 221 (277)
T cd05607 155 AGTNGYMAPEILKEEPYSYPVDWFAMGCSIYEMVAGRTPFKDHKEKVAKEEL---KR---------RTLEDEVK-FEHQN 221 (277)
T ss_pred CCCCCccCHHHHccCCCCCchhHHHHHHHHHHHHhCCCCCCCCcchhhHHHH---HH---------Hhhccccc-ccccc
Confidence 5899999999999888999999999999999999999998653221111000 00 00000000 00113
Q ss_pred HHHHHHHHHHHccccCCCCCCCHHhHHH
Q 003836 744 MLHRFVMVAFWCIQEDPSHRPTMRKVTQ 771 (792)
Q Consensus 744 ~~~~l~~l~~~Cl~~~p~~RPs~~evl~ 771 (792)
...++.+++..||+.||++||+++|+++
T Consensus 222 ~~~~~~~li~~~L~~~P~~R~~~~~~~~ 249 (277)
T cd05607 222 FTEESKDICRLFLAKKPEDRLGSREKND 249 (277)
T ss_pred CCHHHHHHHHHHhccCHhhCCCCccchh
Confidence 4567889999999999999999976653
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr |
| >cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-35 Score=309.74 Aligned_cols=262 Identities=23% Similarity=0.275 Sum_probs=204.6
Q ss_pred HHhhhhhhcCccccceEEEeeecCCCceEEEEEEccccc-ccchHHHHHHHHHhcccCCCCcccccceeccCCceEEEEE
Q 003836 501 VTRGFKEELGRGAFGTVYKGFVNMGSSNHVAVKKLNSVF-QDSEKEFKAEVNGIGQTHHKNLVRLLGYCDEGQNRLLVYE 579 (792)
Q Consensus 501 ~~~~~~~~lG~G~~g~Vy~g~~~~~~~~~vavK~~~~~~-~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~lV~E 579 (792)
..+.+.+.||+|+||+||++... ..++.+|+|++.... ....+.+.+|+++++.++|+||+++++++.....+++|||
T Consensus 5 ~~~~~~~~ig~g~~g~v~~~~~~-~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 83 (284)
T cd06620 5 EDLETISDLGAGNGGSVSKVKHI-PTGTVMAKKVVHIGAKSSVRKQILRELQIMHECRSPYIVSFYGAFLNENNICMCME 83 (284)
T ss_pred HHHHHHHHcCCCCCeEEEEEEEc-CCCcEEEEEEEEecCcchHHHHHHHHHHHHHHcCCCCcceEeeeEecCCEEEEEEe
Confidence 34556789999999999999754 346789999876543 3345789999999999999999999999999999999999
Q ss_pred eccCCCccccccCCCCCchhHHHHHHHHHHHHHHHHhhccCCCeEecCCCCCcEEEcCCCCeEEeecCCCccccCCCCCc
Q 003836 580 FMSNGTVASFLFGDSKPNWKLRTEIAMGIAGGLFYLHEECCTQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLDQSHT 659 (792)
Q Consensus 580 ~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dikp~NILl~~~~~~kl~Dfg~a~~~~~~~~~~ 659 (792)
|+++++|.+++...+.+++.....++.+++.||.|||+. .+++|+||+|+||++++++.++|+|||++.......
T Consensus 84 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~--~~i~H~dl~p~nil~~~~~~~~l~d~gl~~~~~~~~--- 158 (284)
T cd06620 84 FMDCGSLDRIYKKGGPIPVEILGKIAVAVVEGLTYLYNV--HRIMHRDIKPSNILVNSRGQIKLCDFGVSGELINSI--- 158 (284)
T ss_pred cCCCCCHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHHh--cCeeccCCCHHHEEECCCCcEEEccCCcccchhhhc---
Confidence 999999999988777889999999999999999999974 289999999999999999999999999987542211
Q ss_pred cccccccCCcccccccccCCCCcccceehHHHHHHHHHhcCcCCCcchhhhhhhhHHHHHHHhhcccchhHhhhchhccc
Q 003836 660 NTAIRGTKGYVAPEWFRNMPITVKVDVYSYGVLLLEIICLRRNIDNEISKVDKAILTDWAYDRYQERTLEALVENDLEAM 739 (792)
Q Consensus 660 ~~~~~gt~~y~aPE~~~~~~~~~k~DV~S~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 739 (792)
.....|+..|+|||.+.+..++.++|||||||++|||++|+.||.......+..... .... .....+........
T Consensus 159 ~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~----~~~~-~~~~~~~~~~~~~~ 233 (284)
T cd06620 159 ADTFVGTSTYMSPERIQGGKYTVKSDVWSLGISIIELALGKFPFAFSNIDDDGQDDP----MGIL-DLLQQIVQEPPPRL 233 (284)
T ss_pred cCccccCcccCCHHHHccCCCCccchHHHHHHHHHHHHhCCCCCcccchhhhhhhhh----hHHH-HHHHHHhhccCCCC
Confidence 123468999999999988899999999999999999999999997543321100000 0000 00111111111111
Q ss_pred CCHHHHHHHHHHHHHccccCCCCCCCHHhHHHHh
Q 003836 740 NNVTMLHRFVMVAFWCIQEDPSHRPTMRKVTQML 773 (792)
Q Consensus 740 ~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~L 773 (792)
.....+.++.+++.+||+.+|++||+++|++++.
T Consensus 234 ~~~~~~~~~~~li~~~l~~dp~~Rpt~~e~~~~~ 267 (284)
T cd06620 234 PSSDFPEDLRDFVDACLLKDPTERPTPQQLCAMP 267 (284)
T ss_pred CchhcCHHHHHHHHHHhcCCcccCcCHHHHhcCc
Confidence 1122456788999999999999999999999864
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-36 Score=287.64 Aligned_cols=246 Identities=25% Similarity=0.351 Sum_probs=200.0
Q ss_pred hhhhcCccccceEEEeeecCCCceEEEEEEcccccc----c----chHHHHHHHHHhccc-CCCCcccccceeccCCceE
Q 003836 505 FKEELGRGAFGTVYKGFVNMGSSNHVAVKKLNSVFQ----D----SEKEFKAEVNGIGQT-HHKNLVRLLGYCDEGQNRL 575 (792)
Q Consensus 505 ~~~~lG~G~~g~Vy~g~~~~~~~~~vavK~~~~~~~----~----~~~~~~~Ei~~l~~l-~h~niv~l~g~~~~~~~~~ 575 (792)
-++.||+|..++|-++... .++...|+|++..... . -.+.-..|+.+|+++ -||+|+++.++++.+...+
T Consensus 21 pkeilgrgvss~vrRci~k-~t~~e~a~kii~~~at~~~~e~~~~~~EaT~~Ev~ILRqv~GHP~II~l~D~yes~sF~F 99 (411)
T KOG0599|consen 21 PKEILGRGVSSVVRRCIHK-ETGKEFAVKIIDVTATTESGETPYEMREATRQEISILRQVMGHPYIIDLQDVYESDAFVF 99 (411)
T ss_pred hHHHhcccchhhhhhhhhc-ccccceeEEEEEecccccCCccHHHHHHHHHHHHHHHHHhcCCCcEEEeeeeccCcchhh
Confidence 3578999999999998654 5567888888754221 1 123456799999998 5999999999999999999
Q ss_pred EEEEeccCCCccccccCCCCCchhHHHHHHHHHHHHHHHHhhccCCCeEecCCCCCcEEEcCCCCeEEeecCCCccccCC
Q 003836 576 LVYEFMSNGTVASFLFGDSKPNWKLRTEIAMGIAGGLFYLHEECCTQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLD 655 (792)
Q Consensus 576 lV~E~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dikp~NILl~~~~~~kl~Dfg~a~~~~~~ 655 (792)
+|+|.|+.|.|.++|.+.-.++++...+|+.|+..|++|||.+ .||||||||+|||+|++.++||+|||++..+.+
T Consensus 100 lVFdl~prGELFDyLts~VtlSEK~tR~iMrqlfegVeylHa~---~IVHRDLKpENILlddn~~i~isDFGFa~~l~~- 175 (411)
T KOG0599|consen 100 LVFDLMPRGELFDYLTSKVTLSEKETRRIMRQLFEGVEYLHAR---NIVHRDLKPENILLDDNMNIKISDFGFACQLEP- 175 (411)
T ss_pred hhhhhcccchHHHHhhhheeecHHHHHHHHHHHHHHHHHHHHh---hhhhcccChhheeeccccceEEeccceeeccCC-
Confidence 9999999999999999888899999999999999999999999 999999999999999999999999999997754
Q ss_pred CCCccccccccCCccccccccc------CCCCcccceehHHHHHHHHHhcCcCCCcchhhhhhhhHHHHHHHhhcccchh
Q 003836 656 QSHTNTAIRGTKGYVAPEWFRN------MPITVKVDVYSYGVLLLEIICLRRNIDNEISKVDKAILTDWAYDRYQERTLE 729 (792)
Q Consensus 656 ~~~~~~~~~gt~~y~aPE~~~~------~~~~~k~DV~S~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 729 (792)
....+..+|||+|+|||.+.. ..|+...|+|+.||++|.|+.|..||-...+.... .
T Consensus 176 -GekLrelCGTPgYLAPEtikC~m~e~~pGYs~EVD~Wa~GVImyTLLaGcpPFwHRkQmlML----------------R 238 (411)
T KOG0599|consen 176 -GEKLRELCGTPGYLAPETIKCSMYENHPGYSKEVDEWACGVIMYTLLAGCPPFWHRKQMLML----------------R 238 (411)
T ss_pred -chhHHHhcCCCcccChhheeeecccCCCCccchhhHHHHHHHHHHHHcCCCchhHHHHHHHH----------------H
Confidence 344567899999999998853 35888999999999999999999999654322111 1
Q ss_pred Hhhhchhccc--CCHHHHHHHHHHHHHccccCCCCCCCHHhHHHH
Q 003836 730 ALVENDLEAM--NNVTMLHRFVMVAFWCIQEDPSHRPTMRKVTQM 772 (792)
Q Consensus 730 ~~~~~~~~~~--~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~ 772 (792)
.++.....-. .=.+.+....+++.+||+.||.+|.|.+|+++.
T Consensus 239 ~ImeGkyqF~speWadis~~~KdLIsrlLqVdp~~Ritake~LaH 283 (411)
T KOG0599|consen 239 MIMEGKYQFRSPEWADISATVKDLISRLLQVDPTKRITAKEALAH 283 (411)
T ss_pred HHHhcccccCCcchhhccccHHHHHHHHHeeCchhcccHHHHhcC
Confidence 1111111111 112456778899999999999999999999863
|
|
| >PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-35 Score=307.39 Aligned_cols=252 Identities=27% Similarity=0.419 Sum_probs=200.6
Q ss_pred hhhhhcCccccceEEEeeecCCCceEEEEEEcccccccchH--HHHHHHHHhcccCCCCcccccceeccCCceEEEEEec
Q 003836 504 GFKEELGRGAFGTVYKGFVNMGSSNHVAVKKLNSVFQDSEK--EFKAEVNGIGQTHHKNLVRLLGYCDEGQNRLLVYEFM 581 (792)
Q Consensus 504 ~~~~~lG~G~~g~Vy~g~~~~~~~~~vavK~~~~~~~~~~~--~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~lV~E~~ 581 (792)
.+.+.||+|+||+||++... ..++.+|+|++......... ...+|+.++++++|+||+++++++.+....++||||+
T Consensus 2 ~~~~~lg~G~~g~v~~~~~~-~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~v~~~~ 80 (260)
T PF00069_consen 2 RLVKKLGSGGFGTVYKAKNK-KNGQKVAVKIIDKSEIEEEEREENIREIKILRRLRHPNIVQILDVFQDDNYLYIVMEYC 80 (260)
T ss_dssp EEEEEEEEESSEEEEEEEET-TTTEEEEEEEEESTTHHHHHHHHHHHHHHHHHHHTBTTBCHEEEEEEESSEEEEEEEEE
T ss_pred EEeEEEEeCCCEEEEEEEEC-CCCeEEEEEEeccccccccccchhhhhhhcccccccccccccccccccccccccccccc
Confidence 35678999999999999754 55678999999876443332 3456999999999999999999999999999999999
Q ss_pred cCCCccccccCCCCCchhHHHHHHHHHHHHHHHHhhccCCCeEecCCCCCcEEEcCCCCeEEeecCCCccccCCCCCccc
Q 003836 582 SNGTVASFLFGDSKPNWKLRTEIAMGIAGGLFYLHEECCTQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLDQSHTNT 661 (792)
Q Consensus 582 ~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dikp~NILl~~~~~~kl~Dfg~a~~~~~~~~~~~~ 661 (792)
++++|.+++.....+++..+..++.||++||++||+. +|+|+||||+||++++++.++|+|||.+... ........
T Consensus 81 ~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~Lh~~---~i~H~dikp~NIl~~~~~~~~l~Dfg~~~~~-~~~~~~~~ 156 (260)
T PF00069_consen 81 PGGSLQDYLQKNKPLSEEEILKIAYQILEALAYLHSK---GIVHRDIKPENILLDENGEVKLIDFGSSVKL-SENNENFN 156 (260)
T ss_dssp TTEBHHHHHHHHSSBBHHHHHHHHHHHHHHHHHHHHT---TEEESSBSGGGEEESTTSEEEESSGTTTEES-TSTTSEBS
T ss_pred ccccccccccccccccccccccccccccccccccccc---ccccccccccccccccccccccccccccccc-cccccccc
Confidence 9999999998778889999999999999999999998 9999999999999999999999999999764 12222333
Q ss_pred cccccCCcccccccc-cCCCCcccceehHHHHHHHHHhcCcCCCcchhhhhhhhHHHHHHHhhcccchhHhhhchhcccC
Q 003836 662 AIRGTKGYVAPEWFR-NMPITVKVDVYSYGVLLLEIICLRRNIDNEISKVDKAILTDWAYDRYQERTLEALVENDLEAMN 740 (792)
Q Consensus 662 ~~~gt~~y~aPE~~~-~~~~~~k~DV~S~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 740 (792)
...++..|+|||.+. +..++.++||||+|+++++|++|+.|+................ .. ........
T Consensus 157 ~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~p~~~~~~~~~~~~~~~~~-----~~---~~~~~~~~--- 225 (260)
T PF00069_consen 157 PFVGTPEYMAPEVLQQGKKYTRKSDIWSLGIILYELLTGKLPFEESNSDDQLEIIEKIL-----KR---PLPSSSQQ--- 225 (260)
T ss_dssp SSSSSGGGSCHHHHTTTSSBSTHHHHHHHHHHHHHHHHSSSSSTTSSHHHHHHHHHHHH-----HT---HHHHHTTS---
T ss_pred cccccccccccccccccccccccccccccccccccccccccccccccchhhhhhhhhcc-----cc---cccccccc---
Confidence 456899999999998 8889999999999999999999999997651111111110000 00 00000000
Q ss_pred CHHHHHHHHHHHHHccccCCCCCCCHHhHHH
Q 003836 741 NVTMLHRFVMVAFWCIQEDPSHRPTMRKVTQ 771 (792)
Q Consensus 741 ~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~ 771 (792)
.......+.+++.+||+.||++||++.++++
T Consensus 226 ~~~~~~~l~~li~~~l~~~p~~R~~~~~l~~ 256 (260)
T PF00069_consen 226 SREKSEELRDLIKKMLSKDPEQRPSAEELLK 256 (260)
T ss_dssp HTTSHHHHHHHHHHHSSSSGGGSTTHHHHHT
T ss_pred cchhHHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 0011278899999999999999999999987
|
Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A .... |
| >cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-34 Score=301.97 Aligned_cols=247 Identities=26% Similarity=0.400 Sum_probs=198.7
Q ss_pred hhcCccccceEEEeeecCCCceEEEEEEccccccc-chHHHHHHHHHhcccCCCCcccccceeccCCceEEEEEeccCCC
Q 003836 507 EELGRGAFGTVYKGFVNMGSSNHVAVKKLNSVFQD-SEKEFKAEVNGIGQTHHKNLVRLLGYCDEGQNRLLVYEFMSNGT 585 (792)
Q Consensus 507 ~~lG~G~~g~Vy~g~~~~~~~~~vavK~~~~~~~~-~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~lV~E~~~~gs 585 (792)
++||+|++|.||++.... ++.+++|++...... ....+.+|++++++++|+||+++++++.+....++||||+++++
T Consensus 1 ~~lg~g~~g~v~~~~~~~--~~~v~~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~ 78 (251)
T cd05041 1 EKIGKGNFGDVYKGVLKG--NTEVAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKLIGVCVQKQPIYIVMELVPGGS 78 (251)
T ss_pred CccccCCCceEEEEEEeC--CCcEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeEEEEEEEecCCCeEEEEEcCCCCc
Confidence 369999999999997653 678999998765433 45689999999999999999999999999999999999999999
Q ss_pred ccccccCC-CCCchhHHHHHHHHHHHHHHHHhhccCCCeEecCCCCCcEEEcCCCCeEEeecCCCccccCCCCCcc-ccc
Q 003836 586 VASFLFGD-SKPNWKLRTEIAMGIAGGLFYLHEECCTQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLDQSHTN-TAI 663 (792)
Q Consensus 586 L~~~l~~~-~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dikp~NILl~~~~~~kl~Dfg~a~~~~~~~~~~~-~~~ 663 (792)
|.+++... ..+++..+..++.+++.||+|||+. +++||||||+|||++.++.+||+|||+++.......... ...
T Consensus 79 l~~~l~~~~~~~~~~~~~~~~~~~~~~l~~lH~~---~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~~~ 155 (251)
T cd05041 79 LLTFLRKKKNRLTVKKLLQMSLDAAAGMEYLESK---NCIHRDLAARNCLVGENNVLKISDFGMSREEEGGIYTVSDGLK 155 (251)
T ss_pred HHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhC---CEehhhcCcceEEEcCCCcEEEeeccccccccCCcceeccccC
Confidence 99998653 4678899999999999999999998 999999999999999999999999999986542221111 112
Q ss_pred cccCCcccccccccCCCCcccceehHHHHHHHHHh-cCcCCCcchhhhhhhhHHHHHHHhhcccchhHhhhchhcccCCH
Q 003836 664 RGTKGYVAPEWFRNMPITVKVDVYSYGVLLLEIIC-LRRNIDNEISKVDKAILTDWAYDRYQERTLEALVENDLEAMNNV 742 (792)
Q Consensus 664 ~gt~~y~aPE~~~~~~~~~k~DV~S~Gv~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 742 (792)
..+..|+|||.+.+..++.++||||||++++||++ |..||......... ..+........+.
T Consensus 156 ~~~~~y~~PE~~~~~~~~~~~Di~slG~i~~~l~t~~~~p~~~~~~~~~~-----------------~~~~~~~~~~~~~ 218 (251)
T cd05041 156 QIPIKWTAPEALNYGRYTSESDVWSYGILLWETFSLGDTPYPGMSNQQTR-----------------ERIESGYRMPAPQ 218 (251)
T ss_pred cceeccCChHhhccCCCCcchhHHHHHHHHHHHHhccCCCCccCCHHHHH-----------------HHHhcCCCCCCCc
Confidence 23567999999988899999999999999999999 77787543221110 0011111111223
Q ss_pred HHHHHHHHHHHHccccCCCCCCCHHhHHHHhcc
Q 003836 743 TMLHRFVMVAFWCIQEDPSHRPTMRKVTQMLEG 775 (792)
Q Consensus 743 ~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~L~~ 775 (792)
..+..+.+++.+||+.+|.+||+++|+++.|+.
T Consensus 219 ~~~~~~~~li~~~l~~~p~~Rp~~~ell~~l~~ 251 (251)
T cd05041 219 LCPEEIYRLMLQCWAYDPENRPSFSEIYNELQI 251 (251)
T ss_pred cCCHHHHHHHHHHhccChhhCcCHHHHHHHhhC
Confidence 345678999999999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k |
| >cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-35 Score=306.73 Aligned_cols=245 Identities=22% Similarity=0.297 Sum_probs=196.3
Q ss_pred hhcCccccceEEEeeecCCCceEEEEEEcccccccchHHHHHHHHHhcccCCCCcccccceeccCCceEEEEEeccCCCc
Q 003836 507 EELGRGAFGTVYKGFVNMGSSNHVAVKKLNSVFQDSEKEFKAEVNGIGQTHHKNLVRLLGYCDEGQNRLLVYEFMSNGTV 586 (792)
Q Consensus 507 ~~lG~G~~g~Vy~g~~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~lV~E~~~~gsL 586 (792)
..||+|+||.||+|... .++..|++|.+........+.+.+|+.++++++|+||+++++++..++..++|+||+++++|
T Consensus 14 ~~lg~g~~g~v~~~~~~-~~~~~v~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L 92 (268)
T cd06624 14 VVLGKGTYGIVYAARDL-STQVRIAIKEIPERDSRYVQPLHEEIALHSYLKHRNIVQYLGSDSENGFFKIFMEQVPGGSL 92 (268)
T ss_pred EEEecCCceEEEEeEec-CCCcEEEEEEecCCCHHHHHHHHHHHHHHHhcCCCCeeeeeeeeccCCEEEEEEecCCCCCH
Confidence 47999999999999754 45678999998776666677899999999999999999999999999999999999999999
Q ss_pred cccccCC-CCC--chhHHHHHHHHHHHHHHHHhhccCCCeEecCCCCCcEEEcC-CCCeEEeecCCCccccCCCCCcccc
Q 003836 587 ASFLFGD-SKP--NWKLRTEIAMGIAGGLFYLHEECCTQIIHCDIKPQNILLDD-HYNARISDFGLAKLLTLDQSHTNTA 662 (792)
Q Consensus 587 ~~~l~~~-~~l--~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dikp~NILl~~-~~~~kl~Dfg~a~~~~~~~~~~~~~ 662 (792)
.+++... ..+ ++..+..++.||+.||+|||+. +|+|+||||+||+++. ++.+||+|||++........ ....
T Consensus 93 ~~~l~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~---~i~h~dl~p~nil~~~~~~~~~l~dfg~~~~~~~~~~-~~~~ 168 (268)
T cd06624 93 SALLRSKWGPLKDNEQTIIFYTKQILEGLKYLHDN---QIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGINP-CTET 168 (268)
T ss_pred HHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHHHC---CEeecCCCHHHEEEcCCCCeEEEecchhheecccCCC-cccc
Confidence 9999764 444 7888899999999999999998 9999999999999986 67999999999876543221 2223
Q ss_pred ccccCCcccccccccC--CCCcccceehHHHHHHHHHhcCcCCCcchhhhhhhhHHHHHHHhhcccchhHhhhchhcccC
Q 003836 663 IRGTKGYVAPEWFRNM--PITVKVDVYSYGVLLLEIICLRRNIDNEISKVDKAILTDWAYDRYQERTLEALVENDLEAMN 740 (792)
Q Consensus 663 ~~gt~~y~aPE~~~~~--~~~~k~DV~S~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 740 (792)
..+++.|+|||.+... .++.++||||||+++|+|++|+.||.......... +. ..........
T Consensus 169 ~~~~~~~~aPE~~~~~~~~~~~~~Dv~slGvvl~~l~~g~~p~~~~~~~~~~~----~~-----------~~~~~~~~~~ 233 (268)
T cd06624 169 FTGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPFIELGEPQAAM----FK-----------VGMFKIHPEI 233 (268)
T ss_pred CCCCccccChhhhccccccCCchhhhHHHHHHHHHHHhCCCCCccccChhhhH----hh-----------hhhhccCCCC
Confidence 3578999999998664 37899999999999999999999986432110000 00 0000011122
Q ss_pred CHHHHHHHHHHHHHccccCCCCCCCHHhHHH
Q 003836 741 NVTMLHRFVMVAFWCIQEDPSHRPTMRKVTQ 771 (792)
Q Consensus 741 ~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~ 771 (792)
+.....++.+++.+||+.+|.+|||+.|+++
T Consensus 234 ~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~ 264 (268)
T cd06624 234 PESLSAEAKNFILRCFEPDPDKRASAHDLLQ 264 (268)
T ss_pred CcccCHHHHHHHHHHcCCCchhCCCHHHHHh
Confidence 3345567889999999999999999999987
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina |
| >cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-35 Score=314.26 Aligned_cols=255 Identities=24% Similarity=0.360 Sum_probs=199.4
Q ss_pred hhhhhhcCccccceEEEeeec------CCCceEEEEEEccccc-ccchHHHHHHHHHhccc-CCCCcccccceeccCCce
Q 003836 503 RGFKEELGRGAFGTVYKGFVN------MGSSNHVAVKKLNSVF-QDSEKEFKAEVNGIGQT-HHKNLVRLLGYCDEGQNR 574 (792)
Q Consensus 503 ~~~~~~lG~G~~g~Vy~g~~~------~~~~~~vavK~~~~~~-~~~~~~~~~Ei~~l~~l-~h~niv~l~g~~~~~~~~ 574 (792)
..+.++||+|+||.||++... ......+|+|+++... .....++.+|+++++++ +|+||+++++++.+....
T Consensus 14 ~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~ 93 (314)
T cd05099 14 LVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELMKLIGKHKNIINLLGVCTQEGPL 93 (314)
T ss_pred eeeeeeecCCCcccEEEeeecccCCccCCcceEEEEEecCCCCChHHHHHHHHHHHHHHhccCCCCeeeEEEEEccCCce
Confidence 345678999999999998642 1234579999987532 23356788999999999 699999999999999999
Q ss_pred EEEEEeccCCCccccccCC----------------CCCchhHHHHHHHHHHHHHHHHhhccCCCeEecCCCCCcEEEcCC
Q 003836 575 LLVYEFMSNGTVASFLFGD----------------SKPNWKLRTEIAMGIAGGLFYLHEECCTQIIHCDIKPQNILLDDH 638 (792)
Q Consensus 575 ~lV~E~~~~gsL~~~l~~~----------------~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dikp~NILl~~~ 638 (792)
++||||+++|+|.+++... ..+++..+.+++.||+.||.|||+. +|+|+||||+|||++++
T Consensus 94 ~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~---gi~H~dlkp~Nill~~~ 170 (314)
T cd05099 94 YVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLESR---RCIHRDLAARNVLVTED 170 (314)
T ss_pred EEEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHHHHC---CeeeccccceeEEEcCC
Confidence 9999999999999998542 2478889999999999999999998 99999999999999999
Q ss_pred CCeEEeecCCCccccCCCCCc-cccccccCCcccccccccCCCCcccceehHHHHHHHHHh-cCcCCCcchhhhhhhhHH
Q 003836 639 YNARISDFGLAKLLTLDQSHT-NTAIRGTKGYVAPEWFRNMPITVKVDVYSYGVLLLEIIC-LRRNIDNEISKVDKAILT 716 (792)
Q Consensus 639 ~~~kl~Dfg~a~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~k~DV~S~Gv~l~el~t-g~~p~~~~~~~~~~~~~~ 716 (792)
+.+||+|||+++......... .....++..|+|||.+.+..++.++||||||+++|||++ |..||........
T Consensus 171 ~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~~----- 245 (314)
T cd05099 171 NVMKIADFGLARGVHDIDYYKKTSNGRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFTLGGSPYPGIPVEEL----- 245 (314)
T ss_pred CcEEEccccccccccccccccccccCCCCccccCHHHHccCCcCccchhhHHHHHHHHHHhCCCCCCCCCCHHHH-----
Confidence 999999999998664322211 112234567999999998899999999999999999999 7888754321100
Q ss_pred HHHHHhhcccchhHhhhchhcccCCHHHHHHHHHHHHHccccCCCCCCCHHhHHHHhccCc
Q 003836 717 DWAYDRYQERTLEALVENDLEAMNNVTMLHRFVMVAFWCIQEDPSHRPTMRKVTQMLEGVV 777 (792)
Q Consensus 717 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~L~~~~ 777 (792)
..... .......+...+.++.+++.+||+.+|++||++.|+++.|+++.
T Consensus 246 ---~~~~~---------~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~~l~~~~ 294 (314)
T cd05099 246 ---FKLLR---------EGHRMDKPSNCTHELYMLMRECWHAVPTQRPTFKQLVEALDKVL 294 (314)
T ss_pred ---HHHHH---------cCCCCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHH
Confidence 00000 11111112234557889999999999999999999999998765
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-35 Score=304.15 Aligned_cols=245 Identities=27% Similarity=0.389 Sum_probs=196.0
Q ss_pred hhhhhhcCccccceEEEeeecCCCceEEEEEEcccccccchHHHHHHHHHhcccCCCCccccccee-ccCCceEEEEEec
Q 003836 503 RGFKEELGRGAFGTVYKGFVNMGSSNHVAVKKLNSVFQDSEKEFKAEVNGIGQTHHKNLVRLLGYC-DEGQNRLLVYEFM 581 (792)
Q Consensus 503 ~~~~~~lG~G~~g~Vy~g~~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~g~~-~~~~~~~lV~E~~ 581 (792)
+.+.+.||+|+||.||++... +..+++|.++.. ...+.+.+|+.++++++|+|++++++++ .+++..++|+||+
T Consensus 8 ~~~~~~lg~g~~~~v~~~~~~---~~~~~~k~~~~~--~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e~~ 82 (256)
T cd05082 8 LKLLQTIGKGEFGDVMLGDYR---GNKVAVKCIKND--ATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYM 82 (256)
T ss_pred CeeeeeecccCCCeEEEEEEc---CCcEEEEEeCCC--chHHHHHHHHHHHHhCCCCCeeeEEEEEEcCCCceEEEEECC
Confidence 345678999999999999654 457999988643 3356799999999999999999999976 4556789999999
Q ss_pred cCCCccccccCCC--CCchhHHHHHHHHHHHHHHHHhhccCCCeEecCCCCCcEEEcCCCCeEEeecCCCccccCCCCCc
Q 003836 582 SNGTVASFLFGDS--KPNWKLRTEIAMGIAGGLFYLHEECCTQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLDQSHT 659 (792)
Q Consensus 582 ~~gsL~~~l~~~~--~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dikp~NILl~~~~~~kl~Dfg~a~~~~~~~~~~ 659 (792)
++++|.+++.... .+++..+.+++.||+.||+|||+. +++||||||+||++++++.+||+|||+++......
T Consensus 83 ~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~--- 156 (256)
T cd05082 83 AKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEAN---NFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQ--- 156 (256)
T ss_pred CCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhC---CEeccccchheEEEcCCCcEEecCCccceeccccC---
Confidence 9999999987543 478999999999999999999998 99999999999999999999999999988643222
Q ss_pred cccccccCCcccccccccCCCCcccceehHHHHHHHHHh-cCcCCCcchhhhhhhhHHHHHHHhhcccchhHhhhchhcc
Q 003836 660 NTAIRGTKGYVAPEWFRNMPITVKVDVYSYGVLLLEIIC-LRRNIDNEISKVDKAILTDWAYDRYQERTLEALVENDLEA 738 (792)
Q Consensus 660 ~~~~~gt~~y~aPE~~~~~~~~~k~DV~S~Gv~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 738 (792)
....++..|+|||.+.+..++.++||||||+++|||++ |+.||...... ..... +......
T Consensus 157 -~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~~l~~~g~~p~~~~~~~-------~~~~~----------~~~~~~~ 218 (256)
T cd05082 157 -DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLK-------DVVPR----------VEKGYKM 218 (256)
T ss_pred -CCCccceeecCHHHHccCCCCchhhhHHHHHHHHHHHhCCCCCCCCCCHH-------HHHHH----------HhcCCCC
Confidence 12234568999999998899999999999999999998 88887543211 00000 0011111
Q ss_pred cCCHHHHHHHHHHHHHccccCCCCCCCHHhHHHHhccC
Q 003836 739 MNNVTMLHRFVMVAFWCIQEDPSHRPTMRKVTQMLEGV 776 (792)
Q Consensus 739 ~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~L~~~ 776 (792)
..+...+..+.+++.+||+.+|++|||+.++++.|+.+
T Consensus 219 ~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~~ 256 (256)
T cd05082 219 DAPDGCPPVVYDVMKQCWHLDAATRPSFLQLREQLEHI 256 (256)
T ss_pred CCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHhcC
Confidence 12223456788999999999999999999999999764
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re |
| >cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-35 Score=322.21 Aligned_cols=251 Identities=19% Similarity=0.240 Sum_probs=196.5
Q ss_pred HhhhhhhcCccccceEEEeeecCCCceEEEEEEccccc---ccchHHHHHHHHHhcccCCCCcccccceeccCCceEEEE
Q 003836 502 TRGFKEELGRGAFGTVYKGFVNMGSSNHVAVKKLNSVF---QDSEKEFKAEVNGIGQTHHKNLVRLLGYCDEGQNRLLVY 578 (792)
Q Consensus 502 ~~~~~~~lG~G~~g~Vy~g~~~~~~~~~vavK~~~~~~---~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~lV~ 578 (792)
.+.+.+.||+|+||.||++... .+++.+|+|++.+.. ....+.+.+|+.+++.++||||+++++.+.++...++||
T Consensus 44 ~y~i~~~lG~G~fg~Vy~~~~~-~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~~~~lv~ 122 (371)
T cd05622 44 DYEVVKVIGRGAFGEVQLVRHK-STRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDRYLYMVM 122 (371)
T ss_pred hcEEEEEEeecCCeEEEEEEEC-CCCcEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCEEEEEE
Confidence 3445578999999999999754 456789999986422 223456789999999999999999999999999999999
Q ss_pred EeccCCCccccccCCCCCchhHHHHHHHHHHHHHHHHhhccCCCeEecCCCCCcEEEcCCCCeEEeecCCCccccCCCCC
Q 003836 579 EFMSNGTVASFLFGDSKPNWKLRTEIAMGIAGGLFYLHEECCTQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLDQSH 658 (792)
Q Consensus 579 E~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dikp~NILl~~~~~~kl~Dfg~a~~~~~~~~~ 658 (792)
||+++|+|.+++... .+++..+..++.||+.||.|||+. +|+||||||+|||++.++.+||+|||+++........
T Consensus 123 Ey~~gg~L~~~~~~~-~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDLkp~NIll~~~~~ikL~DfG~a~~~~~~~~~ 198 (371)
T cd05622 123 EYMPGGDLVNLMSNY-DVPEKWARFYTAEVVLALDAIHSM---GFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMV 198 (371)
T ss_pred cCCCCCcHHHHHHhc-CCCHHHHHHHHHHHHHHHHHHHHC---CEEeCCCCHHHEEECCCCCEEEEeCCceeEcCcCCcc
Confidence 999999999998653 578888899999999999999998 9999999999999999999999999999876543333
Q ss_pred ccccccccCCcccccccccC----CCCcccceehHHHHHHHHHhcCcCCCcchhhhhhhhHHHHHHHhhcccchhHhhhc
Q 003836 659 TNTAIRGTKGYVAPEWFRNM----PITVKVDVYSYGVLLLEIICLRRNIDNEISKVDKAILTDWAYDRYQERTLEALVEN 734 (792)
Q Consensus 659 ~~~~~~gt~~y~aPE~~~~~----~~~~k~DV~S~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 734 (792)
......||+.|+|||++... .++.++|||||||++|||++|+.||........ . ..++..
T Consensus 199 ~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~---~-------------~~i~~~ 262 (371)
T cd05622 199 RCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGT---Y-------------SKIMNH 262 (371)
T ss_pred cccCcccCccccCHHHHhccCCCccCCCccceeehhHHHHHHHhCCCCCCCCCHHHH---H-------------HHHHcC
Confidence 33456799999999998653 378999999999999999999999975432110 0 011110
Q ss_pred --hhcccCCHHHHHHHHHHHHHccccCCCC--CCCHHhHHHHh
Q 003836 735 --DLEAMNNVTMLHRFVMVAFWCIQEDPSH--RPTMRKVTQML 773 (792)
Q Consensus 735 --~~~~~~~~~~~~~l~~l~~~Cl~~~p~~--RPs~~evl~~L 773 (792)
..........+..+.+++..||+.++.+ ||+++|+++..
T Consensus 263 ~~~~~~~~~~~~s~~~~~li~~~L~~~~~r~~r~~~~ei~~h~ 305 (371)
T cd05622 263 KNSLTFPDDNDISKEAKNLICAFLTDREVRLGRNGVEEIKRHL 305 (371)
T ss_pred CCcccCCCcCCCCHHHHHHHHHHcCChhhhcCCCCHHHHhcCc
Confidence 0111112234567888999999844433 78999988753
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an |
| >KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-35 Score=297.01 Aligned_cols=260 Identities=23% Similarity=0.317 Sum_probs=198.1
Q ss_pred hhhhcCccccceEEEeeecCCCceEEEEEEccccccc--chHHHHHHHHHhcccCCCC-cccccceeccCC------ceE
Q 003836 505 FKEELGRGAFGTVYKGFVNMGSSNHVAVKKLNSVFQD--SEKEFKAEVNGIGQTHHKN-LVRLLGYCDEGQ------NRL 575 (792)
Q Consensus 505 ~~~~lG~G~~g~Vy~g~~~~~~~~~vavK~~~~~~~~--~~~~~~~Ei~~l~~l~h~n-iv~l~g~~~~~~------~~~ 575 (792)
..++||+|+||+||+|... .+++.||+|++.....+ ......+|+.++++++|+| ||+|++++...+ ..+
T Consensus 15 ~~eklGeGtyg~Vykar~~-~~g~~VALKkirl~~~~EG~P~taiREisllk~L~~~~~iv~L~dv~~~~~~~~~~~~l~ 93 (323)
T KOG0594|consen 15 KVEKLGEGTYGVVYKARSK-RTGKFVALKKIRLEFEEEGVPSTAIREISLLKRLSHANHIVRLHDVIHTSNNHRGIGKLY 93 (323)
T ss_pred HHHHhCCCCceEEEEEEEe-cCCCEEEEEEEeccccccCCCchhhHHHHHHHHhCCCcceEEEEeeeeecccccccceEE
Confidence 3467999999999999754 45689999999765432 3456789999999999999 999999998777 788
Q ss_pred EEEEeccCCCccccccCCC----CCchhHHHHHHHHHHHHHHHHhhccCCCeEecCCCCCcEEEcCCCCeEEeecCCCcc
Q 003836 576 LVYEFMSNGTVASFLFGDS----KPNWKLRTEIAMGIAGGLFYLHEECCTQIIHCDIKPQNILLDDHYNARISDFGLAKL 651 (792)
Q Consensus 576 lV~E~~~~gsL~~~l~~~~----~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dikp~NILl~~~~~~kl~Dfg~a~~ 651 (792)
+|+||++. +|..++.... .++...+..++.||++||+|||++ +|+||||||.||||+++|.+||+|||+|+.
T Consensus 94 lvfe~~d~-DL~~ymd~~~~~~~g~~~~~ik~~m~Qll~gl~~~H~~---~IlHRDLKPQNlLi~~~G~lKlaDFGlAra 169 (323)
T KOG0594|consen 94 LVFEFLDR-DLKKYMDSLPKKPQGLPPRLIKSFMRQLLRGLAFLHSH---GILHRDLKPQNLLISSSGVLKLADFGLARA 169 (323)
T ss_pred EEEEeecc-cHHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHHhC---CeecccCCcceEEECCCCcEeeeccchHHH
Confidence 99999976 8999987654 466678999999999999999999 999999999999999999999999999997
Q ss_pred ccCCCCCccccccccCCcccccccccC-CCCcccceehHHHHHHHHHhcCcCCCcchhhhhhhhHHHHHH----Hhhccc
Q 003836 652 LTLDQSHTNTAIRGTKGYVAPEWFRNM-PITVKVDVYSYGVLLLEIICLRRNIDNEISKVDKAILTDWAY----DRYQER 726 (792)
Q Consensus 652 ~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~k~DV~S~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~----~~~~~~ 726 (792)
..-+.. ..+..++|.-|+|||++.+. .|+...||||+||++.||++++..|....+......+....- ..|.
T Consensus 170 ~~ip~~-~yt~evvTlWYRaPEvLlGs~~Ys~~vDiWs~GcIfaEm~~~~~LFpG~se~~ql~~If~~lGtP~e~~Wp-- 246 (323)
T KOG0594|consen 170 FSIPMR-TYTPEVVTLWYRAPEVLLGSTSYSTSVDIWSLGCIFAEMFTRRPLFPGDSEIDQLFRIFRLLGTPNEKDWP-- 246 (323)
T ss_pred hcCCcc-cccccEEEeeccCHHHhcCCCcCCCCcchHhHHHHHHHHHhCCCCCCCCcHHHHHHHHHHHcCCCCccCCC--
Confidence 653322 24556689999999998775 799999999999999999999888876554222111110000 0000
Q ss_pred chhHhhhch-----hcccC--C---HHHHHHHHHHHHHccccCCCCCCCHHhHHHH
Q 003836 727 TLEALVEND-----LEAMN--N---VTMLHRFVMVAFWCIQEDPSHRPTMRKVTQM 772 (792)
Q Consensus 727 ~~~~~~~~~-----~~~~~--~---~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~ 772 (792)
.+..+.+.. ..... . ........+++.+||+.+|.+|.|++.++++
T Consensus 247 ~v~~~~~~k~~f~~~~~~~~l~~~~~~~~~~~~dll~~~L~y~p~~R~Sa~~al~h 302 (323)
T KOG0594|consen 247 GVSSLPDYKAPFPKWPGPKDLSSILPKLDPDGIELLSKLLQYDPAKRISAKGALTH 302 (323)
T ss_pred CccccccccccCcCCCCccchHHhccccCccHHHHHHHHhccCcccCcCHHHHhcC
Confidence 001111110 00000 0 0111478899999999999999999999886
|
|
| >cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-34 Score=303.52 Aligned_cols=255 Identities=21% Similarity=0.348 Sum_probs=203.9
Q ss_pred hhhhhhcCccccceEEEeeecCCCceEEEEEEcccc---cccchHHHHHHHHHhcccCCCCcccccceeccCCceEEEEE
Q 003836 503 RGFKEELGRGAFGTVYKGFVNMGSSNHVAVKKLNSV---FQDSEKEFKAEVNGIGQTHHKNLVRLLGYCDEGQNRLLVYE 579 (792)
Q Consensus 503 ~~~~~~lG~G~~g~Vy~g~~~~~~~~~vavK~~~~~---~~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~lV~E 579 (792)
+.+.+.||+|++|.||+|... .+++.+|+|.++.. .....+.+.+|++++++++|+|++++++++.+.+..++|||
T Consensus 4 y~~~~~lg~g~~~~v~~~~~~-~~~~~~~ik~~~~~~~~~~~~~~~~~~ei~~l~~~~~~~i~~~~~~~~~~~~~~lv~e 82 (267)
T cd08224 4 FKIEKKIGKGQFSVVYKAICL-LDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPNVIKYLASFIENNELNIVLE 82 (267)
T ss_pred eeeeeeeccCCceEEEEEEEc-CCCCEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEEEe
Confidence 345678999999999999765 45678999988632 22235689999999999999999999999999999999999
Q ss_pred eccCCCccccccC----CCCCchhHHHHHHHHHHHHHHHHhhccCCCeEecCCCCCcEEEcCCCCeEEeecCCCccccCC
Q 003836 580 FMSNGTVASFLFG----DSKPNWKLRTEIAMGIAGGLFYLHEECCTQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLD 655 (792)
Q Consensus 580 ~~~~gsL~~~l~~----~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dikp~NILl~~~~~~kl~Dfg~a~~~~~~ 655 (792)
|+++++|.+++.. ...+++..+..++.|+++||.|||+. +|+|+||+|+||+++.++.++|+|||+++.....
T Consensus 83 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~dl~p~nil~~~~~~~~l~d~~~~~~~~~~ 159 (267)
T cd08224 83 LADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMHSK---RIMHRDIKPANVFITATGVVKLGDLGLGRFFSSK 159 (267)
T ss_pred cCCCCCHHHHHHHhcccCCCcCHHHHHHHHHHHHHHHHHHHhC---CEecCCcChhhEEECCCCcEEEeccceeeeccCC
Confidence 9999999998853 24578999999999999999999998 9999999999999999999999999998865433
Q ss_pred CCCccccccccCCcccccccccCCCCcccceehHHHHHHHHHhcCcCCCcchhhhhhhhHHHHHHHhhcccchhHhhhch
Q 003836 656 QSHTNTAIRGTKGYVAPEWFRNMPITVKVDVYSYGVLLLEIICLRRNIDNEISKVDKAILTDWAYDRYQERTLEALVEND 735 (792)
Q Consensus 656 ~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DV~S~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 735 (792)
... .....+++.|+|||.+.+..++.++|||||||++|||++|+.||........ .. ...... ..
T Consensus 160 ~~~-~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~-----~~-~~~~~~--------~~ 224 (267)
T cd08224 160 TTA-AHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLY-----SL-CKKIEK--------CD 224 (267)
T ss_pred Ccc-cceecCCccccCHHHhccCCCCchhcHHHHHHHHHHHHHCCCCcccCCccHH-----HH-Hhhhhc--------CC
Confidence 221 2234578899999999988999999999999999999999999854321100 00 000000 00
Q ss_pred hcccCCHHHHHHHHHHHHHccccCCCCCCCHHhHHHHhccC
Q 003836 736 LEAMNNVTMLHRFVMVAFWCIQEDPSHRPTMRKVTQMLEGV 776 (792)
Q Consensus 736 ~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~L~~~ 776 (792)
............+.+++.+||+.+|++||++.+|+++|+.+
T Consensus 225 ~~~~~~~~~~~~~~~~i~~cl~~~p~~Rp~~~~il~~~~~~ 265 (267)
T cd08224 225 YPPLPADHYSEELRDLVSRCINPDPEKRPDISYVLQVAKEM 265 (267)
T ss_pred CCCCChhhcCHHHHHHHHHHcCCCcccCCCHHHHHHHHHHh
Confidence 11111124556788999999999999999999999999875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a |
| >KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-35 Score=314.74 Aligned_cols=248 Identities=26% Similarity=0.318 Sum_probs=209.3
Q ss_pred HHhhhhhhcCccccceEEEeeecCCCceEEEEEEccccccc---chHHHHHHHHHhcccC-CCCcccccceeccCCceEE
Q 003836 501 VTRGFKEELGRGAFGTVYKGFVNMGSSNHVAVKKLNSVFQD---SEKEFKAEVNGIGQTH-HKNLVRLLGYCDEGQNRLL 576 (792)
Q Consensus 501 ~~~~~~~~lG~G~~g~Vy~g~~~~~~~~~vavK~~~~~~~~---~~~~~~~Ei~~l~~l~-h~niv~l~g~~~~~~~~~l 576 (792)
..+.+.++||+|.||.||++... .+++.+|+|.+.+.... ....+.+|+++|+++. |||||.+.+.++.....++
T Consensus 35 ~~Y~l~~~lG~G~Fg~v~~~~~~-~tg~~~A~K~i~k~~~~~~~~~~~v~~Ev~il~~l~~hpniv~l~~~~e~~~~~~l 113 (382)
T KOG0032|consen 35 EKYELGRELGRGQFGVVYLCREK-STGKEVACKVIPKRKLRGKEDREDVRREVAILQQLSGHPNIVQLKDAFEDPDSVYL 113 (382)
T ss_pred ccEEehhhhCCCCceEEEEEEec-CCCceeEEEEeehhhccccccHHHHHHHHHHHHhccCCCCEEEEEEEEEcCCeEEE
Confidence 34556689999999999999754 55789999999765443 3368999999999998 9999999999999999999
Q ss_pred EEEeccCCCccccccCCCCCchhHHHHHHHHHHHHHHHHhhccCCCeEecCCCCCcEEEcCC----CCeEEeecCCCccc
Q 003836 577 VYEFMSNGTVASFLFGDSKPNWKLRTEIAMGIAGGLFYLHEECCTQIIHCDIKPQNILLDDH----YNARISDFGLAKLL 652 (792)
Q Consensus 577 V~E~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dikp~NILl~~~----~~~kl~Dfg~a~~~ 652 (792)
|||++.+|.|.+.+... .+++.....++.||+.++.|||+. +|+||||||+|+|+... +.+|++|||++...
T Consensus 114 vmEL~~GGeLfd~i~~~-~~sE~da~~~~~~il~av~~lH~~---gvvHrDlKpEN~L~~~~~~~~~~ik~~DFGla~~~ 189 (382)
T KOG0032|consen 114 VMELCEGGELFDRIVKK-HYSERDAAGIIRQILEAVKYLHSL---GVVHRDLKPENLLLASKDEGSGRIKLIDFGLAKFI 189 (382)
T ss_pred EEEecCCchHHHHHHHc-cCCHHHHHHHHHHHHHHHHHHHhC---CceeccCCHHHeeeccccCCCCcEEEeeCCCceEc
Confidence 99999999999998766 489999999999999999999998 99999999999999643 57999999999987
Q ss_pred cCCCCCccccccccCCcccccccccCCCCcccceehHHHHHHHHHhcCcCCCcchhhhhhhhHHHHHHHhhcccchhHhh
Q 003836 653 TLDQSHTNTAIRGTKGYVAPEWFRNMPITVKVDVYSYGVLLLEIICLRRNIDNEISKVDKAILTDWAYDRYQERTLEALV 732 (792)
Q Consensus 653 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DV~S~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 732 (792)
.. ......++||+.|+|||++....|+..+||||+||++|.|++|..||.......... .+.
T Consensus 190 ~~--~~~~~~~~Gtp~y~APEvl~~~~y~~~~DiWS~Gvi~yiLL~G~~PF~~~~~~~~~~----------------~i~ 251 (382)
T KOG0032|consen 190 KP--GERLHTIVGTPEYVAPEVLGGRPYGDEVDVWSIGVILYILLSGVPPFWGETEFEIFL----------------AIL 251 (382)
T ss_pred cC--CceEeeecCCccccCchhhcCCCCCcccchhHHHHHHHHHhhCCCCCcCCChhHHHH----------------HHH
Confidence 65 445566789999999999999999999999999999999999999998765432221 111
Q ss_pred hc--hhcccCCHHHHHHHHHHHHHccccCCCCCCCHHhHHH
Q 003836 733 EN--DLEAMNNVTMLHRFVMVAFWCIQEDPSHRPTMRKVTQ 771 (792)
Q Consensus 733 ~~--~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~ 771 (792)
.. ......-...+..+.+++..++..||.+|+|+.++++
T Consensus 252 ~~~~~f~~~~w~~is~~akd~i~~ll~~dp~~R~ta~~~L~ 292 (382)
T KOG0032|consen 252 RGDFDFTSEPWDDISESAKDFIRKLLEFDPRKRLTAAQALQ 292 (382)
T ss_pred cCCCCCCCCCccccCHHHHHHHHHhcccCcccCCCHHHHhc
Confidence 11 1222222345778889999999999999999999999
|
|
| >cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-35 Score=303.76 Aligned_cols=248 Identities=25% Similarity=0.439 Sum_probs=198.9
Q ss_pred hhhhhcCccccceEEEeeecCCCceEEEEEEcccccccchHHHHHHHHHhcccCCCCcccccceeccCCceEEEEEeccC
Q 003836 504 GFKEELGRGAFGTVYKGFVNMGSSNHVAVKKLNSVFQDSEKEFKAEVNGIGQTHHKNLVRLLGYCDEGQNRLLVYEFMSN 583 (792)
Q Consensus 504 ~~~~~lG~G~~g~Vy~g~~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~lV~E~~~~ 583 (792)
.+.+.||+|+||.||++.... +..+|+|++... .....++.+|++++++++|||++++++++......++||||+++
T Consensus 7 ~~~~~ig~g~~g~v~~~~~~~--~~~~~~k~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~ 83 (256)
T cd05112 7 TLVQEIGSGQFGLVWLGYWLE--KRKVAIKTIREG-AMSEEDFIEEAQVMMKLSHPKLVQLYGVCTERSPICLVFEFMEH 83 (256)
T ss_pred EEEeeecCcccceEEEEEEeC--CCeEEEEECCCC-CCCHHHHHHHHHHHHhCCCCCeeeEEEEEccCCceEEEEEcCCC
Confidence 456789999999999997643 457999998753 23456799999999999999999999999999999999999999
Q ss_pred CCccccccCC-CCCchhHHHHHHHHHHHHHHHHhhccCCCeEecCCCCCcEEEcCCCCeEEeecCCCccccCCCCCcccc
Q 003836 584 GTVASFLFGD-SKPNWKLRTEIAMGIAGGLFYLHEECCTQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLDQSHTNTA 662 (792)
Q Consensus 584 gsL~~~l~~~-~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dikp~NILl~~~~~~kl~Dfg~a~~~~~~~~~~~~~ 662 (792)
++|.+++... ..+++..+..++.|++.||+|||+. +++|+||||+||+++.++.+||+|||+++............
T Consensus 84 ~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~---~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~~~~~~ 160 (256)
T cd05112 84 GCLSDYLRAQRGKFSQETLLGMCLDVCEGMAYLESS---NVIHRDLAARNCLVGENQVVKVSDFGMTRFVLDDQYTSSTG 160 (256)
T ss_pred CcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHC---CccccccccceEEEcCCCeEEECCCcceeecccCcccccCC
Confidence 9999998764 4678999999999999999999998 99999999999999999999999999998654332222222
Q ss_pred ccccCCcccccccccCCCCcccceehHHHHHHHHHh-cCcCCCcchhhhhhhhHHHHHHHhhcccchhHhhhchhcccCC
Q 003836 663 IRGTKGYVAPEWFRNMPITVKVDVYSYGVLLLEIIC-LRRNIDNEISKVDKAILTDWAYDRYQERTLEALVENDLEAMNN 741 (792)
Q Consensus 663 ~~gt~~y~aPE~~~~~~~~~k~DV~S~Gv~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 741 (792)
..++.+|+|||.+.+..++.++||||||+++|||++ |+.||........ . .... .......+
T Consensus 161 ~~~~~~~~aPe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~---~-----~~~~---------~~~~~~~~ 223 (256)
T cd05112 161 TKFPVKWSSPEVFSFSKYSSKSDVWSFGVLMWEVFSEGKTPYENRSNSEV---V-----ETIN---------AGFRLYKP 223 (256)
T ss_pred CccchhhcCHhHhccCCcChHHHHHHHHHHHHHHHcCCCCCCCcCCHHHH---H-----HHHh---------CCCCCCCC
Confidence 335678999999998899999999999999999998 8888865432110 0 0000 00011111
Q ss_pred HHHHHHHHHHHHHccccCCCCCCCHHhHHHHhc
Q 003836 742 VTMLHRFVMVAFWCIQEDPSHRPTMRKVTQMLE 774 (792)
Q Consensus 742 ~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~L~ 774 (792)
...+..+.+++.+||+.+|++||++.|++++|.
T Consensus 224 ~~~~~~~~~l~~~~l~~~p~~Rp~~~~~l~~l~ 256 (256)
T cd05112 224 RLASQSVYELMQHCWKERPEDRPSFSLLLHQLA 256 (256)
T ss_pred CCCCHHHHHHHHHHcccChhhCCCHHHHHHhhC
Confidence 123467899999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ |
| >cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-34 Score=305.65 Aligned_cols=247 Identities=26% Similarity=0.375 Sum_probs=199.8
Q ss_pred hhhhhhcCccccceEEEeeecCCCceEEEEEEccccc-ccchHHHHHHHHHhcccCCCCcccccceeccCCceEEEEEec
Q 003836 503 RGFKEELGRGAFGTVYKGFVNMGSSNHVAVKKLNSVF-QDSEKEFKAEVNGIGQTHHKNLVRLLGYCDEGQNRLLVYEFM 581 (792)
Q Consensus 503 ~~~~~~lG~G~~g~Vy~g~~~~~~~~~vavK~~~~~~-~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~lV~E~~ 581 (792)
+...+.||+|+||.||+|... .+++.||+|.+.... ....+.+.+|++++++++|+||+++++++...+..++||||+
T Consensus 6 y~~~~~l~~g~~~~vy~~~~~-~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 84 (277)
T cd06642 6 FTKLERIGKGSFGEVYKGIDN-RTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYITRYYGSYLKGTKLWIIMEYL 84 (277)
T ss_pred HHHHHHhcCCCCeeEEEEEEc-CCCeEEEEEEeccccchHHHHHHHHHHHHHHcCCCCccHhhhcccccCCceEEEEEcc
Confidence 444578999999999999754 456789999987433 334567899999999999999999999999999999999999
Q ss_pred cCCCccccccCCCCCchhHHHHHHHHHHHHHHHHhhccCCCeEecCCCCCcEEEcCCCCeEEeecCCCccccCCCCCccc
Q 003836 582 SNGTVASFLFGDSKPNWKLRTEIAMGIAGGLFYLHEECCTQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLDQSHTNT 661 (792)
Q Consensus 582 ~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dikp~NILl~~~~~~kl~Dfg~a~~~~~~~~~~~~ 661 (792)
++++|.+++.. ..+++..+..++.|+++||.|||+. +++|+||+|+||++++++.+||+|||++........ ...
T Consensus 85 ~~~~L~~~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~---~ivH~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~-~~~ 159 (277)
T cd06642 85 GGGSALDLLKP-GPLEETYIATILREILKGLDYLHSE---RKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQI-KRN 159 (277)
T ss_pred CCCcHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHhcC---CeeccCCChheEEEeCCCCEEEccccccccccCcch-hhh
Confidence 99999998854 4678999999999999999999998 999999999999999999999999999986543221 122
Q ss_pred cccccCCcccccccccCCCCcccceehHHHHHHHHHhcCcCCCcchhhhhhhhHHHHHHHhhcccchhHhhhchhcccCC
Q 003836 662 AIRGTKGYVAPEWFRNMPITVKVDVYSYGVLLLEIICLRRNIDNEISKVDKAILTDWAYDRYQERTLEALVENDLEAMNN 741 (792)
Q Consensus 662 ~~~gt~~y~aPE~~~~~~~~~k~DV~S~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 741 (792)
...++..|+|||.+.+..++.++||||||++++||++|+.|+.......... .+.........
T Consensus 160 ~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~-----------------~~~~~~~~~~~ 222 (277)
T cd06642 160 TFVGTPFWMAPEVIKQSAYDFKADIWSLGITAIELAKGEPPNSDLHPMRVLF-----------------LIPKNSPPTLE 222 (277)
T ss_pred cccCcccccCHHHhCcCCCchhhhHHHHHHHHHHHHhCCCCCcccchhhHHh-----------------hhhcCCCCCCC
Confidence 3457889999999999899999999999999999999999986432111000 00011111112
Q ss_pred HHHHHHHHHHHHHccccCCCCCCCHHhHHHH
Q 003836 742 VTMLHRFVMVAFWCIQEDPSHRPTMRKVTQM 772 (792)
Q Consensus 742 ~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~ 772 (792)
...+..+.+++.+||+.+|++||++.+++++
T Consensus 223 ~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 253 (277)
T cd06642 223 GQYSKPFKEFVEACLNKDPRFRPTAKELLKH 253 (277)
T ss_pred cccCHHHHHHHHHHccCCcccCcCHHHHHHh
Confidence 2345678899999999999999999999984
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 |
| >cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-35 Score=316.23 Aligned_cols=261 Identities=26% Similarity=0.353 Sum_probs=203.8
Q ss_pred HHHHHhhhhhhcCccccceEEEeeecC------CCceEEEEEEccccc-ccchHHHHHHHHHhccc-CCCCcccccceec
Q 003836 498 LVEVTRGFKEELGRGAFGTVYKGFVNM------GSSNHVAVKKLNSVF-QDSEKEFKAEVNGIGQT-HHKNLVRLLGYCD 569 (792)
Q Consensus 498 l~~~~~~~~~~lG~G~~g~Vy~g~~~~------~~~~~vavK~~~~~~-~~~~~~~~~Ei~~l~~l-~h~niv~l~g~~~ 569 (792)
+....+.+.+.||+|+||.||++.... .....+|+|.++... ....+++.+|++++.++ +|+||++++++|.
T Consensus 9 ~~~~~~~i~~~ig~G~~g~v~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~ 88 (334)
T cd05100 9 LSRTRLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIGKHKNIINLLGACT 88 (334)
T ss_pred cCHhHeeecceeccccCCcEEEEEEeccCCccCCcceeEEEEEcccccCHHHHHHHHHHHHHHHhhcCCCCeeeeeEEEc
Confidence 334456677899999999999996421 122468999887533 23456899999999999 7999999999999
Q ss_pred cCCceEEEEEeccCCCccccccCC----------------CCCchhHHHHHHHHHHHHHHHHhhccCCCeEecCCCCCcE
Q 003836 570 EGQNRLLVYEFMSNGTVASFLFGD----------------SKPNWKLRTEIAMGIAGGLFYLHEECCTQIIHCDIKPQNI 633 (792)
Q Consensus 570 ~~~~~~lV~E~~~~gsL~~~l~~~----------------~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dikp~NI 633 (792)
+.+..++++||+++|+|.+++... ..+.+..+..++.||+.||+|||+. +|+||||||+||
T Consensus 89 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~---givH~dlkp~Ni 165 (334)
T cd05100 89 QDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLASQ---KCIHRDLAARNV 165 (334)
T ss_pred cCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHC---CeeccccccceE
Confidence 999999999999999999998642 2467888999999999999999998 999999999999
Q ss_pred EEcCCCCeEEeecCCCccccCCCCC-ccccccccCCcccccccccCCCCcccceehHHHHHHHHHh-cCcCCCcchhhhh
Q 003836 634 LLDDHYNARISDFGLAKLLTLDQSH-TNTAIRGTKGYVAPEWFRNMPITVKVDVYSYGVLLLEIIC-LRRNIDNEISKVD 711 (792)
Q Consensus 634 Ll~~~~~~kl~Dfg~a~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~k~DV~S~Gv~l~el~t-g~~p~~~~~~~~~ 711 (792)
|+++++.+||+|||+++........ ......++..|+|||.+.+..++.++||||||+++|||++ |..||........
T Consensus 166 ll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~ 245 (334)
T cd05100 166 LVTEDNVMKIADFGLARDVHNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVEEL 245 (334)
T ss_pred EEcCCCcEEECCcccceecccccccccccCCCcCceEcCHHHhccCCcCchhhhHHHHHHHHHHHhcCCCCCCCCCHHHH
Confidence 9999999999999999865432211 1122234567999999999999999999999999999998 7788754321110
Q ss_pred hhhHHHHHHHhhcccchhHhhhchhcccCCHHHHHHHHHHHHHccccCCCCCCCHHhHHHHhccCcC
Q 003836 712 KAILTDWAYDRYQERTLEALVENDLEAMNNVTMLHRFVMVAFWCIQEDPSHRPTMRKVTQMLEGVVE 778 (792)
Q Consensus 712 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~L~~~~~ 778 (792)
. . .+........+...+..+.+++.+||+.+|++||++.|+++.|+++..
T Consensus 246 ~--------~---------~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~ell~~l~~~~~ 295 (334)
T cd05100 246 F--------K---------LLKEGHRMDKPANCTHELYMIMRECWHAVPSQRPTFKQLVEDLDRVLT 295 (334)
T ss_pred H--------H---------HHHcCCCCCCCCCCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHhh
Confidence 0 0 000111111222345678899999999999999999999999988763
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-35 Score=304.04 Aligned_cols=239 Identities=26% Similarity=0.439 Sum_probs=190.5
Q ss_pred hhcCccccceEEEeeecCCC---------ceEEEEEEcccccccchHHHHHHHHHhcccCCCCcccccceeccCCceEEE
Q 003836 507 EELGRGAFGTVYKGFVNMGS---------SNHVAVKKLNSVFQDSEKEFKAEVNGIGQTHHKNLVRLLGYCDEGQNRLLV 577 (792)
Q Consensus 507 ~~lG~G~~g~Vy~g~~~~~~---------~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~lV 577 (792)
+.||+|+||.||+|...... ...+++|.+...... ...+.+|+.++++++|+||+++++++.. ...++|
T Consensus 1 ~~lg~G~~~~v~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~-~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~lv 78 (259)
T cd05037 1 EHLGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRD-SLAFFETASLMSQLSHKHLVKLYGVCVR-DENIMV 78 (259)
T ss_pred CcccccccceEEEEEEeccCCccccCCccceeeeeeccccchhh-HHHHHHHHHHHHcCCCcchhheeeEEec-CCcEEE
Confidence 46999999999999875432 135788877654333 6789999999999999999999999988 778999
Q ss_pred EEeccCCCccccccCCC-CCchhHHHHHHHHHHHHHHHHhhccCCCeEecCCCCCcEEEcCCC-------CeEEeecCCC
Q 003836 578 YEFMSNGTVASFLFGDS-KPNWKLRTEIAMGIAGGLFYLHEECCTQIIHCDIKPQNILLDDHY-------NARISDFGLA 649 (792)
Q Consensus 578 ~E~~~~gsL~~~l~~~~-~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dikp~NILl~~~~-------~~kl~Dfg~a 649 (792)
|||+++|+|.+++.... .+++..+..++.||+.||+|||+. +|+|+||||+|||++.++ .+||+|||++
T Consensus 79 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~dlkp~Nill~~~~~~~~~~~~~kl~Dfg~a 155 (259)
T cd05037 79 EEYVKFGPLDVFLHREKNNVSLHWKLDVAKQLASALHYLEDK---KLVHGNVCGKNILVARYGLNEGYVPFIKLSDPGIP 155 (259)
T ss_pred EEcCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHhhC---CeecccCccceEEEecCccccCCceeEEeCCCCcc
Confidence 99999999999998765 789999999999999999999998 999999999999999887 7999999999
Q ss_pred ccccCCCCCccccccccCCcccccccccC--CCCcccceehHHHHHHHHHhc-CcCCCcchhhhhhhhHHHHHHHhhccc
Q 003836 650 KLLTLDQSHTNTAIRGTKGYVAPEWFRNM--PITVKVDVYSYGVLLLEIICL-RRNIDNEISKVDKAILTDWAYDRYQER 726 (792)
Q Consensus 650 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~k~DV~S~Gv~l~el~tg-~~p~~~~~~~~~~~~~~~~~~~~~~~~ 726 (792)
+.... .....++..|+|||.+... .++.++||||||+++|||++| ..|+........... +.
T Consensus 156 ~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~~~~~l~~~~~~p~~~~~~~~~~~~--------~~-- 220 (259)
T cd05037 156 ITVLS-----REERVERIPWIAPECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLSTLSSSEKERF--------YQ-- 220 (259)
T ss_pred ccccc-----ccccccCCCccChhhhcCCCCCcchhhHHHHHHHHHHHHHhCCCCCcccCCchhHHHH--------Hh--
Confidence 86543 1223466789999999876 789999999999999999995 666644321110000 00
Q ss_pred chhHhhhchhcccCCHHHHHHHHHHHHHccccCCCCCCCHHhHHHHhc
Q 003836 727 TLEALVENDLEAMNNVTMLHRFVMVAFWCIQEDPSHRPTMRKVTQMLE 774 (792)
Q Consensus 727 ~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~L~ 774 (792)
.... .+......+.+++.+||+.+|.+||++.+|++.|+
T Consensus 221 ------~~~~---~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~ 259 (259)
T cd05037 221 ------DQHR---LPMPDCAELANLINQCWTYDPTKRPSFRAILRDLN 259 (259)
T ss_pred ------cCCC---CCCCCchHHHHHHHHHhccChhhCCCHHHHHHhcC
Confidence 0000 01111267889999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki |
| >cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-35 Score=316.28 Aligned_cols=249 Identities=19% Similarity=0.226 Sum_probs=194.3
Q ss_pred hhhhhcCccccceEEEeeecCCCceEEEEEEccccc---ccchHHHHHHHHHhcccCCCCcccccceeccCCceEEEEEe
Q 003836 504 GFKEELGRGAFGTVYKGFVNMGSSNHVAVKKLNSVF---QDSEKEFKAEVNGIGQTHHKNLVRLLGYCDEGQNRLLVYEF 580 (792)
Q Consensus 504 ~~~~~lG~G~~g~Vy~g~~~~~~~~~vavK~~~~~~---~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~lV~E~ 580 (792)
.+.++||+|+||.||++... ..++.+|+|++.+.. ......+.+|+.++..++|+||+++++++.+.+..++||||
T Consensus 4 ~~~~~lG~G~fg~V~~~~~~-~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ey 82 (332)
T cd05623 4 EILKVIGRGAFGEVAVVKLK-NADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQWITTLHYAFQDENNLYLVMDY 82 (332)
T ss_pred eEEEEEEeCCCeEEEEEEEC-CCCCEEEEEEEeHHHHHHhhHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCEEEEEEec
Confidence 34578999999999999765 456789999986421 22334588899999999999999999999999999999999
Q ss_pred ccCCCccccccC-CCCCchhHHHHHHHHHHHHHHHHhhccCCCeEecCCCCCcEEEcCCCCeEEeecCCCccccCCCCCc
Q 003836 581 MSNGTVASFLFG-DSKPNWKLRTEIAMGIAGGLFYLHEECCTQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLDQSHT 659 (792)
Q Consensus 581 ~~~gsL~~~l~~-~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dikp~NILl~~~~~~kl~Dfg~a~~~~~~~~~~ 659 (792)
+++|+|.+++.+ ...+++..+..++.||+.||.|||+. +|+||||||+|||++.++.+||+|||+++.........
T Consensus 83 ~~~g~L~~~l~~~~~~l~~~~~~~~~~qi~~al~~lH~~---~iiHrDlkp~Nili~~~~~~kL~DfG~a~~~~~~~~~~ 159 (332)
T cd05623 83 YVGGDLLTLLSKFEDRLPEDMARFYLAEMVIAIDSVHQL---HYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQ 159 (332)
T ss_pred cCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHEEECCCCCEEEeecchheecccCCcce
Confidence 999999999976 35788999999999999999999998 99999999999999999999999999997654333333
Q ss_pred cccccccCCcccccccc-----cCCCCcccceehHHHHHHHHHhcCcCCCcchhhhhhhhHHHHHHHhhcccchhHhhhc
Q 003836 660 NTAIRGTKGYVAPEWFR-----NMPITVKVDVYSYGVLLLEIICLRRNIDNEISKVDKAILTDWAYDRYQERTLEALVEN 734 (792)
Q Consensus 660 ~~~~~gt~~y~aPE~~~-----~~~~~~k~DV~S~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 734 (792)
.....||+.|+|||++. ...++.++|||||||++|||++|+.||.......... .+...
T Consensus 160 ~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwSlGvil~ell~g~~Pf~~~~~~~~~~----------------~i~~~ 223 (332)
T cd05623 160 SSVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYG----------------KIMNH 223 (332)
T ss_pred ecccccCccccCHHHHhccccCCCCCCCcCCEEeeHHHHHHHhcCCCCCCCCCHHHHHH----------------HHhCC
Confidence 33456999999999986 3468899999999999999999999997543211100 00000
Q ss_pred hhc---ccCCHHHHHHHHHHHHHccccCC--CCCCCHHhHHHH
Q 003836 735 DLE---AMNNVTMLHRFVMVAFWCIQEDP--SHRPTMRKVTQM 772 (792)
Q Consensus 735 ~~~---~~~~~~~~~~l~~l~~~Cl~~~p--~~RPs~~evl~~ 772 (792)
... .......+.++.+++.+|+..++ ..||+++|+++.
T Consensus 224 ~~~~~~p~~~~~~s~~~~~li~~ll~~~~~r~~r~~~~~~~~h 266 (332)
T cd05623 224 KERFQFPAQVTDVSEDAKDLIRRLICSREHRLGQNGIEDFKQH 266 (332)
T ss_pred CccccCCCccccCCHHHHHHHHHHccChhhhcCCCCHHHHhCC
Confidence 000 00112235667788888875544 347899999876
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw |
| >cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-35 Score=305.65 Aligned_cols=248 Identities=28% Similarity=0.412 Sum_probs=196.7
Q ss_pred hcCccccceEEEeeecC-----CCceEEEEEEccccc-ccchHHHHHHHHHhcccCCCCcccccceeccCCceEEEEEec
Q 003836 508 ELGRGAFGTVYKGFVNM-----GSSNHVAVKKLNSVF-QDSEKEFKAEVNGIGQTHHKNLVRLLGYCDEGQNRLLVYEFM 581 (792)
Q Consensus 508 ~lG~G~~g~Vy~g~~~~-----~~~~~vavK~~~~~~-~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~lV~E~~ 581 (792)
.||+|+||.||+|+... ..++.+++|.+.... ......+.+|+.++++++||||+++++++...+..++||||+
T Consensus 2 ~lg~g~~g~vy~~~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~ 81 (269)
T cd05044 2 FLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPNIVKLLGVCLLNEPQYIIMELM 81 (269)
T ss_pred ccccccceeEEeeeecccccCcccceeehhhhhhcccchhhHHHHHHHHHHHHhcCCCCeeeEeeeecCCCCeEEEEecc
Confidence 58999999999997642 123579999886543 234568899999999999999999999999999999999999
Q ss_pred cCCCccccccCC-------CCCchhHHHHHHHHHHHHHHHHhhccCCCeEecCCCCCcEEEcCCC-----CeEEeecCCC
Q 003836 582 SNGTVASFLFGD-------SKPNWKLRTEIAMGIAGGLFYLHEECCTQIIHCDIKPQNILLDDHY-----NARISDFGLA 649 (792)
Q Consensus 582 ~~gsL~~~l~~~-------~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dikp~NILl~~~~-----~~kl~Dfg~a 649 (792)
++++|.+++... ..+++..++.++.|++.||+|||+. +++|+||||+||+++.+. .+||+|||++
T Consensus 82 ~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~---~i~H~dl~p~nil~~~~~~~~~~~~~l~dfg~~ 158 (269)
T cd05044 82 EGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLEQM---HFIHRDLAARNCLVSEKGYDADRVVKIGDFGLA 158 (269)
T ss_pred CCCcHHHHHHHhhhcccCCccccHHHHHHHHHHHHHHHHHHHhC---CcccCCCChheEEEecCCCCCCcceEECCcccc
Confidence 999999999642 3467899999999999999999998 999999999999999877 8999999999
Q ss_pred ccccCCCCC-ccccccccCCcccccccccCCCCcccceehHHHHHHHHHh-cCcCCCcchhhhhhhhHHHHHHHhhcccc
Q 003836 650 KLLTLDQSH-TNTAIRGTKGYVAPEWFRNMPITVKVDVYSYGVLLLEIIC-LRRNIDNEISKVDKAILTDWAYDRYQERT 727 (792)
Q Consensus 650 ~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~k~DV~S~Gv~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 727 (792)
+........ ......++..|+|||.+.+..++.++||||||+++|||++ |+.||........ . .
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt~g~~p~~~~~~~~~---~-~---------- 224 (269)
T cd05044 159 RDIYKSDYYRKEGEGLLPVRWMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQPYPALNNQEV---L-Q---------- 224 (269)
T ss_pred cccccccccccCcccCCCccccCHHHHccCCcccchhHHHHHHHHHHHHHcCCCCCcccCHHHH---H-H----------
Confidence 765432221 1112335678999999999999999999999999999998 8988864322100 0 0
Q ss_pred hhHhhhchhcccCCHHHHHHHHHHHHHccccCCCCCCCHHhHHHHhcc
Q 003836 728 LEALVENDLEAMNNVTMLHRFVMVAFWCIQEDPSHRPTMRKVTQMLEG 775 (792)
Q Consensus 728 ~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~L~~ 775 (792)
.+........+...+..+.+++.+||+.+|.+||++++|++.|++
T Consensus 225 ---~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~ 269 (269)
T cd05044 225 ---HVTAGGRLQKPENCPDKIYQLMTNCWAQDPSERPTFDRIQEILQN 269 (269)
T ss_pred ---HHhcCCccCCcccchHHHHHHHHHHcCCCcccCCCHHHHHHHHhC
Confidence 001111111223345678899999999999999999999999864
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male |
| >cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-35 Score=323.07 Aligned_cols=249 Identities=21% Similarity=0.282 Sum_probs=194.5
Q ss_pred hhhhcCccccceEEEeeecCCCceEEEEEEccccc---ccchHHHHHHHHHhcccCCCCcccccceeccCCceEEEEEec
Q 003836 505 FKEELGRGAFGTVYKGFVNMGSSNHVAVKKLNSVF---QDSEKEFKAEVNGIGQTHHKNLVRLLGYCDEGQNRLLVYEFM 581 (792)
Q Consensus 505 ~~~~lG~G~~g~Vy~g~~~~~~~~~vavK~~~~~~---~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~lV~E~~ 581 (792)
+.+.||+|+||.||++... .+++.+|+|++.... ......+.+|+.++.+++|+||+++++.+.+.+..++||||+
T Consensus 5 ~~~~lG~G~~g~V~~~~~~-~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~lv~E~~ 83 (360)
T cd05627 5 SLKVIGRGAFGEVRLVQKK-DTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGAWVVKMFYSFQDKRNLYLIMEFL 83 (360)
T ss_pred EEEEEeeCCCEEEEEEEEC-CCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEEeCC
Confidence 3468999999999999754 456789999987532 233467888999999999999999999999999999999999
Q ss_pred cCCCccccccCCCCCchhHHHHHHHHHHHHHHHHhhccCCCeEecCCCCCcEEEcCCCCeEEeecCCCccccCCCC----
Q 003836 582 SNGTVASFLFGDSKPNWKLRTEIAMGIAGGLFYLHEECCTQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLDQS---- 657 (792)
Q Consensus 582 ~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dikp~NILl~~~~~~kl~Dfg~a~~~~~~~~---- 657 (792)
++|+|.+++.....+++..+..++.|++.||.|||+. +|+||||||+|||++.++.+||+|||+++.+.....
T Consensus 84 ~gg~L~~~l~~~~~l~~~~~~~~~~qi~~~L~~lH~~---givHrDLkp~NIli~~~~~vkL~DfG~~~~~~~~~~~~~~ 160 (360)
T cd05627 84 PGGDMMTLLMKKDTLSEEATQFYIAETVLAIDAIHQL---GFIHRDIKPDNLLLDAKGHVKLSDFGLCTGLKKAHRTEFY 160 (360)
T ss_pred CCccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---CeEccCCCHHHEEECCCCCEEEeeccCCcccccccccccc
Confidence 9999999998888899999999999999999999998 999999999999999999999999999875432110
Q ss_pred ------------------------------CccccccccCCcccccccccCCCCcccceehHHHHHHHHHhcCcCCCcch
Q 003836 658 ------------------------------HTNTAIRGTKGYVAPEWFRNMPITVKVDVYSYGVLLLEIICLRRNIDNEI 707 (792)
Q Consensus 658 ------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~k~DV~S~Gv~l~el~tg~~p~~~~~ 707 (792)
.......||+.|+|||++.+..++.++|||||||++|||++|+.||....
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvilyel~tG~~Pf~~~~ 240 (360)
T cd05627 161 RNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPPFCSET 240 (360)
T ss_pred cccccCCcccccccccccccccccccccccccccccCCCccccCHHHHcCCCCCCcceeccccceeeecccCCCCCCCCC
Confidence 00113469999999999999999999999999999999999999997543
Q ss_pred hhhhhhhHHHHHHHhhcccchhHhhhchhcccCCHHHHHHHHHHHHHccccCCCCCCC---HHhHHHH
Q 003836 708 SKVDKAILTDWAYDRYQERTLEALVENDLEAMNNVTMLHRFVMVAFWCIQEDPSHRPT---MRKVTQM 772 (792)
Q Consensus 708 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs---~~evl~~ 772 (792)
.......+.. + ...+........+.++.+++.+++. +|.+|++ ++|+++.
T Consensus 241 ~~~~~~~i~~-----~---------~~~~~~p~~~~~s~~~~~li~~l~~-~p~~R~~~~~~~ei~~h 293 (360)
T cd05627 241 PQETYRKVMN-----W---------KETLVFPPEVPISEKAKDLILRFCT-DSENRIGSNGVEEIKSH 293 (360)
T ss_pred HHHHHHHHHc-----C---------CCceecCCCCCCCHHHHHHHHHhcc-ChhhcCCCCCHHHHhcC
Confidence 3211100000 0 0000000011134566777777664 9999985 5666654
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul |
| >cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-34 Score=303.87 Aligned_cols=252 Identities=27% Similarity=0.380 Sum_probs=199.4
Q ss_pred hhhhhcCccccceEEEeeecCCCceEEEEEEcccc----------cccchHHHHHHHHHhcc-cCCCCcccccceeccCC
Q 003836 504 GFKEELGRGAFGTVYKGFVNMGSSNHVAVKKLNSV----------FQDSEKEFKAEVNGIGQ-THHKNLVRLLGYCDEGQ 572 (792)
Q Consensus 504 ~~~~~lG~G~~g~Vy~g~~~~~~~~~vavK~~~~~----------~~~~~~~~~~Ei~~l~~-l~h~niv~l~g~~~~~~ 572 (792)
.+.+.||+|+||.||+|......++.+|+|.+... ......++.+|+.++.+ ++|+||+++++++.+++
T Consensus 3 ~~~~~ig~G~~~~v~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~ 82 (269)
T cd08528 3 AVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLRHPNIVRYYKTFLEND 82 (269)
T ss_pred hhhhhhcCCCCceEEEEEEcCCCCceeeeeEeeccccccccccccchHHHHHHHHHHHHHhhcCCCCCeeeEEeeEccCC
Confidence 34578999999999999876546678999987532 12233557788888865 79999999999999999
Q ss_pred ceEEEEEeccCCCccccccC----CCCCchhHHHHHHHHHHHHHHHHhhccCCCeEecCCCCCcEEEcCCCCeEEeecCC
Q 003836 573 NRLLVYEFMSNGTVASFLFG----DSKPNWKLRTEIAMGIAGGLFYLHEECCTQIIHCDIKPQNILLDDHYNARISDFGL 648 (792)
Q Consensus 573 ~~~lV~E~~~~gsL~~~l~~----~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dikp~NILl~~~~~~kl~Dfg~ 648 (792)
..++||||+++++|.+++.. ...+++..+.+++.|++.||.|||+. .+++|+||+|+||+++.++.+||+|||+
T Consensus 83 ~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~--~~i~H~dl~~~nil~~~~~~~~l~dfg~ 160 (269)
T cd08528 83 RLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALRYLHKE--KRIVHRDLTPNNIMLGEDDKVTITDFGL 160 (269)
T ss_pred eEEEEEecCCCCcHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHhccC--CceeecCCCHHHEEECCCCcEEEecccc
Confidence 99999999999999988743 34678899999999999999999963 2899999999999999999999999999
Q ss_pred CccccCCCCCccccccccCCcccccccccCCCCcccceehHHHHHHHHHhcCcCCCcchhhhhhhhHHHHHHHhhcccch
Q 003836 649 AKLLTLDQSHTNTAIRGTKGYVAPEWFRNMPITVKVDVYSYGVLLLEIICLRRNIDNEISKVDKAILTDWAYDRYQERTL 728 (792)
Q Consensus 649 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DV~S~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 728 (792)
+....... ......++..|+|||.+.+..++.++||||||+++|||++|+.||.........
T Consensus 161 ~~~~~~~~--~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~ll~~l~~g~~p~~~~~~~~~~---------------- 222 (269)
T cd08528 161 AKQKQPES--KLTSVVGTILYSCPEIVKNEPYGEKADVWAFGCILYQMCTLQPPFYSTNMLSLA---------------- 222 (269)
T ss_pred eeeccccc--ccccccCcccCcChhhhcCCCCchHHHHHHHHHHHHHHHhCCCcccccCHHHHH----------------
Confidence 98754433 233456889999999999888999999999999999999999998643221110
Q ss_pred hHhhhchhcccCCHHHHHHHHHHHHHccccCCCCCCCHHhHHHHhcc
Q 003836 729 EALVENDLEAMNNVTMLHRFVMVAFWCIQEDPSHRPTMRKVTQMLEG 775 (792)
Q Consensus 729 ~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~L~~ 775 (792)
..+................+.+++.+||+.||++||++.|+.++++.
T Consensus 223 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rp~~~e~~~~~~~ 269 (269)
T cd08528 223 TKIVEAVYEPLPEGMYSEDVTDVITSCLTPDAEARPDIIQVSAMISD 269 (269)
T ss_pred HHHhhccCCcCCcccCCHHHHHHHHHHCCCCCccCCCHHHHHHHhcC
Confidence 00111111111111234678899999999999999999999999863
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. |
| >cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-35 Score=310.71 Aligned_cols=248 Identities=24% Similarity=0.322 Sum_probs=200.9
Q ss_pred hhhhhcCccccceEEEeeecCCCceEEEEEEcccccccchHHHHHHHHHhcccCCCCcccccceeccCCceEEEEEeccC
Q 003836 504 GFKEELGRGAFGTVYKGFVNMGSSNHVAVKKLNSVFQDSEKEFKAEVNGIGQTHHKNLVRLLGYCDEGQNRLLVYEFMSN 583 (792)
Q Consensus 504 ~~~~~lG~G~~g~Vy~g~~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~lV~E~~~~ 583 (792)
.+.+.||+|++|.||+|.. ..+++.+++|.+........+.+.+|+.+++.++|+||+++++.+..+...++||||+++
T Consensus 23 ~~~~~lg~g~~~~v~~~~~-~~~~~~v~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~v~~~~~~~~~~~~~~lv~e~~~~ 101 (296)
T cd06654 23 TRFEKIGQGASGTVYTAMD-VATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAG 101 (296)
T ss_pred eeEEEecCCCCeEEEEEEE-CCCCcEEEEEEEecCCcchHHHHHHHHHHHHhCCCCCEeeEEEEEEeCCEEEEeecccCC
Confidence 3456799999999999964 345678999998766555567899999999999999999999999999999999999999
Q ss_pred CCccccccCCCCCchhHHHHHHHHHHHHHHHHhhccCCCeEecCCCCCcEEEcCCCCeEEeecCCCccccCCCCCccccc
Q 003836 584 GTVASFLFGDSKPNWKLRTEIAMGIAGGLFYLHEECCTQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLDQSHTNTAI 663 (792)
Q Consensus 584 gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dikp~NILl~~~~~~kl~Dfg~a~~~~~~~~~~~~~~ 663 (792)
++|.+++.. ..+++.++..++.|++.||+|||+. +|+|+||||+|||++.++.+||+|||++........ .....
T Consensus 102 ~~L~~~~~~-~~~~~~~~~~i~~ql~~aL~~LH~~---gi~H~dLkp~Nill~~~~~~kl~dfg~~~~~~~~~~-~~~~~ 176 (296)
T cd06654 102 GSLTDVVTE-TCMDEGQIAAVCRECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS-KRSTM 176 (296)
T ss_pred CCHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEcCCCCEEECccccchhcccccc-ccCcc
Confidence 999999854 4578899999999999999999998 999999999999999999999999999886543221 12234
Q ss_pred cccCCcccccccccCCCCcccceehHHHHHHHHHhcCcCCCcchhhhhhhhHHHHHHHhhcccchhHhhhchhcccCCHH
Q 003836 664 RGTKGYVAPEWFRNMPITVKVDVYSYGVLLLEIICLRRNIDNEISKVDKAILTDWAYDRYQERTLEALVENDLEAMNNVT 743 (792)
Q Consensus 664 ~gt~~y~aPE~~~~~~~~~k~DV~S~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 743 (792)
.+++.|+|||.+.+..++.++|||||||++|||++|+.||......... . .... ........+..
T Consensus 177 ~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~~l~~g~~pf~~~~~~~~~--~-----~~~~--------~~~~~~~~~~~ 241 (296)
T cd06654 177 VGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRAL--Y-----LIAT--------NGTPELQNPEK 241 (296)
T ss_pred cCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCCCCCHHHhH--H-----HHhc--------CCCCCCCCccc
Confidence 5888999999999888999999999999999999999999654321100 0 0000 00001111233
Q ss_pred HHHHHHHHHHHccccCCCCCCCHHhHHHH
Q 003836 744 MLHRFVMVAFWCIQEDPSHRPTMRKVTQM 772 (792)
Q Consensus 744 ~~~~l~~l~~~Cl~~~p~~RPs~~evl~~ 772 (792)
....+.+++.+||+.+|++||++.++++.
T Consensus 242 ~~~~l~~li~~~l~~~p~~Rpt~~eil~~ 270 (296)
T cd06654 242 LSAIFRDFLNRCLDMDVEKRGSAKELLQH 270 (296)
T ss_pred cCHHHHHHHHHHCcCCcccCcCHHHHhhC
Confidence 45678899999999999999999999973
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-34 Score=304.22 Aligned_cols=252 Identities=21% Similarity=0.298 Sum_probs=200.8
Q ss_pred HhhhhhhcCccccceEEEeeecCCCceEEEEEEcccccccchHHHHHHHHHhcccCCCCcccccceeccCCceEEEEEec
Q 003836 502 TRGFKEELGRGAFGTVYKGFVNMGSSNHVAVKKLNSVFQDSEKEFKAEVNGIGQTHHKNLVRLLGYCDEGQNRLLVYEFM 581 (792)
Q Consensus 502 ~~~~~~~lG~G~~g~Vy~g~~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~lV~E~~ 581 (792)
.+.+.+.||+|+||.||++... .+++.+|+|.++.........+.+|+.+++.++||||+++++.+...+..++|+||+
T Consensus 10 ~~~~~~~lg~g~~~~v~~~~~~-~~~~~~~ik~~~~~~~~~~~~~~~e~~~~~~l~h~~ii~~~~~~~~~~~~~lv~e~~ 88 (267)
T cd06645 10 DFELIQRIGSGTYGDVYKARNV-NTGELAAIKVIKLEPGEDFAVVQQEIIMMKDCKHSNIVAYFGSYLRRDKLWICMEFC 88 (267)
T ss_pred HHHHHHHhCCCCCeEEEEEEEc-CCCcEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEEEEEecc
Confidence 4556688999999999999654 456789999987654445567889999999999999999999999999999999999
Q ss_pred cCCCccccccCCCCCchhHHHHHHHHHHHHHHHHhhccCCCeEecCCCCCcEEEcCCCCeEEeecCCCccccCCCCCccc
Q 003836 582 SNGTVASFLFGDSKPNWKLRTEIAMGIAGGLFYLHEECCTQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLDQSHTNT 661 (792)
Q Consensus 582 ~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dikp~NILl~~~~~~kl~Dfg~a~~~~~~~~~~~~ 661 (792)
++++|.+++.....+++.++..++.|++.||.|||+. +++|+||||+||+++.++.+||+|||++....... ....
T Consensus 89 ~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~nili~~~~~~~l~dfg~~~~~~~~~-~~~~ 164 (267)
T cd06645 89 GGGSLQDIYHVTGPLSESQIAYVSRETLQGLYYLHSK---GKMHRDIKGANILLTDNGHVKLADFGVSAQITATI-AKRK 164 (267)
T ss_pred CCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEECcceeeeEccCcc-cccc
Confidence 9999999998878899999999999999999999998 99999999999999999999999999987654321 2223
Q ss_pred cccccCCcccccccc---cCCCCcccceehHHHHHHHHHhcCcCCCcchhhhhhhhHHHHHHHhhcccchhHhhhchhcc
Q 003836 662 AIRGTKGYVAPEWFR---NMPITVKVDVYSYGVLLLEIICLRRNIDNEISKVDKAILTDWAYDRYQERTLEALVENDLEA 738 (792)
Q Consensus 662 ~~~gt~~y~aPE~~~---~~~~~~k~DV~S~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 738 (792)
...|+..|+|||.+. ...++.++|||||||++|||++|+.|+.......... ........ .+....
T Consensus 165 ~~~~~~~y~aPE~~~~~~~~~~~~~~DvwSlG~il~~l~~~~~p~~~~~~~~~~~---~~~~~~~~--------~~~~~~ 233 (267)
T cd06645 165 SFIGTPYWMAPEVAAVERKGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALF---LMTKSNFQ--------PPKLKD 233 (267)
T ss_pred cccCcccccChhhhccccCCCCCchhhhHHHHHHHHHHhcCCCCcccccchhhHH---hhhccCCC--------CCcccc
Confidence 346899999999874 4568899999999999999999999985432211100 00000000 000000
Q ss_pred cCCHHHHHHHHHHHHHccccCCCCCCCHHhHHH
Q 003836 739 MNNVTMLHRFVMVAFWCIQEDPSHRPTMRKVTQ 771 (792)
Q Consensus 739 ~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~ 771 (792)
....+..+.+++.+||+.+|++||++++|++
T Consensus 234 --~~~~~~~~~~li~~~l~~~P~~R~~~~~ll~ 264 (267)
T cd06645 234 --KMKWSNSFHHFVKMALTKNPKKRPTAEKLLQ 264 (267)
T ss_pred --cCCCCHHHHHHHHHHccCCchhCcCHHHHhc
Confidence 1123456789999999999999999999987
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-34 Score=304.72 Aligned_cols=250 Identities=24% Similarity=0.322 Sum_probs=199.5
Q ss_pred hhhhhhcCccccceEEEeeecCCCceEEEEEEcccccccchHHHHHHHHHhcccCCCCcccccceeccCCceEEEEEecc
Q 003836 503 RGFKEELGRGAFGTVYKGFVNMGSSNHVAVKKLNSVFQDSEKEFKAEVNGIGQTHHKNLVRLLGYCDEGQNRLLVYEFMS 582 (792)
Q Consensus 503 ~~~~~~lG~G~~g~Vy~g~~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~lV~E~~~ 582 (792)
+.+.++||+|+||.||+|... .++..+++|.+........+.+.+|+++++.++|+||+++++++...+..++|+||++
T Consensus 7 ~~i~~~lg~g~~g~v~~~~~~-~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~~v~e~~~ 85 (282)
T cd06643 7 WEIIGELGDGAFGKVYKAQNK-ETGVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFCA 85 (282)
T ss_pred HHHHhhcccCCCeEEEEEEEC-CCCeEEEEEEeCCCCHHHHHHHHHHHHHHHHCCCCCeeeEEEEEeeCCEEEEEEEecC
Confidence 345578999999999999754 4567889999876555556789999999999999999999999999999999999999
Q ss_pred CCCccccccC-CCCCchhHHHHHHHHHHHHHHHHhhccCCCeEecCCCCCcEEEcCCCCeEEeecCCCccccCCCCCccc
Q 003836 583 NGTVASFLFG-DSKPNWKLRTEIAMGIAGGLFYLHEECCTQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLDQSHTNT 661 (792)
Q Consensus 583 ~gsL~~~l~~-~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dikp~NILl~~~~~~kl~Dfg~a~~~~~~~~~~~~ 661 (792)
+++|..++.+ ...+++..+..++.|+++||.|||+. +++|+||||+|||++.++.+||+|||+++...... ....
T Consensus 86 ~~~l~~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~---~i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~~~-~~~~ 161 (282)
T cd06643 86 GGAVDAVMLELERPLTEPQIRVVCKQTLEALNYLHEN---KIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTI-QRRD 161 (282)
T ss_pred CCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCcccEEEccCCCEEEccccccccccccc-cccc
Confidence 9999998865 35689999999999999999999998 99999999999999999999999999987653222 1223
Q ss_pred cccccCCcccccccc-----cCCCCcccceehHHHHHHHHHhcCcCCCcchhhhhhhhHHHHHHHhhcccchhHhhhchh
Q 003836 662 AIRGTKGYVAPEWFR-----NMPITVKVDVYSYGVLLLEIICLRRNIDNEISKVDKAILTDWAYDRYQERTLEALVENDL 736 (792)
Q Consensus 662 ~~~gt~~y~aPE~~~-----~~~~~~k~DV~S~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 736 (792)
...++..|+|||.+. +..++.++|||||||++|||++|+.||........ ..... ... ..
T Consensus 162 ~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~---~~~~~----~~~--------~~ 226 (282)
T cd06643 162 SFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAQIEPPHHELNPMRV---LLKIA----KSE--------PP 226 (282)
T ss_pred cccccccccCHhhccccCCCCCCCCccchhhhHHHHHHHHccCCCCccccCHHHH---HHHHh----hcC--------CC
Confidence 345889999999984 34578899999999999999999999865432111 00000 000 00
Q ss_pred cccCCHHHHHHHHHHHHHccccCCCCCCCHHhHHHH
Q 003836 737 EAMNNVTMLHRFVMVAFWCIQEDPSHRPTMRKVTQM 772 (792)
Q Consensus 737 ~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~ 772 (792)
....+...+..+.+++.+||+.+|.+||++.++++.
T Consensus 227 ~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 262 (282)
T cd06643 227 TLAQPSRWSSEFKDFLKKCLEKNVDARWTTTQLLQH 262 (282)
T ss_pred CCCCccccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 001122345678899999999999999999999874
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. |
| >cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-34 Score=304.57 Aligned_cols=247 Identities=25% Similarity=0.350 Sum_probs=200.4
Q ss_pred hhhhhcCccccceEEEeeecCCCceEEEEEEccccccc---------chHHHHHHHHHhcccCCCCcccccceeccCCce
Q 003836 504 GFKEELGRGAFGTVYKGFVNMGSSNHVAVKKLNSVFQD---------SEKEFKAEVNGIGQTHHKNLVRLLGYCDEGQNR 574 (792)
Q Consensus 504 ~~~~~lG~G~~g~Vy~g~~~~~~~~~vavK~~~~~~~~---------~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~ 574 (792)
.+.+.||+|++|.||+|... ..++.+|+|.+...... ..+.+.+|+.++++++|+||+++++++.+....
T Consensus 3 ~~~~~ig~g~~~~v~~a~~~-~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 81 (267)
T cd06628 3 IKGALIGSGSFGSVYLGMNA-SSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHENIVQYLGSSLDADHL 81 (267)
T ss_pred cccceeecCCCeEEEEEEec-CCCcEEEEEEecCCCcccchhHHHHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCcc
Confidence 34568999999999999754 44678999988654322 125688999999999999999999999999999
Q ss_pred EEEEEeccCCCccccccCCCCCchhHHHHHHHHHHHHHHHHhhccCCCeEecCCCCCcEEEcCCCCeEEeecCCCccccC
Q 003836 575 LLVYEFMSNGTVASFLFGDSKPNWKLRTEIAMGIAGGLFYLHEECCTQIIHCDIKPQNILLDDHYNARISDFGLAKLLTL 654 (792)
Q Consensus 575 ~lV~E~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dikp~NILl~~~~~~kl~Dfg~a~~~~~ 654 (792)
++|+||+++++|.+++.....+++..+..++.|++.||+|||+. +++|+||+|+||++++++.+||+|||.++....
T Consensus 82 ~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~~l~~~l~~lH~~---~ivH~di~p~nil~~~~~~~~l~dfg~~~~~~~ 158 (267)
T cd06628 82 NIFLEYVPGGSVAALLNNYGAFEETLVRNFVRQILKGLNYLHNR---GIIHRDIKGANILVDNKGGIKISDFGISKKLEA 158 (267)
T ss_pred EEEEEecCCCCHHHHHHhccCccHHHHHHHHHHHHHHHHHHHhc---CcccccCCHHHEEEcCCCCEEecccCCCccccc
Confidence 99999999999999998777889999999999999999999998 999999999999999999999999999987653
Q ss_pred CCCC-----ccccccccCCcccccccccCCCCcccceehHHHHHHHHHhcCcCCCcchhhhhhhhHHHHHHHhhcccchh
Q 003836 655 DQSH-----TNTAIRGTKGYVAPEWFRNMPITVKVDVYSYGVLLLEIICLRRNIDNEISKVDKAILTDWAYDRYQERTLE 729 (792)
Q Consensus 655 ~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~k~DV~S~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 729 (792)
.... ......++..|+|||.+.+..++.++||||||+++|||++|+.||......... .
T Consensus 159 ~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~----------------~ 222 (267)
T cd06628 159 NSLSTKTNGARPSLQGSVFWMAPEVVKQTSYTRKADIWSLGCLVVEMLTGKHPFPDCTQLQAI----------------F 222 (267)
T ss_pred ccccCCccccccccCCCcCccChhHhccCCCCchhhhHHHHHHHHHHhhCCCCCCCccHHHHH----------------H
Confidence 2211 112245788999999999889999999999999999999999999754221100 0
Q ss_pred HhhhchhcccCCHHHHHHHHHHHHHccccCCCCCCCHHhHHH
Q 003836 730 ALVENDLEAMNNVTMLHRFVMVAFWCIQEDPSHRPTMRKVTQ 771 (792)
Q Consensus 730 ~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~ 771 (792)
.... ......+......+.+++.+||+.+|.+||++.||++
T Consensus 223 ~~~~-~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~ 263 (267)
T cd06628 223 KIGE-NASPEIPSNISSEAIDFLEKTFEIDHNKRPTAAELLK 263 (267)
T ss_pred HHhc-cCCCcCCcccCHHHHHHHHHHccCCchhCcCHHHHhh
Confidence 0000 1111223345577889999999999999999999987
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate |
| >cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-34 Score=314.73 Aligned_cols=252 Identities=19% Similarity=0.219 Sum_probs=193.5
Q ss_pred hhhhhcCccccceEEEeeecCCCceEEEEEEcccc---cccchHHHHHHHHHhcccCCCCcccccceeccCCceEEEEEe
Q 003836 504 GFKEELGRGAFGTVYKGFVNMGSSNHVAVKKLNSV---FQDSEKEFKAEVNGIGQTHHKNLVRLLGYCDEGQNRLLVYEF 580 (792)
Q Consensus 504 ~~~~~lG~G~~g~Vy~g~~~~~~~~~vavK~~~~~---~~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~lV~E~ 580 (792)
.+.+.||+|+||.||++... .+++.+|+|++.+. .....+.+.+|+.++..++|+||+++++++.+++..++||||
T Consensus 4 ~~~~~lG~G~~g~V~~~~~~-~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~ 82 (331)
T cd05597 4 EILKVIGRGAFGEVAVVKMK-NTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDRRWITNLHYAFQDENNLYLVMDY 82 (331)
T ss_pred eEEEEEEecCCeEEEEEEEC-CCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCceEEEEecCCeEEEEEec
Confidence 35578999999999999764 45678999998642 223345688999999999999999999999999999999999
Q ss_pred ccCCCccccccC-CCCCchhHHHHHHHHHHHHHHHHhhccCCCeEecCCCCCcEEEcCCCCeEEeecCCCccccCCCCCc
Q 003836 581 MSNGTVASFLFG-DSKPNWKLRTEIAMGIAGGLFYLHEECCTQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLDQSHT 659 (792)
Q Consensus 581 ~~~gsL~~~l~~-~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dikp~NILl~~~~~~kl~Dfg~a~~~~~~~~~~ 659 (792)
+++|+|.+++.. ...+++..+..++.||+.||+|||++ +|+||||||+|||++.++.+||+|||++..........
T Consensus 83 ~~g~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~ 159 (331)
T cd05597 83 YVGGDLLTLLSKFEDRLPEDMARFYLAEMVLAIDSVHQL---GYVHRDIKPDNVLLDKNGHIRLADFGSCLRLLADGTVQ 159 (331)
T ss_pred CCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC---CeEECCCCHHHEEECCCCCEEEEECCceeecCCCCCcc
Confidence 999999999975 45788999999999999999999998 99999999999999999999999999997654433333
Q ss_pred cccccccCCccccccccc-----CCCCcccceehHHHHHHHHHhcCcCCCcchhhhhhhhHHHHHHHhhcccchhHhhhc
Q 003836 660 NTAIRGTKGYVAPEWFRN-----MPITVKVDVYSYGVLLLEIICLRRNIDNEISKVDKAILTDWAYDRYQERTLEALVEN 734 (792)
Q Consensus 660 ~~~~~gt~~y~aPE~~~~-----~~~~~k~DV~S~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 734 (792)
.....||+.|+|||++.. ..++.++|||||||++|||++|+.||.......... ..........
T Consensus 160 ~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~-------~i~~~~~~~~---- 228 (331)
T cd05597 160 SNVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYG-------KIMNHKEHFQ---- 228 (331)
T ss_pred ccceeccccccCHHHHhhccccccCCCCcceeehhhhHHHHHhhCCCCCCCCCHHHHHH-------HHHcCCCccc----
Confidence 333568999999999863 457889999999999999999999996542211100 0000000000
Q ss_pred hhcccCCHHHHHHHHHHHHHcccc--CCCCCCCHHhHHHH
Q 003836 735 DLEAMNNVTMLHRFVMVAFWCIQE--DPSHRPTMRKVTQM 772 (792)
Q Consensus 735 ~~~~~~~~~~~~~l~~l~~~Cl~~--~p~~RPs~~evl~~ 772 (792)
.. ......+..+.+++.+|+.. ++..||+++++++.
T Consensus 229 -~~-~~~~~~~~~~~~li~~ll~~~~~r~~r~~~~~~l~h 266 (331)
T cd05597 229 -FP-PDVTDVSEEAKDLIRRLICSPETRLGRNGLQDFKDH 266 (331)
T ss_pred -CC-CccCCCCHHHHHHHHHHccCcccccCCCCHHHHhcC
Confidence 00 00112345667778777754 33347899998876
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, |
| >cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-35 Score=316.62 Aligned_cols=249 Identities=18% Similarity=0.227 Sum_probs=194.8
Q ss_pred hhhhhcCccccceEEEeeecCCCceEEEEEEccccc---ccchHHHHHHHHHhcccCCCCcccccceeccCCceEEEEEe
Q 003836 504 GFKEELGRGAFGTVYKGFVNMGSSNHVAVKKLNSVF---QDSEKEFKAEVNGIGQTHHKNLVRLLGYCDEGQNRLLVYEF 580 (792)
Q Consensus 504 ~~~~~lG~G~~g~Vy~g~~~~~~~~~vavK~~~~~~---~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~lV~E~ 580 (792)
.+.+.||+|+||.||+++.. .+++.+|+|++.+.. ......+.+|+.++..++|+||+++++++.+.+..++||||
T Consensus 4 ~i~~~lG~G~fg~V~~~~~~-~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~l~~~~~~~~~~~lv~Ey 82 (331)
T cd05624 4 EIIKVIGRGAFGEVAVVKMK-HTERIYAMKILNKWEMLKRAETACFREERNVLVNGDCQWITTLHYAFQDENYLYLVMDY 82 (331)
T ss_pred eEEEEEeeCCCeEEEEEEEC-CCCCEEEEEEEeHHHHHhhHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEEeC
Confidence 34578999999999999754 456789999986521 22345588899999999999999999999999999999999
Q ss_pred ccCCCccccccC-CCCCchhHHHHHHHHHHHHHHHHhhccCCCeEecCCCCCcEEEcCCCCeEEeecCCCccccCCCCCc
Q 003836 581 MSNGTVASFLFG-DSKPNWKLRTEIAMGIAGGLFYLHEECCTQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLDQSHT 659 (792)
Q Consensus 581 ~~~gsL~~~l~~-~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dikp~NILl~~~~~~kl~Dfg~a~~~~~~~~~~ 659 (792)
+++|+|.+++.. ...+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++.........
T Consensus 83 ~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~~L~~lH~~---~iiHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~~ 159 (331)
T cd05624 83 YVGGDLLTLLSKFEDRLPEDMARFYIAEMVLAIHSIHQL---HYVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQDGTVQ 159 (331)
T ss_pred CCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCchHHEEEcCCCCEEEEeccceeeccCCCcee
Confidence 999999999976 45788999999999999999999998 99999999999999999999999999998765443333
Q ss_pred cccccccCCccccccccc-----CCCCcccceehHHHHHHHHHhcCcCCCcchhhhhhhhHHHHHHHhhcccchhHhhhc
Q 003836 660 NTAIRGTKGYVAPEWFRN-----MPITVKVDVYSYGVLLLEIICLRRNIDNEISKVDKAILTDWAYDRYQERTLEALVEN 734 (792)
Q Consensus 660 ~~~~~gt~~y~aPE~~~~-----~~~~~k~DV~S~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 734 (792)
.....||+.|+|||.+.+ ..++.++|||||||++|||++|+.||......... ..+...
T Consensus 160 ~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~----------------~~i~~~ 223 (331)
T cd05624 160 SSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETY----------------GKIMNH 223 (331)
T ss_pred eccccCCcccCCHHHHhccccCCCCCCCcccEEeeehhhhhhhhCCCCccCCCHHHHH----------------HHHHcC
Confidence 334569999999999865 46889999999999999999999999654321110 000000
Q ss_pred hhc---ccCCHHHHHHHHHHHHHccccCCCC--CCCHHhHHHH
Q 003836 735 DLE---AMNNVTMLHRFVMVAFWCIQEDPSH--RPTMRKVTQM 772 (792)
Q Consensus 735 ~~~---~~~~~~~~~~l~~l~~~Cl~~~p~~--RPs~~evl~~ 772 (792)
... .......+.++.+++.+|+..++.+ |++++++++.
T Consensus 224 ~~~~~~p~~~~~~~~~~~~li~~ll~~~~~~~~~~~~~~~~~h 266 (331)
T cd05624 224 EERFQFPSHITDVSEEAKDLIQRLICSRERRLGQNGIEDFKKH 266 (331)
T ss_pred CCcccCCCccccCCHHHHHHHHHHccCchhhcCCCCHHHHhcC
Confidence 000 0001123567788888888865544 4688888764
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. |
| >PTZ00036 glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-35 Score=329.53 Aligned_cols=259 Identities=22% Similarity=0.280 Sum_probs=188.4
Q ss_pred hhhhhhcCccccceEEEeeecCCCceEEEEEEcccccccchHHHHHHHHHhcccCCCCcccccceeccC--------Cce
Q 003836 503 RGFKEELGRGAFGTVYKGFVNMGSSNHVAVKKLNSVFQDSEKEFKAEVNGIGQTHHKNLVRLLGYCDEG--------QNR 574 (792)
Q Consensus 503 ~~~~~~lG~G~~g~Vy~g~~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~--------~~~ 574 (792)
+.+.+.||+|+||.||+|... .+++.||||++... .....+|+.++++++|+||+++++++... ...
T Consensus 68 y~~~~~LG~G~fg~Vy~~~~~-~~~~~vAiK~i~~~----~~~~~~Ei~il~~l~h~niv~l~~~~~~~~~~~~~~~~~l 142 (440)
T PTZ00036 68 YKLGNIIGNGSFGVVYEAICI-DTSEKVAIKKVLQD----PQYKNRELLIMKNLNHINIIFLKDYYYTECFKKNEKNIFL 142 (440)
T ss_pred EEEeEEEEeCCCEEEEEEEEC-CCCCEEEEEEEecC----cchHHHHHHHHHhcCCCCCcceeeeEeecccccCCCceEE
Confidence 345678999999999999754 45678999988542 23346799999999999999999876321 236
Q ss_pred EEEEEeccCCCcccccc----CCCCCchhHHHHHHHHHHHHHHHHhhccCCCeEecCCCCCcEEEcCCC-CeEEeecCCC
Q 003836 575 LLVYEFMSNGTVASFLF----GDSKPNWKLRTEIAMGIAGGLFYLHEECCTQIIHCDIKPQNILLDDHY-NARISDFGLA 649 (792)
Q Consensus 575 ~lV~E~~~~gsL~~~l~----~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dikp~NILl~~~~-~~kl~Dfg~a 649 (792)
++||||+++ +|.+++. ....+++..+..++.||+.||+|||+. +|+||||||+|||++.++ .+||+|||++
T Consensus 143 ~lvmE~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~gL~yLH~~---~IiHrDLKp~NILl~~~~~~vkL~DFGla 218 (440)
T PTZ00036 143 NVVMEFIPQ-TVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYIHSK---FICHRDLKPQNLLIDPNTHTLKLCDFGSA 218 (440)
T ss_pred EEEEecCCc-cHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCcCHHHEEEcCCCCceeeeccccc
Confidence 689999985 6666553 345788999999999999999999998 999999999999999664 7999999999
Q ss_pred ccccCCCCCccccccccCCccccccccc-CCCCcccceehHHHHHHHHHhcCcCCCcchhhhhhhhHHHHH----HH---
Q 003836 650 KLLTLDQSHTNTAIRGTKGYVAPEWFRN-MPITVKVDVYSYGVLLLEIICLRRNIDNEISKVDKAILTDWA----YD--- 721 (792)
Q Consensus 650 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~k~DV~S~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~----~~--- 721 (792)
+...... ......||+.|+|||++.+ ..++.++|||||||++|||++|..||................ ..
T Consensus 219 ~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~~~p~~~~~~ 296 (440)
T PTZ00036 219 KNLLAGQ--RSVSYICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMILGYPIFSGQSSVDQLVRIIQVLGTPTEDQLK 296 (440)
T ss_pred hhccCCC--CcccCCCCcCccCHHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHH
Confidence 8764322 2223468999999999865 468999999999999999999999997643321111100000 00
Q ss_pred ----hhcccchhHhhhchhcccCCHHHHHHHHHHHHHccccCCCCCCCHHhHHHH
Q 003836 722 ----RYQERTLEALVENDLEAMNNVTMLHRFVMVAFWCIQEDPSHRPTMRKVTQM 772 (792)
Q Consensus 722 ----~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~ 772 (792)
.+.+.....+....+....+...+.++.+|+.+||+.+|.+|||+.|+++.
T Consensus 297 ~~~~~~~~~~~~~~~~~~l~~~~p~~~~~~~~~li~~~L~~dP~~R~ta~e~l~h 351 (440)
T PTZ00036 297 EMNPNYADIKFPDVKPKDLKKVFPKGTPDDAINFISQFLKYEPLKRLNPIEALAD 351 (440)
T ss_pred HhchhhhcccCCccCchhHHHHhccCCCHHHHHHHHHHCCCChhHCcCHHHHhCC
Confidence 000000000001111111222345678999999999999999999999864
|
|
| >cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-34 Score=304.35 Aligned_cols=247 Identities=25% Similarity=0.378 Sum_probs=195.0
Q ss_pred hhhhhhcCccccceEEEeeecCCCceEEEEEEcccccccchHHHHHHHHHhccc-CCCCcccccceeccC------CceE
Q 003836 503 RGFKEELGRGAFGTVYKGFVNMGSSNHVAVKKLNSVFQDSEKEFKAEVNGIGQT-HHKNLVRLLGYCDEG------QNRL 575 (792)
Q Consensus 503 ~~~~~~lG~G~~g~Vy~g~~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l-~h~niv~l~g~~~~~------~~~~ 575 (792)
+.+.+.||+|+||.||+|... ..++.+|+|++... .....++.+|+.++.++ +|+||+++++++... ...+
T Consensus 8 y~~~~~lg~g~~g~vy~~~~~-~~~~~~aik~~~~~-~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~~~~ 85 (272)
T cd06637 8 FELVELVGNGTYGQVYKGRHV-KTGQLAAIKVMDVT-GDEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMDDQLW 85 (272)
T ss_pred hhHHHheeecCCeEEEEEEEc-CCCcEEEEEEEEcC-CccHHHHHHHHHHHHHhcCCCCeeeEeeEEeecCCCCCCcEEE
Confidence 345578999999999999764 45678999998654 34456789999999998 799999999998653 4578
Q ss_pred EEEEeccCCCccccccCC--CCCchhHHHHHHHHHHHHHHHHhhccCCCeEecCCCCCcEEEcCCCCeEEeecCCCcccc
Q 003836 576 LVYEFMSNGTVASFLFGD--SKPNWKLRTEIAMGIAGGLFYLHEECCTQIIHCDIKPQNILLDDHYNARISDFGLAKLLT 653 (792)
Q Consensus 576 lV~E~~~~gsL~~~l~~~--~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dikp~NILl~~~~~~kl~Dfg~a~~~~ 653 (792)
+||||+++++|.+++... ..+++..+..++.|++.||+|||+. +|+|+||||+||++++++.+||+|||+++...
T Consensus 86 iv~e~~~~~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~LH~~---~ivh~dl~~~nili~~~~~~~l~Dfg~~~~~~ 162 (272)
T cd06637 86 LVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQH---KVIHRDIKGQNVLLTENAEVKLVDFGVSAQLD 162 (272)
T ss_pred EEEEcCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHC---CCccCCCCHHHEEECCCCCEEEccCCCceecc
Confidence 999999999999998763 4678999999999999999999998 99999999999999999999999999998654
Q ss_pred CCCCCccccccccCCcccccccc-----cCCCCcccceehHHHHHHHHHhcCcCCCcchhhhhhhhHHHHHHHhhcccch
Q 003836 654 LDQSHTNTAIRGTKGYVAPEWFR-----NMPITVKVDVYSYGVLLLEIICLRRNIDNEISKVDKAILTDWAYDRYQERTL 728 (792)
Q Consensus 654 ~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~k~DV~S~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 728 (792)
.... ......|++.|+|||++. ...++.++|||||||++|||++|+.||............ ..
T Consensus 163 ~~~~-~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGv~l~el~~g~~p~~~~~~~~~~~~~-------~~---- 230 (272)
T cd06637 163 RTVG-RRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALFLI-------PR---- 230 (272)
T ss_pred cccc-cCCcccccccccCHhHhccccCcCCCCCchhhHHHHHHHHHHHHhCCCCccccCHHHHHHHH-------hc----
Confidence 3222 223456899999999986 346888999999999999999999999643221111000 00
Q ss_pred hHhhhchhcccCCHHHHHHHHHHHHHccccCCCCCCCHHhHHH
Q 003836 729 EALVENDLEAMNNVTMLHRFVMVAFWCIQEDPSHRPTMRKVTQ 771 (792)
Q Consensus 729 ~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~ 771 (792)
...........+..+.+++.+||+.+|.+|||+.|+++
T Consensus 231 -----~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~ 268 (272)
T cd06637 231 -----NPAPRLKSKKWSKKFQSFIESCLVKNHSQRPTTEQLMK 268 (272)
T ss_pred -----CCCCCCCCCCcCHHHHHHHHHHcCCChhhCCCHHHHhh
Confidence 00011111223457889999999999999999999987
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ |
| >cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-34 Score=304.17 Aligned_cols=251 Identities=27% Similarity=0.407 Sum_probs=188.3
Q ss_pred hcCccccceEEEeeecCC-CceEEEEEEccccc-ccchHHHHHHHHHhcccCCCCcccccceeccCCceEEEEEeccCCC
Q 003836 508 ELGRGAFGTVYKGFVNMG-SSNHVAVKKLNSVF-QDSEKEFKAEVNGIGQTHHKNLVRLLGYCDEGQNRLLVYEFMSNGT 585 (792)
Q Consensus 508 ~lG~G~~g~Vy~g~~~~~-~~~~vavK~~~~~~-~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~lV~E~~~~gs 585 (792)
+||+|+||.||+|....+ ....+++|.+.... ......+.+|+.+++.++|+||+++++.+.+....++||||+++|+
T Consensus 2 ~lg~G~fg~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~nii~~~~~~~~~~~~~lv~e~~~~g~ 81 (269)
T cd05042 2 EIGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQCLGQCIESIPYLLVLEFCPLGD 81 (269)
T ss_pred cCCccCCceEEEEEEecCCCCeEEEEeecCccCChHHHHHHHHHHHHHHhCCCCCcceEEEEECCCCceEEEEEeCCCCc
Confidence 699999999999975433 34578899876543 2334678899999999999999999999999999999999999999
Q ss_pred ccccccCCC-----CCchhHHHHHHHHHHHHHHHHhhccCCCeEecCCCCCcEEEcCCCCeEEeecCCCccccCCCCC-c
Q 003836 586 VASFLFGDS-----KPNWKLRTEIAMGIAGGLFYLHEECCTQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLDQSH-T 659 (792)
Q Consensus 586 L~~~l~~~~-----~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dikp~NILl~~~~~~kl~Dfg~a~~~~~~~~~-~ 659 (792)
|.+++.... ...+.....++.||+.||+|||+. +|+||||||+|||+++++.+||+|||+++........ .
T Consensus 82 L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~~ 158 (269)
T cd05042 82 LKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQA---DFIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYIT 158 (269)
T ss_pred HHHHHHhccccccccccHHHHHHHHHHHHHHHHHHHhc---CEecccccHhheEecCCCcEEEeccccccccccchheec
Confidence 999996542 245778889999999999999998 9999999999999999999999999998754322211 1
Q ss_pred cccccccCCccccccccc-------CCCCcccceehHHHHHHHHHh-cCcCCCcchhhhhhhhHHHHHHHhhcccchhHh
Q 003836 660 NTAIRGTKGYVAPEWFRN-------MPITVKVDVYSYGVLLLEIIC-LRRNIDNEISKVDKAILTDWAYDRYQERTLEAL 731 (792)
Q Consensus 660 ~~~~~gt~~y~aPE~~~~-------~~~~~k~DV~S~Gv~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 731 (792)
.....+++.|+|||++.. ..++.++|||||||++|||++ |+.||....... .+.. ..... ...+
T Consensus 159 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~---~~~~----~~~~~-~~~~ 230 (269)
T cd05042 159 KDCHAVPLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDLSDEQ---VLKQ----VVREQ-DIKL 230 (269)
T ss_pred cCCCCCcccccCHHHHhhccccccccccchhhHHHHHHHHHHHHHhCCCCCCCcCCHHH---HHHH----Hhhcc-CccC
Confidence 122345678999998743 457889999999999999999 677775432211 0100 00000 0001
Q ss_pred hhchhcccCCHHHHHHHHHHHHHccccCCCCCCCHHhHHHHhc
Q 003836 732 VENDLEAMNNVTMLHRFVMVAFWCIQEDPSHRPTMRKVTQMLE 774 (792)
Q Consensus 732 ~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~L~ 774 (792)
..+ ..+......+.+++..|+ .+|++||++++|+++|.
T Consensus 231 ~~~----~~~~~~~~~~~~~~~~~~-~dp~~Rpt~~~v~~~l~ 268 (269)
T cd05042 231 PKP----QLDLKYSDRWYEVMQFCW-LDPETRPTAEEVHELLT 268 (269)
T ss_pred CCC----cccccCCHHHHHHHHHHh-cCcccccCHHHHHHHhc
Confidence 111 112234456677888888 59999999999999874
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina |
| >smart00219 TyrKc Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-34 Score=301.13 Aligned_cols=249 Identities=29% Similarity=0.444 Sum_probs=201.3
Q ss_pred hhhhcCccccceEEEeeecCCC---ceEEEEEEccccccc-chHHHHHHHHHhcccCCCCcccccceeccCCceEEEEEe
Q 003836 505 FKEELGRGAFGTVYKGFVNMGS---SNHVAVKKLNSVFQD-SEKEFKAEVNGIGQTHHKNLVRLLGYCDEGQNRLLVYEF 580 (792)
Q Consensus 505 ~~~~lG~G~~g~Vy~g~~~~~~---~~~vavK~~~~~~~~-~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~lV~E~ 580 (792)
+.+.||+|+||.||++...... ...+|+|++...... ..+.+.+|++.+.+++|+||+++++++.+.+..+++|||
T Consensus 3 ~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~i~e~ 82 (258)
T smart00219 3 LGKKLGEGAFGEVYKGTLKGLSGEKEVEVAVKTLKEDADEQQIEEFLREARIMRKLDHPNIVKLLGVCTEEEPLMIVMEY 82 (258)
T ss_pred ccceeccCCCcceEEEEecCCCCCCCceEEEEEccCCCChHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCeeEEEEec
Confidence 4578999999999999875432 478999999765433 567899999999999999999999999999999999999
Q ss_pred ccCCCccccccCCCC--CchhHHHHHHHHHHHHHHHHhhccCCCeEecCCCCCcEEEcCCCCeEEeecCCCccccCCCCC
Q 003836 581 MSNGTVASFLFGDSK--PNWKLRTEIAMGIAGGLFYLHEECCTQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLDQSH 658 (792)
Q Consensus 581 ~~~gsL~~~l~~~~~--l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dikp~NILl~~~~~~kl~Dfg~a~~~~~~~~~ 658 (792)
+++++|.+++..... +++..+..++.|++.||+|||+. +++|+||||+||++++++.++|+|||+++........
T Consensus 83 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lh~~---~~~h~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~~~ 159 (258)
T smart00219 83 MEGGDLLDYLRKNRPKELSLSDLLSFALQIARGMEYLESK---NFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYY 159 (258)
T ss_pred cCCCCHHHHHHhhhhccCCHHHHHHHHHHHHHHHHHHhcC---CeeecccccceEEEccCCeEEEcccCCceeccccccc
Confidence 999999999976543 89999999999999999999998 9999999999999999999999999999876544222
Q ss_pred ccccccccCCcccccccccCCCCcccceehHHHHHHHHHh-cCcCCCcchhhhhhhhHHHHHHHhhcccchhHhhhchhc
Q 003836 659 TNTAIRGTKGYVAPEWFRNMPITVKVDVYSYGVLLLEIIC-LRRNIDNEISKVDKAILTDWAYDRYQERTLEALVENDLE 737 (792)
Q Consensus 659 ~~~~~~gt~~y~aPE~~~~~~~~~k~DV~S~Gv~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 737 (792)
......+++.|+|||.+.+..++.++||||||++++||++ |+.||........ . .. +.....
T Consensus 160 ~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~i~~~l~~~g~~p~~~~~~~~~-------~-~~---------~~~~~~ 222 (258)
T smart00219 160 KKKGGKLPIRWMAPESLKDGKFTSKSDVWSFGVLLWEIFTLGESPYPGMSNEEV-------L-EY---------LKKGYR 222 (258)
T ss_pred ccccCCCcccccChHHhccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCHHHH-------H-HH---------HhcCCC
Confidence 2222336789999999988889999999999999999998 6777754221100 0 00 000011
Q ss_pred ccCCHHHHHHHHHHHHHccccCCCCCCCHHhHHHHh
Q 003836 738 AMNNVTMLHRFVMVAFWCIQEDPSHRPTMRKVTQML 773 (792)
Q Consensus 738 ~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~L 773 (792)
...+...+.++.+++.+|++.+|++|||+.|+++.|
T Consensus 223 ~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~~l 258 (258)
T smart00219 223 LPKPENCPPEIYKLMLQCWAEDPEDRPTFSELVEIL 258 (258)
T ss_pred CCCCCcCCHHHHHHHHHHCcCChhhCcCHHHHHhhC
Confidence 111223566788999999999999999999999865
|
Phosphotransferases. Tyrosine-specific kinase subfamily. |
| >KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-35 Score=299.42 Aligned_cols=258 Identities=24% Similarity=0.354 Sum_probs=199.2
Q ss_pred hhhhcCccccceEEEeeecCCCceEEEEEEcccccccchHHHHHHHHHhcc--cCCCCcccccceeccCC----ceEEEE
Q 003836 505 FKEELGRGAFGTVYKGFVNMGSSNHVAVKKLNSVFQDSEKEFKAEVNGIGQ--THHKNLVRLLGYCDEGQ----NRLLVY 578 (792)
Q Consensus 505 ~~~~lG~G~~g~Vy~g~~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~--l~h~niv~l~g~~~~~~----~~~lV~ 578 (792)
+.+.||+|.||.||+|.++ ++.||||++... .+..+.+|.++++. |+|+||+.+++.-..+. .++||.
T Consensus 215 L~e~IGkGRyGEVwrG~wr---Ge~VAVKiF~sr---dE~SWfrEtEIYqTvmLRHENILgFIaaD~~~~gs~TQLwLvT 288 (513)
T KOG2052|consen 215 LQEIIGKGRFGEVWRGRWR---GEDVAVKIFSSR---DERSWFRETEIYQTVMLRHENILGFIAADNKDNGSWTQLWLVT 288 (513)
T ss_pred EEEEecCccccceeecccc---CCceEEEEeccc---chhhhhhHHHHHHHHHhccchhhhhhhccccCCCceEEEEEee
Confidence 4567999999999999987 567999999753 45677888888886 59999999999876554 578999
Q ss_pred EeccCCCccccccCCCCCchhHHHHHHHHHHHHHHHHhhcc-----CCCeEecCCCCCcEEEcCCCCeEEeecCCCcccc
Q 003836 579 EFMSNGTVASFLFGDSKPNWKLRTEIAMGIAGGLFYLHEEC-----CTQIIHCDIKPQNILLDDHYNARISDFGLAKLLT 653 (792)
Q Consensus 579 E~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~-----~~~ivH~dikp~NILl~~~~~~kl~Dfg~a~~~~ 653 (792)
+|.+.|||.+||.+ ..++....++++..+|.||++||.+. .+.|.|||||+.|||+..++.+.|+|+|+|....
T Consensus 289 dYHe~GSL~DyL~r-~tv~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIAHRDlKSKNILVKkn~~C~IADLGLAv~h~ 367 (513)
T KOG2052|consen 289 DYHEHGSLYDYLNR-NTVTTEGMLKLALSIASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHD 367 (513)
T ss_pred ecccCCcHHHHHhh-ccCCHHHHHHHHHHHhhhHHHHHHHHhcCCCCchhhccccccccEEEccCCcEEEeeceeeEEec
Confidence 99999999999977 67889999999999999999999763 5789999999999999999999999999998766
Q ss_pred CCCCC---ccccccccCCcccccccccCC----CC--cccceehHHHHHHHHHhc----------CcCCCcchhhhhhhh
Q 003836 654 LDQSH---TNTAIRGTKGYVAPEWFRNMP----IT--VKVDVYSYGVLLLEIICL----------RRNIDNEISKVDKAI 714 (792)
Q Consensus 654 ~~~~~---~~~~~~gt~~y~aPE~~~~~~----~~--~k~DV~S~Gv~l~el~tg----------~~p~~~~~~~~~~~~ 714 (792)
.+... .....+||.+|||||++.+.. |. ..+||||||.++||+... +.||.+....
T Consensus 368 ~~t~~idi~~N~rVGTKRYMAPEvLdetin~~~Fesyk~ADIYafgLVlWEiarRc~~ggi~eey~~Pyyd~Vp~----- 442 (513)
T KOG2052|consen 368 SDTDTIDIPPNPRVGTKRYMAPEVLDETINMKHFESYKRADIYAFGLVLWEIARRCESGGIVEEYQLPYYDVVPS----- 442 (513)
T ss_pred ccCCcccCCCCCccceeeccChHHhhhhcChhhhhhhhHHHHHHHHHHHHHHHHHhhcCCEehhhcCCcccCCCC-----
Confidence 54322 123467999999999996532 22 359999999999998753 2333322110
Q ss_pred HHHHHHHhhcccchhHhhhchhcccC-----CHHHHHHHHHHHHHccccCCCCCCCHHhHHHHhccCcCCC
Q 003836 715 LTDWAYDRYQERTLEALVENDLEAMN-----NVTMLHRFVMVAFWCIQEDPSHRPTMRKVTQMLEGVVEVP 780 (792)
Q Consensus 715 ~~~~~~~~~~~~~~~~~~~~~~~~~~-----~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~L~~~~~~~ 780 (792)
+.-.++..+.+-.+.+++.. +.+.+..+.++++.||..||+.|-|+-.|.+.|.++.+.+
T Consensus 443 ------DPs~eeMrkVVCv~~~RP~ipnrW~s~~~l~~m~klMkeCW~~Np~aRltALriKKtl~~l~~~~ 507 (513)
T KOG2052|consen 443 ------DPSFEEMRKVVCVQKLRPNIPNRWKSDPALRVMAKLMKECWYANPAARLTALRIKKTLAKLSNSD 507 (513)
T ss_pred ------CCCHHHHhcceeecccCCCCCcccccCHHHHHHHHHHHHhhcCCchhhhHHHHHHHHHHHHhcCh
Confidence 00001111122223333333 3467888999999999999999999999999998876543
|
|
| >cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-34 Score=312.15 Aligned_cols=194 Identities=21% Similarity=0.341 Sum_probs=159.1
Q ss_pred hhcCccccceEEEeeecC-CCceEEEEEEcccccccchHHHHHHHHHhcccCCCCcccccceecc--CCceEEEEEeccC
Q 003836 507 EELGRGAFGTVYKGFVNM-GSSNHVAVKKLNSVFQDSEKEFKAEVNGIGQTHHKNLVRLLGYCDE--GQNRLLVYEFMSN 583 (792)
Q Consensus 507 ~~lG~G~~g~Vy~g~~~~-~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~--~~~~~lV~E~~~~ 583 (792)
++||+|+||+||+|.... ...+.+|+|++... .....+.+|++++++++||||+++++++.. +...++||||+.+
T Consensus 7 ~~lG~G~~g~Vy~~~~~~~~~~~~~aiK~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~~ 84 (317)
T cd07868 7 CKVGRGTYGHVYKAKRKDGKDDRDYALKQIEGT--GISMSACREIALLRELKHPNVISLQKVFLSHADRKVWLLFDYAEH 84 (317)
T ss_pred cccccCCCeEEEEEEEccCCCCceEEEEEECCC--CCcHHHHHHHHHHHhcCCCCCcceeeeEecCCCcEEEEEEeccCC
Confidence 579999999999997543 34578999998653 234567899999999999999999998854 4567899999975
Q ss_pred CCccccccCC---------CCCchhHHHHHHHHHHHHHHHHhhccCCCeEecCCCCCcEEE----cCCCCeEEeecCCCc
Q 003836 584 GTVASFLFGD---------SKPNWKLRTEIAMGIAGGLFYLHEECCTQIIHCDIKPQNILL----DDHYNARISDFGLAK 650 (792)
Q Consensus 584 gsL~~~l~~~---------~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dikp~NILl----~~~~~~kl~Dfg~a~ 650 (792)
+|.+++... ..+++..+..++.||+.||.|||+. +|+||||||+|||+ +.++.+||+|||+++
T Consensus 85 -~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~---~ivHrDlkp~Nil~~~~~~~~~~~kl~DfG~a~ 160 (317)
T cd07868 85 -DLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHAN---WVLHRDLKPANILVMGEGPERGRVKIADMGFAR 160 (317)
T ss_pred -CHHHHHHhcccccccCCcccCCHHHHHHHHHHHHHHHHHHHhC---CEEcCCCCHHHEEEecCCCCcCcEEEeecCcee
Confidence 777665421 2478888999999999999999998 99999999999999 456789999999998
Q ss_pred cccCCCC--CccccccccCCccccccccc-CCCCcccceehHHHHHHHHHhcCcCCCcc
Q 003836 651 LLTLDQS--HTNTAIRGTKGYVAPEWFRN-MPITVKVDVYSYGVLLLEIICLRRNIDNE 706 (792)
Q Consensus 651 ~~~~~~~--~~~~~~~gt~~y~aPE~~~~-~~~~~k~DV~S~Gv~l~el~tg~~p~~~~ 706 (792)
....... .......+|+.|+|||++.+ ..++.++||||+||++|||++|+.||...
T Consensus 161 ~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~ 219 (317)
T cd07868 161 LFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCR 219 (317)
T ss_pred ccCCCCccccccCCccccccccCCHHHcCCCCcCchhhHHHHHHHHHHHHhCCCCccCC
Confidence 7643322 12234568999999999876 45899999999999999999999999643
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p |
| >PHA03209 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-34 Score=314.73 Aligned_cols=189 Identities=24% Similarity=0.310 Sum_probs=161.4
Q ss_pred HhhhhhhcCccccceEEEeeecCCCceEEEEEEcccccccchHHHHHHHHHhcccCCCCcccccceeccCCceEEEEEec
Q 003836 502 TRGFKEELGRGAFGTVYKGFVNMGSSNHVAVKKLNSVFQDSEKEFKAEVNGIGQTHHKNLVRLLGYCDEGQNRLLVYEFM 581 (792)
Q Consensus 502 ~~~~~~~lG~G~~g~Vy~g~~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~lV~E~~ 581 (792)
.+.+.+.||+|+||.||+|... ..++.||+|+.... ....|+.++++++|+||+++++++.+....++|+||+
T Consensus 67 ~y~~~~~lg~G~~g~Vy~~~~~-~~~~~valK~~~~~------~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 139 (357)
T PHA03209 67 GYTVIKTLTPGSEGRVFVATKP-GQPDPVVLKIGQKG------TTLIEAMLLQNVNHPSVIRMKDTLVSGAITCMVLPHY 139 (357)
T ss_pred CcEEEEEecCCCCeEEEEEEEC-CCCceEEEEeCCcc------ccHHHHHHHHhCCCCCCcChhheEEeCCeeEEEEEcc
Confidence 3455678999999999999754 45678999975432 3456899999999999999999999999999999999
Q ss_pred cCCCccccccC-CCCCchhHHHHHHHHHHHHHHHHhhccCCCeEecCCCCCcEEEcCCCCeEEeecCCCccccCCCCCcc
Q 003836 582 SNGTVASFLFG-DSKPNWKLRTEIAMGIAGGLFYLHEECCTQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLDQSHTN 660 (792)
Q Consensus 582 ~~gsL~~~l~~-~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dikp~NILl~~~~~~kl~Dfg~a~~~~~~~~~~~ 660 (792)
. ++|.+++.. ...+++..+..|+.||+.||.|||+. +|+||||||+|||++.++.+||+|||+++..... ...
T Consensus 140 ~-~~l~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~--~~~ 213 (357)
T PHA03209 140 S-SDLYTYLTKRSRPLPIDQALIIEKQILEGLRYLHAQ---RIIHRDVKTENIFINDVDQVCIGDLGAAQFPVVA--PAF 213 (357)
T ss_pred C-CcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEEecCccccccccC--ccc
Confidence 5 588888765 35789999999999999999999998 9999999999999999999999999999753322 122
Q ss_pred ccccccCCcccccccccCCCCcccceehHHHHHHHHHhcCcCC
Q 003836 661 TAIRGTKGYVAPEWFRNMPITVKVDVYSYGVLLLEIICLRRNI 703 (792)
Q Consensus 661 ~~~~gt~~y~aPE~~~~~~~~~k~DV~S~Gv~l~el~tg~~p~ 703 (792)
....||+.|+|||.+.+..++.++|||||||++|||+++..++
T Consensus 214 ~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvvl~ell~~~~~~ 256 (357)
T PHA03209 214 LGLAGTVETNAPEVLARDKYNSKADIWSAGIVLFEMLAYPSTI 256 (357)
T ss_pred ccccccccccCCeecCCCCCCchhhHHHHHHHHHHHHHcCCcc
Confidence 3456899999999999999999999999999999999976655
|
|
| >cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-34 Score=314.48 Aligned_cols=263 Identities=16% Similarity=0.174 Sum_probs=194.0
Q ss_pred hhhhcCcc--ccceEEEeeecCCCceEEEEEEccccc--ccchHHHHHHHHHhcccCCCCcccccceeccCCceEEEEEe
Q 003836 505 FKEELGRG--AFGTVYKGFVNMGSSNHVAVKKLNSVF--QDSEKEFKAEVNGIGQTHHKNLVRLLGYCDEGQNRLLVYEF 580 (792)
Q Consensus 505 ~~~~lG~G--~~g~Vy~g~~~~~~~~~vavK~~~~~~--~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~lV~E~ 580 (792)
+.++||+| +|++||++... .+++.||+|++.... ....+.+++|+++++.++||||+++++++..++..++||||
T Consensus 2 ~~~~ig~G~~~~~~v~~~~~~-~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~ 80 (327)
T cd08227 2 LLTVIGRGFEDLMTVNLARYK-PTGEYVTVRRINLEACTNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVTSF 80 (327)
T ss_pred hhhhccccccceEEEEEEeec-ccCcEEEEEEechhhccHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEECCEEEEEEec
Confidence 45789999 67899999754 567899999987542 23345688899999999999999999999999999999999
Q ss_pred ccCCCccccccCC--CCCchhHHHHHHHHHHHHHHHHhhccCCCeEecCCCCCcEEEcCCCCeEEeecCCCccccCCCCC
Q 003836 581 MSNGTVASFLFGD--SKPNWKLRTEIAMGIAGGLFYLHEECCTQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLDQSH 658 (792)
Q Consensus 581 ~~~gsL~~~l~~~--~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dikp~NILl~~~~~~kl~Dfg~a~~~~~~~~~ 658 (792)
+++|+|.+++... ..+++..+..++.|++.||+|||+. +|+||||||+|||++.++.++++||+...........
T Consensus 81 ~~~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~---~iiH~dlkp~Nil~~~~~~~~l~~~~~~~~~~~~~~~ 157 (327)
T cd08227 81 MAYGSAKDLICTHFMDGMSELAIAYILQGVLKALDYIHHM---GYVHRSVKASHILISVDGKVYLSGLRSNLSMINHGQR 157 (327)
T ss_pred cCCCcHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCChhhEEEecCCcEEEcccchhhcccccccc
Confidence 9999999998653 4588999999999999999999998 9999999999999999999999999875443211110
Q ss_pred ------ccccccccCCccccccccc--CCCCcccceehHHHHHHHHHhcCcCCCcchhhhhhhh-HHH----------HH
Q 003836 659 ------TNTAIRGTKGYVAPEWFRN--MPITVKVDVYSYGVLLLEIICLRRNIDNEISKVDKAI-LTD----------WA 719 (792)
Q Consensus 659 ------~~~~~~gt~~y~aPE~~~~--~~~~~k~DV~S~Gv~l~el~tg~~p~~~~~~~~~~~~-~~~----------~~ 719 (792)
......++..|+|||.+.+ ..++.++|||||||++|||++|+.||........... ... ..
T Consensus 158 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (327)
T cd08227 158 LRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLNGTVPCLLDTTTIP 237 (327)
T ss_pred ccccccccccccceecccChHHhhcccCCCCchhhHHHHHHHHHHHHHCCCCCCCcchhHHHHHHhcCCccccccccchh
Confidence 0112246778999999976 4689999999999999999999999975332111000 000 00
Q ss_pred HHhhcccchhHhhh-----------------chhcccCCHHHHHHHHHHHHHccccCCCCCCCHHhHHH
Q 003836 720 YDRYQERTLEALVE-----------------NDLEAMNNVTMLHRFVMVAFWCIQEDPSHRPTMRKVTQ 771 (792)
Q Consensus 720 ~~~~~~~~~~~~~~-----------------~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~ 771 (792)
.............+ ..............+.+++.+||+.||++|||++|+++
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~ell~ 306 (327)
T cd08227 238 AEELTMKPSRSGANSGLGESTTVSTPRPSNGESSSHPYNRTFSPHFHHFVEQCLQRNPDARPSASTLLN 306 (327)
T ss_pred hhhcccCCcccCCcCCCCcccccCCcCccccCCcccccccccCHHHHHHHHHHHhhCchhcCCHHHHhc
Confidence 00000000000000 00000112234567899999999999999999999987
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype |
| >KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-36 Score=295.61 Aligned_cols=246 Identities=23% Similarity=0.319 Sum_probs=206.3
Q ss_pred hhhhcCccccceEEEeeecCCCceEEEEEEcccccccchHHHHHHHHHhcccCCCCcccccceeccCCceEEEEEeccCC
Q 003836 505 FKEELGRGAFGTVYKGFVNMGSSNHVAVKKLNSVFQDSEKEFKAEVNGIGQTHHKNLVRLLGYCDEGQNRLLVYEFMSNG 584 (792)
Q Consensus 505 ~~~~lG~G~~g~Vy~g~~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~lV~E~~~~g 584 (792)
+.++||+|+||.|||+. +..+++.+|+|++.- ....+++..|+.++++.+.+++|+++|.+.....+++|||||--|
T Consensus 37 i~~KLGEGSYGSV~KAI-H~EsG~v~AIK~VPV--~sDLQEIIKEISIMQQC~S~yVVKYYGSYFK~sDLWIVMEYCGAG 113 (502)
T KOG0574|consen 37 IVGKLGEGSYGSVHKAI-HRESGHVLAIKKVPV--DTDLQEIIKEISIMQQCKSKYVVKYYGSYFKHSDLWIVMEYCGAG 113 (502)
T ss_pred HHHHhcCCcchHHHHHH-HhccCcEEEEEecCc--cchHHHHHHHHHHHHHcCCchhhhhhhhhccCCceEeehhhcCCC
Confidence 45789999999999995 456788999999864 445788999999999999999999999999999999999999999
Q ss_pred CccccccCC-CCCchhHHHHHHHHHHHHHHHHhhccCCCeEecCCCCCcEEEcCCCCeEEeecCCCccccCCCCCccccc
Q 003836 585 TVASFLFGD-SKPNWKLRTEIAMGIAGGLFYLHEECCTQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLDQSHTNTAI 663 (792)
Q Consensus 585 sL~~~l~~~-~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dikp~NILl~~~~~~kl~Dfg~a~~~~~~~~~~~~~~ 663 (792)
++.+.++.+ +.+.+..+..|++..++||+|||.. .-||||||+.||||+.+|.+||+|||+|-.+....... ..+
T Consensus 114 SiSDI~R~R~K~L~E~EIs~iL~~TLKGL~YLH~~---~KIHRDIKAGNILLNT~G~AKLADFGVAGQLTDTMAKR-NTV 189 (502)
T KOG0574|consen 114 SISDIMRARRKPLSEQEISAVLRDTLKGLQYLHDL---KKIHRDIKAGNILLNTDGIAKLADFGVAGQLTDTMAKR-NTV 189 (502)
T ss_pred cHHHHHHHhcCCccHHHHHHHHHHHHhHHHHHHHH---HHHHhhcccccEEEcccchhhhhhccccchhhhhHHhh-Ccc
Confidence 999999754 7899999999999999999999998 88999999999999999999999999998765433222 346
Q ss_pred cccCCcccccccccCCCCcccceehHHHHHHHHHhcCcCCCcchhhhhhhhHHHHHHHhhcccchhHhhhchhcccCCHH
Q 003836 664 RGTKGYVAPEWFRNMPITVKVDVYSYGVLLLEIICLRRNIDNEISKVDKAILTDWAYDRYQERTLEALVENDLEAMNNVT 743 (792)
Q Consensus 664 ~gt~~y~aPE~~~~~~~~~k~DV~S~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 743 (792)
.|||-|||||++....|+.++||||||+...||..|+.|+...........++. .+...-..+..
T Consensus 190 IGTPFWMAPEVI~EIGY~~~ADIWSLGITaIEMAEG~PPYsDIHPMRAIFMIPT---------------~PPPTF~KPE~ 254 (502)
T KOG0574|consen 190 IGTPFWMAPEVIEEIGYDTKADIWSLGITAIEMAEGRPPYSDIHPMRAIFMIPT---------------KPPPTFKKPEE 254 (502)
T ss_pred ccCcccccHHHHHHhccchhhhHhhhcchhhhhhcCCCCcccccccceeEeccC---------------CCCCCCCChHh
Confidence 699999999999999999999999999999999999999865432111111100 01111123456
Q ss_pred HHHHHHHHHHHccccCCCCCCCHHhHHHH
Q 003836 744 MLHRFVMVAFWCIQEDPSHRPTMRKVTQM 772 (792)
Q Consensus 744 ~~~~l~~l~~~Cl~~~p~~RPs~~evl~~ 772 (792)
.+.++-++++.||-.+|++|-|+-++++.
T Consensus 255 WS~~F~DFi~~CLiK~PE~R~TA~~L~~H 283 (502)
T KOG0574|consen 255 WSSEFNDFIRSCLIKKPEERKTALRLCEH 283 (502)
T ss_pred hhhHHHHHHHHHhcCCHHHHHHHHHHhhh
Confidence 78899999999999999999999888763
|
|
| >cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-34 Score=307.70 Aligned_cols=247 Identities=28% Similarity=0.328 Sum_probs=196.6
Q ss_pred hhhhcCccccceEEEeeecCCCceEEEEEEcccccc---cchHHHHHHHHHhcccCCCCcccccceeccCCceEEEEEec
Q 003836 505 FKEELGRGAFGTVYKGFVNMGSSNHVAVKKLNSVFQ---DSEKEFKAEVNGIGQTHHKNLVRLLGYCDEGQNRLLVYEFM 581 (792)
Q Consensus 505 ~~~~lG~G~~g~Vy~g~~~~~~~~~vavK~~~~~~~---~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~lV~E~~ 581 (792)
..+.||+|+||+||++... .+++.+|+|++..... .....+.+|+.++++++|+|++++++.+.+.+..++||||+
T Consensus 4 ~~~~ig~G~~g~v~~~~~~-~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~~ 82 (285)
T cd05630 4 QYRVLGKGGFGEVCACQVR-ATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLTLM 82 (285)
T ss_pred eeEEeecCCCeEEEEEEEc-CCCceEEEEEEehhhccchHHHHHHHHHHHHHHhCCCCCeeeeeEEEecCCEEEEEEEec
Confidence 3467999999999999654 4567999999865322 22346788999999999999999999999999999999999
Q ss_pred cCCCccccccCC--CCCchhHHHHHHHHHHHHHHHHhhccCCCeEecCCCCCcEEEcCCCCeEEeecCCCccccCCCCCc
Q 003836 582 SNGTVASFLFGD--SKPNWKLRTEIAMGIAGGLFYLHEECCTQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLDQSHT 659 (792)
Q Consensus 582 ~~gsL~~~l~~~--~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dikp~NILl~~~~~~kl~Dfg~a~~~~~~~~~~ 659 (792)
++++|.+++... ..+++..+..++.|++.||.|||+. +|+|+||||+||++++++.++|+|||++........
T Consensus 83 ~g~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~---~iiH~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~~-- 157 (285)
T cd05630 83 NGGDLKFHIYHMGEAGFEEGRAVFYAAEICCGLEDLHQE---RIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQT-- 157 (285)
T ss_pred CCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhC---CEEeCCCCHHHEEECCCCCEEEeeccceeecCCCcc--
Confidence 999999988543 3588999999999999999999998 999999999999999999999999999876543221
Q ss_pred cccccccCCcccccccccCCCCcccceehHHHHHHHHHhcCcCCCcchhhhhhhhHHHHHHHhhcccchhHhhhchhccc
Q 003836 660 NTAIRGTKGYVAPEWFRNMPITVKVDVYSYGVLLLEIICLRRNIDNEISKVDKAILTDWAYDRYQERTLEALVENDLEAM 739 (792)
Q Consensus 660 ~~~~~gt~~y~aPE~~~~~~~~~k~DV~S~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 739 (792)
.....|+..|+|||.+.+..++.++||||||+++|||++|+.||............. .+.+. ....
T Consensus 158 ~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~Pf~~~~~~~~~~~~~-------------~~~~~-~~~~ 223 (285)
T cd05630 158 IKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVE-------------RLVKE-VQEE 223 (285)
T ss_pred ccCCCCCccccChHHHcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCccchHHHHH-------------hhhhh-hhhh
Confidence 123468999999999999999999999999999999999999997543211110000 00000 0011
Q ss_pred CCHHHHHHHHHHHHHccccCCCCCCC-----HHhHHH
Q 003836 740 NNVTMLHRFVMVAFWCIQEDPSHRPT-----MRKVTQ 771 (792)
Q Consensus 740 ~~~~~~~~l~~l~~~Cl~~~p~~RPs-----~~evl~ 771 (792)
........+.+++..||+.||++||| ++|+++
T Consensus 224 ~~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~~~~~ 260 (285)
T cd05630 224 YSEKFSPDARSLCKMLLCKDPKERLGCQGGGAREVKE 260 (285)
T ss_pred cCccCCHHHHHHHHHHhhcCHHHccCCCCCchHHHHc
Confidence 12234456789999999999999999 888886
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as |
| >PRK13184 pknD serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-34 Score=337.71 Aligned_cols=256 Identities=24% Similarity=0.367 Sum_probs=198.3
Q ss_pred hhhhhcCccccceEEEeeecCCCceEEEEEEcccccc---cchHHHHHHHHHhcccCCCCcccccceeccCCceEEEEEe
Q 003836 504 GFKEELGRGAFGTVYKGFVNMGSSNHVAVKKLNSVFQ---DSEKEFKAEVNGIGQTHHKNLVRLLGYCDEGQNRLLVYEF 580 (792)
Q Consensus 504 ~~~~~lG~G~~g~Vy~g~~~~~~~~~vavK~~~~~~~---~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~lV~E~ 580 (792)
.+.++||+|+||.||+|.. ..+++.||+|++..... ...+++.+|++++++++||||+++++++.+++..++||||
T Consensus 5 eIi~~LGkGgfG~VYlA~d-~~tg~~VAIK~I~~~l~~~e~~~~rflrEi~ILs~L~HPNIVkl~~v~~d~~~lyLVMEY 83 (932)
T PRK13184 5 DIIRLIGKGGMGEVYLAYD-PVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVYSICSDGDPVYYTMPY 83 (932)
T ss_pred EEEEEEecCCCEEEEEEEE-CCCCcEEEEEEECcccccCHHHHHHHHHHHHHHHhCCCcCcCeEEEEEeeCCEEEEEEEc
Confidence 3457899999999999965 34567899999875322 2346789999999999999999999999999999999999
Q ss_pred ccCCCccccccCC-----------CCCchhHHHHHHHHHHHHHHHHhhccCCCeEecCCCCCcEEEcCCCCeEEeecCCC
Q 003836 581 MSNGTVASFLFGD-----------SKPNWKLRTEIAMGIAGGLFYLHEECCTQIIHCDIKPQNILLDDHYNARISDFGLA 649 (792)
Q Consensus 581 ~~~gsL~~~l~~~-----------~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dikp~NILl~~~~~~kl~Dfg~a 649 (792)
+++|+|.+++... ...++..+++++.||++||+|||+. +|+||||||+|||++.++.+||+|||++
T Consensus 84 ~eGGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLHs~---GIIHRDLKPeNILLd~dg~vKLiDFGLA 160 (932)
T PRK13184 84 IEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVHSK---GVLHRDLKPDNILLGLFGEVVILDWGAA 160 (932)
T ss_pred CCCCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHHHC---CccccCCchheEEEcCCCCEEEEecCcc
Confidence 9999999988531 2345677889999999999999998 9999999999999999999999999999
Q ss_pred ccccCCCC-----------------CccccccccCCcccccccccCCCCcccceehHHHHHHHHHhcCcCCCcchhhhhh
Q 003836 650 KLLTLDQS-----------------HTNTAIRGTKGYVAPEWFRNMPITVKVDVYSYGVLLLEIICLRRNIDNEISKVDK 712 (792)
Q Consensus 650 ~~~~~~~~-----------------~~~~~~~gt~~y~aPE~~~~~~~~~k~DV~S~Gv~l~el~tg~~p~~~~~~~~~~ 712 (792)
+....... .......||+.|+|||.+.+..++.++|||||||++|||+||+.||.......
T Consensus 161 k~i~~~~~~~~~l~~~~~~s~~s~~t~~g~~vGT~~YmAPE~l~g~~~S~kSDIWSLGVILyELLTG~~PF~~~~~~k-- 238 (932)
T PRK13184 161 IFKKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTLSFPYRRKKGRK-- 238 (932)
T ss_pred eecccccccccccccccccccccccccCCCCCCCCCCCCHHHhcCCCCCcHhHHHHHHHHHHHHHHCCCCCCCcchhh--
Confidence 87622110 01112468999999999999999999999999999999999999996532110
Q ss_pred hhHHHHHHHhhcccchhHhhhchhcccCCHHHHHHHHHHHHHccccCCCCCC-CHHhHHHHhccCcC
Q 003836 713 AILTDWAYDRYQERTLEALVENDLEAMNNVTMLHRFVMVAFWCIQEDPSHRP-TMRKVTQMLEGVVE 778 (792)
Q Consensus 713 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RP-s~~evl~~L~~~~~ 778 (792)
.. ... .+..........+.+..+.+++.+||+.||++|| +++++++.|+..++
T Consensus 239 i~-----~~~--------~i~~P~~~~p~~~iP~~L~~LI~rcL~~DP~kR~ss~eeLl~~Le~~lq 292 (932)
T PRK13184 239 IS-----YRD--------VILSPIEVAPYREIPPFLSQIAMKALAVDPAERYSSVQELKQDLEPHLQ 292 (932)
T ss_pred hh-----hhh--------hccChhhccccccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHh
Confidence 00 000 0000000000123445678899999999999995 67777777766543
|
|
| >cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-35 Score=316.40 Aligned_cols=241 Identities=24% Similarity=0.269 Sum_probs=187.8
Q ss_pred cCccccceEEEeeecCCCceEEEEEEcccccc---cchHHHHHHHHHhccc---CCCCcccccceeccCCceEEEEEecc
Q 003836 509 LGRGAFGTVYKGFVNMGSSNHVAVKKLNSVFQ---DSEKEFKAEVNGIGQT---HHKNLVRLLGYCDEGQNRLLVYEFMS 582 (792)
Q Consensus 509 lG~G~~g~Vy~g~~~~~~~~~vavK~~~~~~~---~~~~~~~~Ei~~l~~l---~h~niv~l~g~~~~~~~~~lV~E~~~ 582 (792)
||+|+||+||++... .+++.||+|++.+... .....+..|..++.+. +||||+++++.+.+.+..++||||++
T Consensus 1 lG~G~~g~Vy~~~~~-~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~p~i~~~~~~~~~~~~~~lv~e~~~ 79 (330)
T cd05586 1 IGKGTFGQVYQVRKK-DTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVGLKFSFQTDSDLYLVTDYMS 79 (330)
T ss_pred CCCCCceEEEEEEEC-CCCCEEEEEEEeHHHHhhhhHHHHHHHHHHHHHHhccCCCCcCcceEEEEecCCeEEEEEcCCC
Confidence 799999999999754 4567899999865321 1223445566666655 69999999999999999999999999
Q ss_pred CCCccccccCCCCCchhHHHHHHHHHHHHHHHHhhccCCCeEecCCCCCcEEEcCCCCeEEeecCCCccccCCCCCcccc
Q 003836 583 NGTVASFLFGDSKPNWKLRTEIAMGIAGGLFYLHEECCTQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLDQSHTNTA 662 (792)
Q Consensus 583 ~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dikp~NILl~~~~~~kl~Dfg~a~~~~~~~~~~~~~ 662 (792)
+|+|..++.....+++..+..++.||+.||+|||+. +|+||||||+|||++.++.+||+|||+++...... .....
T Consensus 80 ~g~L~~~l~~~~~~~~~~~~~~~~qil~al~~LH~~---~ivHrDlkp~Nili~~~~~~kl~Dfg~a~~~~~~~-~~~~~ 155 (330)
T cd05586 80 GGELFWHLQKEGRFSEDRAKFYIAELVLALEHLHKY---DIVYRDLKPENILLDATGHIALCDFGLSKANLTDN-KTTNT 155 (330)
T ss_pred CChHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCCHHHeEECCCCCEEEecCCcCcCCCCCC-CCccC
Confidence 999999998888899999999999999999999998 99999999999999999999999999987543222 22234
Q ss_pred ccccCCcccccccccC-CCCcccceehHHHHHHHHHhcCcCCCcchhhhhhhhHHHHHHHhhcccchhHhhhchhcccCC
Q 003836 663 IRGTKGYVAPEWFRNM-PITVKVDVYSYGVLLLEIICLRRNIDNEISKVDKAILTDWAYDRYQERTLEALVENDLEAMNN 741 (792)
Q Consensus 663 ~~gt~~y~aPE~~~~~-~~~~k~DV~S~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 741 (792)
..||+.|+|||.+.+. .++.++|||||||++|||++|+.||........ . .... ...... ..
T Consensus 156 ~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~elltG~~Pf~~~~~~~~---~-----~~i~--------~~~~~~-~~ 218 (330)
T cd05586 156 FCGTTEYLAPEVLLDEKGYTKHVDFWSLGVLVFEMCCGWSPFYAEDTQQM---Y-----RNIA--------FGKVRF-PK 218 (330)
T ss_pred ccCCccccCHHHHcCCCCCCCccceeccccEEEEeccCCCCCCCCCHHHH---H-----HHHH--------cCCCCC-CC
Confidence 5689999999998764 489999999999999999999999965422110 0 0000 000000 01
Q ss_pred HHHHHHHHHHHHHccccCCCCCC----CHHhHHH
Q 003836 742 VTMLHRFVMVAFWCIQEDPSHRP----TMRKVTQ 771 (792)
Q Consensus 742 ~~~~~~l~~l~~~Cl~~~p~~RP----s~~evl~ 771 (792)
.....++.+++.+||+.+|.+|| ++.++++
T Consensus 219 ~~~~~~~~~li~~~L~~~P~~R~~~~~~~~~ll~ 252 (330)
T cd05586 219 NVLSDEGRQFVKGLLNRNPQHRLGAHRDAVELKE 252 (330)
T ss_pred ccCCHHHHHHHHHHcCCCHHHCCCCCCCHHHHhc
Confidence 12345678899999999999998 4566554
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of |
| >cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-34 Score=302.37 Aligned_cols=246 Identities=24% Similarity=0.355 Sum_probs=200.7
Q ss_pred hhhhhhcCccccceEEEeeecCCCceEEEEEEccccc-ccchHHHHHHHHHhcccCCCCcccccceeccCCceEEEEEec
Q 003836 503 RGFKEELGRGAFGTVYKGFVNMGSSNHVAVKKLNSVF-QDSEKEFKAEVNGIGQTHHKNLVRLLGYCDEGQNRLLVYEFM 581 (792)
Q Consensus 503 ~~~~~~lG~G~~g~Vy~g~~~~~~~~~vavK~~~~~~-~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~lV~E~~ 581 (792)
+.+.+.||.|++|.||+|... .+++.+++|.+.... ......+.+|++++++++|+||+++++++.++...++|+||+
T Consensus 3 y~~~~~lg~g~~~~v~~~~~~-~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~ 81 (274)
T cd06609 3 FTLLECIGKGSFGEVYKAIDK-RTNQVVAIKVIDLEEAEDEIEDIQQEIQFLSQCRSPYITKYYGSFLKGSKLWIIMEYC 81 (274)
T ss_pred hhhhhhhcCCCCeEEEEEEEC-CCCeEEEEEEeeccccchHHHHHHHHHHHHHHcCCCCeeeeeEEEEECCeEEEEEEee
Confidence 345678999999999999764 456789999987543 334567899999999999999999999999999999999999
Q ss_pred cCCCccccccCCCCCchhHHHHHHHHHHHHHHHHhhccCCCeEecCCCCCcEEEcCCCCeEEeecCCCccccCCCCCccc
Q 003836 582 SNGTVASFLFGDSKPNWKLRTEIAMGIAGGLFYLHEECCTQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLDQSHTNT 661 (792)
Q Consensus 582 ~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dikp~NILl~~~~~~kl~Dfg~a~~~~~~~~~~~~ 661 (792)
++++|.+++... .+++..+..++.|++.||.|||+. +++|+||+|+||++++++.++|+|||+++...... ....
T Consensus 82 ~~~~L~~~~~~~-~~~~~~~~~~~~ql~~~l~~lh~~---~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~-~~~~ 156 (274)
T cd06609 82 GGGSCLDLLKPG-KLDETYIAFILREVLLGLEYLHEE---GKIHRDIKAANILLSEEGDVKLADFGVSGQLTSTM-SKRN 156 (274)
T ss_pred CCCcHHHHHhhc-CCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEECCCCCEEEcccccceeecccc-cccc
Confidence 999999998765 789999999999999999999998 99999999999999999999999999998765432 2223
Q ss_pred cccccCCcccccccccCCCCcccceehHHHHHHHHHhcCcCCCcchhhhhhhhHHHHHHHhhcccchhHhhhchhcccCC
Q 003836 662 AIRGTKGYVAPEWFRNMPITVKVDVYSYGVLLLEIICLRRNIDNEISKVDKAILTDWAYDRYQERTLEALVENDLEAMNN 741 (792)
Q Consensus 662 ~~~gt~~y~aPE~~~~~~~~~k~DV~S~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 741 (792)
...+++.|+|||.+.+..++.++||||||+++|||++|+.||........ . .... ........
T Consensus 157 ~~~~~~~y~~PE~~~~~~~~~~sDv~slG~il~~l~tg~~p~~~~~~~~~---~-----~~~~---------~~~~~~~~ 219 (274)
T cd06609 157 TFVGTPFWMAPEVIKQSGYDEKADIWSLGITAIELAKGEPPLSDLHPMRV---L-----FLIP---------KNNPPSLE 219 (274)
T ss_pred cccCCccccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCcccCchHHH---H-----HHhh---------hcCCCCCc
Confidence 34578899999999988899999999999999999999999964321100 0 0000 00011111
Q ss_pred HH-HHHHHHHHHHHccccCCCCCCCHHhHHH
Q 003836 742 VT-MLHRFVMVAFWCIQEDPSHRPTMRKVTQ 771 (792)
Q Consensus 742 ~~-~~~~l~~l~~~Cl~~~p~~RPs~~evl~ 771 (792)
.. .+..+.+++.+||+.+|++||+++++++
T Consensus 220 ~~~~~~~~~~~l~~~l~~~p~~Rpt~~~il~ 250 (274)
T cd06609 220 GNKFSKPFKDFVSLCLNKDPKERPSAKELLK 250 (274)
T ss_pred ccccCHHHHHHHHHHhhCChhhCcCHHHHhh
Confidence 11 4567889999999999999999999987
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) |
| >cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-34 Score=301.55 Aligned_cols=246 Identities=22% Similarity=0.303 Sum_probs=192.9
Q ss_pred hhhhcCccccceEEEeeecCCCceEEEEEEccccc-----ccchHHHHHHHHHhcccCCCCcccccceecc--CCceEEE
Q 003836 505 FKEELGRGAFGTVYKGFVNMGSSNHVAVKKLNSVF-----QDSEKEFKAEVNGIGQTHHKNLVRLLGYCDE--GQNRLLV 577 (792)
Q Consensus 505 ~~~~lG~G~~g~Vy~g~~~~~~~~~vavK~~~~~~-----~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~--~~~~~lV 577 (792)
..+.||+|+||.||++... .++..+++|++.... ....+.+.+|+.++++++|+||+++++++.+ ....+++
T Consensus 6 ~~~~lg~g~~g~vy~~~~~-~~~~~~~~k~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~l~ 84 (266)
T cd06651 6 RGKLLGQGAFGRVYLCYDV-DTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQYYGCLRDRAEKTLTIF 84 (266)
T ss_pred ccceecCCCCEEEEEEEEc-CCCcEEEEEEeecCcCCchhHHHHHHHHHHHHHHHHcCCCCeeeEEEEEEcCCCCEEEEE
Confidence 4578999999999999643 456789999886432 1233568899999999999999999998865 3567899
Q ss_pred EEeccCCCccccccCCCCCchhHHHHHHHHHHHHHHHHhhccCCCeEecCCCCCcEEEcCCCCeEEeecCCCccccCCCC
Q 003836 578 YEFMSNGTVASFLFGDSKPNWKLRTEIAMGIAGGLFYLHEECCTQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLDQS 657 (792)
Q Consensus 578 ~E~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dikp~NILl~~~~~~kl~Dfg~a~~~~~~~~ 657 (792)
+||+++++|.+++.....+++.....++.|++.||+|||+. +|+|+||+|+||+++.++.+||+|||+++.......
T Consensus 85 ~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~LH~~---~i~H~~l~p~nil~~~~~~~~l~dfg~~~~~~~~~~ 161 (266)
T cd06651 85 MEYMPGGSVKDQLKAYGALTESVTRKYTRQILEGMSYLHSN---MIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICM 161 (266)
T ss_pred EeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHEEECCCCCEEEccCCCccccccccc
Confidence 99999999999998777789999999999999999999998 999999999999999999999999999986543211
Q ss_pred --CccccccccCCcccccccccCCCCcccceehHHHHHHHHHhcCcCCCcchhhhhhhhHHHHHHHhhcccchhHhhhch
Q 003836 658 --HTNTAIRGTKGYVAPEWFRNMPITVKVDVYSYGVLLLEIICLRRNIDNEISKVDKAILTDWAYDRYQERTLEALVEND 735 (792)
Q Consensus 658 --~~~~~~~gt~~y~aPE~~~~~~~~~k~DV~S~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 735 (792)
.......++..|+|||.+.+..++.++|||||||++|||++|+.||......... .......
T Consensus 162 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~el~~g~~pf~~~~~~~~~----------------~~~~~~~ 225 (266)
T cd06651 162 SGTGIRSVTGTPYWMSPEVISGEGYGRKADVWSLGCTVVEMLTEKPPWAEYEAMAAI----------------FKIATQP 225 (266)
T ss_pred cCCccccCCccccccCHHHhCCCCCCchhhhHHHHHHHHHHHHCCCCccccchHHHH----------------HHHhcCC
Confidence 1122345788999999999888999999999999999999999999653211100 0001111
Q ss_pred hcccCCHHHHHHHHHHHHHccccCCCCCCCHHhHHH
Q 003836 736 LEAMNNVTMLHRFVMVAFWCIQEDPSHRPTMRKVTQ 771 (792)
Q Consensus 736 ~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~ 771 (792)
.....+....+.+.+++ +||..+|++||+++||++
T Consensus 226 ~~~~~~~~~~~~~~~li-~~~~~~p~~Rp~~~eil~ 260 (266)
T cd06651 226 TNPQLPSHISEHARDFL-GCIFVEARHRPSAEELLR 260 (266)
T ss_pred CCCCCchhcCHHHHHHH-HHhcCChhhCcCHHHHhc
Confidence 11222233344555666 688899999999999987
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development |
| >cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-34 Score=304.48 Aligned_cols=249 Identities=22% Similarity=0.322 Sum_probs=199.1
Q ss_pred hhhhhhcCccccceEEEeeecCCCceEEEEEEcccccccchHHHHHHHHHhcccCCCCcccccceeccCCceEEEEEecc
Q 003836 503 RGFKEELGRGAFGTVYKGFVNMGSSNHVAVKKLNSVFQDSEKEFKAEVNGIGQTHHKNLVRLLGYCDEGQNRLLVYEFMS 582 (792)
Q Consensus 503 ~~~~~~lG~G~~g~Vy~g~~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~lV~E~~~ 582 (792)
+.+.++||.|+||.||+|... .+++.+++|.+........+.+.+|+.++++++|+||+++++.+..+...++||||++
T Consensus 14 y~i~~~lg~g~~g~vy~~~~~-~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 92 (292)
T cd06644 14 WEIIGELGDGAFGKVYKAKNK-ETGALAAAKVIETKSEEELEDYMVEIEILATCNHPYIVKLLGAFYWDGKLWIMIEFCP 92 (292)
T ss_pred hhhhheecCCCCeEEEEEEEC-CCCceEEEEEeccCCHHHHHHHHHHHHHHHhCCCCcEeeeEEEEEeCCeEEEEEecCC
Confidence 456678999999999999764 4567899999987666667789999999999999999999999999999999999999
Q ss_pred CCCccccccC-CCCCchhHHHHHHHHHHHHHHHHhhccCCCeEecCCCCCcEEEcCCCCeEEeecCCCccccCCCCCccc
Q 003836 583 NGTVASFLFG-DSKPNWKLRTEIAMGIAGGLFYLHEECCTQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLDQSHTNT 661 (792)
Q Consensus 583 ~gsL~~~l~~-~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dikp~NILl~~~~~~kl~Dfg~a~~~~~~~~~~~~ 661 (792)
+++|..++.. ...+++..+..++.|++.||+|||+. +++|+||||+||+++.++.+||+|||++....... ....
T Consensus 93 ~~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~---~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~~-~~~~ 168 (292)
T cd06644 93 GGAVDAIMLELDRGLTEPQIQVICRQMLEALQYLHSM---KIIHRDLKAGNVLLTLDGDIKLADFGVSAKNVKTL-QRRD 168 (292)
T ss_pred CCcHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhcC---CeeecCCCcceEEEcCCCCEEEccCccceeccccc-cccc
Confidence 9999988755 35689999999999999999999998 99999999999999999999999999987543221 1223
Q ss_pred cccccCCcccccccc-----cCCCCcccceehHHHHHHHHHhcCcCCCcchhhhhhhhHHHHHHHhhcccchhHhhhchh
Q 003836 662 AIRGTKGYVAPEWFR-----NMPITVKVDVYSYGVLLLEIICLRRNIDNEISKVDKAILTDWAYDRYQERTLEALVENDL 736 (792)
Q Consensus 662 ~~~gt~~y~aPE~~~-----~~~~~~k~DV~S~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 736 (792)
...+++.|+|||.+. ...++.++|||||||++|||++|+.||........ ... ..... .+
T Consensus 169 ~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~---~~~-----~~~~~-----~~-- 233 (292)
T cd06644 169 SFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRV---LLK-----IAKSE-----PP-- 233 (292)
T ss_pred eecCCccccCceeeccccccCCCCCchhhhHhHHHHHHHHhcCCCCCccccHHHH---HHH-----HhcCC-----Cc--
Confidence 345788999999984 34578899999999999999999999865322100 000 00000 00
Q ss_pred cccCCHHHHHHHHHHHHHccccCCCCCCCHHhHHH
Q 003836 737 EAMNNVTMLHRFVMVAFWCIQEDPSHRPTMRKVTQ 771 (792)
Q Consensus 737 ~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~ 771 (792)
....+...+.++.+++.+||+.+|++||+++++++
T Consensus 234 ~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~ 268 (292)
T cd06644 234 TLSQPSKWSMEFRDFLKTALDKHPETRPSAAQLLE 268 (292)
T ss_pred cCCCCcccCHHHHHHHHHHhcCCcccCcCHHHHhc
Confidence 01112234557889999999999999999999986
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. |
| >cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-34 Score=304.38 Aligned_cols=255 Identities=27% Similarity=0.366 Sum_probs=201.7
Q ss_pred hhhhhhcCccccceEEEeeecCCC---ceEEEEEEcccccc-cchHHHHHHHHHhcccCCCCcccccceeccCCceEEEE
Q 003836 503 RGFKEELGRGAFGTVYKGFVNMGS---SNHVAVKKLNSVFQ-DSEKEFKAEVNGIGQTHHKNLVRLLGYCDEGQNRLLVY 578 (792)
Q Consensus 503 ~~~~~~lG~G~~g~Vy~g~~~~~~---~~~vavK~~~~~~~-~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~lV~ 578 (792)
..+.+.||+|+||.||+|...... ...+|+|.+..... ....++.+|+.++++++|+||+++++++.. ...++|+
T Consensus 9 ~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~~v~ 87 (279)
T cd05057 9 LEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDHPHVVRLLGICLS-SQVQLIT 87 (279)
T ss_pred cEEcceecCCCCccEEEEEEecCCCCcceEEEEEeccCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEec-CceEEEE
Confidence 445678999999999999764322 23689998875432 345678999999999999999999999987 7889999
Q ss_pred EeccCCCccccccCC-CCCchhHHHHHHHHHHHHHHHHhhccCCCeEecCCCCCcEEEcCCCCeEEeecCCCccccCCCC
Q 003836 579 EFMSNGTVASFLFGD-SKPNWKLRTEIAMGIAGGLFYLHEECCTQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLDQS 657 (792)
Q Consensus 579 E~~~~gsL~~~l~~~-~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dikp~NILl~~~~~~kl~Dfg~a~~~~~~~~ 657 (792)
||+++|+|.+++... ..+++..+.+++.||+.||+|||+. +|+|+||||+|||+++++.+||+|||+++.......
T Consensus 88 e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~---~i~H~di~p~nil~~~~~~~kL~dfg~~~~~~~~~~ 164 (279)
T cd05057 88 QLMPLGCLLDYVRNHKDNIGSQYLLNWCVQIAKGMSYLEEK---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLDVDEK 164 (279)
T ss_pred ecCCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhC---CEEecccCcceEEEcCCCeEEECCCcccccccCccc
Confidence 999999999999764 4689999999999999999999998 999999999999999999999999999987653322
Q ss_pred Ccc-ccccccCCcccccccccCCCCcccceehHHHHHHHHHh-cCcCCCcchhhhhhhhHHHHHHHhhcccchhHhhhch
Q 003836 658 HTN-TAIRGTKGYVAPEWFRNMPITVKVDVYSYGVLLLEIIC-LRRNIDNEISKVDKAILTDWAYDRYQERTLEALVEND 735 (792)
Q Consensus 658 ~~~-~~~~gt~~y~aPE~~~~~~~~~k~DV~S~Gv~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 735 (792)
... ....++..|+|||.+....++.++||||||+++||+++ |+.||........ . ..+...
T Consensus 165 ~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~-------~----------~~~~~~ 227 (279)
T cd05057 165 EYHAEGGKVPIKWMALESILHRIYTHKSDVWSYGVTVWELMTFGAKPYEGIPAVEI-------P----------DLLEKG 227 (279)
T ss_pred ceecCCCcccccccCHHHhhcCCcCchhhHHHHHHHHHHHhcCCCCCCCCCCHHHH-------H----------HHHhCC
Confidence 111 11223568999999988899999999999999999999 9999865422110 0 001111
Q ss_pred hcccCCHHHHHHHHHHHHHccccCCCCCCCHHhHHHHhccCcC
Q 003836 736 LEAMNNVTMLHRFVMVAFWCIQEDPSHRPTMRKVTQMLEGVVE 778 (792)
Q Consensus 736 ~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~L~~~~~ 778 (792)
.....+......+.+++.+||..+|.+||++.++++.|+.+..
T Consensus 228 ~~~~~~~~~~~~~~~~~~~~l~~~p~~Rp~~~~l~~~l~~~~~ 270 (279)
T cd05057 228 ERLPQPPICTIDVYMVLVKCWMIDAESRPTFKELINEFSKMAR 270 (279)
T ss_pred CCCCCCCCCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHh
Confidence 1111122234567889999999999999999999999988643
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea |
| >cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-34 Score=311.48 Aligned_cols=263 Identities=18% Similarity=0.269 Sum_probs=195.4
Q ss_pred hhhhhcCccccceEEEeeecCCCceEEEEEEccccc-ccchHHHHHHHHHhcccCCCCcccccceeccCCceEEEEEecc
Q 003836 504 GFKEELGRGAFGTVYKGFVNMGSSNHVAVKKLNSVF-QDSEKEFKAEVNGIGQTHHKNLVRLLGYCDEGQNRLLVYEFMS 582 (792)
Q Consensus 504 ~~~~~lG~G~~g~Vy~g~~~~~~~~~vavK~~~~~~-~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~lV~E~~~ 582 (792)
...++||+|+||.||+|... .+++.+|+|+++... ......+.+|++++++++|+||+++++++..++..++||||++
T Consensus 9 ~~~~~lg~G~~g~Vy~~~~~-~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~ 87 (309)
T cd07872 9 IKLEKLGEGTYATVFKGRSK-LTENLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIVHTDKSLTLVFEYLD 87 (309)
T ss_pred EEEEEecccCCEEEEEEEec-CCCCeEEEEEeeccccCCcchhHHHHHHHHHhCCCCCcceEEEEEeeCCeEEEEEeCCC
Confidence 34578999999999999754 456789999987543 2334567899999999999999999999999999999999998
Q ss_pred CCCccccccCC-CCCchhHHHHHHHHHHHHHHHHhhccCCCeEecCCCCCcEEEcCCCCeEEeecCCCccccCCCCCccc
Q 003836 583 NGTVASFLFGD-SKPNWKLRTEIAMGIAGGLFYLHEECCTQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLDQSHTNT 661 (792)
Q Consensus 583 ~gsL~~~l~~~-~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dikp~NILl~~~~~~kl~Dfg~a~~~~~~~~~~~~ 661 (792)
+ +|.+++... ..+++..+..++.||+.||+|||+. +|+||||||+|||+++++.+||+|||+++....... ...
T Consensus 88 ~-~l~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~---~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~-~~~ 162 (309)
T cd07872 88 K-DLKQYMDDCGNIMSMHNVKIFLYQILRGLAYCHRR---KVLHRDLKPQNLLINERGELKLADFGLARAKSVPTK-TYS 162 (309)
T ss_pred C-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEECccccceecCCCcc-ccc
Confidence 6 788877654 4578889999999999999999998 999999999999999999999999999976433222 122
Q ss_pred cccccCCccccccccc-CCCCcccceehHHHHHHHHHhcCcCCCcchhhhhhhhHHHH-------HHHhhcccc-hhHhh
Q 003836 662 AIRGTKGYVAPEWFRN-MPITVKVDVYSYGVLLLEIICLRRNIDNEISKVDKAILTDW-------AYDRYQERT-LEALV 732 (792)
Q Consensus 662 ~~~gt~~y~aPE~~~~-~~~~~k~DV~S~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~-------~~~~~~~~~-~~~~~ 732 (792)
...+++.|+|||.+.+ ..++.++||||||+++|||++|+.||............... .+....... ....-
T Consensus 163 ~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 242 (309)
T cd07872 163 NEVVTLWYRPPDVLLGSSEYSTQIDMWGVGCIFFEMASGRPLFPGSTVEDELHLIFRLLGTPTEETWPGISSNDEFKNYN 242 (309)
T ss_pred cccccccccCCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhhcchhhhhhhh
Confidence 3457899999998865 56899999999999999999999999654322111111000 000000000 00000
Q ss_pred hchhcc----cCCHHHHHHHHHHHHHccccCCCCCCCHHhHHHH
Q 003836 733 ENDLEA----MNNVTMLHRFVMVAFWCIQEDPSHRPTMRKVTQM 772 (792)
Q Consensus 733 ~~~~~~----~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~ 772 (792)
.+.... ........++.+++.+||+.||.+|||++|+++.
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h 286 (309)
T cd07872 243 FPKYKPQPLINHAPRLDTEGIELLTKFLQYESKKRISAEEAMKH 286 (309)
T ss_pred cCccCCCchhhhccCCCHHHHHHHHHhccCChhhCCCHHHHhcC
Confidence 000000 0011234577899999999999999999999873
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play |
| >KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-34 Score=313.88 Aligned_cols=196 Identities=28% Similarity=0.438 Sum_probs=168.3
Q ss_pred HhhhhhhcCccccceEEEeeecCCCceEEEEEEcccccccchHHHHHHHHHhcccC-C-----CCcccccceeccCCceE
Q 003836 502 TRGFKEELGRGAFGTVYKGFVNMGSSNHVAVKKLNSVFQDSEKEFKAEVNGIGQTH-H-----KNLVRLLGYCDEGQNRL 575 (792)
Q Consensus 502 ~~~~~~~lG~G~~g~Vy~g~~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~-h-----~niv~l~g~~~~~~~~~ 575 (792)
+|.+.+.||+|.||.|.|+. +..+++.||||++++. ..-..+...|+++|..|+ | -|+|+++++|...++.+
T Consensus 187 rY~V~e~LGkGtFGQVvk~~-d~~T~e~VAIKIiKN~-k~f~~Q~~~Ei~iL~~ln~~d~~~~~n~Vrm~d~F~fr~Hlc 264 (586)
T KOG0667|consen 187 RYEVLEVLGKGSFGQVVKAY-DHKTGEIVAIKIIKNK-KRFLRQAQIEIRILELLNKHDPDDKYNIVRMLDYFYFRNHLC 264 (586)
T ss_pred EEEEEEEecccccceeEEEE-ecCCCcEEEEEeeccC-hHHHHHHHHHHHHHHHHhccCCCCCeeEEEeeecccccccee
Confidence 45567899999999999995 5577889999999875 334566788999999986 3 56999999999999999
Q ss_pred EEEEeccCCCccccccCC--CCCchhHHHHHHHHHHHHHHHHhhccCCCeEecCCCCCcEEEcCC--CCeEEeecCCCcc
Q 003836 576 LVYEFMSNGTVASFLFGD--SKPNWKLRTEIAMGIAGGLFYLHEECCTQIIHCDIKPQNILLDDH--YNARISDFGLAKL 651 (792)
Q Consensus 576 lV~E~~~~gsL~~~l~~~--~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dikp~NILl~~~--~~~kl~Dfg~a~~ 651 (792)
||+|.++. +|.++|..+ ..++...+..|+.||+.||.+||+. +|||+||||+||||.+- ..+||+|||.+..
T Consensus 265 iVfELL~~-NLYellK~n~f~Glsl~~ir~~~~Qil~~L~~L~~l---~IIHcDLKPENILL~~~~r~~vKVIDFGSSc~ 340 (586)
T KOG0667|consen 265 IVFELLST-NLYELLKNNKFRGLSLPLVRKFAQQILTALLFLHEL---GIIHCDLKPENILLKDPKRSRIKVIDFGSSCF 340 (586)
T ss_pred eeehhhhh-hHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeeccCChhheeeccCCcCceeEEecccccc
Confidence 99999966 999999877 4678999999999999999999998 99999999999999754 4799999999986
Q ss_pred ccCCCCCccccccccCCcccccccccCCCCcccceehHHHHHHHHHhcCcCCCcch
Q 003836 652 LTLDQSHTNTAIRGTKGYVAPEWFRNMPITVKVDVYSYGVLLLEIICLRRNIDNEI 707 (792)
Q Consensus 652 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DV~S~Gv~l~el~tg~~p~~~~~ 707 (792)
....-. ....+..|+|||++.+.+|+.+.||||||||+.||++|...|..+.
T Consensus 341 ~~q~vy----tYiQSRfYRAPEVILGlpY~~~IDmWSLGCIlAEL~tG~PLfpG~n 392 (586)
T KOG0667|consen 341 ESQRVY----TYIQSRFYRAPEVILGLPYDTAIDMWSLGCILAELFTGEPLFPGDN 392 (586)
T ss_pred cCCcce----eeeeccccccchhhccCCCCCccceeehhhhHHhHhcCccccCCCC
Confidence 542221 4557889999999999999999999999999999999977665543
|
|
| >PHA03207 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-34 Score=320.61 Aligned_cols=262 Identities=20% Similarity=0.221 Sum_probs=198.3
Q ss_pred HhhhhhhcCccccceEEEeeecC-CCceEEEEEEcccccccchHHHHHHHHHhcccCCCCcccccceeccCCceEEEEEe
Q 003836 502 TRGFKEELGRGAFGTVYKGFVNM-GSSNHVAVKKLNSVFQDSEKEFKAEVNGIGQTHHKNLVRLLGYCDEGQNRLLVYEF 580 (792)
Q Consensus 502 ~~~~~~~lG~G~~g~Vy~g~~~~-~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~lV~E~ 580 (792)
.+.+.+.||+|+||.||++.... ...+.|++|.+... +...+|++++++++|+||+++++++......++|||+
T Consensus 93 ~y~i~~~Lg~G~~g~Vy~~~~~~~~~~~~v~vK~~~~~-----~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~e~ 167 (392)
T PHA03207 93 QYNILSSLTPGSEGEVFVCTKHGDEQRKKVIVKAVTGG-----KTPGREIDILKTISHRAIINLIHAYRWKSTVCMVMPK 167 (392)
T ss_pred ceEEEEeecCCCCeEEEEEEEcCCccceeEEEEecccc-----ccHHHHHHHHHhcCCCCccceeeeEeeCCEEEEEehh
Confidence 35566889999999999986532 34578999987643 3457899999999999999999999999999999999
Q ss_pred ccCCCccccccCCCCCchhHHHHHHHHHHHHHHHHhhccCCCeEecCCCCCcEEEcCCCCeEEeecCCCccccCCCCC-c
Q 003836 581 MSNGTVASFLFGDSKPNWKLRTEIAMGIAGGLFYLHEECCTQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLDQSH-T 659 (792)
Q Consensus 581 ~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dikp~NILl~~~~~~kl~Dfg~a~~~~~~~~~-~ 659 (792)
+. ++|.+++.....+++..+..++.||+.||.|||+. +|+||||||+|||++.++.+||+|||+++........ .
T Consensus 168 ~~-~~l~~~l~~~~~l~~~~~~~i~~ql~~aL~~LH~~---givHrDlkp~Nill~~~~~~~l~DfG~a~~~~~~~~~~~ 243 (392)
T PHA03207 168 YK-CDLFTYVDRSGPLPLEQAITIQRRLLEALAYLHGR---GIIHRDVKTENIFLDEPENAVLGDFGAACKLDAHPDTPQ 243 (392)
T ss_pred cC-CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEEcCCCCEEEccCccccccCccccccc
Confidence 96 58888886667899999999999999999999998 9999999999999999999999999999865443222 2
Q ss_pred cccccccCCcccccccccCCCCcccceehHHHHHHHHHhcCcCCCcchhhhhhhhHHHHHHHh------hcccc---h-h
Q 003836 660 NTAIRGTKGYVAPEWFRNMPITVKVDVYSYGVLLLEIICLRRNIDNEISKVDKAILTDWAYDR------YQERT---L-E 729 (792)
Q Consensus 660 ~~~~~gt~~y~aPE~~~~~~~~~k~DV~S~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~------~~~~~---~-~ 729 (792)
.....||+.|+|||++....++.++|||||||++|||++|+.||...........+....... +.... + .
T Consensus 244 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~l~~i~~~~~~~~~~~~~~~~~~~~~ 323 (392)
T PHA03207 244 CYGWSGTLETNSPELLALDPYCAKTDIWSAGLVLFEMSVKNVTLFGKQVKSSSSQLRSIIRCMQVHPLEFPQNGSTNLCK 323 (392)
T ss_pred ccccccccCccCHhHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCCCCcHHHHHHHHHHhccCccccCCccchhHHH
Confidence 234568999999999999999999999999999999999999996543211111111000000 00000 0 0
Q ss_pred Hh--hhchhcccCC-------HHHHHHHHHHHHHccccCCCCCCCHHhHHHH
Q 003836 730 AL--VENDLEAMNN-------VTMLHRFVMVAFWCIQEDPSHRPTMRKVTQM 772 (792)
Q Consensus 730 ~~--~~~~~~~~~~-------~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~ 772 (792)
.+ .....+.... .....++.+++.+||+.+|++|||+.|++..
T Consensus 324 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~Rpsa~e~l~~ 375 (392)
T PHA03207 324 HFKQYAIVLRPPYTIPPVIRKYGMHMDVEYLIAKMLTFDQEFRPSAQDILSL 375 (392)
T ss_pred HHHhhcccccCCccccchhhccCcchhHHHHHHHHhccChhhCCCHHHHhhC
Confidence 00 0000000000 1124567889999999999999999999984
|
|
| >cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-34 Score=308.64 Aligned_cols=261 Identities=20% Similarity=0.271 Sum_probs=195.1
Q ss_pred hhhhhcCccccceEEEeeecCCCceEEEEEEccccc-ccchHHHHHHHHHhcccCCCCcccccceeccCCceEEEEEecc
Q 003836 504 GFKEELGRGAFGTVYKGFVNMGSSNHVAVKKLNSVF-QDSEKEFKAEVNGIGQTHHKNLVRLLGYCDEGQNRLLVYEFMS 582 (792)
Q Consensus 504 ~~~~~lG~G~~g~Vy~g~~~~~~~~~vavK~~~~~~-~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~lV~E~~~ 582 (792)
.+.++||+|+||.||+|... .+++.||+|.+.... ......+.+|+.++++++|+||+++++++......++||||++
T Consensus 9 ~~~~~lg~g~~g~vy~~~~~-~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~~~lv~e~~~ 87 (301)
T cd07873 9 IKLDKLGEGTYATVYKGRSK-LTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFEYLD 87 (301)
T ss_pred EEeeEeccCcCEEEEEEEEc-CCCcEEEEEEEecccccCchhHHHHHHHHHHhcCCCCcceEEEEEecCCeEEEEEeccc
Confidence 34578999999999999754 456789999986432 2334567899999999999999999999999999999999998
Q ss_pred CCCccccccCC-CCCchhHHHHHHHHHHHHHHHHhhccCCCeEecCCCCCcEEEcCCCCeEEeecCCCccccCCCCCccc
Q 003836 583 NGTVASFLFGD-SKPNWKLRTEIAMGIAGGLFYLHEECCTQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLDQSHTNT 661 (792)
Q Consensus 583 ~gsL~~~l~~~-~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dikp~NILl~~~~~~kl~Dfg~a~~~~~~~~~~~~ 661 (792)
++|.+++... ..+++..+..++.||++||+|||+. +|+|+||||+|||+++++.+||+|||+++....... ...
T Consensus 88 -~~l~~~l~~~~~~~~~~~~~~~~~qi~~aL~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~-~~~ 162 (301)
T cd07873 88 -KDLKQYLDDCGNSINMHNVKLFLFQLLRGLNYCHRR---KVLHRDLKPQNLLINERGELKLADFGLARAKSIPTK-TYS 162 (301)
T ss_pred -cCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCCHHHEEECCCCcEEECcCcchhccCCCCC-ccc
Confidence 5888888654 4678899999999999999999998 999999999999999999999999999976433221 122
Q ss_pred cccccCCccccccccc-CCCCcccceehHHHHHHHHHhcCcCCCcchhhhhhhhHHHHHHHhhcccchhHhhh-------
Q 003836 662 AIRGTKGYVAPEWFRN-MPITVKVDVYSYGVLLLEIICLRRNIDNEISKVDKAILTDWAYDRYQERTLEALVE------- 733 (792)
Q Consensus 662 ~~~gt~~y~aPE~~~~-~~~~~k~DV~S~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~------- 733 (792)
...+++.|+|||.+.+ ..++.++|||||||++|||++|+.||................ ....+.....++.
T Consensus 163 ~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~tg~~~f~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~ 241 (301)
T cd07873 163 NEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMSTGRPLFPGSTVEEQLHFIFRIL-GTPTEETWPGILSNEEFKSY 241 (301)
T ss_pred ccceeecccCcHHHhCCCCCccHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHc-CCCChhhchhhhcccccccc
Confidence 3346889999998865 457899999999999999999999997543221110000000 0000000000000
Q ss_pred --chhcc----cCCHHHHHHHHHHHHHccccCCCCCCCHHhHHH
Q 003836 734 --NDLEA----MNNVTMLHRFVMVAFWCIQEDPSHRPTMRKVTQ 771 (792)
Q Consensus 734 --~~~~~----~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~ 771 (792)
+.... .........+.+++.+||+.||.+|||++|+++
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~eil~ 285 (301)
T cd07873 242 NYPKYRADCLHNHAPRLDSDGAELLSKLLQFEGRKRISAEEAMK 285 (301)
T ss_pred ccCccccccHHhhcCCCCHHHHHHHHHHhcCCcccCcCHHHHhc
Confidence 00000 001123456789999999999999999999998
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl |
| >cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-34 Score=306.88 Aligned_cols=265 Identities=22% Similarity=0.267 Sum_probs=202.9
Q ss_pred hhhhhhcCccccceEEEeeecCCCceEEEEEEccccc--ccchHHHHHHHHHhcccCCCCcccccceeccCCceEEEEEe
Q 003836 503 RGFKEELGRGAFGTVYKGFVNMGSSNHVAVKKLNSVF--QDSEKEFKAEVNGIGQTHHKNLVRLLGYCDEGQNRLLVYEF 580 (792)
Q Consensus 503 ~~~~~~lG~G~~g~Vy~g~~~~~~~~~vavK~~~~~~--~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~lV~E~ 580 (792)
+.+.+.||+|++|.||+|... .+++.|++|+++... ....+.+.+|++++++++|+||+++++++..++..++||||
T Consensus 3 y~~~~~i~~g~~~~v~~~~~~-~~~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e~ 81 (288)
T cd07833 3 YEVLGVVGEGAYGVVLKCRNK-ATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHENIVNLKEAFRRKGRLYLVFEY 81 (288)
T ss_pred eeEEEEecccCCeeEEEEEeC-CCCcEEEEehhhhhcccccchhHHHHHHHHHHhcCCCCeeehhheEEECCEEEEEEec
Confidence 345678999999999999764 346789999987532 33357899999999999999999999999999999999999
Q ss_pred ccCCCccccccCCCCCchhHHHHHHHHHHHHHHHHhhccCCCeEecCCCCCcEEEcCCCCeEEeecCCCccccCCCCCcc
Q 003836 581 MSNGTVASFLFGDSKPNWKLRTEIAMGIAGGLFYLHEECCTQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLDQSHTN 660 (792)
Q Consensus 581 ~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dikp~NILl~~~~~~kl~Dfg~a~~~~~~~~~~~ 660 (792)
++++.+..+......+++..+..++.||+.||+|||+. +++|+||+|+||++++++.+||+|||++...........
T Consensus 82 ~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~dl~~~ni~~~~~~~~kl~d~g~~~~~~~~~~~~~ 158 (288)
T cd07833 82 VERTLLELLEASPGGLPPDAVRSYIWQLLQAIAYCHSH---NIIHRDIKPENILVSESGVLKLCDFGFARALRARPASPL 158 (288)
T ss_pred CCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEECCCCCEEEEeeecccccCCCccccc
Confidence 99988877776666789999999999999999999998 999999999999999999999999999987665443233
Q ss_pred ccccccCCcccccccccC-CCCcccceehHHHHHHHHHhcCcCCCcchhhhhhhhHHHHH-------HHhhc-ccchh--
Q 003836 661 TAIRGTKGYVAPEWFRNM-PITVKVDVYSYGVLLLEIICLRRNIDNEISKVDKAILTDWA-------YDRYQ-ERTLE-- 729 (792)
Q Consensus 661 ~~~~gt~~y~aPE~~~~~-~~~~k~DV~S~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~-------~~~~~-~~~~~-- 729 (792)
....++..|+|||++.+. .++.++||||||+++|+|++|+.||................ ...+. .....
T Consensus 159 ~~~~~~~~~~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (288)
T cd07833 159 TDYVATRWYRAPELLVGDTNYGKPVDVWAIGCIMAELLDGEPLFPGDSDIDQLYLIQKCLGPLPPSHQELFSSNPRFAGV 238 (288)
T ss_pred cCcccccCCcCCchhcCCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHhhhcccCcccccc
Confidence 445678899999999887 88999999999999999999999986543221110000000 00000 00000
Q ss_pred ---Hhhhc-hhcccCCHHHHHHHHHHHHHccccCCCCCCCHHhHHH
Q 003836 730 ---ALVEN-DLEAMNNVTMLHRFVMVAFWCIQEDPSHRPTMRKVTQ 771 (792)
Q Consensus 730 ---~~~~~-~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~ 771 (792)
...+. ......+...+.++.+++.+||+.+|++||+++++++
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~ 284 (288)
T cd07833 239 AFPEPSQPESLERRYPGKVSSPALDFLKACLRMDPKERLTCDELLQ 284 (288)
T ss_pred ccCCCCCcHHHHHhcCCccchHHHHHHHHHhccCchhcccHHHHhc
Confidence 00000 0001112223678999999999999999999999987
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning |
| >cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-34 Score=306.56 Aligned_cols=247 Identities=23% Similarity=0.337 Sum_probs=200.9
Q ss_pred hhhhcCccccceEEEeeecCCCceEEEEEEcccccccchHHHHHHHHHhcccCCCCcccccceeccCCceEEEEEeccCC
Q 003836 505 FKEELGRGAFGTVYKGFVNMGSSNHVAVKKLNSVFQDSEKEFKAEVNGIGQTHHKNLVRLLGYCDEGQNRLLVYEFMSNG 584 (792)
Q Consensus 505 ~~~~lG~G~~g~Vy~g~~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~lV~E~~~~g 584 (792)
+.+.||.|++|.||+|.. ..+++.|++|.+........+.+.+|+.+++.++|+||+++++++...+..++|+||++++
T Consensus 23 ~~~~lg~g~~g~vy~~~~-~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~ 101 (296)
T cd06655 23 RYEKIGQGASGTVFTAID-VATGQEVAIKQINLQKQPKKELIINEILVMKELKNPNIVNFLDSFLVGDELFVVMEYLAGG 101 (296)
T ss_pred EEEEEecCCCeEEEEEEE-cCCCcEEEEEEEecccCchHHHHHHHHHHHHhcCCCceeeeeeeEecCceEEEEEEecCCC
Confidence 446799999999999964 3456789999987655556678899999999999999999999999999999999999999
Q ss_pred CccccccCCCCCchhHHHHHHHHHHHHHHHHhhccCCCeEecCCCCCcEEEcCCCCeEEeecCCCccccCCCCCcccccc
Q 003836 585 TVASFLFGDSKPNWKLRTEIAMGIAGGLFYLHEECCTQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLDQSHTNTAIR 664 (792)
Q Consensus 585 sL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dikp~NILl~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~ 664 (792)
+|.+++.. ..+++.++..++.|++.||+|||+. +++|+||||+||+++.++.+||+|||++......... .....
T Consensus 102 ~L~~~~~~-~~l~~~~~~~i~~~l~~al~~LH~~---~i~H~dL~p~Nili~~~~~~kl~dfg~~~~~~~~~~~-~~~~~ 176 (296)
T cd06655 102 SLTDVVTE-TCMDEAQIAAVCRECLQALEFLHAN---QVIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPEQSK-RSTMV 176 (296)
T ss_pred cHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEccCccchhccccccc-CCCcC
Confidence 99998864 3589999999999999999999998 9999999999999999999999999998865433221 22345
Q ss_pred ccCCcccccccccCCCCcccceehHHHHHHHHHhcCcCCCcchhhhhhhhHHHHHHHhhcccchhHhhhchhcccCCHHH
Q 003836 665 GTKGYVAPEWFRNMPITVKVDVYSYGVLLLEIICLRRNIDNEISKVDKAILTDWAYDRYQERTLEALVENDLEAMNNVTM 744 (792)
Q Consensus 665 gt~~y~aPE~~~~~~~~~k~DV~S~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 744 (792)
++..|+|||.+.+..++.++|||||||++|+|++|+.||............ .. ........+...
T Consensus 177 ~~~~y~aPE~~~~~~~~~~~Dv~slGvil~~lltg~~pf~~~~~~~~~~~~----~~-----------~~~~~~~~~~~~ 241 (296)
T cd06655 177 GTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLI----AT-----------NGTPELQNPEKL 241 (296)
T ss_pred CCccccCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH----Hh-----------cCCcccCCcccC
Confidence 788999999999888999999999999999999999999664322111000 00 000001112234
Q ss_pred HHHHHHHHHHccccCCCCCCCHHhHHHH
Q 003836 745 LHRFVMVAFWCIQEDPSHRPTMRKVTQM 772 (792)
Q Consensus 745 ~~~l~~l~~~Cl~~~p~~RPs~~evl~~ 772 (792)
...+.+++.+||+.+|.+||++.++++.
T Consensus 242 ~~~~~~li~~~l~~dp~~Rpt~~~il~~ 269 (296)
T cd06655 242 SPIFRDFLNRCLEMDVEKRGSAKELLQH 269 (296)
T ss_pred CHHHHHHHHHHhhcChhhCCCHHHHhhC
Confidence 4578889999999999999999999964
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-34 Score=304.79 Aligned_cols=247 Identities=26% Similarity=0.314 Sum_probs=196.3
Q ss_pred hhhcCccccceEEEeeecCCCceEEEEEEccccc---ccchHHHHHHHHHhcccCCCCcccccceeccCCceEEEEEecc
Q 003836 506 KEELGRGAFGTVYKGFVNMGSSNHVAVKKLNSVF---QDSEKEFKAEVNGIGQTHHKNLVRLLGYCDEGQNRLLVYEFMS 582 (792)
Q Consensus 506 ~~~lG~G~~g~Vy~g~~~~~~~~~vavK~~~~~~---~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~lV~E~~~ 582 (792)
.+.||+|+||+||++... .+++.+|+|++.... ......+.+|++++++++|+|++++++.+..++..++||||++
T Consensus 5 ~~~lg~G~~g~vy~~~~~-~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~~~ 83 (285)
T cd05632 5 YRVLGKGGFGEVCACQVR-ATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNLAYAYETKDALCLVLTIMN 83 (285)
T ss_pred EEEEecCCCeEEEEEEEC-CCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCcCceeEEEEEecCCEEEEEEEecc
Confidence 467999999999999764 456799999986532 1223457889999999999999999999999999999999999
Q ss_pred CCCccccccCC--CCCchhHHHHHHHHHHHHHHHHhhccCCCeEecCCCCCcEEEcCCCCeEEeecCCCccccCCCCCcc
Q 003836 583 NGTVASFLFGD--SKPNWKLRTEIAMGIAGGLFYLHEECCTQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLDQSHTN 660 (792)
Q Consensus 583 ~gsL~~~l~~~--~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dikp~NILl~~~~~~kl~Dfg~a~~~~~~~~~~~ 660 (792)
+++|.+++... ..+++..+..++.|++.||.|||+. +|+||||||+||++++++.+||+|||++....... ..
T Consensus 84 ~~~L~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~---~iiH~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~--~~ 158 (285)
T cd05632 84 GGDLKFHIYNMGNPGFEEERALFYAAEILCGLEDLHRE---NTVYRDLKPENILLDDYGHIRISDLGLAVKIPEGE--SI 158 (285)
T ss_pred CccHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeecCCCHHHEEECCCCCEEEecCCcceecCCCC--cc
Confidence 99999888653 4689999999999999999999998 99999999999999999999999999997653221 12
Q ss_pred ccccccCCcccccccccCCCCcccceehHHHHHHHHHhcCcCCCcchhhhhhhhHHHHHHHhhcccchhHhhhchhcccC
Q 003836 661 TAIRGTKGYVAPEWFRNMPITVKVDVYSYGVLLLEIICLRRNIDNEISKVDKAILTDWAYDRYQERTLEALVENDLEAMN 740 (792)
Q Consensus 661 ~~~~gt~~y~aPE~~~~~~~~~k~DV~S~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 740 (792)
....|+..|+|||.+.+..++.++||||||+++|||++|+.||............ . . .+... ....
T Consensus 159 ~~~~g~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~P~~~~~~~~~~~~~---~-~--------~~~~~--~~~~ 224 (285)
T cd05632 159 RGRVGTVGYMAPEVLNNQRYTLSPDYWGLGCLIYEMIEGQSPFRGRKEKVKREEV---D-R--------RVLET--EEVY 224 (285)
T ss_pred cCCCCCcCccChHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHH---H-H--------hhhcc--cccc
Confidence 3346899999999999889999999999999999999999999754322111000 0 0 00000 0111
Q ss_pred CHHHHHHHHHHHHHccccCCCCCCC-----HHhHHHH
Q 003836 741 NVTMLHRFVMVAFWCIQEDPSHRPT-----MRKVTQM 772 (792)
Q Consensus 741 ~~~~~~~l~~l~~~Cl~~~p~~RPs-----~~evl~~ 772 (792)
.......+.+++..||+.+|++||+ ++++++.
T Consensus 225 ~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~~ 261 (285)
T cd05632 225 SAKFSEEAKSICKMLLTKDPKQRLGCQEEGAGEVKRH 261 (285)
T ss_pred CccCCHHHHHHHHHHccCCHhHcCCCcccChHHHHcC
Confidence 2234556788999999999999999 6677663
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with |
| >cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-34 Score=306.34 Aligned_cols=261 Identities=23% Similarity=0.278 Sum_probs=191.1
Q ss_pred hhhhhcCccccceEEEeeecCCCceEEEEEEcccccc--cchHHHHHHHHHhccc---CCCCcccccceecc-----CCc
Q 003836 504 GFKEELGRGAFGTVYKGFVNMGSSNHVAVKKLNSVFQ--DSEKEFKAEVNGIGQT---HHKNLVRLLGYCDE-----GQN 573 (792)
Q Consensus 504 ~~~~~lG~G~~g~Vy~g~~~~~~~~~vavK~~~~~~~--~~~~~~~~Ei~~l~~l---~h~niv~l~g~~~~-----~~~ 573 (792)
.+.+.||+|+||+||++... .+++.+|+|.++.... .....+.+|+.+++++ +||||+++++++.. ...
T Consensus 3 ~~~~~lg~g~~g~v~~~~~~-~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~ni~~~~~~~~~~~~~~~~~ 81 (288)
T cd07863 3 EPVAEIGVGAYGTVYKARDP-HSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRLMDVCATSRTDRETK 81 (288)
T ss_pred eEeeEEeecCCeEEEEEEEC-CCCcEEEEEEeccCcCCCCCchHHHHHHHHHHHhhhcCCCCeeeeeeeeccccCCCCce
Confidence 34578999999999999754 4577999999875322 2234566777777665 79999999998854 345
Q ss_pred eEEEEEeccCCCccccccCC--CCCchhHHHHHHHHHHHHHHHHhhccCCCeEecCCCCCcEEEcCCCCeEEeecCCCcc
Q 003836 574 RLLVYEFMSNGTVASFLFGD--SKPNWKLRTEIAMGIAGGLFYLHEECCTQIIHCDIKPQNILLDDHYNARISDFGLAKL 651 (792)
Q Consensus 574 ~~lV~E~~~~gsL~~~l~~~--~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dikp~NILl~~~~~~kl~Dfg~a~~ 651 (792)
.++||||+++ +|.+++... ..+++..+..++.||+.||.|||+. +|+||||||+|||++.++.+||+|||+++.
T Consensus 82 ~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~dikp~Nili~~~~~~kl~dfg~~~~ 157 (288)
T cd07863 82 VTLVFEHVDQ-DLRTYLDKVPPPGLPAETIKDLMRQFLRGLDFLHAN---CIVHRDLKPENILVTSGGQVKLADFGLARI 157 (288)
T ss_pred EEEEEccccc-CHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCCEEECccCcccc
Confidence 7899999985 888888653 3578999999999999999999998 999999999999999999999999999987
Q ss_pred ccCCCCCccccccccCCcccccccccCCCCcccceehHHHHHHHHHhcCcCCCcchhhhhhhhHHHHH----HHhhcccc
Q 003836 652 LTLDQSHTNTAIRGTKGYVAPEWFRNMPITVKVDVYSYGVLLLEIICLRRNIDNEISKVDKAILTDWA----YDRYQERT 727 (792)
Q Consensus 652 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DV~S~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~----~~~~~~~~ 727 (792)
..... ......++..|+|||.+.+..++.++|||||||++|||++|+.||................ ...+....
T Consensus 158 ~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (288)
T cd07863 158 YSCQM--ALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPEDDWPRDV 235 (288)
T ss_pred ccCcc--cCCCccccccccCchHhhCCCCCCcchhhhHHHHHHHHHhCCcCcCCCCHHHHHHHHHHHhCCCChhhCcccc
Confidence 64322 2233457899999999998899999999999999999999999986543321111110000 00000000
Q ss_pred -h-hHhhhchh---cccCCHHHHHHHHHHHHHccccCCCCCCCHHhHHH
Q 003836 728 -L-EALVENDL---EAMNNVTMLHRFVMVAFWCIQEDPSHRPTMRKVTQ 771 (792)
Q Consensus 728 -~-~~~~~~~~---~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~ 771 (792)
. .....+.. ..........++.+++.+||+.||++|||+.|++.
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~l~ 284 (288)
T cd07863 236 TLPRGAFSPRGPRPVQSVVPEIEESGAQLLLEMLTFNPHKRISAFRALQ 284 (288)
T ss_pred cccccccCCCCCCchHHhCcCcCHHHHHHHHHHhccCcccCCCHHHHhc
Confidence 0 00000000 00011123466789999999999999999999986
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou |
| >PTZ00284 protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-34 Score=326.43 Aligned_cols=259 Identities=20% Similarity=0.280 Sum_probs=187.7
Q ss_pred hhhhhhcCccccceEEEeeecCCCceEEEEEEcccccccchHHHHHHHHHhcccC------CCCcccccceeccC-CceE
Q 003836 503 RGFKEELGRGAFGTVYKGFVNMGSSNHVAVKKLNSVFQDSEKEFKAEVNGIGQTH------HKNLVRLLGYCDEG-QNRL 575 (792)
Q Consensus 503 ~~~~~~lG~G~~g~Vy~g~~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~------h~niv~l~g~~~~~-~~~~ 575 (792)
+.+.++||+|+||+||++... ..++.||||+++... ....++..|+.++++++ |.+++++++++... .+.+
T Consensus 131 y~i~~~lG~G~fg~V~~a~~~-~~~~~vAvK~i~~~~-~~~~~~~~e~~~l~~l~~~~~~~~~~i~~i~~~~~~~~~~~~ 208 (467)
T PTZ00284 131 FKILSLLGEGTFGKVVEAWDR-KRKEYCAVKIVRNVP-KYTRDAKIEIQFMEKVRQADPADRFPLMKIQRYFQNETGHMC 208 (467)
T ss_pred EEEEEEEEeccCEEEEEEEEc-CCCeEEEEEEEecch-hhHHHHHHHHHHHHHHhhcCcccCcceeeeEEEEEcCCceEE
Confidence 345578999999999999754 456789999986532 22345566776666654 45588898888654 4678
Q ss_pred EEEEeccCCCccccccCCCCCchhHHHHHHHHHHHHHHHHhhccCCCeEecCCCCCcEEEcCCC----------------
Q 003836 576 LVYEFMSNGTVASFLFGDSKPNWKLRTEIAMGIAGGLFYLHEECCTQIIHCDIKPQNILLDDHY---------------- 639 (792)
Q Consensus 576 lV~E~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dikp~NILl~~~~---------------- 639 (792)
+|||++ +++|.+++.....+++..+..|+.||+.||.|||++ .+|+||||||+|||++.++
T Consensus 209 iv~~~~-g~~l~~~l~~~~~l~~~~~~~i~~qi~~aL~yLH~~--~gIiHrDlKP~NILl~~~~~~~~~~~~~~~~~~~~ 285 (467)
T PTZ00284 209 IVMPKY-GPCLLDWIMKHGPFSHRHLAQIIFQTGVALDYFHTE--LHLMHTDLKPENILMETSDTVVDPVTNRALPPDPC 285 (467)
T ss_pred EEEecc-CCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhc--CCeecCCCCHHHEEEecCCcccccccccccCCCCc
Confidence 999988 678998888778899999999999999999999973 2899999999999998765
Q ss_pred CeEEeecCCCccccCCCCCccccccccCCcccccccccCCCCcccceehHHHHHHHHHhcCcCCCcchhhhhhhhHH---
Q 003836 640 NARISDFGLAKLLTLDQSHTNTAIRGTKGYVAPEWFRNMPITVKVDVYSYGVLLLEIICLRRNIDNEISKVDKAILT--- 716 (792)
Q Consensus 640 ~~kl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DV~S~Gv~l~el~tg~~p~~~~~~~~~~~~~~--- 716 (792)
.+||+|||.+.... .......||+.|+|||++.+..++.++|||||||++|||++|+.||...........+.
T Consensus 286 ~vkl~DfG~~~~~~----~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~ 361 (467)
T PTZ00284 286 RVRICDLGGCCDER----HSRTAIVSTRHYRSPEVVLGLGWMYSTDMWSMGCIIYELYTGKLLYDTHDNLEHLHLMEKTL 361 (467)
T ss_pred eEEECCCCccccCc----cccccccCCccccCcHHhhcCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHc
Confidence 49999999876422 22345679999999999999999999999999999999999999997543221111110
Q ss_pred -----HHHHHhhcccchhHhhhchh---------------c--ccCCHHHHHHHHHHHHHccccCCCCCCCHHhHHH
Q 003836 717 -----DWAYDRYQERTLEALVENDL---------------E--AMNNVTMLHRFVMVAFWCIQEDPSHRPTMRKVTQ 771 (792)
Q Consensus 717 -----~~~~~~~~~~~~~~~~~~~~---------------~--~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~ 771 (792)
.|.... .......+.+... . ..........+++|+.+||+.||++|||++|+++
T Consensus 362 g~~p~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~R~ta~e~L~ 437 (467)
T PTZ00284 362 GRLPSEWAGRC-GTEEARLLYNSAGQLRPCTDPKHLARIARARPVREVIRDDLLCDLIYGLLHYDRQKRLNARQMTT 437 (467)
T ss_pred CCCCHHHHhhc-cchhHHHHhhhcccccccCCHHHHHhhhcccchhhhhchHHHHHHHHHhCCcChhhCCCHHHHhc
Confidence 010000 0000000100000 0 0000112356789999999999999999999997
|
|
| >cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-34 Score=299.18 Aligned_cols=251 Identities=24% Similarity=0.374 Sum_probs=186.9
Q ss_pred hcCccccceEEEeeecCCC-ceEEEEEEccccc-ccchHHHHHHHHHhcccCCCCcccccceeccCCceEEEEEeccCCC
Q 003836 508 ELGRGAFGTVYKGFVNMGS-SNHVAVKKLNSVF-QDSEKEFKAEVNGIGQTHHKNLVRLLGYCDEGQNRLLVYEFMSNGT 585 (792)
Q Consensus 508 ~lG~G~~g~Vy~g~~~~~~-~~~vavK~~~~~~-~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~lV~E~~~~gs 585 (792)
+||+|+||.||+|...... ...+++|.+.... ....+.+.+|+.++++++||||+++++.|.+....++||||+++|+
T Consensus 2 ~lg~G~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~ 81 (268)
T cd05086 2 EIGNGWFGKVLLSEIYTDTGVARVVVKELKANASSKEQNEFLQQGDPYRILQHPNILQCLGQCVEAIPYLLVFEYCELGD 81 (268)
T ss_pred cCCCCcCceEEEEEEEcCCCcceEEEEEecCCCChHHHHHHHHHHHHHhccCCcchhheEEEecCCCccEEEEecCCCCc
Confidence 5999999999999754332 3356677766433 2345789999999999999999999999999999999999999999
Q ss_pred ccccccCC----CCCchhHHHHHHHHHHHHHHHHhhccCCCeEecCCCCCcEEEcCCCCeEEeecCCCccccCCC-CCcc
Q 003836 586 VASFLFGD----SKPNWKLRTEIAMGIAGGLFYLHEECCTQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLDQ-SHTN 660 (792)
Q Consensus 586 L~~~l~~~----~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dikp~NILl~~~~~~kl~Dfg~a~~~~~~~-~~~~ 660 (792)
|.+++... ...++..+..++.||++||+|||+. +++|+||||+|||++.++.+||+|||++....... ....
T Consensus 82 L~~~l~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~---~i~H~dikp~nil~~~~~~~~l~Dfg~~~~~~~~~~~~~~ 158 (268)
T cd05086 82 LKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMHKH---NFLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDYIETE 158 (268)
T ss_pred HHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHC---CeeccCCccceEEEcCCccEEecccccccccCcchhhhcc
Confidence 99999753 2356677889999999999999998 99999999999999999999999999986432211 1122
Q ss_pred ccccccCCccccccccc-------CCCCcccceehHHHHHHHHHhc-CcCCCcchhhhhhhhHHHHHHHhhcccchhHhh
Q 003836 661 TAIRGTKGYVAPEWFRN-------MPITVKVDVYSYGVLLLEIICL-RRNIDNEISKVDKAILTDWAYDRYQERTLEALV 732 (792)
Q Consensus 661 ~~~~gt~~y~aPE~~~~-------~~~~~k~DV~S~Gv~l~el~tg-~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 732 (792)
....++..|+|||++.. ..++.++||||||+++|||+++ ..||....... .+.. ... +....+.
T Consensus 159 ~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~---~~~~----~~~-~~~~~~~ 230 (268)
T cd05086 159 DDKCVPLRWLAPELVGEFHGGLITAEQTKPSNVWALGVTLWELFENAAQPYSHLSDRE---VLNH----VIK-DQQVKLF 230 (268)
T ss_pred cCCcCcccccCchhcccccCccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCHHH---HHHH----HHh-hcccccC
Confidence 33457889999998743 2467899999999999999975 55664332211 0000 000 1111112
Q ss_pred hchhcccCCHHHHHHHHHHHHHccccCCCCCCCHHhHHHHhc
Q 003836 733 ENDLEAMNNVTMLHRFVMVAFWCIQEDPSHRPTMRKVTQMLE 774 (792)
Q Consensus 733 ~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~L~ 774 (792)
++.+. .....++.+++..|| .+|++||++++|++.|.
T Consensus 231 ~~~~~----~~~~~~~~~l~~~c~-~~P~~Rp~~~~i~~~l~ 267 (268)
T cd05086 231 KPQLE----LPYSERWYEVLQFCW-LSPEKRATAEEVHRLLT 267 (268)
T ss_pred CCccC----CCCcHHHHHHHHHHh-hCcccCCCHHHHHHHhc
Confidence 22221 123456777888999 57999999999999874
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage |
| >cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-34 Score=308.38 Aligned_cols=251 Identities=28% Similarity=0.413 Sum_probs=196.1
Q ss_pred hhhcCccccceEEEeeecCCCc---eEEEEEEcccccc-cchHHHHHHHHHhcccCCCCcccccceeccCCceEEEEEec
Q 003836 506 KEELGRGAFGTVYKGFVNMGSS---NHVAVKKLNSVFQ-DSEKEFKAEVNGIGQTHHKNLVRLLGYCDEGQNRLLVYEFM 581 (792)
Q Consensus 506 ~~~lG~G~~g~Vy~g~~~~~~~---~~vavK~~~~~~~-~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~lV~E~~ 581 (792)
.+.||+|+||.||+|....... ..+|+|.+..... ....++.+|+.++++++|+||+++++++... ..++++||+
T Consensus 12 ~~~lg~G~~g~vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~-~~~~v~e~~ 90 (303)
T cd05110 12 VKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVRLLGVCLSP-TIQLVTQLM 90 (303)
T ss_pred ccccccCCCccEEEEEEecCCCcceeeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEcCC-Cceeeehhc
Confidence 4679999999999997643322 3578998875432 2344788999999999999999999998754 467999999
Q ss_pred cCCCccccccCC-CCCchhHHHHHHHHHHHHHHHHhhccCCCeEecCCCCCcEEEcCCCCeEEeecCCCccccCCCCCc-
Q 003836 582 SNGTVASFLFGD-SKPNWKLRTEIAMGIAGGLFYLHEECCTQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLDQSHT- 659 (792)
Q Consensus 582 ~~gsL~~~l~~~-~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dikp~NILl~~~~~~kl~Dfg~a~~~~~~~~~~- 659 (792)
++|+|.+++... ..+++..+..++.|++.||+|||+. +|+|+||||+|||+++++.+||+|||+++.........
T Consensus 91 ~~g~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~---~ivH~dikp~Nill~~~~~~kL~Dfg~~~~~~~~~~~~~ 167 (303)
T cd05110 91 PHGCLLDYVHEHKDNIGSQLLLNWCVQIAKGMMYLEER---RLVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKEYN 167 (303)
T ss_pred CCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHhhc---CeeccccccceeeecCCCceEEccccccccccCcccccc
Confidence 999999998765 3678999999999999999999998 99999999999999999999999999998765333221
Q ss_pred cccccccCCcccccccccCCCCcccceehHHHHHHHHHh-cCcCCCcchhhhhhhhHHHHHHHhhcccchhHhhhchhcc
Q 003836 660 NTAIRGTKGYVAPEWFRNMPITVKVDVYSYGVLLLEIIC-LRRNIDNEISKVDKAILTDWAYDRYQERTLEALVENDLEA 738 (792)
Q Consensus 660 ~~~~~gt~~y~aPE~~~~~~~~~k~DV~S~Gv~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 738 (792)
.....++..|+|||.+.+..++.++||||||+++|||++ |+.||........ .. ++......
T Consensus 168 ~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~el~t~g~~p~~~~~~~~~----~~-------------~~~~~~~~ 230 (303)
T cd05110 168 ADGGKMPIKWMALECIHYRKFTHQSDVWSYGVTIWELMTFGGKPYDGIPTREI----PD-------------LLEKGERL 230 (303)
T ss_pred cCCCccccccCCHHHhccCCCChHHHHHHHHHHHHHHHhCCCCCCCCCCHHHH----HH-------------HHHCCCCC
Confidence 122335678999999998999999999999999999997 8888865321110 01 01111111
Q ss_pred cCCHHHHHHHHHHHHHccccCCCCCCCHHhHHHHhccCc
Q 003836 739 MNNVTMLHRFVMVAFWCIQEDPSHRPTMRKVTQMLEGVV 777 (792)
Q Consensus 739 ~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~L~~~~ 777 (792)
..+......+.+++..||..+|++||+++++++.|+.+.
T Consensus 231 ~~~~~~~~~~~~li~~c~~~~p~~Rp~~~~l~~~l~~~~ 269 (303)
T cd05110 231 PQPPICTIDVYMVMVKCWMIDADSRPKFKELAAEFSRMA 269 (303)
T ss_pred CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHH
Confidence 111223456789999999999999999999999987654
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin |
| >cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-34 Score=306.31 Aligned_cols=261 Identities=22% Similarity=0.290 Sum_probs=199.3
Q ss_pred hhhhhcCccccceEEEeeecCCCceEEEEEEcccccc--cchHHHHHHHHHhcccCCCCcccccceeccCCceEEEEEec
Q 003836 504 GFKEELGRGAFGTVYKGFVNMGSSNHVAVKKLNSVFQ--DSEKEFKAEVNGIGQTHHKNLVRLLGYCDEGQNRLLVYEFM 581 (792)
Q Consensus 504 ~~~~~lG~G~~g~Vy~g~~~~~~~~~vavK~~~~~~~--~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~lV~E~~ 581 (792)
.+.++||+|+||.||++... ..++.+|+|++..... ...+.+.+|++++++++|+||+++++++..++..++|+||+
T Consensus 4 ~~~~~lg~g~~~~vy~~~~~-~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 82 (286)
T cd07846 4 ENLGLVGEGSYGMVMKCKHK-ETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNLIEVFRRKKRLYLVFEFV 82 (286)
T ss_pred eEeeeeccCCCeEEEEEEEC-CCCCEEEEEeHhhccCcchhhHHHHHHHHHHHhcCCcchhhHHHhcccCCeEEEEEecC
Confidence 34578999999999999764 3467899999865332 23567889999999999999999999999999999999999
Q ss_pred cCCCccccccCCCCCchhHHHHHHHHHHHHHHHHhhccCCCeEecCCCCCcEEEcCCCCeEEeecCCCccccCCCCCccc
Q 003836 582 SNGTVASFLFGDSKPNWKLRTEIAMGIAGGLFYLHEECCTQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLDQSHTNT 661 (792)
Q Consensus 582 ~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dikp~NILl~~~~~~kl~Dfg~a~~~~~~~~~~~~ 661 (792)
++++|.++......+++..+..++.||++||+|||+. +++|+||+|+||++++++.+||+|||+++...... ....
T Consensus 83 ~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~---~i~h~~l~p~ni~~~~~~~~~l~dfg~~~~~~~~~-~~~~ 158 (286)
T cd07846 83 DHTVLDDLEKYPNGLDESRVRKYLFQILRGIEFCHSH---NIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPG-EVYT 158 (286)
T ss_pred CccHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEECCCCcEEEEeeeeeeeccCCc-cccC
Confidence 9999998877666789999999999999999999998 99999999999999999999999999998754333 2223
Q ss_pred cccccCCccccccccc-CCCCcccceehHHHHHHHHHhcCcCCCcchhhhhhhhHHHHHHHhhcccchhHhhh-------
Q 003836 662 AIRGTKGYVAPEWFRN-MPITVKVDVYSYGVLLLEIICLRRNIDNEISKVDKAILTDWAYDRYQERTLEALVE------- 733 (792)
Q Consensus 662 ~~~gt~~y~aPE~~~~-~~~~~k~DV~S~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~------- 733 (792)
...++..|+|||.+.+ ..++.++||||||+++|||++|+.||...........+.... ....+. .....+
T Consensus 159 ~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~~g~~~~~~~~~~~~~~~~~~~~-~~~~~~-~~~~~~~~~~~~~ 236 (286)
T cd07846 159 DYVATRWYRAPELLVGDTKYGRAVDIWAVGCLVTEMLTGEPLFPGDSDIDQLYHIIKCL-GNLIPR-HQEIFQKNPLFAG 236 (286)
T ss_pred cccceeeccCcHHhccccccCchHhHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHHHh-CCCchh-hHHHhccchHhhc
Confidence 3457889999999865 457889999999999999999998886543221111111000 000000 000000
Q ss_pred ---chhcc-----cCCHHHHHHHHHHHHHccccCCCCCCCHHhHHH
Q 003836 734 ---NDLEA-----MNNVTMLHRFVMVAFWCIQEDPSHRPTMRKVTQ 771 (792)
Q Consensus 734 ---~~~~~-----~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~ 771 (792)
+.... ......+..+.+++.+||+.+|++||+++++++
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~ 282 (286)
T cd07846 237 MRLPEVKEIEPLEKRFPKLSGLVLDLAKQCLRIDPDDRPSSSQLLH 282 (286)
T ss_pred cccccccCcchHHHhCCCcCHHHHHHHHHHhcCCcccchhHHHHhc
Confidence 00000 001134567899999999999999999999987
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI |
| >KOG0584 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-35 Score=313.83 Aligned_cols=246 Identities=27% Similarity=0.399 Sum_probs=195.8
Q ss_pred hhhhcCccccceEEEeeecCCCceEEEEE--Ecccccc--cchHHHHHHHHHhcccCCCCcccccceeccCCc--eEEEE
Q 003836 505 FKEELGRGAFGTVYKGFVNMGSSNHVAVK--KLNSVFQ--DSEKEFKAEVNGIGQTHHKNLVRLLGYCDEGQN--RLLVY 578 (792)
Q Consensus 505 ~~~~lG~G~~g~Vy~g~~~~~~~~~vavK--~~~~~~~--~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~--~~lV~ 578 (792)
|.++||+|+|-+||||.. ...+..||-- ++.+..+ ...+.|..|+++|+.|+|+||++++.+..+... ..+|.
T Consensus 44 ~~evLGrGafKtVYka~D-e~~giEVAWnqvk~~d~~q~~~~leR~~~Ev~lLKsL~H~NIirfy~SW~d~~n~~in~iT 122 (632)
T KOG0584|consen 44 FDEVLGRGAFKTVYKAFD-EEEGIEVAWNQVKIRDVTQSPEELERLYSEVHLLKSLKHPNIIRFYDSWVDTDNKTINFIT 122 (632)
T ss_pred hhhhcccccceeeeeccc-cccchhhHHHHHhHHHhhcChHHHHHHHHHHHHHccCCCCceeeeeeheecCCCceeeeee
Confidence 557899999999999965 4556566632 2223223 334789999999999999999999998876655 77999
Q ss_pred EeccCCCccccccCCCCCchhHHHHHHHHHHHHHHHHhhccCCCeEecCCCCCcEEEcCC-CCeEEeecCCCccccCCCC
Q 003836 579 EFMSNGTVASFLFGDSKPNWKLRTEIAMGIAGGLFYLHEECCTQIIHCDIKPQNILLDDH-YNARISDFGLAKLLTLDQS 657 (792)
Q Consensus 579 E~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dikp~NILl~~~-~~~kl~Dfg~a~~~~~~~~ 657 (792)
|.|..|+|..|+.+.+..+.+.+..|++||++||.|||++ .++|||||||.+||+|+.+ |.+||+|+|+|.......
T Consensus 123 EL~TSGtLr~Y~kk~~~vn~kaik~W~RQILkGL~yLHs~-~PPIIHRDLKCDNIFinG~~G~VKIGDLGLAtl~r~s~- 200 (632)
T KOG0584|consen 123 ELFTSGTLREYRKKHRRVNIKAIKSWCRQILKGLVYLHSQ-DPPIIHRDLKCDNIFVNGNLGEVKIGDLGLATLLRKSH- 200 (632)
T ss_pred ecccCCcHHHHHHHhccCCHHHHHHHHHHHHHHhhhhhcC-CCCccccccccceEEEcCCcCceeecchhHHHHhhccc-
Confidence 9999999999999999999999999999999999999997 5689999999999999865 899999999999875332
Q ss_pred CccccccccCCcccccccccCCCCcccceehHHHHHHHHHhcCcCCCcchhhhhhhhHHHHHHHhhcccchhHhhhchhc
Q 003836 658 HTNTAIRGTKGYVAPEWFRNMPITVKVDVYSYGVLLLEIICLRRNIDNEISKVDKAILTDWAYDRYQERTLEALVENDLE 737 (792)
Q Consensus 658 ~~~~~~~gt~~y~aPE~~~~~~~~~k~DV~S~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 737 (792)
...+.|||.|||||++. ..|++..||||||++++||+|+..|+..-..... .+.+...+...+-+..
T Consensus 201 --aksvIGTPEFMAPEmYE-E~YnE~VDVYaFGMCmLEMvT~eYPYsEC~n~AQ-------IYKKV~SGiKP~sl~k--- 267 (632)
T KOG0584|consen 201 --AKSVIGTPEFMAPEMYE-ENYNELVDVYAFGMCMLEMVTSEYPYSECTNPAQ-------IYKKVTSGIKPAALSK--- 267 (632)
T ss_pred --cceeccCccccChHHHh-hhcchhhhhhhhhHHHHHHHhccCChhhhCCHHH-------HHHHHHcCCCHHHhhc---
Confidence 23478999999999987 7899999999999999999999999865432211 1122222221111111
Q ss_pred ccCCHHHHHHHHHHHHHccccCCCCCCCHHhHHHH
Q 003836 738 AMNNVTMLHRFVMVAFWCIQEDPSHRPTMRKVTQM 772 (792)
Q Consensus 738 ~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~ 772 (792)
-.-.++.++|.+||.. .++|||+.|+++.
T Consensus 268 -----V~dPevr~fIekCl~~-~~~R~sa~eLL~d 296 (632)
T KOG0584|consen 268 -----VKDPEVREFIEKCLAT-KSERLSAKELLKD 296 (632)
T ss_pred -----cCCHHHHHHHHHHhcC-chhccCHHHHhhC
Confidence 1124678899999999 9999999999963
|
|
| >cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-34 Score=298.72 Aligned_cols=250 Identities=23% Similarity=0.301 Sum_probs=202.6
Q ss_pred hhhhhcCccccceEEEeeecCCCceEEEEEEcccccccchHHHHHHHHHhcccCCCCcccccceeccCCceEEEEEeccC
Q 003836 504 GFKEELGRGAFGTVYKGFVNMGSSNHVAVKKLNSVFQDSEKEFKAEVNGIGQTHHKNLVRLLGYCDEGQNRLLVYEFMSN 583 (792)
Q Consensus 504 ~~~~~lG~G~~g~Vy~g~~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~lV~E~~~~ 583 (792)
.+.+.||+|++|.||++... .+++.+++|.+........+.+.+|++++++++|+||+++++++.+....+++|||+++
T Consensus 6 ~~~~~l~~g~~~~v~~~~~~-~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~l~~e~~~~ 84 (262)
T cd06613 6 ELIQRIGSGTYGDVYKARDI-ATGELVAIKVIKLEPGDDFEIIQQEISMLKECRHPNIVAYFGSYLRRDKLWIVMEYCGG 84 (262)
T ss_pred EEEEEecCCCceEEEEeEec-CCCCEEEEEEEEcCchhhHHHHHHHHHHHHhCCCCChhceEEEEEeCCEEEEEEeCCCC
Confidence 45578999999999999764 34568999998876555678899999999999999999999999999999999999999
Q ss_pred CCccccccCC-CCCchhHHHHHHHHHHHHHHHHhhccCCCeEecCCCCCcEEEcCCCCeEEeecCCCccccCCCCCcccc
Q 003836 584 GTVASFLFGD-SKPNWKLRTEIAMGIAGGLFYLHEECCTQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLDQSHTNTA 662 (792)
Q Consensus 584 gsL~~~l~~~-~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dikp~NILl~~~~~~kl~Dfg~a~~~~~~~~~~~~~ 662 (792)
++|.+++... ..+++..+..++.|++.||+|||+. +|+|+||+|+||++++++.+||+|||.+....... .....
T Consensus 85 ~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh~~---~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~-~~~~~ 160 (262)
T cd06613 85 GSLQDIYQVTRGPLSELQIAYVCRETLKGLAYLHET---GKIHRDIKGANILLTEDGDVKLADFGVSAQLTATI-AKRKS 160 (262)
T ss_pred CcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhC---CceecCCChhhEEECCCCCEEECccccchhhhhhh-hcccc
Confidence 9999999776 6789999999999999999999998 99999999999999999999999999998654322 12223
Q ss_pred ccccCCcccccccccC---CCCcccceehHHHHHHHHHhcCcCCCcchhhhhhhhHHHHHHHhhcccchhHhhhchhccc
Q 003836 663 IRGTKGYVAPEWFRNM---PITVKVDVYSYGVLLLEIICLRRNIDNEISKVDKAILTDWAYDRYQERTLEALVENDLEAM 739 (792)
Q Consensus 663 ~~gt~~y~aPE~~~~~---~~~~k~DV~S~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 739 (792)
..++..|+|||.+... .++.++||||||+++|||++|+.||........... ... .. + ......
T Consensus 161 ~~~~~~y~~Pe~~~~~~~~~~~~~~Di~slG~~l~~~~tg~~p~~~~~~~~~~~~---~~~-----~~---~--~~~~~~ 227 (262)
T cd06613 161 FIGTPYWMAPEVAAVERKGGYDGKCDIWALGITAIELAELQPPMFDLHPMRALFL---ISK-----SN---F--PPPKLK 227 (262)
T ss_pred ccCCccccCchhhcccccCCcCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHH---HHh-----cc---C--CCcccc
Confidence 4578899999999776 889999999999999999999999865432111000 000 00 0 000011
Q ss_pred CCHHHHHHHHHHHHHccccCCCCCCCHHhHHH
Q 003836 740 NNVTMLHRFVMVAFWCIQEDPSHRPTMRKVTQ 771 (792)
Q Consensus 740 ~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~ 771 (792)
.....+..+.+++.+||+.+|.+||++++|+.
T Consensus 228 ~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~ 259 (262)
T cd06613 228 DKEKWSPVFHDFIKKCLTKDPKKRPTATKLLQ 259 (262)
T ss_pred chhhhhHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 12345667899999999999999999999986
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ |
| >cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-34 Score=299.21 Aligned_cols=245 Identities=25% Similarity=0.345 Sum_probs=199.4
Q ss_pred hhhhcCccccceEEEeeecCCCceEEEEEEccccc-----ccchHHHHHHHHHhcccCCCCcccccceeccCCceEEEEE
Q 003836 505 FKEELGRGAFGTVYKGFVNMGSSNHVAVKKLNSVF-----QDSEKEFKAEVNGIGQTHHKNLVRLLGYCDEGQNRLLVYE 579 (792)
Q Consensus 505 ~~~~lG~G~~g~Vy~g~~~~~~~~~vavK~~~~~~-----~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~lV~E 579 (792)
..+.||+|++|.||+|... .+++.|++|.+.... .+..+.+.+|+.++++++|+||+++++++..+...++|+|
T Consensus 4 ~~~~ig~g~~~~vy~~~~~-~~~~~~~ik~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e 82 (258)
T cd06632 4 KGELLGSGSFGSVYEGLNL-DDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQYLGTEREEDNLYIFLE 82 (258)
T ss_pred ccceeeecCCceEEEEEEc-CCCcEEEEEEEEEccccccchHHHHHHHHHHHHHHhcCCCCchheeeeEecCCeEEEEEE
Confidence 4567999999999999764 346789999886533 2245678999999999999999999999999999999999
Q ss_pred eccCCCccccccCCCCCchhHHHHHHHHHHHHHHHHhhccCCCeEecCCCCCcEEEcCCCCeEEeecCCCccccCCCCCc
Q 003836 580 FMSNGTVASFLFGDSKPNWKLRTEIAMGIAGGLFYLHEECCTQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLDQSHT 659 (792)
Q Consensus 580 ~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dikp~NILl~~~~~~kl~Dfg~a~~~~~~~~~~ 659 (792)
|+++++|.+++.+...+++..+..++.||++||+|||+. +++|+||+|+||+++.++.+||+|||++....... .
T Consensus 83 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~~~ni~~~~~~~~kl~d~~~~~~~~~~~--~ 157 (258)
T cd06632 83 LVPGGSLAKLLKKYGSFPEPVIRLYTRQILLGLEYLHDR---NTVHRDIKGANILVDTNGVVKLADFGMAKQVVEFS--F 157 (258)
T ss_pred ecCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEccCccceeccccc--c
Confidence 999999999998777789999999999999999999998 99999999999999999999999999988754332 2
Q ss_pred cccccccCCcccccccccCC-CCcccceehHHHHHHHHHhcCcCCCcchhhhhhhhHHHHHHHhhcccchhHhhhchhcc
Q 003836 660 NTAIRGTKGYVAPEWFRNMP-ITVKVDVYSYGVLLLEIICLRRNIDNEISKVDKAILTDWAYDRYQERTLEALVENDLEA 738 (792)
Q Consensus 660 ~~~~~gt~~y~aPE~~~~~~-~~~k~DV~S~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 738 (792)
.....++..|+|||.+.... ++.++|+||||+++|+|++|+.||........ .... .......
T Consensus 158 ~~~~~~~~~y~~pe~~~~~~~~~~~~D~~slG~~l~~l~~g~~pf~~~~~~~~---~~~~-------------~~~~~~~ 221 (258)
T cd06632 158 AKSFKGSPYWMAPEVIAQQGGYGLAADIWSLGCTVLEMATGKPPWSQLEGVAA---VFKI-------------GRSKELP 221 (258)
T ss_pred ccccCCCcceeCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcccCcHHHH---HHHH-------------HhcccCC
Confidence 23455788999999987766 89999999999999999999999865431100 0000 0000011
Q ss_pred cCCHHHHHHHHHHHHHccccCCCCCCCHHhHHH
Q 003836 739 MNNVTMLHRFVMVAFWCIQEDPSHRPTMRKVTQ 771 (792)
Q Consensus 739 ~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~ 771 (792)
..+......+.+++.+||+.+|++||+++++++
T Consensus 222 ~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~ 254 (258)
T cd06632 222 PIPDHLSDEAKDFILKCLQRDPSLRPTAAELLE 254 (258)
T ss_pred CcCCCcCHHHHHHHHHHhhcCcccCcCHHHHhc
Confidence 122234567788999999999999999999987
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops |
| >cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-34 Score=298.44 Aligned_cols=247 Identities=23% Similarity=0.334 Sum_probs=201.1
Q ss_pred hhhhhhcCccccceEEEeeecCCCceEEEEEEcccccccchHHHHHHHHHhcccCCCCcccccceeccCCceEEEEEecc
Q 003836 503 RGFKEELGRGAFGTVYKGFVNMGSSNHVAVKKLNSVFQDSEKEFKAEVNGIGQTHHKNLVRLLGYCDEGQNRLLVYEFMS 582 (792)
Q Consensus 503 ~~~~~~lG~G~~g~Vy~g~~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~lV~E~~~ 582 (792)
+.+.+.||+|++|.||++.... +++.+++|.+..... .+++.+|++++++++|+||+++++++.+....++++||++
T Consensus 5 y~~~~~i~~g~~~~v~~~~~~~-~~~~~~~k~~~~~~~--~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~~ 81 (256)
T cd06612 5 FDILEKLGEGSYGSVYKAIHKE-TGQVVAIKVVPVEED--LQEIIKEISILKQCDSPYIVKYYGSYFKNTDLWIVMEYCG 81 (256)
T ss_pred chhhhhhcCCCCeEEEEEEEcC-CCcEEEEEEeecHHH--HHHHHHHHHHHHhCCCCcEeeeeeeeecCCcEEEEEecCC
Confidence 4456789999999999997653 457899999875432 6789999999999999999999999999999999999999
Q ss_pred CCCccccccC-CCCCchhHHHHHHHHHHHHHHHHhhccCCCeEecCCCCCcEEEcCCCCeEEeecCCCccccCCCCCccc
Q 003836 583 NGTVASFLFG-DSKPNWKLRTEIAMGIAGGLFYLHEECCTQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLDQSHTNT 661 (792)
Q Consensus 583 ~gsL~~~l~~-~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dikp~NILl~~~~~~kl~Dfg~a~~~~~~~~~~~~ 661 (792)
+++|.+++.. ...+++..+..++.|++.||.|||+. +++|+||+|+||++++++.+||+|||++........ ...
T Consensus 82 ~~~L~~~l~~~~~~l~~~~~~~~~~~l~~~l~~lh~~---~i~H~dl~~~ni~~~~~~~~~l~dfg~~~~~~~~~~-~~~ 157 (256)
T cd06612 82 AGSVSDIMKITNKTLTEEEIAAILYQTLKGLEYLHSN---KKIHRDIKAGNILLNEEGQAKLADFGVSGQLTDTMA-KRN 157 (256)
T ss_pred CCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCcceEEECCCCcEEEcccccchhcccCcc-ccc
Confidence 9999999865 35789999999999999999999998 999999999999999999999999999987643321 222
Q ss_pred cccccCCcccccccccCCCCcccceehHHHHHHHHHhcCcCCCcchhhhhhhhHHHHHHHhhcccchhHhhhchhcccCC
Q 003836 662 AIRGTKGYVAPEWFRNMPITVKVDVYSYGVLLLEIICLRRNIDNEISKVDKAILTDWAYDRYQERTLEALVENDLEAMNN 741 (792)
Q Consensus 662 ~~~gt~~y~aPE~~~~~~~~~k~DV~S~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 741 (792)
...++..|+|||.+.+..++.++||||||+++|||++|+.||............ .. ........+
T Consensus 158 ~~~~~~~y~~PE~~~~~~~~~~~Di~s~G~il~~l~~g~~p~~~~~~~~~~~~~--------~~-------~~~~~~~~~ 222 (256)
T cd06612 158 TVIGTPFWMAPEVIQEIGYNNKADIWSLGITAIEMAEGKPPYSDIHPMRAIFMI--------PN-------KPPPTLSDP 222 (256)
T ss_pred cccCCccccCHHHHhcCCCCchhhHHHHHHHHHHHHhCCCCCCCcchhhhhhhh--------cc-------CCCCCCCch
Confidence 344788999999999889999999999999999999999998654221110000 00 000001112
Q ss_pred HHHHHHHHHHHHHccccCCCCCCCHHhHHH
Q 003836 742 VTMLHRFVMVAFWCIQEDPSHRPTMRKVTQ 771 (792)
Q Consensus 742 ~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~ 771 (792)
......+.+++.+||+.+|++|||++||++
T Consensus 223 ~~~~~~~~~~i~~~l~~~P~~Rps~~~il~ 252 (256)
T cd06612 223 EKWSPEFNDFVKKCLVKDPEERPSAIQLLQ 252 (256)
T ss_pred hhcCHHHHHHHHHHHhcChhhCcCHHHHhc
Confidence 234567889999999999999999999987
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a |
| >cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-34 Score=297.47 Aligned_cols=246 Identities=23% Similarity=0.326 Sum_probs=198.0
Q ss_pred hhhhhcCccccceEEEeeecCCCceEEEEEEccccc--ccchHHHHHHHHHhcccCCCCcccccceecc-CCceEEEEEe
Q 003836 504 GFKEELGRGAFGTVYKGFVNMGSSNHVAVKKLNSVF--QDSEKEFKAEVNGIGQTHHKNLVRLLGYCDE-GQNRLLVYEF 580 (792)
Q Consensus 504 ~~~~~lG~G~~g~Vy~g~~~~~~~~~vavK~~~~~~--~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~-~~~~~lV~E~ 580 (792)
.+.+.||+|++|.||+++.. .+++.+++|++.... ....+.+.+|++++++++|+|++++++.+.. ....++||||
T Consensus 3 ~~~~~lg~g~~~~v~~~~~~-~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e~ 81 (257)
T cd08223 3 CFVRVVGKGSYGEVSLVRHR-TDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAYRESWEGEDGLLYIVMGF 81 (257)
T ss_pred eEEEEecCCCCeEEEEEEEc-CCCcEEEEEEEehhhcCHHHHHHHHHHHHHHHhCCCCCeeeeeeeecCCCCEEEEEecc
Confidence 45678999999999999764 446789999986432 2345678999999999999999999998764 4467899999
Q ss_pred ccCCCccccccCC--CCCchhHHHHHHHHHHHHHHHHhhccCCCeEecCCCCCcEEEcCCCCeEEeecCCCccccCCCCC
Q 003836 581 MSNGTVASFLFGD--SKPNWKLRTEIAMGIAGGLFYLHEECCTQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLDQSH 658 (792)
Q Consensus 581 ~~~gsL~~~l~~~--~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dikp~NILl~~~~~~kl~Dfg~a~~~~~~~~~ 658 (792)
+++++|.+++... ..+++.++..++.|++.||+|||+. +|+|+||||+||+++.++.++|+|||++........
T Consensus 82 ~~~~~l~~~l~~~~~~~l~~~~~~~~~~~l~~~l~~lH~~---~i~H~di~p~nil~~~~~~~~l~df~~~~~~~~~~~- 157 (257)
T cd08223 82 CEGGDLYHKLKEQKGKLLPENQVVEWFVQIAMALQYLHEK---HILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQCD- 157 (257)
T ss_pred cCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCchhEEEecCCcEEEecccceEEecccCC-
Confidence 9999999998753 4589999999999999999999998 999999999999999999999999999987643322
Q ss_pred ccccccccCCcccccccccCCCCcccceehHHHHHHHHHhcCcCCCcchhhhhhhhHHHHHHHhhcccchhHhhhchhcc
Q 003836 659 TNTAIRGTKGYVAPEWFRNMPITVKVDVYSYGVLLLEIICLRRNIDNEISKVDKAILTDWAYDRYQERTLEALVENDLEA 738 (792)
Q Consensus 659 ~~~~~~gt~~y~aPE~~~~~~~~~k~DV~S~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 738 (792)
......+++.|+|||.+.+..++.++||||||++++||++|+.||........ ... +... ...
T Consensus 158 ~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~-------~~~---------~~~~-~~~ 220 (257)
T cd08223 158 MASTLIGTPYYMSPELFSNKPYNYKSDVWALGCCVYEMATLKHAFNAKDMNSL-------VYR---------IIEG-KLP 220 (257)
T ss_pred ccccccCCcCccChhHhcCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCHHHH-------HHH---------HHhc-CCC
Confidence 22344588999999999999999999999999999999999999864321100 000 0000 011
Q ss_pred cCCHHHHHHHHHHHHHccccCCCCCCCHHhHHH
Q 003836 739 MNNVTMLHRFVMVAFWCIQEDPSHRPTMRKVTQ 771 (792)
Q Consensus 739 ~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~ 771 (792)
..+......+.+++.+|++.+|++||++.++++
T Consensus 221 ~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~ 253 (257)
T cd08223 221 PMPKDYSPELGELIATMLSKRPEKRPSVKSILR 253 (257)
T ss_pred CCccccCHHHHHHHHHHhccCcccCCCHHHHhc
Confidence 123345577899999999999999999999987
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. |
| >cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-34 Score=301.17 Aligned_cols=252 Identities=23% Similarity=0.372 Sum_probs=195.7
Q ss_pred hhhhcCccccceEEEeeecC--CCceEEEEEEccccc--ccchHHHHHHHHHhcccCCCCcccccceeccCC------ce
Q 003836 505 FKEELGRGAFGTVYKGFVNM--GSSNHVAVKKLNSVF--QDSEKEFKAEVNGIGQTHHKNLVRLLGYCDEGQ------NR 574 (792)
Q Consensus 505 ~~~~lG~G~~g~Vy~g~~~~--~~~~~vavK~~~~~~--~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~------~~ 574 (792)
+.+.||+|+||.||+|.+.. +.++.+|||++.... ....+++.+|++++++++||||+++++++...+ ..
T Consensus 3 ~~~~ig~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~ 82 (273)
T cd05074 3 LGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVIKLIGVSLRSRAKGRLPIP 82 (273)
T ss_pred chhcccCCCCCCEEeeEeeccCCCceEEEEEEeccccCChHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCCCCcccce
Confidence 45689999999999997643 346789999987532 234567899999999999999999999886542 24
Q ss_pred EEEEEeccCCCccccccCC------CCCchhHHHHHHHHHHHHHHHHhhccCCCeEecCCCCCcEEEcCCCCeEEeecCC
Q 003836 575 LLVYEFMSNGTVASFLFGD------SKPNWKLRTEIAMGIAGGLFYLHEECCTQIIHCDIKPQNILLDDHYNARISDFGL 648 (792)
Q Consensus 575 ~lV~E~~~~gsL~~~l~~~------~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dikp~NILl~~~~~~kl~Dfg~ 648 (792)
++++||+++|+|..++... ..+++....+++.||+.||+|||+. +|+|+||||+||++++++.+||+|||+
T Consensus 83 ~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~---~i~H~dikp~nili~~~~~~kl~dfg~ 159 (273)
T cd05074 83 MVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLSSK---NFIHRDLAARNCMLNENMTVCVADFGL 159 (273)
T ss_pred EEEEecCCCCcHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhC---CEeecccchhhEEEcCCCCEEECcccc
Confidence 7889999999998887422 2468888999999999999999998 999999999999999999999999999
Q ss_pred CccccCCCCC-ccccccccCCcccccccccCCCCcccceehHHHHHHHHHh-cCcCCCcchhhhhhhhHHHHHHHhhccc
Q 003836 649 AKLLTLDQSH-TNTAIRGTKGYVAPEWFRNMPITVKVDVYSYGVLLLEIIC-LRRNIDNEISKVDKAILTDWAYDRYQER 726 (792)
Q Consensus 649 a~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~k~DV~S~Gv~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 726 (792)
++........ ......+++.|++||.+....++.++||||||+++|||++ |+.||....... +..+ ....
T Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~sDi~slG~il~el~~~g~~p~~~~~~~~----~~~~----~~~~ 231 (273)
T cd05074 160 SKKIYSGDYYRQGCASKLPVKWLALESLADNVYTTHSDVWAFGVTMWEIMTRGQTPYAGVENSE----IYNY----LIKG 231 (273)
T ss_pred cccccCCcceecCCCccCchhhcCHhHHhcCccchhhhhHHHHHHHHHHhhCCCCCCCCCCHHH----HHHH----HHcC
Confidence 9876433221 1122335678999999998889999999999999999999 778875432210 0000 0000
Q ss_pred chhHhhhchhcccCCHHHHHHHHHHHHHccccCCCCCCCHHhHHHHhccC
Q 003836 727 TLEALVENDLEAMNNVTMLHRFVMVAFWCIQEDPSHRPTMRKVTQMLEGV 776 (792)
Q Consensus 727 ~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~L~~~ 776 (792)
.....+...+..+.+++.+||+.+|++||++.|+++.|+++
T Consensus 232 ---------~~~~~~~~~~~~~~~l~~~~l~~~p~~Rps~~~~~~~l~~~ 272 (273)
T cd05074 232 ---------NRLKQPPDCLEDVYELMCQCWSPEPKCRPSFQHLRDQLELI 272 (273)
T ss_pred ---------CcCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence 00011123456889999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac |
| >cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-34 Score=306.40 Aligned_cols=248 Identities=24% Similarity=0.332 Sum_probs=200.5
Q ss_pred hhhhhhcCccccceEEEeeecCCCceEEEEEEcccccccchHHHHHHHHHhcccCCCCcccccceeccCCceEEEEEecc
Q 003836 503 RGFKEELGRGAFGTVYKGFVNMGSSNHVAVKKLNSVFQDSEKEFKAEVNGIGQTHHKNLVRLLGYCDEGQNRLLVYEFMS 582 (792)
Q Consensus 503 ~~~~~~lG~G~~g~Vy~g~~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~lV~E~~~ 582 (792)
+.+.+.||+|++|.||++.. ..+++.||+|.+........+.+.+|+.+++.++|+||+++++++..++..++||||++
T Consensus 21 y~~~~~lg~g~~g~v~~~~~-~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~ 99 (297)
T cd06656 21 YTRFEKIGQGASGTVYTAID-IATGQEVAIKQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLA 99 (297)
T ss_pred ceeeeeeccCCCeEEEEEEE-CCCCCEEEEEEEecCccchHHHHHHHHHHHHhCCCCCEeeEEEEEecCCEEEEeecccC
Confidence 34557899999999999964 34567899999976555566778999999999999999999999999999999999999
Q ss_pred CCCccccccCCCCCchhHHHHHHHHHHHHHHHHhhccCCCeEecCCCCCcEEEcCCCCeEEeecCCCccccCCCCCcccc
Q 003836 583 NGTVASFLFGDSKPNWKLRTEIAMGIAGGLFYLHEECCTQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLDQSHTNTA 662 (792)
Q Consensus 583 ~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dikp~NILl~~~~~~kl~Dfg~a~~~~~~~~~~~~~ 662 (792)
+++|.+++.+ ..+++.++..++.|++.||.|||+. +++|+||||+|||++.++.+||+|||++......... ...
T Consensus 100 ~~~L~~~~~~-~~~~~~~~~~~~~~l~~~L~~LH~~---~i~H~dL~p~Nili~~~~~~~l~Dfg~~~~~~~~~~~-~~~ 174 (297)
T cd06656 100 GGSLTDVVTE-TCMDEGQIAAVCRECLQALDFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSK-RST 174 (297)
T ss_pred CCCHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEECcCccceEccCCccC-cCc
Confidence 9999999854 4578889999999999999999998 9999999999999999999999999998765433221 223
Q ss_pred ccccCCcccccccccCCCCcccceehHHHHHHHHHhcCcCCCcchhhhhhhhHHHHHHHhhcccchhHhhhchhcccCCH
Q 003836 663 IRGTKGYVAPEWFRNMPITVKVDVYSYGVLLLEIICLRRNIDNEISKVDKAILTDWAYDRYQERTLEALVENDLEAMNNV 742 (792)
Q Consensus 663 ~~gt~~y~aPE~~~~~~~~~k~DV~S~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 742 (792)
..+++.|+|||.+.+..++.++|||||||++|++++|+.||........... ...........+.
T Consensus 175 ~~~~~~y~aPE~~~~~~~~~~~Di~slGvil~~l~tg~~pf~~~~~~~~~~~---------------~~~~~~~~~~~~~ 239 (297)
T cd06656 175 MVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYL---------------IATNGTPELQNPE 239 (297)
T ss_pred ccCCccccCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcchheee---------------eccCCCCCCCCcc
Confidence 4578899999999988899999999999999999999999965322110000 0000000011122
Q ss_pred HHHHHHHHHHHHccccCCCCCCCHHhHHH
Q 003836 743 TMLHRFVMVAFWCIQEDPSHRPTMRKVTQ 771 (792)
Q Consensus 743 ~~~~~l~~l~~~Cl~~~p~~RPs~~evl~ 771 (792)
.....+.+++.+||+.+|++||+++++++
T Consensus 240 ~~~~~~~~li~~~l~~~p~~Rps~~~il~ 268 (297)
T cd06656 240 RLSAVFRDFLNRCLEMDVDRRGSAKELLQ 268 (297)
T ss_pred ccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 34566788999999999999999999998
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >PHA03211 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-34 Score=320.14 Aligned_cols=257 Identities=20% Similarity=0.216 Sum_probs=191.1
Q ss_pred hhhhhcCccccceEEEeeecCCCceEEEEEEcccccccchHHHHHHHHHhcccCCCCcccccceeccCCceEEEEEeccC
Q 003836 504 GFKEELGRGAFGTVYKGFVNMGSSNHVAVKKLNSVFQDSEKEFKAEVNGIGQTHHKNLVRLLGYCDEGQNRLLVYEFMSN 583 (792)
Q Consensus 504 ~~~~~lG~G~~g~Vy~g~~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~lV~E~~~~ 583 (792)
.+.+.||+|+||.||++... ..++.||||... ...+.+|++++++++|+|||++++++..++..++|||++.
T Consensus 172 ~i~~~Lg~G~~G~Vy~a~~~-~~~~~vavK~~~------~~~~~~E~~iL~~L~HpnIv~l~~~~~~~~~~~lv~e~~~- 243 (461)
T PHA03211 172 AIHRALTPGSEGCVFESSHP-DYPQRVVVKAGW------YASSVHEARLLRRLSHPAVLALLDVRVVGGLTCLVLPKYR- 243 (461)
T ss_pred EEEEEEccCCCeEEEEEEEC-CCCCEEEEeccc------ccCHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEEEccC-
Confidence 34578999999999999765 446789999642 2346789999999999999999999999999999999995
Q ss_pred CCccccccCC-CCCchhHHHHHHHHHHHHHHHHhhccCCCeEecCCCCCcEEEcCCCCeEEeecCCCccccCCCCC-ccc
Q 003836 584 GTVASFLFGD-SKPNWKLRTEIAMGIAGGLFYLHEECCTQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLDQSH-TNT 661 (792)
Q Consensus 584 gsL~~~l~~~-~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dikp~NILl~~~~~~kl~Dfg~a~~~~~~~~~-~~~ 661 (792)
++|.+++... ..+++..+.+|+.||++||.|||++ +|+||||||+||||+.++.+||+|||+++........ ...
T Consensus 244 ~~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~---gIvHrDLKP~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~ 320 (461)
T PHA03211 244 SDLYTYLGARLRPLGLAQVTAVARQLLSAIDYIHGE---GIIHRDIKTENVLVNGPEDICLGDFGAACFARGSWSTPFHY 320 (461)
T ss_pred CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC---CEEECcCCHHHEEECCCCCEEEcccCCceeccccccccccc
Confidence 6888887654 5689999999999999999999998 9999999999999999999999999999876433222 122
Q ss_pred cccccCCcccccccccCCCCcccceehHHHHHHHHHhcCcCCCcchhh-hh---hhhHHHHHHH-h-----hcc---cch
Q 003836 662 AIRGTKGYVAPEWFRNMPITVKVDVYSYGVLLLEIICLRRNIDNEISK-VD---KAILTDWAYD-R-----YQE---RTL 728 (792)
Q Consensus 662 ~~~gt~~y~aPE~~~~~~~~~k~DV~S~Gv~l~el~tg~~p~~~~~~~-~~---~~~~~~~~~~-~-----~~~---~~~ 728 (792)
...||+.|+|||++.+..++.++|||||||+||||++|..++...... .. ...+...... . +.. ..+
T Consensus 321 ~~~GT~~Y~APE~~~~~~~~~~sDvwSlGviL~El~~g~~~lf~~~~~~~~~~~~~~l~~~i~~~~~~~~~~~~~~~~~l 400 (461)
T PHA03211 321 GIAGTVDTNAPEVLAGDPYTPSVDIWSAGLVIFEAAVHTASLFSASRGDERRPYDAQILRIIRQAQVHVDEFPQHAGSRL 400 (461)
T ss_pred ccCCCcCCcCHHHHcCCCCCchHHHHHHHHHHHHHHHcCCCcccCCcccccCCcHHHHHHHHHhhccccccCCCCcchHH
Confidence 456999999999999999999999999999999999988765322110 00 0000000000 0 000 000
Q ss_pred h-Hhhhc---hhccc--C-----CHHHHHHHHHHHHHccccCCCCCCCHHhHHH
Q 003836 729 E-ALVEN---DLEAM--N-----NVTMLHRFVMVAFWCIQEDPSHRPTMRKVTQ 771 (792)
Q Consensus 729 ~-~~~~~---~~~~~--~-----~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~ 771 (792)
. .+... ..... . .......+.+|+.+||+.||.+|||+.|+++
T Consensus 401 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~DP~~RPsa~elL~ 454 (461)
T PHA03211 401 VSQYRHRAARNRRPAYTRPAWTRYYKLDLDVEYLVCRALTFDGARRPSAAELLR 454 (461)
T ss_pred HHHHHhhhhcccCCccCCcchhhhccccchHHHHHHHHcccChhhCcCHHHHhh
Confidence 0 00000 00000 0 0012346888999999999999999999998
|
|
| >cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-34 Score=308.28 Aligned_cols=194 Identities=21% Similarity=0.339 Sum_probs=158.7
Q ss_pred hhcCccccceEEEeeecC-CCceEEEEEEcccccccchHHHHHHHHHhcccCCCCcccccceec--cCCceEEEEEeccC
Q 003836 507 EELGRGAFGTVYKGFVNM-GSSNHVAVKKLNSVFQDSEKEFKAEVNGIGQTHHKNLVRLLGYCD--EGQNRLLVYEFMSN 583 (792)
Q Consensus 507 ~~lG~G~~g~Vy~g~~~~-~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~--~~~~~~lV~E~~~~ 583 (792)
.+||+|+||+||+|.... ..+..+|+|.+... .....+.+|++++++++||||+++++++. .....++|+||+++
T Consensus 7 ~~lG~G~~g~Vy~~~~~~~~~~~~~a~k~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~~ 84 (317)
T cd07867 7 CKVGRGTYGHVYKAKRKDGKDEKEYALKQIEGT--GISMSACREIALLRELKHPNVIALQKVFLSHSDRKVWLLFDYAEH 84 (317)
T ss_pred eEeccCCCeeEEEEEecCCCccceEEEEEecCC--CCcHHHHHHHHHHHhCCCCCeeeEEEEEeccCCCeEEEEEeeeCC
Confidence 469999999999998643 34578999998653 23356889999999999999999999884 45578899999875
Q ss_pred CCccccccC---------CCCCchhHHHHHHHHHHHHHHHHhhccCCCeEecCCCCCcEEE----cCCCCeEEeecCCCc
Q 003836 584 GTVASFLFG---------DSKPNWKLRTEIAMGIAGGLFYLHEECCTQIIHCDIKPQNILL----DDHYNARISDFGLAK 650 (792)
Q Consensus 584 gsL~~~l~~---------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dikp~NILl----~~~~~~kl~Dfg~a~ 650 (792)
+|.+++.. ...+++..+..++.||+.||.|||+. +|+||||||+|||+ +.++.+||+|||+++
T Consensus 85 -~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~---~ivH~Dlkp~Nil~~~~~~~~~~~kl~DfG~a~ 160 (317)
T cd07867 85 -DLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHAN---WVLHRDLKPANILVMGEGPERGRVKIADMGFAR 160 (317)
T ss_pred -cHHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhC---CEEcCCCCHHHEEEccCCCCCCcEEEeecccee
Confidence 66666532 12478888999999999999999998 99999999999999 566799999999998
Q ss_pred cccCCCCC--ccccccccCCccccccccc-CCCCcccceehHHHHHHHHHhcCcCCCcc
Q 003836 651 LLTLDQSH--TNTAIRGTKGYVAPEWFRN-MPITVKVDVYSYGVLLLEIICLRRNIDNE 706 (792)
Q Consensus 651 ~~~~~~~~--~~~~~~gt~~y~aPE~~~~-~~~~~k~DV~S~Gv~l~el~tg~~p~~~~ 706 (792)
........ ......+|+.|+|||.+.+ ..++.++|||||||++|||+||+.||...
T Consensus 161 ~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~el~tg~~~f~~~ 219 (317)
T cd07867 161 LFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCR 219 (317)
T ss_pred ccCCCcccccccCcceecccccCcHHhcCCCccCcHHHHHhHHHHHHHHHhCCCCcccc
Confidence 76433221 2234568999999999876 45899999999999999999999999643
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as |
| >cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-34 Score=300.30 Aligned_cols=250 Identities=24% Similarity=0.384 Sum_probs=196.8
Q ss_pred hhhcCccccceEEEeeecCCCceEEEEEEccccccc----------chHHHHHHHHHhcccCCCCcccccceeccCCceE
Q 003836 506 KEELGRGAFGTVYKGFVNMGSSNHVAVKKLNSVFQD----------SEKEFKAEVNGIGQTHHKNLVRLLGYCDEGQNRL 575 (792)
Q Consensus 506 ~~~lG~G~~g~Vy~g~~~~~~~~~vavK~~~~~~~~----------~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~ 575 (792)
.+.||+|++|.||+|... .+++.+|+|.++..... ..+.+.+|+.++++++|+|++++++++...+..+
T Consensus 6 ~~~lg~g~~~~vy~~~~~-~~~~~~a~K~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 84 (272)
T cd06629 6 GELIGKGTYGRVYLALNV-TTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHLNIVQYLGFETTEEYLS 84 (272)
T ss_pred cceecccCceEEEEEeec-CCCceeeeeeeechhhhhcccchHHHHHHHHHHHHHHHHHhcCCCCcceEEEEeccCCceE
Confidence 467999999999999653 45678999987532111 1246788999999999999999999999999999
Q ss_pred EEEEeccCCCccccccCCCCCchhHHHHHHHHHHHHHHHHhhccCCCeEecCCCCCcEEEcCCCCeEEeecCCCccccCC
Q 003836 576 LVYEFMSNGTVASFLFGDSKPNWKLRTEIAMGIAGGLFYLHEECCTQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLD 655 (792)
Q Consensus 576 lV~E~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dikp~NILl~~~~~~kl~Dfg~a~~~~~~ 655 (792)
+||||+++++|.+++.+...+++..+..++.||+.||.|||+. +++|+||+|+||+++.++.+||+|||+++.....
T Consensus 85 lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~~~nil~~~~~~~~l~d~~~~~~~~~~ 161 (272)
T cd06629 85 IFLEYVPGGSIGSCLRTYGRFEEQLVRFFTEQVLEGLAYLHSK---GILHRDLKADNLLVDADGICKISDFGISKKSDDI 161 (272)
T ss_pred EEEecCCCCcHHHHHhhccCCCHHHHHHHHHHHHHHHHHHhhC---CeeecCCChhhEEEcCCCeEEEeecccccccccc
Confidence 9999999999999998877889999999999999999999998 9999999999999999999999999999865432
Q ss_pred CCC-ccccccccCCcccccccccCC--CCcccceehHHHHHHHHHhcCcCCCcchhhhhhhhHHHHHHHhhcccchhHhh
Q 003836 656 QSH-TNTAIRGTKGYVAPEWFRNMP--ITVKVDVYSYGVLLLEIICLRRNIDNEISKVDKAILTDWAYDRYQERTLEALV 732 (792)
Q Consensus 656 ~~~-~~~~~~gt~~y~aPE~~~~~~--~~~k~DV~S~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 732 (792)
... ......++..|+|||.+.... ++.++||||||+++||+++|..||......... ..... ...
T Consensus 162 ~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~-------~~~~~-~~~---- 229 (272)
T cd06629 162 YDNDQNMSMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDEEAIAAM-------FKLGN-KRS---- 229 (272)
T ss_pred ccccccccccCCccccCHHHhccccCCCCccchhHHHHHHHHHHHhCCCCCcCcchHHHH-------HHhhc-ccc----
Confidence 221 123345788999999987654 889999999999999999999998543221100 00000 000
Q ss_pred hchhcccCCHHHHHHHHHHHHHccccCCCCCCCHHhHHH
Q 003836 733 ENDLEAMNNVTMLHRFVMVAFWCIQEDPSHRPTMRKVTQ 771 (792)
Q Consensus 733 ~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~ 771 (792)
............+..+.+++.+||+.+|++||++++|++
T Consensus 230 ~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~ 268 (272)
T cd06629 230 APPIPPDVSMNLSPVALDFLNACFTINPDNRPTARELLQ 268 (272)
T ss_pred CCcCCccccccCCHHHHHHHHHHhcCChhhCCCHHHHhh
Confidence 000011111234578889999999999999999999987
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte |
| >cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-34 Score=298.81 Aligned_cols=247 Identities=21% Similarity=0.282 Sum_probs=198.9
Q ss_pred hhhhhcCccccceEEEeeecCCCceEEEEEEcccc-cccchHHHHHHHHHhcccCCCCcccccceeccCCceEEEEEecc
Q 003836 504 GFKEELGRGAFGTVYKGFVNMGSSNHVAVKKLNSV-FQDSEKEFKAEVNGIGQTHHKNLVRLLGYCDEGQNRLLVYEFMS 582 (792)
Q Consensus 504 ~~~~~lG~G~~g~Vy~g~~~~~~~~~vavK~~~~~-~~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~lV~E~~~ 582 (792)
.+.+.||+|+||.||++... .+++.+|+|.++.. .....+.+.+|+.++++++|+||+++++.+.++...++||||++
T Consensus 3 ~~~~~lg~g~~g~v~~~~~~-~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 81 (255)
T cd08219 3 NVLRVVGEGSFGRALLVQHV-NSDQKYAMKEIRLPKSSSAVEDSRKEAVLLAKMKHPNIVAFKESFEADGHLYIVMEYCD 81 (255)
T ss_pred eEEEEeeccCCeEEEEEEEc-CCCceEEEEEEEcCcchHHHHHHHHHHHHHHhCCCCCcceEEEEEEECCEEEEEEeeCC
Confidence 34578999999999999754 45678999988643 23345678899999999999999999999999999999999999
Q ss_pred CCCccccccCC--CCCchhHHHHHHHHHHHHHHHHhhccCCCeEecCCCCCcEEEcCCCCeEEeecCCCccccCCCCCcc
Q 003836 583 NGTVASFLFGD--SKPNWKLRTEIAMGIAGGLFYLHEECCTQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLDQSHTN 660 (792)
Q Consensus 583 ~gsL~~~l~~~--~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dikp~NILl~~~~~~kl~Dfg~a~~~~~~~~~~~ 660 (792)
+++|.+++... ..+++.....++.||+.||.|||+. +|+|+||||+||++++++.++|+|||.++....... ..
T Consensus 82 ~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~---~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~-~~ 157 (255)
T cd08219 82 GGDLMQKIKLQRGKLFPEDTILQWFVQMCLGVQHIHEK---RVLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPGA-YA 157 (255)
T ss_pred CCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHhhC---CcccCCCCcceEEECCCCcEEEcccCcceeeccccc-cc
Confidence 99999988643 4578899999999999999999998 999999999999999999999999999986643222 22
Q ss_pred ccccccCCcccccccccCCCCcccceehHHHHHHHHHhcCcCCCcchhhhhhhhHHHHHHHhhcccchhHhhhchhcccC
Q 003836 661 TAIRGTKGYVAPEWFRNMPITVKVDVYSYGVLLLEIICLRRNIDNEISKVDKAILTDWAYDRYQERTLEALVENDLEAMN 740 (792)
Q Consensus 661 ~~~~gt~~y~aPE~~~~~~~~~k~DV~S~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 740 (792)
....+++.|+|||.+.+..++.++||||||+++|+|++|+.||........ . . ...... ....
T Consensus 158 ~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~~---~----~-~~~~~~---------~~~~ 220 (255)
T cd08219 158 CTYVGTPYYVPPEIWENMPYNNKSDIWSLGCILYELCTLKHPFQANSWKNL---I----L-KVCQGS---------YKPL 220 (255)
T ss_pred ccccCCccccCHHHHccCCcCchhhhhhhchhheehhhccCCCCCCCHHHH---H----H-HHhcCC---------CCCC
Confidence 234588899999999988999999999999999999999999975422110 0 0 000000 1111
Q ss_pred CHHHHHHHHHHHHHccccCCCCCCCHHhHHHH
Q 003836 741 NVTMLHRFVMVAFWCIQEDPSHRPTMRKVTQM 772 (792)
Q Consensus 741 ~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~ 772 (792)
+...+..+.+++.+||+.+|++||++.+|+..
T Consensus 221 ~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~ 252 (255)
T cd08219 221 PSHYSYELRSLIKQMFKRNPRSRPSATTILSR 252 (255)
T ss_pred CcccCHHHHHHHHHHHhCCcccCCCHHHHhhc
Confidence 22344568899999999999999999999864
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati |
| >cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-34 Score=297.13 Aligned_cols=247 Identities=22% Similarity=0.318 Sum_probs=201.1
Q ss_pred hhhhhcCccccceEEEeeecCCCceEEEEEEcccc--cccchHHHHHHHHHhcccCCCCcccccceeccCCceEEEEEec
Q 003836 504 GFKEELGRGAFGTVYKGFVNMGSSNHVAVKKLNSV--FQDSEKEFKAEVNGIGQTHHKNLVRLLGYCDEGQNRLLVYEFM 581 (792)
Q Consensus 504 ~~~~~lG~G~~g~Vy~g~~~~~~~~~vavK~~~~~--~~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~lV~E~~ 581 (792)
.+.+.||.|+||.||.++.. .+++.+++|++... .....+++.+|++++++++|+||+++++++.+.+..+++|||+
T Consensus 3 ~~~~~ig~g~~g~v~~~~~~-~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~~~e~~ 81 (256)
T cd08221 3 IPIRVLGKGAFGEATLYRRT-EDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAYYNHFMDDNTLLIEMEYA 81 (256)
T ss_pred eEeeEecccCCceEEEEEEc-CCCcEEEEEEEeecccchhHHHHHHHHHHHHHhCCCCCeeEEEeEEecCCeEEEEEEec
Confidence 45678999999999988754 45678999987643 2344567899999999999999999999999999999999999
Q ss_pred cCCCccccccCC--CCCchhHHHHHHHHHHHHHHHHhhccCCCeEecCCCCCcEEEcCCCCeEEeecCCCccccCCCCCc
Q 003836 582 SNGTVASFLFGD--SKPNWKLRTEIAMGIAGGLFYLHEECCTQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLDQSHT 659 (792)
Q Consensus 582 ~~gsL~~~l~~~--~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dikp~NILl~~~~~~kl~Dfg~a~~~~~~~~~~ 659 (792)
++++|.+++... ..+++.++..++.|+++||.|||+. +++|+||+|+||++++++.+||+|||+++....... .
T Consensus 82 ~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~dl~p~ni~~~~~~~~kl~d~~~~~~~~~~~~-~ 157 (256)
T cd08221 82 NGGTLYDKIVRQKGQLFEEEMVLWYLFQIVSAVSYIHKA---GILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEYS-M 157 (256)
T ss_pred CCCcHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhC---CccccCCChHhEEEeCCCCEEECcCcceEEcccccc-c
Confidence 999999999765 4578999999999999999999998 999999999999999999999999999987644332 2
Q ss_pred cccccccCCcccccccccCCCCcccceehHHHHHHHHHhcCcCCCcchhhhhhhhHHHHHHHhhcccchhHhhhchhccc
Q 003836 660 NTAIRGTKGYVAPEWFRNMPITVKVDVYSYGVLLLEIICLRRNIDNEISKVDKAILTDWAYDRYQERTLEALVENDLEAM 739 (792)
Q Consensus 660 ~~~~~gt~~y~aPE~~~~~~~~~k~DV~S~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 739 (792)
.....+++.|+|||.+.+..++.++||||||+++|||++|+.||........ . ..+..... ..
T Consensus 158 ~~~~~~~~~y~ape~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~~~-------~---------~~~~~~~~-~~ 220 (256)
T cd08221 158 AETVVGTPYYMSPELCQGVKYNFKSDIWALGCVLYELLTLKRTFDATNPLNL-------V---------VKIVQGNY-TP 220 (256)
T ss_pred ccccCCCccccCHhhcCCCCCCCcchhHHHHHHHHHHHHCCCCCCCCCHHHH-------H---------HHHHcCCC-CC
Confidence 2345589999999999888899999999999999999999999865322110 0 00000111 11
Q ss_pred CCHHHHHHHHHHHHHccccCCCCCCCHHhHHHH
Q 003836 740 NNVTMLHRFVMVAFWCIQEDPSHRPTMRKVTQM 772 (792)
Q Consensus 740 ~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~ 772 (792)
.+.....++.+++.+||+.+|++||+++++++.
T Consensus 221 ~~~~~~~~~~~~i~~~l~~~p~~R~s~~~ll~~ 253 (256)
T cd08221 221 VVSVYSSELISLVHSLLQQDPEKRPTADEVLDQ 253 (256)
T ss_pred CccccCHHHHHHHHHHcccCcccCCCHHHHhhC
Confidence 123345678899999999999999999999985
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa |
| >cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-34 Score=299.92 Aligned_cols=247 Identities=24% Similarity=0.343 Sum_probs=198.0
Q ss_pred hhhhcCccccceEEEeeecCCCceEEEEEEcccccc------cchHHHHHHHHHhcccCCCCcccccceeccCCceEEEE
Q 003836 505 FKEELGRGAFGTVYKGFVNMGSSNHVAVKKLNSVFQ------DSEKEFKAEVNGIGQTHHKNLVRLLGYCDEGQNRLLVY 578 (792)
Q Consensus 505 ~~~~lG~G~~g~Vy~g~~~~~~~~~vavK~~~~~~~------~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~lV~ 578 (792)
..+.||+|+||.||+|... +++.+|+|.+..... .....+.+|++++++++|+||+++++++.+.+..++|+
T Consensus 4 ~~~~ig~g~~~~v~~~~~~--~~~~~avk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 81 (265)
T cd06631 4 KGEVLGKGAYGTVYCGLTN--QGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQYLGTCLDDNTISIFM 81 (265)
T ss_pred ccceEeccCCeEEEEEEEc--CCCeEEEEEeecCccchhhHHHHHHHHHHHHHHHHhcCCCCEeeEeeEeecCCeEEEEE
Confidence 3467999999999999753 456899998864321 12356889999999999999999999999999999999
Q ss_pred EeccCCCccccccCCCCCchhHHHHHHHHHHHHHHHHhhccCCCeEecCCCCCcEEEcCCCCeEEeecCCCccccCCC--
Q 003836 579 EFMSNGTVASFLFGDSKPNWKLRTEIAMGIAGGLFYLHEECCTQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLDQ-- 656 (792)
Q Consensus 579 E~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dikp~NILl~~~~~~kl~Dfg~a~~~~~~~-- 656 (792)
||+++++|.+++.+...+++..+..++.|++.||+|||+. +|+|+||+|+||++++++.+||+|||+++......
T Consensus 82 e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~~ 158 (265)
T cd06631 82 EFVPGGSISSILNRFGPLPEPVFCKYTKQILDGVAYLHNN---CVVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVGLH 158 (265)
T ss_pred ecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCcCHHhEEECCCCeEEeccchhhHhhhhcccc
Confidence 9999999999998777788999999999999999999998 99999999999999999999999999988653211
Q ss_pred ---CCccccccccCCcccccccccCCCCcccceehHHHHHHHHHhcCcCCCcchhhhhhhhHHHHHHHhhcccchhHhhh
Q 003836 657 ---SHTNTAIRGTKGYVAPEWFRNMPITVKVDVYSYGVLLLEIICLRRNIDNEISKVDKAILTDWAYDRYQERTLEALVE 733 (792)
Q Consensus 657 ---~~~~~~~~gt~~y~aPE~~~~~~~~~k~DV~S~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 733 (792)
........++..|+|||.+.+..++.++||||||++++||++|+.||............ . . .
T Consensus 159 ~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~------~-~--------~ 223 (265)
T cd06631 159 GTHSNMLKSMHGTPYWMAPEVINESGYGRKSDIWSIGCTVFEMATGKPPLASMDRLAAMFYI------G-A--------H 223 (265)
T ss_pred ccccccccccCCCccccChhhhcCCCCcchhhHHHHHHHHHHHHhCCCccccCChHHHHHHh------h-h--------c
Confidence 11122345889999999999989999999999999999999999999653221110000 0 0 0
Q ss_pred chhcccCCHHHHHHHHHHHHHccccCCCCCCCHHhHHH
Q 003836 734 NDLEAMNNVTMLHRFVMVAFWCIQEDPSHRPTMRKVTQ 771 (792)
Q Consensus 734 ~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~ 771 (792)
.......+.....++.+++.+||+.+|++||++.|+++
T Consensus 224 ~~~~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~ 261 (265)
T cd06631 224 RGLMPRLPDSFSAAAIDFVTSCLTRDQHERPSALQLLR 261 (265)
T ss_pred cCCCCCCCCCCCHHHHHHHHHHhcCCcccCCCHHHHhc
Confidence 00011122234567889999999999999999999986
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. |
| >cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-33 Score=298.49 Aligned_cols=247 Identities=25% Similarity=0.361 Sum_probs=201.3
Q ss_pred hhhhhhcCccccceEEEeeecCCCceEEEEEEccccc-ccchHHHHHHHHHhcccCCCCcccccceeccCCceEEEEEec
Q 003836 503 RGFKEELGRGAFGTVYKGFVNMGSSNHVAVKKLNSVF-QDSEKEFKAEVNGIGQTHHKNLVRLLGYCDEGQNRLLVYEFM 581 (792)
Q Consensus 503 ~~~~~~lG~G~~g~Vy~g~~~~~~~~~vavK~~~~~~-~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~lV~E~~ 581 (792)
+...+.||.|+||.||+|... ..+..+|+|.+.... ......+.+|+.++++++|+||+++++++.++...++||||+
T Consensus 6 y~~~~~lg~g~~~~vy~~~~~-~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 84 (277)
T cd06640 6 FTKLERIGKGSFGEVFKGIDN-RTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKGTKLWIIMEYL 84 (277)
T ss_pred hhhhhhcccCCCeEEEEEEEc-cCCEEEEEEEEeccccHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEEecC
Confidence 334577999999999999754 446789999887532 344567899999999999999999999999999999999999
Q ss_pred cCCCccccccCCCCCchhHHHHHHHHHHHHHHHHhhccCCCeEecCCCCCcEEEcCCCCeEEeecCCCccccCCCCCccc
Q 003836 582 SNGTVASFLFGDSKPNWKLRTEIAMGIAGGLFYLHEECCTQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLDQSHTNT 661 (792)
Q Consensus 582 ~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dikp~NILl~~~~~~kl~Dfg~a~~~~~~~~~~~~ 661 (792)
++++|.+++.. ..+++.....++.|++.||+|||+. +++|+||+|+||+++.++.++|+|||++........ ...
T Consensus 85 ~~~~L~~~i~~-~~l~~~~~~~~~~~l~~~l~~lh~~---~ivH~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~~-~~~ 159 (277)
T cd06640 85 GGGSALDLLRA-GPFDEFQIATMLKEILKGLDYLHSE---KKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQI-KRN 159 (277)
T ss_pred CCCcHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhC---CccCcCCChhhEEEcCCCCEEEcccccceeccCCcc-ccc
Confidence 99999999864 4678889999999999999999998 999999999999999999999999999987643322 222
Q ss_pred cccccCCcccccccccCCCCcccceehHHHHHHHHHhcCcCCCcchhhhhhhhHHHHHHHhhcccchhHhhhchhcccCC
Q 003836 662 AIRGTKGYVAPEWFRNMPITVKVDVYSYGVLLLEIICLRRNIDNEISKVDKAILTDWAYDRYQERTLEALVENDLEAMNN 741 (792)
Q Consensus 662 ~~~gt~~y~aPE~~~~~~~~~k~DV~S~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 741 (792)
...++..|+|||.+.+..++.++||||||+++|||++|+.|+......... ..+.........
T Consensus 160 ~~~~~~~y~apE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~-----------------~~~~~~~~~~~~ 222 (277)
T cd06640 160 TFVGTPFWMAPEVIQQSAYDSKADIWSLGITAIELAKGEPPNSDMHPMRVL-----------------FLIPKNNPPTLT 222 (277)
T ss_pred cccCcccccCHhHhccCCCccHHHHHHHHHHHHHHHHCCCCCCCcChHhHh-----------------hhhhcCCCCCCc
Confidence 345788999999998888999999999999999999999998654321100 000111112233
Q ss_pred HHHHHHHHHHHHHccccCCCCCCCHHhHHHH
Q 003836 742 VTMLHRFVMVAFWCIQEDPSHRPTMRKVTQM 772 (792)
Q Consensus 742 ~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~ 772 (792)
...+..+.+++.+||+.+|++||+++++++.
T Consensus 223 ~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 253 (277)
T cd06640 223 GEFSKPFKEFIDACLNKDPSFRPTAKELLKH 253 (277)
T ss_pred hhhhHHHHHHHHHHcccCcccCcCHHHHHhC
Confidence 4566788999999999999999999999874
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter |
| >cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-34 Score=297.13 Aligned_cols=243 Identities=29% Similarity=0.442 Sum_probs=194.9
Q ss_pred hhhhhhcCccccceEEEeeecCCCceEEEEEEcccccccchHHHHHHHHHhcccCCCCcccccceeccCCceEEEEEecc
Q 003836 503 RGFKEELGRGAFGTVYKGFVNMGSSNHVAVKKLNSVFQDSEKEFKAEVNGIGQTHHKNLVRLLGYCDEGQNRLLVYEFMS 582 (792)
Q Consensus 503 ~~~~~~lG~G~~g~Vy~g~~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~lV~E~~~ 582 (792)
+.+.+.||+|+||.||++.. .++.+|+|+++.. .....+.+|+.++++++|+|++++++++... ..++||||++
T Consensus 8 ~~~~~~lg~g~~g~v~~~~~---~~~~~~iK~~~~~--~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-~~~~v~e~~~ 81 (254)
T cd05083 8 LTLGEIIGEGEFGAVLQGEY---TGQKVAVKNIKCD--VTAQAFLEETAVMTKLHHKNLVRLLGVILHN-GLYIVMELMS 81 (254)
T ss_pred ceeeeeeccCCCCceEeccc---CCCceEEEeecCc--chHHHHHHHHHHHHhCCCCCcCeEEEEEcCC-CcEEEEECCC
Confidence 45567899999999999864 3567999998653 2346789999999999999999999998764 4799999999
Q ss_pred CCCccccccCC--CCCchhHHHHHHHHHHHHHHHHhhccCCCeEecCCCCCcEEEcCCCCeEEeecCCCccccCCCCCcc
Q 003836 583 NGTVASFLFGD--SKPNWKLRTEIAMGIAGGLFYLHEECCTQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLDQSHTN 660 (792)
Q Consensus 583 ~gsL~~~l~~~--~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dikp~NILl~~~~~~kl~Dfg~a~~~~~~~~~~~ 660 (792)
+++|.+++... ..+++..+..++.|++.||.|||+. +++||||||+||+++.++.+||+|||+++......
T Consensus 82 ~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~al~~lH~~---~~~H~dl~p~nili~~~~~~kl~Dfg~~~~~~~~~---- 154 (254)
T cd05083 82 KGNLVNFLRTRGRALVSVIQLLQFSLDVAEGMEYLESK---KLVHRDLAARNILVSEDGVAKVSDFGLARVGSMGV---- 154 (254)
T ss_pred CCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccccCcceEEEcCCCcEEECCCccceeccccC----
Confidence 99999999754 3578899999999999999999998 99999999999999999999999999987643221
Q ss_pred ccccccCCcccccccccCCCCcccceehHHHHHHHHHh-cCcCCCcchhhhhhhhHHHHHHHhhcccchhHhhhchhccc
Q 003836 661 TAIRGTKGYVAPEWFRNMPITVKVDVYSYGVLLLEIIC-LRRNIDNEISKVDKAILTDWAYDRYQERTLEALVENDLEAM 739 (792)
Q Consensus 661 ~~~~gt~~y~aPE~~~~~~~~~k~DV~S~Gv~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 739 (792)
.....+..|+|||.+.+..++.++||||||+++|||++ |+.||......... . .+.......
T Consensus 155 ~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~--------~---------~~~~~~~~~ 217 (254)
T cd05083 155 DNSKLPVKWTAPEALKHKKFSSKSDVWSYGVLLWEVFSYGRAPYPKMSLKEVK--------E---------CVEKGYRME 217 (254)
T ss_pred CCCCCCceecCHHHhccCCcCchhhHHHHHHHHHHHHhCCCCCCccCCHHHHH--------H---------HHhCCCCCC
Confidence 12234568999999998899999999999999999998 88888644221100 0 001111111
Q ss_pred CCHHHHHHHHHHHHHccccCCCCCCCHHhHHHHhcc
Q 003836 740 NNVTMLHRFVMVAFWCIQEDPSHRPTMRKVTQMLEG 775 (792)
Q Consensus 740 ~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~L~~ 775 (792)
.+...+..+.+++.+||+.+|++||+++++++.|++
T Consensus 218 ~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~ 253 (254)
T cd05083 218 PPEGCPADVYVLMTSCWETEPKKRPSFHKLREKLEK 253 (254)
T ss_pred CCCcCCHHHHHHHHHHcCCChhhCcCHHHHHHHHcc
Confidence 122345678899999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki |
| >cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-34 Score=304.14 Aligned_cols=262 Identities=22% Similarity=0.246 Sum_probs=197.1
Q ss_pred hhhhcCccccceEEEeeecCCCceEEEEEEccccccc-----chHHHHHHHHHhcccCCCCcccccceeccCCceEEEEE
Q 003836 505 FKEELGRGAFGTVYKGFVNMGSSNHVAVKKLNSVFQD-----SEKEFKAEVNGIGQTHHKNLVRLLGYCDEGQNRLLVYE 579 (792)
Q Consensus 505 ~~~~lG~G~~g~Vy~g~~~~~~~~~vavK~~~~~~~~-----~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~lV~E 579 (792)
+.+.||+|++|.||+|... .+++.|++|++...... ....+.+|++++++++|+||+++++++.+.+..++|||
T Consensus 4 ~~~~lg~g~~~~vy~~~~~-~~~~~v~iK~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e 82 (298)
T cd07841 4 KGKKLGEGTYAVVYKARDK-ETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIGLLDVFGHKSNINLVFE 82 (298)
T ss_pred eeeeeeeccccEEEEEEEC-CCCcEEEEEEEeccccccccchhhHHHHHHHHHHhhcCCCCChhhhheeecCCEEEEEEc
Confidence 4567999999999999754 34678999998754322 24567789999999999999999999999999999999
Q ss_pred eccCCCccccccCCC-CCchhHHHHHHHHHHHHHHHHhhccCCCeEecCCCCCcEEEcCCCCeEEeecCCCccccCCCCC
Q 003836 580 FMSNGTVASFLFGDS-KPNWKLRTEIAMGIAGGLFYLHEECCTQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLDQSH 658 (792)
Q Consensus 580 ~~~~gsL~~~l~~~~-~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dikp~NILl~~~~~~kl~Dfg~a~~~~~~~~~ 658 (792)
|+ +++|.+++.... .+++..+..++.||++||+|||+. +|+|+||+|+||+++.++.+||+|||+++.......
T Consensus 83 ~~-~~~L~~~i~~~~~~~~~~~~~~~~~qi~~al~~lH~~---~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~~~- 157 (298)
T cd07841 83 FM-ETDLEKVIKDKSIVLTPADIKSYMLMTLRGLEYLHSN---WILHRDLKPNNLLIASDGVLKLADFGLARSFGSPNR- 157 (298)
T ss_pred cc-CCCHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeecCCChhhEEEcCCCCEEEccceeeeeccCCCc-
Confidence 99 899999997765 789999999999999999999998 999999999999999999999999999987643322
Q ss_pred ccccccccCCccccccccc-CCCCcccceehHHHHHHHHHhcCcCCCcchhhhhhhhHHHHH----HHhhc-ccchhHhh
Q 003836 659 TNTAIRGTKGYVAPEWFRN-MPITVKVDVYSYGVLLLEIICLRRNIDNEISKVDKAILTDWA----YDRYQ-ERTLEALV 732 (792)
Q Consensus 659 ~~~~~~gt~~y~aPE~~~~-~~~~~k~DV~S~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~----~~~~~-~~~~~~~~ 732 (792)
......+++.|+|||.+.+ ..++.++|||||||+++||++|..+|................ ...+. ........
T Consensus 158 ~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~e~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (298)
T cd07841 158 KMTHQVVTRWYRAPELLFGARHYGVGVDMWSVGCIFAELLLRVPFLPGDSDIDQLGKIFEALGTPTEENWPGVTSLPDYV 237 (298)
T ss_pred cccccccceeeeCHHHHhCCCCCCcHHHHHHHHHHHHHHHcCCccccCCccHHHHHHHHHHcCCCchhhhhhcccccccc
Confidence 1222346788999998854 467899999999999999999977775433211110000000 00000 00000000
Q ss_pred hchhccc-----CCHHHHHHHHHHHHHccccCCCCCCCHHhHHHH
Q 003836 733 ENDLEAM-----NNVTMLHRFVMVAFWCIQEDPSHRPTMRKVTQM 772 (792)
Q Consensus 733 ~~~~~~~-----~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~ 772 (792)
....... .....+..+.+++.+||+.+|++|||+.|++++
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~e~l~~ 282 (298)
T cd07841 238 EFKPFPPTPLKQIFPAASDDALDLLQRLLTLNPNKRITARQALEH 282 (298)
T ss_pred cccccCCcchhhhcccccHHHHHHHHHHhcCCcccCcCHHHHhhC
Confidence 0000000 112335788999999999999999999999985
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is |
| >cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-33 Score=300.04 Aligned_cols=250 Identities=24% Similarity=0.339 Sum_probs=198.4
Q ss_pred hhhhhhcCccccceEEEeeecCCCceEEEEEEcccc-cccchHHHHHHHHHhcccCCCCcccccceeccCCceEEEEEec
Q 003836 503 RGFKEELGRGAFGTVYKGFVNMGSSNHVAVKKLNSV-FQDSEKEFKAEVNGIGQTHHKNLVRLLGYCDEGQNRLLVYEFM 581 (792)
Q Consensus 503 ~~~~~~lG~G~~g~Vy~g~~~~~~~~~vavK~~~~~-~~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~lV~E~~ 581 (792)
+++.+.||+|+||.||++... ..++.+|+|.+... .......+.+|+.++++++|+||+++++.+...+..++||||+
T Consensus 3 ~~~~~~ig~g~~g~v~~~~~~-~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~ 81 (286)
T cd06622 3 IEVLDELGKGNYGSVYKVLHR-PTGVTMAMKEIRLELDESKFNQIIMELDILHKAVSPYIVDFYGAFFIEGAVYMCMEYM 81 (286)
T ss_pred hhhhhhhcccCCeEEEEEEEc-CCCcEEEEEEeecccCHHHHHHHHHHHHHHHhcCCCcHHhhhhheecCCeEEEEEeec
Confidence 456688999999999999754 45678999988653 2333467899999999999999999999999999999999999
Q ss_pred cCCCccccccCC---CCCchhHHHHHHHHHHHHHHHHhhccCCCeEecCCCCCcEEEcCCCCeEEeecCCCccccCCCCC
Q 003836 582 SNGTVASFLFGD---SKPNWKLRTEIAMGIAGGLFYLHEECCTQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLDQSH 658 (792)
Q Consensus 582 ~~gsL~~~l~~~---~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dikp~NILl~~~~~~kl~Dfg~a~~~~~~~~~ 658 (792)
++++|..++... ..+++..+..++.|++.||.|||+. .+|+|+||||+||+++.++.+||+|||++......
T Consensus 82 ~~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~--~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~--- 156 (286)
T cd06622 82 DAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKEE--HNIIHRDVKPTNVLVNGNGQVKLCDFGVSGNLVAS--- 156 (286)
T ss_pred CCCCHHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhc--CCEeeCCCCHHHEEECCCCCEEEeecCCcccccCC---
Confidence 999999998763 3689999999999999999999974 38999999999999999999999999999765322
Q ss_pred ccccccccCCcccccccccC------CCCcccceehHHHHHHHHHhcCcCCCcchhhhhhhhHHHHHHHhhcccchhHhh
Q 003836 659 TNTAIRGTKGYVAPEWFRNM------PITVKVDVYSYGVLLLEIICLRRNIDNEISKVDKAILTDWAYDRYQERTLEALV 732 (792)
Q Consensus 659 ~~~~~~gt~~y~aPE~~~~~------~~~~k~DV~S~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 732 (792)
......+++.|+|||.+.+. .++.++|||||||++|||++|+.||.......... .+..+.
T Consensus 157 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~-------------~~~~~~ 223 (286)
T cd06622 157 LAKTNIGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYPPETYANIFA-------------QLSAIV 223 (286)
T ss_pred ccccCCCccCccCcchhcCCCCCccCCCCcccchHhHHHHHHHHHhCCCCCCCcchhhHHH-------------HHHHHh
Confidence 12233578899999998554 35889999999999999999999996532211000 011111
Q ss_pred hchhcccCCHHHHHHHHHHHHHccccCCCCCCCHHhHHHH
Q 003836 733 ENDLEAMNNVTMLHRFVMVAFWCIQEDPSHRPTMRKVTQM 772 (792)
Q Consensus 733 ~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~ 772 (792)
.. .....+.....++.+++.+||+.+|++||+++++++.
T Consensus 224 ~~-~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~ 262 (286)
T cd06622 224 DG-DPPTLPSGYSDDAQDFVAKCLNKIPNRRPTYAQLLEH 262 (286)
T ss_pred hc-CCCCCCcccCHHHHHHHHHHcccCcccCCCHHHHhcC
Confidence 11 1112233466778899999999999999999999974
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-33 Score=289.31 Aligned_cols=248 Identities=23% Similarity=0.284 Sum_probs=206.0
Q ss_pred hhhhcCccccceEEEeeecCCCceEEEEEEccccc---ccchHHHHHHHHHhcccCCCCcccccceeccCCceEEEEEec
Q 003836 505 FKEELGRGAFGTVYKGFVNMGSSNHVAVKKLNSVF---QDSEKEFKAEVNGIGQTHHKNLVRLLGYCDEGQNRLLVYEFM 581 (792)
Q Consensus 505 ~~~~lG~G~~g~Vy~g~~~~~~~~~vavK~~~~~~---~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~lV~E~~ 581 (792)
+.+.||.|.-|+||++.+. ++....|+|++.+.. +....+.+.|-+||+.++||.++.|++.++.++..+||||||
T Consensus 81 llk~LG~GdiG~VyL~~l~-~t~~~fAmKVmdK~~l~~rkKl~Ra~tE~eIL~~lDHPFlPTLYa~fet~~~~cl~meyC 159 (459)
T KOG0610|consen 81 LLKRLGCGDIGTVYLVELR-GTNCLFAMKVMDKESLASRKKLKRAQTEREILSLLDHPFLPTLYASFETDKYSCLVMEYC 159 (459)
T ss_pred HHHHcCCCCceeEEEEEec-CCCceEEEEEecHHHHhhhhHHHHHHHHHHHHHhcCCCccchhhheeeccceeEEEEecC
Confidence 3467999999999999875 455899999998743 344567788999999999999999999999999999999999
Q ss_pred cCCCccccccCC--CCCchhHHHHHHHHHHHHHHHHhhccCCCeEecCCCCCcEEEcCCCCeEEeecCCCccccCC----
Q 003836 582 SNGTVASFLFGD--SKPNWKLRTEIAMGIAGGLFYLHEECCTQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLD---- 655 (792)
Q Consensus 582 ~~gsL~~~l~~~--~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dikp~NILl~~~~~~kl~Dfg~a~~~~~~---- 655 (792)
+||+|...+++. +.+++..+.-++..|+-||+|||-. |||.|||||+||||.++|++-|+||.++......
T Consensus 160 pGGdL~~LrqkQp~~~fse~~aRFYaAEvl~ALEYLHml---GivYRDLKPENILvredGHIMLsDFDLS~~~~~~Pt~~ 236 (459)
T KOG0610|consen 160 PGGDLHSLRQKQPGKRFSESAARFYAAEVLLALEYLHML---GIVYRDLKPENILVREDGHIMLSDFDLSLRCPVSPTLV 236 (459)
T ss_pred CCccHHHHHhhCCCCccchhhHHHHHHHHHHHHHHHHhh---ceeeccCCcceeEEecCCcEEeeeccccccCCCCCeee
Confidence 999999999765 5789999999999999999999998 9999999999999999999999999987543110
Q ss_pred ------------------------------CC---------------------CccccccccCCcccccccccCCCCccc
Q 003836 656 ------------------------------QS---------------------HTNTAIRGTKGYVAPEWFRNMPITVKV 684 (792)
Q Consensus 656 ------------------------------~~---------------------~~~~~~~gt~~y~aPE~~~~~~~~~k~ 684 (792)
.. ......+||-.|+|||++.+...+.++
T Consensus 237 ~s~~~~~~~~~~~~~~~~~s~f~~r~~~~~~~~~k~~~~~~~~~p~~~aep~~~RSnSFVGThEYlAPEvI~G~GHgsAV 316 (459)
T KOG0610|consen 237 KSSSPRSSGSQPSCRSRQPSCFSPRCLSSSKKRKKKDESASRSLPELVAEPTGARSNSFVGTHEYLAPEVIRGEGHGSAV 316 (459)
T ss_pred ccCCCCCCCCCcccccccccccccchhccccccccccccccccchhhhcCCCCccccccccccccccceeeecCCCCchh
Confidence 00 001124699999999999999999999
Q ss_pred ceehHHHHHHHHHhcCcCCCcchhhhhhhhHHHHHHHhhcccchhHhhhchhcccCCHHHHHHHHHHHHHccccCCCCCC
Q 003836 685 DVYSYGVLLLEIICLRRNIDNEISKVDKAILTDWAYDRYQERTLEALVENDLEAMNNVTMLHRFVMVAFWCIQEDPSHRP 764 (792)
Q Consensus 685 DV~S~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RP 764 (792)
|.|+|||+||||+.|..||....... .+..++.+.+.-...++.+..+.+||+..|..||++|.
T Consensus 317 DWWtfGIflYEmLyG~TPFKG~~~~~----------------Tl~NIv~~~l~Fp~~~~vs~~akDLIr~LLvKdP~kRl 380 (459)
T KOG0610|consen 317 DWWTFGIFLYEMLYGTTPFKGSNNKE----------------TLRNIVGQPLKFPEEPEVSSAAKDLIRKLLVKDPSKRL 380 (459)
T ss_pred hHHHHHHHHHHHHhCCCCcCCCCchh----------------hHHHHhcCCCcCCCCCcchhHHHHHHHHHhccChhhhh
Confidence 99999999999999999997654321 12333444444444446778899999999999999999
Q ss_pred C----HHhHHHH
Q 003836 765 T----MRKVTQM 772 (792)
Q Consensus 765 s----~~evl~~ 772 (792)
- +.||.+.
T Consensus 381 g~~rGA~eIK~H 392 (459)
T KOG0610|consen 381 GSKRGAAEIKRH 392 (459)
T ss_pred ccccchHHhhcC
Confidence 8 8888765
|
|
| >cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-34 Score=303.42 Aligned_cols=245 Identities=23% Similarity=0.355 Sum_probs=198.0
Q ss_pred hhcCccccceEEEeeecCCCceEEEEEEcccccccchHHHHHHHHHhcccCCCCcccccceeccCCceEEEEEeccCCCc
Q 003836 507 EELGRGAFGTVYKGFVNMGSSNHVAVKKLNSVFQDSEKEFKAEVNGIGQTHHKNLVRLLGYCDEGQNRLLVYEFMSNGTV 586 (792)
Q Consensus 507 ~~lG~G~~g~Vy~g~~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~lV~E~~~~gsL 586 (792)
..||+|+||.||++... .++..+|+|++........+.+.+|+.++++++|+||+++++.+..++..++||||+++++|
T Consensus 28 ~~lg~g~~g~v~~~~~~-~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~lv~e~~~~~~L 106 (292)
T cd06658 28 IKIGEGSTGIVCIATEK-HTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHENVVDMYNSYLVGDELWVVMEFLEGGAL 106 (292)
T ss_pred hcccCCCCeEEEEEEEC-CCCCEEEEEEEecchHHHHHHHHHHHHHHHhCCCCcHHHHHHheecCCeEEEEEeCCCCCcH
Confidence 56999999999999654 45678999998765555667799999999999999999999999999999999999999999
Q ss_pred cccccCCCCCchhHHHHHHHHHHHHHHHHhhccCCCeEecCCCCCcEEEcCCCCeEEeecCCCccccCCCCCcccccccc
Q 003836 587 ASFLFGDSKPNWKLRTEIAMGIAGGLFYLHEECCTQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLDQSHTNTAIRGT 666 (792)
Q Consensus 587 ~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dikp~NILl~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~gt 666 (792)
.+++.. ..+++..+..++.||+.||+|||+. +|+||||||+||++++++.+||+|||++........ ......++
T Consensus 107 ~~~~~~-~~l~~~~~~~~~~qi~~~l~~LH~~---~ivH~dlkp~Nill~~~~~~kL~dfg~~~~~~~~~~-~~~~~~~~ 181 (292)
T cd06658 107 TDIVTH-TRMNEEQIATVCLSVLRALSYLHNQ---GVIHRDIKSDSILLTSDGRIKLSDFGFCAQVSKEVP-KRKSLVGT 181 (292)
T ss_pred HHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHC---CEeecCCCHHHEEEcCCCCEEEccCcchhhcccccc-cCceeecC
Confidence 998854 4588999999999999999999998 999999999999999999999999999876533222 22234588
Q ss_pred CCcccccccccCCCCcccceehHHHHHHHHHhcCcCCCcchhhhhhhhHHHHHHHhhcccchhHhhhchhcccCCHHHHH
Q 003836 667 KGYVAPEWFRNMPITVKVDVYSYGVLLLEIICLRRNIDNEISKVDKAILTDWAYDRYQERTLEALVENDLEAMNNVTMLH 746 (792)
Q Consensus 667 ~~y~aPE~~~~~~~~~k~DV~S~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 746 (792)
..|+|||.+.+..++.++||||||+++|||++|+.||........ +.. +.......... ......
T Consensus 182 ~~y~aPE~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~---~~~----------~~~~~~~~~~~--~~~~~~ 246 (292)
T cd06658 182 PYWMAPEVISRLPYGTEVDIWSLGIMVIEMIDGEPPYFNEPPLQA---MRR----------IRDNLPPRVKD--SHKVSS 246 (292)
T ss_pred ccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH---HHH----------HHhcCCCcccc--ccccCH
Confidence 999999999888999999999999999999999999865322110 000 00001111111 112345
Q ss_pred HHHHHHHHccccCCCCCCCHHhHHHH
Q 003836 747 RFVMVAFWCIQEDPSHRPTMRKVTQM 772 (792)
Q Consensus 747 ~l~~l~~~Cl~~~p~~RPs~~evl~~ 772 (792)
.+.+++.+|++.+|.+|||++|+++.
T Consensus 247 ~~~~li~~~l~~~P~~Rpt~~~il~~ 272 (292)
T cd06658 247 VLRGFLDLMLVREPSQRATAQELLQH 272 (292)
T ss_pred HHHHHHHHHccCChhHCcCHHHHhhC
Confidence 67889999999999999999999974
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express |
| >cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-34 Score=299.90 Aligned_cols=249 Identities=25% Similarity=0.396 Sum_probs=201.0
Q ss_pred hhhhhcCccccceEEEeeecCCCceEEEEEEccccc-ccchHHHHHHHHHhcccCCCCcccccceeccCCceEEEEEecc
Q 003836 504 GFKEELGRGAFGTVYKGFVNMGSSNHVAVKKLNSVF-QDSEKEFKAEVNGIGQTHHKNLVRLLGYCDEGQNRLLVYEFMS 582 (792)
Q Consensus 504 ~~~~~lG~G~~g~Vy~g~~~~~~~~~vavK~~~~~~-~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~lV~E~~~ 582 (792)
.+.+.||+|++|.||++... .+++.+++|++.... ....+++.+|++++++++|+||+++++.+......++|+||++
T Consensus 4 ~~~~~ig~g~~~~v~~~~~~-~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~ 82 (265)
T cd06605 4 EYLGELGAGNSGVVSKVLHR-PTGKIMAVKTIRLEINEAIQKQILRELDILHKCNSPYIVGFYGAFYNNGDISICMEYMD 82 (265)
T ss_pred hHHHHhcCCCCeEEEEEEEc-CCCcEEEEEEEecccChHHHHHHHHHHHHHHHCCCCchhhhheeeecCCEEEEEEEecC
Confidence 35678999999999999764 456789999987643 3455678999999999999999999999999999999999999
Q ss_pred CCCccccccCC-CCCchhHHHHHHHHHHHHHHHHhh-ccCCCeEecCCCCCcEEEcCCCCeEEeecCCCccccCCCCCcc
Q 003836 583 NGTVASFLFGD-SKPNWKLRTEIAMGIAGGLFYLHE-ECCTQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLDQSHTN 660 (792)
Q Consensus 583 ~gsL~~~l~~~-~~l~~~~~~~i~~~ia~gL~yLH~-~~~~~ivH~dikp~NILl~~~~~~kl~Dfg~a~~~~~~~~~~~ 660 (792)
+++|.+++... ..+++..+.+++.|++.||+|||+ . +++|+||||+||++++++.+||+|||.+.........
T Consensus 83 ~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~---~i~H~dl~~~ni~~~~~~~~~l~d~g~~~~~~~~~~~-- 157 (265)
T cd06605 83 GGSLDKILKEVQGRIPERILGKIAVAVLKGLTYLHEKH---KIIHRDVKPSNILVNSRGQIKLCDFGVSGQLVNSLAK-- 157 (265)
T ss_pred CCcHHHHHHHccCCCCHHHHHHHHHHHHHHHHHHcCCC---CeecCCCCHHHEEECCCCCEEEeecccchhhHHHHhh--
Confidence 99999999776 678899999999999999999999 7 9999999999999999999999999998765432221
Q ss_pred ccccccCCcccccccccCCCCcccceehHHHHHHHHHhcCcCCCcchhhhhhhhHHHHHHHhhcccchhHhhhchhcccC
Q 003836 661 TAIRGTKGYVAPEWFRNMPITVKVDVYSYGVLLLEIICLRRNIDNEISKVDKAILTDWAYDRYQERTLEALVENDLEAMN 740 (792)
Q Consensus 661 ~~~~gt~~y~aPE~~~~~~~~~k~DV~S~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 740 (792)
...++..|+|||.+.+..++.++||||||+++++|++|+.||.......... ... +....... ....
T Consensus 158 -~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~--~~~---------~~~~~~~~-~~~~ 224 (265)
T cd06605 158 -TFVGTSSYMAPERIQGNDYSVKSDIWSLGLSLIELATGRFPYPPENDPPDGI--FEL---------LQYIVNEP-PPRL 224 (265)
T ss_pred -cccCChhccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCccccccccH--HHH---------HHHHhcCC-CCCC
Confidence 1557889999999998899999999999999999999999986542211100 000 01111111 1111
Q ss_pred CHH-HHHHHHHHHHHccccCCCCCCCHHhHHH
Q 003836 741 NVT-MLHRFVMVAFWCIQEDPSHRPTMRKVTQ 771 (792)
Q Consensus 741 ~~~-~~~~l~~l~~~Cl~~~p~~RPs~~evl~ 771 (792)
+.. ....+.+++.+||..+|++|||+.+++.
T Consensus 225 ~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~ 256 (265)
T cd06605 225 PSGKFSPDFQDFVNLCLIKDPRERPSYKELLE 256 (265)
T ss_pred ChhhcCHHHHHHHHHHcCCCchhCcCHHHHhh
Confidence 112 5667889999999999999999999987
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity |
| >cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-34 Score=312.50 Aligned_cols=260 Identities=24% Similarity=0.263 Sum_probs=192.7
Q ss_pred hhhhhhcCccccceEEEeeecCCCceEEEEEEccccc--ccchHHHHHHHHHhcccCCCCcccccceeccC------Cce
Q 003836 503 RGFKEELGRGAFGTVYKGFVNMGSSNHVAVKKLNSVF--QDSEKEFKAEVNGIGQTHHKNLVRLLGYCDEG------QNR 574 (792)
Q Consensus 503 ~~~~~~lG~G~~g~Vy~g~~~~~~~~~vavK~~~~~~--~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~------~~~ 574 (792)
+.+.+.||+|+||.||++... ..++.+|||++.... ....+.+.+|+.+++.++|+||+++++++... ...
T Consensus 26 y~~~~~lg~G~~g~V~~~~~~-~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~~~~~~~~~~~ 104 (364)
T cd07875 26 YQNLKPIGSGAQGIVCAAYDA-ILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDV 104 (364)
T ss_pred eeEEEEeecCCCeEEEEEEEC-CCCcEEEEEEeCccccCchhHHHHHHHHHHHHhcCCCCccccceeecccccccccCeE
Confidence 444578999999999999643 456789999987532 23456788999999999999999999987543 357
Q ss_pred EEEEEeccCCCccccccCCCCCchhHHHHHHHHHHHHHHHHhhccCCCeEecCCCCCcEEEcCCCCeEEeecCCCccccC
Q 003836 575 LLVYEFMSNGTVASFLFGDSKPNWKLRTEIAMGIAGGLFYLHEECCTQIIHCDIKPQNILLDDHYNARISDFGLAKLLTL 654 (792)
Q Consensus 575 ~lV~E~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dikp~NILl~~~~~~kl~Dfg~a~~~~~ 654 (792)
++||||+++ +|.+++. ..+++..+..++.|++.||+|||++ +|+||||||+|||++.++.+||+|||+++....
T Consensus 105 ~lv~e~~~~-~l~~~~~--~~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~ 178 (364)
T cd07875 105 YIVMELMDA-NLCQVIQ--MELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLARTAGT 178 (364)
T ss_pred EEEEeCCCC-CHHHHHH--hcCCHHHHHHHHHHHHHHHHHHhhC---CeecCCCCHHHEEECCCCcEEEEeCCCccccCC
Confidence 999999976 6666664 3477888999999999999999998 999999999999999999999999999986532
Q ss_pred CCCCccccccccCCcccccccccCCCCcccceehHHHHHHHHHhcCcCCCcchhhhhhhhHHHH-------HHHhhcccc
Q 003836 655 DQSHTNTAIRGTKGYVAPEWFRNMPITVKVDVYSYGVLLLEIICLRRNIDNEISKVDKAILTDW-------AYDRYQERT 727 (792)
Q Consensus 655 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DV~S~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~-------~~~~~~~~~ 727 (792)
. .......+|+.|+|||.+.+..++.++|||||||++|||++|+.||............... ..... ...
T Consensus 179 ~--~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~ 255 (364)
T cd07875 179 S--FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKKL-QPT 255 (364)
T ss_pred C--CcccCCcccCCcCCHHHHhCCCCCchhhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHhh-hHH
Confidence 2 2223456899999999999999999999999999999999999999654322110000000 00000 000
Q ss_pred hhHhhhch--------------h----cccCCHHHHHHHHHHHHHccccCCCCCCCHHhHHHH
Q 003836 728 LEALVEND--------------L----EAMNNVTMLHRFVMVAFWCIQEDPSHRPTMRKVTQM 772 (792)
Q Consensus 728 ~~~~~~~~--------------~----~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~ 772 (792)
........ . ...........+.+++.+||+.||++|||+.|+++.
T Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~R~t~~e~L~h 318 (364)
T cd07875 256 VRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQH 318 (364)
T ss_pred HHHHHhhCCCcCCCChHhhCccccccccccccccccHHHHHHHHHhcCcCcccCCCHHHHhcC
Confidence 00000000 0 000111234578899999999999999999999985
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-34 Score=301.61 Aligned_cols=250 Identities=22% Similarity=0.302 Sum_probs=200.6
Q ss_pred hhhhhhcCccccceEEEeeecCCCceEEEEEEcccccccchHHHHHHHHHhcccCCCCcccccceeccCCceEEEEEecc
Q 003836 503 RGFKEELGRGAFGTVYKGFVNMGSSNHVAVKKLNSVFQDSEKEFKAEVNGIGQTHHKNLVRLLGYCDEGQNRLLVYEFMS 582 (792)
Q Consensus 503 ~~~~~~lG~G~~g~Vy~g~~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~lV~E~~~ 582 (792)
+.+.+.||.|++|.||++.... +++.+|+|.+........+.+.+|++++++++|+||+++++.+......++||||++
T Consensus 7 ~~i~~~l~~g~~~~v~~~~~~~-~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 85 (280)
T cd06611 7 WEIIGELGDGAFGKVYKAQHKE-TGLFAAAKIIQIESEEELEDFMVEIDILSECKHPNIVGLYEAYFYENKLWILIEFCD 85 (280)
T ss_pred HHHHHHhcCCCCceEEEEEEcC-CCcEEEEEEEeeCCHHHHHHHHHHHHHHHhCCCCceeEEEEEEecCCeEEEEeeccC
Confidence 4566889999999999997653 567899999876655566789999999999999999999999999999999999999
Q ss_pred CCCccccccCC-CCCchhHHHHHHHHHHHHHHHHhhccCCCeEecCCCCCcEEEcCCCCeEEeecCCCccccCCCCCccc
Q 003836 583 NGTVASFLFGD-SKPNWKLRTEIAMGIAGGLFYLHEECCTQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLDQSHTNT 661 (792)
Q Consensus 583 ~gsL~~~l~~~-~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dikp~NILl~~~~~~kl~Dfg~a~~~~~~~~~~~~ 661 (792)
+++|.+++... ..+++..+.+++.|++.||.|||+. +|+|+||||+||+++.++.++|+|||++........ ...
T Consensus 86 ~~~L~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh~~---~i~h~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~-~~~ 161 (280)
T cd06611 86 GGALDSIMLELERGLTEPQIRYVCRQMLEALNFLHSH---KVIHRDLKAGNILLTLDGDVKLADFGVSAKNKSTLQ-KRD 161 (280)
T ss_pred CCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCChhhEEECCCCCEEEccCccchhhccccc-ccc
Confidence 99999998764 5689999999999999999999998 999999999999999999999999999876533221 222
Q ss_pred cccccCCcccccccc-----cCCCCcccceehHHHHHHHHHhcCcCCCcchhhhhhhhHHHHHHHhhcccchhHhhhchh
Q 003836 662 AIRGTKGYVAPEWFR-----NMPITVKVDVYSYGVLLLEIICLRRNIDNEISKVDKAILTDWAYDRYQERTLEALVENDL 736 (792)
Q Consensus 662 ~~~gt~~y~aPE~~~-----~~~~~~k~DV~S~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 736 (792)
...+++.|+|||.+. ...++.++||||||+++|||++|+.||........ .... ..... +
T Consensus 162 ~~~~~~~y~~PE~~~~~~~~~~~~~~~sDi~slG~il~~l~~g~~p~~~~~~~~~---~~~~-----~~~~~-----~-- 226 (280)
T cd06611 162 TFIGTPYWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQMEPPHHELNPMRV---LLKI-----LKSEP-----P-- 226 (280)
T ss_pred eeecchhhcCHHHHhhcccCCCCCCccccHHHHHHHHHHHHhCCCCcccCCHHHH---HHHH-----hcCCC-----C--
Confidence 345889999999874 34578899999999999999999999865422110 0000 00000 0
Q ss_pred cccCCHHHHHHHHHHHHHccccCCCCCCCHHhHHHH
Q 003836 737 EAMNNVTMLHRFVMVAFWCIQEDPSHRPTMRKVTQM 772 (792)
Q Consensus 737 ~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~ 772 (792)
....+.....++.+++..||+.+|++||++.++++.
T Consensus 227 ~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~ 262 (280)
T cd06611 227 TLDQPSKWSSSFNDFLKSCLVKDPDDRPTAAELLKH 262 (280)
T ss_pred CcCCcccCCHHHHHHHHHHhccChhhCcCHHHHhcC
Confidence 001122344578899999999999999999999873
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti |
| >cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-34 Score=297.39 Aligned_cols=250 Identities=25% Similarity=0.360 Sum_probs=200.8
Q ss_pred hhhhhcCccccceEEEeeecCCCceEEEEEEccccccc--chHHHHHHHHHhcccCCCCcccccceeccCCceEEEEEec
Q 003836 504 GFKEELGRGAFGTVYKGFVNMGSSNHVAVKKLNSVFQD--SEKEFKAEVNGIGQTHHKNLVRLLGYCDEGQNRLLVYEFM 581 (792)
Q Consensus 504 ~~~~~lG~G~~g~Vy~g~~~~~~~~~vavK~~~~~~~~--~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~lV~E~~ 581 (792)
...+.||+|++|.||+|... .+++.+++|.+...... ..+.+.+|+.++++++|+||+++++++...+..++|+||+
T Consensus 3 ~~~~~lg~G~~~~v~~~~~~-~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~lv~e~~ 81 (264)
T cd06626 3 QRGNKIGGGTFGKVYTAVNL-DTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYYGVEVHREKVYIFMEYC 81 (264)
T ss_pred eeeeEeecCCCcEEEEEEEC-CCCcEEEEEEEECcccchHHHHHHHHHHHHHHhCCCCChhheeeeEecCCEEEEEEecC
Confidence 34578999999999999754 34678999998765442 5678999999999999999999999999999999999999
Q ss_pred cCCCccccccCCCCCchhHHHHHHHHHHHHHHHHhhccCCCeEecCCCCCcEEEcCCCCeEEeecCCCccccCCCCCccc
Q 003836 582 SNGTVASFLFGDSKPNWKLRTEIAMGIAGGLFYLHEECCTQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLDQSHTNT 661 (792)
Q Consensus 582 ~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dikp~NILl~~~~~~kl~Dfg~a~~~~~~~~~~~~ 661 (792)
++++|.+++.....+++..+..++.|+++||.|||+. +|+|+||+|+||++++++.+||+|||++............
T Consensus 82 ~~~~L~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~---~i~H~dl~~~nil~~~~~~~kl~d~g~~~~~~~~~~~~~~ 158 (264)
T cd06626 82 SGGTLEELLEHGRILDEHVIRVYTLQLLEGLAYLHSH---GIVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTTTMGE 158 (264)
T ss_pred CCCcHHHHHhhcCCCChHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEcccccccccCCCCCcccc
Confidence 9999999998877789999999999999999999998 9999999999999999999999999999876543332211
Q ss_pred ---cccccCCcccccccccCC---CCcccceehHHHHHHHHHhcCcCCCcchhhhhhhhHHHHHHHhhcccchhHhhhch
Q 003836 662 ---AIRGTKGYVAPEWFRNMP---ITVKVDVYSYGVLLLEIICLRRNIDNEISKVDKAILTDWAYDRYQERTLEALVEND 735 (792)
Q Consensus 662 ---~~~gt~~y~aPE~~~~~~---~~~k~DV~S~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 735 (792)
...+++.|+|||.+.... ++.++||||||++++|+++|+.||......... ...... ...
T Consensus 159 ~~~~~~~~~~~~~PE~~~~~~~~~~~~~~Dv~s~G~il~~l~~g~~pf~~~~~~~~~------~~~~~~--------~~~ 224 (264)
T cd06626 159 EVQSLAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSELDNEFQI------MFHVGA--------GHK 224 (264)
T ss_pred cccCCcCCcCccChhhccCCCCCCCCcccchHHHHHHHHHHHhCCCCccCCcchHHH------HHHHhc--------CCC
Confidence 345788999999998766 899999999999999999999999643211110 000000 000
Q ss_pred hcccCCHHHHHHHHHHHHHccccCCCCCCCHHhHHH
Q 003836 736 LEAMNNVTMLHRFVMVAFWCIQEDPSHRPTMRKVTQ 771 (792)
Q Consensus 736 ~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~ 771 (792)
............+.+++.+||+.+|.+||++++++.
T Consensus 225 ~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~i~~ 260 (264)
T cd06626 225 PPIPDSLQLSPEGKDFLDRCLESDPKKRPTASELLQ 260 (264)
T ss_pred CCCCcccccCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence 000011123567789999999999999999999886
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4 |
| >KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-35 Score=308.11 Aligned_cols=256 Identities=22% Similarity=0.366 Sum_probs=209.0
Q ss_pred hhhhhcCccccceEEEeeecCCCceEEEEEEcccccccchHHHHHHHHHhcccCCCCcccccceeccCCceEEEEEeccC
Q 003836 504 GFKEELGRGAFGTVYKGFVNMGSSNHVAVKKLNSVFQDSEKEFKAEVNGIGQTHHKNLVRLLGYCDEGQNRLLVYEFMSN 583 (792)
Q Consensus 504 ~~~~~lG~G~~g~Vy~g~~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~lV~E~~~~ 583 (792)
++.-.||-|+||.||+++-. .++...|.|.+........+++.-||++|+..+||+||+|++.|...+.++++.|||.|
T Consensus 35 eIiGELGDGAFGKVyKA~nk-et~~lAAaKvIetkseEELEDylVEIeILa~CdHP~ivkLl~ayy~enkLwiliEFC~G 113 (1187)
T KOG0579|consen 35 EIIGELGDGAFGKVYKAVNK-ETKLLAAAKVIETKSEEELEDYLVEIEILAECDHPVIVKLLSAYYFENKLWILIEFCGG 113 (1187)
T ss_pred HHHhhhcCccchhhhhhhcc-cchhhhhhhhhcccchhHHhhhhhhhhhhhcCCChHHHHHHHHHhccCceEEEEeecCC
Confidence 44567999999999999643 55556788888887777888999999999999999999999999999999999999999
Q ss_pred CCccccccC-CCCCchhHHHHHHHHHHHHHHHHhhccCCCeEecCCCCCcEEEcCCCCeEEeecCCCccccCCCCCcccc
Q 003836 584 GTVASFLFG-DSKPNWKLRTEIAMGIAGGLFYLHEECCTQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLDQSHTNTA 662 (792)
Q Consensus 584 gsL~~~l~~-~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dikp~NILl~~~~~~kl~Dfg~a~~~~~~~~~~~~~ 662 (792)
|-.+..+-. ...+.+.++.-++.|++.||.|||++ .|||||||+.|||++-+|.++|+|||++-..... ......
T Consensus 114 GAVDaimlEL~r~LtE~QIqvvc~q~ldALn~LHs~---~iIHRDLKAGNiL~TldGdirLADFGVSAKn~~t-~qkRDs 189 (1187)
T KOG0579|consen 114 GAVDAIMLELGRVLTEDQIQVVCYQVLDALNWLHSQ---NIIHRDLKAGNILLTLDGDIRLADFGVSAKNKST-RQKRDS 189 (1187)
T ss_pred chHhHHHHHhccccchHHHHHHHHHHHHHHHHHhhc---chhhhhccccceEEEecCcEeeecccccccchhH-Hhhhcc
Confidence 999998754 46789999999999999999999999 9999999999999999999999999998653322 122345
Q ss_pred ccccCCcccccccc-----cCCCCcccceehHHHHHHHHHhcCcCCCcchhhhhhhhHHHHHHHhhcccchhHhhhch-h
Q 003836 663 IRGTKGYVAPEWFR-----NMPITVKVDVYSYGVLLLEIICLRRNIDNEISKVDKAILTDWAYDRYQERTLEALVEND-L 736 (792)
Q Consensus 663 ~~gt~~y~aPE~~~-----~~~~~~k~DV~S~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~ 736 (792)
+.|||.|||||+.. ..+|+.++||||||+.|.||..+.+|.+..... ..+ ..+.... .
T Consensus 190 FIGTPYWMAPEVvmCET~KD~PYDykaDiWSlGITLIEMAqiEPPHhelnpM--RVl--------------lKiaKSePP 253 (1187)
T KOG0579|consen 190 FIGTPYWMAPEVVMCETFKDQPYDYKADIWSLGITLIEMAQIEPPHHELNPM--RVL--------------LKIAKSEPP 253 (1187)
T ss_pred ccCCcccccchheeeccccCCCchhhhhHHhhhhHHHHHhccCCCccccchH--HHH--------------HHHhhcCCC
Confidence 67999999999874 468999999999999999999999886543211 000 0111111 0
Q ss_pred cccCCHHHHHHHHHHHHHccccCCCCCCCHHhHHHHhccCcCCCCCCCCCCCCCCC
Q 003836 737 EAMNNVTMLHRFVMVAFWCIQEDPSHRPTMRKVTQMLEGVVEVPIPPCPWTLNITS 792 (792)
Q Consensus 737 ~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~L~~~~~~~~p~~P~~~~~~~ 792 (792)
....+...+..+.+++..||..||..||++.++++ |||.+++.|
T Consensus 254 TLlqPS~Ws~~F~DfLk~cL~Knp~~Rp~aaqll~------------Hpfv~~~~S 297 (1187)
T KOG0579|consen 254 TLLQPSHWSRSFSDFLKRCLVKNPRNRPPAAQLLK------------HPFVQNAPS 297 (1187)
T ss_pred cccCcchhhhHHHHHHHHHHhcCCccCCCHHHHhh------------CcccccCCc
Confidence 11124456778899999999999999999999998 788877654
|
|
| >cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-34 Score=301.32 Aligned_cols=263 Identities=21% Similarity=0.274 Sum_probs=199.4
Q ss_pred hhhhhcCccccceEEEeeecCCCceEEEEEEccccc--ccchHHHHHHHHHhcccCCCCcccccceeccCCceEEEEEec
Q 003836 504 GFKEELGRGAFGTVYKGFVNMGSSNHVAVKKLNSVF--QDSEKEFKAEVNGIGQTHHKNLVRLLGYCDEGQNRLLVYEFM 581 (792)
Q Consensus 504 ~~~~~lG~G~~g~Vy~g~~~~~~~~~vavK~~~~~~--~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~lV~E~~ 581 (792)
.+.+.||+|++|.||++... .+++.+|+|++.... ....+.+.+|+.++++++|+||+++++++..+...++||||+
T Consensus 4 ~~~~~l~~g~~~~v~~~~~~-~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~e~~ 82 (286)
T cd07847 4 EKLSKIGEGSYGVVFKCRNR-ETGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKHPNLVNLIEVFRRKRKLHLVFEYC 82 (286)
T ss_pred eeeeeecccCCeEEEEEEEC-CCCcEEEEEEEeecccCccccHHHHHHHHHHHhCCCCCEeeeeeEEeeCCEEEEEEecc
Confidence 34578999999999999764 446789999886432 223467889999999999999999999999999999999999
Q ss_pred cCCCccccccCCCCCchhHHHHHHHHHHHHHHHHhhccCCCeEecCCCCCcEEEcCCCCeEEeecCCCccccCCCCCccc
Q 003836 582 SNGTVASFLFGDSKPNWKLRTEIAMGIAGGLFYLHEECCTQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLDQSHTNT 661 (792)
Q Consensus 582 ~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dikp~NILl~~~~~~kl~Dfg~a~~~~~~~~~~~~ 661 (792)
++++|..++.....+++..+..++.||+.||+|||+. +++|+||||+||+++.++.+||+|||++........ ...
T Consensus 83 ~~~~l~~~~~~~~~~~~~~~~~~~~ql~~~l~~LH~~---~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~-~~~ 158 (286)
T cd07847 83 DHTVLNELEKNPRGVPEHLIKKIIWQTLQAVNFCHKH---NCIHRDVKPENILITKQGQIKLCDFGFARILTGPGD-DYT 158 (286)
T ss_pred CccHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHC---CceecCCChhhEEEcCCCcEEECccccceecCCCcc-ccc
Confidence 9999998887767789999999999999999999998 999999999999999999999999999987644322 122
Q ss_pred cccccCCccccccccc-CCCCcccceehHHHHHHHHHhcCcCCCcchhhhhhhhHHHHHH-------Hhhcccc-hhHhh
Q 003836 662 AIRGTKGYVAPEWFRN-MPITVKVDVYSYGVLLLEIICLRRNIDNEISKVDKAILTDWAY-------DRYQERT-LEALV 732 (792)
Q Consensus 662 ~~~gt~~y~aPE~~~~-~~~~~k~DV~S~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~-------~~~~~~~-~~~~~ 732 (792)
...++..|+|||.+.+ ..++.++||||||+++|||++|+.||................. ..+.... .....
T Consensus 159 ~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (286)
T cd07847 159 DYVATRWYRAPELLVGDTQYGPPVDVWAIGCVFAELLTGQPLWPGKSDVDQLYLIRKTLGDLIPRHQQIFSTNQFFKGLS 238 (286)
T ss_pred CcccccccCCHHHHhCCCCcCchhhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChHHhhhccccccccccc
Confidence 3347889999999876 5688999999999999999999999965432211111000000 0000000 00000
Q ss_pred hchhcccCC-----HHHHHHHHHHHHHccccCCCCCCCHHhHHH
Q 003836 733 ENDLEAMNN-----VTMLHRFVMVAFWCIQEDPSHRPTMRKVTQ 771 (792)
Q Consensus 733 ~~~~~~~~~-----~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~ 771 (792)
.+......+ ......+.+++.+||+.+|++||++.|++.
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~ 282 (286)
T cd07847 239 IPEPETREPLESKFPNISSPALSFLKGCLQMDPTERLSCEELLE 282 (286)
T ss_pred CCCcccccCHHHHhccCCHHHHHHHHHHhcCCccccCCHHHHhc
Confidence 000000000 123567889999999999999999999987
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio |
| >cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-34 Score=313.70 Aligned_cols=260 Identities=24% Similarity=0.280 Sum_probs=192.4
Q ss_pred hhhhhhcCccccceEEEeeecCCCceEEEEEEccccc--ccchHHHHHHHHHhcccCCCCcccccceeccC------Cce
Q 003836 503 RGFKEELGRGAFGTVYKGFVNMGSSNHVAVKKLNSVF--QDSEKEFKAEVNGIGQTHHKNLVRLLGYCDEG------QNR 574 (792)
Q Consensus 503 ~~~~~~lG~G~~g~Vy~g~~~~~~~~~vavK~~~~~~--~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~------~~~ 574 (792)
+...+.||+|+||.||++.. ...++.+|||++.... ....+.+.+|+.+++.++|+||+++++++... ...
T Consensus 19 y~~~~~lg~G~~g~V~~~~~-~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 97 (355)
T cd07874 19 YQNLKPIGSGAQGIVCAAYD-AVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKSLEEFQDV 97 (355)
T ss_pred eeEEEEeeecCCEEEEEEEe-cCCCceEEEEEeCCcccChHHHHHHHHHHHHHHHhCCCchhceeeeeecccccccccee
Confidence 33457899999999999964 3456789999987542 23346788999999999999999999988543 357
Q ss_pred EEEEEeccCCCccccccCCCCCchhHHHHHHHHHHHHHHHHhhccCCCeEecCCCCCcEEEcCCCCeEEeecCCCccccC
Q 003836 575 LLVYEFMSNGTVASFLFGDSKPNWKLRTEIAMGIAGGLFYLHEECCTQIIHCDIKPQNILLDDHYNARISDFGLAKLLTL 654 (792)
Q Consensus 575 ~lV~E~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dikp~NILl~~~~~~kl~Dfg~a~~~~~ 654 (792)
++||||+++ +|.+.+. ..+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++....
T Consensus 98 ~lv~e~~~~-~l~~~~~--~~l~~~~~~~~~~qi~~aL~~LH~~---givHrDikp~Nill~~~~~~kl~Dfg~~~~~~~ 171 (355)
T cd07874 98 YLVMELMDA-NLCQVIQ--MELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLARTAGT 171 (355)
T ss_pred EEEhhhhcc-cHHHHHh--hcCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCChHHEEECCCCCEEEeeCcccccCCC
Confidence 999999976 5666553 3478888999999999999999998 999999999999999999999999999986532
Q ss_pred CCCCccccccccCCcccccccccCCCCcccceehHHHHHHHHHhcCcCCCcchhhhhhhhHHHH-------HHHhhcccc
Q 003836 655 DQSHTNTAIRGTKGYVAPEWFRNMPITVKVDVYSYGVLLLEIICLRRNIDNEISKVDKAILTDW-------AYDRYQERT 727 (792)
Q Consensus 655 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DV~S~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~-------~~~~~~~~~ 727 (792)
. .......+|+.|+|||.+.+..++.++|||||||++|||++|+.||............... ...... ..
T Consensus 172 ~--~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~ 248 (355)
T cd07874 172 S--FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQ-PT 248 (355)
T ss_pred c--cccCCccccCCccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhhc-HH
Confidence 2 2223456899999999999989999999999999999999999999654321110000000 000000 00
Q ss_pred hhHhhhch----------------h--cccCCHHHHHHHHHHHHHccccCCCCCCCHHhHHHH
Q 003836 728 LEALVEND----------------L--EAMNNVTMLHRFVMVAFWCIQEDPSHRPTMRKVTQM 772 (792)
Q Consensus 728 ~~~~~~~~----------------~--~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~ 772 (792)
....++.. . ...........+.+++.+||+.||++|||+.|+++.
T Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rps~~ell~h 311 (355)
T cd07874 249 VRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDEALQH 311 (355)
T ss_pred HHHHHhcCCccccccchhhccccccccccccccccchHHHHHHHHHhcCCchhcCCHHHHhcC
Confidence 00000000 0 001112234678899999999999999999999985
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok |
| >cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-34 Score=297.20 Aligned_cols=246 Identities=20% Similarity=0.279 Sum_probs=195.3
Q ss_pred hhhhcCccccceEEEeeecCCCceEEEEEEccccc-----ccchHHHHHHHHHhcccCCCCcccccceeccC--CceEEE
Q 003836 505 FKEELGRGAFGTVYKGFVNMGSSNHVAVKKLNSVF-----QDSEKEFKAEVNGIGQTHHKNLVRLLGYCDEG--QNRLLV 577 (792)
Q Consensus 505 ~~~~lG~G~~g~Vy~g~~~~~~~~~vavK~~~~~~-----~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~--~~~~lV 577 (792)
..+.||+|+||.||++... .+++.||+|++.... ....+.+.+|+.++++++|+||+++++++.+. ...++|
T Consensus 6 ~~~~l~~g~~g~v~~~~~~-~~~~~v~ik~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~v 84 (265)
T cd06652 6 LGKLLGQGAFGRVYLCYDA-DTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQYYGCLRDPMERTLSIF 84 (265)
T ss_pred EeeEEecCCceEEEEEEEc-CCCcEEEEEEeecCcCCcccHHHHHHHHHHHHHHHhcCCCCeeeEEeEeccCCCceEEEE
Confidence 3578999999999999754 556789999875321 12235788999999999999999999998764 467899
Q ss_pred EEeccCCCccccccCCCCCchhHHHHHHHHHHHHHHHHhhccCCCeEecCCCCCcEEEcCCCCeEEeecCCCccccCCCC
Q 003836 578 YEFMSNGTVASFLFGDSKPNWKLRTEIAMGIAGGLFYLHEECCTQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLDQS 657 (792)
Q Consensus 578 ~E~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dikp~NILl~~~~~~kl~Dfg~a~~~~~~~~ 657 (792)
|||+++++|.+++.....+++....+++.|++.||+|||+. +++|+||||+||+++.++.+||+|||+++.......
T Consensus 85 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~l~~~l~~lH~~---~i~H~dl~p~nil~~~~~~~~l~Dfg~~~~~~~~~~ 161 (265)
T cd06652 85 MEHMPGGSIKDQLKSYGALTENVTRKYTRQILEGVSYLHSN---MIVHRDIKGANILRDSVGNVKLGDFGASKRLQTICL 161 (265)
T ss_pred EEecCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEecCCCCEEECcCccccccccccc
Confidence 99999999999998777788999999999999999999998 999999999999999999999999999986543211
Q ss_pred --CccccccccCCcccccccccCCCCcccceehHHHHHHHHHhcCcCCCcchhhhhhhhHHHHHHHhhcccchhHhhhch
Q 003836 658 --HTNTAIRGTKGYVAPEWFRNMPITVKVDVYSYGVLLLEIICLRRNIDNEISKVDKAILTDWAYDRYQERTLEALVEND 735 (792)
Q Consensus 658 --~~~~~~~gt~~y~aPE~~~~~~~~~k~DV~S~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 735 (792)
.......++..|+|||.+.+..++.++||||||+++|||++|+.||........ ........
T Consensus 162 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~----------------~~~~~~~~ 225 (265)
T cd06652 162 SGTGMKSVTGTPYWMSPEVISGEGYGRKADIWSVGCTVVEMLTEKPPWAEFEAMAA----------------IFKIATQP 225 (265)
T ss_pred cccccccCCCCccccChhhhcCCCCCcchhHHHHHHHHHHHhhCCCCCCccchHHH----------------HHHHhcCC
Confidence 112234588899999999888899999999999999999999999864321110 00011111
Q ss_pred hcccCCHHHHHHHHHHHHHccccCCCCCCCHHhHHH
Q 003836 736 LEAMNNVTMLHRFVMVAFWCIQEDPSHRPTMRKVTQ 771 (792)
Q Consensus 736 ~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~ 771 (792)
.....+......+.+++.+|+. +|++||+++||++
T Consensus 226 ~~~~~~~~~~~~~~~~i~~~l~-~p~~Rp~~~~il~ 260 (265)
T cd06652 226 TNPVLPPHVSDHCRDFLKRIFV-EAKLRPSADELLR 260 (265)
T ss_pred CCCCCchhhCHHHHHHHHHHhc-ChhhCCCHHHHhc
Confidence 1222344556678889999985 8999999999987
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re |
| >KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-35 Score=306.58 Aligned_cols=240 Identities=27% Similarity=0.346 Sum_probs=198.5
Q ss_pred hhcCccccceEEEeeecCCCceEEEEEEccc---ccccchHHHHHHHHHhcccCCCCcccccceeccCCceEEEEEeccC
Q 003836 507 EELGRGAFGTVYKGFVNMGSSNHVAVKKLNS---VFQDSEKEFKAEVNGIGQTHHKNLVRLLGYCDEGQNRLLVYEFMSN 583 (792)
Q Consensus 507 ~~lG~G~~g~Vy~g~~~~~~~~~vavK~~~~---~~~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~lV~E~~~~ 583 (792)
+.||.|+||.||-+.. ..+.+.||||++.- .......++..|++.|++++|||++.+.|||..+...+||||||-|
T Consensus 32 rEIGHGSFGAVYfArd-~~n~evVAIKKMsySGKQs~EKWqDIlKEVrFL~~l~HPntieYkgCyLre~TaWLVMEYClG 110 (948)
T KOG0577|consen 32 REIGHGSFGAVYFARD-VRNSEVVAIKKMSYSGKQSNEKWQDILKEVRFLRQLRHPNTIEYKGCYLREHTAWLVMEYCLG 110 (948)
T ss_pred HHhcCCccceeEEeec-cCccceeeeeeccccccccHHHHHHHHHHHHHHHhccCCCcccccceeeccchHHHHHHHHhc
Confidence 4699999999999964 45667999999863 3344567899999999999999999999999999999999999965
Q ss_pred CCccccccCC-CCCchhHHHHHHHHHHHHHHHHhhccCCCeEecCCCCCcEEEcCCCCeEEeecCCCccccCCCCCcccc
Q 003836 584 GTVASFLFGD-SKPNWKLRTEIAMGIAGGLFYLHEECCTQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLDQSHTNTA 662 (792)
Q Consensus 584 gsL~~~l~~~-~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dikp~NILl~~~~~~kl~Dfg~a~~~~~~~~~~~~~ 662 (792)
|-.+++.-. +++.+-.+..|..+.+.||+|||+. +.||||||+.||||++.|.+||+|||.|.+..+ ...
T Consensus 111 -SAsDlleVhkKplqEvEIAAi~~gaL~gLaYLHS~---~~IHRDiKAGNILLse~g~VKLaDFGSAsi~~P-----Ans 181 (948)
T KOG0577|consen 111 -SASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSH---NRIHRDIKAGNILLSEPGLVKLADFGSASIMAP-----ANS 181 (948)
T ss_pred -cHHHHHHHHhccchHHHHHHHHHHHHHHHHHHHHh---hHHhhhccccceEecCCCeeeeccccchhhcCc-----hhc
Confidence 777777543 6788999999999999999999999 999999999999999999999999999977543 334
Q ss_pred ccccCCcccccccc---cCCCCcccceehHHHHHHHHHhcCcCCCcchhhhhhhhHHHHHHHhhcccchhHhhhchhccc
Q 003836 663 IRGTKGYVAPEWFR---NMPITVKVDVYSYGVLLLEIICLRRNIDNEISKVDKAILTDWAYDRYQERTLEALVENDLEAM 739 (792)
Q Consensus 663 ~~gt~~y~aPE~~~---~~~~~~k~DV~S~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 739 (792)
++|||.|||||++. .++|+-|+||||||++..||...++|..++..... +-..+ .....-.
T Consensus 182 FvGTPywMAPEVILAMDEGqYdgkvDvWSLGITCIELAERkPPlFnMNAMSA---LYHIA-------------QNesPtL 245 (948)
T KOG0577|consen 182 FVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSA---LYHIA-------------QNESPTL 245 (948)
T ss_pred ccCCccccchhHheeccccccCCccceeeccchhhhhhhcCCCccCchHHHH---HHHHH-------------hcCCCCC
Confidence 67999999999874 58999999999999999999999999866532111 00000 0111111
Q ss_pred CCHHHHHHHHHHHHHccccCCCCCCCHHhHHHH
Q 003836 740 NNVTMLHRFVMVAFWCIQEDPSHRPTMRKVTQM 772 (792)
Q Consensus 740 ~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~ 772 (792)
...+.+..+.+++..||+.-|.+|||.++++..
T Consensus 246 qs~eWS~~F~~Fvd~CLqKipqeRptse~ll~H 278 (948)
T KOG0577|consen 246 QSNEWSDYFRNFVDSCLQKIPQERPTSEELLKH 278 (948)
T ss_pred CCchhHHHHHHHHHHHHhhCcccCCcHHHHhhc
Confidence 245678889999999999999999999998874
|
|
| >cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-33 Score=309.77 Aligned_cols=261 Identities=24% Similarity=0.273 Sum_probs=192.2
Q ss_pred hhhhhhcCccccceEEEeeecCCCceEEEEEEccccc--ccchHHHHHHHHHhcccCCCCcccccceeccCC------ce
Q 003836 503 RGFKEELGRGAFGTVYKGFVNMGSSNHVAVKKLNSVF--QDSEKEFKAEVNGIGQTHHKNLVRLLGYCDEGQ------NR 574 (792)
Q Consensus 503 ~~~~~~lG~G~~g~Vy~g~~~~~~~~~vavK~~~~~~--~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~------~~ 574 (792)
+...+.||+|+||.||++... .+++.+|+|++.... ......+.+|+.+++.++||||+++++++.... ..
T Consensus 23 y~~~~~lg~G~~g~V~~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 101 (359)
T cd07876 23 YQQLKPIGSGAQGIVCAAFDT-VLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKSLEEFQDV 101 (359)
T ss_pred eEEEEEeecCCCEEEEEEEEc-CCCceeEEEEecccccchhHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCCcccccee
Confidence 445578999999999999653 556799999986532 334567889999999999999999999986443 57
Q ss_pred EEEEEeccCCCccccccCCCCCchhHHHHHHHHHHHHHHHHhhccCCCeEecCCCCCcEEEcCCCCeEEeecCCCccccC
Q 003836 575 LLVYEFMSNGTVASFLFGDSKPNWKLRTEIAMGIAGGLFYLHEECCTQIIHCDIKPQNILLDDHYNARISDFGLAKLLTL 654 (792)
Q Consensus 575 ~lV~E~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dikp~NILl~~~~~~kl~Dfg~a~~~~~ 654 (792)
++||||+++ +|...+. ..+++..+..++.||+.||.|||+. +|+||||||+|||++.++.+||+|||+++....
T Consensus 102 ~lv~e~~~~-~l~~~~~--~~~~~~~~~~~~~qi~~~L~~LH~~---~ivHrDlkp~NIl~~~~~~~kl~Dfg~a~~~~~ 175 (359)
T cd07876 102 YLVMELMDA-NLCQVIH--MELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLARTACT 175 (359)
T ss_pred EEEEeCCCc-CHHHHHh--ccCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEECCCCCEEEecCCCcccccc
Confidence 999999976 5555553 3477888899999999999999998 999999999999999999999999999976432
Q ss_pred CCCCccccccccCCcccccccccCCCCcccceehHHHHHHHHHhcCcCCCcchhhhhhhhHHHH---HHHhhc---ccch
Q 003836 655 DQSHTNTAIRGTKGYVAPEWFRNMPITVKVDVYSYGVLLLEIICLRRNIDNEISKVDKAILTDW---AYDRYQ---ERTL 728 (792)
Q Consensus 655 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DV~S~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~---~~~~~~---~~~~ 728 (792)
. .......+|+.|+|||.+.+..++.++|||||||++|||++|+.||............... +...+. ....
T Consensus 176 ~--~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 253 (359)
T cd07876 176 N--FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELVKGSVIFQGTDHIDQWNKVIEQLGTPSAEFMNRLQPTV 253 (359)
T ss_pred C--ccCCCCcccCCCCCchhccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCcHHHHHHHHHHH
Confidence 2 2223456899999999999999999999999999999999999999754321110000000 000000 0000
Q ss_pred hHhhhchh------------------cccCCHHHHHHHHHHHHHccccCCCCCCCHHhHHHH
Q 003836 729 EALVENDL------------------EAMNNVTMLHRFVMVAFWCIQEDPSHRPTMRKVTQM 772 (792)
Q Consensus 729 ~~~~~~~~------------------~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~ 772 (792)
..+..... ....+......+.+++.+||+.||++|||+.|+++.
T Consensus 254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~h 315 (359)
T cd07876 254 RNYVENRPQYPGISFEELFPDWIFPSESERDKLKTSQARDLLSKMLVIDPDKRISVDEALRH 315 (359)
T ss_pred HHHHhhCCCCCCcchhhhccccccccccccccccchhHHHHHHHHhccCcccCCCHHHHhcC
Confidence 00000000 000111234568899999999999999999999985
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-34 Score=301.63 Aligned_cols=261 Identities=21% Similarity=0.272 Sum_probs=194.2
Q ss_pred hhhhcCccccceEEEeeecCCCceEEEEEEccccc--ccchHHHHHHHHHhcccCCCCcccccceeccCCceEEEEEecc
Q 003836 505 FKEELGRGAFGTVYKGFVNMGSSNHVAVKKLNSVF--QDSEKEFKAEVNGIGQTHHKNLVRLLGYCDEGQNRLLVYEFMS 582 (792)
Q Consensus 505 ~~~~lG~G~~g~Vy~g~~~~~~~~~vavK~~~~~~--~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~lV~E~~~ 582 (792)
+.+.||+|++|.||+|... .+++.||+|++.... ....+.+.+|+.++++++|+||+++++++.+++..++||||++
T Consensus 4 ~~~~l~~g~~~~v~~~~~~-~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~ 82 (285)
T cd07861 4 KIEKIGEGTYGVVYKGRNK-KTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPNIVCLQDVLMQESRLYLIFEFLS 82 (285)
T ss_pred EeeEecccCceEEEEEEEC-CCCcEEEEEEeccccccCCchHHHHHHHHHHHhcCCCCEeeeEEEEeeCCeEEEEEecCC
Confidence 4578999999999999754 446789999986532 2234678899999999999999999999999999999999997
Q ss_pred CCCccccccCC---CCCchhHHHHHHHHHHHHHHHHhhccCCCeEecCCCCCcEEEcCCCCeEEeecCCCccccCCCCCc
Q 003836 583 NGTVASFLFGD---SKPNWKLRTEIAMGIAGGLFYLHEECCTQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLDQSHT 659 (792)
Q Consensus 583 ~gsL~~~l~~~---~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dikp~NILl~~~~~~kl~Dfg~a~~~~~~~~~~ 659 (792)
++|.+++... ..+++..+..++.||++||+|||+. +|+|+||||+|||+++++.+||+|||+++....... .
T Consensus 83 -~~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~---~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~-~ 157 (285)
T cd07861 83 -MDLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCHSR---RVLHRDLKPQNLLIDNKGVIKLADFGLARAFGIPVR-V 157 (285)
T ss_pred -CCHHHHHhcCCCCCcCCHHHHHHHHHHHHHHHHHHHhC---CeeecCCCHHHEEEcCCCcEEECcccceeecCCCcc-c
Confidence 5888887542 4678999999999999999999998 999999999999999999999999999976543221 1
Q ss_pred cccccccCCcccccccccC-CCCcccceehHHHHHHHHHhcCcCCCcchhhhhhhhHHHHH----HHhhcc-cchhH---
Q 003836 660 NTAIRGTKGYVAPEWFRNM-PITVKVDVYSYGVLLLEIICLRRNIDNEISKVDKAILTDWA----YDRYQE-RTLEA--- 730 (792)
Q Consensus 660 ~~~~~gt~~y~aPE~~~~~-~~~~k~DV~S~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~----~~~~~~-~~~~~--- 730 (792)
.....+++.|+|||.+.+. .++.++||||||++++||+||+.||................ ...+.. ..+..
T Consensus 158 ~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (285)
T cd07861 158 YTHEVVTLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMATKKPLFHGDSEIDQLFRIFRILGTPTEDVWPGVTSLPDYKN 237 (285)
T ss_pred ccCCcccccccChHHhcCCCCcCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCChhhhhcchhhHHHHh
Confidence 2223468899999988654 57899999999999999999999997543321111000000 000000 00000
Q ss_pred hhhchhc---ccCCHHHHHHHHHHHHHccccCCCCCCCHHhHHH
Q 003836 731 LVENDLE---AMNNVTMLHRFVMVAFWCIQEDPSHRPTMRKVTQ 771 (792)
Q Consensus 731 ~~~~~~~---~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~ 771 (792)
....... .......+.++.+++.+||+.||++|||+++|++
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~~ll~ 281 (285)
T cd07861 238 TFPKWKKGSLRSAVKNLDEDGLDLLEKMLIYDPAKRISAKKALN 281 (285)
T ss_pred hccccCcchhHHhcCCCCHHHHHHHHHHhcCChhhCCCHHHHhc
Confidence 0000000 0001123567789999999999999999999987
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 |
| >cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-34 Score=303.26 Aligned_cols=245 Identities=21% Similarity=0.311 Sum_probs=197.9
Q ss_pred hhcCccccceEEEeeecCCCceEEEEEEcccccccchHHHHHHHHHhcccCCCCcccccceeccCCceEEEEEeccCCCc
Q 003836 507 EELGRGAFGTVYKGFVNMGSSNHVAVKKLNSVFQDSEKEFKAEVNGIGQTHHKNLVRLLGYCDEGQNRLLVYEFMSNGTV 586 (792)
Q Consensus 507 ~~lG~G~~g~Vy~g~~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~lV~E~~~~gsL 586 (792)
..||+|+||.||++... .+++.+|+|.+........+.+.+|+.+++.++||||+++++++..++..++|+||+++++|
T Consensus 27 ~~ig~g~~g~v~~~~~~-~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~iv~e~~~~~~L 105 (297)
T cd06659 27 IKIGEGSTGIVCIAREK-HSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHQNVVEMYKSYLVGEELWVLMEFLQGGAL 105 (297)
T ss_pred hhcCCCCceeEEEEEEc-CCCCEEEEEEEEecccchHHHHHHHHHHHHhCCCCchhhhhhheeeCCeEEEEEecCCCCCH
Confidence 46999999999999754 45678999998765555567889999999999999999999999999999999999999999
Q ss_pred cccccCCCCCchhHHHHHHHHHHHHHHHHhhccCCCeEecCCCCCcEEEcCCCCeEEeecCCCccccCCCCCcccccccc
Q 003836 587 ASFLFGDSKPNWKLRTEIAMGIAGGLFYLHEECCTQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLDQSHTNTAIRGT 666 (792)
Q Consensus 587 ~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dikp~NILl~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~gt 666 (792)
.+++.. ..+++..+..++.|++.||+|||+. +++|+||||+||+++.++.+||+|||+++...... .......++
T Consensus 106 ~~~~~~-~~~~~~~~~~~~~qi~~~L~~LH~~---~ivH~dl~p~Nill~~~~~~kL~dfg~~~~~~~~~-~~~~~~~~~ 180 (297)
T cd06659 106 TDIVSQ-TRLNEEQIATVCESVLQALCYLHSQ---GVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDV-PKRKSLVGT 180 (297)
T ss_pred HHHHhh-cCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHeEEccCCcEEEeechhHhhccccc-ccccceecC
Confidence 987744 5678999999999999999999998 99999999999999999999999999987654322 122335688
Q ss_pred CCcccccccccCCCCcccceehHHHHHHHHHhcCcCCCcchhhhhhhhHHHHHHHhhcccchhHhhhchhcccCCHHHHH
Q 003836 667 KGYVAPEWFRNMPITVKVDVYSYGVLLLEIICLRRNIDNEISKVDKAILTDWAYDRYQERTLEALVENDLEAMNNVTMLH 746 (792)
Q Consensus 667 ~~y~aPE~~~~~~~~~k~DV~S~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 746 (792)
..|+|||.+.+..++.++||||||++++||++|+.||.......... . ...... . ..........
T Consensus 181 ~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~---~-----~~~~~~-----~--~~~~~~~~~~ 245 (297)
T cd06659 181 PYWMAPEVISRTPYGTEVDIWSLGIMVIEMVDGEPPYFSDSPVQAMK---R-----LRDSPP-----P--KLKNAHKISP 245 (297)
T ss_pred ccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHH---H-----HhccCC-----C--CccccCCCCH
Confidence 99999999998899999999999999999999999986543211100 0 000000 0 0001112345
Q ss_pred HHHHHHHHccccCCCCCCCHHhHHHH
Q 003836 747 RFVMVAFWCIQEDPSHRPTMRKVTQM 772 (792)
Q Consensus 747 ~l~~l~~~Cl~~~p~~RPs~~evl~~ 772 (792)
.+.+++.+||+.+|.+||+++++++.
T Consensus 246 ~l~~~i~~~l~~~P~~Rps~~~ll~~ 271 (297)
T cd06659 246 VLRDFLERMLTREPQERATAQELLDH 271 (297)
T ss_pred HHHHHHHHHhcCCcccCcCHHHHhhC
Confidence 67889999999999999999999984
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i |
| >cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-33 Score=296.08 Aligned_cols=249 Identities=25% Similarity=0.392 Sum_probs=200.5
Q ss_pred hhhcCccccceEEEeeecCCCceEEEEEEcccccc------cchHHHHHHHHHhcccCCCCcccccceeccCCceEEEEE
Q 003836 506 KEELGRGAFGTVYKGFVNMGSSNHVAVKKLNSVFQ------DSEKEFKAEVNGIGQTHHKNLVRLLGYCDEGQNRLLVYE 579 (792)
Q Consensus 506 ~~~lG~G~~g~Vy~g~~~~~~~~~vavK~~~~~~~------~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~lV~E 579 (792)
.+.||+|++|.||++.. ..+++.+|+|.+..... ...+.+.+|++++++++|+||+++++++.+.+..++|+|
T Consensus 5 ~~~lg~g~~~~v~~~~~-~~~~~~~alk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~v~e 83 (268)
T cd06630 5 GQQLGTGAFSSCYQARD-VKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIRMLGATCEDSHFNLFVE 83 (268)
T ss_pred cceecCcCceEEEEEEE-cCCCcEEEEEEeecccCCchhHHHHHHHHHHHHHHHHHcCCCceehhhceeccCCeEEEEEe
Confidence 46799999999999975 35567899999864321 134678999999999999999999999999999999999
Q ss_pred eccCCCccccccCCCCCchhHHHHHHHHHHHHHHHHhhccCCCeEecCCCCCcEEEcCCC-CeEEeecCCCccccCCCCC
Q 003836 580 FMSNGTVASFLFGDSKPNWKLRTEIAMGIAGGLFYLHEECCTQIIHCDIKPQNILLDDHY-NARISDFGLAKLLTLDQSH 658 (792)
Q Consensus 580 ~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dikp~NILl~~~~-~~kl~Dfg~a~~~~~~~~~ 658 (792)
|+++++|.+++.+...+++..+..++.||+.||.|||+. +++|+||+|+||+++.++ .+||+|||.+.........
T Consensus 84 ~~~~~~L~~~l~~~~~~~~~~~~~~~~ql~~al~~LH~~---~i~H~~i~~~nil~~~~~~~~~l~dfg~~~~~~~~~~~ 160 (268)
T cd06630 84 WMAGGSVSHLLSKYGAFKEAVIINYTEQLLRGLSYLHEN---QIIHRDVKGANLLIDSTGQRLRIADFGAAARLAAKGTG 160 (268)
T ss_pred ccCCCcHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEEccccccccccccccc
Confidence 999999999998777889999999999999999999998 999999999999998776 5999999999876543211
Q ss_pred ---ccccccccCCcccccccccCCCCcccceehHHHHHHHHHhcCcCCCcchhhhhhhhHHHHHHHhhcccchhHhhhch
Q 003836 659 ---TNTAIRGTKGYVAPEWFRNMPITVKVDVYSYGVLLLEIICLRRNIDNEISKVDKAILTDWAYDRYQERTLEALVEND 735 (792)
Q Consensus 659 ---~~~~~~gt~~y~aPE~~~~~~~~~k~DV~S~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 735 (792)
......++..|+|||.+.+..++.++||||+|+++++|++|+.||........... ........
T Consensus 161 ~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~-------------~~~~~~~~ 227 (268)
T cd06630 161 AGEFQGQLLGTIAFMAPEVLRGEQYGRSCDVWSVGCVIIEMATAKPPWNAEKHSNHLAL-------------IFKIASAT 227 (268)
T ss_pred CCccccccccccceeCHhHhccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCcchHHH-------------HHHHhccC
Confidence 12234578899999999888899999999999999999999999864321110000 00111111
Q ss_pred hcccCCHHHHHHHHHHHHHccccCCCCCCCHHhHHH
Q 003836 736 LEAMNNVTMLHRFVMVAFWCIQEDPSHRPTMRKVTQ 771 (792)
Q Consensus 736 ~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~ 771 (792)
.....+.....++.+++.+||+.+|++||++.|+++
T Consensus 228 ~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~ll~ 263 (268)
T cd06630 228 TAPSIPEHLSPGLRDVTLRCLELQPEDRPPSRELLK 263 (268)
T ss_pred CCCCCchhhCHHHHHHHHHHcCCCcccCcCHHHHhc
Confidence 122234455678899999999999999999999986
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their |
| >cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-34 Score=304.18 Aligned_cols=252 Identities=19% Similarity=0.271 Sum_probs=199.4
Q ss_pred hhhhhcCccccceEEEeeecCCCceEEEEEEccccc---ccchHHHHHHHHHhcccCCCCcccccceeccCCceEEEEEe
Q 003836 504 GFKEELGRGAFGTVYKGFVNMGSSNHVAVKKLNSVF---QDSEKEFKAEVNGIGQTHHKNLVRLLGYCDEGQNRLLVYEF 580 (792)
Q Consensus 504 ~~~~~lG~G~~g~Vy~g~~~~~~~~~vavK~~~~~~---~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~lV~E~ 580 (792)
.+.+.||+|+||.||++.. ...++.|++|.+.... ....+.+.+|++++++++|+||+++++.+..++..++||||
T Consensus 4 ~~~~~l~~g~~~~v~~~~~-~~~~~~v~ik~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~ 82 (305)
T cd05609 4 ETIKLISNGAYGAVYLVRH-KETRQRFAMKKINKQNLILRNQIQQVFVERDILTFAENPFVVSMFCSFETKRHLCMVMEY 82 (305)
T ss_pred eEeeEeecCCCeeEEEEEE-CCCCcEEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEecCCEEEEEEec
Confidence 3457899999999999965 4556789999987543 22345788999999999999999999999999999999999
Q ss_pred ccCCCccccccCCCCCchhHHHHHHHHHHHHHHHHhhccCCCeEecCCCCCcEEEcCCCCeEEeecCCCccccCCC----
Q 003836 581 MSNGTVASFLFGDSKPNWKLRTEIAMGIAGGLFYLHEECCTQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLDQ---- 656 (792)
Q Consensus 581 ~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dikp~NILl~~~~~~kl~Dfg~a~~~~~~~---- 656 (792)
+++++|.+++.....+++..+..++.|++.||.|||+. +++|+||||+||+++.++.+||+|||+++......
T Consensus 83 ~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~NIll~~~~~~~l~dfg~~~~~~~~~~~~~ 159 (305)
T cd05609 83 VEGGDCATLLKNIGALPVDMARMYFAETVLALEYLHNY---GIVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSLTTNL 159 (305)
T ss_pred CCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCchHHEEECCCCCEEEeeCCCccccCcCccccc
Confidence 99999999998777889999999999999999999998 99999999999999999999999999987421110
Q ss_pred ----------CCccccccccCCcccccccccCCCCcccceehHHHHHHHHHhcCcCCCcchhhhhhhhHHHHHHHhhccc
Q 003836 657 ----------SHTNTAIRGTKGYVAPEWFRNMPITVKVDVYSYGVLLLEIICLRRNIDNEISKVDKAILTDWAYDRYQER 726 (792)
Q Consensus 657 ----------~~~~~~~~gt~~y~aPE~~~~~~~~~k~DV~S~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 726 (792)
........++..|+|||.+.+..++.++||||||+++|||++|+.||....... ...
T Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~vl~el~~g~~pf~~~~~~~---~~~---------- 226 (305)
T cd05609 160 YEGHIEKDTREFLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEE---LFG---------- 226 (305)
T ss_pred cccccccchhhccccCCccCccccCchhccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH---HHH----------
Confidence 001122457889999999988889999999999999999999999986432110 000
Q ss_pred chhHhhhchhc-ccCCHHHHHHHHHHHHHccccCCCCCCCHHhHHHHhcc
Q 003836 727 TLEALVENDLE-AMNNVTMLHRFVMVAFWCIQEDPSHRPTMRKVTQMLEG 775 (792)
Q Consensus 727 ~~~~~~~~~~~-~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~L~~ 775 (792)
........ .......+..+.+++.+||+.+|++||++.++.+.|+.
T Consensus 227 ---~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~ll~~ 273 (305)
T cd05609 227 ---QVISDDIEWPEGDEALPADAQDLISRLLRQNPLERLGTGGAFEVKQH 273 (305)
T ss_pred ---HHHhcccCCCCccccCCHHHHHHHHHHhccChhhccCccCHHHHHhC
Confidence 00000000 00111345678899999999999999997777777655
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a |
| >cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-33 Score=303.77 Aligned_cols=248 Identities=21% Similarity=0.253 Sum_probs=198.6
Q ss_pred hhhhcCccccceEEEeeecCCCceEEEEEEccccccc---chHHHHHHHHHhcccCCCCcccccceeccCCceEEEEEec
Q 003836 505 FKEELGRGAFGTVYKGFVNMGSSNHVAVKKLNSVFQD---SEKEFKAEVNGIGQTHHKNLVRLLGYCDEGQNRLLVYEFM 581 (792)
Q Consensus 505 ~~~~lG~G~~g~Vy~g~~~~~~~~~vavK~~~~~~~~---~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~lV~E~~ 581 (792)
+.+.||+|++|+||++... .+++.+|+|.+...... ..+.+.+|++++++++|+||+++++.+.+....++||||+
T Consensus 5 ~~~~ig~g~~g~vy~~~~~-~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~ 83 (316)
T cd05574 5 KIKLLGKGDVGRVFLVRLK-GTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTLYASFQTETYLCLVMDYC 83 (316)
T ss_pred EeeeecCCccEEEEEEEEc-CCCcEEEEEEEeccccchHHHHHHHHHHHHHHHhCCCCCchhheeeeecCCEEEEEEEec
Confidence 3467999999999999754 45678999998754322 4467899999999999999999999999999999999999
Q ss_pred cCCCccccccCC--CCCchhHHHHHHHHHHHHHHHHhhccCCCeEecCCCCCcEEEcCCCCeEEeecCCCccccCCCCC-
Q 003836 582 SNGTVASFLFGD--SKPNWKLRTEIAMGIAGGLFYLHEECCTQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLDQSH- 658 (792)
Q Consensus 582 ~~gsL~~~l~~~--~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dikp~NILl~~~~~~kl~Dfg~a~~~~~~~~~- 658 (792)
++++|.+++... ..+++..+..++.||++||+|||+. +++|+||||+||+++.++.++|+|||++.........
T Consensus 84 ~~~~L~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~~~ 160 (316)
T cd05574 84 PGGELFRLLQRQPGKCLSEEVARFYAAEVLLALEYLHLL---GIVYRDLKPENILLHESGHIMLSDFDLSKQSDVEPPPV 160 (316)
T ss_pred CCCCHHHHHHhCCCCccCHHHHHHHHHHHHHHHHHHHHC---CeeccCCChHHeEEcCCCCEEEeecchhhccccccccc
Confidence 999999998754 4688999999999999999999998 9999999999999999999999999998754321110
Q ss_pred ---------------------------ccccccccCCcccccccccCCCCcccceehHHHHHHHHHhcCcCCCcchhhhh
Q 003836 659 ---------------------------TNTAIRGTKGYVAPEWFRNMPITVKVDVYSYGVLLLEIICLRRNIDNEISKVD 711 (792)
Q Consensus 659 ---------------------------~~~~~~gt~~y~aPE~~~~~~~~~k~DV~S~Gv~l~el~tg~~p~~~~~~~~~ 711 (792)
......|+..|+|||.+.+..++.++||||||+++|+|++|+.||........
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~ 240 (316)
T cd05574 161 SKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILLYEMLYGTTPFKGSNRDET 240 (316)
T ss_pred ccccccccccccccccchhhhcccccCCCCCCcCccCCcCHHHHcCCCCCchHHHHHHHHHHHHHhhCCCCCCCCchHHH
Confidence 11123578899999999988899999999999999999999999965432211
Q ss_pred hhhHHHHHHHhhcccchhHhhhchhcccCCHHHHHHHHHHHHHccccCCCCCCC----HHhHHHH
Q 003836 712 KAILTDWAYDRYQERTLEALVENDLEAMNNVTMLHRFVMVAFWCIQEDPSHRPT----MRKVTQM 772 (792)
Q Consensus 712 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs----~~evl~~ 772 (792)
...+................+.+++.+||+.+|++||+ ++|+++.
T Consensus 241 ----------------~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~ll~~ 289 (316)
T cd05574 241 ----------------FSNILKKEVTFPGSPPVSSSARDLIRKLLVKDPSKRLGSKRGAAEIKQH 289 (316)
T ss_pred ----------------HHHHhcCCccCCCccccCHHHHHHHHHHccCCHhHCCCchhhHHHHHcC
Confidence 01111111111111225678899999999999999999 7777763
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin |
| >cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-33 Score=300.28 Aligned_cols=263 Identities=21% Similarity=0.262 Sum_probs=199.1
Q ss_pred hhhhhcCccccceEEEeeecCCCceEEEEEEccccc--ccchHHHHHHHHHhcccCCCCcccccceeccCCceEEEEEec
Q 003836 504 GFKEELGRGAFGTVYKGFVNMGSSNHVAVKKLNSVF--QDSEKEFKAEVNGIGQTHHKNLVRLLGYCDEGQNRLLVYEFM 581 (792)
Q Consensus 504 ~~~~~lG~G~~g~Vy~g~~~~~~~~~vavK~~~~~~--~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~lV~E~~ 581 (792)
.+.+.||+|++|.||+|... .+++.+++|++.... ....+.+.+|+.++++++|+||+++++++..+...++||||+
T Consensus 3 ~~~~~l~~g~~~~v~~~~~~-~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~~ 81 (286)
T cd07832 3 KILGRIGEGAHGIVFKAKDR-ETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLDVFPHGSGFVLVMEYM 81 (286)
T ss_pred eEEeecccCCCcEEEEEEEC-CCCceEEEEEEEcccccchhhHHHHHHHHHHHhCCCCCCcceeeEEecCCeeEEEeccc
Confidence 45578999999999999764 346789999987643 334568999999999999999999999999999999999999
Q ss_pred cCCCccccccCC-CCCchhHHHHHHHHHHHHHHHHhhccCCCeEecCCCCCcEEEcCCCCeEEeecCCCccccCCCCCcc
Q 003836 582 SNGTVASFLFGD-SKPNWKLRTEIAMGIAGGLFYLHEECCTQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLDQSHTN 660 (792)
Q Consensus 582 ~~gsL~~~l~~~-~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dikp~NILl~~~~~~kl~Dfg~a~~~~~~~~~~~ 660 (792)
+++|.+++... ..+++.++..++.||++||+|||+. +++|+||||+||+++.++.++|+|||++...........
T Consensus 82 -~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~ni~~~~~~~~~l~dfg~~~~~~~~~~~~~ 157 (286)
T cd07832 82 -PSDLSEVLRDEERPLPEAQVKSYMRMLLKGVAYMHAN---GIMHRDLKPANLLISADGVLKIADFGLARLFSEEEPRLY 157 (286)
T ss_pred -CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCcCHHHEEEcCCCcEEEeeeeecccccCCCCCcc
Confidence 99999998653 5689999999999999999999998 999999999999999999999999999987654433223
Q ss_pred ccccccCCcccccccccC-CCCcccceehHHHHHHHHHhcCcCCCcchhhhhhhhHHHH-------HHHhhcc-cchhHh
Q 003836 661 TAIRGTKGYVAPEWFRNM-PITVKVDVYSYGVLLLEIICLRRNIDNEISKVDKAILTDW-------AYDRYQE-RTLEAL 731 (792)
Q Consensus 661 ~~~~gt~~y~aPE~~~~~-~~~~k~DV~S~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~-------~~~~~~~-~~~~~~ 731 (792)
....++..|+|||.+.+. .++.++||||+|++++||++|+.+|............... .+....+ .....+
T Consensus 158 ~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (286)
T cd07832 158 SHQVATRWYRAPELLYGARKYDPGVDLWAVGCIFAELLNGSPLFPGENDIEQLAIVFRTLGTPNEETWPGLTSLPDYNKI 237 (286)
T ss_pred ccccCcccccCceeeeccccCCchhHHHHHHHHHHHHHcCCcCcCCCCHHHHHHHHHHHcCCCChHHHhhccCcchhhcc
Confidence 345688999999998654 4689999999999999999998777544321111000000 0000000 000000
Q ss_pred hhchhc----ccCCHHHHHHHHHHHHHccccCCCCCCCHHhHHH
Q 003836 732 VENDLE----AMNNVTMLHRFVMVAFWCIQEDPSHRPTMRKVTQ 771 (792)
Q Consensus 732 ~~~~~~----~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~ 771 (792)
...... .....+....+.+++.+||+.+|++||+++++++
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~l~ 281 (286)
T cd07832 238 TFPESKPIPLEEIFPDASPEALDLLKGLLVYDPSKRLSAAEALR 281 (286)
T ss_pred cCCCCCcchHHHhCCCccHHHHHHHHHHhccChhhCCCHHHHhh
Confidence 000000 0001123478899999999999999999999998
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea |
| >cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-33 Score=306.12 Aligned_cols=259 Identities=22% Similarity=0.275 Sum_probs=190.9
Q ss_pred hhhhhhcCccccceEEEeeecCCCceEEEEEEcccccc--cchHHHHHHHHHhcccCCCCcccccceeccC------Cce
Q 003836 503 RGFKEELGRGAFGTVYKGFVNMGSSNHVAVKKLNSVFQ--DSEKEFKAEVNGIGQTHHKNLVRLLGYCDEG------QNR 574 (792)
Q Consensus 503 ~~~~~~lG~G~~g~Vy~g~~~~~~~~~vavK~~~~~~~--~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~------~~~ 574 (792)
+...+.||+|+||+||++... .+++.||||++..... ...+.+.+|++++++++|+||+++++++... ...
T Consensus 17 y~~~~~lg~G~~g~V~~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~ 95 (343)
T cd07878 17 YQNLTPVGSGAYGSVCSAYDT-RLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHMKHENVIGLLDVFTPATSIENFNEV 95 (343)
T ss_pred hhhheecccCCCeEEEEEEEC-CCCCEEEEEEeCchhhhhHHHHHHHHHHHHHHhcCCCchhhhhhhhcccccccccCcE
Confidence 344578999999999999654 4567899999875322 2345678999999999999999999988543 457
Q ss_pred EEEEEeccCCCccccccCCCCCchhHHHHHHHHHHHHHHHHhhccCCCeEecCCCCCcEEEcCCCCeEEeecCCCccccC
Q 003836 575 LLVYEFMSNGTVASFLFGDSKPNWKLRTEIAMGIAGGLFYLHEECCTQIIHCDIKPQNILLDDHYNARISDFGLAKLLTL 654 (792)
Q Consensus 575 ~lV~E~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dikp~NILl~~~~~~kl~Dfg~a~~~~~ 654 (792)
++++|++ +++|.+++. ...+++..+..++.||+.||.|||+. +|+||||||+|||+++++.+||+|||+++....
T Consensus 96 ~~~~~~~-~~~l~~~~~-~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~~~ 170 (343)
T cd07878 96 YLVTNLM-GADLNNIVK-CQKLSDEHVQFLIYQLLRGLKYIHSA---GIIHRDLKPSNVAVNEDCELRILDFGLARQADD 170 (343)
T ss_pred EEEeecC-CCCHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHC---CeecccCChhhEEECCCCCEEEcCCccceecCC
Confidence 8999988 678887774 35688999999999999999999998 999999999999999999999999999986543
Q ss_pred CCCCccccccccCCccccccccc-CCCCcccceehHHHHHHHHHhcCcCCCcchhhhhhhhHHHHH-------HHhhccc
Q 003836 655 DQSHTNTAIRGTKGYVAPEWFRN-MPITVKVDVYSYGVLLLEIICLRRNIDNEISKVDKAILTDWA-------YDRYQER 726 (792)
Q Consensus 655 ~~~~~~~~~~gt~~y~aPE~~~~-~~~~~k~DV~S~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~-------~~~~~~~ 726 (792)
. .....||+.|+|||.+.+ ..++.++|||||||++|||++|+.||................ .......
T Consensus 171 ~----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 246 (343)
T cd07878 171 E----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGKALFPGNDYIDQLKRIMEVVGTPSPEVLKKISSE 246 (343)
T ss_pred C----cCCccccccccCchHhcCCccCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhcchh
Confidence 2 233468999999999876 578999999999999999999999996532211100000000 0000000
Q ss_pred chhHhhhchhcccCC-------HHHHHHHHHHHHHccccCCCCCCCHHhHHHH
Q 003836 727 TLEALVENDLEAMNN-------VTMLHRFVMVAFWCIQEDPSHRPTMRKVTQM 772 (792)
Q Consensus 727 ~~~~~~~~~~~~~~~-------~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~ 772 (792)
.....+.. +..... ......+.+++.+||+.||.+|||+.|+++.
T Consensus 247 ~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dp~~R~s~~ell~h 298 (343)
T cd07878 247 HARKYIQS-LPHMPQQDLKKIFRGANPLAIDLLEKMLVLDSDKRISASEALAH 298 (343)
T ss_pred hHHHHhhc-cccccchhHHHhccCCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 00000000 000000 0122457899999999999999999999975
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is |
| >cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-33 Score=295.30 Aligned_cols=243 Identities=22% Similarity=0.280 Sum_probs=198.5
Q ss_pred cCccccceEEEeeecCCCceEEEEEEccccc---ccchHHHHHHHHHhcccCCCCcccccceeccCCceEEEEEeccCCC
Q 003836 509 LGRGAFGTVYKGFVNMGSSNHVAVKKLNSVF---QDSEKEFKAEVNGIGQTHHKNLVRLLGYCDEGQNRLLVYEFMSNGT 585 (792)
Q Consensus 509 lG~G~~g~Vy~g~~~~~~~~~vavK~~~~~~---~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~lV~E~~~~gs 585 (792)
||.|++|.||++... ..++.+++|++.... ....+.+.+|+.++++++|+||+++++.+.++...++|+||+++++
T Consensus 1 lg~g~~~~v~~~~~~-~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~ 79 (262)
T cd05572 1 LGVGGFGRVELVKVK-SKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYRTFKDKKYIYMLMEYCLGGE 79 (262)
T ss_pred CCCCCceEEEEEEEC-CCCcEEEEEEEehhcchhhhHHHHHHHHHHHHHhCCCCCEeeeeeeEEcCCccEEEEecCCCCc
Confidence 699999999999764 456789999986532 2345679999999999999999999999999999999999999999
Q ss_pred ccccccCCCCCchhHHHHHHHHHHHHHHHHhhccCCCeEecCCCCCcEEEcCCCCeEEeecCCCccccCCCCCccccccc
Q 003836 586 VASFLFGDSKPNWKLRTEIAMGIAGGLFYLHEECCTQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLDQSHTNTAIRG 665 (792)
Q Consensus 586 L~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dikp~NILl~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~g 665 (792)
|.+++.+...+++..+..++.||+.||+|||+. +++|+||+|+||+++.++.+||+|||+++...... ......+
T Consensus 80 L~~~l~~~~~l~~~~~~~~~~~i~~~l~~lH~~---~~~h~dl~~~nilv~~~~~~~l~df~~~~~~~~~~--~~~~~~~ 154 (262)
T cd05572 80 LWTILRDRGLFDEYTARFYIACVVLAFEYLHNR---GIIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQ--KTWTFCG 154 (262)
T ss_pred HHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhC---CcccCCCCHHHEEEcCCCCEEEeeCCcccccCccc--ccccccC
Confidence 999998877889999999999999999999998 99999999999999999999999999998764332 2223457
Q ss_pred cCCcccccccccCCCCcccceehHHHHHHHHHhcCcCCCcchhhhhhhhHHHHHHHhhcccchhHhhhchhcccCCHHHH
Q 003836 666 TKGYVAPEWFRNMPITVKVDVYSYGVLLLEIICLRRNIDNEISKVDKAILTDWAYDRYQERTLEALVENDLEAMNNVTML 745 (792)
Q Consensus 666 t~~y~aPE~~~~~~~~~k~DV~S~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 745 (792)
++.|+|||.+....++.++|+||||+++|||++|..||.......... ...+.........+....
T Consensus 155 ~~~~~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~--------------~~~~~~~~~~~~~~~~~~ 220 (262)
T cd05572 155 TPEYVAPEIILNKGYDFSVDYWSLGILLYELLTGRPPFGEDDEDPMEI--------------YNDILKGNGKLEFPNYID 220 (262)
T ss_pred CcCccChhHhcCCCCCChhhhhhhHHHHHHHHhCCCCcCCCCCCHHHH--------------HHHHhccCCCCCCCcccC
Confidence 889999999988889999999999999999999999997543211000 011111111122233336
Q ss_pred HHHHHHHHHccccCCCCCCC-----HHhHHH
Q 003836 746 HRFVMVAFWCIQEDPSHRPT-----MRKVTQ 771 (792)
Q Consensus 746 ~~l~~l~~~Cl~~~p~~RPs-----~~evl~ 771 (792)
..+.+++.+||+.+|++||+ ++|+++
T Consensus 221 ~~~~~~i~~~l~~~p~~R~~~~~~~~~~l~~ 251 (262)
T cd05572 221 KAAKDLIKQLLRRNPEERLGNLKGGIKDIKK 251 (262)
T ss_pred HHHHHHHHHHccCChhhCcCCcccCHHHHhc
Confidence 78899999999999999999 666665
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi |
| >cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-34 Score=300.66 Aligned_cols=261 Identities=19% Similarity=0.263 Sum_probs=194.2
Q ss_pred hhhhhcCccccceEEEeeecCCCceEEEEEEccccc--ccchHHHHHHHHHhcccCCCCcccccceeccCCceEEEEEec
Q 003836 504 GFKEELGRGAFGTVYKGFVNMGSSNHVAVKKLNSVF--QDSEKEFKAEVNGIGQTHHKNLVRLLGYCDEGQNRLLVYEFM 581 (792)
Q Consensus 504 ~~~~~lG~G~~g~Vy~g~~~~~~~~~vavK~~~~~~--~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~lV~E~~ 581 (792)
.+.+.||+|+||.||++... .+++.+|+|++.... ......+.+|++++++++|+||+++++++.+....++|+||+
T Consensus 3 ~~~~~l~~g~~~~vy~~~~~-~~g~~~~~k~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 81 (284)
T cd07839 3 EKLEKIGEGTYGTVFKAKNR-ETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLYDVLHSDKKLTLVFEYC 81 (284)
T ss_pred eeEEEecccCCeEEEEEEEC-CCCcEEEEEEeecccccccCccchhHHHHHHHhcCCCCeeeHHHHhccCCceEEEEecC
Confidence 34578999999999999754 456789999986432 223456888999999999999999999999999999999999
Q ss_pred cCCCccccccC-CCCCchhHHHHHHHHHHHHHHHHhhccCCCeEecCCCCCcEEEcCCCCeEEeecCCCccccCCCCCcc
Q 003836 582 SNGTVASFLFG-DSKPNWKLRTEIAMGIAGGLFYLHEECCTQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLDQSHTN 660 (792)
Q Consensus 582 ~~gsL~~~l~~-~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dikp~NILl~~~~~~kl~Dfg~a~~~~~~~~~~~ 660 (792)
++ +|.+++.. ...+++..+..++.||++||.|||+. +|+|+||||+||+++.++.+||+|||+++....... ..
T Consensus 82 ~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~---~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~~-~~ 156 (284)
T cd07839 82 DQ-DLKKYFDSCNGDIDPEIVKSFMFQLLKGLAFCHSH---NVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVR-CY 156 (284)
T ss_pred CC-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCCHHHEEEcCCCcEEECccchhhccCCCCC-Cc
Confidence 75 78777754 45689999999999999999999998 999999999999999999999999999986543222 12
Q ss_pred ccccccCCcccccccccC-CCCcccceehHHHHHHHHHhcCcCCCcchhhhhhh-hHHHHHHHhhccc---chhHhhhch
Q 003836 661 TAIRGTKGYVAPEWFRNM-PITVKVDVYSYGVLLLEIICLRRNIDNEISKVDKA-ILTDWAYDRYQER---TLEALVEND 735 (792)
Q Consensus 661 ~~~~gt~~y~aPE~~~~~-~~~~k~DV~S~Gv~l~el~tg~~p~~~~~~~~~~~-~~~~~~~~~~~~~---~~~~~~~~~ 735 (792)
....+++.|+|||.+.+. .++.++|||||||++|||++|+.|+.......... .+.... ....+. .+....+..
T Consensus 157 ~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~ 235 (284)
T cd07839 157 SAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLL-GTPTEESWPGVSKLPDYK 235 (284)
T ss_pred CCCccccCCcChHHHhCCcccCcHHHHHHHHHHHHHHHhcCCCCcCCCCHHHHHHHHHHHh-CCCChHHhHHhhhccccc
Confidence 234578899999998764 47899999999999999999999875432211110 000000 000000 000000000
Q ss_pred ----hc-----ccCCHHHHHHHHHHHHHccccCCCCCCCHHhHHH
Q 003836 736 ----LE-----AMNNVTMLHRFVMVAFWCIQEDPSHRPTMRKVTQ 771 (792)
Q Consensus 736 ----~~-----~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~ 771 (792)
.. .......+.++.+++.+||+.||.+|||++|+++
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~il~ 280 (284)
T cd07839 236 PYPMYPATTSLVNVVPKLNSTGRDLLQNLLVCNPVQRISAEEALQ 280 (284)
T ss_pred ccCCCCCcchhhhhcccCCHHHHHHHHHHhcCChhhcCCHHHHhc
Confidence 00 0011224567889999999999999999999987
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also |
| >cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-33 Score=295.27 Aligned_cols=249 Identities=26% Similarity=0.348 Sum_probs=204.9
Q ss_pred hhhhhcCccccceEEEeeecCCCceEEEEEEcccccc-cchHHHHHHHHHhcccCCCCcccccceeccCCceEEEEEecc
Q 003836 504 GFKEELGRGAFGTVYKGFVNMGSSNHVAVKKLNSVFQ-DSEKEFKAEVNGIGQTHHKNLVRLLGYCDEGQNRLLVYEFMS 582 (792)
Q Consensus 504 ~~~~~lG~G~~g~Vy~g~~~~~~~~~vavK~~~~~~~-~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~lV~E~~~ 582 (792)
.+.+.||+|++|.||++.... +++.+++|++..... ...+.+.+|++.+.+++|+||+++++++...+..++|+||++
T Consensus 4 ~~~~~i~~g~~~~v~~~~~~~-~~~~~~vk~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~ 82 (264)
T cd06623 4 ERVKVLGQGSSGVVYKVRHKP-TGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPYVVKCYGAFYKEGEISIVLEYMD 82 (264)
T ss_pred eeeeeeeecCCeEEEEEEEcC-CCcEEEEEEeccCcchHHHHHHHHHHHHHHhcCCCCeeeEEEEEccCCeEEEEEEecC
Confidence 345789999999999997653 567899999876543 456789999999999999999999999999999999999999
Q ss_pred CCCccccccCCCCCchhHHHHHHHHHHHHHHHHhh-ccCCCeEecCCCCCcEEEcCCCCeEEeecCCCccccCCCCCccc
Q 003836 583 NGTVASFLFGDSKPNWKLRTEIAMGIAGGLFYLHE-ECCTQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLDQSHTNT 661 (792)
Q Consensus 583 ~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~-~~~~~ivH~dikp~NILl~~~~~~kl~Dfg~a~~~~~~~~~~~~ 661 (792)
+++|.+++.....+++..+..++.|+++||+|||+ . +++|+||+|+||+++.++.++|+|||++.......... .
T Consensus 83 ~~~L~~~l~~~~~l~~~~~~~~~~~l~~~l~~lh~~~---~~~H~~l~~~ni~~~~~~~~~l~df~~~~~~~~~~~~~-~ 158 (264)
T cd06623 83 GGSLADLLKKVGKIPEPVLAYIARQILKGLDYLHTKR---HIIHRDIKPSNLLINSKGEVKIADFGISKVLENTLDQC-N 158 (264)
T ss_pred CCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhccC---CCccCCCCHHHEEECCCCCEEEccCccceecccCCCcc-c
Confidence 99999999877889999999999999999999999 8 99999999999999999999999999998765433222 2
Q ss_pred cccccCCcccccccccCCCCcccceehHHHHHHHHHhcCcCCCcchhhhhhhhHHHHHHHhhcccchhHhhhchhcccCC
Q 003836 662 AIRGTKGYVAPEWFRNMPITVKVDVYSYGVLLLEIICLRRNIDNEISKVDKAILTDWAYDRYQERTLEALVENDLEAMNN 741 (792)
Q Consensus 662 ~~~gt~~y~aPE~~~~~~~~~k~DV~S~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 741 (792)
...++..|+|||.+.+..++.++||||||+++|||++|+.|+........... ...+.... ....+
T Consensus 159 ~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~-------------~~~~~~~~-~~~~~ 224 (264)
T cd06623 159 TFVGTVTYMSPERIQGESYSYAADIWSLGLTLLECALGKFPFLPPGQPSFFEL-------------MQAICDGP-PPSLP 224 (264)
T ss_pred ceeecccccCHhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCccccccCHHHH-------------HHHHhcCC-CCCCC
Confidence 34578899999999998999999999999999999999999865432100000 01111111 11122
Q ss_pred HH-HHHHHHHHHHHccccCCCCCCCHHhHHH
Q 003836 742 VT-MLHRFVMVAFWCIQEDPSHRPTMRKVTQ 771 (792)
Q Consensus 742 ~~-~~~~l~~l~~~Cl~~~p~~RPs~~evl~ 771 (792)
.. .+..+.+++.+||+.+|++||++.|+++
T Consensus 225 ~~~~~~~l~~li~~~l~~~p~~R~~~~~ll~ 255 (264)
T cd06623 225 AEEFSPEFRDFISACLQKDPKKRPSAAELLQ 255 (264)
T ss_pred cccCCHHHHHHHHHHccCChhhCCCHHHHHh
Confidence 22 5678899999999999999999999998
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of |
| >cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-33 Score=294.40 Aligned_cols=246 Identities=20% Similarity=0.293 Sum_probs=199.5
Q ss_pred hhhhhcCccccceEEEeeecCCCceEEEEEEcccc--cccchHHHHHHHHHhcccCCCCcccccceeccCCceEEEEEec
Q 003836 504 GFKEELGRGAFGTVYKGFVNMGSSNHVAVKKLNSV--FQDSEKEFKAEVNGIGQTHHKNLVRLLGYCDEGQNRLLVYEFM 581 (792)
Q Consensus 504 ~~~~~lG~G~~g~Vy~g~~~~~~~~~vavK~~~~~--~~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~lV~E~~ 581 (792)
.+.+.||+|+||.||++... .+++.+++|++... .....+++.+|+.++++++|+||+++++++.+.+..++|+||+
T Consensus 3 ~~~~~lg~g~~g~~~~~~~~-~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~ 81 (256)
T cd08218 3 VKVKKIGEGSFGKAILVKSK-EDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQYQESFEENGNLYIVMDYC 81 (256)
T ss_pred eEEEEeccCCceEEEEEEEc-CCCCEEEEEEEEhHhCChHHHHHHHHHHHHHHhCCCCCeeeeEeeecCCCeEEEEEecC
Confidence 34578999999999999764 35678999998643 2334568999999999999999999999999999999999999
Q ss_pred cCCCccccccCC--CCCchhHHHHHHHHHHHHHHHHhhccCCCeEecCCCCCcEEEcCCCCeEEeecCCCccccCCCCCc
Q 003836 582 SNGTVASFLFGD--SKPNWKLRTEIAMGIAGGLFYLHEECCTQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLDQSHT 659 (792)
Q Consensus 582 ~~gsL~~~l~~~--~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dikp~NILl~~~~~~kl~Dfg~a~~~~~~~~~~ 659 (792)
++++|.+++... ..+++..+.+++.|++.||.|||+. +++|+||+|+|||++.++.++|+|||++........ .
T Consensus 82 ~~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~~l~~~nil~~~~~~~~l~d~~~~~~~~~~~~-~ 157 (256)
T cd08218 82 EGGDLYKKINAQRGVLFPEDQILDWFVQICLALKHVHDR---KILHRDIKSQNIFLTKDGTIKLGDFGIARVLNSTVE-L 157 (256)
T ss_pred CCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEEcCCCCEEEeeccceeecCcchh-h
Confidence 999999988654 3578899999999999999999998 999999999999999999999999999986543221 1
Q ss_pred cccccccCCcccccccccCCCCcccceehHHHHHHHHHhcCcCCCcchhhhhhhhHHHHHHHhhcccchhHhhhchhccc
Q 003836 660 NTAIRGTKGYVAPEWFRNMPITVKVDVYSYGVLLLEIICLRRNIDNEISKVDKAILTDWAYDRYQERTLEALVENDLEAM 739 (792)
Q Consensus 660 ~~~~~gt~~y~aPE~~~~~~~~~k~DV~S~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 739 (792)
.....+++.|+|||.+.+..++.++||||||+++++|++|+.||........ . ..++.. ....
T Consensus 158 ~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~~~-------~---------~~~~~~-~~~~ 220 (256)
T cd08218 158 ARTCIGTPYYLSPEICENRPYNNKSDIWALGCVLYEMCTLKHAFEAGNMKNL-------V---------LKIIRG-SYPP 220 (256)
T ss_pred hhhccCCccccCHHHhCCCCCCCccchhHHHHHHHHHHcCCCCccCCCHHHH-------H---------HHHhcC-CCCC
Confidence 2234578899999999988999999999999999999999999864322100 0 001111 0111
Q ss_pred CCHHHHHHHHHHHHHccccCCCCCCCHHhHHH
Q 003836 740 NNVTMLHRFVMVAFWCIQEDPSHRPTMRKVTQ 771 (792)
Q Consensus 740 ~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~ 771 (792)
.+......+.+++.+||+.+|++||++.+|++
T Consensus 221 ~~~~~~~~~~~li~~~l~~~p~~Rp~~~~vl~ 252 (256)
T cd08218 221 VSSHYSYDLRNLVSQLFKRNPRDRPSVNSILE 252 (256)
T ss_pred CcccCCHHHHHHHHHHhhCChhhCcCHHHHhh
Confidence 23344667899999999999999999999998
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti |
| >cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-33 Score=300.02 Aligned_cols=256 Identities=25% Similarity=0.355 Sum_probs=196.3
Q ss_pred HHHHHHHHhhh--hhhcCccccceEEEeeecCCCceEEEEEEcccccccchHHHHHHHHHhccc-CCCCcccccceeccC
Q 003836 495 YKELVEVTRGF--KEELGRGAFGTVYKGFVNMGSSNHVAVKKLNSVFQDSEKEFKAEVNGIGQT-HHKNLVRLLGYCDEG 571 (792)
Q Consensus 495 ~~el~~~~~~~--~~~lG~G~~g~Vy~g~~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l-~h~niv~l~g~~~~~ 571 (792)
..++..++.+| .+.||+|+||.||++... .+++.+|+|.+... ......+.+|+.+++++ +|+|++++++++...
T Consensus 14 ~~~~~~~~~~y~~~~~l~~g~~~~vy~~~~~-~~~~~~aik~~~~~-~~~~~~~~~e~~~l~~l~~h~ni~~~~~~~~~~ 91 (291)
T cd06639 14 LESLGDPTDTWEIIETIGKGTYGKVYKVTNK-KDGSLAAVKILDPI-SDVDEEIEAEYNILQSLPNHPNVVKFYGMFYKA 91 (291)
T ss_pred cccCCCCCCCeEEEEEeecCCCeEEEEEEEC-CCCCEEEEEEeccc-ccHHHHHHHHHHHHHHhcCCCCeEEEEEEEEec
Confidence 33444444444 468999999999999754 45678999998653 23346788899999998 899999999998643
Q ss_pred -----CceEEEEEeccCCCccccccC----CCCCchhHHHHHHHHHHHHHHHHhhccCCCeEecCCCCCcEEEcCCCCeE
Q 003836 572 -----QNRLLVYEFMSNGTVASFLFG----DSKPNWKLRTEIAMGIAGGLFYLHEECCTQIIHCDIKPQNILLDDHYNAR 642 (792)
Q Consensus 572 -----~~~~lV~E~~~~gsL~~~l~~----~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dikp~NILl~~~~~~k 642 (792)
...++|+||+++++|.+++.. ...+++..+..++.|++.||.|||+. +++|+||||+||++++++.+|
T Consensus 92 ~~~~~~~~~lv~ey~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~dlkp~nili~~~~~~k 168 (291)
T cd06639 92 DKLVGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHLHNN---RIIHRDVKGNNILLTTEGGVK 168 (291)
T ss_pred cccCCCeeEEEEEECCCCcHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHEEEcCCCCEE
Confidence 358999999999999998753 35688999999999999999999998 999999999999999999999
Q ss_pred EeecCCCccccCCCCCccccccccCCcccccccccC-----CCCcccceehHHHHHHHHHhcCcCCCcchhhhhhhhHHH
Q 003836 643 ISDFGLAKLLTLDQSHTNTAIRGTKGYVAPEWFRNM-----PITVKVDVYSYGVLLLEIICLRRNIDNEISKVDKAILTD 717 (792)
Q Consensus 643 l~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-----~~~~k~DV~S~Gv~l~el~tg~~p~~~~~~~~~~~~~~~ 717 (792)
|+|||+++........ .....++..|+|||.+... .++.++|||||||++|||++|+.||........ +..
T Consensus 169 l~dfg~~~~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slGvi~~el~~g~~p~~~~~~~~~---~~~ 244 (291)
T cd06639 169 LVDFGVSAQLTSTRLR-RNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDMHPVKT---LFK 244 (291)
T ss_pred Eeecccchhccccccc-ccCccCCccccChhhhcCCCCcccccCCccchHHHHHHHHHHhhCCCCCCCCcHHHH---HHH
Confidence 9999998865432211 1234578899999998643 368999999999999999999999865422111 000
Q ss_pred HHHHhhcccchhHhhhchhcccCCHHHHHHHHHHHHHccccCCCCCCCHHhHHH
Q 003836 718 WAYDRYQERTLEALVENDLEAMNNVTMLHRFVMVAFWCIQEDPSHRPTMRKVTQ 771 (792)
Q Consensus 718 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~ 771 (792)
........ ...+......+.+++.+||+.+|++||++.|+++
T Consensus 245 -----~~~~~~~~-------~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~ 286 (291)
T cd06639 245 -----IPRNPPPT-------LLHPEKWCRSFNHFISQCLIKDFEARPSVTHLLE 286 (291)
T ss_pred -----HhcCCCCC-------CCcccccCHHHHHHHHHHhhcChhhCcCHHHHhc
Confidence 00000000 0112234457889999999999999999999998
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre |
| >cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-33 Score=295.02 Aligned_cols=250 Identities=25% Similarity=0.368 Sum_probs=198.2
Q ss_pred hhhhhcCccccceEEEeeecCCCceEEEEEEcccc--cccchHHHHHHHHHhcccCCCCcccccceecc--CCceEEEEE
Q 003836 504 GFKEELGRGAFGTVYKGFVNMGSSNHVAVKKLNSV--FQDSEKEFKAEVNGIGQTHHKNLVRLLGYCDE--GQNRLLVYE 579 (792)
Q Consensus 504 ~~~~~lG~G~~g~Vy~g~~~~~~~~~vavK~~~~~--~~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~--~~~~~lV~E 579 (792)
.+.+.||.|+||.||++... .+++.+|+|++... .....+.+.+|++++++++|+||+++++++.. ....+++||
T Consensus 3 ~~~~~lg~g~~~~v~~~~~~-~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~e 81 (265)
T cd08217 3 EVLETIGKGSFGTVRKVRRK-SDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIVRYYDRIIDRSNQTLYIVME 81 (265)
T ss_pred eeeeeeccCCCeEEEEeeec-CCCCEEEEEEEecccCCHHHHHHHHHHHHHHHhcCCCccceeeeeeecCCCCEEEEEeh
Confidence 34577999999999999654 45678999988643 23345678899999999999999999998753 456789999
Q ss_pred eccCCCccccccC----CCCCchhHHHHHHHHHHHHHHHHhhcc--CCCeEecCCCCCcEEEcCCCCeEEeecCCCcccc
Q 003836 580 FMSNGTVASFLFG----DSKPNWKLRTEIAMGIAGGLFYLHEEC--CTQIIHCDIKPQNILLDDHYNARISDFGLAKLLT 653 (792)
Q Consensus 580 ~~~~gsL~~~l~~----~~~l~~~~~~~i~~~ia~gL~yLH~~~--~~~ivH~dikp~NILl~~~~~~kl~Dfg~a~~~~ 653 (792)
|+++++|.+++.. ...+++..+..++.||+.||+|||..+ ..+++|+||+|+||++++++.+||+|||+++...
T Consensus 82 ~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~~i~h~dl~p~nili~~~~~~kl~d~g~~~~~~ 161 (265)
T cd08217 82 YCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKILG 161 (265)
T ss_pred hccCCCHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhcCccccCcceecCCCHHHEEEecCCCEEEeccccccccc
Confidence 9999999999865 356889999999999999999999322 2399999999999999999999999999998765
Q ss_pred CCCCCccccccccCCcccccccccCCCCcccceehHHHHHHHHHhcCcCCCcchhhhhhhhHHHHHHHhhcccchhHhhh
Q 003836 654 LDQSHTNTAIRGTKGYVAPEWFRNMPITVKVDVYSYGVLLLEIICLRRNIDNEISKVDKAILTDWAYDRYQERTLEALVE 733 (792)
Q Consensus 654 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DV~S~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 733 (792)
..... .....+++.|+|||.+.+..++.++||||||+++++|++|+.||....... +. .. +.
T Consensus 162 ~~~~~-~~~~~~~~~~~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~----~~----~~---------~~ 223 (265)
T cd08217 162 HDSSF-AKTYVGTPYYMSPEQLNHMSYDEKSDIWSLGCLIYELCALSPPFTARNQLQ----LA----SK---------IK 223 (265)
T ss_pred CCccc-ccccccCCCccChhhhcCCCCCchhHHHHHHHHHHHHHHCCCcccCcCHHH----HH----HH---------Hh
Confidence 43321 233458999999999998889999999999999999999999997543110 00 00 11
Q ss_pred chhcccCCHHHHHHHHHHHHHccccCCCCCCCHHhHHHH
Q 003836 734 NDLEAMNNVTMLHRFVMVAFWCIQEDPSHRPTMRKVTQM 772 (792)
Q Consensus 734 ~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~ 772 (792)
.......+...+..+.+++.+||+.+|++||++++|+++
T Consensus 224 ~~~~~~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~il~~ 262 (265)
T cd08217 224 EGKFRRIPYRYSSELNEVIKSMLNVDPDKRPSTEELLQL 262 (265)
T ss_pred cCCCCCCccccCHHHHHHHHHHccCCcccCCCHHHHhhC
Confidence 111112233456788999999999999999999999983
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi |
| >cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-33 Score=294.65 Aligned_cols=246 Identities=23% Similarity=0.350 Sum_probs=198.5
Q ss_pred cCccccceEEEeeecCCCceEEEEEEcccccc---cchHHHHHHHHHhcccCCCCcccccceeccCCceEEEEEeccCCC
Q 003836 509 LGRGAFGTVYKGFVNMGSSNHVAVKKLNSVFQ---DSEKEFKAEVNGIGQTHHKNLVRLLGYCDEGQNRLLVYEFMSNGT 585 (792)
Q Consensus 509 lG~G~~g~Vy~g~~~~~~~~~vavK~~~~~~~---~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~lV~E~~~~gs 585 (792)
||+|+||.||++... .+++.+++|.+..... ...+.+.+|++++++++|+||+++++.+..+...++|+||+++++
T Consensus 1 lg~g~~~~vy~~~~~-~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~ 79 (265)
T cd05579 1 ISKGAYGRVFLAKKK-STGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYYSFQGKKNLYLVMEYLPGGD 79 (265)
T ss_pred CCCCCceEEEEEEEC-CCCCEEEEEEecchhhhhhhHHHHHHHHHHHHHhCCCcchhHHHHheecCcEEEEEEecCCCCc
Confidence 689999999999764 4467899999865433 345678999999999999999999999999999999999999999
Q ss_pred ccccccCCCCCchhHHHHHHHHHHHHHHHHhhccCCCeEecCCCCCcEEEcCCCCeEEeecCCCccccCCCC-------C
Q 003836 586 VASFLFGDSKPNWKLRTEIAMGIAGGLFYLHEECCTQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLDQS-------H 658 (792)
Q Consensus 586 L~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dikp~NILl~~~~~~kl~Dfg~a~~~~~~~~-------~ 658 (792)
|.+++.+...+++..+..++.||+.||+|||+. +++|+||+|+||++++++.+||+|||++........ .
T Consensus 80 L~~~l~~~~~~~~~~~~~i~~qi~~~L~~lH~~---~i~H~di~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~ 156 (265)
T cd05579 80 LASLLENVGSLDEDVARIYIAEIVLALEYLHSN---GIIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDEK 156 (265)
T ss_pred HHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHc---CeecCCCCHHHeEEcCCCCEEEEecccchhcccCcccccccccc
Confidence 999998777889999999999999999999998 999999999999999999999999999886543321 1
Q ss_pred ccccccccCCcccccccccCCCCcccceehHHHHHHHHHhcCcCCCcchhhhhhhhHHHHHHHhhcccchhHhhhchhcc
Q 003836 659 TNTAIRGTKGYVAPEWFRNMPITVKVDVYSYGVLLLEIICLRRNIDNEISKVDKAILTDWAYDRYQERTLEALVENDLEA 738 (792)
Q Consensus 659 ~~~~~~gt~~y~aPE~~~~~~~~~k~DV~S~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 738 (792)
......++..|+|||.+.....+.++||||||++++||++|+.||........ . ..+.......
T Consensus 157 ~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~---~-------------~~~~~~~~~~ 220 (265)
T cd05579 157 EDKRIVGTPDYIAPEVILGQGHSKTVDWWSLGCILYEFLVGIPPFHGETPEEI---F-------------QNILNGKIEW 220 (265)
T ss_pred cccCcccCccccCHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHH---H-------------HHHhcCCcCC
Confidence 22334578899999999888899999999999999999999999965432110 0 0011111111
Q ss_pred cCCHHHHHHHHHHHHHccccCCCCCCCHHhHHHHhc
Q 003836 739 MNNVTMLHRFVMVAFWCIQEDPSHRPTMRKVTQMLE 774 (792)
Q Consensus 739 ~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~L~ 774 (792)
......+..+.+++.+||+.+|.+|||+.++.+.|+
T Consensus 221 ~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~~~~~l~ 256 (265)
T cd05579 221 PEDVEVSDEAIDLISKLLVPDPEKRLGAKSIEEIKN 256 (265)
T ss_pred CccccCCHHHHHHHHHHhcCCHhhcCCCccHHHHhc
Confidence 111112577889999999999999999966666664
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re |
| >cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-33 Score=292.53 Aligned_cols=245 Identities=24% Similarity=0.354 Sum_probs=197.6
Q ss_pred hhhhhcCccccceEEEeeecCCCceEEEEEEcccc--cccchHHHHHHHHHhcccCCCCcccccceeccCCceEEEEEec
Q 003836 504 GFKEELGRGAFGTVYKGFVNMGSSNHVAVKKLNSV--FQDSEKEFKAEVNGIGQTHHKNLVRLLGYCDEGQNRLLVYEFM 581 (792)
Q Consensus 504 ~~~~~lG~G~~g~Vy~g~~~~~~~~~vavK~~~~~--~~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~lV~E~~ 581 (792)
.+.+.||+|++|.||++... .+++.+|+|.+... .....+.+.+|++++++++|+||+++++.+..++..++||||+
T Consensus 3 ~~~~~lg~g~~~~v~~~~~~-~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~ 81 (256)
T cd08220 3 EKIRVVGRGAFGIVHLCRRK-ADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNIIEYYENFLEDKALMIVMEYA 81 (256)
T ss_pred eEEEEecccCceEEEEEEEc-CCCcEEEEEEEeccccccHHHHHHHHHHHHHhhCCCCchhheeeeEecCCEEEEEEecC
Confidence 45578999999999999654 45678999998653 2334568999999999999999999999999999999999999
Q ss_pred cCCCccccccCC--CCCchhHHHHHHHHHHHHHHHHhhccCCCeEecCCCCCcEEEcCC-CCeEEeecCCCccccCCCCC
Q 003836 582 SNGTVASFLFGD--SKPNWKLRTEIAMGIAGGLFYLHEECCTQIIHCDIKPQNILLDDH-YNARISDFGLAKLLTLDQSH 658 (792)
Q Consensus 582 ~~gsL~~~l~~~--~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dikp~NILl~~~-~~~kl~Dfg~a~~~~~~~~~ 658 (792)
++++|.+++... ..+++..+.+++.|+++||+|||+. +++|+||+|+||+++++ ..+||+|||+++......
T Consensus 82 ~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~---~i~h~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~-- 156 (256)
T cd08220 82 PGGTLAEYIQKRCNSLLDEDTILHFFVQILLALHHVHTK---LILHRDLKTQNILLDKHKMVVKIGDFGISKILSSKS-- 156 (256)
T ss_pred CCCCHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEEccCCCceecCCCc--
Confidence 999999999764 3578999999999999999999998 99999999999999865 458999999998764322
Q ss_pred ccccccccCCcccccccccCCCCcccceehHHHHHHHHHhcCcCCCcchhhhhhhhHHHHHHHhhcccchhHhhhchhcc
Q 003836 659 TNTAIRGTKGYVAPEWFRNMPITVKVDVYSYGVLLLEIICLRRNIDNEISKVDKAILTDWAYDRYQERTLEALVENDLEA 738 (792)
Q Consensus 659 ~~~~~~gt~~y~aPE~~~~~~~~~k~DV~S~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 738 (792)
......++..|+|||.+....++.++||||||+++|+|++|+.||........ ... .... ...
T Consensus 157 ~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~-------~~~---------~~~~-~~~ 219 (256)
T cd08220 157 KAYTVVGTPCYISPELCEGKPYNQKSDIWALGCVLYELASLKRAFEAANLPAL-------VLK---------IMSG-TFA 219 (256)
T ss_pred cccccccCCcccCchhccCCCCCcccchHHHHHHHHHHHhCCCCcccCchHHH-------HHH---------HHhc-CCC
Confidence 12234578899999999988899999999999999999999999865422110 000 0000 001
Q ss_pred cCCHHHHHHHHHHHHHccccCCCCCCCHHhHHH
Q 003836 739 MNNVTMLHRFVMVAFWCIQEDPSHRPTMRKVTQ 771 (792)
Q Consensus 739 ~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~ 771 (792)
..+......+.+++.+||+.+|++|||++|+++
T Consensus 220 ~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~ll~ 252 (256)
T cd08220 220 PISDRYSPDLRQLILSMLNLDPSKRPQLSQIMA 252 (256)
T ss_pred CCCCCcCHHHHHHHHHHccCChhhCCCHHHHhh
Confidence 112234567889999999999999999999987
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with |
| >cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-33 Score=297.44 Aligned_cols=244 Identities=23% Similarity=0.357 Sum_probs=198.1
Q ss_pred hhcCccccceEEEeeecCCCceEEEEEEcccccccchHHHHHHHHHhcccCCCCcccccceeccCCceEEEEEeccCCCc
Q 003836 507 EELGRGAFGTVYKGFVNMGSSNHVAVKKLNSVFQDSEKEFKAEVNGIGQTHHKNLVRLLGYCDEGQNRLLVYEFMSNGTV 586 (792)
Q Consensus 507 ~~lG~G~~g~Vy~g~~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~lV~E~~~~gsL 586 (792)
+.||+|++|.||++... ..++.+++|++........+.+.+|+.++++++|+||+++++++...+..++|+||+++++|
T Consensus 25 ~~lg~g~~g~v~~~~~~-~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~~~h~~vv~~~~~~~~~~~~~~v~e~~~~~~L 103 (285)
T cd06648 25 VKIGEGSTGIVCIATDK-STGRQVAVKKMDLRKQQRRELLFNEVVIMRDYQHPNIVEMYSSYLVGDELWVVMEFLEGGAL 103 (285)
T ss_pred eEeccCCCeEEEEEEEC-CCCCEEEEEEEeccchhHHHHHHHHHHHHHHcCCCChheEEEEEEcCCeEEEEEeccCCCCH
Confidence 57999999999999754 45678999998765555567789999999999999999999999999999999999999999
Q ss_pred cccccCCCCCchhHHHHHHHHHHHHHHHHhhccCCCeEecCCCCCcEEEcCCCCeEEeecCCCccccCCCCCcccccccc
Q 003836 587 ASFLFGDSKPNWKLRTEIAMGIAGGLFYLHEECCTQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLDQSHTNTAIRGT 666 (792)
Q Consensus 587 ~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dikp~NILl~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~gt 666 (792)
.+++.. ..+++..+..++.|++.||+|||+. +++||||+|+||+++.++.++|+|||.+........ ......|+
T Consensus 104 ~~~~~~-~~~~~~~~~~~~~ql~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~~l~d~g~~~~~~~~~~-~~~~~~~~ 178 (285)
T cd06648 104 TDIVTH-TRMNEEQIATVCLAVLKALSFLHAQ---GVIHRDIKSDSILLTSDGRVKLSDFGFCAQVSKEVP-RRKSLVGT 178 (285)
T ss_pred HHHHHh-CCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCChhhEEEcCCCcEEEcccccchhhccCCc-ccccccCC
Confidence 999876 5688999999999999999999998 999999999999999999999999998876543221 12234588
Q ss_pred CCcccccccccCCCCcccceehHHHHHHHHHhcCcCCCcchhhhhhhhHHHHHHHhhcccchhHhhhchhcccCCHHHHH
Q 003836 667 KGYVAPEWFRNMPITVKVDVYSYGVLLLEIICLRRNIDNEISKVDKAILTDWAYDRYQERTLEALVENDLEAMNNVTMLH 746 (792)
Q Consensus 667 ~~y~aPE~~~~~~~~~k~DV~S~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 746 (792)
+.|+|||.+.+..++.++||||||++++||++|+.||......... ....... .+.. ........
T Consensus 179 ~~y~aPE~~~~~~~~~~~Dv~slGv~l~ell~g~~p~~~~~~~~~~--------~~~~~~~-----~~~~--~~~~~~~~ 243 (285)
T cd06648 179 PYWMAPEVISRLPYGTEVDIWSLGIMVIEMVDGEPPYFNEPPLQAM--------KRIRDNL-----PPKL--KNLHKVSP 243 (285)
T ss_pred ccccCHHHhcCCCCCCcccHHHHHHHHHHHHhCCCCCcCCCHHHHH--------HHHHhcC-----CCCC--cccccCCH
Confidence 9999999998888999999999999999999999998653221000 0000000 0000 01112456
Q ss_pred HHHHHHHHccccCCCCCCCHHhHHH
Q 003836 747 RFVMVAFWCIQEDPSHRPTMRKVTQ 771 (792)
Q Consensus 747 ~l~~l~~~Cl~~~p~~RPs~~evl~ 771 (792)
.+.+++.+||+.+|++||++.++++
T Consensus 244 ~l~~li~~~l~~~p~~Rpt~~~il~ 268 (285)
T cd06648 244 RLRSFLDRMLVRDPAQRATAAELLN 268 (285)
T ss_pred HHHHHHHHHcccChhhCcCHHHHcc
Confidence 7899999999999999999999986
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun |
| >cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-33 Score=295.30 Aligned_cols=247 Identities=24% Similarity=0.344 Sum_probs=198.9
Q ss_pred hhhhhhcCccccceEEEeeecCCCceEEEEEEccccc-ccchHHHHHHHHHhcccCCCCcccccceeccCCceEEEEEec
Q 003836 503 RGFKEELGRGAFGTVYKGFVNMGSSNHVAVKKLNSVF-QDSEKEFKAEVNGIGQTHHKNLVRLLGYCDEGQNRLLVYEFM 581 (792)
Q Consensus 503 ~~~~~~lG~G~~g~Vy~g~~~~~~~~~vavK~~~~~~-~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~lV~E~~ 581 (792)
+.+.++||+|+||.||+|... .+++.+|+|.+.... ....+.+.+|+.++.+++|+||+++++++..+...++||||+
T Consensus 6 ~~~~~~ig~G~~~~vy~~~~~-~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 84 (277)
T cd06641 6 FTKLEKIGKGSFGEVFKGIDN-RTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEYL 84 (277)
T ss_pred hhhheeEeecCCeEEEEEEEC-CCCcEEEEEEeccccchHHHHHHHHHHHHHHhcCCCCEeEEEEEEEeCCeEEEEEEeC
Confidence 345678999999999999653 456789999876432 234467899999999999999999999999999999999999
Q ss_pred cCCCccccccCCCCCchhHHHHHHHHHHHHHHHHhhccCCCeEecCCCCCcEEEcCCCCeEEeecCCCccccCCCCCccc
Q 003836 582 SNGTVASFLFGDSKPNWKLRTEIAMGIAGGLFYLHEECCTQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLDQSHTNT 661 (792)
Q Consensus 582 ~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dikp~NILl~~~~~~kl~Dfg~a~~~~~~~~~~~~ 661 (792)
++++|.+++.. ..+++..+..++.|++.||.|||+. +++|+||+|+||+++.++.++|+|||++....... ....
T Consensus 85 ~~~~l~~~i~~-~~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~dl~p~Ni~i~~~~~~~l~dfg~~~~~~~~~-~~~~ 159 (277)
T cd06641 85 GGGSALDLLEP-GPLDETQIATILREILKGLDYLHSE---KKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQ-IKRN 159 (277)
T ss_pred CCCcHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHccC---CeecCCCCHHhEEECCCCCEEEeecccceecccch-hhhc
Confidence 99999999864 4578999999999999999999998 99999999999999999999999999987654322 1122
Q ss_pred cccccCCcccccccccCCCCcccceehHHHHHHHHHhcCcCCCcchhhhhhhhHHHHHHHhhcccchhHhhhchhcccCC
Q 003836 662 AIRGTKGYVAPEWFRNMPITVKVDVYSYGVLLLEIICLRRNIDNEISKVDKAILTDWAYDRYQERTLEALVENDLEAMNN 741 (792)
Q Consensus 662 ~~~gt~~y~aPE~~~~~~~~~k~DV~S~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 741 (792)
...++..|+|||.+.+..++.++|||||||++|||++|..|+........ . .. +........+
T Consensus 160 ~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~-------~-~~---------~~~~~~~~~~ 222 (277)
T cd06641 160 TFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPPHSELHPMKV-------L-FL---------IPKNNPPTLE 222 (277)
T ss_pred cccCCccccChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCccchHHH-------H-HH---------HhcCCCCCCC
Confidence 34578899999999888899999999999999999999999864321100 0 00 0000111122
Q ss_pred HHHHHHHHHHHHHccccCCCCCCCHHhHHHH
Q 003836 742 VTMLHRFVMVAFWCIQEDPSHRPTMRKVTQM 772 (792)
Q Consensus 742 ~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~ 772 (792)
......+.+++.+||+.+|.+||++.++++.
T Consensus 223 ~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~~ 253 (277)
T cd06641 223 GNYSKPLKEFVEACLNKEPSFRPTAKELLKH 253 (277)
T ss_pred cccCHHHHHHHHHHccCChhhCcCHHHHHhC
Confidence 2345678899999999999999999999984
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int |
| >cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-33 Score=296.32 Aligned_cols=243 Identities=23% Similarity=0.253 Sum_probs=189.8
Q ss_pred hcCccccceEEEeeecCCCceEEEEEEcccccc---cchHHHHHHHHHhc---ccCCCCcccccceeccCCceEEEEEec
Q 003836 508 ELGRGAFGTVYKGFVNMGSSNHVAVKKLNSVFQ---DSEKEFKAEVNGIG---QTHHKNLVRLLGYCDEGQNRLLVYEFM 581 (792)
Q Consensus 508 ~lG~G~~g~Vy~g~~~~~~~~~vavK~~~~~~~---~~~~~~~~Ei~~l~---~l~h~niv~l~g~~~~~~~~~lV~E~~ 581 (792)
.||+|+||.||++... .+++.+|+|.+..... .....+.+|..+++ ..+|+||+.+++++...+..++||||+
T Consensus 1 ~lg~G~~g~Vy~~~~~-~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~ 79 (279)
T cd05633 1 IIGRGGFGEVYGCRKA-DTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMTYAFHTPDKLCFILDLM 79 (279)
T ss_pred CcccCCCeEEEEEEEC-CCCcEEEEEEEEccccccchHHHHHHHHHHHHHHHhhCCCCcEeEEEEEEecCCeEEEEEecC
Confidence 4899999999999754 4567999998865322 22233445544433 347999999999999999999999999
Q ss_pred cCCCccccccCCCCCchhHHHHHHHHHHHHHHHHhhccCCCeEecCCCCCcEEEcCCCCeEEeecCCCccccCCCCCccc
Q 003836 582 SNGTVASFLFGDSKPNWKLRTEIAMGIAGGLFYLHEECCTQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLDQSHTNT 661 (792)
Q Consensus 582 ~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dikp~NILl~~~~~~kl~Dfg~a~~~~~~~~~~~~ 661 (792)
++++|.+++.....+++..+..++.|++.||.|||+. +|+|+||||+|||+++++.+||+|||++....... ..
T Consensus 80 ~~~~L~~~i~~~~~l~~~~~~~i~~qi~~al~~lH~~---~ivH~dikp~Nil~~~~~~~~l~dfg~~~~~~~~~---~~ 153 (279)
T cd05633 80 NGGDLHYHLSQHGVFSEKEMRFYATEIILGLEHMHNR---FVVYRDLKPANILLDEHGHVRISDLGLACDFSKKK---PH 153 (279)
T ss_pred CCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---CcCCCCCCHHHEEECCCCCEEEccCCcceeccccC---cc
Confidence 9999999998778899999999999999999999998 99999999999999999999999999987553221 12
Q ss_pred cccccCCccccccccc-CCCCcccceehHHHHHHHHHhcCcCCCcchhhhhhhhHHHHHHHhhcccchhHhhhchhcccC
Q 003836 662 AIRGTKGYVAPEWFRN-MPITVKVDVYSYGVLLLEIICLRRNIDNEISKVDKAILTDWAYDRYQERTLEALVENDLEAMN 740 (792)
Q Consensus 662 ~~~gt~~y~aPE~~~~-~~~~~k~DV~S~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 740 (792)
...|++.|+|||.+.+ ..++.++|||||||+++||++|+.||......... .+.. . ........
T Consensus 154 ~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~-~~~~-------------~-~~~~~~~~ 218 (279)
T cd05633 154 ASVGTHGYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKH-EIDR-------------M-TLTVNVEL 218 (279)
T ss_pred CcCCCcCccCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcCCCCCcCHH-HHHH-------------H-hhcCCcCC
Confidence 3458999999999864 56899999999999999999999999643221110 0000 0 00011122
Q ss_pred CHHHHHHHHHHHHHccccCCCCCC-----CHHhHHHH
Q 003836 741 NVTMLHRFVMVAFWCIQEDPSHRP-----TMRKVTQM 772 (792)
Q Consensus 741 ~~~~~~~l~~l~~~Cl~~~p~~RP-----s~~evl~~ 772 (792)
+...+.++.+++.+||+.||++|| +++|++++
T Consensus 219 ~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~~~~h 255 (279)
T cd05633 219 PDSFSPELKSLLEGLLQRDVSKRLGCLGRGAQEVKEH 255 (279)
T ss_pred ccccCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHhC
Confidence 334567888999999999999999 69999885
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi |
| >cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-33 Score=299.23 Aligned_cols=242 Identities=25% Similarity=0.287 Sum_probs=199.2
Q ss_pred hhhhhcCccccceEEEeeecCCCceEEEEEEccccc---ccchHHHHHHHHHhcccCCCCcccccceeccCCceEEEEEe
Q 003836 504 GFKEELGRGAFGTVYKGFVNMGSSNHVAVKKLNSVF---QDSEKEFKAEVNGIGQTHHKNLVRLLGYCDEGQNRLLVYEF 580 (792)
Q Consensus 504 ~~~~~lG~G~~g~Vy~g~~~~~~~~~vavK~~~~~~---~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~lV~E~ 580 (792)
.+.+.||+|++|.||++... ..++.+|+|.+.... ....+.+.+|++++++++||||+++++++.+++..++||||
T Consensus 4 ~~~~~ig~g~~~~vy~~~~~-~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 82 (290)
T cd05580 4 EFIKTLGTGSFGRVMLVRHK-GSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFLVNLYGSFQDDSNLYLVMEY 82 (290)
T ss_pred EEEEEeecCCCeEEEEEEEc-CCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCccceeeEEEcCCeEEEEEec
Confidence 45578999999999999764 356789999986532 22346788999999999999999999999999999999999
Q ss_pred ccCCCccccccCCCCCchhHHHHHHHHHHHHHHHHhhccCCCeEecCCCCCcEEEcCCCCeEEeecCCCccccCCCCCcc
Q 003836 581 MSNGTVASFLFGDSKPNWKLRTEIAMGIAGGLFYLHEECCTQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLDQSHTN 660 (792)
Q Consensus 581 ~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dikp~NILl~~~~~~kl~Dfg~a~~~~~~~~~~~ 660 (792)
+++++|.+++.....+++..+..++.||+.||.|||+. +|+|+||+|+|||+++++.+||+|||+++..... .
T Consensus 83 ~~~~~L~~~~~~~~~l~~~~~~~~~~qil~~l~~lH~~---~i~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~----~ 155 (290)
T cd05580 83 VPGGELFSHLRKSGRFPEPVARFYAAQVVLALEYLHSL---DIVYRDLKPENLLLDSDGYIKITDFGFAKRVKGR----T 155 (290)
T ss_pred CCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCCHHHEEECCCCCEEEeeCCCccccCCC----C
Confidence 99999999998888899999999999999999999998 9999999999999999999999999999876433 2
Q ss_pred ccccccCCcccccccccCCCCcccceehHHHHHHHHHhcCcCCCcchhhhhhhhHHHHHHHhhcccchhHhhhchhcccC
Q 003836 661 TAIRGTKGYVAPEWFRNMPITVKVDVYSYGVLLLEIICLRRNIDNEISKVDKAILTDWAYDRYQERTLEALVENDLEAMN 740 (792)
Q Consensus 661 ~~~~gt~~y~aPE~~~~~~~~~k~DV~S~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 740 (792)
....+++.|+|||.+.+...+.++||||||+++|+|++|+.||........ . ..+.... ...
T Consensus 156 ~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~---~-------------~~~~~~~--~~~ 217 (290)
T cd05580 156 YTLCGTPEYLAPEIILSKGYGKAVDWWALGILIYEMLAGYPPFFDDNPIQI---Y-------------EKILEGK--VRF 217 (290)
T ss_pred CCCCCCccccChhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCHHHH---H-------------HHHhcCC--ccC
Confidence 334588999999999888899999999999999999999999865431100 0 0011110 112
Q ss_pred CHHHHHHHHHHHHHccccCCCCCC-----CHHhHHH
Q 003836 741 NVTMLHRFVMVAFWCIQEDPSHRP-----TMRKVTQ 771 (792)
Q Consensus 741 ~~~~~~~l~~l~~~Cl~~~p~~RP-----s~~evl~ 771 (792)
+......+.+++.+||+.+|.+|| +++|+++
T Consensus 218 ~~~~~~~l~~li~~~l~~~p~~R~~~~~~~~~~l~~ 253 (290)
T cd05580 218 PSFFSPDAKDLIRNLLQVDLTKRLGNLKNGVNDIKN 253 (290)
T ss_pred CccCCHHHHHHHHHHccCCHHHccCcccCCHHHHHc
Confidence 223356788999999999999999 7777764
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi |
| >cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-33 Score=298.08 Aligned_cols=247 Identities=25% Similarity=0.343 Sum_probs=191.5
Q ss_pred hhhhcCccccceEEEeeecCCCceEEEEEEcccccccchHHHHHHHHHhccc-CCCCcccccceec-----cCCceEEEE
Q 003836 505 FKEELGRGAFGTVYKGFVNMGSSNHVAVKKLNSVFQDSEKEFKAEVNGIGQT-HHKNLVRLLGYCD-----EGQNRLLVY 578 (792)
Q Consensus 505 ~~~~lG~G~~g~Vy~g~~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l-~h~niv~l~g~~~-----~~~~~~lV~ 578 (792)
+.+.||+|+||.||++... ..++.+|+|++... .....++.+|+.+++++ +|+||+++++++. .++..++||
T Consensus 22 ~~~~lg~g~~~~vy~~~~~-~~~~~~~ik~~~~~-~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~~~~lv~ 99 (286)
T cd06638 22 IIETIGKGTYGKVFKVLNK-KNGSKAAVKILDPI-HDIDEEIEAEYNILKALSDHPNVVKFYGMYYKKDVKNGDQLWLVL 99 (286)
T ss_pred eeeeeccCCCcEEEEEEEC-CCCceeEEEeeccc-cchHHHHHHHHHHHHHHhcCCCeeeeeeeeeecccCCCCeEEEEE
Confidence 4578999999999999764 45678999987653 23346788999999999 6999999999883 445689999
Q ss_pred EeccCCCccccccC----CCCCchhHHHHHHHHHHHHHHHHhhccCCCeEecCCCCCcEEEcCCCCeEEeecCCCccccC
Q 003836 579 EFMSNGTVASFLFG----DSKPNWKLRTEIAMGIAGGLFYLHEECCTQIIHCDIKPQNILLDDHYNARISDFGLAKLLTL 654 (792)
Q Consensus 579 E~~~~gsL~~~l~~----~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dikp~NILl~~~~~~kl~Dfg~a~~~~~ 654 (792)
||+++++|.+++.. ...+++..+..++.|+++||.|||+. +|+||||||+||++++++.+||+|||+++....
T Consensus 100 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~ 176 (286)
T cd06638 100 ELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLHVN---KTIHRDVKGNNILLTTEGGVKLVDFGVSAQLTS 176 (286)
T ss_pred eecCCCCHHHHHHHhhccCccccHHHHHHHHHHHHHHHHHHHhC---CccccCCCHHhEEECCCCCEEEccCCceeeccc
Confidence 99999999988752 34678889999999999999999998 999999999999999999999999999986643
Q ss_pred CCCCccccccccCCccccccccc-----CCCCcccceehHHHHHHHHHhcCcCCCcchhhhhhhhHHHHHHHhhcccchh
Q 003836 655 DQSHTNTAIRGTKGYVAPEWFRN-----MPITVKVDVYSYGVLLLEIICLRRNIDNEISKVDKAILTDWAYDRYQERTLE 729 (792)
Q Consensus 655 ~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~k~DV~S~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 729 (792)
.. .......|++.|+|||.+.. ..++.++|||||||++|||++|+.|+.......... .......
T Consensus 177 ~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvi~~el~~g~~p~~~~~~~~~~~--------~~~~~~~- 246 (286)
T cd06638 177 TR-LRRNTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLADLHPMRALF--------KIPRNPP- 246 (286)
T ss_pred CC-CccccccCCCcccChhhhchhhhccccccchhhhhhHHHHHHHHhcCCCCCCCCchhHHHh--------hccccCC-
Confidence 22 12233458999999999853 457899999999999999999999986542211000 0000000
Q ss_pred HhhhchhcccCCHHHHHHHHHHHHHccccCCCCCCCHHhHHHH
Q 003836 730 ALVENDLEAMNNVTMLHRFVMVAFWCIQEDPSHRPTMRKVTQM 772 (792)
Q Consensus 730 ~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~ 772 (792)
. ....+......+.+++.+||+.+|++|||+.||++.
T Consensus 247 ----~--~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~ 283 (286)
T cd06638 247 ----P--TLHQPELWSNEFNDFIRKCLTKDYEKRPTVSDLLQH 283 (286)
T ss_pred ----C--cccCCCCcCHHHHHHHHHHccCCcccCCCHHHHhhc
Confidence 0 000111234568899999999999999999999974
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear |
| >PTZ00266 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-34 Score=331.62 Aligned_cols=250 Identities=20% Similarity=0.293 Sum_probs=193.1
Q ss_pred HhhhhhhcCccccceEEEeeecCCCceEEEEEEcccc--cccchHHHHHHHHHhcccCCCCcccccceecc--CCceEEE
Q 003836 502 TRGFKEELGRGAFGTVYKGFVNMGSSNHVAVKKLNSV--FQDSEKEFKAEVNGIGQTHHKNLVRLLGYCDE--GQNRLLV 577 (792)
Q Consensus 502 ~~~~~~~lG~G~~g~Vy~g~~~~~~~~~vavK~~~~~--~~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~--~~~~~lV 577 (792)
.+.+.+.||+|+||+||++... ..++.+|+|++... .......+..|+.++++++|||||++++++.+ ....+||
T Consensus 14 ~YeIl~kLG~GgFGtVYLAkdk-~tg~~vAlKvIk~~~l~e~~~~~~~~EI~IL~~L~HPNIVrl~d~f~de~~~~lyIV 92 (1021)
T PTZ00266 14 EYEVIKKIGNGRFGEVFLVKHK-RTQEFFCWKAISYRGLKEREKSQLVIEVNVMRELKHKNIVRYIDRFLNKANQKLYIL 92 (1021)
T ss_pred CEEEEEEEecCCCeEEEEEEEC-CCCeEEEEEEEeccccCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEecCCCEEEEE
Confidence 4556688999999999999764 45678999988643 23345678999999999999999999998854 4568999
Q ss_pred EEeccCCCccccccCC----CCCchhHHHHHHHHHHHHHHHHhhccC----CCeEecCCCCCcEEEcC------------
Q 003836 578 YEFMSNGTVASFLFGD----SKPNWKLRTEIAMGIAGGLFYLHEECC----TQIIHCDIKPQNILLDD------------ 637 (792)
Q Consensus 578 ~E~~~~gsL~~~l~~~----~~l~~~~~~~i~~~ia~gL~yLH~~~~----~~ivH~dikp~NILl~~------------ 637 (792)
|||+++|+|.++|... ..+++..++.|+.||+.||+|||+... .+|+||||||+||||+.
T Consensus 93 MEY~~gGSL~~lL~k~~~~~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~IVHRDLKPeNILL~s~~~~lg~i~~~~ 172 (1021)
T PTZ00266 93 MEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKITAQA 172 (1021)
T ss_pred EeCCCCCcHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhcccccccCCceeccCcHHHeEeecCccccccccccc
Confidence 9999999999998642 468999999999999999999998521 25999999999999964
Q ss_pred -----CCCeEEeecCCCccccCCCCCccccccccCCccccccccc--CCCCcccceehHHHHHHHHHhcCcCCCcchhhh
Q 003836 638 -----HYNARISDFGLAKLLTLDQSHTNTAIRGTKGYVAPEWFRN--MPITVKVDVYSYGVLLLEIICLRRNIDNEISKV 710 (792)
Q Consensus 638 -----~~~~kl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~k~DV~S~Gv~l~el~tg~~p~~~~~~~~ 710 (792)
...+||+|||+++...... ......||+.|+|||++.. ..++.++|||||||+||||++|+.||.......
T Consensus 173 ~n~ng~~iVKLsDFGlAr~l~~~s--~~~s~vGTp~YmAPEvL~ge~~~~s~KSDVWSLG~ILYELLTGk~PF~~~~~~~ 250 (1021)
T PTZ00266 173 NNLNGRPIAKIGDFGLSKNIGIES--MAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGKTPFHKANNFS 250 (1021)
T ss_pred cccCCCCceEEccCCccccccccc--cccccCCCccccCHHHHhccCCCCCchhHHHHHHHHHHHHHHCCCCCCcCCcHH
Confidence 2348999999998654322 2234568999999999854 458999999999999999999999996432211
Q ss_pred hhhhHHHHHHHhhcccchhHhhhchhcccCCHHHHHHHHHHHHHccccCCCCCCCHHhHHH
Q 003836 711 DKAILTDWAYDRYQERTLEALVENDLEAMNNVTMLHRFVMVAFWCIQEDPSHRPTMRKVTQ 771 (792)
Q Consensus 711 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~ 771 (792)
. .+ ...... +.+ .....+.++.+|+..||+.+|.+||++.|+++
T Consensus 251 q--li-----~~lk~~-------p~l---pi~~~S~eL~dLI~~~L~~dPeeRPSa~QlL~ 294 (1021)
T PTZ00266 251 Q--LI-----SELKRG-------PDL---PIKGKSKELNILIKNLLNLSAKERPSALQCLG 294 (1021)
T ss_pred H--HH-----HHHhcC-------CCC---CcCCCCHHHHHHHHHHhcCChhHCcCHHHHhc
Confidence 1 00 000000 000 01123567889999999999999999999984
|
|
| >KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-33 Score=292.63 Aligned_cols=246 Identities=22% Similarity=0.348 Sum_probs=208.0
Q ss_pred hhhhhhcCccccceEEEeeecCCCceEEEEEEccccccc--chHHHHHHHHHhcccCCCCcccccceeccCCceEEEEEe
Q 003836 503 RGFKEELGRGAFGTVYKGFVNMGSSNHVAVKKLNSVFQD--SEKEFKAEVNGIGQTHHKNLVRLLGYCDEGQNRLLVYEF 580 (792)
Q Consensus 503 ~~~~~~lG~G~~g~Vy~g~~~~~~~~~vavK~~~~~~~~--~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~lV~E~ 580 (792)
|.+.+.||+|-|..|-++++ .-+++.||||++.+..-+ ....+..|++.|+.++|||||+||.+......+|||+|.
T Consensus 20 YDLekTlG~GHFAVVKLArH-VFTGekVAVKviDKTKlD~~st~hlfqEVRCMKLVQHpNiVRLYEViDTQTKlyLiLEL 98 (864)
T KOG4717|consen 20 YDLEKTLGRGHFAVVKLARH-VFTGEKVAVKVIDKTKLDTLSTGHLFQEVRCMKLVQHPNIVRLYEVIDTQTKLYLILEL 98 (864)
T ss_pred ehhhhhhcCCceehhhhhhh-hcccceeEEEEecccccchhhhhHHHHHHHHHHHhcCcCeeeeeehhcccceEEEEEEe
Confidence 44567899999999998864 456789999999865333 346788999999999999999999999999999999999
Q ss_pred ccCCCccccccCC-CCCchhHHHHHHHHHHHHHHHHhhccCCCeEecCCCCCcEEE-cCCCCeEEeecCCCccccCCCCC
Q 003836 581 MSNGTVASFLFGD-SKPNWKLRTEIAMGIAGGLFYLHEECCTQIIHCDIKPQNILL-DDHYNARISDFGLAKLLTLDQSH 658 (792)
Q Consensus 581 ~~~gsL~~~l~~~-~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dikp~NILl-~~~~~~kl~Dfg~a~~~~~~~~~ 658 (792)
=++|+|.+|+-++ ..+++....+++.||..|+.|+|+. .+|||||||+|+.+ ..-|-+||.|||++-.+.+.+
T Consensus 99 GD~GDl~DyImKHe~Gl~E~La~kYF~QI~~AI~YCHqL---HVVHRDLKPENVVFFEKlGlVKLTDFGFSNkf~PG~-- 173 (864)
T KOG4717|consen 99 GDGGDLFDYIMKHEEGLNEDLAKKYFAQIVHAISYCHQL---HVVHRDLKPENVVFFEKLGLVKLTDFGFSNKFQPGK-- 173 (864)
T ss_pred cCCchHHHHHHhhhccccHHHHHHHHHHHHHHHHHHhhh---hhhcccCCcceeEEeeecCceEeeeccccccCCCcc--
Confidence 9999999999765 6789999999999999999999998 99999999999976 566889999999998775443
Q ss_pred ccccccccCCcccccccccCCCC-cccceehHHHHHHHHHhcCcCCCcchhhhhhhhHHHHHHHhhcccchhHhhhchhc
Q 003836 659 TNTAIRGTKGYVAPEWFRNMPIT-VKVDVYSYGVLLLEIICLRRNIDNEISKVDKAILTDWAYDRYQERTLEALVENDLE 737 (792)
Q Consensus 659 ~~~~~~gt~~y~aPE~~~~~~~~-~k~DV~S~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 737 (792)
.....+|+..|-|||++.+..|+ ++.||||||||||-|++|+.||....+. +.+..++|-.
T Consensus 174 kL~TsCGSLAYSAPEILLGDsYDAPAVDiWSLGVILyMLVCGq~PFqeANDS----------------ETLTmImDCK-- 235 (864)
T KOG4717|consen 174 KLTTSCGSLAYSAPEILLGDSYDAPAVDIWSLGVILYMLVCGQPPFQEANDS----------------ETLTMIMDCK-- 235 (864)
T ss_pred hhhcccchhhccCchhhhcCccCCcchhhhHHHHHHHHHHhCCCccccccch----------------hhhhhhhccc--
Confidence 34567899999999999999987 6899999999999999999999754322 1222333322
Q ss_pred ccCCHHHHHHHHHHHHHccccCCCCCCCHHhHHHH
Q 003836 738 AMNNVTMLHRFVMVAFWCIQEDPSHRPTMRKVTQM 772 (792)
Q Consensus 738 ~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~ 772 (792)
-..+...+.++.+||..||+.||.+|.+.+||+..
T Consensus 236 YtvPshvS~eCrdLI~sMLvRdPkkRAslEeI~s~ 270 (864)
T KOG4717|consen 236 YTVPSHVSKECRDLIQSMLVRDPKKRASLEEIVST 270 (864)
T ss_pred ccCchhhhHHHHHHHHHHHhcCchhhccHHHHhcc
Confidence 23456788999999999999999999999999863
|
|
| >cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-33 Score=298.46 Aligned_cols=249 Identities=24% Similarity=0.330 Sum_probs=200.3
Q ss_pred hhhhhhcCccccceEEEeeecCCCceEEEEEEcccccccchHHHHHHHHHhcccCCCCcccccceeccCCceEEEEEecc
Q 003836 503 RGFKEELGRGAFGTVYKGFVNMGSSNHVAVKKLNSVFQDSEKEFKAEVNGIGQTHHKNLVRLLGYCDEGQNRLLVYEFMS 582 (792)
Q Consensus 503 ~~~~~~lG~G~~g~Vy~g~~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~lV~E~~~ 582 (792)
+.+.+.||+|+||.||++... .++..+++|.+........+.+.+|+.++++++||||+++++.+...+..++|+||++
T Consensus 21 ~~~~~~lg~g~~g~v~~~~~~-~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~~ 99 (293)
T cd06647 21 YTRFEKIGQGASGTVYTAIDV-ATGQEVAIKQMNLQQQPKKELIINEILVMRENKHPNIVNYLDSYLVGDELWVVMEYLA 99 (293)
T ss_pred ceeeeEecCCCCeEEEEEEEc-CCCCEEEEEEeccccchHHHHHHHHHHHHhhcCCCCeeehhheeeeCCcEEEEEecCC
Confidence 345578999999999999643 4457899999875555556788999999999999999999999999999999999999
Q ss_pred CCCccccccCCCCCchhHHHHHHHHHHHHHHHHhhccCCCeEecCCCCCcEEEcCCCCeEEeecCCCccccCCCCCcccc
Q 003836 583 NGTVASFLFGDSKPNWKLRTEIAMGIAGGLFYLHEECCTQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLDQSHTNTA 662 (792)
Q Consensus 583 ~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dikp~NILl~~~~~~kl~Dfg~a~~~~~~~~~~~~~ 662 (792)
+++|.+++.+. .+++..+..++.|++.||.|||+. +++|+||||+||+++.++.+||+|||++........ ....
T Consensus 100 ~~~L~~~~~~~-~l~~~~~~~i~~~l~~al~~LH~~---gi~H~dL~p~Nili~~~~~~kL~dfg~~~~~~~~~~-~~~~ 174 (293)
T cd06647 100 GGSLTDVVTET-CMDEGQIAAVCRECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS-KRST 174 (293)
T ss_pred CCcHHHHHhhc-CCCHHHHHHHHHHHHHHHHHHHhC---CEeeccCCHHHEEEcCCCCEEEccCcceeccccccc-cccc
Confidence 99999998653 578889999999999999999998 999999999999999999999999999876543322 2223
Q ss_pred ccccCCcccccccccCCCCcccceehHHHHHHHHHhcCcCCCcchhhhhhhhHHHHHHHhhcccchhHhhhchhcccCCH
Q 003836 663 IRGTKGYVAPEWFRNMPITVKVDVYSYGVLLLEIICLRRNIDNEISKVDKAILTDWAYDRYQERTLEALVENDLEAMNNV 742 (792)
Q Consensus 663 ~~gt~~y~aPE~~~~~~~~~k~DV~S~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 742 (792)
..+++.|+|||.+....++.++||||||+++||+++|+.||............ . ...........
T Consensus 175 ~~~~~~y~~PE~~~~~~~~~~~Dv~slG~ll~~ll~g~~pf~~~~~~~~~~~~-------~--------~~~~~~~~~~~ 239 (293)
T cd06647 175 MVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLI-------A--------TNGTPELQNPE 239 (293)
T ss_pred ccCChhhcCchhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhhheeeh-------h--------cCCCCCCCCcc
Confidence 45888999999998888999999999999999999999999654321110000 0 00000011122
Q ss_pred HHHHHHHHHHHHccccCCCCCCCHHhHHHH
Q 003836 743 TMLHRFVMVAFWCIQEDPSHRPTMRKVTQM 772 (792)
Q Consensus 743 ~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~ 772 (792)
.....+.+++.+||+.+|++||++++++.+
T Consensus 240 ~~~~~l~~li~~~l~~~p~~Rp~~~~il~h 269 (293)
T cd06647 240 KLSAIFRDFLNRCLEMDVEKRGSAKELLQH 269 (293)
T ss_pred ccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 344568889999999999999999999976
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi |
| >cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-33 Score=294.68 Aligned_cols=251 Identities=26% Similarity=0.378 Sum_probs=200.9
Q ss_pred hhhhhcCccccceEEEeeecCCCceEEEEEEccccc-ccchHHHHHHHHHhcccCCCCcccccceeccCCceEEEEEecc
Q 003836 504 GFKEELGRGAFGTVYKGFVNMGSSNHVAVKKLNSVF-QDSEKEFKAEVNGIGQTHHKNLVRLLGYCDEGQNRLLVYEFMS 582 (792)
Q Consensus 504 ~~~~~lG~G~~g~Vy~g~~~~~~~~~vavK~~~~~~-~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~lV~E~~~ 582 (792)
.+.+.||.|++|+||+|... .++..+++|++.... ....+.+.+|++.+++++|+||+++++.+..++..++|+|+++
T Consensus 4 ~~~~~lg~g~~~~v~~~~~~-~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e~~~ 82 (267)
T cd06610 4 ELIEVIGVGATAVVYAAICL-PNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPNVVKYYTSFVVGDELWLVMPYLS 82 (267)
T ss_pred eeeeeecCCCCeEEEEEEEc-CCCcEEEEEEeccCCcchHHHHHHHHHHHHHhcCCCCEEEEEEEEeeCCEEEEEEeccC
Confidence 45678999999999999754 356789999986532 2355789999999999999999999999999999999999999
Q ss_pred CCCccccccCC---CCCchhHHHHHHHHHHHHHHHHhhccCCCeEecCCCCCcEEEcCCCCeEEeecCCCccccCCCCC-
Q 003836 583 NGTVASFLFGD---SKPNWKLRTEIAMGIAGGLFYLHEECCTQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLDQSH- 658 (792)
Q Consensus 583 ~gsL~~~l~~~---~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dikp~NILl~~~~~~kl~Dfg~a~~~~~~~~~- 658 (792)
+++|.+++... ..+++.....++.|++.||+|||+. +++|+||+|+||++++++.+||+|||++.........
T Consensus 83 ~~~l~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lh~~---~i~h~~l~p~ni~~~~~~~~~l~df~~~~~~~~~~~~~ 159 (267)
T cd06610 83 GGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLHSN---GQIHRDIKAGNILLGEDGSVKIADFGVSASLADGGDRT 159 (267)
T ss_pred CCcHHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHhEEEcCCCCEEEcccchHHHhccCcccc
Confidence 99999999764 4588999999999999999999998 9999999999999999999999999999876543332
Q ss_pred --ccccccccCCcccccccccC-CCCcccceehHHHHHHHHHhcCcCCCcchhhhhhhhHHHHHHHhhcccchhHhhhch
Q 003836 659 --TNTAIRGTKGYVAPEWFRNM-PITVKVDVYSYGVLLLEIICLRRNIDNEISKVDKAILTDWAYDRYQERTLEALVEND 735 (792)
Q Consensus 659 --~~~~~~gt~~y~aPE~~~~~-~~~~k~DV~S~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 735 (792)
......++..|+|||.+... .++.++|+|||||++|||++|+.||........ .... ... . .+.
T Consensus 160 ~~~~~~~~~~~~y~~Pe~~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~~---~~~~----~~~-~-----~~~ 226 (267)
T cd06610 160 RKVRKTFVGTPCWMAPEVMEQVHGYDFKADIWSFGITAIELATGAAPYSKYPPMKV---LMLT----LQN-D-----PPS 226 (267)
T ss_pred ccccccccCChhhcChHHHccccCcCcccchHhHhHHHHHHHhCCCCccccChhhh---HHHH----hcC-C-----CCC
Confidence 22334588999999998776 789999999999999999999999965432110 0000 000 0 000
Q ss_pred hcccC-CHHHHHHHHHHHHHccccCCCCCCCHHhHHH
Q 003836 736 LEAMN-NVTMLHRFVMVAFWCIQEDPSHRPTMRKVTQ 771 (792)
Q Consensus 736 ~~~~~-~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~ 771 (792)
..... ....+..+.+++.+||+.+|++||++++|++
T Consensus 227 ~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~ll~ 263 (267)
T cd06610 227 LETGADYKKYSKSFRKMISLCLQKDPSKRPTAEELLK 263 (267)
T ss_pred cCCccccccccHHHHHHHHHHcCCChhhCcCHHHHhh
Confidence 11100 1244577889999999999999999999987
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 |
| >cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-33 Score=296.87 Aligned_cols=260 Identities=22% Similarity=0.296 Sum_probs=192.9
Q ss_pred hhhhcCccccceEEEeeecCCCceEEEEEEccccc--ccchHHHHHHHHHhcccCCCCcccccceeccCCceEEEEEecc
Q 003836 505 FKEELGRGAFGTVYKGFVNMGSSNHVAVKKLNSVF--QDSEKEFKAEVNGIGQTHHKNLVRLLGYCDEGQNRLLVYEFMS 582 (792)
Q Consensus 505 ~~~~lG~G~~g~Vy~g~~~~~~~~~vavK~~~~~~--~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~lV~E~~~ 582 (792)
..+.||+|++|.||+|+.. .+++.+|||++.... ......+.+|++++++++||||+++++++.+.+..++||||+.
T Consensus 4 ~~~~l~~g~~~~v~~~~~~-~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~ 82 (284)
T cd07860 4 KVEKIGEGTYGVVYKARNK-LTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLH 82 (284)
T ss_pred eeeeecCCCceEEEEEEEC-CCCCEEEEEEccccccccccchHHHHHHHHHHhcCCCCCcchhhhcccCCcEEEEeeccc
Confidence 3467999999999999754 456789999886432 2234678999999999999999999999999999999999996
Q ss_pred CCCccccccCC--CCCchhHHHHHHHHHHHHHHHHhhccCCCeEecCCCCCcEEEcCCCCeEEeecCCCccccCCCCCcc
Q 003836 583 NGTVASFLFGD--SKPNWKLRTEIAMGIAGGLFYLHEECCTQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLDQSHTN 660 (792)
Q Consensus 583 ~gsL~~~l~~~--~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dikp~NILl~~~~~~kl~Dfg~a~~~~~~~~~~~ 660 (792)
++|.+++... ..+++..+..++.|++.||+|||+. +++|+||+|+||++++++.+||+|||+++....... ..
T Consensus 83 -~~l~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~---~i~H~~l~p~nill~~~~~~~l~dfg~~~~~~~~~~-~~ 157 (284)
T cd07860 83 -QDLKKFMDASPLSGIPLPLIKSYLFQLLQGLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVR-TY 157 (284)
T ss_pred -cCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEEeeccchhhcccCcc-cc
Confidence 5888888553 5678999999999999999999998 999999999999999999999999999876543221 12
Q ss_pred ccccccCCcccccccccCC-CCcccceehHHHHHHHHHhcCcCCCcchhhhhhhhHHHHH-------HHhhcc-----cc
Q 003836 661 TAIRGTKGYVAPEWFRNMP-ITVKVDVYSYGVLLLEIICLRRNIDNEISKVDKAILTDWA-------YDRYQE-----RT 727 (792)
Q Consensus 661 ~~~~gt~~y~aPE~~~~~~-~~~k~DV~S~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~-------~~~~~~-----~~ 727 (792)
....+++.|+|||.+.+.. ++.++||||||+++|||+||+.||................ +..... ..
T Consensus 158 ~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (284)
T cd07860 158 THEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSLPDYKPS 237 (284)
T ss_pred ccccccccccCCeEEecCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCChhhhhhhhHHHHHHhh
Confidence 2234678999999887644 6889999999999999999999986543221110000000 000000 00
Q ss_pred hhHhhhchhcccCCHHHHHHHHHHHHHccccCCCCCCCHHhHHH
Q 003836 728 LEALVENDLEAMNNVTMLHRFVMVAFWCIQEDPSHRPTMRKVTQ 771 (792)
Q Consensus 728 ~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~ 771 (792)
........... .......++.+++.+||+.||++||+++++++
T Consensus 238 ~~~~~~~~~~~-~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~ 280 (284)
T cd07860 238 FPKWARQDFSK-VVPPLDEDGRDLLSQMLHYDPNKRISAKAALA 280 (284)
T ss_pred cccccccCHHH-HcccCCHHHHHHHHHhcCCCcccCCCHHHHhc
Confidence 00000000000 01123456789999999999999999999987
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex |
| >cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-33 Score=293.44 Aligned_cols=247 Identities=27% Similarity=0.324 Sum_probs=201.9
Q ss_pred hhhhhcCccccceEEEeeecCCCceEEEEEEccccc---ccchHHHHHHHHHhcccCCCCcccccceeccCCceEEEEEe
Q 003836 504 GFKEELGRGAFGTVYKGFVNMGSSNHVAVKKLNSVF---QDSEKEFKAEVNGIGQTHHKNLVRLLGYCDEGQNRLLVYEF 580 (792)
Q Consensus 504 ~~~~~lG~G~~g~Vy~g~~~~~~~~~vavK~~~~~~---~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~lV~E~ 580 (792)
.+.+.||.|+||.||++... .+++.+|+|.+.... ....+.+.+|++++++++||||+++++++.+++..++|+||
T Consensus 3 ~~~~~i~~g~~~~v~~~~~~-~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 81 (258)
T cd05578 3 ELLRVIGKGAFGKVCIVQKR-DTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNLWYSFQDEENMYLVVDL 81 (258)
T ss_pred eEEEEeccCCCceEEEEEEc-cCCcEEEEEEEehhhhcchhHHHHHHHHHHHHHhCCCCChHHHHHhhcCCCeEEEEEeC
Confidence 34578999999999999754 456789999987532 23457899999999999999999999999999999999999
Q ss_pred ccCCCccccccCCCCCchhHHHHHHHHHHHHHHHHhhccCCCeEecCCCCCcEEEcCCCCeEEeecCCCccccCCCCCcc
Q 003836 581 MSNGTVASFLFGDSKPNWKLRTEIAMGIAGGLFYLHEECCTQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLDQSHTN 660 (792)
Q Consensus 581 ~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dikp~NILl~~~~~~kl~Dfg~a~~~~~~~~~~~ 660 (792)
+++++|.+++.....+++..+..++.||++||.|||+. +++|+||+|+||++++++.++|+|||.+....... ..
T Consensus 82 ~~~~~L~~~l~~~~~l~~~~~~~~~~~i~~~l~~lh~~---~i~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~--~~ 156 (258)
T cd05578 82 LLGGDLRYHLSQKVKFSEEQVKFWICEIVLALEYLHSK---GIIHRDIKPDNILLDEQGHVHITDFNIATKVTPDT--LT 156 (258)
T ss_pred CCCCCHHHHHHhcCCcCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHeEEcCCCCEEEeecccccccCCCc--cc
Confidence 99999999998777889999999999999999999998 99999999999999999999999999988764332 22
Q ss_pred ccccccCCcccccccccCCCCcccceehHHHHHHHHHhcCcCCCcchhhhhhhhHHHHHHHhhcccchhHhhhchhcccC
Q 003836 661 TAIRGTKGYVAPEWFRNMPITVKVDVYSYGVLLLEIICLRRNIDNEISKVDKAILTDWAYDRYQERTLEALVENDLEAMN 740 (792)
Q Consensus 661 ~~~~gt~~y~aPE~~~~~~~~~k~DV~S~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 740 (792)
....++..|+|||.+.+..++.++|+||||+++|+|++|+.||............ .. ... .....
T Consensus 157 ~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~-----~~---------~~~-~~~~~ 221 (258)
T cd05578 157 TSTSGTPGYMAPEVLCRQGYSVAVDWWSLGVTAYECLRGKRPYRGHSRTIRDQIR-----AK---------QET-ADVLY 221 (258)
T ss_pred cccCCChhhcCHHHHcccCCCCcccchhhHHHHHHHHhCCCCCCCCCccHHHHHH-----HH---------hcc-ccccC
Confidence 3345788999999998888999999999999999999999999765432111100 00 000 11222
Q ss_pred CHHHHHHHHHHHHHccccCCCCCCCH--HhHHH
Q 003836 741 NVTMLHRFVMVAFWCIQEDPSHRPTM--RKVTQ 771 (792)
Q Consensus 741 ~~~~~~~l~~l~~~Cl~~~p~~RPs~--~evl~ 771 (792)
+...+..+.+++.+||+.+|.+||++ +|+++
T Consensus 222 ~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~l~~ 254 (258)
T cd05578 222 PATWSTEAIDAINKLLERDPQKRLGDNLKDLKN 254 (258)
T ss_pred cccCcHHHHHHHHHHccCChhHcCCccHHHHhc
Confidence 33445788899999999999999999 66553
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. |
| >cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-33 Score=295.94 Aligned_cols=247 Identities=24% Similarity=0.362 Sum_probs=193.0
Q ss_pred hhhhhhcCccccceEEEeeecCCCceEEEEEEcccccccchHHHHHHHHHhccc-CCCCcccccceecc------CCceE
Q 003836 503 RGFKEELGRGAFGTVYKGFVNMGSSNHVAVKKLNSVFQDSEKEFKAEVNGIGQT-HHKNLVRLLGYCDE------GQNRL 575 (792)
Q Consensus 503 ~~~~~~lG~G~~g~Vy~g~~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l-~h~niv~l~g~~~~------~~~~~ 575 (792)
+.+.+.||.|+||.||+|... ..++.+|+|++... .....++..|+.++.++ +|+||+++++++.. ....+
T Consensus 18 ~~~~~~lg~g~~~~v~~~~~~-~~~~~~a~K~~~~~-~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~~~~ 95 (282)
T cd06636 18 FELVEVVGNGTYGQVYKGRHV-KTGQLAAIKVMDVT-EDEEEEIKLEINMLKKYSHHRNIATYYGAFIKKSPPGHDDQLW 95 (282)
T ss_pred hhhheeeccCCCeEEEEEEEc-CCCcEEEEEEEecC-hHHHHHHHHHHHHHHHhcCCCcEEEEeeehhcccccCCCCEEE
Confidence 344578999999999999764 45678999988654 23346788999999998 79999999999853 45789
Q ss_pred EEEEeccCCCccccccCC--CCCchhHHHHHHHHHHHHHHHHhhccCCCeEecCCCCCcEEEcCCCCeEEeecCCCcccc
Q 003836 576 LVYEFMSNGTVASFLFGD--SKPNWKLRTEIAMGIAGGLFYLHEECCTQIIHCDIKPQNILLDDHYNARISDFGLAKLLT 653 (792)
Q Consensus 576 lV~E~~~~gsL~~~l~~~--~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dikp~NILl~~~~~~kl~Dfg~a~~~~ 653 (792)
++|||+++|+|.+++... ..+++..+..++.||+.||+|||+. +|+|+||+|+||++++++.++|+|||+++...
T Consensus 96 iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~---~ivH~dl~~~nili~~~~~~~l~dfg~~~~~~ 172 (282)
T cd06636 96 LVMEFCGAGSVTDLVKNTKGNALKEDWIAYICREILRGLAHLHAH---KVIHRDIKGQNVLLTENAEVKLVDFGVSAQLD 172 (282)
T ss_pred EEEEeCCCCcHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEeeCcchhhhh
Confidence 999999999999998653 4577888899999999999999998 99999999999999999999999999987653
Q ss_pred CCCCCccccccccCCcccccccc-----cCCCCcccceehHHHHHHHHHhcCcCCCcchhhhhhhhHHHHHHHhhcccch
Q 003836 654 LDQSHTNTAIRGTKGYVAPEWFR-----NMPITVKVDVYSYGVLLLEIICLRRNIDNEISKVDKAILTDWAYDRYQERTL 728 (792)
Q Consensus 654 ~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~k~DV~S~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 728 (792)
.... ......|++.|+|||.+. ...++.++|||||||++|||++|+.||..........
T Consensus 173 ~~~~-~~~~~~~~~~y~aPE~l~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~~~~~--------------- 236 (282)
T cd06636 173 RTVG-RRNTFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPLCDMHPMRALF--------------- 236 (282)
T ss_pred cccc-CCCcccccccccCHhhcCcccCcCcCCCcccchhHHHHHHHHHHhCCCCccccCHHhhhh---------------
Confidence 2221 122345889999999885 3468889999999999999999999996532211100
Q ss_pred hHhhhchhcccCCHHHHHHHHHHHHHccccCCCCCCCHHhHHH
Q 003836 729 EALVENDLEAMNNVTMLHRFVMVAFWCIQEDPSHRPTMRKVTQ 771 (792)
Q Consensus 729 ~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~ 771 (792)
.+.............+..+.+++.+||+.+|.+||++.|+++
T Consensus 237 -~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~ell~ 278 (282)
T cd06636 237 -LIPRNPPPKLKSKKWSKKFIDFIEGCLVKNYLSRPSTEQLLK 278 (282)
T ss_pred -hHhhCCCCCCcccccCHHHHHHHHHHhCCChhhCcCHHHHhc
Confidence 000000011111234567899999999999999999999986
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea |
| >cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-33 Score=295.53 Aligned_cols=253 Identities=26% Similarity=0.357 Sum_probs=195.6
Q ss_pred hhhhcCccccceEEEeeecCCCceEEEEEEcccccc-cchHHHHHHHHHhcccCCCCcccccceecc--CCceEEEEEec
Q 003836 505 FKEELGRGAFGTVYKGFVNMGSSNHVAVKKLNSVFQ-DSEKEFKAEVNGIGQTHHKNLVRLLGYCDE--GQNRLLVYEFM 581 (792)
Q Consensus 505 ~~~~lG~G~~g~Vy~g~~~~~~~~~vavK~~~~~~~-~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~--~~~~~lV~E~~ 581 (792)
+.+.||.|++|.||++... ..++.+|+|.+..... .....+.+|++++++++|+||+++++++.+ .+..++||||+
T Consensus 5 ~~~~lg~g~~~~v~~~~~~-~~~~~~~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~e~~ 83 (287)
T cd06621 5 ELSRLGEGAGGSVTKCRLK-NTGMIFALKTITTDPNPDLQKQILRELEINKSCKSPYIVKYYGAFLDESSSSIGIAMEYC 83 (287)
T ss_pred EEEEeccCCceEEEEEEEC-CCCeEEEEEEEecCCchHHHHHHHHHHHHHHhCCCCCeeeeeeEEEccCCCeEEEEEEec
Confidence 3468999999999999764 3567899999875432 345779999999999999999999998854 34689999999
Q ss_pred cCCCccccccC----CCCCchhHHHHHHHHHHHHHHHHhhccCCCeEecCCCCCcEEEcCCCCeEEeecCCCccccCCCC
Q 003836 582 SNGTVASFLFG----DSKPNWKLRTEIAMGIAGGLFYLHEECCTQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLDQS 657 (792)
Q Consensus 582 ~~gsL~~~l~~----~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dikp~NILl~~~~~~kl~Dfg~a~~~~~~~~ 657 (792)
++++|.+++.. ...+++..+..++.||+.||+|||+. +++|+||+|+||++++++.++|+|||++........
T Consensus 84 ~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~---~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~~ 160 (287)
T cd06621 84 EGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLHSR---KIIHRDIKPSNILLTRKGQVKLCDFGVSGELVNSLA 160 (287)
T ss_pred CCCCHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEecCCeEEEeecccccccccccc
Confidence 99999988643 34578889999999999999999998 999999999999999999999999999876532211
Q ss_pred CccccccccCCcccccccccCCCCcccceehHHHHHHHHHhcCcCCCcchhhh-hhhhHHHHHHHhhcccchhHhhhchh
Q 003836 658 HTNTAIRGTKGYVAPEWFRNMPITVKVDVYSYGVLLLEIICLRRNIDNEISKV-DKAILTDWAYDRYQERTLEALVENDL 736 (792)
Q Consensus 658 ~~~~~~~gt~~y~aPE~~~~~~~~~k~DV~S~Gv~l~el~tg~~p~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~ 736 (792)
....++..|+|||.+.+..++.++||||||+++|||++|+.||....... .......+... .....+ ...
T Consensus 161 ---~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~----~~~~~~-~~~- 231 (287)
T cd06621 161 ---GTFTGTSFYMAPERIQGKPYSITSDVWSLGLTLLEVAQNRFPFPPEGEPPLGPIELLSYIVN----MPNPEL-KDE- 231 (287)
T ss_pred ---ccccCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCcccCCCCChHHHHHHHhc----CCchhh-ccC-
Confidence 23346889999999999999999999999999999999999997552210 00001111000 000000 000
Q ss_pred cccCCHHHHHHHHHHHHHccccCCCCCCCHHhHHH
Q 003836 737 EAMNNVTMLHRFVMVAFWCIQEDPSHRPTMRKVTQ 771 (792)
Q Consensus 737 ~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~ 771 (792)
........+.+.+++.+||+.+|++|||+.||++
T Consensus 232 -~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~eil~ 265 (287)
T cd06621 232 -PGNGIKWSEEFKDFIKQCLEKDPTRRPTPWDMLE 265 (287)
T ss_pred -CCCCCchHHHHHHHHHHHcCCCcccCCCHHHHHh
Confidence 0001124567899999999999999999999998
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-33 Score=300.09 Aligned_cols=252 Identities=25% Similarity=0.320 Sum_probs=197.6
Q ss_pred hhhhhhcCccccceEEEeeecCCCceEEEEEEcccccc---cchHHHHHHHHHhcccCCCCcccccceeccCCceEEEEE
Q 003836 503 RGFKEELGRGAFGTVYKGFVNMGSSNHVAVKKLNSVFQ---DSEKEFKAEVNGIGQTHHKNLVRLLGYCDEGQNRLLVYE 579 (792)
Q Consensus 503 ~~~~~~lG~G~~g~Vy~g~~~~~~~~~vavK~~~~~~~---~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~lV~E 579 (792)
+...+.||+|+||.||+++.. .++..+|+|++..... ...+.+.+|++++++++|+|++++++++.++...++|||
T Consensus 27 f~~~~~lg~G~~~~v~~~~~~-~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 105 (317)
T cd06635 27 FTDLREIGHGSFGAVYFARDV-RTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYKGCYLREHTAWLVME 105 (317)
T ss_pred hhhhheeccCCCeEEEEEEEc-CCCcEEEEEEEecCCCCchHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCCeEEEEEe
Confidence 445678999999999999754 3467899999864322 234578899999999999999999999999999999999
Q ss_pred eccCCCccccccC-CCCCchhHHHHHHHHHHHHHHHHhhccCCCeEecCCCCCcEEEcCCCCeEEeecCCCccccCCCCC
Q 003836 580 FMSNGTVASFLFG-DSKPNWKLRTEIAMGIAGGLFYLHEECCTQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLDQSH 658 (792)
Q Consensus 580 ~~~~gsL~~~l~~-~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dikp~NILl~~~~~~kl~Dfg~a~~~~~~~~~ 658 (792)
|+++ +|.+.+.. ...+++..+..++.||+.||.|||+. +|+|+||+|+||+++.++.+||+|||++.....
T Consensus 106 ~~~g-~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~---~i~H~dL~p~Nil~~~~~~~kl~dfg~~~~~~~---- 177 (317)
T cd06635 106 YCLG-SASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSH---NMIHRDIKAGNILLTEPGQVKLADFGSASIASP---- 177 (317)
T ss_pred CCCC-CHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCcccEEECCCCCEEEecCCCccccCC----
Confidence 9975 77776654 45689999999999999999999998 999999999999999999999999999875432
Q ss_pred ccccccccCCcccccccc---cCCCCcccceehHHHHHHHHHhcCcCCCcchhhhhhhhHHHHHHHhhcccchhHhhhch
Q 003836 659 TNTAIRGTKGYVAPEWFR---NMPITVKVDVYSYGVLLLEIICLRRNIDNEISKVDKAILTDWAYDRYQERTLEALVEND 735 (792)
Q Consensus 659 ~~~~~~gt~~y~aPE~~~---~~~~~~k~DV~S~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 735 (792)
.....+++.|+|||.+. ...++.++|||||||++|||++|+.||........ . ..+....
T Consensus 178 -~~~~~~~~~y~aPE~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~---~-------------~~~~~~~ 240 (317)
T cd06635 178 -ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSA---L-------------YHIAQNE 240 (317)
T ss_pred -cccccCCccccChhhhhcCCCCCCCccccHHHHHHHHHHHHhCCCCCCCccHHHH---H-------------HHHHhcc
Confidence 12345788999999974 45789999999999999999999999865321110 0 0000111
Q ss_pred hcccCCHHHHHHHHHHHHHccccCCCCCCCHHhHHHHhccCcCCC
Q 003836 736 LEAMNNVTMLHRFVMVAFWCIQEDPSHRPTMRKVTQMLEGVVEVP 780 (792)
Q Consensus 736 ~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~L~~~~~~~ 780 (792)
............+.+++.+||+.+|.+||++.+|++.+.-....+
T Consensus 241 ~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~~~~~~~~~ 285 (317)
T cd06635 241 SPTLQSNEWSDYFRNFVDSCLQKIPQDRPTSEELLKHMFVLRERP 285 (317)
T ss_pred CCCCCCccccHHHHHHHHHHccCCcccCcCHHHHHhChhhhccCc
Confidence 111112234567889999999999999999999998765544433
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron |
| >cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-33 Score=295.74 Aligned_cols=262 Identities=22% Similarity=0.251 Sum_probs=198.3
Q ss_pred hhhhcCccccceEEEeeecCCCceEEEEEEccccc--ccchHHHHHHHHHhcccCCCCcccccceeccC--CceEEEEEe
Q 003836 505 FKEELGRGAFGTVYKGFVNMGSSNHVAVKKLNSVF--QDSEKEFKAEVNGIGQTHHKNLVRLLGYCDEG--QNRLLVYEF 580 (792)
Q Consensus 505 ~~~~lG~G~~g~Vy~g~~~~~~~~~vavK~~~~~~--~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~--~~~~lV~E~ 580 (792)
+.++||+|++|.||+|... ..++.+|+|++.... ......+.+|++++++++|+|++++++++.+. +..++|+||
T Consensus 3 ~~~~l~~g~~~~vy~~~~~-~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~e~ 81 (287)
T cd07840 3 KIAQIGEGTYGQVYKARNK-KTGELVALKKIRMENEKEGFPITAIREIKLLQKLRHPNIVRLKEIVTSKGKGSIYMVFEY 81 (287)
T ss_pred eeEEeccCCCeEEEEEEEC-CCCeEEEEEEEecccccccchHHHHHHHHHHHhccCCCeeeheeeEecCCCCcEEEEecc
Confidence 4567999999999999764 446789999998653 33446788999999999999999999999888 889999999
Q ss_pred ccCCCccccccCC-CCCchhHHHHHHHHHHHHHHHHhhccCCCeEecCCCCCcEEEcCCCCeEEeecCCCccccCCCCCc
Q 003836 581 MSNGTVASFLFGD-SKPNWKLRTEIAMGIAGGLFYLHEECCTQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLDQSHT 659 (792)
Q Consensus 581 ~~~gsL~~~l~~~-~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dikp~NILl~~~~~~kl~Dfg~a~~~~~~~~~~ 659 (792)
+++ +|.+++... ..+++..+..++.||++||+|||+. +++|+||+|+||++++++.+||+|||++..........
T Consensus 82 ~~~-~l~~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~---~~~h~dl~p~nil~~~~~~~~l~d~g~~~~~~~~~~~~ 157 (287)
T cd07840 82 MDH-DLTGLLDSPEVKFTESQIKCYMKQLLEGLQYLHSN---GILHRDIKGSNILINNDGVLKLADFGLARPYTKRNSAD 157 (287)
T ss_pred ccc-cHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHC---CceeccCcHHHeEEcCCCCEEEccccceeeccCCCccc
Confidence 985 888888665 5789999999999999999999998 99999999999999999999999999998765543322
Q ss_pred cccccccCCccccccccc-CCCCcccceehHHHHHHHHHhcCcCCCcchhhhhhhhHHHHHH----Hhhccc-ch--h--
Q 003836 660 NTAIRGTKGYVAPEWFRN-MPITVKVDVYSYGVLLLEIICLRRNIDNEISKVDKAILTDWAY----DRYQER-TL--E-- 729 (792)
Q Consensus 660 ~~~~~gt~~y~aPE~~~~-~~~~~k~DV~S~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~----~~~~~~-~~--~-- 729 (792)
.....++..|+|||.+.+ ..++.++||||||+++|||++|+.||...........+..... ..+... .+ .
T Consensus 158 ~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~t~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (287)
T cd07840 158 YTNRVITLWYRPPELLLGATRYGPEVDMWSVGCILAELFLGKPIFQGSTELEQLEKIFELCGSPTDENWPGVSKLPWFEN 237 (287)
T ss_pred ccccccccccCCceeeEccccCChHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchhhccccccchhhhh
Confidence 333456888999998764 4689999999999999999999999975443211111100000 000000 00 0
Q ss_pred ----HhhhchhcccCCHHHHHHHHHHHHHccccCCCCCCCHHhHHH
Q 003836 730 ----ALVENDLEAMNNVTMLHRFVMVAFWCIQEDPSHRPTMRKVTQ 771 (792)
Q Consensus 730 ----~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~ 771 (792)
......+.......++..+.+++.+||+.+|.+||+++++++
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~ 283 (287)
T cd07840 238 LKPKKPYKRRLREFFKHLIDPSALDLLDKLLTLDPKKRISADQALQ 283 (287)
T ss_pred ccccccchhHHHHHhcccCCHHHHHHHHHHcCCChhhCcCHHHHhh
Confidence 000000000011113678899999999999999999999987
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po |
| >cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-33 Score=294.88 Aligned_cols=247 Identities=24% Similarity=0.341 Sum_probs=197.1
Q ss_pred hhhhhcCccccceEEEeeecCCCceEEEEEEccccc-ccchHHHHHHHHHhcccC---CCCcccccceeccCCceEEEEE
Q 003836 504 GFKEELGRGAFGTVYKGFVNMGSSNHVAVKKLNSVF-QDSEKEFKAEVNGIGQTH---HKNLVRLLGYCDEGQNRLLVYE 579 (792)
Q Consensus 504 ~~~~~lG~G~~g~Vy~g~~~~~~~~~vavK~~~~~~-~~~~~~~~~Ei~~l~~l~---h~niv~l~g~~~~~~~~~lV~E 579 (792)
.+.+.||+|+||.||+|... .+++.+++|.+.... ....+++.+|+.++++++ |+|++++++++.++...++|||
T Consensus 4 ~~~~~l~~g~~g~v~~~~~~-~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~vi~~~~~~~~~~~~~lv~e 82 (277)
T cd06917 4 QRLELIGRGAYGAVYRGKHV-PTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPPNITKYYGSYLKGPRLWIIME 82 (277)
T ss_pred hhhhheeccCCceEEEEEEc-CCCcEEEEEEecCCCCchhHHHHHHHHHHHHHhccCCCCCeeeEeeeeeeCCEEEEEEe
Confidence 44578999999999999764 456789999986542 334567889999999986 9999999999999999999999
Q ss_pred eccCCCccccccCCCCCchhHHHHHHHHHHHHHHHHhhccCCCeEecCCCCCcEEEcCCCCeEEeecCCCccccCCCCCc
Q 003836 580 FMSNGTVASFLFGDSKPNWKLRTEIAMGIAGGLFYLHEECCTQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLDQSHT 659 (792)
Q Consensus 580 ~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dikp~NILl~~~~~~kl~Dfg~a~~~~~~~~~~ 659 (792)
|+++++|.+++.. ..+++.....++.|++.||.|||+. +|+|+||+|+||++++++.++|+|||++........ .
T Consensus 83 ~~~~~~L~~~~~~-~~l~~~~~~~i~~~i~~~l~~lh~~---~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~-~ 157 (277)
T cd06917 83 YAEGGSVRTLMKA-GPIAEKYISVIIREVLVALKYIHKV---GVIHRDIKAANILVTNTGNVKLCDFGVAALLNQNSS-K 157 (277)
T ss_pred cCCCCcHHHHHHc-cCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCcCHHHEEEcCCCCEEEccCCceeecCCCcc-c
Confidence 9999999999865 4688999999999999999999998 999999999999999999999999999987654332 2
Q ss_pred cccccccCCccccccccc-CCCCcccceehHHHHHHHHHhcCcCCCcchhhhhhhhHHHHHHHhhcccchhHhhhchhcc
Q 003836 660 NTAIRGTKGYVAPEWFRN-MPITVKVDVYSYGVLLLEIICLRRNIDNEISKVDKAILTDWAYDRYQERTLEALVENDLEA 738 (792)
Q Consensus 660 ~~~~~gt~~y~aPE~~~~-~~~~~k~DV~S~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 738 (792)
.....|+..|+|||.+.+ ..++.++||||||+++|+|++|+.||......... ...... ..+.+.
T Consensus 158 ~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~~--------~~~~~~-----~~~~~~- 223 (277)
T cd06917 158 RSTFVGTPYWMAPEVITEGKYYDTKADIWSLGITIYEMATGNPPYSDVDAFRAM--------MLIPKS-----KPPRLE- 223 (277)
T ss_pred cccccCCcceeCHHHhccCCccccchhHHHHHHHHHHHHhCCCCCCCCChhhhh--------hccccC-----CCCCCC-
Confidence 233468889999999875 45789999999999999999999999654221100 000000 000111
Q ss_pred cCCHHHHHHHHHHHHHccccCCCCCCCHHhHHHH
Q 003836 739 MNNVTMLHRFVMVAFWCIQEDPSHRPTMRKVTQM 772 (792)
Q Consensus 739 ~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~ 772 (792)
......++.+++.+||+.+|++||++.|++..
T Consensus 224 --~~~~~~~~~~~i~~~l~~~p~~R~~~~~il~~ 255 (277)
T cd06917 224 --DNGYSKLLREFVAACLDEEPKERLSAEELLKS 255 (277)
T ss_pred --cccCCHHHHHHHHHHcCCCcccCcCHHHHhhC
Confidence 11145678899999999999999999999873
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent |
| >KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-33 Score=278.55 Aligned_cols=265 Identities=23% Similarity=0.325 Sum_probs=206.6
Q ss_pred CHHHHHHHHhhhhhhcCccccceEEEeeecCCCceEEEEEEcccccccchHHHHHHHHHhcccC-CCCcccccceeccCC
Q 003836 494 TYKELVEVTRGFKEELGRGAFGTVYKGFVNMGSSNHVAVKKLNSVFQDSEKEFKAEVNGIGQTH-HKNLVRLLGYCDEGQ 572 (792)
Q Consensus 494 ~~~el~~~~~~~~~~lG~G~~g~Vy~g~~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~-h~niv~l~g~~~~~~ 572 (792)
++.|+.+.|. +.||+|+|+.|--++ ...++..+|||++.+.......++.+|++++...+ |+||++|+.+|+++.
T Consensus 74 ~F~d~YkLt~---e~LGeGAyasVqtcv-~i~t~~EYAVKiidKq~gHsR~RvfREVe~f~~Cqgh~nilqLiefFEdd~ 149 (463)
T KOG0607|consen 74 KFEDMYKLTS---ELLGEGAYASVQTCV-SIQTGKEYAVKIIDKQPGHSRSRVFREVETFYQCQGHKNILQLIEFFEDDT 149 (463)
T ss_pred hHHHHHHhHH---HHhcCccceeeeeee-eeccchhhhhhhhhcCCchHHHHHHHHHHHHHHhcCCccHHHHHHHhcccc
Confidence 4666666554 679999999998874 45677899999999887777889999999999985 999999999999999
Q ss_pred ceEEEEEeccCCCccccccCCCCCchhHHHHHHHHHHHHHHHHhhccCCCeEecCCCCCcEEEcCCC---CeEEeecCCC
Q 003836 573 NRLLVYEFMSNGTVASFLFGDSKPNWKLRTEIAMGIAGGLFYLHEECCTQIIHCDIKPQNILLDDHY---NARISDFGLA 649 (792)
Q Consensus 573 ~~~lV~E~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dikp~NILl~~~~---~~kl~Dfg~a 649 (792)
..|||||-|.+|+|..++..++.+++....++..+|+.||.|||.+ +|.||||||+|||-.+-. -+||+||.++
T Consensus 150 ~FYLVfEKm~GGplLshI~~~~~F~E~EAs~vvkdia~aLdFlH~k---gIAHRDlKPENiLC~~pn~vsPvKiCDfDLg 226 (463)
T KOG0607|consen 150 RFYLVFEKMRGGPLLSHIQKRKHFNEREASRVVKDIASALDFLHTK---GIAHRDLKPENILCESPNKVSPVKICDFDLG 226 (463)
T ss_pred eEEEEEecccCchHHHHHHHhhhccHHHHHHHHHHHHHHHHHHhhc---CcccccCCccceeecCCCCcCceeeeccccc
Confidence 9999999999999999999999999999999999999999999999 999999999999997543 4899999887
Q ss_pred ccccCCC--C----CccccccccCCcccccccc-----cCCCCcccceehHHHHHHHHHhcCcCCCcchhhh---hhhhH
Q 003836 650 KLLTLDQ--S----HTNTAIRGTKGYVAPEWFR-----NMPITVKVDVYSYGVLLLEIICLRRNIDNEISKV---DKAIL 715 (792)
Q Consensus 650 ~~~~~~~--~----~~~~~~~gt~~y~aPE~~~-----~~~~~~k~DV~S~Gv~l~el~tg~~p~~~~~~~~---~~~~~ 715 (792)
.-..... + ....+.+|+..|||||+.. ..-|+.+.|.||||||||-|++|..||....... +....
T Consensus 227 Sg~k~~~~~spastP~L~tPvGSAEfMAPEVVd~fv~qA~~YDKrCDlwSLGvIlYImLsGYpPFvG~Cg~dCGWdrGe~ 306 (463)
T KOG0607|consen 227 SGIKLNNDCSPASTPELLTPVGSAEFMAPEVVDVFVDQATFYDKRCDLWSLGVILYIMLSGYPPFVGHCGADCGWDRGEV 306 (463)
T ss_pred cccccCCCCCCCCCccccCcccchhhcchhHHhhhccccccccccccHHHHHHHHHHHHhCCCCccCccCCcCCccCCCc
Confidence 6433221 1 1223457888999999863 3468899999999999999999999997654311 00000
Q ss_pred HHHHHHhhcccchhHhhhchhcccCC----HHHHHHHHHHHHHccccCCCCCCCHHhHHH
Q 003836 716 TDWAYDRYQERTLEALVENDLEAMNN----VTMLHRFVMVAFWCIQEDPSHRPTMRKVTQ 771 (792)
Q Consensus 716 ~~~~~~~~~~~~~~~~~~~~~~~~~~----~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~ 771 (792)
....+. ...+.+.+...+ ++ ...+.+..+++...+..++.+|.++.++++
T Consensus 307 Cr~CQ~----~LFesIQEGkYe--FPdkdWahIS~eakdlisnLlvrda~~rlsa~~vln 360 (463)
T KOG0607|consen 307 CRVCQN----KLFESIQEGKYE--FPDKDWAHISSEAKDLISNLLVRDAKQRLSAAQVLN 360 (463)
T ss_pred cHHHHH----HHHHHHhccCCc--CChhhhHHhhHHHHHHHHHHHhccHHhhhhhhhccC
Confidence 010111 111111111111 12 134677788999999999999999998887
|
|
| >cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-33 Score=296.80 Aligned_cols=263 Identities=19% Similarity=0.227 Sum_probs=196.8
Q ss_pred hhhhhhcCccccceEEEeeecCCCceEEEEEEcccccc--cchHHHHHHHHHhcccCCCCcccccceeccC--CceEEEE
Q 003836 503 RGFKEELGRGAFGTVYKGFVNMGSSNHVAVKKLNSVFQ--DSEKEFKAEVNGIGQTHHKNLVRLLGYCDEG--QNRLLVY 578 (792)
Q Consensus 503 ~~~~~~lG~G~~g~Vy~g~~~~~~~~~vavK~~~~~~~--~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~--~~~~lV~ 578 (792)
+.+.+.||+|++|.||+|... .+++.+++|.++.... .....+.+|+.++++++||||+++++++... ...++||
T Consensus 7 y~~~~~lg~g~~~~v~~~~~~-~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~lv~ 85 (293)
T cd07843 7 YEKLNRIEEGTYGVVYRARDK-KTGEIVALKKLKMEKEKEGFPITSLREINILLKLQHPNIVTVKEVVVGSNLDKIYMVM 85 (293)
T ss_pred hhhhhhhcCCCCeEEEEEEEC-CCCcEEEEEEEeeccccccchhhHHHHHHHHHhcCCCCEEEEEEEEEecCCCcEEEEe
Confidence 445678999999999999764 4567899999875332 2234678899999999999999999998777 8899999
Q ss_pred EeccCCCccccccCC-CCCchhHHHHHHHHHHHHHHHHhhccCCCeEecCCCCCcEEEcCCCCeEEeecCCCccccCCCC
Q 003836 579 EFMSNGTVASFLFGD-SKPNWKLRTEIAMGIAGGLFYLHEECCTQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLDQS 657 (792)
Q Consensus 579 E~~~~gsL~~~l~~~-~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dikp~NILl~~~~~~kl~Dfg~a~~~~~~~~ 657 (792)
||+++ +|.+++... ..+++..+..++.||+.||+|||+. +++|+||||+|||++.++.+||+|||+++.......
T Consensus 86 e~~~~-~L~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---~i~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~ 161 (293)
T cd07843 86 EYVEH-DLKSLMETMKQPFLQSEVKCLMLQLLSGVAHLHDN---WILHRDLKTSNLLLNNRGILKICDFGLAREYGSPLK 161 (293)
T ss_pred hhcCc-CHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCCHHHEEECCCCcEEEeecCceeeccCCcc
Confidence 99985 898888654 4589999999999999999999998 999999999999999999999999999987654321
Q ss_pred CccccccccCCcccccccccC-CCCcccceehHHHHHHHHHhcCcCCCcchhhhhhhhHHHH-------HHHhhcc----
Q 003836 658 HTNTAIRGTKGYVAPEWFRNM-PITVKVDVYSYGVLLLEIICLRRNIDNEISKVDKAILTDW-------AYDRYQE---- 725 (792)
Q Consensus 658 ~~~~~~~gt~~y~aPE~~~~~-~~~~k~DV~S~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~-------~~~~~~~---- 725 (792)
......+++.|+|||.+.+. .++.++||||||+++|||++|+.||...........+... .+..+.+
T Consensus 162 -~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (293)
T cd07843 162 -PYTQLVVTLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKKPLFPGKSEIDQLNKIFKLLGTPTEKIWPGFSELPGA 240 (293)
T ss_pred -ccccccccccccCchhhcCCccccchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchHHHHHhhccchh
Confidence 12233468899999998754 4689999999999999999999999754332111111000 0000000
Q ss_pred --cchhHhhhchhcccCCHH-HHHHHHHHHHHccccCCCCCCCHHhHHH
Q 003836 726 --RTLEALVENDLEAMNNVT-MLHRFVMVAFWCIQEDPSHRPTMRKVTQ 771 (792)
Q Consensus 726 --~~~~~~~~~~~~~~~~~~-~~~~l~~l~~~Cl~~~p~~RPs~~evl~ 771 (792)
..........+....+.. ..+.+.+++.+||+.+|++|||+.|+++
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~t~~ell~ 289 (293)
T cd07843 241 KKKTFTKYPYNQLRKKFPALSLSDNGFDLLNRLLTYDPAKRISAEDALK 289 (293)
T ss_pred cccccccccchhhhccccccCCChHHHHHHHHHhccCccccCCHHHHhc
Confidence 000001111111112222 3667889999999999999999999987
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the |
| >cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-33 Score=298.15 Aligned_cols=244 Identities=27% Similarity=0.342 Sum_probs=193.4
Q ss_pred hhhhhhcCccccceEEEeeecCCCceEEEEEEcccccc---cchHHHHHHHHHhcccCCCCcccccceeccCCceEEEEE
Q 003836 503 RGFKEELGRGAFGTVYKGFVNMGSSNHVAVKKLNSVFQ---DSEKEFKAEVNGIGQTHHKNLVRLLGYCDEGQNRLLVYE 579 (792)
Q Consensus 503 ~~~~~~lG~G~~g~Vy~g~~~~~~~~~vavK~~~~~~~---~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~lV~E 579 (792)
+...+.||+|+||+||+|... .+++.||+|++..... ...+++.+|++++++++||||++++++|.+.+..++|+|
T Consensus 17 y~~~~~lg~g~~g~vy~~~~~-~~~~~v~iK~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~~lv~e 95 (307)
T cd06607 17 FTDLREIGHGSFGAVYFARDV-RTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYKGCYLREHTAWLVME 95 (307)
T ss_pred hhhheeecCCCCeEEEEEEEc-CCCcEEEEEEEeccccCcHHHHHHHHHHHHHHHhCCCCCEEEEEEEEEeCCeEEEEHH
Confidence 445578999999999999754 4467899998864322 234578899999999999999999999999999999999
Q ss_pred eccCCCccccccC-CCCCchhHHHHHHHHHHHHHHHHhhccCCCeEecCCCCCcEEEcCCCCeEEeecCCCccccCCCCC
Q 003836 580 FMSNGTVASFLFG-DSKPNWKLRTEIAMGIAGGLFYLHEECCTQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLDQSH 658 (792)
Q Consensus 580 ~~~~gsL~~~l~~-~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dikp~NILl~~~~~~kl~Dfg~a~~~~~~~~~ 658 (792)
|++ |+|.+++.. ...+++..+..++.|++.||.|||+. +|+|+||+|+||++++++.+||+|||++......
T Consensus 96 ~~~-g~l~~~~~~~~~~l~~~~~~~~~~ql~~~L~~LH~~---~i~H~dl~p~nIl~~~~~~~kL~dfg~~~~~~~~--- 168 (307)
T cd06607 96 YCL-GSASDILEVHKKPLQEVEIAAICHGALQGLAYLHSH---ERIHRDIKAGNILLTEPGTVKLADFGSASLVSPA--- 168 (307)
T ss_pred hhC-CCHHHHHHHcccCCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCcccEEECCCCCEEEeecCcceecCCC---
Confidence 997 467666643 45689999999999999999999998 9999999999999999999999999998765322
Q ss_pred ccccccccCCcccccccc---cCCCCcccceehHHHHHHHHHhcCcCCCcchhhhhhhhHHHHHHHhhcccchhHhhhch
Q 003836 659 TNTAIRGTKGYVAPEWFR---NMPITVKVDVYSYGVLLLEIICLRRNIDNEISKVDKAILTDWAYDRYQERTLEALVEND 735 (792)
Q Consensus 659 ~~~~~~gt~~y~aPE~~~---~~~~~~k~DV~S~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 735 (792)
....+++.|+|||.+. ...++.++||||||+++|||++|+.||......... .. +....
T Consensus 169 --~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~s~G~il~el~tg~~p~~~~~~~~~~-------~~---------~~~~~ 230 (307)
T cd06607 169 --NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSAL-------YH---------IAQND 230 (307)
T ss_pred --CCccCCccccCceeeeccCCCCCCcccchHHHHHHHHHHHcCCCCCCCccHHHHH-------HH---------HhcCC
Confidence 2335788999999874 456889999999999999999999998654221100 00 00000
Q ss_pred hcccCCHHHHHHHHHHHHHccccCCCCCCCHHhHHHH
Q 003836 736 LEAMNNVTMLHRFVMVAFWCIQEDPSHRPTMRKVTQM 772 (792)
Q Consensus 736 ~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~ 772 (792)
............+.+++.+||+.+|++||++.+|+..
T Consensus 231 ~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 267 (307)
T cd06607 231 SPTLSSNDWSDYFRNFVDSCLQKIPQDRPSSEELLKH 267 (307)
T ss_pred CCCCCchhhCHHHHHHHHHHhcCChhhCcCHHHHhcC
Confidence 0111122345678999999999999999999999874
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily |
| >cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-33 Score=294.59 Aligned_cols=247 Identities=26% Similarity=0.360 Sum_probs=200.8
Q ss_pred hhhhhcCccccceEEEeeecCCCceEEEEEEcccccccchHHHHHHHHHhcccCCCCcccccceeccCCceEEEEEeccC
Q 003836 504 GFKEELGRGAFGTVYKGFVNMGSSNHVAVKKLNSVFQDSEKEFKAEVNGIGQTHHKNLVRLLGYCDEGQNRLLVYEFMSN 583 (792)
Q Consensus 504 ~~~~~lG~G~~g~Vy~g~~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~lV~E~~~~ 583 (792)
.+.+.||+|++|.||++.... ++..+++|++..... ..+.+.+|++.+++++|+|++++++.+...+..++|+||+++
T Consensus 22 ~~~~~l~~g~~~~v~~~~~~~-~~~~~~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~ 99 (286)
T cd06614 22 KNLEKIGEGASGEVYKATDRA-TGKEVAIKKMRLRKQ-NKELIINEILIMKDCKHPNIVDYYDSYLVGDELWVVMEYMDG 99 (286)
T ss_pred hHhHhccCCCCeEEEEEEEcc-CCcEEEEEEEecCch-hHHHHHHHHHHHHHCCCCCeeEEEEEEEECCEEEEEEeccCC
Confidence 345689999999999997653 457899999876543 567889999999999999999999999999999999999999
Q ss_pred CCccccccCCC-CCchhHHHHHHHHHHHHHHHHhhccCCCeEecCCCCCcEEEcCCCCeEEeecCCCccccCCCCCcccc
Q 003836 584 GTVASFLFGDS-KPNWKLRTEIAMGIAGGLFYLHEECCTQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLDQSHTNTA 662 (792)
Q Consensus 584 gsL~~~l~~~~-~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dikp~NILl~~~~~~kl~Dfg~a~~~~~~~~~~~~~ 662 (792)
++|.+++.... .+++..+..++.|++.||+|||+. +|+|+||+|+||+++.++.++|+|||++........ ....
T Consensus 100 ~~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~lH~~---gi~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~-~~~~ 175 (286)
T cd06614 100 GSLTDIITQNFVRMNEPQIAYVCREVLQGLEYLHSQ---NVIHRDIKSDNILLSKDGSVKLADFGFAAQLTKEKS-KRNS 175 (286)
T ss_pred CcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCChhhEEEcCCCCEEECccchhhhhccchh-hhcc
Confidence 99999998776 889999999999999999999998 999999999999999999999999999876543222 1223
Q ss_pred ccccCCcccccccccCCCCcccceehHHHHHHHHHhcCcCCCcchhhhhhhhHHHHHHHhhcccchhHhhhchhc-ccCC
Q 003836 663 IRGTKGYVAPEWFRNMPITVKVDVYSYGVLLLEIICLRRNIDNEISKVDKAILTDWAYDRYQERTLEALVENDLE-AMNN 741 (792)
Q Consensus 663 ~~gt~~y~aPE~~~~~~~~~k~DV~S~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~ 741 (792)
..++..|+|||.+.+..++.++||||||+++|+|++|+.|+.......... . ....... ....
T Consensus 176 ~~~~~~y~~PE~~~~~~~~~~~Dv~slGvil~~l~~g~~p~~~~~~~~~~~---~-------------~~~~~~~~~~~~ 239 (286)
T cd06614 176 VVGTPYWMAPEVIKRKDYGPKVDIWSLGIMCIEMAEGEPPYLREPPLRALF---L-------------ITTKGIPPLKNP 239 (286)
T ss_pred ccCCcccCCHhHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCHHHHHH---H-------------HHhcCCCCCcch
Confidence 347889999999988889999999999999999999999986532211100 0 0000000 0111
Q ss_pred HHHHHHHHHHHHHccccCCCCCCCHHhHHHH
Q 003836 742 VTMLHRFVMVAFWCIQEDPSHRPTMRKVTQM 772 (792)
Q Consensus 742 ~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~ 772 (792)
......+.+++.+||+.+|.+||++.++++.
T Consensus 240 ~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~ 270 (286)
T cd06614 240 EKWSPEFKDFLNKCLVKDPEKRPSAEELLQH 270 (286)
T ss_pred hhCCHHHHHHHHHHhccChhhCcCHHHHhhC
Confidence 1245678899999999999999999999873
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou |
| >cd05122 PKc_STE Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-33 Score=287.85 Aligned_cols=246 Identities=25% Similarity=0.383 Sum_probs=202.0
Q ss_pred hhhhcCccccceEEEeeecCCCceEEEEEEcccccccchHHHHHHHHHhcccCCCCcccccceeccCCceEEEEEeccCC
Q 003836 505 FKEELGRGAFGTVYKGFVNMGSSNHVAVKKLNSVFQDSEKEFKAEVNGIGQTHHKNLVRLLGYCDEGQNRLLVYEFMSNG 584 (792)
Q Consensus 505 ~~~~lG~G~~g~Vy~g~~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~lV~E~~~~g 584 (792)
..+.||+|++|.||++.... +++.+++|++........+.+.+|++.+++++|+|++++++++......++++||++++
T Consensus 4 ~~~~l~~g~~~~v~~~~~~~-~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~~ 82 (253)
T cd05122 4 ILEKIGKGGFGEVYKARHKR-TGKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIVKYYGSYLKKDELWIVMEFCSGG 82 (253)
T ss_pred eeeeeccCCceEEEEEEECC-CCcEEEEEEecccchhHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEecCCCC
Confidence 34679999999999997653 46789999998765556788999999999999999999999999999999999999999
Q ss_pred CccccccCC-CCCchhHHHHHHHHHHHHHHHHhhccCCCeEecCCCCCcEEEcCCCCeEEeecCCCccccCCCCCccccc
Q 003836 585 TVASFLFGD-SKPNWKLRTEIAMGIAGGLFYLHEECCTQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLDQSHTNTAI 663 (792)
Q Consensus 585 sL~~~l~~~-~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dikp~NILl~~~~~~kl~Dfg~a~~~~~~~~~~~~~~ 663 (792)
+|.+++... ..+++..+..++.|++.||+|||+. +++|+||+|+||++++++.++|+|||.+........ ....
T Consensus 83 ~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~---~i~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~--~~~~ 157 (253)
T cd05122 83 SLKDLLKSTNQTLTESQIAYVCKELLKGLEYLHSN---GIIHRDIKAANILLTSDGEVKLIDFGLSAQLSDTKA--RNTM 157 (253)
T ss_pred cHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHhhcC---CEecCCCCHHHEEEccCCeEEEeecccccccccccc--ccce
Confidence 999999776 6789999999999999999999998 999999999999999999999999999987654332 2345
Q ss_pred cccCCcccccccccCCCCcccceehHHHHHHHHHhcCcCCCcchhhhhhhhHHHHHHHhhcccchhHhhhchhcccCCHH
Q 003836 664 RGTKGYVAPEWFRNMPITVKVDVYSYGVLLLEIICLRRNIDNEISKVDKAILTDWAYDRYQERTLEALVENDLEAMNNVT 743 (792)
Q Consensus 664 ~gt~~y~aPE~~~~~~~~~k~DV~S~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 743 (792)
.++..|+|||.+.+..++.++||||||+++++|++|+.|+............ .......+ .....
T Consensus 158 ~~~~~~~~PE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~--------~~~~~~~~-------~~~~~ 222 (253)
T cd05122 158 VGTPYWMAPEVINGKPYDYKADIWSLGITAIELAEGKPPYSELPPMKALFKI--------ATNGPPGL-------RNPEK 222 (253)
T ss_pred ecCCcccCHHHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCchHHHHHHH--------HhcCCCCc-------Ccccc
Confidence 5788999999998888999999999999999999999998754221110000 00000000 01111
Q ss_pred HHHHHHHHHHHccccCCCCCCCHHhHHH
Q 003836 744 MLHRFVMVAFWCIQEDPSHRPTMRKVTQ 771 (792)
Q Consensus 744 ~~~~l~~l~~~Cl~~~p~~RPs~~evl~ 771 (792)
....+.+++.+||+.+|++|||+.|+++
T Consensus 223 ~~~~~~~~i~~~l~~~p~~R~t~~~~l~ 250 (253)
T cd05122 223 WSDEFKDFLKKCLQKNPEKRPTAEQLLK 250 (253)
T ss_pred cCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence 2567889999999999999999999987
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core |
| >cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-33 Score=295.59 Aligned_cols=259 Identities=22% Similarity=0.275 Sum_probs=195.3
Q ss_pred hhhhcCccccceEEEeeecCCCceEEEEEEccccc--ccchHHHHHHHHHhcccCCCCcccccceeccCCceEEEEEecc
Q 003836 505 FKEELGRGAFGTVYKGFVNMGSSNHVAVKKLNSVF--QDSEKEFKAEVNGIGQTHHKNLVRLLGYCDEGQNRLLVYEFMS 582 (792)
Q Consensus 505 ~~~~lG~G~~g~Vy~g~~~~~~~~~vavK~~~~~~--~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~lV~E~~~ 582 (792)
+.++||+|++|.||+|... .++..+++|++.... ....+.+.+|++++++++|+|++++++++.+++..++||||++
T Consensus 3 ~~~~l~~g~~~~vy~~~~~-~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~~~~iv~~~~~~~~~~~~~iv~e~~~ 81 (283)
T cd07835 3 KVEKIGEGTYGVVYKARDK-LTGEIVALKKIRLETEDEGVPSTAIREISLLKELNHPNIVRLLDVVHSENKLYLVFEFLD 81 (283)
T ss_pred hheEecCCCCeEEEEEEEc-CCCCEEEEEEeecccccccchhHHHHHHHHHHhcCCCCccCHhheeccCCeEEEEEeccC
Confidence 4568999999999999764 356789999986543 2234678899999999999999999999999999999999995
Q ss_pred CCCccccccCCC--CCchhHHHHHHHHHHHHHHHHhhccCCCeEecCCCCCcEEEcCCCCeEEeecCCCccccCCCCCcc
Q 003836 583 NGTVASFLFGDS--KPNWKLRTEIAMGIAGGLFYLHEECCTQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLDQSHTN 660 (792)
Q Consensus 583 ~gsL~~~l~~~~--~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dikp~NILl~~~~~~kl~Dfg~a~~~~~~~~~~~ 660 (792)
++|.+++.... .+++..+..++.|+++||+|||+. +++|+||+|+||+++.++.++|+|||+++....... ..
T Consensus 82 -~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~L~~lH~~---~~~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~-~~ 156 (283)
T cd07835 82 -LDLKKYMDSSPLTGLDPPLIKSYLYQLLQGIAYCHSH---RVLHRDLKPQNLLIDREGALKLADFGLARAFGVPVR-TY 156 (283)
T ss_pred -cCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeCCCCCHHHEEEcCCCcEEEeecccccccCCCcc-cc
Confidence 68999987654 689999999999999999999998 999999999999999999999999999976543221 11
Q ss_pred ccccccCCcccccccccC-CCCcccceehHHHHHHHHHhcCcCCCcchhhhhhhhHHHH-------HHHhhcccchhHhh
Q 003836 661 TAIRGTKGYVAPEWFRNM-PITVKVDVYSYGVLLLEIICLRRNIDNEISKVDKAILTDW-------AYDRYQERTLEALV 732 (792)
Q Consensus 661 ~~~~gt~~y~aPE~~~~~-~~~~k~DV~S~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~-------~~~~~~~~~~~~~~ 732 (792)
....++..|+|||.+.+. .++.++||||||+++|||++|+.||............... .+... ..+..+.
T Consensus 157 ~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~ 234 (283)
T cd07835 157 THEVVTLWYRAPEILLGSRQYSTPVDIWSIGCIFAEMVNRRPLFPGDSEIDQLFRIFRTLGTPDEDVWPGV--TSLPDYK 234 (283)
T ss_pred CccccccCCCCCceeecCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHHhhhh--hhchhhh
Confidence 223468899999988654 5789999999999999999999998654322111110000 00000 0000000
Q ss_pred hch------hcccCCHHHHHHHHHHHHHccccCCCCCCCHHhHHH
Q 003836 733 END------LEAMNNVTMLHRFVMVAFWCIQEDPSHRPTMRKVTQ 771 (792)
Q Consensus 733 ~~~------~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~ 771 (792)
... .........+..+.+++.+||+.+|++||+++|+++
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~ 279 (283)
T cd07835 235 PTFPKWARQDLSKVVPNLDEDGLDLLSKMLVYDPAKRISAKAALQ 279 (283)
T ss_pred hhcccccccchhhhcCCCCHHHHHHHHHHhcCChhhCcCHHHHhc
Confidence 000 000011223467889999999999999999999986
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc |
| >PHA03210 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-33 Score=320.55 Aligned_cols=267 Identities=18% Similarity=0.277 Sum_probs=186.5
Q ss_pred HHhhhhhhcCccccceEEEeeecCCCceEEEEE------------------EcccccccchHHHHHHHHHhcccCCCCcc
Q 003836 501 VTRGFKEELGRGAFGTVYKGFVNMGSSNHVAVK------------------KLNSVFQDSEKEFKAEVNGIGQTHHKNLV 562 (792)
Q Consensus 501 ~~~~~~~~lG~G~~g~Vy~g~~~~~~~~~vavK------------------~~~~~~~~~~~~~~~Ei~~l~~l~h~niv 562 (792)
..+.+.++||+|+||+||++.+....+...++| ++. ........+.+|+.++++++|+||+
T Consensus 148 ~~Y~ii~~LG~G~fG~Vyl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~-~~~~~~~~~~~Ei~il~~l~HpnIv 226 (501)
T PHA03210 148 AHFRVIDDLPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVK-AGSRAAIQLENEILALGRLNHENIL 226 (501)
T ss_pred hccEEEeEecCCCCcceEEEEEeccchhhhhhhccccccccchhhhhhHhHHhh-cchHHHHHHHHHHHHHHhCCCCCcC
Confidence 345667889999999999987643333222222 111 1122345688999999999999999
Q ss_pred cccceeccCCceEEEEEeccCCCccccccCC-----CCCchhHHHHHHHHHHHHHHHHhhccCCCeEecCCCCCcEEEcC
Q 003836 563 RLLGYCDEGQNRLLVYEFMSNGTVASFLFGD-----SKPNWKLRTEIAMGIAGGLFYLHEECCTQIIHCDIKPQNILLDD 637 (792)
Q Consensus 563 ~l~g~~~~~~~~~lV~E~~~~gsL~~~l~~~-----~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dikp~NILl~~ 637 (792)
++++++.+.+..++|+|++.. +|.+++... ..........|+.||+.||.|||+. +|+||||||+|||++.
T Consensus 227 ~l~~~~~~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~~i~~ql~~aL~yLH~~---gIiHrDLKP~NILl~~ 302 (501)
T PHA03210 227 KIEEILRSEANTYMITQKYDF-DLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIHDK---KLIHRDIKLENIFLNC 302 (501)
T ss_pred cEeEEEEECCeeEEEEecccc-CHHHHHhhccccccccccHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECC
Confidence 999999999999999999864 666666432 2234566778999999999999998 9999999999999999
Q ss_pred CCCeEEeecCCCccccCCCCCccccccccCCcccccccccCCCCcccceehHHHHHHHHHhcCcCC-CcchhhhhhhhHH
Q 003836 638 HYNARISDFGLAKLLTLDQSHTNTAIRGTKGYVAPEWFRNMPITVKVDVYSYGVLLLEIICLRRNI-DNEISKVDKAILT 716 (792)
Q Consensus 638 ~~~~kl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DV~S~Gv~l~el~tg~~p~-~~~~~~~~~~~~~ 716 (792)
++.+||+|||+++.+............||..|+|||.+.+..++.++|||||||++|||++|+.++ .............
T Consensus 303 ~~~vkL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~~~~~p~~~~~~~~~~~~~~ 382 (501)
T PHA03210 303 DGKIVLGDFGTAMPFEKEREAFDYGWVGTVATNSPEILAGDGYCEITDIWSCGLILLDMLSHDFCPIGDGGGKPGKQLLK 382 (501)
T ss_pred CCCEEEEeCCCceecCcccccccccccCCcCCCCchhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCccCCCCCHHHHHHH
Confidence 999999999999877544333334457999999999999999999999999999999999998643 2221111100000
Q ss_pred HH-----HHHhhccc--chhHhhhchhcccC---------CHHHHHHHHHHHHHccccCCCCCCCHHhHHHH
Q 003836 717 DW-----AYDRYQER--TLEALVENDLEAMN---------NVTMLHRFVMVAFWCIQEDPSHRPTMRKVTQM 772 (792)
Q Consensus 717 ~~-----~~~~~~~~--~~~~~~~~~~~~~~---------~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~ 772 (792)
.. ....+.+. .+..+++....... ......++.+++.+||+.||.+|||+.|++++
T Consensus 383 ~~~~~~~~~~~~p~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~li~kmL~~DP~~Rpsa~elL~h 454 (501)
T PHA03210 383 IIDSLSVCDEEFPDPPCKLFDYIDSAEIDHAGHSVPPLIRNLGLPADFEYPLVKMLTFDWHLRPGAAELLAL 454 (501)
T ss_pred HHHhcccChhhcCCcHHHHHHHhhhhhcccCccchhhHHHhcCCChHHHHHHHHHhccCcccCcCHHHHhhC
Confidence 00 00000000 01111110000000 00123456778999999999999999999873
|
|
| >cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-33 Score=292.55 Aligned_cols=248 Identities=25% Similarity=0.352 Sum_probs=194.8
Q ss_pred hhhhhhcCccccceEEEeeecCCCceEEEEEEcccccccchHHHHHHHHHhccc-CCCCcccccceeccCC------ceE
Q 003836 503 RGFKEELGRGAFGTVYKGFVNMGSSNHVAVKKLNSVFQDSEKEFKAEVNGIGQT-HHKNLVRLLGYCDEGQ------NRL 575 (792)
Q Consensus 503 ~~~~~~lG~G~~g~Vy~g~~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l-~h~niv~l~g~~~~~~------~~~ 575 (792)
+.+.+.||+|++|.||+|... .+++.+++|++.... ...+.+.+|+.+++++ +|+||+++++++.... ..+
T Consensus 8 y~~~~~l~~g~~~~v~~~~~~-~~~~~~~~k~~~~~~-~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~~~~ 85 (275)
T cd06608 8 FELVEVIGEGTYGKVYKARHK-KTGQLVAIKIMDIIE-DEEEEIKEEYNILRKYSNHPNIATFYGAFIKKNPPGNDDQLW 85 (275)
T ss_pred eeheeeecCCCCeEEEEEEEC-CCCcEEEEEEEecCc-hhHHHHHHHHHHHHHhcCCCChheEEEEEEecCCCCcceEEE
Confidence 445678999999999999764 346789999887543 3456799999999999 7999999999996544 489
Q ss_pred EEEEeccCCCccccccC----CCCCchhHHHHHHHHHHHHHHHHhhccCCCeEecCCCCCcEEEcCCCCeEEeecCCCcc
Q 003836 576 LVYEFMSNGTVASFLFG----DSKPNWKLRTEIAMGIAGGLFYLHEECCTQIIHCDIKPQNILLDDHYNARISDFGLAKL 651 (792)
Q Consensus 576 lV~E~~~~gsL~~~l~~----~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dikp~NILl~~~~~~kl~Dfg~a~~ 651 (792)
+||||+++++|.+++.. +..+++..+..++.|++.||.|||+. +++|+||+|+||++++++.+||+|||++..
T Consensus 86 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~---~i~H~~l~p~ni~~~~~~~~~l~d~~~~~~ 162 (275)
T cd06608 86 LVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGLAYLHEN---KVIHRDIKGQNILLTKNAEVKLVDFGVSAQ 162 (275)
T ss_pred EEEEcCCCCcHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcC---CcccCCCCHHHEEEccCCeEEECCCcccee
Confidence 99999999999998864 34688999999999999999999998 999999999999999999999999999876
Q ss_pred ccCCCCCccccccccCCccccccccc-----CCCCcccceehHHHHHHHHHhcCcCCCcchhhhhhhhHHHHHHHhhccc
Q 003836 652 LTLDQSHTNTAIRGTKGYVAPEWFRN-----MPITVKVDVYSYGVLLLEIICLRRNIDNEISKVDKAILTDWAYDRYQER 726 (792)
Q Consensus 652 ~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~k~DV~S~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 726 (792)
..... .......++..|+|||.+.. ..++.++||||||++++||++|+.||........ +.. ....
T Consensus 163 ~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~---~~~-----~~~~ 233 (275)
T cd06608 163 LDSTL-GRRNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCDMHPMRA---LFK-----IPRN 233 (275)
T ss_pred cccch-hhhcCccccccccCHhHhcccccccCCccccccHHHhHHHHHHHHhCCCCccccchHHH---HHH-----hhcc
Confidence 54322 12223458889999998753 3477899999999999999999999964322111 000 0000
Q ss_pred chhHhhhchhcccCCHHHHHHHHHHHHHccccCCCCCCCHHhHHH
Q 003836 727 TLEALVENDLEAMNNVTMLHRFVMVAFWCIQEDPSHRPTMRKVTQ 771 (792)
Q Consensus 727 ~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~ 771 (792)
. ......+....+++.+++.+||+.||++|||+.++++
T Consensus 234 ~-------~~~~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~ll~ 271 (275)
T cd06608 234 P-------PPTLKSPENWSKKFNDFISECLIKNYEQRPFMEELLE 271 (275)
T ss_pred C-------CCCCCchhhcCHHHHHHHHHHhhcChhhCcCHHHHhc
Confidence 0 0011112235678889999999999999999999987
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I |
| >cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-33 Score=296.02 Aligned_cols=259 Identities=19% Similarity=0.283 Sum_probs=192.7
Q ss_pred hhhhhcCccccceEEEeeecCCCceEEEEEEcccccc-cchHHHHHHHHHhcccCCCCcccccceeccCCceEEEEEecc
Q 003836 504 GFKEELGRGAFGTVYKGFVNMGSSNHVAVKKLNSVFQ-DSEKEFKAEVNGIGQTHHKNLVRLLGYCDEGQNRLLVYEFMS 582 (792)
Q Consensus 504 ~~~~~lG~G~~g~Vy~g~~~~~~~~~vavK~~~~~~~-~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~lV~E~~~ 582 (792)
.+.+.||+|++|.||+|... .+++.||+|.+..... .....+.+|++++++++|+||+++++++.+.+..++||||++
T Consensus 8 ~~~~~lg~g~~~~vy~~~~~-~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 86 (291)
T cd07844 8 KKLDKLGEGSYATVYKGRSK-LTGQLVALKEIRLEHEEGAPFTAIREASLLKDLKHANIVTLHDIIHTKKTLTLVFEYLD 86 (291)
T ss_pred eEEEEEeecCCeEEEEEEEc-CCCcEEEEEEEecccccCCchhHHHHHHHHhhCCCcceeeEEEEEecCCeEEEEEecCC
Confidence 34578999999999999754 4467899999865432 233567889999999999999999999999999999999998
Q ss_pred CCCccccccCC-CCCchhHHHHHHHHHHHHHHHHhhccCCCeEecCCCCCcEEEcCCCCeEEeecCCCccccCCCCCccc
Q 003836 583 NGTVASFLFGD-SKPNWKLRTEIAMGIAGGLFYLHEECCTQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLDQSHTNT 661 (792)
Q Consensus 583 ~gsL~~~l~~~-~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dikp~NILl~~~~~~kl~Dfg~a~~~~~~~~~~~~ 661 (792)
+ +|.+++... ..+++.....++.|++.||.|||+. +|+|+||||+||+++.++.+||+|||+++....... ...
T Consensus 87 ~-~L~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~---~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~-~~~ 161 (291)
T cd07844 87 T-DLKQYMDDCGGGLSMHNVRLFLFQLLRGLAYCHQR---RVLHRDLKPQNLLISERGELKLADFGLARAKSVPSK-TYS 161 (291)
T ss_pred C-CHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhC---CeecccCCHHHEEEcCCCCEEECccccccccCCCCc-ccc
Confidence 5 899888654 4678899999999999999999998 999999999999999999999999999875432211 112
Q ss_pred cccccCCccccccccc-CCCCcccceehHHHHHHHHHhcCcCCCcchhhhhhhhHHHHHHHhhcc---cchhHh------
Q 003836 662 AIRGTKGYVAPEWFRN-MPITVKVDVYSYGVLLLEIICLRRNIDNEISKVDKAILTDWAYDRYQE---RTLEAL------ 731 (792)
Q Consensus 662 ~~~gt~~y~aPE~~~~-~~~~~k~DV~S~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~------ 731 (792)
...++..|+|||.+.+ ..++.++||||||+++|||++|+.||.......+.... ....... ......
T Consensus 162 ~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~ 238 (291)
T cd07844 162 NEVVTLWYRPPDVLLGSTEYSTSLDMWGVGCIFYEMATGRPLFPGSTDVEDQLHK---IFRVLGTPTEETWPGVSSNPEF 238 (291)
T ss_pred ccccccccCCcHHhhcCcccCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHH---HHHhcCCCChhhhhhhhhcccc
Confidence 2346788999998865 55899999999999999999999999654321111100 0000000 000000
Q ss_pred h--------hchhccc-CCHHHHHHHHHHHHHccccCCCCCCCHHhHHH
Q 003836 732 V--------ENDLEAM-NNVTMLHRFVMVAFWCIQEDPSHRPTMRKVTQ 771 (792)
Q Consensus 732 ~--------~~~~~~~-~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~ 771 (792)
. ...+... ........+.+++.+||+.+|++|||+.|+++
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~p~~Rps~~e~l~ 287 (291)
T cd07844 239 KPYSFPFYPPRPLINHAPRLDRIPHGEELALKFLQYEPKKRISAAEAMK 287 (291)
T ss_pred ccccccccCChhHHHhCcCCCCchhHHHHHHHHhccCcccccCHHHHhc
Confidence 0 0000000 00111267789999999999999999999886
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the |
| >cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-33 Score=289.49 Aligned_cols=246 Identities=22% Similarity=0.346 Sum_probs=197.0
Q ss_pred hhhhhcCccccceEEEeeecCCCceEEEEEEccccc--ccchHHHHHHHHHhcccCCCCcccccceeccCCceEEEEEec
Q 003836 504 GFKEELGRGAFGTVYKGFVNMGSSNHVAVKKLNSVF--QDSEKEFKAEVNGIGQTHHKNLVRLLGYCDEGQNRLLVYEFM 581 (792)
Q Consensus 504 ~~~~~lG~G~~g~Vy~g~~~~~~~~~vavK~~~~~~--~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~lV~E~~ 581 (792)
.+.+.||+|+||.||++... .++..+|+|.+.... ....+.+.+|+.++++++|+||+++++.+.+....++|+||+
T Consensus 3 ~~~~~l~~g~~~~v~~~~~~-~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~ 81 (257)
T cd08225 3 EIIKKIGEGSFGKIYLAKAK-SDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNIVTFFASFQENGRLFIVMEYC 81 (257)
T ss_pred eEEEEecCCCcceEEEEEEc-CCCceEEEEEeeHhhccchhhHHHHHHHHHHHhCCCCChhhhhheeccCCeEEEEEecC
Confidence 34578999999999999765 445689999986532 234567889999999999999999999999999999999999
Q ss_pred cCCCccccccCCC--CCchhHHHHHHHHHHHHHHHHhhccCCCeEecCCCCCcEEEcCCCC-eEEeecCCCccccCCCCC
Q 003836 582 SNGTVASFLFGDS--KPNWKLRTEIAMGIAGGLFYLHEECCTQIIHCDIKPQNILLDDHYN-ARISDFGLAKLLTLDQSH 658 (792)
Q Consensus 582 ~~gsL~~~l~~~~--~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dikp~NILl~~~~~-~kl~Dfg~a~~~~~~~~~ 658 (792)
++++|.+++.... .+++..+..++.|++.||.|||+. +++|+||||+||++++++. +||+|||.+........
T Consensus 82 ~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~---~i~H~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~~- 157 (257)
T cd08225 82 DGGDLMKRINRQRGVLFSEDQILSWFVQISLGLKHIHDR---KILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDSME- 157 (257)
T ss_pred CCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHC---CcccccCCHHHEEEcCCCCeEEecccccchhccCCcc-
Confidence 9999999986543 578999999999999999999998 9999999999999998864 69999999987643221
Q ss_pred ccccccccCCcccccccccCCCCcccceehHHHHHHHHHhcCcCCCcchhhhhhhhHHHHHHHhhcccchhHhhhchhcc
Q 003836 659 TNTAIRGTKGYVAPEWFRNMPITVKVDVYSYGVLLLEIICLRRNIDNEISKVDKAILTDWAYDRYQERTLEALVENDLEA 738 (792)
Q Consensus 659 ~~~~~~gt~~y~aPE~~~~~~~~~k~DV~S~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 738 (792)
......|++.|+|||.+.+..++.++||||||++++||++|+.||....... .... ..... ..
T Consensus 158 ~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~-------~~~~---------~~~~~-~~ 220 (257)
T cd08225 158 LAYTCVGTPYYLSPEICQNRPYNNKTDIWSLGCVLYELCTLKHPFEGNNLHQ-------LVLK---------ICQGY-FA 220 (257)
T ss_pred cccccCCCccccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCccHHH-------HHHH---------Hhccc-CC
Confidence 2223458889999999988889999999999999999999999986432110 0000 00000 01
Q ss_pred cCCHHHHHHHHHHHHHccccCCCCCCCHHhHHH
Q 003836 739 MNNVTMLHRFVMVAFWCIQEDPSHRPTMRKVTQ 771 (792)
Q Consensus 739 ~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~ 771 (792)
.........+.+++.+|++.+|++|||+.|+++
T Consensus 221 ~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~ 253 (257)
T cd08225 221 PISPNFSRDLRSLISQLFKVSPRDRPSITSILK 253 (257)
T ss_pred CCCCCCCHHHHHHHHHHhccChhhCcCHHHHhh
Confidence 112234467889999999999999999999987
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. |
| >KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-33 Score=323.34 Aligned_cols=254 Identities=26% Similarity=0.365 Sum_probs=207.8
Q ss_pred hhhhhcCccccceEEEeeecCC------CceEEEEEEccccccc-chHHHHHHHHHhccc-CCCCcccccceeccCCceE
Q 003836 504 GFKEELGRGAFGTVYKGFVNMG------SSNHVAVKKLNSVFQD-SEKEFKAEVNGIGQT-HHKNLVRLLGYCDEGQNRL 575 (792)
Q Consensus 504 ~~~~~lG~G~~g~Vy~g~~~~~------~~~~vavK~~~~~~~~-~~~~~~~Ei~~l~~l-~h~niv~l~g~~~~~~~~~ 575 (792)
.+.+.||+|.||.|++|..... ....||||.++..... ..+.+..|+++|..+ +|+||+.++|+|.+....+
T Consensus 299 ~~~~~lg~g~fG~v~~~~~~~~~~~~~~~~~~VaVK~~k~~~~~~~~~~~~~El~~m~~~g~H~niv~llG~~t~~~~~~ 378 (609)
T KOG0200|consen 299 KLGKYLGEGAFGQVVKALLFGLSKALLSIYVTVAVKMLKENASSSEKKDLMSELNVLKELGKHPNIVNLLGACTQDGPLY 378 (609)
T ss_pred cccceeecccccceEeEEEeecccccccceEEEEEEecccccCcHHHHHHHHHHHHHHHhcCCcchhhheeeeccCCceE
Confidence 3456899999999999986421 1467999999865443 457899999999998 6999999999999999999
Q ss_pred EEEEeccCCCccccccCCC----------------CCchhHHHHHHHHHHHHHHHHhhccCCCeEecCCCCCcEEEcCCC
Q 003836 576 LVYEFMSNGTVASFLFGDS----------------KPNWKLRTEIAMGIAGGLFYLHEECCTQIIHCDIKPQNILLDDHY 639 (792)
Q Consensus 576 lV~E~~~~gsL~~~l~~~~----------------~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dikp~NILl~~~~ 639 (792)
+|+||++.|+|.++|+..+ .+.....+.++.|||.||+||++. ++|||||.++|||+.++.
T Consensus 379 ~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L~~~---~~vHRDLAaRNVLi~~~~ 455 (609)
T KOG0200|consen 379 VIVEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGMEYLASV---PCVHRDLAARNVLITKNK 455 (609)
T ss_pred EEEEeccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHHHHHhhC---CccchhhhhhhEEecCCC
Confidence 9999999999999997655 377889999999999999999999 999999999999999999
Q ss_pred CeEEeecCCCccccCCCCCccccccc--cCCcccccccccCCCCcccceehHHHHHHHHHhc-CcCCCcchhhhhhhhHH
Q 003836 640 NARISDFGLAKLLTLDQSHTNTAIRG--TKGYVAPEWFRNMPITVKVDVYSYGVLLLEIICL-RRNIDNEISKVDKAILT 716 (792)
Q Consensus 640 ~~kl~Dfg~a~~~~~~~~~~~~~~~g--t~~y~aPE~~~~~~~~~k~DV~S~Gv~l~el~tg-~~p~~~~~~~~~~~~~~ 716 (792)
.+||+|||+|+............-.+ ...|||||.+....|+.|+|||||||+||||+|. ..|+......
T Consensus 456 ~~kIaDFGlar~~~~~~~y~~~~~~~~LP~kWmApEsl~~~~ft~kSDVWSfGI~L~EifsLG~~PYp~~~~~------- 528 (609)
T KOG0200|consen 456 VIKIADFGLARDHYNKDYYRTKSSAGTLPVKWMAPESLFDRVFTSKSDVWSFGILLWEIFTLGGTPYPGIPPT------- 528 (609)
T ss_pred EEEEccccceeccCCCCceEecCCCCccceeecCHHHhccCcccccchhhHHHHHHHHHhhCCCCCCCCCCcH-------
Confidence 99999999999655444433222222 3459999999999999999999999999999985 4555431100
Q ss_pred HHHHHhhcccchhHhhhchhcccCCHHHHHHHHHHHHHccccCCCCCCCHHhHHHHhccC
Q 003836 717 DWAYDRYQERTLEALVENDLEAMNNVTMLHRFVMVAFWCIQEDPSHRPTMRKVTQMLEGV 776 (792)
Q Consensus 717 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~L~~~ 776 (792)
..+.+.+.+..+...+..+..++.++++.||+.+|++||++.++++.++.+
T Consensus 529 ---------~~l~~~l~~G~r~~~P~~c~~eiY~iM~~CW~~~p~~RP~F~~~~~~~~~~ 579 (609)
T KOG0200|consen 529 ---------EELLEFLKEGNRMEQPEHCSDEIYDLMKSCWNADPEDRPTFSECVEFFEKH 579 (609)
T ss_pred ---------HHHHHHHhcCCCCCCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHHHHHH
Confidence 111224445555556667788999999999999999999999999998873
|
|
| >cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-33 Score=293.75 Aligned_cols=255 Identities=21% Similarity=0.234 Sum_probs=201.1
Q ss_pred hhhhcCccccceEEEeeec--CCCceEEEEEEccccc----ccchHHHHHHHHHhccc-CCCCcccccceeccCCceEEE
Q 003836 505 FKEELGRGAFGTVYKGFVN--MGSSNHVAVKKLNSVF----QDSEKEFKAEVNGIGQT-HHKNLVRLLGYCDEGQNRLLV 577 (792)
Q Consensus 505 ~~~~lG~G~~g~Vy~g~~~--~~~~~~vavK~~~~~~----~~~~~~~~~Ei~~l~~l-~h~niv~l~g~~~~~~~~~lV 577 (792)
+.+.||+|++|.||++... ...++.+|||.+++.. ....+.+.+|+.++.++ +|+||+++++.+..+...++|
T Consensus 4 ~~~~ig~G~~~~vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~~~~~~~~lv 83 (288)
T cd05583 4 LLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPFLVTLHYAFQTDTKLHLI 83 (288)
T ss_pred EEEEeccCCCceEEEEEEeccccCCcEEEEEEEehHHHHhhhhHHHHHHHHHHHHHhccCCcchhhhheeeecCCEEEEE
Confidence 4578999999999998753 2345689999986432 22345688999999999 699999999999999999999
Q ss_pred EEeccCCCccccccCCCCCchhHHHHHHHHHHHHHHHHhhccCCCeEecCCCCCcEEEcCCCCeEEeecCCCccccCCCC
Q 003836 578 YEFMSNGTVASFLFGDSKPNWKLRTEIAMGIAGGLFYLHEECCTQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLDQS 657 (792)
Q Consensus 578 ~E~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dikp~NILl~~~~~~kl~Dfg~a~~~~~~~~ 657 (792)
|||+++++|.+++.....+++..+..++.|+++||.|||+. +++|+||+|+||+++.++.++|+|||+++.......
T Consensus 84 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~---~~~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~ 160 (288)
T cd05583 84 LDYVNGGELFTHLYQREHFTESEVRVYIAEIVLALDHLHQL---GIIYRDIKLENILLDSEGHVVLTDFGLSKEFLAEEE 160 (288)
T ss_pred EecCCCCcHHHHHhhcCCcCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHeEECCCCCEEEEECccccccccccc
Confidence 99999999999998777788999999999999999999998 999999999999999999999999999987654433
Q ss_pred CccccccccCCcccccccccCC--CCcccceehHHHHHHHHHhcCcCCCcchhhhhhhhHHHHHHHhhcccchhHhhhch
Q 003836 658 HTNTAIRGTKGYVAPEWFRNMP--ITVKVDVYSYGVLLLEIICLRRNIDNEISKVDKAILTDWAYDRYQERTLEALVEND 735 (792)
Q Consensus 658 ~~~~~~~gt~~y~aPE~~~~~~--~~~k~DV~S~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 735 (792)
.......++..|+|||.+.+.. .+.++||||||++++||++|..||......... ..... .+...
T Consensus 161 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~---~~~~~---------~~~~~- 227 (288)
T cd05583 161 ERAYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTVDGEQNSQ---SEISR---------RILKS- 227 (288)
T ss_pred cccccccCCccccCHHHhcCCCCCCcchhhhHHHHHHHHHHHhCCCCcccCcccchH---HHHHH---------HHHcc-
Confidence 3333456889999999987655 789999999999999999999998543211100 00000 00110
Q ss_pred hcccCCHHHHHHHHHHHHHccccCCCCCCCHHhHHHHhccC
Q 003836 736 LEAMNNVTMLHRFVMVAFWCIQEDPSHRPTMRKVTQMLEGV 776 (792)
Q Consensus 736 ~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~L~~~ 776 (792)
....+......+.+++.+||+.+|++|||+.++.+.|+..
T Consensus 228 -~~~~~~~~~~~l~~li~~~l~~~p~~R~t~~~~~~~l~~~ 267 (288)
T cd05583 228 -KPPFPKTMSAEARDFIQKLLEKDPKKRLGANGADEIKNHP 267 (288)
T ss_pred -CCCCCcccCHHHHHHHHHHhcCCHhhccCcchHHHHhcCc
Confidence 1112223446778999999999999999999888877653
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines |
| >cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-33 Score=292.02 Aligned_cols=243 Identities=28% Similarity=0.346 Sum_probs=192.9
Q ss_pred cCccccceEEEeeecCCCceEEEEEEccccc---ccchHHHHHHHHHhcccCCCCcccccceeccCCceEEEEEeccCCC
Q 003836 509 LGRGAFGTVYKGFVNMGSSNHVAVKKLNSVF---QDSEKEFKAEVNGIGQTHHKNLVRLLGYCDEGQNRLLVYEFMSNGT 585 (792)
Q Consensus 509 lG~G~~g~Vy~g~~~~~~~~~vavK~~~~~~---~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~lV~E~~~~gs 585 (792)
||+|+||+||++... ..++.+|+|.+.... ......+.+|++++++++||||+++++.+...+..++||||+++++
T Consensus 1 lg~g~~g~vy~~~~~-~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~ 79 (277)
T cd05577 1 LGKGGFGEVCACQVK-ATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAYAFETKDDLCLVMTLMNGGD 79 (277)
T ss_pred CCCCCceeEEEEEEc-CCCcEEEEEEEehhhhhhhhhhHHHHHHHHHHHhCCCCCEeeeeeEEecCCeEEEEEecCCCCc
Confidence 699999999999654 456789999986432 2234567889999999999999999999999999999999999999
Q ss_pred ccccccCCC--CCchhHHHHHHHHHHHHHHHHhhccCCCeEecCCCCCcEEEcCCCCeEEeecCCCccccCCCCCccccc
Q 003836 586 VASFLFGDS--KPNWKLRTEIAMGIAGGLFYLHEECCTQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLDQSHTNTAI 663 (792)
Q Consensus 586 L~~~l~~~~--~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dikp~NILl~~~~~~kl~Dfg~a~~~~~~~~~~~~~~ 663 (792)
|.+++.... .+++..+..++.|++.||.|||+. +++|+||+|+||++++++.+||+|||.+...... ......
T Consensus 80 L~~~l~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~---~i~H~di~p~Nil~~~~~~~~l~dfg~~~~~~~~--~~~~~~ 154 (277)
T cd05577 80 LKYHIYNVGEPGFPEARAIFYAAQIICGLEHLHQR---RIVYRDLKPENVLLDDHGNVRISDLGLAVELKGG--KKIKGR 154 (277)
T ss_pred HHHHHHHcCcCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEECCCCCEEEccCcchhhhccC--Cccccc
Confidence 999997654 688999999999999999999998 9999999999999999999999999998765432 122234
Q ss_pred cccCCcccccccccCCCCcccceehHHHHHHHHHhcCcCCCcchhhhhhhhHHHHHHHhhcccchhHhhhchhcccCCHH
Q 003836 664 RGTKGYVAPEWFRNMPITVKVDVYSYGVLLLEIICLRRNIDNEISKVDKAILTDWAYDRYQERTLEALVENDLEAMNNVT 743 (792)
Q Consensus 664 ~gt~~y~aPE~~~~~~~~~k~DV~S~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 743 (792)
.++..|+|||.+.+..++.++||||||+++++|++|+.||...........+. . . ... .....+..
T Consensus 155 ~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~----~----~----~~~--~~~~~~~~ 220 (277)
T cd05577 155 AGTPGYMAPEVLQGEVYDFSVDWFALGCTLYEMIAGRSPFRQRKEKVEKEELK----R----R----TLE--MAVEYPDK 220 (277)
T ss_pred cCCCCcCCHHHhcCCCCCchhhhHHHHHHHHHHhhCCCCCCCCcccccHHHHH----h----c----ccc--ccccCCcc
Confidence 57889999999988889999999999999999999999996543211110000 0 0 000 01112223
Q ss_pred HHHHHHHHHHHccccCCCCCC-----CHHhHHH
Q 003836 744 MLHRFVMVAFWCIQEDPSHRP-----TMRKVTQ 771 (792)
Q Consensus 744 ~~~~l~~l~~~Cl~~~p~~RP-----s~~evl~ 771 (792)
....+.+++.+||+.+|++|| ++.++++
T Consensus 221 ~~~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~ 253 (277)
T cd05577 221 FSPEAKDLCEALLQKDPEKRLGCRGGSADEVRE 253 (277)
T ss_pred CCHHHHHHHHHHccCChhHccCCCcccHHHHHh
Confidence 466788999999999999999 6666664
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of |
| >cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-32 Score=290.86 Aligned_cols=259 Identities=20% Similarity=0.236 Sum_probs=191.4
Q ss_pred hhhhcCccccceEEEeeecCCCceEEEEEEccccc-ccchHHHHHHHHHhcccC-CCCcccccceeccC--CceEEEEEe
Q 003836 505 FKEELGRGAFGTVYKGFVNMGSSNHVAVKKLNSVF-QDSEKEFKAEVNGIGQTH-HKNLVRLLGYCDEG--QNRLLVYEF 580 (792)
Q Consensus 505 ~~~~lG~G~~g~Vy~g~~~~~~~~~vavK~~~~~~-~~~~~~~~~Ei~~l~~l~-h~niv~l~g~~~~~--~~~~lV~E~ 580 (792)
+.++||+|+||.||++... .+++.+|+|+++... ........+|+.++.++. |+|++++++++.+. +..++|+||
T Consensus 3 ~~~~lg~g~~~~v~~~~~~-~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~lv~e~ 81 (282)
T cd07831 3 ILGKIGEGTFSEVLKAQSR-KTGKYYAIKCMKKHFKSLEQVNNLREIQALRRLSPHPNILRLIEVLFDRKTGRLALVFEL 81 (282)
T ss_pred eEeeccccccceEEEEEEc-CCCcEEEEEEehhccCCchhhhHHHHHHHHhhcCCCCCccceEEEEecCCCCcEEEEEec
Confidence 4578999999999999754 456789999987542 222344567888999885 99999999999887 889999999
Q ss_pred ccCCCccccccCC-CCCchhHHHHHHHHHHHHHHHHhhccCCCeEecCCCCCcEEEcCCCCeEEeecCCCccccCCCCCc
Q 003836 581 MSNGTVASFLFGD-SKPNWKLRTEIAMGIAGGLFYLHEECCTQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLDQSHT 659 (792)
Q Consensus 581 ~~~gsL~~~l~~~-~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dikp~NILl~~~~~~kl~Dfg~a~~~~~~~~~~ 659 (792)
++ ++|.+++... ..+++..+..++.||+.||+|||+. +++|+||+|+||+++. +.+||+|||+++.......
T Consensus 82 ~~-~~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~LH~~---~i~H~dl~p~ni~l~~-~~~kl~dfg~~~~~~~~~~-- 154 (282)
T cd07831 82 MD-MNLYELIKGRKRPLPEKRVKSYMYQLLKSLDHMHRN---GIFHRDIKPENILIKD-DILKLADFGSCRGIYSKPP-- 154 (282)
T ss_pred CC-ccHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHC---CceecccCHHHEEEcC-CCeEEEecccccccccCCC--
Confidence 97 4787777653 5689999999999999999999998 9999999999999999 9999999999987643222
Q ss_pred cccccccCCcccccccc-cCCCCcccceehHHHHHHHHHhcCcCCCcchhhhhhhhHHHH-------HHHhhcccchhHh
Q 003836 660 NTAIRGTKGYVAPEWFR-NMPITVKVDVYSYGVLLLEIICLRRNIDNEISKVDKAILTDW-------AYDRYQERTLEAL 731 (792)
Q Consensus 660 ~~~~~gt~~y~aPE~~~-~~~~~~k~DV~S~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~-------~~~~~~~~~~~~~ 731 (792)
.....++..|+|||.+. +..++.++|||||||++|||++|..||............... .............
T Consensus 155 ~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slGv~l~el~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (282)
T cd07831 155 YTEYISTRWYRAPECLLTDGYYGPKMDIWAVGCVFFEILSLFPLFPGTNELDQIAKIHDVLGTPDAEVLKKFRKSRHMNY 234 (282)
T ss_pred cCCCCCCcccCChhHhhcCCCCCcchhHHHHHHHHHHHHcCCcCCCCCCHHHHHHHHHHHcCCCCHHHHHhhcccccccc
Confidence 12345788999999764 456789999999999999999999999654322110000000 0000000000000
Q ss_pred hhchhcc----cCCHHHHHHHHHHHHHccccCCCCCCCHHhHHH
Q 003836 732 VENDLEA----MNNVTMLHRFVMVAFWCIQEDPSHRPTMRKVTQ 771 (792)
Q Consensus 732 ~~~~~~~----~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~ 771 (792)
..+.... ......+..+.+++.+||+.+|++||+++++++
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~ 278 (282)
T cd07831 235 NFPSKKGTGLRKLLPNASAEGLDLLKKLLAYDPDERITAKQALR 278 (282)
T ss_pred cCcccccccHHHHcccccHHHHHHHHHHhccCcccccCHHHHhh
Confidence 0000000 001234678999999999999999999999987
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. |
| >KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-33 Score=294.74 Aligned_cols=248 Identities=21% Similarity=0.294 Sum_probs=196.3
Q ss_pred hhhhhhcCccccceEEEeeecCCCceEEEEEEccc--ccccchHHHHHHHHHhcccC-CCCcccccceeccCCceEEEEE
Q 003836 503 RGFKEELGRGAFGTVYKGFVNMGSSNHVAVKKLNS--VFQDSEKEFKAEVNGIGQTH-HKNLVRLLGYCDEGQNRLLVYE 579 (792)
Q Consensus 503 ~~~~~~lG~G~~g~Vy~g~~~~~~~~~vavK~~~~--~~~~~~~~~~~Ei~~l~~l~-h~niv~l~g~~~~~~~~~lV~E 579 (792)
+...++||+||.+.||++.. .+.+.+|+|++.. .+.+...-|.+|+..|.+|+ |.+||+|++|-..++.+|||||
T Consensus 363 Yeilk~iG~GGSSkV~kV~~--s~~~iyalkkv~~~~~D~qtl~gy~nEI~lL~KLkg~~~IIqL~DYEv~d~~lYmvmE 440 (677)
T KOG0596|consen 363 YEILKQIGSGGSSKVFKVLN--SDKQIYALKKVVLLEADNQTLDGYRNEIALLNKLKGHDKIIQLYDYEVTDGYLYMVME 440 (677)
T ss_pred hhHHHhhcCCCcceeeeeec--CCCcchhhhHHHHhhcCHHHHHHHHHHHHHHHHhcCCceEEEEeeeeccCceEEEEee
Confidence 44567899999999999853 2345788887654 33445678999999999995 9999999999999999999999
Q ss_pred eccCCCccccccCCCC-CchhHHHHHHHHHHHHHHHHhhccCCCeEecCCCCCcEEEcCCCCeEEeecCCCccccCCCCC
Q 003836 580 FMSNGTVASFLFGDSK-PNWKLRTEIAMGIAGGLFYLHEECCTQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLDQSH 658 (792)
Q Consensus 580 ~~~~gsL~~~l~~~~~-l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dikp~NILl~~~~~~kl~Dfg~a~~~~~~~~~ 658 (792)
|=+- +|..+|..... ...-.+..+..|++.++.++|++ ||||.||||.|+|+-. |.+||+|||+|.....+...
T Consensus 441 ~Gd~-DL~kiL~k~~~~~~~~~lk~ywkqML~aV~~IH~~---gIVHSDLKPANFLlVk-G~LKLIDFGIA~aI~~DTTs 515 (677)
T KOG0596|consen 441 CGDI-DLNKILKKKKSIDPDWFLKFYWKQMLLAVKTIHQH---GIVHSDLKPANFLLVK-GRLKLIDFGIANAIQPDTTS 515 (677)
T ss_pred cccc-cHHHHHHhccCCCchHHHHHHHHHHHHHHHHHHHh---ceeecCCCcccEEEEe-eeEEeeeechhcccCccccc
Confidence 8754 89999977643 33237888999999999999999 9999999999999875 58999999999988766554
Q ss_pred c-cccccccCCcccccccccC-----------CCCcccceehHHHHHHHHHhcCcCCCcchhhhhhhhHHHHHHHhhccc
Q 003836 659 T-NTAIRGTKGYVAPEWFRNM-----------PITVKVDVYSYGVLLLEIICLRRNIDNEISKVDKAILTDWAYDRYQER 726 (792)
Q Consensus 659 ~-~~~~~gt~~y~aPE~~~~~-----------~~~~k~DV~S~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 726 (792)
. ....+||+.||+||.+... ..++++||||+|||||+|+.|+.||...... ..
T Consensus 516 I~kdsQvGT~NYMsPEAl~~~~s~~~~~~~k~Ki~r~SDvWSLGCILYqMvYgktPf~~~~n~---------------~a 580 (677)
T KOG0596|consen 516 IVKDSQVGTVNYMSPEALTDMSSSRENGKSKIKISRKSDVWSLGCILYQMVYGKTPFGQIINQ---------------IA 580 (677)
T ss_pred eeeccccCcccccCHHHHhhccccccCCCcceeecCccchhhhhhHHHHHHhcCCchHHHHHH---------------HH
Confidence 3 3456899999999988432 3678999999999999999999999643211 12
Q ss_pred chhHhhhchhcccCCHH-HHHHHHHHHHHccccCCCCCCCHHhHHHH
Q 003836 727 TLEALVENDLEAMNNVT-MLHRFVMVAFWCIQEDPSHRPTMRKVTQM 772 (792)
Q Consensus 727 ~~~~~~~~~~~~~~~~~-~~~~l~~l~~~Cl~~~p~~RPs~~evl~~ 772 (792)
++..+.++..+-+++.. .-.++++++..||+.||.+||++.|+++.
T Consensus 581 Kl~aI~~P~~~Iefp~~~~~~~li~~mK~CL~rdPkkR~si~eLLqh 627 (677)
T KOG0596|consen 581 KLHAITDPNHEIEFPDIPENDELIDVMKCCLARDPKKRWSIPELLQH 627 (677)
T ss_pred HHHhhcCCCccccccCCCCchHHHHHHHHHHhcCcccCCCcHHHhcC
Confidence 34556666443333221 12238999999999999999999999984
|
|
| >cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-32 Score=288.04 Aligned_cols=245 Identities=22% Similarity=0.268 Sum_probs=190.9
Q ss_pred hhcCccccceEEEeeecCCCceEEEEEEcccccc---cchHHHHHHHHH-hcccCCCCcccccceeccCCceEEEEEecc
Q 003836 507 EELGRGAFGTVYKGFVNMGSSNHVAVKKLNSVFQ---DSEKEFKAEVNG-IGQTHHKNLVRLLGYCDEGQNRLLVYEFMS 582 (792)
Q Consensus 507 ~~lG~G~~g~Vy~g~~~~~~~~~vavK~~~~~~~---~~~~~~~~Ei~~-l~~l~h~niv~l~g~~~~~~~~~lV~E~~~ 582 (792)
+.||+|++|.||+|... ..++.+|+|.+..... .....+..|..+ ....+|+|++++++++...+..++|+||++
T Consensus 2 ~~l~~g~~~~v~~a~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~ 80 (260)
T cd05611 2 KPISKGAFGSVYLAKKR-STGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYSFQSKDYLYLVMEYLN 80 (260)
T ss_pred ccCCcCCCeeEEEEEec-CCCCeEEEEEecchhhhHHHHHHHHHHHHHHHhhcCCCCCeeeeeeeEEcCCeEEEEEeccC
Confidence 46899999999999754 4567899999865321 122334455444 445589999999999999999999999999
Q ss_pred CCCccccccCCCCCchhHHHHHHHHHHHHHHHHhhccCCCeEecCCCCCcEEEcCCCCeEEeecCCCccccCCCCCcccc
Q 003836 583 NGTVASFLFGDSKPNWKLRTEIAMGIAGGLFYLHEECCTQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLDQSHTNTA 662 (792)
Q Consensus 583 ~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dikp~NILl~~~~~~kl~Dfg~a~~~~~~~~~~~~~ 662 (792)
+++|.+++.....+++..+.+++.||+.||.|||+. +++|+||+|+||++++++.+||+|||+++.... ...
T Consensus 81 ~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~lH~~---~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~-----~~~ 152 (260)
T cd05611 81 GGDCASLIKTLGGLPEDWAKQYIAEVVLGVEDLHQR---GIIHRDIKPENLLIDQTGHLKLTDFGLSRNGLE-----NKK 152 (260)
T ss_pred CCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEECCCCcEEEeecccceeccc-----ccc
Confidence 999999998777889999999999999999999998 999999999999999999999999999876432 223
Q ss_pred ccccCCcccccccccCCCCcccceehHHHHHHHHHhcCcCCCcchhhhhhhhHHHHHHHhhcccchhHhhhchhcccCCH
Q 003836 663 IRGTKGYVAPEWFRNMPITVKVDVYSYGVLLLEIICLRRNIDNEISKVDKAILTDWAYDRYQERTLEALVENDLEAMNNV 742 (792)
Q Consensus 663 ~~gt~~y~aPE~~~~~~~~~k~DV~S~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 742 (792)
..++..|+|||.+.+..++.++||||||+++|||++|..||........ . ........ ........
T Consensus 153 ~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~---~-----~~~~~~~~------~~~~~~~~ 218 (260)
T cd05611 153 FVGTPDYLAPETILGVGDDKMSDWWSLGCVIFEFLFGYPPFHAETPDAV---F-----DNILSRRI------NWPEEVKE 218 (260)
T ss_pred CCCCcCccChhhhcCCCCcchhhhHHHHHHHHHHHHCCCCCCCCCHHHH---H-----HHHHhccc------CCCCcccc
Confidence 4578899999999888899999999999999999999999965422110 0 00000000 00011111
Q ss_pred HHHHHHHHHHHHccccCCCCCCCHHhHHHHhc
Q 003836 743 TMLHRFVMVAFWCIQEDPSHRPTMRKVTQMLE 774 (792)
Q Consensus 743 ~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~L~ 774 (792)
..+..+.+++.+||+.+|++||++.++.+.|+
T Consensus 219 ~~~~~~~~~i~~~l~~~p~~R~~~~~~~~~l~ 250 (260)
T cd05611 219 FCSPEAVDLINRLLCMDPAKRLGANGYQEIKS 250 (260)
T ss_pred cCCHHHHHHHHHHccCCHHHccCCCcHHHHHc
Confidence 34567899999999999999998876666554
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do |
| >cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-32 Score=296.12 Aligned_cols=263 Identities=20% Similarity=0.280 Sum_probs=194.3
Q ss_pred hhhhhcCccccceEEEeeecCC-CceEEEEEEccccc---ccchHHHHHHHHHhcccCCCCcccccceeccC--CceEEE
Q 003836 504 GFKEELGRGAFGTVYKGFVNMG-SSNHVAVKKLNSVF---QDSEKEFKAEVNGIGQTHHKNLVRLLGYCDEG--QNRLLV 577 (792)
Q Consensus 504 ~~~~~lG~G~~g~Vy~g~~~~~-~~~~vavK~~~~~~---~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~--~~~~lV 577 (792)
.+.++||+|++|.||+|..... .++.+|+|.+.... ......+.+|+.++.+++||||+++++++.+. ...++|
T Consensus 3 ~~~~~ig~g~~g~v~~~~~~~~~~~~~~alK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv 82 (316)
T cd07842 3 EIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVSLVEVFLEHADKSVYLL 82 (316)
T ss_pred eEEEEeccCCcEEEEEEEecCCCCCCeEEEEEeccccccccCccHHHHHHHHHHHhcCCCCccceEEEEeCCCCceEEEE
Confidence 3457799999999999986542 56799999998633 34456788999999999999999999999888 789999
Q ss_pred EEeccCCCccccccCC-----CCCchhHHHHHHHHHHHHHHHHhhccCCCeEecCCCCCcEEEcC----CCCeEEeecCC
Q 003836 578 YEFMSNGTVASFLFGD-----SKPNWKLRTEIAMGIAGGLFYLHEECCTQIIHCDIKPQNILLDD----HYNARISDFGL 648 (792)
Q Consensus 578 ~E~~~~gsL~~~l~~~-----~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dikp~NILl~~----~~~~kl~Dfg~ 648 (792)
|||+++ +|.+++... ..+++..+..++.||+.||.|||+. +|+||||||+|||++. ++.+||+|||+
T Consensus 83 ~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~h~dlkp~Nil~~~~~~~~~~~kl~Dfg~ 158 (316)
T cd07842 83 FDYAEH-DLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLHSN---WVLHRDLKPANILVMGEGPERGVVKIGDLGL 158 (316)
T ss_pred EeCCCc-CHHHHHHhhccCCCcCcCHHHHHHHHHHHHHHHHHHHhC---CEeeCCCCHHHEEEcCCCCccceEEECCCcc
Confidence 999986 566555321 2578889999999999999999998 9999999999999999 99999999999
Q ss_pred CccccCCCC--CccccccccCCccccccccc-CCCCcccceehHHHHHHHHHhcCcCCCcchhhhh------hhhHHHHH
Q 003836 649 AKLLTLDQS--HTNTAIRGTKGYVAPEWFRN-MPITVKVDVYSYGVLLLEIICLRRNIDNEISKVD------KAILTDWA 719 (792)
Q Consensus 649 a~~~~~~~~--~~~~~~~gt~~y~aPE~~~~-~~~~~k~DV~S~Gv~l~el~tg~~p~~~~~~~~~------~~~~~~~~ 719 (792)
++....... .......+++.|+|||.+.+ ..++.++||||||++++||++|+.||........ ...+....
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (316)
T cd07842 159 ARLFNAPLKPLADLDPVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLTLEPIFKGREAKIKKSNPFQRDQLERIF 238 (316)
T ss_pred ccccCCCcccccccCCccccccccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhcCCCCcCCcccccccchhHHHHHHHHH
Confidence 987643322 12223457889999998866 4589999999999999999999999965433220 00000000
Q ss_pred HHhhcc------------cchhHhhhchhcccCC---------H--HHHHHHHHHHHHccccCCCCCCCHHhHHH
Q 003836 720 YDRYQE------------RTLEALVENDLEAMNN---------V--TMLHRFVMVAFWCIQEDPSHRPTMRKVTQ 771 (792)
Q Consensus 720 ~~~~~~------------~~~~~~~~~~~~~~~~---------~--~~~~~l~~l~~~Cl~~~p~~RPs~~evl~ 771 (792)
..+.. .......+.......+ . ....++.+++.+||+.+|++|||+.|+++
T Consensus 239 -~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~eil~ 312 (316)
T cd07842 239 -EVLGTPTEKDWPDIKKMPEYDTLMKDFKTKTYPSNSLAKWMEKHKKPDSQGFDLLRKLLEYDPTKRITAEEALE 312 (316)
T ss_pred -HHhCCCchhHHHHHhhcccchhhhhhccCCCCCCccHHHHHHhccCCCHHHHHHHHHHhcCCcccCcCHHHHhc
Confidence 00000 0000000000000000 0 23457899999999999999999999987
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the |
| >cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-32 Score=291.69 Aligned_cols=246 Identities=25% Similarity=0.359 Sum_probs=189.0
Q ss_pred hhhhcCccccceEEEeeecCCCceEEEEEEccccc-ccchHHHHHHHHH-hcccCCCCcccccceeccCCceEEEEEecc
Q 003836 505 FKEELGRGAFGTVYKGFVNMGSSNHVAVKKLNSVF-QDSEKEFKAEVNG-IGQTHHKNLVRLLGYCDEGQNRLLVYEFMS 582 (792)
Q Consensus 505 ~~~~lG~G~~g~Vy~g~~~~~~~~~vavK~~~~~~-~~~~~~~~~Ei~~-l~~l~h~niv~l~g~~~~~~~~~lV~E~~~ 582 (792)
+.+.||+|+||.||++... .+++.||+|+++... ...+.++..|+.. ++.++|+||+++++++..++..++||||++
T Consensus 5 ~~~~ig~g~~g~v~~~~~~-~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~iv~~~~~~~~~~~~~lv~e~~~ 83 (283)
T cd06617 5 VIEELGRGAYGVVDKMRHV-PTGTIMAVKRIRATVNSQEQKRLLMDLDISMRSVDCPYTVTFYGALFREGDVWICMEVMD 83 (283)
T ss_pred EEEEecccCCeEEEEEEEc-CCCcEEEEEEEecCCCcHHHHHHHHHHHHHHHHcCCCCeeeeeEEEecCCcEEEEhhhhc
Confidence 4578999999999999754 557899999987542 2334566667665 556789999999999999999999999997
Q ss_pred CCCccccccC----CCCCchhHHHHHHHHHHHHHHHHhhccCCCeEecCCCCCcEEEcCCCCeEEeecCCCccccCCCCC
Q 003836 583 NGTVASFLFG----DSKPNWKLRTEIAMGIAGGLFYLHEECCTQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLDQSH 658 (792)
Q Consensus 583 ~gsL~~~l~~----~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dikp~NILl~~~~~~kl~Dfg~a~~~~~~~~~ 658 (792)
|+|.+++.. ...+++..+..++.||+.||+|||++ .+++||||||+|||++.++.+||+|||+++......
T Consensus 84 -~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~--~~i~h~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~-- 158 (283)
T cd06617 84 -TSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLHSK--LSVIHRDVKPSNVLINRNGQVKLCDFGISGYLVDSV-- 158 (283)
T ss_pred -ccHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhc--CCeecCCCCHHHEEECCCCCEEEeeccccccccccc--
Confidence 578777643 24678999999999999999999985 389999999999999999999999999998653221
Q ss_pred ccccccccCCccccccccc----CCCCcccceehHHHHHHHHHhcCcCCCcchhhhhhhhHHHHHHHhhcccchhHhhhc
Q 003836 659 TNTAIRGTKGYVAPEWFRN----MPITVKVDVYSYGVLLLEIICLRRNIDNEISKVDKAILTDWAYDRYQERTLEALVEN 734 (792)
Q Consensus 659 ~~~~~~gt~~y~aPE~~~~----~~~~~k~DV~S~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 734 (792)
......++..|+|||.+.+ ..++.++|+||||+++|||++|+.||.......+. + ......
T Consensus 159 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~--~-------------~~~~~~ 223 (283)
T cd06617 159 AKTIDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYDSWKTPFQQ--L-------------KQVVEE 223 (283)
T ss_pred ccccccCCccccChhhcCCcccccccCccccchhhHHHHHHHHhCCCCCCccccCHHH--H-------------HHHHhc
Confidence 1223457889999998864 45789999999999999999999998643211110 0 011111
Q ss_pred hhcccCCHHHHHHHHHHHHHccccCCCCCCCHHhHHH
Q 003836 735 DLEAMNNVTMLHRFVMVAFWCIQEDPSHRPTMRKVTQ 771 (792)
Q Consensus 735 ~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~ 771 (792)
..........+.++.+++.+||+.+|.+||+++++++
T Consensus 224 ~~~~~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~ 260 (283)
T cd06617 224 PSPQLPAEKFSPEFQDFVNKCLKKNYKERPNYPELLQ 260 (283)
T ss_pred CCCCCCccccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 0000011124567889999999999999999999987
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs |
| >cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-32 Score=287.77 Aligned_cols=247 Identities=21% Similarity=0.280 Sum_probs=197.4
Q ss_pred hhhhhcCccccceEEEeeecCCCceEEEEEEcccc-----cccchHHHHHHHHHhcccCCCCcccccceeccC--CceEE
Q 003836 504 GFKEELGRGAFGTVYKGFVNMGSSNHVAVKKLNSV-----FQDSEKEFKAEVNGIGQTHHKNLVRLLGYCDEG--QNRLL 576 (792)
Q Consensus 504 ~~~~~lG~G~~g~Vy~g~~~~~~~~~vavK~~~~~-----~~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~--~~~~l 576 (792)
.+.+.||+|++|.||++... .+++.+|+|++... .....+.+++|++++++++|+||+++++++.+. ...++
T Consensus 5 ~~~~~lg~g~~g~v~~~~~~-~~~~~~~ik~~~~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 83 (264)
T cd06653 5 RLGKLLGRGAFGEVYLCYDA-DTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQYYGCLRDPEEKKLSI 83 (264)
T ss_pred eeeeeEccCCCeEEEEEEEc-CCCCEEEEEEEecCcccchhhHHHHHHHHHHHHHHHcCCCCcceEEEEEEcCCCCEEEE
Confidence 45678999999999999754 45678999987432 123345788999999999999999999998654 45789
Q ss_pred EEEeccCCCccccccCCCCCchhHHHHHHHHHHHHHHHHhhccCCCeEecCCCCCcEEEcCCCCeEEeecCCCccccCCC
Q 003836 577 VYEFMSNGTVASFLFGDSKPNWKLRTEIAMGIAGGLFYLHEECCTQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLDQ 656 (792)
Q Consensus 577 V~E~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dikp~NILl~~~~~~kl~Dfg~a~~~~~~~ 656 (792)
|+||+++++|.+++.....+++....+++.||+.||.|||+. +++|+||||+||+++.++.++|+|||+++......
T Consensus 84 v~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~i~~al~~LH~~---~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~ 160 (264)
T cd06653 84 FVEYMPGGSIKDQLKAYGALTENVTRRYTRQILQGVSYLHSN---MIVHRDIKGANILRDSAGNVKLGDFGASKRIQTIC 160 (264)
T ss_pred EEEeCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEEcCCCCEEECcccccccccccc
Confidence 999999999999998777788999999999999999999998 99999999999999999999999999998654211
Q ss_pred C--CccccccccCCcccccccccCCCCcccceehHHHHHHHHHhcCcCCCcchhhhhhhhHHHHHHHhhcccchhHhhhc
Q 003836 657 S--HTNTAIRGTKGYVAPEWFRNMPITVKVDVYSYGVLLLEIICLRRNIDNEISKVDKAILTDWAYDRYQERTLEALVEN 734 (792)
Q Consensus 657 ~--~~~~~~~gt~~y~aPE~~~~~~~~~k~DV~S~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 734 (792)
. .......++..|+|||.+.+..++.++|||||||+++||++|+.||........ .......
T Consensus 161 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~----------------~~~~~~~ 224 (264)
T cd06653 161 MSGTGIKSVTGTPYWMSPEVISGEGYGRKADVWSVACTVVEMLTEKPPWAEYEAMAA----------------IFKIATQ 224 (264)
T ss_pred ccCccccccCCcccccCHhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCccCHHHH----------------HHHHHcC
Confidence 1 112234588999999999988899999999999999999999999864321110 1111111
Q ss_pred hhcccCCHHHHHHHHHHHHHccccCCCCCCCHHhHHH
Q 003836 735 DLEAMNNVTMLHRFVMVAFWCIQEDPSHRPTMRKVTQ 771 (792)
Q Consensus 735 ~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~ 771 (792)
......+....+.+.+++.+|++ +|..||+..+++.
T Consensus 225 ~~~~~~p~~~~~~~~~~i~~~l~-~~~~r~~~~~~~~ 260 (264)
T cd06653 225 PTKPMLPDGVSDACRDFLKQIFV-EEKRRPTAEFLLR 260 (264)
T ss_pred CCCCCCCcccCHHHHHHHHHHhc-CcccCccHHHHhc
Confidence 12233445566788999999999 5799999998876
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho |
| >cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-32 Score=291.49 Aligned_cols=260 Identities=19% Similarity=0.240 Sum_probs=190.8
Q ss_pred hhhhcCccccceEEEeeecCCCceEEEEEEcccccc-cchHHHHHHHHHhcccCCCCcccccceeccCCceEEEEEeccC
Q 003836 505 FKEELGRGAFGTVYKGFVNMGSSNHVAVKKLNSVFQ-DSEKEFKAEVNGIGQTHHKNLVRLLGYCDEGQNRLLVYEFMSN 583 (792)
Q Consensus 505 ~~~~lG~G~~g~Vy~g~~~~~~~~~vavK~~~~~~~-~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~lV~E~~~~ 583 (792)
+.+.||+|+||.||+|... .+++.+++|++..... .....+.+|+.++++++|+||+++++++..+...++|+||++
T Consensus 9 ~~~~ig~g~~~~v~~~~~~-~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e~~~- 86 (291)
T cd07870 9 NLEKLGEGSYATVYKGISR-INGQLVALKVISMKTEEGVPFTAIREASLLKGLKHANIVLLHDIIHTKETLTFVFEYMH- 86 (291)
T ss_pred EEEEEEecCCEEEEEEEEc-CCCcEEEEEEecccCcCCCcHHHHHHHHHHHhcCCCCEeEEEEEEecCCeEEEEEeccc-
Confidence 4578999999999999654 3456899999865432 234577899999999999999999999999999999999996
Q ss_pred CCccccccC-CCCCchhHHHHHHHHHHHHHHHHhhccCCCeEecCCCCCcEEEcCCCCeEEeecCCCccccCCCCCcccc
Q 003836 584 GTVASFLFG-DSKPNWKLRTEIAMGIAGGLFYLHEECCTQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLDQSHTNTA 662 (792)
Q Consensus 584 gsL~~~l~~-~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dikp~NILl~~~~~~kl~Dfg~a~~~~~~~~~~~~~ 662 (792)
++|.+++.. ...+.+..+..++.||+.||.|||+. +|+|+||||+|||++.++.+||+|||+++....... ....
T Consensus 87 ~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~---~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~~-~~~~ 162 (291)
T cd07870 87 TDLAQYMIQHPGGLHPYNVRLFMFQLLRGLAYIHGQ---HILHRDLKPQNLLISYLGELKLADFGLARAKSIPSQ-TYSS 162 (291)
T ss_pred CCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCChHHEEEcCCCcEEEeccccccccCCCCC-CCCC
Confidence 577666644 35577888899999999999999998 999999999999999999999999999976433221 1223
Q ss_pred ccccCCcccccccccC-CCCcccceehHHHHHHHHHhcCcCCCcchhhhhhhhHHHHHHHh---------hc--ccchhH
Q 003836 663 IRGTKGYVAPEWFRNM-PITVKVDVYSYGVLLLEIICLRRNIDNEISKVDKAILTDWAYDR---------YQ--ERTLEA 730 (792)
Q Consensus 663 ~~gt~~y~aPE~~~~~-~~~~k~DV~S~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~---------~~--~~~~~~ 730 (792)
..+++.|+|||.+.+. .++.++||||||+++|||++|+.||.......+.. ...+.... .. ......
T Consensus 163 ~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~f~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (291)
T cd07870 163 EVVTLWYRPPDVLLGATDYSSALDIWGAGCIFIEMLQGQPAFPGVSDVFEQL-EKIWTVLGVPTEDTWPGVSKLPNYKPE 241 (291)
T ss_pred ccccccccCCceeecCCCCCcHHHHHHHHHHHHHHHhCCCCCCCchhHHHHH-HHHHHHcCCCChhhhhhhhhcccccch
Confidence 3468899999998754 57899999999999999999999997543321110 00000000 00 000000
Q ss_pred hhhchhccc-----CCHHHHHHHHHHHHHccccCCCCCCCHHhHHH
Q 003836 731 LVENDLEAM-----NNVTMLHRFVMVAFWCIQEDPSHRPTMRKVTQ 771 (792)
Q Consensus 731 ~~~~~~~~~-----~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~ 771 (792)
......... ........+.+++.+|++.||++|||++|++.
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dp~~R~t~~~~l~ 287 (291)
T cd07870 242 WFLPCKPQQLRVVWKRLSRPPKAEDLASQMLMMFPKDRISAQDALL 287 (291)
T ss_pred hccccCCcchhhhccccCCChHHHHHHHHHhCcCcccCcCHHHHhc
Confidence 000000000 00012456788999999999999999999886
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess |
| >cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-32 Score=286.01 Aligned_cols=247 Identities=26% Similarity=0.345 Sum_probs=203.4
Q ss_pred hhhcCccccceEEEeeecCCCceEEEEEEcccccc--cchHHHHHHHHHhcccCCCCcccccceeccC--CceEEEEEec
Q 003836 506 KEELGRGAFGTVYKGFVNMGSSNHVAVKKLNSVFQ--DSEKEFKAEVNGIGQTHHKNLVRLLGYCDEG--QNRLLVYEFM 581 (792)
Q Consensus 506 ~~~lG~G~~g~Vy~g~~~~~~~~~vavK~~~~~~~--~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~--~~~~lV~E~~ 581 (792)
.+.||+|++|.||+|... .+++.+++|++..... ...+.+.+|+..+++++|+||+++++.+.+. ...++|+||+
T Consensus 5 ~~~i~~g~~~~v~~~~~~-~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~e~~ 83 (260)
T cd06606 5 GELLGRGSFGSVYLALDK-DTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYYGSERDEEKNTLNIFLEYV 83 (260)
T ss_pred eeEeeecCceEEEEEEEC-CCCcEEEEEEeeccccchHHHHHHHHHHHHHHHcCCCCEeeEEEEEecCCCCeEEEEEEec
Confidence 467999999999999764 3567899999876542 4567899999999999999999999999988 8899999999
Q ss_pred cCCCccccccCCCCCchhHHHHHHHHHHHHHHHHhhccCCCeEecCCCCCcEEEcCCCCeEEeecCCCccccCCCCC-cc
Q 003836 582 SNGTVASFLFGDSKPNWKLRTEIAMGIAGGLFYLHEECCTQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLDQSH-TN 660 (792)
Q Consensus 582 ~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dikp~NILl~~~~~~kl~Dfg~a~~~~~~~~~-~~ 660 (792)
++++|.+++.....+++..+..++.|+++||+|||+. +++|+||+|+||+++.++.+||+|||.+......... ..
T Consensus 84 ~~~~L~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~---~~~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~~~~ 160 (260)
T cd06606 84 SGGSLSSLLKKFGKLPEPVIRKYTRQILEGLAYLHSN---GIVHRDIKGANILVDSDGVVKLADFGCAKRLGDIETGEGT 160 (260)
T ss_pred CCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEEcCCCCEEEcccccEEecccccccccc
Confidence 9999999998777899999999999999999999998 9999999999999999999999999999876544321 12
Q ss_pred ccccccCCcccccccccCCCCcccceehHHHHHHHHHhcCcCCCcchhhhhhhhHHHHHHHhhcccchhHhhhchhcccC
Q 003836 661 TAIRGTKGYVAPEWFRNMPITVKVDVYSYGVLLLEIICLRRNIDNEISKVDKAILTDWAYDRYQERTLEALVENDLEAMN 740 (792)
Q Consensus 661 ~~~~gt~~y~aPE~~~~~~~~~k~DV~S~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 740 (792)
....++..|+|||.+.....+.++||||||+++++|++|+.||......... . ..+.........
T Consensus 161 ~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~------~---------~~~~~~~~~~~~ 225 (260)
T cd06606 161 GSVRGTPYWMAPEVIRGEEYGRAADIWSLGCTVIEMATGKPPWSELGNPMAA------L---------YKIGSSGEPPEI 225 (260)
T ss_pred cCCCCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchHHH------H---------HhccccCCCcCC
Confidence 3345788999999998888999999999999999999999999754311000 0 001111111222
Q ss_pred CHHHHHHHHHHHHHccccCCCCCCCHHhHHH
Q 003836 741 NVTMLHRFVMVAFWCIQEDPSHRPTMRKVTQ 771 (792)
Q Consensus 741 ~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~ 771 (792)
+......+.+++.+|++.+|++||++.++++
T Consensus 226 ~~~~~~~l~~~i~~~l~~~p~~Rp~~~~ll~ 256 (260)
T cd06606 226 PEHLSEEAKDFLRKCLRRDPKKRPTADELLQ 256 (260)
T ss_pred CcccCHHHHHHHHHhCcCChhhCCCHHHHhh
Confidence 3334678899999999999999999999987
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK |
| >cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-32 Score=290.43 Aligned_cols=245 Identities=24% Similarity=0.342 Sum_probs=197.4
Q ss_pred hhcCccccceEEEeeecCCCceEEEEEEcccccccchHHHHHHHHHhcccCCCCcccccceeccCCceEEEEEeccCCCc
Q 003836 507 EELGRGAFGTVYKGFVNMGSSNHVAVKKLNSVFQDSEKEFKAEVNGIGQTHHKNLVRLLGYCDEGQNRLLVYEFMSNGTV 586 (792)
Q Consensus 507 ~~lG~G~~g~Vy~g~~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~lV~E~~~~gsL 586 (792)
.+||+|+||.||++... .+++.+|+|++..........+.+|+.++++++|+||+++++.+...+..++||||+++++|
T Consensus 26 ~~lg~g~~g~v~~~~~~-~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L 104 (292)
T cd06657 26 IKIGEGSTGIVCIATVK-SSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGAL 104 (292)
T ss_pred HHcCCCCCeEEEEEEEc-CCCeEEEEEEecccchhHHHHHHHHHHHHHhcCCcchhheeeEEEeCCEEEEEEecCCCCcH
Confidence 57999999999999754 45679999998765555567799999999999999999999999999999999999999999
Q ss_pred cccccCCCCCchhHHHHHHHHHHHHHHHHhhccCCCeEecCCCCCcEEEcCCCCeEEeecCCCccccCCCCCcccccccc
Q 003836 587 ASFLFGDSKPNWKLRTEIAMGIAGGLFYLHEECCTQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLDQSHTNTAIRGT 666 (792)
Q Consensus 587 ~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dikp~NILl~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~gt 666 (792)
.+++.. ..+++.....++.|++.||+|||+. +++|+||+|+||++++++.++|+|||++....... .......++
T Consensus 105 ~~~~~~-~~~~~~~~~~~~~ql~~~l~~lH~~---givH~dl~p~Nilv~~~~~~~l~dfg~~~~~~~~~-~~~~~~~~~ 179 (292)
T cd06657 105 TDIVTH-TRMNEEQIAAVCLAVLKALSVLHAQ---GVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEV-PRRKSLVGT 179 (292)
T ss_pred HHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEEcccccceeccccc-ccccccccC
Confidence 998754 4578899999999999999999998 99999999999999999999999999987654322 122334578
Q ss_pred CCcccccccccCCCCcccceehHHHHHHHHHhcCcCCCcchhhhhhhhHHHHHHHhhcccchhHhhhchhcccCCHHHHH
Q 003836 667 KGYVAPEWFRNMPITVKVDVYSYGVLLLEIICLRRNIDNEISKVDKAILTDWAYDRYQERTLEALVENDLEAMNNVTMLH 746 (792)
Q Consensus 667 ~~y~aPE~~~~~~~~~k~DV~S~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 746 (792)
+.|+|||.+.+..++.++||||||+++|||++|..||...........+ .. ....... .......
T Consensus 180 ~~y~~pE~~~~~~~~~~~Dv~slGvil~el~tg~~p~~~~~~~~~~~~~----~~---------~~~~~~~--~~~~~~~ 244 (292)
T cd06657 180 PYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMI----RD---------NLPPKLK--NLHKVSP 244 (292)
T ss_pred ccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH----Hh---------hCCcccC--CcccCCH
Confidence 9999999998888999999999999999999999998654221110000 00 0000000 0112345
Q ss_pred HHHHHHHHccccCCCCCCCHHhHHHH
Q 003836 747 RFVMVAFWCIQEDPSHRPTMRKVTQM 772 (792)
Q Consensus 747 ~l~~l~~~Cl~~~p~~RPs~~evl~~ 772 (792)
.+.+++.+||+.+|.+||++.++++.
T Consensus 245 ~l~~li~~~l~~~P~~R~~~~~ll~~ 270 (292)
T cd06657 245 SLKGFLDRLLVRDPAQRATAAELLKH 270 (292)
T ss_pred HHHHHHHHHHhCCcccCcCHHHHhcC
Confidence 67889999999999999999999873
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo |
| >cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-32 Score=291.25 Aligned_cols=250 Identities=22% Similarity=0.247 Sum_probs=196.7
Q ss_pred hhhhcCccccceEEEeeecC--CCceEEEEEEccccc----ccchHHHHHHHHHhccc-CCCCcccccceeccCCceEEE
Q 003836 505 FKEELGRGAFGTVYKGFVNM--GSSNHVAVKKLNSVF----QDSEKEFKAEVNGIGQT-HHKNLVRLLGYCDEGQNRLLV 577 (792)
Q Consensus 505 ~~~~lG~G~~g~Vy~g~~~~--~~~~~vavK~~~~~~----~~~~~~~~~Ei~~l~~l-~h~niv~l~g~~~~~~~~~lV 577 (792)
+.+.||+|+||.||++.... .+++.+|+|++.... ....+.+.+|+++++++ +|+||+++++++..+...++|
T Consensus 4 ~~~~lg~G~~g~v~~~~~~~~~~~g~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv 83 (290)
T cd05613 4 LLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTDTKLHLI 83 (290)
T ss_pred eeeeeccCCcceEEEEEeccCCCCCceEEEEEeehhhhhhcchHHHHHHHHHHHHHhcccCCChhceeeEeecCCeEEEE
Confidence 45789999999999987532 356789999986532 22346788999999999 599999999999999999999
Q ss_pred EEeccCCCccccccCCCCCchhHHHHHHHHHHHHHHHHhhccCCCeEecCCCCCcEEEcCCCCeEEeecCCCccccCCCC
Q 003836 578 YEFMSNGTVASFLFGDSKPNWKLRTEIAMGIAGGLFYLHEECCTQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLDQS 657 (792)
Q Consensus 578 ~E~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dikp~NILl~~~~~~kl~Dfg~a~~~~~~~~ 657 (792)
+||+++++|.+++.....+++..+..++.|+++||.|||+. +++||||+|+|||+++++.+||+|||+++.......
T Consensus 84 ~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~al~~lH~~---~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~ 160 (290)
T cd05613 84 LDYINGGELFTHLSQRERFKEQEVQIYSGEIVLALEHLHKL---GIIYRDIKLENILLDSNGHVVLTDFGLSKEFHEDEV 160 (290)
T ss_pred EecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHeEECCCCCEEEeeCccceecccccc
Confidence 99999999999998777888999999999999999999998 999999999999999999999999999987654333
Q ss_pred CccccccccCCcccccccccC--CCCcccceehHHHHHHHHHhcCcCCCcchhhhhhhhHHHHHHHhhcccchhHhhhch
Q 003836 658 HTNTAIRGTKGYVAPEWFRNM--PITVKVDVYSYGVLLLEIICLRRNIDNEISKVDKAILTDWAYDRYQERTLEALVEND 735 (792)
Q Consensus 658 ~~~~~~~gt~~y~aPE~~~~~--~~~~k~DV~S~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 735 (792)
.......|+..|+|||.+... .++.++||||||+++|+|++|+.||........ ....... +...
T Consensus 161 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~---~~~~~~~---------~~~~- 227 (290)
T cd05613 161 ERAYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTVDGEKNS---QAEISRR---------ILKS- 227 (290)
T ss_pred cccccccCCcccCChhhccCCCCCCCccccHHHHHHHHHHHhcCCCCCCcCCcccc---HHHHHHH---------hhcc-
Confidence 333345688999999998753 478899999999999999999999864221100 0000000 0000
Q ss_pred hcccCCHHHHHHHHHHHHHccccCCCCCC-----CHHhHHH
Q 003836 736 LEAMNNVTMLHRFVMVAFWCIQEDPSHRP-----TMRKVTQ 771 (792)
Q Consensus 736 ~~~~~~~~~~~~l~~l~~~Cl~~~p~~RP-----s~~evl~ 771 (792)
....+......+.+++.+||+.+|++|| +.++++.
T Consensus 228 -~~~~~~~~~~~~~~ll~~~l~~~p~~R~~~~~~~~~~l~~ 267 (290)
T cd05613 228 -EPPYPQEMSALAKDIIQRLLMKDPKKRLGCGPSDADEIKK 267 (290)
T ss_pred -CCCCCccCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHc
Confidence 1112233456788999999999999997 6777765
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-32 Score=296.79 Aligned_cols=265 Identities=21% Similarity=0.278 Sum_probs=195.9
Q ss_pred HhhhhhhcCccccceEEEeeecCCCceEEEEEEcccc--cccchHHHHHHHHHhccc-CCCCcccccceeccC--CceEE
Q 003836 502 TRGFKEELGRGAFGTVYKGFVNMGSSNHVAVKKLNSV--FQDSEKEFKAEVNGIGQT-HHKNLVRLLGYCDEG--QNRLL 576 (792)
Q Consensus 502 ~~~~~~~lG~G~~g~Vy~g~~~~~~~~~vavK~~~~~--~~~~~~~~~~Ei~~l~~l-~h~niv~l~g~~~~~--~~~~l 576 (792)
.+.+.+.||+|+||.||+|... .+++.+|+|++... .......+.+|+.+++++ +|+||+++++++... ...++
T Consensus 8 ~y~~~~~lg~g~~~~v~~~~~~-~~~~~~~vK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~ni~~~~~~~~~~~~~~~~l 86 (337)
T cd07852 8 KYEILQKLGKGAYGIVWKAIDR-RTKEVVALKKIFDAFRNATDAQRTFREIMFLQELGDHPNIVKLLNVIKAENDKDIYL 86 (337)
T ss_pred HHHHhHhhcCCCCeeEEEEEEc-CCCeEEEEEeeccccCcchhhhhhhHHHHHHHHhcCCCCccceeeeeccCCCceEEE
Confidence 3455688999999999999754 44678999988643 223345678899999999 999999999998643 46899
Q ss_pred EEEeccCCCccccccCCCCCchhHHHHHHHHHHHHHHHHhhccCCCeEecCCCCCcEEEcCCCCeEEeecCCCccccCCC
Q 003836 577 VYEFMSNGTVASFLFGDSKPNWKLRTEIAMGIAGGLFYLHEECCTQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLDQ 656 (792)
Q Consensus 577 V~E~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dikp~NILl~~~~~~kl~Dfg~a~~~~~~~ 656 (792)
||||++ ++|.+++... .+++..+..++.||+.||+|||+. +|+|+||||+||++++++.+||+|||+++......
T Consensus 87 v~e~~~-~~L~~~~~~~-~~~~~~~~~i~~qi~~~L~~LH~~---~i~H~dl~p~nill~~~~~~kl~d~g~~~~~~~~~ 161 (337)
T cd07852 87 VFEYME-TDLHAVIRAN-ILEDVHKRYIMYQLLKALKYIHSG---NVIHRDLKPSNILLNSDCRVKLADFGLARSLSELE 161 (337)
T ss_pred Eecccc-cCHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCcEEEeeccchhcccccc
Confidence 999998 5998888665 778899999999999999999998 99999999999999999999999999998764433
Q ss_pred CC----ccccccccCCccccccccc-CCCCcccceehHHHHHHHHHhcCcCCCcchhhhhhhhHHHHH-------HHhhc
Q 003836 657 SH----TNTAIRGTKGYVAPEWFRN-MPITVKVDVYSYGVLLLEIICLRRNIDNEISKVDKAILTDWA-------YDRYQ 724 (792)
Q Consensus 657 ~~----~~~~~~gt~~y~aPE~~~~-~~~~~k~DV~S~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~-------~~~~~ 724 (792)
.. ......++..|+|||.+.+ ..++.++||||||+++|||++|+.||................ .....
T Consensus 162 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (337)
T cd07852 162 ENPENPVLTDYVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGKPLFPGTSTLNQLEKIIEVIGPPSAEDIESIK 241 (337)
T ss_pred ccccCcchhcccccccccCceeeeccccccccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHHH
Confidence 21 2223468899999998755 567899999999999999999999986543221111000000 00000
Q ss_pred ccchhHhhhchhcc------cCCHHHHHHHHHHHHHccccCCCCCCCHHhHHHH
Q 003836 725 ERTLEALVENDLEA------MNNVTMLHRFVMVAFWCIQEDPSHRPTMRKVTQM 772 (792)
Q Consensus 725 ~~~~~~~~~~~~~~------~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~ 772 (792)
......+++..... ......+..+.+++.+||+.+|++|||+.++++.
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rps~~~il~~ 295 (337)
T cd07852 242 SPFAATMLDSLPSRPRKPLDELLPKASDDALDLLKKLLVFNPNKRLTAEEALEH 295 (337)
T ss_pred hhhHHHhhhhcccccccchhhhccCCCHHHHHHHHHhccCCcccccCHHHHhhC
Confidence 00011111100000 0011135678999999999999999999999975
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul |
| >cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-32 Score=291.71 Aligned_cols=250 Identities=27% Similarity=0.371 Sum_probs=192.0
Q ss_pred hhhhcCccccceEEEeeecCCCceEEEEEEccccc-ccchHHHHHHHHHhcccC-CCCcccccceeccCCceEEEEEecc
Q 003836 505 FKEELGRGAFGTVYKGFVNMGSSNHVAVKKLNSVF-QDSEKEFKAEVNGIGQTH-HKNLVRLLGYCDEGQNRLLVYEFMS 582 (792)
Q Consensus 505 ~~~~lG~G~~g~Vy~g~~~~~~~~~vavK~~~~~~-~~~~~~~~~Ei~~l~~l~-h~niv~l~g~~~~~~~~~lV~E~~~ 582 (792)
+.++||+|+||.||++... .+++.+|+|++.... ......+.+|+.++.++. |+||+++++++..+...+++|||+.
T Consensus 8 ~~~~lg~G~~g~vy~~~~~-~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~~~~~~~iv~~~~~~~~~~~~~~~~e~~~ 86 (288)
T cd06616 8 DLGEIGRGAFGTVNKMLHK-PSGTIMAVKRIRSTVDEKEQKRLLMDLDVVMRSSDCPYIVKFYGALFREGDCWICMELMD 86 (288)
T ss_pred HHHHhCCCCceEEEEEEEC-CCCCEEEEEEehhccChHHHHHHHHHHHHHHHhcCCCCEeeeeeEEecCCcEEEEEeccc
Confidence 3467999999999999754 456799999987533 234567899999999996 9999999999999999999999987
Q ss_pred CCCccccc---c--CCCCCchhHHHHHHHHHHHHHHHHhhccCCCeEecCCCCCcEEEcCCCCeEEeecCCCccccCCCC
Q 003836 583 NGTVASFL---F--GDSKPNWKLRTEIAMGIAGGLFYLHEECCTQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLDQS 657 (792)
Q Consensus 583 ~gsL~~~l---~--~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dikp~NILl~~~~~~kl~Dfg~a~~~~~~~~ 657 (792)
. +|.++. . ....+++.....++.|++.||+|||+. .+++||||||+||+++.++.+||+|||+++......
T Consensus 87 ~-~l~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~--~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~- 162 (288)
T cd06616 87 I-SLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLKEE--LKIIHRDVKPSNILLDRNGNIKLCDFGISGQLVDSI- 162 (288)
T ss_pred C-CHHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhc--CCeeccCCCHHHEEEccCCcEEEeecchhHHhccCC-
Confidence 4 554432 2 235688999999999999999999974 389999999999999999999999999997654322
Q ss_pred CccccccccCCcccccccccC---CCCcccceehHHHHHHHHHhcCcCCCcchhhhhhhhHHHHHHHhhcccchhHhhhc
Q 003836 658 HTNTAIRGTKGYVAPEWFRNM---PITVKVDVYSYGVLLLEIICLRRNIDNEISKVDKAILTDWAYDRYQERTLEALVEN 734 (792)
Q Consensus 658 ~~~~~~~gt~~y~aPE~~~~~---~~~~k~DV~S~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 734 (792)
......+++.|+|||.+... .++.++||||||+++|||++|+.||......... ...... .. .+
T Consensus 163 -~~~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~------~~~~~~-~~-----~~ 229 (288)
T cd06616 163 -AKTRDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPKWNSVFDQ------LTQVVK-GD-----PP 229 (288)
T ss_pred -ccccccCccCccCHHHhccccccCCcchhhhhHHHHHHHHHHhCCCCchhcchHHHH------HhhhcC-CC-----CC
Confidence 12233578899999998765 6899999999999999999999998643211000 000000 00 01
Q ss_pred hhcccCCHHHHHHHHHHHHHccccCCCCCCCHHhHHHH
Q 003836 735 DLEAMNNVTMLHRFVMVAFWCIQEDPSHRPTMRKVTQM 772 (792)
Q Consensus 735 ~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~ 772 (792)
.+........+.++.+++.+||+.+|++|||+++|++.
T Consensus 230 ~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~i~~~ 267 (288)
T cd06616 230 ILSNSEEREFSPSFVNFINLCLIKDESKRPKYKELLEH 267 (288)
T ss_pred cCCCcCCCccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 11111122356678999999999999999999999873
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates |
| >PHA02882 putative serine/threonine kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-32 Score=292.92 Aligned_cols=259 Identities=19% Similarity=0.206 Sum_probs=182.9
Q ss_pred HhhhhhhcCccccceEEEeeecCCC--ceEEEEEEcccccccc--h---------HHHHHHHHHhcccCCCCccccccee
Q 003836 502 TRGFKEELGRGAFGTVYKGFVNMGS--SNHVAVKKLNSVFQDS--E---------KEFKAEVNGIGQTHHKNLVRLLGYC 568 (792)
Q Consensus 502 ~~~~~~~lG~G~~g~Vy~g~~~~~~--~~~vavK~~~~~~~~~--~---------~~~~~Ei~~l~~l~h~niv~l~g~~ 568 (792)
.+.+.+.||+|+||+||+|...... ...+++|+........ + .....+...+..++|+|++++++++
T Consensus 13 ~y~i~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~k~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~ 92 (294)
T PHA02882 13 EWKIDKLIGCGGFGCVYETQCASDHCINNQAVAKIENLENETIVMETLVYNNIYDIDKIALWKNIHNIDHLGIPKYYGCG 92 (294)
T ss_pred ceEEeeEEecCCCceEEEEEEcCCcccccceEEEeccccCCchhhHHHHHHhhhhHHHHHHHHHhccCCCCCCCcEEEee
Confidence 4556688999999999999765331 3456666533221111 1 1122334456677999999999977
Q ss_pred ccCC----ceEEEEEeccCCCccccccCCCCCchhHHHHHHHHHHHHHHHHhhccCCCeEecCCCCCcEEEcCCCCeEEe
Q 003836 569 DEGQ----NRLLVYEFMSNGTVASFLFGDSKPNWKLRTEIAMGIAGGLFYLHEECCTQIIHCDIKPQNILLDDHYNARIS 644 (792)
Q Consensus 569 ~~~~----~~~lV~E~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dikp~NILl~~~~~~kl~ 644 (792)
.... ..++++|++.. ++.+.+......++..+..|+.|+++||+|||+. +|+||||||+|||++.++.+||+
T Consensus 93 ~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~iiHrDiKp~Nill~~~~~~~l~ 168 (294)
T PHA02882 93 SFKRCRMYYRFILLEKLVE-NTKEIFKRIKCKNKKLIKNIMKDMLTTLEYIHEH---GISHGDIKPENIMVDGNNRGYII 168 (294)
T ss_pred eEecCCceEEEEEEehhcc-CHHHHHHhhccCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCcEEEE
Confidence 5443 34677777643 5555555444467888899999999999999998 99999999999999999999999
Q ss_pred ecCCCccccCCCC------CccccccccCCcccccccccCCCCcccceehHHHHHHHHHhcCcCCCcchhhhhhhhHHHH
Q 003836 645 DFGLAKLLTLDQS------HTNTAIRGTKGYVAPEWFRNMPITVKVDVYSYGVLLLEIICLRRNIDNEISKVDKAILTDW 718 (792)
Q Consensus 645 Dfg~a~~~~~~~~------~~~~~~~gt~~y~aPE~~~~~~~~~k~DV~S~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~ 718 (792)
|||+++.+..... .......||+.|+|||.+.+..++.++|||||||+++||++|+.||..............
T Consensus 169 DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~ape~~~~~~~~~~~DiwSlG~~l~el~~g~~P~~~~~~~~~~~~~~~- 247 (294)
T PHA02882 169 DYGIASHFIIHGKHIEYSKEQKDLHRGTLYYAGLDAHNGACVTRRGDLESLGYCMLKWAGIKLPWKGFGHNGNLIHAAK- 247 (294)
T ss_pred EcCCceeeccCCcccccccccccccCCCccccCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCccccchHHHHHhH-
Confidence 9999987643221 111234699999999999999999999999999999999999999976532211110000
Q ss_pred HHHhhcccchhHhhhchhcccCCHHHHHHHHHHHHHccccCCCCCCCHHhHHHHhc
Q 003836 719 AYDRYQERTLEALVENDLEAMNNVTMLHRFVMVAFWCIQEDPSHRPTMRKVTQMLE 774 (792)
Q Consensus 719 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~L~ 774 (792)
. ..+..+...... .......+.+++..|++.+|++||+++++++.|+
T Consensus 248 --~----~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~rp~~~~l~~~~~ 294 (294)
T PHA02882 248 --C----DFIKRLHEGKIK---IKNANKFIYDFIECVTKLSYEEKPDYDALIKIFD 294 (294)
T ss_pred --H----HHHHHhhhhhhc---cCCCCHHHHHHHHHHHhCCCCCCCCHHHHHHhhC
Confidence 0 000111111111 1123467889999999999999999999999764
|
|
| >cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-32 Score=300.60 Aligned_cols=261 Identities=24% Similarity=0.281 Sum_probs=193.5
Q ss_pred hhhhhhcCccccceEEEeeecCCCceEEEEEEccccc--ccchHHHHHHHHHhcccCCCCcccccceeccC------Cce
Q 003836 503 RGFKEELGRGAFGTVYKGFVNMGSSNHVAVKKLNSVF--QDSEKEFKAEVNGIGQTHHKNLVRLLGYCDEG------QNR 574 (792)
Q Consensus 503 ~~~~~~lG~G~~g~Vy~g~~~~~~~~~vavK~~~~~~--~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~------~~~ 574 (792)
+...+.||+|+||.||++... .+++.+|+|++.... ....+.+.+|+.++++++|+||+++++++... ...
T Consensus 18 y~~~~~lg~g~~g~V~~~~~~-~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~ 96 (353)
T cd07850 18 YQNLKPIGSGAQGIVCAAYDT-VTGQNVAIKKLSRPFQNVTHAKRAYRELVLMKLVNHKNIIGLLNVFTPQKSLEEFQDV 96 (353)
T ss_pred eEEEEEeccCCCEEEEEEEEC-CCCCEEEEEecCccccChhHHHHHHHHHHHHHhcCCCCCcceeeeeccCCCccccCcE
Confidence 334578999999999999654 456799999986532 23345778899999999999999999988543 357
Q ss_pred EEEEEeccCCCccccccCCCCCchhHHHHHHHHHHHHHHHHhhccCCCeEecCCCCCcEEEcCCCCeEEeecCCCccccC
Q 003836 575 LLVYEFMSNGTVASFLFGDSKPNWKLRTEIAMGIAGGLFYLHEECCTQIIHCDIKPQNILLDDHYNARISDFGLAKLLTL 654 (792)
Q Consensus 575 ~lV~E~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dikp~NILl~~~~~~kl~Dfg~a~~~~~ 654 (792)
++||||+++ +|.+.+... ++...+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++....
T Consensus 97 ~lv~e~~~~-~l~~~~~~~--l~~~~~~~~~~ql~~aL~~LH~~---gi~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~ 170 (353)
T cd07850 97 YLVMELMDA-NLCQVIQMD--LDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLARTAGT 170 (353)
T ss_pred EEEEeccCC-CHHHHHhhc--CCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHEEECCCCCEEEccCccceeCCC
Confidence 999999965 788777543 78889999999999999999998 999999999999999999999999999986543
Q ss_pred CCCCccccccccCCcccccccccCCCCcccceehHHHHHHHHHhcCcCCCcchhhhhhhhHH--------HHH------H
Q 003836 655 DQSHTNTAIRGTKGYVAPEWFRNMPITVKVDVYSYGVLLLEIICLRRNIDNEISKVDKAILT--------DWA------Y 720 (792)
Q Consensus 655 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DV~S~Gv~l~el~tg~~p~~~~~~~~~~~~~~--------~~~------~ 720 (792)
.. ......+++.|+|||.+.+..++.++|||||||++|+|++|+.||...........+. .+. .
T Consensus 171 ~~--~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 248 (353)
T cd07850 171 SF--MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGTVLFPGTDHIDQWNKIIEQLGTPSDEFMSRLQPTV 248 (353)
T ss_pred CC--CCCCCcccccccCHHHHhCCCCCCchhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHhhhhh
Confidence 22 1233457889999999999999999999999999999999999996543211100000 000 0
Q ss_pred Hhh-cc------cchhHhhhchh----cccCCHHHHHHHHHHHHHccccCCCCCCCHHhHHHH
Q 003836 721 DRY-QE------RTLEALVENDL----EAMNNVTMLHRFVMVAFWCIQEDPSHRPTMRKVTQM 772 (792)
Q Consensus 721 ~~~-~~------~~~~~~~~~~~----~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~ 772 (792)
... .. .....+..... ...........+.+++.+||+.||++|||+.|+++.
T Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~eiL~~ 311 (353)
T cd07850 249 RNYVENRPKYAGYSFEELFPDVLFPPDSESHNKLKASQARDLLSKMLVIDPEKRISVDDALQH 311 (353)
T ss_pred hHHhhcCCCCCCcchhhhCcccccCcccccccccchhHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 000 00 00001110000 001112345678899999999999999999999975
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK |
| >cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-32 Score=285.50 Aligned_cols=244 Identities=23% Similarity=0.311 Sum_probs=200.1
Q ss_pred hhhhcCccccceEEEeeecCCCceEEEEEEccccc--ccchHHHHHHHHHhcccCCCCcccccceeccCCceEEEEEecc
Q 003836 505 FKEELGRGAFGTVYKGFVNMGSSNHVAVKKLNSVF--QDSEKEFKAEVNGIGQTHHKNLVRLLGYCDEGQNRLLVYEFMS 582 (792)
Q Consensus 505 ~~~~lG~G~~g~Vy~g~~~~~~~~~vavK~~~~~~--~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~lV~E~~~ 582 (792)
+.++||+|++|.||+++.. .+++.+++|++.... .....++.+|++++++++|+||+++++++.+....++|+||++
T Consensus 4 ~~~~i~~g~~~~v~~~~~~-~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~ 82 (256)
T cd08530 4 VLKKLGKGSYGSVYKVKRL-SDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPNIISYKEAFLDGNKLCIVMEYAP 82 (256)
T ss_pred EeeeecCCCceeEEEEEEC-CCCCEEEEEEEehhhccHHHHHHHHHHHHHHHhCCCCCchhhhhhhccCCEEEEEehhcC
Confidence 4578999999999999754 456789999987532 2335578899999999999999999999999999999999999
Q ss_pred CCCccccccC----CCCCchhHHHHHHHHHHHHHHHHhhccCCCeEecCCCCCcEEEcCCCCeEEeecCCCccccCCCCC
Q 003836 583 NGTVASFLFG----DSKPNWKLRTEIAMGIAGGLFYLHEECCTQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLDQSH 658 (792)
Q Consensus 583 ~gsL~~~l~~----~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dikp~NILl~~~~~~kl~Dfg~a~~~~~~~~~ 658 (792)
+++|.+++.+ ...+++..+..++.|++.||+|||+. +++|+||+|+||++++++.+||+|||+++.....
T Consensus 83 ~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lh~~---~i~h~~l~~~ni~~~~~~~~kl~d~g~~~~~~~~--- 156 (256)
T cd08530 83 FGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALHEQ---KILHRDLKSANILLVANDLVKIGDLGISKVLKKN--- 156 (256)
T ss_pred CCCHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhC---CcccCCCCcceEEEecCCcEEEeeccchhhhccC---
Confidence 9999999865 35678899999999999999999998 9999999999999999999999999999876543
Q ss_pred ccccccccCCcccccccccCCCCcccceehHHHHHHHHHhcCcCCCcchhhhhhhhHHHHHHHhhcccchhHhhhchhcc
Q 003836 659 TNTAIRGTKGYVAPEWFRNMPITVKVDVYSYGVLLLEIICLRRNIDNEISKVDKAILTDWAYDRYQERTLEALVENDLEA 738 (792)
Q Consensus 659 ~~~~~~gt~~y~aPE~~~~~~~~~k~DV~S~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 738 (792)
......+++.|+|||.+.+..++.++|+||||+++|||++|+.||......... ..+......
T Consensus 157 ~~~~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~~~~-----------------~~~~~~~~~ 219 (256)
T cd08530 157 MAKTQIGTPHYMAPEVWKGRPYSYKSDIWSLGCLLYEMATFAPPFEARSMQDLR-----------------YKVQRGKYP 219 (256)
T ss_pred CcccccCCccccCHHHHCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHH-----------------HHHhcCCCC
Confidence 222345788999999999999999999999999999999999999654321000 000111111
Q ss_pred cCCHHHHHHHHHHHHHccccCCCCCCCHHhHHHH
Q 003836 739 MNNVTMLHRFVMVAFWCIQEDPSHRPTMRKVTQM 772 (792)
Q Consensus 739 ~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~ 772 (792)
..+.....++.+++.+|++.+|++||++.++++.
T Consensus 220 ~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~ 253 (256)
T cd08530 220 PIPPIYSQDLQNFIRSMLQVKPKLRPNCDKILAS 253 (256)
T ss_pred CCchhhCHHHHHHHHHHcCCCcccCCCHHHHhcC
Confidence 2233456778999999999999999999999873
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an |
| >cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-32 Score=295.93 Aligned_cols=262 Identities=22% Similarity=0.264 Sum_probs=193.2
Q ss_pred hhcCcc--ccceEEEeeecCCCceEEEEEEccccc--ccchHHHHHHHHHhcccCCCCcccccceeccCCceEEEEEecc
Q 003836 507 EELGRG--AFGTVYKGFVNMGSSNHVAVKKLNSVF--QDSEKEFKAEVNGIGQTHHKNLVRLLGYCDEGQNRLLVYEFMS 582 (792)
Q Consensus 507 ~~lG~G--~~g~Vy~g~~~~~~~~~vavK~~~~~~--~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~lV~E~~~ 582 (792)
++||+| +||+||++.. ...++.||+|++.... ....+.+.+|+.+++.++||||++++++|..++..++|+||++
T Consensus 4 ~~ig~g~~~~~~v~~a~~-~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~~~v~e~~~ 82 (328)
T cd08226 4 VEIGRGFCNLTSVYLARH-TPTGTLVTVRITDLENCTEEHLKALQNEVVLSHFFRHPNIMTSWTVFTTGSWLWVISPFMA 82 (328)
T ss_pred HHhCCcccCceeEEEEEE-cCCCcEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceEeeeEecCCceEEEEeccc
Confidence 457777 8899999965 3456899999986432 2334678999999999999999999999999999999999999
Q ss_pred CCCccccccCC--CCCchhHHHHHHHHHHHHHHHHhhccCCCeEecCCCCCcEEEcCCCCeEEeecCCCccccCCCCCc-
Q 003836 583 NGTVASFLFGD--SKPNWKLRTEIAMGIAGGLFYLHEECCTQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLDQSHT- 659 (792)
Q Consensus 583 ~gsL~~~l~~~--~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dikp~NILl~~~~~~kl~Dfg~a~~~~~~~~~~- 659 (792)
+++|.+++... ..+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+|++||+.+..........
T Consensus 83 ~~~l~~~l~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~---~ivHrDlkp~Nill~~~~~~~~~~~~~~~~~~~~~~~~~ 159 (328)
T cd08226 83 YGSANSLLKTYFPEGMSEALIGNILFGALRGLNYLHQN---GYIHRNIKASHILISGDGLVSLSGLSHLYSLVRNGQKAK 159 (328)
T ss_pred CCCHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEeCCCcEEEechHHHhhhhccCcccc
Confidence 99999998764 3578889999999999999999998 99999999999999999999999998654332211110
Q ss_pred -----cccccccCCcccccccccC--CCCcccceehHHHHHHHHHhcCcCCCcchhhhhhhhHHHH-------------H
Q 003836 660 -----NTAIRGTKGYVAPEWFRNM--PITVKVDVYSYGVLLLEIICLRRNIDNEISKVDKAILTDW-------------A 719 (792)
Q Consensus 660 -----~~~~~gt~~y~aPE~~~~~--~~~~k~DV~S~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~-------------~ 719 (792)
.....++..|+|||++.+. .++.++|||||||+++||++|+.||............... .
T Consensus 160 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (328)
T cd08226 160 VVYDFPQFSTSVLPWLSPELLRQDLYGYNVKSDIYSVGITACELATGRVPFQDMLRTQMLLQKLKGPPYSPLDITTFPCE 239 (328)
T ss_pred ccccccccccCccCccChhhhcCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcChHHHHHHHhcCCCCCCccccccchh
Confidence 0112245679999999763 5789999999999999999999999754322110000000 0
Q ss_pred HHhh-------c----ccc-----hhHhhhchhcccCCHHHHHHHHHHHHHccccCCCCCCCHHhHHHH
Q 003836 720 YDRY-------Q----ERT-----LEALVENDLEAMNNVTMLHRFVMVAFWCIQEDPSHRPTMRKVTQM 772 (792)
Q Consensus 720 ~~~~-------~----~~~-----~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~ 772 (792)
.... . +.. ...+....+...........+.+++.+||+.||++|||++|+++.
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpta~e~l~~ 308 (328)
T cd08226 240 ESRMKNSQSGVDSGIGESVVAAGMTQTMTSERLRTPSSKTFSPAFQNLVELCLQQDPEKRPSASSLLSH 308 (328)
T ss_pred hhhhccchhhhhcccccchhccccccccccccccchhhhhhhHHHHHHHHHHccCCcccCCCHHHHhhC
Confidence 0000 0 000 001111112222234567789999999999999999999999863
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig |
| >cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-32 Score=289.46 Aligned_cols=260 Identities=21% Similarity=0.287 Sum_probs=195.4
Q ss_pred hhhhcCccccceEEEeeecCCCceEEEEEEcccccc-cchHHHHHHHHHhcccCCCCcccccceeccCCceEEEEEeccC
Q 003836 505 FKEELGRGAFGTVYKGFVNMGSSNHVAVKKLNSVFQ-DSEKEFKAEVNGIGQTHHKNLVRLLGYCDEGQNRLLVYEFMSN 583 (792)
Q Consensus 505 ~~~~lG~G~~g~Vy~g~~~~~~~~~vavK~~~~~~~-~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~lV~E~~~~ 583 (792)
+.++||.|++|.||+|+.. .+++.+|+|++..... .....+.+|+.++++++|+||+++++++.+.+..++||||+++
T Consensus 4 ~~~~l~~g~~~~v~~~~~~-~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~ 82 (284)
T cd07836 4 QLEKLGEGTYATVYKGRNR-TTGEIVALKEIHLDAEEGTPSTAIREISLMKELKHENIVRLHDVIHTENKLMLVFEYMDK 82 (284)
T ss_pred EeeeeccCCceEEEEEEEC-CCCeEEEEEEecccccccchHHHHHHHHHHHhhcCCCEeeeeeeEeeCCcEEEEEecCCc
Confidence 4578999999999999764 4567899999875433 2346778899999999999999999999999999999999985
Q ss_pred CCccccccCC---CCCchhHHHHHHHHHHHHHHHHhhccCCCeEecCCCCCcEEEcCCCCeEEeecCCCccccCCCCCcc
Q 003836 584 GTVASFLFGD---SKPNWKLRTEIAMGIAGGLFYLHEECCTQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLDQSHTN 660 (792)
Q Consensus 584 gsL~~~l~~~---~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dikp~NILl~~~~~~kl~Dfg~a~~~~~~~~~~~ 660 (792)
+|.+++... ..+++..+.+++.||+.||+|||+. +++|+||||+||++++++.+||+|||+++....... ..
T Consensus 83 -~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~h~dl~p~ni~~~~~~~~~l~d~g~~~~~~~~~~-~~ 157 (284)
T cd07836 83 -DLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCHEN---RVLHRDLKPQNLLINKRGELKLADFGLARAFGIPVN-TF 157 (284)
T ss_pred -cHHHHHHhcCCCCCcCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCHHHEEECCCCcEEEeecchhhhhcCCcc-cc
Confidence 888887543 3579999999999999999999998 999999999999999999999999999976543222 12
Q ss_pred ccccccCCccccccccc-CCCCcccceehHHHHHHHHHhcCcCCCcchhhhhhhhHHHHHHHhhcccchhHhhh-chh--
Q 003836 661 TAIRGTKGYVAPEWFRN-MPITVKVDVYSYGVLLLEIICLRRNIDNEISKVDKAILTDWAYDRYQERTLEALVE-NDL-- 736 (792)
Q Consensus 661 ~~~~gt~~y~aPE~~~~-~~~~~k~DV~S~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~-- 736 (792)
....+++.|++||.+.+ ..++.++||||||+++|||++|+.||................. ...+.....+.. +..
T Consensus 158 ~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~ 236 (284)
T cd07836 158 SNEVVTLWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMITGRPLFPGTNNEDQLLKIFRIMG-TPTESTWPGISQLPEYKP 236 (284)
T ss_pred ccccccccccChHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhC-CCChhhHHHHhcCchhcc
Confidence 23446889999998865 4578999999999999999999999875432211111100000 000000000000 000
Q ss_pred ---------cccCCHHHHHHHHHHHHHccccCCCCCCCHHhHHH
Q 003836 737 ---------EAMNNVTMLHRFVMVAFWCIQEDPSHRPTMRKVTQ 771 (792)
Q Consensus 737 ---------~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~ 771 (792)
...........+.+++.+|++.+|.+||++.|+++
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~ 280 (284)
T cd07836 237 TFPRYPPQDLQQLFPHADPLGIDLLHRLLQLNPELRISAHDALQ 280 (284)
T ss_pred cccCCChHHHHHHhhhcCcHHHHHHHHHhcCCcccCCCHHHHhc
Confidence 00011233567889999999999999999999986
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. |
| >cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-32 Score=296.37 Aligned_cols=264 Identities=22% Similarity=0.301 Sum_probs=197.5
Q ss_pred hhhhhcCccccceEEEeeecCCCceEEEEEEccccc--ccchHHHHHHHHHhcccCCCCcccccceecc----CCceEEE
Q 003836 504 GFKEELGRGAFGTVYKGFVNMGSSNHVAVKKLNSVF--QDSEKEFKAEVNGIGQTHHKNLVRLLGYCDE----GQNRLLV 577 (792)
Q Consensus 504 ~~~~~lG~G~~g~Vy~g~~~~~~~~~vavK~~~~~~--~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~----~~~~~lV 577 (792)
.+.+.||+|++|.||++... .+++.||+|++.... ....+.+.+|+.++.+++|+||+++++++.. ....++|
T Consensus 8 ~~~~~lg~g~~g~v~~~~~~-~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~lv 86 (334)
T cd07855 8 KPIENIGSGAYGVVCSAIDT-RSGKKVAIKKIPHAFDVPTLAKRTLRELKILRHFKHDNIIAIRDILRPPGADFKDVYVV 86 (334)
T ss_pred eeeeeeecCCCeEEEEEEEc-CCCCEEEEEEeccccccccchHHHHHHHHHHHhcCCCCccCHHHhccccCCCCceEEEE
Confidence 34568999999999999654 456799999987542 2345678889999999999999999998853 3568999
Q ss_pred EEeccCCCccccccCCCCCchhHHHHHHHHHHHHHHHHhhccCCCeEecCCCCCcEEEcCCCCeEEeecCCCccccCCCC
Q 003836 578 YEFMSNGTVASFLFGDSKPNWKLRTEIAMGIAGGLFYLHEECCTQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLDQS 657 (792)
Q Consensus 578 ~E~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dikp~NILl~~~~~~kl~Dfg~a~~~~~~~~ 657 (792)
|||+. ++|.+++.....+++..+..++.||+.||.|||+. +|+||||||+||++++++.+||+|||+++.......
T Consensus 87 ~e~~~-~~l~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~ 162 (334)
T cd07855 87 MDLME-SDLHHIIHSDQPLTEEHIRYFLYQLLRGLKYIHSA---NVIHRDLKPSNLLVNEDCELRIGDFGMARGLSSSPT 162 (334)
T ss_pred Eehhh-hhHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCcEEecccccceeecccCc
Confidence 99996 58999998777899999999999999999999998 999999999999999999999999999987643322
Q ss_pred C---ccccccccCCccccccccc-CCCCcccceehHHHHHHHHHhcCcCCCcchhhhhhhhHHHH-------HHHhhccc
Q 003836 658 H---TNTAIRGTKGYVAPEWFRN-MPITVKVDVYSYGVLLLEIICLRRNIDNEISKVDKAILTDW-------AYDRYQER 726 (792)
Q Consensus 658 ~---~~~~~~gt~~y~aPE~~~~-~~~~~k~DV~S~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~-------~~~~~~~~ 726 (792)
. ......++..|+|||.+.+ ..++.++||||||+++|||++|+.||............... ........
T Consensus 163 ~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~~~~~~~~~~~~~~~g~~~~~~~~~~~~~ 242 (334)
T cd07855 163 EHKYFMTEYVATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRRQLFPGKNYVHQLKLILSVLGSPSEEVLNRIGSD 242 (334)
T ss_pred CCCcccccccccccccChHHhcCCcccccccchHHHHHHHHHHHcCCCccCCCChHHHHHHHHHHhCCChhHhhhhhchh
Confidence 1 1223468889999999865 56899999999999999999999999654321110000000 00000001
Q ss_pred chhHhhhch-hcccC-----CHHHHHHHHHHHHHccccCCCCCCCHHhHHHH
Q 003836 727 TLEALVEND-LEAMN-----NVTMLHRFVMVAFWCIQEDPSHRPTMRKVTQM 772 (792)
Q Consensus 727 ~~~~~~~~~-~~~~~-----~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~ 772 (792)
......... ..... ....+.++.+++.+||+.+|.+||+++++++.
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~ 294 (334)
T cd07855 243 RVRKYIQNLPRKQPVPWSKIFPKASPEALDLLSQMLQFDPEERITVEQALQH 294 (334)
T ss_pred hHHHHHhhcccCCCCCHHHHcccCCHHHHHHHHHHccCChhhCcCHHHHHhC
Confidence 111111100 00000 12246788999999999999999999999874
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the |
| >cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=99.98 E-value=2.4e-32 Score=297.18 Aligned_cols=265 Identities=21% Similarity=0.265 Sum_probs=197.9
Q ss_pred hhhhcCccccceEEEeeecCCCceEEEEEEcccc--cccchHHHHHHHHHhcccCCCCcccccceeccC-----CceEEE
Q 003836 505 FKEELGRGAFGTVYKGFVNMGSSNHVAVKKLNSV--FQDSEKEFKAEVNGIGQTHHKNLVRLLGYCDEG-----QNRLLV 577 (792)
Q Consensus 505 ~~~~lG~G~~g~Vy~g~~~~~~~~~vavK~~~~~--~~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~-----~~~~lV 577 (792)
..+.||+|+||+||++... .+++.||||++... .......+.+|+.++++++|+||+++++++... ...++|
T Consensus 9 ~~~~lg~G~~~~vy~~~~~-~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~~~~~~lv 87 (337)
T cd07858 9 PIKPIGRGAYGIVCSAKNS-ETNEKVAIKKIANAFDNRIDAKRTLREIKLLRHLDHENVIAIKDIMPPPHREAFNDVYIV 87 (337)
T ss_pred EEEEeccCCCeEEEEEEec-CCCCeEEEEEecccccccchhHHHHHHHHHHHhcCCCCccchHHheecccccccCcEEEE
Confidence 3467999999999999754 56789999998753 233345778899999999999999999988644 357999
Q ss_pred EEeccCCCccccccCCCCCchhHHHHHHHHHHHHHHHHhhccCCCeEecCCCCCcEEEcCCCCeEEeecCCCccccCCCC
Q 003836 578 YEFMSNGTVASFLFGDSKPNWKLRTEIAMGIAGGLFYLHEECCTQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLDQS 657 (792)
Q Consensus 578 ~E~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dikp~NILl~~~~~~kl~Dfg~a~~~~~~~~ 657 (792)
+||+. ++|.+++.....+++..+..++.||+.||.|||+. +++|+||||+||+++.++.+||+|||+++......
T Consensus 88 ~e~~~-~~L~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~- 162 (337)
T cd07858 88 YELMD-TDLHQIIRSSQTLSDDHCQYFLYQLLRGLKYIHSA---NVLHRDLKPSNLLLNANCDLKICDFGLARTTSEKG- 162 (337)
T ss_pred EeCCC-CCHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEEcCCCCEEECcCccccccCCCc-
Confidence 99996 68998888777899999999999999999999998 99999999999999999999999999998764332
Q ss_pred CccccccccCCccccccccc-CCCCcccceehHHHHHHHHHhcCcCCCcchhhhhhhhHHHHH-------HHhhcccchh
Q 003836 658 HTNTAIRGTKGYVAPEWFRN-MPITVKVDVYSYGVLLLEIICLRRNIDNEISKVDKAILTDWA-------YDRYQERTLE 729 (792)
Q Consensus 658 ~~~~~~~gt~~y~aPE~~~~-~~~~~k~DV~S~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~-------~~~~~~~~~~ 729 (792)
.......++..|+|||.+.. ..++.++||||||+++|+|++|+.||................ ..........
T Consensus 163 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 242 (337)
T cd07858 163 DFMTEYVVTRWYRAPELLLNCSEYTTAIDVWSVGCIFAELLGRKPLFPGKDYVHQLKLITELLGSPSEEDLGFIRNEKAR 242 (337)
T ss_pred ccccccccccCccChHHHhcCCCCCCcccHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCChHHhhhcCchhhh
Confidence 22233457889999998865 568999999999999999999999996542211111000000 0000011111
Q ss_pred Hhhhchhcc------cCCHHHHHHHHHHHHHccccCCCCCCCHHhHHHH--hcc
Q 003836 730 ALVENDLEA------MNNVTMLHRFVMVAFWCIQEDPSHRPTMRKVTQM--LEG 775 (792)
Q Consensus 730 ~~~~~~~~~------~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~--L~~ 775 (792)
..+...... ......+.++.+++.+||+.+|++|||++|+++. ++.
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rps~~ell~h~~~~~ 296 (337)
T cd07858 243 RYIRSLPYTPRQSFARLFPHANPLAIDLLEKMLVFDPSKRITVEEALAHPYLAS 296 (337)
T ss_pred HHHHhcCcccccCHHHHcccCCHHHHHHHHHHhcCChhhccCHHHHHcCcchhh
Confidence 111100000 0012345778999999999999999999999976 544
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati |
| >cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.98 E-value=2.2e-32 Score=284.48 Aligned_cols=246 Identities=24% Similarity=0.371 Sum_probs=202.0
Q ss_pred hhhhhcCccccceEEEeeecCCCceEEEEEEcccccc--cchHHHHHHHHHhcccCCCCcccccceeccCCceEEEEEec
Q 003836 504 GFKEELGRGAFGTVYKGFVNMGSSNHVAVKKLNSVFQ--DSEKEFKAEVNGIGQTHHKNLVRLLGYCDEGQNRLLVYEFM 581 (792)
Q Consensus 504 ~~~~~lG~G~~g~Vy~g~~~~~~~~~vavK~~~~~~~--~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~lV~E~~ 581 (792)
.+.+.||+|++|.||++... ..++.+++|.+..... .....+.+|++++++++|+|++++++++.+.+..++||||+
T Consensus 3 ~~~~~l~~g~~~~v~~~~~~-~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~ 81 (254)
T cd06627 3 QLGDLIGRGAFGVVYKGLNL-ETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVKYIGSIETSDSLYIILEYA 81 (254)
T ss_pred eeeeEEcccCCeEEEEEEEc-CCCcEEEEEEecccccCHHHHHHHHHHHHHHHhCCCCCccEEEEEEEeCCEEEEEEecC
Confidence 34578999999999999754 4457899999876543 34568999999999999999999999999999999999999
Q ss_pred cCCCccccccCCCCCchhHHHHHHHHHHHHHHHHhhccCCCeEecCCCCCcEEEcCCCCeEEeecCCCccccCCCCCccc
Q 003836 582 SNGTVASFLFGDSKPNWKLRTEIAMGIAGGLFYLHEECCTQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLDQSHTNT 661 (792)
Q Consensus 582 ~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dikp~NILl~~~~~~kl~Dfg~a~~~~~~~~~~~~ 661 (792)
++++|.+++.....+++..+..++.|++.||.|||+. +|+|+||+|+||+++.++.+||+|||.+......... ..
T Consensus 82 ~~~~L~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~-~~ 157 (254)
T cd06627 82 ENGSLRQIIKKFGPFPESLVAVYVYQVLQGLAYLHEQ---GVIHRDIKAANILTTKDGVVKLADFGVATKLNDVSKD-DA 157 (254)
T ss_pred CCCcHHHHHHhccCCCHHHHHHHHHHHHHHHHHHhhC---CcccCCCCHHHEEECCCCCEEEeccccceecCCCccc-cc
Confidence 9999999998878899999999999999999999998 9999999999999999999999999999876543321 23
Q ss_pred cccccCCcccccccccCCCCcccceehHHHHHHHHHhcCcCCCcchhhhhhhhHHHHHHHhhcccchhHhhhchhcccCC
Q 003836 662 AIRGTKGYVAPEWFRNMPITVKVDVYSYGVLLLEIICLRRNIDNEISKVDKAILTDWAYDRYQERTLEALVENDLEAMNN 741 (792)
Q Consensus 662 ~~~gt~~y~aPE~~~~~~~~~k~DV~S~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 741 (792)
...++..|+|||...+..++.++||||+|+++++|++|+.|+......... +... .......+
T Consensus 158 ~~~~~~~y~~pe~~~~~~~~~~~Dv~~lG~~l~~l~~g~~p~~~~~~~~~~-----~~~~------------~~~~~~~~ 220 (254)
T cd06627 158 SVVGTPYWMAPEVIEMSGASTASDIWSLGCTVIELLTGNPPYYDLNPMAAL-----FRIV------------QDDHPPLP 220 (254)
T ss_pred ccccchhhcCHhhhcCCCCCcchhHHHHHHHHHHHHhCCCCCCCccHHHHH-----HHHh------------ccCCCCCC
Confidence 345788999999998888999999999999999999999998654321000 0000 00111122
Q ss_pred HHHHHHHHHHHHHccccCCCCCCCHHhHHH
Q 003836 742 VTMLHRFVMVAFWCIQEDPSHRPTMRKVTQ 771 (792)
Q Consensus 742 ~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~ 771 (792)
......+.+++.+||+.+|++||++.+++.
T Consensus 221 ~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~ 250 (254)
T cd06627 221 EGISPELKDFLMQCFQKDPNLRPTAKQLLK 250 (254)
T ss_pred CCCCHHHHHHHHHHHhCChhhCcCHHHHhc
Confidence 234567889999999999999999999986
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast |
| >cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Probab=99.98 E-value=3.2e-32 Score=287.85 Aligned_cols=243 Identities=23% Similarity=0.239 Sum_probs=189.6
Q ss_pred hcCccccceEEEeeecCCCceEEEEEEcccccc---cchHHHHHHHH---HhcccCCCCcccccceeccCCceEEEEEec
Q 003836 508 ELGRGAFGTVYKGFVNMGSSNHVAVKKLNSVFQ---DSEKEFKAEVN---GIGQTHHKNLVRLLGYCDEGQNRLLVYEFM 581 (792)
Q Consensus 508 ~lG~G~~g~Vy~g~~~~~~~~~vavK~~~~~~~---~~~~~~~~Ei~---~l~~l~h~niv~l~g~~~~~~~~~lV~E~~ 581 (792)
.||+|+||.||++... .+++.||+|.+..... .....+.+|.. .++..+|+||+++++++.+.+..++||||+
T Consensus 1 ~ig~g~~g~Vy~~~~~-~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~ 79 (278)
T cd05606 1 IIGRGGFGEVYGCRKA-DTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLM 79 (278)
T ss_pred CcccCCCeEEEEEEEe-cCCCEEEEEEeeccccccchhHHHHHHHHHHHHHHHhCCCCcEeeeeeeeecCCEEEEEEecC
Confidence 4899999999999653 4567999999865321 12223444444 344457999999999999999999999999
Q ss_pred cCCCccccccCCCCCchhHHHHHHHHHHHHHHHHhhccCCCeEecCCCCCcEEEcCCCCeEEeecCCCccccCCCCCccc
Q 003836 582 SNGTVASFLFGDSKPNWKLRTEIAMGIAGGLFYLHEECCTQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLDQSHTNT 661 (792)
Q Consensus 582 ~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dikp~NILl~~~~~~kl~Dfg~a~~~~~~~~~~~~ 661 (792)
++++|..++.....+++..+..++.|+++||.|||+. +|+|+||||+||++++++.+||+|||+++...... ..
T Consensus 80 ~g~~L~~~l~~~~~l~~~~~~~~~~ql~~~l~~lH~~---~i~H~di~p~nili~~~~~~kl~dfg~~~~~~~~~---~~ 153 (278)
T cd05606 80 NGGDLHYHLSQHGVFSEAEMRFYAAEIILGLEHMHNR---FVVYRDLKPANILLDEHGHVRISDLGLACDFSKKK---PH 153 (278)
T ss_pred CCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---CEEcCCCCHHHEEECCCCCEEEccCcCccccCccC---Cc
Confidence 9999999998777899999999999999999999998 99999999999999999999999999987653222 12
Q ss_pred cccccCCcccccccccC-CCCcccceehHHHHHHHHHhcCcCCCcchhhhhhhhHHHHHHHhhcccchhHhhhchhcccC
Q 003836 662 AIRGTKGYVAPEWFRNM-PITVKVDVYSYGVLLLEIICLRRNIDNEISKVDKAILTDWAYDRYQERTLEALVENDLEAMN 740 (792)
Q Consensus 662 ~~~gt~~y~aPE~~~~~-~~~~k~DV~S~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 740 (792)
...|+..|+|||.+.+. .++.++||||+|+++|||++|+.||............ ... .......
T Consensus 154 ~~~~~~~y~aPE~~~~~~~~~~~~Di~s~G~~l~~l~~g~~p~~~~~~~~~~~~~--------------~~~-~~~~~~~ 218 (278)
T cd05606 154 ASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEID--------------RMT-LTMAVEL 218 (278)
T ss_pred CcCCCcCCcCcHHhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCccchHHHH--------------HHh-hccCCCC
Confidence 34589999999998754 6899999999999999999999999754221110000 000 0001112
Q ss_pred CHHHHHHHHHHHHHccccCCCCCC-----CHHhHHHH
Q 003836 741 NVTMLHRFVMVAFWCIQEDPSHRP-----TMRKVTQM 772 (792)
Q Consensus 741 ~~~~~~~l~~l~~~Cl~~~p~~RP-----s~~evl~~ 772 (792)
+...+..+.+++.+||+.+|.+|| ++.++++.
T Consensus 219 ~~~~s~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~~ 255 (278)
T cd05606 219 PDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKEH 255 (278)
T ss_pred CCcCCHHHHHHHHHHhhcCHHhccCCCCCCHHHHHhC
Confidence 223457888999999999999999 99999864
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co |
| >cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.98 E-value=4.5e-32 Score=287.38 Aligned_cols=259 Identities=24% Similarity=0.343 Sum_probs=194.6
Q ss_pred hhhhcCccccceEEEeeecCCCceEEEEEEcccccc-cchHHHHHHHHHhcccC-CCCcccccceeccCCceEEEEEecc
Q 003836 505 FKEELGRGAFGTVYKGFVNMGSSNHVAVKKLNSVFQ-DSEKEFKAEVNGIGQTH-HKNLVRLLGYCDEGQNRLLVYEFMS 582 (792)
Q Consensus 505 ~~~~lG~G~~g~Vy~g~~~~~~~~~vavK~~~~~~~-~~~~~~~~Ei~~l~~l~-h~niv~l~g~~~~~~~~~lV~E~~~ 582 (792)
+.+.||+|++|+||+|+.. .+++.+++|++..... .......+|+..+++++ |+||+++++++.+++..++||||+
T Consensus 3 ~~~~ig~g~~g~v~~~~~~-~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e~~- 80 (283)
T cd07830 3 VIKQLGDGTFGSVYLARNK-ETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNEHPNIVKLKEVFRENDELYFVFEYM- 80 (283)
T ss_pred eheeeccCCceEEEEEEEC-CCCcEEEEEEehhhccchhHHHHHHHHHHHHhccCCCCchhHHHHhhcCCcEEEEEecC-
Confidence 4578999999999999764 3457899999875433 23345567999999999 999999999999999999999999
Q ss_pred CCCccccccCCC--CCchhHHHHHHHHHHHHHHHHhhccCCCeEecCCCCCcEEEcCCCCeEEeecCCCccccCCCCCcc
Q 003836 583 NGTVASFLFGDS--KPNWKLRTEIAMGIAGGLFYLHEECCTQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLDQSHTN 660 (792)
Q Consensus 583 ~gsL~~~l~~~~--~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dikp~NILl~~~~~~kl~Dfg~a~~~~~~~~~~~ 660 (792)
+|+|.+++.... .+++..+..++.|++.+|.|||+. +++|+||+|+||++++++.++|+|||+++....... .
T Consensus 81 ~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~Lh~~---~i~H~dl~~~ni~i~~~~~~~l~d~~~~~~~~~~~~--~ 155 (283)
T cd07830 81 EGNLYQLMKDRKGKPFSESVIRSIIYQILQGLAHIHKH---GFFHRDLKPENLLVSGPEVVKIADFGLAREIRSRPP--Y 155 (283)
T ss_pred CCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCChhhEEEcCCCCEEEeecccceeccCCCC--c
Confidence 789999887654 789999999999999999999998 999999999999999999999999999986543222 2
Q ss_pred ccccccCCcccccccc-cCCCCcccceehHHHHHHHHHhcCcCCCcchhhhhhhhHH---------HHHHHhhcccchhH
Q 003836 661 TAIRGTKGYVAPEWFR-NMPITVKVDVYSYGVLLLEIICLRRNIDNEISKVDKAILT---------DWAYDRYQERTLEA 730 (792)
Q Consensus 661 ~~~~gt~~y~aPE~~~-~~~~~~k~DV~S~Gv~l~el~tg~~p~~~~~~~~~~~~~~---------~~~~~~~~~~~~~~ 730 (792)
....++..|+|||.+. ...++.++||||||++++||++|+.||............. .|............
T Consensus 156 ~~~~~~~~~~aPE~~~~~~~~~~~~Di~s~G~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (283)
T cd07830 156 TDYVSTRWYRAPEILLRSTSYSSPVDIWALGCIMAELYTLRPLFPGSSEIDQLYKICSVLGTPTKQDWPEGYKLASKLGF 235 (283)
T ss_pred CCCCCcccccCceeeecCcCcCCccchhhHHHHHHHHHhCCCccCCCChHHHHHHHHHhcCCCChhhhhhHhhhhccccc
Confidence 2345788999999885 4568999999999999999999999886543211110000 00000000000000
Q ss_pred h----hhchhcccCCHHHHHHHHHHHHHccccCCCCCCCHHhHHH
Q 003836 731 L----VENDLEAMNNVTMLHRFVMVAFWCIQEDPSHRPTMRKVTQ 771 (792)
Q Consensus 731 ~----~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~ 771 (792)
. ......... .....++.+++.+||+.+|++||+++|++.
T Consensus 236 ~~~~~~~~~~~~~~-~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~ 279 (283)
T cd07830 236 RFPQFAPTSLHQLI-PNASPEAIDLIKDMLRWDPKKRPTASQALQ 279 (283)
T ss_pred cccccccccHHHHc-ccCCHHHHHHHHHhcccCcccCCCHHHHhh
Confidence 0 000000000 112467899999999999999999999987
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili |
| >KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=6.7e-34 Score=325.22 Aligned_cols=246 Identities=25% Similarity=0.322 Sum_probs=203.5
Q ss_pred hhcCccccceEEEeeecCCCceEEEEEEccccc--ccchHHHHHHHHHhcccCCCCcccccceeccCCceEEEEEeccCC
Q 003836 507 EELGRGAFGTVYKGFVNMGSSNHVAVKKLNSVF--QDSEKEFKAEVNGIGQTHHKNLVRLLGYCDEGQNRLLVYEFMSNG 584 (792)
Q Consensus 507 ~~lG~G~~g~Vy~g~~~~~~~~~vavK~~~~~~--~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~lV~E~~~~g 584 (792)
..||.|.||.||-+. +..+++..|+|-+.... ....+.+.+|+.++..++|||+|+++|+-.+.++.+|.||||++|
T Consensus 1241 ~~Ig~G~fG~VYtav-N~~tGellAvKEI~iq~~~~k~~~~i~eEm~vlE~lnHpNlV~YyGVEvHRekv~IFMEyC~~G 1319 (1509)
T KOG4645|consen 1241 NFIGGGTFGKVYTAV-NLDTGELLAVKEIKIQDSDHKTFKLIAEEMKVLEGLNHPNLVRYYGVEVHREKVYIFMEYCEGG 1319 (1509)
T ss_pred cccCCcceeeeEEee-cCCccchhhhhhhhcCccccccCcchHHHHHHHHhccCccccccCceeecHHHHHHHHHHhccC
Confidence 469999999999995 56778899999876432 334567899999999999999999999999999999999999999
Q ss_pred CccccccCCCCCchhHHHHHHHHHHHHHHHHhhccCCCeEecCCCCCcEEEcCCCCeEEeecCCCccccCCCCC---ccc
Q 003836 585 TVASFLFGDSKPNWKLRTEIAMGIAGGLFYLHEECCTQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLDQSH---TNT 661 (792)
Q Consensus 585 sL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dikp~NILl~~~~~~kl~Dfg~a~~~~~~~~~---~~~ 661 (792)
+|.+.+...+..++.....+..|++.|++|||+. +||||||||.||+|+.+|.+|++|||.|......... ...
T Consensus 1320 sLa~ll~~gri~dE~vt~vyt~qll~gla~LH~~---gIVHRDIK~aNI~Ld~~g~iK~~DFGsa~ki~~~~~~~~~el~ 1396 (1509)
T KOG4645|consen 1320 SLASLLEHGRIEDEMVTRVYTKQLLEGLAYLHEH---GIVHRDIKPANILLDFNGLIKYGDFGSAVKIKNNAQTMPGELQ 1396 (1509)
T ss_pred cHHHHHHhcchhhhhHHHHHHHHHHHHHHHHHhc---CceecCCCccceeeecCCcEEeecccceeEecCchhcCCHHHH
Confidence 9999998888888888888999999999999999 9999999999999999999999999999987654211 122
Q ss_pred cccccCCcccccccccC---CCCcccceehHHHHHHHHHhcCcCCCcchhhhhhhhHHHHHHHhhcccchhHhhhchhcc
Q 003836 662 AIRGTKGYVAPEWFRNM---PITVKVDVYSYGVLLLEIICLRRNIDNEISKVDKAILTDWAYDRYQERTLEALVENDLEA 738 (792)
Q Consensus 662 ~~~gt~~y~aPE~~~~~---~~~~k~DV~S~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 738 (792)
...||+.|||||++.+. ....++||||+|||++||+||++||......-. +.-.+.-.-.+
T Consensus 1397 ~~~GT~~YMAPEvit~t~~kG~~~A~DiWslGCVVlEM~tGkrPW~~~dne~a----------------IMy~V~~gh~P 1460 (1509)
T KOG4645|consen 1397 SMMGTPMYMAPEVITGTKGKGHGGAADIWSLGCVVLEMATGKRPWAELDNEWA----------------IMYHVAAGHKP 1460 (1509)
T ss_pred hhcCCchhcCchhhcccccCCCCcchhhhcccceEEEeecCCCchhhccchhH----------------HHhHHhccCCC
Confidence 45699999999999753 466899999999999999999999965432211 00011112233
Q ss_pred cCCHHHHHHHHHHHHHccccCCCCCCCHHhHHHH
Q 003836 739 MNNVTMLHRFVMVAFWCIQEDPSHRPTMRKVTQM 772 (792)
Q Consensus 739 ~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~ 772 (792)
..|...+.+-.+++..||+.||.+|-++.|+++.
T Consensus 1461 q~P~~ls~~g~dFle~Cl~~dP~~Rw~~~qlle~ 1494 (1509)
T KOG4645|consen 1461 QIPERLSSEGRDFLEHCLEQDPKMRWTASQLLEH 1494 (1509)
T ss_pred CCchhhhHhHHHHHHHHHhcCchhhhHHHHHHHh
Confidence 4455677888999999999999999999888875
|
|
| >PHA03390 pk1 serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Probab=99.98 E-value=4.5e-32 Score=284.88 Aligned_cols=235 Identities=19% Similarity=0.217 Sum_probs=184.5
Q ss_pred cCccccceEEEeeecCCCceEEEEEEcccccccchHHHHHHHHHhccc-CCCCcccccceeccCCceEEEEEeccCCCcc
Q 003836 509 LGRGAFGTVYKGFVNMGSSNHVAVKKLNSVFQDSEKEFKAEVNGIGQT-HHKNLVRLLGYCDEGQNRLLVYEFMSNGTVA 587 (792)
Q Consensus 509 lG~G~~g~Vy~g~~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l-~h~niv~l~g~~~~~~~~~lV~E~~~~gsL~ 587 (792)
||+|+||.||++... .+++.+|+|.+....... . |+.....+ +|+||+++++.+...+..++||||+++++|.
T Consensus 24 lg~g~~g~v~~~~~~-~~~~~~~~k~~~~~~~~~---~--e~~~~~~~~~h~~iv~~~~~~~~~~~~~iv~e~~~~~~L~ 97 (267)
T PHA03390 24 LIDGKFGKVSVLKHK-PTQKLFVQKIIKAKNFNA---I--EPMVHQLMKDNPNFIKLYYSVTTLKGHVLIMDYIKDGDLF 97 (267)
T ss_pred ecCCCceEEEEEEEc-CCCcEEEEEEEehhhcch---h--hHHHHHHhhcCCCEEEEEEEEecCCeeEEEEEcCCCCcHH
Confidence 599999999999654 456789999986532111 1 22222222 7999999999999999999999999999999
Q ss_pred ccccCCCCCchhHHHHHHHHHHHHHHHHhhccCCCeEecCCCCCcEEEcCCC-CeEEeecCCCccccCCCCCcccccccc
Q 003836 588 SFLFGDSKPNWKLRTEIAMGIAGGLFYLHEECCTQIIHCDIKPQNILLDDHY-NARISDFGLAKLLTLDQSHTNTAIRGT 666 (792)
Q Consensus 588 ~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dikp~NILl~~~~-~~kl~Dfg~a~~~~~~~~~~~~~~~gt 666 (792)
+++.....+++..+..++.||++||.|||+. +++||||||+||+++.++ .++|+|||+++...... ...++
T Consensus 98 ~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~nil~~~~~~~~~l~dfg~~~~~~~~~-----~~~~~ 169 (267)
T PHA03390 98 DLLKKEGKLSEAEVKKIIRQLVEALNDLHKH---NIIHNDIKLENVLYDRAKDRIYLCDYGLCKIIGTPS-----CYDGT 169 (267)
T ss_pred HHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHEEEeCCCCeEEEecCccceecCCCc-----cCCCC
Confidence 9998777899999999999999999999998 999999999999999998 99999999987654222 23578
Q ss_pred CCcccccccccCCCCcccceehHHHHHHHHHhcCcCCCcchhhhhhhhHHHHHHHhhcccchhHhhhchhcccCCHHHHH
Q 003836 667 KGYVAPEWFRNMPITVKVDVYSYGVLLLEIICLRRNIDNEISKVDKAILTDWAYDRYQERTLEALVENDLEAMNNVTMLH 746 (792)
Q Consensus 667 ~~y~aPE~~~~~~~~~k~DV~S~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 746 (792)
..|+|||.+.+..++.++||||||++++||++|+.||....... .....+... ... ........+.
T Consensus 170 ~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~--~~~~~~~~~----------~~~--~~~~~~~~~~ 235 (267)
T PHA03390 170 LDYFSPEKIKGHNYDVSFDWWAVGVLTYELLTGKHPFKEDEDEE--LDLESLLKR----------QQK--KLPFIKNVSK 235 (267)
T ss_pred CcccChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCcch--hhHHHHHHh----------hcc--cCCcccccCH
Confidence 89999999999899999999999999999999999997432211 001111000 000 0111224567
Q ss_pred HHHHHHHHccccCCCCCCC-HHhHHH
Q 003836 747 RFVMVAFWCIQEDPSHRPT-MRKVTQ 771 (792)
Q Consensus 747 ~l~~l~~~Cl~~~p~~RPs-~~evl~ 771 (792)
.+.+++.+||+.+|.+||+ ++|+++
T Consensus 236 ~~~~li~~~l~~~p~~R~~~~~~~l~ 261 (267)
T PHA03390 236 NANDFVQSMLKYNINYRLTNYNEIIK 261 (267)
T ss_pred HHHHHHHHHhccChhhCCchHHHHhc
Confidence 7899999999999999995 699886
|
|
| >cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Probab=99.98 E-value=2.8e-32 Score=290.80 Aligned_cols=260 Identities=19% Similarity=0.234 Sum_probs=190.6
Q ss_pred hhhhcCccccceEEEeeecCCCceEEEEEEcccccc--cchHHHHHHHHHhcccC-CCCcccccceeccCCc-----eEE
Q 003836 505 FKEELGRGAFGTVYKGFVNMGSSNHVAVKKLNSVFQ--DSEKEFKAEVNGIGQTH-HKNLVRLLGYCDEGQN-----RLL 576 (792)
Q Consensus 505 ~~~~lG~G~~g~Vy~g~~~~~~~~~vavK~~~~~~~--~~~~~~~~Ei~~l~~l~-h~niv~l~g~~~~~~~-----~~l 576 (792)
..+.||+|+||.||+|... .+++.||+|++..... .....+.+|+.++++++ |+||+++++++...+. .++
T Consensus 5 ~~~~lg~g~~g~vy~~~~~-~~~~~v~lK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~~~~l 83 (295)
T cd07837 5 KLEKIGEGTYGKVYKARDK-NTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSESIYIVRLLDVEHVEEKNGKPSLYL 83 (295)
T ss_pred EeeEecccCCeEEEEEEEC-CCCcEEEEEeehhhccccCCchHHHHHHHHHHHccCCCCccceeeeEeecCCCCCceEEE
Confidence 4568999999999999764 4567899998765322 23467889999999994 6999999999977665 899
Q ss_pred EEEeccCCCccccccCC-----CCCchhHHHHHHHHHHHHHHHHhhccCCCeEecCCCCCcEEEcC-CCCeEEeecCCCc
Q 003836 577 VYEFMSNGTVASFLFGD-----SKPNWKLRTEIAMGIAGGLFYLHEECCTQIIHCDIKPQNILLDD-HYNARISDFGLAK 650 (792)
Q Consensus 577 V~E~~~~gsL~~~l~~~-----~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dikp~NILl~~-~~~~kl~Dfg~a~ 650 (792)
||||+++ +|.+++... ..+++..+..++.||++||.|||+. +|+||||+|+||+++. ++.+||+|||+++
T Consensus 84 v~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~---~i~H~dl~~~nil~~~~~~~~kl~dfg~~~ 159 (295)
T cd07837 84 VFEYLDS-DLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCHKH---GVMHRDLKPQNLLVDKQKGLLKIADLGLGR 159 (295)
T ss_pred EeeccCc-CHHHHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCChHHEEEecCCCeEEEeecccce
Confidence 9999986 788887542 3578999999999999999999998 9999999999999998 8999999999998
Q ss_pred cccCCCCCccccccccCCccccccccc-CCCCcccceehHHHHHHHHHhcCcCCCcchhhhhhhhHHHHHHHhhcccchh
Q 003836 651 LLTLDQSHTNTAIRGTKGYVAPEWFRN-MPITVKVDVYSYGVLLLEIICLRRNIDNEISKVDKAILTDWAYDRYQERTLE 729 (792)
Q Consensus 651 ~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~k~DV~S~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 729 (792)
........ .....+++.|+|||++.+ ..++.++||||||+++|||++|..||...........+.... .........
T Consensus 160 ~~~~~~~~-~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~ 237 (295)
T cd07837 160 AFSIPVKS-YTHEIVTLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPLFPGDSELQQLLHIFKLL-GTPTEQVWP 237 (295)
T ss_pred ecCCCccc-cCCcccccCCCChHHhhCCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHh-CCCChhhCc
Confidence 65432211 122346788999998865 467999999999999999999999986543221111110000 000000000
Q ss_pred Hh---hh----c----hhcccCCHHHHHHHHHHHHHccccCCCCCCCHHhHHH
Q 003836 730 AL---VE----N----DLEAMNNVTMLHRFVMVAFWCIQEDPSHRPTMRKVTQ 771 (792)
Q Consensus 730 ~~---~~----~----~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~ 771 (792)
.. .. + ............++.+++.+||+.+|.+||+++|++.
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~R~~~~eil~ 290 (295)
T cd07837 238 GVSKLRDWHEFPQWKPQDLSRAVPDLSPEGLDLLQKMLRYDPAKRISAKAALT 290 (295)
T ss_pred chhhccchhhcCcccchhHHHhccccCHHHHHHHHHHccCChhhcCCHHHHhc
Confidence 00 00 0 0000001124567889999999999999999999987
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm |
| >cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Probab=99.98 E-value=4.2e-32 Score=291.42 Aligned_cols=247 Identities=25% Similarity=0.309 Sum_probs=193.8
Q ss_pred HhhhhhhcCccccceEEEeeecCCCceEEEEEEcccc---cccchHHHHHHHHHhcccCCCCcccccceeccCCceEEEE
Q 003836 502 TRGFKEELGRGAFGTVYKGFVNMGSSNHVAVKKLNSV---FQDSEKEFKAEVNGIGQTHHKNLVRLLGYCDEGQNRLLVY 578 (792)
Q Consensus 502 ~~~~~~~lG~G~~g~Vy~g~~~~~~~~~vavK~~~~~---~~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~lV~ 578 (792)
++...+.||+|++|.||+|... .+++.+++|++... .....+++.+|++++++++|+|++++++++......++||
T Consensus 16 ~~~~~~~lg~g~~g~v~~~~~~-~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 94 (308)
T cd06634 16 LFSDLREIGHGSFGAVYFARDV-RNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVM 94 (308)
T ss_pred HHHHHHheeeCCCEEEEEEEEc-CCCcEEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCcccEEEEEEcCCeeEEEE
Confidence 3444578999999999999764 44678999988642 2233457889999999999999999999999999999999
Q ss_pred EeccCCCccccccC-CCCCchhHHHHHHHHHHHHHHHHhhccCCCeEecCCCCCcEEEcCCCCeEEeecCCCccccCCCC
Q 003836 579 EFMSNGTVASFLFG-DSKPNWKLRTEIAMGIAGGLFYLHEECCTQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLDQS 657 (792)
Q Consensus 579 E~~~~gsL~~~l~~-~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dikp~NILl~~~~~~kl~Dfg~a~~~~~~~~ 657 (792)
||+. |+|.+++.. ...+++..+..++.|++.||.|||+. +++|+||+|+|||++.++.+||+|||++......
T Consensus 95 e~~~-~~l~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~---~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~-- 168 (308)
T cd06634 95 EYCL-GSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSH---NMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA-- 168 (308)
T ss_pred EccC-CCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHhEEECCCCcEEECCcccceeecCc--
Confidence 9997 577776643 45688999999999999999999998 9999999999999999999999999998765322
Q ss_pred CccccccccCCcccccccc---cCCCCcccceehHHHHHHHHHhcCcCCCcchhhhhhhhHHHHHHHhhcccchhHhhhc
Q 003836 658 HTNTAIRGTKGYVAPEWFR---NMPITVKVDVYSYGVLLLEIICLRRNIDNEISKVDKAILTDWAYDRYQERTLEALVEN 734 (792)
Q Consensus 658 ~~~~~~~gt~~y~aPE~~~---~~~~~~k~DV~S~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 734 (792)
....+++.|+|||.+. ...++.++|||||||++|||++|+.|+.......... . +...
T Consensus 169 ---~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~---~-------------~~~~ 229 (308)
T cd06634 169 ---NXFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALY---H-------------IAQN 229 (308)
T ss_pred ---ccccCCccccCHHHHhhcccCCCCcccchHHHHHHHHHHHcCCCCCccccHHHHHH---H-------------Hhhc
Confidence 2345788999999974 3568899999999999999999999986532111000 0 0000
Q ss_pred hhcccCCHHHHHHHHHHHHHccccCCCCCCCHHhHHHHhc
Q 003836 735 DLEAMNNVTMLHRFVMVAFWCIQEDPSHRPTMRKVTQMLE 774 (792)
Q Consensus 735 ~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~L~ 774 (792)
.............+.+++.+||+.+|++||+++++++...
T Consensus 230 ~~~~~~~~~~~~~~~~li~~cl~~~P~~Rp~~~~ll~~~~ 269 (308)
T cd06634 230 ESPALQSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHRF 269 (308)
T ss_pred CCCCcCcccccHHHHHHHHHHhhCCcccCCCHHHHhhCcc
Confidence 0011112234567889999999999999999999998643
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin |
| >KOG0586 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.98 E-value=8.1e-33 Score=297.06 Aligned_cols=243 Identities=23% Similarity=0.327 Sum_probs=205.3
Q ss_pred hhhhhcCccccceEEEeeecCCCceEEEEEEccccccc--chHHHHHHHHHhcccCCCCcccccceeccCCceEEEEEec
Q 003836 504 GFKEELGRGAFGTVYKGFVNMGSSNHVAVKKLNSVFQD--SEKEFKAEVNGIGQTHHKNLVRLLGYCDEGQNRLLVYEFM 581 (792)
Q Consensus 504 ~~~~~lG~G~~g~Vy~g~~~~~~~~~vavK~~~~~~~~--~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~lV~E~~ 581 (792)
.+.+.||+|.|++|.++... .++..||+|.+++..-. ....+.+|+++|..++|||||+++.+......+|+||||.
T Consensus 59 ~i~~tig~g~f~~V~La~~~-~t~~~VaiK~idkt~ln~~~~~k~~rev~imk~l~HPnIvkl~~v~~t~~~lylV~eya 137 (596)
T KOG0586|consen 59 VIIKTIGKGNFAKVKLARHI-LTGTEVAIKIIDKTQLNPSKRQKLGREVDIMKSLNHPNIVKLFSVIETEATLYLVMEYA 137 (596)
T ss_pred eeeeeeccceeEEEEeeEec-CCCceEEEEEehhcccChHHHHHHHHHHHHHHhcCCcceeeeeeeeeecceeEEEEEec
Confidence 34578999999999999765 45789999999875433 2345889999999999999999999999999999999999
Q ss_pred cCCCccccccCCCCCchhHHHHHHHHHHHHHHHHhhccCCCeEecCCCCCcEEEcCCCCeEEeecCCCccccCCCCCccc
Q 003836 582 SNGTVASFLFGDSKPNWKLRTEIAMGIAGGLFYLHEECCTQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLDQSHTNT 661 (792)
Q Consensus 582 ~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dikp~NILl~~~~~~kl~Dfg~a~~~~~~~~~~~~ 661 (792)
.+|.+.++|.++....+.....++.|+..|++|+|++ .|+|||||++||||+.+.++||+|||++..+. ......
T Consensus 138 ~~ge~~~yl~~~gr~~e~~ar~~F~q~vsaveYcH~k---~ivHrdLk~eNilL~~~mnikIaDfgfS~~~~--~~~~lq 212 (596)
T KOG0586|consen 138 SGGELFDYLVKHGRMKEKEARAKFRQIVSAVEYCHSK---NIVHRDLKAENILLDENMNIKIADFGFSTFFD--YGLMLQ 212 (596)
T ss_pred cCchhHHHHHhcccchhhhhhhhhHHHHHHHHHHhhc---ceeccccchhhcccccccceeeeccccceeec--cccccc
Confidence 9999999999998888899999999999999999999 99999999999999999999999999999875 334455
Q ss_pred cccccCCcccccccccCCC-CcccceehHHHHHHHHHhcCcCCCcchhhhhhhhHHHHHHHhhcccchhHhhhchhcc--
Q 003836 662 AIRGTKGYVAPEWFRNMPI-TVKVDVYSYGVLLLEIICLRRNIDNEISKVDKAILTDWAYDRYQERTLEALVENDLEA-- 738 (792)
Q Consensus 662 ~~~gt~~y~aPE~~~~~~~-~~k~DV~S~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-- 738 (792)
..+|++.|.|||++.+.++ ++++|+||+|++||-|+.|..||+...-.. +-...+..
T Consensus 213 t~cgsppyAaPEl~~g~~y~gpe~D~Wslgvvly~LV~GsLPFDG~~lk~--------------------Lr~rvl~gk~ 272 (596)
T KOG0586|consen 213 TFCGSPPYAAPELFNGKKYDGPEVDIWSLGVVLYALVEGSLPFDGQNLKE--------------------LRPRVLRGKY 272 (596)
T ss_pred ccCCCCCccChHhhcCcccCCcceehhhhhhhheeeeecccccCCccccc--------------------ccchheeeee
Confidence 6789999999999998776 489999999999999999999998542211 11111111
Q ss_pred cCCHHHHHHHHHHHHHccccCCCCCCCHHhHHHH
Q 003836 739 MNNVTMLHRFVMVAFWCIQEDPSHRPTMRKVTQM 772 (792)
Q Consensus 739 ~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~ 772 (792)
..+.-.+.++-++++++|-.+|.+|++++++.+.
T Consensus 273 rIp~~ms~dce~lLrk~lvl~Pskr~~~dqim~~ 306 (596)
T KOG0586|consen 273 RIPFYMSCDCEDLLRKFLVLNPSKRGPCDQIMKD 306 (596)
T ss_pred cccceeechhHHHHHHhhccCccccCCHHHhhhh
Confidence 1233345678889999999999999999999864
|
|
| >cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.98 E-value=6.8e-32 Score=294.12 Aligned_cols=273 Identities=20% Similarity=0.272 Sum_probs=197.2
Q ss_pred hhhcCccccceEEEeeecCCCceEEEEEEccccc--ccchHHHHHHHHHhcccCCCCcccccceeccC------CceEEE
Q 003836 506 KEELGRGAFGTVYKGFVNMGSSNHVAVKKLNSVF--QDSEKEFKAEVNGIGQTHHKNLVRLLGYCDEG------QNRLLV 577 (792)
Q Consensus 506 ~~~lG~G~~g~Vy~g~~~~~~~~~vavK~~~~~~--~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~------~~~~lV 577 (792)
.+.||+|+||.||+|... .+++.+|+|++.... ......+.+|+.++++++|+||+++++++... ...++|
T Consensus 20 ~~~ig~g~~g~v~~~~~~-~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~~lv 98 (342)
T cd07879 20 LKQVGSGAYGSVCSAIDK-RTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHENVIGLLDVFTSAVSGDEFQDFYLV 98 (342)
T ss_pred EEEeeecCCeEEEEEEeC-CCCcEEEEEEecCccccccchhHHHHHHHHHHhcCCCCccchhheecccccCCCCceEEEE
Confidence 367999999999999753 456789999986532 22345688999999999999999999998654 346899
Q ss_pred EEeccCCCccccccCCCCCchhHHHHHHHHHHHHHHHHhhccCCCeEecCCCCCcEEEcCCCCeEEeecCCCccccCCCC
Q 003836 578 YEFMSNGTVASFLFGDSKPNWKLRTEIAMGIAGGLFYLHEECCTQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLDQS 657 (792)
Q Consensus 578 ~E~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dikp~NILl~~~~~~kl~Dfg~a~~~~~~~~ 657 (792)
+||+.. +|..++ ...+++..+..++.|+++||+|||+. +|+||||||+|||++.++.+||+|||+++.....
T Consensus 99 ~e~~~~-~l~~~~--~~~~~~~~~~~~~~qi~~aL~~LH~~---~i~H~dlkp~NIll~~~~~~kL~dfg~~~~~~~~-- 170 (342)
T cd07879 99 MPYMQT-DLQKIM--GHPLSEDKVQYLVYQMLCGLKYIHSA---GIIHRDLKPGNLAVNEDCELKILDFGLARHADAE-- 170 (342)
T ss_pred eccccc-CHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEeeCCCCcCCCCC--
Confidence 999974 666654 23578899999999999999999998 9999999999999999999999999998764321
Q ss_pred CccccccccCCccccccccc-CCCCcccceehHHHHHHHHHhcCcCCCcchhhhhhhhHHHH-------HHHhhcccchh
Q 003836 658 HTNTAIRGTKGYVAPEWFRN-MPITVKVDVYSYGVLLLEIICLRRNIDNEISKVDKAILTDW-------AYDRYQERTLE 729 (792)
Q Consensus 658 ~~~~~~~gt~~y~aPE~~~~-~~~~~k~DV~S~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~-------~~~~~~~~~~~ 729 (792)
.....++..|+|||.+.+ ..++.++|||||||++|||++|+.||............... ...........
T Consensus 171 --~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 248 (342)
T cd07879 171 --MTGYVVTRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGPEFVQKLEDKAAK 248 (342)
T ss_pred --CCCceeeecccChhhhcCccccCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHhcccchH
Confidence 223457889999999876 46899999999999999999999999754321110000000 00000000000
Q ss_pred Hhhhch--h-ccc---CCHHHHHHHHHHHHHccccCCCCCCCHHhHHHH--hccCcCCCCCCCCCCCC
Q 003836 730 ALVEND--L-EAM---NNVTMLHRFVMVAFWCIQEDPSHRPTMRKVTQM--LEGVVEVPIPPCPWTLN 789 (792)
Q Consensus 730 ~~~~~~--~-~~~---~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~--L~~~~~~~~p~~P~~~~ 789 (792)
...... . ... .......++.+++.+||+.||.+||+++|+++. ++...+.+..+.|.+.+
T Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~~~~e~l~h~~f~~~~~~~~~~~~~~~~ 316 (342)
T cd07879 249 SYIKSLPKYPRKDFSTLFPKASPQAVDLLEKMLELDVDKRLTATEALEHPYFDSFRDADEETEQQPYD 316 (342)
T ss_pred HHHhhcCCcccchHHHHhcCCCHHHHHHHHHHcCCChhhCcCHHHHhcCcchhhcccccccCCCCccc
Confidence 010000 0 000 001234568899999999999999999999965 77776665555555443
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13 |
| >cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Probab=99.98 E-value=3.8e-32 Score=290.85 Aligned_cols=263 Identities=22% Similarity=0.275 Sum_probs=194.1
Q ss_pred hhhhhhcCccccceEEEeeecCCCceEEEEEEccccc--ccchHHHHHHHHHhcccCCCCcccccceeccCC--------
Q 003836 503 RGFKEELGRGAFGTVYKGFVNMGSSNHVAVKKLNSVF--QDSEKEFKAEVNGIGQTHHKNLVRLLGYCDEGQ-------- 572 (792)
Q Consensus 503 ~~~~~~lG~G~~g~Vy~g~~~~~~~~~vavK~~~~~~--~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~-------- 572 (792)
+.+.+.||+|+||.||+|... .+++.||+|+++... ......+.+|++++++++||||+++++++.+..
T Consensus 9 ~~~~~~lg~g~~g~v~~~~~~-~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~~~~~~ 87 (302)
T cd07864 9 FDIIGQIGEGTYGQVYKARDK-DTGELVALKKVRLDNEKEGFPITAIREIKILRQLNHRNIVNLKEIVTDKQDALDFKKD 87 (302)
T ss_pred hheeeeecccCCEEEEEEEEC-CCCcEEEEEEEeecccccCchHHHHHHHHHHHhCCCCCeeeeeheecCcchhhhcccc
Confidence 445678999999999999865 345789999987532 233457788999999999999999999987654
Q ss_pred --ceEEEEEeccCCCccccccCC-CCCchhHHHHHHHHHHHHHHHHhhccCCCeEecCCCCCcEEEcCCCCeEEeecCCC
Q 003836 573 --NRLLVYEFMSNGTVASFLFGD-SKPNWKLRTEIAMGIAGGLFYLHEECCTQIIHCDIKPQNILLDDHYNARISDFGLA 649 (792)
Q Consensus 573 --~~~lV~E~~~~gsL~~~l~~~-~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dikp~NILl~~~~~~kl~Dfg~a 649 (792)
..++|+||+++ +|..++... ..+++..+..++.||+.||+|||+. +|+|+||||+||++++++.+||+|||++
T Consensus 88 ~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~i~H~dl~p~nili~~~~~~kl~dfg~~ 163 (302)
T cd07864 88 KGAFYLVFEYMDH-DLMGLLESGLVHFSEDHIKSFMKQLLEGLNYCHKK---NFLHRDIKCSNILLNNKGQIKLADFGLA 163 (302)
T ss_pred CCcEEEEEcccCc-cHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCcEEeCccccc
Confidence 78999999987 666666543 4689999999999999999999998 9999999999999999999999999999
Q ss_pred ccccCCCCCccccccccCCccccccccc-CCCCcccceehHHHHHHHHHhcCcCCCcchhhhhhhhHHHHHHHhhcc--c
Q 003836 650 KLLTLDQSHTNTAIRGTKGYVAPEWFRN-MPITVKVDVYSYGVLLLEIICLRRNIDNEISKVDKAILTDWAYDRYQE--R 726 (792)
Q Consensus 650 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~k~DV~S~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~--~ 726 (792)
...............++..|+|||.+.+ ..++.++|||||||+++||++|+.||...........+.......... .
T Consensus 164 ~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~~~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 243 (302)
T cd07864 164 RLYNSEESRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKKPIFQANQELAQLELISRLCGSPCPAVWP 243 (302)
T ss_pred ccccCCcccccccceeccCccChHHhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhhcc
Confidence 8765433222233346778999998865 457899999999999999999999997543221111111100000000 0
Q ss_pred chhHh-----------hhchhcccCCHHHHHHHHHHHHHccccCCCCCCCHHhHHH
Q 003836 727 TLEAL-----------VENDLEAMNNVTMLHRFVMVAFWCIQEDPSHRPTMRKVTQ 771 (792)
Q Consensus 727 ~~~~~-----------~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~ 771 (792)
.+... ........ ....+..+.+++.+||+.+|++||+++++++
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~ 298 (302)
T cd07864 244 DVIKLPYFNTMKPKKQYRRRLREE-FSFIPTPALDLLDHMLTLDPSKRCTAEEALN 298 (302)
T ss_pred cccccccccccccccccccchhhh-cCCCCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence 00000 00000000 0113567889999999999999999999987
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely |
| >cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.98 E-value=4e-32 Score=287.60 Aligned_cols=261 Identities=21% Similarity=0.274 Sum_probs=198.2
Q ss_pred hhhhcCccccceEEEeeecCCCceEEEEEEccccccc--chHHHHHHHHHhcccCCCCcccccceeccCCceEEEEEecc
Q 003836 505 FKEELGRGAFGTVYKGFVNMGSSNHVAVKKLNSVFQD--SEKEFKAEVNGIGQTHHKNLVRLLGYCDEGQNRLLVYEFMS 582 (792)
Q Consensus 505 ~~~~lG~G~~g~Vy~g~~~~~~~~~vavK~~~~~~~~--~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~lV~E~~~ 582 (792)
..+.||+|++|.||++... .+++.+++|++...... ....+.+|++++++++|+||+++++++..+...++|+||++
T Consensus 3 ~~~~i~~g~~~~v~~~~~~-~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~ 81 (283)
T cd05118 3 KLGKIGEGTYGVVYKARDK-LTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLDVFRHKGDLYLVFEFMD 81 (283)
T ss_pred cceeeecCCCceEEEEEcC-CCCcEEEEEEeccccccchhHHHHHHHHHHHHHhcCCCcchHHHhhccCCCEEEEEeccC
Confidence 3467999999999999754 45678999998754332 45678899999999999999999999999999999999998
Q ss_pred CCCccccccCC-CCCchhHHHHHHHHHHHHHHHHhhccCCCeEecCCCCCcEEEcCCCCeEEeecCCCccccCCCCCccc
Q 003836 583 NGTVASFLFGD-SKPNWKLRTEIAMGIAGGLFYLHEECCTQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLDQSHTNT 661 (792)
Q Consensus 583 ~gsL~~~l~~~-~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dikp~NILl~~~~~~kl~Dfg~a~~~~~~~~~~~~ 661 (792)
+ +|.+++... ..+++..+..++.||+.||.|||+. +|+|+||||+||+++.++.+||+|||.+....... ....
T Consensus 82 ~-~l~~~l~~~~~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~dl~p~nili~~~~~~~l~df~~~~~~~~~~-~~~~ 156 (283)
T cd05118 82 T-DLYKLIKDRQRGLPESLIKSYLYQLLQGLAFCHSH---GILHRDLKPENLLINTEGVLKLADFGLARSFGSPV-RPYT 156 (283)
T ss_pred C-CHHHHHHhhcccCCHHHHHHHHHHHHHHHHHHHHC---CeeecCcCHHHEEECCCCcEEEeeeeeeEecCCCc-cccc
Confidence 6 888887664 5789999999999999999999998 99999999999999999999999999998765443 1222
Q ss_pred cccccCCcccccccccC-CCCcccceehHHHHHHHHHhcCcCCCcchhhhhhhhHHHH-------HHHhhcc---cchhH
Q 003836 662 AIRGTKGYVAPEWFRNM-PITVKVDVYSYGVLLLEIICLRRNIDNEISKVDKAILTDW-------AYDRYQE---RTLEA 730 (792)
Q Consensus 662 ~~~gt~~y~aPE~~~~~-~~~~k~DV~S~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~-------~~~~~~~---~~~~~ 730 (792)
...++..|+|||.+.+. .++.++||||||+++|+|++|+.||............... .+....+ .....
T Consensus 157 ~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (283)
T cd05118 157 HYVVTRWYRAPELLLGDKGYSTPVDIWSVGCIFAELLSRRPLFPGKSEIDQLFKIFRTLGTPDPEVWPKFTSLARNYKFS 236 (283)
T ss_pred CccCcccccCcHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCchHhcccchhhhhhhhhh
Confidence 34578889999998776 7899999999999999999999998654321111000000 0000000 00000
Q ss_pred hhhchhc--ccCCHHHHHHHHHHHHHccccCCCCCCCHHhHHH
Q 003836 731 LVENDLE--AMNNVTMLHRFVMVAFWCIQEDPSHRPTMRKVTQ 771 (792)
Q Consensus 731 ~~~~~~~--~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~ 771 (792)
+.+.... .......+.++.+++.+||+.+|.+||++++++.
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~ll~ 279 (283)
T cd05118 237 FPKKAGMPLPKLFPNASPQALDLLSQMLHYDPHKRITAEQALA 279 (283)
T ss_pred hccccccCHHHhhhhhCHHHHHHHHHHhccCcccCcCHHHHhh
Confidence 0000000 0011235678999999999999999999999987
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They |
| >cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Probab=99.98 E-value=6.6e-32 Score=290.76 Aligned_cols=260 Identities=17% Similarity=0.159 Sum_probs=192.1
Q ss_pred hhcCccccceEEEeeecCCCceEEEEEEcccc--cccchHHHHHHHHHhcccCCCCcccccceeccCCceEEEEEeccCC
Q 003836 507 EELGRGAFGTVYKGFVNMGSSNHVAVKKLNSV--FQDSEKEFKAEVNGIGQTHHKNLVRLLGYCDEGQNRLLVYEFMSNG 584 (792)
Q Consensus 507 ~~lG~G~~g~Vy~g~~~~~~~~~vavK~~~~~--~~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~lV~E~~~~g 584 (792)
+.+|.|+++.|+++.. +++.+|||++... .....+.+.+|++++++++|+||+++++++.+.+..+++|||+++|
T Consensus 8 ~~~~~~~~v~~~~~~~---~~~~~avK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~e~~~~~ 84 (314)
T cd08216 8 KCFEDLMIVHLAKHKP---TNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPYVTSFIVDSELYVVSPLMAYG 84 (314)
T ss_pred HhhcCCceEEEEEecC---CCCEEEEEEEeccccchhHHHHHHHHHHHHHhcCCcchhhhhheeecCCeEEEEEeccCCC
Confidence 4455666666666542 5678999998754 3445578999999999999999999999999999999999999999
Q ss_pred CccccccCC--CCCchhHHHHHHHHHHHHHHHHhhccCCCeEecCCCCCcEEEcCCCCeEEeecCCCccccCCCC-----
Q 003836 585 TVASFLFGD--SKPNWKLRTEIAMGIAGGLFYLHEECCTQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLDQS----- 657 (792)
Q Consensus 585 sL~~~l~~~--~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dikp~NILl~~~~~~kl~Dfg~a~~~~~~~~----- 657 (792)
+|.+++... ..+++.....++.|+++||+|||+. +|+|+||||+||+++.++.+||+|||.+........
T Consensus 85 ~l~~~l~~~~~~~~~~~~~~~~~~~l~~~L~~LH~~---~ivH~dlk~~Nili~~~~~~kl~d~~~~~~~~~~~~~~~~~ 161 (314)
T cd08216 85 SCEDLLKTHFPEGLPELAIAFILKDVLNALDYIHSK---GFIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQRVV 161 (314)
T ss_pred CHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCcceEEEecCCceEEecCccceeecccccccccc
Confidence 999999754 4578889999999999999999998 999999999999999999999999998875532211
Q ss_pred -CccccccccCCccccccccc--CCCCcccceehHHHHHHHHHhcCcCCCcchhhhhhhh-HHHHHHHhhcc-------c
Q 003836 658 -HTNTAIRGTKGYVAPEWFRN--MPITVKVDVYSYGVLLLEIICLRRNIDNEISKVDKAI-LTDWAYDRYQE-------R 726 (792)
Q Consensus 658 -~~~~~~~gt~~y~aPE~~~~--~~~~~k~DV~S~Gv~l~el~tg~~p~~~~~~~~~~~~-~~~~~~~~~~~-------~ 726 (792)
.......++..|+|||.+.. ..++.++|||||||++|||++|+.||........... ........... .
T Consensus 162 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Diws~G~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (314)
T cd08216 162 HDFPKSSVKNLPWLSPEVLQQNLQGYNEKSDIYSVGITACELANGHVPFKDMPATQMLLEKVRGTVPCLLDKSTYPLYED 241 (314)
T ss_pred ccccccccccccccCHHHhcCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCccccccCchhhhcC
Confidence 11123446788999999875 3588999999999999999999999975432211000 00000000000 0
Q ss_pred chh--------HhhhchhcccCCHHHHHHHHHHHHHccccCCCCCCCHHhHHHH
Q 003836 727 TLE--------ALVENDLEAMNNVTMLHRFVMVAFWCIQEDPSHRPTMRKVTQM 772 (792)
Q Consensus 727 ~~~--------~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~ 772 (792)
... .................++.+++.+||+.+|++|||++++++.
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~ 295 (314)
T cd08216 242 SMSQSRSSNEHPNNRDSVDHPYTRTFSEHFHQFVELCLQRDPESRPSASQLLNH 295 (314)
T ss_pred CcCcccccccccchhhhhhcchhhHHHHHHHHHHHHHhhcCCCcCcCHHHHhcC
Confidence 000 0000011111233456788999999999999999999999973
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc |
| >cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Probab=99.98 E-value=3.5e-32 Score=283.41 Aligned_cols=245 Identities=23% Similarity=0.373 Sum_probs=200.8
Q ss_pred hhhhcCccccceEEEeeecCCCceEEEEEEcccccc--cchHHHHHHHHHhcccCCCCcccccceeccCCceEEEEEecc
Q 003836 505 FKEELGRGAFGTVYKGFVNMGSSNHVAVKKLNSVFQ--DSEKEFKAEVNGIGQTHHKNLVRLLGYCDEGQNRLLVYEFMS 582 (792)
Q Consensus 505 ~~~~lG~G~~g~Vy~g~~~~~~~~~vavK~~~~~~~--~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~lV~E~~~ 582 (792)
+.+.||+|++|.||++... .+++.+++|++..... ...+.+.+|++++++++|+|++++++.+..+...++|+||++
T Consensus 4 ~~~~l~~g~~~~v~~~~~~-~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~lv~e~~~ 82 (258)
T cd08215 4 IIKQIGKGSFGKVYLVRRK-SDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKYYESFEEKGKLCIVMEYAD 82 (258)
T ss_pred EEeeeccCCCeEEEEEEEc-CCCcEEEEEEeecccCChHHHHHHHHHHHHHHhcCCCChhheEEEEecCCEEEEEEEecC
Confidence 4567999999999999765 3567899999876433 456678999999999999999999999999999999999999
Q ss_pred CCCccccccCC----CCCchhHHHHHHHHHHHHHHHHhhccCCCeEecCCCCCcEEEcCCCCeEEeecCCCccccCCCCC
Q 003836 583 NGTVASFLFGD----SKPNWKLRTEIAMGIAGGLFYLHEECCTQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLDQSH 658 (792)
Q Consensus 583 ~gsL~~~l~~~----~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dikp~NILl~~~~~~kl~Dfg~a~~~~~~~~~ 658 (792)
+++|.+++... ..+++..+..++.+++.||.|||+. +++|+||+|+||++++++.++|+|||.+....... .
T Consensus 83 ~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~---~~~H~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~-~ 158 (258)
T cd08215 83 GGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLHSR---KILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTV-D 158 (258)
T ss_pred CCcHHHHHHHhhccCCCcCHHHHHHHHHHHHHHHHHHHhC---CEecccCChHHeEEcCCCcEEECCccceeecccCc-c
Confidence 99999998763 6789999999999999999999998 99999999999999999999999999998765433 1
Q ss_pred ccccccccCCcccccccccCCCCcccceehHHHHHHHHHhcCcCCCcchhhhhhhhHHHHHHHhhcccchhHhhhchhcc
Q 003836 659 TNTAIRGTKGYVAPEWFRNMPITVKVDVYSYGVLLLEIICLRRNIDNEISKVDKAILTDWAYDRYQERTLEALVENDLEA 738 (792)
Q Consensus 659 ~~~~~~gt~~y~aPE~~~~~~~~~k~DV~S~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 738 (792)
......+++.|+|||.+....++.++||||+|+++++|++|+.||....... . .. ...... ..
T Consensus 159 ~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~---~----~~---------~~~~~~-~~ 221 (258)
T cd08215 159 LAKTVVGTPYYLSPELCQNKPYNYKSDIWSLGCVLYELCTLKHPFEGENLLE---L----AL---------KILKGQ-YP 221 (258)
T ss_pred eecceeeeecccChhHhccCCCCccccHHHHHHHHHHHHcCCCCCCCCcHHH---H----HH---------HHhcCC-CC
Confidence 2233468889999999988889999999999999999999999986542110 0 00 001110 11
Q ss_pred cCCHHHHHHHHHHHHHccccCCCCCCCHHhHHH
Q 003836 739 MNNVTMLHRFVMVAFWCIQEDPSHRPTMRKVTQ 771 (792)
Q Consensus 739 ~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~ 771 (792)
..+......+.+++.+||+.+|++||++.|+++
T Consensus 222 ~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~ 254 (258)
T cd08215 222 PIPSQYSSELRNLVSSLLQKDPEERPSIAQILQ 254 (258)
T ss_pred CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHhc
Confidence 112234567889999999999999999999987
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They |
| >cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.98 E-value=2.2e-32 Score=296.72 Aligned_cols=268 Identities=21% Similarity=0.273 Sum_probs=204.0
Q ss_pred hhhhhcCccccceEEEeeecCCCceEEEEEEccccc--ccchHHHHHHHHHhcccCCCCcccccceeccCC-----ceEE
Q 003836 504 GFKEELGRGAFGTVYKGFVNMGSSNHVAVKKLNSVF--QDSEKEFKAEVNGIGQTHHKNLVRLLGYCDEGQ-----NRLL 576 (792)
Q Consensus 504 ~~~~~lG~G~~g~Vy~g~~~~~~~~~vavK~~~~~~--~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~-----~~~l 576 (792)
.+.+.||+|++|.||+++.. ..++.+++|++.... ....+.+.+|+.++++++|+||+++++++.... ..++
T Consensus 3 ~i~~~ig~g~~~~v~~~~~~-~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~l 81 (330)
T cd07834 3 ELLKPIGSGAYGVVCSAVDK-RTGRKVAIKKISNVFDDLIDAKRILREIKLLRHLRHENIIGLLDILRPPSPEDFNDVYI 81 (330)
T ss_pred eeeeeecCCCCeEEEEEEeC-CCCcEEEEEeeccccccchhhhhHHHHHHHHHhcCCcchhhhhhhhcccCcccccceEE
Confidence 35578999999999999754 446789999987654 344578999999999999999999999998775 7899
Q ss_pred EEEeccCCCccccccCCCCCchhHHHHHHHHHHHHHHHHhhccCCCeEecCCCCCcEEEcCCCCeEEeecCCCccccCCC
Q 003836 577 VYEFMSNGTVASFLFGDSKPNWKLRTEIAMGIAGGLFYLHEECCTQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLDQ 656 (792)
Q Consensus 577 V~E~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dikp~NILl~~~~~~kl~Dfg~a~~~~~~~ 656 (792)
||||+++ +|.+++.....+++..+..++.||+.||+|||+. +|+|+||||+|||++.++.++|+|||++.......
T Consensus 82 v~e~~~~-~l~~~l~~~~~l~~~~~~~i~~~l~~~l~~LH~~---gi~H~dlkp~nili~~~~~~~L~dfg~~~~~~~~~ 157 (330)
T cd07834 82 VTELMET-DLHKVIKSPQPLTDDHIQYFLYQILRGLKYLHSA---NVIHRDLKPSNILVNSNCDLKICDFGLARGVDPDE 157 (330)
T ss_pred Eecchhh-hHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEcccCceEeecccc
Confidence 9999984 8999988777899999999999999999999998 99999999999999999999999999998765443
Q ss_pred C--CccccccccCCcccccccccC-CCCcccceehHHHHHHHHHhcCcCCCcchhhhhhhhHHHHH-------HHhhccc
Q 003836 657 S--HTNTAIRGTKGYVAPEWFRNM-PITVKVDVYSYGVLLLEIICLRRNIDNEISKVDKAILTDWA-------YDRYQER 726 (792)
Q Consensus 657 ~--~~~~~~~gt~~y~aPE~~~~~-~~~~k~DV~S~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~-------~~~~~~~ 726 (792)
. .......++..|+|||.+.+. .++.++||||||+++++|++|+.||...........+.... .......
T Consensus 158 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 237 (330)
T cd07834 158 DEKGFLTEYVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRKPLFPGRDYIDQLNLIVEVLGTPSEEDLKFITSE 237 (330)
T ss_pred cccccccccccccCcCCceeeecccCCCcchhHHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHhcCCCChhHhhhcccc
Confidence 1 122334578899999999887 89999999999999999999999996553321111100000 0000011
Q ss_pred chhHhhhchh-ccc-----CCHHHHHHHHHHHHHccccCCCCCCCHHhHHHH--hccC
Q 003836 727 TLEALVENDL-EAM-----NNVTMLHRFVMVAFWCIQEDPSHRPTMRKVTQM--LEGV 776 (792)
Q Consensus 727 ~~~~~~~~~~-~~~-----~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~--L~~~ 776 (792)
.....+.... ... ........+.+++.+||+.+|.+||+++++++. +++.
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~~~~~~~ 295 (330)
T cd07834 238 KARNYLKSLPKKPKKPLSKLFPGASPEAIDLLEKMLVFDPKKRITADEALAHPYLAQL 295 (330)
T ss_pred chhhHHhhcccCCcchhHHhcccCCHHHHHHHHHHccCChhhCCCHHHHHhCccHHhh
Confidence 1111111000 000 011245678899999999999999999999985 4444
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and |
| >KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription] | Back alignment and domain information |
|---|
Probab=99.98 E-value=8.1e-33 Score=272.14 Aligned_cols=280 Identities=22% Similarity=0.316 Sum_probs=202.2
Q ss_pred hhhhhcCccccceEEEeeecCCC---ceEEEEEEcccccc--cchHHHHHHHHHhcccCCCCcccccceecc-CCceEEE
Q 003836 504 GFKEELGRGAFGTVYKGFVNMGS---SNHVAVKKLNSVFQ--DSEKEFKAEVNGIGQTHHKNLVRLLGYCDE-GQNRLLV 577 (792)
Q Consensus 504 ~~~~~lG~G~~g~Vy~g~~~~~~---~~~vavK~~~~~~~--~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~-~~~~~lV 577 (792)
+....||+|.||.|||++-.+.. .+.+|+|+++.... .......+|+.+++.++|+||+.|..++.. +..++|+
T Consensus 27 e~ig~Ig~GTYG~VykA~~~~~n~kr~k~yAiKkfk~~kd~tGiS~SAcREiaL~REl~h~nvi~Lv~Vfl~~d~~v~l~ 106 (438)
T KOG0666|consen 27 EGIGKIGRGTYGKVYKAVRKNTNDKRTKEYAIKKFKGEKDGTGISMSACREIALLRELKHPNVISLVKVFLSHDKKVWLL 106 (438)
T ss_pred hccceecccccceeeEeeeccCCcccchhhHHHHHhccCCCCCcCHHHHHHHHHHHHhcCCcchhHHHHHhccCceEEEE
Confidence 34567999999999999654332 23799999975422 234567899999999999999999999977 7889999
Q ss_pred EEeccCCCccccccCC-----CCCchhHHHHHHHHHHHHHHHHhhccCCCeEecCCCCCcEEEcCC----CCeEEeecCC
Q 003836 578 YEFMSNGTVASFLFGD-----SKPNWKLRTEIAMGIAGGLFYLHEECCTQIIHCDIKPQNILLDDH----YNARISDFGL 648 (792)
Q Consensus 578 ~E~~~~gsL~~~l~~~-----~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dikp~NILl~~~----~~~kl~Dfg~ 648 (792)
+||.+. +|...++-+ +.++......|+.||+.|+.|||+. -|+||||||.|||+..+ |.+||+|||+
T Consensus 107 fdYAEh-DL~~II~fHr~~~~~~lp~~mvKsilwQil~Gv~YLH~N---WvlHRDLKPaNIlvmgdgperG~VKIaDlGl 182 (438)
T KOG0666|consen 107 FDYAEH-DLWHIIKFHRASKAKQLPRSMVKSILWQILDGVHYLHSN---WVLHRDLKPANILVMGDGPERGRVKIADLGL 182 (438)
T ss_pred ehhhhh-hHHHHHHHhccchhccCCHHHHHHHHHHHHhhhHHHhhh---heeeccCCcceEEEeccCCccCeeEeecccH
Confidence 999988 787777532 3578889999999999999999999 99999999999999877 8999999999
Q ss_pred CccccCCCCC--ccccccccCCccccccccc-CCCCcccceehHHHHHHHHHhcCcCCCcchhhhhhhh------H----
Q 003836 649 AKLLTLDQSH--TNTAIRGTKGYVAPEWFRN-MPITVKVDVYSYGVLLLEIICLRRNIDNEISKVDKAI------L---- 715 (792)
Q Consensus 649 a~~~~~~~~~--~~~~~~gt~~y~aPE~~~~-~~~~~k~DV~S~Gv~l~el~tg~~p~~~~~~~~~~~~------~---- 715 (792)
++.+...-.. ....++-|.-|+|||.+.+ ..||.+.|||+.|||..||+|-+..|.....+.+... +
T Consensus 183 aR~~~~plkpl~s~d~VVVTiWYRAPELLLGa~hYT~AiDvWAiGCIfaElLtl~PlF~g~E~k~~~~~Pfq~dQl~rIf 262 (438)
T KOG0666|consen 183 ARLFNNPLKPLASLDPVVVTIWYRAPELLLGARHYTKAIDVWAIGCIFAELLTLEPLFKGREEKIKTKNPFQHDQLDRIF 262 (438)
T ss_pred HHHhhccccccccCCceEEEEEecChHHhcccccccchhhhHHHHHHHHHHHccCccccchhhhcccCCCchHHHHHHHH
Confidence 9998654332 3345677999999999877 5699999999999999999999887755432221110 0
Q ss_pred --------HHHHHHhhcccchhHhhhc-hhcccCCH----------HHHHHHHHHHHHccccCCCCCCCHHhHHHHhccC
Q 003836 716 --------TDWAYDRYQERTLEALVEN-DLEAMNNV----------TMLHRFVMVAFWCIQEDPSHRPTMRKVTQMLEGV 776 (792)
Q Consensus 716 --------~~~~~~~~~~~~~~~~~~~-~~~~~~~~----------~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~L~~~ 776 (792)
..|+.-.-- ......+.. +...-.+. ...+...+|...+|+.||.+|.|+++.++.. -.
T Consensus 263 ~vLG~Pt~~~Wp~lkk~-Pe~q~~ls~f~~~~~~n~sL~~~~~~~k~k~~~a~~LL~klL~yDP~kRIta~qAleh~-yF 340 (438)
T KOG0666|consen 263 EVLGTPTDKDWPDLKKM-PEYQTLLSDFRRHYYDNVSLHKYYHKHKVKDPSALDLLQKLLTYDPIKRITAEQALEHP-YF 340 (438)
T ss_pred HHcCCCccccchhhhhC-cchHHHHHHhHHhhcCcchHHHHHHHhcCCCchHHHHHHHHhccCchhhccHHHHhccc-cc
Confidence 011110000 000000000 00000000 0122367899999999999999999776632 24
Q ss_pred cCCCCCCCCCCCC
Q 003836 777 VEVPIPPCPWTLN 789 (792)
Q Consensus 777 ~~~~~p~~P~~~~ 789 (792)
.+-+.||.|..-+
T Consensus 341 ~~d~lpp~pt~~~ 353 (438)
T KOG0666|consen 341 TEDPLPPLPTSDN 353 (438)
T ss_pred ccCCCCCCcccce
Confidence 5667777776543
|
|
| >cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Probab=99.98 E-value=4.8e-32 Score=291.19 Aligned_cols=263 Identities=22% Similarity=0.276 Sum_probs=192.7
Q ss_pred hhhhhcCccccceEEEeeecCCCceEEEEEEcccccc--cchHHHHHHHHHhcccCCCCcccccceeccC--CceEEEEE
Q 003836 504 GFKEELGRGAFGTVYKGFVNMGSSNHVAVKKLNSVFQ--DSEKEFKAEVNGIGQTHHKNLVRLLGYCDEG--QNRLLVYE 579 (792)
Q Consensus 504 ~~~~~lG~G~~g~Vy~g~~~~~~~~~vavK~~~~~~~--~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~--~~~~lV~E 579 (792)
.+.+.||+|+||.||+|... .+++.||+|+++.... .....+.+|+.++++++|+||+++++++.+. +..++|||
T Consensus 10 ~~~~~ig~g~~~~v~~~~~~-~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv~e 88 (309)
T cd07845 10 EKLNRIGEGTYGIVYRARDT-TSGEIVALKKVRMDNERDGIPISSLREITLLLNLRHPNIVELKEVVVGKHLDSIFLVME 88 (309)
T ss_pred eEeeeeeecCCEEEEEEEEC-CCCcEEEEEEEEeccCCCCCcchhhHHHHHHHhCCCCCCcceEEEEecCCCCeEEEEEe
Confidence 34567999999999999764 4567899999864322 2234567899999999999999999998655 46899999
Q ss_pred eccCCCccccccCC-CCCchhHHHHHHHHHHHHHHHHhhccCCCeEecCCCCCcEEEcCCCCeEEeecCCCccccCCCCC
Q 003836 580 FMSNGTVASFLFGD-SKPNWKLRTEIAMGIAGGLFYLHEECCTQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLDQSH 658 (792)
Q Consensus 580 ~~~~gsL~~~l~~~-~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dikp~NILl~~~~~~kl~Dfg~a~~~~~~~~~ 658 (792)
|+++ +|.+++... ..+++..+..++.||++||+|||+. +++|+||||+||++++++.+||+|||+++.......
T Consensus 89 ~~~~-~l~~~l~~~~~~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~nil~~~~~~~kL~dfg~~~~~~~~~~- 163 (309)
T cd07845 89 YCEQ-DLASLLDNMPTPFSESQVKCLMLQLLRGLQYLHEN---FIIHRDLKVSNLLLTDKGCLKIADFGLARTYGLPAK- 163 (309)
T ss_pred cCCC-CHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCCEEECccceeeecCCccC-
Confidence 9975 788877653 5689999999999999999999998 999999999999999999999999999987653321
Q ss_pred ccccccccCCccccccccc-CCCCcccceehHHHHHHHHHhcCcCCCcchhhhhhhhHHHH-------HHHhhcccch-h
Q 003836 659 TNTAIRGTKGYVAPEWFRN-MPITVKVDVYSYGVLLLEIICLRRNIDNEISKVDKAILTDW-------AYDRYQERTL-E 729 (792)
Q Consensus 659 ~~~~~~gt~~y~aPE~~~~-~~~~~k~DV~S~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~-------~~~~~~~~~~-~ 729 (792)
......+++.|+|||.+.+ ..++.++||||||+++|||++|+.||............... .+........ .
T Consensus 164 ~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 243 (309)
T cd07845 164 PMTPKVVTLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHKPLLPGKSEIEQLDLIIQLLGTPNESIWPGFSDLPLVG 243 (309)
T ss_pred CCCcccccccccChhhhcCCCCcCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCChhhchhhhcccccc
Confidence 2222345788999999865 56899999999999999999999999754332211111110 0000000000 0
Q ss_pred Hhhh--chhcc--cCCHHHHHHHHHHHHHccccCCCCCCCHHhHHHH
Q 003836 730 ALVE--NDLEA--MNNVTMLHRFVMVAFWCIQEDPSHRPTMRKVTQM 772 (792)
Q Consensus 730 ~~~~--~~~~~--~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~ 772 (792)
.+.. ..... .........+.+++.+||+.||++|||++|+++.
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~~il~h 290 (309)
T cd07845 244 KFTLPKQPYNNLKHKFPWLSEAGLRLLNFLLMYDPKKRATAEEALES 290 (309)
T ss_pred cccccCCCCCchHHhccccCHHHHHHHHHHhcCChhhCcCHHHHhcC
Confidence 0000 00000 0001135677899999999999999999999974
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing |
| >PTZ00024 cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.98 E-value=3.9e-32 Score=295.39 Aligned_cols=261 Identities=21% Similarity=0.248 Sum_probs=194.8
Q ss_pred hhhcCccccceEEEeeecCCCceEEEEEEcccccccc--------------hHHHHHHHHHhcccCCCCcccccceeccC
Q 003836 506 KEELGRGAFGTVYKGFVNMGSSNHVAVKKLNSVFQDS--------------EKEFKAEVNGIGQTHHKNLVRLLGYCDEG 571 (792)
Q Consensus 506 ~~~lG~G~~g~Vy~g~~~~~~~~~vavK~~~~~~~~~--------------~~~~~~Ei~~l~~l~h~niv~l~g~~~~~ 571 (792)
.+.||+|+||+||++... ..++.||+|++....... ...+.+|++++++++|+||+++++++...
T Consensus 14 ~~~ig~G~~g~vy~~~~~-~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~ 92 (335)
T PTZ00024 14 GAHLGEGTYGKVEKAYDT-LTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEIKHENIMGLVDVYVEG 92 (335)
T ss_pred hhcccCCCceeEEEEEEC-CCCCeEEEEEeeccccccccccchhhhcccccchhHHHHHHHHHhCCCcceeeeeEEEecC
Confidence 467999999999999754 456789999986532221 12578999999999999999999999999
Q ss_pred CceEEEEEeccCCCccccccCCCCCchhHHHHHHHHHHHHHHHHhhccCCCeEecCCCCCcEEEcCCCCeEEeecCCCcc
Q 003836 572 QNRLLVYEFMSNGTVASFLFGDSKPNWKLRTEIAMGIAGGLFYLHEECCTQIIHCDIKPQNILLDDHYNARISDFGLAKL 651 (792)
Q Consensus 572 ~~~~lV~E~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dikp~NILl~~~~~~kl~Dfg~a~~ 651 (792)
+..++||||++ |+|.+++.....+++.....++.|++.||.|||+. +|+|+||+|+||+++.++.+||+|||+++.
T Consensus 93 ~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~ql~~aL~~LH~~---~i~H~dl~~~nill~~~~~~kl~dfg~~~~ 168 (335)
T PTZ00024 93 DFINLVMDIMA-SDLKKVVDRKIRLTESQVKCILLQILNGLNVLHKW---YFMHRDLSPANIFINSKGICKIADFGLARR 168 (335)
T ss_pred CcEEEEEeccc-cCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC---CeecccccHHHeEECCCCCEEECCccceee
Confidence 99999999997 58999998777889999999999999999999998 999999999999999999999999999986
Q ss_pred ccCCC-------------CCccccccccCCcccccccccC-CCCcccceehHHHHHHHHHhcCcCCCcchhhhhhhhHHH
Q 003836 652 LTLDQ-------------SHTNTAIRGTKGYVAPEWFRNM-PITVKVDVYSYGVLLLEIICLRRNIDNEISKVDKAILTD 717 (792)
Q Consensus 652 ~~~~~-------------~~~~~~~~gt~~y~aPE~~~~~-~~~~k~DV~S~Gv~l~el~tg~~p~~~~~~~~~~~~~~~ 717 (792)
..... ........+++.|+|||.+.+. .++.++||||||+++|||++|+.||...........+..
T Consensus 169 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~i~~ 248 (335)
T PTZ00024 169 YGYPPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKPLFPGENEIDQLGRIFE 248 (335)
T ss_pred cccccccccccccccccccccccccccccCCCCChhcccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHH
Confidence 54111 1111223467889999998764 478999999999999999999999965533211111100
Q ss_pred HHH----Hhhcccc-h------hHhhhchhcccCCHHHHHHHHHHHHHccccCCCCCCCHHhHHHH
Q 003836 718 WAY----DRYQERT-L------EALVENDLEAMNNVTMLHRFVMVAFWCIQEDPSHRPTMRKVTQM 772 (792)
Q Consensus 718 ~~~----~~~~~~~-~------~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~ 772 (792)
... ..+.... + ......... ........++.+++..||+.+|++||+++|++..
T Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~~ 313 (335)
T PTZ00024 249 LLGTPNEDNWPQAKKLPLYTEFTPRKPKDLK-TIFPNASDDAIDLLQSLLKLNPLERISAKEALKH 313 (335)
T ss_pred HhCCCchhhCcchhhcccccccCcCCcccHH-HhCcCCChHHHHHHHHHcCCCchhccCHHHHhcC
Confidence 000 0000000 0 000000000 0011235678899999999999999999999975
|
|
| >cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.98 E-value=2.7e-32 Score=296.70 Aligned_cols=264 Identities=21% Similarity=0.283 Sum_probs=194.4
Q ss_pred hhhhhcCccccceEEEeeecCCCceEEEEEEccccc-ccchHHHHHHHHHhcccCCCCcccccceeccC-----CceEEE
Q 003836 504 GFKEELGRGAFGTVYKGFVNMGSSNHVAVKKLNSVF-QDSEKEFKAEVNGIGQTHHKNLVRLLGYCDEG-----QNRLLV 577 (792)
Q Consensus 504 ~~~~~lG~G~~g~Vy~g~~~~~~~~~vavK~~~~~~-~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~-----~~~~lV 577 (792)
.+.++||+|+||.||+|... .+++.||+|++.... ......+.+|+.++++++|+||+++++++... ...++|
T Consensus 8 ~i~~~lg~G~~g~vy~~~~~-~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv 86 (336)
T cd07849 8 QNLSYIGEGAYGMVCSATHK-PTGVKVAIKKISPFEHQTFCQRTLREIKILRRFKHENIIGILDIIRPPSFESFNDVYIV 86 (336)
T ss_pred EEEEEEEecCCeEEEEEEEc-CCCCeEEEEEecccccchhHHHHHHHHHHHHhCCCCCcCchhheeecccccccceEEEE
Confidence 34578999999999999654 556789999986432 23345688899999999999999999987544 357999
Q ss_pred EEeccCCCccccccCCCCCchhHHHHHHHHHHHHHHHHhhccCCCeEecCCCCCcEEEcCCCCeEEeecCCCccccCCCC
Q 003836 578 YEFMSNGTVASFLFGDSKPNWKLRTEIAMGIAGGLFYLHEECCTQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLDQS 657 (792)
Q Consensus 578 ~E~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dikp~NILl~~~~~~kl~Dfg~a~~~~~~~~ 657 (792)
+||+++ +|.+++. ...+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++.......
T Consensus 87 ~e~~~~-~l~~~~~-~~~l~~~~~~~i~~ql~~aL~~LH~~---~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~ 161 (336)
T cd07849 87 QELMET-DLYKLIK-TQHLSNDHIQYFLYQILRGLKYIHSA---NVLHRDLKPSNLLLNTNCDLKICDFGLARIADPEHD 161 (336)
T ss_pred ehhccc-CHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHEEECCCCCEEECcccceeecccccc
Confidence 999975 7777764 35688999999999999999999998 999999999999999999999999999987543222
Q ss_pred C--ccccccccCCccccccccc-CCCCcccceehHHHHHHHHHhcCcCCCcchhhhhhhhHHHHHHHhhcc---cchhHh
Q 003836 658 H--TNTAIRGTKGYVAPEWFRN-MPITVKVDVYSYGVLLLEIICLRRNIDNEISKVDKAILTDWAYDRYQE---RTLEAL 731 (792)
Q Consensus 658 ~--~~~~~~gt~~y~aPE~~~~-~~~~~k~DV~S~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~ 731 (792)
. ......+++.|+|||.+.+ ..++.++|||||||++|||++|+.||............ ...... .....+
T Consensus 162 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGvil~el~~G~~~f~~~~~~~~~~~~----~~~~~~~~~~~~~~~ 237 (336)
T cd07849 162 HTGFLTEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNRPLFPGKDYLHQLNLI----LGVLGTPSQEDLNCI 237 (336)
T ss_pred ccCCcCCcCcCCCccChHHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH----HHHcCCCCHHHHHHh
Confidence 1 1123467899999998754 56899999999999999999999999643211100000 000000 000000
Q ss_pred hhch---------hccc-----CCHHHHHHHHHHHHHccccCCCCCCCHHhHHHH--hccCc
Q 003836 732 VEND---------LEAM-----NNVTMLHRFVMVAFWCIQEDPSHRPTMRKVTQM--LEGVV 777 (792)
Q Consensus 732 ~~~~---------~~~~-----~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~--L~~~~ 777 (792)
.... .... .....+.++.+++.+||+.+|++|||+.|+++. ++...
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~e~l~hp~~~~~~ 299 (336)
T cd07849 238 ISLRARNYIKSLPFKPKVPWNKLFPNADPKALDLLDKMLTFNPHKRITVEEALAHPYLEQYH 299 (336)
T ss_pred hchhhhhHHhhcCcCCcccHHHHhcccCcHHHHHHHHHcCCChhhCcCHHHHhcCccccccC
Confidence 0000 0000 011235678899999999999999999999987 55543
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase |
| >cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Probab=99.98 E-value=2.6e-32 Score=288.45 Aligned_cols=246 Identities=24% Similarity=0.347 Sum_probs=201.1
Q ss_pred hhhhhcCccccceEEEeeecCCCceEEEEEEcccc---cccchHHHHHHHHHhcccC-CCCcccccceeccCCceEEEEE
Q 003836 504 GFKEELGRGAFGTVYKGFVNMGSSNHVAVKKLNSV---FQDSEKEFKAEVNGIGQTH-HKNLVRLLGYCDEGQNRLLVYE 579 (792)
Q Consensus 504 ~~~~~lG~G~~g~Vy~g~~~~~~~~~vavK~~~~~---~~~~~~~~~~Ei~~l~~l~-h~niv~l~g~~~~~~~~~lV~E 579 (792)
.+.+.||+|++|.||++... .+++.+++|++... .....+.+.+|++++++++ |+||+++++++.+++..++|||
T Consensus 4 ~~~~~lg~g~~~~vy~~~~~-~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv~e 82 (280)
T cd05581 4 KFGKIIGEGSFSTVVLAKEK-ETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIKLYYTFQDEENLYFVLE 82 (280)
T ss_pred eEeeeecCCCceEEEEEEEc-CCCCEEEEEEechHhccchHHHHHHHHHHHHHHhcccCCCchhHHHHhcCCceEEEEEc
Confidence 34578999999999999764 45678999998652 2233567889999999998 9999999999999999999999
Q ss_pred eccCCCccccccCCCCCchhHHHHHHHHHHHHHHHHhhccCCCeEecCCCCCcEEEcCCCCeEEeecCCCccccCCCC--
Q 003836 580 FMSNGTVASFLFGDSKPNWKLRTEIAMGIAGGLFYLHEECCTQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLDQS-- 657 (792)
Q Consensus 580 ~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dikp~NILl~~~~~~kl~Dfg~a~~~~~~~~-- 657 (792)
|+++++|.+++.....+++..+..++.|++.||.|||+. +++|+||+|+||+++.++.++|+|||++........
T Consensus 83 ~~~~~~L~~~l~~~~~l~~~~~~~i~~ql~~~l~~Lh~~---~~~H~dl~~~ni~i~~~~~~~l~df~~~~~~~~~~~~~ 159 (280)
T cd05581 83 YAPNGELLQYIRKYGSLDEKCTRFYAAEILLALEYLHSK---GIIHRDLKPENILLDKDMHIKITDFGTAKVLDPNSSPE 159 (280)
T ss_pred CCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCHHHeEECCCCCEEecCCccccccCCccccc
Confidence 999999999998887899999999999999999999998 999999999999999999999999999987643321
Q ss_pred -----------------CccccccccCCcccccccccCCCCcccceehHHHHHHHHHhcCcCCCcchhhhhhhhHHHHHH
Q 003836 658 -----------------HTNTAIRGTKGYVAPEWFRNMPITVKVDVYSYGVLLLEIICLRRNIDNEISKVDKAILTDWAY 720 (792)
Q Consensus 658 -----------------~~~~~~~gt~~y~aPE~~~~~~~~~k~DV~S~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~ 720 (792)
.......++..|+|||.+....++.++||||||++++++++|+.||........ +
T Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~---~----- 231 (280)
T cd05581 160 SNKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPPFRGSNEYLT---F----- 231 (280)
T ss_pred cCCCCCccccccccccccccccccCCccccCHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCccHHHH---H-----
Confidence 112234578899999999888899999999999999999999999975432100 0
Q ss_pred HhhcccchhHhhhchhcccCCHHHHHHHHHHHHHccccCCCCCCCH----HhHHH
Q 003836 721 DRYQERTLEALVENDLEAMNNVTMLHRFVMVAFWCIQEDPSHRPTM----RKVTQ 771 (792)
Q Consensus 721 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~----~evl~ 771 (792)
..+. ......+....+.+.+++.+||+.+|++||++ +++++
T Consensus 232 --------~~~~--~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~ll~ 276 (280)
T cd05581 232 --------QKIL--KLEYSFPPNFPPDAKDLIEKLLVLDPQDRLGVNEGYDELKA 276 (280)
T ss_pred --------HHHH--hcCCCCCCccCHHHHHHHHHHhcCCHhhCCCcccCHHHHhc
Confidence 0011 11112223346678899999999999999999 77765
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto |
| >PLN00009 cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Probab=99.98 E-value=2.7e-32 Score=290.84 Aligned_cols=262 Identities=23% Similarity=0.294 Sum_probs=191.6
Q ss_pred hhhhhcCccccceEEEeeecCCCceEEEEEEcccccc--cchHHHHHHHHHhcccCCCCcccccceeccCCceEEEEEec
Q 003836 504 GFKEELGRGAFGTVYKGFVNMGSSNHVAVKKLNSVFQ--DSEKEFKAEVNGIGQTHHKNLVRLLGYCDEGQNRLLVYEFM 581 (792)
Q Consensus 504 ~~~~~lG~G~~g~Vy~g~~~~~~~~~vavK~~~~~~~--~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~lV~E~~ 581 (792)
.+.+.||+|++|+||+|... .+++.+|+|++..... ...+.+.+|++++++++|+||+++++++......++||||+
T Consensus 5 ~~~~~l~~g~~~~v~~~~~~-~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 83 (294)
T PLN00009 5 EKVEKIGEGTYGVVYKARDR-VTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVHSEKRLYLVFEYL 83 (294)
T ss_pred EEEEEecCCCCEEEEEEEec-CCCcEEEEEehhhccccccchHHHHHHHHHHHhccCCCEeeEEEEEecCCeEEEEEecc
Confidence 34578999999999999754 4567899999865322 23467889999999999999999999999999999999999
Q ss_pred cCCCccccccCCC--CCchhHHHHHHHHHHHHHHHHhhccCCCeEecCCCCCcEEEcC-CCCeEEeecCCCccccCCCCC
Q 003836 582 SNGTVASFLFGDS--KPNWKLRTEIAMGIAGGLFYLHEECCTQIIHCDIKPQNILLDD-HYNARISDFGLAKLLTLDQSH 658 (792)
Q Consensus 582 ~~gsL~~~l~~~~--~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dikp~NILl~~-~~~~kl~Dfg~a~~~~~~~~~ 658 (792)
+ ++|.+++.... ..++.....++.||+.||+|||++ +++|+||+|+||+++. ++.+||+|||+++.......
T Consensus 84 ~-~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~---~i~H~dl~p~nill~~~~~~~kl~dfg~~~~~~~~~~- 158 (294)
T PLN00009 84 D-LDLKKHMDSSPDFAKNPRLIKTYLYQILRGIAYCHSH---RVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVR- 158 (294)
T ss_pred c-ccHHHHHHhCCCCCcCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCCcceEEEECCCCEEEEcccccccccCCCcc-
Confidence 6 47877775443 357788889999999999999998 9999999999999985 56799999999976543211
Q ss_pred ccccccccCCccccccccc-CCCCcccceehHHHHHHHHHhcCcCCCcchhhhhhhhHHHHHH----Hhhcc-cchhHhh
Q 003836 659 TNTAIRGTKGYVAPEWFRN-MPITVKVDVYSYGVLLLEIICLRRNIDNEISKVDKAILTDWAY----DRYQE-RTLEALV 732 (792)
Q Consensus 659 ~~~~~~gt~~y~aPE~~~~-~~~~~k~DV~S~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~----~~~~~-~~~~~~~ 732 (792)
......+++.|+|||.+.+ ..++.++||||||+++|+|+||+.||................. ..+.. ..+....
T Consensus 159 ~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~i~~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (294)
T PLN00009 159 TFTHEVVTLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQKPLFPGDSEIDELFKIFRILGTPNEETWPGVTSLPDYK 238 (294)
T ss_pred ccccCceeecccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhccccccchhhh
Confidence 1223356889999998866 4578999999999999999999999975433211110000000 00000 0000000
Q ss_pred h--chhcc----cCCHHHHHHHHHHHHHccccCCCCCCCHHhHHH
Q 003836 733 E--NDLEA----MNNVTMLHRFVMVAFWCIQEDPSHRPTMRKVTQ 771 (792)
Q Consensus 733 ~--~~~~~----~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~ 771 (792)
. +.... ......+.++.+++.+||+.+|++||++.++++
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~~l~ 283 (294)
T PLN00009 239 SAFPKWPPKDLATVVPTLEPAGVDLLSKMLRLDPSKRITARAALE 283 (294)
T ss_pred hhcccCCCCCHHHhCcCCChHHHHHHHHHccCChhhCcCHHHHhc
Confidence 0 00000 011223566889999999999999999999997
|
|
| >cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.98 E-value=5.3e-32 Score=286.50 Aligned_cols=260 Identities=24% Similarity=0.306 Sum_probs=198.2
Q ss_pred hhhhcCccccceEEEeeecCCCceEEEEEEccccc--ccchHHHHHHHHHhcccCCCCcccccceeccCCceEEEEEecc
Q 003836 505 FKEELGRGAFGTVYKGFVNMGSSNHVAVKKLNSVF--QDSEKEFKAEVNGIGQTHHKNLVRLLGYCDEGQNRLLVYEFMS 582 (792)
Q Consensus 505 ~~~~lG~G~~g~Vy~g~~~~~~~~~vavK~~~~~~--~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~lV~E~~~ 582 (792)
+.+.||+|++|.||+|+.. .+++.+++|++.... ....+.+.+|+.++++++|+||+++++++.+....++|+||++
T Consensus 3 ~~~~ig~g~~~~vy~~~~~-~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~~~ 81 (282)
T cd07829 3 KLEKLGEGTYGVVYKARDK-KTGEIVALKKIRLDNEEEGIPSTALREISLLKELKHPNIVKLLDVIHTERKLYLVFEYCD 81 (282)
T ss_pred eehcccccCcceEEEeeec-CCCcEEEEEEeccccccccccHHHHHHHHHHHhcCCCCHHHHHhhhhcCCceEEEecCcC
Confidence 3467999999999999764 446789999987653 3335678899999999999999999999999999999999998
Q ss_pred CCCccccccCC-CCCchhHHHHHHHHHHHHHHHHhhccCCCeEecCCCCCcEEEcCCCCeEEeecCCCccccCCCCCccc
Q 003836 583 NGTVASFLFGD-SKPNWKLRTEIAMGIAGGLFYLHEECCTQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLDQSHTNT 661 (792)
Q Consensus 583 ~gsL~~~l~~~-~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dikp~NILl~~~~~~kl~Dfg~a~~~~~~~~~~~~ 661 (792)
++|.+++... ..+++..+.+++.|+++||+|||+. +|+|+||+|+||++++++.+||+|||.++....... ...
T Consensus 82 -~~l~~~i~~~~~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~~l~~~ni~~~~~~~~~l~d~g~~~~~~~~~~-~~~ 156 (282)
T cd07829 82 -MDLKKYLDKRPGPLSPNLIKSIMYQLLRGLAYCHSH---RILHRDLKPQNILINRDGVLKLADFGLARAFGIPLR-TYT 156 (282)
T ss_pred -cCHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCChheEEEcCCCCEEEecCCcccccCCCcc-ccC
Confidence 5899999776 5789999999999999999999998 999999999999999999999999999987643322 222
Q ss_pred cccccCCcccccccccC-CCCcccceehHHHHHHHHHhcCcCCCcchhhhhhhhHHHH-------HHHhhc-----ccch
Q 003836 662 AIRGTKGYVAPEWFRNM-PITVKVDVYSYGVLLLEIICLRRNIDNEISKVDKAILTDW-------AYDRYQ-----ERTL 728 (792)
Q Consensus 662 ~~~gt~~y~aPE~~~~~-~~~~k~DV~S~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~-------~~~~~~-----~~~~ 728 (792)
...++..|+|||.+.+. .++.++||||||++++||++|+.||............... .+.... ....
T Consensus 157 ~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (282)
T cd07829 157 HEVVTLWYRAPEILLGSKHYSTAVDIWSVGCIFAEMITGKPLFPGDSEIDQLFKIFQILGTPTEESWPGVTKLPDYKPTF 236 (282)
T ss_pred ccccCcCcCChHHhcCCcCCCccccHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHHHhCCCcHHHHHhhcccccccccc
Confidence 23457789999998766 8899999999999999999999998664322111111000 000000 0000
Q ss_pred hHhhhchhcccCCHHHHHHHHHHHHHccccCCCCCCCHHhHHH
Q 003836 729 EALVENDLEAMNNVTMLHRFVMVAFWCIQEDPSHRPTMRKVTQ 771 (792)
Q Consensus 729 ~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~ 771 (792)
.......... ........+.+++.+||+.+|++||++++++.
T Consensus 237 ~~~~~~~~~~-~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~ 278 (282)
T cd07829 237 PKFPPKDLEK-VLPRLDPEGIDLLSKMLQYNPAKRISAKEALK 278 (282)
T ss_pred cccCccchHH-hcccccHHHHHHHHHhhccCcccCCCHHHHhh
Confidence 0000000000 01122567899999999999999999999987
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the |
| >cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.2e-31 Score=288.59 Aligned_cols=240 Identities=27% Similarity=0.350 Sum_probs=189.4
Q ss_pred hhcCccccceEEEeeecCCCceEEEEEEcccccc---cchHHHHHHHHHhcccCCCCcccccceeccCCceEEEEEeccC
Q 003836 507 EELGRGAFGTVYKGFVNMGSSNHVAVKKLNSVFQ---DSEKEFKAEVNGIGQTHHKNLVRLLGYCDEGQNRLLVYEFMSN 583 (792)
Q Consensus 507 ~~lG~G~~g~Vy~g~~~~~~~~~vavK~~~~~~~---~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~lV~E~~~~ 583 (792)
++||+|+||+||+|+.. .+++.+++|++..... .....+.+|++++++++|+|++++++++.+.+..++||||+.
T Consensus 27 ~~lg~g~~g~v~~~~~~-~~~~~v~ik~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~- 104 (313)
T cd06633 27 HEIGHGSFGAVYFATNS-HTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKGCYLKEHTAWLVMEYCL- 104 (313)
T ss_pred eeeccCCCeEEEEEEEC-CCCcEEEEEEEeccccCchHHHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEEecCC-
Confidence 56999999999999754 4567899999864322 233568899999999999999999999999999999999996
Q ss_pred CCccccccC-CCCCchhHHHHHHHHHHHHHHHHhhccCCCeEecCCCCCcEEEcCCCCeEEeecCCCccccCCCCCcccc
Q 003836 584 GTVASFLFG-DSKPNWKLRTEIAMGIAGGLFYLHEECCTQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLDQSHTNTA 662 (792)
Q Consensus 584 gsL~~~l~~-~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dikp~NILl~~~~~~kl~Dfg~a~~~~~~~~~~~~~ 662 (792)
|+|.+++.. ...+++..+..++.||+.||.|||+. +++|+||+|+||+++.++.+||+|||++..... ...
T Consensus 105 ~~l~~~l~~~~~~l~~~~~~~~~~qi~~al~~LH~~---gi~H~dl~p~nili~~~~~~kL~dfg~~~~~~~-----~~~ 176 (313)
T cd06633 105 GSASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSH---NMIHRDIKAGNILLTEPGQVKLADFGSASKSSP-----ANS 176 (313)
T ss_pred CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCChhhEEECCCCCEEEeecCCCcccCC-----CCC
Confidence 477776654 45689999999999999999999998 999999999999999999999999999864321 223
Q ss_pred ccccCCcccccccc---cCCCCcccceehHHHHHHHHHhcCcCCCcchhhhhhhhHHHHHHHhhcccchhHhhhchhccc
Q 003836 663 IRGTKGYVAPEWFR---NMPITVKVDVYSYGVLLLEIICLRRNIDNEISKVDKAILTDWAYDRYQERTLEALVENDLEAM 739 (792)
Q Consensus 663 ~~gt~~y~aPE~~~---~~~~~~k~DV~S~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 739 (792)
..++..|+|||.+. ...++.++||||||+++|||++|+.|+.......... .... ......
T Consensus 177 ~~~~~~y~aPE~~~~~~~~~~~~~sDv~slGvil~el~~g~~p~~~~~~~~~~~-------~~~~---------~~~~~~ 240 (313)
T cd06633 177 FVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALY-------HIAQ---------NDSPTL 240 (313)
T ss_pred ccccccccChhhccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHH-------HHHh---------cCCCCC
Confidence 45788999999984 4668899999999999999999999986542211100 0000 000001
Q ss_pred CCHHHHHHHHHHHHHccccCCCCCCCHHhHHHH
Q 003836 740 NNVTMLHRFVMVAFWCIQEDPSHRPTMRKVTQM 772 (792)
Q Consensus 740 ~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~ 772 (792)
........+.+++.+||+.+|.+||++.+++..
T Consensus 241 ~~~~~~~~l~~li~~~l~~~P~~Rp~~~~~l~~ 273 (313)
T cd06633 241 QSNEWTDSFRGFVDYCLQKIPQERPASAELLRH 273 (313)
T ss_pred CccccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 111233567889999999999999999999863
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co |
| >cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Probab=99.97 E-value=8.3e-32 Score=289.25 Aligned_cols=264 Identities=20% Similarity=0.281 Sum_probs=190.9
Q ss_pred hhhhhhcCccccceEEEeeecCCCceEEEEEEccccc--ccchHHHHHHHHHhcccCCCCcccccceeccCC--------
Q 003836 503 RGFKEELGRGAFGTVYKGFVNMGSSNHVAVKKLNSVF--QDSEKEFKAEVNGIGQTHHKNLVRLLGYCDEGQ-------- 572 (792)
Q Consensus 503 ~~~~~~lG~G~~g~Vy~g~~~~~~~~~vavK~~~~~~--~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~-------- 572 (792)
+.+.++||+|+||.||++... .+++.||||++.... ......+.+|++++++++||||+++++++...+
T Consensus 14 y~~~~~lg~g~~~~v~~~~~~-~~~~~~aik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~ 92 (310)
T cd07865 14 YEKLAKIGQGTFGEVFKARHK-KTKQIVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPYNRYKG 92 (310)
T ss_pred eEEEEEeecCCCEEEEEEEEC-CCCcEEEEEEEeccCCcCCchhHHHHHHHHHHhCCCCCccceEEEEecccccccCCCc
Confidence 445578999999999999754 457899999886432 222345678999999999999999999986554
Q ss_pred ceEEEEEeccCCCccccccCC-CCCchhHHHHHHHHHHHHHHHHhhccCCCeEecCCCCCcEEEcCCCCeEEeecCCCcc
Q 003836 573 NRLLVYEFMSNGTVASFLFGD-SKPNWKLRTEIAMGIAGGLFYLHEECCTQIIHCDIKPQNILLDDHYNARISDFGLAKL 651 (792)
Q Consensus 573 ~~~lV~E~~~~gsL~~~l~~~-~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dikp~NILl~~~~~~kl~Dfg~a~~ 651 (792)
..++||||+.+ +|.+++... ..+++..+..++.||+.||.|||+. +++|+||||+||+++.++.+||+|||++..
T Consensus 93 ~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~---~i~H~dl~p~nil~~~~~~~kl~dfg~~~~ 168 (310)
T cd07865 93 SFYLVFEFCEH-DLAGLLSNKNVKFTLSEIKKVMKMLLNGLYYIHRN---KILHRDMKAANILITKDGILKLADFGLARA 168 (310)
T ss_pred eEEEEEcCCCc-CHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHEEECCCCcEEECcCCCccc
Confidence 35999999975 777777554 3689999999999999999999998 999999999999999999999999999987
Q ss_pred ccCCCCC---ccccccccCCcccccccccC-CCCcccceehHHHHHHHHHhcCcCCCcchhhhhhhhHHHHH----HHhh
Q 003836 652 LTLDQSH---TNTAIRGTKGYVAPEWFRNM-PITVKVDVYSYGVLLLEIICLRRNIDNEISKVDKAILTDWA----YDRY 723 (792)
Q Consensus 652 ~~~~~~~---~~~~~~gt~~y~aPE~~~~~-~~~~k~DV~S~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~----~~~~ 723 (792)
....... ......++..|+|||.+.+. .++.++||||||+++|||++|+.||...........+.... ...+
T Consensus 169 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~el~t~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 248 (310)
T cd07865 169 FSLSKNSKPNRYTNRVVTLWYRPPELLLGERDYGPPIDMWGAGCIMAEMWTRSPIMQGNTEQHQLTLISQLCGSITPEVW 248 (310)
T ss_pred ccCCcccCCCCccCcccCccccCcHHhcCCcccCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhc
Confidence 6433221 11234568889999988664 47899999999999999999999986543221111111100 0000
Q ss_pred cccchhHhhhc-hhccc---------CCHHHHHHHHHHHHHccccCCCCCCCHHhHHH
Q 003836 724 QERTLEALVEN-DLEAM---------NNVTMLHRFVMVAFWCIQEDPSHRPTMRKVTQ 771 (792)
Q Consensus 724 ~~~~~~~~~~~-~~~~~---------~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~ 771 (792)
.........+. ..... ........+.+++.+||+.||.+|||++|+++
T Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~dli~~~l~~~P~~R~t~~e~l~ 306 (310)
T cd07865 249 PGVDKLELFKKMELPQGQKRKVKERLKPYVKDPHALDLIDKLLVLDPAKRIDADTALN 306 (310)
T ss_pred ccccchhhhhhccCCCccchhhHHhcccccCCHHHHHHHHHHhcCChhhccCHHHHhc
Confidence 00000000000 00000 00012346678999999999999999999987
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl |
| >KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.3e-32 Score=266.22 Aligned_cols=246 Identities=23% Similarity=0.399 Sum_probs=193.1
Q ss_pred hhhcCccccceEEEeeecCCCceEEEEEEcccccc-cchHHHHHHHHHhcccC-CCCcccccceeccCCceEEEEEeccC
Q 003836 506 KEELGRGAFGTVYKGFVNMGSSNHVAVKKLNSVFQ-DSEKEFKAEVNGIGQTH-HKNLVRLLGYCDEGQNRLLVYEFMSN 583 (792)
Q Consensus 506 ~~~lG~G~~g~Vy~g~~~~~~~~~vavK~~~~~~~-~~~~~~~~Ei~~l~~l~-h~niv~l~g~~~~~~~~~lV~E~~~~ 583 (792)
...||.|..|.|++.... .++..+|||.+..... +..+++...+.++.+-+ .|.||+.+|+|..+....+.||.|.-
T Consensus 97 l~dlGsGtcG~V~k~~~r-s~~~iiAVK~M~rt~Nkee~kRILmDldvv~~s~dcpyIV~c~GyFi~n~dV~IcMelMs~ 175 (391)
T KOG0983|consen 97 LGDLGSGTCGQVWKMRFR-STGHIIAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVQCFGYFITNTDVFICMELMST 175 (391)
T ss_pred HHhhcCCCccceEEEEEc-ccceEEEEEeecccCCHHHHHHHHHhhhHHhhccCCCeeeeeeeEEeeCchHHHHHHHHHH
Confidence 456999999999999775 4567999999976543 44567888888777665 89999999999999999999999854
Q ss_pred CCccccccCC-CCCchhHHHHHHHHHHHHHHHHhhccCCCeEecCCCCCcEEEcCCCCeEEeecCCCccccCCCCCcccc
Q 003836 584 GTVASFLFGD-SKPNWKLRTEIAMGIAGGLFYLHEECCTQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLDQSHTNTA 662 (792)
Q Consensus 584 gsL~~~l~~~-~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dikp~NILl~~~~~~kl~Dfg~a~~~~~~~~~~~~~ 662 (792)
-++.+|.+- .++++.-.-++...+.+||.||.++ .+|+|||+||+|||+|+.|++||+|||++-.+... ...+.
T Consensus 176 -C~ekLlkrik~piPE~ilGk~tva~v~AL~YLKeK--H~viHRDvKPSNILlDe~GniKlCDFGIsGrlvdS--kAhtr 250 (391)
T KOG0983|consen 176 -CAEKLLKRIKGPIPERILGKMTVAIVKALYYLKEK--HGVIHRDVKPSNILLDERGNIKLCDFGISGRLVDS--KAHTR 250 (391)
T ss_pred -HHHHHHHHhcCCchHHhhhhhHHHHHHHHHHHHHh--cceeecccCccceEEccCCCEEeecccccceeecc--ccccc
Confidence 455555443 4677888888999999999999998 69999999999999999999999999999876543 33344
Q ss_pred ccccCCcccccccc---cCCCCcccceehHHHHHHHHHhcCcCCCcchhhhhhhhHHHHHHHhhcccchhHhhhchh-cc
Q 003836 663 IRGTKGYVAPEWFR---NMPITVKVDVYSYGVLLLEIICLRRNIDNEISKVDKAILTDWAYDRYQERTLEALVENDL-EA 738 (792)
Q Consensus 663 ~~gt~~y~aPE~~~---~~~~~~k~DV~S~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~ 738 (792)
..|-+.|||||.+. ...|+.++||||||+.|+||.||+.||.....+.+ .+ ..+++... ..
T Consensus 251 sAGC~~YMaPERidp~~~~kYDiRaDVWSlGITlveLaTg~yPy~~c~tdFe--~l-------------tkvln~ePP~L 315 (391)
T KOG0983|consen 251 SAGCAAYMAPERIDPPDKPKYDIRADVWSLGITLVELATGQYPYKGCKTDFE--VL-------------TKVLNEEPPLL 315 (391)
T ss_pred ccCCccccCccccCCCCCCccchhhhhhhhccchhhhhcccCCCCCCCccHH--HH-------------HHHHhcCCCCC
Confidence 56889999999985 34689999999999999999999999976432211 11 11111110 01
Q ss_pred cCCHHHHHHHHHHHHHccccCCCCCCCHHhHHHH
Q 003836 739 MNNVTMLHRFVMVAFWCIQEDPSHRPTMRKVTQM 772 (792)
Q Consensus 739 ~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~ 772 (792)
......+..+++++..||+.|+.+||...++++.
T Consensus 316 ~~~~gFSp~F~~fv~~CL~kd~r~RP~Y~~Ll~h 349 (391)
T KOG0983|consen 316 PGHMGFSPDFQSFVKDCLTKDHRKRPKYNKLLEH 349 (391)
T ss_pred CcccCcCHHHHHHHHHHhhcCcccCcchHHHhcC
Confidence 1122367889999999999999999999998874
|
|
| >KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.6e-32 Score=282.64 Aligned_cols=245 Identities=27% Similarity=0.323 Sum_probs=202.2
Q ss_pred hhcCccccceEEEeeecCCCceEEEEEEcccc---cccchHHHHHHHHHhcccCCCCcccccceeccCCceEEEEEeccC
Q 003836 507 EELGRGAFGTVYKGFVNMGSSNHVAVKKLNSV---FQDSEKEFKAEVNGIGQTHHKNLVRLLGYCDEGQNRLLVYEFMSN 583 (792)
Q Consensus 507 ~~lG~G~~g~Vy~g~~~~~~~~~vavK~~~~~---~~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~lV~E~~~~ 583 (792)
++||+|+||.|+-+... .+++.+|.|++.+. .+.++....+|-.+|.+++.+.||.+--.|+..+.++||+..|.|
T Consensus 191 RvlGkGGFGEV~acqvr-aTGKMYAcKkL~KKRiKkr~ge~maLnEk~iL~kV~s~FiVslaYAfeTkd~LClVLtlMNG 269 (591)
T KOG0986|consen 191 RVLGKGGFGEVCACQVR-ATGKMYACKKLDKKRIKKRKGETMALNEKQILEKVSSPFIVSLAYAFETKDALCLVLTLMNG 269 (591)
T ss_pred EEEecccccceeEEEEe-cchhhHHHHHHHHHHHHHhhhhHHhhHHHHHHHHhccCcEEEEeeeecCCCceEEEEEeecC
Confidence 57999999999988654 56788999988653 244566788999999999999999999999999999999999999
Q ss_pred CCccccccCCC--CCchhHHHHHHHHHHHHHHHHhhccCCCeEecCCCCCcEEEcCCCCeEEeecCCCccccCCCCCccc
Q 003836 584 GTVASFLFGDS--KPNWKLRTEIAMGIAGGLFYLHEECCTQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLDQSHTNT 661 (792)
Q Consensus 584 gsL~~~l~~~~--~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dikp~NILl~~~~~~kl~Dfg~a~~~~~~~~~~~~ 661 (792)
|+|.-+|.... .+++....-.+.+|+-||.+||.+ +||.||+||+|||||+.|+++|+|.|+|..+...+ ..+
T Consensus 270 GDLkfHiyn~g~~gF~e~ra~FYAAEi~cGLehlH~~---~iVYRDLKPeNILLDd~GhvRISDLGLAvei~~g~--~~~ 344 (591)
T KOG0986|consen 270 GDLKFHIYNHGNPGFDEQRARFYAAEIICGLEHLHRR---RIVYRDLKPENILLDDHGHVRISDLGLAVEIPEGK--PIR 344 (591)
T ss_pred CceeEEeeccCCCCCchHHHHHHHHHHHhhHHHHHhc---ceeeccCChhheeeccCCCeEeeccceEEecCCCC--ccc
Confidence 99999998764 788999999999999999999999 99999999999999999999999999998775433 334
Q ss_pred cccccCCcccccccccCCCCcccceehHHHHHHHHHhcCcCCCcchhhhhhhhHHHHHHHhhcccchhHhhhchhcccCC
Q 003836 662 AIRGTKGYVAPEWFRNMPITVKVDVYSYGVLLLEIICLRRNIDNEISKVDKAILTDWAYDRYQERTLEALVENDLEAMNN 741 (792)
Q Consensus 662 ~~~gt~~y~aPE~~~~~~~~~k~DV~S~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 741 (792)
..+||.+|||||++.+..|+...|.|||||+||||+.|+.||...-+.... +.+...+... ...++
T Consensus 345 ~rvGT~GYMAPEvl~ne~Y~~s~Dwf~lGCllYemi~G~sPFr~~KeKvk~-------------eEvdrr~~~~-~~ey~ 410 (591)
T KOG0986|consen 345 GRVGTVGYMAPEVLQNEVYDFSPDWFSLGCLLYEMIAGHSPFRQRKEKVKR-------------EEVDRRTLED-PEEYS 410 (591)
T ss_pred cccCcccccCHHHHcCCcccCCccHHHHHhHHHHHHcccCchhhhhhhhhH-------------HHHHHHHhcc-hhhcc
Confidence 447999999999999999999999999999999999999999765333221 1111111111 12245
Q ss_pred HHHHHHHHHHHHHccccCCCCCC-----CHHhHHH
Q 003836 742 VTMLHRFVMVAFWCIQEDPSHRP-----TMRKVTQ 771 (792)
Q Consensus 742 ~~~~~~l~~l~~~Cl~~~p~~RP-----s~~evl~ 771 (792)
...++++.++....|+.||++|. ..++|.+
T Consensus 411 ~kFS~eakslc~~LL~Kdp~~RLGcrg~ga~evk~ 445 (591)
T KOG0986|consen 411 DKFSEEAKSLCEGLLTKDPEKRLGCRGEGAQEVKE 445 (591)
T ss_pred cccCHHHHHHHHHHHccCHHHhccCCCcCcchhhh
Confidence 56778889999999999999996 3445554
|
|
| >cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.6e-31 Score=277.63 Aligned_cols=237 Identities=27% Similarity=0.303 Sum_probs=194.7
Q ss_pred cCccccceEEEeeecCCCceEEEEEEcccccc---cchHHHHHHHHHhcccCCCCcccccceeccCCceEEEEEeccCCC
Q 003836 509 LGRGAFGTVYKGFVNMGSSNHVAVKKLNSVFQ---DSEKEFKAEVNGIGQTHHKNLVRLLGYCDEGQNRLLVYEFMSNGT 585 (792)
Q Consensus 509 lG~G~~g~Vy~g~~~~~~~~~vavK~~~~~~~---~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~lV~E~~~~gs 585 (792)
||+|+||.||++... ..++.+++|.+..... .....+.+|+.++++++|+||+++++.+..++..++||||+++++
T Consensus 1 lg~G~~~~v~~~~~~-~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~ 79 (250)
T cd05123 1 LGKGSFGKVLLVRKK-DTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHYAFQTEEKLYLVLEYAPGGE 79 (250)
T ss_pred CCCCCceEEEEEEEC-CCCcEEEEEEeehhhhcchHHHHHHHHHHHHHHHcCCCcHHHHHHHeecCCeeEEEEecCCCCc
Confidence 699999999999764 4567899999875432 245678999999999999999999999999999999999999999
Q ss_pred ccccccCCCCCchhHHHHHHHHHHHHHHHHhhccCCCeEecCCCCCcEEEcCCCCeEEeecCCCccccCCCCCccccccc
Q 003836 586 VASFLFGDSKPNWKLRTEIAMGIAGGLFYLHEECCTQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLDQSHTNTAIRG 665 (792)
Q Consensus 586 L~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dikp~NILl~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~g 665 (792)
|.+++.....+++..+..++.|++.||.|||+. +++|+||+|+||+++.++.++|+|||++....... .......+
T Consensus 80 L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lh~~---~~~H~~l~p~ni~~~~~~~~~l~d~~~~~~~~~~~-~~~~~~~~ 155 (250)
T cd05123 80 LFSHLSKEGRFSEERARFYAAEIVLALEYLHSL---GIIYRDLKPENILLDADGHIKLTDFGLAKELSSEG-SRTNTFCG 155 (250)
T ss_pred HHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCcceEEEcCCCcEEEeecCcceecccCC-CcccCCcC
Confidence 999998877889999999999999999999998 99999999999999999999999999998764332 12234557
Q ss_pred cCCcccccccccCCCCcccceehHHHHHHHHHhcCcCCCcchhhhhhhhHHHHHHHhhcccchhHhhhchhcccCCHHHH
Q 003836 666 TKGYVAPEWFRNMPITVKVDVYSYGVLLLEIICLRRNIDNEISKVDKAILTDWAYDRYQERTLEALVENDLEAMNNVTML 745 (792)
Q Consensus 666 t~~y~aPE~~~~~~~~~k~DV~S~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 745 (792)
+..|+|||.+.+...+.++|+||||+++||+++|+.||....... .. ..+... ....+....
T Consensus 156 ~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~~---~~-------------~~~~~~--~~~~~~~~~ 217 (250)
T cd05123 156 TPEYLAPEVLLGKGYGKAVDWWSLGVLLYEMLTGKPPFYAEDRKE---IY-------------EKILKD--PLRFPEFLS 217 (250)
T ss_pred CccccChHHhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHH---HH-------------HHHhcC--CCCCCCCCC
Confidence 889999999988889999999999999999999999996543210 00 001111 111222335
Q ss_pred HHHHHHHHHccccCCCCCCCHHh
Q 003836 746 HRFVMVAFWCIQEDPSHRPTMRK 768 (792)
Q Consensus 746 ~~l~~l~~~Cl~~~p~~RPs~~e 768 (792)
..+.+++.+||..+|++||++.+
T Consensus 218 ~~l~~~i~~~l~~~p~~R~~~~~ 240 (250)
T cd05123 218 PEARDLISGLLQKDPTKRLGSGG 240 (250)
T ss_pred HHHHHHHHHHhcCCHhhCCCccc
Confidence 67889999999999999999944
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the |
| >cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Probab=99.97 E-value=8.5e-32 Score=287.36 Aligned_cols=248 Identities=25% Similarity=0.402 Sum_probs=190.0
Q ss_pred hhhhhcCccccceEEEeeecCCCceEEEEEEccccc-ccchHHHHHHHHHhcccC-CCCcccccceeccCCceEEEEEec
Q 003836 504 GFKEELGRGAFGTVYKGFVNMGSSNHVAVKKLNSVF-QDSEKEFKAEVNGIGQTH-HKNLVRLLGYCDEGQNRLLVYEFM 581 (792)
Q Consensus 504 ~~~~~lG~G~~g~Vy~g~~~~~~~~~vavK~~~~~~-~~~~~~~~~Ei~~l~~l~-h~niv~l~g~~~~~~~~~lV~E~~ 581 (792)
.+.+.||+|++|.||+|... .+++.+|||+++... .....++..|+.++.+.+ |+||+++++++.++...++||||+
T Consensus 18 ~~~~~lg~g~~~~v~~~~~~-~~~~~~avK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~ 96 (296)
T cd06618 18 ENLGEIGSGTCGQVYKMRFK-KTGHVMAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVKCYGYFITDSDVFICMELM 96 (296)
T ss_pred eeeeEeeccCCeEEEEEEEC-CCCeEEEEEEEeccCChHHHHHHHHHHHHHHhccCCCchHhhheeeecCCeEEEEeecc
Confidence 45678999999999999765 346789999987543 234456777887777765 999999999999999999999998
Q ss_pred cCCCccccccC-CCCCchhHHHHHHHHHHHHHHHHhhccCCCeEecCCCCCcEEEcCCCCeEEeecCCCccccCCCCCcc
Q 003836 582 SNGTVASFLFG-DSKPNWKLRTEIAMGIAGGLFYLHEECCTQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLDQSHTN 660 (792)
Q Consensus 582 ~~gsL~~~l~~-~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dikp~NILl~~~~~~kl~Dfg~a~~~~~~~~~~~ 660 (792)
++ +|.+++.. ...+++..+..++.||++||+|||+. .+|+||||+|+||++++++.+||+|||++.........
T Consensus 97 ~~-~l~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~--~~i~H~dl~p~nill~~~~~~kL~dfg~~~~~~~~~~~-- 171 (296)
T cd06618 97 ST-CLDKLLKRIQGPIPEDILGKMTVAIVKALHYLKEK--HGVIHRDVKPSNILLDASGNVKLCDFGISGRLVDSKAK-- 171 (296)
T ss_pred Cc-CHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhh--CCEecCCCcHHHEEEcCCCCEEECccccchhccCCCcc--
Confidence 64 66666644 35688999999999999999999973 28999999999999999999999999999765432221
Q ss_pred ccccccCCcccccccccC----CCCcccceehHHHHHHHHHhcCcCCCcchhhhhhhhHHHHHHHhhcccchhHhhhchh
Q 003836 661 TAIRGTKGYVAPEWFRNM----PITVKVDVYSYGVLLLEIICLRRNIDNEISKVDKAILTDWAYDRYQERTLEALVENDL 736 (792)
Q Consensus 661 ~~~~gt~~y~aPE~~~~~----~~~~k~DV~S~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 736 (792)
....++..|+|||.+... .++.++||||||+++|||++|+.||.......+ .+ ..++....
T Consensus 172 ~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~--~~-------------~~~~~~~~ 236 (296)
T cd06618 172 TRSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKNCKTEFE--VL-------------TKILQEEP 236 (296)
T ss_pred cCCCCCccccCHhhcCCCCCccccccchhHHHHHHHHHHHHhCCCCCCcchhHHH--HH-------------HHHhcCCC
Confidence 223478899999998754 388999999999999999999999865322110 00 00111100
Q ss_pred -cccCCHHHHHHHHHHHHHccccCCCCCCCHHhHHHH
Q 003836 737 -EAMNNVTMLHRFVMVAFWCIQEDPSHRPTMRKVTQM 772 (792)
Q Consensus 737 -~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~ 772 (792)
..........++.+++.+||+.+|++||+++++++.
T Consensus 237 ~~~~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~~ 273 (296)
T cd06618 237 PSLPPNEGFSPDFCSFVDLCLTKDHRKRPKYRELLQH 273 (296)
T ss_pred CCCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 000011235678999999999999999999999874
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it |
| >cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.1e-31 Score=284.75 Aligned_cols=260 Identities=23% Similarity=0.298 Sum_probs=192.1
Q ss_pred hhhhcCccccceEEEeeecCCCceEEEEEEcccccc--cchHHHHHHHHHhccc---CCCCcccccceeccCCc-----e
Q 003836 505 FKEELGRGAFGTVYKGFVNMGSSNHVAVKKLNSVFQ--DSEKEFKAEVNGIGQT---HHKNLVRLLGYCDEGQN-----R 574 (792)
Q Consensus 505 ~~~~lG~G~~g~Vy~g~~~~~~~~~vavK~~~~~~~--~~~~~~~~Ei~~l~~l---~h~niv~l~g~~~~~~~-----~ 574 (792)
+.+.||+|+||.||+|+... +++.+|+|++..... .....+.+|+.++.++ +|+|++++++++...+. .
T Consensus 3 ~~~~l~~g~~~~v~~~~~~~-~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~~~~ 81 (287)
T cd07838 3 ELAEIGEGAYGTVYKARDLN-TGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEHPNIVRLLDVCHGPRTDRELKL 81 (287)
T ss_pred EEEEecccCceEEEEEEECC-CCCEEEEEEeccccccchhhhhHHHHHHHHHHhhccCCCCcceEEEEEeeccCCCCcee
Confidence 45679999999999998753 467899999874322 2234566787776655 69999999999987776 8
Q ss_pred EEEEEeccCCCccccccCC--CCCchhHHHHHHHHHHHHHHHHhhccCCCeEecCCCCCcEEEcCCCCeEEeecCCCccc
Q 003836 575 LLVYEFMSNGTVASFLFGD--SKPNWKLRTEIAMGIAGGLFYLHEECCTQIIHCDIKPQNILLDDHYNARISDFGLAKLL 652 (792)
Q Consensus 575 ~lV~E~~~~gsL~~~l~~~--~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dikp~NILl~~~~~~kl~Dfg~a~~~ 652 (792)
+++|||+++ +|.+++... ..+++..+..++.||++||.|||+. +++|+||+|+||+++.++.+||+|||++...
T Consensus 82 ~l~~e~~~~-~l~~~l~~~~~~~l~~~~~~~~~~~i~~al~~LH~~---~i~h~~l~~~nili~~~~~~~l~dfg~~~~~ 157 (287)
T cd07838 82 TLVFEHVDQ-DLATYLSKCPKPGLPPETIKDLMRQLLRGVDFLHSH---RIVHRDLKPQNILVTSDGQVKIADFGLARIY 157 (287)
T ss_pred EEEehhccc-CHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCChhhEEEccCCCEEEeccCcceec
Confidence 999999975 888888654 3589999999999999999999998 9999999999999999999999999999876
Q ss_pred cCCCCCccccccccCCcccccccccCCCCcccceehHHHHHHHHHhcCcCCCcchhhhhhhhHHHHHH----Hhhcccc-
Q 003836 653 TLDQSHTNTAIRGTKGYVAPEWFRNMPITVKVDVYSYGVLLLEIICLRRNIDNEISKVDKAILTDWAY----DRYQERT- 727 (792)
Q Consensus 653 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DV~S~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~----~~~~~~~- 727 (792)
..... .....++..|+|||.+.+..++.++||||||+++|||++|+.||................. ..+....
T Consensus 158 ~~~~~--~~~~~~~~~~~~PE~~~~~~~~~~~Di~s~G~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (287)
T cd07838 158 SFEMA--LTSVVVTLWYRAPEVLLQSSYATPVDMWSVGCIFAELFRRRPLFRGTSEADQLDKIFDVIGLPSEEEWPRNVS 235 (287)
T ss_pred cCCcc--cccccccccccChHHhccCCCCCcchhhhHHHHHHHHHhCCCcccCCChHHHHHHHHHHcCCCChHhcCCCcc
Confidence 43322 1233478899999999998999999999999999999999988875433211110000000 0000000
Q ss_pred -hhHhhhchhc---ccCCHHHHHHHHHHHHHccccCCCCCCCHHhHHH
Q 003836 728 -LEALVENDLE---AMNNVTMLHRFVMVAFWCIQEDPSHRPTMRKVTQ 771 (792)
Q Consensus 728 -~~~~~~~~~~---~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~ 771 (792)
.......... .....+....+.+++.+||+.+|++||+++|+++
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~il~ 283 (287)
T cd07838 236 LPRSSFPSYTPRSFKSFVPEICEEGLDLLKKMLTFNPHKRISAFEALQ 283 (287)
T ss_pred cchhhcccccccchhhhhhhhhHHHHHHHHHHhccCCccCCCHHHHhc
Confidence 0000000000 1111234577889999999999999999999986
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both |
| >cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.4e-31 Score=280.01 Aligned_cols=246 Identities=22% Similarity=0.326 Sum_probs=192.4
Q ss_pred hhhhhhcCccccceEEEeeecCCCceEEEEEEcccc-----cccchHHHHHHHHHhcccCCCCcccccceeccCCceEEE
Q 003836 503 RGFKEELGRGAFGTVYKGFVNMGSSNHVAVKKLNSV-----FQDSEKEFKAEVNGIGQTHHKNLVRLLGYCDEGQNRLLV 577 (792)
Q Consensus 503 ~~~~~~lG~G~~g~Vy~g~~~~~~~~~vavK~~~~~-----~~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~lV 577 (792)
+.+.++||+|+||.||++.... ....+++|.++.. ......++..|+.++++++||||+++++++.+....++|
T Consensus 2 y~i~~~ig~g~~g~v~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 80 (260)
T cd08222 2 YILQQRLGKGSFGTVYLVKDKK-AVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIVKFHASFLERDAFCII 80 (260)
T ss_pred ceeeeeecCCCCceEEEEEecC-CCCcceEEEeccccccccCcchHHHHHHHHHHHHhCCCCcHHHHHHHHhcCCceEEE
Confidence 3456789999999999997543 2334555555432 122344677899999999999999999999999999999
Q ss_pred EEeccCCCccccccC----CCCCchhHHHHHHHHHHHHHHHHhhccCCCeEecCCCCCcEEEcCCCCeEEeecCCCcccc
Q 003836 578 YEFMSNGTVASFLFG----DSKPNWKLRTEIAMGIAGGLFYLHEECCTQIIHCDIKPQNILLDDHYNARISDFGLAKLLT 653 (792)
Q Consensus 578 ~E~~~~gsL~~~l~~----~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dikp~NILl~~~~~~kl~Dfg~a~~~~ 653 (792)
|||+++++|.+++.. ...+++..+..++.|++.||.|||+. +++|+||+|+||++++ +.+||+|||+++...
T Consensus 81 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~---~i~h~~l~~~nili~~-~~~~l~d~g~~~~~~ 156 (260)
T cd08222 81 TEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMHQR---RILHRDLKAKNIFLKN-NLLKIGDFGVSRLLM 156 (260)
T ss_pred EEeCCCCCHHHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHc---CccccCCChhheEeec-CCEeecccCceeecC
Confidence 999999999988853 35689999999999999999999998 9999999999999976 569999999998764
Q ss_pred CCCCCccccccccCCcccccccccCCCCcccceehHHHHHHHHHhcCcCCCcchhhhhhhhHHHHHHHhhcccchhHhhh
Q 003836 654 LDQSHTNTAIRGTKGYVAPEWFRNMPITVKVDVYSYGVLLLEIICLRRNIDNEISKVDKAILTDWAYDRYQERTLEALVE 733 (792)
Q Consensus 654 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DV~S~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 733 (792)
.... ......+++.|+|||.+.+..++.++|+||||+++|+|++|+.||......... ....
T Consensus 157 ~~~~-~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~~~~~~~~~~~~~~~----------------~~~~- 218 (260)
T cd08222 157 GSCD-LATTFTGTPYYMSPEALKHQGYDSKSDIWSLGCILYEMCCLAHAFEGQNFLSVV----------------LRIV- 218 (260)
T ss_pred CCcc-cccCCCCCcCccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCccHHHHH----------------HHHH-
Confidence 3322 222345788999999998888999999999999999999999998643211000 0000
Q ss_pred chhcccCCHHHHHHHHHHHHHccccCCCCCCCHHhHHH
Q 003836 734 NDLEAMNNVTMLHRFVMVAFWCIQEDPSHRPTMRKVTQ 771 (792)
Q Consensus 734 ~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~ 771 (792)
.......+...+.++.+++.+||+.+|++||++.|+++
T Consensus 219 ~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~ 256 (260)
T cd08222 219 EGPTPSLPETYSRQLNSIMQSMLNKDPSLRPSAAEILR 256 (260)
T ss_pred cCCCCCCcchhcHHHHHHHHHHhcCChhhCcCHHHHhh
Confidence 01111123345678899999999999999999999997
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check |
| >KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.9e-32 Score=267.65 Aligned_cols=245 Identities=24% Similarity=0.299 Sum_probs=202.1
Q ss_pred hhhhhcCccccceEEEeeecCCCceEEEEEEccccc---ccchHHHHHHHHHhcccCCCCcccccceeccCCceEEEEEe
Q 003836 504 GFKEELGRGAFGTVYKGFVNMGSSNHVAVKKLNSVF---QDSEKEFKAEVNGIGQTHHKNLVRLLGYCDEGQNRLLVYEF 580 (792)
Q Consensus 504 ~~~~~lG~G~~g~Vy~g~~~~~~~~~vavK~~~~~~---~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~lV~E~ 580 (792)
.|.++||+|.||.|.+++ .+.+++.+|+|++++.. .+....-..|-++|+..+||.+..|.-.|...+++++||||
T Consensus 171 dfLKvLGkGTFGKVIL~r-EKat~k~YAiKIlkKeviiakdEVAHTlTE~RVL~~~~HPFLt~LKYsFQt~drlCFVMey 249 (516)
T KOG0690|consen 171 DFLKVLGKGTFGKVILCR-EKATGKLYAIKILKKEVIIAKDEVAHTLTENRVLQNCRHPFLTSLKYSFQTQDRLCFVMEY 249 (516)
T ss_pred hHHHHhcCCccceEEEEe-ecccCceeehhhhhhhheeehHHhhhhhhHHHHHHhccCcHHHHhhhhhccCceEEEEEEE
Confidence 367899999999999985 55678899999998743 33334566788999999999999999999999999999999
Q ss_pred ccCCCccccccCCCCCchhHHHHHHHHHHHHHHHHhhccCCCeEecCCCCCcEEEcCCCCeEEeecCCCccccCCCCCcc
Q 003836 581 MSNGTVASFLFGDSKPNWKLRTEIAMGIAGGLFYLHEECCTQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLDQSHTN 660 (792)
Q Consensus 581 ~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dikp~NILl~~~~~~kl~Dfg~a~~~~~~~~~~~ 660 (792)
..+|.|.-+|.+.+.+++....-.-..|..||.|||++ +||.||||.+|.|||.+|++||.|||+++.... .....
T Consensus 250 anGGeLf~HLsrer~FsE~RtRFYGaEIvsAL~YLHs~---~ivYRDlKLENLlLDkDGHIKitDFGLCKE~I~-~g~t~ 325 (516)
T KOG0690|consen 250 ANGGELFFHLSRERVFSEDRTRFYGAEIVSALGYLHSR---NIVYRDLKLENLLLDKDGHIKITDFGLCKEEIK-YGDTT 325 (516)
T ss_pred ccCceEeeehhhhhcccchhhhhhhHHHHHHhhhhhhC---CeeeeechhhhheeccCCceEeeecccchhccc-cccee
Confidence 99999999998888888888888889999999999998 999999999999999999999999999986432 23345
Q ss_pred ccccccCCcccccccccCCCCcccceehHHHHHHHHHhcCcCCCcchhhhhhhhHHHHHHHhhcccchhHhhhchhcccC
Q 003836 661 TAIRGTKGYVAPEWFRNMPITVKVDVYSYGVLLLEIICLRRNIDNEISKVDKAILTDWAYDRYQERTLEALVENDLEAMN 740 (792)
Q Consensus 661 ~~~~gt~~y~aPE~~~~~~~~~k~DV~S~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 740 (792)
...+|||.|+|||++....|+.+.|.|.+||++|||++|+.||.......- .+-++..+++ +
T Consensus 326 kTFCGTPEYLAPEVleDnDYgraVDWWG~GVVMYEMmCGRLPFyn~dh~kL----------------FeLIl~ed~k--F 387 (516)
T KOG0690|consen 326 KTFCGTPEYLAPEVLEDNDYGRAVDWWGVGVVMYEMMCGRLPFYNKDHEKL----------------FELILMEDLK--F 387 (516)
T ss_pred ccccCChhhcCchhhccccccceeehhhhhHHHHHHHhccCcccccchhHH----------------HHHHHhhhcc--C
Confidence 568999999999999999999999999999999999999999976543211 1111222221 3
Q ss_pred CHHHHHHHHHHHHHccccCCCCCC-----CHHhHHH
Q 003836 741 NVTMLHRFVMVAFWCIQEDPSHRP-----TMRKVTQ 771 (792)
Q Consensus 741 ~~~~~~~l~~l~~~Cl~~~p~~RP-----s~~evl~ 771 (792)
+...+++...|..-.|..||.+|. .+.||.+
T Consensus 388 Pr~ls~eAktLLsGLL~kdP~kRLGgGpdDakEi~~ 423 (516)
T KOG0690|consen 388 PRTLSPEAKTLLSGLLKKDPKKRLGGGPDDAKEIMR 423 (516)
T ss_pred CccCCHHHHHHHHHHhhcChHhhcCCCchhHHHHHh
Confidence 444566777888889999999995 3455544
|
|
| >cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Probab=99.97 E-value=2e-31 Score=286.42 Aligned_cols=263 Identities=22% Similarity=0.271 Sum_probs=190.1
Q ss_pred hhhhhcCccccceEEEeeecCCCceEEEEEEccccccc--chHHHHHHHHHhcccCCCCcccccceeccCC--------c
Q 003836 504 GFKEELGRGAFGTVYKGFVNMGSSNHVAVKKLNSVFQD--SEKEFKAEVNGIGQTHHKNLVRLLGYCDEGQ--------N 573 (792)
Q Consensus 504 ~~~~~lG~G~~g~Vy~g~~~~~~~~~vavK~~~~~~~~--~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~--------~ 573 (792)
.+.++||+|++|.||+|... .+++.+++|++...... ....+.+|++++++++|+||+++++++.+.. .
T Consensus 11 ~~~~~lg~g~~~~v~~~~~~-~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~ 89 (311)
T cd07866 11 EILGKLGEGTFGEVYKARQI-KTGRVVALKKILMHNEKDGFPITALREIKILKKLKHPNVVPLIDMAVERPDKSKRKRGS 89 (311)
T ss_pred EEEEEeccCCCEEEEEEEEC-CCCcEEEEEEEEeccCCCCcchhHHHHHHHHHhcCCCCccchhhheecccccccccCce
Confidence 34578999999999999754 45678999988653322 2346789999999999999999999875433 4
Q ss_pred eEEEEEeccCCCccccccC-CCCCchhHHHHHHHHHHHHHHHHhhccCCCeEecCCCCCcEEEcCCCCeEEeecCCCccc
Q 003836 574 RLLVYEFMSNGTVASFLFG-DSKPNWKLRTEIAMGIAGGLFYLHEECCTQIIHCDIKPQNILLDDHYNARISDFGLAKLL 652 (792)
Q Consensus 574 ~~lV~E~~~~gsL~~~l~~-~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dikp~NILl~~~~~~kl~Dfg~a~~~ 652 (792)
.++|+||+.. +|...+.. ...+++..+..++.||++||+|||+. +|+|+||||+||++++++.+||+|||+++..
T Consensus 90 ~~lv~~~~~~-~l~~~~~~~~~~~~~~~~~~i~~~l~~al~~lH~~---~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~ 165 (311)
T cd07866 90 VYMVTPYMDH-DLSGLLENPSVKLTESQIKCYMLQLLEGINYLHEN---HILHRDIKAANILIDNQGILKIADFGLARPY 165 (311)
T ss_pred EEEEEecCCc-CHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCCEEECcCccchhc
Confidence 6899999976 66666654 35789999999999999999999998 9999999999999999999999999999865
Q ss_pred cCCCCC----------ccccccccCCccccccccc-CCCCcccceehHHHHHHHHHhcCcCCCcchhhhhhhhHHHHHH-
Q 003836 653 TLDQSH----------TNTAIRGTKGYVAPEWFRN-MPITVKVDVYSYGVLLLEIICLRRNIDNEISKVDKAILTDWAY- 720 (792)
Q Consensus 653 ~~~~~~----------~~~~~~gt~~y~aPE~~~~-~~~~~k~DV~S~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~- 720 (792)
...... ..+...+++.|+|||.+.+ ..++.++||||||+++|||++|+.||...........+.....
T Consensus 166 ~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~~g~~~~~~~~~~~~~~~~~~~~~~ 245 (311)
T cd07866 166 DGPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRRPILQGKSDIDQLHLIFKLCGT 245 (311)
T ss_pred cCCCcccccCCcccccccccceeccCcCChHHhhCCCccCchhHhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCC
Confidence 432211 1123456888999998765 4589999999999999999999999865433211111100000
Q ss_pred ---Hhhcc-cchhHhh----hchhcc---cCCHHHHHHHHHHHHHccccCCCCCCCHHhHHH
Q 003836 721 ---DRYQE-RTLEALV----ENDLEA---MNNVTMLHRFVMVAFWCIQEDPSHRPTMRKVTQ 771 (792)
Q Consensus 721 ---~~~~~-~~~~~~~----~~~~~~---~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~ 771 (792)
..+.. ..+.... ...... .......+.+.+++.+||+.+|++|||+.|++.
T Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~t~~ell~ 307 (311)
T cd07866 246 PTEETWPGWRSLPGCEGVHSFTNYPRTLEERFGKLGPEGLDLLSKLLSLDPYKRLTASDALE 307 (311)
T ss_pred CChhhchhhhhcccccccccCCCCCccHHHHcccCChhHHHHHHHHcccCcccCcCHHHHhc
Confidence 00000 0000000 000000 000122367889999999999999999999987
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic |
| >cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.6e-31 Score=289.51 Aligned_cols=264 Identities=19% Similarity=0.228 Sum_probs=191.9
Q ss_pred hhhhhhcCccccceEEEeeecCCCceEEEEEEcccccccchHHHHHHHHHhcccCCCCcccccceeccC-----------
Q 003836 503 RGFKEELGRGAFGTVYKGFVNMGSSNHVAVKKLNSVFQDSEKEFKAEVNGIGQTHHKNLVRLLGYCDEG----------- 571 (792)
Q Consensus 503 ~~~~~~lG~G~~g~Vy~g~~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~----------- 571 (792)
+.+.+.||+|+||.||+|... .+++.||+|++........+.+.+|++++++++|+||+++++++...
T Consensus 7 y~~~~~Lg~g~~g~vy~~~~~-~~~~~v~iK~i~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~~ 85 (342)
T cd07854 7 YMDLRPLGCGSNGLVFSAVDS-DCDKRVAVKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVYEVLGPSGSDLTEDVGSL 85 (342)
T ss_pred eEEEEEecCCCCEEEEEEEEC-CCCcEEEEEEEecCCCchHHHHHHHHHHHHhcCCCcchhhHhhhcccccccccccccc
Confidence 344578999999999999653 45679999998766556667899999999999999999999876543
Q ss_pred ---CceEEEEEeccCCCccccccCCCCCchhHHHHHHHHHHHHHHHHhhccCCCeEecCCCCCcEEEc-CCCCeEEeecC
Q 003836 572 ---QNRLLVYEFMSNGTVASFLFGDSKPNWKLRTEIAMGIAGGLFYLHEECCTQIIHCDIKPQNILLD-DHYNARISDFG 647 (792)
Q Consensus 572 ---~~~~lV~E~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dikp~NILl~-~~~~~kl~Dfg 647 (792)
...++|+||++ ++|.+++.. ..+++.....++.||+.||.|||+. +|+||||||+||+++ +++.+||+|||
T Consensus 86 ~~~~~~~lv~e~~~-~~L~~~~~~-~~l~~~~~~~~~~qi~~aL~~LH~~---givH~dikp~Nili~~~~~~~kl~dfg 160 (342)
T cd07854 86 TELNSVYIVQEYME-TDLANVLEQ-GPLSEEHARLFMYQLLRGLKYIHSA---NVLHRDLKPANVFINTEDLVLKIGDFG 160 (342)
T ss_pred cccceEEEEeeccc-ccHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEEcCCCceEEECCcc
Confidence 35789999997 488887754 4578999999999999999999998 999999999999997 45678999999
Q ss_pred CCccccCCCCCc--cccccccCCccccccccc-CCCCcccceehHHHHHHHHHhcCcCCCcchhhhhhhhHHH-HH----
Q 003836 648 LAKLLTLDQSHT--NTAIRGTKGYVAPEWFRN-MPITVKVDVYSYGVLLLEIICLRRNIDNEISKVDKAILTD-WA---- 719 (792)
Q Consensus 648 ~a~~~~~~~~~~--~~~~~gt~~y~aPE~~~~-~~~~~k~DV~S~Gv~l~el~tg~~p~~~~~~~~~~~~~~~-~~---- 719 (792)
+++......... .....++..|+|||.+.. ..++.++|||||||++|||++|+.||.............. .+
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~ 240 (342)
T cd07854 161 LARIVDPHYSHKGYLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFAGAHELEQMQLILESVPVVRE 240 (342)
T ss_pred cceecCCccccccccccccccccccCHHHHhCccccCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCh
Confidence 998654322111 122357889999998654 5688999999999999999999999965432211111000 00
Q ss_pred --HHhhcccchhHhhhchhcccC-----CHHHHHHHHHHHHHccccCCCCCCCHHhHHHH
Q 003836 720 --YDRYQERTLEALVENDLEAMN-----NVTMLHRFVMVAFWCIQEDPSHRPTMRKVTQM 772 (792)
Q Consensus 720 --~~~~~~~~~~~~~~~~~~~~~-----~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~ 772 (792)
..................... ......++.+++.+||+.+|.+|||++|+++.
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~h 300 (342)
T cd07854 241 EDRNELLNVIPSFVRNDGGEPRRPLRDLLPGVNPEALDFLEQILTFNPMDRLTAEEALMH 300 (342)
T ss_pred HHhhhhhhhhhhhhhhcccccCCCHHHHccCCCHHHHHHHHHHhCCCchhccCHHHHhCC
Confidence 000000000000000000000 11234678899999999999999999999863
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi |
| >KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.7e-33 Score=269.14 Aligned_cols=258 Identities=28% Similarity=0.379 Sum_probs=199.8
Q ss_pred CccccCHHHHHHHHhhhhhhcCccccceEEEeeecCCCceEEEEEEcccccc-cchHHHHHHHHHhccc-CCCCcccccc
Q 003836 489 NLRCFTYKELVEVTRGFKEELGRGAFGTVYKGFVNMGSSNHVAVKKLNSVFQ-DSEKEFKAEVNGIGQT-HHKNLVRLLG 566 (792)
Q Consensus 489 ~~~~~~~~el~~~~~~~~~~lG~G~~g~Vy~g~~~~~~~~~vavK~~~~~~~-~~~~~~~~Ei~~l~~l-~h~niv~l~g 566 (792)
+...|+-.+|++. ..||.|+||+|+|-. +..+++.+|||+++.... ..++++..|.+...+- +.||||+++|
T Consensus 57 ~~~~F~~~~Lqdl-----g~iG~G~fG~V~KM~-hk~sg~~mAVKrIr~~n~~keq~rll~e~d~~mks~~cp~IVkfyG 130 (361)
T KOG1006|consen 57 HLHTFTSDNLQDL-----GEIGNGAFGTVNKML-HKPSGKLMAVKRIRSNNIEKEQKRLLMEHDTVMKSSNCPNIVKFYG 130 (361)
T ss_pred cccccccchHHHH-----HHhcCCcchhhhhhh-cCccCcEEEEEEeeeccchHHHHHHHHHHHHHHhhcCCcHHHHHhh
Confidence 3445665565543 469999999999985 457789999999986544 5677899999876654 7999999999
Q ss_pred eeccCCceEEEEEeccCCCcccccc-----CCCCCchhHHHHHHHHHHHHHHHHhhccCCCeEecCCCCCcEEEcCCCCe
Q 003836 567 YCDEGQNRLLVYEFMSNGTVASFLF-----GDSKPNWKLRTEIAMGIAGGLFYLHEECCTQIIHCDIKPQNILLDDHYNA 641 (792)
Q Consensus 567 ~~~~~~~~~lV~E~~~~gsL~~~l~-----~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dikp~NILl~~~~~~ 641 (792)
.+..+..-++.||.|+- ||+.+.. .+..+++.-.-.|.....+||.||.+. ..||||||||+|||||..|.+
T Consensus 131 a~F~EGdcWiCMELMd~-SlDklYk~vy~vq~~~ipE~Ilg~ItvatV~AL~yLK~~--lkiIHRDvKPSNILldr~G~v 207 (361)
T KOG1006|consen 131 ALFSEGDCWICMELMDI-SLDKLYKRVYSVQKSRIPENILGHITVATVDALDYLKEE--LKIIHRDVKPSNILLDRHGDV 207 (361)
T ss_pred hhhcCCceeeeHHHHhh-hHHHHHHHHHHHHhccCcHhhhhheeeeehhHHHHHHHH--hhhhhccCChhheEEecCCCE
Confidence 99999999999999965 7776653 235788888888999999999999987 689999999999999999999
Q ss_pred EEeecCCCccccCCCCCccccccccCCccccccccc--CCCCcccceehHHHHHHHHHhcCcCCCcchhhhhhhhHHHHH
Q 003836 642 RISDFGLAKLLTLDQSHTNTAIRGTKGYVAPEWFRN--MPITVKVDVYSYGVLLLEIICLRRNIDNEISKVDKAILTDWA 719 (792)
Q Consensus 642 kl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~k~DV~S~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~ 719 (792)
||+|||++-.+.. +...+.-.|-..|||||.+.. ..|+.++||||||++|+|+.||+.|+..-.+..++
T Consensus 208 KLCDFGIcGqLv~--SiAkT~daGCrpYmAPERi~p~~~gyDiRSDvWSLGITL~EvAtG~fPyr~w~svfeq------- 278 (361)
T KOG1006|consen 208 KLCDFGICGQLVD--SIAKTVDAGCRPYMAPERIDPSDKGYDIRSDVWSLGITLYEVATGNFPYRKWDSVFEQ------- 278 (361)
T ss_pred eeecccchHhHHH--HHHhhhccCCccccChhccCCccCCcchhhhhhhhcceEeeeecCCCCcchHHHHHHH-------
Confidence 9999999876532 223344458889999999853 45999999999999999999999998643222111
Q ss_pred HHhhcccchhHhhhchh----cccCCHHHHHHHHHHHHHccccCCCCCCCHHhHHHH
Q 003836 720 YDRYQERTLEALVENDL----EAMNNVTMLHRFVMVAFWCIQEDPSHRPTMRKVTQM 772 (792)
Q Consensus 720 ~~~~~~~~~~~~~~~~~----~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~ 772 (792)
+..++..+. ......+.+..++.++-.||..|.++||...++.++
T Consensus 279 --------l~~Vv~gdpp~l~~~~~~~~~s~~~~~fintCl~Kd~~~Rpky~~Lk~~ 327 (361)
T KOG1006|consen 279 --------LCQVVIGDPPILLFDKECVHYSFSMVRFINTCLIKDRSDRPKYDDLKKF 327 (361)
T ss_pred --------HHHHHcCCCCeecCcccccccCHHHHHHHHHHhhcccccCcchhhhhcC
Confidence 111111111 111123467788999999999999999999988753
|
|
| >KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.1e-32 Score=287.14 Aligned_cols=243 Identities=24% Similarity=0.354 Sum_probs=197.0
Q ss_pred hhcCccccceEEEeeecCCCceEEEEEEcccc--cccchHHHHHHHHHhcccCCCCcccccceeccCCceEEEEEeccCC
Q 003836 507 EELGRGAFGTVYKGFVNMGSSNHVAVKKLNSV--FQDSEKEFKAEVNGIGQTHHKNLVRLLGYCDEGQNRLLVYEFMSNG 584 (792)
Q Consensus 507 ~~lG~G~~g~Vy~g~~~~~~~~~vavK~~~~~--~~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~lV~E~~~~g 584 (792)
++||+|-||+||-|+.. .+++.||||++.+. ....+.++.+|+.+|++++||.||.+--.|+..+..++|||-+.+.
T Consensus 570 evLGSGQFG~VYgg~hR-ktGrdVAvKvIdKlrFp~kqesqlR~EVaILq~l~HPGiV~le~M~ET~ervFVVMEKl~GD 648 (888)
T KOG4236|consen 570 EVLGSGQFGTVYGGKHR-KTGRDVAVKVIDKLRFPTKQESQLRNEVAILQNLHHPGIVNLECMFETPERVFVVMEKLHGD 648 (888)
T ss_pred hhccCCcceeeecceec-ccCceeeeeeeecccCCCchHHHHHHHHHHHHhcCCCCeeEEEEeecCCceEEEEehhhcch
Confidence 68999999999999765 56789999999763 3455678999999999999999999999999999999999999765
Q ss_pred CccccccC-CCCCchhHHHHHHHHHHHHHHHHhhccCCCeEecCCCCCcEEEcCC---CCeEEeecCCCccccCCCCCcc
Q 003836 585 TVASFLFG-DSKPNWKLRTEIAMGIAGGLFYLHEECCTQIIHCDIKPQNILLDDH---YNARISDFGLAKLLTLDQSHTN 660 (792)
Q Consensus 585 sL~~~l~~-~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dikp~NILl~~~---~~~kl~Dfg~a~~~~~~~~~~~ 660 (792)
-|.-.|.. ..++++..-..++.||+.||.|||.+ +|+|+||||+||||... -.+||+|||.|++..... -.
T Consensus 649 MLEMILSsEkgRL~er~TkFlvtQIL~ALr~LH~k---nIvHCDLKPENVLLas~~~FPQvKlCDFGfARiIgEks--FR 723 (888)
T KOG4236|consen 649 MLEMILSSEKGRLPERITKFLVTQILVALRYLHFK---NIVHCDLKPENVLLASASPFPQVKLCDFGFARIIGEKS--FR 723 (888)
T ss_pred HHHHHHHhhcccchHHHHHHHHHHHHHHHHHhhhc---ceeeccCCchheeeccCCCCCceeeccccceeecchhh--hh
Confidence 55555543 36788888888999999999999999 99999999999999755 369999999999875332 33
Q ss_pred ccccccCCcccccccccCCCCcccceehHHHHHHHHHhcCcCCCcchhhhhhhhHHHHHHHhhcccchhHhhhchhcccC
Q 003836 661 TAIRGTKGYVAPEWFRNMPITVKVDVYSYGVLLLEIICLRRNIDNEISKVDKAILTDWAYDRYQERTLEALVENDLEAMN 740 (792)
Q Consensus 661 ~~~~gt~~y~aPE~~~~~~~~~k~DV~S~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 740 (792)
..++|||.|+|||+++++.|...-|+||.||++|--++|..||....+..++..... ++-+ ...
T Consensus 724 rsVVGTPAYLaPEVLrnkGyNrSLDMWSVGVIiYVsLSGTFPFNEdEdIndQIQNAa-------------FMyP---p~P 787 (888)
T KOG4236|consen 724 RSVVGTPAYLAPEVLRNKGYNRSLDMWSVGVIIYVSLSGTFPFNEDEDINDQIQNAA-------------FMYP---PNP 787 (888)
T ss_pred hhhcCCccccCHHHHhhccccccccceeeeEEEEEEecccccCCCccchhHHhhccc-------------cccC---CCc
Confidence 457899999999999999999999999999999999999999975433222111100 1111 000
Q ss_pred CHHHHHHHHHHHHHccccCCCCCCCHHhHHH
Q 003836 741 NVTMLHRFVMVAFWCIQEDPSHRPTMRKVTQ 771 (792)
Q Consensus 741 ~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~ 771 (792)
=.+.+...+++|...||..-++|-|.++.+.
T Consensus 788 W~eis~~AidlIn~LLqVkm~kRysvdk~ls 818 (888)
T KOG4236|consen 788 WSEISPEAIDLINNLLQVKMRKRYSVDKSLS 818 (888)
T ss_pred hhhcCHHHHHHHHHHHHHHHHHhcchHhhcc
Confidence 1245567889999999999999999987765
|
|
| >KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=8.1e-32 Score=264.05 Aligned_cols=243 Identities=21% Similarity=0.242 Sum_probs=193.3
Q ss_pred hhcCccccceEEEeeecCCCceEEEEEEcccccccchHHHHHHHHHhccc-CCCCcccccceecc----CCceEEEEEec
Q 003836 507 EELGRGAFGTVYKGFVNMGSSNHVAVKKLNSVFQDSEKEFKAEVNGIGQT-HHKNLVRLLGYCDE----GQNRLLVYEFM 581 (792)
Q Consensus 507 ~~lG~G~~g~Vy~g~~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l-~h~niv~l~g~~~~----~~~~~lV~E~~ 581 (792)
++||-|-.|.|-.+. +..+++.+|+|++... ....+|++..-+. .|+|||.+++++.. .+.+++|||.|
T Consensus 68 qvLG~GinGkV~~C~-~k~T~ekfALKvL~Ds-----~KARrEVeLHw~~s~h~~iV~IidVyeNs~~~rkcLLiVmE~m 141 (400)
T KOG0604|consen 68 QVLGAGINGKVVQCV-HKRTQEKFALKVLLDS-----PKARREVELHWMASGHPHIVSIIDVYENSYQGRKCLLIVMECM 141 (400)
T ss_pred hhhccccCCceEEEE-eccchhhhHHHHHhcC-----HHHHhHhhhhhhhcCCCceEEeehhhhhhccCceeeEeeeecc
Confidence 689999999999885 4567789999998653 4567888876665 59999999998854 45678999999
Q ss_pred cCCCccccccCCC--CCchhHHHHHHHHHHHHHHHHhhccCCCeEecCCCCCcEEEcC---CCCeEEeecCCCccccCCC
Q 003836 582 SNGTVASFLFGDS--KPNWKLRTEIAMGIAGGLFYLHEECCTQIIHCDIKPQNILLDD---HYNARISDFGLAKLLTLDQ 656 (792)
Q Consensus 582 ~~gsL~~~l~~~~--~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dikp~NILl~~---~~~~kl~Dfg~a~~~~~~~ 656 (792)
+||.|...+.++. .+++++..+|+.||+.|+.|||+. .|.||||||+|+|... |-.+||+|||+|+.-..
T Consensus 142 eGGeLfsriq~~g~~afTErea~eI~~qI~~Av~~lH~~---nIAHRDlKpENLLyt~t~~na~lKLtDfGFAK~t~~-- 216 (400)
T KOG0604|consen 142 EGGELFSRIQDRGDQAFTEREASEIMKQIGLAVRYLHSM---NIAHRDLKPENLLYTTTSPNAPLKLTDFGFAKETQE-- 216 (400)
T ss_pred cchHHHHHHHHcccccchHHHHHHHHHHHHHHHHHHHhc---chhhccCChhheeeecCCCCcceEecccccccccCC--
Confidence 9999999997764 589999999999999999999998 9999999999999974 45699999999997543
Q ss_pred CCccccccccCCcccccccccCCCCcccceehHHHHHHHHHhcCcCCCcchhhhhhhhHHHHHHHhhcccchhHhhhchh
Q 003836 657 SHTNTAIRGTKGYVAPEWFRNMPITVKVDVYSYGVLLLEIICLRRNIDNEISKVDKAILTDWAYDRYQERTLEALVENDL 736 (792)
Q Consensus 657 ~~~~~~~~gt~~y~aPE~~~~~~~~~k~DV~S~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 736 (792)
.....+.+-||.|.|||++...+|+...|+||+||++|-|++|-.||......... .+.-..+.....
T Consensus 217 ~~~L~TPc~TPyYvaPevlg~eKydkscdmwSlgVimYIlLCGyPPFYS~hg~ais------------pgMk~rI~~gqy 284 (400)
T KOG0604|consen 217 PGDLMTPCFTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAIS------------PGMKRRIRTGQY 284 (400)
T ss_pred CccccCCcccccccCHHHhCchhcCCCCCccchhHHHHHhhcCCCcccccCCccCC------------hhHHhHhhccCc
Confidence 23334556799999999999999999999999999999999999999765432111 011111111111
Q ss_pred cccCC--HHHHHHHHHHHHHccccCCCCCCCHHhHHHH
Q 003836 737 EAMNN--VTMLHRFVMVAFWCIQEDPSHRPTMRKVTQM 772 (792)
Q Consensus 737 ~~~~~--~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~ 772 (792)
.-..+ ...++...++++.+|..+|.+|.|+.|++..
T Consensus 285 ~FP~pEWs~VSe~aKdlIR~LLkt~PteRlTI~~~m~h 322 (400)
T KOG0604|consen 285 EFPEPEWSCVSEAAKDLIRKLLKTEPTERLTIEEVMDH 322 (400)
T ss_pred cCCChhHhHHHHHHHHHHHHHhcCCchhheeHHHhhcC
Confidence 11111 2356788899999999999999999999874
|
|
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=7.6e-32 Score=291.19 Aligned_cols=238 Identities=24% Similarity=0.260 Sum_probs=195.7
Q ss_pred hhhhhhcCccccceEEEeeecCCCceEEEEEEcccccccchHHHHHHHHHhccc-CCCCcccccceeccCCceEEEEEec
Q 003836 503 RGFKEELGRGAFGTVYKGFVNMGSSNHVAVKKLNSVFQDSEKEFKAEVNGIGQT-HHKNLVRLLGYCDEGQNRLLVYEFM 581 (792)
Q Consensus 503 ~~~~~~lG~G~~g~Vy~g~~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l-~h~niv~l~g~~~~~~~~~lV~E~~ 581 (792)
+.+...+|.|+|+.|-++.. ..+.+..+||++.+. ..+..+|+.++.+. +|+||+++.+.+.++.+.++|||.+
T Consensus 324 y~~~~~~~~gs~s~~~~~~~-~~t~~~~~vkii~~~----~~~~~~e~~~~~~~~~h~niv~~~~v~~~~~~~~~v~e~l 398 (612)
T KOG0603|consen 324 YEFREELGEGSFSAVKYCES-SPTDQEPAVKIISKR----ADDNQDEIPISLLVRDHPNIVKSHDVYEDGKEIYLVMELL 398 (612)
T ss_pred hccccccCCCCccceeeeec-cccccchhheecccc----ccccccccchhhhhcCCCcceeecceecCCceeeeeehhc
Confidence 34556799999999999864 456678999999765 23456677666665 7999999999999999999999999
Q ss_pred cCCCccccccCCCCCchhHHHHHHHHHHHHHHHHhhccCCCeEecCCCCCcEEE-cCCCCeEEeecCCCccccCCCCCcc
Q 003836 582 SNGTVASFLFGDSKPNWKLRTEIAMGIAGGLFYLHEECCTQIIHCDIKPQNILL-DDHYNARISDFGLAKLLTLDQSHTN 660 (792)
Q Consensus 582 ~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dikp~NILl-~~~~~~kl~Dfg~a~~~~~~~~~~~ 660 (792)
.++-|.+.+....... ..+..|+.+|+.|+.|||++ ++|||||||+|||+ ++.++++|+|||.++..... .
T Consensus 399 ~g~ell~ri~~~~~~~-~e~~~w~~~lv~Av~~LH~~---gvvhRDLkp~NIL~~~~~g~lrltyFG~a~~~~~~----~ 470 (612)
T KOG0603|consen 399 DGGELLRRIRSKPEFC-SEASQWAAELVSAVDYLHEQ---GVVHRDLKPGNILLDGSAGHLRLTYFGFWSELERS----C 470 (612)
T ss_pred cccHHHHHHHhcchhH-HHHHHHHHHHHHHHHHHHhc---CeeecCCChhheeecCCCCcEEEEEechhhhCchh----h
Confidence 9998888887665555 77778999999999999999 99999999999999 58899999999999987654 2
Q ss_pred ccccccCCcccccccccCCCCcccceehHHHHHHHHHhcCcCCCcchhhhhhhhHHHHHHHhhcccchhHhhhchhcccC
Q 003836 661 TAIRGTKGYVAPEWFRNMPITVKVDVYSYGVLLLEIICLRRNIDNEISKVDKAILTDWAYDRYQERTLEALVENDLEAMN 740 (792)
Q Consensus 661 ~~~~gt~~y~aPE~~~~~~~~~k~DV~S~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 740 (792)
...+-|..|.|||++....+++++|+||||++||+|++|+.||.....+ .++......+..
T Consensus 471 ~tp~~t~~y~APEvl~~~~yt~acD~WSLGvlLy~ML~G~tp~~~~P~~-------------------~ei~~~i~~~~~ 531 (612)
T KOG0603|consen 471 DTPALTLQYVAPEVLAIQEYTEACDWWSLGVLLYEMLTGRTLFAAHPAG-------------------IEIHTRIQMPKF 531 (612)
T ss_pred cccchhhcccChhhhccCCCCcchhhHHHHHHHHHHHhCCCccccCCch-------------------HHHHHhhcCCcc
Confidence 2334588999999999999999999999999999999999999765443 111112222223
Q ss_pred CHHHHHHHHHHHHHccccCCCCCCCHHhHHHH
Q 003836 741 NVTMLHRFVMVAFWCIQEDPSHRPTMRKVTQM 772 (792)
Q Consensus 741 ~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~ 772 (792)
....+....+|+.+||+.||.+||+|.++...
T Consensus 532 s~~vS~~AKdLl~~LL~~dP~~Rl~~~~i~~h 563 (612)
T KOG0603|consen 532 SECVSDEAKDLLQQLLQVDPALRLGADEIGAH 563 (612)
T ss_pred ccccCHHHHHHHHHhccCChhhCcChhhhccC
Confidence 35567788999999999999999999999874
|
|
| >KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=7.4e-32 Score=304.87 Aligned_cols=264 Identities=20% Similarity=0.225 Sum_probs=214.7
Q ss_pred hhhhhcCccccceEEEeeecCCCceEEEEEEcccc---cccchHHHHHHHHHhcccCCCCcccccceeccCCceEEEEEe
Q 003836 504 GFKEELGRGAFGTVYKGFVNMGSSNHVAVKKLNSV---FQDSEKEFKAEVNGIGQTHHKNLVRLLGYCDEGQNRLLVYEF 580 (792)
Q Consensus 504 ~~~~~lG~G~~g~Vy~g~~~~~~~~~vavK~~~~~---~~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~lV~E~ 580 (792)
.+.++||+|+||.|..++. ..+++.+|+|++.+. .+....-|.+|-.+|..-+.+=|+.++-.|.+..++|+||||
T Consensus 78 eilKvIGrGaFGEV~lVr~-k~t~~VYAMK~lnK~eMlKr~~tA~F~EERDimv~~ns~Wiv~LhyAFQD~~~LYlVMdY 156 (1317)
T KOG0612|consen 78 EILKVIGRGAFGEVALVRH-KSTEKVYAMKILNKWEMLKRAETACFREERDIMVFGNSEWIVQLHYAFQDERYLYLVMDY 156 (1317)
T ss_pred HHHHHhcccccceeEEEEe-eccccchhHHHhhHHHHhhchhHHHHHHHhHHHHcCCcHHHHHHHHHhcCccceEEEEec
Confidence 3468899999999999875 466789999999873 344556799999999998999999999999999999999999
Q ss_pred ccCCCccccccCCCCCchhHHHHHHHHHHHHHHHHhhccCCCeEecCCCCCcEEEcCCCCeEEeecCCCccccCCCCCcc
Q 003836 581 MSNGTVASFLFGDSKPNWKLRTEIAMGIAGGLFYLHEECCTQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLDQSHTN 660 (792)
Q Consensus 581 ~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dikp~NILl~~~~~~kl~Dfg~a~~~~~~~~~~~ 660 (792)
|+||+|-.+|.+..++++.....++..|.-||.-||+. |+|||||||+|||||..|++||+|||.+-.+..+..-..
T Consensus 157 ~pGGDlltLlSk~~~~pE~~ArFY~aEiVlAldslH~m---gyVHRDiKPDNvLld~~GHikLADFGsClkm~~dG~V~s 233 (1317)
T KOG0612|consen 157 MPGGDLLTLLSKFDRLPEDWARFYTAEIVLALDSLHSM---GYVHRDIKPDNVLLDKSGHIKLADFGSCLKMDADGTVRS 233 (1317)
T ss_pred ccCchHHHHHhhcCCChHHHHHHHHHHHHHHHHHHHhc---cceeccCCcceeEecccCcEeeccchhHHhcCCCCcEEe
Confidence 99999999998777899999999999999999999998 999999999999999999999999999988877766666
Q ss_pred ccccccCCcccccccc----c-CCCCcccceehHHHHHHHHHhcCcCCCcchhhhhhhhHHHHHHHhhcccchhHhhhch
Q 003836 661 TAIRGTKGYVAPEWFR----N-MPITVKVDVYSYGVLLLEIICLRRNIDNEISKVDKAILTDWAYDRYQERTLEALVEND 735 (792)
Q Consensus 661 ~~~~gt~~y~aPE~~~----~-~~~~~k~DV~S~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 735 (792)
...+|||-|.+||+++ + +.|++.+|.||+||++|||+.|..||..+.-......+..+ ...
T Consensus 234 ~~aVGTPDYISPEvLqs~~~~~g~yG~ecDwWSlGV~~YEMlyG~TPFYadslveTY~KIm~h--------------k~~ 299 (1317)
T KOG0612|consen 234 SVAVGTPDYISPEVLQSQGDGKGEYGRECDWWSLGVFMYEMLYGETPFYADSLVETYGKIMNH--------------KES 299 (1317)
T ss_pred ccccCCCCccCHHHHHhhcCCccccCCccchhhhHHHHHHHHcCCCcchHHHHHHHHHHHhch--------------hhh
Confidence 6778999999999985 3 57999999999999999999999999765332221111111 111
Q ss_pred hcccCCHHHHHHHHHHHHHccccCCCCCCC---HHhHHHHh-------ccCcCCCCCCCCC
Q 003836 736 LEAMNNVTMLHRFVMVAFWCIQEDPSHRPT---MRKVTQML-------EGVVEVPIPPCPW 786 (792)
Q Consensus 736 ~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs---~~evl~~L-------~~~~~~~~p~~P~ 786 (792)
+..+...+.++...+||+..+. +|+.|.. ++++.... +.+.+..+|-.|-
T Consensus 300 l~FP~~~~VSeeakdLI~~ll~-~~e~RLgrngiedik~HpFF~g~~W~~iR~~~pP~vPe 359 (1317)
T KOG0612|consen 300 LSFPDETDVSEEAKDLIEALLC-DREVRLGRNGIEDIKNHPFFEGIDWDNIRESVPPVVPE 359 (1317)
T ss_pred cCCCcccccCHHHHHHHHHHhc-ChhhhcccccHHHHHhCccccCCChhhhhhcCCCCCCc
Confidence 1222223467778888888775 6788887 88888753 4456666666664
|
|
| >cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.1e-31 Score=285.36 Aligned_cols=258 Identities=22% Similarity=0.264 Sum_probs=191.0
Q ss_pred hhhhcCccccceEEEeeecCCCceEEEEEEccccc--ccchHHHHHHHHHhcccCCCCcccccceecc-CCceEEEEEec
Q 003836 505 FKEELGRGAFGTVYKGFVNMGSSNHVAVKKLNSVF--QDSEKEFKAEVNGIGQTHHKNLVRLLGYCDE-GQNRLLVYEFM 581 (792)
Q Consensus 505 ~~~~lG~G~~g~Vy~g~~~~~~~~~vavK~~~~~~--~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~-~~~~~lV~E~~ 581 (792)
+.+.||+|+||.||++... .+++.+|+|++.... ....+.+.+|++++++++||||+++++++.. ....++|+||+
T Consensus 14 ~~~~ig~g~~g~v~~~~~~-~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~lv~e~~ 92 (328)
T cd07856 14 DLQPVGMGAFGLVCSARDQ-LTGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHLRHENIISLSDIFISPLEDIYFVTELL 92 (328)
T ss_pred EEEeecccCCeEEEEEEEC-CCCCEEEEEEecccccccchhHHHHHHHHHHHhcCCCCeeeEeeeEecCCCcEEEEeehh
Confidence 4578999999999999643 456789999886432 2345678899999999999999999998865 56789999998
Q ss_pred cCCCccccccCCCCCchhHHHHHHHHHHHHHHHHhhccCCCeEecCCCCCcEEEcCCCCeEEeecCCCccccCCCCCccc
Q 003836 582 SNGTVASFLFGDSKPNWKLRTEIAMGIAGGLFYLHEECCTQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLDQSHTNT 661 (792)
Q Consensus 582 ~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dikp~NILl~~~~~~kl~Dfg~a~~~~~~~~~~~~ 661 (792)
+++|.+++.. ..+++.....++.|++.||+|||+. +|+|+||+|+|||+++++.+||+|||.++.... ...
T Consensus 93 -~~~L~~~~~~-~~~~~~~~~~~~~ql~~aL~~LH~~---~iiH~dl~p~Nili~~~~~~~l~dfg~~~~~~~----~~~ 163 (328)
T cd07856 93 -GTDLHRLLTS-RPLEKQFIQYFLYQILRGLKYVHSA---GVVHRDLKPSNILINENCDLKICDFGLARIQDP----QMT 163 (328)
T ss_pred -ccCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEeECCCCCEEeCccccccccCC----CcC
Confidence 4588887754 3567888889999999999999998 999999999999999999999999999875422 112
Q ss_pred cccccCCccccccccc-CCCCcccceehHHHHHHHHHhcCcCCCcchhhhhhhhHHHHH-------HHhhcccchhHhhh
Q 003836 662 AIRGTKGYVAPEWFRN-MPITVKVDVYSYGVLLLEIICLRRNIDNEISKVDKAILTDWA-------YDRYQERTLEALVE 733 (792)
Q Consensus 662 ~~~gt~~y~aPE~~~~-~~~~~k~DV~S~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~-------~~~~~~~~~~~~~~ 733 (792)
...++..|+|||.+.+ ..++.++||||||++++||++|+.||...........+.... ...........+..
T Consensus 164 ~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 243 (328)
T cd07856 164 GYVSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGKPLFPGKDHVNQFSIITDLLGTPPDDVINTICSENTLRFVQ 243 (328)
T ss_pred CCcccccccCceeeeccCCcCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhccchhhHHHHh
Confidence 3456889999998866 568999999999999999999999986543211111111000 00000011111111
Q ss_pred c-hhcccCC-----HHHHHHHHHHHHHccccCCCCCCCHHhHHHH
Q 003836 734 N-DLEAMNN-----VTMLHRFVMVAFWCIQEDPSHRPTMRKVTQM 772 (792)
Q Consensus 734 ~-~~~~~~~-----~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~ 772 (792)
. ......+ ......+.+++.+||+.+|++||++++++..
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~ell~~ 288 (328)
T cd07856 244 SLPKREPVPFSEKFKNADPSAIDLLEKMLVFDPQKRISAAEALAH 288 (328)
T ss_pred hccccCCCcHHHHcCCCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 0 0011111 1234678999999999999999999999875
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U |
| >KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.1e-31 Score=292.01 Aligned_cols=197 Identities=29% Similarity=0.407 Sum_probs=170.4
Q ss_pred hhhcCccccceEEEeeecCCCceEEEEEEcccccc-cchHHHHHHHHHhcccCCCCcccccceeccCC------ceEEEE
Q 003836 506 KEELGRGAFGTVYKGFVNMGSSNHVAVKKLNSVFQ-DSEKEFKAEVNGIGQTHHKNLVRLLGYCDEGQ------NRLLVY 578 (792)
Q Consensus 506 ~~~lG~G~~g~Vy~g~~~~~~~~~vavK~~~~~~~-~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~------~~~lV~ 578 (792)
.+.||+|+||.||+|. +..+++.||||.+.+... ...+...+|++++++++|+|||++.+.-++.. ...+||
T Consensus 18 ~e~LG~Ga~g~V~rgr-nketG~~vAvK~~~~~~~~r~~e~~~~EieilkKLnh~NIVk~f~iee~~~~~~~~~~~vlvm 96 (732)
T KOG4250|consen 18 DERLGKGAFGNVYRGR-NKETGRLVAVKTFNKESSLRPRERWCREIEILKKLNHPNIVKLFDIEETKFLGLVTRLPVLVM 96 (732)
T ss_pred hhhhcCCccceeeeec-ccccccchhHHhhhhhcccchHHHHHHHHHHHHHcCchhhhhhcccCCccccCcccccceEEE
Confidence 4679999999999996 456789999999987543 33456789999999999999999999876544 568999
Q ss_pred EeccCCCccccccCC---CCCchhHHHHHHHHHHHHHHHHhhccCCCeEecCCCCCcEEEc--CCC--CeEEeecCCCcc
Q 003836 579 EFMSNGTVASFLFGD---SKPNWKLRTEIAMGIAGGLFYLHEECCTQIIHCDIKPQNILLD--DHY--NARISDFGLAKL 651 (792)
Q Consensus 579 E~~~~gsL~~~l~~~---~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dikp~NILl~--~~~--~~kl~Dfg~a~~ 651 (792)
|||.+|||...|.+. ..+++...+.+..+++.||.|||+. +|+||||||.||++- ++| .-||+|||.||.
T Consensus 97 EyC~gGsL~~~L~~PEN~~GLpE~e~l~lL~d~~~al~~LrEn---~IvHRDlKP~NIvl~~Gedgq~IyKLtDfG~Are 173 (732)
T KOG4250|consen 97 EYCSGGSLRKVLNSPENAYGLPESEFLDLLSDLVSALRHLREN---GIVHRDLKPGNIVLQIGEDGQSIYKLTDFGAARE 173 (732)
T ss_pred eecCCCcHHHHhcCcccccCCCHHHHHHHHHHHHHHHHHHHHc---CceeccCCCCcEEEeecCCCceEEeeeccccccc
Confidence 999999999999764 4689999999999999999999998 999999999999984 333 479999999998
Q ss_pred ccCCCCCccccccccCCccccccccc-CCCCcccceehHHHHHHHHHhcCcCCCcchh
Q 003836 652 LTLDQSHTNTAIRGTKGYVAPEWFRN-MPITVKVDVYSYGVLLLEIICLRRNIDNEIS 708 (792)
Q Consensus 652 ~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~k~DV~S~Gv~l~el~tg~~p~~~~~~ 708 (792)
+..+. ....+.||+.|++||.+.. +.|+..+|.|||||++||.+||..||.+...
T Consensus 174 l~d~s--~~~S~vGT~~YLhPel~E~q~~y~~tVDLWS~GvtlY~caTG~lPF~p~~~ 229 (732)
T KOG4250|consen 174 LDDNS--LFTSLVGTEEYLHPELYERQKKYTATVDLWSFGVTLYECATGELPFIPFGG 229 (732)
T ss_pred CCCCC--eeeeecCchhhcChHHHhhccCcCceeehhhhhhHHHHHhccCCCCCcCCC
Confidence 76443 5667889999999999985 8899999999999999999999999976543
|
|
| >cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=9.2e-31 Score=284.11 Aligned_cols=265 Identities=21% Similarity=0.241 Sum_probs=192.2
Q ss_pred hhhhhcCccccceEEEeeecCC-CceEEEEEEccccc--ccchHHHHHHHHHhccc-CCCCcccccceecc----CCceE
Q 003836 504 GFKEELGRGAFGTVYKGFVNMG-SSNHVAVKKLNSVF--QDSEKEFKAEVNGIGQT-HHKNLVRLLGYCDE----GQNRL 575 (792)
Q Consensus 504 ~~~~~lG~G~~g~Vy~g~~~~~-~~~~vavK~~~~~~--~~~~~~~~~Ei~~l~~l-~h~niv~l~g~~~~----~~~~~ 575 (792)
.+.+.||+|+||.||++..... .+..+|+|++.... ....+.+.+|+++++++ +|+||+++++.+.. ....+
T Consensus 3 ~~~~~lg~G~~g~vy~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~~~~ 82 (332)
T cd07857 3 ELIKELGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKILAKRALRELKLLRHFRGHKNITCLYDMDIVFPGNFNELY 82 (332)
T ss_pred eEEEEccccCCeEEEEEEeCCCCcCceEEEEEeccccccchhHHHHHHHHHHHHHhcCCCChheeeeeeeeccccCCcEE
Confidence 3457899999999999976432 15689999987532 22356788999999999 59999999987543 24578
Q ss_pred EEEEeccCCCccccccCCCCCchhHHHHHHHHHHHHHHHHhhccCCCeEecCCCCCcEEEcCCCCeEEeecCCCccccCC
Q 003836 576 LVYEFMSNGTVASFLFGDSKPNWKLRTEIAMGIAGGLFYLHEECCTQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLD 655 (792)
Q Consensus 576 lV~E~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dikp~NILl~~~~~~kl~Dfg~a~~~~~~ 655 (792)
+++||+. ++|.+++.....+++..+..++.||+.||.|||+. +|+||||||+|||++.++.+||+|||+++.....
T Consensus 83 ~~~e~~~-~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~---givH~dlkp~Nili~~~~~~kl~Dfg~a~~~~~~ 158 (332)
T cd07857 83 LYEELME-ADLHQIIRSGQPLTDAHFQSFIYQILCGLKYIHSA---NVLHRDLKPGNLLVNADCELKICDFGLARGFSEN 158 (332)
T ss_pred EEEeccc-CCHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHeEEcCCCCEEeCcCCCceecccc
Confidence 8889886 58999998778899999999999999999999998 9999999999999999999999999999876432
Q ss_pred CCC---ccccccccCCccccccccc-CCCCcccceehHHHHHHHHHhcCcCCCcchhhhhhhhHHHH-------HHHhhc
Q 003836 656 QSH---TNTAIRGTKGYVAPEWFRN-MPITVKVDVYSYGVLLLEIICLRRNIDNEISKVDKAILTDW-------AYDRYQ 724 (792)
Q Consensus 656 ~~~---~~~~~~gt~~y~aPE~~~~-~~~~~k~DV~S~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~-------~~~~~~ 724 (792)
... ......|++.|+|||.+.+ ..++.++|||||||++|+|++|+.||............... ......
T Consensus 159 ~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slGv~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (332)
T cd07857 159 PGENAGFMTEYVATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRKPVFKGKDYVDQLNQILQVLGTPDEETLSRIG 238 (332)
T ss_pred cccccccccCcccCccccCcHHHhCCCCCCcHHHHHHHHHHHHHHHhCCcCCCCCCHHHHHHHHHHHhCCCCHHHHHhhh
Confidence 221 1223468999999998765 56899999999999999999999998654321100000000 000000
Q ss_pred ccchhHhhhchhc-cc-----CCHHHHHHHHHHHHHccccCCCCCCCHHhHHHH
Q 003836 725 ERTLEALVENDLE-AM-----NNVTMLHRFVMVAFWCIQEDPSHRPTMRKVTQM 772 (792)
Q Consensus 725 ~~~~~~~~~~~~~-~~-----~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~ 772 (792)
............. .. ........+.+++.+||+.+|.+|||+.++++.
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~ll~~ 292 (332)
T cd07857 239 SPKAQNYIRSLPNIPKKPFESIFPNANPLALDLLEKLLAFDPTKRISVEEALEH 292 (332)
T ss_pred hhhHHHHHHhccccCCcchHhhCCCCCHHHHHHHHHHccCCcccCCCHHHHhcC
Confidence 0000000000000 00 001124678899999999999999999998853
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co |
| >cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.8e-31 Score=272.68 Aligned_cols=221 Identities=20% Similarity=0.143 Sum_probs=177.8
Q ss_pred cccceEEEeeecCCCceEEEEEEcccccccchHHHHHHHHHhcccCCCCcccccceeccCCceEEEEEeccCCCcccccc
Q 003836 512 GAFGTVYKGFVNMGSSNHVAVKKLNSVFQDSEKEFKAEVNGIGQTHHKNLVRLLGYCDEGQNRLLVYEFMSNGTVASFLF 591 (792)
Q Consensus 512 G~~g~Vy~g~~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~lV~E~~~~gsL~~~l~ 591 (792)
|.++.||++.. ..+++.+|+|++.... .+.+|...+....||||+++++++.+.+..++||||+++|+|.+++.
T Consensus 4 g~~~~v~~~~~-~~~~~~~~~K~i~~~~-----~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~ 77 (237)
T cd05576 4 GVIDKVLLVMD-TRTQQTFILKGLRKSS-----EYSRERLTIIPHCVPNMVCLHKYIVSEDSVFLVLQHAEGGKLWSHIS 77 (237)
T ss_pred cccceEEEEEE-ccCCcEEEEEeecchh-----hhhhHHHHHHhcCCCceeehhhheecCCeEEEEEecCCCCCHHHHHH
Confidence 88999999965 4556789999987542 33445555556679999999999999999999999999999999997
Q ss_pred CCCCCchhHHHHHHHHHHHHHHHHhhccCCCeEecCCCCCcEEEcCCCCeEEeecCCCccccCCCCCccccccccCCccc
Q 003836 592 GDSKPNWKLRTEIAMGIAGGLFYLHEECCTQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLDQSHTNTAIRGTKGYVA 671 (792)
Q Consensus 592 ~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dikp~NILl~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~gt~~y~a 671 (792)
....+++..+..++.|++.||.|||+. +|+||||||+||+++.++.++++|||.+...... .....++..|+|
T Consensus 78 ~~~~l~~~~~~~~~~ql~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~~l~df~~~~~~~~~----~~~~~~~~~y~a 150 (237)
T cd05576 78 KFLNIPEECVKRWAAEMVVALDALHRE---GIVCRDLNPNNILLDDRGHIQLTYFSRWSEVEDS----CDGEAVENMYCA 150 (237)
T ss_pred HhcCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHEEEcCCCCEEEecccchhccccc----cccCCcCccccC
Confidence 777789999999999999999999998 9999999999999999999999999988655432 122335678999
Q ss_pred ccccccCCCCcccceehHHHHHHHHHhcCcCCCcchhhhhhhhHHHHHHHhhcccchhHhhhchhcccCCHHHHHHHHHH
Q 003836 672 PEWFRNMPITVKVDVYSYGVLLLEIICLRRNIDNEISKVDKAILTDWAYDRYQERTLEALVENDLEAMNNVTMLHRFVMV 751 (792)
Q Consensus 672 PE~~~~~~~~~k~DV~S~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 751 (792)
||.+....++.++||||+|+++|||++|+.|+........ .......+......+.++
T Consensus 151 PE~~~~~~~~~~~DvwslG~il~el~~g~~~~~~~~~~~~----------------------~~~~~~~~~~~~~~~~~l 208 (237)
T cd05576 151 PEVGGISEETEACDWWSLGAILFELLTGKTLVECHPSGIN----------------------THTTLNIPEWVSEEARSL 208 (237)
T ss_pred CcccCCCCCCchhhHHHHHHHHHHHHHCcchhhcCchhcc----------------------cccccCCcccCCHHHHHH
Confidence 9999888899999999999999999999987643211100 000001122345678899
Q ss_pred HHHccccCCCCCCCHH
Q 003836 752 AFWCIQEDPSHRPTMR 767 (792)
Q Consensus 752 ~~~Cl~~~p~~RPs~~ 767 (792)
+.+||+.||++||++.
T Consensus 209 i~~~l~~dp~~R~~~~ 224 (237)
T cd05576 209 LQQLLQFNPTERLGAG 224 (237)
T ss_pred HHHHccCCHHHhcCCC
Confidence 9999999999999973
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha |
| >cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=7.4e-31 Score=286.08 Aligned_cols=258 Identities=22% Similarity=0.274 Sum_probs=192.8
Q ss_pred hhhhcCccccceEEEeeecCCCceEEEEEEccccc--ccchHHHHHHHHHhcccCCCCcccccceeccCCc------eEE
Q 003836 505 FKEELGRGAFGTVYKGFVNMGSSNHVAVKKLNSVF--QDSEKEFKAEVNGIGQTHHKNLVRLLGYCDEGQN------RLL 576 (792)
Q Consensus 505 ~~~~lG~G~~g~Vy~g~~~~~~~~~vavK~~~~~~--~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~------~~l 576 (792)
+.+.||+|++|.||+|... .+++.+|+|++.... ....+.+.+|+.++++++|+||+++++++...+. .++
T Consensus 19 ~~~~ig~g~~g~vy~~~~~-~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~l 97 (343)
T cd07851 19 NLSPVGSGAYGQVCSAFDT-KTGRKVAIKKLSRPFQSAIHAKRTYRELRLLKHMDHENVIGLLDVFTPASSLEDFQDVYL 97 (343)
T ss_pred EEEEeccCCceEEEEEEEC-CCCcEEEEEecccccchhhHHHHHHHHHHHHHhccCCCHHHHHHHhhccccccccccEEE
Confidence 4567999999999999764 356789999986532 2334667889999999999999999998876654 899
Q ss_pred EEEeccCCCccccccCCCCCchhHHHHHHHHHHHHHHHHhhccCCCeEecCCCCCcEEEcCCCCeEEeecCCCccccCCC
Q 003836 577 VYEFMSNGTVASFLFGDSKPNWKLRTEIAMGIAGGLFYLHEECCTQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLDQ 656 (792)
Q Consensus 577 V~E~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dikp~NILl~~~~~~kl~Dfg~a~~~~~~~ 656 (792)
|+||+ +++|.+++.. ..+++..+..++.|+++||.|||+. +|+|+||||+||++++++.+||+|||++......
T Consensus 98 v~e~~-~~~L~~~~~~-~~l~~~~~~~~~~ql~~aL~~LH~~---gi~H~dlkp~Nill~~~~~~kL~dfg~~~~~~~~- 171 (343)
T cd07851 98 VTHLM-GADLNNIVKC-QKLSDDHIQFLVYQILRGLKYIHSA---GIIHRDLKPSNIAVNEDCELKILDFGLARHTDDE- 171 (343)
T ss_pred EEecC-CCCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEECCCCCEEEcccccccccccc-
Confidence 99998 5689888865 4689999999999999999999998 9999999999999999999999999999865432
Q ss_pred CCccccccccCCccccccccc-CCCCcccceehHHHHHHHHHhcCcCCCcchhhhhhhhHHHH-------HHHhhcccch
Q 003836 657 SHTNTAIRGTKGYVAPEWFRN-MPITVKVDVYSYGVLLLEIICLRRNIDNEISKVDKAILTDW-------AYDRYQERTL 728 (792)
Q Consensus 657 ~~~~~~~~gt~~y~aPE~~~~-~~~~~k~DV~S~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~-------~~~~~~~~~~ 728 (792)
.....++..|+|||.+.+ ..++.++||||||+++||+++|+.||...........+... ..........
T Consensus 172 ---~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~ 248 (343)
T cd07851 172 ---MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGKTLFPGSDHIDQLKRIMNLVGTPDEELLQKISSESA 248 (343)
T ss_pred ---ccCCcccccccCHHHHhCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCHHHHhhccchhH
Confidence 223457889999999865 46789999999999999999999999654322111100000 0000111111
Q ss_pred hHhhhchhcc---c---CCHHHHHHHHHHHHHccccCCCCCCCHHhHHHH
Q 003836 729 EALVENDLEA---M---NNVTMLHRFVMVAFWCIQEDPSHRPTMRKVTQM 772 (792)
Q Consensus 729 ~~~~~~~~~~---~---~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~ 772 (792)
..++...... . .....+.++.+++.+||+.+|.+|||+.||++.
T Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~s~~l~dli~~~l~~~P~~Rpt~~ell~h 298 (343)
T cd07851 249 RNYIQSLPQMPKKDFKEVFSGANPLAIDLLEKMLVLDPDKRITAAEALAH 298 (343)
T ss_pred HHHHHhccccCCCCHHHHhccCCHHHHHHHHHhCCCChhhCCCHHHHhcC
Confidence 1111110000 0 001235788999999999999999999999873
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK |
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=99.97 E-value=2e-31 Score=303.88 Aligned_cols=245 Identities=28% Similarity=0.395 Sum_probs=182.1
Q ss_pred hhcCccccceEEEeeecCCCceEEEEEEccccc-ccchHHHHHHHHHhcccCCCCcccccceecc---------------
Q 003836 507 EELGRGAFGTVYKGFVNMGSSNHVAVKKLNSVF-QDSEKEFKAEVNGIGQTHHKNLVRLLGYCDE--------------- 570 (792)
Q Consensus 507 ~~lG~G~~g~Vy~g~~~~~~~~~vavK~~~~~~-~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~--------------- 570 (792)
+.||+||||.|||++ ++-+++.+|||++.... ...-..+.+|+.++++|+|||||+++....+
T Consensus 485 ~lLGkGGFG~VvkVR-NKlDGr~YAIKKIpl~~s~~~~skI~rEVk~LArLnHpNVVRYysAWVEs~~~~~~~ei~~~~~ 563 (1351)
T KOG1035|consen 485 ELLGKGGFGSVVKVR-NKLDGREYAIKKIPLKASDKLYSKILREVKLLARLNHPNVVRYYSAWVESTAELTVLEIVASDS 563 (1351)
T ss_pred HHhcCCCCceEEEEe-ecccchhhhhhhccCchHHHHHHHHHHHHHHHhhcCCcceeeeehhhhccCCccccccccccch
Confidence 469999999999996 44567899999997653 2334568899999999999999998621100
Q ss_pred ---------------------------------------------------------------C----------------
Q 003836 571 ---------------------------------------------------------------G---------------- 571 (792)
Q Consensus 571 ---------------------------------------------------------------~---------------- 571 (792)
+
T Consensus 564 ~~~sQs~s~~~~~~~~~q~t~~p~~~~~~~~~~~~dd~sss~~~~~~~~~~~~d~e~~d~dedg~~~S~tS~~e~~~~~d 643 (1351)
T KOG1035|consen 564 ESRSQSASKYNGVDIRYQPTSSPSLTLSELDSEDEDDKSSSYTTRKASYESSTDEENDDSDEDGRNLSNTSDSEGSVILD 643 (1351)
T ss_pred hhhcccCCCcccceeeeccCCCcccCcchhhccccCccccccccccccccccCCcccccccccccccccccccCCccccC
Confidence 0
Q ss_pred -------------------------CceEEEEEeccCCCccccccCCCCC-chhHHHHHHHHHHHHHHHHhhccCCCeEe
Q 003836 572 -------------------------QNRLLVYEFMSNGTVASFLFGDSKP-NWKLRTEIAMGIAGGLFYLHEECCTQIIH 625 (792)
Q Consensus 572 -------------------------~~~~lV~E~~~~gsL~~~l~~~~~l-~~~~~~~i~~~ia~gL~yLH~~~~~~ivH 625 (792)
..+||-||||+...|++++.++... .....++++++|+.||+|+|++ +|||
T Consensus 644 ~~~ess~s~~~~~n~~e~~~~~q~~~~LYIQMEyCE~~ll~~iI~~N~~~~~~d~~wrLFreIlEGLaYIH~~---giIH 720 (1351)
T KOG1035|consen 644 DTSESSESIPKTENSSEPMVPVQKPLILYIQMEYCEKTLLRDIIRRNHFNSQRDEAWRLFREILEGLAYIHDQ---GIIH 720 (1351)
T ss_pred cchhhhhhccccCCccccccccccceEEEEEHhhhhhhHHHHHHHhcccchhhHHHHHHHHHHHHHHHHHHhC---ceee
Confidence 1246789999988888887766544 5667889999999999999999 9999
Q ss_pred cCCCCCcEEEcCCCCeEEeecCCCcccc-----------------CCCCCccccccccCCcccccccccC---CCCcccc
Q 003836 626 CDIKPQNILLDDHYNARISDFGLAKLLT-----------------LDQSHTNTAIRGTKGYVAPEWFRNM---PITVKVD 685 (792)
Q Consensus 626 ~dikp~NILl~~~~~~kl~Dfg~a~~~~-----------------~~~~~~~~~~~gt~~y~aPE~~~~~---~~~~k~D 685 (792)
|||||.||+||++..+||+|||+|.... .......+..+||.-|+|||++.+. .|+.|+|
T Consensus 721 RDLKP~NIFLd~~~~VKIGDFGLAt~~~~~~~~~d~~~~~~~~~~g~~~~~~Ts~VGTalYvAPEll~~~~~~~Yn~KiD 800 (1351)
T KOG1035|consen 721 RDLKPRNIFLDSRNSVKIGDFGLATDLKENLESIDQDLSFSTNRAGSNDGDLTSQVGTALYVAPELLSDTSSNKYNSKID 800 (1351)
T ss_pred ccCCcceeEEcCCCCeeecccccchhhhhhhhhHhhccCccccccCCCCcccccccceeeeecHHHhcccccccccchhh
Confidence 9999999999999999999999998721 0111234567899999999999765 4999999
Q ss_pred eehHHHHHHHHHhcCcCCCcchhhhhhhhHHHHHHHhhcccchhHhhhchhcccCCHHHHHHHHHHHHHccccCCCCCCC
Q 003836 686 VYSYGVLLLEIICLRRNIDNEISKVDKAILTDWAYDRYQERTLEALVENDLEAMNNVTMLHRFVMVAFWCIQEDPSHRPT 765 (792)
Q Consensus 686 V~S~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs 765 (792)
+||+|||++||+. ||....+-. ..+ ...+.+.+..- .....+....-..++.++++.||++|||
T Consensus 801 mYSLGIVlFEM~y---PF~TsMERa--~iL-----~~LR~g~iP~~------~~f~~~~~~~e~slI~~Ll~hdP~kRPt 864 (1351)
T KOG1035|consen 801 MYSLGIVLFEMLY---PFGTSMERA--SIL-----TNLRKGSIPEP------ADFFDPEHPEEASLIRWLLSHDPSKRPT 864 (1351)
T ss_pred hHHHHHHHHHHhc---cCCchHHHH--HHH-----HhcccCCCCCC------cccccccchHHHHHHHHHhcCCCccCCC
Confidence 9999999999986 344322110 111 11122211111 1112233445568999999999999999
Q ss_pred HHhHHH
Q 003836 766 MRKVTQ 771 (792)
Q Consensus 766 ~~evl~ 771 (792)
+.|++.
T Consensus 865 A~eLL~ 870 (1351)
T KOG1035|consen 865 ATELLN 870 (1351)
T ss_pred HHHHhh
Confidence 999986
|
|
| >KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.8e-31 Score=271.04 Aligned_cols=241 Identities=26% Similarity=0.337 Sum_probs=202.3
Q ss_pred HHhhhhhhcCccccceEEEeeecCCCceEEEEEEccccc---ccchHHHHHHHHHhccc-CCCCcccccceeccCCceEE
Q 003836 501 VTRGFKEELGRGAFGTVYKGFVNMGSSNHVAVKKLNSVF---QDSEKEFKAEVNGIGQT-HHKNLVRLLGYCDEGQNRLL 576 (792)
Q Consensus 501 ~~~~~~~~lG~G~~g~Vy~g~~~~~~~~~vavK~~~~~~---~~~~~~~~~Ei~~l~~l-~h~niv~l~g~~~~~~~~~l 576 (792)
...+|..+||+|+||.|.++. ..++.+.+|||++++.. .+..+--+.|-++|+.. +-|.++++..+|..-+.+|+
T Consensus 349 tDFnFl~VlGKGSFGKVlLae-rkgtdELyAiKiLkKDViiQdDDvectm~EKrvLAL~~kppFL~qlHScFQTmDRLyF 427 (683)
T KOG0696|consen 349 TDFNFLMVLGKGSFGKVLLAE-RKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLVQLHSCFQTMDRLYF 427 (683)
T ss_pred cccceEEEeccCccceeeeec-ccCcchhhhhhhhccceeeecCcccceehhhhheecCCCCchHHHHHHHhhhhhheee
Confidence 345788999999999999995 55777899999998642 23344456788888876 57889999999999999999
Q ss_pred EEEeccCCCccccccCCCCCchhHHHHHHHHHHHHHHHHhhccCCCeEecCCCCCcEEEcCCCCeEEeecCCCccccCCC
Q 003836 577 VYEFMSNGTVASFLFGDSKPNWKLRTEIAMGIAGGLFYLHEECCTQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLDQ 656 (792)
Q Consensus 577 V~E~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dikp~NILl~~~~~~kl~Dfg~a~~~~~~~ 656 (792)
||||+.+|+|--+++.-.++.++...-+|..||-||-+||++ +||.||||..|||||.+|.+||+|||+++.-.- .
T Consensus 428 VMEyvnGGDLMyhiQQ~GkFKEp~AvFYAaEiaigLFFLh~k---gIiYRDLKLDNvmLd~eGHiKi~DFGmcKEni~-~ 503 (683)
T KOG0696|consen 428 VMEYVNGGDLMYHIQQVGKFKEPVAVFYAAEIAIGLFFLHSK---GIIYRDLKLDNVMLDSEGHIKIADFGMCKENIF-D 503 (683)
T ss_pred EEEEecCchhhhHHHHhcccCCchhhhhhHHHHHHhhhhhcC---CeeeeeccccceEeccCCceEeeeccccccccc-C
Confidence 999999999999998888899999999999999999999999 999999999999999999999999999985322 2
Q ss_pred CCccccccccCCcccccccccCCCCcccceehHHHHHHHHHhcCcCCCcchhhhhhhhHHHHHHHhhcccchhHhhhchh
Q 003836 657 SHTNTAIRGTKGYVAPEWFRNMPITVKVDVYSYGVLLLEIICLRRNIDNEISKVDKAILTDWAYDRYQERTLEALVENDL 736 (792)
Q Consensus 657 ~~~~~~~~gt~~y~aPE~~~~~~~~~k~DV~S~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 736 (792)
.....+.+|||.|+|||++...+|+..+|.|||||+||||+.|+.||+.+.+..-.. .+.+.
T Consensus 504 ~~TTkTFCGTPdYiAPEIi~YqPYgksvDWWa~GVLLyEmlaGQpPFdGeDE~elF~----------------aI~eh-- 565 (683)
T KOG0696|consen 504 GVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDELFQ----------------AIMEH-- 565 (683)
T ss_pred CcceeeecCCCcccccceEEecccccchhHHHHHHHHHHHHcCCCCCCCCCHHHHHH----------------HHHHc--
Confidence 234456889999999999999999999999999999999999999998765432211 11221
Q ss_pred cccCCHHHHHHHHHHHHHccccCCCCCC
Q 003836 737 EAMNNVTMLHRFVMVAFWCIQEDPSHRP 764 (792)
Q Consensus 737 ~~~~~~~~~~~l~~l~~~Cl~~~p~~RP 764 (792)
.-.++...+.+.+.++...|...|.+|.
T Consensus 566 nvsyPKslSkEAv~ickg~ltK~P~kRL 593 (683)
T KOG0696|consen 566 NVSYPKSLSKEAVAICKGLLTKHPGKRL 593 (683)
T ss_pred cCcCcccccHHHHHHHHHHhhcCCcccc
Confidence 1235667778889999999999999994
|
|
| >cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.2e-30 Score=284.70 Aligned_cols=267 Identities=23% Similarity=0.280 Sum_probs=193.1
Q ss_pred HHHHHHHhhh--hhhcCccccceEEEeeecCCCceEEEEEEccccc--ccchHHHHHHHHHhcccCCCCcccccceeccC
Q 003836 496 KELVEVTRGF--KEELGRGAFGTVYKGFVNMGSSNHVAVKKLNSVF--QDSEKEFKAEVNGIGQTHHKNLVRLLGYCDEG 571 (792)
Q Consensus 496 ~el~~~~~~~--~~~lG~G~~g~Vy~g~~~~~~~~~vavK~~~~~~--~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~ 571 (792)
.++...+++| .+.||+|+||.||++... .+++.||+|++.... ....+.+.+|+.++++++|+||+++++++...
T Consensus 10 ~~~~~~~~~y~~~~~lg~G~~g~v~~~~~~-~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~iv~~~~~~~~~ 88 (345)
T cd07877 10 KTIWEVPERYQNLSPVGSGAYGSVCAAFDT-KTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPA 88 (345)
T ss_pred HHHhhccCceEEEEEeeecCCeEEEEEEEc-CCCeEEEEEEecCcchhhHHHHHHHHHHHHHHHcCCCcccceeeeeeec
Confidence 4444454554 367999999999999653 456789999987532 22346788999999999999999999988533
Q ss_pred ------CceEEEEEeccCCCccccccCCCCCchhHHHHHHHHHHHHHHHHhhccCCCeEecCCCCCcEEEcCCCCeEEee
Q 003836 572 ------QNRLLVYEFMSNGTVASFLFGDSKPNWKLRTEIAMGIAGGLFYLHEECCTQIIHCDIKPQNILLDDHYNARISD 645 (792)
Q Consensus 572 ------~~~~lV~E~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dikp~NILl~~~~~~kl~D 645 (792)
...+++++++ +++|.+++.. ..+++..+..++.||++||+|||+. +|+||||||+||++++++.+||+|
T Consensus 89 ~~~~~~~~~~lv~~~~-~~~L~~~~~~-~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~NIll~~~~~~kl~d 163 (345)
T cd07877 89 RSLEEFNDVYLVTHLM-GADLNNIVKC-QKLTDDHVQFLIYQILRGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILD 163 (345)
T ss_pred ccccccccEEEEehhc-ccCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCChHHEEEcCCCCEEEec
Confidence 3467888876 7788887754 3588999999999999999999998 999999999999999999999999
Q ss_pred cCCCccccCCCCCccccccccCCccccccccc-CCCCcccceehHHHHHHHHHhcCcCCCcchhhhhhhhHHH-------
Q 003836 646 FGLAKLLTLDQSHTNTAIRGTKGYVAPEWFRN-MPITVKVDVYSYGVLLLEIICLRRNIDNEISKVDKAILTD------- 717 (792)
Q Consensus 646 fg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~k~DV~S~Gv~l~el~tg~~p~~~~~~~~~~~~~~~------- 717 (792)
||+++.... ......++..|+|||.+.+ ..++.++|||||||++|||++|+.||..............
T Consensus 164 fg~~~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~ 239 (345)
T cd07877 164 FGLARHTDD----EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGA 239 (345)
T ss_pred ccccccccc----cccccccCCCccCHHHHhCccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCH
Confidence 999876432 1223457889999999866 5688999999999999999999999864322111000000
Q ss_pred HHHHhhcccchhHhhhc---hhccc---CCHHHHHHHHHHHHHccccCCCCCCCHHhHHHH
Q 003836 718 WAYDRYQERTLEALVEN---DLEAM---NNVTMLHRFVMVAFWCIQEDPSHRPTMRKVTQM 772 (792)
Q Consensus 718 ~~~~~~~~~~~~~~~~~---~~~~~---~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~ 772 (792)
..............+.. ..... .......++.+++.+||+.+|.+||++.++++.
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h 300 (345)
T cd07877 240 ELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAH 300 (345)
T ss_pred HHHhhcccHhHHHHHHHhcccCCcchhhhcCCCCHHHHHHHHHHcCCChhhcCCHHHHhcC
Confidence 00000000000011000 00000 000134568899999999999999999999875
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14 |
| >cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.6e-30 Score=283.36 Aligned_cols=258 Identities=24% Similarity=0.255 Sum_probs=190.7
Q ss_pred hhhhcCccccceEEEeeecCCCceEEEEEEccccc--ccchHHHHHHHHHhcccCCCCcccccceeccCC------ceEE
Q 003836 505 FKEELGRGAFGTVYKGFVNMGSSNHVAVKKLNSVF--QDSEKEFKAEVNGIGQTHHKNLVRLLGYCDEGQ------NRLL 576 (792)
Q Consensus 505 ~~~~lG~G~~g~Vy~g~~~~~~~~~vavK~~~~~~--~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~------~~~l 576 (792)
..+.||+|+||.||++... .+++.||||++.... ....+.+.+|+.++++++|+||+++++++.... ..++
T Consensus 19 ~~~~lg~G~~g~V~~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~l 97 (343)
T cd07880 19 DLKQVGSGAYGTVCSALDR-RTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMKHENVIGLLDVFTPDLSLDRFHDFYL 97 (343)
T ss_pred EEEEeeecCCeEEEEEEEC-CCCcEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCccceeeeecCCccccccceEEE
Confidence 3467999999999999754 456789999986432 223456889999999999999999999986553 3589
Q ss_pred EEEeccCCCccccccCCCCCchhHHHHHHHHHHHHHHHHhhccCCCeEecCCCCCcEEEcCCCCeEEeecCCCccccCCC
Q 003836 577 VYEFMSNGTVASFLFGDSKPNWKLRTEIAMGIAGGLFYLHEECCTQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLDQ 656 (792)
Q Consensus 577 V~E~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dikp~NILl~~~~~~kl~Dfg~a~~~~~~~ 656 (792)
||||+ +++|.+++.. ..+++..+..++.||++||+|||+. +|+||||||+||+++.++.+||+|||+++.....
T Consensus 98 v~e~~-~~~l~~~~~~-~~l~~~~~~~i~~qi~~al~~LH~~---gi~H~dlkp~Nill~~~~~~kl~dfg~~~~~~~~- 171 (343)
T cd07880 98 VMPFM-GTDLGKLMKH-EKLSEDRIQFLVYQMLKGLKYIHAA---GIIHRDLKPGNLAVNEDCELKILDFGLARQTDSE- 171 (343)
T ss_pred EEecC-CCCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEeecccccccccC-
Confidence 99999 6788888754 5688999999999999999999998 9999999999999999999999999999865322
Q ss_pred CCccccccccCCccccccccc-CCCCcccceehHHHHHHHHHhcCcCCCcchhhhhhhhHHHH-------HHHhhcccch
Q 003836 657 SHTNTAIRGTKGYVAPEWFRN-MPITVKVDVYSYGVLLLEIICLRRNIDNEISKVDKAILTDW-------AYDRYQERTL 728 (792)
Q Consensus 657 ~~~~~~~~gt~~y~aPE~~~~-~~~~~k~DV~S~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~-------~~~~~~~~~~ 728 (792)
.....+++.|+|||.+.+ ..++.++||||||+++++|++|+.||............... ..........
T Consensus 172 ---~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 248 (343)
T cd07880 172 ---MTGYVVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGKPLFKGHDHLDQLMEIMKVTGTPSKEFVQKLQSEDA 248 (343)
T ss_pred ---ccccccCCcccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHhhcchhH
Confidence 223457889999999876 46889999999999999999999999754321110000000 0000000001
Q ss_pred hHhhhchhcc------cCCHHHHHHHHHHHHHccccCCCCCCCHHhHHHH
Q 003836 729 EALVENDLEA------MNNVTMLHRFVMVAFWCIQEDPSHRPTMRKVTQM 772 (792)
Q Consensus 729 ~~~~~~~~~~------~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~ 772 (792)
.......... .........+.+++.+|++.||++|||+.++++.
T Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~t~~~~l~~ 298 (343)
T cd07880 249 KNYVKKLPRFRKKDFRSLLPNANPLAVNVLEKMLVLDAESRITAAEALAH 298 (343)
T ss_pred HHHHHhccccCcchHHHhccCCChHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 1111100000 0011234568899999999999999999999953
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12 |
| >KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.1e-31 Score=270.37 Aligned_cols=270 Identities=19% Similarity=0.263 Sum_probs=205.1
Q ss_pred ccCHHHHHHHHhhhhhhcCccccceEEEeeecCCCceEEEEEEcccccccchHHHHHHHHHhcccC--CCC----ccccc
Q 003836 492 CFTYKELVEVTRGFKEELGRGAFGTVYKGFVNMGSSNHVAVKKLNSVFQDSEKEFKAEVNGIGQTH--HKN----LVRLL 565 (792)
Q Consensus 492 ~~~~~el~~~~~~~~~~lG~G~~g~Vy~g~~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~--h~n----iv~l~ 565 (792)
.|...+.....+.+...+|+|.||.|-++..+. .+..||||+++... ...+..+-|+++++++. .|+ +|.+.
T Consensus 80 v~~~gD~l~~Ry~i~~~lGeGtFGkV~ec~D~~-~~~~vAlKIik~V~-kYreAa~iEi~vLqki~~~DP~g~~rcv~m~ 157 (415)
T KOG0671|consen 80 VYQVGDILTNRYEIVDLLGEGTFGKVVECWDRE-TKEHVALKIIKNVD-KYREAALIEIEVLQKINESDPNGKFRCVQMR 157 (415)
T ss_pred EEEeccccccceehhhhhcCCcccceEEEeecC-CCceehHHHHHHHH-HHhhHHHHHHHHHHHHHhcCCCCceEEEeee
Confidence 455666667778888999999999999986554 47899999998763 33456778999999993 233 78899
Q ss_pred ceeccCCceEEEEEeccCCCccccccCC--CCCchhHHHHHHHHHHHHHHHHhhccCCCeEecCCCCCcEEEcC------
Q 003836 566 GYCDEGQNRLLVYEFMSNGTVASFLFGD--SKPNWKLRTEIAMGIAGGLFYLHEECCTQIIHCDIKPQNILLDD------ 637 (792)
Q Consensus 566 g~~~~~~~~~lV~E~~~~gsL~~~l~~~--~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dikp~NILl~~------ 637 (792)
++|.-.++.+||+|.+ |-|+.++|..+ .+++..++..|+.|++++++|||+. +++|.||||+|||+.+
T Consensus 158 ~wFdyrghiCivfell-G~S~~dFlk~N~y~~fpi~~ir~m~~QL~~sv~fLh~~---kl~HTDLKPENILfvss~~~~~ 233 (415)
T KOG0671|consen 158 DWFDYRGHICIVFELL-GLSTFDFLKENNYIPFPIDHIRHMGYQLLESVAFLHDL---KLTHTDLKPENILFVSSEYFKT 233 (415)
T ss_pred hhhhccCceEEEEecc-ChhHHHHhccCCccccchHHHHHHHHHHHHHHHHHHhc---ceeecCCChheEEEeccceEEE
Confidence 9999999999999998 45999999876 4678899999999999999999998 9999999999999941
Q ss_pred --------------CCCeEEeecCCCccccCCCCCccccccccCCcccccccccCCCCcccceehHHHHHHHHHhcCcCC
Q 003836 638 --------------HYNARISDFGLAKLLTLDQSHTNTAIRGTKGYVAPEWFRNMPITVKVDVYSYGVLLLEIICLRRNI 703 (792)
Q Consensus 638 --------------~~~~kl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DV~S~Gv~l~el~tg~~p~ 703 (792)
+..+||+|||.|+.-.... ..++.|..|+|||++.+-.++.++||||+||||.|+.||...|
T Consensus 234 ~~~k~~~~~~r~~ks~~I~vIDFGsAtf~~e~h----s~iVsTRHYRAPEViLgLGwS~pCDvWSiGCIL~ElytG~~LF 309 (415)
T KOG0671|consen 234 YNPKKKVCFIRPLKSTAIKVIDFGSATFDHEHH----STIVSTRHYRAPEVILGLGWSQPCDVWSIGCILVELYTGETLF 309 (415)
T ss_pred eccCCccceeccCCCcceEEEecCCcceeccCc----ceeeeccccCCchheeccCcCCccCceeeeeEEEEeeccceec
Confidence 3458999999998643322 5567899999999999999999999999999999999999988
Q ss_pred CcchhhhhhhhH----HHHHHHhhc---------cc-----------chhHhhhchh----cccCCHHHHHHHHHHHHHc
Q 003836 704 DNEISKVDKAIL----TDWAYDRYQ---------ER-----------TLEALVENDL----EAMNNVTMLHRFVMVAFWC 755 (792)
Q Consensus 704 ~~~~~~~~~~~~----~~~~~~~~~---------~~-----------~~~~~~~~~~----~~~~~~~~~~~l~~l~~~C 755 (792)
......+..... ...+..... .+ +...+.+... .......+..+|++|+..+
T Consensus 310 qtHen~EHLaMMerIlGp~P~~mi~r~~~~Kyf~~~rldw~e~~~~~~~k~v~~~ckpl~~~~~~~d~e~~~LfDLl~~m 389 (415)
T KOG0671|consen 310 QTHENLEHLAMMERILGPIPSRMIKKTRKEKYFRRGRLDWPEVSSKGKSKYVFEPCKPLKKYMLQDDLEHVQLFDLLRRM 389 (415)
T ss_pred ccCCcHHHHHHHHHhhCCCcHHHhhhhhhHhhhhcccccCccccccccchhhhcCCccHHHHhccCcHHHhHHHHHHHHH
Confidence 654432221111 000000000 00 0011111100 0112234667899999999
Q ss_pred cccCCCCCCCHHhHHH
Q 003836 756 IQEDPSHRPTMRKVTQ 771 (792)
Q Consensus 756 l~~~p~~RPs~~evl~ 771 (792)
|..||.+|+|+.|++.
T Consensus 390 L~fDP~~RiTl~EAL~ 405 (415)
T KOG0671|consen 390 LEFDPARRITLREALS 405 (415)
T ss_pred HccCccccccHHHHhc
Confidence 9999999999999987
|
|
| >KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.3e-31 Score=269.04 Aligned_cols=252 Identities=27% Similarity=0.382 Sum_probs=196.3
Q ss_pred hhhhcCccccceEEEeeecCCCceEEEEEEccc--cccc-----chHHHHHHHHHhcccCCCCcccccceec-cCCceEE
Q 003836 505 FKEELGRGAFGTVYKGFVNMGSSNHVAVKKLNS--VFQD-----SEKEFKAEVNGIGQTHHKNLVRLLGYCD-EGQNRLL 576 (792)
Q Consensus 505 ~~~~lG~G~~g~Vy~g~~~~~~~~~vavK~~~~--~~~~-----~~~~~~~Ei~~l~~l~h~niv~l~g~~~-~~~~~~l 576 (792)
+...||+|+|+.|||+. +....+.||||+-.- .-++ ..+...+|-++...|+||.||++++++. +.+..+-
T Consensus 467 lLhLLGrGGFSEVyKAF-Dl~EqRYvAvKIHqlNK~WrdEKKeNYhKHAcREyrIHKeLDHpRIVKlYDyfslDtdsFCT 545 (775)
T KOG1151|consen 467 LLHLLGRGGFSEVYKAF-DLTEQRYVAVKIHQLNKNWRDEKKENYHKHACREYRIHKELDHPRIVKLYDYFSLDTDSFCT 545 (775)
T ss_pred HHHHhccccHHHHHHhc-ccchhheeeEeeehhccchhhHhhhhHHHHHHHHHhhhhccCcceeeeeeeeeeecccccee
Confidence 44679999999999995 455668999998532 1111 1245678999999999999999999995 5567889
Q ss_pred EEEeccCCCccccccCCCCCchhHHHHHHHHHHHHHHHHhhccCCCeEecCCCCCcEEEcC---CCCeEEeecCCCcccc
Q 003836 577 VYEFMSNGTVASFLFGDSKPNWKLRTEIAMGIAGGLFYLHEECCTQIIHCDIKPQNILLDD---HYNARISDFGLAKLLT 653 (792)
Q Consensus 577 V~E~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dikp~NILl~~---~~~~kl~Dfg~a~~~~ 653 (792)
|+||+++.+|+-||..++.++++....|++||+.||.||.+. .++|||-||||.||||.+ -|.+||.|||+++++.
T Consensus 546 VLEYceGNDLDFYLKQhklmSEKEARSIiMQiVnAL~YLNEi-kpPIIHYDLKPgNILLv~GtacGeIKITDFGLSKIMd 624 (775)
T KOG1151|consen 546 VLEYCEGNDLDFYLKQHKLMSEKEARSIIMQIVNALKYLNEI-KPPIIHYDLKPGNILLVNGTACGEIKITDFGLSKIMD 624 (775)
T ss_pred eeeecCCCchhHHHHhhhhhhHHHHHHHHHHHHHHHHHHhcc-CCCeeeeccCCccEEEecCcccceeEeeecchhhhcc
Confidence 999999999999999999999999999999999999999987 578999999999999964 4789999999999987
Q ss_pred CCCCCc------cccccccCCccccccccc----CCCCcccceehHHHHHHHHHhcCcCCCcchhhhhhhhHHHHHHHhh
Q 003836 654 LDQSHT------NTAIRGTKGYVAPEWFRN----MPITVKVDVYSYGVLLLEIICLRRNIDNEISKVDKAILTDWAYDRY 723 (792)
Q Consensus 654 ~~~~~~------~~~~~gt~~y~aPE~~~~----~~~~~k~DV~S~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~ 723 (792)
.+.... .....||..|++||.+.- -.++.|.||||.|||+|+.+.|++||.......+ ++..
T Consensus 625 ddSy~~vdGmeLTSQgAGTYWYLPPEcFvVgkePPKIsnKVDVWSvGVIFyQClYGrKPFGhnqsQQd--ILqe------ 696 (775)
T KOG1151|consen 625 DDSYNSVDGMELTSQGAGTYWYLPPECFVVGKEPPKISNKVDVWSVGVIFYQCLYGRKPFGHNQSQQD--ILQE------ 696 (775)
T ss_pred CCccCcccceeeecccCceeeecCcceeecCCCCCccccceeeEeeehhhhhhhccCCCCCCchhHHH--HHhh------
Confidence 654332 233569999999998853 3588999999999999999999999977644322 1100
Q ss_pred cccchhHhhhch-hcccCCHHHHHHHHHHHHHccccCCCCCCCHHhHHH
Q 003836 724 QERTLEALVEND-LEAMNNVTMLHRFVMVAFWCIQEDPSHRPTMRKVTQ 771 (792)
Q Consensus 724 ~~~~~~~~~~~~-~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~ 771 (792)
. .++... ......+..+.+...+|++||+..-++|....++..
T Consensus 697 --N---TIlkAtEVqFP~KPvVsseAkaFIRRCLaYRKeDR~DV~qLA~ 740 (775)
T KOG1151|consen 697 --N---TILKATEVQFPPKPVVSSEAKAFIRRCLAYRKEDRIDVQQLAC 740 (775)
T ss_pred --h---chhcceeccCCCCCccCHHHHHHHHHHHHhhhhhhhhHHHHcc
Confidence 0 011111 111112345567788999999999999988877664
|
|
| >KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.3e-30 Score=263.78 Aligned_cols=251 Identities=21% Similarity=0.285 Sum_probs=201.7
Q ss_pred hhhhcCccccceEEEeeecCC----CceEEEEEEccccccc-chHHHHHHHHHhcccCCCCcccccceeccC-CceEEEE
Q 003836 505 FKEELGRGAFGTVYKGFVNMG----SSNHVAVKKLNSVFQD-SEKEFKAEVNGIGQTHHKNLVRLLGYCDEG-QNRLLVY 578 (792)
Q Consensus 505 ~~~~lG~G~~g~Vy~g~~~~~----~~~~vavK~~~~~~~~-~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~-~~~~lV~ 578 (792)
.+..+-+|.||.||+|.+... +.+.|-||.++....+ ....+..|.-.+..+.|||+..+.+++.++ ...+.+|
T Consensus 288 l~~llqEGtFGri~~gI~~eEdt~n~~q~v~vKTvk~~AS~iQv~~~L~es~lly~~sH~nll~V~~V~ie~~~~P~V~y 367 (563)
T KOG1024|consen 288 LSCLLQEGTFGRIYRGIWREEDTYNDCQEVLVKTVKQHASQIQVNLLLQESMLLYGASHPNLLSVLGVSIEDYATPFVLY 367 (563)
T ss_pred chhhhhcCchhheeeeeecccCCcchHHHHHHHHHHhcccHHHHHHHHHHHHHHhcCcCCCccceeEEEeeccCcceEEE
Confidence 345789999999999976532 2356778877654333 345678888899999999999999998654 5678999
Q ss_pred EeccCCCcccccc-----CC---CCCchhHHHHHHHHHHHHHHHHhhccCCCeEecCCCCCcEEEcCCCCeEEeecCCCc
Q 003836 579 EFMSNGTVASFLF-----GD---SKPNWKLRTEIAMGIAGGLFYLHEECCTQIIHCDIKPQNILLDDHYNARISDFGLAK 650 (792)
Q Consensus 579 E~~~~gsL~~~l~-----~~---~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dikp~NILl~~~~~~kl~Dfg~a~ 650 (792)
.++.-|+|..||. +. +.+...+...++.|++.|++|||.. ++||.||.++|.+||+...+||+|=.++|
T Consensus 368 ~~~~~gNLK~FL~~Cr~~~~~~aqtvtt~qlV~masQla~am~hlh~~---~ViHkDiAaRNCvIdd~LqVkltDsaLSR 444 (563)
T KOG1024|consen 368 PATGVGNLKSFLQICRGDDPSYAQTVTTIQLVLMASQLAMAMEHLHNH---GVIHKDIAARNCVIDDQLQVKLTDSALSR 444 (563)
T ss_pred eccCcchHHHHHHHhccCCCccccchhHHHHHHHHHHHHHHHHHHHhc---CcccchhhhhcceehhheeEEeccchhcc
Confidence 9999999999997 21 3456677888999999999999999 99999999999999999999999999998
Q ss_pred cccCCCCCc-cccccccCCcccccccccCCCCcccceehHHHHHHHHHh-cCcCCCcchhhhhhhhHHHHHHHhhcccch
Q 003836 651 LLTLDQSHT-NTAIRGTKGYVAPEWFRNMPITVKVDVYSYGVLLLEIIC-LRRNIDNEISKVDKAILTDWAYDRYQERTL 728 (792)
Q Consensus 651 ~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~k~DV~S~Gv~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 728 (792)
.+.+...+. ....-....||+||.+.+..|+.++|||||||+||||+| |+.|+.... . ..+
T Consensus 445 DLFP~DYhcLGDnEnRPvkWMslEal~n~~yssasDvWsfGVllWELmtlg~~PyaeID-P----------------fEm 507 (563)
T KOG1024|consen 445 DLFPGDYHCLGDNENRPVKWMSLEALQNSHYSSASDVWSFGVLLWELMTLGKLPYAEID-P----------------FEM 507 (563)
T ss_pred ccCcccccccCCCCCCcccccCHHHHhhhhhcchhhhHHHHHHHHHHHhcCCCCccccC-H----------------HHH
Confidence 765543322 222334668999999999999999999999999999998 566654321 1 223
Q ss_pred hHhhhchhcccCCHHHHHHHHHHHHHccccCCCCCCCHHhHHHHhcc
Q 003836 729 EALVENDLEAMNNVTMLHRFVMVAFWCIQEDPSHRPTMRKVTQMLEG 775 (792)
Q Consensus 729 ~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~L~~ 775 (792)
+..+....+-..+.+++.++..++..||...|++||+++|++.-|.+
T Consensus 508 ~~ylkdGyRlaQP~NCPDeLf~vMacCWallpeeRPsf~Qlv~cLse 554 (563)
T KOG1024|consen 508 EHYLKDGYRLAQPFNCPDELFTVMACCWALLPEERPSFSQLVICLSE 554 (563)
T ss_pred HHHHhccceecCCCCCcHHHHHHHHHHHhcCcccCCCHHHHHHHHHH
Confidence 44455555666677889999999999999999999999999998865
|
|
| >cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.5e-30 Score=303.75 Aligned_cols=143 Identities=29% Similarity=0.423 Sum_probs=128.0
Q ss_pred hhhhhcCccccceEEEeeecCCCceEEEEEEccccc---ccchHHHHHHHHHhcccCCCCcccccceeccCCceEEEEEe
Q 003836 504 GFKEELGRGAFGTVYKGFVNMGSSNHVAVKKLNSVF---QDSEKEFKAEVNGIGQTHHKNLVRLLGYCDEGQNRLLVYEF 580 (792)
Q Consensus 504 ~~~~~lG~G~~g~Vy~g~~~~~~~~~vavK~~~~~~---~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~lV~E~ 580 (792)
.+.++||+|+||+||+|... ..++.||||++.... ......+.+|+.++..++|+||+++++++......+|||||
T Consensus 7 ~i~~~LG~G~fg~Vy~a~~~-~~~~~vAiKvi~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lVmEy 85 (669)
T cd05610 7 VIVKPISRGAFGKVYLGRKK-NNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHLYYSLQSANNVYLVMEY 85 (669)
T ss_pred EEEEEEecCCCeEEEEEEEC-CCCcEEEEEEEehhhccCHHHHHHHHHHHHHHHhcCCCCcCeEEEEEEECCEEEEEEeC
Confidence 34578999999999999754 456799999987532 22346788999999999999999999999999999999999
Q ss_pred ccCCCccccccCCCCCchhHHHHHHHHHHHHHHHHhhccCCCeEecCCCCCcEEEcCCCCeEEeecCCCc
Q 003836 581 MSNGTVASFLFGDSKPNWKLRTEIAMGIAGGLFYLHEECCTQIIHCDIKPQNILLDDHYNARISDFGLAK 650 (792)
Q Consensus 581 ~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dikp~NILl~~~~~~kl~Dfg~a~ 650 (792)
+++++|.+++.....+++..++.|+.||+.||+|||.. +|+||||||+||||+.++.+||+|||+++
T Consensus 86 ~~g~~L~~li~~~~~l~~~~~~~i~~qil~aL~yLH~~---gIiHrDLKP~NILl~~~g~vkL~DFGls~ 152 (669)
T cd05610 86 LIGGDVKSLLHIYGYFDEEMAVKYISEVALALDYLHRH---GIIHRDLKPDNMLISNEGHIKLTDFGLSK 152 (669)
T ss_pred CCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC---CEEeCCccHHHEEEcCCCCEEEEeCCCCc
Confidence 99999999998777788999999999999999999998 99999999999999999999999999986
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481 |
| >smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.4e-30 Score=263.88 Aligned_cols=237 Identities=26% Similarity=0.348 Sum_probs=194.3
Q ss_pred ccceEEEeeecCCCceEEEEEEcccccccc-hHHHHHHHHHhcccCCCCcccccceeccCCceEEEEEeccCCCcccccc
Q 003836 513 AFGTVYKGFVNMGSSNHVAVKKLNSVFQDS-EKEFKAEVNGIGQTHHKNLVRLLGYCDEGQNRLLVYEFMSNGTVASFLF 591 (792)
Q Consensus 513 ~~g~Vy~g~~~~~~~~~vavK~~~~~~~~~-~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~lV~E~~~~gsL~~~l~ 591 (792)
+||.||+|+.. ++++.+++|++....... .+.+.+|++.+++++|+|++++++++......++++||+++++|.+++.
T Consensus 1 ~~g~v~~~~~~-~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~~~L~~~~~ 79 (244)
T smart00220 1 SFGKVYLARDK-KTGKLVAIKVIKKEKIKKKRERILREISILKKLKHPNIVRLYDVFEDEDKLYLVMEYCDGGDLFDLLK 79 (244)
T ss_pred CceEEEEEEEC-CCCcEEEEEEecccccccHHHHHHHHHHHHHhCCCCcHHHHHhheeeCCEEEEEEeCCCCCCHHHHHH
Confidence 57999999765 446789999998655444 6899999999999999999999999999999999999999999999997
Q ss_pred CCCCCchhHHHHHHHHHHHHHHHHhhccCCCeEecCCCCCcEEEcCCCCeEEeecCCCccccCCCCCccccccccCCccc
Q 003836 592 GDSKPNWKLRTEIAMGIAGGLFYLHEECCTQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLDQSHTNTAIRGTKGYVA 671 (792)
Q Consensus 592 ~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dikp~NILl~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~gt~~y~a 671 (792)
....+++..+..++.+++++|.|||+. +++|+||+|+||++++++.++|+|||.+....... ......++..|++
T Consensus 80 ~~~~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~--~~~~~~~~~~~~~ 154 (244)
T smart00220 80 KRGRLSEDEARFYARQILSALEYLHSN---GIIHRDLKPENILLDEDGHVKLADFGLARQLDPGG--LLTTFVGTPEYMA 154 (244)
T ss_pred hccCCCHHHHHHHHHHHHHHHHHHHHc---CeecCCcCHHHeEECCCCcEEEccccceeeecccc--ccccccCCcCCCC
Confidence 766688999999999999999999998 99999999999999999999999999998765432 2234457889999
Q ss_pred ccccccCCCCcccceehHHHHHHHHHhcCcCCCcchhhhhhhhHHHHHHHhhcccchhHhhhchhcccCCHH--HHHHHH
Q 003836 672 PEWFRNMPITVKVDVYSYGVLLLEIICLRRNIDNEISKVDKAILTDWAYDRYQERTLEALVENDLEAMNNVT--MLHRFV 749 (792)
Q Consensus 672 PE~~~~~~~~~k~DV~S~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~l~ 749 (792)
||.+....++.++||||||+++++|++|..|+........ .. ..+........... ...++.
T Consensus 155 pE~~~~~~~~~~~Di~slG~~l~~l~~~~~p~~~~~~~~~---~~-------------~~~~~~~~~~~~~~~~~~~~~~ 218 (244)
T smart00220 155 PEVLLGKGYGKAVDVWSLGVILYELLTGKPPFPGDDQLLE---LF-------------KKIGKPKPPFPPPEWKISPEAK 218 (244)
T ss_pred HHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHH---HH-------------HHHhccCCCCccccccCCHHHH
Confidence 9999888899999999999999999999999865311100 00 00000000000111 456788
Q ss_pred HHHHHccccCCCCCCCHHhHHH
Q 003836 750 MVAFWCIQEDPSHRPTMRKVTQ 771 (792)
Q Consensus 750 ~l~~~Cl~~~p~~RPs~~evl~ 771 (792)
+++.+|+..+|++||++.++++
T Consensus 219 ~~i~~~l~~~p~~Rp~~~~~~~ 240 (244)
T smart00220 219 DLIRKLLVKDPEKRLTAEEALQ 240 (244)
T ss_pred HHHHHHccCCchhccCHHHHhh
Confidence 9999999999999999999997
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. |
| >PLN03224 probable serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=8.7e-30 Score=284.21 Aligned_cols=266 Identities=21% Similarity=0.237 Sum_probs=179.6
Q ss_pred hhhhcCccccceEEEeeec---------------CCCceEEEEEEcccccccchHHH--------------HHHHHHhcc
Q 003836 505 FKEELGRGAFGTVYKGFVN---------------MGSSNHVAVKKLNSVFQDSEKEF--------------KAEVNGIGQ 555 (792)
Q Consensus 505 ~~~~lG~G~~g~Vy~g~~~---------------~~~~~~vavK~~~~~~~~~~~~~--------------~~Ei~~l~~ 555 (792)
+.++||+|+||+||+|.+. ...++.||||++........++| ..|+.++.+
T Consensus 149 i~~~LG~GgFG~VYkG~~~~~~~~~v~~~~~~~~~~~~r~VAVK~l~~~~~~~~~~fl~e~~~~~~~~e~~~vE~~~l~~ 228 (507)
T PLN03224 149 LRDKLGGGNFGITFEGLRLQADDQGVTQRSKLTAEQKKRRVVLKRVNMDRQGVRQDFLKTGTLAKGSAETGMVEAYMCAK 228 (507)
T ss_pred EeeEeecCCCeEEEEEEecccccchhhhhccccccccCceEEEEEecccchhhHHHHHhhhhhhhcccchhHHHHHHHHH
Confidence 3478999999999999641 12345799999875433323333 346667777
Q ss_pred cCCCCc-----ccccceecc--------CCceEEEEEeccCCCccccccCC------------------------CCCch
Q 003836 556 THHKNL-----VRLLGYCDE--------GQNRLLVYEFMSNGTVASFLFGD------------------------SKPNW 598 (792)
Q Consensus 556 l~h~ni-----v~l~g~~~~--------~~~~~lV~E~~~~gsL~~~l~~~------------------------~~l~~ 598 (792)
++|.++ ++++++|.. ....+|||||+++++|.++++.. ..+++
T Consensus 229 l~~~~l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~~~~~~~~~~ 308 (507)
T PLN03224 229 IKRNPIAAASCAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPDNMPQDKRDI 308 (507)
T ss_pred hhcccchhhhhhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchhhhcccccCCH
Confidence 766654 677888753 35689999999999999988642 12356
Q ss_pred hHHHHHHHHHHHHHHHHhhccCCCeEecCCCCCcEEEcCCCCeEEeecCCCccccCCCCCccccccccCCcccccccccC
Q 003836 599 KLRTEIAMGIAGGLFYLHEECCTQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLDQSHTNTAIRGTKGYVAPEWFRNM 678 (792)
Q Consensus 599 ~~~~~i~~~ia~gL~yLH~~~~~~ivH~dikp~NILl~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~ 678 (792)
..+..++.|++.||.|||+. +|+||||||+|||++.++.+||+|||+++..............+++.|+|||.+...
T Consensus 309 ~~~~~i~~ql~~aL~~lH~~---~ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~g~~tp~Y~aPE~l~~~ 385 (507)
T PLN03224 309 NVIKGVMRQVLTGLRKLHRI---GIVHRDIKPENLLVTVDGQVKIIDFGAAVDMCTGINFNPLYGMLDPRYSPPEELVMP 385 (507)
T ss_pred HHHHHHHHHHHHHHHHHHHC---CeecCCCchHhEEECCCCcEEEEeCcCccccccCCccCccccCCCcceeChhhhcCC
Confidence 67888999999999999998 999999999999999999999999999976543322222222357899999987532
Q ss_pred C----------------------CCcccceehHHHHHHHHHhcCc-CCCcchhhhhhhhHHHHHHHhhcccchhHhhhch
Q 003836 679 P----------------------ITVKVDVYSYGVLLLEIICLRR-NIDNEISKVDKAILTDWAYDRYQERTLEALVEND 735 (792)
Q Consensus 679 ~----------------------~~~k~DV~S~Gv~l~el~tg~~-p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 735 (792)
. ...+.||||+||+++||+++.. |+...................+. ......
T Consensus 386 ~~~~~~~~~~~~~~l~~~~~~yg~~~~~DvwSlGvil~em~~~~l~p~~~~~~f~~~~~~~~~~~~~~r-----~~~~~~ 460 (507)
T PLN03224 386 QSCPRAPAPAMAALLSPFAWLYGRPDLFDSYTAGVLLMQMCVPELRPVANIRLFNTELRQYDNDLNRWR-----MYKGQK 460 (507)
T ss_pred CCCCccchhhhhhhhhhhHHhcCCCCccchhhHHHHHHHHHhCCCCCccchhhhhhHHhhccchHHHHH-----hhcccC
Confidence 2 1235799999999999999875 55432110000000000000000 000011
Q ss_pred hcccCCHHHHHHHHHHHHHccccCC---CCCCCHHhHHHHhccCcCCCCCCCCCCCCC
Q 003836 736 LEAMNNVTMLHRFVMVAFWCIQEDP---SHRPTMRKVTQMLEGVVEVPIPPCPWTLNI 790 (792)
Q Consensus 736 ~~~~~~~~~~~~l~~l~~~Cl~~~p---~~RPs~~evl~~L~~~~~~~~p~~P~~~~~ 790 (792)
..............+++.++|..+| .+|+|++|+++ |||..++
T Consensus 461 ~~~~~~d~~s~~~~dLi~~LL~~~~~~~~~RlSa~eaL~------------Hp~f~~~ 506 (507)
T PLN03224 461 YDFSLLDRNKEAGWDLACKLITKRDQANRGRLSVGQALS------------HRFFLPE 506 (507)
T ss_pred CCcccccccChHHHHHHHHHhccCCCCcccCCCHHHHhC------------CCCcCCC
Confidence 1111112345677889999998766 78999999998 7777654
|
|
| >KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.9e-30 Score=235.02 Aligned_cols=260 Identities=20% Similarity=0.268 Sum_probs=195.5
Q ss_pred hhhcCccccceEEEeeecCCCceEEEEEEccccc--ccchHHHHHHHHHhcccCCCCcccccceeccCCceEEEEEeccC
Q 003836 506 KEELGRGAFGTVYKGFVNMGSSNHVAVKKLNSVF--QDSEKEFKAEVNGIGQTHHKNLVRLLGYCDEGQNRLLVYEFMSN 583 (792)
Q Consensus 506 ~~~lG~G~~g~Vy~g~~~~~~~~~vavK~~~~~~--~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~lV~E~~~~ 583 (792)
.++||+|.||+|||++ +..+.+.||+|+++-.. +.......+|+-+++.++|+|||++++....++...||+|||..
T Consensus 7 mekigegtygtvfkar-n~~t~eivalkrvrlddddegvpssalreicllkelkhknivrl~dvlhsdkkltlvfe~cdq 85 (292)
T KOG0662|consen 7 MEKIGEGTYGTVFKAR-NRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFEFCDQ 85 (292)
T ss_pred HHhhcCCcceeeEecc-cCCccceEEEEEEeccCCCCCCcHHHHHHHHHHHHhhhcceeehhhhhccCceeEEeHHHhhH
Confidence 3689999999999996 44677899999986432 33346789999999999999999999999999999999999975
Q ss_pred CCccccccC-CCCCchhHHHHHHHHHHHHHHHHhhccCCCeEecCCCCCcEEEcCCCCeEEeecCCCccccCCCCCcccc
Q 003836 584 GTVASFLFG-DSKPNWKLRTEIAMGIAGGLFYLHEECCTQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLDQSHTNTA 662 (792)
Q Consensus 584 gsL~~~l~~-~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dikp~NILl~~~~~~kl~Dfg~a~~~~~~~~~~~~~ 662 (792)
+|..+... +..++......++.|+++||.+.|++ .+.|||+||.|.||+.+|+.|++|||+++.+..+-.... .
T Consensus 86 -dlkkyfdslng~~d~~~~rsfmlqllrgl~fchsh---nvlhrdlkpqnllin~ngelkladfglarafgipvrcys-a 160 (292)
T KOG0662|consen 86 -DLKKYFDSLNGDLDPEIVRSFMLQLLRGLGFCHSH---NVLHRDLKPQNLLINRNGELKLADFGLARAFGIPVRCYS-A 160 (292)
T ss_pred -HHHHHHHhcCCcCCHHHHHHHHHHHHhhhhhhhhh---hhhhccCCcceEEeccCCcEEecccchhhhcCCceEeee-c
Confidence 77777654 35678888899999999999999999 999999999999999999999999999998765443332 2
Q ss_pred ccccCCccccccccc-CCCCcccceehHHHHHHHHHhcCcCCCcchhhhhhhhHHHHHHHhhcc---cchhHhhhchhcc
Q 003836 663 IRGTKGYVAPEWFRN-MPITVKVDVYSYGVLLLEIICLRRNIDNEISKVDKAILTDWAYDRYQE---RTLEALVENDLEA 738 (792)
Q Consensus 663 ~~gt~~y~aPE~~~~-~~~~~k~DV~S~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~ 738 (792)
.+-|..|++|.++-+ +-|+...|+||-||++.|+....+|..+..+..++....-+......+ ..+..+.|...-+
T Consensus 161 evvtlwyrppdvlfgakly~tsidmwsagcifaelanagrplfpg~dvddqlkrif~~lg~p~ed~wps~t~lpdyk~yp 240 (292)
T KOG0662|consen 161 EVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEDQWPSMTKLPDYKPYP 240 (292)
T ss_pred eeeeeeccCcceeeeeehhccchHhhhcchHHHHHhhcCCCCCCCCcHHHHHHHHHHHhCCCccccCCccccCCCCcccC
Confidence 345889999999876 458999999999999999998777765544332222111111111111 1122222222222
Q ss_pred cCC---------HHHHHHHHHHHHHccccCCCCCCCHHhHHH
Q 003836 739 MNN---------VTMLHRFVMVAFWCIQEDPSHRPTMRKVTQ 771 (792)
Q Consensus 739 ~~~---------~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~ 771 (792)
.++ +.....-.++....+.-+|..|.++++.++
T Consensus 241 ~ypattswsqivp~lns~grdllqkll~cnp~qrisaeaalq 282 (292)
T KOG0662|consen 241 IYPATTSWSQIVPKLNSTGRDLLQKLLKCNPAQRISAEAALQ 282 (292)
T ss_pred CccccchHHHHhhhhcchhHHHHHHHhccCcccccCHHHHhc
Confidence 222 112233467778888899999999998877
|
|
| >PLN03225 Serine/threonine-protein kinase SNT7; Provisional | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.6e-29 Score=289.59 Aligned_cols=258 Identities=19% Similarity=0.212 Sum_probs=166.9
Q ss_pred hhhhhcCccccceEEEeeecCC---CceEEEEEEcccccccchHHHHHHHHHhcccCCCCcccccce------eccCCce
Q 003836 504 GFKEELGRGAFGTVYKGFVNMG---SSNHVAVKKLNSVFQDSEKEFKAEVNGIGQTHHKNLVRLLGY------CDEGQNR 574 (792)
Q Consensus 504 ~~~~~lG~G~~g~Vy~g~~~~~---~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~g~------~~~~~~~ 574 (792)
.+.++||+|+||.||+|.+... .+..||+|++..... .+...+| .+.+..+.+++.++.. +.++...
T Consensus 135 ~l~~~LG~G~FG~VYka~~~~~~~~~~~~vAvK~~~~~~~--~e~~~~e--~l~~~~~~~~~~~~~~~~~~~~~~~~~~~ 210 (566)
T PLN03225 135 VLGKKLGEGAFGVVYKASLVNKQSKKEGKYVLKKATEYGA--VEIWMNE--RVRRACPNSCADFVYGFLEPVSSKKEDEY 210 (566)
T ss_pred EEeEEEeeCCCeEEEEEEEcCCccccCcEEEEEEecccch--hHHHHHH--HHHhhchhhHHHHHHhhhcccccccCCce
Confidence 3457899999999999987532 156899998764321 1111111 1222223333333222 2456789
Q ss_pred EEEEEeccCCCccccccCCCC--------------------CchhHHHHHHHHHHHHHHHHhhccCCCeEecCCCCCcEE
Q 003836 575 LLVYEFMSNGTVASFLFGDSK--------------------PNWKLRTEIAMGIAGGLFYLHEECCTQIIHCDIKPQNIL 634 (792)
Q Consensus 575 ~lV~E~~~~gsL~~~l~~~~~--------------------l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dikp~NIL 634 (792)
+|||||+++++|.+++..... .....+..++.||+.||+|||++ +|+||||||+|||
T Consensus 211 ~LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH~~---gIiHRDLKP~NIL 287 (566)
T PLN03225 211 WLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLHST---GIVHRDVKPQNII 287 (566)
T ss_pred EEEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHHHC---CEEeCcCCHHHEE
Confidence 999999999999988864321 11234567999999999999998 9999999999999
Q ss_pred EcC-CCCeEEeecCCCccccCCCCCccccccccCCcccccccccC----------------------CCCcccceehHHH
Q 003836 635 LDD-HYNARISDFGLAKLLTLDQSHTNTAIRGTKGYVAPEWFRNM----------------------PITVKVDVYSYGV 691 (792)
Q Consensus 635 l~~-~~~~kl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~----------------------~~~~k~DV~S~Gv 691 (792)
+++ ++.+||+|||+++.+............+++.|+|||.+... .++.++|||||||
T Consensus 288 l~~~~~~~KL~DFGlA~~l~~~~~~~~~~~~~t~~Y~APE~~~~~~~~~~~~~~~~~~~~sp~l~~~~~~~k~DVwSlGv 367 (566)
T PLN03225 288 FSEGSGSFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFDIYSAGL 367 (566)
T ss_pred EeCCCCcEEEEeCCCccccccccccCCcccccCCCccChHHhhccCCCCCCccccccccccchhccccCCCCcccHHHHH
Confidence 996 58999999999987654444444556789999999965321 2345679999999
Q ss_pred HHHHHHhcCcCCCcchhhhhhhhHHHHHHHhhcccchhHhhhchhccc----C--CHHHHHHHHHHHHHccccCCCCCCC
Q 003836 692 LLLEIICLRRNIDNEISKVDKAILTDWAYDRYQERTLEALVENDLEAM----N--NVTMLHRFVMVAFWCIQEDPSHRPT 765 (792)
Q Consensus 692 ~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~----~--~~~~~~~l~~l~~~Cl~~~p~~RPs 765 (792)
+||||+++..+++.......... .............+.+..... . .........+|+.+||+.||++|||
T Consensus 368 iL~el~~~~~~~~~~~~~~~~~l----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~dLi~~mL~~dP~kR~t 443 (566)
T PLN03225 368 IFLQMAFPNLRSDSNLIQFNRQL----KRNDYDLVAWRKLVEPRASPDLRRGFEVLDLDGGAGWELLKSMMRFKGRQRIS 443 (566)
T ss_pred HHHHHHhCcCCCchHHHHHHHHH----HhcCCcHHHHHHhhccccchhhhhhhhhccccchHHHHHHHHHccCCcccCCC
Confidence 99999998776544321111000 000000000000011100000 0 0011234568999999999999999
Q ss_pred HHhHHHH
Q 003836 766 MRKVTQM 772 (792)
Q Consensus 766 ~~evl~~ 772 (792)
++|+++.
T Consensus 444 a~e~L~H 450 (566)
T PLN03225 444 AKAALAH 450 (566)
T ss_pred HHHHhCC
Confidence 9999983
|
|
| >KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.1e-30 Score=271.78 Aligned_cols=261 Identities=22% Similarity=0.249 Sum_probs=211.9
Q ss_pred hhcCccccceEEEeeecCCCceEEEEEEcccc---cccchHHHHHHHHHhcccCCCCcccccceeccCCceEEEEEeccC
Q 003836 507 EELGRGAFGTVYKGFVNMGSSNHVAVKKLNSV---FQDSEKEFKAEVNGIGQTHHKNLVRLLGYCDEGQNRLLVYEFMSN 583 (792)
Q Consensus 507 ~~lG~G~~g~Vy~g~~~~~~~~~vavK~~~~~---~~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~lV~E~~~~ 583 (792)
..||-|+||.|=+++.+... ..+|+|++++. ....++.+..|-.+|...+.+.||+++..|.+.+..|++||-|-+
T Consensus 426 aTLGvGgFGRVELV~~~~~~-~~fAlKilkK~hIVdtkQqeHv~sEr~Im~~~~s~fIvrLYrTfrd~kyvYmLmEaClG 504 (732)
T KOG0614|consen 426 ATLGVGGFGRVELVKVNSQK-ATFALKILKKKHIVDTKQQEHVFSERNIMMECRSDFIVRLYRTFRDSKYVYMLMEACLG 504 (732)
T ss_pred hhcccCccceEEEEEecccc-hHHHHHHHhHhhccchhHHHHHHhHHHHHHhcCchHHHHHHHHhccchhhhhhHHhhcC
Confidence 46999999999998776432 25788887653 344566788999999999999999999999999999999999999
Q ss_pred CCccccccCCCCCchhHHHHHHHHHHHHHHHHhhccCCCeEecCCCCCcEEEcCCCCeEEeecCCCccccCCCCCccccc
Q 003836 584 GTVASFLFGDSKPNWKLRTEIAMGIAGGLFYLHEECCTQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLDQSHTNTAI 663 (792)
Q Consensus 584 gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dikp~NILl~~~~~~kl~Dfg~a~~~~~~~~~~~~~~ 663 (792)
|.|...|.++..++..+..-++..+.+|++|||.+ +||.|||||+|.|||.+|-+||.|||+|+.... ....-++
T Consensus 505 GElWTiLrdRg~Fdd~tarF~~acv~EAfeYLH~k---~iIYRDLKPENllLd~~Gy~KLVDFGFAKki~~--g~KTwTF 579 (732)
T KOG0614|consen 505 GELWTILRDRGSFDDYTARFYVACVLEAFEYLHRK---GIIYRDLKPENLLLDNRGYLKLVDFGFAKKIGS--GRKTWTF 579 (732)
T ss_pred chhhhhhhhcCCcccchhhhhHHHHHHHHHHHHhc---CceeccCChhheeeccCCceEEeehhhHHHhcc--CCceeee
Confidence 99999999999999999999999999999999999 999999999999999999999999999998753 3344568
Q ss_pred cccCCcccccccccCCCCcccceehHHHHHHHHHhcCcCCCcchhhhhhhhHHHHHHHhhcccchhHhhhchhcccCCHH
Q 003836 664 RGTKGYVAPEWFRNMPITVKVDVYSYGVLLLEIICLRRNIDNEISKVDKAILTDWAYDRYQERTLEALVENDLEAMNNVT 743 (792)
Q Consensus 664 ~gt~~y~aPE~~~~~~~~~k~DV~S~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 743 (792)
+|||.|.|||++.++..+.++|.||||++++||++|.+||......... ..++...-....|..
T Consensus 580 cGTpEYVAPEIILnKGHD~avDyWaLGIli~ELL~G~pPFs~~dpmktY----------------n~ILkGid~i~~Pr~ 643 (732)
T KOG0614|consen 580 CGTPEYVAPEIILNKGHDRAVDYWALGILIYELLTGSPPFSGVDPMKTY----------------NLILKGIDKIEFPRR 643 (732)
T ss_pred cCCcccccchhhhccCcchhhHHHHHHHHHHHHHcCCCCCCCCchHHHH----------------HHHHhhhhhhhcccc
Confidence 9999999999999999999999999999999999999999765332111 111111112223445
Q ss_pred HHHHHHHHHHHccccCCCCCCC-----HHhHHHHh-------ccC--cCCCCCCCCCCCC
Q 003836 744 MLHRFVMVAFWCIQEDPSHRPT-----MRKVTQML-------EGV--VEVPIPPCPWTLN 789 (792)
Q Consensus 744 ~~~~l~~l~~~Cl~~~p~~RPs-----~~evl~~L-------~~~--~~~~~p~~P~~~~ 789 (792)
......++++.....+|.+|.- +.+|.+.- +++ ..+++|-.|...+
T Consensus 644 I~k~a~~Lik~LCr~~P~ERLG~~~~gI~DIkkH~Wf~gfdweglr~~~L~pPi~~~va~ 703 (732)
T KOG0614|consen 644 ITKTATDLIKKLCRDNPTERLGYQKGGINDIKKHRWFEGFDWEGLRSRTLPPPIIPSVAN 703 (732)
T ss_pred cchhHHHHHHHHHhcCcHhhhccccCChHHHHhhhhhhcCChhhhhhccCCCCccccCCC
Confidence 5667788999999999999975 66776552 332 3566666665543
|
|
| >KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.8e-30 Score=247.23 Aligned_cols=262 Identities=19% Similarity=0.316 Sum_probs=192.9
Q ss_pred hhhcCccccceEEEeeecCCCceEEEEEEcccc--cccchHHHHHHHHHhcccCCCCcccccceeccC--------CceE
Q 003836 506 KEELGRGAFGTVYKGFVNMGSSNHVAVKKLNSV--FQDSEKEFKAEVNGIGQTHHKNLVRLLGYCDEG--------QNRL 575 (792)
Q Consensus 506 ~~~lG~G~~g~Vy~g~~~~~~~~~vavK~~~~~--~~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~--------~~~~ 575 (792)
..+||+|.||.||++... .+++.||+|++--. ...--....+|+++|..++|+|++.++..|... ...+
T Consensus 22 ~~kigqGtfgeVFkAr~~-n~~kkvalkkvlmeneKeGfpitalreikiL~~lkHenv~nliEic~tk~Tp~~r~r~t~y 100 (376)
T KOG0669|consen 22 LAKIGQGTFGEVFKARSK-NTGKKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPTNRDRATFY 100 (376)
T ss_pred HHhcCCchHHHHHHHhhc-CccchhHHHHHHHhccccCCcHHHHHHHHHHHHhcchhHHHHHHHHhhccCCcccccceee
Confidence 357999999999999754 44567888876431 122235678999999999999999999998532 3478
Q ss_pred EEEEeccCCCccccccCC-CCCchhHHHHHHHHHHHHHHHHhhccCCCeEecCCCCCcEEEcCCCCeEEeecCCCccccC
Q 003836 576 LVYEFMSNGTVASFLFGD-SKPNWKLRTEIAMGIAGGLFYLHEECCTQIIHCDIKPQNILLDDHYNARISDFGLAKLLTL 654 (792)
Q Consensus 576 lV~E~~~~gsL~~~l~~~-~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dikp~NILl~~~~~~kl~Dfg~a~~~~~ 654 (792)
|||.+|+. +|.-+|... .+++..++.+++.++..||.|+|.. .|+|||+||.|+||+.++.+||+|||+++.+..
T Consensus 101 lVf~~ceh-DLaGlLsn~~vr~sls~Ikk~Mk~Lm~GL~~iHr~---kilHRDmKaaNvLIt~dgilklADFGlar~fs~ 176 (376)
T KOG0669|consen 101 LVFDFCEH-DLAGLLSNRKVRFSLSEIKKVMKGLMNGLYYIHRN---KILHRDMKAANVLITKDGILKLADFGLARAFST 176 (376)
T ss_pred eeHHHhhh-hHHHHhcCccccccHHHHHHHHHHHHHHHHHHHHh---hHHhhcccHhhEEEcCCceEEeeccccccceec
Confidence 99999987 788888665 5789999999999999999999998 999999999999999999999999999987654
Q ss_pred CCCC---ccccccccCCccccccccc-CCCCcccceehHHHHHHHHHhcCcCCCcchhhhhhhhHHHH-------HHHhh
Q 003836 655 DQSH---TNTAIRGTKGYVAPEWFRN-MPITVKVDVYSYGVLLLEIICLRRNIDNEISKVDKAILTDW-------AYDRY 723 (792)
Q Consensus 655 ~~~~---~~~~~~gt~~y~aPE~~~~-~~~~~k~DV~S~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~-------~~~~~ 723 (792)
.... ..+..+-|..|++||.+.+ .+++++.|||.-||++.||+|+...+...........+... .|+..
T Consensus 177 ~~n~~kprytnrvvTLwYrppEllLG~r~yg~~iDiWgAgCimaeMwtrspimqgnteqqql~~Is~LcGs~tkevWP~~ 256 (376)
T KOG0669|consen 177 SKNVVKPRYTNRVVTLWYRPPELLLGDREYGPPIDIWGAGCIMAEMWTRSPIMQGNTEQQQLHLISQLCGSITKEVWPNV 256 (376)
T ss_pred ccccCCCCcccceeeeecCCHHHhhcccccCCcchhHhHHHHHHHHHccCccccCChHHHHHHHHHHHhccCCcccCCCc
Confidence 3321 2334556999999998875 67999999999999999999999888766544322222111 11111
Q ss_pred cccchhHhhhch-h-ccc--CCHHH------HHHHHHHHHHccccCCCCCCCHHhHHHH
Q 003836 724 QERTLEALVEND-L-EAM--NNVTM------LHRFVMVAFWCIQEDPSHRPTMRKVTQM 772 (792)
Q Consensus 724 ~~~~~~~~~~~~-~-~~~--~~~~~------~~~l~~l~~~Cl~~~p~~RPs~~evl~~ 772 (792)
.+-.+-+-+... + .+. .-.+. -++.++++..++..||.+||+.++++..
T Consensus 257 d~lpL~~sie~ePl~~~~~rkv~n~~kp~~kd~~a~dLle~ll~~DP~kR~~ad~alnh 315 (376)
T KOG0669|consen 257 DNLPLYQSIELEPLPKGQKRKVKNRLKPYVKDDEALDLLEKLLKLDPTKRIDADQALNH 315 (376)
T ss_pred ccchHHHhccCCCCCcchhhhhhhhcccccCChhHHHHHHHHhccCcccCcchHhhhch
Confidence 111111111000 0 000 00111 2367889999999999999999998753
|
|
| >KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.9e-29 Score=279.38 Aligned_cols=247 Identities=25% Similarity=0.371 Sum_probs=202.2
Q ss_pred hhhhhcCccccceEEEeeecCCCceEEEEEEcccccccchHHHHHHHHHhccc-CCCCcccccceec-----cCCceEEE
Q 003836 504 GFKEELGRGAFGTVYKGFVNMGSSNHVAVKKLNSVFQDSEKEFKAEVNGIGQT-HHKNLVRLLGYCD-----EGQNRLLV 577 (792)
Q Consensus 504 ~~~~~lG~G~~g~Vy~g~~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l-~h~niv~l~g~~~-----~~~~~~lV 577 (792)
.|.++||.|.+|.||+++. ...++..|+|++... .+..++++.|.++++.. +|||++.++|++. .++.++||
T Consensus 22 ei~evig~Gtygkv~k~k~-~~~~~~aa~kI~~~~-~d~deEiE~eynil~~~~~hpnv~~fyg~~~k~~~~~~DqLWLV 99 (953)
T KOG0587|consen 22 EIIEVIGNGTYGKVYKGRH-VKTGQLAAIKIMDPT-EDEEEEIELEYNMLKKYSHHPNVATFYGAFIKKDPGNGDQLWLV 99 (953)
T ss_pred EEEEEEeeccceeEEEEee-eecCceeeeEeecCC-ccccHHHHHHHHHHHhccCCCCcceEEEEEEEecCCCCCeEEEE
Confidence 4568899999999999964 445678899988754 55677889999999988 6999999999984 35679999
Q ss_pred EEeccCCCccccccCC--CCCchhHHHHHHHHHHHHHHHHhhccCCCeEecCCCCCcEEEcCCCCeEEeecCCCccccCC
Q 003836 578 YEFMSNGTVASFLFGD--SKPNWKLRTEIAMGIAGGLFYLHEECCTQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLD 655 (792)
Q Consensus 578 ~E~~~~gsL~~~l~~~--~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dikp~NILl~~~~~~kl~Dfg~a~~~~~~ 655 (792)
||||.+||.-+++.+- .++.|..+..|+..+++||.+||.. .++|||||-.|||++.++.+||.|||++..+...
T Consensus 100 MEfC~gGSVTDLVKn~~g~rl~E~~IaYI~re~lrgl~HLH~n---kviHRDikG~NiLLT~e~~VKLvDFGvSaQldsT 176 (953)
T KOG0587|consen 100 MEFCGGGSVTDLVKNTKGNRLKEEWIAYILREILRGLAHLHNN---KVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDST 176 (953)
T ss_pred eeccCCccHHHHHhhhcccchhhHHHHHHHHHHHHHHHHHhhc---ceeeecccCceEEEeccCcEEEeeeeeeeeeecc
Confidence 9999999999988653 5789999999999999999999998 9999999999999999999999999999887655
Q ss_pred CCCccccccccCCccccccccc-----CCCCcccceehHHHHHHHHHhcCcCCCcchhhhhhhhHHHHHHHhhcccchhH
Q 003836 656 QSHTNTAIRGTKGYVAPEWFRN-----MPITVKVDVYSYGVLLLEIICLRRNIDNEISKVDKAILTDWAYDRYQERTLEA 730 (792)
Q Consensus 656 ~~~~~~~~~gt~~y~aPE~~~~-----~~~~~k~DV~S~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 730 (792)
.....+ ..||+.|||||++.. ..|+.++|+||||++..||--|..|+.++....-...+.
T Consensus 177 ~grRnT-~iGtP~WMAPEViac~e~~d~tyd~R~D~WsLGITaIEladG~PPl~DmHPmraLF~Ip-------------- 241 (953)
T KOG0587|consen 177 VGRRNT-FIGTPYWMAPEVIACDESPDATYDYRSDLWSLGITAIEMAEGAPPLCDMHPMRALFLIP-------------- 241 (953)
T ss_pred cccccC-cCCCcccccceeeecccCCCCCcccccchhhccceeehhcCCCCCccCcchhhhhccCC--------------
Confidence 444433 459999999999954 357889999999999999999999986653321111000
Q ss_pred hhhchhcccCCHHHHHHHHHHHHHccccCCCCCCCHHhHHH
Q 003836 731 LVENDLEAMNNVTMLHRFVMVAFWCIQEDPSHRPTMRKVTQ 771 (792)
Q Consensus 731 ~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~ 771 (792)
..+......+....+++.++|..||..|-+.||++.++++
T Consensus 242 -RNPPPkLkrp~kWs~~FndFIs~cL~Kd~e~RP~~~~ll~ 281 (953)
T KOG0587|consen 242 -RNPPPKLKRPKKWSKKFNDFISTCLVKDYEQRPSTEELLK 281 (953)
T ss_pred -CCCCccccchhhHHHHHHHHHHHHHhhccccCcchhhhcc
Confidence 1122222335677899999999999999999999998876
|
|
| >KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.3e-28 Score=244.15 Aligned_cols=245 Identities=22% Similarity=0.292 Sum_probs=196.0
Q ss_pred hhhhcCccccceEEEeeecCCCceEEEEEEccccc---ccchHHHHHHHHHhccc-CCCCcccccceeccCCceEEEEEe
Q 003836 505 FKEELGRGAFGTVYKGFVNMGSSNHVAVKKLNSVF---QDSEKEFKAEVNGIGQT-HHKNLVRLLGYCDEGQNRLLVYEF 580 (792)
Q Consensus 505 ~~~~lG~G~~g~Vy~g~~~~~~~~~vavK~~~~~~---~~~~~~~~~Ei~~l~~l-~h~niv~l~g~~~~~~~~~lV~E~ 580 (792)
+..+||+|+|..|.++.+. .+.+.+|+|++++.. .+...-.+.|-.++... +||.+|.+..+|..+..+++|.||
T Consensus 254 ll~vigrgsyakvl~~~~~-~t~qiyamkvvkkel~nddedidwvqtek~vfe~asn~pflvglhscfqtesrlffviey 332 (593)
T KOG0695|consen 254 LLRVIGRGSYAKVLLVRLK-KTDQIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNNPFLVGLHSCFQTESRLFFVIEY 332 (593)
T ss_pred eeeeecCcchhhhhheehc-ccceeeehhhHHHHhcCCcccchhHHhhHHHHHhccCCCeEEehhhhhcccceEEEEEEE
Confidence 3468999999999998765 456799999998642 22334567777777765 799999999999999999999999
Q ss_pred ccCCCccccccCCCCCchhHHHHHHHHHHHHHHHHhhccCCCeEecCCCCCcEEEcCCCCeEEeecCCCccccCCCCCcc
Q 003836 581 MSNGTVASFLFGDSKPNWKLRTEIAMGIAGGLFYLHEECCTQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLDQSHTN 660 (792)
Q Consensus 581 ~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dikp~NILl~~~~~~kl~Dfg~a~~~~~~~~~~~ 660 (792)
+++|+|--++.+.++++++........|.-||.|||++ |||.||||..|+|||..|.+||.|||+.+....+ ....
T Consensus 333 v~ggdlmfhmqrqrklpeeharfys~ei~lal~flh~r---giiyrdlkldnvlldaeghikltdygmcke~l~~-gd~t 408 (593)
T KOG0695|consen 333 VNGGDLMFHMQRQRKLPEEHARFYSAEICLALNFLHER---GIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGLGP-GDTT 408 (593)
T ss_pred ecCcceeeehhhhhcCcHHHhhhhhHHHHHHHHHHhhc---CeeeeeccccceEEccCCceeecccchhhcCCCC-Cccc
Confidence 99999999999989999999999999999999999999 9999999999999999999999999999875433 3445
Q ss_pred ccccccCCcccccccccCCCCcccceehHHHHHHHHHhcCcCCCcchhhhhhhhHHHHHHHhhcccchhHhhhchhcccC
Q 003836 661 TAIRGTKGYVAPEWFRNMPITVKVDVYSYGVLLLEIICLRRNIDNEISKVDKAILTDWAYDRYQERTLEALVENDLEAMN 740 (792)
Q Consensus 661 ~~~~gt~~y~aPE~~~~~~~~~k~DV~S~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 740 (792)
.+.+|||.|.|||++++..|....|.|++||+++||+.|+.||+-...+..+..-.++... .+++..++ .
T Consensus 409 stfcgtpnyiapeilrgeeygfsvdwwalgvlmfemmagrspfdivgm~n~d~ntedylfq--------vilekqir--i 478 (593)
T KOG0695|consen 409 STFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIVGMDNPDMNTEDYLFQ--------VILEKQIR--I 478 (593)
T ss_pred ccccCCCcccchhhhcccccCceehHHHHHHHHHHHHcCCCCcceecCCCcccchhHHHHH--------HHhhhccc--c
Confidence 6688999999999999999999999999999999999999999754322111111111111 12222222 2
Q ss_pred CHHHHHHHHHHHHHccccCCCCCC
Q 003836 741 NVTMLHRFVMVAFWCIQEDPSHRP 764 (792)
Q Consensus 741 ~~~~~~~l~~l~~~Cl~~~p~~RP 764 (792)
+...+.+...+.+.-|+.||.+|.
T Consensus 479 prslsvkas~vlkgflnkdp~erl 502 (593)
T KOG0695|consen 479 PRSLSVKASHVLKGFLNKDPKERL 502 (593)
T ss_pred cceeehhhHHHHHHhhcCCcHHhc
Confidence 334455667788888999999984
|
|
| >KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=2.4e-29 Score=243.12 Aligned_cols=262 Identities=25% Similarity=0.316 Sum_probs=197.6
Q ss_pred hhcCccccceEEEeeecCCCceEEEEEEccccccc--chHHHHHHHHHhcccCCCCcccccceeccC-----CceEEEEE
Q 003836 507 EELGRGAFGTVYKGFVNMGSSNHVAVKKLNSVFQD--SEKEFKAEVNGIGQTHHKNLVRLLGYCDEG-----QNRLLVYE 579 (792)
Q Consensus 507 ~~lG~G~~g~Vy~g~~~~~~~~~vavK~~~~~~~~--~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~-----~~~~lV~E 579 (792)
+.||-|+||.||..... .+++.||.|++...... ..+.+.+|+++|..++|.|++..++...-. .+.|+|.|
T Consensus 59 RPIGYGAFGVVWsVTDP-RdgrrvalkK~pnvfq~L~s~krvFre~kmLcfFkHdNVLSaLDILQPph~dfFqEiYV~TE 137 (449)
T KOG0664|consen 59 RPIGYGAFGVVWSVTDP-RSGKRVALKKMPNVFQNLASCKRVFREIKMLSSFRHDNVLSLLDILQPANPSFFQELYVLTE 137 (449)
T ss_pred CcccccceeEEEeccCC-CCccchhHhhcchHHHHHHHHHHHHHHHHHHHhhccccHHHHHHhcCCCCchHHHHHHHHHH
Confidence 46999999999998654 56789999998765432 357889999999999999999998876443 35788899
Q ss_pred eccCCCccccccCCCCCchhHHHHHHHHHHHHHHHHhhccCCCeEecCCCCCcEEEcCCCCeEEeecCCCccccCCCCCc
Q 003836 580 FMSNGTVASFLFGDSKPNWKLRTEIAMGIAGGLFYLHEECCTQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLDQSHT 659 (792)
Q Consensus 580 ~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dikp~NILl~~~~~~kl~Dfg~a~~~~~~~~~~ 659 (792)
.|.. +|...+-....++...+.-+..||++||+|||+. +|.||||||.|.|++.|...||+|||+++.-..++...
T Consensus 138 LmQS-DLHKIIVSPQ~Ls~DHvKVFlYQILRGLKYLHsA---~ILHRDIKPGNLLVNSNCvLKICDFGLARvee~d~~~h 213 (449)
T KOG0664|consen 138 LMQS-DLHKIIVSPQALTPDHVKVFVYQILRGLKYLHTA---NILHRDIKPGNLLVNSNCILKICDFGLARTWDQRDRLN 213 (449)
T ss_pred HHHh-hhhheeccCCCCCcchhhhhHHHHHhhhHHHhhc---chhhccCCCccEEeccCceEEecccccccccchhhhhh
Confidence 9976 8999998888899999999999999999999999 99999999999999999999999999999887777766
Q ss_pred cccccccCCccccccccc-CCCCcccceehHHHHHHHHHhcCcCCCcchhhhhhhhHHHH----HHHhh---cccchhHh
Q 003836 660 NTAIRGTKGYVAPEWFRN-MPITVKVDVYSYGVLLLEIICLRRNIDNEISKVDKAILTDW----AYDRY---QERTLEAL 731 (792)
Q Consensus 660 ~~~~~gt~~y~aPE~~~~-~~~~~k~DV~S~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~----~~~~~---~~~~~~~~ 731 (792)
.+..+-|..|+|||++++ ..|+.+.||||.||++.||+..+..|...........+.+. ..+.+ -++...-+
T Consensus 214 MTqEVVTQYYRAPEiLMGaRhYs~AvDiWSVGCIFaELLgRrILFQAq~PiqQL~lItdLLGTPs~EaMr~ACEGAk~H~ 293 (449)
T KOG0664|consen 214 MTHEVVTQYYRAPELLMGARRYTGAVDIWSVGCIFAELLQRKILFQAAGPIEQLQMIIDLLGTPSQEAMKYACEGAKNHV 293 (449)
T ss_pred hHHHHHHHHhccHHHhhcchhhcCccceehhhHHHHHHHhhhhhhhccChHHHHHHHHHHhCCCcHHHHHHHhhhhHHHh
Confidence 666677999999999987 46999999999999999999888777543322111111110 00000 00000001
Q ss_pred hhchhcc---------cCCHHHHHHHHHHHHHccccCCCCCCCHHhHHHHh
Q 003836 732 VENDLEA---------MNNVTMLHRFVMVAFWCIQEDPSHRPTMRKVTQML 773 (792)
Q Consensus 732 ~~~~~~~---------~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~L 773 (792)
+....+. ..+...-.+.+++..+++..+|++|.+..+.+..+
T Consensus 294 LR~~~k~Ps~~vLYtlsS~~~~~heav~~~~~~l~~d~dkris~~~A~~~~ 344 (449)
T KOG0664|consen 294 LRAGLRAPDTQRLYKIASPDDKNHEAVDLLQKLLHFDPDKRISVEEALQHR 344 (449)
T ss_pred hccCCCCCCccceeeecCCcccchHHHHHHHHHhCCCCcccccHhhhcccc
Confidence 1100000 00112234556777889999999999999988765
|
|
| >KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.5e-28 Score=229.16 Aligned_cols=195 Identities=29% Similarity=0.407 Sum_probs=164.0
Q ss_pred hhcCccccceEEEeeecCCCceEEEEEEccccc-ccchHHHHHHHHHhccc-CCCCcccccceeccCCceEEEEEeccCC
Q 003836 507 EELGRGAFGTVYKGFVNMGSSNHVAVKKLNSVF-QDSEKEFKAEVNGIGQT-HHKNLVRLLGYCDEGQNRLLVYEFMSNG 584 (792)
Q Consensus 507 ~~lG~G~~g~Vy~g~~~~~~~~~vavK~~~~~~-~~~~~~~~~Ei~~l~~l-~h~niv~l~g~~~~~~~~~lV~E~~~~g 584 (792)
+.||+|++|.|-+-.+ ..++..+|+|++.... .+.+++..+|+.+..+. ..|.+|.++|........++.||.|.-
T Consensus 52 ~elGrGayG~vekmrh-~~sg~imAvKri~~tvn~q~q~r~L~dldi~~r~~~CPf~V~FyGa~~regdvwIcME~M~t- 129 (282)
T KOG0984|consen 52 EELGRGAYGVVEKMRH-IQSGTIMAVKRIRATVNSQEQKRLLMDLDIIMRTVDCPFTVHFYGALFREGDVWICMELMDT- 129 (282)
T ss_pred hhhcCCccchhhheee-ccCCeEEEEeeehhhcChHHHHHHHHhhhhhccCCCCCeEEEeehhhhccccEEEeHHHhhh-
Confidence 5699999999977654 4567899999997543 45567888999987765 799999999999999999999999965
Q ss_pred Ccccccc----CCCCCchhHHHHHHHHHHHHHHHHhhccCCCeEecCCCCCcEEEcCCCCeEEeecCCCccccCCCCCcc
Q 003836 585 TVASFLF----GDSKPNWKLRTEIAMGIAGGLFYLHEECCTQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLDQSHTN 660 (792)
Q Consensus 585 sL~~~l~----~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dikp~NILl~~~~~~kl~Dfg~a~~~~~~~~~~~ 660 (792)
||+.|.. .....++..+-+||..|.+||.|||++ ..+||||+||+||||+.+|++|++|||++-.+... -..
T Consensus 130 Sldkfy~~v~~~g~~ipE~vlGkIa~Svv~al~~L~~k--L~vIHRDvKPsNiLIn~~GqVKiCDFGIsG~L~dS--iAk 205 (282)
T KOG0984|consen 130 SLDKFYRKVLKKGGTIPEDVLGKIAVSVVHALEFLHSK--LSVIHRDVKPSNILINYDGQVKICDFGISGYLVDS--IAK 205 (282)
T ss_pred hHHHHHHHHHhcCCcCchHHhhHhHHHHHHHHHHHHHH--hhhhhccCCcceEEEccCCcEEEcccccceeehhh--hHH
Confidence 7776653 456789999999999999999999998 79999999999999999999999999999776432 222
Q ss_pred ccccccCCcccccccc----cCCCCcccceehHHHHHHHHHhcCcCCCcch
Q 003836 661 TAIRGTKGYVAPEWFR----NMPITVKVDVYSYGVLLLEIICLRRNIDNEI 707 (792)
Q Consensus 661 ~~~~gt~~y~aPE~~~----~~~~~~k~DV~S~Gv~l~el~tg~~p~~~~~ 707 (792)
+.-.|-..|||||.+. ...|+.|+||||||+.+.||.+++.|++.-.
T Consensus 206 t~daGCkpYmaPEri~~e~n~~gY~vksDvWSLGItmiElA~lr~PY~~w~ 256 (282)
T KOG0984|consen 206 TMDAGCKPYMAPERINPELNQKGYSVKSDVWSLGITMIEMAILRFPYESWG 256 (282)
T ss_pred HHhcCCCccCChhhcCcccCcccceeehhhhhhhhhhhhhhhccccccccC
Confidence 2244778999999885 3479999999999999999999999986543
|
|
| >KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=9.5e-29 Score=272.66 Aligned_cols=238 Identities=27% Similarity=0.348 Sum_probs=184.9
Q ss_pred hhcCccccc-eEEEeeecCCCceEEEEEEcccccccchHHHHHHHHHhccc-CCCCcccccceeccCCceEEEEEeccCC
Q 003836 507 EELGRGAFG-TVYKGFVNMGSSNHVAVKKLNSVFQDSEKEFKAEVNGIGQT-HHKNLVRLLGYCDEGQNRLLVYEFMSNG 584 (792)
Q Consensus 507 ~~lG~G~~g-~Vy~g~~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l-~h~niv~l~g~~~~~~~~~lV~E~~~~g 584 (792)
+.+|.|..| .||+|..+ ++.||||++-. +...-.++|+..|+.- +|||||++++.-.+...+||..|.|.-
T Consensus 515 eilG~Gs~Gt~Vf~G~ye---~R~VAVKrll~---e~~~~A~rEi~lL~eSD~H~NviRyyc~E~d~qF~YIalELC~~- 587 (903)
T KOG1027|consen 515 EILGYGSNGTVVFRGVYE---GREVAVKRLLE---EFFDFAQREIQLLQESDEHPNVIRYYCSEQDRQFLYIALELCAC- 587 (903)
T ss_pred HHcccCCCCcEEEEEeeC---CceehHHHHhh---HhHHHHHHHHHHHHhccCCCceEEEEeeccCCceEEEEehHhhh-
Confidence 568999987 56999886 57999999853 3345678999999987 699999999999999999999999965
Q ss_pred CccccccCC-C---CCchhHHHHHHHHHHHHHHHHhhccCCCeEecCCCCCcEEEcC-----CCCeEEeecCCCccccCC
Q 003836 585 TVASFLFGD-S---KPNWKLRTEIAMGIAGGLFYLHEECCTQIIHCDIKPQNILLDD-----HYNARISDFGLAKLLTLD 655 (792)
Q Consensus 585 sL~~~l~~~-~---~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dikp~NILl~~-----~~~~kl~Dfg~a~~~~~~ 655 (792)
+|++++... . ...-.....+..|++.||++||+. +||||||||.||||+. ...++|+|||+++.+..+
T Consensus 588 sL~dlie~~~~d~~~~~~i~~~~~l~q~~~GlaHLHsl---~iVHRDLkPQNILI~~~~~~~~~ra~iSDfglsKkl~~~ 664 (903)
T KOG1027|consen 588 SLQDLIESSGLDVEMQSDIDPISVLSQIASGLAHLHSL---KIVHRDLKPQNILISVPSADGTLRAKISDFGLSKKLAGG 664 (903)
T ss_pred hHHHHHhccccchhhcccccHHHHHHHHHHHHHHHHhc---ccccccCCCceEEEEccCCCcceeEEecccccccccCCC
Confidence 999999774 1 111134567889999999999997 9999999999999975 257999999999998776
Q ss_pred CCCc--cccccccCCcccccccccCCCCcccceehHHHHHHHHHhc-CcCCCcchhhhhhhhHHHHHHHhhcccchhHhh
Q 003836 656 QSHT--NTAIRGTKGYVAPEWFRNMPITVKVDVYSYGVLLLEIICL-RRNIDNEISKVDKAILTDWAYDRYQERTLEALV 732 (792)
Q Consensus 656 ~~~~--~~~~~gt~~y~aPE~~~~~~~~~k~DV~S~Gv~l~el~tg-~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 732 (792)
.... .....||-||+|||.+....-+.++||||+||++|+.++| ..||........ .+.. .+..+. .
T Consensus 665 ~sS~~r~s~~sGt~GW~APE~L~~~~~~~avDiFslGCvfyYvltgG~HpFGd~~~R~~--NIl~------~~~~L~-~- 734 (903)
T KOG1027|consen 665 KSSFSRLSGGSGTSGWQAPEQLREDRKTQAVDIFSLGCVFYYVLTGGSHPFGDSLERQA--NILT------GNYTLV-H- 734 (903)
T ss_pred cchhhcccCCCCcccccCHHHHhccccCcccchhhcCceEEEEecCCccCCCchHHhhh--hhhc------Ccccee-e-
Confidence 6543 3356799999999999998888899999999999999997 678865432111 0000 000000 0
Q ss_pred hchhcccCCHHHHHHHHHHHHHccccCCCCCCCHHhHHH
Q 003836 733 ENDLEAMNNVTMLHRFVMVAFWCIQEDPSHRPTMRKVTQ 771 (792)
Q Consensus 733 ~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~ 771 (792)
+.. ..+. +..+||.+|+.++|..||++.+|+.
T Consensus 735 ---L~~--~~d~--eA~dLI~~ml~~dP~~RPsa~~VL~ 766 (903)
T KOG1027|consen 735 ---LEP--LPDC--EAKDLISRMLNPDPQLRPSATDVLN 766 (903)
T ss_pred ---ecc--CchH--HHHHHHHHhcCCCcccCCCHHHHhC
Confidence 000 1111 7789999999999999999999985
|
|
| >PF01453 B_lectin: D-mannose binding lectin; InterPro: IPR001480 A bulb lectin super-family (Amaryllidaceae, Orchidaceae and Aliaceae) contains a ~115-residue-long domain whose overall three dimensional fold is very similar to that of [, ]: Dictyostelium discoideum comitin, an actin binding protein Curculigo latifolia curculin, a sweet tasting and taste-modifying protein This domain generally binds mannose, but in at least one protein, curculin, it is apparently devoid of mannose-binding activity | Back alignment and domain information |
|---|
Probab=99.95 E-value=8.5e-29 Score=220.86 Aligned_cols=102 Identities=38% Similarity=0.617 Sum_probs=75.3
Q ss_pred CCcEEEEecCCCCCC---CCeeEEEEeCccEEEEcCCCCEEEEe-ccCCCc--ceeEEEecCCcEEEEecCCcccccccc
Q 003836 72 SKTIVWYASAVNPAP---RGSKLRLTANRGLVLEDPEGREIWKS-EISTGQ--AAFGVLYDTGNFLIVNTNSERLWQSFD 145 (792)
Q Consensus 72 ~~tvvWvANr~~P~~---~~~~l~~~~~G~Lvl~~~~~~~vWst-~~~~~~--~~~a~LldsGNlVl~~~~~~~lWQSFd 145 (792)
++||||+|||+.|+. ....|.|+.||+|+|+|++++++|+| ++...+ ...|+|+|+|||||+|..+.+||||||
T Consensus 1 ~~tvvW~an~~~p~~~~s~~~~L~l~~dGnLvl~~~~~~~iWss~~t~~~~~~~~~~~L~~~GNlvl~d~~~~~lW~Sf~ 80 (114)
T PF01453_consen 1 PRTVVWVANRNSPLTSSSGNYTLILQSDGNLVLYDSNGSVIWSSNNTSGRGNSGCYLVLQDDGNLVLYDSSGNVLWQSFD 80 (114)
T ss_dssp ---------TTEEEEECETTEEEEEETTSEEEEEETTTEEEEE--S-TTSS-SSEEEEEETTSEEEEEETTSEEEEESTT
T ss_pred CcccccccccccccccccccccceECCCCeEEEEcCCCCEEEEecccCCccccCeEEEEeCCCCEEEEeecceEEEeecC
Confidence 479999999999993 34789999999999999999999999 555444 689999999999999999999999999
Q ss_pred CCcccccCCCccccc------eEEeeeccCCCCC
Q 003836 146 HPTDTLLPTQTMERG------GVVSSRRKDTYFS 173 (792)
Q Consensus 146 ~PtDtlLpg~~l~~~------~~L~S~~s~~~~s 173 (792)
|||||+||+|+|+.+ ..++||++.+|||
T Consensus 81 ~ptdt~L~~q~l~~~~~~~~~~~~~sw~s~~dps 114 (114)
T PF01453_consen 81 YPTDTLLPGQKLGDGNVTGKNDSLTSWSSNTDPS 114 (114)
T ss_dssp SSS-EEEEEET--TSEEEEESTSSEEEESS----
T ss_pred CCccEEEeccCcccCCCccccceEEeECCCCCCC
Confidence 999999999999873 2499999999986
|
Each bulb-type lectin domain consists of three sequential beta-sheet subdomains (I, II, III) that are inter-related by pseudo three-fold symmetry. The three subdomains are flat four-stranded, antiparrallel beta-sheets. Together they form a 12-stranded beta-barrel in which the barrel axis coincides with the pseudo 3-fold axis.; GO: 0005529 sugar binding; PDB: 3M7H_A 3M7J_B 3MEZ_D 1DLP_A 1BWU_D 1KJ1_A 1B2P_A 1XD6_A 2DPF_C 2D04_B .... |
| >KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription] | Back alignment and domain information |
|---|
Probab=99.95 E-value=6.3e-28 Score=228.09 Aligned_cols=258 Identities=18% Similarity=0.295 Sum_probs=194.7
Q ss_pred HhhhhhhcCccccceEEEeeecCCCceEEEEEEcccccccchHHHHHHHHHhcccC-CCCcccccceeccCC--ceEEEE
Q 003836 502 TRGFKEELGRGAFGTVYKGFVNMGSSNHVAVKKLNSVFQDSEKEFKAEVNGIGQTH-HKNLVRLLGYCDEGQ--NRLLVY 578 (792)
Q Consensus 502 ~~~~~~~lG~G~~g~Vy~g~~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~-h~niv~l~g~~~~~~--~~~lV~ 578 (792)
.+.+.+++|+|.++.||.|. +..+.+.++||+++.. ..+.+.+|+.+|+.|+ ||||++|++...+.. ...||+
T Consensus 39 dYeivrk~GRGKYSEVFeg~-~~~~~eK~ViKiLKPV---kkkKIkREikIL~nL~gg~NIi~L~DiV~Dp~SktpaLiF 114 (338)
T KOG0668|consen 39 DYEIVRKVGRGKYSEVFEGI-NITNNEKCVIKILKPV---KKKKIKREIKILQNLRGGPNIIKLLDIVKDPESKTPSLIF 114 (338)
T ss_pred hHHHHHHHcCccHhhHhccc-ccCCCceEEEeeechH---HHHHHHHHHHHHHhccCCCCeeehhhhhcCccccCchhHh
Confidence 35567889999999999995 4455678999999754 4578999999999997 999999999997654 567999
Q ss_pred EeccCCCccccccCCCCCchhHHHHHHHHHHHHHHHHhhccCCCeEecCCCCCcEEEcC-CCCeEEeecCCCccccCCCC
Q 003836 579 EFMSNGTVASFLFGDSKPNWKLRTEIAMGIAGGLFYLHEECCTQIIHCDIKPQNILLDD-HYNARISDFGLAKLLTLDQS 657 (792)
Q Consensus 579 E~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dikp~NILl~~-~~~~kl~Dfg~a~~~~~~~~ 657 (792)
||+.+.+...+. ..++...+...+.++++||.|+|+. ||+|||+||.|++||. ...++|+|+|+|....+...
T Consensus 115 E~v~n~Dfk~ly---~tl~d~dIryY~~elLkALdyCHS~---GImHRDVKPhNvmIdh~~rkLrlIDWGLAEFYHp~~e 188 (338)
T KOG0668|consen 115 EYVNNTDFKQLY---PTLTDYDIRYYIYELLKALDYCHSM---GIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKE 188 (338)
T ss_pred hhhccccHHHHh---hhhchhhHHHHHHHHHHHHhHHHhc---CcccccCCcceeeechhhceeeeeecchHhhcCCCce
Confidence 999998777665 4567778888999999999999999 9999999999999995 46799999999998765544
Q ss_pred CccccccccCCccccccccc-CCCCcccceehHHHHHHHHHhcCcCCCcchhhhhhhhH----------HHHHH--Hhhc
Q 003836 658 HTNTAIRGTKGYVAPEWFRN-MPITVKVDVYSYGVLLLEIICLRRNIDNEISKVDKAIL----------TDWAY--DRYQ 724 (792)
Q Consensus 658 ~~~~~~~gt~~y~aPE~~~~-~~~~~k~DV~S~Gv~l~el~tg~~p~~~~~~~~~~~~~----------~~~~~--~~~~ 724 (792)
... .+.+..|..||.+.. ..|+..-|+|||||+|.+|+-.+.||....+..++..- ..+.. ....
T Consensus 189 YnV--RVASRyfKGPELLVdy~~YDYSLD~WS~GcmlA~miFrkepFFhG~dN~DQLVkIakVLGt~el~~Yl~KY~i~L 266 (338)
T KOG0668|consen 189 YNV--RVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVKIAKVLGTDELYAYLNKYQIDL 266 (338)
T ss_pred eee--eeehhhcCCchheeechhccccHHHHHHHHHHHHHHhccCcccCCCCCHHHHHHHHHHhChHHHHHHHHHHccCC
Confidence 332 235667899999876 46899999999999999999999999665443332110 00000 0011
Q ss_pred ccchhHhhhchhc--------ccCCHHHHHHHHHHHHHccccCCCCCCCHHhHHH
Q 003836 725 ERTLEALVENDLE--------AMNNVTMLHRFVMVAFWCIQEDPSHRPTMRKVTQ 771 (792)
Q Consensus 725 ~~~~~~~~~~~~~--------~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~ 771 (792)
+.....++....+ .....-...+.++++...|.-|-.+|||++|.+.
T Consensus 267 dp~~~~i~~~~~rk~w~~Fi~~~n~hl~~peaiDlldklLrYDHqeRlTakEam~ 321 (338)
T KOG0668|consen 267 DPQFEDILGRHSRKPWSRFINSENQHLVSPEAIDLLDKLLRYDHQERLTAKEAMA 321 (338)
T ss_pred ChhHhhHhhccccccHHHhCCccccccCChHHHHHHHHHHhhccccccchHHHhc
Confidence 1222222222111 1111123478899999999999999999999876
|
|
| >KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.95 E-value=9.2e-28 Score=255.59 Aligned_cols=202 Identities=24% Similarity=0.334 Sum_probs=173.3
Q ss_pred hhcCccccceEEEeeecCCCceEEEEEEcccccc---cchHHHHHHHHHhcccCCCCcccccceeccCCceEEEEEeccC
Q 003836 507 EELGRGAFGTVYKGFVNMGSSNHVAVKKLNSVFQ---DSEKEFKAEVNGIGQTHHKNLVRLLGYCDEGQNRLLVYEFMSN 583 (792)
Q Consensus 507 ~~lG~G~~g~Vy~g~~~~~~~~~vavK~~~~~~~---~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~lV~E~~~~ 583 (792)
+.||-|+||.|-++. ..++...+|+|.+++.+. ......+.|-.||+..+.+=||+|+-.|.+++.+|+||+|++|
T Consensus 635 k~iGvGAFGeV~Lv~-KvDT~~lYAmKTLrKaDVl~rnQvaHVKAERDILAEADn~WVVrLyySFQDkdnLYFVMdYIPG 713 (1034)
T KOG0608|consen 635 KTIGVGAFGEVCLVR-KVDTRALYAMKTLRKADVLMRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVMDYIPG 713 (1034)
T ss_pred eeecccccceeEEEe-ecchhhHHHHhhhHHHHHHhhhhhhhhhhhhhhHhhcCCcceEEEEEEeccCCceEEEEeccCC
Confidence 459999999999985 345667899999987543 2334678899999999999999999999999999999999999
Q ss_pred CCccccccCCCCCchhHHHHHHHHHHHHHHHHhhccCCCeEecCCCCCcEEEcCCCCeEEeecCCCccccCCC-------
Q 003836 584 GTVASFLFGDSKPNWKLRTEIAMGIAGGLFYLHEECCTQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLDQ------- 656 (792)
Q Consensus 584 gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dikp~NILl~~~~~~kl~Dfg~a~~~~~~~------- 656 (792)
|++-.+|.+...+.+.....++..+..|+++.|.. |+|||||||+|||||.+|.+||.|||++.-+.-..
T Consensus 714 GDmMSLLIrmgIFeE~LARFYIAEltcAiesVHkm---GFIHRDiKPDNILIDrdGHIKLTDFGLCTGfRWTHdskYYq~ 790 (1034)
T KOG0608|consen 714 GDMMSLLIRMGIFEEDLARFYIAELTCAIESVHKM---GFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQE 790 (1034)
T ss_pred ccHHHHHHHhccCHHHHHHHHHHHHHHHHHHHHhc---cceecccCccceEEccCCceeeeeccccccceeccccccccC
Confidence 99999999989999999888999999999999998 99999999999999999999999999986542100
Q ss_pred -C---------------------------------CccccccccCCcccccccccCCCCcccceehHHHHHHHHHhcCcC
Q 003836 657 -S---------------------------------HTNTAIRGTKGYVAPEWFRNMPITVKVDVYSYGVLLLEIICLRRN 702 (792)
Q Consensus 657 -~---------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~k~DV~S~Gv~l~el~tg~~p 702 (792)
. ......+||+.|+|||++....++..+|.||.|||||||+-|+.|
T Consensus 791 gdH~RqDSmep~~e~~d~~~~lkvL~~ra~~~h~r~~ahslvgt~nyiapevl~r~g~~q~cdwws~gvil~em~~g~~p 870 (1034)
T KOG0608|consen 791 GDHHRQDSMEPSPEWADISKCLKVLERRAMRQHQRILAHSLVGTPNYIAPEVLARTGYTQLCDWWSVGVILYEMLVGQPP 870 (1034)
T ss_pred CCccccccCCCchhhccccccchHHHHHHHhhhhhhhhhhhcCCCcccChHHhcccCccccchhhHhhHHHHHHhhCCCC
Confidence 0 001224699999999999999999999999999999999999999
Q ss_pred CCcchhhhhh
Q 003836 703 IDNEISKVDK 712 (792)
Q Consensus 703 ~~~~~~~~~~ 712 (792)
|........+
T Consensus 871 f~~~tp~~tq 880 (1034)
T KOG0608|consen 871 FLADTPGETQ 880 (1034)
T ss_pred ccCCCCCcce
Confidence 9776554433
|
|
| >cd00180 PKc Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Probab=99.94 E-value=1e-26 Score=233.51 Aligned_cols=211 Identities=34% Similarity=0.528 Sum_probs=183.6
Q ss_pred cCccccceEEEeeecCCCceEEEEEEccccccc-chHHHHHHHHHhcccCCCCcccccceeccCCceEEEEEeccCCCcc
Q 003836 509 LGRGAFGTVYKGFVNMGSSNHVAVKKLNSVFQD-SEKEFKAEVNGIGQTHHKNLVRLLGYCDEGQNRLLVYEFMSNGTVA 587 (792)
Q Consensus 509 lG~G~~g~Vy~g~~~~~~~~~vavK~~~~~~~~-~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~lV~E~~~~gsL~ 587 (792)
||+|.+|.||++.... +++.+++|++...... ..+.+.+|++.+++++|++++++++++......++++||+++++|.
T Consensus 1 l~~g~~~~v~~~~~~~-~~~~~~~K~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~~~e~~~~~~l~ 79 (215)
T cd00180 1 LGEGGFGTVYLARDKK-TGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVFEDENHLYLVMEYCEGGSLK 79 (215)
T ss_pred CCcCCceEEEEEEecC-CCcEEEEEEeccccchhHHHHHHHHHHHHHhcCCCCeeeEeeeeecCCeEEEEEecCCCCcHH
Confidence 6899999999997643 4678999998765332 3578999999999999999999999999999999999999999999
Q ss_pred ccccCC-CCCchhHHHHHHHHHHHHHHHHhhccCCCeEecCCCCCcEEEcC-CCCeEEeecCCCccccCCCCCccccccc
Q 003836 588 SFLFGD-SKPNWKLRTEIAMGIAGGLFYLHEECCTQIIHCDIKPQNILLDD-HYNARISDFGLAKLLTLDQSHTNTAIRG 665 (792)
Q Consensus 588 ~~l~~~-~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dikp~NILl~~-~~~~kl~Dfg~a~~~~~~~~~~~~~~~g 665 (792)
+++... ..+++..+..++.+++++|.+||+. +++|+||+|.||+++. ++.++|+|||.+........ ......+
T Consensus 80 ~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~---~~~H~dl~~~ni~~~~~~~~~~l~d~~~~~~~~~~~~-~~~~~~~ 155 (215)
T cd00180 80 DLLKENEGKLSEDEILRILLQILEGLEYLHSN---GIIHRDLKPENILLDSDNGKVKLADFGLSKLLTSDKS-LLKTIVG 155 (215)
T ss_pred HHHHhccCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHhhEEEeCCCCcEEEecCCceEEccCCcc-hhhcccC
Confidence 999765 5688999999999999999999999 9999999999999999 89999999999987644321 1223447
Q ss_pred cCCcccccccccC-CCCcccceehHHHHHHHHHhcCcCCCcchhhhhhhhHHHHHHHhhcccchhHhhhchhcccCCHHH
Q 003836 666 TKGYVAPEWFRNM-PITVKVDVYSYGVLLLEIICLRRNIDNEISKVDKAILTDWAYDRYQERTLEALVENDLEAMNNVTM 744 (792)
Q Consensus 666 t~~y~aPE~~~~~-~~~~k~DV~S~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 744 (792)
...|++||.+... ..+.++|+|++|+++++|
T Consensus 156 ~~~~~~pe~~~~~~~~~~~~D~~~lg~~~~~l------------------------------------------------ 187 (215)
T cd00180 156 TPAYMAPEVLLGKGYYSEKSDIWSLGVILYEL------------------------------------------------ 187 (215)
T ss_pred CCCccChhHhcccCCCCchhhhHHHHHHHHHH------------------------------------------------
Confidence 8899999999887 888999999999999998
Q ss_pred HHHHHHHHHHccccCCCCCCCHHhHHHHh
Q 003836 745 LHRFVMVAFWCIQEDPSHRPTMRKVTQML 773 (792)
Q Consensus 745 ~~~l~~l~~~Cl~~~p~~RPs~~evl~~L 773 (792)
..+.+++..|++.+|++||++.++++.+
T Consensus 188 -~~~~~~l~~~l~~~p~~R~~~~~l~~~~ 215 (215)
T cd00180 188 -PELKDLIRKMLQKDPEKRPSAKEILEHL 215 (215)
T ss_pred -HHHHHHHHHHhhCCcccCcCHHHHhhCC
Confidence 4567889999999999999999998743
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which |
| >KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=6.1e-27 Score=243.86 Aligned_cols=141 Identities=28% Similarity=0.408 Sum_probs=116.0
Q ss_pred cccCHHHHHH-HHhhhhhhcCccccceEEEeeecCCCceEEEEEEcccccccchHHHHHHHHHhcccC-----C---CCc
Q 003836 491 RCFTYKELVE-VTRGFKEELGRGAFGTVYKGFVNMGSSNHVAVKKLNSVFQDSEKEFKAEVNGIGQTH-----H---KNL 561 (792)
Q Consensus 491 ~~~~~~el~~-~~~~~~~~lG~G~~g~Vy~g~~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~-----h---~ni 561 (792)
......|... .+|...++||-|-|+|||++. +....+.||+|+.+.. +...+....||++|++++ | ..|
T Consensus 67 HpV~IGD~F~~gRY~v~rKLGWGHFSTVWLaw-Dtq~~r~VAlKVvKSA-qhYtEaAlDEIklL~~v~~~Dp~~~~~~~V 144 (590)
T KOG1290|consen 67 HPVRIGDVFNGGRYHVQRKLGWGHFSTVWLAW-DTQNKRYVALKVVKSA-QHYTEAALDEIKLLQQVREGDPNDPGKKCV 144 (590)
T ss_pred ceeeccccccCceEEEEEeccccccceeEEEe-eccCCeEEEEEEEehh-hHHHHHHHHHHHHHHHHHhcCCCCCCCcee
Confidence 3445566665 677778899999999999995 5566789999998754 344566788999999883 3 349
Q ss_pred ccccceec----cCCceEEEEEeccCCCccccccCC--CCCchhHHHHHHHHHHHHHHHHhhccCCCeEecCCCCCcEEE
Q 003836 562 VRLLGYCD----EGQNRLLVYEFMSNGTVASFLFGD--SKPNWKLRTEIAMGIAGGLFYLHEECCTQIIHCDIKPQNILL 635 (792)
Q Consensus 562 v~l~g~~~----~~~~~~lV~E~~~~gsL~~~l~~~--~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dikp~NILl 635 (792)
|+|+++|. .+.++++|+|++ |-+|..++... +.++...+.+|+.||+.||.|||.+| +|||.||||+|||+
T Consensus 145 V~LlD~FkhsGpNG~HVCMVfEvL-GdnLLklI~~s~YrGlpl~~VK~I~~qvL~GLdYLH~ec--gIIHTDlKPENvLl 221 (590)
T KOG1290|consen 145 VQLLDHFKHSGPNGQHVCMVFEVL-GDNLLKLIKYSNYRGLPLSCVKEICRQVLTGLDYLHREC--GIIHTDLKPENVLL 221 (590)
T ss_pred eeeeccceecCCCCcEEEEEehhh-hhHHHHHHHHhCCCCCcHHHHHHHHHHHHHHHHHHHHhc--CccccCCCcceeee
Confidence 99999995 456899999999 55788887653 67899999999999999999999997 99999999999999
Q ss_pred c
Q 003836 636 D 636 (792)
Q Consensus 636 ~ 636 (792)
-
T Consensus 222 ~ 222 (590)
T KOG1290|consen 222 C 222 (590)
T ss_pred e
Confidence 3
|
|
| >cd00028 B_lectin Bulb-type mannose-specific lectin | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.1e-26 Score=209.56 Aligned_cols=108 Identities=31% Similarity=0.538 Sum_probs=98.7
Q ss_pred CceecCCCeEEEeeeecCCCCceEEEEEeecCCCCcEEEEecCCCCCCCCeeEEEEeCccEEEEcCCCCEEEEeccCC-C
Q 003836 39 EPWLSPSKDFALGFHQLDSKDLFLPAIWYYKIPSKTIVWYASAVNPAPRGSKLRLTANRGLVLEDPEGREIWKSEIST-G 117 (792)
Q Consensus 39 ~~lvS~~g~F~lGF~~~~~~~~~~~gIW~~~~~~~tvvWvANr~~P~~~~~~l~~~~~G~Lvl~~~~~~~vWst~~~~-~ 117 (792)
++|+|++|.|++|||++.....++.+|||.+++ +++||+||++.|....+.|.|+.||+|+|.|.+|.++|+|++++ .
T Consensus 8 ~~l~s~~~~f~~G~~~~~~q~~dgnlv~~~~~~-~~~vW~snt~~~~~~~~~l~l~~dGnLvl~~~~g~~vW~S~~~~~~ 86 (116)
T cd00028 8 QTLVSSGSLFELGFFKLIMQSRDYNLILYKGSS-RTVVWVANRDNPSGSSCTLTLQSDGNLVIYDGSGTVVWSSNTTRVN 86 (116)
T ss_pred CEEEeCCCcEEEecccCCCCCCeEEEEEEeCCC-CeEEEECCCCCCCCCCEEEEEecCCCeEEEcCCCcEEEEecccCCC
Confidence 478999999999999987654599999999887 89999999999977778999999999999999999999999876 5
Q ss_pred cceeEEEecCCcEEEEecCCccccccccCC
Q 003836 118 QAAFGVLYDTGNFLIVNTNSERLWQSFDHP 147 (792)
Q Consensus 118 ~~~~a~LldsGNlVl~~~~~~~lWQSFd~P 147 (792)
+..+|+|+|+|||||++.++.+||||||||
T Consensus 87 ~~~~~~L~ddGnlvl~~~~~~~~W~Sf~~P 116 (116)
T cd00028 87 GNYVLVLLDDGNLVLYDSDGNFLWQSFDYP 116 (116)
T ss_pred CceEEEEeCCCCEEEECCCCCEEEcCCCCC
Confidence 567899999999999999999999999999
|
The domain contains a three-fold internal repeat (beta-prism architecture). The consensus sequence motif QXDXNXVXY is involved in alpha-D-mannose recognition. Lectins are carbohydrate-binding proteins which specifically recognize diverse carbohydrates and mediate a wide variety of biological processes, such as cell-cell and host-pathogen interactions, serum glycoprotein turnover, and innate immune responses. |
| >KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=3.7e-27 Score=234.13 Aligned_cols=255 Identities=23% Similarity=0.232 Sum_probs=188.0
Q ss_pred hcCccccceEEEeeecCCCceEEEEEEcccc--cccchHHHHHHHHHhcccCCCCcccccceecc------CCceEEEEE
Q 003836 508 ELGRGAFGTVYKGFVNMGSSNHVAVKKLNSV--FQDSEKEFKAEVNGIGQTHHKNLVRLLGYCDE------GQNRLLVYE 579 (792)
Q Consensus 508 ~lG~G~~g~Vy~g~~~~~~~~~vavK~~~~~--~~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~------~~~~~lV~E 579 (792)
.+|.|.- .|--+ .+.-.+++||+|++... .....++..+|+.++..++|+||++++.++.- -.+.|+|||
T Consensus 24 p~~~g~~-~v~~a-~D~v~~~~v~ikk~~~pf~n~~~akra~rel~l~~~v~~~nii~l~n~ftP~~~l~~~~e~y~v~e 101 (369)
T KOG0665|consen 24 PIGSGAQ-IVVAA-FDQVLGRPVAIKKLSRPFQNQTHAKRAYRELKLMKCVNHKNIISLLNVFTPQKTLEEFQEVYLVME 101 (369)
T ss_pred ccCCCCc-eEEec-chhhccCceehhhhcCccccCccchhhhhhhhhhhhhcccceeeeeeccCccccHHHHHhHHHHHH
Confidence 4677776 44444 33445678999998654 23456788999999999999999999999843 346799999
Q ss_pred eccCCCccccccCCCCCchhHHHHHHHHHHHHHHHHhhccCCCeEecCCCCCcEEEcCCCCeEEeecCCCccccCCCCCc
Q 003836 580 FMSNGTVASFLFGDSKPNWKLRTEIAMGIAGGLFYLHEECCTQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLDQSHT 659 (792)
Q Consensus 580 ~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dikp~NILl~~~~~~kl~Dfg~a~~~~~~~~~~ 659 (792)
+|.. +|.+.+. -.++-..+..|..|++.|++|||+. +|+||||||+||++..+..+||.|||+|+....+ ..
T Consensus 102 ~m~~-nl~~vi~--~elDH~tis~i~yq~~~~ik~lhs~---~IihRdLkPsnivv~~~~~lKi~dfg~ar~e~~~--~~ 173 (369)
T KOG0665|consen 102 LMDA-NLCQVIL--MELDHETISYILYQMLCGIKHLHSA---GIIHRDLKPSNIVVNSDCTLKILDFGLARTEDTD--FM 173 (369)
T ss_pred hhhh-HHHHHHH--HhcchHHHHHHHHHHHHHHHHHHhc---ceeecccCcccceecchhheeeccchhhcccCcc--cc
Confidence 9965 8888776 4567788899999999999999999 9999999999999999999999999999865433 45
Q ss_pred cccccccCCcccccccccCCCCcccceehHHHHHHHHHhcCcCCCcchhhhhhhh---------------HHHHHHHhhc
Q 003836 660 NTAIRGTKGYVAPEWFRNMPITVKVDVYSYGVLLLEIICLRRNIDNEISKVDKAI---------------LTDWAYDRYQ 724 (792)
Q Consensus 660 ~~~~~gt~~y~aPE~~~~~~~~~k~DV~S~Gv~l~el~tg~~p~~~~~~~~~~~~---------------~~~~~~~~~~ 724 (792)
.+..+.|..|+|||++.+..+.+.+||||.||++.||++|+..|........-.. +......-..
T Consensus 174 mtpyVvtRyyrapevil~~~~ke~vdiwSvGci~gEli~~~Vlf~g~d~idQ~~ki~~~lgtpd~~F~~qL~~~~r~yv~ 253 (369)
T KOG0665|consen 174 MTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELILGTVLFPGKDHIDQWNKIIEQLGTPDPSFMKQLQPTVRNYVE 253 (369)
T ss_pred cCchhheeeccCchheeccCCcccchhhhhhhHHHHHhhceEEecCchHHHHHHHHHHHhcCCCHHHHHHhhHHHHHHhh
Confidence 5667789999999999998899999999999999999999988764322111000 0000000000
Q ss_pred c------cchh-Hhhhchhc--ccCCHHHHHHHHHHHHHccccCCCCCCCHHhHHHH
Q 003836 725 E------RTLE-ALVENDLE--AMNNVTMLHRFVMVAFWCIQEDPSHRPTMRKVTQM 772 (792)
Q Consensus 725 ~------~~~~-~~~~~~~~--~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~ 772 (792)
. .... -+-|.... .+.+......+.+++.+||-.+|++|.+++++++.
T Consensus 254 ~~~~y~~~~f~~~fpD~~f~~~~e~~~~~~~~ardll~~MLvi~pe~Risv~daL~H 310 (369)
T KOG0665|consen 254 NRPQYQAISFSELFPDSLFPVVLEGSKLDCSLARDLLSKMLVIDPEKRISVDDALRH 310 (369)
T ss_pred cChHhhccchhhhCCcccccccccCCccchHHHHHHHHHhhccChhhcccHHHHhcC
Confidence 0 0000 00111110 11122345567889999999999999999999975
|
|
| >smart00221 STYKc Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=99.93 E-value=9.6e-26 Score=229.68 Aligned_cols=197 Identities=30% Similarity=0.439 Sum_probs=172.5
Q ss_pred hhhhcCccccceEEEeeecCCCceEEEEEEccccccc-chHHHHHHHHHhcccCCCCcccccceeccCCceEEEEEeccC
Q 003836 505 FKEELGRGAFGTVYKGFVNMGSSNHVAVKKLNSVFQD-SEKEFKAEVNGIGQTHHKNLVRLLGYCDEGQNRLLVYEFMSN 583 (792)
Q Consensus 505 ~~~~lG~G~~g~Vy~g~~~~~~~~~vavK~~~~~~~~-~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~lV~E~~~~ 583 (792)
+.+.||+|++|+||++.... +++.+++|.+...... ..+.+.+|++.+++++|+|++++++++......++++||+++
T Consensus 3 ~~~~i~~g~~~~v~~~~~~~-~~~~~~iK~~~~~~~~~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~~ 81 (225)
T smart00221 3 LGKKLGEGAFGKVYLARDKG-TGELVAVKVLKKEKTEKQREEFLREIRILKKLKHPNIVKLYGVFEDPEPLYLVMEYCEG 81 (225)
T ss_pred eeeEeecCCCeEEEEEEEcC-CCcEEEEEeeccccchHHHHHHHHHHHHHHhCCCCChhhheeeeecCCceEEEEeccCC
Confidence 45679999999999997653 4578999999865444 567899999999999999999999999999999999999999
Q ss_pred CCccccccCCCC-CchhHHHHHHHHHHHHHHHHhhccCCCeEecCCCCCcEEEcCCCCeEEeecCCCccccCCCCCcccc
Q 003836 584 GTVASFLFGDSK-PNWKLRTEIAMGIAGGLFYLHEECCTQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLDQSHTNTA 662 (792)
Q Consensus 584 gsL~~~l~~~~~-l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dikp~NILl~~~~~~kl~Dfg~a~~~~~~~~~~~~~ 662 (792)
++|.+++..... +++..+..++.+++.+|.+||+. +++|+||+|+||+++.++.++|+|||.+.............
T Consensus 82 ~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~di~~~ni~v~~~~~~~l~d~g~~~~~~~~~~~~~~~ 158 (225)
T smart00221 82 GDLFDYLRKKGGKLSEEEARFYLRQILEALEYLHSL---GIVHRDLKPENILLGMDGLVKLADFGLARFIHRDLAALLKT 158 (225)
T ss_pred CCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEeeCceeeEecCcccccccc
Confidence 999999987665 89999999999999999999998 99999999999999999999999999998775443112233
Q ss_pred ccccCCccccccc-ccCCCCcccceehHHHHHHHHHhcCcCCCc
Q 003836 663 IRGTKGYVAPEWF-RNMPITVKVDVYSYGVLLLEIICLRRNIDN 705 (792)
Q Consensus 663 ~~gt~~y~aPE~~-~~~~~~~k~DV~S~Gv~l~el~tg~~p~~~ 705 (792)
..++..|++||.+ ....++.++|||+||++++||++|+.||..
T Consensus 159 ~~~~~~~~~pe~~~~~~~~~~~~Dv~~lG~~~~~l~~g~~pf~~ 202 (225)
T smart00221 159 VKGTPFYLAPEVLLGGKGYGEAVDIWSLGVILYELLWGPEPFSG 202 (225)
T ss_pred eeccCCcCCHhHhcCCCCCCchhhHHHHHHHHHHHHHCCCCccc
Confidence 4578889999998 667788899999999999999999999965
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. |
| >KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.5e-26 Score=241.85 Aligned_cols=273 Identities=19% Similarity=0.216 Sum_probs=205.2
Q ss_pred ccccCHHHHHHHHhhhhhhcCccccceEEEeeecCCCceEEEEEEcccccccchHHHHHHHHHhcccC------CCCccc
Q 003836 490 LRCFTYKELVEVTRGFKEELGRGAFGTVYKGFVNMGSSNHVAVKKLNSVFQDSEKEFKAEVNGIGQTH------HKNLVR 563 (792)
Q Consensus 490 ~~~~~~~el~~~~~~~~~~lG~G~~g~Vy~g~~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~------h~niv~ 563 (792)
.-.+.+.|+....|......|+|-|++|-+|... ..++.||||++.+. +.-.+.=+.|+++|.+|+ ..+.++
T Consensus 421 YYrv~igE~LD~RY~V~~~~GkGvFs~Vvra~D~-~r~~~vAiKIIRnN-E~M~KtGl~EleiLkKL~~AD~Edk~Hclr 498 (752)
T KOG0670|consen 421 YYRVRIGELLDSRYEVQGYTGKGVFSTVVRARDQ-ARGQEVAIKIIRNN-EVMHKTGLKELEILKKLNDADPEDKFHCLR 498 (752)
T ss_pred eEEEehhhhhcceeEEEeccccceeeeeeecccc-CCCCeeEEEEeecc-hHHhhhhhHHHHHHHHhhccCchhhhHHHH
Confidence 3456788888888888888999999999999754 34569999999864 223355578999999984 467999
Q ss_pred ccceeccCCceEEEEEeccCCCccccccCC---CCCchhHHHHHHHHHHHHHHHHhhccCCCeEecCCCCCcEEEcCCC-
Q 003836 564 LLGYCDEGQNRLLVYEFMSNGTVASFLFGD---SKPNWKLRTEIAMGIAGGLFYLHEECCTQIIHCDIKPQNILLDDHY- 639 (792)
Q Consensus 564 l~g~~~~~~~~~lV~E~~~~gsL~~~l~~~---~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dikp~NILl~~~~- 639 (792)
|+..|.+.++++||+|-+. .+|.++|..- -.+....+..++.|+.-||..|..- +|+|.||||.|||+++..
T Consensus 499 l~r~F~hknHLClVFE~Ls-lNLRevLKKyG~nvGL~ikaVRsYaqQLflALklLK~c---~vlHaDIKPDNiLVNE~k~ 574 (752)
T KOG0670|consen 499 LFRHFKHKNHLCLVFEPLS-LNLREVLKKYGRNVGLHIKAVRSYAQQLFLALKLLKKC---GVLHADIKPDNILVNESKN 574 (752)
T ss_pred HHHHhhhcceeEEEehhhh-chHHHHHHHhCcccceeehHHHHHHHHHHHHHHHHHhc---CeeecccCccceEeccCcc
Confidence 9999999999999999874 4888988653 3578889999999999999999987 999999999999999764
Q ss_pred CeEEeecCCCccccCCCCCccccccccCCcccccccccCCCCcccceehHHHHHHHHHhcCcCCCcchhhhhhhhHHH--
Q 003836 640 NARISDFGLAKLLTLDQSHTNTAIRGTKGYVAPEWFRNMPITVKVDVYSYGVLLLEIICLRRNIDNEISKVDKAILTD-- 717 (792)
Q Consensus 640 ~~kl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DV~S~Gv~l~el~tg~~p~~~~~~~~~~~~~~~-- 717 (792)
.+||||||.|......+ .+...-+.-|.|||++.+.+|+...|+||.||.||||.||+..|.........-+..+
T Consensus 575 iLKLCDfGSA~~~~ene---itPYLVSRFYRaPEIiLG~~yd~~iD~WSvgctLYElYtGkIlFpG~TNN~MLrl~me~K 651 (752)
T KOG0670|consen 575 ILKLCDFGSASFASENE---ITPYLVSRFYRAPEIILGLPYDYPIDTWSVGCTLYELYTGKILFPGRTNNQMLRLFMELK 651 (752)
T ss_pred eeeeccCcccccccccc---ccHHHHHHhccCcceeecCcccCCccceeeceeeEEeeccceecCCCCcHHHHHHHHHhc
Confidence 58999999997654332 2333446679999999999999999999999999999999988855322111000000
Q ss_pred ------------HHHHhhcc---------------------------cchhHhhhch-hcccCCHHHHHHHHHHHHHccc
Q 003836 718 ------------WAYDRYQE---------------------------RTLEALVEND-LEAMNNVTMLHRFVMVAFWCIQ 757 (792)
Q Consensus 718 ------------~~~~~~~~---------------------------~~~~~~~~~~-~~~~~~~~~~~~l~~l~~~Cl~ 757 (792)
+...++.. ..+...+... -.....+.....+.+|+..||.
T Consensus 652 Gk~p~KmlRKgqF~dqHFD~d~nf~~~e~D~vT~r~~~~vm~~vkPtkdl~s~l~~~q~~~deq~~~~~~~rdLLdkml~ 731 (752)
T KOG0670|consen 652 GKFPNKMLRKGQFKDQHFDQDLNFLYIEVDKVTEREKRTVMVNVKPTKDLGSELIAVQRLPDEQPKIVQQLRDLLDKMLI 731 (752)
T ss_pred CCCcHHHhhhcchhhhhcccccceEEEeccccccceeEEEecccCcchhHHHHHhccCCCCchhHHHHHHHHHHHHHHhc
Confidence 00000000 0011111110 0112235567889999999999
Q ss_pred cCCCCCCCHHhHHH
Q 003836 758 EDPSHRPTMRKVTQ 771 (792)
Q Consensus 758 ~~p~~RPs~~evl~ 771 (792)
.||++|.|..+.++
T Consensus 732 LdP~KRit~nqAL~ 745 (752)
T KOG0670|consen 732 LDPEKRITVNQALK 745 (752)
T ss_pred cChhhcCCHHHHhc
Confidence 99999999999887
|
|
| >KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.4e-26 Score=245.10 Aligned_cols=191 Identities=23% Similarity=0.324 Sum_probs=165.3
Q ss_pred hhcCccccceEEEeeecCCCceEEEEEEcccccc--------cchHHHHHHHHHhcccC---CCCcccccceeccCCceE
Q 003836 507 EELGRGAFGTVYKGFVNMGSSNHVAVKKLNSVFQ--------DSEKEFKAEVNGIGQTH---HKNLVRLLGYCDEGQNRL 575 (792)
Q Consensus 507 ~~lG~G~~g~Vy~g~~~~~~~~~vavK~~~~~~~--------~~~~~~~~Ei~~l~~l~---h~niv~l~g~~~~~~~~~ 575 (792)
+.+|+|+||.|+++.++. ....|+||.+.+..- .....+--||++|.+++ |+||++++++|++.+.+|
T Consensus 567 q~lG~GAyGkV~lai~K~-n~~eVViK~I~KeRIL~DtWvrDrkLGtVp~EIqIla~l~~~sH~NIlKlLdfFEddd~yy 645 (772)
T KOG1152|consen 567 QPLGEGAYGKVNLAIHKE-NNYEVVIKMIFKERILVDTWVRDRKLGTVPSEIQILATLNKHSHENILKLLDFFEDDDYYY 645 (772)
T ss_pred eeccccccceEEEeeecc-cceEEEeeehhhhhhhhhhhhcccccCccchhHHHHHHhhhcCccchhhhhheeecCCeeE
Confidence 579999999999997654 467899998865321 11223557999999997 999999999999999999
Q ss_pred EEEEec-cCCCccccccCCCCCchhHHHHHHHHHHHHHHHHhhccCCCeEecCCCCCcEEEcCCCCeEEeecCCCccccC
Q 003836 576 LVYEFM-SNGTVASFLFGDSKPNWKLRTEIAMGIAGGLFYLHEECCTQIIHCDIKPQNILLDDHYNARISDFGLAKLLTL 654 (792)
Q Consensus 576 lV~E~~-~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dikp~NILl~~~~~~kl~Dfg~a~~~~~ 654 (792)
|++|-. ++-+|.+++..+..+++.+..-|+.||+.|+++||++ +|||||||-+|+.++.+|-+||+|||.+....
T Consensus 646 l~te~hg~gIDLFd~IE~kp~m~E~eAk~IFkQV~agi~hlh~~---~ivhrdikdenvivd~~g~~klidfgsaa~~k- 721 (772)
T KOG1152|consen 646 LETEVHGEGIDLFDFIEFKPRMDEPEAKLIFKQVVAGIKHLHDQ---GIVHRDIKDENVIVDSNGFVKLIDFGSAAYTK- 721 (772)
T ss_pred EEecCCCCCcchhhhhhccCccchHHHHHHHHHHHhcccccccc---CceecccccccEEEecCCeEEEeeccchhhhc-
Confidence 999965 4568899999999999999999999999999999999 99999999999999999999999999997654
Q ss_pred CCCCccccccccCCcccccccccCCCC-cccceehHHHHHHHHHhcCcCCC
Q 003836 655 DQSHTNTAIRGTKGYVAPEWFRNMPIT-VKVDVYSYGVLLLEIICLRRNID 704 (792)
Q Consensus 655 ~~~~~~~~~~gt~~y~aPE~~~~~~~~-~k~DV~S~Gv~l~el~tg~~p~~ 704 (792)
+.+...++||..|.|||++.+.+|- ..-|||++|++||.++....|+.
T Consensus 722 --sgpfd~f~gtv~~aapevl~g~~y~gk~qdiwalgillytivykenpyy 770 (772)
T KOG1152|consen 722 --SGPFDVFVGTVDYAAPEVLGGEKYLGKPQDIWALGILLYTIVYKENPYY 770 (772)
T ss_pred --CCCcceeeeeccccchhhhCCCccCCCcchhhhhhheeeEEEeccCCCc
Confidence 3344567899999999999998875 55899999999999999888875
|
|
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.6e-26 Score=248.63 Aligned_cols=249 Identities=22% Similarity=0.292 Sum_probs=202.0
Q ss_pred hhhhcCccccceEEEeeecCCCceEEEEEEcccccccchHHHHHHHHHhcccCCCCcccccceeccCCceEEEEEeccCC
Q 003836 505 FKEELGRGAFGTVYKGFVNMGSSNHVAVKKLNSVFQDSEKEFKAEVNGIGQTHHKNLVRLLGYCDEGQNRLLVYEFMSNG 584 (792)
Q Consensus 505 ~~~~lG~G~~g~Vy~g~~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~lV~E~~~~g 584 (792)
+...+|.|.||.|||++. ..+++..|+|.++-...+..+-++.|+-+++..+|+|||.++|.+...+..++.|||+.+|
T Consensus 19 llqrvgsgTygdvyKaRd-~~s~elaavkvVkLep~dd~~~iqqei~~~~dc~h~nivay~gsylr~dklwicMEycggg 97 (829)
T KOG0576|consen 19 LLQRVGSGTYGDVYKARD-KRSGELAAVKVVKLEPGDDFSGIQQEIGMLRDCRHPNIVAYFGSYLRRDKLWICMEYCGGG 97 (829)
T ss_pred heeeecCCcccchhhhcc-cccCchhhheeeeccCCccccccccceeeeecCCCcChHHHHhhhhhhcCcEEEEEecCCC
Confidence 346799999999999964 4667899999998877777788899999999999999999999999999999999999999
Q ss_pred CccccccCCCCCchhHHHHHHHHHHHHHHHHhhccCCCeEecCCCCCcEEEcCCCCeEEeecCCCccccCCCCCcccccc
Q 003836 585 TVASFLFGDSKPNWKLRTEIAMGIAGGLFYLHEECCTQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLDQSHTNTAIR 664 (792)
Q Consensus 585 sL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dikp~NILl~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~ 664 (792)
+|++..+....+++.++....+...+||+|||+. +=+|||||-.|||+++.+.+|++|||.+-.....-. ....+.
T Consensus 98 slQdiy~~TgplselqiayvcRetl~gl~ylhs~---gk~hRdiKGanilltd~gDvklaDfgvsaqitati~-Krksfi 173 (829)
T KOG0576|consen 98 SLQDIYHVTGPLSELQIAYVCRETLQGLKYLHSQ---GKIHRDIKGANILLTDEGDVKLADFGVSAQITATIA-KRKSFI 173 (829)
T ss_pred cccceeeecccchhHHHHHHHhhhhccchhhhcC---CcccccccccceeecccCceeecccCchhhhhhhhh-hhhccc
Confidence 9999999999999999999999999999999998 889999999999999999999999999865542211 223467
Q ss_pred ccCCccccccc---ccCCCCcccceehHHHHHHHHHhcCcCCCcchhhhhhhhHHHHHHHhhcccchhHhhhchhcccCC
Q 003836 665 GTKGYVAPEWF---RNMPITVKVDVYSYGVLLLEIICLRRNIDNEISKVDKAILTDWAYDRYQERTLEALVENDLEAMNN 741 (792)
Q Consensus 665 gt~~y~aPE~~---~~~~~~~k~DV~S~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 741 (792)
||+.|||||+. +.+.|..++|||+.|+...|+-..+.|....... ....+.. ....++ ......
T Consensus 174 GtpywmapEvaaverkggynqlcdiwa~gitAiel~eLqpplfdlhpm-r~l~LmT-----------kS~~qp-p~lkDk 240 (829)
T KOG0576|consen 174 GTPYWMAPEVAAVERKGGYNQLCDIWALGITAIELGELQPPLFDLHPM-RALFLMT-----------KSGFQP-PTLKDK 240 (829)
T ss_pred CCccccchhHHHHHhcccccccccccccccchhhhhhcCCcccccchH-HHHHHhh-----------ccCCCC-CcccCC
Confidence 99999999986 4678999999999999999998877775433211 0000000 000011 111123
Q ss_pred HHHHHHHHHHHHHccccCCCCCCCHHhHHH
Q 003836 742 VTMLHRFVMVAFWCIQEDPSHRPTMRKVTQ 771 (792)
Q Consensus 742 ~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~ 771 (792)
....+.+-++++.|+..+|.+||+++.+++
T Consensus 241 ~kws~~fh~fvK~altknpKkRptaeklL~ 270 (829)
T KOG0576|consen 241 TKWSEFFHNFVKGALTKNPKKRPTAEKLLQ 270 (829)
T ss_pred ccchHHHHHHHHHHhcCCCccCCChhhhee
Confidence 456677889999999999999999987764
|
|
| >smart00108 B_lectin Bulb-type mannose-specific lectin | Back alignment and domain information |
|---|
Probab=99.93 E-value=2.9e-25 Score=199.73 Aligned_cols=106 Identities=34% Similarity=0.551 Sum_probs=96.8
Q ss_pred CceecCCCeEEEeeeecCCCCceEEEEEeecCCCCcEEEEecCCCCCCCCeeEEEEeCccEEEEcCCCCEEEEeccC-CC
Q 003836 39 EPWLSPSKDFALGFHQLDSKDLFLPAIWYYKIPSKTIVWYASAVNPAPRGSKLRLTANRGLVLEDPEGREIWKSEIS-TG 117 (792)
Q Consensus 39 ~~lvS~~g~F~lGF~~~~~~~~~~~gIW~~~~~~~tvvWvANr~~P~~~~~~l~~~~~G~Lvl~~~~~~~vWst~~~-~~ 117 (792)
++|+|++|.|++|||.+... .++.+|||++.+ +++||+|||+.|+.+++.|.++.||+|+|.|.+|.+||+|++. +.
T Consensus 8 ~~l~s~~~~f~~G~~~~~~q-~dgnlV~~~~~~-~~~vW~snt~~~~~~~~~l~l~~dGnLvl~~~~g~~vW~S~t~~~~ 85 (114)
T smart00108 8 QTLVSGNSLFELGFFTLIMQ-NDYNLILYKSSS-RTVVWVANRDNPVSDSCTLTLQSDGNLVLYDGDGRVVWSSNTTGAN 85 (114)
T ss_pred CEEecCCCcEeeeccccCCC-CCEEEEEEECCC-CcEEEECCCCCCCCCCEEEEEeCCCCEEEEeCCCCEEEEecccCCC
Confidence 47899999999999998655 589999999887 8999999999999777899999999999999999999999987 45
Q ss_pred cceeEEEecCCcEEEEecCCccccccccC
Q 003836 118 QAAFGVLYDTGNFLIVNTNSERLWQSFDH 146 (792)
Q Consensus 118 ~~~~a~LldsGNlVl~~~~~~~lWQSFd~ 146 (792)
+..+|+|+|+|||||++..+.+|||||||
T Consensus 86 ~~~~~~L~ddGnlvl~~~~~~~~W~Sf~~ 114 (114)
T smart00108 86 GNYVLVLLDDGNLVIYDSDGNFLWQSFDY 114 (114)
T ss_pred CceEEEEeCCCCEEEECCCCCEEeCCCCC
Confidence 56789999999999999999999999997
|
|
| >KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=99.92 E-value=9.2e-26 Score=232.72 Aligned_cols=258 Identities=22% Similarity=0.291 Sum_probs=191.2
Q ss_pred hhhcCccccceEEEeeecCC--CceEEEEEEcccccccchHHHHHHHHHhcccC-CCCcccccceeccCCceEEEEEecc
Q 003836 506 KEELGRGAFGTVYKGFVNMG--SSNHVAVKKLNSVFQDSEKEFKAEVNGIGQTH-HKNLVRLLGYCDEGQNRLLVYEFMS 582 (792)
Q Consensus 506 ~~~lG~G~~g~Vy~g~~~~~--~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~-h~niv~l~g~~~~~~~~~lV~E~~~ 582 (792)
.++||+|.|++||++++... ..+.||+|.+... .....+.+|++.|.++. +.||+++.+++...+.+.+|+||++
T Consensus 41 v~kigeGsFssv~~a~~~~~~~~~~~valk~i~~t--s~p~ri~~El~~L~~~gG~~ni~~~~~~~rnnd~v~ivlp~~~ 118 (418)
T KOG1167|consen 41 VNKIGEGSFSSVYKATDIEQDTKRRYVALKAIYRT--SSPSRILNELEMLYRLGGSDNIIKLNGCFRNNDQVAIVLPYFE 118 (418)
T ss_pred hccccccchhhhhhhhHhhhccccceEeeeecccc--cCchHHHHHHHHHHHhccchhhhcchhhhccCCeeEEEecccC
Confidence 46899999999999987652 5678999998764 34567999999999995 9999999999999999999999999
Q ss_pred CCCccccccCCCCCchhHHHHHHHHHHHHHHHHhhccCCCeEecCCCCCcEEEcC-CCCeEEeecCCCccccCCC-----
Q 003836 583 NGTVASFLFGDSKPNWKLRTEIAMGIAGGLFYLHEECCTQIIHCDIKPQNILLDD-HYNARISDFGLAKLLTLDQ----- 656 (792)
Q Consensus 583 ~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dikp~NILl~~-~~~~kl~Dfg~a~~~~~~~----- 656 (792)
.....+++.. ++...+...+..+++||+++|.. |||||||||+|+|.+. .+.-.|.|||+|.......
T Consensus 119 H~~f~~l~~~---l~~~~i~~Yl~~ll~Al~~~h~~---GIvHRDiKpsNFL~n~~t~rg~LvDFgLA~~~d~~~~~~~s 192 (418)
T KOG1167|consen 119 HDRFRDLYRS---LSLAEIRWYLRNLLKALAHLHKN---GIVHRDIKPSNFLYNRRTQRGVLVDFGLAQRYDGYQQTEHS 192 (418)
T ss_pred ccCHHHHHhc---CCHHHHHHHHHHHHHHhhhhhcc---CccccCCCccccccccccCCceEEechhHHHHHhhhhhhhh
Confidence 9888888744 67889999999999999999999 9999999999999984 5778999999997221000
Q ss_pred --------CC------------------------------ccccccccCCccccccccc-CCCCcccceehHHHHHHHHH
Q 003836 657 --------SH------------------------------TNTAIRGTKGYVAPEWFRN-MPITVKVDVYSYGVLLLEII 697 (792)
Q Consensus 657 --------~~------------------------------~~~~~~gt~~y~aPE~~~~-~~~~~k~DV~S~Gv~l~el~ 697 (792)
.. ......||+||+|||++.. ..-++++||||-|||++.++
T Consensus 193 ~~~~~~~~~~~~g~~~~~~~~~~~~~p~g~~~~~~~~r~~~~anrAGT~GfRaPEvL~k~~~QttaiDiws~GVI~Lsll 272 (418)
T KOG1167|consen 193 RSYSGRHATPAMGKDVHCQSVATASKPAGYYRRCNDGRPSERANRAGTPGFRAPEVLFRCPRQTTAIDIWSAGVILLSLL 272 (418)
T ss_pred hhhhcccCCccccCcccccccccccCCCCceeccCCCccceecccCCCCCCCchHHHhhccCcCCccceeeccceeehhh
Confidence 00 0012359999999999865 56789999999999999999
Q ss_pred hcCcCCCcchhhhhh----hhHHHH------HHH--h--hcc-c---chh-------Hh-hhchhccc--------CCHH
Q 003836 698 CLRRNIDNEISKVDK----AILTDW------AYD--R--YQE-R---TLE-------AL-VENDLEAM--------NNVT 743 (792)
Q Consensus 698 tg~~p~~~~~~~~~~----~~~~~~------~~~--~--~~~-~---~~~-------~~-~~~~~~~~--------~~~~ 743 (792)
+++.||.....+.+. ..+..+ +.. . ..+ . .+. .+ ........ ....
T Consensus 273 s~~~PFf~a~dd~~al~ei~tifG~~~mrk~A~l~g~~~l~~ksn~~~~~e~~~~f~s~~~~~~~~~~q~n~~~~~~~d~ 352 (418)
T KOG1167|consen 273 SRRYPFFKAKDDADALAEIATIFGSAEMRKCAALPGRILLWQKSNIPTIPELRVNFETLHIESIYKSRQPNTEREIGSDV 352 (418)
T ss_pred ccccccccCccccchHHHHHHHhChHHHHHHhhcCCceeeeccccccccHHHHhchhccChhhcccccccceeecccccc
Confidence 999999654333221 110000 000 0 000 0 000 00 00000000 0112
Q ss_pred HHHHHHHHHHHccccCCCCCCCHHhHHH
Q 003836 744 MLHRFVMVAFWCIQEDPSHRPTMRKVTQ 771 (792)
Q Consensus 744 ~~~~l~~l~~~Cl~~~p~~RPs~~evl~ 771 (792)
.+..++++..+|+..||.+|.|+++.++
T Consensus 353 ~~~~~~dlLdk~le~np~kRitAEeALk 380 (418)
T KOG1167|consen 353 FPALLLDLLDKCLELNPQKRITAEDALK 380 (418)
T ss_pred ccHHHHHHHHHHccCChhhcccHHHHhc
Confidence 3457899999999999999999999986
|
|
| >PLN00181 protein SPA1-RELATED; Provisional | Back alignment and domain information |
|---|
Probab=99.91 E-value=2.2e-25 Score=268.55 Aligned_cols=196 Identities=15% Similarity=0.221 Sum_probs=140.9
Q ss_pred cccCC-CCccccccee-------ccCCceEEEEEeccCCCccccccCC-CCCchhHHHHHHHHHHHHHHHHhhccCCCeE
Q 003836 554 GQTHH-KNLVRLLGYC-------DEGQNRLLVYEFMSNGTVASFLFGD-SKPNWKLRTEIAMGIAGGLFYLHEECCTQII 624 (792)
Q Consensus 554 ~~l~h-~niv~l~g~~-------~~~~~~~lV~E~~~~gsL~~~l~~~-~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iv 624 (792)
++++| .||++++++| .+....++++|++ +++|.++|... ..+++.+++.++.||++||+|||++ +|+
T Consensus 27 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~-~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~---gIv 102 (793)
T PLN00181 27 KSLSHIDYVRSLLGSHKEGNLDGLDDDSIVRALECE-DVSLRQWLDNPDRSVDAFECFHVFRQIVEIVNAAHSQ---GIV 102 (793)
T ss_pred chhhHHHHHHHhhcccCCccccccccchhhhhhccC-CccHHHHHhcccccccHHHHHHHHHHHHHHHHHHHhC---Cee
Confidence 34556 6888899988 3334567888988 55999999754 5689999999999999999999998 999
Q ss_pred ecCCCCCcEEEcC-------------------CCCeEEeecCCCccccCCCC---------------CccccccccCCcc
Q 003836 625 HCDIKPQNILLDD-------------------HYNARISDFGLAKLLTLDQS---------------HTNTAIRGTKGYV 670 (792)
Q Consensus 625 H~dikp~NILl~~-------------------~~~~kl~Dfg~a~~~~~~~~---------------~~~~~~~gt~~y~ 670 (792)
||||||+||||+. ++.+||+|||+++....... .......||+.||
T Consensus 103 HrDlKP~NiLl~~~~~~k~~d~~~~~~~~~~~~~~~ki~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~ 182 (793)
T PLN00181 103 VHNVRPSCFVMSSFNHVSFIESASCSDSGSDEDATTKSREIGSSRREEILSERRIEKLEEVKKQPFPMKQILAMEMSWYT 182 (793)
T ss_pred eccCCchhEEEcccCcEEEeeccccCcccccccCcccccccccccccccccccchhhhhccccCCCcccccccCCCcceE
Confidence 9999999999954 44566666666654211000 0001135788899
Q ss_pred cccccccCCCCcccceehHHHHHHHHHhcCcCCCcchhhhhhhhHHHHHHHhhcccchhHhhhchhcccCCHHHHHHHHH
Q 003836 671 APEWFRNMPITVKVDVYSYGVLLLEIICLRRNIDNEISKVDKAILTDWAYDRYQERTLEALVENDLEAMNNVTMLHRFVM 750 (792)
Q Consensus 671 aPE~~~~~~~~~k~DV~S~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 750 (792)
|||++.+..++.++|||||||+||||++|..|+...... ....... ...+ .......+..+
T Consensus 183 APE~~~~~~~~~~sDVwSlGviL~ELl~~~~~~~~~~~~-----~~~~~~~---------~~~~-----~~~~~~~~~~~ 243 (793)
T PLN00181 183 SPEEDNGSSSNCASDVYRLGVLLFELFCPVSSREEKSRT-----MSSLRHR---------VLPP-----QILLNWPKEAS 243 (793)
T ss_pred ChhhhccCCCCchhhhhhHHHHHHHHhhCCCchhhHHHH-----HHHHHHh---------hcCh-----hhhhcCHHHHH
Confidence 999999999999999999999999999988876432111 0000000 0000 00112334567
Q ss_pred HHHHccccCCCCCCCHHhHHHH
Q 003836 751 VAFWCIQEDPSHRPTMRKVTQM 772 (792)
Q Consensus 751 l~~~Cl~~~p~~RPs~~evl~~ 772 (792)
++.+||+.+|.+||+|.||++.
T Consensus 244 ~~~~~L~~~P~~Rps~~eil~h 265 (793)
T PLN00181 244 FCLWLLHPEPSCRPSMSELLQS 265 (793)
T ss_pred HHHHhCCCChhhCcChHHHhhc
Confidence 8889999999999999999873
|
|
| >KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.91 E-value=5.1e-24 Score=206.67 Aligned_cols=260 Identities=16% Similarity=0.288 Sum_probs=186.7
Q ss_pred CccccCHHHHHHHHhhhhhhcCccccceEEEeeecCCCceEEEEEEcccccccchHHHHHHHHHhccc-CCCCcccccce
Q 003836 489 NLRCFTYKELVEVTRGFKEELGRGAFGTVYKGFVNMGSSNHVAVKKLNSVFQDSEKEFKAEVNGIGQT-HHKNLVRLLGY 567 (792)
Q Consensus 489 ~~~~~~~~el~~~~~~~~~~lG~G~~g~Vy~g~~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l-~h~niv~l~g~ 567 (792)
++...++.|. +++.+.||+|.||.+-++.+. ++...+++|.+... ....++|.+|..---.| .|.||+.-++.
T Consensus 16 el~kv~l~d~----y~I~k~lgeG~FgkIlL~eHr-~s~t~ivlKavp~p-~tt~~dF~rEfhY~~~Ls~H~hIi~tY~v 89 (378)
T KOG1345|consen 16 ELKKVDLEDV----YTINKQLGEGRFGKILLAEHR-QSKTRIVLKAVPRP-QTTQADFVREFHYSFFLSPHQHIIDTYEV 89 (378)
T ss_pred cccccchhhh----hhHHHHhcccceeeEEeeecc-CCceEEEeeccCcc-hhhHHHHHHHhccceeeccchhhhHHHHH
Confidence 3444455443 445678999999999999754 66788999998775 34568899998744444 69999988765
Q ss_pred -eccCCceEEEEEeccCCCccccccCCCCCchhHHHHHHHHHHHHHHHHhhccCCCeEecCCCCCcEEEc--CCCCeEEe
Q 003836 568 -CDEGQNRLLVYEFMSNGTVASFLFGDSKPNWKLRTEIAMGIAGGLFYLHEECCTQIIHCDIKPQNILLD--DHYNARIS 644 (792)
Q Consensus 568 -~~~~~~~~lV~E~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dikp~NILl~--~~~~~kl~ 644 (792)
|...+.+++++||+|.|+|.+-+.. ..+.+..-.+++.|++.||.|+|++ .+||||||.+||||= +..++||+
T Consensus 90 aFqt~d~YvF~qE~aP~gdL~snv~~-~GigE~~~K~v~~ql~SAi~fMHsk---nlVHRdlK~eNiLif~~df~rvKlc 165 (378)
T KOG1345|consen 90 AFQTSDAYVFVQEFAPRGDLRSNVEA-AGIGEANTKKVFAQLLSAIEFMHSK---NLVHRDLKAENILIFDADFYRVKLC 165 (378)
T ss_pred HhhcCceEEEeeccCccchhhhhcCc-ccccHHHHHHHHHHHHHHHHHhhcc---chhhcccccceEEEecCCccEEEee
Confidence 5666778899999999999998855 4466777889999999999999999 999999999999993 44589999
Q ss_pred ecCCCccccCCCCCccccccccCCccccccccc-----CCCCcccceehHHHHHHHHHhcCcCCCcchhhhhhhhHHHHH
Q 003836 645 DFGLAKLLTLDQSHTNTAIRGTKGYVAPEWFRN-----MPITVKVDVYSYGVLLLEIICLRRNIDNEISKVDKAILTDWA 719 (792)
Q Consensus 645 Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~k~DV~S~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~ 719 (792)
|||+.+..... .....-+..|.+||.... ....+.+|||.||++++.++||..|+....... -..|.
T Consensus 166 DFG~t~k~g~t----V~~~~~~~~y~~pe~~~~~~ne~~~~~ps~D~WqfGIi~f~cltG~~PWQka~~~d----~~Y~~ 237 (378)
T KOG1345|consen 166 DFGLTRKVGTT----VKYLEYVNNYHAPELCDTVVNEKLVVNPSTDIWQFGIIFFYCLTGKFPWQKASIMD----KPYWE 237 (378)
T ss_pred ecccccccCce----ehhhhhhcccCCcHHHhhccccceEecccccchheeeeeeeeecCCCcchhhhccC----chHHH
Confidence 99998754321 111223567999998743 245688999999999999999999997433221 11233
Q ss_pred HHhhcccchhHhhhchhcccCCHHHHHHHHHHHHHccccCCCCCCCHHhHHHH
Q 003836 720 YDRYQERTLEALVENDLEAMNNVTMLHRFVMVAFWCIQEDPSHRPTMRKVTQM 772 (792)
Q Consensus 720 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~ 772 (792)
+..|..+....+.+. -...++++.++-++-|..+|++|=-+.++.++
T Consensus 238 ~~~w~~rk~~~~P~~------F~~fs~~a~r~Fkk~lt~~~~drcki~~~kk~ 284 (378)
T KOG1345|consen 238 WEQWLKRKNPALPKK------FNPFSEKALRLFKKSLTPRFKDRCKIWTAKKM 284 (378)
T ss_pred HHHHhcccCccCchh------hcccCHHHHHHHHHhcCCcccccchhHHHHHH
Confidence 444444333221111 11234566667777888888888555555544
|
|
| >KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.90 E-value=1.1e-24 Score=210.81 Aligned_cols=248 Identities=20% Similarity=0.342 Sum_probs=194.0
Q ss_pred hhhhhcCccccceEEEeeecCCCceEEEEEEccc--ccccchHHHHHHHHHhcccCCCCcccccceeccCCceEEEEEec
Q 003836 504 GFKEELGRGAFGTVYKGFVNMGSSNHVAVKKLNS--VFQDSEKEFKAEVNGIGQTHHKNLVRLLGYCDEGQNRLLVYEFM 581 (792)
Q Consensus 504 ~~~~~lG~G~~g~Vy~g~~~~~~~~~vavK~~~~--~~~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~lV~E~~ 581 (792)
++..+|.+.-.|..|+|+++. ..+++|++.- ......++|.+|.-.|+.+.||||+.++|.|....+..++..||
T Consensus 193 nl~tkl~e~hsgelwrgrwqg---ndivakil~vr~~t~risrdfneefp~lrifshpnilpvlgacnsppnlv~isq~m 269 (448)
T KOG0195|consen 193 NLITKLAESHSGELWRGRWQG---NDIVAKILNVREVTARISRDFNEEFPALRIFSHPNILPVLGACNSPPNLVIISQYM 269 (448)
T ss_pred hhhhhhccCCCcccccccccC---cchhhhhhhhhhcchhhcchhhhhCcceeeecCCchhhhhhhccCCCCceEeeeec
Confidence 355678899999999999863 4577777653 33344578999999999999999999999999999999999999
Q ss_pred cCCCccccccCCCC--CchhHHHHHHHHHHHHHHHHhhccCCCeEecCCCCCcEEEcCCCCeEEeecCCCccccCCCCCc
Q 003836 582 SNGTVASFLFGDSK--PNWKLRTEIAMGIAGGLFYLHEECCTQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLDQSHT 659 (792)
Q Consensus 582 ~~gsL~~~l~~~~~--l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dikp~NILl~~~~~~kl~Dfg~a~~~~~~~~~~ 659 (792)
+.|||...|++... .+..+..+++.+||+|++|||+.- +-|..--|....++||++.+++|+- +-++. +..
T Consensus 270 p~gslynvlhe~t~vvvd~sqav~faldiargmaflhsle-p~ipr~~lns~hvmidedltarism-ad~kf-----sfq 342 (448)
T KOG0195|consen 270 PFGSLYNVLHEQTSVVVDHSQAVRFALDIARGMAFLHSLE-PMIPRFYLNSKHVMIDEDLTARISM-ADTKF-----SFQ 342 (448)
T ss_pred cchHHHHHHhcCccEEEecchHHHHHHHHHhhHHHHhhcc-hhhhhhhcccceEEecchhhhheec-cccee-----eee
Confidence 99999999998753 577899999999999999999972 2244456889999999999998862 11111 111
Q ss_pred cccccccCCcccccccccCCCC---cccceehHHHHHHHHHhcCcCCCcchhhhhhhhHHHHHHHhhcccchhHhhhchh
Q 003836 660 NTAIRGTKGYVAPEWFRNMPIT---VKVDVYSYGVLLLEIICLRRNIDNEISKVDKAILTDWAYDRYQERTLEALVENDL 736 (792)
Q Consensus 660 ~~~~~gt~~y~aPE~~~~~~~~---~k~DV~S~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 736 (792)
.....-.|.||+||.++..+-+ .++|+|||.++||||.|...||......+- -..+.-+.+
T Consensus 343 e~gr~y~pawmspealqrkped~n~raadmwsfaillwel~trevpfadlspmec----------------gmkialegl 406 (448)
T KOG0195|consen 343 EVGRAYSPAWMSPEALQRKPEDLNIRAADMWSFAILLWELNTREVPFADLSPMEC----------------GMKIALEGL 406 (448)
T ss_pred ccccccCcccCCHHHHhcCchhcchhhhhHHHHHHHHHHhhccccccccCCchhh----------------hhhhhhccc
Confidence 1112236789999999877644 579999999999999999999965432211 112223455
Q ss_pred cccCCHHHHHHHHHHHHHccccCCCCCCCHHhHHHHhccCc
Q 003836 737 EAMNNVTMLHRFVMVAFWCIQEDPSHRPTMRKVTQMLEGVV 777 (792)
Q Consensus 737 ~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~L~~~~ 777 (792)
+...++..+..+.+++.-|++.||.+||.+..|+-+||+++
T Consensus 407 rv~ippgis~hm~klm~icmnedpgkrpkfdmivpilekm~ 447 (448)
T KOG0195|consen 407 RVHIPPGISRHMNKLMNICMNEDPGKRPKFDMIVPILEKMI 447 (448)
T ss_pred cccCCCCccHHHHHHHHHHhcCCCCcCCCcceehhhHHHhc
Confidence 56677778888899999999999999999999999999874
|
|
| >smart00750 KIND kinase non-catalytic C-lobe domain | Back alignment and domain information |
|---|
Probab=99.90 E-value=5.7e-24 Score=208.46 Aligned_cols=165 Identities=21% Similarity=0.173 Sum_probs=125.3
Q ss_pred CCccccccCC-CCCchhHHHHHHHHHHHHHHHHhhccCCCeEecCCCCCcEEEcCCCCeEEeecCCCccccCCCCCcccc
Q 003836 584 GTVASFLFGD-SKPNWKLRTEIAMGIAGGLFYLHEECCTQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLDQSHTNTA 662 (792)
Q Consensus 584 gsL~~~l~~~-~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dikp~NILl~~~~~~kl~Dfg~a~~~~~~~~~~~~~ 662 (792)
|+|.+++... ..+++..+..|+.||++||.|||++ + ||+|||++.++.+|+ ||+++......
T Consensus 1 GsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~lH~~---~------kp~Nil~~~~~~~~~--fG~~~~~~~~~------ 63 (176)
T smart00750 1 VSLADILEVRGRPLNEEEIWAVCLQCLRALRELHRQ---A------KSGNILLTWDGLLKL--DGSVAFKTPEQ------ 63 (176)
T ss_pred CcHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhc---C------CcccEeEcCccceee--ccceEeecccc------
Confidence 6889999764 5689999999999999999999998 4 999999999999999 99998754322
Q ss_pred ccccCCcccccccccCCCCcccceehHHHHHHHHHhcCcCCCcchhhhhhhhHHHHHHHhhcccchhHhhhchhcc-cCC
Q 003836 663 IRGTKGYVAPEWFRNMPITVKVDVYSYGVLLLEIICLRRNIDNEISKVDKAILTDWAYDRYQERTLEALVENDLEA-MNN 741 (792)
Q Consensus 663 ~~gt~~y~aPE~~~~~~~~~k~DV~S~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~ 741 (792)
..||+.|+|||++.+..++.++|||||||++|||++|+.||........ .+...... ... ..... ...
T Consensus 64 ~~g~~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~p~~~~~~~~~--~~~~~~~~-~~~--------~~~~~~~~~ 132 (176)
T smart00750 64 SRVDPYFMAPEVIQGQSYTEKADIYSLGITLYEALDYELPYNEERELSA--ILEILLNG-MPA--------DDPRDRSNL 132 (176)
T ss_pred CCCcccccChHHhcCCCCcchhhHHHHHHHHHHHHhCCCCccccchhcH--HHHHHHHH-hcc--------CCccccccH
Confidence 2588999999999999999999999999999999999999865432111 01000000 000 00000 011
Q ss_pred HHHHH--HHHHHHHHccccCCCCCCCHHhHHHHhccC
Q 003836 742 VTMLH--RFVMVAFWCIQEDPSHRPTMRKVTQMLEGV 776 (792)
Q Consensus 742 ~~~~~--~l~~l~~~Cl~~~p~~RPs~~evl~~L~~~ 776 (792)
..... ++.+++.+||+.+|.+||++.|+++.+..+
T Consensus 133 ~~~~~~~~~~~~i~~cl~~~p~~Rp~~~~ll~~~~~~ 169 (176)
T smart00750 133 ESVSAARSFADFMRVCASRLPQRREAANHYLAHCRAL 169 (176)
T ss_pred HHHHhhhhHHHHHHHHHhcccccccCHHHHHHHHHHH
Confidence 12222 689999999999999999999999987543
|
It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features |
| >PRK09188 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.88 E-value=2.2e-22 Score=215.60 Aligned_cols=172 Identities=19% Similarity=0.132 Sum_probs=130.6
Q ss_pred hhhhhhcCccccceEEEeeecCCCceEEEEEEcccc-----cccchHHHHHHHHHhcccCCCCcccccceeccCCceEEE
Q 003836 503 RGFKEELGRGAFGTVYKGFVNMGSSNHVAVKKLNSV-----FQDSEKEFKAEVNGIGQTHHKNLVRLLGYCDEGQNRLLV 577 (792)
Q Consensus 503 ~~~~~~lG~G~~g~Vy~g~~~~~~~~~vavK~~~~~-----~~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~lV 577 (792)
+.+.+.||+|+||+||+|.....+++.+|||++... .....+.+.+|++++++++|+|+++.+.. ....+||
T Consensus 20 Y~~~~~IG~G~fg~Vy~a~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~E~~iL~~L~h~~iv~~l~~---~~~~~LV 96 (365)
T PRK09188 20 FVETAVLKRDVFSTVERGYFAGDPGTARAVRRRVSEVPWWSKPLARHLAAREIRALKTVRGIGVVPQLLA---TGKDGLV 96 (365)
T ss_pred ceEccEEeecCcEEEEEEEEcCCCCeEEEEEEecccccccccHHHHHHHHHHHHHHHhccCCCCCcEEEE---cCCcEEE
Confidence 445678999999999999866545667899987532 12235679999999999999999853322 2457999
Q ss_pred EEeccCCCccccccCCCCCchhHHHHHHHHHHHHHHHHhhccCCCeEecCC-CCCcEEEcCCCCeEEeecCCCccccCCC
Q 003836 578 YEFMSNGTVASFLFGDSKPNWKLRTEIAMGIAGGLFYLHEECCTQIIHCDI-KPQNILLDDHYNARISDFGLAKLLTLDQ 656 (792)
Q Consensus 578 ~E~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~di-kp~NILl~~~~~~kl~Dfg~a~~~~~~~ 656 (792)
|||+++++|... ... ....++.|+++||.|||+. +|+|||| ||+|||++.++.+||+|||+++.+....
T Consensus 97 mE~~~G~~L~~~-~~~------~~~~~~~~i~~aL~~lH~~---gIiHrDL~KP~NILv~~~~~ikLiDFGlA~~~~~~~ 166 (365)
T PRK09188 97 RGWTEGVPLHLA-RPH------GDPAWFRSAHRALRDLHRA---GITHNDLAKPQNWLMGPDGEAAVIDFQLASVFRRRG 166 (365)
T ss_pred EEccCCCCHHHh-Ccc------chHHHHHHHHHHHHHHHHC---CCeeCCCCCcceEEEcCCCCEEEEECccceecccCc
Confidence 999999999632 111 1246788999999999998 9999999 9999999999999999999999775433
Q ss_pred CC-------ccccccccCCcccccccccCC------CCccccee
Q 003836 657 SH-------TNTAIRGTKGYVAPEWFRNMP------ITVKVDVY 687 (792)
Q Consensus 657 ~~-------~~~~~~gt~~y~aPE~~~~~~------~~~k~DV~ 687 (792)
.. ..+...+++.|+|||.+...+ .+..+|-|
T Consensus 167 ~~~~~~~~~d~~~~~~~~~~~~pe~~~~~~~~~~~~~~~~~dgW 210 (365)
T PRK09188 167 ALYRIAAYEDLRHLLKHKRTYAPDALTPRERKILARKSLPSRIW 210 (365)
T ss_pred chhhhhhhhhhhhhhccCccCCcccCChhhhccccccccccCcE
Confidence 21 113556888999999986432 33346666
|
|
| >KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.85 E-value=1.1e-20 Score=203.42 Aligned_cols=257 Identities=19% Similarity=0.210 Sum_probs=189.2
Q ss_pred hhhhhhcCccccceEEEeeecCCCceEEEEEEcccccccchHHHHHHHHHhcccCC----CCccccccee-ccCCceEEE
Q 003836 503 RGFKEELGRGAFGTVYKGFVNMGSSNHVAVKKLNSVFQDSEKEFKAEVNGIGQTHH----KNLVRLLGYC-DEGQNRLLV 577 (792)
Q Consensus 503 ~~~~~~lG~G~~g~Vy~g~~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h----~niv~l~g~~-~~~~~~~lV 577 (792)
+.+.++||+|+||.||++.........+|+|............+..|+.++..+.+ +++..+++.. ..+...++|
T Consensus 20 ~~i~~~iG~G~fG~V~~v~~~~~~~~~~a~K~e~~~~~~~~~~l~~E~~vl~~l~~~~~~~~~~~~~~~G~~~~~~~~iV 99 (322)
T KOG1164|consen 20 YKLGKKIGEGGFGAVYLVSDKSEKNKEYAKKLEKKELGSKPSVLKIEIQVLKKLEKKNGPSHFPKLLDHGRSTEDFNFIV 99 (322)
T ss_pred eEEeeeccccCCceEEEEEecCCCCeeEEEEEEEecccCCCccchhHHHHHHHHhhhcCCCCCCEEEEeccCCCceeEEE
Confidence 44567899999999999975443345788887765433333378888888888863 6888888888 477788999
Q ss_pred EEeccCCCccccccCC--CCCchhHHHHHHHHHHHHHHHHhhccCCCeEecCCCCCcEEEcCC-----CCeEEeecCCCc
Q 003836 578 YEFMSNGTVASFLFGD--SKPNWKLRTEIAMGIAGGLFYLHEECCTQIIHCDIKPQNILLDDH-----YNARISDFGLAK 650 (792)
Q Consensus 578 ~E~~~~gsL~~~l~~~--~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dikp~NILl~~~-----~~~kl~Dfg~a~ 650 (792)
|+.. +.+|.++.... +.++..+.++|+.|++.+|.+||+. |++||||||.|+++... ..+.|.|||+++
T Consensus 100 M~l~-G~sL~dl~~~~~~~~fs~~T~l~ia~q~l~~l~~lH~~---G~iHRDiKp~N~~~g~~~~~~~~~~~llDfGlar 175 (322)
T KOG1164|consen 100 MSLL-GPSLEDLRKRNPPGRFSRKTVLRIAIQNLNALEDLHSK---GFIHRDIKPENFVVGQSSRSEVRTLYLLDFGLAR 175 (322)
T ss_pred Eecc-CccHHHHHHhCCCCCcCHhHHHHHHHHHHHHHHHHHhc---CcccCCcCHHHeeecCCCCcccceEEEEecCCCc
Confidence 9987 66999977443 5789999999999999999999999 99999999999999854 469999999999
Q ss_pred --cccCCCCC------c-cccccccCCcccccccccCCCCcccceehHHHHHHHHHhcCcCCCcchhhhhhhhHHHHHHH
Q 003836 651 --LLTLDQSH------T-NTAIRGTKGYVAPEWFRNMPITVKVDVYSYGVLLLEIICLRRNIDNEISKVDKAILTDWAYD 721 (792)
Q Consensus 651 --~~~~~~~~------~-~~~~~gt~~y~aPE~~~~~~~~~k~DV~S~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~ 721 (792)
........ . ....+||..|.++....+.+.+++.|+||++.++.|++.|..|+...........+......
T Consensus 176 ~~~~~~~~~~~~~~~r~~~~~~rGT~ry~S~~~H~~~e~~r~DDles~~Y~l~el~~g~LPW~~~~~~~~~~~~~~~~~~ 255 (322)
T KOG1164|consen 176 RFKYVGDSGGNLRPPRPQKGLFRGTLRYASINVHLGIEQGRRDDLESLFYMLLELLKGSLPWEALEMTDLKSKFEKDPRK 255 (322)
T ss_pred cccccCCCCcccccCCCCccCCCCccccccHHHhCCCccCCchhhhhHHHHHHHHhcCCCCCccccccchHHHHHHHhhh
Confidence 43222211 1 22356999999999999999999999999999999999999998654332221111111111
Q ss_pred hhcccchhHhhhchhcccCCHHHHHHHHHHHHHccccCCCCCCCHHhHHHHhccC
Q 003836 722 RYQERTLEALVENDLEAMNNVTMLHRFVMVAFWCIQEDPSHRPTMRKVTQMLEGV 776 (792)
Q Consensus 722 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~L~~~ 776 (792)
. .... ........+.++...+-..+..++|....+...|+..
T Consensus 256 ~--------~~~~-----~~~~~~~~~~~~~~~~~~~~~~~~Pdy~~~~~~l~~~ 297 (322)
T KOG1164|consen 256 L--------LTDR-----FGDLKPEEFAKILEYIDSLDYEDKPDYEKLAELLKDV 297 (322)
T ss_pred h--------cccc-----ccCCChHHHHHHHHHhhccCCcCCCCHHHHHHHHHHH
Confidence 0 0000 1111233445555556668999999999999887654
|
|
| >COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Probab=99.82 E-value=1.3e-19 Score=195.08 Aligned_cols=256 Identities=26% Similarity=0.341 Sum_probs=194.5
Q ss_pred hhhhcCccccceEEEeeecCCCceEEEEEEccccccc---chHHHHHHHHHhcccCCC-CcccccceeccCCceEEEEEe
Q 003836 505 FKEELGRGAFGTVYKGFVNMGSSNHVAVKKLNSVFQD---SEKEFKAEVNGIGQTHHK-NLVRLLGYCDEGQNRLLVYEF 580 (792)
Q Consensus 505 ~~~~lG~G~~g~Vy~g~~~~~~~~~vavK~~~~~~~~---~~~~~~~Ei~~l~~l~h~-niv~l~g~~~~~~~~~lV~E~ 580 (792)
..+.||.|+|+.||++... ..+++|.+...... ....+.+|+.+++.+.|+ +++++.+++......++++|+
T Consensus 4 ~~~~l~~g~~~~v~~~~~~----~~~~~k~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 79 (384)
T COG0515 4 ILRKLGEGSFGEVYLARDR----KLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLYDFFQDEGSLYLVMEY 79 (384)
T ss_pred eEEeecCCCCeEEEEEEec----cEEEEEeechhhccchhHHHHHHHHHHHHHHccCCcceeeEEEEEecCCEEEEEEec
Confidence 3467999999999999765 57899998765443 367899999999999988 799999999777778999999
Q ss_pred ccCCCccccccCCC---CCchhHHHHHHHHHHHHHHHHhhccCCCeEecCCCCCcEEEcCCC-CeEEeecCCCccccCCC
Q 003836 581 MSNGTVASFLFGDS---KPNWKLRTEIAMGIAGGLFYLHEECCTQIIHCDIKPQNILLDDHY-NARISDFGLAKLLTLDQ 656 (792)
Q Consensus 581 ~~~gsL~~~l~~~~---~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dikp~NILl~~~~-~~kl~Dfg~a~~~~~~~ 656 (792)
+.++++.+++.... .+.......++.|++.++.|+|+. +++||||||+||+++..+ .+++.|||.++......
T Consensus 80 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~H~~---~~~hrd~kp~nil~~~~~~~~~l~dfg~~~~~~~~~ 156 (384)
T COG0515 80 VDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLHSK---GIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPG 156 (384)
T ss_pred CCCCcHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHeeecCCCCeEEEeccCcceecCCCC
Confidence 99999997776654 688999999999999999999999 899999999999999998 79999999998665443
Q ss_pred CC-----ccccccccCCccccccccc---CCCCcccceehHHHHHHHHHhcCcCCCcchhhhhhhhHHHHHHHhhcccch
Q 003836 657 SH-----TNTAIRGTKGYVAPEWFRN---MPITVKVDVYSYGVLLLEIICLRRNIDNEISKVDKAILTDWAYDRYQERTL 728 (792)
Q Consensus 657 ~~-----~~~~~~gt~~y~aPE~~~~---~~~~~k~DV~S~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 728 (792)
.. ......|+..|+|||.+.. ...+...|+||+|++++++++|..|+......................
T Consensus 157 ~~~~~~~~~~~~~~t~~~~~pe~~~~~~~~~~~~~~D~~s~g~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~--- 233 (384)
T COG0515 157 STSSIPALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLKIILELPTP--- 233 (384)
T ss_pred ccccccccccccccccccCCHHHhcCCCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCccccHHHHHHHHHhcCCc---
Confidence 32 2355679999999999987 578899999999999999999999965443210000000000000000
Q ss_pred hHhhhchhcccCCHHHHHHHHHHHHHccccCCCCCCCHHhHHHH
Q 003836 729 EALVENDLEAMNNVTMLHRFVMVAFWCIQEDPSHRPTMRKVTQM 772 (792)
Q Consensus 729 ~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~ 772 (792)
.................+.+++..++..+|.+|.++.+....
T Consensus 234 --~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~~~~~ 275 (384)
T COG0515 234 --SLASPLSPSNPELISKAASDLLKKLLAKDPKNRLSSSSDLSH 275 (384)
T ss_pred --ccccccCccccchhhHHHHHHHHHHHhcCchhcCCHHHHhhc
Confidence 000000000002223567888999999999999999887764
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.82 E-value=4.1e-21 Score=219.44 Aligned_cols=252 Identities=20% Similarity=0.254 Sum_probs=186.0
Q ss_pred hhhcCccccceEEEeeecCCCceEEEEEEcccc--cccc----hHHHHHHHHHhcccCCCCcccccceeccCCceEEEEE
Q 003836 506 KEELGRGAFGTVYKGFVNMGSSNHVAVKKLNSV--FQDS----EKEFKAEVNGIGQTHHKNLVRLLGYCDEGQNRLLVYE 579 (792)
Q Consensus 506 ~~~lG~G~~g~Vy~g~~~~~~~~~vavK~~~~~--~~~~----~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~lV~E 579 (792)
...+|.|++|.|+....... .+..+.|..... .... ...+..|.-+-..++|+|++..+..+.+.....-+||
T Consensus 323 ~~~~g~ga~g~~~~~~~~~~-~~~~~~~~~r~~~~~~~s~~~~~~~i~sE~~i~~~l~h~~~~e~l~~~~~~~~~~~~mE 401 (601)
T KOG0590|consen 323 GRVLGSGAYGSVRIAKRRSD-LKSFPEKEFRVRVKPTESERKYNYNITSEFCIGSSLSHPNIIETLDIVQEIDGILQSME 401 (601)
T ss_pred cceeeecccCceEEEEecCC-CccchhhhhhcccCCcccHHHHhhhhhhheeecccccCCchhhhHHHHhhcccchhhhh
Confidence 35799999997766543322 122333322100 1111 1225567777788999999999998888887777799
Q ss_pred eccCCCccccccCCCCCchhHHHHHHHHHHHHHHHHhhccCCCeEecCCCCCcEEEcCCCCeEEeecCCCccccCCCC--
Q 003836 580 FMSNGTVASFLFGDSKPNWKLRTEIAMGIAGGLFYLHEECCTQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLDQS-- 657 (792)
Q Consensus 580 ~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dikp~NILl~~~~~~kl~Dfg~a~~~~~~~~-- 657 (792)
|+++ +|..++.+...+....+..++.|+..|+.|+|+. +|.|||||++|++++.++.+||+|||.+..+..+..
T Consensus 402 ~~~~-Dlf~~~~~~~~~~~~e~~c~fKqL~~Gv~y~h~~---GiahrdlK~enll~~~~g~lki~Dfg~~~vf~~~~e~~ 477 (601)
T KOG0590|consen 402 YCPY-DLFSLVMSNGKLTPLEADCFFKQLLRGVKYLHSM---GLAHRDLKLENLLVTENGILKIIDFGAASVFRYPWEKN 477 (601)
T ss_pred cccH-HHHHHHhcccccchhhhhHHHHHHHHHHHHHHhc---CceeccCccccEEEecCCceEEeecCcceeeccCcchh
Confidence 9999 9999998877888899999999999999999999 999999999999999999999999999988765443
Q ss_pred -CccccccccCCcccccccccCCCCcc-cceehHHHHHHHHHhcCcCCCcchhhhhhhhHHHHHHHhhcccchhHhhhch
Q 003836 658 -HTNTAIRGTKGYVAPEWFRNMPITVK-VDVYSYGVLLLEIICLRRNIDNEISKVDKAILTDWAYDRYQERTLEALVEND 735 (792)
Q Consensus 658 -~~~~~~~gt~~y~aPE~~~~~~~~~k-~DV~S~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 735 (792)
.....++|+.+|+|||.+...+|++. .||||.|+++..|++|+.||........... ....... .-...
T Consensus 478 ~~~~~g~~gS~pY~apE~~~~~~ydpr~vDiwS~~ii~~~m~~~~~~Wk~a~~~~~~~~-----~~~~~~~----~~~~~ 548 (601)
T KOG0590|consen 478 IHESSGIVGSDPYLAPEVLTGKEYDPRAVDVWSCGIIYICMILGRFPWKVAKKSDNSFK-----TNNYSDQ----RNIFE 548 (601)
T ss_pred hhhhcCcccCCcCcCcccccccccCcchhhhhhccceEEEEecCCCccccccccccchh-----hhccccc----ccccc
Confidence 34556789999999999999999864 8999999999999999999865432211100 0000000 00000
Q ss_pred hcccCCHHHHHHHHHHHHHccccCCCCCCCHHhHHH
Q 003836 736 LEAMNNVTMLHRFVMVAFWCIQEDPSHRPTMRKVTQ 771 (792)
Q Consensus 736 ~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~ 771 (792)
-........+.+...++.++|+.+|.+|.|+++|++
T Consensus 549 ~~~~~~~~lp~~~~~~~~~~l~~~P~~R~ti~~i~~ 584 (601)
T KOG0590|consen 549 GPNRLLSLLPRETRIIIYRMLQLDPTKRITIEQILN 584 (601)
T ss_pred ChHHHHHhchhhHHHHHHHHccCChhheecHHHHhh
Confidence 000011234567788999999999999999999997
|
|
| >KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.80 E-value=1.4e-19 Score=173.14 Aligned_cols=201 Identities=20% Similarity=0.255 Sum_probs=166.7
Q ss_pred HHHhhhhhhcCccccceEEEeeecCCCceEEEEEEcccccccchHHHHHHHHHhcccCC-CCcccccceeccCCceEEEE
Q 003836 500 EVTRGFKEELGRGAFGTVYKGFVNMGSSNHVAVKKLNSVFQDSEKEFKAEVNGIGQTHH-KNLVRLLGYCDEGQNRLLVY 578 (792)
Q Consensus 500 ~~~~~~~~~lG~G~~g~Vy~g~~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h-~niv~l~g~~~~~~~~~lV~ 578 (792)
...+.+.++||.|+||.+|.|. ...+++.||+|.-+.. ....++..|.++++.++| ..|..+..+..+...-.|||
T Consensus 14 ~gky~lvrkiGsGSFGdIy~~~-~i~~ge~VAiK~Es~~--a~hpqL~yEskvY~iL~~g~GiP~i~~y~~e~~ynvlVM 90 (341)
T KOG1163|consen 14 GGKYKLVRKIGSGSFGDIYLGI-SITSGEEVAIKLESSK--AKHPQLLYESKVYRILQGGVGIPHIRHYGTEKDYNVLVM 90 (341)
T ss_pred ccceEEEEeecCCchhheeeee-eccCCceEEEEeeccc--CCCcchhHHHHHHHHhccCCCCchhhhhccccccceeee
Confidence 3345667899999999999995 4567889999986553 334567889999999975 77888888889999999999
Q ss_pred EeccCCCcccccc-CCCCCchhHHHHHHHHHHHHHHHHhhccCCCeEecCCCCCcEEEcCC---CCeEEeecCCCccccC
Q 003836 579 EFMSNGTVASFLF-GDSKPNWKLRTEIAMGIAGGLFYLHEECCTQIIHCDIKPQNILLDDH---YNARISDFGLAKLLTL 654 (792)
Q Consensus 579 E~~~~gsL~~~l~-~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dikp~NILl~~~---~~~kl~Dfg~a~~~~~ 654 (792)
+.. +-||.+++. -.+.++.++.+-++-|++.-++|+|.+ ++|||||||+|+|..-+ ..+.++|||+|+.+..
T Consensus 91 dLL-GPsLEdLfnfC~R~ftmkTvLMLaDQml~RiEyvH~r---~fiHRDIKPdNFLMGlgrh~~kl~LIDFGLaKky~d 166 (341)
T KOG1163|consen 91 DLL-GPSLEDLFNFCSRRFTMKTVLMLADQMLSRIEYVHLR---NFIHRDIKPDNFLMGLGRHCNKLYLIDFGLAKKYRD 166 (341)
T ss_pred ecc-CccHHHHHHHHhhhhhHHhHHHHHHHHHHHHHHHHhh---ccccccCCccceeeccccccceEEEEeccchhhhcc
Confidence 998 568888774 346788899999999999999999999 99999999999999744 4689999999998765
Q ss_pred CCCC------ccccccccCCcccccccccCCCCcccceehHHHHHHHHHhcCcCCCcch
Q 003836 655 DQSH------TNTAIRGTKGYVAPEWFRNMPITVKVDVYSYGVLLLEIICLRRNIDNEI 707 (792)
Q Consensus 655 ~~~~------~~~~~~gt~~y~aPE~~~~~~~~~k~DV~S~Gv~l~el~tg~~p~~~~~ 707 (792)
.... ..+...||.+|.+--...+.+.+.+.|+=|+|.+|..+--|..||....
T Consensus 167 ~~t~~HIpyre~r~ltGTaRYASinAh~g~eqSRRDDmeSvgYvLmYfnrG~LPWQglk 225 (341)
T KOG1163|consen 167 IRTRQHIPYREDRNLTGTARYASINAHLGIEQSRRDDMESVGYVLMYFNRGSLPWQGLK 225 (341)
T ss_pred ccccccCccccCCccceeeeehhhhhhhhhhhhhhhhhhhhcceeeeeecCCCcccccc
Confidence 4332 2334569999998888888888999999999999999999999997654
|
|
| >cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain | Back alignment and domain information |
|---|
Probab=99.80 E-value=2e-19 Score=177.48 Aligned_cols=138 Identities=15% Similarity=0.142 Sum_probs=108.2
Q ss_pred hhcCccccceEEEeeecCCCceEEEEEEccccccc--c-------h-----------------HHHHHHHHHhcccCCCC
Q 003836 507 EELGRGAFGTVYKGFVNMGSSNHVAVKKLNSVFQD--S-------E-----------------KEFKAEVNGIGQTHHKN 560 (792)
Q Consensus 507 ~~lG~G~~g~Vy~g~~~~~~~~~vavK~~~~~~~~--~-------~-----------------~~~~~Ei~~l~~l~h~n 560 (792)
..||+|++|.||+|... +++.||||+++..... . . ....+|++.+.++.|++
T Consensus 3 ~~ig~G~~~~Vy~a~~~--~g~~vAvKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~ 80 (190)
T cd05147 3 GCISTGKEANVYHATTA--NGEERAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKSNPRKMVRTWAEKEMRNLKRLVTAG 80 (190)
T ss_pred CccccccceEEEEEECC--CCCEEEEEEEEecccccccHHHhhcCCchhhccccCCCHHHHHHHHHHHHHHHHHHHHHCC
Confidence 57999999999999764 5789999998753211 0 1 12245999999998887
Q ss_pred cccccceeccCCceEEEEEeccCCCccccccCCCCCchhHHHHHHHHHHHHHHHH-hhccCCCeEecCCCCCcEEEcCCC
Q 003836 561 LVRLLGYCDEGQNRLLVYEFMSNGTVASFLFGDSKPNWKLRTEIAMGIAGGLFYL-HEECCTQIIHCDIKPQNILLDDHY 639 (792)
Q Consensus 561 iv~l~g~~~~~~~~~lV~E~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yL-H~~~~~~ivH~dikp~NILl~~~~ 639 (792)
+.....+.. ...+|||||++++++.........++.....+++.|++.+|.|+ |+. +|+||||||+|||++ ++
T Consensus 81 v~~p~~~~~--~~~~iVmE~i~g~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~l~H~~---giiHrDlkP~NIli~-~~ 154 (190)
T cd05147 81 IPCPEPILL--KSHVLVMEFIGDDGWAAPRLKDAPLSESKARELYLQVIQIMRILYQDC---RLVHADLSEYNLLYH-DG 154 (190)
T ss_pred CCCCcEEEe--cCCEEEEEEeCCCCCcchhhhcCCCCHHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEEE-CC
Confidence 744333222 22389999999988776544456788899999999999999999 677 999999999999998 47
Q ss_pred CeEEeecCCCccc
Q 003836 640 NARISDFGLAKLL 652 (792)
Q Consensus 640 ~~kl~Dfg~a~~~ 652 (792)
.++|+|||++...
T Consensus 155 ~v~LiDFG~a~~~ 167 (190)
T cd05147 155 KLYIIDVSQSVEH 167 (190)
T ss_pred cEEEEEccccccC
Confidence 8999999999754
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c |
| >PRK10359 lipopolysaccharide core biosynthesis protein; Provisional | Back alignment and domain information |
|---|
Probab=99.79 E-value=1.3e-19 Score=180.66 Aligned_cols=173 Identities=10% Similarity=0.087 Sum_probs=131.2
Q ss_pred HHHHHHhhhhhhcCccccceEEEeeecCCCceEEEEEEcccccccchHH---------HHHHHHHhcccCCCCcccccce
Q 003836 497 ELVEVTRGFKEELGRGAFGTVYKGFVNMGSSNHVAVKKLNSVFQDSEKE---------FKAEVNGIGQTHHKNLVRLLGY 567 (792)
Q Consensus 497 el~~~~~~~~~~lG~G~~g~Vy~g~~~~~~~~~vavK~~~~~~~~~~~~---------~~~Ei~~l~~l~h~niv~l~g~ 567 (792)
++....++..+.||.|+||.||+... +...+|+|.+.......+.. +++|+..+.+++|++|..+..+
T Consensus 27 ~~l~~~y~~~~~l~~~~f~~v~l~~~---~~~~~iiKvf~~~~~~~~~~~~~f~~g~~~e~Ea~~l~rL~~~GI~~~~d~ 103 (232)
T PRK10359 27 DFLSYNIKTIKVFRNIDDTKVSLIDT---DYGKYILKVFAPKVKRTERFLKSFVKGDYYENLIVQTDRVRSEGLASLNDF 103 (232)
T ss_pred HHhhCceEEEEEecCCCceEEEEEec---CCCcEEEEEechhcCchHHHHHhhhhhHHHHHHHHHHHHHHHCCCCcceEe
Confidence 33444455567899999999998633 24579999997654433332 6899999999999999999888
Q ss_pred eccC--------CceEEEEEeccCCCccccccCCCCCchhHHHHHHHHHHHHHHHHhhccCCCeEecCCCCCcEEEcCCC
Q 003836 568 CDEG--------QNRLLVYEFMSNGTVASFLFGDSKPNWKLRTEIAMGIAGGLFYLHEECCTQIIHCDIKPQNILLDDHY 639 (792)
Q Consensus 568 ~~~~--------~~~~lV~E~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dikp~NILl~~~~ 639 (792)
+... ...+|||||++|.+|.++.. ++. ....+++.+|..+|+. +++||||||+||+++.++
T Consensus 104 ~~~~~~~~~~~~~~~~lvmEyi~G~tL~~~~~----~~~----~~~~~i~~~l~~lH~~---gi~H~Dikp~Nili~~~g 172 (232)
T PRK10359 104 YLLAERKTLRYAHTYIMLIEYIEGVELNDMPE----ISE----DVKAKIKASIESLHQH---GMVSGDPHKGNFIVSKNG 172 (232)
T ss_pred eeecccccccccCCeEEEEEEECCccHHHhhh----ccH----HHHHHHHHHHHHHHHc---CCccCCCChHHEEEeCCC
Confidence 6533 35789999999999988742 222 3456999999999999 999999999999999988
Q ss_pred CeEEeecCCCccccCCCCCccccccccCCcccccccccCCCCcccceehHHHHHHHHH
Q 003836 640 NARISDFGLAKLLTLDQSHTNTAIRGTKGYVAPEWFRNMPITVKVDVYSYGVLLLEII 697 (792)
Q Consensus 640 ~~kl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DV~S~Gv~l~el~ 697 (792)
++|+|||..+....+.... .+.....+..++|+||||+.+..+.
T Consensus 173 -i~liDfg~~~~~~e~~a~d-------------~~vler~y~~~~di~~lg~~~~~~~ 216 (232)
T PRK10359 173 -LRIIDLSGKRCTAQRKAKD-------------RIDLERHYGIKNEIKDLGYYLLIYK 216 (232)
T ss_pred -EEEEECCCcccccchhhHH-------------HHHHHhHhcccccccceeEeehHHH
Confidence 9999999887553211111 1233445678999999999987654
|
|
| >KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.78 E-value=4.4e-19 Score=193.30 Aligned_cols=215 Identities=25% Similarity=0.434 Sum_probs=163.1
Q ss_pred hcccCCCCcccccceeccCCceEEEEEeccCCCccccccCC-CCCchhHHHHHHHHHHHHHHHHhhccCCCe-EecCCCC
Q 003836 553 IGQTHHKNLVRLLGYCDEGQNRLLVYEFMSNGTVASFLFGD-SKPNWKLRTEIAMGIAGGLFYLHEECCTQI-IHCDIKP 630 (792)
Q Consensus 553 l~~l~h~niv~l~g~~~~~~~~~lV~E~~~~gsL~~~l~~~-~~l~~~~~~~i~~~ia~gL~yLH~~~~~~i-vH~dikp 630 (792)
|+.+.|.|+.+++|.+.++...+.|.+|+..|+|.+.+... ..+++..+..++++|++||.|||+. .| .|+.+++
T Consensus 1 l~~l~h~n~~~f~g~~~~~~~~~~i~~~c~rGsl~D~i~~~~~~~d~~F~~s~~rdi~~Gl~ylh~s---~i~~hg~l~s 77 (484)
T KOG1023|consen 1 LRQLDHDNLNKFIGASVDGPEMIVIWEYCSRGSLLDILSNEDIKLDYFFILSFIRDISKGLAYLHNS---PIGYHGALKS 77 (484)
T ss_pred CcccchhhhhhheeeEecCCceEEEEeeecCccHHhHHhccccCccHHHHHHHHHHHHHHHHHHhcC---cceeeeeecc
Confidence 45789999999999999999999999999999999999874 5789999999999999999999997 44 9999999
Q ss_pred CcEEEcCCCCeEEeecCCCccccCC-CCCccccccccCCcccccccccC-------CCCcccceehHHHHHHHHHhcCcC
Q 003836 631 QNILLDDHYNARISDFGLAKLLTLD-QSHTNTAIRGTKGYVAPEWFRNM-------PITVKVDVYSYGVLLLEIICLRRN 702 (792)
Q Consensus 631 ~NILl~~~~~~kl~Dfg~a~~~~~~-~~~~~~~~~gt~~y~aPE~~~~~-------~~~~k~DV~S~Gv~l~el~tg~~p 702 (792)
.|.++|....+||+|||+....... .........-..-|.|||.++.. ..+.+.||||||++++|+++.+.|
T Consensus 78 ~nClvd~~w~lklt~~Gl~~~~~~~~~~~~~~~~~~~~lw~aPellr~~~~~~~~~~~~~~gdiYs~~ii~~ei~~r~~~ 157 (484)
T KOG1023|consen 78 SNCLVDSRWVLKLTDFGLNSLLEETAEPEAHHPIRKALLWTAPELLRGALSQSLESALTQKGDIYSFGIIMYEILFRSGP 157 (484)
T ss_pred ccceeeeeEEEEechhhhcccccccccccccchhHHHHhccCHHHhcccccccccccccccCCeehHHHHHHHHHhccCc
Confidence 9999999999999999998876431 11111222245569999998763 257789999999999999999999
Q ss_pred CCcchhhhhhhhHHHHHHHhhcccchhHhhhchhcccCCHHHHHHHHHHHHHccccCCCCCCCHHhHHHHhccCc
Q 003836 703 IDNEISKVDKAILTDWAYDRYQERTLEALVENDLEAMNNVTMLHRFVMVAFWCIQEDPSHRPTMRKVTQMLEGVV 777 (792)
Q Consensus 703 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~L~~~~ 777 (792)
|+......+...+...... .......+.+.... +...++..++..||..+|++||++++|...++.+.
T Consensus 158 ~~~~~~~~~~~eii~~~~~-----~~~~~~rP~i~~~~--e~~~~l~~l~~~cw~e~P~~rPs~~~i~~~~~~~~ 225 (484)
T KOG1023|consen 158 FDLRNLVEDPDEIILRVKK-----GGSNPFRPSIELLN--ELPPELLLLVARCWEEIPEKRPSIEQIRSKLLTIN 225 (484)
T ss_pred cccccccCChHHHHHHHHh-----cCCCCcCcchhhhh--hcchHHHHHHHHhcccChhhCccHHHHHhhhhhhc
Confidence 9775443221111111100 00011111111111 33447899999999999999999999999887654
|
|
| >cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain | Back alignment and domain information |
|---|
Probab=99.78 E-value=1.3e-18 Score=172.36 Aligned_cols=139 Identities=17% Similarity=0.117 Sum_probs=110.2
Q ss_pred hhcCccccceEEEeeecCCCceEEEEEEcccccccc--------------------------hHHHHHHHHHhcccCCCC
Q 003836 507 EELGRGAFGTVYKGFVNMGSSNHVAVKKLNSVFQDS--------------------------EKEFKAEVNGIGQTHHKN 560 (792)
Q Consensus 507 ~~lG~G~~g~Vy~g~~~~~~~~~vavK~~~~~~~~~--------------------------~~~~~~Ei~~l~~l~h~n 560 (792)
..||+|++|.||+|... +++.||||+++...... ...+..|.+.+.++.|++
T Consensus 3 ~~ig~G~~~~Vy~a~~~--~g~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~ 80 (190)
T cd05145 3 GCISTGKEANVYHARTG--DGEELAVKIYKTSTLSFKDRDKYIEGDPRFRSRYSKSNPRKLVFAWAEKEFRNLKRLYEAG 80 (190)
T ss_pred ceeecCCCcEEEEEEcC--CCCEEEEEEEEcCcceEeeHHHHhcCCcccccccccCCHHHHHHHHHHHHHHHHHHHHhCC
Confidence 56999999999999765 57899999987542110 122467899999999998
Q ss_pred cccccceeccCCceEEEEEeccCCCccccccCCCCCchhHHHHHHHHHHHHHHHHhh-ccCCCeEecCCCCCcEEEcCCC
Q 003836 561 LVRLLGYCDEGQNRLLVYEFMSNGTVASFLFGDSKPNWKLRTEIAMGIAGGLFYLHE-ECCTQIIHCDIKPQNILLDDHY 639 (792)
Q Consensus 561 iv~l~g~~~~~~~~~lV~E~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~-~~~~~ivH~dikp~NILl~~~~ 639 (792)
+.....+... ..+|||||++++++.........++.....+++.|++.+|.++|+ . +|+||||||+|||++ ++
T Consensus 81 i~~p~~~~~~--~~~lVmE~~~g~~~~~~~l~~~~~~~~~~~~i~~~l~~~l~~lH~~~---givHrDlkP~NIll~-~~ 154 (190)
T cd05145 81 VPVPEPILLK--KNVLVMEFIGDDGSPAPRLKDVPLEEEEAEELYEQVVEQMRRLYQEA---GLVHGDLSEYNILYH-DG 154 (190)
T ss_pred CCCceEEEec--CCEEEEEEecCCCchhhhhhhccCCHHHHHHHHHHHHHHHHHHHHhC---CEecCCCChhhEEEE-CC
Confidence 7554443332 248999999988655443334567788899999999999999999 7 999999999999999 88
Q ss_pred CeEEeecCCCcccc
Q 003836 640 NARISDFGLAKLLT 653 (792)
Q Consensus 640 ~~kl~Dfg~a~~~~ 653 (792)
.++|+|||+++...
T Consensus 155 ~~~liDFG~a~~~~ 168 (190)
T cd05145 155 KPYIIDVSQAVELD 168 (190)
T ss_pred CEEEEEcccceecC
Confidence 99999999998764
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro |
| >KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.77 E-value=2.9e-18 Score=171.54 Aligned_cols=197 Identities=19% Similarity=0.288 Sum_probs=166.6
Q ss_pred hhhhhhcCccccceEEEeeecCCCceEEEEEEcccccccchHHHHHHHHHhccc-CCCCcccccceeccCCceEEEEEec
Q 003836 503 RGFKEELGRGAFGTVYKGFVNMGSSNHVAVKKLNSVFQDSEKEFKAEVNGIGQT-HHKNLVRLLGYCDEGQNRLLVYEFM 581 (792)
Q Consensus 503 ~~~~~~lG~G~~g~Vy~g~~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l-~h~niv~l~g~~~~~~~~~lV~E~~ 581 (792)
+.+.++||+|.||.++.|+ +.-.+++||||.-... ...-++..|-+.++.| ..++|..++-|-.++.+-.||+|.+
T Consensus 30 yrVGkKIGeGsFG~lf~G~-Nl~nne~VAIKfEPrk--S~APQLrdEYr~YKlL~g~~GIP~vYYFGqeG~~NiLVidLL 106 (449)
T KOG1165|consen 30 YRVGKKIGEGSFGVLFLGK-NLYNNEPVAIKFEPRK--SEAPQLRDEYRTYKLLGGTEGIPQVYYFGQEGKYNILVIDLL 106 (449)
T ss_pred ceeccccccCcceeeeccc-ccccCceEEEEecccc--CCcchHHHHHHHHHHHcCCCCCCceeeeccccchhhhhhhhh
Confidence 3456889999999999996 4556789999975443 2345788888888888 4799999999999999999999988
Q ss_pred cCCCcccccc-CCCCCchhHHHHHHHHHHHHHHHHhhccCCCeEecCCCCCcEEEcC-----CCCeEEeecCCCccccCC
Q 003836 582 SNGTVASFLF-GDSKPNWKLRTEIAMGIAGGLFYLHEECCTQIIHCDIKPQNILLDD-----HYNARISDFGLAKLLTLD 655 (792)
Q Consensus 582 ~~gsL~~~l~-~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dikp~NILl~~-----~~~~kl~Dfg~a~~~~~~ 655 (792)
+-||++++. -.++++.++...||.|+..-++|+|++ .+|.|||||+|+||.. ...+.|+|||+|+.....
T Consensus 107 -GPSLEDLFD~CgR~FSvKTV~miA~Qmi~rie~vH~k---~LIYRDIKPdNFLIGrp~~k~~n~IhiiDFGmAK~YrDp 182 (449)
T KOG1165|consen 107 -GPSLEDLFDLCGRRFSVKTVAMIAKQMITRIEYVHEK---DLIYRDIKPDNFLIGRPGTKDANVIHIIDFGMAKEYRDP 182 (449)
T ss_pred -CcCHHHHHHHhcCcccHHhHHHHHHHHHHHHHHHHhc---ceeecccCccceeecCCCCCCCceEEEEeccchhhhcCc
Confidence 568888764 346899999999999999999999999 9999999999999963 335899999999988665
Q ss_pred CCCc------cccccccCCcccccccccCCCCcccceehHHHHHHHHHhcCcCCCcc
Q 003836 656 QSHT------NTAIRGTKGYVAPEWFRNMPITVKVDVYSYGVLLLEIICLRRNIDNE 706 (792)
Q Consensus 656 ~~~~------~~~~~gt~~y~aPE~~~~~~~~~k~DV~S~Gv~l~el~tg~~p~~~~ 706 (792)
.... .....||.+||+--...+.+-+.+.|.=|+|-+++..+-|..||...
T Consensus 183 ~TkqHIPYrE~KSLsGTARYMSINTHlGrEQSRRDDLEaLGHvFmYFLRGsLPWQGL 239 (449)
T KOG1165|consen 183 KTKQHIPYREHKSLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGL 239 (449)
T ss_pred cccccCccccccccccceeeeEeeccccchhhhhhhHHHhhhhhhhhccCCCccccc
Confidence 4332 34456999999999999999999999999999999999999999764
|
|
| >KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.76 E-value=4.9e-19 Score=200.97 Aligned_cols=246 Identities=23% Similarity=0.251 Sum_probs=180.7
Q ss_pred hhhhhcCccccceEEEeeecCCCceEEEEEEccccc-ccchHHHHHHHHH--hcccCCCCcccccceeccCCceEEEEEe
Q 003836 504 GFKEELGRGAFGTVYKGFVNMGSSNHVAVKKLNSVF-QDSEKEFKAEVNG--IGQTHHKNLVRLLGYCDEGQNRLLVYEF 580 (792)
Q Consensus 504 ~~~~~lG~G~~g~Vy~g~~~~~~~~~vavK~~~~~~-~~~~~~~~~Ei~~--l~~l~h~niv~l~g~~~~~~~~~lV~E~ 580 (792)
.+.+.||++.|=.|.+++.+.| .|+||++-+.. .-....|.++++- ...++|||.+++.-.-...+..|||-+|
T Consensus 26 ~~~~~LGstRFlKv~r~k~~eG---~vVvKVFvk~~p~~sL~~~~qrL~~ik~~l~~~pn~lPfqk~~~t~kAAylvRqy 102 (1431)
T KOG1240|consen 26 HYVENLGSTRFLKVARAKDREG---LVVVKVFVKQDPTISLRPFKQRLEEIKFALMKAPNCLPFQKVLVTDKAAYLVRQY 102 (1431)
T ss_pred eeecccCchhhhhhhhccCCCc---eEEEEEEeccCCCCCchHHHHHHHHHHHHhhcCCcccchHHHHHhhHHHHHHHHH
Confidence 4567899999999999987643 49999987654 3344555554443 4456899999999888888888899999
Q ss_pred ccCCCccccccCCCCCchhHHHHHHHHHHHHHHHHhhccCCCeEecCCCCCcEEEcCCCCeEEeecCCCccccCCCCCcc
Q 003836 581 MSNGTVASFLFGDSKPNWKLRTEIAMGIAGGLFYLHEECCTQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLDQSHTN 660 (792)
Q Consensus 581 ~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dikp~NILl~~~~~~kl~Dfg~a~~~~~~~~~~~ 660 (792)
..+ +|.+.|..+..+...+..-|+.|++.||.-+|.. +|+|||||.+||||+.-.=+.|+||.--+-...++..+.
T Consensus 103 vkh-nLyDRlSTRPFL~~iEKkWiaFQLL~al~qcH~~---gVcHGDIKsENILiTSWNW~~LtDFAsFKPtYLPeDNPa 178 (1431)
T KOG1240|consen 103 VKH-NLYDRLSTRPFLVLIEKKWIAFQLLKALSQCHKL---GVCHGDIKSENILITSWNWLYLTDFASFKPTYLPEDNPA 178 (1431)
T ss_pred Hhh-hhhhhhccchHHHHHHHHHHHHHHHHHHHHHHHc---CccccccccceEEEeeechhhhhcccccCCccCCCCCcc
Confidence 877 8999998777888889999999999999999999 999999999999999998899999988765433332221
Q ss_pred ------ccccccCCcccccccccC----------C-CCcccceehHHHHHHHHHhc-CcCCCcchhhhhhhhHHHHHHHh
Q 003836 661 ------TAIRGTKGYVAPEWFRNM----------P-ITVKVDVYSYGVLLLEIICL-RRNIDNEISKVDKAILTDWAYDR 722 (792)
Q Consensus 661 ------~~~~gt~~y~aPE~~~~~----------~-~~~k~DV~S~Gv~l~el~tg-~~p~~~~~~~~~~~~~~~~~~~~ 722 (792)
.+.+.-..|+|||.+... . .+++-||||+||++.||++- +.+|+.. +. .++..
T Consensus 179 df~fFFDTSrRRtCYiAPERFv~~~~~~~~~q~~~~L~paMDIFS~GCViaELf~Eg~PlF~LS-QL--------~aYr~ 249 (1431)
T KOG1240|consen 179 DFTFFFDTSRRRTCYIAPERFVSALGKTSVGQDAPLLTPAMDIFSAGCVIAELFLEGRPLFTLS-QL--------LAYRS 249 (1431)
T ss_pred cceEEEecCCceeeecChHhhhccccccccCCcccccChhhhhhhhhHHHHHHHhcCCCcccHH-HH--------HhHhc
Confidence 111223369999987431 2 67889999999999999985 5555421 11 11222
Q ss_pred hcccchhHhhhchhcccCCHHHHHHHHHHHHHccccCCCCCCCHHhHHHHh
Q 003836 723 YQERTLEALVENDLEAMNNVTMLHRFVMVAFWCIQEDPSHRPTMRKVTQML 773 (792)
Q Consensus 723 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~L 773 (792)
......+.++.. +++ ..+..++..|++.||++|.++++.++.-
T Consensus 250 ~~~~~~e~~Le~-Ied-------~~~Rnlil~Mi~rdPs~RlSAedyL~~y 292 (1431)
T KOG1240|consen 250 GNADDPEQLLEK-IED-------VSLRNLILSMIQRDPSKRLSAEDYLQKY 292 (1431)
T ss_pred cCccCHHHHHHh-CcC-------ccHHHHHHHHHccCchhccCHHHHHHhh
Confidence 212222222221 111 2567789999999999999999999863
|
|
| >PF00954 S_locus_glycop: S-locus glycoprotein family; InterPro: IPR000858 In Brassicaceae, self-incompatible plants have a self/non-self recognition system, which involves the inability of flowering plants to achieve self-fertilisation | Back alignment and domain information |
|---|
Probab=99.75 E-value=3.9e-18 Score=151.99 Aligned_cols=87 Identities=28% Similarity=0.499 Sum_probs=69.3
Q ss_pred EEEEecccceeeeccccccccccEEEEEEecCCcEEEEecCCCCCCCcceeEEeccCCccccccccccCCCCcCCCCCCc
Q 003836 228 LYVLRENKQRASLVPETVSAKENYLRATLNFDGVFIFYSHPKNNSTGDAIWSVSDVLPENICINNDIRKGLGSGICGFNS 307 (792)
Q Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~~r~~L~~dG~l~~y~~~~~~~~~~~~w~~~~~~p~~~C~~~~~~~~~~~g~CG~~g 307 (792)
.+.+..+.++.+++. ...+.+.++|++|+++|++++|.|...... |...|.+|.++||+ |+.||+||
T Consensus 24 ~~~fv~~~~e~~~t~-~~~~~s~~~r~~ld~~G~l~~~~w~~~~~~----W~~~~~~p~d~Cd~--------y~~CG~~g 90 (110)
T PF00954_consen 24 NYSFVSNNEEVYYTY-SLSNSSVLSRLVLDSDGQLQRYIWNESTQS----WSVFWSAPKDQCDV--------YGFCGPNG 90 (110)
T ss_pred EEEEEECCCeEEEEE-ecCCCceEEEEEEeeeeEEEEEEEecCCCc----EEEEEEecccCCCC--------ccccCCcc
Confidence 344556666666653 344667899999999999999999765544 66666679999998 89999999
Q ss_pred ccccCCCCCCceecCCCCccCC
Q 003836 308 ICSISGAKRPICQCPKGFSLLD 329 (792)
Q Consensus 308 ~C~~~~~~~~~C~Cl~GF~~~~ 329 (792)
+|+. +..+.|+||+||+|++
T Consensus 91 ~C~~--~~~~~C~Cl~GF~P~n 110 (110)
T PF00954_consen 91 ICNS--NNSPKCSCLPGFEPKN 110 (110)
T ss_pred EeCC--CCCCceECCCCcCCCc
Confidence 9975 4568899999999975
|
This is sporophytically controlled by multiple alleles at a single locus (S). There are a total of 50 different S alleles in Brassica oleracea. S-locus glycoproteins, as well as S-receptor kinases, are in linkage with the S-alleles []. Most of the proteins within this family contain apple-like domain (IPR003609 from INTERPRO), which is predicted to possess protein- and/or carbohydrate-binding functions.; GO: 0048544 recognition of pollen |
| >PRK12274 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.73 E-value=1e-17 Score=163.23 Aligned_cols=183 Identities=16% Similarity=0.071 Sum_probs=136.5
Q ss_pred hhhcCccccceEEEeeecCCCceEEEEEEcccccccc----hHHHHHHHHHhcccC-CCCcccccceeccCCceEEEEEe
Q 003836 506 KEELGRGAFGTVYKGFVNMGSSNHVAVKKLNSVFQDS----EKEFKAEVNGIGQTH-HKNLVRLLGYCDEGQNRLLVYEF 580 (792)
Q Consensus 506 ~~~lG~G~~g~Vy~g~~~~~~~~~vavK~~~~~~~~~----~~~~~~Ei~~l~~l~-h~niv~l~g~~~~~~~~~lV~E~ 580 (792)
...|++|+||+||.+. ..+.+++.+.+.....-. ...+.+|+++|++++ |+++++++++ +..+++|||
T Consensus 7 ~~~l~~~~f~~v~~~~---~~~~k~~~~~l~~~~~~~~~~~~~l~~rE~~iL~~L~~~~~vP~ll~~----~~~~lvmey 79 (218)
T PRK12274 7 NEPLKSDTFGRILLVR---GGERKFVRRDLSAAPWWLRGVAWWLARREALALRQLDGLPRTPRLLHW----DGRHLDRSY 79 (218)
T ss_pred ceeecCCCcceEEEee---cCCceeeecccccchhhhhhHHHHHHHHHHHHHHhcCCCCCCCEEEEE----cCEEEEEee
Confidence 3579999999999763 345678877776543211 225889999999995 5889999886 457999999
Q ss_pred ccCCCccccccCCCCCchhHHHHHHHHHHHHHHHHhhccCCCeEecCC-CCCcEEEcCCCCeEEeecCCCccccCCCCC-
Q 003836 581 MSNGTVASFLFGDSKPNWKLRTEIAMGIAGGLFYLHEECCTQIIHCDI-KPQNILLDDHYNARISDFGLAKLLTLDQSH- 658 (792)
Q Consensus 581 ~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~di-kp~NILl~~~~~~kl~Dfg~a~~~~~~~~~- 658 (792)
+++.+|...+.. ....++.|++++|.++|+. +|+|||| ||+|||++.++.++|+|||++.........
T Consensus 80 I~G~~L~~~~~~-------~~~~~~~qi~~~L~~lH~~---GIvHrDL~kp~NILv~~~g~i~LIDFG~A~~~~~~~~~~ 149 (218)
T PRK12274 80 LAGAAMYQRPPR-------GDLAYFRAARRLLQQLHRC---GVAHNDLAKEANWLVQEDGSPAVIDFQLAVRGNPRARWM 149 (218)
T ss_pred ecCccHHhhhhh-------hhHHHHHHHHHHHHHHHHC---cCccCCCCCcceEEEcCCCCEEEEECCCceecCCcchHH
Confidence 999988754321 1245788999999999999 9999999 799999999999999999999865432210
Q ss_pred ---c--------cccccccCCccccccccc-CCCC-cccceehHHHHHHHHHhcCcCCCc
Q 003836 659 ---T--------NTAIRGTKGYVAPEWFRN-MPIT-VKVDVYSYGVLLLEIICLRRNIDN 705 (792)
Q Consensus 659 ---~--------~~~~~gt~~y~aPE~~~~-~~~~-~k~DV~S~Gv~l~el~tg~~p~~~ 705 (792)
. ......++.|++|+...- ...+ ...+.++.|.-+|.++|++.+.-.
T Consensus 150 r~L~~rDl~~llk~~~~y~~~~l~~~~~~~l~~~~~~~~~w~~~g~~~~~~~~~~~~~~~ 209 (218)
T PRK12274 150 RLLAREDLRHLLKHKRMYCPAALTPVERRVLKRTSWIRELWFATGKPVYRFVTRRVLHWE 209 (218)
T ss_pred HHHHHHHHHHHHHHHHhcCCCCCCHHHHhhhccchhHHHHHHHhcchHHHHHhccCCccc
Confidence 0 011225777777775432 2333 567889999999999999987643
|
|
| >PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A | Back alignment and domain information |
|---|
Probab=99.73 E-value=1.3e-17 Score=171.18 Aligned_cols=226 Identities=20% Similarity=0.266 Sum_probs=145.8
Q ss_pred hhcCccccceEEEeeecCCCceEEEEEEccccc---ccchHHHHHHHHHhcccCC----------CCccccccee-----
Q 003836 507 EELGRGAFGTVYKGFVNMGSSNHVAVKKLNSVF---QDSEKEFKAEVNGIGQTHH----------KNLVRLLGYC----- 568 (792)
Q Consensus 507 ~~lG~G~~g~Vy~g~~~~~~~~~vavK~~~~~~---~~~~~~~~~Ei~~l~~l~h----------~niv~l~g~~----- 568 (792)
+.||.|+++.||.+.. ..+++.+|||+..... ....+++++|.-.+..+.+ -.++..++..
T Consensus 18 ~~i~~g~~~~v~~v~d-~~t~~~~avkvf~~~~~~~~~~~~~~~~e~l~~~~~~~~~~p~~a~~~~r~l~P~d~~~i~~~ 96 (288)
T PF14531_consen 18 RIIGKGGFSIVFEVTD-VETGEEFAVKVFLLPADASANEYEQLKEEQLAITLFPGVKNPKEAYRHLRFLVPLDLLRIPGK 96 (288)
T ss_dssp EEEEEETTEEEEEEEE-TTTTEEEEEEEEEESSTTHTTHHHHHHHHHHGGGGSTT--SHHHHHHHH-B---SEEEEETTS
T ss_pred cccccCCceEEEEEEE-ccCCceEEEEEEecccccchHHHHHHHHHHHHhhhhccCCCHHHHHHhceEEeeeEEEEEcCC
Confidence 5699999999999975 4667899999875433 3345677777766665433 2222222221
Q ss_pred ----ccCC--------ceEEEEEeccCCCcccccc---CC----CCCchhHHHHHHHHHHHHHHHHhhccCCCeEecCCC
Q 003836 569 ----DEGQ--------NRLLVYEFMSNGTVASFLF---GD----SKPNWKLRTEIAMGIAGGLFYLHEECCTQIIHCDIK 629 (792)
Q Consensus 569 ----~~~~--------~~~lV~E~~~~gsL~~~l~---~~----~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dik 629 (792)
.... ..+++|+-+. ++|.+++. .. ..+....++.+..|+.+.+++||+. |++|+||+
T Consensus 97 ~~~~~~~~~~~~~~v~n~~~l~P~~~-~dL~~~~~~l~~~~~~~~~l~~~arl~lT~Q~I~lvA~Lh~~---GlVHgdi~ 172 (288)
T PF14531_consen 97 PPFFERGPGQSIYWVLNRFLLMPRAQ-GDLQDLVEALFSRAQTHSPLAFAARLSLTVQMIRLVANLHSY---GLVHGDIK 172 (288)
T ss_dssp -SEEEECETTEEEEEESEEEEEE--S-EEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHT---TEEEST-S
T ss_pred CcceecCCCCccceeehhhhccchhh-hcHHHHHHHHhhcccccchhHHHHHHHHHHHHHHHHHHHhhc---ceEecccc
Confidence 1111 2367777774 57877653 21 1234455677779999999999999 99999999
Q ss_pred CCcEEEcCCCCeEEeecCCCccccCCCCCccccccccCCccccccccc--------CCCCcccceehHHHHHHHHHhcCc
Q 003836 630 PQNILLDDHYNARISDFGLAKLLTLDQSHTNTAIRGTKGYVAPEWFRN--------MPITVKVDVYSYGVLLLEIICLRR 701 (792)
Q Consensus 630 p~NILl~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~--------~~~~~k~DV~S~Gv~l~el~tg~~ 701 (792)
|+|++++.+|.++|+||+........... ...+..|.+||.... ..++.+.|.|++|+++|.|++++.
T Consensus 173 ~~nfll~~~G~v~Lg~F~~~~r~g~~~~~----~~~~~~~~PPe~~~~~~~~~~~~~~~t~~~DaW~LG~~ly~lWC~~l 248 (288)
T PF14531_consen 173 PENFLLDQDGGVFLGDFSSLVRAGTRYRC----SEFPVAFTPPELESCAGQFGQNNAPYTFATDAWQLGITLYSLWCGRL 248 (288)
T ss_dssp GGGEEE-TTS-EEE--GGGEEETTEEEEG----GGS-TTTS-HHHHHHHTSCHHSEEEE-HHHHHHHHHHHHHHHHHSS-
T ss_pred eeeEEEcCCCCEEEcChHHHeecCceeec----cCCCcccCChhhhhhhcccCcccceeeeccCHHHHHHHHHHHHHccC
Confidence 99999999999999999877654321111 224577999997643 357899999999999999999999
Q ss_pred CCCcchhhhhhhhHHHHHHHhhcccchhHhhhchhcccCCHHHHHHHHHHHHHccccCCCCC
Q 003836 702 NIDNEISKVDKAILTDWAYDRYQERTLEALVENDLEAMNNVTMLHRFVMVAFWCIQEDPSHR 763 (792)
Q Consensus 702 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~R 763 (792)
||........... .+ ..+. +.++.+..++..+|+.+|.+|
T Consensus 249 Pf~~~~~~~~~~~--------------------~f-~~C~-~~Pe~v~~LI~~lL~~~~~~R 288 (288)
T PF14531_consen 249 PFGLSSPEADPEW--------------------DF-SRCR-DMPEPVQFLIRGLLQRNPEDR 288 (288)
T ss_dssp STCCCGGGSTSGG--------------------GG-TTSS----HHHHHHHHHHT-SSGGGS
T ss_pred CCCCCCccccccc--------------------cc-hhcC-CcCHHHHHHHHHHccCCcccC
Confidence 9986543322110 11 1233 677888999999999999988
|
|
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.72 E-value=1.6e-18 Score=188.29 Aligned_cols=227 Identities=21% Similarity=0.197 Sum_probs=178.5
Q ss_pred hcCccccceEEEeeec--CCCceEEEEEEcccccccc--hHHHHHHHHHhcccC-CCCcccccceeccCCceEEEEEecc
Q 003836 508 ELGRGAFGTVYKGFVN--MGSSNHVAVKKLNSVFQDS--EKEFKAEVNGIGQTH-HKNLVRLLGYCDEGQNRLLVYEFMS 582 (792)
Q Consensus 508 ~lG~G~~g~Vy~g~~~--~~~~~~vavK~~~~~~~~~--~~~~~~Ei~~l~~l~-h~niv~l~g~~~~~~~~~lV~E~~~ 582 (792)
++|+|.||.|+++.-- .+.+..+|+|.+++..... ......|..+++..+ ||.+|++.-.+..+...+++++|..
T Consensus 1 vlg~g~~gkvfLvrk~~g~da~~~yamkvl~k~t~~~~~~~~t~~er~il~~~~~~~f~v~lhyafqt~~kl~l~ld~~r 80 (612)
T KOG0603|consen 1 VLGQGSYGKVFLVRKAGGADAGHLYAMKVLKKATLKVRDRTHTKQERIILAFVHNTPFLVKLHYAFQTDGKLYLILDFLR 80 (612)
T ss_pred CCCcCCCcchHHHHHhccccccchhhhhcccccccccccccccccHHHHHhhccCCCceeeeeeeeccccchhHhhhhcc
Confidence 3789999999875321 1234567888776543211 125566778888887 9999999999999999999999999
Q ss_pred CCCccccccCCCCCchhHHHHHHHHHHHHHHHHhhccCCCeEecCCCCCcEEEcCCCCeEEeecCCCccccCCCCCcccc
Q 003836 583 NGTVASFLFGDSKPNWKLRTEIAMGIAGGLFYLHEECCTQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLDQSHTNTA 662 (792)
Q Consensus 583 ~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dikp~NILl~~~~~~kl~Dfg~a~~~~~~~~~~~~~ 662 (792)
+|.|...+.......+.........++-+++++|+. +|+|||+|++||+++.+|.+|+.|||+++..-.....
T Consensus 81 gg~lft~l~~~~~f~~~~~~~~~aelaLald~lh~l---~iiyrd~k~enilld~~Ghi~~tdfglske~v~~~~~---- 153 (612)
T KOG0603|consen 81 GGDLFTRLSKEVMFDELDVAFYLAELALALDHLHKL---GIAYRDYKLENVLLLLEGHIKLTDFGLSKEAVKEKIA---- 153 (612)
T ss_pred cchhhhccccCCchHHHHHHHHHHHHHHHHhhcchh---HHHHhcccccceeecccCccccCCchhhhHhHhhhhc----
Confidence 999999998887777777777888899999999999 9999999999999999999999999999876433222
Q ss_pred ccccCCcccccccccCCCCcccceehHHHHHHHHHhcCcCCCcchhhhhhhhHHHHHHHhhcccchhHhhhchhcccCCH
Q 003836 663 IRGTKGYVAPEWFRNMPITVKVDVYSYGVLLLEIICLRRNIDNEISKVDKAILTDWAYDRYQERTLEALVENDLEAMNNV 742 (792)
Q Consensus 663 ~~gt~~y~aPE~~~~~~~~~k~DV~S~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 742 (792)
+||..|||||++. ....++|.||||++++||+||..||..+.. ..++. .....+.
T Consensus 154 -cgt~eymApEI~~--gh~~a~D~ws~gvl~felltg~~pf~~~~~--------------------~~Il~--~~~~~p~ 208 (612)
T KOG0603|consen 154 -CGTYEYRAPEIIN--GHLSAADWWSFGVLAFELLTGTLPFGGDTM--------------------KRILK--AELEMPR 208 (612)
T ss_pred -ccchhhhhhHhhh--ccCCcccchhhhhhHHHHhhCCCCCchHHH--------------------HHHhh--hccCCch
Confidence 7899999999998 678899999999999999999999976211 11111 1223355
Q ss_pred HHHHHHHHHHHHccccCCCCCCCH
Q 003836 743 TMLHRFVMVAFWCIQEDPSHRPTM 766 (792)
Q Consensus 743 ~~~~~l~~l~~~Cl~~~p~~RPs~ 766 (792)
+....+.++...++..+|..|.-.
T Consensus 209 ~l~~~a~~~~~~l~~r~p~nrLg~ 232 (612)
T KOG0603|consen 209 ELSAEARSLFRQLFKRNPENRLGA 232 (612)
T ss_pred hhhHHHHHHHHHHHhhCHHHHhcc
Confidence 566667777777888888888644
|
|
| >PRK10345 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.70 E-value=5.1e-17 Score=161.74 Aligned_cols=134 Identities=18% Similarity=0.209 Sum_probs=105.0
Q ss_pred hhcCccccceEEEeeecCCCceEEEEEEcccccccchHHHHHHHHHhccc-----CCCCcccccceeccCC---ceE-EE
Q 003836 507 EELGRGAFGTVYKGFVNMGSSNHVAVKKLNSVFQDSEKEFKAEVNGIGQT-----HHKNLVRLLGYCDEGQ---NRL-LV 577 (792)
Q Consensus 507 ~~lG~G~~g~Vy~g~~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l-----~h~niv~l~g~~~~~~---~~~-lV 577 (792)
+.||+|++|.||. .. .... .+||++........+.+.+|+.++.++ +||||++++|++.++. ..+ +|
T Consensus 8 ~~LG~G~~~~Vy~--hp-~~~~-k~IKv~~~~~~~~~~~~~rEi~~l~~L~~~~~~h~nIvr~yg~~et~~g~g~v~~~I 83 (210)
T PRK10345 8 SPLGTGRHRKCYA--HP-EDAQ-RCIKIVYHRGDGGDKEIRRELKYYAHLSRRLIDWSGIPRYYGTVETDCGTGYVYDVI 83 (210)
T ss_pred ceecCCCceEEEE--CC-CCcC-eEEEEEeccccchHHHHHHHHHHHHHhhccCCCCcccceeeEEEEeCCCCeEEEEEE
Confidence 5799999999996 33 2233 368887665444567899999999999 5799999999998764 333 78
Q ss_pred EEe--ccCCCccccccCCCCCchhHHHHHHHHHHHHH-HHHhhccCCCeEecCCCCCcEEEcC----CCCeEEeecCCCc
Q 003836 578 YEF--MSNGTVASFLFGDSKPNWKLRTEIAMGIAGGL-FYLHEECCTQIIHCDIKPQNILLDD----HYNARISDFGLAK 650 (792)
Q Consensus 578 ~E~--~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL-~yLH~~~~~~ivH~dikp~NILl~~----~~~~kl~Dfg~a~ 650 (792)
+|| +++|+|.+++.+. .+++. ..++.+++.++ +|||+. +|+||||||+|||++. +..++|+||+.+.
T Consensus 84 ~e~~G~~~~tL~~~l~~~-~~~e~--~~~~~~~L~~l~~yLh~~---~IvhrDlKp~NILl~~~~~~~~~~~LiDg~G~~ 157 (210)
T PRK10345 84 ADFDGKPSITLTEFAEQC-RYEED--VAQLRQLLKKLKRYLLDN---RIVTMELKPQNILCQRISESEVIPVVCDNIGES 157 (210)
T ss_pred ecCCCCcchhHHHHHHcc-cccHh--HHHHHHHHHHHHHHHHHC---CEeecCCCHHHEEEeccCCCCCcEEEEECCCCc
Confidence 999 6689999999653 34444 35678888887 999999 9999999999999974 3479999954443
|
|
| >smart00090 RIO RIO-like kinase | Back alignment and domain information |
|---|
Probab=99.70 E-value=1.2e-16 Score=163.21 Aligned_cols=142 Identities=19% Similarity=0.211 Sum_probs=110.0
Q ss_pred hhhhhcCccccceEEEeeecCCCceEEEEEEccccccc------------------------chHHHHHHHHHhcccCCC
Q 003836 504 GFKEELGRGAFGTVYKGFVNMGSSNHVAVKKLNSVFQD------------------------SEKEFKAEVNGIGQTHHK 559 (792)
Q Consensus 504 ~~~~~lG~G~~g~Vy~g~~~~~~~~~vavK~~~~~~~~------------------------~~~~~~~Ei~~l~~l~h~ 559 (792)
.+.+.||+|++|.||+|..+..+++.||+|+++..... ....+.+|+.++.++.+.
T Consensus 31 ~i~~~Lg~G~~g~Vy~a~~~~~~g~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~L~~L~~~ 110 (237)
T smart00090 31 AIGGCISTGKEANVYHALDFDGSGKERAVKIYRTGTLEFKRRDRYVDGDFRFKYRKINPRKLVRLWAEKEFRNLQRLYEA 110 (237)
T ss_pred HhCCeeccCcceeEEEEEecCCCCcEEEEEEEEcCcceecchhhhcccchhhccCCCCHHHHHHHHHHHHHHHHHHHHhc
Confidence 34578999999999999733445789999998743210 012357899999999763
Q ss_pred C--cccccceeccCCceEEEEEeccCCCccccccCCCCCchhHHHHHHHHHHHHHHHHhhccCCC-eEecCCCCCcEEEc
Q 003836 560 N--LVRLLGYCDEGQNRLLVYEFMSNGTVASFLFGDSKPNWKLRTEIAMGIAGGLFYLHEECCTQ-IIHCDIKPQNILLD 636 (792)
Q Consensus 560 n--iv~l~g~~~~~~~~~lV~E~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~-ivH~dikp~NILl~ 636 (792)
. +.+++++ ...++||||+++.+|...+.............++.||+.+|++||+. + |+|+||||+||+++
T Consensus 111 ~i~~p~~~~~----~~~~lV~E~~~g~~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~---g~iiH~Dikp~NIli~ 183 (237)
T smart00090 111 GVPVPKPIAW----RRNVLVMEFIGGDGLPAPRLKDVEPEEEEEFELYDDILEEMRKLYKE---GELVHGDLSEYNILVH 183 (237)
T ss_pred CCCCCeeeEe----cCceEEEEEecCCcccccccccCCcchHHHHHHHHHHHHHHHHHHhc---CCEEeCCCChhhEEEE
Confidence 3 3444433 23589999999999887764444556666789999999999999999 8 99999999999999
Q ss_pred CCCCeEEeecCCCcccc
Q 003836 637 DHYNARISDFGLAKLLT 653 (792)
Q Consensus 637 ~~~~~kl~Dfg~a~~~~ 653 (792)
++.++|+|||.+....
T Consensus 184 -~~~i~LiDFg~a~~~~ 199 (237)
T smart00090 184 -DGKVVIIDVSQSVELD 199 (237)
T ss_pred -CCCEEEEEChhhhccC
Confidence 8899999999987543
|
|
| >PRK14879 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.65 E-value=4.4e-16 Score=157.33 Aligned_cols=134 Identities=19% Similarity=0.248 Sum_probs=112.6
Q ss_pred hhcCccccceEEEeeecCCCceEEEEEEccccccc--------chHHHHHHHHHhcccCCCCcccccceeccCCceEEEE
Q 003836 507 EELGRGAFGTVYKGFVNMGSSNHVAVKKLNSVFQD--------SEKEFKAEVNGIGQTHHKNLVRLLGYCDEGQNRLLVY 578 (792)
Q Consensus 507 ~~lG~G~~g~Vy~g~~~~~~~~~vavK~~~~~~~~--------~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~lV~ 578 (792)
+.||+|++|.||+|.. .+..+++|+....... ....+.+|++++..++|+++.....++.+....++||
T Consensus 2 ~~l~~G~~~~vy~~~~---~~~~~~vK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~ 78 (211)
T PRK14879 2 KLIKRGAEAEIYLGDF---LGIKAVIKWRIPKRYRHPELDERIRRERTRREARIMSRARKAGVNVPAVYFVDPENFIIVM 78 (211)
T ss_pred cccccCceEEEEEEee---CCCceEEEEeCCcCCcChHHHHHHHHHHHHHHHHHHHHHHHCCCCCCeEEEEeCCCCEEEE
Confidence 4689999999999975 3456888876532211 1245788999999999999988888887778889999
Q ss_pred EeccCCCccccccCCCCCchhHHHHHHHHHHHHHHHHhhccCCCeEecCCCCCcEEEcCCCCeEEeecCCCcc
Q 003836 579 EFMSNGTVASFLFGDSKPNWKLRTEIAMGIAGGLFYLHEECCTQIIHCDIKPQNILLDDHYNARISDFGLAKL 651 (792)
Q Consensus 579 E~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dikp~NILl~~~~~~kl~Dfg~a~~ 651 (792)
||+++++|.+++..... .+..++.+++.+|.++|+. +++|+|++|+|||++ ++.++|+|||.++.
T Consensus 79 e~~~G~~L~~~~~~~~~----~~~~i~~~i~~~l~~lH~~---~i~H~Dl~p~Nil~~-~~~~~liDf~~a~~ 143 (211)
T PRK14879 79 EYIEGEPLKDLINSNGM----EELELSREIGRLVGKLHSA---GIIHGDLTTSNMILS-GGKIYLIDFGLAEF 143 (211)
T ss_pred EEeCCcCHHHHHHhccH----HHHHHHHHHHHHHHHHHhC---CcccCCCCcccEEEE-CCCEEEEECCcccC
Confidence 99999999998854322 7889999999999999998 999999999999999 78999999999874
|
|
| >KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.65 E-value=1.8e-16 Score=184.51 Aligned_cols=197 Identities=21% Similarity=0.210 Sum_probs=155.8
Q ss_pred HHHHHHhhhhhhcCccccceEEEeeecCCCceEEEEEEcccccccchHHHHHHHHHhcccC---CCCcccccceeccCCc
Q 003836 497 ELVEVTRGFKEELGRGAFGTVYKGFVNMGSSNHVAVKKLNSVFQDSEKEFKAEVNGIGQTH---HKNLVRLLGYCDEGQN 573 (792)
Q Consensus 497 el~~~~~~~~~~lG~G~~g~Vy~g~~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~---h~niv~l~g~~~~~~~ 573 (792)
++...+..+.++||+|+||+||+|...+ ++.||+|.-+... --+|.--.+++.||+ -+-|..+.....-.+.
T Consensus 694 ~~~~~~~~I~~e~G~g~y~~vy~a~~~~--~~~~alK~e~P~~---~WEfYI~~q~~~RLk~~~~~~~~~~~~a~~~~~~ 768 (974)
T KOG1166|consen 694 EVGGEKFCISKEIGEGSYGSVYVATHSN--GKLVALKVEKPPN---PWEFYICLQVMERLKPQMLPSIMHISSAHVFQNA 768 (974)
T ss_pred eecceeEEEEeeeccccceEEEEeecCC--CcEEEEEeecCCC---ceeeeehHHHHHhhchhhhcchHHHHHHHccCCc
Confidence 3334444566789999999999998654 7899999866432 223333344445554 2334445555566677
Q ss_pred eEEEEEeccCCCccccccCCCCCchhHHHHHHHHHHHHHHHHhhccCCCeEecCCCCCcEEEc-------CCCCeEEeec
Q 003836 574 RLLVYEFMSNGTVASFLFGDSKPNWKLRTEIAMGIAGGLFYLHEECCTQIIHCDIKPQNILLD-------DHYNARISDF 646 (792)
Q Consensus 574 ~~lV~E~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dikp~NILl~-------~~~~~kl~Df 646 (792)
-+||+||.+.|+|.+++...+.++|.....++.|+++-++.||.. +|||+||||+|+||. ++.-++|+||
T Consensus 769 S~lv~ey~~~Gtlld~~N~~~~m~e~lv~~~~~qml~ive~lH~~---~IIHgDiKPDNfll~~~~~~~~~~~~l~lIDf 845 (974)
T KOG1166|consen 769 SVLVSEYSPYGTLLDLINTNKVMDEYLVMFFSCQMLRIVEHLHAM---GIIHGDIKPDNFLLRREICADSDSKGLYLIDF 845 (974)
T ss_pred ceeeeeccccccHHHhhccCCCCCchhhhHHHHHHHHHHHHHHhc---ceecccCCcceeEeecccCCCCcccceEEEec
Confidence 889999999999999999888999999999999999999999998 999999999999995 3456899999
Q ss_pred CCCccccCCCC-CccccccccCCcccccccccCCCCcccceehHHHHHHHHHhcCc
Q 003836 647 GLAKLLTLDQS-HTNTAIRGTKGYVAPEWFRNMPITVKVDVYSYGVLLLEIICLRR 701 (792)
Q Consensus 647 g~a~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~k~DV~S~Gv~l~el~tg~~ 701 (792)
|.+.-+..-.. ......++|-.+-.+|...+.++++++|-|.|.-+++-|+-|+.
T Consensus 846 G~siDm~lfp~~~~F~~~~~td~f~C~EM~~grpWtYq~DyfGlAa~~h~mLFG~y 901 (974)
T KOG1166|consen 846 GRSIDMKLFPDGTKFKAVWHTDLFDCIEMREGRPWTYQIDYFGLAATVHVMLFGKY 901 (974)
T ss_pred ccceeeeEcCCCcEEeeeeccccchhHHHhcCCCCchhhhhHHHHHHHHHHHHHHH
Confidence 99876543332 24455678999999999999999999999999999999999874
|
|
| >KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.64 E-value=3.9e-16 Score=159.62 Aligned_cols=196 Identities=23% Similarity=0.293 Sum_probs=136.8
Q ss_pred CCCCcccccceecc---------------------------CCceEEEEEeccCCCccccccCCCCCchhHHHHHHHHHH
Q 003836 557 HHKNLVRLLGYCDE---------------------------GQNRLLVYEFMSNGTVASFLFGDSKPNWKLRTEIAMGIA 609 (792)
Q Consensus 557 ~h~niv~l~g~~~~---------------------------~~~~~lV~E~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia 609 (792)
+|||||++.++|.+ +...|+||..++. +|.+++..+. .+.....-|+.|++
T Consensus 274 ~HPNIvri~~aF~dsv~~lPda~~~YPdalp~R~~p~g~g~~~tlylvMkrY~~-tLr~yl~~~~-~s~r~~~~~laQlL 351 (598)
T KOG4158|consen 274 KHPNIVRIQTAFIDSVKVLPDAIERYPDALPARWYPSGAGEPKTLYLVMKRYRQ-TLREYLWTRH-RSYRTGRVILAQLL 351 (598)
T ss_pred CCCCEEeehhhhhhhhccCCchhhhCcccccceecccccCCCceEEEehhcchh-hHHHHHhcCC-CchHHHHHHHHHHH
Confidence 68888888877642 3457889888765 8888886543 45556667888999
Q ss_pred HHHHHHhhccCCCeEecCCCCCcEEEc--CCCC--eEEeecCCCccccCC-----CCCccccccccCCcccccccccCC-
Q 003836 610 GGLFYLHEECCTQIIHCDIKPQNILLD--DHYN--ARISDFGLAKLLTLD-----QSHTNTAIRGTKGYVAPEWFRNMP- 679 (792)
Q Consensus 610 ~gL~yLH~~~~~~ivH~dikp~NILl~--~~~~--~kl~Dfg~a~~~~~~-----~~~~~~~~~gt~~y~aPE~~~~~~- 679 (792)
+|+.|||.+ +|.|||+|.+||||. ++.. ..|+|||++---... -.......-|...-||||+....+
T Consensus 352 Eav~hL~~h---gvAhRDlKSDNiL~ElddD~~P~LVvaDFGCcLAd~~hGlqlpy~S~~Vd~GGNa~lmAPEi~ta~PG 428 (598)
T KOG4158|consen 352 EAVTHLHKH---GVAHRDLKSDNILLELDDDEIPQLVVADFGCCLADDNHGLQLPYESDEVDLGGNAKLMAPEIATAVPG 428 (598)
T ss_pred HHHHHHHHc---cchhhcccccceEEEecCCCCcEEEEcccceeeeccccccccccccccccCCCcceecchhhhhcCCC
Confidence 999999999 999999999999984 4443 688999987532221 111122334777899999985432
Q ss_pred -----CCcccceehHHHHHHHHHhcCcCCCcchhhhhhhhHHHHHHHhhcccchhHhhhchhcccCCHHHHHHHHHHHHH
Q 003836 680 -----ITVKVDVYSYGVLLLEIICLRRNIDNEISKVDKAILTDWAYDRYQERTLEALVENDLEAMNNVTMLHRFVMVAFW 754 (792)
Q Consensus 680 -----~~~k~DV~S~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~ 754 (792)
--.|+|.|+.|.+.||+++...||....+. .+.. ..+++..+.. .+...+..+.+++..
T Consensus 429 p~avvny~kAD~WA~GalaYEIfg~~NPFY~rGem----~L~~---r~Yqe~qLPa---------lp~~vpp~~rqlV~~ 492 (598)
T KOG4158|consen 429 PNAVVNYEKADTWAAGALAYEIFGRSNPFYKRGEM----LLDT---RTYQESQLPA---------LPSRVPPVARQLVFD 492 (598)
T ss_pred CceeeccchhhhhhhhhhHHHHhccCCcccccchh----eech---hhhhhhhCCC---------CcccCChHHHHHHHH
Confidence 226899999999999999999999763211 0000 1122222221 223345667889999
Q ss_pred ccccCCCCCCCHHhHHHHh
Q 003836 755 CIQEDPSHRPTMRKVTQML 773 (792)
Q Consensus 755 Cl~~~p~~RPs~~evl~~L 773 (792)
.|+.||++|++..-....|
T Consensus 493 lL~r~pskRvsp~iAANvl 511 (598)
T KOG4158|consen 493 LLKRDPSKRVSPNIAANVL 511 (598)
T ss_pred HhcCCccccCCccHHHhHH
Confidence 9999999999986555444
|
|
| >TIGR03724 arch_bud32 Kae1-associated kinase Bud32 | Back alignment and domain information |
|---|
Probab=99.64 E-value=6.2e-16 Score=154.71 Aligned_cols=130 Identities=18% Similarity=0.274 Sum_probs=106.7
Q ss_pred hcCccccceEEEeeecCCCceEEEEEEccccc-cc-------chHHHHHHHHHhcccCCCCcccccceeccCCceEEEEE
Q 003836 508 ELGRGAFGTVYKGFVNMGSSNHVAVKKLNSVF-QD-------SEKEFKAEVNGIGQTHHKNLVRLLGYCDEGQNRLLVYE 579 (792)
Q Consensus 508 ~lG~G~~g~Vy~g~~~~~~~~~vavK~~~~~~-~~-------~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~lV~E 579 (792)
.||+|++|.||+|... +..+++|+..... .. ...++.+|++++.+++|+++.....++......++|||
T Consensus 1 ~ig~G~~~~vy~~~~~---~~~~viK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e 77 (199)
T TIGR03724 1 LIAKGAEAIIYLGDFL---GLKAVIKERVPKSYRHPELDERIRRERTRNEARLLSRARKAGVNTPVVYDVDPDNKTIVME 77 (199)
T ss_pred CCCCCceEEEEEeecC---CccEEEEEecCCcCcCchHHHHHHHHHHHHHHHHHHHHHHCCCCCCEEEEEECCCCEEEEE
Confidence 3899999999999743 4578999854321 11 12567889999999999887666666667777899999
Q ss_pred eccCCCccccccCCCCCchhHHHHHHHHHHHHHHHHhhccCCCeEecCCCCCcEEEcCCCCeEEeecCCCcc
Q 003836 580 FMSNGTVASFLFGDSKPNWKLRTEIAMGIAGGLFYLHEECCTQIIHCDIKPQNILLDDHYNARISDFGLAKL 651 (792)
Q Consensus 580 ~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dikp~NILl~~~~~~kl~Dfg~a~~ 651 (792)
|+++++|.+++..... .++.+++++|.+||+. +++|+|++|+||+++ ++.++++|||+++.
T Consensus 78 ~~~g~~l~~~~~~~~~-------~~~~~i~~~l~~lH~~---gi~H~Dl~~~Nil~~-~~~~~liDfg~a~~ 138 (199)
T TIGR03724 78 YIEGKPLKDVIEEGND-------ELLREIGRLVGKLHKA---GIVHGDLTTSNIIVR-DDKLYLIDFGLGKY 138 (199)
T ss_pred EECCccHHHHHhhcHH-------HHHHHHHHHHHHHHHC---CeecCCCCcceEEEE-CCcEEEEECCCCcC
Confidence 9999999988754221 8899999999999998 999999999999999 88999999999875
|
Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine. |
| >KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=99.64 E-value=5.5e-17 Score=173.24 Aligned_cols=169 Identities=22% Similarity=0.341 Sum_probs=128.2
Q ss_pred ceEEEEEeccCCCccccccCC---CCCchhHHHHHHHHHHHHHHHHhhccCCCeEecCCCCCcEEEcCCCCeEEeecCCC
Q 003836 573 NRLLVYEFMSNGTVASFLFGD---SKPNWKLRTEIAMGIAGGLFYLHEECCTQIIHCDIKPQNILLDDHYNARISDFGLA 649 (792)
Q Consensus 573 ~~~lV~E~~~~gsL~~~l~~~---~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dikp~NILl~~~~~~kl~Dfg~a 649 (792)
..++.|+++...+|.++|.++ ...++...+.++.|++.|+.| + +.+|+|+||.||.+..+..+||.|||+.
T Consensus 330 ~lyI~Mn~c~~~tledWl~rr~~~e~~s~s~~~~~~~q~~~~~~y---k---~~ihrdlkp~nif~~~d~q~kIgDFgl~ 403 (516)
T KOG1033|consen 330 YLYIQMNLCEKETLEDWLRRRRTGEERSLSLMLDIFKQIAPAVEY---K---GLIHRDLKPSNIFFSDDDQLKIGDFGLV 403 (516)
T ss_pred chhhhhhhhhhhhHHHHhhCCCcccccchhHHHHHHHhhccchhh---c---cchhhhccccccccccchhhhhhhhhhe
Confidence 578999999999999999765 356788899999999999999 5 8999999999999999999999999999
Q ss_pred ccccCCC-----CCccccccccCCcccccccccCCCCcccceehHHHHHHHHHh-cCcCCCcchhhhhhhhHHHHHHHhh
Q 003836 650 KLLTLDQ-----SHTNTAIRGTKGYVAPEWFRNMPITVKVDVYSYGVLLLEIIC-LRRNIDNEISKVDKAILTDWAYDRY 723 (792)
Q Consensus 650 ~~~~~~~-----~~~~~~~~gt~~y~aPE~~~~~~~~~k~DV~S~Gv~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~ 723 (792)
....... ....+...||..||+||.+.+..|+.|+||||||++|+|++. -..+++.. .+....
T Consensus 404 ts~~~~~~~~~~~a~~t~~~gt~~YmsPEQi~g~~y~~kvdIyaLGlil~EL~~~f~T~~er~-----------~t~~d~ 472 (516)
T KOG1033|consen 404 TSQDKDETVAPAAASHTQQVGTLLYMSPEQIRGQQYSEKVDIYALGLILAELLIQFSTQFERI-----------ATLTDI 472 (516)
T ss_pred eecccCCcccchhhhhhhcccccccCCHHHHhhhhhhhhcchhhHHHHHHHHHHHhccHHHHH-----------Hhhhhh
Confidence 8766554 223345679999999999999999999999999999999987 33332211 111222
Q ss_pred cccchhHhhhchhcccCCHHHHHHHHHHHHHccccCCCCCCCHH
Q 003836 724 QERTLEALVENDLEAMNNVTMLHRFVMVAFWCIQEDPSHRPTMR 767 (792)
Q Consensus 724 ~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~ 767 (792)
+++.+.... ...+ ++-..+..+++.+.|.+||++.
T Consensus 473 r~g~ip~~~----~~d~-----p~e~~ll~~lls~~p~~RP~~~ 507 (516)
T KOG1033|consen 473 RDGIIPPEF----LQDY-----PEEYTLLQQLLSPSPEERPSAI 507 (516)
T ss_pred hcCCCChHH----hhcC-----cHHHHHHHHhcCCCcccCchHH
Confidence 222222111 0111 1224678889999999999443
|
|
| >cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain | Back alignment and domain information |
|---|
Probab=99.62 E-value=2.2e-15 Score=150.48 Aligned_cols=137 Identities=18% Similarity=0.170 Sum_probs=106.9
Q ss_pred hhhhhhcCccccceEEEeeecCCCceEEEEEEcccccc----------------------cchHHHHHHHHHhcccCCCC
Q 003836 503 RGFKEELGRGAFGTVYKGFVNMGSSNHVAVKKLNSVFQ----------------------DSEKEFKAEVNGIGQTHHKN 560 (792)
Q Consensus 503 ~~~~~~lG~G~~g~Vy~g~~~~~~~~~vavK~~~~~~~----------------------~~~~~~~~Ei~~l~~l~h~n 560 (792)
+.+.+.||+|+||.||++... +++.+|||++..... .....+..|..++..+.|++
T Consensus 17 ~~~~~~i~~G~~g~Vy~~~~~--~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~ 94 (198)
T cd05144 17 ESLGNQIGVGKESDVYLALDP--DGNPVALKFHRLGRTSFRKVKRKRDYLGDRKHASWLYLSRLAAQKEFAALKALYEEG 94 (198)
T ss_pred hhcCCccccCcceEEEEEEcC--CCCEEEEEEEecccchhhhhcchHHHHhccccchhHHHhHHHHHHHHHHHHHHHHcC
Confidence 455678999999999999754 467899998654210 01123677888899988874
Q ss_pred --cccccceeccCCceEEEEEeccCCCccccccCCCCCchhHHHHHHHHHHHHHHHHhhccCCCeEecCCCCCcEEEcCC
Q 003836 561 --LVRLLGYCDEGQNRLLVYEFMSNGTVASFLFGDSKPNWKLRTEIAMGIAGGLFYLHEECCTQIIHCDIKPQNILLDDH 638 (792)
Q Consensus 561 --iv~l~g~~~~~~~~~lV~E~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dikp~NILl~~~ 638 (792)
+++.++. ...++||||+++++|...... ....+++.+++.++.++|+. +|+|+||||+||+++++
T Consensus 95 i~v~~~~~~----~~~~lv~e~~~g~~L~~~~~~------~~~~~~~~~i~~~l~~lh~~---gi~H~Dl~p~Nill~~~ 161 (198)
T cd05144 95 FPVPKPIDW----NRHAVVMEYIDGVELYRVRVL------EDPEEVLDEILEEIVKAYKH---GIIHGDLSEFNILVDDD 161 (198)
T ss_pred CCCCceeec----CCceEEEEEeCCcchhhcccc------ccHHHHHHHHHHHHHHHHHC---CCCcCCCCcccEEEcCC
Confidence 4444432 345899999999998876431 34567899999999999998 99999999999999999
Q ss_pred CCeEEeecCCCccccC
Q 003836 639 YNARISDFGLAKLLTL 654 (792)
Q Consensus 639 ~~~kl~Dfg~a~~~~~ 654 (792)
+.++|+|||++.....
T Consensus 162 ~~~~liDfg~~~~~~~ 177 (198)
T cd05144 162 EKIYIIDWPQMVSTDH 177 (198)
T ss_pred CcEEEEECCccccCCC
Confidence 9999999999976543
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom |
| >PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated | Back alignment and domain information |
|---|
Probab=99.61 E-value=1.9e-15 Score=173.93 Aligned_cols=132 Identities=18% Similarity=0.265 Sum_probs=108.3
Q ss_pred hhhcCccccceEEEeeecCCCceEEEEEEc-ccccc-------cchHHHHHHHHHhcccCCCCcccccceeccCCceEEE
Q 003836 506 KEELGRGAFGTVYKGFVNMGSSNHVAVKKL-NSVFQ-------DSEKEFKAEVNGIGQTHHKNLVRLLGYCDEGQNRLLV 577 (792)
Q Consensus 506 ~~~lG~G~~g~Vy~g~~~~~~~~~vavK~~-~~~~~-------~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~lV 577 (792)
.+.||+|+||+||+|.+.. +.+++|+. .+... ...+.+.+|++++.+++|++++....++......++|
T Consensus 338 ~~~iG~G~~g~Vy~~~~~~---~~~v~k~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv 414 (535)
T PRK09605 338 DHLIGKGAEADIKKGEYLG---RDAVIKERVPKGYRHPELDERLRTERTRAEARLLSEARRAGVPTPVIYDVDPEEKTIV 414 (535)
T ss_pred cceeccCCcEEEEEEeecC---ccceeEEEecccccchhHHHHHHHHHHHHHHHHHHhhcccCCCeeEEEEEeCCCCEEE
Confidence 4689999999999997642 23444432 21111 1235688999999999999999888888777788999
Q ss_pred EEeccCCCccccccCCCCCchhHHHHHHHHHHHHHHHHhhccCCCeEecCCCCCcEEEcCCCCeEEeecCCCccc
Q 003836 578 YEFMSNGTVASFLFGDSKPNWKLRTEIAMGIAGGLFYLHEECCTQIIHCDIKPQNILLDDHYNARISDFGLAKLL 652 (792)
Q Consensus 578 ~E~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dikp~NILl~~~~~~kl~Dfg~a~~~ 652 (792)
|||+++++|.+++. ...+++.+++++|.|||+. +++||||||+|||+ +++.++|+|||+++..
T Consensus 415 ~E~~~g~~L~~~l~--------~~~~~~~~i~~~L~~lH~~---giiHrDlkp~NILl-~~~~~~liDFGla~~~ 477 (535)
T PRK09605 415 MEYIGGKDLKDVLE--------GNPELVRKVGEIVAKLHKA---GIVHGDLTTSNFIV-RDDRLYLIDFGLGKYS 477 (535)
T ss_pred EEecCCCcHHHHHH--------HHHHHHHHHHHHHHHHHhC---CCccCCCChHHEEE-ECCcEEEEeCcccccC
Confidence 99999999999874 4678999999999999998 99999999999999 6789999999999753
|
|
| >cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Probab=99.53 E-value=5.1e-14 Score=133.59 Aligned_cols=133 Identities=22% Similarity=0.173 Sum_probs=114.2
Q ss_pred hhcCccccceEEEeeecCCCceEEEEEEcccccccchHHHHHHHHHhcccCC--CCcccccceeccCCceEEEEEeccCC
Q 003836 507 EELGRGAFGTVYKGFVNMGSSNHVAVKKLNSVFQDSEKEFKAEVNGIGQTHH--KNLVRLLGYCDEGQNRLLVYEFMSNG 584 (792)
Q Consensus 507 ~~lG~G~~g~Vy~g~~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h--~niv~l~g~~~~~~~~~lV~E~~~~g 584 (792)
+.||+|.++.||++.... ..+++|....... ...+.+|+..++.++| .++++++++....+..++++||++++
T Consensus 4 ~~i~~g~~~~v~~~~~~~---~~~~iK~~~~~~~--~~~~~~e~~~~~~l~~~~~~~p~~~~~~~~~~~~~~v~e~~~g~ 78 (155)
T cd05120 4 KLLKGGLTNRVYLLGTKD---EDYVLKINPSREK--GADREREVAILQLLARKGLPVPKVLASGESDGWSYLLMEWIEGE 78 (155)
T ss_pred eecccccccceEEEEecC---CeEEEEecCCCCc--hhHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCccEEEEEecCCe
Confidence 569999999999997642 5799999865433 5679999999999976 58999999988888999999999998
Q ss_pred CccccccCCCCCchhHHHHHHHHHHHHHHHHhhccCCCeEecCCCCCcEEEcCCCCeEEeecCCCcc
Q 003836 585 TVASFLFGDSKPNWKLRTEIAMGIAGGLFYLHEECCTQIIHCDIKPQNILLDDHYNARISDFGLAKL 651 (792)
Q Consensus 585 sL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dikp~NILl~~~~~~kl~Dfg~a~~ 651 (792)
.+..+ +......++.+++++|++||.....+++|+|++|+|||+++.+.++++|||.++.
T Consensus 79 ~~~~~-------~~~~~~~~~~~~~~~l~~lh~~~~~~i~H~Dl~~~Nil~~~~~~~~l~Df~~~~~ 138 (155)
T cd05120 79 TLDEV-------SEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVDDGKILGIIDWEYAGY 138 (155)
T ss_pred ecccC-------CHHHHHHHHHHHHHHHHHHhCCCceEEEecCCCcceEEEECCcEEEEEecccccC
Confidence 77765 5567788899999999999986445799999999999999989999999999874
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves |
| >cd05119 RIO RIO kinase family, catalytic domain | Back alignment and domain information |
|---|
Probab=99.53 E-value=3.1e-14 Score=140.84 Aligned_cols=137 Identities=20% Similarity=0.205 Sum_probs=96.3
Q ss_pred hhhcCccccceEEEeeecCCCceEEEEEEcccccccc--hHH----------------------HHHHHHHhcccCCCC-
Q 003836 506 KEELGRGAFGTVYKGFVNMGSSNHVAVKKLNSVFQDS--EKE----------------------FKAEVNGIGQTHHKN- 560 (792)
Q Consensus 506 ~~~lG~G~~g~Vy~g~~~~~~~~~vavK~~~~~~~~~--~~~----------------------~~~Ei~~l~~l~h~n- 560 (792)
.+.||+|+||+||++... +++.||||++....... ... ...|.+.+.++++..
T Consensus 2 ~~~lg~G~~g~Vy~a~~~--~~~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~ 79 (187)
T cd05119 2 GGPIGTGKEADVYLALDG--DGEPVAVKIYRTGRTSFKKRKRYRTGDYRFGRKKSNWRYLSRLWAEKEFRNLKRLYEAGV 79 (187)
T ss_pred CcccccccceeEEEEECC--CCCEEEEEEEecCccchhhhhhhhHHHHHhccCCcchhhhhhHHHHHHHHHHHHHHHcCC
Confidence 357999999999999765 56789999876532111 111 134555555554332
Q ss_pred -cccccceeccCCceEEEEEeccCCCccccccCCCCCchhHHHHHHHHHHHHHHHHhh-ccCCCeEecCCCCCcEEEcCC
Q 003836 561 -LVRLLGYCDEGQNRLLVYEFMSNGTVASFLFGDSKPNWKLRTEIAMGIAGGLFYLHE-ECCTQIIHCDIKPQNILLDDH 638 (792)
Q Consensus 561 -iv~l~g~~~~~~~~~lV~E~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~-~~~~~ivH~dikp~NILl~~~ 638 (792)
+.+.+++ ...++||||++++.+........... .....++.+++.++.++|. . +|+|+||||+||+++ +
T Consensus 80 ~~~~~~~~----~~~~lv~e~~~g~~~~~~~l~~~~~~-~~~~~~~~~~~~~l~~lh~~~---~ivH~Dl~p~Nili~-~ 150 (187)
T cd05119 80 PVPKPIDL----NRHVLVMEFIGGDGIPAPRLKDVRLL-EDPEELYDQILELMRKLYREA---GLVHGDLSEYNILVD-D 150 (187)
T ss_pred CCCceEec----CCCEEEEEEeCCCCccChhhhhhhhc-ccHHHHHHHHHHHHHHHhhcc---CcCcCCCChhhEEEE-C
Confidence 3333332 24589999999965433221111111 6678899999999999999 7 999999999999999 8
Q ss_pred CCeEEeecCCCcccc
Q 003836 639 YNARISDFGLAKLLT 653 (792)
Q Consensus 639 ~~~kl~Dfg~a~~~~ 653 (792)
+.++|+|||.+....
T Consensus 151 ~~~~liDfg~a~~~~ 165 (187)
T cd05119 151 GKVYIIDVPQAVEID 165 (187)
T ss_pred CcEEEEECccccccc
Confidence 999999999997554
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct |
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.52 E-value=1.8e-15 Score=173.20 Aligned_cols=253 Identities=22% Similarity=0.316 Sum_probs=190.0
Q ss_pred hhhhhhcCccccceEEEeeecCCCceEEEEEEccccc--ccchHHHHHHHHHhcccC-CCCcccccceeccCCceEEEEE
Q 003836 503 RGFKEELGRGAFGTVYKGFVNMGSSNHVAVKKLNSVF--QDSEKEFKAEVNGIGQTH-HKNLVRLLGYCDEGQNRLLVYE 579 (792)
Q Consensus 503 ~~~~~~lG~G~~g~Vy~g~~~~~~~~~vavK~~~~~~--~~~~~~~~~Ei~~l~~l~-h~niv~l~g~~~~~~~~~lV~E 579 (792)
+++.+.||+|+|+.|-...........+|+|.+.... ....+....|..+-..+. |+|++.+++...+.+..+++.|
T Consensus 22 ~~~~~~ig~gs~~~~~~~~~~~~~~~~~a~~~~s~~~~~~~~~~~i~~e~~~~~~~s~h~n~~~~~~~~~~~~~~~~~~~ 101 (601)
T KOG0590|consen 22 YKLSRSIGKGSFSSSALASNSRDPESSSATKPISIPPKSEDSSEHIDTETDIQKKLSKHSNTVHMIEPSSSPRSYLLSLS 101 (601)
T ss_pred ccccccccccccchhhhhhhcCCCcceeeccCCCCCCCccchhhhcCccccccccccccccccccCCccCCCcccccccC
Confidence 3445569999999998876555556678888876553 223344555777666776 9999999999999999999999
Q ss_pred eccCCCccccc-cCCC-CCchhHHHHHHHHHHHHHHHHh-hccCCCeEecCCCCCcEEEcCCC-CeEEeecCCCccccC-
Q 003836 580 FMSNGTVASFL-FGDS-KPNWKLRTEIAMGIAGGLFYLH-EECCTQIIHCDIKPQNILLDDHY-NARISDFGLAKLLTL- 654 (792)
Q Consensus 580 ~~~~gsL~~~l-~~~~-~l~~~~~~~i~~~ia~gL~yLH-~~~~~~ivH~dikp~NILl~~~~-~~kl~Dfg~a~~~~~- 654 (792)
|..++++.+.+ +... ..+....-....|+..++.|+| .. ++.|+||||+|.+++..+ ..|++|||+|..+..
T Consensus 102 ~s~g~~~f~~i~~~~~~~~~~~~~~~~~~ql~s~l~~~H~~~---~~~h~~ikP~n~~l~~s~~~l~~~df~~At~~~~~ 178 (601)
T KOG0590|consen 102 YSDGGSLFSKISHPDSTGTSSSSASRYLPQLNSGLSYLHPEN---GVTHRDIKPSNSLLDESGSALKIADFGLATAYRNK 178 (601)
T ss_pred cccccccccccccCCccCCCCcchhhhhhhhccCccccCccc---ccccCCCCCccchhccCCCcccCCCchhhcccccc
Confidence 99999999999 5554 6677788889999999999999 76 999999999999999999 999999999998766
Q ss_pred CCC-Cccccccc-cCCcccccccccC-CCCcccceehHHHHHHHHHhcCcCCCcchhhhhhhhHHHHHHHhhcccchhHh
Q 003836 655 DQS-HTNTAIRG-TKGYVAPEWFRNM-PITVKVDVYSYGVLLLEIICLRRNIDNEISKVDKAILTDWAYDRYQERTLEAL 731 (792)
Q Consensus 655 ~~~-~~~~~~~g-t~~y~aPE~~~~~-~~~~k~DV~S~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 731 (792)
... ......+| ++.|+|||...+. -..+..|+||.|+++.-+++|..|++........ ...| .+..
T Consensus 179 ~g~~~~~~~~~g~s~~y~a~E~~~~~~~~~~~~d~~S~g~~l~~~~~g~~p~~~~~~~~~~--~~~~-----~~~~---- 247 (601)
T KOG0590|consen 179 NGAERSLKDRCGSSPPYGAPEHLSGKAYRGPSVDVWSLGIVLSAMLTGELPWDFPSRKDGR--YSSW-----KSNK---- 247 (601)
T ss_pred CCcceeeecccCCCCCCCCcccccchhhcCCCcccccccccccccccCCCCcccccccccc--ceee-----cccc----
Confidence 222 22334567 9999999999874 4567899999999999999999998654432211 0011 1100
Q ss_pred hhchhcccCCHHHHHHHHHHHHHccccCCCCCCCHHhHHH
Q 003836 732 VENDLEAMNNVTMLHRFVMVAFWCIQEDPSHRPTMRKVTQ 771 (792)
Q Consensus 732 ~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~ 771 (792)
.......-........++...++..+|+.|.+.+++..
T Consensus 248 --~~~~~~~~~~~~~~~~~~l~k~l~~~~~~r~s~~~~~~ 285 (601)
T KOG0590|consen 248 --GRFTQLPWNSISDQAHDLLHKILKENPSNRLSIEELKL 285 (601)
T ss_pred --cccccCccccCChhhhhcccccccCCchhccccccccc
Confidence 00000111123345667778889899999999988764
|
|
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.51 E-value=8.3e-15 Score=167.08 Aligned_cols=206 Identities=19% Similarity=0.241 Sum_probs=140.1
Q ss_pred hhhcCccccceEEEeeecCCCceEEEEEEcccccccchHHHHHHHHHhcccCCCCcccccceeccCCceEEEEEeccCCC
Q 003836 506 KEELGRGAFGTVYKGFVNMGSSNHVAVKKLNSVFQDSEKEFKAEVNGIGQTHHKNLVRLLGYCDEGQNRLLVYEFMSNGT 585 (792)
Q Consensus 506 ~~~lG~G~~g~Vy~g~~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~lV~E~~~~gs 585 (792)
.+.|..|++|.||...+. .+.++.|+|+-++. .+.+- ++.....|.+| |+
T Consensus 88 IklisngAygavylvrh~-~trqrfa~kiNkq~------lilRn--ilt~a~npfvv---------------------gD 137 (1205)
T KOG0606|consen 88 IKLISNGAYGAVYLVRHK-ETRQRFAMKINKQN------LILRN--ILTFAGNPFVV---------------------GD 137 (1205)
T ss_pred eEeeccCCCCceeeeecc-ccccchhhcccccc------hhhhc--cccccCCccee---------------------ch
Confidence 357899999999998643 45667888543221 11110 22222333333 44
Q ss_pred ccccccCCCCCchhHHHHHHHHHHHHHHHHhhccCCCeEecCCCCCcEEEcCCCCeEEeecCCCccccCCC---------
Q 003836 586 VASFLFGDSKPNWKLRTEIAMGIAGGLFYLHEECCTQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLDQ--------- 656 (792)
Q Consensus 586 L~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dikp~NILl~~~~~~kl~Dfg~a~~~~~~~--------- 656 (792)
-...+...+.++... +.+++|||+. +|+|||+||+|.||+.-|.+|+.|||+.+......
T Consensus 138 c~tllk~~g~lPvdm--------vla~Eylh~y---givhrdlkpdnllIT~mGhiKlTDfgLsk~GLms~atnl~eg~I 206 (1205)
T KOG0606|consen 138 CATLLKNIGPLPVDM--------VLAVEYLHSY---GIVHRDLKPDNLLITSMGHIKLTDFGLSKKGLMSLATNLKEGHI 206 (1205)
T ss_pred hhhhcccCCCCcchh--------hHHhHhhccC---CeecCCCCCCcceeeecccccccchhhhhhhhhhccchhhhcch
Confidence 444554434443332 7889999998 99999999999999999999999999998643211
Q ss_pred -----CCccccccccCCcccccccccCCCCcccceehHHHHHHHHHhcCcCCCcchhhhhhhhHHHHHHHhhcccchhHh
Q 003836 657 -----SHTNTAIRGTKGYVAPEWFRNMPITVKVDVYSYGVLLLEIICLRRNIDNEISKVDKAILTDWAYDRYQERTLEAL 731 (792)
Q Consensus 657 -----~~~~~~~~gt~~y~aPE~~~~~~~~~k~DV~S~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 731 (792)
......++||+.|+|||++....|...+|.|++|+|+||.+-|..||..+...+-...+
T Consensus 207 ~k~t~Ef~dKqvcgTPeyiaPeVilrqgygkpvdwwamGiIlyeFLVgcvpffGdtpeelfg~v---------------- 270 (1205)
T KOG0606|consen 207 EKDTHEFQDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEELFGQV---------------- 270 (1205)
T ss_pred HHHHHHhhhccccCCccccChhhhhhhccCCCccHHHHHHHHHHHheeeeeccCCCHHHHHhhh----------------
Confidence 11123458999999999999999999999999999999999999999876432111111
Q ss_pred hhchh-cccCCHHHHHHHHHHHHHccccCCCCCCCHHh
Q 003836 732 VENDL-EAMNNVTMLHRFVMVAFWCIQEDPSHRPTMRK 768 (792)
Q Consensus 732 ~~~~~-~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~e 768 (792)
+.... -.+-+.....++.+++.+.|+.+|.+|--...
T Consensus 271 isd~i~wpE~dea~p~Ea~dli~~LL~qnp~~Rlgt~g 308 (1205)
T KOG0606|consen 271 ISDDIEWPEEDEALPPEAQDLIEQLLRQNPLCRLGTGG 308 (1205)
T ss_pred hhhhccccccCcCCCHHHHHHHHHHHHhChHhhcccch
Confidence 11111 01112234567788899999999999964433
|
|
| >PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | Back alignment and domain information |
|---|
Probab=99.48 E-value=1.3e-13 Score=141.18 Aligned_cols=135 Identities=17% Similarity=0.115 Sum_probs=104.2
Q ss_pred hhcC-ccccceEEEeeecCCCceEEEEEEccccc-------------ccchHHHHHHHHHhcccCCCCc--ccccceecc
Q 003836 507 EELG-RGAFGTVYKGFVNMGSSNHVAVKKLNSVF-------------QDSEKEFKAEVNGIGQTHHKNL--VRLLGYCDE 570 (792)
Q Consensus 507 ~~lG-~G~~g~Vy~g~~~~~~~~~vavK~~~~~~-------------~~~~~~~~~Ei~~l~~l~h~ni--v~l~g~~~~ 570 (792)
..|| .|+.|+||+.... +..++||+..... ......+.+|++++.+++|++| ++.+++...
T Consensus 37 ~~lg~~~g~gtv~~v~~~---~~~~vlk~~~r~~~i~kv~~~~~~~~~~~~~r~~rE~~ll~~L~~~gi~vP~pl~~~~~ 113 (239)
T PRK01723 37 RVVGSAKGRGTTWFVQTP---GVNWVLRHYRRGGLIGKLSKDRYLFTGLERTRAFAEFRLLAQLYEAGLPVPRPIAARVV 113 (239)
T ss_pred ceeecCCCCccEEEEEeC---CceEEEEEeeEcchHHhhhhhcccccchhhhHHHHHHHHHHHHHhCCCCCceeEeeeee
Confidence 4687 8999999998654 4578998775311 1233568899999999998885 677776543
Q ss_pred CCc----eEEEEEeccC-CCccccccCCCCCchhHHHHHHHHHHHHHHHHhhccCCCeEecCCCCCcEEEcCCCCeEEee
Q 003836 571 GQN----RLLVYEFMSN-GTVASFLFGDSKPNWKLRTEIAMGIAGGLFYLHEECCTQIIHCDIKPQNILLDDHYNARISD 645 (792)
Q Consensus 571 ~~~----~~lV~E~~~~-gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dikp~NILl~~~~~~kl~D 645 (792)
... .++|+|++++ .+|.+++... .++. ..+.+|+.+|.+||+. +|+|+||||.|||++.++.++|+|
T Consensus 114 ~~~~~~~~~lV~e~l~G~~~L~~~l~~~-~l~~----~~~~~i~~~l~~lH~~---GI~HrDlkp~NILv~~~~~v~LID 185 (239)
T PRK01723 114 RHGLFYRADILIERIEGARDLVALLQEA-PLSE----EQWQAIGQLIARFHDA---GVYHADLNAHNILLDPDGKFWLID 185 (239)
T ss_pred ecCcceeeeEEEEecCCCCCHHHHHhcC-CCCH----HHHHHHHHHHHHHHHC---CCCCCCCCchhEEEcCCCCEEEEE
Confidence 322 3599999997 6888887543 3332 3467899999999999 999999999999999999999999
Q ss_pred cCCCccc
Q 003836 646 FGLAKLL 652 (792)
Q Consensus 646 fg~a~~~ 652 (792)
||.+...
T Consensus 186 fg~~~~~ 192 (239)
T PRK01723 186 FDRGELR 192 (239)
T ss_pred CCCcccC
Confidence 9998753
|
|
| >KOG1266 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.37 E-value=5.7e-13 Score=133.81 Aligned_cols=199 Identities=23% Similarity=0.328 Sum_probs=139.4
Q ss_pred HHhcccCCCCcccccceeccCC-----ceEEEEEeccCCCccccccCC----CCCchhHHHHHHHHHHHHHHHHhhccCC
Q 003836 551 NGIGQTHHKNLVRLLGYCDEGQ-----NRLLVYEFMSNGTVASFLFGD----SKPNWKLRTEIAMGIAGGLFYLHEECCT 621 (792)
Q Consensus 551 ~~l~~l~h~niv~l~g~~~~~~-----~~~lV~E~~~~gsL~~~l~~~----~~l~~~~~~~i~~~ia~gL~yLH~~~~~ 621 (792)
..|-++-|.|||+++.|..+.+ +..++.|||..|+|..+|++. ..+......+++-||..||.|||+ |.+
T Consensus 119 dnllqlvHsnlvkfH~yw~d~K~~e~~rviFiteymssgs~~~fLkrt~~~~~a~~~~~wkkw~tqIlsal~yLhs-~~P 197 (458)
T KOG1266|consen 119 DNLLQLVHSNLVKFHKYWTDKKYEEKPRVIFITEYMSSGSLKQFLKRTKKNQKALFQKAWKKWCTQILSALSYLHS-CDP 197 (458)
T ss_pred HHHHHHHHHHHHHHHHhhcccccccccceEEEEecccchhHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhhhhhhc-cCC
Confidence 3455567999999999885443 578999999999999999764 467788888999999999999998 578
Q ss_pred CeEecCCCCCcEEEcCCCCeEEeecCCCcc---ccCCCCCccccccccCCcccccccccCCCCcccceehHHHHHHHHHh
Q 003836 622 QIIHCDIKPQNILLDDHYNARISDFGLAKL---LTLDQSHTNTAIRGTKGYVAPEWFRNMPITVKVDVYSYGVLLLEIIC 698 (792)
Q Consensus 622 ~ivH~dikp~NILl~~~~~~kl~Dfg~a~~---~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DV~S~Gv~l~el~t 698 (792)
.|+|+++..+-|++..++-+||.--.-... .............+-++|.+||.=.....+.++|||+||...+||.-
T Consensus 198 piihgnlTc~tifiq~ngLIkig~~ap~s~h~s~~~~~~~Ek~~~~~~~g~~a~~sg~~tn~~~a~dIy~fgmcAlemai 277 (458)
T KOG1266|consen 198 PIIHGNLTCDTIFIQHNGLIKIGSVAPDSTHPSVNSTREAEKSVNTSLPGFSAPESGTTTNTTGASDIYKFGMCALEMAI 277 (458)
T ss_pred ccccCCcchhheeecCCceEEecccCccccchhhhhhhHhhhhccccCCccccCCcCcccccccchhhhhhhHHHHHHHH
Confidence 899999999999999999888853211100 00001111222346789999998777788899999999999999988
Q ss_pred cCcCCCcchhhhh-hhhHHHHHHHhhcccchhHhhhchhcccCCHHHHHHHHHHHHHccccCCCCCCCHHhHHH
Q 003836 699 LRRNIDNEISKVD-KAILTDWAYDRYQERTLEALVENDLEAMNNVTMLHRFVMVAFWCIQEDPSHRPTMRKVTQ 771 (792)
Q Consensus 699 g~~p~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~ 771 (792)
+........+... ..... ..+..+-+. .-..++..|++..|..||+|++++.
T Consensus 278 lEiq~tnseS~~~~ee~ia---------~~i~~len~------------lqr~~i~kcl~~eP~~rp~ar~llf 330 (458)
T KOG1266|consen 278 LEIQSTNSESKVEVEENIA---------NVIIGLENG------------LQRGSITKCLEGEPNGRPDARLLLF 330 (458)
T ss_pred heeccCCCcceeehhhhhh---------hheeeccCc------------cccCcCcccccCCCCCCcchhhhhc
Confidence 8754322221111 00000 000000011 1123566799999999999998875
|
|
| >TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase | Back alignment and domain information |
|---|
Probab=99.32 E-value=5.1e-12 Score=140.65 Aligned_cols=140 Identities=20% Similarity=0.242 Sum_probs=98.0
Q ss_pred hhcCccccceEEEeeecCCCceEEEEEEcccccccc----------------------------------------hHHH
Q 003836 507 EELGRGAFGTVYKGFVNMGSSNHVAVKKLNSVFQDS----------------------------------------EKEF 546 (792)
Q Consensus 507 ~~lG~G~~g~Vy~g~~~~~~~~~vavK~~~~~~~~~----------------------------------------~~~~ 546 (792)
+.||.|++|.||+|++.. ++.||||+.+...... +-+|
T Consensus 123 ~plasaSigQVh~A~l~~--G~~VaVKv~rp~i~~~i~~Dl~~l~~~~~~~~~~~~~~~~~~~~~~~~e~~~~l~~Eldf 200 (437)
T TIGR01982 123 KPLAAASIAQVHRARLVD--GKEVAVKVLRPGIEKTIAADIALLYRLARIVERLSPDSRRLRPTEVVKEFEKTLRRELDL 200 (437)
T ss_pred cceeeeehhheEEEEecC--CCEEEEEeeCCCcHHHHHHHHHHHHHHHHHHHHhCccccccCHHHHHHHHHHHHHHHHCH
Confidence 359999999999998863 5789999986431110 0124
Q ss_pred HHHHHHhcccC----CCCccccccee-ccCCceEEEEEeccCCCccccccCCCCCchhHHHHHHHHHHH-HHHHHhhccC
Q 003836 547 KAEVNGIGQTH----HKNLVRLLGYC-DEGQNRLLVYEFMSNGTVASFLFGDSKPNWKLRTEIAMGIAG-GLFYLHEECC 620 (792)
Q Consensus 547 ~~Ei~~l~~l~----h~niv~l~g~~-~~~~~~~lV~E~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~-gL~yLH~~~~ 620 (792)
.+|.+.+.+++ |.+-+.+-..+ ......+|||||+++++|.++...... . ..+.+++..+++ .+..+|..
T Consensus 201 ~~Ea~n~~~~~~~~~~~~~v~vP~v~~~~~~~~vLvmE~i~G~~L~~~~~~~~~-~-~~~~~ia~~~~~~~l~ql~~~-- 276 (437)
T TIGR01982 201 RREAANASELGENFKNDPGVYVPEVYWDRTSERVLTMEWIDGIPLSDIAALDEA-G-LDRKALAENLARSFLNQVLRD-- 276 (437)
T ss_pred HHHHHHHHHHHHhcCCCCCEEeCCEehhhcCCceEEEEeECCcccccHHHHHhc-C-CCHHHHHHHHHHHHHHHHHhC--
Confidence 45555555542 22222322223 234457999999999999987643211 0 134567777766 46788887
Q ss_pred CCeEecCCCCCcEEEcCCCCeEEeecCCCcccc
Q 003836 621 TQIIHCDIKPQNILLDDHYNARISDFGLAKLLT 653 (792)
Q Consensus 621 ~~ivH~dikp~NILl~~~~~~kl~Dfg~a~~~~ 653 (792)
+++|+|+||.||++++++.++++|||++..+.
T Consensus 277 -g~~H~D~hPgNilv~~~g~i~liDfG~~~~l~ 308 (437)
T TIGR01982 277 -GFFHADLHPGNIFVLKDGKIIALDFGIVGRLS 308 (437)
T ss_pred -CceeCCCCcccEEECCCCcEEEEeCCCeeECC
Confidence 99999999999999999999999999998764
|
This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species. |
| >cd05151 ChoK Choline Kinase (ChoK) | Back alignment and domain information |
|---|
Probab=99.18 E-value=9.1e-11 Score=113.95 Aligned_cols=130 Identities=19% Similarity=0.130 Sum_probs=96.6
Q ss_pred hhcCccccceEEEeeecCCCceEEEEEEcccccccchHHHHHHHHHhcccCCCCcc-cccceeccCCceEEEEEeccCCC
Q 003836 507 EELGRGAFGTVYKGFVNMGSSNHVAVKKLNSVFQDSEKEFKAEVNGIGQTHHKNLV-RLLGYCDEGQNRLLVYEFMSNGT 585 (792)
Q Consensus 507 ~~lG~G~~g~Vy~g~~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h~niv-~l~g~~~~~~~~~lV~E~~~~gs 585 (792)
+.|+.|..+.||++... ++.+++|....... ....+.+|+.+++.+.+.+++ +++.+. ....++||||+++.+
T Consensus 4 ~~l~~G~~~~vy~~~~~---~~~~~lK~~~~~~~-~~~~~~~E~~~l~~l~~~~~~P~~~~~~--~~~~~lv~e~i~G~~ 77 (170)
T cd05151 4 SPLKGGMTNKNYRVEVA---NKKYVVRIPGNGTE-LLINRENEAENSKLAAEAGIGPKLYYFD--PETGVLITEFIEGSE 77 (170)
T ss_pred eecCCcccCceEEEEEC---CeEEEEEeCCCCcc-cccCHHHHHHHHHHHHHhCCCCceEEEe--CCCCeEEEEecCCCc
Confidence 45889999999998653 56799998765422 234568899999998765654 444443 234589999999988
Q ss_pred ccccccCCCCCchhHHHHHHHHHHHHHHHHhhcc--CCCeEecCCCCCcEEEcCCCCeEEeecCCCcc
Q 003836 586 VASFLFGDSKPNWKLRTEIAMGIAGGLFYLHEEC--CTQIIHCDIKPQNILLDDHYNARISDFGLAKL 651 (792)
Q Consensus 586 L~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~--~~~ivH~dikp~NILl~~~~~~kl~Dfg~a~~ 651 (792)
+.... .....++.+++++|+.||... ...++|+|++|.||+++ ++.++++||+.+..
T Consensus 78 l~~~~--------~~~~~~~~~l~~~l~~LH~~~~~~~~~~HgD~~~~Nil~~-~~~~~liDf~~a~~ 136 (170)
T cd05151 78 LLTED--------FSDPENLEKIAKLLKKLHSSPLPDLVPCHNDLLPGNFLLD-DGRLWLIDWEYAGM 136 (170)
T ss_pred ccccc--------ccCHHHHHHHHHHHHHHhCCCCCCceeecCCCCcCcEEEE-CCeEEEEecccccC
Confidence 76541 112346788999999999983 22369999999999999 66899999999864
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph |
| >cd01098 PAN_AP_plant Plant PAN/APPLE-like domain; present in plant S-receptor protein kinases and secreted glycoproteins | Back alignment and domain information |
|---|
Probab=99.13 E-value=7.7e-11 Score=99.85 Aligned_cols=72 Identities=18% Similarity=0.360 Sum_probs=58.6
Q ss_pred ceeeEeccCCCCCCCcccccCcCChhhHhhhccCCCccccceec--cCceeecccCCccCccCCCCCCcEEEeec
Q 003836 356 LYYIEELRNTDWPTSDYEQISPYGKDECVSSCLKDCQCSAAVLR--DDTCWKKKLPLSYGKTDRDETGTTFIKIR 428 (792)
Q Consensus 356 ~~~~~~~~~~~~p~~~~~~~~~~s~~~C~~~Cl~nCsC~A~~~~--~~~C~~~~~~~~~~~~~~~~~~~~~lkl~ 428 (792)
.+.|+.++++++|+..+.. ..+++++|++.||+||+|.||+|. +++|+.|..++.+..........+|||++
T Consensus 11 ~~~f~~~~~~~~~~~~~~~-~~~s~~~C~~~Cl~nCsC~a~~~~~~~~~C~~~~~~~~~~~~~~~~~~~~yiKv~ 84 (84)
T cd01098 11 TDGFLKLPDVKLPDNASAI-TAISLEECREACLSNCSCTAYAYNNGSGGCLLWNGLLNNLRSLSSGGGTLYLRLA 84 (84)
T ss_pred CCEEEEeCCeeCCCchhhh-ccCCHHHHHHHHhcCCCcceeeecCCCCeEEEEeceecceEeecCCCcEEEEEeC
Confidence 3468899999999876554 678999999999999999999996 47899998888776654444578888874
|
PAN/APPLE domains fulfill diverse biological functions by mediating protein-protein or protein-carbohydrate interactions. S-receptor protein kinases and S-locus glycoproteins are involved in sporophytic self-incompatibility response in Brassica, one of probably many molecular mechanisms, by which hermaphrodite flowering plants avoid self-fertilization. |
| >cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain | Back alignment and domain information |
|---|
Probab=99.13 E-value=5.4e-10 Score=109.34 Aligned_cols=139 Identities=16% Similarity=0.184 Sum_probs=99.1
Q ss_pred hhcCccccceEEEeeecCC-----CceEEEEEEccccc----------------------ccchHHHH----HHHHHhcc
Q 003836 507 EELGRGAFGTVYKGFVNMG-----SSNHVAVKKLNSVF----------------------QDSEKEFK----AEVNGIGQ 555 (792)
Q Consensus 507 ~~lG~G~~g~Vy~g~~~~~-----~~~~vavK~~~~~~----------------------~~~~~~~~----~Ei~~l~~ 555 (792)
..||.|.-+.||.|.-..+ .+..+|||+.+... ....+.+. +|.+.|.+
T Consensus 3 g~i~~GKEa~V~~~~~~~~~~~~~~~~~~avKi~r~~~~~Fk~~~~y~~~~~rf~~~~~k~~~~~~~~~wa~kE~r~L~r 82 (197)
T cd05146 3 GCISTGKESVVLHANGGSNETEQVIPTECAIKVFKTTLNEFKNRDKYIKDDYRFKDRFSKLNPRKIIRMWAEKEMHNLKR 82 (197)
T ss_pred CccccCcceEEEEEecCcccccccCCceEEEEEEeccceeEcChhhhccCCcccccCcCCCCHHHHHHHHHHHHHHHHHH
Confidence 3689999999999964432 24689999764211 00122233 89999999
Q ss_pred cCC--CCcccccceeccCCceEEEEEeccCCCccccccCCCCCchhHHHHHHHHHHHHHHHH-hhccCCCeEecCCCCCc
Q 003836 556 THH--KNLVRLLGYCDEGQNRLLVYEFMSNGTVASFLFGDSKPNWKLRTEIAMGIAGGLFYL-HEECCTQIIHCDIKPQN 632 (792)
Q Consensus 556 l~h--~niv~l~g~~~~~~~~~lV~E~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yL-H~~~~~~ivH~dikp~N 632 (792)
+.. -++.+++++ ...+|||||+.+..+..-.-....++......+..+++.+|..| |.. +|+|+||++.|
T Consensus 83 l~~~Gv~vP~pi~~----~~~~lvME~Ig~~~~~~~~Lkd~~~~~~~~~~i~~~i~~~l~~l~H~~---glVHGDLs~~N 155 (197)
T cd05146 83 MQKAGIPCPEVVVL----KKHVLVMSFIGDDQVPAPKLKDAKLNDEEMKNAYYQVLSMMKQLYKEC---NLVHADLSEYN 155 (197)
T ss_pred HHHcCCCCCeEEEe----cCCEEEEEEcCCCCccchhhhccccCHHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHH
Confidence 854 456666654 56789999998754433222222344556677889999999999 676 99999999999
Q ss_pred EEEcCCCCeEEeecCCCcccc
Q 003836 633 ILLDDHYNARISDFGLAKLLT 653 (792)
Q Consensus 633 ILl~~~~~~kl~Dfg~a~~~~ 653 (792)
||+++ +.+.|+|||.+....
T Consensus 156 IL~~~-~~v~iIDF~qav~~~ 175 (197)
T cd05146 156 MLWHD-GKVWFIDVSQSVEPT 175 (197)
T ss_pred EEEEC-CcEEEEECCCceeCC
Confidence 99974 679999999987654
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown. |
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.12 E-value=6.6e-11 Score=129.68 Aligned_cols=253 Identities=21% Similarity=0.205 Sum_probs=182.4
Q ss_pred HHHHHHhhhhhhcCc--cccceEEEeeec-CCCceEEEEEEcccccc--cchHHHHHHHHHhcccC-CCCcccccceecc
Q 003836 497 ELVEVTRGFKEELGR--GAFGTVYKGFVN-MGSSNHVAVKKLNSVFQ--DSEKEFKAEVNGIGQTH-HKNLVRLLGYCDE 570 (792)
Q Consensus 497 el~~~~~~~~~~lG~--G~~g~Vy~g~~~-~~~~~~vavK~~~~~~~--~~~~~~~~Ei~~l~~l~-h~niv~l~g~~~~ 570 (792)
+.+...-++.+.+|. |.+|.||.+... ..+...+|+|+-+.... ...+.-.+|+....+++ |+|.++.......
T Consensus 110 s~~~~~~~~~~~~g~~~g~~~s~~~~~~~~~~s~~~~a~k~s~~p~s~p~~~~~k~~~~~s~~~i~~~~~~v~~~~~~e~ 189 (524)
T KOG0601|consen 110 SFFDQRFPISSRTGSLPGSKGSVFKSRCTNSESPHKFAVKKSKIPFSPPLDSKRKLREFLSHHKIDSHENPVRDSPAWEG 189 (524)
T ss_pred chhhhhcccccccccCCCCCceeecccCCcccCCcccccccccCCCCCccccccccchhhcccccCccccccccCccccc
Confidence 344444556678999 999999998651 23456789998554333 33445567777777774 9999998888899
Q ss_pred CCceEEEEEeccCCCccccccCCC-CCchhHHHHHHHHHHH----HHHHHhhccCCCeEecCCCCCcEEEcCC-CCeEEe
Q 003836 571 GQNRLLVYEFMSNGTVASFLFGDS-KPNWKLRTEIAMGIAG----GLFYLHEECCTQIIHCDIKPQNILLDDH-YNARIS 644 (792)
Q Consensus 571 ~~~~~lV~E~~~~gsL~~~l~~~~-~l~~~~~~~i~~~ia~----gL~yLH~~~~~~ivH~dikp~NILl~~~-~~~kl~ 644 (792)
.+..++-.|++. .+|.++.+... .++......+..+... ||.++|.. .++|-|+||.||++..+ ...++.
T Consensus 190 ~~~lfiqtE~~~-~sl~~~~~~~~~~~p~~~l~~~~~~~~~~~~~al~~~hs~---~~~~~~~kp~~i~~~~~~~s~~~~ 265 (524)
T KOG0601|consen 190 SGILFIQTELCG-ESLQSYCHTPCNFLPDNLLWNSLRDWLSRDVTALSHLHSN---NIVHDDLKPANIFTTSDWTSCKLT 265 (524)
T ss_pred CCcceeeecccc-chhHHhhhcccccCCchhhhhHHhhhhhcccccccccCCC---cccccccchhheecccccceeecC
Confidence 999999999986 68888887664 3777888888888888 99999998 99999999999999999 889999
Q ss_pred ecCCCccccCCCCCc----cccccccCCcccccccccCCCCcccceehHHHHHHHHHhcCcCCCcchhhhhhhhHHHHHH
Q 003836 645 DFGLAKLLTLDQSHT----NTAIRGTKGYVAPEWFRNMPITVKVDVYSYGVLLLEIICLRRNIDNEISKVDKAILTDWAY 720 (792)
Q Consensus 645 Dfg~a~~~~~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~k~DV~S~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~ 720 (792)
|||+...+....... .....|...|++||...+ .++.+.|||++|.+.++..++-.+..... ...|.+
T Consensus 266 df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~-l~~~~~di~sl~ev~l~~~l~~~~~~~g~-------~~~W~~ 337 (524)
T KOG0601|consen 266 DFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNG-LATFASDIFSLGEVILEAILGSHLPSVGK-------NSSWSQ 337 (524)
T ss_pred CcceeEEccCCccccceeeeecCCCCceEeChhhhcc-ccchHhhhcchhhhhHhhHhhcccccCCC-------CCCccc
Confidence 999998776544221 112257778999998754 66889999999999999998876543321 011111
Q ss_pred HhhcccchhHhhhchhcccCCHHHHHHHHHHHHHccccCCCCCCCHHhHHH
Q 003836 721 DRYQERTLEALVENDLEAMNNVTMLHRFVMVAFWCIQEDPSHRPTMRKVTQ 771 (792)
Q Consensus 721 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~ 771 (792)
... .. +..++...-..++...+.++++.+|..|++.+.+..
T Consensus 338 ~r~--~~--------ip~e~~~~~s~~l~~~~~~~~d~~~~~~~~~q~~~~ 378 (524)
T KOG0601|consen 338 LRQ--GY--------IPLEFCEGGSSSLRSVTSQMLDEDPRLRLTAQILTA 378 (524)
T ss_pred ccc--cc--------CchhhhcCcchhhhhHHHHhcCcchhhhhHHHHHhc
Confidence 110 00 011111112234444888899999999998877765
|
|
| >PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed | Back alignment and domain information |
|---|
Probab=99.11 E-value=1.2e-10 Score=131.20 Aligned_cols=137 Identities=17% Similarity=0.155 Sum_probs=88.5
Q ss_pred hhcCccccceEEEeeecCCCceEEEEEEccccccc----------------------------------chH------HH
Q 003836 507 EELGRGAFGTVYKGFVNMGSSNHVAVKKLNSVFQD----------------------------------SEK------EF 546 (792)
Q Consensus 507 ~~lG~G~~g~Vy~g~~~~~~~~~vavK~~~~~~~~----------------------------------~~~------~~ 546 (792)
+.||+|++|.||+|++.. +++.||||+++..... -.+ ++
T Consensus 125 ~PlasaSiaQVh~A~l~~-~G~~VAVKV~rP~i~~~I~~Dl~~l~~~a~~l~~~~~~~~~l~~~~~v~e~~~~l~~ElD~ 203 (537)
T PRK04750 125 KPLASASIAQVHFARLKD-NGREVVVKVLRPDILPVIDADLALMYRLARWVERLLPDGRRLKPREVVAEFEKTLHDELDL 203 (537)
T ss_pred hhhcCCCccEEEEEEECC-CCCEEEEEEeCcchHHHHHHHHHHHHHHHHHHHHhCcccccCCHHHHHHHHHHHHHHhhCH
Confidence 369999999999998864 3678999998743110 011 23
Q ss_pred HHHHHHhcccC----CCCcccccceecc-CCceEEEEEeccCCCccccc--cCCC----CCchhHHHHHHHHHHHHHHHH
Q 003836 547 KAEVNGIGQTH----HKNLVRLLGYCDE-GQNRLLVYEFMSNGTVASFL--FGDS----KPNWKLRTEIAMGIAGGLFYL 615 (792)
Q Consensus 547 ~~Ei~~l~~l~----h~niv~l~g~~~~-~~~~~lV~E~~~~gsL~~~l--~~~~----~l~~~~~~~i~~~ia~gL~yL 615 (792)
.+|+..+.+++ +.+.+.+-.++.+ ....+|||||++|+++.++- .... .+.......++.||
T Consensus 204 ~~Ea~N~~~~~~~f~~~~~v~VP~v~~d~st~~VLvmE~i~G~~l~d~~~l~~~g~d~~~la~~~v~~~~~Qi------- 276 (537)
T PRK04750 204 MREAANASQLRRNFEDSDMLYVPEVYWDYCSETVMVMERMYGIPVSDVAALRAAGTDMKLLAERGVEVFFTQV------- 276 (537)
T ss_pred HHHHHHHHHHHHHccCCCCeecceeecccCCCceEEEeeecCccHHhHHHHHhcCCCHHHHHHHHHHHHHHHH-------
Confidence 44444444442 3333333333322 44678999999999997742 2211 12222222233333
Q ss_pred hhccCCCeEecCCCCCcEEEcCCC----CeEEeecCCCccccC
Q 003836 616 HEECCTQIIHCDIKPQNILLDDHY----NARISDFGLAKLLTL 654 (792)
Q Consensus 616 H~~~~~~ivH~dikp~NILl~~~~----~~kl~Dfg~a~~~~~ 654 (792)
+.. +++|+|+||.||+++.++ .+++.|||++..+..
T Consensus 277 f~~---GffHaDpHPGNIlv~~~g~~~~~i~llDFGivg~l~~ 316 (537)
T PRK04750 277 FRD---GFFHADMHPGNIFVSYDPPENPRYIALDFGIVGSLNK 316 (537)
T ss_pred HhC---CeeeCCCChHHeEEecCCCCCCeEEEEecceEEECCH
Confidence 334 999999999999999888 999999999987754
|
|
| >KOG1243 consensus Protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.10 E-value=6.1e-10 Score=123.08 Aligned_cols=165 Identities=15% Similarity=0.192 Sum_probs=124.2
Q ss_pred CceEEEEEEcccccccchHHHHHHHHHhcccCCCCcccccceeccCCceEEEEEeccCCCccccccCCCCCchhHHHHHH
Q 003836 526 SSNHVAVKKLNSVFQDSEKEFKAEVNGIGQTHHKNLVRLLGYCDEGQNRLLVYEFMSNGTVASFLFGDSKPNWKLRTEIA 605 (792)
Q Consensus 526 ~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~lV~E~~~~gsL~~~l~~~~~l~~~~~~~i~ 605 (792)
.+.+|.|+..+...........+-++.|+.++||||++++.........|||.|.+. .|..++.. +......-.+
T Consensus 36 ~~~~vsVF~~~~~~~~~~~~~~~A~k~lKtlRHP~Il~yL~t~e~~~~~ylvTErV~--Pl~~~lk~---l~~~~v~~Gl 110 (690)
T KOG1243|consen 36 DGGPVSVFVYKRSNGEVTELAKRAVKRLKTLRHPNILSYLDTTEEEGTLYLVTERVR--PLETVLKE---LGKEEVCLGL 110 (690)
T ss_pred cCCceEEEEEeCCCchhhHHHHHHHHHhhhccCchhhhhhhhhcccCceEEEeeccc--cHHHHHHH---hHHHHHHHHH
Confidence 456788888776544445567888899999999999999999999999999999884 45555533 2244555678
Q ss_pred HHHHHHHHHHhhccCCCeEecCCCCCcEEEcCCCCeEEeecCCCccccCCCCCccccccccCCcccccccccCCCCcccc
Q 003836 606 MGIAGGLFYLHEECCTQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLDQSHTNTAIRGTKGYVAPEWFRNMPITVKVD 685 (792)
Q Consensus 606 ~~ia~gL~yLH~~~~~~ivH~dikp~NILl~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~D 685 (792)
.||+.||.|||++| +++|++|...-|++++.|..||++|.++........ ......--..|..|+.+.... -..|
T Consensus 111 ~qIl~AL~FL~~d~--~lvHgNv~~~SVfVn~~GeWkLggle~v~~~~~~~~-~~~~~~~~~s~~~P~~~~~s~--~s~D 185 (690)
T KOG1243|consen 111 FQILAALSFLNDDC--NLVHGNVCKDSVFVNESGEWKLGGLELVSKASGFNA-PAKSLYLIESFDDPEEIDPSE--WSID 185 (690)
T ss_pred HHHHHHHHHHhccC--CeeeccEeeeeEEEcCCCcEEEeeeEEEeccccCCc-ccccchhhhcccChhhcCccc--cchh
Confidence 89999999999874 899999999999999999999999988765432211 111111223466676553322 4579
Q ss_pred eehHHHHHHHHHhcC
Q 003836 686 VYSYGVLLLEIICLR 700 (792)
Q Consensus 686 V~S~Gv~l~el~tg~ 700 (792)
.|-||++++|++.|.
T Consensus 186 ~~~Lg~li~el~ng~ 200 (690)
T KOG1243|consen 186 SWGLGCLIEELFNGS 200 (690)
T ss_pred hhhHHHHHHHHhCcc
Confidence 999999999999993
|
|
| >PF08276 PAN_2: PAN-like domain; InterPro: IPR013227 PAN domains have significant functional versatility fulfilling diverse biological functions by mediating protein-protein or protein-carbohydrate interactions [] | Back alignment and domain information |
|---|
Probab=99.10 E-value=6.4e-11 Score=94.42 Aligned_cols=56 Identities=25% Similarity=0.359 Sum_probs=46.5
Q ss_pred eeeEeccCCCCCCCcccc-cCcCChhhHhhhccCCCccccceecc----CceeecccCCcc
Q 003836 357 YYIEELRNTDWPTSDYEQ-ISPYGKDECVSSCLKDCQCSAAVLRD----DTCWKKKLPLSY 412 (792)
Q Consensus 357 ~~~~~~~~~~~p~~~~~~-~~~~s~~~C~~~Cl~nCsC~A~~~~~----~~C~~~~~~~~~ 412 (792)
+.|++++++++|+.+... ..++++++|+..||+||||+||+|.+ ++|+.|...|.+
T Consensus 5 d~F~~l~~~~~p~~~~~~~~~~~s~~~C~~~Cl~nCsC~Ayay~~~~~~~~C~lW~~~L~d 65 (66)
T PF08276_consen 5 DGFLKLPNMKLPDFDNAIVDSSVSLEECEKACLSNCSCTAYAYSNLSGGGGCLLWYGDLVD 65 (66)
T ss_pred CEEEEECCeeCCCCcceeeecCCCHHHHHhhcCCCCCEeeEEeeccCCCCEEEEEcCEeec
Confidence 369999999999975544 25699999999999999999999973 679999776643
|
These domains contain a hair-pin loop like structure, similar to knottins, but the pattern of disulphide bonds differs |
| >cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins | Back alignment and domain information |
|---|
Probab=99.02 E-value=2.4e-09 Score=108.79 Aligned_cols=142 Identities=17% Similarity=0.202 Sum_probs=110.4
Q ss_pred hhcCccccceEEEeeecCCCceEEEEEEcccccc-cchHHHHHHHHHhcccCC--CCcccccceeccCC---ceEEEEEe
Q 003836 507 EELGRGAFGTVYKGFVNMGSSNHVAVKKLNSVFQ-DSEKEFKAEVNGIGQTHH--KNLVRLLGYCDEGQ---NRLLVYEF 580 (792)
Q Consensus 507 ~~lG~G~~g~Vy~g~~~~~~~~~vavK~~~~~~~-~~~~~~~~Ei~~l~~l~h--~niv~l~g~~~~~~---~~~lV~E~ 580 (792)
+.|+.|..+.||++.... ++.+++|....... .....+.+|.++++.+++ .++.+++.+..+.. ..++||||
T Consensus 4 ~~l~~G~~n~~~~v~~~~--g~~~ilK~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~vp~~~~~~~~~~~~~~~~~v~e~ 81 (223)
T cd05154 4 RQLSGGQSNLTYLLTAGG--GRRLVLRRPPPGALLPSAHDVAREYRVLRALAGTGVPVPKVLALCEDPSVLGTPFYVMER 81 (223)
T ss_pred eecCCCccceEEEEEecC--CcceEEEeCCCcccCcccccHHHHHHHHHHhhCCCCCCCCEEEECCCCCccCCceEEEEE
Confidence 458999999999987643 46799998765332 135678999999999976 44677788776643 56899999
Q ss_pred ccCCCccccccCCCCCchhHHHHHHHHHHHHHHHHhhcc-----------------------------------------
Q 003836 581 MSNGTVASFLFGDSKPNWKLRTEIAMGIAGGLFYLHEEC----------------------------------------- 619 (792)
Q Consensus 581 ~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~----------------------------------------- 619 (792)
+++.++.+.+.. ..++...+..++.+++++|.+||+..
T Consensus 82 i~G~~l~~~~~~-~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 160 (223)
T cd05154 82 VDGRVLRDRLLR-PELSPEERRALARALADTLAALHSVDPAAVGLGDLGRPGGYLERQVARWRRQYDASRTDEPPAMERL 160 (223)
T ss_pred eCCEecCCCCCC-CCCCHHHHHHHHHHHHHHHHHHhCCChhhcCCcccCCCCchHHHHHHHHHHHHHhhcccccHHHHHH
Confidence 999988887642 35677788888899999999998531
Q ss_pred ------------CCCeEecCCCCCcEEEcC--CCCeEEeecCCCcc
Q 003836 620 ------------CTQIIHCDIKPQNILLDD--HYNARISDFGLAKL 651 (792)
Q Consensus 620 ------------~~~ivH~dikp~NILl~~--~~~~kl~Dfg~a~~ 651 (792)
...++|+|++|.||+++. ++.+.|+||+.+..
T Consensus 161 ~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~~~iID~e~~~~ 206 (223)
T cd05154 161 LRWLEAHLPADSRPGLVHGDYRLGNVLFHPDEPRVVAVLDWELATL 206 (223)
T ss_pred HHHHHhhCCCCCCcEEEECCCCcccEEEcCCCCcEEEEEecccccc
Confidence 246899999999999998 66789999998864
|
This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain |
| >COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.97 E-value=3.6e-09 Score=99.71 Aligned_cols=130 Identities=19% Similarity=0.278 Sum_probs=103.2
Q ss_pred hcCccccceEEEeeecCCCceEEEEEE-ccccccc-------chHHHHHHHHHhcccCCCCcccccceeccCCceEEEEE
Q 003836 508 ELGRGAFGTVYKGFVNMGSSNHVAVKK-LNSVFQD-------SEKEFKAEVNGIGQTHHKNLVRLLGYCDEGQNRLLVYE 579 (792)
Q Consensus 508 ~lG~G~~g~Vy~g~~~~~~~~~vavK~-~~~~~~~-------~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~lV~E 579 (792)
.+++|+-+.+|.+.+. +.++++|. +.+.... ....-.+|.+++.+++--.|...+-+..+.+...|+||
T Consensus 3 ~i~~GAEa~i~~~~~~---g~~av~K~Ri~K~YR~p~LD~klrr~Rt~~Earil~~a~~~GV~~P~v~dvD~~~~~I~me 79 (204)
T COG3642 3 LIKQGAEAIIYLTDFL---GLPAVVKERIPKRYRHPELDEKLRRERTRREARILAKAREAGVPVPIVYDVDPDNGLIVME 79 (204)
T ss_pred hhhCCcceeEEeeecc---CcceEEEeecCcccCChHHHHHHHHHHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCEEEEE
Confidence 5789999999998553 23455553 3332222 12456789999999987788777778888889999999
Q ss_pred eccCCCccccccCCCCCchhHHHHHHHHHHHHHHHHhhccCCCeEecCCCCCcEEEcCCCCeEEeecCCCcc
Q 003836 580 FMSNGTVASFLFGDSKPNWKLRTEIAMGIAGGLFYLHEECCTQIIHCDIKPQNILLDDHYNARISDFGLAKL 651 (792)
Q Consensus 580 ~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dikp~NILl~~~~~~kl~Dfg~a~~ 651 (792)
|+++..|.+.+... +..++..|-.-+.-||.. +|+|+||.++||++..+. +.++|||++..
T Consensus 80 ~I~G~~lkd~l~~~-------~~~~~r~vG~~vg~lH~~---givHGDLTtsNiIl~~~~-i~~IDfGLg~~ 140 (204)
T COG3642 80 YIEGELLKDALEEA-------RPDLLREVGRLVGKLHKA---GIVHGDLTTSNIILSGGR-IYFIDFGLGEF 140 (204)
T ss_pred EeCChhHHHHHHhc-------chHHHHHHHHHHHHHHhc---CeecCCCccceEEEeCCc-EEEEECCcccc
Confidence 99999999888654 366777888888899999 999999999999998875 99999999974
|
|
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=98.96 E-value=4e-10 Score=123.57 Aligned_cols=243 Identities=18% Similarity=0.205 Sum_probs=170.9
Q ss_pred hhhhcCccccceEEEeeecCCCceEEEEEEcccccccchHH--HHHHHHHhccc-CCCCcccccceeccCCceEEEEEec
Q 003836 505 FKEELGRGAFGTVYKGFVNMGSSNHVAVKKLNSVFQDSEKE--FKAEVNGIGQT-HHKNLVRLLGYCDEGQNRLLVYEFM 581 (792)
Q Consensus 505 ~~~~lG~G~~g~Vy~g~~~~~~~~~vavK~~~~~~~~~~~~--~~~Ei~~l~~l-~h~niv~l~g~~~~~~~~~lV~E~~ 581 (792)
+...||.|.|+.|++...+..++..+++|.+.+.......+ -..|+.+...+ .|.++++...........++=-||+
T Consensus 269 ~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~W~~~r~~~ip~e~~ 348 (524)
T KOG0601|consen 269 LVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNGLATFASDIFSLGEVILEAILGSHLPSVGKNSSWSQLRQGYIPLEFC 348 (524)
T ss_pred eeEEccCCccccceeeeecCCCCceEeChhhhccccchHhhhcchhhhhHhhHhhcccccCCCCCCccccccccCchhhh
Confidence 34579999999999987665566789999887654333222 23455555555 5888888877777777778999999
Q ss_pred cCCCccccccCCCCCchhHHHHHHHHHHHHHHHHhhccCCCeEecCCCCCcEEEcCC-CCeEEeecCCCccccCCCCCcc
Q 003836 582 SNGTVASFLFGDSKPNWKLRTEIAMGIAGGLFYLHEECCTQIIHCDIKPQNILLDDH-YNARISDFGLAKLLTLDQSHTN 660 (792)
Q Consensus 582 ~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dikp~NILl~~~-~~~kl~Dfg~a~~~~~~~~~~~ 660 (792)
+++++...+.-...+++..++++..|++.++.++|+. .++|+|+||+||++..+ +.-++.|||++..+.....
T Consensus 349 ~~~s~~l~~~~~~~~d~~~~~~~~~q~~~~l~~i~s~---~~~~~d~~psni~i~~~~~~~~~~~~~~~t~~~~~~~--- 422 (524)
T KOG0601|consen 349 EGGSSSLRSVTSQMLDEDPRLRLTAQILTALNVIHSK---LFVHLDVKPSNILISNDGFFSKLGDFGCWTRLAFSSG--- 422 (524)
T ss_pred cCcchhhhhHHHHhcCcchhhhhHHHHHhccccccch---hhhcccccccceeeccchhhhhccccccccccceecc---
Confidence 9999888774445678888999999999999999998 99999999999999886 7889999999875321111
Q ss_pred ccccccCCc-ccccccccCCCCcccceehHHHHHHHHHhcCcCCCcchhhhhhhhHHHHHHHhhcccchhHhhhchhccc
Q 003836 661 TAIRGTKGY-VAPEWFRNMPITVKVDVYSYGVLLLEIICLRRNIDNEISKVDKAILTDWAYDRYQERTLEALVENDLEAM 739 (792)
Q Consensus 661 ~~~~gt~~y-~aPE~~~~~~~~~k~DV~S~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 739 (792)
.....+..| .+|+......+-.+.|++|||.-+.|.+++..-......- ..+.......
T Consensus 423 ~~~~~~r~~p~~~~~~e~~~~~~~~~~~sl~~~~~e~~~~~~ls~~~~~~-------------------~~i~~~~~p~- 482 (524)
T KOG0601|consen 423 VFHHIDRLYPIAEILLEDYPHLSKADIFSLGLSVDEAITGSPLSESGVQS-------------------LTIRSGDTPN- 482 (524)
T ss_pred cccccccccccchhhccccccccccccccccccccccccCcccCcccccc-------------------eeeecccccC-
Confidence 111123334 3666667788999999999999999999887543221110 0000000000
Q ss_pred CCHHHHHHHHHHHHHccccCCCCCCCHHhHHHHhc
Q 003836 740 NNVTMLHRFVMVAFWCIQEDPSHRPTMRKVTQMLE 774 (792)
Q Consensus 740 ~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~L~ 774 (792)
.......+..+..-++..++..||.+.++..+.+
T Consensus 483 -~~~~~~~~q~~~kv~~~~~~~~~~l~~~l~~~~~ 516 (524)
T KOG0601|consen 483 -LPGLKLQLQVLLKVMINPDRKRRPSAVELSLHSE 516 (524)
T ss_pred -CCchHHhhhhhhhhhcCCccccchhhhhhcccch
Confidence 1111245556666788899999999888776543
|
|
| >KOG3741 consensus Poly(A) ribonuclease subunit [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=98.92 E-value=1.3e-08 Score=109.14 Aligned_cols=167 Identities=20% Similarity=0.263 Sum_probs=128.7
Q ss_pred cceEEEeeecCCCceEEEEEEcccccccchHHHHHHHHHhcccCCCCcccccceec----cCCceEEEEEeccC-CCccc
Q 003836 514 FGTVYKGFVNMGSSNHVAVKKLNSVFQDSEKEFKAEVNGIGQTHHKNLVRLLGYCD----EGQNRLLVYEFMSN-GTVAS 588 (792)
Q Consensus 514 ~g~Vy~g~~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~----~~~~~~lV~E~~~~-gsL~~ 588 (792)
-.+.||+... -++..+++|+++............-++.++++.|.|+|++..++. .+..++|||+|.|+ ++|.+
T Consensus 289 ~~Ttyk~~s~-~DG~~YvLkRlhg~r~~~~nk~t~lve~wkkl~h~NvV~frevf~t~tF~D~SlvlvYDYyP~s~TL~d 367 (655)
T KOG3741|consen 289 SITTYKATSN-VDGNAYVLKRLHGDRDQSTNKDTSLVEAWKKLCHTNVVPFREVFLTYTFGDLSLVLVYDYYPSSPTLYD 367 (655)
T ss_pred cceeEeeeec-cCCceeeeeeeccccccCcccchHHHHHHHHhccCceeehhhhhhhhccCcceEEEEEecCCCCchHHH
Confidence 3578998654 557789999995443333334445578899999999999999886 45578999999986 56766
Q ss_pred cccCC---------------CCCchhHHHHHHHHHHHHHHHHhhccCCCeEecCCCCCcEEEcCCCCeEEeecCCCcccc
Q 003836 589 FLFGD---------------SKPNWKLRTEIAMGIAGGLFYLHEECCTQIIHCDIKPQNILLDDHYNARISDFGLAKLLT 653 (792)
Q Consensus 589 ~l~~~---------------~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dikp~NILl~~~~~~kl~Dfg~a~~~~ 653 (792)
..+.. ...++..++.++.|+..||.++|+. |+.-+-|.+++||++.+.+++|+..|....+.
T Consensus 368 ~~F~~~~~t~~~n~~~~~~~~~~~e~~lW~y~~QLtaaL~sIHss---GLAck~L~~~kIlv~G~~RIriS~C~i~Dvl~ 444 (655)
T KOG3741|consen 368 LYFANPPFTKRTNSFYPSQNLKAPEEVLWSYISQLTAALYSIHSS---GLACKTLDLKKILVTGKMRIRISGCGIMDVLQ 444 (655)
T ss_pred HHccCCccccccccccccCCCCchHHHHHHHHHHHHHHHHHHHhc---CceeecccHhHeEeeCcceEEEecccceeeec
Confidence 55432 2356789999999999999999998 99999999999999999999999999887765
Q ss_pred CCCCCccccccccCCcccccccccCCCCcccceehHHHHHHHHHhcCcC
Q 003836 654 LDQSHTNTAIRGTKGYVAPEWFRNMPITVKVDVYSYGVLLLEIICLRRN 702 (792)
Q Consensus 654 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DV~S~Gv~l~el~tg~~p 702 (792)
.+.... + +--.+-|.=.||.+++.|.||...
T Consensus 445 ~d~~~~---------------l---e~~Qq~D~~~lG~ll~aLAt~~~n 475 (655)
T KOG3741|consen 445 EDPTEP---------------L---ESQQQNDLRDLGLLLLALATGTEN 475 (655)
T ss_pred CCCCcc---------------h---hHHhhhhHHHHHHHHHHHhhcccc
Confidence 443111 1 112467888899999999999654
|
|
| >KOG3087 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.88 E-value=9.2e-09 Score=96.31 Aligned_cols=140 Identities=22% Similarity=0.278 Sum_probs=106.5
Q ss_pred hhcCccccceEEEeeecCCCceEEEEEE-cccccc-------cchHHHHHHHHHhcccCCCCcccccceeccCCceEEEE
Q 003836 507 EELGRGAFGTVYKGFVNMGSSNHVAVKK-LNSVFQ-------DSEKEFKAEVNGIGQTHHKNLVRLLGYCDEGQNRLLVY 578 (792)
Q Consensus 507 ~~lG~G~~g~Vy~g~~~~~~~~~vavK~-~~~~~~-------~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~lV~ 578 (792)
..|-+|+-+.|+++.+. ++...||. +.+..+ -..++..+|++.+.+++--.|....-++.+...-.|+|
T Consensus 13 ~likQGAEArv~~~~~~---Ge~~iIK~Rf~K~YRHP~LD~kLtr~Rt~~Ear~l~k~~~~GI~~P~l~~~D~~~~~i~M 89 (229)
T KOG3087|consen 13 ELIKQGAEARVPRGSFS---GEAAIIKERFSKRYRHPALDQKLTRKRTKQEARLLAKCRALGIPAPRLIFIDTYGGQIYM 89 (229)
T ss_pred eeeeccceeeEeeeccC---CceeEEeecccccccchHHHHHHHHHHHHHHHHHHHHHHHhCCCCceEEEEecCCCeEEE
Confidence 46889999999999764 45666664 333222 12456789999999998778877777788888889999
Q ss_pred EeccC-CCccccccCC-CCCchh-HHHHHHHHHHHHHHHHhhccCCCeEecCCCCCcEEEcCCC---CeEEeecCCCccc
Q 003836 579 EFMSN-GTVASFLFGD-SKPNWK-LRTEIAMGIAGGLFYLHEECCTQIIHCDIKPQNILLDDHY---NARISDFGLAKLL 652 (792)
Q Consensus 579 E~~~~-gsL~~~l~~~-~~l~~~-~~~~i~~~ia~gL~yLH~~~~~~ivH~dikp~NILl~~~~---~~kl~Dfg~a~~~ 652 (792)
||+++ .++.+++... ...... ....++.+|-+.+.-||.. +|+|+||..+||+|..++ .+.++|||++...
T Consensus 90 E~~~g~~~vk~~i~~~~~~~~~d~~~~~~~~~iG~~igklH~n---diiHGDLTTSNill~~~~~~~~~~lIdfgls~~s 166 (229)
T KOG3087|consen 90 EFIDGASTVKDFILSTMEDESEDEGLAELARRIGELIGKLHDN---DIIHGDLTTSNILLRSDGNQITPILIDFGLSSVS 166 (229)
T ss_pred EeccchhHHHHHHHHHccCcccchhHHHHHHHHHHHHHHhhhC---CeecccccccceEEecCCCcCceEEEeecchhcc
Confidence 99987 4677777543 222223 3378889999999999999 999999999999997654 3589999998653
|
|
| >cd00129 PAN_APPLE PAN/APPLE-like domain; present in N-terminal (N) domains of plasminogen/ hepatocyte growth factor proteins, plasma prekallikrein/coagulation factor XI and microneme antigen proteins, plant receptor-like protein kinases, and various nematode and leech anti-platelet proteins | Back alignment and domain information |
|---|
Probab=98.74 E-value=1e-08 Score=84.37 Aligned_cols=63 Identities=17% Similarity=0.157 Sum_probs=51.2
Q ss_pred eEeccCCCCCCCcccccCcCChhhHhhhccC---CCccccceec--cCceeecccCC-ccCccCCCCCCcEEEe
Q 003836 359 IEELRNTDWPTSDYEQISPYGKDECVSSCLK---DCQCSAAVLR--DDTCWKKKLPL-SYGKTDRDETGTTFIK 426 (792)
Q Consensus 359 ~~~~~~~~~p~~~~~~~~~~s~~~C~~~Cl~---nCsC~A~~~~--~~~C~~~~~~~-~~~~~~~~~~~~~~lk 426 (792)
|+++.++++|+... +++++|++.|++ ||||+||+|. ..+|+.|..++ .+.+...+.+.++|+|
T Consensus 11 fl~~~~~klpd~~~-----~s~~eC~~~Cl~~~~nCsC~Aya~~~~~~gC~~W~~~l~~d~~~~~~~g~~Ly~r 79 (80)
T cd00129 11 TLIKIALKIKTTKA-----NTADECANRCEKNGLPFSCKAFVFAKARKQCLWFPFNSMSGVRKEFSHGFDLYEN 79 (80)
T ss_pred EEEeecccCCcccc-----cCHHHHHHHHhcCCCCCCceeeeccCCCCCeEEecCcchhhHHhccCCCceeEeE
Confidence 77888899998654 689999999999 9999999995 35799998888 6655555556778875
|
Common structural features include two disulfide bonds that link the alpha-helix to the central region of the protein. PAN domains have significant functional versatility, fulfilling diverse biological functions by mediating protein-protein or protein-carbohydrate interactions. |
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=98.68 E-value=7.3e-09 Score=119.42 Aligned_cols=192 Identities=20% Similarity=0.213 Sum_probs=137.8
Q ss_pred CCCCcccccceeccCCceEEEEEeccCCCccccccCCCCCchhHHHHHHHHHHHHHHHHhhccCCCeEecCCCCCcEEEc
Q 003836 557 HHKNLVRLLGYCDEGQNRLLVYEFMSNGTVASFLFGDSKPNWKLRTEIAMGIAGGLFYLHEECCTQIIHCDIKPQNILLD 636 (792)
Q Consensus 557 ~h~niv~l~g~~~~~~~~~lV~E~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dikp~NILl~ 636 (792)
+||-++...--+......+||++|..+++|..-|+.....+.......+..+.+++.|||.. .+.|+|++|.|+|+.
T Consensus 862 ~~P~v~~~~~s~~~rsP~~L~~~~~~~~~~~Skl~~~~~~saepaRs~i~~~vqs~e~L~s~---~r~h~~~~p~~~l~~ 938 (1205)
T KOG0606|consen 862 RSPAVVRSFPSFPCRSPLPLVGHYLNGGDLPSKLHNSGCLSAEPARSPILERVQSLESLHSS---LRKHRDLKPDSLLIA 938 (1205)
T ss_pred CCCceecccCCCCCCCCcchhhHHhccCCchhhhhcCCCcccccccchhHHHHhhhhccccc---hhhcccccccchhhc
Confidence 44555554444556678899999999999999998776555555555666688899999997 699999999999999
Q ss_pred CCCCeEEeecCCCccccC---------------------CC---------CCccccccccCCcccccccccCCCCcccce
Q 003836 637 DHYNARISDFGLAKLLTL---------------------DQ---------SHTNTAIRGTKGYVAPEWFRNMPITVKVDV 686 (792)
Q Consensus 637 ~~~~~kl~Dfg~a~~~~~---------------------~~---------~~~~~~~~gt~~y~aPE~~~~~~~~~k~DV 686 (792)
.++..++.||+....... .. ........+|+.|.+||...+......+|.
T Consensus 939 ~~gh~~l~~~~t~~~vg~~~p~~~~sg~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~t~~~laPe~~lg~~hgs~ad~ 1018 (1205)
T KOG0606|consen 939 YDGHRPLTDFGTLSKVGLIPPTTDLSGPSSSGTPRRLSRSERRPQLSADEARRKHAVVGTPDYLAPEILLGRRHGSAADW 1018 (1205)
T ss_pred ccCCcccCccccccccccccCcCCcccccccCccccccccccccccccchhhccccccCCCcccCCcccccccCCCcchh
Confidence 999999999983322110 00 011223468999999999999999999999
Q ss_pred ehHHHHHHHHHhcCcCCCcchhhhhhhhHHHHHHHhhcccchhHhhhchhcc-cCCHHHHHHHHHHHHHccccCCCCCCC
Q 003836 687 YSYGVLLLEIICLRRNIDNEISKVDKAILTDWAYDRYQERTLEALVENDLEA-MNNVTMLHRFVMVAFWCIQEDPSHRPT 765 (792)
Q Consensus 687 ~S~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~l~~l~~~Cl~~~p~~RPs 765 (792)
|+.|++++|.++|..||......... +.+....... .-+.+...+..+++...+..+|.+|-.
T Consensus 1019 ~~~g~~l~e~l~g~pp~na~tpq~~f----------------~ni~~~~~~~p~g~~~~s~~aq~~~~~ll~~~~~qr~~ 1082 (1205)
T KOG0606|consen 1019 WSSGVCLFEVLTGIPPFNAETPQQIF----------------ENILNRDIPWPEGPEEGSYEAQDLINRLLTEEPTQRLG 1082 (1205)
T ss_pred hhhhhhhhhhhcCCCCCCCcchhhhh----------------hccccCCCCCCCCccccChhhhhhhhhhhccCchhccC
Confidence 99999999999999999765432111 0111111111 112334455666777788899999987
Q ss_pred HH
Q 003836 766 MR 767 (792)
Q Consensus 766 ~~ 767 (792)
+.
T Consensus 1083 a~ 1084 (1205)
T KOG0606|consen 1083 AK 1084 (1205)
T ss_pred cc
Confidence 76
|
|
| >PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional | Back alignment and domain information |
|---|
Probab=98.68 E-value=9.9e-08 Score=98.89 Aligned_cols=130 Identities=12% Similarity=0.114 Sum_probs=95.4
Q ss_pred eEEEeeecCCCceEEEEEEccccccc-----------chHHHHHHHHHhcccCCCCc--ccccceecc-----CCceEEE
Q 003836 516 TVYKGFVNMGSSNHVAVKKLNSVFQD-----------SEKEFKAEVNGIGQTHHKNL--VRLLGYCDE-----GQNRLLV 577 (792)
Q Consensus 516 ~Vy~g~~~~~~~~~vavK~~~~~~~~-----------~~~~~~~Ei~~l~~l~h~ni--v~l~g~~~~-----~~~~~lV 577 (792)
.|.+..+. ++.+.||+....... ....+.+|.+.+.++...+| ++++++... ...-+||
T Consensus 37 rvvr~~~~---g~~~~vKr~~~~~~~~~~k~l~~~~~p~~~a~rE~~~l~~L~~~GIptP~pVa~~e~~~~~~~~~s~LV 113 (268)
T PRK15123 37 RTLRFELA---GKSYFLKWHRGTGWGEIFKNLLSLRMPVLGADREWRAIHRLHEVGVDTMTGVAFGERGSNPATRTSFII 113 (268)
T ss_pred eEEEEEEC---CEEEEEEEecCCcHHHHhhhhcccccccHHHHHHHHHHHHHHHcCCCCCCeeEEEEecCCCccceeEEE
Confidence 35565443 457999976432211 11247899999999865554 444556543 2346899
Q ss_pred EEeccCC-CccccccC--CCCCchhHHHHHHHHHHHHHHHHhhccCCCeEecCCCCCcEEEcC-------CCCeEEeecC
Q 003836 578 YEFMSNG-TVASFLFG--DSKPNWKLRTEIAMGIAGGLFYLHEECCTQIIHCDIKPQNILLDD-------HYNARISDFG 647 (792)
Q Consensus 578 ~E~~~~g-sL~~~l~~--~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dikp~NILl~~-------~~~~kl~Dfg 647 (792)
+|++++- +|.+++.. ....+...+..++.+++..+.-||+. +|+|+|++++|||++. +..+.|+||+
T Consensus 114 te~l~~~~sL~~~~~~~~~~~~~~~~~~~ll~~la~~i~~LH~~---Gi~HgDL~~~NiLl~~~~~~~~~~~~~~LIDl~ 190 (268)
T PRK15123 114 TEDLAPTISLEDYCADWATNPPDPRLKRMLIKRVATMVRDMHAA---GINHRDCYICHFLLHLPFPGREEDLKLSVIDLH 190 (268)
T ss_pred EeeCCCCccHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHHC---cCccCCCChhhEEEeccccCCCCCceEEEEECC
Confidence 9999986 78888753 23455667789999999999999999 9999999999999985 4679999999
Q ss_pred CCcc
Q 003836 648 LAKL 651 (792)
Q Consensus 648 ~a~~ 651 (792)
.++.
T Consensus 191 r~~~ 194 (268)
T PRK15123 191 RAQI 194 (268)
T ss_pred cccc
Confidence 8863
|
|
| >PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.65 E-value=1.8e-07 Score=91.37 Aligned_cols=126 Identities=21% Similarity=0.240 Sum_probs=81.7
Q ss_pred eEEEeeecCCCceEEEEEEccccc--------------c------------cchHHHHHHHHHhcccCCC--Ccccccce
Q 003836 516 TVYKGFVNMGSSNHVAVKKLNSVF--------------Q------------DSEKEFKAEVNGIGQTHHK--NLVRLLGY 567 (792)
Q Consensus 516 ~Vy~g~~~~~~~~~vavK~~~~~~--------------~------------~~~~~~~~Ei~~l~~l~h~--niv~l~g~ 567 (792)
.||.|... ++..+|||+.+... + ......++|.+.|.++... ++.+++.+
T Consensus 1 ~Vy~~~~~--~~~~~a~K~~r~~~~~Fk~~~~y~~~~~r~~~~~~~~~~~~~~~~~~~~E~~~L~~l~~~Gv~vP~p~~~ 78 (188)
T PF01163_consen 1 DVYHAIDP--DGEEVAVKIYRTGRTSFKRRKKYRDYDYRFKKYRHKSSWRYLIREWAKKEFRNLKRLYEAGVPVPKPYDY 78 (188)
T ss_dssp EEEEEEEC--TTEEEEEEEE-S---SS-HHHHHTTTSTTSTTC--G--CHHHHHHHHHHHHHHHHHCCCTT-SS--EEEE
T ss_pred CEEEEECC--CCCEEEEEEeccCceEEEEeeeeecccchhcccccccCHHHHHHHHHHHHHHHHHHHHHCCccCCcEEEE
Confidence 37888643 45689999764310 0 0123467899999999765 45666655
Q ss_pred eccCCceEEEEEecc--CCCccccccCCCCCchhHHHHHHHHHHHHHHHH-hhccCCCeEecCCCCCcEEEcCCCCeEEe
Q 003836 568 CDEGQNRLLVYEFMS--NGTVASFLFGDSKPNWKLRTEIAMGIAGGLFYL-HEECCTQIIHCDIKPQNILLDDHYNARIS 644 (792)
Q Consensus 568 ~~~~~~~~lV~E~~~--~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yL-H~~~~~~ivH~dikp~NILl~~~~~~kl~ 644 (792)
- ...|||||++ +..+..+... .++......++.+++..+..+ |.. +|+|+||.+.|||++++ .+.|+
T Consensus 79 ~----~~~ivME~I~~~G~~~~~l~~~--~~~~~~~~~~~~~il~~~~~~~~~~---givHGDLs~~NIlv~~~-~~~iI 148 (188)
T PF01163_consen 79 N----RNVIVMEYIGEDGVPLPRLKDV--DLSPEEPKELLEEILEEIIKMLHKA---GIVHGDLSEYNILVDDG-KVYII 148 (188)
T ss_dssp E----TTEEEEE--EETTEEGGCHHHC--GGGGSTHHHHHHHHHHHHHHHHHCT---TEEESS-STTSEEEETT-CEEE-
T ss_pred e----CCEEEEEecCCCccchhhHHhc--cccchhHHHHHHHHHHHHHHHHHhc---CceecCCChhhEEeecc-eEEEE
Confidence 3 4479999999 5555443321 122456677888888866664 566 99999999999999988 99999
Q ss_pred ecCCCcccc
Q 003836 645 DFGLAKLLT 653 (792)
Q Consensus 645 Dfg~a~~~~ 653 (792)
|||.+....
T Consensus 149 Df~qav~~~ 157 (188)
T PF01163_consen 149 DFGQAVDSS 157 (188)
T ss_dssp -GTTEEETT
T ss_pred ecCcceecC
Confidence 999887543
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A. |
| >smart00108 B_lectin Bulb-type mannose-specific lectin | Back alignment and domain information |
|---|
Probab=98.61 E-value=1.1e-07 Score=85.35 Aligned_cols=76 Identities=22% Similarity=0.458 Sum_probs=59.4
Q ss_pred EEEEeCccEEEEcCC-CCEEEEeccCCC--cceeEEEecCCcEEEEecCCccccccccCCcccccCCCccccceEEeeec
Q 003836 91 LRLTANRGLVLEDPE-GREIWKSEISTG--QAAFGVLYDTGNFLIVNTNSERLWQSFDHPTDTLLPTQTMERGGVVSSRR 167 (792)
Q Consensus 91 l~~~~~G~Lvl~~~~-~~~vWst~~~~~--~~~~a~LldsGNlVl~~~~~~~lWQSFd~PtDtlLpg~~l~~~~~L~S~~ 167 (792)
+.+..||+||+.+.. +.+||++++... ....+.|.++|||||++.++.++|+| +|- +
T Consensus 24 ~~~q~dgnlV~~~~~~~~~vW~snt~~~~~~~~~l~l~~dGnLvl~~~~g~~vW~S-----~t~-~-------------- 83 (114)
T smart00108 24 LIMQNDYNLILYKSSSRTVVWVANRDNPVSDSCTLTLQSDGNLVLYDGDGRVVWSS-----NTT-G-------------- 83 (114)
T ss_pred cCCCCCEEEEEEECCCCcEEEECCCCCCCCCCEEEEEeCCCCEEEEeCCCCEEEEe-----ccc-C--------------
Confidence 345578999999765 589999998533 23678999999999999989999998 111 1
Q ss_pred cCCCCCCCceeEeecCCCceeeee
Q 003836 168 KDTYFSRGRFQFRLLEDGNAVLNT 191 (792)
Q Consensus 168 s~~~~s~G~~~~~~~~~g~~~~~~ 191 (792)
..|.+.+.++++|+++++-
T Consensus 84 -----~~~~~~~~L~ddGnlvl~~ 102 (114)
T smart00108 84 -----ANGNYVLVLLDDGNLVIYD 102 (114)
T ss_pred -----CCCceEEEEeCCCCEEEEC
Confidence 3567889999999998853
|
|
| >cd00028 B_lectin Bulb-type mannose-specific lectin | Back alignment and domain information |
|---|
Probab=98.58 E-value=1.4e-07 Score=85.00 Aligned_cols=75 Identities=24% Similarity=0.433 Sum_probs=58.9
Q ss_pred EEEe-CccEEEEcCC-CCEEEEeccCC--CcceeEEEecCCcEEEEecCCccccccccCCcccccCCCccccceEEeeec
Q 003836 92 RLTA-NRGLVLEDPE-GREIWKSEIST--GQAAFGVLYDTGNFLIVNTNSERLWQSFDHPTDTLLPTQTMERGGVVSSRR 167 (792)
Q Consensus 92 ~~~~-~G~Lvl~~~~-~~~vWst~~~~--~~~~~a~LldsGNlVl~~~~~~~lWQSFd~PtDtlLpg~~l~~~~~L~S~~ 167 (792)
.+.. ||+||+++.. +++||++|+.. .....+.|.++|||||.|.++.++|||=-.
T Consensus 25 ~~q~~dgnlv~~~~~~~~~vW~snt~~~~~~~~~l~l~~dGnLvl~~~~g~~vW~S~~~--------------------- 83 (116)
T cd00028 25 IMQSRDYNLILYKGSSRTVVWVANRDNPSGSSCTLTLQSDGNLVIYDGSGTVVWSSNTT--------------------- 83 (116)
T ss_pred CCCCCeEEEEEEeCCCCeEEEECCCCCCCCCCEEEEEecCCCeEEEcCCCcEEEEeccc---------------------
Confidence 3444 8999998754 58999999864 345678999999999999999999987211
Q ss_pred cCCCCCCCceeEeecCCCceeeee
Q 003836 168 KDTYFSRGRFQFRLLEDGNAVLNT 191 (792)
Q Consensus 168 s~~~~s~G~~~~~~~~~g~~~~~~ 191 (792)
...+.+.+.+++||+++++.
T Consensus 84 ----~~~~~~~~~L~ddGnlvl~~ 103 (116)
T cd00028 84 ----RVNGNYVLVLLDDGNLVLYD 103 (116)
T ss_pred ----CCCCceEEEEeCCCCEEEEC
Confidence 02577899999999999864
|
The domain contains a three-fold internal repeat (beta-prism architecture). The consensus sequence motif QXDXNXVXY is involved in alpha-D-mannose recognition. Lectins are carbohydrate-binding proteins which specifically recognize diverse carbohydrates and mediate a wide variety of biological processes, such as cell-cell and host-pathogen interactions, serum glycoprotein turnover, and innate immune responses. |
| >PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.50 E-value=5e-07 Score=90.52 Aligned_cols=108 Identities=19% Similarity=0.237 Sum_probs=87.8
Q ss_pred chHHHHHHHHHhcccCCCC--cccccceeccCC----ceEEEEEeccC-CCccccccCCCCCchhHHHHHHHHHHHHHHH
Q 003836 542 SEKEFKAEVNGIGQTHHKN--LVRLLGYCDEGQ----NRLLVYEFMSN-GTVASFLFGDSKPNWKLRTEIAMGIAGGLFY 614 (792)
Q Consensus 542 ~~~~~~~Ei~~l~~l~h~n--iv~l~g~~~~~~----~~~lV~E~~~~-gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~y 614 (792)
......+|...+.+++... .++.+++..... ..+||+|++++ .+|.+++......+......++.++++.++-
T Consensus 54 ~~~ra~~E~~~~~~L~~~Gi~tP~pva~~~~r~~~~~~s~lite~l~~~~~L~~~~~~~~~~~~~~~~~ll~~l~~~i~~ 133 (206)
T PF06293_consen 54 RRSRAKREWRNLQRLREAGIPTPEPVAYGERRKGGGYRSYLITEALPGAQDLRDLLQQWEQLDPSQRRELLRALARLIAK 133 (206)
T ss_pred cchHHHHHHHHHHHHHHcCCCCCcEEEEEEEcCCCceeEEEEEEeCCCcccHHHHHHhhcccchhhHHHHHHHHHHHHHH
Confidence 3457888999888886444 456666665432 35799999998 4799998765557777889999999999999
Q ss_pred HhhccCCCeEecCCCCCcEEEcCCC---CeEEeecCCCccc
Q 003836 615 LHEECCTQIIHCDIKPQNILLDDHY---NARISDFGLAKLL 652 (792)
Q Consensus 615 LH~~~~~~ivH~dikp~NILl~~~~---~~kl~Dfg~a~~~ 652 (792)
||+. +|+|+|+++.|||++.+. .+.++||+.++..
T Consensus 134 lH~~---gi~H~Dl~~~NILv~~~~~~~~~~lIDld~~~~~ 171 (206)
T PF06293_consen 134 LHDA---GIYHGDLNPSNILVDPDDGQYRFYLIDLDRMRFR 171 (206)
T ss_pred HHHC---cCCCCCCCcccEEEeCCCCceeEEEEcchhceeC
Confidence 9999 999999999999999887 8999999988753
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane |
| >KOG2137 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.46 E-value=5.7e-08 Score=108.19 Aligned_cols=150 Identities=18% Similarity=0.255 Sum_probs=102.6
Q ss_pred HHHHHHHHHHhhccCCCeEecCCCCCcEEEcCCCCeEEeecCCCccccCCCCCc--------cccccccCCccccccccc
Q 003836 606 MGIAGGLFYLHEECCTQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLDQSHT--------NTAIRGTKGYVAPEWFRN 677 (792)
Q Consensus 606 ~~ia~gL~yLH~~~~~~ivH~dikp~NILl~~~~~~kl~Dfg~a~~~~~~~~~~--------~~~~~gt~~y~aPE~~~~ 677 (792)
.+++.||.|+|.. .++||++|.|++|.++.++..||+.|+.+.......... ..-......|.|||++.+
T Consensus 106 ~~v~dgl~flh~s--Ak~VH~ni~p~~i~~na~~~wkl~Gf~f~v~~~~~~~~p~~~yd~~lp~~~~~~~~f~apE~~~~ 183 (700)
T KOG2137|consen 106 GNVADGLAFLHRS--AKVVHGNIQPEAIVVNANGDWKLAGFSFCVNANGPTEYPFSEYDPPLPLLLQPHLNFLAPEYLLG 183 (700)
T ss_pred hcccchhhhhccC--cceeecccchhheeeccCcceeeccchhhhccCCCCccccccCCCCCChhhccCcccccchhhcc
Confidence 4456999999987 689999999999999999999999999876554321111 011234567999999999
Q ss_pred CCCCcccceehHHHHHHHHHhcCcCC-CcchhhhhhhhHHHHHHHhhcccchhHhhhchhcccCCHHHHHHHHHHHHHcc
Q 003836 678 MPITVKVDVYSYGVLLLEIICLRRNI-DNEISKVDKAILTDWAYDRYQERTLEALVENDLEAMNNVTMLHRFVMVAFWCI 756 (792)
Q Consensus 678 ~~~~~k~DV~S~Gv~l~el~tg~~p~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl 756 (792)
...+.++|+||+||+++.+..|+.+. ......... . .....+..-...+..+.+.++.+=+.+.+
T Consensus 184 ~~~~~~sd~fSlG~li~~i~~~gk~i~~a~~~~~~~------~--------~~~~~~~~~~~~~s~~~p~el~~~l~k~l 249 (700)
T KOG2137|consen 184 TTNTPASDVFSLGVLIYTIYNGGKSIIAANGGLLSY------S--------FSRNLLNAGAFGYSNNLPSELRESLKKLL 249 (700)
T ss_pred ccccccccceeeeeEEEEEecCCcchhhccCCcchh------h--------hhhcccccccccccccCcHHHHHHHHHHh
Confidence 88999999999999999999555443 222111000 0 00001111111122345566777777889
Q ss_pred ccCCCCCCCHHhHHH
Q 003836 757 QEDPSHRPTMRKVTQ 771 (792)
Q Consensus 757 ~~~p~~RPs~~evl~ 771 (792)
..++..||++.++..
T Consensus 250 ~~~~~~rp~~~~l~~ 264 (700)
T KOG2137|consen 250 NGDSAVRPTLDLLLS 264 (700)
T ss_pred cCCcccCcchhhhhc
Confidence 999999998877654
|
|
| >COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.44 E-value=1.7e-06 Score=86.72 Aligned_cols=135 Identities=17% Similarity=0.160 Sum_probs=96.1
Q ss_pred hhhhhhcCccccceEEEeeecCCCceEEEEEEccccc----------------------ccchHHHHHHHHHhcccCCC-
Q 003836 503 RGFKEELGRGAFGTVYKGFVNMGSSNHVAVKKLNSVF----------------------QDSEKEFKAEVNGIGQTHHK- 559 (792)
Q Consensus 503 ~~~~~~lG~G~~g~Vy~g~~~~~~~~~vavK~~~~~~----------------------~~~~~~~~~Ei~~l~~l~h~- 559 (792)
+.+.++||.|.-|.||.|..+ .+.++|||.=+... .......++|.++|.+|.-.
T Consensus 93 e~iG~~IGvGKEsdVY~~~~~--~g~~~~vKfHR~GrtsFrkvk~~R~y~~~~~h~sWl~~sRl~A~rEf~~L~~L~~~G 170 (304)
T COG0478 93 EAIGTKIGVGKESDVYVAIDP--KGRKVAVKFHRLGRTSFRKVKRNRDYLADKEHGSWLYVSRLAAEREFEALQRLYPEG 170 (304)
T ss_pred HhhccccccCccceEEEEECC--CCCEEEEEEeecCchhhhhhcchhhhhccccCcchhhhHHHHHHHHHHHHHHhhhcC
Confidence 445678999999999999765 45689998432110 01123567899999998755
Q ss_pred -CcccccceeccCCceEEEEEeccCCCccccccCCCCCchhHHHHHHHHHHHHHHHHhhccCCCeEecCCCCCcEEEcCC
Q 003836 560 -NLVRLLGYCDEGQNRLLVYEFMSNGTVASFLFGDSKPNWKLRTEIAMGIAGGLFYLHEECCTQIIHCDIKPQNILLDDH 638 (792)
Q Consensus 560 -niv~l~g~~~~~~~~~lV~E~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dikp~NILl~~~ 638 (792)
.+.+.+++ +...+||||+++-.|...- ++......|+..|+.-+.-+-.. ||||+|+++=||+++++
T Consensus 171 ~~VP~P~~~----nRHaVvMe~ieG~eL~~~r-----~~~en~~~il~~il~~~~~~~~~---GiVHGDlSefNIlV~~d 238 (304)
T COG0478 171 VKVPKPIAW----NRHAVVMEYIEGVELYRLR-----LDVENPDEILDKILEEVRKAYRR---GIVHGDLSEFNILVTED 238 (304)
T ss_pred CCCCCcccc----ccceeeeehcccceeeccc-----CcccCHHHHHHHHHHHHHHHHHc---CccccCCchheEEEecC
Confidence 67777665 4557999999986665543 13334444555555555544455 99999999999999999
Q ss_pred CCeEEeecCCCcc
Q 003836 639 YNARISDFGLAKL 651 (792)
Q Consensus 639 ~~~kl~Dfg~a~~ 651 (792)
|.+.++||--+..
T Consensus 239 g~~~vIDwPQ~v~ 251 (304)
T COG0478 239 GDIVVIDWPQAVP 251 (304)
T ss_pred CCEEEEeCccccc
Confidence 9999999977654
|
|
| >COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.42 E-value=5.6e-06 Score=87.04 Aligned_cols=189 Identities=15% Similarity=0.191 Sum_probs=127.2
Q ss_pred hhhcCccccceEEEeeecCCCceEEEEEEcccccccchHHHHHHHHHhccc-CCCCcccccce------eccCC-ceEEE
Q 003836 506 KEELGRGAFGTVYKGFVNMGSSNHVAVKKLNSVFQDSEKEFKAEVNGIGQT-HHKNLVRLLGY------CDEGQ-NRLLV 577 (792)
Q Consensus 506 ~~~lG~G~~g~Vy~g~~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l-~h~niv~l~g~------~~~~~-~~~lV 577 (792)
...||+|+-+.+|-. +.-...+.|+..........+...|+ ... .||-+-.-+.+ --+.. ..-++
T Consensus 16 gr~LgqGgea~ly~l----~e~~d~VAKIYh~Pppa~~aqk~a~l---a~~p~~p~~~~rvaWPqa~L~G~~~~~~iGfl 88 (637)
T COG4248 16 GRPLGQGGEADLYTL----GEVRDQVAKIYHAPPPAAQAQKVAEL---AATPDAPLLNYRVAWPQATLHGGRRGKVIGFL 88 (637)
T ss_pred CccccCCccceeeec----chhhchhheeecCCCchHHHHHHHHh---ccCCCCcchhhhhcccHHHhhCCCccceeEEe
Confidence 356999999999953 12233556777765555444444443 333 45543331111 11222 25577
Q ss_pred EEeccCC-CccccccCC------CCCchhHHHHHHHHHHHHHHHHhhccCCCeEecCCCCCcEEEcCCCCeEEeecCCCc
Q 003836 578 YEFMSNG-TVASFLFGD------SKPNWKLRTEIAMGIAGGLFYLHEECCTQIIHCDIKPQNILLDDHYNARISDFGLAK 650 (792)
Q Consensus 578 ~E~~~~g-sL~~~l~~~------~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dikp~NILl~~~~~~kl~Dfg~a~ 650 (792)
|..+++. .+..++.-. ...+|...++.++.+|.+.+-||.. |.+-+|++++|+|+.+++.+.|.|=..-.
T Consensus 89 mP~v~g~~pI~~~y~p~tRRqs~P~~~w~fllrvaRnlA~aFA~lH~~---Gh~vGDVn~~~~lVsd~~~V~LVdsDsfq 165 (637)
T COG4248 89 MPKVSGKEPIHMIYSPATRRQSYPHCAWDFLLRVARNLASAFATLHEH---GHVVGDVNQNSFLVSDDSKVVLVDSDSFQ 165 (637)
T ss_pred cccCCCccchhhhcCchhhcccCCccccHHHHHHHHHHHHHHHHHHhc---CCcccccCccceeeecCceEEEEccccee
Confidence 7777653 233333211 2468999999999999999999999 99999999999999999999999854433
Q ss_pred cccCCCCCccccccccCCcccccccc-----cCCCCcccceehHHHHHHHHHhc-CcCCCcc
Q 003836 651 LLTLDQSHTNTAIRGTKGYVAPEWFR-----NMPITVKVDVYSYGVLLLEIICL-RRNIDNE 706 (792)
Q Consensus 651 ~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~k~DV~S~Gv~l~el~tg-~~p~~~~ 706 (792)
.. .......-.+|...|.+||.-. +..-+...|-|.|||++++++.| +.||...
T Consensus 166 i~--~ng~~~~cpVg~~eftPPElQ~~~sf~g~~r~~~hD~FGLavLiF~lL~ggrHPysGI 225 (637)
T COG4248 166 IN--ANGTLHLCPVGVSEFTPPELQTLPSFVGFERTANHDNFGLAVLIFHLLFGGRHPYSGI 225 (637)
T ss_pred ec--cCCceEecccCccccCCHHHhccccccccCCCccccchhHHHHHHHHHhcCCCCCCcc
Confidence 22 1122222346888999999754 44567889999999999999987 7788653
|
|
| >PRK09902 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=98.41 E-value=1.6e-06 Score=85.02 Aligned_cols=136 Identities=16% Similarity=0.128 Sum_probs=103.8
Q ss_pred cCccccceEEEeeecCCCceEEEEEEccccc------ccchHHHHHHHHHhcccCCCC--cccccceec-cC----CceE
Q 003836 509 LGRGAFGTVYKGFVNMGSSNHVAVKKLNSVF------QDSEKEFKAEVNGIGQTHHKN--LVRLLGYCD-EG----QNRL 575 (792)
Q Consensus 509 lG~G~~g~Vy~g~~~~~~~~~vavK~~~~~~------~~~~~~~~~Ei~~l~~l~h~n--iv~l~g~~~-~~----~~~~ 575 (792)
-|+||-+.|++-.++ ++.+-+|+-.... +..+..|.+|...|.++...+ +.+++ ++. .. -.-+
T Consensus 26 ~~rgG~SgV~r~~~~---g~~~ylKrq~nhl~~s~r~P~g~ptf~rE~~~L~~L~~~GvPVP~pv-f~~~~k~~~~~rA~ 101 (216)
T PRK09902 26 YRRNGMSGVQCVERN---GKKLYVKRMTHHLFHSVRYPFGRPTIVREVAVIKELERAGVIVPKIV-FGEAVKIEGEWRAL 101 (216)
T ss_pred cCCCCcceEEEEEeC---CcEEEEEeccCcccccccCCCCchHHHHHHHHHHHHHHcCCCCCccc-eeeeeccCCceEEE
Confidence 477999999987554 2368888875321 346788999999999996444 44444 332 11 2357
Q ss_pred EEEEeccC-CCccccccCC--CCCchhHHHHHHHHHHHHHHHHhhccCCCeEecCCCCCcEEEcCCCC--eEEeecCCCc
Q 003836 576 LVYEFMSN-GTVASFLFGD--SKPNWKLRTEIAMGIAGGLFYLHEECCTQIIHCDIKPQNILLDDHYN--ARISDFGLAK 650 (792)
Q Consensus 576 lV~E~~~~-gsL~~~l~~~--~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dikp~NILl~~~~~--~kl~Dfg~a~ 650 (792)
||+|-+++ -+|.+++... ...+...+..+..+|++.++-||+. ++.|+|+.+.|||++.++. ++++||.-++
T Consensus 102 LVTe~L~g~~~L~~~l~~~~~~~~~~~~k~~il~~va~~ia~LH~~---Gv~Hgdly~khIll~~~g~~~v~lIDlEk~r 178 (216)
T PRK09902 102 LVTEDMAGFISIADWYAQHAVSPYSDEVRQAMLKAVALAFKKMHSV---NRQHGCCYVRHIYVKTEGKAEAGFLDLEKSR 178 (216)
T ss_pred EEEEeCCCCccHHHHHhcCCcCCcchHHHHHHHHHHHHHHHHHHHC---CCcCCCCCHhheeecCCCCeeEEEEEhhccc
Confidence 99997764 5788888654 4567888899999999999999999 9999999999999986667 9999998776
Q ss_pred c
Q 003836 651 L 651 (792)
Q Consensus 651 ~ 651 (792)
.
T Consensus 179 ~ 179 (216)
T PRK09902 179 R 179 (216)
T ss_pred h
Confidence 4
|
|
| >COG0661 AarF Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.35 E-value=1.7e-06 Score=97.02 Aligned_cols=140 Identities=19% Similarity=0.255 Sum_probs=89.4
Q ss_pred hhcCccccceEEEeeecCCCceEEEEEEcccccccc----------------------------------------hHHH
Q 003836 507 EELGRGAFGTVYKGFVNMGSSNHVAVKKLNSVFQDS----------------------------------------EKEF 546 (792)
Q Consensus 507 ~~lG~G~~g~Vy~g~~~~~~~~~vavK~~~~~~~~~----------------------------------------~~~~ 546 (792)
+.|+.++-|.||+|+++. ++.||||+.+..-... +-++
T Consensus 131 ~PiAsASIaQVH~A~L~s--G~~VAVKVqrPgi~~~i~~DL~il~~~a~~~~~~~~~~~~l~~~~vv~e~~~~l~~ElDy 208 (517)
T COG0661 131 EPIASASIAQVHRAVLKS--GEEVAVKVQRPGIRERIEADLKLLRRLARLIKRLPPGGRRLDLVEVVDEFEKRLREELDY 208 (517)
T ss_pred CchhhhhHhhheeEEecC--CCEEEEEecCCChHHHHHHHHHHHHHHHHHHHHcCCccccCChHHHHHHHHHHHHHHhCH
Confidence 358999999999999875 6789999886422111 0122
Q ss_pred HHHHHHhcccC----CCCccccccee-ccCCceEEEEEeccCCCccccccCC-CCCchhHHHHHHHHHHHHH-HHHhhcc
Q 003836 547 KAEVNGIGQTH----HKNLVRLLGYC-DEGQNRLLVYEFMSNGTVASFLFGD-SKPNWKLRTEIAMGIAGGL-FYLHEEC 619 (792)
Q Consensus 547 ~~Ei~~l~~l~----h~niv~l~g~~-~~~~~~~lV~E~~~~gsL~~~l~~~-~~l~~~~~~~i~~~ia~gL-~yLH~~~ 619 (792)
.+|...+.+++ +..-+++=.++ +-.....|+|||++|-.+.+...-+ ...+ +..|+..++++. ..+-..
T Consensus 209 ~~EA~n~~~~~~nf~~~~~v~VP~V~we~t~~~VLtmE~i~Gi~i~d~~~l~~~g~d---~k~ia~~~~~~f~~q~~~d- 284 (517)
T COG0661 209 RREAANAERFRENFKDDPDVYVPKVYWEYTTRRVLTMEWIDGIKISDIAALKSAGID---RKELAELLVRAFLRQLLRD- 284 (517)
T ss_pred HHHHHHHHHHHHHcCCCCCeEeceeehhccCCcEEEEEeeCCEecccHHHHHhcCCC---HHHHHHHHHHHHHHHHHhc-
Confidence 33444444431 11112222233 2346779999999999998885222 2333 333443333321 122223
Q ss_pred CCCeEecCCCCCcEEEcCCCCeEEeecCCCccccC
Q 003836 620 CTQIIHCDIKPQNILLDDHYNARISDFGLAKLLTL 654 (792)
Q Consensus 620 ~~~ivH~dikp~NILl~~~~~~kl~Dfg~a~~~~~ 654 (792)
+++|.|.+|.||+++.++.+.+.|||+...+..
T Consensus 285 --gffHaDpHpGNi~v~~~g~i~~lDfGi~g~l~~ 317 (517)
T COG0661 285 --GFFHADPHPGNILVRSDGRIVLLDFGIVGRLDP 317 (517)
T ss_pred --CccccCCCccceEEecCCcEEEEcCcceecCCH
Confidence 999999999999999999999999999987654
|
|
| >PF06176 WaaY: Lipopolysaccharide core biosynthesis protein (WaaY); InterPro: IPR009330 This family consists of several bacterial lipopolysaccharide core biosynthesis proteins (WaaY or RfaY) | Back alignment and domain information |
|---|
Probab=98.12 E-value=1.5e-05 Score=78.56 Aligned_cols=130 Identities=15% Similarity=0.146 Sum_probs=82.6
Q ss_pred hhcCccccceEEEeeecCCCceEEEEEEcccccccchHHH---------HHHHHHhcccCCCCcc---cccce-----ec
Q 003836 507 EELGRGAFGTVYKGFVNMGSSNHVAVKKLNSVFQDSEKEF---------KAEVNGIGQTHHKNLV---RLLGY-----CD 569 (792)
Q Consensus 507 ~~lG~G~~g~Vy~g~~~~~~~~~vavK~~~~~~~~~~~~~---------~~Ei~~l~~l~h~niv---~l~g~-----~~ 569 (792)
+++-......|.+-..+ +..+++|..+......++.| .+++..+.+++...+. .++.+ +.
T Consensus 37 kv~k~~~r~~ValIei~---~~kyIlK~pr~~~~r~er~~~sf~kg~~~~~l~~~~~~i~~~g~~~~~~~yl~~ekk~~~ 113 (229)
T PF06176_consen 37 KVFKNTKRNYVALIEID---GKKYILKEPREENRRPERRFKSFFKGSEYSRLINNTDKIRNEGFTEPADPYLAAEKKIFR 113 (229)
T ss_pred EeecCCCccEEEEEEEC---CcEEEEeccchhhhhHHHHHHHHhccHHHHHHHHHHHHHHHcCccccccceeeeeeeecc
Confidence 44555555666665433 35688887765443333332 2344444444332222 22222 22
Q ss_pred cCCceEEEEEeccCCCccccccCCCCCchhHHHHHHHHHHHHHHHHhhccCCCeEecCCCCCcEEEcCCCCeEEeecCCC
Q 003836 570 EGQNRLLVYEFMSNGTVASFLFGDSKPNWKLRTEIAMGIAGGLFYLHEECCTQIIHCDIKPQNILLDDHYNARISDFGLA 649 (792)
Q Consensus 570 ~~~~~~lV~E~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dikp~NILl~~~~~~kl~Dfg~a 649 (792)
-....+|||||++|..|.++.. ++. .++..+.+++.-||+. |+.|+|.+|+|+++++++ ++++||+..
T Consensus 114 ~~~~~~ll~EYIeG~~l~d~~~----i~e----~~~~ki~~~ikqlH~~---G~~HGD~hpgNFlv~~~~-i~iID~~~k 181 (229)
T PF06176_consen 114 YTSSYVLLMEYIEGVELNDIED----IDE----DLAEKIVEAIKQLHKH---GFYHGDPHPGNFLVSNNG-IRIIDTQGK 181 (229)
T ss_pred ceeEEEEEEEEecCeecccchh----cCH----HHHHHHHHHHHHHHHc---CCccCCCCcCcEEEECCc-EEEEECccc
Confidence 2345679999999988877642 111 3556678889999999 999999999999999665 999999877
Q ss_pred cc
Q 003836 650 KL 651 (792)
Q Consensus 650 ~~ 651 (792)
+.
T Consensus 182 ~~ 183 (229)
T PF06176_consen 182 RM 183 (229)
T ss_pred cc
Confidence 64
|
The waaY, waaQ, and waaP genes are located in the central operon of the waa (formerly rfa) locus on the chromosome of Escherichia coli. This locus contains genes whose products are involved in the assembly of the core region of the lipopolysaccharide molecule. WaaY is the enzyme that phosphorylates HepII in this system [].; GO: 0009244 lipopolysaccharide core region biosynthetic process |
| >COG1718 RIO1 Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms / Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Probab=98.09 E-value=3.8e-05 Score=76.49 Aligned_cols=136 Identities=18% Similarity=0.214 Sum_probs=90.9
Q ss_pred hcCccccceEEEeeecCCCceEEEEEEcccccccchH------------------------HHHHHHHHhcccC--CCCc
Q 003836 508 ELGRGAFGTVYKGFVNMGSSNHVAVKKLNSVFQDSEK------------------------EFKAEVNGIGQTH--HKNL 561 (792)
Q Consensus 508 ~lG~G~~g~Vy~g~~~~~~~~~vavK~~~~~~~~~~~------------------------~~~~Ei~~l~~l~--h~ni 561 (792)
.|..|.-+.||+|.- +++..+|||+.+.......+ -..+|...|.++. +-.+
T Consensus 55 ~istGKEA~Vy~a~~--~~~~~~avKiyr~~t~~fk~~~~Yi~gd~Rf~~~~~~rr~lv~~W~~kEf~NL~R~~eAGVrv 132 (268)
T COG1718 55 CISTGKEANVYLAET--GDGRYVAVKIYRTSTSEFKRIRRYIQGDPRFRNSRSNRRKLVFAWARKEFRNLKRAYEAGVRV 132 (268)
T ss_pred eecCCcceEEEeecc--CCCceEEEEEEehhhhhhhhHHHHHhcChhhhcCCCCHHHHHHHHHHHHHHHHHHHHHcCCCC
Confidence 478888999999853 45678999998643211110 1235666666653 3444
Q ss_pred ccccceeccCCceEEEEEeccCCCccc-cccCCCCCchhHHHHHHHHHHHHHHHHhhccCCCeEecCCCCCcEEEcCCCC
Q 003836 562 VRLLGYCDEGQNRLLVYEFMSNGTVAS-FLFGDSKPNWKLRTEIAMGIAGGLFYLHEECCTQIIHCDIKPQNILLDDHYN 640 (792)
Q Consensus 562 v~l~g~~~~~~~~~lV~E~~~~gsL~~-~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dikp~NILl~~~~~ 640 (792)
.+.+++. +-.|||||+....+.. .|.+ -.+.......+..++.+.+.-|-.. .++||+||+.=|||+. ++.
T Consensus 133 P~Pi~~~----~nVLvMEfIg~~g~pAP~LkD-v~~e~~e~~~~~~~~v~~~~~l~~~--a~LVHgDLSEyNiL~~-~~~ 204 (268)
T COG1718 133 PEPIAFR----NNVLVMEFIGDDGLPAPRLKD-VPLELEEAEGLYEDVVEYMRRLYKE--AGLVHGDLSEYNILVH-DGE 204 (268)
T ss_pred CCceeec----CCeEEEEeccCCCCCCCCccc-CCcCchhHHHHHHHHHHHHHHHHHh--cCcccccchhhheEEE-CCe
Confidence 5555443 3479999997642211 2211 1222335667778888888877774 3999999999999999 889
Q ss_pred eEEeecCCCcccc
Q 003836 641 ARISDFGLAKLLT 653 (792)
Q Consensus 641 ~kl~Dfg~a~~~~ 653 (792)
+.|+|++-|....
T Consensus 205 p~iID~~QaV~~~ 217 (268)
T COG1718 205 PYIIDVSQAVTID 217 (268)
T ss_pred EEEEECccccccC
Confidence 9999999987654
|
|
| >TIGR02172 Fb_sc_TIGR02172 Fibrobacter succinogenes paralogous family TIGR02172 | Back alignment and domain information |
|---|
Probab=98.08 E-value=2.8e-05 Score=78.95 Aligned_cols=133 Identities=18% Similarity=0.206 Sum_probs=86.0
Q ss_pred hhcCccccceEEEeeecCCCceEEEEEEcccccccchHHHHHHHHHhcccCCCC--cccccceeccCCceEEEEEeccCC
Q 003836 507 EELGRGAFGTVYKGFVNMGSSNHVAVKKLNSVFQDSEKEFKAEVNGIGQTHHKN--LVRLLGYCDEGQNRLLVYEFMSNG 584 (792)
Q Consensus 507 ~~lG~G~~g~Vy~g~~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h~n--iv~l~g~~~~~~~~~lV~E~~~~g 584 (792)
+.||+|..+.||+.. +..+++|...... ......+|.++++.+..-. +.+.+++....+...+|||+++|.
T Consensus 7 ~~i~~G~t~~~y~~~-----~~~~VlR~~~~~~--~~~~i~~E~~~l~~l~~~glpvP~~~~~~~~~~~~glv~e~i~G~ 79 (226)
T TIGR02172 7 TQTGEGGNGESYTHK-----TGKWMLKLYNPGF--DKETIKREFDASRKVFSLGIPTPHPFDLVEDGGRLGLIYELIVGK 79 (226)
T ss_pred eeecCCCCcceeEec-----CCCEEEEeCCCCC--CHHHHHHHHHHHHHHHHcCCCCCceEEEEecCCeeeeeeeecCCc
Confidence 468999999999841 2357788876432 3456789999999986544 467788887777788999999996
Q ss_pred C-ccccccCCCCCchhHHHHHHHHHHHH---------------------------------------HHHHhhc-cCCCe
Q 003836 585 T-VASFLFGDSKPNWKLRTEIAMGIAGG---------------------------------------LFYLHEE-CCTQI 623 (792)
Q Consensus 585 s-L~~~l~~~~~l~~~~~~~i~~~ia~g---------------------------------------L~yLH~~-~~~~i 623 (792)
+ +.+.+.. +......++.++++. ..+|... ....+
T Consensus 80 ~~~~~~~~~----~~~~~~~l~~~la~~l~~lH~~~~~~~~l~~~~~~~~~~l~~~~~~~~~~~~~l~~~l~~~~~~~~~ 155 (226)
T TIGR02172 80 RSFSRIISD----NPSRLEEIAKIFAEMAKKLHSTKCDTSTFQSYKEKIRKFIEEKDFVPKDYKEKARAFIKEVPDTSTC 155 (226)
T ss_pred cchhhhhcC----CHHHHHHHHHHHHHHHHHHhCCCCCCCcHHHHHHHHHHHHHhccCCCHHHHHHHHHHHHhCCCCCce
Confidence 3 2211110 000111111111111 1222211 12357
Q ss_pred EecCCCCCcEEEcCCCCeEEeecCCCcc
Q 003836 624 IHCDIKPQNILLDDHYNARISDFGLAKL 651 (792)
Q Consensus 624 vH~dikp~NILl~~~~~~kl~Dfg~a~~ 651 (792)
+|+|++|.||++++++ +.|+||+.+..
T Consensus 156 ~HgD~~~~Nii~~~~~-~~iIDwe~a~~ 182 (226)
T TIGR02172 156 LHGDFQIGNLITSGKG-TYWIDLGDFGY 182 (226)
T ss_pred EecCCCCCcEEEcCCC-cEEEechhcCc
Confidence 8999999999999988 99999998764
|
This model describes a paralogous family of five proteins, likely to be enzymes, in the rumen bacterium Fibrobacter succinogenes S85. Members show homology to proteins described by PFAM model pfam01636, a phosphotransferase enzyme family associated with resistance to aminoglycoside antibiotics. However, members of this family score below the current trusted and noise cutoffs for pfam01636. |
| >PF01453 B_lectin: D-mannose binding lectin; InterPro: IPR001480 A bulb lectin super-family (Amaryllidaceae, Orchidaceae and Aliaceae) contains a ~115-residue-long domain whose overall three dimensional fold is very similar to that of [, ]: Dictyostelium discoideum comitin, an actin binding protein Curculigo latifolia curculin, a sweet tasting and taste-modifying protein This domain generally binds mannose, but in at least one protein, curculin, it is apparently devoid of mannose-binding activity | Back alignment and domain information |
|---|
Probab=98.06 E-value=2.7e-05 Score=69.67 Aligned_cols=99 Identities=22% Similarity=0.364 Sum_probs=66.7
Q ss_pred ceecCCCeEEEeeeecCCCCceEEEEEeecCCCCcEEEEe-cCCCCCCCCeeEEEEeCccEEEEcCCCCEEEEeccCCCc
Q 003836 40 PWLSPSKDFALGFHQLDSKDLFLPAIWYYKIPSKTIVWYA-SAVNPAPRGSKLRLTANRGLVLEDPEGREIWKSEISTGQ 118 (792)
Q Consensus 40 ~lvS~~g~F~lGF~~~~~~~~~~~gIW~~~~~~~tvvWvA-Nr~~P~~~~~~l~~~~~G~Lvl~~~~~~~vWst~~~~~~ 118 (792)
++.+.+|.+.|-|...|+- +.|. ...+++|.+ +...+......+.|.+||||||+|.++.++|+|. ....
T Consensus 13 p~~~~s~~~~L~l~~dGnL------vl~~--~~~~~iWss~~t~~~~~~~~~~~L~~~GNlvl~d~~~~~lW~Sf-~~pt 83 (114)
T PF01453_consen 13 PLTSSSGNYTLILQSDGNL------VLYD--SNGSVIWSSNNTSGRGNSGCYLVLQDDGNLVLYDSSGNVLWQSF-DYPT 83 (114)
T ss_dssp EEEECETTEEEEEETTSEE------EEEE--TTTEEEEE--S-TTSS-SSEEEEEETTSEEEEEETTSEEEEEST-TSSS
T ss_pred ccccccccccceECCCCeE------EEEc--CCCCEEEEecccCCccccCeEEEEeCCCCEEEEeecceEEEeec-CCCc
Confidence 4555458888888876532 2233 235779999 4344433568899999999999999999999994 3345
Q ss_pred ceeEEEec--CCcEEEEecCCccccccccCCc
Q 003836 119 AAFGVLYD--TGNFLIVNTNSERLWQSFDHPT 148 (792)
Q Consensus 119 ~~~a~Lld--sGNlVl~~~~~~~lWQSFd~Pt 148 (792)
.+.+..++ .||++ ......+.|.|=+.|+
T Consensus 84 dt~L~~q~l~~~~~~-~~~~~~~sw~s~~dps 114 (114)
T PF01453_consen 84 DTLLPGQKLGDGNVT-GKNDSLTSWSSNTDPS 114 (114)
T ss_dssp -EEEEEET--TSEEE-EESTSSEEEESS----
T ss_pred cEEEeccCcccCCCc-cccceEEeECCCCCCC
Confidence 56667777 89998 7666788998876663
|
Each bulb-type lectin domain consists of three sequential beta-sheet subdomains (I, II, III) that are inter-related by pseudo three-fold symmetry. The three subdomains are flat four-stranded, antiparrallel beta-sheets. Together they form a 12-stranded beta-barrel in which the barrel axis coincides with the pseudo 3-fold axis.; GO: 0005529 sugar binding; PDB: 3M7H_A 3M7J_B 3MEZ_D 1DLP_A 1BWU_D 1KJ1_A 1B2P_A 1XD6_A 2DPF_C 2D04_B .... |
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.03 E-value=1.7e-06 Score=95.54 Aligned_cols=181 Identities=17% Similarity=0.102 Sum_probs=129.7
Q ss_pred hhhcCccccceEEEeeecCCCceEEEEEEcccccccchHHHHHHHHHhcccCCCC-cccccceeccCCceEEEEEeccCC
Q 003836 506 KEELGRGAFGTVYKGFVNMGSSNHVAVKKLNSVFQDSEKEFKAEVNGIGQTHHKN-LVRLLGYCDEGQNRLLVYEFMSNG 584 (792)
Q Consensus 506 ~~~lG~G~~g~Vy~g~~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h~n-iv~l~g~~~~~~~~~lV~E~~~~g 584 (792)
-+.+++++++.++|..-. . ++...++.+.. .....-++++|.+++||| .+..++-+..+....++++++..+
T Consensus 247 fh~fvK~altknpKkRpt-a-eklL~h~fvs~-----~l~~rl~~eLLdK~n~P~~~v~~~~d~~~E~~~~i~~~i~s~~ 319 (829)
T KOG0576|consen 247 FHNFVKGALTKNPKKRPT-A-EKLLQHPFVSQ-----TLSRRLAIELLDKVNNPNPVVRYLEDYDGEDYLWIPMRICSTG 319 (829)
T ss_pred HHHHHHHHhcCCCccCCC-h-hhheeceeecc-----chhhHHHHHHHHHccCCCCcccccccCCcccccchhhhhhcCC
Confidence 355788999999986421 1 22333444432 255667889999999999 777777788888889999999887
Q ss_pred -C-ccccccCCCCCchhHHHHHHHHHHHHHHHHhhccCCCeEecCCCCCcEEEcCCCCeEEeecCCCccccCCCCCcccc
Q 003836 585 -T-VASFLFGDSKPNWKLRTEIAMGIAGGLFYLHEECCTQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLDQSHTNTA 662 (792)
Q Consensus 585 -s-L~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dikp~NILl~~~~~~kl~Dfg~a~~~~~~~~~~~~~ 662 (792)
+ ..+.....-.+...+...+.+.-+++++|||+. .=+|+| ||+..+ ...|..||+.+..+.+.. ....
T Consensus 320 rs~~~~~~~se~~~~~~~~~~~~r~et~~l~~l~~~---~~~~~d----~~l~s~-~~~~~~~~~v~~~L~~~~--~~~t 389 (829)
T KOG0576|consen 320 RSSALEMTVSEIALEQYQFAYPLRKETRPLAELHSS---YKVHRD----NILGSE-EEVKLLDFAVPPQLTRTM--KPRT 389 (829)
T ss_pred ccccccCChhhHhhhhhhhhhhhhhhcccccccccc---cccCcc----cccccc-cccccccccCCcccCccc--cccc
Confidence 2 222211112233444455666677899999986 457888 777766 588999999988765443 3345
Q ss_pred ccccCCcccccccccCCCCcccceehHHHHHHHHHhcCcCC
Q 003836 663 IRGTKGYVAPEWFRNMPITVKVDVYSYGVLLLEIICLRRNI 703 (792)
Q Consensus 663 ~~gt~~y~aPE~~~~~~~~~k~DV~S~Gv~l~el~tg~~p~ 703 (792)
..+++.++|||......+..+.|+|++|+--.++--|-.|-
T Consensus 390 ~~~~~~~~~pev~~~~~~~~~p~~~~~~~~~~~~ap~~pPr 430 (829)
T KOG0576|consen 390 AIGTPEPLAPEVIQENTIDGCPDSGSLAVSAIQMAPGLPPR 430 (829)
T ss_pred CCCCCCCCCchhhcccccccCCCccCCCcchhhcCCCCCCC
Confidence 56899999999999999999999999998766776665553
|
|
| >PF12260 PIP49_C: Protein-kinase domain of FAM69; InterPro: IPR022049 Family with sequence similarity 69 has three members (A, B and C) | Back alignment and domain information |
|---|
Probab=97.98 E-value=2.6e-05 Score=76.56 Aligned_cols=102 Identities=22% Similarity=0.313 Sum_probs=83.4
Q ss_pred HHHHHHhcccCC-CCcccccceeccCCceEEEEEeccCCCcccc---ccCCCCCchhHHHHHHHHHHHHHHHHhhccCCC
Q 003836 547 KAEVNGIGQTHH-KNLVRLLGYCDEGQNRLLVYEFMSNGTVASF---LFGDSKPNWKLRTEIAMGIAGGLFYLHEECCTQ 622 (792)
Q Consensus 547 ~~Ei~~l~~l~h-~niv~l~g~~~~~~~~~lV~E~~~~gsL~~~---l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ 622 (792)
.+|.-+++.+++ +++++++|+|- .++|.||...+++... +..-...+|..|.+||.++++.+.+|++.....
T Consensus 7 ~~E~lll~~l~~~~~~pk~lG~CG----~~~v~E~~~~~~~~~~~~~l~~~~~~~w~~R~~iA~~lL~~l~~l~~~~~~~ 82 (188)
T PF12260_consen 7 NNEPLLLQLLQGSEPFPKLLGSCG----RFYVVEYVGAGSLYGIYRPLSQFLQSPWEQRAKIALQLLELLEELDHGPLGF 82 (188)
T ss_pred ccHHHHHHHcCCCCCCCCeeeECC----CEEEEEeecCccccccccccccccccCHHHHHHHHHHHHHHHHHHhcCCCCc
Confidence 457778888876 69999999993 4789999998766432 212234689999999999999999999975557
Q ss_pred eEecCCCCCcEEEcCCCCeEEeecCCCccc
Q 003836 623 IIHCDIKPQNILLDDHYNARISDFGLAKLL 652 (792)
Q Consensus 623 ivH~dikp~NILl~~~~~~kl~Dfg~a~~~ 652 (792)
+.-+|++++|+-+++++++|+.|...+...
T Consensus 83 ~~lcDv~~~nfgv~~~~~lk~iDld~v~~~ 112 (188)
T PF12260_consen 83 FYLCDVSPDNFGVNDDGRLKLIDLDDVFVE 112 (188)
T ss_pred EEEeecchHHeEEeCCCcEEEEechhcchh
Confidence 888999999999999999999999877543
|
Proteins in this uncharacterised family are described as transmembrane proteins. |
| >smart00473 PAN_AP divergent subfamily of APPLE domains | Back alignment and domain information |
|---|
Probab=97.97 E-value=1.4e-05 Score=66.25 Aligned_cols=57 Identities=26% Similarity=0.443 Sum_probs=44.6
Q ss_pred eeEeccCCCCCCCcccccCcCChhhHhhhccC-CCccccceec--cCceeecc-cCCccCc
Q 003836 358 YIEELRNTDWPTSDYEQISPYGKDECVSSCLK-DCQCSAAVLR--DDTCWKKK-LPLSYGK 414 (792)
Q Consensus 358 ~~~~~~~~~~p~~~~~~~~~~s~~~C~~~Cl~-nCsC~A~~~~--~~~C~~~~-~~~~~~~ 414 (792)
.|..++++.+++.........++++|++.|++ +|+|.|+.|. .+.|++|. .++.+..
T Consensus 5 ~f~~~~~~~l~~~~~~~~~~~s~~~C~~~C~~~~~~C~s~~y~~~~~~C~l~~~~~~~~~~ 65 (78)
T smart00473 5 CFVRLPNTKLPGFSRIVISVASLEECASKCLNSNCSCRSFTYNNGTKGCLLWSESSLGDAR 65 (78)
T ss_pred eeEEecCccCCCCcceeEcCCCHHHHHHHhCCCCCceEEEEEcCCCCEEEEeeCCccccce
Confidence 47888899988554433456799999999999 9999999997 57899887 5554444
|
Apple-like domains present in Plasminogen, C. elegans hypothetical ORFs and the extracellular portion of plant receptor-like protein kinases. Predicted to possess protein- and/or carbohydrate-binding functions. |
| >KOG1235 consensus Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=97.94 E-value=4.5e-05 Score=85.47 Aligned_cols=140 Identities=21% Similarity=0.260 Sum_probs=89.3
Q ss_pred hhcCccccceEEEeeecCCCceEEEEEEcccccccc-------------------------------------hHHHHHH
Q 003836 507 EELGRGAFGTVYKGFVNMGSSNHVAVKKLNSVFQDS-------------------------------------EKEFKAE 549 (792)
Q Consensus 507 ~~lG~G~~g~Vy~g~~~~~~~~~vavK~~~~~~~~~-------------------------------------~~~~~~E 549 (792)
+.||.-+.|.||+++++. ++.||||+-+..-+.. +-+|.+|
T Consensus 167 ~piaaASlaQVhrA~L~~--G~~VaVKVQ~P~l~~~~~~Dl~~~~~~~~~l~k~~p~~~~~~lvdE~~~~L~~ELDF~~E 244 (538)
T KOG1235|consen 167 EPIAAASLAQVHRARLKN--GEDVAVKVQHPGLEKLIMLDLRNLRLLAKVLQKFFPDFDLVWLVDEIAKSLPQELDFTKE 244 (538)
T ss_pred chhhhcchhheEEEEecC--CCEEEEEecCcChHHHHHHHHHHHHHHHHHHHHhCcCCchhhHHHHHHhhhHhhcchHHH
Confidence 469999999999999875 6789999876432111 1134455
Q ss_pred HHHhccc----CCCCc---cccccee-ccCCceEEEEEeccCCCccccccCC-CCCchhHHHHHHHHHHHHHHHHhhccC
Q 003836 550 VNGIGQT----HHKNL---VRLLGYC-DEGQNRLLVYEFMSNGTVASFLFGD-SKPNWKLRTEIAMGIAGGLFYLHEECC 620 (792)
Q Consensus 550 i~~l~~l----~h~ni---v~l~g~~-~~~~~~~lV~E~~~~gsL~~~l~~~-~~l~~~~~~~i~~~ia~gL~yLH~~~~ 620 (792)
.+...+. .|-++ |.+=.++ .-...+.|+||||+|..+.+.-.-. ..++.. +|+..+.++ |++.--.
T Consensus 245 A~Nae~~~~~f~~~~~~~~V~VP~Vy~~~st~RVLtME~~~G~~i~Dl~~i~~~gi~~~---~i~~~l~~~--~~~qIf~ 319 (538)
T KOG1235|consen 245 AKNAERFRENFKDFSLLTYVLVPKVYWDLSTKRVLTMEYVDGIKINDLDAIDKRGISPH---DILNKLVEA--YLEQIFK 319 (538)
T ss_pred HHhHHHHHHHHHhcccccceeCCeehhhcCcceEEEEEecCCccCCCHHHHHHcCCCHH---HHHHHHHHH--HHHHHHh
Confidence 5544443 34441 1122223 2335789999999999888764321 223333 334333333 2222222
Q ss_pred CCeEecCCCCCcEEEcC----CCCeEEeecCCCcccc
Q 003836 621 TQIIHCDIKPQNILLDD----HYNARISDFGLAKLLT 653 (792)
Q Consensus 621 ~~ivH~dikp~NILl~~----~~~~kl~Dfg~a~~~~ 653 (792)
.|++|+|=+|.||+++. ++.+.+-|||+.....
T Consensus 320 ~GffHaDPHPGNilv~~~~~~~~~ivllDhGl~~~is 356 (538)
T KOG1235|consen 320 TGFFHADPHPGNILVRPNPEGDEEIVLLDHGLYAVIS 356 (538)
T ss_pred cCCccCCCCCCcEEEecCCCCCccEEEEccccccccc
Confidence 48999999999999994 6789999999987654
|
|
| >cd05150 APH Aminoglycoside 3'-phosphotransferase (APH) | Back alignment and domain information |
|---|
Probab=97.88 E-value=8.4e-05 Score=76.72 Aligned_cols=137 Identities=15% Similarity=0.060 Sum_probs=83.5
Q ss_pred cCcccc-ceEEEeeecCCCceEEEEEEcccccccchHHHHHHHHHhcccC-CCCcccccceeccCCceEEEEEeccCCCc
Q 003836 509 LGRGAF-GTVYKGFVNMGSSNHVAVKKLNSVFQDSEKEFKAEVNGIGQTH-HKNLVRLLGYCDEGQNRLLVYEFMSNGTV 586 (792)
Q Consensus 509 lG~G~~-g~Vy~g~~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~-h~niv~l~g~~~~~~~~~lV~E~~~~gsL 586 (792)
|-.|.. ..||+.... +..+.||+..... ..++.+|+++++.+. +--+.+++++....+..++|||+++|.+|
T Consensus 6 ~~~g~~~~~v~~~~~~---~~~~~vk~~~~~~---~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv~e~i~G~~l 79 (244)
T cd05150 6 VTEGQSGATVYRLDGK---NPGLYLKIAPSGP---TYELEREAERLRWLAGKLPVPEVIDYGSDDGRAWLLTSAVPGVPA 79 (244)
T ss_pred cCCCCCcCeEEEEcCC---CCcEEEEecCCCc---ccchHHHHHHHHHHHhcCCCCeEEEEEecCCccEEEEEeeCCccH
Confidence 444444 789997532 2578888876542 345778888888874 44466777777766678999999999887
Q ss_pred ccccc-------------------CCC----CCc--hhHHHHHH-HH-------------------HHHHHHHHhhc---
Q 003836 587 ASFLF-------------------GDS----KPN--WKLRTEIA-MG-------------------IAGGLFYLHEE--- 618 (792)
Q Consensus 587 ~~~l~-------------------~~~----~l~--~~~~~~i~-~~-------------------ia~gL~yLH~~--- 618 (792)
..... .-. ... ...+.... .. +...+..|-..
T Consensus 80 ~~~~~~~~~~~~~~~l~~~l~~lH~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~ 159 (244)
T cd05150 80 AALWEELEPERLVDALAEALRRLHALPVADCPFDRRLDRRLAEARARVENGLVDEDDFDDERRGWSAEELYAELEATRPA 159 (244)
T ss_pred hHhhcccCHHHHHHHHHHHHHHHhcCCcccCCcchhHHHHHHHHHHHHhcCCcChhhCcHhhcCCCHHHHHHHHHhhCCC
Confidence 64421 000 000 00000000 00 11111122111
Q ss_pred -cCCCeEecCCCCCcEEEcCCCCeEEeecCCCcc
Q 003836 619 -CCTQIIHCDIKPQNILLDDHYNARISDFGLAKL 651 (792)
Q Consensus 619 -~~~~ivH~dikp~NILl~~~~~~kl~Dfg~a~~ 651 (792)
..+.++|+|+.|.|||++++....|+||+.+..
T Consensus 160 ~~~~~l~HgD~~~~Nil~~~~~~~~iIDwe~a~~ 193 (244)
T cd05150 160 EEDLVVTHGDACLPNIIVDPGKFSGFIDLGRLGV 193 (244)
T ss_pred cCceEEECCCCCCccEEEeCCcEEEEEEcccccc
Confidence 124699999999999999987789999998753
|
The APH subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). APH catalyzes the transfer of the gamma-phosphoryl group from ATP to aminoglycoside antibiotics such as kanamycin, streptomycin, neomycin, and gentamicin, among others. The aminoglycoside antibiotics target the 30S ribosome and promote miscoding, leading to the production of defective proteins which insert into the bacterial membrane, resulting in membrane damage and the ultimate demise of the bacterium. Phosphorylation of the aminoglycoside antibiotics results in their inactivation, leading to bacterial antibiotic resistance. The APH gene is found on transposons and plasmids and is thought to have originated as a self-defense mechanism used by microorganisms that produce the antibio |
| >PF01636 APH: Phosphotransferase enzyme family This family is part of the larger protein kinase superfamily | Back alignment and domain information |
|---|
Probab=97.79 E-value=7.3e-05 Score=76.30 Aligned_cols=140 Identities=20% Similarity=0.179 Sum_probs=81.9
Q ss_pred hhcCccccceEEEeeecCCCceEEEEEEcccccccchHHHHHHHHHhcccCCCC--cccccceecc---CCceEEEEEec
Q 003836 507 EELGRGAFGTVYKGFVNMGSSNHVAVKKLNSVFQDSEKEFKAEVNGIGQTHHKN--LVRLLGYCDE---GQNRLLVYEFM 581 (792)
Q Consensus 507 ~~lG~G~~g~Vy~g~~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h~n--iv~l~g~~~~---~~~~~lV~E~~ 581 (792)
+.|+.|..+.||+..... ..+++|..... .....+.+|..+++.+.... +.+++.+... ....+++|+++
T Consensus 3 ~~l~~G~~n~~~~v~~~~---~~~vlK~~~~~--~~~~~~~~e~~~~~~l~~~~~pvP~~~~~~~~~~~~~~~~~~~~~i 77 (239)
T PF01636_consen 3 RPLSGGFSNRVYRVTTDD---GRYVLKFYRPP--DAAERLRREAAVLRQLAEHGIPVPRVLAFDTSDEFNGFPYLLMEYI 77 (239)
T ss_dssp EEEEESSSSEEEEEEETT---SEEEEEEESSH--HHHHHHHHHHHHHHHHHHTTSBS--EEEEEEETEETSEEEEEEEEE
T ss_pred ccCCCCCeeeEEEEEECC---cEEEEEEeCCC--CCHHHHHHHHHHHHHHHhcCCCCceEEeecccccccccceEEEEEe
Confidence 458889999999986543 47999997654 45577889999988885443 4566664422 23468999999
Q ss_pred cCCCccc----------------ccc---CC----CCCch-h--------HHHHH------------HHHHHH-HHHHHh
Q 003836 582 SNGTVAS----------------FLF---GD----SKPNW-K--------LRTEI------------AMGIAG-GLFYLH 616 (792)
Q Consensus 582 ~~gsL~~----------------~l~---~~----~~l~~-~--------~~~~i------------~~~ia~-gL~yLH 616 (792)
++..+.. .+. .. ..... . ..... ...+.+ .+..++
T Consensus 78 ~g~~~~~~~~~~~~~~~~~~~~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 157 (239)
T PF01636_consen 78 PGRPLDDELSPEQRPELLRQLGRALAQLHQVPPPFSPFADWPEWRLEFLRQLESWTARLRASELFDDLEELEERLLQELE 157 (239)
T ss_dssp SSEEHHHTSTHHHHHHHHHHHHHHHHHHHHSHTTCCCHTHHHHHHHHHHHHHHHHHHHHHHHCCHHHHHHHHHHHHHHHH
T ss_pred ccccccccccccccccccccchhhhhhcccccccccccccccccccccccccccccccccchhhhhhhHHHHHHHHHHHH
Confidence 9988777 110 00 00000 0 00000 111222 233333
Q ss_pred hc----cCCCeEecCCCCCcEEEc-CCCCeEEeecCCCcc
Q 003836 617 EE----CCTQIIHCDIKPQNILLD-DHYNARISDFGLAKL 651 (792)
Q Consensus 617 ~~----~~~~ivH~dikp~NILl~-~~~~~kl~Dfg~a~~ 651 (792)
+. ....++|+|+.|.|||++ +++.+-|+||+.+..
T Consensus 158 ~~~~~~~~~~~~HgD~~~~Nil~~~~~~~i~iID~e~a~~ 197 (239)
T PF01636_consen 158 ALLPKPLPPVLIHGDLHPGNILVDPSDGRIGIIDFEDAGW 197 (239)
T ss_dssp HHHHCCSCEEEE-SS-SGGGEEEESSTTEEEE--GTT-EE
T ss_pred hhhccCCCcEEEEeccccccceeeeccceeEEEecccceE
Confidence 22 234799999999999999 556668999988753
|
; InterPro: IPR002575 This entry consists of bacterial antibiotic resistance proteins, which confer resistance to various aminoglycosides they include:- aminoglycoside 3'-phosphotransferase or kanamycin kinase / neomycin-kanamycin phosphotransferase and streptomycin 3''-kinase or streptomycin 3''-phosphotransferase. The aminoglycoside phosphotransferases inactivate aminoglycoside antibiotics via phosphorylation []. The proteins are found in a range of taxonomic groups.; PDB: 2PPQ_A 2Q83_B 3TDV_B 3TDW_A 3I0O_A 3I0Q_A 3I1A_B 3Q2M_A 3HAV_C 2PUI_B .... |
| >COG2112 Predicted Ser/Thr protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=97.71 E-value=0.00016 Score=68.12 Aligned_cols=128 Identities=18% Similarity=0.272 Sum_probs=86.5
Q ss_pred hhhcCccccceEEEeeecCCCceEEEEEEcccccccchHHHHHHHHHhcccCCCCccc-ccceeccCCceEEEEEeccCC
Q 003836 506 KEELGRGAFGTVYKGFVNMGSSNHVAVKKLNSVFQDSEKEFKAEVNGIGQTHHKNLVR-LLGYCDEGQNRLLVYEFMSNG 584 (792)
Q Consensus 506 ~~~lG~G~~g~Vy~g~~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~-l~g~~~~~~~~~lV~E~~~~g 584 (792)
.+.|++|.+|.||+|.+. +..+|+|+-+. ......++.|+++|..+.-.++-+ ++.|-. ..+.|||+.|-
T Consensus 27 ~~~L~KG~~s~Vyl~~~~---~~~~a~Kvrr~--ds~r~~l~kEakiLeil~g~~~~p~vy~yg~----~~i~me~i~G~ 97 (201)
T COG2112 27 EKELAKGTTSVVYLGEWR---GGEVALKVRRR--DSPRRNLEKEAKILEILAGEGVTPEVYFYGE----DFIRMEYIDGR 97 (201)
T ss_pred hhhhhcccccEEEEeecc---CceEEEEEecC--CcchhhHHHHHHHHHHhhhcCCCceEEEech----hhhhhhhhcCc
Confidence 467999999999999765 34788888654 344678999999999988777644 333322 23459999987
Q ss_pred CccccccCCCCCchhHHHHHHHHHHHHHHHHhhccCCCeEecCCC-CCcEEEcCCCCeEEeecCCCccc
Q 003836 585 TVASFLFGDSKPNWKLRTEIAMGIAGGLFYLHEECCTQIIHCDIK-PQNILLDDHYNARISDFGLAKLL 652 (792)
Q Consensus 585 sL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dik-p~NILl~~~~~~kl~Dfg~a~~~ 652 (792)
+|.+.-... +..+.. .++.. +|.-+. .||-|+.|+ |..++|-.+..+.|+||.-|+..
T Consensus 98 ~L~~~~~~~---~rk~l~----~vlE~-a~~LD~--~GI~H~El~~~~k~vlv~~~~~~iIDFd~At~k 156 (201)
T COG2112 98 PLGKLEIGG---DRKHLL----RVLEK-AYKLDR--LGIEHGELSRPWKNVLVNDRDVYIIDFDSATFK 156 (201)
T ss_pred chhhhhhcc---cHHHHH----HHHHH-HHHHHH--hccchhhhcCCceeEEecCCcEEEEEccchhhc
Confidence 777655321 222333 33343 333332 389999887 55555555559999999999743
|
|
| >cd05155 APH_ChoK_like_1 Uncharacterized bacterial proteins with similarity to Aminoglycoside 3'-phosphotransferase (APH) and Choline kinase (ChoK) family members | Back alignment and domain information |
|---|
Probab=97.62 E-value=0.00041 Score=71.13 Aligned_cols=75 Identities=13% Similarity=0.221 Sum_probs=46.5
Q ss_pred hhcCccccc-eEEEeeecCCCceEEEEEEcccccccchHHHHHHHHHhcccCCC---CcccccceeccCC---ceEEEEE
Q 003836 507 EELGRGAFG-TVYKGFVNMGSSNHVAVKKLNSVFQDSEKEFKAEVNGIGQTHHK---NLVRLLGYCDEGQ---NRLLVYE 579 (792)
Q Consensus 507 ~~lG~G~~g-~Vy~g~~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h~---niv~l~g~~~~~~---~~~lV~E 579 (792)
+.|+.|+.. .||+. . ..+++|..+. ......+.+|.++++.+... -+.++++.....+ ..++|||
T Consensus 3 ~~~~~gG~~n~vy~~--~----~~~VlR~~~~--~~~~~~~~~E~~~l~~L~~~~~v~vP~~~~~~~~~~~~~~~~~l~~ 74 (235)
T cd05155 3 EPVDSGGTDNATFRL--G----DDMSVRLPSA--AGYAGQVRKEQRWLPRLAPHLPLPVPEPLGKGEPGEGYPWPWSVYR 74 (235)
T ss_pred eeccCCCcccceEEc--C----CceEEEcCCc--cchHHHHHHHHHHHHHHhccCCCCCCceeecCCCccCCCcceEEEE
Confidence 346766665 58874 1 2466776543 22345789999999887532 3444444443322 3478999
Q ss_pred eccCCCcccc
Q 003836 580 FMSNGTVASF 589 (792)
Q Consensus 580 ~~~~gsL~~~ 589 (792)
+++|.++.+.
T Consensus 75 ~i~G~~l~~~ 84 (235)
T cd05155 75 WLEGETATAA 84 (235)
T ss_pred eecCCCCCcc
Confidence 9999887543
|
The APH/ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates, such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides, and macrolides leads to their inactivation and to bacterial antibiotic resista |
| >PLN02876 acyl-CoA dehydrogenase | Back alignment and domain information |
|---|
Probab=97.58 E-value=0.00068 Score=82.41 Aligned_cols=81 Identities=12% Similarity=0.240 Sum_probs=56.8
Q ss_pred hhcCccccceEEEeeecCCC-ceEEEEEEccccc-ccchHHHHHHHHHhcccC-CCCc--ccccceeccC---CceEEEE
Q 003836 507 EELGRGAFGTVYKGFVNMGS-SNHVAVKKLNSVF-QDSEKEFKAEVNGIGQTH-HKNL--VRLLGYCDEG---QNRLLVY 578 (792)
Q Consensus 507 ~~lG~G~~g~Vy~g~~~~~~-~~~vavK~~~~~~-~~~~~~~~~Ei~~l~~l~-h~ni--v~l~g~~~~~---~~~~lV~ 578 (792)
+.++.|.+..+|+.....+. ...+++|+..... ......+.+|.++++.+. |.++ .+++.+|.+. ...++||
T Consensus 44 ~~l~gG~sn~ty~l~~~~~~~~~~~VLR~~p~~~~~~~~~~~~rE~~~l~~L~~~~~vpVP~v~~~~~d~~v~G~~flVM 123 (822)
T PLN02876 44 SQFGHGQSNPTFLLEVGNGGSVKRYVLRKKPPGKLLQSAHAVEREYQVLRALGEHTDVPVPKVYCLCTDASVIGTAFYIM 123 (822)
T ss_pred EEeCCCCcCceEEEEECCCCcceeEEEEeCCCCccCccHHHHHHHHHHHHHHhhcCCCCCCcEEEEecCCCcCCCceEEE
Confidence 45889999999987654322 1357777754322 123457889999999995 6665 7788888664 4578999
Q ss_pred EeccCCCcc
Q 003836 579 EFMSNGTVA 587 (792)
Q Consensus 579 E~~~~gsL~ 587 (792)
||+++..+.
T Consensus 124 E~v~G~~~~ 132 (822)
T PLN02876 124 EYLEGRIFV 132 (822)
T ss_pred EecCCcccC
Confidence 999986543
|
|
| >PF10707 YrbL-PhoP_reg: PhoP regulatory network protein YrbL; InterPro: IPR019647 This entry represents proteins that are activated by the protein PhoP | Back alignment and domain information |
|---|
Probab=97.54 E-value=0.00061 Score=67.20 Aligned_cols=127 Identities=17% Similarity=0.268 Sum_probs=88.2
Q ss_pred hhcCccccceEEEeeecCCCceEEEEEEccccc----------------ccchHHHHHHHHHhcccC------CCCcccc
Q 003836 507 EELGRGAFGTVYKGFVNMGSSNHVAVKKLNSVF----------------QDSEKEFKAEVNGIGQTH------HKNLVRL 564 (792)
Q Consensus 507 ~~lG~G~~g~Vy~g~~~~~~~~~vavK~~~~~~----------------~~~~~~~~~Ei~~l~~l~------h~niv~l 564 (792)
..||+|+.-.||. ++.+ ....||+..... ....++..+|+.-..++. +..|.++
T Consensus 7 ~~i~~G~~R~cy~--HP~d--p~~cIKV~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~E~~~y~~l~~~~~~~~~~i~r~ 82 (199)
T PF10707_consen 7 DLIAQGGERDCYQ--HPDD--PNLCIKVMRPDRGERRRPFKRWLKRLRPKSRYRQNRRELRYYKQLSLRRGVDWSHIPRF 82 (199)
T ss_pred cccccCCCceEEE--CCCC--CCeEEEEEccccccccccchhHHHhhcccchhHHHHHHHHHHHHHhhccCCcccccccE
Confidence 4699999999997 3333 357888876544 123466777777666555 8889999
Q ss_pred cceeccCCceEEEEEeccC--C----CccccccCCCCCchhHHHHHHHHHHHHHHHHhhccCCCeEecCCCCCcEEEcCC
Q 003836 565 LGYCDEGQNRLLVYEFMSN--G----TVASFLFGDSKPNWKLRTEIAMGIAGGLFYLHEECCTQIIHCDIKPQNILLDDH 638 (792)
Q Consensus 565 ~g~~~~~~~~~lV~E~~~~--g----sL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dikp~NILl~~~ 638 (792)
+|+.+.+...-+|+|.+.+ | +|.+++... .++. .+...+-+-..||-+. .|+.+|++|.||++...
T Consensus 83 ~G~veT~~G~Glv~e~I~d~dG~~s~TL~~~l~~~-~~~~----~~~~~L~~f~~~l~~~---~Iv~~dl~~~NIv~~~~ 154 (199)
T PF10707_consen 83 YGFVETNLGLGLVVELIRDADGNISPTLEDYLKEG-GLTE----ELRQALDEFKRYLLDH---HIVIRDLNPHNIVVQRR 154 (199)
T ss_pred eEEEecCCceEEEEEEEECCCCCcCccHHHHHHcC-CccH----HHHHHHHHHHHHHHHc---CCeecCCCcccEEEEec
Confidence 9999999999999998864 2 355566332 2333 2223333344577776 89999999999999633
Q ss_pred --C--CeEEee
Q 003836 639 --Y--NARISD 645 (792)
Q Consensus 639 --~--~~kl~D 645 (792)
+ .+.|+|
T Consensus 155 ~~~~~~lvlID 165 (199)
T PF10707_consen 155 DSGEFRLVLID 165 (199)
T ss_pred CCCceEEEEEe
Confidence 2 577777
|
PhoP controls the expression of a large number of genes that mediate adaptation to low Mg2+ environments and/or virulence in several bacterial species. YbrL is proposed to be acting in a loop activity with PhoP and PrmA analogous to the multi-component loop in Salmonella sp., where the PhoP-dependent PmrD protein activates the regulatory protein PmrA, and the activated PmrA then represses transcription from the PmrD promoter which harbours binding sites for both the PhoP and PmrA proteins. Expression of YrbL is induced in low Mg2+ in a PhoP-dependent fashion and repressed by Fe3+ in a PmrA-dependent manner []. |
| >PF13095 FTA2: Kinetochore Sim4 complex subunit FTA2 | Back alignment and domain information |
|---|
Probab=97.41 E-value=0.00094 Score=65.30 Aligned_cols=133 Identities=26% Similarity=0.364 Sum_probs=92.8
Q ss_pred ccccCHHHHHHHHhhhhhhcCcccc-ceEEEeeecCCCceEEEEEEcccc-----------cc----------cchHHHH
Q 003836 490 LRCFTYKELVEVTRGFKEELGRGAF-GTVYKGFVNMGSSNHVAVKKLNSV-----------FQ----------DSEKEFK 547 (792)
Q Consensus 490 ~~~~~~~el~~~~~~~~~~lG~G~~-g~Vy~g~~~~~~~~~vavK~~~~~-----------~~----------~~~~~~~ 547 (792)
++.|+... ....|.+.||.|.- |.|||+.+. ++.+|+|.+... .. .....|.
T Consensus 29 L~~F~~h~---~~I~flefLg~g~~~~~V~kv~I~---g~~YALKlf~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PF~ 102 (207)
T PF13095_consen 29 LEPFTHHG---DDIEFLEFLGHGSHDGYVFKVEID---GRIYALKLFRFWDYTEPDYTRERFAGHETSLSTPAHYADPFN 102 (207)
T ss_pred cCCcCCCC---CcEeeeeecCCCCceeEEEEEEEC---CeEEEEEEeeccccCCCccccccccccccccchhhhhcChHH
Confidence 44555522 44456788999999 999999875 568999993220 00 1123688
Q ss_pred HHHHHhcccC---CCCc--ccccceeccC------------------CceEEEEEeccCCCccccccCCCCCchhHHHHH
Q 003836 548 AEVNGIGQTH---HKNL--VRLLGYCDEG------------------QNRLLVYEFMSNGTVASFLFGDSKPNWKLRTEI 604 (792)
Q Consensus 548 ~Ei~~l~~l~---h~ni--v~l~g~~~~~------------------~~~~lV~E~~~~gsL~~~l~~~~~l~~~~~~~i 604 (792)
.|.+.+.+|+ +.++ |+++||..-. ..+.||.||++... ....+-
T Consensus 103 ~ECRAfgRLke~~~e~~~Avkc~Gyl~L~~~~q~~~~~~~~~~~~~~~~~aIVKD~v~~~~-------------~~~~~~ 169 (207)
T PF13095_consen 103 CECRAFGRLKEAGREGLWAVKCHGYLLLTEDQQFEQLRQRGSDHRPLPIRAIVKDFVPDDP-------------PLQIRD 169 (207)
T ss_pred HHHHhhHHHHhccccCceEEEeeEEEEEchHHHHHHhhcccccCCCCccEEEEEeecCCcc-------------ccchhH
Confidence 9999999885 4456 9999987211 12357888776532 223344
Q ss_pred HHHHHHHHHHHhhccCCCeEecCCCCCcEEEcCCCCeEEeecCCC
Q 003836 605 AMGIAGGLFYLHEECCTQIIHCDIKPQNILLDDHYNARISDFGLA 649 (792)
Q Consensus 605 ~~~ia~gL~yLH~~~~~~ivH~dikp~NILl~~~~~~kl~Dfg~a 649 (792)
+.+|.+-|..+|.. +|+-+|+++.|.. .-||+|||.+
T Consensus 170 ~~~~~~dl~~~~k~---gI~~~Dv~~~ny~-----~G~lvDfs~~ 206 (207)
T PF13095_consen 170 IPQMLRDLKILHKL---GIVPRDVKPRNYR-----GGKLVDFSSS 206 (207)
T ss_pred HHHHHHHHHHHHHC---CeeeccCcccccc-----CCEEEecccC
Confidence 56677788889998 9999999999986 5689999864
|
|
| >PRK10593 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=97.39 E-value=0.0019 Score=68.51 Aligned_cols=75 Identities=9% Similarity=0.089 Sum_probs=53.8
Q ss_pred hhcCccccceEEEeeecCCCceEEEEEEcccccccchHHHHHHHHHhcccCC---CCcccccceeccC---CceEEEEEe
Q 003836 507 EELGRGAFGTVYKGFVNMGSSNHVAVKKLNSVFQDSEKEFKAEVNGIGQTHH---KNLVRLLGYCDEG---QNRLLVYEF 580 (792)
Q Consensus 507 ~~lG~G~~g~Vy~g~~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h---~niv~l~g~~~~~---~~~~lV~E~ 580 (792)
+.||.|..+.||+.... ++ .+.+|..+. ......+.+|.+.++.+.. ..+.+++++|..+ +..+||||+
T Consensus 20 ~~i~~G~~~~vy~~~~~--~~-~~~~k~~~~--~~~~~~~~~Ea~~L~~L~~~~~vpVP~V~~~~~~~~~~g~~~LVmE~ 94 (297)
T PRK10593 20 ECISEQPYAALWALYDS--QG-NPMPLMARS--FSTPGVAQQEAWKLSMLARSGTVRMPTVYGVMTHEQSPGPDVLLLER 94 (297)
T ss_pred eecCCccceeEEEEEcC--CC-CEEEEEecc--cccchHHHHHHHHHHHHccCCCCCcCcEEEEeccCCcCCCeEEEEec
Confidence 46999999999986432 22 466666432 1133588999999988853 4678888887543 568999999
Q ss_pred ccCCCc
Q 003836 581 MSNGTV 586 (792)
Q Consensus 581 ~~~gsL 586 (792)
++++++
T Consensus 95 i~G~~~ 100 (297)
T PRK10593 95 LRGVSV 100 (297)
T ss_pred cCCEec
Confidence 998765
|
|
| >cd05157 ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes | Back alignment and domain information |
|---|
Probab=97.32 E-value=0.0014 Score=67.20 Aligned_cols=76 Identities=16% Similarity=0.153 Sum_probs=47.1
Q ss_pred hhcCccccceEEEeeecCCCceEEEEEEcccccccchHHHHHHHHHhcccCCCCc-ccccceeccCCceEEEEEeccCCC
Q 003836 507 EELGRGAFGTVYKGFVNMGSSNHVAVKKLNSVFQDSEKEFKAEVNGIGQTHHKNL-VRLLGYCDEGQNRLLVYEFMSNGT 585 (792)
Q Consensus 507 ~~lG~G~~g~Vy~g~~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h~ni-v~l~g~~~~~~~~~lV~E~~~~gs 585 (792)
+.|..|-...+|+.....++.+.+++|+..... .......+|+.++..+...++ +++++.+. ..+||||+++.+
T Consensus 4 ~~l~gG~tN~~~~v~~~~~~~~~~vlR~~~~~~-~~~~d~~~E~~~~~~l~~~gl~P~v~~~~~----~~~l~e~i~G~~ 78 (235)
T cd05157 4 KRFTGGITNKLVKVSNKEDNQDAVLVRVYGNKT-ELIIDRERELRIHKLLSKHGLAPKLYATFQ----NGLIYEFIPGRT 78 (235)
T ss_pred EEcCCcccceEEEEEcCCCCCCeEEEEEccCCc-cceecHHHHHHHHHHHHhCCCCCeEEEEeC----CcEEEEeeCCCc
Confidence 346777788999875432124578888765432 222234578888888854444 44444433 247999999977
Q ss_pred cc
Q 003836 586 VA 587 (792)
Q Consensus 586 L~ 587 (792)
+.
T Consensus 79 l~ 80 (235)
T cd05157 79 LE 80 (235)
T ss_pred CC
Confidence 64
|
ETNK is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major phospholipid, phosphatidylethanolamine (PtdEtn). Unlike ChoK, ETNK shows specific activity for its substrate, and displays negligible activity towards N-methylated derivatives of Etn. The Drosophila ETNK is implicated in development and neuronal function. Mammals contain two ETNK proteins, ETNK1 and ETNK2. ETNK1 selectively increases Etn uptake and phosphorylation, as well as PtdEtn synthesis. ETNK2 is found primarily in the liver and reproductive tissues. It plays a critical role in regulating placental hemostasis to support late embryo |
| >TIGR02721 ycfN_thiK thiamine kinase | Back alignment and domain information |
|---|
Probab=97.30 E-value=0.0015 Score=67.91 Aligned_cols=135 Identities=12% Similarity=0.082 Sum_probs=76.8
Q ss_pred cCccccceEEEeeecCCCceEEEEEEcccccccchHHHHHHHHHhcccCCCCc-ccccceeccCCceEEEEEeccCCCcc
Q 003836 509 LGRGAFGTVYKGFVNMGSSNHVAVKKLNSVFQDSEKEFKAEVNGIGQTHHKNL-VRLLGYCDEGQNRLLVYEFMSNGTVA 587 (792)
Q Consensus 509 lG~G~~g~Vy~g~~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h~ni-v~l~g~~~~~~~~~lV~E~~~~gsL~ 587 (792)
+..|-...+|+... +++.+++|..........-...+|.++++.+....+ .+++.... ..+||||++|..+.
T Consensus 4 ~~~G~tn~~y~~~~---~~~~~vlR~~~~~~~~~~~~r~~E~~~l~~l~~~g~~P~~i~~~~----~~~v~e~i~G~~~~ 76 (256)
T TIGR02721 4 LSGGLTNRSWRIEH---PGISFVWRPQSPVCKALGVDRQREYQILQALSALGLAPKPILVNE----HWLLVEWLEGEVIT 76 (256)
T ss_pred CCCcCcCCeEEEEe---CCccEEEeeCCcccccccCcHHHHHHHHHHHHhcCCCCceEEEeC----CEEEEEeccCcccc
Confidence 55677789998752 345688887654322211245778888888864444 34444432 36899999987765
Q ss_pred cc-----------------ccCCC----CCchhHH-HHHHHHH---------HHHHHHHhhc-----cCCCeEecCCCCC
Q 003836 588 SF-----------------LFGDS----KPNWKLR-TEIAMGI---------AGGLFYLHEE-----CCTQIIHCDIKPQ 631 (792)
Q Consensus 588 ~~-----------------l~~~~----~l~~~~~-~~i~~~i---------a~gL~yLH~~-----~~~~ivH~dikp~ 631 (792)
.- |+... ..+...+ .....++ .+.+..+... ....++|+|+.|.
T Consensus 77 ~~~~~~~~~~~~la~~l~~lH~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~H~Dl~~~ 156 (256)
T TIGR02721 77 LDQFVALDLLLELAALLHQLHSQPRFGYPLSLKARIAHYWLQIDPARRTPEWLRLYKQFRSAPEPAPLPLAPLHMDVHAY 156 (256)
T ss_pred cccccCchhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHHhcccccCChHHHHHHHHHHhccCCCCCCCeeecCCCCcC
Confidence 32 11111 1111111 1111111 1111112111 1236899999999
Q ss_pred cEEEcCCCCeEEeecCCCcc
Q 003836 632 NILLDDHYNARISDFGLAKL 651 (792)
Q Consensus 632 NILl~~~~~~kl~Dfg~a~~ 651 (792)
||++++++ +.|+||..+..
T Consensus 157 Nil~~~~~-~~lIDwE~a~~ 175 (256)
T TIGR02721 157 NLVVTPQG-LKLIDWEYASD 175 (256)
T ss_pred cEEEeCCC-CEEEeccccCc
Confidence 99999877 78999998864
|
Members of this family are the ycfN gene product of Escherichia coli, now identified as the salvage enzyme thiamine kinase (thiK), and additional proteobacterial homologs taken to be orthologs with equivalent function. |
| >cd01100 APPLE_Factor_XI_like Subfamily of PAN/APPLE-like domains; present in plasma prekallikrein/coagulation factor XI, microneme antigen proteins, and a few prokaryotic proteins | Back alignment and domain information |
|---|
Probab=97.28 E-value=0.00023 Score=58.13 Aligned_cols=47 Identities=21% Similarity=0.438 Sum_probs=36.7
Q ss_pred ccCCCCCCCcccccCcCChhhHhhhccCCCccccceec--cCceeeccc
Q 003836 362 LRNTDWPTSDYEQISPYGKDECVSSCLKDCQCSAAVLR--DDTCWKKKL 408 (792)
Q Consensus 362 ~~~~~~p~~~~~~~~~~s~~~C~~~Cl~nCsC~A~~~~--~~~C~~~~~ 408 (792)
++++++++.++......+.++|+..|+.+|+|.||.|. .+.|+++..
T Consensus 9 ~~~~~~~g~d~~~~~~~s~~~Cq~~C~~~~~C~afT~~~~~~~C~lk~~ 57 (73)
T cd01100 9 GSNVDFRGGDLSTVFASSAEQCQAACTADPGCLAFTYNTKSKKCFLKSS 57 (73)
T ss_pred cCCCccccCCcceeecCCHHHHHHHcCCCCCceEEEEECCCCeEEcccC
Confidence 35666666555544456899999999999999999995 467998765
|
PAN/APPLE domains fulfill diverse biological functions by mediating protein-protein or protein-carbohydrate interactions. |
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=97.17 E-value=0.00096 Score=79.28 Aligned_cols=197 Identities=18% Similarity=0.146 Sum_probs=136.3
Q ss_pred HHHHHHHHhcccCCCCcccccceeccCCceE----EEEEeccCCCccccccCCCCCchhHHHHHHHHHHHHHHHHhhccC
Q 003836 545 EFKAEVNGIGQTHHKNLVRLLGYCDEGQNRL----LVYEFMSNGTVASFLFGDSKPNWKLRTEIAMGIAGGLFYLHEECC 620 (792)
Q Consensus 545 ~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~----lV~E~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~ 620 (792)
..+-|+..+.++.|+|++.++.|-.+....- +.-|++..-++...+..-...+....+.+..+...||+|+|+.
T Consensus 228 ~~E~e~~~l~k~~~~n~~~~~~~~le~~~~g~~~~v~~~~~s~~~~~~~~q~v~~i~~~~~r~~~~~~~~GL~~~h~~-- 305 (1351)
T KOG1035|consen 228 TTEIELESLSKIAHDNLGGYFVYGLERLFRGIVLDVLQEICSKVELRSLLQSVGSIPLETLRILHQKLLEGLAYLHSL-- 305 (1351)
T ss_pred HHHHHHHHHHhhccccccceeEEeehhhcchHHHHHHHhhcCccchHHHHhhccccCHHHHHHHHHHHhhhHHHHHHh--
Confidence 3455777888899999999999886655433 3457788888888887777888899999999999999999998
Q ss_pred CCeEecCCCCC---cEEEcCCCCeEEe--ecCCCccccCCCCCccccccccCCcccccccccCCCC--cccceehHHHHH
Q 003836 621 TQIIHCDIKPQ---NILLDDHYNARIS--DFGLAKLLTLDQSHTNTAIRGTKGYVAPEWFRNMPIT--VKVDVYSYGVLL 693 (792)
Q Consensus 621 ~~ivH~dikp~---NILl~~~~~~kl~--Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~--~k~DV~S~Gv~l 693 (792)
...|.-+..+ +--.+.++...++ ||+..+.+....... ....+..+.+||......++ ...|+|.+|..+
T Consensus 306 -~l~~v~L~~s~~~~~~~~~e~~~~~sl~~~~ss~~l~d~~~~~--~~~~~~~~~~~e~~~~~~~~~~r~~dL~~lgll~ 382 (1351)
T KOG1035|consen 306 -SLEHVVLSASSSKESTVDGEGVVAISLSDFDSSKPLPDNEKSF--SDLLAEIRNADEDLKENTAKKSRLTDLWCLGLLL 382 (1351)
T ss_pred -ccceeEEecccccccccCccceeecchhhhcccccCCCcccch--hhcCccccccccccccccchhhhhhHHHHHHHHH
Confidence 5555444444 4455666777777 888887664332221 12235567788877665544 458999999999
Q ss_pred HHHHhcCcCCCcchhhhhhhhHHHHHHHhhcccchhHhhhchhcccCCHHHHHHHHHHHHHccccCCCCCCCHHhHHHHh
Q 003836 694 LEIICLRRNIDNEISKVDKAILTDWAYDRYQERTLEALVENDLEAMNNVTMLHRFVMVAFWCIQEDPSHRPTMRKVTQML 773 (792)
Q Consensus 694 ~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~L 773 (792)
..+..|..+-..... ...+++... ...+.+....|+..++++|++..+++...
T Consensus 383 ~~~~~~~~i~~~~~~-------------------~~~~l~~~~--------~~~~~d~~~~~~~~~~~~Rl~~~~ll~~~ 435 (1351)
T KOG1035|consen 383 LQLSQGEDISEKSAV-------------------PVSLLDVLS--------TSELLDALPKCLDEDSEERLSALELLTHP 435 (1351)
T ss_pred hhhhhcCcccccccc-------------------hhhhhcccc--------chhhhhhhhhhcchhhhhccchhhhhhch
Confidence 999988764321110 011111100 01455667789999999999999999865
|
|
| >cd05153 HomoserineK_II Homoserine Kinase, type II | Back alignment and domain information |
|---|
Probab=97.17 E-value=0.0017 Score=69.05 Aligned_cols=139 Identities=17% Similarity=0.147 Sum_probs=84.7
Q ss_pred hhcCccccceEEEeeecCCCceEEEEEEcccccccchHHHHHHHHHhcccCCCC--ccccccee------ccCCceEEEE
Q 003836 507 EELGRGAFGTVYKGFVNMGSSNHVAVKKLNSVFQDSEKEFKAEVNGIGQTHHKN--LVRLLGYC------DEGQNRLLVY 578 (792)
Q Consensus 507 ~~lG~G~~g~Vy~g~~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h~n--iv~l~g~~------~~~~~~~lV~ 578 (792)
+.|..|....+|+...+ +..+++|+... .....+..|++++..+++.+ +.+++... ...+..++|+
T Consensus 20 ~~i~~G~~n~~y~v~~~---~~~~vLr~~~~---~~~~~~~~e~~~l~~L~~~g~~vp~~i~~~~g~~~~~~~~~~~~l~ 93 (296)
T cd05153 20 EGISAGIENTNYFVTTD---SGRYVLTLFEK---VSAEELPFFLALLDHLAERGLPVPRPIADRDGEYLSELAGKPAALV 93 (296)
T ss_pred ecccCccccceEEEEeC---CCcEEEEEcCC---CChHhccHHHHHHHHHHHCCCCCCccccCCCCcEeeeeCCceEEEE
Confidence 35777888899987543 23688888764 23456777888888875433 44544421 2234568999
Q ss_pred EeccCCCcccc----c----------cC---C---C-----CCchhHHH----------HHHHHHHHHHHHHhh----cc
Q 003836 579 EFMSNGTVASF----L----------FG---D---S-----KPNWKLRT----------EIAMGIAGGLFYLHE----EC 619 (792)
Q Consensus 579 E~~~~gsL~~~----l----------~~---~---~-----~l~~~~~~----------~i~~~ia~gL~yLH~----~~ 619 (792)
+|++|..+... + +. . . ...|.... .....+..++.++.. ..
T Consensus 94 ~~i~G~~~~~~~~~~~~~lg~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~~~~~~ 173 (296)
T cd05153 94 EFLAGEHLTRPTAAHCRQIGEALARLHLAAQSFPGERNNLRGLAWIRELGKDLLPLLSAEDRALLADELARQDAFDPSDL 173 (296)
T ss_pred EeCCCCCCCCCCHHHHHHHHHHHHHHHHHhccCCccCCCcCCcHHHHHHHHHhccccCHHHHHHHHHHHHHHHhhhhhcC
Confidence 99999776431 0 00 0 0 01111110 011123344455543 12
Q ss_pred CCCeEecCCCCCcEEEcCCCCeEEeecCCCcc
Q 003836 620 CTQIIHCDIKPQNILLDDHYNARISDFGLAKL 651 (792)
Q Consensus 620 ~~~ivH~dikp~NILl~~~~~~kl~Dfg~a~~ 651 (792)
..+++|+|++|.|||++++..+.|+||+.+..
T Consensus 174 ~~~l~HgD~~~~Nil~~~~~~~~iIDfe~a~~ 205 (296)
T cd05153 174 PRGVIHADLFRDNVLFDGDELSGVIDFYFACT 205 (296)
T ss_pred CCcCCccCcCcccEEEeCCceEEEeehhhhcC
Confidence 34799999999999999987789999988753
|
Homoserine kinase is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of unusual homoserine kinases, from a subset of bacteria, which have a PK fold. These proteins do not bear any similarity to the GHMP family homoserine kinases present in most bacteria and eukaryotes. Homoserine kinase catalyzes the transfer of the gamma-phosphoryl group from ATP to L-homoserine producing L-homoserine phosphate, an intermediate in the production of the amino acids threonine, methionine, and isoleucine. |
| >PRK09550 mtnK methylthioribose kinase; Reviewed | Back alignment and domain information |
|---|
Probab=97.16 E-value=0.0036 Score=68.60 Aligned_cols=76 Identities=17% Similarity=0.220 Sum_probs=51.8
Q ss_pred hhcCccccceEEEeeecCCCceEEEEEEccccc-------ccchHHHHHHHHHhcccC---CCCcccccceeccCCceEE
Q 003836 507 EELGRGAFGTVYKGFVNMGSSNHVAVKKLNSVF-------QDSEKEFKAEVNGIGQTH---HKNLVRLLGYCDEGQNRLL 576 (792)
Q Consensus 507 ~~lG~G~~g~Vy~g~~~~~~~~~vavK~~~~~~-------~~~~~~~~~Ei~~l~~l~---h~niv~l~g~~~~~~~~~l 576 (792)
+.||.|.+..||++....+ ++.++||.-.... ....+.+..|.+.|+.+. -..+++++.+ +.+..++
T Consensus 32 ~elggGn~N~VyrV~~~~g-~~svIVKqa~p~~r~~g~~wpl~~eR~~~Eae~L~~l~~~~p~~VPkV~~~--D~~~~~l 108 (401)
T PRK09550 32 REIGDGNLNLVFRVSDTEG-GKSVIVKQALPYVRVVGESWPLTLDRARIEAEALKIQAKYVPDLVPKVYHY--DEELAVT 108 (401)
T ss_pred eEcCCCceEEEEEEEeCCC-CeEEEEEecCcccccccccccccHHHHHHHHHHHHHHHhhCCCCCCeEEEE--CCCCCEE
Confidence 4699999999999976432 2579999854211 223456777888877763 2456667766 3355789
Q ss_pred EEEeccCCC
Q 003836 577 VYEFMSNGT 585 (792)
Q Consensus 577 V~E~~~~gs 585 (792)
||||+++..
T Consensus 109 VME~L~~~~ 117 (401)
T PRK09550 109 VMEDLSDHK 117 (401)
T ss_pred EEecCCCcc
Confidence 999998643
|
|
| >TIGR00938 thrB_alt homoserine kinase, Neisseria type | Back alignment and domain information |
|---|
Probab=96.76 E-value=0.013 Score=62.58 Aligned_cols=139 Identities=14% Similarity=0.196 Sum_probs=81.1
Q ss_pred hhcCccccceEEEeeecCCCceEEEEEEcccccccchHHHHHHHHHhcccCCCC--ccccccee------ccCCceEEEE
Q 003836 507 EELGRGAFGTVYKGFVNMGSSNHVAVKKLNSVFQDSEKEFKAEVNGIGQTHHKN--LVRLLGYC------DEGQNRLLVY 578 (792)
Q Consensus 507 ~~lG~G~~g~Vy~g~~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h~n--iv~l~g~~------~~~~~~~lV~ 578 (792)
+.++.|....+|+...+ .+ .+++|+..... ...+...|++++..|.... +.+++... ...+..++++
T Consensus 28 ~~~~~G~~n~~y~v~t~--~~-~~vLK~~~~~~--~~~~i~~e~~~l~~L~~~g~pvp~~i~t~~g~~~~~~~g~~~~l~ 102 (307)
T TIGR00938 28 KGIAEGVENSNYLLTTD--VG-RYILTLYEKRV--KAEELPFFLALTTHLAARGLPVPKPVKSRDGRQLSTLAGKPACLV 102 (307)
T ss_pred cccCCccccceEEEEeC--CC-cEEEEEecCCC--CHHHHHHHHHHHHHHHHCCCCCCccccCCCCCeehhcCCeEEEEE
Confidence 34677777899987533 22 57788765421 2345566777777764322 34444422 2234568999
Q ss_pred EeccCCCcccc--------------ccCC-CC-----------CchhHHH------------HHHHHHHHHHHHHhh---
Q 003836 579 EFMSNGTVASF--------------LFGD-SK-----------PNWKLRT------------EIAMGIAGGLFYLHE--- 617 (792)
Q Consensus 579 E~~~~gsL~~~--------------l~~~-~~-----------l~~~~~~------------~i~~~ia~gL~yLH~--- 617 (792)
||++|..+... ++.. .. ..|.... .....+.+.++++..
T Consensus 103 e~i~G~~~~~~~~~~~~~~G~~LA~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~l~~~~~~~l~~~~~~l~~~~~ 182 (307)
T TIGR00938 103 EFLQGLSVGRPTAMHCRPVGEVLAWMHLAGAHFPENRKNSLRLEAWHILAEKCFEAAPQLEAHMGAELDKELDYLDKFWP 182 (307)
T ss_pred EeCCCCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCCCCCCChHHHHHHHHhhhhcccccCHHHHHHHHHHHHHHHhhhh
Confidence 99998665321 1110 00 0111100 011123345555543
Q ss_pred -ccCCCeEecCCCCCcEEEcCCCCeEEeecCCCc
Q 003836 618 -ECCTQIIHCDIKPQNILLDDHYNARISDFGLAK 650 (792)
Q Consensus 618 -~~~~~ivH~dikp~NILl~~~~~~kl~Dfg~a~ 650 (792)
....+++|+|+++.||++++++...|+||+.+.
T Consensus 183 ~~~~~~l~HgD~~~~Nvl~~~~~~~~vIDfd~~~ 216 (307)
T TIGR00938 183 RDLPRGVIHADLFPDNVLFDGDSVKGVIDFYFAC 216 (307)
T ss_pred hcCCCccCCCCCCcCcEEEECCceEEEeeccccc
Confidence 224589999999999999998877899999875
|
Homoserine kinase is required in the biosynthesis of threonine from aspartate.The member of this family from Pseudomonas aeruginosa was shown by direct assay and complementation to act specifically as a homoserine kinase. |
| >PRK05231 homoserine kinase; Provisional | Back alignment and domain information |
|---|
Probab=96.74 E-value=0.012 Score=63.28 Aligned_cols=138 Identities=10% Similarity=0.098 Sum_probs=75.8
Q ss_pred hcCccccceEEEeeecCCCceEEEEEEcccccccchHHHHHHHHHhcccCCCC--cccccce------eccCCceEEEEE
Q 003836 508 ELGRGAFGTVYKGFVNMGSSNHVAVKKLNSVFQDSEKEFKAEVNGIGQTHHKN--LVRLLGY------CDEGQNRLLVYE 579 (792)
Q Consensus 508 ~lG~G~~g~Vy~g~~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h~n--iv~l~g~------~~~~~~~~lV~E 579 (792)
.|..|....+|+..... ..+++|+... ...+....|+.+++.|...+ +.+.+.. ....+..++++|
T Consensus 29 ~l~~G~~n~~y~v~t~~---g~~vLK~~~~---~~~~~l~~~~~~l~~L~~~glpvP~~i~~~~G~~~~~~~g~~~~l~~ 102 (319)
T PRK05231 29 GIAEGIENSNFFLTTTQ---GEYVLTLFER---LTAEDLPFFLGLMQHLAARGVPVPAPVARRDGAALGELAGKPAAIVT 102 (319)
T ss_pred hhccccccceEEEEeCC---CcEEEEEecc---CChHHhHHHHHHHHHHHHCCCCCCcceeCCCCCEeeeeCCEEEEEEE
Confidence 46777778999875432 2588888752 12344445566665553222 3333321 122445789999
Q ss_pred eccCCCcccc----c----------cCC-C----------CCch-hHHHH------------HHHH-HHHHHHHHhh---
Q 003836 580 FMSNGTVASF----L----------FGD-S----------KPNW-KLRTE------------IAMG-IAGGLFYLHE--- 617 (792)
Q Consensus 580 ~~~~gsL~~~----l----------~~~-~----------~l~~-~~~~~------------i~~~-ia~gL~yLH~--- 617 (792)
|++|..+... . +.. . .+.| ..... ...+ +...+..+..
T Consensus 103 ~l~G~~~~~~~~~~~~~~G~~LA~lH~~~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~ 182 (319)
T PRK05231 103 FLEGKWPRAPTAAHCAEVGEMLARMHLAGRDFPLERPNLRGLAWWRELAPRLLPFLADEQAALLEAELAAQLAFLASAAW 182 (319)
T ss_pred ecCCCCCCCCCHHHHHHHHHHHHHHHhhhhcCCccCCCCCChHHHHHHHHHHhhccChhHHHHHHHHHHHHHHhhhcccc
Confidence 9999765321 0 100 0 0111 11111 0111 1112223321
Q ss_pred -ccCCCeEecCCCCCcEEEcCCCCeEEeecCCCcc
Q 003836 618 -ECCTQIIHCDIKPQNILLDDHYNARISDFGLAKL 651 (792)
Q Consensus 618 -~~~~~ivH~dikp~NILl~~~~~~kl~Dfg~a~~ 651 (792)
....+++|+|++|.|||++++...-|+||+.+..
T Consensus 183 ~~lp~~liHgD~~~~Nil~~~~~~~~iIDf~~~~~ 217 (319)
T PRK05231 183 PALPRGVIHADLFRDNVLFEGDRLSGFIDFYFACN 217 (319)
T ss_pred ccCCcccCCCCCCCCcEEEECCceEEEEecccccC
Confidence 1245899999999999999776668999998753
|
|
| >cd05156 ChoK_euk Choline Kinase (ChoK) in eukaryotes | Back alignment and domain information |
|---|
Probab=96.68 E-value=0.0077 Score=64.25 Aligned_cols=139 Identities=22% Similarity=0.230 Sum_probs=81.5
Q ss_pred hcCccccceEEEeeecCC-----CceEEEEEEcccccccchHHHHHHHHHhcccCCCCc-ccccceeccCCceEEEEEec
Q 003836 508 ELGRGAFGTVYKGFVNMG-----SSNHVAVKKLNSVFQDSEKEFKAEVNGIGQTHHKNL-VRLLGYCDEGQNRLLVYEFM 581 (792)
Q Consensus 508 ~lG~G~~g~Vy~g~~~~~-----~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h~ni-v~l~g~~~~~~~~~lV~E~~ 581 (792)
.+..|-...+|+.....+ .++.+++|+..... ....+..+|.+++..+....+ .++++++.. .+|+||+
T Consensus 5 ~l~gGltN~~y~v~~~~~~~~~~~~~~~vlRi~~~~~-~~~~~r~~E~~~~~~l~~~g~~P~~~~~~~~----~~v~e~i 79 (302)
T cd05156 5 KISGGLTNAVYKVSLPDEDALSDEPRKVLLRVYGQSV-ELLIDRERELVVFARLSERNLGPKLYGIFPN----GRIEEFI 79 (302)
T ss_pred EecCcccceeEEEEcCCcccccCCCCeEEEEEecCCC-cceechHHHHHHHHHHHhCCCCCceEEEeCC----Cchhhee
Confidence 355566678888765421 24578888865432 233456788888888754343 455555542 3589999
Q ss_pred cCCCcccc-c----------------cCCC-CC------c----hhHHHH--------------------------HHHH
Q 003836 582 SNGTVASF-L----------------FGDS-KP------N----WKLRTE--------------------------IAMG 607 (792)
Q Consensus 582 ~~gsL~~~-l----------------~~~~-~l------~----~~~~~~--------------------------i~~~ 607 (792)
+|..+... + |... .. . +..+.+ +...
T Consensus 80 ~G~~l~~~~~~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 159 (302)
T cd05156 80 PSRTLTTEELRDPDISAEIARRMAKLHSIVVPLSPEERDLTPAIWKLLKQWLDLAETVIEIVDSDSEKLLEVELSLFLED 159 (302)
T ss_pred CCCcCCHhHcCCcHHHHHHHHHHHHhhCCCCCCCCCcCcccchHHHHHHHHHHHhhhhhhhcccchhhhhhhhHHHHHHH
Confidence 98776531 1 1100 00 0 101100 0111
Q ss_pred HHHHHHHHhh------ccCCCeEecCCCCCcEEEcCC----CCeEEeecCCCcc
Q 003836 608 IAGGLFYLHE------ECCTQIIHCDIKPQNILLDDH----YNARISDFGLAKL 651 (792)
Q Consensus 608 ia~gL~yLH~------~~~~~ivH~dikp~NILl~~~----~~~kl~Dfg~a~~ 651 (792)
+.+-+..|.. .....++|+|+.+.|||++++ +.++++||..+..
T Consensus 160 ~~~~~~~l~~~~~~~~~~~~~lcH~Dl~~~Nil~~~~~~~~~~i~lIDwEya~~ 213 (302)
T cd05156 160 EAKYLRFLLESTSEESGSPVVFCHNDLQEGNILLLNPSSETKKLVLIDFEYASY 213 (302)
T ss_pred HHHHHHHHHhhccCCCCCCceEEecCCCcCeEEecCCCCCCCcEEEEeeCCCCC
Confidence 2222334432 234579999999999999985 8899999998853
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC) and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. ChoK plays an important role in cell signaling pathways and the regulation of cell growth. Along with PCho, it is involved in malignant transformation through Ras oncogenes in various human cancer |
| >PF07387 Seadorna_VP7: Seadornavirus VP7; InterPro: IPR009973 This family consists of several Seadornavirus specific VP7 proteins of around 305 residues in length | Back alignment and domain information |
|---|
Probab=96.10 E-value=0.021 Score=56.01 Aligned_cols=152 Identities=18% Similarity=0.194 Sum_probs=91.9
Q ss_pred ccceEEEeeecCCCceEEEEEEccccccc-chHHHHHHHHHhcccCCCCcccccceeccCCceEEEEEeccCCCcccccc
Q 003836 513 AFGTVYKGFVNMGSSNHVAVKKLNSVFQD-SEKEFKAEVNGIGQTHHKNLVRLLGYCDEGQNRLLVYEFMSNGTVASFLF 591 (792)
Q Consensus 513 ~~g~Vy~g~~~~~~~~~vavK~~~~~~~~-~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~lV~E~~~~gsL~~~l~ 591 (792)
+.++.-.++...+ +..+|++....-. ....|.++.+++++++ .|+++..= ..-.+-++.|+|-.
T Consensus 74 gNsTl~~~kt~iG---~L~lKKi~slp~~~~~~~y~nky~v~Armh--GilrL~ND--n~~~yGvIlE~Cy~-------- 138 (308)
T PF07387_consen 74 GNSTLLIGKTKIG---PLFLKKIRSLPCCINDALYFNKYRVFARMH--GILRLKND--NNYKYGVILERCYK-------- 138 (308)
T ss_pred CceEEEEeccccc---hhhhhhccCCCcccchhhhhhhhhHHHHhh--heeEeecC--CCceeEEEEeeccC--------
Confidence 3344444443332 4566776654333 4567888889988875 46666522 33345689998843
Q ss_pred CCCCCchhHHHHHHHHHHHHHHHHhhccCCCeEecCCCCCcEEEcCCCCeEEeecCCCccccCCCCCccccccccCCccc
Q 003836 592 GDSKPNWKLRTEIAMGIAGGLFYLHEECCTQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLDQSHTNTAIRGTKGYVA 671 (792)
Q Consensus 592 ~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dikp~NILl~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~gt~~y~a 671 (792)
......-.|..+ .++|.-.|+. ..+.+|+|..|+|||-|..|.+||.|=+.... .+--|.-
T Consensus 139 ----~~i~~~N~i~ag-i~~L~~fH~~-~~~~lHGD~np~NiM~D~~G~lKlVDP~~Ll~-------------~~V~~vN 199 (308)
T PF07387_consen 139 ----IKINFSNFITAG-IKDLMDFHSE-NQHCLHGDCNPDNIMCDKFGYLKLVDPVCLLE-------------NQVNMVN 199 (308)
T ss_pred ----cccchhHHHHHh-HHHHHHhhcc-CCCeecCCCChhheeecCCCCEEecChhhhhh-------------heeeEEe
Confidence 111111112222 3567778854 35899999999999999999999999654321 0111222
Q ss_pred ccccccCCCCcccceehHHHHHHHHHhcCc
Q 003836 672 PEWFRNMPITVKVDVYSYGVLLLEIICLRR 701 (792)
Q Consensus 672 PE~~~~~~~~~k~DV~S~Gv~l~el~tg~~ 701 (792)
-| ....|.++.+=+|=.-+++++...+
T Consensus 200 ~~---Y~~lT~~aE~~~fv~s~l~~v~~~~ 226 (308)
T PF07387_consen 200 IE---YESLTQEAEVKVFVKSCLKLVEKQR 226 (308)
T ss_pred ee---ccccChHHHHHHHHHHHHHHHHHHh
Confidence 11 2345777888777777777776554
|
The function of this family is unknown. |
| >PLN02236 choline kinase | Back alignment and domain information |
|---|
Probab=95.99 E-value=0.041 Score=59.76 Aligned_cols=138 Identities=17% Similarity=0.170 Sum_probs=80.7
Q ss_pred cCccccceEEEeeecCC---CceEEEEEEcccccccchHHHHHHHHHhcccCCCCc-ccccceeccCCceEEEEEeccCC
Q 003836 509 LGRGAFGTVYKGFVNMG---SSNHVAVKKLNSVFQDSEKEFKAEVNGIGQTHHKNL-VRLLGYCDEGQNRLLVYEFMSNG 584 (792)
Q Consensus 509 lG~G~~g~Vy~g~~~~~---~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h~ni-v~l~g~~~~~~~~~lV~E~~~~g 584 (792)
|-.|-...+|+.....+ ..+.+++|+....... .-...+|..++..+...++ .++++.+..+ .|.||+++.
T Consensus 44 l~gGlTN~~y~v~~~~~~~~~~~~~v~Ri~g~~t~~-~idR~~E~~~~~~l~~~gl~P~~~~~~~~g----~v~efi~g~ 118 (344)
T PLN02236 44 LKGAMTNEVFQIKWPTKEGNLGRKVLVRIYGEGVEL-FFDRDDEIRTFECMSRHGQGPRLLGRFPNG----RVEEFIHAR 118 (344)
T ss_pred cCCcccceeEEEEeCCCCCCCCCeEEEEEccCCCCe-eechHHHHHHHHHHHHcCCCCceEEEECCc----eEEEeeCCC
Confidence 44566678888764322 2357888887654322 2234778888888865555 4566666443 589999887
Q ss_pred Ccccc-----------------ccCCC------CCchhHHHHHHHH-----------------HHHHHHHHhh-----cc
Q 003836 585 TVASF-----------------LFGDS------KPNWKLRTEIAMG-----------------IAGGLFYLHE-----EC 619 (792)
Q Consensus 585 sL~~~-----------------l~~~~------~l~~~~~~~i~~~-----------------ia~gL~yLH~-----~~ 619 (792)
+|... +|... ...+..+.++..+ +...+..|.. ..
T Consensus 119 ~l~~~~l~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~i~~~~~~~~~l~~~~~~~~~~~~~l~~~~~~L~~~~~~~~~ 198 (344)
T PLN02236 119 TLSAADLRDPEISALIAAKLREFHSLDMPGPKNVLLWDRLRNWLKEAKNLCSPEEAKEFRLDSLEDEINLLEKELSGDDQ 198 (344)
T ss_pred CCCHHHcCChHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhhcCcchhhhcCHHHHHHHHHHHHHHhcccCC
Confidence 76421 11111 1112222222211 1112222221 11
Q ss_pred CCCeEecCCCCCcEEEcC-CCCeEEeecCCCcc
Q 003836 620 CTQIIHCDIKPQNILLDD-HYNARISDFGLAKL 651 (792)
Q Consensus 620 ~~~ivH~dikp~NILl~~-~~~~kl~Dfg~a~~ 651 (792)
...++|+|+++.|||+++ ++.+.++||..+..
T Consensus 199 ~~~~cH~Dl~~~Nil~~~~~~~~~lID~Eya~~ 231 (344)
T PLN02236 199 EIGFCHNDLQYGNIMIDEETRAITIIDYEYASY 231 (344)
T ss_pred CceEEeCCCCcCcEEEeCCCCcEEEEeehhccc
Confidence 236899999999999986 47899999988764
|
|
| >PF03881 Fructosamin_kin: Fructosamine kinase; InterPro: IPR016477 Ketosamines derive from a non-enzymatic reaction between a sugar and a protein [] | Back alignment and domain information |
|---|
Probab=95.97 E-value=0.042 Score=57.75 Aligned_cols=72 Identities=17% Similarity=0.322 Sum_probs=45.5
Q ss_pred hhcCccccceEEEeeecCCCceEEEEEEcccccccchHHHHHHHHHhcccC---CCCcccccceeccCCceEEEEEeccC
Q 003836 507 EELGRGAFGTVYKGFVNMGSSNHVAVKKLNSVFQDSEKEFKAEVNGIGQTH---HKNLVRLLGYCDEGQNRLLVYEFMSN 583 (792)
Q Consensus 507 ~~lG~G~~g~Vy~g~~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~---h~niv~l~g~~~~~~~~~lV~E~~~~ 583 (792)
+.++.|....+|+.. .+++.+-||.-. ......|..|.+-|+.|. --.+++++++....+..+||+||++.
T Consensus 23 ~~v~GG~i~~a~~~~---~~~~~~FvK~~~---~~~~~~f~~Ea~gL~~L~~~~~~~vP~vi~~G~~~~~~fLlle~l~~ 96 (288)
T PF03881_consen 23 EPVSGGDINEAYRLD---TDGGSYFVKVNS---ESGRDMFEGEAEGLKALAEANPIRVPKVIAWGEYDDDAFLLLEFLEM 96 (288)
T ss_dssp EEE--SSSSEEEEEE---TTS-EEEEEEEE---GGGCCHHHHHHHHHHHHCHTTTSBS--EEEEEE-SSCCEEEEE----
T ss_pred EecCCCChhheEEEE---CCCccEEEEecC---hhhHHHHHHHHHHHHHHHhcCCCCCCeEEEEEeecCCceEEEEeecC
Confidence 358888889999864 345689999865 233457888888777773 45577888888777777999999987
Q ss_pred C
Q 003836 584 G 584 (792)
Q Consensus 584 g 584 (792)
+
T Consensus 97 ~ 97 (288)
T PF03881_consen 97 G 97 (288)
T ss_dssp -
T ss_pred C
Confidence 6
|
Ketosamine-3-kinases (KT3K), of which fructosamine-3-kinase (FN3K) is the best-known example, catalyse the phosphorylation of the ketosamine moiety of glycated proteins. The instability of a phosphorylated ketosamine leads to its degradation, and KT3K is thus thought to be involved in protein repair []. The function of the prokaryotic members of this group has not been established. However, several lines of evidence indicate that they may function as fructosamine-3-kinases (FN3K). First, they are similar to characterised FN3K from mouse and human. Second, the Escherichia coli members are found in close proximity on the genome to fructose-6-phosphate kinase (PfkB). Last, FN3K activity has been found in a Anacystis montana (Gloeocapsa montana Kutzing 1843) [], indicating such activity-directly demonstrated in eukaryotes-is nonetheless not confined to eukaryotes. This family includes eukaryotic fructosamine-3-kinase enzymes [] which may initiate a process leading to the deglycation of fructoselysine and of glycated proteins and in the phosphorylation of 1-deoxy-1-morpholinofructose, fructoselysine, fructoseglycine, fructose and glycated lysozyme. The family also includes bacterial members that have not been characterised but probably have a similar or identical function. For additional information please see [].; PDB: 3JR1_B 3F7W_A. |
| >cd05152 MPH2' Macrolide 2'-Phosphotransferase (MPH2') | Back alignment and domain information |
|---|
Probab=95.85 E-value=0.072 Score=55.87 Aligned_cols=31 Identities=29% Similarity=0.528 Sum_probs=26.1
Q ss_pred CeEecCCCCCcEEEcCCCC-eEEeecCCCccc
Q 003836 622 QIIHCDIKPQNILLDDHYN-ARISDFGLAKLL 652 (792)
Q Consensus 622 ~ivH~dikp~NILl~~~~~-~kl~Dfg~a~~~ 652 (792)
.++|+|++|.|||+++++. .-|+||+.+...
T Consensus 186 ~lvHGD~~~~Nilv~~~~~~~gviDWe~a~iG 217 (276)
T cd05152 186 VLVHGDLHPGHILIDEDARVTGLIDWTEAKVG 217 (276)
T ss_pred eeEeCCCCCCcEEEeCCCCEEEEECcHhcccC
Confidence 5899999999999997555 469999998753
|
MPH2' is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). MPH2' catalyzes the transfer of the gamma-phosphoryl group from ATP to the 2'-hydroxyl of macrolide antibiotics such as erythromycin, clarithromycin, and azithromycin, among others. Macrolides penetrate the bacterial cell and bind to ribosomes, where it interrupts protein elongation, leading ultimately to the demise of the bacterium. Phosphorylation of macrolides leads to their inactivation. Based on substrate specificity and amino acid sequence, MPH2' is divided into types I and II, encoded by mphA and mphB genes, respectively. MPH2'I inactivates 14-membered ring macrolides while MPH2'II inactivates both 14- and 16-membered ring macrolides. Enzymatic inactivation of macrolides has been reported |
| >COG3173 Predicted aminoglycoside phosphotransferase [General function prediction only] | Back alignment and domain information |
|---|
Probab=95.74 E-value=0.12 Score=54.65 Aligned_cols=121 Identities=23% Similarity=0.278 Sum_probs=74.7
Q ss_pred ceEEEEEEccc--ccccchHHHHHHHHHhcccCC--CCcccccceeccCC--ceEEEEEeccCCCccccccCCCCCchhH
Q 003836 527 SNHVAVKKLNS--VFQDSEKEFKAEVNGIGQTHH--KNLVRLLGYCDEGQ--NRLLVYEFMSNGTVASFLFGDSKPNWKL 600 (792)
Q Consensus 527 ~~~vavK~~~~--~~~~~~~~~~~Ei~~l~~l~h--~niv~l~g~~~~~~--~~~lV~E~~~~gsL~~~l~~~~~l~~~~ 600 (792)
++.+++. ... ..........+|.++|+.+.- .-....+++|.++. ..+.||+|.++..+.+.+......
T Consensus 48 ~~~~vlR-~P~~~~~~~~~~~~~re~~~i~~l~~~~vP~p~~~~~~~~~~~g~pf~v~~~veGe~~~~~~~~~~~~---- 122 (321)
T COG3173 48 GQKYVLR-KPPRGDPVESAHDEKREYRVIAALLDVDVPVPRAFGLCGEGYLGTPFYVMEWVEGEVVWSALPPESLG---- 122 (321)
T ss_pred CceEEEe-cCCccccchhhhHHHhHHHHHHHhcCCCCCCcccccccccCCCCCceEEEEEecceeccCcCCcccch----
Confidence 4567776 221 222334556677777777643 33455677777666 678999999985444433211100
Q ss_pred HHHHH-HHHHHHH--------------------------------------------------HHHhhcc-----CCCeE
Q 003836 601 RTEIA-MGIAGGL--------------------------------------------------FYLHEEC-----CTQII 624 (792)
Q Consensus 601 ~~~i~-~~ia~gL--------------------------------------------------~yLH~~~-----~~~iv 624 (792)
.+++ ..+++.| .+|+... ...++
T Consensus 123 -~~~~~~~l~~~La~LH~ida~~~~~~g~~~~~~~rql~~~~~~~~~~~~~~~~~~p~~~~~~~Wl~~~~p~~~~~~~lv 201 (321)
T COG3173 123 -RQFALDALADFLAELHSIDAAGLPDPGKPNAYRGRQLARWDDEYRRAKKELGGRIPLADRLIKWLEANRPPWAGPPVLV 201 (321)
T ss_pred -HHHHHHHHHHHHHHHhCCCCcCCCCCCccCccccchhhHHHHHHHHHHHhccCCCchHHHHHHHHHhcCCCcCCCceee
Confidence 1111 1333333 3444332 14699
Q ss_pred ecCCCCCcEEEcCCCCeEEeecCCCcccc
Q 003836 625 HCDIKPQNILLDDHYNARISDFGLAKLLT 653 (792)
Q Consensus 625 H~dikp~NILl~~~~~~kl~Dfg~a~~~~ 653 (792)
|+|+++.||+++.+.-+-+.||+++....
T Consensus 202 HGD~~~gNlii~~~~~~gVlDwe~~~lGD 230 (321)
T COG3173 202 HGDYRPGNLIIDPGRPTGVLDWELATLGD 230 (321)
T ss_pred eCCcccCCEEEeCCCeeEEEeccccccCC
Confidence 99999999999999889999999998654
|
|
| >KOG1826 consensus Ras GTPase activating protein RasGAP/neurofibromin [Defense mechanisms] | Back alignment and domain information |
|---|
Probab=95.66 E-value=0.0007 Score=82.01 Aligned_cols=155 Identities=11% Similarity=-0.032 Sum_probs=108.4
Q ss_pred HHHHHhcccCCCCccccccee--ccCCceEEEEEeccCCCccccccCC----CCCchhHHHHHHHHHHHHHHHHhhccCC
Q 003836 548 AEVNGIGQTHHKNLVRLLGYC--DEGQNRLLVYEFMSNGTVASFLFGD----SKPNWKLRTEIAMGIAGGLFYLHEECCT 621 (792)
Q Consensus 548 ~Ei~~l~~l~h~niv~l~g~~--~~~~~~~lV~E~~~~gsL~~~l~~~----~~l~~~~~~~i~~~ia~gL~yLH~~~~~ 621 (792)
.|...++...|+++.....=. .+..+.+.+++|+..|.+.+.+-+. ..++.......-.+...+..-.|.....
T Consensus 1278 ~e~de~~~~~h~~~~~~p~rI~ps~s~ee~~r~~~~~~g~~f~iIikg~ee~~~ld~~~v~~~~kvsvl~~~~~ls~tnl 1357 (2724)
T KOG1826|consen 1278 SERDELREAKHYLTEVDPLRIPPSESTEEYIRSLYVEFGKLFSIIIKGLEESPDLDRSPVHLRHKVSVLNRNVILSLTNL 1357 (2724)
T ss_pred hhhhhhhhhhceeeecccccCCCCCChHHHHHHHHHHHhHHHHHHHhccccCCcchhchHHHHHHHHHhccchhhhcccC
Confidence 344445556788877655433 2344678899999999999888654 2223332222233324445555554322
Q ss_pred --CeEecCCCCCcEEEcCCCCeEEeecCCCccccCCCCCccccccccCCcccccccccCCCCcccceehHHHHHHHHHhc
Q 003836 622 --QIIHCDIKPQNILLDDHYNARISDFGLAKLLTLDQSHTNTAIRGTKGYVAPEWFRNMPITVKVDVYSYGVLLLEIICL 699 (792)
Q Consensus 622 --~ivH~dikp~NILl~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DV~S~Gv~l~el~tg 699 (792)
-.+|+++|+-|.+|..+.++|+.++|+.+...+.... .....+++.|++|+......++.++|+|..|+.+|+..-|
T Consensus 1358 g~T~v~~~Lkf~lpmIVtny~v~~gk~gLdKIknp~~sf-~Gl~l~sp~~v~qli~N~ik~t~rsdilr~s~~ly~rs~~ 1436 (2724)
T KOG1826|consen 1358 GNTNVSKSLKFTLPMIVTNYNVKLGKGGLDKIKNPVLSF-FGLELCSPIYVLQLIKNEIKFTKRSDILRRSLSLYLRSDG 1436 (2724)
T ss_pred CccchhhhhhhhccceecCCcccccccccccccCchHhh-hhhhhCCHHHHHHHHHHHHhhhhHHHHHHHHHHHHHHhcc
Confidence 3689999999999999999999999999944332222 2234577889999999999999999999999999999888
Q ss_pred CcCC
Q 003836 700 RRNI 703 (792)
Q Consensus 700 ~~p~ 703 (792)
..+|
T Consensus 1437 n~~f 1440 (2724)
T KOG1826|consen 1437 NAYF 1440 (2724)
T ss_pred cHHH
Confidence 7765
|
|
| >PLN02756 S-methyl-5-thioribose kinase | Back alignment and domain information |
|---|
Probab=95.60 E-value=0.099 Score=57.23 Aligned_cols=72 Identities=13% Similarity=0.212 Sum_probs=47.6
Q ss_pred hhcCccccceEEEeeecCCCceEEEEEEcccccc-------cchHHHHHHHHHhcccC---CCCcccccceeccCCceEE
Q 003836 507 EELGRGAFGTVYKGFVNMGSSNHVAVKKLNSVFQ-------DSEKEFKAEVNGIGQTH---HKNLVRLLGYCDEGQNRLL 576 (792)
Q Consensus 507 ~~lG~G~~g~Vy~g~~~~~~~~~vavK~~~~~~~-------~~~~~~~~Ei~~l~~l~---h~niv~l~g~~~~~~~~~l 576 (792)
+.||.|....||+.... +..++||.-..... ....+-..|.+.|+.+. ...+.+++.++. +..++
T Consensus 38 ~eiggGn~N~VyrV~~~---~~svVVKqa~p~~r~vga~wpl~~~R~~~Ea~aL~~~~~~~p~~VPkVy~~de--d~~vl 112 (418)
T PLN02756 38 KEVGDGNLNFVYIVVSS---SGSFVIKQALPYIRCIGESWPMTKERAYFEATALREHGRLCPDHVPEVYHFDR--TMALI 112 (418)
T ss_pred EEcCCCceeeEEEEEcC---CccEEEEeCCccccCCCccccCCccHHHHHHHHHHHhhhcCCCCCCeEEEECC--CCCEE
Confidence 46899999999997542 34688997652111 13334444566665553 357888888887 34678
Q ss_pred EEEeccC
Q 003836 577 VYEFMSN 583 (792)
Q Consensus 577 V~E~~~~ 583 (792)
+||++++
T Consensus 113 vME~L~~ 119 (418)
T PLN02756 113 GMRYLEP 119 (418)
T ss_pred EEeecCC
Confidence 8999977
|
|
| >KOG1236 consensus Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=95.23 E-value=0.051 Score=58.19 Aligned_cols=60 Identities=20% Similarity=0.222 Sum_probs=43.3
Q ss_pred EEEEEeccCCCccccccCCCCCchhHHHHHHHHHHHHHHHHhhccCCCeEecCCCCCcEEEcC
Q 003836 575 LLVYEFMSNGTVASFLFGDSKPNWKLRTEIAMGIAGGLFYLHEECCTQIIHCDIKPQNILLDD 637 (792)
Q Consensus 575 ~lV~E~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dikp~NILl~~ 637 (792)
.|+=+|+++-++..++... ..++....+++.--++||.-+-.- .+.+|.|++|.||++.-
T Consensus 321 vl~E~~~~Gl~v~~~v~~~-~~pe~l~kkva~lg~~AllkMl~v--DNFvHaDlHPGNVlirf 380 (565)
T KOG1236|consen 321 VLVETYERGLSVLRFVKWK-SQPEALVKKVAKLGVNALLKMLIV--DNFVHADLHPGNVLIRF 380 (565)
T ss_pred eeeeeccccccHHhhhhcc-cChHHHHHHHHHHHHHHHHHHHHh--hcceecccCCCcEEEEe
Confidence 4666788888888888543 344567777777777776544332 38999999999999963
|
|
| >TIGR02906 spore_CotS spore coat protein, CotS family | Back alignment and domain information |
|---|
Probab=94.98 E-value=0.16 Score=54.35 Aligned_cols=29 Identities=31% Similarity=0.421 Sum_probs=25.7
Q ss_pred CCeEecCCCCCcEEEcCCCCeEEeecCCCc
Q 003836 621 TQIIHCDIKPQNILLDDHYNARISDFGLAK 650 (792)
Q Consensus 621 ~~ivH~dikp~NILl~~~~~~kl~Dfg~a~ 650 (792)
.+++|+|+++.||+++. +.+.|+||+.+.
T Consensus 187 ~~liHgD~~~~Nil~~~-~~i~lIDfd~~~ 215 (313)
T TIGR02906 187 RGFCHQDYAYHNILLKD-NEVYVIDFDYCT 215 (313)
T ss_pred CceEcCCCCcccEEEeC-CcEEEEECcccc
Confidence 58999999999999998 678999998764
|
Members of this family include the spore coat proteins CotS and YtaA from Bacillus subtilis and, from other endospore-forming bacteria, homologs that are more closely related to these two than to the spore coat proteins YutH and YsxE. The CotS family is more broadly distributed than YutH or YsxE, but still is not universal among spore-formers. |
| >PF01633 Choline_kinase: Choline/ethanolamine kinase; InterPro: IPR002573 Choline kinase, (ATP:choline phosphotransferase, 2 | Back alignment and domain information |
|---|
Probab=94.98 E-value=0.04 Score=55.30 Aligned_cols=119 Identities=17% Similarity=0.225 Sum_probs=60.7
Q ss_pred eEEEEEEcccccccchHHHHHHHHHhcccCCCCc-ccccceeccCCceEEEEEeccCCCcccc-ccC-------------
Q 003836 528 NHVAVKKLNSVFQDSEKEFKAEVNGIGQTHHKNL-VRLLGYCDEGQNRLLVYEFMSNGTVASF-LFG------------- 592 (792)
Q Consensus 528 ~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h~ni-v~l~g~~~~~~~~~lV~E~~~~gsL~~~-l~~------------- 592 (792)
+.|+||+.... ....-...+|..+++.+...++ .++++++.++ .|+||+++..|..- +..
T Consensus 3 ~~~~~Ri~g~~-t~~~idr~~E~~~~~~l~~~g~~p~~~~~~~~g----~v~e~i~g~~l~~~~~~~~~~~~~iA~~l~~ 77 (211)
T PF01633_consen 3 EKYLVRIPGEG-TENFIDRENENEALKLLSEAGLGPKIIYFFENG----RVEEFIEGRTLSPEDFRNPEILKRIAKLLAK 77 (211)
T ss_dssp SEEEEEEEESC-GCSHHHHHHHHHHHHHHHHTTSSS-EEEEETTE----EEEE--SSEE--CGGGGSHHHHHHHHHHHHH
T ss_pred CEEEEEeCCCC-cccccCHHHHHHHHHHHHHcCCCCeEEEEcCCC----cEEEEecccccChhhccChHHHHHHHHHHHH
Confidence 46778877654 3344577888999988876555 5566665443 57799977665431 110
Q ss_pred ---C-------CCCchhHHHHH----------------------HHHHHHHHHHHhh---c--cCCCeEecCCCCCcEEE
Q 003836 593 ---D-------SKPNWKLRTEI----------------------AMGIAGGLFYLHE---E--CCTQIIHCDIKPQNILL 635 (792)
Q Consensus 593 ---~-------~~l~~~~~~~i----------------------~~~ia~gL~yLH~---~--~~~~ivH~dikp~NILl 635 (792)
. ...-+....++ ...+..-+..+.. . ....+.|.|+.+.|||+
T Consensus 78 lH~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~l~~~~~~~v~cHnDl~~~Nil~ 157 (211)
T PF01633_consen 78 LHSIPISPNSKKPDLWDRIDKYMNKKSEFLFKRKKKKKSIDKEDLEDLQEELEELEKLLEKSNSPLVFCHNDLNPGNILI 157 (211)
T ss_dssp HHTHHHTTSSSS-HHHHHHHHHHHHHHTCCCCHHTTTCHHHHHHHHHHHHHHHHHHHHHHTSCGGEEEE-S--SGGGEEE
T ss_pred HhhcccccccCcchHHHHhhhhccchhhhhhhhhhhccccccCCHHHHHHHHhhhhhhhhccCCCceEeeccCccccEEe
Confidence 0 00011111111 0111222222221 1 11368999999999999
Q ss_pred -cCCCCeEEeecCCCcc
Q 003836 636 -DDHYNARISDFGLAKL 651 (792)
Q Consensus 636 -~~~~~~kl~Dfg~a~~ 651 (792)
+.++.++++||..+..
T Consensus 158 ~~~~~~~~lIDfEya~~ 174 (211)
T PF01633_consen 158 NNKDGEVKLIDFEYAGY 174 (211)
T ss_dssp TSSSSCEEE--GTT-EE
T ss_pred ccCCCeEEEecHHHHhh
Confidence 8899999999988753
|
7.1.32 from EC) belongs to the choline/ethanolamine kinase family. Ethanolamine and choline are major membrane phospholipids, in the form of glycerophosphoethanolamine and glycerophosphocholine. Ethanolamine is also a component of the glycosylphosphatidylinositol (GPI) anchor, which is necessary for cell-surface protein attachment []. The de novo synthesis of these phospholipids begins with the creation of phosphoethanolamine and phosphocholine by ethanolamine and choline kinases in the first step of the CDP-ethanolamine pathway [, ]. There are two putative choline/ethanolamine kinases (C/EKs) in the Trypanosoma brucei genome. Ethanolamine kinase has no choline kinase activity [] and its activity is inhibited by ADP []. Inositol supplementation represses ethanolamine kinase, decreasing the incorporation of ethanolamine into the CDP-ethanolamine pathway and into phosphatidylethanolamine and phosphatidylcholine []. ; GO: 0016773 phosphotransferase activity, alcohol group as acceptor; PDB: 3C5I_A 2IG7_A 3LQ3_A 3FEG_A 2QG7_E 3FI8_A 1NW1_A 3MES_A 3G15_A 2CKP_B .... |
| >KOG2268 consensus Serine/threonine protein kinase [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=94.96 E-value=0.037 Score=57.52 Aligned_cols=134 Identities=15% Similarity=0.122 Sum_probs=85.7
Q ss_pred hhhhhhcCccccceEEEeeecCCCceEEEEEEcccc---------cc--------c-----chHHHHHHHHHhcccCC--
Q 003836 503 RGFKEELGRGAFGTVYKGFVNMGSSNHVAVKKLNSV---------FQ--------D-----SEKEFKAEVNGIGQTHH-- 558 (792)
Q Consensus 503 ~~~~~~lG~G~~g~Vy~g~~~~~~~~~vavK~~~~~---------~~--------~-----~~~~~~~Ei~~l~~l~h-- 558 (792)
+.+.+.||-|.-+.||.+... .+++.++|.-+-. .+ . ..-...+|...|..|..
T Consensus 94 ~svGnqIGVGKESDIY~v~d~--~G~~~~lK~HRLGRtSFR~Vk~kRDY~r~r~~~sWlyLSRlaa~kEfafmkaL~e~g 171 (465)
T KOG2268|consen 94 ESVGNQIGVGKESDIYVVADE--EGNPLILKLHRLGRTSFRNVKNKRDYLRKRKSGSWLYLSRLAATKEFAFMKALYERG 171 (465)
T ss_pred hhhccccccccccceEEEecC--CCCchhHHHHhhhhhhHHHhhhhhhhHhcCCccchhhhHHHHHHHHHHHHHHHHHcC
Confidence 345678999999999998654 3456777742110 00 0 01234467777777643
Q ss_pred CCcccccceeccCCceEEEEEeccCCCccccccCCCCCchhHHHHHHHHHHHHHHHHhhccCCCeEecCCCCCcEEEcCC
Q 003836 559 KNLVRLLGYCDEGQNRLLVYEFMSNGTVASFLFGDSKPNWKLRTEIAMGIAGGLFYLHEECCTQIIHCDIKPQNILLDDH 638 (792)
Q Consensus 559 ~niv~l~g~~~~~~~~~lV~E~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dikp~NILl~~~ 638 (792)
--+.+.+++ +..++|||++.+-.|...-+- .+.+++..-++.+ +--|... |+||+|..-=||+++++
T Consensus 172 fpVPkpiD~----~RH~Vvmelv~g~Pl~~v~~v---~d~~~ly~~lm~~---Iv~la~~---GlIHgDFNEFNimv~dd 238 (465)
T KOG2268|consen 172 FPVPKPIDH----NRHCVVMELVDGYPLRQVRHV---EDPPTLYDDLMGL---IVRLANH---GLIHGDFNEFNIMVKDD 238 (465)
T ss_pred CCCCCcccc----cceeeHHHhhcccceeeeeec---CChHHHHHHHHHH---HHHHHHc---CceecccchheeEEecC
Confidence 334555544 345789999999887765432 2333333332222 2334444 99999999999999999
Q ss_pred CCeEEeecCCCcc
Q 003836 639 YNARISDFGLAKL 651 (792)
Q Consensus 639 ~~~kl~Dfg~a~~ 651 (792)
+.++++||--...
T Consensus 239 ~~i~vIDFPQmvS 251 (465)
T KOG2268|consen 239 DKIVVIDFPQMVS 251 (465)
T ss_pred CCEEEeechHhhc
Confidence 9999999965543
|
|
Homologous Structure Templates
Structure Templates Detected by BLAST 
Original result of BLAST against Protein Data Bank
ID ![]() | Alignment Graph ![]() | Length ![]() |
Definition ![]() |
E-value ![]() | |
| Query | 792 | ||||
| 3tl8_A | 349 | The Avrptob-Bak1 Complex Reveals Two Structurally S | 6e-58 | ||
| 3uim_A | 326 | Structural Basis For The Impact Of Phosphorylation | 2e-57 | ||
| 2qkw_B | 321 | Structural Basis For Activation Of Plant Immunity B | 1e-40 | ||
| 3hgk_A | 327 | Crystal Structure Of Effect Protein Avrptob Complex | 9e-40 | ||
| 2nry_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 2e-38 | ||
| 2nru_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 4e-38 | ||
| 2oib_A | 301 | Crystal Structure Of Irak4 Kinase Domain Apo Form L | 6e-38 | ||
| 2o8y_A | 298 | Apo Irak4 Kinase Domain Length = 298 | 4e-35 | ||
| 3ppz_A | 309 | Crystal Structure Of Ctr1 Kinase Domain In Complex | 2e-21 | ||
| 3p86_A | 309 | Crystal Structure Of Ctr1 Kinase Domain Mutant D676 | 4e-21 | ||
| 1jpa_A | 312 | Crystal Structure Of Unphosphorylated Ephb2 Recepto | 2e-20 | ||
| 2zm1_A | 285 | Crystal Structure Of Imidazo Pyrazin 1 Bound To The | 1e-19 | ||
| 3kxz_A | 287 | The Complex Crystal Structure Of Lck With A Probe M | 1e-19 | ||
| 3kmm_A | 288 | Structure Of Human Lck Kinase With A Small Molecule | 1e-19 | ||
| 1qpe_A | 279 | Structural Analysis Of The Lymphocyte-Specific Kina | 1e-19 | ||
| 2ofu_A | 273 | X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam | 1e-19 | ||
| 3lck_A | 271 | The Kinase Domain Of Human Lymphocyte Kinase (Lck), | 1e-19 | ||
| 3bym_A | 272 | X-Ray Co-Crystal Structure Aminobenzimidazole Triaz | 1e-19 | ||
| 2ofv_A | 277 | Crystal Structure Of Aminoquinazoline 1 Bound To Lc | 1e-19 | ||
| 3bys_A | 277 | Co-Crystal Structure Of Lck And Aminopyrimidine Ami | 1e-19 | ||
| 2of2_A | 271 | Crystal Structure Of Furanopyrimidine 8 Bound To Lc | 2e-19 | ||
| 2pl0_A | 289 | Lck Bound To Imatinib Length = 289 | 2e-19 | ||
| 2qok_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 2e-19 | ||
| 4gs6_A | 315 | Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz | 2e-19 | ||
| 1mqb_A | 333 | Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro | 2e-19 | ||
| 2og8_A | 265 | Crystal Structure Of Aminoquinazoline 36 Bound To L | 2e-19 | ||
| 2eva_A | 307 | Structural Basis For The Interaction Of Tak1 Kinase | 3e-19 | ||
| 2qoo_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 3e-19 | ||
| 2qoc_A | 344 | Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp | 4e-19 | ||
| 3dzq_A | 361 | Human Epha3 Kinase Domain In Complex With Inhibitor | 4e-19 | ||
| 2qof_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f | 4e-19 | ||
| 3fxx_A | 371 | Human Epha3 Kinase And Juxtamembrane Region Bound T | 5e-19 | ||
| 2qoi_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 5e-19 | ||
| 2gsf_A | 373 | The Human Epha3 Receptor Tyrosine Kinase And Juxtam | 5e-19 | ||
| 2qod_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y602f | 5e-19 | ||
| 2qol_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596:y | 5e-19 | ||
| 3mpm_A | 267 | Lck Complexed With A Pyrazolopyrimidine Length = 26 | 8e-19 | ||
| 2hen_A | 286 | Crystal Structure Of The Ephb2 Receptor Kinase Doma | 1e-18 | ||
| 2qon_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 1e-18 | ||
| 2qob_A | 344 | Human Epha3 Kinase Domain, Base Structure Length = | 1e-18 | ||
| 2vwu_A | 302 | Ephb4 Kinase Domain Inhibitor Complex Length = 302 | 1e-18 | ||
| 2qo7_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Dephos | 2e-18 | ||
| 2i1m_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An | 2e-18 | ||
| 2gqg_A | 278 | X-Ray Crystal Structure Of Dasatinib (Bms-354825) B | 2e-18 | ||
| 4aw5_A | 291 | Complex Of The Ephb4 Kinase Domain With An Oxindole | 2e-18 | ||
| 1qpd_A | 279 | Structural Analysis Of The Lymphocyte-specific Kina | 2e-18 | ||
| 3qrj_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain T | 2e-18 | ||
| 2v7a_A | 286 | Crystal Structure Of The T315i Abl Mutant In Comple | 2e-18 | ||
| 3bea_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A P | 2e-18 | ||
| 3qri_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain I | 2e-18 | ||
| 3c1x_A | 373 | Crystal Structure Of The Tyrosine Kinase Domain Of | 2e-18 | ||
| 2ogv_A | 317 | Crystal Structure Of The Autoinhibited Human C-Fms | 3e-18 | ||
| 2hzi_A | 277 | Abl Kinase Domain In Complex With Pd180970 Length = | 3e-18 | ||
| 3dkc_A | 317 | Sgx Clone 5698a65kfg1h1 Length = 317 | 3e-18 | ||
| 1k3a_A | 299 | Structure Of The Insulin-Like Growth Factor 1 Recep | 3e-18 | ||
| 1r0p_A | 312 | Crystal Structure Of The Tyrosine Kinase Domain Of | 3e-18 | ||
| 3dkg_A | 317 | Sgx Clone 5698a109kfg1h1 Length = 317 | 3e-18 | ||
| 3cth_A | 314 | Crystal Structure Of The Tyrosine Kinase Domain Of | 3e-18 | ||
| 2hyy_A | 273 | Human Abl Kinase Domain In Complex With Imatinib (S | 3e-18 | ||
| 1rqq_A | 306 | Crystal Structure Of The Insulin Receptor Kinase In | 3e-18 | ||
| 3qti_A | 314 | C-Met Kinase In Complex With Nvp-Bvu972 Length = 31 | 3e-18 | ||
| 3a4p_A | 319 | Human C-Met Kinase Domain Complexed With 6-Benzylox | 3e-18 | ||
| 2hz0_A | 270 | Abl Kinase Domain In Complex With Nvp-Aeg082 Length | 3e-18 | ||
| 4hct_A | 269 | Crystal Structure Of Itk In Complex With Compound 5 | 3e-18 | ||
| 2zm3_A | 308 | Complex Structure Of Insulin-Like Growth Factor Rec | 3e-18 | ||
| 3lcd_A | 329 | Inhibitor Bound To A Dfg-In Structure Of The Kinase | 3e-18 | ||
| 2z8c_A | 303 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 4e-18 | ||
| 1ir3_A | 306 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 4e-18 | ||
| 3pyy_A | 298 | Discovery And Characterization Of A Cell-Permeable, | 4e-18 | ||
| 2e2b_A | 293 | Crystal Structure Of The C-Abl Kinase Domain In Com | 4e-18 | ||
| 2f4j_A | 287 | Structure Of The Kinase Domain Of An Imatinib-Resis | 4e-18 | ||
| 3v5j_A | 266 | Crystal Structure Of Interleukin-2 Inducible T-Cell | 4e-18 | ||
| 2g2f_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 4e-18 | ||
| 2hiw_A | 287 | Crystal Structure Of Inactive Conformation Abl Kina | 4e-18 | ||
| 1sm2_A | 264 | Crystal Structure Of The Phosphorylated Interleukin | 4e-18 | ||
| 2g1t_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 4e-18 | ||
| 3dk6_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 6e-18 | ||
| 2i0v_A | 335 | C-Fms Tyrosine Kinase In Complex With A Quinolone I | 7e-18 | ||
| 3q6w_A | 307 | Structure Of Dually-phosphorylated Met Receptor Kin | 8e-18 | ||
| 2hel_A | 306 | Crystal Structure Of A Mutant Epha4 Kinase Domain ( | 8e-18 | ||
| 3qgw_A | 286 | Crystal Structure Of Itk Kinase Bound To An Inhibit | 9e-18 | ||
| 1p4o_A | 322 | Structure Of Apo Unactivated Igf-1r Kinase Domain A | 9e-18 | ||
| 3oy3_A | 284 | Crystal Structure Of Abl T315i Mutant Kinase Domain | 9e-18 | ||
| 2z60_A | 288 | Crystal Structure Of The T315i Mutant Of Abl Kinase | 9e-18 | ||
| 3dk7_A | 277 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 9e-18 | ||
| 3oxz_A | 284 | Crystal Structure Of Abl Kinase Domain Bound With A | 1e-17 | ||
| 1fpu_A | 293 | Crystal Structure Of Abl Kinase Domain In Complex W | 1e-17 | ||
| 2qoh_A | 288 | Crystal Structure Of Abl Kinase Bound With Ppy-a Le | 1e-17 | ||
| 1m7n_A | 322 | Crystal Structure Of Unactivated Apo Insulin-Like G | 1e-17 | ||
| 3o23_A | 305 | Human Unphosphorylated Igf1-R Kinase Domain In Comp | 1e-17 | ||
| 3i81_A | 315 | Crystal Structure Of Insulin-Like Growth Factor 1 R | 1e-17 | ||
| 1jqh_A | 308 | Igf-1 Receptor Kinase Domain Length = 308 | 1e-17 | ||
| 2wd1_A | 292 | Human C-Met Kinase In Complex With Azaindole Inhibi | 1e-17 | ||
| 3qqu_A | 301 | Cocrystal Structure Of Unphosphorylated Igf With Py | 1e-17 | ||
| 3q6u_A | 308 | Structure Of The Apo Met Receptor Kinase In The Dua | 1e-17 | ||
| 2oj9_A | 307 | Structure Of Igf-1r Kinase Domain Complexed With A | 1e-17 | ||
| 4gg5_A | 319 | Crystal Structure Of Cmet In Complex With Novel Inh | 1e-17 | ||
| 2wgj_A | 306 | X-Ray Structure Of Pf-02341066 Bound To The Kinase | 1e-17 | ||
| 3lw0_A | 304 | Igf-1rk In Complex With Ligand Msc1609119a-1 Length | 1e-17 | ||
| 2g15_A | 318 | Structural Characterization Of Autoinhibited C-Met | 1e-17 | ||
| 3t9t_A | 267 | Crystal Structure Of Btk Mutant (F435t,K596r) Compl | 1e-17 | ||
| 3lq8_A | 302 | Structure Of The Kinase Domain Of C-Met Bound To Xl | 1e-17 | ||
| 1irk_A | 306 | Crystal Structure Of The Tyrosine Kinase Domain Of | 1e-17 | ||
| 3f66_A | 298 | Human C-Met Kinase In Complex With Quinoxaline Inhi | 1e-17 | ||
| 3i5n_A | 309 | Crystal Structure Of C-Met With Triazolopyridazine | 1e-17 | ||
| 2rfn_A | 310 | X-ray Structure Of C-met With Inhibitor. Length = 3 | 1e-17 | ||
| 3eta_A | 317 | Kinase Domain Of Insulin Receptor Complexed With A | 2e-17 | ||
| 3lvp_A | 336 | Crystal Structure Of Bisphosphorylated Igf1-R Kinas | 2e-17 | ||
| 2fo0_A | 495 | Organization Of The Sh3-Sh2 Unit In Active And Inac | 2e-17 | ||
| 1opl_A | 537 | Structural Basis For The Auto-Inhibition Of C-Abl T | 2e-17 | ||
| 1i44_A | 306 | Crystallographic Studies Of An Activation Loop Muta | 2e-17 | ||
| 3dtc_A | 271 | Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp | 3e-17 | ||
| 3dk3_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 3e-17 | ||
| 3d94_A | 301 | Crystal Structure Of The Insulin-Like Growth Factor | 3e-17 | ||
| 2rei_A | 318 | Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep | 4e-17 | ||
| 3miy_A | 266 | X-Ray Crystal Structure Of Itk Complexed With Sunit | 4e-17 | ||
| 3ekk_A | 307 | Insulin Receptor Kinase Complexed With An Inhibitor | 4e-17 | ||
| 1p14_A | 306 | Crystal Structure Of A Catalytic-Loop Mutant Of The | 5e-17 | ||
| 2xyu_A | 285 | Crystal Structure Of Epha4 Kinase Domain In Complex | 5e-17 | ||
| 3s95_A | 310 | Crystal Structure Of The Human Limk1 Kinase Domain | 5e-17 | ||
| 1opk_A | 495 | Structural Basis For The Auto-Inhibition Of C-Abl T | 5e-17 | ||
| 3lco_A | 324 | Inhibitor Bound To A Dfg-Out Structure Of The Kinas | 5e-17 | ||
| 2y6m_A | 291 | Crystal Structure Of Epha4 Kinase Domain Length = 2 | 5e-17 | ||
| 3kul_A | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 9e-17 | ||
| 3a4o_X | 286 | Lyn Kinase Domain Length = 286 | 1e-16 | ||
| 3c4c_A | 280 | B-Raf Kinase In Complex With Plx4720 Length = 280 | 2e-16 | ||
| 2zv7_A | 279 | Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | 2e-16 | ||
| 1yi6_A | 276 | C-Term Tail Segment Of Human Tyrosine Kinase (258-5 | 2e-16 | ||
| 3kul_B | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 2e-16 | ||
| 3tub_A | 293 | Crystal Structure Of Syk Kinase Domain With 1-(5-(6 | 2e-16 | ||
| 3vf8_A | 299 | Crystal Structure Of Spleen Tyrosine Kinase Syk Cat | 2e-16 | ||
| 2bdf_A | 279 | Src Kinase In Complex With Inhibitor Ap23451 Length | 3e-16 | ||
| 1xba_A | 291 | Crystal Structure Of Apo Syk Tyrosine Kinase Domain | 3e-16 | ||
| 3emg_A | 291 | Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylami | 3e-16 | ||
| 3srv_B | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 3e-16 | ||
| 4dfl_A | 274 | Crystal Structure Of Spleen Tyrosine Kinase Complex | 4e-16 | ||
| 4f4p_A | 273 | Syk In Complex With Ligand Lasw836 Length = 273 | 4e-16 | ||
| 1fmk_A | 452 | Crystal Structure Of Human Tyrosine-Protein Kinase | 4e-16 | ||
| 2yjs_A | 342 | Structure Of C1156y Mutant Anaplastic Lymphoma Kina | 4e-16 | ||
| 3dqw_A | 286 | C-Src Kinase Domain Thr338ile Mutant In Complex Wit | 4e-16 | ||
| 4fk3_A | 292 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 4e-16 | ||
| 1y57_A | 452 | Structure Of Unphosphorylated C-Src In Complex With | 5e-16 | ||
| 2h8h_A | 535 | Src Kinase In Complex With A Quinazoline Inhibitor | 5e-16 | ||
| 4fl3_A | 635 | Structural And Biophysical Characterization Of The | 5e-16 | ||
| 4fl2_A | 636 | Structural And Biophysical Characterization Of The | 5e-16 | ||
| 3u4w_A | 275 | Src In Complex With Dna-Templated Macrocyclic Inhib | 6e-16 | ||
| 3d7u_B | 277 | Structural Basis For The Recognition Of C-Src By It | 6e-16 | ||
| 1ksw_A | 452 | Structure Of Human C-Src Tyrosine Kinase (Thr338gly | 6e-16 | ||
| 2r2p_A | 295 | Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep | 7e-16 | ||
| 3srv_A | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 7e-16 | ||
| 3g6h_A | 286 | Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma | 7e-16 | ||
| 3oez_A | 286 | Crystal Structure Of The L317i Mutant Of The Chicke | 7e-16 | ||
| 3og7_A | 289 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 7e-16 | ||
| 2oiq_A | 286 | Crystal Structure Of Chicken C-Src Kinase Domain In | 8e-16 | ||
| 3sxr_A | 268 | Crystal Structure Of Bmx Non-Receptor Tyrosine Kina | 8e-16 | ||
| 3cd3_A | 377 | Crystal Structure Of Phosphorylated Human Feline Sa | 8e-16 | ||
| 4fnw_A | 327 | Crystal Structure Of The Apo F1174l Anaplastic Lymp | 8e-16 | ||
| 3svv_A | 286 | Crystal Structure Of T338c C-Src Covalently Bound T | 9e-16 | ||
| 2fb8_A | 281 | Structure Of The B-Raf Kinase Domain Bound To Sb-59 | 1e-15 | ||
| 4dbn_A | 284 | Crystal Structure Of The Kinase Domain Of Human B-R | 1e-15 | ||
| 4h58_A | 275 | Braf In Complex With Compound 3 Length = 275 | 1e-15 | ||
| 2yjr_A | 342 | Structure Of F1174l Mutant Anaplastic Lymphoma Kina | 1e-15 | ||
| 2xp2_A | 327 | Structure Of The Human Anaplastic Lymphoma Kinase I | 1e-15 | ||
| 2qq7_A | 286 | Crystal Structure Of Drug Resistant Src Kinase Doma | 1e-15 | ||
| 3aox_A | 344 | X-Ray Crystal Structure Of Human Anaplastic Lymphom | 1e-15 | ||
| 3q96_A | 282 | B-Raf Kinase Domain In Complex With A Tetrahydronap | 1e-15 | ||
| 2yfx_A | 327 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 1e-15 | ||
| 4fnz_A | 327 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 1e-15 | ||
| 3d4q_A | 307 | Pyrazole-Based Inhibitors Of B-Raf Kinase Length = | 1e-15 | ||
| 3ii5_A | 306 | The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi | 1e-15 | ||
| 2hk5_A | 270 | Hck Kinase In Complex With Lck Targetted Inhibitor | 1e-15 | ||
| 2hwo_A | 286 | Crystal Structure Of Src Kinase Domain In Complex W | 1e-15 | ||
| 4dce_A | 333 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 1e-15 | ||
| 2yhv_A | 342 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 1e-15 | ||
| 3bkb_A | 377 | Crystal Structure Of Human Feline Sarcoma Viral Onc | 1e-15 | ||
| 4fob_A | 353 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 1e-15 | ||
| 2xb7_A | 315 | Structure Of Human Anaplastic Lymphoma Kinase In Co | 1e-15 | ||
| 1uwh_A | 276 | The Complex Of Wild Type B-Raf And Bay439006 Length | 1e-15 | ||
| 1qcf_A | 454 | Crystal Structure Of Hck In Complex With A Src Fami | 1e-15 | ||
| 1yol_A | 283 | Crystal Structure Of Src Kinase Domain In Complex W | 1e-15 | ||
| 1yoj_A | 283 | Crystal Structure Of Src Kinase Domain Length = 283 | 2e-15 | ||
| 4fnx_A | 327 | Crystal Structure Of The Apo R1275q Anaplastic Lymp | 2e-15 | ||
| 3geq_A | 286 | Structural Basis For The Chemical Rescue Of Src Kin | 2e-15 | ||
| 3lct_A | 344 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 2e-15 | ||
| 3l9p_A | 367 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 2e-15 | ||
| 3gvu_A | 292 | The Crystal Structure Of Human Abl2 In Complex With | 2e-15 | ||
| 3is5_A | 285 | Crystal Structure Of Cdpk Kinase Domain From Toxopl | 2e-15 | ||
| 2r4b_A | 321 | Erbb4 Kinase Domain Complexed With A Thienopyrimidi | 3e-15 | ||
| 3bbt_B | 328 | Crystal Structure Of The Erbb4 Kinase In Complex Wi | 3e-15 | ||
| 1uwj_A | 276 | The Complex Of Mutant V599e B-raf And Bay439006 Len | 3e-15 | ||
| 3idp_A | 300 | B-Raf V600e Kinase Domain In Complex With An Aminoi | 3e-15 | ||
| 2w5a_A | 279 | Human Nek2 Kinase Adp-Bound Length = 279 | 3e-15 | ||
| 4aoj_A | 329 | Human Trka In Complex With The Inhibitor Az-23 Leng | 3e-15 | ||
| 4g9r_A | 307 | B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr | 4e-15 | ||
| 4f0i_A | 300 | Crystal Structure Of Apo Trka Length = 300 | 4e-15 | ||
| 4gt5_A | 306 | Crystal Structure Of The Inactive Trka Kinase Domai | 4e-15 | ||
| 4asz_A | 299 | Crystal Structure Of Apo Trkb Kinase Domain Length | 4e-15 | ||
| 4fsz_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 4e-15 | ||
| 2ptk_A | 453 | Chicken Src Tyrosine Kinase Length = 453 | 4e-15 | ||
| 1u59_A | 287 | Crystal Structure Of The Zap-70 Kinase Domain In Co | 5e-15 | ||
| 2ydj_A | 276 | Discovery Of Checkpoint Kinase Inhibitor Azd7762 By | 5e-15 | ||
| 2y94_A | 476 | Structure Of An Active Form Of Mammalian Ampk Lengt | 6e-15 | ||
| 2dq7_X | 283 | Crystal Structure Of Fyn Kinase Domain Complexed Wi | 6e-15 | ||
| 3omv_A | 307 | Crystal Structure Of C-Raf (Raf-1) Length = 307 | 6e-15 | ||
| 4ft3_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 8e-15 | ||
| 4fsw_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 8e-15 | ||
| 4fst_A | 269 | Crystal Structure Of The Chk1 Length = 269 | 9e-15 | ||
| 2jav_A | 279 | Human Kinase With Pyrrole-Indolinone Ligand Length | 1e-14 | ||
| 4eqm_A | 294 | Structural Analysis Of Staphylococcus Aureus Serine | 1e-14 | ||
| 4fsy_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 1e-14 | ||
| 1zys_A | 273 | Co-Crystal Structure Of Checkpoint Kinase Chk1 With | 1e-14 | ||
| 2ozo_A | 613 | Autoinhibited Intact Human Zap-70 Length = 613 | 1e-14 | ||
| 4fsn_A | 278 | Crystal Structure Of The Chk1 Length = 278 | 2e-14 | ||
| 2r0u_A | 323 | Crystal Structure Of Chek1 In Complex With Inhibito | 2e-14 | ||
| 4fsm_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-14 | ||
| 2hog_A | 322 | Crystal Structure Of Chek1 In Complex With Inhibito | 2e-14 | ||
| 2ayp_A | 269 | Crystal Structure Of Chk1 With An Indol Inhibitor L | 2e-14 | ||
| 2br1_A | 297 | Structure-Based Design Of Novel Chk1 Inhibitors: In | 2e-14 | ||
| 1ia8_A | 289 | The 1.7 A Crystal Structure Of Human Cell Cycle Che | 2e-14 | ||
| 3ot3_A | 273 | X-Ray Crystal Structure Of Compound 22k Bound To Hu | 2e-14 | ||
| 1zlt_A | 295 | Crystal Structure Of Chk1 Complexed With A Hymenald | 2e-14 | ||
| 2ghg_A | 269 | H-Chk1 Complexed With A431994 Length = 269 | 2e-14 | ||
| 2x8e_A | 276 | Discovery Of A Novel Class Of Triazolones As Checkp | 2e-14 | ||
| 2e9v_A | 268 | Structure Of H-Chk1 Complexed With A859017 Length = | 2e-14 | ||
| 1rjb_A | 344 | Crystal Structure Of Flt3 Length = 344 | 2e-14 | ||
| 4a4x_A | 279 | Nek2-Ede Bound To Cct248662 Length = 279 | 2e-14 | ||
| 3jvr_A | 271 | Characterization Of The Chk1 Allosteric Inhibitor B | 2e-14 | ||
| 3d7t_A | 269 | Structural Basis For The Recognition Of C-Src By It | 2e-14 | ||
| 1k9a_A | 450 | Crystal Structure Analysis Of Full-Length Carboxyl- | 2e-14 | ||
| 1byg_A | 278 | Kinase Domain Of Human C-Terminal Src Kinase (Csk) | 2e-14 | ||
| 2oo8_X | 317 | Synthesis, Structural Analysis, And Sar Studies Of | 3e-14 | ||
| 3d7u_A | 263 | Structural Basis For The Recognition Of C-Src By It | 3e-14 | ||
| 1fvr_A | 327 | Tie2 Kinase Domain Length = 327 | 3e-14 | ||
| 3v5q_A | 297 | Discovery Of A Selective Trk Inhibitor With Efficac | 3e-14 | ||
| 3mn3_A | 271 | An Inhibited Conformation For The Protein Kinase Do | 5e-14 | ||
| 2fh9_A | 274 | Structure And Dimerization Of The Kinase Domain Fro | 5e-14 | ||
| 2xuu_A | 334 | Crystal Structure Of A Dap-Kinase 1 Mutant Length = | 6e-14 | ||
| 4fsu_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 6e-14 | ||
| 3ggf_A | 301 | Crystal Structure Of Human SerineTHREONINE-Protein | 6e-14 | ||
| 3hyh_A | 275 | Crystal Structure Of The Protein Kinase Domain Of Y | 6e-14 | ||
| 3dae_A | 283 | Crystal Structure Of Phosphorylated Snf1 Kinase Dom | 6e-14 | ||
| 3k54_A | 283 | Structures Of Human Bruton's Tyrosine Kinase In Act | 7e-14 | ||
| 3g0f_A | 336 | Kit Kinase Domain Mutant D816h In Complex With Suni | 8e-14 | ||
| 2jfm_A | 325 | Crystal Structure Of Human Ste20-Like Kinase (Unlig | 8e-14 | ||
| 2xa4_A | 298 | Inhibitors Of Jak2 Kinase Domain Length = 298 | 8e-14 | ||
| 2j51_A | 325 | Crystal Structure Of Human Ste20-Like Kinase Bound | 8e-14 | ||
| 1t46_A | 313 | Structural Basis For The Autoinhibition And Sti-571 | 8e-14 | ||
| 2j90_A | 304 | Crystal Structure Of Human Zip Kinase In Complex Wi | 9e-14 | ||
| 1t45_A | 331 | Structural Basis For The Autoinhibition And Sti-571 | 1e-13 | ||
| 2x0g_A | 334 | X-ray Structure Of A Dap-kinase Calmodulin Complex | 1e-13 | ||
| 3gen_A | 283 | The 1.6 A Crystal Structure Of Human Bruton's Tyros | 1e-13 | ||
| 2wqb_A | 324 | Structure Of The Tie2 Kinase Domain In Complex With | 1e-13 | ||
| 3bhy_A | 283 | Crystal Structure Of Human Death Associated Protein | 1e-13 | ||
| 1f3m_C | 297 | Crystal Structure Of Human SerineTHREONINE KINASE P | 1e-13 | ||
| 1pkg_A | 329 | Structure Of A C-kit Kinase Product Complex Length | 1e-13 | ||
| 3g0e_A | 336 | Kit Kinase Domain In Complex With Sunitinib Length | 1e-13 | ||
| 1ad5_A | 438 | Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | 1e-13 | ||
| 3oct_A | 265 | Crystal Structure Of Bruton's Tyrosine Kinase Mutan | 1e-13 | ||
| 3uto_A | 573 | Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin- | 1e-13 | ||
| 1yrp_A | 278 | Catalytic Domain Of Human Zip Kinase Phosphorylated | 1e-13 | ||
| 2h6d_A | 276 | Protein Kinase Domain Of The Human 5'-Amp-Activated | 1e-13 | ||
| 3gu4_A | 295 | Crystal Structure Of Dapkq23v-Amppnp Length = 295 | 1e-13 | ||
| 3ckw_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 1e-13 | ||
| 2jfl_A | 325 | Crystal Structure Of Human Ste20-Like Kinase ( Diph | 1e-13 | ||
| 4e6d_A | 298 | Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W | 1e-13 | ||
| 1p4f_A | 293 | Death Associated Protein Kinase Catalytic Domain Wi | 1e-13 | ||
| 1koa_A | 491 | Twitchin Kinase Fragment (C.Elegans), Autoregulated | 1e-13 | ||
| 3p08_A | 267 | Crystal Structure Of The Human Btk Kinase Domain Le | 1e-13 | ||
| 3dfc_B | 295 | Crystal Structure Of A Glycine-Rich Loop Mutant Of | 1e-13 | ||
| 3zhp_C | 294 | Human Mst3 (stk24) In Complex With Mo25beta Length | 1e-13 | ||
| 1ig1_A | 294 | 1.8a X-Ray Structure Of Ternary Complex Of A Cataly | 1e-13 | ||
| 2xzs_A | 312 | Death Associated Protein Kinase 1 Residues 1-312 Le | 1e-13 | ||
| 3f5u_A | 295 | Crystal Structure Of The Death Associated Protein K | 1e-13 | ||
| 2w4k_A | 302 | X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | 2e-13 | ||
| 1wvw_A | 278 | Crystal Structures Of Kinase Domain Of Dap Kinase I | 2e-13 | ||
| 2yak_A | 285 | Structure Of Death-Associated Protein Kinase 1 (Dap | 2e-13 | ||
| 2w4j_A | 277 | X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | 2e-13 | ||
| 2ivt_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 2e-13 | ||
| 3pix_A | 274 | Crystal Structure Of Btk Kinase Domain Complexed Wi | 2e-13 | ||
| 3tjc_A | 298 | Co-Crystal Structure Of Jak2 With Thienopyridine 8 | 2e-13 | ||
| 3e62_A | 293 | Fragment Based Discovery Of Jak-2 Inhibitors Length | 2e-13 | ||
| 3rvg_A | 303 | Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido | 2e-13 | ||
| 3t8o_A | 543 | Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu | 2e-13 | ||
| 2yza_A | 276 | Crystal Structure Of Kinase Domain Of Human 5'-Amp- | 2e-13 | ||
| 2b7a_A | 293 | The Structural Basis Of Janus Kinase 2 Inhibition B | 2e-13 | ||
| 4hge_A | 300 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 | 2e-13 | ||
| 3ocs_A | 271 | Crystal Structure Of Bruton's Tyrosine Kinase In Co | 2e-13 | ||
| 1k2p_A | 263 | Crystal Structure Of Bruton's Tyrosine Kinase Domai | 2e-13 | ||
| 2w1i_A | 326 | Structure Determination Of Aurora Kinase In Complex | 2e-13 | ||
| 3q32_A | 301 | Structure Of Janus Kinase 2 With A Pyrrolotriazine | 2e-13 | ||
| 4e4m_A | 302 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 3 | 2e-13 | ||
| 3c4x_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 2e-13 | ||
| 3coh_A | 268 | Crystal Structure Of Aurora-A In Complex With A Pen | 2e-13 | ||
| 4hvd_A | 314 | Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h | 2e-13 | ||
| 3lpb_A | 295 | Crystal Structure Of Jak2 Complexed With A Potent 2 | 2e-13 | ||
| 4aqc_A | 301 | Triazolopyridine-Based Inhibitor Of Janus Kinase 2 | 2e-13 | ||
| 3qc9_A | 543 | Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4 | 2e-13 | ||
| 2ivs_A | 314 | Crystal Structure Of Non-Phosphorylated Ret Tyrosin | 2e-13 | ||
| 3qbn_A | 281 | Structure Of Human Aurora A In Complex With A Diami | 3e-13 | ||
| 2j4z_A | 306 | Structure Of Aurora-2 In Complex With Pha-680626 Le | 3e-13 | ||
| 3c4w_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 3e-13 | ||
| 2ivv_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 3e-13 | ||
| 2y0a_A | 326 | Structure Of Dapk1 Construct Residues 1-304 Length | 3e-13 | ||
| 3pjc_A | 315 | Crystal Structure Of Jak3 Complexed With A Potent A | 3e-13 | ||
| 1muo_A | 297 | Crystal Structure Of Aurora-2, An Oncogenic Serine- | 3e-13 | ||
| 2xng_A | 283 | Structure Of Aurora-A Bound To A Selective Imidazop | 3e-13 | ||
| 3qa8_A | 676 | Crystal Structure Of Inhibitor Of Kappa B Kinase Be | 3e-13 | ||
| 2x6d_A | 285 | Aurora-A Bound To An Inhibitor Length = 285 | 3e-13 | ||
| 3jy9_A | 311 | Janus Kinase 2 Inhibitors Length = 311 | 3e-13 | ||
| 3io7_A | 313 | 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel | 3e-13 | ||
| 3lxk_A | 327 | Structural And Thermodynamic Characterization Of Th | 3e-13 | ||
| 3gu8_A | 295 | Crystal Structure Of Dapkl93g With N6-Cyclopentylad | 3e-13 | ||
| 2dwb_A | 285 | Aurora-A Kinase Complexed With Amppnp Length = 285 | 3e-13 | ||
| 3rzf_A | 677 | Crystal Structure Of Inhibitor Of Kappab Kinase Bet | 3e-13 | ||
| 2xir_A | 316 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 3e-13 | ||
| 3o50_A | 267 | Crystal Structure Of Benzamide 9 Bound To Auroraa L | 3e-13 | ||
| 3u6j_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 3e-13 | ||
| 1kob_A | 387 | Twitchin Kinase Fragment (Aplysia), Autoregulated P | 4e-13 | ||
| 2j50_A | 280 | Structure Of Aurora-2 In Complex With Pha-739358 Le | 4e-13 | ||
| 4agc_A | 353 | Crystal Structure Of Vegfr2 (Juxtamembrane And Kina | 4e-13 | ||
| 2xru_A | 280 | Aurora-A T288e Complexed With Pha-828300 Length = 2 | 4e-13 | ||
| 3h0y_A | 268 | Aurora A In Complex With A Bisanilinopyrimidine Len | 4e-13 | ||
| 3nrm_A | 283 | Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito | 4e-13 | ||
| 3ugc_A | 295 | Structural Basis Of Jak2 Inhibition By The Type Ii | 4e-13 | ||
| 3ewh_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 4e-13 | ||
| 2xik_A | 294 | Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K | 4e-13 | ||
| 2w1d_A | 275 | Structure Determination Of Aurora Kinase In Complex | 4e-13 | ||
| 1mq4_A | 272 | Crystal Structure Of Aurora-A Protein Kinase Length | 4e-13 | ||
| 3e5a_A | 268 | Crystal Structure Of Aurora A In Complex With Vx-68 | 5e-13 | ||
| 3q52_A | 306 | Structure Of Phosphorylated Pak1 Kinase Domain Leng | 5e-13 | ||
| 1ywn_A | 316 | Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]p | 5e-13 | ||
| 3a7f_A | 303 | Human Mst3 Kinase Length = 303 | 5e-13 | ||
| 3fxz_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Ruthen | 5e-13 | ||
| 2p2i_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 5e-13 | ||
| 3fdn_A | 279 | Structure-Based Drug Design Of Novel Aurora Kinase | 5e-13 | ||
| 2wtw_A | 285 | Aurora-A Inhibitor Structure (2nd Crystal Form) Len | 5e-13 | ||
| 2c6d_A | 275 | Aurora A Kinase Activated Mutant (T287d) In Complex | 5e-13 | ||
| 3q4z_A | 306 | Structure Of Unphosphorylated Pak1 Kinase Domain Le | 5e-13 | ||
| 3lau_A | 287 | Crystal Structure Of Aurora2 Kinase In Complex With | 5e-13 | ||
| 3ckx_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 5e-13 | ||
| 1yhv_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Two Po | 5e-13 | ||
| 3d14_A | 272 | Crystal Structure Of Mouse Aurora A (Asn186->gly, L | 6e-13 | ||
| 4bbe_A | 298 | Aminoalkylpyrimidine Inhibitor Complexes With Jak2 | 6e-13 | ||
| 2p2h_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 6e-13 | ||
| 2c6e_A | 283 | Aurora A Kinase Activated Mutant (T287d) In Complex | 6e-13 | ||
| 1vr2_A | 316 | Human Vascular Endothelial Growth Factor Receptor 2 | 6e-13 | ||
| 2wqe_A | 262 | Structure Of S155r Aurora-A Somatic Mutant Length = | 7e-13 | ||
| 3cjf_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 7e-13 | ||
| 2jam_A | 304 | Crystal Structure Of Human Calmodulin-Dependent Pro | 8e-13 | ||
| 3c7q_A | 316 | Structure Of Vegfr2 Kinase Domain In Complex With B | 8e-13 | ||
| 3vnt_A | 318 | Crystal Structure Of The Kinase Domain Of Human Veg | 9e-13 | ||
| 3cjg_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 9e-13 | ||
| 2wtv_A | 285 | Aurora-A Inhibitor Structure Length = 285 | 1e-12 | ||
| 2oh4_A | 316 | Crystal Structure Of Vegfr2 With A Benzimidazole-Ur | 1e-12 | ||
| 1ol6_A | 282 | Structure Of Unphosphorylated D274n Mutant Of Auror | 1e-12 | ||
| 4fg7_A | 293 | Crystal Structure Of Human Calcium/calmodulin-depen | 1e-12 | ||
| 1luf_A | 343 | Crystal Structure Of The Musk Tyrosine Kinase: Insi | 1e-12 | ||
| 4fg8_A | 315 | Crystal Structure Of Human Calcium/calmodulin-depen | 1e-12 | ||
| 1ol5_A | 282 | Structure Of Aurora-A 122-403, Phosphorylated On Th | 1e-12 | ||
| 2jc6_A | 334 | Crystal Structure Of Human Calmodulin-Dependent Pro | 1e-12 | ||
| 2xne_A | 272 | Structure Of Aurora-A Bound To An Imidazopyrazine I | 1e-12 | ||
| 4fg9_A | 320 | Crystal Structure Of Human Calcium/calmodulin-depen | 1e-12 | ||
| 4e4l_A | 302 | Jak1 Kinase (Jh1 Domain) In Complex With Compound 3 | 1e-12 | ||
| 3unz_A | 279 | Aurora A In Complex With Rpm1679 Length = 279 | 2e-12 | ||
| 1yvj_A | 290 | Crystal Structure Of The Jak3 Kinase Domain In Comp | 2e-12 | ||
| 2bmc_A | 306 | Aurora-2 T287d T288d Complexed With Pha-680632 Leng | 2e-12 | ||
| 1a06_A | 332 | Calmodulin-Dependent Protein Kinase From Rat Length | 2e-12 | ||
| 2x7f_A | 326 | Crystal Structure Of The Kinase Domain Of Human Tra | 2e-12 | ||
| 3eyg_A | 290 | Crystal Structures Of Jak1 And Jak2 Inhibitor Compl | 2e-12 | ||
| 2w1c_A | 275 | Structure Determination Of Aurora Kinase In Complex | 2e-12 | ||
| 3ha6_A | 268 | Crystal Structure Of Aurora A In Complex With Tpx2 | 2e-12 | ||
| 2acx_A | 576 | Crystal Structure Of G Protein Coupled Receptor Kin | 2e-12 | ||
| 3nyn_A | 576 | Crystal Structure Of G Protein-Coupled Receptor Kin | 2e-12 | ||
| 3r21_A | 271 | Design, Synthesis, And Biological Evaluation Of Pyr | 2e-12 | ||
| 3daj_A | 272 | Crystal Structure Of Aurora A Complexed With An Inh | 3e-12 | ||
| 4f0f_A | 287 | Crystal Structure Of The Roco4 Kinase Domain Bound | 3e-12 | ||
| 2uv2_A | 287 | Crystal Structure Of Human Ste20-Like Kinase Bound | 3e-12 | ||
| 3cok_A | 278 | Crystal Structure Of Plk4 Kinase Length = 278 | 3e-12 | ||
| 2p0c_A | 313 | Catalytic Domain Of The Proto-Oncogene Tyrosine-Pro | 4e-12 | ||
| 3pls_A | 298 | Ron In Complex With Ligand Amp-Pnp Length = 298 | 4e-12 | ||
| 3com_A | 314 | Crystal Structure Of Mst1 Kinase Length = 314 | 7e-12 | ||
| 1fot_A | 318 | Structure Of The Unliganded Camp-Dependent Protein | 7e-12 | ||
| 3zzw_A | 289 | Crystal Structure Of The Kinase Domain Of Ror2 Leng | 7e-12 | ||
| 4gt4_A | 308 | Structure Of Unliganded, Inactive Ror2 Kinase Domai | 8e-12 | ||
| 1zy4_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 9e-12 | ||
| 2pzr_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 9e-12 | ||
| 3iw4_A | 360 | Crystal Structure Of Pkc Alpha In Complex With Nvp- | 9e-12 | ||
| 1wmk_A | 321 | Human Death-Associated Kinase Drp-1, Mutant S308d D | 9e-12 | ||
| 2a2a_A | 321 | High-resolution Crystallographic Analysis Of The Au | 1e-11 | ||
| 2pk9_A | 317 | Structure Of The Pho85-pho80 Cdk-cyclin Complex Of | 1e-11 | ||
| 3gqi_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 1e-11 | ||
| 3cly_A | 334 | Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase | 1e-11 | ||
| 2pvf_A | 334 | Crystal Structure Of Tyrosine Phosphorylated Activa | 1e-11 | ||
| 2j7t_A | 302 | Crystal Structure Of Human Serine Threonine Kinase- | 1e-11 | ||
| 2f57_A | 317 | Crystal Structure Of The Human P21-activated Kinase | 1e-11 | ||
| 2a27_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 1e-11 | ||
| 4bc6_A | 293 | Crystal Structure Of Human Serine Threonine Kinase- | 1e-11 | ||
| 1z9x_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 1e-11 | ||
| 1zws_A | 288 | Crystal Structure Of The Catalytic Domain Of Human | 1e-11 | ||
| 3nyx_A | 302 | Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T | 1e-11 | ||
| 4f1m_A | 287 | Crystal Structure Of The G1179s Roco4 Kinase Domain | 1e-11 | ||
| 3nz0_A | 302 | Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3 | 1e-11 | ||
| 4f1o_A | 287 | Crystal Structure Of The L1180t Mutant Roco4 Kinase | 1e-11 | ||
| 3q4t_A | 322 | Crystal Structure Of Activin Receptor Type-Iia (Acv | 2e-11 | ||
| 3lmg_A | 344 | Crystal Structure Of The Erbb3 Kinase Domain In Com | 2e-11 | ||
| 3h4j_B | 336 | Crystal Structure Of Pombe Ampk Kdaid Fragment Leng | 2e-11 | ||
| 2ya9_A | 361 | Crystal Structure Of The Autoinhibited Form Of Mous | 2e-11 | ||
| 3kex_A | 325 | Crystal Structure Of The Catalytically Inactive Kin | 2e-11 | ||
| 2pvy_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-11 | ||
| 3oz6_A | 388 | Crystal Structure Of Mapk From Cryptosporidium Parv | 2e-11 | ||
| 2pwl_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-11 | ||
| 3c4f_A | 302 | Fgfr Tyrosine Kinase Domain In Complex With 3-(3- M | 2e-11 | ||
| 3lxn_A | 318 | Structural And Thermodynamic Characterization Of Th | 2e-11 | ||
| 3kxx_A | 317 | Structure Of The Mutant Fibroblast Growth Factor Re | 2e-11 | ||
| 2pzp_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-11 | ||
| 1zmw_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 3e-11 | ||
| 3rhx_B | 306 | Crystal Structure Of The Catalytic Domain Of Fgfr1 | 3e-11 | ||
| 1fgk_A | 310 | Crystal Structure Of The Tyrosine Kinase Domain Of | 3e-11 | ||
| 2pz5_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 3e-11 | ||
| 4aaa_A | 331 | Crystal Structure Of The Human Cdkl2 Kinase Domain | 3e-11 | ||
| 3gql_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 3e-11 | ||
| 3js2_A | 317 | Crystal Structure Of Minimal Kinase Domain Of Fibro | 3e-11 | ||
| 4f63_A | 309 | Crystal Structure Of Human Fibroblast Growth Factor | 3e-11 | ||
| 2y7j_A | 365 | Structure Of Human Phosphorylase Kinase, Gamma 2 Le | 3e-11 | ||
| 2cdz_A | 303 | Crystal Structure Of The Human P21-Activated Kinase | 3e-11 | ||
| 1y8g_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 3e-11 | ||
| 2q0n_A | 301 | Structure Of Human P21 Activating Kinase 4 (Pak4) I | 3e-11 | ||
| 3kk9_A | 282 | Camkii Substrate Complex B Length = 282 | 4e-11 | ||
| 4fie_A | 423 | Full-Length Human Pak4 Length = 423 | 4e-11 | ||
| 3kk8_A | 284 | Camkii Substrate Complex A Length = 284 | 4e-11 | ||
| 3kl8_A | 269 | Camkiintide Inhibitor Complex Length = 269 | 4e-11 | ||
| 1bi8_A | 326 | Mechanism Of G1 Cyclin Dependent Kinase Inhibition | 4e-11 | ||
| 1jow_B | 308 | Crystal Structure Of A Complex Of Human Cdk6 And A | 4e-11 | ||
| 3pp0_A | 338 | Crystal Structure Of The Kinase Domain Of Human Her | 4e-11 | ||
| 3tt0_A | 382 | Co-Structure Of Fibroblast Growth Factor Receptor 1 | 4e-11 | ||
| 3nup_A | 307 | Cdk6 (Monomeric) In Complex With Inhibitor Length = | 4e-11 | ||
| 4eoj_A | 302 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 5e-11 | ||
| 2bva_A | 292 | Crystal Structure Of The Human P21-Activated Kinase | 5e-11 | ||
| 1zmu_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 5e-11 | ||
| 2clq_A | 295 | Structure Of Mitogen-Activated Protein Kinase Kinas | 5e-11 | ||
| 4eok_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 5e-11 | ||
| 2r0i_A | 327 | Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len | 5e-11 | ||
| 3fpq_A | 290 | Crystal Structure Of The Kinase Domain Of Wnk1 Leng | 6e-11 | ||
| 2vwi_A | 303 | Structure Of The Osr1 Kinase, A Hypertension Drug T | 6e-11 | ||
| 2bdw_A | 362 | Crystal Structure Of The Auto-Inhibited Kinase Doma | 6e-11 | ||
| 3q5i_A | 504 | Crystal Structure Of Pbanka_031420 Length = 504 | 6e-11 | ||
| 3dak_A | 290 | Crystal Structure Of Domain-Swapped Osr1 Kinase Dom | 6e-11 | ||
| 3g33_A | 308 | Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | 6e-11 | ||
| 4fif_A | 346 | Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid | 6e-11 | ||
| 2w4o_A | 349 | Crystal Structure Of Human Camk4 In Complex With 4- | 6e-11 | ||
| 2x4z_A | 296 | Crystal Structure Of The Human P21-Activated Kinase | 6e-11 | ||
| 2psq_A | 370 | Crystal Structure Of Unphosphorylated Unactivated W | 7e-11 | ||
| 1zyc_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 7e-11 | ||
| 1gz8_A | 299 | Human Cyclin Dependent Kinase 2 Complexed With The | 7e-11 | ||
| 4erw_A | 306 | Cdk2 In Complex With Staurosporine Length = 306 | 8e-11 | ||
| 3vw6_A | 269 | Crystal Structure Of Human Apoptosis Signal-Regulat | 8e-11 | ||
| 1pf8_A | 298 | Crystal Structure Of Human Cyclin-dependent Kinase | 9e-11 | ||
| 3b2t_A | 311 | Structure Of Phosphotransferase Length = 311 | 9e-11 | ||
| 1zmv_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 9e-11 | ||
| 3ri1_A | 313 | Crystal Structure Of The Catalytic Domain Of Fgfr2 | 9e-11 | ||
| 3txo_A | 353 | Pkc Eta Kinase In Complex With A Naphthyridine Leng | 9e-11 | ||
| 1gjo_A | 316 | The Fgfr2 Tyrosine Kinase Domain Length = 316 | 1e-10 | ||
| 3pxf_A | 306 | Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N | 1e-10 | ||
| 2w17_A | 299 | Cdk2 In Complex With The Imidazole Pyrimidine Amide | 1e-10 | ||
| 2wzj_A | 327 | Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82 | 1e-10 | ||
| 1fin_A | 298 | Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = | 1e-10 | ||
| 3ezr_A | 300 | Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ | 1e-10 | ||
| 3pj8_A | 299 | Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D] | 1e-10 | ||
| 2a19_B | 284 | Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng | 1e-10 | ||
| 1oit_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 1e-10 | ||
| 1vyw_A | 309 | Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = | 1e-10 | ||
| 2q0b_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 1e-10 | ||
| 2hak_A | 328 | Catalytic And Ubiqutin-Associated Domains Of Mark1P | 1e-10 | ||
| 1e9h_A | 297 | Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex | 1e-10 | ||
| 3vum_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M7 | 1e-10 | ||
| 1w98_A | 298 | The Structural Basis Of Cdk2 Activation By Cyclin E | 1e-10 | ||
| 1qmz_A | 299 | Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com | 1e-10 | ||
| 3fe3_A | 328 | Crystal Structure Of The Kinase Mark3PAR-1: T211a-S | 1e-10 | ||
| 4eos_A | 300 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 1e-10 | ||
| 4eoq_A | 301 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 1e-10 | ||
| 4bcq_A | 301 | Structure Of Cdk2 In Complex With Cyclin A And A 2- | 1e-10 | ||
| 1jst_A | 298 | Phosphorylated Cyclin-Dependent Kinase-2 Bound To C | 1e-10 | ||
| 3bht_A | 300 | Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN | 1e-10 | ||
| 2jgz_A | 289 | Crystal Structure Of Phospho-Cdk2 In Complex With C | 2e-10 | ||
| 2iw6_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com | 2e-10 | ||
| 1h1p_A | 303 | Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP | 2e-10 | ||
| 4i3z_A | 296 | Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES | 2e-10 | ||
| 1ogu_A | 302 | Structure Of Human Thr160-phospho Cdk2/cyclin A Com | 2e-10 | ||
| 4eom_A | 301 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 2e-10 | ||
| 4eon_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 2e-10 | ||
| 3qhr_A | 298 | Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic | 2e-10 | ||
| 2jiu_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 2e-10 | ||
| 2py3_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-10 | ||
| 2jiv_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 2e-10 | ||
| 2w99_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 2e-10 | ||
| 1ua2_A | 346 | Crystal Structure Of Human Cdk7 Length = 346 | 2e-10 | ||
| 4fvp_A | 289 | Crystal Structure Of The Jak2 Pseudokinase Domain ( | 2e-10 | ||
| 4g5p_A | 330 | Crystal Structure Of Egfr Kinase T790m In Complex W | 2e-10 | ||
| 2puu_A | 348 | Crystal Structure Of P38 Complex With 1-(5-Tert-But | 2e-10 | ||
| 4i24_A | 329 | Structure Of T790m Egfr Kinase Domain Co-crystalliz | 2e-10 | ||
| 2jit_A | 327 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 2e-10 | ||
| 3g2f_A | 336 | Crystal Structure Of The Kinase Domain Of Bone Morp | 2e-10 | ||
| 1lew_A | 360 | Crystal Structure Of Map Kinase P38 Complexed To Th | 2e-10 | ||
| 3ika_A | 331 | Crystal Structure Of Egfr 696-1022 T790m Mutant Cov | 2e-10 | ||
| 3p4k_A | 370 | The Third Conformation Of P38a Map Kinase Observed | 2e-10 | ||
| 3vul_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 2e-10 | ||
| 1ywr_A | 360 | Crystal Structure Analysis Of Inactive P38 Kinase D | 3e-10 | ||
| 4hjo_A | 337 | Crystal Structure Of The Inactive Egfr Tyrosine Kin | 3e-10 | ||
| 1yw2_A | 360 | Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | 3e-10 | ||
| 2j5e_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 3e-10 | ||
| 2gtm_A | 348 | Mutated Mouse P38 Map Kinase Domain In Complex With | 3e-10 | ||
| 3d83_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 3e-10 | ||
| 3lzb_A | 327 | Egfr Kinase Domain Complexed With An Imidazo[2,1-B] | 3e-10 | ||
| 3bel_A | 315 | X-Ray Structure Of Egfr In Complex With Oxime Inhib | 3e-10 | ||
| 2j5f_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 3e-10 | ||
| 2w96_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 3e-10 | ||
| 1bmk_A | 379 | The Complex Structure Of The Map Kinase P38SB218655 | 3e-10 | ||
| 3tg1_A | 380 | Crystal Structure Of P38alpha In Complex With A Map | 3e-10 | ||
| 3py3_A | 380 | Crystal Structure Of Phosphorylated P38alpha Map Ki | 3e-10 | ||
| 2baq_A | 365 | P38alpha Bound To Ro3201195 Length = 365 | 3e-10 | ||
| 2qnj_A | 328 | Kinase And Ubiquitin-Associated Domains Of Mark3PAR | 3e-10 | ||
| 4i23_A | 329 | Crystal Structure Of The Wild-type Egfr Kinase Doma | 3e-10 | ||
| 1xjd_A | 345 | Crystal Structure Of Pkc-Theta Complexed With Staur | 3e-10 | ||
| 4g5j_A | 330 | Crystal Structure Of Egfr Kinase In Complex With Bi | 3e-10 | ||
| 3iec_A | 319 | Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K | 3e-10 | ||
| 2gs2_A | 330 | Crystal Structure Of The Active Egfr Kinase Domain | 3e-10 | ||
| 3vjo_A | 334 | Crystal Structure Of The Wild-Type Egfr Kinase Doma | 3e-10 | ||
| 2gs7_A | 330 | Crystal Structure Of The Inactive Egfr Kinase Domai | 3e-10 | ||
| 3uiu_A | 306 | Crystal Structure Of Apo-Pkr Kinase Domain Length = | 3e-10 | ||
| 1m14_A | 333 | Tyrosine Kinase Domain From Epidermal Growth Factor | 3e-10 | ||
| 2ghl_A | 348 | Mutant Mus Musculus P38 Kinase Domain In Complex Wi | 3e-10 | ||
| 1xkk_A | 352 | Egfr Kinase Domain Complexed With A Quinazoline Inh | 3e-10 | ||
| 4eoi_A | 299 | Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc | 4e-10 | ||
| 3oht_A | 389 | Crystal Structure Of Salmo Salar P38alpha Length = | 4e-10 | ||
| 3aln_A | 327 | Crystal Structure Of Human Non-Phosphorylated Mkk4 | 4e-10 | ||
| 2w9f_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 4e-10 | ||
| 2z7q_A | 321 | Crystal Structure Of The N-Terminal Kinase Domain O | 4e-10 | ||
| 2bal_A | 365 | P38alpha Map Kinase Bound To Pyrazoloamine Length = | 4e-10 | ||
| 2oza_B | 366 | Structure Of P38alpha Complex Length = 366 | 4e-10 | ||
| 2jed_A | 352 | The Crystal Structure Of The Kinase Domain Of The P | 4e-10 | ||
| 3rny_A | 346 | Crystal Structure Of Human Rsk1 C-Terminal Kinase D | 4e-10 | ||
| 2rfd_A | 324 | Crystal Structure Of The Complex Between The Egfr K | 4e-10 | ||
| 4eop_A | 300 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 4e-10 | ||
| 3e92_A | 371 | Crystal Structure Of P38 Kinase In Complex With A B | 4e-10 | ||
| 2qr8_A | 342 | 2.0a X-ray Structure Of C-terminal Kinase Domain Of | 4e-10 | ||
| 1oir_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 4e-10 | ||
| 1h01_A | 298 | Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili | 4e-10 | ||
| 3mfr_A | 351 | Cask-4m Cam Kinase Domain, Native Length = 351 | 4e-10 | ||
| 2bfy_A | 284 | Complex Of Aurora-B With Incenp And Hesperidin. Len | 4e-10 | ||
| 4eoo_A | 299 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 4e-10 | ||
| 2bfx_B | 284 | Mechanism Of Aurora-B Activation By Incenp And Inhi | 4e-10 | ||
| 4fvr_A | 289 | Crystal Structure Of The Jak2 Pseudokinase Domain M | 4e-10 | ||
| 3gcp_A | 360 | Human P38 Map Kinase In Complex With Sb203580 Lengt | 5e-10 | ||
| 2wnt_A | 330 | Crystal Structure Of The Human Ribosomal Protein S6 | 5e-10 | ||
| 2y8o_A | 362 | Crystal Structure Of Human P38alpha Complexed With | 5e-10 | ||
| 2vrx_A | 285 | Structure Of Aurora B Kinase In Complex With Zm4474 | 5e-10 | ||
| 3zgw_A | 347 | Crystal Structure Of Maternal Embryonic Leucine Zip | 5e-10 | ||
| 3d7z_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 5e-10 | ||
| 1ove_A | 366 | The Structure Of P38 Alpha In Complex With A Dihydr | 5e-10 | ||
| 3g51_A | 325 | Structural Diversity Of The Active Conformation Of | 5e-10 | ||
| 3npc_A | 364 | Crystal Structure Of Jnk2 Complexed With Birb796 Le | 5e-10 | ||
| 3fi4_A | 372 | P38 Kinase Crystal Structure In Complex With Ro4499 | 6e-10 | ||
| 3elj_A | 369 | Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine | 6e-10 | ||
| 3odz_X | 360 | Crystal Structure Of P38alpha Y323r Active Mutant L | 6e-10 | ||
| 2vz6_A | 313 | Structure Of Human Calcium Calmodulin Dependent Pro | 6e-10 | ||
| 3pze_A | 358 | Jnk1 In Complex With Inhibitor Length = 358 | 6e-10 | ||
| 3ody_X | 360 | Crystal Structure Of P38alpha Y323q Active Mutant L | 6e-10 | ||
| 3od6_X | 360 | Crystal Structure Of P38alpha Y323t Active Mutant L | 6e-10 | ||
| 3igo_A | 486 | Crystal Structure Of Cryptosporidium Parvum Cdpk1, | 6e-10 | ||
| 3mpt_A | 371 | Crystal Structure Of P38 Kinase In Complex With A P | 6e-10 | ||
| 2wei_A | 287 | Crystal Structure Of The Kinase Domain Of Cryptospo | 6e-10 | ||
| 2npq_A | 367 | A Novel Lipid Binding Site In The P38 Alpha Map Kin | 6e-10 | ||
| 1zxe_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 6e-10 | ||
| 2baj_A | 365 | P38alpha Bound To Pyrazolourea Length = 365 | 6e-10 | ||
| 3hrb_A | 359 | P38 Kinase Crystal Structure In Complex With Small | 6e-10 | ||
| 3dfa_A | 286 | Crystal Structure Of Kinase Domain Of Calcium-depen | 6e-10 | ||
| 1oz1_A | 372 | P38 Mitogen-Activated Kinase In Complex With 4-Azai | 6e-10 | ||
| 2gfs_A | 372 | P38 Kinase Crystal Structure In Complex With Ro3201 | 6e-10 | ||
| 4e5a_X | 360 | The W197a Mutant Of P38a Map Kinase Length = 360 | 6e-10 | ||
| 3hvc_A | 362 | Crystal Structure Of Human P38alpha Map Kinase Leng | 7e-10 | ||
| 3k3j_A | 362 | P38alpha Bound To Novel Dfg-Out Compound Pf-0041612 | 7e-10 | ||
| 3gcu_A | 360 | Human P38 Map Kinase In Complex With Rl48 Length = | 7e-10 | ||
| 4ewq_A | 383 | Human P38 Alpha Mapk In Complex With A Pyridazine B | 7e-10 | ||
| 3fi3_A | 364 | Crystal Structure Of Jnk3 With Indazole Inhibitor, | 7e-10 | ||
| 3oef_X | 360 | Crystal Structure Of Y323f Inactive Mutant Of P38al | 7e-10 | ||
| 1di9_A | 360 | The Structure Of P38 Mitogen-Activated Protein Kina | 7e-10 | ||
| 4el9_A | 305 | Structure Of N-Terminal Kinase Domain Of Rsk2 With | 7e-10 | ||
| 3zsg_A | 362 | X-Ray Structure Of P38alpha Bound To Tak-715 Length | 7e-10 | ||
| 1zzl_A | 351 | Crystal Structure Of P38 With Triazolopyridine Leng | 7e-10 | ||
| 3fi2_A | 353 | Crystal Structure Of Jnk3 With Amino-Pyrazole Inhib | 7e-10 | ||
| 1m7q_A | 366 | Crystal Structure Of P38 Map Kinase In Complex With | 7e-10 | ||
| 3nnu_A | 354 | Crystal Structure Of P38 Alpha In Complex With Dp13 | 8e-10 | ||
| 2lgc_A | 359 | Joint Nmr And X-Ray Refinement Reveals The Structur | 8e-10 | ||
| 3s3i_A | 349 | P38 Kinase Crystal Structure In Complex With Small | 8e-10 | ||
| 3ubd_A | 304 | Structure Of N-Terminal Domain Of Rsk2 Kinase In Co | 8e-10 | ||
| 3fv8_A | 355 | Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Le | 8e-10 | ||
| 3nnx_A | 354 | Crystal Structure Of Phosphorylated P38 Alpha In Co | 8e-10 | ||
| 3k3i_A | 350 | P38alpha Bound To Novel Dgf-Out Compound Pf-0021595 | 8e-10 | ||
| 1bl6_A | 379 | The Complex Structure Of The Map Kinase P38SB216995 | 8e-10 | ||
| 3kq7_A | 380 | Structure Of Human P38alpha With N-[4-Methyl-3-(6-{ | 8e-10 | ||
| 3pfq_A | 674 | Crystal Structure And Allosteric Activation Of Prot | 8e-10 | ||
| 3hec_A | 348 | P38 In Complex With Imatinib Length = 348 | 8e-10 | ||
| 3gop_A | 361 | Crystal Structure Of The Egf Receptor Juxtamembrane | 8e-10 | ||
| 2qlu_A | 314 | Crystal Structure Of Activin Receptor Type Ii Kinas | 8e-10 | ||
| 3dt1_A | 383 | P38 Complexed With A Quinazoline Inhibitor Length = | 8e-10 | ||
| 1s9i_A | 354 | X-Ray Structure Of The Human Mitogen-Activated Prot | 9e-10 | ||
| 3niz_A | 311 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 9e-10 | ||
| 4agu_A | 311 | Crystal Structure Of The Human Cdkl1 Kinase Domain | 9e-10 | ||
| 3e7o_A | 360 | Crystal Structure Of Jnk2 Length = 360 | 9e-10 | ||
| 2v7o_A | 336 | Crystal Structure Of Human Calcium-Calmodulin-Depen | 9e-10 | ||
| 3w2o_A | 331 | Egfr Kinase Domain T790m/l858r Mutant With Tak-285 | 1e-09 | ||
| 2x4f_A | 373 | The Crystal Structure Of The Human Myosin Light Cha | 1e-09 | ||
| 3vuk_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M5 | 1e-09 | ||
| 3lij_A | 494 | Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) | 1e-09 | ||
| 3ug1_A | 334 | Crystal Structure Of The Mutated Egfr Kinase Domain | 1e-09 | ||
| 2qkr_A | 313 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 1e-09 | ||
| 1ian_A | 366 | Human P38 Map Kinase Inhibitor Complex Length = 366 | 1e-09 | ||
| 4af3_A | 292 | Human Aurora B Kinase In Complex With Incenp And Vx | 1e-09 | ||
| 4i1z_A | 329 | Crystal Structure Of The Monomeric (v948r) Form Of | 1e-09 | ||
| 1gii_A | 298 | Human Cyclin Dependent Kinase 2 Complexed With The | 1e-09 | ||
| 4fr4_A | 384 | Crystal Structure Of Human SerineTHREONINE-Protein | 1e-09 | ||
| 3soa_A | 444 | Full-Length Human Camkii Length = 444 | 1e-09 | ||
| 2fsl_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a+f3 | 1e-09 | ||
| 3ma6_A | 298 | Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr | 1e-09 | ||
| 4i21_A | 329 | Crystal Structure Of L858r + T790m Egfr Kinase Doma | 1e-09 | ||
| 3ttj_A | 464 | Crystal Structure Of Jnk3 Complexed With Cc-359, A | 1e-09 | ||
| 2itn_A | 327 | Crystal Structure Of Egfr Kinase Domain G719s Mutat | 1e-09 | ||
| 2i0e_A | 353 | Structure Of Catalytic Domain Of Human Protein Kina | 1e-09 | ||
| 2qr7_A | 342 | 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of | 1e-09 | ||
| 2fst_X | 367 | Mitogen Activated Protein Kinase P38alpha (d176a+f3 | 1e-09 | ||
| 3dxn_A | 287 | Crystal Structure Of The Calcium-dependent Kinase F | 1e-09 | ||
| 2eb2_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (G7 | 1e-09 | ||
| 4i20_A | 329 | Crystal Structure Of Monomeric (v948r) Primary Onco | 1e-09 | ||
| 1h4l_A | 292 | Structure And Regulation Of The Cdk5-P25(Nck5a) Com | 1e-09 | ||
| 2fso_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a) A | 1e-09 | ||
| 3mh2_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 1e-09 | ||
| 3kvx_A | 364 | Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Le | 2e-09 | ||
| 3i79_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 2e-09 | ||
| 2r9s_A | 356 | C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Qu | 2e-09 | ||
| 2iw8_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82 | 2e-09 | ||
| 2itt_A | 327 | Crystal Structure Of Egfr Kinase Domain L858r Mutat | 2e-09 | ||
| 1pmn_A | 364 | Crystal Structure Of Jnk3 In Complex With An Imidaz | 2e-09 | ||
| 4e20_A | 290 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 2e-09 | ||
| 3lm0_A | 327 | Crystal Structure Of Human SerineTHREONINE KINASE 1 | 2e-09 | ||
| 2o0u_A | 364 | Crystal Structure Of Human Jnk3 Complexed With N-{3 | 2e-09 | ||
| 3ptg_A | 363 | Design And Synthesis Of A Novel, Orally Efficacious | 2e-09 | ||
| 4e1z_A | 291 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 2e-09 | ||
| 2ok1_A | 365 | Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3 | 2e-09 | ||
| 1cm8_A | 367 | Phosphorylated Map Kinase P38-Gamma Length = 367 | 2e-09 | ||
| 3oxi_A | 362 | Design And Synthesis Of Disubstituted Thiophene And | 2e-09 | ||
| 3orn_A | 307 | Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In | 2e-09 | ||
| 3fzo_A | 277 | Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosin | 2e-09 | ||
| 2eb3_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (L8 | 2e-09 | ||
| 4h36_A | 356 | Crystal Structure Of Jnk3 In Complex With Atf2 Pept | 2e-09 | ||
| 1jnk_A | 423 | The C-Jun N-Terminal Kinase (Jnk3s) Complexed With | 2e-09 | ||
| 4gsb_A | 364 | Monoclinic Crystal Form Of The Apo-Erk2 Length = 36 | 2e-09 | ||
| 2b1p_A | 355 | Inhibitor Complex Of Jnk3 Length = 355 | 2e-09 | ||
| 2exc_X | 356 | Inhibitor Complex Of Jnk3 Length = 356 | 2e-09 | ||
| 4h1j_A | 293 | Crystal Structure Of Pyk2 With The Pyrazole 13a Len | 2e-09 | ||
| 3vui_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 2e-09 | ||
| 3o17_A | 370 | Crystal Structure Of Jnk1-Alpha1 Isoform Length = 3 | 2e-09 | ||
| 3ku2_A | 507 | Crystal Structure Of Inactivated Form Of Cdpk1 From | 2e-09 | ||
| 3gi3_A | 360 | Crystal Structure Of A N-Phenyl-N'-Naphthylurea Ana | 2e-09 | ||
| 3hx4_A | 508 | Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg | 2e-09 | ||
| 3cc6_A | 281 | Crystal Structure Of Kinase Domain Of Protein Tyros | 2e-09 | ||
| 2y4i_C | 395 | Ksr2-Mek1 Heterodimer Length = 395 | 3e-09 | ||
| 2wel_A | 327 | Crystal Structure Of Su6656-Bound CalciumCALMODULIN | 3e-09 | ||
| 1ql6_A | 298 | The Catalytic Mechanism Of Phosphorylase Kinase Pro | 3e-09 | ||
| 3qup_A | 323 | Inhibitor Bound Structure Of The Kinase Domain Of T | 3e-09 | ||
| 1ukh_A | 369 | Structural Basis For The Selective Inhibition Of Jn | 3e-09 | ||
| 2xrw_A | 371 | Linear Binding Motifs For Jnk And For Calcineurin A | 3e-09 | ||
| 3vuh_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M3 | 3e-09 | ||
| 3a60_A | 327 | Crystal Structure Of Unphosphorylated P70s6k1 (Form | 3e-09 | ||
| 2gcd_A | 309 | Tao2 Kinase Domain-Staurosporine Structure Length = | 3e-09 | ||
| 1s9j_A | 341 | X-Ray Structure Of The Human Mitogen-Activated Prot | 3e-09 | ||
| 2p55_A | 333 | X-Ray Structure Of The Human Mitogen-Activated Prot | 3e-09 | ||
| 3vud_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 3e-09 | ||
| 2vn9_A | 301 | Crystal Structure Of Human Calcium Calmodulin Depen | 3e-09 | ||
| 1u5q_A | 348 | Crystal Structure Of The Tao2 Kinase Domain: Activa | 3e-09 | ||
| 3mbl_A | 328 | Crystal Structure Of The Human Mitogen-Activated Pr | 4e-09 | ||
| 3hzt_A | 467 | Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4 | 4e-09 | ||
| 3dv3_A | 322 | Mek1 With Pf-04622664 Bound Length = 322 | 4e-09 | ||
| 2g01_A | 370 | Pyrazoloquinolones As Novel, Selective Jnk1 Inhibit | 4e-09 | ||
| 2j0l_A | 276 | Crystal Structure Of A The Active Conformation Of T | 4e-09 | ||
| 2phk_A | 277 | The Crystal Structure Of A Phosphorylase Kinase Pep | 4e-09 | ||
| 2wqm_A | 310 | Structure Of Apo Human Nek7 Length = 310 | 4e-09 | ||
| 3eqc_A | 360 | X-Ray Structure Of The Human Mitogen-Activated Prot | 4e-09 | ||
| 2y4i_B | 319 | Ksr2-Mek1 Heterodimer Length = 319 | 4e-09 | ||
| 3vug_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 4e-09 | ||
| 2dyl_A | 318 | Crystal Structure Of Human Mitogen-Activated Protei | 4e-09 | ||
| 4hzs_A | 341 | Crystal Structure Of Ack1 Kinase Domain With C-term | 4e-09 | ||
| 3v3v_A | 379 | Structural And Functional Analysis Of Quercetagetin | 4e-09 | ||
| 3qyw_A | 364 | Crystal Structure Of Erk2 In Complex With An Inhibi | 4e-09 | ||
| 3pwy_A | 311 | Crystal Structure Of An Extender (Spd28345)-Modifie | 4e-09 | ||
| 2j0j_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 5e-09 | ||
| 3eqp_B | 276 | Crystal Structure Of Ack1 With Compound T95 Length | 5e-09 | ||
| 3bhh_A | 295 | Crystal Structure Of Human Calcium/calmodulin-depen | 5e-09 | ||
| 2iwi_A | 312 | Crystal Structure Of The Human Pim2 In Complex With | 5e-09 | ||
| 4ewh_B | 275 | Co-Crystal Structure Of Ack1 With Inhibitor Length | 5e-09 | ||
| 1phk_A | 298 | Two Structures Of The Catalytic Domain Of Phosphory | 5e-09 | ||
| 1u54_A | 291 | Crystal Structures Of The Phosphorylated And Unphos | 5e-09 | ||
| 1u46_A | 291 | Crystal Structure Of The Unphosphorylated Kinase Do | 5e-09 | ||
| 2j0m_B | 276 | Crystal Structure A Two-Chain Complex Between The F | 6e-09 | ||
| 2jkm_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 6e-09 | ||
| 4ebw_A | 304 | Structure Of Focal Adhesion Kinase Catalytic Domain | 6e-09 | ||
| 4id7_A | 273 | Ack1 Kinase In Complex With The Inhibitor Cis-3-[8- | 6e-09 | ||
| 4fux_A | 360 | Crystal Structure Of The Erk2 Complexed With E75 Le | 6e-09 | ||
| 3mh0_A | 360 | Mutagenesis Of P38 Map Kinase Eshtablishes Key Role | 6e-09 | ||
| 3o8p_A | 360 | Conformational Plasticity Of P38 Map Kinase Dfg Mot | 6e-09 | ||
| 4hzr_A | 277 | Crystal Structure Of Ack1 Kinase Domain Length = 27 | 6e-09 | ||
| 3sa0_A | 360 | Complex Of Erk2 With Norathyriol Length = 360 | 6e-09 | ||
| 1mp8_A | 281 | Crystal Structure Of Focal Adhesion Kinase (Fak) Le | 6e-09 | ||
| 2etm_A | 281 | Crystal Structure Of Focal Adhesion Kinase Domain C | 6e-09 | ||
| 3zu7_A | 365 | Crystal Structure Of A Designed Selected Ankyrin Re | 6e-09 | ||
| 2z7l_A | 366 | Unphosphorylated Mitogen Activated Protein Kinase E | 6e-09 | ||
| 3c9w_A | 357 | Crystal Structure Of Erk-2 With Hypothemycin Covale | 6e-09 | ||
| 3bz3_A | 276 | Crystal Structure Analysis Of Focal Adhesion Kinase | 6e-09 | ||
| 2fys_B | 364 | Crystal Structure Of Erk2 Complex With Kim Peptide | 6e-09 | ||
| 3pxk_A | 282 | Focal Adhesion Kinase Catalytic Domain In Complex W | 6e-09 | ||
| 3mh3_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 6e-09 | ||
| 3o71_A | 358 | Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length | 7e-09 | ||
| 2f2u_A | 402 | Crystal Structure Of The Rho-Kinase Kinase Domain L | 7e-09 | ||
| 3r63_A | 358 | Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | 7e-09 | ||
| 1ung_A | 292 | Structural Mechanism For The Inhibition Of Cdk5-P25 | 7e-09 | ||
| 3gc9_A | 370 | The Structure Of P38beta C119s, C162s In Complex Wi | 7e-09 | ||
| 2xs0_A | 386 | Linear Binding Motifs For Jnk And For Calcineurin A | 7e-09 | ||
| 4fv7_A | 360 | Crystal Structure Of The Erk2 Complexed With E94 Le | 7e-09 | ||
| 2gph_A | 364 | Docking Motif Interactions In The Map Kinase Erk2 L | 8e-09 | ||
| 3vn9_A | 340 | Rifined Crystal Structure Of Non-Phosphorylated Map | 8e-09 | ||
| 3sls_A | 304 | Crystal Structure Of Human Mek-1 Kinase In Complex | 8e-09 | ||
| 3i7c_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 8e-09 | ||
| 1pme_A | 380 | Structure Of Penta Mutant Human Erk2 Map Kinase Com | 8e-09 | ||
| 2biy_A | 310 | Structure Of Pdk1-S241a Mutant Kinase Domain Length | 8e-09 | ||
| 2r7b_A | 312 | Crystal Structure Of The Phosphoinositide-Dependent | 9e-09 | ||
| 4fv6_A | 360 | Crystal Structure Of The Erk2 Complexed With E57 Le | 9e-09 | ||
| 3mh1_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 9e-09 | ||
| 2y9q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 9e-09 | ||
| 1v0o_A | 288 | Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho | 9e-09 | ||
| 1h1w_A | 289 | High Resolution Crystal Structure Of The Human Pdk1 | 1e-08 | ||
| 1v0b_A | 288 | Crystal Structure Of The T198a Mutant Of Pfpk5 Leng | 1e-08 | ||
| 1wzy_A | 368 | Crystal Structure Of Human Erk2 Complexed With A Py | 1e-08 | ||
| 1tvo_A | 368 | The Structure Of Erk2 In Complex With A Small Molec | 1e-08 | ||
| 4h3q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 1e-08 | ||
| 1uu9_A | 286 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 1e-08 | ||
| 3tei_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 1e-08 | ||
| 3nus_A | 286 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra | 1e-08 | ||
| 1z5m_A | 286 | Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr | 1e-08 | ||
| 3orx_A | 316 | Pdk1 Mutant Bound To Allosteric Disulfide Fragment | 1e-08 | ||
| 2ojg_A | 380 | Crystal Structure Of Erk2 In Complex With N,n-dimet | 1e-08 | ||
| 1gol_A | 364 | Coordinates Of Rat Map Kinase Erk2 With An Arginine | 1e-08 | ||
| 1ob3_A | 288 | Structure Of P. Falciparum Pfpk5 Length = 288 | 1e-08 | ||
| 3a62_A | 327 | Crystal Structure Of Phosphorylated P70s6k1 Length | 1e-08 | ||
| 2j0k_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 1e-08 | ||
| 3h9o_A | 311 | Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) | 1e-08 | ||
| 3nax_A | 311 | Pdk1 In Complex With Inhibitor Mp7 Length = 311 | 1e-08 | ||
| 1uu3_A | 310 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 1e-08 | ||
| 3iop_A | 312 | Pdk-1 In Complex With The Inhibitor Compound-8i Len | 1e-08 | ||
| 2xch_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 1e-08 | ||
| 3rwp_A | 311 | Discovery Of A Novel, Potent And Selective Inhibito | 1e-08 | ||
| 3sc1_A | 311 | Novel Isoquinolone Pdk1 Inhibitors Discovered Throu | 1e-08 | ||
| 2jkk_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 2e-08 | ||
| 4an2_A | 301 | Crystal Structures Of Human Mek1 With Carboxamide-B | 2e-08 | ||
| 3qc4_A | 314 | Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = | 2e-08 | ||
| 4a07_A | 311 | Human Pdk1 Kinase Domain In Complex With Allosteric | 2e-08 | ||
| 3f88_A | 349 | Glycogen Synthase Kinase 3beta Inhibitor Complex Le | 2e-08 | ||
| 3nun_A | 292 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea | 2e-08 | ||
| 2r5t_A | 373 | Crystal Structure Of Inactive Serum And Glucocortic | 2e-08 | ||
| 3fme_A | 290 | Crystal Structure Of Human Mitogen-Activated Protei | 2e-08 | ||
| 3hrc_A | 311 | Crystal Structure Of A Mutant Of Human Pdk1 Kinase | 2e-08 | ||
| 2c30_A | 321 | Crystal Structure Of The Human P21-Activated Kinase | 2e-08 | ||
| 3nay_A | 311 | Pdk1 In Complex With Inhibitor Mp6 Length = 311 | 2e-08 | ||
| 3zuv_A | 364 | Crystal Structure Of A Designed Selected Ankyrin Re | 2e-08 | ||
| 2erk_A | 365 | Phosphorylated Map Kinase Erk2 Length = 365 | 2e-08 | ||
| 3my0_A | 305 | Crystal Structure Of The Acvrl1 (Alk1) Kinase Domai | 2e-08 | ||
| 4e7w_A | 394 | Structure Of Gsk3 From Ustilago Maydis Length = 394 | 3e-08 | ||
| 3gp0_A | 348 | Crystal Structure Of Human Mitogen Activated Protei | 3e-08 | ||
| 2hw6_A | 307 | Crystal Structure Of Mnk1 Catalytic Domain Length = | 3e-08 | ||
| 3gbz_A | 329 | Structure Of The Cmgc Cdk Kinase From Giardia Lambl | 3e-08 | ||
| 3gc8_A | 370 | The Structure Of P38beta C162s In Complex With A Di | 3e-08 | ||
| 3krw_A | 688 | Human Grk2 In Complex With Gbetgamma Subunits And B | 3e-08 | ||
| 3cik_A | 689 | Human Grk2 In Complex With Gbetagamma Subunits Leng | 3e-08 | ||
| 1zrz_A | 364 | Crystal Structure Of The Catalytic Domain Of Atypic | 4e-08 | ||
| 3say_A | 430 | Crystal Structure Of Human Glycogen Synthase Kinase | 4e-08 | ||
| 3coi_A | 353 | Crystal Structure Of P38delta Kinase Length = 353 | 4e-08 | ||
| 1omw_A | 689 | Crystal Structure Of The Complex Between G Protein- | 4e-08 | ||
| 1gng_A | 378 | Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With | 4e-08 | ||
| 3psc_A | 695 | Bovine Grk2 In Complex With Gbetagamma Subunits Len | 4e-08 | ||
| 4afj_A | 367 | 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selec | 4e-08 | ||
| 2xck_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 4e-08 | ||
| 1q5k_A | 414 | Crystal Structure Of Glycogen Synthase Kinase 3 In | 4e-08 | ||
| 1i09_A | 420 | Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Len | 4e-08 | ||
| 3a8w_A | 345 | Crystal Structure Of Pkciota Kinase Domain Length = | 4e-08 | ||
| 3zh8_A | 349 | A Novel Small Molecule Apkc Inhibitor Length = 349 | 5e-08 | ||
| 4dit_A | 382 | Crystal Structure Of Gsk3beta In Complex With A Imi | 5e-08 | ||
| 3zrk_A | 371 | Identification Of 2-(4-Pyridyl)thienopyridinones As | 5e-08 | ||
| 3f3z_A | 277 | Crystal Structure Of Cryptosporidium Parvum Calcium | 5e-08 | ||
| 1pyx_A | 422 | Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | 5e-08 | ||
| 3zdi_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 5e-08 | ||
| 4exu_A | 371 | Mapk13, Inactive Form Length = 371 | 5e-08 | ||
| 1q3d_A | 424 | Gsk-3 Beta Complexed With Staurosporine Length = 42 | 5e-08 | ||
| 3orm_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain D76a | 5e-08 | ||
| 3f7z_A | 350 | X-ray Co-crystal Structure Of Glycogen Synthase Kin | 5e-08 | ||
| 2o5k_A | 372 | Crystal Structure Of Gsk3beta In Complex With A Ben | 5e-08 | ||
| 3f69_A | 311 | Crystal Structure Of The Mycobacterium Tuberculosis | 5e-08 | ||
| 3p23_A | 432 | Crystal Structure Of The Human Kinase And Rnase Dom | 5e-08 | ||
| 3ori_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain L33d | 5e-08 | ||
| 2ow3_A | 352 | Glycogen Synthase Kinase-3 Beta In Complex With Bis | 5e-08 | ||
| 3f61_A | 311 | Crystal Structure Of M. Tuberculosis Pknb Leu33aspV | 5e-08 | ||
| 4dc2_A | 396 | Structure Of Pkc In Complex With A Substrate Peptid | 5e-08 | ||
| 4apc_A | 350 | Crystal Structure Of Human Nima-Related Kinase 1 (N | 5e-08 | ||
| 1r0e_A | 391 | Glycogen Synthase Kinase-3 Beta In Complex With 3-I | 5e-08 | ||
| 3sd0_A | 350 | Identification Of A Glycogen Synthase Kinase-3b Inh | 5e-08 | ||
| 1mru_A | 311 | Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob | 6e-08 | ||
| 2qg5_A | 294 | Cryptosporidium Parvum Calcium Dependent Protein Ki | 6e-08 | ||
| 4aw2_A | 437 | Crystal Structure Of Cdc42 Binding Protein Kinase A | 6e-08 | ||
| 3gb2_A | 353 | Gsk3beta Inhibitor Complex Length = 353 | 7e-08 | ||
| 4g3g_A | 350 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 7e-08 | ||
| 4acc_A | 465 | Gsk3b In Complex With Inhibitor Length = 465 | 7e-08 | ||
| 4g31_A | 299 | Crystal Structure Of Gsk6414 Bound To Perk (R587-R1 | 8e-08 | ||
| 1o6y_A | 299 | Catalytic Domain Of Pknb Kinase From Mycobacterium | 8e-08 | ||
| 2rio_A | 434 | Structure Of The Dual Enzyme Ire1 Reveals The Basis | 9e-08 | ||
| 1xh9_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 9e-08 | ||
| 4g3d_A | 371 | Crystal Structure Of Human Nf-kappab Inducing Kinas | 1e-07 | ||
| 4g3f_A | 336 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 1e-07 | ||
| 2gng_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 1e-07 | ||
| 1smh_A | 350 | Protein Kinase A Variant Complex With Completely Or | 1e-07 | ||
| 3tac_A | 361 | Crystal Structure Of The Liprin-AlphaCASK COMPLEX L | 1e-07 | ||
| 2gnf_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 1e-07 | ||
| 4ejn_A | 446 | Crystal Structure Of Autoinhibited Form Of Akt1 In | 1e-07 | ||
| 4dn5_A | 356 | Crystal Structure Of Nf-kb-inducing Kinase (nik) Le | 1e-07 | ||
| 3o96_A | 446 | Crystal Structure Of Human Akt1 With An Allosteric | 1e-07 | ||
| 2zoq_A | 382 | Structural Dissection Of Human Mitogen-Activated Ki | 1e-07 | ||
| 4g3c_A | 352 | Crystal Structure Of Apo Murine Nf-kappab Inducing | 1e-07 | ||
| 3c0g_A | 351 | Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Len | 1e-07 | ||
| 1ydt_E | 350 | Structure Of Camp-Dependent Protein Kinase, Alpha-C | 2e-07 | ||
| 3qfv_A | 415 | Mrck Beta In Complex With Tpca-1 Length = 415 | 2e-07 | ||
| 2uzt_A | 336 | Pka Structures Of Akt, Indazole-Pyridine Inhibitors | 2e-07 | ||
| 2f7e_E | 351 | Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoqu | 2e-07 | ||
| 3tku_A | 433 | Mrck Beta In Complex With Fasudil Length = 433 | 2e-07 | ||
| 3enm_A | 316 | The Structure Of The Map2k Mek6 Reveals An Autoinhi | 2e-07 | ||
| 3cqu_A | 342 | Crystal Structure Of Akt-1 Complexed With Substrate | 2e-07 | ||
| 4gv1_A | 340 | Pkb Alpha In Complex With Azd5363 Length = 340 | 2e-07 | ||
| 1j3h_A | 350 | Crystal Structure Of Apoenzyme Camp-Dependent Prote | 2e-07 | ||
| 3ocb_A | 341 | Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor | 2e-07 | ||
| 1gzk_A | 315 | Molecular Mechanism For The Regulation Of Protein K | 2e-07 | ||
| 1mrv_A | 339 | Crystal Structure Of An Inactive Akt2 Kinase Domain | 2e-07 | ||
| 3sdj_A | 448 | Structure Of Rnase-Inactive Point Mutant Of Oligome | 2e-07 | ||
| 3fhi_A | 350 | Crystal Structure Of A Complex Between The Catalyti | 3e-07 | ||
| 3fbv_A | 448 | Crystal Structure Of The Oligomer Formed By The Kin | 3e-07 | ||
| 3dnd_A | 350 | Camp-Dependent Protein Kinase Pka Catalytic Subunit | 3e-07 | ||
| 1svh_A | 350 | Crystal Structure Of Protein Kinase A In Complex Wi | 3e-07 | ||
| 2wtk_C | 305 | Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2 | 3e-07 | ||
| 1stc_E | 350 | Camp-Dependent Protein Kinase, Alpha-Catalytic Subu | 3e-07 | ||
| 4ic7_A | 442 | Crystal Structure Of The Erk5 Kinase Domain In Comp | 3e-07 | ||
| 1gzn_A | 335 | Structure Of Pkb Kinase Domain Length = 335 | 3e-07 | ||
| 2gu8_A | 337 | Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel | 3e-07 | ||
| 2pml_X | 348 | Crystal Structure Of Pfpk7 In Complex With An Atp A | 3e-07 | ||
| 2jdo_A | 342 | Structure Of Pkb-Beta (Akt2) Complexed With Isoquin | 3e-07 | ||
| 2c1a_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 3e-07 | ||
| 1o9u_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 3e-07 | ||
| 1o6l_A | 337 | Crystal Structure Of An Activated Akt/protein Kinas | 4e-07 | ||
| 3e87_A | 335 | Crystal Structures Of The Kinase Domain Of Akt2 In | 4e-07 | ||
| 1o6k_A | 336 | Structure Of Activated Form Of Pkb Kinase Domain S4 | 4e-07 | ||
| 4b99_A | 398 | Crystal Structure Of Mapk7 (Erk5) With Inhibitor Le | 4e-07 | ||
| 4dfy_A | 371 | Crystal Structure Of R194a Mutant Of Camp-Dependent | 4e-07 | ||
| 2gnj_A | 350 | Pka Three Fold Mutant Model Of Rho-Kinase With Y-27 | 4e-07 | ||
| 2xk9_A | 322 | Structural Analysis Of Checkpoint Kinase 2 (Chk2) I | 5e-07 | ||
| 2qur_A | 350 | Crystal Structure Of F327aK285P MUTANT OF CAMP-Depe | 5e-07 | ||
| 2w0j_A | 323 | Crystal Structure Of Chk2 In Complex With Nsc 10955 | 5e-07 | ||
| 3p1a_A | 311 | Structure Of Human Membrane-Associated Tyrosine- An | 5e-07 | ||
| 1h8f_A | 352 | Glycogen Synthase Kinase 3 Beta. Length = 352 | 5e-07 | ||
| 2ycf_A | 322 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 5e-07 | ||
| 2ycr_A | 323 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 5e-07 | ||
| 1uv5_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With 6-Br | 5e-07 | ||
| 1fmo_E | 350 | Crystal Structure Of A Polyhistidine-Tagged Recombi | 5e-07 | ||
| 1jbp_E | 350 | Crystal Structure Of The Catalytic Subunit Of Camp- | 5e-07 | ||
| 1bkx_A | 350 | A Binary Complex Of The Catalytic Subunit Of Camp-D | 5e-07 | ||
| 2erz_E | 351 | Crystal Structure Of C-amp Dependent Kinase (pka) B | 5e-07 | ||
| 2cn5_A | 329 | Crystal Structure Of Human Chk2 In Complex With Adp | 6e-07 | ||
| 3qal_E | 350 | Crystal Structure Of Arg280ala Mutant Of Catalytic | 6e-07 | ||
| 1q8w_A | 350 | The Catalytic Subunit Of Camp-Dependent Protein Kin | 6e-07 | ||
| 2jds_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 6e-07 | ||
| 1q61_A | 350 | Pka Triple Mutant Model Of Pkb Length = 350 | 6e-07 | ||
| 1xh7_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 6e-07 | ||
| 3d5u_A | 317 | Crystal Structure Of A Wildtype Polo-Like Kinase 1 | 8e-07 | ||
| 1q24_A | 350 | Pka Double Mutant Model Of Pkb In Complex With Mgat | 8e-07 | ||
| 4dfx_E | 350 | Crystal Structure Of Myristoylated K7c Catalytic Su | 9e-07 | ||
| 1apm_E | 350 | 2.0 Angstrom Refined Crystal Structure Of The Catal | 1e-06 | ||
| 1l3r_E | 350 | Crystal Structure Of A Transition State Mimic Of Th | 1e-06 | ||
| 3mtl_A | 324 | Crystal Structure Of The Pctaire1 Kinase In Complex | 1e-06 | ||
| 2qcs_A | 350 | A Complex Structure Between The Catalytic And Regul | 1e-06 | ||
| 3pvb_A | 345 | Crystal Structure Of (73-244)ria:c Holoenzyme Of Ca | 1e-06 | ||
| 1szm_A | 350 | Dual Binding Mode Of Bisindolylmaleimide 2 To Prote | 1e-06 | ||
| 3vid_A | 356 | Crystal Structure Of Human Vegfr2 Kinase Domain Wit | 1e-06 | ||
| 3vhe_A | 359 | Crystal Structure Of Human Vegfr2 Kinase Domain Wit | 1e-06 | ||
| 3vhk_A | 368 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 1e-06 | ||
| 3lj0_A | 434 | Ire1 Complexed With Adp And Quercetin Length = 434 | 1e-06 | ||
| 1syk_A | 350 | Crystal Structure Of E230q Mutant Of Camp-Dependent | 1e-06 | ||
| 4dg3_E | 371 | Crystal Structure Of R336a Mutant Of Camp-dependent | 1e-06 | ||
| 3o7l_B | 350 | Crystal Structure Of Phospholamban (1-19):pka C-Sub | 1e-06 | ||
| 3mdy_A | 337 | Crystal Structure Of The Cytoplasmic Domain Of The | 1e-06 | ||
| 3mtf_A | 301 | Crystal Structure Of The Acvr1 Kinase In Complex Wi | 1e-06 | ||
| 3i6u_A | 419 | Structure And Activation Mechanism Of The Chk2 Dna- | 1e-06 | ||
| 3i6w_A | 443 | Structure And Activation Mechanism Of The Chk2 Dna- | 1e-06 | ||
| 1y6a_A | 366 | Crystal Structure Of Vegfr2 In Complex With A 2-Ani | 1e-06 | ||
| 4dym_A | 301 | Crystal Structure Of The Acvr1 Kinase Domain In Com | 1e-06 | ||
| 3h9r_A | 330 | Crystal Structure Of The Kinase Domain Of Type I Ac | 2e-06 | ||
| 2b9f_A | 353 | Crystal Structure Of Non-Phosphorylated Fus3 Length | 2e-06 | ||
| 3nie_A | 429 | Crystal Structure Of Pf11_0147 Length = 429 | 2e-06 | ||
| 1cdk_A | 350 | Camp-Dependent Protein Kinase Catalytic Subunit (E. | 2e-06 | ||
| 1cmk_E | 350 | Crystal Structures Of The Myristylated Catalytic Su | 2e-06 | ||
| 2vo0_A | 351 | Structure Of Pka-Pkb Chimera Complexed With C-(4-(4 | 2e-06 | ||
| 3hng_A | 360 | Crystal Structure Of Vegfr1 In Complex With N-(4-ch | 2e-06 | ||
| 4ae6_A | 343 | Structure And Function Of The Human Sperm-specific | 2e-06 | ||
| 2jdt_A | 351 | Structure Of Pka-Pkb Chimera Complexed With Isoquin | 2e-06 | ||
| 1ctp_E | 350 | Structure Of The Mammalian Catalytic Subunit Of Cam | 2e-06 | ||
| 3nx8_A | 351 | Human Camp Dependent Protein Kinase In Complex With | 2e-06 | ||
| 1b6c_B | 342 | Crystal Structure Of The Cytoplasmic Domain Of The | 2e-06 | ||
| 1vjy_A | 303 | Crystal Structure Of A Naphthyridine Inhibitor Of H | 2e-06 | ||
| 3agl_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 2e-06 | ||
| 3agm_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 2e-06 | ||
| 1rw8_A | 301 | Crystal Structure Of Tgf-Beta Receptor I Kinase Wit | 2e-06 | ||
| 3mvj_A | 371 | Human Cyclic Amp-Dependent Protein Kinase Pka Inhib | 2e-06 | ||
| 1py5_A | 326 | Crystal Structure Of Tgf-Beta Receptor I Kinase Wit | 2e-06 | ||
| 2wot_A | 306 | Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl) | 2e-06 | ||
| 3kn5_A | 325 | Crystal Structure Of The C-Terminal Kinase Domain O | 2e-06 | ||
| 3dls_A | 335 | Crystal Structure Of Human Pas Kinase Bound To Adp | 3e-06 | ||
| 1yxs_A | 293 | Crystal Structure Of Kinase Pim1 With P123m Mutatio | 3e-06 | ||
| 3tzm_A | 309 | Tgf-Beta Receptor Type 1 In Complex With Sb431542 L | 3e-06 | ||
| 3qam_E | 350 | Crystal Structure Of Glu208ala Mutant Of Catalytic | 3e-06 | ||
| 3d5w_A | 317 | Crystal Structure Of A Phosphorylated Polo-Like Kin | 3e-06 | ||
| 3ama_A | 351 | Protein Kinase A Sixfold Mutant Model Of Aurora B W | 3e-06 | ||
| 3ll6_A | 337 | Crystal Structure Of The Human Cyclin G Associated | 3e-06 | ||
| 1z57_A | 339 | Crystal Structure Of Human Clk1 In Complex With 10z | 3e-06 | ||
| 3v8s_A | 410 | Human Rho-Associated Protein Kinase 1 (Rock 1) In C | 3e-06 | ||
| 4ae9_A | 343 | Structure And Function Of The Human Sperm-specific | 3e-06 | ||
| 2v55_A | 406 | Mechanism Of Multi-site Phosphorylation From A Rock | 4e-06 | ||
| 2uvy_A | 351 | Structure Of Pka-pkb Chimera Complexed With Methyl- | 4e-06 | ||
| 1q8y_A | 373 | The Structure Of The Yeast Sr Protein Kinase, Sky1p | 4e-06 | ||
| 2esm_A | 415 | Crystal Structure Of Rock 1 Bound To Fasudil Length | 4e-06 | ||
| 3d5v_A | 317 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 4e-06 | ||
| 3db6_A | 301 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 4e-06 | ||
| 1how_A | 373 | The X-Ray Crystal Structure Of Sky1p, An Sr Protein | 4e-06 | ||
| 3n9x_A | 432 | Crystal Structure Of Map Kinase From Plasmodium Ber | 4e-06 | ||
| 3l9m_A | 351 | Crystal Structure Of Pkab3 (Pka Triple Mutant V123a | 4e-06 | ||
| 3hko_A | 345 | Crystal Structure Of A Cdpk Kinase Domain From Cryp | 5e-06 | ||
| 2vd5_A | 412 | Structure Of Human Myotonic Dystrophy Protein Kinas | 5e-06 | ||
| 1rdq_E | 350 | Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of | 6e-06 | ||
| 2yac_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 6e-06 | ||
| 3kb7_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 6e-06 | ||
| 2b9h_A | 353 | Crystal Structure Of Fus3 With A Docking Motif From | 6e-06 | ||
| 2v5q_A | 315 | Crystal Structure Of Wild-type Plk-1 Kinase Domain | 7e-06 | ||
| 3mi9_A | 351 | Crystal Structure Of Hiv-1 Tat Complexed With Human | 9e-06 | ||
| 4bcf_A | 331 | Structure Of Cdk9 In Complex With Cyclin T And A 2- | 9e-06 | ||
| 4ec8_A | 373 | Structure Of Full Length Cdk9 In Complex With Cycli | 9e-06 | ||
| 2zv2_A | 298 | Crystal Structure Of Human CalciumCALMODULIN-Depend | 9e-06 | ||
| 3blh_A | 331 | Crystal Structure Of Human Cdk9CYCLINT1 Length = 33 | 1e-05 | ||
| 3uix_A | 298 | Crystal Structure Of Pim1 Kinase In Complex With Sm | 1e-05 | ||
| 3f2a_A | 300 | Crystal Structure Of Human Pim-1 In Complex With Da | 1e-05 | ||
| 1xqz_A | 300 | Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolut | 1e-05 | ||
| 1ywv_A | 293 | Crystal Structures Of Proto-Oncogene Kinase Pim1: A | 1e-05 | ||
| 1yhs_A | 273 | Crystal Structure Of Pim-1 Bound To Staurosporine L | 1e-05 | ||
| 2xiy_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-2 Fro | 1e-05 | ||
| 3r00_A | 299 | The Discovery Of Novel Benzofuran-2-Carboxylic Acid | 1e-05 | ||
| 3jxw_A | 294 | Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4- | 1e-05 | ||
| 2xj0_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-4 Fro | 1e-05 | ||
| 1vzo_A | 355 | The Structure Of The N-Terminal Kinase Domain Of Ms | 1e-05 | ||
| 3qd2_B | 332 | Crsytal Structure Of Mouse Perk Kinase Domain Lengt | 1e-05 | ||
| 3jpv_A | 313 | Crystal Structure Of Human Proto-Oncogene Serine Th | 1e-05 | ||
| 2xix_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-1 Fro | 1e-05 | ||
| 3a99_A | 320 | Structure Of Pim-1 Kinase Crystallized In The Prese | 1e-05 | ||
| 1xws_A | 313 | Crystal Structure Of The Human Pim1 Kinase Domain L | 1e-05 | ||
| 2exe_A | 357 | Crystal Structure Of The Phosphorylated Clk3 Length | 1e-05 | ||
| 2bil_B | 313 | The Human Protein Kinase Pim1 In Complex With Its C | 1e-05 | ||
| 3cy3_A | 314 | Crystal Structure Of Human Proto-Oncogene Serine Th | 1e-05 | ||
| 4dtk_A | 276 | Novel And Selective Pan-Pim Kinase Inhibitor Length | 2e-05 | ||
| 2f9g_A | 353 | Crystal Structure Of Fus3 Phosphorylated On Tyr182 | 2e-05 | ||
| 4alv_A | 328 | Benzofuropyrimidinone Inhibitors Of Pim-1 Length = | 2e-05 | ||
| 2eu9_A | 355 | Crystal Structure Of Clk3 Length = 355 | 2e-05 | ||
| 3ma3_A | 313 | Crystal Structure Of Human Proto-Oncogene Serine Th | 2e-05 | ||
| 3dcv_A | 328 | Crystal Structure Of Human Pim1 Kinase Complexed Wi | 2e-05 | ||
| 2j2i_B | 312 | Crystal Structure Of The Humab Pim1 In Complex With | 2e-05 | ||
| 1tki_A | 321 | Autoinhibited Serine Kinase Domain Of The Giant Mus | 2e-05 | ||
| 4as0_A | 273 | Cyclometalated Phthalimides As Protein Kinase Inhib | 2e-05 | ||
| 3cxw_A | 314 | Crystal Structure Of Human Proto-Oncogene Serine Th | 2e-05 | ||
| 3c4e_A | 273 | Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7 | 2e-05 | ||
| 4a7c_A | 308 | Crystal Structure Of Pim1 Kinase With Etp46546 Leng | 2e-05 | ||
| 3thb_A | 333 | Structure Of Plk1 Kinase Domain In Complex With A B | 2e-05 | ||
| 2rku_A | 294 | Structure Of Plk1 In Complex With Bi2536 Length = 2 | 2e-05 | ||
| 2bik_B | 313 | Human Pim1 Phosphorylated On Ser261 Length = 313 | 2e-05 | ||
| 2ou7_A | 335 | Structure Of The Catalytic Domain Of Human Polo-Lik | 2e-05 | ||
| 3udb_A | 317 | Crystal Structure Of Snrk2.6 Length = 317 | 2e-05 | ||
| 2vag_A | 339 | Crystal Structure Of Di-Phosphorylated Human Clk1 I | 2e-05 | ||
| 2wu6_A | 381 | Crystal Structure Of The Human Clk3 In Complex With | 2e-05 | ||
| 2obj_A | 333 | Crystal Structure Of Human Pim-1 Kinase In Complex | 2e-05 | ||
| 3e3p_A | 360 | Glycogen Synthase Kinase From Leishmania Major Leng | 3e-05 | ||
| 2ac5_A | 316 | Structure Of Human Mnk2 Kinase Domain Mutant D228g | 3e-05 | ||
| 1kwp_A | 400 | Crystal Structure Of Mapkap2 Length = 400 | 3e-05 | ||
| 3gok_A | 334 | Binding Site Mapping Of Protein Ligands Length = 33 | 3e-05 | ||
| 2jbo_A | 326 | Protein Kinase Mk2 In Complex With An Inhibitor (Cr | 3e-05 |
| >pdb|3TL8|A Chain A, The Avrptob-Bak1 Complex Reveals Two Structurally Similar Kinaseinteracting Domains In A Single Type Iii Effector Length = 349 | Back alignment and structure |
|
| >pdb|3UIM|A Chain A, Structural Basis For The Impact Of Phosphorylation On Plant Receptor- Like Kinase Bak1 Activation Length = 326 | Back alignment and structure |
|
| >pdb|2QKW|B Chain B, Structural Basis For Activation Of Plant Immunity By Bacterial Effector Protein Avrpto Length = 321 | Back alignment and structure |
|
| >pdb|3HGK|A Chain A, Crystal Structure Of Effect Protein Avrptob Complexed With Kinase Pto Length = 327 | Back alignment and structure |
|
| >pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301 | Back alignment and structure |
|
| >pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312 | Back alignment and structure |
|
| >pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285 | Back alignment and structure |
|
| >pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287 | Back alignment and structure |
|
| >pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288 | Back alignment and structure |
|
| >pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273 | Back alignment and structure |
|
| >pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271 | Back alignment and structure |
|
| >pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272 | Back alignment and structure |
|
| >pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277 | Back alignment and structure |
|
| >pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277 | Back alignment and structure |
|
| >pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271 | Back alignment and structure |
|
| >pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289 | Back alignment and structure |
|
| >pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315 | Back alignment and structure |
|
| >pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333 | Back alignment and structure |
|
| >pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265 | Back alignment and structure |
|
| >pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307 | Back alignment and structure |
|
| >pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344 | Back alignment and structure |
|
| >pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361 | Back alignment and structure |
|
| >pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371 | Back alignment and structure |
|
| >pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373 | Back alignment and structure |
|
| >pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267 | Back alignment and structure |
|
| >pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In Complex With Adp Length = 286 | Back alignment and structure |
|
| >pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344 | Back alignment and structure |
|
| >pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302 | Back alignment and structure |
|
| >pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373 | Back alignment and structure |
|
| >pdb|2I1M|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An Arylamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278 | Back alignment and structure |
|
| >pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277 | Back alignment and structure |
|
| >pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286 | Back alignment and structure |
|
| >pdb|3BEA|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A Pyrimidinopyridone Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277 | Back alignment and structure |
|
| >pdb|3C1X|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Pyrrolotriazine Based Inhibitor Length = 373 | Back alignment and structure |
|
| >pdb|2OGV|A Chain A, Crystal Structure Of The Autoinhibited Human C-Fms Kinase Domain Length = 317 | Back alignment and structure |
|
| >pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277 | Back alignment and structure |
|
| >pdb|3DKC|A Chain A, Sgx Clone 5698a65kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|1K3A|A Chain A, Structure Of The Insulin-Like Growth Factor 1 Receptor Kinase Length = 299 | Back alignment and structure |
|
| >pdb|1R0P|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With The Microbial Alkaloid K-252a Length = 312 | Back alignment and structure |
|
| >pdb|3DKG|A Chain A, Sgx Clone 5698a109kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|3CTH|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Aminopyridine Based Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273 | Back alignment and structure |
|
| >pdb|1RQQ|A Chain A, Crystal Structure Of The Insulin Receptor Kinase In Complex With The Sh2 Domain Of Aps Length = 306 | Back alignment and structure |
|
| >pdb|3QTI|A Chain A, C-Met Kinase In Complex With Nvp-Bvu972 Length = 314 | Back alignment and structure |
|
| >pdb|3A4P|A Chain A, Human C-Met Kinase Domain Complexed With 6-Benzyloxyquinoline Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270 | Back alignment and structure |
|
| >pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52 Length = 269 | Back alignment and structure |
|
| >pdb|2ZM3|A Chain A, Complex Structure Of Insulin-Like Growth Factor Receptor And Isoquinolinedione Inhibitor Length = 308 | Back alignment and structure |
|
| >pdb|3LCD|A Chain A, Inhibitor Bound To A Dfg-In Structure Of The Kinase Domain Of Csf-1r Length = 329 | Back alignment and structure |
|
| >pdb|2Z8C|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin-2- Yl]amino}phenyl)acetic Acid Length = 303 | Back alignment and structure |
|
| >pdb|1IR3|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With Peptide Substrate And Atp Analog Length = 306 | Back alignment and structure |
|
| >pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298 | Back alignment and structure |
|
| >pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293 | Back alignment and structure |
|
| >pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287 | Back alignment and structure |
|
| >pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase Itk Catalytic Domain With Thienopyrazolylindole Inhibitor 090 Length = 266 | Back alignment and structure |
|
| >pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2 Tyrosine Kinase Catalytic Domain Length = 264 | Back alignment and structure |
|
| >pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|2I0V|A Chain A, C-Fms Tyrosine Kinase In Complex With A Quinolone Inhibitor Length = 335 | Back alignment and structure |
|
| >pdb|3Q6W|A Chain A, Structure Of Dually-phosphorylated Met Receptor Kinase In Complex With An Mk-2461 Analog With Specificity For The Activated Receptor Length = 307 | Back alignment and structure |
|
| >pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306 | Back alignment and structure |
|
| >pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|1P4O|A Chain A, Structure Of Apo Unactivated Igf-1r Kinase Domain At 1.5a Resolution. Length = 322 | Back alignment and structure |
|
| >pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284 | Back alignment and structure |
|
| >pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288 | Back alignment and structure |
|
| >pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277 | Back alignment and structure |
|
| >pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284 | Back alignment and structure |
|
| >pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288 | Back alignment and structure |
|
| >pdb|1M7N|A Chain A, Crystal Structure Of Unactivated Apo Insulin-Like Growth Factor-1 Receptor Kinase Domain Length = 322 | Back alignment and structure |
|
| >pdb|3O23|A Chain A, Human Unphosphorylated Igf1-R Kinase Domain In Complex With An Hydantoin Inhibitor Length = 305 | Back alignment and structure |
|
| >pdb|3I81|A Chain A, Crystal Structure Of Insulin-Like Growth Factor 1 Receptor (Igf-1r-Wt) Complex With Bms-754807 [1-(4-((5-Cyclopropyl- 1h-Pyrazol-3-Yl)amino)pyrrolo[2,1-F][1,2, 4]triazin-2-Yl)-N- (6-Fluoro-3-Pyridinyl)-2-Methyl-L-Prolinamide] Length = 315 | Back alignment and structure |
|
| >pdb|1JQH|A Chain A, Igf-1 Receptor Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|2WD1|A Chain A, Human C-Met Kinase In Complex With Azaindole Inhibitor Length = 292 | Back alignment and structure |
|
| >pdb|3QQU|A Chain A, Cocrystal Structure Of Unphosphorylated Igf With Pyrimidine 8 Length = 301 | Back alignment and structure |
|
| >pdb|3Q6U|A Chain A, Structure Of The Apo Met Receptor Kinase In The Dually-Phosphorylated, Activated State Length = 308 | Back alignment and structure |
|
| >pdb|2OJ9|A Chain A, Structure Of Igf-1r Kinase Domain Complexed With A Benzimidazole Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|4GG5|A Chain A, Crystal Structure Of Cmet In Complex With Novel Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|2WGJ|A Chain A, X-Ray Structure Of Pf-02341066 Bound To The Kinase Domain Of C-Met Length = 306 | Back alignment and structure |
|
| >pdb|3LW0|A Chain A, Igf-1rk In Complex With Ligand Msc1609119a-1 Length = 304 | Back alignment and structure |
|
| >pdb|2G15|A Chain A, Structural Characterization Of Autoinhibited C-Met Kinase Length = 318 | Back alignment and structure |
|
| >pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed With Imidazo[1,5-A]quinoxaline Length = 267 | Back alignment and structure |
|
| >pdb|3LQ8|A Chain A, Structure Of The Kinase Domain Of C-Met Bound To Xl880 (Gsk1 Length = 302 | Back alignment and structure |
|
| >pdb|1IRK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Human Insulin Receptor Length = 306 | Back alignment and structure |
|
| >pdb|3F66|A Chain A, Human C-Met Kinase In Complex With Quinoxaline Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3I5N|A Chain A, Crystal Structure Of C-Met With Triazolopyridazine Inhibitor 13 Length = 309 | Back alignment and structure |
|
| >pdb|2RFN|A Chain A, X-ray Structure Of C-met With Inhibitor. Length = 310 | Back alignment and structure |
|
| >pdb|3ETA|A Chain A, Kinase Domain Of Insulin Receptor Complexed With A Pyrrolo Pyridine Inhibitor Length = 317 | Back alignment and structure |
|
| >pdb|3LVP|A Chain A, Crystal Structure Of Bisphosphorylated Igf1-R Kinase Domain (2p) In Complex With A Bis-Azaindole Inhibitor Length = 336 | Back alignment and structure |
|
| >pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537 | Back alignment and structure |
|
| >pdb|1I44|A Chain A, Crystallographic Studies Of An Activation Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271 | Back alignment and structure |
|
| >pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|3D94|A Chain A, Crystal Structure Of The Insulin-Like Growth Factor-1 Receptor Kinase In Complex With Pqip Length = 301 | Back alignment and structure |
|
| >pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318 | Back alignment and structure |
|
| >pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266 | Back alignment and structure |
|
| >pdb|3EKK|A Chain A, Insulin Receptor Kinase Complexed With An Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|1P14|A Chain A, Crystal Structure Of A Catalytic-Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285 | Back alignment and structure |
|
| >pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310 | Back alignment and structure |
|
| >pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495 | Back alignment and structure |
|
| >pdb|3LCO|A Chain A, Inhibitor Bound To A Dfg-Out Structure Of The Kinase Domain Of Csf-1r Length = 324 | Back alignment and structure |
|
| >pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286 | Back alignment and structure |
|
| >pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280 | Back alignment and structure |
|
| >pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | Back alignment and structure |
|
| >pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276 | Back alignment and structure |
|
| >pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|3TUB|A Chain A, Crystal Structure Of Syk Kinase Domain With 1-(5-(6,7- Dimethoxyquinolin-4-Yloxy)pyridin-2-Yl)-3-((1r,2s)-2- Phenylcyclopropyl)urea Length = 293 | Back alignment and structure |
|
| >pdb|3VF8|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Syk Catalytic Domain With Pyrazolylbenzimidazole Inhibitor 416 Length = 299 | Back alignment and structure |
|
| >pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279 | Back alignment and structure |
|
| >pdb|1XBA|A Chain A, Crystal Structure Of Apo Syk Tyrosine Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|3EMG|A Chain A, Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylaminopyrimidines As Potent Inhibitors Of Spleen Tyrosine Kinase (Syk) Length = 291 | Back alignment and structure |
|
| >pdb|3SRV|B Chain B, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|4DFL|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With A Sulfonamidopyrazine Piperidine Inhibitor Length = 274 | Back alignment and structure |
|
| >pdb|4F4P|A Chain A, Syk In Complex With Ligand Lasw836 Length = 273 | Back alignment and structure |
|
| >pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452 | Back alignment and structure |
|
| >pdb|2YJS|A Chain A, Structure Of C1156y Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286 | Back alignment and structure |
|
| >pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292 | Back alignment and structure |
|
| >pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452 | Back alignment and structure |
|
| >pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535 | Back alignment and structure |
|
| >pdb|4FL3|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 635 | Back alignment and structure |
|
| >pdb|4FL2|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 636 | Back alignment and structure |
|
| >pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275 | Back alignment and structure |
|
| >pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277 | Back alignment and structure |
|
| >pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452 | Back alignment and structure |
|
| >pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295 | Back alignment and structure |
|
| >pdb|3SRV|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286 | Back alignment and structure |
|
| >pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286 | Back alignment and structure |
|
| >pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289 | Back alignment and structure |
|
| >pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286 | Back alignment and structure |
|
| >pdb|3SXR|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase Complex With Dasatinib Length = 268 | Back alignment and structure |
|
| >pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377 | Back alignment and structure |
|
| >pdb|4FNW|A Chain A, Crystal Structure Of The Apo F1174l Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286 | Back alignment and structure |
|
| >pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281 | Back alignment and structure |
|
| >pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284 | Back alignment and structure |
|
| >pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275 | Back alignment and structure |
|
| >pdb|2YJR|A Chain A, Structure Of F1174l Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|2XP2|A Chain A, Structure Of The Human Anaplastic Lymphoma Kinase In Complex With Crizotinib (Pf-02341066) Length = 327 | Back alignment and structure |
|
| >pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|3AOX|A Chain A, X-Ray Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Ch5424802 Length = 344 | Back alignment and structure |
|
| >pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282 | Back alignment and structure |
|
| >pdb|2YFX|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase In Complex With Crizotinib Length = 327 | Back alignment and structure |
|
| >pdb|4FNZ|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Piperidine-Carboxamide Inhibitor 2 Length = 327 | Back alignment and structure |
|
| >pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307 | Back alignment and structure |
|
| >pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306 | Back alignment and structure |
|
| >pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270 | Back alignment and structure |
|
| >pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|4DCE|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With A Piperidine-Carboxamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2YHV|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377 | Back alignment and structure |
|
| >pdb|4FOB|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Acyliminobenzimidazole Inhibitor 1 Length = 353 | Back alignment and structure |
|
| >pdb|2XB7|A Chain A, Structure Of Human Anaplastic Lymphoma Kinase In Complex With Nvp- Tae684 Length = 315 | Back alignment and structure |
|
| >pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454 | Back alignment and structure |
|
| >pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283 | Back alignment and structure |
|
| >pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|4FNX|A Chain A, Crystal Structure Of The Apo R1275q Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase Activity Length = 286 | Back alignment and structure |
|
| >pdb|3LCT|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 344 | Back alignment and structure |
|
| >pdb|3L9P|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 367 | Back alignment and structure |
|
| >pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292 | Back alignment and structure |
|
| >pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285 | Back alignment and structure |
|
| >pdb|2R4B|A Chain A, Erbb4 Kinase Domain Complexed With A Thienopyrimidine Inhibitor Length = 321 | Back alignment and structure |
|
| >pdb|3BBT|B Chain B, Crystal Structure Of The Erbb4 Kinase In Complex With Lapatinib Length = 328 | Back alignment and structure |
|
| >pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300 | Back alignment and structure |
|
| >pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279 | Back alignment and structure |
|
| >pdb|4AOJ|A Chain A, Human Trka In Complex With The Inhibitor Az-23 Length = 329 | Back alignment and structure |
|
| >pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|4F0I|A Chain A, Crystal Structure Of Apo Trka Length = 300 | Back alignment and structure |
|
| >pdb|4GT5|A Chain A, Crystal Structure Of The Inactive Trka Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain Length = 299 | Back alignment and structure |
|
| >pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453 | Back alignment and structure |
|
| >pdb|1U59|A Chain A, Crystal Structure Of The Zap-70 Kinase Domain In Complex With Staurosporine Length = 287 | Back alignment and structure |
|
| >pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276 | Back alignment and structure |
|
| >pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476 | Back alignment and structure |
|
| >pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283 | Back alignment and structure |
|
| >pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307 | Back alignment and structure |
|
| >pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269 | Back alignment and structure |
|
| >pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279 | Back alignment and structure |
|
| >pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294 | Back alignment and structure |
|
| >pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273 | Back alignment and structure |
|
| >pdb|2OZO|A Chain A, Autoinhibited Intact Human Zap-70 Length = 613 | Back alignment and structure |
|
| >pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278 | Back alignment and structure |
|
| >pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323 | Back alignment and structure |
|
| >pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322 | Back alignment and structure |
|
| >pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297 | Back alignment and structure |
|
| >pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289 | Back alignment and structure |
|
| >pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273 | Back alignment and structure |
|
| >pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295 | Back alignment and structure |
|
| >pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269 | Back alignment and structure |
|
| >pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276 | Back alignment and structure |
|
| >pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268 | Back alignment and structure |
|
| >pdb|1RJB|A Chain A, Crystal Structure Of Flt3 Length = 344 | Back alignment and structure |
|
| >pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279 | Back alignment and structure |
|
| >pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271 | Back alignment and structure |
|
| >pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 269 | Back alignment and structure |
|
| >pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length Carboxyl-Terminal Src Kinase At 2.5 A Resolution Length = 450 | Back alignment and structure |
|
| >pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In Complex With Inhibitor Staurosporine Length = 278 | Back alignment and structure |
|
| >pdb|2OO8|X Chain X, Synthesis, Structural Analysis, And Sar Studies Of Triazine Derivatives As Potent, Selective Tie-2 Inhibitors Length = 317 | Back alignment and structure |
|
| >pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 263 | Back alignment and structure |
|
| >pdb|1FVR|A Chain A, Tie2 Kinase Domain Length = 327 | Back alignment and structure |
|
| >pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In Rodent Cancer Tumor Models Length = 297 | Back alignment and structure |
|
| >pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271 | Back alignment and structure |
|
| >pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274 | Back alignment and structure |
|
| >pdb|2XUU|A Chain A, Crystal Structure Of A Dap-Kinase 1 Mutant Length = 334 | Back alignment and structure |
|
| >pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301 | Back alignment and structure |
|
| >pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275 | Back alignment and structure |
|
| >pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And Inactive Conformations Suggests A Mechanism Of Activation For Tec Family Kinases Length = 283 | Back alignment and structure |
|
| >pdb|3G0F|A Chain A, Kit Kinase Domain Mutant D816h In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325 | Back alignment and structure |
|
| >pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|1T46|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C-kit Tyrosine Kinase Length = 313 | Back alignment and structure |
|
| >pdb|2J90|A Chain A, Crystal Structure Of Human Zip Kinase In Complex With A Tetracyclic Pyridone Inhibitor (pyridone 6) Length = 304 | Back alignment and structure |
|
| >pdb|1T45|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C- Kit Tyrosine Kinase Length = 331 | Back alignment and structure |
|
| >pdb|2X0G|A Chain A, X-ray Structure Of A Dap-kinase Calmodulin Complex Length = 334 | Back alignment and structure |
|
| >pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine Kinase Bound To A Pyrrolopyrimidine-Containing Compound Length = 283 | Back alignment and structure |
|
| >pdb|2WQB|A Chain A, Structure Of The Tie2 Kinase Domain In Complex With A Thiazolopyrimidine Inhibitor Length = 324 | Back alignment and structure |
|
| >pdb|3BHY|A Chain A, Crystal Structure Of Human Death Associated Protein Kinase 3 (Dapk3) In Complex With A Beta-Carboline Ligand Length = 283 | Back alignment and structure |
|
| >pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297 | Back alignment and structure |
|
| >pdb|1PKG|A Chain A, Structure Of A C-kit Kinase Product Complex Length = 329 | Back alignment and structure |
|
| >pdb|3G0E|A Chain A, Kit Kinase Domain In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | Back alignment and structure |
|
| >pdb|3OCT|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Mutant V555r In Complex With Dasatinib Length = 265 | Back alignment and structure |
|
| >pdb|3UTO|A Chain A, Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-Crd-Ig26) Length = 573 | Back alignment and structure |
|
| >pdb|1YRP|A Chain A, Catalytic Domain Of Human Zip Kinase Phosphorylated At Thr265 Length = 278 | Back alignment and structure |
|
| >pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276 | Back alignment and structure |
|
| >pdb|3GU4|A Chain A, Crystal Structure Of Dapkq23v-Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304 | Back alignment and structure |
|
| >pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298 | Back alignment and structure |
|
| >pdb|1P4F|A Chain A, Death Associated Protein Kinase Catalytic Domain With Bound Inhibitor Fragment Length = 293 | Back alignment and structure |
|
| >pdb|1KOA|A Chain A, Twitchin Kinase Fragment (C.Elegans), Autoregulated Protein Kinase And Immunoglobulin Domains Length = 491 | Back alignment and structure |
|
| >pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain Length = 267 | Back alignment and structure |
|
| >pdb|3DFC|B Chain B, Crystal Structure Of A Glycine-Rich Loop Mutant Of The Death Associated Protein Kinase Catalytic Domain With Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294 | Back alignment and structure |
|
| >pdb|1IG1|A Chain A, 1.8a X-Ray Structure Of Ternary Complex Of A Catalytic Domain Of Death-Associated Protein Kinase With Atp Analogue And Mn. Length = 294 | Back alignment and structure |
|
| >pdb|2XZS|A Chain A, Death Associated Protein Kinase 1 Residues 1-312 Length = 312 | Back alignment and structure |
|
| >pdb|3F5U|A Chain A, Crystal Structure Of The Death Associated Protein Kinase In Complex With Amppnp And Mg2+ Length = 295 | Back alignment and structure |
|
| >pdb|2W4K|A Chain A, X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | Back alignment and structure |
|
| >pdb|1WVW|A Chain A, Crystal Structures Of Kinase Domain Of Dap Kinase In Complex With Small Molecular Inhibitors Length = 278 | Back alignment and structure |
|
| >pdb|2YAK|A Chain A, Structure Of Death-Associated Protein Kinase 1 (Dapk1) In Complex With A Ruthenium Octasporine Ligand (Osv) Length = 285 | Back alignment and structure |
|
| >pdb|2W4J|A Chain A, X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | Back alignment and structure |
|
| >pdb|2IVT|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With 2-Isopropyl-7- (4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3- Ylamino)-2h- Phthalazin-1-One Length = 274 | Back alignment and structure |
|
| >pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298 | Back alignment and structure |
|
| >pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293 | Back alignment and structure |
|
| >pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303 | Back alignment and structure |
|
| >pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543 | Back alignment and structure |
|
| >pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276 | Back alignment and structure |
|
| >pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300 | Back alignment and structure |
|
| >pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex With Inhibitor Cgi1746 Length = 271 | Back alignment and structure |
|
| >pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain Length = 263 | Back alignment and structure |
|
| >pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543 | Back alignment and structure |
|
| >pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268 | Back alignment and structure |
|
| >pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314 | Back alignment and structure |
|
| >pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295 | Back alignment and structure |
|
| >pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301 | Back alignment and structure |
|
| >pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543 | Back alignment and structure |
|
| >pdb|2IVS|A Chain A, Crystal Structure Of Non-Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281 | Back alignment and structure |
|
| >pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306 | Back alignment and structure |
|
| >pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543 | Back alignment and structure |
|
| >pdb|2IVV|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Complexed With The Inhibitor Pp1 Length = 314 | Back alignment and structure |
|
| >pdb|2Y0A|A Chain A, Structure Of Dapk1 Construct Residues 1-304 Length = 326 | Back alignment and structure |
|
| >pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315 | Back alignment and structure |
|
| >pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297 | Back alignment and structure |
|
| >pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676 | Back alignment and structure |
|
| >pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285 | Back alignment and structure |
|
| >pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311 | Back alignment and structure |
|
| >pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313 | Back alignment and structure |
|
| >pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327 | Back alignment and structure |
|
| >pdb|3GU8|A Chain A, Crystal Structure Of Dapkl93g With N6-Cyclopentyladenosine Length = 295 | Back alignment and structure |
|
| >pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285 | Back alignment and structure |
|
| >pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677 | Back alignment and structure |
|
| >pdb|2XIR|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With Pf-00337210 (N,2-Dimethyl-6-(7-(2-Morpholinoethoxy) Quinolin-4-Yloxy)benzofuran-3-Carboxamide) Length = 316 | Back alignment and structure |
|
| >pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267 | Back alignment and structure |
|
| >pdb|3U6J|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyrazolone Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|1KOB|A Chain A, Twitchin Kinase Fragment (Aplysia), Autoregulated Protein Kinase Domain Length = 387 | Back alignment and structure |
|
| >pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280 | Back alignment and structure |
|
| >pdb|4AGC|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase Domains) In Complex With Axitinib (Ag-013736) (N-Methyl-2-( 3-((E)-2-Pyridin-2-Yl-Vinyl)-1h-Indazol-6-Ylsulfanyl)- Benzamide) Length = 353 | Back alignment and structure |
|
| >pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280 | Back alignment and structure |
|
| >pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268 | Back alignment and structure |
|
| >pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283 | Back alignment and structure |
|
| >pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295 | Back alignment and structure |
|
| >pdb|3EWH|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridyl-Pyrimidine Benzimidazole Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294 | Back alignment and structure |
|
| >pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272 | Back alignment and structure |
|
| >pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268 | Back alignment and structure |
|
| >pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|1YWN|A Chain A, Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]pyrimidine Length = 316 | Back alignment and structure |
|
| >pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303 | Back alignment and structure |
|
| >pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297 | Back alignment and structure |
|
| >pdb|2P2I|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Nicotinamide Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279 | Back alignment and structure |
|
| >pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285 | Back alignment and structure |
|
| >pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275 | Back alignment and structure |
|
| >pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304 | Back alignment and structure |
|
| >pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297 | Back alignment and structure |
|
| >pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272 | Back alignment and structure |
|
| >pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298 | Back alignment and structure |
|
| >pdb|2P2H|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridinyl-Triazine Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|1VR2|A Chain A, Human Vascular Endothelial Growth Factor Receptor 2 (Kdr) Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262 | Back alignment and structure |
|
| >pdb|3CJF|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304 | Back alignment and structure |
|
| >pdb|3C7Q|A Chain A, Structure Of Vegfr2 Kinase Domain In Complex With Bibf1120 Length = 316 | Back alignment and structure |
|
| >pdb|3VNT|A Chain A, Crystal Structure Of The Kinase Domain Of Human Vegfr2 With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 318 | Back alignment and structure |
|
| >pdb|3CJG|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285 | Back alignment and structure |
|
| >pdb|2OH4|A Chain A, Crystal Structure Of Vegfr2 With A Benzimidazole-Urea Inhibitor Length = 316 | Back alignment and structure |
|
| >pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282 | Back alignment and structure |
|
| >pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293 | Back alignment and structure |
|
| >pdb|1LUF|A Chain A, Crystal Structure Of The Musk Tyrosine Kinase: Insights Into Receptor Autoregulation Length = 343 | Back alignment and structure |
|
| >pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315 | Back alignment and structure |
|
| >pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282 | Back alignment and structure |
|
| >pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334 | Back alignment and structure |
|
| >pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272 | Back alignment and structure |
|
| >pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320 | Back alignment and structure |
|
| >pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279 | Back alignment and structure |
|
| >pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290 | Back alignment and structure |
|
| >pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306 | Back alignment and structure |
|
| >pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332 | Back alignment and structure |
|
| >pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290 | Back alignment and structure |
|
| >pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268 | Back alignment and structure |
|
| >pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6 Bound To Amppnp Length = 576 | Back alignment and structure |
|
| >pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6 In Complex With Sangivamycin Length = 576 | Back alignment and structure |
|
| >pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271 | Back alignment and structure |
|
| >pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272 | Back alignment and structure |
|
| >pdb|4F0F|A Chain A, Crystal Structure Of The Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278 | Back alignment and structure |
|
| >pdb|2P0C|A Chain A, Catalytic Domain Of The Proto-Oncogene Tyrosine-Protein Kina Length = 313 | Back alignment and structure |
|
| >pdb|3PLS|A Chain A, Ron In Complex With Ligand Amp-Pnp Length = 298 | Back alignment and structure |
|
| >pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314 | Back alignment and structure |
|
| >pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318 | Back alignment and structure |
|
| >pdb|3ZZW|A Chain A, Crystal Structure Of The Kinase Domain Of Ror2 Length = 289 | Back alignment and structure |
|
| >pdb|4GT4|A Chain A, Structure Of Unliganded, Inactive Ror2 Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K641r Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071 Length = 360 | Back alignment and structure |
|
| >pdb|1WMK|A Chain A, Human Death-Associated Kinase Drp-1, Mutant S308d D40 Length = 321 | Back alignment and structure |
|
| >pdb|2A2A|A Chain A, High-resolution Crystallographic Analysis Of The Autoinhibited Conformation Of A Human Death-associated Protein Kinase Length = 321 | Back alignment and structure |
|
| >pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317 | Back alignment and structure |
|
| >pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains Trapped In Trans-Phosphorylation Reaction Length = 334 | Back alignment and structure |
|
| >pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp Analog And Substrate Peptide Length = 334 | Back alignment and structure |
|
| >pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302 | Back alignment and structure |
|
| >pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317 | Back alignment and structure |
|
| >pdb|2A27|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 8 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293 | Back alignment and structure |
|
| >pdb|1Z9X|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 3 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|1ZWS|A Chain A, Crystal Structure Of The Catalytic Domain Of Human Drp-1 Kinase Length = 288 | Back alignment and structure |
|
| >pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|4F1M|A Chain A, Crystal Structure Of The G1179s Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302 | Back alignment and structure |
|
| >pdb|4F1O|A Chain A, Crystal Structure Of The L1180t Mutant Roco4 Kinase Domain From D. Discoideum Bound To Appcp Length = 287 | Back alignment and structure |
|
| >pdb|3Q4T|A Chain A, Crystal Structure Of Activin Receptor Type-Iia (Acvr2a) Kinase Domain In Complex With Dorsomorphin Length = 322 | Back alignment and structure |
|
| >pdb|3LMG|A Chain A, Crystal Structure Of The Erbb3 Kinase Domain In Complex With Amp-Pnp Length = 344 | Back alignment and structure |
|
| >pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336 | Back alignment and structure |
|
| >pdb|2YA9|A Chain A, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2 Length = 361 | Back alignment and structure |
|
| >pdb|3KEX|A Chain A, Crystal Structure Of The Catalytically Inactive Kinase Domain Of The Human Epidermal Growth Factor Receptor 3 (Her3) Length = 325 | Back alignment and structure |
|
| >pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K659n Mutation Responsible For An Unclassified Craniosynostosis Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|3OZ6|A Chain A, Crystal Structure Of Mapk From Cryptosporidium Parvum, Cgd2_1960 Length = 388 | Back alignment and structure |
|
| >pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549h Mutation Responsible For Crouzon Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3- Methoxybenzyl)-7-Azaindole Length = 302 | Back alignment and structure |
|
| >pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318 | Back alignment and structure |
|
| >pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor 1 Length = 317 | Back alignment and structure |
|
| >pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K526e Mutation Responsible For Crouzon Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327 | Back alignment and structure |
|
| >pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase In Complex With Arq 069 Length = 306 | Back alignment and structure |
|
| >pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fibroblast Growth Factor Receptor 1 Length = 310 | Back alignment and structure |
|
| >pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549t Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331 | Back alignment and structure |
|
| >pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast Growth Factor Receptor 1 In Complex With 5-(2-Thienyl) Nicotinic Acid Length = 317 | Back alignment and structure |
|
| >pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor Receptor 1 Kinase Domain In Complex With Compound 1 Length = 309 | Back alignment and structure |
|
| >pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365 | Back alignment and structure |
|
| >pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303 | Back alignment and structure |
|
| >pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327 | Back alignment and structure |
|
| >pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301 | Back alignment and structure |
|
| >pdb|3KK9|A Chain A, Camkii Substrate Complex B Length = 282 | Back alignment and structure |
|
| >pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423 | Back alignment and structure |
|
| >pdb|3KK8|A Chain A, Camkii Substrate Complex A Length = 284 | Back alignment and structure |
|
| >pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex Length = 269 | Back alignment and structure |
|
| >pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326 | Back alignment and structure |
|
| >pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308 | Back alignment and structure |
|
| >pdb|3PP0|A Chain A, Crystal Structure Of The Kinase Domain Of Human Her2 (Erbb2). Length = 338 | Back alignment and structure |
|
| >pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase Domain With 3-(2,6-Dichloro-3, 5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1- Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398) Length = 382 | Back alignment and structure |
|
| >pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302 | Back alignment and structure |
|
| >pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292 | Back alignment and structure |
|
| >pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327 | Back alignment and structure |
|
| >pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295 | Back alignment and structure |
|
| >pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300 | Back alignment and structure |
|
| >pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327 | Back alignment and structure |
|
| >pdb|3FPQ|A Chain A, Crystal Structure Of The Kinase Domain Of Wnk1 Length = 290 | Back alignment and structure |
|
| >pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303 | Back alignment and structure |
|
| >pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of CalciumCALMODULIN ACTIVATED KINASE II Length = 362 | Back alignment and structure |
|
| >pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504 | Back alignment and structure |
|
| >pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290 | Back alignment and structure |
|
| >pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | Back alignment and structure |
|
| >pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346 | Back alignment and structure |
|
| >pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino( Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6- Difluoro-Phenyl)-Amide) Length = 349 | Back alignment and structure |
|
| >pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296 | Back alignment and structure |
|
| >pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild Type Fgf Receptor 2 (Fgfr2) Kinase Domain Length = 370 | Back alignment and structure |
|
| >pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299 | Back alignment and structure |
|
| >pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306 | Back alignment and structure |
|
| >pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3B2T|A Chain A, Structure Of Phosphotransferase Length = 311 | Back alignment and structure |
|
| >pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327 | Back alignment and structure |
|
| >pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase In Complex With Arq 069 Length = 313 | Back alignment and structure |
|
| >pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353 | Back alignment and structure |
|
| >pdb|1GJO|A Chain A, The Fgfr2 Tyrosine Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306 | Back alignment and structure |
|
| >pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299 | Back alignment and structure |
|
| >pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327 | Back alignment and structure |
|
| >pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298 | Back alignment and structure |
|
| >pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300 | Back alignment and structure |
|
| >pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299 | Back alignment and structure |
|
| >pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284 | Back alignment and structure |
|
| >pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309 | Back alignment and structure |
|
| >pdb|2Q0B|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565a Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297 | Back alignment and structure |
|
| >pdb|3VUM|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M7 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298 | Back alignment and structure |
|
| >pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299 | Back alignment and structure |
|
| >pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328 | Back alignment and structure |
|
| >pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298 | Back alignment and structure |
|
| >pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300 | Back alignment and structure |
|
| >pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289 | Back alignment and structure |
|
| >pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303 | Back alignment and structure |
|
| >pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296 | Back alignment and structure |
|
| >pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298 | Back alignment and structure |
|
| >pdb|2JIU|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Complex With Aee788 Length = 328 | Back alignment and structure |
|
| >pdb|2PY3|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565g Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2JIV|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Compex With Hki-272 Length = 328 | Back alignment and structure |
|
| >pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346 | Back alignment and structure |
|
| >pdb|4FVP|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain (Apo Form) Length = 289 | Back alignment and structure |
|
| >pdb|4G5P|A Chain A, Crystal Structure Of Egfr Kinase T790m In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348 | Back alignment and structure |
|
| >pdb|4I24|A Chain A, Structure Of T790m Egfr Kinase Domain Co-crystallized With Dacomitinib Length = 329 | Back alignment and structure |
|
| >pdb|2JIT|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation Length = 327 | Back alignment and structure |
|
| >pdb|3G2F|A Chain A, Crystal Structure Of The Kinase Domain Of Bone Morphogenetic Protein Receptor Type Ii (Bmpr2) At 2.35 A Resolution Length = 336 | Back alignment and structure |
|
| >pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360 | Back alignment and structure |
|
| >pdb|3IKA|A Chain A, Crystal Structure Of Egfr 696-1022 T790m Mutant Covalently Binding To Wz4002 Length = 331 | Back alignment and structure |
|
| >pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370 | Back alignment and structure |
|
| >pdb|3VUL|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|4HJO|A Chain A, Crystal Structure Of The Inactive Egfr Tyrosine Kinase Domain With Erlotinib Length = 337 | Back alignment and structure |
|
| >pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | Back alignment and structure |
|
| >pdb|2J5E|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 13-Jab Length = 327 | Back alignment and structure |
|
| >pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348 | Back alignment and structure |
|
| >pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|3LZB|A Chain A, Egfr Kinase Domain Complexed With An Imidazo[2,1-B]thiazole Inhibitor Length = 327 | Back alignment and structure |
|
| >pdb|3BEL|A Chain A, X-Ray Structure Of Egfr In Complex With Oxime Inhibitor Length = 315 | Back alignment and structure |
|
| >pdb|2J5F|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 34-Jab Length = 327 | Back alignment and structure |
|
| >pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379 | Back alignment and structure |
|
| >pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380 | Back alignment and structure |
|
| >pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365 | Back alignment and structure |
|
| >pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|4I23|A Chain A, Crystal Structure Of The Wild-type Egfr Kinase Domain In Complex With Dacomitinib (soaked) Length = 329 | Back alignment and structure |
|
| >pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345 | Back alignment and structure |
|
| >pdb|4G5J|A Chain A, Crystal Structure Of Egfr Kinase In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319 | Back alignment and structure |
|
| >pdb|2GS2|A Chain A, Crystal Structure Of The Active Egfr Kinase Domain Length = 330 | Back alignment and structure |
|
| >pdb|3VJO|A Chain A, Crystal Structure Of The Wild-Type Egfr Kinase Domain In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|2GS7|A Chain A, Crystal Structure Of The Inactive Egfr Kinase Domain In Complex With Amp-Pnp Length = 330 | Back alignment and structure |
|
| >pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|1M14|A Chain A, Tyrosine Kinase Domain From Epidermal Growth Factor Receptor Length = 333 | Back alignment and structure |
|
| >pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348 | Back alignment and structure |
|
| >pdb|1XKK|A Chain A, Egfr Kinase Domain Complexed With A Quinazoline Inhibitor- Gw572016 Length = 352 | Back alignment and structure |
|
| >pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299 | Back alignment and structure |
|
| >pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389 | Back alignment and structure |
|
| >pdb|3ALN|A Chain A, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase Domain Complexed With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321 | Back alignment and structure |
|
| >pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365 | Back alignment and structure |
|
| >pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366 | Back alignment and structure |
|
| >pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352 | Back alignment and structure |
|
| >pdb|3RNY|A Chain A, Crystal Structure Of Human Rsk1 C-Terminal Kinase Domain Length = 346 | Back alignment and structure |
|
| >pdb|2RFD|A Chain A, Crystal Structure Of The Complex Between The Egfr Kinase Domain And A Mig6 Peptide Length = 324 | Back alignment and structure |
|
| >pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|2QR8|A Chain A, 2.0a X-ray Structure Of C-terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 (rsk2) Length = 342 | Back alignment and structure |
|
| >pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3MFR|A Chain A, Cask-4m Cam Kinase Domain, Native Length = 351 | Back alignment and structure |
|
| >pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284 | Back alignment and structure |
|
| >pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299 | Back alignment and structure |
|
| >pdb|4FVR|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain Mutant V617f (Mg- Atp-Bound Form) Length = 289 | Back alignment and structure |
|
| >pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360 | Back alignment and structure |
|
| >pdb|2WNT|A Chain A, Crystal Structure Of The Human Ribosomal Protein S6 Kinase Length = 330 | Back alignment and structure |
|
| >pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285 | Back alignment and structure |
|
| >pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366 | Back alignment and structure |
|
| >pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325 | Back alignment and structure |
|
| >pdb|3NPC|A Chain A, Crystal Structure Of Jnk2 Complexed With Birb796 Length = 364 | Back alignment and structure |
|
| >pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372 | Back alignment and structure |
|
| >pdb|3ELJ|A Chain A, Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine Inhibitor Length = 369 | Back alignment and structure |
|
| >pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|2VZ6|A Chain A, Structure Of Human Calcium Calmodulin Dependent Protein Kinase Type Ii Alpha (Camk2a) In Complex With Indirubin E804 Length = 313 | Back alignment and structure |
|
| >pdb|3PZE|A Chain A, Jnk1 In Complex With Inhibitor Length = 358 | Back alignment and structure |
|
| >pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486 | Back alignment and structure |
|
| >pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287 | Back alignment and structure |
|
| >pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367 | Back alignment and structure |
|
| >pdb|1ZXE|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n Inactivating Mutant In Apo Form Length = 303 | Back alignment and structure |
|
| >pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365 | Back alignment and structure |
|
| >pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286 | Back alignment and structure |
|
| >pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372 | Back alignment and structure |
|
| >pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362 | Back alignment and structure |
|
| >pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362 | Back alignment and structure |
|
| >pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360 | Back alignment and structure |
|
| >pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|3FI3|A Chain A, Crystal Structure Of Jnk3 With Indazole Inhibitor, Sr-3737 Length = 364 | Back alignment and structure |
|
| >pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360 | Back alignment and structure |
|
| >pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305 | Back alignment and structure |
|
| >pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362 | Back alignment and structure |
|
| >pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351 | Back alignment and structure |
|
| >pdb|3FI2|A Chain A, Crystal Structure Of Jnk3 With Amino-Pyrazole Inhibitor, Sr- 3451 Length = 353 | Back alignment and structure |
|
| >pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354 | Back alignment and structure |
|
| >pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359 | Back alignment and structure |
|
| >pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304 | Back alignment and structure |
|
| >pdb|3FV8|A Chain A, Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Length = 355 | Back alignment and structure |
|
| >pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354 | Back alignment and structure |
|
| >pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350 | Back alignment and structure |
|
| >pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379 | Back alignment and structure |
|
| >pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|3PFQ|A Chain A, Crystal Structure And Allosteric Activation Of Protein Kinase C Beta Ii Length = 674 | Back alignment and structure |
|
| >pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348 | Back alignment and structure |
|
| >pdb|3GOP|A Chain A, Crystal Structure Of The Egf Receptor Juxtamembrane And Kinase Domains Length = 361 | Back alignment and structure |
|
| >pdb|2QLU|A Chain A, Crystal Structure Of Activin Receptor Type Ii Kinase Domain From Human Length = 314 | Back alignment and structure |
|
| >pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354 | Back alignment and structure |
|
| >pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311 | Back alignment and structure |
|
| >pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311 | Back alignment and structure |
|
| >pdb|3E7O|A Chain A, Crystal Structure Of Jnk2 Length = 360 | Back alignment and structure |
|
| >pdb|2V7O|A Chain A, Crystal Structure Of Human Calcium-Calmodulin-Dependent Protein Kinase Ii Gamma Length = 336 | Back alignment and structure |
|
| >pdb|3W2O|A Chain A, Egfr Kinase Domain T790m/l858r Mutant With Tak-285 Length = 331 | Back alignment and structure |
|
| >pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain Kinase Loc340156. Length = 373 | Back alignment and structure |
|
| >pdb|3VUK|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M5 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494 | Back alignment and structure |
|
| >pdb|3UG1|A Chain A, Crystal Structure Of The Mutated Egfr Kinase Domain (G719sT790M) IN The Apo Form Length = 334 | Back alignment and structure |
|
| >pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313 | Back alignment and structure |
|
| >pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366 | Back alignment and structure |
|
| >pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292 | Back alignment and structure |
|
| >pdb|4I1Z|A Chain A, Crystal Structure Of The Monomeric (v948r) Form Of The Gefitinib/erlotinib Resistant Egfr Kinase Domain L858r+t790m Length = 329 | Back alignment and structure |
|
| >pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384 | Back alignment and structure |
|
| >pdb|3SOA|A Chain A, Full-Length Human Camkii Length = 444 | Back alignment and structure |
|
| >pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367 | Back alignment and structure |
|
| >pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298 | Back alignment and structure |
|
| >pdb|4I21|A Chain A, Crystal Structure Of L858r + T790m Egfr Kinase Domain In Complex With Mig6 Peptide Length = 329 | Back alignment and structure |
|
| >pdb|3TTJ|A Chain A, Crystal Structure Of Jnk3 Complexed With Cc-359, A Jnk Inhibitor For The Prevention Of Ischemia-Reperfusion Injury Length = 464 | Back alignment and structure |
|
| >pdb|2ITN|A Chain A, Crystal Structure Of Egfr Kinase Domain G719s Mutation In Complex With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|2I0E|A Chain A, Structure Of Catalytic Domain Of Human Protein Kinase C Beta Ii Complexed With A Bisindolylmaleimide Inhibitor Length = 353 | Back alignment and structure |
|
| >pdb|2QR7|A Chain A, 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2: Se-Met Derivative Length = 342 | Back alignment and structure |
|
| >pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|2EB2|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (G719s) Length = 334 | Back alignment and structure |
|
| >pdb|4I20|A Chain A, Crystal Structure Of Monomeric (v948r) Primary Oncogenic Mutant L858r Egfr Kinase Domain Length = 329 | Back alignment and structure |
|
| >pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex Length = 292 | Back alignment and structure |
|
| >pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3KVX|A Chain A, Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Length = 364 | Back alignment and structure |
|
| >pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484 | Back alignment and structure |
|
| >pdb|2R9S|A Chain A, C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Quinoline Inhibitor Length = 356 | Back alignment and structure |
|
| >pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|2ITT|A Chain A, Crystal Structure Of Egfr Kinase Domain L858r Mutation In Complex With Aee788 Length = 327 | Back alignment and structure |
|
| >pdb|1PMN|A Chain A, Crystal Structure Of Jnk3 In Complex With An Imidazole- Pyrimidine Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290 | Back alignment and structure |
|
| >pdb|3LM0|A Chain A, Crystal Structure Of Human SerineTHREONINE KINASE 17B (STK17B) Length = 327 | Back alignment and structure |
|
| >pdb|2O0U|A Chain A, Crystal Structure Of Human Jnk3 Complexed With N-{3-Cyano-6-[3-(1- Piperidinyl)propanoyl]-4,5,6,7-Tetrahydrothieno[2, 3-C]pyridin-2-Yl}- 1-Naphthalenecarboxamide Length = 364 | Back alignment and structure |
|
| >pdb|3PTG|A Chain A, Design And Synthesis Of A Novel, Orally Efficacious Tri-Substituted Thiophene Based Jnk Inhibitor Length = 363 | Back alignment and structure |
|
| >pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|2OK1|A Chain A, Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3- Chlorophenyl)-1h-Pyrazol-3-Yl)-1h-Pyrrole-2-Carboxamide Length = 365 | Back alignment and structure |
|
| >pdb|1CM8|A Chain A, Phosphorylated Map Kinase P38-Gamma Length = 367 | Back alignment and structure |
|
| >pdb|3OXI|A Chain A, Design And Synthesis Of Disubstituted Thiophene And Thiazole Based Inhibitors Of Jnk For The Treatment Of Neurodegenerative Diseases Length = 362 | Back alignment and structure |
|
| >pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307 | Back alignment and structure |
|
| >pdb|3FZO|A Chain A, Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosine Kinase Length = 277 | Back alignment and structure |
|
| >pdb|2EB3|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (L858r) In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|4H36|A Chain A, Crystal Structure Of Jnk3 In Complex With Atf2 Peptide Length = 356 | Back alignment and structure |
|
| >pdb|1JNK|A Chain A, The C-Jun N-Terminal Kinase (Jnk3s) Complexed With Mgamp-Pnp Length = 423 | Back alignment and structure |
|
| >pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|2B1P|A Chain A, Inhibitor Complex Of Jnk3 Length = 355 | Back alignment and structure |
|
| >pdb|2EXC|X Chain X, Inhibitor Complex Of Jnk3 Length = 356 | Back alignment and structure |
|
| >pdb|4H1J|A Chain A, Crystal Structure Of Pyk2 With The Pyrazole 13a Length = 293 | Back alignment and structure |
|
| >pdb|3VUI|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3O17|A Chain A, Crystal Structure Of Jnk1-Alpha1 Isoform Length = 370 | Back alignment and structure |
|
| >pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507 | Back alignment and structure |
|
| >pdb|3GI3|A Chain A, Crystal Structure Of A N-Phenyl-N'-Naphthylurea Analog In Complex With P38 Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508 | Back alignment and structure |
|
| >pdb|3CC6|A Chain A, Crystal Structure Of Kinase Domain Of Protein Tyrosine Kinase 2 Beta (ptk2b) Length = 281 | Back alignment and structure |
|
| >pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395 | Back alignment and structure |
|
| >pdb|2WEL|A Chain A, Crystal Structure Of Su6656-Bound CalciumCALMODULIN- Dependent Protein Kinase Ii Delta In Complex With Calmodulin Length = 327 | Back alignment and structure |
|
| >pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By Mutational Studies Length = 298 | Back alignment and structure |
|
| >pdb|3QUP|A Chain A, Inhibitor Bound Structure Of The Kinase Domain Of The Murine Receptor Tyrosine Kinase Tyro3 (Sky) Length = 323 | Back alignment and structure |
|
| >pdb|1UKH|A Chain A, Structural Basis For The Selective Inhibition Of Jnk1 By The Scaffolding Protein Jip1 And Sp600125 Length = 369 | Back alignment and structure |
|
| >pdb|2XRW|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 371 | Back alignment and structure |
|
| >pdb|3VUH|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M3 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327 | Back alignment and structure |
|
| >pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309 | Back alignment and structure |
|
| >pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341 | Back alignment and structure |
|
| >pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333 | Back alignment and structure |
|
| >pdb|3VUD|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|2VN9|A Chain A, Crystal Structure Of Human Calcium Calmodulin Dependent Protein Kinase Ii Delta Isoform 1, Camkd Length = 301 | Back alignment and structure |
|
| >pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348 | Back alignment and structure |
|
| >pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328 | Back alignment and structure |
|
| >pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467 | Back alignment and structure |
|
| >pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322 | Back alignment and structure |
|
| >pdb|2G01|A Chain A, Pyrazoloquinolones As Novel, Selective Jnk1 Inhibitors Length = 370 | Back alignment and structure |
|
| >pdb|2J0L|A Chain A, Crystal Structure Of A The Active Conformation Of The Kinase Domain Of Focal Adhesion Kinase With A Phosphorylated Activation Loop Length = 276 | Back alignment and structure |
|
| >pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide Substrate Complex: Kinase Substrate Recognition Length = 277 | Back alignment and structure |
|
| >pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310 | Back alignment and structure |
|
| >pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360 | Back alignment and structure |
|
| >pdb|2Y4I|B Chain B, Ksr2-Mek1 Heterodimer Length = 319 | Back alignment and structure |
|
| >pdb|3VUG|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|2DYL|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 7 Activated Mutant (S287d, T291d) Length = 318 | Back alignment and structure |
|
| >pdb|4HZS|A Chain A, Crystal Structure Of Ack1 Kinase Domain With C-terminal Sh3 Domain Length = 341 | Back alignment and structure |
|
| >pdb|3V3V|A Chain A, Structural And Functional Analysis Of Quercetagetin, A Natural Jnk1 Inhibitor Length = 379 | Back alignment and structure |
|
| >pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311 | Back alignment and structure |
|
| >pdb|2J0J|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains Length = 656 | Back alignment and structure |
|
| >pdb|3EQP|B Chain B, Crystal Structure Of Ack1 With Compound T95 Length = 276 | Back alignment and structure |
|
| >pdb|3BHH|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase Iib Isoform 1 (camk2b) Length = 295 | Back alignment and structure |
|
| >pdb|2IWI|A Chain A, Crystal Structure Of The Human Pim2 In Complex With A Ruthenium Organometallic Ligand Ru1 Length = 312 | Back alignment and structure |
|
| >pdb|4EWH|B Chain B, Co-Crystal Structure Of Ack1 With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase, Kinase: An Active Protein Kinase Complexed With Nucleotide, Substrate-Analogue And Product Length = 298 | Back alignment and structure |
|
| >pdb|1U54|A Chain A, Crystal Structures Of The Phosphorylated And Unphosphorylated Kinase Domains Of The Cdc42-Associated Tyrosine Kinase Ack1 Bound To Amp-Pcp Length = 291 | Back alignment and structure |
|
| >pdb|1U46|A Chain A, Crystal Structure Of The Unphosphorylated Kinase Domain Of The Tyrosine Kinase Ack1 Length = 291 | Back alignment and structure |
|
| >pdb|2J0M|B Chain B, Crystal Structure A Two-Chain Complex Between The Ferm And Kinase Domains Of Focal Adhesion Kinase. Length = 276 | Back alignment and structure |
|
| >pdb|2JKM|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|4EBW|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In Complex With Novel Allosteric Inhibitor Length = 304 | Back alignment and structure |
|
| >pdb|4ID7|A Chain A, Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-amino-1-(4- Phenoxyphenyl)imidazo[1,5-a]pyrazin-3-yl]cyclobutanol Length = 273 | Back alignment and structure |
|
| >pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75 Length = 360 | Back alignment and structure |
|
| >pdb|3MH0|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3O8P|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif Mutants In Response To Inhibitor Binding Length = 360 | Back alignment and structure |
|
| >pdb|4HZR|A Chain A, Crystal Structure Of Ack1 Kinase Domain Length = 277 | Back alignment and structure |
|
| >pdb|3SA0|A Chain A, Complex Of Erk2 With Norathyriol Length = 360 | Back alignment and structure |
|
| >pdb|1MP8|A Chain A, Crystal Structure Of Focal Adhesion Kinase (Fak) Length = 281 | Back alignment and structure |
|
| >pdb|2ETM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative Length = 281 | Back alignment and structure |
|
| >pdb|3ZU7|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|2Z7L|A Chain A, Unphosphorylated Mitogen Activated Protein Kinase Erk2 In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin 2-Yl]amino}phenyl)acetic Acid Length = 366 | Back alignment and structure |
|
| >pdb|3C9W|A Chain A, Crystal Structure Of Erk-2 With Hypothemycin Covalently Bound Length = 357 | Back alignment and structure |
|
| >pdb|3BZ3|A Chain A, Crystal Structure Analysis Of Focal Adhesion Kinase With A Methanesulfonamide Diaminopyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|2FYS|B Chain B, Crystal Structure Of Erk2 Complex With Kim Peptide Derived From Mkp3 Length = 364 | Back alignment and structure |
|
| >pdb|3PXK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Pyrrolo[2,3- D]thiazole Length = 282 | Back alignment and structure |
|
| >pdb|3MH3|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3O71|A Chain A, Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length = 358 | Back alignment and structure |
|
| >pdb|2F2U|A Chain A, Crystal Structure Of The Rho-Kinase Kinase Domain Length = 402 | Back alignment and structure |
|
| >pdb|3R63|A Chain A, Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | Back alignment and structure |
|
| >pdb|1UNG|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By Roscovitine, Aloisine And Indirubin. Length = 292 | Back alignment and structure |
|
| >pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A Dihydroquinazolinone Inhibitor Length = 370 | Back alignment and structure |
|
| >pdb|2XS0|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 386 | Back alignment and structure |
|
| >pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94 Length = 360 | Back alignment and structure |
|
| >pdb|2GPH|A Chain A, Docking Motif Interactions In The Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|3VN9|A Chain A, Rifined Crystal Structure Of Non-Phosphorylated Map2k6 In A Putative Auto-Inhibition State Length = 340 | Back alignment and structure |
|
| >pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304 | Back alignment and structure |
|
| >pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484 | Back alignment and structure |
|
| >pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed With A Specific Inhibitor Of Human P38 Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310 | Back alignment and structure |
|
| >pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312 | Back alignment and structure |
|
| >pdb|4FV6|A Chain A, Crystal Structure Of The Erk2 Complexed With E57 Length = 360 | Back alignment and structure |
|
| >pdb|3MH1|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|2Y9Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288 | Back alignment and structure |
|
| >pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289 | Back alignment and structure |
|
| >pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|1WZY|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Pyrazolopyridazine Derivative Length = 368 | Back alignment and structure |
|
| >pdb|1TVO|A Chain A, The Structure Of Erk2 In Complex With A Small Molecule Inhibitor Length = 368 | Back alignment and structure |
|
| >pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286 | Back alignment and structure |
|
| >pdb|3TEI|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286 | Back alignment and structure |
|
| >pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286 | Back alignment and structure |
|
| >pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316 | Back alignment and structure |
|
| >pdb|2OJG|A Chain A, Crystal Structure Of Erk2 In Complex With N,n-dimethyl-4-(4- Phenyl-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|1GOL|A Chain A, Coordinates Of Rat Map Kinase Erk2 With An Arginine Mutation At Position 52 Length = 364 | Back alignment and structure |
|
| >pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327 | Back alignment and structure |
|
| >pdb|2J0K|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains. Length = 656 | Back alignment and structure |
|
| >pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311 | Back alignment and structure |
|
| >pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311 | Back alignment and structure |
|
| >pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310 | Back alignment and structure |
|
| >pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312 | Back alignment and structure |
|
| >pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311 | Back alignment and structure |
|
| >pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311 | Back alignment and structure |
|
| >pdb|2JKK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301 | Back alignment and structure |
|
| >pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314 | Back alignment and structure |
|
| >pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311 | Back alignment and structure |
|
| >pdb|3F88|A Chain A, Glycogen Synthase Kinase 3beta Inhibitor Complex Length = 349 | Back alignment and structure |
|
| >pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292 | Back alignment and structure |
|
| >pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373 | Back alignment and structure |
|
| >pdb|3FME|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 6 (Mek6) Activated Mutant (S207d, T211d) Length = 290 | Back alignment and structure |
|
| >pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311 | Back alignment and structure |
|
| >pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321 | Back alignment and structure |
|
| >pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311 | Back alignment and structure |
|
| >pdb|3ZUV|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Phosphorylated Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|2ERK|A Chain A, Phosphorylated Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|3MY0|A Chain A, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound To Ldn- 193189 Length = 305 | Back alignment and structure |
|
| >pdb|4E7W|A Chain A, Structure Of Gsk3 From Ustilago Maydis Length = 394 | Back alignment and structure |
|
| >pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 11 (p38 Beta) In Complex With Nilotinib Length = 348 | Back alignment and structure |
|
| >pdb|2HW6|A Chain A, Crystal Structure Of Mnk1 Catalytic Domain Length = 307 | Back alignment and structure |
|
| >pdb|3GBZ|A Chain A, Structure Of The Cmgc Cdk Kinase From Giardia Lamblia Length = 329 | Back alignment and structure |
|
| >pdb|3GC8|A Chain A, The Structure Of P38beta C162s In Complex With A Dihydroquinazolinone Length = 370 | Back alignment and structure |
|
| >pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol (Soak) Length = 688 | Back alignment and structure |
|
| >pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits Length = 689 | Back alignment and structure |
|
| >pdb|1ZRZ|A Chain A, Crystal Structure Of The Catalytic Domain Of Atypical Protein Kinase C-Iota Length = 364 | Back alignment and structure |
|
| >pdb|3SAY|A Chain A, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta (Gsk3b) In Complex With Inhibitor 142 Length = 430 | Back alignment and structure |
|
| >pdb|3COI|A Chain A, Crystal Structure Of P38delta Kinase Length = 353 | Back alignment and structure |
|
| >pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled Receptor Kinase 2 And Heterotrimeric G Protein Beta 1 And Gamma 2 Subunits Length = 689 | Back alignment and structure |
|
| >pdb|1GNG|A Chain A, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With Frattide Peptide Length = 378 | Back alignment and structure |
|
| >pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits Length = 695 | Back alignment and structure |
|
| >pdb|4AFJ|A Chain A, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective Gsk-3 Inhibitors Length = 367 | Back alignment and structure |
|
| >pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|1Q5K|A Chain A, Crystal Structure Of Glycogen Synthase Kinase 3 In Complexed With Inhibitor Length = 414 | Back alignment and structure |
|
| >pdb|1I09|A Chain A, Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Length = 420 | Back alignment and structure |
|
| >pdb|3A8W|A Chain A, Crystal Structure Of Pkciota Kinase Domain Length = 345 | Back alignment and structure |
|
| >pdb|3ZH8|A Chain A, A Novel Small Molecule Apkc Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|4DIT|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Imidazopyridine Inhibitor Length = 382 | Back alignment and structure |
|
| >pdb|3ZRK|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-3beta Inhibitors Length = 371 | Back alignment and structure |
|
| >pdb|3F3Z|A Chain A, Crystal Structure Of Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 In Presence Of Indirubin E804 Length = 277 | Back alignment and structure |
|
| >pdb|1PYX|A Chain A, Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | Back alignment and structure |
|
| >pdb|3ZDI|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide And Inhibitor 7d Length = 350 | Back alignment and structure |
|
| >pdb|4EXU|A Chain A, Mapk13, Inactive Form Length = 371 | Back alignment and structure |
|
| >pdb|1Q3D|A Chain A, Gsk-3 Beta Complexed With Staurosporine Length = 424 | Back alignment and structure |
|
| >pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311 | Back alignment and structure |
|
| >pdb|3F7Z|A Chain A, X-ray Co-crystal Structure Of Glycogen Synthase Kinase 3beta In Complex With An Inhibitor Length = 350 | Back alignment and structure |
|
| >pdb|2O5K|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Benzoimidazol Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311 | Back alignment and structure |
|
| >pdb|3P23|A Chain A, Crystal Structure Of The Human Kinase And Rnase Domains In Complex With Adp Length = 432 | Back alignment and structure |
|
| >pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311 | Back alignment and structure |
|
| >pdb|2OW3|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With Bis- (Indole)maleimide Pyridinophane Inhibitor Length = 352 | Back alignment and structure |
|
| >pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311 | Back alignment and structure |
|
| >pdb|4DC2|A Chain A, Structure Of Pkc In Complex With A Substrate Peptide From Par-3 Length = 396 | Back alignment and structure |
|
| >pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350 | Back alignment and structure |
|
| >pdb|1R0E|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With 3-Indolyl-4- Arylmaleimide Inhibitor Length = 391 | Back alignment and structure |
|
| >pdb|3SD0|A Chain A, Identification Of A Glycogen Synthase Kinase-3b Inhibitor That Attenuates Hyperactivity In Clock Mutant Mice Length = 350 | Back alignment and structure |
|
| >pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311 | Back alignment and structure |
|
| >pdb|2QG5|A Chain A, Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 Length = 294 | Back alignment and structure |
|
| >pdb|4AW2|A Chain A, Crystal Structure Of Cdc42 Binding Protein Kinase Alpha (Mrck Alpha) Length = 437 | Back alignment and structure |
|
| >pdb|3GB2|A Chain A, Gsk3beta Inhibitor Complex Length = 353 | Back alignment and structure |
|
| >pdb|4G3G|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) V408l Bound To A 2-(aminothiazolyl)phenol (cmp3) Length = 350 | Back alignment and structure |
|
| >pdb|4ACC|A Chain A, Gsk3b In Complex With Inhibitor Length = 465 | Back alignment and structure |
|
| >pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092, Delete A660- T867) At 2.28 A Resolution Length = 299 | Back alignment and structure |
|
| >pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299 | Back alignment and structure |
|
| >pdb|2RIO|A Chain A, Structure Of The Dual Enzyme Ire1 Reveals The Basis For Catalysis And Regulation Of Non-conventional Splicing Length = 434 | Back alignment and structure |
|
| >pdb|1XH9|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|4G3D|A Chain A, Crystal Structure Of Human Nf-kappab Inducing Kinase (nik) Length = 371 | Back alignment and structure |
|
| >pdb|4G3F|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) Bound To A 2-(aminothiazoly)phenol (cmp2) Length = 336 | Back alignment and structure |
|
| >pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase Length = 350 | Back alignment and structure |
|
| >pdb|1SMH|A Chain A, Protein Kinase A Variant Complex With Completely Ordered N- Terminal Helix Length = 350 | Back alignment and structure |
|
| >pdb|3TAC|A Chain A, Crystal Structure Of The Liprin-AlphaCASK COMPLEX Length = 361 | Back alignment and structure |
|
| >pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With Y- 27632 Length = 350 | Back alignment and structure |
|
| >pdb|4EJN|A Chain A, Crystal Structure Of Autoinhibited Form Of Akt1 In Complex With N-(4- (5-(3-Acetamidophenyl)-2-(2-Aminopyridin-3-Yl)-3h- Imidazo[4,5- B]pyridin-3-Yl)benzyl)-3-Fluorobenzamide Length = 446 | Back alignment and structure |
|
| >pdb|4DN5|A Chain A, Crystal Structure Of Nf-kb-inducing Kinase (nik) Length = 356 | Back alignment and structure |
|
| >pdb|3O96|A Chain A, Crystal Structure Of Human Akt1 With An Allosteric Inhibitor Length = 446 | Back alignment and structure |
|
| >pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase Erk1 Length = 382 | Back alignment and structure |
|
| >pdb|4G3C|A Chain A, Crystal Structure Of Apo Murine Nf-kappab Inducing Kinase (nik) Length = 352 | Back alignment and structure |
|
| >pdb|3C0G|A Chain A, Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Length = 351 | Back alignment and structure |
|
| >pdb|1YDT|E Chain E, Structure Of Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With H89 Protein Kinase Inhibitor N-[2- (4-Bromocinnamylamino)ethyl]-5-Isoquinoline Length = 350 | Back alignment and structure |
|
| >pdb|3QFV|A Chain A, Mrck Beta In Complex With Tpca-1 Length = 415 | Back alignment and structure |
|
| >pdb|2UZT|A Chain A, Pka Structures Of Akt, Indazole-Pyridine Inhibitors Length = 336 | Back alignment and structure |
|
| >pdb|2F7E|E Chain E, Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoquinolin-6- Yl-Pyridin-3-Yloxymethyl-Etylamine Length = 351 | Back alignment and structure |
|
| >pdb|3TKU|A Chain A, Mrck Beta In Complex With Fasudil Length = 433 | Back alignment and structure |
|
| >pdb|3ENM|A Chain A, The Structure Of The Map2k Mek6 Reveals An Autoinhibitory Dimer Length = 316 | Back alignment and structure |
|
| >pdb|3CQU|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate Peptide And Inhibitor Length = 342 | Back alignment and structure |
|
| >pdb|4GV1|A Chain A, Pkb Alpha In Complex With Azd5363 Length = 340 | Back alignment and structure |
|
| >pdb|1J3H|A Chain A, Crystal Structure Of Apoenzyme Camp-Dependent Protein Kinase Catalytic Subunit Length = 350 | Back alignment and structure |
|
| >pdb|3OCB|A Chain A, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor Length = 341 | Back alignment and structure |
|
| >pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B Akt By Hydrophobic Motif Phosphorylation Length = 315 | Back alignment and structure |
|
| >pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain Length = 339 | Back alignment and structure |
|
| >pdb|3SDJ|A Chain A, Structure Of Rnase-Inactive Point Mutant Of Oligomeric KinaseRNASE Ire1 Length = 448 | Back alignment and structure |
|
| >pdb|3FHI|A Chain A, Crystal Structure Of A Complex Between The Catalytic And Regulatory (Ri{alpha}) Subunits Of Pka Length = 350 | Back alignment and structure |
|
| >pdb|3FBV|A Chain A, Crystal Structure Of The Oligomer Formed By The Kinase-Ribonuclease Domain Of Ire1 Length = 448 | Back alignment and structure |
|
| >pdb|3DND|A Chain A, Camp-Dependent Protein Kinase Pka Catalytic Subunit With Pki-5-24 Length = 350 | Back alignment and structure |
|
| >pdb|1SVH|A Chain A, Crystal Structure Of Protein Kinase A In Complex With Azepane Derivative 8 Length = 350 | Back alignment and structure |
|
| >pdb|2WTK|C Chain C, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 305 | Back alignment and structure |
|
| >pdb|1STC|E Chain E, Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With Staurosporine Length = 350 | Back alignment and structure |
|
| >pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex With An Mkk5 Binding Fragment Length = 442 | Back alignment and structure |
|
| >pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain Length = 335 | Back alignment and structure |
|
| >pdb|2GU8|A Chain A, Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel And Potent Inhibitors For Akt: Synthesis And Sar Studies Length = 337 | Back alignment and structure |
|
| >pdb|2PML|X Chain X, Crystal Structure Of Pfpk7 In Complex With An Atp Analogue Length = 348 | Back alignment and structure |
|
| >pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 342 | Back alignment and structure |
|
| >pdb|2C1A|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With Isoquinoline-5-Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl)amide Length = 351 | Back alignment and structure |
|
| >pdb|1O9U|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide Length = 350 | Back alignment and structure |
|
| >pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B (pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3 Peptide Length = 337 | Back alignment and structure |
|
| >pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex With Atp- Competitive Inhibitors Length = 335 | Back alignment and structure |
|
| >pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d With Gsk3 Peptide And Amp-Pnp Length = 336 | Back alignment and structure |
|
| >pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor Length = 398 | Back alignment and structure |
|
| >pdb|4DFY|A Chain A, Crystal Structure Of R194a Mutant Of Camp-Dependent Protein Kinase With Unphosphorylated Activation Loop Length = 371 | Back alignment and structure |
|
| >pdb|2GNJ|A Chain A, Pka Three Fold Mutant Model Of Rho-Kinase With Y-27632 Length = 350 | Back alignment and structure |
|
| >pdb|2XK9|A Chain A, Structural Analysis Of Checkpoint Kinase 2 (Chk2) In Complex With Inhibitor Pv1533 Length = 322 | Back alignment and structure |
|
| >pdb|2QUR|A Chain A, Crystal Structure Of F327aK285P MUTANT OF CAMP-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2W0J|A Chain A, Crystal Structure Of Chk2 In Complex With Nsc 109555, A Specific Inhibitor Length = 323 | Back alignment and structure |
|
| >pdb|3P1A|A Chain A, Structure Of Human Membrane-Associated Tyrosine- And Threonine- Specific Cdc2-Inhibitory Kinase Myt1 (Pkmyt1) Length = 311 | Back alignment and structure |
|
| >pdb|1H8F|A Chain A, Glycogen Synthase Kinase 3 Beta. Length = 352 | Back alignment and structure |
|
| >pdb|2YCF|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv1531 Length = 322 | Back alignment and structure |
|
| >pdb|2YCR|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv976 Length = 323 | Back alignment and structure |
|
| >pdb|1UV5|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With 6-Bromoindirubin-3'-Oxime Length = 350 | Back alignment and structure |
|
| >pdb|1FMO|E Chain E, Crystal Structure Of A Polyhistidine-Tagged Recombinant Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With The Peptide Inhibitor Pki(5-24) And Adenosine Length = 350 | Back alignment and structure |
|
| >pdb|1JBP|E Chain E, Crystal Structure Of The Catalytic Subunit Of Camp- Dependent Protein Kinase Complexed With A Substrate Peptide, Adp And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|1BKX|A Chain A, A Binary Complex Of The Catalytic Subunit Of Camp-Dependent Protein Kinase And Adenosine Further Defines Conformational Flexibility Length = 350 | Back alignment and structure |
|
| >pdb|2ERZ|E Chain E, Crystal Structure Of C-amp Dependent Kinase (pka) Bound To Hydroxyfasudil Length = 351 | Back alignment and structure |
|
| >pdb|2CN5|A Chain A, Crystal Structure Of Human Chk2 In Complex With Adp Length = 329 | Back alignment and structure |
|
| >pdb|3QAL|E Chain E, Crystal Structure Of Arg280ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|1Q8W|A Chain A, The Catalytic Subunit Of Camp-Dependent Protein Kinase In Complex With Rho-Kinase Inhibitor Fasudil (Ha-1077) Length = 350 | Back alignment and structure |
|
| >pdb|2JDS|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With A- 443654 Length = 351 | Back alignment and structure |
|
| >pdb|1Q61|A Chain A, Pka Triple Mutant Model Of Pkb Length = 350 | Back alignment and structure |
|
| >pdb|1XH7|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317 | Back alignment and structure |
|
| >pdb|1Q24|A Chain A, Pka Double Mutant Model Of Pkb In Complex With Mgatp Length = 350 | Back alignment and structure |
|
| >pdb|4DFX|E Chain E, Crystal Structure Of Myristoylated K7c Catalytic Subunit Of Camp- Dependent Protein Kinase In Complex With Sp20 And Amp-Pnp Length = 350 | Back alignment and structure |
|
| >pdb|1APM|E Chain E, 2.0 Angstrom Refined Crystal Structure Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With A Peptide Inhibitor And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|1L3R|E Chain E, Crystal Structure Of A Transition State Mimic Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324 | Back alignment and structure |
|
| >pdb|2QCS|A Chain A, A Complex Structure Between The Catalytic And Regulatory Subunit Of Protein Kinase A That Represents The Inhibited State Length = 350 | Back alignment and structure |
|
| >pdb|3PVB|A Chain A, Crystal Structure Of (73-244)ria:c Holoenzyme Of Camp-Dependent Protein Kinase Length = 345 | Back alignment and structure |
|
| >pdb|1SZM|A Chain A, Dual Binding Mode Of Bisindolylmaleimide 2 To Protein Kinase A (Pka) Length = 350 | Back alignment and structure |
|
| >pdb|3VID|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With Compound A Length = 356 | Back alignment and structure |
|
| >pdb|3VHE|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With A Novel Pyrrolopyrimidine Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|3VHK|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Back Pocket Binder Length = 368 | Back alignment and structure |
|
| >pdb|3LJ0|A Chain A, Ire1 Complexed With Adp And Quercetin Length = 434 | Back alignment and structure |
|
| >pdb|1SYK|A Chain A, Crystal Structure Of E230q Mutant Of Camp-Dependent Protein Kinase Reveals Unexpected Apoenzyme Conformation Length = 350 | Back alignment and structure |
|
| >pdb|4DG3|E Chain E, Crystal Structure Of R336a Mutant Of Camp-dependent Protein Kinase With Unphosphorylated Turn Motif Length = 371 | Back alignment and structure |
|
| >pdb|3O7L|B Chain B, Crystal Structure Of Phospholamban (1-19):pka C-Subunit:amp-Pnp:mg2+ Complex Length = 350 | Back alignment and structure |
|
| >pdb|3MDY|A Chain A, Crystal Structure Of The Cytoplasmic Domain Of The Bone Morp Protein Receptor Type-1b (Bmpr1b) In Complex With Fkbp12 An 193189 Length = 337 | Back alignment and structure |
|
| >pdb|3MTF|A Chain A, Crystal Structure Of The Acvr1 Kinase In Complex With A 2- Aminopyridine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|3I6U|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 419 | Back alignment and structure |
|
| >pdb|3I6W|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 443 | Back alignment and structure |
|
| >pdb|1Y6A|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 2-Anilino-5-Aryl-Oxazole Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|4DYM|A Chain A, Crystal Structure Of The Acvr1 Kinase Domain In Complex With The Imidazo[1,2-B]pyridazine Inhibitor K00135 Length = 301 | Back alignment and structure |
|
| >pdb|3H9R|A Chain A, Crystal Structure Of The Kinase Domain Of Type I Activin Receptor (Acvr1) In Complex With Fkbp12 And Dorsomorphin Length = 330 | Back alignment and structure |
|
| >pdb|2B9F|A Chain A, Crystal Structure Of Non-Phosphorylated Fus3 Length = 353 | Back alignment and structure |
|
| >pdb|3NIE|A Chain A, Crystal Structure Of Pf11_0147 Length = 429 | Back alignment and structure |
|
| >pdb|1CDK|A Chain A, Camp-Dependent Protein Kinase Catalytic Subunit (E.C.2.7.1.37) (Protein Kinase A) Complexed With Protein Kinase Inhibitor Peptide Fragment 5-24 (Pki(5-24) Isoelectric Variant Ca) And Mn2+ Adenylyl Imidodiphosphate (Mnamp-Pnp) At Ph 5.6 And 7c And 4c Length = 350 | Back alignment and structure |
|
| >pdb|1CMK|E Chain E, Crystal Structures Of The Myristylated Catalytic Subunit Of Camp- Dependent Protein Kinase Reveal Open And Closed Conformations Length = 350 | Back alignment and structure |
|
| >pdb|2VO0|A Chain A, Structure Of Pka-Pkb Chimera Complexed With C-(4-(4- Chlorophenyl)-1-(7h-Pyrrolo(2, 3-D)pyrimidin-4-Yl)piperidin- 4-Yl)methylamine Length = 351 | Back alignment and structure |
|
| >pdb|3HNG|A Chain A, Crystal Structure Of Vegfr1 In Complex With N-(4-chlorophenyl)-2- ((pyridin-4-ylmethyl)amino)benzamide Length = 360 | Back alignment and structure |
|
| >pdb|4AE6|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit Calpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|2JDT|A Chain A, Structure Of Pka-Pkb Chimera Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 351 | Back alignment and structure |
|
| >pdb|1CTP|E Chain E, Structure Of The Mammalian Catalytic Subunit Of Camp-Dependent Protein Kinase And An Inhibitor Peptide Displays An Open Conformation Length = 350 | Back alignment and structure |
|
| >pdb|3NX8|A Chain A, Human Camp Dependent Protein Kinase In Complex With Phenol Length = 351 | Back alignment and structure |
|
| >pdb|1B6C|B Chain B, Crystal Structure Of The Cytoplasmic Domain Of The Type I Tgf-Beta Receptor In Complex With Fkbp12 Length = 342 | Back alignment and structure |
|
| >pdb|1VJY|A Chain A, Crystal Structure Of A Naphthyridine Inhibitor Of Human Tgf- Beta Type I Receptor Length = 303 | Back alignment and structure |
|
| >pdb|3AGL|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-1039 Length = 351 | Back alignment and structure |
|
| >pdb|3AGM|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-670 Length = 351 | Back alignment and structure |
|
| >pdb|1RW8|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Atp Site Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|3MVJ|A Chain A, Human Cyclic Amp-Dependent Protein Kinase Pka Inhibitor Complex Length = 371 | Back alignment and structure |
|
| >pdb|1PY5|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|2WOT|A Chain A, Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)-3- Pyridyl)oxy)-N-(3,4,5-Trimethoxyphenyl)pyridin-2-Amine Length = 306 | Back alignment and structure |
|
| >pdb|3KN5|A Chain A, Crystal Structure Of The C-Terminal Kinase Domain Of Msk1 In With Amp-Pnp Length = 325 | Back alignment and structure |
|
| >pdb|3DLS|A Chain A, Crystal Structure Of Human Pas Kinase Bound To Adp Length = 335 | Back alignment and structure |
|
| >pdb|1YXS|A Chain A, Crystal Structure Of Kinase Pim1 With P123m Mutation Length = 293 | Back alignment and structure |
|
| >pdb|3TZM|A Chain A, Tgf-Beta Receptor Type 1 In Complex With Sb431542 Length = 309 | Back alignment and structure |
|
| >pdb|3QAM|E Chain E, Crystal Structure Of Glu208ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317 | Back alignment and structure |
|
| >pdb|3AMA|A Chain A, Protein Kinase A Sixfold Mutant Model Of Aurora B With Inhibitor Jnj- 7706621 Length = 351 | Back alignment and structure |
|
| >pdb|3LL6|A Chain A, Crystal Structure Of The Human Cyclin G Associated Kinase (gak) Length = 337 | Back alignment and structure |
|
| >pdb|1Z57|A Chain A, Crystal Structure Of Human Clk1 In Complex With 10z-Hymenialdisine Length = 339 | Back alignment and structure |
|
| >pdb|3V8S|A Chain A, Human Rho-Associated Protein Kinase 1 (Rock 1) In Complex With Indazole Derivative (Compound 18) Length = 410 | Back alignment and structure |
|
| >pdb|4AE9|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit C Alpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|2V55|A Chain A, Mechanism Of Multi-site Phosphorylation From A Rock-i:rhoe Complex Structure Length = 406 | Back alignment and structure |
|
| >pdb|2UVY|A Chain A, Structure Of Pka-pkb Chimera Complexed With Methyl-(4-(9h- Purin-6-yl)-benzyl)-amine Length = 351 | Back alignment and structure |
|
| >pdb|1Q8Y|A Chain A, The Structure Of The Yeast Sr Protein Kinase, Sky1p, With Bound Adp Length = 373 | Back alignment and structure |
|
| >pdb|2ESM|A Chain A, Crystal Structure Of Rock 1 Bound To Fasudil Length = 415 | Back alignment and structure |
|
| >pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317 | Back alignment and structure |
|
| >pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301 | Back alignment and structure |
|
| >pdb|1HOW|A Chain A, The X-Ray Crystal Structure Of Sky1p, An Sr Protein Kinase In Yeast Length = 373 | Back alignment and structure |
|
| >pdb|3N9X|A Chain A, Crystal Structure Of Map Kinase From Plasmodium Berghei, Pb000659.00.0 Length = 432 | Back alignment and structure |
|
| >pdb|3L9M|A Chain A, Crystal Structure Of Pkab3 (Pka Triple Mutant V123a, L173m, Q181k) With Compound 18 Length = 351 | Back alignment and structure |
|
| >pdb|3HKO|A Chain A, Crystal Structure Of A Cdpk Kinase Domain From Cryptosporidium Parvum, Cgd7_40 Length = 345 | Back alignment and structure |
|
| >pdb|2VD5|A Chain A, Structure Of Human Myotonic Dystrophy Protein Kinase In Complex With The Bisindoylmaleide Inhibitor Bim Viii Length = 412 | Back alignment and structure |
|
| >pdb|1RDQ|E Chain E, Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311 | Back alignment and structure |
|
| >pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311 | Back alignment and structure |
|
| >pdb|2B9H|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Ste7 Length = 353 | Back alignment and structure |
|
| >pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315 | Back alignment and structure |
|
| >pdb|3MI9|A Chain A, Crystal Structure Of Hiv-1 Tat Complexed With Human P-Tefb Length = 351 | Back alignment and structure |
|
| >pdb|4BCF|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 331 | Back alignment and structure |
|
| >pdb|4EC8|A Chain A, Structure Of Full Length Cdk9 In Complex With Cyclint And Drb Length = 373 | Back alignment and structure |
|
| >pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298 | Back alignment and structure |
|
| >pdb|3BLH|A Chain A, Crystal Structure Of Human Cdk9CYCLINT1 Length = 331 | Back alignment and structure |
|
| >pdb|3UIX|A Chain A, Crystal Structure Of Pim1 Kinase In Complex With Small Molecule Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3F2A|A Chain A, Crystal Structure Of Human Pim-1 In Complex With Dappa Length = 300 | Back alignment and structure |
|
| >pdb|1XQZ|A Chain A, Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolution Length = 300 | Back alignment and structure |
|
| >pdb|1YWV|A Chain A, Crystal Structures Of Proto-Oncogene Kinase Pim1: A Target Of Aberrant Somatic Hypermutations In Diffuse Large Cell Lymphoma Length = 293 | Back alignment and structure |
|
| >pdb|1YHS|A Chain A, Crystal Structure Of Pim-1 Bound To Staurosporine Length = 273 | Back alignment and structure |
|
| >pdb|2XIY|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-2 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|3R00|A Chain A, The Discovery Of Novel Benzofuran-2-Carboxylic Acids As Potent Pim-1 Inhibitors Length = 299 | Back alignment and structure |
|
| >pdb|3JXW|A Chain A, Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4-Ones As Potent, Highly Selective And Orally Bioavailable Pim Kinases Inhibitors Length = 294 | Back alignment and structure |
|
| >pdb|2XJ0|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-4 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|1VZO|A Chain A, The Structure Of The N-Terminal Kinase Domain Of Msk1 Reveals A Novel Autoinhibitory Conformation For A Dual Kinase Protein Length = 355 | Back alignment and structure |
|
| >pdb|3QD2|B Chain B, Crsytal Structure Of Mouse Perk Kinase Domain Length = 332 | Back alignment and structure |
|
| >pdb|3JPV|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Pyrrolo[2,3- A]carbazole Ligand Length = 313 | Back alignment and structure |
|
| >pdb|2XIX|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-1 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|3A99|A Chain A, Structure Of Pim-1 Kinase Crystallized In The Presence Of P27kip1 Carboxy-Terminal Peptide Length = 320 | Back alignment and structure |
|
| >pdb|1XWS|A Chain A, Crystal Structure Of The Human Pim1 Kinase Domain Length = 313 | Back alignment and structure |
|
| >pdb|2EXE|A Chain A, Crystal Structure Of The Phosphorylated Clk3 Length = 357 | Back alignment and structure |
|
| >pdb|2BIL|B Chain B, The Human Protein Kinase Pim1 In Complex With Its Consensus Peptide Pimtide Length = 313 | Back alignment and structure |
|
| >pdb|3CY3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And The Jnk Inhibitor V Length = 314 | Back alignment and structure |
|
| >pdb|4DTK|A Chain A, Novel And Selective Pan-Pim Kinase Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|2F9G|A Chain A, Crystal Structure Of Fus3 Phosphorylated On Tyr182 Length = 353 | Back alignment and structure |
|
| >pdb|4ALV|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328 | Back alignment and structure |
|
| >pdb|2EU9|A Chain A, Crystal Structure Of Clk3 Length = 355 | Back alignment and structure |
|
| >pdb|3MA3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Naphtho-Difuran Ligand Length = 313 | Back alignment and structure |
|
| >pdb|3DCV|A Chain A, Crystal Structure Of Human Pim1 Kinase Complexed With 4-(4- Hydroxy-3-Methyl-Phenyl)-6-Phenylpyrimidin-2(1h)-One Length = 328 | Back alignment and structure |
|
| >pdb|2J2I|B Chain B, Crystal Structure Of The Humab Pim1 In Complex With Ly333531 Length = 312 | Back alignment and structure |
|
| >pdb|1TKI|A Chain A, Autoinhibited Serine Kinase Domain Of The Giant Muscle Protein Titin Length = 321 | Back alignment and structure |
|
| >pdb|4AS0|A Chain A, Cyclometalated Phthalimides As Protein Kinase Inhibitors Length = 273 | Back alignment and structure |
|
| >pdb|3CXW|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Beta Carboline Ligand I Length = 314 | Back alignment and structure |
|
| >pdb|3C4E|A Chain A, Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7- Azaindole Length = 273 | Back alignment and structure |
|
| >pdb|4A7C|A Chain A, Crystal Structure Of Pim1 Kinase With Etp46546 Length = 308 | Back alignment and structure |
|
| >pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294 | Back alignment and structure |
|
| >pdb|2BIK|B Chain B, Human Pim1 Phosphorylated On Ser261 Length = 313 | Back alignment and structure |
|
| >pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335 | Back alignment and structure |
|
| >pdb|3UDB|A Chain A, Crystal Structure Of Snrk2.6 Length = 317 | Back alignment and structure |
|
| >pdb|2VAG|A Chain A, Crystal Structure Of Di-Phosphorylated Human Clk1 In Complex With A Novel Substituted Indole Inhibitor Length = 339 | Back alignment and structure |
|
| >pdb|2WU6|A Chain A, Crystal Structure Of The Human Clk3 In Complex With Dki Length = 381 | Back alignment and structure |
|
| >pdb|2OBJ|A Chain A, Crystal Structure Of Human Pim-1 Kinase In Complex With Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3E3P|A Chain A, Glycogen Synthase Kinase From Leishmania Major Length = 360 | Back alignment and structure |
|
| >pdb|2AC5|A Chain A, Structure Of Human Mnk2 Kinase Domain Mutant D228g Length = 316 | Back alignment and structure |
|
| >pdb|1KWP|A Chain A, Crystal Structure Of Mapkap2 Length = 400 | Back alignment and structure |
|
| >pdb|3GOK|A Chain A, Binding Site Mapping Of Protein Ligands Length = 334 | Back alignment and structure |
|
| >pdb|2JBO|A Chain A, Protein Kinase Mk2 In Complex With An Inhibitor (Crystal Form-1, Soaking) Length = 326 | Back alignment and structure |
|
Structure Templates Detected by RPS-BLAST 
Original result of RPS-BLAST against PDB70 database
ID ![]() | Alignment Graph ![]() | Length ![]() |
Definition ![]() |
E-value ![]() |
| Query | 792 | |||
| 3uim_A | 326 | Brassinosteroid insensitive 1-associated receptor; | 1e-127 | |
| 2qkw_B | 321 | Protein kinase; three-helix bundle motif, AVRPTO-P | 1e-116 | |
| 2nru_A | 307 | Interleukin-1 receptor-associated kinase 4; inhibi | 1e-114 | |
| 3soc_A | 322 | Activin receptor type-2A; structural genomics cons | 2e-68 | |
| 3p86_A | 309 | Serine/threonine-protein kinase CTR1; ETR1, ERS1, | 6e-59 | |
| 2eva_A | 307 | TAK1 kinase - TAB1 chimera fusion protein; transfe | 6e-58 | |
| 3og7_A | 289 | AKAP9-BRAF fusion protein; proto-oncogene, V600E, | 1e-55 | |
| 3s95_A | 310 | LIMK-1, LIM domain kinase 1; structural genomics, | 2e-55 | |
| 3lb7_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 2e-54 | |
| 2y4i_B | 319 | KSR2, HKSR2, kinase suppressor of RAS 2; transfera | 2e-54 | |
| 3dtc_A | 271 | Mitogen-activated protein kinase kinase kinase 9; | 1e-53 | |
| 3g2f_A | 336 | Bone morphogenetic protein receptor type-2; kinase | 1e-53 | |
| 4f0f_A | 287 | Serine/threonine-protein kinase ROCO4; LRRK2, ATP- | 2e-52 | |
| 3kmu_A | 271 | ILK, integrin-linked kinase; cell adhesion, ANK re | 2e-50 | |
| 3mdy_A | 337 | Bone morphogenetic protein receptor type-1B; compl | 2e-47 | |
| 3gxj_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 1e-46 | |
| 3q4u_A | 301 | Activin receptor type-1; structural genomics conso | 3e-46 | |
| 1b6c_B | 342 | TGF-B superfamily receptor type I; complex (isomer | 2e-44 | |
| 3cbl_A | 377 | C-FES, proto-oncogene tyrosine-protein kinase FES/ | 2e-40 | |
| 1opk_A | 495 | P150, C-ABL, proto-oncogene tyrosine-protein kinas | 9e-39 | |
| 1t4h_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 7e-38 | |
| 3lxl_A | 327 | Tyrosine-protein kinase JAK3; TYK2, inflammation, | 9e-38 | |
| 3lzb_A | 327 | Epidermal growth factor receptor; epidermal growth | 2e-37 | |
| 3ugc_A | 295 | Tyrosine-protein kinase JAK2; small molecule inhib | 2e-37 | |
| 2w1i_A | 326 | JAK2; chromosomal rearrangement, nucleotide-bindin | 3e-37 | |
| 1mqb_A | 333 | Ephrin type-A receptor 2; tyrosine protein kinase, | 4e-37 | |
| 2wqm_A | 310 | Serine/threonine-protein kinase NEK7; ATP-binding, | 4e-37 | |
| 4e5w_A | 302 | Tyrosine-protein kinase JAK1; kinase domain, trans | 9e-37 | |
| 3kul_A | 325 | Ephrin type-A receptor 8; ATP-binding, kinase, nuc | 1e-36 | |
| 3t9t_A | 267 | Tyrosine-protein kinase ITK/TSK; kinase domain, al | 2e-36 | |
| 3kex_A | 325 | Receptor tyrosine-protein kinase ERBB-3; kinase do | 2e-36 | |
| 2qol_A | 373 | Ephrin receptor; receptor tyrosine kinase, juxtame | 2e-36 | |
| 3kfa_A | 288 | Tyrosine-protein kinase ABL1; CML, drug resistance | 2e-36 | |
| 1xbb_A | 291 | Tyrosine-protein kinase SYK; gleevec, STI-571, ima | 4e-36 | |
| 1fmk_A | 452 | C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros | 5e-36 | |
| 2w5a_A | 279 | Serine/threonine-protein kinase NEK2; Ser/Thr prot | 6e-36 | |
| 2h8h_A | 535 | Proto-oncogene tyrosine-protein kinase SRC; SRC ki | 7e-36 | |
| 1qcf_A | 454 | Haematopoetic cell kinase (HCK); tyrosine kinase-i | 7e-36 | |
| 3lxp_A | 318 | Non-receptor tyrosine-protein kinase TYK2; JAK3, i | 1e-35 | |
| 1k9a_A | 450 | Carboxyl-terminal SRC kinase; COOH-terminal SRC ki | 1e-35 | |
| 3gen_A | 283 | Tyrosine-protein kinase BTK; bruton'S tyrosine kin | 1e-35 | |
| 3sxs_A | 268 | Cytoplasmic tyrosine-protein kinase BMX; transfera | 1e-35 | |
| 1u46_A | 291 | ACK-1, activated CDC42 kinase 1; tyrosine kinase, | 3e-35 | |
| 1u59_A | 287 | Tyrosine-protein kinase ZAP-70; transferase; HET: | 3e-35 | |
| 1byg_A | 278 | CSK, protein (C-terminal SRC kinase); protein kina | 3e-35 | |
| 3poz_A | 327 | Epidermal growth factor receptor; kinase domain, a | 3e-35 | |
| 4fvq_A | 289 | Tyrosine-protein kinase JAK2; janus protein kinase | 4e-35 | |
| 4apc_A | 350 | Serine/threonine-protein kinase NEK1; transferase; | 5e-35 | |
| 1p4o_A | 322 | Insulin-like growth factor I receptor protein; IGF | 9e-35 | |
| 2yfx_A | 327 | Tyrosine-protein kinase receptor; nucleotide-bindi | 9e-35 | |
| 3cc6_A | 281 | Protein tyrosine kinase 2 beta; focal adhesion kin | 1e-34 | |
| 1mp8_A | 281 | Focal adhesion kinase 1; tyrosine protein kinase, | 2e-34 | |
| 3v5q_A | 297 | NT-3 growth factor receptor; kinase domain, kinase | 3e-34 | |
| 1qpc_A | 279 | LCK kinase; alpha beta fold, transferase; HET: PTR | 4e-34 | |
| 3l9p_A | 367 | Anaplastic lymphoma kinase; kinase domain, ATP-bin | 4e-34 | |
| 4aoj_A | 329 | High affinity nerve growth factor receptor; transf | 4e-34 | |
| 4g31_A | 299 | Eukaryotic translation initiation factor 2-alpha; | 8e-34 | |
| 2a19_B | 284 | Interferon-induced, double-stranded RNA-activated | 1e-33 | |
| 3f66_A | 298 | Hepatocyte growth factor receptor; C-Met, protein | 1e-33 | |
| 3c1x_A | 373 | Hepatocyte growth factor receptor; receptor tyrosi | 2e-33 | |
| 3pls_A | 298 | Macrophage-stimulating protein receptor; protein k | 2e-33 | |
| 3p23_A | 432 | Serine/threonine-protein kinase/endoribonuclease; | 6e-33 | |
| 2buj_A | 317 | Serine/threonine-protein kinase 16; transferase, A | 6e-33 | |
| 2ozo_A | 613 | Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t | 1e-32 | |
| 2j0j_A | 656 | Focal adhesion kinase 1; cell migration, FERM, tra | 1e-32 | |
| 2clq_A | 295 | Mitogen-activated protein kinase kinase kinase 5; | 3e-32 | |
| 1zy4_A | 303 | Serine/threonine-protein kinase GCN2; translation | 4e-32 | |
| 2pvf_A | 334 | Fibroblast growth factor receptor 2; kinase domain | 5e-32 | |
| 3zzw_A | 289 | Tyrosine-protein kinase transmembrane receptor RO; | 6e-32 | |
| 3tt0_A | 382 | Basic fibroblast growth factor receptor 1; kinase | 9e-32 | |
| 2i1m_A | 333 | Macrophage colony-stimulating factor 1 receptor; k | 9e-32 | |
| 3brb_A | 313 | Proto-oncogene tyrosine-protein kinase MER; ATP-bi | 1e-31 | |
| 3qup_A | 323 | Tyrosine-protein kinase receptor TYRO3; protein ki | 1e-31 | |
| 2psq_A | 370 | Fibroblast growth factor receptor 2; kinase domain | 1e-31 | |
| 1t46_A | 313 | HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom | 3e-31 | |
| 2xir_A | 316 | Vascular endothelial growth factor receptor 2; ang | 7e-31 | |
| 4eut_A | 396 | Serine/threonine-protein kinase TBK1; ATP binding, | 7e-31 | |
| 1luf_A | 343 | Muscle-specific tyrosine kinase receptor MUSK; pho | 9e-31 | |
| 2ivs_A | 314 | Proto-oncogene tyrosine-protein kinase receptor RE | 1e-30 | |
| 3p1a_A | 311 | MYT1 kinase, membrane-associated tyrosine- and thr | 1e-30 | |
| 4euu_A | 319 | Serine/threonine-protein kinase TBK1; ATP binding, | 1e-30 | |
| 3e7e_A | 365 | HBUB1, BUB1A, mitotic checkpoint serine/threonine- | 2e-30 | |
| 4g3f_A | 336 | NF-kappa-beta-inducing kinase; non-RD kinase, prot | 2e-30 | |
| 1rjb_A | 344 | FL cytokine receptor; kinase, structure, autoinhib | 3e-30 | |
| 1fvr_A | 327 | Tyrosine-protein kinase TIE-2; tyrosine kinase, tr | 6e-30 | |
| 2rio_A | 434 | Serine/threonine-protein kinase/endoribonuclease I | 1e-29 | |
| 3ll6_A | 337 | Cyclin G-associated kinase; transferase, protein k | 4e-29 | |
| 3qa8_A | 676 | MGC80376 protein; kinase ubiquitin-like domain, ph | 4e-29 | |
| 2c30_A | 321 | Serine/threonine-protein kinase PAK 6; CRIB domain | 4e-29 | |
| 3fxz_A | 297 | Serine/threonine-protein kinase PAK 1; transferase | 5e-29 | |
| 4eqm_A | 294 | Protein kinase; transferase; HET: ANP; 3.00A {Stap | 6e-29 | |
| 3c0i_A | 351 | Peripheral plasma membrane protein CASK; neurexin, | 2e-28 | |
| 1x8b_A | 289 | WEE1HU, WEE1-like protein kinase; cell cycle, tran | 3e-28 | |
| 3dbq_A | 343 | Dual specificity protein kinase TTK; MPS1 structur | 4e-28 | |
| 1tki_A | 321 | Titin; serine kinase, muscle, autoinhibition; 2.00 | 5e-28 | |
| 1kob_A | 387 | Twitchin; kinase, intrasteric regulation; 2.30A {A | 6e-28 | |
| 3cek_A | 313 | Dual specificity protein kinase TTK; HMPS1, PYT, E | 7e-28 | |
| 2a2a_A | 321 | Death-associated protein kinase 2; autoinhibition, | 8e-28 | |
| 2zmd_A | 390 | Dual specificity protein kinase TTK; MPS1, T686A, | 1e-27 | |
| 3lm5_A | 327 | Serine/threonine-protein kinase 17B; STK17B, serin | 2e-27 | |
| 2yab_A | 361 | Death-associated protein kinase 2; apoptosis, tran | 2e-27 | |
| 3eqc_A | 360 | Dual specificity mitogen-activated protein kinase; | 3e-27 | |
| 3byv_A | 377 | Rhoptry kinase; malaria, transferase, structural g | 3e-27 | |
| 3bhy_A | 283 | Death-associated protein kinase 3; death associate | 3e-27 | |
| 3fdn_A | 279 | Serine/threonine-protein kinase 6; aurora kinase i | 3e-27 | |
| 2vgo_A | 284 | Serine/threonine-protein kinase 12-A; nucleotide-b | 3e-27 | |
| 2j7t_A | 302 | Serine/threonine-protein kinase 10; transferase, A | 4e-27 | |
| 3com_A | 314 | Serine/threonine-protein kinase 4; MST1, STE20-lik | 5e-27 | |
| 2x4f_A | 373 | Myosin light chain kinase family member 4; LUNG, b | 5e-27 | |
| 1phk_A | 298 | Phosphorylase kinase; glycogen metabolism, transfe | 5e-27 | |
| 3a7i_A | 303 | MST3 kinase, serine/threonine kinase 24 (STE20 hom | 5e-27 | |
| 3q60_A | 371 | ROP5B; pseudokinase, transferase; HET: ATP; 1.72A | 8e-27 | |
| 2qr7_A | 342 | Ribosomal protein S6 kinase alpha-3; kinase domain | 9e-27 | |
| 2y0a_A | 326 | Death-associated protein kinase 1; transferase, ca | 1e-26 | |
| 3kk8_A | 284 | Calcium/calmodulin dependent protein kinase II; AT | 2e-26 | |
| 3uto_A | 573 | Twitchin; kinase, muscle sarcomere, transferase; H | 3e-26 | |
| 3ork_A | 311 | Serine/threonine protein kinase; structural genomi | 3e-26 | |
| 2h34_A | 309 | Serine/threonine-protein kinase PKNE; apoenzyme, t | 4e-26 | |
| 3soa_A | 444 | Calcium/calmodulin-dependent protein kinase type a | 7e-26 | |
| 3aln_A | 327 | Dual specificity mitogen-activated protein kinase; | 7e-26 | |
| 2jam_A | 304 | Calcium/calmodulin-dependent protein kinase type 1 | 8e-26 | |
| 2bdw_A | 362 | Hypothetical protein K11E8.1D; kinase, calmodulin | 1e-25 | |
| 3hko_A | 345 | Calcium/calmodulin-dependent protein kinase with d | 1e-25 | |
| 3cok_A | 278 | Serine/threonine-protein kinase PLK4; POLO-like ki | 1e-25 | |
| 3nyv_A | 484 | Calmodulin-domain protein kinase 1; serine/threoni | 2e-25 | |
| 2x7f_A | 326 | TRAF2 and NCK-interacting protein kinase; serine/t | 2e-25 | |
| 2rku_A | 294 | Serine/threonine-protein kinase PLK1; structure of | 2e-25 | |
| 2owb_A | 335 | Serine/threonine-protein kinase PLK1; catalytic do | 2e-25 | |
| 3qd2_B | 332 | Eukaryotic translation initiation factor 2-alpha; | 2e-25 | |
| 2y7j_A | 365 | Phosphorylase B kinase gamma catalytic chain, test | 2e-25 | |
| 3i6u_A | 419 | CDS1, serine/threonine-protein kinase CHK2; Ser/Th | 3e-25 | |
| 3lij_A | 494 | Calcium/calmodulin dependent protein kinase with A | 3e-25 | |
| 3is5_A | 285 | Calcium-dependent protein kinase; CDPK, structural | 4e-25 | |
| 3fme_A | 290 | Dual specificity mitogen-activated protein kinase; | 5e-25 | |
| 2wei_A | 287 | Calmodulin-domain protein kinase 1, putative; nucl | 5e-25 | |
| 2ycf_A | 322 | Serine/threonine-protein kinase CHK2; transferase, | 6e-25 | |
| 3kn6_A | 325 | Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1 | 9e-25 | |
| 3f3z_A | 277 | Calcium/calmodulin-dependent protein kinase with d | 1e-24 | |
| 2pml_X | 348 | PFPK7, Ser/Thr protein kinase; phosphorylati trans | 1e-24 | |
| 3mwu_A | 486 | Calmodulin-domain protein kinase 1; serine/threoni | 1e-24 | |
| 3c4z_A | 543 | Rhodopsin kinase; Ser/Thr kinase, RGS homology dom | 1e-24 | |
| 2w4o_A | 349 | Calcium/calmodulin-dependent protein kinase type I | 2e-24 | |
| 3q5i_A | 504 | Protein kinase; CDPK, malaria, phosphotransferase, | 3e-24 | |
| 2pzi_A | 681 | Probable serine/threonine-protein kinase PKNG; ATP | 6e-24 | |
| 3an0_A | 340 | Dual specificity mitogen-activated protein kinase; | 1e-23 | |
| 3gni_B | 389 | Strad alpha; kinase fold, pseudokinase, alpha heli | 2e-23 | |
| 2vwi_A | 303 | Serine/threonine-protein kinase OSR1; STE kinase, | 3e-23 | |
| 2dyl_A | 318 | Dual specificity mitogen-activated protein kinase | 3e-23 | |
| 2acx_A | 576 | G protein-coupled receptor kinase 6; GRK, G transf | 9e-23 | |
| 3dzo_A | 413 | Rhoptry kinase domain; parasitic disease, transfer | 1e-22 | |
| 1u5q_A | 348 | Serine/threonine protein kinase TAO2; transferase; | 2e-22 | |
| 2ac3_A | 316 | MAP kinase-interacting serine/threonine kinase 2; | 2e-22 | |
| 3fhr_A | 336 | MAP kinase-activated protein kinase 3; kinase-inhi | 1e-21 | |
| 2wtk_C | 305 | Serine/threonine-protein kinase 11; transferase-me | 2e-21 | |
| 1nxk_A | 400 | MAP kinase-activated protein kinase 2; MK2, phosph | 2e-21 | |
| 2yex_A | 276 | Serine/threonine-protein kinase CHK1; transferase, | 4e-20 | |
| 3pvu_A | 695 | Beta-adrenergic receptor kinase 1; transferase, se | 7e-20 | |
| 2zv2_A | 298 | Calcium/calmodulin-dependent protein kinase kinas; | 8e-20 | |
| 3g51_A | 325 | Ribosomal protein S6 kinase alpha-3; N-terminal ki | 2e-19 | |
| 3tki_A | 323 | Serine/threonine-protein kinase CHK1; cell checkpo | 3e-19 | |
| 3fe3_A | 328 | MAP/microtubule affinity-regulating kinase 3; seri | 4e-19 | |
| 2vd5_A | 412 | DMPK protein; serine/threonine-protein kinase, kin | 4e-19 | |
| 4e7w_A | 394 | Glycogen synthase kinase 3; GSK3, PTyr195, transfe | 6e-19 | |
| 4aw2_A | 437 | Serine/threonine-protein kinase MRCK alpha; transf | 6e-19 | |
| 3dls_A | 335 | PAS domain-containing serine/threonine-protein KI; | 6e-19 | |
| 1j1b_A | 420 | Glycogen synthase kinase-3 beta; complex, TAU, AMP | 8e-19 | |
| 2iwi_A | 312 | Serine/threonine-protein kinase PIM-2; nucleotide- | 1e-18 | |
| 1uu3_A | 310 | HPDK1, 3-phosphoinositide dependent protein kinase | 1e-18 | |
| 3e3p_A | 360 | Protein kinase, putative glycogen synthase kinase; | 2e-18 | |
| 3v8s_A | 410 | RHO-associated protein kinase 1; dimerization, myo | 2e-18 | |
| 3a99_A | 320 | Proto-oncogene serine/threonine-protein kinase PI; | 5e-18 | |
| 4fr4_A | 384 | YANK1, serine/threonine-protein kinase 32A; struct | 8e-18 | |
| 2h6d_A | 276 | 5'-AMP-activated protein kinase catalytic subunit | 1e-17 | |
| 4ejn_A | 446 | RAC-alpha serine/threonine-protein kinase; AKT1, a | 2e-17 | |
| 1rdq_E | 350 | PKA C-alpha, CAMP-dependent protein kinase, alpha- | 3e-17 | |
| 3a62_A | 327 | Ribosomal protein S6 kinase beta-1; kinase domain, | 4e-17 | |
| 2xrw_A | 371 | Mitogen-activated protein kinase 8; transcription, | 5e-17 | |
| 1o6l_A | 337 | RAC-beta serine/threonine protein kinase; protein | 6e-17 | |
| 4agu_A | 311 | Cyclin-dependent kinase-like 1; transferase, phosp | 1e-16 | |
| 3g33_A | 308 | Cell division protein kinase 4; Ser/Thr protein ki | 1e-16 | |
| 3ttj_A | 464 | Mitogen-activated protein kinase 10; JNK3, protein | 1e-16 | |
| 2eue_A | 275 | Carbon catabolite derepressing protein kinase; kin | 1e-16 | |
| 3o0g_A | 292 | Cell division protein kinase 5; kinase activator c | 2e-16 | |
| 2y94_A | 476 | 5'-AMP-activated protein kinase catalytic subunit; | 2e-16 | |
| 3coi_A | 353 | Mitogen-activated protein kinase 13; P38D, P38delt | 2e-16 | |
| 1blx_A | 326 | Cyclin-dependent kinase 6; inhibitor protein, cycl | 2e-16 | |
| 4aaa_A | 331 | Cyclin-dependent kinase-like 2; transferase, phosp | 2e-16 | |
| 1fot_A | 318 | TPK1 delta, CAMP-dependent protein kinase type 1; | 4e-16 | |
| 3uc3_A | 361 | Serine/threonine-protein kinase SRK2I; SNRK2, ABA | 4e-16 | |
| 3h4j_B | 336 | AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin | 5e-16 | |
| 1q8y_A | 373 | SR protein kinase; transferase; HET: ADP ADE; 2.05 | 7e-16 | |
| 2r3i_A | 299 | Cell division protein kinase 2; serine/threonine-p | 1e-15 | |
| 2r5t_A | 373 | Serine/threonine-protein kinase SGK1; AGC protein | 1e-15 | |
| 3a8x_A | 345 | Protein kinase C IOTA type; transferase; HET: TPO; | 1e-15 | |
| 3pfq_A | 674 | PKC-B, PKC-beta, protein kinase C beta type; phosp | 2e-15 | |
| 4dc2_A | 396 | Protein kinase C IOTA type; kinase, substrate, cel | 2e-15 | |
| 3gbz_A | 329 | Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide- | 2e-15 | |
| 1xjd_A | 345 | Protein kinase C, theta type; PKC-theta, ATP, AMP, | 3e-15 | |
| 2b9h_A | 353 | MAP kinase FUS3, mitogen-activated protein kinase | 3e-15 | |
| 1cm8_A | 367 | Phosphorylated MAP kinase P38-gamma; phosphorylati | 3e-15 | |
| 2i0e_A | 353 | Protein kinase C-beta II; serine/threonine protein | 3e-15 | |
| 3txo_A | 353 | PKC-L, NPKC-ETA, protein kinase C ETA type; phosph | 3e-15 | |
| 1vzo_A | 355 | Ribosomal protein S6 kinase alpha 5; protein kinas | 4e-15 | |
| 3m2w_A | 299 | MAP kinase-activated protein kinase 2; small molec | 7e-15 | |
| 3uqc_A | 286 | Probable conserved transmembrane protein; structur | 9e-15 | |
| 3oz6_A | 388 | Mitogen-activated protein kinase 1, serine/threon | 1e-14 | |
| 3nsz_A | 330 | CK II alpha, casein kinase II subunit alpha; inhib | 2e-14 | |
| 2pmi_A | 317 | Negative RE, cyclin-dependent protein kinase PHO85 | 2e-14 | |
| 3niz_A | 311 | Rhodanese family protein; structural genomics, str | 2e-14 | |
| 2fst_X | 367 | Mitogen-activated protein kinase 14; active mutant | 2e-14 | |
| 1ob3_A | 288 | PFPK5, cell division control protein 2 homolog; tr | 2e-14 | |
| 3rp9_A | 458 | Mitogen-activated protein kinase; structural genom | 2e-14 | |
| 3n9x_A | 432 | Phosphotransferase; malaria kinase, structural gen | 3e-14 | |
| 3pg1_A | 362 | Mitogen-activated protein kinase, putative (MAP K | 4e-14 | |
| 3kvw_A | 429 | DYRK2, dual specificity tyrosine-phosphorylation-r | 5e-14 | |
| 1ua2_A | 346 | CAK, cell division protein kinase 7; cell cycle, p | 6e-14 | |
| 3qyz_A | 364 | Mitogen-activated protein kinase 1; transferase, s | 9e-14 | |
| 3mi9_A | 351 | Cell division protein kinase 9; P-TEFB, HIV-1, pro | 1e-13 | |
| 2vx3_A | 382 | Dual specificity tyrosine-phosphorylation- regula | 1e-13 | |
| 3eb0_A | 383 | Putative uncharacterized protein; kinase cryptospo | 1e-13 | |
| 3mtl_A | 324 | Cell division protein kinase 16; pctaire1, indirub | 1e-13 | |
| 2i6l_A | 320 | Mitogen-activated protein kinase 6; MAPK6, ERK3, e | 5e-13 | |
| 3vhe_A | 359 | Vascular endothelial growth factor receptor 2; kin | 7e-13 | |
| 3vhe_A | 359 | Vascular endothelial growth factor receptor 2; kin | 2e-11 | |
| 3m7h_A | 276 | Putidacin L1; monocot mannose-binding lectin, bact | 2e-11 | |
| 3m7h_A | 276 | Putidacin L1; monocot mannose-binding lectin, bact | 6e-04 | |
| 3rgf_A | 405 | Cyclin-dependent kinase 8; protein kinase complex, | 2e-11 | |
| 2eu9_A | 355 | Dual specificity protein kinase CLK3; kinase domai | 7e-11 | |
| 1z57_A | 339 | Dual specificity protein kinase CLK1; protein tyro | 2e-10 | |
| 1wak_A | 397 | Serine/threonine-protein kinase SPRK1; SRPK, trans | 6e-10 | |
| 3llt_A | 360 | Serine/threonine kinase-1, pflammer; lammer kinase | 2e-09 | |
| 2izr_A | 330 | Casein kinase I isoform gamma-3; serine/threonine- | 2e-09 | |
| 2vuw_A | 336 | Serine/threonine-protein kinase haspin; cell cycle | 2e-09 | |
| 1xd5_A | 112 | Gastrodianin-1, antifungal protein GAFP-1; monocot | 3e-09 | |
| 1xd5_A | 112 | Gastrodianin-1, antifungal protein GAFP-1; monocot | 3e-04 | |
| 3uzp_A | 296 | CKI-delta, CKID, casein kinase I isoform delta; CK | 8e-09 | |
| 1csn_A | 298 | Casein kinase-1; phosphotransferase; HET: ATP; 2.0 | 3e-08 | |
| 3sv0_A | 483 | Casein kinase I-like; typical kinase domain fold, | 1e-07 | |
| 1kj1_A | 109 | Lectin I, lecgna 1; BULB lectin, mannose, plant pr | 3e-07 | |
| 1kj1_A | 109 | Lectin I, lecgna 1; BULB lectin, mannose, plant pr | 1e-06 | |
| 2dpf_A | 115 | Curculin; sweet taste, taste modifying, plant prot | 9e-07 | |
| 1vt4_I | 1221 | APAF-1 related killer DARK; drosophila apoptosome, | 2e-06 | |
| 1vt4_I | 1221 | APAF-1 related killer DARK; drosophila apoptosome, | 3e-04 | |
| 2v62_A | 345 | Serine/threonine-protein kinase VRK2; transferase, | 2e-06 | |
| 1dlp_A | 236 | Lectin scafet precursor; two-domain lectin, beta p | 2e-06 | |
| 1dlp_A | 236 | Lectin scafet precursor; two-domain lectin, beta p | 7e-04 | |
| 2jii_A | 352 | Serine/threonine-protein kinase VRK3 molecule: VA | 1e-05 | |
| 3dzw_A | 109 | Agglutinin; lectin, mannobiose, mannose-alpha1, 3- | 4e-05 | |
| 3dzw_A | 109 | Agglutinin; lectin, mannobiose, mannose-alpha1, 3- | 3e-04 | |
| 3r0e_A | 109 | Lectin; carbohydrate binding, carbohydrate, sugar | 4e-05 | |
| 1b2p_A | 119 | Protein (lectin); mannose-binding lectin, monocot, | 5e-05 | |
| 1b2p_A | 119 | Protein (lectin); mannose-binding lectin, monocot, | 3e-04 | |
| 3a0c_A | 110 | Mannose/sialic acid-binding lectin; beta-prism II, | 5e-05 | |
| 3r0e_B | 110 | Lectin; carbohydrate binding, carbohydrate, sugar | 1e-04 | |
| 3op5_A | 364 | Serine/threonine-protein kinase VRK1; adenosine tr | 1e-04 | |
| 3mez_B | 113 | Mannose-specific lectin 3 chain 2; heterotetramer, | 2e-04 | |
| 3mez_B | 113 | Mannose-specific lectin 3 chain 2; heterotetramer, | 3e-04 |
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326 | Back alignment and structure |
|---|
Score = 381 bits (981), Expect = e-127
Identities = 127/306 (41%), Positives = 176/306 (57%), Gaps = 10/306 (3%)
Query: 478 PHQEDQGVSYMNLRCFTYKELVEVTRGFKEE--LGRGAFGTVYKGFVNMGSSNHVAVKKL 535
P +ED V L+ F+ +EL + F + LGRG FG VYKG + G+ VAVK+L
Sbjct: 5 PAEEDPEVHLGQLKRFSLRELQVASDNFSNKNILGRGGFGKVYKGRLADGT--LVAVKRL 62
Query: 536 NS-VFQDSEKEFKAEVNGIGQTHHKNLVRLLGYCDEGQNRLLVYEFMSNGTVASFLFGDS 594
Q E +F+ EV I H+NL+RL G+C RLLVY +M+NG+VAS L
Sbjct: 63 KEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERP 122
Query: 595 KP----NWKLRTEIAMGIAGGLFYLHEECCTQIIHCDIKPQNILLDDHYNARISDFGLAK 650
+ +W R IA+G A GL YLH+ C +IIH D+K NILLD+ + A + DFGLAK
Sbjct: 123 ESQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAK 182
Query: 651 LLTLDQSHTNTAIRGTKGYVAPEWFRNMPITVKVDVYSYGVLLLEIICLRRNID-NEISK 709
L+ +H TA+RGT G++APE+ + K DV+ YGV+LLE+I +R D ++
Sbjct: 183 LMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLAN 242
Query: 710 VDKAILTDWAYDRYQERTLEALVENDLEAMNNVTMLHRFVMVAFWCIQEDPSHRPTMRKV 769
D +L DW +E+ LEALV+ DL+ + + + VA C Q P RP M +V
Sbjct: 243 DDDVMLLDWVKGLLKEKKLEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEV 302
Query: 770 TQMLEG 775
+MLEG
Sbjct: 303 VRMLEG 308
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321 | Back alignment and structure |
|---|
Score = 353 bits (907), Expect = e-116
Identities = 103/298 (34%), Positives = 159/298 (53%), Gaps = 13/298 (4%)
Query: 489 NLRCFTYKELVEVTRGFKEE--LGRGAFGTVYKGFVNMGSSNHVAVKKLNSVFQDSEKEF 546
+L E T F + +G G FG VYKG + G+ VA+K+ +EF
Sbjct: 25 ESYRVPLVDLEEATNNFDHKFLIGHGVFGKVYKGVLRDGAK--VALKRRTPESSQGIEEF 82
Query: 547 KAEVNGIGQTHHKNLVRLLGYCDEGQNRLLVYEFMSNGTVASFLFGDSKP----NWKLRT 602
+ E+ + H +LV L+G+CDE +L+Y++M NG + L+G P +W+ R
Sbjct: 83 ETEIETLSFCRHPHLVSLIGFCDERNEMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRL 142
Query: 603 EIAMGIAGGLFYLHEECCTQIIHCDIKPQNILLDDHYNARISDFGLAKL-LTLDQSHTNT 661
EI +G A GL YLH IIH D+K NILLD+++ +I+DFG++K LDQ+H +T
Sbjct: 143 EICIGAARGLHYLHTRA---IIHRDVKSINILLDENFVPKITDFGISKKGTELDQTHLST 199
Query: 662 AIRGTKGYVAPEWFRNMPITVKVDVYSYGVLLLEIICLRRNIDNEISKVDKAILTDWAYD 721
++GT GY+ PE+F +T K DVYS+GV+L E++C R I + + + L +WA +
Sbjct: 200 VVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPR-EMVNLAEWAVE 258
Query: 722 RYQERTLEALVENDLEAMNNVTMLHRFVMVAFWCIQEDPSHRPTMRKVTQMLEGVVEV 779
+ LE +V+ +L L +F A C+ RP+M V LE + +
Sbjct: 259 SHNNGQLEQIVDPNLADKIRPESLRKFGDTAVKCLALSSEDRPSMGDVLWKLEYALRL 316
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307 | Back alignment and structure |
|---|
Score = 348 bits (896), Expect = e-114
Identities = 108/315 (34%), Positives = 165/315 (52%), Gaps = 28/315 (8%)
Query: 480 QEDQGVSYMNLRCFTYKELVEVTRGFKEE--------LGRGAFGTVYKGFVNMGSSNHVA 531
+ VS F++ EL VT F E +G G FG VYKG+VN + VA
Sbjct: 2 NKSLEVSDTRFHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYVN---NTTVA 58
Query: 532 VKKLNSVFQDS----EKEFKAEVNGIGQTHHKNLVRLLGYCDEGQNRLLVYEFMSNGTVA 587
VKKL ++ + +++F E+ + + H+NLV LLG+ +G + LVY +M NG++
Sbjct: 59 VKKLAAMVDITTEELKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLL 118
Query: 588 SFLFGDSKP---NWKLRTEIAMGIAGGLFYLHEECCTQIIHCDIKPQNILLDDHYNARIS 644
L +W +R +IA G A G+ +LHE IH DIK NILLD+ + A+IS
Sbjct: 119 DRLSCLDGTPPLSWHMRCKIAQGAANGINFLHENH---HIHRDIKSANILLDEAFTAKIS 175
Query: 645 DFGLAKLL-TLDQSHTNTAIRGTKGYVAPEWFRNMPITVKVDVYSYGVLLLEIICLRRNI 703
DFGLA+ Q+ + I GT Y+APE R IT K D+YS+GV+LLEII +
Sbjct: 176 DFGLARASEKFAQTVMTSRIVGTTAYMAPEALRGE-ITPKSDIYSFGVVLLEIITGLPAV 234
Query: 704 DNEISKVDKAILTDWAYDRYQE-RTLEALVENDLEAMNNVTMLHRFVMVAFWCIQEDPSH 762
D + +L D + E +T+E ++ + ++ ++ VA C+ E +
Sbjct: 235 D---EHREPQLLLDIKEEIEDEEKTIEDYIDKKMNDADSTSV-EAMYSVASQCLHEKKNK 290
Query: 763 RPTMRKVTQMLEGVV 777
RP ++KV Q+L+ +
Sbjct: 291 RPDIKKVQQLLQEMT 305
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322 | Back alignment and structure |
|---|
Score = 228 bits (582), Expect = 2e-68
Identities = 69/324 (21%), Positives = 123/324 (37%), Gaps = 35/324 (10%)
Query: 476 MRPHQEDQGVSYMNLRCFTYKELVEVTRGFK--EELGRGAFGTVYKGFVNMGSSNHVAVK 533
M H + + L + + E RG FG V+K + + +VAVK
Sbjct: 1 MGHHHHHH----SSGVDLGTENLYFQSMPLQLLEVKARGRFGCVWKAQLL---NEYVAVK 53
Query: 534 KLNSVFQDSEKEFKAEVNGIGQTHHKNLVRLLGYCDEGQN----RLLVYEFMSNGTVASF 589
+ + EV + H+N+++ +G G + L+ F G+++ F
Sbjct: 54 IFPIQ-DKQSWQNEYEVYSLPGMKHENILQFIGAEKRGTSVDVDLWLITAFHEKGSLSDF 112
Query: 590 LFGDSKPNWKLRTEIAMGIAGGLFYLHEECCTQ-------IIHCDIKPQNILLDDHYNAR 642
L + +W IA +A GL YLHE+ I H DIK +N+LL ++ A
Sbjct: 113 LKA-NVVSWNELCHIAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTAC 171
Query: 643 ISDFGLAKLLTLDQSHTNT-AIRGTKGYVAPEWFR-----NMPITVKVDVYSYGVLLLEI 696
I+DFGLA +S +T GT+ Y+APE +++D+Y+ G++L E+
Sbjct: 172 IADFGLALKFEAGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWEL 231
Query: 697 ICLRRNIDNEISKVDKAILTDWAYDRYQERTLEALVENDL------EAMNNVTMLHRFVM 750
D + + + ++ +V + + +
Sbjct: 232 ASRCTAADGPVDE-YMLPFEEEIGQHPSLEDMQEVVVHKKKRPVLRDYWQKHAGMAMLCE 290
Query: 751 VAFWCIQEDPSHRPTMRKVTQMLE 774
C D R + V + +
Sbjct: 291 TIEECWDHDAEARLSAGCVGERIT 314
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309 | Back alignment and structure |
|---|
Score = 201 bits (514), Expect = 6e-59
Identities = 76/287 (26%), Positives = 139/287 (48%), Gaps = 32/287 (11%)
Query: 505 FKEELGRGAFGTVYKGFVNMGSSNHVAVKKLNSVF--QDSEKEFKAEVNGIGQTHHKNLV 562
KE++G G+FGTV++ + + VAVK L + EF EV + + H N+V
Sbjct: 41 IKEKIGAGSFGTVHRAEWH---GSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIV 97
Query: 563 RLLGYCDEGQNRLLVYEFMSNGTVASFL---FGDSKPNWKLRTEIAMGIAGGLFYLHEEC 619
+G + N +V E++S G++ L + + + R +A +A G+ YLH
Sbjct: 98 LFMGAVTQPPNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHN-R 156
Query: 620 CTQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLDQSHTNTAIRGTKGYVAPEWFRNMP 679
I+H ++K N+L+D Y ++ DFGL++L ++ + GT ++APE R+ P
Sbjct: 157 NPPIVHRNLKSPNLLVDKKYTVKVCDFGLSRLKA-STFLSSKSAAGTPEWMAPEVLRDEP 215
Query: 680 ITVKVDVYSYGVLLLEIICLR---RNIDNEISKVDKAILTDWAYDRYQERTLEALVENDL 736
K DVYS+GV+L E+ L+ N++ ++V A+ ++ + LE + N
Sbjct: 216 SNEKSDVYSFGVILWELATLQQPWGNLNP--AQVVAAVG-------FKCKRLE-IPRNLN 265
Query: 737 EAMNNVTMLHRFVMVAFWCIQEDPSHRPTMRKVTQMLEGVVEVPIPP 783
+ ++ C +P RP+ + +L +++ +PP
Sbjct: 266 PQV-------AAIIEG--CWTNEPWKRPSFATIMDLLRPLIKSAVPP 303
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307 | Back alignment and structure |
|---|
Score = 199 bits (507), Expect = 6e-58
Identities = 76/287 (26%), Positives = 124/287 (43%), Gaps = 41/287 (14%)
Query: 495 YKELVEVTRGFKEELGRGAFGTVYKGFVNMGSSNHVAVKKLNSVFQDSEKEFKAEVNGIG 554
YKE+ +E +GRGAFG V K + VA+K++ S + K F E+ +
Sbjct: 7 YKEIE-----VEEVVGRGAFGVVCKAKWR---AKDVAIKQIES--ESERKAFIVELRQLS 56
Query: 555 QTHHKNLVRLLGYCDEGQNRLLVYEFMSNGTVASFLFGDSKP---NWKLRTEIAMGIAGG 611
+ +H N+V+L G C LV E+ G++ + L G + + G
Sbjct: 57 RVNHPNIVKLYGACL--NPVCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQG 114
Query: 612 LFYLHEECCTQIIHCDIKPQNILLDDHYN-ARISDFGLAKLLTLDQSHTNTAIRGTKGYV 670
+ YLH +IH D+KP N+LL +I DFG A D T +G+ ++
Sbjct: 115 VAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTAC----DIQTHMTNNKGSAAWM 170
Query: 671 APEWFRNMPITVKVDVYSYGVLLLEIICLR---RNIDNEISKVDKAILTDWAYDRYQERT 727
APE F + K DV+S+G++L E+I R I ++ A+ R
Sbjct: 171 APEVFEGSNYSEKCDVFSWGIILWEVITRRKPFDEIGGPAFRIMWAVHNG-------TR- 222
Query: 728 LEALVENDLEAMNNVTMLHRFVMVAFWCIQEDPSHRPTMRKVTQMLE 774
+ N+ +M C +DPS RP+M ++ +++
Sbjct: 223 --------PPLIKNLPKPIESLMTR--CWSKDPSQRPSMEEIVKIMT 259
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289 | Back alignment and structure |
|---|
Score = 192 bits (489), Expect = 1e-55
Identities = 75/281 (26%), Positives = 127/281 (45%), Gaps = 35/281 (12%)
Query: 505 FKEELGRGAFGTVYKGFVNMGSSNHVAVKKLN--SVFQDSEKEFKAEVNGIGQTHHKNLV 562
+ +G G+FGTVYKG + VAVK LN + + FK EV + +T H N++
Sbjct: 28 VGQRIGSGSFGTVYKGKWH----GDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNIL 83
Query: 563 RLLGYCDEGQNRLLVYEFMSNGTVASFL-FGDSKPNWKLRTEIAMGIAGGLFYLHEECCT 621
+GY +V ++ ++ L ++K K +IA A G+ YLH +
Sbjct: 84 LFMGYSTA-PQLAIVTQWCEGSSLYHHLHASETKFEMKKLIDIARQTARGMDYLHAK--- 139
Query: 622 QIIHCDIKPQNILLDDHYNARISDFGLAKLLTLDQ-SHTNTAIRGTKGYVAPEWFRN--- 677
IIH D+K NI L + +I DFGLA + SH + G+ ++APE R
Sbjct: 140 SIIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDS 199
Query: 678 MPITVKVDVYSYGVLLLEIICLR---RNIDNEISKVDKAILTDWAYDRYQERTLEALVEN 734
P + + DVY++G++L E++ + NI+N D+ I R + V +
Sbjct: 200 NPYSFQSDVYAFGIVLYELMTGQLPYSNINN----RDQII---EMVGRGSLSPDLSKVRS 252
Query: 735 DL-EAMNNVTMLHRFVMVAFWCIQEDPSHRPTMRKVTQMLE 774
+ + M + C+++ RP+ ++ +E
Sbjct: 253 NCPKRMKRLMA---------ECLKKKRDERPSFPRILAEIE 284
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310 | Back alignment and structure |
|---|
Score = 192 bits (489), Expect = 2e-55
Identities = 68/288 (23%), Positives = 115/288 (39%), Gaps = 41/288 (14%)
Query: 505 FKEELGRGAFGTVYKGFVNMGSSNHVAVKKLNSVFQDSEKEFKAEVNGIGQTHHKNLVRL 564
E LG+G FG K + + +K+L +++++ F EV + H N+++
Sbjct: 14 HGEVLGKGCFGQAIKVTHR-ETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKF 72
Query: 565 LGYCDEGQNRLLVYEFMSNGTVASFLFGDSKP-NWKLRTEIAMGIAGGLFYLHEECCTQI 623
+G + + + E++ GT+ + W R A IA G+ YLH I
Sbjct: 73 IGVLYKDKRLNFITEYIKGGTLRGIIKSMDSQYPWSQRVSFAKDIASGMAYLHSM---NI 129
Query: 624 IHCDIKPQNILLDDHYNARISDFGLAKLLTLDQSHTN-------------TAIRGTKGYV 670
IH D+ N L+ ++ N ++DFGLA+L+ +++ + G ++
Sbjct: 130 IHRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLRSLKKPDRKKRYTVVGNPYWM 189
Query: 671 APEWFRNMPITVKVDVYSYGVLLLEIICLRRNIDNEISKVDKAILTDWAYDRYQERTLEA 730
APE KVDV+S+G++L EII A Y RT++
Sbjct: 190 APEMINGRSYDEKVDVFSFGIVLCEIIGRVN-----------------ADPDYLPRTMDF 232
Query: 731 LVEND----LEAMNNVTMLHRFVMVAFWCIQEDPSHRPTMRKVTQMLE 774
+ N F + C DP RP+ K+ LE
Sbjct: 233 GLNVRGFLDRYCPPNC--PPSFFPITVRCCDLDPEKRPSFVKLEHWLE 278
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 189 bits (482), Expect = 2e-54
Identities = 65/289 (22%), Positives = 112/289 (38%), Gaps = 46/289 (15%)
Query: 505 FKEELGRGAFGTVYKGFVNMGSSNHVAVKKLN--SVFQDSEKEFKAEVNGIGQTHHKNLV 562
E +G+G FG VY G + VA++ ++ +D K FK EV QT H+N+V
Sbjct: 37 IGELIGKGRFGQVYHGRWH----GEVAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVV 92
Query: 563 RLLGYCDEGQNRLLVYEFMSNGTVASFLFG-DSKPNWKLRTEIAMGIAGGLFYLHEECCT 621
+G C + ++ T+ S + + +IA I G+ YLH +
Sbjct: 93 LFMGACMSPPHLAIITSLCKGRTLYSVVRDAKIVLDVNKTRQIAQEIVKGMGYLHAK--- 149
Query: 622 QIIHCDIKPQNILLDDHYNARISDFGLAKLLTL----DQSHTNTAIRGTKGYVAPEWFRN 677
I+H D+K +N+ D+ I+DFGL + + + G ++APE R
Sbjct: 150 GILHKDLKSKNVFYDNG-KVVITDFGLFSISGVLQAGRREDKLRIQNGWLCHLAPEIIRQ 208
Query: 678 M---------PITVKVDVYSYGVLLLEIICLR---RNIDNEISKVDKAILTDWAYDRYQE 725
+ P + DV++ G + E+ + E AI
Sbjct: 209 LSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQPAE------AI----------- 251
Query: 726 RTLEALVENDLEAMNNVTMLHRFVMVAFWCIQEDPSHRPTMRKVTQMLE 774
+ + ++ + M + +C + RPT K+ MLE
Sbjct: 252 --IWQMGTGMKPNLSQIGMGKEISDILLFCWAFEQEERPTFTKLMDMLE 298
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271 | Back alignment and structure |
|---|
Score = 186 bits (474), Expect = 1e-53
Identities = 75/287 (26%), Positives = 110/287 (38%), Gaps = 45/287 (15%)
Query: 505 FKEELGRGAFGTVYKGFVNMGSSNHVAVKKLNSVFQD----SEKEFKAEVNGIGQTHHKN 560
+E +G G FG VY+ F + VAVK + + + + E H N
Sbjct: 11 LEEIIGIGGFGKVYRAFWI---GDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPN 67
Query: 561 LVRLLGYCDEGQNRLLVYEFMSNGTVASFLFGDSKPNWKLRTEIAMGIAGGLFYLHEECC 620
++ L G C + N LV EF G + L G + + A+ IA G+ YLH+E
Sbjct: 68 IIALRGVCLKEPNLCLVMEFARGGPLNRVLSG-KRIPPDILVNWAVQIARGMNYLHDEAI 126
Query: 621 TQIIHCDIKPQNILLD--------DHYNARISDFGLAKLLTLDQSHTNTAIRGTKGYVAP 672
IIH D+K NIL+ + +I+DFGLA+ T + G ++AP
Sbjct: 127 VPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLAREW---HRTTKMSAAGAYAWMAP 183
Query: 673 EWFRNMPITVKVDVYSYGVLLLEIICLR---RNIDNEISKVDKAILTDWAYDRYQERTLE 729
E R + DV+SYGVLL E++ R ID
Sbjct: 184 EVIRASMFSKGSDVWSYGVLLWELLTGEVPFRGIDG-------------------LAVAY 224
Query: 730 ALVEND--LEAMNNVTMLHRFVMVAFWCIQEDPSHRPTMRKVTQMLE 774
+ N L + +M C DP RP+ + L
Sbjct: 225 GVAMNKLALPIPSTCPEPFAKLMED--CWNPDPHSRPSFTNILDQLT 269
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336 | Back alignment and structure |
|---|
Score = 188 bits (478), Expect = 1e-53
Identities = 68/308 (22%), Positives = 111/308 (36%), Gaps = 48/308 (15%)
Query: 505 FKEELGRGAFGTVYKGFVNMGSSNHVAVKKLNSVFQDSEKEFKAEVNGIGQT---HHKNL 561
E +GRG +G VYKG ++ VAVK + + + F E N I + H N+
Sbjct: 17 LLELIGRGRYGAVYKGSLD---ERPVAVKVFSF---ANRQNFINEKN-IYRVPLMEHDNI 69
Query: 562 VRLLGYCDEG-----QNRLLVYEFMSNGTVASFLFGDSKPNWKLRTEIAMGIAGGLFYLH 616
R + + LLV E+ NG++ +L +W +A + GL YLH
Sbjct: 70 ARFIVGDERVTADGRMEYLLVMEYYPNGSLXKYLS-LHTSDWVSSCRLAHSVTRGLAYLH 128
Query: 617 EECCT------QIIHCDIKPQNILLDDHYNARISDFGLAKLL-------TLDQSHTNTAI 663
E I H D+ +N+L+ + ISDFGL+ L ++ + +
Sbjct: 129 TELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSMRLTGNRLVRPGEEDNAAISE 188
Query: 664 RGTKGYVAPEWFRN-------MPITVKVDVYSYGVLLLEIICLRRNIDNEISKVDKAILT 716
GT Y+APE +VD+Y+ G++ EI R D +
Sbjct: 189 VGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEI--FMRCTDLFPGESVPEYQM 246
Query: 717 DWAYDRYQERTLEAL----VENDL------EAMNNVTMLHRFVMVAFWCIQEDPSHRPTM 766
+ + T E + N + C +D R T
Sbjct: 247 AFQTEVGNHPTFEDMQVLVSREKQRPKFPEAWKENSLAVRSLKETIEDCWDQDAEARLTA 306
Query: 767 RKVTQMLE 774
+ + +
Sbjct: 307 QXAEERMA 314
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287 | Back alignment and structure |
|---|
Score = 183 bits (466), Expect = 2e-52
Identities = 69/296 (23%), Positives = 119/296 (40%), Gaps = 44/296 (14%)
Query: 495 YKELVEVTRGFKEELGRGAFGTVYKG-FVNMGSSNHVAVKKL-------NSVFQDSEKEF 546
E+ +++++G+G FG V+KG V S VA+K L + + +EF
Sbjct: 18 DNEIE-----YEKQIGKGGFGLVHKGRLVKDKSV--VAIKSLILGDSEGETEMIEKFQEF 70
Query: 547 KAEVNGIGQTHHKNLVRLLGYCDEGQNRLLVYEFMSNGTVASFLFGDSKP-NWKLRTEIA 605
+ EV + +H N+V+L G +V EF+ G + L + P W ++ +
Sbjct: 71 QREVFIMSNLNHPNIVKLYGLMHNPPR--MVMEFVPCGDLYHRLLDKAHPIKWSVKLRLM 128
Query: 606 MGIAGGLFYLHEECCTQIIHCDIKPQNILLD-----DHYNARISDFGLAKLLTLDQSHTN 660
+ IA G+ Y+ I+H D++ NI L A+++DFGL++ H+
Sbjct: 129 LDIALGIEYMQN-QNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQ----QSVHSV 183
Query: 661 TAIRGTKGYVAPEWF--RNMPITVKVDVYSYGVLLLEIICLRRNIDNEISKVDKAILTDW 718
+ + G ++APE T K D YS+ ++L I+ D
Sbjct: 184 SGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDE------------- 230
Query: 719 AYDRYQERTLEALVENDLEAMNNVTMLHRFVMVAFWCIQEDPSHRPTMRKVTQMLE 774
Y + + + + E L R V C DP RP + + L
Sbjct: 231 -YSYGKIKFINMIREEGLRPTIPEDCPPRLRNVIELCWSGDPKKRPHFSYIVKELS 285
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271 | Back alignment and structure |
|---|
Score = 177 bits (450), Expect = 2e-50
Identities = 54/291 (18%), Positives = 106/291 (36%), Gaps = 59/291 (20%)
Query: 505 FKEELGRGAFGTVYKGFVNMGSSNHVAVKKLN--SVFQDSEKEFKAEVNGIGQTHHKNLV 562
F +L G ++KG N + VK L ++F E + H N++
Sbjct: 14 FLTKLNENHSGELWKGRWQ---GNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVL 70
Query: 563 RLLGYCDE--GQNRLLVYEFMSNGTVASFLFGDSKP--NWKLRTEIAMGIAGGLFYLHEE 618
+LG C + L+ +M G++ + L + + + A+ +A G+ +LH
Sbjct: 71 PVLGACQSPPAPHPTLITHWMPYGSLYNVLHEGTNFVVDQSQAVKFALDMARGMAFLHT- 129
Query: 619 CCTQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLDQSHTNTAIRGTKGYVAPEWFRNM 678
I + +++++D+ ARIS + S + +VAPE +
Sbjct: 130 LEPLIPRHALNSRSVMIDEDMTARISMADVKF------SFQSPGRMYAPAWVAPEALQKK 183
Query: 679 P---ITVKVDVYSYGVLLLEIICLR---RNIDNEISKVDKAILTDWAYDRYQER------ 726
P D++S+ VLL E++ ++ N ++ + + R
Sbjct: 184 PEDTNRRSADMWSFAVLLWELVTREVPFADLSN--MEIGMKVALE------GLRPTIPPG 235
Query: 727 ---TLEALVENDLEAMNNVTMLHRFVMVAFWCIQEDPSHRPTMRKVTQMLE 774
+ L++ C+ EDP+ RP + +LE
Sbjct: 236 ISPHVSKLMKI--------------------CMNEDPAKRPKFDMIVPILE 266
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 170 bits (433), Expect = 2e-47
Identities = 64/294 (21%), Positives = 119/294 (40%), Gaps = 31/294 (10%)
Query: 505 FKEELGRGAFGTVYKGFVNMGSSNHVAVKKLNSVFQDSEKEFKAEVNGIGQTHHKNLVRL 564
+++G+G +G V+ G VAVK + +++ + E+ H+N++
Sbjct: 41 MVKQIGKGRYGEVWMGKWR---GEKVAVKVFFTT-EEASWFRETEIYQTVLMRHENILGF 96
Query: 565 LGYCDEGQNR----LLVYEFMSNGTVASFLFGDSKPNWKLRTEIAMGIAGGLFYLHEECC 620
+ +G L+ ++ NG++ +L + + K ++A GL +LH E
Sbjct: 97 IAADIKGTGSWTQLYLITDYHENGSLYDYL-KSTTLDAKSMLKLAYSSVSGLCHLHTEIF 155
Query: 621 TQ-----IIHCDIKPQNILLDDHYNARISDFGLAKLLTLDQSHT---NTAIRGTKGYVAP 672
+ I H D+K +NIL+ + I+D GLA D + GTK Y+ P
Sbjct: 156 STQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVKFISDTNEVDIPPNTRVGTKRYMPP 215
Query: 673 E------WFRNMPITVKVDVYSYGVLLLEIICLRRNIDNEISKVDKAILTDWA-YDRYQE 725
E + + D+YS+G++L E+ RR + I + + D D E
Sbjct: 216 EVLDESLNRNHFQSYIMADMYSFGLILWEV--ARRCVSGGIVEEYQLPYHDLVPSDPSYE 273
Query: 726 RTLEALVENDL-----EAMNNVTMLHRFVMVAFWCIQEDPSHRPTMRKVTQMLE 774
E + L ++ L + + C +P+ R T +V + L
Sbjct: 274 DMREIVCIKKLRPSFPNRWSSDECLRQMGKLMTECWAHNPASRLTALRVKKTLA 327
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301 | Back alignment and structure |
|---|
Score = 166 bits (422), Expect = 3e-46
Identities = 69/297 (23%), Positives = 123/297 (41%), Gaps = 37/297 (12%)
Query: 505 FKEELGRGAFGTVYKGFVNMGSSNHVAVKKLNSVFQDSEKEFKAEVNGIGQT---HHKNL 561
E +G+G +G V++G +VAVK +S +D EK + E + T H+N+
Sbjct: 12 LLECVGKGRYGEVWRGSWQ---GENVAVKIFSS--RD-EKSWFRETE-LYNTVMLRHENI 64
Query: 562 VRLLGYCDEGQNR----LLVYEFMSNGTVASFLFGDSKPNWKLRTEIAMGIAGGLFYLHE 617
+ + ++ L+ + G++ +L + + I + IA GL +LH
Sbjct: 65 LGFIASDMTSRHSSTQLWLITHYHEMGSLYDYL-QLTTLDTVSCLRIVLSIASGLAHLHI 123
Query: 618 ECCTQ-----IIHCDIKPQNILLDDHYNARISDFGLAKLLTLDQSH---TNTAIRGTKGY 669
E I H D+K +NIL+ + I+D GLA + + + N GTK Y
Sbjct: 124 EIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRVGTKRY 183
Query: 670 VAPEWFRNMPITV------KVDVYSYGVLLLEIICLRRNIDNEISKVDKAILTDWAY-DR 722
+APE +VD++++G++L E+ RR + N I + K D D
Sbjct: 184 MAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEV--ARRMVSNGIVEDYKPPFYDVVPNDP 241
Query: 723 YQERTLEALVENDL-----EAMNNVTMLHRFVMVAFWCIQEDPSHRPTMRKVTQMLE 774
E + + + + L + C ++PS R T ++ + L
Sbjct: 242 SFEDMRKVVCVDQQRPNIPNRWFSDPTLTSLAKLMKECWYQNPSARLTALRIKKTLT 298
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342 | Back alignment and structure |
|---|
Score = 162 bits (411), Expect = 2e-44
Identities = 63/294 (21%), Positives = 114/294 (38%), Gaps = 31/294 (10%)
Query: 505 FKEELGRGAFGTVYKGFVNMGSSNHVAVKKLNSVFQDSEKEFKAEVNGIGQTHHKNLVRL 564
+E +G+G FG V++G VAVK +S ++ +AE+ H+N++
Sbjct: 46 LQESIGKGRFGEVWRGKWR---GEEVAVKIFSSR-EERSWFREAEIYQTVMLRHENILGF 101
Query: 565 LGYCDEGQNR----LLVYEFMSNGTVASFLFGDSKPNWKLRTEIAMGIAGGLFYLHEECC 620
+ ++ LV ++ +G++ +L + ++A+ A GL +LH E
Sbjct: 102 IAADNKDNGTWTQLWLVSDYHEHGSLFDYL-NRYTVTVEGMIKLALSTASGLAHLHMEIV 160
Query: 621 TQ-----IIHCDIKPQNILLDDHYNARISDFGLAKLLTLDQSHT---NTAIRGTKGYVAP 672
I H D+K +NIL+ + I+D GLA GTK Y+AP
Sbjct: 161 GTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAP 220
Query: 673 E------WFRNMPITVKVDVYSYGVLLLEIICLRRNIDNEISKVDKAILTDWAYDRYQER 726
E ++ + D+Y+ G++ EI RR I + + D
Sbjct: 221 EVLDDSINMKHFESFKRADIYAMGLVFWEI--ARRCSIGGIHEDYQLPYYDLVPSDPSVE 278
Query: 727 TLEALV-ENDL-----EAMNNVTMLHRFVMVAFWCIQEDPSHRPTMRKVTQMLE 774
+ +V E L + L + C + + R T ++ + L
Sbjct: 279 EMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLS 332
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377 | Back alignment and structure |
|---|
Score = 152 bits (385), Expect = 2e-40
Identities = 70/290 (24%), Positives = 115/290 (39%), Gaps = 45/290 (15%)
Query: 505 FKEELGRGAFGTVYKGFVNMGSSNHVAVKKLNSVFQDSEK-EFKAEVNGIGQTHHKNLVR 563
E++GRG FG V+ G + + VAVK K +F E + Q H N+VR
Sbjct: 118 LGEQIGRGNFGEVFSGRLR-ADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVR 176
Query: 564 LLGYCDEGQNRLLVYEFMSNGTVASFLFG-DSKPNWKLRTEIAMGIAGGLFYLHEECCTQ 622
L+G C + Q +V E + G +FL ++ K ++ A G+ YL +CC
Sbjct: 177 LIGVCTQKQPIYIVMELVQGGDFLTFLRTEGARLRVKTLLQMVGDAAAGMEYLESKCC-- 234
Query: 623 IIHCDIKPQNILLDDHYNARISDFGLAKLLTLDQSHTNTAIRGTKGY----VAPEWFRNM 678
IH D+ +N L+ + +ISDFG+++ A G + APE
Sbjct: 235 -IHRDLAARNCLVTEKNVLKISDFGMSREEADGVY---AASGGLRQVPVKWTAPEALNYG 290
Query: 679 PITVKVDVYSYGVLLLEIICLRRNIDNEISKVDKAILTDWAYDR--YQERTLE---ALVE 733
+ + DV+S+G+LL E ++ Y + + VE
Sbjct: 291 RYSSESDVWSFGILLWET---------------------FSLGASPYPNLSNQQTREFVE 329
Query: 734 ND--LEAMNNV-TMLHRFVMVAFWCIQEDPSHRPTMRKVTQMLEGVVEVP 780
L + R +M W +P RP+ + Q L+ + +
Sbjct: 330 KGGRLPCPELCPDAVFR-LMEQCW--AYEPGQRPSFSTIYQELQSIRKRH 376
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495 | Back alignment and structure |
|---|
Score = 149 bits (379), Expect = 9e-39
Identities = 75/282 (26%), Positives = 125/282 (44%), Gaps = 43/282 (15%)
Query: 505 FKEELGRGAFGTVYKGFVNMGSSNHVAVKKLNSVFQDSEKEFKAEVNGIGQTHHKNLVRL 564
K +LG G +G VY+G S VAVK L + E EF E + + H NLV+L
Sbjct: 224 MKHKLGGGQYGEVYEGVWK-KYSLTVAVKTLKEDTMEVE-EFLKEAAVMKEIKHPNLVQL 281
Query: 565 LGYCDEGQNRLLVYEFMSNGTVASFLFGDSKPNWKLRT--EIAMGIAGGLFYLHEECCTQ 622
LG C ++ EFM+ G + +L ++ +A I+ + YL ++
Sbjct: 282 LGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNF-- 339
Query: 623 IIHCDIKPQNILLDDHYNARISDFGLAKLLTLDQ----SHTNTAIRGTKGYVAPEWFRNM 678
IH ++ +N L+ +++ +++DFGL++L+T D + I+ T APE
Sbjct: 340 -IHRNLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWT----APESLAYN 394
Query: 679 PITVKVDVYSYGVLLLEIICLRR----NIDNEISKVDKAILTDWAYDRYQERTLEALVEN 734
++K DV+++GVLL EI ID + E L ++
Sbjct: 395 KFSIKSDVWAFGVLLWEIATYGMSPYPGIDL-------------------SQVYELLEKD 435
Query: 735 D-LEAMNNV-TMLHRFVMVAFWCIQEDPSHRPTMRKVTQMLE 774
+E ++ +M A W Q +PS RP+ ++ Q E
Sbjct: 436 YRMERPEGCPEKVYE-LMRACW--QWNPSDRPSFAEIHQAFE 474
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290 | Back alignment and structure |
|---|
Score = 142 bits (359), Expect = 7e-38
Identities = 65/271 (23%), Positives = 109/271 (40%), Gaps = 34/271 (12%)
Query: 505 FKEELGRGAFGTVYKGFVNMGSSNHVAVK--KLNSVFQDSEKEFKAEVNGIGQTHHKNLV 562
F E+GRG+F TVYKG + ++ VA + + + + FK E + H N+V
Sbjct: 30 FDIEIGRGSFKTVYKGL-DTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIV 88
Query: 563 RLLGYC---DEGQNRLLVY-EFMSNGTVASFLFGDSKPNWKLRTEIAMGIAGGLFYLHEE 618
R +G+ +++ E M++GT+ ++L K+ I GL +LH
Sbjct: 89 RFYDSWESTVKGKKCIVLVTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLH-T 147
Query: 619 CCTQIIHCDIKPQNILLDDHY-NARISDFGLAKLLTLDQSHTNTAIRGTKGYVAPEWFRN 677
IIH D+K NI + + +I D GLA L + + GT ++APE +
Sbjct: 148 RTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRASFAKA---VIGTPEFMAPEMYEE 204
Query: 678 MPITVKVDVYSYGVLLLEIICLRR---NIDNEISKVDKAILTDWAYDRYQERTLEALVEN 734
VDVY++G+ +LE+ N I Y R A +
Sbjct: 205 -KYDESVDVYAFGMCMLEMATSEYPYSECQNA-----AQI-----YRRVTSGVKPASFDK 253
Query: 735 DLEAMNNVTMLHRFVMVAFWCIQEDPSHRPT 765
+ + CI+++ R +
Sbjct: 254 VAIP-----EVKEIIE---GCIRQNKDERYS 276
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327 | Back alignment and structure |
|---|
Score = 143 bits (362), Expect = 9e-38
Identities = 71/288 (24%), Positives = 121/288 (42%), Gaps = 33/288 (11%)
Query: 505 FKEELGRGAFGTVYKGFVNMGSSNH---VAVKKLNSVFQDSEKEFKAEVNGIGQTHHKNL 561
+ +LG+G FG+V + N VAVK+L D +++F+ E+ + H +
Sbjct: 27 YISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFI 86
Query: 562 VRLLGYC--DEGQNRLLVYEFMSNGTVASFLFGDSKPNWKLRT--EIAMGIAGGLFYLHE 617
V+ G Q+ LV E++ +G + FL + + I G+ YL
Sbjct: 87 VKYRGVSYGPGRQSLRLVMEYLPSGCLRDFL-QRHRARLDASRLLLYSSQICKGMEYLGS 145
Query: 618 ECCTQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLDQSHTNTAIRGTKGYV---APEW 674
C +H D+ +NIL++ + +I+DFGLAKLL LD+ + + + APE
Sbjct: 146 RRC---VHRDLAARNILVESEAHVKIADFGLAKLLPLDKDYY-VVREPGQSPIFWYAPES 201
Query: 675 FRNMPITVKVDVYSYGVLLLEII------CLRRNIDNEISKVDKAILTDWAYDRYQERTL 728
+ + + DV+S+GV+L E+ C + ++ + R L
Sbjct: 202 LSDNIFSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLRMMGCERDVPAL-------SRLL 254
Query: 729 EALVEND-LEAMNNVTM-LHRFVMVAFWCIQEDPSHRPTMRKVTQMLE 774
E L E L A +H +M W P RP+ + L+
Sbjct: 255 ELLEEGQRLPAPPACPAEVHE-LMKLCW--APSPQDRPSFSALGPQLD 299
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327 | Back alignment and structure |
|---|
Score = 142 bits (360), Expect = 2e-37
Identities = 71/292 (24%), Positives = 115/292 (39%), Gaps = 46/292 (15%)
Query: 505 FKEELGRGAFGTVYKGFVNMGSSN---HVAVKKLNSVFQDSEK-EFKAEVNGIGQTHHKN 560
+ LG GAFGTVYKG VA+K+L E E + + +
Sbjct: 19 KIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPH 78
Query: 561 LVRLLGYCDEGQNRLLVYEFMSNGTVASFLFGDSKPNWKLRTEIAM--GIAGGLFYLHEE 618
+ RLLG C L+ + M G + ++ + K N + + IA G+ YL +
Sbjct: 79 VCRLLGIC-LTSTVQLITQLMPFGCLLDYVR-EHKDNIGSQYLLNWCVQIAKGMNYLEDR 136
Query: 619 CCTQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLDQSHTNTAIRGTKGYV---APEWF 675
+H D+ +N+L+ + +I+DFGLAKLL ++ + G K + A E
Sbjct: 137 RL---VHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHA--EGGKVPIKWMALESI 191
Query: 676 RNMPITVKVDVYSYGVLLLEIICLRR----NIDNE--ISKVDKAILTDWAYDRYQERTLE 729
+ T + DV+SYGV + E++ I S ++K ER
Sbjct: 192 LHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKG-----------ER--- 237
Query: 730 ALVENDLEAMNNVTM-LHRFVMVAFWCIQEDPSHRPTMRKVTQMLEGVVEVP 780
L T+ ++ +M W D RP R++ + P
Sbjct: 238 ------LPQPPICTIDVYM-IMRKCW--MIDADSRPKFRELIIEFSKMARDP 280
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295 | Back alignment and structure |
|---|
Score = 140 bits (356), Expect = 2e-37
Identities = 67/283 (23%), Positives = 124/283 (43%), Gaps = 22/283 (7%)
Query: 505 FKEELGRGAFGTVYKGFVNMGSSNH---VAVKKLNSVFQDSEKEFKAEVNGIGQTHHKNL 561
F ++LG+G FG+V + N VAVKKL ++ ++F+ E+ + H N+
Sbjct: 14 FLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNI 73
Query: 562 VRLLGYC--DEGQNRLLVYEFMSNGTVASFLFGDSKPNWKLRT--EIAMGIAGGLFYLHE 617
V+ G C +N L+ E++ G++ +L K + I G+ YL
Sbjct: 74 VKYKGVCYSAGRRNLKLIMEYLPYGSLRDYL-QKHKERIDHIKLLQYTSQICKGMEYLGT 132
Query: 618 ECCTQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLDQSHTNTAIRGTKGYV---APEW 674
+ IH D+ +NIL+++ +I DFGL K+L D+ + + APE
Sbjct: 133 KRY---IHRDLATRNILVENENRVKIGDFGLTKVLPQDKEFF-KVKEPGESPIFWYAPES 188
Query: 675 FRNMPITVKVDVYSYGVLLLEIICLRRNIDNEISKVDKAILTDWAYDRYQERTLEALVEN 734
+V DV+S+GV+L E+ + ++ + I D + L L++N
Sbjct: 189 LTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGND-KQGQMIVFHLIELLKN 247
Query: 735 D--LEAMNNVTM-LHRFVMVAFWCIQEDPSHRPTMRKVTQMLE 774
+ L + ++ +M W + + RP+ R + ++
Sbjct: 248 NGRLPRPDGCPDEIYM-IMTECW--NNNVNQRPSFRDLALRVD 287
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 141 bits (357), Expect = 3e-37
Identities = 67/283 (23%), Positives = 125/283 (44%), Gaps = 22/283 (7%)
Query: 505 FKEELGRGAFGTVYKGFVNMGSSNH---VAVKKLNSVFQDSEKEFKAEVNGIGQTHHKNL 561
F ++LG+G FG+V + N VAVKKL ++ ++F+ E+ + H N+
Sbjct: 45 FLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNI 104
Query: 562 VRLLGYC--DEGQNRLLVYEFMSNGTVASFLFGDSKPNWKLRT--EIAMGIAGGLFYLHE 617
V+ G C +N L+ E++ G++ +L K + I G+ YL
Sbjct: 105 VKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQ-KHKERIDHIKLLQYTSQICKGMEYLGT 163
Query: 618 ECCTQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLDQSHTNTAIRGTKGYV---APEW 674
+ IH D+ +NIL+++ +I DFGL K+L D+ + + + APE
Sbjct: 164 KRY---IHRDLATRNILVENENRVKIGDFGLTKVLPQDKEYY-KVKEPGESPIFWYAPES 219
Query: 675 FRNMPITVKVDVYSYGVLLLEIICLRRNIDNEISKVDKAILTDWAYDRYQERTLEALVEN 734
+V DV+S+GV+L E+ + ++ + I D + L L++N
Sbjct: 220 LTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGND-KQGQMIVFHLIELLKN 278
Query: 735 D--LEAMNNVTM-LHRFVMVAFWCIQEDPSHRPTMRKVTQMLE 774
+ L + ++ +M W + + RP+ R + ++
Sbjct: 279 NGRLPRPDGCPDEIYM-IMTECW--NNNVNQRPSFRDLALRVD 318
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333 | Back alignment and structure |
|---|
Score = 141 bits (357), Expect = 4e-37
Identities = 70/292 (23%), Positives = 133/292 (45%), Gaps = 44/292 (15%)
Query: 505 FKEELGRGAFGTVYKGFVNMGSSNH---VAVKKLNSVFQDSEK-EFKAEVNGIGQTHHKN 560
++ +G G FG VYKG + S VA+K L + + + ++ +F E +GQ H N
Sbjct: 48 RQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHN 107
Query: 561 LVRLLGYCDEGQNRLLVYEFMSNGTVASFLFGDSKPNWKLRTEIAM--GIAGGLFYLHEE 618
++RL G + + +++ E+M NG + FL + + + + M GIA G+ YL
Sbjct: 108 IIRLEGVISKYKPMMIITEYMENGALDKFL-REKDGEFSVLQLVGMLRGIAAGMKYLANM 166
Query: 619 CCTQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLDQSHTNTAIRGTKGYV---APEWF 675
+H D+ +NIL++ + ++SDFGL+++L D T T G K + APE
Sbjct: 167 NY---VHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTT-SGGKIPIRWTAPEAI 222
Query: 676 RNMPITVKVDVYSYGVLLLEIICLRR----NIDNE--ISKVDKAILTDWAYDRYQERTLE 729
T DV+S+G+++ E++ + N + ++ R
Sbjct: 223 SYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAINDG-----------FR--- 268
Query: 730 ALVENDLEAMNNVT-MLHRFVMVAFWCIQEDPSHRPTMRKVTQMLEGVVEVP 780
L + +++ +M+ W Q++ + RP + +L+ ++ P
Sbjct: 269 ------LPTPMDCPSAIYQ-LMMQCW--QQERARRPKFADIVSILDKLIRAP 311
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310 | Back alignment and structure |
|---|
Score = 140 bits (355), Expect = 4e-37
Identities = 61/284 (21%), Positives = 110/284 (38%), Gaps = 48/284 (16%)
Query: 507 EELGRGAFGTVYKGFVNMGSSNHVAVKKLNSVFQDSEKEFKA---EVNGIGQTHHKNLVR 563
+++GRG F VY+ + VA+KK+ K E++ + Q +H N+++
Sbjct: 38 KKIGRGQFSEVYRAA-CLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIK 96
Query: 564 LLGYCDEGQNRLLVYEFMSNGTVASFL--FGDSKPN------WKLRTEIAMGIAGGLFYL 615
E +V E G ++ + F K WK ++ L ++
Sbjct: 97 YYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSA----LEHM 152
Query: 616 HEECCTQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLDQSHTNTAIRGTKGYVAPEWF 675
H +++H DIKP N+ + ++ D GL + + + ++ + GT Y++PE
Sbjct: 153 HSR---RVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLV-GTPYYMSPERI 208
Query: 676 RNMPITVKVDVYSYGVLLLEIICLRR-------NIDNEISKVDKAILTDWAYDRYQERTL 728
K D++S G LL E+ L+ N+ + K+++ D Y E
Sbjct: 209 HENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEQCDYPPLPSDHYSEE-- 266
Query: 729 EALVENDLEAMNNVTMLHRFVMVAFWCIQEDPSHRPTMRKVTQM 772
L + V CI DP RP + V +
Sbjct: 267 ----------------LRQLVN---MCINPDPEKRPDVTYVYDV 291
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302 | Back alignment and structure |
|---|
Score = 139 bits (352), Expect = 9e-37
Identities = 68/291 (23%), Positives = 123/291 (42%), Gaps = 30/291 (10%)
Query: 505 FKEELGRGAFGTVYKGFVNMGSSN---HVAVKKLNSVFQDSE-KEFKAEVNGIGQTHHKN 560
+LG G FG V + N VAVK L + + K E+ + +H+N
Sbjct: 25 RIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHEN 84
Query: 561 LVRLLGYC--DEGQNRLLVYEFMSNGTVASFLFGDSKPNWKLRT--EIAMGIAGGLFYLH 616
+V+ G C D G L+ EF+ +G++ +L +K L+ + A+ I G+ YL
Sbjct: 85 IVKYKGICTEDGGNGIKLIMEFLPSGSLKEYL-PKNKNKINLKQQLKYAVQICKGMDYLG 143
Query: 617 EECCTQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLDQSHTNTAIRGTKGYV---APE 673
+H D+ +N+L++ + +I DFGL K + D+ + T V APE
Sbjct: 144 SRQY---VHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYY-TVKDDRDSPVFWYAPE 199
Query: 674 WFRNMPITVKVDVYSYGVLLLEIICLRRNIDNEISKVDKAILTDWAYDRYQERTLEALVE 733
+ DV+S+GV L E++ + A+ + + T+ LV
Sbjct: 200 CLMQSKFYIASDVWSFGVTLHELLTY-----CDSDSSPMALFLKMIGPTHGQMTVTRLVN 254
Query: 734 ND-----LEAMNNVTM-LHRFVMVAFWCIQEDPSHRPTMRKVTQMLEGVVE 778
L N +++ +M W + PS+R + + + + E +++
Sbjct: 255 TLKEGKRLPCPPNCPDEVYQ-LMRKCW--EFQPSNRTSFQNLIEGFEALLK 302
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325 | Back alignment and structure |
|---|
Score = 139 bits (353), Expect = 1e-36
Identities = 71/291 (24%), Positives = 134/291 (46%), Gaps = 43/291 (14%)
Query: 505 FKEELGRGAFGTVYKGFVNMGSSNH--VAVKKLNSVFQDSEK-EFKAEVNGIGQTHHKNL 561
++ +G G G V G + + VA+K L + + + ++ +F +E + +GQ H N+
Sbjct: 53 IEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNI 112
Query: 562 VRLLGYCDEGQNRLLVYEFMSNGTVASFLFGDSKPNWKLRTEIAM--GIAGGLFYLHEEC 619
+RL G G+ ++V E+M NG++ +FL + + + M G+ G+ YL +
Sbjct: 113 IRLEGVVTRGRLAMIVTEYMENGSLDTFL-RTHDGQFTIMQLVGMLRGVGAGMRYLSDLG 171
Query: 620 CTQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLDQSHTNTAIRGTKGYV---APEWFR 676
+H D+ +N+L+D + ++SDFGL+++L D G K + APE
Sbjct: 172 Y---VHRDLAARNVLVDSNLVCKVSDFGLSRVLE-DDPDAAYTTTGGKIPIRWTAPEAIA 227
Query: 677 NMPITVKVDVYSYGVLLLEIICLRR----NIDNE--ISKVDKAILTDWAYDRYQERTLEA 730
+ DV+S+GV++ E++ N+ N IS V++ R
Sbjct: 228 FRTFSSASDVWSFGVVMWEVLAYGERPYWNMTNRDVISSVEEG-----------YR---- 272
Query: 731 LVENDLEAMNN-VTMLHRFVMVAFWCIQEDPSHRPTMRKVTQMLEGVVEVP 780
L A LH+ +M+ W +D + RP ++ +L+ ++ P
Sbjct: 273 -----LPAPMGCPHALHQ-LMLDCW--HKDRAQRPRFSQIVSVLDALIRSP 315
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267 | Back alignment and structure |
|---|
Score = 137 bits (347), Expect = 2e-36
Identities = 71/284 (25%), Positives = 124/284 (43%), Gaps = 35/284 (12%)
Query: 505 FKEELGRGAFGTVYKGFVNMGSSNHVAVKKLNSVFQDSEKEFKAEVNGIGQTHHKNLVRL 564
F +E+G G FG V+ G+ + + VA+K + E++F E + + H LV+L
Sbjct: 12 FVQEIGSGQFGLVHLGYWL--NKDKVAIKTIREGAMS-EEDFIEEAEVMMKLSHPKLVQL 68
Query: 565 LGYCDEGQNRLLVYEFMSNGTVASFL-FGDSKPNWKLRTEIAMGIAGGLFYLHEECCTQI 623
G C E LV EFM +G ++ +L + + + + G+ YL E C
Sbjct: 69 YGVCLEQAPICLVTEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACV--- 125
Query: 624 IHCDIKPQNILLDDHYNARISDFGLAKLLTLDQSHTNTAIRGTKGYV---APEWFRNMPI 680
IH D+ +N L+ ++ ++SDFG+ + + DQ T+ GTK V +PE F
Sbjct: 126 IHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQ---YTSSTGTKFPVKWASPEVFSFSRY 182
Query: 681 TVKVDVYSYGVLLLEIICLRRNIDNEISKVDKAILTDWAYDRYQERTLEALVEND--LEA 738
+ K DV+S+GVL+ E+ + Y+ + + L
Sbjct: 183 SSKSDVWSFGVLMWEVFSEGKI----------------PYENRSNSEVVEDISTGFRLYK 226
Query: 739 MNNV-TMLHRFVMVAFWCIQEDPSHRPTMRKVTQMLEGVVEVPI 781
T +++ +M W +E P RP ++ + L + E +
Sbjct: 227 PRLASTHVYQ-IMNHCW--RERPEDRPAFSRLLRQLAEIAESGL 267
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325 | Back alignment and structure |
|---|
Score = 138 bits (351), Expect = 2e-36
Identities = 67/292 (22%), Positives = 114/292 (39%), Gaps = 46/292 (15%)
Query: 505 FKEELGRGAFGTVYKGFVNMGSSN---HVAVKKLNSVFQD-SEKEFKAEVNGIGQTHHKN 560
+ LG G FGTV+KG + V +K + S + + IG H +
Sbjct: 17 KLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAH 76
Query: 561 LVRLLGYCDEGQNRLLVYEFMSNGTVASFLFGDSKPNWKLRT--EIAMGIAGGLFYLHEE 618
+VRLLG C G + LV +++ G++ + + + + IA G++YL E
Sbjct: 77 IVRLLGLC-PGSSLQLVTQYLPLGSLLDHV-RQHRGALGPQLLLNWGVQIAKGMYYLEEH 134
Query: 619 CCTQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLDQSHTNTAIRGTKGYV---APEWF 675
+H ++ +N+LL +++DFG+A LL D K + A E
Sbjct: 135 GM---VHRNLAARNVLLKSPSQVQVADFGVADLLPPDDKQLLY--SEAKTPIKWMALESI 189
Query: 676 RNMPITVKVDVYSYGVLLLEIICLRR----NIDNE--ISKVDKAILTDWAYDRYQERTLE 729
T + DV+SYGV + E++ + ++K ER
Sbjct: 190 HFGKYTHQSDVWSYGVTVWELMTFGAEPYAGLRLAEVPDLLEKG-----------ER--- 235
Query: 730 ALVENDLEAMNNVTM-LHRFVMVAFWCIQEDPSHRPTMRKVTQMLEGVVEVP 780
L T+ ++ VMV W D + RPT +++ + P
Sbjct: 236 ------LAQPQICTIDVYM-VMVKCW--MIDENIRPTFKELANEFTRMARDP 278
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373 | Back alignment and structure |
|---|
Score = 140 bits (354), Expect = 2e-36
Identities = 75/291 (25%), Positives = 135/291 (46%), Gaps = 43/291 (14%)
Query: 505 FKEELGRGAFGTVYKGFVNMGSSNH--VAVKKLNSVFQDSEK-EFKAEVNGIGQTHHKNL 561
+ +G G FG V G + + S VA+K L + + ++ +F E + +GQ H N+
Sbjct: 49 IDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNI 108
Query: 562 VRLLGYCDEGQNRLLVYEFMSNGTVASFLFGDSKPNWKLRTEIAM--GIAGGLFYLHEEC 619
+RL G + + ++V E+M NG++ SFL + + + M GIA G+ YL +
Sbjct: 109 IRLEGVVTKSKPVMIVTEYMENGSLDSFL-RKHDAQFTVIQLVGMLRGIASGMKYLSDMG 167
Query: 620 CTQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLDQSHTNTAIRGTKGYV---APEWFR 676
+H D+ +NIL++ + ++SDFGL ++L D RG K + +PE
Sbjct: 168 Y---VHRDLAARNILINSNLVCKVSDFGLGRVLE-DDPEAAYTTRGGKIPIRWTSPEAIA 223
Query: 677 NMPITVKVDVYSYGVLLLEIICLRR----NIDNE--ISKVDKAILTDWAYDRYQERTLEA 730
T DV+SYG++L E++ + N+ I VD+ R
Sbjct: 224 YRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQDVIKAVDEG-----------YR---- 268
Query: 731 LVENDLEAMNN-VTMLHRFVMVAFWCIQEDPSHRPTMRKVTQMLEGVVEVP 780
L + L++ +M+ W Q+D ++RP ++ +L+ ++ P
Sbjct: 269 -----LPPPMDCPAALYQ-LMLDCW--QKDRNNRPKFEQIVSILDKLIRNP 311
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288 | Back alignment and structure |
|---|
Score = 137 bits (348), Expect = 2e-36
Identities = 78/284 (27%), Positives = 128/284 (45%), Gaps = 35/284 (12%)
Query: 505 FKEELGRGAFGTVYKGFVNMGSSNHVAVKKLNSVFQDSEKEFKAEVNGIGQTHHKNLVRL 564
K +LG G +G VY+G S VAVK L + E EF E + + H NLV+L
Sbjct: 17 MKHKLGGGQYGEVYEGVWK-KYSLTVAVKTLKEDTMEVE-EFLKEAAVMKEIKHPNLVQL 74
Query: 565 LGYCDEGQNRLLVYEFMSNGTVASFLFGDSKPNWKLRTEIAM--GIAGGLFYLHEECCTQ 622
LG C ++ EFM+ G + +L ++ + M I+ + YL ++
Sbjct: 75 LGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNF-- 132
Query: 623 IIHCDIKPQNILLDDHYNARISDFGLAKLLTLDQSHTNTAIRGTKGYV---APEWFRNMP 679
IH D+ +N L+ +++ +++DFGL++L+T D TA G K + APE
Sbjct: 133 -IHRDLAARNCLVGENHLVKVADFGLSRLMTGDT---YTAHAGAKFPIKWTAPESLAYNK 188
Query: 680 ITVKVDVYSYGVLLLEIICLRRNIDNEISKVDKAILTDWAYDRYQERTLEALVEND--LE 737
++K DV+++GVLL EI + Y + L+E D +E
Sbjct: 189 FSIKSDVWAFGVLLWEIATYGMS----------------PYPGIDLSQVYELLEKDYRME 232
Query: 738 AMNNV-TMLHRFVMVAFWCIQEDPSHRPTMRKVTQMLEGVVEVP 780
++ +M A W Q +PS RP+ ++ Q E + +
Sbjct: 233 RPEGCPEKVYE-LMRACW--QWNPSDRPSFAEIHQAFETMFQES 273
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291 | Back alignment and structure |
|---|
Score = 136 bits (346), Expect = 4e-36
Identities = 76/280 (27%), Positives = 118/280 (42%), Gaps = 41/280 (14%)
Query: 508 ELGRGAFGTVYKGFVNMGSSN-HVAVK--KLNSVFQDSEKEFKAEVNGIGQTHHKNLVRL 564
ELG G FGTV KG+ M VAVK K + + E AE N + Q + +VR+
Sbjct: 24 ELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRM 83
Query: 565 LGYCDEGQNRLLVYEFMSNGTVASFLFGDSKPNWKLRTEIAMGIAGGLFYLHEECCTQII 624
+G C E ++ +LV E G + +L + K E+ ++ G+ YL E +
Sbjct: 84 IGIC-EAESWMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNF---V 139
Query: 625 HCDIKPQNILLDDHYNARISDFGLAKLLTLDQSHTNTAIRGTKGYV---APEWFRNMPIT 681
H D+ +N+LL + A+ISDFGL+K L D+++ A K V APE +
Sbjct: 140 HRDLAARNVLLVTQHYAKISDFGLSKALRADENYY-KAQTHGKWPVKWYAPECINYYKFS 198
Query: 682 VKVDVYSYGVLLLEIICLRR----NIDNE--ISKVDKAILTDWAYDRYQERTLEALVEND 735
K DV+S+GVL+ E + + + ++K ER
Sbjct: 199 SKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKG-----------ER--------- 238
Query: 736 LEAMNNVTM-LHRFVMVAFWCIQEDPSHRPTMRKVTQMLE 774
+ ++ +M W D +RP V L
Sbjct: 239 MGCPAGCPREMYD-LMNLCW--TYDVENRPGFAAVELRLR 275
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452 | Back alignment and structure |
|---|
Score = 141 bits (356), Expect = 5e-36
Identities = 74/279 (26%), Positives = 122/279 (43%), Gaps = 39/279 (13%)
Query: 505 FKEELGRGAFGTVYKGFVNMGSSNHVAVKKLNSVFQDSEKEFKAEVNGIGQTHHKNLVRL 564
+ +LG+G FG V+ G N + VA+K L E F E + + H+ LV+L
Sbjct: 188 LEVKLGQGCFGEVWMGTWNG--TTRVAIKTLKPGTMSPEA-FLQEAQVMKKLRHEKLVQL 244
Query: 565 LGYCDEGQNRLLVYEFMSNGTVASFLFGDSKPNWKLRT--EIAMGIAGGLFYLHEECCTQ 622
E + +V E+MS G++ FL G++ +L ++A IA G+ Y+
Sbjct: 245 YAVVSE-EPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNY-- 301
Query: 623 IIHCDIKPQNILLDDHYNARISDFGLAKLLTLDQ----SHTNTAIRGTKGYVAPEWFRNM 678
+H D++ NIL+ ++ +++DFGLA+L+ ++ I+ T APE
Sbjct: 302 -VHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWT----APEAALYG 356
Query: 679 PITVKVDVYSYGVLLLEIICLRRNIDNEISKVDKAILTDWAYDRYQERTLEALVEND--L 736
T+K DV+S+G+LL E+ R Y R + VE +
Sbjct: 357 RFTIKSDVWSFGILLTELTTKGRV----------------PYPGMVNREVLDQVERGYRM 400
Query: 737 EAMNNV-TMLHRFVMVAFWCIQEDPSHRPTMRKVTQMLE 774
LH +M W +++P RPT + LE
Sbjct: 401 PCPPECPESLHD-LMCQCW--RKEPEERPTFEYLQAFLE 436
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279 | Back alignment and structure |
|---|
Score = 136 bits (344), Expect = 6e-36
Identities = 65/281 (23%), Positives = 112/281 (39%), Gaps = 39/281 (13%)
Query: 507 EELGRGAFGTVYKGFVNMGSSNHVAVKKLN-SVFQDSEKEF-KAEVNGIGQTHHKNLVRL 564
+G G++G K + K+L+ ++EK+ +EVN + + H N+VR
Sbjct: 12 YTIGTGSYGRCQKI-RRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRY 70
Query: 565 LG-YCDEGQNRL-LVYEFMSNGTVASFLFGDSKPNWKLRTEIAMG----IAGGLFYLHE- 617
D L +V E+ G +AS + +K L E + + L H
Sbjct: 71 YDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRR 130
Query: 618 -ECCTQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLDQSHTNTAIRGTKGYVAPEWFR 676
+ ++H D+KP N+ LD N ++ DFGLA++L D S T + GT Y++PE
Sbjct: 131 SDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKTFV-GTPYYMSPEQMN 189
Query: 677 NMPITVKVDVYSYGVLLLEIICLRR-----NIDNEISKVDKAILTDWAYDRYQERTLEAL 731
M K D++S G LL E+ L + K+ + RY + L +
Sbjct: 190 RMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIREGKFRRIP-YRYSDE-LNEI 247
Query: 732 VENDLEAMNNVTMLHRFVMVAFWCIQEDPSHRPTMRKVTQM 772
+ + HRP++ ++ +
Sbjct: 248 IT--------------------RMLNLKDYHRPSVEEILEN 268
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535 | Back alignment and structure |
|---|
Score = 142 bits (359), Expect = 7e-36
Identities = 72/282 (25%), Positives = 122/282 (43%), Gaps = 45/282 (15%)
Query: 505 FKEELGRGAFGTVYKGFVNMGSSNHVAVKKLNSVFQDSEKEFKAEVNGIGQTHHKNLVRL 564
+ +LG+G FG V+ G N + VA+K L E F E + + H+ LV+L
Sbjct: 271 LEVKLGQGCFGEVWMGTWN--GTTRVAIKTLKPGTMSPEA-FLQEAQVMKKLRHEKLVQL 327
Query: 565 LGYCDEGQNRLLVYEFMSNGTVASFLFGDSKPNWKLRT--EIAMGIAGGLFYLHEECCTQ 622
E + +V E+MS G++ FL G++ +L ++A IA G+ Y+
Sbjct: 328 YAVVSE-EPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNY-- 384
Query: 623 IIHCDIKPQNILLDDHYNARISDFGLAKLLTLDQ----SHTNTAIRGTKGYVAPEWFRNM 678
+H D++ NIL+ ++ +++DFGLA+L+ ++ I+ T APE
Sbjct: 385 -VHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWT----APEAALYG 439
Query: 679 PITVKVDVYSYGVLLLEIICLRR----NIDNEISKVDKAILTDWAYDRYQERTLEALVEN 734
T+K DV+S+G+LL E+ R + N L+ +
Sbjct: 440 RFTIKSDVWSFGILLTELTTKGRVPYPGMVN-------------------REVLDQVERG 480
Query: 735 D-LEAMNNV-TMLHRFVMVAFWCIQEDPSHRPTMRKVTQMLE 774
+ LH +M W +++P RPT + LE
Sbjct: 481 YRMPCPPECPESLHD-LMCQCW--RKEPEERPTFEYLQAFLE 519
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454 | Back alignment and structure |
|---|
Score = 140 bits (355), Expect = 7e-36
Identities = 72/281 (25%), Positives = 120/281 (42%), Gaps = 43/281 (15%)
Query: 505 FKEELGRGAFGTVYKGFVNMGSSNHVAVKKLNSVFQDSEKEFKAEVNGIGQTHHKNLVRL 564
+++LG G FG V+ N VAVK + + F AE N + H LV+L
Sbjct: 192 LEKKLGAGQFGEVWMATYN--KHTKVAVKTMKPGSMS-VEAFLAEANVMKTLQHDKLVKL 248
Query: 565 LGYCDEGQNRLLVYEFMSNGTVASFLFGDSKPNWKLRT--EIAMGIAGGLFYLHEECCTQ 622
+ + ++ EFM+ G++ FL D L + + IA G+ ++ +
Sbjct: 249 HAVVTK-EPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRNY-- 305
Query: 623 IIHCDIKPQNILLDDHYNARISDFGLAKLLTLDQSHTNTAIRGTKGYV---APEWFRNMP 679
IH D++ NIL+ +I+DFGLA+++ ++ TA G K + APE
Sbjct: 306 -IHRDLRAANILVSASLVCKIADFGLARVIEDNE---YTAREGAKFPIKWTAPEAINFGS 361
Query: 680 ITVKVDVYSYGVLLLEIICLRR----NIDNEISKVDKAILTDWAYDRYQERTLEALVEND 735
T+K DV+S+G+LL+EI+ R + N + AL
Sbjct: 362 FTIKSDVWSFGILLMEIVTYGRIPYPGMSN-------------------PEVIRALERGY 402
Query: 736 -LEAMNNV-TMLHRFVMVAFWCIQEDPSHRPTMRKVTQMLE 774
+ N L+ +M+ W + P RPT + +L+
Sbjct: 403 RMPRPENCPEELYN-IMMRCW--KNRPEERPTFEYIQSVLD 440
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318 | Back alignment and structure |
|---|
Score = 136 bits (345), Expect = 1e-35
Identities = 68/282 (24%), Positives = 118/282 (41%), Gaps = 22/282 (7%)
Query: 505 FKEELGRGAFGTVYKGFVNM---GSSNHVAVKKLNSVFQDSE-KEFKAEVNGIGQTHHKN 560
+LG G FG V + G+ VAVK L + +K E++ + +H++
Sbjct: 35 KIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEH 94
Query: 561 LVRLLGYC--DEGQNRLLVYEFMSNGTVASFLFGDSKPNWKLRTEIAMGIAGGLFYLHEE 618
+++ G C + LV E++ G++ +L S +L A I G+ YLH +
Sbjct: 95 IIKYKGCCEDAGAASLQLVMEYVPLGSLRDYLPRHSIGLAQL-LLFAQQICEGMAYLHAQ 153
Query: 619 CCTQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLDQSHTNTAIRGTKGYV---APEWF 675
IH D+ +N+LLD+ +I DFGLAK + + V APE
Sbjct: 154 HY---IHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYY-RVREDGDSPVFWYAPECL 209
Query: 676 RNMPITVKVDVYSYGVLLLEIICLRRNIDNEISKVDKAILTDWAYDRYQERTLEALVEND 735
+ DV+S+GV L E++ + + +K + I + L L+E
Sbjct: 210 KEYKFYYASDVWSFGVTLYELLTHCDSSQSPPTKFLELIGIA--QGQMTVLRLTELLERG 267
Query: 736 --LEAMNNVTM-LHRFVMVAFWCIQEDPSHRPTMRKVTQMLE 774
L + ++ +M W + + S RPT + +L+
Sbjct: 268 ERLPRPDKCPAEVYH-LMKNCW--ETEASFRPTFENLIPILK 306
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450 | Back alignment and structure |
|---|
Score = 140 bits (354), Expect = 1e-35
Identities = 69/279 (24%), Positives = 120/279 (43%), Gaps = 43/279 (15%)
Query: 505 FKEELGRGAFGTVYKGFVNMGSSNHVAVKKLNSVFQDSEKEFKAEVNGIGQTHHKNLVRL 564
+ +G+G FG V G N VAVK + + + + F AE + + Q H NLV+L
Sbjct: 197 LLQTIGKGEFGDVMLGDYR---GNKVAVKCIKN--DATAQAFLAEASVMTQLRHSNLVQL 251
Query: 565 LGYCDEGQNRL-LVYEFMSNGTVASFLFGDSKPNWKLRT--EIAMGIAGGLFYLHEECCT 621
LG E + L +V E+M+ G++ +L + + ++ + + YL
Sbjct: 252 LGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNF- 310
Query: 622 QIIHCDIKPQNILLDDHYNARISDFGLAKLLTLDQSHTNTAIRGTKGYVAPEWFRNMPIT 681
+H D+ +N+L+ + A++SDFGL K + Q ++ T APE R +
Sbjct: 311 --VHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKLPVKWT----APEALREKKFS 364
Query: 682 VKVDVYSYGVLLLEIICLRR----NIDNEISKVDKAILTDWAYDRYQERTLEALVEND-L 736
K DV+S+G+LL EI R I + + + + +
Sbjct: 365 TKSDVWSFGILLWEIYSFGRVPYPRIPL-------------------KDVVPRVEKGYKM 405
Query: 737 EAMNNV-TMLHRFVMVAFWCIQEDPSHRPTMRKVTQMLE 774
+A + ++ VM W D + RPT ++ + LE
Sbjct: 406 DAPDGCPPAVYD-VMKNCW--HLDAATRPTFLQLREQLE 441
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283 | Back alignment and structure |
|---|
Score = 135 bits (342), Expect = 1e-35
Identities = 64/285 (22%), Positives = 118/285 (41%), Gaps = 43/285 (15%)
Query: 505 FKEELGRGAFGTVYKGFVNMGSSNHVAVKKLNSVFQDSEKEFKAEVNGIGQTHHKNLVRL 564
F +ELG G FG V G VA+K + E EF E + H+ LV+L
Sbjct: 28 FLKELGTGQFGVVKYGKWR--GQYDVAIKMIKEGSMS-EDEFIEEAKVMMNLSHEKLVQL 84
Query: 565 LGYCDEGQNRLLVYEFMSNGTVASFL-FGDSKPNWKLRTEIAMGIAGGLFYLHEECCTQI 623
G C + + ++ E+M+NG + ++L + + E+ + + YL +
Sbjct: 85 YGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQF--- 141
Query: 624 IHCDIKPQNILLDDHYNARISDFGLAKLLTLDQSHTNTAIRGTKGYV---APEWFRNMPI 680
+H D+ +N L++D ++SDFGL++ + D+ T+ G+K V PE
Sbjct: 142 LHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDE---YTSSVGSKFPVRWSPPEVLMYSKF 198
Query: 681 TVKVDVYSYGVLLLEIICLRR----NIDNE--ISKVDKAILTDWAYDRYQERTLEALVEN 734
+ K D++++GVL+ EI L + N + + +
Sbjct: 199 SSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQ---------GLR---------- 239
Query: 735 DLEAMNNV-TMLHRFVMVAFWCIQEDPSHRPTMRKVTQMLEGVVE 778
L + ++ +M + W E RPT + + + V++
Sbjct: 240 -LYRPHLASEKVYT-IMYSCW--HEKADERPTFKILLSNILDVMD 280
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268 | Back alignment and structure |
|---|
Score = 135 bits (341), Expect = 1e-35
Identities = 69/281 (24%), Positives = 115/281 (40%), Gaps = 43/281 (15%)
Query: 505 FKEELGRGAFGTVYKGFVNMGSSNHVAVKKLNSVFQDSEKEFKAEVNGIGQTHHKNLVRL 564
+ELG G FG V G VAVK + + EF E + + H LV+
Sbjct: 12 LLKELGSGQFGVVKLGKWK--GQYDVAVKMIKEGSMSED-EFFQEAQTMMKLSHPKLVKF 68
Query: 565 LGYCDEGQNRLLVYEFMSNGTVASFL-FGDSKPNWKLRTEIAMGIAGGLFYLHEECCTQI 623
G C + +V E++SNG + ++L E+ + G+ +L
Sbjct: 69 YGVCSKEYPIYIVTEYISNGCLLNYLRSHGKGLEPSQLLEMCYDVCEGMAFLESHQF--- 125
Query: 624 IHCDIKPQNILLDDHYNARISDFGLAKLLTLDQSHTNTAIRGTKGYV---APEWFRNMPI 680
IH D+ +N L+D ++SDFG+ + + DQ + GTK V APE F
Sbjct: 126 IHRDLAARNCLVDRDLCVKVSDFGMTRYVLDDQ---YVSSVGTKFPVKWSAPEVFHYFKY 182
Query: 681 TVKVDVYSYGVLLLEIICLRR----NIDNE--ISKVDKAILTDWAYDRYQERTLEALVEN 734
+ K DV+++G+L+ E+ L + N + KV + R
Sbjct: 183 SSKSDVWAFGILMWEVFSLGKMPYDLYTNSEVVLKVSQG-----------HR-------- 223
Query: 735 DLEAMNNV-TMLHRFVMVAFWCIQEDPSHRPTMRKVTQMLE 774
L + +++ +M + W E P RPT +++ +E
Sbjct: 224 -LYRPHLASDTIYQ-IMYSCW--HELPEKRPTFQQLLSSIE 260
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291 | Back alignment and structure |
|---|
Score = 134 bits (340), Expect = 3e-35
Identities = 72/285 (25%), Positives = 112/285 (39%), Gaps = 41/285 (14%)
Query: 505 FKEELGRGAFGTVYKGFVNMGSSNH--VAVKKLNSVFQDSEK---EFKAEVNGIGQTHHK 559
E+LG G+FG V +G + S VAVK L + +F EVN + H+
Sbjct: 22 LLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHR 81
Query: 560 NLVRLLGYCDEGQNRLLVYEFMSNGTVASFLFGDSKPNWKLRT--EIAMGIAGGLFYLHE 617
NL+RL G +V E G++ L + ++ L T A+ +A G+ YL
Sbjct: 82 NLIRLYGVV-LTPPMKMVTELAPLGSLLDRL-RKHQGHFLLGTLSRYAVQVAEGMGYLES 139
Query: 618 ECCTQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLDQSHTNTAIRGTKGYV---APEW 674
+ IH D+ +N+LL +I DFGL + L + H K APE
Sbjct: 140 KRF---IHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHY-VMQEHRKVPFAWCAPES 195
Query: 675 FRNMPITVKVDVYSYGVLLLEIICLRR----NIDNEISKVDKAILTDWAYDRYQERTLEA 730
+ + D + +GV L E+ + ++ S++ I D+ ER
Sbjct: 196 LKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNG--SQILHKI------DKEGER---- 243
Query: 731 LVENDLEAMNNVTM-LHRFVMVAFWCIQEDPSHRPTMRKVTQMLE 774
L + ++ VMV W P RPT + L
Sbjct: 244 -----LPRPEDCPQDIYN-VMVQCW--AHKPEDRPTFVALRDFLL 280
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287 | Back alignment and structure |
|---|
Score = 134 bits (340), Expect = 3e-35
Identities = 71/283 (25%), Positives = 118/283 (41%), Gaps = 43/283 (15%)
Query: 506 KEELGRGAFGTVYKGFVNMGSSN-HVAVKKL-NSVFQDSEKEFKAEVNGIGQTHHKNLVR 563
ELG G FG+V +G M VA+K L + +E E + Q + +VR
Sbjct: 15 DIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVR 74
Query: 564 LLGYCDEGQNRLLVYEFMSNGTVASFL--FGDSKPNWKLRTEIAMGIAGGLFYLHEECCT 621
L+G C + + +LV E G + FL + P + E+ ++ G+ YL E+
Sbjct: 75 LIGVC-QAEALMLVMEMAGGGPLHKFLVGKREEIPVSNV-AELLHQVSMGMKYLEEKNF- 131
Query: 622 QIIHCDIKPQNILLDDHYNARISDFGLAKLLTLDQSHTNTAIRGTKGYV---APEWFRNM 678
+H D+ +N+LL + + A+ISDFGL+K L D S+ TA K + APE
Sbjct: 132 --VHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYY-TARSAGKWPLKWYAPECINFR 188
Query: 679 PITVKVDVYSYGVLLLEIICLRR----NIDNE--ISKVDKAILTDWAYDRYQERTLEALV 732
+ + DV+SYGV + E + + + ++ +++ +R
Sbjct: 189 KFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQG-----------KR------ 231
Query: 733 ENDLEAMNNVTM-LHRFVMVAFWCIQEDPSHRPTMRKVTQMLE 774
+E L+ +M W RP V Q +
Sbjct: 232 ---MECPPECPPELYA-LMSDCW--IYKWEDRPDFLTVEQRMR 268
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278 | Back alignment and structure |
|---|
Score = 134 bits (339), Expect = 3e-35
Identities = 71/276 (25%), Positives = 119/276 (43%), Gaps = 37/276 (13%)
Query: 505 FKEELGRGAFGTVYKGFVNMGSSNHVAVKKLNSVFQDSEKEFKAEVNGIGQTHHKNLVRL 564
+ +G+G FG V G N VAVK + + + + F AE + + Q H NLV+L
Sbjct: 25 LLQTIGKGEFGDVMLGDYR---GNKVAVKCIKN--DATAQAFLAEASVMTQLRHSNLVQL 79
Query: 565 LGYCDEGQNRL-LVYEFMSNGTVASFLFGDSKPNWKLRTEIAM--GIAGGLFYLHEECCT 621
LG E + L +V E+M+ G++ +L + + + + YL
Sbjct: 80 LGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNF- 138
Query: 622 QIIHCDIKPQNILLDDHYNARISDFGLAKLLTLDQSHTNTAIRGTKGYVAPEWFRNMPIT 681
+H D+ +N+L+ + A++SDFGL K + Q ++ T APE R +
Sbjct: 139 --VHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKLPVKWT----APEALREKKFS 192
Query: 682 VKVDVYSYGVLLLEIICLRRNIDNEISKVDKAILTDWAYDRYQERTLEALVEND--LEAM 739
K DV+S+G+LL EI R Y R + + VE ++A
Sbjct: 193 TKSDVWSFGILLWEIYSFGRV----------------PYPRIPLKDVVPRVEKGYKMDAP 236
Query: 740 NNV-TMLHRFVMVAFWCIQEDPSHRPTMRKVTQMLE 774
+ ++ VM W D + RP+ ++ + LE
Sbjct: 237 DGCPPAVYE-VMKNCW--HLDAAMRPSFLQLREQLE 269
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327 | Back alignment and structure |
|---|
Score = 135 bits (342), Expect = 3e-35
Identities = 72/292 (24%), Positives = 116/292 (39%), Gaps = 46/292 (15%)
Query: 505 FKEELGRGAFGTVYKGFVNMGSSN---HVAVKKLNSVFQDSEK-EFKAEVNGIGQTHHKN 560
+ LG GAFGTVYKG VA+K+L E E + + +
Sbjct: 19 KIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPH 78
Query: 561 LVRLLGYCDEGQNRLLVYEFMSNGTVASFLFGDSKPNWKLRTEIAM--GIAGGLFYLHEE 618
+ RLLG C L+ + M G + ++ + K N + + IA G+ YL +
Sbjct: 79 VCRLLGIC-LTSTVQLITQLMPFGCLLDYVR-EHKDNIGSQYLLNWCVQIAKGMNYLEDR 136
Query: 619 CCTQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLDQSHTNTAIRGTKGYV---APEWF 675
+H D+ +N+L+ + +I+DFGLAKLL ++ + G K + A E
Sbjct: 137 RL---VHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHA--EGGKVPIKWMALESI 191
Query: 676 RNMPITVKVDVYSYGVLLLEIICLRR----NIDNE--ISKVDKAILTDWAYDRYQERTLE 729
+ T + DV+SYGV + E++ I S ++K ER
Sbjct: 192 LHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKG-----------ER--- 237
Query: 730 ALVENDLEAMNNVTM-LHRFVMVAFWCIQEDPSHRPTMRKVTQMLEGVVEVP 780
L T+ ++ +MV W D RP R++ + P
Sbjct: 238 ------LPQPPICTIDVYM-IMVKCW--MIDADSRPKFRELIIEFSKMARDP 280
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289 | Back alignment and structure |
|---|
Score = 134 bits (339), Expect = 4e-35
Identities = 58/296 (19%), Positives = 104/296 (35%), Gaps = 62/296 (20%)
Query: 505 FKEELGRGAFGTVYKGFVNMGSSNH------VAVKKLNSVFQDSEKEFKAEVNGIGQTHH 558
F E LG+G F ++KG V +K L+ ++ + F + + + H
Sbjct: 12 FNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSH 71
Query: 559 KNLVRLLGYCDEGQNRLLVYEFMSNGTVASFL-FGDSKPNWKLRTEIAMGIAGGLFYLHE 617
K+LV G C G +LV EF+ G++ ++L + N + E+A +A + +L E
Sbjct: 72 KHLVLNYGVCVCGDENILVQEFVKFGSLDTYLKKNKNCINILWKLEVAKQLAAAMHFLEE 131
Query: 618 ECCTQIIHCDIKPQNILLDDHYNAR--------ISDFGLAKLLTLDQSHTNTAIRGTKGY 669
IH ++ +NILL + + +SD G++ + L + I
Sbjct: 132 NTL---IHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISITV-LPKDILQERIPWV--- 184
Query: 670 VAPEWFRNMPI-TVKVDVYSYGVLLLEIICLRRNIDNEISKVDKAILTDWAYDRYQERTL 728
PE N + D +S+G L EI
Sbjct: 185 -PPECIENPKNLNLATDKWSFGTTLWEICSG-------------------GDKPLSALDS 224
Query: 729 EALVENDLEAMNNVTMLHRF----------VMVAFWCIQEDPSHRPTMRKVTQMLE 774
+ + H+ ++ +P HRP+ R + + L
Sbjct: 225 Q-------RKLQFYEDRHQLPAPKAAELANLINNCM--DYEPDHRPSFRAIIRDLN 271
|
| >4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350 | Back alignment and structure |
|---|
Score = 135 bits (342), Expect = 5e-35
Identities = 61/310 (19%), Positives = 117/310 (37%), Gaps = 46/310 (14%)
Query: 476 MRPHQEDQGVSYMNLRCFTYKELVEVTRGFKEELGRGAFGTVYKGFVNMGSSNHVAVKKL 535
M H + ++ + + R +++G G+FG + +K++
Sbjct: 1 MHHHHHHSSGVDLGTENLYFQSMEKYVRL--QKIGEGSFGKAILVK-STEDGRQYVIKEI 57
Query: 536 NSVFQDSEKEFKA---EVNGIGQTHHKNLVRLLGYCDEGQNRLLVYEFMSNGTVASFLFG 592
N + + S KE + EV + H N+V+ +E + +V ++ G + +
Sbjct: 58 N-ISRMSSKEREESRREVAVLANMKHPNIVQYRESFEENGSLYIVMDYCEGGDLFKRI-- 114
Query: 593 DSKPNWKLRTE-----IAMGIAGGLFYLHEECCTQIIHCDIKPQNILLDDHYNARISDFG 647
+ L E + I L ++H+ +I+H DIK QNI L ++ DFG
Sbjct: 115 -NAQKGVLFQEDQILDWFVQICLALKHVHDR---KILHRDIKSQNIFLTKDGTVQLGDFG 170
Query: 648 LAKLLTLDQSHTNTAIRGTKGYVAPEWFRNMPITVKVDVYSYGVLLLEIICLRR-----N 702
+A++L I GT Y++PE N P K D+++ G +L E+ L+ +
Sbjct: 171 IARVLNSTVELARACI-GTPYYLSPEICENKPYNNKSDIWALGCVLYELCTLKHAFEAGS 229
Query: 703 IDNEISKVDKAILTDWAYDRYQERTLEALVENDLEAMNNVTMLHRFVMVAFWCIQEDPSH 762
+ N + K+ Y L V + +P
Sbjct: 230 MKNLVLKIISGSFPPV-SLHYSYD------------------LRSLVS---QLFKRNPRD 267
Query: 763 RPTMRKVTQM 772
RP++ + +
Sbjct: 268 RPSVNSILEK 277
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322 | Back alignment and structure |
|---|
Score = 134 bits (339), Expect = 9e-35
Identities = 79/325 (24%), Positives = 137/325 (42%), Gaps = 58/325 (17%)
Query: 487 YMNLRCFTYKELVEVTRG---FKEELGRGAFGTVYKGFVN----MGSSNHVAVKKLNSVF 539
Y + + EV R ELG+G+FG VY+G VA+K +N
Sbjct: 8 YFSAADVYVPDEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAA 67
Query: 540 QDSEK-EFKAEVNGIGQTHHKNLVRLLGYCDEGQNRLLVYEFMSNGTVASFL------FG 592
E+ EF E + + + + ++VRLLG +GQ L++ E M+ G + S+L
Sbjct: 68 SMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMA 127
Query: 593 DSKPNWKLR----TEIAMGIAGGLFYLHEECCTQIIHCDIKPQNILLDDHYNARISDFGL 648
++ ++A IA G+ YL+ +H D+ +N ++ + + +I DFG+
Sbjct: 128 NNPVLAPPSLSKMIQMAGEIADGMAYLNANKF---VHRDLAARNCMVAEDFTVKIGDFGM 184
Query: 649 AKLLTLDQSHTNTAIRGTKGYV-----APEWFRNMPITVKVDVYSYGVLLLEIICLRRNI 703
+ D T+ +G KG + +PE ++ T DV+S+GV+L EI L
Sbjct: 185 TR----DIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATL---- 236
Query: 704 DNEISKVDKAILTDWAYDRYQERTLEALVE-----NDLEAMNNV-TMLHRFVMVAFWCIQ 757
A YQ + E ++ L+ +N ML +M W Q
Sbjct: 237 ---------------AEQPYQGLSNEQVLRFVMEGGLLDKPDNCPDMLFE-LMRMCW--Q 278
Query: 758 EDPSHRPTMRKVTQMLEGVVEVPIP 782
+P RP+ ++ ++ +E
Sbjct: 279 YNPKMRPSFLEIISSIKEEMEPGFR 303
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327 | Back alignment and structure |
|---|
Score = 134 bits (339), Expect = 9e-35
Identities = 85/310 (27%), Positives = 125/310 (40%), Gaps = 58/310 (18%)
Query: 500 EVTRG---FKEELGRGAFGTVYKGFVN----MGSSNHVAVKKLNSVFQDSEK-EFKAEVN 551
EV R LG GAFG VY+G V+ S VAVK L V + ++ +F E
Sbjct: 26 EVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEAL 85
Query: 552 GIGQTHHKNLVRLLGYCDEGQNRLLVYEFMSNGTVASFL-------FGDSKPNWKLRTEI 604
I + +H+N+VR +G + R ++ E M+ G + SFL S +
Sbjct: 86 IISKFNHQNIVRCIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHV 145
Query: 605 AMGIAGGLFYLHEECCTQIIHCDIKPQNILLD---DHYNARISDFGLAKLLTLDQSHTNT 661
A IA G YL E IH DI +N LL A+I DFG+A+ D +
Sbjct: 146 ARDIACGCQYLEENHF---IHRDIAARNCLLTCPGPGRVAKIGDFGMAR----DIYRASY 198
Query: 662 AIRGTKGYV-----APEWFRNMPITVKVDVYSYGVLLLEIICLRRNIDNEISKVDKAILT 716
+G + PE F T K D +S+GVLL EI L
Sbjct: 199 YRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSL----------------- 241
Query: 717 DWAYDRYQERTLEALVE-----NDLEAMNNV-TMLHRFVMVAFWCIQEDPSHRPTMRKVT 770
Y Y ++ + ++E ++ N ++R +M W Q P RP +
Sbjct: 242 --GYMPYPSKSNQEVLEFVTSGGRMDPPKNCPGPVYR-IMTQCW--QHQPEDRPNFAIIL 296
Query: 771 QMLEGVVEVP 780
+ +E + P
Sbjct: 297 ERIEYCTQDP 306
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281 | Back alignment and structure |
|---|
Score = 132 bits (335), Expect = 1e-34
Identities = 64/285 (22%), Positives = 116/285 (40%), Gaps = 46/285 (16%)
Query: 505 FKEELGRGAFGTVYKGFVNM--GSSNHVAVKKLN-SVFQDSEKEFKAEVNGIGQTHHKNL 561
LG G FG VY+G G +VAVK D++++F +E + H ++
Sbjct: 16 LNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHI 75
Query: 562 VRLLGYCDEGQNRLLVYEFMSNGTVASFLFGDSKPNWKLRTEIAM--GIAGGLFYLHEEC 619
V+L+G +E + ++ E G + +L +K + K+ T + I + YL
Sbjct: 76 VKLIGIIEE-EPTWIIMELYPYGELGHYL-ERNKNSLKVLTLVLYSLQICKAMAYLESIN 133
Query: 620 CTQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLDQSHTNTAIRGTKGYV---APEWFR 676
C +H DI +NIL+ ++ DFGL++ + + T+ + +PE
Sbjct: 134 C---VHRDIAVRNILVASPECVKLGDFGLSRYI---EDEDYYKASVTRLPIKWMSPESIN 187
Query: 677 NMPITVKVDVYSYGVLLLEIICLRR----NIDNE--ISKVDKAILTDWAYDRYQERTLEA 730
T DV+ + V + EI+ + ++N+ I ++K +R
Sbjct: 188 FRRFTTASDVWMFAVCMWEILSFGKQPFFWLENKDVIGVLEKG-----------DR---- 232
Query: 731 LVENDLEAMNNVT-MLHRFVMVAFWCIQEDPSHRPTMRKVTQMLE 774
L + +L+ +M W DPS RP ++ L
Sbjct: 233 -----LPKPDLCPPVLYT-LMTRCW--DYDPSDRPRFTELVCSLS 269
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281 | Back alignment and structure |
|---|
Score = 132 bits (334), Expect = 2e-34
Identities = 67/291 (23%), Positives = 115/291 (39%), Gaps = 46/291 (15%)
Query: 505 FKEELGRGAFGTVYKGFVNMGSSNH--VAVKKLNSVFQDSEK-EFKAEVNGIGQTHHKNL 561
+G G FG V++G + VA+K + DS + +F E + Q H ++
Sbjct: 19 LGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHI 78
Query: 562 VRLLGYCDEGQNRLLVYEFMSNGTVASFLFGDSKPNWKLRTEIAM--GIAGGLFYLHEEC 619
V+L+G E ++ E + G + SFL K + L + I ++ L YL +
Sbjct: 79 VKLIGVITE-NPVWIIMELCTLGELRSFL-QVRKYSLDLASLILYAYQLSTALAYLESKR 136
Query: 620 CTQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLDQSHTNTAIRGTKGYV---APEWFR 676
+H DI +N+L+ + ++ DFGL++ + + T K + APE
Sbjct: 137 F---VHRDIAARNVLVSSNDCVKLGDFGLSRYM---EDSTYYKASKGKLPIKWMAPESIN 190
Query: 677 NMPITVKVDVYSYGVLLLEIICLRR----NIDNE--ISKVDKAILTDWAYDRYQERTLEA 730
T DV+ +GV + EI+ + N I +++ ER
Sbjct: 191 FRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENG-----------ER---- 235
Query: 731 LVENDLEAMNNVT-MLHRFVMVAFWCIQEDPSHRPTMRKVTQMLEGVVEVP 780
L N L+ +M W DPS RP ++ L ++E
Sbjct: 236 -----LPMPPNCPPTLYS-LMTKCW--AYDPSRRPRFTELKAQLSTILEEE 278
|
| >3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297 | Back alignment and structure |
|---|
Score = 132 bits (334), Expect = 3e-34
Identities = 68/321 (21%), Positives = 117/321 (36%), Gaps = 75/321 (23%)
Query: 500 EVTRG---FKEELGRGAFGTVYKGFVN----MGSSNHVAVKKLNSVFQDSEKEFKAEVNG 552
+ R K ELG GAFG V+ VAVK L + K+F+ E
Sbjct: 11 HIKRRDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAEL 70
Query: 553 IGQTHHKNLVRLLGYCDEGQNRLLVYEFMSNGTVASFLFGDSKPNWKLR----------- 601
+ H+++V+ G C +G ++V+E+M +G + FL L
Sbjct: 71 LTNLQHEHIVKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGEL 130
Query: 602 -----TEIAMGIAGGLFYLHEECCTQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLDQ 656
IA IA G+ YL + +H D+ +N L+ + +I DFG+++ +
Sbjct: 131 GLSQMLHIASQIASGMVYLASQHF---VHRDLATRNCLVGANLLVKIGDFGMSRDVYSTD 187
Query: 657 ---SHTNTA--IRGTKGYVAPEWFRNMPITVKVDVYSYGVLLLEIICLRRNIDNEISKVD 711
+T IR PE T + DV+S+GV+L EI
Sbjct: 188 YYRVGGHTMLPIRWM----PPESIMYRKFTTESDVWSFGVILWEIFTY------------ 231
Query: 712 KAILTDWAYDRYQERTLEALVENDLEAMNNVTMLHRF------------VMVAFWCIQED 759
+ + + E + +T VM+ W Q +
Sbjct: 232 -------GKQPWFQLSNT-------EVIECITQGRVLERPRVCPKEVYDVMLGCW--QRE 275
Query: 760 PSHRPTMRKVTQMLEGVVEVP 780
P R ++++ ++L + +
Sbjct: 276 PQQRLNIKEIYKILHALGKAT 296
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 131 bits (331), Expect = 4e-34
Identities = 81/281 (28%), Positives = 126/281 (44%), Gaps = 43/281 (15%)
Query: 505 FKEELGRGAFGTVYKGFVNMGSSNHVAVKKLNSVFQDSEKEFKAEVNGIGQTHHKNLVRL 564
E LG G FG V+ G+ N VAVK L + F AE N + Q H+ LVRL
Sbjct: 17 LVERLGAGQFGEVWMGYYN--GHTKVAVKSLKQGSMSPD-AFLAEANLMKQLQHQRLVRL 73
Query: 565 LGYCDEGQNRLLVYEFMSNGTVASFLFGDSKPNWKLRT--EIAMGIAGGLFYLHEECCTQ 622
+ + ++ E+M NG++ FL S + ++A IA G+ ++ E
Sbjct: 74 YAVVTQ-EPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNY-- 130
Query: 623 IIHCDIKPQNILLDDHYNARISDFGLAKLLTLDQSHTNTAIRGTKGYV---APEWFRNMP 679
IH D++ NIL+ D + +I+DFGLA+L+ ++ TA G K + APE
Sbjct: 131 -IHRDLRAANILVSDTLSCKIADFGLARLIEDNE---YTAREGAKFPIKWTAPEAINYGT 186
Query: 680 ITVKVDVYSYGVLLLEIICLRR----NIDNEISKVDKAILTDWAYDRYQERTLEALVEND 735
T+K DV+S+G+LL EI+ R + N ++ L
Sbjct: 187 FTIKSDVWSFGILLTEIVTHGRIPYPGMTN-------------------PEVIQNLERGY 227
Query: 736 -LEAMNNV-TMLHRFVMVAFWCIQEDPSHRPTMRKVTQMLE 774
+ +N L++ +M W +E P RPT + +LE
Sbjct: 228 RMVRPDNCPEELYQ-LMRLCW--KERPEDRPTFDYLRSVLE 265
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367 | Back alignment and structure |
|---|
Score = 133 bits (337), Expect = 4e-34
Identities = 84/310 (27%), Positives = 125/310 (40%), Gaps = 58/310 (18%)
Query: 500 EVTRG---FKEELGRGAFGTVYKGFVN----MGSSNHVAVKKLNSVFQDSEK-EFKAEVN 551
EV R LG GAFG VY+G V+ S VAVK L V + ++ +F E
Sbjct: 67 EVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEAL 126
Query: 552 GIGQTHHKNLVRLLGYCDEGQNRLLVYEFMSNGTVASFL-----FGDSKPNWKLR--TEI 604
I + +H+N+VR +G + R ++ E M+ G + SFL + + +
Sbjct: 127 IISKFNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHV 186
Query: 605 AMGIAGGLFYLHEECCTQIIHCDIKPQNILLD---DHYNARISDFGLAKLLTLDQSHTNT 661
A IA G YL E IH DI +N LL A+I DFG+A+ D
Sbjct: 187 ARDIACGCQYLEENHF---IHRDIAARNCLLTCPGPGRVAKIGDFGMAR----DIYRAGY 239
Query: 662 AIRGTKGYV-----APEWFRNMPITVKVDVYSYGVLLLEIICLRRNIDNEISKVDKAILT 716
+G + PE F T K D +S+GVLL EI L
Sbjct: 240 YRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSL----------------- 282
Query: 717 DWAYDRYQERTLEALVE-----NDLEAMNNV-TMLHRFVMVAFWCIQEDPSHRPTMRKVT 770
Y Y ++ + ++E ++ N ++R +M W Q P RP +
Sbjct: 283 --GYMPYPSKSNQEVLEFVTSGGRMDPPKNCPGPVYR-IMTQCW--QHQPEDRPNFAIIL 337
Query: 771 QMLEGVVEVP 780
+ +E + P
Sbjct: 338 ERIEYCTQDP 347
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329 | Back alignment and structure |
|---|
Score = 132 bits (334), Expect = 4e-34
Identities = 69/320 (21%), Positives = 119/320 (37%), Gaps = 74/320 (23%)
Query: 500 EVTRG---FKEELGRGAFGTVYKGFVN----MGSSNHVAVKKLNSVFQDSEKEFKAEVNG 552
+ R K ELG GAFG V+ + VAVK L + + ++F+ E
Sbjct: 37 HIKRRDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAEL 96
Query: 553 IGQTHHKNLVRLLGYCDEGQNRLLVYEFMSNGTVASFL---------------FGDSKPN 597
+ H+++VR G C EG+ L+V+E+M +G + FL
Sbjct: 97 LTMLQHQHIVRFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLG 156
Query: 598 WKLRTEIAMGIAGGLFYLHEECCTQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLDQS 657
+A +A G+ YL +H D+ +N L+ +I DFG+++ D
Sbjct: 157 LGQLLAVASQVAAGMVYLAGLHF---VHRDLATRNCLVGQGLVVKIGDFGMSR----DIY 209
Query: 658 HTNTAIRGTKGYV-----APEWFRNMPITVKVDVYSYGVLLLEIICLRRNIDNEISKVDK 712
T+ G + + PE T + DV+S+GV+L EI
Sbjct: 210 STDYYRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTY------------- 256
Query: 713 AILTDWAYDRYQERTLEALVENDLEAMNNVTMLHRF------------VMVAFWCIQEDP 760
+ + + EA++ +T +M W Q +P
Sbjct: 257 ------GKQPWYQLSNT-------EAIDCITQGRELERPRACPPEVYAIMRGCW--QREP 301
Query: 761 SHRPTMRKVTQMLEGVVEVP 780
R +++ V L+ + + P
Sbjct: 302 QQRHSIKDVHARLQALAQAP 321
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299 | Back alignment and structure |
|---|
Score = 130 bits (330), Expect = 8e-34
Identities = 54/298 (18%), Positives = 105/298 (35%), Gaps = 59/298 (19%)
Query: 507 EELGRGAFGTVYKGFVNMGSSNHVAVKKLNSVFQDSEKE-FKAEVNGIGQTHHKNLVRLL 565
+ LGRG FG V++ N + A+K++ ++ +E EV + + H +VR
Sbjct: 11 QCLGRGGFGVVFEA-KNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYF 69
Query: 566 GYCDEGQN---------RLLVY---EFMSNGTVASFLF---GDSKPNWKLRTEIAMGIAG 610
E ++ +Y + + ++ + + I + IA
Sbjct: 70 NAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAE 129
Query: 611 GLFYLHEECCTQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLDQSHTNTAIR------ 664
+ +LH + ++H D+KP NI ++ DFGL + D+
Sbjct: 130 AVEFLHSK---GLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYAR 186
Query: 665 -----GTKGYVAPEWFRNMPITVKVDVYSYGVLLLEIIC---LRRNIDNEISKVDKAILT 716
GTK Y++PE + KVD++S G++L E++ + ++ V
Sbjct: 187 HTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLYPFSTQMERVRTLTDVRNLKFP 246
Query: 717 DWAYDRYQERTLEALVENDLEAMNNVTMLHRFVMVAFWCIQEDPSHRPTMRKVTQMLE 774
+Y +V+ + P RP ++E
Sbjct: 247 PLFTQKYPC--EYVMVQ--------------------DMLSPSPMERPE---AINIIE 279
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284 | Back alignment and structure |
|---|
Score = 130 bits (328), Expect = 1e-33
Identities = 59/284 (20%), Positives = 109/284 (38%), Gaps = 56/284 (19%)
Query: 507 EELGRGAFGTVYKGFVNMGSSNHVAVKKLNSVFQDSEKEFKAEVNGIGQTHHKNLVRLLG 566
E +G G FG V+K + +K++ ++EK + EV + + H N+V G
Sbjct: 17 ELIGSGGFGQVFKA-KHRIDGKTYVIKRVK---YNNEKAER-EVKALAKLDHVNIVHYNG 71
Query: 567 YCDEGQNRLLVYEFMSNGTVASFLF--------GD-----SKPNWKLRTE-----IAMGI 608
D S+ + LF G K + + + I
Sbjct: 72 CWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALELFEQI 131
Query: 609 AGGLFYLHEECCTQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLDQSHTNTAIRGTKG 668
G+ Y+H + ++I+ D+KP NI L D +I DFGL L D T + GT
Sbjct: 132 TKGVDYIHSK---KLINRDLKPSNIFLVDTKQVKIGDFGLVTSLKNDGKRTRSK--GTLR 186
Query: 669 YVAPEWFRNMPITVKVDVYSYGVLLLEIICLRR---NIDNEISKVDKAILTDWAYDRYQE 725
Y++PE + +VD+Y+ G++L E++ + + + I+ D + +
Sbjct: 187 YMSPEQISSQDYGKEVDLYALGLILAELLHVCDTAFETSKFFTDLRDGII----SDIFDK 242
Query: 726 RTLEALVENDLEAMNNVTMLHRFVMVAFWCIQEDPSHRPTMRKV 769
+ + L++ + + P RP ++
Sbjct: 243 K-EKTLLQ--------------------KLLSKKPEDRPNTSEI 265
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298 | Back alignment and structure |
|---|
Score = 130 bits (328), Expect = 1e-33
Identities = 70/288 (24%), Positives = 122/288 (42%), Gaps = 39/288 (13%)
Query: 505 FKEELGRGAFGTVYKGFVNM--GSSNHVAVKKLNSVFQDSEK-EFKAEVNGIGQTHHKNL 561
F E +GRG FG VY G + G H AVK LN + E +F E + H N+
Sbjct: 29 FNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNV 88
Query: 562 VRLLGYCDEGQN-RLLVYEFMSNGTVASFLFGDSKPNWKLRT--EIAMGIAGGLFYLHEE 618
+ LLG C + L+V +M +G + +F+ + N ++ + +A G+ YL +
Sbjct: 89 LSLLGICLRSEGSPLVVLPYMKHGDLRNFIR-NETHNPTVKDLIGFGLQVAKGMKYLASK 147
Query: 619 CCTQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLDQSHTNTAIRGTKGYV---APEWF 675
+H D+ +N +LD+ + +++DFGLA+ + + ++ G K V A E
Sbjct: 148 KF---VHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESL 204
Query: 676 RNMPITVKVDVYSYGVLLLEIICLRR----NIDNEISKVDKAILTDWAYDRYQERTLEAL 731
+ T K DV+S+GVLL E++ +++ + +L R
Sbjct: 205 QTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTF--DITVYLLQG-------RR----- 250
Query: 732 VENDLEAMNNV-TMLHRFVMVAFWCIQEDPSHRPTMRKVTQMLEGVVE 778
L L+ VM+ W RP+ ++ + +
Sbjct: 251 ----LLQPEYCPDPLYE-VMLKCW--HPKAEMRPSFSELVSRISAIFS 291
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373 | Back alignment and structure |
|---|
Score = 131 bits (332), Expect = 2e-33
Identities = 68/288 (23%), Positives = 120/288 (41%), Gaps = 39/288 (13%)
Query: 505 FKEELGRGAFGTVYKGFVNMGSSN--HVAVKKLNSVFQDSEK-EFKAEVNGIGQTHHKNL 561
F E +GRG FG VY G + H AVK LN + E +F E + H N+
Sbjct: 93 FNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNV 152
Query: 562 VRLLGYCDEGQN-RLLVYEFMSNGTVASFLFGDSKPNWKLRT--EIAMGIAGGLFYLHEE 618
+ LLG C + L+V +M +G + +F+ + N ++ + +A G+ +L +
Sbjct: 153 LSLLGICLRSEGSPLVVLPYMKHGDLRNFIR-NETHNPTVKDLIGFGLQVAKGMKFLASK 211
Query: 619 CCTQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLDQSHTNTAIRGTKGYV---APEWF 675
+H D+ +N +LD+ + +++DFGLA+ + + + G K V A E
Sbjct: 212 KF---VHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESL 268
Query: 676 RNMPITVKVDVYSYGVLLLEIICLRR----NIDNEISKVDKAILTDWAYDRYQERTLEAL 731
+ T K DV+S+GVLL E++ +++ + +L R
Sbjct: 269 QTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTF--DITVYLLQG-------RR----- 314
Query: 732 VENDLEA-MNNVTMLHRFVMVAFWCIQEDPSHRPTMRKVTQMLEGVVE 778
L L+ VM+ W RP+ ++ + +
Sbjct: 315 ----LLQPEYCPDPLYE-VMLKCW--HPKAEMRPSFSELVSRISAIFS 355
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 129 bits (326), Expect = 2e-33
Identities = 68/289 (23%), Positives = 123/289 (42%), Gaps = 41/289 (14%)
Query: 505 FKEELGRGAFGTVYKGFVNMGSSN--HVAVKKLNSVFQDSEK-EFKAEVNGIGQTHHKNL 561
+G+G FG VY G + N A+K L+ + + + F E + +H N+
Sbjct: 25 SDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNV 84
Query: 562 VRLLGYCDEGQNRLL-VYEFMSNGTVASFLFGDSKPNWKLRTEIAMG--IAGGLFYLHEE 618
+ L+G + + +M +G + F+ + N ++ I+ G +A G+ YL E+
Sbjct: 85 LALIGIMLPPEGLPHVLLPYMCHGDLLQFIR-SPQRNPTVKDLISFGLQVARGMEYLAEQ 143
Query: 619 CCTQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLDQSHTNTAIRGTKGYV---APEWF 675
+H D+ +N +LD+ + +++DFGLA+ + + ++ R + V A E
Sbjct: 144 KF---VHRDLAARNCMLDESFTVKVADFGLARDILDREYYSVQQHRHARLPVKWTALESL 200
Query: 676 RNMPITVKVDVYSYGVLLLEIICLRR----NIDNEISKVDKAILTDWAYDRYQERTLEAL 731
+ T K DV+S+GVLL E++ +ID L
Sbjct: 201 QTYRFTTKSDVWSFGVLLWELLTRGAPPYRHIDP-------------------FDLTHFL 241
Query: 732 VEND-LEAMNNVT-MLHRFVMVAFWCIQEDPSHRPTMRKVTQMLEGVVE 778
+ L L++ VM W + DP+ RPT R + +E +V
Sbjct: 242 AQGRRLPQPEYCPDSLYQ-VMQQCW--EADPAVRPTFRVLVGEVEQIVS 287
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432 | Back alignment and structure |
|---|
Score = 131 bits (332), Expect = 6e-33
Identities = 65/291 (22%), Positives = 113/291 (38%), Gaps = 63/291 (21%)
Query: 505 FKEELGRGAFGTVYKGFVNMGSSNHVAVKKLN-SVFQDSEKEFKA--EVNGIGQTHHKNL 561
K+ LG GA GT+ + M + VAVK++ F +++E + E + H N+
Sbjct: 28 PKDVLGHGAEGTIV--YRGMFDNRDVAVKRILPECFSFADREVQLLRESDE-----HPNV 80
Query: 562 VRLLGYCDEGQNRLLVYEFMSNGTVASFLFGDSKPNWKLRTEIAMG----IAGGLFYLHE 617
+R + Q + + E + T+ ++ + ++ + GL +LH
Sbjct: 81 IRYFCTEKDRQFQYIAIELCA-ATLQEYV---EQKDFAHLGLEPITLLQQTTSGLAHLHS 136
Query: 618 ECCTQIIHCDIKPQNILL-----DDHYNARISDFGLAKLLTLDQS--HTNTAIRGTKGYV 670
I+H D+KP NIL+ A ISDFGL K L + + + + GT+G++
Sbjct: 137 L---NIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHSFSRRSGVPGTEGWI 193
Query: 671 APEWFR---NMPITVKVDVYSYGVLLLEIIC---------LRRNIDNEISKVDKAILTDW 718
APE T VD++S G + +I L+R + + L
Sbjct: 194 APEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQRQANILLGACSLDCLHPE 253
Query: 719 AYDRYQERTLEALVENDLEAMNNVTMLHRFVMVAFWCIQEDPSHRPTMRKV 769
++ D+ A + I DP RP+ + V
Sbjct: 254 KHE-------------DVIARE-------LIE---KMIAMDPQKRPSAKHV 281
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317 | Back alignment and structure |
|---|
Score = 128 bits (324), Expect = 6e-33
Identities = 66/309 (21%), Positives = 110/309 (35%), Gaps = 53/309 (17%)
Query: 505 FKEELGRGAFGTVYKGFVNMGSSNHVAVKKLNSVFQDSEKEFKAEVNGIGQTHHKNLVRL 564
F ++LG G F V + + A+K++ Q +E + E + +H N++RL
Sbjct: 33 FIQKLGEGGFSYVDLV-EGLHDGHFYALKRILCHEQQDREEAQREADMHRLFNHPNILRL 91
Query: 565 LGYCDEGQNR----LLVYEFMSNGTVASFLFGDSKPNWKLRTE-----IAMGIAGGLFYL 615
+ YC + L+ F GT+ + + L TE + +GI GL +
Sbjct: 92 VAYCLRERGAKHEAWLLLPFFKRGTLWNEIERLKDKGNFL-TEDQILWLLLGICRGLEAI 150
Query: 616 HEECCTQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLDQSHTNTAIR--------GTK 667
H H D+KP NILL D + D G + + A+ T
Sbjct: 151 HA---KGYAHRDLKPTNILLGDEGQPVLMDLGSMNQACIHVEGSRQALTLQDWAAQRCTI 207
Query: 668 GYVAPEWF---RNMPITVKVDVYSYGVLLLEIICLR---RNIDNEISKVDKAILTDW--- 718
Y APE F + I + DV+S G +L ++ + + V A+
Sbjct: 208 SYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQKGDSVALAVQNQLSIP 267
Query: 719 AYDRYQERTLEALVENDLEAMNNVTMLHRFVMVAFWCIQEDPSHRPTMRKVTQMLEGVVE 778
R+ L + + + DP RP + + LE ++
Sbjct: 268 QSPRHSSA------------------LWQLLN---SMMTVDPHQRPHIPLLLSQLE-ALQ 305
Query: 779 VPIPPCPWT 787
P P T
Sbjct: 306 PPAPGQHTT 314
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613 | Back alignment and structure |
|---|
Score = 133 bits (336), Expect = 1e-32
Identities = 60/199 (30%), Positives = 97/199 (48%), Gaps = 13/199 (6%)
Query: 506 KEELGRGAFGTVYKGFVNMGSSNH-VAVKKLNSVFQDSEK-EFKAEVNGIGQTHHKNLVR 563
ELG G FG+V +G M VA+K L + ++ E E + Q + +VR
Sbjct: 341 DIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVR 400
Query: 564 LLGYCDEGQNRLLVYEFMSNGTVASFLFGDSKPNWKLRT--EIAMGIAGGLFYLHEECCT 621
L+G C + + +LV E G + FL + + E+ ++ G+ YL E+
Sbjct: 401 LIGVC-QAEALMLVMEMAGGGPLHKFL-VGKREEIPVSNVAELLHQVSMGMKYLEEKNF- 457
Query: 622 QIIHCDIKPQNILLDDHYNARISDFGLAKLLTLDQSHTNTAIRGTKGYV---APEWFRNM 678
+H ++ +N+LL + + A+ISDFGL+K L D S+ TA K + APE
Sbjct: 458 --VHRNLAARNVLLVNRHYAKISDFGLSKALGADDSYY-TARSAGKWPLKWYAPECINFR 514
Query: 679 PITVKVDVYSYGVLLLEII 697
+ + DV+SYGV + E +
Sbjct: 515 KFSSRSDVWSYGVTMWEAL 533
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656 | Back alignment and structure |
|---|
Score = 133 bits (337), Expect = 1e-32
Identities = 67/292 (22%), Positives = 114/292 (39%), Gaps = 48/292 (16%)
Query: 505 FKEELGRGAFGTVYKGFVNMGSSNH--VAVKKLNSVFQDSEK-EFKAEVNGIGQTHHKNL 561
+G G FG V++G + VA+K + DS + +F E + Q H ++
Sbjct: 394 LGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHI 453
Query: 562 VRLLGYCDEGQNRLLVYEFMSNGTVASFLFGDSKPNWKLRTEIAM--GIAGGLFYLHEEC 619
V+L+G E ++ E + G + SFL K + L + I ++ L YL +
Sbjct: 454 VKLIGVITE-NPVWIIMELCTLGELRSFL-QVRKFSLDLASLILYAYQLSTALAYLESKR 511
Query: 620 CTQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLD----QSHTNTAIRGTKGYVAPEWF 675
+H DI +N+L+ + ++ DFGL++ + S I+ APE
Sbjct: 512 F---VHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWM----APESI 564
Query: 676 RNMPITVKVDVYSYGVLLLEIICLRR----NIDNE--ISKVDKAILTDWAYDRYQERTLE 729
T DV+ +GV + EI+ + N I +++ ER
Sbjct: 565 NFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENG-----------ER--- 610
Query: 730 ALVENDLEAMNNVT-MLHRFVMVAFWCIQEDPSHRPTMRKVTQMLEGVVEVP 780
L N L+ +M W DPS RP ++ L ++E
Sbjct: 611 ------LPMPPNCPPTLYS-LMTKCW--AYDPSRRPRFTELKAQLSTILEEE 653
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295 | Back alignment and structure |
|---|
Score = 126 bits (318), Expect = 3e-32
Identities = 56/194 (28%), Positives = 92/194 (47%), Gaps = 13/194 (6%)
Query: 509 LGRGAFGTVYKGFVNMGSSNHVAVKKLNSVFQDSEKEFKAEVNGIGQTHHKNLVRLLGYC 568
LG+G +G VY G ++ + +A+K++ + E+ HKN+V+ LG
Sbjct: 30 LGKGTYGIVYAGR-DLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLG-S 87
Query: 569 DEGQNRLLVY-EFMSNGTVASFL---FGDSKPNWKLRTEIAMGIAGGLFYLHEECCTQII 624
+ ++ E + G++++ L +G K N + I GL YLH+ QI+
Sbjct: 88 FSENGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDN---QIV 144
Query: 625 HCDIKPQNILLDDHY-NARISDFGLAKLLTLDQSHTNTAIRGTKGYVAPEWFRNMPI--T 681
H DIK N+L++ + +ISDFG +K L T T GT Y+APE P
Sbjct: 145 HRDIKGDNVLINTYSGVLKISDFGTSKRLAGINPCTET-FTGTLQYMAPEIIDKGPRGYG 203
Query: 682 VKVDVYSYGVLLLE 695
D++S G ++E
Sbjct: 204 KAADIWSLGCTIIE 217
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303 | Back alignment and structure |
|---|
Score = 126 bits (318), Expect = 4e-32
Identities = 68/298 (22%), Positives = 113/298 (37%), Gaps = 59/298 (19%)
Query: 505 FKEELGRGAFGTVYKGFVNMGSSNHVAVKKLNSVFQDSEKEFKAEVNGIGQTHHKNLVRL 564
LG+GAFG V K N S + A+KK+ ++ +EV + +H+ +VR
Sbjct: 10 EIAVLGQGAFGQVVKA-RNALDSRYYAIKKIRHT-EEKLSTILSEVMLLASLNHQYVVRY 67
Query: 565 LG-YCDEGQNRL------------LVYEFMSNGTVASFL-----FGDSKPNWKLRTEIAM 606
+ + + E+ NGT+ + W+L +I
Sbjct: 68 YAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEYWRLFRQILE 127
Query: 607 GIAGGLFYLHEECCTQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLD----------- 655
++ Y+H + IIH D+KP NI +D+ N +I DFGLAK +
Sbjct: 128 ALS----YIHSQ---GIIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKLDSQNL 180
Query: 656 ---QSHTNTAIRGTKGYVAPEWFRNMPI-TVKVDVYSYGVLLLEIICLRRNIDNEISKVD 711
+ +AI GT YVA E K+D+YS G++ E+I E +
Sbjct: 181 PGSSDNLTSAI-GTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIYPFST-GMERVNIL 238
Query: 712 KAILTDWAYDRYQERTLEALVENDLEAMNNVTMLHRFVMVAFWCIQEDPSHRPTMRKV 769
K + R +++ + + + I DP+ RP R +
Sbjct: 239 KKL-------RSVSIEFPPDFDDNKMK-----VEKKIIR---LLIDHDPNKRPGARTL 281
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334 | Back alignment and structure |
|---|
Score = 126 bits (319), Expect = 5e-32
Identities = 73/316 (23%), Positives = 128/316 (40%), Gaps = 68/316 (21%)
Query: 505 FKEELGRGAFGTVYKGFVN------MGSSNHVAVKKLNSVFQDSEK-EFKAEVN---GIG 554
+ LG GAFG V + VAVK L + + + +E+ IG
Sbjct: 39 LGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIG 98
Query: 555 QTHHKNLVRLLGYCDEGQNRLLVYEFMSNGTVASFLFGDSKPNWKLRTE----------- 603
+ HKN++ LLG C + ++ E+ S G + +L P + +
Sbjct: 99 K--HKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTF 156
Query: 604 -----IAMGIAGGLFYLHEECCTQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLDQSH 658
+A G+ YL + C IH D+ +N+L+ ++ +I+DFGLA+ D ++
Sbjct: 157 KDLVSCTYQLARGMEYLASQKC---IHRDLAARNVLVTENNVMKIADFGLAR----DINN 209
Query: 659 TNTAIRGTKGYV-----APEWFRNMPITVKVDVYSYGVLLLEIICLRRNIDNEISKVDKA 713
+ + T G + APE + T + DV+S+GVL+ EI L
Sbjct: 210 IDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTL-------------- 255
Query: 714 ILTDWAYDRYQERTLEALVE-----NDLEAMNNVT-MLHRFVMVAFWCIQEDPSHRPTMR 767
Y +E L + + ++ N T L+ +M W PS RPT +
Sbjct: 256 -----GGSPYPGIPVEELFKLLKEGHRMDKPANCTNELYM-MMRDCW--HAVPSQRPTFK 307
Query: 768 KVTQMLEGVVEVPIPP 783
++ + L+ ++ +
Sbjct: 308 QLVEDLDRILTLTTNE 323
|
| >3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289 | Back alignment and structure |
|---|
Score = 125 bits (315), Expect = 6e-32
Identities = 67/316 (21%), Positives = 113/316 (35%), Gaps = 76/316 (24%)
Query: 500 EVTRG---FKEELGRGAFGTVYKGFVN----MGSSNHVAVKKLNSVFQDSEK-EFKAEVN 551
E++ F EELG FG VYKG + + VA+K L + + EF+ E
Sbjct: 5 EISLSAVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAM 64
Query: 552 GIGQTHHKNLVRLLGYCDEGQNRLLVYEFMSNGTVASFLFGDSKPNWKLRTE-------- 603
+ H N+V LLG + Q +++ + S+G + FL S + T+
Sbjct: 65 LRARLQHPNVVCLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSA 124
Query: 604 --------IAMGIAGGLFYLHEECCTQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLD 655
+ IA G+ YL +H D+ +N+L+ D N +ISD GL + +
Sbjct: 125 LEPPDFVHLVAQIAAGMEYLSSHHV---VHKDLATRNVLVYDKLNVKISDLGLFREVY-- 179
Query: 656 QSHTNTAIRGTKGYV-----APEWFRNMPITVKVDVYSYGVLLLEIICLRRNIDNEISKV 710
+ + APE ++ D++SYGV+L E+
Sbjct: 180 --AADYYKLLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSY----------- 226
Query: 711 DKAILTDWAYDRYQERTLEALVENDLEAMNNVTMLHRF------------VMVAFWCIQE 758
Y + + + + + +M+ W E
Sbjct: 227 --------GLQPYCGYSNQ-------DVVEMIRNRQVLPCPDDCPAWVYALMIECW--NE 269
Query: 759 DPSHRPTMRKVTQMLE 774
PS RP + + L
Sbjct: 270 FPSRRPRFKDIHSRLR 285
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382 | Back alignment and structure |
|---|
Score = 127 bits (320), Expect = 9e-32
Identities = 79/313 (25%), Positives = 130/313 (41%), Gaps = 68/313 (21%)
Query: 505 FKEELGRGAFGTVYKGFVN------MGSSNHVAVKKLNSVFQDSEK-EFKAEVN---GIG 554
+ LG GAFG V VAVK L S + + + +E+ IG
Sbjct: 73 LGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIG 132
Query: 555 QTHHKNLVRLLGYCDEGQNRLLVYEFMSNGTVASFL------------FGDSKPNWKLRT 602
+ HKN++ LLG C + ++ E+ S G + +L P +L +
Sbjct: 133 K--HKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSS 190
Query: 603 E----IAMGIAGGLFYLHEECCTQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLDQSH 658
+ A +A G+ YL + C IH D+ +N+L+ + +I+DFGLA+ D H
Sbjct: 191 KDLVSCAYQVARGMEYLASKKC---IHRDLAARNVLVTEDNVMKIADFGLAR----DIHH 243
Query: 659 TNTAIRGTKGYV-----APEWFRNMPITVKVDVYSYGVLLLEIICLRRNIDNEISKVDKA 713
+ + T G + APE + T + DV+S+GVLL EI L
Sbjct: 244 IDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTL-------------- 289
Query: 714 ILTDWAYDRYQERTLEALVE-----NDLEAMNNVT-MLHRFVMVAFWCIQEDPSHRPTMR 767
Y +E L + + ++ +N T L+ +M W PS RPT +
Sbjct: 290 -----GGSPYPGVPVEELFKLLKEGHRMDKPSNCTNELYM-MMRDCW--HAVPSQRPTFK 341
Query: 768 KVTQMLEGVVEVP 780
++ + L+ +V +
Sbjct: 342 QLVEDLDRIVALT 354
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333 | Back alignment and structure |
|---|
Score = 125 bits (317), Expect = 9e-32
Identities = 67/222 (30%), Positives = 102/222 (45%), Gaps = 36/222 (16%)
Query: 505 FKEELGRGAFGTVYKG----FVNMGSSNHVAVKKLNSVFQDSEK-EFKAEVN---GIGQT 556
F + LG GAFG V + + VAVK L S EK +E+ +GQ
Sbjct: 50 FGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQ- 108
Query: 557 HHKNLVRLLGYCDEGQNRLLVYEFMSNGTVASFL--------------FGDSKPNWKLRT 602
H+N+V LLG C G L++ E+ G + +FL +S + +
Sbjct: 109 -HENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLL 167
Query: 603 EIAMGIAGGLFYLHEECCTQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLDQSHTNTA 662
+ +A G+ +L + C IH D+ +N+LL + + A+I DFGLA+ D + +
Sbjct: 168 HFSSQVAQGMAFLASKNC---IHRDVAARNVLLTNGHVAKIGDFGLAR----DIMNDSNY 220
Query: 663 IRGTKGYV-----APEWFRNMPITVKVDVYSYGVLLLEIICL 699
I + APE + TV+ DV+SYG+LL EI L
Sbjct: 221 IVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSL 262
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313 | Back alignment and structure |
|---|
Score = 125 bits (315), Expect = 1e-31
Identities = 69/300 (23%), Positives = 119/300 (39%), Gaps = 55/300 (18%)
Query: 505 FKEELGRGAFGTVYKGFVNM--GSSNHVAVKKLNSVF--QDSEKEFKAEVNGIGQTHHKN 560
+ LG G FG+V +G + G+S VAVK + Q +EF +E + H N
Sbjct: 38 LGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPN 97
Query: 561 LVRLLGYCDEGQNR-----LLVYEFMSNGTVASFL------FGDSKPNWKLRTEIAMGIA 609
++RLLG C E ++ +++ FM G + ++L G + + + IA
Sbjct: 98 VIRLLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIA 157
Query: 610 GGLFYLHEECCTQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLDQSHTNTAIRGTKGY 669
G+ YL +H D+ +N +L D ++DFGL+K + +G
Sbjct: 158 LGMEYLSNRNF---LHRDLAARNCMLRDDMTVCVADFGLSK----KIYSGDYYRQGRIAK 210
Query: 670 V-----APEWFRNMPITVKVDVYSYGVLLLEIICLRRNIDNEISKVDKAILTDWAYDRYQ 724
+ A E + T K DV+++GV + EI Y
Sbjct: 211 MPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATR-------------------GMTPYP 251
Query: 725 ERTLEALVE-----NDLEAMNNV-TMLHRFVMVAFWCIQEDPSHRPTMRKVTQMLEGVVE 778
+ + + L+ + L+ +M + W + DP RPT + LE ++E
Sbjct: 252 GVQNHEMYDYLLHGHRLKQPEDCLDELYE-IMYSCW--RTDPLDRPTFSVLRLQLEKLLE 308
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323 | Back alignment and structure |
|---|
Score = 125 bits (316), Expect = 1e-31
Identities = 60/303 (19%), Positives = 110/303 (36%), Gaps = 56/303 (18%)
Query: 505 FKEELGRGAFGTVYKGFVN--MGSSNHVAVK--KLNSVFQDSEKEFKAEVNGIGQTHHKN 560
LG+G FG+V + + GS VAVK K + + +EF E + + H +
Sbjct: 27 LGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPH 86
Query: 561 LVRLLGYCDEGQNR------LLVYEFMSNGTVASFL------FGDSKPNWKLRTEIAMGI 608
+ +L+G + + +++ FM +G + +FL + + I
Sbjct: 87 VAKLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDI 146
Query: 609 AGGLFYLHEECCTQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLDQSHTNTAIRGTKG 668
A G+ YL IH D+ +N +L + ++DFGL++ + +G
Sbjct: 147 ACGMEYLSSRNF---IHRDLAARNCMLAEDMTVCVADFGLSR----KIYSGDYYRQGCAS 199
Query: 669 YV-----APEWFRNMPITVKVDVYSYGVLLLEIICLRRNIDNEISKVDKAILTDWAYDRY 723
+ A E + TV DV+++GV + EI+ Y
Sbjct: 200 KLPVKWLALESLADNLYTVHSDVWAFGVTMWEIMTR-------------------GQTPY 240
Query: 724 QERTLEALVE-----NDLEAMNNV-TMLHRFVMVAFWCIQEDPSHRPTMRKVTQMLEGVV 777
+ N L+ ++ +M W DP RP+ + LE ++
Sbjct: 241 AGIENAEIYNYLIGGNRLKQPPECMEEVYD-LMYQCW--SADPKQRPSFTCLRMELENIL 297
Query: 778 EVP 780
Sbjct: 298 GHL 300
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370 | Back alignment and structure |
|---|
Score = 126 bits (318), Expect = 1e-31
Identities = 74/319 (23%), Positives = 130/319 (40%), Gaps = 71/319 (22%)
Query: 500 EVTRG---FKEELGRGAFGTVYKGFVN------MGSSNHVAVKKLNSVFQDSEK-EFKAE 549
E R + LG G FG V + VAVK L + + + +E
Sbjct: 77 EFPRDKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSE 136
Query: 550 VN---GIGQTHHKNLVRLLGYCDEGQNRLLVYEFMSNGTVASFL------------FGDS 594
+ IG+ HKN++ LLG C + ++ E+ S G + +L +
Sbjct: 137 MEMMKMIGK--HKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINR 194
Query: 595 KPNWKLRTE----IAMGIAGGLFYLHEECCTQIIHCDIKPQNILLDDHYNARISDFGLAK 650
P ++ + +A G+ YL + C IH D+ +N+L+ ++ +I+DFGLA+
Sbjct: 195 VPEEQMTFKDLVSCTYQLARGMEYLASQKC---IHRDLAARNVLVTENNVMKIADFGLAR 251
Query: 651 LLTLDQSHTNTAIRGTKGYV-----APEWFRNMPITVKVDVYSYGVLLLEIICLRRNIDN 705
D ++ + + T G + APE + T + DV+S+GVL+ EI L
Sbjct: 252 ----DINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTL------ 301
Query: 706 EISKVDKAILTDWAYDRYQERTLEALVE-----NDLEAMNNVT-MLHRFVMVAFWCIQED 759
Y +E L + + ++ N T L+ +M W
Sbjct: 302 -------------GGSPYPGIPVEELFKLLKEGHRMDKPANCTNELYM-MMRDCW--HAV 345
Query: 760 PSHRPTMRKVTQMLEGVVE 778
PS RPT +++ + L+ ++
Sbjct: 346 PSQRPTFKQLVEDLDRILT 364
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313 | Back alignment and structure |
|---|
Score = 123 bits (311), Expect = 3e-31
Identities = 73/317 (23%), Positives = 117/317 (36%), Gaps = 79/317 (24%)
Query: 505 FKEELGRGAFGTVYKG----FVNMGSSNHVAVKKLNSVFQDSEK-EFKAEVN---GIGQT 556
F + LG GAFG V + + ++ VAVK L +E+ +E+ +G
Sbjct: 27 FGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGN- 85
Query: 557 HHKNLVRLLGYCDEGQNRLLVYEFMSNGTVASFL----------------FGDSKPNWKL 600
H N+V LLG C G L++ E+ G + +FL D + L
Sbjct: 86 -HMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDL 144
Query: 601 RTEIAMG--IAGGLFYLHEECCTQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLDQSH 658
++ +A G+ +L IH D+ +NILL +I DFGLA+ D +
Sbjct: 145 EDLLSFSYQVAKGMAFLAS---KNCIHRDLAARNILLTHGRITKICDFGLAR----DIKN 197
Query: 659 TNTAIRGTKGYV-----APEWFRNMPITVKVDVYSYGVLLLEIICLRRNIDNEISKVDKA 713
+ + + APE N T + DV+SYG+ L E+ L
Sbjct: 198 DSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSL-------------- 243
Query: 714 ILTDWAYDRYQERTLEALVENDLEAMNNVTMLHR------------FVMVAFWCIQEDPS 761
Y + D + + R +M W DP
Sbjct: 244 -----GSSPYPG------MPVDSKFYKMIKEGFRMLSPEHAPAEMYDIMKTCW--DADPL 290
Query: 762 HRPTMRKVTQMLEGVVE 778
RPT +++ Q++E +
Sbjct: 291 KRPTFKQIVQLIEKQIS 307
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316 | Back alignment and structure |
|---|
Score = 122 bits (309), Expect = 7e-31
Identities = 66/225 (29%), Positives = 94/225 (41%), Gaps = 39/225 (17%)
Query: 505 FKEELGRGAFGTVYKGFVN----MGSSNHVAVKKLNSVFQDSEK-EFKAEVN---GIGQT 556
+ LGRGAFG V + + VAVK L SE +E+ IG
Sbjct: 31 LGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGH- 89
Query: 557 HHKNLVRLLGYC-DEGQNRLLVYEFMSNGTVASFL--------------FGDSKPNWKLR 601
H N+V LLG C G +++ EF G ++++L K L
Sbjct: 90 -HLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLE 148
Query: 602 TEIAMG--IAGGLFYLHEECCTQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLDQSHT 659
I +A G+ +L C IH D+ +NILL + +I DFGLA+ D
Sbjct: 149 HLICYSFQVAKGMEFLASRKC---IHRDLAARNILLSEKNVVKICDFGLAR----DIYKD 201
Query: 660 NTAIRGTKGYV-----APEWFRNMPITVKVDVYSYGVLLLEIICL 699
+R + APE + T++ DV+S+GVLL EI L
Sbjct: 202 PDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSL 246
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396 | Back alignment and structure |
|---|
Score = 124 bits (313), Expect = 7e-31
Identities = 56/308 (18%), Positives = 109/308 (35%), Gaps = 39/308 (12%)
Query: 505 FKEELGRGAFGTVYKGFVNMGSSNHVAVKKLN-SVFQDSEKEFKAEVNGIGQTHHKNLVR 563
+ LG+GA V++G + + + A+K N F E + + +HKN+V+
Sbjct: 13 LSDILGQGATANVFRG-RHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVK 71
Query: 564 LLGYCDEGQNRL--LVYEFMSNGTVASFLFGDSKPNWKLRTE-----IAMGIAGGLFYLH 616
L +E R L+ EF G++ + L + N E + + GG+ +L
Sbjct: 72 LFAIEEETTTRHKVLIMEFCPCGSLYTVL--EEPSNAYGLPESEFLIVLRDVVGGMNHLR 129
Query: 617 EECCTQIIHCDIKPQNILL----DDHYNARISDFGLAKLLTLDQSHTNTAIRGTKGYVAP 672
E I+H +IKP NI+ D +++DFG A+ L D + GT+ Y+ P
Sbjct: 130 EN---GIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELE-DDEQFVSLY-GTEEYLHP 184
Query: 673 E--------WFRNMPITVKVDVYSYGVLLLEIIC---------LRRNIDNEISKVDKAIL 715
+ VD++S GV R + K+
Sbjct: 185 DMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIITGKP 244
Query: 716 TDWAYDRYQERTLEALVENDLEAMNNVTMLHRFVMVAFW--CIQEDPSHRPTMRKVTQML 773
+ + D+ +++ + ++ ++ D +
Sbjct: 245 SGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAET 304
Query: 774 EGVVEVPI 781
++ +
Sbjct: 305 SDILHRMV 312
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343 | Back alignment and structure |
|---|
Score = 123 bits (310), Expect = 9e-31
Identities = 69/324 (21%), Positives = 121/324 (37%), Gaps = 72/324 (22%)
Query: 500 EVTRG---FKEELGRGAFGTVYKGFVN----MGSSNHVAVKKLNSVFQDSEK-EFKAEVN 551
E R + ++G GAFG V++ VAVK L + +F+ E
Sbjct: 43 EYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAA 102
Query: 552 GIGQTHHKNLVRLLGYCDEGQNRLLVYEFMSNGTVASFL--------------------- 590
+ + + N+V+LLG C G+ L++E+M+ G + FL
Sbjct: 103 LMAEFDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRAR 162
Query: 591 ---FGDSKPNWKLRTEIAMGIAGGLFYLHEECCTQIIHCDIKPQNILLDDHYNARISDFG 647
G + + IA +A G+ YL E +H D+ +N L+ ++ +I+DFG
Sbjct: 163 VSSPGPPPLSCAEQLCIARQVAAGMAYLSERKF---VHRDLATRNCLVGENMVVKIADFG 219
Query: 648 LAKLLTLDQSHTNTAIRGTKGYV-----APEWFRNMPITVKVDVYSYGVLLLEIICLRRN 702
L++ + + + PE T + DV++YGV+L EI
Sbjct: 220 LSR----NIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSY--- 272
Query: 703 IDNEISKVDKAILTDWAYDRYQERTLEALVE-----NDLEAMNNV-TMLHRFVMVAFWCI 756
Y E ++ N L N L+ +M W
Sbjct: 273 ----------------GLQPYYGMAHEEVIYYVRDGNILACPENCPLELYN-LMRLCW-- 313
Query: 757 QEDPSHRPTMRKVTQMLEGVVEVP 780
+ P+ RP+ + ++L+ + E
Sbjct: 314 SKLPADRPSFCSIHRILQRMCERA 337
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314 | Back alignment and structure |
|---|
Score = 121 bits (307), Expect = 1e-30
Identities = 72/314 (22%), Positives = 126/314 (40%), Gaps = 69/314 (21%)
Query: 505 FKEELGRGAFGTVYKG----FVNMGSSNHVAVKKLNSVFQDSEK-EFKAEVNGIGQTHHK 559
+ LG G FG V K VAVK L SE + +E N + Q +H
Sbjct: 27 LGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHP 86
Query: 560 NLVRLLGYCDEGQNRLLVYEFMSNGTVASFL------------------------FGDSK 595
++++L G C + LL+ E+ G++ FL +
Sbjct: 87 HVIKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERA 146
Query: 596 PNWKLRTEIAMGIAGGLFYLHEECCTQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLD 655
A I+ G+ YL E +H D+ +NIL+ + +ISDFGL++ D
Sbjct: 147 LTMGDLISFAWQISQGMQYLAEMKL---VHRDLAARNILVAEGRKMKISDFGLSR----D 199
Query: 656 QSHTNTAIRGTKGYV-----APEWFRNMPITVKVDVYSYGVLLLEIICLRRNIDNEISKV 710
++ ++ ++G + A E + T + DV+S+GVLL EI+ L
Sbjct: 200 VYEEDSYVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTL----------- 248
Query: 711 DKAILTDWAYDRYQERTLEALVE-----NDLEAMNNVTM-LHRFVMVAFWCIQEDPSHRP 764
+ Y E L + +E +N + ++R +M+ W +++P RP
Sbjct: 249 --------GGNPYPGIPPERLFNLLKTGHRMERPDNCSEEMYR-LMLQCW--KQEPDKRP 297
Query: 765 TMRKVTQMLEGVVE 778
+++ LE ++
Sbjct: 298 VFADISKDLEKMMV 311
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 122 bits (307), Expect = 1e-30
Identities = 60/277 (21%), Positives = 96/277 (34%), Gaps = 45/277 (16%)
Query: 507 EELGRGAFGTVYKGFVNMGSSNHVAVKKLNSVFQDS--EKEFKAEVNGIGQ-THHKNLVR 563
LG G++G V+K + AVK+ S F+ AEV + H VR
Sbjct: 63 SRLGHGSYGEVFKVR-SKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVR 121
Query: 564 LLGYCDEGQNRLLVYEFMSNGTVASFL--FGDSKPN---WKLRTEIAMGIAGGLFYLHEE 618
L +EG L E ++ +G S P W + + L +LH +
Sbjct: 122 LEQAWEEGGILYLQTEL-CGPSLQQHCEAWGASLPEAQVWGYLRDTLLA----LAHLHSQ 176
Query: 619 CCTQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLDQSHTNTAIRGTKGYVAPEWFRNM 678
++H D+KP NI L ++ DFGL L G Y+APE +
Sbjct: 177 ---GLVHLDVKPANIFLGPRGRCKLGDFGLLVELG-TAGAGEVQE-GDPRYMAPELLQG- 230
Query: 679 PITVKVDVYSYGVLLLEIICLRRNIDNEISKVDKAILTDWAYDRYQERTLEALVENDLEA 738
DV+S G+ +LE+ C + + L + L
Sbjct: 231 SYGTAADVFSLGLTILEVACNMEL-------------------PHGGEGWQQLRQGYLPP 271
Query: 739 MNNVTM---LHRFVMVAFWCIQEDPSHRPTMRKVTQM 772
+ L ++ ++ DP R T + +
Sbjct: 272 EFTAGLSSELRSVLV---MMLEPDPKLRATAEALLAL 305
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 122 bits (307), Expect = 1e-30
Identities = 56/296 (18%), Positives = 106/296 (35%), Gaps = 39/296 (13%)
Query: 505 FKEELGRGAFGTVYKGFVNMGSSNHVAVKKLN-SVFQDSEKEFKAEVNGIGQTHHKNLVR 563
+ LG+GA V++G + + + A+K N F E + + +HKN+V+
Sbjct: 13 LSDILGQGATANVFRG-RHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVK 71
Query: 564 LLGYCDEGQNRL--LVYEFMSNGTVASFLFGDSKPNWKLRTE-----IAMGIAGGLFYLH 616
L +E R L+ EF G++ + L + N E + + GG+ +L
Sbjct: 72 LFAIEEETTTRHKVLIMEFCPCGSLYTVL--EEPSNAYGLPESEFLIVLRDVVGGMNHLR 129
Query: 617 EECCTQIIHCDIKPQNILL----DDHYNARISDFGLAKLLTLDQSHTNTAIRGTKGYVAP 672
E I+H +IKP NI+ D +++DFG A+ L D + GT+ Y+ P
Sbjct: 130 EN---GIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELE-DDEQFVSLY-GTEEYLHP 184
Query: 673 E--------WFRNMPITVKVDVYSYGVLLLEIIC---------LRRNIDNEISKVDKAIL 715
+ VD++S GV R + K+
Sbjct: 185 DMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIITGKP 244
Query: 716 TDWAYDRYQERTLEALVENDLEAMNNVTMLHRFVMVAF--WCIQEDPSHRPTMRKV 769
+ + D+ +++ + ++ ++ D +
Sbjct: 245 SGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQF 300
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365 | Back alignment and structure |
|---|
Score = 122 bits (308), Expect = 2e-30
Identities = 40/218 (18%), Positives = 75/218 (34%), Gaps = 30/218 (13%)
Query: 505 FKEELGRGAFGTVYKG----FVNMGSSNHVAVKKLNSVFQDSEKEF---KAEVNGIGQTH 557
LG GAF VY+ + + +K + EF + + +
Sbjct: 69 VHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQK---PANPWEFYIGTQLMERLKPSM 125
Query: 558 HKNLVRLLGYCDEGQNRLLVYEFMSNGTVASFLFGDSKPNWKLRTE-----IAMGIAGGL 612
++ +LV E S GT+ + + K+ + AM + +
Sbjct: 126 QHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMI 185
Query: 613 FYLHEECCTQIIHCDIKPQNILLDDHYNA-----------RISDFGLAKLLTL-DQSHTN 660
+H+ +IIH DIKP N +L + + + D G + + L +
Sbjct: 186 EQVHDC---EIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIF 242
Query: 661 TAIRGTKGYVAPEWFRNMPITVKVDVYSYGVLLLEIIC 698
TA T G+ E N P ++D + + ++
Sbjct: 243 TAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLF 280
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336 | Back alignment and structure |
|---|
Score = 121 bits (306), Expect = 2e-30
Identities = 55/199 (27%), Positives = 86/199 (43%), Gaps = 22/199 (11%)
Query: 506 KEELGRGAFGTVYKGFVNMGSSNHVAVKKLNSVFQDSEKEFKAEVNGIGQTHHKNLVRLL 565
+ +GRG+FG V++ + + AVKK+ + E E+ +V L
Sbjct: 63 QPRVGRGSFGEVHRMK-DKQTGFQCAVKKVR--LEVFRVE---ELVACAGLSSPRIVPLY 116
Query: 566 GYCDEGQNRLLVYEFMSNGTVASFLFGDSKPNWKLRTEIAMGIAG----GLFYLHEECCT 621
G EG + E + G++ + K L + A+ G GL YLH
Sbjct: 117 GAVREGPWVNIFMELLEGGSLGQLI----KQMGCLPEDRALYYLGQALEGLEYLHTR--- 169
Query: 622 QIIHCDIKPQNILLD-DHYNARISDFGLAKLLTLDQSHTNTA----IRGTKGYVAPEWFR 676
+I+H D+K N+LL D A + DFG A L D + I GT+ ++APE
Sbjct: 170 RILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPGTETHMAPEVVM 229
Query: 677 NMPITVKVDVYSYGVLLLE 695
P KVD++S ++L
Sbjct: 230 GKPCDAKVDIWSSCCMMLH 248
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344 | Back alignment and structure |
|---|
Score = 121 bits (305), Expect = 3e-30
Identities = 72/324 (22%), Positives = 113/324 (34%), Gaps = 84/324 (25%)
Query: 505 FKEELGRGAFGTVYKG----FVNMGSSNHVAVKKLNSVFQDSEK-EFKAEVN---GIGQT 556
F + LG GAFG V G S VAVK L SE+ +E+ +G
Sbjct: 49 FGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGS- 107
Query: 557 HHKNLVRLLGYCDEGQNRLLVYEFMSNGTVASFL-------------------FGDSKPN 597
H+N+V LLG C L++E+ G + ++L + +
Sbjct: 108 -HENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDL 166
Query: 598 WKLRTE----IAMGIAGGLFYLHEECCTQIIHCDIKPQNILLDDHYNARISDFGLAKLLT 653
L E A +A G+ +L + C +H D+ +N+L+ +I DFGLA+
Sbjct: 167 NVLTFEDLLCFAYQVAKGMEFLEFKSC---VHRDLAARNVLVTHGKVVKICDFGLAR--- 220
Query: 654 LDQSHTNTAIRGTKGYV-----APEWFRNMPITVKVDVYSYGVLLLEIICLRRNIDNEIS 708
D + + + APE T+K DV+SYG+LL EI L
Sbjct: 221 -DIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSL--------- 270
Query: 709 KVDKAILTDWAYDRYQERTLEALVENDLEAMNNVTMLHR------------FVMVAFWCI 756
+ Y + D + + +M + W
Sbjct: 271 ----------GVNPYPG------IPVDANFYKLIQNGFKMDQPFYATEEIYIIMQSCW-- 312
Query: 757 QEDPSHRPTMRKVTQMLEGVVEVP 780
D RP+ +T L +
Sbjct: 313 AFDSRKRPSFPNLTSFLGCQLADA 336
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327 | Back alignment and structure |
|---|
Score = 120 bits (303), Expect = 6e-30
Identities = 59/217 (27%), Positives = 97/217 (44%), Gaps = 34/217 (15%)
Query: 505 FKEELGRGAFGTVYKGFVN-MGSSNHVAVKKLNSVFQDSEK-EFKAEVNGIGQ-THHKNL 561
F++ +G G FG V K + G A+K++ + +F E+ + + HH N+
Sbjct: 29 FQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNI 88
Query: 562 VRLLGYCDEGQNRLLVYEFMSNGTVASFL----------------FGDSKPNWKLRTEIA 605
+ LLG C+ L E+ +G + FL S + + A
Sbjct: 89 INLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFA 148
Query: 606 MGIAGGLFYLHEECCTQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLDQSHTNTAIRG 665
+A G+ YL ++ Q IH D+ +NIL+ ++Y A+I+DFGL++ ++
Sbjct: 149 ADVARGMDYLSQK---QFIHRDLAARNILVGENYVAKIADFGLSR-------GQEVYVKK 198
Query: 666 TKGYV-----APEWFRNMPITVKVDVYSYGVLLLEII 697
T G + A E T DV+SYGVLL EI+
Sbjct: 199 TMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIV 235
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434 | Back alignment and structure |
|---|
Score = 121 bits (306), Expect = 1e-29
Identities = 74/302 (24%), Positives = 115/302 (38%), Gaps = 64/302 (21%)
Query: 505 FKEELGRGAFGTVYKGFVNMGSSNHVAVKKLNSVFQDSEKEFKAEVNGIGQT-HHKNLVR 563
++ LG G+ GTV F VAVK++ D E+ + ++ H N++R
Sbjct: 19 SEKILGYGSSGTVV--FQGSFQGRPVAVKRML---IDFCDIALMEIKLLTESDDHPNVIR 73
Query: 564 LLGYCDEGQNRLLVYEFMSNGTVASFLF------GDSKPNWKLRTE-----IAMGIAGGL 612
+ + E N L S N KL+ E + IA G+
Sbjct: 74 YYCSETTDRFLYIALELC-NLN----LQDLVESKNVSDENLKLQKEYNPISLLRQIASGV 128
Query: 613 FYLHEECCTQIIHCDIKPQNILLD-------------DHYNARISDFGLAKLLTLDQSHT 659
+LH +IIH D+KPQNIL+ ++ ISDFGL K L QS
Sbjct: 129 AHLHSL---KIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQSSF 185
Query: 660 NTAIR---GTKGYVAPE-------WFRNMPITVKVDVYSYGVLLLEIICLRRNIDNEISK 709
T + GT G+ APE +T +D++S G + I+ ++ +
Sbjct: 186 RTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDKYS 245
Query: 710 VDKAILTDWAYDRYQERTLEALVENDL--EAMNNVTMLHRFVMVAFWCIQEDPSHRPTMR 767
+ I+ + ++ L + L EA + + I DP RPT
Sbjct: 246 RESNIIR----GIFSLDEMKCLHDRSLIAEATD-------LIS---QMIDHDPLKRPTAM 291
Query: 768 KV 769
KV
Sbjct: 292 KV 293
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 118 bits (297), Expect = 4e-29
Identities = 56/308 (18%), Positives = 110/308 (35%), Gaps = 53/308 (17%)
Query: 506 KEELGRGAFGTVYKGFVNMGSSNHVAVKKLNSVFQDSEKEFKAEVNGIGQ-THHKNLVRL 564
+ L G F VY+ ++GS A+K+L S ++ + EV + + + H N+V+
Sbjct: 33 RRVLAEGGFAFVYEA-QDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNIVQF 91
Query: 565 LGYC-------DEGQNRLLVYEFMSNGTVASFLFGDSKPNWKLRTE-----IAMGIAGGL 612
D GQ L+ + G + FL + + I +
Sbjct: 92 CSAASIGKEESDTGQAEFLLLTELCKGQLVEFL--KKMESRGPLSCDTVLKIFYQTCRAV 149
Query: 613 FYLHEECCTQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLDQSHTNTAI--------- 663
++H IIH D+K +N+LL + ++ DFG A ++ ++ +A
Sbjct: 150 QHMHR-QKPPIIHRDLKVENLLLSNQGTIKLCDFGSATTISHYPDYSWSAQRRALVEEEI 208
Query: 664 --RGTKGYVAPE---WFRNMPITVKVDVYSYGVLLLEIICLRRNIDNE-ISKVDKAILTD 717
T Y PE + N PI K D+++ G +L + + ++ ++ +
Sbjct: 209 TRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFEDGAKLRIVNGKYSI 268
Query: 718 WAYDRYQERTLEALVENDLEAMNNVTMLHRFVMVAFWCIQEDPSHRPTMRKVTQMLEGVV 777
+D H + +Q +P R ++ +V L+ +
Sbjct: 269 PPHDTQYTV------------------FHSLIR---AMLQVNPEERLSIAEVVHQLQEIA 307
Query: 778 EVPIPPCP 785
Sbjct: 308 AARNVNPK 315
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676 | Back alignment and structure |
|---|
Score = 122 bits (308), Expect = 4e-29
Identities = 59/209 (28%), Positives = 87/209 (41%), Gaps = 23/209 (11%)
Query: 505 FKEELGRGAFGTVYKGFVNMGSSNHVAVKKLNSVFQDSEKE-FKAEVNGIGQTHHKNLVR 563
KE LG G FG V + ++ + VA+K+ +E + E+ + + +H N+V
Sbjct: 18 MKERLGTGGFGYVLRW-IHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVS 76
Query: 564 LL------GYCDEGQNRLLVYEFMSNGTVASFLFGDSKPNWKLRTE-----IAMGIAGGL 612
LL E+ G + +L + N E + I+ L
Sbjct: 77 AREVPDGLQKLAPNDLPLLAMEYCEGGDLRKYL--NQFENCCGLKEGPIRTLLSDISSAL 134
Query: 613 FYLHEECCTQIIHCDIKPQNILLD---DHYNARISDFGLAKLLTLDQSHTNTAIRGTKGY 669
YLHE +IIH D+KP+NI+L +I D G AK L + GT Y
Sbjct: 135 RYLHEN---RIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELD-QGELCTEFV-GTLQY 189
Query: 670 VAPEWFRNMPITVKVDVYSYGVLLLEIIC 698
+APE TV VD +S+G L E I
Sbjct: 190 LAPELLEQKKYTVTVDYWSFGTLAFECIT 218
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321 | Back alignment and structure |
|---|
Score = 117 bits (295), Expect = 4e-29
Identities = 48/194 (24%), Positives = 85/194 (43%), Gaps = 12/194 (6%)
Query: 507 EELGRGAFGTVYKGFVNMGSSNHVAVKKLNSVFQDSEKEFKAEVNGIGQTHHKNLVRLLG 566
++G G+ G V S VAVK ++ Q + EV + H N+V +
Sbjct: 51 VKIGEGSTGIVCLA-REKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHFNVVEMYK 109
Query: 567 YCDEGQNRLLVYEFMSNGTVASFLFGDSKPNWKLRTEIAM---GIAGGLFYLHEECCTQI 623
G+ ++ EF+ G + + +IA + L YLH + +
Sbjct: 110 SYLVGEELWVLMEFLQGGALTDIV----SQVRLNEEQIATVCEAVLQALAYLHAQ---GV 162
Query: 624 IHCDIKPQNILLDDHYNARISDFGLAKLLTLDQSHTNTAIRGTKGYVAPEWFRNMPITVK 683
IH DIK +ILL ++SDFG ++ D + + GT ++APE +
Sbjct: 163 IHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPKRKSLV-GTPYWMAPEVISRSLYATE 221
Query: 684 VDVYSYGVLLLEII 697
VD++S G++++E++
Sbjct: 222 VDIWSLGIMVIEMV 235
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297 | Back alignment and structure |
|---|
Score = 116 bits (293), Expect = 5e-29
Identities = 54/194 (27%), Positives = 98/194 (50%), Gaps = 12/194 (6%)
Query: 507 EELGRGAFGTVYKGFVNMGSSNHVAVKKLNSVFQDSEKEFKAEVNGIGQTHHKNLVRLLG 566
E++G+GA GTVY +++ + VA++++N Q ++ E+ + + + N+V L
Sbjct: 26 EKIGQGASGTVYTA-MDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLD 84
Query: 567 YCDEGQNRLLVYEFMSNGTVASFLFGDSKPNWKLRTEIAM---GIAGGLFYLHEECCTQI 623
G +V E+++ G++ + +IA L +LH Q+
Sbjct: 85 SYLVGDELWVVMEYLAGGSLTDVV----TETCMDEGQIAAVCRECLQALEFLHSN---QV 137
Query: 624 IHCDIKPQNILLDDHYNARISDFGLAKLLTLDQSHTNTAIRGTKGYVAPEWFRNMPITVK 683
IH DIK NILL + +++DFG +T +QS +T + GT ++APE K
Sbjct: 138 IHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMV-GTPYWMAPEVVTRKAYGPK 196
Query: 684 VDVYSYGVLLLEII 697
VD++S G++ +E+I
Sbjct: 197 VDIWSLGIMAIEMI 210
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294 | Back alignment and structure |
|---|
Score = 116 bits (293), Expect = 6e-29
Identities = 58/195 (29%), Positives = 99/195 (50%), Gaps = 9/195 (4%)
Query: 507 EELGRGAFGTVYKGFVNMGSSNHVAVKKLNSVFQDSE---KEFKAEVNGIGQTHHKNLVR 563
++LG G TVY + + VA+K + ++ E K F+ EV+ Q H+N+V
Sbjct: 17 DKLGGGGMSTVYLA-EDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVS 75
Query: 564 LLGYCDEGQNRLLVYEFMSNGTVASFLFGDSKPNWKLRTEIAMGIAGGLFYLHEECCTQI 623
++ +E LV E++ T++ ++ + I G+ + H+ +I
Sbjct: 76 MIDVDEEDDCYYLVMEYIEGPTLSEYIESHGPLSVDTAINFTNQILDGIKHAHDM---RI 132
Query: 624 IHCDIKPQNILLDDHYNARISDFGLAKLLTLDQSHTNT-AIRGTKGYVAPEWFRNMPITV 682
+H DIKPQNIL+D + +I DFG+AK L+ + S T T + GT Y +PE +
Sbjct: 133 VHRDIKPQNILIDSNKTLKIFDFGIAKALS-ETSLTQTNHVLGTVQYFSPEQAKGEATDE 191
Query: 683 KVDVYSYGVLLLEII 697
D+YS G++L E++
Sbjct: 192 CTDIYSIGIVLYEML 206
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351 | Back alignment and structure |
|---|
Score = 116 bits (292), Expect = 2e-28
Identities = 52/205 (25%), Positives = 82/205 (40%), Gaps = 25/205 (12%)
Query: 505 FKEELGRGAFGTVYKGFVNMGSSNHVAVK-----KLNSVFQDSEKEFKAEVNGIGQTHHK 559
E +G+G F V + +N + AVK K S S ++ K E + H
Sbjct: 28 LCEVIGKGPFSVVRRC-INRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHP 86
Query: 560 NLVRLLGYCDEGQNRLLVYEFMSNGTVASFLFGD--SKPNWKLR-TE-----IAMGIAGG 611
++V LL +V+EFM L + + + +E I
Sbjct: 87 HIVELLETYSSDGMLYMVFEFMDGAD----LCFEIVKRADAGFVYSEAVASHYMRQILEA 142
Query: 612 LFYLHEECCTQIIHCDIKPQNILL---DDHYNARISDFGLAKLLTLDQSHTNTAIRGTKG 668
L Y H+ IIH D+KP +LL ++ ++ FG+A L + GT
Sbjct: 143 LRYCHDN---NIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGESGLVAGGRV-GTPH 198
Query: 669 YVAPEWFRNMPITVKVDVYSYGVLL 693
++APE + P VDV+ GV+L
Sbjct: 199 FMAPEVVKREPYGKPVDVWGCGVIL 223
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289 | Back alignment and structure |
|---|
Score = 114 bits (287), Expect = 3e-28
Identities = 52/289 (17%), Positives = 94/289 (32%), Gaps = 62/289 (21%)
Query: 507 EELGRGAFGTVYKGFVNMGSSNHVAVKKLNSVFQDSEKEFKA--EVNGIGQ-THHKNLVR 563
E++G G FG+V+K V A+K+ S E A EV H ++VR
Sbjct: 17 EKIGSGEFGSVFKC-VKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSHVVR 75
Query: 564 LLGYCDEGQNRLLVYEFMSNGTVASFLFGDSKPNWKLRTE-----IAMGIAGGLFYLHEE 618
E + L+ E+ + G++A + + + E + + + GL Y+H
Sbjct: 76 YFSAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYF-KEAELKDLLLQVGRGLRYIHSM 134
Query: 619 CCTQIIHCDIKPQNILLD-------------------DHYNARISDFGLAKLLTLDQSHT 659
++H DIKP NI + + +I D G ++ Q
Sbjct: 135 ---SLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHVTRISSPQVEE 191
Query: 660 NTAIRGTKGYVAPE-WFRNMPITVKVDVYSYGVLLLEIICLRRNIDNEISKVDKAILTDW 718
G ++A E N K D+++ + ++
Sbjct: 192 -----GDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEP----------------- 229
Query: 719 AYDRYQERTLEALVENDLEAMNNV--TMLHRFVMVAFWCIQEDPSHRPT 765
+ + + L + V + I DP RP+
Sbjct: 230 LPRNGDQ--WHEIRQGRLPRIPQVLSQEFTELLK---VMIHPDPERRPS 273
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343 | Back alignment and structure |
|---|
Score = 115 bits (289), Expect = 4e-28
Identities = 57/284 (20%), Positives = 108/284 (38%), Gaps = 48/284 (16%)
Query: 507 EELGRGAFGTVYKGFVNMGSSNH-VAVK--KLNSVFQDSEKEFKAEVNGIGQT---HHKN 560
+++G G V++ + A+K L + ++ E+ H
Sbjct: 15 KQIGSGGSSKVFQV---LNEKKQIYAIKYVNLEEADNQTLDSYRNEIA-YLNKLQQHSDK 70
Query: 561 LVRLLGYCDEGQNRLLVYEFMSNGTVASFLFGDSKPNWKLRTEIAMGIAGGLFYLHEECC 620
++RL Y Q +V E N + S+L + R + + +H+
Sbjct: 71 IIRLYDYEITDQYIYMVMEC-GNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQH-- 127
Query: 621 TQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLDQSHTN-TAIRGTKGYVAPEWFRNMP 679
I+H D+KP N L+ D ++ DFG+A + D + + GT Y+ PE ++M
Sbjct: 128 -GIVHSDLKPANFLIVDG-MLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMS 185
Query: 680 -----------ITVKVDVYSYGVLLLEIICLR---RNIDNEISKVDKAILTDWAYDRYQE 725
I+ K DV+S G +L + + + I N+ISK+ I + +
Sbjct: 186 SSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNHEIEFPDI 245
Query: 726 RTLEALVENDLEAMNNVTMLHRFVMVAFWCIQEDPSHRPTMRKV 769
+ D+ L C++ DP R ++ ++
Sbjct: 246 PEKDLQ---DV--------LKC-------CLKRDPKQRISIPEL 271
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321 | Back alignment and structure |
|---|
Score = 114 bits (288), Expect = 5e-28
Identities = 46/198 (23%), Positives = 86/198 (43%), Gaps = 22/198 (11%)
Query: 505 FKEELGRGAFGTVYKGFVNMGSSNHVAVKKLNSVFQDSEKEFKAEVNGIGQTHHKNLVRL 564
E+LGRG FG V++ V S K + D K E++ + H+N++ L
Sbjct: 9 IAEDLGRGEFGIVHRC-VETSSKKTYMAKFVKVKGTDQV-LVKKEISILNIARHRNILHL 66
Query: 565 LGYCDEGQNRLLVYEFMSNGTVASFLFGD--SKPNWKLRTE-----IAMGIAGGLFYLHE 617
+ + ++++EF+S +F + + ++L E + L +LH
Sbjct: 67 HESFESMEELVMIFEFISGLD----IF-ERINTSAFEL-NEREIVSYVHQVCEALQFLHS 120
Query: 618 ECCTQIIHCDIKPQNILLDDHYNA--RISDFGLAKLLTLDQSHTNTAIRGTKGYVAPEWF 675
I H DI+P+NI+ ++ +I +FG A+ L + Y APE
Sbjct: 121 H---NIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFRLLF--TAPEYYAPEVH 175
Query: 676 RNMPITVKVDVYSYGVLL 693
++ ++ D++S G L+
Sbjct: 176 QHDVVSTATDMWSLGTLV 193
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387 | Back alignment and structure |
|---|
Score = 115 bits (291), Expect = 6e-28
Identities = 63/237 (26%), Positives = 103/237 (43%), Gaps = 26/237 (10%)
Query: 472 RKKFMRPHQEDQGVSYMNLRCFTYKELVEVTRG-------FKEELGRGAFGTVYKGFVNM 524
R K+ P D Y ++ + VEV +G EELG GAFG V++ V
Sbjct: 15 RGKYDGPKINDYDKFYEDIWKKYVPQPVEVKQGSVYDYYDILEELGSGAFGVVHRC-VEK 73
Query: 525 GSSNHVAVKKLNSVFQDSEKEFKAEVNGIGQTHHKNLVRLLGYCDEGQNRLLVYEFMSNG 584
+ K +N+ + + K E++ + Q HH L+ L ++ +L+ EF+S G
Sbjct: 74 ATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEFLSGG 133
Query: 585 ------TVASFLFGDSKPNWKLRTEIAMGIAGGLFYLHEECCTQIIHCDIKPQNILLDDH 638
+ +++ +R GL ++HE I+H DIKP+NI+ +
Sbjct: 134 ELFDRIAAEDYKMSEAEVINYMRQ-----ACEGLKHMHEH---SIVHLDIKPENIMCETK 185
Query: 639 YNARI--SDFGLAKLLTLDQSHTNTAIRGTKGYVAPEWFRNMPITVKVDVYSYGVLL 693
+ + DFGLA L D+ T T + APE P+ D+++ GVL
Sbjct: 186 KASSVKIIDFGLATKLNPDEIVKVTT--ATAEFAAPEIVDREPVGFYTDMWAIGVLG 240
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313 | Back alignment and structure |
|---|
Score = 113 bits (286), Expect = 7e-28
Identities = 57/284 (20%), Positives = 108/284 (38%), Gaps = 48/284 (16%)
Query: 507 EELGRGAFGTVYKGFVNMGSSNH-VAVK--KLNSVFQDSEKEFKAEVNGIGQT---HHKN 560
+++G G V++ + A+K L + ++ E+ H
Sbjct: 34 KQIGSGGSSKVFQV---LNEKKQIYAIKYVNLEEADNQTLDSYRNEIA-YLNKLQQHSDK 89
Query: 561 LVRLLGYCDEGQNRLLVYEFMSNGTVASFLFGDSKPNWKLRTEIAMGIAGGLFYLHEECC 620
++RL Y Q +V E N + S+L + R + + +H+
Sbjct: 90 IIRLYDYEITDQYIYMVMEC-GNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQH-- 146
Query: 621 TQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLDQSHTN-TAIRGTKGYVAPEWFRNMP 679
I+H D+KP N L+ D ++ DFG+A + D + + GT Y+ PE ++M
Sbjct: 147 -GIVHSDLKPANFLIVDG-MLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMS 204
Query: 680 -----------ITVKVDVYSYGVLLLEIICLR---RNIDNEISKVDKAILTDWAYDRYQE 725
I+ K DV+S G +L + + + I N+ISK+ I + +
Sbjct: 205 SSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNHEIEFPDI 264
Query: 726 RTLEALVENDLEAMNNVTMLHRFVMVAFWCIQEDPSHRPTMRKV 769
+ D+ L C++ DP R ++ ++
Sbjct: 265 PEKDLQ---DV--------LKC-------CLKRDPKQRISIPEL 290
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321 | Back alignment and structure |
|---|
Score = 113 bits (286), Expect = 8e-28
Identities = 51/204 (25%), Positives = 87/204 (42%), Gaps = 26/204 (12%)
Query: 505 FKEELGRGAFGTVYKGFVNMGSSNHVAVK-----KLNSVFQDSEKE-FKAEVNGIGQTHH 558
EELG G F V K + A K + + + +E + EV+ + Q H
Sbjct: 16 IGEELGSGQFAIVKKC-REKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLH 74
Query: 559 KNLVRLLGYCDEGQNRLLVYEFMSNG-----TVASFLFGDSKPNWKLRTEIAMGIAGGLF 613
N++ L + + +L+ E +S G + + ++ I G+
Sbjct: 75 HNVITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQ-----ILDGVN 129
Query: 614 YLHEECCTQIIHCDIKPQNILL----DDHYNARISDFGLAKLLTLDQSHTNTAIRGTKGY 669
YLH + +I H D+KP+NI+L + ++ DFGLA + N GT +
Sbjct: 130 YLHTK---KIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKNIF--GTPEF 184
Query: 670 VAPEWFRNMPITVKVDVYSYGVLL 693
VAPE P+ ++ D++S GV+
Sbjct: 185 VAPEIVNYEPLGLEADMWSIGVIT 208
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390 | Back alignment and structure |
|---|
Score = 114 bits (288), Expect = 1e-27
Identities = 56/283 (19%), Positives = 110/283 (38%), Gaps = 46/283 (16%)
Query: 507 EELGRGAFGTVYKGFVNMGSSNH-VAVK--KLNSVFQDSEKEFKAEVNGIGQTHHKNL-- 561
+++G G V++ + A+K L + ++ E+ + + +
Sbjct: 62 KQIGSGGSSKVFQV---LNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKI 118
Query: 562 VRLLGYCDEGQNRLLVYEFMSNGTVASFLFGDSKPNWKLRTEIAMGIAGGLFYLHEECCT 621
+RL Y Q +V E N + S+L + R + + +H+
Sbjct: 119 IRLYDYEITDQYIYMVMEC-GNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQH--- 174
Query: 622 QIIHCDIKPQNILLDDHYNARISDFGLAKLLTLDQSHTN-TAIRGTKGYVAPEWFRNMP- 679
I+H D+KP N L+ D ++ DFG+A + D + + G Y+ PE ++M
Sbjct: 175 GIVHSDLKPANFLIVDG-MLKLIDFGIANQMQPDTTSVVKDSQVGAVNYMPPEAIKDMSS 233
Query: 680 ----------ITVKVDVYSYGVLLLEIICLR---RNIDNEISKVDKAILTDWAYDRYQER 726
I+ K DV+S G +L + + + I N+ISK+ I + +
Sbjct: 234 SRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNHEIE----- 288
Query: 727 TLEALVENDLEAMNNVTMLHRFVMVAFWCIQEDPSHRPTMRKV 769
+ E DL+ + C++ DP R ++ ++
Sbjct: 289 -FPDIPEKDLQ---------DVLK---CCLKRDPKQRISIPEL 318
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327 | Back alignment and structure |
|---|
Score = 113 bits (284), Expect = 2e-27
Identities = 50/202 (24%), Positives = 86/202 (42%), Gaps = 26/202 (12%)
Query: 506 KEELGRGAFGTVYKGFVNMGSSNHVAVKKLN--SVFQDSEKEFKAEVNGIGQ-THHKNLV 562
+ELGRG F V + ++ + A K L QD E E+ + ++
Sbjct: 34 SKELGRGKFAVVRQC-ISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVI 92
Query: 563 RLLGYCDEGQNRLLVYEFMSNGTVASFLFGD---SKPNWKLRTE-----IAMGIAGGLFY 614
L + +L+ E+ + G +F + + +E + I G++Y
Sbjct: 93 NLHEVYENTSEIILILEYAAGGE----IF-SLCLPELAEMV-SENDVIRLIKQILEGVYY 146
Query: 615 LHEECCTQIIHCDIKPQNILL---DDHYNARISDFGLAKLLTLDQSHTNTAIRGTKGYVA 671
LH+ I+H D+KPQNILL + +I DFG+++ + GT Y+A
Sbjct: 147 LHQN---NIVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKIGHACELREIM--GTPEYLA 201
Query: 672 PEWFRNMPITVKVDVYSYGVLL 693
PE PIT D+++ G++
Sbjct: 202 PEILNYDPITTATDMWNIGIIA 223
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361 | Back alignment and structure |
|---|
Score = 113 bits (285), Expect = 2e-27
Identities = 51/204 (25%), Positives = 87/204 (42%), Gaps = 26/204 (12%)
Query: 505 FKEELGRGAFGTVYKGFVNMGSSNHVAVK-----KLNSVFQDSEKE-FKAEVNGIGQTHH 558
EELG G F V K + A K + + + +E + EV+ + Q H
Sbjct: 16 IGEELGSGQFAIVKKC-REKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLH 74
Query: 559 KNLVRLLGYCDEGQNRLLVYEFMSNG-----TVASFLFGDSKPNWKLRTEIAMGIAGGLF 613
N++ L + + +L+ E +S G + + ++ I G+
Sbjct: 75 PNIITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQ-----ILDGVN 129
Query: 614 YLHEECCTQIIHCDIKPQNILL----DDHYNARISDFGLAKLLTLDQSHTNTAIRGTKGY 669
YLH + +I H D+KP+NI+L + ++ DFGLA + N GT +
Sbjct: 130 YLHTK---KIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKNIF--GTPEF 184
Query: 670 VAPEWFRNMPITVKVDVYSYGVLL 693
VAPE P+ ++ D++S GV+
Sbjct: 185 VAPEIVNYEPLGLEADMWSIGVIT 208
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360 | Back alignment and structure |
|---|
Score = 113 bits (284), Expect = 3e-27
Identities = 53/295 (17%), Positives = 117/295 (39%), Gaps = 36/295 (12%)
Query: 507 EELGRGAFGTVYKGFVNMGSSNHVAVKKLNSVFQDSE-KEFKAEVNGIGQTHHKNLVRLL 565
ELG G G V+K + S +A K ++ + + + E+ + + + +V
Sbjct: 39 SELGAGNGGVVFKV-SHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFY 97
Query: 566 GYCDEGQNRLLVYEFMSNGTVASFLFGDSKPNWKLRTEIAMGIAGGLFYLHEECCTQIIH 625
G + E M G++ L + ++ ++++ + GL YL E+ +I+H
Sbjct: 98 GAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKH--KIMH 155
Query: 626 CDIKPQNILLDDHYNARISDFGLAKLLTLDQSHTNTAIRGTKGYVAPEWFRNMPITVKVD 685
D+KP NIL++ ++ DFG++ L +++ GT+ Y++PE + +V+ D
Sbjct: 156 RDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSFV---GTRSYMSPERLQGTHYSVQSD 212
Query: 686 VYSYGVLLLEIICLR--------RNIDNEISKVDKAILTDWAYDRYQERTLEALVENDLE 737
++S G+ L+E+ R + ++ + + D
Sbjct: 213 IWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPLNKFGMDSR 272
Query: 738 AMNNVTMLHRFV----------------MVAF--WCIQEDPSHRPTMRKVTQMLE 774
+ L ++ F C+ ++P+ R ++ Q++
Sbjct: 273 PPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLK---QLMV 324
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377 | Back alignment and structure |
|---|
Score = 113 bits (284), Expect = 3e-27
Identities = 38/273 (13%), Positives = 78/273 (28%), Gaps = 64/273 (23%)
Query: 473 KKFMRPHQEDQGVSYMNLRCFTYKELVEVTRGFKEELGRGAFGTVYKGFVNMGSSNHVAV 532
Q + S + R T RG LG+ + + + V
Sbjct: 53 TSLWNTGQPFRVESELGERPRTLV------RG--TVLGQEDPYAYLEA-TDQETGESFEV 103
Query: 533 K---KLNSVFQDSEKEFKAEVNGIGQ-------------------------THHKNLVRL 564
++ K+ K EV + K ++R+
Sbjct: 104 HVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDLVKDPQKKKMIRV 163
Query: 565 LGYCDEGQ--NRLLVYEFMSN------GTVASFLFGDSKPNWKLRTEIAMGIAGGLFYLH 616
+ +R +Y M + + S R ++ + + L LH
Sbjct: 164 RLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLH 223
Query: 617 EECCTQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLDQSHTNTAIRGTKGYVAPEWF- 675
++H ++P +I+LD ++ F + ++G+ PE
Sbjct: 224 HYG---LVHTYLRPVDIVLDQRGGVFLTGFEHLV-----RDGARVVSSVSRGFEPPELEA 275
Query: 676 ----------RNMPITVKVDVYSYGVLLLEIIC 698
R +T D ++ G+++ I C
Sbjct: 276 RRATISYHRDRRTLMTFSFDAWALGLVIYWIWC 308
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283 | Back alignment and structure |
|---|
Score = 111 bits (279), Expect = 3e-27
Identities = 56/203 (27%), Positives = 90/203 (44%), Gaps = 24/203 (11%)
Query: 505 FKEELGRGAFGTVYKGFVNMGSSNHVAVK-----KLNSVFQDSEKE-FKAEVNGIGQTHH 558
EELG G F V K G+ A K +L+S + +E + EVN + + H
Sbjct: 9 MGEELGSGQFAIVRKC-RQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRH 67
Query: 559 KNLVRLLGYCDEGQNRLLVYEFMSNGTVASFLF----GDSKPNWKLRTEIAMGIAGGLFY 614
N++ L + + +L+ E +S G LF T+ I G+ Y
Sbjct: 68 PNIITLHDIFENKTDVVLILELVSGGE----LFDFLAEKESLTEDEATQFLKQILDGVHY 123
Query: 615 LHEECCTQIIHCDIKPQNILL----DDHYNARISDFGLAKLLTLDQSHTNTAIRGTKGYV 670
LH + +I H D+KP+NI+L + ++ DFG+A + N GT +V
Sbjct: 124 LHSK---RIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNEFKNIF--GTPEFV 178
Query: 671 APEWFRNMPITVKVDVYSYGVLL 693
APE P+ ++ D++S GV+
Sbjct: 179 APEIVNYEPLGLEADMWSIGVIT 201
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 111 bits (279), Expect = 3e-27
Identities = 60/194 (30%), Positives = 86/194 (44%), Gaps = 12/194 (6%)
Query: 509 LGRGAFGTVYKGFVNMGSSNHVAVKKLNS---VFQDSEKEFKAEVNGIGQTHHKNLVRLL 565
LG+G FG VY S +A+K L E + + EV H N++RL
Sbjct: 17 LGKGKFGNVYLA-REKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLY 75
Query: 566 GYCDEGQNRLLVYEFMSNGTVASFLFGDSK-PNWKLRTEIAMGIAGGLFYLHEECCTQII 624
GY + L+ E+ GTV L SK + T I +A L Y H + ++I
Sbjct: 76 GYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITE-LANALSYCHSK---RVI 131
Query: 625 HCDIKPQNILLDDHYNARISDFGLAKLLTLDQSHTNTAIRGTKGYVAPEWFRNMPITVKV 684
H DIKP+N+LL +I+DFG + + + GT Y+ PE KV
Sbjct: 132 HRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTD---LCGTLDYLPPEMIEGRMHDEKV 188
Query: 685 DVYSYGVLLLEIIC 698
D++S GVL E +
Sbjct: 189 DLWSLGVLCYEFLV 202
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284 | Back alignment and structure |
|---|
Score = 111 bits (279), Expect = 3e-27
Identities = 52/194 (26%), Positives = 85/194 (43%), Gaps = 12/194 (6%)
Query: 509 LGRGAFGTVYKGFVNMGSSNHVAVKKLNS---VFQDSEKEFKAEVNGIGQTHHKNLVRLL 565
LG+G FG VY + +A+K L + E + + E+ H N++R+
Sbjct: 22 LGKGKFGNVYLA-REKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMY 80
Query: 566 GYCDEGQNRLLVYEFMSNGTVASFLFGDSK-PNWKLRTEIAMGIAGGLFYLHEECCTQII 624
Y + + L+ EF G + L + + T + +A L Y HE ++I
Sbjct: 81 NYFHDRKRIYLMLEFAPRGELYKELQKHGRFDEQRSATFMEE-LADALHYCHER---KVI 136
Query: 625 HCDIKPQNILLDDHYNARISDFGLAKLLTLDQSHTNTAIRGTKGYVAPEWFRNMPITVKV 684
H DIKP+N+L+ +I+DFG + + T + GT Y+ PE KV
Sbjct: 137 HRDIKPENLLMGYKGELKIADFGWSVHAPSLRRRT---MCGTLDYLPPEMIEGKTHDEKV 193
Query: 685 DVYSYGVLLLEIIC 698
D++ GVL E +
Sbjct: 194 DLWCAGVLCYEFLV 207
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302 | Back alignment and structure |
|---|
Score = 111 bits (279), Expect = 4e-27
Identities = 52/200 (26%), Positives = 94/200 (47%), Gaps = 17/200 (8%)
Query: 507 EELGRGAFGTVYKGFVNMGSSNHVAVKKLNSVFQDSEKEFKAEVNGIGQTHHKNLVRLLG 566
ELG GAFG VYK N + A K + + ++ +++ E+ + H +V+LLG
Sbjct: 25 GELGDGAFGKVYKA-KNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVKLLG 83
Query: 567 YCDEGQNRLLVYEFMSNGTVASFLFGDSKPNWKLR-TEIAM---GIAGGLFYLHEECCTQ 622
++ EF G V + + + L +I + + L +LH + +
Sbjct: 84 AYYHDGKLWIMIEFCPGGAVDAIMLELDRG---LTEPQIQVVCRQMLEALNFLHSK---R 137
Query: 623 IIHCDIKPQNILLDDHYNARISDFGLAKLLTLDQSHTNTAIRGTKGYVAPE-----WFRN 677
IIH D+K N+L+ + R++DFG++ ++ I GT ++APE ++
Sbjct: 138 IIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKTLQKRDSFI-GTPYWMAPEVVMCETMKD 196
Query: 678 MPITVKVDVYSYGVLLLEII 697
P K D++S G+ L+E+
Sbjct: 197 TPYDYKADIWSLGITLIEMA 216
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314 | Back alignment and structure |
|---|
Score = 111 bits (280), Expect = 5e-27
Identities = 58/195 (29%), Positives = 100/195 (51%), Gaps = 14/195 (7%)
Query: 507 EELGRGAFGTVYKGFVNMGSSNHVAVKKLNSVFQDSEKEFKAEVNGIGQTHHKNLVRLLG 566
E+LG G++G+VYK + + VA+K++ + +E E++ + Q ++V+ G
Sbjct: 35 EKLGEGSYGSVYKAI-HKETGQIVAIKQVP--VESDLQEIIKEISIMQQCDSPHVVKYYG 91
Query: 567 YCDEGQNRLLVYEFMSNGTVASFLFGDSKPNWKLR-TEIAM---GIAGGLFYLHEECCTQ 622
+ + +V E+ G+V+ + +K L EIA GL YLH +
Sbjct: 92 SYFKNTDLWIVMEYCGAGSVSDIIRLRNKT---LTEDEIATILQSTLKGLEYLHFM---R 145
Query: 623 IIHCDIKPQNILLDDHYNARISDFGLAKLLTLDQSHTNTAIRGTKGYVAPEWFRNMPITV 682
IH DIK NILL+ +A+++DFG+A LT + NT I GT ++APE + +
Sbjct: 146 KIHRDIKAGNILLNTEGHAKLADFGVAGQLTDTMAKRNTVI-GTPFWMAPEVIQEIGYNC 204
Query: 683 KVDVYSYGVLLLEII 697
D++S G+ +E+
Sbjct: 205 VADIWSLGITAIEMA 219
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373 | Back alignment and structure |
|---|
Score = 112 bits (283), Expect = 5e-27
Identities = 49/198 (24%), Positives = 88/198 (44%), Gaps = 19/198 (9%)
Query: 504 GFKEELGRGAFGTVYKGFVNMGSSNHVAVKKLNSVFQDSEKEFKAEVNGIGQTHHKNLVR 563
E LG G FG V+K + +A K + + ++E K E++ + Q H NL++
Sbjct: 92 SKTEILGGGRFGQVHKC-EETATGLKLAAKIIKTRGMKDKEEVKNEISVMNQLDHANLIQ 150
Query: 564 LLGYCDEGQNRLLVYEFMSNG------TVASFLFGDSKPNWKLRTEIAMGIAGGLFYLHE 617
L + + +LV E++ G S+ + ++ I G+ ++H+
Sbjct: 151 LYDAFESKNDIVLVMEYVDGGELFDRIIDESYNLTELDTILFMKQ-----ICEGIRHMHQ 205
Query: 618 ECCTQIIHCDIKPQNILLDDHYNARI--SDFGLAKLLTLDQSHTNTAIRGTKGYVAPEWF 675
I+H D+KP+NIL + +I DFGLA+ + GT ++APE
Sbjct: 206 M---YILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPREKLKVNF--GTPEFLAPEVV 260
Query: 676 RNMPITVKVDVYSYGVLL 693
++ D++S GV+
Sbjct: 261 NYDFVSFPTDMWSVGVIA 278
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298 | Back alignment and structure |
|---|
Score = 110 bits (278), Expect = 5e-27
Identities = 54/210 (25%), Positives = 90/210 (42%), Gaps = 32/210 (15%)
Query: 505 FKEELGRGAFGTVYKGFVNMGSSNHVAVKKLN---------SVFQDSEKEFKAEVNGIGQ 555
KE LGRG V + ++ + AVK ++ Q+ + EV+ + +
Sbjct: 21 PKEILGRGVSSVVRRC-IHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRK 79
Query: 556 -THHKNLVRLLGYCDEGQNRLLVYEFMSNGTVASFLFGDSKPNWKLRTE-----IAMGIA 609
+ H N+++L + LV++ M G LF L +E I +
Sbjct: 80 VSGHPNIIQLKDTYETNTFFFLVFDLMKKGE----LFDYLTEKVTL-SEKETRKIMRALL 134
Query: 610 GGLFYLHEECCTQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLDQSHTNTAIRGTKGY 669
+ LH+ I+H D+KP+NILLDD N +++DFG + L + GT Y
Sbjct: 135 EVICALHKL---NIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEKLREVC--GTPSY 189
Query: 670 VAPEWFRNMPITV------KVDVYSYGVLL 693
+APE +VD++S GV++
Sbjct: 190 LAPEIIECSMNDNHPGYGKEVDMWSTGVIM 219
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303 | Back alignment and structure |
|---|
Score = 110 bits (278), Expect = 5e-27
Identities = 57/195 (29%), Positives = 100/195 (51%), Gaps = 13/195 (6%)
Query: 507 EELGRGAFGTVYKGFVNMGSSNHVAVKKLN-SVFQDSEKEFKAEVNGIGQTHHKNLVRLL 565
E++G+G+FG V+KG ++ + VA+K ++ +D ++ + E+ + Q + +
Sbjct: 28 EKIGKGSFGEVFKG-IDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYY 86
Query: 566 GYCDEGQNRLLVYEFMSNGTVASFLFGDSKPNWKLRTEIAM---GIAGGLFYLHEECCTQ 622
G + ++ E++ G+ L +P T+IA I GL YLH E +
Sbjct: 87 GSYLKDTKLWIIMEYLGGGSALDLL----EPGPLDETQIATILREILKGLDYLHSE---K 139
Query: 623 IIHCDIKPQNILLDDHYNARISDFGLAKLLTLDQSHTNTAIRGTKGYVAPEWFRNMPITV 682
IH DIK N+LL +H +++DFG+A LT Q NT + GT ++APE +
Sbjct: 140 KIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNTFV-GTPFWMAPEVIKQSAYDS 198
Query: 683 KVDVYSYGVLLLEII 697
K D++S G+ +E+
Sbjct: 199 KADIWSLGITAIELA 213
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371 | Back alignment and structure |
|---|
Score = 112 bits (280), Expect = 8e-27
Identities = 33/340 (9%), Positives = 74/340 (21%), Gaps = 68/340 (20%)
Query: 472 RKKFMRPHQEDQGVSYMNLRCFTYKELVEVTRGFKEELGRGAFGTVYKGFVNMGSSNHVA 531
+ E S ++ K E L G V+ ++ A
Sbjct: 41 TATVWPQNAETTVDSLLSQGERKLK--------LVEPLRVGDRSVVFLV-RDVERLEDFA 91
Query: 532 VKKLNSVFQDSEKE---FKAEVNGIGQTHHKNLVRLLGYC-------------------- 568
+K ++S E + ++
Sbjct: 92 LKVFTMGAENSRSELERLHEATFAAARLLGESPEEARDRRRLLLPSDAVAVQSQPPFAQL 151
Query: 569 ------DEGQNRLLVYEFMS------NGTVASFLFGDSKPNWKLRTEIAMGIAGGLFYLH 616
N LL+ S T+ + + L
Sbjct: 152 SPGQDDYAVANYLLLMPAASVDLELLFSTLDFVYVFRGDEGILALHILTAQLIRLAANLQ 211
Query: 617 EECCTQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLDQSHTNTAIRGTKGYVAPEWF- 675
+ ++H P N+ + + D + A Y E+
Sbjct: 212 SKG---LVHGHFTPDNLFIMPDGRLMLGDVSALWKV----GTRGPASSVPVTYAPREFLN 264
Query: 676 -RNMPITVKVDVYSYGVLLLEIICLRRNIDNEISKVDKAILTDWAYDRYQERTLEALVEN 734
T ++ + G+ + + CL T ++ +L +
Sbjct: 265 ASTATFTHALNAWQLGLSIYRVWCLFLPFGLV---------TPGIKGSWKRPSLRVPGTD 315
Query: 735 DLEAMNNVTM---LHRFVMVAFWCIQEDPSHRPTMRKVTQ 771
L + + + + + D R + +
Sbjct: 316 SLAFGSCTPLPDFVKTLIG---RFLNFDRRRRLLPLEAME 352
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342 | Back alignment and structure |
|---|
Score = 111 bits (279), Expect = 9e-27
Identities = 52/208 (25%), Positives = 85/208 (40%), Gaps = 42/208 (20%)
Query: 505 FKEELGRGAFGTVYKGFVNMGSSNHVAVKKLNSVFQDSEKEFKAEVNGIGQ-THHKNLVR 563
KE++G G++ + ++ ++ AVK + S+++ E+ + + H N++
Sbjct: 26 VKEDIGVGSYSVCKRC-IHKATNMEFAVK----IIDKSKRDPTEEIEILLRYGQHPNIIT 80
Query: 564 LLGYCDEGQNRLLVYEFMSNG--------------TVASFLFGDSKPNWKLRTEIAMGIA 609
L D+G+ +V E M G AS + T I
Sbjct: 81 LKDVYDDGKYVYVVTELMKGGELLDKILRQKFFSEREASAVL---------FT-----IT 126
Query: 610 GGLFYLHEECCTQIIHCDIKPQNILL----DDHYNARISDFGLAKLLTLDQSHTNTAIRG 665
+ YLH + ++H D+KP NIL + + RI DFG AK L + T
Sbjct: 127 KTVEYLHAQ---GVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAENGLLMTPC-Y 182
Query: 666 TKGYVAPEWFRNMPITVKVDVYSYGVLL 693
T +VAPE D++S GVLL
Sbjct: 183 TANFVAPEVLERQGYDAACDIWSLGVLL 210
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 110 bits (277), Expect = 1e-26
Identities = 53/204 (25%), Positives = 86/204 (42%), Gaps = 26/204 (12%)
Query: 505 FKEELGRGAFGTVYKGFVNMGSSNHVAVK-----KLNSVFQDSEKE-FKAEVNGIGQTHH 558
EELG G F V K + A K + S + +E + EV+ + + H
Sbjct: 15 TGEELGSGQFAVVKKC-REKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQH 73
Query: 559 KNLVRLLGYCDEGQNRLLVYEFMSNG-----TVASFLFGDSKPNWKLRTEIAMGIAGGLF 613
N++ L + + +L+ E ++ G + + L+ I G++
Sbjct: 74 PNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQ-----ILNGVY 128
Query: 614 YLHEECCTQIIHCDIKPQNILL----DDHYNARISDFGLAKLLTLDQSHTNTAIRGTKGY 669
YLH QI H D+KP+NI+L +I DFGLA + N GT +
Sbjct: 129 YLHSL---QIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIF--GTPEF 183
Query: 670 VAPEWFRNMPITVKVDVYSYGVLL 693
VAPE P+ ++ D++S GV+
Sbjct: 184 VAPEIVNYEPLGLEADMWSIGVIT 207
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284 | Back alignment and structure |
|---|
Score = 108 bits (273), Expect = 2e-26
Identities = 53/208 (25%), Positives = 89/208 (42%), Gaps = 39/208 (18%)
Query: 505 FKEELGRGAFGTVYKGFVNMGSSNHVAVKKLN--SVFQDSEKEFKAEVNGIGQTHHKNLV 562
KEELG+GAF V + V+ + A K +N + ++ + E + H N+V
Sbjct: 10 VKEELGKGAFSVVRRC-VHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIV 68
Query: 563 RLLGYCDEGQNRLLVYEFMSNG--------------TVASFLFGDSKPNWKLRTEIAMGI 608
RL E LV++ ++ G AS + I
Sbjct: 69 RLHDSIQEESFHYLVFDLVTGGELFEDIVAREFYSEADASHCI---------QQ-----I 114
Query: 609 AGGLFYLHEECCTQIIHCDIKPQNILLDDHYNA---RISDFGLAKLLTLDQSHTNTAIRG 665
+ Y H I+H ++KP+N+LL +++DFGLA + ++ A G
Sbjct: 115 LESIAYCHSN---GIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWHGFA--G 169
Query: 666 TKGYVAPEWFRNMPITVKVDVYSYGVLL 693
T GY++PE + P + VD+++ GV+L
Sbjct: 170 TPGYLSPEVLKKDPYSKPVDIWACGVIL 197
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573 | Back alignment and structure |
|---|
Score = 113 bits (283), Expect = 3e-26
Identities = 55/196 (28%), Positives = 86/196 (43%), Gaps = 17/196 (8%)
Query: 505 FKEELGRGAFGTVYKGFVNMGSSNHVAVKKLNSVFQDSEKEFKAEVNGIGQTHHKNLVRL 564
EELG GAFG V++ + N+ A K + + + ++ + E+ + H LV L
Sbjct: 161 IHEELGTGAFGVVHRV-TERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNL 219
Query: 565 LGYCDEGQNRLLVYEFMSNGTVASFLFGDSKPNWKLRTE-----IAMGIAGGLFYLHEEC 619
++ +++YEFMS G LF +E + GL ++HE
Sbjct: 220 HDAFEDDNEMVMIYEFMSGGE----LFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHEN- 274
Query: 620 CTQIIHCDIKPQNILLDDHYNARI--SDFGLAKLLTLDQSHTNTAIRGTKGYVAPEWFRN 677
+H D+KP+NI+ + + DFGL L QS T GT + APE
Sbjct: 275 --NYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKVTT--GTAEFAAPEVAEG 330
Query: 678 MPITVKVDVYSYGVLL 693
P+ D++S GVL
Sbjct: 331 KPVGYYTDMWSVGVLS 346
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311 | Back alignment and structure |
|---|
Score = 108 bits (273), Expect = 3e-26
Identities = 61/269 (22%), Positives = 105/269 (39%), Gaps = 31/269 (11%)
Query: 507 EELGRGAFGTVYKGFVNMGSSNHVAVKKLNSVFQDSE---KEFKAEVNGIGQTHHKNLVR 563
E LG G V+ ++ VAVK L + F+ E +H +V
Sbjct: 18 EILGFGGMSEVHLA-RDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVA 76
Query: 564 LLGY-CDEGQNRLLVY---EFMSNGTVASFLFGDSKPNWKLRTEIAMGIAGGLFYLHEEC 619
+ E L Y E++ T+ + + K E+ L + H+
Sbjct: 77 VYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNFSHQ-- 134
Query: 620 CTQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLDQSH-TNT-AIRGTKGYVAPEWFRN 677
IIH D+KP NI++ ++ DFG+A+ + + T T A+ GT Y++PE R
Sbjct: 135 -NGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQARG 193
Query: 678 MPITVKVDVYSYGVLLLEIICLRRNIDNEISKVDKAILTDWAYDRYQERT--LEALVEND 735
+ + DVYS G +L E++ + S V ++ AY +E A E
Sbjct: 194 DSVDARSDVYSLGCVLYEVLTGEPPFTGD-SPV--SV----AYQHVREDPIPPSARHEGL 246
Query: 736 LEAMNNVTMLHRFVMVAFWCIQEDPSHRP 764
++ V + + ++P +R
Sbjct: 247 SADLDAVVL---------KALAKNPENRY 266
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309 | Back alignment and structure |
|---|
Score = 108 bits (273), Expect = 4e-26
Identities = 45/194 (23%), Positives = 73/194 (37%), Gaps = 11/194 (5%)
Query: 507 EELGRGAFGTVYKGF-VNMGSSNHVAVKKLNSVFQDSE---KEFKAEVNGIGQTHHKNLV 562
+GRG G VY+ VA+K ++ + E G+ ++V
Sbjct: 40 RLVGRGGMGDVYEAEDTVRE--RIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVV 97
Query: 563 RLLGYCDEGQNRLLVYEFMSNGTVASFLFGDSKPNWKLRTEIAMGIAGGLFYLHEECCTQ 622
+ + + + ++ +A+ L I I L H
Sbjct: 98 PIHDFGEIDGQLYVDMRLINGVDLAAMLRRQGPLAPPRAVAIVRQIGSALDAAHAA---G 154
Query: 623 IIHCDIKPQNILLDDHYNARISDFGLAKLLTLDQSHTNT-AIRGTKGYVAPEWFRNMPIT 681
H D+KP+NIL+ A + DFG+A T D+ T GT Y+APE F T
Sbjct: 155 ATHRDVKPENILVSADDFAYLVDFGIASATT-DEKLTQLGNTVGTLYYMAPERFSESHAT 213
Query: 682 VKVDVYSYGVLLLE 695
+ D+Y+ +L E
Sbjct: 214 YRADIYALTCVLYE 227
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444 | Back alignment and structure |
|---|
Score = 110 bits (277), Expect = 7e-26
Identities = 49/208 (23%), Positives = 86/208 (41%), Gaps = 38/208 (18%)
Query: 505 FKEELGRGAFGTVYKGFVNMGSSNHVAVKKLN--SVFQDSEKEFKAEVNGIGQTHHKNLV 562
EELG+GAF V + V + + A +N + ++ + E H N+V
Sbjct: 15 LFEELGKGAFSVVRRC-VKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNIV 73
Query: 563 RLLGYCDEGQNRLLVYEFMSNG--------------TVASFLFGDSKPNWKLRTEIAMGI 608
RL E + L+++ ++ G AS + I
Sbjct: 74 RLHDSISEEGHHYLIFDLVTGGELFEDIVAREYYSEADASHCI---------QQ-----I 119
Query: 609 AGGLFYLHEECCTQIIHCDIKPQNILL---DDHYNARISDFGLAKLLTLDQSHTNTAIRG 665
+ + H+ ++H ++KP+N+LL +++DFGLA + +Q G
Sbjct: 120 LEAVLHCHQM---GVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGEQQAWFGFA-G 175
Query: 666 TKGYVAPEWFRNMPITVKVDVYSYGVLL 693
T GY++PE R P VD+++ GV+L
Sbjct: 176 TPGYLSPEVLRKDPYGKPVDLWACGVIL 203
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327 | Back alignment and structure |
|---|
Score = 108 bits (271), Expect = 7e-26
Identities = 57/201 (28%), Positives = 92/201 (45%), Gaps = 17/201 (8%)
Query: 507 EELGRGAFGTVYKGFVNMGSSNHVAVKKLNSVFQDSE-KEFKAEVN-GIGQTHHKNLVRL 564
E+GRGA+G+V K V+ S +AVK++ S + E K+ +++ + + +V+
Sbjct: 28 GEIGRGAYGSVNKM-VHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCPYIVQF 86
Query: 565 LGYCDEGQNRLLVYEFMSNGTVASFLFGDSKPNWKLRTE-----IAMGIAGGLFYLHEEC 619
G + + E M + + F + E I + L +L E
Sbjct: 87 YGALFREGDCWICMELM-STSFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKEN- 144
Query: 620 CTQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLDQSHTNTAIRGTKGYVAPE----WF 675
+IIH DIKP NILLD N ++ DFG++ L + T A G + Y+APE
Sbjct: 145 -LKIIHRDIKPSNILLDRSGNIKLCDFGISGQLVDSIAKTRDA--GCRPYMAPERIDPSA 201
Query: 676 RNMPITVKVDVYSYGVLLLEI 696
V+ DV+S G+ L E+
Sbjct: 202 SRQGYDVRSDVWSLGITLYEL 222
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304 | Back alignment and structure |
|---|
Score = 107 bits (270), Expect = 8e-26
Identities = 54/206 (26%), Positives = 87/206 (42%), Gaps = 38/206 (18%)
Query: 505 FKEELGRGAFGTVYKGFVNMGSSNHVAVKKLNSVFQDSEKEFKAEVNGIGQTHHKNLVRL 564
F E LG GAF V+ + A+K + + + E+ + + H+N+V L
Sbjct: 13 FMEVLGSGAFSEVFLV-KQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKIKHENIVTL 71
Query: 565 LGYCDEGQNRLLVYEFMSNG--------------TVASFLFGDSKPNWKLRTEIAMGIAG 610
+ + LV + +S G AS + + +
Sbjct: 72 EDIYESTTHYYLVMQLVSGGELFDRILERGVYTEKDASLVI---------QQ-----VLS 117
Query: 611 GLFYLHEECCTQIIHCDIKPQNILL---DDHYNARISDFGLAKLLTLDQSHTNTAIRGTK 667
+ YLHE I+H D+KP+N+L +++ I+DFGL+K+ +TA GT
Sbjct: 118 AVKYLHEN---GIVHRDLKPENLLYLTPEENSKIMITDFGLSKME--QNGIMSTAC-GTP 171
Query: 668 GYVAPEWFRNMPITVKVDVYSYGVLL 693
GYVAPE P + VD +S GV+
Sbjct: 172 GYVAPEVLAQKPYSKAVDCWSIGVIT 197
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362 | Back alignment and structure |
|---|
Score = 108 bits (272), Expect = 1e-25
Identities = 53/208 (25%), Positives = 89/208 (42%), Gaps = 39/208 (18%)
Query: 505 FKEELGRGAFGTVYKGFVNMGSSNHVAVKKLN--SVFQDSEKEFKAEVNGIGQTHHKNLV 562
KEELG+GAF V + V+ + A K +N + ++ + E + H N+V
Sbjct: 33 VKEELGKGAFSVVRRC-VHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIV 91
Query: 563 RLLGYCDEGQNRLLVYEFMSNG--------------TVASFLFGDSKPNWKLRTEIAMGI 608
RL E LV++ ++ G AS + I
Sbjct: 92 RLHDSIQEESFHYLVFDLVTGGELFEDIVAREFYSEADASHCI---------QQ-----I 137
Query: 609 AGGLFYLHEECCTQIIHCDIKPQNILL---DDHYNARISDFGLAKLLTLDQSHTNTAIRG 665
+ Y H I+H ++KP+N+LL +++DFGLA + ++ A G
Sbjct: 138 LESIAYCHSN---GIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWHGFA--G 192
Query: 666 TKGYVAPEWFRNMPITVKVDVYSYGVLL 693
T GY++PE + P + VD+++ GV+L
Sbjct: 193 TPGYLSPEVLKKDPYSKPVDIWACGVIL 220
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345 | Back alignment and structure |
|---|
Score = 108 bits (271), Expect = 1e-25
Identities = 55/246 (22%), Positives = 87/246 (35%), Gaps = 56/246 (22%)
Query: 505 FKEELGRGAFGTVYKGFVNMGSSNHVAVK-----KLNSVFQDSEKEFKAEVNGIGQTHHK 559
K +G+G++G V + + A+K K+ + + K EV + + HH
Sbjct: 30 LKGAIGQGSYGVVRVA-IENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHP 88
Query: 560 NLVRLLGYCDEGQNRLLVYEFMSNG----------------------------------- 584
N+ RL ++ Q LV E G
Sbjct: 89 NIARLYEVYEDEQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEE 148
Query: 585 TVASFLFGDSKPNWKLRTE-----IAMGIAGGLFYLHEECCTQIIHCDIKPQNILLDDHY 639
+ + G + ++ E I I L YLH + I H DIKP+N L +
Sbjct: 149 AINGSIHGFRESLDFVQREKLISNIMRQIFSALHYLHNQ---GICHRDIKPENFLFSTNK 205
Query: 640 NAR--ISDFGLAKLLTLDQSHTNTAIR---GTKGYVAPEWFRNM--PITVKVDVYSYGVL 692
+ + DFGL+K + + GT +VAPE K D +S GVL
Sbjct: 206 SFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKCDAWSAGVL 265
Query: 693 LLEIIC 698
L ++
Sbjct: 266 LHLLLM 271
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278 | Back alignment and structure |
|---|
Score = 106 bits (266), Expect = 1e-25
Identities = 53/198 (26%), Positives = 86/198 (43%), Gaps = 17/198 (8%)
Query: 509 LGRGAFGTVYKGFVNMGSSNHVAVK---KLNSVFQDSEKEFKAEVNGIGQTHHKNLVRLL 565
LG+G+F VY+ ++ + VA+K K + + EV Q H +++ L
Sbjct: 19 LGKGSFAGVYRA-ESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELY 77
Query: 566 GYCDEGQNRLLVYEFMSNGTVASFLFGDSKPNWKLRTEIA-----MGIAGGLFYLHEECC 620
Y ++ LV E NG + K K +E I G+ YLH
Sbjct: 78 NYFEDSNYVYLVLEMCHNGE----MNRYLKNRVKPFSENEARHFMHQIITGMLYLHSH-- 131
Query: 621 TQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLDQSHTNTAIRGTKGYVAPEWFRNMPI 680
I+H D+ N+LL + N +I+DFGLA L + T + GT Y++PE
Sbjct: 132 -GILHRDLTLSNLLLTRNMNIKIADFGLATQLKMPHEKHYT-LCGTPNYISPEIATRSAH 189
Query: 681 TVKVDVYSYGVLLLEIIC 698
++ DV+S G + ++
Sbjct: 190 GLESDVWSLGCMFYTLLI 207
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484 | Back alignment and structure |
|---|
Score = 110 bits (276), Expect = 2e-25
Identities = 57/205 (27%), Positives = 92/205 (44%), Gaps = 23/205 (11%)
Query: 505 FKEELGRGAFGTVYKGFVNMGSSNHVAVK---KLNSVFQDSEKEFKAEVNGIGQTHHKNL 561
+ LG+G+FG V + + AVK K + ++ EV + Q H N+
Sbjct: 30 GQRVLGKGSFGEVILC-KDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNI 88
Query: 562 VRLLGYCDEGQNRLLVYEFMSNGTVASFLFGDSKPNWKLRTE-----IAMGIAGGLFYLH 616
++L + ++ LV E + G LF D + K +E I + G+ Y+H
Sbjct: 89 MKLYEFFEDKGYFYLVGEVYTGGE----LF-DEIISRKRFSEVDAARIIRQVLSGITYMH 143
Query: 617 EECCTQIIHCDIKPQNILL---DDHYNARISDFGLAKLLTLDQSHTNTAIRGTKGYVAPE 673
+ +I+H D+KP+N+LL N RI DFGL+ + + GT Y+APE
Sbjct: 144 KN---KIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKKMKDKI--GTAYYIAPE 198
Query: 674 WFRNMPITVKVDVYSYGVLLLEIIC 698
K DV+S GV+L ++
Sbjct: 199 VLHG-TYDEKCDVWSTGVILYILLS 222
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 107 bits (268), Expect = 2e-25
Identities = 62/207 (29%), Positives = 101/207 (48%), Gaps = 24/207 (11%)
Query: 507 EELGRGAFGTVYKGFVNMGSSNHVAVKKLNSVFQDSEKEFKAEVNGIGQT-HHKNLVRLL 565
E +G G +G VYKG ++ + A+K ++ V D E+E K E+N + + HH+N+
Sbjct: 30 ELVGNGTYGQVYKG-RHVKTGQLAAIKVMD-VTGDEEEEIKQEINMLKKYSHHRNIATYY 87
Query: 566 G-----YCDEGQNRL-LVYEFMSNGTVASFLFGDSKPNWKLR-TEIAM---GIAGGLFYL 615
G ++L LV EF G+V + + L+ IA I GL +L
Sbjct: 88 GAFIKKNPPGMDDQLWLVMEFCGAGSVTDLI--KNTKGNTLKEEWIAYICREILRGLSHL 145
Query: 616 HEECCTQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLDQSHTNTAIRGTKGYVAPE-- 673
H+ ++IH DIK QN+LL ++ ++ DFG++ L NT I GT ++APE
Sbjct: 146 HQH---KVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNTFI-GTPYWMAPEVI 201
Query: 674 ---WFRNMPITVKVDVYSYGVLLLEII 697
+ K D++S G+ +E+
Sbjct: 202 ACDENPDATYDFKSDLWSLGITAIEMA 228
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294 | Back alignment and structure |
|---|
Score = 106 bits (267), Expect = 2e-25
Identities = 46/197 (23%), Positives = 81/197 (41%), Gaps = 16/197 (8%)
Query: 509 LGRGAFGTVYKGFVNMGSSNHVAVK---KLNSVFQDSEKEFKAEVNGIGQTHHKNLVRLL 565
LG+G F ++ + + A K K + ++ E++ H+++V
Sbjct: 23 LGKGGFAKCFEI-SDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFH 81
Query: 566 GYCDEGQNRLLVYEFMSNGTVASFLFGDSKPNWKLRTEIA----MGIAGGLFYLHEECCT 621
G+ ++ +V E + L K L A I G YLH
Sbjct: 82 GFFEDNDFVFVVLELCRRRS----LLELHKRRKALTEPEARYYLRQIVLGCQYLHRN--- 134
Query: 622 QIIHCDIKPQNILLDDHYNARISDFGLAKLLTLDQSHTNTAIRGTKGYVAPEWFRNMPIT 681
++IH D+K N+ L++ +I DFGLA + D + GT Y+APE +
Sbjct: 135 RVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKV-LCGTPNYIAPEVLSKKGHS 193
Query: 682 VKVDVYSYGVLLLEIIC 698
+VDV+S G ++ ++
Sbjct: 194 FEVDVWSIGCIMYTLLV 210
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335 | Back alignment and structure |
|---|
Score = 107 bits (269), Expect = 2e-25
Identities = 45/197 (22%), Positives = 81/197 (41%), Gaps = 16/197 (8%)
Query: 509 LGRGAFGTVYKGFVNMGSSNHVAVK---KLNSVFQDSEKEFKAEVNGIGQTHHKNLVRLL 565
LG+G F ++ + + A K K + ++ E++ H+++V
Sbjct: 49 LGKGGFAKCFEI-SDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFH 107
Query: 566 GYCDEGQNRLLVYEFMSNGTVASFLFGDSKPNWKLRTEIA----MGIAGGLFYLHEECCT 621
G+ ++ +V E ++ K L A I G YLH
Sbjct: 108 GFFEDNDFVFVVLELCRRRSLLELH----KRRKALTEPEARYYLRQIVLGCQYLHRN--- 160
Query: 622 QIIHCDIKPQNILLDDHYNARISDFGLAKLLTLDQSHTNTAIRGTKGYVAPEWFRNMPIT 681
++IH D+K N+ L++ +I DFGLA + D + GT Y+APE +
Sbjct: 161 RVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKV-LCGTPNYIAPEVLSKKGHS 219
Query: 682 VKVDVYSYGVLLLEIIC 698
+VDV+S G ++ ++
Sbjct: 220 FEVDVWSIGCIMYTLLV 236
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332 | Back alignment and structure |
|---|
Score = 106 bits (267), Expect = 2e-25
Identities = 42/275 (15%), Positives = 82/275 (29%), Gaps = 45/275 (16%)
Query: 511 RGAFGTVYKGFVNMGSSNHVAVKKLNSVFQDSEKEFKAEVNGIGQTHHKNLVRLLGYCDE 570
A+ + S A I + + +G
Sbjct: 70 FNAWLETPPEKWQEEMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQP 129
Query: 571 GQNRLLVY---EFMSNGTVASFL---FGDSKPNWKLRTEIAMGIAGGLFYLHEECCTQII 624
++ +Y + + ++ + I + IA + +LH + ++
Sbjct: 130 SSPKVYLYIQMQLCRKENLKDWMNRRCSLEDREHGVCLHIFIQIAEAVEFLHSK---GLM 186
Query: 625 HCDIKPQNILLDDHYNARISDFGLAKLLTLDQSHTNTAIR-----------GTKGYVAPE 673
H D+KP NI ++ DFGL + D+ GTK Y++PE
Sbjct: 187 HRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTKLYMSPE 246
Query: 674 WFRNMPITVKVDVYSYGVLLLEIICLRR---NIDNEISKVDKAILTDWAYDRYQERTLEA 730
+ KVD++S G++L E++ I+ V +Y +
Sbjct: 247 QIHGNNYSHKVDIFSLGLILFELLYSFSTQMERVRIITDVRNLKFPLLFTQKYPQ--EHM 304
Query: 731 LVENDLEAMNNVTMLHRFVMVAFWCIQEDPSHRPT 765
+V+ + P+ RP
Sbjct: 305 MVQ--------------------DMLSPSPTERPE 319
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365 | Back alignment and structure |
|---|
Score = 107 bits (269), Expect = 2e-25
Identities = 49/219 (22%), Positives = 88/219 (40%), Gaps = 51/219 (23%)
Query: 505 FKEELGRGAFGTVYKGFVNMGSSNHVAVKKLN--------SVFQDSEKEFKAEVNGIGQ- 555
K+ +GRG V + V+ + + AVK + ++ + + E + I +
Sbjct: 98 PKDVIGRGVSSVVRRC-VHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETH-ILRQ 155
Query: 556 -THHKNLVRLLGYCDEGQNRLLVYEFMSNG--------------TVASFLFGDSKPNWKL 600
H +++ L+ + LV++ M G +
Sbjct: 156 VAGHPHIITLIDSYESSSFMFLVFDLMRKGELFDYLTEKVALSEKETRSIM--------- 206
Query: 601 RTEIAMGIAGGLFYLHEECCTQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLDQSHTN 660
R+ + + +LH I+H D+KP+NILLDD+ R+SDFG + L +
Sbjct: 207 RS-----LLEAVSFLHAN---NIVHRDLKPENILLDDNMQIRLSDFGFSCHLEPGEKLRE 258
Query: 661 TAIRGTKGYVAPEWFRNMPITV------KVDVYSYGVLL 693
GT GY+APE + +VD+++ GV+L
Sbjct: 259 LC--GTPGYLAPEILKCSMDETHPGYGKEVDLWACGVIL 295
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419 | Back alignment and structure |
|---|
Score = 108 bits (272), Expect = 3e-25
Identities = 57/214 (26%), Positives = 95/214 (44%), Gaps = 33/214 (15%)
Query: 505 FKEELGRGAFGTVYKGFVNMGSSNHVAVKKLN--------SVFQDSEKEFKAEVNGIGQT 556
+ LG GA G V + VA++ ++ + D + E+ + +
Sbjct: 139 MSKTLGSGACGEVKLA-FERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKL 197
Query: 557 HHKNLVRLLGYCDEGQNRLLVYEFMSNGTVASFLFGDSKPNWKLRTE-----IAMGIAGG 611
+H ++++ + D ++ +V E M G LF N +L E +
Sbjct: 198 NHPCIIKIKNFFDA-EDYYIVLELMEGGE----LFDKVVGNKRL-KEATCKLYFYQMLLA 251
Query: 612 LFYLHEECCTQIIHCDIKPQNILL---DDHYNARISDFGLAKLLTLDQSHTNTAIRGTKG 668
+ YLHE IIH D+KP+N+LL ++ +I+DFG +K+L + S T GT
Sbjct: 252 VQYLHEN---GIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILG-ETSLMRTLC-GTPT 306
Query: 669 YVAPEWFRNM---PITVKVDVYSYGVLLLEIICL 699
Y+APE ++ VD +S GV+L ICL
Sbjct: 307 YLAPEVLVSVGTAGYNRAVDCWSLGVILF--ICL 338
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494 | Back alignment and structure |
|---|
Score = 109 bits (273), Expect = 3e-25
Identities = 57/204 (27%), Positives = 91/204 (44%), Gaps = 22/204 (10%)
Query: 505 FKEELGRGAFGTVYKGFVNMGSSNHVAVKKLN--SVFQDSEKEFKAEVNGIGQTHHKNLV 562
++LG GA+G V + + A+K + SV S + EV + H N++
Sbjct: 41 RVKKLGSGAYGEVLLC-RDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIM 99
Query: 563 RLLGYCDEGQNRLLVYEFMSNGTVASFLFGDSKPNWKLRTE-----IAMGIAGGLFYLHE 617
+L + ++ +N LV E G LF D + E I + G+ YLH+
Sbjct: 100 KLYDFFEDKRNYYLVMECYKGGE----LF-DEIIHRMKFNEVDAAVIIKQVLSGVTYLHK 154
Query: 618 ECCTQIIHCDIKPQNILL---DDHYNARISDFGLAKLLTLDQSHTNTAIRGTKGYVAPEW 674
I+H D+KP+N+LL + +I DFGL+ + + GT Y+APE
Sbjct: 155 H---NIVHRDLKPENLLLESKEKDALIKIVDFGLSAVFENQKKMKERL--GTAYYIAPEV 209
Query: 675 FRNMPITVKVDVYSYGVLLLEIIC 698
R K DV+S GV+L ++
Sbjct: 210 LRK-KYDEKCDVWSIGVILFILLA 232
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285 | Back alignment and structure |
|---|
Score = 105 bits (263), Expect = 4e-25
Identities = 59/201 (29%), Positives = 95/201 (47%), Gaps = 23/201 (11%)
Query: 505 FKEELGRGAFGTVYKGFVNMGSSNHVAVKKLN-SVFQDSEKEFKAEVNGIGQTHHKNLVR 563
FK +LG GAFG V+ S +K +N Q ++ +AE+ + H N+++
Sbjct: 26 FKRKLGSGAFGDVHLV-EERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHPNIIK 84
Query: 564 LLGYCDEGQNRLLVYEFMSNGTVASFLF---GDSKPNWKLRTE-----IAMGIAGGLFYL 615
+ ++ N +V E G L ++ K +E + + L Y
Sbjct: 85 IFEVFEDYHNMYIVMETCEGGE----LLERIVSAQARGKALSEGYVAELMKQMMNALAYF 140
Query: 616 HEECCTQIIHCDIKPQNILL---DDHYNARISDFGLAKLLTLDQSHTNTAIRGTKGYVAP 672
H + ++H D+KP+NIL H +I DFGLA+L D+ TN A GT Y+AP
Sbjct: 141 HSQ---HVVHKDLKPENILFQDTSPHSPIKIIDFGLAELFKSDEHSTNAA--GTALYMAP 195
Query: 673 EWFRNMPITVKVDVYSYGVLL 693
E F+ +T K D++S GV++
Sbjct: 196 EVFKR-DVTFKCDIWSAGVVM 215
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290 | Back alignment and structure |
|---|
Score = 105 bits (263), Expect = 5e-25
Identities = 62/284 (21%), Positives = 113/284 (39%), Gaps = 46/284 (16%)
Query: 507 EELGRGAFGTVYKGFVNMGSSNHVAVKKLNSVFQDSE-KEFKAEVN-GIGQTHHKNLVRL 564
ELGRGA+G V K ++ S +AVK++ + E K +++ + V
Sbjct: 13 MELGRGAYGVVEKM-RHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTF 71
Query: 565 LGYCDEGQNRLLVYEFMSNGTVASFLFGDSKPNWKLRTE----IAMGIAGGLFYLHEECC 620
G + + E M + ++ F + + IA+ I L +LH +
Sbjct: 72 YGALFREGDVWICMELM-DTSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSK-- 128
Query: 621 TQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLDQSHTNTAIRGTKGYVAPE----WFR 676
+IH D+KP N+L++ ++ DFG++ L D + G K Y+APE
Sbjct: 129 LSVIHRDVKPSNVLINALGQVKMCDFGISGYLV-DDVAKDIDA-GCKPYMAPERINPELN 186
Query: 677 NMPITVKVDVYSYGVLLLEIICLR---RNIDNEISKVDKAILTDWAYDRYQERTLEALVE 733
+VK D++S G+ ++E+ LR + + L+ +VE
Sbjct: 187 QKGYSVKSDIWSLGITMIELAILRFPYDSWGTPF------------------QQLKQVVE 228
Query: 734 ND---LEAMNNVTMLHRFVMVAFWCIQEDPSHRPTMRKVTQMLE 774
L A F C++++ RPT ++++
Sbjct: 229 EPSPQLPADKFSAEFVDFTSQ---CLKKNSKERPT---YPELMQ 266
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287 | Back alignment and structure |
|---|
Score = 104 bits (262), Expect = 5e-25
Identities = 54/198 (27%), Positives = 88/198 (44%), Gaps = 20/198 (10%)
Query: 505 FKEELGRGAFGTVYKGFVNMGSSNHVAVKKLN--SVFQDSEKEFKAEVNGIGQTHHKNLV 562
LG+G+FG V K + + AVK +N S EV + + H N++
Sbjct: 26 IVCMLGKGSFGEVLKC-KDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIM 84
Query: 563 RLLGYCDEGQNRLLVYEFMSNGTVASFLFGD--SKPNWKLRT--EIAMGIAGGLFYLHEE 618
+L ++ + +V E + G LF + + + I + G+ Y+H+
Sbjct: 85 KLFEILEDSSSFYIVGELYTGGE----LFDEIIKRKRFSEHDAARIIKQVFSGITYMHKH 140
Query: 619 CCTQIIHCDIKPQNILL---DDHYNARISDFGLAKLLTLDQSHTNTAIRGTKGYVAPEWF 675
I+H D+KP+NILL + + +I DFGL+ + + GT Y+APE
Sbjct: 141 ---NIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMKDRI--GTAYYIAPEVL 195
Query: 676 RNMPITVKVDVYSYGVLL 693
R K DV+S GV+L
Sbjct: 196 RG-TYDEKCDVWSAGVIL 212
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322 | Back alignment and structure |
|---|
Score = 105 bits (264), Expect = 6e-25
Identities = 57/213 (26%), Positives = 95/213 (44%), Gaps = 31/213 (14%)
Query: 505 FKEELGRGAFGTVYKGFVNMGSSNHVAVKKLN--------SVFQDSEKEFKAEVNGIGQT 556
+ LG GA G V + VA+K ++ + D + E+ + +
Sbjct: 14 MSKTLGSGACGEVKLA-FERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKL 72
Query: 557 HHKNLVRLLGYCDEGQNRLLVYEFMSNGTVASFLFGDSKPNWKLRTEIAMG----IAGGL 612
+H ++++ + D ++ +V E M G LF N +L+ + +
Sbjct: 73 NHPCIIKIKNFFDA-EDYYIVLELMEGGE----LFDKVVGNKRLKEATCKLYFYQMLLAV 127
Query: 613 FYLHEECCTQIIHCDIKPQNILL---DDHYNARISDFGLAKLLTLDQSHTNTAIRGTKGY 669
YLHE IIH D+KP+N+LL ++ +I+DFG +K+L + S T GT Y
Sbjct: 128 QYLHEN---GIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILG-ETSLMRTLC-GTPTY 182
Query: 670 VAPEWFRNM---PITVKVDVYSYGVLLLEIICL 699
+APE ++ VD +S GV+L ICL
Sbjct: 183 LAPEVLVSVGTAGYNRAVDCWSLGVILF--ICL 213
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325 | Back alignment and structure |
|---|
Score = 105 bits (263), Expect = 9e-25
Identities = 51/199 (25%), Positives = 86/199 (43%), Gaps = 26/199 (13%)
Query: 506 KEELGRGAFGTVYKGFVNMGSSNHVAVKKLNSVFQDSEKEFKAEVNGIGQ-THHKNLVRL 564
+ LG G+F K V+ S+ AVK + + E + E+ + H N+V+L
Sbjct: 16 DKPLGEGSFSICRKC-VHKKSNQAFAVK---IISKRMEANTQKEITALKLCEGHPNIVKL 71
Query: 565 LGYCDEGQNRLLVYEFMSNGTVASFLFGD--SKPNWKLRTE-----IAMGIAGGLFYLHE 617
+ + LV E ++ G LF K ++ +E I + + ++H+
Sbjct: 72 HEVFHDQLHTFLVMELLNGGE----LFERIKKKKHF---SETEASYIMRKLVSAVSHMHD 124
Query: 618 ECCTQIIHCDIKPQNILL---DDHYNARISDFGLAKLLTLDQSHTNTAIRGTKGYVAPEW 674
++H D+KP+N+L +D+ +I DFG A+L D T T Y APE
Sbjct: 125 V---GVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQPLKTPC-FTLHYAAPEL 180
Query: 675 FRNMPITVKVDVYSYGVLL 693
D++S GV+L
Sbjct: 181 LNQNGYDESCDLWSLGVIL 199
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277 | Back alignment and structure |
|---|
Score = 103 bits (260), Expect = 1e-24
Identities = 48/197 (24%), Positives = 82/197 (41%), Gaps = 20/197 (10%)
Query: 505 FKEELGRGAFGTVYKGFVNMGSSNHVAVKKLNSVFQDSEKEFKAEVNGIGQTHHKNLVRL 564
+ +GRG++G V V G+ A KK+ F + FK E+ + H N++RL
Sbjct: 13 LENTIGRGSWGEVKIA-VQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNIIRL 71
Query: 565 LGYCDEGQNRLLVYEFMSNGTVASFLFGDSKPNWKLRTE-----IAMGIAGGLFYLHEEC 619
++ + LV E + G LF + + ++ E I + + Y H+
Sbjct: 72 YETFEDNTDIYLVMELCTGGE----LF-ERVVHKRVFRESDAARIMKDVLSAVAYCHKL- 125
Query: 620 CTQIIHCDIKPQNILL---DDHYNARISDFGLAKLLTLDQSHTNTAIRGTKGYVAPEWFR 676
+ H D+KP+N L ++ DFGLA + GT YV+P+
Sbjct: 126 --NVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGKMMRTKV--GTPYYVSPQVLE 181
Query: 677 NMPITVKVDVYSYGVLL 693
+ D +S GV++
Sbjct: 182 G-LYGPECDEWSAGVMM 197
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348 | Back alignment and structure |
|---|
Score = 105 bits (263), Expect = 1e-24
Identities = 46/221 (20%), Positives = 81/221 (36%), Gaps = 43/221 (19%)
Query: 509 LGRGAFGTVY----KGFVNMGSSNHVAVKKLN-----------------SVFQDSEKEFK 547
L +G F + A+KK + +FK
Sbjct: 39 LNQGKFNKIILCEKDNK-------FYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFK 91
Query: 548 AEVNGIGQTHHKNLVRLLGYCDEGQNRLLVYEFMSNGTVASFL----FGDSKPNWKLRTE 603
E+ I ++ + G ++YE+M N ++ F D + +
Sbjct: 92 NELQIITDIKNEYCLTCEGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQ 151
Query: 604 IAM----GIAGGLFYLHEECCTQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLDQSHT 659
+ + Y+H E I H D+KP NIL+D + ++SDFG ++ + +
Sbjct: 152 VIKCIIKSVLNSFSYIHNE--KNICHRDVKPSNILMDKNGRVKLSDFGESEYMVDKKIKG 209
Query: 660 NTAIRGTKGYVAPEWFRNMPITV--KVDVYSYGVLLLEIIC 698
RGT ++ PE+F N KVD++S G+ L +
Sbjct: 210 ---SRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFY 247
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486 | Back alignment and structure |
|---|
Score = 107 bits (268), Expect = 1e-24
Identities = 57/204 (27%), Positives = 91/204 (44%), Gaps = 22/204 (10%)
Query: 505 FKEELGRGAFGTVYKGFVNMGSSNHVAVKKLN--SVFQDSEKEFKAEVNGIGQTHHKNLV 562
LG+G+FG V K + + AVK +N S EV + + H N++
Sbjct: 26 IVCMLGKGSFGEVLKC-KDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIM 84
Query: 563 RLLGYCDEGQNRLLVYEFMSNGTVASFLFGDSKPNWKLRTE-----IAMGIAGGLFYLHE 617
+L ++ + +V E + G LF D K +E I + G+ Y+H+
Sbjct: 85 KLFEILEDSSSFYIVGELYTGGE----LF-DEIIKRKRFSEHDAARIIKQVFSGITYMHK 139
Query: 618 ECCTQIIHCDIKPQNILL---DDHYNARISDFGLAKLLTLDQSHTNTAIRGTKGYVAPEW 674
I+H D+KP+NILL + + +I DFGL+ + + GT Y+APE
Sbjct: 140 H---NIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMKDRI--GTAYYIAPEV 194
Query: 675 FRNMPITVKVDVYSYGVLLLEIIC 698
R K DV+S GV+L ++
Sbjct: 195 LRG-TYDEKCDVWSAGVILYILLS 217
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543 | Back alignment and structure |
|---|
Score = 107 bits (269), Expect = 1e-24
Identities = 69/223 (30%), Positives = 104/223 (46%), Gaps = 21/223 (9%)
Query: 509 LGRGAFGTVYKGFVNMGSSNHV-AVKKLN--SVFQDSEKEF-KAEVNGIGQTHHKNLVRL 564
LGRG FG V+ M ++ + A KKLN + + + E + + H + +V L
Sbjct: 193 LGRGGFGEVFA--CQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSL 250
Query: 565 LGYCDEGQNRL-LVYEFMSNGTVASFLFGDSKPNWKLRTEIAM----GIAGGLFYLHEEC 619
Y E + L LV M+ G + ++ + N + A+ I GL +LH+
Sbjct: 251 A-YAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQR- 308
Query: 620 CTQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLDQSHTNTAIRGTKGYVAPEWFRNMP 679
II+ D+KP+N+LLDD N RISD GLA L Q+ T GT G++APE
Sbjct: 309 --NIIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTKTKGYA-GTPGFMAPELLLGEE 365
Query: 680 ITVKVDVYSYGVLLLEIICLR-----RNIDNEISKVDKAILTD 717
VD ++ GV L E+I R R E ++ + +L
Sbjct: 366 YDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRVLEQ 408
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349 | Back alignment and structure |
|---|
Score = 104 bits (262), Expect = 2e-24
Identities = 55/199 (27%), Positives = 87/199 (43%), Gaps = 25/199 (12%)
Query: 505 FKEELGRGAFGTVYKGFVNMGSSNHVAVKKLNSVFQDSEKEFKAEVNGIGQTHHKNLVRL 564
+ ELGRGA VY+ G+ A+K L +K + E+ + + H N+++L
Sbjct: 57 VESELGRGATSIVYRC-KQKGTQKPYALKVLKK--TVDKKIVRTEIGVLLRLSHPNIIKL 113
Query: 565 LGYCDEGQNRLLVYEFMSNGTVASFLFGD--SKPNWKLRTE-----IAMGIAGGLFYLHE 617
+ LV E ++ G LF K + +E I + YLHE
Sbjct: 114 KEIFETPTEISLVLELVTGGE----LFDRIVEKGYY---SERDAADAVKQILEAVAYLHE 166
Query: 618 ECCTQIIHCDIKPQNILL---DDHYNARISDFGLAKLLTLDQSHTNTAIRGTKGYVAPEW 674
I+H D+KP+N+L +I+DFGL+K++ GT GY APE
Sbjct: 167 N---GIVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEHQVLMKTVC--GTPGYCAPEI 221
Query: 675 FRNMPITVKVDVYSYGVLL 693
R +VD++S G++
Sbjct: 222 LRGCAYGPEVDMWSVGIIT 240
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504 | Back alignment and structure |
|---|
Score = 106 bits (266), Expect = 3e-24
Identities = 58/215 (26%), Positives = 91/215 (42%), Gaps = 33/215 (15%)
Query: 505 FKEELGRGAFGTVYKGFVNMGSSNHVAVKKLN-------------SVFQDSEKEFKAEVN 551
+LG GA+G V + A+K + + +E E++
Sbjct: 40 KVRKLGSGAYGEVLLC-KEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEIS 98
Query: 552 GIGQTHHKNLVRLLGYCDEGQNRLLVYEFMSNGTVASFLFGDSKPNWKLRTE-----IAM 606
+ H N+++L ++ + LV EF G LF + N E I
Sbjct: 99 LLKSLDHPNIIKLFDVFEDKKYFYLVTEFYEGGE----LF-EQIINRHKFDECDAANIMK 153
Query: 607 GIAGGLFYLHEECCTQIIHCDIKPQNILL---DDHYNARISDFGLAKLLTLDQSHTNTAI 663
I G+ YLH+ I+H DIKP+NILL + N +I DFGL+ + D +
Sbjct: 154 QILSGICYLHKH---NIVHRDIKPENILLENKNSLLNIKIVDFGLSSFFSKDYKLRDRL- 209
Query: 664 RGTKGYVAPEWFRNMPITVKVDVYSYGVLLLEIIC 698
GT Y+APE + K DV+S GV++ ++C
Sbjct: 210 -GTAYYIAPEVLKK-KYNEKCDVWSCGVIMYILLC 242
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681 | Back alignment and structure |
|---|
Score = 106 bits (266), Expect = 6e-24
Identities = 39/201 (19%), Positives = 73/201 (36%), Gaps = 18/201 (8%)
Query: 507 EELGRGAFGTVYKGFVNMGSSNHVAVKKLNSVFQDSEKE-FKAEVNGIGQTHHKNLVRLL 565
+ G G +Y + V +K L + AE + + H ++V++
Sbjct: 86 GCIAHGGLGWIYLALDRNVNGRPVVLKGLVHSGDAEAQAMAMAERQFLAEVVHPSIVQIF 145
Query: 566 GYCDEGQNRL-----LVYEFMSNGTVASFLFGDSKPNWKLRTEIAMGIAGGLFYLHEECC 620
+ + +V E++ ++ + + I L YLH
Sbjct: 146 NFVEHTDRHGDPVGYIVMEYVGGQSLKRSKGQKLPVAEAIA--YLLEILPALSYLHSI-- 201
Query: 621 TQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLDQSHTNTAIRGTKGYVAPEWFRNMPI 680
+++ D+KP+NI+L + ++ D G + GT G+ APE R P
Sbjct: 202 -GLVYNDLKPENIMLTEE-QLKLIDLGAVSRIN----SFGYLY-GTPGFQAPEIVRTGP- 253
Query: 681 TVKVDVYSYGVLLLEIICLRR 701
TV D+Y+ G L +
Sbjct: 254 TVATDIYTVGRTLAALTLDLP 274
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389 | Back alignment and structure |
|---|
Score = 101 bits (254), Expect = 2e-23
Identities = 48/305 (15%), Positives = 88/305 (28%), Gaps = 54/305 (17%)
Query: 507 EELGRGA--FGTVYKGFVNMGSSNHVAVKKLN--SVFQDSEKEFKAEVNGIGQTHHKNLV 562
+G+G TV + +V V+++N + + + E++ +H N+V
Sbjct: 31 TVIGKGFEDLMTVNLA-RYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHPNIV 89
Query: 563 RLLGYCDEGQNRLLVYEFMSNGTVASFLFGDSKPNWKLRTEIAM---GIAGGLFYLHEEC 619
+V FM+ G+ L + IA G+ L Y+H
Sbjct: 90 PYRATFIADNELWVVTSFMAYGSAKD-LICTHFMDGMNELAIAYILQGVLKALDYIHHM- 147
Query: 620 CTQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLDQSHTNTAIRGTKGYV------APE 673
+H +K +IL+ +S + K V +PE
Sbjct: 148 --GYVHRSVKASHILISVDGKVYLSGLRSNLSMISHGQRQRVVHDFPKYSVKVLPWLSPE 205
Query: 674 WFRNMPI--TVKVDVYSYGVLLLEII------------------------CLRRNIDNEI 707
+ K D+YS G+ E+ CL
Sbjct: 206 VLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLNGTVPCLLDTSTIPA 265
Query: 708 SKVDKAILTDWAYDRYQERTLEALVENDLEAMNNVTM-------LHRFVMVAFWCIQEDP 760
++ + A + + + H FV C+Q +P
Sbjct: 266 EELTMSPSRSVANSGLSDSLTTSTPRPSNGDSPSHPYHRTFSPHFHHFVEQ---CLQRNP 322
Query: 761 SHRPT 765
RP+
Sbjct: 323 DARPS 327
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303 | Back alignment and structure |
|---|
Score = 100 bits (250), Expect = 3e-23
Identities = 70/274 (25%), Positives = 109/274 (39%), Gaps = 28/274 (10%)
Query: 507 EELGRGAFGTVYKGFVNMGSSNHVAVKKLN-SVFQDSEKEFKAEVNGIGQTHHKNLVRLL 565
E +G GA V VA+K++N Q S E E+ + Q HH N+V
Sbjct: 21 EVIGSGATAVVQAA-YCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNIVSYY 79
Query: 566 GYCDEGQNRLLVYEFMSNGTVA-----SFLFGDSKPNWKLRTEIAM---GIAGGLFYLHE 617
LV + +S G+V G+ K + IA + GL YLH+
Sbjct: 80 TSFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHK 139
Query: 618 ECCTQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLDQSHTNTAIR----GTKGYVAPE 673
IH D+K NILL + + +I+DFG++ L T +R GT ++APE
Sbjct: 140 N---GQIHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVRKTFVGTPCWMAPE 196
Query: 674 WF-RNMPITVKVDVYSYGVLLLEIICLRR-NIDNEISKVDKAILTDWAYDRYQERTLEAL 731
+ K D++S+G+ +E+ KV L + +LE
Sbjct: 197 VMEQVRGYDFKADIWSFGITAIELATGAAPYHKYPPMKVLMLTLQN------DPPSLETG 250
Query: 732 VENDLEAMNNVTMLHRFVMVAFWCIQEDPSHRPT 765
V++ + + C+Q+DP RPT
Sbjct: 251 VQDKEMLKKYGKSFRKMIS---LCLQKDPEKRPT 281
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318 | Back alignment and structure |
|---|
Score = 100 bits (251), Expect = 3e-23
Identities = 58/282 (20%), Positives = 111/282 (39%), Gaps = 43/282 (15%)
Query: 507 EELGRGAFGTVYKGFVNMGSSNHVAVKKLNSVFQDSE-KEFKAEVNGIGQTH-HKNLVRL 564
E+G G G V+K + + +AVK++ E K +++ + ++H +V+
Sbjct: 31 GEMGSGTCGQVWKMR-FRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCPYIVQC 89
Query: 565 LGYCDEGQNRLLVYEFMSNGTVASFLFGDSKPNWKLRTEIAMGIAGGLFYLHEECCTQII 624
G + + E M ++ ++ + I L+YL E+ +I
Sbjct: 90 FGTFITNTDVFIAMELMGTCAEKLKKRMQGPIPERILGKMTVAIVKALYYLKEK--HGVI 147
Query: 625 HCDIKPQNILLDDHYNARISDFGLAKLLTLDQSHTNTAIRGTKGYVAPE-----WFRNMP 679
H D+KP NILLD+ ++ DFG++ L D++ +A G Y+APE
Sbjct: 148 HRDVKPSNILLDERGQIKLCDFGISGRLVDDKAKDRSA--GCAAYMAPERIDPPDPTKPD 205
Query: 680 ITVKVDVYSYGVLLLEIICLR---RNIDNEISKVDKAILTDWAYDRYQERTLEALVENDL 736
++ DV+S G+ L+E+ + +N + L +++ +
Sbjct: 206 YDIRADVWSLGISLVELATGQFPYKNCKTDF------------------EVLTKVLQEEP 247
Query: 737 EAMNNVTM----LHRFVMVAFWCIQEDPSHRPTMRKVTQMLE 774
+ FV C+ +D RP ++LE
Sbjct: 248 PLLPGHMGFSGDFQSFVKD---CLTKDHRKRPKYN---KLLE 283
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576 | Back alignment and structure |
|---|
Score = 102 bits (255), Expect = 9e-23
Identities = 63/221 (28%), Positives = 105/221 (47%), Gaps = 20/221 (9%)
Query: 509 LGRGAFGTVYKGFVNMGSSNHV-AVKKLN--SVFQDSEKEF-KAEVNGIGQTHHKNLVRL 564
LG+G FG V + ++ + A KKL + + + E + + + + +V
Sbjct: 192 LGKGGFGEVC--ACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVS- 248
Query: 565 LGYCDEGQNRL-LVYEFMSNGTVASFLFGDSKPNWKLRTEI--AMGIAGGLFYLHEECCT 621
L Y E ++ L LV M+ G + ++ + + + A I GL LH E
Sbjct: 249 LAYAYETKDALCLVLTLMNGGDLKFHIYHMGQAGFPEARAVFYAAEICCGLEDLHRE--- 305
Query: 622 QIIHCDIKPQNILLDDHYNARISDFGLAKLLTLDQSHTNTAIRGTKGYVAPEWFRNMPIT 681
+I++ D+KP+NILLDDH + RISD GLA + Q+ + GT GY+APE +N T
Sbjct: 306 RIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQT-IKGRV-GTVGYMAPEVVKNERYT 363
Query: 682 VKVDVYSYGVLLLEIICLR-----RNIDNEISKVDKAILTD 717
D ++ G LL E+I + R + +V++ +
Sbjct: 364 FSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKEV 404
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413 | Back alignment and structure |
|---|
Score = 100 bits (250), Expect = 1e-22
Identities = 37/268 (13%), Positives = 69/268 (25%), Gaps = 53/268 (19%)
Query: 472 RKKFMRPHQEDQGVSYMNLRCFTYKELVEVTRGFKEELGRGAFGTVYKGFVNMGSSNHVA 531
Q + S + R T RG LG+ + + +
Sbjct: 57 STSLWNTGQPFRVESELGERPRTLV------RG--TVLGQEDPYAYLEA-TDQETGESFE 107
Query: 532 VKKLNSVFQDSE---KEFKAEVNGIGQTHH----------------KNLVRLLGYCDEGQ 572
V + K+ K EV + +LV+ +
Sbjct: 108 VHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDLVKDPQKKKMIR 167
Query: 573 -----------NRLLVYEFM--SNGTVASFLFGDSK----PNWKLRTEIAMGIAGGLFYL 615
+R +Y M + T L S R ++ + + L L
Sbjct: 168 VRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASL 227
Query: 616 HEECCTQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLDQSHTNTAIRGTKGYVAPEWF 675
H ++H ++P +I+LD ++ F A
Sbjct: 228 HHYG---LVHTYLRPVDIVLDQRGGVFLTGFEHLVRDGASAVSPIGRGFAPPETTAERML 284
Query: 676 RNMP-----ITVKVDVYSYGVLLLEIIC 698
+T D ++ G+ + I C
Sbjct: 285 PFGQHHPTLMTFAFDTWTLGLAIYWIWC 312
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348 | Back alignment and structure |
|---|
Score = 98.3 bits (245), Expect = 2e-22
Identities = 60/201 (29%), Positives = 94/201 (46%), Gaps = 23/201 (11%)
Query: 507 EELGRGAFGTVYKGFVNMGSSNHVAVKKLNSVFQDSE---KEFKAEVNGIGQTHHKNLVR 563
E+G G+FG VY ++ +S VA+KK++ + S ++ EV + + H N ++
Sbjct: 60 REIGHGSFGAVYFA-RDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQ 118
Query: 564 LLGYCDEGQNRLLVYEFMSNGTVASFLFGDSKPNWKLR-TEIAM---GIAGGLFYLHEEC 619
G LV E+ G+ + L KP L+ EIA G GL YLH
Sbjct: 119 YRGCYLREHTAWLVMEYCL-GSASDLLEVHKKP---LQEVEIAAVTHGALQGLAYLHSH- 173
Query: 620 CTQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLDQSHTNTAIRGTKGYVAPE---WFR 676
+IH D+K NILL + ++ DFG A ++ N+ + GT ++APE
Sbjct: 174 --NMIHRDVKAGNILLSEPGLVKLGDFGSASIMA----PANSFV-GTPYWMAPEVILAMD 226
Query: 677 NMPITVKVDVYSYGVLLLEII 697
KVDV+S G+ +E+
Sbjct: 227 EGQYDGKVDVWSLGITCIELA 247
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316 | Back alignment and structure |
|---|
Score = 97.7 bits (244), Expect = 2e-22
Identities = 52/217 (23%), Positives = 85/217 (39%), Gaps = 47/217 (21%)
Query: 506 KEELGRGAFGTVYKGFVNMGSSNHVAVKKLNSVFQDSEKEFKAEVNGIGQ-THHKNLVRL 564
++ LG GA V +N+ +S AVK + EV + Q H+N++ L
Sbjct: 18 EDVLGEGAHARVQTC-INLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLEL 76
Query: 565 LGYCDEGQNRLLVYEFMSNGTV--------------ASFLFGDSKPNWKLRTEIAMGIAG 610
+ + +E LV+E M G++ AS + D +A
Sbjct: 77 IEFFEEEDRFYLVFEKMRGGSILSHIHKRRHFNELEASVVVQD--------------VAS 122
Query: 611 GLFYLHEECCTQIIHCDIKPQNILL---DDHYNARISDFGLAKLLTLDQSHTNTAIR--- 664
L +LH + I H D+KP+NIL + +I DF L + L+ + +
Sbjct: 123 ALDFLHNK---GIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELL 179
Query: 665 ---GTKGYVAPEWFRNMPITVK-----VDVYSYGVLL 693
G+ Y+APE D++S GV+L
Sbjct: 180 TPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVIL 216
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336 | Back alignment and structure |
|---|
Score = 95.9 bits (239), Expect = 1e-21
Identities = 51/202 (25%), Positives = 82/202 (40%), Gaps = 30/202 (14%)
Query: 506 KEELGRGAFGTVYKGFVNMGSSNHVAVKKLNSVFQDSEKEFKAEVNGIGQ-THHKNLVRL 564
K+ LG G G V + + + A+K L + + EV+ Q + ++V +
Sbjct: 34 KQVLGLGVNGKVLEC-FHRRTGQKCALKLL-----YDSPKARQEVDHHWQASGGPHIVCI 87
Query: 565 LGYCDEGQNR----LLVYEFMSNGTVASFLF------GDSKPNWKLRTEIAMGIAGGLFY 614
L + + L++ E M G LF GD + EI I + +
Sbjct: 88 LDVYENMHHGKRCLLIIMECMEGGE----LFSRIQERGDQAFTEREAAEIMRDIGTAIQF 143
Query: 615 LHEECCTQIIHCDIKPQNILL---DDHYNARISDFGLAKLLTLDQSHTNTAIRGTKGYVA 671
LH I H D+KP+N+L + +++DFG AK T + T T YVA
Sbjct: 144 LHSH---NIAHRDVKPENLLYTSKEKDAVLKLTDFGFAKETTQNALQT---PCYTPYYVA 197
Query: 672 PEWFRNMPITVKVDVYSYGVLL 693
PE D++S GV++
Sbjct: 198 PEVLGPEKYDKSCDMWSLGVIM 219
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305 | Back alignment and structure |
|---|
Score = 94.6 bits (236), Expect = 2e-21
Identities = 56/209 (26%), Positives = 93/209 (44%), Gaps = 32/209 (15%)
Query: 509 LGRGAFGTVYKGFVNMGSSNHVAVKKLN----SVFQDSEKEFKAEVNGIGQTHHKNLVRL 564
LG G++G V + ++ + AVK L + E K E+ + + HKN+++L
Sbjct: 13 LGEGSYGKVKEV-LDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQL 71
Query: 565 LG-YCDEGQNRL-LVYEFMSNGTVASFLFGDSKPNWKLRTEIAMG----IAGGLFYLHEE 618
+ +E + ++ +V E+ G + DS P + A G + GL YLH +
Sbjct: 72 VDVLYNEEKQKMYMVMEYCVCGMQE--ML-DSVPEKRFPVCQAHGYFCQLIDGLEYLHSQ 128
Query: 619 CCTQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLDQS----HTNTAIRGTKGYVAPEW 674
I+H DIKP N+LL +IS G+A+ L + T+ +G+ + PE
Sbjct: 129 G---IVHKDIKPGNLLLTTGGTLKISALGVAEALHPFAADDTCRTS---QGSPAFQPPEI 182
Query: 675 FRNM-----PITVKVDVYSYGVLLLEIIC 698
+ KVD++S GV L I
Sbjct: 183 ANGLDTFSGF---KVDIWSAGVTLYNITT 208
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400 | Back alignment and structure |
|---|
Score = 96.3 bits (240), Expect = 2e-21
Identities = 55/204 (26%), Positives = 83/204 (40%), Gaps = 31/204 (15%)
Query: 505 FKEELGRGAFGTVYKGFVNMGSSNHVAVKKLNSVFQDSEKEFKAEVNGIGQ-THHKNLVR 563
+ LG G G V + N + A+K L D K + EV + + ++VR
Sbjct: 66 TSQVLGLGINGKVLQI-FNKRTQEKFALKMLQ----DCPKARR-EVELHWRASQCPHIVR 119
Query: 564 LLG-YCDEGQNR---LLVYEFMSNGTVASFLFGD--SKPNWKLRTE-----IAMGIAGGL 612
++ Y + R L+V E + G LF + + TE I I +
Sbjct: 120 IVDVYENLYAGRKCLLIVMECLDGGE----LFSRIQDRGDQAF-TEREASEIMKSIGEAI 174
Query: 613 FYLHEECCTQIIHCDIKPQNILL---DDHYNARISDFGLAKLLTLDQSHTNTAIRGTKGY 669
YLH I H D+KP+N+L + +++DFG AK T S T T Y
Sbjct: 175 QYLHSI---NIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPC--YTPYY 229
Query: 670 VAPEWFRNMPITVKVDVYSYGVLL 693
VAPE D++S GV++
Sbjct: 230 VAPEVLGPEKYDKSCDMWSLGVIM 253
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276 | Back alignment and structure |
|---|
Score = 89.9 bits (224), Expect = 4e-20
Identities = 64/200 (32%), Positives = 95/200 (47%), Gaps = 21/200 (10%)
Query: 509 LGRGAFGTVYKGFVNMGSSNHVAVKKLN-SVFQDSEKEFKAEVNGIGQTHHKNLVRLLGY 567
LG GA+G V VN + VAVK ++ D + K E+ +H+N+V+ G+
Sbjct: 15 LGEGAYGEVQLA-VNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGH 73
Query: 568 CDEGQNRLLVYEFMSNGTVASFLFGDSKPNWKLRTEIAMG----IAGGLFYLHEECCTQI 623
EG + L E+ S G LF +P+ + A + G+ YLH I
Sbjct: 74 RREGNIQYLFLEYCSGGE----LFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGI---GI 126
Query: 624 IHCDIKPQNILLDDHYNARISDFGLAKLLTLDQS----HTNTAIRGTKGYVAPEWFRNMP 679
H DIKP+N+LLD+ N +ISDFGLA + + + GT YVAPE +
Sbjct: 127 THRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMC---GTLPYVAPELLKRRE 183
Query: 680 IT-VKVDVYSYGVLLLEIIC 698
VDV+S G++L ++
Sbjct: 184 FHAEPVDVWSCGIVLTAMLA 203
|
| >3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695 | Back alignment and structure |
|---|
Score = 93.8 bits (233), Expect = 7e-20
Identities = 55/225 (24%), Positives = 94/225 (41%), Gaps = 28/225 (12%)
Query: 509 LGRGAFGTVYKGFVNMGSSNHV-AVKKLN--SVFQDSEKEF-KAEVN---GIGQTHHKNL 561
+GRG FG VY + + A+K L+ + + E + +
Sbjct: 197 IGRGGFGEVYG--CRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFI 254
Query: 562 VRLLGYCDEGQNRL-LVYEFMSNGTVASFLFGDSK-PNWKLRTEIAMGIAGGLFYLHEEC 619
V + Y ++L + + M+ G + L +R A I GL ++H
Sbjct: 255 VC-MSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAE-IILGLEHMHNR- 311
Query: 620 CTQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLDQSHTNTAIRGTKGYVAPE-WFRNM 678
+++ D+KP NILLD+H + RISD GLA + + H GT GY+APE + +
Sbjct: 312 --FVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHA---SVGTHGYMAPEVLQKGV 366
Query: 679 PITVKVDVYSYGVLLLEIIC------LRRNIDNEISKVDKAILTD 717
D +S G +L +++ + D ++D+ LT
Sbjct: 367 AYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKH--EIDRMTLTM 409
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 89.6 bits (223), Expect = 8e-20
Identities = 49/230 (21%), Positives = 90/230 (39%), Gaps = 49/230 (21%)
Query: 506 KEELGRGAFGTVYKGFVNMGSSNHVAVK-----KLNSVFQDSEKEFKAEVNGIGQT---- 556
K+E+G+G++G V N + + A+K KL +
Sbjct: 18 KDEIGKGSYGVVKLA-YNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQP 76
Query: 557 -----------------HHKNLVRLLGYC---DEGQNRL-LVYEFMSNGTVASFLFGDSK 595
H N+V+L D ++ L +V+E ++ G + +
Sbjct: 77 RGPIEQVYQEIAILKKLDHPNVVKL--VEVLDDPNEDHLYMVFELVNQGP----VM-EVP 129
Query: 596 PNWKLRTEIAMG----IAGGLFYLHEECCTQIIHCDIKPQNILLDDHYNARISDFGLAKL 651
L + A + G+ YLH + +IIH DIKP N+L+ + + +I+DFG++
Sbjct: 130 TLKPLSEDQARFYFQDLIKGIEYLHYQ---KIIHRDIKPSNLLVGEDGHIKIADFGVSNE 186
Query: 652 LTLDQSHTNTAIRGTKGYVAPEWFRNMPITV---KVDVYSYGVLLLEIIC 698
+ + + GT ++APE +DV++ GV L +
Sbjct: 187 FKGSDALLSNTV-GTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVF 235
|
| >3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325 | Back alignment and structure |
|---|
Score = 89.5 bits (223), Expect = 2e-19
Identities = 57/206 (27%), Positives = 97/206 (47%), Gaps = 32/206 (15%)
Query: 509 LGRGAFGTVY--KGFVNMGSSNHVAVKKLN--SVFQDSEKEFKAEVNGIGQTHHKNLVRL 564
LG+G+FG V+ K + A+K L ++ K E + + + +H +V+L
Sbjct: 32 LGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFIVKL 91
Query: 565 LGYCDEGQNRL-LVYEFMSNGTVASFLFGDSKPNWKLRTE-----------IAMGIAGGL 612
Y + + +L L+ +F+ G LF +L E +A +A L
Sbjct: 92 H-YAFQTEGKLYLILDFLRGGD----LF------TRLSKEVMFTEEDVKFYLAE-LALAL 139
Query: 613 FYLHEECCTQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLDQSHTNTAIRGTKGYVAP 672
+LH II+ D+KP+NILLD+ + +++DFGL+K + + GT Y+AP
Sbjct: 140 DHLHSL---GIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYS-FCGTVEYMAP 195
Query: 673 EWFRNMPITVKVDVYSYGVLLLEIIC 698
E T D +S+GVL+ E++
Sbjct: 196 EVVNRRGHTQSADWWSFGVLMFEMLT 221
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323 | Back alignment and structure |
|---|
Score = 88.5 bits (220), Expect = 3e-19
Identities = 65/198 (32%), Positives = 95/198 (47%), Gaps = 17/198 (8%)
Query: 509 LGRGAFGTVYKGFVNMGSSNHVAVKKLN-SVFQDSEKEFKAEVNGIGQTHHKNLVRLLGY 567
LG GA+G V VN + VAVK ++ D + K E+ +H+N+V+ G+
Sbjct: 15 LGEGAYGEVQLA-VNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGH 73
Query: 568 CDEGQNRLLVYEFMSNGTVASFLFGDSKPNWKLRTEIAMG----IAGGLFYLHEECCTQI 623
EG + L E+ S G LF +P+ + A + G+ YLH I
Sbjct: 74 RREGNIQYLFLEYCSGGE----LFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGI---GI 126
Query: 624 IHCDIKPQNILLDDHYNARISDFGLAKLLTLDQSHT--NTAIRGTKGYVAPEWFRNMPIT 681
H DIKP+N+LLD+ N +ISDFGLA + + N GT YVAPE +
Sbjct: 127 THRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMC-GTLPYVAPELLKRREFH 185
Query: 682 -VKVDVYSYGVLLLEIIC 698
VDV+S G++L ++
Sbjct: 186 AEPVDVWSCGIVLTAMLA 203
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328 | Back alignment and structure |
|---|
Score = 88.1 bits (219), Expect = 4e-19
Identities = 50/199 (25%), Positives = 94/199 (47%), Gaps = 17/199 (8%)
Query: 507 EELGRGAFGTVYKGFVNMGSSNHVAVKKLN--SVFQDSEKEFKAEVNGIGQTHHKNLVRL 564
+ +G+G F V ++ + VA+K ++ + S ++ EV + +H N+V+L
Sbjct: 21 KTIGKGNFAKVKLA-RHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKL 79
Query: 565 LGYCDEGQNRLLVYEFMSNGTVASFLFGDSKPNWKLRTEIAMG----IAGGLFYLHEECC 620
+ + L+ E+ S G +F + +++ + A I + Y H++
Sbjct: 80 FEVIETEKTLYLIMEYASGGE----VFDYLVAHGRMKEKEARSKFRQIVSAVQYCHQKR- 134
Query: 621 TQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLDQSHTNTAIRGTKGYVAPEWFRNMPI 680
I+H D+K +N+LLD N +I+DFG + T+ + G Y APE F+
Sbjct: 135 --IVHRDLKAENLLLDADMNIKIADFGFSNEFTVGG-KLDAFC-GAPPYAAPELFQGKKY 190
Query: 681 T-VKVDVYSYGVLLLEIIC 698
+VDV+S GV+L ++
Sbjct: 191 DGPEVDVWSLGVILYTLVS 209
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412 | Back alignment and structure |
|---|
Score = 89.4 bits (222), Expect = 4e-19
Identities = 55/207 (26%), Positives = 91/207 (43%), Gaps = 27/207 (13%)
Query: 509 LGRGAFGTVYKGFVNMGSSNHV-AVKKLN--SVFQDSEKE-FKAEVNGIGQTHHKNLVRL 564
+GRGAF V V M + V A+K +N + + E F+ E + + + + +L
Sbjct: 69 IGRGAFSEVA--VVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQL 126
Query: 565 LGYCDEGQNRL-LVYEFMSNGTVASFLFGDSKPNWKLRTEIA----MGIAGGLFYLHEEC 619
+ + +N L LV E+ G + + L SK ++ E+A I + +H
Sbjct: 127 H-FAFQDENYLYLVMEYYVGGDLLTLL---SKFGERIPAEMARFYLAEIVMAIDSVHRL- 181
Query: 620 CTQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLDQS-HTNTAIRGTKGYVAPEWFRNM 678
+H DIKP NILLD + R++DFG L D + + A+ GT Y++PE + +
Sbjct: 182 --GYVHRDIKPDNILLDRCGHIRLADFGSCLKLRADGTVRSLVAV-GTPDYLSPEILQAV 238
Query: 679 PITVKVDVY-------SYGVLLLEIIC 698
Y + GV E+
Sbjct: 239 GGGPGTGSYGPECDWWALGVFAYEMFY 265
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394 | Back alignment and structure |
|---|
Score = 88.9 bits (221), Expect = 6e-19
Identities = 61/211 (28%), Positives = 96/211 (45%), Gaps = 34/211 (16%)
Query: 507 EELGRGAFGTVYKGFVNMGSSNHVAVKKLNSVFQDSEKEFKA-EVNGIGQTHHKNLVRLL 565
+ +G G+FG V++ + S+ VA+KK V QD K FK E+ + H N+V L
Sbjct: 46 KVIGNGSFGVVFQAKLV--ESDEVAIKK---VLQD--KRFKNRELQIMRIVKHPNVVDLK 98
Query: 566 GY-----CDEGQNRL-LVYEFMSNGTVASFLFGDSKPNWKLRTEIAMG--------IAGG 611
+ + + L LV E++ TV + KL+ + M +
Sbjct: 99 AFFYSNGDKKDEVFLNLVLEYVPE-TVYRAS----RHYAKLKQTMPMLLIKLYMYQLLRS 153
Query: 612 LFYLHEECCTQIIHCDIKPQNILLDDHYNA-RISDFGLAKLLTLDQSHTNTAIRGTKGYV 670
L Y+H I H DIKPQN+LLD ++ DFG AK L N + ++ Y
Sbjct: 154 LAYIH---SIGICHRDIKPQNLLLDPPSGVLKLIDFGSAK--ILIAGEPNVSYICSRYYR 208
Query: 671 APEW-FRNMPITVKVDVYSYGVLLLEIICLR 700
APE F T +D++S G ++ E++ +
Sbjct: 209 APELIFGATNYTTNIDIWSTGCVMAELMQGQ 239
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437 | Back alignment and structure |
|---|
Score = 89.4 bits (222), Expect = 6e-19
Identities = 58/205 (28%), Positives = 99/205 (48%), Gaps = 25/205 (12%)
Query: 509 LGRGAFGTVYKGFVNMGSSNHV-AVKKLN--SVFQDSEKE-FKAEVNGIGQTHHKNLVRL 564
+GRGAFG V V + +++ V A+K LN + + +E F+ E + + K + L
Sbjct: 82 IGRGAFGEVA--VVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWITTL 139
Query: 565 LGYCDEGQNRL-LVYEFMSNGTVASFLFGDSKPNWKLRTEIA----MGIAGGLFYLHEEC 619
Y + N L LV ++ G + + L SK +L E+A + + +H+
Sbjct: 140 H-YAFQDDNNLYLVMDYYVGGDLLTLL---SKFEDRLPEEMARFYLAEMVIAIDSVHQL- 194
Query: 620 CTQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLDQS-HTNTAIRGTKGYVAPEWFRNM 678
+H DIKP NIL+D + + R++DFG L D + ++ A+ GT Y++PE + M
Sbjct: 195 --HYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQSSVAV-GTPDYISPEILQAM 251
Query: 679 PITVK-----VDVYSYGVLLLEIIC 698
D +S GV + E++
Sbjct: 252 EGGKGRYGPECDWWSLGVCMYEMLY 276
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335 | Back alignment and structure |
|---|
Score = 87.9 bits (218), Expect = 6e-19
Identities = 52/206 (25%), Positives = 88/206 (42%), Gaps = 24/206 (11%)
Query: 507 EELGRGAFGTVYKGFVNMGSSNHVAVKKLN--------SVFQDSEKEFKAEVNGIGQTHH 558
LG GAFG V+ V+ + V VK + + + E+ + + H
Sbjct: 30 SPLGSGAFGFVWTA-VDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEH 88
Query: 559 KNLVRLLGYCDEGQNRLLVYEFMSNGTVASFLFGDSKPNWKLRTEIAMG----IAGGLFY 614
N++++L + LV E +G F F D P +L +A + + Y
Sbjct: 89 ANIIKVLDIFENQGFFQLVMEKHGSGL-DLFAFIDRHP--RLDEPLASYIFRQLVSAVGY 145
Query: 615 LHEECCTQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLDQS-HTNTAIRGTKGYVAPE 673
L + IIH DIK +NI++ + + ++ DFG A L + +T GT Y APE
Sbjct: 146 LRLKD---IIHRDIKDENIVIAEDFTIKLIDFGSAAYLERGKLFYTFC---GTIEYCAPE 199
Query: 674 WFRNMP-ITVKVDVYSYGVLLLEIIC 698
P +++++S GV L ++
Sbjct: 200 VLMGNPYRGPELEMWSLGVTLYTLVF 225
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420 | Back alignment and structure |
|---|
Score = 88.6 bits (220), Expect = 8e-19
Identities = 57/210 (27%), Positives = 93/210 (44%), Gaps = 31/210 (14%)
Query: 507 EELGRGAFGTVYKGFVNMGSSNHVAVKKLNSVFQDSEKEFKAEVNGIGQTHHKNLVRLLG 566
+ +G G+FG VY+ S VA+KK V QD + + E+ + + H N+VRL
Sbjct: 60 KVIGNGSFGVVYQA-KLCDSGELVAIKK---VLQDKRFKNR-ELQIMRKLDHCNIVRLRY 114
Query: 567 YCDEGQNRL------LVYEFMSNGTVASFLFGDSKPNWKLRTEIAMG--------IAGGL 612
+ + LV +++ TV + + + + + + L
Sbjct: 115 FFYSSGEKKDEVYLNLVLDYVPE-TVYRVA----RHYSRAKQTLPVIYVKLYMYQLFRSL 169
Query: 613 FYLHEECCTQIIHCDIKPQNILLDDHYNA-RISDFGLAKLLTLDQSHTNTAIRGTKGYVA 671
Y+H I H DIKPQN+LLD ++ DFG AK L + N + ++ Y A
Sbjct: 170 AYIH---SFGICHRDIKPQNLLLDPDTAVLKLCDFGSAK--QLVRGEPNVSYICSRYYRA 224
Query: 672 PEW-FRNMPITVKVDVYSYGVLLLEIICLR 700
PE F T +DV+S G +L E++ +
Sbjct: 225 PELIFGATDYTSSIDVWSAGCVLAELLLGQ 254
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312 | Back alignment and structure |
|---|
Score = 86.6 bits (215), Expect = 1e-18
Identities = 63/296 (21%), Positives = 110/296 (37%), Gaps = 53/296 (17%)
Query: 507 EELGRGAFGTVYKGFVNMGSSNHVAVK-----KLNSVFQDSEKE-FKAEVNGI----GQT 556
LG+G FGTV+ G + VA+K ++ S+ EV +
Sbjct: 37 PLLGKGGFGTVFAG-HRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGG 95
Query: 557 HHKNLVRLLGYCDEGQNRLLVYEFMSNGTVASFLFGDSKPNWKLRTEIAMG----IAGGL 612
H ++RLL + + + +LV E LF L + + +
Sbjct: 96 GHPGVIRLLDWFETQEGFMLVLERPLPAQD---LFDYITEKGPLGEGPSRCFFGQVVAAI 152
Query: 613 FYLHEECCTQIIHCDIKPQNILLDDHYNA-RISDFGLAKLLTLDQSHTNTAIRGTKGYVA 671
+ H ++H DIK +NIL+D ++ DFG LL + GT+ Y
Sbjct: 153 QHCHSRG---VVHRDIKDENILIDLRRGCAKLIDFGSGALLHDEPYTDFD---GTRVYSP 206
Query: 672 PEWFRNMPIT-VKVDVYSYGVLLLEIICLRRNIDNEISKVDKAILTDWAYDRYQERTLEA 730
PEW + V+S G+LL +++C + + ++ +A L + + A
Sbjct: 207 PEWISRHQYHALPATVWSLGILLYDMVCGDIPFERD-QEILEAELH---FPAHVSPDCCA 262
Query: 731 LVENDLEAMNNVTMLHRFVMVAFWCIQEDPSHRPTMRKVTQ---MLEGVVEVPIPP 783
L+ C+ PS RP++ ++ M +VP+ P
Sbjct: 263 LIR--------------------RCLAPKPSSRPSLEEILLDPWMQTPAEDVPLNP 298
|
| >1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310 | Back alignment and structure |
|---|
Score = 86.5 bits (215), Expect = 1e-18
Identities = 50/207 (24%), Positives = 92/207 (44%), Gaps = 26/207 (12%)
Query: 505 FKEELGRGAFGTVY----KGFVNMGSSNHVAVKKLN--SVFQDSEKEF-KAEVNGIGQTH 557
F + LG G+F TV +S A+K L + ++++ + E + + +
Sbjct: 34 FGKILGEGSFSTVVLARELA-----TSREYAIKILEKRHIIKENKVPYVTRERDVMSRLD 88
Query: 558 HKNLVRLLGYCDEGQNRLLVYEFMSNGTVASFLFGDSK-PNWKLR---TEIAMGIAGGLF 613
H V+L + + + NG + ++ R EI +
Sbjct: 89 HPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALE---- 144
Query: 614 YLHEECCTQIIHCDIKPQNILLDDHYNARISDFGLAKLLT--LDQSHTNTAIRGTKGYVA 671
YLH + IIH D+KP+NILL++ + +I+DFG AK+L+ Q+ N+ GT YV+
Sbjct: 145 YLHGK---GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANS-FVGTAQYVS 200
Query: 672 PEWFRNMPITVKVDVYSYGVLLLEIIC 698
PE D+++ G ++ +++
Sbjct: 201 PELLTEKSACKSSDLWALGCIIYQLVA 227
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360 | Back alignment and structure |
|---|
Score = 87.0 bits (216), Expect = 2e-18
Identities = 49/218 (22%), Positives = 87/218 (39%), Gaps = 47/218 (21%)
Query: 507 EELGRGAFGTVYKGFVNMGSSNHVAVKKLNSVFQDSEKEFK----AEVNGIGQTHHKNLV 562
G+G FGTV G + VA+KK V QD F+ + + HH N+V
Sbjct: 29 RMAGQGTFGTVQLG-KEKSTGMSVAIKK---VIQD--PRFRNRELQIMQDLAVLHHPNIV 82
Query: 563 RLL------GYCDEGQNRL-LVYEFMSNGTVASFLFGDSKPNWKLRTEIAMG-------- 607
+L G D L +V E++ + T+ + ++ +
Sbjct: 83 QLQSYFYTLGERDRRDIYLNVVMEYVPD-TLHRCC----RNYYRRQVAPPPILIKVFLFQ 137
Query: 608 IAGGLFYLHEECCTQIIHCDIKPQNILLDDHYNA-RISDFGLAKLLTLDQSHTNTAIRGT 666
+ + LH + H DIKP N+L+++ ++ DFG AK L+ + +
Sbjct: 138 LIRSIGCLHLPSV-NVCHRDIKPHNVLVNEADGTLKLCDFGSAKKLSPSEPNV------- 189
Query: 667 KGYVAPEWFRNMPI-------TVKVDVYSYGVLLLEII 697
Y+ ++R + T VD++S G + E++
Sbjct: 190 -AYICSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMM 226
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410 | Back alignment and structure |
|---|
Score = 87.1 bits (216), Expect = 2e-18
Identities = 54/203 (26%), Positives = 92/203 (45%), Gaps = 24/203 (11%)
Query: 509 LGRGAFGTVYKGFVNMGSSNHV-AVKKLN--SVFQDSEKE-FKAEVNGIGQTHHKNLVRL 564
+GRGAFG V V S+ V A+K L+ + + S+ F E + + + +V+L
Sbjct: 77 IGRGAFGEVQ--LVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQL 134
Query: 565 LGYCDEGQNRL-LVYEFMSNGTVASFLFGDSKPNWKLR---TEIAMGIAGGLFYLHEECC 620
Y + L +V E+M G + + + P R E+ + L +H
Sbjct: 135 F-YAFQDDRYLYMVMEYMPGGDLVNLMSNYDVPEKWARFYTAEVVLA----LDAIHS--- 186
Query: 621 TQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLD-QSHTNTAIRGTKGYVAPEWFRNMP 679
IH D+KP N+LLD + +++DFG + + +TA+ GT Y++PE ++
Sbjct: 187 MGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTAV-GTPDYISPEVLKSQG 245
Query: 680 ITVK----VDVYSYGVLLLEIIC 698
D +S GV L E++
Sbjct: 246 GDGYYGRECDWWSVGVFLYEMLV 268
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320 | Back alignment and structure |
|---|
Score = 85.1 bits (211), Expect = 5e-18
Identities = 50/206 (24%), Positives = 84/206 (40%), Gaps = 24/206 (11%)
Query: 507 EELGRGAFGTVYKGFVNMGSSNHVAVKKLN------SVFQDSEKEFKAEVNGIGQTHHK- 559
LG G FG+VY G + + + VA+K + + EV + +
Sbjct: 49 PLLGSGGFGSVYSG-IRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGF 107
Query: 560 -NLVRLLGYCDEGQNRLLVYEFMSNGTVASFLFGDSKPNWKLRTEIAMG----IAGGLFY 614
++RLL + + + +L+ E LF L+ E+A + + +
Sbjct: 108 SGVIRLLDWFERPDSFVLILERPEPV---QDLFDFITERGALQEELARSFFWQVLEAVRH 164
Query: 615 LHEECCTQIIHCDIKPQNILLD-DHYNARISDFGLAKLLTLDQSHTNTAIRGTKGYVAPE 673
H ++H DIK +NIL+D + ++ DFG LL GT+ Y PE
Sbjct: 165 CHNCG---VLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVYTDFD---GTRVYSPPE 218
Query: 674 WFRNMPIT-VKVDVYSYGVLLLEIIC 698
W R V+S G+LL +++C
Sbjct: 219 WIRYHRYHGRSAAVWSLGILLYDMVC 244
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384 | Back alignment and structure |
|---|
Score = 85.1 bits (211), Expect = 8e-18
Identities = 59/231 (25%), Positives = 97/231 (41%), Gaps = 40/231 (17%)
Query: 509 LGRGAFGTVYKGFVNMGSSNHV-AVKKLN--SVFQDSEKEF-KAEVNGIGQTHHKNLVRL 564
+G+G+FG V V + + A+K +N + +E E+ + H LV L
Sbjct: 23 IGKGSFGKVCI--VQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNL 80
Query: 565 LGYCDEGQNRL-LVYEFMSNGTVASFLFGDSKPNWKLRTEIAMG----------IAGGLF 613
Y + + + +V + + G L + L+ + + L
Sbjct: 81 W-YSFQDEEDMFMVVDLLLGGD----LR------YHLQQNVHFKEETVKLFICELVMALD 129
Query: 614 YLHEECCTQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLDQSHTNTAIRGTKGYVAPE 673
YL + +IIH D+KP NILLD+H + I+DF +A +L + T A GTK Y+APE
Sbjct: 130 YLQNQ---RIIHRDMKPDNILLDEHGHVHITDFNIAAMLPRETQITTMA--GTKPYMAPE 184
Query: 674 WFRNMPI---TVKVDVYSYGVLLLEIICLRR----NIDNEISKVDKAILTD 717
F + + VD +S GV E++ RR ++ T
Sbjct: 185 MFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHIRSSTSSKEIVHTFETT 235
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276 | Back alignment and structure |
|---|
Score = 82.6 bits (205), Expect = 1e-17
Identities = 57/201 (28%), Positives = 96/201 (47%), Gaps = 24/201 (11%)
Query: 509 LGRGAFGTVYKGFVNMGSSNHVAVK-----KLNSVFQDSEKEFKAEVNGIGQTHHKNLVR 563
LG G FG V G + + + VAVK K+ S D + K E+ + H ++++
Sbjct: 19 LGVGTFGKVKIG-EHQLTGHKVAVKILNRQKIRS--LDVVGKIKREIQNLKLFRHPHIIK 75
Query: 564 LLGYCDEGQNRLLVYEFMSNGTVASFLFGDSKPNWKLRTEIAMG----IAGGLFYLHEEC 619
L + +V E++S G LF + ++ A I + Y H
Sbjct: 76 LYQVISTPTDFFMVMEYVSGGE----LFDYICKHGRVEEMEARRLFQQILSAVDYCHRHM 131
Query: 620 CTQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLDQS-HTNTAIRGTKGYVAPEWFRNM 678
++H D+KP+N+LLD H NA+I+DFGL+ +++ + T+ G+ Y APE
Sbjct: 132 ---VVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLRTSC---GSPNYAAPEVISGR 185
Query: 679 PIT-VKVDVYSYGVLLLEIIC 698
+VD++S GV+L ++C
Sbjct: 186 LYAGPEVDIWSCGVILYALLC 206
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446 | Back alignment and structure |
|---|
Score = 84.8 bits (210), Expect = 2e-17
Identities = 56/205 (27%), Positives = 86/205 (41%), Gaps = 31/205 (15%)
Query: 509 LGRGAFGTVYKGFVNMGSSNHV-AVKKL--NSVFQDSEKEF-KAEVNGIGQTHHKNLVRL 564
LG+G FG V V ++ A+K L + E E + + H L L
Sbjct: 156 LGKGTFGKVI--LVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTAL 213
Query: 565 LGYCDEGQNRL-LVYEFMSNGTVASFLFGDSKPNWKLRTEI----------AMGIAGGLF 613
Y + +RL V E+ + G LF + L E I L
Sbjct: 214 K-YSFQTHDRLCFVMEYANGGE----LF------FHLSRERVFSEDRARFYGAEIVSALD 262
Query: 614 YLHEECCTQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLDQSHTNTAIRGTKGYVAPE 673
YLH E +++ D+K +N++LD + +I+DFGL K D + T GT Y+APE
Sbjct: 263 YLHSE--KNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKT-FCGTPEYLAPE 319
Query: 674 WFRNMPITVKVDVYSYGVLLLEIIC 698
+ VD + GV++ E++C
Sbjct: 320 VLEDNDYGRAVDWWGLGVVMYEMMC 344
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350 | Back alignment and structure |
|---|
Score = 82.7 bits (205), Expect = 3e-17
Identities = 55/198 (27%), Positives = 90/198 (45%), Gaps = 21/198 (10%)
Query: 509 LGRGAFGTVYKGFV-NMGSSNHVAVKKLN--SVFQDSEKE-FKAEVNGIGQTHHKNLVRL 564
LG G+FG V V + S NH A+K L+ V + + E E + + LV+L
Sbjct: 49 LGTGSFGRVM--LVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKL 106
Query: 565 LGYCDEGQNRLLVYEFMSNGTVASFLFGDSK-PNWKLR---TEIAMGIAGGLFYLHEECC 620
+ N +V E+++ G + S L + R +I + YLH
Sbjct: 107 EFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLT----FEYLHSL-- 160
Query: 621 TQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLDQSHTNTAIRGTKGYVAPEWFRNMPI 680
+I+ D+KP+N+L+D +++DFG AK + T T + GT +APE +
Sbjct: 161 -DLIYRDLKPENLLIDQQGYIQVTDFGFAK---RVKGRTWT-LCGTPEALAPEIILSKGY 215
Query: 681 TVKVDVYSYGVLLLEIIC 698
VD ++ GVL+ E+
Sbjct: 216 NKAVDWWALGVLIYEMAA 233
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327 | Back alignment and structure |
|---|
Score = 82.2 bits (204), Expect = 4e-17
Identities = 58/209 (27%), Positives = 100/209 (47%), Gaps = 36/209 (17%)
Query: 509 LGRGAFGTVY--KGFVNMGSSNHVAVKKLN--SVFQDSEKEF---KAEVNGIGQTHHKNL 561
LG+G +G V+ + + A+K L + ++ K+ KAE N + + H +
Sbjct: 25 LGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRN-AKDTAHTKAERNILEEVKHPFI 83
Query: 562 VRLLGYCDEGQNRL-LVYEFMSNGTVASFLFGDSKPNWKLRTE-----------IAMGIA 609
V L+ Y + +L L+ E++S G LF +L E +A I+
Sbjct: 84 VDLI-YAFQTGGKLYLILEYLSGGE----LF------MQLEREGIFMEDTACFYLAE-IS 131
Query: 610 GGLFYLHEECCTQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLDQSHTNTAIRGTKGY 669
L +LH++ II+ D+KP+NI+L+ + +++DFGL K D + T+T GT Y
Sbjct: 132 MALGHLHQK---GIIYRDLKPENIMLNHQGHVKLTDFGLCKESIHDGTVTHT-FCGTIEY 187
Query: 670 VAPEWFRNMPITVKVDVYSYGVLLLEIIC 698
+APE VD +S G L+ +++
Sbjct: 188 MAPEILMRSGHNRAVDWWSLGALMYDMLT 216
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371 | Back alignment and structure |
|---|
Score = 82.8 bits (205), Expect = 5e-17
Identities = 58/233 (24%), Positives = 90/233 (38%), Gaps = 63/233 (27%)
Query: 500 EVTRGFK--EELGRGAFGTVYKGFVNMGSSNHVAVKKLNSVFQDSE------------KE 545
V + ++ + +G GA G V + +VA+KKL+ FQ+ K
Sbjct: 22 TVLKRYQNLKPIGSGAQGIVCAA-YDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKC 80
Query: 546 FKAEVNGIGQTHHKNLVRLL------GYCDEGQNRLLVYEFM------------SNGTVA 587
HKN++ LL +E Q+ +V E M + ++
Sbjct: 81 VN----------HKNIIGLLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQMELDHERMS 130
Query: 588 SFLFGDSKPNWKLRTEIAMGIAGGLFYLHEECCTQIIHCDIKPQNILLDDHYNARISDFG 647
L+ L G+ +LH IIH D+KP NI++ +I DFG
Sbjct: 131 YLLYQ------MLC---------GIKHLHS---AGIIHRDLKPSNIVVKSDCTLKILDFG 172
Query: 648 LAKLLTLDQSHTNTAIRGTKGYVAPEWFRNMPITVKVDVYSYGVLLLEIICLR 700
LA+ T S T T+ Y APE M VD++S G ++ E+I
Sbjct: 173 LAR--TAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGG 223
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337 | Back alignment and structure |
|---|
Score = 81.9 bits (203), Expect = 6e-17
Identities = 57/205 (27%), Positives = 85/205 (41%), Gaps = 32/205 (15%)
Query: 509 LGRGAFGTVYKGFVNMGSSNHV-AVKKLN--SVFQDSEKEF-KAEVNGIGQTHHKNLVRL 564
LG+G FG V V ++ A+K L + E E + T H L L
Sbjct: 13 LGKGTFGKVI--LVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTAL 70
Query: 565 LGYCDEGQNRL-LVYEFMSNGTVASFLFGDSKPNWKLRTEI----------AMGIAGGLF 613
Y + +RL V E+ + G LF + L E I L
Sbjct: 71 K-YAFQTHDRLCFVMEYANGGE----LF------FHLSRERVFTEERARFYGAEIVSALE 119
Query: 614 YLHEECCTQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLDQSHTNTAIRGTKGYVAPE 673
YLH +++ DIK +N++LD + +I+DFGL K D + T GT Y+APE
Sbjct: 120 YLHSR---DVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKT-FCGTPEYLAPE 175
Query: 674 WFRNMPITVKVDVYSYGVLLLEIIC 698
+ VD + GV++ E++C
Sbjct: 176 VLEDNDYGRAVDWWGLGVVMYEMMC 200
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 80.7 bits (200), Expect = 1e-16
Identities = 47/179 (26%), Positives = 75/179 (41%), Gaps = 27/179 (15%)
Query: 507 EELGRGAFGTVYKGFVNMGSSNHVAVKKLNSVFQDSEKE-FKA----EVNGIGQTHHKNL 561
++G G++G V+K N + VA+KK + + K E+ + Q H NL
Sbjct: 9 GKIGEGSYGVVFKC-RNRDTGQIVAIKK---FLESEDDPVIKKIALREIRMLKQLKHPNL 64
Query: 562 VRLLGYCDEGQNRLLVYEFMSNGTVASFLFGDSKPNWKLRTEI---AMGIAGGLFYLHEE 618
V LL + LV+E+ + TV L D + + + H+
Sbjct: 65 VNLLEVFRRKRRLHLVFEYCDH-TVLHEL--DRYQRGVPEHLVKSITWQTLQAVNFCHKH 121
Query: 619 CCTQIIHCDIKPQNILLDDHYNARISDFGLAKLLTL-DQSHTNTAIRGTKGYVAPEWFR 676
IH D+KP+NIL+ H ++ DFG A+LLT + + VA W+R
Sbjct: 122 ---NCIHRDVKPENILITKHSVIKLCDFGFARLLTGPSDYYDD--------EVATRWYR 169
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308 | Back alignment and structure |
|---|
Score = 80.7 bits (200), Expect = 1e-16
Identities = 57/229 (24%), Positives = 101/229 (44%), Gaps = 36/229 (15%)
Query: 507 EELGRGAFGTVYKGFVNMGSSNHVAVKKLNSVFQDSEKEFKAEVN-----------GIGQ 555
E+G GA+GTVYK + S + VA+K + + + +
Sbjct: 15 AEIGVGAYGTVYKA-RDPHSGHFVALKSVR---VPNGGGGGGGLPISTVREVALLRRLEA 70
Query: 556 THHKNLVRLL----GYCDEGQNRL-LVYEFMSNGTVASFLFGDSKPNWKLRTE----IAM 606
H N+VRL+ + + ++ LV+E + + ++L D P L E +
Sbjct: 71 FEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQ-DLRTYL--DKAPPPGLPAETIKDLMR 127
Query: 607 GIAGGLFYLHEECCTQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLDQSHTNTAIRGT 666
GL +LH I+H D+KP+NIL+ +++DFGLA++ + + T + T
Sbjct: 128 QFLRGLDFLHAN---CIVHRDLKPENILVTSGGTVKLADFGLARIYSYQMALTPVVV--T 182
Query: 667 KGYVAPEWFRNMPITVKVDVYSYGVLLLEIICLRRNI---DNEISKVDK 712
Y APE VD++S G + E+ R+ + ++E ++ K
Sbjct: 183 LWYRAPEVLLQSTYATPVDMWSVGCIFAEMF-RRKPLFCGNSEADQLGK 230
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464 | Back alignment and structure |
|---|
Score = 82.2 bits (203), Expect = 1e-16
Identities = 58/230 (25%), Positives = 90/230 (39%), Gaps = 63/230 (27%)
Query: 500 EVTRGFK--EELGRGAFGTVYKGFVNMGSSNHVAVKKLNSVFQDSE------------KE 545
V + ++ + +G GA G V + +VA+KKL+ FQ+ K
Sbjct: 59 TVLKRYQNLKPIGSGAQGIVCAA-YDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKC 117
Query: 546 FKAEVNGIGQTHHKNLVRLL------GYCDEGQNRLLVYEFM------------SNGTVA 587
HKN++ LL +E Q+ LV E M + ++
Sbjct: 118 VN----------HKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMELDHERMS 167
Query: 588 SFLFGDSKPNWKLRTEIAMGIAGGLFYLHEECCTQIIHCDIKPQNILLDDHYNARISDFG 647
L+ L G+ +LH IIH D+KP NI++ +I DFG
Sbjct: 168 YLLYQ------MLC---------GIKHLHS---AGIIHRDLKPSNIVVKSDCTLKILDFG 209
Query: 648 LAKLLTLDQSHTNTAIRGTKGYVAPEWFRNMPITVKVDVYSYGVLLLEII 697
LA+ T S T T+ Y APE M VD++S G ++ E++
Sbjct: 210 LAR--TAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMV 257
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292 | Back alignment and structure |
|---|
Score = 79.9 bits (198), Expect = 2e-16
Identities = 49/219 (22%), Positives = 100/219 (45%), Gaps = 25/219 (11%)
Query: 507 EELGRGAFGTVYKGFVNMGSSNHVAVKKLNSVFQDSEKE---FKA--EVNGIGQTHHKNL 561
E++G G +GTV+K N + VA+K++ D + E A E+ + + HKN+
Sbjct: 8 EKIGEGTYGTVFKA-KNRETHEIVALKRVR---LDDDDEGVPSSALREICLLKELKHKNI 63
Query: 562 VRLLGYCDEGQNRLLVYEFMSNGTVASFLFGDSKPNWKLRTEI---AMGIAGGLFYLHEE 618
VRL + LV+EF + + DS + + GL + H
Sbjct: 64 VRLHDVLHSDKKLTLVFEFCDQ-DLKKYF--DSCNGDLDPEIVKSFLFQLLKGLGFCHSR 120
Query: 619 CCTQIIHCDIKPQNILLDDHYNARISDFGLAKLLTL-DQSHTNTAIRGTKGYVAPEWFRN 677
++H D+KPQN+L++ + ++++FGLA+ + + ++ + T Y P+
Sbjct: 121 ---NVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCYSAEVV--TLWYRPPDVLFG 175
Query: 678 MPI-TVKVDVYSYGVLLLEIICLRRNI---DNEISKVDK 712
+ + +D++S G + E+ R + ++ ++ +
Sbjct: 176 AKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKR 214
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476 | Back alignment and structure |
|---|
Score = 82.1 bits (203), Expect = 2e-16
Identities = 58/201 (28%), Positives = 99/201 (49%), Gaps = 24/201 (11%)
Query: 509 LGRGAFGTVYKGFVNMGSSNHVAVK-----KLNSVFQDSEKEFKAEVNGIGQTHHKNLVR 563
LG G FG V G + + + VAVK K+ S+ D + + E+ + H ++++
Sbjct: 24 LGVGTFGKVKVG-KHELTGHKVAVKILNRQKIRSL--DVVGKIRREIQNLKLFRHPHIIK 80
Query: 564 LLGYCDEGQNRLLVYEFMSNGTVASFLFGDSKPNWKLRTEIAMG----IAGGLFYLHEEC 619
L + +V E++S G LF N +L + + I G+ Y H
Sbjct: 81 LYQVISTPSDIFMVMEYVSGGE----LFDYICKNGRLDEKESRRLFQQILSGVDYCH--- 133
Query: 620 CTQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLDQS-HTNTAIRGTKGYVAPEWFRNM 678
++H D+KP+N+LLD H NA+I+DFGL+ +++ + T+ G+ Y APE
Sbjct: 134 RHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLRTSC---GSPNYAAPEVISGR 190
Query: 679 P-ITVKVDVYSYGVLLLEIIC 698
+VD++S GV+L ++C
Sbjct: 191 LYAGPEVDIWSSGVILYALLC 211
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 80.8 bits (200), Expect = 2e-16
Identities = 54/227 (23%), Positives = 92/227 (40%), Gaps = 58/227 (25%)
Query: 500 EVTRGFK--EELGRGAFGTVYKGFVNMGSSNHVAVKKLNSVFQDSEKEFKA--EVNGIGQ 555
E+ + + +G GA+G+V ++ S VA+KKL+ FQ +A E+ +
Sbjct: 21 ELPKTYVSPTHVGSGAYGSVCSA-IDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKH 79
Query: 556 THHKNLVRLL------GYCDEGQNRLLVYEFM------------SNGTVASFLFGDSKPN 597
H+N++ LL + LV FM S + ++
Sbjct: 80 MQHENVIGLLDVFTPASSLRNFYDFYLVMPFMQTDLQKIMGLKFSEEKIQYLVYQ----- 134
Query: 598 WKLRTEIAMGIAGGLFYLHEECCTQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLDQS 657
L+ GL Y+H ++H D+KP N+ +++ +I DFGLA+ D
Sbjct: 135 -MLK---------GLKYIHS---AGVVHRDLKPGNLAVNEDCELKILDFGLAR--HADAE 179
Query: 658 HTNTAIRGTKGYVAPEWFR-------NMPITVKVDVYSYGVLLLEII 697
T GYV W+R M VD++S G ++ E++
Sbjct: 180 MT--------GYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEML 218
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326 | Back alignment and structure |
|---|
Score = 80.3 bits (199), Expect = 2e-16
Identities = 57/226 (25%), Positives = 103/226 (45%), Gaps = 32/226 (14%)
Query: 507 EELGRGAFGTVYKGFVNMGSSNHVAVKKLNSVFQDSEKE---FKA--EVN---GIGQTHH 558
E+G GA+G V+K VA+K++ + +E EV + H
Sbjct: 17 AEIGEGAYGKVFKARDLKNGGRFVALKRVR---VQTGEEGMPLSTIREVAVLRHLETFEH 73
Query: 559 KNLVRLL----GYCDEGQNRL-LVYEFMSNGTVASFLFGDSKPNWKLRTE----IAMGIA 609
N+VRL + + +L LV+E + + ++L D P + TE + +
Sbjct: 74 PNVVRLFDVCTVSRTDRETKLTLVFEHVDQ-DLTTYL--DKVPEPGVPTETIKDMMFQLL 130
Query: 610 GGLFYLHEECCTQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLDQSHTNTAIRGTKGY 669
GL +LH ++H D+KPQNIL+ +++DFGLA++ + + T+ + T Y
Sbjct: 131 RGLDFLHSHR---VVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMALTSVVV--TLWY 185
Query: 670 VAPEWFRNMPITVKVDVYSYGVLLLEIICLRRNI---DNEISKVDK 712
APE VD++S G + E+ R+ + +++ ++ K
Sbjct: 186 RAPEVLLQSSYATPVDLWSVGCIFAEMF-RRKPLFRGSSDVDQLGK 230
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331 | Back alignment and structure |
|---|
Score = 80.0 bits (198), Expect = 2e-16
Identities = 50/179 (27%), Positives = 80/179 (44%), Gaps = 27/179 (15%)
Query: 507 EELGRGAFGTVYKGFVNMGSSNHVAVKKLNSVFQDSEKE-FKA----EVNGIGQTHHKNL 561
+G G++G V K N + VA+KK + + + K E+ + Q H+NL
Sbjct: 31 GLVGEGSYGMVMKC-RNKDTGRIVAIKKFL---ESDDDKMVKKIAMREIKLLKQLRHENL 86
Query: 562 VRLLGYCDEGQNRLLVYEFMSNGTVASFLFGDSKPNWKLRTEI---AMGIAGGLFYLHEE 618
V LL C + + LV+EF+ + T+ L + PN + I G+ + H
Sbjct: 87 VNLLEVCKKKKRWYLVFEFVDH-TILDDL--ELFPNGLDYQVVQKYLFQIINGIGFCHSH 143
Query: 619 CCTQIIHCDIKPQNILLDDHYNARISDFGLAKLLTL-DQSHTNTAIRGTKGYVAPEWFR 676
IIH DIKP+NIL+ ++ DFG A+ L + + + VA W+R
Sbjct: 144 ---NIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEVYDD--------EVATRWYR 191
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318 | Back alignment and structure |
|---|
Score = 79.1 bits (196), Expect = 4e-16
Identities = 56/211 (26%), Positives = 93/211 (44%), Gaps = 47/211 (22%)
Query: 509 LGRGAFGTVY----KGFVNMGSSNHVAVKKLN--SVFQDSEKE-FKAEVNGIGQTHHKNL 561
LG G+FG V+ + + + A+K L V + + E E + H +
Sbjct: 14 LGTGSFGRVHLIRSRH-----NGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFI 68
Query: 562 VRLLGYCDEGQNRLLVYEFMSNGTVASFLFGDSKPNWKLR--------------TEIAMG 607
+R+ G + Q ++ +++ G LF LR E+ +
Sbjct: 69 IRMWGTFQDAQQIFMIMDYIEGGE----LF------SLLRKSQRFPNPVAKFYAAEVCLA 118
Query: 608 IAGGLFYLHEECCTQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLDQSHTNTAIRGTK 667
L YLH + II+ D+KP+NILLD + + +I+DFG AK T T + GT
Sbjct: 119 ----LEYLHSK---DIIYRDLKPENILLDKNGHIKITDFGFAK---YVPDVTYT-LCGTP 167
Query: 668 GYVAPEWFRNMPITVKVDVYSYGVLLLEIIC 698
Y+APE P +D +S+G+L+ E++
Sbjct: 168 DYIAPEVVSTKPYNKSIDWWSFGILIYEMLA 198
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361 | Back alignment and structure |
|---|
Score = 79.7 bits (197), Expect = 4e-16
Identities = 50/197 (25%), Positives = 76/197 (38%), Gaps = 18/197 (9%)
Query: 509 LGRGAFGTVYKGFVNMGSSNHVAVKKLNSVFQDSEKEFKAEVNGIGQTHHKNLVRLLGYC 568
+G G FG + + VAVK + E + E+ H N+VR
Sbjct: 28 IGSGNFGVARLM-RDKLTKELVAVKYIERGAAIDEN-VQREIINHRSLRHPNIVRFKEVI 85
Query: 569 DEGQNRLLVYEFMSNGTVASFLFGDSKPNWKLRTEIAMG----IAGGLFYLHEECCTQII 624
+ ++ E+ S G L+ + + A + G+ Y H QI
Sbjct: 86 LTPTHLAIIMEYASGGE----LYERICNAGRFSEDEARFFFQQLLSGVSYCHSM---QIC 138
Query: 625 HCDIKPQNILLDDHY--NARISDFGLAKLLTLDQSHTNTAIRGTKGYVAPEWFRNMPIT- 681
H D+K +N LLD +I DFG +K L S + + GT Y+APE
Sbjct: 139 HRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH-SQPKSTV-GTPAYIAPEVLLRQEYDG 196
Query: 682 VKVDVYSYGVLLLEIIC 698
DV+S GV L ++
Sbjct: 197 KIADVWSCGVTLYVMLV 213
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336 | Back alignment and structure |
|---|
Score = 79.2 bits (196), Expect = 5e-16
Identities = 50/206 (24%), Positives = 94/206 (45%), Gaps = 35/206 (16%)
Query: 509 LGRGAFGTVYKGFVNMGSSNHVAVKKLN-SVFQDSEKEFKA--EVNGIGQTHHKNLVRLL 565
LG G+FG V + + VA+K ++ + + S+ + E++ + H ++++L
Sbjct: 17 LGEGSFGKVKLA-THYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKL- 74
Query: 566 GYCDEGQNRLLVYEFMSNGT--------VASFLFGDSKPNWKLRTEIAMG----IAGGLF 613
Y+ ++ T LF ++ + I +
Sbjct: 75 ------------YDVITTPTDIVMVIEYAGGELFDYIVEKKRMTEDEGRRFFQQIICAIE 122
Query: 614 YLHEECCTQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLDQSHTNTAIRGTKGYVAPE 673
Y H +I+H D+KP+N+LLDD+ N +I+DFGL+ ++T D + T+ G+ Y APE
Sbjct: 123 YCH---RHKIVHRDLKPENLLLDDNLNVKIADFGLSNIMT-DGNFLKTSC-GSPNYAAPE 177
Query: 674 WFRNMPIT-VKVDVYSYGVLLLEIIC 698
+VDV+S G++L ++
Sbjct: 178 VINGKLYAGPEVDVWSCGIVLYVMLV 203
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373 | Back alignment and structure |
|---|
Score = 79.4 bits (196), Expect = 7e-16
Identities = 54/213 (25%), Positives = 96/213 (45%), Gaps = 30/213 (14%)
Query: 507 EELGRGAFGTVYKGFVNMGSSNHVAVKKLNSV---FQDSEKEFK--AEVNGIGQTHH--- 558
+LG G F TV+ +M ++ HVA+K + + +E E K VN T
Sbjct: 25 RKLGWGHFSTVWLAK-DMVNNTHVAMKIVRGDKVYTEAAEDEIKLLQRVNDADNTKEDSM 83
Query: 559 --KNLVRLLGYCD-EGQNRL---LVYEFMSNGTVASFL--FGDSKPNWKLRTEIAMGIAG 610
++++LL + + +G N + +V+E + + + + + +I+ +
Sbjct: 84 GANHILKLLDHFNHKGPNGVHVVMVFEVLGE-NLLALIKKYEHRGIPLIYVKQISKQLLL 142
Query: 611 GLFYLHEECCTQIIHCDIKPQNILLDD------HYNARISDFGLAKLLTLDQSHTNTAIR 664
GL Y+H C IIH DIKP+N+L++ +I+D G A H +I+
Sbjct: 143 GLDYMHRRC--GIIHTDIKPENVLMEIVDSPENLIQIKIADLGNA---CWYDEHYTNSIQ 197
Query: 665 GTKGYVAPEWFRNMPITVKVDVYSYGVLLLEII 697
T+ Y +PE P D++S L+ E+I
Sbjct: 198 -TREYRSPEVLLGAPWGCGADIWSTACLIFELI 229
|
| >2r3i_A Cell division protein kinase 2; serine/threonine-protein kinase, cell cycle, inhibition, cyclin-dependent kinase, cancer, ATP-binding; HET: SCF; 1.28A {Homo sapiens} PDB: 2r3j_A* 2r3k_A* 2r3l_A* 2r3m_A* 2r3n_A* 2r3o_A* 2r3p_A* 2r3q_A* 1jvp_P* 1buh_A 1ckp_A* 1di8_A* 1dm2_A* 1f5q_A 1fin_A* 1fq1_B* 1fvt_A* 1fvv_A* 1g5s_A* 1gih_A* ... Length = 299 | Back alignment and structure |
|---|
Score = 77.2 bits (191), Expect = 1e-15
Identities = 49/177 (27%), Positives = 88/177 (49%), Gaps = 22/177 (12%)
Query: 507 EELGRGAFGTVYKGFVNMGSSNHVAVKKLNSVFQDSEKE---FKA--EVNGIGQTHHKNL 561
E++G G +G VYK N + VA+KK+ D+E E A E++ + + +H N+
Sbjct: 9 EKIGEGTYGVVYKA-RNKLTGEVVALKKIR---LDTETEGVPSTAIREISLLKELNHPNI 64
Query: 562 VRLLGYCDEGQNRLLVYEFMSNGTVASFLFGDSKPNWKLRTEIAMGIA----GGLFYLHE 617
V+LL LV+EF+ + F+ D+ + + GL + H
Sbjct: 65 VKLLDVIHTENKLYLVFEFLHQ-DLKKFM--DASALTGIPLPLIKSYLFQLLQGLAFCHS 121
Query: 618 ECCTQIIHCDIKPQNILLDDHYNARISDFGLAKLLTL-DQSHTNTAIRGTKGYVAPE 673
+++H D+KPQN+L++ +++DFGLA+ + +++T+ + T Y APE
Sbjct: 122 H---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVV--TLWYRAPE 173
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373 | Back alignment and structure |
|---|
Score = 78.5 bits (194), Expect = 1e-15
Identities = 59/206 (28%), Positives = 94/206 (45%), Gaps = 33/206 (16%)
Query: 509 LGRGAFGTVYKGFVNMGSSNHV-AVKKLN--SVFQDSEKEF-KAEVNGIGQ-THHKNLVR 563
+G+G+FG V + AVK L ++ + E++ +E N + + H LV
Sbjct: 46 IGKGSFGKVL--LARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVG 103
Query: 564 LLGYCDEGQNRL-LVYEFMSNGTVASFLFGDSKPNWKLRTEI----------AMGIAGGL 612
L + + ++L V ++++ G LF + L+ E A IA L
Sbjct: 104 LH-FSFQTADKLYFVLDYINGGE----LF------YHLQRERCFLEPRARFYAAEIASAL 152
Query: 613 FYLHEECCTQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLDQSHTNTAIRGTKGYVAP 672
YLH I++ D+KP+NILLD + ++DFGL K S T+T GT Y+AP
Sbjct: 153 GYLHSL---NIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNSTTST-FCGTPEYLAP 208
Query: 673 EWFRNMPITVKVDVYSYGVLLLEIIC 698
E P VD + G +L E++
Sbjct: 209 EVLHKQPYDRTVDWWCLGAVLYEMLY 234
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345 | Back alignment and structure |
|---|
Score = 78.0 bits (193), Expect = 1e-15
Identities = 54/206 (26%), Positives = 98/206 (47%), Gaps = 33/206 (16%)
Query: 509 LGRGAFGTVYKGFVNMGSSNHV-AVKKL--NSVFQDSEKEF-KAEVNGIGQ-THHKNLVR 563
+GRG++ V V + ++ + A+K + V D + ++ + E + Q ++H LV
Sbjct: 17 IGRGSYAKVL--LVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVG 74
Query: 564 LLGYCDEGQNRL-LVYEFMSNGTVASFLFGDSKPNWKLRTEIAMG----------IAGGL 612
L C + ++RL V E+++ G L + ++ + + I+ L
Sbjct: 75 LH-SCFQTESRLFFVIEYVNGGD----LM------FHMQRQRKLPEEHARFYSAEISLAL 123
Query: 613 FYLHEECCTQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLDQSHTNTAIRGTKGYVAP 672
YLHE II+ D+K N+LLD + +++D+G+ K T+T GT Y+AP
Sbjct: 124 NYLHER---GIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTST-FCGTPNYIAP 179
Query: 673 EWFRNMPITVKVDVYSYGVLLLEIIC 698
E R VD ++ GVL+ E++
Sbjct: 180 EILRGEDYGFSVDWWALGVLMFEMMA 205
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674 | Back alignment and structure |
|---|
Score = 79.3 bits (195), Expect = 2e-15
Identities = 60/200 (30%), Positives = 94/200 (47%), Gaps = 21/200 (10%)
Query: 509 LGRGAFGTVYKGFVNMGSSNHV-AVKKL--NSVFQDSEKEF-KAEVNGIGQ-THHKNLVR 563
LG+G+FG V ++ + AVK L + V QD + E E + L +
Sbjct: 349 LGKGSFGKVM--LSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQ 406
Query: 564 LLGYCDEGQNRL-LVYEFMSNGTVASFLFGDSKPNWKLRTEIAM----GIAGGLFYLHEE 618
L C + +RL V E+++ G L + + + A+ IA GLF+L +
Sbjct: 407 LH-SCFQTMDRLYFVMEYVNGGD----LMYHIQQVGRFKEPHAVFYAAEIAIGLFFLQSK 461
Query: 619 CCTQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLDQSHTNTAIRGTKGYVAPEWFRNM 678
II+ D+K N++LD + +I+DFG+ K D T T GT Y+APE
Sbjct: 462 ---GIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGVTTKT-FCGTPDYIAPEIIAYQ 517
Query: 679 PITVKVDVYSYGVLLLEIIC 698
P VD +++GVLL E++
Sbjct: 518 PYGKSVDWWAFGVLLYEMLA 537
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396 | Back alignment and structure |
|---|
Score = 77.8 bits (192), Expect = 2e-15
Identities = 53/206 (25%), Positives = 98/206 (47%), Gaps = 33/206 (16%)
Query: 509 LGRGAFGTVYKGFVNMGSSNHV-AVKKL--NSVFQDSEKEF-KAEVNGIGQ-THHKNLVR 563
+GRG++ V V + ++ + A++ + V D + ++ + E + Q ++H LV
Sbjct: 60 IGRGSYAKVL--LVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVG 117
Query: 564 LLGYCDEGQNRL-LVYEFMSNGTVASFLFGDSKPNWKLRTEIAMG----------IAGGL 612
L C + ++RL V E+++ G L + ++ + + I+ L
Sbjct: 118 LH-SCFQTESRLFFVIEYVNGGD----LM------FHMQRQRKLPEEHARFYSAEISLAL 166
Query: 613 FYLHEECCTQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLDQSHTNTAIRGTKGYVAP 672
YLHE II+ D+K N+LLD + +++D+G+ K T+T GT Y+AP
Sbjct: 167 NYLHER---GIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTST-FCGTPNYIAP 222
Query: 673 EWFRNMPITVKVDVYSYGVLLLEIIC 698
E R VD ++ GVL+ E++
Sbjct: 223 EILRGEDYGFSVDWWALGVLMFEMMA 248
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329 | Back alignment and structure |
|---|
Score = 76.9 bits (190), Expect = 2e-15
Identities = 46/180 (25%), Positives = 83/180 (46%), Gaps = 25/180 (13%)
Query: 507 EELGRGAFGTVYKGFVNMGSSNHVAVKKLNSVFQDSEKE---FKA--EVNGIGQTHHKNL 561
+LG G +G VYK ++ ++ VA+K++ + E+E A EV+ + + H+N+
Sbjct: 40 TKLGEGTYGEVYKA-IDTVTNETVAIKRIR---LEHEEEGVPGTAIREVSLLKELQHRNI 95
Query: 562 VRLLGYCDEGQNRLLVYEFMSNGTVASFLFGDSKPNWKLRT--EIAMGIAGGLFYLHEEC 619
+ L L++E+ N + ++ D P+ +R + G+ + H
Sbjct: 96 IELKSVIHHNHRLHLIFEYAEN-DLKKYM--DKNPDVSMRVIKSFLYQLINGVNFCHSR- 151
Query: 620 CTQIIHCDIKPQNILLDDHYNAR-----ISDFGLAKLLTL-DQSHTNTAIRGTKGYVAPE 673
+ +H D+KPQN+LL + I DFGLA+ + + T+ I T Y PE
Sbjct: 152 --RCLHRDLKPQNLLLSVSDASETPVLKIGDFGLARAFGIPIRQFTHEII--TLWYRPPE 207
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345 | Back alignment and structure |
|---|
Score = 76.9 bits (190), Expect = 3e-15
Identities = 58/206 (28%), Positives = 91/206 (44%), Gaps = 33/206 (16%)
Query: 509 LGRGAFGTVYKGFVNMGSSNHV-AVKKL--NSVFQDSEKE-FKAEVNGIGQ-THHKNLVR 563
LG+G+FG V+ +N A+K L + V D + E E + H L
Sbjct: 25 LGKGSFGKVF--LAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTH 82
Query: 564 LLGYCDEGQNRL-LVYEFMSNGTVASFLFGDSKPNWKLRTE----------IAMGIAGGL 612
+ + + L V E+++ G L + +++ A I GL
Sbjct: 83 MF-CTFQTKENLFFVMEYLNGGD----LM------YHIQSCHKFDLSRATFYAAEIILGL 131
Query: 613 FYLHEECCTQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLDQSHTNTAIRGTKGYVAP 672
+LH + I++ D+K NILLD + +I+DFG+ K L + TNT GT Y+AP
Sbjct: 132 QFLHSK---GIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKTNT-FCGTPDYIAP 187
Query: 673 EWFRNMPITVKVDVYSYGVLLLEIIC 698
E VD +S+GVLL E++
Sbjct: 188 EILLGQKYNHSVDWWSFGVLLYEMLI 213
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353 | Back alignment and structure |
|---|
Score = 77.3 bits (191), Expect = 3e-15
Identities = 47/240 (19%), Positives = 90/240 (37%), Gaps = 72/240 (30%)
Query: 500 EVTRGFK--EELGRGAFGTVYKGFVNMGSSNHVAVKKLNSVFQDSE------------KE 545
++ F+ LG GA+G V + + VA+KK+ F K
Sbjct: 8 NISSDFQLKSLLGEGAYGVVCSA-THKPTGEIVAIKKIE-PFDKPLFALRTLREIKILKH 65
Query: 546 FKAEVNGIGQTHHKNLVRLL-----GYCDEGQNRLLVYEFM-------------SNGTVA 587
FK H+N++ + + ++ E M S+ +
Sbjct: 66 FK----------HENIITIFNIQRPDSFENFNEVYIIQELMQTDLHRVISTQMLSDDHIQ 115
Query: 588 SFLFGDSKPNWKLRTEIAMGIAGGLFYLHEECCTQIIHCDIKPQNILLDDHYNARISDFG 647
F++ LR + LH + +IH D+KP N+L++ + + ++ DFG
Sbjct: 116 YFIYQ------TLR---------AVKVLHG---SNVIHRDLKPSNLLINSNCDLKVCDFG 157
Query: 648 LAKLLTLDQSHTNTAIRGTK---GYVAPEWFR-------NMPITVKVDVYSYGVLLLEII 697
LA+++ + + +VA W+R + + +DV+S G +L E+
Sbjct: 158 LARIIDESAADNSEPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELF 217
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367 | Back alignment and structure |
|---|
Score = 77.4 bits (191), Expect = 3e-15
Identities = 59/228 (25%), Positives = 93/228 (40%), Gaps = 59/228 (25%)
Query: 500 EVTRGFK--EELGRGAFGTVYKGFVNMGSSNHVAVKKLNSVFQDSEKEFKA--EVNGIGQ 555
EV ++ + +G GA+G V V+ + VA+KKL FQ +A E+ +
Sbjct: 22 EVRAVYRDLQPVGSGAYGAVCSA-VDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKH 80
Query: 556 THHKNLVRLL------GYCDEGQNRLLVYEFM-------------SNGTVASFLFGDSKP 596
H+N++ LL D+ + LV FM + ++
Sbjct: 81 MRHENVIGLLDVFTPDETLDDFTDFYLVMPFMGTDLGKLMKHEKLGEDRIQFLVYQ---- 136
Query: 597 NWKLRTEIAMGIAGGLFYLHEECCTQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLDQ 656
L+ GL Y+H IIH D+KP N+ +++ +I DFGLA+ D
Sbjct: 137 --MLK---------GLRYIHA---AGIIHRDLKPGNLAVNEDCELKILDFGLAR--QADS 180
Query: 657 SHTNTAIRGTKGYVAPEWFR-------NMPITVKVDVYSYGVLLLEII 697
T GYV W+R M T VD++S G ++ E+I
Sbjct: 181 EMT--------GYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMI 220
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353 | Back alignment and structure |
|---|
Score = 76.9 bits (190), Expect = 3e-15
Identities = 60/206 (29%), Positives = 93/206 (45%), Gaps = 33/206 (16%)
Query: 509 LGRGAFGTVYKGFVNMGSSNHV-AVKKL--NSVFQDSEKEF-KAEVNGIGQ-THHKNLVR 563
LG+G+FG V ++ + AVK L + V QD + E E + L +
Sbjct: 28 LGKGSFGKVM--LSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQ 85
Query: 564 LLGYCDEGQNRL-LVYEFMSNGTVASFLFGDSKPNWKLRTE----------IAMGIAGGL 612
L C + +RL V E+++ G L + ++ A IA GL
Sbjct: 86 LH-SCFQTMDRLYFVMEYVNGGD----LM------YHIQQVGRFKEPHAVFYAAEIAIGL 134
Query: 613 FYLHEECCTQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLDQSHTNTAIRGTKGYVAP 672
F+L + II+ D+K N++LD + +I+DFG+ K D T T GT Y+AP
Sbjct: 135 FFLQSK---GIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGVTTKT-FCGTPDYIAP 190
Query: 673 EWFRNMPITVKVDVYSYGVLLLEIIC 698
E P VD +++GVLL E++
Sbjct: 191 EIIAYQPYGKSVDWWAFGVLLYEMLA 216
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 76.9 bits (190), Expect = 3e-15
Identities = 59/206 (28%), Positives = 95/206 (46%), Gaps = 33/206 (16%)
Query: 509 LGRGAFGTVYKGFVNMGSSNHV-AVKKL--NSVFQDSEKEF-KAEVNGIGQ-THHKNLVR 563
LG+G+FG V + + + AVK L + + QD + E E + +H L +
Sbjct: 31 LGKGSFGKVM--LARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQ 88
Query: 564 LLGYCDEGQNRL-LVYEFMSNGTVASFLFGDSKPNWKLRTE----------IAMGIAGGL 612
L C + +RL V EF++ G L + ++ A I L
Sbjct: 89 LF-CCFQTPDRLFFVMEFVNGGD----LM------FHIQKSRRFDEARARFYAAEIISAL 137
Query: 613 FYLHEECCTQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLDQSHTNTAIRGTKGYVAP 672
+LH++ II+ D+K N+LLD + +++DFG+ K + T T GT Y+AP
Sbjct: 138 MFLHDK---GIIYRDLKLDNVLLDHEGHCKLADFGMCKEGICNGVTTAT-FCGTPDYIAP 193
Query: 673 EWFRNMPITVKVDVYSYGVLLLEIIC 698
E + M VD ++ GVLL E++C
Sbjct: 194 EILQEMLYGPAVDWWAMGVLLYEMLC 219
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355 | Back alignment and structure |
|---|
Score = 76.6 bits (189), Expect = 4e-15
Identities = 57/240 (23%), Positives = 98/240 (40%), Gaps = 51/240 (21%)
Query: 509 LGRGAFGTVY--KGFVNMGSSNHVAVKKLN--SVFQD--------SEKEFKAEVNGIGQT 556
LG GA+G V+ + + A+K L ++ Q +E++ +
Sbjct: 62 LGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIR----- 116
Query: 557 HHKNLVRLLGYCDEGQNRL-LVYEFMSNGTVASFLFGDSKPNWKLRTE-----------I 604
LV L Y + + +L L+ ++++ G LF L +
Sbjct: 117 QSPFLVTLH-YAFQTETKLHLILDYINGGE----LF------THLSQRERFTEHEVQIYV 165
Query: 605 AMGIAGGLFYLHEECCTQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLDQSHTNTAIR 664
I L +LH+ II+ DIK +NILLD + + ++DFGL+K D++
Sbjct: 166 GE-IVLALEHLHKL---GIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETERAYDFC 221
Query: 665 GTKGYVAPEWFRNMPI--TVKVDVYSYGVLLLEIIC-----LRRNIDNEISKVDKAILTD 717
GT Y+AP+ R VD +S GVL+ E++ N +++ + IL
Sbjct: 222 GTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILKS 281
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299 | Back alignment and structure |
|---|
Score = 75.0 bits (185), Expect = 7e-15
Identities = 46/205 (22%), Positives = 75/205 (36%), Gaps = 54/205 (26%)
Query: 505 FKEELGRGAFGTVYKGFVNMGSSNHVAVKKLNSVFQDSEKEFKAEVNGIGQ-THHKNLVR 563
+ LG G G V + N + A+K L D K + EV + + ++VR
Sbjct: 22 TSQVLGLGINGKVLQI-FNKRTQEKFALKMLQ----DCPK-ARREVELHWRASQCPHIVR 75
Query: 564 LLG-YCDEGQNRLLVY---EFMSNGTVASFLFGD---SKPNWKLRTE-----IAMGIAGG 611
++ Y + R + E + G LF + + TE I I
Sbjct: 76 IVDVYENLYAGRKCLLIVMECLDGGE----LF-SRIQDRGDQAF-TEREASEIMKSIGEA 129
Query: 612 LFYLHEECCTQIIHCDIKPQNILL---DDHYNARISDFGLAKLLTLDQSHTNTAIRGTKG 668
+ YLH I H D+KP+N+L + +++DFG AK T +
Sbjct: 130 IQYLHSI---NIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETT------------GEK 174
Query: 669 YVAPEWFRNMPITVKVDVYSYGVLL 693
Y D++S GV++
Sbjct: 175 Y-----------DKSCDMWSLGVIM 188
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286 | Back alignment and structure |
|---|
Score = 74.4 bits (183), Expect = 9e-15
Identities = 34/286 (11%), Positives = 74/286 (25%), Gaps = 54/286 (18%)
Query: 507 EELGRGAFGTVYKGF-VNMGSSNHVAVKKLNSVFQDSE---KEFKAEVNGIGQTHHKNLV 562
G ++ + VA+ ++ + +E + + + +
Sbjct: 37 IFHGGVPPLQFWQALDTALD--RQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVA 94
Query: 563 RLLGYCDEGQNRLLVYEFMSNGTVASFLFGDSKPNWKLRTEIAMGIAGGLFYLHEECCTQ 622
R+L L+V E++ G++ D+ P+ +A H
Sbjct: 95 RVLDVVHTRAGGLVVAEWIRGGSLQEVA--DTSPSPVGAIRAMQSLAAAADAAHRA---G 149
Query: 623 IIHCDIKPQNILLDDHYNARISDFGLAKLLTLDQSHTNTAIRGTKGYVAPEWFRNMPITV 682
+ P + +S G L +
Sbjct: 150 VALSIDHPSRVR--------VSIDGDVVL-------------AYPATMPDA-------NP 181
Query: 683 KVDVYSYGVLLLEIICLRRNIDNEISKVDKAILTDWAYDRYQE-RTLEALVENDLEAMNN 741
+ D+ G L ++ R + + A + E ++ + + A
Sbjct: 182 QDDIRGIGASLYALLVNRWPLPEAGVRSGLAPAERDTAGQPIEPADIDRDIPFQISA--- 238
Query: 742 VTMLHRFVMVAFWCIQEDPSHRP--TMRKVTQMLEGVVEVPIPPCP 785
VA +Q D R T+ + Q V + P
Sbjct: 239 ---------VAARSVQGDGGIRSASTLLNLMQQATAVADRTEVLGP 275
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388 | Back alignment and structure |
|---|
Score = 75.5 bits (186), Expect = 1e-14
Identities = 56/248 (22%), Positives = 98/248 (39%), Gaps = 78/248 (31%)
Query: 500 EVTRGFK--EELGRGAFGTVYKGFVNMGSSNHVAVKKLNSVFQDSE------------KE 545
V R ++ ++LG+GA+G V+K ++ + VAVKK+ FQ+S E
Sbjct: 6 HVLRKYELVKKLGKGAYGIVWKS-IDRRTGEVVAVKKIFDAFQNSTDAQRTFREIMILTE 64
Query: 546 FKAEVNGIGQTHHKNLVRLLG--YCDEGQNRLLVYEFM-------------SNGTVASFL 590
H+N+V LL D ++ LV+++M +
Sbjct: 65 LS---------GHENIVNLLNVLRADNDRDVYLVFDYMETDLHAVIRANILEPVHKQYVV 115
Query: 591 FGDSKPNWKLRTEIAMGIAGGLFYLHEECCTQIIHCDIKPQNILLDDHYNARISDFGLAK 650
+ ++ + YLH ++H D+KP NILL+ + +++DFGL++
Sbjct: 116 YQ------LIK---------VIKYLHS---GGLLHRDMKPSNILLNAECHVKVADFGLSR 157
Query: 651 LLTLDQSHTNTAIRGTK--------------GYVAPEWFR-------NMPITVKVDVYSY 689
+ TN YVA W+R + T +D++S
Sbjct: 158 SFVNIRRVTNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSL 217
Query: 690 GVLLLEII 697
G +L EI+
Sbjct: 218 GCILGEIL 225
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330 | Back alignment and structure |
|---|
Score = 74.6 bits (184), Expect = 2e-14
Identities = 46/215 (21%), Positives = 87/215 (40%), Gaps = 55/215 (25%)
Query: 507 EELGRGAFGTVYKGFVNMGSSNHVAVKKLNSVFQDSEKEFKAEVNGIGQ--THHKNLVRL 564
+LGRG + V++ +N+ ++ V VK L V +K+ K E+ I + N++ L
Sbjct: 42 RKLGRGKYSEVFEA-INITNNEKVVVKILKPV---KKKKIKREIK-ILENLRGGPNIITL 96
Query: 565 LG--YCDEGQNRLLVYEFM------------SNGTVASFLFGDSKPNWKLRTEIAMGIAG 610
+ LV+E + ++ + +++ EI +
Sbjct: 97 ADIVKDPVSRTPALVFEHVNNTDFKQLYQTLTDYDIRFYMY-----------EILKALD- 144
Query: 611 GLFYLHEECCTQIIHCDIKPQNILLD-DHYNARISDFGLAKLLTLDQSHTNTAIRGTKGY 669
Y H I+H D+KP N+++D +H R+ D+GLA+ Q +
Sbjct: 145 ---YCHSM---GIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYN--------VR 190
Query: 670 VAPEWFR-------NMPITVKVDVYSYGVLLLEII 697
VA +F+ +D++S G +L +I
Sbjct: 191 VASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMI 225
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317 | Back alignment and structure |
|---|
Score = 74.2 bits (183), Expect = 2e-14
Identities = 51/180 (28%), Positives = 91/180 (50%), Gaps = 25/180 (13%)
Query: 507 EELGRGAFGTVYKGFVNMGSSNHVAVKKLNSVFQDSEKEFKA----EVNGIGQTHHKNLV 562
E+LG G + TVYKG +N + +VA+K++ DSE+ + E++ + + H+N+V
Sbjct: 11 EKLGNGTYATVYKG-LNKTTGVYVALKEVK---LDSEEGTPSTAIREISLMKELKHENIV 66
Query: 563 RLLGYCDEGQNRLLVYEFMSNGTVASFLFGDSKPNWKLRTEIAMGIA--------GGLFY 614
RL LV+EFM N + ++ DS+ + + + GL +
Sbjct: 67 RLYDVIHTENKLTLVFEFMDN-DLKKYM--DSRTVGNTPRGLELNLVKYFQWQLLQGLAF 123
Query: 615 LHEECCTQIIHCDIKPQNILLDDHYNARISDFGLAKLLTL-DQSHTNTAIRGTKGYVAPE 673
HE +I+H D+KPQN+L++ ++ DFGLA+ + + ++ + T Y AP+
Sbjct: 124 CHEN---KILHRDLKPQNLLINKRGQLKLGDFGLARAFGIPVNTFSSEVV--TLWYRAPD 178
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311 | Back alignment and structure |
|---|
Score = 74.1 bits (183), Expect = 2e-14
Identities = 50/176 (28%), Positives = 89/176 (50%), Gaps = 22/176 (12%)
Query: 507 EELGRGAFGTVYKGFVNMGSSNHVAVKKLNSVFQDSEKE---FKA--EVNGIGQTHHKNL 561
E++G G +G VYK + G VA+K+ + D+E E A E++ + + HH N+
Sbjct: 27 EKVGEGTYGVVYKAKDSQG--RIVALKR---IRLDAEDEGIPSTAIREISLLKELHHPNI 81
Query: 562 VRLLGYCDEGQNRLLVYEFMSNGTVASFLFGDSKPNWKLRTEI---AMGIAGGLFYLHEE 618
V L+ + LV+EFM + L D ++I + G+ + H+
Sbjct: 82 VSLIDVIHSERCLTLVFEFMEKD-LKKVL--DENKTGLQDSQIKIYLYQLLRGVAHCHQH 138
Query: 619 CCTQIIHCDIKPQNILLDDHYNARISDFGLAKLLTL-DQSHTNTAIRGTKGYVAPE 673
+I+H D+KPQN+L++ +++DFGLA+ + +S+T+ + T Y AP+
Sbjct: 139 ---RILHRDLKPQNLLINSDGALKLADFGLARAFGIPVRSYTHEVV--TLWYRAPD 189
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367 | Back alignment and structure |
|---|
Score = 74.7 bits (184), Expect = 2e-14
Identities = 57/228 (25%), Positives = 92/228 (40%), Gaps = 59/228 (25%)
Query: 500 EVTRGFK--EELGRGAFGTVYKGFVNMGSSNHVAVKKLNSVFQDSEKEFKA--EVNGIGQ 555
EV ++ +G GA+G+V + + VAVKKL+ FQ + E+ +
Sbjct: 26 EVPERYQNLSPVGSGAYGSVCAA-FDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKH 84
Query: 556 THHKNLVRLL------GYCDEGQNRLLVYEFM-------------SNGTVASFLFGDSKP 596
H+N++ LL +E + LV M ++ V ++
Sbjct: 85 MKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQ---- 140
Query: 597 NWKLRTEIAMGIAGGLFYLHEECCTQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLDQ 656
LR GL Y+H IIH D+KP N+ +++ +I DFGLA+
Sbjct: 141 --ILR---------GLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLAR--HTAD 184
Query: 657 SHTNTAIRGTKGYVAPEWFR-------NMPITVKVDVYSYGVLLLEII 697
T GYVA W+R M VD++S G ++ E++
Sbjct: 185 EMT--------GYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELL 224
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288 | Back alignment and structure |
|---|
Score = 73.3 bits (181), Expect = 2e-14
Identities = 45/176 (25%), Positives = 82/176 (46%), Gaps = 22/176 (12%)
Query: 507 EELGRGAFGTVYKGFVNMGSSNHVAVKKLNSVFQDSEKE---FKA--EVNGIGQTHHKNL 561
E++G G +G VYK N G A+KK + + E E E++ + + H N+
Sbjct: 8 EKIGEGTYGVVYKAQNNYG--ETFALKK---IRLEKEDEGIPSTTIREISILKELKHSNI 62
Query: 562 VRLLGYCDEGQNRLLVYEFMSNGTVASFLFGDSKPNWKLRTEI---AMGIAGGLFYLHEE 618
V+L + +LV+E + + L D + + G+ Y H+
Sbjct: 63 VKLYDVIHTKKRLVLVFEHLDQD-LKKLL--DVCEGGLESVTAKSFLLQLLNGIAYCHDR 119
Query: 619 CCTQIIHCDIKPQNILLDDHYNARISDFGLAKLLTL-DQSHTNTAIRGTKGYVAPE 673
+++H D+KPQN+L++ +I+DFGLA+ + + +T+ + T Y AP+
Sbjct: 120 ---RVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEIV--TLWYRAPD 170
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458 | Back alignment and structure |
|---|
Score = 75.2 bits (185), Expect = 2e-14
Identities = 45/258 (17%), Positives = 89/258 (34%), Gaps = 89/258 (34%)
Query: 500 EVTRGFK--EELGRGAFGTVYKGFVNMGSSNHVAVKKLNSVFQDSE------------KE 545
++ ++ +G G++G V + + VA+KK+ VF+D
Sbjct: 50 QIPDRYEIRHLIGTGSYGHVCEA-YDKLEKRVVAIKKILRVFEDLIDCKRILREIAILNR 108
Query: 546 FKAEVNGIGQTHHKNLVRLL----GYCDEGQNRL-LVYEFM--------------SNGTV 586
H ++V++L E + L +V E + +
Sbjct: 109 LN----------HDHVVKVLDIVIPKDVEKFDELYVVLEIADSDFKKLFRTPVYLTELHI 158
Query: 587 ASFLFGDSKPNWKLRTEIAMGIAGGLFYLHEECCTQIIHCDIKPQNILLDDHYNARISDF 646
+ L+ L G+ Y+H I+H D+KP N L++ + ++ DF
Sbjct: 159 KTLLYN------LLV---------GVKYVHS---AGILHRDLKPANCLVNQDCSVKVCDF 200
Query: 647 GLAKLLTLDQSHTNTAIRGTK--------------------GYVAPEWFR-------NMP 679
GLA+ + ++ + + G+V W+R
Sbjct: 201 GLARTVDYPENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQEN 260
Query: 680 ITVKVDVYSYGVLLLEII 697
T +DV+S G + E++
Sbjct: 261 YTEAIDVWSIGCIFAELL 278
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432 | Back alignment and structure |
|---|
Score = 74.8 bits (184), Expect = 3e-14
Identities = 50/274 (18%), Positives = 90/274 (32%), Gaps = 84/274 (30%)
Query: 479 HQEDQGVSYMNLRCFTYKELVEVTRGFK--EELGRGAFGTVYKGFVNMGSSNHVAVKKLN 536
H S F + V V + +GRG++G VY + + +VA+KK+N
Sbjct: 2 HHHHHHSSGRENLYFQGIKNVHVPDNYIIKHLIGRGSYGYVYLA-YDKNTEKNVAIKKVN 60
Query: 537 SVFQDSE------------KEFKAEVNGIGQTHHKNLVRLL-----GYCDEGQNRLLVYE 579
+F+D K ++RL + +V E
Sbjct: 61 RMFEDLIDCKRILREITILNRLK----------SDYIIRLYDLIIPDDLLKFDELYIVLE 110
Query: 580 FM--------------SNGTVASFLFGDSKPNWKLRTEIAMGIAGGLFYLHEECCTQIIH 625
+ + + L+ L G ++HE + IIH
Sbjct: 111 IADSDLKKLFKTPIFLTEEHIKTILYN------LLL---------GENFIHE---SGIIH 152
Query: 626 CDIKPQNILLDDHYNARISDFGLAKLLTLDQSHTNTAIRGTK---------------GYV 670
D+KP N LL+ + ++ DFGLA+ + ++ +V
Sbjct: 153 RDLKPANCLLNQDCSVKVCDFGLARTINSEKDTNIVNDLEENEEPGPHNKNLKKQLTSHV 212
Query: 671 APEWFR-------NMPITVKVDVYSYGVLLLEII 697
W+R T +D++S G + E++
Sbjct: 213 VTRWYRAPELILLQENYTKSIDIWSTGCIFAELL 246
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362 | Back alignment and structure |
|---|
Score = 73.9 bits (182), Expect = 4e-14
Identities = 56/243 (23%), Positives = 90/243 (37%), Gaps = 68/243 (27%)
Query: 495 YKELVEVTRGFK--EELGRGAFGTVYKGFVNMGSSNHVAVKKLNSVFQDS------EKEF 546
EL + + + G++G V G + G VA+K++ + D F
Sbjct: 14 IAELHAMQSPYTVQRFISSGSYGAVCAGVDSEG--IPVAIKRVFNTVSDGRTVNILSDSF 71
Query: 547 KA-----EVNGIGQTHHKNLVRLLG----YCDEGQNRL-LVYEFM--------------- 581
E+ + HH N++ L + + ++L LV E M
Sbjct: 72 LCKRVLREIRLLNHFHHPNILGLRDIFVHFEEPAMHKLYLVTELMRTDLAQVIHDQRIVI 131
Query: 582 SNGTVASFLFGDSKPNWKLRTEIAMGIAGGLFYLHEECCTQIIHCDIKPQNILLDDHYNA 641
S + F++ L GL LHE ++H D+ P NILL D+ +
Sbjct: 132 SPQHIQYFMYH------ILL---------GLHVLHE---AGVVHRDLHPGNILLADNNDI 173
Query: 642 RISDFGLAKLLTLDQSHTNTAIRGTKGYVAPEWFR-------NMPITVKVDVYSYGVLLL 694
I DF LA+ T D + T YV W+R T VD++S G ++
Sbjct: 174 TICDFNLAREDTADANKT--------HYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMA 225
Query: 695 EII 697
E+
Sbjct: 226 EMF 228
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429 | Back alignment and structure |
|---|
Score = 74.0 bits (182), Expect = 5e-14
Identities = 49/208 (23%), Positives = 90/208 (43%), Gaps = 36/208 (17%)
Query: 507 EELGRGAFGTVYKGFVNMGSSNHVAVKKLNSV---FQDSEKEFK--AEVNGIGQTHHKNL 561
+ +G+G+FG V K + + HVA+K + + + + +E + + + + N+
Sbjct: 103 KVIGKGSFGQVVKAY-DHKVHQHVALKMVRNEKRFHRQAAEEIRILEHLRKQDKDNTMNV 161
Query: 562 VRLLGYCD---------E--GQNRLLVYEFMSNGTVASFLFGDSKPNWKLRTEIAMGIAG 610
+ +L E N +YE + F + L + A I
Sbjct: 162 IHMLENFTFRNHICMTFELLSMN---LYELIKKNKFQGF-------SLPLVRKFAHSILQ 211
Query: 611 GLFYLHEECCTQIIHCDIKPQNILLDDHYNA--RISDFGLAKLLTLDQSHTNTAIRGTKG 668
L LH+ +IIHCD+KP+NILL + ++ DFG + + T I+ ++
Sbjct: 212 CLDALHKN---RIIHCDLKPENILLKQQGRSGIKVIDFGSS---CYEHQRVYTYIQ-SRF 264
Query: 669 YVAPEWFRNMPITVKVDVYSYGVLLLEI 696
Y APE + +D++S G +L E+
Sbjct: 265 YRAPEVILGARYGMPIDMWSLGCILAEL 292
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346 | Back alignment and structure |
|---|
Score = 73.0 bits (180), Expect = 6e-14
Identities = 46/170 (27%), Positives = 73/170 (42%), Gaps = 51/170 (30%)
Query: 507 EELGRGAFGTVYKGFVNMGSSNHVAVKKLNSVFQDSEKEFKAEVNGIGQT---------- 556
+ LG G F TVYK + ++ VA+KK+ + K+ GI +T
Sbjct: 16 DFLGEGQFATVYKA-RDKNTNQIVAIKKIKLGHRSEAKD------GINRTALREIKLLQE 68
Query: 557 -HHKNLVRLLGYCDEGQNRLLVYEFM---------------SNGTVASFLFGDSKPNWKL 600
H N++ LL N LV++FM + + +++
Sbjct: 69 LSHPNIIGLLDAFGHKSNISLVFDFMETDLEVIIKDNSLVLTPSHIKAYML--------- 119
Query: 601 RTEIAMGIAGGLFYLHEECCTQIIHCDIKPQNILLDDHYNARISDFGLAK 650
M GL YLH+ I+H D+KP N+LLD++ +++DFGLAK
Sbjct: 120 -----M-TLQGLEYLHQH---WILHRDLKPNNLLLDENGVLKLADFGLAK 160
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364 | Back alignment and structure |
|---|
Score = 72.7 bits (179), Expect = 9e-14
Identities = 54/239 (22%), Positives = 95/239 (39%), Gaps = 77/239 (32%)
Query: 500 EVTRGFK--EELGRGAFGTVYKGFVNMGSSNHVAVKKLNSVFQDSE------------KE 545
+V + +G GA+G V + + VA+KK++ F+
Sbjct: 24 DVGPRYTNLSYIGEGAYGMVCSA-YDNLNKVRVAIKKIS-PFEHQTYCQRTLREIKILLR 81
Query: 546 FKAEVNGIGQTHHKNLVRLL-----GYCDEGQNRLLVYEFM-------------SNGTVA 587
F+ H+N++ + ++ ++ +V + M SN +
Sbjct: 82 FR----------HENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHIC 131
Query: 588 SFLFGDSKPNWKLRTEIAMGIAGGLFYLHEECCTQIIHCDIKPQNILLDDHYNARISDFG 647
FL+ LR GL Y+H ++H D+KP N+LL+ + +I DFG
Sbjct: 132 YFLYQ------ILR---------GLKYIHS---ANVLHRDLKPSNLLLNTTCDLKICDFG 173
Query: 648 LAKLLTLDQSHTN--TAIRGTKGYVAPEWFR-------NMPITVKVDVYSYGVLLLEII 697
LA++ D HT T YVA W+R + T +D++S G +L E++
Sbjct: 174 LARVADPDHDHTGFLT------EYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEML 226
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351 | Back alignment and structure |
|---|
Score = 72.3 bits (178), Expect = 1e-13
Identities = 43/159 (27%), Positives = 75/159 (47%), Gaps = 26/159 (16%)
Query: 507 EELGRGAFGTVYKGFVNMGSSNHVAVKKLNSVFQDSEKE---FKA--EVNGIGQTHHKNL 561
++G+G FG V+K + + VA+KK V ++EKE A E+ + H+N+
Sbjct: 23 AKIGQGTFGEVFKA-RHRKTGQKVALKK---VLMENEKEGFPITALREIKILQLLKHENV 78
Query: 562 VRLLGYCDEGQNRL--------LVYEFMSNGTVASFLFGDSKPNWKLRTEI---AMGIAG 610
V L+ C + LV++F + +A L + +EI +
Sbjct: 79 VNLIEICRTKASPYNRCKGSIYLVFDFCEH-DLAGLL--SNVLVKFTLSEIKRVMQMLLN 135
Query: 611 GLFYLHEECCTQIIHCDIKPQNILLDDHYNARISDFGLA 649
GL+Y+H +I+H D+K N+L+ +++DFGLA
Sbjct: 136 GLYYIHRN---KILHRDMKAANVLITRDGVLKLADFGLA 171
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382 | Back alignment and structure |
|---|
Score = 72.4 bits (178), Expect = 1e-13
Identities = 51/203 (25%), Positives = 88/203 (43%), Gaps = 26/203 (12%)
Query: 507 EELGRGAFGTVYKGFVNMGSSNHVAVK--KLNSVFQD-SEKEFK--AEVNGIGQTHHKNL 561
+G+G+FG V K + + VA+K K F + ++ E + +N +
Sbjct: 60 SLIGKGSFGQVVKAY-DRVEQEWVAIKIIKNKKAFLNQAQIEVRLLELMNKHDTEMKYYI 118
Query: 562 VRLLGYCDEGQNRLLVYEFMS-NGTVASFLFGDSKPN------WKLRTEIAMGIAGGLFY 614
V L + + LV+E +S N L+ + L + A + L +
Sbjct: 119 VHLKRHFMFRNHLCLVFEMLSYN------LYDLLRNTNFRGVSLNLTRKFAQQMCTALLF 172
Query: 615 LHEECCTQIIHCDIKPQNILLDDHYNA--RISDFGLAKLLTLDQSHTNTAIRGTKGYVAP 672
L IIHCD+KP+NILL + + +I DFG + I+ ++ Y +P
Sbjct: 173 LATPEL-SIIHCDLKPENILLCNPKRSAIKIVDFGSS---CQLGQRIYQYIQ-SRFYRSP 227
Query: 673 EWFRNMPITVKVDVYSYGVLLLE 695
E MP + +D++S G +L+E
Sbjct: 228 EVLLGMPYDLAIDMWSLGCILVE 250
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383 | Back alignment and structure |
|---|
Score = 72.5 bits (178), Expect = 1e-13
Identities = 46/242 (19%), Positives = 87/242 (35%), Gaps = 69/242 (28%)
Query: 507 EELGRGAFGTVYKGFVNMGSSNHVAVKKLNSVFQDSEKEFKA-EVNGIGQTHHKNLVRLL 565
+ LG G+FG V + ++ S A+KK V QD +K E++ + H N+++L+
Sbjct: 13 KTLGTGSFGIVCEV-FDIESGKRFALKK---VLQD--PRYKNRELDIMKVLDHVNIIKLV 66
Query: 566 GYCDEGQNRL--------------------------------------LVYEFMSNGTVA 587
Y + ++ E++ + T+
Sbjct: 67 DYFYTTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVPD-TLH 125
Query: 588 SFLFGDSKPNWKLRTE----IAMGIAGGLFYLHEECCTQIIHCDIKPQNILLD-DHYNAR 642
L + + + + ++H I H DIKPQN+L++ +
Sbjct: 126 KVLKSFIRSGRSIPMNLISIYIYQLFRAVGFIH---SLGICHRDIKPQNLLVNSKDNTLK 182
Query: 643 ISDFGLAKLLTLDQSHTNTAIRGTKGYVAPEWFR-------NMPITVKVDVYSYGVLLLE 695
+ DFG AK L + Y+ ++R T +D++S G + E
Sbjct: 183 LCDFGSAKKLIPSEPSV--------AYICSRFYRAPELMLGATEYTPSIDLWSIGCVFGE 234
Query: 696 II 697
+I
Sbjct: 235 LI 236
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324 | Back alignment and structure |
|---|
Score = 71.5 bits (176), Expect = 1e-13
Identities = 45/175 (25%), Positives = 88/175 (50%), Gaps = 20/175 (11%)
Query: 507 EELGRGAFGTVYKGFVNMGSSNHVAVKKLNSVFQDSEKEFKA----EVNGIGQTHHKNLV 562
++LG G + TVYKG + + N VA+K+ + + E+ EV+ + H N+V
Sbjct: 8 DKLGEGTYATVYKGK-SKLTDNLVALKE---IRLEHEEGAPCTAIREVSLLKDLKHANIV 63
Query: 563 RLLGYCDEGQNRLLVYEFMSNGTVASFLFGDSKPNWKLRTEIA--MG-IAGGLFYLHEEC 619
L ++ LV+E++ + +L D N + + + GL Y H +
Sbjct: 64 TLHDIIHTEKSLTLVFEYLDK-DLKQYL--DDCGNIINMHNVKLFLFQLLRGLAYCHRQ- 119
Query: 620 CTQIIHCDIKPQNILLDDHYNARISDFGLAKLLTL-DQSHTNTAIRGTKGYVAPE 673
+++H D+KPQN+L+++ +++DFGLA+ ++ +++ N + T Y P+
Sbjct: 120 --KVLHRDLKPQNLLINERGELKLADFGLARAKSIPTKTYDNEVV--TLWYRPPD 170
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320 | Back alignment and structure |
|---|
Score = 70.0 bits (172), Expect = 5e-13
Identities = 49/239 (20%), Positives = 91/239 (38%), Gaps = 68/239 (28%)
Query: 500 EVTRGFK--EELGRGAFGTVYKGFVNMGSSNHVAVKKLNSVFQDSEKEFKA--EVNGIGQ 555
++ + + LG G G V+ V+ VA+KK+ V D + A E+ I +
Sbjct: 8 DLGSRYMDLKPLGCGGNGLVFSA-VDNDCDKRVAIKKI--VLTDPQSVKHALREIKIIRR 64
Query: 556 THHKNLVRLL--------------GYCDEGQNRLLVYEFM-------------SNGTVAS 588
H N+V++ G E + +V E+M
Sbjct: 65 LDHDNIVKVFEILGPSGSQLTDDVGSLTELNSVYIVQEYMETDLANVLEQGPLLEEHARL 124
Query: 589 FLFGDSKPNWKLRTEIAMGIAGGLFYLHEECCTQIIHCDIKPQNILLD-DHYNARISDFG 647
F++ LR GL Y+H ++H D+KP N+ ++ + +I DFG
Sbjct: 125 FMYQ------LLR---------GLKYIHS---ANVLHRDLKPANLFINTEDLVLKIGDFG 166
Query: 648 LAKLLTLDQSHTN--TAIRGTKGYVAPEWFR-------NMPITVKVDVYSYGVLLLEII 697
LA+++ SH + + +W+R T +D+++ G + E++
Sbjct: 167 LARIMDPHYSHKGHLS------EGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEML 219
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 70.0 bits (171), Expect = 7e-13
Identities = 46/192 (23%), Positives = 72/192 (37%), Gaps = 51/192 (26%)
Query: 604 IAMGIAGGLFYLHEECCTQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLDQSHTNTAI 663
+ +A G+ +L C IH D+ +NILL + +I DFGLA+ D +
Sbjct: 198 YSFQVAKGMEFLASRKC---IHRDLAARNILLSEKNVVKICDFGLAR----DIYKDPDYV 250
Query: 664 RGTKGYV-----APEWFRNMPITVKVDVYSYGVLLLEIICLRRNIDNEISKVDKAILTDW 718
R + APE + T++ DV+S+GVLL EI L
Sbjct: 251 RKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSL------------------- 291
Query: 719 AYDRYQERTLEALVENDLEAMNNVTMLHR------------FVMVAFWCIQEDPSHRPTM 766
Y V+ D E + R M+ W +PS RPT
Sbjct: 292 GASPYPG------VKIDEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCW--HGEPSQRPTF 343
Query: 767 RKVTQMLEGVVE 778
++ + L +++
Sbjct: 344 SELVEHLGNLLQ 355
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 65.3 bits (159), Expect = 2e-11
Identities = 40/155 (25%), Positives = 61/155 (39%), Gaps = 18/155 (11%)
Query: 505 FKEELGRGAFGTVYKGFVN----MGSSNHVAVKKLNSVFQDSE-KEFKAEVN---GIGQT 556
+ LGRGAFG V + + VAVK L SE + +E+ IG
Sbjct: 26 LGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIG-- 83
Query: 557 HHKNLVRLLGYC-DEGQNRLLVYEFMSNGTVASFLFGDSKPNWKLRTEIAMGIAGGLFYL 615
HH N+V LLG C G +++ EF G ++++L R E G +
Sbjct: 84 HHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYL-------RSKRNEFVPYKTKGARFR 136
Query: 616 HEECCTQIIHCDIKPQNILLDDHYNARISDFGLAK 650
+ I D+K + + ++ S F K
Sbjct: 137 QGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEEK 171
|
| >3m7h_A Putidacin L1; monocot mannose-binding lectin, bacteriocin, LLPA, pseudomon bacterial toxin, siras, antimicrobial protein; 2.20A {Pseudomonas SP} PDB: 3m7j_A* Length = 276 | Back alignment and structure |
|---|
Score = 64.7 bits (156), Expect = 2e-11
Identities = 47/278 (16%), Positives = 77/278 (27%), Gaps = 42/278 (15%)
Query: 18 TAAQSNGTISIGQQLTAAESTEPWLSPSKDFALGFHQLDSKDLFL----PAIWYYKIPSK 73
+ Q L+A + LSP++ F L Q D L + +W
Sbjct: 9 FNGVGTSVLPAYQTLSAGQY---LLSPNQRFKLLL-QGDGN-LVIQDNGATVWVANEQQP 63
Query: 74 TIVWYASAVNPAPRGSKLRLTANRGLVLEDPEGREIWKSEIST------GQAAFGVLYDT 127
AP L G L+D R +W ++ ST VL D
Sbjct: 64 FSSTIPLRNKKAP----LAFYVQYGAFLDDYSRRRVWLTDNSTFTSNDQWNRTHLVLQDD 119
Query: 128 GNFLIVNTNSERLWQSFDHPTDTLLPTQTMERGGVVSSRRKDTYFSRGRFQFRLLEDGNA 187
GN ++V++ + + + + S + + G + DGN
Sbjct: 120 GNIVLVDSLALWNGTPAIPLVPGAIDSLLL---APGSELVQGVVYGAGASKLVFQGDGNL 176
Query: 188 VLNTINLESGFAYDAYFWSNTFDTNRSNAGYRVVFNESGQLYVLRENKQRASLVPETVSA 247
V G A + + T R VF G L V + + +
Sbjct: 177 VA------YGPNGAATWNAGTQ----GKGAVRAVFQGDGNLVVYGAGNAV---LWHSHTG 223
Query: 248 KENYLRATLNFDGVFIFYSHPKNNSTGDAIWSVSDVLP 285
L +G +W+ P
Sbjct: 224 GHASAVLRLQANGSIAILD-------EKPVWARFGFQP 254
|
| >3m7h_A Putidacin L1; monocot mannose-binding lectin, bacteriocin, LLPA, pseudomon bacterial toxin, siras, antimicrobial protein; 2.20A {Pseudomonas SP} PDB: 3m7j_A* Length = 276 | Back alignment and structure |
|---|
Score = 41.6 bits (96), Expect = 6e-04
Identities = 13/91 (14%), Positives = 24/91 (26%), Gaps = 4/91 (4%)
Query: 71 PSKTIVWYASAVNPAPRGSKLRLTANRGLVLEDPEGREIWKSEISTGQAAFGVLYDTGNF 130
P+ W A + + LV+ +W S +A L G+
Sbjct: 181 PNGAATWNAGTQGKG--AVRAVFQGDGNLVVYGAGNAVLWHSHTGGHASAVLRLQANGSI 238
Query: 131 LIVNTNSERLWQSFDHPTDTLLPTQTMERGG 161
I++ +W F +
Sbjct: 239 AILDEKP--VWARFGFQPTYRHIRKINPDQK 267
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405 | Back alignment and structure |
|---|
Score = 65.6 bits (160), Expect = 2e-11
Identities = 35/168 (20%), Positives = 66/168 (39%), Gaps = 34/168 (20%)
Query: 506 KEELGRGAFGTVYKG-FVNMGSSNHVAVKKLNSVFQDSEKEFKAEVNGIGQT------HH 558
++GRG +G VYK + A+K++ + ++ + H
Sbjct: 26 GCKVGRGTYGHVYKAKRKDGKDDKDYALKQI--------EGTGISMSACREIALLRELKH 77
Query: 559 KNLVRLLGYCDEGQNRL--LVYEFMSNGTVASFL-FGDSKPNWKLRTEIAMG-------- 607
N++ L +R L++++ + + + F + K ++ G
Sbjct: 78 PNVISLQKVFLSHADRKVWLLFDYAEH-DLWHIIKFHRASKANKKPVQLPRGMVKSLLYQ 136
Query: 608 IAGGLFYLHEECCTQIIHCDIKPQNILLDDHYNAR----ISDFGLAKL 651
I G+ YLH ++H D+KP NIL+ R I+D G A+L
Sbjct: 137 ILDGIHYLHAN---WVLHRDLKPANILVMGEGPERGRVKIADMGFARL 181
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* Length = 355 | Back alignment and structure |
|---|
Score = 63.5 bits (155), Expect = 7e-11
Identities = 50/224 (22%), Positives = 84/224 (37%), Gaps = 52/224 (23%)
Query: 507 EELGRGAFGTVYKGFVNMGSSNHVAVKKLNSV---FQDSEKEFK--AEVNGIGQTHHKNL 561
LG G FG V + + + VA+K + +V + + E ++ + +
Sbjct: 25 GNLGEGTFGKVVECLDHARGKSQVALKIIRNVGKYREAARLEINVLKKIKEKDKENKFLC 84
Query: 562 VRLLGYCDE-----------GQNRLLVYEFMSNGTVASFLFGDSKPNWKLRTEIAMGIAG 610
V + + + G+N +EF+ + P +R +A +
Sbjct: 85 VLMSDWFNFHGHMCIAFELLGKN---TFEFLKENNFQPY------PLPHVR-HMAYQLCH 134
Query: 611 GLFYLHEECCTQIIHCDIKPQNILLDDHYNA-------------------RISDFGLAKL 651
L +LHE Q+ H D+KP+NIL + R++DFG A
Sbjct: 135 ALRFLHEN---QLTHTDLKPENILFVNSEFETLYNEHKSCEEKSVKNTSIRVADFGSA-- 189
Query: 652 LTLDQSHTNTAIRGTKGYVAPEWFRNMPITVKVDVYSYGVLLLE 695
T D H T + T+ Y PE + DV+S G +L E
Sbjct: 190 -TFDHEHHTTIVA-TRHYRPPEVILELGWAQPCDVWSIGCILFE 231
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* Length = 339 | Back alignment and structure |
|---|
Score = 62.3 bits (152), Expect = 2e-10
Identities = 53/224 (23%), Positives = 87/224 (38%), Gaps = 52/224 (23%)
Query: 507 EELGRGAFGTVYKGFVNMGSSNHVAVK--KLNSVFQD-SEKEFK--AEVNGIGQTHHKNL 561
+ LG GAFG V + + HVAVK K + + + E + +N
Sbjct: 20 DTLGEGAFGKVVECIDHKAGGRHVAVKIVKNVDRYCEAARSEIQVLEHLNTTDPNSTFRC 79
Query: 562 VRLLGYCD---------E--GQNRLLVYEFMSNGTVASFLFGDSKPNWKLRTEIAMGIAG 610
V++L + + E G + Y+F+ F +R ++A I
Sbjct: 80 VQMLEWFEHHGHICIVFELLGLS---TYDFIKENGFLPF------RLDHIR-KMAYQICK 129
Query: 611 GLFYLHEECCTQIIHCDIKPQNILLDDHYNA-------------------RISDFGLAKL 651
+ +LH ++ H D+KP+NIL ++ DFG A
Sbjct: 130 SVNFLHSN---KLTHTDLKPENILFVQSDYTEAYNPKIKRDERTLINPDIKVVDFGSA-- 184
Query: 652 LTLDQSHTNTAIRGTKGYVAPEWFRNMPITVKVDVYSYGVLLLE 695
T D H +T + T+ Y APE + + DV+S G +L+E
Sbjct: 185 -TYDDEHHSTLVS-TRHYRAPEVILALGWSQPCDVWSIGCILIE 226
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* Length = 397 | Back alignment and structure |
|---|
Score = 61.1 bits (148), Expect = 6e-10
Identities = 50/252 (19%), Positives = 87/252 (34%), Gaps = 72/252 (28%)
Query: 509 LGRGAFGTVYKGFVNMGSSNHVAVKKLNSVFQDSE---KEFKAE--VNGIGQTH--HKNL 561
LG G F TV+ + ++ VA+K + S +E E + V + +
Sbjct: 45 LGWGHFSTVWLSW-DIQGKKFVAMKVVKSAEHYTETALDEIRLLKSVRNSDPNDPNREMV 103
Query: 562 VRLLGYCD----EGQNRLLVYEFMSNGTVASFL---FGDSKPNWKLRTEIAMGIAGGLFY 614
V+LL G + +V+E + + + ++ P ++ +I + GL Y
Sbjct: 104 VQLLDDFKISGVNGTHICMVFEVLGH-HLLKWIIKSNYQGLPLPCVK-KIIQQVLQGLDY 161
Query: 615 LHEECCTQIIHCDIKPQNILL--DDHY--------------------------------- 639
LH +C +IIH DIKP+NILL ++ Y
Sbjct: 162 LHTKC--RIIHTDIKPENILLSVNEQYIRRLAAEATEWQRSGAPPPSGSAVSTAPATAGN 219
Query: 640 --------------NARISDFGLAKLLTLDQSHTNTAIRGTKGYVAPEWFRNMPITVKVD 685
+I+D G A + T T+ Y + E D
Sbjct: 220 FLVNPLEPKNAEKLKVKIADLGNACWV----HKHFTEDIQTRQYRSLEVLIGSGYNTPAD 275
Query: 686 VYSYGVLLLEII 697
++S + E+
Sbjct: 276 IWSTACMAFELA 287
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} Length = 360 | Back alignment and structure |
|---|
Score = 59.3 bits (144), Expect = 2e-09
Identities = 53/233 (22%), Positives = 88/233 (37%), Gaps = 66/233 (28%)
Query: 507 EELGRGAFGTVYKGFVNMGSSNHVAVK--KLNSVFQDSEKEFKAEVNGIGQT------HH 558
++G G FG V ++ + + AVK + + S K E + I + ++
Sbjct: 41 RKMGDGTFGRVLLCQ-HIDNKKYYAVKVVRNIKKYTRSAKI---EAD-ILKKIQNDDINN 95
Query: 559 KNLVRLLGYCD---------E--GQNRLLVYEFMSNGTVASFLFGDSKPNWKLRTEIAMG 607
N+V+ G E G + +YE ++ F ++ +
Sbjct: 96 NNIVKYHGKFMYYDHMCLIFEPLGPS---LYEIITRNNYNGF------HIEDIK-LYCIE 145
Query: 608 IAGGLFYLHEECCTQIIHCDIKPQNILLDDHYNA-------------------------R 642
I L YL + + H D+KP+NILLDD Y +
Sbjct: 146 ILKALNYLRKM---SLTHTDLKPENILLDDPYFEKSLITVRRVTDGKKIQIYRTKSTGIK 202
Query: 643 ISDFGLAKLLTLDQSHTNTAIRGTKGYVAPEWFRNMPITVKVDVYSYGVLLLE 695
+ DFG A T + + I T+ Y APE N+ V D++S+G +L E
Sbjct: 203 LIDFGCA---TFKSDYHGSIIN-TRQYRAPEVILNLGWDVSSDMWSFGCVLAE 251
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* Length = 330 | Back alignment and structure |
|---|
Score = 58.5 bits (142), Expect = 2e-09
Identities = 36/153 (23%), Positives = 66/153 (43%), Gaps = 18/153 (11%)
Query: 507 EELGRGAFGTVYKGFVNMGSSNHVAVK--KLNSVFQDSEKEFKAEVNGIGQTHHKNLVRL 564
+++G G FG + G N+ ++ +VA+K + S E++ + ++
Sbjct: 15 KKIGCGNFGELRLG-KNLYTNEYVAIKLEPMKSRAPQLHLEYRFYKQLGSGDG---IPQV 70
Query: 565 LGYCDEGQNRLLVYEFMSNGTVASFLFGDSKPNWKLRT--EIAMGIAGGLFYLHEECCTQ 622
+ G+ +V E + G LF + L+T IA+ + + Y+H +
Sbjct: 71 YYFGPCGKYNAMVLELL--GPSLEDLFDLCDRTFSLKTVLMIAIQLISRMEYVHSKNL-- 126
Query: 623 IIHCDIKPQNILLDDHYNAR-----ISDFGLAK 650
I+ D+KP+N L+ N I DF LAK
Sbjct: 127 -IYRDVKPENFLIGRPGNKTQQVIHIIDFALAK 158
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336 | Back alignment and structure |
|---|
Score = 58.7 bits (141), Expect = 2e-09
Identities = 27/204 (13%), Positives = 53/204 (25%), Gaps = 51/204 (25%)
Query: 507 EELGRGAFGTVYKGFVNMGSSNHVAVKKL--------NSVFQDSEKEFKAEV-------- 550
E++G G FG V++ + VA+K + N Q + +E E+
Sbjct: 26 EKIGEGVFGEVFQTIADHTP---VAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSL 82
Query: 551 -NGIGQTHHKNLVRLLGYC-----------------------------DEGQNRLLVYEF 580
+G + + L ++L +
Sbjct: 83 LSGEVCNRTEGFIGLNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLE 142
Query: 581 MSNGTVASFLFGDSKPNWKLRTEIAMGIAGGLFYLHEECCTQIIHCDIKPQNILLDDHYN 640
G + + I + L + H D+ N+LL
Sbjct: 143 FEFGGIDLEQMRTKLSSLATAKSILHQLTASLAVAEASL--RFEHRDLHWGNVLLKKTSL 200
Query: 641 ARISDFGLAKLLTLDQSHTNTAIR 664
++ K T+ +I
Sbjct: 201 KKLHYTLNGKSSTIPSCGLQVSII 224
|
| >1xd5_A Gastrodianin-1, antifungal protein GAFP-1; monocot mannose binding lectin, monomer, homogeneous beta- sheet; 2.00A {Gastrodia elata} SCOP: b.78.1.1 PDB: 1xd6_A Length = 112 | Back alignment and structure |
|---|
Score = 54.2 bits (130), Expect = 3e-09
Identities = 28/132 (21%), Positives = 47/132 (35%), Gaps = 27/132 (20%)
Query: 148 TDTLLPTQTMERGGVVSSRRKDTYFSRGRFQFRLLEDGNAVLNTINLESGFAYDAYFWSN 207
+D L ++ GG ++ G + F + D N VL N W++
Sbjct: 1 SDRLNSGHQLDTGGSLAE---------GGYLFIIQNDCNLVLYDNN--------RAVWAS 43
Query: 208 TFDTNRSNAGYRVVFNESGQLYVLRENKQRASLVPETVSAKENYLRATLNFDGVFIFYSH 267
TN +G + G L + + RA T NY L D + Y
Sbjct: 44 --GTNGKASGCVLKMQNDGNLVIY--SGSRAIWASNTNRQNGNY-YLILQRDRNVVIY-- 96
Query: 268 PKNNSTGDAIWS 279
+++ +AIW+
Sbjct: 97 ---DNSNNAIWA 105
|
| >1xd5_A Gastrodianin-1, antifungal protein GAFP-1; monocot mannose binding lectin, monomer, homogeneous beta- sheet; 2.00A {Gastrodia elata} SCOP: b.78.1.1 PDB: 1xd6_A Length = 112 | Back alignment and structure |
|---|
Score = 40.3 bits (94), Expect = 3e-04
Identities = 22/120 (18%), Positives = 40/120 (33%), Gaps = 17/120 (14%)
Query: 25 TISIGQQLTAAESTEPWLSPSKDFALGFHQLDSKDLFLPAIWYYKIPSKTIVWYASAVNP 84
++ G QL S + Q D + Y +AS N
Sbjct: 3 RLNSGHQLDTGGS-----LAEGGYLFII-QNDCN-----LVLYDN----NRAVWASGTNG 47
Query: 85 APRGSKLRLTANRGLVLEDPEGREIWKSEISTGQAAFG-VLYDTGNFLIVNTNSERLWQS 143
G L++ + LV+ R IW S + + +L N +I + ++ +W +
Sbjct: 48 KASGCVLKMQNDGNLVIYSG-SRAIWASNTNRQNGNYYLILQRDRNVVIYDNSNNAIWAT 106
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A Length = 296 | Back alignment and structure |
|---|
Score = 56.6 bits (137), Expect = 8e-09
Identities = 43/178 (24%), Positives = 70/178 (39%), Gaps = 26/178 (14%)
Query: 507 EELGRGAFGTVYKGFVNMGSSNHVAVK--KLNSVFQDSEKEFKA--EVNGIGQTHHKNLV 562
++G G+FG +Y G ++ + VA+K + + E K + G +
Sbjct: 15 RKIGSGSFGDIYLG-TDIAAGEEVAIKLECVKTKHPQLHIESKIYKMMQGG-----VGIP 68
Query: 563 RLLGYCDEGQNRLLVYEFMSNGTVASFLFGDSKPNWKLRT--EIAMGIAGGLFYLHEECC 620
+ EG ++V E + G LF + L+T +A + + Y+H
Sbjct: 69 TIRWCGAEGDYNVMVMELL--GPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHS--- 123
Query: 621 TQIIHCDIKPQNILL---DDHYNARISDFGLAKLLTLDQSHT------NTAIRGTKGY 669
IH D+KP N L+ I DFGLAK ++H N + GT Y
Sbjct: 124 KNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARY 181
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* Length = 298 | Back alignment and structure |
|---|
Score = 55.1 bits (133), Expect = 3e-08
Identities = 33/153 (21%), Positives = 65/153 (42%), Gaps = 18/153 (11%)
Query: 507 EELGRGAFGTVYKGFVNMGSSNHVAVK--KLNSVFQDSEKEFKAEVNGIGQTHHKNLVRL 564
+G G+FG +++G N+ ++ VA+K S E++ G T + +
Sbjct: 16 RRIGEGSFGVIFEG-TNLLNNQQVAIKFEPRRSDAPQLRDEYRTYKLLAGCTG---IPNV 71
Query: 565 LGYCDEGQNRLLVYEFMSNGTVASFLFGDSKPNWKLRT--EIAMGIAGGLFYLHEECCTQ 622
+ EG + +LV + + G L + ++T A + + +HE+
Sbjct: 72 YYFGQEGLHNVLVIDLL--GPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEKS--- 126
Query: 623 IIHCDIKPQNILLDDHYNAR-----ISDFGLAK 650
+++ DIKP N L+ + + DFG+ K
Sbjct: 127 LVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVK 159
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} Length = 483 | Back alignment and structure |
|---|
Score = 53.9 bits (129), Expect = 1e-07
Identities = 44/178 (24%), Positives = 72/178 (40%), Gaps = 26/178 (14%)
Query: 507 EELGRGAFGTVYKGFVNMGSSNHVAVK--KLNSVFQDSEKEFKA--EVNGIGQTHHKNLV 562
++G G+FG +Y G N+ ++ VA+K + + E K + G +
Sbjct: 13 RKIGSGSFGEIYLG-TNIQTNEEVAIKLENVKTKHPQLLYESKIYRILQGG-----TGIP 66
Query: 563 RLLGYCDEGQNRLLVYEFMSNGTVASFLFGDSKPNWKLRT--EIAMGIAGGLFYLHEECC 620
+ + EG +LV + + G LF L+T +A + + ++H +
Sbjct: 67 NVRWFGVEGDYNVLVMDLL--GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKS- 123
Query: 621 TQIIHCDIKPQNILLDDHYNAR---ISDFGLAKLLTLDQSHT------NTAIRGTKGY 669
+H DIKP N L+ A I DFGLAK +H N + GT Y
Sbjct: 124 --FLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARY 179
|
| >1kj1_A Lectin I, lecgna 1; BULB lectin, mannose, plant protein; HET: MAN; 2.20A {Allium sativum} SCOP: b.78.1.1 PDB: 1bwu_P* 1kj1_D* 1bwu_Q* 1bwu_A* 1bwu_D* Length = 109 | Back alignment and structure |
|---|
Score = 48.7 bits (116), Expect = 3e-07
Identities = 27/123 (21%), Positives = 50/123 (40%), Gaps = 18/123 (14%)
Query: 25 TISIGQQLTAAESTEPWLSPSKDFALGFHQLDSKDLFLPAIWYYKIPSKTIVWYASAVNP 84
++ G+ L A +S + + + Q D + Y T VW ++
Sbjct: 3 LLTNGEGLYAGQSLD-----VEPYHFIM-QEDCN-----LVLYDH---STSVWASNTGIL 48
Query: 85 APRGSKLRLTANRGLVLEDPEGREIWKSEISTGQAAFG-VLYDTGNFLIVNTNSERLWQS 143
+G K L ++ V+ D EGR +W S G + VL + GN +I ++ +W +
Sbjct: 49 GKKGCKAVLQSDGNFVVYDAEGRSLWASHSVRGNGNYVLVLQEDGNVVIYGSD---IWST 105
Query: 144 FDH 146
+
Sbjct: 106 GTY 108
|
| >1kj1_A Lectin I, lecgna 1; BULB lectin, mannose, plant protein; HET: MAN; 2.20A {Allium sativum} SCOP: b.78.1.1 PDB: 1bwu_P* 1kj1_D* 1bwu_Q* 1bwu_A* 1bwu_D* Length = 109 | Back alignment and structure |
|---|
Score = 46.8 bits (111), Expect = 1e-06
Identities = 25/131 (19%), Positives = 42/131 (32%), Gaps = 28/131 (21%)
Query: 149 DTLLPTQTMERGGVVSSRRKDTYFSRGRFQFRLLEDGNAVLNTINLESGFAYDAYFWSNT 208
+ L + + G + + F + ED N VL + + W+ +
Sbjct: 2 NLLTNGEGLYAGQSLDV---------EPYHFIMQEDCNLVL--------YDHSTSVWA-S 43
Query: 209 FDTNRSNAGYRVVFNESGQLYVLRENKQRASLVPETVSAKENYLRATLNFDGVFIFYSHP 268
G + V G V+ + + R+ +V NY L DG + Y
Sbjct: 44 NTGILGKKGCKAVLQSDGNF-VVYDAEGRSLWASHSVRGNGNY-VLVLQEDGNVVIY--- 98
Query: 269 KNNSTGDAIWS 279
G IWS
Sbjct: 99 -----GSDIWS 104
|
| >2dpf_A Curculin; sweet taste, taste modifying, plant protein; 1.50A {Curculigo latifolia} PDB: 2d04_B* 2d04_A* Length = 115 | Back alignment and structure |
|---|
Score = 47.2 bits (112), Expect = 9e-07
Identities = 24/131 (18%), Positives = 42/131 (32%), Gaps = 29/131 (22%)
Query: 149 DTLLPTQTMERGGVVSSRRKDTYFSRGRFQFRLLEDGNAVLNTINLESGFAYDAYFWSNT 208
+ LL QT+ + + G + + N V + W++
Sbjct: 3 NVLLSGQTLHADHSLQA---------GAYTLTIQNKCNLVK--------YQNGRQIWAS- 44
Query: 209 FDTNRSNAGYRVVFNESGQLYVLRENKQRASLVPETVSAKENYLRATLNFDGVFIFYSHP 268
+T+R +G R+ G L V+ ++ Y L DG F+ Y
Sbjct: 45 -NTDRRGSGCRLTLLSDGNL-VIYDHNNNDVWGSACWGDNGKY-ALVLQKDGRFVIY--- 98
Query: 269 KNNSTGDAIWS 279
G +WS
Sbjct: 99 -----GPVLWS 104
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 51.0 bits (121), Expect = 2e-06
Identities = 77/502 (15%), Positives = 141/502 (28%), Gaps = 152/502 (30%)
Query: 325 FSLLDPDDAYGSCKPDFILGCEEDGKKSGEDLYYIEELRNTDWPTSDYEQISPYGKDECV 384
F + Y F E+ + D ++++ + + + I + V
Sbjct: 9 FETGEHQYQYKDILSVF----EDAFVDN-FDCKDVQDMPKSILSKEEIDHI--IMSKDAV 61
Query: 385 SS------CLKDCQCSAA------VLRDDTCWKKKLPLSYGKTDRDETGTTFI--KIRKV 430
S L Q VLR + Y F+ I+
Sbjct: 62 SGTLRLFWTLLSKQEEMVQKFVEEVLRIN----------YK----------FLMSPIKTE 101
Query: 431 PSGGKKKVDVLIPVVSVLFGSSALINLLLVSACCLGFLVVNRKKFMRPHQEDQGVSYMNL 490
+ I L+ + + VS R Y+ L
Sbjct: 102 QRQPSMMTRMYIEQRDRLYNDNQVFAKYNVS---------------RLQP------YLKL 140
Query: 491 RCFTYKELVEVTRGFKEELGRGAFGTVY--KGFVNMGSSNHVAVKKLNSVFQDSEKEFKA 548
R + L EL + G G + V + + K
Sbjct: 141 R----QAL--------LELRPAKNVLIDGVLGS---GKTWVAL-----DVCLSYKVQCKM 180
Query: 549 EVNGIGQTHHKNLVRLLGYCDEGQNRL-----LVYEFMSNGTVASFLFGDSKPNWKLRTE 603
+ I NL C+ + L L+Y+ N T S D N KLR
Sbjct: 181 D-FKI---FWLNL----KNCNSPETVLEMLQKLLYQIDPNWTSRS----DHSSNIKLRIH 228
Query: 604 IAMGIAGGLFYL--HEECCTQIIHCDIKPQNILLDDHYNARISD-FGL-AKLL--TLDQS 657
L +E C ++L + NA+ + F L K+L T +
Sbjct: 229 SIQAELRRLLKSKPYENCL------------LVLLNVQNAKAWNAFNLSCKILLTTRFKQ 276
Query: 658 HTNTAIRGTKGYVAPEWFRNMPITVKVDVYSYGVLL--LEIIC--LRRNIDNEISKVD-- 711
T+ T +++ + +M +T +LL L+ L R E+ +
Sbjct: 277 VTDFLSAATTTHISLD-HHSMTLT---PDEVKSLLLKYLDCRPQDLPR----EVLTTNPR 328
Query: 712 -----KAILTDWA--YDRYQERTLEAL---VENDLEAMNNVTMLHRFVMVA-FWCIQEDP 760
+ D +D ++ + L +E+ L + F ++ F
Sbjct: 329 RLSIIAESIRDGLATWDNWKHVNCDKLTTIIESSLNVLEPAEYRKMFDRLSVF---PPS- 384
Query: 761 SHRPTMRKVTQML--EGVVEVP 780
+H PT + ++ + +
Sbjct: 385 AHIPT--ILLSLIWFDVIKSDV 404
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 43.7 bits (102), Expect = 3e-04
Identities = 50/355 (14%), Positives = 98/355 (27%), Gaps = 96/355 (27%)
Query: 26 ISIGQQLTAAESTEPWLSPSKDFALGFHQLDSKDLFLPAIW--YYKIPSKTIVWYASAVN 83
+ L+AA +T ++ + K L L + +P + N
Sbjct: 275 KQVTDFLSAATTTHI---SLDHHSMTLTPDEVKSLLLKYLDCRPQDLPRE-----VLTTN 326
Query: 84 PAPRGSKLRLTANRGLVLEDPEGR-EIWKSEISTGQAAFGVLYDTGNFLI---VNT-NSE 138
P R + + D + WK V D +I +N
Sbjct: 327 P-------RRLSIIAESIRDGLATWDNWKH----------VNCDKLTTIIESSLNVLEPA 369
Query: 139 RLWQSFDH----PTDTLLPTQTME-------------------RGGVVSSRRKDTYFSRG 175
+ FD P +PT + + +V + K++ S
Sbjct: 370 EYRKMFDRLSVFPPSAHIPTILLSLIWFDVIKSDVMVVVNKLHKYSLVEKQPKESTISIP 429
Query: 176 RFQFRLLE--DGNAVLNTINLESGFAYDAYFWSNTFDTNRSNAGYRVVFNESGQLYVLR- 232
L + L+ ++ + + Y ++ G + L+
Sbjct: 430 SIYLELKVKLENEYALHRSIVDHYNIPKTFDSDDLIPPYLDQ--Y--FYSHIG--HHLKN 483
Query: 233 -ENKQRASLVPETVSAKENYLRATLNFDGVFIFYSHPKNNSTGDAIWSVSDVLP------ 285
E+ +R +L + L+F F+ K A + +L
Sbjct: 484 IEHPERMTLFRMV------F----LDFR--FL---EQKIRHDSTAWNASGSILNTLQQLK 528
Query: 286 ---ENICINNDIRKGLGSGICGFNSICS---ISGAKRPICQCPKGFSLLDPDDAY 334
IC N+ + L + I F I + + +L+ D+A
Sbjct: 529 FYKPYICDNDPKYERLVNAILDFLPKIEENLICSKYTDLLR----IALMAEDEAI 579
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} Length = 345 | Back alignment and structure |
|---|
Score = 49.7 bits (119), Expect = 2e-06
Identities = 36/186 (19%), Positives = 65/186 (34%), Gaps = 35/186 (18%)
Query: 509 LGRGAFGTVYKGFVNMGSSNHVAVKKLNSVFQDS---EKEFK-----AEVNGIGQTHHKN 560
+G G FG +Y A + +Q++ E K A+ + I + +
Sbjct: 45 IGSGGFGLIYLA-FPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERK 103
Query: 561 LVRLLG-----YC-----DEGQNRLLVYEFMSNGTVASFLFGDSKPNWKLRT--EIAMGI 608
+ LG R +V E + G + +K T ++ + +
Sbjct: 104 QLDYLGIPLFYGSGLTEFKGRSYRFMVMERL--GIDLQKIS-GQNGTFKKSTVLQLGIRM 160
Query: 609 AGGLFYLHEECCTQIIHCDIKPQNILLDDHYNARI--SDFGLAKLLTLDQSH------TN 660
L Y+HE +H DIK N+LL ++ +D+GL+ + +H
Sbjct: 161 LDVLEYIHENE---YVHGDIKAANLLLGYKNPDQVYLADYGLSYRYCPNGNHKQYQENPR 217
Query: 661 TAIRGT 666
GT
Sbjct: 218 KGHNGT 223
|
| >1dlp_A Lectin scafet precursor; two-domain lectin, beta prism II fold, native, sugar binding protein; 3.30A {Hyacinthoides hispanica} SCOP: b.78.1.1 b.78.1.1 Length = 236 | Back alignment and structure |
|---|
Score = 48.8 bits (115), Expect = 2e-06
Identities = 35/253 (13%), Positives = 62/253 (24%), Gaps = 59/253 (23%)
Query: 65 IWYYKIPSKTIVWYASAVNPAPRGS-KLRLTANRGLVLEDPEGREIWKSEISTGQAAFGV 123
I + + A S + + ++ LVL D +W S + V
Sbjct: 3 ILFGLSHEGSHPQTLHAAQSLELSSFRFTMQSDCNLVLFD-SDVRVWASNTAGATGCRAV 61
Query: 124 LYDTGNFLIVNTNSERLWQS-------------------------------------FDH 146
L G +I+ + W S
Sbjct: 62 LQSDGLLVILTAQNTIRWSSGTKGSIGNYVLVLQPDRTVTIYGPGLWDSGTSNKGSVVVA 121
Query: 147 PTDTLLPTQTMERGGVVSSRRKDTYFSRGRFQFRLLEDGNAVLNTINLESGFAYDAYFWS 206
+ T + ++ + D N VL +D
Sbjct: 122 NNGNSILYSTQGNDNHPQTLHATQSLQLSPYRLSMETDCNLVL----------FDRDDRV 171
Query: 207 NTFDTNRSNAGYRVVFNESGQLYVLRENKQRASLVPETVSAKENYLRATLNFDGVFIFYS 266
+ +T G R V +G++ + N+ A + Y L D Y
Sbjct: 172 WSTNTAGKGTGCRAVLQPNGRM-DVLTNQNIAVWTSGNSRSAGRY-VFVLQPDRNLAIY- 228
Query: 267 HPKNNSTGDAIWS 279
G A+W+
Sbjct: 229 -------GGALWT 234
|
| >1dlp_A Lectin scafet precursor; two-domain lectin, beta prism II fold, native, sugar binding protein; 3.30A {Hyacinthoides hispanica} SCOP: b.78.1.1 b.78.1.1 Length = 236 | Back alignment and structure |
|---|
Score = 41.1 bits (95), Expect = 7e-04
Identities = 21/145 (14%), Positives = 38/145 (26%), Gaps = 37/145 (25%)
Query: 63 PAIWYYKIPSKTIVWYASAVNPAPRGSKLRLTANRGLVLEDPEGREIWKSE-ISTGQAAF 121
++ + + + +L + + LVL D +W + G
Sbjct: 126 SILYSTQGNDNHPQTLHATQSLQLSPYRLSMETDCNLVLFDR-DDRVWSTNTAGKGTGCR 184
Query: 122 GVLYDTGNFLIVNTNSERLWQSFDHPTDTLLPTQTMERGGVVSSRRKDTYFSRGRFQFRL 181
VL G ++ + +W S S GR+ F L
Sbjct: 185 AVLQPNGRMDVLTNQNIAVWTS-------------------------GNSRSAGRYVFVL 219
Query: 182 LEDGNAVLNTINLESGFAYDAYFWS 206
D N + Y W+
Sbjct: 220 QPDRNLAI----------YGGALWT 234
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} Length = 352 | Back alignment and structure |
|---|
Score = 47.0 bits (112), Expect = 1e-05
Identities = 30/187 (16%), Positives = 65/187 (34%), Gaps = 34/187 (18%)
Query: 509 LGRGAFGTVYKGF-------VNMGSSNHVAVK------KLNSVFQDSEKEFKA-EVNGIG 554
R G +Y+ + ++K +L + ++ K +VN
Sbjct: 50 QTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKDGRLFNEQNFFQRAAKPLQVNKWK 109
Query: 555 QTHHKNLV---RLLGY-CDEGQNRLLVYEFMSNGTVASFLFGDS-KPNWKLRT--EIAMG 607
+ + L+ +G+ + + R LV + G S K R+ ++A
Sbjct: 110 KLYSTPLLAIPTCMGFGVHQDKYRFLVLPSL--GRSLQSALDVSPKHVLSERSVLQVACR 167
Query: 608 IAGGLFYLHEECCTQIIHCDIKPQNILLDDHYNARI--SDFGLAKLLTLDQSH------T 659
+ L +LHE +H ++ +NI +D +++ + +G A H +
Sbjct: 168 LLDALEFLHENE---YVHGNVTAENIFVDPEDQSQVTLAGYGFAFRYCPSGKHVAYVEGS 224
Query: 660 NTAIRGT 666
+ G
Sbjct: 225 RSPHEGD 231
|
| >3dzw_A Agglutinin; lectin, mannobiose, mannose-alpha1, 3-mannose, D sugar binding protein; HET: MAN; 1.70A {Narcissus pseudonarcissus} PDB: 1npl_A* 1jpc_A* 1msa_A* 1niv_A* Length = 109 | Back alignment and structure |
|---|
Score = 42.6 bits (100), Expect = 4e-05
Identities = 25/131 (19%), Positives = 43/131 (32%), Gaps = 29/131 (22%)
Query: 149 DTLLPTQTMERGGVVSSRRKDTYFSRGRFQFRLLEDGNAVLNTINLESGFAYDAYFWSNT 208
+ L +T+ G +++ GR+ F + ED N VL ++ W+
Sbjct: 2 NILYSGETLSPGEFLNN---------GRYVFIMQEDCNLVLYDVD--------KPIWAT- 43
Query: 209 FDTNRSNAGYRVVFNESGQLYVLRENKQRASLVPETVSAKENYLRATLNFDGVFIFYSHP 268
+T + + G L V+ + T NY L D + Y
Sbjct: 44 -NTGGLDRRCHLSMQSDGNL-VVYSPRNNPIWASNTGGENGNY-VCVLQKDRNVVIY--- 97
Query: 269 KNNSTGDAIWS 279
G A W+
Sbjct: 98 -----GTARWA 103
|
| >3dzw_A Agglutinin; lectin, mannobiose, mannose-alpha1, 3-mannose, D sugar binding protein; HET: MAN; 1.70A {Narcissus pseudonarcissus} PDB: 1npl_A* 1jpc_A* 1msa_A* 1niv_A* Length = 109 | Back alignment and structure |
|---|
Score = 39.9 bits (93), Expect = 3e-04
Identities = 22/122 (18%), Positives = 38/122 (31%), Gaps = 19/122 (15%)
Query: 23 NGTISIGQQLTAAESTEPWLSPSKDFALGFHQLDSKDLFLPAIWYYKIPSKTIVWYASAV 82
+ + G+ L+ E + + Q D + Y +W A+
Sbjct: 1 DNILYSGETLSPGEF-----LNNGRYVFIM-QEDCN------LVLYD--VDKPIW-ATNT 45
Query: 83 NPAPRGSKLRLTANRGLVLEDPEGREIWKSEISTGQAAFG-VLYDTGNFLIVNTNSERLW 141
R L + ++ LV+ P IW S + VL N +I T W
Sbjct: 46 GGLDRRCHLSMQSDGNLVVYSPRNNPIWASNTGGENGNYVCVLQKDRNVVIYGTA---RW 102
Query: 142 QS 143
+
Sbjct: 103 AT 104
|
| >3r0e_A Lectin; carbohydrate binding, carbohydrate, sugar binding protein; 2.40A {Remusatia vivipara} Length = 109 | Back alignment and structure |
|---|
Score = 42.5 bits (100), Expect = 4e-05
Identities = 25/132 (18%), Positives = 48/132 (36%), Gaps = 32/132 (24%)
Query: 148 TDTLLPTQTMERGGVVSSRRKDTYFSRGRFQFRLLEDGNAVLNTINLESGFAYDAYFWSN 207
T+ LL QT++ G + + G F + +D N VL Y+ W +
Sbjct: 3 TNYLLSGQTLDTEGHLKN---------GDFDLVMQDDCNLVL----------YNGN-WQS 42
Query: 208 TFDTNRSNAGYRVVFNESGQLYVLRENKQRASLVPETVSAKENYLRATLNFDGVFIFYSH 267
T + ++ + G+L V++ S K NY A ++ DG + +
Sbjct: 43 N--TANNGRDCKLTLTDYGEL-VIKNGDGSTVWKSGAQSVKGNY-AAVVHPDGRLVVFGP 98
Query: 268 PKNNSTGDAIWS 279
+++
Sbjct: 99 --------SVFK 102
|
| >1b2p_A Protein (lectin); mannose-binding lectin, monocot, aglutinin, bluebell bulbs, carbohydrate interactions, sugar binding protein; 1.70A {Hyacinthoides hispanica} SCOP: b.78.1.1 Length = 119 | Back alignment and structure |
|---|
Score = 42.6 bits (100), Expect = 5e-05
Identities = 24/123 (19%), Positives = 40/123 (32%), Gaps = 15/123 (12%)
Query: 22 SNGTISIGQQLTAAESTEPWLSPSKDFALGFHQLDSKDLFLPAIWYYKIPSKTIVWYASA 81
+ Q L A ES E + + Q D + Y +W A+
Sbjct: 7 KQPDDNHPQILHATESLEIL-FGTHVYRFIM-QTDCN-----LVLYDN---NNPIW-ATN 55
Query: 82 VNPAPRGSKLRLTANRGLVLEDPEGREIWKSEISTGQAAFG-VLYDTGNFLIVNTNSERL 140
G + L + LV+ E +W+S ++ + VL N +I L
Sbjct: 56 TGGLGNGCRAVLQPDGVLVVITNENVTVWQSPVAGKAGHYVLVLQPDRNVVIYGD---AL 112
Query: 141 WQS 143
W +
Sbjct: 113 WAT 115
|
| >1b2p_A Protein (lectin); mannose-binding lectin, monocot, aglutinin, bluebell bulbs, carbohydrate interactions, sugar binding protein; 1.70A {Hyacinthoides hispanica} SCOP: b.78.1.1 Length = 119 | Back alignment and structure |
|---|
Score = 40.3 bits (94), Expect = 3e-04
Identities = 22/125 (17%), Positives = 34/125 (27%), Gaps = 39/125 (31%)
Query: 90 KLRLTANRGLVLEDPEGREIWKSE-ISTGQAAFGVLYDTGNFLIVNTNSERLWQSFDHPT 148
+ + + LVL D IW + G VL G +++ + +WQS
Sbjct: 33 RFIMQTDCNLVLYD-NNNPIWATNTGGLGNGCRAVLQPDGVLVVITNENVTVWQS----- 86
Query: 149 DTLLPTQTMERGGVVSSRRKDTYFSRGRFQFRLLEDGNAVLNTINLESGFAYDAYFWSNT 208
G + L D N V+ Y W+
Sbjct: 87 --------------------PVAGKAGHYVLVLQPDRNVVI----------YGDALWAT- 115
Query: 209 FDTNR 213
T R
Sbjct: 116 -QTVR 119
|
| >3a0c_A Mannose/sialic acid-binding lectin; beta-prism II, sugar binding protein; 2.00A {Polygonatum cyrtonema} PDB: 3a0d_A* 3a0e_A* Length = 110 | Back alignment and structure |
|---|
Score = 42.1 bits (99), Expect = 5e-05
Identities = 21/124 (16%), Positives = 39/124 (31%), Gaps = 38/124 (30%)
Query: 87 RGSKLRLTANRGLVLEDPEGREIWKSE-ISTGQAAFGVLYDTGNFLIVNTNSERLWQSFD 145
+L + + VL D G+ +W S G L++ GN +I + ++ +WQ+
Sbjct: 20 PSYRLIMQGDCNFVLYDS-GKPVWASNTGGLGSGCRLTLHNNGNLVIYDQSNRVIWQT-- 76
Query: 146 HPTDTLLPTQTMERGGVVSSRRKDTYFSRGRFQFRLLEDGNAVLNTINLESGFAYDAYFW 205
T + L +D N V+ Y W
Sbjct: 77 -----------------------KTNGKEDHYVLVLQQDRNVVI----------YGPVVW 103
Query: 206 -SNT 208
+ +
Sbjct: 104 ATGS 107
|
| >3r0e_B Lectin; carbohydrate binding, carbohydrate, sugar binding protein; 2.40A {Remusatia vivipara} Length = 110 | Back alignment and structure |
|---|
Score = 41.4 bits (97), Expect = 1e-04
Identities = 21/133 (15%), Positives = 43/133 (32%), Gaps = 30/133 (22%)
Query: 147 PTDTLLPTQTMERGGVVSSRRKDTYFSRGRFQFRLLEDGNAVLNTINLESGFAYDAYFWS 206
+ L Q + G +++ Q + D N VL Y W
Sbjct: 5 TNNLLFSGQVLYGDGRLTA---------KNHQLVMQGDCNLVLY---------GGKYGWQ 46
Query: 207 NTFDTNRSNAGYRVVFNESGQLYVLRENKQRASLVPETVSAKENYLRATLNFDGVFIFYS 266
+ +T+ + + N G+L +++++ + + S + Y L DG + Y
Sbjct: 47 S--NTHGNGEHCFLRLNHKGEL-IIKDDDFKTIWSSRSSSKQGEY-VLILQDDGFGVIYG 102
Query: 267 HPKNNSTGDAIWS 279
I+
Sbjct: 103 PA--------IFE 107
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A Length = 364 | Back alignment and structure |
|---|
Score = 44.0 bits (104), Expect = 1e-04
Identities = 38/189 (20%), Positives = 69/189 (36%), Gaps = 38/189 (20%)
Query: 509 LGRGAFGTVYKGFVNMGSSNHVAVKKLNSVFQDSEK------EFK-----AEVNGIGQTH 557
+G+G FG +Y +M SS V V + E K A+ I +
Sbjct: 43 IGQGGFGCIYLA--DMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWI 100
Query: 558 HKNLVRLLG----------YCDEGQNRLLVYEFMSNGTVASFLFGDSKPNWKLRT--EIA 605
++ LG + R ++ + G+ ++ + + +T +++
Sbjct: 101 RTRKLKYLGVPKYWGSGLHDKNGKSYRFMIMDRF--GSDLQKIYEANAKRFSRKTVLQLS 158
Query: 606 MGIAGGLFYLHEECCTQIIHCDIKPQNILLDDHYNARI--SDFGLAKLLTLDQSHT---- 659
+ I L Y+HE +H DIK N+LL+ ++ D+GLA + H
Sbjct: 159 LRILDILEYIHEHE---YVHGDIKASNLLLNYKNPDQVYLVDYGLAYRYCPEGVHKAYAA 215
Query: 660 --NTAIRGT 666
GT
Sbjct: 216 DPKRCHDGT 224
|
| >3mez_B Mannose-specific lectin 3 chain 2; heterotetramer, sugar binding protein; 1.94A {Crocus vernus} Length = 113 | Back alignment and structure |
|---|
Score = 40.2 bits (94), Expect = 2e-04
Identities = 23/139 (16%), Positives = 47/139 (33%), Gaps = 33/139 (23%)
Query: 145 DHP--TDTLLPTQTMERGGVVSSRRKDTYFSRGRFQFRLLEDGNAVLNTINLESGFAYDA 202
+ P + L +Q M +++ + + +D N VL
Sbjct: 1 NIPRVRNVLFSSQVMYDNAQLAT---------RDYSLVMRDDCNLVL----------TKG 41
Query: 203 YFWSNTFDTNRSNAGY--RVVFNESGQLYVLRENKQRASLVPETVSAKENYLRATLNFDG 260
+ +++ S G + SG+L + +++ V TV + +Y L +G
Sbjct: 42 SKTNIVWESGTSGRGQHCFMRLGHSGEL-DITDDRLNTVFVSNTVGQEGDY-VLILQING 99
Query: 261 VFIFYSHPKNNSTGDAIWS 279
+ Y A+WS
Sbjct: 100 QAVVYGP--------AVWS 110
|
| >3mez_B Mannose-specific lectin 3 chain 2; heterotetramer, sugar binding protein; 1.94A {Crocus vernus} Length = 113 | Back alignment and structure |
|---|
Score = 40.2 bits (94), Expect = 3e-04
Identities = 16/124 (12%), Positives = 39/124 (31%), Gaps = 17/124 (13%)
Query: 21 QSNGTISIGQQLTAAESTEPWLSPSKDFALGFHQLDSKDLFLPAIWYYKIPSKTIVWYAS 80
+ + Q + ++D++L + D + K IVW +
Sbjct: 4 RVRNVLFSSQVMYDNAQ-----LATRDYSLVM-RDDCN------LVLTKGSKTNIVWESG 51
Query: 81 AVNPAPRGSKLRLTANRGLVLEDPEGREIWKSEISTGQAAFG-VLYDTGNFLIVNTNSER 139
+ +RL + L + D ++ S + + +L G ++
Sbjct: 52 TSG-RGQHCFMRLGHSGELDITDDRLNTVFVSNTVGQEGDYVLILQINGQAVVYGP---A 107
Query: 140 LWQS 143
+W +
Sbjct: 108 VWST 111
|
Structure Templates Detected by HHsearch 
Original result of HHsearch against PDB70 database
ID ![]() | Alignment Graph ![]() | Length ![]() |
Definition ![]() |
Probability ![]() |
| Query | 792 | |||
| 4gt4_A | 308 | Tyrosine-protein kinase transmembrane receptor RO; | 100.0 | |
| 4aoj_A | 329 | High affinity nerve growth factor receptor; transf | 100.0 | |
| 4asz_A | 299 | BDNF/NT-3 growth factors receptor; transferase, TR | 100.0 | |
| 3omv_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 3fpq_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 4g3f_A | 336 | NF-kappa-beta-inducing kinase; non-RD kinase, prot | 100.0 | |
| 4fih_A | 346 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 4aw0_A | 311 | HPDK1, 3-phosphoinositide-dependent protein kinase | 100.0 | |
| 4ase_A | 353 | Vascular endothelial growth factor receptor 2; tra | 100.0 | |
| 4b9d_A | 350 | Serine/threonine-protein kinase NEK1; transferase, | 100.0 | |
| 3hmm_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 4fie_A | 423 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 3hyh_A | 275 | Carbon catabolite-derepressing protein kinase; kin | 100.0 | |
| 3ubd_A | 304 | Ribosomal protein S6 kinase alpha-3; kinase-inhibi | 100.0 | |
| 4g31_A | 299 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 4f9c_A | 361 | Cell division cycle 7-related protein kinase; Ser/ | 100.0 | |
| 4b99_A | 398 | Mitogen-activated protein kinase 7; transferase, i | 100.0 | |
| 3uim_A | 326 | Brassinosteroid insensitive 1-associated receptor; | 100.0 | |
| 3m7h_A | 276 | Putidacin L1; monocot mannose-binding lectin, bact | 100.0 | |
| 2qkw_B | 321 | Protein kinase; three-helix bundle motif, AVRPTO-P | 100.0 | |
| 3uto_A | 573 | Twitchin; kinase, muscle sarcomere, transferase; H | 100.0 | |
| 3v5w_A | 689 | G-protein coupled receptor kinase 2; inhibitor com | 100.0 | |
| 3p86_A | 309 | Serine/threonine-protein kinase CTR1; ETR1, ERS1, | 100.0 | |
| 3s95_A | 310 | LIMK-1, LIM domain kinase 1; structural genomics, | 100.0 | |
| 2psq_A | 370 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 3kul_A | 325 | Ephrin type-A receptor 8; ATP-binding, kinase, nuc | 100.0 | |
| 3fxz_A | 297 | Serine/threonine-protein kinase PAK 1; transferase | 100.0 | |
| 2nru_A | 307 | Interleukin-1 receptor-associated kinase 4; inhibi | 100.0 | |
| 3zgw_A | 347 | Maternal embryonic leucine zipper kinase; transfer | 100.0 | |
| 3ugc_A | 295 | Tyrosine-protein kinase JAK2; small molecule inhib | 100.0 | |
| 2qol_A | 373 | Ephrin receptor; receptor tyrosine kinase, juxtame | 100.0 | |
| 3fe3_A | 328 | MAP/microtubule affinity-regulating kinase 3; seri | 100.0 | |
| 3soc_A | 322 | Activin receptor type-2A; structural genomics cons | 100.0 | |
| 4eqm_A | 294 | Protein kinase; transferase; HET: ANP; 3.00A {Stap | 100.0 | |
| 3sxs_A | 268 | Cytoplasmic tyrosine-protein kinase BMX; transfera | 100.0 | |
| 4hcu_A | 269 | Tyrosine-protein kinase ITK/TSK; transferase-trans | 100.0 | |
| 2c30_A | 321 | Serine/threonine-protein kinase PAK 6; CRIB domain | 100.0 | |
| 1opk_A | 495 | P150, C-ABL, proto-oncogene tyrosine-protein kinas | 100.0 | |
| 2yab_A | 361 | Death-associated protein kinase 2; apoptosis, tran | 100.0 | |
| 1o6l_A | 337 | RAC-beta serine/threonine protein kinase; protein | 100.0 | |
| 3vhe_A | 359 | Vascular endothelial growth factor receptor 2; kin | 100.0 | |
| 1qcf_A | 454 | Haematopoetic cell kinase (HCK); tyrosine kinase-i | 100.0 | |
| 2y0a_A | 326 | Death-associated protein kinase 1; transferase, ca | 100.0 | |
| 4aw2_A | 437 | Serine/threonine-protein kinase MRCK alpha; transf | 100.0 | |
| 3gen_A | 283 | Tyrosine-protein kinase BTK; bruton'S tyrosine kin | 100.0 | |
| 3poz_A | 327 | Epidermal growth factor receptor; kinase domain, a | 100.0 | |
| 3tki_A | 323 | Serine/threonine-protein kinase CHK1; cell checkpo | 100.0 | |
| 3cbl_A | 377 | C-FES, proto-oncogene tyrosine-protein kinase FES/ | 100.0 | |
| 1luf_A | 343 | Muscle-specific tyrosine kinase receptor MUSK; pho | 100.0 | |
| 3tt0_A | 382 | Basic fibroblast growth factor receptor 1; kinase | 100.0 | |
| 3l9p_A | 367 | Anaplastic lymphoma kinase; kinase domain, ATP-bin | 100.0 | |
| 1fmk_A | 452 | C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros | 100.0 | |
| 1mp8_A | 281 | Focal adhesion kinase 1; tyrosine protein kinase, | 100.0 | |
| 4e5w_A | 302 | Tyrosine-protein kinase JAK1; kinase domain, trans | 100.0 | |
| 1rjb_A | 344 | FL cytokine receptor; kinase, structure, autoinhib | 100.0 | |
| 4fvq_A | 289 | Tyrosine-protein kinase JAK2; janus protein kinase | 100.0 | |
| 1t46_A | 313 | HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom | 100.0 | |
| 2ivs_A | 314 | Proto-oncogene tyrosine-protein kinase receptor RE | 100.0 | |
| 3o0g_A | 292 | Cell division protein kinase 5; kinase activator c | 100.0 | |
| 4dc2_A | 396 | Protein kinase C IOTA type; kinase, substrate, cel | 100.0 | |
| 3lb7_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 1k9a_A | 450 | Carboxyl-terminal SRC kinase; COOH-terminal SRC ki | 100.0 | |
| 3txo_A | 353 | PKC-L, NPKC-ETA, protein kinase C ETA type; phosph | 100.0 | |
| 3soa_A | 444 | Calcium/calmodulin-dependent protein kinase type a | 100.0 | |
| 4euu_A | 319 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 3dtc_A | 271 | Mitogen-activated protein kinase kinase kinase 9; | 100.0 | |
| 3kfa_A | 288 | Tyrosine-protein kinase ABL1; CML, drug resistance | 100.0 | |
| 2zv2_A | 298 | Calcium/calmodulin-dependent protein kinase kinas; | 100.0 | |
| 3lxl_A | 327 | Tyrosine-protein kinase JAK3; TYK2, inflammation, | 100.0 | |
| 1fot_A | 318 | TPK1 delta, CAMP-dependent protein kinase type 1; | 100.0 | |
| 4fr4_A | 384 | YANK1, serine/threonine-protein kinase 32A; struct | 100.0 | |
| 4f0f_A | 287 | Serine/threonine-protein kinase ROCO4; LRRK2, ATP- | 100.0 | |
| 3q4u_A | 301 | Activin receptor type-1; structural genomics conso | 100.0 | |
| 1qpc_A | 279 | LCK kinase; alpha beta fold, transferase; HET: PTR | 100.0 | |
| 3qd2_B | 332 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 1kob_A | 387 | Twitchin; kinase, intrasteric regulation; 2.30A {A | 100.0 | |
| 2v62_A | 345 | Serine/threonine-protein kinase VRK2; transferase, | 100.0 | |
| 3kex_A | 325 | Receptor tyrosine-protein kinase ERBB-3; kinase do | 100.0 | |
| 3op5_A | 364 | Serine/threonine-protein kinase VRK1; adenosine tr | 100.0 | |
| 1tki_A | 321 | Titin; serine kinase, muscle, autoinhibition; 2.00 | 100.0 | |
| 3kmu_A | 271 | ILK, integrin-linked kinase; cell adhesion, ANK re | 100.0 | |
| 3niz_A | 311 | Rhodanese family protein; structural genomics, str | 100.0 | |
| 3qup_A | 323 | Tyrosine-protein kinase receptor TYRO3; protein ki | 100.0 | |
| 1xjd_A | 345 | Protein kinase C, theta type; PKC-theta, ATP, AMP, | 100.0 | |
| 3v8s_A | 410 | RHO-associated protein kinase 1; dimerization, myo | 100.0 | |
| 2bdw_A | 362 | Hypothetical protein K11E8.1D; kinase, calmodulin | 100.0 | |
| 3c1x_A | 373 | Hepatocyte growth factor receptor; receptor tyrosi | 100.0 | |
| 3lxp_A | 318 | Non-receptor tyrosine-protein kinase TYK2; JAK3, i | 100.0 | |
| 2izr_A | 330 | Casein kinase I isoform gamma-3; serine/threonine- | 100.0 | |
| 3h4j_B | 336 | AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin | 100.0 | |
| 2x4f_A | 373 | Myosin light chain kinase family member 4; LUNG, b | 100.0 | |
| 3cc6_A | 281 | Protein tyrosine kinase 2 beta; focal adhesion kin | 100.0 | |
| 3t9t_A | 267 | Tyrosine-protein kinase ITK/TSK; kinase domain, al | 100.0 | |
| 1rdq_E | 350 | PKA C-alpha, CAMP-dependent protein kinase, alpha- | 100.0 | |
| 2eva_A | 307 | TAK1 kinase - TAB1 chimera fusion protein; transfe | 100.0 | |
| 1csn_A | 298 | Casein kinase-1; phosphotransferase; HET: ATP; 2.0 | 100.0 | |
| 3uc3_A | 361 | Serine/threonine-protein kinase SRK2I; SNRK2, ABA | 100.0 | |
| 3kn6_A | 325 | Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1 | 100.0 | |
| 3pls_A | 298 | Macrophage-stimulating protein receptor; protein k | 100.0 | |
| 2buj_A | 317 | Serine/threonine-protein kinase 16; transferase, A | 100.0 | |
| 1mqb_A | 333 | Ephrin type-A receptor 2; tyrosine protein kinase, | 100.0 | |
| 2h8h_A | 535 | Proto-oncogene tyrosine-protein kinase SRC; SRC ki | 100.0 | |
| 3a8x_A | 345 | Protein kinase C IOTA type; transferase; HET: TPO; | 100.0 | |
| 2i0e_A | 353 | Protein kinase C-beta II; serine/threonine protein | 100.0 | |
| 2w4o_A | 349 | Calcium/calmodulin-dependent protein kinase type I | 100.0 | |
| 3p1a_A | 311 | MYT1 kinase, membrane-associated tyrosine- and thr | 100.0 | |
| 4fl3_A | 635 | Tyrosine-protein kinase SYK; transferase; HET: ANP | 100.0 | |
| 2pvf_A | 334 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 3ork_A | 311 | Serine/threonine protein kinase; structural genomi | 100.0 | |
| 3a62_A | 327 | Ribosomal protein S6 kinase beta-1; kinase domain, | 100.0 | |
| 2vd5_A | 412 | DMPK protein; serine/threonine-protein kinase, kin | 100.0 | |
| 2h34_A | 309 | Serine/threonine-protein kinase PKNE; apoenzyme, t | 100.0 | |
| 3c0i_A | 351 | Peripheral plasma membrane protein CASK; neurexin, | 100.0 | |
| 3f3z_A | 277 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 1u59_A | 287 | Tyrosine-protein kinase ZAP-70; transferase; HET: | 100.0 | |
| 4ejn_A | 446 | RAC-alpha serine/threonine-protein kinase; AKT1, a | 100.0 | |
| 2a2a_A | 321 | Death-associated protein kinase 2; autoinhibition, | 100.0 | |
| 2pmi_A | 317 | Negative RE, cyclin-dependent protein kinase PHO85 | 100.0 | |
| 3f66_A | 298 | Hepatocyte growth factor receptor; C-Met, protein | 100.0 | |
| 2yex_A | 276 | Serine/threonine-protein kinase CHK1; transferase, | 100.0 | |
| 3lzb_A | 327 | Epidermal growth factor receptor; epidermal growth | 100.0 | |
| 3dls_A | 335 | PAS domain-containing serine/threonine-protein KI; | 100.0 | |
| 2ozo_A | 613 | Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t | 100.0 | |
| 4agu_A | 311 | Cyclin-dependent kinase-like 1; transferase, phosp | 100.0 | |
| 2xir_A | 316 | Vascular endothelial growth factor receptor 2; ang | 100.0 | |
| 1p4o_A | 322 | Insulin-like growth factor I receptor protein; IGF | 100.0 | |
| 1xbb_A | 291 | Tyrosine-protein kinase SYK; gleevec, STI-571, ima | 100.0 | |
| 3og7_A | 289 | AKAP9-BRAF fusion protein; proto-oncogene, V600E, | 100.0 | |
| 3gni_B | 389 | Strad alpha; kinase fold, pseudokinase, alpha heli | 100.0 | |
| 3g33_A | 308 | Cell division protein kinase 4; Ser/Thr protein ki | 100.0 | |
| 3brb_A | 313 | Proto-oncogene tyrosine-protein kinase MER; ATP-bi | 100.0 | |
| 2w1i_A | 326 | JAK2; chromosomal rearrangement, nucleotide-bindin | 100.0 | |
| 3gxj_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 1ob3_A | 288 | PFPK5, cell division control protein 2 homolog; tr | 100.0 | |
| 3hko_A | 345 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 2i1m_A | 333 | Macrophage colony-stimulating factor 1 receptor; k | 100.0 | |
| 2eue_A | 275 | Carbon catabolite derepressing protein kinase; kin | 100.0 | |
| 2y94_A | 476 | 5'-AMP-activated protein kinase catalytic subunit; | 100.0 | |
| 2ac3_A | 316 | MAP kinase-interacting serine/threonine kinase 2; | 100.0 | |
| 2r5t_A | 373 | Serine/threonine-protein kinase SGK1; AGC protein | 100.0 | |
| 3dbq_A | 343 | Dual specificity protein kinase TTK; MPS1 structur | 100.0 | |
| 3i6u_A | 419 | CDS1, serine/threonine-protein kinase CHK2; Ser/Th | 100.0 | |
| 3oz6_A | 388 | Mitogen-activated protein kinase 1, serine/threon | 100.0 | |
| 3mdy_A | 337 | Bone morphogenetic protein receptor type-1B; compl | 100.0 | |
| 1fvr_A | 327 | Tyrosine-protein kinase TIE-2; tyrosine kinase, tr | 100.0 | |
| 3fdn_A | 279 | Serine/threonine-protein kinase 6; aurora kinase i | 100.0 | |
| 2zmd_A | 390 | Dual specificity protein kinase TTK; MPS1, T686A, | 100.0 | |
| 3cok_A | 278 | Serine/threonine-protein kinase PLK4; POLO-like ki | 100.0 | |
| 1t4h_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 2wqm_A | 310 | Serine/threonine-protein kinase NEK7; ATP-binding, | 100.0 | |
| 3gbz_A | 329 | Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide- | 100.0 | |
| 2acx_A | 576 | G protein-coupled receptor kinase 6; GRK, G transf | 100.0 | |
| 2a19_B | 284 | Interferon-induced, double-stranded RNA-activated | 100.0 | |
| 3lm5_A | 327 | Serine/threonine-protein kinase 17B; STK17B, serin | 100.0 | |
| 4eut_A | 396 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 1u5q_A | 348 | Serine/threonine protein kinase TAO2; transferase; | 100.0 | |
| 3ttj_A | 464 | Mitogen-activated protein kinase 10; JNK3, protein | 100.0 | |
| 4hgt_A | 296 | Casein kinase I isoform delta; CK1D, inhibitor, tr | 100.0 | |
| 3kk8_A | 284 | Calcium/calmodulin dependent protein kinase II; AT | 100.0 | |
| 3is5_A | 285 | Calcium-dependent protein kinase; CDPK, structural | 100.0 | |
| 3bhy_A | 283 | Death-associated protein kinase 3; death associate | 100.0 | |
| 3rp9_A | 458 | Mitogen-activated protein kinase; structural genom | 100.0 | |
| 2jam_A | 304 | Calcium/calmodulin-dependent protein kinase type 1 | 100.0 | |
| 2qr7_A | 342 | Ribosomal protein S6 kinase alpha-3; kinase domain | 100.0 | |
| 2rku_A | 294 | Serine/threonine-protein kinase PLK1; structure of | 100.0 | |
| 2yfx_A | 327 | Tyrosine-protein kinase receptor; nucleotide-bindi | 100.0 | |
| 1u46_A | 291 | ACK-1, activated CDC42 kinase 1; tyrosine kinase, | 100.0 | |
| 1b6c_B | 342 | TGF-B superfamily receptor type I; complex (isomer | 100.0 | |
| 3llt_A | 360 | Serine/threonine kinase-1, pflammer; lammer kinase | 100.0 | |
| 1byg_A | 278 | CSK, protein (C-terminal SRC kinase); protein kina | 100.0 | |
| 2vgo_A | 284 | Serine/threonine-protein kinase 12-A; nucleotide-b | 100.0 | |
| 3g2f_A | 336 | Bone morphogenetic protein receptor type-2; kinase | 100.0 | |
| 3pfq_A | 674 | PKC-B, PKC-beta, protein kinase C beta type; phosp | 100.0 | |
| 1vzo_A | 355 | Ribosomal protein S6 kinase alpha 5; protein kinas | 100.0 | |
| 3uzp_A | 296 | CKI-delta, CKID, casein kinase I isoform delta; CK | 100.0 | |
| 4aaa_A | 331 | Cyclin-dependent kinase-like 2; transferase, phosp | 100.0 | |
| 3eqc_A | 360 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 2owb_A | 335 | Serine/threonine-protein kinase PLK1; catalytic do | 100.0 | |
| 2jii_A | 352 | Serine/threonine-protein kinase VRK3 molecule: VA | 100.0 | |
| 1x8b_A | 289 | WEE1HU, WEE1-like protein kinase; cell cycle, tran | 100.0 | |
| 3ll6_A | 337 | Cyclin G-associated kinase; transferase, protein k | 100.0 | |
| 1nxk_A | 400 | MAP kinase-activated protein kinase 2; MK2, phosph | 100.0 | |
| 3byv_A | 377 | Rhoptry kinase; malaria, transferase, structural g | 100.0 | |
| 2pml_X | 348 | PFPK7, Ser/Thr protein kinase; phosphorylati trans | 100.0 | |
| 3nsz_A | 330 | CK II alpha, casein kinase II subunit alpha; inhib | 100.0 | |
| 2clq_A | 295 | Mitogen-activated protein kinase kinase kinase 5; | 100.0 | |
| 2w5a_A | 279 | Serine/threonine-protein kinase NEK2; Ser/Thr prot | 100.0 | |
| 3mtl_A | 324 | Cell division protein kinase 16; pctaire1, indirub | 100.0 | |
| 3e7e_A | 365 | HBUB1, BUB1A, mitotic checkpoint serine/threonine- | 100.0 | |
| 3c4z_A | 543 | Rhodopsin kinase; Ser/Thr kinase, RGS homology dom | 100.0 | |
| 3a7i_A | 303 | MST3 kinase, serine/threonine kinase 24 (STE20 hom | 100.0 | |
| 2vwi_A | 303 | Serine/threonine-protein kinase OSR1; STE kinase, | 100.0 | |
| 3mi9_A | 351 | Cell division protein kinase 9; P-TEFB, HIV-1, pro | 100.0 | |
| 3lij_A | 494 | Calcium/calmodulin dependent protein kinase with A | 100.0 | |
| 3n9x_A | 432 | Phosphotransferase; malaria kinase, structural gen | 100.0 | |
| 1cm8_A | 367 | Phosphorylated MAP kinase P38-gamma; phosphorylati | 100.0 | |
| 2j7t_A | 302 | Serine/threonine-protein kinase 10; transferase, A | 100.0 | |
| 2j0j_A | 656 | Focal adhesion kinase 1; cell migration, FERM, tra | 100.0 | |
| 2h6d_A | 276 | 5'-AMP-activated protein kinase catalytic subunit | 100.0 | |
| 3mwu_A | 486 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 1ua2_A | 346 | CAK, cell division protein kinase 7; cell cycle, p | 100.0 | |
| 3nyv_A | 484 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 3com_A | 314 | Serine/threonine-protein kinase 4; MST1, STE20-lik | 100.0 | |
| 2y7j_A | 365 | Phosphorylase B kinase gamma catalytic chain, test | 100.0 | |
| 2y4i_B | 319 | KSR2, HKSR2, kinase suppressor of RAS 2; transfera | 100.0 | |
| 2wtk_C | 305 | Serine/threonine-protein kinase 11; transferase-me | 100.0 | |
| 2r3i_A | 299 | Cell division protein kinase 2; serine/threonine-p | 100.0 | |
| 1z57_A | 339 | Dual specificity protein kinase CLK1; protein tyro | 100.0 | |
| 2ycf_A | 322 | Serine/threonine-protein kinase CHK2; transferase, | 100.0 | |
| 3rgf_A | 405 | Cyclin-dependent kinase 8; protein kinase complex, | 100.0 | |
| 3kvw_A | 429 | DYRK2, dual specificity tyrosine-phosphorylation-r | 100.0 | |
| 3q5i_A | 504 | Protein kinase; CDPK, malaria, phosphotransferase, | 100.0 | |
| 3sv0_A | 483 | Casein kinase I-like; typical kinase domain fold, | 100.0 | |
| 1phk_A | 298 | Phosphorylase kinase; glycogen metabolism, transfe | 100.0 | |
| 2fst_X | 367 | Mitogen-activated protein kinase 14; active mutant | 100.0 | |
| 3q60_A | 371 | ROP5B; pseudokinase, transferase; HET: ATP; 1.72A | 100.0 | |
| 3qyz_A | 364 | Mitogen-activated protein kinase 1; transferase, s | 100.0 | |
| 3eb0_A | 383 | Putative uncharacterized protein; kinase cryptospo | 100.0 | |
| 2xrw_A | 371 | Mitogen-activated protein kinase 8; transcription, | 100.0 | |
| 3fme_A | 290 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 3an0_A | 340 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 3pg1_A | 362 | Mitogen-activated protein kinase, putative (MAP K | 100.0 | |
| 1blx_A | 326 | Cyclin-dependent kinase 6; inhibitor protein, cycl | 100.0 | |
| 1zy4_A | 303 | Serine/threonine-protein kinase GCN2; translation | 100.0 | |
| 4e7w_A | 394 | Glycogen synthase kinase 3; GSK3, PTyr195, transfe | 100.0 | |
| 2x7f_A | 326 | TRAF2 and NCK-interacting protein kinase; serine/t | 100.0 | |
| 2i6l_A | 320 | Mitogen-activated protein kinase 6; MAPK6, ERK3, e | 100.0 | |
| 4exu_A | 371 | Mitogen-activated protein kinase 13; P38 kinase, t | 100.0 | |
| 2b9h_A | 353 | MAP kinase FUS3, mitogen-activated protein kinase | 100.0 | |
| 1j1b_A | 420 | Glycogen synthase kinase-3 beta; complex, TAU, AMP | 100.0 | |
| 2wei_A | 287 | Calmodulin-domain protein kinase 1, putative; nucl | 100.0 | |
| 3cek_A | 313 | Dual specificity protein kinase TTK; HMPS1, PYT, E | 100.0 | |
| 2eu9_A | 355 | Dual specificity protein kinase CLK3; kinase domai | 100.0 | |
| 1wak_A | 397 | Serine/threonine-protein kinase SPRK1; SRPK, trans | 100.0 | |
| 3e3p_A | 360 | Protein kinase, putative glycogen synthase kinase; | 100.0 | |
| 2iwi_A | 312 | Serine/threonine-protein kinase PIM-2; nucleotide- | 100.0 | |
| 3coi_A | 353 | Mitogen-activated protein kinase 13; P38D, P38delt | 100.0 | |
| 2vx3_A | 382 | Dual specificity tyrosine-phosphorylation- regula | 100.0 | |
| 3a99_A | 320 | Proto-oncogene serine/threonine-protein kinase PI; | 100.0 | |
| 1q8y_A | 373 | SR protein kinase; transferase; HET: ADP ADE; 2.05 | 100.0 | |
| 1dlp_A | 236 | Lectin scafet precursor; two-domain lectin, beta p | 100.0 | |
| 2rio_A | 434 | Serine/threonine-protein kinase/endoribonuclease I | 100.0 | |
| 3fhr_A | 336 | MAP kinase-activated protein kinase 3; kinase-inhi | 100.0 | |
| 3aln_A | 327 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 3p23_A | 432 | Serine/threonine-protein kinase/endoribonuclease; | 100.0 | |
| 3qa8_A | 676 | MGC80376 protein; kinase ubiquitin-like domain, ph | 100.0 | |
| 2pzi_A | 681 | Probable serine/threonine-protein kinase PKNG; ATP | 100.0 | |
| 2dyl_A | 318 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| 3uqc_A | 286 | Probable conserved transmembrane protein; structur | 100.0 | |
| 2vuw_A | 336 | Serine/threonine-protein kinase haspin; cell cycle | 100.0 | |
| 3m2w_A | 299 | MAP kinase-activated protein kinase 2; small molec | 100.0 | |
| 3dzo_A | 413 | Rhoptry kinase domain; parasitic disease, transfer | 100.0 | |
| 4azs_A | 569 | Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15 | 99.94 | |
| 3en9_A | 540 | Glycoprotease, O-sialoglycoprotein endopeptidase/p | 99.91 | |
| 1zar_A | 282 | RIO2 kinase; serine kinase, winged-helix, RIO doma | 99.84 | |
| 1b2p_A | 119 | Protein (lectin); mannose-binding lectin, monocot, | 99.83 | |
| 4h3o_A | 105 | Lectin; cadmium, plant protein; 2.17A {Allium sati | 99.83 | |
| 3a0c_A | 110 | Mannose/sialic acid-binding lectin; beta-prism II, | 99.82 | |
| 2dpf_A | 115 | Curculin; sweet taste, taste modifying, plant prot | 99.8 | |
| 1xd5_A | 112 | Gastrodianin-1, antifungal protein GAFP-1; monocot | 99.78 | |
| 3dzw_A | 109 | Agglutinin; lectin, mannobiose, mannose-alpha1, 3- | 99.74 | |
| 1zth_A | 258 | RIO1 serine protein kinase; ribosome biogenesis, r | 99.71 | |
| 3r0e_B | 110 | Lectin; carbohydrate binding, carbohydrate, sugar | 99.65 | |
| 3mez_B | 113 | Mannose-specific lectin 3 chain 2; heterotetramer, | 99.64 | |
| 3a0c_A | 110 | Mannose/sialic acid-binding lectin; beta-prism II, | 99.62 | |
| 3r0e_A | 109 | Lectin; carbohydrate binding, carbohydrate, sugar | 99.57 | |
| 1b2p_A | 119 | Protein (lectin); mannose-binding lectin, monocot, | 99.57 | |
| 1xd5_A | 112 | Gastrodianin-1, antifungal protein GAFP-1; monocot | 99.56 | |
| 4gyi_A | 397 | RIO2 kinase; protein kinase, ADP complex, phosphoa | 99.55 | |
| 2dpf_A | 115 | Curculin; sweet taste, taste modifying, plant prot | 99.51 | |
| 3mez_A | 111 | Mannose-specific lectin 3 chain 1; heterotetramer, | 99.42 | |
| 3mez_B | 113 | Mannose-specific lectin 3 chain 2; heterotetramer, | 99.33 | |
| 3mez_A | 111 | Mannose-specific lectin 3 chain 1; heterotetramer, | 99.3 | |
| 3m7h_A | 276 | Putidacin L1; monocot mannose-binding lectin, bact | 99.27 | |
| 3dzw_A | 109 | Agglutinin; lectin, mannobiose, mannose-alpha1, 3- | 99.25 | |
| 3r0e_B | 110 | Lectin; carbohydrate binding, carbohydrate, sugar | 99.17 | |
| 1dlp_A | 236 | Lectin scafet precursor; two-domain lectin, beta p | 99.15 | |
| 3tm0_A | 263 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.12 | |
| 3r0e_A | 109 | Lectin; carbohydrate binding, carbohydrate, sugar | 99.06 | |
| 4h3o_A | 105 | Lectin; cadmium, plant protein; 2.17A {Allium sati | 99.01 | |
| 1nd4_A | 264 | Aminoglycoside 3'-phosphotransferase; protein kina | 98.92 | |
| 3dxp_A | 359 | Putative acyl-COA dehydrogenase; protein kinase-li | 98.87 | |
| 3sg8_A | 304 | APH(2'')-ID; antibiotic resistance enzyme, transfe | 98.68 | |
| 3r70_A | 320 | Aminoglycoside phosphotransferase; structural geno | 98.26 | |
| 3d1u_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 98.19 | |
| 4gkh_A | 272 | Aminoglycoside 3'-phosphotransferase APHA1-IAB; py | 98.04 | |
| 3tdw_A | 306 | Gentamicin resistance protein; kinase, phosphoryl | 98.0 | |
| 3ovc_A | 362 | Hygromycin-B 4-O-kinase; aminoglycoside phosphotra | 97.99 | |
| 3ats_A | 357 | Putative uncharacterized protein; hypothetical pro | 97.94 | |
| 2olc_A | 397 | MTR kinase, methylthioribose kinase; kinase ADP-2H | 97.58 | |
| 2q83_A | 346 | YTAA protein; 2635576, structural genomics, joint | 97.53 | |
| 3jr1_A | 312 | Putative fructosamine-3-kinase; YP_719053.1, struc | 97.42 | |
| 3f7w_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 97.2 | |
| 2pyw_A | 420 | Uncharacterized protein; 5-methylthioribose kinase | 97.14 | |
| 1nw1_A | 429 | Choline kinase (49.2 KD); phospholipid synthesis, | 96.8 | |
| 2ppq_A | 322 | HSK, HK, homoserine kinase; structural genomics, M | 96.78 | |
| 3feg_A | 379 | Choline/ethanolamine kinase; non-protein kinase, c | 96.71 | |
| 3dxq_A | 301 | Choline/ethanolamine kinase family protein; NP_106 | 96.71 | |
| 2qg7_A | 458 | Ethanolamine kinase PV091845; malaria, SGC, struct | 96.52 | |
| 3c5i_A | 369 | Choline kinase; choline, kinase, malaria, transfer | 96.29 | |
| 1zyl_A | 328 | Hypothetical protein YIHE; putative protein kinase | 96.22 | |
| 3csv_A | 333 | Aminoglycoside phosphotransferase; YP_614837.1, ph | 95.92 | |
| 3f2s_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 95.57 | |
| 3i1a_A | 339 | Spectinomycin phosphotransferase; protein kinase, | 95.28 | |
| 2yle_A | 229 | Protein spire homolog 1; actin-binding protein, ac | 95.17 | |
| 3mes_A | 424 | Choline kinase; malaria, structural genomics, stru | 93.7 | |
| 3no2_A | 276 | Uncharacterized protein; six-bladed beta-propeller | 90.23 | |
| 4ann_A | 215 | ESSB; membrane protein, membrane secretion, ESS ty | 87.88 | |
| 3no2_A | 276 | Uncharacterized protein; six-bladed beta-propeller | 87.44 | |
| 3g15_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 86.82 | |
| 2ll3_A | 82 | Micronemal protein 4; cell adhesion; NMR {Toxoplas | 85.28 |
| >4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-53 Score=447.91 Aligned_cols=259 Identities=25% Similarity=0.328 Sum_probs=213.0
Q ss_pred HHHhhhhhhcCccccceEEEeeec----CCCceEEEEEEccccc-ccchHHHHHHHHHhcccCCCCcccccceeccCCce
Q 003836 500 EVTRGFKEELGRGAFGTVYKGFVN----MGSSNHVAVKKLNSVF-QDSEKEFKAEVNGIGQTHHKNLVRLLGYCDEGQNR 574 (792)
Q Consensus 500 ~~~~~~~~~lG~G~~g~Vy~g~~~----~~~~~~vavK~~~~~~-~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~ 574 (792)
..+..|.++||+|+||+||+|.+. ..+++.||||+++... ....++|.+|+.++++++|||||+++|+|.+++..
T Consensus 25 ~~~~~~~~~lG~G~fG~Vykg~~~~~~~~~~~~~VAvK~l~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~~~~~ 104 (308)
T 4gt4_A 25 LSAVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPNVVCLLGVVTKDQPL 104 (308)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEEC-------CEEEEEEECCC-CCC-CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSC
T ss_pred HHHCeEeeEeccCCCcEEEEEEEcCCccCCCCeEEEEEEECcccChHHHHHHHHHHHHHHhCCCCCCCCcceEEEECCEE
Confidence 344567889999999999999873 2345789999997543 33457899999999999999999999999999999
Q ss_pred EEEEEeccCCCccccccCC----------------CCCchhHHHHHHHHHHHHHHHHhhccCCCeEecCCCCCcEEEcCC
Q 003836 575 LLVYEFMSNGTVASFLFGD----------------SKPNWKLRTEIAMGIAGGLFYLHEECCTQIIHCDIKPQNILLDDH 638 (792)
Q Consensus 575 ~lV~E~~~~gsL~~~l~~~----------------~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dikp~NILl~~~ 638 (792)
+||||||++|+|.++|... ..++|..+.+|+.|||+||+|||++ +||||||||+||||+++
T Consensus 105 ~lV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~---~iiHRDLK~~NILl~~~ 181 (308)
T 4gt4_A 105 SMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLSSH---HVVHKDLATRNVLVYDK 181 (308)
T ss_dssp EEEEECCSSCBHHHHHHTTCSSCCCC-----CCEECCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGG
T ss_pred EEEEEcCCCCcHHHHHHhhCccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhC---CCCCCCccccceEECCC
Confidence 9999999999999999642 3578999999999999999999998 99999999999999999
Q ss_pred CCeEEeecCCCccccCCCC-CccccccccCCcccccccccCCCCcccceehHHHHHHHHHh-cCcCCCcchhhhhhhhHH
Q 003836 639 YNARISDFGLAKLLTLDQS-HTNTAIRGTKGYVAPEWFRNMPITVKVDVYSYGVLLLEIIC-LRRNIDNEISKVDKAILT 716 (792)
Q Consensus 639 ~~~kl~Dfg~a~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~k~DV~S~Gv~l~el~t-g~~p~~~~~~~~~~~~~~ 716 (792)
+.+||+|||+++....... .......||+.|||||++.+..++.++|||||||+||||+| |+.||.......
T Consensus 182 ~~~Ki~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~~s~ksDVwSfGvvl~El~t~g~~Pf~~~~~~~------ 255 (308)
T 4gt4_A 182 LNVKISDLGLFREVYAADYYKLLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQD------ 255 (308)
T ss_dssp GCEEECCSCCBCGGGGGGCBCSSSSSCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTCCHHH------
T ss_pred CCEEECCcccceeccCCCceeEecccccCCcccCHHHHhCCCCCccchhhhHHHHHHHHHhCCCCCCCCCCHHH------
Confidence 9999999999997654332 23345679999999999999999999999999999999998 889997543211
Q ss_pred HHHHHhhcccchhHhhhchhcccCCHHHHHHHHHHHHHccccCCCCCCCHHhHHHHhccCcC
Q 003836 717 DWAYDRYQERTLEALVENDLEAMNNVTMLHRFVMVAFWCIQEDPSHRPTMRKVTQMLEGVVE 778 (792)
Q Consensus 717 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~L~~~~~ 778 (792)
+...+........+...+.++.+|+.+||+.||++||||+||+++|+....
T Consensus 256 -----------~~~~i~~~~~~~~p~~~~~~~~~li~~C~~~dP~~RPs~~ei~~~L~a~~n 306 (308)
T 4gt4_A 256 -----------VVEMIRNRQVLPCPDDCPAWVYALMIECWNEFPSRRPRFKDIHSRLRAWGN 306 (308)
T ss_dssp -----------HHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSCC
T ss_pred -----------HHHHHHcCCCCCCcccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHhccC
Confidence 011111222223344566788999999999999999999999999987543
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-52 Score=448.69 Aligned_cols=256 Identities=24% Similarity=0.401 Sum_probs=207.0
Q ss_pred hhhhcCccccceEEEeeecC----CCceEEEEEEcccccccchHHHHHHHHHhcccCCCCcccccceeccCCceEEEEEe
Q 003836 505 FKEELGRGAFGTVYKGFVNM----GSSNHVAVKKLNSVFQDSEKEFKAEVNGIGQTHHKNLVRLLGYCDEGQNRLLVYEF 580 (792)
Q Consensus 505 ~~~~lG~G~~g~Vy~g~~~~----~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~lV~E~ 580 (792)
+.++||+|+||+||+|.+.. .+++.||||+++.......++|.+|+++|++++|||||+++|+|.+.+..+|||||
T Consensus 45 l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~~~lV~Ey 124 (329)
T 4aoj_A 45 LKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRFFGVCTEGRPLLMVFEY 124 (329)
T ss_dssp EEEEEEECSSEEEEEEEESSSCC---CEEEEEEEESCCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSEEEEEEC
T ss_pred EEEEEccCCCcEEEEEEECCcccCCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEc
Confidence 45789999999999998642 35678999999877666778899999999999999999999999999999999999
Q ss_pred ccCCCccccccCC---------------CCCchhHHHHHHHHHHHHHHHHhhccCCCeEecCCCCCcEEEcCCCCeEEee
Q 003836 581 MSNGTVASFLFGD---------------SKPNWKLRTEIAMGIAGGLFYLHEECCTQIIHCDIKPQNILLDDHYNARISD 645 (792)
Q Consensus 581 ~~~gsL~~~l~~~---------------~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dikp~NILl~~~~~~kl~D 645 (792)
|++|+|.++|+.. ..++|.++++|+.|||+||+|||++ +||||||||+||||++++.+||+|
T Consensus 125 ~~~G~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~---~iiHRDLKp~NILl~~~~~~Ki~D 201 (329)
T 4aoj_A 125 MRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGL---HFVHRDLATRNCLVGQGLVVKIGD 201 (329)
T ss_dssp CTTCBHHHHHHTSSCC-----------CCSCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEETTTEEEECC
T ss_pred CCCCcHHHHHHhcCcccccccccccccCCCCCHHHHHHHHHHHHHHHHHHhcC---CeecccccHhhEEECCCCcEEEcc
Confidence 9999999998653 3589999999999999999999998 999999999999999999999999
Q ss_pred cCCCccccCCCC-CccccccccCCcccccccccCCCCcccceehHHHHHHHHHh-cCcCCCcchhhhhhhhHHHHHHHhh
Q 003836 646 FGLAKLLTLDQS-HTNTAIRGTKGYVAPEWFRNMPITVKVDVYSYGVLLLEIIC-LRRNIDNEISKVDKAILTDWAYDRY 723 (792)
Q Consensus 646 fg~a~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~k~DV~S~Gv~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~ 723 (792)
||+++....... .......||+.|||||++.+..++.++|||||||+||||+| |+.||........ +
T Consensus 202 FGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~~sDvwS~Gvvl~Ellt~G~~Pf~~~~~~~~---~-------- 270 (329)
T 4aoj_A 202 FGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLSNTEA---I-------- 270 (329)
T ss_dssp CC----------------CCCCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSSCHHHH---H--------
T ss_pred cccceeccCCCcceecCcccccccccChhhhcCCCCCccccccchHHHHHHHHcCCCCCCCCCCHHHH---H--------
Confidence 999997654332 22344679999999999999999999999999999999999 8999975432110 0
Q ss_pred cccchhHhhhchhcccCCHHHHHHHHHHHHHccccCCCCCCCHHhHHHHhccCcCCC
Q 003836 724 QERTLEALVENDLEAMNNVTMLHRFVMVAFWCIQEDPSHRPTMRKVTQMLEGVVEVP 780 (792)
Q Consensus 724 ~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~L~~~~~~~ 780 (792)
..+....+...+...++++.+|+.+||+.||++||||+||+++|+.+.+.|
T Consensus 271 ------~~i~~g~~~~~p~~~~~~~~~li~~cl~~dP~~RPs~~ei~~~L~~l~~~p 321 (329)
T 4aoj_A 271 ------DCITQGRELERPRACPPEVYAIMRGCWQREPQQRHSIKDVHARLQALAQAP 321 (329)
T ss_dssp ------HHHHHTCCCCCCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHHHHHHHHHSC
T ss_pred ------HHHHcCCCCCCcccccHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHhhCC
Confidence 011111122234445678899999999999999999999999999987654
|
| >4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-52 Score=443.35 Aligned_cols=254 Identities=24% Similarity=0.405 Sum_probs=210.9
Q ss_pred hhhhcCccccceEEEeeecC----CCceEEEEEEcccccccchHHHHHHHHHhcccCCCCcccccceeccCCceEEEEEe
Q 003836 505 FKEELGRGAFGTVYKGFVNM----GSSNHVAVKKLNSVFQDSEKEFKAEVNGIGQTHHKNLVRLLGYCDEGQNRLLVYEF 580 (792)
Q Consensus 505 ~~~~lG~G~~g~Vy~g~~~~----~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~lV~E~ 580 (792)
+.++||+|+||+||+|.+.. .+++.||||+++.......++|.+|++++++++|||||+++|+|.+++..+|||||
T Consensus 17 l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~~~lV~Ey 96 (299)
T 4asz_A 17 LKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPLIMVFEY 96 (299)
T ss_dssp EEEEEEC--CCCEEEEEECSCC----CEEEEEEEECSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSEEEEEEC
T ss_pred EeeEEeeCCCcEEEEEEECCcccCCCCEEEEEEEeCCCChHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCCEEEEEEEc
Confidence 55789999999999998642 34678999999877666778899999999999999999999999999999999999
Q ss_pred ccCCCccccccCC-------------CCCchhHHHHHHHHHHHHHHHHhhccCCCeEecCCCCCcEEEcCCCCeEEeecC
Q 003836 581 MSNGTVASFLFGD-------------SKPNWKLRTEIAMGIAGGLFYLHEECCTQIIHCDIKPQNILLDDHYNARISDFG 647 (792)
Q Consensus 581 ~~~gsL~~~l~~~-------------~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dikp~NILl~~~~~~kl~Dfg 647 (792)
|++|+|.++|+.. ..++|.++++|+.|||+||+|||++ +|+||||||+||||++++.+||+|||
T Consensus 97 ~~~G~L~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~---~iiHRDlKp~NILl~~~~~~Ki~DFG 173 (299)
T 4asz_A 97 MKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAGMVYLASQ---HFVHRDLATRNCLVGENLLVKIGDFG 173 (299)
T ss_dssp CTTCBHHHHHHHTSHHHHHC----CCCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCEEECCCS
T ss_pred CCCCcHHHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCccCHhhEEECCCCcEEECCcc
Confidence 9999999999643 3689999999999999999999998 99999999999999999999999999
Q ss_pred CCccccCCCCC-ccccccccCCcccccccccCCCCcccceehHHHHHHHHHh-cCcCCCcchhhhhhhhHHHHHHHhhcc
Q 003836 648 LAKLLTLDQSH-TNTAIRGTKGYVAPEWFRNMPITVKVDVYSYGVLLLEIIC-LRRNIDNEISKVDKAILTDWAYDRYQE 725 (792)
Q Consensus 648 ~a~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~k~DV~S~Gv~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~ 725 (792)
+|+........ ......||+.|||||.+.+..++.|+|||||||+||||+| |+.||....... .+
T Consensus 174 la~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~k~DVwS~Gvvl~Ellt~G~~Pf~~~~~~~---~~---------- 240 (299)
T 4asz_A 174 MSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNE---VI---------- 240 (299)
T ss_dssp CHHHHTGGGCEEETTTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHH---HH----------
T ss_pred cceecCCCCceeecCceecChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCHHH---HH----------
Confidence 99876543332 2234568999999999999999999999999999999999 899997543211 00
Q ss_pred cchhHhhhchhcccCCHHHHHHHHHHHHHccccCCCCCCCHHhHHHHhccCcC
Q 003836 726 RTLEALVENDLEAMNNVTMLHRFVMVAFWCIQEDPSHRPTMRKVTQMLEGVVE 778 (792)
Q Consensus 726 ~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~L~~~~~ 778 (792)
..+........+...++++.+|+.+||+.||++||||+||++.|+++.+
T Consensus 241 ----~~i~~~~~~~~p~~~~~~~~~li~~cl~~dP~~RPs~~~i~~~L~~~~~ 289 (299)
T 4asz_A 241 ----ECITQGRVLQRPRTCPQEVYELMLGCWQREPHMRKNIKGIHTLLQNLAK 289 (299)
T ss_dssp ----HHHHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred ----HHHHcCCCCCCCccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHh
Confidence 0111111122344556788999999999999999999999999988654
|
| >3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-51 Score=431.08 Aligned_cols=253 Identities=27% Similarity=0.405 Sum_probs=199.1
Q ss_pred hhhhcCccccceEEEeeecCCCceEEEEEEccccc--ccchHHHHHHHHHhcccCCCCcccccceeccCCceEEEEEecc
Q 003836 505 FKEELGRGAFGTVYKGFVNMGSSNHVAVKKLNSVF--QDSEKEFKAEVNGIGQTHHKNLVRLLGYCDEGQNRLLVYEFMS 582 (792)
Q Consensus 505 ~~~~lG~G~~g~Vy~g~~~~~~~~~vavK~~~~~~--~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~lV~E~~~ 582 (792)
+.++||+|+||+||+|++. ..||||+++... ....+.|.+|++++++++|||||+++|+|.+ +..+||||||+
T Consensus 40 l~~~iG~G~fG~Vy~~~~~----~~vAvK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~-~~~~iVmEy~~ 114 (307)
T 3omv_A 40 LSTRIGSGSFGTVYKGKWH----GDVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGYMTK-DNLAIVTQWCE 114 (307)
T ss_dssp EEEECCCCSSSEEEEEESS----SEEEEEECCCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECS-SSCEEEEECCS
T ss_pred EeeEEeeCCCcEEEEEEEC----CcEEEEEEEecCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEC-CeEEEEEEcCC
Confidence 5678999999999999764 259999987533 3345789999999999999999999999865 56899999999
Q ss_pred CCCccccccCC-CCCchhHHHHHHHHHHHHHHHHhhccCCCeEecCCCCCcEEEcCCCCeEEeecCCCccccCCCC-Ccc
Q 003836 583 NGTVASFLFGD-SKPNWKLRTEIAMGIAGGLFYLHEECCTQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLDQS-HTN 660 (792)
Q Consensus 583 ~gsL~~~l~~~-~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dikp~NILl~~~~~~kl~Dfg~a~~~~~~~~-~~~ 660 (792)
+|+|.++|+.. ..+++.++.+|+.|||+||+|||++ +||||||||+||||++++.+||+|||+|+....... ...
T Consensus 115 gGsL~~~l~~~~~~l~~~~~~~i~~qia~gL~yLH~~---~IiHRDlKp~NILl~~~~~~Ki~DFGla~~~~~~~~~~~~ 191 (307)
T 3omv_A 115 GSSLYKHLHVQETKFQMFQLIDIARQTAQGMDYLHAK---NIIHRDMKSNNIFLHEGLTVKIGDFGLATVKSRWSGSQQV 191 (307)
T ss_dssp SCBHHHHHHTSCCCCCHHHHHHHHHHHHHHHHHHHHT---TCBCSCCCSSSEEEETTEEEEECCCSSCBC----------
T ss_pred CCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHC---CccCCccCHHHEEECCCCcEEEeeccCceecccCCcceee
Confidence 99999999764 5799999999999999999999998 999999999999999999999999999987654332 233
Q ss_pred ccccccCCccccccccc---CCCCcccceehHHHHHHHHHhcCcCCCcchhhhhhhhHHHHHHHhhcccchhHhhhchhc
Q 003836 661 TAIRGTKGYVAPEWFRN---MPITVKVDVYSYGVLLLEIICLRRNIDNEISKVDKAILTDWAYDRYQERTLEALVENDLE 737 (792)
Q Consensus 661 ~~~~gt~~y~aPE~~~~---~~~~~k~DV~S~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 737 (792)
....||+.|||||++.+ ..|+.|+|||||||+||||+||+.||........ +......... .+..
T Consensus 192 ~~~~GT~~ymAPE~l~~~~~~~y~~ksDVwS~Gvvl~Elltg~~Pf~~~~~~~~---~~~~~~~~~~--------~p~~- 259 (307)
T 3omv_A 192 EQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHINNRDQ---IIFMVGRGYA--------SPDL- 259 (307)
T ss_dssp --CCCCTTSCCHHHHHCCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHH---HHHHHHTTCC--------CCCS-
T ss_pred cccccCCCccCHHHhhccCCCCCCcHHHhHhHHHHHHHHHHCCCCCCCCChHHH---HHHHHhcCCC--------CCCc-
Confidence 45679999999999863 4699999999999999999999999975432111 0000000000 0111
Q ss_pred ccCCHHHHHHHHHHHHHccccCCCCCCCHHhHHHHhccCc
Q 003836 738 AMNNVTMLHRFVMVAFWCIQEDPSHRPTMRKVTQMLEGVV 777 (792)
Q Consensus 738 ~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~L~~~~ 777 (792)
...+...++.+.+|+.+||+.||++||||.||+++|+.+.
T Consensus 260 ~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~Le~l~ 299 (307)
T 3omv_A 260 SKLYKNCPKAMKRLVADCVKKVKEERPLFPQILSSIELLQ 299 (307)
T ss_dssp TTSCTTSCHHHHHHHHHHTCSSSTTSCCHHHHHHHHHHHH
T ss_pred ccccccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHh
Confidence 1122345677889999999999999999999999997653
|
| >3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-49 Score=416.11 Aligned_cols=244 Identities=27% Similarity=0.415 Sum_probs=197.2
Q ss_pred hhhhcCccccceEEEeeecCCCceEEEEEEccccc--ccchHHHHHHHHHhcccCCCCcccccceecc----CCceEEEE
Q 003836 505 FKEELGRGAFGTVYKGFVNMGSSNHVAVKKLNSVF--QDSEKEFKAEVNGIGQTHHKNLVRLLGYCDE----GQNRLLVY 578 (792)
Q Consensus 505 ~~~~lG~G~~g~Vy~g~~~~~~~~~vavK~~~~~~--~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~----~~~~~lV~ 578 (792)
|.++||+|+||+||+|... .+++.||+|++.... ....+.|.+|++++++++|||||++++++.+ .+..+|||
T Consensus 30 ~~~~iG~G~fg~Vy~a~~~-~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~lvm 108 (290)
T 3fpq_A 30 FDIEIGRGSFKTVYKGLDT-ETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVT 108 (290)
T ss_dssp EEEEEEECSSEEEEEEEET-TTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEEETTEEEEEEEE
T ss_pred eeeEEecCcCcEEEEEEEC-CCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEeeccCCCcEEEEEE
Confidence 4567999999999999754 567899999986532 3345679999999999999999999999864 35689999
Q ss_pred EeccCCCccccccCCCCCchhHHHHHHHHHHHHHHHHhhccCCC--eEecCCCCCcEEEc-CCCCeEEeecCCCccccCC
Q 003836 579 EFMSNGTVASFLFGDSKPNWKLRTEIAMGIAGGLFYLHEECCTQ--IIHCDIKPQNILLD-DHYNARISDFGLAKLLTLD 655 (792)
Q Consensus 579 E~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~--ivH~dikp~NILl~-~~~~~kl~Dfg~a~~~~~~ 655 (792)
|||++|+|.+++.+...+++..+..|+.||+.||+|||++ + |+||||||+||||+ .++.+||+|||+|+....
T Consensus 109 Ey~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~ylH~~---~~~IiHRDlKp~NILl~~~~g~vKl~DFGla~~~~~- 184 (290)
T 3fpq_A 109 ELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLHTR---TPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRA- 184 (290)
T ss_dssp ECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTS---SSCCCCCCCCGGGEEESSTTSCEEECCTTGGGGCCT-
T ss_pred eCCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---CCCEEecccChhheeEECCCCCEEEEeCcCCEeCCC-
Confidence 9999999999998888899999999999999999999998 6 99999999999998 479999999999986432
Q ss_pred CCCccccccccCCcccccccccCCCCcccceehHHHHHHHHHhcCcCCCcchhhhhhhhHHHHHHHhhcccchhHhhhch
Q 003836 656 QSHTNTAIRGTKGYVAPEWFRNMPITVKVDVYSYGVLLLEIICLRRNIDNEISKVDKAILTDWAYDRYQERTLEALVEND 735 (792)
Q Consensus 656 ~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DV~S~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 735 (792)
......+||+.|||||++.+ .++.++|||||||+||||+||+.||........ + .........
T Consensus 185 --~~~~~~~GTp~YmAPE~~~~-~y~~~~DiwSlGvilyelltg~~Pf~~~~~~~~---~----~~~i~~~~~------- 247 (290)
T 3fpq_A 185 --SFAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQ---I----YRRVTSGVK------- 247 (290)
T ss_dssp --TSBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHH---H----HHHHTTTCC-------
T ss_pred --CccCCcccCccccCHHHcCC-CCCcHHHHHHHHHHHHHHHHCCCCCCCCCcHHH---H----HHHHHcCCC-------
Confidence 23345689999999998865 699999999999999999999999965322111 0 011111100
Q ss_pred hcccCCHHHHHHHHHHHHHccccCCCCCCCHHhHHH
Q 003836 736 LEAMNNVTMLHRFVMVAFWCIQEDPSHRPTMRKVTQ 771 (792)
Q Consensus 736 ~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~ 771 (792)
....+...++++.+|+.+||+.||++|||++|+++
T Consensus 248 -~~~~~~~~~~~~~~li~~~L~~dP~~R~s~~e~l~ 282 (290)
T 3fpq_A 248 -PASFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLN 282 (290)
T ss_dssp -CGGGGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred -CCCCCccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 00111123356889999999999999999999987
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-49 Score=422.82 Aligned_cols=259 Identities=22% Similarity=0.233 Sum_probs=209.1
Q ss_pred hhhhcCccccceEEEeeecCCCceEEEEEEcccccccchHHHHHHHHHhcccCCCCcccccceeccCCceEEEEEeccCC
Q 003836 505 FKEELGRGAFGTVYKGFVNMGSSNHVAVKKLNSVFQDSEKEFKAEVNGIGQTHHKNLVRLLGYCDEGQNRLLVYEFMSNG 584 (792)
Q Consensus 505 ~~~~lG~G~~g~Vy~g~~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~lV~E~~~~g 584 (792)
+.++||+|+||+||+|.. ..+++.||||+++... ...+|+.++++++|||||++++++.+++..+||||||++|
T Consensus 62 ~~~~lG~G~fG~Vy~a~~-~~~g~~vAiK~i~~~~-----~~~~E~~il~~l~HpnIV~l~~~~~~~~~~~ivmEy~~gg 135 (336)
T 4g3f_A 62 HQPRVGRGSFGEVHRMKD-KQTGFQCAVKKVRLEV-----FRVEELVACAGLSSPRIVPLYGAVREGPWVNIFMELLEGG 135 (336)
T ss_dssp EEEEEEEETTEEEEEEEE-TTTCCEEEEEEEETTT-----CCTHHHHTTTTCCCTTBCCEEEEEEETTEEEEEECCCTTC
T ss_pred eCcEeccCCCeEEEEEEE-CCCCCEEEEEEECHHH-----hHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEeccCCC
Confidence 346799999999999975 4567899999997532 2357999999999999999999999999999999999999
Q ss_pred CccccccCCCCCchhHHHHHHHHHHHHHHHHhhccCCCeEecCCCCCcEEEcCCC-CeEEeecCCCccccCCCCC----c
Q 003836 585 TVASFLFGDSKPNWKLRTEIAMGIAGGLFYLHEECCTQIIHCDIKPQNILLDDHY-NARISDFGLAKLLTLDQSH----T 659 (792)
Q Consensus 585 sL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dikp~NILl~~~~-~~kl~Dfg~a~~~~~~~~~----~ 659 (792)
+|.++|.....+++..+..++.||+.||+|||++ +||||||||+||||+.++ .+||+|||+|+.+..+... .
T Consensus 136 ~L~~~l~~~~~l~e~~~~~~~~qi~~aL~ylH~~---~IiHRDlKp~NILl~~~g~~vKl~DFGla~~~~~~~~~~~~~~ 212 (336)
T 4g3f_A 136 SLGQLIKQMGCLPEDRALYYLGQALEGLEYLHTR---RILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLT 212 (336)
T ss_dssp BHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTT---TEECSCCCGGGEEECTTSCCEEECCCTTCEEC-----------
T ss_pred cHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC---CceecccCHHHEEEeCCCCEEEEeeCCCCeEccCCCcccceec
Confidence 9999998888899999999999999999999998 999999999999999987 6999999999987543321 1
Q ss_pred cccccccCCcccccccccCCCCcccceehHHHHHHHHHhcCcCCCcchhhhhhhhHHHHHHHhhcccchhHhhhchh-cc
Q 003836 660 NTAIRGTKGYVAPEWFRNMPITVKVDVYSYGVLLLEIICLRRNIDNEISKVDKAILTDWAYDRYQERTLEALVENDL-EA 738 (792)
Q Consensus 660 ~~~~~gt~~y~aPE~~~~~~~~~k~DV~S~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~ 738 (792)
...++||+.|||||++.+..++.++|||||||++|||+||+.||........ +.. +..... ..
T Consensus 213 ~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~~---~~~-------------i~~~~~~~~ 276 (336)
T 4g3f_A 213 GDYIPGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNGCHPWTQYFRGPL---CLK-------------IASEPPPIR 276 (336)
T ss_dssp -CCCCCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSTTTCCSCC---HHH-------------HHHSCCGGG
T ss_pred CCccccCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHHH---HHH-------------HHcCCCCch
Confidence 2345799999999999999999999999999999999999999975432211 100 111100 01
Q ss_pred cCCHHHHHHHHHHHHHccccCCCCCCCHHhHHHHhccCc-CCCCCCCCCCC
Q 003836 739 MNNVTMLHRFVMVAFWCIQEDPSHRPTMRKVTQMLEGVV-EVPIPPCPWTL 788 (792)
Q Consensus 739 ~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~L~~~~-~~~~p~~P~~~ 788 (792)
..+...+..+.+++.+||+.||++|||+.|+++.|...+ ++..-.+||..
T Consensus 277 ~~~~~~s~~~~~li~~~L~~dP~~R~sa~el~~~l~~~l~~~~~l~hPw~~ 327 (336)
T 4g3f_A 277 EIPPSCAPLTAQAIQEGLRKEPVHRASAMELRRKVGKALQEVGGLKSPWKG 327 (336)
T ss_dssp GSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHTTSSCSCSSS
T ss_pred hcCccCCHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHHhhhhhccCCCcC
Confidence 123345678889999999999999999999999887643 34445567654
|
| >4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-49 Score=423.91 Aligned_cols=246 Identities=23% Similarity=0.319 Sum_probs=206.4
Q ss_pred hhhhcCccccceEEEeeecCCCceEEEEEEcccccccchHHHHHHHHHhcccCCCCcccccceeccCCceEEEEEeccCC
Q 003836 505 FKEELGRGAFGTVYKGFVNMGSSNHVAVKKLNSVFQDSEKEFKAEVNGIGQTHHKNLVRLLGYCDEGQNRLLVYEFMSNG 584 (792)
Q Consensus 505 ~~~~lG~G~~g~Vy~g~~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~lV~E~~~~g 584 (792)
+.++||+|+||+||+|.. ..+++.||||++........+.+.+|+++|++++|||||++++++.+++..+||||||++|
T Consensus 78 ~~~~iG~G~fG~V~~a~~-~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~ivmEy~~gg 156 (346)
T 4fih_A 78 NFIKIGEGSTGIVCIATV-RSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGG 156 (346)
T ss_dssp EEEEEEECSSCEEEEEEE-TTTCCEEEEEEEEGGGCSSGGGGHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEECCCTTE
T ss_pred EeEEeecCcCeEEEEEEE-CCCCCEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEeCCCCC
Confidence 446799999999999975 4567899999998766666778999999999999999999999999999999999999999
Q ss_pred CccccccCCCCCchhHHHHHHHHHHHHHHHHhhccCCCeEecCCCCCcEEEcCCCCeEEeecCCCccccCCCCCcccccc
Q 003836 585 TVASFLFGDSKPNWKLRTEIAMGIAGGLFYLHEECCTQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLDQSHTNTAIR 664 (792)
Q Consensus 585 sL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dikp~NILl~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~ 664 (792)
+|.+++.. ..+++..+..++.||+.||+|||++ +|+||||||+||||+.++.+||+|||+|+.+..... .....+
T Consensus 157 ~L~~~l~~-~~l~e~~~~~~~~qi~~aL~ylH~~---~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~~~-~~~~~~ 231 (346)
T 4fih_A 157 ALTDIVTH-TRMNEEQIAAVCLAVLQALSVLHAQ---GVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVP-RRKSLV 231 (346)
T ss_dssp EHHHHHHH-SCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECCCTTCEECCSSSC-CBCCCC
T ss_pred cHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHC---CcccccCCHHHEEECCCCCEEEecCcCceecCCCCC-cccccc
Confidence 99999865 5689999999999999999999999 999999999999999999999999999997654322 334568
Q ss_pred ccCCcccccccccCCCCcccceehHHHHHHHHHhcCcCCCcchhhhhhhhHHHHHHHhhcccchhHhhhch-hcccCCHH
Q 003836 665 GTKGYVAPEWFRNMPITVKVDVYSYGVLLLEIICLRRNIDNEISKVDKAILTDWAYDRYQERTLEALVEND-LEAMNNVT 743 (792)
Q Consensus 665 gt~~y~aPE~~~~~~~~~k~DV~S~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~ 743 (792)
||+.|||||++.+..|+.++|||||||++|||++|+.||........ +. .+.+.. ........
T Consensus 232 GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~---~~-------------~i~~~~~~~~~~~~~ 295 (346)
T 4fih_A 232 GTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKA---MK-------------MIRDNLPPRLKNLHK 295 (346)
T ss_dssp SCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHH---HH-------------HHHHSSCCCCSCGGG
T ss_pred cCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHH---HH-------------HHHcCCCCCCCcccc
Confidence 99999999999999999999999999999999999999975432211 00 000000 01111223
Q ss_pred HHHHHHHHHHHccccCCCCCCCHHhHHHH
Q 003836 744 MLHRFVMVAFWCIQEDPSHRPTMRKVTQM 772 (792)
Q Consensus 744 ~~~~l~~l~~~Cl~~~p~~RPs~~evl~~ 772 (792)
.+.++.+|+.+||+.||++|||++|+++.
T Consensus 296 ~s~~~~dli~~~L~~dP~~R~ta~e~l~H 324 (346)
T 4fih_A 296 VSPSLKGFLDRLLVRDPAQRATAAELLKH 324 (346)
T ss_dssp SCHHHHHHHHHHSCSSTTTSCCHHHHTTC
T ss_pred CCHHHHHHHHHHcCCChhHCcCHHHHhcC
Confidence 45678899999999999999999999873
|
| >4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-49 Score=416.02 Aligned_cols=246 Identities=20% Similarity=0.285 Sum_probs=208.0
Q ss_pred hhhhhhcCccccceEEEeeecCCCceEEEEEEcccc---cccchHHHHHHHHHhcccCCCCcccccceeccCCceEEEEE
Q 003836 503 RGFKEELGRGAFGTVYKGFVNMGSSNHVAVKKLNSV---FQDSEKEFKAEVNGIGQTHHKNLVRLLGYCDEGQNRLLVYE 579 (792)
Q Consensus 503 ~~~~~~lG~G~~g~Vy~g~~~~~~~~~vavK~~~~~---~~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~lV~E 579 (792)
+.+.++||+|+||+||++.. ..+++.||||++.+. .....+.+.+|++++++++|||||++++++.+.+..+||||
T Consensus 34 y~i~~~lG~G~fg~V~~a~~-~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~yivmE 112 (311)
T 4aw0_A 34 FKFGKILGEGSFSTVVLARE-LATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGLS 112 (311)
T ss_dssp EEEEEEEEEETTEEEEEEEE-TTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred cEEEEEEecccCeEEEEEEE-CCCCCEEEEEEEEHHHCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEEe
Confidence 45668999999999999975 456789999999753 23446789999999999999999999999999999999999
Q ss_pred eccCCCccccccCCCCCchhHHHHHHHHHHHHHHHHhhccCCCeEecCCCCCcEEEcCCCCeEEeecCCCccccCCCC-C
Q 003836 580 FMSNGTVASFLFGDSKPNWKLRTEIAMGIAGGLFYLHEECCTQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLDQS-H 658 (792)
Q Consensus 580 ~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dikp~NILl~~~~~~kl~Dfg~a~~~~~~~~-~ 658 (792)
|+++|+|.+++.+...+++.....++.||+.||+|||++ +|+||||||+||||+.++.+||+|||+|+.+..... .
T Consensus 113 y~~gG~L~~~i~~~~~l~e~~~~~~~~qi~~al~ylH~~---~IiHRDlKPeNILl~~~g~vKl~DFGla~~~~~~~~~~ 189 (311)
T 4aw0_A 113 YAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGK---GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQA 189 (311)
T ss_dssp CCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTSCEEECCCTTCEECCTTTTCC
T ss_pred cCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC---CCccCCCCHHHeEEcCCCCEEEEEcCCceecCCCCCcc
Confidence 999999999998888899999999999999999999999 999999999999999999999999999998764433 2
Q ss_pred ccccccccCCcccccccccCCCCcccceehHHHHHHHHHhcCcCCCcchhhhhhhhHHHHHHHhhcccchhHhhhchhcc
Q 003836 659 TNTAIRGTKGYVAPEWFRNMPITVKVDVYSYGVLLLEIICLRRNIDNEISKVDKAILTDWAYDRYQERTLEALVENDLEA 738 (792)
Q Consensus 659 ~~~~~~gt~~y~aPE~~~~~~~~~k~DV~S~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 738 (792)
.....+||+.|||||++.+..++.++||||+||++|||++|+.||........ + ..+.....
T Consensus 190 ~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~---~-------------~~i~~~~~-- 251 (311)
T 4aw0_A 190 RANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEGLI---F-------------AKIIKLEY-- 251 (311)
T ss_dssp CBCCCCSCGGGCCHHHHHHSCBCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHH---H-------------HHHHHTCC--
T ss_pred cccCcccCcccCCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHH---H-------------HHHHcCCC--
Confidence 34457899999999999999999999999999999999999999975432211 1 01111111
Q ss_pred cCCHHHHHHHHHHHHHccccCCCCCCCHHhHH
Q 003836 739 MNNVTMLHRFVMVAFWCIQEDPSHRPTMRKVT 770 (792)
Q Consensus 739 ~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl 770 (792)
..+...++++.+|+.+||+.||++|||++|++
T Consensus 252 ~~p~~~s~~~~dli~~lL~~dp~~R~t~~e~~ 283 (311)
T 4aw0_A 252 DFPEKFFPKARDLVEKLLVLDATKRLGCEEME 283 (311)
T ss_dssp CCCTTCCHHHHHHHHHHSCSSGGGSTTSGGGT
T ss_pred CCCcccCHHHHHHHHHHccCCHhHCcChHHHc
Confidence 12233456788999999999999999999863
|
| >4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-49 Score=429.75 Aligned_cols=258 Identities=24% Similarity=0.347 Sum_probs=210.3
Q ss_pred HhhhhhhcCccccceEEEeeecC----CCceEEEEEEcccccc-cchHHHHHHHHHhcccC-CCCcccccceeccC-Cce
Q 003836 502 TRGFKEELGRGAFGTVYKGFVNM----GSSNHVAVKKLNSVFQ-DSEKEFKAEVNGIGQTH-HKNLVRLLGYCDEG-QNR 574 (792)
Q Consensus 502 ~~~~~~~lG~G~~g~Vy~g~~~~----~~~~~vavK~~~~~~~-~~~~~~~~Ei~~l~~l~-h~niv~l~g~~~~~-~~~ 574 (792)
.+.+.++||+|+||+||+|.+.. ...+.||||++..... ...+.|.+|+++|.+++ |||||+++|+|.+. +..
T Consensus 65 ~~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~k~VAvK~l~~~~~~~~~~~~~~E~~il~~l~hhpnIV~l~g~~~~~~~~~ 144 (353)
T 4ase_A 65 RLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPL 144 (353)
T ss_dssp GEEEEEEEEECSSEEEEEEEEETSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECCTTSCC
T ss_pred HeEEeeEEecCCCeEEEEEEEcCCCcccCCeEEEEEEEccccChHHHHHHHHHHHHHHHcCCCCcEEEEEEEEEecCCEE
Confidence 34556889999999999997643 2346899999976543 34567999999999995 59999999999764 578
Q ss_pred EEEEEeccCCCccccccCC----------------CCCchhHHHHHHHHHHHHHHHHhhccCCCeEecCCCCCcEEEcCC
Q 003836 575 LLVYEFMSNGTVASFLFGD----------------SKPNWKLRTEIAMGIAGGLFYLHEECCTQIIHCDIKPQNILLDDH 638 (792)
Q Consensus 575 ~lV~E~~~~gsL~~~l~~~----------------~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dikp~NILl~~~ 638 (792)
+||||||++|+|.++|+.. ..+++..+..|+.|||+||+|||++ +||||||||+|||++++
T Consensus 145 ~iV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~yLH~~---~iiHRDLK~~NILl~~~ 221 (353)
T 4ase_A 145 MVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASR---KCIHRDLAARNILLSEK 221 (353)
T ss_dssp EEEEECCTTEEHHHHHHHTGGGBCCC-------CTTCBCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGG
T ss_pred EEEEEcCCCCCHHHHHHhcccccccccccchhhccccCCHHHHHHHHHHHHHHHHhHhhC---CeecCccCccceeeCCC
Confidence 9999999999999999642 3478999999999999999999999 99999999999999999
Q ss_pred CCeEEeecCCCccccCCCCCc-cccccccCCcccccccccCCCCcccceehHHHHHHHHHh-cCcCCCcchhhhhhhhHH
Q 003836 639 YNARISDFGLAKLLTLDQSHT-NTAIRGTKGYVAPEWFRNMPITVKVDVYSYGVLLLEIIC-LRRNIDNEISKVDKAILT 716 (792)
Q Consensus 639 ~~~kl~Dfg~a~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~k~DV~S~Gv~l~el~t-g~~p~~~~~~~~~~~~~~ 716 (792)
+.+||+|||+|+....+.... .....||+.|||||++.+..++.++|||||||+||||+| |+.||........
T Consensus 222 ~~vKi~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~y~~ksDVwS~Gv~l~El~t~G~~Pf~~~~~~~~----- 296 (353)
T 4ase_A 222 NVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEE----- 296 (353)
T ss_dssp GCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSHH-----
T ss_pred CCEEECcchhhhhcccCCCceeeccccccccccCHHHHhcCCCCCcccEeehHHHHHHHHhCCCCCCCCCCHHHH-----
Confidence 999999999999775544332 334679999999999999999999999999999999998 8999965432111
Q ss_pred HHHHHhhcccchhHhhhchhcccCCHHHHHHHHHHHHHccccCCCCCCCHHhHHHHhccCcC
Q 003836 717 DWAYDRYQERTLEALVENDLEAMNNVTMLHRFVMVAFWCIQEDPSHRPTMRKVTQMLEGVVE 778 (792)
Q Consensus 717 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~L~~~~~ 778 (792)
+...+....+...+...++++.+++.+||+.||++|||++||+++|+.+++
T Consensus 297 -----------~~~~i~~g~~~~~p~~~~~~~~~li~~c~~~dP~~RPt~~eil~~L~~llq 347 (353)
T 4ase_A 297 -----------FCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQ 347 (353)
T ss_dssp -----------HHHHHHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred -----------HHHHHHcCCCCCCCccCCHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHHH
Confidence 111122222233344456788999999999999999999999999988764
|
| >4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-49 Score=420.85 Aligned_cols=247 Identities=20% Similarity=0.305 Sum_probs=198.5
Q ss_pred hhhhhhcCccccceEEEeeecCCCceEEEEEEccccc--ccchHHHHHHHHHhcccCCCCcccccceeccCCceEEEEEe
Q 003836 503 RGFKEELGRGAFGTVYKGFVNMGSSNHVAVKKLNSVF--QDSEKEFKAEVNGIGQTHHKNLVRLLGYCDEGQNRLLVYEF 580 (792)
Q Consensus 503 ~~~~~~lG~G~~g~Vy~g~~~~~~~~~vavK~~~~~~--~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~lV~E~ 580 (792)
|.+.++||+|+||+||+|.. ..+++.||||++.... ....+.+.+|++++++++|||||++++++.+++..+|||||
T Consensus 26 Y~~~~~lG~G~fg~V~~a~~-~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~yiVmEy 104 (350)
T 4b9d_A 26 YVRLQKIGEGSFGKAILVKS-TEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNIVQYRESFEENGSLYIVMDY 104 (350)
T ss_dssp EEEEEEC------CEEEEEE-TTTCCEEEEEEEECTTSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred eEEeEEEecCCCeEEEEEEE-CCCCCEEEEEEEehHHCCHHHHHHHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEEeC
Confidence 44567899999999999975 4567899999997542 33456799999999999999999999999999999999999
Q ss_pred ccCCCccccccCC--CCCchhHHHHHHHHHHHHHHHHhhccCCCeEecCCCCCcEEEcCCCCeEEeecCCCccccCCCCC
Q 003836 581 MSNGTVASFLFGD--SKPNWKLRTEIAMGIAGGLFYLHEECCTQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLDQSH 658 (792)
Q Consensus 581 ~~~gsL~~~l~~~--~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dikp~NILl~~~~~~kl~Dfg~a~~~~~~~~~ 658 (792)
+++|+|.++|... ..+++..+..|+.||+.||+|||++ +|+||||||+||||++++.+||+|||+|+...... .
T Consensus 105 ~~gg~L~~~i~~~~~~~~~e~~~~~~~~qi~~aL~ylH~~---~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~~-~ 180 (350)
T 4b9d_A 105 CEGGDLFKRINAQKGVLFQEDQILDWFVQICLALKHVHDR---KILHRDIKSQNIFLTKDGTVQLGDFGIARVLNSTV-E 180 (350)
T ss_dssp CTTCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHT---TCEETTCCGGGEEECTTCCEEECSTTEESCCCHHH-H
T ss_pred CCCCcHHHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCCHHHEEECCCCCEEEcccccceeecCCc-c
Confidence 9999999999654 4568889999999999999999999 99999999999999999999999999998764321 1
Q ss_pred ccccccccCCcccccccccCCCCcccceehHHHHHHHHHhcCcCCCcchhhhhhhhHHHHHHHhhcccchhHhhhchhcc
Q 003836 659 TNTAIRGTKGYVAPEWFRNMPITVKVDVYSYGVLLLEIICLRRNIDNEISKVDKAILTDWAYDRYQERTLEALVENDLEA 738 (792)
Q Consensus 659 ~~~~~~gt~~y~aPE~~~~~~~~~k~DV~S~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 738 (792)
.....+||+.|||||++.+..|+.++|||||||+||||++|+.||........ + ..++.... .
T Consensus 181 ~~~~~~GT~~YmAPE~l~~~~y~~~~DiwSlGvilyemltG~~PF~~~~~~~~---~-------------~~i~~~~~-~ 243 (350)
T 4b9d_A 181 LARACIGTPYYLSPEICENKPYNNKSDIWALGCVLYELCTLKHAFEAGSMKNL---V-------------LKIISGSF-P 243 (350)
T ss_dssp HHHHHHSCCTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHH---H-------------HHHHHTCC-C
T ss_pred cccccCCCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHH---H-------------HHHHcCCC-C
Confidence 22346799999999999999999999999999999999999999976432211 1 01111111 1
Q ss_pred cCCHHHHHHHHHHHHHccccCCCCCCCHHhHHH
Q 003836 739 MNNVTMLHRFVMVAFWCIQEDPSHRPTMRKVTQ 771 (792)
Q Consensus 739 ~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~ 771 (792)
..+...+.++.+|+.+||+.||++|||++|+++
T Consensus 244 ~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~l~ 276 (350)
T 4b9d_A 244 PVSLHYSYDLRSLVSQLFKRNPRDRPSVNSILE 276 (350)
T ss_dssp CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred CCCccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 122345567899999999999999999999986
|
| >3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.3e-49 Score=417.12 Aligned_cols=267 Identities=22% Similarity=0.275 Sum_probs=199.3
Q ss_pred hhhhcCccccceEEEeeecCCCceEEEEEEcccccccchHHHHHHHHHhcccCCCCcccccceeccCC----ceEEEEEe
Q 003836 505 FKEELGRGAFGTVYKGFVNMGSSNHVAVKKLNSVFQDSEKEFKAEVNGIGQTHHKNLVRLLGYCDEGQ----NRLLVYEF 580 (792)
Q Consensus 505 ~~~~lG~G~~g~Vy~g~~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~----~~~lV~E~ 580 (792)
+.++||+|+||+||+|++. ++.||||+++... .....++.|+..+.+++|||||+++|+|.+++ ..+|||||
T Consensus 7 L~~~iG~G~fG~Vy~~~~~---g~~VAvK~l~~~~-~~~~~~e~Ei~~~~~l~HpNIv~l~g~~~~~~~~~~~~~lV~Ey 82 (303)
T 3hmm_A 7 LQESIGKGRFGEVWRGKWR---GEEVAVKIFSSRE-ERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVSDY 82 (303)
T ss_dssp EEEEEEECSSSEEEEEEET---TEEEEEEEECGGG-HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEEEEC
T ss_pred EEEEEeeCCCeEEEEEEEC---CEEEEEEEECccc-hhhHHHHHHHHHHhcCCCCCCCcEEEEEEecCCCceEEEEEecC
Confidence 4578999999999999863 5789999997532 22334556777888999999999999997654 57999999
Q ss_pred ccCCCccccccCCCCCchhHHHHHHHHHHHHHHHHhhcc-----CCCeEecCCCCCcEEEcCCCCeEEeecCCCccccCC
Q 003836 581 MSNGTVASFLFGDSKPNWKLRTEIAMGIAGGLFYLHEEC-----CTQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLD 655 (792)
Q Consensus 581 ~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~-----~~~ivH~dikp~NILl~~~~~~kl~Dfg~a~~~~~~ 655 (792)
|++|+|.++|+. ..+++..+.+|+.|+++||+|||+++ .++|+||||||+||||++++++||+|||+|+.....
T Consensus 83 ~~~gsL~~~l~~-~~l~~~~~~~i~~~ia~gl~ylH~~~~~~~~~~~IiHRDlKp~NILl~~~~~~Ki~DFGla~~~~~~ 161 (303)
T 3hmm_A 83 HEHGSLFDYLNR-YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSA 161 (303)
T ss_dssp CTTCBHHHHHHH-CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCCEECSCCCGGGEEECTTSCEEECCCTTCEEEETT
T ss_pred CCCCcHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCEeeccCCcccEEECCCCCEEEEeCCCCccccCC
Confidence 999999999965 46899999999999999999999863 358999999999999999999999999999876544
Q ss_pred CCC---ccccccccCCcccccccccC------CCCcccceehHHHHHHHHHhcCcCCCcchhhhhhhhHHHHHHHh-hcc
Q 003836 656 QSH---TNTAIRGTKGYVAPEWFRNM------PITVKVDVYSYGVLLLEIICLRRNIDNEISKVDKAILTDWAYDR-YQE 725 (792)
Q Consensus 656 ~~~---~~~~~~gt~~y~aPE~~~~~------~~~~k~DV~S~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~-~~~ 725 (792)
... ......||+.|||||++.+. .++.|+|||||||+||||+||+.|+........... ...... ..+
T Consensus 162 ~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~~~~~~~k~DVwS~Gvvl~El~tg~~~~~~~~~~~~p~~--~~~~~~~~~~ 239 (303)
T 3hmm_A 162 TDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYY--DLVPSDPSVE 239 (303)
T ss_dssp TTEESCC-----CCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTT--TTSCSSCCHH
T ss_pred CCceeeecccccccccccCHHHhcccccccCCccChhHhhhhHHHHHHHHHHCCCCCCccccccccch--hcccccchHH
Confidence 332 12345799999999998754 477899999999999999999887753321100000 000000 000
Q ss_pred cchhHhhhchhcccC-----CHHHHHHHHHHHHHccccCCCCCCCHHhHHHHhccCcC
Q 003836 726 RTLEALVENDLEAMN-----NVTMLHRFVMVAFWCIQEDPSHRPTMRKVTQMLEGVVE 778 (792)
Q Consensus 726 ~~~~~~~~~~~~~~~-----~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~L~~~~~ 778 (792)
.....+.....++.. +.+.+..+.+|+.+||+.||++||||.||+++|+.+.+
T Consensus 240 ~~~~~~~~~~~rp~~p~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~L~~l~~ 297 (303)
T 3hmm_A 240 EMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQ 297 (303)
T ss_dssp HHHHHHTTSCCCCCCCGGGGSSHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHHHHHH
T ss_pred HHHHHHhcccCCCCCCccccchHHHHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHHH
Confidence 001111222222221 23567789999999999999999999999999987653
|
| >4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-48 Score=424.74 Aligned_cols=248 Identities=23% Similarity=0.312 Sum_probs=206.9
Q ss_pred hhhhhcCccccceEEEeeecCCCceEEEEEEcccccccchHHHHHHHHHhcccCCCCcccccceeccCCceEEEEEeccC
Q 003836 504 GFKEELGRGAFGTVYKGFVNMGSSNHVAVKKLNSVFQDSEKEFKAEVNGIGQTHHKNLVRLLGYCDEGQNRLLVYEFMSN 583 (792)
Q Consensus 504 ~~~~~lG~G~~g~Vy~g~~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~lV~E~~~~ 583 (792)
.+.++||+|+||.||+|.. ..+++.||||++........+.+.+|+.+|++++|||||++++++.+.+..|||||||++
T Consensus 154 ~~~~~iG~G~fG~V~~a~~-~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~iVmEy~~g 232 (423)
T 4fie_A 154 DNFIKIGEGSTGIVCIATV-RSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEG 232 (423)
T ss_dssp EEEEEEEECSSCEEEEEEE-TTTCCEEEEEEEESTTCSSGGGHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCTT
T ss_pred EeeeEeccCcCcEEEEEEE-CCCCCEEEEEEEeccchhHHHHHHHHHHHHHhCCCCCCCceEEEEEECCEEEEEEeCCCC
Confidence 3457899999999999975 456789999999876666677899999999999999999999999999999999999999
Q ss_pred CCccccccCCCCCchhHHHHHHHHHHHHHHHHhhccCCCeEecCCCCCcEEEcCCCCeEEeecCCCccccCCCCCccccc
Q 003836 584 GTVASFLFGDSKPNWKLRTEIAMGIAGGLFYLHEECCTQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLDQSHTNTAI 663 (792)
Q Consensus 584 gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dikp~NILl~~~~~~kl~Dfg~a~~~~~~~~~~~~~~ 663 (792)
|+|.+++.. ..+++..+..|+.||+.||+|||++ +||||||||+||||+.++.+||+|||+|+.+..... .....
T Consensus 233 G~L~~~i~~-~~l~e~~~~~~~~qil~aL~ylH~~---~IiHRDiKp~NILl~~~g~vKl~DFGla~~~~~~~~-~~~~~ 307 (423)
T 4fie_A 233 GALTDIVTH-TRMNEEQIAAVCLAVLQALSVLHAQ---GVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVP-RRKSL 307 (423)
T ss_dssp EEHHHHHHH-SCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSTTTEEECTTCCEEECCCTTCEECCSSCC-CBCCC
T ss_pred CcHHHHHhc-cCCCHHHHHHHHHHHHHHHHHHHHC---CeecccCCHHHEEEcCCCCEEEecCccceECCCCCc-ccccc
Confidence 999999864 4689999999999999999999999 999999999999999999999999999997654322 33456
Q ss_pred cccCCcccccccccCCCCcccceehHHHHHHHHHhcCcCCCcchhhhhhhhHHHHHHHhhcccchhHhhhchhcccCCHH
Q 003836 664 RGTKGYVAPEWFRNMPITVKVDVYSYGVLLLEIICLRRNIDNEISKVDKAILTDWAYDRYQERTLEALVENDLEAMNNVT 743 (792)
Q Consensus 664 ~gt~~y~aPE~~~~~~~~~k~DV~S~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 743 (792)
+||+.|||||++.+..|+.++|||||||++|||++|+.||.......... . .... ... .......
T Consensus 308 ~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~---~-----i~~~-----~~~--~~~~~~~ 372 (423)
T 4fie_A 308 VGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMK---M-----IRDN-----LPP--RLKNLHK 372 (423)
T ss_dssp EECTTTCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHH---H-----HHHS-----CCC--CCSCTTS
T ss_pred ccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHH---H-----HHcC-----CCC--CCccccc
Confidence 89999999999999999999999999999999999999997543221100 0 0000 000 0111223
Q ss_pred HHHHHHHHHHHccccCCCCCCCHHhHHHH
Q 003836 744 MLHRFVMVAFWCIQEDPSHRPTMRKVTQM 772 (792)
Q Consensus 744 ~~~~l~~l~~~Cl~~~p~~RPs~~evl~~ 772 (792)
.+.++.+|+.+||+.||++|||++|+++.
T Consensus 373 ~s~~~~dli~~~L~~dP~~R~ta~ell~H 401 (423)
T 4fie_A 373 VSPSLKGFLDRLLVRDPAQRATAAELLKH 401 (423)
T ss_dssp SCHHHHHHHHHHSCSSTTTSCCHHHHTTC
T ss_pred CCHHHHHHHHHHcCCChhHCcCHHHHhcC
Confidence 45678899999999999999999999873
|
| >3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-47 Score=398.87 Aligned_cols=244 Identities=23% Similarity=0.391 Sum_probs=191.2
Q ss_pred hhhhhhcCccccceEEEeeecCCCceEEEEEEccccc---ccchHHHHHHHHHhcccCCCCcccccceeccCCceEEEEE
Q 003836 503 RGFKEELGRGAFGTVYKGFVNMGSSNHVAVKKLNSVF---QDSEKEFKAEVNGIGQTHHKNLVRLLGYCDEGQNRLLVYE 579 (792)
Q Consensus 503 ~~~~~~lG~G~~g~Vy~g~~~~~~~~~vavK~~~~~~---~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~lV~E 579 (792)
+.+.+.||+|+||+||+|.. ..+++.||||++.+.. ....+.+.+|++++++++|||||++++++.+.+..++|||
T Consensus 15 Y~i~~~lG~G~fg~V~~~~~-~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivmE 93 (275)
T 3hyh_A 15 YQIVKTLGEGSFGKVKLAYH-TTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYDVIKSKDEIIMVIE 93 (275)
T ss_dssp CEEEEEEEC---CCEEEEEC-TTTCCEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred eEEEEEEecCcCeEEEEEEE-CCCCCEEEEEEEeHHHcCCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEEe
Confidence 45668899999999999964 4567899999997532 2345679999999999999999999999999999999999
Q ss_pred eccCCCccccccCCCCCchhHHHHHHHHHHHHHHHHhhccCCCeEecCCCCCcEEEcCCCCeEEeecCCCccccCCCCCc
Q 003836 580 FMSNGTVASFLFGDSKPNWKLRTEIAMGIAGGLFYLHEECCTQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLDQSHT 659 (792)
Q Consensus 580 ~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dikp~NILl~~~~~~kl~Dfg~a~~~~~~~~~~ 659 (792)
|+ +|+|.+++.....+++.....++.||+.||+|||++ +|+||||||+||||++++.+||+|||+|+..... ..
T Consensus 94 y~-~g~L~~~l~~~~~l~e~~~~~~~~qi~~al~ylH~~---~IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~~--~~ 167 (275)
T 3hyh_A 94 YA-GNELFDYIVQRDKMSEQEARRFFQQIISAVEYCHRH---KIVHRDLKPENLLLDEHLNVKIADFGLSNIMTDG--NF 167 (275)
T ss_dssp CC-CEEHHHHHHHSCSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCTTTEEECTTCCEEECCSSCC----------
T ss_pred CC-CCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC---CcccccCChHHeEECCCCCEEEeecCCCeecCCC--Cc
Confidence 99 679999998888999999999999999999999999 9999999999999999999999999999875432 22
Q ss_pred cccccccCCcccccccccCCC-CcccceehHHHHHHHHHhcCcCCCcchhhhhhhhHHHHHHHhhcccchhHhhhchhcc
Q 003836 660 NTAIRGTKGYVAPEWFRNMPI-TVKVDVYSYGVLLLEIICLRRNIDNEISKVDKAILTDWAYDRYQERTLEALVENDLEA 738 (792)
Q Consensus 660 ~~~~~gt~~y~aPE~~~~~~~-~~k~DV~S~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 738 (792)
....+||+.|||||++.+..+ +.++||||+||++|||+||+.||....... .+.. +.... .
T Consensus 168 ~~~~~GT~~Y~APE~~~~~~y~~~~~DiwSlGvily~lltg~~PF~~~~~~~---~~~~-------------i~~~~--~ 229 (275)
T 3hyh_A 168 LKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYVMLCRRLPFDDESIPV---LFKN-------------ISNGV--Y 229 (275)
T ss_dssp -------CTTSCHHHHSSSSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH---HHHH-------------HHHTC--C
T ss_pred cCCeeECcccCChhhhcCCCCCCChhhhHHHHHHHHHHHHCCCCCCCCCHHH---HHHH-------------HHcCC--C
Confidence 345679999999999998876 579999999999999999999997643211 1100 01110 1
Q ss_pred cCCHHHHHHHHHHHHHccccCCCCCCCHHhHHH
Q 003836 739 MNNVTMLHRFVMVAFWCIQEDPSHRPTMRKVTQ 771 (792)
Q Consensus 739 ~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~ 771 (792)
..+...++++.+++.+||+.||++|||++|+++
T Consensus 230 ~~p~~~s~~~~~li~~~L~~dP~~R~s~~eil~ 262 (275)
T 3hyh_A 230 TLPKFLSPGAAGLIKRMLIVNPLNRISIHEIMQ 262 (275)
T ss_dssp CCCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred CCCCCCCHHHHHHHHHHccCChhHCcCHHHHHc
Confidence 112234567889999999999999999999987
|
| >3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-48 Score=409.93 Aligned_cols=247 Identities=21% Similarity=0.243 Sum_probs=197.7
Q ss_pred hhhhhhcCccccceEEEeeec--CCCceEEEEEEccccc--ccchHHHHHHHHHhcccCCCCcccccceeccCCceEEEE
Q 003836 503 RGFKEELGRGAFGTVYKGFVN--MGSSNHVAVKKLNSVF--QDSEKEFKAEVNGIGQTHHKNLVRLLGYCDEGQNRLLVY 578 (792)
Q Consensus 503 ~~~~~~lG~G~~g~Vy~g~~~--~~~~~~vavK~~~~~~--~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~lV~ 578 (792)
+.+.+.||+|+||+||+++.. ..+++.||||++++.. ......+.+|++++++++|||||++++++.+++..+|||
T Consensus 26 Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~ivm 105 (304)
T 3ubd_A 26 FELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFIVKLHYAFQTEGKLYLIL 105 (304)
T ss_dssp EEEEEEEECGGGCEEEEEEECSSTTTTCEEEEEEEESEEEEEEECC------CCCCCCCCTTEECEEEEEEETTEEEEEE
T ss_pred cEEEEEEecCCCeEEEEEEEccCCCCCEEEEEEEEehHHcChHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEE
Confidence 456689999999999999753 2356789999997542 223457889999999999999999999999999999999
Q ss_pred EeccCCCccccccCCCCCchhHHHHHHHHHHHHHHHHhhccCCCeEecCCCCCcEEEcCCCCeEEeecCCCccccCCCCC
Q 003836 579 EFMSNGTVASFLFGDSKPNWKLRTEIAMGIAGGLFYLHEECCTQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLDQSH 658 (792)
Q Consensus 579 E~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dikp~NILl~~~~~~kl~Dfg~a~~~~~~~~~ 658 (792)
||+++|+|.+++.+...+++..+..++.||+.||+|||++ +|+||||||+|||+++++.+||+|||+|+...... .
T Consensus 106 Ey~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~ylH~~---~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~~-~ 181 (304)
T 3ubd_A 106 DFLRGGDLFTRLSKEVMFTEEDVKFYLAELALALDHLHSL---GIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHE-K 181 (304)
T ss_dssp CCCTTCEEHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSSCCGGGEEECTTSCEEEESSEEEEC------C
T ss_pred EcCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---CCcCCCCCHHHeEEcCCCCEEecccccceeccCCC-c
Confidence 9999999999998888899999999999999999999999 99999999999999999999999999998654332 2
Q ss_pred ccccccccCCcccccccccCCCCcccceehHHHHHHHHHhcCcCCCcchhhhhhhhHHHHHHHhhcccchhHhhhchhcc
Q 003836 659 TNTAIRGTKGYVAPEWFRNMPITVKVDVYSYGVLLLEIICLRRNIDNEISKVDKAILTDWAYDRYQERTLEALVENDLEA 738 (792)
Q Consensus 659 ~~~~~~gt~~y~aPE~~~~~~~~~k~DV~S~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 738 (792)
.....+||+.|||||++.+..++.++|||||||++|||+||+.||........ + ..+.... .
T Consensus 182 ~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~PF~~~~~~~~---~-------------~~i~~~~--~ 243 (304)
T 3ubd_A 182 KAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLPFQGKDRKET---M-------------TMILKAK--L 243 (304)
T ss_dssp CCCSCCCCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH---H-------------HHHHHCC--C
T ss_pred cccccccCcccCCHHHhccCCCCCCCcccchHHHHHHHHhCCCCCCCcCHHHH---H-------------HHHHcCC--C
Confidence 23456799999999999999999999999999999999999999976432211 1 0111111 1
Q ss_pred cCCHHHHHHHHHHHHHccccCCCCCCC-----HHhHHH
Q 003836 739 MNNVTMLHRFVMVAFWCIQEDPSHRPT-----MRKVTQ 771 (792)
Q Consensus 739 ~~~~~~~~~l~~l~~~Cl~~~p~~RPs-----~~evl~ 771 (792)
..+...++++.+|+.+||+.||++||| ++|+++
T Consensus 244 ~~p~~~s~~~~~li~~~L~~dP~~R~ta~~~~~~eil~ 281 (304)
T 3ubd_A 244 GMPQFLSPEAQSLLRMLFKRNPANRLGAGPDGVEEIKR 281 (304)
T ss_dssp CCCTTSCHHHHHHHHHHTCSSGGGSTTCSTTTHHHHHT
T ss_pred CCCCcCCHHHHHHHHHHcccCHHHCCCCCcCCHHHHHc
Confidence 122334567889999999999999998 467765
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-46 Score=395.69 Aligned_cols=246 Identities=21% Similarity=0.337 Sum_probs=185.0
Q ss_pred hhhhhhcCccccceEEEeeecCCCceEEEEEEcccccc-cchHHHHHHHHHhcccCCCCcccccceeccCC---------
Q 003836 503 RGFKEELGRGAFGTVYKGFVNMGSSNHVAVKKLNSVFQ-DSEKEFKAEVNGIGQTHHKNLVRLLGYCDEGQ--------- 572 (792)
Q Consensus 503 ~~~~~~lG~G~~g~Vy~g~~~~~~~~~vavK~~~~~~~-~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~--------- 572 (792)
+.+.+.||+|+||+||+|... .+++.||||+++.... ...+.+.+|++++++++|||||++++++.+.+
T Consensus 7 y~~~~~lG~G~fg~V~~a~~~-~~~~~vAiK~i~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~~~ 85 (299)
T 4g31_A 7 FEPIQCLGRGGFGVVFEAKNK-VDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLEKNTTEKLQPSS 85 (299)
T ss_dssp EEEEEEEEECC--EEEEEEET-TTCCEEEEEEEEECSSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEEC---------
T ss_pred CEEeeEEecCCCeEEEEEEEC-CCCCEEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEecCccccccccC
Confidence 345678999999999999754 5678999999875433 34467999999999999999999999986544
Q ss_pred ---ceEEEEEeccCCCccccccCCCCC---chhHHHHHHHHHHHHHHHHhhccCCCeEecCCCCCcEEEcCCCCeEEeec
Q 003836 573 ---NRLLVYEFMSNGTVASFLFGDSKP---NWKLRTEIAMGIAGGLFYLHEECCTQIIHCDIKPQNILLDDHYNARISDF 646 (792)
Q Consensus 573 ---~~~lV~E~~~~gsL~~~l~~~~~l---~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dikp~NILl~~~~~~kl~Df 646 (792)
..++||||+++|+|.+++.....+ .+..+..|+.||+.||+|||++ +|+||||||+||||+.++.+||+||
T Consensus 86 ~~~~l~ivmE~~~gg~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~ylH~~---~IiHRDlKp~NILl~~~~~vKl~DF 162 (299)
T 4g31_A 86 PKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAEAVEFLHSK---GLMHRDLKPSNIFFTMDDVVKVGDF 162 (299)
T ss_dssp -CEEEEEEEECCCSCCHHHHHHTCCSGGGSCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEECCC
T ss_pred CCcEEEEEEecCCCCcHHHHHHhcCCCChhHHHHHHHHHHHHHHHHHHHHHC---cCccccCcHHHeEECCCCcEEEccC
Confidence 368999999999999999876543 4456788999999999999999 9999999999999999999999999
Q ss_pred CCCccccCCCCC-----------ccccccccCCcccccccccCCCCcccceehHHHHHHHHHhcCcCCCcchhhhhhhhH
Q 003836 647 GLAKLLTLDQSH-----------TNTAIRGTKGYVAPEWFRNMPITVKVDVYSYGVLLLEIICLRRNIDNEISKVDKAIL 715 (792)
Q Consensus 647 g~a~~~~~~~~~-----------~~~~~~gt~~y~aPE~~~~~~~~~k~DV~S~Gv~l~el~tg~~p~~~~~~~~~~~~~ 715 (792)
|+|+.+...... ..+..+||+.|||||++.+..++.++|||||||++|||++ ||........ .+
T Consensus 163 Gla~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyell~---Pf~~~~~~~~--~~ 237 (299)
T 4g31_A 163 GLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLY---PFSTQMERVR--TL 237 (299)
T ss_dssp CCC--------------------------CCCTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHS---CCSSHHHHHH--HH
T ss_pred ccceecCCCccccccccccccccccCCcccCccccCHHHHcCCCCCCHHHHHHHHHHHHHHcc---CCCCccHHHH--HH
Confidence 999987543321 1233579999999999999999999999999999999996 7754322111 00
Q ss_pred HHHHHHhhcccchhHhhhchhcccCCHHHHHHHHHHHHHccccCCCCCCCHHhHHH
Q 003836 716 TDWAYDRYQERTLEALVENDLEAMNNVTMLHRFVMVAFWCIQEDPSHRPTMRKVTQ 771 (792)
Q Consensus 716 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~ 771 (792)
......... .......+.+.+++.+||+.||++|||+.|+++
T Consensus 238 -----~~~~~~~~p---------~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~ 279 (299)
T 4g31_A 238 -----TDVRNLKFP---------PLFTQKYPCEYVMVQDMLSPSPMERPEAINIIE 279 (299)
T ss_dssp -----HHHHTTCCC---------HHHHHHCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred -----HHHhcCCCC---------CCCcccCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 000000000 011223455678999999999999999999987
|
| >4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.6e-44 Score=386.97 Aligned_cols=261 Identities=18% Similarity=0.261 Sum_probs=197.1
Q ss_pred hhhhhhcCccccceEEEeeec--CCCceEEEEEEcccccccchHHHHHHHHHhccc-CCCCcccccceeccCCceEEEEE
Q 003836 503 RGFKEELGRGAFGTVYKGFVN--MGSSNHVAVKKLNSVFQDSEKEFKAEVNGIGQT-HHKNLVRLLGYCDEGQNRLLVYE 579 (792)
Q Consensus 503 ~~~~~~lG~G~~g~Vy~g~~~--~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l-~h~niv~l~g~~~~~~~~~lV~E 579 (792)
+.+.++||+|+||+||+|+.. ..+++.||+|++... ....++.+|++++.++ +|||||++++++.+.++.+||||
T Consensus 23 Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~--~~~~~~~~E~~~l~~~~~h~nIv~l~~~~~~~~~~~lvmE 100 (361)
T 4f9c_A 23 FKIEDKIGEGTFSSVYLATAQLQVGPEEKIALKHLIPT--SHPIRIAAELQCLTVAGGQDNVMGVKYCFRKNDHVVIAMP 100 (361)
T ss_dssp CEEEEEEEECSSEEEEEEEEEBTTSCEEEEEEEEECTT--SCHHHHHHHHHHHHHTCSBTTBCCCSEEEEETTEEEEEEE
T ss_pred EEEEEEEecccCcEEEEEEEcccCCCCCEEEEEEEccc--cCHHHHHHHHHHHHHhcCCCCCceEEEEEEECCEEEEEEe
Confidence 445678999999999999753 346789999998653 3456788999999998 69999999999999999999999
Q ss_pred eccCCCccccccCCCCCchhHHHHHHHHHHHHHHHHhhccCCCeEecCCCCCcEEEcCC-CCeEEeecCCCccccCCCC-
Q 003836 580 FMSNGTVASFLFGDSKPNWKLRTEIAMGIAGGLFYLHEECCTQIIHCDIKPQNILLDDH-YNARISDFGLAKLLTLDQS- 657 (792)
Q Consensus 580 ~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dikp~NILl~~~-~~~kl~Dfg~a~~~~~~~~- 657 (792)
|+++|+|.+++. .+++.++..++.||+.||+|||++ +|+||||||+|||++.+ +.+||+|||+|+.......
T Consensus 101 ~~~g~~L~~~~~---~l~~~~~~~~~~qll~al~ylH~~---gIiHRDiKPeNiLl~~~~~~~kl~DFGla~~~~~~~~~ 174 (361)
T 4f9c_A 101 YLEHESFLDILN---SLSFQEVREYMLNLFKALKRIHQF---GIVHRDVKPSNFLYNRRLKKYALVDFGLAQGTHDTKIE 174 (361)
T ss_dssp CCCCCCHHHHHT---TCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEETTTTEEEECCCTTCEECTTCSCG
T ss_pred CCCcccHHHHHc---CCCHHHHHHHHHHHHHHHHHHHHC---CeEeCcCCHHHeEEeCCCCeEEECcCCCCcccCCcccc
Confidence 999999999984 589999999999999999999999 99999999999999877 7999999999986543211
Q ss_pred --------------------------CccccccccCCcccccccccC-CCCcccceehHHHHHHHHHhcCcCCCcchhhh
Q 003836 658 --------------------------HTNTAIRGTKGYVAPEWFRNM-PITVKVDVYSYGVLLLEIICLRRNIDNEISKV 710 (792)
Q Consensus 658 --------------------------~~~~~~~gt~~y~aPE~~~~~-~~~~k~DV~S~Gv~l~el~tg~~p~~~~~~~~ 710 (792)
......+||+.|+|||++.+. .++.++||||+||++|||++|+.||.......
T Consensus 175 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~y~~~~DiWSlG~il~ell~G~~Pf~~~~~~~ 254 (361)
T 4f9c_A 175 LLKFVQSEAQQERCSQNKCSICLSRRQQVAPRAGTPGFRAPEVLTKCPNQTTAIDMWSAGVIFLSLLSGRYPFYKASDDL 254 (361)
T ss_dssp GGGGC--------------------------CCCCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHH
T ss_pred ccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCCccchhhhHHHHHHHHHCCCCCCCCCCHH
Confidence 112335799999999999775 58999999999999999999999996544322
Q ss_pred hhhhH-HH-------HHHH-hhc----------ccchhHhhhch------------------hcccCCHHHHHHHHHHHH
Q 003836 711 DKAIL-TD-------WAYD-RYQ----------ERTLEALVEND------------------LEAMNNVTMLHRFVMVAF 753 (792)
Q Consensus 711 ~~~~~-~~-------~~~~-~~~----------~~~~~~~~~~~------------------~~~~~~~~~~~~l~~l~~ 753 (792)
+.... .. .... ... ......+.... .........++++.+|+.
T Consensus 255 ~~l~~I~~~~G~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~is~~a~DLl~ 334 (361)
T 4f9c_A 255 TALAQIMTIRGSRETIQAAKTFGKSILCSKEVPAQDLRKLCERLRGMDSSTPKLTSDIQGHATNLEGWNEVPDEAYDLLD 334 (361)
T ss_dssp HHHHHHHHHHCHHHHHHHHHHTTEEEEESSCCCCCCHHHHHHHHC----------------------CTTCCHHHHHHHH
T ss_pred HHHHHHHHhcCCccchhhhhhccccccccccCcchhhhHHHHhhccccccccccccccccccccccccccCCHHHHHHHH
Confidence 21100 00 0000 000 00000000000 000001123467889999
Q ss_pred HccccCCCCCCCHHhHHH
Q 003836 754 WCIQEDPSHRPTMRKVTQ 771 (792)
Q Consensus 754 ~Cl~~~p~~RPs~~evl~ 771 (792)
+||+.||++|||++|+++
T Consensus 335 ~lL~~dP~~R~ta~eaL~ 352 (361)
T 4f9c_A 335 KLLDLNPASRITAEEALL 352 (361)
T ss_dssp HHTCSCTTTSCCHHHHHT
T ss_pred HHCcCChhHCcCHHHHhc
Confidence 999999999999999998
|
| >4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-43 Score=388.99 Aligned_cols=265 Identities=20% Similarity=0.267 Sum_probs=201.0
Q ss_pred hhhhhhcCccccceEEEeeecCCCceEEEEEEcccccc--cchHHHHHHHHHhcccCCCCcccccceec------cCCce
Q 003836 503 RGFKEELGRGAFGTVYKGFVNMGSSNHVAVKKLNSVFQ--DSEKEFKAEVNGIGQTHHKNLVRLLGYCD------EGQNR 574 (792)
Q Consensus 503 ~~~~~~lG~G~~g~Vy~g~~~~~~~~~vavK~~~~~~~--~~~~~~~~Ei~~l~~l~h~niv~l~g~~~------~~~~~ 574 (792)
+.+.++||+|+||+||+|.. ..+++.||||++++... ...+.+.+|+++|++++|||||++++++. +.+..
T Consensus 56 Y~~~~~lG~G~fG~V~~a~~-~~t~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~~~~ 134 (398)
T 4b99_A 56 YEIIETIGNGAYGVVSSARR-RLTGQQVAIKKIPNAFDVVTNAKRTLRELKILKHFKHDNIIAIKDILRPTVPYGEFKSV 134 (398)
T ss_dssp EEEEEEEEECSSCEEEEEEE-TTTCCEEEEEEETTTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSSCTTTCCCE
T ss_pred eEEEEEEecccCeEEEEEEE-CCCCCEEEEEEECccccchHHHHHHHHHHHHHHhcCCCCcceEeeeeecccccccCCEE
Confidence 44567899999999999965 45678999999975432 33467889999999999999999999875 34678
Q ss_pred EEEEEeccCCCccccccCCCCCchhHHHHHHHHHHHHHHHHhhccCCCeEecCCCCCcEEEcCCCCeEEeecCCCccccC
Q 003836 575 LLVYEFMSNGTVASFLFGDSKPNWKLRTEIAMGIAGGLFYLHEECCTQIIHCDIKPQNILLDDHYNARISDFGLAKLLTL 654 (792)
Q Consensus 575 ~lV~E~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dikp~NILl~~~~~~kl~Dfg~a~~~~~ 654 (792)
+||||||+ |+|.+++.....+++..+..++.||+.||+|||++ +|+||||||+|||++.++.+||+|||+|+.+..
T Consensus 135 ~ivmE~~~-g~L~~~i~~~~~l~~~~~~~~~~qil~al~ylH~~---~iiHRDlKP~NIl~~~~~~~Ki~DFGla~~~~~ 210 (398)
T 4b99_A 135 YVVLDLME-SDLHQIIHSSQPLTLEHVRYFLYQLLRGLKYMHSA---QVIHRDLKPSNLLVNENCELKIGDFGMARGLCT 210 (398)
T ss_dssp EEEEECCS-EEHHHHHTSSSCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTCCEEECCCTTCBCC--
T ss_pred EEEEeCCC-CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---cCcCCCcCccccccCCCCCEEEeecceeeeccc
Confidence 99999996 68999998888999999999999999999999999 999999999999999999999999999987643
Q ss_pred CC---CCccccccccCCcccccccccC-CCCcccceehHHHHHHHHHhcCcCCCcchhhhhhhhHHHHHHH----hh---
Q 003836 655 DQ---SHTNTAIRGTKGYVAPEWFRNM-PITVKVDVYSYGVLLLEIICLRRNIDNEISKVDKAILTDWAYD----RY--- 723 (792)
Q Consensus 655 ~~---~~~~~~~~gt~~y~aPE~~~~~-~~~~k~DV~S~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~----~~--- 723 (792)
.. .......+||+.|||||++.+. .++.++||||+||++|||++|+.||...........+...... .+
T Consensus 211 ~~~~~~~~~~~~~GT~~Y~APEv~~~~~~~~~~~DiWSlG~il~ell~G~~pF~g~~~~~~l~~I~~~~g~p~~~~~~~~ 290 (398)
T 4b99_A 211 SPAEHQYFMTEYVATRWYRAPELMLSLHEYTQAIDLWSVGCIFGEMLARRQLFPGKNYVHQLQLIMMVLGTPSPAVIQAV 290 (398)
T ss_dssp -----CCCCCSSCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHHHHHCCCCGGGTC--
T ss_pred CccccccccccceeChHhcCHHHhcCCCCCCChhheehhHHHHHHHHHCCCCCCCCCHHHHHHHHHHhcCCCChHHhhhh
Confidence 32 2233457899999999998775 5699999999999999999999999765432211111110000 00
Q ss_pred cccchhHhhhchh-cccCC-----HHHHHHHHHHHHHccccCCCCCCCHHhHHHH
Q 003836 724 QERTLEALVENDL-EAMNN-----VTMLHRFVMVAFWCIQEDPSHRPTMRKVTQM 772 (792)
Q Consensus 724 ~~~~~~~~~~~~~-~~~~~-----~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~ 772 (792)
........+.... ....+ ...+.++.+|+.+||+.||++|||++|+++.
T Consensus 291 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~H 345 (398)
T 4b99_A 291 GAERVRAYIQSLPPRQPVPWETVYPGADRQALSLLGRMLRFEPSARISAAAALRH 345 (398)
T ss_dssp ---CHHHHHHSSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSTTTSCCHHHHTTS
T ss_pred hhhhhhhhhhcCCCcCCCCHHHhCCCCCHHHHHHHHHHCcCChhHCcCHHHHhcC
Confidence 0000001110000 00000 1234678899999999999999999999874
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-43 Score=377.91 Aligned_cols=290 Identities=42% Similarity=0.690 Sum_probs=243.9
Q ss_pred cccCccccCHHHHHHHHhhhh--hhcCccccceEEEeeecCCCceEEEEEEcccccc-cchHHHHHHHHHhcccCCCCcc
Q 003836 486 SYMNLRCFTYKELVEVTRGFK--EELGRGAFGTVYKGFVNMGSSNHVAVKKLNSVFQ-DSEKEFKAEVNGIGQTHHKNLV 562 (792)
Q Consensus 486 ~~~~~~~~~~~el~~~~~~~~--~~lG~G~~g~Vy~g~~~~~~~~~vavK~~~~~~~-~~~~~~~~Ei~~l~~l~h~niv 562 (792)
.....+.|++.++.....+|. +.||+|+||.||+|... +++.||||++..... .....+.+|++++++++||||+
T Consensus 13 ~~~~~~~~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~--~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv 90 (326)
T 3uim_A 13 HLGQLKRFSLRELQVASDNFSNKNILGRGGFGKVYKGRLA--DGTLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLL 90 (326)
T ss_dssp --CCCEECCTHHHHTTTTSSCSTTEEECCSSSEEEEECCS--SSCCEEEEECCC-----CCCHHHHHHHGGGTCCCTTBC
T ss_pred ccCccceecHHHHHHHhhccccceeEecCCCcEEEEEEec--CCCEEEEEEeccccCchHHHHHHHHHHHHHhccCCCcc
Confidence 344567789999998887775 68999999999999753 467899999976432 2344799999999999999999
Q ss_pred cccceeccCCceEEEEEeccCCCccccccCCC----CCchhHHHHHHHHHHHHHHHHhhccCCCeEecCCCCCcEEEcCC
Q 003836 563 RLLGYCDEGQNRLLVYEFMSNGTVASFLFGDS----KPNWKLRTEIAMGIAGGLFYLHEECCTQIIHCDIKPQNILLDDH 638 (792)
Q Consensus 563 ~l~g~~~~~~~~~lV~E~~~~gsL~~~l~~~~----~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dikp~NILl~~~ 638 (792)
++++++.+.+..++||||+++|+|.+++.... .+++..+..|+.||+.||+|||+.+..+|+||||||+|||++++
T Consensus 91 ~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nil~~~~ 170 (326)
T 3uim_A 91 RLRGFCMTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEE 170 (326)
T ss_dssp CCCEEECCSSCCEEEEECCTTCBHHHHHHCCSTTCCCCCHHHHHHHHHHHHHHHHHHHHSSSSCEECCCCSGGGEEECTT
T ss_pred ceEEEEecCCceEEEEEeccCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCchhhEEECCC
Confidence 99999999999999999999999999997642 48999999999999999999999877799999999999999999
Q ss_pred CCeEEeecCCCccccCCCCCccccccccCCcccccccccCCCCcccceehHHHHHHHHHhcCcCCCcchh-hhhhhhHHH
Q 003836 639 YNARISDFGLAKLLTLDQSHTNTAIRGTKGYVAPEWFRNMPITVKVDVYSYGVLLLEIICLRRNIDNEIS-KVDKAILTD 717 (792)
Q Consensus 639 ~~~kl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DV~S~Gv~l~el~tg~~p~~~~~~-~~~~~~~~~ 717 (792)
+.+||+|||+++..............||+.|+|||.+.+..++.++||||||+++|||++|+.||..... .........
T Consensus 171 ~~~kl~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~ 250 (326)
T 3uim_A 171 FEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLD 250 (326)
T ss_dssp CCEEECCCSSCEECCSSSSCEECCCCSCGGGCCHHHHHHSEECHHHHHHHHHHHHHHHHHCCCSBCHHHHTTTSCSBHHH
T ss_pred CCEEeccCccccccCcccccccccccCCcCccCHHHhccCCCCccccchhHHHHHHHHHhCCCcccccccccccchhHHH
Confidence 9999999999998765555555556799999999999988999999999999999999999999964322 122233445
Q ss_pred HHHHhhcccchhHhhhchhcccCCHHHHHHHHHHHHHccccCCCCCCCHHhHHHHhccCc
Q 003836 718 WAYDRYQERTLEALVENDLEAMNNVTMLHRFVMVAFWCIQEDPSHRPTMRKVTQMLEGVV 777 (792)
Q Consensus 718 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~L~~~~ 777 (792)
+.........+..+.+.......+...+..+.+++.+||+.||.+|||++||+++|++..
T Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~~~ 310 (326)
T 3uim_A 251 WVKGLLKEKKLEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRMLEGDG 310 (326)
T ss_dssp HHTTTTSSCCSTTSSCTTCTTSCCHHHHHHHHHHHHHHTCSCGGGSCCHHHHHHHHHTSS
T ss_pred HHHHHhhchhhhhhcChhhccccCHHHHHHHHHHHHHHhCcCCccCCCHHHHHHHhcCcc
Confidence 555555666677777777777888899999999999999999999999999999998753
|
| >3m7h_A Putidacin L1; monocot mannose-binding lectin, bacteriocin, LLPA, pseudomon bacterial toxin, siras, antimicrobial protein; 2.20A {Pseudomonas SP} PDB: 3m7j_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-43 Score=362.86 Aligned_cols=229 Identities=22% Similarity=0.293 Sum_probs=185.5
Q ss_pred hcccCcccCCcceeecCCCCceecCCCeEEEeeeecCCCCceEEEEEeecCCCCcEEEEecCCCCCCC-----CeeEEEE
Q 003836 20 AQSNGTISIGQQLTAAESTEPWLSPSKDFALGFHQLDSKDLFLPAIWYYKIPSKTIVWYASAVNPAPR-----GSKLRLT 94 (792)
Q Consensus 20 ~~~~~~i~~g~~l~~~~~~~~lvS~~g~F~lGF~~~~~~~~~~~gIW~~~~~~~tvvWvANr~~P~~~-----~~~l~~~ 94 (792)
+++.|+|.+||+|+++ ++|||++|+|+||||+++ ++|+ |+ |.+ ||||||||+|+.+ ++.|+|+
T Consensus 11 ~~~~~~l~~g~~l~~~---~~l~S~~g~F~lgf~~~~---~~~l---y~--~~~-vvW~Anr~~p~~~~~~~~~~~l~l~ 78 (276)
T 3m7h_A 11 GVGTSVLPAYQTLSAG---QYLLSPNQRFKLLLQGDG---NLVI---QD--NGA-TVWVANEQQPFSSTIPLRNKKAPLA 78 (276)
T ss_dssp CTTSSEECTTEEBCTT---CEEECTTSSEEEEECTTS---CEEE---EE--TTE-EEEECSTTSTTEEEEECCCTTCCSE
T ss_pred cccCCEecCCCEecCC---CEEEcCCCcEEEEEECCC---CeEE---EC--CCC-eEEECCCCCCcCCcccccceEEEEe
Confidence 3457999999999864 599999999999999432 5677 76 778 9999999999965 6789999
Q ss_pred eCccEEE--EcCCCCEEEEeccCC------CcceeEEEecCCcEEEEecCCccccccccCCcccccCCCc----cccceE
Q 003836 95 ANRGLVL--EDPEGREIWKSEIST------GQAAFGVLYDTGNFLIVNTNSERLWQSFDHPTDTLLPTQT----MERGGV 162 (792)
Q Consensus 95 ~~G~Lvl--~~~~~~~vWst~~~~------~~~~~a~LldsGNlVl~~~~~~~lWQSFd~PtDtlLpg~~----l~~~~~ 162 (792)
.||+|+| .|++|++||||+++. .++++|+|+|+|||||+| +.+|||| ||||||||||+ |..+++
T Consensus 79 ~~G~Lvl~~~~~~~~~vWst~~~~~~~~~~~~~~~a~L~d~GNlVl~~--~~~lWqS--~ptdtlLpg~~~~~~l~~g~~ 154 (276)
T 3m7h_A 79 FYVQYGAFLDDYSRRRVWLTDNSTFTSNDQWNRTHLVLQDDGNIVLVD--SLALWNG--TPAIPLVPGAIDSLLLAPGSE 154 (276)
T ss_dssp EEESSSEEEEEGGGTEEEEECCCCCCCTTHHHHEEEEECTTSCEEEEE--EEEEEES--CTTSCCCCSCTTCEEECSSEE
T ss_pred CCCcEEEEEeCCCCCEEEEeCCCcccccccCCceEEEEeCCCCEEecC--CceeeCc--ccccccccccccccccccCcc
Confidence 9999999 788899999999865 345789999999999998 7899999 99999999999 777788
Q ss_pred EeeeccCCCCCCCceeEeecCCCceeeeeeccCCCcccccccccCCcccccCCCcceeEEccCCcEEEEecccceeeecc
Q 003836 163 VSSRRKDTYFSRGRFQFRLLEDGNAVLNTINLESGFAYDAYFWSNTFDTNRSNAGYRVVFNESGQLYVLRENKQRASLVP 242 (792)
Q Consensus 163 L~S~~s~~~~s~G~~~~~~~~~g~~~~~~~~~~~~~~~~~y~~~~~~~~~~~~~~~~~~~~~~g~~~~~~~~~~~~~~~~ 242 (792)
| ++.+||++|.|+++++++|+++++ +.. ..+||.++++.. +. ..+.++.+|.+++++.++..++.+.
T Consensus 155 L---~S~~dps~G~fsl~l~~dGnlvLy--~~~----~~~yW~Sgt~~~---~~-~~l~l~~dGnLvl~d~~~~~vWsS~ 221 (276)
T 3m7h_A 155 L---VQGVVYGAGASKLVFQGDGNLVAY--GPN----GAATWNAGTQGK---GA-VRAVFQGDGNLVVYGAGNAVLWHSH 221 (276)
T ss_dssp E---CTTCEEEETTEEEEECTTSCEEEE--CTT----SSEEEECCCTTT---TC-CEEEECTTSCEEEECTTSCEEEECS
T ss_pred c---ccCCCCCCceEEEeecCCceEEEE--eCC----CeEEEECCCCCC---cc-EEEEEcCCCeEEEEeCCCcEEEEec
Confidence 8 557899999999999999987663 221 267999988754 22 5678899999999887665555553
Q ss_pred ccccccccEEEEEEecCCcEEEEecCCCCCCCcceeEEeccCCcc
Q 003836 243 ETVSAKENYLRATLNFDGVFIFYSHPKNNSTGDAIWSVSDVLPEN 287 (792)
Q Consensus 243 ~~~~~~~~~~r~~L~~dG~l~~y~~~~~~~~~~~~w~~~~~~p~~ 287 (792)
.. . ...+|++|+.||++++|.| ...|+.++..|..
T Consensus 222 t~-~--~~~~rl~Ld~dGnLvly~~-------~~~Wqsf~~~P~~ 256 (276)
T 3m7h_A 222 TG-G--HASAVLRLQANGSIAILDE-------KPVWARFGFQPTY 256 (276)
T ss_dssp CT-T--CTTCEEEECTTSCEEEEEE-------EEEEESSSCCTTS
T ss_pred CC-C--CCCEEEEEcCCccEEEEcC-------CCeEEccCccCCc
Confidence 21 1 2247999999999999997 1248876666653
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-42 Score=369.29 Aligned_cols=270 Identities=36% Similarity=0.650 Sum_probs=227.7
Q ss_pred hhhcCccccceEEEeeecCCCceEEEEEEcccccccchHHHHHHHHHhcccCCCCcccccceeccCCceEEEEEeccCCC
Q 003836 506 KEELGRGAFGTVYKGFVNMGSSNHVAVKKLNSVFQDSEKEFKAEVNGIGQTHHKNLVRLLGYCDEGQNRLLVYEFMSNGT 585 (792)
Q Consensus 506 ~~~lG~G~~g~Vy~g~~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~lV~E~~~~gs 585 (792)
.+.||+|+||+||+|... +++.||||++........+.+.+|++++++++||||+++++++.+.+..++||||+++|+
T Consensus 44 ~~~lg~G~~g~Vy~~~~~--~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~ 121 (321)
T 2qkw_B 44 KFLIGHGVFGKVYKGVLR--DGAKVALKRRTPESSQGIEEFETEIETLSFCRHPHLVSLIGFCDERNEMILIYKYMENGN 121 (321)
T ss_dssp CCCSCBCSSSEEEEEECT--TCCEEEEEECCSCCSSHHHHHHHHHHGGGSCCCTTBCCEEEECCCTTCCEEEEECCTTCB
T ss_pred cceeecCCCeeEEEEEEC--CCCEEEEEEecccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCeEEEEEEcCCCCc
Confidence 467999999999999854 467899999987766677889999999999999999999999999999999999999999
Q ss_pred ccccccCCC----CCchhHHHHHHHHHHHHHHHHhhccCCCeEecCCCCCcEEEcCCCCeEEeecCCCccccCCC-CCcc
Q 003836 586 VASFLFGDS----KPNWKLRTEIAMGIAGGLFYLHEECCTQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLDQ-SHTN 660 (792)
Q Consensus 586 L~~~l~~~~----~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dikp~NILl~~~~~~kl~Dfg~a~~~~~~~-~~~~ 660 (792)
|.+++.... .+++..+..++.||++||+|||++ +|+||||||+|||++.++.+||+|||+++...... ....
T Consensus 122 L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~ 198 (321)
T 2qkw_B 122 LKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLHTR---AIIHRDVKSINILLDENFVPKITDFGISKKGTELDQTHLS 198 (321)
T ss_dssp TGGGSSSSCCCSCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCSTTEEECTTCCEEECCCTTCEECSSSSCCCCB
T ss_pred HHHHHhccCCCccccCHHHHHHHHHHHHHHHHHhcCC---CeecCCCCHHHEEECCCCCEEEeecccccccccccccccc
Confidence 999997653 588999999999999999999998 99999999999999999999999999998754322 2223
Q ss_pred ccccccCCcccccccccCCCCcccceehHHHHHHHHHhcCcCCCcchhhhhhhhHHHHHHHhhcccchhHhhhchhcccC
Q 003836 661 TAIRGTKGYVAPEWFRNMPITVKVDVYSYGVLLLEIICLRRNIDNEISKVDKAILTDWAYDRYQERTLEALVENDLEAMN 740 (792)
Q Consensus 661 ~~~~gt~~y~aPE~~~~~~~~~k~DV~S~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 740 (792)
....||+.|+|||.+.+..++.++||||||+++|||++|+.||........ .....+.........+...+++......
T Consensus 199 ~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~p~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 277 (321)
T 2qkw_B 199 TVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREM-VNLAEWAVESHNNGQLEQIVDPNLADKI 277 (321)
T ss_dssp CCCEEETTTCCHHHHHHCBCCTHHHHHHHHHHHHHHHHCCTTCSCSSSSSC-CCHHHHTHHHHTTTCCCSSSSSSCTTCS
T ss_pred cccCCCccccCHHHhcCCCCCcccchHhHHHHHHHHHhCCCcccccCcHHH-HHHHHHhhhccccccHHHhcChhhcccc
Confidence 445689999999999988999999999999999999999999975433211 1222333333444455566666666667
Q ss_pred CHHHHHHHHHHHHHccccCCCCCCCHHhHHHHhccCcCCCC
Q 003836 741 NVTMLHRFVMVAFWCIQEDPSHRPTMRKVTQMLEGVVEVPI 781 (792)
Q Consensus 741 ~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~L~~~~~~~~ 781 (792)
..+.+..+.+++.+||+.||++|||++|+++.|+.++++..
T Consensus 278 ~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~l~~~~ 318 (321)
T 2qkw_B 278 RPESLRKFGDTAVKCLALSSEDRPSMGDVLWKLEYALRLQE 318 (321)
T ss_dssp CHHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHSSC
T ss_pred CHHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHhhccc
Confidence 78899999999999999999999999999999998776543
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-42 Score=400.10 Aligned_cols=250 Identities=23% Similarity=0.335 Sum_probs=206.7
Q ss_pred hhhhhhcCccccceEEEeeecCCCceEEEEEEcccccccchHHHHHHHHHhcccCCCCcccccceeccCCceEEEEEecc
Q 003836 503 RGFKEELGRGAFGTVYKGFVNMGSSNHVAVKKLNSVFQDSEKEFKAEVNGIGQTHHKNLVRLLGYCDEGQNRLLVYEFMS 582 (792)
Q Consensus 503 ~~~~~~lG~G~~g~Vy~g~~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~lV~E~~~ 582 (792)
+.+.++||+|+||.||++.. ..+++.||+|++........+.+.+|+++|++++|||||++++++.+.+..+||||||+
T Consensus 159 Y~i~~~lG~G~fg~V~~~~~-~~tg~~~AiK~i~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iv~E~~~ 237 (573)
T 3uto_A 159 YDIHEELGTGAFGVVHRVTE-RATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEFMS 237 (573)
T ss_dssp EEEEEEEEEETTEEEEEEEE-TTTCCEEEEEEEECCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEEECSSEEEEEEECCC
T ss_pred cEEEEEEeeccCeEEEEEEE-CCCCCEEEEEEEeccchhhHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEeecC
Confidence 45668899999999999975 45678999999987666667789999999999999999999999999999999999999
Q ss_pred CCCccccccCC-CCCchhHHHHHHHHHHHHHHHHhhccCCCeEecCCCCCcEEEcCC--CCeEEeecCCCccccCCCCCc
Q 003836 583 NGTVASFLFGD-SKPNWKLRTEIAMGIAGGLFYLHEECCTQIIHCDIKPQNILLDDH--YNARISDFGLAKLLTLDQSHT 659 (792)
Q Consensus 583 ~gsL~~~l~~~-~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dikp~NILl~~~--~~~kl~Dfg~a~~~~~~~~~~ 659 (792)
+|+|.++|... ..+++..+..++.||+.||+|||++ +|+||||||+|||++.+ +.+||+|||+++.+... ..
T Consensus 238 gg~L~~~i~~~~~~l~e~~~~~~~~qi~~al~ylH~~---~iiHRDlKp~Nill~~~~~~~vKl~DFG~a~~~~~~--~~ 312 (573)
T 3uto_A 238 GGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHEN---NYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPK--QS 312 (573)
T ss_dssp CCBHHHHHTCTTSCEEHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSSSCCCEEECCCSSCEECCTT--SE
T ss_pred CCcHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCChhhccccCCCCCCEEEeeccceeEccCC--Cc
Confidence 99999998654 5799999999999999999999999 99999999999999854 89999999999987533 23
Q ss_pred cccccccCCcccccccccCCCCcccceehHHHHHHHHHhcCcCCCcchhhhhhhhHHHHHHHhhcccchhHhhhchhccc
Q 003836 660 NTAIRGTKGYVAPEWFRNMPITVKVDVYSYGVLLLEIICLRRNIDNEISKVDKAILTDWAYDRYQERTLEALVENDLEAM 739 (792)
Q Consensus 660 ~~~~~gt~~y~aPE~~~~~~~~~k~DV~S~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 739 (792)
....+||+.|||||++.+..|+.++|||||||++|||++|+.||........ +... .... ......
T Consensus 313 ~~~~~GT~~y~APEv~~~~~y~~~~DiWSlGvilyeml~G~~Pf~~~~~~~~---~~~i-----~~~~------~~~~~~ 378 (573)
T 3uto_A 313 VKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDET---LRNV-----KSCD------WNMDDS 378 (573)
T ss_dssp EEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHH---HHHH-----HTTC------CCCCSG
T ss_pred eeeeEECccccCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHH---HHHH-----HhCC------CCCCcc
Confidence 3456799999999999999999999999999999999999999976433211 1000 0000 000111
Q ss_pred CCHHHHHHHHHHHHHccccCCCCCCCHHhHHHH
Q 003836 740 NNVTMLHRFVMVAFWCIQEDPSHRPTMRKVTQM 772 (792)
Q Consensus 740 ~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~ 772 (792)
.....+.++.+|+.+||+.||.+|||++|+++.
T Consensus 379 ~~~~~s~~~~dli~~~L~~dp~~R~t~~e~l~H 411 (573)
T 3uto_A 379 AFSGISEDGKDFIRKLLLADPNTRMTIHQALEH 411 (573)
T ss_dssp GGTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred cccCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 112345678899999999999999999999883
|
| >3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-42 Score=396.36 Aligned_cols=247 Identities=22% Similarity=0.244 Sum_probs=199.6
Q ss_pred hhhhhcCccccceEEEeeecCCCceEEEEEEccccc---ccchHHHHH---HHHHhcccCCCCcccccceeccCCceEEE
Q 003836 504 GFKEELGRGAFGTVYKGFVNMGSSNHVAVKKLNSVF---QDSEKEFKA---EVNGIGQTHHKNLVRLLGYCDEGQNRLLV 577 (792)
Q Consensus 504 ~~~~~lG~G~~g~Vy~g~~~~~~~~~vavK~~~~~~---~~~~~~~~~---Ei~~l~~l~h~niv~l~g~~~~~~~~~lV 577 (792)
.+.++||+|+||.||++.. ..+++.||||++.+.. ......+.+ ++.++..++|||||++++++.+.+..|||
T Consensus 192 ~i~k~LG~G~fG~V~la~~-~~tg~~~AiK~i~K~~i~~~~~~~~~~~E~~~l~ll~~~~HP~IV~l~~~f~~~~~lylV 270 (689)
T 3v5w_A 192 SVHRIIGRGGFGEVYGCRK-ADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFI 270 (689)
T ss_dssp EEEEEEEECSSEEEEEEEE-TTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEEEEE
T ss_pred EEEEEEecccCeEEEEEEE-CCCCCEEEEEEEeHHHcchhhhHHHHHHHHHHHHHHhhCCCCCEeEEEEEEEECCEEEEE
Confidence 3457899999999999975 4567899999996532 222333444 46677788999999999999999999999
Q ss_pred EEeccCCCccccccCCCCCchhHHHHHHHHHHHHHHHHhhccCCCeEecCCCCCcEEEcCCCCeEEeecCCCccccCCCC
Q 003836 578 YEFMSNGTVASFLFGDSKPNWKLRTEIAMGIAGGLFYLHEECCTQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLDQS 657 (792)
Q Consensus 578 ~E~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dikp~NILl~~~~~~kl~Dfg~a~~~~~~~~ 657 (792)
|||+++|+|.++|.....+++.....++.||+.||+|||++ +||||||||+||||+.+|.+||+|||+|+.+....
T Consensus 271 mEy~~GGdL~~~l~~~~~l~E~~a~~y~~qIl~aL~yLH~~---gIiHRDLKPeNILld~~G~vKL~DFGlA~~~~~~~- 346 (689)
T 3v5w_A 271 LDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEHMHNR---FVVYRDLKPANILLDEHGHVRISDLGLACDFSKKK- 346 (689)
T ss_dssp ECCCCSCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCSGGGEEECTTSCEEECCCTTCEECSSCC-
T ss_pred EecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCchHHeEEeCCCCEEecccceeeecCCCC-
Confidence 99999999999998888899999999999999999999999 99999999999999999999999999998765332
Q ss_pred CccccccccCCccccccccc-CCCCcccceehHHHHHHHHHhcCcCCCcchhhhhhhhHHHHHHHhhcccchhHhhhchh
Q 003836 658 HTNTAIRGTKGYVAPEWFRN-MPITVKVDVYSYGVLLLEIICLRRNIDNEISKVDKAILTDWAYDRYQERTLEALVENDL 736 (792)
Q Consensus 658 ~~~~~~~gt~~y~aPE~~~~-~~~~~k~DV~S~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 736 (792)
....+||+.|||||++.. ..|+.++|||||||+||||++|+.||............ ......
T Consensus 347 --~~t~~GTp~YmAPEvl~~~~~y~~~vDiWSLGvilYEmLtG~~PF~~~~~~~~~~i~-------------~~i~~~-- 409 (689)
T 3v5w_A 347 --PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEID-------------RMTLTM-- 409 (689)
T ss_dssp --CCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCTTCGGGCCCHHHHH-------------HHHHHC--
T ss_pred --CCCccCCcCccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHH-------------HhhcCC--
Confidence 234679999999999964 57999999999999999999999999754322111110 001111
Q ss_pred cccCCHHHHHHHHHHHHHccccCCCCCCC-----HHhHHHH
Q 003836 737 EAMNNVTMLHRFVMVAFWCIQEDPSHRPT-----MRKVTQM 772 (792)
Q Consensus 737 ~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs-----~~evl~~ 772 (792)
....+...+.++.+|+.+||+.||.+|++ ++||+++
T Consensus 410 ~~~~p~~~S~~a~dLI~~lL~~dP~~Rl~~~~~ga~ei~~H 450 (689)
T 3v5w_A 410 AVELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKES 450 (689)
T ss_dssp CCCCCTTSCHHHHHHHHHHTCSCGGGCTTCSSSTHHHHTTS
T ss_pred CCCCCccCCHHHHHHHHHHccCCHhHCCCCCCCCHHHHhcC
Confidence 11123345677899999999999999998 6787753
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-41 Score=364.33 Aligned_cols=260 Identities=28% Similarity=0.443 Sum_probs=200.1
Q ss_pred hhhhhhcCccccceEEEeeecCCCceEEEEEEccccc--ccchHHHHHHHHHhcccCCCCcccccceeccCCceEEEEEe
Q 003836 503 RGFKEELGRGAFGTVYKGFVNMGSSNHVAVKKLNSVF--QDSEKEFKAEVNGIGQTHHKNLVRLLGYCDEGQNRLLVYEF 580 (792)
Q Consensus 503 ~~~~~~lG~G~~g~Vy~g~~~~~~~~~vavK~~~~~~--~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~lV~E~ 580 (792)
+.+.+.||+|+||+||+|.. .++.||||++.... ....+++.+|++++++++||||+++++++.+.+..++||||
T Consensus 39 y~i~~~lG~G~~g~V~~~~~---~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~ 115 (309)
T 3p86_A 39 LNIKEKIGAGSFGTVHRAEW---HGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAVTQPPNLSIVTEY 115 (309)
T ss_dssp EEEEEEEEECSSEEEEEEEE---TTEEEEEEEECCCCCSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTTCCEEEEEC
T ss_pred ceeeeEeecCCCeEEEEEEE---CCCcEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCceEEEEec
Confidence 34557899999999999975 35689999987543 23346789999999999999999999999999999999999
Q ss_pred ccCCCccccccCCCC---CchhHHHHHHHHHHHHHHHHhhccCCC--eEecCCCCCcEEEcCCCCeEEeecCCCccccCC
Q 003836 581 MSNGTVASFLFGDSK---PNWKLRTEIAMGIAGGLFYLHEECCTQ--IIHCDIKPQNILLDDHYNARISDFGLAKLLTLD 655 (792)
Q Consensus 581 ~~~gsL~~~l~~~~~---l~~~~~~~i~~~ia~gL~yLH~~~~~~--ivH~dikp~NILl~~~~~~kl~Dfg~a~~~~~~ 655 (792)
+++|+|.+++..... +++..+..++.||+.||+|||+. + |+||||||+|||++.++.+||+|||+++.....
T Consensus 116 ~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~~~~ 192 (309)
T 3p86_A 116 LSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNR---NPPIVHRNLKSPNLLVDKKYTVKVCDFGLSRLKAST 192 (309)
T ss_dssp CTTCBHHHHHHSTTHHHHSCHHHHHHHHHHHHHHHHHHHTS---SSCCCCTTCCGGGEEECTTCCEEECCCC--------
T ss_pred CCCCcHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcC---CCCEECCCCChhhEEEeCCCcEEECCCCCCcccccc
Confidence 999999999987643 89999999999999999999998 8 999999999999999999999999999864332
Q ss_pred CCCccccccccCCcccccccccCCCCcccceehHHHHHHHHHhcCcCCCcchhhhhhhhHHHHHHHhhcccchhHhhhch
Q 003836 656 QSHTNTAIRGTKGYVAPEWFRNMPITVKVDVYSYGVLLLEIICLRRNIDNEISKVDKAILTDWAYDRYQERTLEALVEND 735 (792)
Q Consensus 656 ~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DV~S~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 735 (792)
. .......||+.|+|||.+.+..++.++||||||+++|||++|+.||.......... .+....
T Consensus 193 ~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~Pf~~~~~~~~~~----------------~~~~~~ 255 (309)
T 3p86_A 193 F-LSSKSAAGTPEWMAPEVLRDEPSNEKSDVYSFGVILWELATLQQPWGNLNPAQVVA----------------AVGFKC 255 (309)
T ss_dssp ----------CCTTSCHHHHTTCCCCTTHHHHHHHHHHHHHHHCCCTTTTSCHHHHHH----------------HHHHSC
T ss_pred c-cccccCCCCccccChhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHH----------------HHHhcC
Confidence 2 22334568999999999999999999999999999999999999997543221100 000011
Q ss_pred hcccCCHHHHHHHHHHHHHccccCCCCCCCHHhHHHHhccCcCCCCCCCC
Q 003836 736 LEAMNNVTMLHRFVMVAFWCIQEDPSHRPTMRKVTQMLEGVVEVPIPPCP 785 (792)
Q Consensus 736 ~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~L~~~~~~~~p~~P 785 (792)
.....+...+..+.+++.+||+.+|.+|||++|+++.|+.+++-..||.+
T Consensus 256 ~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~~L~~~~~~~~p~~~ 305 (309)
T 3p86_A 256 KRLEIPRNLNPQVAAIIEGCWTNEPWKRPSFATIMDLLRPLIKSAVPPPN 305 (309)
T ss_dssp CCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHC-------
T ss_pred CCCCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHhCCCCCC
Confidence 11122334456788999999999999999999999999998776555544
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-41 Score=361.39 Aligned_cols=255 Identities=25% Similarity=0.435 Sum_probs=208.9
Q ss_pred hhhhhcCccccceEEEeeecCCCceEEEEEEcccccccchHHHHHHHHHhcccCCCCcccccceeccCCceEEEEEeccC
Q 003836 504 GFKEELGRGAFGTVYKGFVNMGSSNHVAVKKLNSVFQDSEKEFKAEVNGIGQTHHKNLVRLLGYCDEGQNRLLVYEFMSN 583 (792)
Q Consensus 504 ~~~~~lG~G~~g~Vy~g~~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~lV~E~~~~ 583 (792)
.+.+.||+|+||+||++... .+++.||+|++........+.+.+|++++++++||||+++++++.+++..++||||+++
T Consensus 13 ~~~~~lG~G~~g~V~~~~~~-~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~ 91 (310)
T 3s95_A 13 IHGEVLGKGCFGQAIKVTHR-ETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKFIGVLYKDKRLNFITEYIKG 91 (310)
T ss_dssp EEEEEEECCSSEEEEEEEET-TTCCEEEEEEESCCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEECCTT
T ss_pred eccceecCCCCEEEEEEEEC-CCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCcCcccEEEEEecCCeeEEEEEecCC
Confidence 34578999999999999764 45679999998776667778899999999999999999999999999999999999999
Q ss_pred CCccccccC-CCCCchhHHHHHHHHHHHHHHHHhhccCCCeEecCCCCCcEEEcCCCCeEEeecCCCccccCCCCCc---
Q 003836 584 GTVASFLFG-DSKPNWKLRTEIAMGIAGGLFYLHEECCTQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLDQSHT--- 659 (792)
Q Consensus 584 gsL~~~l~~-~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dikp~NILl~~~~~~kl~Dfg~a~~~~~~~~~~--- 659 (792)
|+|.+++.. ...+++..+..++.||+.||+|||+. +|+||||||+|||++.++.+||+|||+++.........
T Consensus 92 ~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~---~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~ 168 (310)
T 3s95_A 92 GTLRGIIKSMDSQYPWSQRVSFAKDIASGMAYLHSM---NIIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQPEGL 168 (310)
T ss_dssp CBHHHHHHHCCTTSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSTTSEEECTTSCEEECCCTTCEECC---------
T ss_pred CcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCCcCeEEECCCCCEEEeecccceeccccccccccc
Confidence 999999976 46789999999999999999999999 99999999999999999999999999998764332211
Q ss_pred ----------cccccccCCcccccccccCCCCcccceehHHHHHHHHHhcCcCCCcchhhhhhhhHHHHHHHhhcccchh
Q 003836 660 ----------NTAIRGTKGYVAPEWFRNMPITVKVDVYSYGVLLLEIICLRRNIDNEISKVDKAILTDWAYDRYQERTLE 729 (792)
Q Consensus 660 ----------~~~~~gt~~y~aPE~~~~~~~~~k~DV~S~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 729 (792)
.....||+.|+|||.+.+..++.++||||||+++|||++|..|+........... ....
T Consensus 169 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~~~~~~~~~~~~~~-----------~~~~ 237 (310)
T 3s95_A 169 RSLKKPDRKKRYTVVGNPYWMAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNADPDYLPRTMDFG-----------LNVR 237 (310)
T ss_dssp -----------CCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHTCCSSTTTSCBCTTSS-----------BCHH
T ss_pred ccccccccccccccCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHhcCCCCCcchhhhHHHHh-----------hhhh
Confidence 1145699999999999999999999999999999999999998865332211100 0011
Q ss_pred HhhhchhcccCCHHHHHHHHHHHHHccccCCCCCCCHHhHHHHhccCc
Q 003836 730 ALVENDLEAMNNVTMLHRFVMVAFWCIQEDPSHRPTMRKVTQMLEGVV 777 (792)
Q Consensus 730 ~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~L~~~~ 777 (792)
..... ..+...+..+.+++.+||+.||++|||++|+++.|+.+.
T Consensus 238 ~~~~~----~~~~~~~~~l~~li~~~l~~dP~~Rps~~~l~~~L~~l~ 281 (310)
T 3s95_A 238 GFLDR----YCPPNCPPSFFPITVRCCDLDPEKRPSFVKLEHWLETLR 281 (310)
T ss_dssp HHHHH----TCCTTCCTTHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred ccccc----cCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHH
Confidence 11111 112233456888999999999999999999999998764
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-40 Score=365.41 Aligned_cols=255 Identities=24% Similarity=0.347 Sum_probs=208.1
Q ss_pred hhhhhcCccccceEEEeeecC------CCceEEEEEEcccccc-cchHHHHHHHHHhccc-CCCCcccccceeccCCceE
Q 003836 504 GFKEELGRGAFGTVYKGFVNM------GSSNHVAVKKLNSVFQ-DSEKEFKAEVNGIGQT-HHKNLVRLLGYCDEGQNRL 575 (792)
Q Consensus 504 ~~~~~lG~G~~g~Vy~g~~~~------~~~~~vavK~~~~~~~-~~~~~~~~Ei~~l~~l-~h~niv~l~g~~~~~~~~~ 575 (792)
.+.+.||+|+||.||+|.... ..+..||||+++.... ...+.+.+|+.+++++ +||||+++++++.+.+..+
T Consensus 84 ~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~~~~~ 163 (370)
T 2psq_A 84 TLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLY 163 (370)
T ss_dssp EEEEEESCCSSSEEEEEEEETCSTTCTTCEEEEEEEECCTTCBHHHHHHHHHHHHHHHHSCCCTTBCCEEEEECSSSSCE
T ss_pred EeeeEEeeCCCeeEEEEEEecccCcCcCcceeEEEEEecCCcCHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEccCCCEE
Confidence 345789999999999997531 3456799999976432 3456799999999999 8999999999999999999
Q ss_pred EEEEeccCCCccccccCCC----------------CCchhHHHHHHHHHHHHHHHHhhccCCCeEecCCCCCcEEEcCCC
Q 003836 576 LVYEFMSNGTVASFLFGDS----------------KPNWKLRTEIAMGIAGGLFYLHEECCTQIIHCDIKPQNILLDDHY 639 (792)
Q Consensus 576 lV~E~~~~gsL~~~l~~~~----------------~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dikp~NILl~~~~ 639 (792)
+||||+++|+|.+++.... .+++..+..++.||+.||+|||++ +|+||||||+|||++.++
T Consensus 164 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~~ 240 (370)
T 2psq_A 164 VIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQ---KCIHRDLAARNVLVTENN 240 (370)
T ss_dssp EEEECCTTCBHHHHHHHTCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECTTC
T ss_pred EEEEcCCCCCHHHHHHhhCCccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhC---CeeccccchhhEEECCCC
Confidence 9999999999999997542 478899999999999999999998 999999999999999999
Q ss_pred CeEEeecCCCccccCCCCC-ccccccccCCcccccccccCCCCcccceehHHHHHHHHHh-cCcCCCcchhhhhhhhHHH
Q 003836 640 NARISDFGLAKLLTLDQSH-TNTAIRGTKGYVAPEWFRNMPITVKVDVYSYGVLLLEIIC-LRRNIDNEISKVDKAILTD 717 (792)
Q Consensus 640 ~~kl~Dfg~a~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~k~DV~S~Gv~l~el~t-g~~p~~~~~~~~~~~~~~~ 717 (792)
.+||+|||+++........ ......+|+.|+|||.+.+..++.++|||||||++|||++ |+.||........
T Consensus 241 ~~kl~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~p~~~~~~~~~------ 314 (370)
T 2psq_A 241 VMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEEL------ 314 (370)
T ss_dssp CEEECCCSSCEETTCCCTTCTTTTTTSCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGH------
T ss_pred CEEEccccCCcccCcccceecccCCCcccceECHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCCCCCCHHHH------
Confidence 9999999999876543322 2233457889999999999999999999999999999999 9999865422110
Q ss_pred HHHHhhcccchhHhhhchhcccCCHHHHHHHHHHHHHccccCCCCCCCHHhHHHHhccCcC
Q 003836 718 WAYDRYQERTLEALVENDLEAMNNVTMLHRFVMVAFWCIQEDPSHRPTMRKVTQMLEGVVE 778 (792)
Q Consensus 718 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~L~~~~~ 778 (792)
...+........+...+.++.+++.+||+.+|++||++.|+++.|+.++.
T Consensus 315 -----------~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~L~~il~ 364 (370)
T 2psq_A 315 -----------FKLLKEGHRMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILT 364 (370)
T ss_dssp -----------HHHHHTTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred -----------HHHHhcCCCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHH
Confidence 11111111222333456678999999999999999999999999998754
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.5e-41 Score=360.57 Aligned_cols=261 Identities=24% Similarity=0.409 Sum_probs=209.4
Q ss_pred hhhhhhcCccccceEEEeeecCC--CceEEEEEEccccc-ccchHHHHHHHHHhcccCCCCcccccceeccCCceEEEEE
Q 003836 503 RGFKEELGRGAFGTVYKGFVNMG--SSNHVAVKKLNSVF-QDSEKEFKAEVNGIGQTHHKNLVRLLGYCDEGQNRLLVYE 579 (792)
Q Consensus 503 ~~~~~~lG~G~~g~Vy~g~~~~~--~~~~vavK~~~~~~-~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~lV~E 579 (792)
+.+.+.||+|+||+||+|..... .+..||||+++... ....+.+.+|+.++++++||||+++++++.+.+..++|||
T Consensus 51 y~i~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 130 (325)
T 3kul_A 51 IHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNIIRLEGVVTRGRLAMIVTE 130 (325)
T ss_dssp EEEEEEEEETTTEEEEEEEECCTTSCCEEEEEEEECTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECGGGCCEEEEE
T ss_pred eEEeeEEEeCCCcEEEEEEEecCCCCCceEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCccEEEee
Confidence 34457899999999999987432 23569999997643 3445689999999999999999999999999999999999
Q ss_pred eccCCCccccccCC-CCCchhHHHHHHHHHHHHHHHHhhccCCCeEecCCCCCcEEEcCCCCeEEeecCCCccccCCCCC
Q 003836 580 FMSNGTVASFLFGD-SKPNWKLRTEIAMGIAGGLFYLHEECCTQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLDQSH 658 (792)
Q Consensus 580 ~~~~gsL~~~l~~~-~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dikp~NILl~~~~~~kl~Dfg~a~~~~~~~~~ 658 (792)
|+++|+|.+++... ..+++..+..++.||+.||+|||+. +|+||||||+|||++.++.+||+|||+++........
T Consensus 131 ~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~ 207 (325)
T 3kul_A 131 YMENGSLDTFLRTHDGQFTIMQLVGMLRGVGAGMRYLSDL---GYVHRDLAARNVLVDSNLVCKVSDFGLSRVLEDDPDA 207 (325)
T ss_dssp CCTTCBHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCCSSCEECC----C
T ss_pred CCCCCcHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHC---CeeCCCCCcceEEECCCCCEEECCCCcccccccCccc
Confidence 99999999999655 5789999999999999999999998 9999999999999999999999999999876543322
Q ss_pred c--cccccccCCcccccccccCCCCcccceehHHHHHHHHHh-cCcCCCcchhhhhhhhHHHHHHHhhcccchhHhhhch
Q 003836 659 T--NTAIRGTKGYVAPEWFRNMPITVKVDVYSYGVLLLEIIC-LRRNIDNEISKVDKAILTDWAYDRYQERTLEALVEND 735 (792)
Q Consensus 659 ~--~~~~~gt~~y~aPE~~~~~~~~~k~DV~S~Gv~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 735 (792)
. .....+|+.|+|||.+.+..++.++||||||+++|||++ |+.||........ ...+...
T Consensus 208 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~-----------------~~~~~~~ 270 (325)
T 3kul_A 208 AYTTTGGKIPIRWTAPEAIAFRTFSSASDVWSFGVVMWEVLAYGERPYWNMTNRDV-----------------ISSVEEG 270 (325)
T ss_dssp CEECC---CCGGGSCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTSCHHHH-----------------HHHHHTT
T ss_pred eeeccCCCCcccccCHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCcccCCHHHH-----------------HHHHHcC
Confidence 2 223346778999999998899999999999999999999 9999865432211 0111111
Q ss_pred hcccCCHHHHHHHHHHHHHccccCCCCCCCHHhHHHHhccCcCCCCCC
Q 003836 736 LEAMNNVTMLHRFVMVAFWCIQEDPSHRPTMRKVTQMLEGVVEVPIPP 783 (792)
Q Consensus 736 ~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~L~~~~~~~~p~ 783 (792)
.....+...+..+.+++.+||+.||++|||++||+++|+.+++.+...
T Consensus 271 ~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~~L~~l~~~~~~~ 318 (325)
T 3kul_A 271 YRLPAPMGCPHALHQLMLDCWHKDRAQRPRFSQIVSVLDALIRSPESL 318 (325)
T ss_dssp CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHSCC--
T ss_pred CCCCCCCCcCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhCcccc
Confidence 222233345678899999999999999999999999999987655433
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-40 Score=352.10 Aligned_cols=248 Identities=25% Similarity=0.340 Sum_probs=205.6
Q ss_pred hhhhhcCccccceEEEeeecCCCceEEEEEEcccccccchHHHHHHHHHhcccCCCCcccccceeccCCceEEEEEeccC
Q 003836 504 GFKEELGRGAFGTVYKGFVNMGSSNHVAVKKLNSVFQDSEKEFKAEVNGIGQTHHKNLVRLLGYCDEGQNRLLVYEFMSN 583 (792)
Q Consensus 504 ~~~~~lG~G~~g~Vy~g~~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~lV~E~~~~ 583 (792)
.+.+.||+|+||+||+|.. ..+++.||||++........+.+.+|+.++++++||||+++++++..++..++||||+++
T Consensus 23 ~~~~~lg~G~~g~V~~~~~-~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~ 101 (297)
T 3fxz_A 23 TRFEKIGQGASGTVYTAMD-VATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAG 101 (297)
T ss_dssp CCCEEEEEETTEEEEEEEB-TTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCTT
T ss_pred eeeeeeccCCCeEEEEEEE-CCCCcEEEEEEeecccccHHHHHHHHHHHHhcCCCCCCCeEeEEEEECCEEEEEEECCCC
Confidence 3457899999999999964 456789999999876666678899999999999999999999999999999999999999
Q ss_pred CCccccccCCCCCchhHHHHHHHHHHHHHHHHhhccCCCeEecCCCCCcEEEcCCCCeEEeecCCCccccCCCCCccccc
Q 003836 584 GTVASFLFGDSKPNWKLRTEIAMGIAGGLFYLHEECCTQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLDQSHTNTAI 663 (792)
Q Consensus 584 gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dikp~NILl~~~~~~kl~Dfg~a~~~~~~~~~~~~~~ 663 (792)
|+|.+++... .+++..+..++.||+.||+|||++ +|+||||||+|||++.++.+||+|||+++....... .....
T Consensus 102 ~~L~~~~~~~-~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~-~~~~~ 176 (297)
T 3fxz_A 102 GSLTDVVTET-CMDEGQIAAVCRECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS-KRSTM 176 (297)
T ss_dssp CBHHHHHHHS-CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECCCTTCEECCSTTC-CBCCC
T ss_pred CCHHHHHhhc-CCCHHHHHHHHHHHHHHHHHHHhC---CceeCCCCHHHEEECCCCCEEEeeCCCceecCCccc-ccCCc
Confidence 9999999654 588999999999999999999999 999999999999999999999999999987654332 23345
Q ss_pred cccCCcccccccccCCCCcccceehHHHHHHHHHhcCcCCCcchhhhhhhhHHHHHHHhhcccchhHhhhchhcccCCHH
Q 003836 664 RGTKGYVAPEWFRNMPITVKVDVYSYGVLLLEIICLRRNIDNEISKVDKAILTDWAYDRYQERTLEALVENDLEAMNNVT 743 (792)
Q Consensus 664 ~gt~~y~aPE~~~~~~~~~k~DV~S~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 743 (792)
.||+.|+|||.+.+..++.++||||||+++|||++|+.||............ . .........+..
T Consensus 177 ~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~---~------------~~~~~~~~~~~~ 241 (297)
T 3fxz_A 177 VGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLI---A------------TNGTPELQNPEK 241 (297)
T ss_dssp CSCGGGCCHHHHHCSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHH---H------------HHCSCCCSCGGG
T ss_pred cCCcCccChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH---H------------hCCCCCCCCccc
Confidence 6999999999999999999999999999999999999999654322111000 0 000001111233
Q ss_pred HHHHHHHHHHHccccCCCCCCCHHhHHHH
Q 003836 744 MLHRFVMVAFWCIQEDPSHRPTMRKVTQM 772 (792)
Q Consensus 744 ~~~~l~~l~~~Cl~~~p~~RPs~~evl~~ 772 (792)
.+..+.+++.+||+.||++|||++|+++.
T Consensus 242 ~~~~~~~li~~~l~~dp~~Rps~~ell~h 270 (297)
T 3fxz_A 242 LSAIFRDFLNRCLEMDVEKRGSAKELLQH 270 (297)
T ss_dssp SCHHHHHHHHHHSCSSTTTSCCHHHHTTC
T ss_pred cCHHHHHHHHHHccCChhHCcCHHHHhhC
Confidence 45678899999999999999999999873
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-39 Score=348.38 Aligned_cols=280 Identities=36% Similarity=0.626 Sum_probs=225.6
Q ss_pred cCccccCHHHHHHHHhhhh--------hhcCccccceEEEeeecCCCceEEEEEEccccc----ccchHHHHHHHHHhcc
Q 003836 488 MNLRCFTYKELVEVTRGFK--------EELGRGAFGTVYKGFVNMGSSNHVAVKKLNSVF----QDSEKEFKAEVNGIGQ 555 (792)
Q Consensus 488 ~~~~~~~~~el~~~~~~~~--------~~lG~G~~g~Vy~g~~~~~~~~~vavK~~~~~~----~~~~~~~~~Ei~~l~~ 555 (792)
.....|++.++..++.+|. +.||+|+||.||+|.. .++.||||++.... ....+.+.+|+.++++
T Consensus 10 ~~~~~~~~~~l~~~~~~f~~~~~~~~~~~lg~G~~g~Vy~~~~---~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~ 86 (307)
T 2nru_A 10 TRFHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYV---NNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAK 86 (307)
T ss_dssp -CCEECCHHHHHHHTTTTCCSBTTTTCCEEEECSSEEEEEEES---SSCEEEEEEECCCTTSCTTTHHHHHHHHHHHHHH
T ss_pred CCCCcccHHHHHHHHcccccccccccCCccccCCCeEEEEEEE---CCceEEEEEEecccCcchHHHHHHHHHHHHHHHh
Confidence 3467799999999999986 3599999999999975 35689999986532 2345789999999999
Q ss_pred cCCCCcccccceeccCCceEEEEEeccCCCccccccC---CCCCchhHHHHHHHHHHHHHHHHhhccCCCeEecCCCCCc
Q 003836 556 THHKNLVRLLGYCDEGQNRLLVYEFMSNGTVASFLFG---DSKPNWKLRTEIAMGIAGGLFYLHEECCTQIIHCDIKPQN 632 (792)
Q Consensus 556 l~h~niv~l~g~~~~~~~~~lV~E~~~~gsL~~~l~~---~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dikp~N 632 (792)
++||||+++++++.+.+..++||||+++++|.+++.. ...+++..+..++.||+.||.|||+. +|+||||||+|
T Consensus 87 l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~---~i~H~dlkp~N 163 (307)
T 2nru_A 87 CQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLHEN---HHIHRDIKSAN 163 (307)
T ss_dssp CCCTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHTGGGCCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGG
T ss_pred cCCCCeEEEEEEEecCCceEEEEEecCCCcHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhcC---CeecCCCCHHH
Confidence 9999999999999999999999999999999999864 24689999999999999999999998 99999999999
Q ss_pred EEEcCCCCeEEeecCCCccccCCCCC-ccccccccCCcccccccccCCCCcccceehHHHHHHHHHhcCcCCCcchhhhh
Q 003836 633 ILLDDHYNARISDFGLAKLLTLDQSH-TNTAIRGTKGYVAPEWFRNMPITVKVDVYSYGVLLLEIICLRRNIDNEISKVD 711 (792)
Q Consensus 633 ILl~~~~~~kl~Dfg~a~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~k~DV~S~Gv~l~el~tg~~p~~~~~~~~~ 711 (792)
||+++++.+||+|||+++........ ......||+.|+|||.+.+ .++.++||||||+++|||++|+.||........
T Consensus 164 ili~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~ 242 (307)
T 2nru_A 164 ILLDEAFTAKISDFGLARASEKFAQTVMTSRIVGTTAYMAPEALRG-EITPKSDIYSFGVVLLEIITGLPAVDEHREPQL 242 (307)
T ss_dssp EEECTTCCEEECCCTTCEECCSCSSCEECSSCCSCGGGCCHHHHTT-EECTHHHHHHHHHHHHHHHHCCCSBCTTBSSSB
T ss_pred EEEcCCCcEEEeecccccccccccccccccccCCCcCcCChHHhcC-CCCccchhHHHHHHHHHHHHCCCCcccCcchHH
Confidence 99999999999999999876543222 2234568999999998865 589999999999999999999999976433211
Q ss_pred hhhHHHHHHHhhcccchhHhhhchhcccCCHHHHHHHHHHHHHccccCCCCCCCHHhHHHHhccCc
Q 003836 712 KAILTDWAYDRYQERTLEALVENDLEAMNNVTMLHRFVMVAFWCIQEDPSHRPTMRKVTQMLEGVV 777 (792)
Q Consensus 712 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~L~~~~ 777 (792)
...+.. ........+...++... ...+...+..+.+++.+||+.+|.+|||+++|+++|+++.
T Consensus 243 ~~~~~~--~~~~~~~~~~~~~~~~~-~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~l~~~L~~l~ 305 (307)
T 2nru_A 243 LLDIKE--EIEDEEKTIEDYIDKKM-NDADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQLLQEMT 305 (307)
T ss_dssp TTHHHH--HHHTTSCCHHHHSCSSC-SCCCHHHHHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHC
T ss_pred HHHHHH--Hhhhhhhhhhhhccccc-cccchHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHh
Confidence 111100 00111223344444433 2345677889999999999999999999999999998764
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-41 Score=358.75 Aligned_cols=271 Identities=23% Similarity=0.369 Sum_probs=208.5
Q ss_pred hhhhhhcCccccceEEEeee---cCCCceEEEEEEcccccccchHHHHHHHHHhcccCCCCcccccceecc--CCceEEE
Q 003836 503 RGFKEELGRGAFGTVYKGFV---NMGSSNHVAVKKLNSVFQDSEKEFKAEVNGIGQTHHKNLVRLLGYCDE--GQNRLLV 577 (792)
Q Consensus 503 ~~~~~~lG~G~~g~Vy~g~~---~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~--~~~~~lV 577 (792)
+.+.+.||+|+||+||++.+ +..+++.||||++........+.+.+|++++++++||||+++++++.. ....++|
T Consensus 12 ~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv 91 (295)
T 3ugc_A 12 LKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLI 91 (295)
T ss_dssp EEEEEEEEECSSEEEEEEEECTTCSSCCEEEEEEEESCCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECHHHHTSCEEE
T ss_pred hhhhheeeccCCEEEEEEEEecccCCCCcEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCCceEEE
Confidence 44567899999999999975 345678999999987666667889999999999999999999999854 3568999
Q ss_pred EEeccCCCccccccCC-CCCchhHHHHHHHHHHHHHHHHhhccCCCeEecCCCCCcEEEcCCCCeEEeecCCCccccCCC
Q 003836 578 YEFMSNGTVASFLFGD-SKPNWKLRTEIAMGIAGGLFYLHEECCTQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLDQ 656 (792)
Q Consensus 578 ~E~~~~gsL~~~l~~~-~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dikp~NILl~~~~~~kl~Dfg~a~~~~~~~ 656 (792)
|||+++|+|.+++... ..+++..+..++.||+.||+|||+. +|+||||||+|||++.++.+||+|||+++......
T Consensus 92 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~ 168 (295)
T 3ugc_A 92 MEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTK---RYIHRDLATRNILVENENRVKIGDFGLTKVLPQDK 168 (295)
T ss_dssp EECCTTCBHHHHHHHCGGGCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETTEEEECCCCSCC------
T ss_pred EEeCCCCCHHHHHHhcccccCHHHHHHHHHHHHHHHHHHhcC---CcccCCCCHhhEEEcCCCeEEEccCcccccccCCc
Confidence 9999999999999765 3589999999999999999999998 99999999999999999999999999998765433
Q ss_pred CC--ccccccccCCcccccccccCCCCcccceehHHHHHHHHHhcCcCCCcchhhhhhhhHHHHHHHhhcccchhHhhhc
Q 003836 657 SH--TNTAIRGTKGYVAPEWFRNMPITVKVDVYSYGVLLLEIICLRRNIDNEISKVDKAILTDWAYDRYQERTLEALVEN 734 (792)
Q Consensus 657 ~~--~~~~~~gt~~y~aPE~~~~~~~~~k~DV~S~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 734 (792)
.. ......++..|+|||.+.+..++.++||||||+++|||++|..|+............ ...........+...+..
T Consensus 169 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~ 247 (295)
T 3ugc_A 169 EFFKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIG-NDKQGQMIVFHLIELLKN 247 (295)
T ss_dssp -------CTTCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTTCTTCSHHHHHHHHHC-TTCCTHHHHHHHHHHHHT
T ss_pred ceeeeccCCCCccceeCcHHhcCCCCChHHHHHHHHHHHHHHHhcccccCCChHHHHhhhc-CccccchhHHHHHHHHhc
Confidence 21 222345677899999999999999999999999999999999998654322110000 000000000011222222
Q ss_pred hhcccCCHHHHHHHHHHHHHccccCCCCCCCHHhHHHHhccCc
Q 003836 735 DLEAMNNVTMLHRFVMVAFWCIQEDPSHRPTMRKVTQMLEGVV 777 (792)
Q Consensus 735 ~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~L~~~~ 777 (792)
......+...+.++.+++.+||+.||++|||++|++++|+.+.
T Consensus 248 ~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~el~~~L~~l~ 290 (295)
T 3ugc_A 248 NGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIR 290 (295)
T ss_dssp TCCCCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHH
T ss_pred cCcCCCCcCcCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHH
Confidence 2233334456678999999999999999999999999998764
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=7.7e-41 Score=367.19 Aligned_cols=256 Identities=25% Similarity=0.420 Sum_probs=197.7
Q ss_pred hhhhhhcCccccceEEEeeecC--CCceEEEEEEccccc-ccchHHHHHHHHHhcccCCCCcccccceeccCCceEEEEE
Q 003836 503 RGFKEELGRGAFGTVYKGFVNM--GSSNHVAVKKLNSVF-QDSEKEFKAEVNGIGQTHHKNLVRLLGYCDEGQNRLLVYE 579 (792)
Q Consensus 503 ~~~~~~lG~G~~g~Vy~g~~~~--~~~~~vavK~~~~~~-~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~lV~E 579 (792)
+.+.+.||+|+||.||+|.... ..+..||||+++... ....+.+.+|+.++++++||||+++++++.+.+..++|||
T Consensus 47 ~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 126 (373)
T 2qol_A 47 ISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTE 126 (373)
T ss_dssp CCCCEEEEECSSSEEEEC-CBCTTSCBCCEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCEEEEE
T ss_pred ceeeeEEeeCCCeEEEEEEEecCCCCceeEEEEEecCccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCceEEEEe
Confidence 3445789999999999997642 345689999997643 3345689999999999999999999999999999999999
Q ss_pred eccCCCccccccCC-CCCchhHHHHHHHHHHHHHHHHhhccCCCeEecCCCCCcEEEcCCCCeEEeecCCCccccCCCCC
Q 003836 580 FMSNGTVASFLFGD-SKPNWKLRTEIAMGIAGGLFYLHEECCTQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLDQSH 658 (792)
Q Consensus 580 ~~~~gsL~~~l~~~-~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dikp~NILl~~~~~~kl~Dfg~a~~~~~~~~~ 658 (792)
|+++|+|.+++... ..+++..+..++.||+.||+|||+. +|+||||||+|||++.++.+||+|||+++........
T Consensus 127 ~~~~~sL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~ 203 (373)
T 2qol_A 127 YMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLSDM---GYVHRDLAARNILINSNLVCKVSDFGLGRVLEDDPEA 203 (373)
T ss_dssp CCTTCBHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECCC------------
T ss_pred CCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeCCCCCcceEEEcCCCCEEECcCccccccccCCcc
Confidence 99999999999765 4689999999999999999999998 9999999999999999999999999999876543322
Q ss_pred cc--ccccccCCcccccccccCCCCcccceehHHHHHHHHHh-cCcCCCcchhhhhhhhHHHHHHHhhcccchhHhhhch
Q 003836 659 TN--TAIRGTKGYVAPEWFRNMPITVKVDVYSYGVLLLEIIC-LRRNIDNEISKVDKAILTDWAYDRYQERTLEALVEND 735 (792)
Q Consensus 659 ~~--~~~~gt~~y~aPE~~~~~~~~~k~DV~S~Gv~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 735 (792)
.. ....+++.|+|||.+.+..++.++||||||+++|||++ |+.||....... +...+...
T Consensus 204 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~SlG~il~ellt~g~~P~~~~~~~~-----------------~~~~i~~~ 266 (373)
T 2qol_A 204 AYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQD-----------------VIKAVDEG 266 (373)
T ss_dssp ----------CTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTC-CTTTTCCHHH-----------------HHHHHHTT
T ss_pred ceeccCCCcCCCccChhhhccCCcCchhcHHHHHHHHHHHHhCCCCCCCCCCHHH-----------------HHHHHHcC
Confidence 21 12235778999999999999999999999999999998 999986543211 01111122
Q ss_pred hcccCCHHHHHHHHHHHHHccccCCCCCCCHHhHHHHhccCcC
Q 003836 736 LEAMNNVTMLHRFVMVAFWCIQEDPSHRPTMRKVTQMLEGVVE 778 (792)
Q Consensus 736 ~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~L~~~~~ 778 (792)
.....+...+..+.+++.+||+.+|++||+++||+++|+.+++
T Consensus 267 ~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~~i~~~L~~~~~ 309 (373)
T 2qol_A 267 YRLPPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVSILDKLIR 309 (373)
T ss_dssp EECCCCTTCBHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred CCCCCCccccHHHHHHHHHHhCcChhhCcCHHHHHHHHHHHHh
Confidence 2222233456778999999999999999999999999987654
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-40 Score=356.90 Aligned_cols=245 Identities=24% Similarity=0.347 Sum_probs=204.0
Q ss_pred hhhhhcCccccceEEEeeecCCCceEEEEEEccccc--ccchHHHHHHHHHhcccCCCCcccccceeccCCceEEEEEec
Q 003836 504 GFKEELGRGAFGTVYKGFVNMGSSNHVAVKKLNSVF--QDSEKEFKAEVNGIGQTHHKNLVRLLGYCDEGQNRLLVYEFM 581 (792)
Q Consensus 504 ~~~~~lG~G~~g~Vy~g~~~~~~~~~vavK~~~~~~--~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~lV~E~~ 581 (792)
.+.+.||+|+||.||+|... .+++.||||++.... ....+.+.+|++++++++||||+++++++...+..++||||+
T Consensus 18 ~~~~~lG~G~~g~V~~a~~~-~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~e~~ 96 (328)
T 3fe3_A 18 RLLKTIGKGNFAKVKLARHI-LTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEVIETEKTLYLIMEYA 96 (328)
T ss_dssp EEEEEEEECSSEEEEEEEET-TTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECCC
T ss_pred EEEEEEeeCCCEEEEEEEEC-CCCCEEEEEEEEhhcCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEEECC
Confidence 34578999999999999753 456799999987542 334567889999999999999999999999999999999999
Q ss_pred cCCCccccccCCCCCchhHHHHHHHHHHHHHHHHhhccCCCeEecCCCCCcEEEcCCCCeEEeecCCCccccCCCCCccc
Q 003836 582 SNGTVASFLFGDSKPNWKLRTEIAMGIAGGLFYLHEECCTQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLDQSHTNT 661 (792)
Q Consensus 582 ~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dikp~NILl~~~~~~kl~Dfg~a~~~~~~~~~~~~ 661 (792)
++|+|.+++.....+++..+..++.||+.||+|||+. +|+||||||+|||++.++.+||+|||+++..... ....
T Consensus 97 ~~~~L~~~l~~~~~l~~~~~~~~~~qi~~al~~lH~~---~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~--~~~~ 171 (328)
T 3fe3_A 97 SGGEVFDYLVAHGRMKEKEARSKFRQIVSAVQYCHQK---RIVHRDLKAENLLLDADMNIKIADFGFSNEFTVG--GKLD 171 (328)
T ss_dssp TTCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECSTTCCGGGSSS--CGGG
T ss_pred CCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC---CEeccCCCHHHEEEcCCCCEEEeeccCceecCCC--Cccc
Confidence 9999999998888899999999999999999999998 9999999999999999999999999999876433 2334
Q ss_pred cccccCCcccccccccCCCC-cccceehHHHHHHHHHhcCcCCCcchhhhhhhhHHHHHHHhhcccchhHhhhchhcccC
Q 003836 662 AIRGTKGYVAPEWFRNMPIT-VKVDVYSYGVLLLEIICLRRNIDNEISKVDKAILTDWAYDRYQERTLEALVENDLEAMN 740 (792)
Q Consensus 662 ~~~gt~~y~aPE~~~~~~~~-~k~DV~S~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 740 (792)
...||+.|+|||.+.+..++ .++|||||||++|||++|+.||......... ..+..... ..
T Consensus 172 ~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~----------------~~i~~~~~--~~ 233 (328)
T 3fe3_A 172 AFCGAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQNLKELR----------------ERVLRGKY--RI 233 (328)
T ss_dssp TTSSSGGGCCHHHHHTCCCCSHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHH----------------HHHHHCCC--CC
T ss_pred cccCCcceeCcccccCCCcCCchhhhhhhHHHHHHHHhCCCCCCCCCHHHHH----------------HHHHhCCC--CC
Confidence 56799999999999888765 8999999999999999999999764322110 00111111 11
Q ss_pred CHHHHHHHHHHHHHccccCCCCCCCHHhHHHH
Q 003836 741 NVTMLHRFVMVAFWCIQEDPSHRPTMRKVTQM 772 (792)
Q Consensus 741 ~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~ 772 (792)
+...+.++.+++.+||+.||.+|||++|+++.
T Consensus 234 p~~~s~~~~~li~~~L~~dP~~R~t~~eil~h 265 (328)
T 3fe3_A 234 PFYMSTDCENLLKRFLVLNPIKRGTLEQIMKD 265 (328)
T ss_dssp CTTSCHHHHHHHHHHCCSSTTTSCCHHHHTTC
T ss_pred CCCCCHHHHHHHHHHCCCChhHCcCHHHHhcC
Confidence 22345678899999999999999999999875
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.9e-41 Score=359.61 Aligned_cols=269 Identities=24% Similarity=0.360 Sum_probs=203.8
Q ss_pred hhhhhcCccccceEEEeeecCCCceEEEEEEcccccccchHHHHHHHHHhcccCCCCcccccceeccCC----ceEEEEE
Q 003836 504 GFKEELGRGAFGTVYKGFVNMGSSNHVAVKKLNSVFQDSEKEFKAEVNGIGQTHHKNLVRLLGYCDEGQ----NRLLVYE 579 (792)
Q Consensus 504 ~~~~~lG~G~~g~Vy~g~~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~----~~~lV~E 579 (792)
.+.++||+|+||+||+|... ++.||||++... ......+.+|+.++++++||||+++++++.+.. ..++|||
T Consensus 27 ~~~~~lg~G~~g~Vy~~~~~---~~~vavK~~~~~-~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~lv~e 102 (322)
T 3soc_A 27 QLLEVKARGRFGCVWKAQLL---NEYVAVKIFPIQ-DKQSWQNEYEVYSLPGMKHENILQFIGAEKRGTSVDVDLWLITA 102 (322)
T ss_dssp EEEEEEECSTTCEEEEEEET---TEEEEEEEECGG-GHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEEEE
T ss_pred hhhheecccCceEEEEEEEC---CCEEEEEEeecC-chHHHHHHHHHHHHhcCCCCCchhhcceeccCCCCCceEEEEEe
Confidence 35578999999999999764 578999999654 333456677999999999999999999997754 4699999
Q ss_pred eccCCCccccccCCCCCchhHHHHHHHHHHHHHHHHhhcc-------CCCeEecCCCCCcEEEcCCCCeEEeecCCCccc
Q 003836 580 FMSNGTVASFLFGDSKPNWKLRTEIAMGIAGGLFYLHEEC-------CTQIIHCDIKPQNILLDDHYNARISDFGLAKLL 652 (792)
Q Consensus 580 ~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~-------~~~ivH~dikp~NILl~~~~~~kl~Dfg~a~~~ 652 (792)
|+++|+|.+++.. ..+++..+..++.||+.||+|||+.+ ..+|+||||||+|||++.++.+||+|||+++..
T Consensus 103 ~~~~g~L~~~l~~-~~~~~~~~~~i~~qi~~al~~LH~~~~~l~~~~~~~ivH~Dlkp~Nill~~~~~~kL~DFg~a~~~ 181 (322)
T 3soc_A 103 FHEKGSLSDFLKA-NVVSWNELCHIAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFGLALKF 181 (322)
T ss_dssp CCTTCBHHHHHHH-CCBCHHHHHHHHHHHHHHHHHHTCCEEEETTEEECEEECSCCSGGGEEECTTCCEEECCCTTCEEE
T ss_pred cCCCCCHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHHhhccccccccCCCEEeCCCChHhEEECCCCeEEEccCCccccc
Confidence 9999999999965 45899999999999999999999852 238999999999999999999999999999876
Q ss_pred cCCCCC-ccccccccCCccccccccc-----CCCCcccceehHHHHHHHHHhcCcCCCcchhhhhhhhHHHHHHHhhccc
Q 003836 653 TLDQSH-TNTAIRGTKGYVAPEWFRN-----MPITVKVDVYSYGVLLLEIICLRRNIDNEISKVDKAILTDWAYDRYQER 726 (792)
Q Consensus 653 ~~~~~~-~~~~~~gt~~y~aPE~~~~-----~~~~~k~DV~S~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 726 (792)
...... ......||+.|+|||.+.+ ..++.++|||||||++|||++|+.||............... .......
T Consensus 182 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~-~~~~~~~ 260 (322)
T 3soc_A 182 EAGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEYMLPFEEEI-GQHPSLE 260 (322)
T ss_dssp CTTSCCCCCTTCCCCGGGCCHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHTTBTTSSSCCCCCCCTTHHHH-CSSCCHH
T ss_pred ccccCccccccCccCccccCHhhcccccccCcCCCccchhHHHHHHHHHHHhCCCCCCCCcchhccchhhhh-ccCCchh
Confidence 544332 2334579999999999976 35677899999999999999999999754322111100000 0000000
Q ss_pred chhH-hhhchhccc-----CCHHHHHHHHHHHHHccccCCCCCCCHHhHHHHhccCcC
Q 003836 727 TLEA-LVENDLEAM-----NNVTMLHRFVMVAFWCIQEDPSHRPTMRKVTQMLEGVVE 778 (792)
Q Consensus 727 ~~~~-~~~~~~~~~-----~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~L~~~~~ 778 (792)
.+.. ......... .....+.++.+++.+||+.||++|||++||++.|+.+.+
T Consensus 261 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~l~~ 318 (322)
T 3soc_A 261 DMQEVVVHKKKRPVLRDYWQKHAGMAMLCETIEECWDHDAEARLSAGCVGERITQMQR 318 (322)
T ss_dssp HHHHHHTTSCCCCCCCGGGGSSHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred hhhhhhhcccCCCCccccccccchHHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHH
Confidence 0000 111111111 123456779999999999999999999999999987643
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-40 Score=350.06 Aligned_cols=264 Identities=24% Similarity=0.342 Sum_probs=208.0
Q ss_pred hhhhhhcCccccceEEEeeecCCCceEEEEEEccccc---ccchHHHHHHHHHhcccCCCCcccccceeccCCceEEEEE
Q 003836 503 RGFKEELGRGAFGTVYKGFVNMGSSNHVAVKKLNSVF---QDSEKEFKAEVNGIGQTHHKNLVRLLGYCDEGQNRLLVYE 579 (792)
Q Consensus 503 ~~~~~~lG~G~~g~Vy~g~~~~~~~~~vavK~~~~~~---~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~lV~E 579 (792)
+.+.+.||+|+||.||++... ..++.||+|++.... ....+.+.+|+.++++++||||+++++++.+.+..++|||
T Consensus 13 y~i~~~lg~G~~g~V~~~~~~-~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e 91 (294)
T 4eqm_A 13 YKIVDKLGGGGMSTVYLAEDT-ILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSMIDVDEEDDCYYLVME 91 (294)
T ss_dssp EEEEEEEEEETTEEEEEEEET-TTCSEEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCBTTBCCEEEEEECSSEEEEEEE
T ss_pred EEEEEEEccCCCEEEEEEEEC-CCCCeEEEEEeccCccccHHHHHHHHHHHHHHhcCCCCCCceEEEeeeeCCeEEEEEe
Confidence 345678999999999999754 456789999985432 2334678999999999999999999999999999999999
Q ss_pred eccCCCccccccCCCCCchhHHHHHHHHHHHHHHHHhhccCCCeEecCCCCCcEEEcCCCCeEEeecCCCccccCCCCCc
Q 003836 580 FMSNGTVASFLFGDSKPNWKLRTEIAMGIAGGLFYLHEECCTQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLDQSHT 659 (792)
Q Consensus 580 ~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dikp~NILl~~~~~~kl~Dfg~a~~~~~~~~~~ 659 (792)
|+++++|.+++.....+++..+..++.||+.||+|||+. +|+||||||+|||++.++.+||+|||+++.........
T Consensus 92 ~~~g~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~ 168 (294)
T 4eqm_A 92 YIEGPTLSEYIESHGPLSVDTAINFTNQILDGIKHAHDM---RIVHRDIKPQNILIDSNKTLKIFDFGIAKALSETSLTQ 168 (294)
T ss_dssp CCCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEECCCSSSTTC-------
T ss_pred CCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEEeCCCccccccccccc
Confidence 999999999998878899999999999999999999998 99999999999999999999999999998765444344
Q ss_pred cccccccCCcccccccccCCCCcccceehHHHHHHHHHhcCcCCCcchhhhhhhhHHHHHHHhhcccchhHhhhchhccc
Q 003836 660 NTAIRGTKGYVAPEWFRNMPITVKVDVYSYGVLLLEIICLRRNIDNEISKVDKAILTDWAYDRYQERTLEALVENDLEAM 739 (792)
Q Consensus 660 ~~~~~gt~~y~aPE~~~~~~~~~k~DV~S~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 739 (792)
.....||+.|+|||.+.+..++.++||||||+++|||++|+.||........ ........ .. .....
T Consensus 169 ~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~-------~~~~~~~~-~~-----~~~~~ 235 (294)
T 4eqm_A 169 TNHVLGTVQYFSPEQAKGEATDECTDIYSIGIVLYEMLVGEPPFNGETAVSI-------AIKHIQDS-VP-----NVTTD 235 (294)
T ss_dssp ------CCSSCCHHHHHTCCCCTTHHHHHHHHHHHHHHHSSCSSCSSCHHHH-------HHHHHSSC-CC-----CHHHH
T ss_pred cCccccCccccCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHH-------HHHHhhcc-CC-----Ccchh
Confidence 4456799999999999999999999999999999999999999976532211 00111110 00 00011
Q ss_pred CCHHHHHHHHHHHHHccccCCCCCC-CHHhHHHHhccCcCCCCCC
Q 003836 740 NNVTMLHRFVMVAFWCIQEDPSHRP-TMRKVTQMLEGVVEVPIPP 783 (792)
Q Consensus 740 ~~~~~~~~l~~l~~~Cl~~~p~~RP-s~~evl~~L~~~~~~~~p~ 783 (792)
.....+..+.+++.+||+.||++|| +++++.+.|+.++.-....
T Consensus 236 ~~~~~~~~l~~li~~~l~~dp~~R~~~~~~l~~~l~~~~~~~~~~ 280 (294)
T 4eqm_A 236 VRKDIPQSLSNVILRATEKDKANRYKTIQEMKDDLSSVLHENRAN 280 (294)
T ss_dssp SCTTSCHHHHHHHHHHSCSSGGGSCSSHHHHHHHHHTSSSSSSTT
T ss_pred cccCCCHHHHHHHHHHhcCCHhHccccHHHHHHHHHHHHhhccCC
Confidence 1223456788999999999999998 9999999999876554443
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-40 Score=348.47 Aligned_cols=254 Identities=25% Similarity=0.383 Sum_probs=208.8
Q ss_pred hhhhhhcCccccceEEEeeecCCCceEEEEEEcccccccchHHHHHHHHHhcccCCCCcccccceeccCCceEEEEEecc
Q 003836 503 RGFKEELGRGAFGTVYKGFVNMGSSNHVAVKKLNSVFQDSEKEFKAEVNGIGQTHHKNLVRLLGYCDEGQNRLLVYEFMS 582 (792)
Q Consensus 503 ~~~~~~lG~G~~g~Vy~g~~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~lV~E~~~ 582 (792)
+.+.+.||+|+||.||++... ++..||+|++... ....+++.+|++++.+++||||+++++++.+....++||||++
T Consensus 10 y~~~~~lg~G~~g~V~~~~~~--~~~~vavK~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 86 (268)
T 3sxs_A 10 ITLLKELGSGQFGVVKLGKWK--GQYDVAVKMIKEG-SMSEDEFFQEAQTMMKLSHPKLVKFYGVCSKEYPIYIVTEYIS 86 (268)
T ss_dssp EEEEEEEEEETTEEEEEEEET--TTEEEEEEEECBT-TBCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEEEEEECCT
T ss_pred eeeeeeeccCCCceEEEEEec--CceeEEEEEeccC-CCcHHHHHHHHHHHHhCCCCCEeeEEEEEccCCceEEEEEccC
Confidence 345678999999999999765 3567999999764 3345789999999999999999999999999999999999999
Q ss_pred CCCccccccCC-CCCchhHHHHHHHHHHHHHHHHhhccCCCeEecCCCCCcEEEcCCCCeEEeecCCCccccCCCCCccc
Q 003836 583 NGTVASFLFGD-SKPNWKLRTEIAMGIAGGLFYLHEECCTQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLDQSHTNT 661 (792)
Q Consensus 583 ~gsL~~~l~~~-~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dikp~NILl~~~~~~kl~Dfg~a~~~~~~~~~~~~ 661 (792)
+++|.+++... ..+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++...........
T Consensus 87 ~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~~~~~~ 163 (268)
T 3sxs_A 87 NGCLLNYLRSHGKGLEPSQLLEMCYDVCEGMAFLESH---QFIHRDLAARNCLVDRDLCVKVSDFGMTRYVLDDQYVSSV 163 (268)
T ss_dssp TCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHHT---TEEESSCSGGGEEECTTCCEEECCTTCEEECCTTCEEECC
T ss_pred CCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCcCcceEEECCCCCEEEccCccceecchhhhhccc
Confidence 99999999765 4589999999999999999999998 9999999999999999999999999999876554433334
Q ss_pred cccccCCcccccccccCCCCcccceehHHHHHHHHHh-cCcCCCcchhhhhhhhHHHHHHHhhcccchhHhhhchhcccC
Q 003836 662 AIRGTKGYVAPEWFRNMPITVKVDVYSYGVLLLEIIC-LRRNIDNEISKVDKAILTDWAYDRYQERTLEALVENDLEAMN 740 (792)
Q Consensus 662 ~~~gt~~y~aPE~~~~~~~~~k~DV~S~Gv~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 740 (792)
...+|+.|+|||.+.+..++.++||||||+++|||++ |+.||.......... .+........
T Consensus 164 ~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~-----------------~~~~~~~~~~ 226 (268)
T 3sxs_A 164 GTKFPVKWSAPEVFHYFKYSSKSDVWAFGILMWEVFSLGKMPYDLYTNSEVVL-----------------KVSQGHRLYR 226 (268)
T ss_dssp SCCCCGGGCCHHHHHHSEEETTHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHH-----------------HHHTTCCCCC
T ss_pred CCCcCcccCCHHHHhccCCchhhhhHHHHHHHHHHHcCCCCCccccChHHHHH-----------------HHHcCCCCCC
Confidence 4456778999999998899999999999999999999 999986543221100 0001111111
Q ss_pred CHHHHHHHHHHHHHccccCCCCCCCHHhHHHHhccCcCC
Q 003836 741 NVTMLHRFVMVAFWCIQEDPSHRPTMRKVTQMLEGVVEV 779 (792)
Q Consensus 741 ~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~L~~~~~~ 779 (792)
+...+..+.+++.+||+.+|++|||++|+++.|+.+.+-
T Consensus 227 ~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~l~~~ 265 (268)
T 3sxs_A 227 PHLASDTIYQIMYSCWHELPEKRPTFQQLLSSIEPLREK 265 (268)
T ss_dssp CTTSCHHHHHHHHHTTCSSGGGSCCHHHHHHHHGGGCC-
T ss_pred CCcChHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhhhc
Confidence 222345788999999999999999999999999988653
|
| >4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-40 Score=348.30 Aligned_cols=253 Identities=25% Similarity=0.424 Sum_probs=208.2
Q ss_pred hhhhhhcCccccceEEEeeecCCCceEEEEEEcccccccchHHHHHHHHHhcccCCCCcccccceeccCCceEEEEEecc
Q 003836 503 RGFKEELGRGAFGTVYKGFVNMGSSNHVAVKKLNSVFQDSEKEFKAEVNGIGQTHHKNLVRLLGYCDEGQNRLLVYEFMS 582 (792)
Q Consensus 503 ~~~~~~lG~G~~g~Vy~g~~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~lV~E~~~ 582 (792)
+.+.+.||+|+||.||++... +++.||+|++... ....+++.+|++++++++||||+++++++.+.+..++||||++
T Consensus 12 y~~~~~lg~G~~g~V~~~~~~--~~~~vavK~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 88 (269)
T 4hcu_A 12 LTFVQEIGSGQFGLVHLGYWL--NKDKVAIKTIREG-AMSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFME 88 (269)
T ss_dssp EEEEEEEEECSSCEEEEEEET--TTEEEEEEEECTT-SBCHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEEECCT
T ss_pred ceeeheecCCCccEEEEEEec--CCCeEEEEEeccc-ccCHHHHHHHHHHHHhCCCCCEeeEEEEEecCCceEEEEEeCC
Confidence 345578999999999999764 3567999999764 3345789999999999999999999999999999999999999
Q ss_pred CCCccccccCC-CCCchhHHHHHHHHHHHHHHHHhhccCCCeEecCCCCCcEEEcCCCCeEEeecCCCccccCCCCCccc
Q 003836 583 NGTVASFLFGD-SKPNWKLRTEIAMGIAGGLFYLHEECCTQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLDQSHTNT 661 (792)
Q Consensus 583 ~gsL~~~l~~~-~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dikp~NILl~~~~~~kl~Dfg~a~~~~~~~~~~~~ 661 (792)
+++|.+++... ..+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++...........
T Consensus 89 ~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~ 165 (269)
T 4hcu_A 89 HGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEA---CVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSST 165 (269)
T ss_dssp TCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECGGGCEEECCTTGGGGBCCHHHHSTT
T ss_pred CCcHHHHHHhcCcccCHHHHHHHHHHHHHHHHHHHhC---CeecCCcchheEEEcCCCCEEecccccccccccccccccc
Confidence 99999999654 5689999999999999999999998 9999999999999999999999999999876543333333
Q ss_pred cccccCCcccccccccCCCCcccceehHHHHHHHHHh-cCcCCCcchhhhhhhhHHHHHHHhhcccchhHhhhchhcccC
Q 003836 662 AIRGTKGYVAPEWFRNMPITVKVDVYSYGVLLLEIIC-LRRNIDNEISKVDKAILTDWAYDRYQERTLEALVENDLEAMN 740 (792)
Q Consensus 662 ~~~gt~~y~aPE~~~~~~~~~k~DV~S~Gv~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 740 (792)
...+++.|+|||.+.+..++.++||||||+++|||++ |+.||........ . ..+........
T Consensus 166 ~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~~g~~p~~~~~~~~~---~--------------~~~~~~~~~~~ 228 (269)
T 4hcu_A 166 GTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEV---V--------------EDISTGFRLYK 228 (269)
T ss_dssp STTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHH---H--------------HHHHTTCCCCC
T ss_pred CcccccccCCHHHhcCCCCCchhhhHHHHHHHHHHhcCCCCCCCCCCHHHH---H--------------HHHhcCccCCC
Confidence 4457888999999998999999999999999999999 8999865432211 0 00011111122
Q ss_pred CHHHHHHHHHHHHHccccCCCCCCCHHhHHHHhccCcC
Q 003836 741 NVTMLHRFVMVAFWCIQEDPSHRPTMRKVTQMLEGVVE 778 (792)
Q Consensus 741 ~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~L~~~~~ 778 (792)
+...+..+.+++.+||+.+|++|||++|++++|+++.+
T Consensus 229 ~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~l~~ 266 (269)
T 4hcu_A 229 PRLASTHVYQIMNHCWRERPEDRPAFSRLLRQLAEIAE 266 (269)
T ss_dssp CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred CCcCCHHHHHHHHHHccCCcccCcCHHHHHHHHHHHHH
Confidence 22345678899999999999999999999999987653
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-39 Score=350.63 Aligned_cols=261 Identities=21% Similarity=0.286 Sum_probs=213.3
Q ss_pred cccCHHHHHHHHhhh------------hhhcCccccceEEEeeecCCCceEEEEEEcccccccchHHHHHHHHHhcccCC
Q 003836 491 RCFTYKELVEVTRGF------------KEELGRGAFGTVYKGFVNMGSSNHVAVKKLNSVFQDSEKEFKAEVNGIGQTHH 558 (792)
Q Consensus 491 ~~~~~~el~~~~~~~------------~~~lG~G~~g~Vy~g~~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h 558 (792)
..+++++++.++... .+.||+|+||.||+|... .+++.||||++........+.+.+|+.++++++|
T Consensus 23 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lg~G~~g~V~~a~~~-~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h 101 (321)
T 2c30_A 23 GVVTHEQFKAALRMVVDQGDPRLLLDSYVKIGEGSTGIVCLAREK-HSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQH 101 (321)
T ss_dssp --CCHHHHHHHHHTTSCSSCHHHHEEEEEEEEEETTEEEEEEEET-TTCCEEEEEEEETTTCCSHHHHHHHHHHHTTCCC
T ss_pred CcCcHHHHHHHHhhccCCCCchhhhhccEEeccCCCeEEEEEEEC-CCCcEEEEEEEeccchhHHHHHHHHHHHHHhCCC
Confidence 568899999888642 247999999999999764 4567999999987666677889999999999999
Q ss_pred CCcccccceeccCCceEEEEEeccCCCccccccCCCCCchhHHHHHHHHHHHHHHHHhhccCCCeEecCCCCCcEEEcCC
Q 003836 559 KNLVRLLGYCDEGQNRLLVYEFMSNGTVASFLFGDSKPNWKLRTEIAMGIAGGLFYLHEECCTQIIHCDIKPQNILLDDH 638 (792)
Q Consensus 559 ~niv~l~g~~~~~~~~~lV~E~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dikp~NILl~~~ 638 (792)
|||+++++++...+..++||||+++++|.+++.. ..+++..+..++.||+.||+|||+. +|+||||||+|||++.+
T Consensus 102 ~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~-~~l~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~ 177 (321)
T 2c30_A 102 FNVVEMYKSYLVGEELWVLMEFLQGGALTDIVSQ-VRLNEEQIATVCEAVLQALAYLHAQ---GVIHRDIKSDSILLTLD 177 (321)
T ss_dssp TTBCCEEEEEEETTEEEEEECCCCSCBHHHHHTT-CCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTT
T ss_pred CCcceEEEEEEECCEEEEEEecCCCCCHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCC
Confidence 9999999999999999999999999999999864 4689999999999999999999998 99999999999999999
Q ss_pred CCeEEeecCCCccccCCCCCccccccccCCcccccccccCCCCcccceehHHHHHHHHHhcCcCCCcchhhhhhhhHHHH
Q 003836 639 YNARISDFGLAKLLTLDQSHTNTAIRGTKGYVAPEWFRNMPITVKVDVYSYGVLLLEIICLRRNIDNEISKVDKAILTDW 718 (792)
Q Consensus 639 ~~~kl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DV~S~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~ 718 (792)
+.+||+|||+++....... ......||+.|+|||.+.+..++.++||||||+++|||++|+.||..........
T Consensus 178 ~~~kl~Dfg~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~pf~~~~~~~~~~----- 251 (321)
T 2c30_A 178 GRVKLSDFGFCAQISKDVP-KRKSLVGTPYWMAPEVISRSLYATEVDIWSLGIMVIEMVDGEPPYFSDSPVQAMK----- 251 (321)
T ss_dssp CCEEECCCTTCEECCSSSC-CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHH-----
T ss_pred CcEEEeeeeeeeecccCcc-ccccccCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHH-----
Confidence 9999999999987654322 2234569999999999999999999999999999999999999996543211100
Q ss_pred HHHhhcccchhHhhhchhcccCCHHHHHHHHHHHHHccccCCCCCCCHHhHHHH
Q 003836 719 AYDRYQERTLEALVENDLEAMNNVTMLHRFVMVAFWCIQEDPSHRPTMRKVTQM 772 (792)
Q Consensus 719 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~ 772 (792)
..... ..+.. ......+..+.+++.+||+.||++|||++|+++.
T Consensus 252 ---~~~~~-----~~~~~--~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~h 295 (321)
T 2c30_A 252 ---RLRDS-----PPPKL--KNSHKVSPVLRDFLERMLVRDPQERATAQELLDH 295 (321)
T ss_dssp ---HHHHS-----SCCCC--TTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred ---HHhcC-----CCCCc--CccccCCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 00000 00000 0112234578899999999999999999999874
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-40 Score=375.94 Aligned_cols=254 Identities=27% Similarity=0.391 Sum_probs=211.9
Q ss_pred hhhhhhcCccccceEEEeeecCCCceEEEEEEcccccccchHHHHHHHHHhcccCCCCcccccceeccCCceEEEEEecc
Q 003836 503 RGFKEELGRGAFGTVYKGFVNMGSSNHVAVKKLNSVFQDSEKEFKAEVNGIGQTHHKNLVRLLGYCDEGQNRLLVYEFMS 582 (792)
Q Consensus 503 ~~~~~~lG~G~~g~Vy~g~~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~lV~E~~~ 582 (792)
+.+.++||+|+||.||+|... ..++.||||+++... ...++|.+|++++++++||||++++++|.+....+|||||++
T Consensus 222 ~~~~~~lG~G~fg~Vy~~~~~-~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~E~~~ 299 (495)
T 1opk_A 222 ITMKHKLGGGQYGEVYEGVWK-KYSLTVAVKTLKEDT-MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMT 299 (495)
T ss_dssp EEEEEESGGGTTSSEEEEEEG-GGTEEEEEEECCSSS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCT
T ss_pred ceeeeEecCCCCeEEEEEEEc-CCCeEEEEEEecCcc-cchHHHHHHHHHHHhcCCCCEeeEEEEEecCCcEEEEEEccC
Confidence 345678999999999999865 346789999997643 346789999999999999999999999999999999999999
Q ss_pred CCCccccccCC--CCCchhHHHHHHHHHHHHHHHHhhccCCCeEecCCCCCcEEEcCCCCeEEeecCCCccccCCCCCcc
Q 003836 583 NGTVASFLFGD--SKPNWKLRTEIAMGIAGGLFYLHEECCTQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLDQSHTN 660 (792)
Q Consensus 583 ~gsL~~~l~~~--~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dikp~NILl~~~~~~kl~Dfg~a~~~~~~~~~~~ 660 (792)
+|+|.+++... ..+++..+..|+.||+.||+|||++ +|+||||||+|||++.++.+||+|||+++..........
T Consensus 300 ~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~---~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~~ 376 (495)
T 1opk_A 300 YGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKK---NFIHRNLAARNCLVGENHLVKVADFGLSRLMTGDTYTAH 376 (495)
T ss_dssp TCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECGGGCEEECCTTCEECCTTCCEECC
T ss_pred CCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCChhhEEECCCCcEEEeecccceeccCCceeec
Confidence 99999999753 4688999999999999999999998 999999999999999999999999999987654433333
Q ss_pred ccccccCCcccccccccCCCCcccceehHHHHHHHHHh-cCcCCCcchhhhhhhhHHHHHHHhhcccchhHhhhchhccc
Q 003836 661 TAIRGTKGYVAPEWFRNMPITVKVDVYSYGVLLLEIIC-LRRNIDNEISKVDKAILTDWAYDRYQERTLEALVENDLEAM 739 (792)
Q Consensus 661 ~~~~gt~~y~aPE~~~~~~~~~k~DV~S~Gv~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 739 (792)
....+++.|+|||.+....++.++|||||||++|||++ |+.||....... +...+.......
T Consensus 377 ~~~~~~~~y~aPE~~~~~~~~~~sDvwSlG~~l~el~t~g~~p~~~~~~~~-----------------~~~~~~~~~~~~ 439 (495)
T 1opk_A 377 AGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQ-----------------VYELLEKDYRME 439 (495)
T ss_dssp TTCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCGGG-----------------HHHHHHTTCCCC
T ss_pred CCCcCCcceeCHhHHhcCCCCcHHhHHhHHHHHHHHHhCCCCCCCCCCHHH-----------------HHHHHHcCCCCC
Confidence 34456789999999998899999999999999999999 888886542211 111122222233
Q ss_pred CCHHHHHHHHHHHHHccccCCCCCCCHHhHHHHhccCcC
Q 003836 740 NNVTMLHRFVMVAFWCIQEDPSHRPTMRKVTQMLEGVVE 778 (792)
Q Consensus 740 ~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~L~~~~~ 778 (792)
.+...+..+.+++.+||+.||++|||+.+|+++|+.+.+
T Consensus 440 ~~~~~~~~l~~li~~cl~~dP~~RPs~~el~~~L~~~~~ 478 (495)
T 1opk_A 440 RPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQ 478 (495)
T ss_dssp CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSCS
T ss_pred CCCCCCHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHHh
Confidence 344456788999999999999999999999999998754
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-39 Score=355.86 Aligned_cols=249 Identities=24% Similarity=0.316 Sum_probs=203.7
Q ss_pred hhhhhhcCccccceEEEeeecCCCceEEEEEEccccccc------chHHHHHHHHHhcccCCCCcccccceeccCCceEE
Q 003836 503 RGFKEELGRGAFGTVYKGFVNMGSSNHVAVKKLNSVFQD------SEKEFKAEVNGIGQTHHKNLVRLLGYCDEGQNRLL 576 (792)
Q Consensus 503 ~~~~~~lG~G~~g~Vy~g~~~~~~~~~vavK~~~~~~~~------~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~l 576 (792)
+.+.+.||+|+||.||++... .+++.+|+|++...... ..+.+.+|+.++++++||||+++++++.+....++
T Consensus 14 y~~~~~LG~G~fg~V~~~~~~-~~~~~~avK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~l 92 (361)
T 2yab_A 14 YDIGEELGSGQFAIVKKCREK-STGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIITLHDVYENRTDVVL 92 (361)
T ss_dssp EEEEEEEEEETTEEEEEEEET-TTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEE
T ss_pred eEEeeEEeeCcCEEEEEEEEC-CCCCEEEEEEEEccccccccchhHHHHHHHHHHHHHhCCCcCCCcEEEEEEeCCEEEE
Confidence 345678999999999999754 56789999999764322 35789999999999999999999999999999999
Q ss_pred EEEeccCCCccccccCCCCCchhHHHHHHHHHHHHHHHHhhccCCCeEecCCCCCcEEEcCCC----CeEEeecCCCccc
Q 003836 577 VYEFMSNGTVASFLFGDSKPNWKLRTEIAMGIAGGLFYLHEECCTQIIHCDIKPQNILLDDHY----NARISDFGLAKLL 652 (792)
Q Consensus 577 V~E~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dikp~NILl~~~~----~~kl~Dfg~a~~~ 652 (792)
||||+++|+|.+++.....+++..+..++.||+.||.|||+. +|+||||||+|||++.++ .+||+|||+++..
T Consensus 93 v~e~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~---givHrDlkp~NIll~~~~~~~~~vkl~DFG~a~~~ 169 (361)
T 2yab_A 93 ILELVSGGELFDFLAQKESLSEEEATSFIKQILDGVNYLHTK---KIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEI 169 (361)
T ss_dssp EEECCCSCBHHHHHTTCSCCBHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESCTTSSSCCEEECCCSSCEEC
T ss_pred EEEcCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEeCCCCCccCEEEEecCCceEc
Confidence 999999999999998888899999999999999999999998 999999999999998877 7999999999876
Q ss_pred cCCCCCccccccccCCcccccccccCCCCcccceehHHHHHHHHHhcCcCCCcchhhhhhhhHHHHHHHhhcccchhHhh
Q 003836 653 TLDQSHTNTAIRGTKGYVAPEWFRNMPITVKVDVYSYGVLLLEIICLRRNIDNEISKVDKAILTDWAYDRYQERTLEALV 732 (792)
Q Consensus 653 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DV~S~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 732 (792)
.... ......||+.|+|||++.+..++.++|||||||++|||++|..||........ +... .....
T Consensus 170 ~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~~ll~g~~Pf~~~~~~~~---~~~i-----~~~~~---- 235 (361)
T 2yab_A 170 EDGV--EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQET---LANI-----TAVSY---- 235 (361)
T ss_dssp CTTC--CCCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHH---HHHH-----HTTCC----
T ss_pred CCCC--ccccCCCCccEECchHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCHHHH---HHHH-----HhcCC----
Confidence 5422 23345699999999999999999999999999999999999999976432211 1000 00000
Q ss_pred hchhcccCCHHHHHHHHHHHHHccccCCCCCCCHHhHHH
Q 003836 733 ENDLEAMNNVTMLHRFVMVAFWCIQEDPSHRPTMRKVTQ 771 (792)
Q Consensus 733 ~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~ 771 (792)
..........+..+.+++.+||+.||++|||++|+++
T Consensus 236 --~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~ 272 (361)
T 2yab_A 236 --DFDEEFFSQTSELAKDFIRKLLVKETRKRLTIQEALR 272 (361)
T ss_dssp --CCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred --CCCchhccCCCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence 0000000123467889999999999999999999987
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-39 Score=352.66 Aligned_cols=246 Identities=24% Similarity=0.282 Sum_probs=204.8
Q ss_pred hhhhhcCccccceEEEeeecCCCceEEEEEEcccc---cccchHHHHHHHHHhcccCCCCcccccceeccCCceEEEEEe
Q 003836 504 GFKEELGRGAFGTVYKGFVNMGSSNHVAVKKLNSV---FQDSEKEFKAEVNGIGQTHHKNLVRLLGYCDEGQNRLLVYEF 580 (792)
Q Consensus 504 ~~~~~lG~G~~g~Vy~g~~~~~~~~~vavK~~~~~---~~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~lV~E~ 580 (792)
.+.+.||+|+||.||++... .+++.||+|++++. .......+.+|++++++++||||+++++++.+.+..++||||
T Consensus 8 ~~~~~lG~G~fg~V~~~~~~-~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~lv~E~ 86 (337)
T 1o6l_A 8 DYLKLLGKGTFGKVILVREK-ATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEY 86 (337)
T ss_dssp EEEEEEEECSSEEEEEEEET-TTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEEEEC
T ss_pred EEEEEEecCCCeEEEEEEEC-CCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhCCCCcCcceEEEEEeCCEEEEEEeC
Confidence 34578999999999999754 56789999999753 234456789999999999999999999999999999999999
Q ss_pred ccCCCccccccCCCCCchhHHHHHHHHHHHHHHHHhhccCCCeEecCCCCCcEEEcCCCCeEEeecCCCccccCCCCCcc
Q 003836 581 MSNGTVASFLFGDSKPNWKLRTEIAMGIAGGLFYLHEECCTQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLDQSHTN 660 (792)
Q Consensus 581 ~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dikp~NILl~~~~~~kl~Dfg~a~~~~~~~~~~~ 660 (792)
+++|+|..++.....+++..+..++.||+.||+|||++ +|+||||||+|||++.++.+||+|||+++...... ...
T Consensus 87 ~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~~-~~~ 162 (337)
T 1o6l_A 87 ANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSR---DVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDG-ATM 162 (337)
T ss_dssp CTTCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCCTTCBCSCCTT-CCB
T ss_pred CCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCcCCHHHEEECCCCCEEEeeccchhhcccCC-Ccc
Confidence 99999999998878899999999999999999999998 99999999999999999999999999998643222 223
Q ss_pred ccccccCCcccccccccCCCCcccceehHHHHHHHHHhcCcCCCcchhhhhhhhHHHHHHHhhcccchhHhhhchhcccC
Q 003836 661 TAIRGTKGYVAPEWFRNMPITVKVDVYSYGVLLLEIICLRRNIDNEISKVDKAILTDWAYDRYQERTLEALVENDLEAMN 740 (792)
Q Consensus 661 ~~~~gt~~y~aPE~~~~~~~~~k~DV~S~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 740 (792)
....||+.|+|||++.+..++.++|||||||++|||++|+.||........ . ..+..... ..
T Consensus 163 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~---~-------------~~i~~~~~--~~ 224 (337)
T 1o6l_A 163 KTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERL---F-------------ELILMEEI--RF 224 (337)
T ss_dssp CCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHH---H-------------HHHHHCCC--CC
T ss_pred cccccChhhCChhhhcCCCCCchhhcccchhHHHHHhcCCCCCCCCCHHHH---H-------------HHHHcCCC--CC
Confidence 456799999999999999999999999999999999999999975432111 0 00111111 12
Q ss_pred CHHHHHHHHHHHHHccccCCCCCC-----CHHhHHHH
Q 003836 741 NVTMLHRFVMVAFWCIQEDPSHRP-----TMRKVTQM 772 (792)
Q Consensus 741 ~~~~~~~l~~l~~~Cl~~~p~~RP-----s~~evl~~ 772 (792)
+...+.++.+++.+||+.||++|| +++||++.
T Consensus 225 p~~~s~~~~~li~~lL~~dP~~R~g~~~~~~~ei~~h 261 (337)
T 1o6l_A 225 PRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEH 261 (337)
T ss_dssp CTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTS
T ss_pred CCCCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHHcC
Confidence 233456788999999999999999 89999864
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-40 Score=362.70 Aligned_cols=256 Identities=25% Similarity=0.372 Sum_probs=205.8
Q ss_pred hhhhhhcCccccceEEEeee----cCCCceEEEEEEcccccc-cchHHHHHHHHHhccc-CCCCcccccceeccCCc-eE
Q 003836 503 RGFKEELGRGAFGTVYKGFV----NMGSSNHVAVKKLNSVFQ-DSEKEFKAEVNGIGQT-HHKNLVRLLGYCDEGQN-RL 575 (792)
Q Consensus 503 ~~~~~~lG~G~~g~Vy~g~~----~~~~~~~vavK~~~~~~~-~~~~~~~~Ei~~l~~l-~h~niv~l~g~~~~~~~-~~ 575 (792)
+.+.+.||+|+||.||+|.. +..+++.||||+++.... ...+.+.+|++++.++ +||||+++++++.+.+. .+
T Consensus 24 y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv~~~~~~~~~~~~~~ 103 (359)
T 3vhe_A 24 LKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLM 103 (359)
T ss_dssp EEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTTSCCE
T ss_pred eeeceeecCCCCceEEEEEeccccccccceEEEEEEecCcCCHHHHHHHHHHHHHHHhhcCCcceeeeeeeeecCCCceE
Confidence 34457899999999999974 334568999999976433 3346799999999999 79999999999987654 89
Q ss_pred EEEEeccCCCccccccCCCC------------------------------------------------------------
Q 003836 576 LVYEFMSNGTVASFLFGDSK------------------------------------------------------------ 595 (792)
Q Consensus 576 lV~E~~~~gsL~~~l~~~~~------------------------------------------------------------ 595 (792)
+||||+++|+|.+++.....
T Consensus 104 iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 183 (359)
T 3vhe_A 104 VIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEEKSLSDVEEEEAPE 183 (359)
T ss_dssp EEEECCTTEEHHHHHHTTTTSBCSCC------------------------------------------------------
T ss_pred EEEEecCCCcHHHHHHhccccccccccccchhhcccccccccchhhhccccccCccccccccccccccccchhhhccccc
Confidence 99999999999999976432
Q ss_pred ------CchhHHHHHHHHHHHHHHHHhhccCCCeEecCCCCCcEEEcCCCCeEEeecCCCccccCCCC-CccccccccCC
Q 003836 596 ------PNWKLRTEIAMGIAGGLFYLHEECCTQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLDQS-HTNTAIRGTKG 668 (792)
Q Consensus 596 ------l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dikp~NILl~~~~~~kl~Dfg~a~~~~~~~~-~~~~~~~gt~~ 668 (792)
+++..+..++.||+.||+|||++ +|+||||||+|||++.++.+||+|||+++....... .......||+.
T Consensus 184 ~~~~~~l~~~~~~~~~~ql~~aL~~LH~~---~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~t~~ 260 (359)
T 3vhe_A 184 DLYKDFLTLEHLICYSFQVAKGMEFLASR---KCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLK 260 (359)
T ss_dssp CTTTTCBCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCEEECCCGGGSCTTSCTTCEEC--CEECGG
T ss_pred chhccccCHHHHHHHHHHHHHHHHHHHHC---CcccCCCChhhEEEcCCCcEEEEeccceeeecccccchhccccCCCce
Confidence 78899999999999999999999 999999999999999999999999999987644332 22334568999
Q ss_pred cccccccccCCCCcccceehHHHHHHHHHh-cCcCCCcchhhhhhhhHHHHHHHhhcccchhHhhhchhcccCCHHHHHH
Q 003836 669 YVAPEWFRNMPITVKVDVYSYGVLLLEIIC-LRRNIDNEISKVDKAILTDWAYDRYQERTLEALVENDLEAMNNVTMLHR 747 (792)
Q Consensus 669 y~aPE~~~~~~~~~k~DV~S~Gv~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 747 (792)
|+|||.+.+..++.++||||||+++|||++ |+.||........ +...+........+...+.+
T Consensus 261 y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~----------------~~~~~~~~~~~~~~~~~~~~ 324 (359)
T 3vhe_A 261 WMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEE----------------FCRRLKEGTRMRAPDYTTPE 324 (359)
T ss_dssp GCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSHH----------------HHHHHHHTCCCCCCTTCCHH
T ss_pred eEChhhhcCCCCCchhhhhhHHHHHHHHHhcCCCCCCccchhHH----------------HHHHHHcCCCCCCCCCCCHH
Confidence 999999999999999999999999999998 9999965432111 00111111112223334567
Q ss_pred HHHHHHHccccCCCCCCCHHhHHHHhccCc
Q 003836 748 FVMVAFWCIQEDPSHRPTMRKVTQMLEGVV 777 (792)
Q Consensus 748 l~~l~~~Cl~~~p~~RPs~~evl~~L~~~~ 777 (792)
+.+++.+||+.||++|||++||+++|+.++
T Consensus 325 l~~li~~~l~~dP~~Rps~~ell~~L~~~~ 354 (359)
T 3vhe_A 325 MYQTMLDCWHGEPSQRPTFSELVEHLGNLL 354 (359)
T ss_dssp HHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred HHHHHHHHccCChhhCCCHHHHHHHHHHHH
Confidence 889999999999999999999999998765
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-40 Score=371.62 Aligned_cols=253 Identities=26% Similarity=0.403 Sum_probs=207.7
Q ss_pred hhhhhhcCccccceEEEeeecCCCceEEEEEEcccccccchHHHHHHHHHhcccCCCCcccccceeccCCceEEEEEecc
Q 003836 503 RGFKEELGRGAFGTVYKGFVNMGSSNHVAVKKLNSVFQDSEKEFKAEVNGIGQTHHKNLVRLLGYCDEGQNRLLVYEFMS 582 (792)
Q Consensus 503 ~~~~~~lG~G~~g~Vy~g~~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~lV~E~~~ 582 (792)
..+.+.||+|+||.||+|... .+..||||+++... ...+.|.+|++++++++||||+++++++. .+..++||||++
T Consensus 190 ~~~~~~lG~G~fg~V~~~~~~--~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~iv~l~~~~~-~~~~~lv~e~~~ 265 (454)
T 1qcf_A 190 LKLEKKLGAGQFGEVWMATYN--KHTKVAVKTMKPGS-MSVEAFLAEANVMKTLQHDKLVKLHAVVT-KEPIYIITEFMA 265 (454)
T ss_dssp EEEEEEEECCSSEEEEEEEET--TTEEEEEEEECTTS-BCHHHHHHHHHHHTTCCCTTBCCEEEEEC-SSSCEEEECCCT
T ss_pred eEEEEEcccCCceEEEEEEEC--CccEEEEEEecCCC-ccHHHHHHHHHHHhhCCCCCEeeEEEEEe-CCccEEEEeecC
Confidence 345678999999999999875 35679999997643 45788999999999999999999999986 567899999999
Q ss_pred CCCccccccCC--CCCchhHHHHHHHHHHHHHHHHhhccCCCeEecCCCCCcEEEcCCCCeEEeecCCCccccCCCCCcc
Q 003836 583 NGTVASFLFGD--SKPNWKLRTEIAMGIAGGLFYLHEECCTQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLDQSHTN 660 (792)
Q Consensus 583 ~gsL~~~l~~~--~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dikp~NILl~~~~~~kl~Dfg~a~~~~~~~~~~~ 660 (792)
+|+|.+++... ..+++..+.+++.||+.||+|||++ +|+||||||+|||++.++.+||+|||+++..........
T Consensus 266 ~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~---~ivHrDlkp~Nill~~~~~~kl~DFG~a~~~~~~~~~~~ 342 (454)
T 1qcf_A 266 KGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQR---NYIHRDLRAANILVSASLVCKIADFGLARVIEDNEYTAR 342 (454)
T ss_dssp TCBHHHHHHSHHHHTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSSCSGGGEEECTTCCEEECSTTGGGGBCCHHHHTT
T ss_pred CCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCCHHHEEECCCCcEEEeeCCCceEcCCCceecc
Confidence 99999999764 3678899999999999999999998 999999999999999999999999999987643322222
Q ss_pred ccccccCCcccccccccCCCCcccceehHHHHHHHHHh-cCcCCCcchhhhhhhhHHHHHHHhhcccchhHhhhchhccc
Q 003836 661 TAIRGTKGYVAPEWFRNMPITVKVDVYSYGVLLLEIIC-LRRNIDNEISKVDKAILTDWAYDRYQERTLEALVENDLEAM 739 (792)
Q Consensus 661 ~~~~gt~~y~aPE~~~~~~~~~k~DV~S~Gv~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 739 (792)
....+++.|+|||.+....++.++|||||||++|||++ |+.||......... ..+.......
T Consensus 343 ~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~t~g~~P~~~~~~~~~~-----------------~~i~~~~~~~ 405 (454)
T 1qcf_A 343 EGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVI-----------------RALERGYRMP 405 (454)
T ss_dssp CSSSSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHH-----------------HHHHHTCCCC
T ss_pred CCCcccccccCHHHhccCCCCcHHHHHhHHHHHHHHHhCCCCCCCCCCHHHHH-----------------HHHHcCCCCC
Confidence 33446788999999998999999999999999999999 99999654321110 0111111222
Q ss_pred CCHHHHHHHHHHHHHccccCCCCCCCHHhHHHHhccCcCC
Q 003836 740 NNVTMLHRFVMVAFWCIQEDPSHRPTMRKVTQMLEGVVEV 779 (792)
Q Consensus 740 ~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~L~~~~~~ 779 (792)
.+...+.++.+++.+||+.||++|||+++|+++|+.+...
T Consensus 406 ~~~~~~~~l~~li~~cl~~dp~~RPt~~~i~~~L~~~~~~ 445 (454)
T 1qcf_A 406 RPENCPEELYNIMMRCWKNRPEERPTFEYIQSVLDDFYTA 445 (454)
T ss_dssp CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSSSS
T ss_pred CCCCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHHhc
Confidence 2334567889999999999999999999999999998653
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-39 Score=348.81 Aligned_cols=250 Identities=25% Similarity=0.341 Sum_probs=204.5
Q ss_pred HhhhhhhcCccccceEEEeeecCCCceEEEEEEccccccc------chHHHHHHHHHhcccCCCCcccccceeccCCceE
Q 003836 502 TRGFKEELGRGAFGTVYKGFVNMGSSNHVAVKKLNSVFQD------SEKEFKAEVNGIGQTHHKNLVRLLGYCDEGQNRL 575 (792)
Q Consensus 502 ~~~~~~~lG~G~~g~Vy~g~~~~~~~~~vavK~~~~~~~~------~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~ 575 (792)
.+.+.+.||+|+||.||++... .+++.||+|++...... ..+.+.+|+.++++++||||+++++++.+....+
T Consensus 12 ~y~~~~~lG~G~~g~V~~~~~~-~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~ 90 (326)
T 2y0a_A 12 YYDTGEELGSGQFAVVKKCREK-STGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDVI 90 (326)
T ss_dssp HEEEEEEEECCSSEEEEEEEET-TTCCEEEEEEEEBCCSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred ceEeceEEeeCCCeEEEEEEEC-CCCcEEEEEEEEccccccccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEE
Confidence 4556688999999999999754 45679999998754321 3578999999999999999999999999999999
Q ss_pred EEEEeccCCCccccccCCCCCchhHHHHHHHHHHHHHHHHhhccCCCeEecCCCCCcEEEcCCC----CeEEeecCCCcc
Q 003836 576 LVYEFMSNGTVASFLFGDSKPNWKLRTEIAMGIAGGLFYLHEECCTQIIHCDIKPQNILLDDHY----NARISDFGLAKL 651 (792)
Q Consensus 576 lV~E~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dikp~NILl~~~~----~~kl~Dfg~a~~ 651 (792)
+||||+++++|.+++.....+++..+..++.||+.||.|||+. +|+||||||+|||++.++ .+||+|||+++.
T Consensus 91 lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dlkp~NIll~~~~~~~~~~kl~Dfg~a~~ 167 (326)
T 2y0a_A 91 LILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHSL---QIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHK 167 (326)
T ss_dssp EEEECCCSCBHHHHHTTSSCCBHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESCSSSSSCCEEECCCTTCEE
T ss_pred EEEEcCCCCCHHHHHHhcCCcCHHHHHHHHHHHHHHHHHHHHC---CeEcCCCCHHHEEEecCCCCCCCEEEEECCCCeE
Confidence 9999999999999998888899999999999999999999998 999999999999999887 899999999987
Q ss_pred ccCCCCCccccccccCCcccccccccCCCCcccceehHHHHHHHHHhcCcCCCcchhhhhhhhHHHHHHHhhcccchhHh
Q 003836 652 LTLDQSHTNTAIRGTKGYVAPEWFRNMPITVKVDVYSYGVLLLEIICLRRNIDNEISKVDKAILTDWAYDRYQERTLEAL 731 (792)
Q Consensus 652 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DV~S~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 731 (792)
..... ......||+.|+|||.+.+..++.++|||||||++|||++|+.||........ +.......
T Consensus 168 ~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~---~~~~~~~~--------- 233 (326)
T 2y0a_A 168 IDFGN--EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQET---LANVSAVN--------- 233 (326)
T ss_dssp CCTTS--CCCCCCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHH---HHHHHHTC---------
T ss_pred CCCCC--ccccccCCcCcCCceeecCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHHH---HHHHHhcC---------
Confidence 64332 22345699999999999999999999999999999999999999965432211 10000000
Q ss_pred hhchhcccCCHHHHHHHHHHHHHccccCCCCCCCHHhHHH
Q 003836 732 VENDLEAMNNVTMLHRFVMVAFWCIQEDPSHRPTMRKVTQ 771 (792)
Q Consensus 732 ~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~ 771 (792)
...........+..+.+++.+||+.||++|||++|+++
T Consensus 234 --~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 271 (326)
T 2y0a_A 234 --YEFEDEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQ 271 (326)
T ss_dssp --CCCCHHHHTTSCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred --CCcCccccccCCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence 00000000123456889999999999999999999998
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-40 Score=370.11 Aligned_cols=250 Identities=20% Similarity=0.235 Sum_probs=202.2
Q ss_pred hhhcCccccceEEEeeecCCCceEEEEEEccccc---ccchHHHHHHHHHhcccCCCCcccccceeccCCceEEEEEecc
Q 003836 506 KEELGRGAFGTVYKGFVNMGSSNHVAVKKLNSVF---QDSEKEFKAEVNGIGQTHHKNLVRLLGYCDEGQNRLLVYEFMS 582 (792)
Q Consensus 506 ~~~lG~G~~g~Vy~g~~~~~~~~~vavK~~~~~~---~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~lV~E~~~ 582 (792)
.++||+|+||+||++... .+++.||+|++.+.. ......+.+|+.++.+++||||++++++|.+.+..+|||||++
T Consensus 79 ~~~LG~G~fG~V~~~~~~-~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~~~~~~lV~Ey~~ 157 (437)
T 4aw2_A 79 LKVIGRGAFGEVAVVKLK-NADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWITTLHYAFQDDNNLYLVMDYYV 157 (437)
T ss_dssp EEEEEECSSEEEEEEEET-TTTEEEEEEEEEHHHHHHTTTTCCHHHHHHHHHHSCTTTBCCEEEEEECSSEEEEEECCCT
T ss_pred EEEEEeCCCEEEEEEEEc-CCCcEEEEEEEEHHHhhhHHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCCEEEEEEecCC
Confidence 468999999999999765 456899999997532 2223448899999999999999999999999999999999999
Q ss_pred CCCccccccC-CCCCchhHHHHHHHHHHHHHHHHhhccCCCeEecCCCCCcEEEcCCCCeEEeecCCCccccCCCCCccc
Q 003836 583 NGTVASFLFG-DSKPNWKLRTEIAMGIAGGLFYLHEECCTQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLDQSHTNT 661 (792)
Q Consensus 583 ~gsL~~~l~~-~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dikp~NILl~~~~~~kl~Dfg~a~~~~~~~~~~~~ 661 (792)
+|+|.+++.. ...+++..+..++.||+.||+|||+. +|+||||||+||||+.++.+||+|||+++...........
T Consensus 158 gg~L~~~l~~~~~~l~e~~~~~~~~qi~~aL~~LH~~---giiHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~~~~~~ 234 (437)
T 4aw2_A 158 GGDLLTLLSKFEDRLPEEMARFYLAEMVIAIDSVHQL---HYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQSS 234 (437)
T ss_dssp TCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECCTTSCEECC
T ss_pred CCcHHHHHHHccCCCCHHHHHHHHHHHHHHHHHHHhC---CeEecccCHHHeeEcCCCCEEEcchhhhhhcccCCCcccc
Confidence 9999999987 46799999999999999999999998 9999999999999999999999999999877655444445
Q ss_pred cccccCCcccccccc-----cCCCCcccceehHHHHHHHHHhcCcCCCcchhhhhhhhHHHHHHHhhcccchhHhhhchh
Q 003836 662 AIRGTKGYVAPEWFR-----NMPITVKVDVYSYGVLLLEIICLRRNIDNEISKVDKAILTDWAYDRYQERTLEALVENDL 736 (792)
Q Consensus 662 ~~~gt~~y~aPE~~~-----~~~~~~k~DV~S~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 736 (792)
...||+.|+|||++. ...++.++|||||||++|||++|+.||...........+.... ..+. .
T Consensus 235 ~~~GT~~Y~APE~l~~~~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~---------~~~~---~ 302 (437)
T 4aw2_A 235 VAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHK---------ERFQ---F 302 (437)
T ss_dssp SCCSCGGGCCHHHHHHHHTSCCEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTHH---------HHCC---C
T ss_pred cccCCcCeeChHHHhhcccCCCCCCCcCeeHHHHHHHHHHHhCCCCCCCCChhHHHHhhhhcc---------cccc---C
Confidence 567999999999987 5678999999999999999999999997643221111110000 0000 0
Q ss_pred cccCCHHHHHHHHHHHHHccccCCCC--CCCHHhHHHH
Q 003836 737 EAMNNVTMLHRFVMVAFWCIQEDPSH--RPTMRKVTQM 772 (792)
Q Consensus 737 ~~~~~~~~~~~l~~l~~~Cl~~~p~~--RPs~~evl~~ 772 (792)
.......+.++.+++.+||+.+|++ ||+++|+++.
T Consensus 303 -p~~~~~~s~~~~dLi~~lL~~~~~r~~r~~~~eil~H 339 (437)
T 4aw2_A 303 -PTQVTDVSENAKDLIRRLICSREHRLGQNGIEDFKKH 339 (437)
T ss_dssp -CSSCCCSCHHHHHHHHTTSSCGGGCTTTTTTHHHHTS
T ss_pred -CcccccCCHHHHHHHHHHhcccccccCCCCHHHHhCC
Confidence 0011124567889999999888888 9999999975
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-40 Score=347.39 Aligned_cols=252 Identities=23% Similarity=0.388 Sum_probs=205.0
Q ss_pred hhhhhhcCccccceEEEeeecCCCceEEEEEEcccccccchHHHHHHHHHhcccCCCCcccccceeccCCceEEEEEecc
Q 003836 503 RGFKEELGRGAFGTVYKGFVNMGSSNHVAVKKLNSVFQDSEKEFKAEVNGIGQTHHKNLVRLLGYCDEGQNRLLVYEFMS 582 (792)
Q Consensus 503 ~~~~~~lG~G~~g~Vy~g~~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~lV~E~~~ 582 (792)
+.+.+.||+|+||.||++... ++..||+|++... ....+++.+|++++.+++|+||+++++++.+.+..++||||++
T Consensus 26 y~~~~~lg~G~~g~V~~~~~~--~~~~vavK~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 102 (283)
T 3gen_A 26 LTFLKELGTGQFGVVKYGKWR--GQYDVAIKMIKEG-SMSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYMA 102 (283)
T ss_dssp EEEEEECC---CEEEEEEEET--TTEEEEEEEECTT-SBCHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEECCCT
T ss_pred HHhHhhcCCCCCceEEEEEEc--CCCeEEEEEecCC-CCCHHHHHHHHHHHhcCCCCCEeeEEEEEecCCCeEEEEeccC
Confidence 345678999999999999765 4568999999764 3345789999999999999999999999999999999999999
Q ss_pred CCCccccccC-CCCCchhHHHHHHHHHHHHHHHHhhccCCCeEecCCCCCcEEEcCCCCeEEeecCCCccccCCCCCccc
Q 003836 583 NGTVASFLFG-DSKPNWKLRTEIAMGIAGGLFYLHEECCTQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLDQSHTNT 661 (792)
Q Consensus 583 ~gsL~~~l~~-~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dikp~NILl~~~~~~kl~Dfg~a~~~~~~~~~~~~ 661 (792)
+++|.+++.. ...+++..+..++.||+.||+|||++ +|+||||||+|||++.++.+||+|||+++...........
T Consensus 103 ~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~ 179 (283)
T 3gen_A 103 NGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESK---QFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSV 179 (283)
T ss_dssp TCBHHHHHHCGGGCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSSCSGGGEEECTTSCEEECSTTGGGGBCCHHHHSTT
T ss_pred CCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHHC---CccCCCCccceEEEcCCCCEEEcccccccccccccccccc
Confidence 9999999976 45789999999999999999999998 9999999999999999999999999999876543333333
Q ss_pred cccccCCcccccccccCCCCcccceehHHHHHHHHHh-cCcCCCcchhhhhhhhHHHHHHHhhcccchhHhhhchhcccC
Q 003836 662 AIRGTKGYVAPEWFRNMPITVKVDVYSYGVLLLEIIC-LRRNIDNEISKVDKAILTDWAYDRYQERTLEALVENDLEAMN 740 (792)
Q Consensus 662 ~~~gt~~y~aPE~~~~~~~~~k~DV~S~Gv~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 740 (792)
...+|+.|+|||.+.+..++.++||||||+++|||++ |+.||......... ..+........
T Consensus 180 ~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~t~g~~p~~~~~~~~~~-----------------~~~~~~~~~~~ 242 (283)
T 3gen_A 180 GSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETA-----------------EHIAQGLRLYR 242 (283)
T ss_dssp STTSCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHH-----------------HHHHTTCCCCC
T ss_pred CCccCcccCCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCccccChhHHH-----------------HHHhcccCCCC
Confidence 3456788999999998899999999999999999998 99998654322110 00111111112
Q ss_pred CHHHHHHHHHHHHHccccCCCCCCCHHhHHHHhccCc
Q 003836 741 NVTMLHRFVMVAFWCIQEDPSHRPTMRKVTQMLEGVV 777 (792)
Q Consensus 741 ~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~L~~~~ 777 (792)
+...++.+.+++.+||+.+|++|||++|+++.|+++.
T Consensus 243 ~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~~~ 279 (283)
T 3gen_A 243 PHLASEKVYTIMYSCWHEKADERPTFKILLSNILDVM 279 (283)
T ss_dssp CTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHH
T ss_pred CCcCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHh
Confidence 2233467889999999999999999999999998764
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-40 Score=354.91 Aligned_cols=254 Identities=24% Similarity=0.356 Sum_probs=200.8
Q ss_pred hhhhhhcCccccceEEEeeecCCC---ceEEEEEEccccc-ccchHHHHHHHHHhcccCCCCcccccceeccCCceEEEE
Q 003836 503 RGFKEELGRGAFGTVYKGFVNMGS---SNHVAVKKLNSVF-QDSEKEFKAEVNGIGQTHHKNLVRLLGYCDEGQNRLLVY 578 (792)
Q Consensus 503 ~~~~~~lG~G~~g~Vy~g~~~~~~---~~~vavK~~~~~~-~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~lV~ 578 (792)
+.+.+.||+|+||+||+|...... ...||+|++.... ....+++.+|+.++++++||||++++++|.+.. .++|+
T Consensus 17 y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~-~~~v~ 95 (327)
T 3poz_A 17 FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTST-VQLIT 95 (327)
T ss_dssp EEEEEEEEEETTEEEEEEEECC----CCEEEEEEEC-------CHHHHHHHHHHHHHCCBTTBCCEEEEEESSS-EEEEE
T ss_pred cccceEEeeCCCeEEEEEEEcCCCceEEEEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCC-eEEEE
Confidence 344578999999999999764322 1246888886433 345678999999999999999999999998764 78999
Q ss_pred EeccCCCccccccCC-CCCchhHHHHHHHHHHHHHHHHhhccCCCeEecCCCCCcEEEcCCCCeEEeecCCCccccCCCC
Q 003836 579 EFMSNGTVASFLFGD-SKPNWKLRTEIAMGIAGGLFYLHEECCTQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLDQS 657 (792)
Q Consensus 579 E~~~~gsL~~~l~~~-~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dikp~NILl~~~~~~kl~Dfg~a~~~~~~~~ 657 (792)
||+++|+|.+++... ..+++..+..++.||+.||+|||+. +|+||||||+|||++.++.+||+|||+++.......
T Consensus 96 e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~---~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~ 172 (327)
T 3poz_A 96 QLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEK 172 (327)
T ss_dssp ECCTTCBHHHHHHHSTTSCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEEETTEEEECCTTHHHHHTTTCC
T ss_pred EecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhC---CeeCCCCChheEEECCCCCEEEccCcceeEccCCcc
Confidence 999999999999764 5789999999999999999999999 999999999999999999999999999987654433
Q ss_pred Cc-cccccccCCcccccccccCCCCcccceehHHHHHHHHHh-cCcCCCcchhhhhhhhHHHHHHHhhcccchhHhhhch
Q 003836 658 HT-NTAIRGTKGYVAPEWFRNMPITVKVDVYSYGVLLLEIIC-LRRNIDNEISKVDKAILTDWAYDRYQERTLEALVEND 735 (792)
Q Consensus 658 ~~-~~~~~gt~~y~aPE~~~~~~~~~k~DV~S~Gv~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 735 (792)
.. .....+|+.|+|||.+.+..++.++|||||||++|||++ |+.||....... +...+...
T Consensus 173 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~-----------------~~~~~~~~ 235 (327)
T 3poz_A 173 EYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASE-----------------ISSILEKG 235 (327)
T ss_dssp -------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGG-----------------HHHHHHTT
T ss_pred cccccCCCccccccChHHhccCCCCchhhhhhhHHHHHHHHhcCCCCccCCCHHH-----------------HHHHHHcC
Confidence 22 223456889999999999999999999999999999999 999996543221 11122222
Q ss_pred hcccCCHHHHHHHHHHHHHccccCCCCCCCHHhHHHHhccCc
Q 003836 736 LEAMNNVTMLHRFVMVAFWCIQEDPSHRPTMRKVTQMLEGVV 777 (792)
Q Consensus 736 ~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~L~~~~ 777 (792)
.....+...+..+.+++.+||+.+|++||+++|+++.|+.+.
T Consensus 236 ~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~l~~~~ 277 (327)
T 3poz_A 236 ERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMA 277 (327)
T ss_dssp CCCCCCTTBCHHHHHHHHHHTCSCGGGSCCHHHHHHHHHHHH
T ss_pred CCCCCCccCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHH
Confidence 222233345567889999999999999999999999997754
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-39 Score=350.89 Aligned_cols=250 Identities=27% Similarity=0.377 Sum_probs=200.9
Q ss_pred hhhhhcCccccceEEEeeecCCCceEEEEEEccccc-ccchHHHHHHHHHhcccCCCCcccccceeccCCceEEEEEecc
Q 003836 504 GFKEELGRGAFGTVYKGFVNMGSSNHVAVKKLNSVF-QDSEKEFKAEVNGIGQTHHKNLVRLLGYCDEGQNRLLVYEFMS 582 (792)
Q Consensus 504 ~~~~~lG~G~~g~Vy~g~~~~~~~~~vavK~~~~~~-~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~lV~E~~~ 582 (792)
.+.+.||+|+||+||++... .+++.||||++.... ....+.+.+|+.++++++||||+++++++.+++..++||||++
T Consensus 10 ~i~~~lG~G~~g~V~~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~~ 88 (323)
T 3tki_A 10 DLVQTLGEGAYGEVQLAVNR-VTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEYCS 88 (323)
T ss_dssp EEEEEEEEETTEEEEEEEET-TTCCEEEEEEEECC-------CHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEECCT
T ss_pred eeeeEEecCCCEEEEEEEEC-CCCcEEEEEEEEcccccchHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEEEEEcCC
Confidence 34578999999999999754 456799999986533 2334678999999999999999999999999999999999999
Q ss_pred CCCccccccCCCCCchhHHHHHHHHHHHHHHHHhhccCCCeEecCCCCCcEEEcCCCCeEEeecCCCccccCCCC-Cccc
Q 003836 583 NGTVASFLFGDSKPNWKLRTEIAMGIAGGLFYLHEECCTQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLDQS-HTNT 661 (792)
Q Consensus 583 ~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dikp~NILl~~~~~~kl~Dfg~a~~~~~~~~-~~~~ 661 (792)
+|+|.+++.....+++..+..++.||+.||+|||+. +|+||||||+|||++.++.+||+|||+++....... ....
T Consensus 89 ~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~---givH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~ 165 (323)
T 3tki_A 89 GGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGI---GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLN 165 (323)
T ss_dssp TEEGGGGSBTTTBCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCCTTCEECEETTEECCBC
T ss_pred CCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHC---CccccccchHHEEEeCCCCEEEEEeeccceeccCCcccccC
Confidence 999999998888899999999999999999999998 999999999999999999999999999987643322 2233
Q ss_pred cccccCCcccccccccCCC-CcccceehHHHHHHHHHhcCcCCCcchhhhhhhhHHHHHHHhhcccchhHhhhchhcccC
Q 003836 662 AIRGTKGYVAPEWFRNMPI-TVKVDVYSYGVLLLEIICLRRNIDNEISKVDKAILTDWAYDRYQERTLEALVENDLEAMN 740 (792)
Q Consensus 662 ~~~gt~~y~aPE~~~~~~~-~~k~DV~S~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 740 (792)
...||+.|+|||.+.+..+ +.++|||||||++|||++|+.||......... ...+ . ........
T Consensus 166 ~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~--~~~~-----~--------~~~~~~~~ 230 (323)
T 3tki_A 166 KMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQE--YSDW-----K--------EKKTYLNP 230 (323)
T ss_dssp SCCSCGGGSCHHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSCTTSHH--HHHH-----H--------TTCTTSTT
T ss_pred CCccCcCccCcHHhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCchHHHH--HHHH-----h--------cccccCCc
Confidence 4679999999999987765 78999999999999999999999754322110 1010 0 00000001
Q ss_pred CHHHHHHHHHHHHHccccCCCCCCCHHhHHHH
Q 003836 741 NVTMLHRFVMVAFWCIQEDPSHRPTMRKVTQM 772 (792)
Q Consensus 741 ~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~ 772 (792)
.......+.+++.+||+.||++|||++|+++.
T Consensus 231 ~~~~~~~~~~li~~~L~~dP~~R~t~~eil~h 262 (323)
T 3tki_A 231 WKKIDSAPLALLHKILVENPSARITIPDIKKD 262 (323)
T ss_dssp GGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTC
T ss_pred cccCCHHHHHHHHHHccCChhhCcCHHHHhhC
Confidence 12234667889999999999999999999875
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-40 Score=364.67 Aligned_cols=253 Identities=25% Similarity=0.365 Sum_probs=205.7
Q ss_pred hhhhhcCccccceEEEeeecCCCceEEEEEEcccccc-cchHHHHHHHHHhcccCCCCcccccceeccCCceEEEEEecc
Q 003836 504 GFKEELGRGAFGTVYKGFVNMGSSNHVAVKKLNSVFQ-DSEKEFKAEVNGIGQTHHKNLVRLLGYCDEGQNRLLVYEFMS 582 (792)
Q Consensus 504 ~~~~~lG~G~~g~Vy~g~~~~~~~~~vavK~~~~~~~-~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~lV~E~~~ 582 (792)
.+.+.||+|+||.||+|... .+++.||||+++.... ...+.+.+|++++++++||||+++++++.+.+..++||||++
T Consensus 117 ~~~~~lG~G~~g~V~~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~ 195 (377)
T 3cbl_A 117 VLGEQIGRGNFGEVFSGRLR-ADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQ 195 (377)
T ss_dssp EEEEEEEEETTEEEEEEEET-TTCCEEEEEECCTTSCHHHHTTTTHHHHHHTTCCCTTBCCEEEEECSSSSCEEEEECCT
T ss_pred EEeeEeccCCCCeEEEEEEe-cCCeEEEEEEccccCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEecCCCcEEEEEcCC
Confidence 34578999999999999865 3467899999875432 234578899999999999999999999999999999999999
Q ss_pred CCCccccccCC-CCCchhHHHHHHHHHHHHHHHHhhccCCCeEecCCCCCcEEEcCCCCeEEeecCCCccccCCCCCcc-
Q 003836 583 NGTVASFLFGD-SKPNWKLRTEIAMGIAGGLFYLHEECCTQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLDQSHTN- 660 (792)
Q Consensus 583 ~gsL~~~l~~~-~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dikp~NILl~~~~~~kl~Dfg~a~~~~~~~~~~~- 660 (792)
+|+|.+++... ..+++..+..++.||+.||+|||++ +|+||||||+|||++.++.+||+|||+++..........
T Consensus 196 ~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~---~ivHrDlkp~Nil~~~~~~~kl~DfG~s~~~~~~~~~~~~ 272 (377)
T 3cbl_A 196 GGDFLTFLRTEGARLRVKTLLQMVGDAAAGMEYLESK---CCIHRDLAARNCLVTEKNVLKISDFGMSREEADGVYAASG 272 (377)
T ss_dssp TCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCGGGCEECTTSEEECCS
T ss_pred CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC---CcCCcccCHHHEEEcCCCcEEECcCCCceecCCCceeecC
Confidence 99999999764 4689999999999999999999999 999999999999999999999999999986543221111
Q ss_pred ccccccCCcccccccccCCCCcccceehHHHHHHHHHh-cCcCCCcchhhhhhhhHHHHHHHhhcccchhHhhhchhccc
Q 003836 661 TAIRGTKGYVAPEWFRNMPITVKVDVYSYGVLLLEIIC-LRRNIDNEISKVDKAILTDWAYDRYQERTLEALVENDLEAM 739 (792)
Q Consensus 661 ~~~~gt~~y~aPE~~~~~~~~~k~DV~S~Gv~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 739 (792)
....+++.|+|||.+....++.++||||||+++|||++ |+.||........ ...+.......
T Consensus 273 ~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~t~g~~p~~~~~~~~~-----------------~~~~~~~~~~~ 335 (377)
T 3cbl_A 273 GLRQVPVKWTAPEALNYGRYSSESDVWSFGILLWETFSLGASPYPNLSNQQT-----------------REFVEKGGRLP 335 (377)
T ss_dssp SCCEEEGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCSSTTSCHHHH-----------------HHHHHTTCCCC
T ss_pred CCCCCCcCcCCHhHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHH-----------------HHHHHcCCCCC
Confidence 12235778999999998899999999999999999998 8999865432111 11111111222
Q ss_pred CCHHHHHHHHHHHHHccccCCCCCCCHHhHHHHhccCc
Q 003836 740 NNVTMLHRFVMVAFWCIQEDPSHRPTMRKVTQMLEGVV 777 (792)
Q Consensus 740 ~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~L~~~~ 777 (792)
.+...+..+.+++.+||+.||++|||+++|++.|+.+.
T Consensus 336 ~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~i~ 373 (377)
T 3cbl_A 336 CPELCPDAVFRLMEQCWAYEPGQRPSFSTIYQELQSIR 373 (377)
T ss_dssp CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred CCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHH
Confidence 23334567889999999999999999999999998764
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=7.8e-40 Score=355.36 Aligned_cols=255 Identities=24% Similarity=0.365 Sum_probs=207.4
Q ss_pred hhhhhcCccccceEEEeeecC----CCceEEEEEEccccc-ccchHHHHHHHHHhcccCCCCcccccceeccCCceEEEE
Q 003836 504 GFKEELGRGAFGTVYKGFVNM----GSSNHVAVKKLNSVF-QDSEKEFKAEVNGIGQTHHKNLVRLLGYCDEGQNRLLVY 578 (792)
Q Consensus 504 ~~~~~lG~G~~g~Vy~g~~~~----~~~~~vavK~~~~~~-~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~lV~ 578 (792)
.+.+.||+|+||.||+|.... .+++.||||+++... ....+.+.+|+.++++++||||+++++++.+.+..++||
T Consensus 50 ~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 129 (343)
T 1luf_A 50 EYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCAVGKPMCLLF 129 (343)
T ss_dssp EEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSCEEEE
T ss_pred eeeeeeeecCCeeEEEEEecCcCCCCCceeEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEccCCceEEEE
Confidence 345789999999999998753 345789999997643 334567999999999999999999999999999999999
Q ss_pred EeccCCCccccccCC------------------------CCCchhHHHHHHHHHHHHHHHHhhccCCCeEecCCCCCcEE
Q 003836 579 EFMSNGTVASFLFGD------------------------SKPNWKLRTEIAMGIAGGLFYLHEECCTQIIHCDIKPQNIL 634 (792)
Q Consensus 579 E~~~~gsL~~~l~~~------------------------~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dikp~NIL 634 (792)
||+++|+|.+++... ..+++..++.++.||+.||.|||++ +|+||||||+|||
T Consensus 130 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~---~ivH~Dlkp~NIl 206 (343)
T 1luf_A 130 EYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSER---KFVHRDLATRNCL 206 (343)
T ss_dssp ECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEE
T ss_pred ecCCCCcHHHHHHHhCcccccccccccccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCcceEE
Confidence 999999999999653 4678999999999999999999999 9999999999999
Q ss_pred EcCCCCeEEeecCCCccccCCCC-CccccccccCCcccccccccCCCCcccceehHHHHHHHHHh-cCcCCCcchhhhhh
Q 003836 635 LDDHYNARISDFGLAKLLTLDQS-HTNTAIRGTKGYVAPEWFRNMPITVKVDVYSYGVLLLEIIC-LRRNIDNEISKVDK 712 (792)
Q Consensus 635 l~~~~~~kl~Dfg~a~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~k~DV~S~Gv~l~el~t-g~~p~~~~~~~~~~ 712 (792)
++.++.+||+|||+++....... .......+|+.|+|||.+.+..++.++||||||+++|||++ |+.||........
T Consensus 207 ~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~- 285 (343)
T 1luf_A 207 VGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYYGMAHEEV- 285 (343)
T ss_dssp ECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHH-
T ss_pred ECCCCeEEEeecCCCcccccCccccccCCCcccceecChhhhccCCcCcccccHHHHHHHHHHHhcCCCcCCCCChHHH-
Confidence 99999999999999987643322 22234557899999999998899999999999999999999 9999865432110
Q ss_pred hhHHHHHHHhhcccchhHhhhchhcccCCHHHHHHHHHHHHHccccCCCCCCCHHhHHHHhccCcC
Q 003836 713 AILTDWAYDRYQERTLEALVENDLEAMNNVTMLHRFVMVAFWCIQEDPSHRPTMRKVTQMLEGVVE 778 (792)
Q Consensus 713 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~L~~~~~ 778 (792)
. .. +.+. .....+...+..+.+++.+||+.+|++||++.+|++.|+++.+
T Consensus 286 --~-----~~--------~~~~-~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~~~~L~~~~~ 335 (343)
T 1luf_A 286 --I-----YY--------VRDG-NILACPENCPLELYNLMRLCWSKLPADRPSFCSIHRILQRMCE 335 (343)
T ss_dssp --H-----HH--------HHTT-CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTC
T ss_pred --H-----HH--------HhCC-CcCCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHHHHHHh
Confidence 0 00 0010 1111223345678899999999999999999999999998764
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-39 Score=359.84 Aligned_cols=259 Identities=26% Similarity=0.355 Sum_probs=210.2
Q ss_pred HhhhhhhcCccccceEEEeeecC------CCceEEEEEEcccccc-cchHHHHHHHHHhccc-CCCCcccccceeccCCc
Q 003836 502 TRGFKEELGRGAFGTVYKGFVNM------GSSNHVAVKKLNSVFQ-DSEKEFKAEVNGIGQT-HHKNLVRLLGYCDEGQN 573 (792)
Q Consensus 502 ~~~~~~~lG~G~~g~Vy~g~~~~------~~~~~vavK~~~~~~~-~~~~~~~~Ei~~l~~l-~h~niv~l~g~~~~~~~ 573 (792)
.+.+.+.||+|+||+||+|.... .....||||++..... ...+.+.+|+++++++ +||||+++++++.+.+.
T Consensus 70 ~y~i~~~LG~G~~g~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~~~ 149 (382)
T 3tt0_A 70 RLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDGP 149 (382)
T ss_dssp GEEEEEEEEECSSEEEEEEEEETSSTTCTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSS
T ss_pred heEeeeEEecCCCeEEEEEEEccccccccccceEEEEEeeccccCHHHHHHHHHHHHHHHHhcCCchhhhheeeeccCCc
Confidence 34456789999999999997532 2346799999976433 3446799999999999 99999999999999999
Q ss_pred eEEEEEeccCCCccccccCCC----------------CCchhHHHHHHHHHHHHHHHHhhccCCCeEecCCCCCcEEEcC
Q 003836 574 RLLVYEFMSNGTVASFLFGDS----------------KPNWKLRTEIAMGIAGGLFYLHEECCTQIIHCDIKPQNILLDD 637 (792)
Q Consensus 574 ~~lV~E~~~~gsL~~~l~~~~----------------~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dikp~NILl~~ 637 (792)
.++||||+++|+|.+++.... .+++..+..|+.||+.||+|||+. +|+||||||+|||+++
T Consensus 150 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~ 226 (382)
T 3tt0_A 150 LYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASK---KCIHRDLAARNVLVTE 226 (382)
T ss_dssp CEEEEECCTTCBHHHHHHHTCCSSSSSCCCCCSSCCCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECT
T ss_pred eEEEEEecCCCcHHHHHHHhcccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCcceEEEcC
Confidence 999999999999999996542 489999999999999999999998 9999999999999999
Q ss_pred CCCeEEeecCCCccccCCCC-CccccccccCCcccccccccCCCCcccceehHHHHHHHHHh-cCcCCCcchhhhhhhhH
Q 003836 638 HYNARISDFGLAKLLTLDQS-HTNTAIRGTKGYVAPEWFRNMPITVKVDVYSYGVLLLEIIC-LRRNIDNEISKVDKAIL 715 (792)
Q Consensus 638 ~~~~kl~Dfg~a~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~k~DV~S~Gv~l~el~t-g~~p~~~~~~~~~~~~~ 715 (792)
++.+||+|||+++....... .......+|+.|+|||.+.+..++.++|||||||++|||++ |+.||.......
T Consensus 227 ~~~~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~ellt~g~~p~~~~~~~~----- 301 (382)
T 3tt0_A 227 DNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEE----- 301 (382)
T ss_dssp TCCEEECSCSCCCCSSCCCTTCCCTTCCCGGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHH-----
T ss_pred CCcEEEcccCcccccccccccccccCCCCCcceeCHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCHHH-----
Confidence 99999999999987654332 22334457889999999999999999999999999999999 999986543211
Q ss_pred HHHHHHhhcccchhHhhhchhcccCCHHHHHHHHHHHHHccccCCCCCCCHHhHHHHhccCcCCC
Q 003836 716 TDWAYDRYQERTLEALVENDLEAMNNVTMLHRFVMVAFWCIQEDPSHRPTMRKVTQMLEGVVEVP 780 (792)
Q Consensus 716 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~L~~~~~~~ 780 (792)
+...+........+...+.++.+++.+||+.+|++|||++||++.|+.++...
T Consensus 302 ------------~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~~~ 354 (382)
T 3tt0_A 302 ------------LFKLLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIVALT 354 (382)
T ss_dssp ------------HHHHHHTTCCCCCCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHS
T ss_pred ------------HHHHHHcCCCCCCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHHH
Confidence 01111111122223344567889999999999999999999999998876443
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-40 Score=360.43 Aligned_cols=255 Identities=29% Similarity=0.347 Sum_probs=205.2
Q ss_pred hhhhhhcCccccceEEEeeec----CCCceEEEEEEcccc-cccchHHHHHHHHHhcccCCCCcccccceeccCCceEEE
Q 003836 503 RGFKEELGRGAFGTVYKGFVN----MGSSNHVAVKKLNSV-FQDSEKEFKAEVNGIGQTHHKNLVRLLGYCDEGQNRLLV 577 (792)
Q Consensus 503 ~~~~~~lG~G~~g~Vy~g~~~----~~~~~~vavK~~~~~-~~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~lV 577 (792)
+.+.+.||+|+||.||+|.+. ...++.||||++... .......+.+|+.++++++||||+++++++.+....++|
T Consensus 73 ~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv 152 (367)
T 3l9p_A 73 ITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPRFIL 152 (367)
T ss_dssp EEEEEECCCCSSSCEEEEEECC-----CCEEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEE
T ss_pred eEEeeEeeeCCCEEEEEEEEccCCCCCcceeEEEEecccccChhhHHHHHHHHHHHHhCCCCCCCeEEEEEecCCCCEEE
Confidence 445678999999999999853 234678999999754 234456789999999999999999999999999999999
Q ss_pred EEeccCCCccccccCC-------CCCchhHHHHHHHHHHHHHHHHhhccCCCeEecCCCCCcEEEcCCC---CeEEeecC
Q 003836 578 YEFMSNGTVASFLFGD-------SKPNWKLRTEIAMGIAGGLFYLHEECCTQIIHCDIKPQNILLDDHY---NARISDFG 647 (792)
Q Consensus 578 ~E~~~~gsL~~~l~~~-------~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dikp~NILl~~~~---~~kl~Dfg 647 (792)
|||+++|+|.+++... ..+++..++.++.||+.||+|||++ +|+||||||+|||++.++ .+||+|||
T Consensus 153 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~~~~~~~kL~DFG 229 (367)
T 3l9p_A 153 LELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEEN---HFIHRDIAARNCLLTCPGPGRVAKIGDFG 229 (367)
T ss_dssp EECCTTEEHHHHHHHHSCCSSSCCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESCSSTTCCEEECCCH
T ss_pred EEeCCCCCHHHHHHhhccccCccccccHHHHHHHHHHHHHHHHHHHhC---CeeCCCCChhhEEEecCCCCceEEECCCc
Confidence 9999999999999653 3578999999999999999999999 999999999999999555 59999999
Q ss_pred CCccccCCCC-CccccccccCCcccccccccCCCCcccceehHHHHHHHHHh-cCcCCCcchhhhhhhhHHHHHHHhhcc
Q 003836 648 LAKLLTLDQS-HTNTAIRGTKGYVAPEWFRNMPITVKVDVYSYGVLLLEIIC-LRRNIDNEISKVDKAILTDWAYDRYQE 725 (792)
Q Consensus 648 ~a~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~k~DV~S~Gv~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~ 725 (792)
+++....... .......+|+.|+|||.+.+..++.++|||||||++|||++ |+.||........
T Consensus 230 ~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~pf~~~~~~~~-------------- 295 (367)
T 3l9p_A 230 MARDIYRAGYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEV-------------- 295 (367)
T ss_dssp HHHHHHHHSSCTTCCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHH--------------
T ss_pred cccccccccccccCCCcCCcccEECHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHH--------------
Confidence 9986533222 22334567899999999999999999999999999999998 9999865432111
Q ss_pred cchhHhhhchhcccCCHHHHHHHHHHHHHccccCCCCCCCHHhHHHHhccCc
Q 003836 726 RTLEALVENDLEAMNNVTMLHRFVMVAFWCIQEDPSHRPTMRKVTQMLEGVV 777 (792)
Q Consensus 726 ~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~L~~~~ 777 (792)
...+........+...+..+.+++.+||+.+|++|||++||++.|+.+.
T Consensus 296 ---~~~i~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~eil~~l~~~~ 344 (367)
T 3l9p_A 296 ---LEFVTSGGRMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCT 344 (367)
T ss_dssp ---HHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred ---HHHHHcCCCCCCCccCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHh
Confidence 0111111112223344567889999999999999999999999997754
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-39 Score=367.07 Aligned_cols=255 Identities=26% Similarity=0.405 Sum_probs=203.4
Q ss_pred hhhhhcCccccceEEEeeecCCCceEEEEEEcccccccchHHHHHHHHHhcccCCCCcccccceeccCCceEEEEEeccC
Q 003836 504 GFKEELGRGAFGTVYKGFVNMGSSNHVAVKKLNSVFQDSEKEFKAEVNGIGQTHHKNLVRLLGYCDEGQNRLLVYEFMSN 583 (792)
Q Consensus 504 ~~~~~lG~G~~g~Vy~g~~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~lV~E~~~~ 583 (792)
.+.++||+|+||.||+|.... +..||||+++... ...+.|.+|++++++++||||+++++++.+ +..++||||+++
T Consensus 187 ~~~~~lG~G~fg~Vy~~~~~~--~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~-~~~~iv~e~~~~ 262 (452)
T 1fmk_A 187 RLEVKLGQGCFGEVWMGTWNG--TTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEYMSK 262 (452)
T ss_dssp EEEEEEEECSSCEEEEEEETT--TEEEEEEECCTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEECCCTT
T ss_pred eeeeeecCCCCeEEEEEEECC--CceEEEEEeccCC-CCHHHHHHHHHHHHhCCCCCEeeEEEEEcC-CceEEEehhhcC
Confidence 455789999999999998753 3579999998643 345789999999999999999999999976 678999999999
Q ss_pred CCccccccCC--CCCchhHHHHHHHHHHHHHHHHhhccCCCeEecCCCCCcEEEcCCCCeEEeecCCCccccCCCCCccc
Q 003836 584 GTVASFLFGD--SKPNWKLRTEIAMGIAGGLFYLHEECCTQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLDQSHTNT 661 (792)
Q Consensus 584 gsL~~~l~~~--~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dikp~NILl~~~~~~kl~Dfg~a~~~~~~~~~~~~ 661 (792)
|+|.+++... ..+++..+..++.||+.||+|||++ +|+||||||+|||+++++.+||+|||+++...........
T Consensus 263 gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~---~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~~~~ 339 (452)
T 1fmk_A 263 GSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERM---NYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQ 339 (452)
T ss_dssp CBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCEEECCCCTTC-----------
T ss_pred CCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCChhhEEECCCCCEEECCCccceecCCCceeccc
Confidence 9999999753 5689999999999999999999998 9999999999999999999999999999876543333333
Q ss_pred cccccCCcccccccccCCCCcccceehHHHHHHHHHh-cCcCCCcchhhhhhhhHHHHHHHhhcccchhHhhhchhcccC
Q 003836 662 AIRGTKGYVAPEWFRNMPITVKVDVYSYGVLLLEIIC-LRRNIDNEISKVDKAILTDWAYDRYQERTLEALVENDLEAMN 740 (792)
Q Consensus 662 ~~~gt~~y~aPE~~~~~~~~~k~DV~S~Gv~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 740 (792)
...+++.|+|||.+....++.++||||||+++|||++ |+.||........ ...+........
T Consensus 340 ~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~~-----------------~~~i~~~~~~~~ 402 (452)
T 1fmk_A 340 GAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREV-----------------LDQVERGYRMPC 402 (452)
T ss_dssp ---CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHH-----------------HHHHHTTCCCCC
T ss_pred CCcccccccCHhHHhcCCCCccccHHhHHHHHHHHHhCCCCCCCCCCHHHH-----------------HHHHHcCCCCCC
Confidence 4457789999999999999999999999999999999 8999865432110 011111122223
Q ss_pred CHHHHHHHHHHHHHccccCCCCCCCHHhHHHHhccCcCCCCC
Q 003836 741 NVTMLHRFVMVAFWCIQEDPSHRPTMRKVTQMLEGVVEVPIP 782 (792)
Q Consensus 741 ~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~L~~~~~~~~p 782 (792)
+...+..+.+++.+||+.+|++|||+++|++.|+.+..-..|
T Consensus 403 ~~~~~~~l~~li~~cl~~dP~~Rpt~~~l~~~L~~~~~~~~~ 444 (452)
T 1fmk_A 403 PPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTSTEP 444 (452)
T ss_dssp CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTTSCSCC
T ss_pred CCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHhccCCc
Confidence 344567889999999999999999999999999998654443
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7e-40 Score=345.43 Aligned_cols=254 Identities=21% Similarity=0.298 Sum_probs=194.0
Q ss_pred hhhhhhcCccccceEEEeeecCC--CceEEEEEEcccccc-cchHHHHHHHHHhcccCCCCcccccceeccCCceEEEEE
Q 003836 503 RGFKEELGRGAFGTVYKGFVNMG--SSNHVAVKKLNSVFQ-DSEKEFKAEVNGIGQTHHKNLVRLLGYCDEGQNRLLVYE 579 (792)
Q Consensus 503 ~~~~~~lG~G~~g~Vy~g~~~~~--~~~~vavK~~~~~~~-~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~lV~E 579 (792)
+.+.+.||+|+||.||+|..... ....||+|++..... ...+.+.+|+.++++++||||+++++++. .+..++|||
T Consensus 17 y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~lv~e 95 (281)
T 1mp8_A 17 IELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPVWIIME 95 (281)
T ss_dssp EEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-SSSCEEEEE
T ss_pred eEEEeEeeecCCeeEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCccceEEEEEc-cCccEEEEe
Confidence 44567899999999999976432 345799999876432 34567999999999999999999999985 467899999
Q ss_pred eccCCCccccccCC-CCCchhHHHHHHHHHHHHHHHHhhccCCCeEecCCCCCcEEEcCCCCeEEeecCCCccccCCCCC
Q 003836 580 FMSNGTVASFLFGD-SKPNWKLRTEIAMGIAGGLFYLHEECCTQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLDQSH 658 (792)
Q Consensus 580 ~~~~gsL~~~l~~~-~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dikp~NILl~~~~~~kl~Dfg~a~~~~~~~~~ 658 (792)
|+++++|.+++... ..+++..+..++.||+.||+|||+. +|+||||||+|||++.++.+||+|||+++........
T Consensus 96 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~ 172 (281)
T 1mp8_A 96 LCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESK---RFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYY 172 (281)
T ss_dssp CCTTEEHHHHHHHTTTTSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETTEEEECC-------------
T ss_pred cCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhC---CeecccccHHHEEECCCCCEEECccccccccCccccc
Confidence 99999999999765 3689999999999999999999998 9999999999999999999999999999876544333
Q ss_pred ccccccccCCcccccccccCCCCcccceehHHHHHHHHHh-cCcCCCcchhhhhhhhHHHHHHHhhcccchhHhhhchhc
Q 003836 659 TNTAIRGTKGYVAPEWFRNMPITVKVDVYSYGVLLLEIIC-LRRNIDNEISKVDKAILTDWAYDRYQERTLEALVENDLE 737 (792)
Q Consensus 659 ~~~~~~gt~~y~aPE~~~~~~~~~k~DV~S~Gv~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 737 (792)
......+++.|+|||.+....++.++||||||+++|||++ |+.||........ . . . +.....
T Consensus 173 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~pf~~~~~~~~---~-~------------~-i~~~~~ 235 (281)
T 1mp8_A 173 KASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDV---I-G------------R-IENGER 235 (281)
T ss_dssp ------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGH---H-H------------H-HHTTCC
T ss_pred ccccCCCcccccChhhcccCCCCCccCchHHHHHHHHHHhcCCCCCCcCCHHHH---H-H------------H-HHcCCC
Confidence 3334457889999999998899999999999999999997 8889865432211 0 0 0 001111
Q ss_pred ccCCHHHHHHHHHHHHHccccCCCCCCCHHhHHHHhccCc
Q 003836 738 AMNNVTMLHRFVMVAFWCIQEDPSHRPTMRKVTQMLEGVV 777 (792)
Q Consensus 738 ~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~L~~~~ 777 (792)
...+...+..+.+++.+||+.||++|||+.|+++.|+.++
T Consensus 236 ~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~ 275 (281)
T 1mp8_A 236 LPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTIL 275 (281)
T ss_dssp CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred CCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHH
Confidence 1123344567889999999999999999999999998764
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-40 Score=350.78 Aligned_cols=270 Identities=23% Similarity=0.335 Sum_probs=208.8
Q ss_pred hhhhhhcCccccceEEEeee---cCCCceEEEEEEccccc-ccchHHHHHHHHHhcccCCCCcccccceeccC--CceEE
Q 003836 503 RGFKEELGRGAFGTVYKGFV---NMGSSNHVAVKKLNSVF-QDSEKEFKAEVNGIGQTHHKNLVRLLGYCDEG--QNRLL 576 (792)
Q Consensus 503 ~~~~~~lG~G~~g~Vy~g~~---~~~~~~~vavK~~~~~~-~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~--~~~~l 576 (792)
+.+.+.||+|+||.||++.+ +..+++.||+|++.... ....+.+.+|++++++++||||+++++++.+. ...++
T Consensus 23 ~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~l 102 (302)
T 4e5w_A 23 LKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGIKL 102 (302)
T ss_dssp EEEEEEEEECSSEEEEEEEECTTSSSCSEEEEEEEEC-----CCHHHHHHHHHHHHTCCCTTBCCEEEEEEC---CCEEE
T ss_pred hhhhhccCCCCceEEEEEEEccccCccCeEEEEEEecccccchhHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCceEEE
Confidence 44567899999999999974 34567899999997543 33457899999999999999999999999876 67899
Q ss_pred EEEeccCCCccccccC-CCCCchhHHHHHHHHHHHHHHHHhhccCCCeEecCCCCCcEEEcCCCCeEEeecCCCccccCC
Q 003836 577 VYEFMSNGTVASFLFG-DSKPNWKLRTEIAMGIAGGLFYLHEECCTQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLD 655 (792)
Q Consensus 577 V~E~~~~gsL~~~l~~-~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dikp~NILl~~~~~~kl~Dfg~a~~~~~~ 655 (792)
||||+++|+|.+++.. ...+++..+..++.||+.||+|||+. +|+||||||+|||++.++.+||+|||+++.....
T Consensus 103 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~ 179 (302)
T 4e5w_A 103 IMEFLPSGSLKEYLPKNKNKINLKQQLKYAVQICKGMDYLGSR---QYVHRDLAARNVLVESEHQVKIGDFGLTKAIETD 179 (302)
T ss_dssp EEECCTTCBHHHHHHHHTTTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEEETTEEEECCCTTCEECCTT
T ss_pred EEEeCCCCcHHHHHHhccccCCHHHHHHHHHHHHHHHHHhhcC---CcccCCCchheEEEcCCCCEEECcccccccccCC
Confidence 9999999999999954 45789999999999999999999998 9999999999999999999999999999876544
Q ss_pred CC--CccccccccCCcccccccccCCCCcccceehHHHHHHHHHhcCcCCCcchhhhhhhhHHHHHHHhhcccchhHhhh
Q 003836 656 QS--HTNTAIRGTKGYVAPEWFRNMPITVKVDVYSYGVLLLEIICLRRNIDNEISKVDKAILTDWAYDRYQERTLEALVE 733 (792)
Q Consensus 656 ~~--~~~~~~~gt~~y~aPE~~~~~~~~~k~DV~S~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 733 (792)
.. .......+|..|+|||.+.+..++.++||||||+++|||++|+.|+............ ..........+...+.
T Consensus 180 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~ 257 (302)
T 4e5w_A 180 KEYYTVKDDRDSPVFWYAPECLMQSKFYIASDVWSFGVTLHELLTYCDSDSSPMALFLKMIG--PTHGQMTVTRLVNTLK 257 (302)
T ss_dssp CCEEECCCCTTCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHHC--SCCGGGHHHHHHHHHH
T ss_pred CcceeccCCCCCCccccCCeeecCCCCCcchhHHHHHHHHHHHHHccCCCcchhhHHhhccC--CcccccCHHHHHHHHh
Confidence 32 1223456788899999999999999999999999999999999886443211100000 0000000011112222
Q ss_pred chhcccCCHHHHHHHHHHHHHccccCCCCCCCHHhHHHHhccCc
Q 003836 734 NDLEAMNNVTMLHRFVMVAFWCIQEDPSHRPTMRKVTQMLEGVV 777 (792)
Q Consensus 734 ~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~L~~~~ 777 (792)
.......+...+..+.+++.+||+.||.+|||++|++++|+.++
T Consensus 258 ~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~ll 301 (302)
T 4e5w_A 258 EGKRLPCPPNCPDEVYQLMRKCWEFQPSNRTSFQNLIEGFEALL 301 (302)
T ss_dssp TTCCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHH
T ss_pred ccCCCCCCCCCCHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHh
Confidence 22223334455678999999999999999999999999998764
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-39 Score=354.51 Aligned_cols=257 Identities=26% Similarity=0.376 Sum_probs=207.3
Q ss_pred hhhhhhcCccccceEEEeee----cCCCceEEEEEEccccc-ccchHHHHHHHHHhccc-CCCCcccccceeccCCceEE
Q 003836 503 RGFKEELGRGAFGTVYKGFV----NMGSSNHVAVKKLNSVF-QDSEKEFKAEVNGIGQT-HHKNLVRLLGYCDEGQNRLL 576 (792)
Q Consensus 503 ~~~~~~lG~G~~g~Vy~g~~----~~~~~~~vavK~~~~~~-~~~~~~~~~Ei~~l~~l-~h~niv~l~g~~~~~~~~~l 576 (792)
+.+.+.||+|+||.||+|.. ..+.++.||||++.... ....+.+.+|+.++.++ +||||+++++++...+..++
T Consensus 47 y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~l 126 (344)
T 1rjb_A 47 LEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLSGPIYL 126 (344)
T ss_dssp EEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEE
T ss_pred ceeeeeecCCCCceeEEeeeeccccCCcceEEEEEecccccCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEeeCCccEE
Confidence 44567899999999999986 23456789999997542 33457899999999999 89999999999999999999
Q ss_pred EEEeccCCCccccccCCC-----------------------CCchhHHHHHHHHHHHHHHHHhhccCCCeEecCCCCCcE
Q 003836 577 VYEFMSNGTVASFLFGDS-----------------------KPNWKLRTEIAMGIAGGLFYLHEECCTQIIHCDIKPQNI 633 (792)
Q Consensus 577 V~E~~~~gsL~~~l~~~~-----------------------~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dikp~NI 633 (792)
||||+++|+|.+++.... .+++..+..++.||+.||+|||+. +|+||||||+||
T Consensus 127 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dikp~NI 203 (344)
T 1rjb_A 127 IFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFK---SCVHRDLAARNV 203 (344)
T ss_dssp EEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHT---TEEETTCSGGGE
T ss_pred EEecCCCCcHHHHHhhccccccccccchhhhcccccccccccCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCChhhE
Confidence 999999999999997643 268899999999999999999998 999999999999
Q ss_pred EEcCCCCeEEeecCCCccccCCCCCc-cccccccCCcccccccccCCCCcccceehHHHHHHHHHh-cCcCCCcchhhhh
Q 003836 634 LLDDHYNARISDFGLAKLLTLDQSHT-NTAIRGTKGYVAPEWFRNMPITVKVDVYSYGVLLLEIIC-LRRNIDNEISKVD 711 (792)
Q Consensus 634 Ll~~~~~~kl~Dfg~a~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~k~DV~S~Gv~l~el~t-g~~p~~~~~~~~~ 711 (792)
|++.++.+||+|||+++......... .....+|+.|+|||.+.+..++.++||||||+++|||+| |+.||........
T Consensus 204 ll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~ 283 (344)
T 1rjb_A 204 LVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGIPVDAN 283 (344)
T ss_dssp EEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSHH
T ss_pred EEcCCCcEEeCCCccCcccccCccceeccCccCccCccCHHHhccCCCChhHhHHHHHHHHHHHHcCCCCCcccCCcHHH
Confidence 99999999999999998765443322 233457889999999999999999999999999999998 9999965432211
Q ss_pred hhhHHHHHHHhhcccchhHhhhchhcccCCHHHHHHHHHHHHHccccCCCCCCCHHhHHHHhccCcC
Q 003836 712 KAILTDWAYDRYQERTLEALVENDLEAMNNVTMLHRFVMVAFWCIQEDPSHRPTMRKVTQMLEGVVE 778 (792)
Q Consensus 712 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~L~~~~~ 778 (792)
....+........+...+..+.+++.+||+.||.+|||+.|+++.|+.++.
T Consensus 284 ----------------~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~~~ 334 (344)
T 1rjb_A 284 ----------------FYKLIQNGFKMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLGCQLA 334 (344)
T ss_dssp ----------------HHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC-
T ss_pred ----------------HHHHHhcCCCCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHHH
Confidence 011111112222233345678899999999999999999999999988654
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-40 Score=350.01 Aligned_cols=253 Identities=23% Similarity=0.384 Sum_probs=203.4
Q ss_pred hhhhhhcCccccceEEEeeecCCC------ceEEEEEEcccccccchHHHHHHHHHhcccCCCCcccccceeccCCceEE
Q 003836 503 RGFKEELGRGAFGTVYKGFVNMGS------SNHVAVKKLNSVFQDSEKEFKAEVNGIGQTHHKNLVRLLGYCDEGQNRLL 576 (792)
Q Consensus 503 ~~~~~~lG~G~~g~Vy~g~~~~~~------~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~l 576 (792)
+.+.+.||+|+||+||+|...... ...||+|++........+.+.+|++++++++||||+++++++.+++..++
T Consensus 10 y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 89 (289)
T 4fvq_A 10 LIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSHKHLVLNYGVCVCGDENIL 89 (289)
T ss_dssp EEEEEEEEEETTEEEEEEEEEEECGGGCEEEEEEEEEEECGGGGGGHHHHHHHHHHHHTSCCTTBCCEEEEECCTTCCEE
T ss_pred eeeeeeeccCCCceEEEEEEecccccccccchhhhhhhcccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEeCCCCEE
Confidence 445678999999999999765332 25799999987766777889999999999999999999999999999999
Q ss_pred EEEeccCCCccccccCCC-CCchhHHHHHHHHHHHHHHHHhhccCCCeEecCCCCCcEEEcCCCC--------eEEeecC
Q 003836 577 VYEFMSNGTVASFLFGDS-KPNWKLRTEIAMGIAGGLFYLHEECCTQIIHCDIKPQNILLDDHYN--------ARISDFG 647 (792)
Q Consensus 577 V~E~~~~gsL~~~l~~~~-~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dikp~NILl~~~~~--------~kl~Dfg 647 (792)
||||+++|+|.+++.... .+++..+..++.||+.||+|||++ +|+||||||+|||++.++. +||+|||
T Consensus 90 v~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~~~~~~~~~~~~kl~Dfg 166 (289)
T 4fvq_A 90 VQEFVKFGSLDTYLKKNKNCINILWKLEVAKQLAAAMHFLEEN---TLIHGNVCAKNILLIREEDRKTGNPPFIKLSDPG 166 (289)
T ss_dssp EEECCTTCBHHHHHHHTGGGCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEEEECCBGGGTBCCEEEECCCC
T ss_pred EEECCCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHhhC---CeECCCcCcceEEEecCCcccccccceeeeccCc
Confidence 999999999999997764 489999999999999999999999 9999999999999998887 9999999
Q ss_pred CCccccCCCCCccccccccCCccccccccc-CCCCcccceehHHHHHHHHHhcCcCCCcchhhhhhhhHHHHHHHhhccc
Q 003836 648 LAKLLTLDQSHTNTAIRGTKGYVAPEWFRN-MPITVKVDVYSYGVLLLEIICLRRNIDNEISKVDKAILTDWAYDRYQER 726 (792)
Q Consensus 648 ~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~k~DV~S~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 726 (792)
+++.... .....+|+.|+|||.+.+ ..++.++||||||+++|||++|+.|+............
T Consensus 167 ~~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~~~~~~~~~~~~~~----------- 230 (289)
T 4fvq_A 167 ISITVLP-----KDILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSALDSQRKLQF----------- 230 (289)
T ss_dssp SCTTTSC-----HHHHHHTTTTSCHHHHHCGGGCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHH-----------
T ss_pred ccccccC-----ccccCCcCcccCHHHhCCCCCCCchhHHHHHHHHHHHHHcCCCCCccccchHHHHHH-----------
Confidence 9875432 223457899999999987 77999999999999999999976655433221110000
Q ss_pred chhHhhhchhcccCCHHHHHHHHHHHHHccccCCCCCCCHHhHHHHhccCcCCCC
Q 003836 727 TLEALVENDLEAMNNVTMLHRFVMVAFWCIQEDPSHRPTMRKVTQMLEGVVEVPI 781 (792)
Q Consensus 727 ~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~L~~~~~~~~ 781 (792)
... ....+...+.++.+++.+||+.||++|||++|+++.|+.+..-..
T Consensus 231 -----~~~--~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~l~~p~~ 278 (289)
T 4fvq_A 231 -----YED--RHQLPAPKAAELANLINNCMDYEPDHRPSFRAIIRDLNSLFTPDL 278 (289)
T ss_dssp -----HHT--TCCCCCCSSCTTHHHHHHHSCSSGGGSCCHHHHHHHHHTCC----
T ss_pred -----hhc--cCCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhcCCCC
Confidence 000 001111124467889999999999999999999999999876443
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.1e-40 Score=350.39 Aligned_cols=256 Identities=25% Similarity=0.402 Sum_probs=209.7
Q ss_pred hhhhhhcCccccceEEEeee----cCCCceEEEEEEcccccc-cchHHHHHHHHHhccc-CCCCcccccceeccCCceEE
Q 003836 503 RGFKEELGRGAFGTVYKGFV----NMGSSNHVAVKKLNSVFQ-DSEKEFKAEVNGIGQT-HHKNLVRLLGYCDEGQNRLL 576 (792)
Q Consensus 503 ~~~~~~lG~G~~g~Vy~g~~----~~~~~~~vavK~~~~~~~-~~~~~~~~Ei~~l~~l-~h~niv~l~g~~~~~~~~~l 576 (792)
+.+.+.||+|+||.||+|.. +..+++.||||++..... ...+.+.+|++++.++ +||||+++++++.+.+..++
T Consensus 25 y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~l 104 (313)
T 1t46_A 25 LSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIGGPTLV 104 (313)
T ss_dssp EEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEE
T ss_pred hhHHHhhCccCCcceEEEEEeeccccchhhhhHHHhcCcchhHHHHHHHHHHHHHHhhcccCCCeeeEEEEEecCCCcEE
Confidence 44567899999999999975 345678999999975433 3457799999999999 99999999999999999999
Q ss_pred EEEeccCCCccccccCCC------------------CCchhHHHHHHHHHHHHHHHHhhccCCCeEecCCCCCcEEEcCC
Q 003836 577 VYEFMSNGTVASFLFGDS------------------KPNWKLRTEIAMGIAGGLFYLHEECCTQIIHCDIKPQNILLDDH 638 (792)
Q Consensus 577 V~E~~~~gsL~~~l~~~~------------------~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dikp~NILl~~~ 638 (792)
||||+++|+|.+++.... .+++..+..++.||+.||+|||+. +|+||||||+|||++.+
T Consensus 105 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~ 181 (313)
T 1t46_A 105 ITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASK---NCIHRDLAARNILLTHG 181 (313)
T ss_dssp EEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEETT
T ss_pred EEecCCCCCHHHHHHhcccccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCccceEEEcCC
Confidence 999999999999997543 388999999999999999999999 99999999999999999
Q ss_pred CCeEEeecCCCccccCCCCCc-cccccccCCcccccccccCCCCcccceehHHHHHHHHHh-cCcCCCcchhhhhhhhHH
Q 003836 639 YNARISDFGLAKLLTLDQSHT-NTAIRGTKGYVAPEWFRNMPITVKVDVYSYGVLLLEIIC-LRRNIDNEISKVDKAILT 716 (792)
Q Consensus 639 ~~~kl~Dfg~a~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~k~DV~S~Gv~l~el~t-g~~p~~~~~~~~~~~~~~ 716 (792)
+.+||+|||+++......... .....+|+.|+|||.+.+..++.++||||||+++|||++ |+.||........
T Consensus 182 ~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~----- 256 (313)
T 1t46_A 182 RITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSK----- 256 (313)
T ss_dssp TEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCSSHH-----
T ss_pred CCEEEccccccccccccccceeccCCCCcceeeChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCCcccchhH-----
Confidence 999999999998765443322 223457889999999999999999999999999999999 9999865432211
Q ss_pred HHHHHhhcccchhHhhhchhcccCCHHHHHHHHHHHHHccccCCCCCCCHHhHHHHhccCc
Q 003836 717 DWAYDRYQERTLEALVENDLEAMNNVTMLHRFVMVAFWCIQEDPSHRPTMRKVTQMLEGVV 777 (792)
Q Consensus 717 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~L~~~~ 777 (792)
....+........+...+..+.+++.+||+.||.+|||++|++++|++++
T Consensus 257 -----------~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~ 306 (313)
T 1t46_A 257 -----------FYKMIKEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQI 306 (313)
T ss_dssp -----------HHHHHHHTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred -----------HHHHhccCCCCCCcccCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHH
Confidence 01111111112222334567889999999999999999999999998764
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-39 Score=347.82 Aligned_cols=255 Identities=25% Similarity=0.355 Sum_probs=207.8
Q ss_pred hhhhhhcCccccceEEEeeec----CCCceEEEEEEccccc-ccchHHHHHHHHHhcccCCCCcccccceeccCCceEEE
Q 003836 503 RGFKEELGRGAFGTVYKGFVN----MGSSNHVAVKKLNSVF-QDSEKEFKAEVNGIGQTHHKNLVRLLGYCDEGQNRLLV 577 (792)
Q Consensus 503 ~~~~~~lG~G~~g~Vy~g~~~----~~~~~~vavK~~~~~~-~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~lV 577 (792)
+.+.+.||+|+||.||++... ..+++.||||++.... ....+.+.+|++++++++||||+++++++.+.+..++|
T Consensus 25 y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv 104 (314)
T 2ivs_A 25 LVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHVIKLYGACSQDGPLLLI 104 (314)
T ss_dssp EEEEEEEEECSSSEEEEEEEETGGGCSSEEEEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCEEE
T ss_pred eeeeeeecccCCeeEEEEEEeccCcccCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCceeeEEEEEecCCceEEE
Confidence 334578999999999999753 2345789999997543 33456789999999999999999999999999999999
Q ss_pred EEeccCCCccccccCCC------------------------CCchhHHHHHHHHHHHHHHHHhhccCCCeEecCCCCCcE
Q 003836 578 YEFMSNGTVASFLFGDS------------------------KPNWKLRTEIAMGIAGGLFYLHEECCTQIIHCDIKPQNI 633 (792)
Q Consensus 578 ~E~~~~gsL~~~l~~~~------------------------~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dikp~NI 633 (792)
|||+++++|.+++.... .+++..+..++.||+.||+|||++ +|+||||||+||
T Consensus 105 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~dikp~NI 181 (314)
T 2ivs_A 105 VEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEM---KLVHRDLAARNI 181 (314)
T ss_dssp EECCTTCBHHHHHHHTTTSTTEEC----------------CEECHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGE
T ss_pred EeecCCCCHHHHHHHHhhccCCcccccccccccccccccccCcCHHHHHHHHHHHHHHHHHHHHC---CCcccccchheE
Confidence 99999999999997543 378899999999999999999998 999999999999
Q ss_pred EEcCCCCeEEeecCCCccccCCCCC-ccccccccCCcccccccccCCCCcccceehHHHHHHHHHh-cCcCCCcchhhhh
Q 003836 634 LLDDHYNARISDFGLAKLLTLDQSH-TNTAIRGTKGYVAPEWFRNMPITVKVDVYSYGVLLLEIIC-LRRNIDNEISKVD 711 (792)
Q Consensus 634 Ll~~~~~~kl~Dfg~a~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~k~DV~S~Gv~l~el~t-g~~p~~~~~~~~~ 711 (792)
|+++++.+||+|||+++........ ......+++.|+|||.+.+..++.++||||||+++|||++ |+.||........
T Consensus 182 li~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~ 261 (314)
T 2ivs_A 182 LVAEGRKMKISDFGLSRDVYEEDSYVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIPPERL 261 (314)
T ss_dssp EEETTTEEEECCCTTCEECTTTSCEECSSCCCSCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGH
T ss_pred EEcCCCCEEEccccccccccccccceeccCCCCcccccChhhhcCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHH
Confidence 9999999999999999876543322 2223457889999999998899999999999999999999 9999865432111
Q ss_pred hhhHHHHHHHhhcccchhHhhhchhcccCCHHHHHHHHHHHHHccccCCCCCCCHHhHHHHhccCc
Q 003836 712 KAILTDWAYDRYQERTLEALVENDLEAMNNVTMLHRFVMVAFWCIQEDPSHRPTMRKVTQMLEGVV 777 (792)
Q Consensus 712 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~L~~~~ 777 (792)
...+........+...+..+.+++.+||+.||++||++.|+++.|++++
T Consensus 262 -----------------~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~l~~~l~~~~ 310 (314)
T 2ivs_A 262 -----------------FNLLKTGHRMERPDNCSEEMYRLMLQCWKQEPDKRPVFADISKDLEKMM 310 (314)
T ss_dssp -----------------HHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred -----------------HHHhhcCCcCCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHH
Confidence 1111111112223345577899999999999999999999999998864
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-39 Score=341.93 Aligned_cols=261 Identities=20% Similarity=0.237 Sum_probs=198.2
Q ss_pred hhhhhcCccccceEEEeeecCCCceEEEEEEccccc--ccchHHHHHHHHHhcccCCCCcccccceeccCCceEEEEEec
Q 003836 504 GFKEELGRGAFGTVYKGFVNMGSSNHVAVKKLNSVF--QDSEKEFKAEVNGIGQTHHKNLVRLLGYCDEGQNRLLVYEFM 581 (792)
Q Consensus 504 ~~~~~lG~G~~g~Vy~g~~~~~~~~~vavK~~~~~~--~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~lV~E~~ 581 (792)
.+.+.||+|+||+||+|... .+++.||+|++.... ....+.+.+|+.++++++||||+++++++.+++..++||||+
T Consensus 5 ~~~~~lg~G~~g~V~~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 83 (292)
T 3o0g_A 5 EKLEKIGEGTYGTVFKAKNR-ETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFEFC 83 (292)
T ss_dssp EEEEEEEECSSSEEEEEEET-TTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred eeeeEecCCCCeEEEEEEEC-CCCceEEEEeeeccCCcCCcchHHHHHHHHHhcCCCCCEeeEEeEEEeCCEEEEEEecC
Confidence 44578999999999999754 456799999987543 233477899999999999999999999999999999999999
Q ss_pred cCCCccccccCCCCCchhHHHHHHHHHHHHHHHHhhccCCCeEecCCCCCcEEEcCCCCeEEeecCCCccccCCCCCccc
Q 003836 582 SNGTVASFLFGDSKPNWKLRTEIAMGIAGGLFYLHEECCTQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLDQSHTNT 661 (792)
Q Consensus 582 ~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dikp~NILl~~~~~~kl~Dfg~a~~~~~~~~~~~~ 661 (792)
+++.+..+......+++..+..++.||+.||+|||+. +|+||||||+|||++.++.+||+|||+++...... ....
T Consensus 84 ~~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~---~ivH~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~-~~~~ 159 (292)
T 3o0g_A 84 DQDLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSR---NVLHRDLKPQNLLINRNGELKLANFGLARAFGIPV-RCYS 159 (292)
T ss_dssp SEEHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECCSCC-SCCC
T ss_pred CCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEeecccceecCCcc-cccc
Confidence 8754444444467899999999999999999999999 99999999999999999999999999998764332 2233
Q ss_pred cccccCCcccccccccCC-CCcccceehHHHHHHHHHhcCcCCCcchhhhhhhhHHHHHHHhh--cccc---hhHhhhc-
Q 003836 662 AIRGTKGYVAPEWFRNMP-ITVKVDVYSYGVLLLEIICLRRNIDNEISKVDKAILTDWAYDRY--QERT---LEALVEN- 734 (792)
Q Consensus 662 ~~~gt~~y~aPE~~~~~~-~~~k~DV~S~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~--~~~~---~~~~~~~- 734 (792)
...||+.|+|||.+.+.. ++.++|||||||++|||++|+.|+......... +........ .... .....+.
T Consensus 160 ~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~~~~p~~~~~~~~~~--~~~i~~~~~~~~~~~~~~~~~~~~~~ 237 (292)
T 3o0g_A 160 AEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQ--LKRIFRLLGTPTEEQWPSMTKLPDYK 237 (292)
T ss_dssp SCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHH--HHHHHHHHCCCCTTTCTTGGGSTTCC
T ss_pred CCccccCCcChHHHcCCCCcCchHHHHHHHHHHHHHHHcCCCCcCCCCHHHH--HHHHHHHhCCCChhhhhhhccccccc
Confidence 456899999999997765 899999999999999999999986543322111 111100000 0000 0000000
Q ss_pred --------hhcccCCHHHHHHHHHHHHHccccCCCCCCCHHhHHH
Q 003836 735 --------DLEAMNNVTMLHRFVMVAFWCIQEDPSHRPTMRKVTQ 771 (792)
Q Consensus 735 --------~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~ 771 (792)
.............+.+++.+||+.||++|||++|+++
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 282 (292)
T 3o0g_A 238 PYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQ 282 (292)
T ss_dssp CCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred ccccccCCcchhhcccccChHHHHHHHHHhccChhhCCCHHHHhc
Confidence 0000111234567889999999999999999999997
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-39 Score=355.24 Aligned_cols=254 Identities=22% Similarity=0.291 Sum_probs=201.6
Q ss_pred hhhhhcCccccceEEEeeecCCCceEEEEEEccccc---ccchHHHHHHHHHhccc-CCCCcccccceeccCCceEEEEE
Q 003836 504 GFKEELGRGAFGTVYKGFVNMGSSNHVAVKKLNSVF---QDSEKEFKAEVNGIGQT-HHKNLVRLLGYCDEGQNRLLVYE 579 (792)
Q Consensus 504 ~~~~~lG~G~~g~Vy~g~~~~~~~~~vavK~~~~~~---~~~~~~~~~Ei~~l~~l-~h~niv~l~g~~~~~~~~~lV~E 579 (792)
.+.++||+|+||.||++... .+++.+|+|++++.. ....+.+.+|..++.++ +||||+++++++.+.+..++|||
T Consensus 55 ~~~~~LG~G~fG~V~~~~~~-~~~~~~AvK~~~k~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~~lV~E 133 (396)
T 4dc2_A 55 DLLRVIGRGSYAKVLLVRLK-KTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIE 133 (396)
T ss_dssp EEEEEEEECSSEEEEEEEET-TTTEEEEEEEEEGGGTC----CCHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEEEE
T ss_pred EEEEEEeeCCCeEEEEEEEC-CCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhcCCCCCcCeeEEEEEECCEEEEEEE
Confidence 44578999999999999764 457899999997643 22334688999999887 89999999999999999999999
Q ss_pred eccCCCccccccCCCCCchhHHHHHHHHHHHHHHHHhhccCCCeEecCCCCCcEEEcCCCCeEEeecCCCccccCCCCCc
Q 003836 580 FMSNGTVASFLFGDSKPNWKLRTEIAMGIAGGLFYLHEECCTQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLDQSHT 659 (792)
Q Consensus 580 ~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dikp~NILl~~~~~~kl~Dfg~a~~~~~~~~~~ 659 (792)
|+++|+|..++.....+++..+..++.||+.||+|||++ +|+||||||+||||+.++.+||+|||+++..... ...
T Consensus 134 ~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~---givHrDLKp~NILl~~~g~ikL~DFGla~~~~~~-~~~ 209 (396)
T 4dc2_A 134 YVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHER---GIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRP-GDT 209 (396)
T ss_dssp CCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCCTTCBCCCCT-TCC
T ss_pred cCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC---CEEeccCCHHHEEECCCCCEEEeecceeeecccC-CCc
Confidence 999999999998888899999999999999999999999 9999999999999999999999999999864322 223
Q ss_pred cccccccCCcccccccccCCCCcccceehHHHHHHHHHhcCcCCCcchhhhhh-hhHHHHHHHhhcccchhHhhhchhcc
Q 003836 660 NTAIRGTKGYVAPEWFRNMPITVKVDVYSYGVLLLEIICLRRNIDNEISKVDK-AILTDWAYDRYQERTLEALVENDLEA 738 (792)
Q Consensus 660 ~~~~~gt~~y~aPE~~~~~~~~~k~DV~S~Gv~l~el~tg~~p~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~ 738 (792)
....+||+.|+|||++.+..++.++|||||||++|||++|+.||......... ....... ...+.... .
T Consensus 210 ~~~~~gt~~Y~aPE~l~~~~~~~~~DiwslGvllyell~G~~Pf~~~~~~~~~~~~~~~~~--------~~~i~~~~--~ 279 (396)
T 4dc2_A 210 TSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYL--------FQVILEKQ--I 279 (396)
T ss_dssp BCCCCBCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSTTTTC------CCHHHH--------HHHHHHCC--C
T ss_pred cccccCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCcccccccccchhhHHHH--------HHHHhccc--c
Confidence 34567999999999999999999999999999999999999999643211100 0000000 11111111 1
Q ss_pred cCCHHHHHHHHHHHHHccccCCCCCCCH------HhHHHH
Q 003836 739 MNNVTMLHRFVMVAFWCIQEDPSHRPTM------RKVTQM 772 (792)
Q Consensus 739 ~~~~~~~~~l~~l~~~Cl~~~p~~RPs~------~evl~~ 772 (792)
..+...+.++.+++.+||+.||.+||++ +||++.
T Consensus 280 ~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~ei~~H 319 (396)
T 4dc2_A 280 RIPRSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGH 319 (396)
T ss_dssp CCCTTSCHHHHHHHHHHTCSCTTTSTTCSTTTHHHHHHHS
T ss_pred CCCCcCCHHHHHHHHHHhcCCHhHcCCCCCCCCHHHHhcC
Confidence 1233456678899999999999999995 566653
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-39 Score=364.62 Aligned_cols=245 Identities=27% Similarity=0.371 Sum_probs=202.0
Q ss_pred hhhhcCccccceEEEeeecCCCceEEEEEEcccccccchHHHHHHHHHhcccCCCCcccccceeccCC-ceEEEEEeccC
Q 003836 505 FKEELGRGAFGTVYKGFVNMGSSNHVAVKKLNSVFQDSEKEFKAEVNGIGQTHHKNLVRLLGYCDEGQ-NRLLVYEFMSN 583 (792)
Q Consensus 505 ~~~~lG~G~~g~Vy~g~~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~-~~~lV~E~~~~ 583 (792)
+.+.||+|+||.||+|... ++.||||+++... ..+.|.+|++++++++||||+++++++.+.+ ..++||||+++
T Consensus 197 ~~~~lG~G~fg~V~~~~~~---~~~vavK~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~iv~e~~~~ 271 (450)
T 1k9a_A 197 LLQTIGKGEFGDVMLGDYR---GNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAK 271 (450)
T ss_dssp EEEEEEECSSEEEEEEEET---TEEEEEEEESSCT--TSHHHHHHHHHHHTCCCTTBCCEEEEEECTTSCEEEEEECCTT
T ss_pred EEeeecCcCCeeEEEEEec---CCeEEEEEeCCch--HHHHHHHHHHHHHhccCCCEEEEEEEEEcCCCceEEEEEecCC
Confidence 4578999999999999764 4689999997643 5678999999999999999999999987665 78999999999
Q ss_pred CCccccccCCC--CCchhHHHHHHHHHHHHHHHHhhccCCCeEecCCCCCcEEEcCCCCeEEeecCCCccccCCCCCccc
Q 003836 584 GTVASFLFGDS--KPNWKLRTEIAMGIAGGLFYLHEECCTQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLDQSHTNT 661 (792)
Q Consensus 584 gsL~~~l~~~~--~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dikp~NILl~~~~~~kl~Dfg~a~~~~~~~~~~~~ 661 (792)
|+|.+++.... .+++..+..++.||+.||+|||++ +|+||||||+|||++.++.+||+|||+++..... ..
T Consensus 272 g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~---~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~----~~ 344 (450)
T 1k9a_A 272 GSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGN---NFVHRDLAARNVLVSEDNVAKVSDFGLTKEASST----QD 344 (450)
T ss_dssp CBHHHHHHHHCTTTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECTTSCEEECCCTTCEECC--------
T ss_pred CcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCCHhhEEECCCCCEEEeeCCCccccccc----cc
Confidence 99999997653 378999999999999999999999 9999999999999999999999999999854322 12
Q ss_pred cccccCCcccccccccCCCCcccceehHHHHHHHHHh-cCcCCCcchhhhhhhhHHHHHHHhhcccchhHhhhchhcccC
Q 003836 662 AIRGTKGYVAPEWFRNMPITVKVDVYSYGVLLLEIIC-LRRNIDNEISKVDKAILTDWAYDRYQERTLEALVENDLEAMN 740 (792)
Q Consensus 662 ~~~gt~~y~aPE~~~~~~~~~k~DV~S~Gv~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 740 (792)
...+++.|+|||.+.+..++.++||||||+++|||++ |+.||........ ...+........
T Consensus 345 ~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~~-----------------~~~i~~~~~~~~ 407 (450)
T 1k9a_A 345 TGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDV-----------------VPRVEKGYKMDA 407 (450)
T ss_dssp --CCCTTTSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTTCCSSTTSCTTTH-----------------HHHHHTTCCCCC
T ss_pred CCCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHH-----------------HHHHHcCCCCCC
Confidence 2356889999999999999999999999999999998 9999865422110 011111122223
Q ss_pred CHHHHHHHHHHHHHccccCCCCCCCHHhHHHHhccCcC
Q 003836 741 NVTMLHRFVMVAFWCIQEDPSHRPTMRKVTQMLEGVVE 778 (792)
Q Consensus 741 ~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~L~~~~~ 778 (792)
+...+..+.+++.+||+.||++|||+.++++.|+.+..
T Consensus 408 p~~~~~~l~~li~~cl~~dp~~Rpt~~~l~~~L~~i~~ 445 (450)
T 1k9a_A 408 PDGCPPAVYDVMKNCWHLDAATRPTFLQLREQLEHIRT 445 (450)
T ss_dssp CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred CCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHH
Confidence 34456788999999999999999999999999987643
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.5e-40 Score=355.27 Aligned_cols=246 Identities=24% Similarity=0.333 Sum_probs=199.7
Q ss_pred hhhhhhcCccccceEEEeeecCCCceEEEEEEcccc---cccchHHHHHHHHHhccc-CCCCcccccceeccCCceEEEE
Q 003836 503 RGFKEELGRGAFGTVYKGFVNMGSSNHVAVKKLNSV---FQDSEKEFKAEVNGIGQT-HHKNLVRLLGYCDEGQNRLLVY 578 (792)
Q Consensus 503 ~~~~~~lG~G~~g~Vy~g~~~~~~~~~vavK~~~~~---~~~~~~~~~~Ei~~l~~l-~h~niv~l~g~~~~~~~~~lV~ 578 (792)
+.+.+.||+|+||+||++... .+++.||||++++. .....+.+.+|.+++.++ +||||+++++++.+.+..++||
T Consensus 25 y~~~~~lG~G~fg~V~~~~~~-~~~~~~AvK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~~lv~ 103 (353)
T 3txo_A 25 FEFIRVLGKGSFGKVMLARVK-ETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLFCCFQTPDRLFFVM 103 (353)
T ss_dssp EEEEEEEEEETTEEEEEEEET-TTCCEEEEEEEEHHHHHHHTTHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEE
T ss_pred eEEEEEEeeCCCEEEEEEEEc-CCCCEEEEEEEEHHHhcchhHHHHHHHHHHHHHhccCCCceeeEEEEEEeCCEEEEEE
Confidence 345678999999999999754 45689999999753 233456788999999988 7999999999999999999999
Q ss_pred EeccCCCccccccCCCCCchhHHHHHHHHHHHHHHHHhhccCCCeEecCCCCCcEEEcCCCCeEEeecCCCccccCCCCC
Q 003836 579 EFMSNGTVASFLFGDSKPNWKLRTEIAMGIAGGLFYLHEECCTQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLDQSH 658 (792)
Q Consensus 579 E~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dikp~NILl~~~~~~kl~Dfg~a~~~~~~~~~ 658 (792)
||+++|+|..++.....+++..+..++.||+.||+|||+. +|+||||||+|||++.++.+||+|||+++..... ..
T Consensus 104 E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~---givHrDlkp~NILl~~~g~ikL~DFG~a~~~~~~-~~ 179 (353)
T 3txo_A 104 EFVNGGDLMFHIQKSRRFDEARARFYAAEIISALMFLHDK---GIIYRDLKLDNVLLDHEGHCKLADFGMCKEGICN-GV 179 (353)
T ss_dssp ECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCCTTCBCSCC----
T ss_pred eCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC---CCcccCCCHHHEEECCCCCEEEccccceeecccC-Cc
Confidence 9999999999998888899999999999999999999999 9999999999999999999999999999864322 22
Q ss_pred ccccccccCCcccccccccCCCCcccceehHHHHHHHHHhcCcCCCcchhhhhhhhHHHHHHHhhcccchhHhhhchhcc
Q 003836 659 TNTAIRGTKGYVAPEWFRNMPITVKVDVYSYGVLLLEIICLRRNIDNEISKVDKAILTDWAYDRYQERTLEALVENDLEA 738 (792)
Q Consensus 659 ~~~~~~gt~~y~aPE~~~~~~~~~k~DV~S~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 738 (792)
.....+||+.|+|||++.+..++.++|||||||++|||++|+.||......... ..+.....
T Consensus 180 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~~----------------~~i~~~~~-- 241 (353)
T 3txo_A 180 TTATFCGTPDYIAPEILQEMLYGPAVDWWAMGVLLYEMLCGHAPFEAENEDDLF----------------EAILNDEV-- 241 (353)
T ss_dssp ------CCGGGCCHHHHHHHHCTTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHH----------------HHHHHCCC--
T ss_pred cccccCCCcCeEChhhcCCCCcCCccCCCcchHHHHHHHhCCCCCCCCCHHHHH----------------HHHHcCCC--
Confidence 334567999999999999989999999999999999999999999765332110 11111111
Q ss_pred cCCHHHHHHHHHHHHHccccCCCCCCCH------HhHHH
Q 003836 739 MNNVTMLHRFVMVAFWCIQEDPSHRPTM------RKVTQ 771 (792)
Q Consensus 739 ~~~~~~~~~l~~l~~~Cl~~~p~~RPs~------~evl~ 771 (792)
..+...+..+.+++.+||+.||++||++ +|+++
T Consensus 242 ~~p~~~~~~~~~li~~lL~~dP~~R~~~~~~~~~~~il~ 280 (353)
T 3txo_A 242 VYPTWLHEDATGILKSFMTKNPTMRLGSLTQGGEHAILR 280 (353)
T ss_dssp CCCTTSCHHHHHHHHHHTCSSGGGSTTSGGGTCTHHHHT
T ss_pred CCCCCCCHHHHHHHHHHhhhCHHHccCCcccCCHHHHhh
Confidence 1223345678899999999999999998 67775
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.5e-39 Score=358.82 Aligned_cols=249 Identities=21% Similarity=0.275 Sum_probs=202.8
Q ss_pred HhhhhhhcCccccceEEEeeecCCCceEEEEEEccccc--ccchHHHHHHHHHhcccCCCCcccccceeccCCceEEEEE
Q 003836 502 TRGFKEELGRGAFGTVYKGFVNMGSSNHVAVKKLNSVF--QDSEKEFKAEVNGIGQTHHKNLVRLLGYCDEGQNRLLVYE 579 (792)
Q Consensus 502 ~~~~~~~lG~G~~g~Vy~g~~~~~~~~~vavK~~~~~~--~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~lV~E 579 (792)
.+.+.+.||+|+||+||++.. ..+++.+|+|++.... ....+.+.+|++++++++||||+++++++.+.+..++|||
T Consensus 12 ~Y~i~~~LG~G~fg~V~~~~~-~~~~~~~a~K~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lv~E 90 (444)
T 3soa_A 12 EYQLFEELGKGAFSVVRRCVK-VLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDSISEEGHHYLIFD 90 (444)
T ss_dssp HEEEEEEEEEC--CEEEEEEE-TTTTEEEEEEEEESCSCHHHHHHHHHHHHHHHHHCCBTTBCCEEEEEECSSEEEEEEC
T ss_pred CeEEEEEeccCCCeEEEEEEE-CCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCcCCCeEEEEEEECCEEEEEEE
Confidence 455668899999999999964 4567899999987543 2335678999999999999999999999999999999999
Q ss_pred eccCCCccccccCCCCCchhHHHHHHHHHHHHHHHHhhccCCCeEecCCCCCcEEEc---CCCCeEEeecCCCccccCCC
Q 003836 580 FMSNGTVASFLFGDSKPNWKLRTEIAMGIAGGLFYLHEECCTQIIHCDIKPQNILLD---DHYNARISDFGLAKLLTLDQ 656 (792)
Q Consensus 580 ~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dikp~NILl~---~~~~~kl~Dfg~a~~~~~~~ 656 (792)
|+++|+|.+++.....+++..+..++.||+.||.|||++ +|+||||||+|||++ +++.+||+|||+++......
T Consensus 91 ~~~gg~L~~~i~~~~~~~e~~~~~i~~qil~aL~~lH~~---givHrDlKp~NIll~~~~~~~~vkL~DFG~a~~~~~~~ 167 (444)
T 3soa_A 91 LVTGGELFEDIVAREYYSEADASHCIQQILEAVLHCHQM---GVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGEQ 167 (444)
T ss_dssp CCBCCBHHHHHHHCSCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCSSTTEEESBSSTTCCEEECCCSSCBCCCTTC
T ss_pred eCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEEeccCCCCcEEEccCceeEEecCCC
Confidence 999999999998888899999999999999999999999 999999999999998 56789999999998765432
Q ss_pred CCccccccccCCcccccccccCCCCcccceehHHHHHHHHHhcCcCCCcchhhhhhhhHHHHHHHhhcccchhHhhhchh
Q 003836 657 SHTNTAIRGTKGYVAPEWFRNMPITVKVDVYSYGVLLLEIICLRRNIDNEISKVDKAILTDWAYDRYQERTLEALVENDL 736 (792)
Q Consensus 657 ~~~~~~~~gt~~y~aPE~~~~~~~~~k~DV~S~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 736 (792)
. ......||+.|+|||.+.+..++.++|||||||++|+|++|+.||........ ... +.....
T Consensus 168 ~-~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyell~G~~Pf~~~~~~~~---~~~-------------i~~~~~ 230 (444)
T 3soa_A 168 Q-AWFGFAGTPGYLSPEVLRKDPYGKPVDLWACGVILYILLVGYPPFWDEDQHRL---YQQ-------------IKAGAY 230 (444)
T ss_dssp C-BCCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHH---HHH-------------HHHTCC
T ss_pred c-eeecccCCcccCCHHHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCccHHHH---HHH-------------HHhCCC
Confidence 2 22345799999999999999999999999999999999999999965432211 100 011100
Q ss_pred c--ccCCHHHHHHHHHHHHHccccCCCCCCCHHhHHH
Q 003836 737 E--AMNNVTMLHRFVMVAFWCIQEDPSHRPTMRKVTQ 771 (792)
Q Consensus 737 ~--~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~ 771 (792)
. .......+.++.+++.+||+.||++|||+.|+++
T Consensus 231 ~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~e~L~ 267 (444)
T 3soa_A 231 DFPSPEWDTVTPEAKDLINKMLTINPSKRITAAEALK 267 (444)
T ss_dssp CCCTTTTTTSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred CCCccccccCCHHHHHHHHHHcCCChhHCCCHHHHhc
Confidence 0 0011123567889999999999999999999998
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.3e-39 Score=343.36 Aligned_cols=268 Identities=19% Similarity=0.254 Sum_probs=208.2
Q ss_pred hhhhhhcCccccceEEEeeecCCCceEEEEEEccccc-ccchHHHHHHHHHhcccCCCCcccccceeccCC--ceEEEEE
Q 003836 503 RGFKEELGRGAFGTVYKGFVNMGSSNHVAVKKLNSVF-QDSEKEFKAEVNGIGQTHHKNLVRLLGYCDEGQ--NRLLVYE 579 (792)
Q Consensus 503 ~~~~~~lG~G~~g~Vy~g~~~~~~~~~vavK~~~~~~-~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~--~~~lV~E 579 (792)
+.+.+.||+|+||+||+|... .+++.||||++.... ....+.+.+|++++++++||||+++++++.... ..++|||
T Consensus 11 y~~~~~lg~G~~g~V~~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~e 89 (319)
T 4euu_A 11 WLLSDILGQGATANVFRGRHK-KTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLIME 89 (319)
T ss_dssp EEEEEEEEECSSEEEEEEEET-TTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEEEEE
T ss_pred EEEEEEecCCCCeEEEEEEEC-CCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCcceEEEEeecCCCceEEEEEe
Confidence 345678999999999999764 456799999997543 334577889999999999999999999987655 7799999
Q ss_pred eccCCCccccccCCC---CCchhHHHHHHHHHHHHHHHHhhccCCCeEecCCCCCcEEE----cCCCCeEEeecCCCccc
Q 003836 580 FMSNGTVASFLFGDS---KPNWKLRTEIAMGIAGGLFYLHEECCTQIIHCDIKPQNILL----DDHYNARISDFGLAKLL 652 (792)
Q Consensus 580 ~~~~gsL~~~l~~~~---~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dikp~NILl----~~~~~~kl~Dfg~a~~~ 652 (792)
|+++++|.+++.... .+++..+..++.||+.||+|||+. +|+||||||+|||+ +.++.+||+|||+++..
T Consensus 90 ~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~~~~~~~~kL~Dfg~a~~~ 166 (319)
T 4euu_A 90 FCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLREN---GIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAAREL 166 (319)
T ss_dssp CCTTCBHHHHHHSGGGTTCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEEECTTSCEEEEECCCTTCEEC
T ss_pred CCCCCCHHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCCHHHEEEeccCCCCceEEEccCCCceec
Confidence 999999999997653 389999999999999999999999 99999999999999 78888999999999876
Q ss_pred cCCCCCccccccccCCcccccccc--------cCCCCcccceehHHHHHHHHHhcCcCCCcchhhhhh-hhHHHHHHHhh
Q 003836 653 TLDQSHTNTAIRGTKGYVAPEWFR--------NMPITVKVDVYSYGVLLLEIICLRRNIDNEISKVDK-AILTDWAYDRY 723 (792)
Q Consensus 653 ~~~~~~~~~~~~gt~~y~aPE~~~--------~~~~~~k~DV~S~Gv~l~el~tg~~p~~~~~~~~~~-~~~~~~~~~~~ 723 (792)
..... .....||+.|+|||.+. +..++.++|||||||++|||++|+.||......... ..+.......
T Consensus 167 ~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~- 243 (319)
T 4euu_A 167 EDDEQ--FVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIITGK- 243 (319)
T ss_dssp CTTCC--BCCCCSCGGGCCHHHHHHHTSCCCCCCCBCTTHHHHHHHHHHHHHHHSSCSEECTTCGGGCHHHHHHHHHHC-
T ss_pred CCCCc--eeecccCCCccCHHHhhhccccccccCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCccchhHHHHHHHhcCC-
Confidence 54332 23456899999999986 578899999999999999999999999643322111 1111111110
Q ss_pred cccch---hHhhh--------chhcccCCHHHHHHHHHHHHHccccCCCCCCCHHhHHHHhccCc
Q 003836 724 QERTL---EALVE--------NDLEAMNNVTMLHRFVMVAFWCIQEDPSHRPTMRKVTQMLEGVV 777 (792)
Q Consensus 724 ~~~~~---~~~~~--------~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~L~~~~ 777 (792)
..... ..... -.............+.+++.+||+.||++|||++|+++...+..
T Consensus 244 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L~~dP~~R~s~~ell~h~~d~~ 308 (319)
T 4euu_A 244 PSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSDIL 308 (319)
T ss_dssp CTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHHHHT
T ss_pred CcccchhhhcccCCccccCccCCcccccchhHHHHhHHHHHHhccCChhhhccHHHhhhccHHHh
Confidence 00000 00000 01112345677888999999999999999999999999887644
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-39 Score=338.98 Aligned_cols=250 Identities=29% Similarity=0.409 Sum_probs=192.5
Q ss_pred hhhhhcCccccceEEEeeecCCCceEEEEEEcccccc----cchHHHHHHHHHhcccCCCCcccccceeccCCceEEEEE
Q 003836 504 GFKEELGRGAFGTVYKGFVNMGSSNHVAVKKLNSVFQ----DSEKEFKAEVNGIGQTHHKNLVRLLGYCDEGQNRLLVYE 579 (792)
Q Consensus 504 ~~~~~lG~G~~g~Vy~g~~~~~~~~~vavK~~~~~~~----~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~lV~E 579 (792)
.+.+.||+|+||.||+|... ++.+|||++..... ...+.+.+|++++++++||||+++++++.+.+..++|||
T Consensus 10 ~~~~~lg~G~~g~V~~~~~~---~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 86 (271)
T 3dtc_A 10 TLEEIIGIGGFGKVYRAFWI---GDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALRGVCLKEPNLCLVME 86 (271)
T ss_dssp EEEEEEEEETTEEEEEEEET---TEEEEEEEC----------CHHHHHHHHHHHHHCCCTTBCCEEEEECCC--CEEEEE
T ss_pred eeeeeeccCCCeEEEEEEEc---CCeEEEEEEecCCcccHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecCCceEEEEE
Confidence 34578999999999999753 57899999875432 234678999999999999999999999999999999999
Q ss_pred eccCCCccccccCCCCCchhHHHHHHHHHHHHHHHHhhccCCCeEecCCCCCcEEEcC--------CCCeEEeecCCCcc
Q 003836 580 FMSNGTVASFLFGDSKPNWKLRTEIAMGIAGGLFYLHEECCTQIIHCDIKPQNILLDD--------HYNARISDFGLAKL 651 (792)
Q Consensus 580 ~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dikp~NILl~~--------~~~~kl~Dfg~a~~ 651 (792)
|+++++|.+++.. ..+++..+..++.|++.||+|||++...+|+||||||+|||++. ++.+||+|||+++.
T Consensus 87 ~~~~~~L~~~~~~-~~~~~~~~~~i~~~l~~~l~~lH~~~~~~i~H~dikp~Nil~~~~~~~~~~~~~~~kl~Dfg~~~~ 165 (271)
T 3dtc_A 87 FARGGPLNRVLSG-KRIPPDILVNWAVQIARGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLARE 165 (271)
T ss_dssp CCTTEEHHHHHTS-SCCCHHHHHHHHHHHHHHHHHHHHSSSSCCCCSCCSGGGEEESSCCSSSCCSSCCEEECCCCC---
T ss_pred cCCCCCHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCchHHEEEecccccccccCcceEEccCCcccc
Confidence 9999999999854 57899999999999999999999982222999999999999986 77899999999986
Q ss_pred ccCCCCCccccccccCCcccccccccCCCCcccceehHHHHHHHHHhcCcCCCcchhhhhhhhHHHHHHHhhcccchhHh
Q 003836 652 LTLDQSHTNTAIRGTKGYVAPEWFRNMPITVKVDVYSYGVLLLEIICLRRNIDNEISKVDKAILTDWAYDRYQERTLEAL 731 (792)
Q Consensus 652 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DV~S~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 731 (792)
...... ....||+.|+|||.+.+..++.++||||||+++|||++|+.||......... ...
T Consensus 166 ~~~~~~---~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~----------------~~~ 226 (271)
T 3dtc_A 166 WHRTTK---MSAAGAYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVPFRGIDGLAVA----------------YGV 226 (271)
T ss_dssp -------------CCGGGSCHHHHHHCCCSHHHHHHHHHHHHHHHHHCCCTTTTSCHHHHH----------------HHH
T ss_pred cccccc---cCCCCccceeCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHH----------------Hhh
Confidence 543222 2346899999999999999999999999999999999999999754322110 011
Q ss_pred hhchhcccCCHHHHHHHHHHHHHccccCCCCCCCHHhHHHHhccC
Q 003836 732 VENDLEAMNNVTMLHRFVMVAFWCIQEDPSHRPTMRKVTQMLEGV 776 (792)
Q Consensus 732 ~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~L~~~ 776 (792)
.........+...+..+.+++.+||+.+|++|||++|++++|+.+
T Consensus 227 ~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~L~~l 271 (271)
T 3dtc_A 227 AMNKLALPIPSTCPEPFAKLMEDCWNPDPHSRPSFTNILDQLTTI 271 (271)
T ss_dssp HTSCCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHC-
T ss_pred hcCCCCCCCCcccCHHHHHHHHHHhcCCcccCcCHHHHHHHHhcC
Confidence 111112222334456788999999999999999999999999864
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=7.9e-40 Score=346.16 Aligned_cols=253 Identities=27% Similarity=0.396 Sum_probs=211.0
Q ss_pred hhhhhhcCccccceEEEeeecCCCceEEEEEEcccccccchHHHHHHHHHhcccCCCCcccccceeccCCceEEEEEecc
Q 003836 503 RGFKEELGRGAFGTVYKGFVNMGSSNHVAVKKLNSVFQDSEKEFKAEVNGIGQTHHKNLVRLLGYCDEGQNRLLVYEFMS 582 (792)
Q Consensus 503 ~~~~~~lG~G~~g~Vy~g~~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~lV~E~~~ 582 (792)
+.+.+.||+|+||+||+|... ..++.||+|++... ....+.+.+|++++++++||||+++++++.+.+..++||||++
T Consensus 15 ~~~~~~lg~G~~g~V~~~~~~-~~~~~vaiK~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~ 92 (288)
T 3kfa_A 15 ITMKHKLGGGQYGEVYEGVWK-KYSLTVAVKTLKED-TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMT 92 (288)
T ss_dssp EEEEEESGGGTTCSEEEEEEG-GGTEEEEEEEECSC-STHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEEEEEECCT
T ss_pred eeEEeecCCCCceeEEEeEec-CCCEEEEEEecCcC-HHHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCEEEEEEcCC
Confidence 445678999999999999765 45678999998754 3456789999999999999999999999999999999999999
Q ss_pred CCCccccccCC--CCCchhHHHHHHHHHHHHHHHHhhccCCCeEecCCCCCcEEEcCCCCeEEeecCCCccccCCCCCcc
Q 003836 583 NGTVASFLFGD--SKPNWKLRTEIAMGIAGGLFYLHEECCTQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLDQSHTN 660 (792)
Q Consensus 583 ~gsL~~~l~~~--~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dikp~NILl~~~~~~kl~Dfg~a~~~~~~~~~~~ 660 (792)
+++|.+++... ..+++..+..++.||+.||+|||+. +|+|+||||+|||++.++.+||+|||+++..........
T Consensus 93 ~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~~~~~ 169 (288)
T 3kfa_A 93 YGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKK---NFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAH 169 (288)
T ss_dssp TEEHHHHHHHCCTTTSCHHHHHHHHHHHHHHHHHHHHH---TCCCSCCSGGGEEECGGGCEEECCCCGGGTSCSSSSEEE
T ss_pred CCcHHHHHHhcccCCccHhHHHHHHHHHHHHHHHHHHC---CccCCCCCcceEEEcCCCCEEEccCccceeccCCccccc
Confidence 99999999753 4589999999999999999999999 999999999999999999999999999987765544444
Q ss_pred ccccccCCcccccccccCCCCcccceehHHHHHHHHHh-cCcCCCcchhhhhhhhHHHHHHHhhcccchhHhhhchhccc
Q 003836 661 TAIRGTKGYVAPEWFRNMPITVKVDVYSYGVLLLEIIC-LRRNIDNEISKVDKAILTDWAYDRYQERTLEALVENDLEAM 739 (792)
Q Consensus 661 ~~~~gt~~y~aPE~~~~~~~~~k~DV~S~Gv~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 739 (792)
....+++.|+|||.+.+..++.++||||||+++|+|++ |..||....... +...+.......
T Consensus 170 ~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~~g~~p~~~~~~~~-----------------~~~~~~~~~~~~ 232 (288)
T 3kfa_A 170 AGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQ-----------------VYELLEKDYRME 232 (288)
T ss_dssp TTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGG-----------------HHHHHHTTCCCC
T ss_pred cCCccccCcCChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHH-----------------HHHHHhccCCCC
Confidence 44567889999999998999999999999999999999 888886542211 111111222222
Q ss_pred CCHHHHHHHHHHHHHccccCCCCCCCHHhHHHHhccCc
Q 003836 740 NNVTMLHRFVMVAFWCIQEDPSHRPTMRKVTQMLEGVV 777 (792)
Q Consensus 740 ~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~L~~~~ 777 (792)
.+...+..+.+++.+||+.||.+|||++|+++.|+.+.
T Consensus 233 ~~~~~~~~l~~li~~~l~~dp~~Rps~~~~~~~l~~~~ 270 (288)
T 3kfa_A 233 RPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMF 270 (288)
T ss_dssp CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred CCCCCCHHHHHHHHHHhCCChhhCcCHHHHHHHHHHHH
Confidence 33345577899999999999999999999999997753
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.9e-39 Score=340.02 Aligned_cols=247 Identities=21% Similarity=0.309 Sum_probs=193.7
Q ss_pred hhhhhhcCccccceEEEeeecCCCceEEEEEEcccccc--------------------------cchHHHHHHHHHhccc
Q 003836 503 RGFKEELGRGAFGTVYKGFVNMGSSNHVAVKKLNSVFQ--------------------------DSEKEFKAEVNGIGQT 556 (792)
Q Consensus 503 ~~~~~~lG~G~~g~Vy~g~~~~~~~~~vavK~~~~~~~--------------------------~~~~~~~~Ei~~l~~l 556 (792)
+.+.+.||+|+||.||+|... .+++.||||++..... ...+.+.+|+++++++
T Consensus 15 y~~~~~lG~G~~g~Vy~a~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l 93 (298)
T 2zv2_A 15 YTLKDEIGKGSYGVVKLAYNE-NDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIEQVYQEIAILKKL 93 (298)
T ss_dssp EEEEEEEEC--CCEEEEEEET-TTTEEEEEEEEECC-------------------------------CHHHHHHHHHHTC
T ss_pred eEEEeEEeecCCEEEEEEEEC-CCCcEEEEEEeehhhhhhhcccccccccccccccccccccccchHHHHHHHHHHHHhC
Confidence 345678999999999999754 4578999999865321 1135688999999999
Q ss_pred CCCCcccccceecc--CCceEEEEEeccCCCccccccCCCCCchhHHHHHHHHHHHHHHHHhhccCCCeEecCCCCCcEE
Q 003836 557 HHKNLVRLLGYCDE--GQNRLLVYEFMSNGTVASFLFGDSKPNWKLRTEIAMGIAGGLFYLHEECCTQIIHCDIKPQNIL 634 (792)
Q Consensus 557 ~h~niv~l~g~~~~--~~~~~lV~E~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dikp~NIL 634 (792)
+||||+++++++.+ ....++||||+++++|.+++. ...+++..+..++.||+.||+|||+. +|+||||||+|||
T Consensus 94 ~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dlkp~Nil 169 (298)
T 2zv2_A 94 DHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVPT-LKPLSEDQARFYFQDLIKGIEYLHYQ---KIIHRDIKPSNLL 169 (298)
T ss_dssp CCTTBCCEEEEEECSSSSEEEEEEECCTTCBSCCSSC-SSCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEE
T ss_pred CCCCCCeEEEEEEcCCCCEEEEEEecCCCCcHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHEE
Confidence 99999999999976 567899999999999999764 35689999999999999999999999 9999999999999
Q ss_pred EcCCCCeEEeecCCCccccCCCCCccccccccCCcccccccccCC---CCcccceehHHHHHHHHHhcCcCCCcchhhhh
Q 003836 635 LDDHYNARISDFGLAKLLTLDQSHTNTAIRGTKGYVAPEWFRNMP---ITVKVDVYSYGVLLLEIICLRRNIDNEISKVD 711 (792)
Q Consensus 635 l~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~---~~~k~DV~S~Gv~l~el~tg~~p~~~~~~~~~ 711 (792)
++.++.+||+|||+++....... ......||+.|+|||.+.+.. .+.++||||||+++|||++|+.||........
T Consensus 170 ~~~~~~~kl~Dfg~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~ 248 (298)
T 2zv2_A 170 VGEDGHIKIADFGVSNEFKGSDA-LLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPFMDERIMCL 248 (298)
T ss_dssp ECTTSCEEECCCTTCEECSSSSC-EECCCCSCGGGCCGGGCCTTCCCEESHHHHHHHHHHHHHHHHHSSCSSCCSSHHHH
T ss_pred ECCCCCEEEecCCCccccccccc-cccCCcCCccccChhhhccCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCccHHHH
Confidence 99999999999999987653322 223456899999999997655 47889999999999999999999975432110
Q ss_pred hhhHHHHHHHhhcccchhHhhhchhcccCCHHHHHHHHHHHHHccccCCCCCCCHHhHHH
Q 003836 712 KAILTDWAYDRYQERTLEALVENDLEAMNNVTMLHRFVMVAFWCIQEDPSHRPTMRKVTQ 771 (792)
Q Consensus 712 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~ 771 (792)
. . .+.............+..+.+++.+||+.||++|||++|+++
T Consensus 249 ---~-----~--------~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~R~s~~e~l~ 292 (298)
T 2zv2_A 249 ---H-----S--------KIKSQALEFPDQPDIAEDLKDLITRMLDKNPESRIVVPEIKL 292 (298)
T ss_dssp ---H-----H--------HHHHCCCCCCSSSCCCHHHHHHHHHHTCSCTTTSCCHHHHTT
T ss_pred ---H-----H--------HHhcccCCCCCccccCHHHHHHHHHHhhcChhhCCCHHHHhc
Confidence 0 0 001111111111234567889999999999999999999976
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-39 Score=351.75 Aligned_cols=270 Identities=23% Similarity=0.322 Sum_probs=214.0
Q ss_pred hhhhhhcCccccceEEEeee---cCCCceEEEEEEcccccccchHHHHHHHHHhcccCCCCcccccceec--cCCceEEE
Q 003836 503 RGFKEELGRGAFGTVYKGFV---NMGSSNHVAVKKLNSVFQDSEKEFKAEVNGIGQTHHKNLVRLLGYCD--EGQNRLLV 577 (792)
Q Consensus 503 ~~~~~~lG~G~~g~Vy~g~~---~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~--~~~~~~lV 577 (792)
+.+.+.||+|+||.||++.+ +...++.||||++........+.+.+|++++++++|+||+++++++. +....++|
T Consensus 25 y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv 104 (327)
T 3lxl_A 25 LKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKYRGVSYGPGRQSLRLV 104 (327)
T ss_dssp EEEEEEEEEETTEEEEEEEECTTSSSCSEEEEEEEESSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSSCEEEEE
T ss_pred hhhhhhccCCCCeEEEEEEeccCCCCcceEEEEEEeccCCHHHHHHHHHHHHHHHhcCCCceeEEEEEEecCCCceEEEE
Confidence 34567899999999999975 34567899999998776666778999999999999999999999886 45668899
Q ss_pred EEeccCCCccccccCC-CCCchhHHHHHHHHHHHHHHHHhhccCCCeEecCCCCCcEEEcCCCCeEEeecCCCccccCCC
Q 003836 578 YEFMSNGTVASFLFGD-SKPNWKLRTEIAMGIAGGLFYLHEECCTQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLDQ 656 (792)
Q Consensus 578 ~E~~~~gsL~~~l~~~-~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dikp~NILl~~~~~~kl~Dfg~a~~~~~~~ 656 (792)
|||+++++|.+++... ..+++..+..++.||+.||+|||+. +|+||||||+|||++.++.+||+|||+++......
T Consensus 105 ~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~~~~~~ 181 (327)
T 3lxl_A 105 MEYLPSGCLRDFLQRHRARLDASRLLLYSSQICKGMEYLGSR---RCVHRDLAARNILVESEAHVKIADFGLAKLLPLDK 181 (327)
T ss_dssp EECCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEEETTEEEECCGGGCEECCTTC
T ss_pred EeecCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCChhhEEECCCCCEEEcccccceecccCC
Confidence 9999999999999763 5689999999999999999999998 99999999999999999999999999998765433
Q ss_pred CC--ccccccccCCcccccccccCCCCcccceehHHHHHHHHHhcCcCCCcchhhhhhhhHHHHHHHhhcccchhHhhhc
Q 003836 657 SH--TNTAIRGTKGYVAPEWFRNMPITVKVDVYSYGVLLLEIICLRRNIDNEISKVDKAILTDWAYDRYQERTLEALVEN 734 (792)
Q Consensus 657 ~~--~~~~~~gt~~y~aPE~~~~~~~~~k~DV~S~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 734 (792)
.. ......+|+.|+|||.+.+..++.++||||||+++|||++|+.||............ ..........+...+..
T Consensus 182 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~ 259 (327)
T 3lxl_A 182 DYYVVREPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLRMMG--CERDVPALSRLLELLEE 259 (327)
T ss_dssp SEEECSSCCCSCGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHCC------CCHHHHHHHHHHT
T ss_pred ccceeeccCCccccccCHHHhccCCCChHHhHHHHHHHHHHHHhCCCCCccccchhhhhcc--cccccccHHHHHHHhhc
Confidence 22 223345788899999999989999999999999999999999998654322110000 00000000112223333
Q ss_pred hhcccCCHHHHHHHHHHHHHccccCCCCCCCHHhHHHHhccCc
Q 003836 735 DLEAMNNVTMLHRFVMVAFWCIQEDPSHRPTMRKVTQMLEGVV 777 (792)
Q Consensus 735 ~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~L~~~~ 777 (792)
......+...+..+.+++.+||+.||++|||++|++++|+.+.
T Consensus 260 ~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~ 302 (327)
T 3lxl_A 260 GQRLPAPPACPAEVHELMKLCWAPSPQDRPSFSALGPQLDMLW 302 (327)
T ss_dssp TCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHC-
T ss_pred ccCCCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHH
Confidence 3333344556778999999999999999999999999998875
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-39 Score=344.40 Aligned_cols=243 Identities=23% Similarity=0.323 Sum_probs=203.3
Q ss_pred hhhhhcCccccceEEEeeecCCCceEEEEEEccccc---ccchHHHHHHHHHhcccCCCCcccccceeccCCceEEEEEe
Q 003836 504 GFKEELGRGAFGTVYKGFVNMGSSNHVAVKKLNSVF---QDSEKEFKAEVNGIGQTHHKNLVRLLGYCDEGQNRLLVYEF 580 (792)
Q Consensus 504 ~~~~~lG~G~~g~Vy~g~~~~~~~~~vavK~~~~~~---~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~lV~E~ 580 (792)
.+.+.||+|+||.||++... .+++.||+|++++.. ....+.+.+|+.++++++||||+++++++.+.+..++||||
T Consensus 9 ~~~~~lG~G~~g~V~~~~~~-~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lv~e~ 87 (318)
T 1fot_A 9 QILRTLGTGSFGRVHLIRSR-HNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMIMDY 87 (318)
T ss_dssp EEEEEEEECSSCEEEEEEET-TTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEEECC
T ss_pred EEEEEEeeCCCEEEEEEEEC-CCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhhCCCCCCceEeEEEEeCCEEEEEEeC
Confidence 34578999999999999754 457899999987532 23456788999999999999999999999999999999999
Q ss_pred ccCCCccccccCCCCCchhHHHHHHHHHHHHHHHHhhccCCCeEecCCCCCcEEEcCCCCeEEeecCCCccccCCCCCcc
Q 003836 581 MSNGTVASFLFGDSKPNWKLRTEIAMGIAGGLFYLHEECCTQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLDQSHTN 660 (792)
Q Consensus 581 ~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dikp~NILl~~~~~~kl~Dfg~a~~~~~~~~~~~ 660 (792)
+++|+|.+++.....+++..+..++.||+.||+|||+. +|+||||||+|||++.++.+||+|||+++.... ..
T Consensus 88 ~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~g~~kL~Dfg~a~~~~~----~~ 160 (318)
T 1fot_A 88 IEGGELFSLLRKSQRFPNPVAKFYAAEVCLALEYLHSK---DIIYRDLKPENILLDKNGHIKITDFGFAKYVPD----VT 160 (318)
T ss_dssp CCSCBHHHHHHHTSSCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEECTTSCEEECCCSSCEECSS----CB
T ss_pred CCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCChheEEEcCCCCEEEeecCcceecCC----cc
Confidence 99999999998888899999999999999999999998 999999999999999999999999999986542 22
Q ss_pred ccccccCCcccccccccCCCCcccceehHHHHHHHHHhcCcCCCcchhhhhhhhHHHHHHHhhcccchhHhhhchhcccC
Q 003836 661 TAIRGTKGYVAPEWFRNMPITVKVDVYSYGVLLLEIICLRRNIDNEISKVDKAILTDWAYDRYQERTLEALVENDLEAMN 740 (792)
Q Consensus 661 ~~~~gt~~y~aPE~~~~~~~~~k~DV~S~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 740 (792)
....||+.|+|||.+.+..++.++|||||||++|||++|+.||........ ...++.... ..
T Consensus 161 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~----------------~~~i~~~~~--~~ 222 (318)
T 1fot_A 161 YTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKT----------------YEKILNAEL--RF 222 (318)
T ss_dssp CCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHH----------------HHHHHHCCC--CC
T ss_pred ccccCCccccCHhHhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHHH----------------HHHHHhCCC--CC
Confidence 345799999999999999999999999999999999999999975432111 011111111 12
Q ss_pred CHHHHHHHHHHHHHccccCCCCCC-----CHHhHHHH
Q 003836 741 NVTMLHRFVMVAFWCIQEDPSHRP-----TMRKVTQM 772 (792)
Q Consensus 741 ~~~~~~~l~~l~~~Cl~~~p~~RP-----s~~evl~~ 772 (792)
+...+.++.+++.+||+.||++|| +++|+++.
T Consensus 223 p~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~~i~~h 259 (318)
T 1fot_A 223 PPFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKNH 259 (318)
T ss_dssp CTTSCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHTS
T ss_pred CCCCCHHHHHHHHHHhccCHHHcCCCcCCCHHHHhcC
Confidence 223456788999999999999999 89999854
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.9e-39 Score=351.46 Aligned_cols=248 Identities=25% Similarity=0.336 Sum_probs=203.5
Q ss_pred hhhhhhcCccccceEEEeeecCCCceEEEEEEccccc---ccchHHHHHHHHHhcccCCCCcccccceeccCCceEEEEE
Q 003836 503 RGFKEELGRGAFGTVYKGFVNMGSSNHVAVKKLNSVF---QDSEKEFKAEVNGIGQTHHKNLVRLLGYCDEGQNRLLVYE 579 (792)
Q Consensus 503 ~~~~~~lG~G~~g~Vy~g~~~~~~~~~vavK~~~~~~---~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~lV~E 579 (792)
+.+.+.||+|+||.||++... .+++.||+|++.+.. ....+.+.+|++++++++||||+++++++.+.+..++|||
T Consensus 17 y~i~~~LG~G~fG~V~~~~~~-~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lv~e 95 (384)
T 4fr4_A 17 FEILRAIGKGSFGKVCIVQKN-DTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNLWYSFQDEEDMFMVVD 95 (384)
T ss_dssp EEEEEEEECCTTCCEEEEEET-TTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred eEEEEEEeeCCCeEEEEEEEC-CCCCEEEEEEEehhhcccHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEEEEe
Confidence 345678999999999999754 567899999986532 3345788999999999999999999999999999999999
Q ss_pred eccCCCccccccCCCCCchhHHHHHHHHHHHHHHHHhhccCCCeEecCCCCCcEEEcCCCCeEEeecCCCccccCCCCCc
Q 003836 580 FMSNGTVASFLFGDSKPNWKLRTEIAMGIAGGLFYLHEECCTQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLDQSHT 659 (792)
Q Consensus 580 ~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dikp~NILl~~~~~~kl~Dfg~a~~~~~~~~~~ 659 (792)
|+++|+|..++.....+++..+..++.||+.||.|||+. +|+||||||+|||++.++.+||+|||+++..... ..
T Consensus 96 ~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~---givHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~--~~ 170 (384)
T 4fr4_A 96 LLLGGDLRYHLQQNVHFKEETVKLFICELVMALDYLQNQ---RIIHRDMKPDNILLDEHGHVHITDFNIAAMLPRE--TQ 170 (384)
T ss_dssp CCTTEEHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECCTT--CC
T ss_pred cCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---CceeccCcHHHeEECCCCCEEEeccceeeeccCC--Cc
Confidence 999999999998888899999999999999999999999 9999999999999999999999999999876432 23
Q ss_pred cccccccCCccccccccc---CCCCcccceehHHHHHHHHHhcCcCCCcchhhhhhhhHHHHHHHhhcccchhHhhhchh
Q 003836 660 NTAIRGTKGYVAPEWFRN---MPITVKVDVYSYGVLLLEIICLRRNIDNEISKVDKAILTDWAYDRYQERTLEALVENDL 736 (792)
Q Consensus 660 ~~~~~gt~~y~aPE~~~~---~~~~~k~DV~S~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 736 (792)
.....||+.|+|||++.. ..++.++|||||||++|||++|+.||.............. +.. .
T Consensus 171 ~~~~~gt~~Y~aPE~~~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~-------------~~~--~ 235 (384)
T 4fr4_A 171 ITTMAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHIRSSTSSKEIVHT-------------FET--T 235 (384)
T ss_dssp BCCCCSCGGGCCGGGTCCCSSCCBCTTHHHHHHHHHHHHHHHSSCSSCCCTTSCHHHHHHH-------------HHH--C
T ss_pred eeccCCCccccCCeeeccCCCCCCCccceeechHHHHHHHHhCCCCCCCCCCccHHHHHHH-------------Hhh--c
Confidence 345679999999999964 4589999999999999999999999975432211111100 000 0
Q ss_pred cccCCHHHHHHHHHHHHHccccCCCCCCC-HHhHHH
Q 003836 737 EAMNNVTMLHRFVMVAFWCIQEDPSHRPT-MRKVTQ 771 (792)
Q Consensus 737 ~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs-~~evl~ 771 (792)
....+...+..+.+++.+||+.||.+||+ +++|++
T Consensus 236 ~~~~p~~~s~~~~~li~~lL~~dP~~R~s~~~~l~~ 271 (384)
T 4fr4_A 236 VVTYPSAWSQEMVSLLKKLLEPNPDQRFSQLSDVQN 271 (384)
T ss_dssp CCCCCTTSCHHHHHHHHHHSCSSGGGSCCSHHHHHT
T ss_pred ccCCCCcCCHHHHHHHHHHhcCCHhHhcccHHHHHc
Confidence 11123344577899999999999999998 777765
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.1e-39 Score=337.91 Aligned_cols=250 Identities=26% Similarity=0.414 Sum_probs=200.6
Q ss_pred hhhhhhcCccccceEEEeeecCCCceEEEEEEcccccccc-------hHHHHHHHHHhcccCCCCcccccceeccCCceE
Q 003836 503 RGFKEELGRGAFGTVYKGFVNMGSSNHVAVKKLNSVFQDS-------EKEFKAEVNGIGQTHHKNLVRLLGYCDEGQNRL 575 (792)
Q Consensus 503 ~~~~~~lG~G~~g~Vy~g~~~~~~~~~vavK~~~~~~~~~-------~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~ 575 (792)
+.+.+.||+|+||+||+|... .+++.||+|++....... .+.+.+|++++++++||||+++++++.+.. +
T Consensus 21 y~~~~~lg~G~~g~V~~~~~~-~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~--~ 97 (287)
T 4f0f_A 21 IEYEKQIGKGGFGLVHKGRLV-KDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIVKLYGLMHNPP--R 97 (287)
T ss_dssp EEEEEECCCCSSSCEEEEEET-TTCCEEEEEECCCCTTTCCHHHHCCSHHHHHHHHHHTTCCCTTBCCEEEEETTTT--E
T ss_pred ceehhccccCCceeEEEEEEc-CCceEEEEEEeeccccccchhHHHHHHHHHHHHHHHHhCCCCCchhhheeecCCC--e
Confidence 345578999999999999764 456789999986543222 167899999999999999999999997665 6
Q ss_pred EEEEeccCCCccccccCC-CCCchhHHHHHHHHHHHHHHHHhhccCCC--eEecCCCCCcEEEcCCCC-----eEEeecC
Q 003836 576 LVYEFMSNGTVASFLFGD-SKPNWKLRTEIAMGIAGGLFYLHEECCTQ--IIHCDIKPQNILLDDHYN-----ARISDFG 647 (792)
Q Consensus 576 lV~E~~~~gsL~~~l~~~-~~l~~~~~~~i~~~ia~gL~yLH~~~~~~--ivH~dikp~NILl~~~~~-----~kl~Dfg 647 (792)
+||||+++|+|.+++... ..+++..+..++.|++.||+|||+. + |+||||||+|||++.++. +||+|||
T Consensus 98 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~l~~~l~~lH~~---~~~ivH~dikp~Nil~~~~~~~~~~~~kl~Dfg 174 (287)
T 4f0f_A 98 MVMEFVPCGDLYHRLLDKAHPIKWSVKLRLMLDIALGIEYMQNQ---NPPIVHRDLRSPNIFLQSLDENAPVCAKVADFG 174 (287)
T ss_dssp EEEECCTTCBHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHTS---SSCCBCSCCSGGGEEESCCCTTCSCCEEECCCT
T ss_pred EEEEecCCCCHHHHHhcccCCccHHHHHHHHHHHHHHHHHHHhC---CCCeecCCCCcceEEEeccCCCCceeEEeCCCC
Confidence 999999999998888655 5789999999999999999999998 8 999999999999988776 9999999
Q ss_pred CCccccCCCCCccccccccCCccccccc--ccCCCCcccceehHHHHHHHHHhcCcCCCcchhhhhhhhHHHHHHHhhcc
Q 003836 648 LAKLLTLDQSHTNTAIRGTKGYVAPEWF--RNMPITVKVDVYSYGVLLLEIICLRRNIDNEISKVDKAILTDWAYDRYQE 725 (792)
Q Consensus 648 ~a~~~~~~~~~~~~~~~gt~~y~aPE~~--~~~~~~~k~DV~S~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~ 725 (792)
+++.... ......||+.|+|||.+ ....++.++||||||+++|||++|+.||..........
T Consensus 175 ~~~~~~~----~~~~~~g~~~y~aPE~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~------------ 238 (287)
T 4f0f_A 175 LSQQSVH----SVSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGKIKF------------ 238 (287)
T ss_dssp TCBCCSS----CEECCCCCCTTSCGGGSSCSSCEECHHHHHHHHHHHHHHHHHSSCTTTTCCCCHHHH------------
T ss_pred ccccccc----cccccCCCccccCchhhccCCCCcCchhhHHHHHHHHHHHHcCCCCCccccccHHHH------------
Confidence 9975432 23345689999999998 44568899999999999999999999996543221100
Q ss_pred cchhHhhhchhcccCCHHHHHHHHHHHHHccccCCCCCCCHHhHHHHhccC
Q 003836 726 RTLEALVENDLEAMNNVTMLHRFVMVAFWCIQEDPSHRPTMRKVTQMLEGV 776 (792)
Q Consensus 726 ~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~L~~~ 776 (792)
.............+...+..+.+++.+||+.||++|||++|+++.|+++
T Consensus 239 --~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~l 287 (287)
T 4f0f_A 239 --INMIREEGLRPTIPEDCPPRLRNVIELCWSGDPKKRPHFSYIVKELSEL 287 (287)
T ss_dssp --HHHHHHSCCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTC
T ss_pred --HHHHhccCCCCCCCcccCHHHHHHHHHHhcCChhhCcCHHHHHHHHHhC
Confidence 0111111222223334567889999999999999999999999999864
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-39 Score=344.98 Aligned_cols=258 Identities=23% Similarity=0.321 Sum_probs=195.5
Q ss_pred hhhhhhcCccccceEEEeeecCCCceEEEEEEcccccccchHHHHHHHHHhcc--cCCCCcccccceecc----CCceEE
Q 003836 503 RGFKEELGRGAFGTVYKGFVNMGSSNHVAVKKLNSVFQDSEKEFKAEVNGIGQ--THHKNLVRLLGYCDE----GQNRLL 576 (792)
Q Consensus 503 ~~~~~~lG~G~~g~Vy~g~~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~--l~h~niv~l~g~~~~----~~~~~l 576 (792)
+.+.+.||+|+||+||+|.. +++.||||++... ....+.+|.+++.. ++||||+++++++.+ ....++
T Consensus 10 y~~~~~lg~G~~g~V~~~~~---~~~~vavK~~~~~---~~~~~~~e~~~~~~~~l~h~niv~~~~~~~~~~~~~~~~~l 83 (301)
T 3q4u_A 10 ITLLECVGKGRYGEVWRGSW---QGENVAVKIFSSR---DEKSWFRETELYNTVMLRHENILGFIASDMTSRHSSTQLWL 83 (301)
T ss_dssp CEEEEEEEECSSEEEEEEEE---TTEEEEEEEECGG---GHHHHHHHHHHHHHTCCCCTTBCCEEEEEEEEETTEEEEEE
T ss_pred EEEEEeeccCCCcEEEEEEE---CCEEEEEEEeccc---cchhhHHHHHHHHHhhccCcCeeeEEEeeccccCCCceeEE
Confidence 34567899999999999976 3678999998643 34556666666655 799999999998644 346889
Q ss_pred EEEeccCCCccccccCCCCCchhHHHHHHHHHHHHHHHHh--------hccCCCeEecCCCCCcEEEcCCCCeEEeecCC
Q 003836 577 VYEFMSNGTVASFLFGDSKPNWKLRTEIAMGIAGGLFYLH--------EECCTQIIHCDIKPQNILLDDHYNARISDFGL 648 (792)
Q Consensus 577 V~E~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH--------~~~~~~ivH~dikp~NILl~~~~~~kl~Dfg~ 648 (792)
||||+++|+|.+++.. ..+++..+.+++.||+.||+||| +. +|+||||||+|||++.++.+||+|||+
T Consensus 84 v~e~~~~g~L~~~l~~-~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~---~ivH~Dlkp~Nill~~~~~~kl~Dfg~ 159 (301)
T 3q4u_A 84 ITHYHEMGSLYDYLQL-TTLDTVSCLRIVLSIASGLAHLHIEIFGTQGKP---AIAHRDLKSKNILVKKNGQCCIADLGL 159 (301)
T ss_dssp EECCCTTCBHHHHHTT-CCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBC---EEECSCCCGGGEEECTTSCEEECCCTT
T ss_pred ehhhccCCCHHHHHhh-cccCHHHHHHHHHHHHHHHHHHHHhhhhccCCC---CeecCCCChHhEEEcCCCCEEEeeCCC
Confidence 9999999999999954 56899999999999999999999 66 999999999999999999999999999
Q ss_pred CccccCCCCCc---cccccccCCcccccccccC------CCCcccceehHHHHHHHHHhc----------CcCCCcchhh
Q 003836 649 AKLLTLDQSHT---NTAIRGTKGYVAPEWFRNM------PITVKVDVYSYGVLLLEIICL----------RRNIDNEISK 709 (792)
Q Consensus 649 a~~~~~~~~~~---~~~~~gt~~y~aPE~~~~~------~~~~k~DV~S~Gv~l~el~tg----------~~p~~~~~~~ 709 (792)
++......... .....||+.|+|||.+.+. .++.++||||||+++|||++| +.||......
T Consensus 160 a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~pf~~~~~~ 239 (301)
T 3q4u_A 160 AVMHSQSTNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFYDVVPN 239 (301)
T ss_dssp CEEEETTTTEEECCCCCCCCCGGGCCHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTTTSCS
T ss_pred eeecccccccccccccccccccceeChhhhcCcCCCCcccCCchhhHHHHHHHHHHHHhhhcCccccccccccccccCCC
Confidence 98765433321 2234699999999999876 556799999999999999999 7777543221
Q ss_pred hhhhhHHHHHHHhhcccchhHhhhchhcccCCHHHHHHHHHHHHHccccCCCCCCCHHhHHHHhccC
Q 003836 710 VDKAILTDWAYDRYQERTLEALVENDLEAMNNVTMLHRFVMVAFWCIQEDPSHRPTMRKVTQMLEGV 776 (792)
Q Consensus 710 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~L~~~ 776 (792)
..... ............. .......+...+..+.+++.+||+.||++|||++||++.|+++
T Consensus 240 ~~~~~--~~~~~~~~~~~~~----~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~i 300 (301)
T 3q4u_A 240 DPSFE--DMRKVVCVDQQRP----NIPNRWFSDPTLTSLAKLMKECWYQNPSARLTALRIKKTLTKI 300 (301)
T ss_dssp SCCHH--HHHHHHTTSCCCC----CCCGGGGGSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHHHHHH
T ss_pred Ccchh--hhhHHHhccCCCC----CCChhhccCccHHHHHHHHHHHhhcChhhCCCHHHHHHHHhcc
Confidence 11000 0000000000000 0000112235678899999999999999999999999999864
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-39 Score=341.33 Aligned_cols=251 Identities=30% Similarity=0.452 Sum_probs=205.2
Q ss_pred hhhhhhcCccccceEEEeeecCCCceEEEEEEcccccccchHHHHHHHHHhcccCCCCcccccceeccCCceEEEEEecc
Q 003836 503 RGFKEELGRGAFGTVYKGFVNMGSSNHVAVKKLNSVFQDSEKEFKAEVNGIGQTHHKNLVRLLGYCDEGQNRLLVYEFMS 582 (792)
Q Consensus 503 ~~~~~~lG~G~~g~Vy~g~~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~lV~E~~~ 582 (792)
+.+.+.||+|+||.||+|... +++.||+|++.... ...+.+.+|++++++++||||+++++++.+ +..++||||++
T Consensus 15 y~~~~~lg~G~~g~Vy~~~~~--~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-~~~~~v~e~~~ 90 (279)
T 1qpc_A 15 LKLVERLGAGQFGEVWMGYYN--GHTKVAVKSLKQGS-MSPDAFLAEANLMKQLQHQRLVRLYAVVTQ-EPIYIITEYME 90 (279)
T ss_dssp EEEEEEEEEETTEEEEEEEET--TTEEEEEEEECTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEEECCT
T ss_pred hhheeeecCCCCeEEEEEEEc--CCcEEEEEEecCCc-ccHHHHHHHHHHHHhCCCcCcceEEEEEcC-CCcEEEEecCC
Confidence 345678999999999999764 35689999987543 346789999999999999999999999874 46899999999
Q ss_pred CCCccccccCCC--CCchhHHHHHHHHHHHHHHHHhhccCCCeEecCCCCCcEEEcCCCCeEEeecCCCccccCCCCCcc
Q 003836 583 NGTVASFLFGDS--KPNWKLRTEIAMGIAGGLFYLHEECCTQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLDQSHTN 660 (792)
Q Consensus 583 ~gsL~~~l~~~~--~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dikp~NILl~~~~~~kl~Dfg~a~~~~~~~~~~~ 660 (792)
+++|.+++.... .+++..+..++.||+.||+|||+. +|+||||||+|||+++++.+||+|||+++..........
T Consensus 91 ~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~ 167 (279)
T 1qpc_A 91 NGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEER---NYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAR 167 (279)
T ss_dssp TCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTSCEEECCCTTCEECSSSCEECC
T ss_pred CCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHhhEEEcCCCCEEECCCcccccccCcccccc
Confidence 999999997653 689999999999999999999998 999999999999999999999999999987754433333
Q ss_pred ccccccCCcccccccccCCCCcccceehHHHHHHHHHh-cCcCCCcchhhhhhhhHHHHHHHhhcccchhHhhhchhccc
Q 003836 661 TAIRGTKGYVAPEWFRNMPITVKVDVYSYGVLLLEIIC-LRRNIDNEISKVDKAILTDWAYDRYQERTLEALVENDLEAM 739 (792)
Q Consensus 661 ~~~~gt~~y~aPE~~~~~~~~~k~DV~S~Gv~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 739 (792)
....+++.|+|||.+.+..++.++||||||+++|||++ |+.||........ . ..+.......
T Consensus 168 ~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~---~--------------~~~~~~~~~~ 230 (279)
T 1qpc_A 168 EGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEV---I--------------QNLERGYRMV 230 (279)
T ss_dssp TTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHH---H--------------HHHHTTCCCC
T ss_pred cCCCCccCccChhhhccCCCCchhhhHHHHHHHHHHHhCCCCCCcccCHHHH---H--------------HHHhcccCCC
Confidence 34457889999999998889999999999999999999 8889865432110 0 0001111112
Q ss_pred CCHHHHHHHHHHHHHccccCCCCCCCHHhHHHHhccCc
Q 003836 740 NNVTMLHRFVMVAFWCIQEDPSHRPTMRKVTQMLEGVV 777 (792)
Q Consensus 740 ~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~L~~~~ 777 (792)
.+...+..+.+++.+||+.+|++|||++++++.|+.+.
T Consensus 231 ~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~ 268 (279)
T 1qpc_A 231 RPDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDFF 268 (279)
T ss_dssp CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred CcccccHHHHHHHHHHhccChhhCCCHHHHHHHHHHHH
Confidence 22334567889999999999999999999999998864
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-39 Score=346.09 Aligned_cols=246 Identities=20% Similarity=0.313 Sum_probs=192.8
Q ss_pred hhhhhhcCccccceEEEeeecCCCceEEEEEEccccc-ccchHHHHHHHHHhcccCCCCcccccceeccCC---------
Q 003836 503 RGFKEELGRGAFGTVYKGFVNMGSSNHVAVKKLNSVF-QDSEKEFKAEVNGIGQTHHKNLVRLLGYCDEGQ--------- 572 (792)
Q Consensus 503 ~~~~~~lG~G~~g~Vy~g~~~~~~~~~vavK~~~~~~-~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~--------- 572 (792)
+.+.+.||+|+||.||+|... .+++.||||++.... ....+.+.+|++++++++||||+++++++.+..
T Consensus 8 y~~~~~lG~G~~g~V~~a~~~-~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~~ 86 (332)
T 3qd2_B 8 FEPIQCMGRGGFGVVFEAKNK-VDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLETPPEKWQEEMD 86 (332)
T ss_dssp EEEEEEEECC-CSEEEEEEET-TTCCEEEEEEEECCSTTTHHHHHHHHHHHHTSCCCTTBCCEEEEEEECCSCHHHHHHH
T ss_pred CceeeEecCCCCeEEEEEEEc-CCCcEEEEEEeecCCchhHHHHHHHHHHHHHhCCCCCEeeEEEEEEEeccchhhhhhh
Confidence 345578999999999999764 456799999987543 334578999999999999999999999985543
Q ss_pred ------------------------------------------------ceEEEEEeccCCCccccccCCCC---CchhHH
Q 003836 573 ------------------------------------------------NRLLVYEFMSNGTVASFLFGDSK---PNWKLR 601 (792)
Q Consensus 573 ------------------------------------------------~~~lV~E~~~~gsL~~~l~~~~~---l~~~~~ 601 (792)
..++||||+++++|.+++..... ..+..+
T Consensus 87 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~ 166 (332)
T 3qd2_B 87 EIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDREHGVC 166 (332)
T ss_dssp C--------------------------------------------CCCEEEEEEECCCSSCHHHHHHTCCSGGGSCHHHH
T ss_pred hhhhccccccccccCCCcccccccceeeccccCcccccccccCCCCCceEEEEEEecCCCCHHHHHhcccCccchhhHHH
Confidence 27899999999999999987643 355568
Q ss_pred HHHHHHHHHHHHHHhhccCCCeEecCCCCCcEEEcCCCCeEEeecCCCccccCCCC-----------CccccccccCCcc
Q 003836 602 TEIAMGIAGGLFYLHEECCTQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLDQS-----------HTNTAIRGTKGYV 670 (792)
Q Consensus 602 ~~i~~~ia~gL~yLH~~~~~~ivH~dikp~NILl~~~~~~kl~Dfg~a~~~~~~~~-----------~~~~~~~gt~~y~ 670 (792)
..++.||+.||+|||++ +|+||||||+|||++.++.+||+|||+++....... .......||+.|+
T Consensus 167 ~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~ 243 (332)
T 3qd2_B 167 LHIFIQIAEAVEFLHSK---GLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTKLYM 243 (332)
T ss_dssp HHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTCEECSCC--------------CCCSCC-CGGGS
T ss_pred HHHHHHHHHHHHHHHhC---CeeecCCCcccEEEeCCCCEEEeecCcccccccchhhccccccccccccccccCCCcCcc
Confidence 99999999999999998 999999999999999999999999999987754422 1223356999999
Q ss_pred cccccccCCCCcccceehHHHHHHHHHhcCcCCCcchhhhhhhhHHHHHHHhhcccchhHhhhchhcccCCHHHHHHHHH
Q 003836 671 APEWFRNMPITVKVDVYSYGVLLLEIICLRRNIDNEISKVDKAILTDWAYDRYQERTLEALVENDLEAMNNVTMLHRFVM 750 (792)
Q Consensus 671 aPE~~~~~~~~~k~DV~S~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 750 (792)
|||.+.+..++.++||||||+++|||++|..|+...... . ....... ...........+.+
T Consensus 244 aPE~~~~~~~~~~~Di~slG~il~el~~~~~~~~~~~~~-----~-----~~~~~~~---------~~~~~~~~~~~~~~ 304 (332)
T 3qd2_B 244 SPEQIHGNNYSHKVDIFSLGLILFELLYSFSTQMERVRI-----I-----TDVRNLK---------FPLLFTQKYPQEHM 304 (332)
T ss_dssp CHHHHHCCCCCTHHHHHHHHHHHHHHHSCCCCHHHHHHH-----H-----HHHHTTC---------CCHHHHHHCHHHHH
T ss_pred ChHHhcCCCCcchhhHHHHHHHHHHHHHcCCChhHHHHH-----H-----HHhhccC---------CCcccccCChhHHH
Confidence 999999999999999999999999999987654211100 0 0000000 01111234466789
Q ss_pred HHHHccccCCCCCCCHHhHHH
Q 003836 751 VAFWCIQEDPSHRPTMRKVTQ 771 (792)
Q Consensus 751 l~~~Cl~~~p~~RPs~~evl~ 771 (792)
++.+||+.||++|||++|+++
T Consensus 305 li~~~l~~~p~~Rps~~~~l~ 325 (332)
T 3qd2_B 305 MVQDMLSPSPTERPEATDIIE 325 (332)
T ss_dssp HHHHHHCSSGGGSCCHHHHHH
T ss_pred HHHHHccCCCCcCCCHHHHhh
Confidence 999999999999999999998
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=9.6e-39 Score=351.45 Aligned_cols=250 Identities=24% Similarity=0.307 Sum_probs=204.4
Q ss_pred hhhhhhcCccccceEEEeeecCCCceEEEEEEcccccccchHHHHHHHHHhcccCCCCcccccceeccCCceEEEEEecc
Q 003836 503 RGFKEELGRGAFGTVYKGFVNMGSSNHVAVKKLNSVFQDSEKEFKAEVNGIGQTHHKNLVRLLGYCDEGQNRLLVYEFMS 582 (792)
Q Consensus 503 ~~~~~~lG~G~~g~Vy~g~~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~lV~E~~~ 582 (792)
+.+.+.||+|+||.||+|... .+++.+|+|++..........+.+|++++++++||||+++++++.+....++||||++
T Consensus 53 y~i~~~LG~G~~g~Vy~~~~~-~~~~~~a~K~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv~E~~~ 131 (387)
T 1kob_A 53 YDILEELGSGAFGVVHRCVEK-ATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEFLS 131 (387)
T ss_dssp EEEEEEEEEETTEEEEEEEET-TTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEEECCC
T ss_pred eEEEEEEecCCCEEEEEEEEC-CCCCEEEEEEecccchhhHHHHHHHHHHHHhCCCcCCCeEEEEEEeCCEEEEEEEcCC
Confidence 445678999999999999754 4567999999987655566789999999999999999999999999999999999999
Q ss_pred CCCccccccCC-CCCchhHHHHHHHHHHHHHHHHhhccCCCeEecCCCCCcEEEcC--CCCeEEeecCCCccccCCCCCc
Q 003836 583 NGTVASFLFGD-SKPNWKLRTEIAMGIAGGLFYLHEECCTQIIHCDIKPQNILLDD--HYNARISDFGLAKLLTLDQSHT 659 (792)
Q Consensus 583 ~gsL~~~l~~~-~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dikp~NILl~~--~~~~kl~Dfg~a~~~~~~~~~~ 659 (792)
+|+|.+++... ..+++..+..++.||+.||+|||+. +|+||||||+|||++. ++.+||+|||+++...... .
T Consensus 132 gg~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---givHrDlkp~NIll~~~~~~~vkL~DFG~a~~~~~~~--~ 206 (387)
T 1kob_A 132 GGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEH---SIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDE--I 206 (387)
T ss_dssp CCBHHHHTTCTTCCBCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSTTCCCEEECCCTTCEECCTTS--C
T ss_pred CCcHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhC---CeeecccchHHeEEecCCCCceEEEecccceecCCCc--c
Confidence 99999999765 4789999999999999999999998 9999999999999974 5779999999998765432 2
Q ss_pred cccccccCCcccccccccCCCCcccceehHHHHHHHHHhcCcCCCcchhhhhhhhHHHHHHHhhcccchhHhhhchhccc
Q 003836 660 NTAIRGTKGYVAPEWFRNMPITVKVDVYSYGVLLLEIICLRRNIDNEISKVDKAILTDWAYDRYQERTLEALVENDLEAM 739 (792)
Q Consensus 660 ~~~~~gt~~y~aPE~~~~~~~~~k~DV~S~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 739 (792)
.....||+.|+|||++.+..++.++|||||||++|||++|+.||........ +....... ......
T Consensus 207 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~---~~~i~~~~-----------~~~~~~ 272 (387)
T 1kob_A 207 VKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLET---LQNVKRCD-----------WEFDED 272 (387)
T ss_dssp EEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHH---HHHHHHCC-----------CCCCSS
T ss_pred eeeeccCCCccCchhccCCCCCCcccEeeHhHHHHHHHhCCCCCCCCCHHHH---HHHHHhCC-----------CCCCcc
Confidence 2344689999999999999999999999999999999999999976432111 10000000 000111
Q ss_pred CCHHHHHHHHHHHHHccccCCCCCCCHHhHHHH
Q 003836 740 NNVTMLHRFVMVAFWCIQEDPSHRPTMRKVTQM 772 (792)
Q Consensus 740 ~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~ 772 (792)
.....+.++.+++.+||+.||++|||++|+++.
T Consensus 273 ~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~h 305 (387)
T 1kob_A 273 AFSSVSPEAKDFIKNLLQKEPRKRLTVHDALEH 305 (387)
T ss_dssp TTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHTS
T ss_pred ccccCCHHHHHHHHHHcCCChhHCcCHHHHhhC
Confidence 112345678899999999999999999999974
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7e-39 Score=348.29 Aligned_cols=272 Identities=16% Similarity=0.193 Sum_probs=202.1
Q ss_pred hhhhhhcCccccceEEEeeecC--CCceEEEEEEccccccc-----------chHHHHHHHHHhcccCCCCcccccceec
Q 003836 503 RGFKEELGRGAFGTVYKGFVNM--GSSNHVAVKKLNSVFQD-----------SEKEFKAEVNGIGQTHHKNLVRLLGYCD 569 (792)
Q Consensus 503 ~~~~~~lG~G~~g~Vy~g~~~~--~~~~~vavK~~~~~~~~-----------~~~~~~~Ei~~l~~l~h~niv~l~g~~~ 569 (792)
+.+.+.||+|+||.||+|.... ..+..+|+|+....... ....+.+|+..+..++||||+++++++.
T Consensus 39 y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~ni~~~~~~~~ 118 (345)
T 2v62_A 39 WVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQLDYLGIPLFYGSGL 118 (345)
T ss_dssp EEEEEEC------CEEEEEESSSCGGGCCEEEEEEECC-CHHHHHHHHHHHHCCHHHHHHHHHHHTCSCCCCCCEEEEEE
T ss_pred EEEEeeEeecCCeEEEEEEecCCCCccceEEEEeeecCCcchHHHHHHHHHHhhhHHHHHHHhhccccccCcceeecccc
Confidence 4456789999999999997653 14578999998754321 1234667888999999999999999997
Q ss_pred c----CCceEEEEEeccCCCccccccCCCCCchhHHHHHHHHHHHHHHHHhhccCCCeEecCCCCCcEEEcCCC--CeEE
Q 003836 570 E----GQNRLLVYEFMSNGTVASFLFGDSKPNWKLRTEIAMGIAGGLFYLHEECCTQIIHCDIKPQNILLDDHY--NARI 643 (792)
Q Consensus 570 ~----~~~~~lV~E~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dikp~NILl~~~~--~~kl 643 (792)
. ....++||||+ +++|.+++.....+++..+..++.||+.||+|||+. +|+||||||+|||++.++ .+||
T Consensus 119 ~~~~~~~~~~lv~e~~-~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~~~kL 194 (345)
T 2v62_A 119 TEFKGRSYRFMVMERL-GIDLQKISGQNGTFKKSTVLQLGIRMLDVLEYIHEN---EYVHGDIKAANLLLGYKNPDQVYL 194 (345)
T ss_dssp EESSSCEEEEEEEECE-EEEHHHHCBGGGBCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEESSSTTSEEE
T ss_pred cccCCCcEEEEEEecc-CCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCcCHHHEEEccCCCCcEEE
Confidence 7 77899999999 999999998877899999999999999999999998 999999999999999887 9999
Q ss_pred eecCCCccccCCCCC------ccccccccCCcccccccccCCCCcccceehHHHHHHHHHhcCcCCCcchhhhhhhhHHH
Q 003836 644 SDFGLAKLLTLDQSH------TNTAIRGTKGYVAPEWFRNMPITVKVDVYSYGVLLLEIICLRRNIDNEISKVDKAILTD 717 (792)
Q Consensus 644 ~Dfg~a~~~~~~~~~------~~~~~~gt~~y~aPE~~~~~~~~~k~DV~S~Gv~l~el~tg~~p~~~~~~~~~~~~~~~ 717 (792)
+|||+++........ ......||+.|+|||.+.+..++.++|||||||++|||++|+.||............
T Consensus 195 ~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~~-- 272 (345)
T 2v62_A 195 ADYGLSYRYCPNGNHKQYQENPRKGHNGTIEFTSLDAHKGVALSRRSDVEILGYCMLRWLCGKLPWEQNLKDPVAVQT-- 272 (345)
T ss_dssp CCCTTCEESSGGGCCCCCCCCGGGCSCSCTTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCTTGGGTTCHHHHHH--
T ss_pred EeCCCceecccccccccchhccccccCCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCccccccccHHHHH--
Confidence 999999876433221 123457999999999999999999999999999999999999999653222111100
Q ss_pred HHHHhhcccchhHhhhchhcccCCHHHHHHHHHHHHHccccCCCCCCCHHhHHHHhccCcCCCCCCCCC
Q 003836 718 WAYDRYQERTLEALVENDLEAMNNVTMLHRFVMVAFWCIQEDPSHRPTMRKVTQMLEGVVEVPIPPCPW 786 (792)
Q Consensus 718 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~L~~~~~~~~p~~P~ 786 (792)
....... .+...+.... .....+.++.+++.+||+.||++||++++|++.|+.+.. +.++..+
T Consensus 273 -~~~~~~~-~~~~~~~~~~---~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~~-~~~~~d~ 335 (345)
T 2v62_A 273 -AKTNLLD-ELPQSVLKWA---PSGSSCCEIAQFLVCAHSLAYDEKPNYQALKKILNPHGI-PLGPLDF 335 (345)
T ss_dssp -HHHHHHH-TTTHHHHHHS---CTTSCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHCTTCC-CCCCCCC
T ss_pred -HHHhhcc-cccHHHHhhc---cccccHHHHHHHHHHHhhcCcccCCCHHHHHHHHhccCC-cccCCCc
Confidence 0000000 0111111000 011344678899999999999999999999999988643 4444433
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-39 Score=348.82 Aligned_cols=253 Identities=25% Similarity=0.351 Sum_probs=200.2
Q ss_pred hhhhhcCccccceEEEeeecCCCc---eEEEEEEccccc-ccchHHHHHHHHHhcccCCCCcccccceeccCCceEEEEE
Q 003836 504 GFKEELGRGAFGTVYKGFVNMGSS---NHVAVKKLNSVF-QDSEKEFKAEVNGIGQTHHKNLVRLLGYCDEGQNRLLVYE 579 (792)
Q Consensus 504 ~~~~~lG~G~~g~Vy~g~~~~~~~---~~vavK~~~~~~-~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~lV~E 579 (792)
.+.+.||+|+||+||+|....... ..||+|.+.... ....+.+.+|+.++++++||||+++++++. ++..++|||
T Consensus 16 ~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~~v~e 94 (325)
T 3kex_A 16 RKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIVRLLGLCP-GSSLQLVTQ 94 (325)
T ss_dssp EEEEEEECCSSCEEEEEEECCTTCSCCEEEEEEEECCTTSCSCBCSCCHHHHHHHTCCCTTBCCEEEEEC-BSSEEEEEE
T ss_pred eeeeeeeecCCceEEEEEEcCCCceEEEEEEEEeccccccHHHHHHHHHHHHHHhcCCCCCcCeEEEEEc-CCccEEEEE
Confidence 345789999999999997643221 248888875432 333467889999999999999999999986 466899999
Q ss_pred eccCCCccccccCC-CCCchhHHHHHHHHHHHHHHHHhhccCCCeEecCCCCCcEEEcCCCCeEEeecCCCccccCCCCC
Q 003836 580 FMSNGTVASFLFGD-SKPNWKLRTEIAMGIAGGLFYLHEECCTQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLDQSH 658 (792)
Q Consensus 580 ~~~~gsL~~~l~~~-~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dikp~NILl~~~~~~kl~Dfg~a~~~~~~~~~ 658 (792)
|+++|+|.+++... ..+++..+..++.||+.||+|||+. +|+||||||+|||++.++.+||+|||+++........
T Consensus 95 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~~~~~~~ 171 (325)
T 3kex_A 95 YLPLGSLLDHVRQHRGALGPQLLLNWGVQIAKGMYYLEEH---GMVHRNLAARNVLLKSPSQVQVADFGVADLLPPDDKQ 171 (325)
T ss_dssp CCTTCBSHHHHHSSGGGSCTTHHHHHHHHHHHHHHHHHHT---TCCCSCCSSTTEEESSSSCEEECSCSGGGGSCCCTTC
T ss_pred eCCCCCHHHHHHHccccCCHHHHHHHHHHHHHHHHHHHhC---CCCCCccchheEEECCCCeEEECCCCcccccCccccc
Confidence 99999999999775 5789999999999999999999999 9999999999999999999999999999987544332
Q ss_pred -ccccccccCCcccccccccCCCCcccceehHHHHHHHHHh-cCcCCCcchhhhhhhhHHHHHHHhhcccchhHhhhchh
Q 003836 659 -TNTAIRGTKGYVAPEWFRNMPITVKVDVYSYGVLLLEIIC-LRRNIDNEISKVDKAILTDWAYDRYQERTLEALVENDL 736 (792)
Q Consensus 659 -~~~~~~gt~~y~aPE~~~~~~~~~k~DV~S~Gv~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 736 (792)
......+++.|+|||.+.+..++.++||||||+++|||++ |+.||........ ...+....
T Consensus 172 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~-----------------~~~~~~~~ 234 (325)
T 3kex_A 172 LLYSEAKTPIKWMALESIHFGKYTHQSDVWSYGVTVWELMTFGAEPYAGLRLAEV-----------------PDLLEKGE 234 (325)
T ss_dssp CC-----CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCTTHH-----------------HHHHHTTC
T ss_pred ccccCCCCcccccChHHhccCCCChhhHhHHhHHHHHHHHhCCCCCccccCHHHH-----------------HHHHHcCC
Confidence 2334567889999999999999999999999999999999 9999975432111 11111111
Q ss_pred cccCCHHHHHHHHHHHHHccccCCCCCCCHHhHHHHhccCc
Q 003836 737 EAMNNVTMLHRFVMVAFWCIQEDPSHRPTMRKVTQMLEGVV 777 (792)
Q Consensus 737 ~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~L~~~~ 777 (792)
....+...+..+.+++.+||+.||.+||+++|+++.|+.+.
T Consensus 235 ~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~el~~~l~~~~ 275 (325)
T 3kex_A 235 RLAQPQICTIDVYMVMVKCWMIDENIRPTFKELANEFTRMA 275 (325)
T ss_dssp BCCCCTTBCTTTTHHHHHHTCSCTTTSCCHHHHHHHHHHHT
T ss_pred CCCCCCcCcHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHH
Confidence 11122223456788999999999999999999999998764
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-39 Score=353.50 Aligned_cols=264 Identities=16% Similarity=0.188 Sum_probs=202.5
Q ss_pred hhhhhhcCccccceEEEeeecCC----CceEEEEEEcccccccc-----------hHHHHHHHHHhcccCCCCcccccce
Q 003836 503 RGFKEELGRGAFGTVYKGFVNMG----SSNHVAVKKLNSVFQDS-----------EKEFKAEVNGIGQTHHKNLVRLLGY 567 (792)
Q Consensus 503 ~~~~~~lG~G~~g~Vy~g~~~~~----~~~~vavK~~~~~~~~~-----------~~~~~~Ei~~l~~l~h~niv~l~g~ 567 (792)
+.+.+.||+|+||.||+|....+ .++.||||++....... ...+..|+..+.+++|+||++++++
T Consensus 37 y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~ 116 (364)
T 3op5_A 37 WKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRTRKLKYLGVPKYWGS 116 (364)
T ss_dssp EEEEEECCCC-CCEEEEEEECCSSCCCTTCSEEEEEEETTCHHHHHHHHHHHHHCCHHHHHHHHHHTTCSCCCSCCEEEE
T ss_pred EEEEEEEecCCCeEEEEeeecCccccccccceEEEEeeccchhHHHHHHHHHhhhhhHHHHHHHHHhhccCCCCCeEEee
Confidence 44567899999999999977543 24789999986543211 1233455667778899999999999
Q ss_pred eccC----CceEEEEEeccCCCccccccCC-CCCchhHHHHHHHHHHHHHHHHhhccCCCeEecCCCCCcEEEc--CCCC
Q 003836 568 CDEG----QNRLLVYEFMSNGTVASFLFGD-SKPNWKLRTEIAMGIAGGLFYLHEECCTQIIHCDIKPQNILLD--DHYN 640 (792)
Q Consensus 568 ~~~~----~~~~lV~E~~~~gsL~~~l~~~-~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dikp~NILl~--~~~~ 640 (792)
+.+. ...+|||||+ +++|.+++... ..+++..+..|+.||+.||+|||+. +|+||||||+|||++ .++.
T Consensus 117 ~~~~~~~~~~~~lv~e~~-g~~L~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~---~iiHrDlkp~Nill~~~~~~~ 192 (364)
T 3op5_A 117 GLHDKNGKSYRFMIMDRF-GSDLQKIYEANAKRFSRKTVLQLSLRILDILEYIHEH---EYVHGDIKASNLLLNYKNPDQ 192 (364)
T ss_dssp EEEEETTEEEEEEEEECE-EEEHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEEESSCTTC
T ss_pred eeeccCCcceEEEEEeCC-CCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHC---CeEEecCCHHHEEEecCCCCe
Confidence 8764 4589999999 99999999765 6789999999999999999999999 999999999999999 8899
Q ss_pred eEEeecCCCccccCCCCCc------cccccccCCcccccccccCCCCcccceehHHHHHHHHHhcCcCCCcchhhhhhhh
Q 003836 641 ARISDFGLAKLLTLDQSHT------NTAIRGTKGYVAPEWFRNMPITVKVDVYSYGVLLLEIICLRRNIDNEISKVDKAI 714 (792)
Q Consensus 641 ~kl~Dfg~a~~~~~~~~~~------~~~~~gt~~y~aPE~~~~~~~~~k~DV~S~Gv~l~el~tg~~p~~~~~~~~~~~~ 714 (792)
+||+|||+++.+....... .....||+.|+|||.+.+..++.++|||||||++|||++|+.||...........
T Consensus 193 ~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~Pf~~~~~~~~~~~ 272 (364)
T 3op5_A 193 VYLVDYGLAYRYCPEGVHKAYAADPKRCHDGTIEFTSIDAHNGVAPSRRGDLEILGYCMIQWLTGHLPWEDNLKDPKYVR 272 (364)
T ss_dssp EEECCCTTCEESSGGGCCCCSSCCSSCCCCCCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTGGGTTCHHHHH
T ss_pred EEEEECCcceecccCCcccccccCcccccCCCCCccCHHHhCCCCCCchhhHHHHHHHHHHHHhCCCCccccccCHHHHH
Confidence 9999999998765432211 1334599999999999999999999999999999999999999975433211111
Q ss_pred HHHHHHHhhcccchhHhhhchhcccCCHHHHHHHHHHHHHccccCCCCCCCHHhHHHHhccCc
Q 003836 715 LTDWAYDRYQERTLEALVENDLEAMNNVTMLHRFVMVAFWCIQEDPSHRPTMRKVTQMLEGVV 777 (792)
Q Consensus 715 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~L~~~~ 777 (792)
. ..... ...+..+++..+.. ...+.++.+++..||+.+|.+||++++|++.|+.++
T Consensus 273 ~---~~~~~-~~~~~~~~~~~~~~---~~~~~~~~~li~~cl~~~p~~RP~~~~l~~~l~~~~ 328 (364)
T 3op5_A 273 D---SKIRY-RENIASLMDKCFPA---ANAPGEIAKYMETVKLLDYTEKPLYENLRDILLQGL 328 (364)
T ss_dssp H---HHHHH-HHCHHHHHHHHSCT---TCCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHH
T ss_pred H---HHHHh-hhhHHHHHHHhccc---ccCHHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHH
Confidence 0 11111 11233333333221 123467889999999999999999999999987754
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-39 Score=345.66 Aligned_cols=247 Identities=19% Similarity=0.246 Sum_probs=202.8
Q ss_pred hhhhhhcCccccceEEEeeecCCCceEEEEEEcccccccchHHHHHHHHHhcccCCCCcccccceeccCCceEEEEEecc
Q 003836 503 RGFKEELGRGAFGTVYKGFVNMGSSNHVAVKKLNSVFQDSEKEFKAEVNGIGQTHHKNLVRLLGYCDEGQNRLLVYEFMS 582 (792)
Q Consensus 503 ~~~~~~lG~G~~g~Vy~g~~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~lV~E~~~ 582 (792)
+.+.+.||+|+||+||++... .+++.+|+|.+... ......+.+|+.++++++||||+++++++.+.+..++||||++
T Consensus 7 y~~~~~lG~G~~g~Vy~~~~~-~~~~~~a~K~~~~~-~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~~ 84 (321)
T 1tki_A 7 YMIAEDLGRGEFGIVHRCVET-SSKKTYMAKFVKVK-GTDQVLVKKEISILNIARHRNILHLHESFESMEELVMIFEFIS 84 (321)
T ss_dssp EEEEEEEEECSSEEEEEEEET-TTTEEEEEEEECCC-THHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEECCCC
T ss_pred eEeeeEEecCCCeEEEEEEEC-CCCcEEEEEEEecC-cccHHHHHHHHHHHHhCCCCCCCeEeEEEecCCEEEEEEEeCC
Confidence 345678999999999999754 56789999998754 3445678999999999999999999999999999999999999
Q ss_pred CCCccccccCC-CCCchhHHHHHHHHHHHHHHHHhhccCCCeEecCCCCCcEEEcC--CCCeEEeecCCCccccCCCCCc
Q 003836 583 NGTVASFLFGD-SKPNWKLRTEIAMGIAGGLFYLHEECCTQIIHCDIKPQNILLDD--HYNARISDFGLAKLLTLDQSHT 659 (792)
Q Consensus 583 ~gsL~~~l~~~-~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dikp~NILl~~--~~~~kl~Dfg~a~~~~~~~~~~ 659 (792)
+|+|.+++... ..+++..+..++.||+.||.|||+. +|+||||||+|||++. ++.+||+|||+++...... .
T Consensus 85 g~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~---givH~Dlkp~NIl~~~~~~~~~kl~Dfg~a~~~~~~~--~ 159 (321)
T 1tki_A 85 GLDIFERINTSAFELNEREIVSYVHQVCEALQFLHSH---NIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGD--N 159 (321)
T ss_dssp CCBHHHHHTSSSCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSSSCCCEEECCCTTCEECCTTC--E
T ss_pred CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC---CCCcCCCCHHHEEEccCCCCCEEEEECCCCeECCCCC--c
Confidence 99999999765 4789999999999999999999998 9999999999999997 7899999999998765322 2
Q ss_pred cccccccCCcccccccccCCCCcccceehHHHHHHHHHhcCcCCCcchhhhhhhhHHHHHHHhhcccchhHhhhchhccc
Q 003836 660 NTAIRGTKGYVAPEWFRNMPITVKVDVYSYGVLLLEIICLRRNIDNEISKVDKAILTDWAYDRYQERTLEALVENDLEAM 739 (792)
Q Consensus 660 ~~~~~gt~~y~aPE~~~~~~~~~k~DV~S~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 739 (792)
.....||+.|+|||.+.+..++.++||||||+++|||++|+.||........ +. .+........
T Consensus 160 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~---~~-------------~i~~~~~~~~ 223 (321)
T 1tki_A 160 FRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQI---IE-------------NIMNAEYTFD 223 (321)
T ss_dssp EEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSHHHH---HH-------------HHHHTCCCCC
T ss_pred cccccCChhhcCcHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCcCCCHHHH---HH-------------HHHcCCCCCC
Confidence 3345689999999999988899999999999999999999999976432211 10 0111100000
Q ss_pred --CCHHHHHHHHHHHHHccccCCCCCCCHHhHHHH
Q 003836 740 --NNVTMLHRFVMVAFWCIQEDPSHRPTMRKVTQM 772 (792)
Q Consensus 740 --~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~ 772 (792)
.....+.++.+++.+||+.||++|||+.|+++.
T Consensus 224 ~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~e~l~h 258 (321)
T 1tki_A 224 EEAFKEISIEAMDFVDRLLVKERKSRMTASEALQH 258 (321)
T ss_dssp HHHHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred hhhhccCCHHHHHHHHHHcCCChhHCcCHHHHhcC
Confidence 001235678899999999999999999999974
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-39 Score=337.11 Aligned_cols=246 Identities=21% Similarity=0.332 Sum_probs=201.4
Q ss_pred hhhhhcCccccceEEEeeecCCCceEEEEEEccccc--ccchHHHHHHHHHhcccCCCCcccccceeccC--CceEEEEE
Q 003836 504 GFKEELGRGAFGTVYKGFVNMGSSNHVAVKKLNSVF--QDSEKEFKAEVNGIGQTHHKNLVRLLGYCDEG--QNRLLVYE 579 (792)
Q Consensus 504 ~~~~~lG~G~~g~Vy~g~~~~~~~~~vavK~~~~~~--~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~--~~~~lV~E 579 (792)
.+.+.||+|+||+||+|... ++.+|||++.... ....+.+.+|+.++++++||||+++++++.+. ...++|||
T Consensus 13 ~~~~~lg~G~~g~V~~~~~~---~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~e 89 (271)
T 3kmu_A 13 NFLTKLNENHSGELWKGRWQ---GNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLGACQSPPAPHPTLITH 89 (271)
T ss_dssp EEEEEEEEETTEEEEEEEET---TEEEEEEEECCTTCCHHHHHHHHHHGGGGCCCSCTTEECEEEEECTTTSSSCEEEEE
T ss_pred HHHHHhcCCCcceEEEEEEC---CeeEEEEEecccccCHHHHHHHHHHHHHHHhcCCCchhheEEEEccCCCCCeEeeec
Confidence 45578999999999999864 5789999987543 33456799999999999999999999999877 78899999
Q ss_pred eccCCCccccccCCC--CCchhHHHHHHHHHHHHHHHHhhccCCC--eEecCCCCCcEEEcCCCCeEEeecCCCccccCC
Q 003836 580 FMSNGTVASFLFGDS--KPNWKLRTEIAMGIAGGLFYLHEECCTQ--IIHCDIKPQNILLDDHYNARISDFGLAKLLTLD 655 (792)
Q Consensus 580 ~~~~gsL~~~l~~~~--~l~~~~~~~i~~~ia~gL~yLH~~~~~~--ivH~dikp~NILl~~~~~~kl~Dfg~a~~~~~~ 655 (792)
|+++|+|.+++.... .+++..+..++.||+.||+|||+. + |+||||||+|||++.++.++|+|||++.....
T Consensus 90 ~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~~~i~H~dikp~Nil~~~~~~~~l~~~~~~~~~~~- 165 (271)
T 3kmu_A 90 WMPYGSLYNVLHEGTNFVVDQSQAVKFALDMARGMAFLHTL---EPLIPRHALNSRSVMIDEDMTARISMADVKFSFQS- 165 (271)
T ss_dssp CCTTCBHHHHHHSCSSCCCCHHHHHHHHHHHHHHHHHHTTS---SSCCTTCCCSGGGEEECTTSCEEEEGGGSCCTTSC-
T ss_pred ccCCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHhcC---CCceecCCCccceEEEcCCcceeEEeccceeeecc-
Confidence 999999999998764 489999999999999999999998 7 99999999999999999999999998764322
Q ss_pred CCCccccccccCCcccccccccCCCCc---ccceehHHHHHHHHHhcCcCCCcchhhhhhhhHHHHHHHhhcccchhHhh
Q 003836 656 QSHTNTAIRGTKGYVAPEWFRNMPITV---KVDVYSYGVLLLEIICLRRNIDNEISKVDKAILTDWAYDRYQERTLEALV 732 (792)
Q Consensus 656 ~~~~~~~~~gt~~y~aPE~~~~~~~~~---k~DV~S~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 732 (792)
....||+.|+|||.+.+...+. ++||||||+++|||++|+.||........ .....
T Consensus 166 -----~~~~~t~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~----------------~~~~~ 224 (271)
T 3kmu_A 166 -----PGRMYAPAWVAPEALQKKPEDTNRRSADMWSFAVLLWELVTREVPFADLSNMEI----------------GMKVA 224 (271)
T ss_dssp -----TTCBSCGGGSCHHHHHSCGGGSCHHHHHHHHHHHHHHHHHHCSCTTTTSCHHHH----------------HHHHH
T ss_pred -----cCccCCccccChhhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCccccChHHH----------------HHHHH
Confidence 2345799999999998755444 89999999999999999999975432211 01111
Q ss_pred hchhcccCCHHHHHHHHHHHHHccccCCCCCCCHHhHHHHhccCc
Q 003836 733 ENDLEAMNNVTMLHRFVMVAFWCIQEDPSHRPTMRKVTQMLEGVV 777 (792)
Q Consensus 733 ~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~L~~~~ 777 (792)
........+...+..+.+++..||+.||++|||++|+++.|+.+.
T Consensus 225 ~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~L~~l~ 269 (271)
T 3kmu_A 225 LEGLRPTIPPGISPHVSKLMKICMNEDPAKRPKFDMIVPILEKMQ 269 (271)
T ss_dssp HSCCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC
T ss_pred hcCCCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhh
Confidence 112222233345667899999999999999999999999998764
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-39 Score=344.01 Aligned_cols=261 Identities=20% Similarity=0.257 Sum_probs=196.1
Q ss_pred hhhhhcCccccceEEEeeecCCCceEEEEEEcccccc--cchHHHHHHHHHhcccCCCCcccccceeccCCceEEEEEec
Q 003836 504 GFKEELGRGAFGTVYKGFVNMGSSNHVAVKKLNSVFQ--DSEKEFKAEVNGIGQTHHKNLVRLLGYCDEGQNRLLVYEFM 581 (792)
Q Consensus 504 ~~~~~lG~G~~g~Vy~g~~~~~~~~~vavK~~~~~~~--~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~lV~E~~ 581 (792)
.+.++||+|+||+||++... +++.||+|++..... ...+.+.+|++++++++||||+++++++.+.+..++||||+
T Consensus 24 ~~~~~lG~G~~g~V~~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~ 101 (311)
T 3niz_A 24 QKLEKVGEGTYGVVYKAKDS--QGRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPNIVSLIDVIHSERCLTLVFEFM 101 (311)
T ss_dssp EEEEEEEECSSCEEEEEEET--TSCEEEEEEEC------CHHHHHHHHHHHHHHCCCTTBCCEEEEECCSSCEEEEEECC
T ss_pred HhhhhccCCCCeEEEEEEEC--CCCEEEEEEEecccccchhhHHHHHHHHHHHHcCCCCEeeeeeEEccCCEEEEEEcCC
Confidence 34578999999999999764 367899999875422 23467899999999999999999999999999999999999
Q ss_pred cCCCccccccCC-CCCchhHHHHHHHHHHHHHHHHhhccCCCeEecCCCCCcEEEcCCCCeEEeecCCCccccCCCCCcc
Q 003836 582 SNGTVASFLFGD-SKPNWKLRTEIAMGIAGGLFYLHEECCTQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLDQSHTN 660 (792)
Q Consensus 582 ~~gsL~~~l~~~-~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dikp~NILl~~~~~~kl~Dfg~a~~~~~~~~~~~ 660 (792)
++ +|.+++... ..+++..+..++.||+.||+|||+. +|+||||||+|||++.++.+||+|||+++...... ...
T Consensus 102 ~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~---~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~~-~~~ 176 (311)
T 3niz_A 102 EK-DLKKVLDENKTGLQDSQIKIYLYQLLRGVAHCHQH---RILHRDLKPQNLLINSDGALKLADFGLARAFGIPV-RSY 176 (311)
T ss_dssp SE-EHHHHHHTCTTCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTCEETTSCC-C--
T ss_pred CC-CHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCchHhEEECCCCCEEEccCcCceecCCCc-ccc
Confidence 85 777777654 4689999999999999999999998 99999999999999999999999999998764322 222
Q ss_pred ccccccCCccccccccc-CCCCcccceehHHHHHHHHHhcCcCCCcchhhhhhhhHHHHHHHh----hcc-cchhHhhhc
Q 003836 661 TAIRGTKGYVAPEWFRN-MPITVKVDVYSYGVLLLEIICLRRNIDNEISKVDKAILTDWAYDR----YQE-RTLEALVEN 734 (792)
Q Consensus 661 ~~~~gt~~y~aPE~~~~-~~~~~k~DV~S~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~----~~~-~~~~~~~~~ 734 (792)
....||+.|+|||.+.+ ..++.++|||||||++|||++|+.||...........+....... +.. ..+......
T Consensus 177 ~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~ 256 (311)
T 3niz_A 177 THEVVTLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGKPLFPGVTDDDQLPKIFSILGTPNPREWPQVQELPLWKQR 256 (311)
T ss_dssp -CCCCCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSTTTHHHHHHHHHCCCCTTTSGGGTTSHHHHSC
T ss_pred cCCcccCCcCCHHHhcCCCCCCchHHhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHCCCChHHhhhhhccchhhhc
Confidence 33468999999999876 568999999999999999999999997654332211111100000 000 000000000
Q ss_pred hh-------cccCCHHHHHHHHHHHHHccccCCCCCCCHHhHHH
Q 003836 735 DL-------EAMNNVTMLHRFVMVAFWCIQEDPSHRPTMRKVTQ 771 (792)
Q Consensus 735 ~~-------~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~ 771 (792)
.. ..........++.+++.+||+.||++|||++|+++
T Consensus 257 ~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 300 (311)
T 3niz_A 257 TFQVFEKKPWSSIIPGFCQEGIDLLSNMLCFDPNKRISARDAMN 300 (311)
T ss_dssp CCCCCCCCCHHHHSTTCCHHHHHHHHHHSCSCTTTSCCHHHHHT
T ss_pred ccccccCCcHHHhCcccCHHHHHHHHHHcCCChhHCCCHHHHhc
Confidence 00 00011123467889999999999999999999997
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-39 Score=348.90 Aligned_cols=256 Identities=21% Similarity=0.339 Sum_probs=193.3
Q ss_pred hhhhhhcCccccceEEEeeecCCCc--eEEEEEEcccc--cccchHHHHHHHHHhcccCCCCcccccceeccCCce----
Q 003836 503 RGFKEELGRGAFGTVYKGFVNMGSS--NHVAVKKLNSV--FQDSEKEFKAEVNGIGQTHHKNLVRLLGYCDEGQNR---- 574 (792)
Q Consensus 503 ~~~~~~lG~G~~g~Vy~g~~~~~~~--~~vavK~~~~~--~~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~---- 574 (792)
+.+.+.||+|+||+||+|......+ ..||||++... .....+.+.+|++++++++||||+++++++......
T Consensus 25 y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 104 (323)
T 3qup_A 25 FTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHVAKLVGVSLRSRAKGRLP 104 (323)
T ss_dssp CEEEEEEEEETTEEEEEEEC-------CEEEEEEC------CHHHHHHHHHHHHHTTCCCTTBCCCCEEEECC-------
T ss_pred eEEeceecccCCeEEEEEEEcccCCcceeEEEEEecccccCHHHHHHHHHHHHHHHHCCCCceehhhceeeccccccCCC
Confidence 4456789999999999997653322 37999998754 344567899999999999999999999999877655
Q ss_pred --EEEEEeccCCCccccccCCC------CCchhHHHHHHHHHHHHHHHHhhccCCCeEecCCCCCcEEEcCCCCeEEeec
Q 003836 575 --LLVYEFMSNGTVASFLFGDS------KPNWKLRTEIAMGIAGGLFYLHEECCTQIIHCDIKPQNILLDDHYNARISDF 646 (792)
Q Consensus 575 --~lV~E~~~~gsL~~~l~~~~------~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dikp~NILl~~~~~~kl~Df 646 (792)
++||||+++|+|.+++.... .+++..+..++.||+.||+|||+. +|+||||||+|||+++++.+||+||
T Consensus 105 ~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~---~ivH~Dikp~NIli~~~~~~kl~Df 181 (323)
T 3qup_A 105 IPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYLSSR---NFIHRDLAARNCMLAEDMTVCVADF 181 (323)
T ss_dssp CEEEEEECCTTCBHHHHHHHHHC---CCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTSCEEECCC
T ss_pred ccEEEEEeccCCcHHHHHHhhhccccccccCHHHHHHHHHHHHHHHHHHHcC---CcccCCCCcceEEEcCCCCEEEeec
Confidence 99999999999999985432 588999999999999999999999 9999999999999999999999999
Q ss_pred CCCccccCCCCC-ccccccccCCcccccccccCCCCcccceehHHHHHHHHHh-cCcCCCcchhhhhhhhHHHHHHHhhc
Q 003836 647 GLAKLLTLDQSH-TNTAIRGTKGYVAPEWFRNMPITVKVDVYSYGVLLLEIIC-LRRNIDNEISKVDKAILTDWAYDRYQ 724 (792)
Q Consensus 647 g~a~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~k~DV~S~Gv~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~ 724 (792)
|+++........ ......+++.|+|||.+.+..++.++||||||+++|||++ |+.||.........
T Consensus 182 g~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~------------ 249 (323)
T 3qup_A 182 GLSRKIYSGDYYRQGCASKLPVKWLALESLADNLYTVHSDVWAFGVTMWEIMTRGQTPYAGIENAEIY------------ 249 (323)
T ss_dssp CC-----------------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHH------------
T ss_pred cccccccccccccccccccCcccccCchhhcCCCCCCccchhhHHHHHHHHHhCCCCCccccChHHHH------------
Confidence 999876443322 2223456789999999999999999999999999999999 88888654322110
Q ss_pred ccchhHhhhchhcccCCHHHHHHHHHHHHHccccCCCCCCCHHhHHHHhccCcC
Q 003836 725 ERTLEALVENDLEAMNNVTMLHRFVMVAFWCIQEDPSHRPTMRKVTQMLEGVVE 778 (792)
Q Consensus 725 ~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~L~~~~~ 778 (792)
..+........+...+..+.+++.+||+.||++|||+.++++.|++++.
T Consensus 250 -----~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~l~ 298 (323)
T 3qup_A 250 -----NYLIGGNRLKQPPECMEEVYDLMYQCWSADPKQRPSFTCLRMELENILG 298 (323)
T ss_dssp -----HHHHTTCCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred -----HHHhcCCCCCCCCccCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHH
Confidence 0011111112233455678999999999999999999999999988764
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-39 Score=350.50 Aligned_cols=245 Identities=23% Similarity=0.325 Sum_probs=202.2
Q ss_pred hhhhhcCccccceEEEeeecCCCceEEEEEEccccc---ccchHHHHHHHHHhccc-CCCCcccccceeccCCceEEEEE
Q 003836 504 GFKEELGRGAFGTVYKGFVNMGSSNHVAVKKLNSVF---QDSEKEFKAEVNGIGQT-HHKNLVRLLGYCDEGQNRLLVYE 579 (792)
Q Consensus 504 ~~~~~lG~G~~g~Vy~g~~~~~~~~~vavK~~~~~~---~~~~~~~~~Ei~~l~~l-~h~niv~l~g~~~~~~~~~lV~E 579 (792)
.+.+.||+|+||.||++... .+++.||+|++++.. ....+.+.+|..++.++ +||||+++++++.+.+..++|||
T Consensus 20 ~~~~~lG~G~fg~V~~~~~~-~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~iv~l~~~~~~~~~~~lv~E 98 (345)
T 1xjd_A 20 ILHKMLGKGSFGKVFLAEFK-KTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFFVME 98 (345)
T ss_dssp EEEEEEEECSSSEEEEEEET-TTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEEEE
T ss_pred EEEEEEeeCCCeEEEEEEEC-CCCCEEEEEEEEhHHhhhhhhHHHHHHHHHHHHhcCCCCCCCcEEEEEEeCCEEEEEEe
Confidence 34578999999999999764 467899999997532 33456788899999887 89999999999999999999999
Q ss_pred eccCCCccccccCCCCCchhHHHHHHHHHHHHHHHHhhccCCCeEecCCCCCcEEEcCCCCeEEeecCCCccccCCCCCc
Q 003836 580 FMSNGTVASFLFGDSKPNWKLRTEIAMGIAGGLFYLHEECCTQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLDQSHT 659 (792)
Q Consensus 580 ~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dikp~NILl~~~~~~kl~Dfg~a~~~~~~~~~~ 659 (792)
|+++|+|.+++.....+++..+..++.||+.||+|||++ +|+||||||+|||++.++.+||+|||+++...... ..
T Consensus 99 ~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~~-~~ 174 (345)
T 1xjd_A 99 YLNGGDLMYHIQSCHKFDLSRATFYAAEIILGLQFLHSK---GIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGD-AK 174 (345)
T ss_dssp CCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCCTTCBCCCCTT-CC
T ss_pred CCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC---CeEeCCCChhhEEECCCCCEEEeEChhhhhcccCC-Cc
Confidence 999999999998777899999999999999999999999 99999999999999999999999999998643222 22
Q ss_pred cccccccCCcccccccccCCCCcccceehHHHHHHHHHhcCcCCCcchhhhhhhhHHHHHHHhhcccchhHhhhchhccc
Q 003836 660 NTAIRGTKGYVAPEWFRNMPITVKVDVYSYGVLLLEIICLRRNIDNEISKVDKAILTDWAYDRYQERTLEALVENDLEAM 739 (792)
Q Consensus 660 ~~~~~gt~~y~aPE~~~~~~~~~k~DV~S~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 739 (792)
.....||+.|+|||++.+..++.++|||||||++|||++|+.||........ .. .+.... ..
T Consensus 175 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~---~~-------------~i~~~~--~~ 236 (345)
T 1xjd_A 175 TNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEEL---FH-------------SIRMDN--PF 236 (345)
T ss_dssp BCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH---HH-------------HHHHCC--CC
T ss_pred ccCCCCCcccCChhhhcCCCCCChhhhHHHHHHHHHHhcCCCCCCCCCHHHH---HH-------------HHHhCC--CC
Confidence 3456799999999999999999999999999999999999999975432211 00 001110 11
Q ss_pred CCHHHHHHHHHHHHHccccCCCCCCCHH-hHHH
Q 003836 740 NNVTMLHRFVMVAFWCIQEDPSHRPTMR-KVTQ 771 (792)
Q Consensus 740 ~~~~~~~~l~~l~~~Cl~~~p~~RPs~~-evl~ 771 (792)
.+...+.++.+++.+||+.||++||++. +|++
T Consensus 237 ~p~~~s~~~~~li~~lL~~dp~~R~~~~~~i~~ 269 (345)
T 1xjd_A 237 YPRWLEKEAKDLLVKLFVREPEKRLGVRGDIRQ 269 (345)
T ss_dssp CCTTSCHHHHHHHHHHSCSSGGGSBTTBSCGGG
T ss_pred CCcccCHHHHHHHHHHhcCCHhHcCCChHHHHc
Confidence 2223456788999999999999999998 7764
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-39 Score=360.04 Aligned_cols=247 Identities=19% Similarity=0.243 Sum_probs=201.2
Q ss_pred hhhhcCccccceEEEeeecCCCceEEEEEEccccc---ccchHHHHHHHHHhcccCCCCcccccceeccCCceEEEEEec
Q 003836 505 FKEELGRGAFGTVYKGFVNMGSSNHVAVKKLNSVF---QDSEKEFKAEVNGIGQTHHKNLVRLLGYCDEGQNRLLVYEFM 581 (792)
Q Consensus 505 ~~~~lG~G~~g~Vy~g~~~~~~~~~vavK~~~~~~---~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~lV~E~~ 581 (792)
+.++||+|+||+||++... .+++.||+|++.+.. ....+.+.+|+.+++.++||||+++++++.+.+..++||||+
T Consensus 73 ~~~~LG~G~fG~V~~~~~~-~~~~~~AiK~~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lV~E~~ 151 (410)
T 3v8s_A 73 VVKVIGRGAFGEVQLVRHK-STRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDRYLYMVMEYM 151 (410)
T ss_dssp EEEEEEECSSEEEEEEEET-TTCCEEEEEEEEHHHHHHTCCCSTHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECCC
T ss_pred EEEEEEcCCCEEEEEEEEC-CCCcEEEEEEEehhhhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEeCC
Confidence 3468999999999999764 456799999986521 223456889999999999999999999999999999999999
Q ss_pred cCCCccccccCCCCCchhHHHHHHHHHHHHHHHHhhccCCCeEecCCCCCcEEEcCCCCeEEeecCCCccccCCCCCccc
Q 003836 582 SNGTVASFLFGDSKPNWKLRTEIAMGIAGGLFYLHEECCTQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLDQSHTNT 661 (792)
Q Consensus 582 ~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dikp~NILl~~~~~~kl~Dfg~a~~~~~~~~~~~~ 661 (792)
++|+|.+++.. ..+++..+..++.||+.||+|||+. +|+||||||+|||++.++.+||+|||+++...........
T Consensus 152 ~gg~L~~~l~~-~~~~e~~~~~~~~qi~~aL~~LH~~---givHrDLKp~NILl~~~g~ikL~DFG~a~~~~~~~~~~~~ 227 (410)
T 3v8s_A 152 PGGDLVNLMSN-YDVPEKWARFYTAEVVLALDAIHSM---GFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCD 227 (410)
T ss_dssp TTEEHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECCTTSEEECC
T ss_pred CCCcHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCCHHHeeECCCCCEEEeccceeEeeccCCccccc
Confidence 99999999865 4688999999999999999999998 9999999999999999999999999999876544433344
Q ss_pred cccccCCcccccccccCC----CCcccceehHHHHHHHHHhcCcCCCcchhhhhhhhHHHHHHHhhcccchhHhhhch--
Q 003836 662 AIRGTKGYVAPEWFRNMP----ITVKVDVYSYGVLLLEIICLRRNIDNEISKVDKAILTDWAYDRYQERTLEALVEND-- 735 (792)
Q Consensus 662 ~~~gt~~y~aPE~~~~~~----~~~k~DV~S~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-- 735 (792)
...||+.|+|||++.+.. ++.++|||||||++|||++|+.||.......... .++...
T Consensus 228 ~~~gt~~Y~APE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~----------------~i~~~~~~ 291 (410)
T 3v8s_A 228 TAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYS----------------KIMNHKNS 291 (410)
T ss_dssp SCCSCGGGCCHHHHHTTTTTCEEETHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHH----------------HHHTHHHH
T ss_pred CCcCCccccCHHHhhccCCCcCCCCcceEecchHHHHHHHhCCCCCCCCChhhHHH----------------HHHhcccc
Confidence 567999999999997655 8899999999999999999999997543221111 111110
Q ss_pred hcccCCHHHHHHHHHHHHHccccCCCC--CCCHHhHHHH
Q 003836 736 LEAMNNVTMLHRFVMVAFWCIQEDPSH--RPTMRKVTQM 772 (792)
Q Consensus 736 ~~~~~~~~~~~~l~~l~~~Cl~~~p~~--RPs~~evl~~ 772 (792)
+........+.++.+++.+||+.+|.+ ||+++||++.
T Consensus 292 ~~~p~~~~~s~~~~~li~~lL~~~~~rlgR~~~~ei~~H 330 (410)
T 3v8s_A 292 LTFPDDNDISKEAKNLICAFLTDREVRLGRNGVEEIKRH 330 (410)
T ss_dssp CCCCTTCCCCHHHHHHHHHHSSCGGGCTTSSCHHHHHTS
T ss_pred ccCCCcccccHHHHHHHHHHccChhhhCCCCCHHHHhcC
Confidence 011111134567889999999999988 9999999975
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B | Back alignment and structure |
|---|
Probab=100.00 E-value=8.1e-39 Score=349.64 Aligned_cols=252 Identities=22% Similarity=0.295 Sum_probs=203.6
Q ss_pred HHhhhhhhcCccccceEEEeeecCCCceEEEEEEccccc--ccchHHHHHHHHHhcccCCCCcccccceeccCCceEEEE
Q 003836 501 VTRGFKEELGRGAFGTVYKGFVNMGSSNHVAVKKLNSVF--QDSEKEFKAEVNGIGQTHHKNLVRLLGYCDEGQNRLLVY 578 (792)
Q Consensus 501 ~~~~~~~~lG~G~~g~Vy~g~~~~~~~~~vavK~~~~~~--~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~lV~ 578 (792)
..+.+.+.||+|+||.||++... .+++.||+|++.... ....+.+.+|+.++++++||||+++++++.+.+..++||
T Consensus 29 ~~y~~~~~lG~G~~g~V~~~~~~-~~~~~~avK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv~ 107 (362)
T 2bdw_A 29 DNYDVKEELGKGAFSVVRRCVHK-TTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVF 107 (362)
T ss_dssp HHEEEEEEEEEETTEEEEEEEET-TTCCEEEEEEEETTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred cCeEEeeEEecCCCeEEEEEEEC-CCCCEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEE
Confidence 34556688999999999999754 456799999987542 234467899999999999999999999999999999999
Q ss_pred EeccCCCccccccCCCCCchhHHHHHHHHHHHHHHHHhhccCCCeEecCCCCCcEEEcCCC---CeEEeecCCCccccCC
Q 003836 579 EFMSNGTVASFLFGDSKPNWKLRTEIAMGIAGGLFYLHEECCTQIIHCDIKPQNILLDDHY---NARISDFGLAKLLTLD 655 (792)
Q Consensus 579 E~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dikp~NILl~~~~---~~kl~Dfg~a~~~~~~ 655 (792)
||+++|+|.+++.....+++..+..++.||+.||+|||+. +|+||||||+|||++.++ .+||+|||+++.....
T Consensus 108 e~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~Dlkp~NIll~~~~~~~~~kl~DfG~a~~~~~~ 184 (362)
T 2bdw_A 108 DLVTGGELFEDIVAREFYSEADASHCIQQILESIAYCHSN---GIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDS 184 (362)
T ss_dssp CCCCSCBHHHHHTTCSCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCSGGGEEESCSSTTCCEEECCCTTCBCCTTC
T ss_pred ecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCchHHEEEecCCCCCCEEEeecCcceEecCC
Confidence 9999999999998888899999999999999999999999 999999999999998654 5999999999876532
Q ss_pred CCCccccccccCCcccccccccCCCCcccceehHHHHHHHHHhcCcCCCcchhhhhhhhHHHHHHHhhcccchhHhhhch
Q 003836 656 QSHTNTAIRGTKGYVAPEWFRNMPITVKVDVYSYGVLLLEIICLRRNIDNEISKVDKAILTDWAYDRYQERTLEALVEND 735 (792)
Q Consensus 656 ~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DV~S~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 735 (792)
. ......||+.|+|||++.+..++.++|||||||++|||++|+.||........ .... ..... .
T Consensus 185 ~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~---~~~i-----~~~~~------~ 248 (362)
T 2bdw_A 185 E--AWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRL---YAQI-----KAGAY------D 248 (362)
T ss_dssp C--SCCCSCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH---HHHH-----HHTCC------C
T ss_pred c--ccccCCCCccccCHHHHccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHHH---HHHH-----HhCCC------C
Confidence 2 22345799999999999999999999999999999999999999975432111 0000 00000 0
Q ss_pred hcccCCHHHHHHHHHHHHHccccCCCCCCCHHhHHHH
Q 003836 736 LEAMNNVTMLHRFVMVAFWCIQEDPSHRPTMRKVTQM 772 (792)
Q Consensus 736 ~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~ 772 (792)
.........+.++.+++.+||+.||++||++.|+++.
T Consensus 249 ~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 285 (362)
T 2bdw_A 249 YPSPEWDTVTPEAKSLIDSMLTVNPKKRITADQALKV 285 (362)
T ss_dssp CCTTGGGGSCHHHHHHHHHHSCSSGGGSCCHHHHTTS
T ss_pred CCcccccCCCHHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 0000011234678899999999999999999999864
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-39 Score=351.48 Aligned_cols=254 Identities=24% Similarity=0.397 Sum_probs=192.9
Q ss_pred hhhhcCccccceEEEeeecCC--CceEEEEEEccccc-ccchHHHHHHHHHhcccCCCCcccccceecc-CCceEEEEEe
Q 003836 505 FKEELGRGAFGTVYKGFVNMG--SSNHVAVKKLNSVF-QDSEKEFKAEVNGIGQTHHKNLVRLLGYCDE-GQNRLLVYEF 580 (792)
Q Consensus 505 ~~~~lG~G~~g~Vy~g~~~~~--~~~~vavK~~~~~~-~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~-~~~~~lV~E~ 580 (792)
+.+.||+|+||+||+|..... ....+|||.+.... ....+.+.+|+.++++++||||+++++++.+ .+..++||||
T Consensus 93 ~~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~lv~e~ 172 (373)
T 3c1x_A 93 FNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPY 172 (373)
T ss_dssp EEEEEECCSSSEEEEEEEEETTTEEEEEEEEECCSCSCSHHHHHHHHHHTTSTTCCCTTBCCCCEEECCCSSCCEEEEEC
T ss_pred cCcEeeeCCCeEEEEEEEECCCCcEEEEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCCCeEEEEEC
Confidence 457899999999999987433 23578999987543 3445789999999999999999999998754 5578999999
Q ss_pred ccCCCccccccCC-CCCchhHHHHHHHHHHHHHHHHhhccCCCeEecCCCCCcEEEcCCCCeEEeecCCCccccCCCCC-
Q 003836 581 MSNGTVASFLFGD-SKPNWKLRTEIAMGIAGGLFYLHEECCTQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLDQSH- 658 (792)
Q Consensus 581 ~~~gsL~~~l~~~-~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dikp~NILl~~~~~~kl~Dfg~a~~~~~~~~~- 658 (792)
+++|+|.+++... ..+++..+..++.||++||+|||++ +|+||||||+|||+++++.+||+|||+++........
T Consensus 173 ~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~~~~kL~DFG~a~~~~~~~~~~ 249 (373)
T 3c1x_A 173 MKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASK---KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDS 249 (373)
T ss_dssp CTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECCC-------------
T ss_pred CCCCCHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHHC---CEecCccchheEEECCCCCEEEeecccccccccccccc
Confidence 9999999999765 4688999999999999999999999 9999999999999999999999999999876433221
Q ss_pred --ccccccccCCcccccccccCCCCcccceehHHHHHHHHHh-cCcCCCcchhhhhhhhHHHHHHHhhcccchhHhhhch
Q 003836 659 --TNTAIRGTKGYVAPEWFRNMPITVKVDVYSYGVLLLEIIC-LRRNIDNEISKVDKAILTDWAYDRYQERTLEALVEND 735 (792)
Q Consensus 659 --~~~~~~gt~~y~aPE~~~~~~~~~k~DV~S~Gv~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 735 (792)
......+++.|+|||.+.+..++.++||||||+++|||++ |..||......... ..+...
T Consensus 250 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt~~~~p~~~~~~~~~~-----------------~~~~~~ 312 (373)
T 3c1x_A 250 VHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDIT-----------------VYLLQG 312 (373)
T ss_dssp --------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCSSCHH-----------------HHHHTT
T ss_pred ccccCCCCCcccccChHHhcCCCCCcHHHHHHHHHHHHHHHhCcCCCCCCCCHHHHH-----------------HHHHcC
Confidence 1233457889999999999999999999999999999999 55566433211100 000011
Q ss_pred hcccCCHHHHHHHHHHHHHccccCCCCCCCHHhHHHHhccCcC
Q 003836 736 LEAMNNVTMLHRFVMVAFWCIQEDPSHRPTMRKVTQMLEGVVE 778 (792)
Q Consensus 736 ~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~L~~~~~ 778 (792)
.....+...+..+.+++.+||+.+|++|||++|+++.|+.+..
T Consensus 313 ~~~~~p~~~~~~l~~li~~cl~~dp~~RPs~~ell~~L~~i~~ 355 (373)
T 3c1x_A 313 RRLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFS 355 (373)
T ss_dssp CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred CCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHH
Confidence 1111222345678899999999999999999999999988653
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-39 Score=350.41 Aligned_cols=270 Identities=24% Similarity=0.343 Sum_probs=210.7
Q ss_pred hhhhhcCccccceEEEeee---cCCCceEEEEEEcccccc-cchHHHHHHHHHhcccCCCCcccccceecc--CCceEEE
Q 003836 504 GFKEELGRGAFGTVYKGFV---NMGSSNHVAVKKLNSVFQ-DSEKEFKAEVNGIGQTHHKNLVRLLGYCDE--GQNRLLV 577 (792)
Q Consensus 504 ~~~~~lG~G~~g~Vy~g~~---~~~~~~~vavK~~~~~~~-~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~--~~~~~lV 577 (792)
.+.+.||+|+||+||++.+ +..+++.||||++..... ...+.+.+|++++++++||||+++++++.+ ....++|
T Consensus 34 ~~~~~lG~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv 113 (318)
T 3lxp_A 34 KKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHIIKYKGCCEDAGAASLQLV 113 (318)
T ss_dssp EEEEEEEECSSEEEEEEEECSCC--CCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTTTEEEEE
T ss_pred hhhheecCCCCeEEEEEEEccCCCCCCcEEEEEEeccccChHHHHHHHHHHHHHHhCCCcchhhEEEEEecCCCceEEEE
Confidence 4557899999999988754 234578899999976432 345679999999999999999999999976 4578999
Q ss_pred EEeccCCCccccccCCCCCchhHHHHHHHHHHHHHHHHhhccCCCeEecCCCCCcEEEcCCCCeEEeecCCCccccCCCC
Q 003836 578 YEFMSNGTVASFLFGDSKPNWKLRTEIAMGIAGGLFYLHEECCTQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLDQS 657 (792)
Q Consensus 578 ~E~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dikp~NILl~~~~~~kl~Dfg~a~~~~~~~~ 657 (792)
|||+++|+|.+++... .+++..+..++.||+.||+|||+. +|+||||||+|||++.++.+||+|||+++.......
T Consensus 114 ~e~~~~~~L~~~l~~~-~~~~~~~~~i~~~l~~~l~~LH~~---~ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~~~~~~ 189 (318)
T 3lxp_A 114 MEYVPLGSLRDYLPRH-SIGLAQLLLFAQQICEGMAYLHAQ---HYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHE 189 (318)
T ss_dssp ECCCTTCBHHHHGGGS-CCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCGGGCEECCTTCS
T ss_pred EecccCCcHHHHHhhC-CCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCchheEEEcCCCCEEECCcccccccccccc
Confidence 9999999999999764 488999999999999999999999 999999999999999999999999999987654332
Q ss_pred C--ccccccccCCcccccccccCCCCcccceehHHHHHHHHHhcCcCCCcchhhhhhhhHHHHHHHhhcccchhHhhhch
Q 003836 658 H--TNTAIRGTKGYVAPEWFRNMPITVKVDVYSYGVLLLEIICLRRNIDNEISKVDKAILTDWAYDRYQERTLEALVEND 735 (792)
Q Consensus 658 ~--~~~~~~gt~~y~aPE~~~~~~~~~k~DV~S~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 735 (792)
. ......+++.|+|||.+.+..++.++||||||+++|||++|+.||.......... ..+.........+...+...
T Consensus 190 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~ 267 (318)
T 3lxp_A 190 YYRVREDGDSPVFWYAPECLKEYKFYYASDVWSFGVTLYELLTHCDSSQSPPTKFLEL--IGIAQGQMTVLRLTELLERG 267 (318)
T ss_dssp EEEC---CCCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHH--HCSCCHHHHHHHHHHHHHTT
T ss_pred ccccccCCCCCceeeChHHhcCCCCCcHHHHHHHHHHHHHHHhCCCcccccchhhhhh--hcccccchhHHHHHHHHhcc
Confidence 1 2233457888999999999899999999999999999999999986543211100 00000001111223333333
Q ss_pred hcccCCHHHHHHHHHHHHHccccCCCCCCCHHhHHHHhccCcCC
Q 003836 736 LEAMNNVTMLHRFVMVAFWCIQEDPSHRPTMRKVTQMLEGVVEV 779 (792)
Q Consensus 736 ~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~L~~~~~~ 779 (792)
.....+...+..+.+++.+||+.||++|||++|+++.|+.+.+.
T Consensus 268 ~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~l~~~ 311 (318)
T 3lxp_A 268 ERLPRPDKCPAEVYHLMKNCWETEASFRPTFENLIPILKTVHEK 311 (318)
T ss_dssp CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred cCCCCCccccHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHHh
Confidence 34444555667899999999999999999999999999887543
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.5e-39 Score=345.41 Aligned_cols=255 Identities=16% Similarity=0.185 Sum_probs=202.8
Q ss_pred hhhhhcCccccceEEEeeecCCCceEEEEEEcccccccchHHHHHHHHHhccc-CCCCcccccceeccCCceEEEEEecc
Q 003836 504 GFKEELGRGAFGTVYKGFVNMGSSNHVAVKKLNSVFQDSEKEFKAEVNGIGQT-HHKNLVRLLGYCDEGQNRLLVYEFMS 582 (792)
Q Consensus 504 ~~~~~lG~G~~g~Vy~g~~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l-~h~niv~l~g~~~~~~~~~lV~E~~~ 582 (792)
.+.+.||+|+||+||+|.. ..+++.||||++.... ..+.+.+|+++++++ +|+||+++++++.+.+..++||||+
T Consensus 12 ~~~~~lg~G~~g~V~~~~~-~~~~~~vavK~~~~~~--~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~lv~e~~- 87 (330)
T 2izr_A 12 RVGKKIGCGNFGELRLGKN-LYTNEYVAIKLEPMKS--RAPQLHLEYRFYKQLGSGDGIPQVYYFGPCGKYNAMVLELL- 87 (330)
T ss_dssp EEEEECCC-CTTSEEEEEE-TTTTEEEEEEEEETTC--SSCCHHHHHHHHHHHCSCTTSCCEEEEEEETTEEEEEEECC-
T ss_pred EEEEEeeccCCceEEEEEE-CCCCcEEEEEEecccc--chHHHHHHHHHHHHhhCCCCCCEEEEEEecCCccEEEEEeC-
Confidence 3457899999999999974 3567899999987542 234688999999999 9999999999999999999999999
Q ss_pred CCCccccccCC-CCCchhHHHHHHHHHHHHHHHHhhccCCCeEecCCCCCcEEEcCCCC-----eEEeecCCCccccCCC
Q 003836 583 NGTVASFLFGD-SKPNWKLRTEIAMGIAGGLFYLHEECCTQIIHCDIKPQNILLDDHYN-----ARISDFGLAKLLTLDQ 656 (792)
Q Consensus 583 ~gsL~~~l~~~-~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dikp~NILl~~~~~-----~kl~Dfg~a~~~~~~~ 656 (792)
+++|.+++... ..+++..+..++.||+.||+|||+. +|+||||||+|||++.++. +||+|||+++......
T Consensus 88 ~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~---~iiHrDlkp~Nill~~~~~~~~~~~kl~DFg~a~~~~~~~ 164 (330)
T 2izr_A 88 GPSLEDLFDLCDRTFSLKTVLMIAIQLISRMEYVHSK---NLIYRDVKPENFLIGRPGNKTQQVIHIIDFALAKEYIDPE 164 (330)
T ss_dssp CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECCGGGTCTTSEEECCCTTCEESBCTT
T ss_pred CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHeeeccCCCCCCceEEEEEcccceeeecCC
Confidence 99999999763 6789999999999999999999999 9999999999999998887 9999999999765433
Q ss_pred CC------ccccccccCCcccccccccCCCCcccceehHHHHHHHHHhcCcCCCcchhhhhhhhHHHHHHHhhcccchhH
Q 003836 657 SH------TNTAIRGTKGYVAPEWFRNMPITVKVDVYSYGVLLLEIICLRRNIDNEISKVDKAILTDWAYDRYQERTLEA 730 (792)
Q Consensus 657 ~~------~~~~~~gt~~y~aPE~~~~~~~~~k~DV~S~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 730 (792)
.. ......||+.|+|||.+.+..++.++||||||+++|||++|+.||..................... .....
T Consensus 165 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~Pf~~~~~~~~~~~~~~i~~~~~~-~~~~~ 243 (330)
T 2izr_A 165 TKKHIPYREHKSLTGTARYMSINTHLGKEQSRRDDLEALGHMFMYFLRGSLPWQGLKADTLKERYQKIGDTKRA-TPIEV 243 (330)
T ss_dssp TCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCSSHHHHHHHHHHHHHH-SCHHH
T ss_pred CCccccccccCCcCCCccccChHHHcCCCCCchhHHHHHHHHHHHHhcCCCCccccccccHHHHHHHHHhhhcc-CCHHH
Confidence 22 123567999999999999999999999999999999999999999764322111111111000000 00000
Q ss_pred hhhchhcccCCHHHHHHHHHHHHHccccCCCCCCCHHhHHHHhccC
Q 003836 731 LVENDLEAMNNVTMLHRFVMVAFWCIQEDPSHRPTMRKVTQMLEGV 776 (792)
Q Consensus 731 ~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~L~~~ 776 (792)
. ....+ ++.+++..||+.+|.+||++++|++.|+.+
T Consensus 244 -----~----~~~~p-~~~~li~~~l~~~p~~RP~~~~l~~~l~~~ 279 (330)
T 2izr_A 244 -----L----CENFP-EMATYLRYVRRLDFFEKPDYDYLRKLFTDL 279 (330)
T ss_dssp -----H----TTTCH-HHHHHHHHHHHCCTTCCCCHHHHHHHHHHH
T ss_pred -----H----hccCh-HHHHHHHHHHhCCCCCCCCHHHHHHHHHHH
Confidence 0 00122 788999999999999999999999998654
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-39 Score=347.89 Aligned_cols=245 Identities=23% Similarity=0.336 Sum_probs=201.3
Q ss_pred hhhhhhcCccccceEEEeeecCCCceEEEEEEccccc---ccchHHHHHHHHHhcccCCCCcccccceeccCCceEEEEE
Q 003836 503 RGFKEELGRGAFGTVYKGFVNMGSSNHVAVKKLNSVF---QDSEKEFKAEVNGIGQTHHKNLVRLLGYCDEGQNRLLVYE 579 (792)
Q Consensus 503 ~~~~~~lG~G~~g~Vy~g~~~~~~~~~vavK~~~~~~---~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~lV~E 579 (792)
+.+.+.||+|+||.||+|... .+++.||+|++.... ......+.+|+.++++++||||+++++++.+.+..++|||
T Consensus 11 Y~i~~~lG~G~~g~V~~a~~~-~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~E 89 (336)
T 3h4j_B 11 YIIRETLGEGSFGKVKLATHY-KTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYDVITTPTDIVMVIE 89 (336)
T ss_dssp EEEEEEEEEETTEEEEEEEET-TTCCEEEEEEEEHHHHHHTTCSHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred EEEEEEEecCCCeEEEEEEEC-CCCCEEEEEEEehHHccchhHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEEE
Confidence 345678999999999999753 456799999986532 2334679999999999999999999999999999999999
Q ss_pred eccCCCccccccCCCCCchhHHHHHHHHHHHHHHHHhhccCCCeEecCCCCCcEEEcCCCCeEEeecCCCccccCCCCCc
Q 003836 580 FMSNGTVASFLFGDSKPNWKLRTEIAMGIAGGLFYLHEECCTQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLDQSHT 659 (792)
Q Consensus 580 ~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dikp~NILl~~~~~~kl~Dfg~a~~~~~~~~~~ 659 (792)
|+ +|+|.+++.....+++..+..++.||+.||.|||+. +|+||||||+|||+++++.+||+|||+++...... .
T Consensus 90 ~~-~g~l~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~---givH~Dlkp~NIll~~~~~~kl~DFG~s~~~~~~~--~ 163 (336)
T 3h4j_B 90 YA-GGELFDYIVEKKRMTEDEGRRFFQQIICAIEYCHRH---KIVHRDLKPENLLLDDNLNVKIADFGLSNIMTDGN--F 163 (336)
T ss_dssp CC-CEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHH---TCCCCCCSTTTEEECTTCCEEECCSSCTBTTTTSB--T
T ss_pred CC-CCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCchhhEEEcCCCCEEEEEeccceeccCCc--c
Confidence 99 689999998878899999999999999999999999 99999999999999999999999999998764332 2
Q ss_pred cccccccCCcccccccccCCC-CcccceehHHHHHHHHHhcCcCCCcchhhhhhhhHHHHHHHhhcccchhHhhhchhcc
Q 003836 660 NTAIRGTKGYVAPEWFRNMPI-TVKVDVYSYGVLLLEIICLRRNIDNEISKVDKAILTDWAYDRYQERTLEALVENDLEA 738 (792)
Q Consensus 660 ~~~~~gt~~y~aPE~~~~~~~-~~k~DV~S~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 738 (792)
.....||+.|+|||.+.+..+ +.++|||||||++|||++|+.||......... ..+.. ...
T Consensus 164 ~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~----------------~~i~~--~~~ 225 (336)
T 3h4j_B 164 LKTSCGSPNYAAPEVINGKLYAGPEVDVWSCGIVLYVMLVGRLPFDDEFIPNLF----------------KKVNS--CVY 225 (336)
T ss_dssp TCCCTTSTTTSCGGGSCCSGGGCHHHHHHHHHHHHHHHHHSSCSSBCSSSTTCB----------------CCCCS--SCC
T ss_pred cccccCCcCcCCHHHHcCCCCCCCccchhHHHHHHHHHHhCCCCCCCccHHHHH----------------HHHHc--CCC
Confidence 334569999999999988776 78999999999999999999999654221100 00000 001
Q ss_pred cCCHHHHHHHHHHHHHccccCCCCCCCHHhHHHH
Q 003836 739 MNNVTMLHRFVMVAFWCIQEDPSHRPTMRKVTQM 772 (792)
Q Consensus 739 ~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~ 772 (792)
..+...+..+.+++.+||+.||.+|||++|+++.
T Consensus 226 ~~p~~~s~~~~~li~~~L~~dP~~Rpt~~eil~h 259 (336)
T 3h4j_B 226 VMPDFLSPGAQSLIRRMIVADPMQRITIQEIRRD 259 (336)
T ss_dssp CCCTTSCHHHHHHHHTTSCSSGGGSCCHHHHTTC
T ss_pred CCcccCCHHHHHHHHHHcCCChhHCcCHHHHHhC
Confidence 1122345678899999999999999999999874
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-38 Score=349.40 Aligned_cols=245 Identities=22% Similarity=0.276 Sum_probs=196.2
Q ss_pred hhcCccccceEEEeeecCCCceEEEEEEcccccccchHHHHHHHHHhcccCCCCcccccceeccCCceEEEEEeccCCCc
Q 003836 507 EELGRGAFGTVYKGFVNMGSSNHVAVKKLNSVFQDSEKEFKAEVNGIGQTHHKNLVRLLGYCDEGQNRLLVYEFMSNGTV 586 (792)
Q Consensus 507 ~~lG~G~~g~Vy~g~~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~lV~E~~~~gsL 586 (792)
+.||+|+||.||+|... .+++.||+|++........+.+.+|++++++++||||+++++++.+.+..+|||||+++++|
T Consensus 95 ~~lG~G~~g~Vy~a~~~-~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~E~~~~~~L 173 (373)
T 2x4f_A 95 EILGGGRFGQVHKCEET-ATGLKLAAKIIKTRGMKDKEEVKNEISVMNQLDHANLIQLYDAFESKNDIVLVMEYVDGGEL 173 (373)
T ss_dssp EECC-----CEEEEEET-TTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECCTTCEE
T ss_pred eEEecCcCEEEEEEEEc-CCCcEEEEEEEcccccccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEeCCCCCcH
Confidence 56999999999999754 45679999999876556677899999999999999999999999999999999999999999
Q ss_pred cccccCC-CCCchhHHHHHHHHHHHHHHHHhhccCCCeEecCCCCCcEEE--cCCCCeEEeecCCCccccCCCCCccccc
Q 003836 587 ASFLFGD-SKPNWKLRTEIAMGIAGGLFYLHEECCTQIIHCDIKPQNILL--DDHYNARISDFGLAKLLTLDQSHTNTAI 663 (792)
Q Consensus 587 ~~~l~~~-~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dikp~NILl--~~~~~~kl~Dfg~a~~~~~~~~~~~~~~ 663 (792)
.+++... ..+++..+..++.||++||+|||+. +|+||||||+|||+ ++++.+||+|||+++....... ....
T Consensus 174 ~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~~~kl~DFG~a~~~~~~~~--~~~~ 248 (373)
T 2x4f_A 174 FDRIIDESYNLTELDTILFMKQICEGIRHMHQM---YILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPREK--LKVN 248 (373)
T ss_dssp HHHHHHTGGGCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEEEETTTTEEEECCCSSCEECCTTCB--CCCC
T ss_pred HHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC---CcccccCCHHHEEEecCCCCcEEEEeCCCceecCCccc--cccc
Confidence 9988654 4689999999999999999999998 99999999999999 5678899999999987653322 2334
Q ss_pred cccCCcccccccccCCCCcccceehHHHHHHHHHhcCcCCCcchhhhhhhhHHHHHHHhhcccchhHhhhchhcccCCHH
Q 003836 664 RGTKGYVAPEWFRNMPITVKVDVYSYGVLLLEIICLRRNIDNEISKVDKAILTDWAYDRYQERTLEALVENDLEAMNNVT 743 (792)
Q Consensus 664 ~gt~~y~aPE~~~~~~~~~k~DV~S~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 743 (792)
.||+.|+|||.+.+..++.++|||||||++|||++|+.||........ +.......+. ........
T Consensus 249 ~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~---~~~i~~~~~~-----------~~~~~~~~ 314 (373)
T 2x4f_A 249 FGTPEFLAPEVVNYDFVSFPTDMWSVGVIAYMLLSGLSPFLGDNDAET---LNNILACRWD-----------LEDEEFQD 314 (373)
T ss_dssp CSSCTTCCHHHHTTCBCCHHHHHHHHHHHHHHHHHSSCTTCCSSHHHH---HHHHHHTCCC-----------SCSGGGTT
T ss_pred cCCCcEeChhhccCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCHHHH---HHHHHhccCC-----------CChhhhcc
Confidence 689999999999989999999999999999999999999976432211 1111000000 00001112
Q ss_pred HHHHHHHHHHHccccCCCCCCCHHhHHH
Q 003836 744 MLHRFVMVAFWCIQEDPSHRPTMRKVTQ 771 (792)
Q Consensus 744 ~~~~l~~l~~~Cl~~~p~~RPs~~evl~ 771 (792)
.+.++.+++.+||+.||.+|||++|+++
T Consensus 315 ~~~~~~~li~~~L~~dp~~Rps~~e~l~ 342 (373)
T 2x4f_A 315 ISEEAKEFISKLLIKEKSWRISASEALK 342 (373)
T ss_dssp SCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred CCHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 3567889999999999999999999997
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-39 Score=340.43 Aligned_cols=254 Identities=22% Similarity=0.303 Sum_probs=201.5
Q ss_pred hhhhhcCccccceEEEeeecCC--CceEEEEEEccccc-ccchHHHHHHHHHhcccCCCCcccccceeccCCceEEEEEe
Q 003836 504 GFKEELGRGAFGTVYKGFVNMG--SSNHVAVKKLNSVF-QDSEKEFKAEVNGIGQTHHKNLVRLLGYCDEGQNRLLVYEF 580 (792)
Q Consensus 504 ~~~~~lG~G~~g~Vy~g~~~~~--~~~~vavK~~~~~~-~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~lV~E~ 580 (792)
.+.+.||+|+||+||+|..... .+..||+|++.... ....+.+.+|+.++++++||||+++++++.++ ..++||||
T Consensus 15 ~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~-~~~~v~e~ 93 (281)
T 3cc6_A 15 VLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKLIGIIEEE-PTWIIMEL 93 (281)
T ss_dssp EEEEEEEECSSSEEEEEEEECTTCCEEEEEEEECCTTSCHHHHHHHHHHHHHHHHHCCTTBCCEEEEECSS-SCEEEEEC
T ss_pred EEEEEEEecCCeeEEEeEEcCCCCCcceEEEEecccccCchHHHHHHHHHHHHHhCCCCCcceEEEEEcCC-CCEEEEec
Confidence 3457899999999999976432 34579999987643 34467899999999999999999999998754 56899999
Q ss_pred ccCCCccccccCC-CCCchhHHHHHHHHHHHHHHHHhhccCCCeEecCCCCCcEEEcCCCCeEEeecCCCccccCCCCCc
Q 003836 581 MSNGTVASFLFGD-SKPNWKLRTEIAMGIAGGLFYLHEECCTQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLDQSHT 659 (792)
Q Consensus 581 ~~~gsL~~~l~~~-~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dikp~NILl~~~~~~kl~Dfg~a~~~~~~~~~~ 659 (792)
+++++|.+++... ..+++..+..++.||+.||.|||+. +|+||||||+|||++.++.+||+|||+++.........
T Consensus 94 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~ 170 (281)
T 3cc6_A 94 YPYGELGHYLERNKNSLKVLTLVLYSLQICKAMAYLESI---NCVHRDIAVRNILVASPECVKLGDFGLSRYIEDEDYYK 170 (281)
T ss_dssp CTTCBHHHHHHHHTTTCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEEEETTEEEECCCCGGGCC-------
T ss_pred CCCCCHHHHHHhccccCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCccceEEECCCCcEEeCccCCCcccccccccc
Confidence 9999999999764 4589999999999999999999998 99999999999999999999999999998765544333
Q ss_pred cccccccCCcccccccccCCCCcccceehHHHHHHHHHh-cCcCCCcchhhhhhhhHHHHHHHhhcccchhHhhhchhcc
Q 003836 660 NTAIRGTKGYVAPEWFRNMPITVKVDVYSYGVLLLEIIC-LRRNIDNEISKVDKAILTDWAYDRYQERTLEALVENDLEA 738 (792)
Q Consensus 660 ~~~~~gt~~y~aPE~~~~~~~~~k~DV~S~Gv~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 738 (792)
.....+++.|+|||.+.+..++.++||||||+++|||++ |+.||.......... .+......
T Consensus 171 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~llt~g~~p~~~~~~~~~~~-----------------~~~~~~~~ 233 (281)
T 3cc6_A 171 ASVTRLPIKWMSPESINFRRFTTASDVWMFAVCMWEILSFGKQPFFWLENKDVIG-----------------VLEKGDRL 233 (281)
T ss_dssp --CCCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCGGGHHH-----------------HHHHTCCC
T ss_pred cccCCCCcceeCchhhccCCCCchhccHHHHHHHHHHHhCCCCCcccCChHHHHH-----------------HHhcCCCC
Confidence 344557889999999998899999999999999999998 999996433221100 00011111
Q ss_pred cCCHHHHHHHHHHHHHccccCCCCCCCHHhHHHHhccCcC
Q 003836 739 MNNVTMLHRFVMVAFWCIQEDPSHRPTMRKVTQMLEGVVE 778 (792)
Q Consensus 739 ~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~L~~~~~ 778 (792)
..+...++.+.+++.+||+.+|++|||+.|+++.|+.+.+
T Consensus 234 ~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~~~ 273 (281)
T 3cc6_A 234 PKPDLCPPVLYTLMTRCWDYDPSDRPRFTELVCSLSDVYQ 273 (281)
T ss_dssp CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred CCCCCCCHHHHHHHHHHccCCchhCcCHHHHHHHHHHHHH
Confidence 1122345678899999999999999999999999987643
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-39 Score=338.30 Aligned_cols=252 Identities=25% Similarity=0.425 Sum_probs=206.5
Q ss_pred hhhhhcCccccceEEEeeecCCCceEEEEEEcccccccchHHHHHHHHHhcccCCCCcccccceeccCCceEEEEEeccC
Q 003836 504 GFKEELGRGAFGTVYKGFVNMGSSNHVAVKKLNSVFQDSEKEFKAEVNGIGQTHHKNLVRLLGYCDEGQNRLLVYEFMSN 583 (792)
Q Consensus 504 ~~~~~lG~G~~g~Vy~g~~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~lV~E~~~~ 583 (792)
.+.+.||+|+||.||++... +++.||+|++.... ...+.+.+|++++++++||||+++++++.+.+..++||||+++
T Consensus 11 ~~~~~lg~G~~g~V~~~~~~--~~~~vaiK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~ 87 (267)
T 3t9t_A 11 TFVQEIGSGQFGLVHLGYWL--NKDKVAIKTIREGA-MSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVTEFMEH 87 (267)
T ss_dssp EEEEEEEEETTEEEEEEEET--TTEEEEEEEECTTT-BCHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSCEEEECCCTT
T ss_pred eeeeEecCCCceeEEEEEec--CCCeEEEEEccccC-CCHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCeEEEEeCCCC
Confidence 34578999999999999764 35689999997643 3457899999999999999999999999999999999999999
Q ss_pred CCccccccCC-CCCchhHHHHHHHHHHHHHHHHhhccCCCeEecCCCCCcEEEcCCCCeEEeecCCCccccCCCCCcccc
Q 003836 584 GTVASFLFGD-SKPNWKLRTEIAMGIAGGLFYLHEECCTQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLDQSHTNTA 662 (792)
Q Consensus 584 gsL~~~l~~~-~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dikp~NILl~~~~~~kl~Dfg~a~~~~~~~~~~~~~ 662 (792)
++|.+++... ..+++..+..++.|++.||.|||+. +|+|+||||+||+++.++.+||+|||+++............
T Consensus 88 ~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~~~~~~~ 164 (267)
T 3t9t_A 88 GCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEA---CVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTG 164 (267)
T ss_dssp CBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSSCCGGGEEECGGGCEEECCTTGGGGBCCHHHHSTTS
T ss_pred CcHHHHHhhCcccCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCchheEEECCCCCEEEccccccccccccccccccc
Confidence 9999999765 5689999999999999999999999 99999999999999999999999999998764332222333
Q ss_pred ccccCCcccccccccCCCCcccceehHHHHHHHHHh-cCcCCCcchhhhhhhhHHHHHHHhhcccchhHhhhchhcccCC
Q 003836 663 IRGTKGYVAPEWFRNMPITVKVDVYSYGVLLLEIIC-LRRNIDNEISKVDKAILTDWAYDRYQERTLEALVENDLEAMNN 741 (792)
Q Consensus 663 ~~gt~~y~aPE~~~~~~~~~k~DV~S~Gv~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 741 (792)
..+++.|+|||.+.+..++.++||||||+++|||++ |+.||........ . .. +........+
T Consensus 165 ~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~---~-----~~---------i~~~~~~~~~ 227 (267)
T 3t9t_A 165 TKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEV---V-----ED---------ISTGFRLYKP 227 (267)
T ss_dssp TTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHH---H-----HH---------HHTTCCCCCC
T ss_pred ccccccccChhhhcCCCccchhchhhhHHHHHHHhccCCCCCCCCCHHHH---H-----HH---------HhcCCcCCCC
Confidence 457788999999998899999999999999999999 8889865432110 0 00 0011111122
Q ss_pred HHHHHHHHHHHHHccccCCCCCCCHHhHHHHhccCcC
Q 003836 742 VTMLHRFVMVAFWCIQEDPSHRPTMRKVTQMLEGVVE 778 (792)
Q Consensus 742 ~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~L~~~~~ 778 (792)
...+..+.+++.+||+.+|++|||++|++++|+++.+
T Consensus 228 ~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~l~~ 264 (267)
T 3t9t_A 228 RLASTHVYQIMNHCWRERPEDRPAFSRLLRQLAEIAE 264 (267)
T ss_dssp TTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred ccCcHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence 2345678899999999999999999999999987643
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-38 Score=346.90 Aligned_cols=243 Identities=23% Similarity=0.217 Sum_probs=203.3
Q ss_pred hhhhhcCccccceEEEeeecCCCceEEEEEEccccc---ccchHHHHHHHHHhcccCCCCcccccceeccCCceEEEEEe
Q 003836 504 GFKEELGRGAFGTVYKGFVNMGSSNHVAVKKLNSVF---QDSEKEFKAEVNGIGQTHHKNLVRLLGYCDEGQNRLLVYEF 580 (792)
Q Consensus 504 ~~~~~lG~G~~g~Vy~g~~~~~~~~~vavK~~~~~~---~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~lV~E~ 580 (792)
.+.+.||+|+||.||++... .+++.||+|++.+.. ....+.+.+|++++++++||||+++++++.+.+..++||||
T Consensus 44 ~~~~~lG~G~~g~V~~~~~~-~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~ 122 (350)
T 1rdq_E 44 DRIKTLGTGSFGRVMLVKHK-ESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEY 122 (350)
T ss_dssp EEEEEEEECSSCEEEEEEET-TTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEEC
T ss_pred EEEEEeecCcCcEEEEEEEC-CCCCEEEEEEEEhHHhccHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCEEEEEEcC
Confidence 34578999999999999754 456799999986532 23456789999999999999999999999999999999999
Q ss_pred ccCCCccccccCCCCCchhHHHHHHHHHHHHHHHHhhccCCCeEecCCCCCcEEEcCCCCeEEeecCCCccccCCCCCcc
Q 003836 581 MSNGTVASFLFGDSKPNWKLRTEIAMGIAGGLFYLHEECCTQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLDQSHTN 660 (792)
Q Consensus 581 ~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dikp~NILl~~~~~~kl~Dfg~a~~~~~~~~~~~ 660 (792)
+++|+|.+++.....+++..+..++.||+.||+|||+. +|+||||||+|||++.++.+||+|||+++..... .
T Consensus 123 ~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~g~~kL~DFg~a~~~~~~----~ 195 (350)
T 1rdq_E 123 VAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSL---DLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR----T 195 (350)
T ss_dssp CTTCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECSSC----B
T ss_pred CCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC---CcccccCccceEEECCCCCEEEcccccceeccCC----c
Confidence 99999999998878899999999999999999999998 9999999999999999999999999999876432 2
Q ss_pred ccccccCCcccccccccCCCCcccceehHHHHHHHHHhcCcCCCcchhhhhhhhHHHHHHHhhcccchhHhhhchhcccC
Q 003836 661 TAIRGTKGYVAPEWFRNMPITVKVDVYSYGVLLLEIICLRRNIDNEISKVDKAILTDWAYDRYQERTLEALVENDLEAMN 740 (792)
Q Consensus 661 ~~~~gt~~y~aPE~~~~~~~~~k~DV~S~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 740 (792)
....||+.|+|||.+.+..++.++|||||||++|||++|+.||........ . ..+..... ..
T Consensus 196 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~---~-------------~~i~~~~~--~~ 257 (350)
T 1rdq_E 196 WTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQI---Y-------------EKIVSGKV--RF 257 (350)
T ss_dssp CCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH---H-------------HHHHHCCC--CC
T ss_pred ccccCCccccCHHHhcCCCCCCcCCEecccHhHhHHhhCCCCCCCCCHHHH---H-------------HHHHcCCC--CC
Confidence 345799999999999999999999999999999999999999975432111 0 01111111 12
Q ss_pred CHHHHHHHHHHHHHccccCCCCCCC-----HHhHHHH
Q 003836 741 NVTMLHRFVMVAFWCIQEDPSHRPT-----MRKVTQM 772 (792)
Q Consensus 741 ~~~~~~~l~~l~~~Cl~~~p~~RPs-----~~evl~~ 772 (792)
+...+..+.+++.+||+.||.+||+ ++||++.
T Consensus 258 p~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~ei~~h 294 (350)
T 1rdq_E 258 PSHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNH 294 (350)
T ss_dssp CTTCCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHTS
T ss_pred CCCCCHHHHHHHHHHhhcCHHhccCCccCCHHHHHhC
Confidence 2334567889999999999999998 8888764
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-38 Score=340.46 Aligned_cols=248 Identities=29% Similarity=0.466 Sum_probs=193.5
Q ss_pred hhhhhcCccccceEEEeeecCCCceEEEEEEcccccccchHHHHHHHHHhcccCCCCcccccceeccCCceEEEEEeccC
Q 003836 504 GFKEELGRGAFGTVYKGFVNMGSSNHVAVKKLNSVFQDSEKEFKAEVNGIGQTHHKNLVRLLGYCDEGQNRLLVYEFMSN 583 (792)
Q Consensus 504 ~~~~~lG~G~~g~Vy~g~~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~lV~E~~~~ 583 (792)
.+.+.||+|+||+||++... ++.||||++.. ....+.+.+|++++++++||||+++++++.+ ..++||||+++
T Consensus 11 ~~~~~lg~G~~g~V~~~~~~---~~~vavK~~~~--~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~--~~~lv~e~~~~ 83 (307)
T 2eva_A 11 EVEEVVGRGAFGVVCKAKWR---AKDVAIKQIES--ESERKAFIVELRQLSRVNHPNIVKLYGACLN--PVCLVMEYAEG 83 (307)
T ss_dssp EEEEEEECCSSSEEEEEEET---TEEEEEEECSS--TTHHHHHHHHHHHHHHCCCTTBCCEEEBCTT--TTEEEEECCTT
T ss_pred eeeeEeecCCCceEEEEEEC---CeeEEEEEecC--hhHHHHHHHHHHHHhcCCCCCcCeEEEEEcC--CcEEEEEcCCC
Confidence 34578999999999999764 56899999865 3446789999999999999999999999874 47999999999
Q ss_pred CCccccccCCC---CCchhHHHHHHHHHHHHHHHHhhccCCCeEecCCCCCcEEEcCCCC-eEEeecCCCccccCCCCCc
Q 003836 584 GTVASFLFGDS---KPNWKLRTEIAMGIAGGLFYLHEECCTQIIHCDIKPQNILLDDHYN-ARISDFGLAKLLTLDQSHT 659 (792)
Q Consensus 584 gsL~~~l~~~~---~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dikp~NILl~~~~~-~kl~Dfg~a~~~~~~~~~~ 659 (792)
|+|.+++.... .+++..++.++.||++||+|||+....+|+||||||+|||++.++. +||+|||+++.....
T Consensus 84 ~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~~kl~Dfg~~~~~~~~---- 159 (307)
T 2eva_A 84 GSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQTH---- 159 (307)
T ss_dssp CBHHHHHHCSSSEECCCHHHHHHHHHHHHHHHHHHHTCSSSCCCCCCCSGGGEEEETTTTEEEECCCCC-----------
T ss_pred CCHHHHHhccCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeecCCCChhHEEEeCCCCEEEEcccccccccccc----
Confidence 99999998664 3678899999999999999999932238999999999999998887 799999999765322
Q ss_pred cccccccCCcccccccccCCCCcccceehHHHHHHHHHhcCcCCCcchhhhhhhhHHHHHHHhhcccchhHhhhchhccc
Q 003836 660 NTAIRGTKGYVAPEWFRNMPITVKVDVYSYGVLLLEIICLRRNIDNEISKVDKAILTDWAYDRYQERTLEALVENDLEAM 739 (792)
Q Consensus 660 ~~~~~gt~~y~aPE~~~~~~~~~k~DV~S~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 739 (792)
.....||+.|+|||.+.+..++.++||||||+++|||++|+.||.......... .+. . .......
T Consensus 160 ~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~---~~~--~----------~~~~~~~ 224 (307)
T 2eva_A 160 MTNNKGSAAWMAPEVFEGSNYSEKCDVFSWGIILWEVITRRKPFDEIGGPAFRI---MWA--V----------HNGTRPP 224 (307)
T ss_dssp -----CCTTSSCHHHHTCCCCCTHHHHHHHHHHHHHHHHTCCTTTTTCSSHHHH---HHH--H----------HTTCCCC
T ss_pred cccCCCCCceEChhhhCCCCCCcHHHHHHHHHHHHHHHHCCCCchhhCccHHHH---HHH--H----------hcCCCCC
Confidence 223458999999999999999999999999999999999999996532211100 000 0 0001111
Q ss_pred CCHHHHHHHHHHHHHccccCCCCCCCHHhHHHHhccCc
Q 003836 740 NNVTMLHRFVMVAFWCIQEDPSHRPTMRKVTQMLEGVV 777 (792)
Q Consensus 740 ~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~L~~~~ 777 (792)
.....+..+.+++.+||+.||++|||++|++++|+.+.
T Consensus 225 ~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~ 262 (307)
T 2eva_A 225 LIKNLPKPIESLMTRCWSKDPSQRPSMEEIVKIMTHLM 262 (307)
T ss_dssp CBTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHG
T ss_pred cccccCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHH
Confidence 12234567889999999999999999999999998764
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-39 Score=341.17 Aligned_cols=259 Identities=16% Similarity=0.216 Sum_probs=206.3
Q ss_pred hhhhhhcCccccceEEEeeecCCCceEEEEEEcccccccchHHHHHHHHHhccc-CCCCcccccceeccCCceEEEEEec
Q 003836 503 RGFKEELGRGAFGTVYKGFVNMGSSNHVAVKKLNSVFQDSEKEFKAEVNGIGQT-HHKNLVRLLGYCDEGQNRLLVYEFM 581 (792)
Q Consensus 503 ~~~~~~lG~G~~g~Vy~g~~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l-~h~niv~l~g~~~~~~~~~lV~E~~ 581 (792)
+.+.+.||+|+||.||+|.. ..+++.||||++... ...+.+.+|+++++++ +|+|++++++++.+....++||||+
T Consensus 12 y~~~~~lg~G~~g~V~~~~~-~~~~~~vavK~~~~~--~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv~e~~ 88 (298)
T 1csn_A 12 YKVGRRIGEGSFGVIFEGTN-LLNNQQVAIKFEPRR--SDAPQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVIDLL 88 (298)
T ss_dssp EEEEEEEEECSSCEEEEEEE-TTTTEEEEEEEEECC--TTSCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEEEECC
T ss_pred eEEEEEEeecCCEEEEEEEE-CCCCcEEEEEEeccC--CccHHHHHHHHHHHHHhcCCCCCeEEeecCCCceeEEEEEec
Confidence 34557899999999999974 356789999998653 2345688999999999 7999999999999999999999999
Q ss_pred cCCCccccccCC-CCCchhHHHHHHHHHHHHHHHHhhccCCCeEecCCCCCcEEEcCCCC-----eEEeecCCCccccCC
Q 003836 582 SNGTVASFLFGD-SKPNWKLRTEIAMGIAGGLFYLHEECCTQIIHCDIKPQNILLDDHYN-----ARISDFGLAKLLTLD 655 (792)
Q Consensus 582 ~~gsL~~~l~~~-~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dikp~NILl~~~~~-----~kl~Dfg~a~~~~~~ 655 (792)
+++|.+++... ..+++..+..++.||+.||+|||+. +|+||||||+|||++.++. +||+|||+++.....
T Consensus 89 -~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~Dlkp~NIl~~~~~~~~~~~~kl~Dfg~~~~~~~~ 164 (298)
T 1csn_A 89 -GPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEK---SLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDP 164 (298)
T ss_dssp -CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEECCSSSTTTTCEEECCCTTCEESBCT
T ss_pred -CCCHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEeccCCCCCCCeEEEEECccccccccc
Confidence 99999999765 4689999999999999999999998 9999999999999987776 999999999876544
Q ss_pred CCC------ccccccccCCcccccccccCCCCcccceehHHHHHHHHHhcCcCCCcchhhhhhhhHHHHHHHhhcccchh
Q 003836 656 QSH------TNTAIRGTKGYVAPEWFRNMPITVKVDVYSYGVLLLEIICLRRNIDNEISKVDKAILTDWAYDRYQERTLE 729 (792)
Q Consensus 656 ~~~------~~~~~~gt~~y~aPE~~~~~~~~~k~DV~S~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 729 (792)
... ......||+.|+|||.+.+..++.++||||||+++|||++|+.||.................... .....
T Consensus 165 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~-~~~~~ 243 (298)
T 1csn_A 165 VTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQ-STPLR 243 (298)
T ss_dssp TTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHHHHH-HSCHH
T ss_pred cccccccccCccCCCCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHcCCCCcchhhccccHHHHHHHHhhcc-CccHH
Confidence 321 23345699999999999999999999999999999999999999976432211111111100000 00000
Q ss_pred HhhhchhcccCCHHHHHHHHHHHHHccccCCCCCCCHHhHHHHhccCcC
Q 003836 730 ALVENDLEAMNNVTMLHRFVMVAFWCIQEDPSHRPTMRKVTQMLEGVVE 778 (792)
Q Consensus 730 ~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~L~~~~~ 778 (792)
.+ ....++.+.+++.+||+.+|++||++++|++.|+.+.+
T Consensus 244 ~~---------~~~~~~~l~~li~~~l~~dp~~RP~~~~l~~~l~~~~~ 283 (298)
T 1csn_A 244 EL---------CAGFPEEFYKYMHYARNLAFDATPDYDYLQGLFSKVLE 283 (298)
T ss_dssp HH---------TTTSCHHHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHH
T ss_pred HH---------HhhCcHHHHHHHHHHhcCCcccCCCHHHHHHHHHHHHH
Confidence 00 11234678899999999999999999999999988653
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.7e-39 Score=349.82 Aligned_cols=251 Identities=21% Similarity=0.267 Sum_probs=193.6
Q ss_pred hhhhhhcCccccceEEEeeecCCCceEEEEEEcccccccchHHHHHHHHHhcccCCCCcccccceeccCCceEEEEEecc
Q 003836 503 RGFKEELGRGAFGTVYKGFVNMGSSNHVAVKKLNSVFQDSEKEFKAEVNGIGQTHHKNLVRLLGYCDEGQNRLLVYEFMS 582 (792)
Q Consensus 503 ~~~~~~lG~G~~g~Vy~g~~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~lV~E~~~ 582 (792)
+.+.+.||+|+||+||++... .+++.||||++.... ...+.+.+|+.++++++||||+++++++.+....++||||++
T Consensus 22 y~~~~~lG~G~~g~V~~~~~~-~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~ 99 (361)
T 3uc3_A 22 YDFVKDIGSGNFGVARLMRDK-LTKELVAVKYIERGA-AIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIIMEYAS 99 (361)
T ss_dssp EEEEEEESSSTTSSEEEEEET-TTCCEEEEEEEESST-TSCHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEECCC
T ss_pred EEEEEEeccCCCEEEEEEEEC-CCCcEEEEEEEecCc-cccHHHHHHHHHHHhCCCCCCCcEEEEEeeCCEEEEEEEeCC
Confidence 445678999999999999754 456799999997543 334678999999999999999999999999999999999999
Q ss_pred CCCccccccCCCCCchhHHHHHHHHHHHHHHHHhhccCCCeEecCCCCCcEEEcCCCC--eEEeecCCCccccCCCCCcc
Q 003836 583 NGTVASFLFGDSKPNWKLRTEIAMGIAGGLFYLHEECCTQIIHCDIKPQNILLDDHYN--ARISDFGLAKLLTLDQSHTN 660 (792)
Q Consensus 583 ~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dikp~NILl~~~~~--~kl~Dfg~a~~~~~~~~~~~ 660 (792)
+|+|.+++.....+++..+..++.||+.||+|||+. +|+||||||+|||++.++. +||+|||+++..... ...
T Consensus 100 ~~~L~~~l~~~~~~~~~~~~~i~~ql~~~L~~LH~~---~ivH~Dlkp~Nill~~~~~~~~kl~Dfg~a~~~~~~--~~~ 174 (361)
T 3uc3_A 100 GGELYERICNAGRFSEDEARFFFQQLLSGVSYCHSM---QICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH--SQP 174 (361)
T ss_dssp SCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHT---TCCSCCCCGGGEEECSSSSCCEEECCCCCC-----------
T ss_pred CCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEcCCCCceEEEeecCcccccccc--CCC
Confidence 999999998778899999999999999999999998 9999999999999987765 999999999854322 222
Q ss_pred ccccccCCcccccccccCCCCcc-cceehHHHHHHHHHhcCcCCCcchhhhhhhhHHHHHHHhhcccchhHhhhchhccc
Q 003836 661 TAIRGTKGYVAPEWFRNMPITVK-VDVYSYGVLLLEIICLRRNIDNEISKVDKAILTDWAYDRYQERTLEALVENDLEAM 739 (792)
Q Consensus 661 ~~~~gt~~y~aPE~~~~~~~~~k-~DV~S~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 739 (792)
....||+.|+|||.+.+..++.+ +|||||||++|||++|+.||............ +..+........
T Consensus 175 ~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~------------~~~~~~~~~~~~ 242 (361)
T 3uc3_A 175 KSTVGTPAYIAPEVLLRQEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPRDYRKT------------IQRILSVKYSIP 242 (361)
T ss_dssp ------CTTSCHHHHHCSSCCHHHHHHHHHHHHHHHHHHSSCSCC----CCCHHHH------------HHHHHTTCCCCC
T ss_pred CCCcCCCCcCChhhhcCCCCCCCeeeeehhHHHHHHHHhCCCCCCCCccHHHHHHH------------HHHHhcCCCCCC
Confidence 34569999999999988887665 89999999999999999999754332111100 111111111111
Q ss_pred CCHHHHHHHHHHHHHccccCCCCCCCHHhHHHH
Q 003836 740 NNVTMLHRFVMVAFWCIQEDPSHRPTMRKVTQM 772 (792)
Q Consensus 740 ~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~ 772 (792)
.....+..+.+++.+||+.||++|||++|+++.
T Consensus 243 ~~~~~s~~~~~li~~~L~~dP~~Rps~~ell~h 275 (361)
T 3uc3_A 243 DDIRISPECCHLISRIFVADPATRISIPEIKTH 275 (361)
T ss_dssp TTSCCCHHHHHHHHHHSCSCTTTSCCHHHHHTS
T ss_pred CcCCCCHHHHHHHHHHccCChhHCcCHHHHHhC
Confidence 111235678899999999999999999999975
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7e-39 Score=345.10 Aligned_cols=249 Identities=20% Similarity=0.278 Sum_probs=181.6
Q ss_pred hhcCccccceEEEeeecCCCceEEEEEEcccccccchHHHHHHHHHhcccC-CCCcccccceeccCCceEEEEEeccCCC
Q 003836 507 EELGRGAFGTVYKGFVNMGSSNHVAVKKLNSVFQDSEKEFKAEVNGIGQTH-HKNLVRLLGYCDEGQNRLLVYEFMSNGT 585 (792)
Q Consensus 507 ~~lG~G~~g~Vy~g~~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~-h~niv~l~g~~~~~~~~~lV~E~~~~gs 585 (792)
+.||+|+||+||++... .+++.||||++.. .....+.+|+.++.+++ ||||+++++++.+....++||||+++|+
T Consensus 17 ~~lG~G~~g~V~~~~~~-~~~~~vavK~~~~---~~~~~~~~e~~~l~~l~~h~niv~~~~~~~~~~~~~lv~e~~~~~~ 92 (325)
T 3kn6_A 17 KPLGEGSFSICRKCVHK-KSNQAFAVKIISK---RMEANTQKEITALKLCEGHPNIVKLHEVFHDQLHTFLVMELLNGGE 92 (325)
T ss_dssp CCSEEETTEEEEEEEET-TTCCEEEEEEEEG---GGHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEECCCCSCB
T ss_pred CccccCCCeEEEEEEEC-CCCCEEEEEEECh---hhhhhHHHHHHHHHHhcCCCCeeEEEEEEEcCCEEEEEEEccCCCc
Confidence 57999999999999754 4568999999864 34567889999999997 9999999999999999999999999999
Q ss_pred ccccccCCCCCchhHHHHHHHHHHHHHHHHhhccCCCeEecCCCCCcEEEcCCC---CeEEeecCCCccccCCCCCcccc
Q 003836 586 VASFLFGDSKPNWKLRTEIAMGIAGGLFYLHEECCTQIIHCDIKPQNILLDDHY---NARISDFGLAKLLTLDQSHTNTA 662 (792)
Q Consensus 586 L~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dikp~NILl~~~~---~~kl~Dfg~a~~~~~~~~~~~~~ 662 (792)
|.+++.....+++..+..++.||+.||+|||+. +|+||||||+|||++.++ .+||+|||+++...... .....
T Consensus 93 L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~---~ivH~Dlkp~NIll~~~~~~~~~kl~Dfg~a~~~~~~~-~~~~~ 168 (325)
T 3kn6_A 93 LFERIKKKKHFSETEASYIMRKLVSAVSHMHDV---GVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDN-QPLKT 168 (325)
T ss_dssp HHHHHHHCSCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEEEC----CEEEECCCTTCEECCC--------
T ss_pred HHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---CCeecCCCHHHEEEecCCCcccEEEeccccceecCCCC-Ccccc
Confidence 999998888899999999999999999999998 999999999999998765 79999999998654332 22334
Q ss_pred ccccCCcccccccccCCCCcccceehHHHHHHHHHhcCcCCCcchhhhhhhhHHHHHHHhhcccchhHhhhchhccc--C
Q 003836 663 IRGTKGYVAPEWFRNMPITVKVDVYSYGVLLLEIICLRRNIDNEISKVDKAILTDWAYDRYQERTLEALVENDLEAM--N 740 (792)
Q Consensus 663 ~~gt~~y~aPE~~~~~~~~~k~DV~S~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~ 740 (792)
..||+.|+|||.+.+..++.++||||||+++|||++|+.||............... +..+........ .
T Consensus 169 ~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~---------~~~i~~~~~~~~~~~ 239 (325)
T 3kn6_A 169 PCFTLHYAAPELLNQNGYDESCDLWSLGVILYTMLSGQVPFQSHDRSLTCTSAVEI---------MKKIKKGDFSFEGEA 239 (325)
T ss_dssp ---------------CCCCHHHHHHHHHHHHHHHHHSSCTTC-------CCCHHHH---------HHHHTTTCCCCCSHH
T ss_pred cCCCcCccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCccccccccHHHH---------HHHHHcCCCCCCccc
Confidence 56899999999999999999999999999999999999999754321110000000 011111111100 0
Q ss_pred CHHHHHHHHHHHHHccccCCCCCCCHHhHHHH
Q 003836 741 NVTMLHRFVMVAFWCIQEDPSHRPTMRKVTQM 772 (792)
Q Consensus 741 ~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~ 772 (792)
....++++.+++.+||+.||++|||++|+++.
T Consensus 240 ~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~h 271 (325)
T 3kn6_A 240 WKNVSQEAKDLIQGLLTVDPNKRLKMSGLRYN 271 (325)
T ss_dssp HHTSCHHHHHHHHHHHCCCTTTCCCTTTSTTC
T ss_pred ccCCCHHHHHHHHHHCCCChhHCCCHHHHhcC
Confidence 12245778999999999999999999999864
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-38 Score=337.56 Aligned_cols=254 Identities=24% Similarity=0.389 Sum_probs=203.7
Q ss_pred hhhcCccccceEEEeeecCC--CceEEEEEEcccccc-cchHHHHHHHHHhcccCCCCcccccceeccCCce-EEEEEec
Q 003836 506 KEELGRGAFGTVYKGFVNMG--SSNHVAVKKLNSVFQ-DSEKEFKAEVNGIGQTHHKNLVRLLGYCDEGQNR-LLVYEFM 581 (792)
Q Consensus 506 ~~~lG~G~~g~Vy~g~~~~~--~~~~vavK~~~~~~~-~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~-~lV~E~~ 581 (792)
.+.||+|+||+||+|..... ....+|+|++..... ...+.+.+|+.++++++||||+++++++.+.+.. ++||||+
T Consensus 26 ~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~v~e~~ 105 (298)
T 3pls_A 26 DRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNVLALIGIMLPPEGLPHVLLPYM 105 (298)
T ss_dssp EEEEEEETTEEEEEEEEECSSSCEEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCEEEECCC
T ss_pred CceeccCCCceEEEEEEecCCCceeeeeeeeccccccHHHHHHHHHHHHHHHhCCCCCeeeEEEEEecCCCCcEEEEecc
Confidence 36799999999999976432 334799999876433 3456789999999999999999999999877665 9999999
Q ss_pred cCCCccccccCC-CCCchhHHHHHHHHHHHHHHHHhhccCCCeEecCCCCCcEEEcCCCCeEEeecCCCccccCCC---C
Q 003836 582 SNGTVASFLFGD-SKPNWKLRTEIAMGIAGGLFYLHEECCTQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLDQ---S 657 (792)
Q Consensus 582 ~~gsL~~~l~~~-~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dikp~NILl~~~~~~kl~Dfg~a~~~~~~~---~ 657 (792)
.+|+|.+++... ..+++..+..++.|++.||+|||+. +|+||||||+|||+++++.+||+|||+++...... .
T Consensus 106 ~~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~---~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~ 182 (298)
T 3pls_A 106 CHGDLLQFIRSPQRNPTVKDLISFGLQVARGMEYLAEQ---KFVHRDLAARNCMLDESFTVKVADFGLARDILDREYYSV 182 (298)
T ss_dssp TTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTCCEEECCTTSSCTTTTGGGGCS
T ss_pred cCCCHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCcceEEEcCCCcEEeCcCCCcccccCCccccc
Confidence 999999999764 5689999999999999999999999 99999999999999999999999999998654332 1
Q ss_pred CccccccccCCcccccccccCCCCcccceehHHHHHHHHHhcCcCCCcchhhhhhhhHHHHHHHhhcccchhHhhhchhc
Q 003836 658 HTNTAIRGTKGYVAPEWFRNMPITVKVDVYSYGVLLLEIICLRRNIDNEISKVDKAILTDWAYDRYQERTLEALVENDLE 737 (792)
Q Consensus 658 ~~~~~~~gt~~y~aPE~~~~~~~~~k~DV~S~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 737 (792)
.......+++.|+|||.+.+..++.++||||||+++|||++|+.|+........ +...+.....
T Consensus 183 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~~~~~~~~~~~----------------~~~~~~~~~~ 246 (298)
T 3pls_A 183 QQHRHARLPVKWTALESLQTYRFTTKSDVWSFGVLLWELLTRGAPPYRHIDPFD----------------LTHFLAQGRR 246 (298)
T ss_dssp CCSSCTTCGGGGSCHHHHTTCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCGGG----------------HHHHHHTTCC
T ss_pred ccCcCCCCCccccChhhhccCCCChhhchhhHHHHHHHHhhCCCCCCccCCHHH----------------HHHHhhcCCC
Confidence 222345678899999999999999999999999999999997776543322211 1111111111
Q ss_pred ccCCHHHHHHHHHHHHHccccCCCCCCCHHhHHHHhccCcC
Q 003836 738 AMNNVTMLHRFVMVAFWCIQEDPSHRPTMRKVTQMLEGVVE 778 (792)
Q Consensus 738 ~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~L~~~~~ 778 (792)
...+...+..+.+++.+||+.||.+|||++++++.|+.+++
T Consensus 247 ~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~l~~~~~ 287 (298)
T 3pls_A 247 LPQPEYCPDSLYQVMQQCWEADPAVRPTFRVLVGEVEQIVS 287 (298)
T ss_dssp CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred CCCCccchHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHH
Confidence 12223345678899999999999999999999999988653
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-38 Score=341.82 Aligned_cols=258 Identities=24% Similarity=0.287 Sum_probs=203.2
Q ss_pred hhhhhhcCccccceEEEeeecCCCceEEEEEEcccccccchHHHHHHHHHhcccCCCCcccccceec----cCCceEEEE
Q 003836 503 RGFKEELGRGAFGTVYKGFVNMGSSNHVAVKKLNSVFQDSEKEFKAEVNGIGQTHHKNLVRLLGYCD----EGQNRLLVY 578 (792)
Q Consensus 503 ~~~~~~lG~G~~g~Vy~g~~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~----~~~~~~lV~ 578 (792)
+.+.+.||+|+||.||++... .+++.||||++........+.+.+|++++++++||||+++++++. .....++||
T Consensus 31 y~~~~~lg~G~~g~V~~~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~lv~ 109 (317)
T 2buj_A 31 YLFIQKLGEGGFSYVDLVEGL-HDGHFYALKRILCHEQQDREEAQREADMHRLFNHPNILRLVAYCLRERGAKHEAWLLL 109 (317)
T ss_dssp EEEEEEEEC--CEEEEEEEET-TTCCEEEEEEEEESSHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEEEETTEEEEEEEE
T ss_pred EEEEEEecCCCCeEEEEEEec-CCCcEEEEEEEecCCHHHHHHHHHHHHHHhhcCCCCeeeEEEEEEeccCCCceeEEEE
Confidence 345678999999999999753 456899999987665666778999999999999999999999986 345788999
Q ss_pred EeccCCCccccccC----CCCCchhHHHHHHHHHHHHHHHHhhccCCCeEecCCCCCcEEEcCCCCeEEeecCCCccccC
Q 003836 579 EFMSNGTVASFLFG----DSKPNWKLRTEIAMGIAGGLFYLHEECCTQIIHCDIKPQNILLDDHYNARISDFGLAKLLTL 654 (792)
Q Consensus 579 E~~~~gsL~~~l~~----~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dikp~NILl~~~~~~kl~Dfg~a~~~~~ 654 (792)
||+++|+|.+++.. ...+++..+..++.||+.||+|||+. +|+||||||+|||++.++.+||+|||+++....
T Consensus 110 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~dlkp~NIl~~~~~~~kl~dfg~~~~~~~ 186 (317)
T 2buj_A 110 PFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIHAK---GYAHRDLKPTNILLGDEGQPVLMDLGSMNQACI 186 (317)
T ss_dssp ECCTTCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTSCEEECCCSSCEESCE
T ss_pred EeCCCCcHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEEcCCCCEEEEecCcchhccc
Confidence 99999999999865 46789999999999999999999999 999999999999999999999999999876532
Q ss_pred CCCCc--------cccccccCCcccccccccCC---CCcccceehHHHHHHHHHhcCcCCCcchhhhhhhhHHHHHHHhh
Q 003836 655 DQSHT--------NTAIRGTKGYVAPEWFRNMP---ITVKVDVYSYGVLLLEIICLRRNIDNEISKVDKAILTDWAYDRY 723 (792)
Q Consensus 655 ~~~~~--------~~~~~gt~~y~aPE~~~~~~---~~~k~DV~S~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~ 723 (792)
..... .....||+.|+|||.+.... ++.++||||||+++|||++|+.||.........
T Consensus 187 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~----------- 255 (317)
T 2buj_A 187 HVEGSRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQKGDS----------- 255 (317)
T ss_dssp EEESHHHHHHHHHHHHHHSCGGGCCGGGSSCCSEEEECTHHHHHHHHHHHHHHHHSSCTTHHHHHTTSC-----------
T ss_pred ccccccccccccccccccCCcccCCHhHhccCCCcCCCchhhHHHHHHHHHHHHhCCCChhhhhcccch-----------
Confidence 21111 12235799999999987543 789999999999999999999998543221110
Q ss_pred cccchhHhhhchhcccCCHHHHHHHHHHHHHccccCCCCCCCHHhHHHHhccCcCC
Q 003836 724 QERTLEALVENDLEAMNNVTMLHRFVMVAFWCIQEDPSHRPTMRKVTQMLEGVVEV 779 (792)
Q Consensus 724 ~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~L~~~~~~ 779 (792)
.................+..+.+++.+||+.||.+|||++|+++.|+.+...
T Consensus 256 ----~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~~~~~ 307 (317)
T 2buj_A 256 ----VALAVQNQLSIPQSPRHSSALWQLLNSMMTVDPHQRPHIPLLLSQLEALQPP 307 (317)
T ss_dssp ----HHHHHHCC--CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTCCC
T ss_pred ----hhHHhhccCCCCccccCCHHHHHHHHHHhhcChhhCCCHHHHHHHhhhcCCC
Confidence 0011111111112223456789999999999999999999999999987543
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=6.2e-39 Score=346.87 Aligned_cols=253 Identities=25% Similarity=0.432 Sum_probs=198.5
Q ss_pred hhhhcCccccceEEEeeecCCC---ceEEEEEEcccccc-cchHHHHHHHHHhcccCCCCcccccceeccCCceEEEEEe
Q 003836 505 FKEELGRGAFGTVYKGFVNMGS---SNHVAVKKLNSVFQ-DSEKEFKAEVNGIGQTHHKNLVRLLGYCDEGQNRLLVYEF 580 (792)
Q Consensus 505 ~~~~lG~G~~g~Vy~g~~~~~~---~~~vavK~~~~~~~-~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~lV~E~ 580 (792)
+.+.||+|+||+||+|...... +..||||++..... .....+.+|++++++++||||+++++++.+.+..++||||
T Consensus 48 ~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 127 (333)
T 1mqb_A 48 RQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMMIITEY 127 (333)
T ss_dssp EEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEEEC
T ss_pred cccEEecCCCeEEEEEEEecCCCCccccEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCCcEEEEeC
Confidence 3467999999999999865332 34699999975432 3456789999999999999999999999999999999999
Q ss_pred ccCCCccccccCC-CCCchhHHHHHHHHHHHHHHHHhhccCCCeEecCCCCCcEEEcCCCCeEEeecCCCccccCCCCCc
Q 003836 581 MSNGTVASFLFGD-SKPNWKLRTEIAMGIAGGLFYLHEECCTQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLDQSHT 659 (792)
Q Consensus 581 ~~~gsL~~~l~~~-~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dikp~NILl~~~~~~kl~Dfg~a~~~~~~~~~~ 659 (792)
+++|+|.+++... ..+++..+..++.||+.||.|||+. +|+||||||+|||++.++.+||+|||+++.........
T Consensus 128 ~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~ 204 (333)
T 1mqb_A 128 MENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLANM---NYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEAT 204 (333)
T ss_dssp CTTEEHHHHHHHTTTCSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECCCCC-----------
T ss_pred CCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCChheEEECCCCcEEECCCCcchhhccccccc
Confidence 9999999999764 5789999999999999999999999 99999999999999999999999999998765432221
Q ss_pred --cccccccCCcccccccccCCCCcccceehHHHHHHHHHh-cCcCCCcchhhhhhhhHHHHHHHhhcccchhHhhhchh
Q 003836 660 --NTAIRGTKGYVAPEWFRNMPITVKVDVYSYGVLLLEIIC-LRRNIDNEISKVDKAILTDWAYDRYQERTLEALVENDL 736 (792)
Q Consensus 660 --~~~~~gt~~y~aPE~~~~~~~~~k~DV~S~Gv~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 736 (792)
.....+|+.|+|||.+.+..++.++||||||+++|||++ |+.||........ . ..+....
T Consensus 205 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~~~~---~--------------~~~~~~~ 267 (333)
T 1mqb_A 205 YTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEV---M--------------KAINDGF 267 (333)
T ss_dssp ------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHH---H--------------HHHHTTC
T ss_pred cccCCCCccccccCchhcccCCCCchhhhHHHHHHHHHHHcCCCCCcccCCHHHH---H--------------HHHHCCC
Confidence 122346788999999999999999999999999999999 9999965432110 0 0011111
Q ss_pred cccCCHHHHHHHHHHHHHccccCCCCCCCHHhHHHHhccCc
Q 003836 737 EAMNNVTMLHRFVMVAFWCIQEDPSHRPTMRKVTQMLEGVV 777 (792)
Q Consensus 737 ~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~L~~~~ 777 (792)
....+...+..+.+++.+||+.+|++||++.+++++|+.++
T Consensus 268 ~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~~~ 308 (333)
T 1mqb_A 268 RLPTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLI 308 (333)
T ss_dssp CCCCCTTCBHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHH
T ss_pred cCCCcccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHH
Confidence 11222344567889999999999999999999999997754
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-39 Score=370.85 Aligned_cols=256 Identities=26% Similarity=0.400 Sum_probs=208.6
Q ss_pred hhhhhhcCccccceEEEeeecCCCceEEEEEEcccccccchHHHHHHHHHhcccCCCCcccccceeccCCceEEEEEecc
Q 003836 503 RGFKEELGRGAFGTVYKGFVNMGSSNHVAVKKLNSVFQDSEKEFKAEVNGIGQTHHKNLVRLLGYCDEGQNRLLVYEFMS 582 (792)
Q Consensus 503 ~~~~~~lG~G~~g~Vy~g~~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~lV~E~~~ 582 (792)
+.+.++||+|+||.||+|.+.. ...||||+++... ...++|.+|++++++++|+||+++++++.+ +..+|||||++
T Consensus 269 ~~~~~~lG~G~fg~Vy~~~~~~--~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hpniv~~~~~~~~-~~~~lv~e~~~ 344 (535)
T 2h8h_A 269 LRLEVKLGQGCFGEVWMGTWNG--TTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEYMS 344 (535)
T ss_dssp EEEEEEEEECSSEEEEEEEETT--TEEEEEEEECTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEECCCT
T ss_pred hhhheecccCCCeEEEEEEECC--CceEEEEEeCCCC-CCHHHHHHHHHHHHhCCCCCEeeEEEEEee-ccceEeeehhc
Confidence 3456789999999999998753 3579999997643 345789999999999999999999999976 67899999999
Q ss_pred CCCccccccCC--CCCchhHHHHHHHHHHHHHHHHhhccCCCeEecCCCCCcEEEcCCCCeEEeecCCCccccCCCCCcc
Q 003836 583 NGTVASFLFGD--SKPNWKLRTEIAMGIAGGLFYLHEECCTQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLDQSHTN 660 (792)
Q Consensus 583 ~gsL~~~l~~~--~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dikp~NILl~~~~~~kl~Dfg~a~~~~~~~~~~~ 660 (792)
+|+|.++|... ..+++..+..|+.||+.||+|||++ +|+||||||+|||+++++.+||+|||+++..........
T Consensus 345 ~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~---~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~~ 421 (535)
T 2h8h_A 345 KGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERM---NYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTAR 421 (535)
T ss_dssp TEEHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCEEECCTTSTTTCCCHHHHTT
T ss_pred CCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCCHhhEEEcCCCcEEEcccccceecCCCceecc
Confidence 99999999753 5689999999999999999999998 999999999999999999999999999987643222222
Q ss_pred ccccccCCcccccccccCCCCcccceehHHHHHHHHHh-cCcCCCcchhhhhhhhHHHHHHHhhcccchhHhhhchhccc
Q 003836 661 TAIRGTKGYVAPEWFRNMPITVKVDVYSYGVLLLEIIC-LRRNIDNEISKVDKAILTDWAYDRYQERTLEALVENDLEAM 739 (792)
Q Consensus 661 ~~~~gt~~y~aPE~~~~~~~~~k~DV~S~Gv~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 739 (792)
....++..|+|||.+....++.++|||||||+||||++ |+.||........ ...+.......
T Consensus 422 ~~~~~~~~y~aPE~~~~~~~~~~sDvwSlGv~l~el~t~g~~P~~~~~~~~~-----------------~~~i~~~~~~~ 484 (535)
T 2h8h_A 422 QGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREV-----------------LDQVERGYRMP 484 (535)
T ss_dssp CSTTSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTTCCSSTTCCHHHH-----------------HHHHHTTCCCC
T ss_pred cCCcCcccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHH-----------------HHHHHcCCCCC
Confidence 23446788999999999999999999999999999999 8999865432110 01111112222
Q ss_pred CCHHHHHHHHHHHHHccccCCCCCCCHHhHHHHhccCcCCCCC
Q 003836 740 NNVTMLHRFVMVAFWCIQEDPSHRPTMRKVTQMLEGVVEVPIP 782 (792)
Q Consensus 740 ~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~L~~~~~~~~p 782 (792)
.+...+..+.+|+.+||+.||++|||+++|+++|+.+..-..|
T Consensus 485 ~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~L~~~~~~~~~ 527 (535)
T 2h8h_A 485 CPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTSTEP 527 (535)
T ss_dssp CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSSCCCSC
T ss_pred CCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHhhccCc
Confidence 2334567788999999999999999999999999998654433
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.2e-39 Score=346.71 Aligned_cols=254 Identities=22% Similarity=0.295 Sum_probs=201.8
Q ss_pred hhhhhcCccccceEEEeeecCCCceEEEEEEccccc---ccchHHHHHHHHHhccc-CCCCcccccceeccCCceEEEEE
Q 003836 504 GFKEELGRGAFGTVYKGFVNMGSSNHVAVKKLNSVF---QDSEKEFKAEVNGIGQT-HHKNLVRLLGYCDEGQNRLLVYE 579 (792)
Q Consensus 504 ~~~~~lG~G~~g~Vy~g~~~~~~~~~vavK~~~~~~---~~~~~~~~~Ei~~l~~l-~h~niv~l~g~~~~~~~~~lV~E 579 (792)
.+.+.||+|+||.||++... .+++.||+|++.+.. ....+.+.+|+.++.++ +||||+++++++.+.+..++|||
T Consensus 12 ~~~~~lG~G~fg~V~~~~~~-~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~lv~e 90 (345)
T 3a8x_A 12 DLLRVIGRGSYAKVLLVRLK-KTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIE 90 (345)
T ss_dssp EEEEEEEECSSEEEEEEEET-TTTEEEEEEEEEGGGSCSHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEEC
T ss_pred EEEEEEEecCCeEEEEEEEC-CCCCEEEEEEEEhHHhcchHHHHHHHHHHHHHHhcCCCCccCeEEEEEEeCCEEEEEEe
Confidence 34578999999999999764 457899999997643 22345688999999987 89999999999999999999999
Q ss_pred eccCCCccccccCCCCCchhHHHHHHHHHHHHHHHHhhccCCCeEecCCCCCcEEEcCCCCeEEeecCCCccccCCCCCc
Q 003836 580 FMSNGTVASFLFGDSKPNWKLRTEIAMGIAGGLFYLHEECCTQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLDQSHT 659 (792)
Q Consensus 580 ~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dikp~NILl~~~~~~kl~Dfg~a~~~~~~~~~~ 659 (792)
|+++|+|.+++.....+++..+..++.||+.||+|||++ +|+||||||+|||++.++.+||+|||+++...... ..
T Consensus 91 ~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~g~~kL~DFG~a~~~~~~~-~~ 166 (345)
T 3a8x_A 91 YVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHER---GIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPG-DT 166 (345)
T ss_dssp CCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCGGGCBCSCCTT-CC
T ss_pred CCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCHHHEEECCCCCEEEEeccccccccCCC-Cc
Confidence 999999999998778899999999999999999999998 99999999999999999999999999998643222 22
Q ss_pred cccccccCCcccccccccCCCCcccceehHHHHHHHHHhcCcCCCcchhhhhh-hhHHHHHHHhhcccchhHhhhchhcc
Q 003836 660 NTAIRGTKGYVAPEWFRNMPITVKVDVYSYGVLLLEIICLRRNIDNEISKVDK-AILTDWAYDRYQERTLEALVENDLEA 738 (792)
Q Consensus 660 ~~~~~gt~~y~aPE~~~~~~~~~k~DV~S~Gv~l~el~tg~~p~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~ 738 (792)
.....||+.|+|||++.+..++.++|||||||++|||++|+.||......... ....... ...+.....
T Consensus 167 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~--------~~~i~~~~~-- 236 (345)
T 3a8x_A 167 TSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYL--------FQVILEKQI-- 236 (345)
T ss_dssp BCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTTTC-------CHHHH--------HHHHHHCCC--
T ss_pred ccccCCCccccCccccCCCCCChHHhHHHHHHHHHHHHhCCCCcCCcccccccccccHHHH--------HHHHHcCCC--
Confidence 34567999999999999999999999999999999999999999643211000 0000000 011111111
Q ss_pred cCCHHHHHHHHHHHHHccccCCCCCCCH------HhHHHH
Q 003836 739 MNNVTMLHRFVMVAFWCIQEDPSHRPTM------RKVTQM 772 (792)
Q Consensus 739 ~~~~~~~~~l~~l~~~Cl~~~p~~RPs~------~evl~~ 772 (792)
..+...+.++.+++.+||+.||++||++ +|+++.
T Consensus 237 ~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~~i~~h 276 (345)
T 3a8x_A 237 RIPRSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGH 276 (345)
T ss_dssp CCCTTSCHHHHHHHHHHTCSSTTTSTTCCTTTHHHHHHTS
T ss_pred CCCCCCCHHHHHHHHHHhcCCHhHCCCCCCcCCHHHHhcC
Confidence 1233455678899999999999999995 566653
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-38 Score=346.72 Aligned_cols=247 Identities=25% Similarity=0.328 Sum_probs=203.3
Q ss_pred hhhhhhcCccccceEEEeeecCCCceEEEEEEcccc---cccchHHHHHHHHHhccc-CCCCcccccceeccCCceEEEE
Q 003836 503 RGFKEELGRGAFGTVYKGFVNMGSSNHVAVKKLNSV---FQDSEKEFKAEVNGIGQT-HHKNLVRLLGYCDEGQNRLLVY 578 (792)
Q Consensus 503 ~~~~~~lG~G~~g~Vy~g~~~~~~~~~vavK~~~~~---~~~~~~~~~~Ei~~l~~l-~h~niv~l~g~~~~~~~~~lV~ 578 (792)
+.+.+.||+|+||.||++... .+++.||+|++++. .....+.+.+|..++..+ +||||+++++++.+.+..++||
T Consensus 22 y~~~~~lG~G~fg~V~~~~~~-~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~lv~ 100 (353)
T 2i0e_A 22 FNFLMVLGKGSFGKVMLSERK-GTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVM 100 (353)
T ss_dssp EEEEEEEEEETTEEEEEEEET-TEEEEEEEEEEEHHHHHHTTCHHHHHHHHHHHTCTTCCTTBCCEEEEEECSSEEEEEE
T ss_pred cEEEEEEeeCCCEEEEEEEEC-CCCCEEEEEEEEHHHhhcchHHHHHHHHHHHHHhcCCCCEEeeEEEEEEcCCEEEEEE
Confidence 345578999999999999754 55789999999754 234456788999999988 8999999999999999999999
Q ss_pred EeccCCCccccccCCCCCchhHHHHHHHHHHHHHHHHhhccCCCeEecCCCCCcEEEcCCCCeEEeecCCCccccCCCCC
Q 003836 579 EFMSNGTVASFLFGDSKPNWKLRTEIAMGIAGGLFYLHEECCTQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLDQSH 658 (792)
Q Consensus 579 E~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dikp~NILl~~~~~~kl~Dfg~a~~~~~~~~~ 658 (792)
||+++|+|.+++.....+++..+..++.||+.||.|||+. +|+||||||+|||++.++.+||+|||+++...... .
T Consensus 101 E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~---givHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~~-~ 176 (353)
T 2i0e_A 101 EYVNGGDLMYHIQQVGRFKEPHAVFYAAEIAIGLFFLQSK---GIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDG-V 176 (353)
T ss_dssp ECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCCTTCBCCCCTT-C
T ss_pred eCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---CEEeccCCHHHEEEcCCCcEEEEeCCcccccccCC-c
Confidence 9999999999998777899999999999999999999998 99999999999999999999999999998643222 2
Q ss_pred ccccccccCCcccccccccCCCCcccceehHHHHHHHHHhcCcCCCcchhhhhhhhHHHHHHHhhcccchhHhhhchhcc
Q 003836 659 TNTAIRGTKGYVAPEWFRNMPITVKVDVYSYGVLLLEIICLRRNIDNEISKVDKAILTDWAYDRYQERTLEALVENDLEA 738 (792)
Q Consensus 659 ~~~~~~gt~~y~aPE~~~~~~~~~k~DV~S~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 738 (792)
......||+.|+|||++.+..++.++|||||||++|||++|+.||........ . ..+.....
T Consensus 177 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~---~-------------~~i~~~~~-- 238 (353)
T 2i0e_A 177 TTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDEL---F-------------QSIMEHNV-- 238 (353)
T ss_dssp CBCCCCSCGGGCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH---H-------------HHHHHCCC--
T ss_pred ccccccCCccccChhhhcCCCcCCcccccchHHHHHHHHcCCCCCCCCCHHHH---H-------------HHHHhCCC--
Confidence 23456799999999999999999999999999999999999999975432111 0 11111111
Q ss_pred cCCHHHHHHHHHHHHHccccCCCCCCC-----HHhHHHH
Q 003836 739 MNNVTMLHRFVMVAFWCIQEDPSHRPT-----MRKVTQM 772 (792)
Q Consensus 739 ~~~~~~~~~l~~l~~~Cl~~~p~~RPs-----~~evl~~ 772 (792)
..+...+.++.+++.+||+.||.+||+ +++|++.
T Consensus 239 ~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~i~~h 277 (353)
T 2i0e_A 239 AYPKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKEH 277 (353)
T ss_dssp CCCTTSCHHHHHHHHHHTCSCTTSCTTCSTTHHHHHHTS
T ss_pred CCCCCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcC
Confidence 122345567889999999999999995 5777654
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9e-39 Score=347.71 Aligned_cols=245 Identities=24% Similarity=0.336 Sum_probs=187.0
Q ss_pred hhhhhcCccccceEEEeeecCCCceEEEEEEcccccccchHHHHHHHHHhcccCCCCcccccceeccCCceEEEEEeccC
Q 003836 504 GFKEELGRGAFGTVYKGFVNMGSSNHVAVKKLNSVFQDSEKEFKAEVNGIGQTHHKNLVRLLGYCDEGQNRLLVYEFMSN 583 (792)
Q Consensus 504 ~~~~~lG~G~~g~Vy~g~~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~lV~E~~~~ 583 (792)
.+.+.||+|+||.||+|... .+++.||||++.... ..+.+.+|++++++++||||+++++++.+.+..++||||+++
T Consensus 56 ~~~~~lG~G~~g~Vy~~~~~-~~~~~vavK~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~ 132 (349)
T 2w4o_A 56 EVESELGRGATSIVYRCKQK-GTQKPYALKVLKKTV--DKKIVRTEIGVLLRLSHPNIIKLKEIFETPTEISLVLELVTG 132 (349)
T ss_dssp EEEEEEEECSSEEEEEEEET-TTCCEEEEEEEEC------------CHHHHHCCCTTBCCEEEEEECSSEEEEEECCCCS
T ss_pred EEeeEEeeCCCEEEEEEEEC-CCCcEEEEEEeccch--hHHHHHHHHHHHHhCCCCCCcceeeeEecCCeEEEEEEeCCC
Confidence 34578999999999999764 456789999997642 456788999999999999999999999999999999999999
Q ss_pred CCccccccCCCCCchhHHHHHHHHHHHHHHHHhhccCCCeEecCCCCCcEEEcC---CCCeEEeecCCCccccCCCCCcc
Q 003836 584 GTVASFLFGDSKPNWKLRTEIAMGIAGGLFYLHEECCTQIIHCDIKPQNILLDD---HYNARISDFGLAKLLTLDQSHTN 660 (792)
Q Consensus 584 gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dikp~NILl~~---~~~~kl~Dfg~a~~~~~~~~~~~ 660 (792)
|+|.+++.....+++..+..++.||+.||.|||+. +|+||||||+|||++. ++.+||+|||+++..... ...
T Consensus 133 ~~L~~~l~~~~~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dikp~NIll~~~~~~~~~kl~Dfg~a~~~~~~--~~~ 207 (349)
T 2w4o_A 133 GELFDRIVEKGYYSERDAADAVKQILEAVAYLHEN---GIVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEHQ--VLM 207 (349)
T ss_dssp CBHHHHHTTCSSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEESSSSTTCCEEECCCC-------------
T ss_pred CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCcccEEEecCCCCCCEEEccCccccccCcc--ccc
Confidence 99999998888899999999999999999999998 9999999999999975 889999999999875432 222
Q ss_pred ccccccCCcccccccccCCCCcccceehHHHHHHHHHhcCcCCCcchhhhhhhhHHHHHHHhhcccchhHhhhchh--cc
Q 003836 661 TAIRGTKGYVAPEWFRNMPITVKVDVYSYGVLLLEIICLRRNIDNEISKVDKAILTDWAYDRYQERTLEALVENDL--EA 738 (792)
Q Consensus 661 ~~~~gt~~y~aPE~~~~~~~~~k~DV~S~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~ 738 (792)
....||+.|+|||.+.+..++.++|||||||++|||++|+.||........ .. . .+..... ..
T Consensus 208 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~--~~-----~--------~i~~~~~~~~~ 272 (349)
T 2w4o_A 208 KTVCGTPGYCAPEILRGCAYGPEVDMWSVGIITYILLCGFEPFYDERGDQF--MF-----R--------RILNCEYYFIS 272 (349)
T ss_dssp -----CGGGSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCTTCHHH--HH-----H--------HHHTTCCCCCT
T ss_pred ccccCCCCccCHHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCcccHH--HH-----H--------HHHhCCCccCC
Confidence 345689999999999999999999999999999999999999965432211 00 0 0111100 00
Q ss_pred cCCHHHHHHHHHHHHHccccCCCCCCCHHhHHH
Q 003836 739 MNNVTMLHRFVMVAFWCIQEDPSHRPTMRKVTQ 771 (792)
Q Consensus 739 ~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~ 771 (792)
......+.++.+++.+||+.||++|||+.|+++
T Consensus 273 ~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 305 (349)
T 2w4o_A 273 PWWDEVSLNAKDLVRKLIVLDPKKRLTTFQALQ 305 (349)
T ss_dssp TTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred chhhhCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 111234567889999999999999999999998
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-38 Score=341.41 Aligned_cols=250 Identities=22% Similarity=0.256 Sum_probs=194.7
Q ss_pred HHHHHHHHhhhhhhcCccccceEEEeeecCCCceEEEEEEcccccc--cchHHHHHHHHHhccc-CCCCcccccceeccC
Q 003836 495 YKELVEVTRGFKEELGRGAFGTVYKGFVNMGSSNHVAVKKLNSVFQ--DSEKEFKAEVNGIGQT-HHKNLVRLLGYCDEG 571 (792)
Q Consensus 495 ~~el~~~~~~~~~~lG~G~~g~Vy~g~~~~~~~~~vavK~~~~~~~--~~~~~~~~Ei~~l~~l-~h~niv~l~g~~~~~ 571 (792)
..++....+.+.++||+|+||+||+|... .+++.||||++..... .....+..|+..+.++ +|+||+++++++.++
T Consensus 51 ~~~~~~~~y~~~~~LG~G~~g~Vy~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~e~~~~~~~~~h~~iv~l~~~~~~~ 129 (311)
T 3p1a_A 51 PESFFQQSFQRLSRLGHGSYGEVFKVRSK-EDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRLEQAWEEG 129 (311)
T ss_dssp SSCHHHHHEEEEEEEEEETTEEEEEEEET-TTSCEEEEEEESSSCCSHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEET
T ss_pred ccchhhhheeeeheeccCCCeEEEEEEEC-CCCeEEEEEEecccccChHHHHHHHHHHHHHHHhcCCCcEEEEEEEEEeC
Confidence 34455556666789999999999999764 4567999999865432 2334555666666555 899999999999999
Q ss_pred CceEEEEEeccCCCccccccCC-CCCchhHHHHHHHHHHHHHHHHhhccCCCeEecCCCCCcEEEcCCCCeEEeecCCCc
Q 003836 572 QNRLLVYEFMSNGTVASFLFGD-SKPNWKLRTEIAMGIAGGLFYLHEECCTQIIHCDIKPQNILLDDHYNARISDFGLAK 650 (792)
Q Consensus 572 ~~~~lV~E~~~~gsL~~~l~~~-~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dikp~NILl~~~~~~kl~Dfg~a~ 650 (792)
+..++||||+ +++|.+++... ..+++..+..|+.||+.||+|||+. +|+||||||+|||++.++.+||+|||+++
T Consensus 130 ~~~~lv~e~~-~~~L~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dikp~NIll~~~~~~kl~DFG~a~ 205 (311)
T 3p1a_A 130 GILYLQTELC-GPSLQQHCEAWGASLPEAQVWGYLRDTLLALAHLHSQ---GLVHLDVKPANIFLGPRGRCKLGDFGLLV 205 (311)
T ss_dssp TEEEEEEECC-CCBHHHHHHHHCSCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECGGGCEEECCCTTCE
T ss_pred CEEEEEEecc-CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCCHHHEEECCCCCEEEccceeee
Confidence 9999999999 66888888654 4689999999999999999999998 99999999999999999999999999998
Q ss_pred cccCCCCCccccccccCCcccccccccCCCCcccceehHHHHHHHHHhcCcCCCcchhhhhhhhHHHHHHHhhcccchhH
Q 003836 651 LLTLDQSHTNTAIRGTKGYVAPEWFRNMPITVKVDVYSYGVLLLEIICLRRNIDNEISKVDKAILTDWAYDRYQERTLEA 730 (792)
Q Consensus 651 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DV~S~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 730 (792)
...... ......||+.|+|||++.+ .++.++|||||||++|||++|..++...... ........
T Consensus 206 ~~~~~~--~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~el~~g~~~~~~~~~~-----------~~~~~~~~-- 269 (311)
T 3p1a_A 206 ELGTAG--AGEVQEGDPRYMAPELLQG-SYGTAADVFSLGLTILEVACNMELPHGGEGW-----------QQLRQGYL-- 269 (311)
T ss_dssp ECC--------CCCCCGGGCCGGGGGT-CCSTHHHHHHHHHHHHHHHHTCCCCSSHHHH-----------HHHTTTCC--
T ss_pred ecccCC--CCcccCCCccccCHhHhcC-CCCchhhHHHHHHHHHHHHhCCCCCCCccHH-----------HHHhccCC--
Confidence 764322 2334568999999999876 7999999999999999999998776543110 01111110
Q ss_pred hhhchhcccCCHHHHHHHHHHHHHccccCCCCCCCHHhHHH
Q 003836 731 LVENDLEAMNNVTMLHRFVMVAFWCIQEDPSHRPTMRKVTQ 771 (792)
Q Consensus 731 ~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~ 771 (792)
........+.++.+++.+||+.||++|||++|+++
T Consensus 270 ------~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~ 304 (311)
T 3p1a_A 270 ------PPEFTAGLSSELRSVLVMMLEPDPKLRATAEALLA 304 (311)
T ss_dssp ------CHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred ------CcccccCCCHHHHHHHHHHcCCChhhCcCHHHHHh
Confidence 00111123467889999999999999999999997
|
| >4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-39 Score=375.95 Aligned_cols=249 Identities=29% Similarity=0.406 Sum_probs=202.7
Q ss_pred hhcCccccceEEEeeecC-CCceEEEEEEcccccc--cchHHHHHHHHHhcccCCCCcccccceeccCCceEEEEEeccC
Q 003836 507 EELGRGAFGTVYKGFVNM-GSSNHVAVKKLNSVFQ--DSEKEFKAEVNGIGQTHHKNLVRLLGYCDEGQNRLLVYEFMSN 583 (792)
Q Consensus 507 ~~lG~G~~g~Vy~g~~~~-~~~~~vavK~~~~~~~--~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~lV~E~~~~ 583 (792)
++||+|+||.||+|.+.. ..++.||||+++.... ...+++.+|++++++++|||||++++++.+ +..++||||+++
T Consensus 375 ~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~-~~~~lv~E~~~~ 453 (635)
T 4fl3_A 375 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEA-ESWMLVMEMAEL 453 (635)
T ss_dssp EEEEECSSEEEEEEEEECSSCEEEEEEEEECGGGGCGGGHHHHHHHHHHHHHCCCTTBCCEEEEEES-SSEEEEEECCTT
T ss_pred CEeccCCCEEEEEEEEcCCCcceEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEec-CCEEEEEEccCC
Confidence 469999999999996643 3457899999976433 335789999999999999999999999964 568899999999
Q ss_pred CCccccccCCCCCchhHHHHHHHHHHHHHHHHhhccCCCeEecCCCCCcEEEcCCCCeEEeecCCCccccCCCCC--ccc
Q 003836 584 GTVASFLFGDSKPNWKLRTEIAMGIAGGLFYLHEECCTQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLDQSH--TNT 661 (792)
Q Consensus 584 gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dikp~NILl~~~~~~kl~Dfg~a~~~~~~~~~--~~~ 661 (792)
|+|.+++.....+++..+..|+.||+.||+|||++ +|+||||||+||||+.++.+||+|||+++........ ...
T Consensus 454 g~L~~~l~~~~~l~~~~~~~i~~qi~~~L~yLH~~---~iiHrDLkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~ 530 (635)
T 4fl3_A 454 GPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEES---NFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQT 530 (635)
T ss_dssp EEHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETTEEEECCTTHHHHTTC---------
T ss_pred CCHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHHHC---CEeCCCCChHhEEEeCCCCEEEEEcCCccccccCcccccccc
Confidence 99999998888899999999999999999999998 9999999999999999999999999999876544322 222
Q ss_pred cccccCCcccccccccCCCCcccceehHHHHHHHHHh-cCcCCCcchhhhhhhhHHHHHHHhhcccchhHhhhchhcccC
Q 003836 662 AIRGTKGYVAPEWFRNMPITVKVDVYSYGVLLLEIIC-LRRNIDNEISKVDKAILTDWAYDRYQERTLEALVENDLEAMN 740 (792)
Q Consensus 662 ~~~gt~~y~aPE~~~~~~~~~k~DV~S~Gv~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 740 (792)
...+|+.|+|||++.+..++.++|||||||++|||++ |+.||....... +...+........
T Consensus 531 ~~~~t~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~-----------------~~~~i~~~~~~~~ 593 (635)
T 4fl3_A 531 HGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSE-----------------VTAMLEKGERMGC 593 (635)
T ss_dssp ----CGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHH-----------------HHHHHHTTCCCCC
T ss_pred CCCCceeeeChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHH-----------------HHHHHHcCCCCCC
Confidence 3456789999999999999999999999999999998 999997543221 1111122222233
Q ss_pred CHHHHHHHHHHHHHccccCCCCCCCHHhHHHHhccC
Q 003836 741 NVTMLHRFVMVAFWCIQEDPSHRPTMRKVTQMLEGV 776 (792)
Q Consensus 741 ~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~L~~~ 776 (792)
+...+.++.+++..||+.||++||++++|++.|+.+
T Consensus 594 p~~~~~~l~~li~~cl~~dP~~RPs~~~l~~~L~~~ 629 (635)
T 4fl3_A 594 PAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNY 629 (635)
T ss_dssp CTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHH
T ss_pred CCCCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHH
Confidence 444567889999999999999999999999999864
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-39 Score=347.99 Aligned_cols=258 Identities=24% Similarity=0.346 Sum_probs=207.5
Q ss_pred HhhhhhhcCccccceEEEeeecC------CCceEEEEEEcccccc-cchHHHHHHHHHhccc-CCCCcccccceeccCCc
Q 003836 502 TRGFKEELGRGAFGTVYKGFVNM------GSSNHVAVKKLNSVFQ-DSEKEFKAEVNGIGQT-HHKNLVRLLGYCDEGQN 573 (792)
Q Consensus 502 ~~~~~~~lG~G~~g~Vy~g~~~~------~~~~~vavK~~~~~~~-~~~~~~~~Ei~~l~~l-~h~niv~l~g~~~~~~~ 573 (792)
.+.+.+.||+|+||.||+|.... ..++.||||++..... ...+.+.+|+++++++ +||||+++++++.+.+.
T Consensus 36 ~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~ 115 (334)
T 2pvf_A 36 KLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGP 115 (334)
T ss_dssp GEEEEEEEEECSSCEEEEEEETTCSTTCC---CEEEEEECCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSC
T ss_pred HeEEeeEEeecCceeEEEeEeccccccccccceEEEEeeeccCCcHHHHHHHHHHHHHHHHhhcCCCEeeEEEEEccCCc
Confidence 34556889999999999997632 3456899999976432 3456789999999999 89999999999999999
Q ss_pred eEEEEEeccCCCccccccCCC----------------CCchhHHHHHHHHHHHHHHHHhhccCCCeEecCCCCCcEEEcC
Q 003836 574 RLLVYEFMSNGTVASFLFGDS----------------KPNWKLRTEIAMGIAGGLFYLHEECCTQIIHCDIKPQNILLDD 637 (792)
Q Consensus 574 ~~lV~E~~~~gsL~~~l~~~~----------------~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dikp~NILl~~ 637 (792)
.++||||+++|+|.+++.... .+++..+..++.||+.||+|||+. +|+||||||+|||++.
T Consensus 116 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~ 192 (334)
T 2pvf_A 116 LYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQ---KCIHRDLAARNVLVTE 192 (334)
T ss_dssp CEEEEECCTTCBHHHHHHTTSCTTCCSCC--------CCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECT
T ss_pred eEEEEECCCCCcHHHHHHHhccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCccceEEEcC
Confidence 999999999999999997643 378899999999999999999998 9999999999999999
Q ss_pred CCCeEEeecCCCccccCCCCC-ccccccccCCcccccccccCCCCcccceehHHHHHHHHHh-cCcCCCcchhhhhhhhH
Q 003836 638 HYNARISDFGLAKLLTLDQSH-TNTAIRGTKGYVAPEWFRNMPITVKVDVYSYGVLLLEIIC-LRRNIDNEISKVDKAIL 715 (792)
Q Consensus 638 ~~~~kl~Dfg~a~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~k~DV~S~Gv~l~el~t-g~~p~~~~~~~~~~~~~ 715 (792)
++.+||+|||+++........ ......+++.|+|||.+.+..++.++||||||+++|||++ |+.||.........
T Consensus 193 ~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~--- 269 (334)
T 2pvf_A 193 NNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELF--- 269 (334)
T ss_dssp TCCEEECCCTTCEECTTTSSEECCSCCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHH---
T ss_pred CCCEEEccccccccccccccccccCCCCcccceeChHHhcCCCcChHHHHHHHHHHHHHHHhCCCCCcCcCCHHHHH---
Confidence 999999999999876543322 2233457889999999988889999999999999999999 99998654321100
Q ss_pred HHHHHHhhcccchhHhhhchhcccCCHHHHHHHHHHHHHccccCCCCCCCHHhHHHHhccCcCC
Q 003836 716 TDWAYDRYQERTLEALVENDLEAMNNVTMLHRFVMVAFWCIQEDPSHRPTMRKVTQMLEGVVEV 779 (792)
Q Consensus 716 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~L~~~~~~ 779 (792)
..+........+...+..+.+++.+||+.+|.+|||++|+++.|++++..
T Consensus 270 --------------~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~l~~~ 319 (334)
T 2pvf_A 270 --------------KLLKEGHRMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILTL 319 (334)
T ss_dssp --------------HHHHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred --------------HHHhcCCCCCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhc
Confidence 00111111112233456788999999999999999999999999887643
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-39 Score=344.84 Aligned_cols=265 Identities=22% Similarity=0.309 Sum_probs=198.2
Q ss_pred hhhhhhcCccccceEEEeeecCCCceEEEEEEcccccc---cchHHHHHHHHHhcccCCCCcccccceeccCCc----eE
Q 003836 503 RGFKEELGRGAFGTVYKGFVNMGSSNHVAVKKLNSVFQ---DSEKEFKAEVNGIGQTHHKNLVRLLGYCDEGQN----RL 575 (792)
Q Consensus 503 ~~~~~~lG~G~~g~Vy~g~~~~~~~~~vavK~~~~~~~---~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~----~~ 575 (792)
+.+.+.||+|+||.||++... .+++.||||++..... .....+.+|++++++++||||+++++++..... .+
T Consensus 14 y~~~~~lg~G~~g~V~~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~~~ 92 (311)
T 3ork_A 14 YELGEILGFGGMSEVHLARDL-RDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPLPY 92 (311)
T ss_dssp EEEEEEEEECSSEEEEEEEET-TTTEEEEEEEECTTTTTSHHHHHHHHHHHTTCCCCCCTTBCCEEEEEEEEETTEEEEE
T ss_pred EEEEEEEccCCCEEEEEEEEC-CCCceEEEEEeCccccCCHHHHHHHHHHHHHHHcCCCCCcceEEEeeeccCCCCcccE
Confidence 345678999999999999753 4578999999976432 234578999999999999999999999876554 39
Q ss_pred EEEEeccCCCccccccCCCCCchhHHHHHHHHHHHHHHHHhhccCCCeEecCCCCCcEEEcCCCCeEEeecCCCccccCC
Q 003836 576 LVYEFMSNGTVASFLFGDSKPNWKLRTEIAMGIAGGLFYLHEECCTQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLD 655 (792)
Q Consensus 576 lV~E~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dikp~NILl~~~~~~kl~Dfg~a~~~~~~ 655 (792)
+||||+++++|.+++.....+++..+..++.||+.||+|||++ +|+||||||+|||++.++.+||+|||+++.....
T Consensus 93 lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~ 169 (311)
T 3ork_A 93 IVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNFSHQN---GIIHRDVKPANIMISATNAVKVMDFGIARAIADS 169 (311)
T ss_dssp EEEECCCEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEEETTSCEEECCCSCC------
T ss_pred EEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---CCCcCCCCHHHEEEcCCCCEEEeeccCccccccc
Confidence 9999999999999998878899999999999999999999998 9999999999999999999999999999876543
Q ss_pred CCC--ccccccccCCcccccccccCCCCcccceehHHHHHHHHHhcCcCCCcchhhhhhhhHHHHHHHhhcccchhHhhh
Q 003836 656 QSH--TNTAIRGTKGYVAPEWFRNMPITVKVDVYSYGVLLLEIICLRRNIDNEISKVDKAILTDWAYDRYQERTLEALVE 733 (792)
Q Consensus 656 ~~~--~~~~~~gt~~y~aPE~~~~~~~~~k~DV~S~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 733 (792)
... ......||+.|+|||.+.+..++.++||||||+++|||++|+.||........ ............
T Consensus 170 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~-------~~~~~~~~~~~~--- 239 (311)
T 3ork_A 170 GNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSV-------AYQHVREDPIPP--- 239 (311)
T ss_dssp ------------CCTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHH-------HHHHHHCCCCCH---
T ss_pred ccccccccccCcCcccCCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHH-------HHHHhcCCCCCc---
Confidence 222 22345689999999999999999999999999999999999999976432211 001111100000
Q ss_pred chhcccCCHHHHHHHHHHHHHccccCCCCCCCHHhHH-HHhccCcCCCCCCCC
Q 003836 734 NDLEAMNNVTMLHRFVMVAFWCIQEDPSHRPTMRKVT-QMLEGVVEVPIPPCP 785 (792)
Q Consensus 734 ~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl-~~L~~~~~~~~p~~P 785 (792)
.......+.++.+++.+||+.||++||+..+++ +.+..+.....|..|
T Consensus 240 ----~~~~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~~~~~~~~~~~ 288 (311)
T 3ork_A 240 ----SARHEGLSADLDAVVLKALAKNPENRYQTAAEMRADLVRVHNGEPPEAP 288 (311)
T ss_dssp ----HHHSTTCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHHHTTCCCSSC
T ss_pred ----ccccCCCCHHHHHHHHHHHhcCHhhChhhHHHHHHHHHHHhcCCCCCCC
Confidence 000112356788999999999999999666555 555554444444333
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-38 Score=343.81 Aligned_cols=248 Identities=22% Similarity=0.262 Sum_probs=193.9
Q ss_pred hhhhhhcCccccceEEEeeec--CCCceEEEEEEccccc----ccchHHHHHHHHHhcccCCCCcccccceeccCCceEE
Q 003836 503 RGFKEELGRGAFGTVYKGFVN--MGSSNHVAVKKLNSVF----QDSEKEFKAEVNGIGQTHHKNLVRLLGYCDEGQNRLL 576 (792)
Q Consensus 503 ~~~~~~lG~G~~g~Vy~g~~~--~~~~~~vavK~~~~~~----~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~l 576 (792)
+.+.+.||+|+||.||++... ..+++.+|+|++++.. ......+.+|+.++++++||||+++++++.+.+..++
T Consensus 19 y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~l 98 (327)
T 3a62_A 19 FELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFIVDLIYAFQTGGKLYL 98 (327)
T ss_dssp EEEEEEEEEETTEEEEEEEECSSTTTTCEEEEEEECCC--------------HHHHHHHCCCTTBCCEEEEEECSSCEEE
T ss_pred eEEEEEEEeCCCEEEEEEEEeccCCCCcEEEEEEEEHHHhhhhhhHHHHHHHHHHHHHhCCCCCccceeEEEEcCCEEEE
Confidence 345678999999999999763 2456899999997642 2234568899999999999999999999999999999
Q ss_pred EEEeccCCCccccccCCCCCchhHHHHHHHHHHHHHHHHhhccCCCeEecCCCCCcEEEcCCCCeEEeecCCCccccCCC
Q 003836 577 VYEFMSNGTVASFLFGDSKPNWKLRTEIAMGIAGGLFYLHEECCTQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLDQ 656 (792)
Q Consensus 577 V~E~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dikp~NILl~~~~~~kl~Dfg~a~~~~~~~ 656 (792)
||||+++++|.+++.....+++..+..++.||+.||.|||++ +|+||||||+|||++.++.+||+|||+++......
T Consensus 99 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~ 175 (327)
T 3a62_A 99 ILEYLSGGELFMQLEREGIFMEDTACFYLAEISMALGHLHQK---GIIYRDLKPENIMLNHQGHVKLTDFGLCKESIHDG 175 (327)
T ss_dssp EEECCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCTTTEEECTTSCEEECCCSCC-------
T ss_pred EEeCCCCCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhC---CEEcccCCHHHeEECCCCcEEEEeCCcccccccCC
Confidence 999999999999998777889999999999999999999999 99999999999999999999999999998643222
Q ss_pred CCccccccccCCcccccccccCCCCcccceehHHHHHHHHHhcCcCCCcchhhhhhhhHHHHHHHhhcccchhHhhhchh
Q 003836 657 SHTNTAIRGTKGYVAPEWFRNMPITVKVDVYSYGVLLLEIICLRRNIDNEISKVDKAILTDWAYDRYQERTLEALVENDL 736 (792)
Q Consensus 657 ~~~~~~~~gt~~y~aPE~~~~~~~~~k~DV~S~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 736 (792)
. ......||+.|+|||.+.+..++.++||||||+++|||++|+.||........ . ..+....
T Consensus 176 ~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~---~-------------~~i~~~~- 237 (327)
T 3a62_A 176 T-VTHTFCGTIEYMAPEILMRSGHNRAVDWWSLGALMYDMLTGAPPFTGENRKKT---I-------------DKILKCK- 237 (327)
T ss_dssp ----CTTSSCCTTSCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHH---H-------------HHHHHTC-
T ss_pred c-cccccCCCcCccCHhhCcCCCCCCcccchhHHHHHHHHHHCCCCCCCCCHHHH---H-------------HHHHhCC-
Confidence 2 22345689999999999999999999999999999999999999975432211 0 0111111
Q ss_pred cccCCHHHHHHHHHHHHHccccCCCCCC-----CHHhHHHH
Q 003836 737 EAMNNVTMLHRFVMVAFWCIQEDPSHRP-----TMRKVTQM 772 (792)
Q Consensus 737 ~~~~~~~~~~~l~~l~~~Cl~~~p~~RP-----s~~evl~~ 772 (792)
...+...+..+.+++.+||+.||++|| +++|+++.
T Consensus 238 -~~~p~~~~~~~~~li~~~L~~dp~~R~~~~~~~~~e~l~h 277 (327)
T 3a62_A 238 -LNLPPYLTQEARDLLKKLLKRNAASRLGAGPGDAGEVQAH 277 (327)
T ss_dssp -CCCCTTSCHHHHHHHHHHSCSCGGGSTTSSTTTHHHHHHS
T ss_pred -CCCCCCCCHHHHHHHHHHHhcCHhhccCCCCCCHHHHHcC
Confidence 112223456788999999999999999 77788764
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-39 Score=356.17 Aligned_cols=249 Identities=19% Similarity=0.211 Sum_probs=199.7
Q ss_pred hhhcCccccceEEEeeecCCCceEEEEEEccccc---ccchHHHHHHHHHhcccCCCCcccccceeccCCceEEEEEecc
Q 003836 506 KEELGRGAFGTVYKGFVNMGSSNHVAVKKLNSVF---QDSEKEFKAEVNGIGQTHHKNLVRLLGYCDEGQNRLLVYEFMS 582 (792)
Q Consensus 506 ~~~lG~G~~g~Vy~g~~~~~~~~~vavK~~~~~~---~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~lV~E~~~ 582 (792)
.++||+|+||.||++... .+++.||||++.+.. ....+.+.+|+.++.+++||||+++++++.+.+..+|||||++
T Consensus 66 ~~~lG~G~fG~V~~~~~~-~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~~~~~~lVmE~~~ 144 (412)
T 2vd5_A 66 LKVIGRGAFSEVAVVKMK-QTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQLHFAFQDENYLYLVMEYYV 144 (412)
T ss_dssp EEEEEECSSCEEEEEEET-TTCCEEEEEEEEHHHHHHHGGGCCHHHHHHHHHHSCTTTBCCEEEEEECSSEEEEEECCCC
T ss_pred EEEEeeCCCeEEEEEEEC-CCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeCCEEEEEEcCCC
Confidence 468999999999999764 467899999997532 2233458899999999999999999999999999999999999
Q ss_pred CCCccccccCC-CCCchhHHHHHHHHHHHHHHHHhhccCCCeEecCCCCCcEEEcCCCCeEEeecCCCccccCCCCCccc
Q 003836 583 NGTVASFLFGD-SKPNWKLRTEIAMGIAGGLFYLHEECCTQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLDQSHTNT 661 (792)
Q Consensus 583 ~gsL~~~l~~~-~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dikp~NILl~~~~~~kl~Dfg~a~~~~~~~~~~~~ 661 (792)
+|+|.+++.+. ..+++..+..++.||+.||+|||+. +|+||||||+|||++.++.+||+|||+++...........
T Consensus 145 gg~L~~~l~~~~~~l~~~~~~~~~~qi~~aL~~LH~~---giiHrDLKp~NILld~~g~vkL~DFGla~~~~~~~~~~~~ 221 (412)
T 2vd5_A 145 GGDLLTLLSKFGERIPAEMARFYLAEIVMAIDSVHRL---GYVHRDIKPDNILLDRCGHIRLADFGSCLKLRADGTVRSL 221 (412)
T ss_dssp SCBHHHHHHHHSSCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECCTTSCEECS
T ss_pred CCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecccCHHHeeecCCCCEEEeechhheeccCCCccccc
Confidence 99999999764 4789999999999999999999998 9999999999999999999999999999877554443344
Q ss_pred cccccCCcccccccc-------cCCCCcccceehHHHHHHHHHhcCcCCCcchhhhhhhhHHHHHHHhhcccchhHhhhc
Q 003836 662 AIRGTKGYVAPEWFR-------NMPITVKVDVYSYGVLLLEIICLRRNIDNEISKVDKAILTDWAYDRYQERTLEALVEN 734 (792)
Q Consensus 662 ~~~gt~~y~aPE~~~-------~~~~~~k~DV~S~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 734 (792)
...||+.|+|||++. ...++.++|||||||++|||++|+.||...........+..+. ..+.
T Consensus 222 ~~~Gt~~Y~APE~l~~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~---------~~~~-- 290 (412)
T 2vd5_A 222 VAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYADSTAETYGKIVHYK---------EHLS-- 290 (412)
T ss_dssp SCCSCGGGCCHHHHHHHHTCTTCSEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTHH---------HHCC--
T ss_pred eeccccCcCCHHHHhhcccCcCCCCCChHHhhhHHhHHHHHHHhCCCCCCCCCHHHHHHHHHhcc---------cCcC--
Confidence 567999999999987 3578999999999999999999999997653321111110000 0000
Q ss_pred hhcccCCHHHHHHHHHHHHHccccCCCCC---CCHHhHHHH
Q 003836 735 DLEAMNNVTMLHRFVMVAFWCIQEDPSHR---PTMRKVTQM 772 (792)
Q Consensus 735 ~~~~~~~~~~~~~l~~l~~~Cl~~~p~~R---Ps~~evl~~ 772 (792)
....+...+.++.+++.+||+ +|.+| |+++||++.
T Consensus 291 --~p~~~~~~s~~~~dli~~lL~-~p~~Rlgr~~~~ei~~H 328 (412)
T 2vd5_A 291 --LPLVDEGVPEEARDFIQRLLC-PPETRLGRGGAGDFRTH 328 (412)
T ss_dssp --CC----CCCHHHHHHHHTTSS-CGGGCTTTTTHHHHHTS
T ss_pred --CCccccCCCHHHHHHHHHHcC-ChhhcCCCCCHHHHhcC
Confidence 000112345678899999999 99998 589999875
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-38 Score=339.36 Aligned_cols=262 Identities=19% Similarity=0.231 Sum_probs=199.3
Q ss_pred hhhhhhcCccccceEEEeeecCCCceEEEEEEccccccc---chHHHHHHHHHhcccCCCCcccccceeccCCceEEEEE
Q 003836 503 RGFKEELGRGAFGTVYKGFVNMGSSNHVAVKKLNSVFQD---SEKEFKAEVNGIGQTHHKNLVRLLGYCDEGQNRLLVYE 579 (792)
Q Consensus 503 ~~~~~~lG~G~~g~Vy~g~~~~~~~~~vavK~~~~~~~~---~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~lV~E 579 (792)
+.+.+.||+|+||.||++... .+++.||+|++...... ..+.+.+|+.++++++||||+++++++.+.+..++|||
T Consensus 36 y~~~~~lg~G~~g~Vy~~~~~-~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e 114 (309)
T 2h34_A 36 YRLRRLVGRGGMGDVYEAEDT-VRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVPIHDFGEIDGQLYVDMR 114 (309)
T ss_dssp EEEEEEEEECSSSEEEEEEET-TTTEEEEEEECGGGGGGSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred EEEEEEEcCCCCeeEEEEEEc-CCCeEEEEEecCcccccCHHHHHHHHHHHHHHhhcCCCCeeEEEEEEeeCCeEEEEEE
Confidence 345678999999999999754 45689999999764322 24678999999999999999999999999999999999
Q ss_pred eccCCCccccccCCCCCchhHHHHHHHHHHHHHHHHhhccCCCeEecCCCCCcEEEcCCCCeEEeecCCCccccCCCCCc
Q 003836 580 FMSNGTVASFLFGDSKPNWKLRTEIAMGIAGGLFYLHEECCTQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLDQSHT 659 (792)
Q Consensus 580 ~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dikp~NILl~~~~~~kl~Dfg~a~~~~~~~~~~ 659 (792)
|+++++|.+++.....+++..+..++.||+.||+|||+. +|+||||||+|||++.++.+||+|||+++.........
T Consensus 115 ~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~ 191 (309)
T 2h34_A 115 LINGVDLAAMLRRQGPLAPPRAVAIVRQIGSALDAAHAA---GATHRDVKPENILVSADDFAYLVDFGIASATTDEKLTQ 191 (309)
T ss_dssp CCCCEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECSCCC-----------
T ss_pred ecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---cCCcCCCChHHEEEcCCCCEEEecCccCcccccccccc
Confidence 999999999998878899999999999999999999999 99999999999999999999999999998765443333
Q ss_pred cccccccCCcccccccccCCCCcccceehHHHHHHHHHhcCcCCCcchhhhhhhhHHHHHHHhhcccchhHhhhchhccc
Q 003836 660 NTAIRGTKGYVAPEWFRNMPITVKVDVYSYGVLLLEIICLRRNIDNEISKVDKAILTDWAYDRYQERTLEALVENDLEAM 739 (792)
Q Consensus 660 ~~~~~gt~~y~aPE~~~~~~~~~k~DV~S~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 739 (792)
.....|++.|+|||.+.+..++.++||||||+++|||++|+.||....... +. ....... . ....
T Consensus 192 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~----~~----~~~~~~~-~------~~~~ 256 (309)
T 2h34_A 192 LGNTVGTLYYMAPERFSESHATYRADIYALTCVLYECLTGSPPYQGDQLSV----MG----AHINQAI-P------RPST 256 (309)
T ss_dssp -----CCGGGCCGGGTCC----CCCHHHHHHHHHHHHHHSSCSSCSCHHHH----HH----HHHHSCC-C------CGGG
T ss_pred ccccCCCcCccCHHHHcCCCCCchHhHHHHHHHHHHHHHCCCCCCCchHHH----HH----HHhccCC-C------Cccc
Confidence 345568999999999999999999999999999999999999997643221 00 0000000 0 0011
Q ss_pred CCHHHHHHHHHHHHHccccCCCCCC-CHHhHHHHhccCcCCCCCC
Q 003836 740 NNVTMLHRFVMVAFWCIQEDPSHRP-TMRKVTQMLEGVVEVPIPP 783 (792)
Q Consensus 740 ~~~~~~~~l~~l~~~Cl~~~p~~RP-s~~evl~~L~~~~~~~~p~ 783 (792)
.....+.++.+++.+||+.||++|| +++++++.|+..+.-..+.
T Consensus 257 ~~~~~~~~l~~li~~~l~~dP~~Rp~s~~~l~~~l~~~l~~~~~~ 301 (309)
T 2h34_A 257 VRPGIPVAFDAVIARGMAKNPEDRYVTCGDLSAAAHAALATADQD 301 (309)
T ss_dssp TSTTCCTHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHTCC-----
T ss_pred cCCCCCHHHHHHHHHhccCCHHHHHHhHHHHHHHHHHHHHhhccc
Confidence 1223445788999999999999999 9999999999876655443
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-39 Score=349.13 Aligned_cols=249 Identities=21% Similarity=0.278 Sum_probs=200.7
Q ss_pred HHhhhhhhcCccccceEEEeeecCCCceEEEEEEccccc-----ccchHHHHHHHHHhcccCCCCcccccceeccCCceE
Q 003836 501 VTRGFKEELGRGAFGTVYKGFVNMGSSNHVAVKKLNSVF-----QDSEKEFKAEVNGIGQTHHKNLVRLLGYCDEGQNRL 575 (792)
Q Consensus 501 ~~~~~~~~lG~G~~g~Vy~g~~~~~~~~~vavK~~~~~~-----~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~ 575 (792)
..+.+.+.||+|+||+||++... .+++.||||++.... ....+.+.+|+.++++++||||+++++++.+.+..+
T Consensus 24 ~~y~~~~~lG~G~~g~V~~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~ 102 (351)
T 3c0i_A 24 DVYELCEVIGKGPFSVVRRCINR-ETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVELLETYSSDGMLY 102 (351)
T ss_dssp HHEEEEEEEEECSSEEEEEEEET-TTCCEEEEEEEEHHHHHTSSSCCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEE
T ss_pred cceEEeeEEeeCCCEEEEEEEEC-CCCCEEEEEEEEhhhccccccchHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEE
Confidence 45666789999999999999654 456899999986421 224678999999999999999999999999999999
Q ss_pred EEEEeccCCCccccccCC----CCCchhHHHHHHHHHHHHHHHHhhccCCCeEecCCCCCcEEEcCCCC---eEEeecCC
Q 003836 576 LVYEFMSNGTVASFLFGD----SKPNWKLRTEIAMGIAGGLFYLHEECCTQIIHCDIKPQNILLDDHYN---ARISDFGL 648 (792)
Q Consensus 576 lV~E~~~~gsL~~~l~~~----~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dikp~NILl~~~~~---~kl~Dfg~ 648 (792)
+||||+++++|.+++... ..+++..+..++.||+.||+|||++ +|+||||||+|||++.++. +||+|||+
T Consensus 103 lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~---~ivHrDlkp~NIl~~~~~~~~~vkl~Dfg~ 179 (351)
T 3c0i_A 103 MVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCHDN---NIIHRDVKPHCVLLASKENSAPVKLGGFGV 179 (351)
T ss_dssp EEEECCSSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECSSSTTCCEEECCCTT
T ss_pred EEEeCCCCCCHHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHC---CceeccCChHHeEEecCCCCCcEEEecCcc
Confidence 999999999998887543 3578999999999999999999998 9999999999999987655 99999999
Q ss_pred CccccCCCCCccccccccCCcccccccccCCCCcccceehHHHHHHHHHhcCcCCCcchhhhhhhhHHHHHHHhhcccch
Q 003836 649 AKLLTLDQSHTNTAIRGTKGYVAPEWFRNMPITVKVDVYSYGVLLLEIICLRRNIDNEISKVDKAILTDWAYDRYQERTL 728 (792)
Q Consensus 649 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DV~S~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 728 (792)
++...... .......||+.|+|||.+.+..++.++|||||||++|||++|+.||...... ....
T Consensus 180 a~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~----~~~~----------- 243 (351)
T 3c0i_A 180 AIQLGESG-LVAGGRVGTPHFMAPEVVKREPYGKPVDVWGCGVILFILLSGCLPFYGTKER----LFEG----------- 243 (351)
T ss_dssp CEECCTTS-CBCCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCSSHHH----HHHH-----------
T ss_pred eeEecCCC-eeecCCcCCcCccCHHHHcCCCCCchHhhHHHHHHHHHHHHCCCCCCCcHHH----HHHH-----------
Confidence 98765432 2233456999999999999999999999999999999999999999764221 1100
Q ss_pred hHhhhchhccc--CCHHHHHHHHHHHHHccccCCCCCCCHHhHHH
Q 003836 729 EALVENDLEAM--NNVTMLHRFVMVAFWCIQEDPSHRPTMRKVTQ 771 (792)
Q Consensus 729 ~~~~~~~~~~~--~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~ 771 (792)
+........ .....+.++.+++.+||+.||++|||+.|+++
T Consensus 244 --i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~l~ 286 (351)
T 3c0i_A 244 --IIKGKYKMNPRQWSHISESAKDLVRRMLMLDPAERITVYEALN 286 (351)
T ss_dssp --HHHTCCCCCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred --HHcCCCCCCccccccCCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence 000000000 00123467889999999999999999999986
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-38 Score=332.56 Aligned_cols=245 Identities=20% Similarity=0.303 Sum_probs=204.1
Q ss_pred HhhhhhhcCccccceEEEeeecCCCceEEEEEEcccccccchHHHHHHHHHhcccCCCCcccccceeccCCceEEEEEec
Q 003836 502 TRGFKEELGRGAFGTVYKGFVNMGSSNHVAVKKLNSVFQDSEKEFKAEVNGIGQTHHKNLVRLLGYCDEGQNRLLVYEFM 581 (792)
Q Consensus 502 ~~~~~~~lG~G~~g~Vy~g~~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~lV~E~~ 581 (792)
.+.+.+.||+|+||.||+|... .++..+|+|++........+.+.+|++++++++||||+++++++.+....++||||+
T Consensus 10 ~y~~~~~lg~G~~g~V~~~~~~-~~~~~~a~k~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 88 (277)
T 3f3z_A 10 YYTLENTIGRGSWGEVKIAVQK-GTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNIIRLYETFEDNTDIYLVMELC 88 (277)
T ss_dssp HEEEEEEEEEETTEEEEEEEET-TTCCEEEEEEEEGGGCSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEECC
T ss_pred hEEeeeEEeecCCEEEEEEEeC-CCCcEEEEEeehhhccchHHHHHHHHHHHHhCCCCCEeeEEEEEecCCeEEEEEecc
Confidence 3455678999999999999754 556789999998776667789999999999999999999999999999999999999
Q ss_pred cCCCccccccCCCCCchhHHHHHHHHHHHHHHHHhhccCCCeEecCCCCCcEEE---cCCCCeEEeecCCCccccCCCCC
Q 003836 582 SNGTVASFLFGDSKPNWKLRTEIAMGIAGGLFYLHEECCTQIIHCDIKPQNILL---DDHYNARISDFGLAKLLTLDQSH 658 (792)
Q Consensus 582 ~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dikp~NILl---~~~~~~kl~Dfg~a~~~~~~~~~ 658 (792)
++++|.+++.....+++..+..++.|++.||+|||+. +|+||||||+|||+ +.++.+||+|||++.......
T Consensus 89 ~~~~L~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~~~~~l~Dfg~~~~~~~~~-- 163 (277)
T 3f3z_A 89 TGGELFERVVHKRVFRESDAARIMKDVLSAVAYCHKL---NVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGK-- 163 (277)
T ss_dssp CSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESSSSTTCCEEECCCTTCEECCTTS--
T ss_pred CCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC---CccCCCCCHHHEEEecCCCCCcEEEEecccceeccCcc--
Confidence 9999999998888899999999999999999999998 99999999999999 788999999999998765332
Q ss_pred ccccccccCCcccccccccCCCCcccceehHHHHHHHHHhcCcCCCcchhhhhhhhHHHHHHHhhcccchhHhhhchhcc
Q 003836 659 TNTAIRGTKGYVAPEWFRNMPITVKVDVYSYGVLLLEIICLRRNIDNEISKVDKAILTDWAYDRYQERTLEALVENDLEA 738 (792)
Q Consensus 659 ~~~~~~gt~~y~aPE~~~~~~~~~k~DV~S~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 738 (792)
......||+.|+|||.+.+. ++.++||||||+++|||++|+.||.......... . +.....
T Consensus 164 ~~~~~~~t~~y~aPE~~~~~-~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~---~-------------~~~~~~-- 224 (277)
T 3f3z_A 164 MMRTKVGTPYYVSPQVLEGL-YGPECDEWSAGVMMYVLLCGYPPFSAPTDSEVML---K-------------IREGTF-- 224 (277)
T ss_dssp CBCCCCSCTTTCCHHHHTTC-BCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHH---H-------------HHHCCC--
T ss_pred chhccCCCCCccChHHhccc-CCchhhehhHHHHHHHHHHCCCCCCCCCHHHHHH---H-------------HHhCCC--
Confidence 22345689999999998654 8999999999999999999999997643221100 0 000000
Q ss_pred cCCH----HHHHHHHHHHHHccccCCCCCCCHHhHHH
Q 003836 739 MNNV----TMLHRFVMVAFWCIQEDPSHRPTMRKVTQ 771 (792)
Q Consensus 739 ~~~~----~~~~~l~~l~~~Cl~~~p~~RPs~~evl~ 771 (792)
..+. ..+..+.+++.+||+.||++|||+.|+++
T Consensus 225 ~~~~~~~~~~~~~~~~li~~~l~~dp~~R~s~~~~l~ 261 (277)
T 3f3z_A 225 TFPEKDWLNVSPQAESLIRRLLTKSPKQRITSLQALE 261 (277)
T ss_dssp CCCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHTT
T ss_pred CCCchhhhcCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 0011 23467889999999999999999999986
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-38 Score=336.55 Aligned_cols=249 Identities=27% Similarity=0.364 Sum_probs=203.6
Q ss_pred hcCccccceEEEeeec-CCCceEEEEEEccccc-ccchHHHHHHHHHhcccCCCCcccccceeccCCceEEEEEeccCCC
Q 003836 508 ELGRGAFGTVYKGFVN-MGSSNHVAVKKLNSVF-QDSEKEFKAEVNGIGQTHHKNLVRLLGYCDEGQNRLLVYEFMSNGT 585 (792)
Q Consensus 508 ~lG~G~~g~Vy~g~~~-~~~~~~vavK~~~~~~-~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~lV~E~~~~gs 585 (792)
.||+|+||.||+|... ...++.||||+++... ....+.+.+|++++++++||||+++++++ +.+..++||||+++++
T Consensus 17 ~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~-~~~~~~lv~e~~~~~~ 95 (287)
T 1u59_A 17 ELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVC-QAEALMLVMEMAGGGP 95 (287)
T ss_dssp EEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEE-ESSSEEEEEECCTTEE
T ss_pred cccccCceeEEEeEeccCCCcceEEEEecCCccchhHHHHHHHHHHHHHhCCCCCEeEEEEEe-cCCCcEEEEEeCCCCC
Confidence 7999999999999753 3456789999997643 33457799999999999999999999999 5567899999999999
Q ss_pred ccccccCC-CCCchhHHHHHHHHHHHHHHHHhhccCCCeEecCCCCCcEEEcCCCCeEEeecCCCccccCCCCCc--ccc
Q 003836 586 VASFLFGD-SKPNWKLRTEIAMGIAGGLFYLHEECCTQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLDQSHT--NTA 662 (792)
Q Consensus 586 L~~~l~~~-~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dikp~NILl~~~~~~kl~Dfg~a~~~~~~~~~~--~~~ 662 (792)
|.+++... ..+++..+..++.||+.||.|||+. +|+||||||+|||++.++.+||+|||+++......... ...
T Consensus 96 L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~ 172 (287)
T 1u59_A 96 LHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEK---NFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSA 172 (287)
T ss_dssp HHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEEETTEEEECCCTTCEECTTCSCEECCCCS
T ss_pred HHHHHHhCCccCCHHHHHHHHHHHHHHHHHHHHC---CEeeCCCchheEEEcCCCCEEECcccceeeeccCcceeecccc
Confidence 99999754 5689999999999999999999999 99999999999999999999999999998765433221 223
Q ss_pred ccccCCcccccccccCCCCcccceehHHHHHHHHHh-cCcCCCcchhhhhhhhHHHHHHHhhcccchhHhhhchhcccCC
Q 003836 663 IRGTKGYVAPEWFRNMPITVKVDVYSYGVLLLEIIC-LRRNIDNEISKVDKAILTDWAYDRYQERTLEALVENDLEAMNN 741 (792)
Q Consensus 663 ~~gt~~y~aPE~~~~~~~~~k~DV~S~Gv~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 741 (792)
..+|+.|+|||.+.+..++.++||||||+++|||++ |+.||......... ..+........+
T Consensus 173 ~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~-----------------~~i~~~~~~~~~ 235 (287)
T 1u59_A 173 GKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVM-----------------AFIEQGKRMECP 235 (287)
T ss_dssp SCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTHHHH-----------------HHHHTTCCCCCC
T ss_pred ccccccccCHHHhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCCHHHHH-----------------HHHhcCCcCCCC
Confidence 346889999999988889999999999999999998 99999654321110 011111112223
Q ss_pred HHHHHHHHHHHHHccccCCCCCCCHHhHHHHhccCc
Q 003836 742 VTMLHRFVMVAFWCIQEDPSHRPTMRKVTQMLEGVV 777 (792)
Q Consensus 742 ~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~L~~~~ 777 (792)
...+..+.+++.+||+.+|++||++.++++.|+.+.
T Consensus 236 ~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~ 271 (287)
T 1u59_A 236 PECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACY 271 (287)
T ss_dssp TTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHH
T ss_pred CCcCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHH
Confidence 345678899999999999999999999999998864
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-38 Score=358.74 Aligned_cols=247 Identities=23% Similarity=0.258 Sum_probs=194.3
Q ss_pred hhhhhhcCccccceEEEeeecCCCceEEEEEEcccc---cccchHHHHHHHHHhcccCCCCcccccceeccCCceEEEEE
Q 003836 503 RGFKEELGRGAFGTVYKGFVNMGSSNHVAVKKLNSV---FQDSEKEFKAEVNGIGQTHHKNLVRLLGYCDEGQNRLLVYE 579 (792)
Q Consensus 503 ~~~~~~lG~G~~g~Vy~g~~~~~~~~~vavK~~~~~---~~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~lV~E 579 (792)
+.+.+.||+|+||.||++.. ..+++.||||++... .......+.+|++++++++||||+++++++.+.+..++|||
T Consensus 150 y~~~~~lG~G~~g~V~~~~~-~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~lv~e 228 (446)
T 4ejn_A 150 FEYLKLLGKGTFGKVILVKE-KATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVME 228 (446)
T ss_dssp EEEEEEEEEETTEEEEEEEE-TTTCCEEEEEEEEHHHHC-------------CCCCCSCTTSCCEEEEEEETTEEEEEEC
T ss_pred cEEeEEEeeCcCEEEEEEEE-cCCCCEEEEEEEEhhhhhhhHHHHHHHHHHHHHHhCCCCeEeeEEEEEeeCCEEEEEEe
Confidence 33457899999999999975 456789999998753 23344678899999999999999999999999999999999
Q ss_pred eccCCCccccccCCCCCchhHHHHHHHHHHHHHHHHhh-ccCCCeEecCCCCCcEEEcCCCCeEEeecCCCccccCCCCC
Q 003836 580 FMSNGTVASFLFGDSKPNWKLRTEIAMGIAGGLFYLHE-ECCTQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLDQSH 658 (792)
Q Consensus 580 ~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~-~~~~~ivH~dikp~NILl~~~~~~kl~Dfg~a~~~~~~~~~ 658 (792)
|+++|+|.+++.....+++..+..++.||+.||+|||+ . +|+||||||+||||+.++.+||+|||+++...... .
T Consensus 229 ~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~---giiHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~-~ 304 (446)
T 4ejn_A 229 YANGGELFFHLSRERVFSEDRARFYGAEIVSALDYLHSEK---NVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDG-A 304 (446)
T ss_dssp CCSSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHHT---CCCCCCCCGGGEEECSSSCEEECCCCCCCTTCC----
T ss_pred eCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcC---CEEECCCCHHHEEECCCCCEEEccCCCceeccCCC-c
Confidence 99999999999887889999999999999999999998 7 99999999999999999999999999998643322 2
Q ss_pred ccccccccCCcccccccccCCCCcccceehHHHHHHHHHhcCcCCCcchhhhhhhhHHHHHHHhhcccchhHhhhchhcc
Q 003836 659 TNTAIRGTKGYVAPEWFRNMPITVKVDVYSYGVLLLEIICLRRNIDNEISKVDKAILTDWAYDRYQERTLEALVENDLEA 738 (792)
Q Consensus 659 ~~~~~~gt~~y~aPE~~~~~~~~~k~DV~S~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 738 (792)
......||+.|+|||++.+..++.++|||||||++|||++|+.||......... ..+.....
T Consensus 305 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~----------------~~i~~~~~-- 366 (446)
T 4ejn_A 305 TMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLF----------------ELILMEEI-- 366 (446)
T ss_dssp --CCSSSCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHH----------------HHHHHCCC--
T ss_pred ccccccCCccccCHhhcCCCCCCCccchhhhHHHHHHHhhCCCCCCCCCHHHHH----------------HHHHhCCC--
Confidence 234467999999999999999999999999999999999999999654322110 00111111
Q ss_pred cCCHHHHHHHHHHHHHccccCCCCCC-----CHHhHHHH
Q 003836 739 MNNVTMLHRFVMVAFWCIQEDPSHRP-----TMRKVTQM 772 (792)
Q Consensus 739 ~~~~~~~~~l~~l~~~Cl~~~p~~RP-----s~~evl~~ 772 (792)
..+...+.++.+++.+||+.||.+|| +++|+++.
T Consensus 367 ~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~t~~ell~h 405 (446)
T 4ejn_A 367 RFPRTLGPEAKSLLSGLLKKDPKQRLGGGSEDAKEIMQH 405 (446)
T ss_dssp CCCTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTS
T ss_pred CCCccCCHHHHHHHHHHcccCHHHhCCCCCCCHHHHHhC
Confidence 12223456788999999999999999 99999863
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-38 Score=339.66 Aligned_cols=250 Identities=24% Similarity=0.313 Sum_probs=204.3
Q ss_pred HhhhhhhcCccccceEEEeeecCCCceEEEEEEccccccc------chHHHHHHHHHhcccCCCCcccccceeccCCceE
Q 003836 502 TRGFKEELGRGAFGTVYKGFVNMGSSNHVAVKKLNSVFQD------SEKEFKAEVNGIGQTHHKNLVRLLGYCDEGQNRL 575 (792)
Q Consensus 502 ~~~~~~~lG~G~~g~Vy~g~~~~~~~~~vavK~~~~~~~~------~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~ 575 (792)
.+.+.+.||+|+||.||++... .+++.||+|++...... ..+.+.+|+.++++++||||+++++++.+....+
T Consensus 13 ~y~~~~~lg~G~~g~V~~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 91 (321)
T 2a2a_A 13 FYDIGEELGSGQFAIVKKCREK-STGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVITLHDVYENRTDVV 91 (321)
T ss_dssp HEEEEEEEEECSSEEEEEEEET-TTCCEEEEEEEEBCSSSSCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred cEEEeeEeeecCCEEEEEEEEC-CCCeEEEEEEEecccccccccchhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEEE
Confidence 4556789999999999999754 45679999998754322 3578999999999999999999999999999999
Q ss_pred EEEEeccCCCccccccCCCCCchhHHHHHHHHHHHHHHHHhhccCCCeEecCCCCCcEEEcCCC----CeEEeecCCCcc
Q 003836 576 LVYEFMSNGTVASFLFGDSKPNWKLRTEIAMGIAGGLFYLHEECCTQIIHCDIKPQNILLDDHY----NARISDFGLAKL 651 (792)
Q Consensus 576 lV~E~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dikp~NILl~~~~----~~kl~Dfg~a~~ 651 (792)
+||||+++++|.+++.....+++..+..++.||+.||+|||+. +|+||||||+|||++.++ .+||+|||+++.
T Consensus 92 lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~lH~~---~ivH~dikp~NIl~~~~~~~~~~~kl~Dfg~~~~ 168 (321)
T 2a2a_A 92 LILELVSGGELFDFLAQKESLSEEEATSFIKQILDGVNYLHTK---KIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHE 168 (321)
T ss_dssp EEECCCCSCBHHHHHHTCSCEEHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESCTTSSSCCEEECCCTTCEE
T ss_pred EEEEcCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCChHHEEEecCCCCcCCEEEccCcccee
Confidence 9999999999999998888899999999999999999999998 999999999999999888 799999999987
Q ss_pred ccCCCCCccccccccCCcccccccccCCCCcccceehHHHHHHHHHhcCcCCCcchhhhhhhhHHHHHHHhhcccchhHh
Q 003836 652 LTLDQSHTNTAIRGTKGYVAPEWFRNMPITVKVDVYSYGVLLLEIICLRRNIDNEISKVDKAILTDWAYDRYQERTLEAL 731 (792)
Q Consensus 652 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DV~S~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 731 (792)
..... ......||+.|+|||.+.+..++.++||||||+++|||++|+.||........ +... ....
T Consensus 169 ~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~---~~~i-----~~~~---- 234 (321)
T 2a2a_A 169 IEDGV--EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQET---LANI-----TSVS---- 234 (321)
T ss_dssp CCTTC--CCCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHH---HHHH-----HTTC----
T ss_pred cCccc--cccccCCCCCccCcccccCCCCCCccccHHHHHHHHHHHHCCCCCCCCCHHHH---HHHH-----Hhcc----
Confidence 65332 22345689999999999999999999999999999999999999975432211 0000 0000
Q ss_pred hhchhcccCCHHHHHHHHHHHHHccccCCCCCCCHHhHHH
Q 003836 732 VENDLEAMNNVTMLHRFVMVAFWCIQEDPSHRPTMRKVTQ 771 (792)
Q Consensus 732 ~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~ 771 (792)
...........+..+.+++.+||+.||++|||++|+++
T Consensus 235 --~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~ 272 (321)
T 2a2a_A 235 --YDFDEEFFSHTSELAKDFIRKLLVKETRKRLTIQEALR 272 (321)
T ss_dssp --CCCCHHHHTTCCHHHHHHHHTTSCSSTTTSCCHHHHHH
T ss_pred --cccChhhhcccCHHHHHHHHHHcCCChhhCcCHHHHhc
Confidence 00000000123456889999999999999999999998
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-38 Score=338.46 Aligned_cols=259 Identities=22% Similarity=0.338 Sum_probs=190.4
Q ss_pred hhhhhhcCccccceEEEeeecCCCceEEEEEEccccc-ccchHHHHHHHHHhcccCCCCcccccceeccCCceEEEEEec
Q 003836 503 RGFKEELGRGAFGTVYKGFVNMGSSNHVAVKKLNSVF-QDSEKEFKAEVNGIGQTHHKNLVRLLGYCDEGQNRLLVYEFM 581 (792)
Q Consensus 503 ~~~~~~lG~G~~g~Vy~g~~~~~~~~~vavK~~~~~~-~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~lV~E~~ 581 (792)
+.+.+.||+|+||+||+|.. ..+++.||+|++.... ....+.+.+|++++++++||||+++++++.+++..++||||+
T Consensus 7 y~~~~~lg~G~~g~V~~~~~-~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~ 85 (317)
T 2pmi_A 7 FKQLEKLGNGTYATVYKGLN-KTTGVYVALKEVKLDSEEGTPSTAIREISLMKELKHENIVRLYDVIHTENKLTLVFEFM 85 (317)
T ss_dssp ------------CEEEEEEC-SSSCCEEEEEEEECCSTTCSCHHHHHHHHHHTTCCBTTBCCEEEEECCTTEEEEEEECC
T ss_pred eeEeeEECCCCCEEEEEEEE-CCCCcEEEEEEeecccccccHHHHHHHHHHHHhcCCCCcceEEEEEEECCeEEEEEEec
Confidence 34567899999999999965 3457899999987543 234578899999999999999999999999999999999999
Q ss_pred cCCCccccccCC------CCCchhHHHHHHHHHHHHHHHHhhccCCCeEecCCCCCcEEEcCCCCeEEeecCCCccccCC
Q 003836 582 SNGTVASFLFGD------SKPNWKLRTEIAMGIAGGLFYLHEECCTQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLD 655 (792)
Q Consensus 582 ~~gsL~~~l~~~------~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dikp~NILl~~~~~~kl~Dfg~a~~~~~~ 655 (792)
+ |+|.+++... ..+++..+..++.||+.||+|||+. +|+||||||+|||++.++.+||+|||+++.....
T Consensus 86 ~-~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~---~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~ 161 (317)
T 2pmi_A 86 D-NDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCHEN---KILHRDLKPQNLLINKRGQLKLGDFGLARAFGIP 161 (317)
T ss_dssp C-CBHHHHHHHHHSSSCCCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCSSCEETTSC
T ss_pred C-CCHHHHHHhccccccccCCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCChHHeEEcCCCCEEECcCccceecCCC
Confidence 8 5999888543 3578999999999999999999998 9999999999999999999999999999876432
Q ss_pred CCCccccccccCCccccccccc-CCCCcccceehHHHHHHHHHhcCcCCCcchhhhhhhhHHHHHHH----hhc------
Q 003836 656 QSHTNTAIRGTKGYVAPEWFRN-MPITVKVDVYSYGVLLLEIICLRRNIDNEISKVDKAILTDWAYD----RYQ------ 724 (792)
Q Consensus 656 ~~~~~~~~~gt~~y~aPE~~~~-~~~~~k~DV~S~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~----~~~------ 724 (792)
.. ......||+.|+|||.+.+ ..++.++|||||||++|||++|+.||...........+...... .+.
T Consensus 162 ~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 240 (317)
T 2pmi_A 162 VN-TFSSEVVTLWYRAPDVLMGSRTYSTSIDIWSCGCILAEMITGKPLFPGTNDEEQLKLIFDIMGTPNESLWPSVTKLP 240 (317)
T ss_dssp CC-CCCCCCSCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCTTTCGGGGGCT
T ss_pred cc-cCCCCcccccccCchHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhHhhhhhhhh
Confidence 22 2234468999999999876 46899999999999999999999999765432211111110000 000
Q ss_pred ----------ccchhHhhhchhcccCCHHHHHHHHHHHHHccccCCCCCCCHHhHHH
Q 003836 725 ----------ERTLEALVENDLEAMNNVTMLHRFVMVAFWCIQEDPSHRPTMRKVTQ 771 (792)
Q Consensus 725 ----------~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~ 771 (792)
...+...+.+ ........++.+++.+||+.||++|||++|+++
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~l~~li~~~L~~dP~~Rpt~~e~l~ 293 (317)
T 2pmi_A 241 KYNPNIQQRPPRDLRQVLQP----HTKEPLDGNLMDFLHGLLQLNPDMRLSAKQALH 293 (317)
T ss_dssp TCCTTCCCCCCCCSHHHHGG----GCSSCCCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred hcccccccccchhHHHhhcc----cccccCCHHHHHHHHHHCCCCcccCCCHHHHhC
Confidence 0000111111 111123457899999999999999999999987
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-38 Score=338.38 Aligned_cols=255 Identities=25% Similarity=0.412 Sum_probs=199.3
Q ss_pred hhhhhcCccccceEEEeeecCC--CceEEEEEEcccccc-cchHHHHHHHHHhcccCCCCcccccceec-cCCceEEEEE
Q 003836 504 GFKEELGRGAFGTVYKGFVNMG--SSNHVAVKKLNSVFQ-DSEKEFKAEVNGIGQTHHKNLVRLLGYCD-EGQNRLLVYE 579 (792)
Q Consensus 504 ~~~~~lG~G~~g~Vy~g~~~~~--~~~~vavK~~~~~~~-~~~~~~~~Ei~~l~~l~h~niv~l~g~~~-~~~~~~lV~E 579 (792)
.+.+.||+|+||+||+|..... ....+|+|++..... ...+.+.+|+.++++++||||+++++++. .++..++|||
T Consensus 28 ~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~v~e 107 (298)
T 3f66_A 28 HFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLP 107 (298)
T ss_dssp EEEEEEEEETTEEEEEEEEC-----CEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCEEEEE
T ss_pred hhcceeeecCCceEEEEEEecCCCceeEEEEEecccCCCHHHHHHHHHHHHHHHhCCCCCEeeeeeEEEcCCCceEEEEe
Confidence 3457899999999999976432 334689999876433 34567999999999999999999999864 5567899999
Q ss_pred eccCCCccccccCC-CCCchhHHHHHHHHHHHHHHHHhhccCCCeEecCCCCCcEEEcCCCCeEEeecCCCccccCCCC-
Q 003836 580 FMSNGTVASFLFGD-SKPNWKLRTEIAMGIAGGLFYLHEECCTQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLDQS- 657 (792)
Q Consensus 580 ~~~~gsL~~~l~~~-~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dikp~NILl~~~~~~kl~Dfg~a~~~~~~~~- 657 (792)
|+++|+|.+++... ..+++..+..++.|++.||+|||+. +|+||||||+|||+++++.+||+|||+++.......
T Consensus 108 ~~~~~~L~~~l~~~~~~~~~~~~~~i~~ql~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~kl~Dfg~a~~~~~~~~~ 184 (298)
T 3f66_A 108 YMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLASK---KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYY 184 (298)
T ss_dssp CCTTCBHHHHHHCTTCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTCCEEECSCGGGCCCSCGGGC
T ss_pred CCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCchheEEECCCCCEEECcccccccccccchh
Confidence 99999999999764 5688999999999999999999998 999999999999999999999999999987644322
Q ss_pred --CccccccccCCcccccccccCCCCcccceehHHHHHHHHHhcCcC-CCcchhhhhhhhHHHHHHHhhcccchhHhhhc
Q 003836 658 --HTNTAIRGTKGYVAPEWFRNMPITVKVDVYSYGVLLLEIICLRRN-IDNEISKVDKAILTDWAYDRYQERTLEALVEN 734 (792)
Q Consensus 658 --~~~~~~~gt~~y~aPE~~~~~~~~~k~DV~S~Gv~l~el~tg~~p-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 734 (792)
.......+|+.|+|||.+.+..++.++||||||+++|||++|+.| |......... ..+..
T Consensus 185 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~~~~~~~-----------------~~~~~ 247 (298)
T 3f66_A 185 SVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDIT-----------------VYLLQ 247 (298)
T ss_dssp BC-----CCBCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTSCTTTHH-----------------HHHHT
T ss_pred ccccccCCCCCccccChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCccCCHHHHH-----------------HHHhc
Confidence 122334578899999999999999999999999999999996554 4332211100 00011
Q ss_pred hhcccCCHHHHHHHHHHHHHccccCCCCCCCHHhHHHHhccCcC
Q 003836 735 DLEAMNNVTMLHRFVMVAFWCIQEDPSHRPTMRKVTQMLEGVVE 778 (792)
Q Consensus 735 ~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~L~~~~~ 778 (792)
......+...+..+.+++.+||+.+|++|||++|++++|+.+..
T Consensus 248 ~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~~~ 291 (298)
T 3f66_A 248 GRRLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFS 291 (298)
T ss_dssp TCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred CCCCCCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHH
Confidence 11111122334678899999999999999999999999998754
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-38 Score=329.67 Aligned_cols=250 Identities=27% Similarity=0.376 Sum_probs=203.0
Q ss_pred hhhhhhcCccccceEEEeeecCCCceEEEEEEccccc-ccchHHHHHHHHHhcccCCCCcccccceeccCCceEEEEEec
Q 003836 503 RGFKEELGRGAFGTVYKGFVNMGSSNHVAVKKLNSVF-QDSEKEFKAEVNGIGQTHHKNLVRLLGYCDEGQNRLLVYEFM 581 (792)
Q Consensus 503 ~~~~~~lG~G~~g~Vy~g~~~~~~~~~vavK~~~~~~-~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~lV~E~~ 581 (792)
+.+.+.||+|+||.||++... .+++.||+|++.... ....+.+.+|+.++++++||||+++++++.+.+..++||||+
T Consensus 9 y~~~~~lg~G~~g~V~~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 87 (276)
T 2yex_A 9 WDLVQTLGEGAYGEVQLAVNR-VTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEYC 87 (276)
T ss_dssp EEEEEEEEECSSSEEEEEEET-TTCCEEEEEEEEGGGCTTHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred eEEEEEeecCCCcEEEEEEEC-CCCcEEEEEEeeeccchhhhHHHHHHHHHHHhcCCCCceeeeeEEEcCCEEEEEEEec
Confidence 445678999999999999754 456799999986533 334578999999999999999999999999999999999999
Q ss_pred cCCCccccccCCCCCchhHHHHHHHHHHHHHHHHhhccCCCeEecCCCCCcEEEcCCCCeEEeecCCCccccCCCC-Ccc
Q 003836 582 SNGTVASFLFGDSKPNWKLRTEIAMGIAGGLFYLHEECCTQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLDQS-HTN 660 (792)
Q Consensus 582 ~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dikp~NILl~~~~~~kl~Dfg~a~~~~~~~~-~~~ 660 (792)
++++|.+++.....+++..+..++.||+.||.|||+. +|+|+||||+||+++.++.+||+|||++........ ...
T Consensus 88 ~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~ 164 (276)
T 2yex_A 88 SGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGI---GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLL 164 (276)
T ss_dssp TTEEGGGGSBTTTBCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCCTTCEECEETTEECCB
T ss_pred CCCcHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCChHHEEEccCCCEEEeeCCCccccCCCcchhcc
Confidence 9999999998888899999999999999999999998 999999999999999999999999999987643322 223
Q ss_pred ccccccCCcccccccccCCC-CcccceehHHHHHHHHHhcCcCCCcchhhhhhhhHHHHHHHhhcccchhHhhhchhccc
Q 003836 661 TAIRGTKGYVAPEWFRNMPI-TVKVDVYSYGVLLLEIICLRRNIDNEISKVDKAILTDWAYDRYQERTLEALVENDLEAM 739 (792)
Q Consensus 661 ~~~~gt~~y~aPE~~~~~~~-~~k~DV~S~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 739 (792)
....|++.|+|||.+.+..+ +.++||||||+++|||++|+.||........ ....+ .... ....
T Consensus 165 ~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~--~~~~~-----~~~~--------~~~~ 229 (276)
T 2yex_A 165 NKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQ--EYSDW-----KEKK--------TYLN 229 (276)
T ss_dssp CCCCSCGGGCCGGGGTCSSBCHHHHHHHHHHHHHHHHHHSSCCCSCSCTTSH--HHHHH-----HTTC--------TTST
T ss_pred cCCccccCccChHHHhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCchHHH--HHHHh-----hhcc--------cccC
Confidence 34568999999999987665 7899999999999999999999975432211 01111 0000 0000
Q ss_pred CCHHHHHHHHHHHHHccccCCCCCCCHHhHHH
Q 003836 740 NNVTMLHRFVMVAFWCIQEDPSHRPTMRKVTQ 771 (792)
Q Consensus 740 ~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~ 771 (792)
.....+..+.+++.+||+.||++|||++|+++
T Consensus 230 ~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~ 261 (276)
T 2yex_A 230 PWKKIDSAPLALLHKILVENPSARITIPDIKK 261 (276)
T ss_dssp TGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred chhhcCHHHHHHHHHHCCCCchhCCCHHHHhc
Confidence 11123457788999999999999999999987
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.6e-39 Score=344.76 Aligned_cols=254 Identities=24% Similarity=0.358 Sum_probs=198.3
Q ss_pred hhhhhcCccccceEEEeeecCCCc---eEEEEEEcccc-cccchHHHHHHHHHhcccCCCCcccccceeccCCceEEEEE
Q 003836 504 GFKEELGRGAFGTVYKGFVNMGSS---NHVAVKKLNSV-FQDSEKEFKAEVNGIGQTHHKNLVRLLGYCDEGQNRLLVYE 579 (792)
Q Consensus 504 ~~~~~lG~G~~g~Vy~g~~~~~~~---~~vavK~~~~~-~~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~lV~E 579 (792)
.+.+.||+|+||+||+|....... ..|++|.+... .....+.+.+|+.++++++||||+++++++.... .++|+|
T Consensus 18 ~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~iK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~-~~~v~~ 96 (327)
T 3lzb_A 18 KKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTST-VQLITQ 96 (327)
T ss_dssp EEEEEEEECSSEEEEEEEECCTTCSCCEEEEEEEECCCSSCCCHHHHHHHHHHHTTCCBTTBCCCCEEEESSS-EEEEEC
T ss_pred eEEEEeeeCCCeEEEEEEEcCCCceEEEEEEEEeeccccCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEecCC-ceEEEE
Confidence 445789999999999997643222 24688877543 3445678999999999999999999999998765 789999
Q ss_pred eccCCCccccccCC-CCCchhHHHHHHHHHHHHHHHHhhccCCCeEecCCCCCcEEEcCCCCeEEeecCCCccccCCCCC
Q 003836 580 FMSNGTVASFLFGD-SKPNWKLRTEIAMGIAGGLFYLHEECCTQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLDQSH 658 (792)
Q Consensus 580 ~~~~gsL~~~l~~~-~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dikp~NILl~~~~~~kl~Dfg~a~~~~~~~~~ 658 (792)
|+++|+|.+++... ..+++..+..++.||+.||.|||+. +|+||||||+|||++.++.+||+|||+++........
T Consensus 97 ~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dikp~NIl~~~~~~~kL~DfG~a~~~~~~~~~ 173 (327)
T 3lzb_A 97 LMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKE 173 (327)
T ss_dssp CCSSCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEEETTEEEECCTTC----------
T ss_pred ecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhC---CCcCCCCCHHHEEEcCCCCEEEccCcceeEccCcccc
Confidence 99999999999764 5689999999999999999999999 9999999999999999999999999999876543322
Q ss_pred -ccccccccCCcccccccccCCCCcccceehHHHHHHHHHh-cCcCCCcchhhhhhhhHHHHHHHhhcccchhHhhhchh
Q 003836 659 -TNTAIRGTKGYVAPEWFRNMPITVKVDVYSYGVLLLEIIC-LRRNIDNEISKVDKAILTDWAYDRYQERTLEALVENDL 736 (792)
Q Consensus 659 -~~~~~~gt~~y~aPE~~~~~~~~~k~DV~S~Gv~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 736 (792)
......+|+.|+|||.+.+..++.++||||||+++|||++ |+.||....... +...+....
T Consensus 174 ~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~-----------------~~~~~~~~~ 236 (327)
T 3lzb_A 174 YHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASE-----------------ISSILEKGE 236 (327)
T ss_dssp ------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGG-----------------HHHHHHTTC
T ss_pred ccccCCCccccccCHHHHcCCCCChHHHHHHHHHHHHHHHHCCCCCCCCCCHHH-----------------HHHHHHcCC
Confidence 2223456888999999999999999999999999999999 999996543221 111122222
Q ss_pred cccCCHHHHHHHHHHHHHccccCCCCCCCHHhHHHHhccCcC
Q 003836 737 EAMNNVTMLHRFVMVAFWCIQEDPSHRPTMRKVTQMLEGVVE 778 (792)
Q Consensus 737 ~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~L~~~~~ 778 (792)
....+...+..+.+++.+||+.||.+||+++|+++.|+.+..
T Consensus 237 ~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~ 278 (327)
T 3lzb_A 237 RLPQPPICTIDVYMIMRKCWMIDADSRPKFRELIIEFSKMAR 278 (327)
T ss_dssp CCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHT
T ss_pred CCCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHh
Confidence 222233455678899999999999999999999999988754
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-38 Score=342.88 Aligned_cols=241 Identities=22% Similarity=0.307 Sum_probs=201.2
Q ss_pred HhhhhhhcCccccceEEEeeecCCCceEEEEEEcccccc--------cchHHHHHHHHHhcccCCCCcccccceeccCCc
Q 003836 502 TRGFKEELGRGAFGTVYKGFVNMGSSNHVAVKKLNSVFQ--------DSEKEFKAEVNGIGQTHHKNLVRLLGYCDEGQN 573 (792)
Q Consensus 502 ~~~~~~~lG~G~~g~Vy~g~~~~~~~~~vavK~~~~~~~--------~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~ 573 (792)
.+.+.+.||+|+||+||+|... .+++.||||++..... ...+.+.+|+.++++++||||+++++++.+.+.
T Consensus 25 ~y~~~~~lG~G~~g~Vy~a~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~ 103 (335)
T 3dls_A 25 KYSTMSPLGSGAFGFVWTAVDK-EKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANIIKVLDIFENQGF 103 (335)
T ss_dssp HEEEEEECSSSSSCSEEEEEET-TTTEEEEEEEEESTTSCTTSEEEETTTEEEEHHHHHHTTCCCTTBCCEEEEEECSSE
T ss_pred ceEEEeEEEecCCEEEEEEEEC-CCCcEEEEEEEehhhcccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEeeCCE
Confidence 3445578999999999999653 5578999999876421 133467889999999999999999999999999
Q ss_pred eEEEEEeccCC-CccccccCCCCCchhHHHHHHHHHHHHHHHHhhccCCCeEecCCCCCcEEEcCCCCeEEeecCCCccc
Q 003836 574 RLLVYEFMSNG-TVASFLFGDSKPNWKLRTEIAMGIAGGLFYLHEECCTQIIHCDIKPQNILLDDHYNARISDFGLAKLL 652 (792)
Q Consensus 574 ~~lV~E~~~~g-sL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dikp~NILl~~~~~~kl~Dfg~a~~~ 652 (792)
.++||||+.+| +|.+++.....+++..+..|+.||+.||+|||+. +|+||||||+|||++.++.+||+|||+++..
T Consensus 104 ~~lv~e~~~~g~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~~ 180 (335)
T 3dls_A 104 FQLVMEKHGSGLDLFAFIDRHPRLDEPLASYIFRQLVSAVGYLRLK---DIIHRDIKDENIVIAEDFTIKLIDFGSAAYL 180 (335)
T ss_dssp EEEEEECCTTSCBHHHHHHTCCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTSCEEECCCTTCEEC
T ss_pred EEEEEEeCCCCccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC---CeEEeccCHHHEEEcCCCcEEEeecccceEC
Confidence 99999999877 9999998888899999999999999999999999 9999999999999999999999999999876
Q ss_pred cCCCCCccccccccCCcccccccccCCC-CcccceehHHHHHHHHHhcCcCCCcchhhhhhhhHHHHHHHhhcccchhHh
Q 003836 653 TLDQSHTNTAIRGTKGYVAPEWFRNMPI-TVKVDVYSYGVLLLEIICLRRNIDNEISKVDKAILTDWAYDRYQERTLEAL 731 (792)
Q Consensus 653 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~k~DV~S~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 731 (792)
.... ......||+.|+|||.+.+..+ +.++||||||+++|||++|+.||........
T Consensus 181 ~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~-------------------- 238 (335)
T 3dls_A 181 ERGK--LFYTFCGTIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEENPFCELEETVE-------------------- 238 (335)
T ss_dssp CTTC--CBCEECSCGGGCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSCSSGGGGTT--------------------
T ss_pred CCCC--ceeccCCCccccChhhhcCCCCCCCcccchhHHHHHHHHHhCCCchhhHHHHHh--------------------
Confidence 5332 2234568999999999988776 8899999999999999999999965321100
Q ss_pred hhchhcccCCHHHHHHHHHHHHHccccCCCCCCCHHhHHHH
Q 003836 732 VENDLEAMNNVTMLHRFVMVAFWCIQEDPSHRPTMRKVTQM 772 (792)
Q Consensus 732 ~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~ 772 (792)
... ..+...+.++.+++.+||+.||++|||++|+++.
T Consensus 239 --~~~--~~~~~~~~~l~~li~~~L~~dP~~Rps~~ell~h 275 (335)
T 3dls_A 239 --AAI--HPPYLVSKELMSLVSGLLQPVPERRTTLEKLVTD 275 (335)
T ss_dssp --TCC--CCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHHC
T ss_pred --hcc--CCCcccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 000 0111234578899999999999999999999985
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-38 Score=368.99 Aligned_cols=248 Identities=27% Similarity=0.376 Sum_probs=201.1
Q ss_pred hcCccccceEEEeeecC-CCceEEEEEEccccc-ccchHHHHHHHHHhcccCCCCcccccceeccCCceEEEEEeccCCC
Q 003836 508 ELGRGAFGTVYKGFVNM-GSSNHVAVKKLNSVF-QDSEKEFKAEVNGIGQTHHKNLVRLLGYCDEGQNRLLVYEFMSNGT 585 (792)
Q Consensus 508 ~lG~G~~g~Vy~g~~~~-~~~~~vavK~~~~~~-~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~lV~E~~~~gs 585 (792)
+||+|+||.||+|.+.. ..+..||||+++... ....+++.+|++++++++|||||+++++|.. +..++||||+++|+
T Consensus 343 ~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~-~~~~lv~E~~~~g~ 421 (613)
T 2ozo_A 343 ELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EALMLVMEMAGGGP 421 (613)
T ss_dssp EEEECSSSEEEEEEEECSSCEEEEEEEECCCCCSSTTHHHHHHHHHHHTTCCCTTBCCEEEEEES-SSEEEEEECCTTCB
T ss_pred EEecCCCcEEEEEEEecCCCcEEEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEecc-CCeEEEEEeCCCCc
Confidence 69999999999997653 345689999998643 3356789999999999999999999999976 56899999999999
Q ss_pred ccccccCC-CCCchhHHHHHHHHHHHHHHHHhhccCCCeEecCCCCCcEEEcCCCCeEEeecCCCccccCCCCCcc--cc
Q 003836 586 VASFLFGD-SKPNWKLRTEIAMGIAGGLFYLHEECCTQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLDQSHTN--TA 662 (792)
Q Consensus 586 L~~~l~~~-~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dikp~NILl~~~~~~kl~Dfg~a~~~~~~~~~~~--~~ 662 (792)
|.+++... ..+++..+..|+.||+.||+|||++ +|+||||||+||||++++.+||+|||+++.......... ..
T Consensus 422 L~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~---~iiHrDlkp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~~~ 498 (613)
T 2ozo_A 422 LHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEK---NFVHRNLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSA 498 (613)
T ss_dssp HHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETTEEEECCCSTTTTCC-----------
T ss_pred HHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHC---CEEcCcCCHHHEEEcCCCcEEEeeccCcccccCCCceeeeccC
Confidence 99999765 5689999999999999999999998 999999999999999999999999999987654332221 22
Q ss_pred ccccCCcccccccccCCCCcccceehHHHHHHHHHh-cCcCCCcchhhhhhhhHHHHHHHhhcccchhHhhhchhcccCC
Q 003836 663 IRGTKGYVAPEWFRNMPITVKVDVYSYGVLLLEIIC-LRRNIDNEISKVDKAILTDWAYDRYQERTLEALVENDLEAMNN 741 (792)
Q Consensus 663 ~~gt~~y~aPE~~~~~~~~~k~DV~S~Gv~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 741 (792)
..+++.|+|||++.+..++.++|||||||++|||++ |+.||....... +...+........+
T Consensus 499 ~~~~~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~-----------------~~~~i~~~~~~~~p 561 (613)
T 2ozo_A 499 GKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPE-----------------VMAFIEQGKRMECP 561 (613)
T ss_dssp ---CCTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCSHH-----------------HHHHHHTTCCCCCC
T ss_pred CCCccceeCHhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCCHHH-----------------HHHHHHcCCCCCCC
Confidence 345689999999999999999999999999999998 999997543221 11111122222334
Q ss_pred HHHHHHHHHHHHHccccCCCCCCCHHhHHHHhccC
Q 003836 742 VTMLHRFVMVAFWCIQEDPSHRPTMRKVTQMLEGV 776 (792)
Q Consensus 742 ~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~L~~~ 776 (792)
...+.++.+++.+||+.+|++||++++|++.|+.+
T Consensus 562 ~~~~~~l~~li~~cl~~dP~~RPs~~~l~~~L~~~ 596 (613)
T 2ozo_A 562 PECPPELYALMSDCWIYKWEDRPDFLTVEQRMRAC 596 (613)
T ss_dssp TTCCHHHHHHHHHTTCSSTTTSCCHHHHHHHHHHH
T ss_pred CcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHH
Confidence 45567889999999999999999999999999875
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-38 Score=339.21 Aligned_cols=264 Identities=22% Similarity=0.263 Sum_probs=198.4
Q ss_pred hhhhhcCccccceEEEeeecCCCceEEEEEEcccccc--cchHHHHHHHHHhcccCCCCcccccceeccCCceEEEEEec
Q 003836 504 GFKEELGRGAFGTVYKGFVNMGSSNHVAVKKLNSVFQ--DSEKEFKAEVNGIGQTHHKNLVRLLGYCDEGQNRLLVYEFM 581 (792)
Q Consensus 504 ~~~~~lG~G~~g~Vy~g~~~~~~~~~vavK~~~~~~~--~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~lV~E~~ 581 (792)
.+.+.||+|+||+||++... .+++.||+|++..... ...+.+.+|++++++++||||+++++++.+.+..++||||+
T Consensus 6 ~~~~~lg~G~~g~V~~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 84 (311)
T 4agu_A 6 EKIGKIGEGSYGVVFKCRNR-DTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHPNLVNLLEVFRRKRRLHLVFEYC 84 (311)
T ss_dssp EEEEEEEECSSEEEEEEEET-TTCCEEEEEEECCCCC-HHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred eEeeEEeecCCeEEEEEEeC-CCCcEEEEEEeeccccchHHHHHHHHHHHHHHhCCCCCccchhheeecCCeEEEEEEeC
Confidence 34578999999999999754 4567999999865432 23467889999999999999999999999999999999999
Q ss_pred cCCCccccccCCCCCchhHHHHHHHHHHHHHHHHhhccCCCeEecCCCCCcEEEcCCCCeEEeecCCCccccCCCCCccc
Q 003836 582 SNGTVASFLFGDSKPNWKLRTEIAMGIAGGLFYLHEECCTQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLDQSHTNT 661 (792)
Q Consensus 582 ~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dikp~NILl~~~~~~kl~Dfg~a~~~~~~~~~~~~ 661 (792)
++++|.+++.....+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++....... ...
T Consensus 85 ~~~~l~~~~~~~~~~~~~~~~~i~~~l~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~-~~~ 160 (311)
T 4agu_A 85 DHTVLHELDRYQRGVPEHLVKSITWQTLQAVNFCHKH---NCIHRDVKPENILITKHSVIKLCDFGFARLLTGPSD-YYD 160 (311)
T ss_dssp SEEHHHHHHHTSSCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECC--------
T ss_pred CCchHHHHHhhhcCCCHHHHHHHHHHHHHHHHHHHHC---CCcCCCCChhhEEEcCCCCEEEeeCCCchhccCccc-ccC
Confidence 9999999998878899999999999999999999999 999999999999999999999999999987653322 223
Q ss_pred cccccCCccccccccc-CCCCcccceehHHHHHHHHHhcCcCCCcchhhhhhhhHHHHH-------HHhhcccc-hhHhh
Q 003836 662 AIRGTKGYVAPEWFRN-MPITVKVDVYSYGVLLLEIICLRRNIDNEISKVDKAILTDWA-------YDRYQERT-LEALV 732 (792)
Q Consensus 662 ~~~gt~~y~aPE~~~~-~~~~~k~DV~S~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~-------~~~~~~~~-~~~~~ 732 (792)
...||+.|+|||.+.+ ..++.++||||||+++|||++|+.||................ ...+.... .....
T Consensus 161 ~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (311)
T 4agu_A 161 DEVATRWYRSPELLVGDTQYGPPVDVWAIGCVFAELLSGVPLWPGKSDVDQLYLIRKTLGDLIPRHQQVFSTNQYFSGVK 240 (311)
T ss_dssp -----GGGCCHHHHHTCSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHHHHTCGGGTTCC
T ss_pred CCcCCccccChHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhcccccccccccccccccccCc
Confidence 4468999999999876 678999999999999999999999997654332211111000 00000000 00000
Q ss_pred hchhcccC-----CHHHHHHHHHHHHHccccCCCCCCCHHhHHHH
Q 003836 733 ENDLEAMN-----NVTMLHRFVMVAFWCIQEDPSHRPTMRKVTQM 772 (792)
Q Consensus 733 ~~~~~~~~-----~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~ 772 (792)
.+...... ....+..+.+++.+||+.||++|||++|+++.
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 285 (311)
T 4agu_A 241 IPDPEDMEPLELKFPNISYPALGLLKGCLHMDPTERLTCEQLLHH 285 (311)
T ss_dssp CCCCSSCCCHHHHCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHTS
T ss_pred CCCccccchhhhhcccccHHHHHHHHHHccCChhhcCCHHHHhcC
Confidence 00000000 01245668899999999999999999999974
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-39 Score=344.35 Aligned_cols=256 Identities=25% Similarity=0.366 Sum_probs=205.6
Q ss_pred hhhhhhcCccccceEEEeeec----CCCceEEEEEEcccccc-cchHHHHHHHHHhccc-CCCCcccccceeccCC-ceE
Q 003836 503 RGFKEELGRGAFGTVYKGFVN----MGSSNHVAVKKLNSVFQ-DSEKEFKAEVNGIGQT-HHKNLVRLLGYCDEGQ-NRL 575 (792)
Q Consensus 503 ~~~~~~lG~G~~g~Vy~g~~~----~~~~~~vavK~~~~~~~-~~~~~~~~Ei~~l~~l-~h~niv~l~g~~~~~~-~~~ 575 (792)
+.+.+.||+|+||+||+|... ..+++.||||++..... ...+.+.+|++++.++ +||||+++++++.+.+ ..+
T Consensus 29 y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~~ 108 (316)
T 2xir_A 29 LKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLM 108 (316)
T ss_dssp EEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECCTTSCCE
T ss_pred eeeeeEEcCCCceeEEEEEEecCCccccceEEEEEecccCCCcHHHHHHHHHHHHHHhcccCCCeeeEEEEEecCCCceE
Confidence 345578999999999999752 34568999999976433 3346789999999999 7999999999987655 589
Q ss_pred EEEEeccCCCccccccCCCC----------------CchhHHHHHHHHHHHHHHHHhhccCCCeEecCCCCCcEEEcCCC
Q 003836 576 LVYEFMSNGTVASFLFGDSK----------------PNWKLRTEIAMGIAGGLFYLHEECCTQIIHCDIKPQNILLDDHY 639 (792)
Q Consensus 576 lV~E~~~~gsL~~~l~~~~~----------------l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dikp~NILl~~~~ 639 (792)
+||||+++|+|.+++..... +++..+..++.||+.||.|||+. +|+||||||+|||++.++
T Consensus 109 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~---~i~H~dikp~Nil~~~~~ 185 (316)
T 2xir_A 109 VIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASR---KCIHRDLAARNILLSEKN 185 (316)
T ss_dssp EEEECCTTEEHHHHHHTCTTSEECC-------CTTCEEHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGG
T ss_pred EEEEcCCCCcHHHHHHhcccccccccccchhhhccccCHHHHHHHHHHHHHHHHHHHhC---CcccccCccceEEECCCC
Confidence 99999999999999976543 78999999999999999999998 999999999999999999
Q ss_pred CeEEeecCCCccccCCCCC-ccccccccCCcccccccccCCCCcccceehHHHHHHHHHh-cCcCCCcchhhhhhhhHHH
Q 003836 640 NARISDFGLAKLLTLDQSH-TNTAIRGTKGYVAPEWFRNMPITVKVDVYSYGVLLLEIIC-LRRNIDNEISKVDKAILTD 717 (792)
Q Consensus 640 ~~kl~Dfg~a~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~k~DV~S~Gv~l~el~t-g~~p~~~~~~~~~~~~~~~ 717 (792)
.+||+|||+++........ ......+|+.|+|||.+.+..++.++||||||+++|||++ |+.||........ ..
T Consensus 186 ~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~~--~~-- 261 (316)
T 2xir_A 186 VVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEE--FC-- 261 (316)
T ss_dssp CEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCCSHH--HH--
T ss_pred CEEECCCccccccccCccceeccCCCcceeecCchhhccccccchhHHHHHHHHHHHHHhCCCCCCcccchhHH--HH--
Confidence 9999999999876543332 2234567889999999999999999999999999999998 9999865432111 00
Q ss_pred HHHHhhcccchhHhhhchhcccCCHHHHHHHHHHHHHccccCCCCCCCHHhHHHHhccCc
Q 003836 718 WAYDRYQERTLEALVENDLEAMNNVTMLHRFVMVAFWCIQEDPSHRPTMRKVTQMLEGVV 777 (792)
Q Consensus 718 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~L~~~~ 777 (792)
..+........+...+..+.+++.+||+.||.+|||++|+++.|+.++
T Consensus 262 ------------~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~ 309 (316)
T 2xir_A 262 ------------RRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLL 309 (316)
T ss_dssp ------------HHHHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred ------------HHhccCccCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHH
Confidence 001111111122234567889999999999999999999999998765
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-38 Score=341.95 Aligned_cols=256 Identities=24% Similarity=0.384 Sum_probs=206.1
Q ss_pred hhhhhhcCccccceEEEeeecC----CCceEEEEEEcccccc-cchHHHHHHHHHhcccCCCCcccccceeccCCceEEE
Q 003836 503 RGFKEELGRGAFGTVYKGFVNM----GSSNHVAVKKLNSVFQ-DSEKEFKAEVNGIGQTHHKNLVRLLGYCDEGQNRLLV 577 (792)
Q Consensus 503 ~~~~~~lG~G~~g~Vy~g~~~~----~~~~~vavK~~~~~~~-~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~lV 577 (792)
+.+.+.||+|+||.||+|.... ..++.||+|++..... .....+.+|++++++++||||+++++++.+.+..++|
T Consensus 27 y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv 106 (322)
T 1p4o_A 27 ITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVI 106 (322)
T ss_dssp EEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEEECSSSSCEEE
T ss_pred eeeeeEeccCCceEEEeeeecCccCCCCceEEEEEecccccCHHHHHHHHHHHHHHHhcCCCCEeeeEEEEccCCccEEE
Confidence 4456789999999999997542 3457899999975433 3345789999999999999999999999999999999
Q ss_pred EEeccCCCccccccCC----------CCCchhHHHHHHHHHHHHHHHHhhccCCCeEecCCCCCcEEEcCCCCeEEeecC
Q 003836 578 YEFMSNGTVASFLFGD----------SKPNWKLRTEIAMGIAGGLFYLHEECCTQIIHCDIKPQNILLDDHYNARISDFG 647 (792)
Q Consensus 578 ~E~~~~gsL~~~l~~~----------~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dikp~NILl~~~~~~kl~Dfg 647 (792)
|||+++|+|.+++... ..+++..+..++.||+.||.|||++ +|+||||||+|||++.++.+||+|||
T Consensus 107 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dikp~NIli~~~~~~kl~Dfg 183 (322)
T 1p4o_A 107 MELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFG 183 (322)
T ss_dssp EECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHT---TCBCSCCSGGGEEECTTCCEEECCTT
T ss_pred EEeCCCCcHHHHHHHhchhhccCCCCCCcCHHHHHHHHHHHHHHHHHHHHC---CCccCCCccceEEEcCCCeEEECcCc
Confidence 9999999999998642 3468899999999999999999999 99999999999999999999999999
Q ss_pred CCccccCCCCC-ccccccccCCcccccccccCCCCcccceehHHHHHHHHHh-cCcCCCcchhhhhhhhHHHHHHHhhcc
Q 003836 648 LAKLLTLDQSH-TNTAIRGTKGYVAPEWFRNMPITVKVDVYSYGVLLLEIIC-LRRNIDNEISKVDKAILTDWAYDRYQE 725 (792)
Q Consensus 648 ~a~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~k~DV~S~Gv~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~ 725 (792)
+++........ ......+|+.|+|||.+.+..++.++||||||+++|||++ |+.||......... .
T Consensus 184 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~--------~---- 251 (322)
T 1p4o_A 184 MTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVL--------R---- 251 (322)
T ss_dssp CCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCHHHHH--------H----
T ss_pred cccccccccccccccCCCCCCCccChhhhccCCCCchhhHHHHHHHHHHHHhcCCCccccCCHHHHH--------H----
Confidence 99866433221 1223456889999999999999999999999999999999 78888654221100 0
Q ss_pred cchhHhhhchhcccCCHHHHHHHHHHHHHccccCCCCCCCHHhHHHHhccCcC
Q 003836 726 RTLEALVENDLEAMNNVTMLHRFVMVAFWCIQEDPSHRPTMRKVTQMLEGVVE 778 (792)
Q Consensus 726 ~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~L~~~~~ 778 (792)
.+... .....+...+..+.+++.+||+.||++|||+.|+++.|+++++
T Consensus 252 ----~~~~~-~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~e~l~~L~~~~~ 299 (322)
T 1p4o_A 252 ----FVMEG-GLLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEME 299 (322)
T ss_dssp ----HHHTT-CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGGSC
T ss_pred ----HHHcC-CcCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHhhc
Confidence 00000 0111223345678899999999999999999999999988654
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-38 Score=337.24 Aligned_cols=252 Identities=28% Similarity=0.390 Sum_probs=203.6
Q ss_pred hhh-hcCccccceEEEeeec-CCCceEEEEEEcccccc--cchHHHHHHHHHhcccCCCCcccccceeccCCceEEEEEe
Q 003836 505 FKE-ELGRGAFGTVYKGFVN-MGSSNHVAVKKLNSVFQ--DSEKEFKAEVNGIGQTHHKNLVRLLGYCDEGQNRLLVYEF 580 (792)
Q Consensus 505 ~~~-~lG~G~~g~Vy~g~~~-~~~~~~vavK~~~~~~~--~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~lV~E~ 580 (792)
+.+ .||+|+||+||+|... ...++.||||++..... ...+++.+|++++++++||||+++++++ +.+..++||||
T Consensus 20 ~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-~~~~~~lv~e~ 98 (291)
T 1xbb_A 20 LEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGIC-EAESWMLVMEM 98 (291)
T ss_dssp EEEEEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEE-ESSSEEEEEEC
T ss_pred hccCccccccCeeeEeeeecCCCceeeEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEE-CCCCcEEEEEe
Confidence 344 8999999999999653 34467899999975432 2357899999999999999999999999 56778999999
Q ss_pred ccCCCccccccCCCCCchhHHHHHHHHHHHHHHHHhhccCCCeEecCCCCCcEEEcCCCCeEEeecCCCccccCCCCCc-
Q 003836 581 MSNGTVASFLFGDSKPNWKLRTEIAMGIAGGLFYLHEECCTQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLDQSHT- 659 (792)
Q Consensus 581 ~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dikp~NILl~~~~~~kl~Dfg~a~~~~~~~~~~- 659 (792)
+++++|.+++.....+++..+..++.||+.||+|||+. +|+||||||+|||++.++.+||+|||+++.........
T Consensus 99 ~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~---~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~ 175 (291)
T 1xbb_A 99 AELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEES---NFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYK 175 (291)
T ss_dssp CTTEEHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEEETTEEEECCCTTCEECCTTCSEEE
T ss_pred CCCCCHHHHHHhCcCCCHHHHHHHHHHHHHHHHHHHhC---CeEcCCCCcceEEEeCCCcEEEccCCcceeeccCCCccc
Confidence 99999999998888899999999999999999999999 99999999999999999999999999998765443322
Q ss_pred -cccccccCCcccccccccCCCCcccceehHHHHHHHHHh-cCcCCCcchhhhhhhhHHHHHHHhhcccchhHhhhchhc
Q 003836 660 -NTAIRGTKGYVAPEWFRNMPITVKVDVYSYGVLLLEIIC-LRRNIDNEISKVDKAILTDWAYDRYQERTLEALVENDLE 737 (792)
Q Consensus 660 -~~~~~gt~~y~aPE~~~~~~~~~k~DV~S~Gv~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 737 (792)
.....+++.|+|||.+.+..++.++||||||+++|||++ |+.||........ ...+.....
T Consensus 176 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~-----------------~~~~~~~~~ 238 (291)
T 1xbb_A 176 AQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEV-----------------TAMLEKGER 238 (291)
T ss_dssp C----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHH-----------------HHHHHTTCC
T ss_pred ccccCCCCceeeChHHhccCCCChhhhHHHHHHHHHHHHhcCCCCCCCCCHHHH-----------------HHHHHcCCC
Confidence 122346788999999998889999999999999999999 9999975432110 011111111
Q ss_pred ccCCHHHHHHHHHHHHHccccCCCCCCCHHhHHHHhccCc
Q 003836 738 AMNNVTMLHRFVMVAFWCIQEDPSHRPTMRKVTQMLEGVV 777 (792)
Q Consensus 738 ~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~L~~~~ 777 (792)
...+...+..+.+++.+||+.||++||++.++++.|+++.
T Consensus 239 ~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~ 278 (291)
T 1xbb_A 239 MGCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYY 278 (291)
T ss_dssp CCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHH
T ss_pred CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHH
Confidence 2223345677899999999999999999999999998764
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=7.9e-39 Score=338.86 Aligned_cols=257 Identities=28% Similarity=0.435 Sum_probs=192.5
Q ss_pred HHhhhhhhcCccccceEEEeeecCCCceEEEEEEccccc--ccchHHHHHHHHHhcccCCCCcccccceeccCCceEEEE
Q 003836 501 VTRGFKEELGRGAFGTVYKGFVNMGSSNHVAVKKLNSVF--QDSEKEFKAEVNGIGQTHHKNLVRLLGYCDEGQNRLLVY 578 (792)
Q Consensus 501 ~~~~~~~~lG~G~~g~Vy~g~~~~~~~~~vavK~~~~~~--~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~lV~ 578 (792)
..+.+.+.||+|+||+||+|+.. ..+|+|+++... ....+.+.+|++++++++|+||+++++++ .....++||
T Consensus 24 ~~y~~~~~lG~G~~g~Vy~~~~~----~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-~~~~~~lv~ 98 (289)
T 3og7_A 24 GQITVGQRIGSGSFGTVYKGKWH----GDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS-TAPQLAIVT 98 (289)
T ss_dssp TSCEEEEEEEECSSEEEEEEESS----SEEEEEEESCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEE-CSSSCEEEE
T ss_pred cceeeeeEecCCCCeEEEEEEEc----CceEEEEEeccCCCHHHHHHHHHHHHHHHhCCCCcEEEEEeec-cCCccEEEE
Confidence 34456688999999999999753 359999987543 33456799999999999999999999966 455689999
Q ss_pred EeccCCCccccccCC-CCCchhHHHHHHHHHHHHHHHHhhccCCCeEecCCCCCcEEEcCCCCeEEeecCCCccccCCC-
Q 003836 579 EFMSNGTVASFLFGD-SKPNWKLRTEIAMGIAGGLFYLHEECCTQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLDQ- 656 (792)
Q Consensus 579 E~~~~gsL~~~l~~~-~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dikp~NILl~~~~~~kl~Dfg~a~~~~~~~- 656 (792)
||+++++|.+++... ..+++..+..++.||+.||+|||+. +|+||||||+|||++.++.+||+|||+++......
T Consensus 99 e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~lH~~---~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~ 175 (289)
T 3og7_A 99 QWCEGSSLYHHLHASETKFEMKKLIDIARQTARGMDYLHAK---SIIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSG 175 (289)
T ss_dssp ECCCEEEHHHHHTTC---CCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEETTTEEEECCCC----------
T ss_pred EecCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhC---CcccccCccceEEECCCCCEEEccceeccccccccc
Confidence 999999999999654 5689999999999999999999998 99999999999999999999999999998654322
Q ss_pred CCccccccccCCcccccccc---cCCCCcccceehHHHHHHHHHhcCcCCCcchhhhhhhhHHHHHHHhhcccchhHhhh
Q 003836 657 SHTNTAIRGTKGYVAPEWFR---NMPITVKVDVYSYGVLLLEIICLRRNIDNEISKVDKAILTDWAYDRYQERTLEALVE 733 (792)
Q Consensus 657 ~~~~~~~~gt~~y~aPE~~~---~~~~~~k~DV~S~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 733 (792)
........||+.|+|||.+. +..++.++||||||+++|||++|+.||......... ...... ... .
T Consensus 176 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~---~~~~~~----~~~----~ 244 (289)
T 3og7_A 176 SHQFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQI---IEMVGR----GSL----S 244 (289)
T ss_dssp --------CCCTTCCHHHHC----CCSCHHHHHHHHHHHHHHHHHSSCTTSSCCCHHHH---HHHHHH----TSC----C
T ss_pred cccccccCCCccccCchhhcccCCCCCCcccchHHHHHHHHHHHHCCCCccccchHHHH---HHHhcc----ccc----C
Confidence 22233456899999999986 567899999999999999999999999754322110 000000 000 0
Q ss_pred chhcccCCHHHHHHHHHHHHHccccCCCCCCCHHhHHHHhccCc
Q 003836 734 NDLEAMNNVTMLHRFVMVAFWCIQEDPSHRPTMRKVTQMLEGVV 777 (792)
Q Consensus 734 ~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~L~~~~ 777 (792)
+.. .......+..+.+++.+||+.+|++|||++|++++|+++.
T Consensus 245 ~~~-~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~l~ 287 (289)
T 3og7_A 245 PDL-SKVRSNCPKRMKRLMAECLKKKRDERPSFPRILAEIEELA 287 (289)
T ss_dssp CCT-TSSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTT
T ss_pred cch-hhccccCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHh
Confidence 000 0112234567899999999999999999999999999875
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-38 Score=350.48 Aligned_cols=266 Identities=16% Similarity=0.158 Sum_probs=200.5
Q ss_pred hhhhhhcCcc--ccceEEEeeecCCCceEEEEEEccccc--ccchHHHHHHHHHhcccCCCCcccccceeccCCceEEEE
Q 003836 503 RGFKEELGRG--AFGTVYKGFVNMGSSNHVAVKKLNSVF--QDSEKEFKAEVNGIGQTHHKNLVRLLGYCDEGQNRLLVY 578 (792)
Q Consensus 503 ~~~~~~lG~G--~~g~Vy~g~~~~~~~~~vavK~~~~~~--~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~lV~ 578 (792)
+.+.++||+| +||+||++... .+++.||||++.... ....+.+.+|+.++++++||||+++++++.+.+..++||
T Consensus 27 y~~~~~lG~G~~~~g~V~~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 105 (389)
T 3gni_B 27 YELLTVIGKGFEDLMTVNLARYK-PTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVT 105 (389)
T ss_dssp EEEEEEEEEETTTTEEEEEEEET-TTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred EEEEecccCCcCCceEEEEEEEc-CCCCEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCCCcEeEEEEECCEEEEEE
Confidence 4456789999 99999999754 457899999997543 333467889999999999999999999999999999999
Q ss_pred EeccCCCccccccCC--CCCchhHHHHHHHHHHHHHHHHhhccCCCeEecCCCCCcEEEcCCCCeEEeecCCCccccCCC
Q 003836 579 EFMSNGTVASFLFGD--SKPNWKLRTEIAMGIAGGLFYLHEECCTQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLDQ 656 (792)
Q Consensus 579 E~~~~gsL~~~l~~~--~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dikp~NILl~~~~~~kl~Dfg~a~~~~~~~ 656 (792)
||+++|+|.+++... ..+++..+..++.||+.||+|||+. +|+||||||+|||++.++.+||+|||.+.......
T Consensus 106 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~---~ivHrDlkp~NIll~~~~~~kl~dfg~~~~~~~~~ 182 (389)
T 3gni_B 106 SFMAYGSAKDLICTHFMDGMNELAIAYILQGVLKALDYIHHM---GYVHRSVKASHILISVDGKVYLSGLRSNLSMISHG 182 (389)
T ss_dssp ECCTTCBHHHHHHHTCTTCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECCGGGCEECEETT
T ss_pred EccCCCCHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEcccccceeecccc
Confidence 999999999999765 6789999999999999999999999 99999999999999999999999999987543221
Q ss_pred C------CccccccccCCccccccccc--CCCCcccceehHHHHHHHHHhcCcCCCcchhhhhhhhHHHHHHHhh-----
Q 003836 657 S------HTNTAIRGTKGYVAPEWFRN--MPITVKVDVYSYGVLLLEIICLRRNIDNEISKVDKAILTDWAYDRY----- 723 (792)
Q Consensus 657 ~------~~~~~~~gt~~y~aPE~~~~--~~~~~k~DV~S~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~----- 723 (792)
. .......||+.|+|||.+.+ ..++.++|||||||++|||++|+.||....................
T Consensus 183 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 262 (389)
T 3gni_B 183 QRQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLNGTVPCLLDTST 262 (389)
T ss_dssp EECSCBCCCCTTCTTTGGGSCHHHHSTTSSCBCTHHHHHHHHHHHHHHHHSSCTTTTCCSTTHHHHC-------------
T ss_pred ccccccccccccccccccccCHHHHhccCCCCCcHhHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHhcCCCCccccccc
Confidence 1 11223468999999999987 6799999999999999999999999965432211100000000000
Q ss_pred -cc-------------cchhHhhh---------chhcccCCHHHHHHHHHHHHHccccCCCCCCCHHhHHHH
Q 003836 724 -QE-------------RTLEALVE---------NDLEAMNNVTMLHRFVMVAFWCIQEDPSHRPTMRKVTQM 772 (792)
Q Consensus 724 -~~-------------~~~~~~~~---------~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~ 772 (792)
.. ........ ...........+..+.+|+.+||+.||++|||++|+++.
T Consensus 263 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~ell~h 334 (389)
T 3gni_B 263 IPAEELTMSPSRSVANSGLSDSLTTSTPRPSNGDSPSHPYHRTFSPHFHHFVEQCLQRNPDARPSASTLLNH 334 (389)
T ss_dssp -------------------------------------------CCHHHHHHHHHHTCSCTTTSCCHHHHTTS
T ss_pred cccccccccccccccccccccccccCccccccCCCCCCccccccCHHHHHHHHHHhhcCcccCCCHHHHhcC
Confidence 00 00000000 000001123345678999999999999999999999865
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-38 Score=337.97 Aligned_cols=264 Identities=23% Similarity=0.273 Sum_probs=198.3
Q ss_pred HHHhhhhhhcCccccceEEEeeecCCCceEEEEEEccccc-----ccchHHHHHHHHHhcccC---CCCcccccceeccC
Q 003836 500 EVTRGFKEELGRGAFGTVYKGFVNMGSSNHVAVKKLNSVF-----QDSEKEFKAEVNGIGQTH---HKNLVRLLGYCDEG 571 (792)
Q Consensus 500 ~~~~~~~~~lG~G~~g~Vy~g~~~~~~~~~vavK~~~~~~-----~~~~~~~~~Ei~~l~~l~---h~niv~l~g~~~~~ 571 (792)
...+.+.+.||+|+||+||+|.. ..+++.||||++.... ......+.+|+.++++++ ||||+++++++...
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~niv~~~~~~~~~ 86 (308)
T 3g33_A 8 TSRYEPVAEIGVGAYGTVYKARD-PHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPNVVRLMDVCATS 86 (308)
T ss_dssp --CCEEEEEECCSSSCCEEEEEC-TTTCCEEEEEEEEEECCCTTSSCCCHHHHHHHHHHHHHHHHCCTTBCCEEEEEEEC
T ss_pred ccceEEEEEEecCCCeEEEEEEE-CCCCcEEEEEEEecccccccccccchhHHHHHHHHHHHhhcCCCCeEEeeeeeecc
Confidence 34455678899999999999974 3457899999987432 122456778888877775 99999999999765
Q ss_pred C-----ceEEEEEeccCCCccccccCCCC--CchhHHHHHHHHHHHHHHHHhhccCCCeEecCCCCCcEEEcCCCCeEEe
Q 003836 572 Q-----NRLLVYEFMSNGTVASFLFGDSK--PNWKLRTEIAMGIAGGLFYLHEECCTQIIHCDIKPQNILLDDHYNARIS 644 (792)
Q Consensus 572 ~-----~~~lV~E~~~~gsL~~~l~~~~~--l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dikp~NILl~~~~~~kl~ 644 (792)
. ..++||||++ ++|.+++..... +++..+..++.||+.||+|||++ +|+||||||+|||++.++.+||+
T Consensus 87 ~~~~~~~~~lv~e~~~-~~L~~~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dlkp~Nil~~~~~~~kl~ 162 (308)
T 3g33_A 87 RTDREIKVTLVFEHVD-QDLRTYLDKAPPPGLPAETIKDLMRQFLRGLDFLHAN---CIVHRDLKPENILVTSGGTVKLA 162 (308)
T ss_dssp CSSSEEEEEEEEECCC-CBHHHHHHTCCTTCSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCTTTEEECTTSCEEEC
T ss_pred CCCCceeEEEEehhhh-cCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEcCCCCEEEe
Confidence 5 4789999997 599999977643 89999999999999999999999 99999999999999999999999
Q ss_pred ecCCCccccCCCCCccccccccCCcccccccccCCCCcccceehHHHHHHHHHhcCcCCCcchhhhhhhhHHHHHHHhhc
Q 003836 645 DFGLAKLLTLDQSHTNTAIRGTKGYVAPEWFRNMPITVKVDVYSYGVLLLEIICLRRNIDNEISKVDKAILTDWAYDRYQ 724 (792)
Q Consensus 645 Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DV~S~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~ 724 (792)
|||+++..... .......||+.|+|||.+.+..++.++|||||||++|||++|+.||...........+.... ....
T Consensus 163 Dfg~a~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~-~~~~ 239 (308)
T 3g33_A 163 DFGLARIYSYQ--MALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLI-GLPP 239 (308)
T ss_dssp SCSCTTTSTTC--CCSGGGGCCCSSCCHHHHHTSCCCSTHHHHHHHHHHHHTTTSSCSCCCSSHHHHHHHHHHHH-CCCC
T ss_pred eCccccccCCC--cccCCccccccccCchHHcCCCCCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHh-CCCC
Confidence 99999866432 22345678999999999999999999999999999999999999997654322111111000 0000
Q ss_pred ccchh---Hhhhchhc-------ccCCHHHHHHHHHHHHHccccCCCCCCCHHhHHH
Q 003836 725 ERTLE---ALVENDLE-------AMNNVTMLHRFVMVAFWCIQEDPSHRPTMRKVTQ 771 (792)
Q Consensus 725 ~~~~~---~~~~~~~~-------~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~ 771 (792)
+.... .+...... .....+....+.+++.+||+.||++|||+.|+++
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 296 (308)
T 3g33_A 240 EDDWPRDVSLPRGAFPPRGPRPVQSVVPEMEESGAQLLLEMLTFNPHKRISAFRALQ 296 (308)
T ss_dssp TTTSCSSCSSCGGGSCCCCCCCHHHHSCSCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred hhhccchhhccccccCCCCCCcHHHhCccccHHHHHHHHHHhcCCCccCCCHHHHhc
Confidence 00000 00000000 0001124467889999999999999999999997
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-38 Score=339.41 Aligned_cols=255 Identities=25% Similarity=0.370 Sum_probs=194.2
Q ss_pred hhhhhhcCccccceEEEeeecCC--CceEEEEEEccccc--ccchHHHHHHHHHhcccCCCCcccccceeccCC-----c
Q 003836 503 RGFKEELGRGAFGTVYKGFVNMG--SSNHVAVKKLNSVF--QDSEKEFKAEVNGIGQTHHKNLVRLLGYCDEGQ-----N 573 (792)
Q Consensus 503 ~~~~~~lG~G~~g~Vy~g~~~~~--~~~~vavK~~~~~~--~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~-----~ 573 (792)
+.+.+.||+|+||.||+|..... .++.||+|++.... ....+.+.+|+.++++++||||+++++++.+.. .
T Consensus 36 y~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 115 (313)
T 3brb_A 36 LILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVIRLLGVCIEMSSQGIPK 115 (313)
T ss_dssp EEEEEEEEC-CCCCEEEEEEECTTSCEEEEEEEEC---CCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEC-------C
T ss_pred eeeccceeecCCeEEEEEEEeccCCceeEEEEEEEeccccchhHHHHHHHHHHHHhcCCCCCeeeeeEEEeeccccCCcc
Confidence 33457899999999999976542 45689999987542 233467999999999999999999999997765 3
Q ss_pred eEEEEEeccCCCcccccc------CCCCCchhHHHHHHHHHHHHHHHHhhccCCCeEecCCCCCcEEEcCCCCeEEeecC
Q 003836 574 RLLVYEFMSNGTVASFLF------GDSKPNWKLRTEIAMGIAGGLFYLHEECCTQIIHCDIKPQNILLDDHYNARISDFG 647 (792)
Q Consensus 574 ~~lV~E~~~~gsL~~~l~------~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dikp~NILl~~~~~~kl~Dfg 647 (792)
.++||||+++|+|.+++. ....+++..+..++.||+.||.|||+. +|+||||||+|||++.++.+||+|||
T Consensus 116 ~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dikp~NIli~~~~~~kl~Dfg 192 (313)
T 3brb_A 116 PMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLSNR---NFLHRDLAARNCMLRDDMTVCVADFG 192 (313)
T ss_dssp EEEEEECCTTCBHHHHHHHTTBTTSCCCCCHHHHHHHHHHHHHHHHHHHTT---TCCCCCCSGGGEEECTTSCEEECSCS
T ss_pred cEEEEecccCCCHHHHHHHhhhhcCCccCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCcceEEEcCCCcEEEeecC
Confidence 599999999999999983 335689999999999999999999998 99999999999999999999999999
Q ss_pred CCccccCCCC-CccccccccCCcccccccccCCCCcccceehHHHHHHHHHh-cCcCCCcchhhhhhhhHHHHHHHhhcc
Q 003836 648 LAKLLTLDQS-HTNTAIRGTKGYVAPEWFRNMPITVKVDVYSYGVLLLEIIC-LRRNIDNEISKVDKAILTDWAYDRYQE 725 (792)
Q Consensus 648 ~a~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~k~DV~S~Gv~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~ 725 (792)
+++....... .......+++.|+|||.+.+..++.++||||||+++|||++ |+.||.........
T Consensus 193 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~------------- 259 (313)
T 3brb_A 193 LSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGMTPYPGVQNHEMY------------- 259 (313)
T ss_dssp CC----------------CCGGGSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHH-------------
T ss_pred cceecccccccCcccccCCCccccCchhhcCCCccchhhhHHHHHHHHHHHhcCCCCCccCCHHHHH-------------
Confidence 9987644332 22233457889999999999999999999999999999999 88888654322110
Q ss_pred cchhHhhhchhcccCCHHHHHHHHHHHHHccccCCCCCCCHHhHHHHhccCc
Q 003836 726 RTLEALVENDLEAMNNVTMLHRFVMVAFWCIQEDPSHRPTMRKVTQMLEGVV 777 (792)
Q Consensus 726 ~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~L~~~~ 777 (792)
..+........+...+..+.+++.+||+.+|.+|||++++++.|+.++
T Consensus 260 ----~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~l~ 307 (313)
T 3brb_A 260 ----DYLLHGHRLKQPEDCLDELYEIMYSCWRTDPLDRPTFSVLRLQLEKLL 307 (313)
T ss_dssp ----HHHHTTCCCCCBTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHH
T ss_pred ----HHHHcCCCCCCCccccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHH
Confidence 000011111222344567899999999999999999999999998864
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-39 Score=346.22 Aligned_cols=271 Identities=23% Similarity=0.363 Sum_probs=210.3
Q ss_pred hhhhhhcCccccceEEEeee---cCCCceEEEEEEcccccccchHHHHHHHHHhcccCCCCcccccceeccCC--ceEEE
Q 003836 503 RGFKEELGRGAFGTVYKGFV---NMGSSNHVAVKKLNSVFQDSEKEFKAEVNGIGQTHHKNLVRLLGYCDEGQ--NRLLV 577 (792)
Q Consensus 503 ~~~~~~lG~G~~g~Vy~g~~---~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~--~~~lV 577 (792)
+.+.+.||+|+||.||++.. +..+++.||||++........+.+.+|++++++++||||+++++++...+ ..++|
T Consensus 43 y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv 122 (326)
T 2w1i_A 43 LKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLI 122 (326)
T ss_dssp EEEEEEEECCSSEEEEEEEECTTSSSCCEEEEEEEESSCCSHHHHHHHHHHHHHHTCCCTTBCCEEEEECC----CCEEE
T ss_pred ceeeeeeccCCCeEEEEEEeccccCCCceEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEecCCCceEEE
Confidence 34567899999999999975 34567899999998766666788999999999999999999999987654 78999
Q ss_pred EEeccCCCccccccCC-CCCchhHHHHHHHHHHHHHHHHhhccCCCeEecCCCCCcEEEcCCCCeEEeecCCCccccCCC
Q 003836 578 YEFMSNGTVASFLFGD-SKPNWKLRTEIAMGIAGGLFYLHEECCTQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLDQ 656 (792)
Q Consensus 578 ~E~~~~gsL~~~l~~~-~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dikp~NILl~~~~~~kl~Dfg~a~~~~~~~ 656 (792)
|||+++++|.+++... ..+++..+..++.||+.||+|||+. +|+||||||+|||++.++.+||+|||+++......
T Consensus 123 ~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dikp~NIli~~~~~~kL~Dfg~~~~~~~~~ 199 (326)
T 2w1i_A 123 MEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTK---RYIHRDLATRNILVENENRVKIGDFGLTKVLPQDK 199 (326)
T ss_dssp ECCCTTCBHHHHHHHSTTSSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEEEETTEEEECCCTTCEECCSSC
T ss_pred EECCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhC---CEeccCCCcceEEEcCCCcEEEecCcchhhccccc
Confidence 9999999999999765 4689999999999999999999998 99999999999999999999999999998765443
Q ss_pred CCc--cccccccCCcccccccccCCCCcccceehHHHHHHHHHhcCcCCCcchhhhhhhhHHHHHHHhhcccchhHhhhc
Q 003836 657 SHT--NTAIRGTKGYVAPEWFRNMPITVKVDVYSYGVLLLEIICLRRNIDNEISKVDKAILTDWAYDRYQERTLEALVEN 734 (792)
Q Consensus 657 ~~~--~~~~~gt~~y~aPE~~~~~~~~~k~DV~S~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 734 (792)
... .....++..|+|||.+.+..++.++||||||+++|||++|+.|+............ ...........+...+..
T Consensus 200 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~ 278 (326)
T 2w1i_A 200 EYYKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIG-NDKQGQMIVFHLIELLKN 278 (326)
T ss_dssp SEEECSSCCSCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHHTTCGGGSHHHHHHHHHC-TTCCTHHHHHHHHHHHHT
T ss_pred cccccccCCCCceeEECchhhcCCCCCchhhHHHHHHHHHHHHhcCCCCCCCHHHHHHhhc-cccchhhhHHHHHHHhhc
Confidence 211 22345677899999999888999999999999999999999887543211100000 000000000011122222
Q ss_pred hhcccCCHHHHHHHHHHHHHccccCCCCCCCHHhHHHHhccCc
Q 003836 735 DLEAMNNVTMLHRFVMVAFWCIQEDPSHRPTMRKVTQMLEGVV 777 (792)
Q Consensus 735 ~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~L~~~~ 777 (792)
......+...+.++.+++.+||+.||++|||+.||++.|+.+.
T Consensus 279 ~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~el~~~L~~l~ 321 (326)
T 2w1i_A 279 NGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIR 321 (326)
T ss_dssp TCCCCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHH
T ss_pred CCCCCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHH
Confidence 2222233445678899999999999999999999999998754
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-38 Score=334.94 Aligned_cols=260 Identities=19% Similarity=0.264 Sum_probs=195.7
Q ss_pred hhhhhcCccccceEEEeeecCCCceEEEEEEccccc--ccchHHHHHHHHHhcccCCCCcccccceeccCCceEEEEEec
Q 003836 504 GFKEELGRGAFGTVYKGFVNMGSSNHVAVKKLNSVF--QDSEKEFKAEVNGIGQTHHKNLVRLLGYCDEGQNRLLVYEFM 581 (792)
Q Consensus 504 ~~~~~lG~G~~g~Vy~g~~~~~~~~~vavK~~~~~~--~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~lV~E~~ 581 (792)
.+.+.||+|+||+||++.. ..++.+|+|++.... ....+.+.+|++++++++||||+++++++.+.+..++||||+
T Consensus 5 ~~~~~lg~G~~g~V~~~~~--~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 82 (288)
T 1ob3_A 5 HGLEKIGEGTYGVVYKAQN--NYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEHL 82 (288)
T ss_dssp EEEEEEEEETTEEEEEEEE--TTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEECC
T ss_pred hhhhhcccCCCEEEEEEEc--CCCCEEEEEEEeccccccccchhHHHHHHHHHhcCCCCEeeeeeEEccCCeEEEEEEec
Confidence 3457899999999999976 346789999986543 223478899999999999999999999999999999999999
Q ss_pred cCCCccccccCC-CCCchhHHHHHHHHHHHHHHHHhhccCCCeEecCCCCCcEEEcCCCCeEEeecCCCccccCCCCCcc
Q 003836 582 SNGTVASFLFGD-SKPNWKLRTEIAMGIAGGLFYLHEECCTQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLDQSHTN 660 (792)
Q Consensus 582 ~~gsL~~~l~~~-~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dikp~NILl~~~~~~kl~Dfg~a~~~~~~~~~~~ 660 (792)
++ +|.+++... ..+++..+..++.||+.||+|||++ +|+||||||+|||++.++.+||+|||+++....... ..
T Consensus 83 ~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~-~~ 157 (288)
T 1ob3_A 83 DQ-DLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDR---RVLHRDLKPQNLLINREGELKIADFGLARAFGIPVR-KY 157 (288)
T ss_dssp SE-EHHHHHHTSTTCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECCTTHHHHHCC------
T ss_pred CC-CHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCCEEEeECccccccCcccc-cc
Confidence 86 898888654 6789999999999999999999998 999999999999999999999999999987543221 22
Q ss_pred ccccccCCccccccccc-CCCCcccceehHHHHHHHHHhcCcCCCcchhhhhhhhHHHHHHHhhcccc---hhHh--hhc
Q 003836 661 TAIRGTKGYVAPEWFRN-MPITVKVDVYSYGVLLLEIICLRRNIDNEISKVDKAILTDWAYDRYQERT---LEAL--VEN 734 (792)
Q Consensus 661 ~~~~gt~~y~aPE~~~~-~~~~~k~DV~S~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~--~~~ 734 (792)
....||+.|+|||.+.+ ..++.++|||||||++|||++|+.||................ ....... .... .++
T Consensus 158 ~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~ 236 (288)
T 1ob3_A 158 THEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRIL-GTPNSKNWPNVTELPKYDP 236 (288)
T ss_dssp ----CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHH-CCCCTTTSTTGGGSTTCCT
T ss_pred ccccccccccCchheeCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHH-CCCChhhchhhhccccccc
Confidence 33468999999999876 458999999999999999999999997653321111110000 0000000 0000 000
Q ss_pred hhc-------ccCCHHHHHHHHHHHHHccccCCCCCCCHHhHHH
Q 003836 735 DLE-------AMNNVTMLHRFVMVAFWCIQEDPSHRPTMRKVTQ 771 (792)
Q Consensus 735 ~~~-------~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~ 771 (792)
... .........++.+++.+||+.||++|||++|+++
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 280 (288)
T 1ob3_A 237 NFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALE 280 (288)
T ss_dssp TCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred ccccccCccHHHHhhhcCHHHHHHHHHHcCCCcccCCCHHHHhc
Confidence 000 0011124567889999999999999999999987
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-38 Score=343.05 Aligned_cols=251 Identities=25% Similarity=0.261 Sum_probs=196.0
Q ss_pred HhhhhhhcCccccceEEEeeecCCCceEEEEEEcccc-----cccchHHHHHHHHHhcccCCCCcccccceeccCCceEE
Q 003836 502 TRGFKEELGRGAFGTVYKGFVNMGSSNHVAVKKLNSV-----FQDSEKEFKAEVNGIGQTHHKNLVRLLGYCDEGQNRLL 576 (792)
Q Consensus 502 ~~~~~~~lG~G~~g~Vy~g~~~~~~~~~vavK~~~~~-----~~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~l 576 (792)
.+.+.+.||+|+||+||++... .+++.+|+|++... .....+.+.+|++++++++||||+++++++.+.+..++
T Consensus 27 ~y~~~~~lG~G~~g~V~~~~~~-~~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~l 105 (345)
T 3hko_A 27 KYHLKGAIGQGSYGVVRVAIEN-QTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARLYEVYEDEQYICL 105 (345)
T ss_dssp HEEEEEEEEECSSCEEEEEEET-TTCCEEEEEEEEHHHHHC---CHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEE
T ss_pred heeecceeeecCCeEEEEEEEC-CCCceEEEeehhhhhhcccCHHHHHHHHHHHHHHHhCCCCCcceeehhhccCCeEEE
Confidence 3455688999999999999754 55678999998643 23456789999999999999999999999999999999
Q ss_pred EEEeccCCCccccccCC----------------------------------------CCCchhHHHHHHHHHHHHHHHHh
Q 003836 577 VYEFMSNGTVASFLFGD----------------------------------------SKPNWKLRTEIAMGIAGGLFYLH 616 (792)
Q Consensus 577 V~E~~~~gsL~~~l~~~----------------------------------------~~l~~~~~~~i~~~ia~gL~yLH 616 (792)
||||+++|+|.+++... ..+++..+..++.||+.||+|||
T Consensus 106 v~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH 185 (345)
T 3hko_A 106 VMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSALHYLH 185 (345)
T ss_dssp EEECCCSCBHHHHEEEEEETTTTEEEEEEECCCCCCSHHHHHHHHHSCC--CEEECCHHHHHHHHHHHHHHHHHHHHHHH
T ss_pred EEeCCCCCcHHHHHHHhhcccccccccccccccccccccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHH
Confidence 99999999999988521 12356778889999999999999
Q ss_pred hccCCCeEecCCCCCcEEEcCCC--CeEEeecCCCccccCCCC---CccccccccCCccccccccc--CCCCcccceehH
Q 003836 617 EECCTQIIHCDIKPQNILLDDHY--NARISDFGLAKLLTLDQS---HTNTAIRGTKGYVAPEWFRN--MPITVKVDVYSY 689 (792)
Q Consensus 617 ~~~~~~ivH~dikp~NILl~~~~--~~kl~Dfg~a~~~~~~~~---~~~~~~~gt~~y~aPE~~~~--~~~~~k~DV~S~ 689 (792)
+. +|+||||||+|||++.++ .+||+|||+++....... .......||+.|+|||.+.+ ..++.++|||||
T Consensus 186 ~~---~ivH~Dlkp~NIll~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~Diwsl 262 (345)
T 3hko_A 186 NQ---GICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKCDAWSA 262 (345)
T ss_dssp HT---TEECCCCCGGGEEESCSSSCCEEECCCTTCEEGGGTTCC--------CCCGGGCCHHHHTCSSSCCCTHHHHHHH
T ss_pred HC---CccccCCChhhEEEecCCCceEEEeeccccccccccCccccccccccCCCccccCchhhccCCCCCCcHHHHHHH
Confidence 99 999999999999998776 899999999987643222 12344569999999999865 678999999999
Q ss_pred HHHHHHHHhcCcCCCcchhhhhhhhHHHHHHHhhcccchhHhhhchhc--ccCCHHHHHHHHHHHHHccccCCCCCCCHH
Q 003836 690 GVLLLEIICLRRNIDNEISKVDKAILTDWAYDRYQERTLEALVENDLE--AMNNVTMLHRFVMVAFWCIQEDPSHRPTMR 767 (792)
Q Consensus 690 Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~ 767 (792)
|+++|||++|+.||......... ..+...... .......+..+.+++.+||+.+|.+||++.
T Consensus 263 G~il~el~~g~~pf~~~~~~~~~----------------~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ 326 (345)
T 3hko_A 263 GVLLHLLLMGAVPFPGVNDADTI----------------SQVLNKKLCFENPNYNVLSPLARDLLSNLLNRNVDERFDAM 326 (345)
T ss_dssp HHHHHHHHHSSCSSCCSSHHHHH----------------HHHHHCCCCTTSGGGGGSCHHHHHHHHHHSCSCTTTSCCHH
T ss_pred HHHHHHHHHCCCCCCCCChHHHH----------------HHHHhcccccCCcccccCCHHHHHHHHHHcCCChhHCCCHH
Confidence 99999999999999754332111 011111110 001112356788999999999999999999
Q ss_pred hHHHH
Q 003836 768 KVTQM 772 (792)
Q Consensus 768 evl~~ 772 (792)
|+++.
T Consensus 327 ~~l~h 331 (345)
T 3hko_A 327 RALQH 331 (345)
T ss_dssp HHHHS
T ss_pred HHhcC
Confidence 99873
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.3e-39 Score=346.33 Aligned_cols=256 Identities=28% Similarity=0.406 Sum_probs=205.7
Q ss_pred hhhhhhcCccccceEEEeeecCCC----ceEEEEEEcccccc-cchHHHHHHHHHhccc-CCCCcccccceeccCCceEE
Q 003836 503 RGFKEELGRGAFGTVYKGFVNMGS----SNHVAVKKLNSVFQ-DSEKEFKAEVNGIGQT-HHKNLVRLLGYCDEGQNRLL 576 (792)
Q Consensus 503 ~~~~~~lG~G~~g~Vy~g~~~~~~----~~~vavK~~~~~~~-~~~~~~~~Ei~~l~~l-~h~niv~l~g~~~~~~~~~l 576 (792)
+.+.+.||+|+||.||+|...... .+.||+|++..... ...+.+.+|+.+++++ +||||+++++++.+.+..++
T Consensus 48 ~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~l 127 (333)
T 2i1m_A 48 LQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIVNLLGACTHGGPVLV 127 (333)
T ss_dssp EEEEEEEEECSSEEEEEEEETTCSSSCCCCEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEE
T ss_pred ceeeeEeccCCCcceEEEEecCCCcccchhHHHHHhcccccChHHHHHHHHHHHHHHhhcCCCCeeeEEEEEecCCceEE
Confidence 445678999999999999764322 24799999976432 3456799999999999 89999999999999999999
Q ss_pred EEEeccCCCccccccCC--------------CCCchhHHHHHHHHHHHHHHHHhhccCCCeEecCCCCCcEEEcCCCCeE
Q 003836 577 VYEFMSNGTVASFLFGD--------------SKPNWKLRTEIAMGIAGGLFYLHEECCTQIIHCDIKPQNILLDDHYNAR 642 (792)
Q Consensus 577 V~E~~~~gsL~~~l~~~--------------~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dikp~NILl~~~~~~k 642 (792)
||||+++|+|.+++... ..+++..+..++.||+.||+|||+. +|+||||||+|||++.++.+|
T Consensus 128 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dlkp~NIl~~~~~~~k 204 (333)
T 2i1m_A 128 ITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLASK---NCIHRDVAARNVLLTNGHVAK 204 (333)
T ss_dssp EEECCTTEEHHHHHHHHHHHHSCC-------CCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGCEEEGGGEEE
T ss_pred EEecCCCCcHHHHHHHhcccccccccccccccccCHHHHHHHHHHHHHHHHHHhcC---CcccCCcccceEEECCCCeEE
Confidence 99999999999998642 3568899999999999999999998 999999999999999999999
Q ss_pred EeecCCCccccCCCCC-ccccccccCCcccccccccCCCCcccceehHHHHHHHHHh-cCcCCCcchhhhhhhhHHHHHH
Q 003836 643 ISDFGLAKLLTLDQSH-TNTAIRGTKGYVAPEWFRNMPITVKVDVYSYGVLLLEIIC-LRRNIDNEISKVDKAILTDWAY 720 (792)
Q Consensus 643 l~Dfg~a~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~k~DV~S~Gv~l~el~t-g~~p~~~~~~~~~~~~~~~~~~ 720 (792)
|+|||+++........ ......+|+.|+|||.+.+..++.++||||||+++|||++ |..||.........
T Consensus 205 l~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~-------- 276 (333)
T 2i1m_A 205 IGDFGLARDIMNDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPYPGILVNSKF-------- 276 (333)
T ss_dssp BCCCGGGCCGGGCTTSEECSSCEECGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCSSHHH--------
T ss_pred ECccccccccccccceeecCCCCCCccccCHHHhccCCCChHHHHHHHHHHHHHHHcCCCCCCcccchhHHH--------
Confidence 9999999876443322 2233457889999999999899999999999999999999 88888654322110
Q ss_pred HhhcccchhHhhhchhcccCCHHHHHHHHHHHHHccccCCCCCCCHHhHHHHhccCc
Q 003836 721 DRYQERTLEALVENDLEAMNNVTMLHRFVMVAFWCIQEDPSHRPTMRKVTQMLEGVV 777 (792)
Q Consensus 721 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~L~~~~ 777 (792)
...+........+...+..+.+++.+||+.||.+|||++||++.|+.+.
T Consensus 277 --------~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~~~ 325 (333)
T 2i1m_A 277 --------YKLVKDGYQMAQPAFAPKNIYSIMQACWALEPTHRPTFQQICSFLQEQA 325 (333)
T ss_dssp --------HHHHHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred --------HHHHhcCCCCCCCCCCCHHHHHHHHHHhccChhhCcCHHHHHHHHHHHH
Confidence 0111111111122233567889999999999999999999999998753
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-38 Score=353.70 Aligned_cols=245 Identities=24% Similarity=0.417 Sum_probs=203.2
Q ss_pred hhhhhcCccccceEEEeeecCCCceEEEEEEccccc---ccchHHHHHHHHHhcccCCCCcccccceeccCCceEEEEEe
Q 003836 504 GFKEELGRGAFGTVYKGFVNMGSSNHVAVKKLNSVF---QDSEKEFKAEVNGIGQTHHKNLVRLLGYCDEGQNRLLVYEF 580 (792)
Q Consensus 504 ~~~~~lG~G~~g~Vy~g~~~~~~~~~vavK~~~~~~---~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~lV~E~ 580 (792)
.+.+.||+|+||.||+|... .+++.||||++.... ......+.+|+.++++++||||+++++++...+..++||||
T Consensus 19 ~l~~~LG~G~fg~V~~a~~~-~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lv~E~ 97 (476)
T 2y94_A 19 ILGDTLGVGTFGKVKVGKHE-LTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQVISTPSDIFMVMEY 97 (476)
T ss_dssp EEEEEEECCSSSCEEEEEET-TTCCEEEEEEEEHHHHHHTTTHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEEC
T ss_pred EEEEEEeeCCCeEEEEEEEC-CCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEeC
Confidence 45578999999999999754 456899999987532 23356789999999999999999999999999999999999
Q ss_pred ccCCCccccccCCCCCchhHHHHHHHHHHHHHHHHhhccCCCeEecCCCCCcEEEcCCCCeEEeecCCCccccCCCCCcc
Q 003836 581 MSNGTVASFLFGDSKPNWKLRTEIAMGIAGGLFYLHEECCTQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLDQSHTN 660 (792)
Q Consensus 581 ~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dikp~NILl~~~~~~kl~Dfg~a~~~~~~~~~~~ 660 (792)
+++|+|.+++.....+++..+..++.||+.||+|||+. +|+||||||+|||++.++.+||+|||+++...... ..
T Consensus 98 ~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~---givHrDLkp~NIll~~~~~vkL~DFG~a~~~~~~~--~~ 172 (476)
T 2y94_A 98 VSGGELFDYICKNGRLDEKESRRLFQQILSGVDYCHRH---MVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGE--FL 172 (476)
T ss_dssp CSSEEHHHHTTSSSSCCHHHHHHHHHHHHHHHHHHHTT---TEECSCCSGGGEEECTTCCEEECCCSSCEECCTTC--CB
T ss_pred CCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---CCCcccccHHHEEEecCCCeEEEeccchhhccccc--cc
Confidence 99999999998888899999999999999999999998 99999999999999999999999999998764322 23
Q ss_pred ccccccCCcccccccccCCC-CcccceehHHHHHHHHHhcCcCCCcchhhhhhhhHHHHHHHhhcccchhHhhhchhccc
Q 003836 661 TAIRGTKGYVAPEWFRNMPI-TVKVDVYSYGVLLLEIICLRRNIDNEISKVDKAILTDWAYDRYQERTLEALVENDLEAM 739 (792)
Q Consensus 661 ~~~~gt~~y~aPE~~~~~~~-~~k~DV~S~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 739 (792)
....||+.|+|||.+.+..+ +.++|||||||++|||++|+.||........ . ..+.+... .
T Consensus 173 ~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~---~-------------~~i~~~~~--~ 234 (476)
T 2y94_A 173 RTSCGSPNYAAPEVISGRLYAGPEVDIWSSGVILYALLCGTLPFDDDHVPTL---F-------------KKICDGIF--Y 234 (476)
T ss_dssp CCCCSCSTTCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSSCCSSSHHH---H-------------HHHHTTCC--C
T ss_pred cccCCCcCeEChhhccCCCCCCCcceehhhHHHHHHHhhCCCCCCCCCHHHH---H-------------HHHhcCCc--C
Confidence 34579999999999988765 7899999999999999999999975432110 0 01111111 1
Q ss_pred CCHHHHHHHHHHHHHccccCCCCCCCHHhHHHH
Q 003836 740 NNVTMLHRFVMVAFWCIQEDPSHRPTMRKVTQM 772 (792)
Q Consensus 740 ~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~ 772 (792)
.+......+.+++.+||+.||++|||++|+++.
T Consensus 235 ~p~~~s~~~~~Li~~~L~~dP~~Rpt~~eil~h 267 (476)
T 2y94_A 235 TPQYLNPSVISLLKHMLQVDPMKRATIKDIREH 267 (476)
T ss_dssp CCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHTC
T ss_pred CCccCCHHHHHHHHHHcCCCchhCcCHHHHHhC
Confidence 122234578899999999999999999999973
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-38 Score=340.15 Aligned_cols=259 Identities=22% Similarity=0.251 Sum_probs=196.4
Q ss_pred hhcCccccceEEEeeecCCCceEEEEEEcccccccchHHHHHHHHHhccc-CCCCcccccceeccCCceEEEEEeccCCC
Q 003836 507 EELGRGAFGTVYKGFVNMGSSNHVAVKKLNSVFQDSEKEFKAEVNGIGQT-HHKNLVRLLGYCDEGQNRLLVYEFMSNGT 585 (792)
Q Consensus 507 ~~lG~G~~g~Vy~g~~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l-~h~niv~l~g~~~~~~~~~lV~E~~~~gs 585 (792)
+.||+|+||+||++.. ..+++.||||++........+.+.+|++++.++ +||||+++++++.+.+..++||||+++|+
T Consensus 19 ~~lg~G~~g~V~~~~~-~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~ 97 (316)
T 2ac3_A 19 DVLGEGAHARVQTCIN-LITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRFYLVFEKMRGGS 97 (316)
T ss_dssp CCCCCCSSEEEEEEEC-SSSCCEEEEEEEECCSSCCHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECCTTCB
T ss_pred ceecCCceEEEEEEEE-cCCCcEEEEEEEeeCcchhHHHHHHHHHHHHHhcCCCCeeeEEEEEeeCCEEEEEEEcCCCCc
Confidence 5699999999999964 345679999999876666678899999999885 79999999999999999999999999999
Q ss_pred ccccccCCCCCchhHHHHHHHHHHHHHHHHhhccCCCeEecCCCCCcEEEcCCCC---eEEeecCCCccccCCCC-----
Q 003836 586 VASFLFGDSKPNWKLRTEIAMGIAGGLFYLHEECCTQIIHCDIKPQNILLDDHYN---ARISDFGLAKLLTLDQS----- 657 (792)
Q Consensus 586 L~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dikp~NILl~~~~~---~kl~Dfg~a~~~~~~~~----- 657 (792)
|.+++.....+++..+..++.||+.||+|||+. +|+||||||+|||++.++. +||+|||+++.......
T Consensus 98 L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~ 174 (316)
T 2ac3_A 98 ILSHIHKRRHFNELEASVVVQDVASALDFLHNK---GIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPIS 174 (316)
T ss_dssp HHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEESCSSSSCSEEECCTTCCC------------
T ss_pred HHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhC---CceeCCCCHHHEEEccCCCcCceEEEEccCccccccCCcccccc
Confidence 999998878899999999999999999999999 9999999999999998776 99999999986543221
Q ss_pred -CccccccccCCccccccccc-----CCCCcccceehHHHHHHHHHhcCcCCCcchhhhhhhhHHHHHHHhhcccchhHh
Q 003836 658 -HTNTAIRGTKGYVAPEWFRN-----MPITVKVDVYSYGVLLLEIICLRRNIDNEISKVDKAILTDWAYDRYQERTLEAL 731 (792)
Q Consensus 658 -~~~~~~~gt~~y~aPE~~~~-----~~~~~k~DV~S~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 731 (792)
.......||+.|+|||.+.. ..++.++|||||||++|||++|+.||.............. ............+
T Consensus 175 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~-~~~~~~~~~~~~i 253 (316)
T 2ac3_A 175 TPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGE-ACPACQNMLFESI 253 (316)
T ss_dssp -------CCSGGGCCHHHHHHTSHHHHHHTTTHHHHHHHHHHHHHHHSSCSCCCCCCSCSCC-----CCHHHHHHHHHHH
T ss_pred ccccccccCCcCccChHHhhcccccccCCCcccccHhHHHHHHHHHHCCCCCcccccccccccccc-cchhHHHHHHHHH
Confidence 11223458999999999875 5688999999999999999999999975432110000000 0000000000111
Q ss_pred hhchhcccCCH----HHHHHHHHHHHHccccCCCCCCCHHhHHHH
Q 003836 732 VENDLEAMNNV----TMLHRFVMVAFWCIQEDPSHRPTMRKVTQM 772 (792)
Q Consensus 732 ~~~~~~~~~~~----~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~ 772 (792)
..... ..+. ..+..+.+++.+||+.||++|||++|+++.
T Consensus 254 ~~~~~--~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~h 296 (316)
T 2ac3_A 254 QEGKY--EFPDKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQH 296 (316)
T ss_dssp HHCCC--CCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred hccCc--ccCchhcccCCHHHHHHHHHHhhCChhhCCCHHHHhcC
Confidence 11111 0111 234678899999999999999999999984
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-38 Score=346.76 Aligned_cols=243 Identities=24% Similarity=0.279 Sum_probs=191.6
Q ss_pred hhhhhhcCccccceEEEeeecCCCceEEEEEEcccccc---cchHHHHHHHHH-hcccCCCCcccccceeccCCceEEEE
Q 003836 503 RGFKEELGRGAFGTVYKGFVNMGSSNHVAVKKLNSVFQ---DSEKEFKAEVNG-IGQTHHKNLVRLLGYCDEGQNRLLVY 578 (792)
Q Consensus 503 ~~~~~~lG~G~~g~Vy~g~~~~~~~~~vavK~~~~~~~---~~~~~~~~Ei~~-l~~l~h~niv~l~g~~~~~~~~~lV~ 578 (792)
+.+.+.||+|+||.||++... .+++.+|+|++.+... .....+.+|..+ ++.++||||+++++++.+.+..++||
T Consensus 40 y~~~~~lG~G~fg~V~~~~~~-~~~~~~AiK~~~~~~~~~~~~~~~~~~e~~~ll~~~~hp~Iv~l~~~~~~~~~~~lv~ 118 (373)
T 2r5t_A 40 FHFLKVIGKGSFGKVLLARHK-AEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFVL 118 (373)
T ss_dssp EEEEEEEECCTTCEEEEEEET-TTCCEEEEEEEEGGGBC-------------CCBCCCCCTTBCCEEEEEECSSEEEEEE
T ss_pred eEEEEEEeeCCCeEEEEEEEc-CCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHHhCCCCCCCCEEEEEEeCCEEEEEE
Confidence 345678999999999999754 5578999999976432 234556777776 57789999999999999999999999
Q ss_pred EeccCCCccccccCCCCCchhHHHHHHHHHHHHHHHHhhccCCCeEecCCCCCcEEEcCCCCeEEeecCCCccccCCCCC
Q 003836 579 EFMSNGTVASFLFGDSKPNWKLRTEIAMGIAGGLFYLHEECCTQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLDQSH 658 (792)
Q Consensus 579 E~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dikp~NILl~~~~~~kl~Dfg~a~~~~~~~~~ 658 (792)
||+++|+|.+++.....+++..+..++.||+.||+|||++ +|+||||||+|||++.++.+||+|||+++..... ..
T Consensus 119 E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~---givHrDlkp~NIll~~~g~ikL~DFG~a~~~~~~-~~ 194 (373)
T 2r5t_A 119 DYINGGELFYHLQRERCFLEPRARFYAAEIASALGYLHSL---NIVYRDLKPENILLDSQGHIVLTDFGLCKENIEH-NS 194 (373)
T ss_dssp ECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEECCCCBCGGGBCC-CC
T ss_pred eCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCHHHEEECCCCCEEEeeCccccccccC-CC
Confidence 9999999999998878889999999999999999999998 9999999999999999999999999999864322 22
Q ss_pred ccccccccCCcccccccccCCCCcccceehHHHHHHHHHhcCcCCCcchhhhhhhhHHHHHHHhhcccchhHhhhchhcc
Q 003836 659 TNTAIRGTKGYVAPEWFRNMPITVKVDVYSYGVLLLEIICLRRNIDNEISKVDKAILTDWAYDRYQERTLEALVENDLEA 738 (792)
Q Consensus 659 ~~~~~~gt~~y~aPE~~~~~~~~~k~DV~S~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 738 (792)
......||+.|+|||++.+..++.++|||||||++|||++|+.||......... ..++....
T Consensus 195 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~~----------------~~i~~~~~-- 256 (373)
T 2r5t_A 195 TTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMY----------------DNILNKPL-- 256 (373)
T ss_dssp CCCSBSCCCCCCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSBHHHHH----------------HHHHHSCC--
T ss_pred ccccccCCccccCHHHhCCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCHHHHH----------------HHHHhccc--
Confidence 334567999999999999999999999999999999999999999754322110 11111111
Q ss_pred cCCHHHHHHHHHHHHHccccCCCCCCCHHh
Q 003836 739 MNNVTMLHRFVMVAFWCIQEDPSHRPTMRK 768 (792)
Q Consensus 739 ~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~e 768 (792)
..+...+..+.+++.+||+.||.+||++.+
T Consensus 257 ~~~~~~~~~~~~li~~lL~~dp~~R~~~~~ 286 (373)
T 2r5t_A 257 QLKPNITNSARHLLEGLLQKDRTKRLGAKD 286 (373)
T ss_dssp CCCSSSCHHHHHHHHHHTCSSGGGSTTTTT
T ss_pred CCCCCCCHHHHHHHHHHcccCHHhCCCCCC
Confidence 112234567889999999999999999853
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-38 Score=344.18 Aligned_cols=248 Identities=21% Similarity=0.320 Sum_probs=195.3
Q ss_pred hhhhhhcCccccceEEEeeecCCCceEEEEEEccccc--ccchHHHHHHHHHhcccCC--CCcccccceeccCCceEEEE
Q 003836 503 RGFKEELGRGAFGTVYKGFVNMGSSNHVAVKKLNSVF--QDSEKEFKAEVNGIGQTHH--KNLVRLLGYCDEGQNRLLVY 578 (792)
Q Consensus 503 ~~~~~~lG~G~~g~Vy~g~~~~~~~~~vavK~~~~~~--~~~~~~~~~Ei~~l~~l~h--~niv~l~g~~~~~~~~~lV~ 578 (792)
+.+.+.||+|+||.||++... +++.||||++.... ....+.+.+|+.++.+++| +||+++++++.+....++||
T Consensus 11 y~i~~~lG~G~~g~Vy~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~~~lv~ 88 (343)
T 3dbq_A 11 YSILKQIGSGGSSKVFQVLNE--KKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVM 88 (343)
T ss_dssp EEEEEEESCCSSEEEEEEECT--TSCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEE
T ss_pred EEEEEEEecCCCeEEEEEEeC--CCCEEEEEEeeccccchHHHHHHHHHHHHHHhhhhcCCceEEEeeeEeeCCEEEEEE
Confidence 345678999999999999753 46789999986532 3334678999999999976 99999999999999999999
Q ss_pred EeccCCCccccccCCCCCchhHHHHHHHHHHHHHHHHhhccCCCeEecCCCCCcEEEcCCCCeEEeecCCCccccCCCCC
Q 003836 579 EFMSNGTVASFLFGDSKPNWKLRTEIAMGIAGGLFYLHEECCTQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLDQSH 658 (792)
Q Consensus 579 E~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dikp~NILl~~~~~~kl~Dfg~a~~~~~~~~~ 658 (792)
| +.+++|.+++.....+++..+..++.||+.||+|||+. +|+||||||+|||++ ++.+||+|||+++........
T Consensus 89 e-~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH~~---~iiHrDikp~NIll~-~~~~kl~DFG~a~~~~~~~~~ 163 (343)
T 3dbq_A 89 E-CGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQH---GIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDTTS 163 (343)
T ss_dssp C-CCSEEHHHHHHHSCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEEE-TTEEEECCCSSSCCC------
T ss_pred e-CCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCcceEEEE-CCcEEEeecccccccCccccc
Confidence 9 56889999998888899999999999999999999998 999999999999997 578999999999876543332
Q ss_pred -ccccccccCCccccccccc-----------CCCCcccceehHHHHHHHHHhcCcCCCcchhhhhhhhHHHHHHHhhccc
Q 003836 659 -TNTAIRGTKGYVAPEWFRN-----------MPITVKVDVYSYGVLLLEIICLRRNIDNEISKVDKAILTDWAYDRYQER 726 (792)
Q Consensus 659 -~~~~~~gt~~y~aPE~~~~-----------~~~~~k~DV~S~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 726 (792)
......||+.|+|||.+.+ ..++.++|||||||++|||++|+.||........
T Consensus 164 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~--------------- 228 (343)
T 3dbq_A 164 VVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQIS--------------- 228 (343)
T ss_dssp ------CCCCSSCCHHHHHHCC-----------CCHHHHHHHHHHHHHHHHHSSCTTTTCCSHHH---------------
T ss_pred ccCCCCcCCcCcCCHHHHhhccccccccccccCCCchhhHHHHHHHHHHHHhCCCcchhhhhHHH---------------
Confidence 2334579999999999864 6789999999999999999999999965332111
Q ss_pred chhHhhhchhcccCCHHHHHHHHHHHHHccccCCCCCCCHHhHHHH
Q 003836 727 TLEALVENDLEAMNNVTMLHRFVMVAFWCIQEDPSHRPTMRKVTQM 772 (792)
Q Consensus 727 ~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~ 772 (792)
.+..+++.......+......+.+++.+||+.||.+|||+.|+++.
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~h 274 (343)
T 3dbq_A 229 KLHAIIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAH 274 (343)
T ss_dssp HHHHHHCTTSCCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred HHHHHhcCCcccCCcccCCHHHHHHHHHHcCCChhHCCCHHHHHhC
Confidence 1112222222222233334578899999999999999999999875
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.4e-38 Score=349.00 Aligned_cols=250 Identities=22% Similarity=0.316 Sum_probs=189.7
Q ss_pred HhhhhhhcCccccceEEEeeecCCCceEEEEEEccccc--------ccchHHHHHHHHHhcccCCCCcccccceeccCCc
Q 003836 502 TRGFKEELGRGAFGTVYKGFVNMGSSNHVAVKKLNSVF--------QDSEKEFKAEVNGIGQTHHKNLVRLLGYCDEGQN 573 (792)
Q Consensus 502 ~~~~~~~lG~G~~g~Vy~g~~~~~~~~~vavK~~~~~~--------~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~ 573 (792)
.+.+.+.||+|+||+||+|... .+++.||||++.... ......+.+|++++++++||||+++++++.. +.
T Consensus 136 ~y~~~~~LG~G~~g~V~~a~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~-~~ 213 (419)
T 3i6u_A 136 EYIMSKTLGSGACGEVKLAFER-KTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDA-ED 213 (419)
T ss_dssp TEEEEEEEEECSSSEEEEEEET-TTCCEEEEEEEEGGGGTTC--------CCHHHHHHHHHHCCCTTBCCCCEEEES-SE
T ss_pred cEEEEeEEeeCCCeEEEEEEEC-CCCcEEEEEEEEechhcccccccchhHHHHHHHHHHHHhCCCCCEeeEEEEEec-Cc
Confidence 4555688999999999999754 556899999987532 1122358899999999999999999999854 45
Q ss_pred eEEEEEeccCCCccccccCCCCCchhHHHHHHHHHHHHHHHHhhccCCCeEecCCCCCcEEEcCC---CCeEEeecCCCc
Q 003836 574 RLLVYEFMSNGTVASFLFGDSKPNWKLRTEIAMGIAGGLFYLHEECCTQIIHCDIKPQNILLDDH---YNARISDFGLAK 650 (792)
Q Consensus 574 ~~lV~E~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dikp~NILl~~~---~~~kl~Dfg~a~ 650 (792)
.++||||+++|+|.+++.....+++..+..++.||+.||+|||+. +|+||||||+|||++.+ ..+||+|||+++
T Consensus 214 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~---~ivHrDlkp~NIll~~~~~~~~~kl~DFG~a~ 290 (419)
T 3i6u_A 214 YYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQYLHEN---GIIHRDLKPENVLLSSQEEDCLIKITDFGHSK 290 (419)
T ss_dssp EEEEEECCTTCBGGGGTSSSCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESSSSSSCCEEECCSSTTT
T ss_pred eEEEEEcCCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCChHhEEEecCCCcceEEEeecccce
Confidence 799999999999999998888899999999999999999999998 99999999999999754 459999999998
Q ss_pred cccCCCCCccccccccCCccccccccc---CCCCcccceehHHHHHHHHHhcCcCCCcchhhhhhhhHHHHHHHhhcccc
Q 003836 651 LLTLDQSHTNTAIRGTKGYVAPEWFRN---MPITVKVDVYSYGVLLLEIICLRRNIDNEISKVDKAILTDWAYDRYQERT 727 (792)
Q Consensus 651 ~~~~~~~~~~~~~~gt~~y~aPE~~~~---~~~~~k~DV~S~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 727 (792)
..... .......||+.|+|||++.+ ..++.++|||||||++|||++|+.||.......... ... ....
T Consensus 291 ~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~---~~i----~~~~ 361 (419)
T 3i6u_A 291 ILGET--SLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLK---DQI----TSGK 361 (419)
T ss_dssp SCC-------------CTTCCTTTTC----CTTHHHHHHHHHHHHHHHHHHSSCSSCCCSSSCCHH---HHH----HTTC
T ss_pred ecCCC--ccccccCCCCCccCceeeecCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCcchHHHH---HHH----hcCC
Confidence 76432 22334679999999999853 678899999999999999999999997543221100 000 0000
Q ss_pred hhHhhhchhcccCCHHHHHHHHHHHHHccccCCCCCCCHHhHHH
Q 003836 728 LEALVENDLEAMNNVTMLHRFVMVAFWCIQEDPSHRPTMRKVTQ 771 (792)
Q Consensus 728 ~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~ 771 (792)
.. .........+..+.+++.+||+.||++|||++|+++
T Consensus 362 ~~------~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~ 399 (419)
T 3i6u_A 362 YN------FIPEVWAEVSEKALDLVKKLLVVDPKARFTTEEALR 399 (419)
T ss_dssp CC------CCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred CC------CCchhhcccCHHHHHHHHHHccCChhHCcCHHHHhC
Confidence 00 000000123567889999999999999999999998
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-38 Score=347.05 Aligned_cols=264 Identities=21% Similarity=0.314 Sum_probs=188.3
Q ss_pred hhhhhhcCccccceEEEeeecCCCceEEEEEEccccc--ccchHHHHHHHHHhcccC-CCCcccccceeccCC--ceEEE
Q 003836 503 RGFKEELGRGAFGTVYKGFVNMGSSNHVAVKKLNSVF--QDSEKEFKAEVNGIGQTH-HKNLVRLLGYCDEGQ--NRLLV 577 (792)
Q Consensus 503 ~~~~~~lG~G~~g~Vy~g~~~~~~~~~vavK~~~~~~--~~~~~~~~~Ei~~l~~l~-h~niv~l~g~~~~~~--~~~lV 577 (792)
+.+.+.||+|+||.||+|... .+++.||||++.... ....+.+.+|+.++.++. ||||+++++++...+ ..++|
T Consensus 11 y~~~~~lG~G~~g~V~~~~~~-~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~lv 89 (388)
T 3oz6_A 11 YELVKKLGKGAYGIVWKSIDR-RTGEVVAVKKIFDAFQNSTDAQRTFREIMILTELSGHENIVNLLNVLRADNDRDVYLV 89 (388)
T ss_dssp EEEEEC-------CEEEEEET-TTCCEEEEEEECC--CCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECTTSSCEEEE
T ss_pred eEEEEEeeeCCCeEEEEEEEC-CCCCEEEEEEecccccChHHHHHHHHHHHHHHhccCCCCCCeeeeEEecCCCCEEEEE
Confidence 445678999999999999654 557899999986532 334567889999999997 999999999996543 78999
Q ss_pred EEeccCCCccccccCCCCCchhHHHHHHHHHHHHHHHHhhccCCCeEecCCCCCcEEEcCCCCeEEeecCCCccccCCC-
Q 003836 578 YEFMSNGTVASFLFGDSKPNWKLRTEIAMGIAGGLFYLHEECCTQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLDQ- 656 (792)
Q Consensus 578 ~E~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dikp~NILl~~~~~~kl~Dfg~a~~~~~~~- 656 (792)
|||++ ++|..++.. ..+++..+..++.||+.||+|||+. +|+||||||+|||++.++.+||+|||+++......
T Consensus 90 ~e~~~-~~L~~~~~~-~~~~~~~~~~i~~qi~~~L~~LH~~---~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~ 164 (388)
T 3oz6_A 90 FDYME-TDLHAVIRA-NILEPVHKQYVVYQLIKVIKYLHSG---GLLHRDMKPSNILLNAECHVKVADFGLSRSFVNIRR 164 (388)
T ss_dssp EECCS-EEHHHHHHH-TCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTCEESSSCCC
T ss_pred ecccC-cCHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHhC---CEEeCCCCHHHeEEcCCCCEEecCCccccccccccc
Confidence 99998 589888865 4688999999999999999999998 99999999999999999999999999998754311
Q ss_pred -------------------CCccccccccCCccccccccc-CCCCcccceehHHHHHHHHHhcCcCCCcchhhhhhhhHH
Q 003836 657 -------------------SHTNTAIRGTKGYVAPEWFRN-MPITVKVDVYSYGVLLLEIICLRRNIDNEISKVDKAILT 716 (792)
Q Consensus 657 -------------------~~~~~~~~gt~~y~aPE~~~~-~~~~~k~DV~S~Gv~l~el~tg~~p~~~~~~~~~~~~~~ 716 (792)
........||+.|+|||++.+ ..++.++|||||||++|||++|+.||...........+.
T Consensus 165 ~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~ 244 (388)
T 3oz6_A 165 VTNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGKPIFPGSSTMNQLERII 244 (388)
T ss_dssp CCCCGGGCCC---------------CCCGGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHH
T ss_pred ccccccccccccccccccccccccCCcccCCcCCHHHhcCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH
Confidence 112234579999999999876 679999999999999999999999997653322111110
Q ss_pred HHH-------HHhhcccchhHhhhc----------hhc------------ccCCHHHHHHHHHHHHHccccCCCCCCCHH
Q 003836 717 DWA-------YDRYQERTLEALVEN----------DLE------------AMNNVTMLHRFVMVAFWCIQEDPSHRPTMR 767 (792)
Q Consensus 717 ~~~-------~~~~~~~~~~~~~~~----------~~~------------~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~ 767 (792)
... ...........++.. ... .........++.+|+.+||+.||++|||++
T Consensus 245 ~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~~L~~dP~~R~t~~ 324 (388)
T 3oz6_A 245 GVIDFPSNEDVESIQSPFAKTMIESLKEKVEIRQSNKRDIFTKWKNLLLKINPKADCNEEALDLLDKLLQFNPNKRISAN 324 (388)
T ss_dssp HHHCCCCHHHHHTSCCSSHHHHHHHHHHHCC-----CCCCHHHHHHHHHHHCTTCCCCHHHHHHHHHHCCSSGGGSCCHH
T ss_pred HhcCCCCHHHHHhccCHHHHHHHHhCcccccccCCCHHHhCcchhhhcccccccccCCHHHHHHHHHhhccCcccCCCHH
Confidence 000 000000000000000 000 000012346788999999999999999999
Q ss_pred hHHHH
Q 003836 768 KVTQM 772 (792)
Q Consensus 768 evl~~ 772 (792)
|+++.
T Consensus 325 e~l~H 329 (388)
T 3oz6_A 325 DALKH 329 (388)
T ss_dssp HHTTS
T ss_pred HHhCC
Confidence 99976
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=8.5e-38 Score=338.35 Aligned_cols=265 Identities=23% Similarity=0.333 Sum_probs=198.5
Q ss_pred HHHHHhhhhhhcCccccceEEEeeecCCCceEEEEEEcccccccchHHHHHHHHHhcc--cCCCCcccccceeccC----
Q 003836 498 LVEVTRGFKEELGRGAFGTVYKGFVNMGSSNHVAVKKLNSVFQDSEKEFKAEVNGIGQ--THHKNLVRLLGYCDEG---- 571 (792)
Q Consensus 498 l~~~~~~~~~~lG~G~~g~Vy~g~~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~--l~h~niv~l~g~~~~~---- 571 (792)
.....+.+.+.||+|+||.||+|+.. ++.||||++... ....+..|.+++.. ++||||+++++++.+.
T Consensus 34 ~~~~~y~~~~~lg~G~~g~V~~~~~~---~~~vavK~~~~~---~~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~ 107 (337)
T 3mdy_A 34 TIAKQIQMVKQIGKGRYGEVWMGKWR---GEKVAVKVFFTT---EEASWFRETEIYQTVLMRHENILGFIAADIKGTGSW 107 (337)
T ss_dssp THHHHCEEEEEEEEETTEEEEEEEET---TEEEEEEEEEGG---GHHHHHHHHHHHTSTTCCCTTBCCEEEEEEESCGGG
T ss_pred ccccceEEEeEeecCCCeEEEEEEEC---CceEEEEEEecc---ccchhhhHHHHHHHHhhcCCCeeeEEEEEccCCCCC
Confidence 33445566789999999999999764 678999998643 23444555555544 5999999999999877
Q ss_pred CceEEEEEeccCCCccccccCCCCCchhHHHHHHHHHHHHHHHHhhcc-----CCCeEecCCCCCcEEEcCCCCeEEeec
Q 003836 572 QNRLLVYEFMSNGTVASFLFGDSKPNWKLRTEIAMGIAGGLFYLHEEC-----CTQIIHCDIKPQNILLDDHYNARISDF 646 (792)
Q Consensus 572 ~~~~lV~E~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~-----~~~ivH~dikp~NILl~~~~~~kl~Df 646 (792)
...++||||+++|+|.+++.. ..+++..+..++.|++.||+|||+++ ..+|+||||||+|||++.++.+||+||
T Consensus 108 ~~~~lv~e~~~~g~L~~~l~~-~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dikp~Nill~~~~~~kl~Df 186 (337)
T 3mdy_A 108 TQLYLITDYHENGSLYDYLKS-TTLDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNILVKKNGTCCIADL 186 (337)
T ss_dssp CEEEEEECCCTTCBHHHHHHH-CCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCCEECSCCCGGGEEECTTSCEEECCC
T ss_pred CceEEEEeccCCCcHHHHhhc-cCCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCEEecccchHHEEECCCCCEEEEeC
Confidence 678999999999999999965 46899999999999999999999862 238999999999999999999999999
Q ss_pred CCCccccCCCCCc---cccccccCCcccccccccCCCCcc------cceehHHHHHHHHHhc----------CcCCCcch
Q 003836 647 GLAKLLTLDQSHT---NTAIRGTKGYVAPEWFRNMPITVK------VDVYSYGVLLLEIICL----------RRNIDNEI 707 (792)
Q Consensus 647 g~a~~~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~k------~DV~S~Gv~l~el~tg----------~~p~~~~~ 707 (792)
|+++......... .....||+.|+|||.+.+...+.+ +|||||||++|||++| +.||....
T Consensus 187 g~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~~~~~~~~~~~p~~~~~ 266 (337)
T 3mdy_A 187 GLAVKFISDTNEVDIPPNTRVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEYQLPYHDLV 266 (337)
T ss_dssp TTCEECC---------CCSSCSCGGGCCHHHHTTCCCTTCTHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTTTS
T ss_pred CCceeeccccccccCCCCCCccCcceeChhhcccccCCccccCccccchHHHHHHHHHHHhccCcccccccccccHhhhc
Confidence 9998765433221 124569999999999987766655 9999999999999999 44543321
Q ss_pred hhhhhhhHHHHHHHhhcccchhHhhhchhcccC-----CHHHHHHHHHHHHHccccCCCCCCCHHhHHHHhccCcCCC
Q 003836 708 SKVDKAILTDWAYDRYQERTLEALVENDLEAMN-----NVTMLHRFVMVAFWCIQEDPSHRPTMRKVTQMLEGVVEVP 780 (792)
Q Consensus 708 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-----~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~L~~~~~~~ 780 (792)
..... ..... . ........... ....+.++.+++.+||+.||++|||+.||++.|+.+.+-.
T Consensus 267 ~~~~~--~~~~~-~--------~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~l~~~~ 333 (337)
T 3mdy_A 267 PSDPS--YEDMR-E--------IVCIKKLRPSFPNRWSSDECLRQMGKLMTECWAHNPASRLTALRVKKTLAKMSESQ 333 (337)
T ss_dssp CSSCC--HHHHH-H--------HHTTSCCCCCCCGGGGGSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHTT
T ss_pred CCCCc--hhhhH-H--------HHhhhccCccccccchhhHHHHHHHHHHHHhhhhChhhCCCHHHHHHHHHHHHhhc
Confidence 11100 00000 0 00011111111 2367788999999999999999999999999999876544
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-38 Score=341.45 Aligned_cols=253 Identities=26% Similarity=0.420 Sum_probs=200.8
Q ss_pred hhhhhhcCccccceEEEeeecCCCce--EEEEEEccccc-ccchHHHHHHHHHhccc-CCCCcccccceeccCCceEEEE
Q 003836 503 RGFKEELGRGAFGTVYKGFVNMGSSN--HVAVKKLNSVF-QDSEKEFKAEVNGIGQT-HHKNLVRLLGYCDEGQNRLLVY 578 (792)
Q Consensus 503 ~~~~~~lG~G~~g~Vy~g~~~~~~~~--~vavK~~~~~~-~~~~~~~~~Ei~~l~~l-~h~niv~l~g~~~~~~~~~lV~ 578 (792)
+.+.+.||+|+||.||++..... +. .+|+|++.... ....+.+.+|+++++++ +||||+++++++.+.+..++||
T Consensus 27 y~~~~~lg~G~~g~Vy~~~~~~~-~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv~ 105 (327)
T 1fvr_A 27 IKFQDVIGEGNFGQVLKARIKKD-GLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAI 105 (327)
T ss_dssp CEEEEEEECGGGCEEEEEEEEET-TEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEEEEE
T ss_pred ccceeeeecCCCceEEEEEEccC-CcccceeeeeeccccchHHHHHHHHHHHHHHhccCCCchhhhceeeeeCCceEEEE
Confidence 34567899999999999976533 33 45999887532 33456799999999999 8999999999999999999999
Q ss_pred EeccCCCccccccCCC----------------CCchhHHHHHHHHHHHHHHHHhhccCCCeEecCCCCCcEEEcCCCCeE
Q 003836 579 EFMSNGTVASFLFGDS----------------KPNWKLRTEIAMGIAGGLFYLHEECCTQIIHCDIKPQNILLDDHYNAR 642 (792)
Q Consensus 579 E~~~~gsL~~~l~~~~----------------~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dikp~NILl~~~~~~k 642 (792)
||+++|+|.+++.... .+++..+..++.||+.||+|||+. +|+||||||+|||++.++.+|
T Consensus 106 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~NIl~~~~~~~k 182 (327)
T 1fvr_A 106 EYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQK---QFIHRDLAARNILVGENYVAK 182 (327)
T ss_dssp CCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECGGGCEE
T ss_pred ecCCCCCHHHHHHhcccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCccceEEEcCCCeEE
Confidence 9999999999997653 689999999999999999999998 999999999999999999999
Q ss_pred EeecCCCccccCCCCCccccccccCCcccccccccCCCCcccceehHHHHHHHHHh-cCcCCCcchhhhhhhhHHHHHHH
Q 003836 643 ISDFGLAKLLTLDQSHTNTAIRGTKGYVAPEWFRNMPITVKVDVYSYGVLLLEIIC-LRRNIDNEISKVDKAILTDWAYD 721 (792)
Q Consensus 643 l~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DV~S~Gv~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~ 721 (792)
|+|||+++..... .......+++.|+|||.+.+..++.++||||||+++|||++ |+.||........ ..
T Consensus 183 L~Dfg~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~~~~--------~~ 252 (327)
T 1fvr_A 183 IADFGLSRGQEVY--VKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAEL--------YE 252 (327)
T ss_dssp ECCTTCEESSCEE--CCC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHH--------HH
T ss_pred EcccCcCcccccc--ccccCCCCCccccChhhhccccCCchhcchHHHHHHHHHHcCCCCCCCCCcHHHH--------HH
Confidence 9999999743221 12223456889999999988889999999999999999998 9999965432110 00
Q ss_pred hhcccchhHhhhchhcccCCHHHHHHHHHHHHHccccCCCCCCCHHhHHHHhccCcC
Q 003836 722 RYQERTLEALVENDLEAMNNVTMLHRFVMVAFWCIQEDPSHRPTMRKVTQMLEGVVE 778 (792)
Q Consensus 722 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~L~~~~~ 778 (792)
. +........+...+..+.+++.+||+.+|++|||++|+++.|+.+++
T Consensus 253 ~---------~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~ 300 (327)
T 1fvr_A 253 K---------LPQGYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLE 300 (327)
T ss_dssp H---------GGGTCCCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred H---------hhcCCCCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHH
Confidence 0 11111112223345678899999999999999999999999987643
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-38 Score=331.20 Aligned_cols=244 Identities=27% Similarity=0.364 Sum_probs=199.3
Q ss_pred hhhhhcCccccceEEEeeecCCCceEEEEEEccccc---ccchHHHHHHHHHhcccCCCCcccccceeccCCceEEEEEe
Q 003836 504 GFKEELGRGAFGTVYKGFVNMGSSNHVAVKKLNSVF---QDSEKEFKAEVNGIGQTHHKNLVRLLGYCDEGQNRLLVYEF 580 (792)
Q Consensus 504 ~~~~~lG~G~~g~Vy~g~~~~~~~~~vavK~~~~~~---~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~lV~E~ 580 (792)
.+.+.||+|+||+||++... .+++.||+|++.... ......+.+|+.++++++||||+++++++.+....++||||
T Consensus 12 ~~~~~lg~G~~g~V~~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 90 (279)
T 3fdn_A 12 EIGRPLGKGKFGNVYLAREK-QSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEY 90 (279)
T ss_dssp EEEEEEEECSSEEEEEEEET-TTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEECC
T ss_pred EEeeEEecCCCeEEEEEEEc-cCCcEEEEEEEeccccchhhHHHHHHHHHHHHHcCCCCCCcchhheEecCCEEEEEEec
Confidence 34578999999999999754 456789999986532 22356789999999999999999999999999999999999
Q ss_pred ccCCCccccccCCCCCchhHHHHHHHHHHHHHHHHhhccCCCeEecCCCCCcEEEcCCCCeEEeecCCCccccCCCCCcc
Q 003836 581 MSNGTVASFLFGDSKPNWKLRTEIAMGIAGGLFYLHEECCTQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLDQSHTN 660 (792)
Q Consensus 581 ~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dikp~NILl~~~~~~kl~Dfg~a~~~~~~~~~~~ 660 (792)
+++++|.+++.....+++..+..++.||+.||+|||+. +|+||||||+|||++.++.+||+|||++...... ..
T Consensus 91 ~~~~~l~~~l~~~~~~~~~~~~~~~~qi~~~l~~LH~~---~i~H~dlkp~Nili~~~~~~~l~Dfg~~~~~~~~---~~ 164 (279)
T 3fdn_A 91 APLGTVYRELQKLSKFDEQRTATYITELANALSYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWSVHAPSS---RR 164 (279)
T ss_dssp CTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTT---TCEECCCCGGGEEECTTSCEEECSCCEESCC--------
T ss_pred CCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC---CEecccCChHhEEEcCCCCEEEEeccccccCCcc---cc
Confidence 99999999998778899999999999999999999998 9999999999999999999999999998654322 22
Q ss_pred ccccccCCcccccccccCCCCcccceehHHHHHHHHHhcCcCCCcchhhhhhhhHHHHHHHhhcccchhHhhhchhcccC
Q 003836 661 TAIRGTKGYVAPEWFRNMPITVKVDVYSYGVLLLEIICLRRNIDNEISKVDKAILTDWAYDRYQERTLEALVENDLEAMN 740 (792)
Q Consensus 661 ~~~~gt~~y~aPE~~~~~~~~~k~DV~S~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 740 (792)
....|++.|+|||.+.+..++.++||||||+++|||++|+.||............ .. .....
T Consensus 165 ~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~----------------~~--~~~~~ 226 (279)
T 3fdn_A 165 TDLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRI----------------SR--VEFTF 226 (279)
T ss_dssp ---CCCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHH----------------HH--TCCCC
T ss_pred cccCCCCCccCHhHhccCCCCccchhHhHHHHHHHHHHCCCCCCCCcHHHHHHHH----------------Hh--CCCCC
Confidence 3456899999999999999999999999999999999999999754322110000 00 01112
Q ss_pred CHHHHHHHHHHHHHccccCCCCCCCHHhHHHH
Q 003836 741 NVTMLHRFVMVAFWCIQEDPSHRPTMRKVTQM 772 (792)
Q Consensus 741 ~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~ 772 (792)
+...+..+.+++.+||+.||++|||++|+++.
T Consensus 227 ~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~h 258 (279)
T 3fdn_A 227 PDFVTEGARDLISRLLKHNPSQRPMLREVLEH 258 (279)
T ss_dssp CTTSCHHHHHHHHHHCCSSGGGSCCHHHHHHC
T ss_pred CCcCCHHHHHHHHHHhccChhhCCCHHHHhhC
Confidence 22345678899999999999999999999974
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-38 Score=348.08 Aligned_cols=248 Identities=20% Similarity=0.316 Sum_probs=195.7
Q ss_pred hhhhhhcCccccceEEEeeecCCCceEEEEEEccccc--ccchHHHHHHHHHhcccC--CCCcccccceeccCCceEEEE
Q 003836 503 RGFKEELGRGAFGTVYKGFVNMGSSNHVAVKKLNSVF--QDSEKEFKAEVNGIGQTH--HKNLVRLLGYCDEGQNRLLVY 578 (792)
Q Consensus 503 ~~~~~~lG~G~~g~Vy~g~~~~~~~~~vavK~~~~~~--~~~~~~~~~Ei~~l~~l~--h~niv~l~g~~~~~~~~~lV~ 578 (792)
+.+.+.||+|+||.||++... .++.||||++.... ....+.+.+|+.++.+++ |+||+++++++...+..++||
T Consensus 58 y~~~~~LG~G~fg~Vy~~~~~--~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~~~~~~iv~~~~~~~~~~~~~lv~ 135 (390)
T 2zmd_A 58 YSILKQIGSGGSSKVFQVLNE--KKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVM 135 (390)
T ss_dssp EEEEEEEECCSSEEEEEEECT--TCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEE
T ss_pred eEEEEEEccCCCeEEEEEEcC--CCCEEEEEEEecccccHHHHHHHHHHHHHHHHcccCCCeEEEEEEEEecCCEEEEEE
Confidence 345678999999999999754 36789999986532 334578999999999996 599999999999999999999
Q ss_pred EeccCCCccccccCCCCCchhHHHHHHHHHHHHHHHHhhccCCCeEecCCCCCcEEEcCCCCeEEeecCCCccccCCCCC
Q 003836 579 EFMSNGTVASFLFGDSKPNWKLRTEIAMGIAGGLFYLHEECCTQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLDQSH 658 (792)
Q Consensus 579 E~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dikp~NILl~~~~~~kl~Dfg~a~~~~~~~~~ 658 (792)
| +.+++|.+++.....+++..+..++.||+.||.|||+. +|+||||||+|||++ ++.+||+|||+++........
T Consensus 136 E-~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~lH~~---~ivHrDlkp~NIll~-~~~~kl~DFG~a~~~~~~~~~ 210 (390)
T 2zmd_A 136 E-CGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQH---GIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDTTS 210 (390)
T ss_dssp E-CCSEEHHHHHHHCSSCCHHHHHHHHHHHHHHHHHHHTT---TCCCCCCCGGGEEES-SSCEEECCCSSSCCC------
T ss_pred e-cCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCHHHEEEE-CCeEEEEecCccccccCCCcc
Confidence 9 67889999998888889999999999999999999998 999999999999996 579999999999876543322
Q ss_pred -ccccccccCCccccccccc-----------CCCCcccceehHHHHHHHHHhcCcCCCcchhhhhhhhHHHHHHHhhccc
Q 003836 659 -TNTAIRGTKGYVAPEWFRN-----------MPITVKVDVYSYGVLLLEIICLRRNIDNEISKVDKAILTDWAYDRYQER 726 (792)
Q Consensus 659 -~~~~~~gt~~y~aPE~~~~-----------~~~~~k~DV~S~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 726 (792)
......||+.|+|||++.+ ..++.++|||||||++|||++|+.||........
T Consensus 211 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~--------------- 275 (390)
T 2zmd_A 211 VVKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQIS--------------- 275 (390)
T ss_dssp ---CCSCCCGGGCCHHHHHCC------------CCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHH---------------
T ss_pred ccCCCCCcCCCccChHHhhhccccccccccccCCCChhhHHHHHHHHHHHHHCCCcchhhhHHHH---------------
Confidence 2334579999999999865 4689999999999999999999999965322111
Q ss_pred chhHhhhchhcccCCHHHHHHHHHHHHHccccCCCCCCCHHhHHHH
Q 003836 727 TLEALVENDLEAMNNVTMLHRFVMVAFWCIQEDPSHRPTMRKVTQM 772 (792)
Q Consensus 727 ~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~ 772 (792)
.+..+++.......+.....++.+++.+||+.||.+|||+.|+++.
T Consensus 276 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~ell~h 321 (390)
T 2zmd_A 276 KLHAIIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAH 321 (390)
T ss_dssp HHHHHHCTTSCCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred HHHHHhCccccCCCCccchHHHHHHHHHHcccChhhCCCHHHHhhC
Confidence 0112222222222222234678899999999999999999999864
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-38 Score=330.41 Aligned_cols=244 Identities=24% Similarity=0.368 Sum_probs=180.0
Q ss_pred hhhhcCccccceEEEeeecCCCceEEEEEEccccc---ccchHHHHHHHHHhcccCCCCcccccceeccCCceEEEEEec
Q 003836 505 FKEELGRGAFGTVYKGFVNMGSSNHVAVKKLNSVF---QDSEKEFKAEVNGIGQTHHKNLVRLLGYCDEGQNRLLVYEFM 581 (792)
Q Consensus 505 ~~~~lG~G~~g~Vy~g~~~~~~~~~vavK~~~~~~---~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~lV~E~~ 581 (792)
+.+.||+|+||.||+|... .+++.||||++.... ....+.+.+|+.++++++||||+++++++.+.+..++||||+
T Consensus 15 ~~~~lg~G~~g~Vy~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 93 (278)
T 3cok_A 15 VGNLLGKGSFAGVYRAESI-HTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYNYFEDSNYVYLVLEMC 93 (278)
T ss_dssp EEEEEEECSSEEEEEEEET-TTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTBCCTTBCCEEEEEECSSEEEEEEECC
T ss_pred eeeeecCCCceEEEEEEEc-cCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHhCCCCCeEeEEEEEccCCeEEEEEecC
Confidence 4578999999999999753 456789999986532 223477999999999999999999999999999999999999
Q ss_pred cCCCccccccCC-CCCchhHHHHHHHHHHHHHHHHhhccCCCeEecCCCCCcEEEcCCCCeEEeecCCCccccCCCCCcc
Q 003836 582 SNGTVASFLFGD-SKPNWKLRTEIAMGIAGGLFYLHEECCTQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLDQSHTN 660 (792)
Q Consensus 582 ~~gsL~~~l~~~-~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dikp~NILl~~~~~~kl~Dfg~a~~~~~~~~~~~ 660 (792)
++++|.+++... ..+++..+..++.||+.||+|||+. +|+|+||||+|||++.++.+||+|||++........ ..
T Consensus 94 ~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~~-~~ 169 (278)
T 3cok_A 94 HNGEMNRYLKNRVKPFSENEARHFMHQIITGMLYLHSH---GILHRDLTLSNLLLTRNMNIKIADFGLATQLKMPHE-KH 169 (278)
T ss_dssp TTEEHHHHHHTCSSCCCHHHHHHHHHHHHHHHHHHHHT---TEECSSCCGGGEEECTTCCEEECCCTTCEECC-------
T ss_pred CCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCCEEEEeecceeeccCCCC-cc
Confidence 999999999765 5789999999999999999999998 999999999999999999999999999987643322 12
Q ss_pred ccccccCCcccccccccCCCCcccceehHHHHHHHHHhcCcCCCcchhhhhhhhHHHHHHHhhcccchhHhhhchhcccC
Q 003836 661 TAIRGTKGYVAPEWFRNMPITVKVDVYSYGVLLLEIICLRRNIDNEISKVDKAILTDWAYDRYQERTLEALVENDLEAMN 740 (792)
Q Consensus 661 ~~~~gt~~y~aPE~~~~~~~~~k~DV~S~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 740 (792)
....||+.|+|||.+.+..++.++||||||+++|||++|+.||........ +..+..... ..
T Consensus 170 ~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~----------------~~~~~~~~~--~~ 231 (278)
T 3cok_A 170 YTLCGTPNYISPEIATRSAHGLESDVWSLGCMFYTLLIGRPPFDTDTVKNT----------------LNKVVLADY--EM 231 (278)
T ss_dssp ----------------------CTHHHHHHHHHHHHHHSSCSSCCCSCC---------------------CCSSCC--CC
T ss_pred eeccCCCCcCCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCChhHHHH----------------HHHHhhccc--CC
Confidence 235689999999999998999999999999999999999999975432110 000000000 11
Q ss_pred CHHHHHHHHHHHHHccccCCCCCCCHHhHHH
Q 003836 741 NVTMLHRFVMVAFWCIQEDPSHRPTMRKVTQ 771 (792)
Q Consensus 741 ~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~ 771 (792)
+...+.++.+++.+||+.||++|||++++++
T Consensus 232 ~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~ 262 (278)
T 3cok_A 232 PSFLSIEAKDLIHQLLRRNPADRLSLSSVLD 262 (278)
T ss_dssp CTTSCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred ccccCHHHHHHHHHHcccCHhhCCCHHHHhc
Confidence 2234567889999999999999999999987
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-38 Score=332.75 Aligned_cols=244 Identities=27% Similarity=0.405 Sum_probs=195.6
Q ss_pred hhhhcCccccceEEEeeecCCCceEEEEEEccccc--ccchHHHHHHHHHhcccCCCCcccccceecc----CCceEEEE
Q 003836 505 FKEELGRGAFGTVYKGFVNMGSSNHVAVKKLNSVF--QDSEKEFKAEVNGIGQTHHKNLVRLLGYCDE----GQNRLLVY 578 (792)
Q Consensus 505 ~~~~lG~G~~g~Vy~g~~~~~~~~~vavK~~~~~~--~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~----~~~~~lV~ 578 (792)
+.+.||+|+||+||+|... .++..||+|++.... ....+.+.+|+.++++++||||+++++++.. ....++||
T Consensus 30 ~~~~lg~G~~g~Vy~~~~~-~~~~~va~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~lv~ 108 (290)
T 1t4h_A 30 FDIEIGRGSFKTVYKGLDT-ETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVT 108 (290)
T ss_dssp EEEEEEECSSEEEEEEEET-TTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEEEEE
T ss_pred eeeeccCCCCeEEEEeEec-CCceEEEEEEecchhhCHHHHHHHHHHHHHHHhCCCCCeeeeeeeeccccCCCceEEEEE
Confidence 4567999999999999654 566789999987532 3345678999999999999999999998864 45689999
Q ss_pred EeccCCCccccccCCCCCchhHHHHHHHHHHHHHHHHhhccCCC--eEecCCCCCcEEEc-CCCCeEEeecCCCccccCC
Q 003836 579 EFMSNGTVASFLFGDSKPNWKLRTEIAMGIAGGLFYLHEECCTQ--IIHCDIKPQNILLD-DHYNARISDFGLAKLLTLD 655 (792)
Q Consensus 579 E~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~--ivH~dikp~NILl~-~~~~~kl~Dfg~a~~~~~~ 655 (792)
||+++++|.+++.....+++..+..++.||+.||.|||+. + |+||||||+|||++ +++.+||+|||++......
T Consensus 109 e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~~~i~H~dikp~Nil~~~~~~~~kl~Dfg~~~~~~~~ 185 (290)
T 1t4h_A 109 ELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLHTR---TPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRAS 185 (290)
T ss_dssp ECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTS---SSCCCCSCCCGGGEEESSTTSCEEECCTTGGGGCCTT
T ss_pred EecCCCCHHHHHHHccCCCHHHHHHHHHHHHHHHHHHHcC---CCCEEECCCCHHHEEEECCCCCEEEeeCCCccccccc
Confidence 9999999999998778899999999999999999999998 7 99999999999998 7899999999999754322
Q ss_pred CCCccccccccCCcccccccccCCCCcccceehHHHHHHHHHhcCcCCCcchhhhhhhhHHHHHHHhhcccchhHhhhch
Q 003836 656 QSHTNTAIRGTKGYVAPEWFRNMPITVKVDVYSYGVLLLEIICLRRNIDNEISKVDKAILTDWAYDRYQERTLEALVEND 735 (792)
Q Consensus 656 ~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DV~S~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 735 (792)
......||+.|+|||.+. ..++.++||||||+++|||++|+.||......... .........
T Consensus 186 ---~~~~~~~t~~y~aPE~~~-~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~-------~~~~~~~~~------- 247 (290)
T 1t4h_A 186 ---FAKAVIGTPEFMAPEMYE-EKYDESVDVYAFGMCMLEMATSEYPYSECQNAAQI-------YRRVTSGVK------- 247 (290)
T ss_dssp ---SBEESCSSCCCCCGGGGG-TCCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHH-------HHHHTTTCC-------
T ss_pred ---ccccccCCcCcCCHHHHh-ccCCCcchHHHHHHHHHHHHhCCCCCCCcCcHHHH-------HHHHhccCC-------
Confidence 223456899999999886 45899999999999999999999999653322110 000011000
Q ss_pred hcccCCHHHHHHHHHHHHHccccCCCCCCCHHhHHH
Q 003836 736 LEAMNNVTMLHRFVMVAFWCIQEDPSHRPTMRKVTQ 771 (792)
Q Consensus 736 ~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~ 771 (792)
....+...+.++.+++.+||+.||.+|||++|+++
T Consensus 248 -~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~ 282 (290)
T 1t4h_A 248 -PASFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLN 282 (290)
T ss_dssp -CGGGGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred -ccccCCCCCHHHHHHHHHHccCChhhCCCHHHHhh
Confidence 00111122356889999999999999999999997
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-38 Score=337.19 Aligned_cols=259 Identities=20% Similarity=0.332 Sum_probs=195.7
Q ss_pred hhhhhhcCccccceEEEeeecCCCceEEEEEEccccc---ccchHHHHHHHHHhcccCCCCcccccceeccCCceEEEEE
Q 003836 503 RGFKEELGRGAFGTVYKGFVNMGSSNHVAVKKLNSVF---QDSEKEFKAEVNGIGQTHHKNLVRLLGYCDEGQNRLLVYE 579 (792)
Q Consensus 503 ~~~~~~lG~G~~g~Vy~g~~~~~~~~~vavK~~~~~~---~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~lV~E 579 (792)
+.+.+.||+|+||.||+|... .+++.||+|++.... ......+.+|+.++++++||||+++++++.+.+..++|||
T Consensus 34 y~~~~~lg~G~~g~Vy~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 112 (310)
T 2wqm_A 34 FRIEKKIGRGQFSEVYRAACL-LDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVLE 112 (310)
T ss_dssp EEEEEEEECC--CEEEEEEET-TTCCEEEEEEECTTSSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred eEEEEeecCCCCceEEEEEEc-CCCceEEEEeeehhhccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCcEEEEEe
Confidence 445678999999999999754 456799999987532 3345678999999999999999999999999999999999
Q ss_pred eccCCCccccccC----CCCCchhHHHHHHHHHHHHHHHHhhccCCCeEecCCCCCcEEEcCCCCeEEeecCCCccccCC
Q 003836 580 FMSNGTVASFLFG----DSKPNWKLRTEIAMGIAGGLFYLHEECCTQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLD 655 (792)
Q Consensus 580 ~~~~gsL~~~l~~----~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dikp~NILl~~~~~~kl~Dfg~a~~~~~~ 655 (792)
|+++++|.+++.. ...+++..+..++.||+.||.|||+. +|+|+||||+|||++.++.+||+|||+++.....
T Consensus 113 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~---~i~H~dl~p~NIl~~~~~~~kl~Dfg~~~~~~~~ 189 (310)
T 2wqm_A 113 LADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMHSR---RVMHRDIKPANVFITATGVVKLGDLGLGRFFSSK 189 (310)
T ss_dssp CCCSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEECCC---------
T ss_pred cCCCCCHHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHhhC---CeeCCCCcHHHEEEcCCCCEEEEeccceeeecCC
Confidence 9999999999864 45688999999999999999999998 9999999999999999999999999999865432
Q ss_pred CCCccccccccCCcccccccccCCCCcccceehHHHHHHHHHhcCcCCCcchhhhhhhhHHHHHHHhhcccchhHhhhch
Q 003836 656 QSHTNTAIRGTKGYVAPEWFRNMPITVKVDVYSYGVLLLEIICLRRNIDNEISKVDKAILTDWAYDRYQERTLEALVEND 735 (792)
Q Consensus 656 ~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DV~S~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 735 (792)
.. ......|++.|+|||.+.+..++.++||||||+++|||++|+.||......... + . . .+....
T Consensus 190 ~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~--~---~-~--------~~~~~~ 254 (310)
T 2wqm_A 190 TT-AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYS--L---C-K--------KIEQCD 254 (310)
T ss_dssp ----------CCSSCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTC---CCHHH--H---H-H--------HHHTTC
T ss_pred Cc-cccccCCCeeEeChHHhCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchhHHH--H---H-H--------Hhhccc
Confidence 22 223346899999999999999999999999999999999999999653221100 0 0 0 000001
Q ss_pred hcccCCHHHHHHHHHHHHHccccCCCCCCCHHhHHHHhccCcCCC
Q 003836 736 LEAMNNVTMLHRFVMVAFWCIQEDPSHRPTMRKVTQMLEGVVEVP 780 (792)
Q Consensus 736 ~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~L~~~~~~~ 780 (792)
.........+.++.+++.+||+.||++|||+++|++.|+.+....
T Consensus 255 ~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~il~~l~~l~~~~ 299 (310)
T 2wqm_A 255 YPPLPSDHYSEELRQLVNMCINPDPEKRPDVTYVYDVAKRMHACT 299 (310)
T ss_dssp SCCCCTTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred CCCCcccccCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHHhh
Confidence 111111234567889999999999999999999999999876443
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-38 Score=341.53 Aligned_cols=262 Identities=18% Similarity=0.267 Sum_probs=191.9
Q ss_pred hhhhhhcCccccceEEEeeecCCCceEEEEEEcccccc--cchHHHHHHHHHhcccCCCCcccccceeccCCceEEEEEe
Q 003836 503 RGFKEELGRGAFGTVYKGFVNMGSSNHVAVKKLNSVFQ--DSEKEFKAEVNGIGQTHHKNLVRLLGYCDEGQNRLLVYEF 580 (792)
Q Consensus 503 ~~~~~~lG~G~~g~Vy~g~~~~~~~~~vavK~~~~~~~--~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~lV~E~ 580 (792)
+.+.+.||+|+||+||++.. ..+++.||||++..... ...+.+.+|++++++++||||+++++++.+.+..++||||
T Consensus 36 y~~~~~lg~G~~g~V~~~~~-~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 114 (329)
T 3gbz_A 36 YRRITKLGEGTYGEVYKAID-TVTNETVAIKRIRLEHEEEGVPGTAIREVSLLKELQHRNIIELKSVIHHNHRLHLIFEY 114 (329)
T ss_dssp EEEEEEEEECSSSEEEEEEE-TTTTEEEEEEECCCCC--------CHHHHHHGGGCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred EEEEEEEEecCCeEEEEEEE-CCCCceEEEEEEcccccccccchhHHHHHHHHHHcCCCCcceEEEEEecCCEEEEEEec
Confidence 34457899999999999964 35678999999975432 2345678999999999999999999999999999999999
Q ss_pred ccCCCccccccCCCCCchhHHHHHHHHHHHHHHHHhhccCCCeEecCCCCCcEEEc-----CCCCeEEeecCCCccccCC
Q 003836 581 MSNGTVASFLFGDSKPNWKLRTEIAMGIAGGLFYLHEECCTQIIHCDIKPQNILLD-----DHYNARISDFGLAKLLTLD 655 (792)
Q Consensus 581 ~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dikp~NILl~-----~~~~~kl~Dfg~a~~~~~~ 655 (792)
+++ +|.+++.....+++..+..|+.||+.||+|||+. +|+||||||+|||++ +++.+||+|||+++.....
T Consensus 115 ~~~-~L~~~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~---~ivH~Dlkp~NIll~~~~~~~~~~~kl~Dfg~a~~~~~~ 190 (329)
T 3gbz_A 115 AEN-DLKKYMDKNPDVSMRVIKSFLYQLINGVNFCHSR---RCLHRDLKPQNLLLSVSDASETPVLKIGDFGLARAFGIP 190 (329)
T ss_dssp CSE-EHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEEC-----CCEEEECCTTHHHHHC--
T ss_pred CCC-CHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhC---CEECCCCCHHHEEEecCCCCccceEEECcCCCccccCCc
Confidence 985 9999998888899999999999999999999999 999999999999994 4556999999999876432
Q ss_pred CCCccccccccCCcccccccccC-CCCcccceehHHHHHHHHHhcCcCCCcchhhhhhhhHHHHHHHhhcccchh-----
Q 003836 656 QSHTNTAIRGTKGYVAPEWFRNM-PITVKVDVYSYGVLLLEIICLRRNIDNEISKVDKAILTDWAYDRYQERTLE----- 729 (792)
Q Consensus 656 ~~~~~~~~~gt~~y~aPE~~~~~-~~~~k~DV~S~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~----- 729 (792)
.. ......||+.|+|||.+.+. .++.++|||||||++|||++|+.||................ .........
T Consensus 191 ~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~ 268 (329)
T 3gbz_A 191 IR-QFTHEIITLWYRPPEILLGSRHYSTSVDIWSIACIWAEMLMKTPLFPGDSEIDQLFKIFEVL-GLPDDTTWPGVTAL 268 (329)
T ss_dssp ----------CCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHH-CCCCTTTSTTGGGS
T ss_pred cc-ccCCCcCCccccCHHHhcCCCCCCcHHHHHHHHHHHHHHHHCCCCcCCCCHHHHHHHHHHHh-CCCchhhhhhhhhh
Confidence 22 22344679999999999774 58999999999999999999999997654322111110000 000000000
Q ss_pred --------HhhhchhcccCCHHHHHHHHHHHHHccccCCCCCCCHHhHHH
Q 003836 730 --------ALVENDLEAMNNVTMLHRFVMVAFWCIQEDPSHRPTMRKVTQ 771 (792)
Q Consensus 730 --------~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~ 771 (792)
......+..........++.+++.+||+.||++|||++|+++
T Consensus 269 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 318 (329)
T 3gbz_A 269 PDWKQSFPKFRGKTLKRVLGALLDDEGLDLLTAMLEMDPVKRISAKNALE 318 (329)
T ss_dssp TTCCTTCCCCCCCCHHHHHGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred hhhhhhhhhhccccHhhhcccccCHHHHHHHHHHccCChhhCCCHHHHhC
Confidence 000000000001113467889999999999999999999997
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-38 Score=359.04 Aligned_cols=248 Identities=28% Similarity=0.331 Sum_probs=202.8
Q ss_pred hhhhcCccccceEEEeeecCCCceEEEEEEcccc---cccchHHHHHHHHHhcccCCCCcccccceeccCCceEEEEEec
Q 003836 505 FKEELGRGAFGTVYKGFVNMGSSNHVAVKKLNSV---FQDSEKEFKAEVNGIGQTHHKNLVRLLGYCDEGQNRLLVYEFM 581 (792)
Q Consensus 505 ~~~~lG~G~~g~Vy~g~~~~~~~~~vavK~~~~~---~~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~lV~E~~ 581 (792)
+.+.||+|+||.||++... .+++.||+|++.+. .......+.+|++++++++||||+++++++.+.+..++||||+
T Consensus 188 ~~~~LG~G~fG~Vy~a~~~-~tg~~vAvK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~lVmEy~ 266 (576)
T 2acx_A 188 QYRVLGKGGFGEVCACQVR-ATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLTLM 266 (576)
T ss_dssp EEEEEEEETTEEEEEEEET-TTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECCC
T ss_pred EEEEEeeCCCEEEEEEEEC-CCCCEEEEEEEEhHhhhhhHHHHHHHHHHHHHHHcCCCCEeeEEEEEeeCCEEEEEEEcC
Confidence 4468999999999999754 46789999998653 2334567899999999999999999999999999999999999
Q ss_pred cCCCccccccCCC--CCchhHHHHHHHHHHHHHHHHhhccCCCeEecCCCCCcEEEcCCCCeEEeecCCCccccCCCCCc
Q 003836 582 SNGTVASFLFGDS--KPNWKLRTEIAMGIAGGLFYLHEECCTQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLDQSHT 659 (792)
Q Consensus 582 ~~gsL~~~l~~~~--~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dikp~NILl~~~~~~kl~Dfg~a~~~~~~~~~~ 659 (792)
++|+|.+++.... .+++..+..++.||+.||.|||++ +|+||||||+||||+.++.+||+|||+++...... .
T Consensus 267 ~gg~L~~~l~~~~~~~l~e~~~~~i~~qIl~aL~yLH~~---gIvHrDLKPeNILld~~g~vKL~DFGla~~~~~~~--~ 341 (576)
T 2acx_A 267 NGGDLKFHIYHMGQAGFPEARAVFYAAEICCGLEDLHRE---RIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQ--T 341 (576)
T ss_dssp CSCBHHHHHHSSSSCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTSCEEECCCTTCEECCTTC--C
T ss_pred CCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHC---CEeccCCchheEEEeCCCCeEEEecccceecccCc--c
Confidence 9999999997653 489999999999999999999999 99999999999999999999999999998764332 2
Q ss_pred cccccccCCcccccccccCCCCcccceehHHHHHHHHHhcCcCCCcchhhhhhhhHHHHHHHhhcccchhHhhhchhccc
Q 003836 660 NTAIRGTKGYVAPEWFRNMPITVKVDVYSYGVLLLEIICLRRNIDNEISKVDKAILTDWAYDRYQERTLEALVENDLEAM 739 (792)
Q Consensus 660 ~~~~~gt~~y~aPE~~~~~~~~~k~DV~S~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 739 (792)
.....||+.|+|||++.+..++.++|||||||++|||++|+.||...........+.. .+. .....
T Consensus 342 ~~~~~GT~~Y~APEvl~~~~~~~~~DiwSLGvilyeLltG~~PF~~~~~~~~~~~i~~-------------~i~-~~~~~ 407 (576)
T 2acx_A 342 IKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVER-------------LVK-EVPEE 407 (576)
T ss_dssp EECCCSCGGGCCHHHHTTCEESSHHHHHHHHHHHHHHHHSSCSSSCSSSCCCHHHHHH-------------HHH-HCCCC
T ss_pred ccccCCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCcccccchhHHHHHH-------------Hhh-ccccc
Confidence 2345799999999999998999999999999999999999999976432211111100 000 00111
Q ss_pred CCHHHHHHHHHHHHHccccCCCCCC-----CHHhHHHH
Q 003836 740 NNVTMLHRFVMVAFWCIQEDPSHRP-----TMRKVTQM 772 (792)
Q Consensus 740 ~~~~~~~~l~~l~~~Cl~~~p~~RP-----s~~evl~~ 772 (792)
.+...+.++.+++.+||+.||.+|| +++||++.
T Consensus 408 ~p~~~s~~~~dLI~~lL~~dP~~R~g~~~~sa~eil~H 445 (576)
T 2acx_A 408 YSERFSPQARSLCSQLLCKDPAERLGCRGGSAREVKEH 445 (576)
T ss_dssp CCTTSCHHHHHHHHHHTCSSGGGSTTCSSSHHHHHHTS
T ss_pred CCccCCHHHHHHHHHhccCCHHHcCCCCCCCHHHHHhC
Confidence 2233456788999999999999999 78888864
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-38 Score=333.17 Aligned_cols=254 Identities=23% Similarity=0.346 Sum_probs=202.7
Q ss_pred HHHHHhhhhhhcCccccceEEEeeecCCCceEEEEEEcccccccchHHHHHHHHHhcccCCCCcccccceecc-------
Q 003836 498 LVEVTRGFKEELGRGAFGTVYKGFVNMGSSNHVAVKKLNSVFQDSEKEFKAEVNGIGQTHHKNLVRLLGYCDE------- 570 (792)
Q Consensus 498 l~~~~~~~~~~lG~G~~g~Vy~g~~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~------- 570 (792)
.....+.+.+.||+|+||.||++... .+++.||+|++.... +.+.+|++++++++||||+++++++..
T Consensus 8 ~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~~vavK~~~~~~----~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 82 (284)
T 2a19_B 8 RFGMDFKEIELIGSGGFGQVFKAKHR-IDGKTYVIKRVKYNN----EKAEREVKALAKLDHVNIVHYNGCWDGFDYDPET 82 (284)
T ss_dssp HHHHHEEEEEEEECSSSCCEEEEEET-TTCCEEEEEEEECCS----GGGHHHHHHHHHCCCTTBCCEEEEEEEEEEC---
T ss_pred hhccccceeeeeccCCceEEEEEEEc-CCCeEEEEEEecccc----HHHHHHHHHHHhCCCCCEEEEeeeEeccccCccc
Confidence 33444556688999999999999764 456799999987542 457789999999999999999998854
Q ss_pred ---------CCceEEEEEeccCCCccccccCC--CCCchhHHHHHHHHHHHHHHHHhhccCCCeEecCCCCCcEEEcCCC
Q 003836 571 ---------GQNRLLVYEFMSNGTVASFLFGD--SKPNWKLRTEIAMGIAGGLFYLHEECCTQIIHCDIKPQNILLDDHY 639 (792)
Q Consensus 571 ---------~~~~~lV~E~~~~gsL~~~l~~~--~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dikp~NILl~~~~ 639 (792)
....++||||+++++|.+++... ..+++..+..++.||+.||.|||+. +|+|+||||+|||+++++
T Consensus 83 ~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~ 159 (284)
T 2a19_B 83 SSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALELFEQITKGVDYIHSK---KLINRDLKPSNIFLVDTK 159 (284)
T ss_dssp ------CCEEEEEEEEECCCCSCBHHHHHHHGGGSCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEEETT
T ss_pred ccccccccCcceEEEEEeccCCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeeccCCHHHEEEcCCC
Confidence 44578999999999999999654 5789999999999999999999998 999999999999999999
Q ss_pred CeEEeecCCCccccCCCCCccccccccCCcccccccccCCCCcccceehHHHHHHHHHhcCcCCCcchhhhhhhhHHHHH
Q 003836 640 NARISDFGLAKLLTLDQSHTNTAIRGTKGYVAPEWFRNMPITVKVDVYSYGVLLLEIICLRRNIDNEISKVDKAILTDWA 719 (792)
Q Consensus 640 ~~kl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DV~S~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~ 719 (792)
.+||+|||+++...... ......|++.|+|||.+.+..++.++||||||+++|||++|..|+..... .
T Consensus 160 ~~kl~Dfg~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~~----------~ 227 (284)
T 2a19_B 160 QVKIGDFGLVTSLKNDG--KRTRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDTAFETSK----------F 227 (284)
T ss_dssp EEEECCCTTCEESSCCS--CCCCCCSCCTTSCHHHHHCSCCCTHHHHHHHHHHHHHHHSCCSSHHHHHH----------H
T ss_pred CEEECcchhheeccccc--cccccCCcccccChhhhccCCCcchhhhHHHHHHHHHHHhcCCcchhHHH----------H
Confidence 99999999998765432 22334689999999999999999999999999999999999987632110 0
Q ss_pred HHhhcccchhHhhhchhcccCCHHHHHHHHHHHHHccccCCCCCCCHHhHHHHhccCcCCCCCC
Q 003836 720 YDRYQERTLEALVENDLEAMNNVTMLHRFVMVAFWCIQEDPSHRPTMRKVTQMLEGVVEVPIPP 783 (792)
Q Consensus 720 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~L~~~~~~~~p~ 783 (792)
.. .+..... +...+..+.+++.+||+.||++|||+.|+++.|+.+..-+...
T Consensus 228 ~~--------~~~~~~~----~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~~l~~~~~~~~~~ 279 (284)
T 2a19_B 228 FT--------DLRDGII----SDIFDKKEKTLLQKLLSKKPEDRPNTSEILRTLTVWKKSPEKN 279 (284)
T ss_dssp HH--------HHHTTCC----CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHTC-----
T ss_pred HH--------Hhhcccc----cccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHhhCCCcc
Confidence 00 0111111 1123456788999999999999999999999998876554443
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-37 Score=335.40 Aligned_cols=260 Identities=23% Similarity=0.325 Sum_probs=204.6
Q ss_pred cCHHHHHHHHhhhh-hhcCccccceEEEeeecCCCceEEEEEEccccc--ccchHHHHHHHHHhccc-CCCCccccccee
Q 003836 493 FTYKELVEVTRGFK-EELGRGAFGTVYKGFVNMGSSNHVAVKKLNSVF--QDSEKEFKAEVNGIGQT-HHKNLVRLLGYC 568 (792)
Q Consensus 493 ~~~~el~~~~~~~~-~~lG~G~~g~Vy~g~~~~~~~~~vavK~~~~~~--~~~~~~~~~Ei~~l~~l-~h~niv~l~g~~ 568 (792)
|...+.....+.+. +.||+|+||+||++... .+++.||+|++.... ......+.+|+.++.++ +||||+++++++
T Consensus 20 ~~~~~~~~~~y~~~~~~lG~G~~g~V~~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~iv~~~~~~ 98 (327)
T 3lm5_A 20 FQSMENFNNFYILTSKELGRGKFAVVRQCISK-STGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINLHEVY 98 (327)
T ss_dssp SBCHHHHHHHEEEEEEEEEEETTEEEEEEEET-TTCCEEEEEEEESEETTEECHHHHHHHHHHHHHTTTCTTBCCEEEEE
T ss_pred HHHHHhhhhEEeeccceeCCCCCeEEEEEEEC-CCCCEEEEEEEehhhcchHHHHHHHHHHHHHHhccCCCCEEEEEEEE
Confidence 34444455555555 78999999999999754 456899999987543 23467899999999999 569999999999
Q ss_pred ccCCceEEEEEeccCCCccccccCC--CCCchhHHHHHHHHHHHHHHHHhhccCCCeEecCCCCCcEEEcC---CCCeEE
Q 003836 569 DEGQNRLLVYEFMSNGTVASFLFGD--SKPNWKLRTEIAMGIAGGLFYLHEECCTQIIHCDIKPQNILLDD---HYNARI 643 (792)
Q Consensus 569 ~~~~~~~lV~E~~~~gsL~~~l~~~--~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dikp~NILl~~---~~~~kl 643 (792)
.+.+..++||||+++|+|.+++... ..+++..+..++.||+.||+|||+. +|+||||||+|||++. ++.+||
T Consensus 99 ~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~ql~~~L~~LH~~---givH~Dikp~NIl~~~~~~~~~~kL 175 (327)
T 3lm5_A 99 ENTSEIILILEYAAGGEIFSLCLPELAEMVSENDVIRLIKQILEGVYYLHQN---NIVHLDLKPQNILLSSIYPLGDIKI 175 (327)
T ss_dssp ECSSEEEEEEECCTTEEGGGGGSSCC-CCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEESCBTTBCCEEE
T ss_pred EeCCeEEEEEEecCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHC---CeecCcCChHHEEEecCCCCCcEEE
Confidence 9999999999999999999999654 6789999999999999999999999 9999999999999998 789999
Q ss_pred eecCCCccccCCCCCccccccccCCcccccccccCCCCcccceehHHHHHHHHHhcCcCCCcchhhhhhhhHHHHHHHhh
Q 003836 644 SDFGLAKLLTLDQSHTNTAIRGTKGYVAPEWFRNMPITVKVDVYSYGVLLLEIICLRRNIDNEISKVDKAILTDWAYDRY 723 (792)
Q Consensus 644 ~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DV~S~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~ 723 (792)
+|||+++...... ......||+.|+|||.+.+..++.++||||||+++|||++|+.||...........+ . .
T Consensus 176 ~Dfg~a~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i---~--~- 247 (327)
T 3lm5_A 176 VDFGMSRKIGHAC--ELREIMGTPEYLAPEILNYDPITTATDMWNIGIIAYMLLTHTSPFVGEDNQETYLNI---S--Q- 247 (327)
T ss_dssp CCGGGCEEC-----------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHH---H--H-
T ss_pred eeCccccccCCcc--ccccccCCcCccCCeeecCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchHHHHHH---H--h-
Confidence 9999998764322 223456899999999999999999999999999999999999999764332111000 0 0
Q ss_pred cccchhHhhhchhcccCCHHHHHHHHHHHHHccccCCCCCCCHHhHHHH
Q 003836 724 QERTLEALVENDLEAMNNVTMLHRFVMVAFWCIQEDPSHRPTMRKVTQM 772 (792)
Q Consensus 724 ~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~ 772 (792)
.............+..+.+++.+||+.||++|||++|+++.
T Consensus 248 --------~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~~ll~h 288 (327)
T 3lm5_A 248 --------VNVDYSEETFSSVSQLATDFIQSLLVKNPEKRPTAEICLSH 288 (327)
T ss_dssp --------TCCCCCTTTTTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTC
T ss_pred --------cccccCchhhcccCHHHHHHHHHHcCCChhhCcCHHHHhCC
Confidence 00011111112345678899999999999999999999874
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-38 Score=348.32 Aligned_cols=270 Identities=19% Similarity=0.246 Sum_probs=208.7
Q ss_pred hhhhhhcCccccceEEEeeecCCCceEEEEEEccccc-ccchHHHHHHHHHhcccCCCCcccccceeccCC--ceEEEEE
Q 003836 503 RGFKEELGRGAFGTVYKGFVNMGSSNHVAVKKLNSVF-QDSEKEFKAEVNGIGQTHHKNLVRLLGYCDEGQ--NRLLVYE 579 (792)
Q Consensus 503 ~~~~~~lG~G~~g~Vy~g~~~~~~~~~vavK~~~~~~-~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~--~~~lV~E 579 (792)
+.+.+.||+|+||+||+|... .+++.||||++.... ....+.+.+|++++++++||||+++++++.+.. ..++|||
T Consensus 11 y~i~~~LG~G~~g~Vy~~~~~-~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~lv~e 89 (396)
T 4eut_A 11 WLLSDILGQGATANVFRGRHK-KTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLIME 89 (396)
T ss_dssp EEEEEEEEECSSEEEEEEEET-TTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEEEEC
T ss_pred eEEEEEEEcCCCeEEEEEEEC-CCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCCCeEEEeeccCCCCeeEEEEe
Confidence 345678999999999999764 456799999997543 334577889999999999999999999997655 7799999
Q ss_pred eccCCCccccccCCC---CCchhHHHHHHHHHHHHHHHHhhccCCCeEecCCCCCcEEE----cCCCCeEEeecCCCccc
Q 003836 580 FMSNGTVASFLFGDS---KPNWKLRTEIAMGIAGGLFYLHEECCTQIIHCDIKPQNILL----DDHYNARISDFGLAKLL 652 (792)
Q Consensus 580 ~~~~gsL~~~l~~~~---~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dikp~NILl----~~~~~~kl~Dfg~a~~~ 652 (792)
|+++|+|.+++.... .+++..+..++.||+.||+|||+. +|+||||||+|||+ +.++.+||+|||+++..
T Consensus 90 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~~~~~kL~DFG~a~~~ 166 (396)
T 4eut_A 90 FCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLREN---GIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAAREL 166 (396)
T ss_dssp CCTTEEHHHHTTSGGGTTCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEEEECTTSCEEEEECCGGGCEEC
T ss_pred cCCCCCHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHHC---CEEECCcCHHHEEEeecCCCceeEEEecCCCceEc
Confidence 999999999997653 389999999999999999999999 99999999999999 77888999999999876
Q ss_pred cCCCCCccccccccCCccccccccc--------CCCCcccceehHHHHHHHHHhcCcCCCcchhhhh-hhhHHHHHHHhh
Q 003836 653 TLDQSHTNTAIRGTKGYVAPEWFRN--------MPITVKVDVYSYGVLLLEIICLRRNIDNEISKVD-KAILTDWAYDRY 723 (792)
Q Consensus 653 ~~~~~~~~~~~~gt~~y~aPE~~~~--------~~~~~k~DV~S~Gv~l~el~tg~~p~~~~~~~~~-~~~~~~~~~~~~ 723 (792)
.... ......||+.|+|||.+.+ ..++.++|||||||++|||++|+.||........ ...+...... .
T Consensus 167 ~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~~~~-~ 243 (396)
T 4eut_A 167 EDDE--QFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIITG-K 243 (396)
T ss_dssp CCGG--GSSCSSSCCTTCCHHHHHHHCC--CHHHHHHHHHHHHHHHHHHHHHHHSSCSEECTTCTTTCHHHHHHHHHS-C
T ss_pred cCCC--ccccccCCccccCHHHhhccccccccccCCCcHHHHHHHHHHHHHHHHCCCCCCCCCcccchHHHHHHHhcC-C
Confidence 4332 2234568999999999865 5678899999999999999999999965332211 1111111100 0
Q ss_pred cccch---hHhhh--------chhcccCCHHHHHHHHHHHHHccccCCCCCCCHHhHHHHhccCcCC
Q 003836 724 QERTL---EALVE--------NDLEAMNNVTMLHRFVMVAFWCIQEDPSHRPTMRKVTQMLEGVVEV 779 (792)
Q Consensus 724 ~~~~~---~~~~~--------~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~L~~~~~~ 779 (792)
..... ..... ..............+.+++.+||+.||++||+++|+++.++.+++.
T Consensus 244 p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~ll~~~L~~dP~~R~s~~e~l~~l~~il~~ 310 (396)
T 4eut_A 244 PSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSDILHR 310 (396)
T ss_dssp CTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHHHHHTC
T ss_pred CcccchhheeccCCCcccCccCCcccccchHHHhhchHHHHHhhccChhhhccHHHHHHHHHHHhhc
Confidence 00000 00000 0111223467788899999999999999999999999999887653
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-38 Score=341.54 Aligned_cols=244 Identities=26% Similarity=0.332 Sum_probs=196.4
Q ss_pred hhhhhhcCccccceEEEeeecCCCceEEEEEEcccccc---cchHHHHHHHHHhcccCCCCcccccceeccCCceEEEEE
Q 003836 503 RGFKEELGRGAFGTVYKGFVNMGSSNHVAVKKLNSVFQ---DSEKEFKAEVNGIGQTHHKNLVRLLGYCDEGQNRLLVYE 579 (792)
Q Consensus 503 ~~~~~~lG~G~~g~Vy~g~~~~~~~~~vavK~~~~~~~---~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~lV~E 579 (792)
+...+.||+|+||+||+|... .+++.||||++..... ...+.+.+|++++++++||||+++++++.+.+..++|||
T Consensus 56 y~~~~~lG~G~~g~Vy~a~~~-~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e 134 (348)
T 1u5q_A 56 FSDLREIGHGSFGAVYFARDV-RNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVME 134 (348)
T ss_dssp EEEEEEEEECSSEEEEEEEET-TTTEEEEEEEEESCSSCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred eeeeeEEccCCCEEEEEEEEc-cCCeEEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCeEEEEEe
Confidence 344578999999999999753 4578999999875322 234578999999999999999999999999999999999
Q ss_pred eccCCCccccccC-CCCCchhHHHHHHHHHHHHHHHHhhccCCCeEecCCCCCcEEEcCCCCeEEeecCCCccccCCCCC
Q 003836 580 FMSNGTVASFLFG-DSKPNWKLRTEIAMGIAGGLFYLHEECCTQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLDQSH 658 (792)
Q Consensus 580 ~~~~gsL~~~l~~-~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dikp~NILl~~~~~~kl~Dfg~a~~~~~~~~~ 658 (792)
|++ |+|.+++.. ...+++..+..++.||++||.|||+. +|+||||||+|||++.++.+||+|||+++.....
T Consensus 135 ~~~-g~l~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~--- 207 (348)
T 1u5q_A 135 YCL-GSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSH---NMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA--- 207 (348)
T ss_dssp CCS-EEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCSGGGEEEETTTEEEECCCTTCBSSSSB---
T ss_pred cCC-CCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHEEECCCCCEEEeeccCceecCCC---
Confidence 998 578777753 46789999999999999999999999 9999999999999999999999999999865432
Q ss_pred ccccccccCCcccccccc---cCCCCcccceehHHHHHHHHHhcCcCCCcchhhhhhhhHHHHHHHhhcccchhHhhhch
Q 003836 659 TNTAIRGTKGYVAPEWFR---NMPITVKVDVYSYGVLLLEIICLRRNIDNEISKVDKAILTDWAYDRYQERTLEALVEND 735 (792)
Q Consensus 659 ~~~~~~gt~~y~aPE~~~---~~~~~~k~DV~S~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 735 (792)
....||+.|+|||.+. ...++.++|||||||++|||++|+.||........ +.. +....
T Consensus 208 --~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~---~~~-------------~~~~~ 269 (348)
T 1u5q_A 208 --NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSA---LYH-------------IAQNE 269 (348)
T ss_dssp --CCCCSCGGGCCHHHHHTTSSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHH---HHH-------------HHHSC
T ss_pred --CcccCCcceeCHhhhccccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHH---HHH-------------HHhcC
Confidence 2346899999999984 56789999999999999999999999865432111 000 00000
Q ss_pred hcccCCHHHHHHHHHHHHHccccCCCCCCCHHhHHHH
Q 003836 736 LEAMNNVTMLHRFVMVAFWCIQEDPSHRPTMRKVTQM 772 (792)
Q Consensus 736 ~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~ 772 (792)
.........+..+.+++.+||+.+|++|||++++++.
T Consensus 270 ~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~h 306 (348)
T 1u5q_A 270 SPALQSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKH 306 (348)
T ss_dssp CCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHTTC
T ss_pred CCCCCCCCCCHHHHHHHHHHcccChhhCcCHHHHhhC
Confidence 0111122334668899999999999999999999864
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-37 Score=349.13 Aligned_cols=260 Identities=24% Similarity=0.258 Sum_probs=192.1
Q ss_pred hhhhhhcCccccceEEEeeecCCCceEEEEEEcccc--cccchHHHHHHHHHhcccCCCCcccccceeccC------Cce
Q 003836 503 RGFKEELGRGAFGTVYKGFVNMGSSNHVAVKKLNSV--FQDSEKEFKAEVNGIGQTHHKNLVRLLGYCDEG------QNR 574 (792)
Q Consensus 503 ~~~~~~lG~G~~g~Vy~g~~~~~~~~~vavK~~~~~--~~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~------~~~ 574 (792)
+.+.+.||+|+||+||++.. ..+++.||||++... .....+.+.+|+.++++++||||+++++++... .+.
T Consensus 64 y~~~~~lG~G~~g~V~~a~~-~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~~~ 142 (464)
T 3ttj_A 64 YQNLKPIGSGAQGIVCAAYD-AVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQDV 142 (464)
T ss_dssp EEEEEEEEECSSCEEEEEEE-TTTTEEEEEEEEESGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCCEE
T ss_pred eEEEEEeecCCCeEEEEEEE-CCCCCEEEEEEECccccChHHHHHHHHHHHHHHhCCCCCCCcEEEEEccCCccccCCeE
Confidence 33457899999999999964 455789999999754 233456789999999999999999999999654 457
Q ss_pred EEEEEeccCCCccccccCCCCCchhHHHHHHHHHHHHHHHHhhccCCCeEecCCCCCcEEEcCCCCeEEeecCCCccccC
Q 003836 575 LLVYEFMSNGTVASFLFGDSKPNWKLRTEIAMGIAGGLFYLHEECCTQIIHCDIKPQNILLDDHYNARISDFGLAKLLTL 654 (792)
Q Consensus 575 ~lV~E~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dikp~NILl~~~~~~kl~Dfg~a~~~~~ 654 (792)
+|||||++++ |.+.+.. .+++..+..++.||+.||+|||+. +|+||||||+|||++.++.+||+|||+++....
T Consensus 143 ~lv~E~~~~~-l~~~~~~--~l~~~~~~~~~~qil~aL~~lH~~---~iiHrDlkp~NIll~~~~~~kl~DFG~a~~~~~ 216 (464)
T 3ttj_A 143 YLVMELMDAN-LCQVIQM--ELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLARTAGT 216 (464)
T ss_dssp EEEEECCSEE-HHHHHTS--CCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEECCCCCC-----
T ss_pred EEEEeCCCCC-HHHHHhh--cCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCChHhEEEeCCCCEEEEEEEeeeecCC
Confidence 9999999875 5555533 488999999999999999999999 999999999999999999999999999987643
Q ss_pred CCCCccccccccCCcccccccccCCCCcccceehHHHHHHHHHhcCcCCCcchhhhhhhhHHHH-------HHHhhcccc
Q 003836 655 DQSHTNTAIRGTKGYVAPEWFRNMPITVKVDVYSYGVLLLEIICLRRNIDNEISKVDKAILTDW-------AYDRYQERT 727 (792)
Q Consensus 655 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DV~S~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~-------~~~~~~~~~ 727 (792)
. .......||+.|+|||++.+..++.++|||||||++|||++|+.||...........+... ..... ...
T Consensus 217 ~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pF~g~~~~~~~~~i~~~lg~p~~~~~~~~-~~~ 293 (464)
T 3ttj_A 217 S--FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKL-QPT 293 (464)
T ss_dssp C--CCC----CCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCCHHHHTTS-CHH
T ss_pred C--cccCCCcccccccCHHHHcCCCCCHHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHc-chh
Confidence 2 2334567999999999999999999999999999999999999999765322111111000 00000 000
Q ss_pred hhHhhhc---------------hhccc---CCHHHHHHHHHHHHHccccCCCCCCCHHhHHHH
Q 003836 728 LEALVEN---------------DLEAM---NNVTMLHRFVMVAFWCIQEDPSHRPTMRKVTQM 772 (792)
Q Consensus 728 ~~~~~~~---------------~~~~~---~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~ 772 (792)
....+.. ..... .......++.+|+.+||+.||++|||++|+++.
T Consensus 294 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~H 356 (464)
T 3ttj_A 294 VRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQH 356 (464)
T ss_dssp HHHHHTTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred hhhHhhcccccCCCChHHhCcccccccccccccccCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 0011110 00000 011236789999999999999999999999974
|
| >4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-37 Score=331.03 Aligned_cols=258 Identities=19% Similarity=0.257 Sum_probs=201.3
Q ss_pred hhhhhhcCccccceEEEeeecCCCceEEEEEEcccccccchHHHHHHHHHhcccCCCCccccccee-ccCCceEEEEEec
Q 003836 503 RGFKEELGRGAFGTVYKGFVNMGSSNHVAVKKLNSVFQDSEKEFKAEVNGIGQTHHKNLVRLLGYC-DEGQNRLLVYEFM 581 (792)
Q Consensus 503 ~~~~~~lG~G~~g~Vy~g~~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~g~~-~~~~~~~lV~E~~ 581 (792)
+.+.+.||+|+||.||+|... .+++.||||++.... ....+.+|++++++++|++++..++.+ .+.+..++||||+
T Consensus 11 y~~~~~lg~G~~g~V~~~~~~-~~~~~vavK~~~~~~--~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~e~~ 87 (296)
T 4hgt_A 11 YRLGRKIGSGSFGDIYLGTDI-AAGEEVAIKLECVKT--KHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMELL 87 (296)
T ss_dssp CEEEEEEEECSSSEEEEEEET-TTTEEEEEEEEEC-----CCCHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEEEECC
T ss_pred eEEeeeecCCCCeEEEEEEEc-CCCceEEEEeecccc--cchHHHHHHHHHHHhcCCCCCCeeeeecCCCCceEEEEEcc
Confidence 445688999999999999753 457899999865432 234688999999999988877777766 6677789999999
Q ss_pred cCCCccccccC-CCCCchhHHHHHHHHHHHHHHHHhhccCCCeEecCCCCCcEEE---cCCCCeEEeecCCCccccCCCC
Q 003836 582 SNGTVASFLFG-DSKPNWKLRTEIAMGIAGGLFYLHEECCTQIIHCDIKPQNILL---DDHYNARISDFGLAKLLTLDQS 657 (792)
Q Consensus 582 ~~gsL~~~l~~-~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dikp~NILl---~~~~~~kl~Dfg~a~~~~~~~~ 657 (792)
+++|.+++.. ...+++..+..++.||+.||+|||+. +|+||||||+|||+ ++++.+||+|||+++.......
T Consensus 88 -~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~---~ivH~Dlkp~NIl~~~~~~~~~~kL~Dfg~a~~~~~~~~ 163 (296)
T 4hgt_A 88 -GPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSK---NFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDART 163 (296)
T ss_dssp -CCBHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECCGGGTTCEEECCCTTCEECBCTTT
T ss_pred -CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeeeeccCCCCeEEEecCccceeccCccc
Confidence 9999999974 45789999999999999999999999 99999999999999 7889999999999987654433
Q ss_pred C------ccccccccCCcccccccccCCCCcccceehHHHHHHHHHhcCcCCCcchhhhhhhhHHHHHHHhhcccchhHh
Q 003836 658 H------TNTAIRGTKGYVAPEWFRNMPITVKVDVYSYGVLLLEIICLRRNIDNEISKVDKAILTDWAYDRYQERTLEAL 731 (792)
Q Consensus 658 ~------~~~~~~gt~~y~aPE~~~~~~~~~k~DV~S~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 731 (792)
. ......||+.|+|||.+.+..++.++|||||||++|||++|+.||...................... ....
T Consensus 164 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~-~~~~- 241 (296)
T 4hgt_A 164 HQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMST-PIEV- 241 (296)
T ss_dssp CCBCCCCCSCCCCSCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHHHHS-CHHH-
T ss_pred CccCCCCcccccCCCccccchHHhcCCCCCchhHHHHHHHHHHHHhcCCCCCcccchhhhhhhhhhhhcccccc-hhhh-
Confidence 1 2234568999999999999999999999999999999999999997643322111111111110000 0000
Q ss_pred hhchhcccCCHHHHHHHHHHHHHccccCCCCCCCHHhHHHHhccCc
Q 003836 732 VENDLEAMNNVTMLHRFVMVAFWCIQEDPSHRPTMRKVTQMLEGVV 777 (792)
Q Consensus 732 ~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~L~~~~ 777 (792)
.....+..+.+++.+||+.+|++|||+++|++.|+++.
T Consensus 242 --------~~~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~~l~~~~ 279 (296)
T 4hgt_A 242 --------LCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLF 279 (296)
T ss_dssp --------HTTTSCHHHHHHHHHHHTSCTTCCCCHHHHHHHHHHHH
T ss_pred --------hhccCCHHHHHHHHHHHhcCCCCCCCHHHHHHHHHHHH
Confidence 00112467889999999999999999999999998864
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-37 Score=329.03 Aligned_cols=249 Identities=23% Similarity=0.310 Sum_probs=201.7
Q ss_pred hhhhhcCccccceEEEeeecCCCceEEEEEEccccc--ccchHHHHHHHHHhcccCCCCcccccceeccCCceEEEEEec
Q 003836 504 GFKEELGRGAFGTVYKGFVNMGSSNHVAVKKLNSVF--QDSEKEFKAEVNGIGQTHHKNLVRLLGYCDEGQNRLLVYEFM 581 (792)
Q Consensus 504 ~~~~~lG~G~~g~Vy~g~~~~~~~~~vavK~~~~~~--~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~lV~E~~ 581 (792)
.+.+.||+|+||.||++... .+++.||+|++.... ....+.+.+|+.++++++||||+++++++.+.+..++||||+
T Consensus 9 ~~~~~lg~G~~g~V~~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~ 87 (284)
T 3kk8_A 9 DVKEELGKGAFSVVRRCVHK-TTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVFDLV 87 (284)
T ss_dssp EEEEEEEEETTEEEEEEEET-TTCCEEEEEEEEGGGCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECCC
T ss_pred hhhhhhcCcCCeEEEEEEEc-CCCceEEEEEeecccCCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEcCCEEEEEEecC
Confidence 44578999999999999754 456789999986543 233467889999999999999999999999999999999999
Q ss_pred cCCCccccccCCCCCchhHHHHHHHHHHHHHHHHhhccCCCeEecCCCCCcEEEcCCCC---eEEeecCCCccccCCCCC
Q 003836 582 SNGTVASFLFGDSKPNWKLRTEIAMGIAGGLFYLHEECCTQIIHCDIKPQNILLDDHYN---ARISDFGLAKLLTLDQSH 658 (792)
Q Consensus 582 ~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dikp~NILl~~~~~---~kl~Dfg~a~~~~~~~~~ 658 (792)
++++|.+++.....+++..+..++.||+.||.|||+. +|+||||||+|||++.++. +||+|||++.......
T Consensus 88 ~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~~~~kl~Dfg~~~~~~~~~-- 162 (284)
T 3kk8_A 88 TGGELFEDIVAREFYSEADASHCIQQILESIAYCHSN---GIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSE-- 162 (284)
T ss_dssp CSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEESSSSTTCCEEECCCTTCEECCSSC--
T ss_pred CCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---CcCcCCCCHHHEEEecCCCCCcEEEeeceeeEEcccCc--
Confidence 9999999998878899999999999999999999998 9999999999999986655 9999999998664322
Q ss_pred ccccccccCCcccccccccCCCCcccceehHHHHHHHHHhcCcCCCcchhhhhhhhHHHHHHHhhcccchhHhhhchhcc
Q 003836 659 TNTAIRGTKGYVAPEWFRNMPITVKVDVYSYGVLLLEIICLRRNIDNEISKVDKAILTDWAYDRYQERTLEALVENDLEA 738 (792)
Q Consensus 659 ~~~~~~gt~~y~aPE~~~~~~~~~k~DV~S~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 738 (792)
......||+.|+|||.+.+..++.++||||||+++|+|++|+.||.......... ....... ....
T Consensus 163 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~---~~~~~~~-----------~~~~ 228 (284)
T 3kk8_A 163 AWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYA---QIKAGAY-----------DYPS 228 (284)
T ss_dssp BCCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHH---HHHHTCC-----------CCCT
T ss_pred cccCCCCCcCCcCchhhcCCCCCcccchHHHHHHHHHHHHCCCCCCCCchhHHHH---HHHhccc-----------cCCc
Confidence 2234568999999999999999999999999999999999999996543221100 0000000 0000
Q ss_pred cCCHHHHHHHHHHHHHccccCCCCCCCHHhHHHH
Q 003836 739 MNNVTMLHRFVMVAFWCIQEDPSHRPTMRKVTQM 772 (792)
Q Consensus 739 ~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~ 772 (792)
......+.++.+++.+||+.||++|||++|+++.
T Consensus 229 ~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h 262 (284)
T 3kk8_A 229 PEWDTVTPEAKSLIDSMLTVNPKKRITADQALKV 262 (284)
T ss_dssp TTTTTSCHHHHHHHHHHSCSSTTTSCCHHHHTTS
T ss_pred hhhcccCHHHHHHHHHHcccChhhCCCHHHHhcC
Confidence 0111234678899999999999999999999874
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=8e-38 Score=330.43 Aligned_cols=248 Identities=25% Similarity=0.376 Sum_probs=195.0
Q ss_pred HhhhhhhcCccccceEEEeeecCCCceEEEEEEccccc-ccchHHHHHHHHHhcccCCCCcccccceeccCCceEEEEEe
Q 003836 502 TRGFKEELGRGAFGTVYKGFVNMGSSNHVAVKKLNSVF-QDSEKEFKAEVNGIGQTHHKNLVRLLGYCDEGQNRLLVYEF 580 (792)
Q Consensus 502 ~~~~~~~lG~G~~g~Vy~g~~~~~~~~~vavK~~~~~~-~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~lV~E~ 580 (792)
.+.+.+.||+|+||+||++... .+++.+|+|++.... ....+.+.+|++++++++||||+++++++.+....++||||
T Consensus 23 ~y~~~~~lg~G~~g~V~~~~~~-~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~ 101 (285)
T 3is5_A 23 LFIFKRKLGSGAFGDVHLVEER-SSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHPNIIKIFEVFEDYHNMYIVMET 101 (285)
T ss_dssp HEEEEEEEEECSSCEEEEEEET-TTCCEEEEEEEEGGGCCSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEECC
T ss_pred heeecceeccCCCeEEEEEEEc-cCCceEEEEEeeccccchhHHHHHHHHHHHHhCCCchHHhHHHheecCCeEEEEEEe
Confidence 4556789999999999999754 456789999987643 33467899999999999999999999999999999999999
Q ss_pred ccCCCccccccCC----CCCchhHHHHHHHHHHHHHHHHhhccCCCeEecCCCCCcEEE---cCCCCeEEeecCCCcccc
Q 003836 581 MSNGTVASFLFGD----SKPNWKLRTEIAMGIAGGLFYLHEECCTQIIHCDIKPQNILL---DDHYNARISDFGLAKLLT 653 (792)
Q Consensus 581 ~~~gsL~~~l~~~----~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dikp~NILl---~~~~~~kl~Dfg~a~~~~ 653 (792)
+++|+|.+++... ..+++..+..++.||+.||+|||+. +|+||||||+|||+ +.++.+||+|||+++...
T Consensus 102 ~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~dikp~NIl~~~~~~~~~~kl~Dfg~a~~~~ 178 (285)
T 3is5_A 102 CEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFHSQ---HVVHKDLKPENILFQDTSPHSPIKIIDFGLAELFK 178 (285)
T ss_dssp CSCCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEESSSSTTCCEEECCCCCCCC--
T ss_pred CCCCcHHHHHHhhhhcccCCCHHHHHHHHHHHHHHHHHHHhC---CEEECCCCHHHEEEecCCCCCCEEEEeeecceecC
Confidence 9999999988543 6789999999999999999999998 99999999999999 456789999999998654
Q ss_pred CCCCCccccccccCCcccccccccCCCCcccceehHHHHHHHHHhcCcCCCcchhhhhhhhHHHHHHHhhcccchhHhhh
Q 003836 654 LDQSHTNTAIRGTKGYVAPEWFRNMPITVKVDVYSYGVLLLEIICLRRNIDNEISKVDKAILTDWAYDRYQERTLEALVE 733 (792)
Q Consensus 654 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DV~S~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 733 (792)
... ......||+.|+|||.+. ..++.++||||||+++|||++|+.||........... ......
T Consensus 179 ~~~--~~~~~~~t~~y~aPE~~~-~~~~~~~Di~slG~il~~ll~g~~pf~~~~~~~~~~~------~~~~~~------- 242 (285)
T 3is5_A 179 SDE--HSTNAAGTALYMAPEVFK-RDVTFKCDIWSAGVVMYFLLTGCLPFTGTSLEEVQQK------ATYKEP------- 242 (285)
T ss_dssp ----------CTTGGGCCHHHHT-TCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHH------HHHCCC-------
T ss_pred Ccc--cCcCcccccCcCChHHhc-cCCCcccCeehHHHHHHHHHhCCCCCCCCCHHHHHhh------hccCCc-------
Confidence 322 223456899999999885 5689999999999999999999999976432211000 000000
Q ss_pred chhcccCCHHHHHHHHHHHHHccccCCCCCCCHHhHHH
Q 003836 734 NDLEAMNNVTMLHRFVMVAFWCIQEDPSHRPTMRKVTQ 771 (792)
Q Consensus 734 ~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~ 771 (792)
.... .....+..+.+++.+||+.||++|||++|+++
T Consensus 243 -~~~~-~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~ 278 (285)
T 3is5_A 243 -NYAV-ECRPLTPQAVDLLKQMLTKDPERRPSAAQVLH 278 (285)
T ss_dssp -CCCC---CCCCHHHHHHHHHHTCSCTTTSCCHHHHHT
T ss_pred -cccc-ccCcCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 0000 00113457789999999999999999999987
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-37 Score=329.12 Aligned_cols=251 Identities=25% Similarity=0.349 Sum_probs=200.9
Q ss_pred HHhhhhhhcCccccceEEEeeecCCCceEEEEEEcccccc------cchHHHHHHHHHhcccCCCCcccccceeccCCce
Q 003836 501 VTRGFKEELGRGAFGTVYKGFVNMGSSNHVAVKKLNSVFQ------DSEKEFKAEVNGIGQTHHKNLVRLLGYCDEGQNR 574 (792)
Q Consensus 501 ~~~~~~~~lG~G~~g~Vy~g~~~~~~~~~vavK~~~~~~~------~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~ 574 (792)
..+.+.+.||+|+||.||++... .+++.+|+|++..... ...+.+.+|+.++++++||||+++++++.+....
T Consensus 5 ~~y~~~~~lg~G~~g~V~~~~~~-~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~ 83 (283)
T 3bhy_A 5 DHYEMGEELGSGQFAIVRKCRQK-GTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIITLHDIFENKTDV 83 (283)
T ss_dssp HHEEEEEEEEECSSEEEEEEEET-TTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred hhhhhHHhhcccCceEEEEEEEc-CCCCeeehHHhhhccccccccchHHHHHHHHHHHHHhCCCCCeeehhheecCCCeE
Confidence 34556788999999999999754 4567999999875321 2367899999999999999999999999999999
Q ss_pred EEEEEeccCCCccccccCCCCCchhHHHHHHHHHHHHHHHHhhccCCCeEecCCCCCcEEEcCCC----CeEEeecCCCc
Q 003836 575 LLVYEFMSNGTVASFLFGDSKPNWKLRTEIAMGIAGGLFYLHEECCTQIIHCDIKPQNILLDDHY----NARISDFGLAK 650 (792)
Q Consensus 575 ~lV~E~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dikp~NILl~~~~----~~kl~Dfg~a~ 650 (792)
++||||+++++|.+++.....+++..+..++.||+.||.|||+. +|+|+||||+||+++.++ .+||+|||+++
T Consensus 84 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~~~~~kl~dfg~~~ 160 (283)
T 3bhy_A 84 VLILELVSGGELFDFLAEKESLTEDEATQFLKQILDGVHYLHSK---RIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAH 160 (283)
T ss_dssp EEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEESCSSSSSCCEEECCCTTCE
T ss_pred EEEEeecCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCChHHEEEecCCCCCCceEEEecccce
Confidence 99999999999999998777899999999999999999999998 999999999999999877 89999999998
Q ss_pred cccCCCCCccccccccCCcccccccccCCCCcccceehHHHHHHHHHhcCcCCCcchhhhhhhhHHHHHHHhhcccchhH
Q 003836 651 LLTLDQSHTNTAIRGTKGYVAPEWFRNMPITVKVDVYSYGVLLLEIICLRRNIDNEISKVDKAILTDWAYDRYQERTLEA 730 (792)
Q Consensus 651 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DV~S~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 730 (792)
...... ......|++.|+|||.+.+..++.++||||||+++|||++|+.||........ +... ....
T Consensus 161 ~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~---~~~~-----~~~~--- 227 (283)
T 3bhy_A 161 KIEAGN--EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGETKQET---LTNI-----SAVN--- 227 (283)
T ss_dssp ECC----------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHH---HHHH-----HTTC---
T ss_pred eccCCC--cccccCCCcCccCcceecCCCCCcchhhhhHHHHHHHHHHCCCCCCCcchHHH---HHHh-----Hhcc---
Confidence 764322 22344689999999999999999999999999999999999999976432211 0000 0000
Q ss_pred hhhchhcccCCHHHHHHHHHHHHHccccCCCCCCCHHhHHH
Q 003836 731 LVENDLEAMNNVTMLHRFVMVAFWCIQEDPSHRPTMRKVTQ 771 (792)
Q Consensus 731 ~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~ 771 (792)
...........+..+.+++.+||+.||++|||+.|+++
T Consensus 228 ---~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~ 265 (283)
T 3bhy_A 228 ---YDFDEEYFSNTSELAKDFIRRLLVKDPKRRMTIAQSLE 265 (283)
T ss_dssp ---CCCCHHHHTTCCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred ---cCCcchhcccCCHHHHHHHHHHccCCHhHCcCHHHHHh
Confidence 00000000123456889999999999999999999997
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-37 Score=352.40 Aligned_cols=192 Identities=23% Similarity=0.355 Sum_probs=153.0
Q ss_pred hhhhhhcCccccceEEEeeecCCCceEEEEEEccccc--ccchHHHHHHHHHhcccCCCCcccccceec-----cCCceE
Q 003836 503 RGFKEELGRGAFGTVYKGFVNMGSSNHVAVKKLNSVF--QDSEKEFKAEVNGIGQTHHKNLVRLLGYCD-----EGQNRL 575 (792)
Q Consensus 503 ~~~~~~lG~G~~g~Vy~g~~~~~~~~~vavK~~~~~~--~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~-----~~~~~~ 575 (792)
+.+.+.||+|+||+||+|... .+++.||||++.... ....+.+.+|++++++++||||+++++++. .....+
T Consensus 55 y~~~~~lG~G~~g~V~~~~~~-~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~ 133 (458)
T 3rp9_A 55 YEIRHLIGTGSYGHVCEAYDK-LEKRVVAIKKILRVFEDLIDCKRILREIAILNRLNHDHVVKVLDIVIPKDVEKFDELY 133 (458)
T ss_dssp EEECCC-------CEEEEEEC-C--CEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCCEE
T ss_pred eEEeeEeeecCCeEEEEEEEC-CCCcEEEEEEechhhcCHHHHHHHHHHHHHHHhCCCCCCCceEEEEecCCcccCceEE
Confidence 445678999999999999654 456899999987542 234567899999999999999999999994 335789
Q ss_pred EEEEeccCCCccccccCCCCCchhHHHHHHHHHHHHHHHHhhccCCCeEecCCCCCcEEEcCCCCeEEeecCCCccccCC
Q 003836 576 LVYEFMSNGTVASFLFGDSKPNWKLRTEIAMGIAGGLFYLHEECCTQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLD 655 (792)
Q Consensus 576 lV~E~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dikp~NILl~~~~~~kl~Dfg~a~~~~~~ 655 (792)
+||||+. ++|.+++.....+++..+..++.||+.||+|||+. +|+||||||+||||+.++.+||+|||+++.....
T Consensus 134 lv~e~~~-~~L~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~---~iiHrDlKp~NILl~~~~~~kl~DFGla~~~~~~ 209 (458)
T 3rp9_A 134 VVLEIAD-SDFKKLFRTPVYLTELHIKTLLYNLLVGVKYVHSA---GILHRDLKPANCLVNQDCSVKVCDFGLARTVDYP 209 (458)
T ss_dssp EEECCCS-EEHHHHHHSSCCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTCCEEECCCTTCBCTTSC
T ss_pred EEEeccc-cchhhhcccCCCCCHHHHHHHHHHHHHHHHHHHhC---CcCCCCCChhhEEECCCCCEeecccccchhccCc
Confidence 9999985 69999998888899999999999999999999999 9999999999999999999999999999876432
Q ss_pred CC--------------------------CccccccccCCccccccc-ccCCCCcccceehHHHHHHHHHhc
Q 003836 656 QS--------------------------HTNTAIRGTKGYVAPEWF-RNMPITVKVDVYSYGVLLLEIICL 699 (792)
Q Consensus 656 ~~--------------------------~~~~~~~gt~~y~aPE~~-~~~~~~~k~DV~S~Gv~l~el~tg 699 (792)
.. .......||+.|+|||++ ....++.++|||||||++|||++|
T Consensus 210 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~DiwSlG~il~elltg 280 (458)
T 3rp9_A 210 ENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELLNM 280 (458)
T ss_dssp TTCCCCCC---------------------------CCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHTT
T ss_pred cccccccccCccccccccccccccccccccccCCcccccccChHHhhCCCCCCcHhHHHHHHHHHHHHHHh
Confidence 21 112345689999999976 566799999999999999999994
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-37 Score=332.73 Aligned_cols=250 Identities=24% Similarity=0.328 Sum_probs=201.5
Q ss_pred HhhhhhhcCccccceEEEeeecCCCceEEEEEEcccccccchHHHHHHHHHhcccCCCCcccccceeccCCceEEEEEec
Q 003836 502 TRGFKEELGRGAFGTVYKGFVNMGSSNHVAVKKLNSVFQDSEKEFKAEVNGIGQTHHKNLVRLLGYCDEGQNRLLVYEFM 581 (792)
Q Consensus 502 ~~~~~~~lG~G~~g~Vy~g~~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~lV~E~~ 581 (792)
.+.+.+.||+|+||+||++... .+++.||+|++........+.+.+|+.++++++||||+++++++.+.+..++||||+
T Consensus 10 ~y~~~~~lg~G~~g~V~~~~~~-~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 88 (304)
T 2jam_A 10 TFIFMEVLGSGAFSEVFLVKQR-LTGKLFALKCIKKSPAFRDSSLENEIAVLKKIKHENIVTLEDIYESTTHYYLVMQLV 88 (304)
T ss_dssp HEEEEEEEEECSSEEEEEEEET-TTCCEEEEEEEECC------HHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECCC
T ss_pred cceeeeeccCCCCceEEEEEEC-CCCCEEEEEEEecccccchHHHHHHHHHHHhCCCCCeeehhhhcccCCEEEEEEEcC
Confidence 4456688999999999999754 456799999998655555677999999999999999999999999999999999999
Q ss_pred cCCCccccccCCCCCchhHHHHHHHHHHHHHHHHhhccCCCeEecCCCCCcEEE---cCCCCeEEeecCCCccccCCCCC
Q 003836 582 SNGTVASFLFGDSKPNWKLRTEIAMGIAGGLFYLHEECCTQIIHCDIKPQNILL---DDHYNARISDFGLAKLLTLDQSH 658 (792)
Q Consensus 582 ~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dikp~NILl---~~~~~~kl~Dfg~a~~~~~~~~~ 658 (792)
++++|.+++.....+++..+..++.||+.||.|||+. +|+||||||+|||+ ++++.+||+|||+++.....
T Consensus 89 ~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dikp~NIl~~~~~~~~~~kl~Dfg~~~~~~~~--- 162 (304)
T 2jam_A 89 SGGELFDRILERGVYTEKDASLVIQQVLSAVKYLHEN---GIVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQNG--- 162 (304)
T ss_dssp CSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCSCCGGGCEESSSSTTCCEEBCSCSTTCCCCCB---
T ss_pred CCccHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEEecCCCCCCEEEccCCcceecCCC---
Confidence 9999999998777899999999999999999999998 99999999999999 78899999999999764322
Q ss_pred ccccccccCCcccccccccCCCCcccceehHHHHHHHHHhcCcCCCcchhhhhhhhHHHHHHHhhcccchhHhhhchhcc
Q 003836 659 TNTAIRGTKGYVAPEWFRNMPITVKVDVYSYGVLLLEIICLRRNIDNEISKVDKAILTDWAYDRYQERTLEALVENDLEA 738 (792)
Q Consensus 659 ~~~~~~gt~~y~aPE~~~~~~~~~k~DV~S~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 738 (792)
......|++.|+|||.+.+..++.++||||||+++|||++|+.||........ ... ..+... ....
T Consensus 163 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~---~~~-----i~~~~~------~~~~ 228 (304)
T 2jam_A 163 IMSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVITYILLCGYPPFYEETESKL---FEK-----IKEGYY------EFES 228 (304)
T ss_dssp TTHHHHSCCCBCCTTTBSSCSCCHHHHHHHHHHHHHHHHHSSCTTTTSCHHHH---HHH-----HHHCCC------CCCT
T ss_pred ccccccCCCCccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHHH---HHH-----HHcCCC------CCCc
Confidence 22334689999999999999999999999999999999999999965432110 000 000000 0011
Q ss_pred cCCHHHHHHHHHHHHHccccCCCCCCCHHhHHHH
Q 003836 739 MNNVTMLHRFVMVAFWCIQEDPSHRPTMRKVTQM 772 (792)
Q Consensus 739 ~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~ 772 (792)
......+..+.+++.+||+.||++|||++|+++.
T Consensus 229 ~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h 262 (304)
T 2jam_A 229 PFWDDISESAKDFICHLLEKDPNERYTCEKALSH 262 (304)
T ss_dssp TTTTTSCHHHHHHHHHHHCSSTTTSCCHHHHHTS
T ss_pred cccccCCHHHHHHHHHHcCCChhHCcCHHHHhcC
Confidence 1112345678899999999999999999999873
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.1e-38 Score=339.30 Aligned_cols=251 Identities=23% Similarity=0.303 Sum_probs=199.2
Q ss_pred HhhhhhhcCccccceEEEeeecCCCceEEEEEEcccccccchHHHHHHHHHhccc-CCCCcccccceeccCCceEEEEEe
Q 003836 502 TRGFKEELGRGAFGTVYKGFVNMGSSNHVAVKKLNSVFQDSEKEFKAEVNGIGQT-HHKNLVRLLGYCDEGQNRLLVYEF 580 (792)
Q Consensus 502 ~~~~~~~lG~G~~g~Vy~g~~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l-~h~niv~l~g~~~~~~~~~lV~E~ 580 (792)
.+.+.+.||+|+||.||++... .+++.||||++.+... ...+|++++.++ +||||+++++++.+++..++||||
T Consensus 23 ~y~~~~~lG~G~~g~V~~~~~~-~~~~~~avK~~~~~~~----~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E~ 97 (342)
T 2qr7_A 23 GYEVKEDIGVGSYSVCKRCIHK-ATNMEFAVKIIDKSKR----DPTEEIEILLRYGQHPNIITLKDVYDDGKYVYVVTEL 97 (342)
T ss_dssp HEEEEEEEEECSSEEEEEEEET-TTTEEEEEEEEETTTC----CCHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEECC
T ss_pred cEEEEEEEeeCCCEEEEEEEEC-CCCCEEEEEEEEcccC----ChHHHHHHHHHhcCCCCcCeEEEEEEcCCEEEEEEeC
Confidence 3455678999999999999754 5678999999976432 345688888887 799999999999999999999999
Q ss_pred ccCCCccccccCCCCCchhHHHHHHHHHHHHHHHHhhccCCCeEecCCCCCcEEEcCC----CCeEEeecCCCccccCCC
Q 003836 581 MSNGTVASFLFGDSKPNWKLRTEIAMGIAGGLFYLHEECCTQIIHCDIKPQNILLDDH----YNARISDFGLAKLLTLDQ 656 (792)
Q Consensus 581 ~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dikp~NILl~~~----~~~kl~Dfg~a~~~~~~~ 656 (792)
+++|+|.+++.....+++..+..++.||+.||+|||+. +|+||||||+|||+.++ +.+||+|||+++......
T Consensus 98 ~~gg~L~~~i~~~~~~~~~~~~~~~~qi~~al~~lH~~---givHrDlkp~NIl~~~~~~~~~~~kl~Dfg~a~~~~~~~ 174 (342)
T 2qr7_A 98 MKGGELLDKILRQKFFSEREASAVLFTITKTVEYLHAQ---GVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAEN 174 (342)
T ss_dssp CCSCBHHHHHHTCTTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEESSSSCSGGGEEECCCTTCEECBCTT
T ss_pred CCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC---CcEeccCCHHHEEEecCCCCcCeEEEEECCCcccCcCCC
Confidence 99999999998888899999999999999999999999 99999999999998543 349999999998765432
Q ss_pred CCccccccccCCcccccccccCCCCcccceehHHHHHHHHHhcCcCCCcchhhhhhhhHHHHHHHhhcccchhHhhhchh
Q 003836 657 SHTNTAIRGTKGYVAPEWFRNMPITVKVDVYSYGVLLLEIICLRRNIDNEISKVDKAILTDWAYDRYQERTLEALVENDL 736 (792)
Q Consensus 657 ~~~~~~~~gt~~y~aPE~~~~~~~~~k~DV~S~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 736 (792)
. ......||+.|+|||.+.+..++.++|||||||++|||++|+.||...........+... ..+.. ..
T Consensus 175 ~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~i-----~~~~~------~~ 242 (342)
T 2qr7_A 175 G-LLMTPCYTANFVAPEVLERQGYDAACDIWSLGVLLYTMLTGYTPFANGPDDTPEEILARI-----GSGKF------SL 242 (342)
T ss_dssp C-CBCCSSCCSSCCCHHHHHHHHHHHHHHHHHHHHHHHHHHHSSCSSCSSTTSCHHHHHHHH-----HHCCC------CC
T ss_pred C-ceeccCCCccccCHHHhcCCCCCCccCeeeHhHHHHHHhcCCCCCCCCCcCCHHHHHHHH-----ccCCc------cc
Confidence 2 233456899999999998888999999999999999999999999753221111111110 00000 00
Q ss_pred cccCCHHHHHHHHHHHHHccccCCCCCCCHHhHHHH
Q 003836 737 EAMNNVTMLHRFVMVAFWCIQEDPSHRPTMRKVTQM 772 (792)
Q Consensus 737 ~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~ 772 (792)
........+..+.+++.+||+.||++||++.|+++.
T Consensus 243 ~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~~il~h 278 (342)
T 2qr7_A 243 SGGYWNSVSDTAKDLVSKMLHVDPHQRLTAALVLRH 278 (342)
T ss_dssp CSTTTTTSCHHHHHHHHHHTCSSTTTSCCHHHHTTS
T ss_pred CccccccCCHHHHHHHHHHCCCChhHCcCHHHHhcC
Confidence 111112345678899999999999999999999864
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-37 Score=330.28 Aligned_cols=245 Identities=20% Similarity=0.293 Sum_probs=203.0
Q ss_pred hhhhcCccccceEEEeeecCCCceEEEEEEccccc---ccchHHHHHHHHHhcccCCCCcccccceeccCCceEEEEEec
Q 003836 505 FKEELGRGAFGTVYKGFVNMGSSNHVAVKKLNSVF---QDSEKEFKAEVNGIGQTHHKNLVRLLGYCDEGQNRLLVYEFM 581 (792)
Q Consensus 505 ~~~~lG~G~~g~Vy~g~~~~~~~~~vavK~~~~~~---~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~lV~E~~ 581 (792)
+.+.||+|+||.||++... .+++.+|+|++.... ....+.+.+|+.++++++|+||+++++++.+.+..++||||+
T Consensus 19 ~~~~lg~G~~g~Vy~~~~~-~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 97 (294)
T 2rku_A 19 RGRFLGKGGFAKCFEISDA-DTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVVLELC 97 (294)
T ss_dssp EEEEEEEETTEEEEEEEET-TTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEECC
T ss_pred EEEEEeecCCEEEEEEEEC-CCCceEEEEEechhhccCHHHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCEEEEEEecC
Confidence 4578999999999999754 456789999986542 234567899999999999999999999999999999999999
Q ss_pred cCCCccccccCCCCCchhHHHHHHHHHHHHHHHHhhccCCCeEecCCCCCcEEEcCCCCeEEeecCCCccccCCCCCccc
Q 003836 582 SNGTVASFLFGDSKPNWKLRTEIAMGIAGGLFYLHEECCTQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLDQSHTNT 661 (792)
Q Consensus 582 ~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dikp~NILl~~~~~~kl~Dfg~a~~~~~~~~~~~~ 661 (792)
++++|.+++.....+++..+..++.||+.||+|||+. +|+||||||+|||++.++.+||+|||+++....... ...
T Consensus 98 ~~~~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~-~~~ 173 (294)
T 2rku_A 98 RRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRN---RVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGE-RKK 173 (294)
T ss_dssp TTCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTCEECCSTTC-CBC
T ss_pred CCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCChHhEEEcCCCCEEEEeccCceecccCcc-ccc
Confidence 9999999998778899999999999999999999999 999999999999999999999999999987643222 223
Q ss_pred cccccCCcccccccccCCCCcccceehHHHHHHHHHhcCcCCCcchhhhhhhhHHHHHHHhhcccchhHhhhchhcccCC
Q 003836 662 AIRGTKGYVAPEWFRNMPITVKVDVYSYGVLLLEIICLRRNIDNEISKVDKAILTDWAYDRYQERTLEALVENDLEAMNN 741 (792)
Q Consensus 662 ~~~gt~~y~aPE~~~~~~~~~k~DV~S~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 741 (792)
...||+.|+|||.+.+..++.++||||||+++|||++|+.||......... . .+.... ...+
T Consensus 174 ~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~--------~--------~~~~~~--~~~~ 235 (294)
T 2rku_A 174 VLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETY--------L--------RIKKNE--YSIP 235 (294)
T ss_dssp CCCSCCSSCCHHHHTTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHH--------H--------HHHTTC--CCCC
T ss_pred cccCCCCcCCcchhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHH--------H--------HHhhcc--CCCc
Confidence 456899999999999989999999999999999999999999764322110 0 000000 0112
Q ss_pred HHHHHHHHHHHHHccccCCCCCCCHHhHHHH
Q 003836 742 VTMLHRFVMVAFWCIQEDPSHRPTMRKVTQM 772 (792)
Q Consensus 742 ~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~ 772 (792)
......+.+++.+||+.||++|||++|+++.
T Consensus 236 ~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~ 266 (294)
T 2rku_A 236 KHINPVAASLIQKMLQTDPTARPTINELLND 266 (294)
T ss_dssp TTSCHHHHHHHHHHTCSSGGGSCCGGGGGGS
T ss_pred cccCHHHHHHHHHHcccChhhCcCHHHHhhC
Confidence 2334578889999999999999999999974
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-38 Score=339.23 Aligned_cols=256 Identities=29% Similarity=0.362 Sum_probs=200.4
Q ss_pred HhhhhhhcCccccceEEEeeec----CCCceEEEEEEccccc-ccchHHHHHHHHHhcccCCCCcccccceeccCCceEE
Q 003836 502 TRGFKEELGRGAFGTVYKGFVN----MGSSNHVAVKKLNSVF-QDSEKEFKAEVNGIGQTHHKNLVRLLGYCDEGQNRLL 576 (792)
Q Consensus 502 ~~~~~~~lG~G~~g~Vy~g~~~----~~~~~~vavK~~~~~~-~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~l 576 (792)
.+.+.+.||+|+||.||+|... ..+++.||||++.... .....++.+|+.++++++||||+++++++.+....++
T Consensus 31 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 110 (327)
T 2yfx_A 31 NITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPRFI 110 (327)
T ss_dssp GCEEEEECC--CSSCEEEEEC--------CCEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEE
T ss_pred heEEEEEEcCCCCeeEEEEEEcCCCCCCccceEEEEEeccccchhhHHHHHHHHHHHhhCCCCCCCeEEEEEcCCCCcEE
Confidence 3455678999999999999752 2346689999997542 3445679999999999999999999999999999999
Q ss_pred EEEeccCCCccccccCC-------CCCchhHHHHHHHHHHHHHHHHhhccCCCeEecCCCCCcEEEcC---CCCeEEeec
Q 003836 577 VYEFMSNGTVASFLFGD-------SKPNWKLRTEIAMGIAGGLFYLHEECCTQIIHCDIKPQNILLDD---HYNARISDF 646 (792)
Q Consensus 577 V~E~~~~gsL~~~l~~~-------~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dikp~NILl~~---~~~~kl~Df 646 (792)
||||+++++|.+++... ..+++..+..++.||+.||.|||+. +|+||||||+|||++. +..+||+||
T Consensus 111 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~---~i~H~dlkp~NIli~~~~~~~~~kl~Df 187 (327)
T 2yfx_A 111 LMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEEN---HFIHRDIAARNCLLTCPGPGRVAKIGDF 187 (327)
T ss_dssp EEECCTTEEHHHHHHHTSCCSSSTTSCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESCSSTTCCEEECCC
T ss_pred EEecCCCCcHHHHHHhhcccccccccccHHHHHHHHHHHHHHHHHHhhC---CeecCcCCHhHEEEecCCCcceEEECcc
Confidence 99999999999999754 3478899999999999999999998 9999999999999994 456999999
Q ss_pred CCCccccCCCC-CccccccccCCcccccccccCCCCcccceehHHHHHHHHHh-cCcCCCcchhhhhhhhHHHHHHHhhc
Q 003836 647 GLAKLLTLDQS-HTNTAIRGTKGYVAPEWFRNMPITVKVDVYSYGVLLLEIIC-LRRNIDNEISKVDKAILTDWAYDRYQ 724 (792)
Q Consensus 647 g~a~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~k~DV~S~Gv~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~ 724 (792)
|+++....... .......+++.|+|||.+.+..++.++||||||+++|||++ |+.||........ .
T Consensus 188 g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~---~--------- 255 (327)
T 2yfx_A 188 GMARDIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEV---L--------- 255 (327)
T ss_dssp HHHHHHHC------CCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHH---H---------
T ss_pred ccccccccccccccCCCcCCCcceeCHhHhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCcCHHHH---H---------
Confidence 99986543322 22233457889999999998899999999999999999998 8888865422110 0
Q ss_pred ccchhHhhhchhcccCCHHHHHHHHHHHHHccccCCCCCCCHHhHHHHhccCc
Q 003836 725 ERTLEALVENDLEAMNNVTMLHRFVMVAFWCIQEDPSHRPTMRKVTQMLEGVV 777 (792)
Q Consensus 725 ~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~L~~~~ 777 (792)
..+........+...+..+.+++.+||+.||.+||++.+|++.|+.+.
T Consensus 256 -----~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~~ 303 (327)
T 2yfx_A 256 -----EFVTSGGRMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCT 303 (327)
T ss_dssp -----HHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred -----HHHhcCCCCCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHh
Confidence 001111111122334567889999999999999999999999998764
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-38 Score=334.30 Aligned_cols=256 Identities=24% Similarity=0.318 Sum_probs=196.5
Q ss_pred hhhhhhcCccccceEEEeeecCCC--ceEEEEEEcccc---cccchHHHHHHHHHhcccCCCCcccccceeccCCceEEE
Q 003836 503 RGFKEELGRGAFGTVYKGFVNMGS--SNHVAVKKLNSV---FQDSEKEFKAEVNGIGQTHHKNLVRLLGYCDEGQNRLLV 577 (792)
Q Consensus 503 ~~~~~~lG~G~~g~Vy~g~~~~~~--~~~vavK~~~~~---~~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~lV 577 (792)
+.+.+.||+|+||+||+|.....+ ...||||+++.. .....+.+.+|++++++++||||+++++++.+.. .++|
T Consensus 20 y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-~~~v 98 (291)
T 1u46_A 20 LRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTPP-MKMV 98 (291)
T ss_dssp EEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS-CEEE
T ss_pred eeeeeeecCCCceeEEEEEeccCCCceeEEEEEEEccCccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEccCC-ceee
Confidence 345678999999999999865433 347999998753 2344578999999999999999999999998765 8899
Q ss_pred EEeccCCCccccccCC-CCCchhHHHHHHHHHHHHHHHHhhccCCCeEecCCCCCcEEEcCCCCeEEeecCCCccccCCC
Q 003836 578 YEFMSNGTVASFLFGD-SKPNWKLRTEIAMGIAGGLFYLHEECCTQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLDQ 656 (792)
Q Consensus 578 ~E~~~~gsL~~~l~~~-~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dikp~NILl~~~~~~kl~Dfg~a~~~~~~~ 656 (792)
+||+++++|.+++... ..+++..+..++.||+.||.|||+. +|+|+||||+|||++.++.+||+|||+++......
T Consensus 99 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~ 175 (291)
T 1u46_A 99 TELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESK---RFIHRDLAARNLLLATRDLVKIGDFGLMRALPQND 175 (291)
T ss_dssp EECCTTCBHHHHHHHHGGGSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEEEETTEEEECCCTTCEECCC-C
T ss_pred EecccCCCHHHHHHhccCCcCHHHHHHHHHHHHHHHHHHHhC---CcccCCCchheEEEcCCCCEEEccccccccccccc
Confidence 9999999999999764 5688999999999999999999998 99999999999999999999999999998765433
Q ss_pred CC--ccccccccCCcccccccccCCCCcccceehHHHHHHHHHh-cCcCCCcchhhhhhhhHHHHHHHhhcccchhHhhh
Q 003836 657 SH--TNTAIRGTKGYVAPEWFRNMPITVKVDVYSYGVLLLEIIC-LRRNIDNEISKVDKAILTDWAYDRYQERTLEALVE 733 (792)
Q Consensus 657 ~~--~~~~~~gt~~y~aPE~~~~~~~~~k~DV~S~Gv~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 733 (792)
.. ......+++.|+|||.+.+..++.++||||||+++|||++ |+.||........ . ..+..
T Consensus 176 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~---~-------------~~~~~ 239 (291)
T 1u46_A 176 DHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQI---L-------------HKIDK 239 (291)
T ss_dssp CEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHH---H-------------HHHHT
T ss_pred cchhhhccCCCCceeeCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCcccCCHHHH---H-------------HHHHc
Confidence 22 1223457888999999998889999999999999999999 9999965432110 0 01111
Q ss_pred chhcccCCHHHHHHHHHHHHHccccCCCCCCCHHhHHHHhccCcC
Q 003836 734 NDLEAMNNVTMLHRFVMVAFWCIQEDPSHRPTMRKVTQMLEGVVE 778 (792)
Q Consensus 734 ~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~L~~~~~ 778 (792)
.......+...+..+.+++.+||+.+|++|||+.++++.|+++..
T Consensus 240 ~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~ 284 (291)
T 1u46_A 240 EGERLPRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLEAQP 284 (291)
T ss_dssp SCCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC-
T ss_pred cCCCCCCCcCcCHHHHHHHHHHccCCcccCcCHHHHHHHHHHhCc
Confidence 111111223455778999999999999999999999999988643
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-37 Score=338.59 Aligned_cols=264 Identities=22% Similarity=0.327 Sum_probs=205.9
Q ss_pred CHHHHHHHHhhhhhhcCccccceEEEeeecCCCceEEEEEEcccccccchHHHHHHHHHhcc--cCCCCcccccceeccC
Q 003836 494 TYKELVEVTRGFKEELGRGAFGTVYKGFVNMGSSNHVAVKKLNSVFQDSEKEFKAEVNGIGQ--THHKNLVRLLGYCDEG 571 (792)
Q Consensus 494 ~~~el~~~~~~~~~~lG~G~~g~Vy~g~~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~--l~h~niv~l~g~~~~~ 571 (792)
...+.....+.+.+.||+|+||.||+|+.. ++.||||++... ....+.+|++++.. ++||||+++++++...
T Consensus 35 ~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~---~~~vavK~~~~~---~~~~~~~e~~~~~~~~l~h~ni~~~~~~~~~~ 108 (342)
T 1b6c_B 35 LVQRTIARTIVLQESIGKGRFGEVWRGKWR---GEEVAVKIFSSR---EERSWFREAEIYQTVMLRHENILGFIAADNKD 108 (342)
T ss_dssp HHHHHHHHHCEEEEEEEEETTEEEEEEEET---TEEEEEEEECGG---GHHHHHHHHHHHHHSCCCCTTBCCEEEEEECC
T ss_pred eecccccccEEEEeeecCCCCcEEEEEEEc---CccEEEEEeCch---hHHHHHHHHHHHHHhhcCCCcEEEEEeeeccc
Confidence 344555566677789999999999999763 678999998643 35677888888877 7999999999999877
Q ss_pred C----ceEEEEEeccCCCccccccCCCCCchhHHHHHHHHHHHHHHHHh--------hccCCCeEecCCCCCcEEEcCCC
Q 003836 572 Q----NRLLVYEFMSNGTVASFLFGDSKPNWKLRTEIAMGIAGGLFYLH--------EECCTQIIHCDIKPQNILLDDHY 639 (792)
Q Consensus 572 ~----~~~lV~E~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH--------~~~~~~ivH~dikp~NILl~~~~ 639 (792)
. ..++||||+++|+|.+++.. ..+++..+..++.||+.||+||| +. +|+||||||+|||++.++
T Consensus 109 ~~~~~~~~lv~e~~~~g~L~~~l~~-~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~---~ivH~Dlkp~NIll~~~~ 184 (342)
T 1b6c_B 109 NGTWTQLWLVSDYHEHGSLFDYLNR-YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKP---AIAHRDLKSKNILVKKNG 184 (342)
T ss_dssp CSSCCCEEEEECCCTTCBHHHHHHH-CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBC---EEECSCCSGGGEEECTTS
T ss_pred CCccceeEEEEeecCCCcHHHHHhc-cCccHHHHHHHHHHHHHHHHHHHHHHhhhcccC---CeeeCCCCHHHEEECCCC
Confidence 6 78999999999999999965 46889999999999999999999 66 999999999999999999
Q ss_pred CeEEeecCCCccccCCCCC---ccccccccCCcccccccccC------CCCcccceehHHHHHHHHHhc----------C
Q 003836 640 NARISDFGLAKLLTLDQSH---TNTAIRGTKGYVAPEWFRNM------PITVKVDVYSYGVLLLEIICL----------R 700 (792)
Q Consensus 640 ~~kl~Dfg~a~~~~~~~~~---~~~~~~gt~~y~aPE~~~~~------~~~~k~DV~S~Gv~l~el~tg----------~ 700 (792)
.+||+|||+++........ ......||+.|+|||.+.+. .++.++||||||+++|||++| +
T Consensus 185 ~~kL~Dfg~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~~ 264 (342)
T 1b6c_B 185 TCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQ 264 (342)
T ss_dssp CEEECCCTTCEEEETTTTEEEECCCSCCCCGGGCCHHHHTSCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCC
T ss_pred CEEEEECCCceeccccccccccccccCCcCcccCCHhhhcccccccccccCCcccHHHHHHHHHHHHhccCcCCcccccc
Confidence 9999999999876543322 22345689999999998765 344789999999999999999 6
Q ss_pred cCCCcchhhhhhhhHHHHHHHhhcccchhHhhhchhccc-----CCHHHHHHHHHHHHHccccCCCCCCCHHhHHHHhcc
Q 003836 701 RNIDNEISKVDKAILTDWAYDRYQERTLEALVENDLEAM-----NNVTMLHRFVMVAFWCIQEDPSHRPTMRKVTQMLEG 775 (792)
Q Consensus 701 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-----~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~L~~ 775 (792)
.||......... ...+. . .+........ ...+....+.+++.+||+.||++|||++||+++|+.
T Consensus 265 ~p~~~~~~~~~~--~~~~~-~--------~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~i~~~L~~ 333 (342)
T 1b6c_B 265 LPYYDLVPSDPS--VEEMR-K--------VVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQ 333 (342)
T ss_dssp CTTTTTSCSSCC--HHHHH-H--------HHTTSCCCCCCCGGGGTSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHHHHH
T ss_pred cCccccCcCccc--HHHHH-H--------HHHHHHhCCCCcccccchhHHHHHHHHHHHHhccChhhCCCHHHHHHHHHH
Confidence 676543211100 00000 0 0111111111 123567889999999999999999999999999987
Q ss_pred CcC
Q 003836 776 VVE 778 (792)
Q Consensus 776 ~~~ 778 (792)
+.+
T Consensus 334 i~~ 336 (342)
T 1b6c_B 334 LSQ 336 (342)
T ss_dssp HHH
T ss_pred HHH
Confidence 643
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.4e-38 Score=341.86 Aligned_cols=259 Identities=22% Similarity=0.296 Sum_probs=198.4
Q ss_pred HhhhhhhcCccccceEEEeeecCCCceEEEEEEcccccccchHHHHHHHHHhcccC-----CCCcccccceeccCCceEE
Q 003836 502 TRGFKEELGRGAFGTVYKGFVNMGSSNHVAVKKLNSVFQDSEKEFKAEVNGIGQTH-----HKNLVRLLGYCDEGQNRLL 576 (792)
Q Consensus 502 ~~~~~~~lG~G~~g~Vy~g~~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~-----h~niv~l~g~~~~~~~~~l 576 (792)
.+.+.++||+|+||+||+|... .+++.||||++... ......+..|+.++++++ ||||+++++++...+..++
T Consensus 36 ~y~~~~~lG~G~~g~V~~~~~~-~~~~~vavK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~h~~iv~~~~~~~~~~~~~l 113 (360)
T 3llt_A 36 AFLVIRKMGDGTFGRVLLCQHI-DNKKYYAVKVVRNI-KKYTRSAKIEADILKKIQNDDINNNNIVKYHGKFMYYDHMCL 113 (360)
T ss_dssp TEEEEEEEEECSSEEEEEEEET-TTCCEEEEEEECSC-HHHHHHHHHHHHHHHHTCCCSTTGGGBCCEEEEEEETTEEEE
T ss_pred EEEEEEEEcccCCeEEEEEEEC-CCCeEEEEEEeccc-hhhhhhhHHHHHHHHHhcccCCCCCCeecccceeeECCeeEE
Confidence 3445688999999999999764 45679999998753 334567788999998886 9999999999999999999
Q ss_pred EEEeccCCCccccccCCC--CCchhHHHHHHHHHHHHHHHHhhccCCCeEecCCCCCcEEEcC-----------------
Q 003836 577 VYEFMSNGTVASFLFGDS--KPNWKLRTEIAMGIAGGLFYLHEECCTQIIHCDIKPQNILLDD----------------- 637 (792)
Q Consensus 577 V~E~~~~gsL~~~l~~~~--~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dikp~NILl~~----------------- 637 (792)
||||+ +++|.+++.... .+++..+..++.||+.||+|||+. +|+||||||+|||++.
T Consensus 114 v~e~~-~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~~~~~~~~~~~~~~~~~ 189 (360)
T 3llt_A 114 IFEPL-GPSLYEIITRNNYNGFHIEDIKLYCIEILKALNYLRKM---SLTHTDLKPENILLDDPYFEKSLITVRRVTDGK 189 (360)
T ss_dssp EECCC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEESCTTCCEEEEEEECTTTCC
T ss_pred EEcCC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCcccEEEccccccccccchhcccccc
Confidence 99999 899999997653 588999999999999999999998 9999999999999975
Q ss_pred --------CCCeEEeecCCCccccCCCCCccccccccCCcccccccccCCCCcccceehHHHHHHHHHhcCcCCCcchhh
Q 003836 638 --------HYNARISDFGLAKLLTLDQSHTNTAIRGTKGYVAPEWFRNMPITVKVDVYSYGVLLLEIICLRRNIDNEISK 709 (792)
Q Consensus 638 --------~~~~kl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DV~S~Gv~l~el~tg~~p~~~~~~~ 709 (792)
++.+||+|||+++..... .....||+.|+|||.+.+..++.++|||||||++|||++|+.||......
T Consensus 190 ~~~~~~~~~~~~kl~DFG~a~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~ 265 (360)
T 3llt_A 190 KIQIYRTKSTGIKLIDFGCATFKSDY----HGSIINTRQYRAPEVILNLGWDVSSDMWSFGCVLAELYTGSLLFRTHEHM 265 (360)
T ss_dssp EEEEEEESCCCEEECCCTTCEETTSC----CCSCCSCGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHH
T ss_pred cccccccCCCCEEEEeccCceecCCC----CcCccCcccccCcHHHcCCCCCCccchHHHHHHHHHHHHCCCCCCCCcHH
Confidence 789999999999864332 23456899999999999999999999999999999999999999764332
Q ss_pred hhhhhHHH--------HHHHhhcccchhHhhh-chhccc--------------------CCHHHHHHHHHHHHHccccCC
Q 003836 710 VDKAILTD--------WAYDRYQERTLEALVE-NDLEAM--------------------NNVTMLHRFVMVAFWCIQEDP 760 (792)
Q Consensus 710 ~~~~~~~~--------~~~~~~~~~~~~~~~~-~~~~~~--------------------~~~~~~~~l~~l~~~Cl~~~p 760 (792)
.....+.. +....... .....+. ...... ......+.+.+++.+||+.||
T Consensus 266 ~~~~~~~~~~~~~p~~~~~~~~~~-~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP 344 (360)
T 3llt_A 266 EHLAMMESIIQPIPKNMLYEATKT-NGSKYVNKDELKLAWPENASSINSIKHVKKCLPLYKIIKHELFCDFLYSILQIDP 344 (360)
T ss_dssp HHHHHHHHHTCCCCHHHHHHHTTS-GGGGGEETTTTEECTTTTCSCHHHHHHHHTCCCHHHHCCCHHHHHHHHHHCCSSG
T ss_pred HHHHHHHHhcCCCCHHHHhhhhhc-cCccccCcccceecCcccccchhhhhhhhhcccccccchHHHHHHHHHHHhcCCh
Confidence 21111100 00000000 0000000 000000 000112668899999999999
Q ss_pred CCCCCHHhHHH
Q 003836 761 SHRPTMRKVTQ 771 (792)
Q Consensus 761 ~~RPs~~evl~ 771 (792)
++|||++|+++
T Consensus 345 ~~Rpta~elL~ 355 (360)
T 3llt_A 345 TLRPSPAELLK 355 (360)
T ss_dssp GGSCCHHHHTT
T ss_pred hhCCCHHHHhc
Confidence 99999999986
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-38 Score=331.50 Aligned_cols=246 Identities=27% Similarity=0.366 Sum_probs=194.3
Q ss_pred hhhhhhcCccccceEEEeeecCCCceEEEEEEcccccccchHHHHHHHHHhcccCCCCcccccceeccC-CceEEEEEec
Q 003836 503 RGFKEELGRGAFGTVYKGFVNMGSSNHVAVKKLNSVFQDSEKEFKAEVNGIGQTHHKNLVRLLGYCDEG-QNRLLVYEFM 581 (792)
Q Consensus 503 ~~~~~~lG~G~~g~Vy~g~~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~-~~~~lV~E~~ 581 (792)
+.+.+.||+|+||+||++... ++.||||++... ...+.+.+|++++++++||||+++++++.+. +..++||||+
T Consensus 23 y~~~~~lg~G~~g~V~~~~~~---~~~vavK~~~~~--~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~~ 97 (278)
T 1byg_A 23 LKLLQTIGKGEFGDVMLGDYR---GNKVAVKCIKND--ATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYM 97 (278)
T ss_dssp EEEEEEEEECSSCEEEEEEET---TEEEEEEECCCC--C--HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEECCC
T ss_pred ceEEeEEecCCCceEEEEEEc---CCEEEEEEecch--hHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCCceEEEEecC
Confidence 345578999999999999753 578999999753 3567899999999999999999999997554 4789999999
Q ss_pred cCCCccccccCCC--CCchhHHHHHHHHHHHHHHHHhhccCCCeEecCCCCCcEEEcCCCCeEEeecCCCccccCCCCCc
Q 003836 582 SNGTVASFLFGDS--KPNWKLRTEIAMGIAGGLFYLHEECCTQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLDQSHT 659 (792)
Q Consensus 582 ~~gsL~~~l~~~~--~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dikp~NILl~~~~~~kl~Dfg~a~~~~~~~~~~ 659 (792)
++++|.+++.... .+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++......
T Consensus 98 ~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~--- 171 (278)
T 1byg_A 98 AKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGN---NFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQ--- 171 (278)
T ss_dssp TTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTSCEEECCCCC-----------
T ss_pred CCCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHHhC---CccccCCCcceEEEeCCCcEEEeeccccccccccc---
Confidence 9999999997653 378899999999999999999998 99999999999999999999999999998654321
Q ss_pred cccccccCCcccccccccCCCCcccceehHHHHHHHHHh-cCcCCCcchhhhhhhhHHHHHHHhhcccchhHhhhchhcc
Q 003836 660 NTAIRGTKGYVAPEWFRNMPITVKVDVYSYGVLLLEIIC-LRRNIDNEISKVDKAILTDWAYDRYQERTLEALVENDLEA 738 (792)
Q Consensus 660 ~~~~~gt~~y~aPE~~~~~~~~~k~DV~S~Gv~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 738 (792)
....+++.|+|||.+.+..++.++||||||+++|||++ |+.||........ ...+......
T Consensus 172 -~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~~-----------------~~~~~~~~~~ 233 (278)
T 1byg_A 172 -DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDV-----------------VPRVEKGYKM 233 (278)
T ss_dssp -----CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGGGH-----------------HHHHTTTCCC
T ss_pred -cCCCccccccCHHHhCCCCCCchhcHHHHHHHHHHHHhCCCCCCCCCCHHHH-----------------HHHHhcCCCC
Confidence 22347889999999998999999999999999999998 9999865422110 0001111112
Q ss_pred cCCHHHHHHHHHHHHHccccCCCCCCCHHhHHHHhccCc
Q 003836 739 MNNVTMLHRFVMVAFWCIQEDPSHRPTMRKVTQMLEGVV 777 (792)
Q Consensus 739 ~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~L~~~~ 777 (792)
..+...+..+.+++.+||+.||++|||+.|+++.|+.+.
T Consensus 234 ~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~i~ 272 (278)
T 1byg_A 234 DAPDGCPPAVYEVMKNCWHLDAAMRPSFLQLREQLEHIK 272 (278)
T ss_dssp CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred CCcccCCHHHHHHHHHHhcCChhhCCCHHHHHHHHHHHH
Confidence 223344567889999999999999999999999998764
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-37 Score=328.09 Aligned_cols=245 Identities=23% Similarity=0.320 Sum_probs=203.2
Q ss_pred hhhhhhcCccccceEEEeeecCCCceEEEEEEccccc---ccchHHHHHHHHHhcccCCCCcccccceeccCCceEEEEE
Q 003836 503 RGFKEELGRGAFGTVYKGFVNMGSSNHVAVKKLNSVF---QDSEKEFKAEVNGIGQTHHKNLVRLLGYCDEGQNRLLVYE 579 (792)
Q Consensus 503 ~~~~~~lG~G~~g~Vy~g~~~~~~~~~vavK~~~~~~---~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~lV~E 579 (792)
+.+.+.||+|+||.||++... .+++.||+|++.... ....+.+.+|++++++++||||+++++++.+.+..++|||
T Consensus 16 y~~~~~lg~G~~g~Vy~~~~~-~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 94 (284)
T 2vgo_A 16 FDIGRPLGKGKFGNVYLAREK-QNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYNYFHDRKRIYLMLE 94 (284)
T ss_dssp EEEEEEEEECSSEEEEEEEET-TTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred ceeeheecCCCCeEEEEEEEc-CCCcEEEEEEEcccccchHHHHHHHHHHHHHHhcCCCCCEeeEEEEEEcCCEEEEEEE
Confidence 345578999999999999754 456789999986532 2335689999999999999999999999999999999999
Q ss_pred eccCCCccccccCCCCCchhHHHHHHHHHHHHHHHHhhccCCCeEecCCCCCcEEEcCCCCeEEeecCCCccccCCCCCc
Q 003836 580 FMSNGTVASFLFGDSKPNWKLRTEIAMGIAGGLFYLHEECCTQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLDQSHT 659 (792)
Q Consensus 580 ~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dikp~NILl~~~~~~kl~Dfg~a~~~~~~~~~~ 659 (792)
|+++++|.+++.....+++..+..++.||+.||.|||+. +|+||||||+|||++.++.+||+|||++...... .
T Consensus 95 ~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~~---~ 168 (284)
T 2vgo_A 95 FAPRGELYKELQKHGRFDEQRSATFMEELADALHYCHER---KVIHRDIKPENLLMGYKGELKIADFGWSVHAPSL---R 168 (284)
T ss_dssp CCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCSGGGEEECTTCCEEECCCTTCEECSSS---C
T ss_pred eCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCHHHEEEcCCCCEEEecccccccCccc---c
Confidence 999999999998777899999999999999999999998 9999999999999999999999999999765432 2
Q ss_pred cccccccCCcccccccccCCCCcccceehHHHHHHHHHhcCcCCCcchhhhhhhhHHHHHHHhhcccchhHhhhchhccc
Q 003836 660 NTAIRGTKGYVAPEWFRNMPITVKVDVYSYGVLLLEIICLRRNIDNEISKVDKAILTDWAYDRYQERTLEALVENDLEAM 739 (792)
Q Consensus 660 ~~~~~gt~~y~aPE~~~~~~~~~k~DV~S~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 739 (792)
.....|++.|+|||.+.+..++.++||||||+++|||++|+.||......... ..+.... ..
T Consensus 169 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~----------------~~~~~~~--~~ 230 (284)
T 2vgo_A 169 RRTMCGTLDYLPPEMIEGKTHDEKVDLWCAGVLCYEFLVGMPPFDSPSHTETH----------------RRIVNVD--LK 230 (284)
T ss_dssp BCCCCSCGGGCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHH----------------HHHHTTC--CC
T ss_pred cccccCCCCcCCHHHhccCCCCcccchhhHHHHHHHHHHCCCCCCCCCHhHHH----------------HHHhccc--cC
Confidence 23456899999999999999999999999999999999999999754322110 0011111 11
Q ss_pred CCHHHHHHHHHHHHHccccCCCCCCCHHhHHHH
Q 003836 740 NNVTMLHRFVMVAFWCIQEDPSHRPTMRKVTQM 772 (792)
Q Consensus 740 ~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~ 772 (792)
.+...+..+.+++.+||+.||.+||+++|+++.
T Consensus 231 ~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~h 263 (284)
T 2vgo_A 231 FPPFLSDGSKDLISKLLRYHPPQRLPLKGVMEH 263 (284)
T ss_dssp CCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTC
T ss_pred CCCcCCHHHHHHHHHHhhcCHhhCCCHHHHhhC
Confidence 222345678899999999999999999999863
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-38 Score=340.47 Aligned_cols=268 Identities=25% Similarity=0.364 Sum_probs=193.1
Q ss_pred hhhhhcCccccceEEEeeecCCCceEEEEEEcccccccchHHHH--HHHHHhcccCCCCccccccee-----ccCCceEE
Q 003836 504 GFKEELGRGAFGTVYKGFVNMGSSNHVAVKKLNSVFQDSEKEFK--AEVNGIGQTHHKNLVRLLGYC-----DEGQNRLL 576 (792)
Q Consensus 504 ~~~~~lG~G~~g~Vy~g~~~~~~~~~vavK~~~~~~~~~~~~~~--~Ei~~l~~l~h~niv~l~g~~-----~~~~~~~l 576 (792)
.+.+.||+|+||.||+|+. +++.||||++... ....+. .|+..+..++|+||+++++.+ ......++
T Consensus 16 ~~~~~lg~G~~g~Vy~~~~---~~~~vavK~~~~~---~~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~~l 89 (336)
T 3g2f_A 16 KLLELIGRGRYGAVYKGSL---DERPVAVKVFSFA---NRQNFINEKNIYRVPLMEHDNIARFIVGDERVTADGRMEYLL 89 (336)
T ss_dssp EEEEEEEECSSEEEEEEEE---TTEEEEEEEEEGG---GHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECTTSCEEEEE
T ss_pred heeeecccCCCeEEEEEEE---CCeEEEEEEeecc---chhhHHHHHHHHHHHhccCcchhhheecccccccCCCceEEE
Confidence 3457899999999999975 3578999998643 233344 444445668999999999744 33346789
Q ss_pred EEEeccCCCccccccCCCCCchhHHHHHHHHHHHHHHHHhhccC------CCeEecCCCCCcEEEcCCCCeEEeecCCCc
Q 003836 577 VYEFMSNGTVASFLFGDSKPNWKLRTEIAMGIAGGLFYLHEECC------TQIIHCDIKPQNILLDDHYNARISDFGLAK 650 (792)
Q Consensus 577 V~E~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~------~~ivH~dikp~NILl~~~~~~kl~Dfg~a~ 650 (792)
||||+++|+|.+++.... .++..+.+++.||++||+|||+.+. .+|+||||||+|||++.++.+||+|||+++
T Consensus 90 v~e~~~~g~L~~~l~~~~-~~~~~~~~i~~qi~~~L~~LH~~~~~~~~~~~~ivH~Dikp~Nill~~~~~~kL~DFG~a~ 168 (336)
T 3g2f_A 90 VMEYYPNGSLXKYLSLHT-SDWVSSCRLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSM 168 (336)
T ss_dssp EECCCTTCBHHHHHHHCC-BCHHHHHHHHHHHHHHHHHHHCCBCCGGGCBCCEECSSCSGGGEEECTTSCEEECCCTTCE
T ss_pred EEecCCCCcHHHHHhhcc-cchhHHHHHHHHHHHHHHHHHhhhccccccccceeecccccceEEEcCCCcEEEeecccee
Confidence 999999999999996543 4888999999999999999998632 389999999999999999999999999998
Q ss_pred cccCCCC-------CccccccccCCccccccccc-------CCCCcccceehHHHHHHHHHhcCcCCCcchhhhhh-hhH
Q 003836 651 LLTLDQS-------HTNTAIRGTKGYVAPEWFRN-------MPITVKVDVYSYGVLLLEIICLRRNIDNEISKVDK-AIL 715 (792)
Q Consensus 651 ~~~~~~~-------~~~~~~~gt~~y~aPE~~~~-------~~~~~k~DV~S~Gv~l~el~tg~~p~~~~~~~~~~-~~~ 715 (792)
....... .......||+.|+|||.+.+ ..++.++|||||||++|||++|+.|+......... ...
T Consensus 169 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~ 248 (336)
T 3g2f_A 169 RLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLFPGESVPEYQMAF 248 (336)
T ss_dssp ECSSSSCC---------CCTTSCGGGCCHHHHTTCCCGGGHHHHHHHHHHHHHHHHHHHHHTTBGGGSTTSCCCCCCCTT
T ss_pred ecccccccCccccccccccCCCccceeCchhhcCCcccccccccccccchHHHHHHHHHHHhcCCcCCCccchhHHHHhh
Confidence 7654321 11224469999999999976 46778999999999999999998877543221110 000
Q ss_pred HHHHHHhhcccchhHhhh-chhccc------CCHHHHHHHHHHHHHccccCCCCCCCHHhHHHHhccCcC
Q 003836 716 TDWAYDRYQERTLEALVE-NDLEAM------NNVTMLHRFVMVAFWCIQEDPSHRPTMRKVTQMLEGVVE 778 (792)
Q Consensus 716 ~~~~~~~~~~~~~~~~~~-~~~~~~------~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~L~~~~~ 778 (792)
...............++. ...... .....+..+.+++.+||+.||++|||++|+++.|+++++
T Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~e~l~~L~~ll~ 318 (336)
T 3g2f_A 249 QTEVGNHPTFEDMQVLVSREKQRPKFPEAWKENSLAVRSLKETIEDCWDQDAEARLTAQXAEERMAELMM 318 (336)
T ss_dssp HHHHCSSCCHHHHHHHHTTSCCCCCCCTTCCCCSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHH
T ss_pred hcccCCCchHHHHHhhhcccccCCCCCcccccccchHHHHHHHHHHHhcCChhhCcchHHHHHHHHHHHH
Confidence 000000000000001110 111111 123466789999999999999999999999999988753
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-37 Score=365.22 Aligned_cols=245 Identities=25% Similarity=0.336 Sum_probs=204.3
Q ss_pred hhhhhcCccccceEEEeeecCCCceEEEEEEcccc---cccchHHHHHHHHHhccc-CCCCcccccceeccCCceEEEEE
Q 003836 504 GFKEELGRGAFGTVYKGFVNMGSSNHVAVKKLNSV---FQDSEKEFKAEVNGIGQT-HHKNLVRLLGYCDEGQNRLLVYE 579 (792)
Q Consensus 504 ~~~~~lG~G~~g~Vy~g~~~~~~~~~vavK~~~~~---~~~~~~~~~~Ei~~l~~l-~h~niv~l~g~~~~~~~~~lV~E 579 (792)
.+.++||+|+||.||++... .+++.||||++++. .....+.+..|..++..+ +|++|+++++++.+.+..+||||
T Consensus 344 ~~~~~LG~G~fG~V~~~~~~-~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~l~~~~~~~~~~~lV~E 422 (674)
T 3pfq_A 344 NFLMVLGKGSFGKVMLSERK-GTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVME 422 (674)
T ss_dssp EEEEESSBTTTBCEEEEEES-SSCCEEEEEEEEHHHHHHTTTTHHHHHHHHHHTCTTCCTTBCCEEEECBCSSEEEEEEE
T ss_pred EEEEEEccCCCEEEEEEEEC-CCCcEEEEEEEeccccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEEEeCCEEEEEEe
Confidence 34578999999999999754 56778999999753 234456788999999987 79999999999999999999999
Q ss_pred eccCCCccccccCCCCCchhHHHHHHHHHHHHHHHHhhccCCCeEecCCCCCcEEEcCCCCeEEeecCCCccccCCCCCc
Q 003836 580 FMSNGTVASFLFGDSKPNWKLRTEIAMGIAGGLFYLHEECCTQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLDQSHT 659 (792)
Q Consensus 580 ~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dikp~NILl~~~~~~kl~Dfg~a~~~~~~~~~~ 659 (792)
|+++|+|.+++.....+++..+..++.||+.||+|||++ +|+||||||+||||+.++.+||+|||+++...... ..
T Consensus 423 ~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~---gIiHrDLKp~NILl~~~g~ikL~DFGla~~~~~~~-~~ 498 (674)
T 3pfq_A 423 YVNGGDLMYHIQQVGRFKEPHAVFYAAEIAIGLFFLQSK---GIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDG-VT 498 (674)
T ss_dssp CCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHT---SEECCCCCSTTEEECSSSCEEECCCTTCEECCCTT-CC
T ss_pred CcCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC---CeEeccCChhhEEEcCCCcEEEeecceeeccccCC-cc
Confidence 999999999998878899999999999999999999999 99999999999999999999999999998643322 23
Q ss_pred cccccccCCcccccccccCCCCcccceehHHHHHHHHHhcCcCCCcchhhhhhhhHHHHHHHhhcccchhHhhhchhccc
Q 003836 660 NTAIRGTKGYVAPEWFRNMPITVKVDVYSYGVLLLEIICLRRNIDNEISKVDKAILTDWAYDRYQERTLEALVENDLEAM 739 (792)
Q Consensus 660 ~~~~~gt~~y~aPE~~~~~~~~~k~DV~S~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 739 (792)
.....||+.|+|||++.+..++.++|||||||+||||++|+.||........ ...++... ..
T Consensus 499 ~~~~~GT~~Y~APE~l~~~~~~~~~DvwSlGvilyelltG~~Pf~~~~~~~~----------------~~~i~~~~--~~ 560 (674)
T 3pfq_A 499 TKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDEL----------------FQSIMEHN--VA 560 (674)
T ss_dssp BCCCCSCSSSCCHHHHTCCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH----------------HHHHHSSC--CC
T ss_pred cccccCCCcccCHhhhcCCCCCccceEechHHHHHHHHcCCCCCCCCCHHHH----------------HHHHHhCC--CC
Confidence 3456799999999999999999999999999999999999999976432211 11111111 11
Q ss_pred CCHHHHHHHHHHHHHccccCCCCCCCH-----HhHHH
Q 003836 740 NNVTMLHRFVMVAFWCIQEDPSHRPTM-----RKVTQ 771 (792)
Q Consensus 740 ~~~~~~~~l~~l~~~Cl~~~p~~RPs~-----~evl~ 771 (792)
.+...+.++.+|+..||+.||++||++ +||++
T Consensus 561 ~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~ei~~ 597 (674)
T 3pfq_A 561 YPKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKE 597 (674)
T ss_dssp CCTTSCHHHHHHHHHHSCSSSTTCTTCSTTHHHHHHS
T ss_pred CCccCCHHHHHHHHHHccCCHHHCCCCCCCcHHHHhc
Confidence 233456788999999999999999998 77765
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-38 Score=345.18 Aligned_cols=254 Identities=22% Similarity=0.249 Sum_probs=203.6
Q ss_pred hhhhhhcCccccceEEEeeecC--CCceEEEEEEccccc----ccchHHHHHHHHHhccc-CCCCcccccceeccCCceE
Q 003836 503 RGFKEELGRGAFGTVYKGFVNM--GSSNHVAVKKLNSVF----QDSEKEFKAEVNGIGQT-HHKNLVRLLGYCDEGQNRL 575 (792)
Q Consensus 503 ~~~~~~lG~G~~g~Vy~g~~~~--~~~~~vavK~~~~~~----~~~~~~~~~Ei~~l~~l-~h~niv~l~g~~~~~~~~~ 575 (792)
+.+.+.||+|+||+||++.... .+++.||||+++... ....+.+.+|++++.++ +|+||+++++++.+.+..+
T Consensus 56 y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~ 135 (355)
T 1vzo_A 56 FELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTETKLH 135 (355)
T ss_dssp EEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETTEEE
T ss_pred eEEEEEeccCCCEEEEEEEEcccCCCCeEEEEEEEeHHHhhhhhhHHHHHHHHHHHHHHccCCCceeEEEEEEeeCceEE
Confidence 3456789999999999997632 356899999987532 22345678899999999 6999999999999999999
Q ss_pred EEEEeccCCCccccccCCCCCchhHHHHHHHHHHHHHHHHhhccCCCeEecCCCCCcEEEcCCCCeEEeecCCCccccCC
Q 003836 576 LVYEFMSNGTVASFLFGDSKPNWKLRTEIAMGIAGGLFYLHEECCTQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLD 655 (792)
Q Consensus 576 lV~E~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dikp~NILl~~~~~~kl~Dfg~a~~~~~~ 655 (792)
+||||+++|+|.+++.....+++..+..++.||+.||.|||+. +|+||||||+|||++.++.+||+|||+++.....
T Consensus 136 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~ 212 (355)
T 1vzo_A 136 LILDYINGGELFTHLSQRERFTEHEVQIYVGEIVLALEHLHKL---GIIYRDIKLENILLDSNGHVVLTDFGLSKEFVAD 212 (355)
T ss_dssp EEECCCCSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEESCSSEEEECCGG
T ss_pred EEeecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCcEEEeeCCCCeecccC
Confidence 9999999999999998877899999999999999999999998 9999999999999999999999999999876544
Q ss_pred CCCccccccccCCccccccccc--CCCCcccceehHHHHHHHHHhcCcCCCcchhhhhhhhHHHHHHHhhcccchhHhhh
Q 003836 656 QSHTNTAIRGTKGYVAPEWFRN--MPITVKVDVYSYGVLLLEIICLRRNIDNEISKVDKAILTDWAYDRYQERTLEALVE 733 (792)
Q Consensus 656 ~~~~~~~~~gt~~y~aPE~~~~--~~~~~k~DV~S~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 733 (792)
.........||+.|+|||.+.+ ..++.++|||||||++|||++|+.||...........+.. .+..
T Consensus 213 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~------------~~~~ 280 (355)
T 1vzo_A 213 ETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISR------------RILK 280 (355)
T ss_dssp GGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHHHHH------------HHHH
T ss_pred CCCcccCcccCcCccChhhhcCCCCCCCchhhHHHHHHHHHHHHHCCCCCccCCccchHHHHHH------------HHhc
Confidence 4444445679999999999975 4578999999999999999999999965432211111100 0010
Q ss_pred chhcccCCHHHHHHHHHHHHHccccCCCCCC-----CHHhHHHHh
Q 003836 734 NDLEAMNNVTMLHRFVMVAFWCIQEDPSHRP-----TMRKVTQML 773 (792)
Q Consensus 734 ~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RP-----s~~evl~~L 773 (792)
. ....+...+..+.+++.+||+.||.+|| +++|+++..
T Consensus 281 ~--~~~~~~~~~~~~~~li~~~L~~dP~~R~~~~~~s~~ell~h~ 323 (355)
T 1vzo_A 281 S--EPPYPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHL 323 (355)
T ss_dssp C--CCCCCTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTSG
T ss_pred c--CCCCCcccCHHHHHHHHHHhhhCHHHhcCCCCCCHHHHHcCc
Confidence 0 1122334456788999999999999999 999998764
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-37 Score=328.70 Aligned_cols=257 Identities=19% Similarity=0.257 Sum_probs=201.6
Q ss_pred hhhhhcCccccceEEEeeecCCCceEEEEEEcccccccchHHHHHHHHHhcccCCCCccccccee-ccCCceEEEEEecc
Q 003836 504 GFKEELGRGAFGTVYKGFVNMGSSNHVAVKKLNSVFQDSEKEFKAEVNGIGQTHHKNLVRLLGYC-DEGQNRLLVYEFMS 582 (792)
Q Consensus 504 ~~~~~lG~G~~g~Vy~g~~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~g~~-~~~~~~~lV~E~~~ 582 (792)
.+.+.||+|+||.||+|... .+++.||||++.... ..+++.+|+.++++++|++++..+..+ .+.+..++||||+
T Consensus 12 ~~~~~lg~G~~g~V~~~~~~-~~~~~vavK~~~~~~--~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~e~~- 87 (296)
T 3uzp_A 12 RLGRKIGSGSFGDIYLGTDI-AAGEEVAIKLECVKT--KHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMELL- 87 (296)
T ss_dssp EEEEEEEEETTEEEEEEEET-TTTEEEEEEEEESCS--SCCHHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEEEECC-
T ss_pred EEEEEEccCCCeEEEEEEEc-CCCcEEEEEEecCCc--chhHHHHHHHHHHHhhcCCCCCccccccCCCCceEEEEEec-
Confidence 34578999999999999753 457899999986533 335689999999999998877776666 5667789999999
Q ss_pred CCCccccccC-CCCCchhHHHHHHHHHHHHHHHHhhccCCCeEecCCCCCcEEE---cCCCCeEEeecCCCccccCCCCC
Q 003836 583 NGTVASFLFG-DSKPNWKLRTEIAMGIAGGLFYLHEECCTQIIHCDIKPQNILL---DDHYNARISDFGLAKLLTLDQSH 658 (792)
Q Consensus 583 ~gsL~~~l~~-~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dikp~NILl---~~~~~~kl~Dfg~a~~~~~~~~~ 658 (792)
+++|.+++.. ...+++..+..++.||+.||+|||++ +|+||||||+|||+ ++++.+||+|||+++........
T Consensus 88 ~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~~~~~~~~~~ 164 (296)
T 3uzp_A 88 GPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSK---NFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTH 164 (296)
T ss_dssp CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECCGGGTTCEEECCCTTCEECBCTTTC
T ss_pred CCCHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHeEEecCCCCCeEEEeeCCCcccccccccc
Confidence 8999999973 45789999999999999999999999 99999999999999 48899999999999876544331
Q ss_pred ------ccccccccCCcccccccccCCCCcccceehHHHHHHHHHhcCcCCCcchhhhhhhhHHHHHHHhhcccchhHhh
Q 003836 659 ------TNTAIRGTKGYVAPEWFRNMPITVKVDVYSYGVLLLEIICLRRNIDNEISKVDKAILTDWAYDRYQERTLEALV 732 (792)
Q Consensus 659 ------~~~~~~gt~~y~aPE~~~~~~~~~k~DV~S~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 732 (792)
......||+.|+|||.+.+..++.++||||||+++|||++|+.||...........+.......... ...
T Consensus 165 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~-~~~--- 240 (296)
T 3uzp_A 165 QHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMST-PIE--- 240 (296)
T ss_dssp CBCCCCCSCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHHHHS-CHH---
T ss_pred cccccccccccccccccCChhhhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCcCchhhhhhhhhhcccccCC-chH---
Confidence 1234579999999999999999999999999999999999999997643221111111111110000 000
Q ss_pred hchhcccCCHHHHHHHHHHHHHccccCCCCCCCHHhHHHHhccCc
Q 003836 733 ENDLEAMNNVTMLHRFVMVAFWCIQEDPSHRPTMRKVTQMLEGVV 777 (792)
Q Consensus 733 ~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~L~~~~ 777 (792)
. .....+.++.+++.+||+.||++|||+++|++.|+.+.
T Consensus 241 --~----~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~~ 279 (296)
T 3uzp_A 241 --V----LCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLF 279 (296)
T ss_dssp --H----HTTTSCHHHHHHHHHHHTSCTTCCCCHHHHHHHHHHHH
T ss_pred --H----HHhhCCHHHHHHHHHHHhcCcCcCCCHHHHHHHHHHHH
Confidence 0 01123467889999999999999999999999998865
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-38 Score=338.57 Aligned_cols=263 Identities=22% Similarity=0.323 Sum_probs=198.3
Q ss_pred hhhhhcCccccceEEEeeecCCCceEEEEEEccccccc--chHHHHHHHHHhcccCCCCcccccceeccCCceEEEEEec
Q 003836 504 GFKEELGRGAFGTVYKGFVNMGSSNHVAVKKLNSVFQD--SEKEFKAEVNGIGQTHHKNLVRLLGYCDEGQNRLLVYEFM 581 (792)
Q Consensus 504 ~~~~~lG~G~~g~Vy~g~~~~~~~~~vavK~~~~~~~~--~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~lV~E~~ 581 (792)
.+.+.||+|+||.||++... .+++.||||++...... ..+.+.+|++++++++||||+++++++.+.+..++||||+
T Consensus 28 ~~~~~lg~G~~g~V~~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 106 (331)
T 4aaa_A 28 ENLGLVGEGSYGMVMKCRNK-DTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLRHENLVNLLEVCKKKKRWYLVFEFV 106 (331)
T ss_dssp EEEEEGGGGTTSSEEEEEET-TTCCEEEEEEEESCSSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred eeeeEEeecCCEEEEEEEEC-CCCceEEEEEEecCCCchHHHHHHHHHHHHHhhCCCCCEeeEEEEeecCCEEEEEEecC
Confidence 34578999999999999754 45679999998654332 3456889999999999999999999999999999999999
Q ss_pred cCCCccccccCCCCCchhHHHHHHHHHHHHHHHHhhccCCCeEecCCCCCcEEEcCCCCeEEeecCCCccccCCCCCccc
Q 003836 582 SNGTVASFLFGDSKPNWKLRTEIAMGIAGGLFYLHEECCTQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLDQSHTNT 661 (792)
Q Consensus 582 ~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dikp~NILl~~~~~~kl~Dfg~a~~~~~~~~~~~~ 661 (792)
++++|.+++.....+++..+..++.||+.||+|||+. +|+||||||+|||++.++.+||+|||+++....... ...
T Consensus 107 ~~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~---~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~-~~~ 182 (331)
T 4aaa_A 107 DHTILDDLELFPNGLDYQVVQKYLFQIINGIGFCHSH---NIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGE-VYD 182 (331)
T ss_dssp SEEHHHHHHHSTTCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEECCCTTC------------
T ss_pred CcchHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHHC---CEEccCcChheEEEcCCCcEEEEeCCCceeecCCcc-ccC
Confidence 9999999887778899999999999999999999999 999999999999999999999999999986543322 223
Q ss_pred cccccCCcccccccccC-CCCcccceehHHHHHHHHHhcCcCCCcchhhhhhhhHHHH-------HHHhhcc-cchhHhh
Q 003836 662 AIRGTKGYVAPEWFRNM-PITVKVDVYSYGVLLLEIICLRRNIDNEISKVDKAILTDW-------AYDRYQE-RTLEALV 732 (792)
Q Consensus 662 ~~~gt~~y~aPE~~~~~-~~~~k~DV~S~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~-------~~~~~~~-~~~~~~~ 732 (792)
...||+.|+|||.+.+. .++.++||||||+++|||++|+.||............... ....+.. .......
T Consensus 183 ~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 262 (331)
T 4aaa_A 183 DEVATRWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMGEPLFPGDSDIDQLYHIMMCLGNLIPRHQELFNKNPVFAGVR 262 (331)
T ss_dssp -CCCCCTTCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHHHHHCGGGTTCC
T ss_pred CCcCCccccCcccccCCCCcchHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhhhHhhhcccccccc
Confidence 34689999999998775 7899999999999999999999999765432211111000 0000000 0000000
Q ss_pred hchhcccC-----CHHHHHHHHHHHHHccccCCCCCCCHHhHHH
Q 003836 733 ENDLEAMN-----NVTMLHRFVMVAFWCIQEDPSHRPTMRKVTQ 771 (792)
Q Consensus 733 ~~~~~~~~-----~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~ 771 (792)
.+...... ....++.+.+++.+||+.||++|||++|+++
T Consensus 263 ~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~ 306 (331)
T 4aaa_A 263 LPEIKEREPLERRYPKLSEVVIDLAKKCLHIDPDKRPFCAELLH 306 (331)
T ss_dssp CCCCSSCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCGGGGGG
T ss_pred CccccccchhhhcccchhHHHHHHHHHHhccCcccCCCHHHHhc
Confidence 00111111 1134577899999999999999999999986
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-38 Score=343.22 Aligned_cols=263 Identities=21% Similarity=0.317 Sum_probs=202.8
Q ss_pred hhhhhcCccccceEEEeeecCCCceEEEEEEccccc-ccchHHHHHHHHHhcccCCCCcccccceeccCCceEEEEEecc
Q 003836 504 GFKEELGRGAFGTVYKGFVNMGSSNHVAVKKLNSVF-QDSEKEFKAEVNGIGQTHHKNLVRLLGYCDEGQNRLLVYEFMS 582 (792)
Q Consensus 504 ~~~~~lG~G~~g~Vy~g~~~~~~~~~vavK~~~~~~-~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~lV~E~~~ 582 (792)
.+.+.||+|+||+||++... .+++.||+|++.... ....+.+.+|+.++++++||||+++++++.+++..++||||++
T Consensus 36 ~~~~~lg~G~~g~V~~~~~~-~~~~~va~K~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~ 114 (360)
T 3eqc_A 36 EKISELGAGNGGVVFKVSHK-PSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMD 114 (360)
T ss_dssp EEEEEEEECSSCEEEEEEET-TTCCEEEEEEEECCCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEETTEEEEEECCCT
T ss_pred eeeeeecCCCCeEEEEEEEC-CCCcEEEEEEeccccCHHHHHHHHHHHHHHHHCCCCCEEEEeEEEEECCEEEEEEECCC
Confidence 34568999999999999754 456799999987643 3345679999999999999999999999999999999999999
Q ss_pred CCCccccccCCCCCchhHHHHHHHHHHHHHHHHhhccCCCeEecCCCCCcEEEcCCCCeEEeecCCCccccCCCCCcccc
Q 003836 583 NGTVASFLFGDSKPNWKLRTEIAMGIAGGLFYLHEECCTQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLDQSHTNTA 662 (792)
Q Consensus 583 ~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dikp~NILl~~~~~~kl~Dfg~a~~~~~~~~~~~~~ 662 (792)
+++|.+++.....+++..+..++.|++.||+|||++ .+|+||||||+|||++.++.+||+|||+++..... ....
T Consensus 115 ~~~L~~~l~~~~~~~~~~~~~i~~~i~~~l~~lh~~--~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~---~~~~ 189 (360)
T 3eqc_A 115 GGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREK--HKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS---MANS 189 (360)
T ss_dssp TCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHH--HCCCCSCCSGGGEEECTTCCEEECCCCCCHHHHHH---C---
T ss_pred CCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHh--CCEEcCCccHHHEEECCCCCEEEEECCCCcccccc---cccC
Confidence 999999998877899999999999999999999984 17999999999999999999999999999765322 1223
Q ss_pred ccccCCcccccccccCCCCcccceehHHHHHHHHHhcCcCCCcchhhhhhhhHHH----------------------HHH
Q 003836 663 IRGTKGYVAPEWFRNMPITVKVDVYSYGVLLLEIICLRRNIDNEISKVDKAILTD----------------------WAY 720 (792)
Q Consensus 663 ~~gt~~y~aPE~~~~~~~~~k~DV~S~Gv~l~el~tg~~p~~~~~~~~~~~~~~~----------------------~~~ 720 (792)
..||+.|+|||.+.+..++.++||||||+++|||++|+.||.............. +..
T Consensus 190 ~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 269 (360)
T 3eqc_A 190 FVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPLNKFGM 269 (360)
T ss_dssp -CCCCTTCCHHHHTTCCCSHHHHHHHHHHHHHHHHHTSCCSSCCCHHHHHHHHC--------------------------
T ss_pred CCCCCCeECHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhcccccccCCCCCCCcccCCCccccccc
Confidence 4689999999999999999999999999999999999999976433211110000 000
Q ss_pred HhhcccchhHhhh----chhcccCCHHHHHHHHHHHHHccccCCCCCCCHHhHHHH
Q 003836 721 DRYQERTLEALVE----NDLEAMNNVTMLHRFVMVAFWCIQEDPSHRPTMRKVTQM 772 (792)
Q Consensus 721 ~~~~~~~~~~~~~----~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~ 772 (792)
...........++ ...........+.++.+++.+||+.||++|||++|+++.
T Consensus 270 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 325 (360)
T 3eqc_A 270 DSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVH 325 (360)
T ss_dssp ----CCCHHHHHHHHHHSCCCCCCTTTSCHHHHHHHHHHHCSSTTTSCCHHHHHTS
T ss_pred CCCCcccchhhhhHHhccCCCCCCcccccHHHHHHHHHHhhcChhhCCCHHHHhhC
Confidence 0000001111111 111111112245678999999999999999999999863
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-37 Score=336.93 Aligned_cols=245 Identities=20% Similarity=0.297 Sum_probs=202.9
Q ss_pred hhhhcCccccceEEEeeecCCCceEEEEEEccccc---ccchHHHHHHHHHhcccCCCCcccccceeccCCceEEEEEec
Q 003836 505 FKEELGRGAFGTVYKGFVNMGSSNHVAVKKLNSVF---QDSEKEFKAEVNGIGQTHHKNLVRLLGYCDEGQNRLLVYEFM 581 (792)
Q Consensus 505 ~~~~lG~G~~g~Vy~g~~~~~~~~~vavK~~~~~~---~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~lV~E~~ 581 (792)
+.+.||+|+||.||++... .+++.+|+|++.... ....+.+.+|+.++++++|+||+++++++.+.+..++||||+
T Consensus 45 ~~~~lg~G~~g~Vy~~~~~-~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 123 (335)
T 2owb_A 45 RGRFLGKGGFAKCFEISDA-DTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVVLELC 123 (335)
T ss_dssp EEEEEEEETTEEEEEEEET-TTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEECCC
T ss_pred EEEEEeeCCCeEEEEEEEC-CCCCEEEEEEechhhhcCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEEEEecC
Confidence 4578999999999999754 456789999986542 234567899999999999999999999999999999999999
Q ss_pred cCCCccccccCCCCCchhHHHHHHHHHHHHHHHHhhccCCCeEecCCCCCcEEEcCCCCeEEeecCCCccccCCCCCccc
Q 003836 582 SNGTVASFLFGDSKPNWKLRTEIAMGIAGGLFYLHEECCTQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLDQSHTNT 661 (792)
Q Consensus 582 ~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dikp~NILl~~~~~~kl~Dfg~a~~~~~~~~~~~~ 661 (792)
++++|.+++.....+++..+..++.||++||+|||++ +|+||||||+|||++.++.+||+|||+++....... ...
T Consensus 124 ~~~~L~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~-~~~ 199 (335)
T 2owb_A 124 RRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRN---RVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGE-RKK 199 (335)
T ss_dssp TTCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECTTCCEEECCCTTCEECCSTTC-CBC
T ss_pred CCCCHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHC---CCEecCCCchhEEEcCCCCEEEeeccCceecccCcc-ccc
Confidence 9999999998778899999999999999999999999 999999999999999999999999999987643322 223
Q ss_pred cccccCCcccccccccCCCCcccceehHHHHHHHHHhcCcCCCcchhhhhhhhHHHHHHHhhcccchhHhhhchhcccCC
Q 003836 662 AIRGTKGYVAPEWFRNMPITVKVDVYSYGVLLLEIICLRRNIDNEISKVDKAILTDWAYDRYQERTLEALVENDLEAMNN 741 (792)
Q Consensus 662 ~~~gt~~y~aPE~~~~~~~~~k~DV~S~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 741 (792)
...||+.|+|||.+.+..++.++||||||+++|||++|+.||.......... . +.... ...+
T Consensus 200 ~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~---~-------------~~~~~--~~~~ 261 (335)
T 2owb_A 200 VLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYL---R-------------IKKNE--YSIP 261 (335)
T ss_dssp CCCSCCSSCCHHHHHTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHH---H-------------HHHTC--CCCC
T ss_pred ccCCCccccCHHHhccCCCCchhhHHHHHHHHHHHHHCcCCCCCCCHHHHHH---H-------------HhcCC--CCCC
Confidence 4568999999999999899999999999999999999999997543221100 0 00000 0112
Q ss_pred HHHHHHHHHHHHHccccCCCCCCCHHhHHHH
Q 003836 742 VTMLHRFVMVAFWCIQEDPSHRPTMRKVTQM 772 (792)
Q Consensus 742 ~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~ 772 (792)
......+.+++.+||+.||++|||++|+++.
T Consensus 262 ~~~~~~~~~li~~~l~~dp~~Rps~~ell~~ 292 (335)
T 2owb_A 262 KHINPVAASLIQKMLQTDPTARPTINELLND 292 (335)
T ss_dssp TTSCHHHHHHHHHHTCSSGGGSCCGGGGGGS
T ss_pred ccCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 2234567889999999999999999999974
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-38 Score=343.03 Aligned_cols=259 Identities=14% Similarity=0.157 Sum_probs=199.7
Q ss_pred hhhhhhcCccccceEEEeeecCC-------CceEEEEEEcccccccchHHHHHHHHHhcccCCCCccc------------
Q 003836 503 RGFKEELGRGAFGTVYKGFVNMG-------SSNHVAVKKLNSVFQDSEKEFKAEVNGIGQTHHKNLVR------------ 563 (792)
Q Consensus 503 ~~~~~~lG~G~~g~Vy~g~~~~~-------~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~------------ 563 (792)
+.+.+.||+|+||.||+|..... .++.||+|++... +.+.+|++++++++||||++
T Consensus 44 y~~~~~lg~G~~g~Vy~~~~~~t~~~~~~~~~~~vavK~~~~~-----~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 118 (352)
T 2jii_A 44 WKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKD-----GRLFNEQNFFQRAAKPLQVNKWKKLYSTPLLA 118 (352)
T ss_dssp EEEEEEEEEETTEEEEEEEECC-----------CEEEEEEETT-----STHHHHHHHHHHHCCHHHHHHHHHHTTCTTCS
T ss_pred EEEEEEecCCCCeEEEEEeecCCccccccccCceEEEEEeccc-----chHHHHHHHHHHhcccchhhhhhhhccCCccC
Confidence 34567899999999999976542 3678999998653 46889999999999999998
Q ss_pred ---ccceecc-CCceEEEEEeccCCCccccccCC--CCCchhHHHHHHHHHHHHHHHHhhccCCCeEecCCCCCcEEEcC
Q 003836 564 ---LLGYCDE-GQNRLLVYEFMSNGTVASFLFGD--SKPNWKLRTEIAMGIAGGLFYLHEECCTQIIHCDIKPQNILLDD 637 (792)
Q Consensus 564 ---l~g~~~~-~~~~~lV~E~~~~gsL~~~l~~~--~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dikp~NILl~~ 637 (792)
+++++.. ....++||||+ +++|.+++... ..+++..+..|+.||+.||+|||++ +|+||||||+|||++.
T Consensus 119 i~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dikp~NIl~~~ 194 (352)
T 2jii_A 119 IPTCMGFGVHQDKYRFLVLPSL-GRSLQSALDVSPKHVLSERSVLQVACRLLDALEFLHEN---EYVHGNVTAENIFVDP 194 (352)
T ss_dssp CCCCCEEEEETTTEEEEEEECC-CEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHT---TCBCSCCCGGGEEEET
T ss_pred ccchhhccccCCcEEEEEecCC-CcCHHHHHHhCCcCCCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCCHHHEEEcC
Confidence 4556654 67889999999 99999999875 6799999999999999999999999 9999999999999999
Q ss_pred CC--CeEEeecCCCccccCCCCC------ccccccccCCcccccccccCCCCcccceehHHHHHHHHHhcCcCCCcchhh
Q 003836 638 HY--NARISDFGLAKLLTLDQSH------TNTAIRGTKGYVAPEWFRNMPITVKVDVYSYGVLLLEIICLRRNIDNEISK 709 (792)
Q Consensus 638 ~~--~~kl~Dfg~a~~~~~~~~~------~~~~~~gt~~y~aPE~~~~~~~~~k~DV~S~Gv~l~el~tg~~p~~~~~~~ 709 (792)
++ .+||+|||+++........ ......||+.|+|||.+.+..++.++||||||+++|||++|+.||......
T Consensus 195 ~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~ 274 (352)
T 2jii_A 195 EDQSQVTLAGYGFAFRYCPSGKHVAYVEGSRSPHEGDLEFISMDLHKGCGPSRRSDLQSLGYCMLKWLYGFLPWTNCLPN 274 (352)
T ss_dssp TEEEEEEECCGGGCBCSSGGGCCCCCCTTSSCTTCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTGGGTTC
T ss_pred CCCceEEEecCcceeeccCCCccccccccccccccCCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCcccCCcC
Confidence 98 8999999999876543221 123357999999999999999999999999999999999999999765322
Q ss_pred hhhhhHHHHHHHhhcccchhHhhhchhcccCCHHHHHHHHHHHHHccccCCCCCCCHHhHHHHhccCc
Q 003836 710 VDKAILTDWAYDRYQERTLEALVENDLEAMNNVTMLHRFVMVAFWCIQEDPSHRPTMRKVTQMLEGVV 777 (792)
Q Consensus 710 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~L~~~~ 777 (792)
..... .... ... .....+...... ....+.++.+++.+||+.||++|||+++|+++|++++
T Consensus 275 ~~~~~--~~~~-~~~-~~~~~~~~~~~~---~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~ 335 (352)
T 2jii_A 275 TEDIM--KQKQ-KFV-DKPGPFVGPCGH---WIRPSETLQKYLKVVMALTYEEKPPYAMLRNNLEALL 335 (352)
T ss_dssp HHHHH--HHHH-HHH-HSCCCEECTTSC---EECCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHH
T ss_pred HHHHH--HHHH-hcc-CChhhhhhhccc---cCCCcHHHHHHHHHHHhCChhhCCCHHHHHHHHHHHH
Confidence 11110 0000 000 000000000000 0122467889999999999999999999999998865
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-37 Score=327.49 Aligned_cols=241 Identities=20% Similarity=0.276 Sum_probs=195.4
Q ss_pred HhhhhhhcCccccceEEEeeecCCCceEEEEEEccccc--ccchHHHHHHHHHhccc-CCCCcccccceeccCCceEEEE
Q 003836 502 TRGFKEELGRGAFGTVYKGFVNMGSSNHVAVKKLNSVF--QDSEKEFKAEVNGIGQT-HHKNLVRLLGYCDEGQNRLLVY 578 (792)
Q Consensus 502 ~~~~~~~lG~G~~g~Vy~g~~~~~~~~~vavK~~~~~~--~~~~~~~~~Ei~~l~~l-~h~niv~l~g~~~~~~~~~lV~ 578 (792)
.+.+.+.||+|+||+||++... .+++.||+|++.... .....++.+|+..+.++ +||||+++++++.+.+..++||
T Consensus 12 ~y~~~~~lg~G~~g~V~~~~~~-~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~~h~~iv~~~~~~~~~~~~~lv~ 90 (289)
T 1x8b_A 12 EFHELEKIGSGEFGSVFKCVKR-LDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSHVVRYFSAWAEDDHMLIQN 90 (289)
T ss_dssp HEEEEEEEEEETTEEEEEEEET-TTCCEEEEEEEECCCTTSHHHHHHHHHHHHHHHSCSCTTBCCEEEEEEETTEEEEEE
T ss_pred hhhhhhhhcCCCceEEEEEEEc-CCCceEEEEEecccccccHHHHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEEE
Confidence 3445678999999999999754 456799999987532 33456788999999998 9999999999999999999999
Q ss_pred EeccCCCccccccCC----CCCchhHHHHHHHHHHHHHHHHhhccCCCeEecCCCCCcEEEcCC----------------
Q 003836 579 EFMSNGTVASFLFGD----SKPNWKLRTEIAMGIAGGLFYLHEECCTQIIHCDIKPQNILLDDH---------------- 638 (792)
Q Consensus 579 E~~~~gsL~~~l~~~----~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dikp~NILl~~~---------------- 638 (792)
||+++++|.+++... ..+++..+..++.||+.||+|||++ +|+||||||+|||++.+
T Consensus 91 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dikp~NIl~~~~~~~~~~~~~~~~~~~~ 167 (289)
T 1x8b_A 91 EYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIHSM---SLVHMDIKPSNIFISRTSIPNAASEEGDEDDWA 167 (289)
T ss_dssp ECCTTCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEC------------------
T ss_pred EecCCCcHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHHhC---CEeecCCCHHHEEEcCCCCCccccccccccccc
Confidence 999999999999764 5689999999999999999999999 99999999999999844
Q ss_pred ---CCeEEeecCCCccccCCCCCccccccccCCcccccccccC-CCCcccceehHHHHHHHHHhcCcCCCcchhhhhhhh
Q 003836 639 ---YNARISDFGLAKLLTLDQSHTNTAIRGTKGYVAPEWFRNM-PITVKVDVYSYGVLLLEIICLRRNIDNEISKVDKAI 714 (792)
Q Consensus 639 ---~~~kl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~k~DV~S~Gv~l~el~tg~~p~~~~~~~~~~~~ 714 (792)
..+||+|||.++...... ...||+.|+|||.+.+. .++.++||||||+++|||++|..++......
T Consensus 168 ~~~~~~kl~Dfg~~~~~~~~~-----~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~~~----- 237 (289)
T 1x8b_A 168 SNKVMFKIGDLGHVTRISSPQ-----VEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLPRNGDQW----- 237 (289)
T ss_dssp --CCCEEECCCTTCEETTCSC-----CCCCCGGGCCHHHHTTCCTTHHHHHHHHHHHHHHHHTTCCCCCSSSHHH-----
T ss_pred CCceEEEEcccccccccCCcc-----ccCCCccccChhHhcCCCCCCchhhHHHHHHHHHHHhcCCCCCcchhHH-----
Confidence 479999999998765332 23489999999999765 6778999999999999999998776433110
Q ss_pred HHHHHHHhhcccchhHhhhchhcccCCHHHHHHHHHHHHHccccCCCCCCCHHhHHH
Q 003836 715 LTDWAYDRYQERTLEALVENDLEAMNNVTMLHRFVMVAFWCIQEDPSHRPTMRKVTQ 771 (792)
Q Consensus 715 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~ 771 (792)
....... ....+...+..+.+++.+||+.||++|||+.|+++
T Consensus 238 ------~~~~~~~---------~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~ 279 (289)
T 1x8b_A 238 ------HEIRQGR---------LPRIPQVLSQEFTELLKVMIHPDPERRPSAMALVK 279 (289)
T ss_dssp ------HHHHTTC---------CCCCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred ------HHHHcCC---------CCCCCcccCHHHHHHHHHHhCCCcccCCCHHHHhh
Confidence 0000110 11122234567889999999999999999999998
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-38 Score=339.32 Aligned_cols=251 Identities=22% Similarity=0.307 Sum_probs=185.5
Q ss_pred hhhhhhcCccccceEEEeeecCCCceEEEEEEcccccccchHHHHHHHHHhcccC-CCCccccccee--------ccCCc
Q 003836 503 RGFKEELGRGAFGTVYKGFVNMGSSNHVAVKKLNSVFQDSEKEFKAEVNGIGQTH-HKNLVRLLGYC--------DEGQN 573 (792)
Q Consensus 503 ~~~~~~lG~G~~g~Vy~g~~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~-h~niv~l~g~~--------~~~~~ 573 (792)
+.+.++||+|+||.||++... .+++.||||++........+.+.+|+.++.++. ||||+++++++ .....
T Consensus 30 y~~~~~lg~G~~g~V~~~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~~~~~~~ 108 (337)
T 3ll6_A 30 LRVRRVLAEGGFAFVYEAQDV-GSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNIVQFCSAASIGKEESDTGQAE 108 (337)
T ss_dssp EEEEEEEECCSSEEEEEEEET-TTCCEEEEEEEEESSHHHHHHHHHHHHHHHHHTTSTTBCCEEEEEEECTTTSTTSSEE
T ss_pred EEEEEEEccCCceEEEEEEEC-CCCcEEEEEEecCCchHHHHHHHHHHHHHHHhccCCChhhccccccccccccccCCce
Confidence 445678999999999999753 456799999987665666778999999999996 99999999998 34445
Q ss_pred eEEEEEeccCCCccccccC---CCCCchhHHHHHHHHHHHHHHHHhhccCCC--eEecCCCCCcEEEcCCCCeEEeecCC
Q 003836 574 RLLVYEFMSNGTVASFLFG---DSKPNWKLRTEIAMGIAGGLFYLHEECCTQ--IIHCDIKPQNILLDDHYNARISDFGL 648 (792)
Q Consensus 574 ~~lV~E~~~~gsL~~~l~~---~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~--ivH~dikp~NILl~~~~~~kl~Dfg~ 648 (792)
.++||||++ |+|.+++.. ...+++..+..++.||+.||+|||+. + |+||||||+|||++.++.+||+|||+
T Consensus 109 ~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~---~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~ 184 (337)
T 3ll6_A 109 FLLLTELCK-GQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHMHRQ---KPPIIHRDLKVENLLLSNQGTIKLCDFGS 184 (337)
T ss_dssp EEEEEECCS-EEHHHHHHHHHTTCSCCHHHHHHHHHHHHHHHHHHHTS---SSCCBCCCCCGGGCEECTTSCEEBCCCTT
T ss_pred EEEEEEecC-CCHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhC---CCCEEEccCCcccEEECCCCCEEEecCcc
Confidence 789999996 699888864 45689999999999999999999998 8 99999999999999999999999999
Q ss_pred CccccCCCCCc-----------cccccccCCccccccc---ccCCCCcccceehHHHHHHHHHhcCcCCCcchhhhhhhh
Q 003836 649 AKLLTLDQSHT-----------NTAIRGTKGYVAPEWF---RNMPITVKVDVYSYGVLLLEIICLRRNIDNEISKVDKAI 714 (792)
Q Consensus 649 a~~~~~~~~~~-----------~~~~~gt~~y~aPE~~---~~~~~~~k~DV~S~Gv~l~el~tg~~p~~~~~~~~~~~~ 714 (792)
++......... .....||+.|+|||.+ .+..++.++||||||+++|||++|+.||.......
T Consensus 185 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~---- 260 (337)
T 3ll6_A 185 ATTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFEDGAKLR---- 260 (337)
T ss_dssp CBCCSSCC-------------------------------CCTTSCSSHHHHHHHHHHHHHHHHHSSCCC-----------
T ss_pred ceeccccCcccccccccccchhhccccCCCCcCChhhhhccccCCCChHHhHHHHHHHHHHHHhCCCCCcchhHHH----
Confidence 98765432211 1134589999999998 56778999999999999999999999996432110
Q ss_pred HHHHHHHhhcccchhHhhhchhcccCCHHHHHHHHHHHHHccccCCCCCCCHHhHHHHhccCcC
Q 003836 715 LTDWAYDRYQERTLEALVENDLEAMNNVTMLHRFVMVAFWCIQEDPSHRPTMRKVTQMLEGVVE 778 (792)
Q Consensus 715 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~L~~~~~ 778 (792)
+................+.+++.+||+.||++|||++|+++.|+.+..
T Consensus 261 ----------------~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~~~~~ 308 (337)
T 3ll6_A 261 ----------------IVNGKYSIPPHDTQYTVFHSLIRAMLQVNPEERLSIAEVVHQLQEIAA 308 (337)
T ss_dssp ---------------------CCCCTTCCSSGGGHHHHHHHSCSSGGGSCCHHHHHHHHHHHHH
T ss_pred ----------------hhcCcccCCcccccchHHHHHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence 000111111111223457789999999999999999999999988653
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-37 Score=342.26 Aligned_cols=243 Identities=22% Similarity=0.279 Sum_probs=188.3
Q ss_pred hhcCccccceEEEeeecCCCceEEEEEEcccccccchHHHHHHHHHhcc-cCCCCcccccceecc----CCceEEEEEec
Q 003836 507 EELGRGAFGTVYKGFVNMGSSNHVAVKKLNSVFQDSEKEFKAEVNGIGQ-THHKNLVRLLGYCDE----GQNRLLVYEFM 581 (792)
Q Consensus 507 ~~lG~G~~g~Vy~g~~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~-l~h~niv~l~g~~~~----~~~~~lV~E~~ 581 (792)
+.||+|+||+||++.. ..+++.||||++.. ...+.+|+.++.+ .+||||+++++++.. ....+|||||+
T Consensus 68 ~~LG~G~~g~V~~~~~-~~~~~~vAiK~~~~-----~~~~~~E~~~~~~~~~hp~iv~l~~~~~~~~~~~~~~~lv~E~~ 141 (400)
T 1nxk_A 68 QVLGLGINGKVLQIFN-KRTQEKFALKMLQD-----CPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECL 141 (400)
T ss_dssp EEEEEETTEEEEEEEE-TTTCCEEEEEEEEC-----SHHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEEEEEECC
T ss_pred ceeeeccCeEEEEEEE-CCCCCEEEEEEeCc-----chhHHHHHHHHHHhcCCCCcceEeEEEeecccCCcEEEEEEEeC
Confidence 5799999999999975 45678999999864 2467788888754 589999999998865 56789999999
Q ss_pred cCCCccccccCC--CCCchhHHHHHHHHHHHHHHHHhhccCCCeEecCCCCCcEEEcC---CCCeEEeecCCCccccCCC
Q 003836 582 SNGTVASFLFGD--SKPNWKLRTEIAMGIAGGLFYLHEECCTQIIHCDIKPQNILLDD---HYNARISDFGLAKLLTLDQ 656 (792)
Q Consensus 582 ~~gsL~~~l~~~--~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dikp~NILl~~---~~~~kl~Dfg~a~~~~~~~ 656 (792)
++|+|.+++... ..+++..+..|+.||+.||.|||+. +|+||||||+|||++. ++.+||+|||+++......
T Consensus 142 ~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~Nill~~~~~~~~~kl~DFG~a~~~~~~~ 218 (400)
T 1nxk_A 142 DGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSI---NIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHN 218 (400)
T ss_dssp CSEEHHHHHHCC---CCBHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSSSTTCCEEECCCTTCEECC---
T ss_pred CCCcHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCcCcceEEEecCCCCccEEEEecccccccCCCC
Confidence 999999999765 3589999999999999999999998 9999999999999997 7899999999998654322
Q ss_pred CCccccccccCCcccccccccCCCCcccceehHHHHHHHHHhcCcCCCcchhhhhhhhHHHHHHHhhcccchhHhhhchh
Q 003836 657 SHTNTAIRGTKGYVAPEWFRNMPITVKVDVYSYGVLLLEIICLRRNIDNEISKVDKAILTDWAYDRYQERTLEALVENDL 736 (792)
Q Consensus 657 ~~~~~~~~gt~~y~aPE~~~~~~~~~k~DV~S~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 736 (792)
......||+.|+|||++.+..++.++|||||||++|||++|+.||............. ..+.....
T Consensus 219 --~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~------------~~i~~~~~ 284 (400)
T 1nxk_A 219 --SLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMK------------TRIRMGQY 284 (400)
T ss_dssp ----------CTTCCGGGSCCCCSSSHHHHHHHHHHHHHHHHSSCSCCCCTTCSSCCSHH------------HHHHHTCC
T ss_pred --ccccCCCCCCccCHhhcCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCccccccHHHH------------HHHHcCcc
Confidence 2334568999999999999999999999999999999999999997543221100000 00000000
Q ss_pred c--ccCCHHHHHHHHHHHHHccccCCCCCCCHHhHHHH
Q 003836 737 E--AMNNVTMLHRFVMVAFWCIQEDPSHRPTMRKVTQM 772 (792)
Q Consensus 737 ~--~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~ 772 (792)
. .......+.++.+++.+||+.||++|||++|+++.
T Consensus 285 ~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~eil~h 322 (400)
T 1nxk_A 285 EFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNH 322 (400)
T ss_dssp CCCTTTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred cCCCcccccCCHHHHHHHHHHCCCChhHCcCHHHHhcC
Confidence 0 00012345678899999999999999999999985
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-38 Score=347.61 Aligned_cols=235 Identities=14% Similarity=0.141 Sum_probs=183.6
Q ss_pred hhhhcCccccceEEEeeecCCCceEEEEEEcccc---cccchHHHHHHH---HHhcccCCCCccccc-------ceeccC
Q 003836 505 FKEELGRGAFGTVYKGFVNMGSSNHVAVKKLNSV---FQDSEKEFKAEV---NGIGQTHHKNLVRLL-------GYCDEG 571 (792)
Q Consensus 505 ~~~~lG~G~~g~Vy~g~~~~~~~~~vavK~~~~~---~~~~~~~~~~Ei---~~l~~l~h~niv~l~-------g~~~~~ 571 (792)
+.+.||+|+||+||+|... .+++.||||++... .....+.+.+|+ +.+++++||||++++ +++.+.
T Consensus 77 ~~~~lG~G~~g~V~~a~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~hpniv~~~~~~~~~~~~~~~~ 155 (377)
T 3byv_A 77 RGTVLGQEDPYAYLEATDQ-ETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDLVKDP 155 (377)
T ss_dssp EEEEEEEETTEEEEEEEC--CCCCEEEEEEEEECC-CCTTHHHHHHHHHHGGGGSTTCCSHHHHHHHHCBCCCSEEEECT
T ss_pred EcceeecCCCEEEEEEEEC-CCCcEEEEEEEeeccccchHHHHHHHHHHHHHHhccccCCHHHHHHHhhhhhhhhhhhcc
Confidence 3578999999999999753 45679999998742 334457899999 566667899999999 444443
Q ss_pred C-----------------ceEEEEEeccCCCccccccCCCCC-------chhHHHHHHHHHHHHHHHHhhccCCCeEecC
Q 003836 572 Q-----------------NRLLVYEFMSNGTVASFLFGDSKP-------NWKLRTEIAMGIAGGLFYLHEECCTQIIHCD 627 (792)
Q Consensus 572 ~-----------------~~~lV~E~~~~gsL~~~l~~~~~l-------~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~d 627 (792)
+ ..+|||||+ +|+|.+++.....+ ++..+..|+.||+.||+|||++ +|+|||
T Consensus 156 ~~~~~~~~~~~~~~~~i~~~~lv~E~~-~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivHrD 231 (377)
T 3byv_A 156 QKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHY---GLVHTY 231 (377)
T ss_dssp TSCSEEEC------CEEESEEEEEECC-SEEHHHHHHHHHHTTTTTHHHHHHHHHHHHHHHHHHHHHHHHT---TEECSC
T ss_pred CCccccccccCCCceEEEEEEEEEecc-CCCHHHHHHhccccccccccccHHHHHHHHHHHHHHHHHHHhC---CeecCC
Confidence 2 378999999 68999999764333 3588889999999999999999 999999
Q ss_pred CCCCcEEEcCCCCeEEeecCCCccccCCCCCccccccccCCcccccccccC-----------CCCcccceehHHHHHHHH
Q 003836 628 IKPQNILLDDHYNARISDFGLAKLLTLDQSHTNTAIRGTKGYVAPEWFRNM-----------PITVKVDVYSYGVLLLEI 696 (792)
Q Consensus 628 ikp~NILl~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-----------~~~~k~DV~S~Gv~l~el 696 (792)
|||+|||++.++.+||+|||+++.... ......| +.|+|||.+.+. .++.++|||||||++|||
T Consensus 232 ikp~NIll~~~~~~kL~DFG~a~~~~~----~~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DvwSlG~il~el 306 (377)
T 3byv_A 232 LRPVDIVLDQRGGVFLTGFEHLVRDGA----RVVSSVS-RGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLVIYWI 306 (377)
T ss_dssp CCGGGEEECTTCCEEECCGGGCEETTC----EEECCCC-TTCCCHHHHHHHTSTHHHHCCEEECCHHHHHHHHHHHHHHH
T ss_pred CCHHHEEEcCCCCEEEEechhheecCC----cccCCCC-cCccChhhhcccccccccccccccCChhhhHHHHHHHHHHH
Confidence 999999999999999999999985322 2334567 999999999887 899999999999999999
Q ss_pred HhcCcCCCcchhhhhhhhHHHHHHHhhcccchhHhhhchhcccCCHHHHHHHHHHHHHccccCCCCCCCHHhHHH
Q 003836 697 ICLRRNIDNEISKVDKAILTDWAYDRYQERTLEALVENDLEAMNNVTMLHRFVMVAFWCIQEDPSHRPTMRKVTQ 771 (792)
Q Consensus 697 ~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~ 771 (792)
++|+.||........ ...+... ....+.++.+++.+||+.||++|||+.|+++
T Consensus 307 ltg~~Pf~~~~~~~~----------------~~~~~~~------~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~ 359 (377)
T 3byv_A 307 WCADLPITKDAALGG----------------SEWIFRS------CKNIPQPVRALLEGFLRYPKEDRLLPLQAME 359 (377)
T ss_dssp HHSSCCC------CC----------------SGGGGSS------CCCCCHHHHHHHHHHTCSSGGGCCCHHHHHT
T ss_pred HHCCCCCcccccccc----------------hhhhhhh------ccCCCHHHHHHHHHHcCCCchhCCCHHHHhh
Confidence 999999965322110 0111110 0123467889999999999999999999986
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-37 Score=334.53 Aligned_cols=253 Identities=21% Similarity=0.334 Sum_probs=199.4
Q ss_pred hhhhhhcCccccceEEEeeecCCCceEEEEEEcccccccc-----------------hHHHHHHHHHhcccCCCCccccc
Q 003836 503 RGFKEELGRGAFGTVYKGFVNMGSSNHVAVKKLNSVFQDS-----------------EKEFKAEVNGIGQTHHKNLVRLL 565 (792)
Q Consensus 503 ~~~~~~lG~G~~g~Vy~g~~~~~~~~~vavK~~~~~~~~~-----------------~~~~~~Ei~~l~~l~h~niv~l~ 565 (792)
+.+.+.||+|+||.||++.. +++.||||++....... .+.+.+|+.++++++||||++++
T Consensus 33 y~~~~~lg~G~~g~V~~~~~---~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~ 109 (348)
T 2pml_X 33 YRIIRTLNQGKFNKIILCEK---DNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDIKNEYCLTCE 109 (348)
T ss_dssp EEEEEEEECCSSCCEEEEEE---TTEEEEEEEEEHHHHSSCEEECCCSSSSCCEEEHHHHHHHHHHHHTTCCCTTBCCCS
T ss_pred eEEEEEEcCCCCeEEEEEEc---CCceEEEEEeecccccchhhhccccchhhhHHhHHHHHHHHHHHHHhCCCCCcceEE
Confidence 34557899999999999976 57899999987532211 18899999999999999999999
Q ss_pred ceeccCCceEEEEEeccCCCcccc------ccC--CCCCchhHHHHHHHHHHHHHHHHhh-ccCCCeEecCCCCCcEEEc
Q 003836 566 GYCDEGQNRLLVYEFMSNGTVASF------LFG--DSKPNWKLRTEIAMGIAGGLFYLHE-ECCTQIIHCDIKPQNILLD 636 (792)
Q Consensus 566 g~~~~~~~~~lV~E~~~~gsL~~~------l~~--~~~l~~~~~~~i~~~ia~gL~yLH~-~~~~~ivH~dikp~NILl~ 636 (792)
+++.+.+..++||||+++++|.++ +.. ...+++..+..++.||+.||.|||+ . +|+|+||||+|||++
T Consensus 110 ~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---~i~H~dl~p~Nil~~ 186 (348)
T 2pml_X 110 GIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKCIIKSVLNSFSYIHNEK---NICHRDVKPSNILMD 186 (348)
T ss_dssp EEEESSSEEEEEEECCTTCBSSEESSSEESSCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTS---CEECCCCCGGGEEEC
T ss_pred EEEeeCCeEEEEEeccCCCcHHHHHHHhhhhhhccccCCCHHHHHHHHHHHHHHHHHHhccC---CEeecCCChHhEEEc
Confidence 999999999999999999999999 665 4678999999999999999999999 7 999999999999999
Q ss_pred CCCCeEEeecCCCccccCCCCCccccccccCCcccccccccC-CCCc-ccceehHHHHHHHHHhcCcCCCcchhhhhhhh
Q 003836 637 DHYNARISDFGLAKLLTLDQSHTNTAIRGTKGYVAPEWFRNM-PITV-KVDVYSYGVLLLEIICLRRNIDNEISKVDKAI 714 (792)
Q Consensus 637 ~~~~~kl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~-k~DV~S~Gv~l~el~tg~~p~~~~~~~~~~~~ 714 (792)
.++.+||+|||+++..... ......|++.|+|||.+.+. .++. ++||||||+++|||++|+.||.........
T Consensus 187 ~~~~~kl~dfg~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~-- 261 (348)
T 2pml_X 187 KNGRVKLSDFGESEYMVDK---KIKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFSLKISLVEL-- 261 (348)
T ss_dssp TTSCEEECCCTTCEECBTT---EECSSCSCGGGCCGGGGSSCCCEEHHHHHHHHHHHHHHHHHHSSCSSCCSSCSHHH--
T ss_pred CCCcEEEeccccccccccc---cccCCCCCcCccCchhhcCCCCCCcchhhHHHHHHHHHHHHhCCCCCCCCCcHHHH--
Confidence 9999999999999876433 23345689999999999877 6766 999999999999999999999764331110
Q ss_pred HHHHHHHhhcccchh------Hhhhc---hhcccCCHHHHHHHHHHHHHccccCCCCCCCHHhHHH
Q 003836 715 LTDWAYDRYQERTLE------ALVEN---DLEAMNNVTMLHRFVMVAFWCIQEDPSHRPTMRKVTQ 771 (792)
Q Consensus 715 ~~~~~~~~~~~~~~~------~~~~~---~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~ 771 (792)
. ......... ..... ..........+..+.+++.+||+.||.+|||++|+++
T Consensus 262 ~-----~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~e~l~ 322 (348)
T 2pml_X 262 F-----NNIRTKNIEYPLDRNHFLYPLTNKKSTCSNNFLSNEDIDFLKLFLRKNPAERITSEDALK 322 (348)
T ss_dssp H-----HHHTSCCCCCCCSSSSSTTTTCC--------CCCHHHHHHHHHHCCSSGGGSCCHHHHHT
T ss_pred H-----HHHhccCcCCccchhhhhccccccccccchhhcCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence 0 000000000 00000 0000001234567899999999999999999999997
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-37 Score=330.75 Aligned_cols=257 Identities=19% Similarity=0.271 Sum_probs=196.8
Q ss_pred hhhhhhcCccccceEEEeeecCCCceEEEEEEcccccccchHHHHHHHHHhcccC-CCCcccccceecc--CCceEEEEE
Q 003836 503 RGFKEELGRGAFGTVYKGFVNMGSSNHVAVKKLNSVFQDSEKEFKAEVNGIGQTH-HKNLVRLLGYCDE--GQNRLLVYE 579 (792)
Q Consensus 503 ~~~~~~lG~G~~g~Vy~g~~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~-h~niv~l~g~~~~--~~~~~lV~E 579 (792)
+.+.+.||+|+||+||+|... .+++.||||+++. ...+.+.+|++++++++ ||||+++++++.+ ....++|||
T Consensus 38 y~~~~~lg~G~~g~V~~~~~~-~~~~~vavK~~~~---~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~lv~e 113 (330)
T 3nsz_A 38 YQLVRKLGRGKYSEVFEAINI-TNNEKVVVKILKP---VKKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVFE 113 (330)
T ss_dssp EEEEEEEEECSSEEEEEEEET-TTCCEEEEEEECS---CCHHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCCEEEEEE
T ss_pred eEEEEEecccCCeEEEEEEEC-CCCcEEEEEEecc---cchHHHHHHHHHHHHcCCCCCEEEeeeeeccCCCCceEEEEe
Confidence 345678999999999999653 4567999999874 34578999999999997 9999999999987 667899999
Q ss_pred eccCCCccccccCCCCCchhHHHHHHHHHHHHHHHHhhccCCCeEecCCCCCcEEEcCCC-CeEEeecCCCccccCCCCC
Q 003836 580 FMSNGTVASFLFGDSKPNWKLRTEIAMGIAGGLFYLHEECCTQIIHCDIKPQNILLDDHY-NARISDFGLAKLLTLDQSH 658 (792)
Q Consensus 580 ~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dikp~NILl~~~~-~~kl~Dfg~a~~~~~~~~~ 658 (792)
|+++++|.+++. .+++..+..++.||+.||+|||+. +|+||||||+|||++.++ .+||+|||+++.......
T Consensus 114 ~~~~~~l~~~~~---~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~~~- 186 (330)
T 3nsz_A 114 HVNNTDFKQLYQ---TLTDYDIRFYMYEILKALDYCHSM---GIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQE- 186 (330)
T ss_dssp CCCCCCHHHHGG---GCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEETTTTEEEECCCTTCEECCTTCC-
T ss_pred ccCchhHHHHHH---hCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHEEEcCCCCEEEEEeCCCceEcCCCCc-
Confidence 999999999984 488899999999999999999998 999999999999999776 899999999987653322
Q ss_pred ccccccccCCccccccccc-CCCCcccceehHHHHHHHHHhcCcCCCcchhhhhhhhH-H---------HHHHHhh--cc
Q 003836 659 TNTAIRGTKGYVAPEWFRN-MPITVKVDVYSYGVLLLEIICLRRNIDNEISKVDKAIL-T---------DWAYDRY--QE 725 (792)
Q Consensus 659 ~~~~~~gt~~y~aPE~~~~-~~~~~k~DV~S~Gv~l~el~tg~~p~~~~~~~~~~~~~-~---------~~~~~~~--~~ 725 (792)
.....+++.|+|||.+.+ ..++.++|||||||++|||++|+.||.......+.... . .+..... ..
T Consensus 187 -~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~ 265 (330)
T 3nsz_A 187 -YNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIELD 265 (330)
T ss_dssp -CCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHHHTTCCCC
T ss_pred -cccccccccccChhhhcCCCcCCchhhHHHHHHHHHHHHhCCCCcccCCchHHHHHHHHHhcCCchhhhHHHHhccccc
Confidence 234468999999999877 67999999999999999999999999554322111100 0 0000000 00
Q ss_pred cchhHhhhc--------hhcccCCHHHHHHHHHHHHHccccCCCCCCCHHhHHH
Q 003836 726 RTLEALVEN--------DLEAMNNVTMLHRFVMVAFWCIQEDPSHRPTMRKVTQ 771 (792)
Q Consensus 726 ~~~~~~~~~--------~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~ 771 (792)
......... ..........+.++.+++.+||+.||++|||++|+++
T Consensus 266 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~e~l~ 319 (330)
T 3nsz_A 266 PRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAME 319 (330)
T ss_dssp THHHHHHCCCCCCCGGGGCCTTTGGGCCHHHHHHHHTTSCSSGGGSCCHHHHHT
T ss_pred cchhhhhhhccccchhhhccccccccCCHHHHHHHHHHhcCCcccCCCHHHHhc
Confidence 000000000 0011111224578899999999999999999999998
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-37 Score=327.81 Aligned_cols=245 Identities=24% Similarity=0.318 Sum_probs=195.8
Q ss_pred hhcCccccceEEEeeecCCCceEEEEEEcccccccchHHHHHHHHHhcccCCCCcccccceeccCCceEEEEEeccCCCc
Q 003836 507 EELGRGAFGTVYKGFVNMGSSNHVAVKKLNSVFQDSEKEFKAEVNGIGQTHHKNLVRLLGYCDEGQNRLLVYEFMSNGTV 586 (792)
Q Consensus 507 ~~lG~G~~g~Vy~g~~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~lV~E~~~~gsL 586 (792)
..||+|+||.||+|... .+++.||||++........+.+.+|+.++++++||||+++++++.+.+..++||||+++++|
T Consensus 28 ~~lg~G~~g~Vy~~~~~-~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L 106 (295)
T 2clq_A 28 VVLGKGTYGIVYAGRDL-SNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGSFSENGFIKIFMEQVPGGSL 106 (295)
T ss_dssp CEEEECSSSEEEEEEET-TTCCEEEEEEEECCCC---HHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECCSEEEH
T ss_pred EEEeecCcEEEEEEEEC-CCCeEEEEEEccCCchHHHHHHHHHHHHHHhCCCCCEeeEeeEEEeCCcEEEEEEeCCCCCH
Confidence 47999999999999753 45679999999876666678899999999999999999999999999999999999999999
Q ss_pred cccccCC---CCCchhHHHHHHHHHHHHHHHHhhccCCCeEecCCCCCcEEEcC-CCCeEEeecCCCccccCCCCCcccc
Q 003836 587 ASFLFGD---SKPNWKLRTEIAMGIAGGLFYLHEECCTQIIHCDIKPQNILLDD-HYNARISDFGLAKLLTLDQSHTNTA 662 (792)
Q Consensus 587 ~~~l~~~---~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dikp~NILl~~-~~~~kl~Dfg~a~~~~~~~~~~~~~ 662 (792)
.+++... ...++..+..++.||+.||.|||+. +|+|+||||+|||++. ++.+||+|||+++...... .....
T Consensus 107 ~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~~kl~Dfg~~~~~~~~~-~~~~~ 182 (295)
T 2clq_A 107 SALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDN---QIVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGIN-PCTET 182 (295)
T ss_dssp HHHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEETTTCCEEECCTTTCEESCC------CC
T ss_pred HHHHHhhccCCCccHHHHHHHHHHHHHHHHHHHhC---CEEccCCChhhEEEECCCCCEEEeecccccccCCCC-Ccccc
Confidence 9999754 2456888999999999999999998 9999999999999987 8999999999998764322 12234
Q ss_pred ccccCCcccccccccCC--CCcccceehHHHHHHHHHhcCcCCCcchhhhhhhhHHHHHHHhhcccchhHhhhchhcccC
Q 003836 663 IRGTKGYVAPEWFRNMP--ITVKVDVYSYGVLLLEIICLRRNIDNEISKVDKAILTDWAYDRYQERTLEALVENDLEAMN 740 (792)
Q Consensus 663 ~~gt~~y~aPE~~~~~~--~~~k~DV~S~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 740 (792)
..|++.|+|||.+.+.. ++.++||||||+++|||++|+.||........... . ..........
T Consensus 183 ~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~--~-------------~~~~~~~~~~ 247 (295)
T 2clq_A 183 FTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPFYELGEPQAAMF--K-------------VGMFKVHPEI 247 (295)
T ss_dssp CCCCGGGCCHHHHHHGGGGCSHHHHHHHHHHHHHHHHHTSCTTGGGSSHHHHHH--H-------------HHHHCCCCCC
T ss_pred cCCCccccChhhhcCCCCCCCcHHHHHHHHHHHHHHHHCCCCccCCCchhHHHH--h-------------hccccccccc
Confidence 56899999999997643 88999999999999999999999964322111000 0 0000111122
Q ss_pred CHHHHHHHHHHHHHccccCCCCCCCHHhHHH
Q 003836 741 NVTMLHRFVMVAFWCIQEDPSHRPTMRKVTQ 771 (792)
Q Consensus 741 ~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~ 771 (792)
+...+.++.+++.+||+.||++||+++|+++
T Consensus 248 ~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~ 278 (295)
T 2clq_A 248 PESMSAEAKAFILKCFEPDPDKRACANDLLV 278 (295)
T ss_dssp CTTSCHHHHHHHHHTTCSSTTTSCCHHHHHT
T ss_pred cccCCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence 3344567889999999999999999999986
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-38 Score=331.03 Aligned_cols=250 Identities=22% Similarity=0.291 Sum_probs=198.5
Q ss_pred hhhhhcCccccceEEEeeecCCCceEEEEEEccccc--ccchHHHHHHHHHhcccCCCCcccccceec--cCCceEEEEE
Q 003836 504 GFKEELGRGAFGTVYKGFVNMGSSNHVAVKKLNSVF--QDSEKEFKAEVNGIGQTHHKNLVRLLGYCD--EGQNRLLVYE 579 (792)
Q Consensus 504 ~~~~~lG~G~~g~Vy~g~~~~~~~~~vavK~~~~~~--~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~--~~~~~~lV~E 579 (792)
.+.+.||+|+||.||++... .+++.||+|++.... ....+.+.+|++++++++||||+++++++. .....++|||
T Consensus 9 ~~~~~lg~G~~g~V~~~~~~-~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv~e 87 (279)
T 2w5a_A 9 EVLYTIGTGSYGRCQKIRRK-SDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYIVME 87 (279)
T ss_dssp EEEEEEEECSSSEEEEEEET-TTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEEGGGTEEEEEEE
T ss_pred eeehhccCCCCcEEEEEEEC-CCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhcCCCCCCeEEEEEecCCCceEEEEEe
Confidence 34578999999999999754 456899999987532 334567999999999999999999999874 4678899999
Q ss_pred eccCCCccccccCC----CCCchhHHHHHHHHHHHHHHHHhhccCCC-----eEecCCCCCcEEEcCCCCeEEeecCCCc
Q 003836 580 FMSNGTVASFLFGD----SKPNWKLRTEIAMGIAGGLFYLHEECCTQ-----IIHCDIKPQNILLDDHYNARISDFGLAK 650 (792)
Q Consensus 580 ~~~~gsL~~~l~~~----~~l~~~~~~~i~~~ia~gL~yLH~~~~~~-----ivH~dikp~NILl~~~~~~kl~Dfg~a~ 650 (792)
|+++++|.+++... ..+++..+..++.||+.||+|||+. + |+||||||+|||++.++.+||+|||+++
T Consensus 88 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~---~~~~~~ivH~dl~p~NIl~~~~~~~kl~dfg~~~ 164 (279)
T 2w5a_A 88 YCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRR---SDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLAR 164 (279)
T ss_dssp CCTTEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHH---C------CCCCCSGGGEEECSSSCEEECCCCHHH
T ss_pred CCCCCCHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcc---cCCCCeeEEeccchhhEEEcCCCCEEEecCchhe
Confidence 99999999999653 3489999999999999999999998 7 9999999999999999999999999998
Q ss_pred cccCCCCCccccccccCCcccccccccCCCCcccceehHHHHHHHHHhcCcCCCcchhhhhhhhHHHHHHHhhcccchhH
Q 003836 651 LLTLDQSHTNTAIRGTKGYVAPEWFRNMPITVKVDVYSYGVLLLEIICLRRNIDNEISKVDKAILTDWAYDRYQERTLEA 730 (792)
Q Consensus 651 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DV~S~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 730 (792)
....... ......|++.|+|||.+.+..++.++||||||+++|||++|+.||........ . .......
T Consensus 165 ~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~---~-----~~i~~~~--- 232 (279)
T 2w5a_A 165 ILNHDTS-FAKTFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKEL---A-----GKIREGK--- 232 (279)
T ss_dssp HC---CH-HHHHHHSCCTTCCHHHHHCC-CCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHH---H-----HHHHHTC---
T ss_pred eeccccc-cccccCCCccccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCcccCHHHH---H-----HHHhhcc---
Confidence 7543221 12234689999999999998999999999999999999999999975432110 0 0000000
Q ss_pred hhhchhcccCCHHHHHHHHHHHHHccccCCCCCCCHHhHHHHhcc
Q 003836 731 LVENDLEAMNNVTMLHRFVMVAFWCIQEDPSHRPTMRKVTQMLEG 775 (792)
Q Consensus 731 ~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~L~~ 775 (792)
....+...+.++.+++.+||+.||++||+++||++.+..
T Consensus 233 ------~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~~~~ 271 (279)
T 2w5a_A 233 ------FRRIPYRYSDELNEIITRMLNLKDYHRPSVEEILENPLI 271 (279)
T ss_dssp ------CCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTSTTC
T ss_pred ------cccCCcccCHHHHHHHHHHcCCCcccCCCHHHHHhChhh
Confidence 111222345678899999999999999999999987644
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-38 Score=338.87 Aligned_cols=262 Identities=20% Similarity=0.278 Sum_probs=191.6
Q ss_pred hhhhhcCccccceEEEeeecCCCceEEEEEEccccccc-chHHHHHHHHHhcccCCCCcccccceeccCCceEEEEEecc
Q 003836 504 GFKEELGRGAFGTVYKGFVNMGSSNHVAVKKLNSVFQD-SEKEFKAEVNGIGQTHHKNLVRLLGYCDEGQNRLLVYEFMS 582 (792)
Q Consensus 504 ~~~~~lG~G~~g~Vy~g~~~~~~~~~vavK~~~~~~~~-~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~lV~E~~~ 582 (792)
.+.+.||+|+||+||+|... .+++.||+|++...... ....+.+|++++++++||||+++++++.+.+..++||||++
T Consensus 5 ~~~~~lG~G~~g~V~~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~ 83 (324)
T 3mtl_A 5 IKLDKLGEGTYATVYKGKSK-LTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFEYLD 83 (324)
T ss_dssp EEEEEEEECSSEEEEEEEET-TTCCEEEEEEECC------CCCCCCCHHHHSCCCCTTBCCEEEEEECSSCEEEEEECCS
T ss_pred EEEEEEcCCCCEEEEEEEEC-CCCcEEEEEEEecccccccchhHHHHHHHHHhcCCCCCCeeeeEEeeCCEEEEEecccc
Confidence 34578999999999999754 45679999998754322 12245679999999999999999999999999999999998
Q ss_pred CCCccccccCC-CCCchhHHHHHHHHHHHHHHHHhhccCCCeEecCCCCCcEEEcCCCCeEEeecCCCccccCCCCCccc
Q 003836 583 NGTVASFLFGD-SKPNWKLRTEIAMGIAGGLFYLHEECCTQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLDQSHTNT 661 (792)
Q Consensus 583 ~gsL~~~l~~~-~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dikp~NILl~~~~~~kl~Dfg~a~~~~~~~~~~~~ 661 (792)
|+|.+++... ..+++..+..++.||+.||.|||+. +|+||||||+|||++.++.+||+|||+++...... ....
T Consensus 84 -~~l~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~~-~~~~ 158 (324)
T 3mtl_A 84 -KDLKQYLDDCGNIINMHNVKLFLFQLLRGLAYCHRQ---KVLHRDLKPQNLLINERGELKLADFGLARAKSIPT-KTYD 158 (324)
T ss_dssp -EEHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHT---TEEESSCCGGGEEECTTCCEEECSSSEEECC---------
T ss_pred -cCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC---CccCCCcCHHHEEECCCCCEEEccCcccccccCCc-cccc
Confidence 5888888654 4689999999999999999999998 99999999999999999999999999998654322 2223
Q ss_pred cccccCCccccccccc-CCCCcccceehHHHHHHHHHhcCcCCCcchhhhhhhhHHHHHHHhhcccchhHhhhc------
Q 003836 662 AIRGTKGYVAPEWFRN-MPITVKVDVYSYGVLLLEIICLRRNIDNEISKVDKAILTDWAYDRYQERTLEALVEN------ 734 (792)
Q Consensus 662 ~~~gt~~y~aPE~~~~-~~~~~k~DV~S~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~------ 734 (792)
...||+.|+|||.+.+ ..++.++|||||||++|||++|+.||...........+.... ..............
T Consensus 159 ~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~-~~~~~~~~~~~~~~~~~~~~ 237 (324)
T 3mtl_A 159 NEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMATGRPLFPGSTVEEQLHFIFRIL-GTPTEETWPGILSNEEFKTY 237 (324)
T ss_dssp ----CGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHH-CCCCTTTSTTGGGCHHHHHT
T ss_pred cccCcccccChhhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHh-CCCChHhchhhhcchhhccc
Confidence 3468999999999876 578999999999999999999999997654322111111100 00000000000000
Q ss_pred ---hhcc----cCCHHHHHHHHHHHHHccccCCCCCCCHHhHHHH
Q 003836 735 ---DLEA----MNNVTMLHRFVMVAFWCIQEDPSHRPTMRKVTQM 772 (792)
Q Consensus 735 ---~~~~----~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~ 772 (792)
.... ........++.+++.+||+.||++|||++|+++.
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 282 (324)
T 3mtl_A 238 NYPKYRAEALLSHAPRLDSDGADLLTKLLQFEGRNRISAEDAMKH 282 (324)
T ss_dssp CCCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTS
T ss_pred ccccccchhhhhhcCCCCHHHHHHHHHHcCcCcccCCCHHHHhcC
Confidence 0000 0011234678899999999999999999999873
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-37 Score=339.56 Aligned_cols=246 Identities=20% Similarity=0.204 Sum_probs=197.8
Q ss_pred hhhhhcCccccceEEEeee----cCCCceEEEEEEcccccccchHHHHHHHHHhcccC---CCCcccccceeccCCceEE
Q 003836 504 GFKEELGRGAFGTVYKGFV----NMGSSNHVAVKKLNSVFQDSEKEFKAEVNGIGQTH---HKNLVRLLGYCDEGQNRLL 576 (792)
Q Consensus 504 ~~~~~lG~G~~g~Vy~g~~----~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~---h~niv~l~g~~~~~~~~~l 576 (792)
.+.+.||+|+||+||+|.. +...++.||||++... ...++.+|++++.+++ |+||+++++++...+..++
T Consensus 68 ~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~---~~~~~~~e~~~~~~l~~~~~~~iv~~~~~~~~~~~~~l 144 (365)
T 3e7e_A 68 YVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPA---NPWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQNGSVL 144 (365)
T ss_dssp EEEEEEEECSSEEEEEEEC-------CCCCEEEEEESSC---CHHHHHHHHHHHHHSCGGGGGGBCCEEEEEECSSCEEE
T ss_pred EEEEEeeccCCEEEEEEEecCCcccccCcEEEEEEeCCC---ChhHHHHHHHHHHHhhhhhhhhhhhhheeeecCCCcEE
Confidence 3457899999999999952 3345678999998753 3557778888877776 9999999999999999999
Q ss_pred EEEeccCCCccccccC-----CCCCchhHHHHHHHHHHHHHHHHhhccCCCeEecCCCCCcEEEcC-----------CCC
Q 003836 577 VYEFMSNGTVASFLFG-----DSKPNWKLRTEIAMGIAGGLFYLHEECCTQIIHCDIKPQNILLDD-----------HYN 640 (792)
Q Consensus 577 V~E~~~~gsL~~~l~~-----~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dikp~NILl~~-----------~~~ 640 (792)
||||+++|+|.+++.. ...+++..+..|+.||+.||+|||+. +|+||||||+||||+. ++.
T Consensus 145 v~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~lH~~---~ivHrDiKp~NIll~~~~~~~~~~~~~~~~ 221 (365)
T 3e7e_A 145 VGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDC---EIIHGDIKPDNFILGNGFLEQDDEDDLSAG 221 (365)
T ss_dssp EECCCCSCBHHHHHHHHHTSTTCSCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCSGGGEEECGGGTCC------CTT
T ss_pred EEeccCCCcHHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHhhC---CeecCCCCHHHEEecccccCccccccccCC
Confidence 9999999999999973 45789999999999999999999998 9999999999999998 899
Q ss_pred eEEeecCCCccccCC-CCCccccccccCCcccccccccCCCCcccceehHHHHHHHHHhcCcCCCcchhhhhhhhHHHHH
Q 003836 641 ARISDFGLAKLLTLD-QSHTNTAIRGTKGYVAPEWFRNMPITVKVDVYSYGVLLLEIICLRRNIDNEISKVDKAILTDWA 719 (792)
Q Consensus 641 ~kl~Dfg~a~~~~~~-~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DV~S~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~ 719 (792)
+||+|||+++..... .........||+.|+|||++.+..++.++|||||||++|||++|+.||.........
T Consensus 222 ~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~------- 294 (365)
T 3e7e_A 222 LALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGECK------- 294 (365)
T ss_dssp EEECCCTTCEEGGGSCTTEEECCSSCTTSCCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCCCEEEETTEEE-------
T ss_pred EEEeeCchhhhhhccCCCceeeeecCCCCCCChHHhcCCCCCccccHHHHHHHHHHHHhCCCccccCCCCcee-------
Confidence 999999999865422 223334567999999999999999999999999999999999999998543221100
Q ss_pred HHhhcccchhHhhhchhcccCCHHHHHHHHHHHHHccccCCCCC-CCHHhHHHHhccCc
Q 003836 720 YDRYQERTLEALVENDLEAMNNVTMLHRFVMVAFWCIQEDPSHR-PTMRKVTQMLEGVV 777 (792)
Q Consensus 720 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~R-Ps~~evl~~L~~~~ 777 (792)
+ ....... ...+.+.+++..|++.+|.+| |+++++.+.|++.+
T Consensus 295 --------~----~~~~~~~---~~~~~~~~~~~~~l~~~p~~r~~~~~~l~~~l~~~l 338 (365)
T 3e7e_A 295 --------P----EGLFRRL---PHLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVF 338 (365)
T ss_dssp --------E----CSCCTTC---SSHHHHHHHHHHHHCCCCTTCCCCHHHHHHHHHHHH
T ss_pred --------e----chhcccc---CcHHHHHHHHHHHcCCCCCCcchHHHHHHHHHHHHH
Confidence 0 0001111 123456678888999999999 67888888887654
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-37 Score=350.99 Aligned_cols=247 Identities=27% Similarity=0.343 Sum_probs=200.4
Q ss_pred hhhcCccccceEEEeeecCCCceEEEEEEccccc---ccchHHHHHHHHHhcccCCCCcccccceeccCCceEEEEEecc
Q 003836 506 KEELGRGAFGTVYKGFVNMGSSNHVAVKKLNSVF---QDSEKEFKAEVNGIGQTHHKNLVRLLGYCDEGQNRLLVYEFMS 582 (792)
Q Consensus 506 ~~~lG~G~~g~Vy~g~~~~~~~~~vavK~~~~~~---~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~lV~E~~~ 582 (792)
.+.||+|+||.||++... .+++.||+|++.+.. ......+.+|++++++++||||+++++++.+....++||||++
T Consensus 190 ~~~LG~G~fG~Vy~a~~~-~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~lVmE~~~ 268 (543)
T 3c4z_A 190 FRVLGRGGFGEVFACQMK-ATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLAYAFETKTDLCLVMTIMN 268 (543)
T ss_dssp EEEEEECSSSEEEEEEET-TTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECCCT
T ss_pred EEEEeeCCCeEEEEEEEC-CCCcEEEEEEEEhHHhhhhHHHHHHHHHHHHHHhcCCCCEeeEEEEEeeCCEEEEEEEecc
Confidence 357999999999999754 457899999997532 2345678999999999999999999999999999999999999
Q ss_pred CCCccccccCC----CCCchhHHHHHHHHHHHHHHHHhhccCCCeEecCCCCCcEEEcCCCCeEEeecCCCccccCCCCC
Q 003836 583 NGTVASFLFGD----SKPNWKLRTEIAMGIAGGLFYLHEECCTQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLDQSH 658 (792)
Q Consensus 583 ~gsL~~~l~~~----~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dikp~NILl~~~~~~kl~Dfg~a~~~~~~~~~ 658 (792)
+|+|.+++... ..+++..+..++.||+.||.|||+. +|+||||||+|||++.++.+||+|||+++.......
T Consensus 269 gg~L~~~l~~~~~~~~~l~e~~~~~~~~qi~~aL~~LH~~---gIvHrDLKP~NILl~~~g~vkL~DFGla~~~~~~~~- 344 (543)
T 3c4z_A 269 GGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQR---NIIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQT- 344 (543)
T ss_dssp TCBHHHHHHTSSTTSCSCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTSCEEECCCTTCEECCTTCC-
T ss_pred CCCHHHHHHHhhcccccccHHHHHHHHHHHHHHHHHHHHc---CCcccCCChHHEEEeCCCCEEEeecceeeeccCCCc-
Confidence 99999998653 3689999999999999999999998 999999999999999999999999999987653322
Q ss_pred ccccccccCCcccccccccCCCCcccceehHHHHHHHHHhcCcCCCcchhhhhhhhHHHHHHHhhcccchhHhhhchhcc
Q 003836 659 TNTAIRGTKGYVAPEWFRNMPITVKVDVYSYGVLLLEIICLRRNIDNEISKVDKAILTDWAYDRYQERTLEALVENDLEA 738 (792)
Q Consensus 659 ~~~~~~gt~~y~aPE~~~~~~~~~k~DV~S~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 738 (792)
......||+.|+|||++.+..++.++|||||||++|||++|+.||...........+. ..+.... .
T Consensus 345 ~~~~~~GT~~Y~APE~l~~~~~~~~~DiwSlGvilyelltG~~PF~~~~~~~~~~~~~------------~~i~~~~--~ 410 (543)
T 3c4z_A 345 KTKGYAGTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELK------------QRVLEQA--V 410 (543)
T ss_dssp CBCCCCSCTTTSCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCTTCCCCHHHHH------------HHHHHCC--C
T ss_pred ccccccCCccccChhhhcCCCCChHHhcCcchHHHHHHHhCCCCCCCCccchhHHHHH------------HHHhhcc--c
Confidence 2234579999999999999999999999999999999999999997643211111110 0111111 1
Q ss_pred cCCHHHHHHHHHHHHHccccCCCCCCCH-----HhHHH
Q 003836 739 MNNVTMLHRFVMVAFWCIQEDPSHRPTM-----RKVTQ 771 (792)
Q Consensus 739 ~~~~~~~~~l~~l~~~Cl~~~p~~RPs~-----~evl~ 771 (792)
..+...+..+.+++.+||+.||++||++ ++|++
T Consensus 411 ~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~a~ei~~ 448 (543)
T 3c4z_A 411 TYPDKFSPASKDFCEALLQKDPEKRLGFRDGSCDGLRT 448 (543)
T ss_dssp CCCTTSCHHHHHHHHHHSCSSGGGSCCCBTTBSHHHHT
T ss_pred CCCcccCHHHHHHHHHhccCCHhHCCCCcccCHHHHHc
Confidence 1233456778899999999999999975 56664
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-37 Score=327.79 Aligned_cols=246 Identities=24% Similarity=0.360 Sum_probs=201.9
Q ss_pred hhhhhcCccccceEEEeeecCCCceEEEEEEccccc-ccchHHHHHHHHHhcccCCCCcccccceeccCCceEEEEEecc
Q 003836 504 GFKEELGRGAFGTVYKGFVNMGSSNHVAVKKLNSVF-QDSEKEFKAEVNGIGQTHHKNLVRLLGYCDEGQNRLLVYEFMS 582 (792)
Q Consensus 504 ~~~~~lG~G~~g~Vy~g~~~~~~~~~vavK~~~~~~-~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~lV~E~~~ 582 (792)
...+.||+|+||.||+|... .+++.||+|++.... ....+.+.+|+.++++++||||+++++++.+....++||||++
T Consensus 25 ~~~~~lg~G~~g~V~~~~~~-~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 103 (303)
T 3a7i_A 25 TKLEKIGKGSFGEVFKGIDN-RTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEYLG 103 (303)
T ss_dssp EEEEEEEECSSSEEEEEEET-TTCCEEEEEEEETTTCSTTHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCT
T ss_pred HHhhhhcccCCeEEEEEEEC-CCCcEEEEEEecccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEEeCC
Confidence 34578999999999999653 456799999987543 3446789999999999999999999999999999999999999
Q ss_pred CCCccccccCCCCCchhHHHHHHHHHHHHHHHHhhccCCCeEecCCCCCcEEEcCCCCeEEeecCCCccccCCCCCcccc
Q 003836 583 NGTVASFLFGDSKPNWKLRTEIAMGIAGGLFYLHEECCTQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLDQSHTNTA 662 (792)
Q Consensus 583 ~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dikp~NILl~~~~~~kl~Dfg~a~~~~~~~~~~~~~ 662 (792)
+++|.+++.. ..+++..+..++.||+.||.|||+. +|+|+||||+|||++.++.+||+|||++........ ....
T Consensus 104 ~~~L~~~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~~~~-~~~~ 178 (303)
T 3a7i_A 104 GGSALDLLEP-GPLDETQIATILREILKGLDYLHSE---KKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQI-KRNT 178 (303)
T ss_dssp TEEHHHHHTT-SCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECBTTBC-CBCC
T ss_pred CCcHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHC---CCccCCCChheEEECCCCCEEEeecccceecCcccc-ccCc
Confidence 9999999864 5689999999999999999999999 999999999999999999999999999987653322 2234
Q ss_pred ccccCCcccccccccCCCCcccceehHHHHHHHHHhcCcCCCcchhhhhhhhHHHHHHHhhcccchhHhhhchhcccCCH
Q 003836 663 IRGTKGYVAPEWFRNMPITVKVDVYSYGVLLLEIICLRRNIDNEISKVDKAILTDWAYDRYQERTLEALVENDLEAMNNV 742 (792)
Q Consensus 663 ~~gt~~y~aPE~~~~~~~~~k~DV~S~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 742 (792)
..|++.|+|||.+.+..++.++||||||+++|||++|+.||........... +........+.
T Consensus 179 ~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~-----------------~~~~~~~~~~~ 241 (303)
T 3a7i_A 179 FVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELARGEPPHSELHPMKVLFL-----------------IPKNNPPTLEG 241 (303)
T ss_dssp CCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHH-----------------HHHSCCCCCCS
T ss_pred cCCCcCccCHHHHhcCCCCchhhhHHHHHHHHHHccCCCCCCCcCHHHHHHH-----------------hhcCCCCCCcc
Confidence 5689999999999999999999999999999999999999965432111000 00000111122
Q ss_pred HHHHHHHHHHHHccccCCCCCCCHHhHHHH
Q 003836 743 TMLHRFVMVAFWCIQEDPSHRPTMRKVTQM 772 (792)
Q Consensus 743 ~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~ 772 (792)
..+..+.+++.+||+.||++|||++|+++.
T Consensus 242 ~~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 271 (303)
T 3a7i_A 242 NYSKPLKEFVEACLNKEPSFRPTAKELLKH 271 (303)
T ss_dssp SCCHHHHHHHHHHCCSSGGGSCCHHHHTTC
T ss_pred ccCHHHHHHHHHHcCCChhhCcCHHHHhhC
Confidence 334568899999999999999999999874
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-37 Score=332.37 Aligned_cols=256 Identities=23% Similarity=0.328 Sum_probs=181.0
Q ss_pred hhhhhcCccccceEEEeeecCCCceEEEEEEccccc-ccchHHHHHHHHHhcccCCCCcccccceeccCCceEEEEEecc
Q 003836 504 GFKEELGRGAFGTVYKGFVNMGSSNHVAVKKLNSVF-QDSEKEFKAEVNGIGQTHHKNLVRLLGYCDEGQNRLLVYEFMS 582 (792)
Q Consensus 504 ~~~~~lG~G~~g~Vy~g~~~~~~~~~vavK~~~~~~-~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~lV~E~~~ 582 (792)
.+.+.||+|+||.||++... .+++.||||++.... ....+++.+|+.++++++||||+++++++...+..++||||++
T Consensus 18 ~~~~~lg~G~~g~V~~~~~~-~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 96 (303)
T 2vwi_A 18 ELQEVIGSGATAVVQAAYCA-PKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNIVSYYTSFVVKDELWLVMKLLS 96 (303)
T ss_dssp EEEEECC---CCCEEEEEC-----CEEEEECCC----------------CCCCCCCTTBCCEEEEEESSSCEEEEEECCT
T ss_pred hhhheeccccceEEEEEEEC-CCCcEEEEEEEEhhhcchhHHHHHHHHHHHhhcCCCCEeeEEEEEeecCCcEEEehhcc
Confidence 34578999999999999653 456789999986532 3345678999999999999999999999999999999999999
Q ss_pred CCCccccccC--------CCCCchhHHHHHHHHHHHHHHHHhhccCCCeEecCCCCCcEEEcCCCCeEEeecCCCccccC
Q 003836 583 NGTVASFLFG--------DSKPNWKLRTEIAMGIAGGLFYLHEECCTQIIHCDIKPQNILLDDHYNARISDFGLAKLLTL 654 (792)
Q Consensus 583 ~gsL~~~l~~--------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dikp~NILl~~~~~~kl~Dfg~a~~~~~ 654 (792)
+++|.+++.. ...+++..+..++.||+.||.|||+. +|+||||||+|||++.++.+||+|||+++....
T Consensus 97 ~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~ 173 (303)
T 2vwi_A 97 GGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHKN---GQIHRDVKAGNILLGEDGSVQIADFGVSAFLAT 173 (303)
T ss_dssp TCBHHHHHHHHHHTTTTTTCSSCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEECTTCCEEECCCHHHHHCC-
T ss_pred CCchHHHHHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhC---CCCCCCCChhhEEEcCCCCEEEEeccchheecc
Confidence 9999999863 35689999999999999999999998 999999999999999999999999999876543
Q ss_pred CCC----CccccccccCCccccccccc-CCCCcccceehHHHHHHHHHhcCcCCCcchhhhhhhhHHHHHHHhhcccchh
Q 003836 655 DQS----HTNTAIRGTKGYVAPEWFRN-MPITVKVDVYSYGVLLLEIICLRRNIDNEISKVDKAILTDWAYDRYQERTLE 729 (792)
Q Consensus 655 ~~~----~~~~~~~gt~~y~aPE~~~~-~~~~~k~DV~S~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 729 (792)
... .......||+.|+|||.+.. ..++.++||||||+++|||++|+.||.......... . ...........
T Consensus 174 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~---~-~~~~~~~~~~~ 249 (303)
T 2vwi_A 174 GGDITRNKVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYPPMKVLM---L-TLQNDPPSLET 249 (303)
T ss_dssp --------------CCCTTCCHHHHHHHHCCCTHHHHHHHHHHHHHHHHSSCTTTTSCGGGHHH---H-HHTSSCCCTTC
T ss_pred CCCccchhhhcccCCCccccCHHHhccccCCCchhhHHHHHHHHHHHHhCCCCCccCchhhHHH---H-HhccCCCcccc
Confidence 221 11234568999999999876 568999999999999999999999997643221100 0 00000000000
Q ss_pred HhhhchhcccCCHHHHHHHHHHHHHccccCCCCCCCHHhHHH
Q 003836 730 ALVENDLEAMNNVTMLHRFVMVAFWCIQEDPSHRPTMRKVTQ 771 (792)
Q Consensus 730 ~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~ 771 (792)
...+. ......+..+.+++.+||+.||++|||++|+++
T Consensus 250 ~~~~~----~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~ 287 (303)
T 2vwi_A 250 GVQDK----EMLKKYGKSFRKMISLCLQKDPEKRPTAAELLR 287 (303)
T ss_dssp ---------CCCCCCCHHHHHHHHHHCCSSGGGSCCHHHHHT
T ss_pred ccccc----hhhhhhhHHHHHHHHHHccCChhhCcCHHHHhh
Confidence 00111 111123457889999999999999999999997
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-37 Score=333.86 Aligned_cols=264 Identities=19% Similarity=0.266 Sum_probs=196.8
Q ss_pred hhhhhhcCccccceEEEeeecCCCceEEEEEEccccc--ccchHHHHHHHHHhcccCCCCcccccceecc--------CC
Q 003836 503 RGFKEELGRGAFGTVYKGFVNMGSSNHVAVKKLNSVF--QDSEKEFKAEVNGIGQTHHKNLVRLLGYCDE--------GQ 572 (792)
Q Consensus 503 ~~~~~~lG~G~~g~Vy~g~~~~~~~~~vavK~~~~~~--~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~--------~~ 572 (792)
+.+.+.||+|+||+||+|... .+++.||||++.... ......+.+|++++++++||||+++++++.. .+
T Consensus 19 y~~~~~lg~G~~g~V~~~~~~-~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~ 97 (351)
T 3mi9_A 19 YEKLAKIGQGTFGEVFKARHR-KTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRCKG 97 (351)
T ss_dssp EEEEEECSSCSTTSEEEEEET-TTCCEEEEEECCCSSCSSSSCHHHHHHHHHHHHCCCTTBCCEEEEEEEC--------C
T ss_pred eeEEEEEecCCCcEEEEEEEC-CCCCEEEEEEEecccccccchHHHHHHHHHHHhccCCCcccHhheeeccccccccCCc
Confidence 445678999999999999754 456799999986543 2335678899999999999999999999876 44
Q ss_pred ceEEEEEeccCCCccccccCC-CCCchhHHHHHHHHHHHHHHHHhhccCCCeEecCCCCCcEEEcCCCCeEEeecCCCcc
Q 003836 573 NRLLVYEFMSNGTVASFLFGD-SKPNWKLRTEIAMGIAGGLFYLHEECCTQIIHCDIKPQNILLDDHYNARISDFGLAKL 651 (792)
Q Consensus 573 ~~~lV~E~~~~gsL~~~l~~~-~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dikp~NILl~~~~~~kl~Dfg~a~~ 651 (792)
..++||||+++ +|.+.+... ..+++..+..++.||+.||+|||+. +|+||||||+|||++.++.+||+|||+++.
T Consensus 98 ~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~---~ivH~Dlkp~NIl~~~~~~~kl~Dfg~a~~ 173 (351)
T 3mi9_A 98 SIYLVFDFCEH-DLAGLLSNVLVKFTLSEIKRVMQMLLNGLYYIHRN---KILHRDMKAANVLITRDGVLKLADFGLARA 173 (351)
T ss_dssp EEEEEEECCSE-EHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEE
T ss_pred eEEEEEeccCC-CHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHC---CeeCCCCCHHHEEEcCCCCEEEccchhccc
Confidence 68999999986 666666543 6789999999999999999999999 999999999999999999999999999987
Q ss_pred ccCCCC---CccccccccCCccccccccc-CCCCcccceehHHHHHHHHHhcCcCCCcchhhhhhhhHHHHHHHhhcccc
Q 003836 652 LTLDQS---HTNTAIRGTKGYVAPEWFRN-MPITVKVDVYSYGVLLLEIICLRRNIDNEISKVDKAILTDWAYDRYQERT 727 (792)
Q Consensus 652 ~~~~~~---~~~~~~~gt~~y~aPE~~~~-~~~~~k~DV~S~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 727 (792)
...... .......||+.|+|||.+.+ ..++.++|||||||++|||++|+.||...........+.... .......
T Consensus 174 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~-~~~~~~~ 252 (351)
T 3mi9_A 174 FSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLC-GSITPEV 252 (351)
T ss_dssp CCCCSSSSCCCCCSSCSCGGGCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHH-CCCCTTT
T ss_pred ccccccccccccCCcccccCccCchhhcCCCCCCcHhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHh-CCCChhh
Confidence 653222 22234568999999999876 568999999999999999999999997654332211111100 0000000
Q ss_pred hhHhhhch--------hcccCC-H------HHHHHHHHHHHHccccCCCCCCCHHhHHHH
Q 003836 728 LEALVEND--------LEAMNN-V------TMLHRFVMVAFWCIQEDPSHRPTMRKVTQM 772 (792)
Q Consensus 728 ~~~~~~~~--------~~~~~~-~------~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~ 772 (792)
........ ...... . .....+.+++.+||+.||++|||++|+++.
T Consensus 253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 312 (351)
T 3mi9_A 253 WPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNH 312 (351)
T ss_dssp STTGGGCGGGTSSCCCSSCCCCHHHHHHHHHCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred ccccccchhhcccccccccccCHHHHhhhccCChHHHHHHHHHhcCChhhCCCHHHHhCC
Confidence 00000000 000000 0 113568899999999999999999999973
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-37 Score=349.06 Aligned_cols=250 Identities=23% Similarity=0.308 Sum_probs=197.8
Q ss_pred HhhhhhhcCccccceEEEeeecCCCceEEEEEEccccc--ccchHHHHHHHHHhcccCCCCcccccceeccCCceEEEEE
Q 003836 502 TRGFKEELGRGAFGTVYKGFVNMGSSNHVAVKKLNSVF--QDSEKEFKAEVNGIGQTHHKNLVRLLGYCDEGQNRLLVYE 579 (792)
Q Consensus 502 ~~~~~~~lG~G~~g~Vy~g~~~~~~~~~vavK~~~~~~--~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~lV~E 579 (792)
.+.+.+.||+|+||+||++... .+++.+|+|++.... ......+.+|+.++++++||||+++++++.+....++|||
T Consensus 38 ~y~~~~~lG~G~~g~V~~~~~~-~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e 116 (494)
T 3lij_A 38 MYQRVKKLGSGAYGEVLLCRDK-VTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLYDFFEDKRNYYLVME 116 (494)
T ss_dssp HEEEEEEEECC---EEEEEEET-TTCCEEEEEEEEC-----CTTHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred CeEEeeEEecCCCEEEEEEEEC-CCCcEEEEEEEeccccCchHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEEe
Confidence 4556788999999999999754 456789999987543 3346789999999999999999999999999999999999
Q ss_pred eccCCCccccccCCCCCchhHHHHHHHHHHHHHHHHhhccCCCeEecCCCCCcEEEcCC---CCeEEeecCCCccccCCC
Q 003836 580 FMSNGTVASFLFGDSKPNWKLRTEIAMGIAGGLFYLHEECCTQIIHCDIKPQNILLDDH---YNARISDFGLAKLLTLDQ 656 (792)
Q Consensus 580 ~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dikp~NILl~~~---~~~kl~Dfg~a~~~~~~~ 656 (792)
|+++|+|.+++.....+++..+..++.||+.||+|||+. +|+||||||+|||++.. +.+||+|||+++......
T Consensus 117 ~~~~g~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~Dlkp~Nil~~~~~~~~~~kl~DfG~a~~~~~~~ 193 (494)
T 3lij_A 117 CYKGGELFDEIIHRMKFNEVDAAVIIKQVLSGVTYLHKH---NIVHRDLKPENLLLESKEKDALIKIVDFGLSAVFENQK 193 (494)
T ss_dssp CCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEESCSSTTCCEEECCCTTCEECBTTB
T ss_pred cCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC---CceeccCChhhEEEeCCCCCCcEEEEECCCCeECCCCc
Confidence 999999999998778899999999999999999999998 99999999999999764 459999999998765332
Q ss_pred CCccccccccCCcccccccccCCCCcccceehHHHHHHHHHhcCcCCCcchhhhhhhhHHHHHHHhhcccchhHhhhchh
Q 003836 657 SHTNTAIRGTKGYVAPEWFRNMPITVKVDVYSYGVLLLEIICLRRNIDNEISKVDKAILTDWAYDRYQERTLEALVENDL 736 (792)
Q Consensus 657 ~~~~~~~~gt~~y~aPE~~~~~~~~~k~DV~S~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 736 (792)
......||+.|+|||++. ..++.++|||||||++|+|++|+.||........ +......... .
T Consensus 194 --~~~~~~gt~~y~aPE~l~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~---~~~i~~~~~~-----------~ 256 (494)
T 3lij_A 194 --KMKERLGTAYYIAPEVLR-KKYDEKCDVWSIGVILFILLAGYPPFGGQTDQEI---LRKVEKGKYT-----------F 256 (494)
T ss_dssp --CBCCCCSCTTTCCHHHHT-TCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH---HHHHHHTCCC-----------C
T ss_pred --cccccCCCcCeeCHHHHc-ccCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHH---HHHHHhCCCC-----------C
Confidence 233456999999999886 5699999999999999999999999976533211 1000000000 0
Q ss_pred cccCCHHHHHHHHHHHHHccccCCCCCCCHHhHHHH
Q 003836 737 EAMNNVTMLHRFVMVAFWCIQEDPSHRPTMRKVTQM 772 (792)
Q Consensus 737 ~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~ 772 (792)
........+..+.+++.+||+.+|.+|||+.|+++.
T Consensus 257 ~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~h 292 (494)
T 3lij_A 257 DSPEWKNVSEGAKDLIKQMLQFDSQRRISAQQALEH 292 (494)
T ss_dssp CSGGGTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTC
T ss_pred CchhcccCCHHHHHHHHHHCCCChhhCccHHHHhcC
Confidence 000011234678899999999999999999999863
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-37 Score=344.98 Aligned_cols=196 Identities=24% Similarity=0.379 Sum_probs=165.1
Q ss_pred hhhhhhcCccccceEEEeeecCCCceEEEEEEccccc--ccchHHHHHHHHHhcccCCCCcccccceeccC-----CceE
Q 003836 503 RGFKEELGRGAFGTVYKGFVNMGSSNHVAVKKLNSVF--QDSEKEFKAEVNGIGQTHHKNLVRLLGYCDEG-----QNRL 575 (792)
Q Consensus 503 ~~~~~~lG~G~~g~Vy~g~~~~~~~~~vavK~~~~~~--~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~-----~~~~ 575 (792)
+.+.+.||+|+||.||+|... .+++.||||++.... ....+.+.+|++++++++|+||+++++++... ...+
T Consensus 28 y~~~~~lG~G~~g~V~~a~~~-~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~~~ 106 (432)
T 3n9x_A 28 YIIKHLIGRGSYGYVYLAYDK-NTEKNVAIKKVNRMFEDLIDCKRILREITILNRLKSDYIIRLYDLIIPDDLLKFDELY 106 (432)
T ss_dssp EEEEEEEEEETTEEEEEEEET-TTTEEEEEEEECSTTTSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCCEE
T ss_pred EEEEEEEeecCCEEEEEEEEC-CCCcEEEEEEeCchhcChHHHHHHHHHHHHHHHcCCCCcceEEEEEecCCCCcCCeEE
Confidence 445678999999999999754 567899999997643 23456889999999999999999999999766 5789
Q ss_pred EEEEeccCCCccccccCCCCCchhHHHHHHHHHHHHHHHHhhccCCCeEecCCCCCcEEEcCCCCeEEeecCCCccccCC
Q 003836 576 LVYEFMSNGTVASFLFGDSKPNWKLRTEIAMGIAGGLFYLHEECCTQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLD 655 (792)
Q Consensus 576 lV~E~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dikp~NILl~~~~~~kl~Dfg~a~~~~~~ 655 (792)
+||||++ ++|.+++.....+++..+..++.||++||+|||+. +|+||||||+|||++.++.+||+|||+++.....
T Consensus 107 lv~e~~~-~~L~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~---givHrDlkp~NILl~~~~~~kL~DFGla~~~~~~ 182 (432)
T 3n9x_A 107 IVLEIAD-SDLKKLFKTPIFLTEEHIKTILYNLLLGENFIHES---GIIHRDLKPANCLLNQDCSVKVCDFGLARTINSE 182 (432)
T ss_dssp EEEECCS-EEHHHHHHSSCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTCEEC---
T ss_pred EEEecCC-cCHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHC---CCCCCCCCHHHeEECCCCCEEEccCCCccccccc
Confidence 9999987 59999998888899999999999999999999999 9999999999999999999999999999976543
Q ss_pred CCC---------------------ccccccccCCccccccc-ccCCCCcccceehHHHHHHHHHhcCcCC
Q 003836 656 QSH---------------------TNTAIRGTKGYVAPEWF-RNMPITVKVDVYSYGVLLLEIICLRRNI 703 (792)
Q Consensus 656 ~~~---------------------~~~~~~gt~~y~aPE~~-~~~~~~~k~DV~S~Gv~l~el~tg~~p~ 703 (792)
... ..+...||+.|+|||++ ....++.++|||||||++|||++|..|+
T Consensus 183 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~~DiwSlG~il~ell~g~~p~ 252 (432)
T 3n9x_A 183 KDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQSH 252 (432)
T ss_dssp ----------------------------CCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHTTCTTT
T ss_pred ccccccccccccccccccccchhccccCCCCCccccCHHHHhcCCCCCcccccchHHHHHHHHHhccccc
Confidence 211 12456789999999986 5667999999999999999999865544
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-36 Score=333.41 Aligned_cols=265 Identities=23% Similarity=0.250 Sum_probs=194.9
Q ss_pred hhhhhhcCccccceEEEeeecCCCceEEEEEEccccc--ccchHHHHHHHHHhcccCCCCcccccceeccCC------ce
Q 003836 503 RGFKEELGRGAFGTVYKGFVNMGSSNHVAVKKLNSVF--QDSEKEFKAEVNGIGQTHHKNLVRLLGYCDEGQ------NR 574 (792)
Q Consensus 503 ~~~~~~lG~G~~g~Vy~g~~~~~~~~~vavK~~~~~~--~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~------~~ 574 (792)
+.+.+.||+|+||.||+|.. ..+++.||||++.... ....+.+.+|++++++++||||+++++++.... ..
T Consensus 27 y~~~~~lG~G~~g~V~~a~~-~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~~~ 105 (367)
T 1cm8_A 27 YRDLQPVGSGAYGAVCSAVD-GRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFTDF 105 (367)
T ss_dssp EEEEEEC------CEEEEEE-TTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCCCC
T ss_pred EEEeEEeeecCCeEEEEEEE-CCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCcCCCCceeeEecCCccccCceE
Confidence 34457899999999999965 3567899999996532 223567899999999999999999999997653 46
Q ss_pred EEEEEeccCCCccccccCCCCCchhHHHHHHHHHHHHHHHHhhccCCCeEecCCCCCcEEEcCCCCeEEeecCCCccccC
Q 003836 575 LLVYEFMSNGTVASFLFGDSKPNWKLRTEIAMGIAGGLFYLHEECCTQIIHCDIKPQNILLDDHYNARISDFGLAKLLTL 654 (792)
Q Consensus 575 ~lV~E~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dikp~NILl~~~~~~kl~Dfg~a~~~~~ 654 (792)
++||||+ +++|.+++.. ..+++..+..++.||++||+|||+. +|+||||||+|||++.++.+||+|||+++....
T Consensus 106 ~lv~e~~-~~~L~~~~~~-~~l~~~~~~~~~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~ 180 (367)
T 1cm8_A 106 YLVMPFM-GTDLGKLMKH-EKLGEDRIQFLVYQMLKGLRYIHAA---GIIHRDLKPGNLAVNEDCELKILDFGLARQADS 180 (367)
T ss_dssp EEEEECC-SEEHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTCEECCS
T ss_pred EEEEecC-CCCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHC---CccccCcCHHHEEEcCCCCEEEEeeeccccccc
Confidence 9999999 7899999865 5688999999999999999999998 999999999999999999999999999987543
Q ss_pred CCCCccccccccCCccccccccc-CCCCcccceehHHHHHHHHHhcCcCCCcchhhhhhhhHHHH-------HHHhhccc
Q 003836 655 DQSHTNTAIRGTKGYVAPEWFRN-MPITVKVDVYSYGVLLLEIICLRRNIDNEISKVDKAILTDW-------AYDRYQER 726 (792)
Q Consensus 655 ~~~~~~~~~~gt~~y~aPE~~~~-~~~~~k~DV~S~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~-------~~~~~~~~ 726 (792)
. .....+|+.|+|||.+.+ ..++.++|||||||+++||++|+.||...........+... ........
T Consensus 181 ~----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~~~~~~~~~~~~~ 256 (367)
T 1cm8_A 181 E----MTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRLQSD 256 (367)
T ss_dssp S----CCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHTCSCH
T ss_pred c----cCcCcCCCCcCCHHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHhhhH
Confidence 2 234568999999999877 68999999999999999999999999765332111111000 00000000
Q ss_pred chhHhhhchh------cccCCHHHHHHHHHHHHHccccCCCCCCCHHhHHHH--hccCc
Q 003836 727 TLEALVENDL------EAMNNVTMLHRFVMVAFWCIQEDPSHRPTMRKVTQM--LEGVV 777 (792)
Q Consensus 727 ~~~~~~~~~~------~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~--L~~~~ 777 (792)
....++.... -..........+.+++.+||+.||++|||++|+++. ++.+.
T Consensus 257 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~mL~~dP~~R~t~~e~l~hp~f~~~~ 315 (367)
T 1cm8_A 257 EAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFESLH 315 (367)
T ss_dssp HHHHHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGTTTC
T ss_pred HHHHHHHhCCCCCCCCHHHHCCCCCHHHHHHHHHHccCChhHCCCHHHHhcChHHHhhc
Confidence 0111111000 000112345678899999999999999999999984 55543
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-37 Score=330.53 Aligned_cols=248 Identities=22% Similarity=0.345 Sum_probs=195.0
Q ss_pred hhhhhcCccccceEEEeeecCCCceEEEEEEcccccccchHHHHHHHHHhcccCCCCcccccceeccCCceEEEEEeccC
Q 003836 504 GFKEELGRGAFGTVYKGFVNMGSSNHVAVKKLNSVFQDSEKEFKAEVNGIGQTHHKNLVRLLGYCDEGQNRLLVYEFMSN 583 (792)
Q Consensus 504 ~~~~~lG~G~~g~Vy~g~~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~lV~E~~~~ 583 (792)
.+.+.||+|+||.||+|... .+++.+|+|++........+.+.+|++++++++||||+++++++.+.+..++||||+++
T Consensus 22 ~i~~~lg~G~~g~V~~~~~~-~~~~~~aiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~ 100 (302)
T 2j7t_A 22 EIVGELGDGAFGKVYKAKNK-ETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVKLLGAYYHDGKLWIMIEFCPG 100 (302)
T ss_dssp EEEEEEECSTTCCEEEEEET-TTCCEEEEEEEC----CCHHHHHHHHHHHHHCCCTTBCCEEEEEECC-CEEEEEECCTT
T ss_pred eecceeccCCCeEEEEEEEc-CCCcEEEEEEecCCCHHHHHHHHHHHHHHhcCCCCCEeeeeeeeeeCCeEEEEEEeCCC
Confidence 45578999999999999764 45678999999876666778999999999999999999999999999999999999999
Q ss_pred CCccccccC-CCCCchhHHHHHHHHHHHHHHHHhhccCCCeEecCCCCCcEEEcCCCCeEEeecCCCccccCCCCCcccc
Q 003836 584 GTVASFLFG-DSKPNWKLRTEIAMGIAGGLFYLHEECCTQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLDQSHTNTA 662 (792)
Q Consensus 584 gsL~~~l~~-~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dikp~NILl~~~~~~kl~Dfg~a~~~~~~~~~~~~~ 662 (792)
++|.+++.. ...+++..+..++.||+.||.|||+. +|+||||||+|||++.++.+||+|||++....... .....
T Consensus 101 ~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~-~~~~~ 176 (302)
T 2j7t_A 101 GAVDAIMLELDRGLTEPQIQVVCRQMLEALNFLHSK---RIIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKTL-QKRDS 176 (302)
T ss_dssp EEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEECTTSCEEECCCHHHHHHHHHH-HC---
T ss_pred CcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHhcC---CcccCCCCHHHEEECCCCCEEEEECCCCccccccc-ccccc
Confidence 999998865 45689999999999999999999998 99999999999999999999999999876432111 11123
Q ss_pred ccccCCccccccc-----ccCCCCcccceehHHHHHHHHHhcCcCCCcchhhhhhhhHHHHHHHhhcccchhHhhhchhc
Q 003836 663 IRGTKGYVAPEWF-----RNMPITVKVDVYSYGVLLLEIICLRRNIDNEISKVDKAILTDWAYDRYQERTLEALVENDLE 737 (792)
Q Consensus 663 ~~gt~~y~aPE~~-----~~~~~~~k~DV~S~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 737 (792)
..||+.|+|||.+ ....++.++||||||+++|||++|+.||........ ..... . .. ...
T Consensus 177 ~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~---~~~~~----~-~~-------~~~ 241 (302)
T 2j7t_A 177 FIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRV---LLKIA----K-SD-------PPT 241 (302)
T ss_dssp --CCGGGCCHHHHHHHHTTSTTTTTHHHHHHHHHHHHHHHHSSCTTTTSCHHHH---HHHHH----H-SC-------CCC
T ss_pred ccCChhhcCCeeeccccCCCCCCchhhhHHHHHHHHHHHhcCCCCCccCCHHHH---HHHHh----c-cC-------Ccc
Confidence 4589999999998 366789999999999999999999999975432111 00000 0 00 000
Q ss_pred ccCCHHHHHHHHHHHHHccccCCCCCCCHHhHHH
Q 003836 738 AMNNVTMLHRFVMVAFWCIQEDPSHRPTMRKVTQ 771 (792)
Q Consensus 738 ~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~ 771 (792)
...+...+..+.+++.+||+.||++|||++|+++
T Consensus 242 ~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 275 (302)
T 2j7t_A 242 LLTPSKWSVEFRDFLKIALDKNPETRPSAAQLLE 275 (302)
T ss_dssp CSSGGGSCHHHHHHHHHHSCSCTTTSCCHHHHTT
T ss_pred cCCccccCHHHHHHHHHHcccChhhCCCHHHHhc
Confidence 0112233567889999999999999999999987
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-37 Score=363.56 Aligned_cols=255 Identities=21% Similarity=0.305 Sum_probs=202.1
Q ss_pred HhhhhhhcCccccceEEEeeecC--CCceEEEEEEcccccc-cchHHHHHHHHHhcccCCCCcccccceeccCCceEEEE
Q 003836 502 TRGFKEELGRGAFGTVYKGFVNM--GSSNHVAVKKLNSVFQ-DSEKEFKAEVNGIGQTHHKNLVRLLGYCDEGQNRLLVY 578 (792)
Q Consensus 502 ~~~~~~~lG~G~~g~Vy~g~~~~--~~~~~vavK~~~~~~~-~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~lV~ 578 (792)
.+.+.+.||+|+||.||+|.... .....||+|++..... ...+.+.+|+.++++++||||+++++++.+ +..++||
T Consensus 391 ~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~-~~~~lv~ 469 (656)
T 2j0j_A 391 RIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVITE-NPVWIIM 469 (656)
T ss_dssp GEEEEEEEECCSSCCEEEEEECCSSSCCEEEEEEECSSTTCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEE
T ss_pred cEEEeeEEeeCCCEEEEEEEEecCCCccEEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEec-CceEEEE
Confidence 34456789999999999997643 2346799999875433 334679999999999999999999999854 5689999
Q ss_pred EeccCCCccccccCC-CCCchhHHHHHHHHHHHHHHHHhhccCCCeEecCCCCCcEEEcCCCCeEEeecCCCccccCCCC
Q 003836 579 EFMSNGTVASFLFGD-SKPNWKLRTEIAMGIAGGLFYLHEECCTQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLDQS 657 (792)
Q Consensus 579 E~~~~gsL~~~l~~~-~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dikp~NILl~~~~~~kl~Dfg~a~~~~~~~~ 657 (792)
||+++|+|.+++... ..+++..+..++.||+.||.|||+. +|+||||||+|||++.++.+||+|||+++.......
T Consensus 470 E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---givHrDikp~NILl~~~~~vkL~DFG~a~~~~~~~~ 546 (656)
T 2j0j_A 470 ELCTLGELRSFLQVRKFSLDLASLILYAYQLSTALAYLESK---RFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTY 546 (656)
T ss_dssp ECCTTCBHHHHHHHTTTTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETTEEEECCCCCCCSCCC---
T ss_pred EcCCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhC---CccccccchHhEEEeCCCCEEEEecCCCeecCCCcc
Confidence 999999999999755 3689999999999999999999998 999999999999999999999999999987654443
Q ss_pred CccccccccCCcccccccccCCCCcccceehHHHHHHHHHh-cCcCCCcchhhhhhhhHHHHHHHhhcccchhHhhhchh
Q 003836 658 HTNTAIRGTKGYVAPEWFRNMPITVKVDVYSYGVLLLEIIC-LRRNIDNEISKVDKAILTDWAYDRYQERTLEALVENDL 736 (792)
Q Consensus 658 ~~~~~~~gt~~y~aPE~~~~~~~~~k~DV~S~Gv~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 736 (792)
.......+++.|+|||.+.+..++.++||||||+++|||++ |..||........ . . . +....
T Consensus 547 ~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~~~~---~-~------------~-i~~~~ 609 (656)
T 2j0j_A 547 YKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDV---I-G------------R-IENGE 609 (656)
T ss_dssp -------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHH---H-H------------H-HHHTC
T ss_pred eeccCCCCCcceeCHHHhcCCCCCchhhHHHHHHHHHHHHHcCCCCCCCCCHHHH---H-H------------H-HHcCC
Confidence 33344557889999999998899999999999999999997 8889865432111 0 0 0 00111
Q ss_pred cccCCHHHHHHHHHHHHHccccCCCCCCCHHhHHHHhccCc
Q 003836 737 EAMNNVTMLHRFVMVAFWCIQEDPSHRPTMRKVTQMLEGVV 777 (792)
Q Consensus 737 ~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~L~~~~ 777 (792)
....+...+..+.+++.+||+.||++|||+.||++.|+.++
T Consensus 610 ~~~~~~~~~~~l~~li~~~l~~dP~~RPs~~el~~~L~~il 650 (656)
T 2j0j_A 610 RLPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTIL 650 (656)
T ss_dssp CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred CCCCCccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHH
Confidence 11123344567889999999999999999999999998764
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-37 Score=322.69 Aligned_cols=245 Identities=24% Similarity=0.392 Sum_probs=193.7
Q ss_pred hhhhhcCccccceEEEeeecCCCceEEEEEEccccc---ccchHHHHHHHHHhcccCCCCcccccceeccCCceEEEEEe
Q 003836 504 GFKEELGRGAFGTVYKGFVNMGSSNHVAVKKLNSVF---QDSEKEFKAEVNGIGQTHHKNLVRLLGYCDEGQNRLLVYEF 580 (792)
Q Consensus 504 ~~~~~lG~G~~g~Vy~g~~~~~~~~~vavK~~~~~~---~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~lV~E~ 580 (792)
.+.+.||+|+||.||+|... .+++.||||++.... ....+.+.+|+.++++++||||+++++++.+.+..++||||
T Consensus 14 ~i~~~lg~G~~g~V~~~~~~-~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 92 (276)
T 2h6d_A 14 VLGDTLGVGTFGKVKIGEHQ-LTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQVISTPTDFFMVMEY 92 (276)
T ss_dssp EEEEEEEECSSEEEEEEEET-TTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEEC
T ss_pred EEEeeecCCCCeEEEEEEEC-CCCceEEEEEeccccccchhHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCeEEEEEec
Confidence 34578999999999999764 456789999986532 23456889999999999999999999999999999999999
Q ss_pred ccCCCccccccCCCCCchhHHHHHHHHHHHHHHHHhhccCCCeEecCCCCCcEEEcCCCCeEEeecCCCccccCCCCCcc
Q 003836 581 MSNGTVASFLFGDSKPNWKLRTEIAMGIAGGLFYLHEECCTQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLDQSHTN 660 (792)
Q Consensus 581 ~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dikp~NILl~~~~~~kl~Dfg~a~~~~~~~~~~~ 660 (792)
+++++|.+++.....+++..+..++.||+.||.|||+. +|+|+||||+|||++.++.+||+|||++....... ..
T Consensus 93 ~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~--~~ 167 (276)
T 2h6d_A 93 VSGGELFDYICKHGRVEEMEARRLFQQILSAVDYCHRH---MVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGE--FL 167 (276)
T ss_dssp CCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHH---CSSCCCCCGGGEEECTTSCEEECCCCGGGCCCC------
T ss_pred cCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHC---CCccCCCChhhEEECCCCCEEEeecccccccCCCc--ce
Confidence 99999999998777899999999999999999999999 99999999999999999999999999998764322 22
Q ss_pred ccccccCCcccccccccCCC-CcccceehHHHHHHHHHhcCcCCCcchhhhhhhhHHHHHHHhhcccchhHhhhchhccc
Q 003836 661 TAIRGTKGYVAPEWFRNMPI-TVKVDVYSYGVLLLEIICLRRNIDNEISKVDKAILTDWAYDRYQERTLEALVENDLEAM 739 (792)
Q Consensus 661 ~~~~gt~~y~aPE~~~~~~~-~~k~DV~S~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 739 (792)
....+++.|+|||.+.+..+ +.++||||||+++|||++|+.||........ . .... ... ..
T Consensus 168 ~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~---~-----~~~~--------~~~--~~ 229 (276)
T 2h6d_A 168 RTSCGSPNYAAPEVISGRLYAGPEVDIWSCGVILYALLCGTLPFDDEHVPTL---F-----KKIR--------GGV--FY 229 (276)
T ss_dssp ---------CCTGGGTTSCCCHHHHHHHHHHHHHHHHHHSSCSSCCSSHHHH---H-----HHHH--------HCC--CC
T ss_pred ecccCCccccCHHHHcCCCCCCccchHHHHHHHHHHHHhCCCCCCCCcHHHH---H-----HHhh--------cCc--cc
Confidence 33468999999999987765 6899999999999999999999975432110 0 0000 000 01
Q ss_pred CCHHHHHHHHHHHHHccccCCCCCCCHHhHHHH
Q 003836 740 NNVTMLHRFVMVAFWCIQEDPSHRPTMRKVTQM 772 (792)
Q Consensus 740 ~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~ 772 (792)
.+......+.+++.+||+.||++|||++|+++.
T Consensus 230 ~~~~~~~~l~~li~~~l~~~p~~Rps~~~~l~h 262 (276)
T 2h6d_A 230 IPEYLNRSVATLLMHMLQVDPLKRATIKDIREH 262 (276)
T ss_dssp CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHS
T ss_pred CchhcCHHHHHHHHHHccCChhhCCCHHHHHhC
Confidence 122234568899999999999999999999984
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.9e-37 Score=347.81 Aligned_cols=251 Identities=23% Similarity=0.301 Sum_probs=202.0
Q ss_pred HHhhhhhhcCccccceEEEeeecCCCceEEEEEEccccc--ccchHHHHHHHHHhcccCCCCcccccceeccCCceEEEE
Q 003836 501 VTRGFKEELGRGAFGTVYKGFVNMGSSNHVAVKKLNSVF--QDSEKEFKAEVNGIGQTHHKNLVRLLGYCDEGQNRLLVY 578 (792)
Q Consensus 501 ~~~~~~~~lG~G~~g~Vy~g~~~~~~~~~vavK~~~~~~--~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~lV~ 578 (792)
..+.+.+.||+|+||+||++... .+++.||||++.... ......+.+|++++++++||||+++++++.+....++||
T Consensus 22 ~~y~~~~~lG~G~~g~V~~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~ 100 (486)
T 3mwu_A 22 ERYNIVCMLGKGSFGEVLKCKDR-ITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYIVG 100 (486)
T ss_dssp HHEEEEEEEECCSSSEEEEEEET-TTCCEEEEEEEEHHHHBCSCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred cceEEeEEEeecCCEEEEEEEEC-CCCCEEEEEEEecccccchHHHHHHHHHHHHHhCCCCCcCeEEEEEEcCCEEEEEE
Confidence 45667789999999999999754 456799999986432 334678999999999999999999999999999999999
Q ss_pred EeccCCCccccccCCCCCchhHHHHHHHHHHHHHHHHhhccCCCeEecCCCCCcEEEc---CCCCeEEeecCCCccccCC
Q 003836 579 EFMSNGTVASFLFGDSKPNWKLRTEIAMGIAGGLFYLHEECCTQIIHCDIKPQNILLD---DHYNARISDFGLAKLLTLD 655 (792)
Q Consensus 579 E~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dikp~NILl~---~~~~~kl~Dfg~a~~~~~~ 655 (792)
||+++|+|.+++.....+++..+..++.||+.||.|||+. +|+||||||+|||++ .++.+||+|||+++.....
T Consensus 101 e~~~~~~L~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~~~ 177 (486)
T 3mwu_A 101 ELYTGGELFDEIIKRKRFSEHDAARIIKQVFSGITYMHKH---NIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQN 177 (486)
T ss_dssp CCCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEESSSSTTCCEEECSCSCTTTBCCC
T ss_pred EcCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCchHHEEEecCCCCCCEEEEECCcCeECCCC
Confidence 9999999999998778899999999999999999999999 999999999999995 4567999999999876433
Q ss_pred CCCccccccccCCcccccccccCCCCcccceehHHHHHHHHHhcCcCCCcchhhhhhhhHHHHHHHhhcccchhHhhhch
Q 003836 656 QSHTNTAIRGTKGYVAPEWFRNMPITVKVDVYSYGVLLLEIICLRRNIDNEISKVDKAILTDWAYDRYQERTLEALVEND 735 (792)
Q Consensus 656 ~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DV~S~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 735 (792)
. ......||+.|+|||++.+ .++.++|||||||++|+|++|+.||........ +.........
T Consensus 178 ~--~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~---~~~i~~~~~~----------- 240 (486)
T 3mwu_A 178 T--KMKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYGKNEYDI---LKRVETGKYA----------- 240 (486)
T ss_dssp ------CCTTGGGGCCGGGGGS-CCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHH---HHHHHHTCCC-----------
T ss_pred C--ccCCCcCCCCCCCHHHhCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH---HHHHHhCCCC-----------
Confidence 2 2334569999999999875 599999999999999999999999976432211 1000000000
Q ss_pred hcccCCHHHHHHHHHHHHHccccCCCCCCCHHhHHHH
Q 003836 736 LEAMNNVTMLHRFVMVAFWCIQEDPSHRPTMRKVTQM 772 (792)
Q Consensus 736 ~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~ 772 (792)
.........+..+.+++.+||+.+|.+|||+.|+++.
T Consensus 241 ~~~~~~~~~s~~~~~li~~~L~~dp~~R~t~~~~l~h 277 (486)
T 3mwu_A 241 FDLPQWRTISDDAKDLIRKMLTFHPSLRITATQCLEH 277 (486)
T ss_dssp SCSGGGGGSCHHHHHHHHHHTCSSTTTSCCHHHHHHC
T ss_pred CCCcccCCCCHHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 0000112235678899999999999999999999984
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-37 Score=333.91 Aligned_cols=261 Identities=23% Similarity=0.251 Sum_probs=196.6
Q ss_pred hhhhhhcCccccceEEEeeecCCCceEEEEEEccccccc-----chHHHHHHHHHhcccCCCCcccccceeccCCceEEE
Q 003836 503 RGFKEELGRGAFGTVYKGFVNMGSSNHVAVKKLNSVFQD-----SEKEFKAEVNGIGQTHHKNLVRLLGYCDEGQNRLLV 577 (792)
Q Consensus 503 ~~~~~~lG~G~~g~Vy~g~~~~~~~~~vavK~~~~~~~~-----~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~lV 577 (792)
+.+.+.||+|+||.||++... .+++.||||++...... ..+.+.+|++++++++||||+++++++.+.+..++|
T Consensus 12 y~~~~~lg~G~~g~Vy~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 90 (346)
T 1ua2_A 12 YEKLDFLGEGQFATVYKARDK-NTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNISLV 90 (346)
T ss_dssp -CEEEEEEEETTEEEEEEECS-SCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCCEEE
T ss_pred cEEEeEEeecCCEEEEEEEEC-CCCcEEEEEEEecCCcchhhhhhhHHHHHHHHHHhhCCCCCCCeEEEEEeeCCceEEE
Confidence 445578999999999999754 45678999998753221 134688999999999999999999999999999999
Q ss_pred EEeccCCCccccccCC-CCCchhHHHHHHHHHHHHHHHHhhccCCCeEecCCCCCcEEEcCCCCeEEeecCCCccccCCC
Q 003836 578 YEFMSNGTVASFLFGD-SKPNWKLRTEIAMGIAGGLFYLHEECCTQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLDQ 656 (792)
Q Consensus 578 ~E~~~~gsL~~~l~~~-~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dikp~NILl~~~~~~kl~Dfg~a~~~~~~~ 656 (792)
|||+++ +|.+++... ..+++..+..++.||+.||+|||+. +|+||||||+|||++.++.+||+|||+++......
T Consensus 91 ~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~ 166 (346)
T 1ua2_A 91 FDFMET-DLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQH---WILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPN 166 (346)
T ss_dssp EECCSE-EHHHHHTTCCSSCCSSHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEECCCGGGSTTTSCC
T ss_pred EEcCCC-CHHHHHHhcCcCCCHHHHHHHHHHHHHHHHHHHHC---CEECCCCCHHHEEEcCCCCEEEEecccceeccCCc
Confidence 999986 888888665 4689999999999999999999999 99999999999999999999999999998764332
Q ss_pred CCccccccccCCccccccccc-CCCCcccceehHHHHHHHHHhcCcCCCcchhhhhhhhHHHHHHHhhc--ccc---hhH
Q 003836 657 SHTNTAIRGTKGYVAPEWFRN-MPITVKVDVYSYGVLLLEIICLRRNIDNEISKVDKAILTDWAYDRYQ--ERT---LEA 730 (792)
Q Consensus 657 ~~~~~~~~gt~~y~aPE~~~~-~~~~~k~DV~S~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~--~~~---~~~ 730 (792)
.......||+.|+|||.+.+ ..++.++|||||||++|||++|..||.......... ........ ... ...
T Consensus 167 -~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~~~~~~~~~~~~~---~i~~~~~~~~~~~~~~~~~ 242 (346)
T 1ua2_A 167 -RAYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLT---RIFETLGTPTEEQWPDMCS 242 (346)
T ss_dssp -CCCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHH---HHHHHHCCCCTTTSSSTTS
T ss_pred -ccCCcccccccccCchHhhCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHHHH---HHHHHcCCCChhhhhhhcc
Confidence 22334568999999999865 458999999999999999999999987653321111 11000000 000 000
Q ss_pred hhhc---hhcccCC-----HHHHHHHHHHHHHccccCCCCCCCHHhHHHH
Q 003836 731 LVEN---DLEAMNN-----VTMLHRFVMVAFWCIQEDPSHRPTMRKVTQM 772 (792)
Q Consensus 731 ~~~~---~~~~~~~-----~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~ 772 (792)
+.+. ......+ ...+.++.+++.+||+.||++|||++|+++.
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 292 (346)
T 1ua2_A 243 LPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKM 292 (346)
T ss_dssp STTCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTS
T ss_pred CcccccccccCCCChHHhhccCCHHHHHHHHHHhccChhhCCCHHHHhcC
Confidence 0000 0000001 2234678999999999999999999999985
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-37 Score=350.24 Aligned_cols=250 Identities=22% Similarity=0.276 Sum_probs=204.7
Q ss_pred HHHhhhhhhcCccccceEEEeeecCCCceEEEEEEccccc---ccchHHHHHHHHHhcccCCCCcccccceeccCCceEE
Q 003836 500 EVTRGFKEELGRGAFGTVYKGFVNMGSSNHVAVKKLNSVF---QDSEKEFKAEVNGIGQTHHKNLVRLLGYCDEGQNRLL 576 (792)
Q Consensus 500 ~~~~~~~~~lG~G~~g~Vy~g~~~~~~~~~vavK~~~~~~---~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~l 576 (792)
...+.+.+.||+|+||.||++... .+++.||||++.... ....+.+.+|+.++++++||||+++++++.+....++
T Consensus 25 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~l 103 (484)
T 3nyv_A 25 SDRYKGQRVLGKGSFGEVILCKDK-ITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYEFFEDKGYFYL 103 (484)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEET-TTCCEEEEEEEETTTCCBSSCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEE
T ss_pred cCceEEeeEEecCCCEEEEEEEEC-CCCCEEEEEEEEhhhcccchHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEE
Confidence 345666788999999999999754 456799999986532 3456789999999999999999999999999999999
Q ss_pred EEEeccCCCccccccCCCCCchhHHHHHHHHHHHHHHHHhhccCCCeEecCCCCCcEEE---cCCCCeEEeecCCCcccc
Q 003836 577 VYEFMSNGTVASFLFGDSKPNWKLRTEIAMGIAGGLFYLHEECCTQIIHCDIKPQNILL---DDHYNARISDFGLAKLLT 653 (792)
Q Consensus 577 V~E~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dikp~NILl---~~~~~~kl~Dfg~a~~~~ 653 (792)
||||+++|+|.+++.....+++..+..++.||+.||.|||++ +|+||||||+|||+ +.++.+||+|||+++...
T Consensus 104 v~e~~~~~~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~ 180 (484)
T 3nyv_A 104 VGEVYTGGELFDEIISRKRFSEVDAARIIRQVLSGITYMHKN---KIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFE 180 (484)
T ss_dssp EECCCCSCBHHHHHHTCSCCBHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESSSSTTCCEEECCTTHHHHBC
T ss_pred EEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCHHHEEEecCCCCCcEEEEeeeeeEEcc
Confidence 999999999999998888899999999999999999999999 99999999999999 567899999999998764
Q ss_pred CCCCCccccccccCCcccccccccCCCCcccceehHHHHHHHHHhcCcCCCcchhhhhhhhHHHHHHHhhcccchhHhhh
Q 003836 654 LDQSHTNTAIRGTKGYVAPEWFRNMPITVKVDVYSYGVLLLEIICLRRNIDNEISKVDKAILTDWAYDRYQERTLEALVE 733 (792)
Q Consensus 654 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DV~S~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 733 (792)
... ......||+.|+|||.+.+ .++.++|||||||++|+|++|+.||........ +.. +..
T Consensus 181 ~~~--~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~---~~~-------------i~~ 241 (484)
T 3nyv_A 181 ASK--KMKDKIGTAYYIAPEVLHG-TYDEKCDVWSTGVILYILLSGCPPFNGANEYDI---LKK-------------VEK 241 (484)
T ss_dssp CCC--SHHHHTTGGGTCCHHHHHT-CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH---HHH-------------HHH
T ss_pred ccc--ccccCCCCccccCceeecC-CCCCcceeHHHHHHHHHHHHCCCCCCCCCHHHH---HHH-------------HHc
Confidence 332 2334569999999999876 699999999999999999999999976432211 100 011
Q ss_pred chhc--ccCCHHHHHHHHHHHHHccccCCCCCCCHHhHHHH
Q 003836 734 NDLE--AMNNVTMLHRFVMVAFWCIQEDPSHRPTMRKVTQM 772 (792)
Q Consensus 734 ~~~~--~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~ 772 (792)
.... .......+..+.+++.+||+.+|.+|||++|+++.
T Consensus 242 ~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~h 282 (484)
T 3nyv_A 242 GKYTFELPQWKKVSESAKDLIRKMLTYVPSMRISARDALDH 282 (484)
T ss_dssp CCCCCCSGGGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred CCCCCCCcccccCCHHHHHHHHHHCCCChhHCcCHHHHhhC
Confidence 1000 00112345678899999999999999999999864
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-36 Score=325.93 Aligned_cols=247 Identities=23% Similarity=0.320 Sum_probs=197.7
Q ss_pred hhhhhhcCccccceEEEeeecCCCceEEEEEEcccccccchHHHHHHHHHhcccCCCCcccccceeccCCceEEEEEecc
Q 003836 503 RGFKEELGRGAFGTVYKGFVNMGSSNHVAVKKLNSVFQDSEKEFKAEVNGIGQTHHKNLVRLLGYCDEGQNRLLVYEFMS 582 (792)
Q Consensus 503 ~~~~~~lG~G~~g~Vy~g~~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~lV~E~~~ 582 (792)
+.+.+.||+|+||.||+|... .+++.||+|++... ...+.+.+|+.++++++||||+++++++.+.+..++||||++
T Consensus 31 y~~~~~lg~G~~g~Vy~~~~~-~~~~~vaiK~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 107 (314)
T 3com_A 31 FDVLEKLGEGSYGSVYKAIHK-ETGQIVAIKQVPVE--SDLQEIIKEISIMQQCDSPHVVKYYGSYFKNTDLWIVMEYCG 107 (314)
T ss_dssp EEEEEECC----CEEEEEEET-TTCCEEEEEEEETT--SCCHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECCT
T ss_pred hhhheeeccCCCeEEEEEEEC-CCCCEEEEEecCch--HHHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEeecCC
Confidence 445678999999999999754 45679999998753 345789999999999999999999999999999999999999
Q ss_pred CCCcccccc-CCCCCchhHHHHHHHHHHHHHHHHhhccCCCeEecCCCCCcEEEcCCCCeEEeecCCCccccCCCCCccc
Q 003836 583 NGTVASFLF-GDSKPNWKLRTEIAMGIAGGLFYLHEECCTQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLDQSHTNT 661 (792)
Q Consensus 583 ~gsL~~~l~-~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dikp~NILl~~~~~~kl~Dfg~a~~~~~~~~~~~~ 661 (792)
+++|.+++. ....+++..+..++.||+.||.|||+. +|+|+||||+|||++.++.+||+|||++........ ...
T Consensus 108 ~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~-~~~ 183 (314)
T 3com_A 108 AGSVSDIIRLRNKTLTEDEIATILQSTLKGLEYLHFM---RKIHRDIKAGNILLNTEGHAKLADFGVAGQLTDTMA-KRN 183 (314)
T ss_dssp TEEHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECCCTTCEECBTTBS-CBC
T ss_pred CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhC---CCcCCCcCHHHEEECCCCCEEEeecccchhhhhhcc-ccC
Confidence 999999986 346789999999999999999999998 999999999999999999999999999987643322 223
Q ss_pred cccccCCcccccccccCCCCcccceehHHHHHHHHHhcCcCCCcchhhhhhhhHHHHHHHhhcccchhHhhhchhcccCC
Q 003836 662 AIRGTKGYVAPEWFRNMPITVKVDVYSYGVLLLEIICLRRNIDNEISKVDKAILTDWAYDRYQERTLEALVENDLEAMNN 741 (792)
Q Consensus 662 ~~~gt~~y~aPE~~~~~~~~~k~DV~S~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 741 (792)
...|++.|+|||.+.+..++.++||||||+++|||++|+.||............ ... .......+
T Consensus 184 ~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~-----~~~----------~~~~~~~~ 248 (314)
T 3com_A 184 TVIGTPFWMAPEVIQEIGYNCVADIWSLGITAIEMAEGKPPYADIHPMRAIFMI-----PTN----------PPPTFRKP 248 (314)
T ss_dssp CCCSCGGGCCHHHHSSSCBCTTHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHH-----HHS----------CCCCCSSG
T ss_pred ccCCCCCccChhhcCCCCCCccccHHHHHHHHHHHHhCCCCCCCCChHHHHHHH-----hcC----------CCcccCCc
Confidence 446899999999999999999999999999999999999999754321110000 000 00000112
Q ss_pred HHHHHHHHHHHHHccccCCCCCCCHHhHHH
Q 003836 742 VTMLHRFVMVAFWCIQEDPSHRPTMRKVTQ 771 (792)
Q Consensus 742 ~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~ 771 (792)
...+..+.+++.+||+.||.+|||+.++++
T Consensus 249 ~~~~~~l~~li~~~l~~dp~~Rpt~~~ll~ 278 (314)
T 3com_A 249 ELWSDNFTDFVKQCLVKSPEQRATATQLLQ 278 (314)
T ss_dssp GGSCHHHHHHHHHHTCSCTTTSCCHHHHTT
T ss_pred ccCCHHHHHHHHHHccCChhhCcCHHHHHh
Confidence 223467889999999999999999999986
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-36 Score=332.93 Aligned_cols=247 Identities=23% Similarity=0.347 Sum_probs=199.2
Q ss_pred hhhhhhcCccccceEEEeeecCCCceEEEEEEcccccc--------cchHHHHHHHHHhccc-CCCCcccccceeccCCc
Q 003836 503 RGFKEELGRGAFGTVYKGFVNMGSSNHVAVKKLNSVFQ--------DSEKEFKAEVNGIGQT-HHKNLVRLLGYCDEGQN 573 (792)
Q Consensus 503 ~~~~~~lG~G~~g~Vy~g~~~~~~~~~vavK~~~~~~~--------~~~~~~~~Ei~~l~~l-~h~niv~l~g~~~~~~~ 573 (792)
+.+.+.||+|+||.||+|... .+++.||||++..... ...+.+.+|+.+++++ +||||+++++++.....
T Consensus 96 y~~~~~lg~G~~g~Vy~a~~~-~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~ 174 (365)
T 2y7j_A 96 YDPKDVIGRGVSSVVRRCVHR-ATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLIDSYESSSF 174 (365)
T ss_dssp EEEEEEEEECSSEEEEEEEET-TTCCEEEEEEEETTSSCCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEEBSSE
T ss_pred cccceEEecCCCEEEEEEEEC-CCCcEEEEEEEEccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeEEEEEEeeCCE
Confidence 344578999999999999764 3567999999865431 1145678999999999 79999999999999999
Q ss_pred eEEEEEeccCCCccccccCCCCCchhHHHHHHHHHHHHHHHHhhccCCCeEecCCCCCcEEEcCCCCeEEeecCCCcccc
Q 003836 574 RLLVYEFMSNGTVASFLFGDSKPNWKLRTEIAMGIAGGLFYLHEECCTQIIHCDIKPQNILLDDHYNARISDFGLAKLLT 653 (792)
Q Consensus 574 ~~lV~E~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dikp~NILl~~~~~~kl~Dfg~a~~~~ 653 (792)
.++||||+++++|.+++.....+++..+..++.||+.||.|||+. +|+|+||||+|||++.++.+||+|||++....
T Consensus 175 ~~lv~e~~~g~~L~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~---gi~H~Dlkp~NIl~~~~~~ikl~DfG~~~~~~ 251 (365)
T 2y7j_A 175 MFLVFDLMRKGELFDYLTEKVALSEKETRSIMRSLLEAVSFLHAN---NIVHRDLKPENILLDDNMQIRLSDFGFSCHLE 251 (365)
T ss_dssp EEEEECCCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCCTTCEECC
T ss_pred EEEEEEeCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCCEEEEecCcccccC
Confidence 999999999999999998777899999999999999999999998 99999999999999999999999999998765
Q ss_pred CCCCCccccccccCCccccccccc------CCCCcccceehHHHHHHHHHhcCcCCCcchhhhhhhhHHHHHHHhhcccc
Q 003836 654 LDQSHTNTAIRGTKGYVAPEWFRN------MPITVKVDVYSYGVLLLEIICLRRNIDNEISKVDKAILTDWAYDRYQERT 727 (792)
Q Consensus 654 ~~~~~~~~~~~gt~~y~aPE~~~~------~~~~~k~DV~S~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 727 (792)
... ......||+.|+|||++.+ ..++.++|||||||++|||++|+.||........ +..
T Consensus 252 ~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~---~~~---------- 316 (365)
T 2y7j_A 252 PGE--KLRELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPPFWHRRQILM---LRM---------- 316 (365)
T ss_dssp TTC--CBCCCCSCGGGCCHHHHHHTTCTTSCCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHH---HHH----------
T ss_pred CCc--ccccCCCCCCccChhhccccccccCcCCCchhhHHhHHHHHHHHHHCCCCCCCCCHHHH---HHH----------
Confidence 332 2334578999999999863 3588999999999999999999999965432111 000
Q ss_pred hhHhhhchhcccC--CHHHHHHHHHHHHHccccCCCCCCCHHhHHH
Q 003836 728 LEALVENDLEAMN--NVTMLHRFVMVAFWCIQEDPSHRPTMRKVTQ 771 (792)
Q Consensus 728 ~~~~~~~~~~~~~--~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~ 771 (792)
+......... ....+..+.+++.+||+.||++|||++|+++
T Consensus 317 ---i~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~ell~ 359 (365)
T 2y7j_A 317 ---IMEGQYQFSSPEWDDRSSTVKDLISRLLQVDPEARLTAEQALQ 359 (365)
T ss_dssp ---HHHTCCCCCHHHHSSSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred ---HHhCCCCCCCcccccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 0000000000 0012456889999999999999999999998
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-37 Score=332.64 Aligned_cols=252 Identities=25% Similarity=0.387 Sum_probs=195.5
Q ss_pred hhhhhcCccccceEEEeeecCCCceEEEEEEccccc--ccchHHHHHHHHHhcccCCCCcccccceeccCCceEEEEEec
Q 003836 504 GFKEELGRGAFGTVYKGFVNMGSSNHVAVKKLNSVF--QDSEKEFKAEVNGIGQTHHKNLVRLLGYCDEGQNRLLVYEFM 581 (792)
Q Consensus 504 ~~~~~lG~G~~g~Vy~g~~~~~~~~~vavK~~~~~~--~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~lV~E~~ 581 (792)
.+.+.||+|+||.||+|... ..+|+|++.... ....+.+.+|+.++++++|+||+++++++.+.+..++||||+
T Consensus 36 ~~~~~lg~G~~g~V~~~~~~----~~~avk~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~iv~e~~ 111 (319)
T 2y4i_B 36 EIGELIGKGRFGQVYHGRWH----GEVAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMGACMSPPHLAIITSLC 111 (319)
T ss_dssp ECCCBCCCSSSSEEEEEEES----SSEEEEECCCCSCCCCCCCCCCTTGGGGTTCCCTTBCCCCEEEECSSCEEEECBCC
T ss_pred EEeeEeccCCceEEEEEEEc----CeEEEEEeecCCCCHHHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCceEEEeecc
Confidence 34578999999999999764 249999987532 233456889999999999999999999999999999999999
Q ss_pred cCCCccccccCCC-CCchhHHHHHHHHHHHHHHHHhhccCCCeEecCCCCCcEEEcCCCCeEEeecCCCccccCCC----
Q 003836 582 SNGTVASFLFGDS-KPNWKLRTEIAMGIAGGLFYLHEECCTQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLDQ---- 656 (792)
Q Consensus 582 ~~gsL~~~l~~~~-~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dikp~NILl~~~~~~kl~Dfg~a~~~~~~~---- 656 (792)
++++|.+++.... .+++..+..++.||+.||+|||+. +|+||||||+|||++ ++.+||+|||+++......
T Consensus 112 ~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~---~i~H~dlkp~NIl~~-~~~~~l~Dfg~~~~~~~~~~~~~ 187 (319)
T 2y4i_B 112 KGRTLYSVVRDAKIVLDVNKTRQIAQEIVKGMGYLHAK---GILHKDLKSKNVFYD-NGKVVITDFGLFSISGVLQAGRR 187 (319)
T ss_dssp CSEEHHHHTTSSCCCCCSHHHHHHHHHHHHHHHHHHHT---TCCCCCCCSTTEEEC---CCEECCCSCCC----------
T ss_pred cCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhC---CccccCCChhhEEEe-CCCEEEeecCCcccccccccccc
Confidence 9999999998754 689999999999999999999999 999999999999998 6799999999987653221
Q ss_pred CCccccccccCCccccccccc---------CCCCcccceehHHHHHHHHHhcCcCCCcchhhhhhhhHHHHHHHhhcccc
Q 003836 657 SHTNTAIRGTKGYVAPEWFRN---------MPITVKVDVYSYGVLLLEIICLRRNIDNEISKVDKAILTDWAYDRYQERT 727 (792)
Q Consensus 657 ~~~~~~~~gt~~y~aPE~~~~---------~~~~~k~DV~S~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 727 (792)
........|++.|+|||.+.. ..++.++||||||+++|||++|+.||......... .. ....
T Consensus 188 ~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~-------~~-~~~~- 258 (319)
T 2y4i_B 188 EDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQPAEAII-------WQ-MGTG- 258 (319)
T ss_dssp CCSCBCCSGGGGTSCHHHHSCBSCC--CCCSCCCHHHHHHHHHHHHHHHHHSSCSSSSCCHHHHH-------HH-HHTT-
T ss_pred ccccccCCCcccccChHHhhhccccccccccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHH-------HH-hccC-
Confidence 122233458999999999864 45789999999999999999999999754322110 00 0000
Q ss_pred hhHhhhchhcccCCHHHHHHHHHHHHHccccCCCCCCCHHhHHHHhccCcCC
Q 003836 728 LEALVENDLEAMNNVTMLHRFVMVAFWCIQEDPSHRPTMRKVTQMLEGVVEV 779 (792)
Q Consensus 728 ~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~L~~~~~~ 779 (792)
..........+.++.+++.+||+.||++|||+++++++|+.+.+.
T Consensus 259 -------~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~~l~~l~~~ 303 (319)
T 2y4i_B 259 -------MKPNLSQIGMGKEISDILLFCWAFEQEERPTFTKLMDMLEKLPKR 303 (319)
T ss_dssp -------CCCCCCCSSCCTTHHHHHHHHHCSSTTTSCCHHHHHHHHTTC---
T ss_pred -------CCCCCCcCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHHh
Confidence 000001112345688999999999999999999999999998643
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-36 Score=322.44 Aligned_cols=247 Identities=23% Similarity=0.284 Sum_probs=194.3
Q ss_pred hhhhhhcCccccceEEEeeecCCCceEEEEEEccccc----ccchHHHHHHHHHhcccCCCCccccccee--ccCCceEE
Q 003836 503 RGFKEELGRGAFGTVYKGFVNMGSSNHVAVKKLNSVF----QDSEKEFKAEVNGIGQTHHKNLVRLLGYC--DEGQNRLL 576 (792)
Q Consensus 503 ~~~~~~lG~G~~g~Vy~g~~~~~~~~~vavK~~~~~~----~~~~~~~~~Ei~~l~~l~h~niv~l~g~~--~~~~~~~l 576 (792)
+.+.+.||+|+||.||++.. ..+++.+|+|++.... ....+.+.+|++++++++|+||+++++++ .+....++
T Consensus 7 y~i~~~lg~G~~g~V~~~~~-~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~l 85 (305)
T 2wtk_C 7 YLMGDLLGEGSYGKVKEVLD-SETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLVDVLYNEEKQKMYM 85 (305)
T ss_dssp BCCCCEEEECSSCEEEEEEB-TTTCCEEEEEEECHHHHHHSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECC---CEEE
T ss_pred eeEeeEEecCCCeEEEEEEE-CCCCcEEEEEEeccccccccchhHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCeEEE
Confidence 34567899999999999964 4566799999987532 23457899999999999999999999998 45568899
Q ss_pred EEEeccCCCccccccC--CCCCchhHHHHHHHHHHHHHHHHhhccCCCeEecCCCCCcEEEcCCCCeEEeecCCCccccC
Q 003836 577 VYEFMSNGTVASFLFG--DSKPNWKLRTEIAMGIAGGLFYLHEECCTQIIHCDIKPQNILLDDHYNARISDFGLAKLLTL 654 (792)
Q Consensus 577 V~E~~~~gsL~~~l~~--~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dikp~NILl~~~~~~kl~Dfg~a~~~~~ 654 (792)
||||++++ |.+++.. ...+++..+..++.||+.||.|||++ +|+||||||+|||++.++.+||+|||++.....
T Consensus 86 v~e~~~~~-l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~---~i~H~dlkp~NIl~~~~~~~kl~dfg~~~~~~~ 161 (305)
T 2wtk_C 86 VMEYCVCG-MQEMLDSVPEKRFPVCQAHGYFCQLIDGLEYLHSQ---GIVHKDIKPGNLLLTTGGTLKISALGVAEALHP 161 (305)
T ss_dssp EEECCSEE-HHHHHHHSTTCSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCCTTCEECCT
T ss_pred EehhccCC-HHHHHHhCcccccCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCcccEEEcCCCcEEeeccccccccCc
Confidence 99999987 6666654 35689999999999999999999999 999999999999999999999999999987653
Q ss_pred CCC-CccccccccCCcccccccccCC--CCcccceehHHHHHHHHHhcCcCCCcchhhhhhhhHHHHHHHhhcccchhHh
Q 003836 655 DQS-HTNTAIRGTKGYVAPEWFRNMP--ITVKVDVYSYGVLLLEIICLRRNIDNEISKVDKAILTDWAYDRYQERTLEAL 731 (792)
Q Consensus 655 ~~~-~~~~~~~gt~~y~aPE~~~~~~--~~~k~DV~S~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 731 (792)
... .......||+.|+|||.+.+.. ++.++||||||+++|||++|+.||........ . . .+
T Consensus 162 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~---~-----~--------~i 225 (305)
T 2wtk_C 162 FAADDTCRTSQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGDNIYKL---F-----E--------NI 225 (305)
T ss_dssp TCSSCEECCCCSCGGGCCHHHHTCCSCEESHHHHHHHHHHHHHHHHHSSCSCCCSSHHHH---H-----H--------HH
T ss_pred cccccccccCCCCCCCcChhhccCcccCCcchhhHHHHHHHHHHHHhCCCCCCCchHHHH---H-----H--------HH
Confidence 222 2223456899999999987643 47899999999999999999999975432111 0 0 00
Q ss_pred hhchhcccCCHHHHHHHHHHHHHccccCCCCCCCHHhHHHH
Q 003836 732 VENDLEAMNNVTMLHRFVMVAFWCIQEDPSHRPTMRKVTQM 772 (792)
Q Consensus 732 ~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~ 772 (792)
.... ...+......+.+++.+||+.||++|||++|+++.
T Consensus 226 ~~~~--~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 264 (305)
T 2wtk_C 226 GKGS--YAIPGDCGPPLSDLLKGMLEYEPAKRFSIRQIRQH 264 (305)
T ss_dssp HHCC--CCCCSSSCHHHHHHHHHHTCSSTTTSCCHHHHHHS
T ss_pred hcCC--CCCCCccCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 0000 01122345677899999999999999999999975
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-36 Score=329.19 Aligned_cols=261 Identities=21% Similarity=0.309 Sum_probs=201.4
Q ss_pred HhhhhhhcCccccceEEEeeecCCCceEEEEEEcccccccchHHHHHHHHHhcccCCCC------cccccceeccCCceE
Q 003836 502 TRGFKEELGRGAFGTVYKGFVNMGSSNHVAVKKLNSVFQDSEKEFKAEVNGIGQTHHKN------LVRLLGYCDEGQNRL 575 (792)
Q Consensus 502 ~~~~~~~lG~G~~g~Vy~g~~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h~n------iv~l~g~~~~~~~~~ 575 (792)
.+.+.+.||+|+||+||++.....+++.||||+++.. ....+.+.+|++++++++|++ ++++++++.+.+..+
T Consensus 15 ~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~~~~~i~~~~~~~~~~~~~~ 93 (339)
T 1z57_A 15 RYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNV-DRYCEAARSEIQVLEHLNTTDPNSTFRCVQMLEWFEHHGHIC 93 (339)
T ss_dssp TEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSS-HHHHHHHHHHHHHHHHHHHHCTTCTTCBCCEEEEEEETTEEE
T ss_pred ceEEEEEEecCCCeEEEEEEecCCCCcEEEEEEEecC-CchhHHHHHHHHHHHHhhhcCCCCceeeEeeecccccCCcEE
Confidence 3455678999999999999765556789999999754 334567889999999987665 999999999999999
Q ss_pred EEEEeccCCCccccccCCC--CCchhHHHHHHHHHHHHHHHHhhccCCCeEecCCCCCcEEEcC----------------
Q 003836 576 LVYEFMSNGTVASFLFGDS--KPNWKLRTEIAMGIAGGLFYLHEECCTQIIHCDIKPQNILLDD---------------- 637 (792)
Q Consensus 576 lV~E~~~~gsL~~~l~~~~--~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dikp~NILl~~---------------- 637 (792)
+||||+ +++|.+++.... .+++..+..++.||+.||+|||+. +|+||||||+|||++.
T Consensus 94 lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dlkp~Nil~~~~~~~~~~~~~~~~~~~ 169 (339)
T 1z57_A 94 IVFELL-GLSTYDFIKENGFLPFRLDHIRKMAYQICKSVNFLHSN---KLTHTDLKPENILFVQSDYTEAYNPKIKRDER 169 (339)
T ss_dssp EEEECC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESCCCEEEEEC----CEEE
T ss_pred EEEcCC-CCCHHHHHHhcCCCCCcHHHHHHHHHHHHHHHHHHHHC---CCcCCCCCHHHEEEeccccccccCCccccccc
Confidence 999999 889999997654 678999999999999999999998 9999999999999987
Q ss_pred ---CCCeEEeecCCCccccCCCCCccccccccCCcccccccccCCCCcccceehHHHHHHHHHhcCcCCCcchhhhhhhh
Q 003836 638 ---HYNARISDFGLAKLLTLDQSHTNTAIRGTKGYVAPEWFRNMPITVKVDVYSYGVLLLEIICLRRNIDNEISKVDKAI 714 (792)
Q Consensus 638 ---~~~~kl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DV~S~Gv~l~el~tg~~p~~~~~~~~~~~~ 714 (792)
++.+||+|||+++..... .....||+.|+|||.+.+..++.++||||||+++|||++|+.||...........
T Consensus 170 ~~~~~~~kl~Dfg~~~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~ 245 (339)
T 1z57_A 170 TLINPDIKVVDFGSATYDDEH----HSTLVSTRHYRAPEVILALGWSQPCDVWSIGCILIEYYLGFTVFPTHDSKEHLAM 245 (339)
T ss_dssp EESCCCEEECCCSSCEETTSC----CCSSCSCGGGCCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSCHHHHHHH
T ss_pred cccCCCceEeeCcccccCccc----cccccCCccccChHHhhCCCCCcchhhHHHHHHHHHHHhCCCCCCCCChHHHHHH
Confidence 678999999999864322 2345689999999999999999999999999999999999999976533221111
Q ss_pred HHHHH-------HHhhcccc------------------hhHhhhch-hcccCCHHHHHHHHHHHHHccccCCCCCCCHHh
Q 003836 715 LTDWA-------YDRYQERT------------------LEALVEND-LEAMNNVTMLHRFVMVAFWCIQEDPSHRPTMRK 768 (792)
Q Consensus 715 ~~~~~-------~~~~~~~~------------------~~~~~~~~-~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~e 768 (792)
+.... ........ ......+. ..........+++.+++.+||+.||++|||++|
T Consensus 246 ~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~e 325 (339)
T 1z57_A 246 MERILGPLPKHMIQKTRKRKYFHHDRLDWDEHSSAGRYVSRACKPLKEFMLSQDVEHERLFDLIQKMLEYDPAKRITLRE 325 (339)
T ss_dssp HHHHHCSCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSSTTTSCCHHH
T ss_pred HHHHhCCCCHHHHhhccchhHHhhccccccccccccchhhhcCcchhhhcccchhhHHHHHHHHHHHhCcCcccccCHHH
Confidence 10000 00000000 00000000 001123356788999999999999999999999
Q ss_pred HHH
Q 003836 769 VTQ 771 (792)
Q Consensus 769 vl~ 771 (792)
+++
T Consensus 326 ll~ 328 (339)
T 1z57_A 326 ALK 328 (339)
T ss_dssp HTT
T ss_pred Hhc
Confidence 987
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-36 Score=326.05 Aligned_cols=251 Identities=23% Similarity=0.318 Sum_probs=195.3
Q ss_pred HHhhhhhhcCccccceEEEeeecCCCceEEEEEEcccccc--------cchHHHHHHHHHhcccCCCCcccccceeccCC
Q 003836 501 VTRGFKEELGRGAFGTVYKGFVNMGSSNHVAVKKLNSVFQ--------DSEKEFKAEVNGIGQTHHKNLVRLLGYCDEGQ 572 (792)
Q Consensus 501 ~~~~~~~~lG~G~~g~Vy~g~~~~~~~~~vavK~~~~~~~--------~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~ 572 (792)
..+.+.+.||+|+||.||+|... .+++.||||++..... .....+.+|++++++++||||+++++++....
T Consensus 10 ~~y~~~~~lg~G~~g~V~~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~ 88 (322)
T 2ycf_A 10 DEYIMSKTLGSGACGEVKLAFER-KTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDAED 88 (322)
T ss_dssp HHEEEEEEEEECSSEEEEEEEET-TTTEEEEEEEECC---------------CHHHHHHHHHHCCCTTBCCEEEEEESSS
T ss_pred hceeEeeEEecCCCEEEEEEEEc-CCCcEEEEEEeehhhhhhcccccchhhhhHHHHHHHHHhCCCCCCceEeeEEcCCc
Confidence 44566789999999999999754 4568999999865321 22345889999999999999999999987655
Q ss_pred ceEEEEEeccCCCccccccCCCCCchhHHHHHHHHHHHHHHHHhhccCCCeEecCCCCCcEEEcCCCC---eEEeecCCC
Q 003836 573 NRLLVYEFMSNGTVASFLFGDSKPNWKLRTEIAMGIAGGLFYLHEECCTQIIHCDIKPQNILLDDHYN---ARISDFGLA 649 (792)
Q Consensus 573 ~~~lV~E~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dikp~NILl~~~~~---~kl~Dfg~a 649 (792)
.++||||+++++|.+++.....+++..+..++.||+.||.|||+. +|+||||||+|||++.++. +||+|||++
T Consensus 89 -~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~ 164 (322)
T 2ycf_A 89 -YYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQYLHEN---GIIHRDLKPENVLLSSQEEDCLIKITDFGHS 164 (322)
T ss_dssp -EEEEEECCTTEETHHHHSTTCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESSSSSSCCEEECCCTTC
T ss_pred -eEEEEecCCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHEEEecCCCCCeEEEccCccc
Confidence 899999999999999998888899999999999999999999998 9999999999999987664 999999999
Q ss_pred ccccCCCCCccccccccCCcccccccc---cCCCCcccceehHHHHHHHHHhcCcCCCcchhhhhhhhHHHHHHHhhccc
Q 003836 650 KLLTLDQSHTNTAIRGTKGYVAPEWFR---NMPITVKVDVYSYGVLLLEIICLRRNIDNEISKVDKAILTDWAYDRYQER 726 (792)
Q Consensus 650 ~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~k~DV~S~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 726 (792)
+..... .......||+.|+|||.+. ...++.++||||||+++|||++|+.||........ +....... ...
T Consensus 165 ~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~---~~~~~~~~-~~~ 238 (322)
T 2ycf_A 165 KILGET--SLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVS---LKDQITSG-KYN 238 (322)
T ss_dssp EECCCC--HHHHHHHSCCTTCCHHHHHHTTTTTCTTHHHHHHHHHHHHHHHHSSCSSCSTTCSSC---HHHHHHHT-CCC
T ss_pred eecccc--cccccccCCcCccCchhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchHHH---HHHHHHhC-ccc
Confidence 876422 1223456899999999974 56789999999999999999999999965432211 00000000 000
Q ss_pred chhHhhhchhcccCCHHHHHHHHHHHHHccccCCCCCCCHHhHHH
Q 003836 727 TLEALVENDLEAMNNVTMLHRFVMVAFWCIQEDPSHRPTMRKVTQ 771 (792)
Q Consensus 727 ~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~ 771 (792)
..... ....+..+.+++.+||+.||++||+++|+++
T Consensus 239 ~~~~~---------~~~~~~~~~~li~~~l~~dP~~Rps~~~~l~ 274 (322)
T 2ycf_A 239 FIPEV---------WAEVSEKALDLVKKLLVVDPKARFTTEEALR 274 (322)
T ss_dssp CCHHH---------HTTSCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred cCchh---------hhhcCHHHHHHHHHHcccCHhhCCCHHHHhh
Confidence 00000 0123467889999999999999999999985
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-37 Score=340.68 Aligned_cols=260 Identities=19% Similarity=0.272 Sum_probs=180.1
Q ss_pred hhcCccccceEEEeeecC-CCceEEEEEEcccccccchHHHHHHHHHhcccCCCCccccccee--ccCCceEEEEEeccC
Q 003836 507 EELGRGAFGTVYKGFVNM-GSSNHVAVKKLNSVFQDSEKEFKAEVNGIGQTHHKNLVRLLGYC--DEGQNRLLVYEFMSN 583 (792)
Q Consensus 507 ~~lG~G~~g~Vy~g~~~~-~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~g~~--~~~~~~~lV~E~~~~ 583 (792)
++||+|+||+||+|.... .+++.||||++... .....+.+|+.++++++||||+++++++ ......++||||+++
T Consensus 27 ~~lG~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~--~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~lv~e~~~~ 104 (405)
T 3rgf_A 27 CKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGT--GISMSACREIALLRELKHPNVISLQKVFLSHADRKVWLLFDYAEH 104 (405)
T ss_dssp CCCC-----EEEEEEESSSSCCCCEEEEECSSS--SCCHHHHHHHHHHHHCCCTTBCCCCEEEEETTTTEEEEEEECCSE
T ss_pred cEeeecCCeEEEEEEEccCCCCeEEEEEEECCC--CCCHHHHHHHHHHHhcCCCCeeeEeeEEecCCCCeEEEEEeCCCC
Confidence 479999999999997643 34678999999753 3345788999999999999999999999 457789999999975
Q ss_pred CCccccccCC---------CCCchhHHHHHHHHHHHHHHHHhhccCCCeEecCCCCCcEEE----cCCCCeEEeecCCCc
Q 003836 584 GTVASFLFGD---------SKPNWKLRTEIAMGIAGGLFYLHEECCTQIIHCDIKPQNILL----DDHYNARISDFGLAK 650 (792)
Q Consensus 584 gsL~~~l~~~---------~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dikp~NILl----~~~~~~kl~Dfg~a~ 650 (792)
+|.+++... ..+++..+..|+.||+.||+|||+. +|+||||||+|||| +.++.+||+|||+++
T Consensus 105 -~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~---~ivH~Dlkp~NIll~~~~~~~~~~kl~Dfg~a~ 180 (405)
T 3rgf_A 105 -DLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHAN---WVLHRDLKPANILVMGEGPERGRVKIADMGFAR 180 (405)
T ss_dssp -EHHHHHHHHHHHC-------CCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECCSSTTTTCEEECCTTCCC
T ss_pred -CHHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHhC---CEeCCCcCHHHeEEecCCCCCCcEEEEECCCce
Confidence 777776421 2488999999999999999999999 99999999999999 778999999999998
Q ss_pred cccCCCC--CccccccccCCccccccccc-CCCCcccceehHHHHHHHHHhcCcCCCcchhhhh------hhhHHHHHHH
Q 003836 651 LLTLDQS--HTNTAIRGTKGYVAPEWFRN-MPITVKVDVYSYGVLLLEIICLRRNIDNEISKVD------KAILTDWAYD 721 (792)
Q Consensus 651 ~~~~~~~--~~~~~~~gt~~y~aPE~~~~-~~~~~k~DV~S~Gv~l~el~tg~~p~~~~~~~~~------~~~~~~~~~~ 721 (792)
....... .......||+.|+|||++.+ ..++.++|||||||++|||++|+.||........ ...+......
T Consensus 181 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~l~~i~~~ 260 (405)
T 3rgf_A 181 LFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLDRIFNV 260 (405)
T ss_dssp ----------------CCCTTCCHHHHTTCCSCCHHHHHHHHHHHHHHHHHSSCTTCCCC------CCCCHHHHHHHHHH
T ss_pred ecCCCCcccccCCCceecCcccCchhhcCCCcccchhhhHHHHHHHHHHHhCCCCCCCccccccccccchHHHHHHHHHh
Confidence 7654322 22334678999999999987 4589999999999999999999999965432110 0000000000
Q ss_pred hh--cccchh---------Hhhhc---hhcccC---------CHHHHHHHHHHHHHccccCCCCCCCHHhHHHH
Q 003836 722 RY--QERTLE---------ALVEN---DLEAMN---------NVTMLHRFVMVAFWCIQEDPSHRPTMRKVTQM 772 (792)
Q Consensus 722 ~~--~~~~~~---------~~~~~---~~~~~~---------~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~ 772 (792)
.. ...... .+... ...... .......+.+|+.+||+.||.+|||++|+++.
T Consensus 261 ~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Ll~~~L~~dP~~R~ta~e~L~h 334 (405)
T 3rgf_A 261 MGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDPIKRITSEQAMQD 334 (405)
T ss_dssp HCCCCTTTCGGGGGSTTHHHHHHHCCGGGGTTCCHHHHHHTTTCCTTSHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred hCCCChhhcchhhcCcchhhhhhhccccCCCcchhhhhHhhcCCCCCHHHHHHHHHHccCCcccCCCHHHHhcC
Confidence 00 000000 00000 000000 00114568899999999999999999999985
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-36 Score=338.84 Aligned_cols=196 Identities=23% Similarity=0.340 Sum_probs=168.0
Q ss_pred hhhhhhcCccccceEEEeeecCCCceEEEEEEcccccccchHHHHHHHHHhccc------CCCCcccccceeccCCceEE
Q 003836 503 RGFKEELGRGAFGTVYKGFVNMGSSNHVAVKKLNSVFQDSEKEFKAEVNGIGQT------HHKNLVRLLGYCDEGQNRLL 576 (792)
Q Consensus 503 ~~~~~~lG~G~~g~Vy~g~~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l------~h~niv~l~g~~~~~~~~~l 576 (792)
+.+.+.||+|+||+||+|... .+++.||||++... ......+.+|+++++.+ +|+||+++++++......++
T Consensus 99 y~~~~~LG~G~fg~V~~a~~~-~~~~~vAvK~~~~~-~~~~~~~~~E~~~l~~l~~~~~~~~~~iv~~~~~~~~~~~~~l 176 (429)
T 3kvw_A 99 YEVLKVIGKGSFGQVVKAYDH-KVHQHVALKMVRNE-KRFHRQAAEEIRILEHLRKQDKDNTMNVIHMLENFTFRNHICM 176 (429)
T ss_dssp EEEEEEEEESSSEEEEEEEET-TTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHTTCTTSCSCBCCEEEEEEETTEEEE
T ss_pred EEEEEEcccCccEEEEEEEEC-CCCcEEEEEEECCc-cchHHHHHHHHHHHHHHhhccccCCcCEEEEEeecccCCeEEE
Confidence 445678999999999999654 45789999999753 23345677888887776 57799999999999999999
Q ss_pred EEEeccCCCccccccCC--CCCchhHHHHHHHHHHHHHHHHhhccCCCeEecCCCCCcEEEcCCCC--eEEeecCCCccc
Q 003836 577 VYEFMSNGTVASFLFGD--SKPNWKLRTEIAMGIAGGLFYLHEECCTQIIHCDIKPQNILLDDHYN--ARISDFGLAKLL 652 (792)
Q Consensus 577 V~E~~~~gsL~~~l~~~--~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dikp~NILl~~~~~--~kl~Dfg~a~~~ 652 (792)
||||+. ++|.+++... ..+++..+..|+.||+.||+|||+. +|+||||||+|||++.++. +||+|||+++..
T Consensus 177 v~e~~~-~~L~~~l~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlKp~NILl~~~~~~~vkL~DFG~a~~~ 252 (429)
T 3kvw_A 177 TFELLS-MNLYELIKKNKFQGFSLPLVRKFAHSILQCLDALHKN---RIIHCDLKPENILLKQQGRSGIKVIDFGSSCYE 252 (429)
T ss_dssp EECCCC-CBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHH---TEECSCCSGGGEEESSTTSCCEEECCCTTCEET
T ss_pred EEeccC-CCHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEEccCCCcceEEeecccceec
Confidence 999996 5899888765 3589999999999999999999999 9999999999999999987 999999999764
Q ss_pred cCCCCCccccccccCCcccccccccCCCCcccceehHHHHHHHHHhcCcCCCcchh
Q 003836 653 TLDQSHTNTAIRGTKGYVAPEWFRNMPITVKVDVYSYGVLLLEIICLRRNIDNEIS 708 (792)
Q Consensus 653 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DV~S~Gv~l~el~tg~~p~~~~~~ 708 (792)
.. ......||+.|+|||++.+..++.++|||||||++|||++|+.||.....
T Consensus 253 ~~----~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~pf~~~~~ 304 (429)
T 3kvw_A 253 HQ----RVYTYIQSRFYRAPEVILGARYGMPIDMWSLGCILAELLTGYPLLPGEDE 304 (429)
T ss_dssp TC----CCCSSCSCGGGCCHHHHHTBCCCTHHHHHHHHHHHHHHHHSSCSSCCSSH
T ss_pred CC----cccccCCCCCccChHHHhCCCCCchHHHHhHHHHHHHHHhCCCCCCCCCH
Confidence 32 22345689999999999999999999999999999999999999976543
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-36 Score=347.97 Aligned_cols=247 Identities=23% Similarity=0.317 Sum_probs=198.2
Q ss_pred hhhhhhcCccccceEEEeeecCCCceEEEEEEcccccc-------------cchHHHHHHHHHhcccCCCCcccccceec
Q 003836 503 RGFKEELGRGAFGTVYKGFVNMGSSNHVAVKKLNSVFQ-------------DSEKEFKAEVNGIGQTHHKNLVRLLGYCD 569 (792)
Q Consensus 503 ~~~~~~lG~G~~g~Vy~g~~~~~~~~~vavK~~~~~~~-------------~~~~~~~~Ei~~l~~l~h~niv~l~g~~~ 569 (792)
+.+.++||+|+||+||++... .+++.+|+|++..... ...+.+.+|+.++++++||||+++++++.
T Consensus 38 Y~~~~~lG~G~~g~V~~~~~~-~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~ 116 (504)
T 3q5i_A 38 YFKVRKLGSGAYGEVLLCKEK-NGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIKLFDVFE 116 (504)
T ss_dssp EEEEEEEEC--CEEEEEEEET-TTCCEEEEEEEEC----------------CTHHHHHHHHHHHHTCCCTTBCCEEEEEE
T ss_pred eEEEeEecccCCeEEEEEEEC-CCCcEEEEEEEEhhhcccccccccchhhHHHHHHHHHHHHHHHhCCCCCCCeEEEEEE
Confidence 445678999999999999754 4567999999875321 23567899999999999999999999999
Q ss_pred cCCceEEEEEeccCCCccccccCCCCCchhHHHHHHHHHHHHHHHHhhccCCCeEecCCCCCcEEEcCCC---CeEEeec
Q 003836 570 EGQNRLLVYEFMSNGTVASFLFGDSKPNWKLRTEIAMGIAGGLFYLHEECCTQIIHCDIKPQNILLDDHY---NARISDF 646 (792)
Q Consensus 570 ~~~~~~lV~E~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dikp~NILl~~~~---~~kl~Df 646 (792)
+....++||||+++|+|.+++.....+++..+..++.||+.||+|||+. +|+||||||+|||++.++ .+||+||
T Consensus 117 ~~~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~Dlkp~Nil~~~~~~~~~~kl~Df 193 (504)
T 3q5i_A 117 DKKYFYLVTEFYEGGELFEQIINRHKFDECDAANIMKQILSGICYLHKH---NIVHRDIKPENILLENKNSLLNIKIVDF 193 (504)
T ss_dssp CSSEEEEEEECCTTCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEESSTTCCSSEEECCC
T ss_pred cCCEEEEEEecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC---CeEeCCCcHHHEEEecCCCCccEEEEEC
Confidence 9999999999999999999998878899999999999999999999998 999999999999999776 6999999
Q ss_pred CCCccccCCCCCccccccccCCcccccccccCCCCcccceehHHHHHHHHHhcCcCCCcchhhhhhhhHHHHHHHhhccc
Q 003836 647 GLAKLLTLDQSHTNTAIRGTKGYVAPEWFRNMPITVKVDVYSYGVLLLEIICLRRNIDNEISKVDKAILTDWAYDRYQER 726 (792)
Q Consensus 647 g~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DV~S~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 726 (792)
|+++...... ......||+.|+|||.+. ..++.++|||||||++|+|++|+.||........ +..
T Consensus 194 g~a~~~~~~~--~~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~---~~~--------- 258 (504)
T 3q5i_A 194 GLSSFFSKDY--KLRDRLGTAYYIAPEVLK-KKYNEKCDVWSCGVIMYILLCGYPPFGGQNDQDI---IKK--------- 258 (504)
T ss_dssp TTCEECCTTS--CBCCCCSCTTTCCHHHHT-TCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH---HHH---------
T ss_pred CCCEEcCCCC--ccccccCCcCCCCHHHhc-cCCCchHHHHHHHHHHHHHHhCCCCCCCCCHHHH---HHH---------
Confidence 9998765432 233456999999999987 4699999999999999999999999976433211 000
Q ss_pred chhHhhhchhccc--CCHHHHHHHHHHHHHccccCCCCCCCHHhHHHH
Q 003836 727 TLEALVENDLEAM--NNVTMLHRFVMVAFWCIQEDPSHRPTMRKVTQM 772 (792)
Q Consensus 727 ~~~~~~~~~~~~~--~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~ 772 (792)
+........ .....+.++.+++.+||+.||.+|||++|+++.
T Consensus 259 ----i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~t~~e~l~h 302 (504)
T 3q5i_A 259 ----VEKGKYYFDFNDWKNISDEAKELIKLMLTYDYNKRCTAEEALNS 302 (504)
T ss_dssp ----HHHCCCCCCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred ----HHcCCCCCCccccCCCCHHHHHHHHHHcCCChhHCCCHHHHhcC
Confidence 000000000 001234678899999999999999999999863
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-36 Score=342.51 Aligned_cols=257 Identities=19% Similarity=0.261 Sum_probs=201.1
Q ss_pred hhhhhhcCccccceEEEeeecCCCceEEEEEEcccccccchHHHHHHHHHhcccCC-CCcccccceeccCCceEEEEEec
Q 003836 503 RGFKEELGRGAFGTVYKGFVNMGSSNHVAVKKLNSVFQDSEKEFKAEVNGIGQTHH-KNLVRLLGYCDEGQNRLLVYEFM 581 (792)
Q Consensus 503 ~~~~~~lG~G~~g~Vy~g~~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h-~niv~l~g~~~~~~~~~lV~E~~ 581 (792)
+.+.++||+|+||.||+|... .+++.||||++.... ...++.+|+++++.++| +++..+..++.+.+..+|||||+
T Consensus 9 y~i~~~LG~G~fG~Vy~a~~~-~~~~~vAvK~~~~~~--~~~~~~~E~~il~~L~~~~~i~~i~~~~~~~~~~~lvme~~ 85 (483)
T 3sv0_A 9 FRLGRKIGSGSFGEIYLGTNI-QTNEEVAIKLENVKT--KHPQLLYESKIYRILQGGTGIPNVRWFGVEGDYNVLVMDLL 85 (483)
T ss_dssp EECCCCCEECSSCEEEEEEET-TTCCEEEEEEEETTC--SSCCHHHHHHHHHHTTTSTTCCCEEEEEEETTEEEEEEECC
T ss_pred EEEEEEEeeCCCEEEEEEEEC-CCCcEEEEEEecccc--ccHHHHHHHHHHHHhcCCCCCCeEEEEEeeCCEEEEEEECC
Confidence 345578999999999999753 456799999876533 23468899999999976 55556666667888889999999
Q ss_pred cCCCccccccC-CCCCchhHHHHHHHHHHHHHHHHhhccCCCeEecCCCCCcEEE---cCCCCeEEeecCCCccccCCCC
Q 003836 582 SNGTVASFLFG-DSKPNWKLRTEIAMGIAGGLFYLHEECCTQIIHCDIKPQNILL---DDHYNARISDFGLAKLLTLDQS 657 (792)
Q Consensus 582 ~~gsL~~~l~~-~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dikp~NILl---~~~~~~kl~Dfg~a~~~~~~~~ 657 (792)
+++|.+++.. ...+++..++.|+.||+.||+|||++ +|+||||||+|||| +.++.+||+|||+++.......
T Consensus 86 -g~sL~~ll~~~~~~l~~~~~~~i~~qi~~aL~yLH~~---gIvHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~~~~~ 161 (483)
T 3sv0_A 86 -GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSK---SFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTST 161 (483)
T ss_dssp -CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECCGGGTTCEEECCCTTCEECBCTTT
T ss_pred -CCCHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHC---CEeecccCcceEEEecCCCCCeEEEEeCCcceeccCCcc
Confidence 9999999974 46789999999999999999999999 99999999999999 6889999999999987654432
Q ss_pred C------ccccccccCCcccccccccCCCCcccceehHHHHHHHHHhcCcCCCcchhhhhhhhHHHHHHHhhcccchhHh
Q 003836 658 H------TNTAIRGTKGYVAPEWFRNMPITVKVDVYSYGVLLLEIICLRRNIDNEISKVDKAILTDWAYDRYQERTLEAL 731 (792)
Q Consensus 658 ~------~~~~~~gt~~y~aPE~~~~~~~~~k~DV~S~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 731 (792)
. ......||+.|+|||.+.+..++.++|||||||+||||++|+.||...........+........ ...+..+
T Consensus 162 ~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~~~-~~~~~~l 240 (483)
T 3sv0_A 162 HQHIPYRENKNLTGTARYASVNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKV-ATSIEAL 240 (483)
T ss_dssp CCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSHHHHHHHHHHHHH-HSCHHHH
T ss_pred ccccccccccccCCCccccCHHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccchhHHHHHHHHhhccc-cccHHHH
Confidence 2 12256799999999999999999999999999999999999999976433222111111111110 0111111
Q ss_pred hhchhcccCCHHHHHHHHHHHHHccccCCCCCCCHHhHHHHhccC
Q 003836 732 VENDLEAMNNVTMLHRFVMVAFWCIQEDPSHRPTMRKVTQMLEGV 776 (792)
Q Consensus 732 ~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~L~~~ 776 (792)
. ...+.++.+++..||+.+|++||++++|+++|+.+
T Consensus 241 ~---------~~~p~~l~~li~~cl~~dP~~RPs~~el~~~L~~l 276 (483)
T 3sv0_A 241 C---------RGYPTEFASYFHYCRSLRFDDKPDYSYLKRLFRDL 276 (483)
T ss_dssp H---------TTSCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHH
T ss_pred h---------cCCcHHHHHHHHHHhcCChhhCcCHHHHHHHHHHH
Confidence 1 12246788999999999999999999999998775
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-36 Score=323.46 Aligned_cols=246 Identities=22% Similarity=0.303 Sum_probs=199.7
Q ss_pred hhhhhcCccccceEEEeeecCCCceEEEEEEccccc---------ccchHHHHHHHHHhcccC-CCCcccccceeccCCc
Q 003836 504 GFKEELGRGAFGTVYKGFVNMGSSNHVAVKKLNSVF---------QDSEKEFKAEVNGIGQTH-HKNLVRLLGYCDEGQN 573 (792)
Q Consensus 504 ~~~~~lG~G~~g~Vy~g~~~~~~~~~vavK~~~~~~---------~~~~~~~~~Ei~~l~~l~-h~niv~l~g~~~~~~~ 573 (792)
.+.+.||+|+||.||++... .+++.||||++.... ....+.+.+|++++++++ ||||+++++++.+...
T Consensus 20 ~~~~~lg~G~~g~V~~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~ 98 (298)
T 1phk_A 20 EPKEILGRGVSSVVRRCIHK-PTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYETNTF 98 (298)
T ss_dssp EEEEEEEECSSEEEEEEEET-TTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSE
T ss_pred ceeeeecCCCceEEEEEEEc-CcCceEEEEEEecccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeeeeeeeccCCe
Confidence 34578999999999999754 567899999986532 122456889999999995 9999999999999999
Q ss_pred eEEEEEeccCCCccccccCCCCCchhHHHHHHHHHHHHHHHHhhccCCCeEecCCCCCcEEEcCCCCeEEeecCCCcccc
Q 003836 574 RLLVYEFMSNGTVASFLFGDSKPNWKLRTEIAMGIAGGLFYLHEECCTQIIHCDIKPQNILLDDHYNARISDFGLAKLLT 653 (792)
Q Consensus 574 ~~lV~E~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dikp~NILl~~~~~~kl~Dfg~a~~~~ 653 (792)
.++||||+++++|.+++.....+++..+..++.||+.||.|||+. +|+|+||||+|||++.++.+||+|||+++...
T Consensus 99 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~ 175 (298)
T 1phk_A 99 FFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLEVICALHKL---NIVHRDLKPENILLDDDMNIKLTDFGFSCQLD 175 (298)
T ss_dssp EEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCCTTCEECC
T ss_pred EEEEEeccCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCcceEEEcCCCcEEEecccchhhcC
Confidence 999999999999999998777899999999999999999999998 99999999999999999999999999998764
Q ss_pred CCCCCccccccccCCcccccccc------cCCCCcccceehHHHHHHHHHhcCcCCCcchhhhhhhhHHHHHHHhhcccc
Q 003836 654 LDQSHTNTAIRGTKGYVAPEWFR------NMPITVKVDVYSYGVLLLEIICLRRNIDNEISKVDKAILTDWAYDRYQERT 727 (792)
Q Consensus 654 ~~~~~~~~~~~gt~~y~aPE~~~------~~~~~~k~DV~S~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 727 (792)
... ......+++.|+|||.+. ...++.++||||||+++|||++|+.||..........
T Consensus 176 ~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~-------------- 239 (298)
T 1phk_A 176 PGE--KLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLR-------------- 239 (298)
T ss_dssp TTC--CBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHH--------------
T ss_pred CCc--ccccccCCccccCHHHhccccccccccCCcccccHhHHHHHHHHHHCCCCCcCccHHHHHH--------------
Confidence 332 223456899999999985 4568899999999999999999999996543211100
Q ss_pred hhHhhhchhc--ccCCHHHHHHHHHHHHHccccCCCCCCCHHhHHH
Q 003836 728 LEALVENDLE--AMNNVTMLHRFVMVAFWCIQEDPSHRPTMRKVTQ 771 (792)
Q Consensus 728 ~~~~~~~~~~--~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~ 771 (792)
.+...... .......+..+.+++.+||+.||++|||++|+++
T Consensus 240 --~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 283 (298)
T 1phk_A 240 --MIMSGNYQFGSPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALA 283 (298)
T ss_dssp --HHHHTCCCCCTTTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTT
T ss_pred --HHhcCCcccCcccccccCHHHHHHHHHHccCCcccCCCHHHHHh
Confidence 00000000 0011234567889999999999999999999987
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-36 Score=330.50 Aligned_cols=259 Identities=23% Similarity=0.284 Sum_probs=180.8
Q ss_pred hhhhhcCccccceEEEeeecCCCceEEEEEEccccc--ccchHHHHHHHHHhcccCCCCcccccceeccC------CceE
Q 003836 504 GFKEELGRGAFGTVYKGFVNMGSSNHVAVKKLNSVF--QDSEKEFKAEVNGIGQTHHKNLVRLLGYCDEG------QNRL 575 (792)
Q Consensus 504 ~~~~~lG~G~~g~Vy~g~~~~~~~~~vavK~~~~~~--~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~------~~~~ 575 (792)
.+.+.||+|+||.||+|.. ..+++.||||++.... ....+.+.+|++++++++||||+++++++... ...+
T Consensus 32 ~~~~~lG~G~~g~V~~a~~-~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~~~~~ 110 (367)
T 2fst_X 32 QNLSPVGSGAYGSVCAAFD-TKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVY 110 (367)
T ss_dssp EEEEECC----CCEEEEEE-TTTTEEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCCCCE
T ss_pred EEeeEEeecCCeEEEEEEE-CCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCccccCCeEE
Confidence 3457899999999999964 4567899999997532 23456788999999999999999999998654 5679
Q ss_pred EEEEeccCCCccccccCCCCCchhHHHHHHHHHHHHHHHHhhccCCCeEecCCCCCcEEEcCCCCeEEeecCCCccccCC
Q 003836 576 LVYEFMSNGTVASFLFGDSKPNWKLRTEIAMGIAGGLFYLHEECCTQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLD 655 (792)
Q Consensus 576 lV~E~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dikp~NILl~~~~~~kl~Dfg~a~~~~~~ 655 (792)
+|+|++ +++|.+++.. ..+++..+..++.||++||+|||+. +|+||||||+|||++.++.+||+|||+++.....
T Consensus 111 lv~e~~-~~~L~~~~~~-~~l~~~~~~~i~~qi~~aL~~LH~~---givH~Dlkp~NIll~~~~~~kL~DFG~a~~~~~~ 185 (367)
T 2fst_X 111 LVTHLM-GADLNNIVKC-QKLTDDHVQFLIYQILRGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLARHTADE 185 (367)
T ss_dssp EEEECC-CEECC------CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEECC----------
T ss_pred EEeccc-CCCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCHhhEEECCCCCEEEeecccccccccc
Confidence 999999 6899999865 5689999999999999999999998 9999999999999999999999999999865322
Q ss_pred CCCccccccccCCccccccccc-CCCCcccceehHHHHHHHHHhcCcCCCcchhhhhhhhHHHH-------HHHhhcccc
Q 003836 656 QSHTNTAIRGTKGYVAPEWFRN-MPITVKVDVYSYGVLLLEIICLRRNIDNEISKVDKAILTDW-------AYDRYQERT 727 (792)
Q Consensus 656 ~~~~~~~~~gt~~y~aPE~~~~-~~~~~k~DV~S~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~-------~~~~~~~~~ 727 (792)
.....||+.|+|||.+.+ ..++.++|||||||++|||++|+.||...........+... .........
T Consensus 186 ----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~p~~~~~~~~~~~~ 261 (367)
T 2fst_X 186 ----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSES 261 (367)
T ss_dssp ---------CCCTTCCHHHHTTCCSCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHTTCCCHH
T ss_pred ----CCCcCcCcCccChHHHcCCcCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHHhhhHH
Confidence 234568999999999876 68999999999999999999999999765332111111000 000000011
Q ss_pred hhHhhhchhc-ccCC-----HHHHHHHHHHHHHccccCCCCCCCHHhHHHH
Q 003836 728 LEALVENDLE-AMNN-----VTMLHRFVMVAFWCIQEDPSHRPTMRKVTQM 772 (792)
Q Consensus 728 ~~~~~~~~~~-~~~~-----~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~ 772 (792)
...++..... .... ......+.+|+.+||+.||++|||++|+++.
T Consensus 262 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~t~~e~L~h 312 (367)
T 2fst_X 262 ARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAH 312 (367)
T ss_dssp HHHHHHTSCCCCCCCHHHHTTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred HHHHHhccCCCCCCCHHHHCCCCCHHHHHHHHHhCCCCcccCcCHHHHhcC
Confidence 1111111000 0000 1224678899999999999999999999975
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-37 Score=340.46 Aligned_cols=250 Identities=11% Similarity=0.055 Sum_probs=178.2
Q ss_pred hhhhhcCccccceEEEeeecCCCceEEEEEEcccccc---cchHHHHHHHHHhccc--CCCCcccccc-------eeccC
Q 003836 504 GFKEELGRGAFGTVYKGFVNMGSSNHVAVKKLNSVFQ---DSEKEFKAEVNGIGQT--HHKNLVRLLG-------YCDEG 571 (792)
Q Consensus 504 ~~~~~lG~G~~g~Vy~g~~~~~~~~~vavK~~~~~~~---~~~~~~~~Ei~~l~~l--~h~niv~l~g-------~~~~~ 571 (792)
.+.+.||+|+||.||+|... .+++.||||++..... ...+.+.+|+.+++.+ +||||++++. ++...
T Consensus 65 ~~~~~lG~G~~g~V~~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~hp~iv~~~~~~~~p~d~~~~~ 143 (371)
T 3q60_A 65 KLVEPLRVGDRSVVFLVRDV-ERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEARDRRRLLLPSDAVAVQ 143 (371)
T ss_dssp EEEEEEEECSSEEEEEEEET-TTTEEEEEEEEECCSTTHHHHHHHHHHHHHHHHHHHC----------CBCCCCEEEEET
T ss_pred eeeeeccCCCCEEEEEEEEC-CCCceeEEEEEEecccccccHHHHHHHHHHHHHHhcccChhhhhhceeEEeeehheecC
Confidence 34578999999999999754 4568999999987432 3345677885544444 6999888553 33222
Q ss_pred -----------------CceEEEEEeccCCCccccccCC-CCCchhHH------HHHHHHHHHHHHHHhhccCCCeEecC
Q 003836 572 -----------------QNRLLVYEFMSNGTVASFLFGD-SKPNWKLR------TEIAMGIAGGLFYLHEECCTQIIHCD 627 (792)
Q Consensus 572 -----------------~~~~lV~E~~~~gsL~~~l~~~-~~l~~~~~------~~i~~~ia~gL~yLH~~~~~~ivH~d 627 (792)
...+|||||++ |+|.+++... ..+.+..+ ..++.||+.||+|||++ +|+|||
T Consensus 144 ~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~~vk~~i~~qi~~aL~~LH~~---~ivHrD 219 (371)
T 3q60_A 144 SQPPFAQLSPGQDDYAVANYLLLMPAAS-VDLELLFSTLDFVYVFRGDEGILALHILTAQLIRLAANLQSK---GLVHGH 219 (371)
T ss_dssp TSCSSSBCSCC---CCEEEEEEEECCCS-EEHHHHHHHHHHSCCCCHHHHHHHHHHHHHHHHHHHHHHHHT---TEEETT
T ss_pred CCCCeeeccCCcccceeeeEEEEecCCC-CCHHHHHHHhccccchhhhhhhhhHHHHHHHHHHHHHHHHHC---CCccCc
Confidence 34799999999 8999999763 34556666 78889999999999998 999999
Q ss_pred CCCCcEEEcCCCCeEEeecCCCccccCCCCCccccccccCCccccccccc--CCCCcccceehHHHHHHHHHhcCcCCCc
Q 003836 628 IKPQNILLDDHYNARISDFGLAKLLTLDQSHTNTAIRGTKGYVAPEWFRN--MPITVKVDVYSYGVLLLEIICLRRNIDN 705 (792)
Q Consensus 628 ikp~NILl~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~k~DV~S~Gv~l~el~tg~~p~~~ 705 (792)
|||+|||++.++.+||+|||+++..... .....+|+.|+|||.+.+ ..++.++|||||||++|||++|+.||..
T Consensus 220 ikp~NIll~~~~~~kL~DFG~a~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~ 295 (371)
T 3q60_A 220 FTPDNLFIMPDGRLMLGDVSALWKVGTR----GPASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCLFLPFGL 295 (371)
T ss_dssp CSGGGEEECTTSCEEECCGGGEEETTCE----EEGGGSCGGGCCHHHHTCSEEECCHHHHHHHHHHHHHHHHHSSCSTTB
T ss_pred CCHHHEEECCCCCEEEEecceeeecCCC----ccCccCCcCCcChhhccCCCCCcCccccHHHHHHHHHHHHhCCCCCCC
Confidence 9999999999999999999999865321 113456799999999987 7899999999999999999999999976
Q ss_pred chhhhhhhhHHHHHHHhhcccchhHhhhchhcccCCHHHHHHHHHHHHHccccCCCCCCCHHhHHH
Q 003836 706 EISKVDKAILTDWAYDRYQERTLEALVENDLEAMNNVTMLHRFVMVAFWCIQEDPSHRPTMRKVTQ 771 (792)
Q Consensus 706 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~ 771 (792)
........ +.....................+..+.+++.+||+.||++|||+.|+++
T Consensus 296 ~~~~~~~~---------~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 352 (371)
T 3q60_A 296 VTPGIKGS---------WKRPSLRVPGTDSLAFGSCTPLPDFVKTLIGRFLNFDRRRRLLPLEAME 352 (371)
T ss_dssp CCTTCTTC---------CCBCCTTSCCCCSCCCTTSSCCCHHHHHHHHHHTCSSTTTCCCHHHHTT
T ss_pred cCcccccc---------hhhhhhhhccccccchhhccCCCHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 53221100 0000000001111111111234567889999999999999999999975
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-36 Score=329.68 Aligned_cols=264 Identities=20% Similarity=0.238 Sum_probs=198.3
Q ss_pred hhhhhhcCccccceEEEeeecCCCceEEEEEEcccccc-cchHHHHHHHHHhcccCCCCcccccceeccC-----CceEE
Q 003836 503 RGFKEELGRGAFGTVYKGFVNMGSSNHVAVKKLNSVFQ-DSEKEFKAEVNGIGQTHHKNLVRLLGYCDEG-----QNRLL 576 (792)
Q Consensus 503 ~~~~~~lG~G~~g~Vy~g~~~~~~~~~vavK~~~~~~~-~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~-----~~~~l 576 (792)
+.+.+.||+|+||.||++... .+++.||||++..... ...+.+.+|++++.+++||||+++++++... ...++
T Consensus 29 y~~~~~lG~G~~g~V~~~~~~-~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~i 107 (364)
T 3qyz_A 29 YTNLSYIGEGAYGMVCSAYDN-LNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDVYI 107 (364)
T ss_dssp EEEEEEEEECSSEEEEEEEET-TTTEEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCEEE
T ss_pred EEEEEEeecCCCeEEEEEEEC-CCCeEEEEEEeccccCcHHHHHHHHHHHHHHhcCCCCCccceeEEecCCccccceEEE
Confidence 445678999999999999654 4578999999975432 3346789999999999999999999998654 46899
Q ss_pred EEEeccCCCccccccCCCCCchhHHHHHHHHHHHHHHHHhhccCCCeEecCCCCCcEEEcCCCCeEEeecCCCccccCCC
Q 003836 577 VYEFMSNGTVASFLFGDSKPNWKLRTEIAMGIAGGLFYLHEECCTQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLDQ 656 (792)
Q Consensus 577 V~E~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dikp~NILl~~~~~~kl~Dfg~a~~~~~~~ 656 (792)
||||++ |+|.+++.. ..+++..+..++.||+.||+|||+. +|+||||||+|||++.++.+||+|||+++......
T Consensus 108 v~e~~~-~~L~~~l~~-~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~~ 182 (364)
T 3qyz_A 108 VQDLME-TDLYKLLKT-QHLSNDHICYFLYQILRGLKYIHSA---NVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDH 182 (364)
T ss_dssp EEECCS-EEHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTCEECCGGG
T ss_pred EEcccC-cCHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCChHhEEECCCCCEEEEeCcceEecCCCC
Confidence 999998 489888854 4689999999999999999999999 99999999999999999999999999998765433
Q ss_pred CCc--cccccccCCccccccccc-CCCCcccceehHHHHHHHHHhcCcCCCcchhhhhhhhHHHHH-------HHhhccc
Q 003836 657 SHT--NTAIRGTKGYVAPEWFRN-MPITVKVDVYSYGVLLLEIICLRRNIDNEISKVDKAILTDWA-------YDRYQER 726 (792)
Q Consensus 657 ~~~--~~~~~gt~~y~aPE~~~~-~~~~~k~DV~S~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~-------~~~~~~~ 726 (792)
... .....||+.|+|||.+.+ ..++.++|||||||++|||++|+.||...........+.... .......
T Consensus 183 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 262 (364)
T 3qyz_A 183 DHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINL 262 (364)
T ss_dssp CBCCTTCCCCSCGGGCCHHHHHTBCSCSTHHHHHHHHHHHHHHHHSSCSSCCSSGGGHHHHHHHHHCSCCHHHHHTCCCH
T ss_pred CccccccccccccCCCCCHHhcCCCCCCcchhHHHHHHHHHHHHHCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHhhhh
Confidence 222 234579999999998754 558999999999999999999999997654322111111000 0000000
Q ss_pred chhHhhhchh-cccC-----CHHHHHHHHHHHHHccccCCCCCCCHHhHHHH
Q 003836 727 TLEALVENDL-EAMN-----NVTMLHRFVMVAFWCIQEDPSHRPTMRKVTQM 772 (792)
Q Consensus 727 ~~~~~~~~~~-~~~~-----~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~ 772 (792)
.......... .... ......++.+++.+||+.||++|||++|+++.
T Consensus 263 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 314 (364)
T 3qyz_A 263 KARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAH 314 (364)
T ss_dssp HHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred hHHHHHHhcCCccCCCHHHhCCCCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 0000000000 0000 11234678899999999999999999999974
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.9e-37 Score=337.46 Aligned_cols=258 Identities=22% Similarity=0.259 Sum_probs=191.6
Q ss_pred hhhhhhcCccccceEEEeeecCCCceEEEEEEcccccccchHHHHHHHHHhcccCCCCcccccceecc------------
Q 003836 503 RGFKEELGRGAFGTVYKGFVNMGSSNHVAVKKLNSVFQDSEKEFKAEVNGIGQTHHKNLVRLLGYCDE------------ 570 (792)
Q Consensus 503 ~~~~~~lG~G~~g~Vy~g~~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~------------ 570 (792)
+.+.+.||+|+||+||+|... .+++.||||++.... ....+|++++++++||||+++++++..
T Consensus 9 y~~~~~lG~G~fg~V~~a~~~-~~~~~vAiK~~~~~~----~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~~ 83 (383)
T 3eb0_A 9 YSLGKTLGTGSFGIVCEVFDI-ESGKRFALKKVLQDP----RYKNRELDIMKVLDHVNIIKLVDYFYTTGDEEPKPPQPP 83 (383)
T ss_dssp EEEEEEEECC-CEEEEEEEET-TTCCEEEEEEEECCT----TSCCHHHHHHTTCCCTTBCCEEEEEEEC-----------
T ss_pred EEEEEEEEeccCEEEEEEEEC-CCCCEEEEEEEecCc----chHHHHHHHHHHcCCCCccchhheeeecCcccccccccc
Confidence 445678999999999999753 467899999986532 223479999999999999999999843
Q ss_pred --------------------------CCceEEEEEeccCCCcccccc----CCCCCchhHHHHHHHHHHHHHHHHhhccC
Q 003836 571 --------------------------GQNRLLVYEFMSNGTVASFLF----GDSKPNWKLRTEIAMGIAGGLFYLHEECC 620 (792)
Q Consensus 571 --------------------------~~~~~lV~E~~~~gsL~~~l~----~~~~l~~~~~~~i~~~ia~gL~yLH~~~~ 620 (792)
....++||||+++ +|.+.+. ....+++..+..++.||++||+|||+.
T Consensus 84 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~-~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~-- 160 (383)
T 3eb0_A 84 DDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVPD-TLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFIHSL-- 160 (383)
T ss_dssp --------------------------CCEEEEEECCCSE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTT--
T ss_pred cccccccccccccccccccccccCCCceEEEEEEecCCc-cHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC--
Confidence 3347899999985 7766654 456789999999999999999999998
Q ss_pred CCeEecCCCCCcEEEc-CCCCeEEeecCCCccccCCCCCccccccccCCcccccccccC-CCCcccceehHHHHHHHHHh
Q 003836 621 TQIIHCDIKPQNILLD-DHYNARISDFGLAKLLTLDQSHTNTAIRGTKGYVAPEWFRNM-PITVKVDVYSYGVLLLEIIC 698 (792)
Q Consensus 621 ~~ivH~dikp~NILl~-~~~~~kl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~k~DV~S~Gv~l~el~t 698 (792)
+|+||||||+|||++ .++.+||+|||+++...... ......+|+.|+|||.+.+. .++.++|||||||++|||++
T Consensus 161 -gi~H~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~ 237 (383)
T 3eb0_A 161 -GICHRDIKPQNLLVNSKDNTLKLCDFGSAKKLIPSE--PSVAYICSRFYRAPELMLGATEYTPSIDLWSIGCVFGELIL 237 (383)
T ss_dssp -TEECSCCCGGGEEEETTTTEEEECCCTTCEECCTTS--CCCCCCCCSSCCCHHHHTTCSSCCTHHHHHHHHHHHHHHHH
T ss_pred -cCccCccCHHHEEEcCCCCcEEEEECCCCcccCCCC--CCcCcccCCCccCHHHhcCCCCCCcchhhhhHHHHHHHHHh
Confidence 999999999999998 68899999999998764332 23345689999999998764 58999999999999999999
Q ss_pred cCcCCCcchhhhhhhhHHHHHH-------Hh----hcccchhHhhhchhcccCCHHHHHHHHHHHHHccccCCCCCCCHH
Q 003836 699 LRRNIDNEISKVDKAILTDWAY-------DR----YQERTLEALVENDLEAMNNVTMLHRFVMVAFWCIQEDPSHRPTMR 767 (792)
Q Consensus 699 g~~p~~~~~~~~~~~~~~~~~~-------~~----~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~ 767 (792)
|+.||...........+..... .. +.+.....+.........+...+.++.+++.+||+.||++|||+.
T Consensus 238 g~~pf~~~~~~~~~~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ 317 (383)
T 3eb0_A 238 GKPLFSGETSIDQLVRIIQIMGTPTKEQMIRMNPHYTEVRFPTLKAKDWRKILPEGTPSLAIDLLEQILRYEPDLRINPY 317 (383)
T ss_dssp SSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHHCTTC--CCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGGSCCHH
T ss_pred CCCCCCCCChHHHHHHHHHHhCCCCHHHHHHhCcccccccCCccCcccHHhhCCCCCCHHHHHHHHHHccCChhhCCCHH
Confidence 9999976543221111110000 00 000000000011111112233456789999999999999999999
Q ss_pred hHHH
Q 003836 768 KVTQ 771 (792)
Q Consensus 768 evl~ 771 (792)
|+++
T Consensus 318 e~l~ 321 (383)
T 3eb0_A 318 EAMA 321 (383)
T ss_dssp HHHT
T ss_pred HHhc
Confidence 9985
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-36 Score=331.06 Aligned_cols=260 Identities=23% Similarity=0.243 Sum_probs=188.9
Q ss_pred hhhhhcCccccceEEEeeecCCCceEEEEEEccccc--ccchHHHHHHHHHhcccCCCCcccccceeccCC------ceE
Q 003836 504 GFKEELGRGAFGTVYKGFVNMGSSNHVAVKKLNSVF--QDSEKEFKAEVNGIGQTHHKNLVRLLGYCDEGQ------NRL 575 (792)
Q Consensus 504 ~~~~~lG~G~~g~Vy~g~~~~~~~~~vavK~~~~~~--~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~------~~~ 575 (792)
.+.+.||+|+||.||+|.. ..+++.||||++.... ....+.+.+|+.++++++||||+++++++...+ ..+
T Consensus 28 ~~~~~lG~G~~g~V~~~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~~ 106 (371)
T 2xrw_A 28 QNLKPIGSGAQGIVCAAYD-AILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVY 106 (371)
T ss_dssp EEEEEEEECSSEEEEEEEE-TTTTEEEEEEEEECTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSCCSTTTCCEEE
T ss_pred eEeeeeEecCCEEEEEEEE-CCCCceEEEEEeccccCChHHHHHHHHHHHHHHhcCCCCccceEEeeccccccccccceE
Confidence 3457899999999999965 3457899999987532 234567889999999999999999999997654 789
Q ss_pred EEEEeccCCCccccccCCCCCchhHHHHHHHHHHHHHHHHhhccCCCeEecCCCCCcEEEcCCCCeEEeecCCCccccCC
Q 003836 576 LVYEFMSNGTVASFLFGDSKPNWKLRTEIAMGIAGGLFYLHEECCTQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLD 655 (792)
Q Consensus 576 lV~E~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dikp~NILl~~~~~~kl~Dfg~a~~~~~~ 655 (792)
+||||+++ +|.+++. ..+++..+..++.||+.||+|||+. +|+||||||+|||++.++.+||+|||+++.....
T Consensus 107 lv~e~~~~-~l~~~~~--~~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dlkp~NIl~~~~~~~kl~Dfg~a~~~~~~ 180 (371)
T 2xrw_A 107 IVMELMDA-NLCQVIQ--MELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTS 180 (371)
T ss_dssp EEEECCSE-EHHHHHH--SCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECCCCC-------
T ss_pred EEEEcCCC-CHHHHHh--hccCHHHHHHHHHHHHHHHHHHHHC---CeecccCCHHHEEEcCCCCEEEEEeecccccccc
Confidence 99999985 7877775 3588899999999999999999998 9999999999999999999999999999865432
Q ss_pred CCCccccccccCCcccccccccCCCCcccceehHHHHHHHHHhcCcCCCcchhhhhhhhHHH-------HHHHhh-----
Q 003836 656 QSHTNTAIRGTKGYVAPEWFRNMPITVKVDVYSYGVLLLEIICLRRNIDNEISKVDKAILTD-------WAYDRY----- 723 (792)
Q Consensus 656 ~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DV~S~Gv~l~el~tg~~p~~~~~~~~~~~~~~~-------~~~~~~----- 723 (792)
.......||+.|+|||.+.+..++.++|||||||++|||++|+.||...........+.. ......
T Consensus 181 --~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~ 258 (371)
T 2xrw_A 181 --FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKKLQPTVR 258 (371)
T ss_dssp -----------CTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHC-CCCCCHHHHTTSCHHHH
T ss_pred --cccCCceecCCccCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHHhhhHHH
Confidence 223345689999999999999999999999999999999999999976433211000000 000000
Q ss_pred ---------cccchhHhhhchhccc---CCHHHHHHHHHHHHHccccCCCCCCCHHhHHHH
Q 003836 724 ---------QERTLEALVENDLEAM---NNVTMLHRFVMVAFWCIQEDPSHRPTMRKVTQM 772 (792)
Q Consensus 724 ---------~~~~~~~~~~~~~~~~---~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~ 772 (792)
................ ........+.+|+.+||+.||++|||++|+++.
T Consensus 259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~h 319 (371)
T 2xrw_A 259 TYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQH 319 (371)
T ss_dssp HHHHSSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSGGGSCCHHHHHHS
T ss_pred HHHhhCccccccchhhhcccccCcccccccccccHHHHHHHHHHCcCChhhCCCHHHHhCC
Confidence 0000001110000000 112346789999999999999999999999975
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A | Back alignment and structure |
|---|
Probab=100.00 E-value=9.9e-37 Score=322.62 Aligned_cols=248 Identities=25% Similarity=0.340 Sum_probs=182.7
Q ss_pred hhhhhhcCccccceEEEeeecCCCceEEEEEEccccccc-c-hHHHHHHHHHhcccCCCCcccccceeccCCceEEEEEe
Q 003836 503 RGFKEELGRGAFGTVYKGFVNMGSSNHVAVKKLNSVFQD-S-EKEFKAEVNGIGQTHHKNLVRLLGYCDEGQNRLLVYEF 580 (792)
Q Consensus 503 ~~~~~~lG~G~~g~Vy~g~~~~~~~~~vavK~~~~~~~~-~-~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~lV~E~ 580 (792)
+.+.+.||+|+||+||++... .+++.||+|++...... . .+.+.++...++.++||||+++++++.+.+..++||||
T Consensus 9 y~~~~~lg~G~~g~V~~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~~~~~~~lv~e~ 87 (290)
T 3fme_A 9 LEPIMELGRGAYGVVEKMRHV-PSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTFYGALFREGDVWICMEL 87 (290)
T ss_dssp EEEEEEEEECSSEEEEEEEET-TTTEEEEEEEEC---CHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSSEEEEEEC
T ss_pred hhhHHhcCCCCCeEEEEEEec-CCCeEEEEEEeecccCcHHHHHHHHHHHHHHHhCCCCeEEEEeeeeeccCCEEEEEeh
Confidence 345578999999999999753 45789999999754222 2 23344555568889999999999999999999999999
Q ss_pred ccCCCccccccC----CCCCchhHHHHHHHHHHHHHHHHhhccCCCeEecCCCCCcEEEcCCCCeEEeecCCCccccCCC
Q 003836 581 MSNGTVASFLFG----DSKPNWKLRTEIAMGIAGGLFYLHEECCTQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLDQ 656 (792)
Q Consensus 581 ~~~gsL~~~l~~----~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dikp~NILl~~~~~~kl~Dfg~a~~~~~~~ 656 (792)
+++ +|.+++.. ...+++..+..++.||+.||+|||++ .+|+||||||+|||++.++.+||+|||+++......
T Consensus 88 ~~~-~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~--~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~ 164 (290)
T 3fme_A 88 MDT-SLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSK--LSVIHRDVKPSNVLINALGQVKMCDFGISGYLVDDV 164 (290)
T ss_dssp CSE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHH--SCCCCCCCSGGGCEECTTCCEEBCCC----------
T ss_pred hcc-chHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhc--CCeecCCCCHHHEEECCCCCEEEeecCCcccccccc
Confidence 984 88777643 46789999999999999999999985 389999999999999999999999999998764332
Q ss_pred CCccccccccCCccccccc----ccCCCCcccceehHHHHHHHHHhcCcCCCcchhhhhhhhHHHHHHHhhcccchhHhh
Q 003836 657 SHTNTAIRGTKGYVAPEWF----RNMPITVKVDVYSYGVLLLEIICLRRNIDNEISKVDKAILTDWAYDRYQERTLEALV 732 (792)
Q Consensus 657 ~~~~~~~~gt~~y~aPE~~----~~~~~~~k~DV~S~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 732 (792)
. .....||+.|+|||.+ .+..++.++||||||+++|||++|+.||......... +....
T Consensus 165 ~--~~~~~~t~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~---------------~~~~~ 227 (290)
T 3fme_A 165 A--KDIDAGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDSWGTPFQQ---------------LKQVV 227 (290)
T ss_dssp -------CCCCCCSCHHHHSCCTTC--CCHHHHHHHHHHHHHHHHHTSCSSCCCSCHHHH---------------HHHHH
T ss_pred c--ccccCCCccccChhhcChhhcCcCCCcHHHHHHHHHHHHHHHHCCCCccccCchHHH---------------HHHHh
Confidence 2 2234689999999996 5667899999999999999999999999753221110 01111
Q ss_pred hchhcccCCHHHHHHHHHHHHHccccCCCCCCCHHhHHH
Q 003836 733 ENDLEAMNNVTMLHRFVMVAFWCIQEDPSHRPTMRKVTQ 771 (792)
Q Consensus 733 ~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~ 771 (792)
............+.++.+++.+||+.||++|||++|+++
T Consensus 228 ~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~e~l~ 266 (290)
T 3fme_A 228 EEPSPQLPADKFSAEFVDFTSQCLKKNSKERPTYPELMQ 266 (290)
T ss_dssp HSCCCCCCTTTSCHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred ccCCCCcccccCCHHHHHHHHHHhhcChhhCcCHHHHHh
Confidence 111111112234567889999999999999999999987
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-36 Score=328.16 Aligned_cols=269 Identities=22% Similarity=0.247 Sum_probs=192.0
Q ss_pred HHHHHHHhhh--hhhcCccccceEEEeeecCCCceEEEEEEccccccc-----------chHHHHHHHHHhcccCCCCcc
Q 003836 496 KELVEVTRGF--KEELGRGAFGTVYKGFVNMGSSNHVAVKKLNSVFQD-----------SEKEFKAEVNGIGQTHHKNLV 562 (792)
Q Consensus 496 ~el~~~~~~~--~~~lG~G~~g~Vy~g~~~~~~~~~vavK~~~~~~~~-----------~~~~~~~Ei~~l~~l~h~niv 562 (792)
.++.....++ .+.||+|+||.||+|... .++.||||++...... ..+.+.+|++++++++||||+
T Consensus 15 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv 92 (362)
T 3pg1_A 15 AELHAMQSPYTVQRFISSGSYGAVCAGVDS--EGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHHPNIL 92 (362)
T ss_dssp HHHHHTTCSCEEEEEEEEETTEEEEEEECT--TSCEEEEEEECEECCTTSCEEGGGSHHHHHHHHHHHHHHHHCCCTTBC
T ss_pred HHHHHhccceEEeEEeccCCCEEEEEEECC--CCCeEEEEeccccCCccchhhhhhhhhHHHHHHHHHHHHHhCCCcCcc
Confidence 4444444443 478999999999999754 3678999998653222 137899999999999999999
Q ss_pred cccceec-----cCCceEEEEEeccCCCccccccCC-CCCchhHHHHHHHHHHHHHHHHhhccCCCeEecCCCCCcEEEc
Q 003836 563 RLLGYCD-----EGQNRLLVYEFMSNGTVASFLFGD-SKPNWKLRTEIAMGIAGGLFYLHEECCTQIIHCDIKPQNILLD 636 (792)
Q Consensus 563 ~l~g~~~-----~~~~~~lV~E~~~~gsL~~~l~~~-~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dikp~NILl~ 636 (792)
++++++. .....++||||++ |+|.+++... ..+++..+..++.||+.||.|||+. +|+||||||+|||++
T Consensus 93 ~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dlkp~NIl~~ 168 (362)
T 3pg1_A 93 GLRDIFVHFEEPAMHKLYLVTELMR-TDLAQVIHDQRIVISPQHIQYFMYHILLGLHVLHEA---GVVHRDLHPGNILLA 168 (362)
T ss_dssp CCSEEEEECCTTTCCEEEEEEECCS-EEHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEEC
T ss_pred ceeeeEEeccCCCcceEEEEEccCC-CCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHC---cCEecCCChHHEEEc
Confidence 9999983 3446899999998 5787777654 4789999999999999999999999 999999999999999
Q ss_pred CCCCeEEeecCCCccccCCCCCccccccccCCccccccccc-CCCCcccceehHHHHHHHHHhcCcCCCcchhhhhhhhH
Q 003836 637 DHYNARISDFGLAKLLTLDQSHTNTAIRGTKGYVAPEWFRN-MPITVKVDVYSYGVLLLEIICLRRNIDNEISKVDKAIL 715 (792)
Q Consensus 637 ~~~~~kl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~k~DV~S~Gv~l~el~tg~~p~~~~~~~~~~~~~ 715 (792)
.++.+||+|||+++...... ......+|+.|+|||.+.+ ..++.++|||||||++|||++|+.||...........+
T Consensus 169 ~~~~~kl~Dfg~~~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i 246 (362)
T 3pg1_A 169 DNNDITICDFNLAREDTADA--NKTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFRGSTFYNQLNKI 246 (362)
T ss_dssp TTCCEEECCTTC-----------------CGGGCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHH
T ss_pred CCCCEEEEecCccccccccc--ccceecccceecCcHHhcCCCCCCcHhHHHhHHHHHHHHHhCCCCCCCCCHHHHHHHH
Confidence 99999999999998543322 2234568999999999876 67999999999999999999999999765432111111
Q ss_pred HHHH-------HHhhcccchhHhhhchhcc-------cCCHHHHHHHHHHHHHccccCCCCCCCHHhHHHH
Q 003836 716 TDWA-------YDRYQERTLEALVENDLEA-------MNNVTMLHRFVMVAFWCIQEDPSHRPTMRKVTQM 772 (792)
Q Consensus 716 ~~~~-------~~~~~~~~~~~~~~~~~~~-------~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~ 772 (792)
.... ...+........+...... .........+.+++.+||+.||++|||++|+++.
T Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 317 (362)
T 3pg1_A 247 VEVVGTPKIEDVVMFSSPSARDYLRNSLSNVPARAWTAVVPTADPVALDLIAKMLEFNPQRRISTEQALRH 317 (362)
T ss_dssp HHHHCCCCHHHHHHTSCHHHHHHTTTCCCCCCCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred HHHcCCCChHHhhhccchhhhHHHHhhcccCChhhHHhhCCCCCHHHHHHHHHHhcCChhhCCCHHHHHcC
Confidence 0000 0000000111111111100 0111234678899999999999999999999974
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-36 Score=328.24 Aligned_cols=264 Identities=21% Similarity=0.292 Sum_probs=197.5
Q ss_pred hhhhhhcCccccceEEEeeecCCCceEEEEEEcccccc--cchHHHHHHHHHhccc---CCCCcccccceec-----cCC
Q 003836 503 RGFKEELGRGAFGTVYKGFVNMGSSNHVAVKKLNSVFQ--DSEKEFKAEVNGIGQT---HHKNLVRLLGYCD-----EGQ 572 (792)
Q Consensus 503 ~~~~~~lG~G~~g~Vy~g~~~~~~~~~vavK~~~~~~~--~~~~~~~~Ei~~l~~l---~h~niv~l~g~~~-----~~~ 572 (792)
+.+.+.||+|+||.||++.....+++.||+|++..... .....+.+|+.+++++ +||||+++++++. ...
T Consensus 13 y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~~ 92 (326)
T 1blx_A 13 YECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDRET 92 (326)
T ss_dssp EEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEECSSEE
T ss_pred eeeeeeecccccEEEEEEEecCCCCEEEEEEEeccCcccccCCchhhHHHHHHHhhhccCCCCeEeeeeeeeecccCCCc
Confidence 34557899999999999986545678999999865322 2234577788777766 8999999999987 566
Q ss_pred ceEEEEEeccCCCccccccCC--CCCchhHHHHHHHHHHHHHHHHhhccCCCeEecCCCCCcEEEcCCCCeEEeecCCCc
Q 003836 573 NRLLVYEFMSNGTVASFLFGD--SKPNWKLRTEIAMGIAGGLFYLHEECCTQIIHCDIKPQNILLDDHYNARISDFGLAK 650 (792)
Q Consensus 573 ~~~lV~E~~~~gsL~~~l~~~--~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dikp~NILl~~~~~~kl~Dfg~a~ 650 (792)
..++||||++ |+|.+++... ..+++..+..++.||+.||.|||+. +|+||||||+|||++.++.+||+|||+++
T Consensus 93 ~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---gi~H~dlkp~Nili~~~~~~kl~Dfg~~~ 168 (326)
T 1blx_A 93 KLTLVFEHVD-QDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLADFGLAR 168 (326)
T ss_dssp EEEEEEECCS-CBHHHHHHHSCTTCSCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEECSCCSCC
T ss_pred eEEEEEecCC-CCHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHC---CceeccCCHHHeEEcCCCCEEEecCcccc
Confidence 7899999998 6999998764 3489999999999999999999999 99999999999999999999999999998
Q ss_pred cccCCCCCccccccccCCcccccccccCCCCcccceehHHHHHHHHHhcCcCCCcchhhhhhhhHHHHHH----Hhhccc
Q 003836 651 LLTLDQSHTNTAIRGTKGYVAPEWFRNMPITVKVDVYSYGVLLLEIICLRRNIDNEISKVDKAILTDWAY----DRYQER 726 (792)
Q Consensus 651 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DV~S~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~----~~~~~~ 726 (792)
...... ......||+.|+|||.+.+..++.++||||||+++|||++|+.||...........+..... ..+...
T Consensus 169 ~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 246 (326)
T 1blx_A 169 IYSFQM--ALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPRD 246 (326)
T ss_dssp CCCGGG--GGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCGGGSCTT
T ss_pred cccCCC--CccccccccceeCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHcCCCCcccCccc
Confidence 654322 23345689999999999999999999999999999999999999976543211111100000 000000
Q ss_pred -ch-hHhhhc---hhcccCCHHHHHHHHHHHHHccccCCCCCCCHHhHHHH
Q 003836 727 -TL-EALVEN---DLEAMNNVTMLHRFVMVAFWCIQEDPSHRPTMRKVTQM 772 (792)
Q Consensus 727 -~~-~~~~~~---~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~ 772 (792)
.. ...... ..........+..+.+++.+||+.||++|||+.|+++.
T Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h 297 (326)
T 1blx_A 247 VALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSH 297 (326)
T ss_dssp CSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred cccchhhhcccCcchhhhccccCCHHHHHHHHHHcCCCcccCCCHHHHhcC
Confidence 00 000000 00001112345678899999999999999999999964
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-36 Score=319.57 Aligned_cols=248 Identities=27% Similarity=0.388 Sum_probs=189.2
Q ss_pred hhhhhhcCccccceEEEeeecCCCceEEEEEEcccccccchHHHHHHHHHhcccCCCCcccccceecc------------
Q 003836 503 RGFKEELGRGAFGTVYKGFVNMGSSNHVAVKKLNSVFQDSEKEFKAEVNGIGQTHHKNLVRLLGYCDE------------ 570 (792)
Q Consensus 503 ~~~~~~lG~G~~g~Vy~g~~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~------------ 570 (792)
+.+.+.||+|+||.||+|... .+++.||||++... ....+.+.+|+.++++++||||+++++++.+
T Consensus 8 y~~~~~lg~G~~g~V~~~~~~-~~~~~vaiK~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~~ 85 (303)
T 1zy4_A 8 FEEIAVLGQGAFGQVVKARNA-LDSRYYAIKKIRHT-EEKLSTILSEVMLLASLNHQYVVRYYAAWLERRNFVKPMTAVK 85 (303)
T ss_dssp EEEEEEEEECSSEEEEEEEET-TTCCEEEEEEEEEE-HHHHHHHHHHHHHHTTCCCTTBCCEEEEEEECCCCCC------
T ss_pred chhhheeccCCcEEEEEEEEc-CCCeEEEEEEEecc-HHHHHHHHHHHHHHHhcCchHHHHHHHHHHhhcchhhhhcccc
Confidence 445578999999999999754 45679999998653 3445788999999999999999999998754
Q ss_pred -CCceEEEEEeccCCCccccccCC-CCCchhHHHHHHHHHHHHHHHHhhccCCCeEecCCCCCcEEEcCCCCeEEeecCC
Q 003836 571 -GQNRLLVYEFMSNGTVASFLFGD-SKPNWKLRTEIAMGIAGGLFYLHEECCTQIIHCDIKPQNILLDDHYNARISDFGL 648 (792)
Q Consensus 571 -~~~~~lV~E~~~~gsL~~~l~~~-~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dikp~NILl~~~~~~kl~Dfg~ 648 (792)
....++||||+++|+|.+++... ..+++..+..++.||+.||+|||++ +|+||||||+|||++.++.+||+|||+
T Consensus 86 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~---~i~H~dlkp~Nil~~~~~~~kl~dfg~ 162 (303)
T 1zy4_A 86 KKSTLFIQMEYCENGTLYDLIHSENLNQQRDEYWRLFRQILEALSYIHSQ---GIIHRDLKPMNIFIDESRNVKIGDFGL 162 (303)
T ss_dssp CEEEEEEEEECCCSCBHHHHHHHSCGGGCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECCCCC
T ss_pred cCCceEEEEecCCCCCHHHhhhccccccchHHHHHHHHHHHHHHHHHHhC---CeecccCCHHhEEEcCCCCEEEeeCcc
Confidence 45678999999999999999754 4577889999999999999999999 999999999999999999999999999
Q ss_pred CccccCCC-------------CCccccccccCCcccccccccC-CCCcccceehHHHHHHHHHhcCcCCCcchhhhhhhh
Q 003836 649 AKLLTLDQ-------------SHTNTAIRGTKGYVAPEWFRNM-PITVKVDVYSYGVLLLEIICLRRNIDNEISKVDKAI 714 (792)
Q Consensus 649 a~~~~~~~-------------~~~~~~~~gt~~y~aPE~~~~~-~~~~k~DV~S~Gv~l~el~tg~~p~~~~~~~~~~~~ 714 (792)
++...... ........|++.|+|||.+.+. .++.++||||||+++|||++ |+........ .
T Consensus 163 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~---p~~~~~~~~~--~ 237 (303)
T 1zy4_A 163 AKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIY---PFSTGMERVN--I 237 (303)
T ss_dssp CSCTTC-------------------------CTTSCHHHHTSCSCCCTHHHHHHHHHHHHHHHS---CCSSHHHHHH--H
T ss_pred hhhcccccchhccccccccccccccccCCCcccccCcccccCCCCCcchhhHHHHHHHHHHHHh---ccCCchhHHH--H
Confidence 98764321 1122345689999999999764 78999999999999999998 5543221110 0
Q ss_pred HHHHHHHhhcccchhHhhhchhcccCCHHHHHHHHHHHHHccccCCCCCCCHHhHHH
Q 003836 715 LTDWAYDRYQERTLEALVENDLEAMNNVTMLHRFVMVAFWCIQEDPSHRPTMRKVTQ 771 (792)
Q Consensus 715 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~ 771 (792)
. ..... .........+...+..+.+++.+||+.||.+|||++|+++
T Consensus 238 ~-----~~~~~------~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~ 283 (303)
T 1zy4_A 238 L-----KKLRS------VSIEFPPDFDDNKMKVEKKIIRLLIDHDPNKRPGARTLLN 283 (303)
T ss_dssp H-----HHHHS------TTCCCCTTCCTTTSHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred H-----Hhccc------cccccCccccccchHHHHHHHHHHHhcCcccCcCHHHHhC
Confidence 0 00000 0011112223344567889999999999999999999998
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-36 Score=335.77 Aligned_cols=259 Identities=22% Similarity=0.222 Sum_probs=189.4
Q ss_pred hhhhhhcCccccceEEEeeecCCCceEEEEEEcccccccchHHHHHHHHHhcccCCCCcccccceeccCC------ceEE
Q 003836 503 RGFKEELGRGAFGTVYKGFVNMGSSNHVAVKKLNSVFQDSEKEFKAEVNGIGQTHHKNLVRLLGYCDEGQ------NRLL 576 (792)
Q Consensus 503 ~~~~~~lG~G~~g~Vy~g~~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~------~~~l 576 (792)
+.+.+.||+|+||+||+|.... + ..+|+|++..... ...+|++++++++||||+++++++.... ..++
T Consensus 42 Y~~~~~lG~G~~g~V~~a~~~~-~-~~~aikk~~~~~~----~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~~l 115 (394)
T 4e7w_A 42 YTNCKVIGNGSFGVVFQAKLVE-S-DEVAIKKVLQDKR----FKNRELQIMRIVKHPNVVDLKAFFYSNGDKKDEVFLNL 115 (394)
T ss_dssp EEEEEEEEEETTEEEEEEEETT-T-EEEEEEEEECCTT----SCCHHHHHHHTCCCTTBCCEEEEEEEESSSSSCEEEEE
T ss_pred EEEeEEEeeCCCeEEEEEEECC-C-CeEEEEEEecCcc----hHHHHHHHHHhCCCCCcceEEEEEEecCCCCCceEEEE
Confidence 3456789999999999997643 3 3489998864322 2347999999999999999999985433 3789
Q ss_pred EEEeccCCCccccc---cCCCCCchhHHHHHHHHHHHHHHHHhhccCCCeEecCCCCCcEEEc-CCCCeEEeecCCCccc
Q 003836 577 VYEFMSNGTVASFL---FGDSKPNWKLRTEIAMGIAGGLFYLHEECCTQIIHCDIKPQNILLD-DHYNARISDFGLAKLL 652 (792)
Q Consensus 577 V~E~~~~gsL~~~l---~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dikp~NILl~-~~~~~kl~Dfg~a~~~ 652 (792)
||||++++.+.... .....+++..+..++.||++||+|||+. +|+||||||+|||++ .++.+||+|||+++..
T Consensus 116 v~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~Nill~~~~~~~kL~DFG~a~~~ 192 (394)
T 4e7w_A 116 VLEYVPETVYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIHSI---GICHRDIKPQNLLLDPPSGVLKLIDFGSAKIL 192 (394)
T ss_dssp EEECCSEEHHHHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEETTTTEEEECCCTTCEEC
T ss_pred EeeccCccHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHC---CccCCCCCHHHEEEcCCCCcEEEeeCCCcccc
Confidence 99999875444332 2346789999999999999999999998 999999999999999 7999999999999876
Q ss_pred cCCCCCccccccccCCcccccccccC-CCCcccceehHHHHHHHHHhcCcCCCcchhhhhhhhHHHHH---------H--
Q 003836 653 TLDQSHTNTAIRGTKGYVAPEWFRNM-PITVKVDVYSYGVLLLEIICLRRNIDNEISKVDKAILTDWA---------Y-- 720 (792)
Q Consensus 653 ~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~k~DV~S~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~---------~-- 720 (792)
.... ......+|+.|+|||.+.+. .++.++|||||||++|||++|+.||...........+.... .
T Consensus 193 ~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~p~~~~~~~~~ 270 (394)
T 4e7w_A 193 IAGE--PNVSYICSRYYRAPELIFGATNYTTNIDIWSTGCVMAELMQGQPLFPGESGIDQLVEIIKVLGTPSREQIKTMN 270 (394)
T ss_dssp CTTC--CCCSSCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHHC
T ss_pred cCCC--CCcccccCcCccCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhhC
Confidence 4332 22345689999999998764 58999999999999999999999997654322111111000 0
Q ss_pred HhhcccchhHhhhchhcccCCHHHHHHHHHHHHHccccCCCCCCCHHhHHHH
Q 003836 721 DRYQERTLEALVENDLEAMNNVTMLHRFVMVAFWCIQEDPSHRPTMRKVTQM 772 (792)
Q Consensus 721 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~ 772 (792)
..+.+...................+.++.+++.+||+.||++|||+.|+++.
T Consensus 271 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 322 (394)
T 4e7w_A 271 PNYMEHKFPQIRPHPFSKVFRPRTPPDAIDLISRLLEYTPSARLTAIEALCH 322 (394)
T ss_dssp GGGSSSCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGGSCCHHHHHTS
T ss_pred hhhhhhccccccCCcHHHhccccCCHHHHHHHHHHhCCChhhCCCHHHHhcC
Confidence 0000000000000001111122245688999999999999999999999975
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-36 Score=326.79 Aligned_cols=245 Identities=25% Similarity=0.377 Sum_probs=190.3
Q ss_pred hhhhcCccccceEEEeeecCCCceEEEEEEcccccccchHHHHHHHHHhccc-CCCCcccccceecc------CCceEEE
Q 003836 505 FKEELGRGAFGTVYKGFVNMGSSNHVAVKKLNSVFQDSEKEFKAEVNGIGQT-HHKNLVRLLGYCDE------GQNRLLV 577 (792)
Q Consensus 505 ~~~~lG~G~~g~Vy~g~~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l-~h~niv~l~g~~~~------~~~~~lV 577 (792)
+.+.||+|+||.||+|... .+++.||||++... ....+.+.+|+.+++++ +||||+++++++.. ....++|
T Consensus 28 ~~~~lg~G~~g~Vy~~~~~-~~~~~vaiK~~~~~-~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~~~~~lv 105 (326)
T 2x7f_A 28 LVELVGNGTYGQVYKGRHV-KTGQLAAIKVMDVT-GDEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMDDQLWLV 105 (326)
T ss_dssp EEEEEEEETTEEEEEEEET-TTCCEEEEEEEECC-SSTTHHHHHHHHHHHHHCCSTTBCCEEEEEEECC--CCCCEEEEE
T ss_pred EEEEeccCCCEEEEEEEEC-CCCCeEEEEEEecC-cccHHHHHHHHHHHHhccCCCCeeeeeeEEeeccCccccceEEEE
Confidence 4578999999999999764 45679999998654 34467899999999999 89999999999976 4678999
Q ss_pred EEeccCCCccccccCC--CCCchhHHHHHHHHHHHHHHHHhhccCCCeEecCCCCCcEEEcCCCCeEEeecCCCccccCC
Q 003836 578 YEFMSNGTVASFLFGD--SKPNWKLRTEIAMGIAGGLFYLHEECCTQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLD 655 (792)
Q Consensus 578 ~E~~~~gsL~~~l~~~--~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dikp~NILl~~~~~~kl~Dfg~a~~~~~~ 655 (792)
|||+++++|.+++... ..+++..+..++.||+.||.|||+. +|+|+||||+|||++.++.+||+|||++......
T Consensus 106 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~ 182 (326)
T 2x7f_A 106 MEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQH---KVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRT 182 (326)
T ss_dssp EECCTTEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEECTTCCEEECCCTTTC-----
T ss_pred EEcCCCCcHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCcHHHEEEcCCCCEEEeeCcCceecCcC
Confidence 9999999999999754 4688999999999999999999998 9999999999999999999999999999875432
Q ss_pred CCCccccccccCCcccccccc-----cCCCCcccceehHHHHHHHHHhcCcCCCcchhhhhhhhHHHHHHHhhcccchhH
Q 003836 656 QSHTNTAIRGTKGYVAPEWFR-----NMPITVKVDVYSYGVLLLEIICLRRNIDNEISKVDKAILTDWAYDRYQERTLEA 730 (792)
Q Consensus 656 ~~~~~~~~~gt~~y~aPE~~~-----~~~~~~k~DV~S~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 730 (792)
.. ......|++.|+|||.+. ...++.++||||||+++|||++|+.||.......... .
T Consensus 183 ~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~---~------------- 245 (326)
T 2x7f_A 183 VG-RRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALF---L------------- 245 (326)
T ss_dssp ---------CCGGGCCHHHHC--------CCTTHHHHHHHHHHHHHHHSSCTTTTSCHHHHHH---H-------------
T ss_pred cc-ccccccCCccccChhhhccccccCcCCCccchHHHHHHHHHHHHhCCCCCCCCcHHHHHH---H-------------
Confidence 21 223346899999999986 5678999999999999999999999996543221100 0
Q ss_pred hhhchhcccCCHHHHHHHHHHHHHccccCCCCCCCHHhHHH
Q 003836 731 LVENDLEAMNNVTMLHRFVMVAFWCIQEDPSHRPTMRKVTQ 771 (792)
Q Consensus 731 ~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~ 771 (792)
+.............+..+.+++.+||+.||.+||+++|+++
T Consensus 246 ~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 286 (326)
T 2x7f_A 246 IPRNPAPRLKSKKWSKKFQSFIESCLVKNHSQRPATEQLMK 286 (326)
T ss_dssp HHHSCCCCCSCSCSCHHHHHHHHHHCCSSGGGSCCHHHHHT
T ss_pred hhcCccccCCccccCHHHHHHHHHHhccChhhCCCHHHHhh
Confidence 00000001111223467889999999999999999999987
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.9e-36 Score=319.77 Aligned_cols=262 Identities=20% Similarity=0.250 Sum_probs=191.4
Q ss_pred hhhhhcCccccceEEEeeecCCCceEEEEEEcccccccchHHHHHHHHHhcccCCCCcccccceec--------------
Q 003836 504 GFKEELGRGAFGTVYKGFVNMGSSNHVAVKKLNSVFQDSEKEFKAEVNGIGQTHHKNLVRLLGYCD-------------- 569 (792)
Q Consensus 504 ~~~~~lG~G~~g~Vy~g~~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~-------------- 569 (792)
...+.||+|+||.||+|... .+++.||+|++........+.+.+|++++++++||||+++++++.
T Consensus 14 ~~~~~lg~G~~g~V~~~~~~-~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~~~ 92 (320)
T 2i6l_A 14 MDLKPLGCGGNGLVFSAVDN-DCDKRVAIKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVFEILGPSGSQLTDDVGSLT 92 (320)
T ss_dssp EEEEECC-----CEEEEEET-TTTEEEEEEEEECCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEECTTSCBCCC----CC
T ss_pred eEEEEeccCCCeEEEEEEEC-CCCeEEEEEEEecCChHHHHHHHHHHHHHHhcCCCCeeEEEEecccccccccccccccc
Confidence 34578999999999999754 457899999998765666788999999999999999999998873
Q ss_pred cCCceEEEEEeccCCCccccccCCCCCchhHHHHHHHHHHHHHHHHhhccCCCeEecCCCCCcEEEc-CCCCeEEeecCC
Q 003836 570 EGQNRLLVYEFMSNGTVASFLFGDSKPNWKLRTEIAMGIAGGLFYLHEECCTQIIHCDIKPQNILLD-DHYNARISDFGL 648 (792)
Q Consensus 570 ~~~~~~lV~E~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dikp~NILl~-~~~~~kl~Dfg~ 648 (792)
+....++||||++ |+|.+++.. ..+++..+..++.||+.||+|||+. +|+||||||+|||++ +++.+||+|||+
T Consensus 93 ~~~~~~lv~e~~~-~~L~~~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~~kl~Dfg~ 167 (320)
T 2i6l_A 93 ELNSVYIVQEYME-TDLANVLEQ-GPLLEEHARLFMYQLLRGLKYIHSA---NVLHRDLKPANLFINTEDLVLKIGDFGL 167 (320)
T ss_dssp SCSEEEEEEECCS-EEHHHHHTT-CCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCSGGGEEEETTTTEEEECCCTT
T ss_pred ccCceeEEeeccC-CCHHHHhhc-CCccHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEEcCCCCeEEEccCcc
Confidence 4467899999998 699999864 5688999999999999999999998 999999999999997 567999999999
Q ss_pred CccccCCCC--CccccccccCCccccccccc-CCCCcccceehHHHHHHHHHhcCcCCCcchhhhhhhhHHHH-------
Q 003836 649 AKLLTLDQS--HTNTAIRGTKGYVAPEWFRN-MPITVKVDVYSYGVLLLEIICLRRNIDNEISKVDKAILTDW------- 718 (792)
Q Consensus 649 a~~~~~~~~--~~~~~~~gt~~y~aPE~~~~-~~~~~k~DV~S~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~------- 718 (792)
++....... .......+++.|+|||.+.. ..++.++||||||+++|||++|+.||...............
T Consensus 168 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~ 247 (320)
T 2i6l_A 168 ARIMDPHYSHKGHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLFAGAHELEQMQLILESIPVVHEE 247 (320)
T ss_dssp CBCC--------CCCGGGSCCTTCCHHHHHCTTCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHSCCCCHH
T ss_pred ccccCCCcccccccccccccccccCcHHhcCcccCCchhhhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCchh
Confidence 987643222 12233457899999998865 67899999999999999999999999765432111111000
Q ss_pred HHHhhcccchhHhhhchhc-cc-----CCHHHHHHHHHHHHHccccCCCCCCCHHhHHHH
Q 003836 719 AYDRYQERTLEALVENDLE-AM-----NNVTMLHRFVMVAFWCIQEDPSHRPTMRKVTQM 772 (792)
Q Consensus 719 ~~~~~~~~~~~~~~~~~~~-~~-----~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~ 772 (792)
...... ..+...+..... .. .....+.++.+++.+||+.||++|||++|+++.
T Consensus 248 ~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 306 (320)
T 2i6l_A 248 DRQELL-SVIPVYIRNDMTEPHKPLTQLLPGISREAVDFLEQILTFSPMDRLTAEEALSH 306 (320)
T ss_dssp HHHHHH-TTSCHHHHHHTTSCCCCHHHHSTTCCHHHHHHHHTTSCSSGGGSCCHHHHHTS
T ss_pred hhhhhh-hcCcccccccccCCCCChhHhcchhhHHHHHHHHHHcCCCccccCCHHHHhCC
Confidence 000000 000000111100 00 011245678999999999999999999999873
|
| >4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8.1e-36 Score=327.39 Aligned_cols=258 Identities=21% Similarity=0.255 Sum_probs=193.2
Q ss_pred hhhhhcCccccceEEEeeecCCCceEEEEEEcccccc--cchHHHHHHHHHhcccCCCCcccccceeccCCce------E
Q 003836 504 GFKEELGRGAFGTVYKGFVNMGSSNHVAVKKLNSVFQ--DSEKEFKAEVNGIGQTHHKNLVRLLGYCDEGQNR------L 575 (792)
Q Consensus 504 ~~~~~lG~G~~g~Vy~g~~~~~~~~~vavK~~~~~~~--~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~------~ 575 (792)
.+.+.||+|+||+||+|... .+++.||||++..... ...+.+.+|+.++++++||||+++++++...+.. +
T Consensus 45 ~~~~~lG~G~~g~Vy~~~~~-~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~~ 123 (371)
T 4exu_A 45 VSPTHVGSGAYGSVCSAIDK-RSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFYDFY 123 (371)
T ss_dssp EEEEEEEECSSEEEEEEEET-TTTEEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSSTTCCCCE
T ss_pred EEEeEEecCCCeEEEEEEEC-CCCCEEEEEEecccccchhHHHHHHHHHHHHHhcCCCCchhhhhheeccCCcccceeEE
Confidence 34578999999999999654 5678999999976432 2356789999999999999999999999877655 9
Q ss_pred EEEEeccCCCccccccCCCCCchhHHHHHHHHHHHHHHHHhhccCCCeEecCCCCCcEEEcCCCCeEEeecCCCccccCC
Q 003836 576 LVYEFMSNGTVASFLFGDSKPNWKLRTEIAMGIAGGLFYLHEECCTQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLD 655 (792)
Q Consensus 576 lV~E~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dikp~NILl~~~~~~kl~Dfg~a~~~~~~ 655 (792)
+||||++ ++|.+++. ..+++..+..++.||+.||+|||+. +|+||||||+|||++.++.+||+|||+++.....
T Consensus 124 lv~e~~~-~~l~~~~~--~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~~~~ 197 (371)
T 4exu_A 124 LVMPFMQ-TDLQKIMG--MEFSEEKIQYLVYQMLKGLKYIHSA---GVVHRDLKPGNLAVNEDCELKILDFGLARHADAE 197 (371)
T ss_dssp EEEECCC-EEHHHHTT--SCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECSTTCC------
T ss_pred EEEcccc-ccHHHHhh--cCCCHHHHHHHHHHHHHHHHHHHHC---CCcCCCcCHHHeEECCCCCEEEEecCcccccccC
Confidence 9999998 58888774 3489999999999999999999999 9999999999999999999999999999865322
Q ss_pred CCCccccccccCCccccccccc-CCCCcccceehHHHHHHHHHhcCcCCCcchhhhhhhhHHHH-------HHHhhcccc
Q 003836 656 QSHTNTAIRGTKGYVAPEWFRN-MPITVKVDVYSYGVLLLEIICLRRNIDNEISKVDKAILTDW-------AYDRYQERT 727 (792)
Q Consensus 656 ~~~~~~~~~gt~~y~aPE~~~~-~~~~~k~DV~S~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~-------~~~~~~~~~ 727 (792)
.....||+.|+|||.+.+ ..++.++|||||||++|||++|+.||............... .........
T Consensus 198 ----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 273 (371)
T 4exu_A 198 ----MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGTEFVQKLNDKA 273 (371)
T ss_dssp ------CTTCCCTTSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHHHTTCSCHH
T ss_pred ----cCCcccCccccCHHHhcCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCcHHHHHHhhhhh
Confidence 234568999999999877 78999999999999999999999999765322111111000 000000000
Q ss_pred hhHhhhchhccc------CCHHHHHHHHHHHHHccccCCCCCCCHHhHHHH
Q 003836 728 LEALVENDLEAM------NNVTMLHRFVMVAFWCIQEDPSHRPTMRKVTQM 772 (792)
Q Consensus 728 ~~~~~~~~~~~~------~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~ 772 (792)
............ .....+..+.+|+.+||+.||++|||++|+++.
T Consensus 274 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 324 (371)
T 4exu_A 274 AKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTH 324 (371)
T ss_dssp HHHHHHHSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSCTTTSCCHHHHHTS
T ss_pred hhhhhhccCCCcchhHHHhccccChHHHHHHHHHCCCChhhcCCHHHHhcC
Confidence 011110000000 011235678999999999999999999999975
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-36 Score=330.87 Aligned_cols=263 Identities=17% Similarity=0.224 Sum_probs=195.8
Q ss_pred hhhhhcCccccceEEEeeecCCCceEEEEEEcccccc-cchHHHHHHHHHhcccCCCCcccccceeccC-----CceEEE
Q 003836 504 GFKEELGRGAFGTVYKGFVNMGSSNHVAVKKLNSVFQ-DSEKEFKAEVNGIGQTHHKNLVRLLGYCDEG-----QNRLLV 577 (792)
Q Consensus 504 ~~~~~lG~G~~g~Vy~g~~~~~~~~~vavK~~~~~~~-~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~-----~~~~lV 577 (792)
.+.+.||+|+||.||+|... .+++.||||++..... .....+.+|++++++++||||+++++++... ...++|
T Consensus 14 ~~~~~lg~G~~g~V~~~~~~-~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv 92 (353)
T 2b9h_A 14 QLKSLLGEGAYGVVCSATHK-PTGEIVAIKKIEPFDKPLFALRTLREIKILKHFKHENIITIFNIQRPDSFENFNEVYII 92 (353)
T ss_dssp EEEEEEEECSSEEEEEEEET-TTTEEEEEEEECCCSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCSTTCCCEEEE
T ss_pred EEeeEEcCCCCeEEEEEEEC-CCCcEEEEEeecccccchHHHHHHHHHHHHHhCcCCCcCCeeeeecccccCccceEEEE
Confidence 34578999999999999754 4568999999975332 3356788999999999999999999988654 678999
Q ss_pred EEeccCCCccccccCCCCCchhHHHHHHHHHHHHHHHHhhccCCCeEecCCCCCcEEEcCCCCeEEeecCCCccccCCCC
Q 003836 578 YEFMSNGTVASFLFGDSKPNWKLRTEIAMGIAGGLFYLHEECCTQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLDQS 657 (792)
Q Consensus 578 ~E~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dikp~NILl~~~~~~kl~Dfg~a~~~~~~~~ 657 (792)
|||++ ++|.+++.. ..+++..+..++.||+.||+|||+. +|+||||||+|||++.++.+||+|||+++.......
T Consensus 93 ~e~~~-~~L~~~~~~-~~~~~~~~~~~~~qi~~~L~~LH~~---~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~~ 167 (353)
T 2b9h_A 93 QELMQ-TDLHRVIST-QMLSDDHIQYFIYQTLRAVKVLHGS---NVIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAA 167 (353)
T ss_dssp ECCCS-EEHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECTTCCEEECCCTTCEECC----
T ss_pred EeccC-ccHHHHHhh-cCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEEcCCCcEEEEecccccccccccc
Confidence 99998 589888865 4689999999999999999999998 999999999999999999999999999987653221
Q ss_pred C---------ccccccccCCccccccccc-CCCCcccceehHHHHHHHHHhcCcCCCcchhhhhhhhHHHHHHHhhcc--
Q 003836 658 H---------TNTAIRGTKGYVAPEWFRN-MPITVKVDVYSYGVLLLEIICLRRNIDNEISKVDKAILTDWAYDRYQE-- 725 (792)
Q Consensus 658 ~---------~~~~~~gt~~y~aPE~~~~-~~~~~k~DV~S~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~-- 725 (792)
. ......||+.|+|||.+.. ..++.++|||||||++|||++|+.||......................
T Consensus 168 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 247 (353)
T 2b9h_A 168 DNSEPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDYRHQLLLIFGIIGTPHSDND 247 (353)
T ss_dssp ------------CCCCCCGGGCCHHHHHSCCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCSTTT
T ss_pred cccCccccccchhhccccccccCCeeeccCCCccchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCchhcc
Confidence 1 1123468999999998764 779999999999999999999999997654321111110000000000
Q ss_pred ------cchhHhhhchhc-c-----cCCHHHHHHHHHHHHHccccCCCCCCCHHhHHHH
Q 003836 726 ------RTLEALVENDLE-A-----MNNVTMLHRFVMVAFWCIQEDPSHRPTMRKVTQM 772 (792)
Q Consensus 726 ------~~~~~~~~~~~~-~-----~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~ 772 (792)
......+..... . ......+.++.+++.+||+.||++|||++|+++.
T Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 306 (353)
T 2b9h_A 248 LRCIESPRAREYIKSLPMYPAAPLEKMFPRVNPKGIDLLQRMLVFDPAKRITAKEALEH 306 (353)
T ss_dssp TTTCCCHHHHHHHHTSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred ccccccchhhHHhhcccCCCCcchhhhcccCCHHHHHHHHHhcCcCcccCCCHHHHhcC
Confidence 000111110000 0 0011345678899999999999999999999974
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-36 Score=337.63 Aligned_cols=254 Identities=23% Similarity=0.240 Sum_probs=188.8
Q ss_pred hhhhhcCccccceEEEeeecCCCceEEEEEEcccccccchHHHHHHHHHhcccCCCCcccccceeccC------CceEEE
Q 003836 504 GFKEELGRGAFGTVYKGFVNMGSSNHVAVKKLNSVFQDSEKEFKAEVNGIGQTHHKNLVRLLGYCDEG------QNRLLV 577 (792)
Q Consensus 504 ~~~~~lG~G~~g~Vy~g~~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~------~~~~lV 577 (792)
.+.+.||+|+||.||+|... .+++.||||++.... ..+.+|++++++++|+||+++++++... ...++|
T Consensus 57 ~~~~~lG~G~fg~Vy~~~~~-~~~~~vaiK~~~~~~----~~~~~E~~il~~l~hpniv~l~~~~~~~~~~~~~~~~~lv 131 (420)
T 1j1b_A 57 TDTKVIGNGSFGVVYQAKLC-DSGELVAIKKVLQDK----RFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLV 131 (420)
T ss_dssp EEEEEEEECSSEEEEEEEET-TTCCEEEEEEEECCT----TSCCHHHHHHHTCCCTTBCCEEEEEEEEETTTTEEEEEEE
T ss_pred EeeeEEeeCCCEEEEEEEEC-CCCcEEEEEEecccc----hhHHHHHHHHHHcCCCCccceeeEEeccCCCCcceeEEee
Confidence 34578999999999999764 456799999986532 2345799999999999999999988432 236799
Q ss_pred EEeccCCCcccccc----CCCCCchhHHHHHHHHHHHHHHHHhhccCCCeEecCCCCCcEEEcCC-CCeEEeecCCCccc
Q 003836 578 YEFMSNGTVASFLF----GDSKPNWKLRTEIAMGIAGGLFYLHEECCTQIIHCDIKPQNILLDDH-YNARISDFGLAKLL 652 (792)
Q Consensus 578 ~E~~~~gsL~~~l~----~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dikp~NILl~~~-~~~kl~Dfg~a~~~ 652 (792)
|||+++ +|.+.+. ....+++..+..++.||++||+|||+. +|+||||||+|||++.+ +.+||+|||+++..
T Consensus 132 ~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NILl~~~~~~~kl~DFG~a~~~ 207 (420)
T 1j1b_A 132 LDYVPE-TVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSF---GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL 207 (420)
T ss_dssp EECCCE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTT---TEECSCCSGGGEEEETTTTEEEECCCTTCEEC
T ss_pred hhcccc-cHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCChhhEEEeCCCCeEEeccchhhhhc
Confidence 999986 5555443 346789999999999999999999998 99999999999999965 56899999999876
Q ss_pred cCCCCCccccccccCCcccccccccC-CCCcccceehHHHHHHHHHhcCcCCCcchhhhhhhhHHHHHHHhhcccchhHh
Q 003836 653 TLDQSHTNTAIRGTKGYVAPEWFRNM-PITVKVDVYSYGVLLLEIICLRRNIDNEISKVDKAILTDWAYDRYQERTLEAL 731 (792)
Q Consensus 653 ~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~k~DV~S~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 731 (792)
.... ......||+.|+|||++.+. .++.++|||||||++|||++|+.||...........+ .. .......+.+
T Consensus 208 ~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~~~~~l~~i---~~-~lg~p~~~~~ 281 (420)
T 1j1b_A 208 VRGE--PNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEI---IK-VLGTPTREQI 281 (420)
T ss_dssp CTTC--CCCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHH---HH-HHCSCCHHHH
T ss_pred ccCC--CceeeeeCCCcCCHHHHcCCCCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHH---HH-HhCCCCHHHH
Confidence 4332 22345689999999998764 7999999999999999999999999765332111111 00 0000000000
Q ss_pred --hh--------c-----hhcccCCHHHHHHHHHHHHHccccCCCCCCCHHhHHHH
Q 003836 732 --VE--------N-----DLEAMNNVTMLHRFVMVAFWCIQEDPSHRPTMRKVTQM 772 (792)
Q Consensus 732 --~~--------~-----~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~ 772 (792)
+. + .+........+.++.+|+.+||+.||++|||+.|+++.
T Consensus 282 ~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~R~t~~e~l~h 337 (420)
T 1j1b_A 282 REMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAH 337 (420)
T ss_dssp HHHCSCCCCCCCCCCCCCCHHHHSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred HhhChhhhhhccCccCCCCHHHhcCCCCCHHHHHHHHHhccCChhHCCCHHHHhCC
Confidence 00 0 00011122335678999999999999999999999864
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-36 Score=317.06 Aligned_cols=252 Identities=23% Similarity=0.293 Sum_probs=201.2
Q ss_pred HHHHhhhhhhcCccccceEEEeeecCCCceEEEEEEccccc--ccchHHHHHHHHHhcccCCCCcccccceeccCCceEE
Q 003836 499 VEVTRGFKEELGRGAFGTVYKGFVNMGSSNHVAVKKLNSVF--QDSEKEFKAEVNGIGQTHHKNLVRLLGYCDEGQNRLL 576 (792)
Q Consensus 499 ~~~~~~~~~~lG~G~~g~Vy~g~~~~~~~~~vavK~~~~~~--~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~l 576 (792)
....+.+.+.||+|+||.||++... .+++.||+|++.... ....+.+.+|++++++++||||+++++++.+.+..++
T Consensus 20 ~~~~y~i~~~lg~G~~g~V~~~~~~-~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 98 (287)
T 2wei_A 20 FAERYNIVCMLGKGSFGEVLKCKDR-ITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYI 98 (287)
T ss_dssp HHHHEEEEEEEEEETTEEEEEEEET-TTCCEEEEEEEEGGGBSSSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEE
T ss_pred HhhcceeeEEEcCCCCEEEEEEEEc-CCCcEEEEEEecccccchHHHHHHHHHHHHHHhccCCCccEEEEEEeCCCeEEE
Confidence 3445566789999999999999754 456789999986532 3346789999999999999999999999999999999
Q ss_pred EEEeccCCCccccccCCCCCchhHHHHHHHHHHHHHHHHhhccCCCeEecCCCCCcEEEcCC---CCeEEeecCCCcccc
Q 003836 577 VYEFMSNGTVASFLFGDSKPNWKLRTEIAMGIAGGLFYLHEECCTQIIHCDIKPQNILLDDH---YNARISDFGLAKLLT 653 (792)
Q Consensus 577 V~E~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dikp~NILl~~~---~~~kl~Dfg~a~~~~ 653 (792)
|+||+++++|.+++.....+++..+..++.||+.||.|||+. +|+|+||||+|||++.+ +.+||+|||+++...
T Consensus 99 v~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~---~i~H~dl~p~NIlv~~~~~~~~~kL~Dfg~~~~~~ 175 (287)
T 2wei_A 99 VGELYTGGELFDEIIKRKRFSEHDAARIIKQVFSGITYMHKH---NIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQ 175 (287)
T ss_dssp EECCCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESCSSTTCCEEECSTTGGGTBC
T ss_pred EEEccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCChhhEEEecCCCcccEEEeccCcceeec
Confidence 999999999999998777899999999999999999999998 99999999999999764 469999999998764
Q ss_pred CCCCCccccccccCCcccccccccCCCCcccceehHHHHHHHHHhcCcCCCcchhhhhhhhHHHHHHHhhcccchhHhhh
Q 003836 654 LDQSHTNTAIRGTKGYVAPEWFRNMPITVKVDVYSYGVLLLEIICLRRNIDNEISKVDKAILTDWAYDRYQERTLEALVE 733 (792)
Q Consensus 654 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DV~S~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 733 (792)
.... .....+++.|+|||.+.+ .++.++||||||+++|+|++|+.||........ ... .......
T Consensus 176 ~~~~--~~~~~~~~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~---~~~-----~~~~~~~---- 240 (287)
T 2wei_A 176 QNTK--MKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYGKNEYDI---LKR-----VETGKYA---- 240 (287)
T ss_dssp CCSS--CSCHHHHHTTCCHHHHTT-CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH---HHH-----HHHCCCC----
T ss_pred CCCc--cccccCcccccChHHhcC-CCCCchhhHhHHHHHHHHHhCCCCCCCCCHHHH---HHH-----HHcCCCC----
Confidence 3322 223458899999998875 489999999999999999999999975432110 000 0000000
Q ss_pred chhcccCCHHHHHHHHHHHHHccccCCCCCCCHHhHHH
Q 003836 734 NDLEAMNNVTMLHRFVMVAFWCIQEDPSHRPTMRKVTQ 771 (792)
Q Consensus 734 ~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~ 771 (792)
.........+.++.+++.+||+.+|++|||++|+++
T Consensus 241 --~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~ 276 (287)
T 2wei_A 241 --FDLPQWRTISDDAKDLIRKMLTFHPSLRITATQCLE 276 (287)
T ss_dssp --CCSGGGTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred --CCchhhhhcCHHHHHHHHHHcccChhhCcCHHHHhc
Confidence 000001123467889999999999999999999997
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-36 Score=323.74 Aligned_cols=248 Identities=21% Similarity=0.328 Sum_probs=193.3
Q ss_pred hhhhhhcCccccceEEEeeecCCCceEEEEEEccccc--ccchHHHHHHHHHhcccC--CCCcccccceeccCCceEEEE
Q 003836 503 RGFKEELGRGAFGTVYKGFVNMGSSNHVAVKKLNSVF--QDSEKEFKAEVNGIGQTH--HKNLVRLLGYCDEGQNRLLVY 578 (792)
Q Consensus 503 ~~~~~~lG~G~~g~Vy~g~~~~~~~~~vavK~~~~~~--~~~~~~~~~Ei~~l~~l~--h~niv~l~g~~~~~~~~~lV~ 578 (792)
+.+.+.||+|+||.||++... +++.||||++.... ....+.+.+|++++.+++ |+||+++++++.+.+..++||
T Consensus 30 y~~~~~lg~G~~g~Vy~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~~~lv~ 107 (313)
T 3cek_A 30 YSILKQIGSGGSSKVFQVLNE--KKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVM 107 (313)
T ss_dssp EEEEEEEECCSSEEEEEEECT--TCCEEEEEEEECSSCCHHHHHHHHHHHHHHHHHGGGCTTBCCEEEEEECSSEEEEEE
T ss_pred EEEEEEecCCCCEEEEEEEcC--CCcEEEEEEeccccccccchHHHHHHHHHHHhccccCCceEEEEEEeecCCEEEEEE
Confidence 344578999999999999754 36789999986532 334578899999999997 599999999999999999999
Q ss_pred EeccCCCccccccCCCCCchhHHHHHHHHHHHHHHHHhhccCCCeEecCCCCCcEEEcCCCCeEEeecCCCccccCCCCC
Q 003836 579 EFMSNGTVASFLFGDSKPNWKLRTEIAMGIAGGLFYLHEECCTQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLDQSH 658 (792)
Q Consensus 579 E~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dikp~NILl~~~~~~kl~Dfg~a~~~~~~~~~ 658 (792)
| +.+++|.+++.....+++..+..++.||++||.|||+. +|+||||||+|||+++ +.+||+|||+++........
T Consensus 108 e-~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~NIl~~~-~~~kL~Dfg~~~~~~~~~~~ 182 (313)
T 3cek_A 108 E-CGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQH---GIVHSDLKPANFLIVD-GMLKLIDFGIANQMQPDTTS 182 (313)
T ss_dssp C-CCSEEHHHHHHHCSSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEEET-TEEEECCCSSSCC-------
T ss_pred e-cCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCcccEEEEC-CeEEEeeccccccccCcccc
Confidence 9 67889999998888899999999999999999999999 9999999999999975 79999999999876543322
Q ss_pred -ccccccccCCccccccccc-----------CCCCcccceehHHHHHHHHHhcCcCCCcchhhhhhhhHHHHHHHhhccc
Q 003836 659 -TNTAIRGTKGYVAPEWFRN-----------MPITVKVDVYSYGVLLLEIICLRRNIDNEISKVDKAILTDWAYDRYQER 726 (792)
Q Consensus 659 -~~~~~~gt~~y~aPE~~~~-----------~~~~~k~DV~S~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 726 (792)
......|++.|+|||.+.+ ..++.++||||||+++|||++|+.||.........
T Consensus 183 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~-------------- 248 (313)
T 3cek_A 183 VVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISK-------------- 248 (313)
T ss_dssp -------CCGGGCCHHHHTTCC----------CCCHHHHHHHHHHHHHHHHHSSCTTTTCCSHHHH--------------
T ss_pred ccccCCCCCCCcCCHHHHhhcccccccccccccCCchHHHHHHHHHHHHHHhCCCchhhHHHHHHH--------------
Confidence 2234568999999999865 47889999999999999999999999654322110
Q ss_pred chhHhhhchhcccCCHHHHHHHHHHHHHccccCCCCCCCHHhHHHH
Q 003836 727 TLEALVENDLEAMNNVTMLHRFVMVAFWCIQEDPSHRPTMRKVTQM 772 (792)
Q Consensus 727 ~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~ 772 (792)
+..+++.......+......+.+++.+||+.||++||+++|+++.
T Consensus 249 -~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~h 293 (313)
T 3cek_A 249 -LHAIIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAH 293 (313)
T ss_dssp -HHHHHCTTSCCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred -HHHHHhcccccCCcccchHHHHHHHHHHccCCcccCcCHHHHhcC
Confidence 111122222222222234678899999999999999999999874
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.9e-36 Score=325.10 Aligned_cols=261 Identities=20% Similarity=0.290 Sum_probs=198.1
Q ss_pred HhhhhhhcCccccceEEEeeecCCCceEEEEEEcccccccchHHHHHHHHHhcccCCCC------cccccceeccCCceE
Q 003836 502 TRGFKEELGRGAFGTVYKGFVNMGSSNHVAVKKLNSVFQDSEKEFKAEVNGIGQTHHKN------LVRLLGYCDEGQNRL 575 (792)
Q Consensus 502 ~~~~~~~lG~G~~g~Vy~g~~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h~n------iv~l~g~~~~~~~~~ 575 (792)
.+.+.+.||+|+||+||++......++.||+|+++.. ....+.+.+|+.++++++|++ ++.+++++...+..+
T Consensus 20 ~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~ 98 (355)
T 2eu9_A 20 RYEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRNV-GKYREAARLEINVLKKIKEKDKENKFLCVLMSDWFNFHGHMC 98 (355)
T ss_dssp TEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHHHCTTSCSCBCCEEEEEEETTEEE
T ss_pred cEEEEEEeeccCCeEEEEEEecCCCceEEEEEEEccc-ccchhHHHHHHHHHHHHhhcCCCCceeEEEeeeeeeeCCeEE
Confidence 3455678999999999999765554578999999753 334567889999999997766 899999999999999
Q ss_pred EEEEeccCCCccccccCC--CCCchhHHHHHHHHHHHHHHHHhhccCCCeEecCCCCCcEEE------------------
Q 003836 576 LVYEFMSNGTVASFLFGD--SKPNWKLRTEIAMGIAGGLFYLHEECCTQIIHCDIKPQNILL------------------ 635 (792)
Q Consensus 576 lV~E~~~~gsL~~~l~~~--~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dikp~NILl------------------ 635 (792)
+||||+ +++|.+++... ..+++..+..++.||+.||+|||+. +|+||||||+|||+
T Consensus 99 lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~lH~~---~ivH~Dlkp~NIll~~~~~~~~~~~~~~~~~~ 174 (355)
T 2eu9_A 99 IAFELL-GKNTFEFLKENNFQPYPLPHVRHMAYQLCHALRFLHEN---QLTHTDLKPENILFVNSEFETLYNEHKSCEEK 174 (355)
T ss_dssp EEEECC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEESCCCEEEEECCC-CCCEE
T ss_pred EEEecc-CCChHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEeccccccccccccccccc
Confidence 999999 55666666544 4689999999999999999999998 99999999999999
Q ss_pred -cCCCCeEEeecCCCccccCCCCCccccccccCCcccccccccCCCCcccceehHHHHHHHHHhcCcCCCcchhhhhhhh
Q 003836 636 -DDHYNARISDFGLAKLLTLDQSHTNTAIRGTKGYVAPEWFRNMPITVKVDVYSYGVLLLEIICLRRNIDNEISKVDKAI 714 (792)
Q Consensus 636 -~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DV~S~Gv~l~el~tg~~p~~~~~~~~~~~~ 714 (792)
+.++.+||+|||+++..... .....||+.|+|||.+.+..++.++|||||||++|||++|+.||...........
T Consensus 175 ~~~~~~~kl~Dfg~~~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~ 250 (355)
T 2eu9_A 175 SVKNTSIRVADFGSATFDHEH----HTTIVATRHYRPPEVILELGWAQPCDVWSIGCILFEYYRGFTLFQTHENREHLVM 250 (355)
T ss_dssp EESCCCEEECCCTTCEETTSC----CCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHH
T ss_pred ccCCCcEEEeecCcccccccc----ccCCcCCCcccCCeeeecCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHHHHHH
Confidence 56889999999999864322 2345689999999999999999999999999999999999999976543221111
Q ss_pred HHHHH-------HHhhcccc--------------hhHhhhch-----hcccCCHHHHHHHHHHHHHccccCCCCCCCHHh
Q 003836 715 LTDWA-------YDRYQERT--------------LEALVEND-----LEAMNNVTMLHRFVMVAFWCIQEDPSHRPTMRK 768 (792)
Q Consensus 715 ~~~~~-------~~~~~~~~--------------~~~~~~~~-----~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~e 768 (792)
+.... ........ ........ ............+.+++.+||+.||++|||++|
T Consensus 251 ~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~e 330 (355)
T 2eu9_A 251 MEKILGPIPSHMIHRTRKQKYFYKGGLVWDENSSDGRYVKENCKPLKSYMLQDSLEHVQLFDLMRRMLEFDPAQRITLAE 330 (355)
T ss_dssp HHHHHCCCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSSTTTSCCHHH
T ss_pred HHHHcCCCcHHHhhhccchhhhcccccccccccchhccccccCCcccccccccchhHHHHHHHHHHHhcCChhhCcCHHH
Confidence 10000 00000000 00000000 001122345678999999999999999999999
Q ss_pred HHH
Q 003836 769 VTQ 771 (792)
Q Consensus 769 vl~ 771 (792)
+++
T Consensus 331 ~l~ 333 (355)
T 2eu9_A 331 ALL 333 (355)
T ss_dssp HTT
T ss_pred Hhc
Confidence 986
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-36 Score=331.59 Aligned_cols=259 Identities=19% Similarity=0.227 Sum_probs=197.9
Q ss_pred HHhhhhhhcCccccceEEEeeecCCCceEEEEEEcccccccchHHHHHHHHHhcccC--------CCCcccccceec---
Q 003836 501 VTRGFKEELGRGAFGTVYKGFVNMGSSNHVAVKKLNSVFQDSEKEFKAEVNGIGQTH--------HKNLVRLLGYCD--- 569 (792)
Q Consensus 501 ~~~~~~~~lG~G~~g~Vy~g~~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~--------h~niv~l~g~~~--- 569 (792)
..+.+.++||+|+||+||++... .+++.||||++... ....+.+.+|++++++++ |+||+++++++.
T Consensus 37 ~~y~~~~~lg~G~~g~V~~~~~~-~~~~~vavK~~~~~-~~~~~~~~~E~~~l~~l~~~~~~~~~~~~iv~~~~~~~~~~ 114 (397)
T 1wak_A 37 GRYHVIRKLGWGHFSTVWLSWDI-QGKKFVAMKVVKSA-EHYTETALDEIRLLKSVRNSDPNDPNREMVVQLLDDFKISG 114 (397)
T ss_dssp TTEEEEEEEEECSSEEEEEEEET-TTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHHSCTTCGGGGGBCCEEEEEEEEE
T ss_pred CeEEEEEEeeecCCeeEEEEEec-CCCeEEEEEEEecC-CcchHHHHHHHHHHHHHhhcCCCCCCcceeeeeecceeecC
Confidence 34556688999999999999654 45789999999753 334567899999999985 788999999987
Q ss_pred -cCCceEEEEEeccCCCccccccCC--CCCchhHHHHHHHHHHHHHHHHhhccCCCeEecCCCCCcEEEcCCC-------
Q 003836 570 -EGQNRLLVYEFMSNGTVASFLFGD--SKPNWKLRTEIAMGIAGGLFYLHEECCTQIIHCDIKPQNILLDDHY------- 639 (792)
Q Consensus 570 -~~~~~~lV~E~~~~gsL~~~l~~~--~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dikp~NILl~~~~------- 639 (792)
+....++||||+. ++|.+++... ..+++..+..|+.||+.||+|||+++ +|+||||||+|||++.++
T Consensus 115 ~~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~--givHrDikp~NIll~~~~~~~~~~~ 191 (397)
T 1wak_A 115 VNGTHICMVFEVLG-HHLLKWIIKSNYQGLPLPCVKKIIQQVLQGLDYLHTKC--RIIHTDIKPENILLSVNEQYIRRLA 191 (397)
T ss_dssp TTEEEEEEEECCCC-CBHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTT--CEECCCCSGGGEEECCCHHHHHHHH
T ss_pred CCCceEEEEEeccC-ccHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHhC--CEecCCCCHHHeeEeccchhhhhhh
Confidence 6668899999995 5555555433 56899999999999999999999952 899999999999999775
Q ss_pred ------------------------------------------CeEEeecCCCccccCCCCCccccccccCCccccccccc
Q 003836 640 ------------------------------------------NARISDFGLAKLLTLDQSHTNTAIRGTKGYVAPEWFRN 677 (792)
Q Consensus 640 ------------------------------------------~~kl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~ 677 (792)
.+||+|||+++..... .....||+.|+|||++.+
T Consensus 192 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DfG~a~~~~~~----~~~~~gt~~y~aPE~~~~ 267 (397)
T 1wak_A 192 AEATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKH----FTEDIQTRQYRSLEVLIG 267 (397)
T ss_dssp HHHC---------------------CCTTSCCTTSGGGGGGCCEEECCGGGCEETTBC----SCSCCSCGGGCCHHHHHT
T ss_pred hhhHHHhhcCCCCCCCCccccCCcccccccccccccccccccceEecccccccccccc----CccCCCCCcccCChhhcC
Confidence 8999999999876432 233468999999999999
Q ss_pred CCCCcccceehHHHHHHHHHhcCcCCCcchhhhh---hhhHHHHHHHhhcccch--------------------------
Q 003836 678 MPITVKVDVYSYGVLLLEIICLRRNIDNEISKVD---KAILTDWAYDRYQERTL-------------------------- 728 (792)
Q Consensus 678 ~~~~~k~DV~S~Gv~l~el~tg~~p~~~~~~~~~---~~~~~~~~~~~~~~~~~-------------------------- 728 (792)
..++.++|||||||++|||++|+.||........ ...+.. ..........
T Consensus 268 ~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~-~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 346 (397)
T 1wak_A 268 SGYNTPADIWSTACMAFELATGDYLFEPHSGEEYTRDEDHIAL-IIELLGKVPRKLIVAGKYSKEFFTKKGDLKHITKLK 346 (397)
T ss_dssp SCCCTHHHHHHHHHHHHHHHHSSCSCCCCCCSSSCHHHHHHHH-HHHHHCSCCHHHHHHCTTGGGTBCTTSSBSSCCCCC
T ss_pred CCCCcHHHHHHHHHHHHHHhhCCCCCCCCcccccCchHHHHHH-HHHhcCCCChHHhhcccccccccCCccccccccccC
Confidence 9999999999999999999999999975432110 000000 0000000000
Q ss_pred ----hHhhhchhcccCCHHHHHHHHHHHHHccccCCCCCCCHHhHHH
Q 003836 729 ----EALVENDLEAMNNVTMLHRFVMVAFWCIQEDPSHRPTMRKVTQ 771 (792)
Q Consensus 729 ----~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~ 771 (792)
...+.. ....+......+.+|+.+||+.||++|||++|+++
T Consensus 347 ~~~~~~~~~~--~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 391 (397)
T 1wak_A 347 PWGLFEVLVE--KYEWSQEEAAGFTDFLLPMLELIPEKRATAAECLR 391 (397)
T ss_dssp CCCHHHHHHH--TSCCCHHHHHHHHHHHGGGGCSSGGGSCCHHHHHT
T ss_pred CcchhHhhhh--hcccchhhHHHHHHHHHHHhccChhhcCCHHHHhh
Confidence 000000 11235677889999999999999999999999997
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-36 Score=330.19 Aligned_cols=262 Identities=21% Similarity=0.223 Sum_probs=182.5
Q ss_pred hhhhhcCccccceEEEeeecCCCceEEEEEEcccccccchHHHHHHHHHhcccCCCCcccccceeccCCc-------eEE
Q 003836 504 GFKEELGRGAFGTVYKGFVNMGSSNHVAVKKLNSVFQDSEKEFKAEVNGIGQTHHKNLVRLLGYCDEGQN-------RLL 576 (792)
Q Consensus 504 ~~~~~lG~G~~g~Vy~g~~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~-------~~l 576 (792)
.+.+.||+|+||+||+|... .+++.||||++... ......+.+|++.+..++||||+++++++..... .++
T Consensus 26 ~~~~~lg~G~~g~V~~~~~~-~~~~~vavK~~~~~-~~~~~~~~~~~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~~~l 103 (360)
T 3e3p_A 26 QVERMAGQGTFGTVQLGKEK-STGMSVAIKKVIQD-PRFRNRELQIMQDLAVLHHPNIVQLQSYFYTLGERDRRDIYLNV 103 (360)
T ss_dssp EEC----------CEEEEET-TTCCEEEEEEEECC-TTCCCHHHHHHHHHHHHCCTTBCCEEEEEEEECSSCTTCEEEEE
T ss_pred EEEEEEecCCCeEEEEEEEC-CCCCEEEEEEEecC-ccccHHHHHHHHHHHhcCCCCcccHHHhhhccccccccceeEEE
Confidence 34578999999999999754 45679999998653 2334466778888899999999999999855332 789
Q ss_pred EEEeccCCCcc---ccccCCCCCchhHHHHHHHHHHHHHHHHh--hccCCCeEecCCCCCcEEEcC-CCCeEEeecCCCc
Q 003836 577 VYEFMSNGTVA---SFLFGDSKPNWKLRTEIAMGIAGGLFYLH--EECCTQIIHCDIKPQNILLDD-HYNARISDFGLAK 650 (792)
Q Consensus 577 V~E~~~~gsL~---~~l~~~~~l~~~~~~~i~~~ia~gL~yLH--~~~~~~ivH~dikp~NILl~~-~~~~kl~Dfg~a~ 650 (792)
||||++++.+. .++.....+++..+..++.||+.||.||| +. +|+||||||+|||++. ++.+||+|||+++
T Consensus 104 v~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~~---~ivH~Dlkp~NIll~~~~~~~kl~Dfg~a~ 180 (360)
T 3e3p_A 104 VMEYVPDTLHRCCRNYYRRQVAPPPILIKVFLFQLIRSIGCLHLPSV---NVCHRDIKPHNVLVNEADGTLKLCDFGSAK 180 (360)
T ss_dssp EEECCSCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHTSTTT---CCBCSCCCGGGEEEETTTTEEEECCCTTCB
T ss_pred EeecccccHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhCCCC---CeecCcCCHHHEEEeCCCCcEEEeeCCCce
Confidence 99999875322 33345567889999999999999999999 77 9999999999999997 8999999999998
Q ss_pred cccCCCCCccccccccCCcccccccccC-CCCcccceehHHHHHHHHHhcCcCCCcchhhhhhhhHHHH-------HHHh
Q 003836 651 LLTLDQSHTNTAIRGTKGYVAPEWFRNM-PITVKVDVYSYGVLLLEIICLRRNIDNEISKVDKAILTDW-------AYDR 722 (792)
Q Consensus 651 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~k~DV~S~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~-------~~~~ 722 (792)
...... ......||+.|+|||.+.+. .++.++|||||||++|||++|+.||...........+... ....
T Consensus 181 ~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 258 (360)
T 3e3p_A 181 KLSPSE--PNVAYICSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGEPIFRGDNSAGQLHEIVRVLGCPSREVLRK 258 (360)
T ss_dssp CCCTTS--CCCSTTSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHH
T ss_pred ecCCCC--CcccccCCcceeCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCcCCCChHHHHHHHHHHcCCCCHHHHHh
Confidence 765332 22345689999999998654 4899999999999999999999999765432211111100 0000
Q ss_pred hccc-chhHhhh------chhcccCCHHHHHHHHHHHHHccccCCCCCCCHHhHHHH
Q 003836 723 YQER-TLEALVE------NDLEAMNNVTMLHRFVMVAFWCIQEDPSHRPTMRKVTQM 772 (792)
Q Consensus 723 ~~~~-~~~~~~~------~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~ 772 (792)
.... ....... ...........+..+.+++.+||+.||.+|||+.|+++.
T Consensus 259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h 315 (360)
T 3e3p_A 259 LNPSHTDVDLYNSKGIPWSNVFSDHSLKDAKEAYDLLSALLQYLPEERMKPYEALCH 315 (360)
T ss_dssp HCTTCCCGGGGCCCCCCHHHHTTTCCCTTHHHHHHHHHHHTCSSGGGSCCHHHHTTS
T ss_pred cccchhhccccccccCCcccccchhhccccHHHHHHHHHHhccCccccCCHHHHhcC
Confidence 0000 0000000 000011122246789999999999999999999999975
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-36 Score=323.40 Aligned_cols=245 Identities=23% Similarity=0.353 Sum_probs=192.5
Q ss_pred HHHHHHhhhhhhcCccccceEEEeeecCCCceEEEEEEccccccc------chHHHHHHHHHhccc----CCCCcccccc
Q 003836 497 ELVEVTRGFKEELGRGAFGTVYKGFVNMGSSNHVAVKKLNSVFQD------SEKEFKAEVNGIGQT----HHKNLVRLLG 566 (792)
Q Consensus 497 el~~~~~~~~~~lG~G~~g~Vy~g~~~~~~~~~vavK~~~~~~~~------~~~~~~~Ei~~l~~l----~h~niv~l~g 566 (792)
+.....+.+.+.||+|+||.||+|... .+++.||||++...... ....+.+|+.++.++ +|+||+++++
T Consensus 27 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~h~~i~~~~~ 105 (312)
T 2iwi_A 27 EAFEAEYRLGPLLGKGGFGTVFAGHRL-TDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHPGVIRLLD 105 (312)
T ss_dssp ------CEEEEEEEEETTEEEEEEECT-TTCCEEEEEECCSTTTC--------CCCCHHHHHHHHHHSSCCCSSBCCEEE
T ss_pred hhhhhceEEeeEEEcCCCEEEEEEEEc-cCCeEEEEEEEecccccccccchhhHHHHHHHHHHHhhcccCCCCCeeeEEE
Confidence 333445666789999999999999653 45679999999754321 223456788888888 8999999999
Q ss_pred eeccCCceEEEEEe-ccCCCccccccCCCCCchhHHHHHHHHHHHHHHHHhhccCCCeEecCCCCCcEEEc-CCCCeEEe
Q 003836 567 YCDEGQNRLLVYEF-MSNGTVASFLFGDSKPNWKLRTEIAMGIAGGLFYLHEECCTQIIHCDIKPQNILLD-DHYNARIS 644 (792)
Q Consensus 567 ~~~~~~~~~lV~E~-~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dikp~NILl~-~~~~~kl~ 644 (792)
++.+.+..++|+|| +++++|.+++.....+++..+..++.||+.||+|||+. +|+||||||+|||++ +++.+||+
T Consensus 106 ~~~~~~~~~~v~e~~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~~kl~ 182 (312)
T 2iwi_A 106 WFETQEGFMLVLERPLPAQDLFDYITEKGPLGEGPSRCFFGQVVAAIQHCHSR---GVVHRDIKDENILIDLRRGCAKLI 182 (312)
T ss_dssp EC-----CEEEEECCSSEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHH---TEECCCCSGGGEEEETTTTEEEEC
T ss_pred EEecCCeEEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCChhhEEEeCCCCeEEEE
Confidence 99999999999999 78999999998877899999999999999999999999 999999999999999 88999999
Q ss_pred ecCCCccccCCCCCccccccccCCcccccccccCCCC-cccceehHHHHHHHHHhcCcCCCcchhhhhhhhHHHHHHHhh
Q 003836 645 DFGLAKLLTLDQSHTNTAIRGTKGYVAPEWFRNMPIT-VKVDVYSYGVLLLEIICLRRNIDNEISKVDKAILTDWAYDRY 723 (792)
Q Consensus 645 Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~k~DV~S~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~ 723 (792)
|||+++...... .....|++.|+|||.+.+..+. .++||||||+++|||++|+.||.......
T Consensus 183 dfg~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~------------- 246 (312)
T 2iwi_A 183 DFGSGALLHDEP---YTDFDGTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGDIPFERDQEIL------------- 246 (312)
T ss_dssp CCSSCEECCSSC---BCCCCSCTTTSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHHHHH-------------
T ss_pred EcchhhhcccCc---ccccCCcccccCceeeecCCCCCccchHHHHHHHHHHHHHCCCCCCChHHHh-------------
Confidence 999998765332 2345689999999998876664 58999999999999999999996532110
Q ss_pred cccchhHhhhchhcccCCHHHHHHHHHHHHHccccCCCCCCCHHhHHHH
Q 003836 724 QERTLEALVENDLEAMNNVTMLHRFVMVAFWCIQEDPSHRPTMRKVTQM 772 (792)
Q Consensus 724 ~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~ 772 (792)
... ...+.....++.+++.+||+.+|++|||++|+++.
T Consensus 247 ---------~~~--~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~ 284 (312)
T 2iwi_A 247 ---------EAE--LHFPAHVSPDCCALIRRCLAPKPSSRPSLEEILLD 284 (312)
T ss_dssp ---------HTC--CCCCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHHS
T ss_pred ---------hhc--cCCcccCCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 000 01122344578899999999999999999999984
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-35 Score=322.53 Aligned_cols=258 Identities=21% Similarity=0.252 Sum_probs=193.2
Q ss_pred hhhhhcCccccceEEEeeecCCCceEEEEEEcccccc--cchHHHHHHHHHhcccCCCCcccccceeccCCc------eE
Q 003836 504 GFKEELGRGAFGTVYKGFVNMGSSNHVAVKKLNSVFQ--DSEKEFKAEVNGIGQTHHKNLVRLLGYCDEGQN------RL 575 (792)
Q Consensus 504 ~~~~~lG~G~~g~Vy~g~~~~~~~~~vavK~~~~~~~--~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~------~~ 575 (792)
.+.+.||+|+||.||+|... .+++.||||++..... ...+.+.+|+.++++++||||+++++++..... .+
T Consensus 27 ~~~~~lg~G~~g~V~~~~~~-~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~ 105 (353)
T 3coi_A 27 VSPTHVGSGAYGSVCSAIDK-RSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFYDFY 105 (353)
T ss_dssp EEEEEEEECSSEEEEEEEET-TTTEEEEEEEESSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCCCCE
T ss_pred EEeeeEecCCCeEEEEEEEC-CCCCEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCcccHhheEecccccccceeEE
Confidence 34578999999999999754 4678999999975432 234678999999999999999999999987654 49
Q ss_pred EEEEeccCCCccccccCCCCCchhHHHHHHHHHHHHHHHHhhccCCCeEecCCCCCcEEEcCCCCeEEeecCCCccccCC
Q 003836 576 LVYEFMSNGTVASFLFGDSKPNWKLRTEIAMGIAGGLFYLHEECCTQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLD 655 (792)
Q Consensus 576 lV~E~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dikp~NILl~~~~~~kl~Dfg~a~~~~~~ 655 (792)
+||||++ ++|.+++.. .+++..+..++.||+.||+|||+. +|+||||||+|||++.++.+||+|||+++.....
T Consensus 106 lv~e~~~-~~l~~~~~~--~~~~~~~~~i~~qi~~al~~LH~~---~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~ 179 (353)
T 3coi_A 106 LVMPFMQ-TDLQKIMGL--KFSEEKIQYLVYQMLKGLKYIHSA---GVVHRDLKPGNLAVNEDCELKILDFGLARHADAE 179 (353)
T ss_dssp EEEECCS-EEGGGTTTS--CCCHHHHHHHHHHHHHHHHHHHHT---TCCCSSCCGGGEEECTTCCEEECSTTCTTC----
T ss_pred EEecccc-CCHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEeECCCCcEEEeecccccCCCCC
Confidence 9999998 588888753 488999999999999999999998 9999999999999999999999999999865322
Q ss_pred CCCccccccccCCccccccccc-CCCCcccceehHHHHHHHHHhcCcCCCcchhhhhhhhHHHH-------HHHhhcccc
Q 003836 656 QSHTNTAIRGTKGYVAPEWFRN-MPITVKVDVYSYGVLLLEIICLRRNIDNEISKVDKAILTDW-------AYDRYQERT 727 (792)
Q Consensus 656 ~~~~~~~~~gt~~y~aPE~~~~-~~~~~k~DV~S~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~-------~~~~~~~~~ 727 (792)
.....+|+.|+|||.+.+ ..++.++||||||+++|||++|+.||............... ......+..
T Consensus 180 ----~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 255 (353)
T 3coi_A 180 ----MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGTEFVQKLNDKA 255 (353)
T ss_dssp --------CCSBCCSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSSBSSCHHHHHHHHHHHHCBCCHHHHTTCSCHH
T ss_pred ----ccccccCcCcCCHHHHhCcCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHHHhhHH
Confidence 234568999999999876 67899999999999999999999999764322111000000 000000000
Q ss_pred hhHhhhchh---c---ccCCHHHHHHHHHHHHHccccCCCCCCCHHhHHHH
Q 003836 728 LEALVENDL---E---AMNNVTMLHRFVMVAFWCIQEDPSHRPTMRKVTQM 772 (792)
Q Consensus 728 ~~~~~~~~~---~---~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~ 772 (792)
....+.... . .......+..+.+++.+||+.||++|||++|+++.
T Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~h 306 (353)
T 3coi_A 256 AKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTH 306 (353)
T ss_dssp HHHHHHTSCBCSSCCTTTTCTTSCHHHHHHHHHHSCSCTTTSCCHHHHHTS
T ss_pred HHHHHHhCcCCCCccHHHhcCCcCHHHHHHHHHHcCCCcccCCCHHHHhcC
Confidence 011111000 0 00112346788999999999999999999999874
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-35 Score=324.97 Aligned_cols=197 Identities=25% Similarity=0.351 Sum_probs=165.8
Q ss_pred hhhhhhcCccccceEEEeeecCCCceEEEEEEcccccccchHHHHHHHHHhcccC-CC-----CcccccceeccCCceEE
Q 003836 503 RGFKEELGRGAFGTVYKGFVNMGSSNHVAVKKLNSVFQDSEKEFKAEVNGIGQTH-HK-----NLVRLLGYCDEGQNRLL 576 (792)
Q Consensus 503 ~~~~~~lG~G~~g~Vy~g~~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~-h~-----niv~l~g~~~~~~~~~l 576 (792)
+.+.+.||+|+||+||+|... .+++.||||+++.. .....++.+|+++++.++ |+ +|+++++++...+..++
T Consensus 56 y~~~~~lG~G~~g~V~~~~~~-~~~~~vaiK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~~~~~iv~~~~~~~~~~~~~l 133 (382)
T 2vx3_A 56 YEIDSLIGKGSFGQVVKAYDR-VEQEWVAIKIIKNK-KAFLNQAQIEVRLLELMNKHDTEMKYYIVHLKRHFMFRNHLCL 133 (382)
T ss_dssp EEEEEEEEEETTEEEEEEEET-TTTEEEEEEEECSS-HHHHHHHHHHHHHHHHHHHCSSGGGGGBCCEEEEEEETTEEEE
T ss_pred EEEEEEEeecCCEEEEEEEEc-CCCcEEEEEEEecc-HHHHHHHHHHHHHHHHHHhcccccceeEEEeeeeeccCCceEE
Confidence 445578999999999999754 45689999999753 334567788888888874 44 49999999999999999
Q ss_pred EEEeccCCCccccccCC--CCCchhHHHHHHHHHHHHHHHHhhccCCCeEecCCCCCcEEEc--CCCCeEEeecCCCccc
Q 003836 577 VYEFMSNGTVASFLFGD--SKPNWKLRTEIAMGIAGGLFYLHEECCTQIIHCDIKPQNILLD--DHYNARISDFGLAKLL 652 (792)
Q Consensus 577 V~E~~~~gsL~~~l~~~--~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dikp~NILl~--~~~~~kl~Dfg~a~~~ 652 (792)
||||++ ++|.+++... ..+++..+..++.||+.||.|||.+ ..+|+||||||+|||++ .++.+||+|||+++..
T Consensus 134 v~e~~~-~~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~-~~~ivHrDlkp~NIll~~~~~~~~kL~DFG~a~~~ 211 (382)
T 2vx3_A 134 VFEMLS-YNLYDLLRNTNFRGVSLNLTRKFAQQMCTALLFLATP-ELSIIHCDLKPENILLCNPKRSAIKIVDFGSSCQL 211 (382)
T ss_dssp EEECCC-CBHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHTST-TTCEECCCCSGGGEEESSTTSCCEEECCCTTCEET
T ss_pred EEecCC-CCHHHHHhhcCcCCCCHHHHHHHHHHHHHHHHHhccC-CCCEEcCCCCcccEEEecCCCCcEEEEeccCceec
Confidence 999996 4999998765 4689999999999999999999952 13899999999999995 5788999999999876
Q ss_pred cCCCCCccccccccCCcccccccccCCCCcccceehHHHHHHHHHhcCcCCCcch
Q 003836 653 TLDQSHTNTAIRGTKGYVAPEWFRNMPITVKVDVYSYGVLLLEIICLRRNIDNEI 707 (792)
Q Consensus 653 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DV~S~Gv~l~el~tg~~p~~~~~ 707 (792)
... .....||+.|+|||++.+..++.++|||||||++|||++|+.||....
T Consensus 212 ~~~----~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~ 262 (382)
T 2vx3_A 212 GQR----IYQYIQSRFYRSPEVLLGMPYDLAIDMWSLGCILVEMHTGEPLFSGAN 262 (382)
T ss_dssp TCC----CCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred ccc----cccccCCccccChHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCC
Confidence 432 234568999999999999999999999999999999999999997653
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-36 Score=324.89 Aligned_cols=239 Identities=23% Similarity=0.385 Sum_probs=196.9
Q ss_pred hhhhhhcCccccceEEEeeecCCCceEEEEEEccccccc------chHHHHHHHHHhcccC--CCCcccccceeccCCce
Q 003836 503 RGFKEELGRGAFGTVYKGFVNMGSSNHVAVKKLNSVFQD------SEKEFKAEVNGIGQTH--HKNLVRLLGYCDEGQNR 574 (792)
Q Consensus 503 ~~~~~~lG~G~~g~Vy~g~~~~~~~~~vavK~~~~~~~~------~~~~~~~Ei~~l~~l~--h~niv~l~g~~~~~~~~ 574 (792)
+.+.+.||+|+||.||+|... .+++.||||++...... ..+.+.+|+.++++++ |+||+++++++.+.+..
T Consensus 45 y~~~~~lg~G~~g~Vy~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~i~~~~~~~~~~~~~ 123 (320)
T 3a99_A 45 YQVGPLLGSGGFGSVYSGIRV-SDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDSF 123 (320)
T ss_dssp EEEEEECSSSSSCEEEEEEET-TTTEEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECSSEE
T ss_pred eEEEEEEeeCCCeEEEEEEEC-CCCcEEEEEEEecccchhhhhhhhhhHHHHHHHHHHhhccCCCCceEEEEEEecCCcE
Confidence 445678999999999999653 45689999998754321 2346778999999996 59999999999999999
Q ss_pred EEEEEeccC-CCccccccCCCCCchhHHHHHHHHHHHHHHHHhhccCCCeEecCCCCCcEEEc-CCCCeEEeecCCCccc
Q 003836 575 LLVYEFMSN-GTVASFLFGDSKPNWKLRTEIAMGIAGGLFYLHEECCTQIIHCDIKPQNILLD-DHYNARISDFGLAKLL 652 (792)
Q Consensus 575 ~lV~E~~~~-gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dikp~NILl~-~~~~~kl~Dfg~a~~~ 652 (792)
++|+|++.+ ++|.+++.....+++..+..++.||+.||+|||+. +|+||||||+|||++ +++.+||+|||+++..
T Consensus 124 ~lv~e~~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~~~~~kL~Dfg~~~~~ 200 (320)
T 3a99_A 124 VLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHNC---GVLHRDIKDENILIDLNRGELKLIDFGSGALL 200 (320)
T ss_dssp EEEEECCSSEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEETTTTEEEECCCTTCEEC
T ss_pred EEEEEcCCCCccHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHC---CcEeCCCCHHHEEEeCCCCCEEEeeCcccccc
Confidence 999999986 89999998878899999999999999999999998 999999999999999 7899999999999876
Q ss_pred cCCCCCccccccccCCcccccccccCCC-CcccceehHHHHHHHHHhcCcCCCcchhhhhhhhHHHHHHHhhcccchhHh
Q 003836 653 TLDQSHTNTAIRGTKGYVAPEWFRNMPI-TVKVDVYSYGVLLLEIICLRRNIDNEISKVDKAILTDWAYDRYQERTLEAL 731 (792)
Q Consensus 653 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~k~DV~S~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 731 (792)
... ......||+.|+|||.+.+..+ +.++||||||+++|||++|+.||........
T Consensus 201 ~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~-------------------- 257 (320)
T 3a99_A 201 KDT---VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIR-------------------- 257 (320)
T ss_dssp CSS---CBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHHHHHH--------------------
T ss_pred ccc---cccCCCCCccCCChHHhccCCCCCccchHHhHHHHHHHHHHCCCCCCChhhhhc--------------------
Confidence 532 2233568999999999987665 6889999999999999999999965321100
Q ss_pred hhchhcccCCHHHHHHHHHHHHHccccCCCCCCCHHhHHHH
Q 003836 732 VENDLEAMNNVTMLHRFVMVAFWCIQEDPSHRPTMRKVTQM 772 (792)
Q Consensus 732 ~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~ 772 (792)
.. ...+...+.++.+++.+||+.||++|||++||++.
T Consensus 258 --~~--~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h 294 (320)
T 3a99_A 258 --GQ--VFFRQRVSSECQHLIRWCLALRPSDRPTFEEIQNH 294 (320)
T ss_dssp --CC--CCCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred --cc--ccccccCCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 00 00111234578899999999999999999999973
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-35 Score=323.57 Aligned_cols=265 Identities=20% Similarity=0.269 Sum_probs=199.4
Q ss_pred hhhhhhcCccccceEEEeeecCCCceEEEEEEcccccccchHHHHHHHHHhcccC-----------CCCcccccceeccC
Q 003836 503 RGFKEELGRGAFGTVYKGFVNMGSSNHVAVKKLNSVFQDSEKEFKAEVNGIGQTH-----------HKNLVRLLGYCDEG 571 (792)
Q Consensus 503 ~~~~~~lG~G~~g~Vy~g~~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~-----------h~niv~l~g~~~~~ 571 (792)
+.+.+.||+|+||+||+|... .+++.||||++... ....+.+.+|+.++++++ |+||+++++++...
T Consensus 21 y~~~~~lg~G~~g~V~~~~~~-~~~~~vaiK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~i~~~~~~~~~~ 98 (373)
T 1q8y_A 21 YILVRKLGWGHFSTVWLAKDM-VNNTHVAMKIVRGD-KVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFNHK 98 (373)
T ss_dssp EEEEEEEEECSSEEEEEEEET-TTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEEEE
T ss_pred EEEEEeeeecCCeEEEEEEec-CCCcEEEEEEecCC-ccchhhhhHHHHHHHHhhcccccchhccccchHHHHHHHhhcc
Confidence 455688999999999999753 45789999998753 334567889999999886 89999999999765
Q ss_pred C----ceEEEEEeccCCCccccccCC--CCCchhHHHHHHHHHHHHHHHHhhccCCCeEecCCCCCcEEEc------CCC
Q 003836 572 Q----NRLLVYEFMSNGTVASFLFGD--SKPNWKLRTEIAMGIAGGLFYLHEECCTQIIHCDIKPQNILLD------DHY 639 (792)
Q Consensus 572 ~----~~~lV~E~~~~gsL~~~l~~~--~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dikp~NILl~------~~~ 639 (792)
+ ..++||||+ +++|.+++... ..+++..+..++.||+.||+|||++ .+|+||||||+|||++ ..+
T Consensus 99 ~~~~~~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~--~~ivH~Dikp~NIll~~~~~~~~~~ 175 (373)
T 1q8y_A 99 GPNGVHVVMVFEVL-GENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRR--CGIIHTDIKPENVLMEIVDSPENLI 175 (373)
T ss_dssp ETTEEEEEEEECCC-CEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHT--TCEECSCCSGGGEEEEEEETTTTEE
T ss_pred CCCCceEEEEEecC-CCCHHHHHHHhhccCCcHHHHHHHHHHHHHHHHHHHhc--CCEEecCCChHHeEEeccCCCcCcc
Confidence 4 788999999 88999998753 4589999999999999999999995 2899999999999994 445
Q ss_pred CeEEeecCCCccccCCCCCccccccccCCcccccccccCCCCcccceehHHHHHHHHHhcCcCCCcchhhh---hhhhHH
Q 003836 640 NARISDFGLAKLLTLDQSHTNTAIRGTKGYVAPEWFRNMPITVKVDVYSYGVLLLEIICLRRNIDNEISKV---DKAILT 716 (792)
Q Consensus 640 ~~kl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DV~S~Gv~l~el~tg~~p~~~~~~~~---~~~~~~ 716 (792)
.+||+|||+++..... .....||+.|+|||.+.+..++.++|||||||++|||++|+.||....... ....+.
T Consensus 176 ~~kl~Dfg~a~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~ 251 (373)
T 1q8y_A 176 QIKIADLGNACWYDEH----YTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHIA 251 (373)
T ss_dssp EEEECCCTTCEETTBC----CCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC---------CHHHHHH
T ss_pred eEEEcccccccccCCC----CCCCCCCccccCcHHHhCCCCCchHhHHHHHHHHHHHHhCCCCCCCCcccccCChHHHHH
Confidence 7999999999876432 233468999999999999999999999999999999999999997543211 000000
Q ss_pred HHHHHhhcc--------c----------------------chhHhhhchhcccCCHHHHHHHHHHHHHccccCCCCCCCH
Q 003836 717 DWAYDRYQE--------R----------------------TLEALVENDLEAMNNVTMLHRFVMVAFWCIQEDPSHRPTM 766 (792)
Q Consensus 717 ~~~~~~~~~--------~----------------------~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~ 766 (792)
... ..... . .+...... ....+.....++.+|+.+||+.||++|||+
T Consensus 252 ~~~-~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~ 328 (373)
T 1q8y_A 252 QII-ELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTE--KYKFSKDEAKEISDFLSPMLQLDPRKRADA 328 (373)
T ss_dssp HHH-HHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHH--TTCCCHHHHHHHHHHHGGGGCSSTTTCBCH
T ss_pred HHH-HhcCCCCHHHHhccchhhhhcCCcchhcccccccccchhhhhhh--cccCCcchHHHHHHHHHHHhccCccccCCH
Confidence 000 00000 0 00111111 112456778899999999999999999999
Q ss_pred HhHHHH--hccCcCC
Q 003836 767 RKVTQM--LEGVVEV 779 (792)
Q Consensus 767 ~evl~~--L~~~~~~ 779 (792)
+|+++. +.+....
T Consensus 329 ~ell~hp~f~~~~~~ 343 (373)
T 1q8y_A 329 GGLVNHPWLKDTLGM 343 (373)
T ss_dssp HHHHTCGGGTTCTTC
T ss_pred HHHhhChhhhcccCc
Confidence 999984 4544433
|
| >1dlp_A Lectin scafet precursor; two-domain lectin, beta prism II fold, native, sugar binding protein; 3.30A {Hyacinthoides hispanica} SCOP: b.78.1.1 b.78.1.1 | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-35 Score=297.36 Aligned_cols=212 Identities=18% Similarity=0.217 Sum_probs=163.4
Q ss_pred cccCcccCCcceeecCCCCceecCCCeEEEeeeecCCCCceEEEEEeecCCCCcEEEEecCCCCCCCCeeEEEEeCccEE
Q 003836 21 QSNGTISIGQQLTAAESTEPWLSPSKDFALGFHQLDSKDLFLPAIWYYKIPSKTIVWYASAVNPAPRGSKLRLTANRGLV 100 (792)
Q Consensus 21 ~~~~~i~~g~~l~~~~~~~~lvS~~g~F~lGF~~~~~~~~~~~gIW~~~~~~~tvvWvANr~~P~~~~~~l~~~~~G~Lv 100 (792)
++.|+|.+|++|++++ +| ++|.|+|||+.+++. ++|.. +|+||+|||+.| .++.|+|+.|||||
T Consensus 6 ~~~~~i~~g~~L~~g~---~l--~~g~f~l~f~~~gnl------~ly~~---~~~vW~an~~~~--~~~~l~l~~dGnLv 69 (236)
T 1dlp_A 6 GLSHEGSHPQTLHAAQ---SL--ELSSFRFTMQSDCNL------VLFDS---DVRVWASNTAGA--TGCRAVLQSDGLLV 69 (236)
T ss_dssp CSSSSSCSCSCCCTTC---EE--CSTTEEEEECTTSCE------EEEES---SSEEECCCCCSC--SCCBCCBCSSSCBC
T ss_pred eccceeCCCCEECCCC---EE--EcCCEEEEECCCCcE------EEEEC---CEEEEECCCCCC--CCeEEEEcCCCcEE
Confidence 4568999999998654 66 599999999876542 23443 799999999999 66789999999999
Q ss_pred EEcCCCCEEEEeccCCC-cceeEEEecCCcEEEEecCCccccccccCCcccc----------cCCCccccc-eEEeeecc
Q 003836 101 LEDPEGREIWKSEISTG-QAAFGVLYDTGNFLIVNTNSERLWQSFDHPTDTL----------LPTQTMERG-GVVSSRRK 168 (792)
Q Consensus 101 l~~~~~~~vWst~~~~~-~~~~a~LldsGNlVl~~~~~~~lWQSFd~PtDtl----------Lpg~~l~~~-~~L~S~~s 168 (792)
|+|++|++||+|+++.. +..+|+|+|+|||||+++ ++||||||||||+ +|||+++.+ ++|++
T Consensus 70 l~d~~~~~vW~s~~~~~~~~~~~~l~d~Gnlvl~~~---~~W~S~~~p~~t~~lp~~g~d~L~~gq~~~~~~~~L~s--- 143 (236)
T 1dlp_A 70 ILTAQNTIRWSSGTKGSIGNYVLVLQPDRTVTIYGP---GLWDSGTSNKGSVVVANNGNSILYSTQGNDNHPQTLHA--- 143 (236)
T ss_dssp CBCTTTCCSCCCCCCCCSSCCEEEECSSSCEEEECS---EEEECSCCCSSCCCCSSCCCEECCCC--CCCCCCEECS---
T ss_pred EEcCCCcEEEeCCccccCCcEEEEEeCCCCEEEecC---CEEECCCCCCcccccCCccceEEecCCcCCCccceEEc---
Confidence 99999999999998643 345899999999999964 8999999998655 777766554 46764
Q ss_pred CCCCCCCceeEeecCCCceeeeeeccCCCcccccccccCCcccccCCCcceeEEccCCcEEEEecccceeeecccccccc
Q 003836 169 DTYFSRGRFQFRLLEDGNAVLNTINLESGFAYDAYFWSNTFDTNRSNAGYRVVFNESGQLYVLRENKQRASLVPETVSAK 248 (792)
Q Consensus 169 ~~~~s~G~~~~~~~~~g~~~~~~~~~~~~~~~~~y~~~~~~~~~~~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~~~~~~ 248 (792)
..||++|.|+++++++|+++++ +.. .+||.++++... ....+.++.+|.++++..++++++.+... ...
T Consensus 144 ~~d~s~G~~~l~l~~dG~LvL~--~~~-----~~~W~s~~~~~~---~~~~~~L~~~Gnl~ly~~~~~~vw~s~~~-~~~ 212 (236)
T 1dlp_A 144 TQSLQLSPYRLSMETDCNLVLF--DRD-----DRVWSTNTAGKG---TGCRAVLQPNGRMDVLTNQNIAVWTSGNS-RSA 212 (236)
T ss_dssp SCCCBCSSCEEEEETTTEEEEE--BTT-----BCCSCCCCCSSC---SSCEEEEETTTEEEEEETTTEEEEECCCC-CSS
T ss_pred CcEeecCcEEEEECCCCcEEEE--cCC-----EeEEeCCCcCCC---CceEEEECCCCcEEEEeCCCcEEEEeCCC-CCC
Confidence 6789999999999999976553 332 468988877432 33456788889888887666666655322 222
Q ss_pred ccEEEEEEecCCcEEEEe
Q 003836 249 ENYLRATLNFDGVFIFYS 266 (792)
Q Consensus 249 ~~~~r~~L~~dG~l~~y~ 266 (792)
..+|++|++||++++|.
T Consensus 213 -~~~rl~Ld~dG~l~ly~ 229 (236)
T 1dlp_A 213 -GRYVFVLQPDRNLAIYG 229 (236)
T ss_dssp -SCCEEEECSSSCEEEEC
T ss_pred -CCEEEEEcCCCcEEEeC
Confidence 35899999999999995
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-35 Score=330.59 Aligned_cols=244 Identities=25% Similarity=0.315 Sum_probs=183.9
Q ss_pred hhhcCccccceEEEeeecCCCceEEEEEEcccccccchHHHHHHHHHhccc-CCCCcccccceeccCCceEEEEEeccCC
Q 003836 506 KEELGRGAFGTVYKGFVNMGSSNHVAVKKLNSVFQDSEKEFKAEVNGIGQT-HHKNLVRLLGYCDEGQNRLLVYEFMSNG 584 (792)
Q Consensus 506 ~~~lG~G~~g~Vy~g~~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l-~h~niv~l~g~~~~~~~~~lV~E~~~~g 584 (792)
.+.||+|+||+||.+.. .+++.||||++... ..+.+.+|++++.++ +||||+++++++.+.+..++||||++ |
T Consensus 20 ~~~LG~G~~g~V~~~~~--~~g~~vAvK~~~~~---~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~lv~E~~~-g 93 (434)
T 2rio_A 20 EKILGYGSSGTVVFQGS--FQGRPVAVKRMLID---FCDIALMEIKLLTESDDHPNVIRYYCSETTDRFLYIALELCN-L 93 (434)
T ss_dssp EEEEEECSTTCEEEEEE--SSSSEEEEEEEEGG---GHHHHHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEECCCS-E
T ss_pred cCeEeeCCCeEEEEEEE--ECCeEEEEEEEcHH---HHHHHHHHHHHHHhccCCCCcCeEEEEEecCCeEEEEEecCC-C
Confidence 36799999999976532 34679999998642 345678999999886 89999999999999999999999996 6
Q ss_pred CccccccCCCCC-------chhHHHHHHHHHHHHHHHHhhccCCCeEecCCCCCcEEEcCC-------------CCeEEe
Q 003836 585 TVASFLFGDSKP-------NWKLRTEIAMGIAGGLFYLHEECCTQIIHCDIKPQNILLDDH-------------YNARIS 644 (792)
Q Consensus 585 sL~~~l~~~~~l-------~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dikp~NILl~~~-------------~~~kl~ 644 (792)
+|.+++...... .+..+..++.||+.||+|||+. +|+||||||+|||++.+ +.+||+
T Consensus 94 sL~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDLkp~NILl~~~~~~~~~~~~~~~~~~~kL~ 170 (434)
T 2rio_A 94 NLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHSL---KIIHRDLKPQNILVSTSSRFTADQQTGAENLRILIS 170 (434)
T ss_dssp EHHHHHHTC------------CCHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEECCHHHHSCCTTCCCSCEEEEC
T ss_pred CHHHHHhccCCCchhhhhccchhHHHHHHHHHHHHHHHHHC---CccccCCChHhEEEecCcccccccccCCCceEEEEc
Confidence 999999765322 3445678999999999999998 99999999999999754 489999
Q ss_pred ecCCCccccCCCCC---ccccccccCCccccccccc-------CCCCcccceehHHHHHHHHHh-cCcCCCcchhhhhhh
Q 003836 645 DFGLAKLLTLDQSH---TNTAIRGTKGYVAPEWFRN-------MPITVKVDVYSYGVLLLEIIC-LRRNIDNEISKVDKA 713 (792)
Q Consensus 645 Dfg~a~~~~~~~~~---~~~~~~gt~~y~aPE~~~~-------~~~~~k~DV~S~Gv~l~el~t-g~~p~~~~~~~~~~~ 713 (792)
|||+++........ ......||+.|+|||++.+ ..++.++|||||||++|||++ |+.||........
T Consensus 171 DFG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~~~~-- 248 (434)
T 2rio_A 171 DFGLCKKLDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDKYSRES-- 248 (434)
T ss_dssp CCTTCEECCC--------------CCTTSCHHHHSCCCTTSCCCCCCTHHHHHHHHHHHHHHHTTSCCTTCSTTTHHH--
T ss_pred ccccceecCCCCccceeeecCCCCCCCccCHHHhccccccccccCcchhhhhHhHHHHHHHHHhCCCCCCCCchhhHH--
Confidence 99999987544322 1234569999999999865 678999999999999999999 8999865432211
Q ss_pred hHHHHHHHhhcccchhHhhhchhcccCCHHHHHHHHHHHHHccccCCCCCCCHHhHHH
Q 003836 714 ILTDWAYDRYQERTLEALVENDLEAMNNVTMLHRFVMVAFWCIQEDPSHRPTMRKVTQ 771 (792)
Q Consensus 714 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~ 771 (792)
......... +......+...+.++.+++.+||+.||++|||+.||++
T Consensus 249 ---~i~~~~~~~--------~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~ 295 (434)
T 2rio_A 249 ---NIIRGIFSL--------DEMKCLHDRSLIAEATDLISQMIDHDPLKRPTAMKVLR 295 (434)
T ss_dssp ---HHHHTCCCC--------CCCTTCCCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred ---HHhcCCCCc--------ccccccccccchHHHHHHHHHHhhCChhhCCCHHHHHh
Confidence 000000000 11112224566788999999999999999999999986
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-35 Score=320.58 Aligned_cols=243 Identities=21% Similarity=0.254 Sum_probs=168.1
Q ss_pred hhcCccccceEEEeeecCCCceEEEEEEcccccccchHHHHHHHHHhcccCCCCcccccceecc----CCceEEEEEecc
Q 003836 507 EELGRGAFGTVYKGFVNMGSSNHVAVKKLNSVFQDSEKEFKAEVNGIGQTHHKNLVRLLGYCDE----GQNRLLVYEFMS 582 (792)
Q Consensus 507 ~~lG~G~~g~Vy~g~~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~----~~~~~lV~E~~~ 582 (792)
+.||+|+||+||++... .+++.||||++... .....+....++.++||||+++++++.. ....++||||++
T Consensus 35 ~~lG~G~~g~V~~~~~~-~~~~~vavK~~~~~----~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~lv~e~~~ 109 (336)
T 3fhr_A 35 QVLGLGVNGKVLECFHR-RTGQKCALKLLYDS----PKARQEVDHHWQASGGPHIVCILDVYENMHHGKRCLLIIMECME 109 (336)
T ss_dssp EEEEEETTEEEEEEEET-TTCCEEEEEEEESS----HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEEEEEECCT
T ss_pred eeeeeCCCeEEEEEEEC-CCCCEEEEEEecCc----HHHHHHHHHHHHhcCCCChHHHHHHHhhccCCCceEEEEEeccC
Confidence 46999999999999754 45679999998653 1222223334566799999999999865 445899999999
Q ss_pred CCCccccccCC--CCCchhHHHHHHHHHHHHHHHHhhccCCCeEecCCCCCcEEEcC---CCCeEEeecCCCccccCCCC
Q 003836 583 NGTVASFLFGD--SKPNWKLRTEIAMGIAGGLFYLHEECCTQIIHCDIKPQNILLDD---HYNARISDFGLAKLLTLDQS 657 (792)
Q Consensus 583 ~gsL~~~l~~~--~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dikp~NILl~~---~~~~kl~Dfg~a~~~~~~~~ 657 (792)
+|+|.+++... ..+++..+..++.||+.||.|||++ +|+||||||+|||++. ++.+||+|||+++.....
T Consensus 110 gg~L~~~l~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~---~ivH~dlkp~NIll~~~~~~~~~kl~Dfg~~~~~~~~-- 184 (336)
T 3fhr_A 110 GGELFSRIQERGDQAFTEREAAEIMRDIGTAIQFLHSH---NIAHRDVKPENLLYTSKEKDAVLKLTDFGFAKETTQN-- 184 (336)
T ss_dssp TEEHHHHHHTC-CCCCBHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEESCSSTTCCEEECCCTTCEEC-----
T ss_pred CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEEecCCCceEEEeccccceecccc--
Confidence 99999999765 3689999999999999999999999 9999999999999986 455999999999865422
Q ss_pred CccccccccCCcccccccccCCCCcccceehHHHHHHHHHhcCcCCCcchhhhhhhhHHHHHHHhhcccchhHhhhc--h
Q 003836 658 HTNTAIRGTKGYVAPEWFRNMPITVKVDVYSYGVLLLEIICLRRNIDNEISKVDKAILTDWAYDRYQERTLEALVEN--D 735 (792)
Q Consensus 658 ~~~~~~~gt~~y~aPE~~~~~~~~~k~DV~S~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~ 735 (792)
......+|+.|+|||.+.+..++.++||||||+++|||++|+.||............ ...+... .
T Consensus 185 -~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~------------~~~~~~~~~~ 251 (336)
T 3fhr_A 185 -ALQTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGFPPFYSNTGQAISPGM------------KRRIRLGQYG 251 (336)
T ss_dssp --------------------CHHHHHHHHHHHHHHHHHHHHSSCCC---------------------------------C
T ss_pred -ccccCCCCcCccChhhhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCccchhhhhhH------------HHhhhccccc
Confidence 223446899999999998889999999999999999999999999654322110000 0000000 0
Q ss_pred hcccCCHHHHHHHHHHHHHccccCCCCCCCHHhHHHH
Q 003836 736 LEAMNNVTMLHRFVMVAFWCIQEDPSHRPTMRKVTQM 772 (792)
Q Consensus 736 ~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~ 772 (792)
.........+..+.+++.+||+.||++|||++|+++.
T Consensus 252 ~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 288 (336)
T 3fhr_A 252 FPNPEWSEVSEDAKQLIRLLLKTDPTERLTITQFMNH 288 (336)
T ss_dssp CCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHS
T ss_pred cCchhhccCCHHHHHHHHHHCCCChhHCcCHHHHhcC
Confidence 0111112345678899999999999999999999984
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-35 Score=320.00 Aligned_cols=249 Identities=26% Similarity=0.365 Sum_probs=174.0
Q ss_pred hhhhcCccccceEEEeeecCCCceEEEEEEcccccc-cchHHHHHHHH-HhcccCCCCcccccceeccCCceEEEEEecc
Q 003836 505 FKEELGRGAFGTVYKGFVNMGSSNHVAVKKLNSVFQ-DSEKEFKAEVN-GIGQTHHKNLVRLLGYCDEGQNRLLVYEFMS 582 (792)
Q Consensus 505 ~~~~lG~G~~g~Vy~g~~~~~~~~~vavK~~~~~~~-~~~~~~~~Ei~-~l~~l~h~niv~l~g~~~~~~~~~lV~E~~~ 582 (792)
+.+.||+|+||.||++... .+++.||||++..... ....++..|+. +++.++||||+++++++.+.+..++||||++
T Consensus 26 ~~~~lg~G~~g~Vy~~~~~-~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~h~niv~~~~~~~~~~~~~lv~e~~~ 104 (327)
T 3aln_A 26 DLGEIGRGAYGSVNKMVHK-PSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCPYIVQFYGALFREGDCWICMELMS 104 (327)
T ss_dssp C-CEEEECSSEEEEEEEET-TTTEEEEEEEEECCCCHHHHHHHHHHHHHHHSSCCCTTBCCEEEEEECSSEEEEEECCCS
T ss_pred ehheeccCCCEEEEEEEEc-CCCCEEEEEEeecccCchHHHHHHHHHHHHHHcCCCCcEeeeeeEEEeCCceEEEEeecC
Confidence 3567999999999999754 4578999999976432 33445666665 7778899999999999999999999999998
Q ss_pred CCCccccccC-----CCCCchhHHHHHHHHHHHHHHHHhhccCCCeEecCCCCCcEEEcCCCCeEEeecCCCccccCCCC
Q 003836 583 NGTVASFLFG-----DSKPNWKLRTEIAMGIAGGLFYLHEECCTQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLDQS 657 (792)
Q Consensus 583 ~gsL~~~l~~-----~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dikp~NILl~~~~~~kl~Dfg~a~~~~~~~~ 657 (792)
+ +|.+++.. ...+++..+..++.|++.||.|||+. .+|+||||||+|||++.++.+||+|||+++......
T Consensus 105 ~-~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~--~~ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~- 180 (327)
T 3aln_A 105 T-SFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKEN--LKIIHRDIKPSNILLDRSGNIKLCDFGISGQLVDSI- 180 (327)
T ss_dssp E-EHHHHHHHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHH--HSCCCSCCCGGGEEEETTTEEEECCCSSSCC------
T ss_pred C-ChHHHHHHHHhhhcccCcHHHHHHHHHHHHHHHHHHhcc--CCEeECCCCHHHEEEcCCCCEEEccCCCceeccccc-
Confidence 5 78777753 46789999999999999999999995 389999999999999999999999999998764322
Q ss_pred CccccccccCCccccccc----ccCCCCcccceehHHHHHHHHHhcCcCCCcchhhhhhhhHHHHHHHhhcccchhHhhh
Q 003836 658 HTNTAIRGTKGYVAPEWF----RNMPITVKVDVYSYGVLLLEIICLRRNIDNEISKVDKAILTDWAYDRYQERTLEALVE 733 (792)
Q Consensus 658 ~~~~~~~gt~~y~aPE~~----~~~~~~~k~DV~S~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 733 (792)
......||+.|+|||.+ .+..++.++||||||+++|||++|+.||.......+.. ....... .
T Consensus 181 -~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~-------~~~~~~~-----~ 247 (327)
T 3aln_A 181 -AKTRDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPKWNSVFDQL-------TQVVKGD-----P 247 (327)
T ss_dssp --------------------------CCSHHHHHHHHHHHHHHHHSCCCSSCC--------------CCCCCSC-----C
T ss_pred -ccccCCCCccccCceeeccccCcCCCCchhhHHHHHHHHHHHHHCCCCCCCcchHHHHH-------HHHhcCC-----C
Confidence 22234689999999998 45678999999999999999999999996532110000 0000000 0
Q ss_pred chhcccCCHHHHHHHHHHHHHccccCCCCCCCHHhHHH
Q 003836 734 NDLEAMNNVTMLHRFVMVAFWCIQEDPSHRPTMRKVTQ 771 (792)
Q Consensus 734 ~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~ 771 (792)
+.+........+..+.+++.+||+.||++|||++|+++
T Consensus 248 ~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~ 285 (327)
T 3aln_A 248 PQLSNSEEREFSPSFINFVNLCLTKDESKRPKYKELLK 285 (327)
T ss_dssp CCCCCCSSCCCCHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred CCCCCcccccCCHHHHHHHHHHhhCChhhCcCHHHHHh
Confidence 01111111234567889999999999999999999875
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-35 Score=326.85 Aligned_cols=243 Identities=24% Similarity=0.306 Sum_probs=180.9
Q ss_pred hhhhcCccccceEEEeeecCCCceEEEEEEcccccccchHHHHHHHHHhccc-CCCCcccccceeccCCceEEEEEeccC
Q 003836 505 FKEELGRGAFGTVYKGFVNMGSSNHVAVKKLNSVFQDSEKEFKAEVNGIGQT-HHKNLVRLLGYCDEGQNRLLVYEFMSN 583 (792)
Q Consensus 505 ~~~~lG~G~~g~Vy~g~~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l-~h~niv~l~g~~~~~~~~~lV~E~~~~ 583 (792)
..+.||+|+||+|+.... .+++.||||++..... ..+.+|+++++++ +||||+++++++.+....++||||++
T Consensus 28 ~~~~LG~G~~G~V~~~~~--~~~~~vAvK~~~~~~~---~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~~~lv~E~~~- 101 (432)
T 3p23_A 28 PKDVLGHGAEGTIVYRGM--FDNRDVAVKRILPECF---SFADREVQLLRESDEHPNVIRYFCTEKDRQFQYIAIELCA- 101 (432)
T ss_dssp EEEEEEECGGGCEEEEEE--SSSSEEEEEEECTTTE---EECHHHHHHHHHSCCCTTBCCEEEEEEETTEEEEEEECCS-
T ss_pred cCCeeecCcCEEEEEEEE--eCCeEEEEEEECHHHH---HHHHHHHHHHHhccCCCCcCeEEEEEecCCEEEEEEECCC-
Confidence 346899999999654322 2457899999865322 2467899999998 79999999999999999999999997
Q ss_pred CCccccccCCC-CCchhHHHHHHHHHHHHHHHHhhccCCCeEecCCCCCcEEEcC-----CCCeEEeecCCCccccCCCC
Q 003836 584 GTVASFLFGDS-KPNWKLRTEIAMGIAGGLFYLHEECCTQIIHCDIKPQNILLDD-----HYNARISDFGLAKLLTLDQS 657 (792)
Q Consensus 584 gsL~~~l~~~~-~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dikp~NILl~~-----~~~~kl~Dfg~a~~~~~~~~ 657 (792)
|+|.+++.... ...+..+..++.||+.||+|||+. +|+||||||+|||++. ...+||+|||+++.......
T Consensus 102 g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlKp~NIll~~~~~~~~~~~kL~DFG~a~~~~~~~~ 178 (432)
T 3p23_A 102 ATLQEYVEQKDFAHLGLEPITLLQQTTSGLAHLHSL---NIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRH 178 (432)
T ss_dssp EEHHHHHHSSSCCCCSSCHHHHHHHHHHHHHHHHHT---TCCCCCCSTTSEEECCCBTTTBCCEEECCTTEEECC-----
T ss_pred CCHHHHHHhcCCCccchhHHHHHHHHHHHHHHHHHC---cCEeCCCCHHHEEEecCCCCCceeEEEecccceeeccCCCc
Confidence 59999997653 456667789999999999999999 9999999999999953 34688999999987654322
Q ss_pred --CccccccccCCcccccccc---cCCCCcccceehHHHHHHHHHh-cCcCCCcchhhhhhhhHHHHHHHhhcccchhHh
Q 003836 658 --HTNTAIRGTKGYVAPEWFR---NMPITVKVDVYSYGVLLLEIIC-LRRNIDNEISKVDKAILTDWAYDRYQERTLEAL 731 (792)
Q Consensus 658 --~~~~~~~gt~~y~aPE~~~---~~~~~~k~DV~S~Gv~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 731 (792)
.......||+.|+|||++. ...++.++|||||||++|||++ |+.||.......... ........
T Consensus 179 ~~~~~~~~~gt~~y~APE~l~~~~~~~~t~~~DiwSlG~il~ellt~g~~pf~~~~~~~~~~--------~~~~~~~~-- 248 (432)
T 3p23_A 179 SFSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQRQANI--------LLGACSLD-- 248 (432)
T ss_dssp -------CCSCTTSCCGGGTSCC---CCCTHHHHHHHHHHHHHHHTTSCBTTBSTTTHHHHH--------HTTCCCCT--
T ss_pred ceeeccccCCCcCccChhhhhcccccCCCcHHHHHHHHHHHHHHHcCCCCCcchhhHHHHHH--------HhccCCcc--
Confidence 2233467999999999997 4567889999999999999999 888885432211100 00000000
Q ss_pred hhchhcccCCHHHHHHHHHHHHHccccCCCCCCCHHhHHH
Q 003836 732 VENDLEAMNNVTMLHRFVMVAFWCIQEDPSHRPTMRKVTQ 771 (792)
Q Consensus 732 ~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~ 771 (792)
...........+.+++.+||+.||++|||++||++
T Consensus 249 -----~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~evl~ 283 (432)
T 3p23_A 249 -----CLHPEKHEDVIARELIEKMIAMDPQKRPSAKHVLK 283 (432)
T ss_dssp -----TSCTTCHHHHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred -----ccCccccccHHHHHHHHHHHhCCHhhCCCHHHHHh
Confidence 00112234566789999999999999999999995
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-35 Score=338.43 Aligned_cols=262 Identities=24% Similarity=0.269 Sum_probs=196.7
Q ss_pred HhhhhhhcCccccceEEEeeecCCCceEEEEEEcccc-cccchHHHHHHHHHhcccCCCCcccccceecc------CCce
Q 003836 502 TRGFKEELGRGAFGTVYKGFVNMGSSNHVAVKKLNSV-FQDSEKEFKAEVNGIGQTHHKNLVRLLGYCDE------GQNR 574 (792)
Q Consensus 502 ~~~~~~~lG~G~~g~Vy~g~~~~~~~~~vavK~~~~~-~~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~------~~~~ 574 (792)
.+.+.+.||+|+||+||++... .+++.||||++... .....+.+.+|++++++++||||+++++++.. .+..
T Consensus 15 rY~i~~~LG~G~fG~Vyla~~~-~tg~~VAVKvi~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~v~~~~~~~~~~~~~ 93 (676)
T 3qa8_A 15 PWEMKERLGTGGFGYVLRWIHQ-DTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVSAREVPDGLQKLAPNDLP 93 (676)
T ss_dssp --CCCCCCCBCSSSBCCCCCCT-TTTCCEEECCCCSCCCHHHHHHHHHHHHHHHHCCBTTBCCEEECCTTTCCCCTTSSC
T ss_pred CeEEEEEEeeCCCeEEEEEEEC-CCCcEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCceeeeecccccccCCCeE
Confidence 3556789999999999999654 45678999998754 23345679999999999999999999998865 6778
Q ss_pred EEEEEeccCCCccccccCCC---CCchhHHHHHHHHHHHHHHHHhhccCCCeEecCCCCCcEEEcCCCC---eEEeecCC
Q 003836 575 LLVYEFMSNGTVASFLFGDS---KPNWKLRTEIAMGIAGGLFYLHEECCTQIIHCDIKPQNILLDDHYN---ARISDFGL 648 (792)
Q Consensus 575 ~lV~E~~~~gsL~~~l~~~~---~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dikp~NILl~~~~~---~kl~Dfg~ 648 (792)
++||||+++|+|.+++.... .+++..+..|+.||+.||+|||+. +|+||||||+|||++.++. +||+|||+
T Consensus 94 ~LVmEy~~ggsL~~~L~~~~~~~~lse~~i~~I~~QLl~aL~yLHs~---gIVHrDLKP~NILl~~~g~~~~vKL~DFG~ 170 (676)
T 3qa8_A 94 LLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYLHEN---RIIHRDLKPENIVLQPGPQRLIHKIIDLGY 170 (676)
T ss_dssp CCEEECCSSCBHHHHHHSSSCTTCCCSSHHHHHHHHHHHHHHHHHHT---TBCCCCCCSTTEEEECCSSSCEEEECSCCC
T ss_pred EEEEEeCCCCCHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHC---CCccCCCCHHHeEeecCCCceeEEEccccc
Confidence 99999999999999997643 689999999999999999999998 9999999999999997765 99999999
Q ss_pred CccccCCCCCccccccccCCcccccccccCCCCcccceehHHHHHHHHHhcCcCCCcchhhhhh--hhHHHHHHHhhccc
Q 003836 649 AKLLTLDQSHTNTAIRGTKGYVAPEWFRNMPITVKVDVYSYGVLLLEIICLRRNIDNEISKVDK--AILTDWAYDRYQER 726 (792)
Q Consensus 649 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DV~S~Gv~l~el~tg~~p~~~~~~~~~~--~~~~~~~~~~~~~~ 726 (792)
++...... ......||+.|+|||.+.+..++.++||||||+++|||++|+.||......... ..............
T Consensus 171 a~~~~~~~--~~~~~~gt~~Y~APE~l~~~~~s~ksDIwSLGviLyeLltG~~Pf~~~~~~~~~~~~i~~~~~~~~~~~~ 248 (676)
T 3qa8_A 171 AKELDQGE--LCTEFVGTLQYLAPELLEQKKYTVTVDYWSFGTLAFECITGFRPFLPNWQPVQWHGKVREKSNEHIVVYD 248 (676)
T ss_dssp CCBTTSCC--CCCCCCSCCTTCSSCSSCCSCCSTTHHHHHHHHHHHHHHSSCSSCCSSCHHHHSSTTCC------CCSCC
T ss_pred cccccccc--ccccccCCcccCChHHhccCCCCchhHHHHHHHHHHHHHHCCCCCCcccchhhhhhhhhcccchhhhhhh
Confidence 98764332 223456899999999999999999999999999999999999999754221110 00000000000000
Q ss_pred chhHhh--hch--hcccCCHHHHHHHHHHHHHccccCCCCCCCHHhH
Q 003836 727 TLEALV--END--LEAMNNVTMLHRFVMVAFWCIQEDPSHRPTMRKV 769 (792)
Q Consensus 727 ~~~~~~--~~~--~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~ev 769 (792)
...... ... .........+..+.+++..||+.||++|||++|+
T Consensus 249 ~l~g~~~~~~~lp~p~~l~~~ls~~L~dLI~~mL~~DP~kRPTa~el 295 (676)
T 3qa8_A 249 DLTGAVKFSSVLPTPNHLSGILAGKLERWLQCMLMWHQRQRGTDPQN 295 (676)
T ss_dssp CCSSSCCCCSSSCCSCCCCGGGHHHHHHHHHHHSCSSCC---CCTTC
T ss_pred hhccccccccccCCchhhchhhhHHHHHHHHHHccCCHhhCcCHHHH
Confidence 000000 000 0111234467889999999999999999999873
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-34 Score=343.28 Aligned_cols=238 Identities=21% Similarity=0.280 Sum_probs=190.2
Q ss_pred hhhhhhcCccccceEEEeeecCCCceEEEEEEccccc-ccchHHHHHHHHHhcccCCCCcccccceeccCCc-----eEE
Q 003836 503 RGFKEELGRGAFGTVYKGFVNMGSSNHVAVKKLNSVF-QDSEKEFKAEVNGIGQTHHKNLVRLLGYCDEGQN-----RLL 576 (792)
Q Consensus 503 ~~~~~~lG~G~~g~Vy~g~~~~~~~~~vavK~~~~~~-~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~-----~~l 576 (792)
+.+.+.||+|+||.||++.....+++.||||++.... ......+.+|++++++++||||+++++++.+.+. .+|
T Consensus 82 y~i~~~lg~G~~g~Vy~a~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~~~~l 161 (681)
T 2pzi_A 82 YEVKGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHSGDAEAQAMAMAERQFLAEVVHPSIVQIFNFVEHTDRHGDPVGYI 161 (681)
T ss_dssp EEEEEEEEEETTEEEEEEEEGGGTTEEEEEEESCSSCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEEECTTSCEEEEE
T ss_pred eEEEEEEeeCCCeEEEEEEEcCCCCcEEEEEEeCccCCHHHHHHHHHHHHHHHhcCCCCcCeEeeeEeecCCCCCceeEE
Confidence 4456789999999999998765457899999986532 3345678999999999999999999999987665 799
Q ss_pred EEEeccCCCccccccCCCCCchhHHHHHHHHHHHHHHHHhhccCCCeEecCCCCCcEEEcCCCCeEEeecCCCccccCCC
Q 003836 577 VYEFMSNGTVASFLFGDSKPNWKLRTEIAMGIAGGLFYLHEECCTQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLDQ 656 (792)
Q Consensus 577 V~E~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dikp~NILl~~~~~~kl~Dfg~a~~~~~~~ 656 (792)
||||+++++|.+++.. .+++..+..|+.||+.||.|||++ +|+||||||+|||++.+ .+||+|||+++.....
T Consensus 162 v~E~~~g~~L~~~~~~--~l~~~~~~~~~~qi~~aL~~lH~~---giiHrDlkp~NIll~~~-~~kl~DFG~a~~~~~~- 234 (681)
T 2pzi_A 162 VMEYVGGQSLKRSKGQ--KLPVAEAIAYLLEILPALSYLHSI---GLVYNDLKPENIMLTEE-QLKLIDLGAVSRINSF- 234 (681)
T ss_dssp EEECCCCEECC----C--CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECSS-CEEECCCTTCEETTCC-
T ss_pred EEEeCCCCcHHHHHhC--CCCHHHHHHHHHHHHHHHHHHHHC---CCeecccChHHeEEeCC-cEEEEecccchhcccC-
Confidence 9999999999998755 789999999999999999999998 99999999999999986 9999999999876432
Q ss_pred CCccccccccCCcccccccccCCCCcccceehHHHHHHHHHhcCcCCCcchhhhhhhhHHHHHHHhhcccchhHhhhchh
Q 003836 657 SHTNTAIRGTKGYVAPEWFRNMPITVKVDVYSYGVLLLEIICLRRNIDNEISKVDKAILTDWAYDRYQERTLEALVENDL 736 (792)
Q Consensus 657 ~~~~~~~~gt~~y~aPE~~~~~~~~~k~DV~S~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 736 (792)
....||+.|+|||.+.+.. +.++|||||||++|||++|..|+........ .
T Consensus 235 ----~~~~gt~~y~aPE~~~~~~-~~~sDi~slG~~l~~l~~g~~~~~~~~~~~~-----------------~------- 285 (681)
T 2pzi_A 235 ----GYLYGTPGFQAPEIVRTGP-TVATDIYTVGRTLAALTLDLPTRNGRYVDGL-----------------P------- 285 (681)
T ss_dssp ----SCCCCCTTTSCTTHHHHCS-CHHHHHHHHHHHHHHHHSCCCEETTEECSSC-----------------C-------
T ss_pred ----CccCCCccccCHHHHcCCC-CCceehhhhHHHHHHHHhCCCCCcccccccc-----------------c-------
Confidence 3456999999999987654 8999999999999999999888754321100 0
Q ss_pred cccCCHHHHHHHHHHHHHccccCCCCCCC-HHhHHHHhccC
Q 003836 737 EAMNNVTMLHRFVMVAFWCIQEDPSHRPT-MRKVTQMLEGV 776 (792)
Q Consensus 737 ~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs-~~evl~~L~~~ 776 (792)
...........+.+++.+||+.||++||+ ++++.+.|.++
T Consensus 286 ~~~~~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~~ 326 (681)
T 2pzi_A 286 EDDPVLKTYDSYGRLLRRAIDPDPRQRFTTAEEMSAQLTGV 326 (681)
T ss_dssp TTCHHHHHCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHH
T ss_pred ccccccccCHHHHHHHhhhccCChhhCCCHHHHHHHHHHHH
Confidence 00001123356889999999999999995 66666666543
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-34 Score=310.94 Aligned_cols=245 Identities=22% Similarity=0.348 Sum_probs=173.3
Q ss_pred hhhhcCccccceEEEeeecCCCceEEEEEEccccccc-c-hHHHHHHHHHhcccCCCCcccccceeccCCceEEEEEecc
Q 003836 505 FKEELGRGAFGTVYKGFVNMGSSNHVAVKKLNSVFQD-S-EKEFKAEVNGIGQTHHKNLVRLLGYCDEGQNRLLVYEFMS 582 (792)
Q Consensus 505 ~~~~lG~G~~g~Vy~g~~~~~~~~~vavK~~~~~~~~-~-~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~lV~E~~~ 582 (792)
+.+.||+|+||.||++... .+++.||||++...... . .+.+.++..+++.++||||+++++++.+.+..++||||+
T Consensus 29 ~~~~lg~G~~g~V~~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~~~~lv~e~~- 106 (318)
T 2dyl_A 29 NLGEMGSGTCGQVWKMRFR-KTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCPYIVQCFGTFITNTDVFIAMELM- 106 (318)
T ss_dssp EEEEC------CEEEEEET-TTCCEEEEEEEETTSCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEECCC-
T ss_pred ccceeeecCCeeEEEEEEe-cCCeEEEEEEecccccchHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCcEEEEEecc-
Confidence 4568999999999999764 45679999999754322 2 233445556788889999999999999999999999999
Q ss_pred CCCccccccC-CCCCchhHHHHHHHHHHHHHHHHhh-ccCCCeEecCCCCCcEEEcCCCCeEEeecCCCccccCCCCCcc
Q 003836 583 NGTVASFLFG-DSKPNWKLRTEIAMGIAGGLFYLHE-ECCTQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLDQSHTN 660 (792)
Q Consensus 583 ~gsL~~~l~~-~~~l~~~~~~~i~~~ia~gL~yLH~-~~~~~ivH~dikp~NILl~~~~~~kl~Dfg~a~~~~~~~~~~~ 660 (792)
++.+..+... ...+++..+..++.||++||.|||+ . +|+|+||||+|||++.++.+||+|||+++...... ..
T Consensus 107 ~~~~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~--~~ 181 (318)
T 2dyl_A 107 GTCAEKLKKRMQGPIPERILGKMTVAIVKALYYLKEKH---GVIHRDVKPSNILLDERGQIKLCDFGISGRLVDDK--AK 181 (318)
T ss_dssp SEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHHH---CCCCCCCCGGGEEECTTSCEEECCCTTC-----------
T ss_pred CCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhhC---CEEeCCCCHHHEEECCCCCEEEEECCCchhccCCc--cc
Confidence 4444444433 3578999999999999999999998 5 89999999999999999999999999997654322 22
Q ss_pred ccccccCCcccccccc-----cCCCCcccceehHHHHHHHHHhcCcCCCcchhhhhhhhHHHHHHHhhcccchhHhhhch
Q 003836 661 TAIRGTKGYVAPEWFR-----NMPITVKVDVYSYGVLLLEIICLRRNIDNEISKVDKAILTDWAYDRYQERTLEALVEND 735 (792)
Q Consensus 661 ~~~~gt~~y~aPE~~~-----~~~~~~k~DV~S~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 735 (792)
....+++.|+|||.+. ...++.++||||||+++|||++|+.||........ .+.. +....
T Consensus 182 ~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~--~~~~-------------~~~~~ 246 (318)
T 2dyl_A 182 DRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKNCKTDFE--VLTK-------------VLQEE 246 (318)
T ss_dssp -----CCTTCCHHHHC--------CCTHHHHHHHHHHHHHHHHSSCTTTTCCSHHH--HHHH-------------HHHSC
T ss_pred cccCCCccccChhhcccccccccCCccccchhhHHHHHHHHHhCCCCCCCCCccHH--HHHH-------------HhccC
Confidence 3346899999999984 45788999999999999999999999975322111 0000 00000
Q ss_pred -hcccCCHHHHHHHHHHHHHccccCCCCCCCHHhHHH
Q 003836 736 -LEAMNNVTMLHRFVMVAFWCIQEDPSHRPTMRKVTQ 771 (792)
Q Consensus 736 -~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~ 771 (792)
.........+.++.+++.+||+.||.+||+++|+++
T Consensus 247 ~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 283 (318)
T 2dyl_A 247 PPLLPGHMGFSGDFQSFVKDCLTKDHRKRPKYNKLLE 283 (318)
T ss_dssp CCCCCSSSCCCHHHHHHHHHHTCSCTTTSCCHHHHTT
T ss_pred CCCCCccCCCCHHHHHHHHHHccCChhHCcCHHHHhh
Confidence 000011123467889999999999999999999986
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-34 Score=301.11 Aligned_cols=228 Identities=11% Similarity=0.054 Sum_probs=180.0
Q ss_pred HhhhhhhcCccccceEEEeeecCCCceEEEEEEccccccc---chHHHHHHHHHhcccCCCCcccccceeccCCceEEEE
Q 003836 502 TRGFKEELGRGAFGTVYKGFVNMGSSNHVAVKKLNSVFQD---SEKEFKAEVNGIGQTHHKNLVRLLGYCDEGQNRLLVY 578 (792)
Q Consensus 502 ~~~~~~~lG~G~~g~Vy~g~~~~~~~~~vavK~~~~~~~~---~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~lV~ 578 (792)
.+.+.+.||+|+||.||+|... .+++.||||++...... ..+.+.+|+..+.+++||||+++++++.+.+..++||
T Consensus 32 ~y~i~~~lg~G~~g~Vy~a~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 110 (286)
T 3uqc_A 32 RYRLLIFHGGVPPLQFWQALDT-ALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARVLDVVHTRAGGLVVA 110 (286)
T ss_dssp TEEEEEEEEBSTTCEEEEEEET-TTTEEEEEEESCTTCCSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred cEEEEEEEcccCCeEEEEEEec-CCCceEEEEEECcccccCHHHHHHHHHHHHHHhcCCCCCcceeeEEEEECCcEEEEE
Confidence 3455678999999999999754 45689999999764332 2467999999999999999999999999999999999
Q ss_pred EeccCCCccccccCCCCCchhHHHHHHHHHHHHHHHHhhccCCCeEecCCCCCcEEEcCCCCeEEeecCCCccccCCCCC
Q 003836 579 EFMSNGTVASFLFGDSKPNWKLRTEIAMGIAGGLFYLHEECCTQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLDQSH 658 (792)
Q Consensus 579 E~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dikp~NILl~~~~~~kl~Dfg~a~~~~~~~~~ 658 (792)
||+++++|.+++... .......+|+.||+.||+|||++ +|+||||||+|||++.++.+||++++
T Consensus 111 e~~~g~~L~~~l~~~--~~~~~~~~i~~ql~~aL~~lH~~---givH~Dikp~NIll~~~g~~kl~~~~----------- 174 (286)
T 3uqc_A 111 EWIRGGSLQEVADTS--PSPVGAIRAMQSLAAAADAAHRA---GVALSIDHPSRVRVSIDGDVVLAYPA----------- 174 (286)
T ss_dssp ECCCEEEHHHHHTTC--CCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEEETTSCEEECSCC-----------
T ss_pred EecCCCCHHHHHhcC--CChHHHHHHHHHHHHHHHHHHHC---CCccCCCCcccEEEcCCCCEEEEecc-----------
Confidence 999999999999543 34557889999999999999999 99999999999999999999998443
Q ss_pred ccccccccCCcccccccccCCCCcccceehHHHHHHHHHhcCcCCCcchhhhhhhhHHHHHHHhhcccchhHhhhchh--
Q 003836 659 TNTAIRGTKGYVAPEWFRNMPITVKVDVYSYGVLLLEIICLRRNIDNEISKVDKAILTDWAYDRYQERTLEALVENDL-- 736 (792)
Q Consensus 659 ~~~~~~gt~~y~aPE~~~~~~~~~k~DV~S~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-- 736 (792)
|++| ++.++||||||+++|||++|+.||............ ...+....
T Consensus 175 ----------~~~~-------~~~~~Di~slG~il~elltg~~Pf~~~~~~~~~~~~-------------~~~~~~~~~~ 224 (286)
T 3uqc_A 175 ----------TMPD-------ANPQDDIRGIGASLYALLVNRWPLPEAGVRSGLAPA-------------ERDTAGQPIE 224 (286)
T ss_dssp ----------CCTT-------CCHHHHHHHHHHHHHHHHHSEECSCCCSBCCCSEEC-------------CBCTTSCBCC
T ss_pred ----------ccCC-------CCchhHHHHHHHHHHHHHHCCCCCCcCCcchhhHHH-------------HHHhccCCCC
Confidence 4433 689999999999999999999999764322100000 00000000
Q ss_pred cccCCHHHHHHHHHHHHHccccCCCCCCCHHhHHHHhccCc
Q 003836 737 EAMNNVTMLHRFVMVAFWCIQEDPSHRPTMRKVTQMLEGVV 777 (792)
Q Consensus 737 ~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~L~~~~ 777 (792)
........+..+.+++.+||+.||++| |+.|+++.|+.+.
T Consensus 225 ~~~~~~~~~~~l~~li~~~l~~dP~~R-s~~el~~~L~~~~ 264 (286)
T 3uqc_A 225 PADIDRDIPFQISAVAARSVQGDGGIR-SASTLLNLMQQAT 264 (286)
T ss_dssp HHHHCTTSCHHHHHHHHHHHCTTSSCC-CHHHHHHHHHHHH
T ss_pred hhhcccCCCHHHHHHHHHHcccCCccC-CHHHHHHHHHHHh
Confidence 000112234678899999999999999 9999999998754
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-34 Score=309.46 Aligned_cols=243 Identities=15% Similarity=0.103 Sum_probs=182.7
Q ss_pred HHHhhhhhhcCccccceEEEeeecCCCceEEEEEEccccc--------ccchHHHHHHHHHhcccC--------------
Q 003836 500 EVTRGFKEELGRGAFGTVYKGFVNMGSSNHVAVKKLNSVF--------QDSEKEFKAEVNGIGQTH-------------- 557 (792)
Q Consensus 500 ~~~~~~~~~lG~G~~g~Vy~g~~~~~~~~~vavK~~~~~~--------~~~~~~~~~Ei~~l~~l~-------------- 557 (792)
...+.+.+.||+|+||+||+|.. +++.||||++.... ....+.+.+|+.++++++
T Consensus 19 ~~~y~~~~~lG~G~~g~V~~~~~---~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~~~~~~~h~niv 95 (336)
T 2vuw_A 19 TEKLQRCEKIGEGVFGEVFQTIA---DHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSGEVCNRTEGFI 95 (336)
T ss_dssp HHHHHTCEEEEEETTEEEEEEEE---TTEEEEEEEEEESCSSCBTTBCCBCHHHHHHHHHHHHHHHHGGGCSSSBCCCBC
T ss_pred cccchheeeecccCceEEEEEEe---CCceEEEEEEecCCccccccccchhHHHHHHHHHHHHHHHHhhccccccCCchh
Confidence 34456678999999999999975 45899999997542 223478899999988886
Q ss_pred ------------CCCcccccceecc-------------CCceEEEEEeccCCCccccccCCCCCchhHHHHHHHHHHHHH
Q 003836 558 ------------HKNLVRLLGYCDE-------------GQNRLLVYEFMSNGTVASFLFGDSKPNWKLRTEIAMGIAGGL 612 (792)
Q Consensus 558 ------------h~niv~l~g~~~~-------------~~~~~lV~E~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL 612 (792)
||||+++++++.+ ....+|||||+++|++.+.+.+ ..+++..+..|+.||+.||
T Consensus 96 ~l~~~~~~~~~~hp~iv~~~~~~~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~ll~~~~~-~~~~~~~~~~i~~qi~~aL 174 (336)
T 2vuw_A 96 GLNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFGGIDLEQMRT-KLSSLATAKSILHQLTASL 174 (336)
T ss_dssp CEEEEEEEESSCCHHHHHHHHHHHHHTCCSSCCSCCCCTTCEEEEEEEECCCEETGGGTT-TCCCHHHHHHHHHHHHHHH
T ss_pred hhcceeEecCCCcHHHHHHHHHHhhhccccccCccccccCeEEEEEEecCCCccHHHHHh-cCCCHHHHHHHHHHHHHHH
Confidence 5666666666654 7889999999999987777744 5679999999999999999
Q ss_pred HHHh-hccCCCeEecCCCCCcEEEcCCC--------------------CeEEeecCCCccccCCCCCccccccccCCccc
Q 003836 613 FYLH-EECCTQIIHCDIKPQNILLDDHY--------------------NARISDFGLAKLLTLDQSHTNTAIRGTKGYVA 671 (792)
Q Consensus 613 ~yLH-~~~~~~ivH~dikp~NILl~~~~--------------------~~kl~Dfg~a~~~~~~~~~~~~~~~gt~~y~a 671 (792)
+||| +. +|+||||||+|||++.++ .+||+|||+++..... ...||+.|+|
T Consensus 175 ~~lH~~~---~ivHrDlKp~NILl~~~~~~~~~~~~~~~~~~~~~~~~~vkL~DFG~a~~~~~~------~~~gt~~y~a 245 (336)
T 2vuw_A 175 AVAEASL---RFEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERDG------IVVFCDVSMD 245 (336)
T ss_dssp HHHHHHH---CCBCSCCCGGGEEEEECSCSEEEEEETTEEEEEECTTEEEEECCCTTCBEEETT------EEECCCCTTC
T ss_pred HHHHHhC---CEeECCCCHHHEEEeccCCcceeeeccCccccccCCCceEEEeeccccEecCCC------cEEEeecccC
Confidence 9999 88 999999999999999887 8999999999876432 3469999999
Q ss_pred ccccccCCCCcccceehHHHH-HHHHHhcCcCCCcchhhhhhhhHHHHHHHhhcccchhHhhhchhcccCCHHHHHHHHH
Q 003836 672 PEWFRNMPITVKVDVYSYGVL-LLEIICLRRNIDNEISKVDKAILTDWAYDRYQERTLEALVENDLEAMNNVTMLHRFVM 750 (792)
Q Consensus 672 PE~~~~~~~~~k~DV~S~Gv~-l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 750 (792)
||++.+.. +.++|||||+++ .+++++|..||...... ..+......... .............+.++.+
T Consensus 246 PE~~~g~~-~~~~Diwsl~~~~~~~~~~g~~p~~~~~~~---~~~~~~~~~~~~-------~~~~~~~~~~~~~s~~~~d 314 (336)
T 2vuw_A 246 EDLFTGDG-DYQFDIYRLMKKENNNRWGEYHPYSNVLWL---HYLTDKMLKQMT-------FKTKCNTPAMKQIKRKIQE 314 (336)
T ss_dssp SGGGCCCS-SHHHHHHHHHHHHHTTCTTSCCTHHHHHHH---HHHHHHHHHTCC-------CSSCCCSHHHHHHHHHHHH
T ss_pred hhhhcCCC-ccceehhhhhCCCCcccccccCCCcchhhh---hHHHHhhhhhhc-------cCcccchhhhhhcCHHHHH
Confidence 99998766 899999998777 77788898887431100 000000000000 0000011122357788999
Q ss_pred HHHHccccCCCCCCCHHhHH-H
Q 003836 751 VAFWCIQEDPSHRPTMRKVT-Q 771 (792)
Q Consensus 751 l~~~Cl~~~p~~RPs~~evl-~ 771 (792)
|+.+||+.| |++|++ +
T Consensus 315 li~~~L~~d-----sa~e~l~~ 331 (336)
T 2vuw_A 315 FHRTMLNFS-----SATDLLCQ 331 (336)
T ss_dssp HHHHGGGSS-----SHHHHHHH
T ss_pred HHHHHhccC-----CHHHHHhc
Confidence 999999966 999998 6
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-33 Score=297.97 Aligned_cols=228 Identities=21% Similarity=0.288 Sum_probs=177.2
Q ss_pred hhcCccccceEEEeeecCCCceEEEEEEcccccccchHHHHHHHHHh-cccCCCCcccccceecc----CCceEEEEEec
Q 003836 507 EELGRGAFGTVYKGFVNMGSSNHVAVKKLNSVFQDSEKEFKAEVNGI-GQTHHKNLVRLLGYCDE----GQNRLLVYEFM 581 (792)
Q Consensus 507 ~~lG~G~~g~Vy~g~~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l-~~l~h~niv~l~g~~~~----~~~~~lV~E~~ 581 (792)
+.||+|+||.||++... .+++.||+|++.. ...+.+|+.++ +.++||||+++++++.. ....++||||+
T Consensus 24 ~~lg~G~~g~V~~~~~~-~~~~~vaiK~~~~-----~~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~lv~e~~ 97 (299)
T 3m2w_A 24 QVLGLGINGKVLQIFNK-RTQEKFALKMLQD-----CPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECL 97 (299)
T ss_dssp EEEEEETTEEEEEEEET-TTCCEEEEEEEEC-----SHHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEEEEECCC
T ss_pred cccccCCCeEEEEEEEc-CCCcEEEEEEecc-----cHHHHHHHHHHHHhccCCCchhHHhhhhhhcCCCceEEEEEeec
Confidence 56999999999999754 4567999999864 35678888888 55699999999999876 67789999999
Q ss_pred cCCCccccccCC--CCCchhHHHHHHHHHHHHHHHHhhccCCCeEecCCCCCcEEEcC---CCCeEEeecCCCccccCCC
Q 003836 582 SNGTVASFLFGD--SKPNWKLRTEIAMGIAGGLFYLHEECCTQIIHCDIKPQNILLDD---HYNARISDFGLAKLLTLDQ 656 (792)
Q Consensus 582 ~~gsL~~~l~~~--~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dikp~NILl~~---~~~~kl~Dfg~a~~~~~~~ 656 (792)
++|+|.+++... ..+++..+..++.||+.||+|||+. +|+||||||+|||++. ++.+||+|||+++...
T Consensus 98 ~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~--- 171 (299)
T 3m2w_A 98 DGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSI---NIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETT--- 171 (299)
T ss_dssp CSCBHHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESSSSTTCCEEECCCTTCEECT---
T ss_pred CCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEEecCCCCCcEEEeccccccccc---
Confidence 999999999765 3689999999999999999999998 9999999999999998 7899999999987532
Q ss_pred CCccccccccCCcccccccccCCCCcccceehHHHHHHHHHhcCcCCCcchhhhhhhhHHHHHHHhhcccchhHhhhchh
Q 003836 657 SHTNTAIRGTKGYVAPEWFRNMPITVKVDVYSYGVLLLEIICLRRNIDNEISKVDKAILTDWAYDRYQERTLEALVENDL 736 (792)
Q Consensus 657 ~~~~~~~~gt~~y~aPE~~~~~~~~~k~DV~S~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 736 (792)
+..++.++|||||||++|||++|+.||......... ......+....
T Consensus 172 --------------------~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~------------~~~~~~~~~~~- 218 (299)
T 3m2w_A 172 --------------------GEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAIS------------PGMKTRIRMGQ- 218 (299)
T ss_dssp --------------------TCGGGGHHHHHHHHHHHHHHHHSSCSCCC-------------------CCSCCSSCTTC-
T ss_pred --------------------cccCCchhhHHHHHHHHHHHHHCCCCCCCCcchhhh------------HHHHHHHhhcc-
Confidence 235688999999999999999999999654321100 00000000000
Q ss_pred cccCC----HHHHHHHHHHHHHccccCCCCCCCHHhHHHH--hccCcCCC
Q 003836 737 EAMNN----VTMLHRFVMVAFWCIQEDPSHRPTMRKVTQM--LEGVVEVP 780 (792)
Q Consensus 737 ~~~~~----~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~--L~~~~~~~ 780 (792)
...+ ...+.++.+++.+||+.||++|||++|+++. +......+
T Consensus 219 -~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~e~l~hp~~~~~~~~~ 267 (299)
T 3m2w_A 219 -YEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQSTKVP 267 (299)
T ss_dssp -CSSCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHTGGGSC
T ss_pred -ccCCchhcccCCHHHHHHHHHHcccChhhCCCHHHHhcChhhcccccCC
Confidence 0011 1235678899999999999999999999974 44433333
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-33 Score=311.57 Aligned_cols=233 Identities=15% Similarity=0.124 Sum_probs=174.7
Q ss_pred hhhcCccccceEEEeeecCCCceEEEEEEcccccc---cchHHHHHHHHHhcccCC-CCcccccce--------------
Q 003836 506 KEELGRGAFGTVYKGFVNMGSSNHVAVKKLNSVFQ---DSEKEFKAEVNGIGQTHH-KNLVRLLGY-------------- 567 (792)
Q Consensus 506 ~~~lG~G~~g~Vy~g~~~~~~~~~vavK~~~~~~~---~~~~~~~~Ei~~l~~l~h-~niv~l~g~-------------- 567 (792)
.+.||+|+||+||+|... .+++.||||++..... ...+.+.+|+.+++.++| +|...+..+
T Consensus 83 ~~~LG~G~fG~Vy~a~~~-~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~ 161 (413)
T 3dzo_A 83 GTVLGQEDPYAYLEATDQ-ETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDLVKDPQ 161 (413)
T ss_dssp EEEEEEETTEEEEEEEET-TTCCEEEEEEECCSCC----CCHHHHHHHHGGGGSTTCCSHHHHHHHTCBCCCCEEEECCC
T ss_pred ecccccCCCEEEEEEEec-CCCCceEEEEEecCCCccHHHHHHHHHHHHHHHhhccCCCHHHHHHhcccccchhhcccCC
Confidence 367999999999999754 4567999999874322 236789999999999987 432222211
Q ss_pred -------ecc-----CCceEEEEEeccCCCcccccc------C-CCCCchhHHHHHHHHHHHHHHHHhhccCCCeEecCC
Q 003836 568 -------CDE-----GQNRLLVYEFMSNGTVASFLF------G-DSKPNWKLRTEIAMGIAGGLFYLHEECCTQIIHCDI 628 (792)
Q Consensus 568 -------~~~-----~~~~~lV~E~~~~gsL~~~l~------~-~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~di 628 (792)
+.. ....+++|+++ +++|.+++. . ...+++..++.|+.||++||+|||++ +|+||||
T Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~L~~ll~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---~iiHrDi 237 (413)
T 3dzo_A 162 KKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHY---GLVHTYL 237 (413)
T ss_dssp ---------------CCSEEEEEECC-SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHT---TEECSCC
T ss_pred CCccccccCCCccccccceEEEeehh-cCCHHHHHHHhhcccccCCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCc
Confidence 111 12356666655 679998884 1 23578889999999999999999998 9999999
Q ss_pred CCCcEEEcCCCCeEEeecCCCccccCCCCCccccccccCCccccccc----------ccCCCCcccceehHHHHHHHHHh
Q 003836 629 KPQNILLDDHYNARISDFGLAKLLTLDQSHTNTAIRGTKGYVAPEWF----------RNMPITVKVDVYSYGVLLLEIIC 698 (792)
Q Consensus 629 kp~NILl~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~----------~~~~~~~k~DV~S~Gv~l~el~t 698 (792)
||+||||+.++.+||+|||+++..... .....| +.|+|||++ ....++.++|||||||++|||++
T Consensus 238 Kp~NILl~~~~~~kL~DFG~a~~~~~~----~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~DvwSlGvil~ellt 312 (413)
T 3dzo_A 238 RPVDIVLDQRGGVFLTGFEHLVRDGAS----AVSPIG-RGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWIWC 312 (413)
T ss_dssp CGGGEEECTTCCEEECCGGGCEETTEE----ECCCCC-TTTCCHHHHHHHTSTTGGGCCEEECHHHHHHHHHHHHHHHHH
T ss_pred ccceEEEecCCeEEEEeccceeecCCc----cccCCC-CceeCchhhhccccccccccCcCCCchhhHHHHHHHHHHHHH
Confidence 999999999999999999999865432 334567 999999999 55668899999999999999999
Q ss_pred cCcCCCcchhhhhhhhHHHHHHHhhcccchhHhhhchhcccCCHHHHHHHHHHHHHccccCCCCCCCHHhHH
Q 003836 699 LRRNIDNEISKVDKAILTDWAYDRYQERTLEALVENDLEAMNNVTMLHRFVMVAFWCIQEDPSHRPTMRKVT 770 (792)
Q Consensus 699 g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl 770 (792)
|+.||........ ...++... ...++.+.+++.+||+.||++||++.|++
T Consensus 313 g~~Pf~~~~~~~~----------------~~~~~~~~------~~~~~~~~~li~~~l~~dP~~Rpt~~~~l 362 (413)
T 3dzo_A 313 ADLPNTDDAALGG----------------SEWIFRSC------KNIPQPVRALLEGFLRYPKEDRLLPLQAM 362 (413)
T ss_dssp SSCCCCTTGGGSC----------------SGGGGSSC------CCCCHHHHHHHHHHTCSSGGGSCCHHHHT
T ss_pred CCCCCCCcchhhh----------------HHHHHhhc------ccCCHHHHHHHHHHccCChhhCcCHHHHH
Confidence 9999975432111 11111100 12236788999999999999999976664
|
| >4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A* | Back alignment and structure |
|---|
Probab=99.94 E-value=1.5e-28 Score=282.93 Aligned_cols=185 Identities=18% Similarity=0.101 Sum_probs=130.5
Q ss_pred hcCccccceEEEeeecCCCceEEEEEEccccc----------ccchHHHHHHHHHhccc-CCCCcccccceeccCCceEE
Q 003836 508 ELGRGAFGTVYKGFVNMGSSNHVAVKKLNSVF----------QDSEKEFKAEVNGIGQT-HHKNLVRLLGYCDEGQNRLL 576 (792)
Q Consensus 508 ~lG~G~~g~Vy~g~~~~~~~~~vavK~~~~~~----------~~~~~~~~~Ei~~l~~l-~h~niv~l~g~~~~~~~~~l 576 (792)
.++.|++|.+..+. ....++.+++|.+.+.. ....++|.+|+++|+++ +|+||++++++++++...||
T Consensus 241 ~~~~~~~~~h~~~r-r~~fg~~~~~K~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~ed~~~~yL 319 (569)
T 4azs_A 241 QPYAGAGLAHKRSR-RYFFGEDYVCKFFYYDMPHGILTAEESQRNKYELHNEIKFLTQPPAGFDAPAVLAHGENAQSGWL 319 (569)
T ss_dssp C-C--------CCE-EEEECSSEEEEEEESSCSTTCSCHHHHHHHHHHHHHHHHHHHSCCTTCCCCCEEEEEECSSEEEE
T ss_pred ccccCCcccccccc-cccccceeEEEEEecccccccchhhhhHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEECCEEEE
Confidence 35566666554432 22235679999986531 22345799999999999 79999999999999999999
Q ss_pred EEEeccCCCccccccCCCCCchhHHHHHHHHHHHHHHHHhhccCCCeEecCCCCCcEEEcCCCCeEEeecCCCccccCCC
Q 003836 577 VYEFMSNGTVASFLFGDSKPNWKLRTEIAMGIAGGLFYLHEECCTQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLDQ 656 (792)
Q Consensus 577 V~E~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dikp~NILl~~~~~~kl~Dfg~a~~~~~~~ 656 (792)
||||++|++|.++|.....++.. +|+.||+.||+|||++ +||||||||+||||++++.+||+|||+|+....+.
T Consensus 320 VMEyv~G~~L~d~i~~~~~l~~~---~I~~QIl~AL~ylH~~---GIIHRDIKPeNILL~~dg~vKL~DFGlAr~~~~~~ 393 (569)
T 4azs_A 320 VMEKLPGRLLSDMLAAGEEIDRE---KILGSLLRSLAALEKQ---GFWHDDVRPWNVMVDARQHARLIDFGSIVTTPQDC 393 (569)
T ss_dssp EEECCCSEEHHHHHHTTCCCCHH---HHHHHHHHHHHHHHHT---TCEESCCCGGGEEECTTSCEEECCCTTEESCC---
T ss_pred EEecCCCCcHHHHHHhCCCCCHH---HHHHHHHHHHHHHHHC---CceeccCchHhEEECCCCCEEEeecccCeeCCCCC
Confidence 99999999999999888777654 5899999999999999 99999999999999999999999999998765433
Q ss_pred CCccccccccCCcccccccccCCCCcccceehHHHHHHHHHhcCc
Q 003836 657 SHTNTAIRGTKGYVAPEWFRNMPITVKVDVYSYGVLLLEIICLRR 701 (792)
Q Consensus 657 ~~~~~~~~gt~~y~aPE~~~~~~~~~k~DV~S~Gv~l~el~tg~~ 701 (792)
. .....+||++|||||++.+ .+..++|+||+|++++++.++..
T Consensus 394 ~-~~~t~vGTp~YmAPE~l~g-~~~~~~d~~s~g~~~~~l~~~~~ 436 (569)
T 4azs_A 394 S-WPTNLVQSFFVFVNELFAE-NKSWNGFWRSAPVHPFNLPQPWS 436 (569)
T ss_dssp C-CSHHHHHHHHHHHHHHC------------------CCCCTTHH
T ss_pred c-cccCceechhhccHHHhCC-CCCCcccccccccchhhhccccc
Confidence 2 2345679999999999875 46788999999999988866544
|
| >3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A* | Back alignment and structure |
|---|
Probab=99.91 E-value=3.3e-25 Score=253.63 Aligned_cols=182 Identities=17% Similarity=0.187 Sum_probs=145.9
Q ss_pred hhhcCccccceEEEeeecCCCceEEEEEEcccccc--------cchHHHHHHHHHhcccCCCCcccccceeccCCceEEE
Q 003836 506 KEELGRGAFGTVYKGFVNMGSSNHVAVKKLNSVFQ--------DSEKEFKAEVNGIGQTHHKNLVRLLGYCDEGQNRLLV 577 (792)
Q Consensus 506 ~~~lG~G~~g~Vy~g~~~~~~~~~vavK~~~~~~~--------~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~lV 577 (792)
.+.||+|+||.||++... ++.+++|+...... ...+.+.+|++++++++||||+++..++...+..+||
T Consensus 341 ~~~LG~G~fg~Vy~~~~~---~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~lV 417 (540)
T 3en9_A 341 EHLIGKGAEADIKRDSYL---DFDVIIKERVKKGYRDERLDENIRKSRTAREARYLALVKDFGIPAPYIFDVDLDNKRIM 417 (540)
T ss_dssp -------CCEEEEEEECS---SCEEEEEEECCCTTSCHHHHHHHHHHHHHHHHHHHHHGGGGTCCCCCEEEEETTTTEEE
T ss_pred CCEEeeCCCEEEEEEEEC---CCeEEEEEEecccccchhhhhHHHHHHHHHHHHHHHhcCCCCcCceEEEEEeCCccEEE
Confidence 368999999999999543 46788887643211 1134589999999999999999777777788888999
Q ss_pred EEeccCCCccccccCCCCCchhHHHHHHHHHHHHHHHHhhccCCCeEecCCCCCcEEEcCCCCeEEeecCCCccccCCCC
Q 003836 578 YEFMSNGTVASFLFGDSKPNWKLRTEIAMGIAGGLFYLHEECCTQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLDQS 657 (792)
Q Consensus 578 ~E~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dikp~NILl~~~~~~kl~Dfg~a~~~~~~~~ 657 (792)
|||+++++|.+++.. +..++.||++||.|||++ +|+||||||+|||+++ .+||+|||+++.......
T Consensus 418 mE~~~ggsL~~~l~~--------~~~i~~qi~~aL~~LH~~---gIiHrDiKp~NILl~~--~~kL~DFGla~~~~~~~~ 484 (540)
T 3en9_A 418 MSYINGKLAKDVIED--------NLDIAYKIGEIVGKLHKN---DVIHNDLTTSNFIFDK--DLYIIDFGLGKISNLDED 484 (540)
T ss_dssp EECCCSEEHHHHSTT--------CTHHHHHHHHHHHHHHHT---TEECTTCCTTSEEESS--SEEECCCTTCEECCCHHH
T ss_pred EECCCCCCHHHHHHH--------HHHHHHHHHHHHHHHHHC---cCccCCCCHHHEEECC--eEEEEECccCEECCCccc
Confidence 999999999999965 668999999999999998 9999999999999999 999999999998754322
Q ss_pred Cc------cccccccCCccccccccc--CCCCcccceehHHHHHHHHHhcCcCC
Q 003836 658 HT------NTAIRGTKGYVAPEWFRN--MPITVKVDVYSYGVLLLEIICLRRNI 703 (792)
Q Consensus 658 ~~------~~~~~gt~~y~aPE~~~~--~~~~~k~DV~S~Gv~l~el~tg~~p~ 703 (792)
.. .....||+.|||||++.. ..|+.+.|+||..+-.++-+.++.++
T Consensus 485 ~~~~~~~~~~~~~GT~~y~APEv~~~~~~~Y~~~~d~ws~vl~~l~~v~~r~rY 538 (540)
T 3en9_A 485 KAVDLIVFKKAVLSTHHEKFDEIWERFLEGYKSVYDRWEIILELMKDVERRARY 538 (540)
T ss_dssp HHHHHHHHHHHHHHHCGGGHHHHHHHHHHHHHHHCTTHHHHHHHHHHHHTCSCC
T ss_pred cccchhhhhhhhcCCCCcCCHHHHHHHHHHHHHHHhHHHHHHHHHHHHHhcccc
Confidence 11 235679999999999987 66888999999999998888777655
|
| >1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A* | Back alignment and structure |
|---|
Probab=99.84 E-value=9.2e-22 Score=206.32 Aligned_cols=140 Identities=13% Similarity=0.101 Sum_probs=115.0
Q ss_pred hhhcCccccceEEEeeecCCCceEEEEEEcccccc------------------cchHHHHHHHHHhcccCCCCcccccce
Q 003836 506 KEELGRGAFGTVYKGFVNMGSSNHVAVKKLNSVFQ------------------DSEKEFKAEVNGIGQTHHKNLVRLLGY 567 (792)
Q Consensus 506 ~~~lG~G~~g~Vy~g~~~~~~~~~vavK~~~~~~~------------------~~~~~~~~Ei~~l~~l~h~niv~l~g~ 567 (792)
.+.||+|+||.||+|.. .+++.||+|+++.... .....+.+|+.++++++ | +++.++
T Consensus 95 ~~~iG~G~~g~Vy~~~~--~~g~~valK~~~~~~~~~~~~~~~~~~~~~~w~~~~~~~~~~E~~~l~~l~--~-~~v~~~ 169 (282)
T 1zar_A 95 GKLMGEGKESAVFNCYS--EKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQ--G-LAVPKV 169 (282)
T ss_dssp EEEEEECSSEEEEEEEE--TTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTT--T-SSSCCE
T ss_pred cCEeccCCCceEEEEEe--CCCCEEEEEEEECCCCchhhhhhhhhhcchhhHHHHHHHHHHHHHHHHhcc--C-CCcCeE
Confidence 37899999999999986 4578999999864321 13457899999999999 5 777776
Q ss_pred eccCCceEEEEEeccCCCccccccCCCCCchhHHHHHHHHHHHHHHHHhhccCCCeEecCCCCCcEEEcCCCCeEEeecC
Q 003836 568 CDEGQNRLLVYEFMSNGTVASFLFGDSKPNWKLRTEIAMGIAGGLFYLHEECCTQIIHCDIKPQNILLDDHYNARISDFG 647 (792)
Q Consensus 568 ~~~~~~~~lV~E~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dikp~NILl~~~~~~kl~Dfg 647 (792)
+.. +..++||||+++++|.+ +.. .....++.||+.||.|||+. +|+||||||+|||++ ++.+||+|||
T Consensus 170 ~~~-~~~~lvmE~~~g~~L~~-l~~------~~~~~i~~qi~~~l~~lH~~---giiHrDlkp~NILl~-~~~vkl~DFG 237 (282)
T 1zar_A 170 YAW-EGNAVLMELIDAKELYR-VRV------ENPDEVLDMILEEVAKFYHR---GIVHGDLSQYNVLVS-EEGIWIIDFP 237 (282)
T ss_dssp EEE-ETTEEEEECCCCEEGGG-CCC------SCHHHHHHHHHHHHHHHHHT---TEECSCCSTTSEEEE-TTEEEECCCT
T ss_pred Eec-cceEEEEEecCCCcHHH-cch------hhHHHHHHHHHHHHHHHHHC---CCEeCCCCHHHEEEE-CCcEEEEECC
Confidence 543 56699999999999999 522 34557999999999999998 999999999999999 9999999999
Q ss_pred CCccccCCCCCccccccccCCcccccccc
Q 003836 648 LAKLLTLDQSHTNTAIRGTKGYVAPEWFR 676 (792)
Q Consensus 648 ~a~~~~~~~~~~~~~~~gt~~y~aPE~~~ 676 (792)
+++. +..++|||++.
T Consensus 238 ~a~~--------------~~~~~a~e~l~ 252 (282)
T 1zar_A 238 QSVE--------------VGEEGWREILE 252 (282)
T ss_dssp TCEE--------------TTSTTHHHHHH
T ss_pred CCeE--------------CCCCCHHHHHH
Confidence 9974 34578999875
|
| >1b2p_A Protein (lectin); mannose-binding lectin, monocot, aglutinin, bluebell bulbs, carbohydrate interactions, sugar binding protein; 1.70A {Hyacinthoides hispanica} SCOP: b.78.1.1 | Back alignment and structure |
|---|
Probab=99.83 E-value=1.7e-20 Score=167.95 Aligned_cols=107 Identities=18% Similarity=0.246 Sum_probs=91.6
Q ss_pred cccCcccCCcceeecCCCCcee--cCCCeEEEeeeecCCCCceEEEEEeecCCCCcEEEEecCCCCCCCCeeEEEEeCcc
Q 003836 21 QSNGTISIGQQLTAAESTEPWL--SPSKDFALGFHQLDSKDLFLPAIWYYKIPSKTIVWYASAVNPAPRGSKLRLTANRG 98 (792)
Q Consensus 21 ~~~~~i~~g~~l~~~~~~~~lv--S~~g~F~lGF~~~~~~~~~~~gIW~~~~~~~tvvWvANr~~P~~~~~~l~~~~~G~ 98 (792)
++.++|.+|++|.+++ +|+ |++|.|+|+|+.+++ . +||++ +++||+||++.| ..++.+.|.+|||
T Consensus 6 ~~~~~l~~g~~L~~g~---~l~~~S~~g~~~L~~~~dgn---l---vly~~---~~~vW~sn~~~~-~~~~~l~l~~dGN 72 (119)
T 1b2p_A 6 SKQPDDNHPQILHATE---SLEILFGTHVYRFIMQTDCN---L---VLYDN---NNPIWATNTGGL-GNGCRAVLQPDGV 72 (119)
T ss_dssp CSCSSSCCCCEEETTC---EEEEEETTEEEEEEECTTSC---E---EEEET---TEEEEECCCTTS-CSSCEEEECTTSC
T ss_pred ecCcccCCCCEEcCCC---EEEEeCCCCCEEEEEecCCC---E---EEEEC---CEEEEeCCCccC-CCceEEEEccCCE
Confidence 3568999999998664 899 999999999998764 2 68875 799999999977 3457899999999
Q ss_pred EEEEcCCCCEEEEeccCCC-cceeEEEecCCcEEEEecCCcccccc
Q 003836 99 LVLEDPEGREIWKSEISTG-QAAFGVLYDTGNFLIVNTNSERLWQS 143 (792)
Q Consensus 99 Lvl~~~~~~~vWst~~~~~-~~~~a~LldsGNlVl~~~~~~~lWQS 143 (792)
|||+|.++.++|+|++... +..+++|+|+|||||++ .++|||
T Consensus 73 LVl~d~~~~~lW~S~~~~~~g~~~l~l~~~Gnlvl~~---~~~W~S 115 (119)
T 1b2p_A 73 LVVITNENVTVWQSPVAGKAGHYVLVLQPDRNVVIYG---DALWAT 115 (119)
T ss_dssp EEEECTTCCEEEECSCCCCSSCEEEEECTTSCEEEEE---SEEEEC
T ss_pred EEEEeCCCcEEEcCCCCCCCCCEEEEEECCCcEEEEC---ccEeCC
Confidence 9999999999999997643 45689999999999998 389998
|
| >4h3o_A Lectin; cadmium, plant protein; 2.17A {Allium sativum} PDB: 1kj1_A* 1bwu_P* 1kj1_D* 1bwu_Q* 1bwu_A* 1bwu_D* | Back alignment and structure |
|---|
Probab=99.83 E-value=2.7e-20 Score=162.75 Aligned_cols=104 Identities=18% Similarity=0.354 Sum_probs=88.0
Q ss_pred cCcccCCcceeecCCCCceecCCCeEEEeeeecCCCCceEEEEEeecCCCCcEEEEecCCCCCCCCeeEEEEeCccEEEE
Q 003836 23 NGTISIGQQLTAAESTEPWLSPSKDFALGFHQLDSKDLFLPAIWYYKIPSKTIVWYASAVNPAPRGSKLRLTANRGLVLE 102 (792)
Q Consensus 23 ~~~i~~g~~l~~~~~~~~lvS~~g~F~lGF~~~~~~~~~~~gIW~~~~~~~tvvWvANr~~P~~~~~~l~~~~~G~Lvl~ 102 (792)
.|+|.+||.|.+++ .|+| |.|.|.|...++ |.++. ..++||+|||+.|..+.+.|.|+.||||||+
T Consensus 1 kn~L~~g~~L~~g~---~L~s--g~y~l~~q~DgN-----Lvly~----~~~~vW~ant~~~~~~~~~L~l~~dGnLvL~ 66 (105)
T 4h3o_A 1 RNILDNNEGLYAGQ---SLDV--EPYHFIMQDDCN-----LVLYD----HSTSTWASNTEIGGKSGCSAVLQSDGNFVVY 66 (105)
T ss_dssp CCEECTTEEECTTC---EEEE--TTEEEEECTTSC-----EEEEE----TTEEEEECCCCCTTCCSCEEEECTTSCEEEE
T ss_pred CCCcCCCCEEcCCC---EEEE--CCEEEEECCCCe-----EEEEE----CCEEEEEecCCCCCCccEEEEEeCCccEEEE
Confidence 37899999998654 7877 889999987764 34543 3689999999999988889999999999999
Q ss_pred cCCCCEEEEeccCCC-cceeEEEecCCcEEEEecCCcccccc
Q 003836 103 DPEGREIWKSEISTG-QAAFGVLYDTGNFLIVNTNSERLWQS 143 (792)
Q Consensus 103 ~~~~~~vWst~~~~~-~~~~a~LldsGNlVl~~~~~~~lWQS 143 (792)
|+++++||+|+++.. +..+|+|+|+|||||++. .||||
T Consensus 67 d~~~~~vWss~t~~~~~~~~l~L~ddGNlVly~~---~~W~S 105 (105)
T 4h3o_A 67 DSSGRSLWASHSTRGSGNYILILQDDGNVIIYGS---DIWST 105 (105)
T ss_dssp CTTCCEEEECCCCCCSSCEEEEECTTSCEEEEES---EEEEC
T ss_pred CCCcEEEEEecCCCCCCCEEEEEeCCCeEEEECC---cEecC
Confidence 999999999998644 456899999999999964 69998
|
| >3a0c_A Mannose/sialic acid-binding lectin; beta-prism II, sugar binding protein; 2.00A {Polygonatum cyrtonema} PDB: 3a0d_A* 3a0e_A* | Back alignment and structure |
|---|
Probab=99.82 E-value=3.2e-20 Score=164.17 Aligned_cols=109 Identities=21% Similarity=0.300 Sum_probs=92.1
Q ss_pred cCcccCCcceeecCCCCceecCCCeEEEeeeecCCCCceEEEEEeecCCCCcEEEEecCCCCCCCCeeEEEEeCccEEEE
Q 003836 23 NGTISIGQQLTAAESTEPWLSPSKDFALGFHQLDSKDLFLPAIWYYKIPSKTIVWYASAVNPAPRGSKLRLTANRGLVLE 102 (792)
Q Consensus 23 ~~~i~~g~~l~~~~~~~~lvS~~g~F~lGF~~~~~~~~~~~gIW~~~~~~~tvvWvANr~~P~~~~~~l~~~~~G~Lvl~ 102 (792)
+|+|.+||.|..++ +|+ ++|.|+|+|+..++. |||+ .+++||+||++.|. .++.+.|.+||||||.
T Consensus 1 ~d~l~~g~~L~~g~---~l~-~~~~~~l~~~~dGnl------vl~~---~~~~vW~sn~~~~~-~~~~l~l~~dGNLVl~ 66 (110)
T 3a0c_A 1 VNSLSSPNSLFTGH---SLE-VGPSYRLIMQGDCNF------VLYD---SGKPVWASNTGGLG-SGCRLTLHNNGNLVIY 66 (110)
T ss_dssp CCEEETTCEECTTC---EEE-ETTTEEEEECTTSCE------EEEE---TTEEEEECCCTTSC-SSCEEEECTTSCEEEE
T ss_pred CCEeCCCCEECCCC---EEE-ECCCEEEEEcCCCcE------EEEE---CCEEEEECCCCCCC-CcEEEEEeCCCCEEEE
Confidence 37899999998654 789 999999999877642 6786 37999999998774 4578999999999999
Q ss_pred cCCCCEEEEeccCCC-cceeEEEecCCcEEEEecCCccccccccCCc
Q 003836 103 DPEGREIWKSEISTG-QAAFGVLYDTGNFLIVNTNSERLWQSFDHPT 148 (792)
Q Consensus 103 ~~~~~~vWst~~~~~-~~~~a~LldsGNlVl~~~~~~~lWQSFd~Pt 148 (792)
|.+|.++|+|++... +..+++|+|+|||||++. .+||||+||.
T Consensus 67 ~~~~~~~W~S~t~~~~g~~~l~l~~dGnlvl~~~---~~W~S~~~~~ 110 (110)
T 3a0c_A 67 DQSNRVIWQTKTNGKEDHYVLVLQQDRNVVIYGP---VVWATGSGPA 110 (110)
T ss_dssp CTTCCEEEECCCCCSSSCCEEEECTTSCEEEECS---EEEECSCCC-
T ss_pred CCCCcEEEecCCCCCCCCEEEEEeCCccEEEECC---CEecCCCcCC
Confidence 999999999998644 345899999999999975 7999999984
|
| >2dpf_A Curculin; sweet taste, taste modifying, plant protein; 1.50A {Curculigo latifolia} PDB: 2d04_B* 2d04_A* | Back alignment and structure |
|---|
Probab=99.80 E-value=1.1e-19 Score=162.27 Aligned_cols=109 Identities=20% Similarity=0.341 Sum_probs=91.2
Q ss_pred cCcccCCcceeecCCCCceecCCCeEEEeeeecCCCCceEEEEEeecCCCCcEEEEecCCCCCCCCeeEEEEeCccEEEE
Q 003836 23 NGTISIGQQLTAAESTEPWLSPSKDFALGFHQLDSKDLFLPAIWYYKIPSKTIVWYASAVNPAPRGSKLRLTANRGLVLE 102 (792)
Q Consensus 23 ~~~i~~g~~l~~~~~~~~lvS~~g~F~lGF~~~~~~~~~~~gIW~~~~~~~tvvWvANr~~P~~~~~~l~~~~~G~Lvl~ 102 (792)
.|+|.+||+|.+++ +|+ +|.|+|+|+++++ . ++|+ .+++||+||++.|. .++.|.|.+||||||.
T Consensus 2 ~dtl~~gq~L~~g~---~L~--~g~~~L~~~~dgn---l---vly~---~~~~vW~sn~~~~~-~~~~l~l~~~GnLvl~ 66 (115)
T 2dpf_A 2 DNVLLSGQTLHADH---SLQ--AGAYTLTIQNKCN---L---VKYQ---NGRQIWASNTDRRG-SGCRLTLLSDGNLVIY 66 (115)
T ss_dssp CCEEETTCEEETTE---EEE--ETTEEEEECTTSC---E---EEEE---TTEEEEECSCTTSC-SSCEEEECTTSCEEEE
T ss_pred CCEeCCCCEECCCC---EEE--CCCEEEEEcCCCc---E---EEEe---CCEEEEeCCCCCCC-CceEEEECCCCcEEEE
Confidence 58999999998654 787 8999999987653 3 2465 37899999999884 4578999999999999
Q ss_pred cCCCCEEEEeccCCC-cceeEEEecCCcEEEEecCCccccccccCCcc
Q 003836 103 DPEGREIWKSEISTG-QAAFGVLYDTGNFLIVNTNSERLWQSFDHPTD 149 (792)
Q Consensus 103 ~~~~~~vWst~~~~~-~~~~a~LldsGNlVl~~~~~~~lWQSFd~PtD 149 (792)
|.++.++|+|++..+ +..+|+|+|+|||||++. ++||||.+++.
T Consensus 67 d~~~~~vW~S~~~~~~g~~~l~l~~dGnlvl~~~---~~W~S~~~~~~ 111 (115)
T 2dpf_A 67 DHNNNDVWGSACWGDNGKYALVLQKDGRFVIYGP---VLWSLGPNGCR 111 (115)
T ss_dssp CTTCCEEEECCCCCSSSCCEEEECTTSCEEEECS---EEECSSTTCBC
T ss_pred CCCceEEEEcCCCCCCCCEEEEEeCCCeEEEECC---CEEECCCCCCc
Confidence 998999999998643 456899999999999964 89999998764
|
| >1xd5_A Gastrodianin-1, antifungal protein GAFP-1; monocot mannose binding lectin, monomer, homogeneous beta- sheet; 2.00A {Gastrodia elata} SCOP: b.78.1.1 PDB: 1xd6_A | Back alignment and structure |
|---|
Probab=99.78 E-value=6.2e-19 Score=156.74 Aligned_cols=109 Identities=17% Similarity=0.357 Sum_probs=91.0
Q ss_pred cCcccCCcceeecCCCCceecCCCeEEEeeeecCCCCceEEEEEeecCCCCcEEEEecCCCCCCCCeeEEEEeCccEEEE
Q 003836 23 NGTISIGQQLTAAESTEPWLSPSKDFALGFHQLDSKDLFLPAIWYYKIPSKTIVWYASAVNPAPRGSKLRLTANRGLVLE 102 (792)
Q Consensus 23 ~~~i~~g~~l~~~~~~~~lvS~~g~F~lGF~~~~~~~~~~~gIW~~~~~~~tvvWvANr~~P~~~~~~l~~~~~G~Lvl~ 102 (792)
+|||.+||.|++++ +| ++|.|+|+|+.+++. +||++ +++||+||++.+ ..++.+.|.++|||||+
T Consensus 1 tdtl~~gq~L~~g~---~L--~~~~~~L~~~~dgnl------vl~~~---~~~vW~sn~~~~-~~~~~l~l~~~GNLvl~ 65 (112)
T 1xd5_A 1 SDRLNSGHQLDTGG---SL--AEGGYLFIIQNDCNL------VLYDN---NRAVWASGTNGK-ASGCVLKMQNDGNLVIY 65 (112)
T ss_dssp CCEEETTEEECTTC---EE--EETTEEEEECTTSCE------EEEET---TEEEEECCCTTS-CSSEEEEECTTSCEEEE
T ss_pred CCCCCCCCEECCCC---EE--eCCCEEEEEcCCCcE------EEEEC---CEEEEeCCCcCC-CCCEEEEEeCCCCEEEE
Confidence 48999999998654 67 589999999987652 46765 689999999864 24578999999999999
Q ss_pred cCCCCEEEEeccCCC-cceeEEEecCCcEEEEecCCccccccccCC
Q 003836 103 DPEGREIWKSEISTG-QAAFGVLYDTGNFLIVNTNSERLWQSFDHP 147 (792)
Q Consensus 103 ~~~~~~vWst~~~~~-~~~~a~LldsGNlVl~~~~~~~lWQSFd~P 147 (792)
| ++.++|+|++... +..+++|+++|||||++..+.++||||+|.
T Consensus 66 d-~~~~~W~S~~~~~~g~~~l~l~~dGnlvl~~~~~~~~W~S~~~~ 110 (112)
T 1xd5_A 66 S-GSRAIWASNTNRQNGNYYLILQRDRNVVIYDNSNNAIWATHTNV 110 (112)
T ss_dssp E-TTEEEEECCCCCSCCCCEEEECTTSCEEEECTTSCEEEECCCCC
T ss_pred c-CCEEEEECCccCCCCCEEEEEeCCCcEEEECCCCceEEECCCcc
Confidence 9 8889999987643 346899999999999987788999999985
|
| >3dzw_A Agglutinin; lectin, mannobiose, mannose-alpha1, 3-mannose, D sugar binding protein; HET: MAN; 1.70A {Narcissus pseudonarcissus} SCOP: b.78.1.1 PDB: 1npl_A* 1jpc_A* 1msa_A* 1niv_A* | Back alignment and structure |
|---|
Probab=99.74 E-value=8.8e-18 Score=148.28 Aligned_cols=103 Identities=18% Similarity=0.305 Sum_probs=84.8
Q ss_pred CcccCCcceeecCCCCceecCCCeEEEeeeecCCCCceEEEEEeecCCCCcEEEEecCCCCCCCCeeEEEEeCccEEEEc
Q 003836 24 GTISIGQQLTAAESTEPWLSPSKDFALGFHQLDSKDLFLPAIWYYKIPSKTIVWYASAVNPAPRGSKLRLTANRGLVLED 103 (792)
Q Consensus 24 ~~i~~g~~l~~~~~~~~lvS~~g~F~lGF~~~~~~~~~~~gIW~~~~~~~tvvWvANr~~P~~~~~~l~~~~~G~Lvl~~ 103 (792)
+||.+||.|.+++ +|+ +|.|+|+|+.+++ .+ .|.. .++||+||++.+ ..++.|.|..||||||.|
T Consensus 2 ntL~~gq~L~~g~---~L~--~g~~~L~~q~dGn---Lv---ly~~---~~~vW~snt~~~-~~~~~l~l~~dGNLvl~~ 66 (109)
T 3dzw_A 2 NILYSGETLSPGE---FLN--NGRYVFIMQEDCN---LV---LYDV---DKPIWATNTGGL-DRRCHLSMQSDGNLVVYS 66 (109)
T ss_dssp CEEETTEEECTTC---EEE--ETTEEEEECTTSC---EE---EEET---TEEEEECCCTTS-SSSCEEEECTTSCEEEEC
T ss_pred CCcCCCCEeCCCC---EEE--CCCEEEEEcCCCc---EE---EEeC---CEEEEECCcccC-CCCEEEEEeCCCCEEEEC
Confidence 6899999998654 675 7999999987764 32 2654 589999999876 345789999999999999
Q ss_pred CCCCEEEEeccCCCc-ceeEEEecCCcEEEEecCCccccccc
Q 003836 104 PEGREIWKSEISTGQ-AAFGVLYDTGNFLIVNTNSERLWQSF 144 (792)
Q Consensus 104 ~~~~~vWst~~~~~~-~~~a~LldsGNlVl~~~~~~~lWQSF 144 (792)
.++.++|+|+++..+ ..+|+|+|+|||||+++ .+|||=
T Consensus 67 ~~~~~~W~S~t~~~~~~~~~~L~ddGNlvly~~---~~W~s~ 105 (109)
T 3dzw_A 67 PRNNPIWASNTGGENGNYVCVLQKDRNVVIYGT---ARWATG 105 (109)
T ss_dssp TTSCEEEECCCCCSSSCEEEEECTTSCEEEEES---CCCCCC
T ss_pred CCCCEEEECCCCCCCCCEEEEEeCCCEEEEECC---CEEeCC
Confidence 999999999986544 46899999999999984 899983
|
| >1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A* | Back alignment and structure |
|---|
Probab=99.71 E-value=1.2e-17 Score=172.72 Aligned_cols=135 Identities=17% Similarity=0.145 Sum_probs=102.8
Q ss_pred hhhhcCccccceEEEeeecCCCceE--EEEEEccccccc------------------------chHHHHHHHHHhcccCC
Q 003836 505 FKEELGRGAFGTVYKGFVNMGSSNH--VAVKKLNSVFQD------------------------SEKEFKAEVNGIGQTHH 558 (792)
Q Consensus 505 ~~~~lG~G~~g~Vy~g~~~~~~~~~--vavK~~~~~~~~------------------------~~~~~~~Ei~~l~~l~h 558 (792)
+.+.||+|+||.||+|... .+++. ||||+++..... ....+.+|+.++.+++|
T Consensus 51 i~~~ig~G~~g~Vy~a~~~-~~g~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~ 129 (258)
T 1zth_A 51 MGGVISTGKEANVFYADGV-FDGKPVAMAVKIYRIETSEFDKMDEYLYGDERFDMRRISPKEKVFIWTEKEFRNLERAKE 129 (258)
T ss_dssp EEEEEEECSSEEEEEEEEE-ETTEEEEEEEEEECCC-------GGGTTTCTTSCC----CHHHHHHHHHHHHHHHHHHHH
T ss_pred hCCEEeecceEEEEEEEEc-CCCcEeeEEEEEEECCccchhhHHHhhcccchhhhhccChHHHHHHHHHHHHHHHHHHHh
Confidence 4467999999999999762 23567 999986542111 12368899999999998
Q ss_pred CCc--ccccceeccCCceEEEEEeccC-C----CccccccCCCCCchhHHHHHHHHHHHHHHHHh-hccCCCeEecCCCC
Q 003836 559 KNL--VRLLGYCDEGQNRLLVYEFMSN-G----TVASFLFGDSKPNWKLRTEIAMGIAGGLFYLH-EECCTQIIHCDIKP 630 (792)
Q Consensus 559 ~ni--v~l~g~~~~~~~~~lV~E~~~~-g----sL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH-~~~~~~ivH~dikp 630 (792)
+++ +.++.+ ...+|||||+.+ | +|.++... .++.....++.||+.||.||| +. +|+||||||
T Consensus 130 ~~i~~p~~~~~----~~~~lVmE~~g~~g~~~~~L~~~~~~---~~~~~~~~i~~qi~~~l~~lH~~~---givHrDlkp 199 (258)
T 1zth_A 130 AGVSVPQPYTY----MKNVLLMEFIGEDELPAPTLVELGRE---LKELDVEGIFNDVVENVKRLYQEA---ELVHADLSE 199 (258)
T ss_dssp TTCCCCCEEEE----ETTEEEEECCEETTEECCBHHHHGGG---GGGSCHHHHHHHHHHHHHHHHHTS---CEECSSCST
T ss_pred CCCCCCeEEEc----CCCEEEEEecCCCCCccccHHHHhhc---cChHHHHHHHHHHHHHHHHHHHHC---CEEeCCCCH
Confidence 864 333332 356899999952 5 44444321 345678899999999999999 87 999999999
Q ss_pred CcEEEcCCCCeEEeecCCCccc
Q 003836 631 QNILLDDHYNARISDFGLAKLL 652 (792)
Q Consensus 631 ~NILl~~~~~~kl~Dfg~a~~~ 652 (792)
+|||+++ .++|+|||+|...
T Consensus 200 ~NILl~~--~~~liDFG~a~~~ 219 (258)
T 1zth_A 200 YNIMYID--KVYFIDMGQAVTL 219 (258)
T ss_dssp TSEEESS--SEEECCCTTCEET
T ss_pred HHEEEcC--cEEEEECcccccC
Confidence 9999998 9999999999764
|
| >3r0e_B Lectin; carbohydrate binding, carbohydrate, sugar binding protein; 2.40A {Remusatia vivipara} | Back alignment and structure |
|---|
Probab=99.65 E-value=2.5e-16 Score=138.88 Aligned_cols=104 Identities=20% Similarity=0.251 Sum_probs=82.6
Q ss_pred cccCcccCCcceeecCCCCceecCCCeEEEeeeecCCCCceEEEEEeecCCCCcEEEEecCCCCCCCCeeEEEEeCccEE
Q 003836 21 QSNGTISIGQQLTAAESTEPWLSPSKDFALGFHQLDSKDLFLPAIWYYKIPSKTIVWYASAVNPAPRGSKLRLTANRGLV 100 (792)
Q Consensus 21 ~~~~~i~~g~~l~~~~~~~~lvS~~g~F~lGF~~~~~~~~~~~gIW~~~~~~~tvvWvANr~~P~~~~~~l~~~~~G~Lv 100 (792)
.++|+|.+||.|..++ +|+| |.|.|-|...++ |.+ |.. ++||++|++.. ..++.+.|..|||||
T Consensus 4 ~~~dtL~~gq~L~~g~---~L~s--g~~~L~~q~dGn-----Lvl-~~~----~~vW~snt~~~-~~~~~l~l~~dGNLv 67 (110)
T 3r0e_B 4 FTNNLLFSGQVLYGDG---RLTA--KNHQLVMQGDCN-----LVL-YGG----KYGWQSNTHGN-GEHCFLRLNHKGELI 67 (110)
T ss_dssp CBTTEEETTCEEETTE---EEEC--SSCEEEECTTSC-----EEE-ECS----SSCEECCCTTS-SSSCEEEECTTSCEE
T ss_pred cccCEECCCCEecCCC---EEEe--CCEEEEEcCCCe-----EEE-ECC----eEEEECCCcCC-CcCEEEEEeCCCcEE
Confidence 4679999999998654 7887 459997765443 333 654 48999999863 234689999999999
Q ss_pred EEcCCCCEEEEeccCCC-cceeEEEecCCcEEEEecCCcccccc
Q 003836 101 LEDPEGREIWKSEISTG-QAAFGVLYDTGNFLIVNTNSERLWQS 143 (792)
Q Consensus 101 l~~~~~~~vWst~~~~~-~~~~a~LldsGNlVl~~~~~~~lWQS 143 (792)
|+|.++.++|+|++... +..+|+|+|+|||||++ ..+|+|
T Consensus 68 l~d~~~~~iW~S~t~~~~~~~~~~L~~dGNlvly~---~~~W~t 108 (110)
T 3r0e_B 68 IKDDDFKTIWSSRSSSKQGEYVLILQDDGFGVIYG---PAIFET 108 (110)
T ss_dssp EECTTCCEEEECCCCCSSSCCEEEECTTSCEEEEC---SEEEES
T ss_pred EEeCCCCEEEEcCCcCCCCCEEEEEcCCccEEEec---CCEecC
Confidence 99999999999998643 34689999999999998 489987
|
| >3mez_B Mannose-specific lectin 3 chain 2; heterotetramer, sugar binding protein; 1.94A {Crocus vernus} SCOP: b.78.1.0 | Back alignment and structure |
|---|
Probab=99.64 E-value=1.2e-15 Score=135.29 Aligned_cols=107 Identities=13% Similarity=0.197 Sum_probs=85.4
Q ss_pred cccCcccCCcceeecCCCCceecCCCeEEEeeeecCCCCceEEEEEeecCCCCcEEEEecCCCCCCCCeeEEEEeCccEE
Q 003836 21 QSNGTISIGQQLTAAESTEPWLSPSKDFALGFHQLDSKDLFLPAIWYYKIPSKTIVWYASAVNPAPRGSKLRLTANRGLV 100 (792)
Q Consensus 21 ~~~~~i~~g~~l~~~~~~~~lvS~~g~F~lGF~~~~~~~~~~~gIW~~~~~~~tvvWvANr~~P~~~~~~l~~~~~G~Lv 100 (792)
.+.|+|.+||.|..++ +|. +|.|.|-|...++ |.+ |.. ...++||.+|+..+. .++.+.|..|||||
T Consensus 4 ~~~~tL~~gq~L~~g~---~L~--~g~~~L~~q~dGN-----LvL-~~~-~~~~~vWssnt~~~~-~~~~l~l~~dGNLV 70 (113)
T 3mez_B 4 RVRNVLFSSQVMYDNA---QLA--TRDYSLVMRDDCN-----LVL-TKG-SKTNIVWESGTSGRG-QHCFMRLGHSGELD 70 (113)
T ss_dssp CCSSEEETTCEEETTC---EEE--ETTEEEEECTTSC-----EEE-EET-TTTEEEEECCCTTSC-SSCEEEECTTSCEE
T ss_pred ccCCEeCCCCEECCCC---EeE--cCCEEEEEcCCCE-----EEE-EEC-CCCEEEEECCcccCC-cCEEEEEeCCCcEE
Confidence 3568999999998654 665 4889999976654 334 322 136899999998763 35789999999999
Q ss_pred EEcCCCCEEEEeccCCC-cceeEEEecCCcEEEEecCCcccccc
Q 003836 101 LEDPEGREIWKSEISTG-QAAFGVLYDTGNFLIVNTNSERLWQS 143 (792)
Q Consensus 101 l~~~~~~~vWst~~~~~-~~~~a~LldsGNlVl~~~~~~~lWQS 143 (792)
|+|.+++++|+|++... +..+|+|+|+|||||++ ..+|+|
T Consensus 71 l~d~~~~~iW~S~t~~~~~~~~~~L~~dGnlvly~---~~~W~s 111 (113)
T 3mez_B 71 ITDDRLNTVFVSNTVGQEGDYVLILQINGQAVVYG---PAVWST 111 (113)
T ss_dssp EECTTSCEEEECSCCCSSSCCEEEECTTSCEEEEC---SEEEES
T ss_pred EECCCCCEEEECCCcCCCCCEEEEEcCCceEEEec---CCEecC
Confidence 99999999999998643 34689999999999997 689997
|
| >3a0c_A Mannose/sialic acid-binding lectin; beta-prism II, sugar binding protein; 2.00A {Polygonatum cyrtonema} PDB: 3a0d_A* 3a0e_A* | Back alignment and structure |
|---|
Probab=99.62 E-value=6e-16 Score=136.63 Aligned_cols=88 Identities=19% Similarity=0.316 Sum_probs=73.0
Q ss_pred CCeeEEEEeCccEEEEcCCCCEEEEeccCCCc-ceeEEEecCCcEEEEecCCccccccccCCcccccCCCccccceEEee
Q 003836 87 RGSKLRLTANRGLVLEDPEGREIWKSEISTGQ-AAFGVLYDTGNFLIVNTNSERLWQSFDHPTDTLLPTQTMERGGVVSS 165 (792)
Q Consensus 87 ~~~~l~~~~~G~Lvl~~~~~~~vWst~~~~~~-~~~a~LldsGNlVl~~~~~~~lWQSFd~PtDtlLpg~~l~~~~~L~S 165 (792)
....|.|..||||||++ .+++||++++...+ ..+|+|+|+|||||+|.++.++||||.
T Consensus 20 ~~~~l~~~~dGnlvl~~-~~~~vW~sn~~~~~~~~~l~l~~dGNLVl~~~~~~~~W~S~t-------------------- 78 (110)
T 3a0c_A 20 PSYRLIMQGDCNFVLYD-SGKPVWASNTGGLGSGCRLTLHNNGNLVIYDQSNRVIWQTKT-------------------- 78 (110)
T ss_dssp TTEEEEECTTSCEEEEE-TTEEEEECCCTTSCSSCEEEECTTSCEEEECTTCCEEEECCC--------------------
T ss_pred CCEEEEEcCCCcEEEEE-CCEEEEECCCCCCCCcEEEEEeCCCCEEEECCCCcEEEecCC--------------------
Confidence 45789999999999998 57899999986443 468999999999999998999999993
Q ss_pred eccCCCCCCCceeEeecCCCceeeeeeccCCCcccccccccCCc
Q 003836 166 RRKDTYFSRGRFQFRLLEDGNAVLNTINLESGFAYDAYFWSNTF 209 (792)
Q Consensus 166 ~~s~~~~s~G~~~~~~~~~g~~~~~~~~~~~~~~~~~y~~~~~~ 209 (792)
++++|.|++.++++|+++++- . .||.+++.
T Consensus 79 -----~~~~g~~~l~l~~dGnlvl~~--~-------~~W~S~~~ 108 (110)
T 3a0c_A 79 -----NGKEDHYVLVLQQDRNVVIYG--P-------VVWATGSG 108 (110)
T ss_dssp -----CCSSSCCEEEECTTSCEEEEC--S-------EEEECSCC
T ss_pred -----CCCCCCEEEEEeCCccEEEEC--C-------CEecCCCc
Confidence 446799999999999987742 1 48877654
|
| >3r0e_A Lectin; carbohydrate binding, carbohydrate, sugar binding protein; 2.40A {Remusatia vivipara} | Back alignment and structure |
|---|
Probab=99.57 E-value=4.8e-15 Score=130.43 Aligned_cols=107 Identities=21% Similarity=0.354 Sum_probs=84.9
Q ss_pred ccCcccCCcceeecCCCCceecCCCeEEEeeeecCCCCceEEEEEeecCCCCcEEEEecCCCCCCCCeeEEEEeCccEEE
Q 003836 22 SNGTISIGQQLTAAESTEPWLSPSKDFALGFHQLDSKDLFLPAIWYYKIPSKTIVWYASAVNPAPRGSKLRLTANRGLVL 101 (792)
Q Consensus 22 ~~~~i~~g~~l~~~~~~~~lvS~~g~F~lGF~~~~~~~~~~~gIW~~~~~~~tvvWvANr~~P~~~~~~l~~~~~G~Lvl 101 (792)
+.|||.+||.|..++ +| .+|.|.|.|...++- +.|.. +|.+|+..+ ..+..|.|..||||||
T Consensus 2 ~~dtL~~gq~L~~g~---~L--~~g~~~L~~q~dGNL------vl~~~------~Wssnt~~~-~~~~~l~l~~dGnLvl 63 (109)
T 3r0e_A 2 GTNYLLSGQTLDTEG---HL--KNGDFDLVMQDDCNL------VLYNG------NWQSNTANN-GRDCKLTLTDYGELVI 63 (109)
T ss_dssp CCSEEETTCEECTTC---EE--EETTEEEEECTTSCE------EEETT------TEECCCTTS-CSSCEEEECTTSCEEE
T ss_pred ccCCcCCCCCcCCCC---Ee--ECCCEEEEEecCCeE------EEEeC------eEEcCCCCC-CCcEEEEEcCCCeEEE
Confidence 568999999998654 56 579999999876543 22432 699998875 3457899999999999
Q ss_pred EcCCCCEEEEeccCCC-cceeEEEecCCcEEEEecCCccccccccCCcccccCC
Q 003836 102 EDPEGREIWKSEISTG-QAAFGVLYDTGNFLIVNTNSERLWQSFDHPTDTLLPT 154 (792)
Q Consensus 102 ~~~~~~~vWst~~~~~-~~~~a~LldsGNlVl~~~~~~~lWQSFd~PtDtlLpg 154 (792)
.|.++.++|+|++... ...+|+|+|+|||||++ ..+|+| .|.+||
T Consensus 64 ~d~~~~~vWss~t~~~~~~~~~~L~~dGNlvly~---~~~W~s-----~t~~~~ 109 (109)
T 3r0e_A 64 KNGDGSTVWKSGAQSVKGNYAAVVHPDGRLVVFG---PSVFKI-----DPWVRG 109 (109)
T ss_dssp ECTTSCEEEECCCCCSSSCCEEEEETTTEEEEEC---SEEEEE-----CTTSCC
T ss_pred EeCCCCEEEcCCCcCCCcCEEEEEcCCCeEEEEe---cCEECC-----CCccCC
Confidence 9999999999998643 34689999999999997 689998 555554
|
| >1b2p_A Protein (lectin); mannose-binding lectin, monocot, aglutinin, bluebell bulbs, carbohydrate interactions, sugar binding protein; 1.70A {Hyacinthoides hispanica} SCOP: b.78.1.1 | Back alignment and structure |
|---|
Probab=99.57 E-value=6.2e-15 Score=131.81 Aligned_cols=86 Identities=23% Similarity=0.365 Sum_probs=71.8
Q ss_pred eeEEEEeCccEEEEcCCCCEEEEeccCCCc-ceeEEEecCCcEEEEecCCccccccccCCcccccCCCccccceEEeeec
Q 003836 89 SKLRLTANRGLVLEDPEGREIWKSEISTGQ-AAFGVLYDTGNFLIVNTNSERLWQSFDHPTDTLLPTQTMERGGVVSSRR 167 (792)
Q Consensus 89 ~~l~~~~~G~Lvl~~~~~~~vWst~~~~~~-~~~a~LldsGNlVl~~~~~~~lWQSFd~PtDtlLpg~~l~~~~~L~S~~ 167 (792)
..|.|..||+|+|++. +++||++++...+ ...|+|+|+|||||+|.++.++||||
T Consensus 32 ~~L~~~~dgnlvly~~-~~~vW~sn~~~~~~~~~l~l~~dGNLVl~d~~~~~lW~S~----------------------- 87 (119)
T 1b2p_A 32 YRFIMQTDCNLVLYDN-NNPIWATNTGGLGNGCRAVLQPDGVLVVITNENVTVWQSP----------------------- 87 (119)
T ss_dssp EEEEECTTSCEEEEET-TEEEEECCCTTSCSSCEEEECTTSCEEEECTTCCEEEECS-----------------------
T ss_pred EEEEEecCCCEEEEEC-CEEEEeCCCccCCCceEEEEccCCEEEEEeCCCcEEEcCC-----------------------
Confidence 5788889999999987 8899999986543 36899999999999999899999999
Q ss_pred cCCCCCCCceeEeecCCCceeeeeeccCCCcccccccccCCc
Q 003836 168 KDTYFSRGRFQFRLLEDGNAVLNTINLESGFAYDAYFWSNTF 209 (792)
Q Consensus 168 s~~~~s~G~~~~~~~~~g~~~~~~~~~~~~~~~~~y~~~~~~ 209 (792)
+++++|.|+++++++|+++++. .+||.+++.
T Consensus 88 --~~~~~g~~~l~l~~~Gnlvl~~---------~~~W~Sg~~ 118 (119)
T 1b2p_A 88 --VAGKAGHYVLVLQPDRNVVIYG---------DALWATQTV 118 (119)
T ss_dssp --CCCCSSCEEEEECTTSCEEEEE---------SEEEECCCC
T ss_pred --CCCCCCCEEEEEECCCcEEEEC---------ccEeCCCCC
Confidence 3456899999999999977742 258887653
|
| >1xd5_A Gastrodianin-1, antifungal protein GAFP-1; monocot mannose binding lectin, monomer, homogeneous beta- sheet; 2.00A {Gastrodia elata} SCOP: b.78.1.1 PDB: 1xd6_A | Back alignment and structure |
|---|
Probab=99.56 E-value=1e-14 Score=129.41 Aligned_cols=91 Identities=23% Similarity=0.349 Sum_probs=74.1
Q ss_pred CCeeEEEEeCccEEEEcCCCCEEEEeccCCCc-ceeEEEecCCcEEEEecCCccccccccCCcccccCCCccccceEEee
Q 003836 87 RGSKLRLTANRGLVLEDPEGREIWKSEISTGQ-AAFGVLYDTGNFLIVNTNSERLWQSFDHPTDTLLPTQTMERGGVVSS 165 (792)
Q Consensus 87 ~~~~l~~~~~G~Lvl~~~~~~~vWst~~~~~~-~~~a~LldsGNlVl~~~~~~~lWQSFd~PtDtlLpg~~l~~~~~L~S 165 (792)
....|.|..||+|+|++. +++||++++...+ ..+|+|+|+|||||+| ++.++||||+.
T Consensus 19 ~~~~L~~~~dgnlvl~~~-~~~vW~sn~~~~~~~~~l~l~~~GNLvl~d-~~~~~W~S~~~------------------- 77 (112)
T 1xd5_A 19 GGYLFIIQNDCNLVLYDN-NRAVWASGTNGKASGCVLKMQNDGNLVIYS-GSRAIWASNTN------------------- 77 (112)
T ss_dssp TTEEEEECTTSCEEEEET-TEEEEECCCTTSCSSEEEEECTTSCEEEEE-TTEEEEECCCC-------------------
T ss_pred CCEEEEEcCCCcEEEEEC-CEEEEeCCCcCCCCCEEEEEeCCCCEEEEc-CCEEEEECCcc-------------------
Confidence 346899999999999987 7899999986433 4689999999999999 78899999953
Q ss_pred eccCCCCCCCceeEeecCCCceeeeeeccCCCcccccccccCCcc
Q 003836 166 RRKDTYFSRGRFQFRLLEDGNAVLNTINLESGFAYDAYFWSNTFD 210 (792)
Q Consensus 166 ~~s~~~~s~G~~~~~~~~~g~~~~~~~~~~~~~~~~~y~~~~~~~ 210 (792)
+++|.|+++++++|+++++. .. ..+||.++++.
T Consensus 78 ------~~~g~~~l~l~~dGnlvl~~--~~----~~~~W~S~~~~ 110 (112)
T 1xd5_A 78 ------RQNGNYYLILQRDRNVVIYD--NS----NNAIWATHTNV 110 (112)
T ss_dssp ------CSCCCCEEEECTTSCEEEEC--TT----SCEEEECCCCC
T ss_pred ------CCCCCEEEEEeCCCcEEEEC--CC----CceEEECCCcc
Confidence 45789999999999977742 11 14789888774
|
| >4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A | Back alignment and structure |
|---|
Probab=99.55 E-value=3.4e-15 Score=160.46 Aligned_cols=139 Identities=11% Similarity=0.025 Sum_probs=95.1
Q ss_pred hhhhhcCccccceEEEeeecCCCceEEEEEEcccccc--------------cchHHHHHHHHHhcccCCCCcccccceec
Q 003836 504 GFKEELGRGAFGTVYKGFVNMGSSNHVAVKKLNSVFQ--------------DSEKEFKAEVNGIGQTHHKNLVRLLGYCD 569 (792)
Q Consensus 504 ~~~~~lG~G~~g~Vy~g~~~~~~~~~vavK~~~~~~~--------------~~~~~~~~Ei~~l~~l~h~niv~l~g~~~ 569 (792)
.+...||+|++|.||+|... +++.||||+++.... ........++++.+...|+|+++++....
T Consensus 98 ~I~~~IG~Gk~a~VY~a~d~--~G~~vAvKi~r~~~~sfr~v~~~r~~~~~~~~~~~~~~~rl~A~kE~~nL~rL~~~gv 175 (397)
T 4gyi_A 98 SVGSRIGVGKESDIMIVADE--KGKQKVLKIHRLGRISFRTVKANRDYLRNRSTGSWMYLSRLAAIKEFAFMKALYEEGF 175 (397)
T ss_dssp EEEEEEEECSSEEEEEEECT--TCCEEEEEEECTTEECCCCCC--CEECTTSCHHHHHHHHHHHHHHHHHHHHHHHHTTC
T ss_pred EecCEeeeCCceEEEEEECC--CCCEEEEEEEecccccHHHHHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHHhcCC
Confidence 34567999999999999754 467899998753210 00112222233333333444444432221
Q ss_pred c------CCceEEEEEeccCCCccccccCCCCCchhHHHHHHHHHHHHHHHHhhccCCCeEecCCCCCcEEEcCCCC---
Q 003836 570 E------GQNRLLVYEFMSNGTVASFLFGDSKPNWKLRTEIAMGIAGGLFYLHEECCTQIIHCDIKPQNILLDDHYN--- 640 (792)
Q Consensus 570 ~------~~~~~lV~E~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dikp~NILl~~~~~--- 640 (792)
. ....+|||||+++++|..+.. ......++.||+.+|.|||+. +||||||||.|||+++++.
T Consensus 176 ~vp~p~~~~~~~LVME~i~G~~L~~l~~------~~~~~~l~~qll~~l~~lH~~---gIVHrDLKp~NILl~~dgd~~d 246 (397)
T 4gyi_A 176 PVPEPIAQSRHTIVMSLVDALPMRQVSS------VPDPASLYADLIALILRLAKH---GLIHGDFNEFNILIREEKDAED 246 (397)
T ss_dssp SCCCEEEEETTEEEEECCSCEEGGGCCC------CSCHHHHHHHHHHHHHHHHHT---TEECSCCSTTSEEEEEEECSSC
T ss_pred CCCeeeeccCceEEEEecCCccHhhhcc------cHHHHHHHHHHHHHHHHHHHC---CCcCCCCCHHHEEEeCCCCccc
Confidence 1 122369999999998877653 234467889999999999998 9999999999999988763
Q ss_pred -------eEEeecCCCcccc
Q 003836 641 -------ARISDFGLAKLLT 653 (792)
Q Consensus 641 -------~kl~Dfg~a~~~~ 653 (792)
+.|+||+-+....
T Consensus 247 ~~~~~~~~~iID~~Q~V~~~ 266 (397)
T 4gyi_A 247 PSSITLTPIIIXFPQMVSMD 266 (397)
T ss_dssp TTSEEEEEEECCCTTCEETT
T ss_pred ccccccceEEEEeCCcccCC
Confidence 8999999886543
|
| >2dpf_A Curculin; sweet taste, taste modifying, plant protein; 1.50A {Curculigo latifolia} PDB: 2d04_B* 2d04_A* | Back alignment and structure |
|---|
Probab=99.51 E-value=4.8e-14 Score=125.66 Aligned_cols=90 Identities=22% Similarity=0.359 Sum_probs=74.7
Q ss_pred CCeeEEEEeCccEEEEcCCCCEEEEeccCCCc-ceeEEEecCCcEEEEecCCccccccccCCcccccCCCccccceEEee
Q 003836 87 RGSKLRLTANRGLVLEDPEGREIWKSEISTGQ-AAFGVLYDTGNFLIVNTNSERLWQSFDHPTDTLLPTQTMERGGVVSS 165 (792)
Q Consensus 87 ~~~~l~~~~~G~Lvl~~~~~~~vWst~~~~~~-~~~a~LldsGNlVl~~~~~~~lWQSFd~PtDtlLpg~~l~~~~~L~S 165 (792)
....|.|..||+|+|++ .+++||++++.... ..+++|+++|||||+|.++.++|||||+|
T Consensus 20 g~~~L~~~~dgnlvly~-~~~~vW~sn~~~~~~~~~l~l~~~GnLvl~d~~~~~vW~S~~~~------------------ 80 (115)
T 2dpf_A 20 GAYTLTIQNKCNLVKYQ-NGRQIWASNTDRRGSGCRLTLLSDGNLVIYDHNNNDVWGSACWG------------------ 80 (115)
T ss_dssp TTEEEEECTTSCEEEEE-TTEEEEECSCTTSCSSCEEEECTTSCEEEECTTCCEEEECCCCC------------------
T ss_pred CCEEEEEcCCCcEEEEe-CCEEEEeCCCCCCCCceEEEECCCCcEEEECCCceEEEEcCCCC------------------
Confidence 34678899999999998 57899999986443 46899999999999998889999999983
Q ss_pred eccCCCCCCCceeEeecCCCceeeeeeccCCCcccccccccCCccc
Q 003836 166 RRKDTYFSRGRFQFRLLEDGNAVLNTINLESGFAYDAYFWSNTFDT 211 (792)
Q Consensus 166 ~~s~~~~s~G~~~~~~~~~g~~~~~~~~~~~~~~~~~y~~~~~~~~ 211 (792)
++|.|++.++++|+++++ +. .||.++++..
T Consensus 81 -------~~g~~~l~l~~dGnlvl~--~~-------~~W~S~~~~~ 110 (115)
T 2dpf_A 81 -------DNGKYALVLQKDGRFVIY--GP-------VLWSLGPNGC 110 (115)
T ss_dssp -------SSSCCEEEECTTSCEEEE--CS-------EEECSSTTCB
T ss_pred -------CCCCEEEEEeCCCeEEEE--CC-------CEEECCCCCC
Confidence 568899999999998774 11 5898888753
|
| >3mez_A Mannose-specific lectin 3 chain 1; heterotetramer, sugar binding protein; 1.94A {Crocus vernus} SCOP: b.78.1.0 | Back alignment and structure |
|---|
Probab=99.42 E-value=1.9e-13 Score=120.57 Aligned_cols=102 Identities=13% Similarity=0.177 Sum_probs=79.7
Q ss_pred cCcccCCcceeecCCCCceecCCCeEEEeeeecCCCCceEEEEEeecCCCCcEEEEecCCCCCCCCeeEEEEeCccEEEE
Q 003836 23 NGTISIGQQLTAAESTEPWLSPSKDFALGFHQLDSKDLFLPAIWYYKIPSKTIVWYASAVNPAPRGSKLRLTANRGLVLE 102 (792)
Q Consensus 23 ~~~i~~g~~l~~~~~~~~lvS~~g~F~lGF~~~~~~~~~~~gIW~~~~~~~tvvWvANr~~P~~~~~~l~~~~~G~Lvl~ 102 (792)
+|+|.+||.|.+++ .| .+|.|.|.|...++- +-|.. .. ||.+|+..+ ...+.+.|..||||||+
T Consensus 2 ~~~l~~gq~L~~g~---~L--~~g~~~L~~q~dGnL------vl~~~---~~-vW~snt~~~-~~~~~l~l~~dGNLVl~ 65 (111)
T 3mez_A 2 NNVLLTGDVIHTDN---QL--SYESAAFVMQGDCNL------VLYNE---AG-GFQSNTHGR-GVDCTLRLNNRGQLEIH 65 (111)
T ss_dssp TTEEETTCEECTTC---EE--EETTEEEEECTTSCE------EEECS---SC-CEECCCTTS-CSSCEEEECTTSCEEEE
T ss_pred cCEeCCCCEeCCCC---EE--ecCCEEEEEccCCeE------EEECC---CC-EEECCcccC-CcCEEEEEcCCCcEEEE
Confidence 57899999998654 56 479999999766542 22432 23 999999876 33578999999999999
Q ss_pred cCCCC-EEEEeccCC---CcceeEEEecCCcEEEEecCCcccccc
Q 003836 103 DPEGR-EIWKSEIST---GQAAFGVLYDTGNFLIVNTNSERLWQS 143 (792)
Q Consensus 103 ~~~~~-~vWst~~~~---~~~~~a~LldsGNlVl~~~~~~~lWQS 143 (792)
|.++. ++|+|++.. .+..+|+|+|+|||||++ ..+|+|
T Consensus 66 ~~~~~~~vW~S~t~~~~~~~~~~l~Lq~dGNlvly~---~~~W~s 107 (111)
T 3mez_A 66 SANSNTPVWVYPRSVNTVRGNYAATLGPDQHVTIYG---PAIWST 107 (111)
T ss_dssp CSSCSSCSEEESSSCCCCSSCCEEEECTTSCEEEEC---SEEEEC
T ss_pred eCCCCEEEEEeccccCCCCcCEEEEECCCCeEEEec---cCEEcc
Confidence 98876 599999632 234689999999999997 689987
|
| >3mez_B Mannose-specific lectin 3 chain 2; heterotetramer, sugar binding protein; 1.94A {Crocus vernus} SCOP: b.78.1.0 | Back alignment and structure |
|---|
Probab=99.33 E-value=3.1e-12 Score=113.25 Aligned_cols=85 Identities=21% Similarity=0.271 Sum_probs=67.7
Q ss_pred CCCCCC-CCeeEEEEeCccEEEEcC-CCCEEEEeccCCCc-ceeEEEecCCcEEEEecCCccccccccCCcccccCCCcc
Q 003836 81 AVNPAP-RGSKLRLTANRGLVLEDP-EGREIWKSEISTGQ-AAFGVLYDTGNFLIVNTNSERLWQSFDHPTDTLLPTQTM 157 (792)
Q Consensus 81 r~~P~~-~~~~l~~~~~G~Lvl~~~-~~~~vWst~~~~~~-~~~a~LldsGNlVl~~~~~~~lWQSFd~PtDtlLpg~~l 157 (792)
.+.|+. ....|.+..||||||++. .++++|++++...+ ...|+|+|+|||||+|.++.++|||-.+-
T Consensus 17 ~g~~L~~g~~~L~~q~dGNLvL~~~~~~~~vWssnt~~~~~~~~l~l~~dGNLVl~d~~~~~iW~S~t~~---------- 86 (113)
T 3mez_B 17 DNAQLATRDYSLVMRDDCNLVLTKGSKTNIVWESGTSGRGQHCFMRLGHSGELDITDDRLNTVFVSNTVG---------- 86 (113)
T ss_dssp TTCEEEETTEEEEECTTSCEEEEETTTTEEEEECCCTTSCSSCEEEECTTSCEEEECTTSCEEEECSCCC----------
T ss_pred CCCEeEcCCEEEEEcCCCEEEEEECCCCEEEEECCcccCCcCEEEEEeCCCcEEEECCCCCEEEECCCcC----------
Confidence 344553 346899999999999998 48899999986443 46899999999999999888999983210
Q ss_pred ccceEEeeeccCCCCCCCceeEeecCCCceeee
Q 003836 158 ERGGVVSSRRKDTYFSRGRFQFRLLEDGNAVLN 190 (792)
Q Consensus 158 ~~~~~L~S~~s~~~~s~G~~~~~~~~~g~~~~~ 190 (792)
..|.|.+.++.||++++|
T Consensus 87 ---------------~~~~~~~~L~~dGnlvly 104 (113)
T 3mez_B 87 ---------------QEGDYVLILQINGQAVVY 104 (113)
T ss_dssp ---------------SSSCCEEEECTTSCEEEE
T ss_pred ---------------CCCCEEEEEcCCceEEEe
Confidence 135689999999999986
|
| >3mez_A Mannose-specific lectin 3 chain 1; heterotetramer, sugar binding protein; 1.94A {Crocus vernus} SCOP: b.78.1.0 | Back alignment and structure |
|---|
Probab=99.30 E-value=6.3e-12 Score=110.82 Aligned_cols=88 Identities=18% Similarity=0.224 Sum_probs=69.5
Q ss_pred CCeeEEEEeCccEEEEcCCCCEEEEeccCCCc-ceeEEEecCCcEEEEecCCc-cccccccCCcccccCCCccccceEEe
Q 003836 87 RGSKLRLTANRGLVLEDPEGREIWKSEISTGQ-AAFGVLYDTGNFLIVNTNSE-RLWQSFDHPTDTLLPTQTMERGGVVS 164 (792)
Q Consensus 87 ~~~~l~~~~~G~Lvl~~~~~~~vWst~~~~~~-~~~a~LldsGNlVl~~~~~~-~lWQSFd~PtDtlLpg~~l~~~~~L~ 164 (792)
....|.+..||||||++.++ +|+|++...+ ...|+|+|+|||||++.++. ++|||.-+
T Consensus 20 g~~~L~~q~dGnLvl~~~~~--vW~snt~~~~~~~~l~l~~dGNLVl~~~~~~~~vW~S~t~------------------ 79 (111)
T 3mez_A 20 ESAAFVMQGDCNLVLYNEAG--GFQSNTHGRGVDCTLRLNNRGQLEIHSANSNTPVWVYPRS------------------ 79 (111)
T ss_dssp TTEEEEECTTSCEEEECSSC--CEECCCTTSCSSCEEEECTTSCEEEECSSCSSCSEEESSS------------------
T ss_pred CCEEEEEccCCeEEEECCCC--EEECCcccCCcCEEEEEcCCCcEEEEeCCCCEEEEEeccc------------------
Confidence 34689999999999999876 9999986543 36899999999999998776 49999621
Q ss_pred eeccCCCCCCCceeEeecCCCceeeeeeccCCCcccccccccCC
Q 003836 165 SRRKDTYFSRGRFQFRLLEDGNAVLNTINLESGFAYDAYFWSNT 208 (792)
Q Consensus 165 S~~s~~~~s~G~~~~~~~~~g~~~~~~~~~~~~~~~~~y~~~~~ 208 (792)
.....|.|.+.++.||++++|. .++|.+++
T Consensus 80 -----~~~~~~~~~l~Lq~dGNlvly~---------~~~W~s~t 109 (111)
T 3mez_A 80 -----VNTVRGNYAATLGPDQHVTIYG---------PAIWSTPA 109 (111)
T ss_dssp -----CCCCSSCCEEEECTTSCEEEEC---------SEEEECCC
T ss_pred -----cCCCCcCEEEEECCCCeEEEec---------cCEEccCC
Confidence 1113578999999999999863 35787665
|
| >3m7h_A Putidacin L1; monocot mannose-binding lectin, bacteriocin, LLPA, pseudomon bacterial toxin, siras, antimicrobial protein; 2.20A {Pseudomonas SP} PDB: 3m7j_A* | Back alignment and structure |
|---|
Probab=99.27 E-value=1e-11 Score=127.97 Aligned_cols=112 Identities=15% Similarity=0.280 Sum_probs=86.1
Q ss_pred ccCcccCCcc----eeecCCCCceecCCCeEEEeeeecC--CCCceEEEEEeecCCCCcEEEEecCCCCCCCCeeEEEEe
Q 003836 22 SNGTISIGQQ----LTAAESTEPWLSPSKDFALGFHQLD--SKDLFLPAIWYYKIPSKTIVWYASAVNPAPRGSKLRLTA 95 (792)
Q Consensus 22 ~~~~i~~g~~----l~~~~~~~~lvS~~g~F~lGF~~~~--~~~~~~~gIW~~~~~~~tvvWvANr~~P~~~~~~l~~~~ 95 (792)
.+||+.||+. |..+ +.|+| +..++.|+|+.. ...+.+ + |.+ ..+++|.+++..+-. ..+.+..
T Consensus 135 ptdtlLpg~~~~~~l~~g---~~L~S-~~dps~G~fsl~l~~dGnlv--L-y~~--~~~~yW~Sgt~~~~~--~~l~l~~ 203 (276)
T 3m7h_A 135 PAIPLVPGAIDSLLLAPG---SELVQ-GVVYGAGASKLVFQGDGNLV--A-YGP--NGAATWNAGTQGKGA--VRAVFQG 203 (276)
T ss_dssp TTSCCCCSCTTCEEECSS---EEECT-TCEEEETTEEEEECTTSCEE--E-ECT--TSSEEEECCCTTTTC--CEEEECT
T ss_pred cccccccccccccccccC---ccccc-CCCCCCceEEEeecCCceEE--E-EeC--CCeEEEECCCCCCcc--EEEEEcC
Confidence 4689999999 6543 35655 457777777642 222343 3 332 258999999988733 6889999
Q ss_pred CccEEEEcCCCCEEEEeccCCCcceeEEEecCCcEEEEecCCccccccccC
Q 003836 96 NRGLVLEDPEGREIWKSEISTGQAAFGVLYDTGNFLIVNTNSERLWQSFDH 146 (792)
Q Consensus 96 ~G~Lvl~~~~~~~vWst~~~~~~~~~a~LldsGNlVl~~~~~~~lWQSFd~ 146 (792)
+|+|+++|.++.++|++++......+|+|+++|||||++. ..+||||||
T Consensus 204 dGnLvl~d~~~~~vWsS~t~~~~~~rl~Ld~dGnLvly~~--~~~Wqsf~~ 252 (276)
T 3m7h_A 204 DGNLVVYGAGNAVLWHSHTGGHASAVLRLQANGSIAILDE--KPVWARFGF 252 (276)
T ss_dssp TSCEEEECTTSCEEEECSCTTCTTCEEEECTTSCEEEEEE--EEEEESSSC
T ss_pred CCeEEEEeCCCcEEEEecCCCCCCEEEEEcCCccEEEEcC--CCeEEccCc
Confidence 9999999998899999998755567899999999999986 689999998
|
| >3dzw_A Agglutinin; lectin, mannobiose, mannose-alpha1, 3-mannose, D sugar binding protein; HET: MAN; 1.70A {Narcissus pseudonarcissus} SCOP: b.78.1.1 PDB: 1npl_A* 1jpc_A* 1msa_A* 1niv_A* | Back alignment and structure |
|---|
Probab=99.25 E-value=2.5e-11 Score=106.74 Aligned_cols=88 Identities=19% Similarity=0.300 Sum_probs=69.7
Q ss_pred CCeeEEEEeCccEEEEcCCCCEEEEeccCCCc-ceeEEEecCCcEEEEecCCccccccccCCcccccCCCccccceEEee
Q 003836 87 RGSKLRLTANRGLVLEDPEGREIWKSEISTGQ-AAFGVLYDTGNFLIVNTNSERLWQSFDHPTDTLLPTQTMERGGVVSS 165 (792)
Q Consensus 87 ~~~~l~~~~~G~Lvl~~~~~~~vWst~~~~~~-~~~a~LldsGNlVl~~~~~~~lWQSFd~PtDtlLpg~~l~~~~~L~S 165 (792)
....|.|..||||||++. ++++|++++...+ ...++|+|+|||||+|.++.++|||....
T Consensus 19 g~~~L~~q~dGnLvly~~-~~~vW~snt~~~~~~~~l~l~~dGNLvl~~~~~~~~W~S~t~~------------------ 79 (109)
T 3dzw_A 19 GRYVFIMQEDCNLVLYDV-DKPIWATNTGGLDRRCHLSMQSDGNLVVYSPRNNPIWASNTGG------------------ 79 (109)
T ss_dssp TTEEEEECTTSCEEEEET-TEEEEECCCTTSSSSCEEEECTTSCEEEECTTSCEEEECCCCC------------------
T ss_pred CCEEEEEcCCCcEEEEeC-CEEEEECCcccCCCCEEEEEeCCCCEEEECCCCCEEEECCCCC------------------
Confidence 346899999999999987 6899999986543 46899999999999998889999985321
Q ss_pred eccCCCCCCCceeEeecCCCceeeeeeccCCCcccccccccCCc
Q 003836 166 RRKDTYFSRGRFQFRLLEDGNAVLNTINLESGFAYDAYFWSNTF 209 (792)
Q Consensus 166 ~~s~~~~s~G~~~~~~~~~g~~~~~~~~~~~~~~~~~y~~~~~~ 209 (792)
..+.|.+.++.||++++|. .+.|.+++.
T Consensus 80 -------~~~~~~~~L~ddGNlvly~---------~~~W~s~t~ 107 (109)
T 3dzw_A 80 -------ENGNYVCVLQKDRNVVIYG---------TARWATGTN 107 (109)
T ss_dssp -------SSSCEEEEECTTSCEEEEE---------SCCCCCCCC
T ss_pred -------CCCCEEEEEeCCCEEEEEC---------CCEEeCCCc
Confidence 2356889999999999863 146766553
|
| >3r0e_B Lectin; carbohydrate binding, carbohydrate, sugar binding protein; 2.40A {Remusatia vivipara} | Back alignment and structure |
|---|
Probab=99.17 E-value=6.6e-11 Score=104.04 Aligned_cols=76 Identities=22% Similarity=0.415 Sum_probs=62.5
Q ss_pred CeeEEEEeCccEEEEcCCCCEEEEeccCCCc-ceeEEEecCCcEEEEecCCccccccccCCcccccCCCccccceEEeee
Q 003836 88 GSKLRLTANRGLVLEDPEGREIWKSEISTGQ-AAFGVLYDTGNFLIVNTNSERLWQSFDHPTDTLLPTQTMERGGVVSSR 166 (792)
Q Consensus 88 ~~~l~~~~~G~Lvl~~~~~~~vWst~~~~~~-~~~a~LldsGNlVl~~~~~~~lWQSFd~PtDtlLpg~~l~~~~~L~S~ 166 (792)
...|.+..||||||++. +++|++++...+ ...++|+|+|||||+|.++.++|||-.+-
T Consensus 25 ~~~L~~q~dGnLvl~~~--~~vW~snt~~~~~~~~l~l~~dGNLvl~d~~~~~iW~S~t~~------------------- 83 (110)
T 3r0e_B 25 NHQLVMQGDCNLVLYGG--KYGWQSNTHGNGEHCFLRLNHKGELIIKDDDFKTIWSSRSSS------------------- 83 (110)
T ss_dssp SCEEEECTTSCEEEECS--SSCEECCCTTSSSSCEEEECTTSCEEEECTTCCEEEECCCCC-------------------
T ss_pred CEEEEEcCCCeEEEECC--eEEEECCCcCCCcCEEEEEeCCCcEEEEeCCCCEEEEcCCcC-------------------
Confidence 46788999999999876 689999986543 35899999999999999889999984321
Q ss_pred ccCCCCCCCceeEeecCCCceeee
Q 003836 167 RKDTYFSRGRFQFRLLEDGNAVLN 190 (792)
Q Consensus 167 ~s~~~~s~G~~~~~~~~~g~~~~~ 190 (792)
..|.|.+.++.||++++|
T Consensus 84 ------~~~~~~~~L~~dGNlvly 101 (110)
T 3r0e_B 84 ------KQGEYVLILQDDGFGVIY 101 (110)
T ss_dssp ------SSSCCEEEECTTSCEEEE
T ss_pred ------CCCCEEEEEcCCccEEEe
Confidence 235688999999999986
|
| >1dlp_A Lectin scafet precursor; two-domain lectin, beta prism II fold, native, sugar binding protein; 3.30A {Hyacinthoides hispanica} SCOP: b.78.1.1 b.78.1.1 | Back alignment and structure |
|---|
Probab=99.15 E-value=1.5e-10 Score=117.25 Aligned_cols=143 Identities=19% Similarity=0.271 Sum_probs=98.1
Q ss_pred CCeeEEEEeCccEEEEcCCCCEEEEeccCCCcceeEEEecCCcEEEEecCCccccccccCCcccccCCCccccceEEeee
Q 003836 87 RGSKLRLTANRGLVLEDPEGREIWKSEISTGQAAFGVLYDTGNFLIVNTNSERLWQSFDHPTDTLLPTQTMERGGVVSSR 166 (792)
Q Consensus 87 ~~~~l~~~~~G~Lvl~~~~~~~vWst~~~~~~~~~a~LldsGNlVl~~~~~~~lWQSFd~PtDtlLpg~~l~~~~~L~S~ 166 (792)
....|.|..||+|+|.+. +++||++|+......+++|+++|||||+|+++.++|+|+++.
T Consensus 26 g~f~l~f~~~gnl~ly~~-~~~vW~an~~~~~~~~l~l~~dGnLvl~d~~~~~vW~s~~~~------------------- 85 (236)
T 1dlp_A 26 SSFRFTMQSDCNLVLFDS-DVRVWASNTAGATGCRAVLQSDGLLVILTAQNTIRWSSGTKG------------------- 85 (236)
T ss_dssp TTEEEEECTTSCEEEEES-SSEEECCCCCSCSCCBCCBCSSSCBCCBCTTTCCSCCCCCCC-------------------
T ss_pred CCEEEEECCCCcEEEEEC-CEEEEECCCCCCCCeEEEEcCCCcEEEEcCCCcEEEeCCccc-------------------
Confidence 345777888899999886 789999998655566899999999999999999999998751
Q ss_pred ccCCCCCCCceeEeecCCCceeeeeeccCCCcccccccccCCcccc------------c------------------CCC
Q 003836 167 RKDTYFSRGRFQFRLLEDGNAVLNTINLESGFAYDAYFWSNTFDTN------------R------------------SNA 216 (792)
Q Consensus 167 ~s~~~~s~G~~~~~~~~~g~~~~~~~~~~~~~~~~~y~~~~~~~~~------------~------------------~~~ 216 (792)
+.|.|.+.++++|+++++. ..+|.+...... . +..
T Consensus 86 ------~~~~~~~~l~d~Gnlvl~~---------~~~W~S~~~p~~t~~lp~~g~d~L~~gq~~~~~~~~L~s~~d~s~G 150 (236)
T 1dlp_A 86 ------SIGNYVLVLQPDRTVTIYG---------PGLWDSGTSNKGSVVVANNGNSILYSTQGNDNHPQTLHATQSLQLS 150 (236)
T ss_dssp ------CSSCCEEEECSSSCEEEEC---------SEEEECSCCCSSCCCCSSCCCEECCCC--CCCCCCEECSSCCCBCS
T ss_pred ------cCCcEEEEEeCCCCEEEec---------CCEEECCCCCCcccccCCccceEEecCCcCCCccceEEcCcEeecC
Confidence 2466788999999998851 135544332110 0 113
Q ss_pred cceeEEccCCcEEEEecccceeeeccccccccccEEEEEEecCCcEEEEec
Q 003836 217 GYRVVFNESGQLYVLRENKQRASLVPETVSAKENYLRATLNFDGVFIFYSH 267 (792)
Q Consensus 217 ~~~~~~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~r~~L~~dG~l~~y~~ 267 (792)
.+.+.++.+|.++++..+ ..+....+. +.....+++|+.+|++++|..
T Consensus 151 ~~~l~l~~dG~LvL~~~~--~~~W~s~~~-~~~~~~~~~L~~~Gnl~ly~~ 198 (236)
T 1dlp_A 151 PYRLSMETDCNLVLFDRD--DRVWSTNTA-GKGTGCRAVLQPNGRMDVLTN 198 (236)
T ss_dssp SCEEEEETTTEEEEEBTT--BCCSCCCCC-SSCSSCEEEEETTTEEEEEET
T ss_pred cEEEEECCCCcEEEEcCC--EeEEeCCCc-CCCCceEEEECCCCcEEEEeC
Confidence 466778888887776543 222221111 111225788999999998863
|
| >3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} SCOP: d.144.1.6 PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A* | Back alignment and structure |
|---|
Probab=99.12 E-value=9.4e-11 Score=121.10 Aligned_cols=138 Identities=13% Similarity=0.053 Sum_probs=108.2
Q ss_pred hhhcCccccceEEEeeecCCCceEEEEEEcccccccchHHHHHHHHHhcccC-CCCcccccceeccCCceEEEEEeccCC
Q 003836 506 KEELGRGAFGTVYKGFVNMGSSNHVAVKKLNSVFQDSEKEFKAEVNGIGQTH-HKNLVRLLGYCDEGQNRLLVYEFMSNG 584 (792)
Q Consensus 506 ~~~lG~G~~g~Vy~g~~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~-h~niv~l~g~~~~~~~~~lV~E~~~~g 584 (792)
...++.|+.+.||+.... ++.+++|+...........+.+|+++++.+. |..+.++++++.+.+..++||||++|.
T Consensus 19 ~~~~~g~s~~~v~~~~~~---~~~~vlK~~~~~~~~~~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv~e~i~G~ 95 (263)
T 3tm0_A 19 VKDTEGMSPAKVYKLVGE---NENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSNLLMSEADGV 95 (263)
T ss_dssp EECCSCCSSSEEEEEECS---SCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEECCSSE
T ss_pred EeeccCCCCCeEEEEECC---CCcEEEEeCCcccCCCHHHHHHHHHHHHHHhcCCCCCeEEEEEecCCceEEEEEecCCe
Confidence 456788888999998532 4689999987532233456899999999884 677889999998888999999999999
Q ss_pred CccccccCCCCCchhHHHHHHHHHHHHHHHHhhcc---------------------------------------------
Q 003836 585 TVASFLFGDSKPNWKLRTEIAMGIAGGLFYLHEEC--------------------------------------------- 619 (792)
Q Consensus 585 sL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~--------------------------------------------- 619 (792)
+|.+.+. +......++.+++++|+.||+..
T Consensus 96 ~l~~~~~-----~~~~~~~~~~~l~~~l~~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 170 (263)
T 3tm0_A 96 LCSEEYE-----DEQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWEEDTPFKDPREL 170 (263)
T ss_dssp EHHHHCC-----TTTCHHHHHHHHHHHHHHHHHSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCSGGGGSTTCSSSSHHHH
T ss_pred ehhhccC-----CcccHHHHHHHHHHHHHHHhCCCcccCCCcchHHHHHHHHHHHHhccccccccccccccccCCCHHHH
Confidence 9887642 22344578899999999999810
Q ss_pred -----------CCCeEecCCCCCcEEEcCCCCeEEeecCCCcc
Q 003836 620 -----------CTQIIHCDIKPQNILLDDHYNARISDFGLAKL 651 (792)
Q Consensus 620 -----------~~~ivH~dikp~NILl~~~~~~kl~Dfg~a~~ 651 (792)
...++|+|++|.|||++++..+.|+||+.+..
T Consensus 171 ~~~l~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~lIDwe~a~~ 213 (263)
T 3tm0_A 171 YDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSGR 213 (263)
T ss_dssp HHHHHHCCCCCCEEEECSSCCTTSEEEETTEEEEECCCTTCEE
T ss_pred HHHHHhcCCCCCceEECCCCCcCcEEEECCcEEEEEEchhccc
Confidence 13599999999999998766677999998753
|
| >3r0e_A Lectin; carbohydrate binding, carbohydrate, sugar binding protein; 2.40A {Remusatia vivipara} | Back alignment and structure |
|---|
Probab=99.06 E-value=2.8e-10 Score=99.81 Aligned_cols=85 Identities=21% Similarity=0.320 Sum_probs=66.9
Q ss_pred CeeEEEEeCccEEEEcCCCCEEEEeccCCCc-ceeEEEecCCcEEEEecCCccccccccCCcccccCCCccccceEEeee
Q 003836 88 GSKLRLTANRGLVLEDPEGREIWKSEISTGQ-AAFGVLYDTGNFLIVNTNSERLWQSFDHPTDTLLPTQTMERGGVVSSR 166 (792)
Q Consensus 88 ~~~l~~~~~G~Lvl~~~~~~~vWst~~~~~~-~~~a~LldsGNlVl~~~~~~~lWQSFd~PtDtlLpg~~l~~~~~L~S~ 166 (792)
...|.+..||||||+++ +|+|++...+ ...++|+++|||||+|.++.++|+|-.+
T Consensus 22 ~~~L~~q~dGNLvl~~~----~Wssnt~~~~~~~~l~l~~dGnLvl~d~~~~~vWss~t~-------------------- 77 (109)
T 3r0e_A 22 DFDLVMQDDCNLVLYNG----NWQSNTANNGRDCKLTLTDYGELVIKNGDGSTVWKSGAQ-------------------- 77 (109)
T ss_dssp TEEEEECTTSCEEEETT----TEECCCTTSCSSCEEEECTTSCEEEECTTSCEEEECCCC--------------------
T ss_pred CEEEEEecCCeEEEEeC----eEEcCCCCCCCcEEEEEcCCCeEEEEeCCCCEEEcCCCc--------------------
Confidence 45899999999999984 7999987543 4689999999999999988999976210
Q ss_pred ccCCCCCCCceeEeecCCCceeeeeeccCCCcccccccccCCcc
Q 003836 167 RKDTYFSRGRFQFRLLEDGNAVLNTINLESGFAYDAYFWSNTFD 210 (792)
Q Consensus 167 ~s~~~~s~G~~~~~~~~~g~~~~~~~~~~~~~~~~~y~~~~~~~ 210 (792)
...+.|.+.+++||++++|. .+.|.++++.
T Consensus 78 -----~~~~~~~~~L~~dGNlvly~---------~~~W~s~t~~ 107 (109)
T 3r0e_A 78 -----SVKGNYAAVVHPDGRLVVFG---------PSVFKIDPWV 107 (109)
T ss_dssp -----CSSSCCEEEEETTTEEEEEC---------SEEEEECTTS
T ss_pred -----CCCcCEEEEEcCCCeEEEEe---------cCEECCCCcc
Confidence 12467889999999999863 3578777663
|
| >4h3o_A Lectin; cadmium, plant protein; 2.17A {Allium sativum} PDB: 1kj1_A* 1bwu_P* 1kj1_D* 1bwu_Q* 1bwu_A* 1bwu_D* | Back alignment and structure |
|---|
Probab=99.01 E-value=1e-09 Score=95.48 Aligned_cols=76 Identities=26% Similarity=0.516 Sum_probs=62.5
Q ss_pred eeEEEEeCccEEEEcCCCCEEEEeccCCC--cceeEEEecCCcEEEEecCCccccccccCCcccccCCCccccceEEeee
Q 003836 89 SKLRLTANRGLVLEDPEGREIWKSEISTG--QAAFGVLYDTGNFLIVNTNSERLWQSFDHPTDTLLPTQTMERGGVVSSR 166 (792)
Q Consensus 89 ~~l~~~~~G~Lvl~~~~~~~vWst~~~~~--~~~~a~LldsGNlVl~~~~~~~lWQSFd~PtDtlLpg~~l~~~~~L~S~ 166 (792)
-.|.+..||||||++. +++||++++... ....+.|+++|||||+|.++.++|+|-.
T Consensus 21 y~l~~q~DgNLvly~~-~~~vW~ant~~~~~~~~~L~l~~dGnLvL~d~~~~~vWss~t--------------------- 78 (105)
T 4h3o_A 21 YHFIMQDDCNLVLYDH-STSTWASNTEIGGKSGCSAVLQSDGNFVVYDSSGRSLWASHS--------------------- 78 (105)
T ss_dssp EEEEECTTSCEEEEET-TEEEEECCCCCTTCCSCEEEECTTSCEEEECTTCCEEEECCC---------------------
T ss_pred EEEEECCCCeEEEEEC-CEEEEEecCCCCCCccEEEEEeCCccEEEECCCcEEEEEecC---------------------
Confidence 5788999999999984 589999998643 3467999999999999999999998721
Q ss_pred ccCCCCCCCceeEeecCCCceeee
Q 003836 167 RKDTYFSRGRFQFRLLEDGNAVLN 190 (792)
Q Consensus 167 ~s~~~~s~G~~~~~~~~~g~~~~~ 190 (792)
....+.+.+.+++||++++|
T Consensus 79 ----~~~~~~~~l~L~ddGNlVly 98 (105)
T 4h3o_A 79 ----TRGSGNYILILQDDGNVIIY 98 (105)
T ss_dssp ----CCCSSCEEEEECTTSCEEEE
T ss_pred ----CCCCCCEEEEEeCCCeEEEE
Confidence 12356789999999999985
|
| >1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=98.92 E-value=1.6e-09 Score=111.33 Aligned_cols=130 Identities=15% Similarity=0.048 Sum_probs=97.5
Q ss_pred cC-ccccceEEEeeecCCCceEEEEEEcccccccchHHHHHHHHHhcccCCCC--cccccceeccCCceEEEEEeccCCC
Q 003836 509 LG-RGAFGTVYKGFVNMGSSNHVAVKKLNSVFQDSEKEFKAEVNGIGQTHHKN--LVRLLGYCDEGQNRLLVYEFMSNGT 585 (792)
Q Consensus 509 lG-~G~~g~Vy~g~~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h~n--iv~l~g~~~~~~~~~lV~E~~~~gs 585 (792)
++ .|..+.||+.... +++.+++|+.... ....+.+|+++++.+++.+ +.+++++...++..++||||+++.+
T Consensus 27 ~~~gg~~~~v~~~~~~--~g~~~vlK~~~~~---~~~~~~~E~~~l~~l~~~~~~vP~~~~~~~~~~~~~~v~e~i~G~~ 101 (264)
T 1nd4_A 27 QTIGCSDAAVFRLSAQ--GRPVLFVKTDLSG---ALNELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEVPGQD 101 (264)
T ss_dssp CSCTTSSCEEEEEECT--TSCCEEEEEECSC---TTSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECCSSEE
T ss_pred cccCCCCceEEEEecC--CCCeEEEEeCCcc---cchhhhHHHHHHHHHHhCCCCCCeEEEeccCCCCCEEEEEecCCcc
Confidence 44 5556999998543 3457999987643 2356788999999886545 5568888888888999999999988
Q ss_pred ccccccCCCCCchhHHHHHHHHHHHHHHHHhhcc----------------------------------------------
Q 003836 586 VASFLFGDSKPNWKLRTEIAMGIAGGLFYLHEEC---------------------------------------------- 619 (792)
Q Consensus 586 L~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~---------------------------------------------- 619 (792)
|. ... .....++.++++.|+.||+..
T Consensus 102 l~--~~~------~~~~~~~~~l~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 173 (264)
T 1nd4_A 102 LL--SSH------LAPAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQGLAPAELFAR 173 (264)
T ss_dssp TT--TSC------CCHHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTTCCHHHHHHH
T ss_pred cC--cCc------CCHhHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhcCCccchhhhhhccCccHHHHHHH
Confidence 84 211 123467788888888888742
Q ss_pred ---------CCCeEecCCCCCcEEEcCCCCeEEeecCCCcc
Q 003836 620 ---------CTQIIHCDIKPQNILLDDHYNARISDFGLAKL 651 (792)
Q Consensus 620 ---------~~~ivH~dikp~NILl~~~~~~kl~Dfg~a~~ 651 (792)
...++|+|++|.|||++++..+.|+||+.+..
T Consensus 174 l~~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~liD~~~a~~ 214 (264)
T 1nd4_A 174 LKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLGV 214 (264)
T ss_dssp HHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCEE
T ss_pred HHHhcCCCCCeEEECCCCCCCcEEEECCcEEEEEcchhccc
Confidence 11399999999999998876678999999863
|
| >3dxp_A Putative acyl-COA dehydrogenase; protein kinase-like fold, structural genomics, joint center structural genomics, JCSG; 2.32A {Ralstonia eutropha JMP134} | Back alignment and structure |
|---|
Probab=98.87 E-value=6e-09 Score=112.85 Aligned_cols=141 Identities=15% Similarity=0.184 Sum_probs=105.6
Q ss_pred hhcCccccceEEEeeecCCCceEEEEEEcc--ccc-ccchHHHHHHHHHhcccC--CCCcccccceeccC---CceEEEE
Q 003836 507 EELGRGAFGTVYKGFVNMGSSNHVAVKKLN--SVF-QDSEKEFKAEVNGIGQTH--HKNLVRLLGYCDEG---QNRLLVY 578 (792)
Q Consensus 507 ~~lG~G~~g~Vy~g~~~~~~~~~vavK~~~--~~~-~~~~~~~~~Ei~~l~~l~--h~niv~l~g~~~~~---~~~~lV~ 578 (792)
+.|+.|.++.||+.... +..+++|+.. ... ......+.+|.++++.++ +..+++++.++.+. +..++||
T Consensus 44 ~~l~~G~sn~~y~v~~~---~~~~vlr~~~~p~~~~~~~~~~~~~E~~~l~~L~~~~vpvP~~~~~~~~~~~~g~~~~vm 120 (359)
T 3dxp_A 44 EQFKGGQSNPTFKLVTP---GQTYVMRAKPGPKSKLLPSAHAIEREYRVMDALAGTDVPVAKMYALCEDESVIGRAFYIM 120 (359)
T ss_dssp EECCC-CCSCEEEEECS---SCEEEEECCCC----------CHHHHHHHHHHHTTSSSCCCCEEEEECCTTTTSSCEEEE
T ss_pred EEcCCcccceEEEEEEC---CceEEEEeCCCCCCCCCCcHHHHHHHHHHHHHhhcCCCCCCcEEEECCCCCccCCeEEEE
Confidence 45899999999998653 2468888775 321 123457888999999886 45678899988776 4589999
Q ss_pred EeccCCCccccccCCCCCchhHHHHHHHHHHHHHHHHhhcc---------------------------------------
Q 003836 579 EFMSNGTVASFLFGDSKPNWKLRTEIAMGIAGGLFYLHEEC--------------------------------------- 619 (792)
Q Consensus 579 E~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~--------------------------------------- 619 (792)
||+++..+.+... ..++...+..++.++++.|+.||...
T Consensus 121 e~v~G~~l~~~~~--~~l~~~~~~~~~~~l~~~La~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 198 (359)
T 3dxp_A 121 EFVSGRVLWDQSL--PGMSPAERTAIYDEMNRVIAAMHTVDYQAIGLGDYGKPGNYFQRQIERWTKQYKLSETESIPAMD 198 (359)
T ss_dssp ECCCCBCCCCTTC--TTCCHHHHHHHHHHHHHHHHHHHHSCTTTTTCTTSSCCSCHHHHHHHHHHHHHHHHCCSCCHHHH
T ss_pred EecCCeecCCCcc--ccCCHHHHHHHHHHHHHHHHHHhCCCchhccccccCCCCCchHHHHHHHHHHHHhcCCcCChHHH
Confidence 9999988855221 33677888899999999999999731
Q ss_pred ----------------CCCeEecCCCCCcEEEcCCCC--eEEeecCCCccc
Q 003836 620 ----------------CTQIIHCDIKPQNILLDDHYN--ARISDFGLAKLL 652 (792)
Q Consensus 620 ----------------~~~ivH~dikp~NILl~~~~~--~kl~Dfg~a~~~ 652 (792)
...++|+|+++.|||++.++. +.|+||+.+...
T Consensus 199 ~~~~~l~~~~~~~~~~~~~lvHgD~~~~Nil~~~~~~~v~~viDwe~a~~g 249 (359)
T 3dxp_A 199 SLMDWLPQHIPQEDADLTSIVHGDYRLDNLMFHPTEPRVLAVLDWELSTLG 249 (359)
T ss_dssp HHHHHGGGCCCSTTSSCCEEECSSCSGGGEEECSSSSCEEEECCCTTCEEE
T ss_pred HHHHHHHhcCCCccCCCceEEeCCCCCCcEEEeCCCCcEEEEECccccccC
Confidence 247999999999999997753 689999998753
|
| >3sg8_A APH(2'')-ID; antibiotic resistance enzyme, transferase, aminoglycoside, phosphorylation, transferase-antibiotic complex; HET: TOY; 1.80A {Enterococcus casseliflavus} PDB: 3sg9_A* 3n4v_A 3n4t_A 3n4u_A 3r81_A* 3r80_A* 3r7z_A* 3r82_A* 3vcq_A* 4dbx_A 4de4_A* 4dfb_A* 4dfu_A* 4dt9_A* 4dt8_A* 4dtb_A* 3sgc_A 4dta_A* 3lzh_A | Back alignment and structure |
|---|
Probab=98.68 E-value=4.7e-09 Score=110.87 Aligned_cols=185 Identities=17% Similarity=0.135 Sum_probs=120.6
Q ss_pred hhcCccccceEEEeeecCCCceEEEEEEcccccccchHHHHHHHHHhcccC-CCC--cccccceeccCC---ceEEEEEe
Q 003836 507 EELGRGAFGTVYKGFVNMGSSNHVAVKKLNSVFQDSEKEFKAEVNGIGQTH-HKN--LVRLLGYCDEGQ---NRLLVYEF 580 (792)
Q Consensus 507 ~~lG~G~~g~Vy~g~~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~-h~n--iv~l~g~~~~~~---~~~lV~E~ 580 (792)
+.++.|....||+.. ..+++|+.... .....+.+|.++++.+. +.. +.+++....... ..++|||+
T Consensus 26 ~~~~~G~~n~v~~v~------~~~vlR~~~~~--~~~~~~~~E~~~l~~l~~~~~v~vP~~~~~~~~~~~~~~~~~vm~~ 97 (304)
T 3sg8_A 26 EISGEGNDCIAYEIN------RDFIFKFPKHS--RGSTNLFNEVNILKRIHNKLPLPIPEVVFTGMPSETYQMSFAGFTK 97 (304)
T ss_dssp CEEEECSSEEEEEST------TSEEEEEESSH--HHHHHHHHHHHHHHHHTTSSSSCCCCEEEECCCCSSCSCSCEEEEC
T ss_pred EecCCCCcceEEEEC------CEEEEEecCCc--chHHHHHHHHHHHHHHHhcCCCCCCceEeecCCCCCCCcceEEEcc
Confidence 347889999999863 35888886432 34567899999998873 333 345555544333 34789999
Q ss_pred ccCCCccccccCCCCCchhHHHHHHHHHHHHHHHHhhc------------------------------------------
Q 003836 581 MSNGTVASFLFGDSKPNWKLRTEIAMGIAGGLFYLHEE------------------------------------------ 618 (792)
Q Consensus 581 ~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~------------------------------------------ 618 (792)
++|.+|.+... ..++..++..++.++++.|+.||+.
T Consensus 98 i~G~~l~~~~~--~~l~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 175 (304)
T 3sg8_A 98 IKGVPLTPLLL--NNLPKQSQNQAAKDLARFLSELHSINISGFKSNLVLDFREKINEDNKKIKKLLSRELKGPQMKKVDD 175 (304)
T ss_dssp CCCEECCHHHH--HTSCHHHHHHHHHHHHHHHHHHHHSCCTTSCGGGBCCHHHHHHHHHHHHHHHHTTTSCHHHHHHHHH
T ss_pred cCCeECCcccc--ccCCHHHHHHHHHHHHHHHHHHHcCCCCCCCccchhhHHHHHHHHHHHHHHHhcccCCcccHHHHHH
Confidence 99988875332 2456677788888888888888861
Q ss_pred -------------cCCCeEecCCCCCcEEEcC--CCCeEEeecCCCccccCCCCCcccc-------------ccccCCcc
Q 003836 619 -------------CCTQIIHCDIKPQNILLDD--HYNARISDFGLAKLLTLDQSHTNTA-------------IRGTKGYV 670 (792)
Q Consensus 619 -------------~~~~ivH~dikp~NILl~~--~~~~kl~Dfg~a~~~~~~~~~~~~~-------------~~gt~~y~ 670 (792)
....++|+|++|.|||+++ ...+.|+||+.+............. .....+..
T Consensus 176 ~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~iD~~~~~~~~~~~Dl~~~~~~~~~~~~~~~~~~l~~Y~~~ 255 (304)
T 3sg8_A 176 FYRDILENEIYFKYYPCLIHNDFSSDHILFDTEKNTICGIIDFGDAAISDPDNDFISLMEDDEEYGMEFVSKILNHYKHK 255 (304)
T ss_dssp HHHHHHTCGGGTCCCCEEECSCCCGGGEEEETTTTEEEEECCCTTCEEECTTHHHHTTCCTTTSCCHHHHHHHHHHHTCS
T ss_pred HHHHHHhccccccCCceeEeCCCCcccEEEeCCCCCEEEEEeCCCCccCChHHHHHHHHhhccccCHHHHHHHHHHcCCC
Confidence 0135899999999999998 5568899999987643211000000 00000111
Q ss_pred c-ccccccCCCCcccceehHHHHHHHHHhcCcCC
Q 003836 671 A-PEWFRNMPITVKVDVYSYGVLLLEIICLRRNI 703 (792)
Q Consensus 671 a-PE~~~~~~~~~k~DV~S~Gv~l~el~tg~~p~ 703 (792)
. |+.... .....+.|+++.++|++.+|..++
T Consensus 256 ~~~~~~~r--~~~~~~~~~l~~~~~~~~~g~~~~ 287 (304)
T 3sg8_A 256 DIPTVLEK--YRMKEKYWSFEKIIYGKEYGYMDW 287 (304)
T ss_dssp CHHHHHHH--HHHHHHHHHHHHHHHHHHTTCHHH
T ss_pred CcHHHHHH--HHHHHHHHHHHHHHHHHHcCCHHH
Confidence 1 221111 112368899999999999998765
|
| >4gkh_A Aminoglycoside 3'-phosphotransferase APHA1-IAB; pyrazolopyrimidine, 1-Na-PP1, bumped kinase inhibitor, BKI, kinase inhibitor; HET: KAN 0J9; 1.86A {Acinetobacter baumannii} PDB: 4feu_A* 4few_A* 4fex_A* 4fev_A* 4gki_A* 4ej7_A* 3r78_A* | Back alignment and structure |
|---|
Probab=98.04 E-value=9.5e-06 Score=83.60 Aligned_cols=136 Identities=15% Similarity=0.127 Sum_probs=95.8
Q ss_pred hcCccccc-eEEEeeecCCCceEEEEEEcccccccchHHHHHHHHHhcccC-CCCcccccceeccCCceEEEEEeccCCC
Q 003836 508 ELGRGAFG-TVYKGFVNMGSSNHVAVKKLNSVFQDSEKEFKAEVNGIGQTH-HKNLVRLLGYCDEGQNRLLVYEFMSNGT 585 (792)
Q Consensus 508 ~lG~G~~g-~Vy~g~~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~-h~niv~l~g~~~~~~~~~lV~E~~~~gs 585 (792)
.+..|..+ .||+.... ..+..+.+|+-.. .....+.+|...|+.+. +--+.++++++.+++..++|||++++.+
T Consensus 31 ~~~~G~S~~~v~rl~~~-~~~~~~~lk~~~~---~~~~~~~~E~~~l~~l~~~vPVP~v~~~~~~~~~~~lvme~l~G~~ 106 (272)
T 4gkh_A 31 RDNVGQSGATIYRLYGK-PNAPELFLKHGKG---SVANDVTDEMVRLNWLTAFMPLPTIKHFIRTPDDAWLLTTAIPGKT 106 (272)
T ss_dssp EEECSSSSCEEEEEECC-TTCCCEEEEEEET---HHHHHHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEECCCSEE
T ss_pred EccCCCcCCeEEEEEec-CCCeEEEEEECCC---CCHhHHHHHHHHHHHhccCCCcCeEEEEEEECCeEEEEEEeeCCcc
Confidence 34445554 68886433 2345688888643 23457888999888774 4447788899988899999999999987
Q ss_pred ccccccCCCCCchhHHHHHHHHHHHHHHHHhhcc----------------------------------------------
Q 003836 586 VASFLFGDSKPNWKLRTEIAMGIAGGLFYLHEEC---------------------------------------------- 619 (792)
Q Consensus 586 L~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~---------------------------------------------- 619 (792)
+.+.... .......+..++++.|+-||...
T Consensus 107 ~~~~~~~----~~~~~~~~~~~l~~~L~~Lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 182 (272)
T 4gkh_A 107 AFQVLEE----YPDSGENIVDALAVFLRRLHSIPVCNCPFNSDRVFRLAQAQSRMNNGLVDASDFDDERNGWPVEQVWKE 182 (272)
T ss_dssp HHHHHHH----CGGGHHHHHHHHHHHHHHHHTSCGGGCCBBCCHHHHHHHHHHHHHTTCCCGGGCCGGGTTCCHHHHHHH
T ss_pred ccccccC----CHHHHHHHHHHHHHHHHHhcCCCcccCCcCcccccchhhHHHHHHHhhhhhhhccccccchHHHHHHHH
Confidence 7665421 12334456666667777776421
Q ss_pred ---------CCCeEecCCCCCcEEEcCCCCeEEeecCCCcc
Q 003836 620 ---------CTQIIHCDIKPQNILLDDHYNARISDFGLAKL 651 (792)
Q Consensus 620 ---------~~~ivH~dikp~NILl~~~~~~kl~Dfg~a~~ 651 (792)
...++|+|+++.|||+++++.+-|+||+.+..
T Consensus 183 l~~~~~~~~~~~l~HGDl~~~Nil~~~~~~~~viDwe~a~~ 223 (272)
T 4gkh_A 183 MHKLLPFSPDSVVTHGDFSLDNLIFDEGKLIGCIDVGRVGI 223 (272)
T ss_dssp HHTTCCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCEE
T ss_pred HHhcccccCCcEEEcCCCCCCeEEEECCeEEEEEECccccc
Confidence 02389999999999999887778999998864
|
| >3tdw_A Gentamicin resistance protein; kinase, phosphoryl transfer, antibiotic resistance, transfer; HET: GDP; 1.70A {Enterococcus gallinarum} PDB: 3tdv_A* | Back alignment and structure |
|---|
Probab=98.00 E-value=1.1e-05 Score=84.79 Aligned_cols=135 Identities=17% Similarity=0.149 Sum_probs=92.8
Q ss_pred hcCccccceEEEeeecCCCceEEEEEEcccccccchHHHHHHHHHhcccCCC---Ccccccceec-cCCceEEEEEeccC
Q 003836 508 ELGRGAFGTVYKGFVNMGSSNHVAVKKLNSVFQDSEKEFKAEVNGIGQTHHK---NLVRLLGYCD-EGQNRLLVYEFMSN 583 (792)
Q Consensus 508 ~lG~G~~g~Vy~g~~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h~---niv~l~g~~~-~~~~~~lV~E~~~~ 583 (792)
.++.|....||+. +..+++|+-.. ......+.+|.++|+.+.+. .+.+++.+.. ..+..++||||++|
T Consensus 26 ~l~~G~~n~v~~v------g~~~VlR~~~~--~~~~~~~~~E~~~L~~L~~~~~v~VP~~~~~~~~~~g~~~~v~e~i~G 97 (306)
T 3tdw_A 26 SLGEGFRNYAILV------NGDWVFRFPKS--QQGADELNKEIQLLPLLVGCVKVNIPQYVYIGKRSDGNPFVGYRKVQG 97 (306)
T ss_dssp EEEECSSEEEEEE------TTTEEEEEESS--HHHHHHHHHHHHHHHHHTTTCSSBCCCEEEEEECTTSCEEEEEECCCS
T ss_pred ecCCCcceeEEEE------CCEEEEEecCC--chHHHHHHHHHHHHHHHHhcCCCCCCCeEeecccCCCceEEEEeccCC
Confidence 4777888899986 23588888432 23456789999999998653 3566666663 45567899999999
Q ss_pred CCccccccCCCCCchhHHHHHHHHHHHHHHHHhhc---------------------------------------------
Q 003836 584 GTVASFLFGDSKPNWKLRTEIAMGIAGGLFYLHEE--------------------------------------------- 618 (792)
Q Consensus 584 gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~--------------------------------------------- 618 (792)
.+|.+... ..++...+..++.++++.|+.||+.
T Consensus 98 ~~l~~~~~--~~l~~~~~~~~~~~lg~~La~LH~~~~~~~~~~g~p~~~w~~~~~~~~~~~~~~~~~~l~~~~~~~l~~~ 175 (306)
T 3tdw_A 98 QILGEDGM--AVLPDDAKDRLALQLAEFMNELSAFPVETAISAGVPVTNLKNKILLLSEAVEDQVFPLLDESLRDYLTLR 175 (306)
T ss_dssp EECHHHHH--TTSCHHHHHHHHHHHHHHHHHHHHSCHHHHHHTTCCBCCHHHHHHHHHHHHHHHTGGGSCHHHHHHHHHH
T ss_pred eECchhhh--hhCCHHHHHHHHHHHHHHHHHHhcCCcccccccCCChHHHHHHHHHHHHHHHHhcccccchhhHHHHHHH
Confidence 88876321 1234445555555555555555542
Q ss_pred ------------cCCCeEecCCCCCcEEEcC---CCC-eEEeecCCCccc
Q 003836 619 ------------CCTQIIHCDIKPQNILLDD---HYN-ARISDFGLAKLL 652 (792)
Q Consensus 619 ------------~~~~ivH~dikp~NILl~~---~~~-~kl~Dfg~a~~~ 652 (792)
....++|+|+++.|||++. ++. ..|+||+.+...
T Consensus 176 ~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~~~iD~~~a~~g 225 (306)
T 3tdw_A 176 FQSYMTHPVYTRYTPRLIHGDLSPDHFLTNLNSRQTPLTGIIDFGDAAIS 225 (306)
T ss_dssp HHHHHHCHHHHCCCCEEECSCCSGGGEEECTTCSSCCEEEECCCTTCEEE
T ss_pred HHHHHhCcccccCCCeeEeCCCCcccEEEecCCCCCceEEEEehhhcCCC
Confidence 1235799999999999997 455 489999988653
|
| >3ats_A Putative uncharacterized protein; hypothetical protein, putative aminoglycoside phosphortransf transferase; 1.67A {Mycobacterium tuberculosis} PDB: 3att_A* | Back alignment and structure |
|---|
Probab=97.94 E-value=1.5e-05 Score=85.75 Aligned_cols=145 Identities=9% Similarity=0.075 Sum_probs=89.9
Q ss_pred hhc-CccccceEEEeeec---CC--CceEEEEEEccccc---ccchHHHHHHHHHhcccC-C--CCcccccceeccC---
Q 003836 507 EEL-GRGAFGTVYKGFVN---MG--SSNHVAVKKLNSVF---QDSEKEFKAEVNGIGQTH-H--KNLVRLLGYCDEG--- 571 (792)
Q Consensus 507 ~~l-G~G~~g~Vy~g~~~---~~--~~~~vavK~~~~~~---~~~~~~~~~Ei~~l~~l~-h--~niv~l~g~~~~~--- 571 (792)
+.| +.|....+|+.... .+ .++.+++|+-.... ......+.+|+.+++.+. + ..+.+++.++.+.
T Consensus 26 ~~l~~~G~~n~~y~v~~~~~~~~~~~~~~~vlR~~~~~~~~~~~~~~~~~~E~~~l~~L~~~~~vpvP~v~~~~~~~~~~ 105 (357)
T 3ats_A 26 SGVDSTGMSSETIILTARWQQDGRSIQQKLVARVAPAAEDVPVFPTYRLDHQFEVIRLVGELTDVPVPRVRWIETTGDVL 105 (357)
T ss_dssp EEECTTSSEEEEEEEEEEEEETTEEEEEEEEEEECCCGGGCCSSSCCCHHHHHHHHHHHHHHCCSCCCCEEEEECSSTTT
T ss_pred EECCCCCccceEEEEEEecccCCCCCCceEEEEeCCCCCccccCchhHHHHHHHHHHHHhhcCCCCCCcEEEEccCCCcc
Confidence 346 78888999987543 11 14578888765432 111246788888888884 3 3567788887665
Q ss_pred CceEEEEEeccCCCccccccCC------CCCchhHHHHHHHHHHHHH---------------------------------
Q 003836 572 QNRLLVYEFMSNGTVASFLFGD------SKPNWKLRTEIAMGIAGGL--------------------------------- 612 (792)
Q Consensus 572 ~~~~lV~E~~~~gsL~~~l~~~------~~l~~~~~~~i~~~ia~gL--------------------------------- 612 (792)
...++||||+++..+.+.+... ..++..++..++.++++.|
T Consensus 106 g~~~~v~e~l~G~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~La~LH~~~~~~~~l~~~~~~~~~~~~~~~~~~~~ 185 (357)
T 3ats_A 106 GTPFFLMDYVEGVVPPDVMPYTFGDNWFADAPAERQRQLQDATVAALATLHSIPNAQNTFSFLTQGRTSDTTLHRHFNWV 185 (357)
T ss_dssp SSCEEEEECCCCBCCCBTTBGGGSCSTTTTSCHHHHHHHHHHHHHHHHHHTTCSSHHHHTGGGC-----CCHHHHHHHHH
T ss_pred CCceEEEEecCCCChhhcCcccccccccCCCCHHHHHHHHHHHHHHHHHHhCCCCccCChhhccCCCCCCchHHHHHHHH
Confidence 3568999999998876532100 0112222222222222222
Q ss_pred ---------------------HHHhhc-------cCCCeEecCCCCCcEEEcCCCCeEEeecCCCcc
Q 003836 613 ---------------------FYLHEE-------CCTQIIHCDIKPQNILLDDHYNARISDFGLAKL 651 (792)
Q Consensus 613 ---------------------~yLH~~-------~~~~ivH~dikp~NILl~~~~~~kl~Dfg~a~~ 651 (792)
.+|.+. ....++|+|+++.|||++++..+.|+||+.+..
T Consensus 186 ~~~~~~~~~~~~~~~~~~~~~~~l~~~~p~~~~~~~~~l~HgDl~~~Nil~~~~~~~~vIDwe~a~~ 252 (357)
T 3ats_A 186 RSWYDFAVEGIGRSPLLERTFEWLQSHWPDDAAAREPVLLWGDARVGNVLYRDFQPVAVLDWEMVAL 252 (357)
T ss_dssp HHHHHHHHHHHCCCHHHHHHHHHHHHTCCHHHHHSCCEEECSSCSGGGEEEETTEEEEECCGGGCEE
T ss_pred HHHHHhhccCCCCChHHHHHHHHHHHhCCCcccCCCceEEeCCCCCCeEEEeCCcEEEEEccccccc
Confidence 233221 135799999999999999655578999998864
|
| >2olc_A MTR kinase, methylthioribose kinase; kinase ADP-2HO complex, transferase; HET: CPS ADP; 2.00A {Bacillus subtilis} SCOP: d.144.1.6 PDB: 2pu8_A* 2pui_A* 2pul_A* 2pun_A* 2pup_A* | Back alignment and structure |
|---|
Probab=97.58 E-value=9e-05 Score=80.94 Aligned_cols=75 Identities=13% Similarity=0.165 Sum_probs=47.9
Q ss_pred hhcCccccceEEEeeecCCCceEEEEEEcccccc-------cchHHHHHHHHHhcccCC--CC-cccccceeccCCceEE
Q 003836 507 EELGRGAFGTVYKGFVNMGSSNHVAVKKLNSVFQ-------DSEKEFKAEVNGIGQTHH--KN-LVRLLGYCDEGQNRLL 576 (792)
Q Consensus 507 ~~lG~G~~g~Vy~g~~~~~~~~~vavK~~~~~~~-------~~~~~~~~Ei~~l~~l~h--~n-iv~l~g~~~~~~~~~l 576 (792)
+.||.|..+.||++.... .++.++||....... .....+..|.++++.+.+ +. +.+++.+ +.+..++
T Consensus 36 ~~lg~G~~n~vyrv~~~~-~~~~~vvK~~~~~~r~~~~~~~~~~~r~~~E~~~L~~l~~~~~~~vP~~~~~--d~~~~~l 112 (397)
T 2olc_A 36 QEIGDGNLNYVFHIYDQE-HDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEMAVT 112 (397)
T ss_dssp EECCSSSSEEEEEEEC-----CEEEEEEECCC-------CCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTTTEE
T ss_pred EECCCCceEEEEEEEECC-CCcEEEEEecchhhcccCCCCcCcHHHHHHHHHHHHHhhhhCCCCcCeEEEE--cCCccEE
Confidence 468999999999986542 346799997643211 123456788888887742 33 3455544 3445689
Q ss_pred EEEeccCC
Q 003836 577 VYEFMSNG 584 (792)
Q Consensus 577 V~E~~~~g 584 (792)
|||++++.
T Consensus 113 vmE~l~g~ 120 (397)
T 2olc_A 113 VMEDLSHL 120 (397)
T ss_dssp EECCCTTS
T ss_pred EEEeCCCc
Confidence 99999864
|
| >2q83_A YTAA protein; 2635576, structural genomics, joint center for structu genomics, JCSG, protein structure initiative, PSI-2, transf; HET: ADN CIT UNL; 2.50A {Bacillus subtilis} | Back alignment and structure |
|---|
Probab=97.53 E-value=0.0006 Score=72.46 Aligned_cols=137 Identities=15% Similarity=0.150 Sum_probs=79.3
Q ss_pred hcCccccceEEEeeecCCCceEEEEEEcccccccchHHHHHHHHHhcccCC--CCcccccce------eccCCceEEEEE
Q 003836 508 ELGRGAFGTVYKGFVNMGSSNHVAVKKLNSVFQDSEKEFKAEVNGIGQTHH--KNLVRLLGY------CDEGQNRLLVYE 579 (792)
Q Consensus 508 ~lG~G~~g~Vy~g~~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h--~niv~l~g~------~~~~~~~~lV~E 579 (792)
.|+.|..+.||+.... + ..+++|+.... ..++..|..+++.+.. -.+.+++.. ....+..++|||
T Consensus 39 ~l~gG~~n~~~~v~~~--~-~~~vlk~~~~~----~~~~~~e~~~l~~L~~~g~~vp~~~~~~~g~~~~~~~~~~~~l~~ 111 (346)
T 2q83_A 39 VIQGNQMALVWKVHTD--S-GAVCLKRIHRP----EKKALFSIFAQDYLAKKGMNVPGILPNKKGSLYSKHGSFLFVVYD 111 (346)
T ss_dssp ECC----CEEEEEEET--T-EEEEEEEECSC----HHHHHHHHHHHHHHHHHTCSSCCBCCCTTSCSCEEETTEEEEEEE
T ss_pred eccccccCcEEEEEeC--C-CCEEEEecCCC----HHHHHHHHHHHHHHHHcCCCCCceeecCCCCEEEEECCEEEEEEE
Confidence 3666778899997643 2 35889988652 2344556666665532 223444431 124556789999
Q ss_pred eccCCCccc--------------cccC----C--C--------CCchhHH------------------------------
Q 003836 580 FMSNGTVAS--------------FLFG----D--S--------KPNWKLR------------------------------ 601 (792)
Q Consensus 580 ~~~~gsL~~--------------~l~~----~--~--------~l~~~~~------------------------------ 601 (792)
|+++..+.. .++. . . ...|...
T Consensus 112 ~i~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ 191 (346)
T 2q83_A 112 WIEGRPFELTVKQDLEFIMKGLADFHTASVGYQPPNGVPIFTKLGRWPNHYTKRCKQMETWKLMAEAEKEDPFSQLYLQE 191 (346)
T ss_dssp CCCCBCCCTTSHHHHHHHHHHHHHHHHHHTTCCCCTTCCCCBCTTCHHHHHHHHHHHHHHHHHHHHHCSSCHHHHHHHHH
T ss_pred eecCccCCCCCHHHHHHHHHHHHHHHHhCCCCCCCccchhcccccchHHHHHHHHHHHHHHHHHHHhccCCcHHHHHHHH
Confidence 999876531 0111 0 0 0112110
Q ss_pred -HHHHHHHHHHHHHHhh----------ccCCCeEecCCCCCcEEEcCCCCeEEeecCCCcc
Q 003836 602 -TEIAMGIAGGLFYLHE----------ECCTQIIHCDIKPQNILLDDHYNARISDFGLAKL 651 (792)
Q Consensus 602 -~~i~~~ia~gL~yLH~----------~~~~~ivH~dikp~NILl~~~~~~kl~Dfg~a~~ 651 (792)
..+...+.+++.+|+. .....++|+|+++.|||++.++.+.|+||+.+..
T Consensus 192 ~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDfe~a~~ 252 (346)
T 2q83_A 192 IDGFIEDGLRIKDRLLQSTYVPWTEQLKKSPNLCHQDYGTGNTLLGENEQIWVIDLDTVSF 252 (346)
T ss_dssp HHHHHHHHHHHHHHHHHTTHHHHHHHHHHSCCEECSSCSTTSEEECGGGCEEECCCTTCEE
T ss_pred HHHHHHHHHHHHHHHHhchHHHHHHhccccCceecCCCCcccEEEeCCCcEEEEehhhccc
Confidence 0111223446667763 1246899999999999998888999999998753
|
| >3jr1_A Putative fructosamine-3-kinase; YP_719053.1, structural genomics, joint center for structural genomics, JCSG; HET: MSE UNL; 2.32A {Haemophilus somnus 129PT} | Back alignment and structure |
|---|
Probab=97.42 E-value=0.00046 Score=72.34 Aligned_cols=74 Identities=18% Similarity=0.187 Sum_probs=57.8
Q ss_pred hhcCccccceEEEeeecCCCceEEEEEEcccccccchHHHHHHHHHhcccC---CCCcccccceeccCCceEEEEEeccC
Q 003836 507 EELGRGAFGTVYKGFVNMGSSNHVAVKKLNSVFQDSEKEFKAEVNGIGQTH---HKNLVRLLGYCDEGQNRLLVYEFMSN 583 (792)
Q Consensus 507 ~~lG~G~~g~Vy~g~~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~---h~niv~l~g~~~~~~~~~lV~E~~~~ 583 (792)
+.|+.|....+|+... ++..+++|+.... ....+..|.+.|+.+. ...+++++.++...+..++||||+++
T Consensus 42 ~~l~gG~~n~~y~v~~---~~~~~vlK~~~~~---~~~~~~~E~~~L~~L~~~~~v~VP~vl~~~~~~g~~~lvme~l~G 115 (312)
T 3jr1_A 42 EKLYSGEMNEIWLIND---EVQTVFVKINERS---YRSMFRAEADQLALLAKTNSINVPLVYGIGNSQGHSFLLLEALNK 115 (312)
T ss_dssp EEECCSSSSEEEEEES---SSCEEEEEEEEGG---GHHHHHHHHHHHHHHHHTTSSBCCCEEEEEECSSEEEEEEECCCC
T ss_pred EEeCCccceeeeEEEE---CCCeEEEEeCCcc---cHHHHHHHHHHHHHHHhhCCCCcceEEEEeecCCceEEEEEeccC
Confidence 3588999999999753 2457888886532 3567889999888884 35688888888877889999999999
Q ss_pred CCc
Q 003836 584 GTV 586 (792)
Q Consensus 584 gsL 586 (792)
..+
T Consensus 116 ~~~ 118 (312)
T 3jr1_A 116 SKN 118 (312)
T ss_dssp CCC
T ss_pred CCC
Confidence 875
|
| >3f7w_A Putative fructosamine-3-kinase; YP_290396.1, structural GENO joint center for structural genomics, JCSG, protein structu initiative, PSI-2; 1.85A {Thermobifida fusca YX} | Back alignment and structure |
|---|
Probab=97.20 E-value=0.00076 Score=69.92 Aligned_cols=74 Identities=19% Similarity=0.232 Sum_probs=52.3
Q ss_pred hhcCccccceEEEeeecCCCceEEEEEEcccccccchHHHHHHHHHhcccCCC---CcccccceeccCCceEEEEEeccC
Q 003836 507 EELGRGAFGTVYKGFVNMGSSNHVAVKKLNSVFQDSEKEFKAEVNGIGQTHHK---NLVRLLGYCDEGQNRLLVYEFMSN 583 (792)
Q Consensus 507 ~~lG~G~~g~Vy~g~~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h~---niv~l~g~~~~~~~~~lV~E~~~~ 583 (792)
+.+|.|..+.||+..+. +++.+.+|+-..........|..|.+.|+.+... -+++++++. ..++||||++.
T Consensus 21 ~~~g~G~~~~vyrv~l~--DG~~~~vK~~~~~~~~~~~~~~~Ea~~L~~L~~~~~vpvP~v~~~~----~~~lv~e~l~~ 94 (288)
T 3f7w_A 21 AERGHSHRWHLYRVELA--DGTPLFVKALPDDAPALDGLFRAEALGLDWLGRSFGSPVPQVAGWD----DRTLAMEWVDE 94 (288)
T ss_dssp EEEEEETTEEEEEEEET--TSCEEEEEECCTTCCCCTTHHHHHHHHHHHHTCSTTCCSCCEEEEE----TTEEEEECCCC
T ss_pred EecCCCCCeEEEEEEEC--CCCEEEEEEeCCCCcchhhHHHHHHHHHHHHHhhCCCCcceEEecc----CceEEEEeecc
Confidence 45899999999998765 3568999987654444455788999988877422 244455442 34789999987
Q ss_pred CCc
Q 003836 584 GTV 586 (792)
Q Consensus 584 gsL 586 (792)
+..
T Consensus 95 ~~~ 97 (288)
T 3f7w_A 95 RPP 97 (288)
T ss_dssp CCC
T ss_pred cCC
Confidence 654
|
| >2pyw_A Uncharacterized protein; 5-methylthioribose kinase, plant methionine recycling, refol transferase; HET: SR1 ADP; 1.90A {Arabidopsis thaliana} | Back alignment and structure |
|---|
Probab=97.14 E-value=0.00066 Score=74.60 Aligned_cols=80 Identities=9% Similarity=0.012 Sum_probs=49.4
Q ss_pred CCCeEecCCCCCcEEEcCCCCeEEeecCCCccccCCCCCccccccccCCcccccccccC---CCCcccceehHHHHHHHH
Q 003836 620 CTQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLDQSHTNTAIRGTKGYVAPEWFRNM---PITVKVDVYSYGVLLLEI 696 (792)
Q Consensus 620 ~~~ivH~dikp~NILl~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~---~~~~k~DV~S~Gv~l~el 696 (792)
...++|+|++|.|||++.++ ++|+||+.+...............-...|.+|+..... .-....++.+....+|+.
T Consensus 231 ~~~liHGDl~~~Nil~~~~~-~~lID~e~a~~G~p~~Dla~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 309 (420)
T 2pyw_A 231 AQALIHGDLHTGSVMVTQDS-TQVIDPEFSFYGPMGFDIGAYLGNLILAFFAQDGHATQENDRKEYKQWILRTIEQTWNL 309 (420)
T ss_dssp CCEEECSCCSGGGEEECSSC-EEECCCTTCEEECHHHHHHHHHHHHHHHHHHGGGGCCSSCCSHHHHHHHHHHHHHHHHH
T ss_pred CCeEEecCCCCCcEEEeCCC-CEEEeCcccccCchHHHHHHHHHHHHHHHHhcccccccccchHHHHHHHHHHHHHHHHH
Confidence 35899999999999999876 99999999875432111000000001245666654311 112235566888888888
Q ss_pred HhcC
Q 003836 697 ICLR 700 (792)
Q Consensus 697 ~tg~ 700 (792)
++++
T Consensus 310 y~~~ 313 (420)
T 2pyw_A 310 FNKR 313 (420)
T ss_dssp HHHH
T ss_pred HHHH
Confidence 7764
|
| >1nw1_A Choline kinase (49.2 KD); phospholipid synthesis, protein kinase fold, transferase; 2.02A {Caenorhabditis elegans} SCOP: d.144.1.8 | Back alignment and structure |
|---|
Probab=96.80 E-value=0.0019 Score=71.04 Aligned_cols=75 Identities=13% Similarity=0.162 Sum_probs=50.2
Q ss_pred hhcCccccceEEEeeecCC------CceEEEEEEcccccccchHHHHHHHHHhcccCCCCc-ccccceeccCCceEEEEE
Q 003836 507 EELGRGAFGTVYKGFVNMG------SSNHVAVKKLNSVFQDSEKEFKAEVNGIGQTHHKNL-VRLLGYCDEGQNRLLVYE 579 (792)
Q Consensus 507 ~~lG~G~~g~Vy~g~~~~~------~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h~ni-v~l~g~~~~~~~~~lV~E 579 (792)
+.|+.|....+|+.....+ .++.+++|+.... .....+.+|..+++.+...++ .++++.+.+ .+|+|
T Consensus 79 ~~l~gG~tN~~y~v~~~~~~~~~~~~~~~~vlRi~~~~--~~~~~li~E~~~l~~L~~~g~~P~l~~~~~~----g~v~e 152 (429)
T 1nw1_A 79 SRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNP--ETESHLVAESVIFTLLSERHLGPKLYGIFSG----GRLEE 152 (429)
T ss_dssp EEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSC--CCHHHHHHHHHHHHHHHHTTSSSCEEEEETT----EEEEC
T ss_pred EEeCCCcccceEEEEeCCCccccCCCCceEEEEEeCCC--CcHHHHHHHHHHHHHHHhCCCCCcEEEEeCC----CEEEE
Confidence 3577888899999875421 2357888887432 122456689999988854444 567776653 38999
Q ss_pred eccCCCcc
Q 003836 580 FMSNGTVA 587 (792)
Q Consensus 580 ~~~~gsL~ 587 (792)
|+++.+|.
T Consensus 153 ~l~G~~l~ 160 (429)
T 1nw1_A 153 YIPSRPLS 160 (429)
T ss_dssp CCCEEECC
T ss_pred EeCCcccC
Confidence 99875553
|
| >2ppq_A HSK, HK, homoserine kinase; structural genomics, MCSG, PSI-2, protein structure initiative; 2.00A {Agrobacterium tumefaciens str} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=96.78 E-value=0.0027 Score=66.76 Aligned_cols=139 Identities=12% Similarity=0.086 Sum_probs=78.5
Q ss_pred hcCccccceEEEeeecCCCceEEEEEEcccccccchHHHHHHHHHhcccCCCC--ccccccee------ccCCceEEEEE
Q 003836 508 ELGRGAFGTVYKGFVNMGSSNHVAVKKLNSVFQDSEKEFKAEVNGIGQTHHKN--LVRLLGYC------DEGQNRLLVYE 579 (792)
Q Consensus 508 ~lG~G~~g~Vy~g~~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h~n--iv~l~g~~------~~~~~~~lV~E 579 (792)
.|+.|....+|+..... + .+++|+.... .....+..|+.+++.+...+ +.+++... ...+..+++++
T Consensus 29 ~i~~G~~n~~~~v~~~~--g-~~vlk~~~~~--~~~~~l~~e~~~l~~L~~~g~~vP~~~~~~~g~~~~~~~g~~~~l~~ 103 (322)
T 2ppq_A 29 GIAEGVENSNFLLHTTK--D-PLILTLYEKR--VEKNDLPFFLGLMQHLAAKGLSCPLPLPRKDGELLGELSGRPAALIS 103 (322)
T ss_dssp EECC---EEEEEEEESS--C-CEEEEEECC-----CCHHHHHHHHHHHHHHTTCCCCCBCCBTTCCSCEEETTEEEEEEE
T ss_pred ccCCCcccceEEEEeCC--c-cEEEEEeCCC--CCHHHHHHHHHHHHHHHHCCCCCCcccCCCCCCEEEEECCEEEEEEE
Confidence 46778888999976542 2 5888887652 12345667777777764323 33444221 12345689999
Q ss_pred eccCCCcccc--------------ccC------CCC------CchhHHHH------------HHHHHHHHHHHHhhc---
Q 003836 580 FMSNGTVASF--------------LFG------DSK------PNWKLRTE------------IAMGIAGGLFYLHEE--- 618 (792)
Q Consensus 580 ~~~~gsL~~~--------------l~~------~~~------l~~~~~~~------------i~~~ia~gL~yLH~~--- 618 (792)
|+++..+... ++. ... ..|..... +...+.+.++.++..
T Consensus 104 ~l~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~~~~~l~~~l~~~~~~l~~~~~~ 183 (322)
T 2ppq_A 104 FLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEVEKGLREEIRPEIDYLAAHWPK 183 (322)
T ss_dssp CCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGTSTTHHHHHHHHHHHHHHHCCC
T ss_pred eCCCcCCCCCCHHHHHHHHHHHHHHHHHhccCCCcccCccChHHHHHHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhCcc
Confidence 9998765321 111 000 01221100 011234445555532
Q ss_pred -cCCCeEecCCCCCcEEEcCCCCeEEeecCCCcc
Q 003836 619 -CCTQIIHCDIKPQNILLDDHYNARISDFGLAKL 651 (792)
Q Consensus 619 -~~~~ivH~dikp~NILl~~~~~~kl~Dfg~a~~ 651 (792)
....++|+|+++.|||++++..+.|+||+.+..
T Consensus 184 ~~~~~liHgDl~~~Nil~~~~~~~~lIDf~~a~~ 217 (322)
T 2ppq_A 184 DLPAGVIHADLFQDNVFFLGDELSGLIDFYFACN 217 (322)
T ss_dssp SSCEEEECSCCCGGGEEEETTEEEEECCCTTCEE
T ss_pred cCCcccCCCCCCccCEEEeCCceEEEecchhccC
Confidence 134799999999999999876668999998753
|
| >3feg_A Choline/ethanolamine kinase; non-protein kinase, choline kinase, structural genomics CONS SGC, hemicholinium-3, phosphorylation; HET: HC7 ADP AMP; 1.30A {Homo sapiens} PDB: 3lq3_A* 2ig7_A* | Back alignment and structure |
|---|
Probab=96.71 E-value=0.0046 Score=66.52 Aligned_cols=139 Identities=15% Similarity=0.176 Sum_probs=82.0
Q ss_pred hcCccccceEEEeeecC------CCceEEEEEEcccccccchHHHHHHHHHhcccCCCC-cccccceeccCCceEEEEEe
Q 003836 508 ELGRGAFGTVYKGFVNM------GSSNHVAVKKLNSVFQDSEKEFKAEVNGIGQTHHKN-LVRLLGYCDEGQNRLLVYEF 580 (792)
Q Consensus 508 ~lG~G~~g~Vy~g~~~~------~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h~n-iv~l~g~~~~~~~~~lV~E~ 580 (792)
.|..|-...+|+..... +.++.+.+|+-... ........+|.++++.+...+ ..++++++.++ +||||
T Consensus 57 ~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlR~~g~~-~~~~~~~~rE~~vl~~L~~~gv~P~ll~~~~~g----~v~e~ 131 (379)
T 3feg_A 57 PVSGGLSNLLFRCSLPDHLPSVGEEPREVLLRLYGAI-LQGVDSLVLESVMFAILAERSLGPQLYGVFPEG----RLEQY 131 (379)
T ss_dssp EC-----CCEEEEECCTTSCCCSSCCSEEEEEECC----CCHHHHHHHHHHHHHHHHTTSSCCEEEEETTE----EEEEC
T ss_pred EcCCcccccEEEEEeCCCccccCCCCCeEEEEECCCc-cchHHHHHHHHHHHHHHHhcCCCCeEEEEcCCc----cEEEE
Confidence 46667778899876532 12357888886332 223456778999998885333 35677766542 99999
Q ss_pred ccCCCcccc-c----------------cCC-----CCC--chhHHHHHHHHHHH-------------------HHHHHhh
Q 003836 581 MSNGTVASF-L----------------FGD-----SKP--NWKLRTEIAMGIAG-------------------GLFYLHE 617 (792)
Q Consensus 581 ~~~gsL~~~-l----------------~~~-----~~l--~~~~~~~i~~~ia~-------------------gL~yLH~ 617 (792)
+++..|..- + +.- +.. -+.++.++..++.. .+..|..
T Consensus 132 i~G~~l~~~~l~~p~~~~~ia~~La~LH~~~~~~~~~~~~l~~~i~~w~~~~~~~~~~~~~~~~~~~~~~l~~~~~~L~~ 211 (379)
T 3feg_A 132 IPSRPLKTQELREPVLSAAIATKMAQFHGMEMPFTKEPHWLFGTMERYLKQIQDLPPTGLPEMNLLEMYSLKDEMGNLRK 211 (379)
T ss_dssp CSEEECCGGGGGCHHHHHHHHHHHHHHHTCCCSSCCSCCHHHHHHHHHHHHHHHCCCCSCCSCCHHHHTTHHHHHHHHHH
T ss_pred ecCccCChhHhCCHHHHHHHHHHHHHHhCCCCCCCCCcccHHHHHHHHHHHHHhccCcccchhhhhhhHHHHHHHHHHHH
Confidence 998766421 1 110 111 13344444433321 2233322
Q ss_pred c-----cCCCeEecCCCCCcEEEcCC----CCeEEeecCCCcc
Q 003836 618 E-----CCTQIIHCDIKPQNILLDDH----YNARISDFGLAKL 651 (792)
Q Consensus 618 ~-----~~~~ivH~dikp~NILl~~~----~~~kl~Dfg~a~~ 651 (792)
. ....++|+|+.+.|||++.+ +.+.|+||..+..
T Consensus 212 ~L~~~~~~~~~~H~D~~~~Nil~~~~~~~~~~~~~IDwE~a~~ 254 (379)
T 3feg_A 212 LLESTPSPVVFCHNDIQEGNILLLSEPENADSLMLVDFEYSSY 254 (379)
T ss_dssp HHHTSCCCEEEECSCCCGGGEEEESCC---CCEEECCCTTCEE
T ss_pred HHhhcCCCcEEEcCCCCCCeEEEcCCCCccCcEEEEecccCCc
Confidence 1 12369999999999999876 7899999998864
|
| >3dxq_A Choline/ethanolamine kinase family protein; NP_106042.1, STR genomics, joint center for structural genomics, JCSG, prote structure initiative; HET: MSE; 2.55A {Mesorhizobium loti} | Back alignment and structure |
|---|
Probab=96.71 E-value=0.0019 Score=67.29 Aligned_cols=127 Identities=15% Similarity=0.145 Sum_probs=73.9
Q ss_pred hhcCccccceEEEeeecCCCceEEEEEEcccccccchHHHHHHHHHhcccCCCCc-ccccceeccCCceEEEEEec-cCC
Q 003836 507 EELGRGAFGTVYKGFVNMGSSNHVAVKKLNSVFQDSEKEFKAEVNGIGQTHHKNL-VRLLGYCDEGQNRLLVYEFM-SNG 584 (792)
Q Consensus 507 ~~lG~G~~g~Vy~g~~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h~ni-v~l~g~~~~~~~~~lV~E~~-~~g 584 (792)
+.|+.|....+|+. ..+++|+....... .....+|..+++.+...++ .++++++ .+.-++|+||+ ++.
T Consensus 24 ~~l~gG~tN~~~~~-------~~~vlR~~~~~~~~-~~~r~~E~~~l~~l~~~g~~P~~~~~~--~~~~~~v~e~i~~g~ 93 (301)
T 3dxq_A 24 LERLGGLTNLVFRA-------GDLCLRIPGKGTEE-YINRANEAVAAREAAKAGVSPEVLHVD--PATGVMVTRYIAGAQ 93 (301)
T ss_dssp EEEESCSSEEEEEE-------TTEEEEEECC-----CCCHHHHHHHHHHHHHTTSSCCEEEEC--TTTCCEEEECCTTCE
T ss_pred eEcCCcccccccee-------eeEEEECCCCCccc-eeCHHHHHHHHHHHHHcCCCCceEEEE--CCCCEEEEeecCCCc
Confidence 45788888999987 24888887543211 1223568877777753333 4555543 33457899999 665
Q ss_pred CccccccCCCCCchhHHHHHHHHHHHHHHHHhh-----------------------------------------------
Q 003836 585 TVASFLFGDSKPNWKLRTEIAMGIAGGLFYLHE----------------------------------------------- 617 (792)
Q Consensus 585 sL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~----------------------------------------------- 617 (792)
+|...... .+..++.++++.|+-||.
T Consensus 94 ~l~~~~~~-------~~~~~~~~~~~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~l~~~l 166 (301)
T 3dxq_A 94 TMSPEKFK-------TRPGSPARAGEAFRKLHGSGAVFPFRFELFAMIDDYLKVLSTKNVTLPAGYHDVVREAGGVRSAL 166 (301)
T ss_dssp ECCHHHHH-------HSTTHHHHHHHHHHHHHTSCCCCSSBCCHHHHHHHHHHHHC--CCCCCTTHHHHHHHHHHHHHHH
T ss_pred cCCHhhHh-------hhHHHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHhhcCCCchhhHHHHHHHHHHHHHHH
Confidence 55321000 000112222222222222
Q ss_pred ---ccCCCeEecCCCCCcEEEcCCCCeEEeecCCCcc
Q 003836 618 ---ECCTQIIHCDIKPQNILLDDHYNARISDFGLAKL 651 (792)
Q Consensus 618 ---~~~~~ivH~dikp~NILl~~~~~~kl~Dfg~a~~ 651 (792)
.....++|+|+.+.||| ..++.+.|+||..+..
T Consensus 167 ~~~~~~~~l~HgDl~~~Nil-~~~~~~~lID~e~a~~ 202 (301)
T 3dxq_A 167 AAHPLPLAACHCDPLCENFL-DTGERMWIVDWEYSGM 202 (301)
T ss_dssp HSSCCCCEEECSCCCGGGEE-ECSSCEEECCCTTCEE
T ss_pred HhcCCCceeeccCCCcCCEE-ECCCCEEEEecccccC
Confidence 11235899999999999 5667789999998864
|
| >2qg7_A Ethanolamine kinase PV091845; malaria, SGC, structural genomics consortium, transferase; 2.41A {Plasmodium vivax} | Back alignment and structure |
|---|
Probab=96.52 E-value=0.0075 Score=66.63 Aligned_cols=75 Identities=11% Similarity=0.021 Sum_probs=47.0
Q ss_pred hhcCccccceEEEeeecCCCceEEEEEEcccccccchHHHHHHHHHhcccCCCCc-ccccceeccCCceEEEEEeccCCC
Q 003836 507 EELGRGAFGTVYKGFVNMGSSNHVAVKKLNSVFQDSEKEFKAEVNGIGQTHHKNL-VRLLGYCDEGQNRLLVYEFMSNGT 585 (792)
Q Consensus 507 ~~lG~G~~g~Vy~g~~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h~ni-v~l~g~~~~~~~~~lV~E~~~~gs 585 (792)
+.|+.|-...+|+..... .+..+++|+...... ..-...+|..+++.+...++ .++++.+.. .+||||+++.+
T Consensus 114 ~~lsgG~tN~~y~v~~~~-~~~~~vLRi~g~~~~-~~idR~~E~~vl~~L~~~gl~P~ll~~~~~----G~v~e~I~G~~ 187 (458)
T 2qg7_A 114 QIINGGITNILIKVKDMS-KQAKYLIRLYGPKTD-EIINREREKKISCILYNKNIAKKIYVFFTN----GRIEEFMDGYA 187 (458)
T ss_dssp EEECC--CEEEEEEEETT-TTEEEEEEEECC-CC-SCSCHHHHHHHHHHHTTSSSBCCEEEEETT----EEEEECCCSEE
T ss_pred EEcCCCeEeEEEEEEECC-CCceEEEEECCCChh-hhcCHHHHHHHHHHHHhcCCCCCEEEEeCC----eEEEEeeCCcc
Confidence 357888889999986542 235788887643221 11123688888888865555 567777632 25999999866
Q ss_pred cc
Q 003836 586 VA 587 (792)
Q Consensus 586 L~ 587 (792)
|.
T Consensus 188 l~ 189 (458)
T 2qg7_A 188 LS 189 (458)
T ss_dssp CC
T ss_pred CC
Confidence 54
|
| >3c5i_A Choline kinase; choline, kinase, malaria, transferase, structural genomics, structural genomics consortium; 2.20A {Plasmodium knowlesi} PDB: 3fi8_A* | Back alignment and structure |
|---|
Probab=96.29 E-value=0.0071 Score=64.98 Aligned_cols=74 Identities=8% Similarity=0.043 Sum_probs=43.3
Q ss_pred hcCccccceEEEeeecCC-------CceEEEEEEcccccccchHHHHHHHHHhcccCCCCc-ccccceeccCCceEEEEE
Q 003836 508 ELGRGAFGTVYKGFVNMG-------SSNHVAVKKLNSVFQDSEKEFKAEVNGIGQTHHKNL-VRLLGYCDEGQNRLLVYE 579 (792)
Q Consensus 508 ~lG~G~~g~Vy~g~~~~~-------~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h~ni-v~l~g~~~~~~~~~lV~E 579 (792)
.|+.|....+|+.....+ .++.+++|+...... .......|.++++.+...++ .++++... -++|||
T Consensus 40 ~l~~G~~N~~y~v~~~~~~~~~~~~~~~~~vlRi~~~~~~-~~~~~~~E~~~l~~L~~~g~~P~~~~~~~----~~~v~e 114 (369)
T 3c5i_A 40 QILSGLTNQLFEVGLKEETANNYNSIRTRVLFRIYGKHVD-ELYNTISEFEVYKTMSKYKIAPQLLNTFN----GGRIEE 114 (369)
T ss_dssp EC----CCEEEEEEECHHHHTTCTTSCCEEEEEECCTTGG-GTSCHHHHHHHHHHHHHTTSSCCEEEEET----TEEEEE
T ss_pred EeCCcccceEEEEEeCCCCcccccCCCceEEEEecCCCcc-ceecHHHHHHHHHHHHhcCCCCceEEecC----CcEEEE
Confidence 477788889999865421 125788888654321 11234678888887754443 46665542 368999
Q ss_pred eccCCCc
Q 003836 580 FMSNGTV 586 (792)
Q Consensus 580 ~~~~gsL 586 (792)
|+++..+
T Consensus 115 ~i~G~~l 121 (369)
T 3c5i_A 115 WLYGDPL 121 (369)
T ss_dssp CCCSEEC
T ss_pred EecCCcC
Confidence 9998655
|
| >1zyl_A Hypothetical protein YIHE; putative protein kinase, structural genomics, PSI, protein structure initiative; 2.80A {Escherichia coli} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=96.22 E-value=0.024 Score=59.48 Aligned_cols=137 Identities=11% Similarity=0.044 Sum_probs=78.2
Q ss_pred cCccccceEEEeeecCCCceEEEEEEcccccccchHHHHHHHHHhcccCCCC--cccccce-----eccCCceEEEEEec
Q 003836 509 LGRGAFGTVYKGFVNMGSSNHVAVKKLNSVFQDSEKEFKAEVNGIGQTHHKN--LVRLLGY-----CDEGQNRLLVYEFM 581 (792)
Q Consensus 509 lG~G~~g~Vy~g~~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h~n--iv~l~g~-----~~~~~~~~lV~E~~ 581 (792)
++ |....||+.... +++.+++|+.... ......+..|..+++.+.... +++++.. ....+..++||||+
T Consensus 34 l~-g~~n~~y~v~~~--~g~~~vlK~~~~~-~~~~~~~~~E~~~~~~L~~~g~~vp~~~~~~g~~~~~~~g~~~~l~~~i 109 (328)
T 1zyl_A 34 LN-SYENRVYQFQDE--DRRRFVVKFYRPE-RWTADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSV 109 (328)
T ss_dssp EC-CSSSEEEEECCT--TCCCEEEEEECTT-TSCHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECC
T ss_pred ec-CcccceEEEEcC--CCCEEEEEEcCCC-CCCHHHHHHHHHHHHHHHHcCCeecceeecCCcEEEEECCEEEEEEEec
Confidence 55 777889987543 3456899997632 123456777888888774322 4445543 11234567899999
Q ss_pred cCCCccc----c----------ccC----C-----CCCchhHH----HHH---------------HHHHHHHHHHHhhc-
Q 003836 582 SNGTVAS----F----------LFG----D-----SKPNWKLR----TEI---------------AMGIAGGLFYLHEE- 618 (792)
Q Consensus 582 ~~gsL~~----~----------l~~----~-----~~l~~~~~----~~i---------------~~~ia~gL~yLH~~- 618 (792)
++..+.. . ++. . ...++... ..+ ...+.+.++.+...
T Consensus 110 ~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~ 189 (328)
T 1zyl_A 110 GGRQFEADNIDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDATLIPSGLKAAFLKATDELIAAVTAHW 189 (328)
T ss_dssp CCEECCSSCHHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCSSSCTTTHHHHHHHHHHHHHHHHHHC
T ss_pred CCCCCCCCCHHHHHHHHHHHHHHHHhhccCCCccCCCCCHHHHHhhHHHHHhhcCcCCHHHHHHHHHHHHHHHHHHHHHh
Confidence 9866531 0 110 0 01111100 000 11111222333221
Q ss_pred ---cCCCeEecCCCCCcEEEcCCCCeEEeecCCCcc
Q 003836 619 ---CCTQIIHCDIKPQNILLDDHYNARISDFGLAKL 651 (792)
Q Consensus 619 ---~~~~ivH~dikp~NILl~~~~~~kl~Dfg~a~~ 651 (792)
....++|+|+++.|||++ + .+.|+||+.+..
T Consensus 190 ~~~~~~~l~HgD~~~~Nil~~-~-~~~lIDfe~a~~ 223 (328)
T 1zyl_A 190 REDFTVLRLHGDCHAGNILWR-D-GPMFVDLDDARN 223 (328)
T ss_dssp CSCSCCEECCSSCSGGGEEES-S-SEEECCCTTCCE
T ss_pred hhcCCeeeeeCCCCcccEeEc-C-CCEEEECCCCCc
Confidence 234689999999999999 4 899999988764
|
| >3csv_A Aminoglycoside phosphotransferase; YP_614837.1, phosphotransferase enzyme family, structural genomics, JOIN for structural genomics, JCSG; HET: MSE; 2.15A {Silicibacter SP} | Back alignment and structure |
|---|
Probab=95.92 E-value=0.019 Score=60.49 Aligned_cols=33 Identities=30% Similarity=0.283 Sum_probs=28.3
Q ss_pred CCCeEecCCCCCcEEEcCC----CCeEEeecCCCccc
Q 003836 620 CTQIIHCDIKPQNILLDDH----YNARISDFGLAKLL 652 (792)
Q Consensus 620 ~~~ivH~dikp~NILl~~~----~~~kl~Dfg~a~~~ 652 (792)
...++|+|+++.|||++.+ ..+.|+||+.+...
T Consensus 182 ~~~lvHgD~~~~Nil~~~~~~~~~~~~lIDf~~a~~G 218 (333)
T 3csv_A 182 DMVFVHRDFHAQNLLWLPEREGLARVGVIDFQDAKLG 218 (333)
T ss_dssp CCEEECSCCSGGGEEECTTSCGGGGEEECCCTTCEEE
T ss_pred CCeeEeCCcCcccEEeccCcCCCCCeEEEeCCCcCcC
Confidence 3479999999999999875 67999999988753
|
| >3i1a_A Spectinomycin phosphotransferase; protein kinase, aminoglycoside phosphotransferase, antibiotic resistance; HET: MES PG4; 1.70A {Legionella pneumophila} PDB: 3i0q_A* 3i0o_A* 3q2m_A* | Back alignment and structure |
|---|
Probab=95.28 E-value=0.14 Score=54.02 Aligned_cols=31 Identities=26% Similarity=0.374 Sum_probs=27.9
Q ss_pred CCeEecCCCCCcEEEcCCCCeEEeecCCCcc
Q 003836 621 TQIIHCDIKPQNILLDDHYNARISDFGLAKL 651 (792)
Q Consensus 621 ~~ivH~dikp~NILl~~~~~~kl~Dfg~a~~ 651 (792)
..++|+|+.+.||++++++.+.|+||+.+..
T Consensus 206 ~~~~HgD~~~~N~l~~~~~~~~~iD~e~~~~ 236 (339)
T 3i1a_A 206 YVLCHSDIHAGNVLVGNEESIYIIDWDEPML 236 (339)
T ss_dssp CEEECSCCCGGGEEECGGGCEEECCCSSCEE
T ss_pred ceeEeCCCCcCCEEEeCCCeEEEEECCCCee
Confidence 4799999999999999888899999987764
|
| >2yle_A Protein spire homolog 1; actin-binding protein, actin polymerization; 1.80A {Homo sapiens} PDB: 2ylf_A 3r7g_A 3rbw_A | Back alignment and structure |
|---|
Probab=95.17 E-value=0.025 Score=54.82 Aligned_cols=103 Identities=12% Similarity=-0.030 Sum_probs=66.6
Q ss_pred CCccccccC-CCCCchhHHHHHHHHHHHHHHHHhhccCCCeEecCCCCCcEEEcCCCCeEEeecCCCccccCCCCCcccc
Q 003836 584 GTVASFLFG-DSKPNWKLRTEIAMGIAGGLFYLHEECCTQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLDQSHTNTA 662 (792)
Q Consensus 584 gsL~~~l~~-~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dikp~NILl~~~~~~kl~Dfg~a~~~~~~~~~~~~~ 662 (792)
-||.+.|.. +.++++.+.+.++.|.+++|.-+-.+. .-..+=+.|..|+|..+|.+.+.+ ..+.
T Consensus 33 vSL~eIL~~~~~PlsEEqaWALc~Qc~~~L~~~~~~~--~~~~~i~~~~~i~l~~dG~V~f~~-~~s~------------ 97 (229)
T 2yle_A 33 LSLEEILRLYNQPINEEQAWAVCYQCCGSLRAAARRR--QPRHRVRSAAQIRVWRDGAVTLAP-AADD------------ 97 (229)
T ss_dssp EEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCSGGGEEEETTSCEEECC-C---------------
T ss_pred ccHHHHHHHcCCCcCHHHHHHHHHHHHHHHHhhhhcc--cCCceecCCcceEEecCCceeccc-cccc------------
Confidence 378888865 478999999999999999987762210 111223446899999999988874 1111
Q ss_pred ccccCCcccccccccCCCCcccceehHHHHHHHHHhcCcCC
Q 003836 663 IRGTKGYVAPEWFRNMPITVKVDVYSYGVLLLEIICLRRNI 703 (792)
Q Consensus 663 ~~gt~~y~aPE~~~~~~~~~k~DV~S~Gv~l~el~tg~~p~ 703 (792)
.....+.|||... ...+.+.=|||+|++||.-+--..|-
T Consensus 98 -~~~~~~~~pe~~~-~~~te~~~IysLG~tLY~ALDygL~e 136 (229)
T 2yle_A 98 -AGEPPPVAGKLGY-SQCMETEVIESLGIIIYKALDYGLKE 136 (229)
T ss_dssp ----------CCSS-SSSCHHHHHHHHHHHHHHHHTTTCCT
T ss_pred -ccccCCCChhhcc-ccchHHHHHHHHHHHHHHHhhcCCCc
Confidence 0123467888763 35567889999999999988655443
|
| >3mes_A Choline kinase; malaria, structural genomics, structural genomics consortium, SGC, transferase; HET: ADP DME PT3; 2.35A {Cryptosporidium parvum} | Back alignment and structure |
|---|
Probab=93.70 E-value=0.11 Score=56.65 Aligned_cols=75 Identities=9% Similarity=0.078 Sum_probs=46.7
Q ss_pred hcCccccceEEEeeecCCC------ceEEEEEEcccccccchHHHHHHHHHhcccCCCCc-ccccceeccCCceEEEEEe
Q 003836 508 ELGRGAFGTVYKGFVNMGS------SNHVAVKKLNSVFQDSEKEFKAEVNGIGQTHHKNL-VRLLGYCDEGQNRLLVYEF 580 (792)
Q Consensus 508 ~lG~G~~g~Vy~g~~~~~~------~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h~ni-v~l~g~~~~~~~~~lV~E~ 580 (792)
.+..|-...+|+.....+. ++.+++|+..... ...-...+|.++++.+...++ .++++.+. -++||||
T Consensus 77 ~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlRi~g~~t-~~~idR~~E~~~l~~L~~~gi~P~l~~~~~----~~~I~ef 151 (424)
T 3mes_A 77 QIFSGLTNQLFVVSIVNESMSLSLKHPRILFRIYGKHV-GKFYDSKVELDVFRYLSNINIAPNIIADFP----EGRIEEF 151 (424)
T ss_dssp EECCCSSSEEEEEEECCC-----CCCSEEEEEECCCCC--CCCCHHHHHHHHHHHHHTTSSCCEEEEET----TEEEEEC
T ss_pred EcCCCcccceEEEEeCCCcccccCCCCeEEEEECCCCc-chhcCHHHHHHHHHHHHhcCCCCCEEEEcC----CCEEEEE
Confidence 4667777889988664211 3578888864432 222234678888887753333 45555432 2789999
Q ss_pred ccCCCcc
Q 003836 581 MSNGTVA 587 (792)
Q Consensus 581 ~~~gsL~ 587 (792)
+++..|.
T Consensus 152 I~G~~l~ 158 (424)
T 3mes_A 152 IDGEPLT 158 (424)
T ss_dssp CCSEECC
T ss_pred eCCccCC
Confidence 9987653
|
| >3no2_A Uncharacterized protein; six-bladed beta-propeller, structural genomics, joint center structural genomics, JCSG, protein structure initiative; HET: MSE CIT PEG; 1.35A {Bacteroides caccae} | Back alignment and structure |
|---|
Probab=90.23 E-value=8.5 Score=38.65 Aligned_cols=72 Identities=21% Similarity=0.342 Sum_probs=45.3
Q ss_pred EEEEEeecCCCCcEEEEecCCCC-------CCCCeeEEEEeCccEEEEcCCCCEEEEeccCC-CcceeEEEecCCcEEEE
Q 003836 62 LPAIWYYKIPSKTIVWYASAVNP-------APRGSKLRLTANRGLVLEDPEGREIWKSEIST-GQAAFGVLYDTGNFLIV 133 (792)
Q Consensus 62 ~~gIW~~~~~~~tvvWvANr~~P-------~~~~~~l~~~~~G~Lvl~~~~~~~vWst~~~~-~~~~~a~LldsGNlVl~ 133 (792)
.+.|| +....+++|...+..+ +.....+.++.++.+..+|++|+.+|.-.... .....++.+.+||+++-
T Consensus 16 ~v~~~--d~~tG~~~w~~~~~~~~~~~~~~~~pdG~ilvs~~~~V~~~d~~G~~~W~~~~~~~~~~~~~~~~~dG~~lv~ 93 (276)
T 3no2_A 16 KIAII--NKDTKEIVWEYPLEKGWECNSVAATKAGEILFSYSKGAKMITRDGRELWNIAAPAGCEMQTARILPDGNALVA 93 (276)
T ss_dssp EEEEE--ETTTTEEEEEEECCTTCCCCEEEECTTSCEEEECBSEEEEECTTSCEEEEEECCTTCEEEEEEECTTSCEEEE
T ss_pred EEEEE--ECCCCeEEEEeCCCccCCCcCeEECCCCCEEEeCCCCEEEECCCCCEEEEEcCCCCccccccEECCCCCEEEE
Confidence 34455 3346778899887652 11122344455666777788999999987642 23345677788888776
Q ss_pred ec
Q 003836 134 NT 135 (792)
Q Consensus 134 ~~ 135 (792)
+.
T Consensus 94 ~~ 95 (276)
T 3no2_A 94 WC 95 (276)
T ss_dssp EE
T ss_pred ec
Confidence 53
|
| >4ann_A ESSB; membrane protein, membrane secretion, ESS type VII secretion virulence; 1.05A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=87.88 E-value=0.91 Score=43.86 Aligned_cols=117 Identities=10% Similarity=0.100 Sum_probs=77.7
Q ss_pred CCCCcccccceeccCCceEEEEEeccCCCccccccCCCCCchhHHHHHHHHHHHHHHHHhhccCCCeEecCCCCCcEEEc
Q 003836 557 HHKNLVRLLGYCDEGQNRLLVYEFMSNGTVASFLFGDSKPNWKLRTEIAMGIAGGLFYLHEECCTQIIHCDIKPQNILLD 636 (792)
Q Consensus 557 ~h~niv~l~g~~~~~~~~~lV~E~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dikp~NILl~ 636 (792)
.||+++.. .+-.+.+.+.+.|+.-+ +...|-. -+..+...+++++..|+....+++.. +|--|+|+||+++
T Consensus 43 ~~~~Fl~~-~I~e~eD~v~~~y~~~~--~~~~f~~-ik~~~~~eKlr~l~ni~~l~~~~~~r-----~tf~L~P~NL~f~ 113 (215)
T 4ann_A 43 HSPYFIDA-ELTELRDSFQIHYDIND--NHTPFDN-IKSFTKNEKLRYLLNIKNLEEVNRTR-----YTFVLAPDELFFT 113 (215)
T ss_dssp CCTTBCCE-EEEECSSEEEEEECCCT--TSEEGGG-GGGSCHHHHHHHHHHGGGGGGGGGSS-----EECCCSGGGEEEC
T ss_pred cCCcccce-EEEEcccEEEEEEEcCc--ccCCHHH-HHhcCHHHHHHHHHHHHHHHHHhcCc-----eEEEEecceEEEc
Confidence 57888866 45555565555555433 2333221 24567889999999999988777654 7889999999999
Q ss_pred CCCCeEEeecCCCccccCCCCCccccccccCCcccccccccCCCCcccceehHHHHHHHHHhcCcCCCc
Q 003836 637 DHYNARISDFGLAKLLTLDQSHTNTAIRGTKGYVAPEWFRNMPITVKVDVYSYGVLLLEIICLRRNIDN 705 (792)
Q Consensus 637 ~~~~~kl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DV~S~Gv~l~el~tg~~p~~~ 705 (792)
.++.+++.=.|+...+ +|. ..+...=.-.+=+++..+++++..|+.
T Consensus 114 ~~~~p~i~~RGik~~l------------------~P~-----~~~ee~fL~qyKAliiall~~K~~Fe~ 159 (215)
T 4ann_A 114 RDGLPIAKTRGLQNVV------------------DPL-----PVSEAEFLTRYKALVICAFNEKQSFDA 159 (215)
T ss_dssp TTSCEEESCCEETTTB------------------SCC-----CCCHHHHHHHHHHHHHHHHCTTCCHHH
T ss_pred CCCCEEEEEccCccCC------------------CCC-----CCCHHHHHHHHHHHHHHHHcCCCCHHH
Confidence 9999999877664332 221 111122233566788888888877754
|
| >3no2_A Uncharacterized protein; six-bladed beta-propeller, structural genomics, joint center structural genomics, JCSG, protein structure initiative; HET: MSE CIT PEG; 1.35A {Bacteroides caccae} | Back alignment and structure |
|---|
Probab=87.44 E-value=2.5 Score=42.76 Aligned_cols=63 Identities=16% Similarity=0.147 Sum_probs=33.0
Q ss_pred CCcEEEEecCCC-CC-----CCCeeEEEEeC-ccEEEEcCC-CCEEEEeccCC-C-----cceeEEEecCCcEEEEe
Q 003836 72 SKTIVWYASAVN-PA-----PRGSKLRLTAN-RGLVLEDPE-GREIWKSEIST-G-----QAAFGVLYDTGNFLIVN 134 (792)
Q Consensus 72 ~~tvvWvANr~~-P~-----~~~~~l~~~~~-G~Lvl~~~~-~~~vWst~~~~-~-----~~~~a~LldsGNlVl~~ 134 (792)
...++|...+.. |. .++..+....+ +.++.+|++ |+++|+..... . ....++++.+||+++.+
T Consensus 154 ~G~~~w~~~~~~~~~~~~~~~~g~~~v~~~~~~~v~~~d~~tG~~~w~~~~~~~~~~~l~~~~~~~~~~~G~i~v~~ 230 (276)
T 3no2_A 154 NGQLLNSVKLSGTPFSSAFLDNGDCLVACGDAHCFVQLNLESNRIVRRVNANDIEGVQLFFVAQLFPLQNGGLYICN 230 (276)
T ss_dssp TSCEEEEEECSSCCCEEEECTTSCEEEECBTTSEEEEECTTTCCEEEEEEGGGSBSCCCSEEEEEEECTTSCEEEEE
T ss_pred CCCEEEEEECCCCccceeEcCCCCEEEEeCCCCeEEEEeCcCCcEEEEecCCCCCCccccccccceEcCCCCEEEEe
Confidence 366777776543 31 11222222222 346666766 77777765321 1 13456667777777765
|
| >3g15_A CK, chetk-alpha, choline kinase alpha; non-protein kinase, structural genomics CONS SGC, hemicholinium-3, transferase; HET: ADP HC6; 1.70A {Homo sapiens} PDB: 3f2r_A* 2i7q_A 2cko_A 2ckp_A* 2ckq_A* | Back alignment and structure |
|---|
Probab=86.82 E-value=0.63 Score=50.20 Aligned_cols=30 Identities=27% Similarity=0.391 Sum_probs=25.2
Q ss_pred CeEecCCCCCcEEE------cCCCCeEEeecCCCcc
Q 003836 622 QIIHCDIKPQNILL------DDHYNARISDFGLAKL 651 (792)
Q Consensus 622 ~ivH~dikp~NILl------~~~~~~kl~Dfg~a~~ 651 (792)
.++|+|+.+.|||+ +++..++++||..|..
T Consensus 245 vfcHnDl~~gNil~~~~~~~~~~~~l~vIDwEya~~ 280 (401)
T 3g15_A 245 VFCHNDCQEGNILLLEGRENSEKQKLMLIDFEYSSY 280 (401)
T ss_dssp EEECSCCCGGGEEEETTGGGCSSCCEEECCCTTCEE
T ss_pred eeEEecCCCCeEEEecCcccCcCCeEEEechHhccC
Confidence 36799999999999 4567799999998864
|
| >2ll3_A Micronemal protein 4; cell adhesion; NMR {Toxoplasma gondii} PDB: 2ll4_M* | Back alignment and structure |
|---|
Probab=85.28 E-value=0.33 Score=38.89 Aligned_cols=32 Identities=22% Similarity=0.512 Sum_probs=27.5
Q ss_pred cCChhhHhhhccCCCccccceec--cCceeeccc
Q 003836 377 PYGKDECVSSCLKDCQCSAAVLR--DDTCWKKKL 408 (792)
Q Consensus 377 ~~s~~~C~~~Cl~nCsC~A~~~~--~~~C~~~~~ 408 (792)
.+++++|++.|+.+=.|.||.|+ ...|++|..
T Consensus 29 ~~sl~~Cq~aC~a~~~C~aFTyN~~s~~CflKs~ 62 (82)
T 2ll3_A 29 ASSLSECRARCQAEKECSHYTYNVKSGLCYPKRG 62 (82)
T ss_dssp CSSHHHHHHHHHHCTTEEEEEEETTTTEEEEEES
T ss_pred CCCHHHHHHHhhccCCCCeEEeccCCCceEcccC
Confidence 46899999999999999999997 456988754
|
Homologous Structure Domains
Structure Domains Detected by RPS-BLAST 
Original result of RPS-BLAST against SCOP70(version1.75) database
ID ![]() | Alignment Graph ![]() | Length ![]() |
Definition ![]() |
E-value ![]() |
| 792 | ||||
| d1uwha_ | 276 | d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) | 2e-63 | |
| d1jpaa_ | 299 | d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou | 1e-62 | |
| d1qpca_ | 272 | d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom | 2e-62 | |
| d1k2pa_ | 258 | d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum | 7e-61 | |
| d1sm2a_ | 263 | d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu | 2e-60 | |
| d1fmka3 | 285 | d.144.1.7 (A:249-533) c-src tyrosine kinase {Human | 9e-60 | |
| d1xbba_ | 277 | d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human | 4e-59 | |
| d1u59a_ | 285 | d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum | 3e-58 | |
| d1opja_ | 287 | d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou | 9e-58 | |
| d1s9ja_ | 322 | d.144.1.7 (A:) Dual specificity mitogen-activated | 2e-57 | |
| d1vjya_ | 303 | d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human | 1e-56 | |
| d1mqba_ | 283 | d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum | 2e-56 | |
| d1rjba_ | 325 | d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s | 2e-56 | |
| d1byga_ | 262 | d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) | 2e-56 | |
| d1r0pa_ | 311 | d.144.1.7 (A:) Hepatocyte growth factor receptor, | 3e-56 | |
| d1t46a_ | 311 | d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens | 4e-56 | |
| d1lufa_ | 301 | d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n | 5e-56 | |
| d1t4ha_ | 270 | d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa | 3e-55 | |
| d1u5ra_ | 309 | d.144.1.7 (A:) Serine/threonine protein kinase TAO | 2e-53 | |
| d2j4za1 | 263 | d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur | 4e-53 | |
| d2java1 | 269 | d.144.1.7 (A:3-271) Serine/threonine-protein kinas | 8e-53 | |
| d1u46a_ | 273 | d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum | 2e-52 | |
| d1nvra_ | 271 | d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 { | 4e-52 | |
| d2jfla1 | 288 | d.144.1.7 (A:21-308) STE20-like serine/threonine-p | 9e-52 | |
| d1fvra_ | 309 | d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [ | 1e-51 | |
| d1mp8a_ | 273 | d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma | 1e-51 | |
| d1xkka_ | 317 | d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb- | 1e-51 | |
| d1yhwa1 | 293 | d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [ | 5e-51 | |
| d1p4oa_ | 308 | d.144.1.7 (A:) Insulin-like growth factor 1 recept | 5e-49 | |
| d1ywna1 | 299 | d.144.1.7 (A:818-1166) Vascular endothelial growth | 2e-47 | |
| d1koaa2 | 350 | d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C | 3e-47 | |
| d1fgka_ | 299 | d.144.1.7 (A:) Fibroblast growth factor receptor 1 | 3e-47 | |
| d1uu3a_ | 288 | d.144.1.7 (A:) 3-phosphoinositide dependent protei | 2e-45 | |
| d1a06a_ | 307 | d.144.1.7 (A:) Calmodulin-dependent protein kinase | 1e-44 | |
| d1koba_ | 352 | d.144.1.7 (A:) Twitchin, kinase domain {California | 1e-44 | |
| d1tkia_ | 321 | d.144.1.7 (A:) Titin, kinase domain {Human (Homo s | 3e-42 | |
| d1o6ya_ | 277 | d.144.1.7 (A:) Mycobacterial protein kinase PknB, | 7e-42 | |
| d1phka_ | 277 | d.144.1.7 (A:) gamma-subunit of glycogen phosphory | 3e-41 | |
| d1ckia_ | 299 | d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n | 4e-41 | |
| d1xjda_ | 320 | d.144.1.7 (A:) Protein kinase C, theta type {Human | 4e-41 | |
| d1fota_ | 316 | d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni | 4e-41 | |
| d1omwa3 | 364 | d.144.1.7 (A:186-549) G-protein coupled receptor k | 9e-41 | |
| d1ua2a_ | 299 | d.144.1.7 (A:) Cell division protein kinase 7, CDK | 4e-40 | |
| d1blxa_ | 305 | d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H | 4e-39 | |
| d1ob3a_ | 286 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod | 1e-38 | |
| d1jksa_ | 293 | d.144.1.7 (A:) Death-associated protein kinase, Da | 3e-38 | |
| d1pmea_ | 345 | d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien | 8e-38 | |
| d1csna_ | 293 | d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast | 9e-38 | |
| d2ozaa1 | 335 | d.144.1.7 (A:51-385) MAP kinase activated protein | 2e-37 | |
| d1unla_ | 292 | d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H | 3e-37 | |
| d1gz8a_ | 298 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H | 3e-37 | |
| d1xwsa_ | 273 | d.144.1.7 (A:) Proto-oncogene serine/threonine-pro | 4e-37 | |
| d1o6la_ | 337 | d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap | 3e-35 | |
| d3blha1 | 318 | d.144.1.7 (A:8-325) Cell division protein kinase 9 | 5e-35 | |
| d1q5ka_ | 350 | d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs | 7e-35 | |
| d1rdqe_ | 350 | d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni | 7e-33 | |
| d1cm8a_ | 346 | d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s | 9e-32 | |
| d3bqca1 | 328 | d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu | 2e-31 | |
| d1vzoa_ | 322 | d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5 | 4e-30 | |
| d2b1pa1 | 355 | d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3 | 6e-30 | |
| d2gfsa1 | 348 | d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa | 2e-27 | |
| d1q8ya_ | 362 | d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces | 6e-24 | |
| d1zara2 | 191 | d.144.1.9 (A:91-281) Rio2 serine protein kinase C- | 7e-18 | |
| d1kj1a_ | 109 | b.78.1.1 (A:) Lectin (agglutinin) {Garlic (Allium | 6e-11 | |
| d1kj1a_ | 109 | b.78.1.1 (A:) Lectin (agglutinin) {Garlic (Allium | 2e-05 | |
| d1dlpa2 | 120 | b.78.1.1 (A:116-235) Fetuin-binding protein Scafet | 2e-10 | |
| d1xd5a_ | 112 | b.78.1.1 (A:) Gastrodianin (antifungal protein) {G | 7e-09 | |
| d1xd5a_ | 112 | b.78.1.1 (A:) Gastrodianin (antifungal protein) {G | 8e-09 | |
| d1b2pa_ | 119 | b.78.1.1 (A:) Lectin (agglutinin) {Bluebell (Scill | 5e-08 | |
| d1dlpa1 | 115 | b.78.1.1 (A:1-115) Fetuin-binding protein Scafet p | 1e-07 | |
| d1jpca_ | 108 | b.78.1.1 (A:) Lectin (agglutinin) {Snowdrop (Galan | 4e-06 | |
| d1jpca_ | 108 | b.78.1.1 (A:) Lectin (agglutinin) {Snowdrop (Galan | 1e-05 |
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 211 bits (539), Expect = 2e-63
Identities = 75/285 (26%), Positives = 127/285 (44%), Gaps = 30/285 (10%)
Query: 500 EVTRG---FKEELGRGAFGTVYKGFVNMGSSNHVAVKKLNSVFQDSE--KEFKAEVNGIG 554
E+ G + +G G+FGTVYKG + VAVK LN + + FK EV +
Sbjct: 4 EIPDGQITVGQRIGSGSFGTVYKGKWH----GDVAVKMLNVTAPTPQQLQAFKNEVGVLR 59
Query: 555 QTHHKNLVRLLGYCDEGQNRLLVYEFMSNGTVASFLFG-DSKPNWKLRTEIAMGIAGGLF 613
+T H N++ +GY Q +V ++ ++ L ++K +IA A G+
Sbjct: 60 KTRHVNILLFMGYSTAPQ-LAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMD 118
Query: 614 YLHEECCTQIIHCDIKPQNILLDDHYNARISDFGLAKLLT-LDQSHTNTAIRGTKGYVAP 672
YLH + IIH D+K NI L + +I DFGLA + + SH + G+ ++AP
Sbjct: 119 YLHAKS---IIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAP 175
Query: 673 EWFRNM---PITVKVDVYSYGVLLLEIICLRRNIDNEISKVDKAILTDWAYDRYQERTLE 729
E R P + + DVY++G++L E++ + N ++ + Y L
Sbjct: 176 EVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNIN---NRDQIIFMVGRGYLSPDLS 232
Query: 730 ALVENDLEAMNNVTMLHRFVMVAFWCIQEDPSHRPTMRKVTQMLE 774
+ N +AM + C+++ RP ++ +E
Sbjct: 233 KVRSNCPKAMKR---------LMAECLKKKRDERPLFPQILASIE 268
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Score = 210 bits (535), Expect = 1e-62
Identities = 73/307 (23%), Positives = 131/307 (42%), Gaps = 38/307 (12%)
Query: 493 FTYKELVEVTRGFKEE-----------LGRGAFGTVYKGFVNMGSSNH--VAVKKLNSVF 539
FT+++ E R F +E +G G FG V G + + VA+K L S +
Sbjct: 7 FTFEDPNEAVREFAKEIDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGY 66
Query: 540 -QDSEKEFKAEVNGIGQTHHKNLVRLLGYCDEGQNRLLVYEFMSNGTVASFLFGDSKP-N 597
+ ++F +E + +GQ H N++ L G + +++ EFM NG++ SFL +
Sbjct: 67 TEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMIITEFMENGSLDSFLRQNDGQFT 126
Query: 598 WKLRTEIAMGIAGGLFYLHEECCTQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLDQS 657
+ GIA G+ YL + +H D+ +NIL++ + ++SDFGL++ L D S
Sbjct: 127 VIQLVGMLRGIAAGMKYLADMN---YVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTS 183
Query: 658 HTNT----AIRGTKGYVAPEWFRNMPITVKVDVYSYGVLLLEIICLRRNIDNEISKVDKA 713
+ + APE + T DV+SYG+++ E++
Sbjct: 184 DPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGE------------ 231
Query: 714 ILTDWAYDRYQERTLEALVENDLEAMNNVTMLHRFVMVAFWCIQEDPSHRPTMRKVTQML 773
Y + + +E D + + C Q+D +HRP ++ L
Sbjct: 232 ----RPYWDMTNQDVINAIEQDYRLPPPMDCPSALHQLMLDCWQKDRNHRPKFGQIVNTL 287
Query: 774 EGVVEVP 780
+ ++ P
Sbjct: 288 DKMIRNP 294
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Score = 208 bits (531), Expect = 2e-62
Identities = 74/272 (27%), Positives = 116/272 (42%), Gaps = 25/272 (9%)
Query: 505 FKEELGRGAFGTVYKGFVNMGSSNHVAVKKLNSVFQDSEKEFKAEVNGIGQTHHKNLVRL 564
E LG G FG V+ G+ N VAVK L S F AE N + Q H+ LVRL
Sbjct: 17 LVERLGAGQFGEVWMGYYNGH--TKVAVKSLKQGSM-SPDAFLAEANLMKQLQHQRLVRL 73
Query: 565 LGYCDEGQNRLLVYEFMSNGTVASFLF--GDSKPNWKLRTEIAMGIAGGLFYLHEECCTQ 622
+ ++ E+M NG++ FL K ++A IA G+ ++ E
Sbjct: 74 YAVVTQE-PIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERN--- 129
Query: 623 IIHCDIKPQNILLDDHYNARISDFGLAKLLTLDQSHTNTAIRGTKGYVAPEWFRNMPITV 682
IH D++ NIL+ D + +I+DFGLA+L+ ++ + + APE T+
Sbjct: 130 YIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYGTFTI 189
Query: 683 KVDVYSYGVLLLEIICLRRNIDNEISKVDKAILTDWAYDRYQERTLEALVENDLEAMNNV 742
K DV+S+G+LL EI+ R ++ + + +E +
Sbjct: 190 KSDVWSFGILLTEIVTHGRIPYPGMTNPE----------------VIQNLERGYRMVRPD 233
Query: 743 TMLHRFVMVAFWCIQEDPSHRPTMRKVTQMLE 774
+ C +E P RPT + +LE
Sbjct: 234 NCPEELYQLMRLCWKERPEDRPTFDYLRSVLE 265
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 204 bits (519), Expect = 7e-61
Identities = 61/271 (22%), Positives = 111/271 (40%), Gaps = 23/271 (8%)
Query: 505 FKEELGRGAFGTVYKGFVNMGSSNHVAVKKLNSVFQDSEKEFKAEVNGIGQTHHKNLVRL 564
F +ELG G FG V G VA+K + SE EF E + H+ LV+L
Sbjct: 8 FLKELGTGQFGVVKYGKWR--GQYDVAIKMIKEGSM-SEDEFIEEAKVMMNLSHEKLVQL 64
Query: 565 LGYCDEGQNRLLVYEFMSNGTVASFLFGDSKP-NWKLRTEIAMGIAGGLFYLHEECCTQI 623
G C + + ++ E+M+NG + ++L + E+ + + YL Q
Sbjct: 65 YGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLE---SKQF 121
Query: 624 IHCDIKPQNILLDDHYNARISDFGLAKLLTLDQSHTNTAIRGTKGYVAPEWFRNMPITVK 683
+H D+ +N L++D ++SDFGL++ + D+ ++ + + PE + K
Sbjct: 122 LHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLMYSKFSSK 181
Query: 684 VDVYSYGVLLLEIICLRRNIDNEISKVDKAILTDWAYDRYQERTLEALVENDLEAMNNVT 743
D++++GVL+ EI L + Y+R+ + L
Sbjct: 182 SDIWAFGVLMWEIYSLGK----------------MPYERFTNSETAEHIAQGLRLYRPHL 225
Query: 744 MLHRFVMVAFWCIQEDPSHRPTMRKVTQMLE 774
+ + + C E RPT + + +
Sbjct: 226 ASEKVYTIMYSCWHEKADERPTFKILLSNIL 256
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Score = 202 bits (516), Expect = 2e-60
Identities = 65/275 (23%), Positives = 118/275 (42%), Gaps = 23/275 (8%)
Query: 505 FKEELGRGAFGTVYKGFVNMGSSNHVAVKKLNSVFQDSEKEFKAEVNGIGQTHHKNLVRL 564
F +E+G G FG V+ G+ + VA+K + SE++F E + + H LV+L
Sbjct: 9 FVQEIGSGQFGLVHLGYWLNK--DKVAIKTIREGAM-SEEDFIEEAEVMMKLSHPKLVQL 65
Query: 565 LGYCDEGQNRLLVYEFMSNGTVASFLFGDSKP-NWKLRTEIAMGIAGGLFYLHEECCTQI 623
G C E LV+EFM +G ++ +L + + + + G+ YL E C +
Sbjct: 66 YGVCLEQAPICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEAC---V 122
Query: 624 IHCDIKPQNILLDDHYNARISDFGLAKLLTLDQSHTNTAIRGTKGYVAPEWFRNMPITVK 683
IH D+ +N L+ ++ ++SDFG+ + + DQ ++T + + +PE F + K
Sbjct: 123 IHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSFSRYSSK 182
Query: 684 VDVYSYGVLLLEIICLRRNIDNEISKVDKAILTDWAYDRYQERTLEALVENDLEAMNNVT 743
DV+S+GVL+ E+ + S + + +
Sbjct: 183 SDVWSFGVLMWEVFSEGKIPYENRSNSE----------------VVEDISTGFRLYKPRL 226
Query: 744 MLHRFVMVAFWCIQEDPSHRPTMRKVTQMLEGVVE 778
+ C +E P RP ++ + L + E
Sbjct: 227 ASTHVYQIMNHCWKERPEDRPAFSRLLRQLAEIAE 261
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 202 bits (514), Expect = 9e-60
Identities = 67/281 (23%), Positives = 115/281 (40%), Gaps = 25/281 (8%)
Query: 505 FKEELGRGAFGTVYKGFVNMGSSNHVAVKKLNSVFQDSEKEFKAEVNGIGQTHHKNLVRL 564
+ +LG+G FG V+ G N + VA+K L + F E + + H+ LV+L
Sbjct: 21 LEVKLGQGCFGEVWMGTWN--GTTRVAIKTLKPGTMS-PEAFLQEAQVMKKLRHEKLVQL 77
Query: 565 LGYCDEGQNRLLVYEFMSNGTVASFLFGDSKP--NWKLRTEIAMGIAGGLFYLHEECCTQ 622
+ +V E+MS G++ FL G++ ++A IA G+ Y+
Sbjct: 78 YAVV-SEEPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVE---RMN 133
Query: 623 IIHCDIKPQNILLDDHYNARISDFGLAKLLTLDQSHTNTAIRGTKGYVAPEWFRNMPITV 682
+H D++ NIL+ ++ +++DFGLA+L+ ++ + + APE T+
Sbjct: 134 YVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTI 193
Query: 683 KVDVYSYGVLLLEIICLRRNIDNEISKVDKAILTDWAYDRYQERTLEALVENDLEAMNNV 742
K DV+S+G+LL E+ R Y R + VE
Sbjct: 194 KSDVWSFGILLTELTTKGRVP----------------YPGMVNREVLDQVERGYRMPCPP 237
Query: 743 TMLHRFVMVAFWCIQEDPSHRPTMRKVTQMLEGVVEVPIPP 783
+ C +++P RPT + LE P
Sbjct: 238 ECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTSTEPQ 278
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Score = 199 bits (508), Expect = 4e-59
Identities = 73/272 (26%), Positives = 114/272 (41%), Gaps = 25/272 (9%)
Query: 508 ELGRGAFGTVYKGFVNMGSSN-HVAVKKLNSVFQDSE--KEFKAEVNGIGQTHHKNLVRL 564
ELG G FGTV KG+ M VAVK L + D E AE N + Q + +VR+
Sbjct: 14 ELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRM 73
Query: 565 LGYCDEGQNRLLVYEFMSNGTVASFLFGDSKPNWKLRTEIAMGIAGGLFYLHEECCTQII 624
+G C E ++ +LV E G + +L + K E+ ++ G+ YL + +
Sbjct: 74 IGIC-EAESWMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLE---ESNFV 129
Query: 625 HCDIKPQNILLDDHYNARISDFGLAKLLTLDQSH--TNTAIRGTKGYVAPEWFRNMPITV 682
H D+ +N+LL + A+ISDFGL+K L D+++ T + + APE +
Sbjct: 130 HRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYYKFSS 189
Query: 683 KVDVYSYGVLLLEIICLRRNIDNEISKVDKAILTDWAYDRYQERTLEALVENDLEAMNNV 742
K DV+S+GVL+ E + Y + + A++E
Sbjct: 190 KSDVWSFGVLMWEAFSYGQ----------------KPYRGMKGSEVTAMLEKGERMGCPA 233
Query: 743 TMLHRFVMVAFWCIQEDPSHRPTMRKVTQMLE 774
+ C D +RP V L
Sbjct: 234 GCPREMYDLMNLCWTYDVENRPGFAAVELRLR 265
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Score = 197 bits (502), Expect = 3e-58
Identities = 67/272 (24%), Positives = 109/272 (40%), Gaps = 25/272 (9%)
Query: 508 ELGRGAFGTVYKGFVNMGSSN-HVAVKKLN-SVFQDSEKEFKAEVNGIGQTHHKNLVRLL 565
ELG G FG+V +G M VA+K L + +E E + Q + +VRL+
Sbjct: 16 ELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLI 75
Query: 566 GYCDEGQNRLLVYEFMSNGTVASFLFGDSKP-NWKLRTEIAMGIAGGLFYLHEECCTQII 624
G C + + +LV E G + FL G + E+ ++ G+ YL +
Sbjct: 76 GVC-QAEALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLE---EKNFV 131
Query: 625 HCDIKPQNILLDDHYNARISDFGLAKLLTLDQSH--TNTAIRGTKGYVAPEWFRNMPITV 682
H D+ +N+LL + + A+ISDFGL+K L D S+ +A + + APE +
Sbjct: 132 HRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFRKFSS 191
Query: 683 KVDVYSYGVLLLEIICLRRNIDNEISKVDKAILTDWAYDRYQERTLEALVENDLEAMNNV 742
+ DV+SYGV + E + + Y + + + A +E
Sbjct: 192 RSDVWSYGVTMWEALSYGQ----------------KPYKKMKGPEVMAFIEQGKRMECPP 235
Query: 743 TMLHRFVMVAFWCIQEDPSHRPTMRKVTQMLE 774
+ C RP V Q +
Sbjct: 236 ECPPELYALMSDCWIYKWEDRPDFLTVEQRMR 267
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Score = 196 bits (500), Expect = 9e-58
Identities = 72/276 (26%), Positives = 122/276 (44%), Gaps = 23/276 (8%)
Query: 505 FKEELGRGAFGTVYKGFVNMGSSNHVAVKKLNSVFQDSEKEFKAEVNGIGQTHHKNLVRL 564
K +LG G +G VY+G V S VAVK L + E EF E + + H NLV+L
Sbjct: 21 MKHKLGGGQYGEVYEG-VWKKYSLTVAVKTLKEDTMEVE-EFLKEAAVMKEIKHPNLVQL 78
Query: 565 LGYCDEGQNRLLVYEFMSNGTVASFLF--GDSKPNWKLRTEIAMGIAGGLFYLHEECCTQ 622
LG C ++ EFM+ G + +L + + + +A I+ + YL ++
Sbjct: 79 LGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKN--- 135
Query: 623 IIHCDIKPQNILLDDHYNARISDFGLAKLLTLDQSHTNTAIRGTKGYVAPEWFRNMPITV 682
IH D+ +N L+ +++ +++DFGL++L+T D + + + APE ++
Sbjct: 136 FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSI 195
Query: 683 KVDVYSYGVLLLEIICLRRNIDNEISKVDKAILTDWAYDRYQERTLEALVENDLEAMNNV 742
K DV+++GVLL EI Y + L+E D
Sbjct: 196 KSDVWAFGVLLWEIATYGM----------------SPYPGIDLSQVYELLEKDYRMERPE 239
Query: 743 TMLHRFVMVAFWCIQEDPSHRPTMRKVTQMLEGVVE 778
+ + C Q +PS RP+ ++ Q E + +
Sbjct: 240 GCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQ 275
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 196 bits (500), Expect = 2e-57
Identities = 52/294 (17%), Positives = 113/294 (38%), Gaps = 33/294 (11%)
Query: 505 FKEELGRGAFGTVYKGFVNMGSSNHVAVKKLN-SVFQDSEKEFKAEVNGIGQTHHKNLVR 563
ELG G G V+K + S +A K ++ + + E+ + + + +V
Sbjct: 10 KISELGAGNGGVVFKV-SHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVG 68
Query: 564 LLGYCDEGQNRLLVYEFMSNGTVASFLFGDSKPNWKLRTEIAMGIAGGLFYLHEECCTQI 623
G + E M G++ L + ++ ++++ + GL YL E+ +I
Sbjct: 69 FYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKH--KI 126
Query: 624 IHCDIKPQNILLDDHYNARISDFGLAKLLTLDQSHTNTAIRGTKGYVAPEWFRNMPITVK 683
+H D+KP NIL++ ++ DFG++ L +++ GT+ Y++PE + +V+
Sbjct: 127 MHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSFV---GTRSYMSPERLQGTHYSVQ 183
Query: 684 VDVYSYGVLLLEIICLRRNIDNEISKVDKAILTDWAYDRYQERTLEALVENDLEAMNNVT 743
D++S G+ L+E+ R I +K + + E + +
Sbjct: 184 SDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPLSSYGMD 243
Query: 744 MLHRFVMVAF--------------------------WCIQEDPSHRPTMRKVTQ 771
+ C+ ++P+ R ++++
Sbjct: 244 SRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMV 297
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Score = 194 bits (493), Expect = 1e-56
Identities = 59/296 (19%), Positives = 118/296 (39%), Gaps = 27/296 (9%)
Query: 505 FKEELGRGAFGTVYKGFVNMGSSNHVAVKKLNSVFQDSEKEFKAEVNGIGQTHHKNLVRL 564
+E +G+G FG V++G VAVK +S ++ +AE+ H+N++
Sbjct: 7 LQESIGKGRFGEVWRGKWR---GEEVAVKIFSSR-EERSWFREAEIYQTVMLRHENILGF 62
Query: 565 LGYCDEGQNRL----LVYEFMSNGTVASFLFGDSKPNWKLRTEIAMGIAGGLFYLHEECC 620
+ ++ LV ++ +G++ +L + ++A+ A GL +LH E
Sbjct: 63 IAADNKDNGTWTQLWLVSDYHEHGSLFDYLN-RYTVTVEGMIKLALSTASGLAHLHMEIV 121
Query: 621 TQ-----IIHCDIKPQNILLDDHYNARISDFGLAKLLTLDQSHTNTA---IRGTKGYVAP 672
I H D+K +NIL+ + I+D GLA + A GTK Y+AP
Sbjct: 122 GTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAP 181
Query: 673 EWF------RNMPITVKVDVYSYGVLLLEIICLRRNIDNEISK---VDKAILTDWAYDRY 723
E ++ + D+Y+ G++ EI + +D + +
Sbjct: 182 EVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVEEM 241
Query: 724 QERTLEALVENDL-EAMNNVTMLHRFVMVAFWCIQEDPSHRPTMRKVTQMLEGVVE 778
++ E + ++ + L + C + + R T ++ + L + +
Sbjct: 242 RKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQ 297
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 192 bits (489), Expect = 2e-56
Identities = 64/285 (22%), Positives = 122/285 (42%), Gaps = 28/285 (9%)
Query: 505 FKEE--LGRGAFGTVYKGFVNMGSSNH---VAVKKLNSVF-QDSEKEFKAEVNGIGQTHH 558
+ +G G FG VYKG + S VA+K L + + + +F E +GQ H
Sbjct: 9 VTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSH 68
Query: 559 KNLVRLLGYCDEGQNRLLVYEFMSNGTVASFLFGDSKP-NWKLRTEIAMGIAGGLFYLHE 617
N++RL G + + +++ E+M NG + FL + + GIA G+ YL
Sbjct: 69 HNIIRLEGVISKYKPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLAN 128
Query: 618 ECCTQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLDQ--SHTNTAIRGTKGYVAPEWF 675
+H D+ +NIL++ + ++SDFGL+++L D ++T + + + APE
Sbjct: 129 MN---YVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTAPEAI 185
Query: 676 RNMPITVKVDVYSYGVLLLEIICLRRNIDNEISKVDKAILTDWAYDRYQERTLEALVEND 735
T DV+S+G+++ E++ E+S + + +
Sbjct: 186 SYRKFTSASDVWSFGIVMWEVMTYGERPYWELS----------------NHEVMKAINDG 229
Query: 736 LEAMNNVTMLHRFVMVAFWCIQEDPSHRPTMRKVTQMLEGVVEVP 780
+ + C Q++ + RP + +L+ ++ P
Sbjct: 230 FRLPTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLIRAP 274
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 194 bits (493), Expect = 2e-56
Identities = 78/327 (23%), Positives = 124/327 (37%), Gaps = 51/327 (15%)
Query: 481 EDQGVSYMNLRCFTYKELVEVTRG---FKEELGRGAFGTVYKGFV----NMGSSNHVAVK 533
D Y++ R + Y E R F + LG GAFG V G S VAVK
Sbjct: 14 SDNEYFYVDFREYEYDLKWEFPRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVK 73
Query: 534 KLNSVFQDSEKE-FKAEVNGIGQ-THHKNLVRLLGYCDEGQNRLLVYEFMSNGTVASFLF 591
L SE+E +E+ + Q H+N+V LLG C L++E+ G + ++L
Sbjct: 74 MLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLR 133
Query: 592 GDSKP-----------------------NWKLRTEIAMGIAGGLFYLHEECCTQIIHCDI 628
+ ++ A +A G+ +L + +H D+
Sbjct: 134 SKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFK---SCVHRDL 190
Query: 629 KPQNILLDDHYNARISDFGLAKLLTLDQSHT-NTAIRGTKGYVAPEWFRNMPITVKVDVY 687
+N+L+ +I DFGLA+ + D ++ R ++APE T+K DV+
Sbjct: 191 AARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVW 250
Query: 688 SYGVLLLEIICLRRNIDNEISKVDKAILTDWAYDRYQERTLEALVENDLEAMNNVTMLHR 747
SYG+LL EI L N I + L++N +
Sbjct: 251 SYGILLWEIFSLGVNPYPGIP---------------VDANFYKLIQNGFKMDQPFYATEE 295
Query: 748 FVMVAFWCIQEDPSHRPTMRKVTQMLE 774
++ C D RP+ +T L
Sbjct: 296 IYIIMQSCWAFDSRKRPSFPNLTSFLG 322
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 192 bits (488), Expect = 2e-56
Identities = 71/275 (25%), Positives = 116/275 (42%), Gaps = 31/275 (11%)
Query: 505 FKEELGRGAFGTVYKGFVNMGSSNHVAVKKLNSVFQDSEKEFKAEVNGIGQTHHKNLVRL 564
+ +G+G FG V G N VAVK + + + + F AE + + Q H NLV+L
Sbjct: 11 LLQTIGKGEFGDVMLGDYR---GNKVAVKCIKN--DATAQAFLAEASVMTQLRHSNLVQL 65
Query: 565 LGYCDEGQNRL-LVYEFMSNGTVASFLF--GDSKPNWKLRTEIAMGIAGGLFYLHEECCT 621
LG E + L +V E+M+ G++ +L G S + ++ + + YL
Sbjct: 66 LGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNN-- 123
Query: 622 QIIHCDIKPQNILLDDHYNARISDFGLAKLLTLDQSHTNTAIRGTKGYVAPEWFRNMPIT 681
+H D+ +N+L+ + A++SDFGL K S T + + APE R +
Sbjct: 124 -FVHRDLAARNVLVSEDNVAKVSDFGLTKEA----SSTQDTGKLPVKWTAPEALREKKFS 178
Query: 682 VKVDVYSYGVLLLEIICLRRNIDNEISKVDKAILTDWAYDRYQERTLEALVENDLEAMNN 741
K DV+S+G+LL EI R Y R + + VE +
Sbjct: 179 TKSDVWSFGILLWEIYSFGR----------------VPYPRIPLKDVVPRVEKGYKMDAP 222
Query: 742 VTMLHRFVMVAFWCIQEDPSHRPTMRKVTQMLEGV 776
V C D + RP+ ++ + LE +
Sbjct: 223 DGCPPAVYEVMKNCWHLDAAMRPSFLQLREQLEHI 257
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Score = 193 bits (491), Expect = 3e-56
Identities = 65/282 (23%), Positives = 115/282 (40%), Gaps = 27/282 (9%)
Query: 505 FKEELGRGAFGTVYKGFV--NMGSSNHVAVKKLNSVF-QDSEKEFKAEVNGIGQTHHKNL 561
F E +GRG FG VY G + N G H AVK LN + +F E + H N+
Sbjct: 31 FNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNV 90
Query: 562 VRLLGYCDEGQNR-LLVYEFMSNGTVASFLFGDS-KPNWKLRTEIAMGIAGGLFYLHEEC 619
+ LLG C + L+V +M +G + +F+ ++ P K + +A G+
Sbjct: 91 LSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGM---KFLA 147
Query: 620 CTQIIHCDIKPQNILLDDHYNARISDFGLAKLLT---LDQSHTNTAIRGTKGYVAPEWFR 676
+ +H D+ +N +LD+ + +++DFGLA+ + D H T + ++A E +
Sbjct: 148 SKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQ 207
Query: 677 NMPITVKVDVYSYGVLLLEIICLRRNIDNEISKVDKAILTDWAYDRYQERTLEALVENDL 736
T K DV+S+GVLL E++ +++ D + +
Sbjct: 208 TQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFD----------------ITVYLLQGR 251
Query: 737 EAMNNVTMLHRFVMVAFWCIQEDPSHRPTMRKVTQMLEGVVE 778
+ V C RP+ ++ + +
Sbjct: 252 RLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFS 293
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 193 bits (490), Expect = 4e-56
Identities = 71/320 (22%), Positives = 123/320 (38%), Gaps = 46/320 (14%)
Query: 487 YMNLRCFTYKELVEVTRG---FKEELGRGAFGTVYKG----FVNMGSSNHVAVKKLN-SV 538
Y++ Y E R F + LG GAFG V + + ++ VAVK L S
Sbjct: 6 YIDPTQLPYDHKWEFPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSA 65
Query: 539 FQDSEKEFKAEVNGIGQ-THHKNLVRLLGYCDEGQNRLLVYEFMSNGTVASFLFGDSKP- 596
+ +E+ + +H N+V LLG C G L++ E+ G + +FL
Sbjct: 66 HLTEREALMSELKVLSYLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSF 125
Query: 597 -----------------NWKLRTEIAMGIAGGLFYLHEECCTQIIHCDIKPQNILLDDHY 639
+ + + +A G+ +L + IH D+ +NILL
Sbjct: 126 ICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKN---CIHRDLAARNILLTHGR 182
Query: 640 NARISDFGLAKLLTLDQSHTN-TAIRGTKGYVAPEWFRNMPITVKVDVYSYGVLLLEIIC 698
+I DFGLA+ + D ++ R ++APE N T + DV+SYG+ L E+
Sbjct: 183 ITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFS 242
Query: 699 LRRNIDNEISKVDKAILTDWAYDRYQERTLEALVENDLEAMNNVTMLHRFVMVAFWCIQE 758
L + + +++ ++ + C
Sbjct: 243 LGSS---------------PYPGMPVDSKFYKMIKEGFRMLSPEHAPAEMYDIMKTCWDA 287
Query: 759 DPSHRPTMRKVTQMLEGVVE 778
DP RPT +++ Q++E +
Sbjct: 288 DPLKRPTFKQIVQLIEKQIS 307
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 192 bits (488), Expect = 5e-56
Identities = 65/304 (21%), Positives = 122/304 (40%), Gaps = 49/304 (16%)
Query: 505 FKEELGRGAFGTVYKG----FVNMGSSNHVAVKKLN-SVFQDSEKEFKAEVNGIGQTHHK 559
+ ++G GAFG V++ + VAVK L D + +F+ E + + +
Sbjct: 17 YVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNP 76
Query: 560 NLVRLLGYCDEGQNRLLVYEFMSNGTVASFLF------------------------GDSK 595
N+V+LLG C G+ L++E+M+ G + FL G
Sbjct: 77 NIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPP 136
Query: 596 PNWKLRTEIAMGIAGGLFYLHEECCTQIIHCDIKPQNILLDDHYNARISDFGLAKLL-TL 654
+ + IA +A G+ YL E +H D+ +N L+ ++ +I+DFGL++ + +
Sbjct: 137 LSCAEQLCIARQVAAGMAYLSERK---FVHRDLATRNCLVGENMVVKIADFGLSRNIYSA 193
Query: 655 DQSHTNTAIRGTKGYVAPEWFRNMPITVKVDVYSYGVLLLEIICLRRNIDNEISKVDKAI 714
D + ++ PE T + DV++YGV+L EI
Sbjct: 194 DYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQ------------ 241
Query: 715 LTDWAYDRYQERTLEALVENDLEAMNNVTMLHRFVMVAFWCIQEDPSHRPTMRKVTQMLE 774
Y E + + + ++ A + C + P+ RP+ + ++L+
Sbjct: 242 ---PYYGMAHEEVIYYVRDGNILACPE-NCPLELYNLMRLCWSKLPADRPSFCSIHRILQ 297
Query: 775 GVVE 778
+ E
Sbjct: 298 RMCE 301
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 189 bits (480), Expect = 3e-55
Identities = 64/272 (23%), Positives = 115/272 (42%), Gaps = 28/272 (10%)
Query: 505 FKEELGRGAFGTVYKGFVNMGSSNHVAVKKLN--SVFQDSEKEFKAEVNGIGQTHHKNLV 562
F E+GRG+F TVYKG ++ ++ VA +L + + + FK E + H N+V
Sbjct: 13 FDIEIGRGSFKTVYKG-LDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIV 71
Query: 563 RLLGYC----DEGQNRLLVYEFMSNGTVASFLFGDSKPNWKLRTEIAMGIAGGLFYLHEE 618
R + +LV E M++GT+ ++L K+ I GL +LH
Sbjct: 72 RFYDSWESTVKGKKCIVLVTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLHTR 131
Query: 619 CCTQIIHCDIKPQNILLDD-HYNARISDFGLAKLLTLDQSHTNTAIRGTKGYVAPEWFRN 677
IIH D+K NI + + +I D GLA L ++ A+ GT ++APE +
Sbjct: 132 TP-PIIHRDLKCDNIFITGPTGSVKIGDLGLATLK---RASFAKAVIGTPEFMAPEMYEE 187
Query: 678 MPITVKVDVYSYGVLLLEIICLRRNIDNEISKVDKAILTDWAYDRYQERTLEALVENDLE 737
VDVY++G+ +LE+ ++ + + +
Sbjct: 188 -KYDESVDVYAFGMCMLEMATSEYP---------------YSECQNAAQIYRRVTSGVKP 231
Query: 738 AMNNVTMLHRFVMVAFWCIQEDPSHRPTMRKV 769
A + + + CI+++ R +++ +
Sbjct: 232 ASFDKVAIPEVKEIIEGCIRQNKDERYSIKDL 263
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 185 bits (470), Expect = 2e-53
Identities = 62/269 (23%), Positives = 104/269 (38%), Gaps = 31/269 (11%)
Query: 507 EELGRGAFGTVYKGFVNMGSSNHVAVKKLNSVFQDSE---KEFKAEVNGIGQTHHKNLVR 563
E+G G+FG VY ++ +S VA+KK++ + S ++ EV + + H N ++
Sbjct: 21 REIGHGSFGAVYFA-RDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQ 79
Query: 564 LLGYCDEGQNRLLVYEFMSNGTVASFLFGDSKPNWKLRTEIAMGIAGGLFYLHEECCTQI 623
G LV E+ + G GL YLH +
Sbjct: 80 YRGCYLREHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSH---NM 136
Query: 624 IHCDIKPQNILLDDHYNARISDFGLAKLLTLDQSHTNTAIRGTKGYVAPEWFRNM---PI 680
IH D+K NILL + ++ DFG A ++ + GT ++APE M
Sbjct: 137 IHRDVKAGNILLSEPGLVKLGDFGSASIMA-----PANSFVGTPYWMAPEVILAMDEGQY 191
Query: 681 TVKVDVYSYGVLLLEIICLRRNIDNEISKVDKAILTDWAYDRYQERTLEALVENDLEAMN 740
KVDV+S G+ +E+ + ++ L + +N+ A+
Sbjct: 192 DGKVDVWSLGITCIELAERKP----------------PLFNMNAMSALYHIAQNESPALQ 235
Query: 741 NVTMLHRFVMVAFWCIQEDPSHRPTMRKV 769
+ F C+Q+ P RPT +
Sbjct: 236 SGHWSEYFRNFVDSCLQKIPQDRPTSEVL 264
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 182 bits (464), Expect = 4e-53
Identities = 71/270 (26%), Positives = 112/270 (41%), Gaps = 28/270 (10%)
Query: 505 FKEELGRGAFGTVYKGFVNMGSSNHVAVKKLNSVF---QDSEKEFKAEVNGIGQTHHKNL 561
LG+G FG VY S +A+K L E + + EV H N+
Sbjct: 10 IGRPLGKGKFGNVYLA-REKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNI 68
Query: 562 VRLLGYCDEGQNRLLVYEFMSNGTVASFLFGDSKPNWKLRTEIAMGIAGGLFYLHEECCT 621
+RL GY + L+ E+ GTV L SK + + +A L Y H +
Sbjct: 69 LRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSK--- 125
Query: 622 QIIHCDIKPQNILLDDHYNARISDFGLAKLLTLDQSHTNTAIRGTKGYVAPEWFRNMPIT 681
++IH DIKP+N+LL +I+DFG + + T + GT Y+ PE
Sbjct: 126 RVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTT---LCGTLDYLPPEMIEGRMHD 182
Query: 682 VKVDVYSYGVLLLEIICLRRNIDNEISKVDKAILTDWAYDRYQERTLEALVENDLEAMNN 741
KVD++S GVL E + + + + YQE T + + + +
Sbjct: 183 EKVDLWSLGVLCYEFLVGKP---------------PFEANTYQE-TYKRISRVEFTFPDF 226
Query: 742 VTMLHRFVMVAFWCIQEDPSHRPTMRKVTQ 771
VT + ++ +PS RP +R+V +
Sbjct: 227 VT--EGARDLISRLLKHNPSQRPMLREVLE 254
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 182 bits (463), Expect = 8e-53
Identities = 62/277 (22%), Positives = 110/277 (39%), Gaps = 29/277 (10%)
Query: 505 FKEELGRGAFGTVYKGFVNMGSSNHVAVKKLN--SVFQDSEKEFKAEVNGIGQTHHKNLV 562
+G G++G K + K+L+ S+ + ++ +EVN + + H N+V
Sbjct: 8 VLYTIGTGSYGRCQKI-RRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIV 66
Query: 563 RLLGYCDEGQNRLL--VYEFMSNGTVASFLFGDSKP----NWKLRTEIAMGIAGGLFYLH 616
R + N L V E+ G +AS + +K + + + + L H
Sbjct: 67 RYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECH 126
Query: 617 E--ECCTQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLDQSHTNTAIRGTKGYVAPEW 674
+ ++H D+KP N+ LD N ++ DFGLA++L D S GT Y++PE
Sbjct: 127 RRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKA-FVGTPYYMSPEQ 185
Query: 675 FRNMPITVKVDVYSYGVLLLEIICLRRNIDNEISKVDKAILTDWAYDRYQERTLEALVEN 734
M K D++S G LL E+ L K + + + R R + L E
Sbjct: 186 MNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIREGKFRRIPYRYSDELNE- 244
Query: 735 DLEAMNNVTMLHRFVMVAFWCIQEDPSHRPTMRKVTQ 771
+ + HRP++ ++ +
Sbjct: 245 ----------------IITRMLNLKDYHRPSVEEILE 265
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 181 bits (461), Expect = 2e-52
Identities = 62/278 (22%), Positives = 100/278 (35%), Gaps = 27/278 (9%)
Query: 505 FKEELGRGAFGTVYKGFVNM--GSSNHVAVKKLNSVFQDSE---KEFKAEVNGIGQTHHK 559
E+LG G+FG V +G + G + VAVK L +F EVN + H+
Sbjct: 12 LLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHR 71
Query: 560 NLVRLLGYCDEGQNRLLVYEFMSNGTVASFLFGDSKP-NWKLRTEIAMGIAGGLFYLHEE 618
NL+RL G + +V E G++ L + A+ +A G+ YL +
Sbjct: 72 NLIRLYGVVLTPPMK-MVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESK 130
Query: 619 CCTQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLDQSH--TNTAIRGTKGYVAPEWFR 676
IH D+ +N+LL +I DFGL + L + H + + APE +
Sbjct: 131 R---FIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLK 187
Query: 677 NMPITVKVDVYSYGVLLLEIICLRRNIDNEISKVDKAILTDWAYDRYQERTLEALVENDL 736
+ D + +GV L E+ + ++ + L + +
Sbjct: 188 TRTFSHASDTWMFGVTLWEMFTYGQEPWIGLN---------------GSQILHKIDKEGE 232
Query: 737 EAMNNVTMLHRFVMVAFWCIQEDPSHRPTMRKVTQMLE 774
V C P RPT + L
Sbjct: 233 RLPRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLL 270
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 180 bits (458), Expect = 4e-52
Identities = 70/268 (26%), Positives = 112/268 (41%), Gaps = 22/268 (8%)
Query: 505 FKEELGRGAFGTVYKGFVNMGSSNHVAVKKLN-SVFQDSEKEFKAEVNGIGQTHHKNLVR 563
+ LG GA+G V VN + VAVK ++ D + K E+ +H+N+V+
Sbjct: 9 LVQTLGEGAYGEVQLA-VNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVK 67
Query: 564 LLGYCDEGQNRLLVYEFMSNGTVASFLFGDSKPNWKLRTEIAMGIAGGLFYLHEECCTQI 623
G+ EG + L E+ S G + + D + G+ YLH I
Sbjct: 68 FYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIG---I 124
Query: 624 IHCDIKPQNILLDDHYNARISDFGLAKLLTLD-QSHTNTAIRGTKGYVAPEWFRNMPI-T 681
H DIKP+N+LLD+ N +ISDFGLA + + + + GT YVAPE +
Sbjct: 125 THRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHA 184
Query: 682 VKVDVYSYGVLLLEIICLRRNIDNEISKVDKAILTDWAYDRYQERTLEALVENDLEAMNN 741
VDV+S G++L ++ D +DW + + + L ++
Sbjct: 185 EPVDVWSCGIVLTAMLAGELPWDQP--SDSCQEYSDWKEKKTYLNPWKKIDSAPLALLH- 241
Query: 742 VTMLHRFVMVAFWCIQEDPSHRPTMRKV 769
+ E+PS R T+ +
Sbjct: 242 ------------KILVENPSARITIPDI 257
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Score = 180 bits (457), Expect = 9e-52
Identities = 62/274 (22%), Positives = 117/274 (42%), Gaps = 28/274 (10%)
Query: 505 FKEELGRGAFGTVYKGFVNMGSSNHVAVKKLNSVFQDSEKEFKAEVNGIGQTHHKNLVRL 564
ELG GAFG VYK N +S A K +++ ++ +++ E++ + H N+V+L
Sbjct: 16 IIGELGDGAFGKVYKA-QNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKL 74
Query: 565 LGYCDEGQNRLLVYEFMSNGTVASFLFGDSKP-NWKLRTEIAMGIAGGLFYLHEECCTQI 623
L N ++ EF + G V + + +P + L YLH+ +I
Sbjct: 75 LDAFYYENNLWILIEFCAGGAVDAVMLELERPLTESQIQVVCKQTLDALNYLHDN---KI 131
Query: 624 IHCDIKPQNILLDDHYNARISDFGLAKLLTLDQSHTNTAIRGTKGYVAPEWF-----RNM 678
IH D+K NIL + +++DFG++ T ++ GT ++APE ++
Sbjct: 132 IHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRDS-FIGTPYWMAPEVVMCETSKDR 190
Query: 679 PITVKVDVYSYGVLLLEIICLRRNIDNEISKVDKAILTDWAYDRYQERTLEALVENDLEA 738
P K DV+S G+ L+E+ + ++ R L + +++
Sbjct: 191 PYDYKADVWSLGITLIEMAEIEP----------------PHHELNPMRVLLKIAKSEPPT 234
Query: 739 MNNVTML-HRFVMVAFWCIQEDPSHRPTMRKVTQ 771
+ + F C++++ R T ++ Q
Sbjct: 235 LAQPSRWSSNFKDFLKKCLEKNVDARWTTSQLLQ 268
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 180 bits (458), Expect = 1e-51
Identities = 70/293 (23%), Positives = 117/293 (39%), Gaps = 40/293 (13%)
Query: 505 FKEELGRGAFGTVYKG-FVNMGSSNHVAVKKLNSVF-QDSEKEFKAEVNGIGQ-THHKNL 561
F++ +G G FG V K G A+K++ +D ++F E+ + + HH N+
Sbjct: 14 FQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNI 73
Query: 562 VRLLGYCDEGQNRLLVYEFMSNGTVASFLFGD----------------SKPNWKLRTEIA 605
+ LLG C+ L E+ +G + FL S + + A
Sbjct: 74 INLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFA 133
Query: 606 MGIAGGLFYLHEECCTQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLDQSHTNTAIRG 665
+A G+ YL ++ Q IH D+ +NIL+ ++Y A+I+DFGL++ + T R
Sbjct: 134 ADVARGMDYLSQK---QFIHRDLAARNILVGENYVAKIADFGLSRG--QEVYVKKTMGRL 188
Query: 666 TKGYVAPEWFRNMPITVKVDVYSYGVLLLEIICLRRNIDNEISKVDKAILTDWAYDRYQE 725
++A E T DV+SYGVLL EI+ L Y
Sbjct: 189 PVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGT----------------PYCGMTC 232
Query: 726 RTLEALVENDLEAMNNVTMLHRFVMVAFWCIQEDPSHRPTMRKVTQMLEGVVE 778
L + + + C +E P RP+ ++ L ++E
Sbjct: 233 AELYEKLPQGYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLE 285
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Score = 179 bits (455), Expect = 1e-51
Identities = 57/278 (20%), Positives = 104/278 (37%), Gaps = 24/278 (8%)
Query: 505 FKEELGRGAFGTVYKGF--VNMGSSNHVAVKKLNSVFQDSEKE-FKAEVNGIGQTHHKNL 561
+G G FG V++G + VA+K + DS +E F E + Q H ++
Sbjct: 11 LGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHI 70
Query: 562 VRLLGYCDEGQNRLLVYEFMSNGTVASFLFGDSKP-NWKLRTEIAMGIAGGLFYLHEECC 620
V+L+G E ++ E + G + SFL + A ++ L YL +
Sbjct: 71 VKLIGVITENP-VWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESKR- 128
Query: 621 TQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLDQSHTNTAIRGTKGYVAPEWFRNMPI 680
+H DI +N+L+ + ++ DFGL++ + + + + ++APE
Sbjct: 129 --FVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINFRRF 186
Query: 681 TVKVDVYSYGVLLLEIICLRRNIDNEISKVDKAILTDWAYDRYQERTLEALVENDLEAMN 740
T DV+ +GV + EI+ + + + M
Sbjct: 187 TSASDVWMFGVCMWEILMHGV---------------KPFQGVKNNDVIGRIENGERLPMP 231
Query: 741 NVTMLHRFVMVAFWCIQEDPSHRPTMRKVTQMLEGVVE 778
+ C DPS RP ++ L ++E
Sbjct: 232 P-NCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILE 268
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 181 bits (459), Expect = 1e-51
Identities = 62/281 (22%), Positives = 107/281 (38%), Gaps = 24/281 (8%)
Query: 505 FKEELGRGAFGTVYKGFV---NMGSSNHVAVKKLN-SVFQDSEKEFKAEVNGIGQTHHKN 560
+ LG GAFGTVYKG VA+K+L + + KE E + + +
Sbjct: 13 KIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPH 72
Query: 561 LVRLLGYCDEGQNRLLVYEFMSNGTVASFLFGDSKPNWKLRTEIAMGIAGGLFYLHEECC 620
+ RLLG C +L+ + + + IA G+ YL
Sbjct: 73 VCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYL---ED 129
Query: 621 TQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLDQSHTNT-AIRGTKGYVAPEWFRNMP 679
+++H D+ +N+L+ + +I+DFGLAKLL ++ + + ++A E +
Sbjct: 130 RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRI 189
Query: 680 ITVKVDVYSYGVLLLEIICLRRNIDNEISKVDKAILTDWAYDRYQERTLEALVENDLEAM 739
T + DV+SYGV + E++ YD + +++E
Sbjct: 190 YTHQSDVWSYGVTVWELMTFGS----------------KPYDGIPASEISSILEKGERLP 233
Query: 740 NNVTMLHRFVMVAFWCIQEDPSHRPTMRKVTQMLEGVVEVP 780
M+ C D RP R++ + P
Sbjct: 234 QPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARDP 274
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 178 bits (452), Expect = 5e-51
Identities = 63/266 (23%), Positives = 120/266 (45%), Gaps = 23/266 (8%)
Query: 507 EELGRGAFGTVYKGFVNMGSSNHVAVKKLNSVFQDSEKEFKAEVNGIGQTHHKNLVRLLG 566
E++G+GA GTVY +++ + VA++++N Q ++ E+ + + + N+V L
Sbjct: 26 EKIGQGASGTVYTA-MDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLD 84
Query: 567 YCDEGQNRLLVYEFMSNGTVASFLFGDSKPNWKLRTEIAMGIAGGLFYLHEECCTQIIHC 626
G +V E+++ G++ + ++ + + L +LH Q+IH
Sbjct: 85 SYLVGDELWVVMEYLAGGSLTDVVT-ETCMDEGQIAAVCRECLQALEFLHSN---QVIHR 140
Query: 627 DIKPQNILLDDHYNARISDFGLAKLLTLDQSHTNTAIRGTKGYVAPEWFRNMPITVKVDV 686
DIK NILL + +++DFG +T +QS +T + GT ++APE KVD+
Sbjct: 141 DIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRST-MVGTPYWMAPEVVTRKAYGPKVDI 199
Query: 687 YSYGVLLLEIICLRRNIDNE-ISKVDKAILTDWAYDRYQERTLEALVENDLEAMNNVTML 745
+S G++ +E+I NE + I T+ + L A+ + L
Sbjct: 200 WSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNPEKLSAIFRDFLN-------- 251
Query: 746 HRFVMVAFWCIQEDPSHRPTMRKVTQ 771
C+ D R + +++ Q
Sbjct: 252 --------RCLDMDVEKRGSAKELLQ 269
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 173 bits (438), Expect = 5e-49
Identities = 68/290 (23%), Positives = 125/290 (43%), Gaps = 35/290 (12%)
Query: 505 FKEELGRGAFGTVYKGF----VNMGSSNHVAVKKLN-SVFQDSEKEFKAEVNGIGQTHHK 559
ELG+G+FG VY+G V VA+K +N + EF E + + + +
Sbjct: 24 MSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCH 83
Query: 560 NLVRLLGYCDEGQNRLLVYEFMSNGTVASFLFGD----------SKPNWKLRTEIAMGIA 609
++VRLLG +GQ L++ E M+ G + S+L + P+ ++A IA
Sbjct: 84 HVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIA 143
Query: 610 GGLFYLHEECCTQIIHCDIKPQNILLDDHYNARISDFGLAKLLT-LDQSHTNTAIRGTKG 668
G+ YL+ + +H D+ +N ++ + + +I DFG+ + + D
Sbjct: 144 DGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVR 200
Query: 669 YVAPEWFRNMPITVKVDVYSYGVLLLEIICLRRNIDNEISKVDKAILTDWAYDRYQERTL 728
+++PE ++ T DV+S+GV+L EI L +S E+ L
Sbjct: 201 WMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLS---------------NEQVL 245
Query: 729 EALVENDLEAMNNVTMLHRFVMVAFWCIQEDPSHRPTMRKVTQMLEGVVE 778
++E L + + C Q +P RP+ ++ ++ +E
Sbjct: 246 RFVMEGGLLDKPD-NCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEME 294
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 168 bits (426), Expect = 2e-47
Identities = 70/298 (23%), Positives = 118/298 (39%), Gaps = 42/298 (14%)
Query: 505 FKEELGRGAFGTVYKGFV----NMGSSNHVAVKKLN-SVFQDSEKEFKAEVNGIGQT-HH 558
+ LGRGAFG V + + VAVK L + +E+ + HH
Sbjct: 17 LGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHH 76
Query: 559 KNLVRLLGYC-DEGQNRLLVYEFMSNGTVASFLFGDSKP----------------NWKLR 601
N+V LLG C G +++ EF G ++++L +
Sbjct: 77 LNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHL 136
Query: 602 TEIAMGIAGGLFYLHEECCTQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLDQSHTNT 661
+ +A G+ +L + IH D+ +NILL + +I DFGLA+ + D +
Sbjct: 137 ICYSFQVAKGMEFLASR---KCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRK 193
Query: 662 A-IRGTKGYVAPEWFRNMPITVKVDVYSYGVLLLEIICLRRNIDNEISKVDKAILTDWAY 720
R ++APE + T++ DV+S+GVLL EI L + + + +
Sbjct: 194 GDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVK------IDEEFC 247
Query: 721 DRYQERTLEALVENDLEAMNNVTMLHRFVMVAFWCIQEDPSHRPTMRKVTQMLEGVVE 778
R +E T + M C +PS RPT ++ + L +++
Sbjct: 248 RRLKEGTRMRAPDYTTPEMYQ---------TMLDCWHGEPSQRPTFSELVEHLGNLLQ 296
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Score = 169 bits (429), Expect = 3e-47
Identities = 59/270 (21%), Positives = 107/270 (39%), Gaps = 27/270 (10%)
Query: 505 FKEELGRGAFGTVYKGFVNMGSSNHVAVKKLNSVFQDSEKEFKAEVNGIGQTHHKNLVRL 564
EELG GAFG V++ + N+ A K + + + ++ + E+ + H LV L
Sbjct: 30 IHEELGTGAFGVVHRV-TERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNL 88
Query: 565 LGYCDEGQNRLLVYEFMSNGTVASFLFGDSKP-NWKLRTEIAMGIAGGLFYLHEECCTQI 623
++ +++YEFMS G + + + + E + GL ++HE
Sbjct: 89 HDAFEDDNEMVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHENN---Y 145
Query: 624 IHCDIKPQNILLDDHYNARI--SDFGLAKLLTLDQSHTNTAIRGTKGYVAPEWFRNMPIT 681
+H D+KP+NI+ + + DFGL LD + GT + APE P+
Sbjct: 146 VHLDLKPENIMFTTKRSNELKLIDFGLTAH--LDPKQSVKVTTGTAEFAAPEVAEGKPVG 203
Query: 682 VKVDVYSYGVLLLEIICLRR--NIDNEISKVDKAILTDWAYDRYQERTLEALVENDLEAM 739
D++S GVL ++ +N+ + DW D + ++ +
Sbjct: 204 YYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDWNMDDSAFSGISEDGKDFIR-- 261
Query: 740 NNVTMLHRFVMVAFWCIQEDPSHRPTMRKV 769
+ DP+ R T+ +
Sbjct: 262 --------------KLLLADPNTRMTIHQA 277
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 167 bits (424), Expect = 3e-47
Identities = 71/300 (23%), Positives = 118/300 (39%), Gaps = 44/300 (14%)
Query: 505 FKEELGRGAFGTVYKGF------VNMGSSNHVAVKKLNS-VFQDSEKEFKAEVNGIGQ-T 556
+ LG GAFG V VAVK L S + + +E+ +
Sbjct: 17 LGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIG 76
Query: 557 HHKNLVRLLGYCDEGQNRLLVYEFMSNGTVASFLFGDSKP----------------NWKL 600
HKN++ LLG C + ++ E+ S G + +L P + K
Sbjct: 77 KHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKD 136
Query: 601 RTEIAMGIAGGLFYLHEECCTQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLDQSHTN 660
A +A G+ YL + + IH D+ +N+L+ + +I+DFGLA+ + +
Sbjct: 137 LVSCAYQVARGMEYLASK---KCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKK 193
Query: 661 T-AIRGTKGYVAPEWFRNMPITVKVDVYSYGVLLLEIICLRRNIDNEISKVDKAILTDWA 719
T R ++APE + T + DV+S+GVLL EI L +
Sbjct: 194 TTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSP---------------- 237
Query: 720 YDRYQERTLEALVENDLEAMNNVTMLHRFVMVAFWCIQEDPSHRPTMRKVTQMLEGVVEV 779
Y L L++ + M+ C PS RPT +++ + L+ +V +
Sbjct: 238 YPGVPVEELFKLLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIVAL 297
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 162 bits (411), Expect = 2e-45
Identities = 57/276 (20%), Positives = 101/276 (36%), Gaps = 30/276 (10%)
Query: 505 FKEELGRGAFGTVYKGFVNMGSSNHVAVKKLNSVFQDSE---KEFKAEVNGIGQTHHKNL 561
F + LG G+F TV + +S A+K L E E + + + H
Sbjct: 12 FGKILGEGSFSTVVLA-RELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFF 70
Query: 562 VRLLGYCDEGQNRLLVYEFMSNGTVASFLFGDSKPNWKLRTEIAMGIAGGLFYLHEECCT 621
V+L + + + NG + ++ + I L YLH +
Sbjct: 71 VKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKG-- 128
Query: 622 QIIHCDIKPQNILLDDHYNARISDFGLAKLLTLDQSHTN-TAIRGTKGYVAPEWFRNMPI 680
IIH D+KP+NILL++ + +I+DFG AK+L+ + + GT YV+PE
Sbjct: 129 -IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLTEKSA 187
Query: 681 TVKVDVYSYGVLLLEIICLRR--NIDNEISKVDKAILTDWAYDRYQERTLEALVENDLEA 738
D+++ G ++ +++ NE K I ++ + LVE
Sbjct: 188 CKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFPEKFFPKARDLVE----- 242
Query: 739 MNNVTMLHRFVMVAFWCIQEDPSHRPTMRKVTQMLE 774
+ D + R ++
Sbjct: 243 ---------------KLLVLDATKRLGCEEMEGYGP 263
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 160 bits (407), Expect = 1e-44
Identities = 60/269 (22%), Positives = 106/269 (39%), Gaps = 20/269 (7%)
Query: 505 FKEELGRGAFGTVYKGFVNMGSSNHVAVKKLN-SVFQDSEKEFKAEVNGIGQTHHKNLVR 563
F++ LG GAF V + + VA+K + + E + E+ + + H N+V
Sbjct: 13 FRDVLGTGAFSEVILA-EDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHPNIVA 71
Query: 564 LLGYCDEGQNRLLVYEFMSNGTVASFLFGDSKPNWKLRTEIAMGIAGGLFYLHEECCTQI 623
L + G + L+ + +S G + + + + + + + YLH+
Sbjct: 72 LDDIYESGGHLYLIMQLVSGGELFDRIVEKGFYTERDASRLIFQVLDAVKYLHDLGIVHR 131
Query: 624 IHCDIKPQNILLDDHYNARISDFGLAKLLTLDQSHTNTAIRGTKGYVAPEWFRNMPITVK 683
LD+ ISDFGL+K+ D + GT GYVAPE P +
Sbjct: 132 DLKPENLLYYSLDEDSKIMISDFGLSKM--EDPGSVLSTACGTPGYVAPEVLAQKPYSKA 189
Query: 684 VDVYSYGVLLLEIICLRRNIDNEISKVDKAILTDWAYDRYQERTLEALVENDLEAMNNVT 743
VD +S GV+ ++C D + E+ L+A E D ++++
Sbjct: 190 VDCWSIGVIAYILLCGYP------------PFYDENDAKLFEQILKAEYEFDSPYWDDIS 237
Query: 744 -MLHRFVMVAFWCIQEDPSHRPTMRKVTQ 771
F+ +++DP R T + Q
Sbjct: 238 DSAKDFIR---HLMEKDPEKRFTCEQALQ 263
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Score = 162 bits (410), Expect = 1e-44
Identities = 61/272 (22%), Positives = 111/272 (40%), Gaps = 27/272 (9%)
Query: 505 FKEELGRGAFGTVYKGFVNMGSSNHVAVKKLNSVFQDSEKEFKAEVNGIGQTHHKNLVRL 564
EELG GAFG V++ V + K +N+ + + K E++ + Q HH L+ L
Sbjct: 33 ILEELGSGAFGVVHRC-VEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINL 91
Query: 565 LGYCDEGQNRLLVYEFMSNGTVASFLFGDSKP-NWKLRTEIAMGIAGGLFYLHEECCTQI 623
++ +L+ EF+S G + + + + GL ++HE I
Sbjct: 92 HDAFEDKYEMVLILEFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEH---SI 148
Query: 624 IHCDIKPQNILLDDHYNARI--SDFGLAKLLTLDQSHTNTAIRGTKGYVAPEWFRNMPIT 681
+H DIKP+NI+ + + + DFGLA L D+ T T + APE P+
Sbjct: 149 VHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEIVKVT--TATAEFAAPEIVDREPVG 206
Query: 682 VKVDVYSYGVLLLEIICLRR--NIDNEISKVDKAILTDWAYDRYQERTLEALVENDLEAM 739
D+++ GVL ++ ++++ + DW +D ++
Sbjct: 207 FYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRCDWEFDEDAFSSVSP--------- 257
Query: 740 NNVTMLHRFVMVAFWCIQEDPSHRPTMRKVTQ 771
F+ +Q++P R T+ +
Sbjct: 258 ----EAKDFIK---NLLQKEPRKRLTVHDALE 282
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Score = 154 bits (390), Expect = 3e-42
Identities = 54/271 (19%), Positives = 103/271 (38%), Gaps = 26/271 (9%)
Query: 505 FKEELGRGAFGTVYKGFVNMGSSNHVAVKKLNSVFQDSEKEFKAEVNGIGQTHHKNLVRL 564
E+LGRG FG V++ V S K + D + K E++ + H+N++ L
Sbjct: 9 IAEDLGRGEFGIVHRC-VETSSKKTYMAKFVKVKGTD-QVLVKKEISILNIARHRNILHL 66
Query: 565 LGYCDEGQNRLLVYEFMSNGTVASFLFGDSKP-NWKLRTEIAMGIAGGLFYLHEECCTQI 623
+ + ++++EF+S + + + N + + L +LH I
Sbjct: 67 HESFESMEELVMIFEFISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHSH---NI 123
Query: 624 IHCDIKPQNILLDDHYNAR--ISDFGLAKLLTLDQSHTNTAIRGTKGYVAPEWFRNMPIT 681
H DI+P+NI+ ++ I +FG A+ L + Y APE ++ ++
Sbjct: 124 GHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFRLL--FTAPEYYAPEVHQHDVVS 181
Query: 682 VKVDVYSYGVLLLEIICLRRNIDNEISKVDKAILTDWAYDRYQERTLEALVENDLEAMNN 741
D++S G L+ ++ + E + A D EA
Sbjct: 182 TATDMWSLGTLVYVLLSGIN------------PFLAETNQQIIENIMNAEYTFDEEAFKE 229
Query: 742 VT-MLHRFVMVAFWCIQEDPSHRPTMRKVTQ 771
++ FV + ++ R T + Q
Sbjct: 230 ISIEAMDFVD---RLLVKERKSRMTASEALQ 257
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Score = 151 bits (383), Expect = 7e-42
Identities = 60/284 (21%), Positives = 106/284 (37%), Gaps = 32/284 (11%)
Query: 505 FKEELGRGAFGTVYKGFVNMGSSNHVAVKKLNSVFQDSE---KEFKAEVNGIGQTHHKNL 561
E LG G V+ ++ VAVK L + F+ E +H +
Sbjct: 11 LGEILGFGGMSEVHLA-RDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAI 69
Query: 562 VRLLGYC----DEGQNRLLVYEFMSNGTVASFLFGDSKPNWKLRTEIAMGIAGGLFYLHE 617
V + G +V E++ T+ + + K E+ L + H+
Sbjct: 70 VAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNFSHQ 129
Query: 618 ECCTQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLDQSHTN--TAIRGTKGYVAPEWF 675
IIH D+KP NI++ ++ DFG+A+ + + A+ GT Y++PE
Sbjct: 130 NG---IIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQA 186
Query: 676 RNMPITVKVDVYSYGVLLLEIICLRR--NIDNEISKVDKAILTDWAYDRYQERTLEALVE 733
R + + DVYS G +L E++ D+ +S + + D + L A
Sbjct: 187 RGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPIPPSARHEGLSA--- 243
Query: 734 NDLEAMNNVTMLHRFVMVAFWCIQEDPSHRP-TMRKVTQMLEGV 776
L V+ + ++P +R T ++ L V
Sbjct: 244 ----------DLDAVVL---KALAKNPENRYQTAAEMRADLVRV 274
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Score = 150 bits (379), Expect = 3e-41
Identities = 57/283 (20%), Positives = 111/283 (39%), Gaps = 40/283 (14%)
Query: 505 FKEELGRGAFGTVYKGFVNMGSSNHVAVKKLN---------SVFQDSEKEFKAEVNGIGQ 555
KE LGRG V + ++ + AVK ++ Q+ + EV+ + +
Sbjct: 7 PKEILGRGVSSVVRRC-IHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRK 65
Query: 556 TH-HKNLVRLLGYCDEGQNRLLVYEFMSNGTVASFLFGDSKPNWKLRTEIAMGIAGGLFY 614
H N+++L + LV++ M G + +L + K +I + +
Sbjct: 66 VSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLEVICA 125
Query: 615 LHEECCTQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLDQSHTNTAIRGTKGYVAPEW 674
LH+ I+H D+KP+NILLDD N +++DFG + LD + GT Y+APE
Sbjct: 126 LHKLN---IVHRDLKPENILLDDDMNIKLTDFGFSCQ--LDPGEKLREVCGTPSYLAPEI 180
Query: 675 FR------NMPITVKVDVYSYGVLLLEIICLRR--NIDNEISKVDKAILTDWAYDRYQER 726
+ +VD++S GV++ ++ ++ + + ++ + +
Sbjct: 181 IECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSGNYQFGSPEWD 240
Query: 727 TLEALVENDLEAMNNVTMLHRFVMVAFWCIQEDPSHRPTMRKV 769
V++ + + P R T +
Sbjct: 241 DYSDTVKDLVS----------------RFLVVQPQKRYTAEEA 267
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 150 bits (380), Expect = 4e-41
Identities = 50/280 (17%), Positives = 93/280 (33%), Gaps = 26/280 (9%)
Query: 505 FKEELGRGAFGTVYKGFVNMGSSNHVAVKKLNSVFQDSEKEFKAEVNGIGQTHHKNLVRL 564
++G G+FG +Y G ++ + VA+K + + E +
Sbjct: 11 LGRKIGSGSFGDIYLG-TDIAAGEEVAIKLECV--KTKHPQLHIESKIYKMMQGGVGIPT 67
Query: 565 LGYC-DEGQNRLLVYEFMSNGTVASFLFGDSKPNWKLRTEIAMGIAGGLFYLHEECCTQI 623
+ +C EG ++V E + F F K + K +A + + Y+H +
Sbjct: 68 IRWCGAEGDYNVMVMELLGPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSK---NF 124
Query: 624 IHCDIKPQNIL---LDDHYNARISDFGLAKLLTLDQSHT------NTAIRGTKGYVAPEW 674
IH D+KP N L I DFGLAK ++H N + GT Y +
Sbjct: 125 IHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASINT 184
Query: 675 FRNMPITVKVDVYSYGVLLLEIICLRRNIDNEISKVDKAILTDWAYDRYQERTLEALVEN 734
+ + + D+ S G +L+ + + + + +E L +
Sbjct: 185 HLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKM-STPIEVLCKG 243
Query: 735 DLEAMNNVTMLHRFVMVAFWCIQEDPSHRPTMRKVTQMLE 774
+C +P + Q+
Sbjct: 244 YPSEFATYLN---------FCRSLRFDDKPDYSYLRQLFR 274
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Score = 151 bits (382), Expect = 4e-41
Identities = 64/269 (23%), Positives = 108/269 (40%), Gaps = 31/269 (11%)
Query: 505 FKEELGRGAFGTVYKGFVNMGSSNHVAVKKLN---SVFQDSEKEFKAEVNGIGQT-HHKN 560
+ LG+G+FG V+ ++ A+K L + D + E + H
Sbjct: 6 LHKMLGKGSFGKVFLA-EFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPF 64
Query: 561 LVRLLGYCDEGQNRLLVYEFMSNGTVASFLFGDSKPNWKLRTEIAMGIAGGLFYLHEECC 620
L + +N V E+++ G + + K + T A I GL +LH +
Sbjct: 65 LTHMFCTFQTKENLFFVMEYLNGGDLMYHIQSCHKFDLSRATFYAAEIILGLQFLHSKG- 123
Query: 621 TQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLDQSHTNTAIRGTKGYVAPEWFRNMPI 680
I++ D+K NILLD + +I+DFG+ K L + TNT GT Y+APE
Sbjct: 124 --IVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKTNT-FCGTPDYIAPEILLGQKY 180
Query: 681 TVKVDVYSYGVLLLEIICLRR--NIDNEISKVDKAILTDWAYDRYQERTLEALVENDLEA 738
VD +S+GVLL E++ + + +E + + Y R+ E+ + L+
Sbjct: 181 NHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRMDNPFYPRWLEKEAKDLLV----- 235
Query: 739 MNNVTMLHRFVMVAFWCIQEDPSHRPTMR 767
+P R +R
Sbjct: 236 ---------------KLFVREPEKRLGVR 249
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 151 bits (381), Expect = 4e-41
Identities = 60/270 (22%), Positives = 106/270 (39%), Gaps = 31/270 (11%)
Query: 505 FKEELGRGAFGTVYKGFVNMGSSNHVAVKKLNSVFQDSEKE---FKAEVNGIGQTHHKNL 561
LG G+FG V+ + + + A+K L K+ E + H +
Sbjct: 8 ILRTLGTGSFGRVHLI-RSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFI 66
Query: 562 VRLLGYCDEGQNRLLVYEFMSNGTVASFLFGDSKPNWKLRTEIAMGIAGGLFYLHEECCT 621
+R+ G + Q ++ +++ G + S L + + A + L YLH +
Sbjct: 67 IRMWGTFQDAQQIFMIMDYIEGGELFSLLRKSQRFPNPVAKFYAAEVCLALEYLHSKD-- 124
Query: 622 QIIHCDIKPQNILLDDHYNARISDFGLAKLLTLDQSHTNTAIRGTKGYVAPEWFRNMPIT 681
II+ D+KP+NILLD + + +I+DFG AK + + GT Y+APE P
Sbjct: 125 -IIYRDLKPENILLDKNGHIKITDFGFAKYV----PDVTYTLCGTPDYIAPEVVSTKPYN 179
Query: 682 VKVDVYSYGVLLLEIICLRRNIDNEISKVDKAILTDWAYDRYQERTLEALVENDLEAMNN 741
+D +S+G+L+ E++ YD +T E ++ +L
Sbjct: 180 KSIDWWSFGILIYEMLAGYTPF----------------YDSNTMKTYEKILNAELRFPPF 223
Query: 742 VT-MLHRFVMVAFWCIQEDPSHRPTMRKVT 770
+ + I D S R +
Sbjct: 224 FNEDVKDLLS---RLITRDLSQRLGNLQNG 250
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Score = 151 bits (382), Expect = 9e-41
Identities = 56/274 (20%), Positives = 94/274 (34%), Gaps = 31/274 (11%)
Query: 505 FKEELGRGAFGTVYKGFVNMGSSNHVAVKKLNSVF---QDSEKEFKAEVNGI---GQTHH 558
+GRG FG VY + A+K L+ + E E +
Sbjct: 8 VHRIIGRGGFGEVYGC-RKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDC 66
Query: 559 KNLVRLLGYCDEGQNRLLVYEFMSNGTVASFLFGDSKPNWKLRTEIAMGIAGGLFYLHEE 618
+V + + + M+ G + L + A I GL ++H
Sbjct: 67 PFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEHMHNR 126
Query: 619 CCTQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLDQSHTNTAIRGTKGYVAPEWF-RN 677
+++ D+KP NILLD+H + RISD GLA + + H GT GY+APE +
Sbjct: 127 F---VVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHA---SVGTHGYMAPEVLQKG 180
Query: 678 MPITVKVDVYSYGVLLLEIICLRRNIDNEISKVDKAILTDWAYDRYQERTLEALVENDLE 737
+ D +S G +L +++ +K I E
Sbjct: 181 VAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAV-------------E 227
Query: 738 AMNNVT-MLHRFVMVAFWCIQEDPSHRPTMRKVT 770
++ + L + +Q D + R
Sbjct: 228 LPDSFSPELRSLLE---GLLQRDVNRRLGCLGRG 258
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Score = 147 bits (372), Expect = 4e-40
Identities = 63/282 (22%), Positives = 111/282 (39%), Gaps = 21/282 (7%)
Query: 507 EELGRGAFGTVYKGFVNMGSSNHVAVKKLNSVFQDSEKE-----FKAEVNGIGQTHHKNL 561
+ LG G F TVYK + ++ VA+KK+ + K+ E+ + + H N+
Sbjct: 4 DFLGEGQFATVYKA-RDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNI 62
Query: 562 VRLLGYCDEGQNRLLVYEFMSNGTVASFLFGDSKPNWKLRTEIAMGIAGGLFYLHEECCT 621
+ LL N LV++FM + GL YLH+
Sbjct: 63 IGLLDAFGHKSNISLVFDFMETDLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQHW-- 120
Query: 622 QIIHCDIKPQNILLDDHYNARISDFGLAKLLTLDQSHTNTAIRGTKGYVAPE-WFRNMPI 680
I+H D+KP N+LLD++ +++DFGLAK + T T+ Y APE F
Sbjct: 121 -ILHRDLKPNNLLLDENGVLKLADFGLAKSFG-SPNRAYTHQVVTRWYRAPELLFGARMY 178
Query: 681 TVKVDVYSYGVLLLEIICLR-----RNIDNEISKVDKAILTDWAYDRYQERTLEALVEND 735
V VD+++ G +L E++ + ++++++ + + T +L V
Sbjct: 179 GVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPDYVTFK 238
Query: 736 LEAMNNVTMLHRFVMVAF-----WCIQEDPSHRPTMRKVTQM 772
+ + +P R T + +M
Sbjct: 239 SFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKM 280
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Score = 145 bits (365), Expect = 4e-39
Identities = 57/285 (20%), Positives = 111/285 (38%), Gaps = 25/285 (8%)
Query: 507 EELGRGAFGTVYKGFVNMGSSNHVAVKKLN--SVFQDSEKEFKAEVN---GIGQTHHKNL 561
E+G GA+G V+K VA+K++ + + EV + H N+
Sbjct: 13 AEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNV 72
Query: 562 VRLLGYC----DEGQNRLLVYEFMSNGTVASFLFGDSKP--NWKLRTEIAMGIAGGLFYL 615
VRL C + + +L + + + ++L +P + ++ + GL +L
Sbjct: 73 VRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFL 132
Query: 616 HEECCTQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLDQSHTNTAIRGTKGYVAPEWF 675
H ++H D+KPQNIL+ +++DFGLA++ T++ T Y APE
Sbjct: 133 HSHR---VVHRDLKPQNILVTSSGQIKLADFGLARIY--SFQMALTSVVVTLWYRAPEVL 187
Query: 676 RNMPITVKVDVYSYGVLLLEIICLRR-----NIDNEISKVDKAILTDWAYDRYQERTLEA 730
VD++S G + E+ + + +++ K+ I D ++ L
Sbjct: 188 LQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPRDVALPR 247
Query: 731 LVENDLEAMNNVTMLHRFVMVAF----WCIQEDPSHRPTMRKVTQ 771
+ A + + C+ +P+ R +
Sbjct: 248 QAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALS 292
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Score = 143 bits (360), Expect = 1e-38
Identities = 51/276 (18%), Positives = 107/276 (38%), Gaps = 18/276 (6%)
Query: 507 EELGRGAFGTVYKGFVNMGSSNHVAVKKLNSVFQDS--EKEFKAEVNGIGQTHHKNLVRL 564
E++G G +G VYK N G A+KK+ +D E++ + + H N+V+L
Sbjct: 8 EKIGEGTYGVVYKAQNNYG--ETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKL 65
Query: 565 LGYCDEGQNRLLVYEFMSNGTVASFLFGDSKPNWKLRTEIAMGIAGGLFYLHEECCTQII 624
+ +LV+E + + + + G+ Y H+ ++
Sbjct: 66 YDVIHTKKRLVLVFEHLDQDLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDRR---VL 122
Query: 625 HCDIKPQNILLDDHYNARISDFGLAKLLTLDQSHTNTAIRGTKGYVAPEWFRNMPITVKV 684
H D+KPQN+L++ +I+DFGLA+ + I + + +
Sbjct: 123 HRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEIVTLWYRAPDVLMGSKKYSTTI 182
Query: 685 DVYSYGVLLLEIICLR-----RNIDNEISKVDKAILTDWAYDRYQERTLEALVEN--DLE 737
D++S G + E++ + +++ ++ + + T + + L N E
Sbjct: 183 DIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKYDPNFTVYE 242
Query: 738 AMNNVTMLHRFVMVAF----WCIQEDPSHRPTMRKV 769
+ + L ++ DP+ R T ++
Sbjct: 243 PLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQA 278
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Score = 142 bits (358), Expect = 3e-38
Identities = 63/277 (22%), Positives = 111/277 (40%), Gaps = 34/277 (12%)
Query: 505 FKEELGRGAFGTVYKGFVNMGSSNHVAVKKLNSVFQDSE------KEFKAEVNGIGQTHH 558
EELG G F V K + A K + S ++ + EV+ + + H
Sbjct: 14 TGEELGSGQFAVVKKC-REKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQH 72
Query: 559 KNLVRLLGYCDEGQNRLLVYEFMSNGTVASFLFGDSKPNWKLRTEIAMGIAGGLFYLHEE 618
N++ L + + +L+ E ++ G + FL + TE I G++YLH
Sbjct: 73 PNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHSL 132
Query: 619 CCTQIIHCDIKPQNILLDDH----YNARISDFGLAKLLTLDQSHTNTAIRGTKGYVAPEW 674
I H D+KP+NI+L D +I DFGLA +D + I GT +VAPE
Sbjct: 133 Q---IAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHK--IDFGNEFKNIFGTPEFVAPEI 187
Query: 675 FRNMPITVKVDVYSYGVLLLEIICLRRNI--DNEISKVDKAILTDWAYDRYQERTLEALV 732
P+ ++ D++S GV+ ++ D + + ++ ++ AL
Sbjct: 188 VNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEYFSNTSALA 247
Query: 733 ENDLEAMNNVTMLHRFVMVAFWCIQEDPSHRPTMRKV 769
++ + + +DP R T++
Sbjct: 248 KDFIR----------------RLLVKDPKKRMTIQDS 268
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 142 bits (358), Expect = 8e-38
Identities = 56/295 (18%), Positives = 116/295 (39%), Gaps = 26/295 (8%)
Query: 497 ELVEVTRGFK--EELGRGAFGTVYKGFVNMGSSNHVAVKKLNSV-FQDSEKEFKAEVNGI 553
++ +V + +G GA+G V + + VA+KK++ Q + E+ +
Sbjct: 2 QVFDVGPRYTNLSYIGEGAYGMVCSA-YDNVNKVRVAIKKISPFEHQTYCQRTLREIKIL 60
Query: 554 GQTHHKNLVRLLGYCDEGQNRLLVYEFMSNGTVASFLFG---DSKPNWKLRTEIAMGIAG 610
+ H+N++ + + ++ + + L+ + I
Sbjct: 61 LRFRHENIIGINDIIRAPTIEQMKDVYLVTHLMGADLYKLLKTQHLSNDHICYFLYQILR 120
Query: 611 GLFYLHEECCTQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLDQSH--TNTAIRGTKG 668
GL Y+H ++H D+KP N+LL+ + +I DFGLA++ D H T T+
Sbjct: 121 GLKYIHSA---NVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRW 177
Query: 669 YVAPEWFRN-MPITVKVDVYSYGVLLLEIICLR-----RNIDNEISKVDKAILTDWAYDR 722
Y APE N T +D++S G +L E++ R ++ ++++ + + + D
Sbjct: 178 YRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDL 237
Query: 723 YQERTLEALVENDLEAMNNVTMLHR--------FVMVAFWCIQEDPSHRPTMRKV 769
L+A N +R + + + +P R + +
Sbjct: 238 NCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQA 292
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 140 bits (354), Expect = 9e-38
Identities = 40/282 (14%), Positives = 89/282 (31%), Gaps = 28/282 (9%)
Query: 505 FKEELGRGAFGTVYKGFVNMGSSNHVAVKKLNSVFQDSEKEFKAEVNGIGQ-THHKNLVR 563
+G G+FG +++G N+ ++ VA+K + + + E +
Sbjct: 9 VGRRIGEGSFGVIFEG-TNLLNNQQVAIKFEPR--RSDAPQLRDEYRTYKLLAGCTGIPN 65
Query: 564 LLGYCDEGQNRLLVYEFMSNGTVASFLFGDSKPNWKLRTEIAMGIAGGLFYLHEECCTQI 623
+ + EG + +LV + + K + K A + + +HE+ +
Sbjct: 66 VYYFGQEGLHNVLVIDLLGPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEKS---L 122
Query: 624 IHCDIKPQNILLDDHYN-----ARISDFGLAKLLTLDQSHTN------TAIRGTKGYVAP 672
++ DIKP N L+ + + DFG+ K + + + GT Y++
Sbjct: 123 VYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTARYMSI 182
Query: 673 EWFRNMPITVKVDVYSYGVLLLEIICLRRNIDNEISKVDKAILTDWAYDRYQERTLEALV 732
+ + D+ + G + + + + ++ Q L L
Sbjct: 183 NTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGL-KAATNKQKYERIGEKKQSTPLRELC 241
Query: 733 ENDLEAMNNVTMLHRFVMVAFWCIQEDPSHRPTMRKVTQMLE 774
E F + P + +
Sbjct: 242 AGFPEE---------FYKYMHYARNLAFDATPDYDYLQGLFS 274
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 141 bits (355), Expect = 2e-37
Identities = 57/274 (20%), Positives = 102/274 (37%), Gaps = 31/274 (11%)
Query: 506 KEELGRGAFGTVYKGFVNMGSSNHVAVKKLNSVFQDSEKEFKAEVNGIGQTHHKNLVRLL 565
+ LG G G V + N + A+K L + +E + + ++VR++
Sbjct: 17 SQVLGLGINGKVLQI-FNKRTQEKFALKMLQDC-PKARREVELHWR---ASQCPHIVRIV 71
Query: 566 GYCD----EGQNRLLVYEFMSNGTVASFL--FGDSKPNWKLRTEIAMGIAGGLFYLHEEC 619
+ + L+V E + G + S + GD + +EI I + YLH
Sbjct: 72 DVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSI- 130
Query: 620 CTQIIHCDIKPQNILLDDHYN---ARISDFGLAKLLTLDQSHTNTAIRGTKGYVAPEWFR 676
I H D+KP+N+L +++DFG AK T S T T YVAPE
Sbjct: 131 --NIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTP--CYTPYYVAPEVLG 186
Query: 677 NMPITVKVDVYSYGVLLLEIICLRRNIDNEISKVDKAILTDWAYDRYQERTLEALVENDL 736
D++S GV++ ++C + + R E
Sbjct: 187 PEKYDKSCDMWSLGVIMYILLCGYPPFYSN--------HGLAISPGMKTRIRMGQYEFPN 238
Query: 737 EAMNNVT-MLHRFVMVAFWCIQEDPSHRPTMRKV 769
+ V+ + + ++ +P+ R T+ +
Sbjct: 239 PEWSEVSEEVKMLIR---NLLKTEPTQRMTITEF 269
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Score = 139 bits (350), Expect = 3e-37
Identities = 51/277 (18%), Positives = 106/277 (38%), Gaps = 18/277 (6%)
Query: 507 EELGRGAFGTVYKGFVNMGSSNHVAVKKLNSVFQDSE--KEFKAEVNGIGQTHHKNLVRL 564
E++G G +GTV+K N + VA+K++ D E+ + + HKN+VRL
Sbjct: 8 EKIGEGTYGTVFKA-KNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRL 66
Query: 565 LGYCDEGQNRLLVYEFMSNGTVASFLFGDSKPNWKLRTEIAMGIAGGLFYLHEECCTQII 624
+ LV+EF F + + ++ + GL + H ++
Sbjct: 67 HDVLHSDKKLTLVFEFCDQDLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCH---SRNVL 123
Query: 625 HCDIKPQNILLDDHYNARISDFGLAKLLTLDQSHTNTAIRGTKGYVAPEWFRNMPITVKV 684
H D+KPQN+L++ + ++++FGLA+ + + + F + +
Sbjct: 124 HRDLKPQNLLINRNGELKLANFGLARAFGIPVRCYSAEVVTLWYRPPDVLFGAKLYSTSI 183
Query: 685 DVYSYGVLLLEIICLRR---NIDNEISKVDKAILTDWAYDRYQERTLEALVENDLEAMNN 741
D++S G + E+ R ++ ++ + Q ++ L + M
Sbjct: 184 DMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPDYKPYPMYP 243
Query: 742 VTMLHRFVMVAF---------WCIQEDPSHRPTMRKV 769
T V+ ++ +P R + +
Sbjct: 244 ATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEA 280
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 139 bits (350), Expect = 3e-37
Identities = 50/278 (17%), Positives = 98/278 (35%), Gaps = 20/278 (7%)
Query: 507 EELGRGAFGTVYKGFVNMGSSNHVAVKKLNSVFQDSE--KEFKAEVNGIGQTHHKNLVRL 564
E++G G +G VYK N + VA+KK+ + E++ + + +H N+V+L
Sbjct: 8 EKIGEGTYGVVYKA-RNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKL 66
Query: 565 LGYCDEGQNRLLVYEFMSNGTVASFLFGDSKP-NWKLRTEIAMGIAGGLFYLHEECCTQI 623
L LV+EF+ L + GL + H +
Sbjct: 67 LDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHR---V 123
Query: 624 IHCDIKPQNILLDDHYNARISDFGLAKLLTLDQSHTNTAIRGTKGYVAPEWFRNMPITVK 683
+H D+KPQN+L++ +++DFGLA+ + + +
Sbjct: 124 LHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKYYSTA 183
Query: 684 VDVYSYGVLLLEIICLR------------RNIDNEISKVDKAILTDWAYDRYQERTLEAL 731
VD++S G + E++ R I + D+ + + +
Sbjct: 184 VDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKW 243
Query: 732 VENDLEAMNNVTMLHRFVMVAFWCIQEDPSHRPTMRKV 769
D + + + + DP+ R + +
Sbjct: 244 ARQDFSKVVP-PLDEDGRSLLSQMLHYDPNKRISAKAA 280
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 138 bits (348), Expect = 4e-37
Identities = 58/278 (20%), Positives = 102/278 (36%), Gaps = 46/278 (16%)
Query: 505 FKEELGRGAFGTVYKGFVNMGSSNHVAVKKLN------SVFQDSEKEFKAEVNGIGQ--T 556
LG G FG+VY G + + + VA+K + + EV + + +
Sbjct: 8 VGPLLGSGGFGSVYSG-IRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSS 66
Query: 557 HHKNLVRLLGYCDEGQNRLLVYEFMSNGTVASFLFGDSKP-NWKLRTEIAMGIAGGLFYL 615
++RLL + + + +L+ E + +L + + +
Sbjct: 67 GFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHC 126
Query: 616 HEECCTQIIHCDIKPQNILLD-DHYNARISDFGLAKLLTLDQSHTNTAIRGTKGYVAPEW 674
H ++H DIK +NIL+D + ++ DFG LL + T GT+ Y PEW
Sbjct: 127 HN---CGVLHRDIKDENILIDLNRGELKLIDFGSGALL---KDTVYTDFDGTRVYSPPEW 180
Query: 675 FRNMP-ITVKVDVYSYGVLLLEIICLRR--NIDNEISKVDKAILTDWAYDRYQERTLEAL 731
R V+S G+LL +++C D EI + + + + L
Sbjct: 181 IRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQVFFRQRVSSE------CQHL 234
Query: 732 VENDLEAMNNVTMLHRFVMVAFWCIQEDPSHRPTMRKV 769
+ WC+ PS RPT ++
Sbjct: 235 IR--------------------WCLALRPSDRPTFEEI 252
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 134 bits (339), Expect = 3e-35
Identities = 58/270 (21%), Positives = 101/270 (37%), Gaps = 28/270 (10%)
Query: 505 FKEELGRGAFGTVYKGFVNMGSSNHVAVKKLNSVFQDSEKE---FKAEVNGIGQTHHKNL 561
+ + LG+G FG V + + A+K L ++ E E + T H L
Sbjct: 9 YLKLLGKGTFGKVILV-REKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFL 67
Query: 562 VRLLGYCDEGQNRLLVYEFMSNGTVASFLFGDSKPNWKLRTEIAMGIAGGLFYLHEECCT 621
L V E+ + G + L + + I L YLH
Sbjct: 68 TALKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSR--- 124
Query: 622 QIIHCDIKPQNILLDDHYNARISDFGLAKLLTLDQSHTNTAIRGTKGYVAPEWFRNMPIT 681
+++ DIK +N++LD + +I+DFGL K D + T GT Y+APE +
Sbjct: 125 DVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKT-FCGTPEYLAPEVLEDNDYG 183
Query: 682 VKVDVYSYGVLLLEIICLRRNIDNEISKVDKAILTDWAYDRYQERTLEALVENDLEAMNN 741
VD + GV++ E++C R Y++ ER E ++ ++
Sbjct: 184 RAVDWWGLGVVMYEMMCGRLPF----------------YNQDHERLFELILMEEIRFPRT 227
Query: 742 VT-MLHRFVMVAFWCIQEDPSHRPTMRKVT 770
++ + +++DP R
Sbjct: 228 LSPEAKSLLA---GLLKKDPKQRLGGGPSD 254
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Score = 133 bits (336), Expect = 5e-35
Identities = 50/291 (17%), Positives = 102/291 (35%), Gaps = 32/291 (10%)
Query: 507 EELGRGAFGTVYKGFVNMGSSNHVAVKKLNSVFQDS--EKEFKAEVNGIGQTHHKNLVRL 564
++G+G FG V+K + + VA+KK+ + E+ + H+N+V L
Sbjct: 16 AKIGQGTFGEVFKA-RHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNL 74
Query: 565 LGYCDEGQNR--------LLVYEFMSNGTVASFLFGDSKPNWKLRTEIAMGIAGGLFYLH 616
+ C + LV++F + K + + GL+Y+H
Sbjct: 75 IEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVMQMLLNGLYYIH 134
Query: 617 EECCTQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLDQS---HTNTAIRGTKGYVAPE 673
I+H D+K N+L+ +++DFGLA+ +L ++ + T T Y PE
Sbjct: 135 RNK---ILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTNRVVTLWYRPPE 191
Query: 674 WFRN-MPITVKVDVYSYGVLLLEIICLR-----RNIDNEISKVDKAILTDWAYDRYQERT 727
+D++ G ++ E+ ++++ + + +
Sbjct: 192 LLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITPEVWPNVDN 251
Query: 728 LEALVENDLEAMNNVTMLHRFVMVAF---------WCIQEDPSHRPTMRKV 769
E + +L + R + DP+ R
Sbjct: 252 YELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDA 302
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Score = 134 bits (337), Expect = 7e-35
Identities = 56/286 (19%), Positives = 101/286 (35%), Gaps = 30/286 (10%)
Query: 507 EELGRGAFGTVYKGFVNMGSSNHVAVKKLNSVFQDSEKEFKAEVNGIGQTHHKNLVRLLG 566
+ +G G+FG VY+ S VA+KK+ ++ E+ + + H N+VRL
Sbjct: 26 KVIGNGSFGVVYQA-KLCDSGELVAIKKVLQ----DKRFKNRELQIMRKLDHCNIVRLRY 80
Query: 567 YCDEGQNR------LLVYEFMSNGTVASFLFGDSKP---NWKLRTEIAMGIAGGLFYLHE 617
+ + LV +++ + L Y+H
Sbjct: 81 FFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHS 140
Query: 618 ECCTQIIHCDIKPQNILLD-DHYNARISDFGLAKLLTLDQSHTNTAIRGTKGYVAPEWFR 676
I H DIKPQN+LLD D ++ DFG AK L + I F
Sbjct: 141 FG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLV-RGEPNVSYICSRYYRAPELIFG 196
Query: 677 NMPITVKVDVYSYGVLLLEIICLRR-----NIDNEISKVDKAILT------DWAYDRYQE 725
T +DV+S G +L E++ + + +++ ++ K + T Y E
Sbjct: 197 ATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTE 256
Query: 726 RTLEALVENDLEAMNNVTMLHRFVMVAFWCIQEDPSHRPTMRKVTQ 771
+ + + + + ++ P+ R T +
Sbjct: 257 FKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACA 302
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Score = 128 bits (322), Expect = 7e-33
Identities = 57/267 (21%), Positives = 100/267 (37%), Gaps = 29/267 (10%)
Query: 507 EELGRGAFGTVYKGFVNMGSSNHVAVKKLNSVFQDSEKE---FKAEVNGIGQTHHKNLVR 563
+ LG G+FG V + S NH A+K L+ K+ E + + LV+
Sbjct: 47 KTLGTGSFGRVMLV-KHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVK 105
Query: 564 LLGYCDEGQNRLLVYEFMSNGTVASFLFGDSKPNWKLRTEIAMGIAGGLFYLHEECCTQI 623
L + N +V E+++ G + S L + + A I YLH +
Sbjct: 106 LEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSL---DL 162
Query: 624 IHCDIKPQNILLDDHYNARISDFGLAKLLTLDQSHTNTAIRGTKGYVAPEWFRNMPITVK 683
I+ D+KP+N+L+D +++DFG AK + GT +APE +
Sbjct: 163 IYRDLKPENLLIDQQGYIQVTDFGFAK----RVKGRTWTLCGTPEALAPEIILSKGYNKA 218
Query: 684 VDVYSYGVLLLEIICLRRNIDNEISKVDKAILTDWAYDRYQERTLEALVENDLEAMNNVT 743
VD ++ GVL+ E+ + + E +V + ++ +
Sbjct: 219 VDWWALGVLIYEMAAGYPPF----------------FADQPIQIYEKIVSGKVRFPSHFS 262
Query: 744 MLHRFVMVAFWCIQEDPSHRPTMRKVT 770
+ +Q D + R K
Sbjct: 263 --SDLKDLLRNLLQVDLTKRFGNLKNG 287
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Score = 124 bits (313), Expect = 9e-32
Identities = 70/305 (22%), Positives = 117/305 (38%), Gaps = 38/305 (12%)
Query: 493 FTYKELVEVTRGFK------EELGRGAFGTVYKGFVNMGSSNHVAVKKLNSVFQDSE--K 544
F +E+ + + + +G GA+G V V+ + VA+KKL FQ K
Sbjct: 4 FYRQEVTKTAWEVRAVYRDLQPVGSGAYGAVCSA-VDGRTGAKVAIKKLYRPFQSELFAK 62
Query: 545 EFKAEVNGIGQTHHKNLVRLLGYCDEGQNR------LLVYEFMSNGTVASFLFGDSKPNW 598
E+ + H+N++ LL + LV FM GT L K
Sbjct: 63 RAYRELRLLKHMRHENVIGLLDVFTPDETLDDFTDFYLVMPFM--GTDLGKLMKHEKLGE 120
Query: 599 KLRTEIAMGIAGGLFYLHEECCTQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLDQSH 658
+ + GL Y+H IH D+KP N+ +++ +I DFGLA+
Sbjct: 121 DRIQFLVYQMLKGLRYIHAAGI---IHRDLKPGNLAVNEDCELKILDFGLARQA----DS 173
Query: 659 TNTAIRGTKGYVAPEWFRN-MPITVKVDVYSYGVLLLEIICLR-----RNIDNEISKVDK 712
T T+ Y APE N M T VD++S G ++ E+I + + +++ ++ K
Sbjct: 174 EMTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMK 233
Query: 713 AILT----DWAYDRYQERTLEALVENDLEAMNNVTMLHRFVMVAF----WCIQEDPSHRP 764
T + E +LE + ++L +A + D R
Sbjct: 234 VTGTPPAEFVQRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRV 293
Query: 765 TMRKV 769
T +
Sbjct: 294 TAGEA 298
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Score = 123 bits (309), Expect = 2e-31
Identities = 59/290 (20%), Positives = 113/290 (38%), Gaps = 37/290 (12%)
Query: 505 FKEELGRGAFGTVYKGFVNMGSSNHVAVKKLNSVFQDSEKEFKAEVNGIGQ-THHKNLVR 563
+LGRG + V++ +N+ ++ V VK L +K+ K E+ + N++
Sbjct: 39 LVRKLGRGKYSEVFEA-INITNNEKVVVKILK---PVKKKKIKREIKILENLRGGPNIIT 94
Query: 564 LLGYCDEGQNRL--LVYEFMSNGTVASFLFGDSKPNWKLRTEIAMGIAGGLFYLHEECCT 621
L + +R LV+E ++N I L Y H
Sbjct: 95 LADIVKDPVSRTPALVFEHVNNTDFKQLY---QTLTDYDIRFYMYEILKALDYCHSMG-- 149
Query: 622 QIIHCDIKPQNILLD-DHYNARISDFGLAKLLTLDQSHTNTAIRGTKGYVAPE-WFRNMP 679
I+H D+KP N+++D +H R+ D+GLA+ Q + ++ + PE
Sbjct: 150 -IMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRV--ASRYFKGPELLVDYQM 206
Query: 680 ITVKVDVYSYGVLLLEIICLR------RNIDNEISKVDKAILTDWAYDRYQERTLEALVE 733
+D++S G +L +I + + +++ ++ K + T+ YD + +E
Sbjct: 207 YDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIELDPR 266
Query: 734 -NDLEAMNNVTMLHRFVMVAFW-------------CIQEDPSHRPTMRKV 769
ND+ ++ RFV ++ D R T R+
Sbjct: 267 FNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREA 316
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 119 bits (299), Expect = 4e-30
Identities = 58/281 (20%), Positives = 106/281 (37%), Gaps = 38/281 (13%)
Query: 505 FKEELGRGAFGTVYKGF--VNMGSSNHVAVKKLN--SVFQDSE--KEFKAEVNGIGQ-TH 557
+ LG GA+G V+ + A+K L ++ Q ++ + + E +
Sbjct: 28 LLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQ 87
Query: 558 HKNLVRLLGYCDEGQNRLLVYEFMSNGTVASFLFGDSKPNWKLRTEIAMGIAGGLFYLHE 617
LV L L+ ++++ G + + L + I L +LH+
Sbjct: 88 SPFLVTLHYAFQTETKLHLILDYINGGELFTHLSQRERFTEHEVQIYVGEIVLALEHLHK 147
Query: 618 ECCTQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLDQSHTNTAIRGTKGYVAPEWFRN 677
II+ DIK +NILLD + + ++DFGL+K D++ GT Y+AP+ R
Sbjct: 148 L---GIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETERAYDFCGTIEYMAPDIVRG 204
Query: 678 MP--ITVKVDVYSYGVLLLEIICLRR-----NIDNEISKVDKAILT-DWAYDRYQERTLE 729
VD +S GVL+ E++ N +++ + IL + Y + +
Sbjct: 205 GDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEPPYPQEMSALAK 264
Query: 730 ALVENDLEAMNNVTMLHRFVMVAFWCIQEDPSHRPTMRKVT 770
L++ + +DP R
Sbjct: 265 DLIQ--------------------RLLMKDPKKRLGCGPRD 285
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Score = 119 bits (299), Expect = 6e-30
Identities = 67/295 (22%), Positives = 119/295 (40%), Gaps = 41/295 (13%)
Query: 507 EELGRGAFGTVYKGFVNMGSSNHVAVKKLNSVFQDSE--KEFKAEVNGIGQTHHKNLVRL 564
+ +G GA G V + +VA+KKL+ FQ+ K E+ + +HKN++ L
Sbjct: 23 KPIGSGAQGIVCAA-YDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISL 81
Query: 565 LGYC------DEGQNRLLVYEFMSNGTVASFLFGDSKPNWKLRTEIAMGIAGGLFYLHEE 618
L +E Q+ LV E M + + + + + + G+ +LH
Sbjct: 82 LNVFTPQKTLEEFQDVYLVMELMDANL---CQVIQMELDHERMSYLLYQMLCGIKHLHSA 138
Query: 619 CCTQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLDQSHTNTAIRGTKGYVAPEWFRNM 678
IH D+KP NI++ +I DFGLA+ T S T T+ Y APE M
Sbjct: 139 GI---IHRDLKPSNIVVKSDCTLKILDFGLAR--TAGTSFMMTPYVVTRYYRAPEVILGM 193
Query: 679 PITVKVDVYSYGVLLLEIICLR-----RNIDNEISKVDKAILTDWAYD------------ 721
VD++S G ++ E++ + R+ ++ +KV + + T
Sbjct: 194 GYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRNYV 253
Query: 722 ----RYQERTLEALVENDL---EAMNNVTMLHRFVMVAFWCIQEDPSHRPTMRKV 769
+Y T L + L ++ +N + + + DP+ R ++
Sbjct: 254 ENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDA 308
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Score = 111 bits (279), Expect = 2e-27
Identities = 61/296 (20%), Positives = 107/296 (36%), Gaps = 30/296 (10%)
Query: 496 KELVEVTRGFK--EELGRGAFGTVYKGFVNMGSSNHVAVKKLNSVFQDSE--KEFKAEVN 551
K + EV ++ +G GA+G+V + + VAVKKL+ FQ K E+
Sbjct: 11 KTIWEVPERYQNLSPVGSGAYGSVCAA-FDTKTGLRVAVKKLSRPFQSIIHAKRTYRELR 69
Query: 552 GIGQTHHKNLVRLLGYCDEGQ----NRLLVYEFMSNGTVASFLFGDSKPNWKLRTEIAMG 607
+ H+N++ LL + + G + + K +
Sbjct: 70 LLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQ 129
Query: 608 IAGGLFYLHEECCTQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLDQSHTNTAIRGTK 667
I GL Y+H IH D+KP N+ +++ +I DFGLA+ T T+
Sbjct: 130 ILRGLKYIHSADI---IHRDLKPSNLAVNEDCELKILDFGLAR----HTDDEMTGYVATR 182
Query: 668 GYVAPEWFRN-MPITVKVDVYSYGVLLLEIICLRRNIDNEISKVDKAILTDWAYDRYQER 726
Y APE N M VD++S G ++ E++ R ++ E
Sbjct: 183 WYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAEL 242
Query: 727 TLEALVENDLEAMNNVTMLHRFVMVAFW-------------CIQEDPSHRPTMRKV 769
+ E+ + ++T + + + + D R T +
Sbjct: 243 LKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQA 298
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 102 bits (253), Expect = 6e-24
Identities = 46/213 (21%), Positives = 82/213 (38%), Gaps = 20/213 (9%)
Query: 505 FKEELGRGAFGTVYKGFVNMGSSNHVAVKKLNS---VFQDSEKEFK-------AEVNGIG 554
+LG G F TV+ +M ++ HVA+K + + +E E K A+
Sbjct: 17 LVRKLGWGHFSTVWLA-KDMVNNTHVAMKIVRGDKVYTEAAEDEIKLLQRVNDADNTKED 75
Query: 555 QTHHKNLVRLLGYCDEGQNRLLVYEFMSNGTVASFLFGDSKPNWKLRTE-----IAMGIA 609
++++LL + + + + + L K + I+ +
Sbjct: 76 SMGANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLL 135
Query: 610 GGLFYLHEECCTQIIHCDIKPQNILLD-DHYNARISDFGLAKLLTLDQSHTNTA-IRGTK 667
GL Y+H C IIH DIKP+N+L++ + +A L + T+
Sbjct: 136 LGLDYMHRRCG--IIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHYTNSIQTR 193
Query: 668 GYVAPEWFRNMPITVKVDVYSYGVLLLEIICLR 700
Y +PE P D++S L+ E+I
Sbjct: 194 EYRSPEVLLGAPWGCGADIWSTACLIFELITGD 226
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Score = 80.2 bits (197), Expect = 7e-18
Identities = 26/201 (12%), Positives = 58/201 (28%), Gaps = 27/201 (13%)
Query: 507 EELGRGAFGTVYKGFVNMGSSNHVAVK----------KLNSVFQDSEKEFKAEVNGIGQT 556
+ +G G V+ + VK K+ + F +
Sbjct: 6 KLMGEGKESAVFNCYSEKF--GECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARN 63
Query: 557 HHKNLVRLLGYCDEGQNRLLVYEFMSNGTVASFLFGDSKPNWKLRT--EIAMGIAGGLFY 614
+ L +L G Y + N + + ++ E+ I +
Sbjct: 64 EFRALQKLQGLAVPKV-----YAWEGNAVLMELIDAKELYRVRVENPDEVLDMILEEVAK 118
Query: 615 LHEECCTQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLDQSHTNTAIRGTKGYVAPEW 674
+ I+H D+ N+L+ + I DF + + + + + +
Sbjct: 119 FYHRG---IVHGDLSQYNVLVSEE-GIWIIDFPQSV--EVGEEGWREILERDVRNII-TY 171
Query: 675 FRNMPITVKVDVYSYGVLLLE 695
F + D+ S +L+
Sbjct: 172 FSR-TYRTEKDINSAIDRILQ 191
|
| >d1kj1a_ b.78.1.1 (A:) Lectin (agglutinin) {Garlic (Allium sativum) [TaxId: 4682]} Length = 109 | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Lectin (agglutinin) species: Garlic (Allium sativum) [TaxId: 4682]
Score = 58.0 bits (140), Expect = 6e-11
Identities = 27/123 (21%), Positives = 51/123 (41%), Gaps = 18/123 (14%)
Query: 25 TISIGQQLTAAESTEPWLSPSKDFALGFHQLDSKDLFLPAIWYYKIPSKTIVWYASAVNP 84
++ G+ L A +S + + + +D L + Y T VW ++
Sbjct: 3 LLTNGEGLYAGQSLD-----VEPYHFIM----QEDCNL--VLYD---HSTSVWASNTGIL 48
Query: 85 APRGSKLRLTANRGLVLEDPEGREIWKSEISTGQAAFG-VLYDTGNFLIVNTNSERLWQS 143
+G K L ++ V+ D EGR +W S G + VL + GN +I ++ +W +
Sbjct: 49 GKKGCKAVLQSDGNFVVYDAEGRSLWASHSVRGNGNYVLVLQEDGNVVIYGSD---IWST 105
Query: 144 FDH 146
+
Sbjct: 106 GTY 108
|
| >d1kj1a_ b.78.1.1 (A:) Lectin (agglutinin) {Garlic (Allium sativum) [TaxId: 4682]} Length = 109 | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Lectin (agglutinin) species: Garlic (Allium sativum) [TaxId: 4682]
Score = 41.9 bits (98), Expect = 2e-05
Identities = 23/120 (19%), Positives = 39/120 (32%), Gaps = 20/120 (16%)
Query: 149 DTLLPTQTMERGGVVSSRRKDTYFSRGRFQFRLLEDGNAVLNTINLESGFAYDAYFWSNT 208
+ L + + G + + F + ED N VL + + + SNT
Sbjct: 2 NLLTNGEGLYAGQSLDV---------EPYHFIMQEDCNLVLYDHS-------TSVWASNT 45
Query: 209 FDTNRSNAGYRVVFNESGQLYVLRENKQRASLVPETVSAKENYLRATLNFDGVFIFYSHP 268
G + V G V+ + + R+ +V NY L DG + Y
Sbjct: 46 --GILGKKGCKAVLQSDGNF-VVYDAEGRSLWASHSVRGNGNY-VLVLQEDGNVVIYGSD 101
|
| >d1dlpa2 b.78.1.1 (A:116-235) Fetuin-binding protein Scafet precursor {Bluebell (Scilla campanulata) [TaxId: 81759]} Length = 120 | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Fetuin-binding protein Scafet precursor species: Bluebell (Scilla campanulata) [TaxId: 81759]
Score = 56.9 bits (137), Expect = 2e-10
Identities = 22/126 (17%), Positives = 34/126 (26%), Gaps = 26/126 (20%)
Query: 65 IWYYKIPSKTIVWYASAVNPAPRGS-KLRLTANRGLVLEDPEGREIWKSEISTGQAAFGV 123
I Y + A +L + + LVL D + R + G V
Sbjct: 12 ILYSTQGNDNHPQTLHATQSLQLSPYRLSMETDCNLVLFDRDDRVWSTNTAGKGTGCRAV 71
Query: 124 LYDTGNFLIVNTNSERLWQSFDHPTDTLLPTQTMERGGVVSSRRKDTYFSRGRFQFRLLE 183
L G ++ + +W S S GR+ F L
Sbjct: 72 LQPNGRMDVLTNQNIAVWTSG-------------------------NSRSAGRYVFVLQP 106
Query: 184 DGNAVL 189
D N +
Sbjct: 107 DRNLAI 112
|
| >d1xd5a_ b.78.1.1 (A:) Gastrodianin (antifungal protein) {Gastrodia elata [TaxId: 91201]} Length = 112 | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Gastrodianin (antifungal protein) species: Gastrodia elata [TaxId: 91201]
Score = 52.1 bits (124), Expect = 7e-09
Identities = 18/125 (14%), Positives = 39/125 (31%), Gaps = 15/125 (12%)
Query: 25 TISIGQQLTAAESTEPWLSPSKDFALGFHQLDSKDLFLPAIWYYKIPSKTIVWYASAVNP 84
++ G QL S + Q D + Y + VW +
Sbjct: 3 RLNSGHQLDTGGS-----LAEGGYLFII-QNDCNL-----VLYD---NNRAVWASGTNGK 48
Query: 85 APRGSKLRLTANRGLVLEDPEGREIWKSEISTGQAAFGVLYDTGNFLIVNTNSERLWQSF 144
A G L++ + LV+ + + +L N +I + ++ +W +
Sbjct: 49 A-SGCVLKMQNDGNLVIYSGSRAIWASNTNRQNGNYYLILQRDRNVVIYDNSNNAIWATH 107
Query: 145 DHPTD 149
+ +
Sbjct: 108 TNVGN 112
|
| >d1xd5a_ b.78.1.1 (A:) Gastrodianin (antifungal protein) {Gastrodia elata [TaxId: 91201]} Length = 112 | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Gastrodianin (antifungal protein) species: Gastrodia elata [TaxId: 91201]
Score = 52.1 bits (124), Expect = 8e-09
Identities = 20/132 (15%), Positives = 45/132 (34%), Gaps = 27/132 (20%)
Query: 148 TDTLLPTQTMERGGVVSSRRKDTYFSRGRFQFRLLEDGNAVLNTINLESGFAYDAYFWSN 207
+D L ++ GG ++ G + F + D N VL + + W++
Sbjct: 1 SDRLNSGHQLDTGGSLAE---------GGYLFIIQNDCNLVL--------YDNNRAVWAS 43
Query: 208 TFDTNRSNAGYRVVFNESGQLYVLRENKQRASLVPETVSAKENYLRATLNFDGVFIFYSH 267
+ S + G L + ++ + + + L D + Y
Sbjct: 44 GTNGKASGC--VLKMQNDGNLVIYSGSRAIWA---SNTNRQNGNYYLILQRDRNVVIY-- 96
Query: 268 PKNNSTGDAIWS 279
+++ +AIW+
Sbjct: 97 ---DNSNNAIWA 105
|
| >d1b2pa_ b.78.1.1 (A:) Lectin (agglutinin) {Bluebell (Scilla campanulata) [TaxId: 81759]} Length = 119 | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Lectin (agglutinin) species: Bluebell (Scilla campanulata) [TaxId: 81759]
Score = 50.0 bits (119), Expect = 5e-08
Identities = 27/139 (19%), Positives = 43/139 (30%), Gaps = 31/139 (22%)
Query: 141 WQSFDHPTDTLLPTQTMERGGVVSSRRKDTYFSRGRFQFRLLEDGNAVLNTINLESGFAY 200
Q D+ L T+++E F ++F + D N VL
Sbjct: 7 KQPDDNHPQILHATESLE-----------ILFGTHVYRFIMQTDCNLVLYD-------NN 48
Query: 201 DAYFWSNTFDTNRSNAGYRVVFNESGQLYVLRENKQRASLVPETVSAKENYLRATLNFDG 260
+ + +N T G R V G V+ N+ +Y L D
Sbjct: 49 NPIWATN---TGGLGNGCRAVLQPDGV-LVVITNENVTVWQSPVAGKAGHY-VLVLQPDR 103
Query: 261 VFIFYSHPKNNSTGDAIWS 279
+ Y GDA+W+
Sbjct: 104 NVVIY--------GDALWA 114
|
| >d1dlpa1 b.78.1.1 (A:1-115) Fetuin-binding protein Scafet precursor {Bluebell (Scilla campanulata) [TaxId: 81759]} Length = 115 | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Fetuin-binding protein Scafet precursor species: Bluebell (Scilla campanulata) [TaxId: 81759]
Score = 48.4 bits (115), Expect = 1e-07
Identities = 23/150 (15%), Positives = 38/150 (25%), Gaps = 39/150 (26%)
Query: 65 IWYYKIPSKTIVWYASAVNPAPRGS-KLRLTANRGLVLEDPEGREIWKSEISTGQAAFGV 123
I + + A S + + ++ LVL D +W S + V
Sbjct: 3 ILFGLSHEGSHPQTLHAAQSLELSSFRFTMQSDCNLVLFDS-DVRVWASNTAGATGCRAV 61
Query: 124 LYDTGNFLIVNTNSERLWQSFDHPTDTLLPTQTMERGGVVSSRRKDTYFSRGRFQFRLLE 183
L G +I+ + W S T S G + L
Sbjct: 62 LQSDGLLVILTAQNTIRWSSG-------------------------TKGSIGNYVLVLQP 96
Query: 184 DGNAVLNTINLESGFAYDAYFWSNTFDTNR 213
D + Y W + T+
Sbjct: 97 DRTVTI----------YGPGLWDS--GTSN 114
|
| >d1jpca_ b.78.1.1 (A:) Lectin (agglutinin) {Snowdrop (Galanthus nivalis) [TaxId: 4670]} Length = 108 | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Lectin (agglutinin) species: Snowdrop (Galanthus nivalis) [TaxId: 4670]
Score = 44.2 bits (104), Expect = 4e-06
Identities = 22/124 (17%), Positives = 37/124 (29%), Gaps = 21/124 (16%)
Query: 149 DTLLPTQTMERGGVVSSRRKDTYFSRGRFQFRLLEDGNAVLNTINLESGFAYDAYFWSNT 208
+ L +T+ G ++ G F F + ED N VL + D W+
Sbjct: 2 NILYSGETLSTGEFLNY---------GSFVFIMQEDCNLVL--------YDVDKPIWATN 44
Query: 209 FDTNRSNAGYRVVFNESGQLYVLRENKQRASLVPETVSAKENYLRATLNFDGVFIFYSHP 268
+ + G L V+ + T NY L D + Y
Sbjct: 45 TGGLSRSC--FLSMQTDGNL-VVYNPSNKPIWASNTGGQNGNY-VCILQKDRNVVIYGTD 100
Query: 269 KNNS 272
+ +
Sbjct: 101 RWAT 104
|
| >d1jpca_ b.78.1.1 (A:) Lectin (agglutinin) {Snowdrop (Galanthus nivalis) [TaxId: 4670]} Length = 108 | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Lectin (agglutinin) species: Snowdrop (Galanthus nivalis) [TaxId: 4670]
Score = 42.7 bits (100), Expect = 1e-05
Identities = 15/74 (20%), Positives = 27/74 (36%), Gaps = 5/74 (6%)
Query: 74 TIVWYASAVNPAPRGSKLRLTANRGLVLEDPEGREIWKSEIS-TGQAAFGVLYDTGNFLI 132
+W + + R L + + LV+ +P + IW S +L N +I
Sbjct: 38 KPIWATNTGGLS-RSCFLSMQTDGNLVVYNPSNKPIWASNTGGQNGNYVCILQKDRNVVI 96
Query: 133 VNTNSERLWQSFDH 146
T+ W + H
Sbjct: 97 YGTD---RWATGTH 107
|
Homologous Domains Detected by HHsearch 
Original result of HHsearch against SCOP70(version1.75) database
ID ![]() | Alignment Graph ![]() | Length ![]() |
Definition ![]() |
Probability ![]() |
| Query | 792 | |||
| d1jpaa_ | 299 | ephb2 receptor tyrosine kinase {Mouse (Mus musculu | 100.0 | |
| d1sm2a_ | 263 | Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie | 100.0 | |
| d1opja_ | 287 | Abelsone tyrosine kinase (abl) {Mouse (Mus musculu | 100.0 | |
| d1qpca_ | 272 | Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax | 100.0 | |
| d1nvra_ | 271 | Cell cycle checkpoint kinase chk1 {Human (Homo sap | 100.0 | |
| d1xbba_ | 277 | Tyrosine-protein kinase SYK {Human (Homo sapiens) | 100.0 | |
| d1uwha_ | 276 | B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1k2pa_ | 258 | Bruton's tyrosine kinase (Btk) {Human (Homo sapien | 100.0 | |
| d1fmka3 | 285 | c-src tyrosine kinase {Human (Homo sapiens) [TaxId | 100.0 | |
| d1mqba_ | 283 | epha2 receptor tyrosine kinase {Human (Homo sapien | 100.0 | |
| d2j4za1 | 263 | Aurora-related kinase 1 (aurora-2) {Human (Homo sa | 100.0 | |
| d1u59a_ | 285 | Tyrosine-protein kinase ZAP-70 {Human (Homo sapien | 100.0 | |
| d1yhwa1 | 293 | pak1 {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1t4ha_ | 270 | Protein kinase wnk1 {Human (Homo sapiens) [TaxId: | 100.0 | |
| d2java1 | 269 | Serine/threonine-protein kinase Nek2 {Human (Homo | 100.0 | |
| d1s9ja_ | 322 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| d1rjba_ | 325 | Fl cytokine receptor {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1uu3a_ | 288 | 3-phosphoinositide dependent protein kinase-1 Pdk1 | 100.0 | |
| d2jfla1 | 288 | STE20-like serine/threonine-protein kinase, SLK {H | 100.0 | |
| d1a06a_ | 307 | Calmodulin-dependent protein kinase {Rat (Rattus n | 100.0 | |
| d1u5ra_ | 309 | Serine/threonine protein kinase TAO2 {Rat (Rattus | 100.0 | |
| d1r0pa_ | 311 | Hepatocyte growth factor receptor, c-MET {Human (H | 100.0 | |
| d1lufa_ | 301 | Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1koaa2 | 350 | Twitchin, kinase domain {Caenorhabditis elegans, p | 100.0 | |
| d1mp8a_ | 273 | Focal adhesion kinase 1 (fak) {Human (Homo sapiens | 100.0 | |
| d1jksa_ | 293 | Death-associated protein kinase, Dap {Human (Homo | 100.0 | |
| d1koba_ | 352 | Twitchin, kinase domain {California sea hare (Aply | 100.0 | |
| d1byga_ | 262 | Carboxyl-terminal src kinase (csk) {Human (Homo sa | 100.0 | |
| d1u46a_ | 273 | Activated CDC42 kinase 1, ACK1 {Human (Homo sapien | 100.0 | |
| d1o6la_ | 337 | Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9 | 100.0 | |
| d1fvra_ | 309 | Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1ywna1 | 299 | Vascular endothelial growth factor receptor 2 (kdr | 100.0 | |
| d1xkka_ | 317 | EGF receptor tyrosine kinase, Erbb-1 {Human (Homo | 100.0 | |
| d1fota_ | 316 | cAMP-dependent PK, catalytic subunit {Baker's yeas | 100.0 | |
| d1t46a_ | 311 | c-KIT receptor {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1fgka_ | 299 | Fibroblast growth factor receptor 1 {Human (Homo s | 100.0 | |
| d1p4oa_ | 308 | Insulin-like growth factor 1 receptor {Human (Homo | 100.0 | |
| d1vjya_ | 303 | Type I TGF-beta receptor R4 {Human (Homo sapiens) | 100.0 | |
| d1ua2a_ | 299 | Cell division protein kinase 7, CDK7 {Human (Homo | 100.0 | |
| d1rdqe_ | 350 | cAMP-dependent PK, catalytic subunit {Mouse (Mus m | 100.0 | |
| d1o6ya_ | 277 | Mycobacterial protein kinase PknB, catalytic domai | 100.0 | |
| d1xjda_ | 320 | Protein kinase C, theta type {Human (Homo sapiens) | 100.0 | |
| d1phka_ | 277 | gamma-subunit of glycogen phosphorylase kinase (Ph | 100.0 | |
| d1omwa3 | 364 | G-protein coupled receptor kinase 2 {Cow (Bos taur | 100.0 | |
| d1tkia_ | 321 | Titin, kinase domain {Human (Homo sapiens) [TaxId: | 100.0 | |
| d2ozaa1 | 335 | MAP kinase activated protein kinase 2, mapkap2 {Hu | 100.0 | |
| d1gz8a_ | 298 | Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T | 100.0 | |
| d1xwsa_ | 273 | Proto-oncogene serine/threonine-protein kinase Pim | 100.0 | |
| d1blxa_ | 305 | Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T | 100.0 | |
| d1ob3a_ | 286 | Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) | 100.0 | |
| d3blha1 | 318 | Cell division protein kinase 9, CDK9 {Human (Homo | 100.0 | |
| d1vzoa_ | 322 | Ribosomal protein S6 kinase alpha 5, Msk1 {Human ( | 100.0 | |
| d1unla_ | 292 | Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T | 100.0 | |
| d1ckia_ | 299 | Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1q5ka_ | 350 | Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho | 100.0 | |
| d1pmea_ | 345 | MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606 | 100.0 | |
| d1cm8a_ | 346 | MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: | 100.0 | |
| d3bqca1 | 328 | Protein kinase CK2, alpha subunit {Rattus norvegic | 100.0 | |
| d1csna_ | 293 | Casein kinase-1, CK1 {Fission yeast (Schizosacchar | 100.0 | |
| d2b1pa1 | 355 | c-jun N-terminal kinase (jnk3s) {Human (Homo sapie | 100.0 | |
| d2gfsa1 | 348 | MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1q8ya_ | 362 | Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T | 100.0 | |
| d1zara2 | 191 | Rio2 serine protein kinase C-terminal domain {Arch | 99.83 | |
| d1xd5a_ | 112 | Gastrodianin (antifungal protein) {Gastrodia elata | 99.82 | |
| d1kj1a_ | 109 | Lectin (agglutinin) {Garlic (Allium sativum) [TaxI | 99.8 | |
| d1jpca_ | 108 | Lectin (agglutinin) {Snowdrop (Galanthus nivalis) | 99.79 | |
| d1dlpa2 | 120 | Fetuin-binding protein Scafet precursor {Bluebell | 99.73 | |
| d1dlpa1 | 115 | Fetuin-binding protein Scafet precursor {Bluebell | 99.65 | |
| d1b2pa_ | 119 | Lectin (agglutinin) {Bluebell (Scilla campanulata) | 99.54 | |
| d1dlpa1 | 115 | Fetuin-binding protein Scafet precursor {Bluebell | 99.3 | |
| d1dlpa2 | 120 | Fetuin-binding protein Scafet precursor {Bluebell | 99.16 | |
| d1b2pa_ | 119 | Lectin (agglutinin) {Bluebell (Scilla campanulata) | 99.12 | |
| d1jpca_ | 108 | Lectin (agglutinin) {Snowdrop (Galanthus nivalis) | 99.06 | |
| d1kj1a_ | 109 | Lectin (agglutinin) {Garlic (Allium sativum) [TaxI | 99.02 | |
| d1xd5a_ | 112 | Gastrodianin (antifungal protein) {Gastrodia elata | 98.97 | |
| d1j7la_ | 263 | Type IIIa 3',5"-aminoglycoside phosphotransferase | 98.16 | |
| d1nd4a_ | 255 | Aminoglycoside 3'-phosphotransferase IIa (Kanamyci | 97.5 | |
| d2pula1 | 392 | Methylthioribose kinase MtnK {Bacillus subtilis [T | 97.09 | |
| d1zyla1 | 325 | RdoA {Escherichia coli [TaxId: 562]} | 96.57 | |
| d1nw1a_ | 395 | Choline kinase {Caenorhabditis elegans [TaxId: 623 | 95.67 | |
| d2ppqa1 | 316 | Homoserine kinase ThrB {Agrobacterium tumefaciens | 94.26 | |
| d1emoa2 | 39 | Fibrillin-1 {Human (Homo sapiens) [TaxId: 9606]} | 92.52 | |
| d2vj3a1 | 42 | Neurogenic locus notch homolog protein 1, Notch1 { | 88.34 | |
| d1lmja2 | 42 | Fibrillin-1 {Human (Homo sapiens) [TaxId: 9606]} | 86.64 | |
| d1xkba1 | 39 | Factor X, N-terminal module {Human (Homo sapiens) | 86.46 | |
| d1emoa1 | 43 | Fibrillin-1 {Human (Homo sapiens) [TaxId: 9606]} | 86.18 | |
| d2vj3a2 | 39 | Neurogenic locus notch homolog protein 1, Notch1 { | 85.42 | |
| d1q4ga2 | 42 | Prostaglandin H2 synthase-1, EGF-like module {Shee | 84.95 | |
| d1uzka2 | 43 | Fibrillin-1 {Human (Homo sapiens) [TaxId: 9606]} | 82.56 | |
| d1gl4a2 | 40 | EGF-like domain of nidogen-1 {Mouse (Mus musculus) | 81.76 | |
| d2vj3a3 | 35 | Neurogenic locus notch homolog protein 1, Notch1 { | 81.57 | |
| d1edmb_ | 39 | Factor IX (IXa) {Human (Homo sapiens) [TaxId: 9606 | 81.37 |
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=6.5e-50 Score=421.83 Aligned_cols=269 Identities=26% Similarity=0.451 Sum_probs=209.6
Q ss_pred cccCHHHHHHHHhhhh-----------hhcCccccceEEEeeecCCC--ceEEEEEEccccc-ccchHHHHHHHHHhccc
Q 003836 491 RCFTYKELVEVTRGFK-----------EELGRGAFGTVYKGFVNMGS--SNHVAVKKLNSVF-QDSEKEFKAEVNGIGQT 556 (792)
Q Consensus 491 ~~~~~~el~~~~~~~~-----------~~lG~G~~g~Vy~g~~~~~~--~~~vavK~~~~~~-~~~~~~~~~Ei~~l~~l 556 (792)
..++|+++.+++.+|. ++||+|+||+||+|.+.... ...||||++.... ....++|.+|+++|+++
T Consensus 5 d~~t~~d~~~a~~~f~~~i~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l 84 (299)
T d1jpaa_ 5 DPFTFEDPNEAVREFAKEIDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQF 84 (299)
T ss_dssp CGGGSSSHHHHHHHHSCBCCGGGEEEEEEEEECSSSEEEEEEECC---CCEEEEEEECCSSCCHHHHHHHHHHHHHHTTC
T ss_pred CCCCHHHHHHHHhhhchhhChhhcEEeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhC
Confidence 3567778888877764 46999999999999875332 2368999987543 33456899999999999
Q ss_pred CCCCcccccceeccCCceEEEEEeccCCCccccccCC-CCCchhHHHHHHHHHHHHHHHHhhccCCCeEecCCCCCcEEE
Q 003836 557 HHKNLVRLLGYCDEGQNRLLVYEFMSNGTVASFLFGD-SKPNWKLRTEIAMGIAGGLFYLHEECCTQIIHCDIKPQNILL 635 (792)
Q Consensus 557 ~h~niv~l~g~~~~~~~~~lV~E~~~~gsL~~~l~~~-~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dikp~NILl 635 (792)
+|||||+++|+|.+++..++||||+++|+|.+++... ..+++.++.+|+.||++||+|||++ +|+||||||+||||
T Consensus 85 ~HpnIv~l~g~~~~~~~~~iv~Ey~~~g~L~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~---~iiHrDlKp~NILl 161 (299)
T d1jpaa_ 85 DHPNVIHLEGVVTKSTPVMIITEFMENGSLDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLADM---NYVHRDLAARNILV 161 (299)
T ss_dssp CCTTBCCEEEEECSSSSCEEEEECCTTEEHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEE
T ss_pred CCCCCccEEEEEeeCCEEEEEEEecCCCcceeeeccccCCCCHHHHHHHHHHHHHHHHHHhhC---CCccCccccceEEE
Confidence 9999999999999999999999999999999988775 5689999999999999999999998 99999999999999
Q ss_pred cCCCCeEEeecCCCccccCCCCCc----cccccccCCcccccccccCCCCcccceehHHHHHHHHHh-cCcCCCcchhhh
Q 003836 636 DDHYNARISDFGLAKLLTLDQSHT----NTAIRGTKGYVAPEWFRNMPITVKVDVYSYGVLLLEIIC-LRRNIDNEISKV 710 (792)
Q Consensus 636 ~~~~~~kl~Dfg~a~~~~~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~k~DV~S~Gv~l~el~t-g~~p~~~~~~~~ 710 (792)
+.++.+||+|||+++......... .....||+.|||||.+.+..++.++|||||||++|||+| |+.||.......
T Consensus 162 ~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~sDvwS~Gvvl~el~t~g~~Pf~~~~~~~ 241 (299)
T d1jpaa_ 162 NSNLVCKVSDFGLSRFLEDDTSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMTNQD 241 (299)
T ss_dssp CTTCCEEECCC-----------------------CGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHH
T ss_pred CCCCcEEECCcccceEccCCCCcceeeecccccCCccccCHHHHhcCCCCcccccccchHHHHHHHhCCCCCCCCCCHHH
Confidence 999999999999999775443322 122457899999999999999999999999999999998 899986543211
Q ss_pred hhhhHHHHHHHhhcccchhHhhhchhcccCCHHHHHHHHHHHHHccccCCCCCCCHHhHHHHhccCcCC
Q 003836 711 DKAILTDWAYDRYQERTLEALVENDLEAMNNVTMLHRFVMVAFWCIQEDPSHRPTMRKVTQMLEGVVEV 779 (792)
Q Consensus 711 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~L~~~~~~ 779 (792)
+...+........+...++.+.+++.+||+.||++||||+||++.|+++++-
T Consensus 242 -----------------~~~~i~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~ei~~~L~~~l~~ 293 (299)
T d1jpaa_ 242 -----------------VINAIEQDYRLPPPMDCPSALHQLMLDCWQKDRNHRPKFGQIVNTLDKMIRN 293 (299)
T ss_dssp -----------------HHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHS
T ss_pred -----------------HHHHHHcCCCCCCCccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhcC
Confidence 0111112222333445667889999999999999999999999999987653
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.6e-50 Score=413.94 Aligned_cols=253 Identities=25% Similarity=0.430 Sum_probs=198.1
Q ss_pred hhhhhcCccccceEEEeeecCCCceEEEEEEcccccccchHHHHHHHHHhcccCCCCcccccceeccCCceEEEEEeccC
Q 003836 504 GFKEELGRGAFGTVYKGFVNMGSSNHVAVKKLNSVFQDSEKEFKAEVNGIGQTHHKNLVRLLGYCDEGQNRLLVYEFMSN 583 (792)
Q Consensus 504 ~~~~~lG~G~~g~Vy~g~~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~lV~E~~~~ 583 (792)
.+.++||+|+||+||+|.+. +++.||||+++.. ....++|.+|++++++++|||||+++|+|.+.+..++||||+++
T Consensus 8 ~~~~~iG~G~fg~Vy~~~~~--~~~~vAvK~i~~~-~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~lv~E~~~~ 84 (263)
T d1sm2a_ 8 TFVQEIGSGQFGLVHLGYWL--NKDKVAIKTIREG-AMSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFMEH 84 (263)
T ss_dssp EEEEEEECCSSCCEEEEEET--TTEEEEEEECCSS-SSCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCTT
T ss_pred EEEEEEeeCCCeEEEEEEEC--CCCEEEEEEECCC-cCcHHHHHHHHHHHHhcCCCCcccccceeccCCceEEEEEecCC
Confidence 35678999999999999865 3467999999764 44567899999999999999999999999999999999999999
Q ss_pred CCccccccCC-CCCchhHHHHHHHHHHHHHHHHhhccCCCeEecCCCCCcEEEcCCCCeEEeecCCCccccCCCCCcccc
Q 003836 584 GTVASFLFGD-SKPNWKLRTEIAMGIAGGLFYLHEECCTQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLDQSHTNTA 662 (792)
Q Consensus 584 gsL~~~l~~~-~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dikp~NILl~~~~~~kl~Dfg~a~~~~~~~~~~~~~ 662 (792)
|+|.+++... ..+++..+..|+.|||+||+|||+. +|+||||||+|||+++++.+||+|||+++............
T Consensus 85 g~L~~~l~~~~~~~~~~~~~~i~~qia~gl~~lH~~---~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~~~~~~~~ 161 (263)
T d1sm2a_ 85 GCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEA---CVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTG 161 (263)
T ss_dssp CBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHT---TCCCTTCSGGGEEECGGGCEEECSCC---------------
T ss_pred CcHHHHhhccccCCCHHHHHHHHHHHHHHHHhhhcc---ceeecccchhheeecCCCCeEecccchheeccCCCceeecc
Confidence 9999998765 5688999999999999999999998 99999999999999999999999999998776554444445
Q ss_pred ccccCCcccccccccCCCCcccceehHHHHHHHHHhcCcCCCcchhhhhhhhHHHHHHHhhcccchhHhhhchhcccCCH
Q 003836 663 IRGTKGYVAPEWFRNMPITVKVDVYSYGVLLLEIICLRRNIDNEISKVDKAILTDWAYDRYQERTLEALVENDLEAMNNV 742 (792)
Q Consensus 663 ~~gt~~y~aPE~~~~~~~~~k~DV~S~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 742 (792)
..||+.|+|||.+.+..++.++|||||||++|||+|++.|+.......+ .+ ..+........+.
T Consensus 162 ~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvil~el~t~~~~~~~~~~~~~--~~--------------~~i~~~~~~~~p~ 225 (263)
T d1sm2a_ 162 TKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSE--VV--------------EDISTGFRLYKPR 225 (263)
T ss_dssp ---CTTSCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSCCHHH--HH--------------HHHHHTCCCCCCT
T ss_pred eecCcccCChHHhcCCCCCchhhhcchHHHHHHHHHCCCCCCCCCCHHH--HH--------------HHHHhcCCCCCcc
Confidence 6789999999999999999999999999999999996655543222111 00 0111111222233
Q ss_pred HHHHHHHHHHHHccccCCCCCCCHHhHHHHhccCcC
Q 003836 743 TMLHRFVMVAFWCIQEDPSHRPTMRKVTQMLEGVVE 778 (792)
Q Consensus 743 ~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~L~~~~~ 778 (792)
..++++.+++.+||+.||++||||+||+++|+++.+
T Consensus 226 ~~~~~l~~li~~cl~~~p~~Rps~~~il~~L~~i~e 261 (263)
T d1sm2a_ 226 LASTHVYQIMNHCWKERPEDRPAFSRLLRQLAEIAE 261 (263)
T ss_dssp TSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred ccCHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHHh
Confidence 445678999999999999999999999999988653
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=1.3e-49 Score=416.87 Aligned_cols=254 Identities=28% Similarity=0.410 Sum_probs=214.4
Q ss_pred hhhhhhcCccccceEEEeeecCCCceEEEEEEcccccccchHHHHHHHHHhcccCCCCcccccceeccCCceEEEEEecc
Q 003836 503 RGFKEELGRGAFGTVYKGFVNMGSSNHVAVKKLNSVFQDSEKEFKAEVNGIGQTHHKNLVRLLGYCDEGQNRLLVYEFMS 582 (792)
Q Consensus 503 ~~~~~~lG~G~~g~Vy~g~~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~lV~E~~~ 582 (792)
..+.++||+|+||+||+|.+. .+++.||||+++.. ....++|.+|++++++++|||||+++++|.+++..++||||++
T Consensus 19 ~~~~~~iG~G~fg~Vy~a~~~-~~~~~vAvK~i~~~-~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~iv~E~~~ 96 (287)
T d1opja_ 19 ITMKHKLGGGQYGEVYEGVWK-KYSLTVAVKTLKED-TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMT 96 (287)
T ss_dssp EEEEEETTTTTTSSEEEEEEG-GGTEEEEEEECCTT-CSCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCT
T ss_pred eEEeeEEeeCCCeEEEEEEEC-CCCeEEEEEEECCc-cchHHHHHHHHHHHHhCCCCCEecCCccEeeCCeeEEEeeccc
Confidence 345678999999999999765 45678999999754 3456789999999999999999999999999999999999999
Q ss_pred CCCccccccCC--CCCchhHHHHHHHHHHHHHHHHhhccCCCeEecCCCCCcEEEcCCCCeEEeecCCCccccCCCCCcc
Q 003836 583 NGTVASFLFGD--SKPNWKLRTEIAMGIAGGLFYLHEECCTQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLDQSHTN 660 (792)
Q Consensus 583 ~gsL~~~l~~~--~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dikp~NILl~~~~~~kl~Dfg~a~~~~~~~~~~~ 660 (792)
+|+|.+++... ..+++..+..|+.||++||+|||++ +|+||||||+||||++++.+||+|||+++..........
T Consensus 97 ~g~l~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~---~iiHrDlKp~NILl~~~~~~Kl~DFG~a~~~~~~~~~~~ 173 (287)
T d1opja_ 97 YGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKK---NFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAH 173 (287)
T ss_dssp TCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCEEECCCCCTTTCCSSSSEEE
T ss_pred CcchHHHhhhccccchHHHHHHHHHHHHHHHHHHHHHC---CcccCccccCeEEECCCCcEEEccccceeecCCCCceee
Confidence 99999999654 5789999999999999999999998 999999999999999999999999999998765555444
Q ss_pred ccccccCCcccccccccCCCCcccceehHHHHHHHHHhcCcCCCcchhhhhhhhHHHHHHHhhcccchhHhhhchhcccC
Q 003836 661 TAIRGTKGYVAPEWFRNMPITVKVDVYSYGVLLLEIICLRRNIDNEISKVDKAILTDWAYDRYQERTLEALVENDLEAMN 740 (792)
Q Consensus 661 ~~~~gt~~y~aPE~~~~~~~~~k~DV~S~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 740 (792)
....|++.|+|||.+.+..++.|+|||||||++|||++|+.|+........ +...+........
T Consensus 174 ~~~~g~~~y~aPE~~~~~~~~~k~DiwS~Gv~l~ell~~~~p~~~~~~~~~----------------~~~~i~~~~~~~~ 237 (287)
T d1opja_ 174 AGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQ----------------VYELLEKDYRMER 237 (287)
T ss_dssp TTEEECGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCSSTTCCHHH----------------HHHHHHTTCCCCC
T ss_pred ccccccccccChHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCcchHHH----------------HHHHHhcCCCCCC
Confidence 556689999999999999999999999999999999998887754322111 1112222333334
Q ss_pred CHHHHHHHHHHHHHccccCCCCCCCHHhHHHHhccCc
Q 003836 741 NVTMLHRFVMVAFWCIQEDPSHRPTMRKVTQMLEGVV 777 (792)
Q Consensus 741 ~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~L~~~~ 777 (792)
+...++++.+|+.+||+.||++|||++||++.|+.+.
T Consensus 238 ~~~~~~~l~~li~~cl~~dP~~Rps~~ei~~~L~~~~ 274 (287)
T d1opja_ 238 PEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMF 274 (287)
T ss_dssp CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTT
T ss_pred CccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHH
Confidence 4456678999999999999999999999999998764
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.8e-49 Score=410.54 Aligned_cols=251 Identities=29% Similarity=0.466 Sum_probs=206.7
Q ss_pred hhhhhhcCccccceEEEeeecCCCceEEEEEEcccccccchHHHHHHHHHhcccCCCCcccccceeccCCceEEEEEecc
Q 003836 503 RGFKEELGRGAFGTVYKGFVNMGSSNHVAVKKLNSVFQDSEKEFKAEVNGIGQTHHKNLVRLLGYCDEGQNRLLVYEFMS 582 (792)
Q Consensus 503 ~~~~~~lG~G~~g~Vy~g~~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~lV~E~~~ 582 (792)
+.+.++||+|+||+||+|.+. +++.||||+++.. ....+.|.+|++++++++|||||+++|++.+ +..++||||++
T Consensus 15 ~~~~~~iG~G~fg~Vy~~~~~--~~~~vAvK~~~~~-~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~-~~~~iv~Ey~~ 90 (272)
T d1qpca_ 15 LKLVERLGAGQFGEVWMGYYN--GHTKVAVKSLKQG-SMSPDAFLAEANLMKQLQHQRLVRLYAVVTQ-EPIYIITEYME 90 (272)
T ss_dssp EEEEEEEEEETTEEEEEEEET--TTEEEEEEEECTT-SSCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEEECCT
T ss_pred eEEeEEEecCCCcEEEEEEEC--CCCEEEEEEEccC-cCCHHHHHHHHHHHHhCCCCCEeEEEeeecc-CCeEEEEEeCC
Confidence 345678999999999999865 3568999999764 3456789999999999999999999998865 56789999999
Q ss_pred CCCccccccCC--CCCchhHHHHHHHHHHHHHHHHhhccCCCeEecCCCCCcEEEcCCCCeEEeecCCCccccCCCCCcc
Q 003836 583 NGTVASFLFGD--SKPNWKLRTEIAMGIAGGLFYLHEECCTQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLDQSHTN 660 (792)
Q Consensus 583 ~gsL~~~l~~~--~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dikp~NILl~~~~~~kl~Dfg~a~~~~~~~~~~~ 660 (792)
+|+|.+++... ..+++..+++|+.||++||.|||++ +|+||||||+||||++++.+||+|||+|+..........
T Consensus 91 ~g~L~~~~~~~~~~~l~~~~~~~i~~qi~~gl~~lH~~---~ivHrDiKp~NIll~~~~~~Kl~DFGla~~~~~~~~~~~ 167 (272)
T d1qpca_ 91 NGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEER---NYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAR 167 (272)
T ss_dssp TCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTSCEEECCCTTCEECSSSCEECC
T ss_pred CCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCccchhheeeecccceeeccccceEEccCCccccc
Confidence 99999988654 3589999999999999999999998 999999999999999999999999999998765544445
Q ss_pred ccccccCCcccccccccCCCCcccceehHHHHHHHHHhcCcCCCcchhhhhhhhHHHHHHHhhcccchhHhhhchhcccC
Q 003836 661 TAIRGTKGYVAPEWFRNMPITVKVDVYSYGVLLLEIICLRRNIDNEISKVDKAILTDWAYDRYQERTLEALVENDLEAMN 740 (792)
Q Consensus 661 ~~~~gt~~y~aPE~~~~~~~~~k~DV~S~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 740 (792)
....||+.|+|||.+.+..++.++|||||||++|||+||+.|+.......+ .+ ..+........
T Consensus 168 ~~~~gt~~y~APE~~~~~~~~~~sDvwS~Gvvl~ellt~~~~~~~~~~~~~--~~--------------~~i~~~~~~~~ 231 (272)
T d1qpca_ 168 EGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPE--VI--------------QNLERGYRMVR 231 (272)
T ss_dssp TTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCHHH--HH--------------HHHHTTCCCCC
T ss_pred cccCCcccccChHHHhCCCCCchhhhhhhHHHHHHHHhCCCCCCCCCCHHH--HH--------------HHHHhcCCCCC
Confidence 556789999999999999999999999999999999997776644322111 00 11111122223
Q ss_pred CHHHHHHHHHHHHHccccCCCCCCCHHhHHHHhccC
Q 003836 741 NVTMLHRFVMVAFWCIQEDPSHRPTMRKVTQMLEGV 776 (792)
Q Consensus 741 ~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~L~~~ 776 (792)
+...++++.+|+.+||+.||++||||+||+++|+..
T Consensus 232 p~~~~~~l~~li~~cl~~~P~~Rpt~~ei~~~L~~~ 267 (272)
T d1qpca_ 232 PDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDF 267 (272)
T ss_dssp CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred cccChHHHHHHHHHHcCCCHhHCcCHHHHHHHhhhh
Confidence 334556789999999999999999999999999863
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.5e-48 Score=404.63 Aligned_cols=249 Identities=27% Similarity=0.351 Sum_probs=202.2
Q ss_pred hhhhhcCccccceEEEeeecCCCceEEEEEEccccc-ccchHHHHHHHHHhcccCCCCcccccceeccCCceEEEEEecc
Q 003836 504 GFKEELGRGAFGTVYKGFVNMGSSNHVAVKKLNSVF-QDSEKEFKAEVNGIGQTHHKNLVRLLGYCDEGQNRLLVYEFMS 582 (792)
Q Consensus 504 ~~~~~lG~G~~g~Vy~g~~~~~~~~~vavK~~~~~~-~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~lV~E~~~ 582 (792)
.+.++||+|+||+||+|... .+++.||||++.... .+..+.+.+|++++++++|||||++++++.+++..+|||||++
T Consensus 8 ~~~~~lG~G~fg~V~~~~~~-~~~~~vAiK~i~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~~~~~~~~~~~~~ivmEy~~ 86 (271)
T d1nvra_ 8 DLVQTLGEGAYGEVQLAVNR-VTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEYCS 86 (271)
T ss_dssp EEEEEEEEETTEEEEEEEET-TTCCEEEEEEEECC-------CHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECCT
T ss_pred EEEEEEecCcCeEEEEEEEC-CCCCEEEEEEEehhhcchHHHHHHHHHHHHHhCCCCCEeeEeeeeccCceeEEEEeccC
Confidence 45578999999999999754 557899999986543 2344679999999999999999999999999999999999999
Q ss_pred CCCccccccCCCCCchhHHHHHHHHHHHHHHHHhhccCCCeEecCCCCCcEEEcCCCCeEEeecCCCccccCCCC-Cccc
Q 003836 583 NGTVASFLFGDSKPNWKLRTEIAMGIAGGLFYLHEECCTQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLDQS-HTNT 661 (792)
Q Consensus 583 ~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dikp~NILl~~~~~~kl~Dfg~a~~~~~~~~-~~~~ 661 (792)
+|+|.+++.....+++..+..++.||+.||+|||++ +|+||||||+|||+++++.+||+|||+|+....... ....
T Consensus 87 gg~L~~~l~~~~~l~e~~~~~i~~qi~~al~ylH~~---~IiHrDiKp~NILl~~~~~~KL~DFG~a~~~~~~~~~~~~~ 163 (271)
T d1nvra_ 87 GGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGI---GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLN 163 (271)
T ss_dssp TEEGGGGSBTTTBCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECTTCCEEECCCTTCEECEETTEECCBC
T ss_pred CCcHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHc---CCccCcccHHHEEECCCCCEEEccchhheeeccCCcccccc
Confidence 999999998888899999999999999999999998 999999999999999999999999999998754332 2344
Q ss_pred cccccCCcccccccccCCC-CcccceehHHHHHHHHHhcCcCCCcchhhhhhhhHHHHHHHhhcccchhHhhhchhcccC
Q 003836 662 AIRGTKGYVAPEWFRNMPI-TVKVDVYSYGVLLLEIICLRRNIDNEISKVDKAILTDWAYDRYQERTLEALVENDLEAMN 740 (792)
Q Consensus 662 ~~~gt~~y~aPE~~~~~~~-~~k~DV~S~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 740 (792)
...||+.|||||++.+..+ +.++|||||||++|||++|+.||........... . ..........
T Consensus 164 ~~~GT~~Y~APE~~~~~~~~~~~~DiwSlGvilyeml~G~~pf~~~~~~~~~~~--~-------------~~~~~~~~~~ 228 (271)
T d1nvra_ 164 KMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYS--D-------------WKEKKTYLNP 228 (271)
T ss_dssp CCCSCGGGSCTHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSSTTSHHHH--H-------------HHTTCTTSTT
T ss_pred ceeeCcCccCHhHhcCCCCCCCceeeeHhHHHHHHHHhCCCCCCCCChHHHHHH--H-------------HhcCCCCCCc
Confidence 5679999999999988776 5789999999999999999999965432211110 0 0001001111
Q ss_pred CHHHHHHHHHHHHHccccCCCCCCCHHhHHH
Q 003836 741 NVTMLHRFVMVAFWCIQEDPSHRPTMRKVTQ 771 (792)
Q Consensus 741 ~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~ 771 (792)
....++++.+|+.+||+.||++|||++|+++
T Consensus 229 ~~~~s~~~~~li~~~L~~dP~~R~t~~eil~ 259 (271)
T d1nvra_ 229 WKKIDSAPLALLHKILVENPSARITIPDIKK 259 (271)
T ss_dssp GGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred cccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 1223467788999999999999999999976
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.7e-48 Score=406.32 Aligned_cols=248 Identities=29% Similarity=0.404 Sum_probs=203.4
Q ss_pred hhcCccccceEEEeeecC-CCceEEEEEEccccc--ccchHHHHHHHHHhcccCCCCcccccceeccCCceEEEEEeccC
Q 003836 507 EELGRGAFGTVYKGFVNM-GSSNHVAVKKLNSVF--QDSEKEFKAEVNGIGQTHHKNLVRLLGYCDEGQNRLLVYEFMSN 583 (792)
Q Consensus 507 ~~lG~G~~g~Vy~g~~~~-~~~~~vavK~~~~~~--~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~lV~E~~~~ 583 (792)
++||+|+||+||+|.+.. ..++.||||+++... ....++|.+|++++++++|||||+++|+|.+ +..+|||||+++
T Consensus 13 k~iG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~g~~~~-~~~~lvmE~~~~ 91 (277)
T d1xbba_ 13 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEA-ESWMLVMEMAEL 91 (277)
T ss_dssp EEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEEES-SSEEEEEECCTT
T ss_pred CCcccCCCeEEEEEEEccCCcCeEEEEEEEChhhCCHHHHHHHHHHHHHHHhCCCCCCceEEEEecc-CCEEEEEEcCCC
Confidence 469999999999998753 445789999996532 2335689999999999999999999999965 467899999999
Q ss_pred CCccccccCCCCCchhHHHHHHHHHHHHHHHHhhccCCCeEecCCCCCcEEEcCCCCeEEeecCCCccccCCCCCc--cc
Q 003836 584 GTVASFLFGDSKPNWKLRTEIAMGIAGGLFYLHEECCTQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLDQSHT--NT 661 (792)
Q Consensus 584 gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dikp~NILl~~~~~~kl~Dfg~a~~~~~~~~~~--~~ 661 (792)
|+|.+++.....+++..+.+|+.||++||+|||++ +|+||||||+||||+.++.+||+|||+++......... ..
T Consensus 92 g~L~~~l~~~~~l~~~~~~~i~~qi~~gl~ylH~~---~iiHrDlKp~Nill~~~~~~kl~DFGla~~~~~~~~~~~~~~ 168 (277)
T d1xbba_ 92 GPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEES---NFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQT 168 (277)
T ss_dssp EEHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEEETTEEEECCCTTCEECCTTCSEEEC--
T ss_pred CcHHHHHhhccCCCHHHHHHHHHHHHHHHhhHHhC---CcccCCCcchhhcccccCcccccchhhhhhcccccccccccc
Confidence 99999999888899999999999999999999998 99999999999999999999999999999775443322 23
Q ss_pred cccccCCcccccccccCCCCcccceehHHHHHHHHHh-cCcCCCcchhhhhhhhHHHHHHHhhcccchhHhhhchhcccC
Q 003836 662 AIRGTKGYVAPEWFRNMPITVKVDVYSYGVLLLEIIC-LRRNIDNEISKVDKAILTDWAYDRYQERTLEALVENDLEAMN 740 (792)
Q Consensus 662 ~~~gt~~y~aPE~~~~~~~~~k~DV~S~Gv~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 740 (792)
...||+.|+|||.+.+..++.++|||||||++|||+| |+.||....... +...+........
T Consensus 169 ~~~gt~~y~APE~l~~~~~~~~sDiwS~Gv~l~ellt~g~~Pf~~~~~~~-----------------~~~~i~~~~~~~~ 231 (277)
T d1xbba_ 169 HGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSE-----------------VTAMLEKGERMGC 231 (277)
T ss_dssp --CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHHH-----------------HHHHHHTTCCCCC
T ss_pred ccCCCceecCchhhcCCCCCchhhhccchhhhhHHhhCCCCCCCCCCHHH-----------------HHHHHHcCCCCCC
Confidence 4568999999999999999999999999999999998 899997543211 0111111222233
Q ss_pred CHHHHHHHHHHHHHccccCCCCCCCHHhHHHHhcc
Q 003836 741 NVTMLHRFVMVAFWCIQEDPSHRPTMRKVTQMLEG 775 (792)
Q Consensus 741 ~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~L~~ 775 (792)
+...+.++.+|+.+||+.||++|||+++|+++|+.
T Consensus 232 p~~~~~~~~~li~~cl~~dp~~RPs~~~i~~~L~~ 266 (277)
T d1xbba_ 232 PAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRN 266 (277)
T ss_dssp CTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHH
T ss_pred CcccCHHHHHHHHHHcCCCHhHCcCHHHHHHHhhC
Confidence 34456788999999999999999999999998865
|
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.9e-48 Score=405.53 Aligned_cols=255 Identities=27% Similarity=0.397 Sum_probs=199.9
Q ss_pred hhhhhcCccccceEEEeeecCCCceEEEEEEcccc--cccchHHHHHHHHHhcccCCCCcccccceeccCCceEEEEEec
Q 003836 504 GFKEELGRGAFGTVYKGFVNMGSSNHVAVKKLNSV--FQDSEKEFKAEVNGIGQTHHKNLVRLLGYCDEGQNRLLVYEFM 581 (792)
Q Consensus 504 ~~~~~lG~G~~g~Vy~g~~~~~~~~~vavK~~~~~--~~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~lV~E~~ 581 (792)
.+.++||+|+||+||+|+++ ..||||+++.. .....+.|.+|++++++++|||||++++++.+ +..+|||||+
T Consensus 11 ~~~~~lG~G~fg~Vy~~~~~----~~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~-~~~~lv~Ey~ 85 (276)
T d1uwha_ 11 TVGQRIGSGSFGTVYKGKWH----GDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTA-PQLAIVTQWC 85 (276)
T ss_dssp CCCSEEEECSSCEEEEEESS----SEEEEEECCCSSCCTTHHHHHHHHHHHHTTCCCTTBCCEEEEECS-SSCEEEEECC
T ss_pred EEEEEEeeCCCcEEEEEEEC----CEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeeeEEEec-cEEEEEEecC
Confidence 34578999999999999754 25999998643 34456789999999999999999999999865 5689999999
Q ss_pred cCCCccccccCC-CCCchhHHHHHHHHHHHHHHHHhhccCCCeEecCCCCCcEEEcCCCCeEEeecCCCccccCCCC-Cc
Q 003836 582 SNGTVASFLFGD-SKPNWKLRTEIAMGIAGGLFYLHEECCTQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLDQS-HT 659 (792)
Q Consensus 582 ~~gsL~~~l~~~-~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dikp~NILl~~~~~~kl~Dfg~a~~~~~~~~-~~ 659 (792)
++|+|.+++... ..+++..+.+|+.||++||+|||++ +|+||||||+||||+.++.+||+|||+|+....... ..
T Consensus 86 ~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~gl~yLH~~---~ivHrDlKp~NiLl~~~~~~Kl~DFGla~~~~~~~~~~~ 162 (276)
T d1uwha_ 86 EGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHAK---SIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQ 162 (276)
T ss_dssp CEEEHHHHHHTSCCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEETTSSEEECCCCCSCC---------
T ss_pred CCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHhcC---CEeccccCHHHEEEcCCCCEEEccccceeeccccCCccc
Confidence 999999999754 5689999999999999999999998 999999999999999999999999999987654332 23
Q ss_pred cccccccCCccccccccc---CCCCcccceehHHHHHHHHHhcCcCCCcchhhhhhhhHHHHHHHhhcccchhHhhhchh
Q 003836 660 NTAIRGTKGYVAPEWFRN---MPITVKVDVYSYGVLLLEIICLRRNIDNEISKVDKAILTDWAYDRYQERTLEALVENDL 736 (792)
Q Consensus 660 ~~~~~gt~~y~aPE~~~~---~~~~~k~DV~S~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 736 (792)
.....||+.|||||++.+ ..++.++|||||||++|||+||+.||.......... ........... .
T Consensus 163 ~~~~~gt~~y~APE~l~~~~~~~~~~~sDiwS~Gv~l~el~tg~~Pf~~~~~~~~~~---~~~~~~~~~p~--------~ 231 (276)
T d1uwha_ 163 FEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQII---FMVGRGYLSPD--------L 231 (276)
T ss_dssp ---CCCCGGGCCHHHHTTCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHH---HHHHHTSCCCC--------G
T ss_pred ccccccCcccCCHHHHhcccCCCCCchhhhhhhHHHHHHHHHCCCCCCCCChHHHHH---HHHhcCCCCCc--------c
Confidence 345679999999999864 458999999999999999999999997543221110 00111111000 0
Q ss_pred cccCCHHHHHHHHHHHHHccccCCCCCCCHHhHHHHhccCcC
Q 003836 737 EAMNNVTMLHRFVMVAFWCIQEDPSHRPTMRKVTQMLEGVVE 778 (792)
Q Consensus 737 ~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~L~~~~~ 778 (792)
...+...++++.+++.+||+.||++|||++||+++|+.+.+
T Consensus 232 -~~~~~~~~~~l~~li~~cl~~dp~~RPt~~~il~~Le~l~~ 272 (276)
T d1uwha_ 232 -SKVRSNCPKAMKRLMAECLKKKRDERPLFPQILASIELLAR 272 (276)
T ss_dssp -GGSCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred -hhccccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHH
Confidence 11223345678899999999999999999999999988753
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.2e-48 Score=398.01 Aligned_cols=249 Identities=24% Similarity=0.392 Sum_probs=211.2
Q ss_pred hhhhcCccccceEEEeeecCCCceEEEEEEcccccccchHHHHHHHHHhcccCCCCcccccceeccCCceEEEEEeccCC
Q 003836 505 FKEELGRGAFGTVYKGFVNMGSSNHVAVKKLNSVFQDSEKEFKAEVNGIGQTHHKNLVRLLGYCDEGQNRLLVYEFMSNG 584 (792)
Q Consensus 505 ~~~~lG~G~~g~Vy~g~~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~lV~E~~~~g 584 (792)
|.++||+|+||+||+|+.+ +++.||||+++.. ....++|.+|++++++++||||++++|+|.+++..++||||+++|
T Consensus 8 ~~~~iG~G~fg~Vy~~~~~--~~~~vAvK~l~~~-~~~~~~~~~Ev~~~~~l~HpnIv~~~g~~~~~~~~~iv~Ey~~~g 84 (258)
T d1k2pa_ 8 FLKELGTGQFGVVKYGKWR--GQYDVAIKMIKEG-SMSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYMANG 84 (258)
T ss_dssp CCCCCCEETTEEEEEEEET--TTEEEEEEEEESS-SSCHHHHHHHHHHHHTCCCTTBCCEEEEECCSSSEEEEEECCTTE
T ss_pred EeEEEecCCCeEEEEEEEC--CCCEEEEEEECcC-cCCHHHHHHHHHHHHhcCCCceeeEEEEEeeCCceEEEEEccCCC
Confidence 5678999999999999874 4678999999864 345678999999999999999999999999999999999999999
Q ss_pred CccccccCC-CCCchhHHHHHHHHHHHHHHHHhhccCCCeEecCCCCCcEEEcCCCCeEEeecCCCccccCCCCCccccc
Q 003836 585 TVASFLFGD-SKPNWKLRTEIAMGIAGGLFYLHEECCTQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLDQSHTNTAI 663 (792)
Q Consensus 585 sL~~~l~~~-~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dikp~NILl~~~~~~kl~Dfg~a~~~~~~~~~~~~~~ 663 (792)
+|.+++... ..+++..+.+++.||++||+|||+. +|+||||||+|||+++++.+||+|||+++.............
T Consensus 85 ~l~~~~~~~~~~~~~~~~~~i~~qi~~gl~~LH~~---~iiH~dlk~~Nill~~~~~~kl~DfG~a~~~~~~~~~~~~~~ 161 (258)
T d1k2pa_ 85 CLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESK---QFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGS 161 (258)
T ss_dssp EHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHT---TBCCSCCSGGGEEECTTCCEEECCCSSCCBCSSSSCCCCCCS
T ss_pred cHHHhhhccccCCcHHHHHHHHHHHHHHHHHHhhc---CcccccccceeEEEcCCCcEEECcchhheeccCCCceeeccc
Confidence 999997654 5688999999999999999999998 999999999999999999999999999987765555555556
Q ss_pred cccCCcccccccccCCCCcccceehHHHHHHHHHh-cCcCCCcchhhhhhhhHHHHHHHhhcccchhHhhhchhcccCCH
Q 003836 664 RGTKGYVAPEWFRNMPITVKVDVYSYGVLLLEIIC-LRRNIDNEISKVDKAILTDWAYDRYQERTLEALVENDLEAMNNV 742 (792)
Q Consensus 664 ~gt~~y~aPE~~~~~~~~~k~DV~S~Gv~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 742 (792)
.||+.|+|||.+.+..++.|+|||||||++|||+| |+.||........ ...+........+.
T Consensus 162 ~~t~~y~aPE~~~~~~~~~ksDiwS~G~~l~el~t~g~~Pf~~~~~~~~-----------------~~~i~~~~~~~~p~ 224 (258)
T d1k2pa_ 162 KFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSET-----------------AEHIAQGLRLYRPH 224 (258)
T ss_dssp CCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCHHHH-----------------HHHHHTTCCCCCCT
T ss_pred CCCCCcCCcHHhcCCCCCcceeecccchhhHhHHhcCCCCCCCCCHHHH-----------------HHHHHhCCCCCCcc
Confidence 78999999999999999999999999999999998 7888875532211 01111122223334
Q ss_pred HHHHHHHHHHHHccccCCCCCCCHHhHHHHhccC
Q 003836 743 TMLHRFVMVAFWCIQEDPSHRPTMRKVTQMLEGV 776 (792)
Q Consensus 743 ~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~L~~~ 776 (792)
..++++.+++.+||+.||++|||++||++.|.++
T Consensus 225 ~~~~~l~~li~~cl~~dP~~RPt~~eil~~L~di 258 (258)
T d1k2pa_ 225 LASEKVYTIMYSCWHEKADERPTFKILLSNILDV 258 (258)
T ss_dssp TCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHCC
T ss_pred cccHHHHHHHHHHccCCHhHCcCHHHHHHHhhCC
Confidence 4557889999999999999999999999998653
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4e-48 Score=404.39 Aligned_cols=263 Identities=25% Similarity=0.377 Sum_probs=207.6
Q ss_pred hhhhhhcCccccceEEEeeecCCCceEEEEEEcccccccchHHHHHHHHHhcccCCCCcccccceeccCCceEEEEEecc
Q 003836 503 RGFKEELGRGAFGTVYKGFVNMGSSNHVAVKKLNSVFQDSEKEFKAEVNGIGQTHHKNLVRLLGYCDEGQNRLLVYEFMS 582 (792)
Q Consensus 503 ~~~~~~lG~G~~g~Vy~g~~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~lV~E~~~ 582 (792)
..+.+.||+|+||+||+|.+.. ++.||||+++.. ....+.|.+|+.++++++|+|||+++|+|.+ +..++||||++
T Consensus 19 ~~i~~~iG~G~fg~Vy~~~~~~--~~~vAiK~l~~~-~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~-~~~~lv~Ey~~ 94 (285)
T d1fmka3 19 LRLEVKLGQGCFGEVWMGTWNG--TTRVAIKTLKPG-TMSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEYMS 94 (285)
T ss_dssp EEEEEEEEECSSCEEEEEEETT--TEEEEEEECCTT-SSCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEECCCT
T ss_pred EEEeeEEeeCCCeEEEEEEECC--CCEEEEEEECcc-cCCHHHHHHHHHHHHhcccCCEeEEEEEEec-CCeEEEEEecC
Confidence 4566789999999999998753 357999999754 4456789999999999999999999999855 56789999999
Q ss_pred CCCccccccCC--CCCchhHHHHHHHHHHHHHHHHhhccCCCeEecCCCCCcEEEcCCCCeEEeecCCCccccCCCCCcc
Q 003836 583 NGTVASFLFGD--SKPNWKLRTEIAMGIAGGLFYLHEECCTQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLDQSHTN 660 (792)
Q Consensus 583 ~gsL~~~l~~~--~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dikp~NILl~~~~~~kl~Dfg~a~~~~~~~~~~~ 660 (792)
+|+|..++... ..+++.+++.|+.||++||+|||+. +|+||||||+||||+.++++||+|||+++..........
T Consensus 95 ~g~l~~~~~~~~~~~l~~~~~~~i~~~i~~gl~~LH~~---~ivH~DlKp~NIll~~~~~~kl~DfGla~~~~~~~~~~~ 171 (285)
T d1fmka3 95 KGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERM---NYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTAR 171 (285)
T ss_dssp TCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCEEECCCCTTC----------
T ss_pred CCchhhhhhhcccccchHHHHHHHHHHHHHHHHHHhhh---heecccccceEEEECCCCcEEEcccchhhhccCCCceee
Confidence 99999998754 5689999999999999999999998 999999999999999999999999999987765544444
Q ss_pred ccccccCCcccccccccCCCCcccceehHHHHHHHHHhcCcCCCcchhhhhhhhHHHHHHHhhcccchhHhhhchhcccC
Q 003836 661 TAIRGTKGYVAPEWFRNMPITVKVDVYSYGVLLLEIICLRRNIDNEISKVDKAILTDWAYDRYQERTLEALVENDLEAMN 740 (792)
Q Consensus 661 ~~~~gt~~y~aPE~~~~~~~~~k~DV~S~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 740 (792)
....||+.|+|||.+....++.++|||||||++|||++|+.|+.......+. ...+........
T Consensus 172 ~~~~gt~~y~aPE~~~~~~~~~ksDI~S~Giil~el~t~~~p~~~~~~~~~~----------------~~~i~~~~~~~~ 235 (285)
T d1fmka3 172 QGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREV----------------LDQVERGYRMPC 235 (285)
T ss_dssp ----CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHH----------------HHHHHTTCCCCC
T ss_pred ccccccccccChHHHhCCCCCcHHhhhcchHHHHHHHhCCCCCCCCCCHHHH----------------HHHHHhcCCCCC
Confidence 5567999999999999999999999999999999999987776543322111 111111222233
Q ss_pred CHHHHHHHHHHHHHccccCCCCCCCHHhHHHHhccCcCCCCCCCCCCC
Q 003836 741 NVTMLHRFVMVAFWCIQEDPSHRPTMRKVTQMLEGVVEVPIPPCPWTL 788 (792)
Q Consensus 741 ~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~L~~~~~~~~p~~P~~~ 788 (792)
+...++++.+++.+||+.||++||||++|+++|+....-..|+.++..
T Consensus 236 ~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~~~~~~~p~~~p~~ 283 (285)
T d1fmka3 236 PPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTSTEPQYQPGE 283 (285)
T ss_dssp CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTTSCSCCCCCCSC
T ss_pred CcccCHHHHHHHHHHcccCHhHCcCHHHHHHHHhhhhcCCCCCCCCCC
Confidence 445567889999999999999999999999999997665555544433
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5e-48 Score=404.71 Aligned_cols=258 Identities=25% Similarity=0.445 Sum_probs=204.0
Q ss_pred hhhhcCccccceEEEeeecCCC---ceEEEEEEccccc-ccchHHHHHHHHHhcccCCCCcccccceeccCCceEEEEEe
Q 003836 505 FKEELGRGAFGTVYKGFVNMGS---SNHVAVKKLNSVF-QDSEKEFKAEVNGIGQTHHKNLVRLLGYCDEGQNRLLVYEF 580 (792)
Q Consensus 505 ~~~~lG~G~~g~Vy~g~~~~~~---~~~vavK~~~~~~-~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~lV~E~ 580 (792)
+.++||+|+||+||+|.+.... ...||||++.... .....+|.+|++++++++|||||+++|++.+.+..++||||
T Consensus 11 ~~~~iG~G~fG~Vy~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~H~nIv~~~g~~~~~~~~~~v~e~ 90 (283)
T d1mqba_ 11 RQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMMIITEY 90 (283)
T ss_dssp EEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEEEC
T ss_pred eeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEEECcccChHHHHHHHHHHHHHHhcCCCCEeeeeEEEecCCceEEEEEe
Confidence 3467999999999999876433 2479999987543 33456799999999999999999999999999999999999
Q ss_pred ccCCCccccccCC-CCCchhHHHHHHHHHHHHHHHHhhccCCCeEecCCCCCcEEEcCCCCeEEeecCCCccccCCCCC-
Q 003836 581 MSNGTVASFLFGD-SKPNWKLRTEIAMGIAGGLFYLHEECCTQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLDQSH- 658 (792)
Q Consensus 581 ~~~gsL~~~l~~~-~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dikp~NILl~~~~~~kl~Dfg~a~~~~~~~~~- 658 (792)
+.+++|.+++... ..+++.++.+++.||+.||+|||+. +|+||||||+||||+.++.+||+|||+++........
T Consensus 91 ~~~~~l~~~~~~~~~~~~~~~~~~i~~~i~~gl~~lH~~---~iiHrDlKp~NILl~~~~~~Kl~DFGla~~~~~~~~~~ 167 (283)
T d1mqba_ 91 MENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLANM---NYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEAT 167 (283)
T ss_dssp CTTEEHHHHHHHTTTCSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECCCCC-----------
T ss_pred cccCcchhhhhcccccccHHHHHHHHHHHHHhhhhcccc---ccccCccccceEEECCCCeEEEcccchhhcccCCCccc
Confidence 9999999988654 6789999999999999999999998 9999999999999999999999999999976543322
Q ss_pred -ccccccccCCcccccccccCCCCcccceehHHHHHHHHHhcCcCCCcchhhhhhhhHHHHHHHhhcccchhHhhhchhc
Q 003836 659 -TNTAIRGTKGYVAPEWFRNMPITVKVDVYSYGVLLLEIICLRRNIDNEISKVDKAILTDWAYDRYQERTLEALVENDLE 737 (792)
Q Consensus 659 -~~~~~~gt~~y~aPE~~~~~~~~~k~DV~S~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 737 (792)
......||+.|+|||.+.+..++.++|||||||++|||++|+.|+.......+ +...+....+
T Consensus 168 ~~~~~~~gt~~Y~APE~l~~~~~~~~sDI~S~Gvil~el~t~~~~~~~~~~~~~----------------~~~~i~~~~~ 231 (283)
T d1mqba_ 168 YTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHE----------------VMKAINDGFR 231 (283)
T ss_dssp ------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHH----------------HHHHHHTTCC
T ss_pred eEeccCCCCccccCHHHHccCCCCCcccccccHHHHHHHHhCCCCccccCCHHH----------------HHHHHhccCC
Confidence 22345689999999999999999999999999999999998777654322211 1111222223
Q ss_pred ccCCHHHHHHHHHHHHHccccCCCCCCCHHhHHHHhccCcCCCC
Q 003836 738 AMNNVTMLHRFVMVAFWCIQEDPSHRPTMRKVTQMLEGVVEVPI 781 (792)
Q Consensus 738 ~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~L~~~~~~~~ 781 (792)
...+...+.++.+|+.+||+.||++||||+||+++|+.+++.|.
T Consensus 232 ~~~~~~~~~~l~~li~~cl~~~p~~RPt~~eil~~L~~l~~~p~ 275 (283)
T d1mqba_ 232 LPTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLIRAPD 275 (283)
T ss_dssp CCCCTTCBHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHSGG
T ss_pred CCCchhhHHHHHHHHHHHCcCCHhHCcCHHHHHHHHHHHhhCcc
Confidence 33444556788999999999999999999999999998876553
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9e-48 Score=397.14 Aligned_cols=244 Identities=27% Similarity=0.362 Sum_probs=205.7
Q ss_pred hhhhhhcCccccceEEEeeecCCCceEEEEEEcccc---cccchHHHHHHHHHhcccCCCCcccccceeccCCceEEEEE
Q 003836 503 RGFKEELGRGAFGTVYKGFVNMGSSNHVAVKKLNSV---FQDSEKEFKAEVNGIGQTHHKNLVRLLGYCDEGQNRLLVYE 579 (792)
Q Consensus 503 ~~~~~~lG~G~~g~Vy~g~~~~~~~~~vavK~~~~~---~~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~lV~E 579 (792)
+.+.+.||+|+||+||+|... .+++.||+|++.+. .....+.+.+|++++++++|||||++++++.+++..++|||
T Consensus 8 y~i~~~iG~G~fg~Vy~~~~~-~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~ivmE 86 (263)
T d2j4za1 8 FEIGRPLGKGKFGNVYLAREK-QSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILE 86 (263)
T ss_dssp EEEEEEEEECSSEEEEEEEET-TTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred eEEEEEEecCCCcEEEEEEEC-CCCcEEEEEEEchHHccChHHHHHHHHHHHHHHhcCCCCCCeEEEEEEECCEEEEEEe
Confidence 445678999999999999754 56789999998643 23446789999999999999999999999999999999999
Q ss_pred eccCCCccccccCCCCCchhHHHHHHHHHHHHHHHHhhccCCCeEecCCCCCcEEEcCCCCeEEeecCCCccccCCCCCc
Q 003836 580 FMSNGTVASFLFGDSKPNWKLRTEIAMGIAGGLFYLHEECCTQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLDQSHT 659 (792)
Q Consensus 580 ~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dikp~NILl~~~~~~kl~Dfg~a~~~~~~~~~~ 659 (792)
|+++|+|.+++.....+++..+..++.||+.||+|||++ +|+||||||+|||++.++.+||+|||+++..... .
T Consensus 87 y~~~g~L~~~l~~~~~l~e~~~~~i~~qi~~al~~lH~~---~ivHrDiKp~Nill~~~~~~kl~DFG~a~~~~~~---~ 160 (263)
T d2j4za1 87 YAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWSVHAPSS---R 160 (263)
T ss_dssp CCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEECCCCSCSCCCCC---C
T ss_pred ecCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeeeeccccceecCCCCEeecccceeeecCCC---c
Confidence 999999999998888899999999999999999999998 9999999999999999999999999999865432 2
Q ss_pred cccccccCCcccccccccCCCCcccceehHHHHHHHHHhcCcCCCcchhhhhhhhHHHHHHHhhcccchhHhhhchhccc
Q 003836 660 NTAIRGTKGYVAPEWFRNMPITVKVDVYSYGVLLLEIICLRRNIDNEISKVDKAILTDWAYDRYQERTLEALVENDLEAM 739 (792)
Q Consensus 660 ~~~~~gt~~y~aPE~~~~~~~~~k~DV~S~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 739 (792)
.....||+.|+|||++.+..++.++|||||||++|||++|+.||........ +. .+... ...
T Consensus 161 ~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~---~~-------------~i~~~--~~~ 222 (263)
T d2j4za1 161 RTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQET---YK-------------RISRV--EFT 222 (263)
T ss_dssp CEETTEEGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHH---HH-------------HHHTT--CCC
T ss_pred ccccCCCCcccCHHHHcCCCCCchhhhhhHhHHHHHHhcCCCCCCCCCHHHH---HH-------------HHHcC--CCC
Confidence 3346799999999999999999999999999999999999999975432211 00 00111 111
Q ss_pred CCHHHHHHHHHHHHHccccCCCCCCCHHhHHH
Q 003836 740 NNVTMLHRFVMVAFWCIQEDPSHRPTMRKVTQ 771 (792)
Q Consensus 740 ~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~ 771 (792)
.+...++++.+++.+||+.||++|||++|+++
T Consensus 223 ~p~~~s~~~~~li~~~L~~dp~~R~t~~eil~ 254 (263)
T d2j4za1 223 FPDFVTEGARDLISRLLKHNPSQRPMLREVLE 254 (263)
T ss_dssp CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred CCccCCHHHHHHHHHHccCCHhHCcCHHHHHc
Confidence 22334567889999999999999999999987
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.5e-47 Score=400.30 Aligned_cols=248 Identities=27% Similarity=0.376 Sum_probs=203.9
Q ss_pred hcCccccceEEEeeecC-CCceEEEEEEccccc-ccchHHHHHHHHHhcccCCCCcccccceeccCCceEEEEEeccCCC
Q 003836 508 ELGRGAFGTVYKGFVNM-GSSNHVAVKKLNSVF-QDSEKEFKAEVNGIGQTHHKNLVRLLGYCDEGQNRLLVYEFMSNGT 585 (792)
Q Consensus 508 ~lG~G~~g~Vy~g~~~~-~~~~~vavK~~~~~~-~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~lV~E~~~~gs 585 (792)
+||+|+||+||+|.+.. +++..||||+++... ....++|.+|++++++++|||||+++|+|.+ +..+|||||+++|+
T Consensus 16 ~iG~G~fg~Vy~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~-~~~~lvmE~~~~g~ 94 (285)
T d1u59a_ 16 ELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EALMLVMEMAGGGP 94 (285)
T ss_dssp EEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEES-SSEEEEEECCTTEE
T ss_pred EEecccCeEEEEEEEecCCCcEEEEEEEEChhcCHHHHHHHHHHHHHHHhCCCCCEeeEeeeecc-CeEEEEEEeCCCCc
Confidence 49999999999997643 344579999997543 3345789999999999999999999999865 56899999999999
Q ss_pred ccccccCC-CCCchhHHHHHHHHHHHHHHHHhhccCCCeEecCCCCCcEEEcCCCCeEEeecCCCccccCCCCC--cccc
Q 003836 586 VASFLFGD-SKPNWKLRTEIAMGIAGGLFYLHEECCTQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLDQSH--TNTA 662 (792)
Q Consensus 586 L~~~l~~~-~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dikp~NILl~~~~~~kl~Dfg~a~~~~~~~~~--~~~~ 662 (792)
|.+++... ..+++..+.+++.||++||+|||++ +|+||||||+||||+.++.+||+|||+++........ ....
T Consensus 95 L~~~l~~~~~~l~~~~~~~i~~qi~~gL~ylH~~---~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~~~~~~~~~~ 171 (285)
T d1u59a_ 95 LHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEK---NFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSA 171 (285)
T ss_dssp HHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEEETTEEEECCCTTCEECTTCSCEECCCCS
T ss_pred HHHHhhccccCCCHHHHHHHHHHHHHHHHHHHhC---CeecCcCchhheeeccCCceeeccchhhhcccccccccccccc
Confidence 99998654 5789999999999999999999998 9999999999999999999999999999987544332 2234
Q ss_pred ccccCCcccccccccCCCCcccceehHHHHHHHHHh-cCcCCCcchhhhhhhhHHHHHHHhhcccchhHhhhchhcccCC
Q 003836 663 IRGTKGYVAPEWFRNMPITVKVDVYSYGVLLLEIIC-LRRNIDNEISKVDKAILTDWAYDRYQERTLEALVENDLEAMNN 741 (792)
Q Consensus 663 ~~gt~~y~aPE~~~~~~~~~k~DV~S~Gv~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 741 (792)
..||+.|+|||.+.+..++.++|||||||++|||+| |+.||........ ...+........+
T Consensus 172 ~~gt~~y~aPE~~~~~~~~~ksDVwS~Gv~l~E~lt~G~~Pf~~~~~~~~-----------------~~~i~~~~~~~~p 234 (285)
T d1u59a_ 172 GKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEV-----------------MAFIEQGKRMECP 234 (285)
T ss_dssp SCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTHHH-----------------HHHHHTTCCCCCC
T ss_pred cccCccccChHHHhCCCCCccchhhcchHHHHHHHhCCCCCCCCCCHHHH-----------------HHHHHcCCCCCCC
Confidence 568999999999999999999999999999999998 8999975432110 0111112222334
Q ss_pred HHHHHHHHHHHHHccccCCCCCCCHHhHHHHhccC
Q 003836 742 VTMLHRFVMVAFWCIQEDPSHRPTMRKVTQMLEGV 776 (792)
Q Consensus 742 ~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~L~~~ 776 (792)
...+.++.+|+.+||+.||++||||.+|++.|+..
T Consensus 235 ~~~~~~l~~li~~cl~~~p~~RPs~~~i~~~L~~~ 269 (285)
T d1u59a_ 235 PECPPELYALMSDCWIYKWEDRPDFLTVEQRMRAC 269 (285)
T ss_dssp TTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHH
T ss_pred CcCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHH
Confidence 45567889999999999999999999999988753
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.1e-47 Score=398.96 Aligned_cols=248 Identities=25% Similarity=0.325 Sum_probs=206.2
Q ss_pred hhhhhhcCccccceEEEeeecCCCceEEEEEEcccccccchHHHHHHHHHhcccCCCCcccccceeccCCceEEEEEecc
Q 003836 503 RGFKEELGRGAFGTVYKGFVNMGSSNHVAVKKLNSVFQDSEKEFKAEVNGIGQTHHKNLVRLLGYCDEGQNRLLVYEFMS 582 (792)
Q Consensus 503 ~~~~~~lG~G~~g~Vy~g~~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~lV~E~~~ 582 (792)
+.+.++||+|+||+||+|.. ..+++.||||++........+.+.+|++++++++|||||++++++.+.+..++||||++
T Consensus 22 Y~~~~~iG~G~fg~Vy~a~~-~~~~~~vAvK~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmEy~~ 100 (293)
T d1yhwa1 22 YTRFEKIGQGASGTVYTAMD-VATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLA 100 (293)
T ss_dssp BCSCEECCCSSSCEEEEEEB-TTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCT
T ss_pred cEEEEEEecCcCcEEEEEEE-CCCCCEEEEEEEecccChHHHHHHHHHHHHHhCCCCCEeeEeEEEEECCEEEEEEEecC
Confidence 34557899999999999964 45678999999987666667889999999999999999999999999999999999999
Q ss_pred CCCccccccCCCCCchhHHHHHHHHHHHHHHHHhhccCCCeEecCCCCCcEEEcCCCCeEEeecCCCccccCCCCCcccc
Q 003836 583 NGTVASFLFGDSKPNWKLRTEIAMGIAGGLFYLHEECCTQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLDQSHTNTA 662 (792)
Q Consensus 583 ~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dikp~NILl~~~~~~kl~Dfg~a~~~~~~~~~~~~~ 662 (792)
+|+|.+++.+ ..+++..+..++.||+.||+|||++ +|+||||||+|||++.++.+||+|||+++.+..... ....
T Consensus 101 gg~L~~~~~~-~~l~~~~~~~i~~qi~~aL~yLH~~---~iiHrDiKp~NILl~~~~~vkl~DFG~a~~~~~~~~-~~~~ 175 (293)
T d1yhwa1 101 GGSLTDVVTE-TCMDEGQIAAVCRECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS-KRST 175 (293)
T ss_dssp TCBHHHHHHH-SCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECCCTTCEECCSTTC-CBCC
T ss_pred CCcHHHHhhc-cCCCHHHHHHHHHHHHHHHHHHHHC---CCcccCCcHHHeEECCCCcEeeccchhheeeccccc-cccc
Confidence 9999998754 4689999999999999999999998 999999999999999999999999999997654332 2344
Q ss_pred ccccCCcccccccccCCCCcccceehHHHHHHHHHhcCcCCCcchhhhhhhhHHHHHHHhhcccchhHhhhchhcccCCH
Q 003836 663 IRGTKGYVAPEWFRNMPITVKVDVYSYGVLLLEIICLRRNIDNEISKVDKAILTDWAYDRYQERTLEALVENDLEAMNNV 742 (792)
Q Consensus 663 ~~gt~~y~aPE~~~~~~~~~k~DV~S~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 742 (792)
..||+.|+|||++.+..++.++|||||||++|||++|+.||.......... ... . ........+.
T Consensus 176 ~~gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~---~~~----~--------~~~~~~~~~~ 240 (293)
T d1yhwa1 176 MVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALY---LIA----T--------NGTPELQNPE 240 (293)
T ss_dssp CCSCGGGCCHHHHSSSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHH---HHH----H--------HCSCCCSSGG
T ss_pred cccCCCccChhhhcCCCCCchhceehHhHHHHHHhhCCCCCCCCCHHHHHH---HHH----h--------CCCCCCCCcc
Confidence 579999999999999999999999999999999999999996543221100 000 0 0011111223
Q ss_pred HHHHHHHHHHHHccccCCCCCCCHHhHHH
Q 003836 743 TMLHRFVMVAFWCIQEDPSHRPTMRKVTQ 771 (792)
Q Consensus 743 ~~~~~l~~l~~~Cl~~~p~~RPs~~evl~ 771 (792)
..+.++.+++.+||+.||++|||++|+++
T Consensus 241 ~~s~~~~~li~~~L~~dP~~R~s~~eil~ 269 (293)
T d1yhwa1 241 KLSAIFRDFLNRCLDMDVEKRGSAKELLQ 269 (293)
T ss_dssp GSCHHHHHHHHHHTCSSTTTSCCHHHHTT
T ss_pred cCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 34567889999999999999999999986
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.5e-47 Score=397.03 Aligned_cols=245 Identities=27% Similarity=0.414 Sum_probs=196.8
Q ss_pred hhhhhcCccccceEEEeeecCCCceEEEEEEccccc--ccchHHHHHHHHHhcccCCCCcccccceecc----CCceEEE
Q 003836 504 GFKEELGRGAFGTVYKGFVNMGSSNHVAVKKLNSVF--QDSEKEFKAEVNGIGQTHHKNLVRLLGYCDE----GQNRLLV 577 (792)
Q Consensus 504 ~~~~~lG~G~~g~Vy~g~~~~~~~~~vavK~~~~~~--~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~----~~~~~lV 577 (792)
.|.++||+|+||+||+|... .+++.||+|++.... ....+.+.+|++++++++|||||++++++.+ ....++|
T Consensus 12 ~~~~~iG~G~fg~Vy~~~~~-~~~~~va~K~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~~~iv 90 (270)
T d1t4ha_ 12 KFDIEIGRGSFKTVYKGLDT-ETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLV 90 (270)
T ss_dssp EEEEEEEECSSEEEEEEEET-TTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEEEE
T ss_pred EeeeEEecCcCcEEEEEEEC-CCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeccccCCEEEEE
Confidence 34568999999999999754 566799999987542 3345679999999999999999999999854 4567899
Q ss_pred EEeccCCCccccccCCCCCchhHHHHHHHHHHHHHHHHhhccCCC--eEecCCCCCcEEEc-CCCCeEEeecCCCccccC
Q 003836 578 YEFMSNGTVASFLFGDSKPNWKLRTEIAMGIAGGLFYLHEECCTQ--IIHCDIKPQNILLD-DHYNARISDFGLAKLLTL 654 (792)
Q Consensus 578 ~E~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~--ivH~dikp~NILl~-~~~~~kl~Dfg~a~~~~~ 654 (792)
|||+++|+|.+++.+...+++..+..++.||++||+|||++ + |+||||||+||||+ +++.+||+|||+++....
T Consensus 91 mE~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~gl~yLH~~---~~~IiHrDiKp~NILl~~~~~~~Kl~DFGla~~~~~ 167 (270)
T d1t4ha_ 91 TELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLHTR---TPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRA 167 (270)
T ss_dssp EECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTS---SSCCCCSCCCGGGEEESSTTSCEEECCTTGGGGCCT
T ss_pred EeCCCCCcHHHHHhccccccHHHHHHHHHHHHHHHHHHHHC---CCCEEeCCcChhhceeeCCCCCEEEeecCcceeccC
Confidence 99999999999998888899999999999999999999998 6 99999999999996 578999999999986432
Q ss_pred CCCCccccccccCCcccccccccCCCCcccceehHHHHHHHHHhcCcCCCcchhhhhhhhHHHHHHHhhcccchhHhhhc
Q 003836 655 DQSHTNTAIRGTKGYVAPEWFRNMPITVKVDVYSYGVLLLEIICLRRNIDNEISKVDKAILTDWAYDRYQERTLEALVEN 734 (792)
Q Consensus 655 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DV~S~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 734 (792)
. ......||+.|+|||++.+ +++.++|||||||++|||++|+.||........ . .........
T Consensus 168 ~---~~~~~~GT~~Y~aPE~~~~-~~~~~~DIwSlGvilyel~~g~~Pf~~~~~~~~--~-----~~~i~~~~~------ 230 (270)
T d1t4ha_ 168 S---FAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQ--I-----YRRVTSGVK------ 230 (270)
T ss_dssp T---SBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHH--H-----HHHHTTTCC------
T ss_pred C---ccCCcccCccccCHHHhCC-CCCCcCchhhHHHHHHHHHHCCCCCCCcccHHH--H-----HHHHHcCCC------
Confidence 2 2335679999999999865 699999999999999999999999964322111 0 011111100
Q ss_pred hhcccCCHHHHHHHHHHHHHccccCCCCCCCHHhHHH
Q 003836 735 DLEAMNNVTMLHRFVMVAFWCIQEDPSHRPTMRKVTQ 771 (792)
Q Consensus 735 ~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~ 771 (792)
....+...++++.+++.+||+.||++|||++|+++
T Consensus 231 --~~~~~~~~~~~~~~li~~~l~~dp~~R~s~~ell~ 265 (270)
T d1t4ha_ 231 --PASFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLN 265 (270)
T ss_dssp --CGGGGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred --CcccCccCCHHHHHHHHHHccCCHhHCcCHHHHhC
Confidence 01111223456889999999999999999999987
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.8e-47 Score=396.44 Aligned_cols=249 Identities=22% Similarity=0.317 Sum_probs=190.3
Q ss_pred hhhhhcCccccceEEEeeecCCCceEEEEEEccccc--ccchHHHHHHHHHhcccCCCCcccccceecc--CCceEEEEE
Q 003836 504 GFKEELGRGAFGTVYKGFVNMGSSNHVAVKKLNSVF--QDSEKEFKAEVNGIGQTHHKNLVRLLGYCDE--GQNRLLVYE 579 (792)
Q Consensus 504 ~~~~~lG~G~~g~Vy~g~~~~~~~~~vavK~~~~~~--~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~--~~~~~lV~E 579 (792)
.+.+.||+|+||+||+|... .+++.||||++.... ....+.+.+|++++++++|||||++++++.+ .+..++|||
T Consensus 7 ~~~~~iG~G~fg~Vy~~~~~-~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~ivmE 85 (269)
T d2java1 7 EVLYTIGTGSYGRCQKIRRK-SDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYIVME 85 (269)
T ss_dssp EEEEEEEECSSEEEEEEEET-TTCCEEEEEEECCTTSCHHHHHHHHHHHHHTTSCCCTTBCCEEEEEEC----CEEEEEE
T ss_pred EEeEEEecCCCeEEEEEEEC-CCCCEEEEEEEChhhCCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEeCCCCEEEEEEe
Confidence 45578999999999999754 556899999987543 3345678999999999999999999999864 456899999
Q ss_pred eccCCCccccccC----CCCCchhHHHHHHHHHHHHHHHHhhcc--CCCeEecCCCCCcEEEcCCCCeEEeecCCCcccc
Q 003836 580 FMSNGTVASFLFG----DSKPNWKLRTEIAMGIAGGLFYLHEEC--CTQIIHCDIKPQNILLDDHYNARISDFGLAKLLT 653 (792)
Q Consensus 580 ~~~~gsL~~~l~~----~~~l~~~~~~~i~~~ia~gL~yLH~~~--~~~ivH~dikp~NILl~~~~~~kl~Dfg~a~~~~ 653 (792)
|+++|+|.+++.. ...+++..+..++.||+.||.|||++. ..+|+||||||+||||+.++.+||+|||+++...
T Consensus 86 y~~~g~L~~~i~~~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~~~~~~IiHrDiKp~NIll~~~~~vkl~DFG~a~~~~ 165 (269)
T d2java1 86 YCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILN 165 (269)
T ss_dssp CCTTEEHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHHCC---------CCGGGEEECTTSCEEECCHHHHHHC-
T ss_pred cCCCCcHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCCCEEeCcCchhhcCcCCCCcEEEeeccceeecc
Confidence 9999999999864 357899999999999999999999972 1249999999999999999999999999999865
Q ss_pred CCCCCccccccccCCcccccccccCCCCcccceehHHHHHHHHHhcCcCCCcchhhhhhhhHHHHHHHhhcccchhHhhh
Q 003836 654 LDQSHTNTAIRGTKGYVAPEWFRNMPITVKVDVYSYGVLLLEIICLRRNIDNEISKVDKAILTDWAYDRYQERTLEALVE 733 (792)
Q Consensus 654 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DV~S~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 733 (792)
.... ......||+.|+|||++.+..++.++|||||||++|||+||+.||........ . . .+..
T Consensus 166 ~~~~-~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyel~tg~~Pf~~~~~~~~---~-----~--------~i~~ 228 (269)
T d2java1 166 HDTS-FAKAFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKEL---A-----G--------KIRE 228 (269)
T ss_dssp -----------CCCSCCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHH---H-----H--------HHHH
T ss_pred cCCC-ccccCCCCcccCCHHHHcCCCCChHHHHHhhCHHHHHHhhCCCCCCCCCHHHH---H-----H--------HHHc
Confidence 4332 23346799999999999999999999999999999999999999975432210 0 0 0111
Q ss_pred chhcccCCHHHHHHHHHHHHHccccCCCCCCCHHhHHH
Q 003836 734 NDLEAMNNVTMLHRFVMVAFWCIQEDPSHRPTMRKVTQ 771 (792)
Q Consensus 734 ~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~ 771 (792)
... ...+...++++.+|+.+||+.||++|||++|+++
T Consensus 229 ~~~-~~~~~~~s~~l~~li~~~L~~dp~~Rps~~ell~ 265 (269)
T d2java1 229 GKF-RRIPYRYSDELNEIITRMLNLKDYHRPSVEEILE 265 (269)
T ss_dssp TCC-CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred CCC-CCCCcccCHHHHHHHHHHcCCChhHCcCHHHHHh
Confidence 111 1122334567899999999999999999999987
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.3e-47 Score=408.97 Aligned_cols=263 Identities=21% Similarity=0.298 Sum_probs=204.2
Q ss_pred hhhhhhcCccccceEEEeeecCCCceEEEEEEccccc-ccchHHHHHHHHHhcccCCCCcccccceeccCCceEEEEEec
Q 003836 503 RGFKEELGRGAFGTVYKGFVNMGSSNHVAVKKLNSVF-QDSEKEFKAEVNGIGQTHHKNLVRLLGYCDEGQNRLLVYEFM 581 (792)
Q Consensus 503 ~~~~~~lG~G~~g~Vy~g~~~~~~~~~vavK~~~~~~-~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~lV~E~~ 581 (792)
+.+.++||+|+||+||+|.. ..+++.||+|+++... ....+.+.+|+.++++++|||||+++++|.+.++.++||||+
T Consensus 8 y~~~~~iG~G~fg~V~~~~~-~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~iVmEy~ 86 (322)
T d1s9ja_ 8 FEKISELGAGNGGVVFKVSH-KPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHM 86 (322)
T ss_dssp EEEEEEEECCSSCCEEEEEE-TTTTEEEEEEEEECCCCTTHHHHHHHHGGGGGGCCCTTBCCEEEEEECSSEEEEEEECC
T ss_pred CEEEEEEecCCCeEEEEEEE-CCCCcEEEEEEEChhhCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEcC
Confidence 34457899999999999975 4567899999987543 334568999999999999999999999999999999999999
Q ss_pred cCCCccccccCCCCCchhHHHHHHHHHHHHHHHHhhccCCCeEecCCCCCcEEEcCCCCeEEeecCCCccccCCCCCccc
Q 003836 582 SNGTVASFLFGDSKPNWKLRTEIAMGIAGGLFYLHEECCTQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLDQSHTNT 661 (792)
Q Consensus 582 ~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dikp~NILl~~~~~~kl~Dfg~a~~~~~~~~~~~~ 661 (792)
++|+|.+++.+...+++..+..++.||+.||.|||++ .+|+||||||+||||++++.+||+|||+|+...... ..
T Consensus 87 ~gg~L~~~l~~~~~l~~~~~~~~~~qil~aL~yLH~~--~~IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~~~---~~ 161 (322)
T d1s9ja_ 87 DGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREK--HKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSM---AN 161 (322)
T ss_dssp TTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHH--HCCCCSCCSGGGEEECTTCCEEECCCCCCHHHHHHT---C-
T ss_pred CCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHh--CCEEccccCHHHeeECCCCCEEEeeCCCccccCCCc---cc
Confidence 9999999998888899999999999999999999973 189999999999999999999999999998764322 23
Q ss_pred cccccCCcccccccccCCCCcccceehHHHHHHHHHhcCcCCCcchhhhhhhhHHHHHH---------------------
Q 003836 662 AIRGTKGYVAPEWFRNMPITVKVDVYSYGVLLLEIICLRRNIDNEISKVDKAILTDWAY--------------------- 720 (792)
Q Consensus 662 ~~~gt~~y~aPE~~~~~~~~~k~DV~S~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~--------------------- 720 (792)
...||+.|+|||++.+..++.++||||+||++|||++|+.||.................
T Consensus 162 ~~~GT~~Y~APEvl~~~~y~~~~DiWSlGvil~ell~G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (322)
T d1s9ja_ 162 SFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPLSSYG 241 (322)
T ss_dssp --CCSSCCCCHHHHHCSCCCTTHHHHHHHHHHHHHHHSSCCSSCCCTTHHHHHC--------------------------
T ss_pred cccCCccccCchHHcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhcCCcccCCcccccccccccccc
Confidence 45799999999999999999999999999999999999999975432211100000000
Q ss_pred -HhhcccchhHhhhchh----cccCCHHHHHHHHHHHHHccccCCCCCCCHHhHHH
Q 003836 721 -DRYQERTLEALVENDL----EAMNNVTMLHRFVMVAFWCIQEDPSHRPTMRKVTQ 771 (792)
Q Consensus 721 -~~~~~~~~~~~~~~~~----~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~ 771 (792)
.........+..+... ........+.++.+++.+||+.||++|||++|+++
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~ta~e~L~ 297 (322)
T d1s9ja_ 242 MDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMV 297 (322)
T ss_dssp ----CCCCHHHHHHHHHTSCCCCCCBTTBCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred cccccchhHHHHHhhhhccCCccCccccCCHHHHHHHHHHcCCChhHCcCHHHHhh
Confidence 0000000111111100 00111123467889999999999999999999987
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.8e-47 Score=405.96 Aligned_cols=254 Identities=26% Similarity=0.356 Sum_probs=206.4
Q ss_pred hhhhhhcCccccceEEEeeecCC----CceEEEEEEcccc-cccchHHHHHHHHHhccc-CCCCcccccceeccCCceEE
Q 003836 503 RGFKEELGRGAFGTVYKGFVNMG----SSNHVAVKKLNSV-FQDSEKEFKAEVNGIGQT-HHKNLVRLLGYCDEGQNRLL 576 (792)
Q Consensus 503 ~~~~~~lG~G~~g~Vy~g~~~~~----~~~~vavK~~~~~-~~~~~~~~~~Ei~~l~~l-~h~niv~l~g~~~~~~~~~l 576 (792)
..+.++||+|+||+||+|..... ....||||++... .......+.+|+.++.++ +|||||++++++.+.+..++
T Consensus 39 ~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~~~l 118 (325)
T d1rjba_ 39 LEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLSGPIYL 118 (325)
T ss_dssp EEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEE
T ss_pred eEEeeEEeeCCCeEEEEEEEcCCCcccceeEEEEEEeccccCHHHHHHHHHHHHHHHHhcCCCcEeEEEEEEeeCCeEEE
Confidence 34568899999999999986432 2347999998653 334456899999999998 89999999999999999999
Q ss_pred EEEeccCCCccccccCCC-----------------------CCchhHHHHHHHHHHHHHHHHhhccCCCeEecCCCCCcE
Q 003836 577 VYEFMSNGTVASFLFGDS-----------------------KPNWKLRTEIAMGIAGGLFYLHEECCTQIIHCDIKPQNI 633 (792)
Q Consensus 577 V~E~~~~gsL~~~l~~~~-----------------------~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dikp~NI 633 (792)
||||+++|+|.++|+... .+++..++.|+.||++||+|||++ +|+||||||+||
T Consensus 119 v~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~yLH~~---~IiHRDlKp~Ni 195 (325)
T d1rjba_ 119 IFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFK---SCVHRDLAARNV 195 (325)
T ss_dssp EEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHT---TEEETTCSGGGE
T ss_pred EEEcCCCCcHHHHHHhccCCCcchhhhhccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhC---CeeeccCchhcc
Confidence 999999999999996542 478899999999999999999998 999999999999
Q ss_pred EEcCCCCeEEeecCCCccccCCCCCc-cccccccCCcccccccccCCCCcccceehHHHHHHHHHh-cCcCCCcchhhhh
Q 003836 634 LLDDHYNARISDFGLAKLLTLDQSHT-NTAIRGTKGYVAPEWFRNMPITVKVDVYSYGVLLLEIIC-LRRNIDNEISKVD 711 (792)
Q Consensus 634 Ll~~~~~~kl~Dfg~a~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~k~DV~S~Gv~l~el~t-g~~p~~~~~~~~~ 711 (792)
|++.++.+||+|||+|+......... .....||+.|||||.+.+..++.++|||||||++|||+| |+.||........
T Consensus 196 ll~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwS~Gvil~emlt~g~~Pf~~~~~~~~ 275 (325)
T d1rjba_ 196 LVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGIPVDAN 275 (325)
T ss_dssp EEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSHH
T ss_pred ccccCCeEEEeeccccccccCCCceeeeccccCCCccCChHHHcCCCCCcceeccchhHHHHHHHhCCCCCCCCCCHHHH
Confidence 99999999999999998765544332 234568999999999999999999999999999999998 8999865432211
Q ss_pred hhhHHHHHHHhhcccchhHhhhchhcccCCHHHHHHHHHHHHHccccCCCCCCCHHhHHHHhcc
Q 003836 712 KAILTDWAYDRYQERTLEALVENDLEAMNNVTMLHRFVMVAFWCIQEDPSHRPTMRKVTQMLEG 775 (792)
Q Consensus 712 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~L~~ 775 (792)
+..++........+...++++.+|+.+||+.||++|||++||+++|..
T Consensus 276 ----------------~~~~~~~~~~~~~p~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~L~~ 323 (325)
T d1rjba_ 276 ----------------FYKLIQNGFKMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLGC 323 (325)
T ss_dssp ----------------HHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred ----------------HHHHHhcCCCCCCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHhC
Confidence 111222222333344556789999999999999999999999999963
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3e-47 Score=398.39 Aligned_cols=246 Identities=20% Similarity=0.275 Sum_probs=202.8
Q ss_pred hhhhhhcCccccceEEEeeecCCCceEEEEEEcccc---cccchHHHHHHHHHhcccCCCCcccccceeccCCceEEEEE
Q 003836 503 RGFKEELGRGAFGTVYKGFVNMGSSNHVAVKKLNSV---FQDSEKEFKAEVNGIGQTHHKNLVRLLGYCDEGQNRLLVYE 579 (792)
Q Consensus 503 ~~~~~~lG~G~~g~Vy~g~~~~~~~~~vavK~~~~~---~~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~lV~E 579 (792)
+.+.+.||+|+||+||+|... .+++.||||++.+. .....+.+.+|++++++++||||+++++++.+.+..++|||
T Consensus 10 y~i~~~lG~G~fg~Vy~a~~~-~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~ivmE 88 (288)
T d1uu3a_ 10 FKFGKILGEGSFSTVVLAREL-ATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGLS 88 (288)
T ss_dssp EEEEEEEEECSSCEEEEEEET-TTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCSTTBCCEEEEEECSSEEEEEEC
T ss_pred CEEEEEEeeCCCeEEEEEEEC-CCCCEEEEEEEehHHccCHHHHHHHHHHHHHHHHcCCCCeeEEEEEEEECCEEEEEEE
Confidence 446688999999999999754 45789999998653 23345789999999999999999999999999999999999
Q ss_pred eccCCCccccccCCCCCchhHHHHHHHHHHHHHHHHhhccCCCeEecCCCCCcEEEcCCCCeEEeecCCCccccCCCC-C
Q 003836 580 FMSNGTVASFLFGDSKPNWKLRTEIAMGIAGGLFYLHEECCTQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLDQS-H 658 (792)
Q Consensus 580 ~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dikp~NILl~~~~~~kl~Dfg~a~~~~~~~~-~ 658 (792)
|+++|+|.+++.....+++..+..++.||+.||+|||+. +|+||||||+|||+++++.+||+|||+|+.+..... .
T Consensus 89 y~~gg~L~~~~~~~~~l~e~~~~~~~~qi~~al~ylH~~---~iiHrDiKp~NIll~~~~~vkl~DFG~a~~~~~~~~~~ 165 (288)
T d1uu3a_ 89 YAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGK---GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQA 165 (288)
T ss_dssp CCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTSCEEECCCTTCEECC------
T ss_pred ccCCCCHHHhhhccCCCCHHHHHHHHHHHHHHHHhhccc---cEEcCcCCccccccCCCceEEecccccceecccCCccc
Confidence 999999999998888999999999999999999999999 999999999999999999999999999998754332 2
Q ss_pred ccccccccCCcccccccccCCCCcccceehHHHHHHHHHhcCcCCCcchhhhhhhhHHHHHHHhhcccchhHhhhchhcc
Q 003836 659 TNTAIRGTKGYVAPEWFRNMPITVKVDVYSYGVLLLEIICLRRNIDNEISKVDKAILTDWAYDRYQERTLEALVENDLEA 738 (792)
Q Consensus 659 ~~~~~~gt~~y~aPE~~~~~~~~~k~DV~S~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 738 (792)
......||+.|+|||++.+..++.++|||||||++|||++|+.||........ . ..+.... .
T Consensus 166 ~~~~~~GT~~Y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~---~-------------~~i~~~~--~ 227 (288)
T d1uu3a_ 166 RANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLI---F-------------QKIIKLE--Y 227 (288)
T ss_dssp ----CCCCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHH---H-------------HHHHTTC--C
T ss_pred ccccccCCccccCceeeccCCCCcccceehhhHHHHHHhhCCCCCCCcCHHHH---H-------------HHHHcCC--C
Confidence 33456799999999999999999999999999999999999999975432111 0 0011111 1
Q ss_pred cCCHHHHHHHHHHHHHccccCCCCCCCHHhHH
Q 003836 739 MNNVTMLHRFVMVAFWCIQEDPSHRPTMRKVT 770 (792)
Q Consensus 739 ~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl 770 (792)
..+...++++.+|+.+||+.||++|||++|++
T Consensus 228 ~~p~~~s~~~~~li~~~L~~dP~~R~t~~e~~ 259 (288)
T d1uu3a_ 228 DFPEKFFPKARDLVEKLLVLDATKRLGCEEME 259 (288)
T ss_dssp CCCTTCCHHHHHHHHTTSCSSGGGSTTSGGGT
T ss_pred CCCccCCHHHHHHHHHHccCCHhHCcCHHHHc
Confidence 12233456788999999999999999999864
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.8e-47 Score=398.83 Aligned_cols=247 Identities=24% Similarity=0.340 Sum_probs=203.7
Q ss_pred hhhhhcCccccceEEEeeecCCCceEEEEEEcccccccchHHHHHHHHHhcccCCCCcccccceeccCCceEEEEEeccC
Q 003836 504 GFKEELGRGAFGTVYKGFVNMGSSNHVAVKKLNSVFQDSEKEFKAEVNGIGQTHHKNLVRLLGYCDEGQNRLLVYEFMSN 583 (792)
Q Consensus 504 ~~~~~lG~G~~g~Vy~g~~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~lV~E~~~~ 583 (792)
.+.+.||+|+||+||+|... .+++.||||++........+.+.+|++++++++|||||++++++.+.+..+|||||+++
T Consensus 15 ~i~~~iG~G~fg~Vy~~~~~-~~~~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lvmEy~~~ 93 (288)
T d2jfla1 15 EIIGELGDGAFGKVYKAQNK-ETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFCAG 93 (288)
T ss_dssp EEEEEEEEETTEEEEEEEET-TTCCEEEEEEEECSSSGGGGGTHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCTT
T ss_pred EEeEEEeeCCCcEEEEEEEC-CCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCeEEEEEecCCC
Confidence 44578999999999999754 56789999999876666778899999999999999999999999999999999999999
Q ss_pred CCccccccC-CCCCchhHHHHHHHHHHHHHHHHhhccCCCeEecCCCCCcEEEcCCCCeEEeecCCCccccCCCCCcccc
Q 003836 584 GTVASFLFG-DSKPNWKLRTEIAMGIAGGLFYLHEECCTQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLDQSHTNTA 662 (792)
Q Consensus 584 gsL~~~l~~-~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dikp~NILl~~~~~~kl~Dfg~a~~~~~~~~~~~~~ 662 (792)
|+|.+++.+ ...+++..+..++.||+.||.|||++ +|+||||||+|||++.++.+||+|||+|+...... .....
T Consensus 94 g~L~~~~~~~~~~l~e~~~~~i~~qi~~gL~ylH~~---~ivHrDiKp~NIll~~~~~~Kl~DFG~a~~~~~~~-~~~~~ 169 (288)
T d2jfla1 94 GAVDAVMLELERPLTESQIQVVCKQTLDALNYLHDN---KIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTI-QRRDS 169 (288)
T ss_dssp EEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECHHHH-HHHTC
T ss_pred CcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC---CEEEeecChhheeECCCCCEEEEechhhhccCCCc-ccccc
Confidence 999999765 45689999999999999999999999 99999999999999999999999999997653221 12234
Q ss_pred ccccCCcccccccc-----cCCCCcccceehHHHHHHHHHhcCcCCCcchhhhhhhhHHHHHHHhhcccchhHhhhch-h
Q 003836 663 IRGTKGYVAPEWFR-----NMPITVKVDVYSYGVLLLEIICLRRNIDNEISKVDKAILTDWAYDRYQERTLEALVEND-L 736 (792)
Q Consensus 663 ~~gt~~y~aPE~~~-----~~~~~~k~DV~S~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~ 736 (792)
..||+.|+|||++. +..++.++|||||||++|||++|+.||........ +.. +.... .
T Consensus 170 ~~Gt~~y~APE~l~~~~~~~~~y~~k~DiwSlGvilyemltg~~Pf~~~~~~~~---~~~-------------i~~~~~~ 233 (288)
T d2jfla1 170 FIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMRV---LLK-------------IAKSEPP 233 (288)
T ss_dssp CCSCCTTCCHHHHTTCSTTTSSTTTHHHHHHHHHHHHHHHHSSCTTTTSCGGGH---HHH-------------HHHSCCC
T ss_pred cccccccCCHHHHhhcccCCCCCChhhhHHHHHHHHHHHhhCCCCCCCCCHHHH---HHH-------------HHcCCCC
Confidence 56999999999984 45689999999999999999999999975432211 100 11110 0
Q ss_pred cccCCHHHHHHHHHHHHHccccCCCCCCCHHhHHH
Q 003836 737 EAMNNVTMLHRFVMVAFWCIQEDPSHRPTMRKVTQ 771 (792)
Q Consensus 737 ~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~ 771 (792)
....+...++++.+|+.+||+.||++|||++|+++
T Consensus 234 ~~~~~~~~s~~~~~li~~~L~~dp~~R~t~~ell~ 268 (288)
T d2jfla1 234 TLAQPSRWSSNFKDFLKKCLEKNVDARWTTSQLLQ 268 (288)
T ss_dssp CCSSGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred CCCccccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 11122344567889999999999999999999987
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=1.5e-46 Score=396.97 Aligned_cols=248 Identities=24% Similarity=0.344 Sum_probs=190.2
Q ss_pred hhhhhhcCccccceEEEeeecCCCceEEEEEEccccc-ccchHHHHHHHHHhcccCCCCcccccceeccCCceEEEEEec
Q 003836 503 RGFKEELGRGAFGTVYKGFVNMGSSNHVAVKKLNSVF-QDSEKEFKAEVNGIGQTHHKNLVRLLGYCDEGQNRLLVYEFM 581 (792)
Q Consensus 503 ~~~~~~lG~G~~g~Vy~g~~~~~~~~~vavK~~~~~~-~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~lV~E~~ 581 (792)
+.+.+.||+|+||+||+|... .+++.||||++.... ....+.+.+|++++++++|||||++++++.+++..+|||||+
T Consensus 11 Y~~~~~lG~G~fg~Vy~~~~~-~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lvmE~~ 89 (307)
T d1a06a_ 11 YDFRDVLGTGAFSEVILAEDK-RTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHPNIVALDDIYESGGHLYLIMQLV 89 (307)
T ss_dssp EEEEEESBSGGGGGEEEEEET-TTCCEEEEEEEEC----------CHHHHHHHTCCCTTBCCEEEEEECSSEEEEEECCC
T ss_pred eEEEEEEeeccCeEEEEEEEC-CCCCEEEEEEEchHHhhhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEecc
Confidence 456688999999999999754 567899999987543 334567889999999999999999999999999999999999
Q ss_pred cCCCccccccCCCCCchhHHHHHHHHHHHHHHHHhhccCCCeEecCCCCCcEEEc---CCCCeEEeecCCCccccCCCCC
Q 003836 582 SNGTVASFLFGDSKPNWKLRTEIAMGIAGGLFYLHEECCTQIIHCDIKPQNILLD---DHYNARISDFGLAKLLTLDQSH 658 (792)
Q Consensus 582 ~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dikp~NILl~---~~~~~kl~Dfg~a~~~~~~~~~ 658 (792)
++|+|.+++.....+++..+..++.||+.||+|||++ +|+||||||+|||+. +++.+||+|||+++......
T Consensus 90 ~gg~L~~~l~~~~~l~e~~~~~~~~qi~~al~ylH~~---~iiHrDiKp~Nil~~~~~~~~~vkl~DFG~a~~~~~~~-- 164 (307)
T d1a06a_ 90 SGGELFDRIVEKGFYTERDASRLIFQVLDAVKYLHDL---GIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGS-- 164 (307)
T ss_dssp CSCBHHHHHHTCSCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESSSSTTCCEEECCC------------
T ss_pred CCCcHHHhhhcccCCCHHHHHHHHHHHHHHHHhhhhc---eeeeEEecccceeecccCCCceEEEeccceeEEccCCC--
Confidence 9999999998888899999999999999999999998 999999999999995 57899999999998654322
Q ss_pred ccccccccCCcccccccccCCCCcccceehHHHHHHHHHhcCcCCCcchhhhhhhhHHHHHHHhhcccchhHhhhch--h
Q 003836 659 TNTAIRGTKGYVAPEWFRNMPITVKVDVYSYGVLLLEIICLRRNIDNEISKVDKAILTDWAYDRYQERTLEALVEND--L 736 (792)
Q Consensus 659 ~~~~~~gt~~y~aPE~~~~~~~~~k~DV~S~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~ 736 (792)
......||+.|||||++.+..++.++|||||||++|||++|+.||......... ..+.... .
T Consensus 165 ~~~~~~GT~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~----------------~~i~~~~~~~ 228 (307)
T d1a06a_ 165 VLSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDENDAKLF----------------EQILKAEYEF 228 (307)
T ss_dssp --------CTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHH----------------HHHHTTCCCC
T ss_pred eeeeeeeCccccCcHHHcCCCCCcHHHhhhhhHHHHHHHhCCCCCCCCCHHHHH----------------HHHhccCCCC
Confidence 233467999999999999999999999999999999999999999754322110 0011111 1
Q ss_pred cccCCHHHHHHHHHHHHHccccCCCCCCCHHhHHHH
Q 003836 737 EAMNNVTMLHRFVMVAFWCIQEDPSHRPTMRKVTQM 772 (792)
Q Consensus 737 ~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~ 772 (792)
........++++.+++.+||+.||++|||++|+++.
T Consensus 229 ~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~h 264 (307)
T d1a06a_ 229 DSPYWDDISDSAKDFIRHLMEKDPEKRFTCEQALQH 264 (307)
T ss_dssp CTTTTTTSCHHHHHHHHHHSCSSGGGSCCHHHHHHS
T ss_pred CCccccCCCHHHHHHHHHHccCCHhHCcCHHHHhcC
Confidence 111122345678999999999999999999999983
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=2e-46 Score=396.06 Aligned_cols=244 Identities=25% Similarity=0.312 Sum_probs=201.1
Q ss_pred hhhhhhcCccccceEEEeeecCCCceEEEEEEcccccc---cchHHHHHHHHHhcccCCCCcccccceeccCCceEEEEE
Q 003836 503 RGFKEELGRGAFGTVYKGFVNMGSSNHVAVKKLNSVFQ---DSEKEFKAEVNGIGQTHHKNLVRLLGYCDEGQNRLLVYE 579 (792)
Q Consensus 503 ~~~~~~lG~G~~g~Vy~g~~~~~~~~~vavK~~~~~~~---~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~lV~E 579 (792)
+...++||+|+||+||+|... .+++.||||++..... ...+.+.+|++++++++|||||++++++.+++..++|||
T Consensus 17 y~~l~~lG~G~fg~Vy~a~~~-~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~iv~E 95 (309)
T d1u5ra_ 17 FSDLREIGHGSFGAVYFARDV-RNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVME 95 (309)
T ss_dssp EEEEEEEEECSSSEEEEEEET-TTTEEEEEEEEECCSSCHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred cEeeEEEecCCCeEEEEEEEC-CCCcEEEEEEEchhhccCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEECCEEEEEEE
Confidence 444578999999999999754 5678999999875432 234578999999999999999999999999999999999
Q ss_pred eccCCCccccccCCCCCchhHHHHHHHHHHHHHHHHhhccCCCeEecCCCCCcEEEcCCCCeEEeecCCCccccCCCCCc
Q 003836 580 FMSNGTVASFLFGDSKPNWKLRTEIAMGIAGGLFYLHEECCTQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLDQSHT 659 (792)
Q Consensus 580 ~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dikp~NILl~~~~~~kl~Dfg~a~~~~~~~~~~ 659 (792)
|+++|+|..++..+..+++..+..++.||+.||.|||++ +|+||||||+||||+.++.+||+|||+++....
T Consensus 96 ~~~~g~l~~~~~~~~~l~e~~~~~i~~qi~~aL~yLH~~---~iiHrDiKp~NILl~~~~~~Kl~DFG~a~~~~~----- 167 (309)
T d1u5ra_ 96 YCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSH---NMIHRDVKAGNILLSEPGLVKLGDFGSASIMAP----- 167 (309)
T ss_dssp CCSEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCSGGGEEEETTTEEEECCCTTCBSSSS-----
T ss_pred ecCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhC---CEeccCCCcceEEECCCCCEEEeecccccccCC-----
Confidence 999999988877778899999999999999999999999 999999999999999999999999999986543
Q ss_pred cccccccCCccccccccc---CCCCcccceehHHHHHHHHHhcCcCCCcchhhhhhhhHHHHHHHhhcccchhHhhhchh
Q 003836 660 NTAIRGTKGYVAPEWFRN---MPITVKVDVYSYGVLLLEIICLRRNIDNEISKVDKAILTDWAYDRYQERTLEALVENDL 736 (792)
Q Consensus 660 ~~~~~gt~~y~aPE~~~~---~~~~~k~DV~S~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 736 (792)
.....||+.|||||++.+ ..++.++|||||||++|||++|+.||........ + ..+.....
T Consensus 168 ~~~~~GT~~Y~APE~~~~~~~~~y~~~~DiwSlGvilyel~~g~~Pf~~~~~~~~---~-------------~~i~~~~~ 231 (309)
T d1u5ra_ 168 ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSA---L-------------YHIAQNES 231 (309)
T ss_dssp BCCCCSCGGGCCHHHHTTTTSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHH---H-------------HHHHHSCC
T ss_pred CCccccCccccCHHHHhccCCCCcCchhhhhhHHHHHHHHHHCCCCCCCCCHHHH---H-------------HHHHhCCC
Confidence 234569999999999864 4689999999999999999999999965432111 0 01111111
Q ss_pred cccCCHHHHHHHHHHHHHccccCCCCCCCHHhHHH
Q 003836 737 EAMNNVTMLHRFVMVAFWCIQEDPSHRPTMRKVTQ 771 (792)
Q Consensus 737 ~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~ 771 (792)
....+...++++.+|+.+||+.||++|||++|+++
T Consensus 232 ~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~ 266 (309)
T d1u5ra_ 232 PALQSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLK 266 (309)
T ss_dssp CCCSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred CCCCCCCCCHHHHHHHHHHCcCChhHCcCHHHHHh
Confidence 11112234567889999999999999999999976
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.7e-46 Score=395.06 Aligned_cols=256 Identities=24% Similarity=0.414 Sum_probs=205.9
Q ss_pred hhhhhcCccccceEEEeeecCCC--ceEEEEEEcccc-cccchHHHHHHHHHhcccCCCCcccccceecc-CCceEEEEE
Q 003836 504 GFKEELGRGAFGTVYKGFVNMGS--SNHVAVKKLNSV-FQDSEKEFKAEVNGIGQTHHKNLVRLLGYCDE-GQNRLLVYE 579 (792)
Q Consensus 504 ~~~~~lG~G~~g~Vy~g~~~~~~--~~~vavK~~~~~-~~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~-~~~~~lV~E 579 (792)
+|.++||+|+||+||+|.+...+ ...||||+++.. .....++|.+|++++++++||||++++|++.+ +...++|||
T Consensus 30 ~~~~~iG~G~fg~Vyk~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~E 109 (311)
T d1r0pa_ 30 HFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLP 109 (311)
T ss_dssp EEEEEEEEETTEEEEEEEECC----CEEEEEEEECCCCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEETTTEEEEEEE
T ss_pred ccceEEeecCCeEEEEEEEECCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCEeEEeEEEEecCCceEEEEE
Confidence 45678999999999999875433 346899999753 33445789999999999999999999999865 457899999
Q ss_pred eccCCCccccccCC-CCCchhHHHHHHHHHHHHHHHHhhccCCCeEecCCCCCcEEEcCCCCeEEeecCCCccccCCCCC
Q 003836 580 FMSNGTVASFLFGD-SKPNWKLRTEIAMGIAGGLFYLHEECCTQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLDQSH 658 (792)
Q Consensus 580 ~~~~gsL~~~l~~~-~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dikp~NILl~~~~~~kl~Dfg~a~~~~~~~~~ 658 (792)
|+++|+|.+++... ...++..+++++.|+++||.|||+. +|+||||||+||||++++.+||+|||+++........
T Consensus 110 ~~~~g~l~~~~~~~~~~~~~~~~~~i~~qia~gL~~lH~~---~iiHrDLK~~NILl~~~~~~kL~DFG~~~~~~~~~~~ 186 (311)
T d1r0pa_ 110 YMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASK---KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFD 186 (311)
T ss_dssp CCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTCCEEECSSGGGCCTTTTTCC
T ss_pred EeecCchhhhhccccccchHHHHHHHHHHHHHhhhhhccc---CcccCCccHHhEeECCCCCEEEecccchhhccccccc
Confidence 99999999998765 4678889999999999999999998 9999999999999999999999999999977544332
Q ss_pred ---ccccccccCCcccccccccCCCCcccceehHHHHHHHHHhcCcCCCcchhhhhhhhHHHHHHHhhcccchhHhhhch
Q 003836 659 ---TNTAIRGTKGYVAPEWFRNMPITVKVDVYSYGVLLLEIICLRRNIDNEISKVDKAILTDWAYDRYQERTLEALVEND 735 (792)
Q Consensus 659 ---~~~~~~gt~~y~aPE~~~~~~~~~k~DV~S~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 735 (792)
......||+.|+|||.+....++.++||||||+++|||+||+.||.......+.. ..+...
T Consensus 187 ~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~SfGivl~El~t~~~p~~~~~~~~~~~----------------~~i~~g 250 (311)
T d1r0pa_ 187 SVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDIT----------------VYLLQG 250 (311)
T ss_dssp CTTCTTCSSCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCC------CH----------------HHHHTT
T ss_pred cceecccccccccccChHHHhcCCCCChhHhhhhHHHHHHHHHCCCCCCCCCCHHHHH----------------HHHHcC
Confidence 2234568999999999999999999999999999999999998886543221110 001111
Q ss_pred hcccCCHHHHHHHHHHHHHccccCCCCCCCHHhHHHHhccCcC
Q 003836 736 LEAMNNVTMLHRFVMVAFWCIQEDPSHRPTMRKVTQMLEGVVE 778 (792)
Q Consensus 736 ~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~L~~~~~ 778 (792)
.+...+...+.++.+++.+||+.||++||+|.||+++|+++..
T Consensus 251 ~~~~~p~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~L~~i~~ 293 (311)
T d1r0pa_ 251 RRLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFS 293 (311)
T ss_dssp CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred CCCCCcccCcHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHH
Confidence 1122233345678899999999999999999999999988753
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=2.8e-46 Score=395.17 Aligned_cols=255 Identities=23% Similarity=0.357 Sum_probs=207.0
Q ss_pred hhhhhcCccccceEEEeeecC----CCceEEEEEEccccccc-chHHHHHHHHHhcccCCCCcccccceeccCCceEEEE
Q 003836 504 GFKEELGRGAFGTVYKGFVNM----GSSNHVAVKKLNSVFQD-SEKEFKAEVNGIGQTHHKNLVRLLGYCDEGQNRLLVY 578 (792)
Q Consensus 504 ~~~~~lG~G~~g~Vy~g~~~~----~~~~~vavK~~~~~~~~-~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~lV~ 578 (792)
.+.++||+|+||+||+|+... .+++.||||+++..... ..++|.+|++++++++||||++++++|.+.+..++||
T Consensus 16 ~~~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~~v~ 95 (301)
T d1lufa_ 16 EYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCAVGKPMCLLF 95 (301)
T ss_dssp EEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSCEEEE
T ss_pred EEeEEEeeCCCeEEEEEEECCCccCCCCeEEEEEEEChhcChHHHHHHHHHHHHHHhcCCCCcccceeeeccCCceEEEE
Confidence 345789999999999998642 34578999999764333 3567999999999999999999999999999999999
Q ss_pred EeccCCCccccccCC------------------------CCCchhHHHHHHHHHHHHHHHHhhccCCCeEecCCCCCcEE
Q 003836 579 EFMSNGTVASFLFGD------------------------SKPNWKLRTEIAMGIAGGLFYLHEECCTQIIHCDIKPQNIL 634 (792)
Q Consensus 579 E~~~~gsL~~~l~~~------------------------~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dikp~NIL 634 (792)
||+++|+|.+++... ..+++..++.|+.||+.||+|||++ +|+||||||+|||
T Consensus 96 e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~ylH~~---~ivHrDlKp~NIL 172 (301)
T d1lufa_ 96 EYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSER---KFVHRDLATRNCL 172 (301)
T ss_dssp ECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEE
T ss_pred EecCCCcHHHHHHhcCccccccccccccchhhhccccCCCCCCHHHHHHHHHHHHHHhhhcccC---CeEeeEEcccceE
Confidence 999999999998632 2378889999999999999999998 9999999999999
Q ss_pred EcCCCCeEEeecCCCccccCCCCC-ccccccccCCcccccccccCCCCcccceehHHHHHHHHHhcCc-CCCcchhhhhh
Q 003836 635 LDDHYNARISDFGLAKLLTLDQSH-TNTAIRGTKGYVAPEWFRNMPITVKVDVYSYGVLLLEIICLRR-NIDNEISKVDK 712 (792)
Q Consensus 635 l~~~~~~kl~Dfg~a~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~k~DV~S~Gv~l~el~tg~~-p~~~~~~~~~~ 712 (792)
|+.++.+||+|||+++........ ......|++.|+|||.+.+..++.|+|||||||++|||++|.. ||........
T Consensus 173 ld~~~~~Kl~DFGls~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~t~ksDVwS~Gvvl~ell~~~~~p~~~~~~~e~- 251 (301)
T d1lufa_ 173 VGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYYGMAHEEV- 251 (301)
T ss_dssp ECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHH-
T ss_pred ECCCCcEEEccchhheeccCCccccccCCCCcCcCcCCHHHHccCCCChhhhhccchhhHHHHHccCCCCCCCCCHHHH-
Confidence 999999999999999876543332 2334668999999999999999999999999999999999975 5554322111
Q ss_pred hhHHHHHHHhhcccchhHhhhchhcccCCHHHHHHHHHHHHHccccCCCCCCCHHhHHHHhccCcC
Q 003836 713 AILTDWAYDRYQERTLEALVENDLEAMNNVTMLHRFVMVAFWCIQEDPSHRPTMRKVTQMLEGVVE 778 (792)
Q Consensus 713 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~L~~~~~ 778 (792)
. ..+. .......+...+.++.+|+.+||+.+|++||||.||+++|+++.+
T Consensus 252 --~-------------~~v~-~~~~~~~p~~~~~~~~~li~~cl~~~P~~RPt~~ev~~~L~~i~~ 301 (301)
T d1lufa_ 252 --I-------------YYVR-DGNILACPENCPLELYNLMRLCWSKLPADRPSFCSIHRILQRMCE 301 (301)
T ss_dssp --H-------------HHHH-TTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTC
T ss_pred --H-------------HHHH-cCCCCCCCccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhcC
Confidence 0 0111 111122333455688999999999999999999999999998864
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Probab=100.00 E-value=1.1e-45 Score=397.00 Aligned_cols=250 Identities=23% Similarity=0.340 Sum_probs=206.1
Q ss_pred hhhhhhcCccccceEEEeeecCCCceEEEEEEcccccccchHHHHHHHHHhcccCCCCcccccceeccCCceEEEEEecc
Q 003836 503 RGFKEELGRGAFGTVYKGFVNMGSSNHVAVKKLNSVFQDSEKEFKAEVNGIGQTHHKNLVRLLGYCDEGQNRLLVYEFMS 582 (792)
Q Consensus 503 ~~~~~~lG~G~~g~Vy~g~~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~lV~E~~~ 582 (792)
+.+.+.||+|+||+||+|... .+++.||||++........+.+.+|++++++++|||||++++++.+.+..+|||||++
T Consensus 28 Y~i~~~lG~G~fg~Vy~~~~~-~~g~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmE~~~ 106 (350)
T d1koaa2 28 YDIHEELGTGAFGVVHRVTER-ATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEFMS 106 (350)
T ss_dssp EEEEEEEEEETTEEEEEEEET-TTTEEEEEEEECCCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEEEETTEEEEEECCCC
T ss_pred eEEEEEEecCcCeEEEEEEEC-CCCCEEEEEEEcccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEcCC
Confidence 456688999999999999753 5678999999987666667789999999999999999999999999999999999999
Q ss_pred CCCccccccCC-CCCchhHHHHHHHHHHHHHHHHhhccCCCeEecCCCCCcEEEc--CCCCeEEeecCCCccccCCCCCc
Q 003836 583 NGTVASFLFGD-SKPNWKLRTEIAMGIAGGLFYLHEECCTQIIHCDIKPQNILLD--DHYNARISDFGLAKLLTLDQSHT 659 (792)
Q Consensus 583 ~gsL~~~l~~~-~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dikp~NILl~--~~~~~kl~Dfg~a~~~~~~~~~~ 659 (792)
+|+|.+++... ..+++..+..|+.||+.||+|||++ +|+||||||+|||++ .++.+||+|||+++..... ..
T Consensus 107 gg~L~~~l~~~~~~l~e~~~~~i~~qi~~aL~ylH~~---~iiHrDiKp~NIll~~~~~~~vkL~DFG~a~~~~~~--~~ 181 (350)
T d1koaa2 107 GGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHEN---NYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPK--QS 181 (350)
T ss_dssp SCBHHHHHTCTTSCBCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSTTSCCEEECCCTTCEECCTT--SC
T ss_pred CCCHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhc---CCeeeeechhHeeeccCCCCeEEEeecchheecccc--cc
Confidence 99999998644 5799999999999999999999999 999999999999996 4678999999999876533 23
Q ss_pred cccccccCCcccccccccCCCCcccceehHHHHHHHHHhcCcCCCcchhhhhhhhHHHHHHHhhcccchhHhhhchhccc
Q 003836 660 NTAIRGTKGYVAPEWFRNMPITVKVDVYSYGVLLLEIICLRRNIDNEISKVDKAILTDWAYDRYQERTLEALVENDLEAM 739 (792)
Q Consensus 660 ~~~~~gt~~y~aPE~~~~~~~~~k~DV~S~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 739 (792)
.....||+.|||||++.+..++.++|||||||++|||++|+.||........ +........ .....
T Consensus 182 ~~~~~gT~~Y~aPEv~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~---~~~i~~~~~-----------~~~~~ 247 (350)
T d1koaa2 182 VKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDET---LRNVKSCDW-----------NMDDS 247 (350)
T ss_dssp EEEECSCTTTCCHHHHHTCCBCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHH---HHHHHHTCC-----------CSCCG
T ss_pred cceecCcccccCHHHHcCCCCChhHhhhhhhHHHHHHHhCCCCCCCCCHHHH---HHHHHhCCC-----------CCCcc
Confidence 3456799999999999999999999999999999999999999975432211 111000000 00011
Q ss_pred CCHHHHHHHHHHHHHccccCCCCCCCHHhHHHH
Q 003836 740 NNVTMLHRFVMVAFWCIQEDPSHRPTMRKVTQM 772 (792)
Q Consensus 740 ~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~ 772 (792)
.....++++.+|+.+||+.||++|||++|+++.
T Consensus 248 ~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~h 280 (350)
T d1koaa2 248 AFSGISEDGKDFIRKLLLADPNTRMTIHQALEH 280 (350)
T ss_dssp GGGGCCHHHHHHHHHHCCSSGGGSCCHHHHHHS
T ss_pred cccCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 112235678899999999999999999999984
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.3e-46 Score=392.02 Aligned_cols=254 Identities=22% Similarity=0.308 Sum_probs=195.5
Q ss_pred hhhhhhcCccccceEEEeeecCC--CceEEEEEEccccccc-chHHHHHHHHHhcccCCCCcccccceeccCCceEEEEE
Q 003836 503 RGFKEELGRGAFGTVYKGFVNMG--SSNHVAVKKLNSVFQD-SEKEFKAEVNGIGQTHHKNLVRLLGYCDEGQNRLLVYE 579 (792)
Q Consensus 503 ~~~~~~lG~G~~g~Vy~g~~~~~--~~~~vavK~~~~~~~~-~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~lV~E 579 (792)
+.+.+.||+|+||.||+|..... ....||||+++..... ..+.|.+|++++++++|||||++++++.+ +..++|||
T Consensus 9 ~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~-~~~~iv~E 87 (273)
T d1mp8a_ 9 IELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVITE-NPVWIIME 87 (273)
T ss_dssp EEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEECS-SSCEEEEE
T ss_pred eEEEEEEeeCCCcEEEEEEEecCCceeEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEec-CeEEEEEE
Confidence 44567899999999999976533 2457899998754333 35679999999999999999999999964 67899999
Q ss_pred eccCCCccccccCC-CCCchhHHHHHHHHHHHHHHHHhhccCCCeEecCCCCCcEEEcCCCCeEEeecCCCccccCCCCC
Q 003836 580 FMSNGTVASFLFGD-SKPNWKLRTEIAMGIAGGLFYLHEECCTQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLDQSH 658 (792)
Q Consensus 580 ~~~~gsL~~~l~~~-~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dikp~NILl~~~~~~kl~Dfg~a~~~~~~~~~ 658 (792)
|+++|+|.+++... ..+++..++.++.||++||.|||+. +|+||||||+|||+++++.+||+|||+++........
T Consensus 88 ~~~~g~l~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~---~iiHrDlKp~NIll~~~~~~Kl~DfG~a~~~~~~~~~ 164 (273)
T d1mp8a_ 88 LCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESK---RFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYY 164 (273)
T ss_dssp CCTTEEHHHHHHHTTTTSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETTEEEECC-------------
T ss_pred eccCCcHHhhhhccCCCCCHHHHHHHHHHHHHHhhhhccc---CeeccccchhheeecCCCcEEEccchhheeccCCcce
Confidence 99999999987654 5789999999999999999999999 9999999999999999999999999999987655544
Q ss_pred ccccccccCCcccccccccCCCCcccceehHHHHHHHHHh-cCcCCCcchhhhhhhhHHHHHHHhhcccchhHhhhchhc
Q 003836 659 TNTAIRGTKGYVAPEWFRNMPITVKVDVYSYGVLLLEIIC-LRRNIDNEISKVDKAILTDWAYDRYQERTLEALVENDLE 737 (792)
Q Consensus 659 ~~~~~~gt~~y~aPE~~~~~~~~~k~DV~S~Gv~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 737 (792)
......||+.|+|||.+.+..++.++|||||||++|||++ |..||........ . ..+.....
T Consensus 165 ~~~~~~gt~~y~apE~l~~~~~~~~~DiwSlGvil~e~lt~g~~P~~~~~~~~~---~--------------~~i~~~~~ 227 (273)
T d1mp8a_ 165 KASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDV---I--------------GRIENGER 227 (273)
T ss_dssp ------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGH---H--------------HHHHTTCC
T ss_pred eccceecCcccchhhHhccCCCCCccccccchHHHHHHHhcCCCCCCCCCHHHH---H--------------HHHHcCCC
Confidence 5555678999999999999999999999999999999998 7888865432211 0 00111111
Q ss_pred ccCCHHHHHHHHHHHHHccccCCCCCCCHHhHHHHhccCc
Q 003836 738 AMNNVTMLHRFVMVAFWCIQEDPSHRPTMRKVTQMLEGVV 777 (792)
Q Consensus 738 ~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~L~~~~ 777 (792)
...+...++++.+|+.+||+.||++|||++||++.|+.++
T Consensus 228 ~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ei~~~L~~i~ 267 (273)
T d1mp8a_ 228 LPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTIL 267 (273)
T ss_dssp CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred CCCCCCCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHH
Confidence 2233445678899999999999999999999999998764
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.5e-45 Score=388.09 Aligned_cols=249 Identities=25% Similarity=0.343 Sum_probs=203.9
Q ss_pred hhhhhhcCccccceEEEeeecCCCceEEEEEEccccc------ccchHHHHHHHHHhcccCCCCcccccceeccCCceEE
Q 003836 503 RGFKEELGRGAFGTVYKGFVNMGSSNHVAVKKLNSVF------QDSEKEFKAEVNGIGQTHHKNLVRLLGYCDEGQNRLL 576 (792)
Q Consensus 503 ~~~~~~lG~G~~g~Vy~g~~~~~~~~~vavK~~~~~~------~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~l 576 (792)
+.+.++||+|+||+||+|... .+++.||||++.+.. ....+.+.+|++++++++|||||++++++.+.+..+|
T Consensus 12 Y~~~~~lG~G~fg~Vy~~~~~-~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~i 90 (293)
T d1jksa_ 12 YDTGEELGSGQFAVVKKCREK-STGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDVIL 90 (293)
T ss_dssp EEEEEEEEECSSEEEEEEEET-TTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEE
T ss_pred EEEeEEEecCCCeEEEEEEEC-CCCCEEEEEEEEhhhcchhhhhHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEE
Confidence 455688999999999999753 567899999986432 1235789999999999999999999999999999999
Q ss_pred EEEeccCCCccccccCCCCCchhHHHHHHHHHHHHHHHHhhccCCCeEecCCCCCcEEEcCCC----CeEEeecCCCccc
Q 003836 577 VYEFMSNGTVASFLFGDSKPNWKLRTEIAMGIAGGLFYLHEECCTQIIHCDIKPQNILLDDHY----NARISDFGLAKLL 652 (792)
Q Consensus 577 V~E~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dikp~NILl~~~~----~~kl~Dfg~a~~~ 652 (792)
||||+++|+|.+++.....+++..+..++.||+.||+|||+. +|+||||||+|||++.++ .+||+|||+++..
T Consensus 91 v~E~~~gg~L~~~i~~~~~l~~~~~~~~~~qi~~al~yLH~~---~ivHrDiKp~Nill~~~~~~~~~vkl~DfG~a~~~ 167 (293)
T d1jksa_ 91 ILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHSL---QIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKI 167 (293)
T ss_dssp EEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESCSSSSSCCEEECCCTTCEEC
T ss_pred EEEcCCCccccchhccccccchhHHHHHHHHHHHHHHhhhhc---ceeecccccceEEEecCCCcccceEecchhhhhhc
Confidence 999999999999998888899999999999999999999999 999999999999998776 4999999999876
Q ss_pred cCCCCCccccccccCCcccccccccCCCCcccceehHHHHHHHHHhcCcCCCcchhhhhhhhHHHHHHHhhcccchhHhh
Q 003836 653 TLDQSHTNTAIRGTKGYVAPEWFRNMPITVKVDVYSYGVLLLEIICLRRNIDNEISKVDKAILTDWAYDRYQERTLEALV 732 (792)
Q Consensus 653 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DV~S~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 732 (792)
.... ......||+.|+|||++.+..++.++|||||||++|||++|+.||........ +... ....
T Consensus 168 ~~~~--~~~~~~~t~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~---~~~i-----~~~~----- 232 (293)
T d1jksa_ 168 DFGN--EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQET---LANV-----SAVN----- 232 (293)
T ss_dssp TTSC--BCSCCCCCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH---HHHH-----HTTC-----
T ss_pred CCCc--cccccCCCCcccCHHHHcCCCCCCcccchhhhHHHHHHHcCCCCCCCCCHHHH---HHHH-----HhcC-----
Confidence 4332 23345689999999999999999999999999999999999999975432211 0000 0000
Q ss_pred hchhcccCCHHHHHHHHHHHHHccccCCCCCCCHHhHHH
Q 003836 733 ENDLEAMNNVTMLHRFVMVAFWCIQEDPSHRPTMRKVTQ 771 (792)
Q Consensus 733 ~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~ 771 (792)
...........+.++.+|+.+||+.||++|||++|+++
T Consensus 233 -~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~ 270 (293)
T d1jksa_ 233 -YEFEDEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQ 270 (293)
T ss_dssp -CCCCHHHHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred -CCCCchhcCCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 00000011123467889999999999999999999987
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Probab=100.00 E-value=3.2e-45 Score=393.81 Aligned_cols=248 Identities=24% Similarity=0.323 Sum_probs=206.8
Q ss_pred hhhhhhcCccccceEEEeeecCCCceEEEEEEcccccccchHHHHHHHHHhcccCCCCcccccceeccCCceEEEEEecc
Q 003836 503 RGFKEELGRGAFGTVYKGFVNMGSSNHVAVKKLNSVFQDSEKEFKAEVNGIGQTHHKNLVRLLGYCDEGQNRLLVYEFMS 582 (792)
Q Consensus 503 ~~~~~~lG~G~~g~Vy~g~~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~lV~E~~~ 582 (792)
+.+.++||+|+||+||+|.. ..+++.||||+++.......+.+.+|++++++++|||||++++++.+++..+|||||++
T Consensus 31 Y~i~~~lG~G~fg~V~~a~~-~~~~~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivmE~~~ 109 (352)
T d1koba_ 31 YDILEELGSGAFGVVHRCVE-KATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEFLS 109 (352)
T ss_dssp EEEEEEEEEETTEEEEEEEE-TTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEEECCC
T ss_pred eEEEEEEecCCCeEEEEEEE-CCCCCEEEEEEECCcchhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEcCC
Confidence 45668899999999999975 35678999999987655566789999999999999999999999999999999999999
Q ss_pred CCCccccccCC-CCCchhHHHHHHHHHHHHHHHHhhccCCCeEecCCCCCcEEEc--CCCCeEEeecCCCccccCCCCCc
Q 003836 583 NGTVASFLFGD-SKPNWKLRTEIAMGIAGGLFYLHEECCTQIIHCDIKPQNILLD--DHYNARISDFGLAKLLTLDQSHT 659 (792)
Q Consensus 583 ~gsL~~~l~~~-~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dikp~NILl~--~~~~~kl~Dfg~a~~~~~~~~~~ 659 (792)
+|+|.+++... ..+++..+..|+.||+.||+|||+. +|+||||||+||||+ .++.+||+|||+|+...... .
T Consensus 110 gg~L~~~~~~~~~~l~e~~~~~i~~qi~~aL~ylH~~---~iiHRDiKp~NILl~~~~~~~vkL~DFGla~~~~~~~--~ 184 (352)
T d1koba_ 110 GGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEH---SIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDE--I 184 (352)
T ss_dssp CCBHHHHTTCTTCCBCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSTTCCCEEECCCTTCEECCTTS--C
T ss_pred CChHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecccccccccccccCCCeEEEeecccceecCCCC--c
Confidence 99999887655 4699999999999999999999998 999999999999998 67899999999999875432 3
Q ss_pred cccccccCCcccccccccCCCCcccceehHHHHHHHHHhcCcCCCcchhhhhhhhHHHHHHHhhcccchhHhhhch--hc
Q 003836 660 NTAIRGTKGYVAPEWFRNMPITVKVDVYSYGVLLLEIICLRRNIDNEISKVDKAILTDWAYDRYQERTLEALVEND--LE 737 (792)
Q Consensus 660 ~~~~~gt~~y~aPE~~~~~~~~~k~DV~S~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~ 737 (792)
.....||+.|+|||++.+..++.++|||||||++|||+||+.||........ + ..+.... ..
T Consensus 185 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~---~-------------~~i~~~~~~~~ 248 (352)
T d1koba_ 185 VKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLET---L-------------QNVKRCDWEFD 248 (352)
T ss_dssp EEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHH---H-------------HHHHHCCCCCC
T ss_pred eeeccCcccccCHHHHcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHHH---H-------------HHHHhCCCCCC
Confidence 3446789999999999999999999999999999999999999975432211 0 0011111 11
Q ss_pred ccCCHHHHHHHHHHHHHccccCCCCCCCHHhHHHH
Q 003836 738 AMNNVTMLHRFVMVAFWCIQEDPSHRPTMRKVTQM 772 (792)
Q Consensus 738 ~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~ 772 (792)
.......+.++.+|+.+||+.||.+|||++|+++.
T Consensus 249 ~~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~H 283 (352)
T d1koba_ 249 EDAFSSVSPEAKDFIKNLLQKEPRKRLTVHDALEH 283 (352)
T ss_dssp SSTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHTS
T ss_pred cccccCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 11122345678899999999999999999999874
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.9e-46 Score=383.23 Aligned_cols=245 Identities=27% Similarity=0.376 Sum_probs=194.9
Q ss_pred hhhhhcCccccceEEEeeecCCCceEEEEEEcccccccchHHHHHHHHHhcccCCCCcccccceecc-CCceEEEEEecc
Q 003836 504 GFKEELGRGAFGTVYKGFVNMGSSNHVAVKKLNSVFQDSEKEFKAEVNGIGQTHHKNLVRLLGYCDE-GQNRLLVYEFMS 582 (792)
Q Consensus 504 ~~~~~lG~G~~g~Vy~g~~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~-~~~~~lV~E~~~ 582 (792)
.+.+.||+|+||.||+|.+. ++.||||++++. ...+.|.+|++++++++||||++++|+|.+ .+..++||||++
T Consensus 10 ~~~~~lG~G~fg~Vy~~~~~---~~~vAvK~i~~~--~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~ey~~ 84 (262)
T d1byga_ 10 KLLQTIGKGEFGDVMLGDYR---GNKVAVKCIKND--ATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMA 84 (262)
T ss_dssp EEEEEEEECSSCEEEEEEET---TEEEEEEECCCC--C--HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEECCCT
T ss_pred EEeEEEecCCCeEEEEEEEC---CeEEEEEEECcH--HHHHHHHHHHHHHHhCCCCCEeeEEEEEEecCCcEEEEEeccC
Confidence 35678999999999999874 468999999753 445789999999999999999999999865 456899999999
Q ss_pred CCCccccccCC--CCCchhHHHHHHHHHHHHHHHHhhccCCCeEecCCCCCcEEEcCCCCeEEeecCCCccccCCCCCcc
Q 003836 583 NGTVASFLFGD--SKPNWKLRTEIAMGIAGGLFYLHEECCTQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLDQSHTN 660 (792)
Q Consensus 583 ~gsL~~~l~~~--~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dikp~NILl~~~~~~kl~Dfg~a~~~~~~~~~~~ 660 (792)
+|+|.++|... ..+++..+++|+.||+.||.|||+. +|+||||||+|||++.++.+||+|||+++..... .
T Consensus 85 ~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~al~ylH~~---~ivH~dlkp~Nil~~~~~~~kl~dfg~s~~~~~~----~ 157 (262)
T d1byga_ 85 KGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGN---NFVHRDLAARNVLVSEDNVAKVSDFGLTKEASST----Q 157 (262)
T ss_dssp TEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTSCEEECCCCC------------
T ss_pred CCCHHHHHHhcCCCCCCHHHHHHHHHHHHhhccccccC---ceeccccchHhheecCCCCEeecccccceecCCC----C
Confidence 99999999754 3589999999999999999999998 9999999999999999999999999999865432 2
Q ss_pred ccccccCCcccccccccCCCCcccceehHHHHHHHHHh-cCcCCCcchhhhhhhhHHHHHHHhhcccchhHhhhchhccc
Q 003836 661 TAIRGTKGYVAPEWFRNMPITVKVDVYSYGVLLLEIIC-LRRNIDNEISKVDKAILTDWAYDRYQERTLEALVENDLEAM 739 (792)
Q Consensus 661 ~~~~gt~~y~aPE~~~~~~~~~k~DV~S~Gv~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 739 (792)
....+++.|+|||.+.+..++.++|||||||++|||+| |+.|+....... +...+....+.+
T Consensus 158 ~~~~~~~~y~aPE~l~~~~~t~~sDIwSfG~il~el~t~~~~p~~~~~~~~-----------------~~~~i~~~~~~~ 220 (262)
T d1byga_ 158 DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKD-----------------VVPRVEKGYKMD 220 (262)
T ss_dssp ----CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGGG-----------------HHHHHTTTCCCC
T ss_pred ccccccccCCChHHHhCCCCChHHHHHhHHHHHHHHHHCCCCCCCCCCHHH-----------------HHHHHHcCCCCC
Confidence 23457889999999999999999999999999999998 566665432211 111111222333
Q ss_pred CCHHHHHHHHHHHHHccccCCCCCCCHHhHHHHhccCc
Q 003836 740 NNVTMLHRFVMVAFWCIQEDPSHRPTMRKVTQMLEGVV 777 (792)
Q Consensus 740 ~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~L~~~~ 777 (792)
.+...++++.+|+.+||+.||.+||||.||+++|+.+.
T Consensus 221 ~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~L~~i~ 258 (262)
T d1byga_ 221 APDGCPPAVYEVMKNCWHLDAAMRPSFLQLREQLEHIK 258 (262)
T ss_dssp CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred CCccCCHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHH
Confidence 44455678899999999999999999999999998753
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7e-46 Score=385.56 Aligned_cols=252 Identities=25% Similarity=0.327 Sum_probs=196.3
Q ss_pred hhhhhcCccccceEEEeeecCCC--ceEEEEEEcccc---cccchHHHHHHHHHhcccCCCCcccccceeccCCceEEEE
Q 003836 504 GFKEELGRGAFGTVYKGFVNMGS--SNHVAVKKLNSV---FQDSEKEFKAEVNGIGQTHHKNLVRLLGYCDEGQNRLLVY 578 (792)
Q Consensus 504 ~~~~~lG~G~~g~Vy~g~~~~~~--~~~vavK~~~~~---~~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~lV~ 578 (792)
.+.+.||+|+||+||+|++...+ ...||||++.+. .....++|.+|++++++++|||||+++|+|.+ +..++||
T Consensus 11 ~~~~~iG~G~fg~Vy~~~~~~~~~~~~~vAiK~l~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~~~g~~~~-~~~~lv~ 89 (273)
T d1u46a_ 11 RLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLT-PPMKMVT 89 (273)
T ss_dssp EEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEE
T ss_pred EEEEEEecCCCeEEEEEEEECCCCcEEEEEEEEEChhhcCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEee-cchheee
Confidence 45678999999999999875433 357999998753 23345689999999999999999999999976 4678999
Q ss_pred EeccCCCccccccCC-CCCchhHHHHHHHHHHHHHHHHhhccCCCeEecCCCCCcEEEcCCCCeEEeecCCCccccCCCC
Q 003836 579 EFMSNGTVASFLFGD-SKPNWKLRTEIAMGIAGGLFYLHEECCTQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLDQS 657 (792)
Q Consensus 579 E~~~~gsL~~~l~~~-~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dikp~NILl~~~~~~kl~Dfg~a~~~~~~~~ 657 (792)
||+++|+|.+++... ..+++..+++++.||++||.|||++ +|+||||||+||||+.++.+||+|||+++.......
T Consensus 90 e~~~~~~l~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~---~iiHrDikp~NIll~~~~~vkl~DfGl~~~~~~~~~ 166 (273)
T d1u46a_ 90 ELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESK---RFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDD 166 (273)
T ss_dssp ECCTTCBHHHHHHHHGGGSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEEEETTEEEECCCTTCEECCC-CC
T ss_pred eeecCcchhhhhhcccCCCCHHHHHHHHHHHHHHHHHhhhC---CEeeeeecHHHhccccccceeeccchhhhhcccCCC
Confidence 999999999887654 5689999999999999999999998 999999999999999999999999999998754433
Q ss_pred Cc--cccccccCCcccccccccCCCCcccceehHHHHHHHHHh-cCcCCCcchhhhhhhhHHHHHHHhhcccchhHhhhc
Q 003836 658 HT--NTAIRGTKGYVAPEWFRNMPITVKVDVYSYGVLLLEIIC-LRRNIDNEISKVDKAILTDWAYDRYQERTLEALVEN 734 (792)
Q Consensus 658 ~~--~~~~~gt~~y~aPE~~~~~~~~~k~DV~S~Gv~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 734 (792)
.. .....|+..|+|||.+.+..++.++|||||||++|||+| |+.||........ +..+...
T Consensus 167 ~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~S~Gvil~emlt~G~~Pf~~~~~~~~----------------~~~i~~~ 230 (273)
T d1u46a_ 167 HYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQI----------------LHKIDKE 230 (273)
T ss_dssp EEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHH----------------HHHHHTS
T ss_pred cceecCccccCcccCCHHHHhCCCCCcchhhhhhHHHHHHHHhCCCCCCCCcCHHHH----------------HHHHHhC
Confidence 22 233567889999999999999999999999999999998 8999865432211 1111122
Q ss_pred hhcccCCHHHHHHHHHHHHHccccCCCCCCCHHhHHHHhcc
Q 003836 735 DLEAMNNVTMLHRFVMVAFWCIQEDPSHRPTMRKVTQMLEG 775 (792)
Q Consensus 735 ~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~L~~ 775 (792)
......+...+..+.+++.+||+.||++||||+||++.|++
T Consensus 231 ~~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~ei~~~L~~ 271 (273)
T d1u46a_ 231 GERLPRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLE 271 (273)
T ss_dssp CCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred CCCCCCcccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHh
Confidence 22222333455678999999999999999999999999875
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.5e-45 Score=389.90 Aligned_cols=247 Identities=23% Similarity=0.267 Sum_probs=207.0
Q ss_pred hhhhhhcCccccceEEEeeecCCCceEEEEEEcccc---cccchHHHHHHHHHhcccCCCCcccccceeccCCceEEEEE
Q 003836 503 RGFKEELGRGAFGTVYKGFVNMGSSNHVAVKKLNSV---FQDSEKEFKAEVNGIGQTHHKNLVRLLGYCDEGQNRLLVYE 579 (792)
Q Consensus 503 ~~~~~~lG~G~~g~Vy~g~~~~~~~~~vavK~~~~~---~~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~lV~E 579 (792)
+.+.+.||+|+||.||+++. ..+++.||||++++. .....+.+.+|+.+|++++||||+++++++.+.+..++|||
T Consensus 7 y~~~~~lG~G~fg~V~~~~~-~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~iv~e 85 (337)
T d1o6la_ 7 FDYLKLLGKGTFGKVILVRE-KATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVME 85 (337)
T ss_dssp EEEEEEEEECSSEEEEEEEE-TTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred cEEEEEEecCcCeEEEEEEE-CCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhCCCCCEEEEEeeecccccccccee
Confidence 34567899999999999975 456789999999753 23446789999999999999999999999999999999999
Q ss_pred eccCCCccccccCCCCCchhHHHHHHHHHHHHHHHHhhccCCCeEecCCCCCcEEEcCCCCeEEeecCCCccccCCCCCc
Q 003836 580 FMSNGTVASFLFGDSKPNWKLRTEIAMGIAGGLFYLHEECCTQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLDQSHT 659 (792)
Q Consensus 580 ~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dikp~NILl~~~~~~kl~Dfg~a~~~~~~~~~~ 659 (792)
|+++|+|.+++.....+++.....++.||+.||+|||++ +|+||||||+|||+++++.+||+|||+|+...... ..
T Consensus 86 y~~gg~L~~~~~~~~~~~e~~~~~~~~qil~al~ylH~~---~iiHRDlKP~NILl~~~g~vkl~DFG~a~~~~~~~-~~ 161 (337)
T d1o6la_ 86 YANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSR---DVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDG-AT 161 (337)
T ss_dssp CCTTCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCCTTCBCSCCTT-CC
T ss_pred ccCCCchhhhhhcccCCcHHHHHHHHHHHhhhhhhhhhc---CccccccCHHHeEecCCCCEEEeecccccccccCC-cc
Confidence 999999999999888899999999999999999999999 99999999999999999999999999998764332 23
Q ss_pred cccccccCCcccccccccCCCCcccceehHHHHHHHHHhcCcCCCcchhhhhhhhHHHHHHHhhcccchhHhhhchhccc
Q 003836 660 NTAIRGTKGYVAPEWFRNMPITVKVDVYSYGVLLLEIICLRRNIDNEISKVDKAILTDWAYDRYQERTLEALVENDLEAM 739 (792)
Q Consensus 660 ~~~~~gt~~y~aPE~~~~~~~~~k~DV~S~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 739 (792)
....+||+.|+|||++.+..++.++|||||||++|||++|+.||........ . ..+.... ..
T Consensus 162 ~~~~~GT~~Y~aPE~~~~~~y~~~~DiwSlGvilyeml~G~~pf~~~~~~~~---~-------------~~i~~~~--~~ 223 (337)
T d1o6la_ 162 MKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERL---F-------------ELILMEE--IR 223 (337)
T ss_dssp BCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHH---H-------------HHHHHCC--CC
T ss_pred cccceeCHHHhhhhhccCCCCChhhcccchhhHHHHHHHCCCCCCCcCHHHH---H-------------HHHhcCC--CC
Confidence 3456799999999999999999999999999999999999999976533211 0 0111111 11
Q ss_pred CCHHHHHHHHHHHHHccccCCCCCCC-----HHhHHHH
Q 003836 740 NNVTMLHRFVMVAFWCIQEDPSHRPT-----MRKVTQM 772 (792)
Q Consensus 740 ~~~~~~~~l~~l~~~Cl~~~p~~RPs-----~~evl~~ 772 (792)
.+...+.++.+|+.+||+.||++||+ ++|+++.
T Consensus 224 ~p~~~s~~~~dli~~~L~~dP~~R~~~~~~~~~eil~H 261 (337)
T d1o6la_ 224 FPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEH 261 (337)
T ss_dssp CCTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTS
T ss_pred CCccCCHHHHHHHHhhccCCchhhcccccccHHHHHcC
Confidence 23345567889999999999999995 7888763
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.9e-45 Score=390.04 Aligned_cols=252 Identities=27% Similarity=0.424 Sum_probs=202.1
Q ss_pred hhhhcCccccceEEEeeecCCCc-eEEEEEEcccc-cccchHHHHHHHHHhccc-CCCCcccccceeccCCceEEEEEec
Q 003836 505 FKEELGRGAFGTVYKGFVNMGSS-NHVAVKKLNSV-FQDSEKEFKAEVNGIGQT-HHKNLVRLLGYCDEGQNRLLVYEFM 581 (792)
Q Consensus 505 ~~~~lG~G~~g~Vy~g~~~~~~~-~~vavK~~~~~-~~~~~~~~~~Ei~~l~~l-~h~niv~l~g~~~~~~~~~lV~E~~ 581 (792)
+.++||+|+||+||+|.+..... ..||||++... .....+.|.+|++++.++ +|||||+++|+|.+.+..++||||+
T Consensus 14 ~~~~iG~G~fg~Vy~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~iV~ey~ 93 (309)
T d1fvra_ 14 FQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYA 93 (309)
T ss_dssp EEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEEEEECCC
T ss_pred EEEEEeeCCCcEEEEEEECCCCeEEEEEEEEECcccChHHHHHHHHHHHHHHhccCCCCEeeEEEEEecCCeeEEEEEec
Confidence 45789999999999998764332 36889988643 334556899999999998 7999999999999999999999999
Q ss_pred cCCCccccccCC----------------CCCchhHHHHHHHHHHHHHHHHhhccCCCeEecCCCCCcEEEcCCCCeEEee
Q 003836 582 SNGTVASFLFGD----------------SKPNWKLRTEIAMGIAGGLFYLHEECCTQIIHCDIKPQNILLDDHYNARISD 645 (792)
Q Consensus 582 ~~gsL~~~l~~~----------------~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dikp~NILl~~~~~~kl~D 645 (792)
++|+|.++|+.. ..+++..+.+++.||++||.|||+. +|+||||||+|||++.++.+||+|
T Consensus 94 ~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~lH~~---~iiHrDlkp~NIL~~~~~~~kl~D 170 (309)
T d1fvra_ 94 PHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQK---QFIHRDLAARNILVGENYVAKIAD 170 (309)
T ss_dssp TTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECGGGCEEECC
T ss_pred CCCcHHHHHhhccccccchhhhccccccCCCCHHHHHHHHHHHHHHHHhhhcC---CccccccccceEEEcCCCceEEcc
Confidence 999999999653 5689999999999999999999998 999999999999999999999999
Q ss_pred cCCCccccCCCCCccccccccCCcccccccccCCCCcccceehHHHHHHHHHhcCc-CCCcchhhhhhhhHHHHHHHhhc
Q 003836 646 FGLAKLLTLDQSHTNTAIRGTKGYVAPEWFRNMPITVKVDVYSYGVLLLEIICLRR-NIDNEISKVDKAILTDWAYDRYQ 724 (792)
Q Consensus 646 fg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DV~S~Gv~l~el~tg~~-p~~~~~~~~~~~~~~~~~~~~~~ 724 (792)
||+++...... ......||..|+|||.+.+..++.++|||||||++|||++|.. ||.......
T Consensus 171 fG~a~~~~~~~--~~~~~~gt~~y~aPE~l~~~~~~~~sDvwSfGvil~ell~~~~~p~~~~~~~~-------------- 234 (309)
T d1fvra_ 171 FGLSRGQEVYV--KKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAE-------------- 234 (309)
T ss_dssp TTCEESSCEEC--CC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCHHH--------------
T ss_pred ccccccccccc--cccceecCCcccchHHhccCCCCccceeehhHHHHHHHHhcCCCCCCCCCHHH--------------
Confidence 99998654322 2233468999999999999999999999999999999999875 454332111
Q ss_pred ccchhHhhhchhcccCCHHHHHHHHHHHHHccccCCCCCCCHHhHHHHhccCcC
Q 003836 725 ERTLEALVENDLEAMNNVTMLHRFVMVAFWCIQEDPSHRPTMRKVTQMLEGVVE 778 (792)
Q Consensus 725 ~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~L~~~~~ 778 (792)
+...+....+...+...++++.+|+.+||+.||++||||+||++.|+++++
T Consensus 235 ---~~~~i~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~L~~i~~ 285 (309)
T d1fvra_ 235 ---LYEKLPQGYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLE 285 (309)
T ss_dssp ---HHHHGGGTCCCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred ---HHHHHHhcCCCCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHh
Confidence 001111122233344456789999999999999999999999999988764
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6e-46 Score=392.66 Aligned_cols=257 Identities=25% Similarity=0.369 Sum_probs=196.8
Q ss_pred hhhhhhcCccccceEEEeeecC----CCceEEEEEEccccc-ccchHHHHHHHHHhccc-CCCCcccccceeccC-CceE
Q 003836 503 RGFKEELGRGAFGTVYKGFVNM----GSSNHVAVKKLNSVF-QDSEKEFKAEVNGIGQT-HHKNLVRLLGYCDEG-QNRL 575 (792)
Q Consensus 503 ~~~~~~lG~G~~g~Vy~g~~~~----~~~~~vavK~~~~~~-~~~~~~~~~Ei~~l~~l-~h~niv~l~g~~~~~-~~~~ 575 (792)
+.+.++||+|+||.||+|.... .+++.||||+++... ....+.+.+|...+.++ +|+||+.+++++.+. ...+
T Consensus 15 y~~~~~iG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~~~~ 94 (299)
T d1ywna1 15 LKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLM 94 (299)
T ss_dssp EEEEEEEEECSSCEEEEEEEESTTSSSCEEEEEEEEC----CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTTSCCE
T ss_pred EEEeeEEeecCCeEEEEEEEcCCCcccCCeEEEEEEEccccCcHHHHHHHHHHHHHHhhcCCCeEEEeeeeeccCCCeEE
Confidence 4456889999999999997642 235689999997543 33456788888888877 799999999998654 5689
Q ss_pred EEEEeccCCCccccccCC----------------CCCchhHHHHHHHHHHHHHHHHhhccCCCeEecCCCCCcEEEcCCC
Q 003836 576 LVYEFMSNGTVASFLFGD----------------SKPNWKLRTEIAMGIAGGLFYLHEECCTQIIHCDIKPQNILLDDHY 639 (792)
Q Consensus 576 lV~E~~~~gsL~~~l~~~----------------~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dikp~NILl~~~~ 639 (792)
+||||+++|+|.++++.. ..+++..+..++.||++||+|||++ +|+||||||+||||++++
T Consensus 95 iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~---~ivHrDlKp~NILl~~~~ 171 (299)
T d1ywna1 95 VIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASR---KCIHRDLAARNILLSEKN 171 (299)
T ss_dssp EEEECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECGGG
T ss_pred EEEEecCCCcHHHHHHhccccccccccchhhhhcccCCHHHHHHHHHHHHHHHHHHHhC---CCcCCcCCccceeECCCC
Confidence 999999999999998643 2478999999999999999999998 999999999999999999
Q ss_pred CeEEeecCCCccccCCCCC-ccccccccCCcccccccccCCCCcccceehHHHHHHHHHhcCc-CCCcchhhhhhhhHHH
Q 003836 640 NARISDFGLAKLLTLDQSH-TNTAIRGTKGYVAPEWFRNMPITVKVDVYSYGVLLLEIICLRR-NIDNEISKVDKAILTD 717 (792)
Q Consensus 640 ~~kl~Dfg~a~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~k~DV~S~Gv~l~el~tg~~-p~~~~~~~~~~~~~~~ 717 (792)
.+||+|||+|+........ ......||+.|+|||.+.+..++.++|||||||++|||+||.. ||........
T Consensus 172 ~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gvil~ellt~~~~p~~~~~~~~~------ 245 (299)
T d1ywna1 172 VVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEE------ 245 (299)
T ss_dssp CEEECC------CCSCTTSCCTTSCCCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCCSHH------
T ss_pred cEEEccCcchhhccccccccccCceeeCccccchhHhhcCCCCcccceeehHHHHHHHHhCCCCCCCCCCHHHH------
Confidence 9999999999876544333 3344679999999999999999999999999999999999765 5644322111
Q ss_pred HHHHhhcccchhHhhhchhcccCCHHHHHHHHHHHHHccccCCCCCCCHHhHHHHhccCcC
Q 003836 718 WAYDRYQERTLEALVENDLEAMNNVTMLHRFVMVAFWCIQEDPSHRPTMRKVTQMLEGVVE 778 (792)
Q Consensus 718 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~L~~~~~ 778 (792)
+...+........+...++++.+++.+||+.||++|||++||+++|+++++
T Consensus 246 ----------~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~eil~~L~~ilq 296 (299)
T d1ywna1 246 ----------FCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQ 296 (299)
T ss_dssp ----------HHHHHHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred ----------HHHHHhcCCCCCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHh
Confidence 011111122222333455678999999999999999999999999998754
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.8e-45 Score=391.64 Aligned_cols=253 Identities=25% Similarity=0.357 Sum_probs=201.2
Q ss_pred hhhhhhcCccccceEEEeeecCCC---ceEEEEEEcccc-cccchHHHHHHHHHhcccCCCCcccccceeccCCceEEEE
Q 003836 503 RGFKEELGRGAFGTVYKGFVNMGS---SNHVAVKKLNSV-FQDSEKEFKAEVNGIGQTHHKNLVRLLGYCDEGQNRLLVY 578 (792)
Q Consensus 503 ~~~~~~lG~G~~g~Vy~g~~~~~~---~~~vavK~~~~~-~~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~lV~ 578 (792)
+.+.++||+|+||+||+|...... ...||+|+++.. .....++|.+|++++++++|||||+++|+|.++ ..++++
T Consensus 11 y~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~-~~~~v~ 89 (317)
T d1xkka_ 11 FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQLIT 89 (317)
T ss_dssp EEEEEEEEECSSEEEEEEEECC----CCEEEEEEEECC----CTHHHHHHHHHHHHHCCCTTBCCEEEEEESS-SEEEEE
T ss_pred CEEeeEEecCCCeEEEEEEEcCCCCEEEEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecC-CeeEEE
Confidence 345578999999999999764322 236899998653 344567899999999999999999999999865 567889
Q ss_pred EeccCCCccccccCC-CCCchhHHHHHHHHHHHHHHHHhhccCCCeEecCCCCCcEEEcCCCCeEEeecCCCccccCCCC
Q 003836 579 EFMSNGTVASFLFGD-SKPNWKLRTEIAMGIAGGLFYLHEECCTQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLDQS 657 (792)
Q Consensus 579 E~~~~gsL~~~l~~~-~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dikp~NILl~~~~~~kl~Dfg~a~~~~~~~~ 657 (792)
||+.+|+|.+++... ..+++..+++++.||++||+|||++ +|+||||||+||||+.++.+||+|||+++.......
T Consensus 90 e~~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~gl~yLH~~---~iiHrDlKp~NIll~~~~~~kl~DFGla~~~~~~~~ 166 (317)
T d1xkka_ 90 QLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEK 166 (317)
T ss_dssp ECCTTCBHHHHHHHTSSSCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEEETTEEEECCCSHHHHTTTTCC
T ss_pred EeccCCcccccccccccCCCHHHHHHHHHHHHHHHHHHHHc---CcccCcchhhcceeCCCCCeEeeccccceecccccc
Confidence 999999999888654 5789999999999999999999998 999999999999999999999999999998765443
Q ss_pred Cc-cccccccCCcccccccccCCCCcccceehHHHHHHHHHh-cCcCCCcchhhhhhhhHHHHHHHhhcccchhHhhhch
Q 003836 658 HT-NTAIRGTKGYVAPEWFRNMPITVKVDVYSYGVLLLEIIC-LRRNIDNEISKVDKAILTDWAYDRYQERTLEALVEND 735 (792)
Q Consensus 658 ~~-~~~~~gt~~y~aPE~~~~~~~~~k~DV~S~Gv~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 735 (792)
.. .....||+.|+|||.+.+..++.++|||||||++|||+| |+.||....... +...+...
T Consensus 167 ~~~~~~~~gt~~y~APE~l~~~~~~~~sDvwS~Gvil~el~t~g~~p~~~~~~~~-----------------~~~~i~~~ 229 (317)
T d1xkka_ 167 EYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASE-----------------ISSILEKG 229 (317)
T ss_dssp --------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCGGG-----------------HHHHHHHT
T ss_pred cccccccccCccccChHHHhcCCCChhhhhhhHHHHHHHHHHCCCCCCCCCCHHH-----------------HHHHHHcC
Confidence 32 233568999999999999999999999999999999999 677776442211 11112222
Q ss_pred hcccCCHHHHHHHHHHHHHccccCCCCCCCHHhHHHHhccC
Q 003836 736 LEAMNNVTMLHRFVMVAFWCIQEDPSHRPTMRKVTQMLEGV 776 (792)
Q Consensus 736 ~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~L~~~ 776 (792)
.....+...+.++.+++.+||+.||++|||++||++.|+.+
T Consensus 230 ~~~~~p~~~~~~~~~li~~cl~~dP~~RPs~~eil~~l~~~ 270 (317)
T d1xkka_ 230 ERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKM 270 (317)
T ss_dssp CCCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred CCCCCCcccCHHHHHHHHHhCCCChhhCcCHHHHHHHHHHH
Confidence 22233444567889999999999999999999999988664
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=7.9e-45 Score=385.39 Aligned_cols=244 Identities=23% Similarity=0.300 Sum_probs=205.1
Q ss_pred hhhhhhcCccccceEEEeeecCCCceEEEEEEcccc---cccchHHHHHHHHHhcccCCCCcccccceeccCCceEEEEE
Q 003836 503 RGFKEELGRGAFGTVYKGFVNMGSSNHVAVKKLNSV---FQDSEKEFKAEVNGIGQTHHKNLVRLLGYCDEGQNRLLVYE 579 (792)
Q Consensus 503 ~~~~~~lG~G~~g~Vy~g~~~~~~~~~vavK~~~~~---~~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~lV~E 579 (792)
+.+.++||+|+||+||+|... .+++.||||++++. .....+.+.+|+.++++++|||||++++++.+.+..++|||
T Consensus 6 y~i~~~lG~G~fg~Vy~a~~~-~~g~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmE 84 (316)
T d1fota_ 6 FQILRTLGTGSFGRVHLIRSR-HNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMIMD 84 (316)
T ss_dssp EEEEEEEEECSSCEEEEEEET-TTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEEEC
T ss_pred eEEEEEEecCcCcEEEEEEEC-CCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHhccCcChhheeeeEeeCCeeeeEee
Confidence 345678999999999999753 55789999998743 23345789999999999999999999999999999999999
Q ss_pred eccCCCccccccCCCCCchhHHHHHHHHHHHHHHHHhhccCCCeEecCCCCCcEEEcCCCCeEEeecCCCccccCCCCCc
Q 003836 580 FMSNGTVASFLFGDSKPNWKLRTEIAMGIAGGLFYLHEECCTQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLDQSHT 659 (792)
Q Consensus 580 ~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dikp~NILl~~~~~~kl~Dfg~a~~~~~~~~~~ 659 (792)
|+++|+|..++.....+++.....++.||+.||+|||++ +|+||||||+||||+.++.+||+|||+|+.....
T Consensus 85 ~~~gg~l~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~---~iiHrDiKp~NILl~~~g~vkL~DFG~a~~~~~~---- 157 (316)
T d1fota_ 85 YIEGGELFSLLRKSQRFPNPVAKFYAAEVCLALEYLHSK---DIIYRDLKPENILLDKNGHIKITDFGFAKYVPDV---- 157 (316)
T ss_dssp CCCSCBHHHHHHHTSSCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEECTTSCEEECCCSSCEECSSC----
T ss_pred ecCCccccccccccccccccHHHHHHHHHHHhhhhhccC---cEEccccCchheeEcCCCCEEEecCccceEeccc----
Confidence 999999999998888899999999999999999999999 9999999999999999999999999999876432
Q ss_pred cccccccCCcccccccccCCCCcccceehHHHHHHHHHhcCcCCCcchhhhhhhhHHHHHHHhhcccchhHhhhchhccc
Q 003836 660 NTAIRGTKGYVAPEWFRNMPITVKVDVYSYGVLLLEIICLRRNIDNEISKVDKAILTDWAYDRYQERTLEALVENDLEAM 739 (792)
Q Consensus 660 ~~~~~gt~~y~aPE~~~~~~~~~k~DV~S~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 739 (792)
.....||+.|+|||++.+..++.++|||||||++|||++|+.||........ . ..+.... ..
T Consensus 158 ~~~~~Gt~~Y~APE~l~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~~---~-------------~~i~~~~--~~ 219 (316)
T d1fota_ 158 TYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKT---Y-------------EKILNAE--LR 219 (316)
T ss_dssp BCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHH---H-------------HHHHHCC--CC
T ss_pred cccccCcccccCHHHHcCCCCCchhhccccchhHHHHHhCCCCCCCcCHHHH---H-------------HHHHcCC--CC
Confidence 2346799999999999999999999999999999999999999976432211 0 1111111 11
Q ss_pred CCHHHHHHHHHHHHHccccCCCCCC-----CHHhHHHH
Q 003836 740 NNVTMLHRFVMVAFWCIQEDPSHRP-----TMRKVTQM 772 (792)
Q Consensus 740 ~~~~~~~~l~~l~~~Cl~~~p~~RP-----s~~evl~~ 772 (792)
.+...++++.+++.+||+.||.+|| |++|+++.
T Consensus 220 ~p~~~s~~~~~li~~~L~~dp~~R~~~~r~t~~~il~H 257 (316)
T d1fota_ 220 FPPFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKNH 257 (316)
T ss_dssp CCTTSCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHTS
T ss_pred CCCCCCHHHHHHHHHHhhhCHHhccccchhhHHHHHcC
Confidence 2233456788999999999999996 89999864
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.8e-45 Score=389.13 Aligned_cols=257 Identities=26% Similarity=0.408 Sum_probs=210.7
Q ss_pred hhhhhhcCccccceEEEeeec----CCCceEEEEEEcccccc-cchHHHHHHHHHhccc-CCCCcccccceeccCCceEE
Q 003836 503 RGFKEELGRGAFGTVYKGFVN----MGSSNHVAVKKLNSVFQ-DSEKEFKAEVNGIGQT-HHKNLVRLLGYCDEGQNRLL 576 (792)
Q Consensus 503 ~~~~~~lG~G~~g~Vy~g~~~----~~~~~~vavK~~~~~~~-~~~~~~~~Ei~~l~~l-~h~niv~l~g~~~~~~~~~l 576 (792)
..+.++||+|+||.||+|++. ...++.||||+++.... ....+|.+|+.+++++ +|||||+++++|.+.+..++
T Consensus 25 ~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~~~~~l~~HpnIv~~~g~~~~~~~~~l 104 (311)
T d1t46a_ 25 LSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIGGPTLV 104 (311)
T ss_dssp EEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEE
T ss_pred eEEeeEEeecCCeEEEEEEEeccccCCCCeEEEEEEECcccCHHHHHHHHHHHHHHHhccCCCCEEEEEEEEeeCCEEEE
Confidence 446688999999999999763 34567999999976433 3455799999999999 69999999999999999999
Q ss_pred EEEeccCCCccccccCCC------------------CCchhHHHHHHHHHHHHHHHHhhccCCCeEecCCCCCcEEEcCC
Q 003836 577 VYEFMSNGTVASFLFGDS------------------KPNWKLRTEIAMGIAGGLFYLHEECCTQIIHCDIKPQNILLDDH 638 (792)
Q Consensus 577 V~E~~~~gsL~~~l~~~~------------------~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dikp~NILl~~~ 638 (792)
||||+++|+|.++++... .+++..+.+++.||++||+|||++ +|+||||||+|||++.+
T Consensus 105 vmE~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~LH~~---~ivHrDLKp~NIl~~~~ 181 (311)
T d1t46a_ 105 ITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASK---NCIHRDLAARNILLTHG 181 (311)
T ss_dssp EEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEETT
T ss_pred EEEcCCCCCHHHHHHhccccccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhC---Ceeeccccccccccccc
Confidence 999999999999986432 578999999999999999999999 99999999999999999
Q ss_pred CCeEEeecCCCccccCCCC-CccccccccCCcccccccccCCCCcccceehHHHHHHHHHhcCcCCCcchhhhhhhhHHH
Q 003836 639 YNARISDFGLAKLLTLDQS-HTNTAIRGTKGYVAPEWFRNMPITVKVDVYSYGVLLLEIICLRRNIDNEISKVDKAILTD 717 (792)
Q Consensus 639 ~~~kl~Dfg~a~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~k~DV~S~Gv~l~el~tg~~p~~~~~~~~~~~~~~~ 717 (792)
+.+||+|||+++....... .......||+.|+|||.+.+..++.++|||||||++|||+|++.|+........
T Consensus 182 ~~~ki~DfG~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DIwS~G~~l~ellt~g~p~~~~~~~~~------ 255 (311)
T d1t46a_ 182 RITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDS------ 255 (311)
T ss_dssp TEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCSSH------
T ss_pred CcccccccchheeccCCCcceEeeecccChHHcCHHHhcCCCCCCcccccchHHHHHHHHhCCCCCCCCCCHHH------
Confidence 9999999999997754433 233446789999999999999999999999999999999996655543222111
Q ss_pred HHHHhhcccchhHhhhchhcccCCHHHHHHHHHHHHHccccCCCCCCCHHhHHHHhccCc
Q 003836 718 WAYDRYQERTLEALVENDLEAMNNVTMLHRFVMVAFWCIQEDPSHRPTMRKVTQMLEGVV 777 (792)
Q Consensus 718 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~L~~~~ 777 (792)
.+..++........+...+.++.+|+.+||+.||++||||+||+++|++.+
T Consensus 256 ---------~~~~~i~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~~il~~L~~~i 306 (311)
T d1t46a_ 256 ---------KFYKMIKEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQI 306 (311)
T ss_dssp ---------HHHHHHHHTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred ---------HHHHHHhcCCCCCCcccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhh
Confidence 112222333333334445678999999999999999999999999998753
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1e-44 Score=382.51 Aligned_cols=256 Identities=27% Similarity=0.347 Sum_probs=204.6
Q ss_pred hhhhhhcCccccceEEEeeecCC------CceEEEEEEcccccc-cchHHHHHHHHHhccc-CCCCcccccceeccCCce
Q 003836 503 RGFKEELGRGAFGTVYKGFVNMG------SSNHVAVKKLNSVFQ-DSEKEFKAEVNGIGQT-HHKNLVRLLGYCDEGQNR 574 (792)
Q Consensus 503 ~~~~~~lG~G~~g~Vy~g~~~~~------~~~~vavK~~~~~~~-~~~~~~~~Ei~~l~~l-~h~niv~l~g~~~~~~~~ 574 (792)
+.+.++||+|+||.||+|..... ....||||+++.... ....++.+|...+.++ +|||||+++++|.+++..
T Consensus 15 ~~l~~~iG~G~fg~Vy~~~~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~e~~~l~~~~~HpnIv~~~~~~~~~~~~ 94 (299)
T d1fgka_ 15 LVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDGPL 94 (299)
T ss_dssp EEEEEECC-----CEEEEEEECC----CCCEEEEEEECCCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSC
T ss_pred eEEeeEEeecCCcEEEEEEEcCCCcccccCceEEEEEEECcccChHHHHHHHHHHHHHHHhcCCCeEEecccccccCCeE
Confidence 34567899999999999976422 234799999976543 3457888999999888 899999999999999999
Q ss_pred EEEEEeccCCCccccccCC----------------CCCchhHHHHHHHHHHHHHHHHhhccCCCeEecCCCCCcEEEcCC
Q 003836 575 LLVYEFMSNGTVASFLFGD----------------SKPNWKLRTEIAMGIAGGLFYLHEECCTQIIHCDIKPQNILLDDH 638 (792)
Q Consensus 575 ~lV~E~~~~gsL~~~l~~~----------------~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dikp~NILl~~~ 638 (792)
++||||+++|+|.+++... ..+++.++++++.||+.||+|||+. +|+||||||+|||++.+
T Consensus 95 ~~v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ylH~~---~ivHrDiKp~NiLl~~~ 171 (299)
T d1fgka_ 95 YVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASK---KCIHRDLAARNVLVTED 171 (299)
T ss_dssp EEEECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTT
T ss_pred EEEEEccCCCcHHHHHHhhcCCccccccccccCccccCCHHHHHHHHHHHHHHHHHhhhC---CEEeeeecccceeecCC
Confidence 9999999999999999644 3479999999999999999999999 99999999999999999
Q ss_pred CCeEEeecCCCccccCCCCCc-cccccccCCcccccccccCCCCcccceehHHHHHHHHHh-cCcCCCcchhhhhhhhHH
Q 003836 639 YNARISDFGLAKLLTLDQSHT-NTAIRGTKGYVAPEWFRNMPITVKVDVYSYGVLLLEIIC-LRRNIDNEISKVDKAILT 716 (792)
Q Consensus 639 ~~~kl~Dfg~a~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~k~DV~S~Gv~l~el~t-g~~p~~~~~~~~~~~~~~ 716 (792)
+.+||+|||+++......... .....+++.|+|||.+.+..++.|+|||||||++|||++ |+.||.......
T Consensus 172 ~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~y~~k~DiwS~Gvvl~ell~~g~~p~~~~~~~~------ 245 (299)
T d1fgka_ 172 NVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEE------ 245 (299)
T ss_dssp CCEEECSTTCCCCGGGCCTTCCCTTSCCGGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHH------
T ss_pred CCeEeccchhhccccccccccccccCCCChhhhhhhHhcCCCCCchhhhHHhHHHHHHhccCCCCCCCCCCHHH------
Confidence 999999999999776544332 344678999999999999999999999999999999998 577775433211
Q ss_pred HHHHHhhcccchhHhhhchhcccCCHHHHHHHHHHHHHccccCCCCCCCHHhHHHHhccCcC
Q 003836 717 DWAYDRYQERTLEALVENDLEAMNNVTMLHRFVMVAFWCIQEDPSHRPTMRKVTQMLEGVVE 778 (792)
Q Consensus 717 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~L~~~~~ 778 (792)
+...+........+...+.++.+|+.+||+.||++|||+.||+++|++++.
T Consensus 246 -----------~~~~i~~~~~~~~p~~~~~~l~~li~~cl~~dP~~Rps~~eil~~L~~i~a 296 (299)
T d1fgka_ 246 -----------LFKLLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIVA 296 (299)
T ss_dssp -----------HHHHHHTTCCCCCCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred -----------HHHHHHcCCCCCCCccchHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHhh
Confidence 111122222233334456788999999999999999999999999998753
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.2e-44 Score=381.52 Aligned_cols=255 Identities=25% Similarity=0.402 Sum_probs=206.6
Q ss_pred hhhhhcCccccceEEEeeecC----CCceEEEEEEcccccc-cchHHHHHHHHHhcccCCCCcccccceeccCCceEEEE
Q 003836 504 GFKEELGRGAFGTVYKGFVNM----GSSNHVAVKKLNSVFQ-DSEKEFKAEVNGIGQTHHKNLVRLLGYCDEGQNRLLVY 578 (792)
Q Consensus 504 ~~~~~lG~G~~g~Vy~g~~~~----~~~~~vavK~~~~~~~-~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~lV~ 578 (792)
.+.+.||+|+||+||+|.+.. ..++.||||+++.... .....|.+|++++++++|||||+++++|...+..++||
T Consensus 23 ~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~VAvK~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~lv~ 102 (308)
T d1p4oa_ 23 TMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIM 102 (308)
T ss_dssp EEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEEECSSSSCEEEE
T ss_pred EEeeEEeeCCCeEEEEEEECCcccCCCCcEEEEEEECcccChHHHHHHHHHHHHHHHcCCCCEeeeeeEEecCCceeEEE
Confidence 355789999999999997642 2346899999975433 33456899999999999999999999999999999999
Q ss_pred EeccCCCccccccCC----------CCCchhHHHHHHHHHHHHHHHHhhccCCCeEecCCCCCcEEEcCCCCeEEeecCC
Q 003836 579 EFMSNGTVASFLFGD----------SKPNWKLRTEIAMGIAGGLFYLHEECCTQIIHCDIKPQNILLDDHYNARISDFGL 648 (792)
Q Consensus 579 E~~~~gsL~~~l~~~----------~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dikp~NILl~~~~~~kl~Dfg~ 648 (792)
||+++|+|.+++... ..+++..+.+++.||++||.|||++ +|+||||||+|||+++++++||+|||+
T Consensus 103 e~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~LH~~---~ivHrDlk~~NiLld~~~~~Kl~DFGl 179 (308)
T d1p4oa_ 103 ELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGM 179 (308)
T ss_dssp ECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHT---TCBCSCCSGGGEEECTTCCEEECCTTC
T ss_pred eecCCCCHHHHHHhcccccccccccCCCCHHHHHHHHHHHHHHHHHHhhC---CeeeceEcCCceeecCCceEEEeeccc
Confidence 999999999998642 2468889999999999999999998 999999999999999999999999999
Q ss_pred CccccCCCCC-ccccccccCCcccccccccCCCCcccceehHHHHHHHHHhcC-cCCCcchhhhhhhhHHHHHHHhhccc
Q 003836 649 AKLLTLDQSH-TNTAIRGTKGYVAPEWFRNMPITVKVDVYSYGVLLLEIICLR-RNIDNEISKVDKAILTDWAYDRYQER 726 (792)
Q Consensus 649 a~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~k~DV~S~Gv~l~el~tg~-~p~~~~~~~~~~~~~~~~~~~~~~~~ 726 (792)
++........ ......||+.|+|||.+.+..++.++||||||+++|||+||+ .|+........
T Consensus 180 a~~~~~~~~~~~~~~~~~t~~y~aPe~l~~~~~~~~~Dv~S~G~il~El~t~~~~p~~~~~~~~~--------------- 244 (308)
T d1p4oa_ 180 TRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQV--------------- 244 (308)
T ss_dssp CCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCHHHH---------------
T ss_pred ceeccCCcceeeccceecccccCCHHHHccCCCCcccccccHHHHHHHHHhCCCCCCCCCCHHHH---------------
Confidence 9876543332 233346899999999999999999999999999999999996 55543321100
Q ss_pred chhHhhhchhcccCCHHHHHHHHHHHHHccccCCCCCCCHHhHHHHhccCcC
Q 003836 727 TLEALVENDLEAMNNVTMLHRFVMVAFWCIQEDPSHRPTMRKVTQMLEGVVE 778 (792)
Q Consensus 727 ~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~L~~~~~ 778 (792)
+..+.+ ......+...+..+.+++.+||+.+|++||||+||+++|++.++
T Consensus 245 -~~~i~~-~~~~~~p~~~~~~l~~li~~cl~~~P~~RPs~~~il~~L~~~~~ 294 (308)
T d1p4oa_ 245 -LRFVME-GGLLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEME 294 (308)
T ss_dssp -HHHHHT-TCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGGSC
T ss_pred -HHHHHh-CCCCCCcccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhcC
Confidence 011111 11122233455689999999999999999999999999998755
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.5e-44 Score=381.70 Aligned_cols=267 Identities=22% Similarity=0.274 Sum_probs=196.7
Q ss_pred hhhhcCccccceEEEeeecCCCceEEEEEEcccccccchHHHHHHHHHhcccCCCCcccccceeccCC----ceEEEEEe
Q 003836 505 FKEELGRGAFGTVYKGFVNMGSSNHVAVKKLNSVFQDSEKEFKAEVNGIGQTHHKNLVRLLGYCDEGQ----NRLLVYEF 580 (792)
Q Consensus 505 ~~~~lG~G~~g~Vy~g~~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~----~~~lV~E~ 580 (792)
+.++||+|+||+||+|+++ ++.||||+++.. ......++.|+..+.+++|||||+++++|.+.+ ..++||||
T Consensus 7 l~~~iG~G~fg~Vy~~~~~---g~~vAvK~~~~~-~~~~~~~e~ei~~~~~~~HpnIv~~~~~~~~~~~~~~~~~lv~Ey 82 (303)
T d1vjya_ 7 LQESIGKGRFGEVWRGKWR---GEEVAVKIFSSR-EERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVSDY 82 (303)
T ss_dssp EEEEEECCSSSEEEEEEET---TEEEEEEEECGG-GHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEEEEC
T ss_pred EEEEEeeCCCeEEEEEEEC---CEEEEEEEECcc-chhHHHHHHHHHHHhhCCCCcCcceEEEEEeCCCcceEEEEEEec
Confidence 3468999999999999863 578999998643 222233455666777899999999999997543 57899999
Q ss_pred ccCCCccccccCCCCCchhHHHHHHHHHHHHHHHHhhcc-----CCCeEecCCCCCcEEEcCCCCeEEeecCCCccccCC
Q 003836 581 MSNGTVASFLFGDSKPNWKLRTEIAMGIAGGLFYLHEEC-----CTQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLD 655 (792)
Q Consensus 581 ~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~-----~~~ivH~dikp~NILl~~~~~~kl~Dfg~a~~~~~~ 655 (792)
+++|+|.++|++. .+++..+.+++.|+|.||+|||+.. ..+|+||||||+||||++++.+||+|||+++.....
T Consensus 83 ~~~g~L~~~l~~~-~l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~IvHrDlKp~NILl~~~~~~Kl~DFGl~~~~~~~ 161 (303)
T d1vjya_ 83 HEHGSLFDYLNRY-TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSA 161 (303)
T ss_dssp CTTCBHHHHHHHC-CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCCGGGEEECTTSCEEECCCTTCEEEETT
T ss_pred ccCCCHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCeeccccCccceEEcCCCCeEEEecCccccccCC
Confidence 9999999999764 6899999999999999999999732 248999999999999999999999999999987544
Q ss_pred CCC---ccccccccCCcccccccccC------CCCcccceehHHHHHHHHHhcCcCCCcchhhhhhhhHHHHHHHhhccc
Q 003836 656 QSH---TNTAIRGTKGYVAPEWFRNM------PITVKVDVYSYGVLLLEIICLRRNIDNEISKVDKAILTDWAYDRYQER 726 (792)
Q Consensus 656 ~~~---~~~~~~gt~~y~aPE~~~~~------~~~~k~DV~S~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 726 (792)
... ......||+.|+|||++.+. .++.|+|||||||+||||+||..|+.............. ......+.
T Consensus 162 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~k~Di~S~Gvvl~el~tg~~~~~~~~~~~~~~~~~~-~~~~~~~~ 240 (303)
T d1vjya_ 162 TDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLV-PSDPSVEE 240 (303)
T ss_dssp TTEECC----CCSCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTS-CSSCCHHH
T ss_pred CcceeccccceecccCcCChhhccccccccCCCcCcchhhhhhHHHHHHHhhCCCCCCcccccccchhhcc-cccchHHH
Confidence 332 22346799999999998654 367899999999999999999988744321110000000 00000000
Q ss_pred chhHhhhchhccc-----CCHHHHHHHHHHHHHccccCCCCCCCHHhHHHHhccCc
Q 003836 727 TLEALVENDLEAM-----NNVTMLHRFVMVAFWCIQEDPSHRPTMRKVTQMLEGVV 777 (792)
Q Consensus 727 ~~~~~~~~~~~~~-----~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~L~~~~ 777 (792)
....+.++..++. .+.+....+.+++.+||+.||++|||+.||+++|+.+.
T Consensus 241 ~~~~~~~~~~~p~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ei~~~L~~i~ 296 (303)
T d1vjya_ 241 MRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLS 296 (303)
T ss_dssp HHHHHTTSCCCCCCCGGGGGCHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHHHHH
T ss_pred HHHHHhccccCCCCCcccCChHHHHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHH
Confidence 0111111111111 12346677999999999999999999999999998764
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.1e-44 Score=376.68 Aligned_cols=260 Identities=23% Similarity=0.243 Sum_probs=197.7
Q ss_pred hhcCccccceEEEeeecCCCceEEEEEEccccccc-----chHHHHHHHHHhcccCCCCcccccceeccCCceEEEEEec
Q 003836 507 EELGRGAFGTVYKGFVNMGSSNHVAVKKLNSVFQD-----SEKEFKAEVNGIGQTHHKNLVRLLGYCDEGQNRLLVYEFM 581 (792)
Q Consensus 507 ~~lG~G~~g~Vy~g~~~~~~~~~vavK~~~~~~~~-----~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~lV~E~~ 581 (792)
++||+|+||+||+|... .+++.||||+++..... ..+.+.+|+.++++++|||||++++++.+.++.+|||||+
T Consensus 4 ~~lG~G~fg~Vy~~~~~-~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~~~~~~~~~ivmE~~ 82 (299)
T d1ua2a_ 4 DFLGEGQFATVYKARDK-NTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNISLVFDFM 82 (299)
T ss_dssp EEEEEETTEEEEEEECS-SCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCCEEEEECC
T ss_pred eEeccCcCeEEEEEEEC-CCCcEEEEEEEehhhhhhhhHHHHHHHHHHHHHHHhCCCCCEeEEEeeeccCCceeehhhhh
Confidence 57999999999999754 56789999998653322 2356899999999999999999999999999999999999
Q ss_pred cCCCccccccCCCCCchhHHHHHHHHHHHHHHHHhhccCCCeEecCCCCCcEEEcCCCCeEEeecCCCccccCCCCCccc
Q 003836 582 SNGTVASFLFGDSKPNWKLRTEIAMGIAGGLFYLHEECCTQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLDQSHTNT 661 (792)
Q Consensus 582 ~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dikp~NILl~~~~~~kl~Dfg~a~~~~~~~~~~~~ 661 (792)
+++++..++.....+++..+..++.||+.||+|||++ +|+||||||+|||+++++.+||+|||+++....... ...
T Consensus 83 ~~~~~~~~~~~~~~l~~~~~~~~~~qil~aL~~lH~~---~iiHrDiKp~NIli~~~~~~KL~DFG~a~~~~~~~~-~~~ 158 (299)
T d1ua2a_ 83 ETDLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQH---WILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNR-AYT 158 (299)
T ss_dssp SEEHHHHHTTCCSSCCSSHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEECCCGGGSTTTSCCC-CCC
T ss_pred cchHHhhhhhcccCCCHHHHHHHHHHHHHHHHHhhcc---ceecccCCcceEEecCCCccccccCccccccCCCcc-ccc
Confidence 9998888887778899999999999999999999998 999999999999999999999999999987654332 223
Q ss_pred cccccCCccccccccc-CCCCcccceehHHHHHHHHHhcCcCCCcchhhhhhhhHHHHHHHhhcccchhHh------hhc
Q 003836 662 AIRGTKGYVAPEWFRN-MPITVKVDVYSYGVLLLEIICLRRNIDNEISKVDKAILTDWAYDRYQERTLEAL------VEN 734 (792)
Q Consensus 662 ~~~gt~~y~aPE~~~~-~~~~~k~DV~S~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~------~~~ 734 (792)
...||+.|+|||.+.. ..++.++|||||||++|||++|+.||...........+..... .......... ...
T Consensus 159 ~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~l~~i~~~~~-~~~~~~~~~~~~~~~~~~~ 237 (299)
T d1ua2a_ 159 HQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLG-TPTEEQWPDMCSLPDYVTF 237 (299)
T ss_dssp CSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHC-CCCTTTSSSTTSSTTCCCC
T ss_pred ceecChhhccHHHHccCCCCChhhhhhhcchHHHHHHhCcCCCCCCCHHHHHHHHHHhcC-CCChhhccchhccchhhhh
Confidence 4568999999999865 4679999999999999999999999976543221111100000 0000000000 000
Q ss_pred hhcccCC-----HHHHHHHHHHHHHccccCCCCCCCHHhHHHH
Q 003836 735 DLEAMNN-----VTMLHRFVMVAFWCIQEDPSHRPTMRKVTQM 772 (792)
Q Consensus 735 ~~~~~~~-----~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~ 772 (792)
......+ ...++++.+|+.+||+.||++|||++|++++
T Consensus 238 ~~~~~~~~~~~~~~~s~~~~dll~~~L~~dP~~R~sa~e~L~H 280 (299)
T d1ua2a_ 238 KSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKM 280 (299)
T ss_dssp CCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTS
T ss_pred ccCCCCChHHhcccCCHHHHHHHHHHccCChhhCcCHHHHhCC
Confidence 0000001 1234678999999999999999999999974
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=5.6e-44 Score=384.04 Aligned_cols=243 Identities=23% Similarity=0.212 Sum_probs=204.0
Q ss_pred hhhhhhcCccccceEEEeeecCCCceEEEEEEcccc---cccchHHHHHHHHHhcccCCCCcccccceeccCCceEEEEE
Q 003836 503 RGFKEELGRGAFGTVYKGFVNMGSSNHVAVKKLNSV---FQDSEKEFKAEVNGIGQTHHKNLVRLLGYCDEGQNRLLVYE 579 (792)
Q Consensus 503 ~~~~~~lG~G~~g~Vy~g~~~~~~~~~vavK~~~~~---~~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~lV~E 579 (792)
+.+.++||+|+||.||+|... .+++.||||++.+. .....+.+.+|++++++++|||||++++++.+....++|||
T Consensus 43 y~i~~~lG~G~fg~Vy~a~~~-~~g~~~AvK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~v~e 121 (350)
T d1rdqe_ 43 FDRIKTLGTGSFGRVMLVKHK-ESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVME 121 (350)
T ss_dssp EEEEEEEEECSSCEEEEEEET-TTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred eEEEEEeecCcCcEEEEEEEC-CCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHHcCCCcEeecccccccccccccccc
Confidence 344578999999999999754 55789999998643 23345678999999999999999999999999999999999
Q ss_pred eccCCCccccccCCCCCchhHHHHHHHHHHHHHHHHhhccCCCeEecCCCCCcEEEcCCCCeEEeecCCCccccCCCCCc
Q 003836 580 FMSNGTVASFLFGDSKPNWKLRTEIAMGIAGGLFYLHEECCTQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLDQSHT 659 (792)
Q Consensus 580 ~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dikp~NILl~~~~~~kl~Dfg~a~~~~~~~~~~ 659 (792)
|+.+|+|..++.....+++..+..++.||+.||.|||++ +|+||||||+||||+.++.+||+|||+|+.....
T Consensus 122 ~~~~g~l~~~l~~~~~l~e~~~~~i~~qi~~aL~yLH~~---~iiHRDIKP~NILl~~~g~ikL~DFG~a~~~~~~---- 194 (350)
T d1rdqe_ 122 YVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSL---DLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR---- 194 (350)
T ss_dssp CCTTCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECSSC----
T ss_pred cccccchhhhHhhcCCCCHHHHHHHHHHHHHHHHHHHhC---CEecCcCCHHHcccCCCCCEEeeeceeeeecccc----
Confidence 999999999998888899999999999999999999998 9999999999999999999999999999876432
Q ss_pred cccccccCCcccccccccCCCCcccceehHHHHHHHHHhcCcCCCcchhhhhhhhHHHHHHHhhcccchhHhhhchhccc
Q 003836 660 NTAIRGTKGYVAPEWFRNMPITVKVDVYSYGVLLLEIICLRRNIDNEISKVDKAILTDWAYDRYQERTLEALVENDLEAM 739 (792)
Q Consensus 660 ~~~~~gt~~y~aPE~~~~~~~~~k~DV~S~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 739 (792)
.....||+.|||||++.+..++.++|||||||++|||+||+.||........ + ..+.... ..
T Consensus 195 ~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~---~-------------~~i~~~~--~~ 256 (350)
T d1rdqe_ 195 TWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQI---Y-------------EKIVSGK--VR 256 (350)
T ss_dssp BCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH---H-------------HHHHHCC--CC
T ss_pred cccccCccccCCHHHHcCCCCCccccccchhHHHHHHHhCCCCCCCcCHHHH---H-------------HHHhcCC--CC
Confidence 2345799999999999999999999999999999999999999975432110 0 0111111 11
Q ss_pred CCHHHHHHHHHHHHHccccCCCCCC-----CHHhHHH
Q 003836 740 NNVTMLHRFVMVAFWCIQEDPSHRP-----TMRKVTQ 771 (792)
Q Consensus 740 ~~~~~~~~l~~l~~~Cl~~~p~~RP-----s~~evl~ 771 (792)
.+...+.++.+++.+||+.||.+|+ |++|+++
T Consensus 257 ~p~~~s~~~~~li~~~L~~dP~kR~~~~r~t~~ell~ 293 (350)
T d1rdqe_ 257 FPSHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKN 293 (350)
T ss_dssp CCTTCCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHT
T ss_pred CCccCCHHHHHHHHHHhhhCHHhccccccccHHHHHc
Confidence 2233456788999999999999994 8999986
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Probab=100.00 E-value=3.2e-44 Score=374.86 Aligned_cols=256 Identities=22% Similarity=0.318 Sum_probs=199.5
Q ss_pred hhhhhhcCccccceEEEeeecCCCceEEEEEEcccccc---cchHHHHHHHHHhcccCCCCcccccceeccCC----ceE
Q 003836 503 RGFKEELGRGAFGTVYKGFVNMGSSNHVAVKKLNSVFQ---DSEKEFKAEVNGIGQTHHKNLVRLLGYCDEGQ----NRL 575 (792)
Q Consensus 503 ~~~~~~lG~G~~g~Vy~g~~~~~~~~~vavK~~~~~~~---~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~----~~~ 575 (792)
+.+.+.||+|+||+||+|.. ..+++.||||+++.... ...+.+.+|++++++++||||+++++++...+ ..+
T Consensus 9 Y~i~~~lG~G~fg~Vy~a~~-~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~~l~~~~hpniv~~~~~~~~~~~~~~~~~ 87 (277)
T d1o6ya_ 9 YELGEILGFGGMSEVHLARD-LRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPLPY 87 (277)
T ss_dssp EEEEEEEEECSSEEEEEEEE-TTTTEEEEEEEECSTTTTCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEECSSSEEEE
T ss_pred eEEeEEEeeCCCeEEEEEEE-CCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhcCCCCCCcccceeeeccCCCceEE
Confidence 44567899999999999975 35678999999975432 23457999999999999999999999987544 378
Q ss_pred EEEEeccCCCccccccCCCCCchhHHHHHHHHHHHHHHHHhhccCCCeEecCCCCCcEEEcCCCCeEEeecCCCccccCC
Q 003836 576 LVYEFMSNGTVASFLFGDSKPNWKLRTEIAMGIAGGLFYLHEECCTQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLD 655 (792)
Q Consensus 576 lV~E~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dikp~NILl~~~~~~kl~Dfg~a~~~~~~ 655 (792)
|||||+++++|.+++.....+++.++..|+.||+.||+|||+. +|+||||||+|||++.++..+|+|||.++.....
T Consensus 88 lvmE~~~g~~L~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~---~iiHrDiKP~NIll~~~~~~~l~d~~~~~~~~~~ 164 (277)
T d1o6ya_ 88 IVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNFSHQN---GIIHRDVKPANIMISATNAVKVMDFGIARAIADS 164 (277)
T ss_dssp EEEECCCEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEETTSCEEECCCTTCEECC--
T ss_pred EEEECCCCCEehhhhcccCCCCHHHHHHHHHHHHHHHHHHHhC---CccCccccCcccccCccccceeehhhhhhhhccc
Confidence 9999999999999998888899999999999999999999998 9999999999999999999999999999865433
Q ss_pred CC--CccccccccCCcccccccccCCCCcccceehHHHHHHHHHhcCcCCCcchhhhhhhhHHHHHHHhhcccchhHhhh
Q 003836 656 QS--HTNTAIRGTKGYVAPEWFRNMPITVKVDVYSYGVLLLEIICLRRNIDNEISKVDKAILTDWAYDRYQERTLEALVE 733 (792)
Q Consensus 656 ~~--~~~~~~~gt~~y~aPE~~~~~~~~~k~DV~S~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 733 (792)
.. .......||+.|+|||++.+..++.++|||||||++|||+||+.||........ ..........
T Consensus 165 ~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~-------~~~~~~~~~~----- 232 (277)
T d1o6ya_ 165 GNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSV-------AYQHVREDPI----- 232 (277)
T ss_dssp --------------TTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHH-------HHHHHHCCCC-----
T ss_pred cccccccccccCcccccCHHHHcCCCCCcceecccchHHHHHHHhCCCCCCCcCHHHH-------HHHHHhcCCC-----
Confidence 22 233456799999999999999999999999999999999999999975432211 0111111100
Q ss_pred chhcccCCHHHHHHHHHHHHHccccCCCCCC-CHHhHHHHhccC
Q 003836 734 NDLEAMNNVTMLHRFVMVAFWCIQEDPSHRP-TMRKVTQMLEGV 776 (792)
Q Consensus 734 ~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RP-s~~evl~~L~~~ 776 (792)
.........++++.+++.+||+.||++|| |++++++.|.++
T Consensus 233 --~~~~~~~~~s~~l~~li~~~L~~dp~~R~~sa~~l~~~l~r~ 274 (277)
T d1o6ya_ 233 --PPSARHEGLSADLDAVVLKALAKNPENRYQTAAEMRADLVRV 274 (277)
T ss_dssp --CGGGTSSSCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHH
T ss_pred --CCchhccCCCHHHHHHHHHHccCCHhHCHhHHHHHHHHHHHH
Confidence 00111123456788999999999999999 899999888764
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.8e-44 Score=381.76 Aligned_cols=246 Identities=23% Similarity=0.313 Sum_probs=202.5
Q ss_pred hhhhhhcCccccceEEEeeecCCCceEEEEEEccccc---ccchHHHHHHHHHhc-ccCCCCcccccceeccCCceEEEE
Q 003836 503 RGFKEELGRGAFGTVYKGFVNMGSSNHVAVKKLNSVF---QDSEKEFKAEVNGIG-QTHHKNLVRLLGYCDEGQNRLLVY 578 (792)
Q Consensus 503 ~~~~~~lG~G~~g~Vy~g~~~~~~~~~vavK~~~~~~---~~~~~~~~~Ei~~l~-~l~h~niv~l~g~~~~~~~~~lV~ 578 (792)
+.+.++||+|+||+||+|+.. .+++.||||++++.. ....+.+..|..++. .++|||||++++++.+++..+|||
T Consensus 4 y~i~~~iG~G~fg~Vy~~~~~-~t~~~vAvK~i~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~~~~~~~~~~~~yivm 82 (320)
T d1xjda_ 4 FILHKMLGKGSFGKVFLAEFK-KTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFFVM 82 (320)
T ss_dssp EEEEEEEEECSSSEEEEEEET-TTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEEE
T ss_pred eEEeeEEecCCCcEEEEEEEC-CCCCEEEEEEEchhhccChHHHHHHHHHHHHHHHhCCCCcEEEEEEEEccCCceeEEE
Confidence 345688999999999999754 567899999997532 334456777777665 689999999999999999999999
Q ss_pred EeccCCCccccccCCCCCchhHHHHHHHHHHHHHHHHhhccCCCeEecCCCCCcEEEcCCCCeEEeecCCCccccCCCCC
Q 003836 579 EFMSNGTVASFLFGDSKPNWKLRTEIAMGIAGGLFYLHEECCTQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLDQSH 658 (792)
Q Consensus 579 E~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dikp~NILl~~~~~~kl~Dfg~a~~~~~~~~~ 658 (792)
||+++|+|.+++.....+++..+..++.||+.||+|||++ +|+||||||+|||+++++.+||+|||+++...... .
T Consensus 83 Ey~~~g~L~~~i~~~~~~~e~~~~~~~~qi~~al~ylH~~---~iiHrDikp~NiL~~~~~~~kl~DFG~a~~~~~~~-~ 158 (320)
T d1xjda_ 83 EYLNGGDLMYHIQSCHKFDLSRATFYAAEIILGLQFLHSK---GIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGD-A 158 (320)
T ss_dssp ECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCCTTCBCCCCTT-C
T ss_pred eecCCCcHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhC---CeeeccCcccceeecCCCceeccccchhhhccccc-c
Confidence 9999999999998888899999999999999999999999 99999999999999999999999999998665332 2
Q ss_pred ccccccccCCcccccccccCCCCcccceehHHHHHHHHHhcCcCCCcchhhhhhhhHHHHHHHhhcccchhHhhhchhcc
Q 003836 659 TNTAIRGTKGYVAPEWFRNMPITVKVDVYSYGVLLLEIICLRRNIDNEISKVDKAILTDWAYDRYQERTLEALVENDLEA 738 (792)
Q Consensus 659 ~~~~~~gt~~y~aPE~~~~~~~~~k~DV~S~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 738 (792)
......||+.|+|||++.+..++.++|||||||++|||++|+.||........ . .. +... ..
T Consensus 159 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~PF~~~~~~~~---~-----~~--------i~~~--~~ 220 (320)
T d1xjda_ 159 KTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEEL---F-----HS--------IRMD--NP 220 (320)
T ss_dssp CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH---H-----HH--------HHHC--CC
T ss_pred cccccCCCCCcCCHHHHcCCCCCchhhhhhhhHHHHHHHhCCCCCCCCCHHHH---H-----HH--------HHcC--CC
Confidence 33446799999999999999999999999999999999999999976432211 0 00 0001 11
Q ss_pred cCCHHHHHHHHHHHHHccccCCCCCCCHH-hHHH
Q 003836 739 MNNVTMLHRFVMVAFWCIQEDPSHRPTMR-KVTQ 771 (792)
Q Consensus 739 ~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~-evl~ 771 (792)
..+...+.++.+|+.+||+.||++||++. |+++
T Consensus 221 ~~p~~~s~~~~dli~~~L~~dP~~R~s~~~~l~~ 254 (320)
T d1xjda_ 221 FYPRWLEKEAKDLLVKLFVREPEKRLGVRGDIRQ 254 (320)
T ss_dssp CCCTTSCHHHHHHHHHHSCSSGGGSBTTBSCGGG
T ss_pred CCCccCCHHHHHHHHHhcccCCCCCcCHHHHHHh
Confidence 12233456789999999999999999996 7764
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Probab=100.00 E-value=7.9e-44 Score=370.36 Aligned_cols=246 Identities=22% Similarity=0.287 Sum_probs=202.3
Q ss_pred hhhhhcCccccceEEEeeecCCCceEEEEEEccccccc---------chHHHHHHHHHhcccC-CCCcccccceeccCCc
Q 003836 504 GFKEELGRGAFGTVYKGFVNMGSSNHVAVKKLNSVFQD---------SEKEFKAEVNGIGQTH-HKNLVRLLGYCDEGQN 573 (792)
Q Consensus 504 ~~~~~lG~G~~g~Vy~g~~~~~~~~~vavK~~~~~~~~---------~~~~~~~Ei~~l~~l~-h~niv~l~g~~~~~~~ 573 (792)
.+.+.||+|+||+||+|+. ..+++.+|||++.+.... ..+.+.+|+.++++++ ||||+++++++.+++.
T Consensus 6 ~~~~~iG~G~~g~V~~~~~-~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~~~ 84 (277)
T d1phka_ 6 EPKEILGRGVSSVVRRCIH-KPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYETNTF 84 (277)
T ss_dssp EEEEEEEECSSEEEEEEEE-TTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSE
T ss_pred EEceEEecCcCeEEEEEEE-CCCCCEEEEEEEecccccchhHHHHHHHHHHHHHHHHHHHHhcCCCCeEEEEeecccCcc
Confidence 3457899999999999975 356789999998754221 2246889999999997 9999999999999999
Q ss_pred eEEEEEeccCCCccccccCCCCCchhHHHHHHHHHHHHHHHHhhccCCCeEecCCCCCcEEEcCCCCeEEeecCCCcccc
Q 003836 574 RLLVYEFMSNGTVASFLFGDSKPNWKLRTEIAMGIAGGLFYLHEECCTQIIHCDIKPQNILLDDHYNARISDFGLAKLLT 653 (792)
Q Consensus 574 ~~lV~E~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dikp~NILl~~~~~~kl~Dfg~a~~~~ 653 (792)
.+|||||+++|+|.++|.....+++..+..++.||++||+|||++ +|+||||||+|||++.++.+||+|||+++...
T Consensus 85 ~~ivmE~~~~g~L~~~l~~~~~l~e~~~~~~~~qi~~al~~lH~~---~ivHrDlkp~Nill~~~~~~kl~DFG~a~~~~ 161 (277)
T d1phka_ 85 FFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLEVICALHKL---NIVHRDLKPENILLDDDMNIKLTDFGFSCQLD 161 (277)
T ss_dssp EEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCCTTCEECC
T ss_pred eEEEEEcCCCchHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHc---CCcccccccceEEEcCCCCeEEccchheeEcc
Confidence 999999999999999998888899999999999999999999998 99999999999999999999999999998765
Q ss_pred CCCCCccccccccCCccccccccc------CCCCcccceehHHHHHHHHHhcCcCCCcchhhhhhhhHHHHHHHhhcccc
Q 003836 654 LDQSHTNTAIRGTKGYVAPEWFRN------MPITVKVDVYSYGVLLLEIICLRRNIDNEISKVDKAILTDWAYDRYQERT 727 (792)
Q Consensus 654 ~~~~~~~~~~~gt~~y~aPE~~~~------~~~~~k~DV~S~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 727 (792)
... ......||+.|+|||++.+ ..++.++||||+||++|||++|+.||..........
T Consensus 162 ~~~--~~~~~~gt~~y~~PE~~~~~~~~~~~~~~~~~DiwslGvilyeml~g~~Pf~~~~~~~~~~-------------- 225 (277)
T d1phka_ 162 PGE--KLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLR-------------- 225 (277)
T ss_dssp TTC--CBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHH--------------
T ss_pred CCC--ceeeeeccCCCCCHHHhhccccccCCCCCchheEcccchhhhhhccCCCCCCCCCHHHHHH--------------
Confidence 432 2344679999999999853 347889999999999999999999997653321110
Q ss_pred hhHhhhch--hcccCCHHHHHHHHHHHHHccccCCCCCCCHHhHHH
Q 003836 728 LEALVEND--LEAMNNVTMLHRFVMVAFWCIQEDPSHRPTMRKVTQ 771 (792)
Q Consensus 728 ~~~~~~~~--~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~ 771 (792)
.+.... .........++++.+++.+||+.||++|||++||++
T Consensus 226 --~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~~p~~R~s~~eil~ 269 (277)
T d1phka_ 226 --MIMSGNYQFGSPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALA 269 (277)
T ss_dssp --HHHHTCCCCCTTTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTT
T ss_pred --HHHhCCCCCCCcccccCCHHHHHHHHHHccCChhHCcCHHHHHc
Confidence 011111 011112235568899999999999999999999987
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Probab=100.00 E-value=1e-43 Score=384.11 Aligned_cols=246 Identities=22% Similarity=0.252 Sum_probs=197.5
Q ss_pred hhhhhcCccccceEEEeeecCCCceEEEEEEccccc---ccchHHHHH---HHHHhcccCCCCcccccceeccCCceEEE
Q 003836 504 GFKEELGRGAFGTVYKGFVNMGSSNHVAVKKLNSVF---QDSEKEFKA---EVNGIGQTHHKNLVRLLGYCDEGQNRLLV 577 (792)
Q Consensus 504 ~~~~~lG~G~~g~Vy~g~~~~~~~~~vavK~~~~~~---~~~~~~~~~---Ei~~l~~l~h~niv~l~g~~~~~~~~~lV 577 (792)
.+.++||+|+||.||+|+. ..+++.||||++.+.. ......+.+ |+++++.++|||||++++++.+.+..++|
T Consensus 7 ~i~~~lG~G~fg~Vy~~~~-~~t~~~vAiK~i~~~~~~~~~~~~~~~~e~~~~~~l~~~~hpnIv~l~~~~~~~~~~~iv 85 (364)
T d1omwa3 7 SVHRIIGRGGFGEVYGCRK-ADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFI 85 (364)
T ss_dssp EEEEEEEECSSCEEEEEEE-TTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEEEEE
T ss_pred eeeeEEecCCCeEEEEEEE-CCCCCEEEEEEEchHHcchhhHHHHHHHHHHHHHHHhcCCCCcEEEEEEEEEECCEEEEE
Confidence 4567899999999999975 4567899999986421 222333444 46778888999999999999999999999
Q ss_pred EEeccCCCccccccCCCCCchhHHHHHHHHHHHHHHHHhhccCCCeEecCCCCCcEEEcCCCCeEEeecCCCccccCCCC
Q 003836 578 YEFMSNGTVASFLFGDSKPNWKLRTEIAMGIAGGLFYLHEECCTQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLDQS 657 (792)
Q Consensus 578 ~E~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dikp~NILl~~~~~~kl~Dfg~a~~~~~~~~ 657 (792)
|||+++|+|.++|.....+++..+..++.||+.||+|||++ +|+||||||+||||+.++.+||+|||+|+......
T Consensus 86 mE~~~gg~L~~~l~~~~~~~e~~~~~~~~qi~~aL~ylH~~---~iiHrDlKP~NILl~~~g~iKl~DFGla~~~~~~~- 161 (364)
T d1omwa3 86 LDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEHMHNR---FVVYRDLKPANILLDEHGHVRISDLGLACDFSKKK- 161 (364)
T ss_dssp ECCCCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECSSSCEEECCCTTCEECSSSC-
T ss_pred EEecCCCcHHHHHHhcccccHHHHHHHHHHHHHHHHHHHHC---CccceeeccceeEEcCCCcEEEeeeceeeecCCCc-
Confidence 99999999999998888899999999999999999999999 99999999999999999999999999998765432
Q ss_pred CccccccccCCccccccccc-CCCCcccceehHHHHHHHHHhcCcCCCcchhhhhhhhHHHHHHHhhcccchhHhhhchh
Q 003836 658 HTNTAIRGTKGYVAPEWFRN-MPITVKVDVYSYGVLLLEIICLRRNIDNEISKVDKAILTDWAYDRYQERTLEALVENDL 736 (792)
Q Consensus 658 ~~~~~~~gt~~y~aPE~~~~-~~~~~k~DV~S~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 736 (792)
.....||+.|+|||++.. ..++.++|||||||++|||+||+.||............ . .... .
T Consensus 162 --~~~~~GT~~y~APE~~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~~-----~--------~~~~--~ 224 (364)
T d1omwa3 162 --PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEID-----R--------MTLT--M 224 (364)
T ss_dssp --CCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCSSCSSCSSCHHHHH-----H--------HSSS--C
T ss_pred --ccccccccccchhHHhhcCCCCCcccchhHHHHHHHHHHhCCCCCCCCCHHHHHHHH-----H--------hccc--C
Confidence 234569999999999875 56899999999999999999999999754322111000 0 0000 0
Q ss_pred cccCCHHHHHHHHHHHHHccccCCCCCCC-----HHhHHH
Q 003836 737 EAMNNVTMLHRFVMVAFWCIQEDPSHRPT-----MRKVTQ 771 (792)
Q Consensus 737 ~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs-----~~evl~ 771 (792)
....+...++++.+|+.+||+.||++||| ++|+++
T Consensus 225 ~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~~~~a~eil~ 264 (364)
T d1omwa3 225 AVELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKE 264 (364)
T ss_dssp CCCCCSSSCHHHHHHHHHHTCSSTTTSTTTSSSTHHHHHT
T ss_pred CCCCCCCCCHHHHHHHHHHcccCHHHhCCCcccCHHHHHc
Confidence 11122234567899999999999999999 588875
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.7e-43 Score=376.25 Aligned_cols=247 Identities=19% Similarity=0.250 Sum_probs=202.3
Q ss_pred hhhhhhcCccccceEEEeeecCCCceEEEEEEcccccccchHHHHHHHHHhcccCCCCcccccceeccCCceEEEEEecc
Q 003836 503 RGFKEELGRGAFGTVYKGFVNMGSSNHVAVKKLNSVFQDSEKEFKAEVNGIGQTHHKNLVRLLGYCDEGQNRLLVYEFMS 582 (792)
Q Consensus 503 ~~~~~~lG~G~~g~Vy~g~~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~lV~E~~~ 582 (792)
|.+.++||+|+||+||+|.. ..+++.||||+++... .....+.+|+++|++++|||||++++++.+.+..+|||||++
T Consensus 7 Y~i~~~lG~G~fg~Vy~~~~-~~~~~~~AiK~i~~~~-~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~lvmE~~~ 84 (321)
T d1tkia_ 7 YMIAEDLGRGEFGIVHRCVE-TSSKKTYMAKFVKVKG-TDQVLVKKEISILNIARHRNILHLHESFESMEELVMIFEFIS 84 (321)
T ss_dssp EEEEEEEEECSSEEEEEEEE-TTTTEEEEEEEECCCT-HHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEECCCC
T ss_pred eEEEEEEecCCCeEEEEEEE-CCCCcEEEEEEEcCCc-ccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEecCC
Confidence 44567899999999999964 4567899999997643 345678899999999999999999999999999999999999
Q ss_pred CCCccccccCCC-CCchhHHHHHHHHHHHHHHHHhhccCCCeEecCCCCCcEEEcCC--CCeEEeecCCCccccCCCCCc
Q 003836 583 NGTVASFLFGDS-KPNWKLRTEIAMGIAGGLFYLHEECCTQIIHCDIKPQNILLDDH--YNARISDFGLAKLLTLDQSHT 659 (792)
Q Consensus 583 ~gsL~~~l~~~~-~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dikp~NILl~~~--~~~kl~Dfg~a~~~~~~~~~~ 659 (792)
+|+|.+++.... .+++.++..|+.||+.||+|||++ +|+||||||+|||++.+ ..+||+|||+++..... ..
T Consensus 85 gg~L~~~i~~~~~~l~e~~~~~i~~qi~~al~yLH~~---~iiHrDlKp~NIll~~~~~~~ikl~DFG~~~~~~~~--~~ 159 (321)
T d1tkia_ 85 GLDIFERINTSAFELNEREIVSYVHQVCEALQFLHSH---NIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPG--DN 159 (321)
T ss_dssp CCBHHHHHTSSSCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSSSCCCEEECCCTTCEECCTT--CE
T ss_pred CCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHc---CCCcccccccceeecCCCceEEEEcccchhhccccC--Cc
Confidence 999999998764 789999999999999999999998 99999999999999854 58999999999876432 22
Q ss_pred cccccccCCcccccccccCCCCcccceehHHHHHHHHHhcCcCCCcchhhhhhhhHHHHHHHhhcccchhHhhhchhcc-
Q 003836 660 NTAIRGTKGYVAPEWFRNMPITVKVDVYSYGVLLLEIICLRRNIDNEISKVDKAILTDWAYDRYQERTLEALVENDLEA- 738 (792)
Q Consensus 660 ~~~~~gt~~y~aPE~~~~~~~~~k~DV~S~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~- 738 (792)
.....+|+.|+|||.+.+..++.++|||||||++|||++|+.||........ + ..+.......
T Consensus 160 ~~~~~~t~~y~ape~~~~~~~~~~~DiWSlGvily~ll~G~~Pf~~~~~~~~---~-------------~~i~~~~~~~~ 223 (321)
T d1tkia_ 160 FRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQI---I-------------ENIMNAEYTFD 223 (321)
T ss_dssp EEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSHHHH---H-------------HHHHHTCCCCC
T ss_pred ccccccccccccchhccCCCCCchhhcccHHHHHHHHHhCCCCCCCCCHHHH---H-------------HHHHhCCCCCC
Confidence 3445689999999999999999999999999999999999999976533211 0 0011110000
Q ss_pred -cCCHHHHHHHHHHHHHccccCCCCCCCHHhHHHH
Q 003836 739 -MNNVTMLHRFVMVAFWCIQEDPSHRPTMRKVTQM 772 (792)
Q Consensus 739 -~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~ 772 (792)
......+.++.+|+.+||+.||++|||++|+++.
T Consensus 224 ~~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~h 258 (321)
T d1tkia_ 224 EEAFKEISIEAMDFVDRLLVKERKSRMTASEALQH 258 (321)
T ss_dssp HHHHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred hhhccCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 0001234678899999999999999999999973
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.4e-43 Score=375.90 Aligned_cols=243 Identities=22% Similarity=0.275 Sum_probs=193.9
Q ss_pred hhcCccccceEEEeeecCCCceEEEEEEcccccccchHHHHHHHHHhccc-CCCCcccccceecc----CCceEEEEEec
Q 003836 507 EELGRGAFGTVYKGFVNMGSSNHVAVKKLNSVFQDSEKEFKAEVNGIGQT-HHKNLVRLLGYCDE----GQNRLLVYEFM 581 (792)
Q Consensus 507 ~~lG~G~~g~Vy~g~~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l-~h~niv~l~g~~~~----~~~~~lV~E~~ 581 (792)
+.||+|+||+||+|... .+++.||||++++ ...+.+|++++.++ +|||||++++++.+ ....++|||||
T Consensus 18 ~~lG~G~fg~Vy~a~~~-~~~~~vAiK~i~~-----~~~~~~E~~~~~~~~~hpnIv~l~~~~~~~~~~~~~~~ivmEy~ 91 (335)
T d2ozaa1 18 QVLGLGINGKVLQIFNK-RTQEKFALKMLQD-----CPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECL 91 (335)
T ss_dssp EEEEECSSCEEEEEEET-TTCCEEEEEEEEC-----SHHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEEEEEECC
T ss_pred EEeeeccCeEEEEEEEC-CCCCEEEEEEECC-----cHHHHHHHHHHHHhcCCCCCCeEEEEEeecccCCCEEEEEEECC
Confidence 46999999999999753 4678999999864 35678899987665 89999999999864 46789999999
Q ss_pred cCCCccccccCC--CCCchhHHHHHHHHHHHHHHHHhhccCCCeEecCCCCCcEEEcC---CCCeEEeecCCCccccCCC
Q 003836 582 SNGTVASFLFGD--SKPNWKLRTEIAMGIAGGLFYLHEECCTQIIHCDIKPQNILLDD---HYNARISDFGLAKLLTLDQ 656 (792)
Q Consensus 582 ~~gsL~~~l~~~--~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dikp~NILl~~---~~~~kl~Dfg~a~~~~~~~ 656 (792)
++|+|.++|... ..+++.++..|+.||+.||+|||+. +|+||||||+|||+++ ++.+||+|||+++......
T Consensus 92 ~gg~L~~~i~~~~~~~l~e~~~~~i~~qi~~al~ylH~~---~iiHRDiKp~NIll~~~~~~~~~Kl~DFG~a~~~~~~~ 168 (335)
T d2ozaa1 92 DGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSI---NIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHN 168 (335)
T ss_dssp CSEEHHHHHHSCSCCCEEHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESCSSTTCCEEECCCTTCEECCCCC
T ss_pred CCCcHHHHHHhcCCCCcCHHHHHHHHHHHHHHHHHHHHc---CCccccccccccccccccccccccccccceeeeccCCC
Confidence 999999999764 4689999999999999999999998 9999999999999985 5679999999998765433
Q ss_pred CCccccccccCCcccccccccCCCCcccceehHHHHHHHHHhcCcCCCcchhhhhhhhHHHHHHHhhcccchhHhhhchh
Q 003836 657 SHTNTAIRGTKGYVAPEWFRNMPITVKVDVYSYGVLLLEIICLRRNIDNEISKVDKAILTDWAYDRYQERTLEALVENDL 736 (792)
Q Consensus 657 ~~~~~~~~gt~~y~aPE~~~~~~~~~k~DV~S~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 736 (792)
......||+.|+|||++.+..++.++|||||||++|||+||+.||...........+ .. .+.....
T Consensus 169 --~~~~~~gt~~y~aPE~~~~~~y~~~~DiwSlGvily~lltg~~Pf~~~~~~~~~~~~----~~--------~i~~~~~ 234 (335)
T d2ozaa1 169 --SLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGM----KT--------RIRMGQY 234 (335)
T ss_dssp --CCCCCSCCCSSCCCCCCCGGGGSHHHHHHHHHHHHHHHTTSSCSCEETTCC--------------------CCCSCSS
T ss_pred --ccccccCCcccCCcHHHcCCCCCHHHHHHhhchhHHHHhhCCCCCCCCCHHHHHHHH----HH--------HHhcCCC
Confidence 234457999999999999999999999999999999999999999654321110000 00 0000111
Q ss_pred ccc--CCHHHHHHHHHHHHHccccCCCCCCCHHhHHHH
Q 003836 737 EAM--NNVTMLHRFVMVAFWCIQEDPSHRPTMRKVTQM 772 (792)
Q Consensus 737 ~~~--~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~ 772 (792)
... .....++++.+|+.+||+.||++|||++|+++.
T Consensus 235 ~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~h 272 (335)
T d2ozaa1 235 EFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNH 272 (335)
T ss_dssp SCCTTHHHHSCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred CCCCcccccCCHHHHHHHHHHccCChhHCcCHHHHHcC
Confidence 111 112346788999999999999999999999884
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.6e-43 Score=367.86 Aligned_cols=262 Identities=21% Similarity=0.263 Sum_probs=195.9
Q ss_pred hhhhcCccccceEEEeeecCCCceEEEEEEccccc--ccchHHHHHHHHHhcccCCCCcccccceeccCCceEEEEEecc
Q 003836 505 FKEELGRGAFGTVYKGFVNMGSSNHVAVKKLNSVF--QDSEKEFKAEVNGIGQTHHKNLVRLLGYCDEGQNRLLVYEFMS 582 (792)
Q Consensus 505 ~~~~lG~G~~g~Vy~g~~~~~~~~~vavK~~~~~~--~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~lV~E~~~ 582 (792)
..++||+|+||+||+|+.. .+++.||||+++... ....+++.+|++++++++|||||++++++.++.+.++||||+.
T Consensus 6 ~~~~lG~G~fg~Vy~~~~~-~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~Hp~Iv~~~~~~~~~~~~~iv~e~~~ 84 (298)
T d1gz8a_ 6 KVEKIGEGTYGVVYKARNK-LTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLH 84 (298)
T ss_dssp EEEEEEECSSSEEEEEEET-TTCCEEEEEEEC-------CCHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEECCS
T ss_pred eccEEecCcCeEEEEEEEC-CCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEEeccccccccceeEEEeecC
Confidence 3478999999999999754 456789999996532 2345789999999999999999999999999999999999998
Q ss_pred CCCccccccC-CCCCchhHHHHHHHHHHHHHHHHhhccCCCeEecCCCCCcEEEcCCCCeEEeecCCCccccCCCCCccc
Q 003836 583 NGTVASFLFG-DSKPNWKLRTEIAMGIAGGLFYLHEECCTQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLDQSHTNT 661 (792)
Q Consensus 583 ~gsL~~~l~~-~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dikp~NILl~~~~~~kl~Dfg~a~~~~~~~~~~~~ 661 (792)
++.+...... ...+++..+..++.||+.||+|||++ +|+||||||+|||++.++.+||+|||+++...... ....
T Consensus 85 ~~~~~~~~~~~~~~l~e~~~~~~~~qil~~L~yLH~~---~IiHrDiKpeNIl~~~~~~~kl~DFG~a~~~~~~~-~~~~ 160 (298)
T d1gz8a_ 85 QDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPV-RTYT 160 (298)
T ss_dssp EEHHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECSTTHHHHHCCCS-BCTT
T ss_pred CchhhhhhhhcccCCCHHHHHHHHHHHHHHHHHhhcC---CEEccccCchheeecccCcceeccCCcceeccCCc-ccce
Confidence 7555444333 35789999999999999999999998 99999999999999999999999999998764332 2233
Q ss_pred cccccCCcccccccccCC-CCcccceehHHHHHHHHHhcCcCCCcchhhhhhhhHHHHHHHhhcccchhHhhh-chhccc
Q 003836 662 AIRGTKGYVAPEWFRNMP-ITVKVDVYSYGVLLLEIICLRRNIDNEISKVDKAILTDWAYDRYQERTLEALVE-NDLEAM 739 (792)
Q Consensus 662 ~~~gt~~y~aPE~~~~~~-~~~k~DV~S~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~ 739 (792)
...||+.|+|||.+.... ++.++|||||||++|||++|+.||............... .....+........ ......
T Consensus 161 ~~~gt~~y~apE~~~~~~~~~~~~DiwSlGvily~m~~G~~Pf~~~~~~~~~~~i~~~-~~~~~~~~~~~~~~~~~~~~~ 239 (298)
T d1gz8a_ 161 HEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRT-LGTPDEVVWPGVTSMPDYKPS 239 (298)
T ss_dssp CCBCCCTTCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHH-HCCCCTTTSTTGGGSTTCCTT
T ss_pred eecccceeeehhhhccccCCCccccccccchhhhHHhhCCCCCCCCCHHHHHHHHHHh-cCCCchhhccccccccccccc
Confidence 456999999999877655 578999999999999999999999754322111000000 00000000000000 000000
Q ss_pred -----------CCHHHHHHHHHHHHHccccCCCCCCCHHhHHHH
Q 003836 740 -----------NNVTMLHRFVMVAFWCIQEDPSHRPTMRKVTQM 772 (792)
Q Consensus 740 -----------~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~ 772 (792)
.....++++.+|+.+||+.||++|||++|+++.
T Consensus 240 ~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~t~~ell~H 283 (298)
T d1gz8a_ 240 FPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAH 283 (298)
T ss_dssp SCCCCCCCHHHHSTTCCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred cccccccchhhhccCCCHHHHHHHHHHccCChhHCcCHHHHhCC
Confidence 011234678899999999999999999999985
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-43 Score=369.22 Aligned_cols=238 Identities=23% Similarity=0.381 Sum_probs=195.0
Q ss_pred hhhhhhcCccccceEEEeeecCCCceEEEEEEccccccc------chHHHHHHHHHhcccC--CCCcccccceeccCCce
Q 003836 503 RGFKEELGRGAFGTVYKGFVNMGSSNHVAVKKLNSVFQD------SEKEFKAEVNGIGQTH--HKNLVRLLGYCDEGQNR 574 (792)
Q Consensus 503 ~~~~~~lG~G~~g~Vy~g~~~~~~~~~vavK~~~~~~~~------~~~~~~~Ei~~l~~l~--h~niv~l~g~~~~~~~~ 574 (792)
+.+.+.||+|+||+||+|... .+++.||||++.+.... ...++.+|+.++++++ |||||++++++.+.+..
T Consensus 6 Y~i~~~lG~G~fg~Vy~a~~~-~~~~~vAvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~~~h~nIv~~~~~~~~~~~~ 84 (273)
T d1xwsa_ 6 YQVGPLLGSGGFGSVYSGIRV-SDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDSF 84 (273)
T ss_dssp EEEEEEEEEETTEEEEEEEET-TTCCEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECSSEE
T ss_pred EEEeEEEeeCCCeEEEEEEEC-CCCCEEEEEEEehHHccchhhhhHHHHHHHHHHHHHHhccCCCCccEEEEEEeeCCeE
Confidence 445678999999999999753 55789999998653211 1244778999999986 89999999999999999
Q ss_pred EEEEEeccC-CCccccccCCCCCchhHHHHHHHHHHHHHHHHhhccCCCeEecCCCCCcEEEcC-CCCeEEeecCCCccc
Q 003836 575 LLVYEFMSN-GTVASFLFGDSKPNWKLRTEIAMGIAGGLFYLHEECCTQIIHCDIKPQNILLDD-HYNARISDFGLAKLL 652 (792)
Q Consensus 575 ~lV~E~~~~-gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dikp~NILl~~-~~~~kl~Dfg~a~~~ 652 (792)
++||||+.+ +++.+++.....+++..+..++.||+.||+|||++ +|+||||||+|||++. ++.+||+|||+++..
T Consensus 85 ~lv~e~~~~~~~l~~~~~~~~~l~e~~~~~~~~qi~~al~~lH~~---~iiHrDiKp~NIll~~~~~~vkl~DFG~a~~~ 161 (273)
T d1xwsa_ 85 VLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHNC---GVLHRDIKDENILIDLNRGELKLIDFGSGALL 161 (273)
T ss_dssp EEEEECCSSEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEETTTTEEEECCCTTCEEC
T ss_pred EEEEEeccCcchHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHC---CCccccCcccceEEecCCCeEEECccccceec
Confidence 999999976 67788887778899999999999999999999998 9999999999999985 478999999999865
Q ss_pred cCCCCCccccccccCCcccccccccCCC-CcccceehHHHHHHHHHhcCcCCCcchhhhhhhhHHHHHHHhhcccchhHh
Q 003836 653 TLDQSHTNTAIRGTKGYVAPEWFRNMPI-TVKVDVYSYGVLLLEIICLRRNIDNEISKVDKAILTDWAYDRYQERTLEAL 731 (792)
Q Consensus 653 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~k~DV~S~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 731 (792)
... ......||+.|+|||++.+.++ +.++|||||||++|||++|+.||.......
T Consensus 162 ~~~---~~~~~~GT~~y~aPE~~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~i~--------------------- 217 (273)
T d1xwsa_ 162 KDT---VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEII--------------------- 217 (273)
T ss_dssp CSS---CBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHHHHH---------------------
T ss_pred ccc---cccccccCCCcCCHHHHcCCCCCCcccccccceeeehhHhhCCCCCCCchHHh---------------------
Confidence 432 2345679999999999987765 577999999999999999999997532110
Q ss_pred hhchhcccCCHHHHHHHHHHHHHccccCCCCCCCHHhHHH
Q 003836 732 VENDLEAMNNVTMLHRFVMVAFWCIQEDPSHRPTMRKVTQ 771 (792)
Q Consensus 732 ~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~ 771 (792)
... ...+...+.++.+++.+||+.||++|||++|+++
T Consensus 218 -~~~--~~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~ 254 (273)
T d1xwsa_ 218 -RGQ--VFFRQRVSSECQHLIRWCLALRPSDRPTFEEIQN 254 (273)
T ss_dssp -HCC--CCCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred -hcc--cCCCCCCCHHHHHHHHHHccCCHhHCcCHHHHhc
Confidence 000 0111223467889999999999999999999987
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-42 Score=368.64 Aligned_cols=264 Identities=20% Similarity=0.274 Sum_probs=195.6
Q ss_pred hhhhhhcCccccceEEEeeecCCCceEEEEEEccccc--ccchHHHHHHHHHhccc---CCCCcccccceec-----cCC
Q 003836 503 RGFKEELGRGAFGTVYKGFVNMGSSNHVAVKKLNSVF--QDSEKEFKAEVNGIGQT---HHKNLVRLLGYCD-----EGQ 572 (792)
Q Consensus 503 ~~~~~~lG~G~~g~Vy~g~~~~~~~~~vavK~~~~~~--~~~~~~~~~Ei~~l~~l---~h~niv~l~g~~~-----~~~ 572 (792)
+.+.++||+|+||+||+|.....+++.||||+++... ......+.+|+.+++.+ +||||++++++|. ...
T Consensus 9 Y~i~~~LG~G~fg~V~~a~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~~l~~l~~~~HpnIv~~~~~~~~~~~~~~~ 88 (305)
T d1blxa_ 9 YECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDRET 88 (305)
T ss_dssp EEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEECSSEE
T ss_pred EEEEEEEecccCeEEEEEEEECCCCEEEEEEEEehhhccchHHHHHHHHHHHHHHHhhcCCCCcceeeeeecccccccCc
Confidence 3455789999999999997654556789999986532 22234567788877766 7999999999984 335
Q ss_pred ceEEEEEeccCCCccccccC-CCCCchhHHHHHHHHHHHHHHHHhhccCCCeEecCCCCCcEEEcCCCCeEEeecCCCcc
Q 003836 573 NRLLVYEFMSNGTVASFLFG-DSKPNWKLRTEIAMGIAGGLFYLHEECCTQIIHCDIKPQNILLDDHYNARISDFGLAKL 651 (792)
Q Consensus 573 ~~~lV~E~~~~gsL~~~l~~-~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dikp~NILl~~~~~~kl~Dfg~a~~ 651 (792)
..+++|||++++++...... ...+++..+..++.||+.||+|||++ +|+||||||+|||+++++.+||+|||+++.
T Consensus 89 ~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~---~ivHrDiKp~NILi~~~~~~kl~dfg~~~~ 165 (305)
T d1blxa_ 89 KLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLADFGLARI 165 (305)
T ss_dssp EEEEEEECCSCBHHHHHHHSCTTCSCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEECSCCSCCC
T ss_pred eEEEEEEeccCCchhhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhC---CEEecCCCccEEEEcCCCCeeecchhhhhh
Confidence 68899999999877655443 45688999999999999999999998 999999999999999999999999999986
Q ss_pred ccCCCCCccccccccCCcccccccccCCCCcccceehHHHHHHHHHhcCcCCCcchhhhhhhhHHHHHHH----hhccc-
Q 003836 652 LTLDQSHTNTAIRGTKGYVAPEWFRNMPITVKVDVYSYGVLLLEIICLRRNIDNEISKVDKAILTDWAYD----RYQER- 726 (792)
Q Consensus 652 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DV~S~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~----~~~~~- 726 (792)
.... .......||+.|+|||++.+..++.++||||+||++|||++|+.||...........+...... .+...
T Consensus 166 ~~~~--~~~~~~~gT~~Y~APE~~~~~~y~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 243 (305)
T d1blxa_ 166 YSFQ--MALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPRDV 243 (305)
T ss_dssp CCGG--GGGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCGGGSCTTC
T ss_pred hccc--ccCCCcccChhhcCcchhcCCCCChhehhhchHHHHHHHHHCCCCCCCCCHHHHHHHHHHhhCCCchhcccccc
Confidence 5432 2334567999999999999999999999999999999999999999765432111111000000 00000
Q ss_pred ch-hHhhhc---hhcccCCHHHHHHHHHHHHHccccCCCCCCCHHhHHH
Q 003836 727 TL-EALVEN---DLEAMNNVTMLHRFVMVAFWCIQEDPSHRPTMRKVTQ 771 (792)
Q Consensus 727 ~~-~~~~~~---~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~ 771 (792)
.. ...... ..........++.+.+|+.+||+.||++|||++|+++
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~sa~e~L~ 292 (305)
T d1blxa_ 244 ALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALS 292 (305)
T ss_dssp SSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred cchhhhhccccccchhhccccCCHHHHHHHHHHCcCChhHCcCHHHHhc
Confidence 00 000000 0000111233567889999999999999999999987
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Probab=100.00 E-value=2.9e-42 Score=361.98 Aligned_cols=259 Identities=19% Similarity=0.232 Sum_probs=198.9
Q ss_pred hhhhhcCccccceEEEeeecCCCceEEEEEEccccc--ccchHHHHHHHHHhcccCCCCcccccceeccCCceEEEEEec
Q 003836 504 GFKEELGRGAFGTVYKGFVNMGSSNHVAVKKLNSVF--QDSEKEFKAEVNGIGQTHHKNLVRLLGYCDEGQNRLLVYEFM 581 (792)
Q Consensus 504 ~~~~~lG~G~~g~Vy~g~~~~~~~~~vavK~~~~~~--~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~lV~E~~ 581 (792)
...++||+|+||+||+|... +++.||||++.... ....+.+.+|+.++++++|||||++++++.+.++.++++||+
T Consensus 5 ~~~~~iG~G~fg~Vy~~~~~--~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~i~~e~~ 82 (286)
T d1ob3a_ 5 HGLEKIGEGTYGVVYKAQNN--YGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEHL 82 (286)
T ss_dssp EEEEEEEEETTEEEEEEEET--TSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEECC
T ss_pred eeccEEecCCCcEEEEEEeC--CCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEeeeeecccCCceeEEEEee
Confidence 34578999999999999764 45789999986542 334678999999999999999999999999999999999999
Q ss_pred cCCCccccccCCCCCchhHHHHHHHHHHHHHHHHhhccCCCeEecCCCCCcEEEcCCCCeEEeecCCCccccCCCCCccc
Q 003836 582 SNGTVASFLFGDSKPNWKLRTEIAMGIAGGLFYLHEECCTQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLDQSHTNT 661 (792)
Q Consensus 582 ~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dikp~NILl~~~~~~kl~Dfg~a~~~~~~~~~~~~ 661 (792)
.++.+..+......+++..+..++.||+.||+|||+. +|+||||||+|||++.++.+||+|||.+........ ...
T Consensus 83 ~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~---~IvHrDiKp~NIll~~~~~~kl~DfG~a~~~~~~~~-~~~ 158 (286)
T d1ob3a_ 83 DQDLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDR---RVLHRDLKPQNLLINREGELKIADFGLARAFGIPVR-KYT 158 (286)
T ss_dssp SEEHHHHHHTSTTCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECCTTHHHHHCC-------
T ss_pred hhhhHHHHHhhcCCcchhhhHHHHHHHHHHHHHhccC---cEEecCCCCceeeEcCCCCEEecccccceecccCcc-ccc
Confidence 9988888887788899999999999999999999998 999999999999999999999999999987653322 223
Q ss_pred cccccCCccccccccc-CCCCcccceehHHHHHHHHHhcCcCCCcchhhhhhhhHHHHHHHhhc--ccc---hhHhhh--
Q 003836 662 AIRGTKGYVAPEWFRN-MPITVKVDVYSYGVLLLEIICLRRNIDNEISKVDKAILTDWAYDRYQ--ERT---LEALVE-- 733 (792)
Q Consensus 662 ~~~gt~~y~aPE~~~~-~~~~~k~DV~S~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~--~~~---~~~~~~-- 733 (792)
...+++.|+|||.+.+ ..++.++|||||||++|||++|+.||......... ......... ... ......
T Consensus 159 ~~~~~~~y~~pE~~~~~~~~~~~~DiwslGv~l~el~~G~~pf~~~~~~~~~---~~i~~~~~~~~~~~~~~~~~~~~~~ 235 (286)
T d1ob3a_ 159 HEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQL---MRIFRILGTPNSKNWPNVTELPKYD 235 (286)
T ss_dssp ---CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHH---HHHHHHHCCCCTTTSTTGGGSTTCC
T ss_pred eecccchhhhHHHHhCCCCCCcceeehhcCcHHHHHHHCCCCCCCCCHHHHH---HHHHHhhCCCChhhccchhhhhhcc
Confidence 3458999999999875 45799999999999999999999999754322111 010000000 000 000000
Q ss_pred -------chhcccCCHHHHHHHHHHHHHccccCCCCCCCHHhHHH
Q 003836 734 -------NDLEAMNNVTMLHRFVMVAFWCIQEDPSHRPTMRKVTQ 771 (792)
Q Consensus 734 -------~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~ 771 (792)
...........++.+.+++.+||+.||++|||++|+++
T Consensus 236 ~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~s~~ell~ 280 (286)
T d1ob3a_ 236 PNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALE 280 (286)
T ss_dssp TTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred cccccccCcchhhhcccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 00001111223567889999999999999999999986
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.3e-40 Score=354.84 Aligned_cols=265 Identities=19% Similarity=0.241 Sum_probs=196.7
Q ss_pred hhhhhhcCccccceEEEeeecCCCceEEEEEEcccc--cccchHHHHHHHHHhcccCCCCcccccceecc--------CC
Q 003836 503 RGFKEELGRGAFGTVYKGFVNMGSSNHVAVKKLNSV--FQDSEKEFKAEVNGIGQTHHKNLVRLLGYCDE--------GQ 572 (792)
Q Consensus 503 ~~~~~~lG~G~~g~Vy~g~~~~~~~~~vavK~~~~~--~~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~--------~~ 572 (792)
+.+.++||+|+||+||+|... .+++.||||++... .....+.+.+|+++|++++|+||+++++++.. ..
T Consensus 12 Y~i~~~LG~G~fg~Vy~a~~~-~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~nii~~~~~~~~~~~~~~~~~~ 90 (318)
T d3blha1 12 YEKLAKIGQGTFGEVFKARHR-KTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRCKG 90 (318)
T ss_dssp EEEEEEEEECSSSEEEEEEET-TTCCEEEEEEC----CTTSSCHHHHHHHHHHHHCCCTTBCCEEEEEEC----------
T ss_pred EEEEEEEecCcCeEEEEEEEC-CCCCEEEEEEEehhhcchHHHHHHHHHHHHHHHhcCCCccceEeeeecccccccccCc
Confidence 345578999999999999754 56789999998643 23345788999999999999999999998854 34
Q ss_pred ceEEEEEeccCCCccccccCCCCCchhHHHHHHHHHHHHHHHHhhccCCCeEecCCCCCcEEEcCCCCeEEeecCCCccc
Q 003836 573 NRLLVYEFMSNGTVASFLFGDSKPNWKLRTEIAMGIAGGLFYLHEECCTQIIHCDIKPQNILLDDHYNARISDFGLAKLL 652 (792)
Q Consensus 573 ~~~lV~E~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dikp~NILl~~~~~~kl~Dfg~a~~~ 652 (792)
+.++||||++++.+..+......+++..+..++.||+.||.|||+. +|+||||||+|||++.++.+||+|||+++..
T Consensus 91 ~~~iv~e~~~~~~~~~~~~~~~~~~~~~~~~i~~qil~~l~~lH~~---~ivHrDlKp~NILl~~~~~~kl~dfg~~~~~ 167 (318)
T d3blha1 91 SIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVMQMLLNGLYYIHRN---KILHRDMKAANVLITRDGVLKLADFGLARAF 167 (318)
T ss_dssp CEEEEEECCCEEHHHHHTCTTCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTSCEEECCCTTCEEC
T ss_pred eEEEEEeccCCCccchhhhcccccccHHHHHHHHHHHHHHHHhccC---CEEecCcCchheeecCCCcEEeeecceeeec
Confidence 6889999999988887777777889999999999999999999998 9999999999999999999999999999876
Q ss_pred cCCCC---CccccccccCCcccccccccC-CCCcccceehHHHHHHHHHhcCcCCCcchhhhhhhhHHHHHHHhhccc--
Q 003836 653 TLDQS---HTNTAIRGTKGYVAPEWFRNM-PITVKVDVYSYGVLLLEIICLRRNIDNEISKVDKAILTDWAYDRYQER-- 726 (792)
Q Consensus 653 ~~~~~---~~~~~~~gt~~y~aPE~~~~~-~~~~k~DV~S~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~-- 726 (792)
..... .......||+.|+|||.+.+. .++.++|||||||++|||++|+.||................ ......
T Consensus 168 ~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~~~~~k~DiwSlGvil~el~~g~~pf~~~~~~~~~~~i~~~~-~~~~~~~~ 246 (318)
T d3blha1 168 SLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLC-GSITPEVW 246 (318)
T ss_dssp CC-----CCCCCSCCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHH-CCCCTTTS
T ss_pred ccccccccccccceecCHHHhhHHHHcCCCCCCcHHHcccCCceeeeHhhCCCCCCCCCHHHHHHHHHHhc-CCCChhhc
Confidence 54322 122335699999999998764 68999999999999999999999997654322211111110 000000
Q ss_pred ------chhHhhhchhcccCC-------HHHHHHHHHHHHHccccCCCCCCCHHhHHHH
Q 003836 727 ------TLEALVENDLEAMNN-------VTMLHRFVMVAFWCIQEDPSHRPTMRKVTQM 772 (792)
Q Consensus 727 ------~~~~~~~~~~~~~~~-------~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~ 772 (792)
............... ......+++|+.+||+.||++|||++|+++.
T Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~sa~elL~H 305 (318)
T d3blha1 247 PNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNH 305 (318)
T ss_dssp TTCCCC-------CCSSCCBCHHHHHHHHHCCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred cccchhhhhhhhcccccccccchhhhccccCCHHHHHHHHHHCcCChhHCcCHHHHHcC
Confidence 000000000000001 1123567889999999999999999999974
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.7e-41 Score=359.23 Aligned_cols=253 Identities=22% Similarity=0.238 Sum_probs=204.8
Q ss_pred hhhhhhcCccccceEEEeeec--CCCceEEEEEEccccc----ccchHHHHHHHHHhcccCC-CCcccccceeccCCceE
Q 003836 503 RGFKEELGRGAFGTVYKGFVN--MGSSNHVAVKKLNSVF----QDSEKEFKAEVNGIGQTHH-KNLVRLLGYCDEGQNRL 575 (792)
Q Consensus 503 ~~~~~~lG~G~~g~Vy~g~~~--~~~~~~vavK~~~~~~----~~~~~~~~~Ei~~l~~l~h-~niv~l~g~~~~~~~~~ 575 (792)
+.+.++||+|+||+||+|... ..+++.||||++++.. ....+.+.+|++++++++| |||+++++++.+....+
T Consensus 26 y~~~~~IG~G~fg~Vy~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~~E~~il~~l~h~pnIv~~~~~~~~~~~~~ 105 (322)
T d1vzoa_ 26 FELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTETKLH 105 (322)
T ss_dssp EEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETTEEE
T ss_pred eEEEEEEecCCCeEEEEEEECccCCCCcEEEEEEEehHHhccchHHHHHHHHHHHHHHhccCCCeEEEeeeeeccCCcee
Confidence 456689999999999999752 3457899999986532 2235678899999999966 89999999999999999
Q ss_pred EEEEeccCCCccccccCCCCCchhHHHHHHHHHHHHHHHHhhccCCCeEecCCCCCcEEEcCCCCeEEeecCCCccccCC
Q 003836 576 LVYEFMSNGTVASFLFGDSKPNWKLRTEIAMGIAGGLFYLHEECCTQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLD 655 (792)
Q Consensus 576 lV~E~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dikp~NILl~~~~~~kl~Dfg~a~~~~~~ 655 (792)
+||||+.+|+|.+++.....+.+.....++.||+.||+|||+. +|+||||||+|||++.++.+||+|||+++.+...
T Consensus 106 ~v~e~~~~~~L~~~i~~~~~~~e~~~~~~~~Qi~~al~~lH~~---~ivHrDiKp~Nill~~~~~vkL~DFG~a~~~~~~ 182 (322)
T d1vzoa_ 106 LILDYINGGELFTHLSQRERFTEHEVQIYVGEIVLALEHLHKL---GIIYRDIKLENILLDSNGHVVLTDFGLSKEFVAD 182 (322)
T ss_dssp EEECCCCSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEESCSSEEEECCGG
T ss_pred eeeecccccHHHHHHHhcccccHHHHHHHHHHHHHHHHHhhcC---CEEeccCCccceeecCCCCEEEeeccchhhhccc
Confidence 9999999999999998888888999999999999999999998 9999999999999999999999999999877655
Q ss_pred CCCccccccccCCcccccccccC--CCCcccceehHHHHHHHHHhcCcCCCcchhhhhhhhHHHHHHHhhcccchhHhhh
Q 003836 656 QSHTNTAIRGTKGYVAPEWFRNM--PITVKVDVYSYGVLLLEIICLRRNIDNEISKVDKAILTDWAYDRYQERTLEALVE 733 (792)
Q Consensus 656 ~~~~~~~~~gt~~y~aPE~~~~~--~~~~k~DV~S~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 733 (792)
.........|++.|+|||.+.+. .++.++|||||||+||||++|+.||...........+.. . ...
T Consensus 183 ~~~~~~~~~g~~~~~~pe~~~~~~~~~~~ksDIWSlG~iLyelltG~~PF~~~~~~~~~~~i~~---~---------~~~ 250 (322)
T d1vzoa_ 183 ETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISR---R---------ILK 250 (322)
T ss_dssp GGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHHHHH---H---------HHH
T ss_pred ccccccccccccccchhHHhhcCCcCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHH---h---------ccc
Confidence 55555566799999999998754 478899999999999999999999976533211111100 0 000
Q ss_pred chhcccCCHHHHHHHHHHHHHccccCCCCCCC-----HHhHHHH
Q 003836 734 NDLEAMNNVTMLHRFVMVAFWCIQEDPSHRPT-----MRKVTQM 772 (792)
Q Consensus 734 ~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs-----~~evl~~ 772 (792)
.....+...+.++.+++.+||+.||++||| ++|+++.
T Consensus 251 --~~~~~~~~~s~~~~~li~~~l~~dP~~R~s~~~~t~~eil~H 292 (322)
T d1vzoa_ 251 --SEPPYPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEH 292 (322)
T ss_dssp --CCCCCCTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTS
T ss_pred --CCCCCcccCCHHHHHHHHHHcccCHHHcCCCCcccHHHHHcC
Confidence 011223345678899999999999999994 7888863
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.6e-40 Score=348.31 Aligned_cols=263 Identities=19% Similarity=0.231 Sum_probs=203.2
Q ss_pred hhhhhcCccccceEEEeeecCCCceEEEEEEccccc--ccchHHHHHHHHHhcccCCCCcccccceeccCCceEEEEEec
Q 003836 504 GFKEELGRGAFGTVYKGFVNMGSSNHVAVKKLNSVF--QDSEKEFKAEVNGIGQTHHKNLVRLLGYCDEGQNRLLVYEFM 581 (792)
Q Consensus 504 ~~~~~lG~G~~g~Vy~g~~~~~~~~~vavK~~~~~~--~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~~~~lV~E~~ 581 (792)
...++||+|+||+||+|+.. .+++.||||+++... ....+.+.+|+.++++++||||+++++++.+....++|+|++
T Consensus 5 ~~i~~LG~G~fg~V~~~~~~-~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~iv~~~~ 83 (292)
T d1unla_ 5 EKLEKIGEGTYGTVFKAKNR-ETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFEFC 83 (292)
T ss_dssp EEEEEEEECSSSEEEEEEET-TTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECC
T ss_pred EeeeEEecCcCeEEEEEEEC-CCCcEEEEEEEehhhCChHHHHHHHHHHHHHHhcCcCCEEeeccccccccceeEEeeec
Confidence 34578999999999999754 567899999986433 334578999999999999999999999999999999999999
Q ss_pred cCCCccccccCCCCCchhHHHHHHHHHHHHHHHHhhccCCCeEecCCCCCcEEEcCCCCeEEeecCCCccccCCCCCccc
Q 003836 582 SNGTVASFLFGDSKPNWKLRTEIAMGIAGGLFYLHEECCTQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLDQSHTNT 661 (792)
Q Consensus 582 ~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dikp~NILl~~~~~~kl~Dfg~a~~~~~~~~~~~~ 661 (792)
.+++|..++.....+++..+..++.|++.||+|||++ +|+||||||+|||++.++.+||+|||.++....... ...
T Consensus 84 ~~~~l~~~~~~~~~~~~~~~~~~~~q~~~aL~~lH~~---~IvHrDiKP~NIli~~~~~~kl~DFG~a~~~~~~~~-~~~ 159 (292)
T d1unla_ 84 DQDLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSR---NVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVR-CYS 159 (292)
T ss_dssp SEEHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECCCTTCEECCSCCS-CCC
T ss_pred cccccccccccccccchhHHHHHHHHHHHHHHHhhcC---CEeeecccCcccccccCCceeeeecchhhcccCCCc-cce
Confidence 9999999988888899999999999999999999998 999999999999999999999999999987654332 223
Q ss_pred cccccCCcccccccccCC-CCcccceehHHHHHHHHHhcCcCCCcchhhhhhhhHHHHHHHhhcccc---hhHhhh----
Q 003836 662 AIRGTKGYVAPEWFRNMP-ITVKVDVYSYGVLLLEIICLRRNIDNEISKVDKAILTDWAYDRYQERT---LEALVE---- 733 (792)
Q Consensus 662 ~~~gt~~y~aPE~~~~~~-~~~k~DV~S~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~---- 733 (792)
...+++.|+|||.+.... ++.++|||||||++|||++|+.||.......+.............+.. .....+
T Consensus 160 ~~~~~~~~~~pe~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (292)
T d1unla_ 160 AEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPDYKPY 239 (292)
T ss_dssp SCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHHHHHHHCCCCTTTCTTGGGSTTCCCC
T ss_pred eeccccchhhhhHhccCCCCCchhhccccchHHHHHhhCCCCCCCCCCHHHHHHHHHhhcCCCChhhhhhhhhccccccc
Confidence 345788899999987654 699999999999999999999997543322211110000000000000 000000
Q ss_pred -----chhcccCCHHHHHHHHHHHHHccccCCCCCCCHHhHHH
Q 003836 734 -----NDLEAMNNVTMLHRFVMVAFWCIQEDPSHRPTMRKVTQ 771 (792)
Q Consensus 734 -----~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~ 771 (792)
............+.+.+|+.+||+.||.+|||++|+++
T Consensus 240 ~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~sa~e~L~ 282 (292)
T d1unla_ 240 PMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQ 282 (292)
T ss_dssp CCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred ccccccchhhhccccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 00011112234567889999999999999999999987
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=2.7e-40 Score=349.11 Aligned_cols=257 Identities=19% Similarity=0.247 Sum_probs=193.9
Q ss_pred hhhhhhcCccccceEEEeeecCCCceEEEEEEcccccccchHHHHHHHHHhcccCCCCcccc-cceeccCCceEEEEEec
Q 003836 503 RGFKEELGRGAFGTVYKGFVNMGSSNHVAVKKLNSVFQDSEKEFKAEVNGIGQTHHKNLVRL-LGYCDEGQNRLLVYEFM 581 (792)
Q Consensus 503 ~~~~~~lG~G~~g~Vy~g~~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l-~g~~~~~~~~~lV~E~~ 581 (792)
+.+.+.||+|+||+||+|... .+++.||||++.... ..+++..|++++++++|+|++.. ..+..+.+..++||||+
T Consensus 9 Y~l~~~iG~G~fG~Vy~a~~~-~~~~~vAvK~~~~~~--~~~~~~~E~~i~~~l~~~~~i~~~~~~~~~~~~~~ivme~~ 85 (299)
T d1ckia_ 9 YRLGRKIGSGSFGDIYLGTDI-AAGEEVAIKLECVKT--KHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMELL 85 (299)
T ss_dssp EEEEEEEEECSSSEEEEEEET-TTTEEEEEEEEESCT--TSCCHHHHHHHHHHSTTSTTCCCEEEEEEETTEEEEEEECC
T ss_pred EEEeEEEeeCCCcEEEEEEEC-CCCCEEEEEEEchhc--cCHHHHHHHHHHHHccCCCcccEEEEEEecCCEEEEEEEEc
Confidence 456688999999999999753 457899999887533 33468899999999987775555 45557778889999999
Q ss_pred cCCCccccc-cCCCCCchhHHHHHHHHHHHHHHHHhhccCCCeEecCCCCCcEEEc---CCCCeEEeecCCCccccCCCC
Q 003836 582 SNGTVASFL-FGDSKPNWKLRTEIAMGIAGGLFYLHEECCTQIIHCDIKPQNILLD---DHYNARISDFGLAKLLTLDQS 657 (792)
Q Consensus 582 ~~gsL~~~l-~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dikp~NILl~---~~~~~kl~Dfg~a~~~~~~~~ 657 (792)
.+ +|...+ .....+++..+..++.|++.||+|||++ +|+||||||+|||++ .+..+||+|||+|+.......
T Consensus 86 ~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~iiHrDiKp~NIl~~~~~~~~~vkl~DFG~a~~~~~~~~ 161 (299)
T d1ckia_ 86 GP-SLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSK---NFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDART 161 (299)
T ss_dssp CC-BHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECCGGGTTCEEECCCSSCEECBCTTT
T ss_pred CC-chhhhhhhccCCCcHHHHHHHHHHHHHHHHHHHHC---CeeeccCCHhhccccccCCCceeeeeccCcceecccccc
Confidence 65 555544 4456899999999999999999999999 999999999999986 456799999999998754332
Q ss_pred C------ccccccccCCcccccccccCCCCcccceehHHHHHHHHHhcCcCCCcchhhhhhhhHHHHHHHhhcccchhHh
Q 003836 658 H------TNTAIRGTKGYVAPEWFRNMPITVKVDVYSYGVLLLEIICLRRNIDNEISKVDKAILTDWAYDRYQERTLEAL 731 (792)
Q Consensus 658 ~------~~~~~~gt~~y~aPE~~~~~~~~~k~DV~S~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 731 (792)
. ......||+.|+|||.+.+..++.++|||||||++|||++|+.||..................... ....
T Consensus 162 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~-~~~~-- 238 (299)
T d1ckia_ 162 HQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMS-TPIE-- 238 (299)
T ss_dssp CCBCCCCBCCSCCCCSSSCCHHHHTTBCCCHHHHHHHHHHHHHHHHHSSCTTCCCC-------HHHHHHHHHH-SCHH--
T ss_pred ccceeccccCCcCCCccccCHHHHhCCCCCChhhEEecCHHHHHHHhCCCcccccchHHHHHHHHHhhcccCC-CChh--
Confidence 2 233467999999999999999999999999999999999999999764332211111110000000 0000
Q ss_pred hhchhcccCCHHHHHHHHHHHHHccccCCCCCCCHHhHHHHhccC
Q 003836 732 VENDLEAMNNVTMLHRFVMVAFWCIQEDPSHRPTMRKVTQMLEGV 776 (792)
Q Consensus 732 ~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~L~~~ 776 (792)
.. ....++++.+++..||+.+|++||+++++.+.|+.+
T Consensus 239 ---~~----~~~~p~~~~~li~~cl~~~p~~RP~~~~i~~~l~~~ 276 (299)
T d1ckia_ 239 ---VL----CKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNL 276 (299)
T ss_dssp ---HH----TTTSCHHHHHHHHHHHHSCTTCCCCHHHHHHHHHHH
T ss_pred ---Hh----ccCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHH
Confidence 00 112346788999999999999999999998888764
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.6e-40 Score=358.59 Aligned_cols=258 Identities=21% Similarity=0.216 Sum_probs=190.6
Q ss_pred hhhhcCccccceEEEeeecCCCceEEEEEEcccccccchHHHHHHHHHhcccCCCCcccccceecc------CCceEEEE
Q 003836 505 FKEELGRGAFGTVYKGFVNMGSSNHVAVKKLNSVFQDSEKEFKAEVNGIGQTHHKNLVRLLGYCDE------GQNRLLVY 578 (792)
Q Consensus 505 ~~~~lG~G~~g~Vy~g~~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~------~~~~~lV~ 578 (792)
..++||+|+||+||+|+.. .+++.||||++..... .+.+|+++|++++|+||++++++|.. ..+.+|||
T Consensus 24 ~~k~LG~G~fg~Vy~a~~~-~~~~~vAiK~i~~~~~----~~~~Ei~il~~l~h~niv~~~~~~~~~~~~~~~~~~~lv~ 98 (350)
T d1q5ka_ 24 DTKVIGNGSFGVVYQAKLC-DSGELVAIKKVLQDKR----FKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVL 98 (350)
T ss_dssp EEEEEEEETTEEEEEEEET-TTCCEEEEEEEECCSS----SCCHHHHHHHHCCCTTBCCEEEEEEEC--CCSCCEEEEEE
T ss_pred eeeEEeeCcCeEEEEEEEC-CCCCEEEEEEECccch----HHHHHHHHHHhcCCCCCCcEEEEEEecCccCCceEEEEEE
Confidence 4568999999999999754 5678999999975432 23579999999999999999999843 33578999
Q ss_pred EeccCCCccccc---cCCCCCchhHHHHHHHHHHHHHHHHhhccCCCeEecCCCCCcEEEcCCC-CeEEeecCCCccccC
Q 003836 579 EFMSNGTVASFL---FGDSKPNWKLRTEIAMGIAGGLFYLHEECCTQIIHCDIKPQNILLDDHY-NARISDFGLAKLLTL 654 (792)
Q Consensus 579 E~~~~gsL~~~l---~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dikp~NILl~~~~-~~kl~Dfg~a~~~~~ 654 (792)
||++++.+..+. .....+++..+..++.||+.||+|||++ +|+||||||+|||++.++ .+||+|||+++....
T Consensus 99 Ey~~~~~~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~yLH~~---~IiHrDiKp~NILl~~~~~~~kl~DFG~a~~~~~ 175 (350)
T d1q5ka_ 99 DYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSF---GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVR 175 (350)
T ss_dssp ECCSEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEECTTTCCEEECCCTTCEECCT
T ss_pred eccCCccHHHHHhhhhccCCCCHHHHHHHHHHHHHHHHHHHhc---CCcccCCCcceEEEecCCCceeEecccchhhccC
Confidence 999876444333 3456789999999999999999999998 999999999999999775 899999999987654
Q ss_pred CCCCccccccccCCccccccccc-CCCCcccceehHHHHHHHHHhcCcCCCcchhhhhhhhHHHH-------HHHhhcc-
Q 003836 655 DQSHTNTAIRGTKGYVAPEWFRN-MPITVKVDVYSYGVLLLEIICLRRNIDNEISKVDKAILTDW-------AYDRYQE- 725 (792)
Q Consensus 655 ~~~~~~~~~~gt~~y~aPE~~~~-~~~~~k~DV~S~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~-------~~~~~~~- 725 (792)
.. ......||+.|+|||.+.+ ..++.++||||+||++|||++|+.||...........+... .......
T Consensus 176 ~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~DIwSlG~il~el~~g~~pf~~~~~~~~l~~i~~~~g~~~~~~~~~~~~~ 253 (350)
T d1q5ka_ 176 GE--PNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMNPN 253 (350)
T ss_dssp TS--CCCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHHCC-
T ss_pred Cc--ccccccccccccChHHhhcccCCCcceeecccceEEEehhhCCCCCCCCCHHHHHHHHHHHhCCChHHhhhhhccc
Confidence 33 2234568999999998765 57899999999999999999999999755332111110000 0000000
Q ss_pred ---cchhHhhhchhcccCCHHHHHHHHHHHHHccccCCCCCCCHHhHHHH
Q 003836 726 ---RTLEALVENDLEAMNNVTMLHRFVMVAFWCIQEDPSHRPTMRKVTQM 772 (792)
Q Consensus 726 ---~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~ 772 (792)
...................++++.+|+.+||+.||++|||++|+++.
T Consensus 254 ~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~H 303 (350)
T d1q5ka_ 254 YTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAH 303 (350)
T ss_dssp --CCCCCCCCCCCGGGTSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred hhhccccccccCchhhhcccCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 00000000001111122345678899999999999999999999964
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.8e-40 Score=355.85 Aligned_cols=265 Identities=19% Similarity=0.223 Sum_probs=194.2
Q ss_pred hhhhhhcCccccceEEEeeecCCCceEEEEEEccccc-ccchHHHHHHHHHhcccCCCCcccccceeccCC----ceEEE
Q 003836 503 RGFKEELGRGAFGTVYKGFVNMGSSNHVAVKKLNSVF-QDSEKEFKAEVNGIGQTHHKNLVRLLGYCDEGQ----NRLLV 577 (792)
Q Consensus 503 ~~~~~~lG~G~~g~Vy~g~~~~~~~~~vavK~~~~~~-~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~----~~~lV 577 (792)
+.+.++||+|+||+||+|.. ..+++.||||++.+.. ....+.+.+|+.+|++++||||+++++++.... ..+++
T Consensus 10 Y~~~~~LG~G~fg~Vy~~~~-~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~hp~iv~~~~~~~~~~~~~~~~~~l 88 (345)
T d1pmea_ 10 YTNLSYIGEGAYGMVCSAYD-NVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDVYL 88 (345)
T ss_dssp EEEEEECC---CCCEEEEEE-TTTCSEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCEEE
T ss_pred eEEEEEEeeccCeEEEEEEE-CCCCcEEEEEEEehhcChHHHHHHHHHHHHHHHcCCCCCCcEEEEEeeccccccceEEE
Confidence 34457899999999999974 4567899999997543 234567899999999999999999999996553 34566
Q ss_pred EEeccCCCccccccCCCCCchhHHHHHHHHHHHHHHHHhhccCCCeEecCCCCCcEEEcCCCCeEEeecCCCccccCCCC
Q 003836 578 YEFMSNGTVASFLFGDSKPNWKLRTEIAMGIAGGLFYLHEECCTQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLDQS 657 (792)
Q Consensus 578 ~E~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dikp~NILl~~~~~~kl~Dfg~a~~~~~~~~ 657 (792)
++|+.+|+|.+++.. ..+++..+..++.||+.||+|||++ +|+||||||+||||++++.+||+|||+++.......
T Consensus 89 ~~~~~~g~L~~~l~~-~~l~~~~i~~i~~qil~al~yLH~~---~iiHRDIKp~NILl~~~~~~kl~DfG~a~~~~~~~~ 164 (345)
T d1pmea_ 89 VTHLMGADLYKLLKT-QHLSNDHICYFLYQILRGLKYIHSA---NVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHD 164 (345)
T ss_dssp EEECCCEEHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTCEECCGGGC
T ss_pred EEeecCCchhhhhhc-CCCCHHHHHHHHHHHHHHHHHHHHC---CCcCCCCCcceEEECCCCCEEEcccCceeeccCCCc
Confidence 677889999999964 4689999999999999999999998 999999999999999999999999999987654332
Q ss_pred C--ccccccccCCccccccccc-CCCCcccceehHHHHHHHHHhcCcCCCcchhhhhhhhHHHHH-------HHhhcccc
Q 003836 658 H--TNTAIRGTKGYVAPEWFRN-MPITVKVDVYSYGVLLLEIICLRRNIDNEISKVDKAILTDWA-------YDRYQERT 727 (792)
Q Consensus 658 ~--~~~~~~gt~~y~aPE~~~~-~~~~~k~DV~S~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~-------~~~~~~~~ 727 (792)
. ......||+.|+|||.+.. ..++.++||||+||+++||++|+.||................ ........
T Consensus 165 ~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~eml~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 244 (345)
T d1pmea_ 165 HTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLK 244 (345)
T ss_dssp BCCTTCCCCSCGGGCCGGGTTTBCSCSTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHTCCCHH
T ss_pred cceeeccccccceechHHHhhcCCCCCchhhhhccCceehHHhhCCCCCCCCCHHHHHHHHhhhccCCChhhhhhhhhhh
Confidence 2 2344569999999999854 567899999999999999999999997653321111000000 00000000
Q ss_pred hhHhhhc-hhcccCC-----HHHHHHHHHHHHHccccCCCCCCCHHhHHHH
Q 003836 728 LEALVEN-DLEAMNN-----VTMLHRFVMVAFWCIQEDPSHRPTMRKVTQM 772 (792)
Q Consensus 728 ~~~~~~~-~~~~~~~-----~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~ 772 (792)
....... ......+ ...+.++.+|+.+||+.||++|||++|+++.
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~ta~e~L~h 295 (345)
T d1pmea_ 245 ARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAH 295 (345)
T ss_dssp HHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred hhcccccCCccCCCCHHHhCCCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 0000000 0000001 1223578899999999999999999999985
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.3e-40 Score=352.74 Aligned_cols=267 Identities=24% Similarity=0.270 Sum_probs=192.3
Q ss_pred hhhhhhcCccccceEEEeeecCCCceEEEEEEccccc--ccchHHHHHHHHHhcccCCCCcccccceeccCC------ce
Q 003836 503 RGFKEELGRGAFGTVYKGFVNMGSSNHVAVKKLNSVF--QDSEKEFKAEVNGIGQTHHKNLVRLLGYCDEGQ------NR 574 (792)
Q Consensus 503 ~~~~~~lG~G~~g~Vy~g~~~~~~~~~vavK~~~~~~--~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~~------~~ 574 (792)
+...++||+|+||+||+|.. ..+++.||||+++... ....+.+.+|+++|++++|||||+++++|...+ +.
T Consensus 20 Y~~i~~lG~G~fg~V~~~~~-~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~hpniv~l~~~~~~~~~~~~~~~~ 98 (346)
T d1cm8a_ 20 YRDLQPVGSGAYGAVCSAVD-GRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFTDF 98 (346)
T ss_dssp EEEEEEC------CEEEEEE-TTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCCCC
T ss_pred EEEEEEEecCCCeEEEEEEE-CCCCCEEEEEEEchhhcChHHHHHHHHHHHHHHhcCCCCeeEEEEEeccCccccccceE
Confidence 34457899999999999964 4567899999997532 233567899999999999999999999997654 57
Q ss_pred EEEEEeccCCCccccccCCCCCchhHHHHHHHHHHHHHHHHhhccCCCeEecCCCCCcEEEcCCCCeEEeecCCCccccC
Q 003836 575 LLVYEFMSNGTVASFLFGDSKPNWKLRTEIAMGIAGGLFYLHEECCTQIIHCDIKPQNILLDDHYNARISDFGLAKLLTL 654 (792)
Q Consensus 575 ~lV~E~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dikp~NILl~~~~~~kl~Dfg~a~~~~~ 654 (792)
++||||+ +.+|..++. ...+++..+..++.||+.||+|||++ +|+||||||+|||++.++.+||+|||+++....
T Consensus 99 ~lv~e~~-~~~l~~~~~-~~~l~~~~~~~~~~qi~~aL~~LH~~---~IiHrDiKp~NIL~~~~~~~kl~Dfg~a~~~~~ 173 (346)
T d1cm8a_ 99 YLVMPFM-GTDLGKLMK-HEKLGEDRIQFLVYQMLKGLRYIHAA---GIIHRDLKPGNLAVNEDCELKILDFGLARQADS 173 (346)
T ss_dssp EEEEECC-SEEHHHHHH-HCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTCEECCS
T ss_pred EEEEecc-cccHHHHHH-hccccHHHHHHHHHHHHHHHHHHHhC---CCcccccCcchhhcccccccccccccceeccCC
Confidence 9999999 456666553 45789999999999999999999998 999999999999999999999999999987643
Q ss_pred CCCCccccccccCCccccccccc-CCCCcccceehHHHHHHHHHhcCcCCCcchhhhhhhhHHHH-------HHHhhccc
Q 003836 655 DQSHTNTAIRGTKGYVAPEWFRN-MPITVKVDVYSYGVLLLEIICLRRNIDNEISKVDKAILTDW-------AYDRYQER 726 (792)
Q Consensus 655 ~~~~~~~~~~gt~~y~aPE~~~~-~~~~~k~DV~S~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~-------~~~~~~~~ 726 (792)
. .+...||+.|+|||.+.+ ..++.++||||+||++|||++|+.||............... ........
T Consensus 174 ~----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 249 (346)
T d1cm8a_ 174 E----MTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRLQSD 249 (346)
T ss_dssp S----CCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHTCSCH
T ss_pred c----cccccccccccCHHHHcCCCCCCccchhhcchHHHHHHHHCcCCCCCCChHHHHHHHHhccCCCcHHHHhhhcch
Confidence 2 234568999999999876 45789999999999999999999999765322111100000 00000000
Q ss_pred chhHhhhc--hh----cccCCHHHHHHHHHHHHHccccCCCCCCCHHhHHHH--hccCcCC
Q 003836 727 TLEALVEN--DL----EAMNNVTMLHRFVMVAFWCIQEDPSHRPTMRKVTQM--LEGVVEV 779 (792)
Q Consensus 727 ~~~~~~~~--~~----~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~--L~~~~~~ 779 (792)
........ .. ...........+.+|+.+||+.||++|||++|+++. ++.+.+.
T Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~eiL~Hp~f~~~~~~ 310 (346)
T d1cm8a_ 250 EAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFESLHDT 310 (346)
T ss_dssp HHHHHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGTTTC--
T ss_pred hhhhhhccCCcccccchHHhccCCCHHHHHHHHHHCcCChhHCcCHHHHhcChhhCcCCCc
Confidence 00000000 00 000112234677899999999999999999999986 6665433
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Probab=100.00 E-value=9.1e-40 Score=349.84 Aligned_cols=257 Identities=20% Similarity=0.291 Sum_probs=195.3
Q ss_pred hhhhhhcCccccceEEEeeecCCCceEEEEEEcccccccchHHHHHHHHHhcccC-CCCcccccceecc--CCceEEEEE
Q 003836 503 RGFKEELGRGAFGTVYKGFVNMGSSNHVAVKKLNSVFQDSEKEFKAEVNGIGQTH-HKNLVRLLGYCDE--GQNRLLVYE 579 (792)
Q Consensus 503 ~~~~~~lG~G~~g~Vy~g~~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~-h~niv~l~g~~~~--~~~~~lV~E 579 (792)
+.+.++||+|+||+||+|.. ..+++.||||+++.. ..+++.+|+++|++++ ||||+++++++.. ....++|||
T Consensus 37 y~i~~~LG~G~fg~V~~a~~-~~~~~~vAiK~i~~~---~~~~~~~Ei~il~~l~~hpnIv~~~~~~~~~~~~~~~~v~e 112 (328)
T d3bqca1 37 YQLVRKLGRGKYSEVFEAIN-ITNNEKVVVKILKPV---KKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVFE 112 (328)
T ss_dssp EEEEEEEEECSSEEEEEEEE-TTTTEEEEEEEECSS---CHHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCSEEEEEE
T ss_pred eEEEEEEecCcCeEEEEEEE-CCCCCEEEEEEECHH---HHHHHHHHHHHHHhccCCCCCcEEEEEEEecCCCceeEEEe
Confidence 45568899999999999974 456789999998753 3578899999999995 9999999999864 456899999
Q ss_pred eccCCCccccccCCCCCchhHHHHHHHHHHHHHHHHhhccCCCeEecCCCCCcEEEcCCC-CeEEeecCCCccccCCCCC
Q 003836 580 FMSNGTVASFLFGDSKPNWKLRTEIAMGIAGGLFYLHEECCTQIIHCDIKPQNILLDDHY-NARISDFGLAKLLTLDQSH 658 (792)
Q Consensus 580 ~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dikp~NILl~~~~-~~kl~Dfg~a~~~~~~~~~ 658 (792)
|+++++|..+. +.+++..+..++.||+.||+|||++ +|+||||||+|||++.++ .+||+|||+++......
T Consensus 113 ~~~~~~L~~~~---~~l~e~~i~~i~~qil~aL~~LH~~---gIvHrDiKp~NILi~~~~~~vkl~DFG~a~~~~~~~-- 184 (328)
T d3bqca1 113 HVNNTDFKQLY---QTLTDYDIRFYMYEILKALDYCHSM---GIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQ-- 184 (328)
T ss_dssp CCCSCBGGGTT---TSCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEETTTTEEEECCGGGCEECCTTC--
T ss_pred ecCCCcHHHHh---cCCCHHHHHHHHHHHHHHHHHHhhc---ccccccccccceEEcCCCCeeeecccccceeccCCC--
Confidence 99999998875 4689999999999999999999999 999999999999998655 69999999998765432
Q ss_pred ccccccccCCcccccccccC-CCCcccceehHHHHHHHHHhcCcCCCcchhhhhhhhH-H---------HHHHHhhcc--
Q 003836 659 TNTAIRGTKGYVAPEWFRNM-PITVKVDVYSYGVLLLEIICLRRNIDNEISKVDKAIL-T---------DWAYDRYQE-- 725 (792)
Q Consensus 659 ~~~~~~gt~~y~aPE~~~~~-~~~~k~DV~S~Gv~l~el~tg~~p~~~~~~~~~~~~~-~---------~~~~~~~~~-- 725 (792)
......+|+.|+|||.+.+. .++.++||||+||+++||++|+.||............ . .+.......
T Consensus 185 ~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~~l~e~~~g~~pf~~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~ 264 (328)
T d3bqca1 185 EYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIELD 264 (328)
T ss_dssp CCCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHHHTTCCCC
T ss_pred cccccccCccccCcccccCCCCCCcccchhhhhhhhHHhccCCCCCCCCchhHHHHHHHHHHHCCchhhhhhhhcccccC
Confidence 23445689999999998764 5799999999999999999999999654332211110 0 000000000
Q ss_pred cchhHhhh--------chhcccCCHHHHHHHHHHHHHccccCCCCCCCHHhHHH
Q 003836 726 RTLEALVE--------NDLEAMNNVTMLHRFVMVAFWCIQEDPSHRPTMRKVTQ 771 (792)
Q Consensus 726 ~~~~~~~~--------~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~ 771 (792)
........ ...........+.++.+|+.+||+.||++|||++|+++
T Consensus 265 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~e~L~ 318 (328)
T d3bqca1 265 PRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAME 318 (328)
T ss_dssp GGGGGTCCCCCCCCGGGGCCTTTGGGCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred cccchhcccccccchhhcccccccccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 00000000 00011111234567889999999999999999999988
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=100.00 E-value=3.3e-40 Score=346.79 Aligned_cols=258 Identities=16% Similarity=0.202 Sum_probs=201.4
Q ss_pred hhhhhhcCccccceEEEeeecCCCceEEEEEEcccccccchHHHHHHHHHhcccCC-CCcccccceeccCCceEEEEEec
Q 003836 503 RGFKEELGRGAFGTVYKGFVNMGSSNHVAVKKLNSVFQDSEKEFKAEVNGIGQTHH-KNLVRLLGYCDEGQNRLLVYEFM 581 (792)
Q Consensus 503 ~~~~~~lG~G~~g~Vy~g~~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h-~niv~l~g~~~~~~~~~lV~E~~ 581 (792)
+.+.++||+|+||+||+|... .+++.||||++.... ....+.+|++.++.++| +|++.+++++.++...++||||+
T Consensus 7 Y~i~~~iG~G~fG~Vy~a~~~-~~~~~vAvK~~~~~~--~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~~vme~~ 83 (293)
T d1csna_ 7 YKVGRRIGEGSFGVIFEGTNL-LNNQQVAIKFEPRRS--DAPQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVIDLL 83 (293)
T ss_dssp EEEEEEEEECSSCEEEEEEET-TTTEEEEEEEEECCT--TSCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEEEECC
T ss_pred eEEEEEEecCCCeEEEEEEEC-CCCCEEEEEEEcccc--CcHHHHHHHHHHHHhcCCCCCCEEEEEeecCCccEEEEEec
Confidence 456688999999999999754 457899999886532 23457888999999865 89999999999999999999999
Q ss_pred cCCCccccccCC-CCCchhHHHHHHHHHHHHHHHHhhccCCCeEecCCCCCcEEEcC-----CCCeEEeecCCCccccCC
Q 003836 582 SNGTVASFLFGD-SKPNWKLRTEIAMGIAGGLFYLHEECCTQIIHCDIKPQNILLDD-----HYNARISDFGLAKLLTLD 655 (792)
Q Consensus 582 ~~gsL~~~l~~~-~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dikp~NILl~~-----~~~~kl~Dfg~a~~~~~~ 655 (792)
+++|.+++... ..+++..+..++.|++.||+|||++ +|+||||||+|||++. ++.+||+|||+|+.....
T Consensus 84 -~~~l~~~~~~~~~~~~~~~~~~i~~q~~~~l~~lH~~---giiHrDiKp~Nili~~~~~~~~~~vkl~DFG~a~~~~~~ 159 (293)
T d1csna_ 84 -GPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEK---SLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDP 159 (293)
T ss_dssp -CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEECCSSSTTTTCEEECCCTTCEESBCT
T ss_pred -CCCHHHHHHhhccchhhHHHHHHHHHHHHHHHHHHHC---CceeccCCccceeecCcccccCCceEEcccceeEEcccC
Confidence 67999888654 4689999999999999999999999 9999999999999974 578999999999986543
Q ss_pred CCC------ccccccccCCcccccccccCCCCcccceehHHHHHHHHHhcCcCCCcchhhhhhhhHHHHHHHhhcccchh
Q 003836 656 QSH------TNTAIRGTKGYVAPEWFRNMPITVKVDVYSYGVLLLEIICLRRNIDNEISKVDKAILTDWAYDRYQERTLE 729 (792)
Q Consensus 656 ~~~------~~~~~~gt~~y~aPE~~~~~~~~~k~DV~S~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 729 (792)
... ......||+.|||||.+.+..++.++|||||||++|||++|+.||................... ......
T Consensus 160 ~~~~~~~~~~~~~~~GT~~y~aPE~~~~~~~~~~~DiwSlG~~l~elltg~~Pf~~~~~~~~~~~~~~i~~~~-~~~~~~ 238 (293)
T d1csna_ 160 VTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKK-QSTPLR 238 (293)
T ss_dssp TTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHHHH-HHSCHH
T ss_pred ccccceeecccCceEEchhhcCHHHhcCCCCChHHHHHHhhHHHHHHHhCCCcCCCccchhHHHHHHHHHhcc-CCCChH
Confidence 221 2334679999999999999999999999999999999999999997543321111111100000 000111
Q ss_pred HhhhchhcccCCHHHHHHHHHHHHHccccCCCCCCCHHhHHHHhccCc
Q 003836 730 ALVENDLEAMNNVTMLHRFVMVAFWCIQEDPSHRPTMRKVTQMLEGVV 777 (792)
Q Consensus 730 ~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~L~~~~ 777 (792)
++ . ...++++.+++..|++.+|++||+++.+.+.|++++
T Consensus 239 ~l-----~----~~~p~~l~~ii~~~~~~~~~~rP~y~~l~~~l~~~~ 277 (293)
T d1csna_ 239 EL-----C----AGFPEEFYKYMHYARNLAFDATPDYDYLQGLFSKVL 277 (293)
T ss_dssp HH-----T----TTSCHHHHHHHHHHHHCCTTCCCCHHHHHHHHHHHH
T ss_pred Hh-----c----CCCCHHHHHHHHHHhcCCcccCcCHHHHHHHHHHHH
Confidence 11 1 112356888999999999999999999988887653
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.6e-39 Score=348.55 Aligned_cols=260 Identities=24% Similarity=0.257 Sum_probs=187.3
Q ss_pred hhhhhcCccccceEEEeeecCCCceEEEEEEccccc--ccchHHHHHHHHHhcccCCCCcccccceecc------CCceE
Q 003836 504 GFKEELGRGAFGTVYKGFVNMGSSNHVAVKKLNSVF--QDSEKEFKAEVNGIGQTHHKNLVRLLGYCDE------GQNRL 575 (792)
Q Consensus 504 ~~~~~lG~G~~g~Vy~g~~~~~~~~~vavK~~~~~~--~~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~------~~~~~ 575 (792)
.+.++||+|+||+||+|.. ..+++.||||++.... ....+++.+|+.++++++|||||++++++.. ....+
T Consensus 20 ~i~~~LG~G~fg~V~~~~d-~~t~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~f~~~~~~~~~~~~~ 98 (355)
T d2b1pa1 20 QNLKPIGSGAQGIVCAAYD-AVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVY 98 (355)
T ss_dssp EEEEECSCC--CEEEEEEE-TTTTEEEEEEEEESTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCCEEE
T ss_pred EEEEEeecCcCeEEEEEEE-CCCCCEEEEEEEChhhcCHHHHHHHHHHHHHHHhcCCCCeeEEEEEEecccccccCceeE
Confidence 3457899999999999964 4567899999997543 2334578999999999999999999999953 46789
Q ss_pred EEEEeccCCCccccccCCCCCchhHHHHHHHHHHHHHHHHhhccCCCeEecCCCCCcEEEcCCCCeEEeecCCCccccCC
Q 003836 576 LVYEFMSNGTVASFLFGDSKPNWKLRTEIAMGIAGGLFYLHEECCTQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLD 655 (792)
Q Consensus 576 lV~E~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dikp~NILl~~~~~~kl~Dfg~a~~~~~~ 655 (792)
+||||+.++.+... . ..+++..+..++.||+.||+|||+. +|+||||||+|||++.++.+|++|||+++.....
T Consensus 99 iv~Ey~~~~l~~~~-~--~~~~~~~i~~~~~qil~gl~~LH~~---giiHrDlKP~Nil~~~~~~~kl~df~~~~~~~~~ 172 (355)
T d2b1pa1 99 LVMELMDANLCQVI-Q--MELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTS 172 (355)
T ss_dssp EEEECCSEEHHHHH-T--SCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECCCCC-------
T ss_pred EEEeccchHHHHhh-h--cCCCHHHHHHHHHHHHHHHHHhhhc---ccccccCCccccccccccceeeechhhhhccccc
Confidence 99999987655443 2 4578999999999999999999999 9999999999999999999999999998865432
Q ss_pred CCCccccccccCCcccccccccCCCCcccceehHHHHHHHHHhcCcCCCcchhhhhhhhHHH------------------
Q 003836 656 QSHTNTAIRGTKGYVAPEWFRNMPITVKVDVYSYGVLLLEIICLRRNIDNEISKVDKAILTD------------------ 717 (792)
Q Consensus 656 ~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DV~S~Gv~l~el~tg~~p~~~~~~~~~~~~~~~------------------ 717 (792)
.......+|+.|+|||.+.+..++.++||||+||+++||++|+.||..............
T Consensus 173 --~~~~~~~~t~~y~aPE~l~~~~~~~~~DiwSlG~~l~ell~g~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~ 250 (355)
T d2b1pa1 173 --FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVR 250 (355)
T ss_dssp ----------CCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHTTSCHHHH
T ss_pred --cccccccccccccChhhhcCCCCCCCcccccccchHHHHhhCCCCCCCCCHHHHHHHHHHhccCCCHHHHHHhhhhHH
Confidence 233445689999999999999999999999999999999999999965432211100000
Q ss_pred -HHHHhh--cccchhHhhhchhcc---cCCHHHHHHHHHHHHHccccCCCCCCCHHhHHHH
Q 003836 718 -WAYDRY--QERTLEALVENDLEA---MNNVTMLHRFVMVAFWCIQEDPSHRPTMRKVTQM 772 (792)
Q Consensus 718 -~~~~~~--~~~~~~~~~~~~~~~---~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~ 772 (792)
...... ............... ......+.++.+|+.+||+.||++|||++|+++.
T Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~ta~elL~H 311 (355)
T d2b1pa1 251 NYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQH 311 (355)
T ss_dssp HHHHTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred HHhhcCccccccccccccccccccccccccccCCHHHHHHHHHHCcCChhHCcCHHHHhcC
Confidence 000000 000001111111111 1123457789999999999999999999999974
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.9e-38 Score=341.13 Aligned_cols=266 Identities=21% Similarity=0.249 Sum_probs=194.4
Q ss_pred hhhhhhcCccccceEEEeeecCCCceEEEEEEcccccc--cchHHHHHHHHHhcccCCCCcccccceeccC-----CceE
Q 003836 503 RGFKEELGRGAFGTVYKGFVNMGSSNHVAVKKLNSVFQ--DSEKEFKAEVNGIGQTHHKNLVRLLGYCDEG-----QNRL 575 (792)
Q Consensus 503 ~~~~~~lG~G~~g~Vy~g~~~~~~~~~vavK~~~~~~~--~~~~~~~~Ei~~l~~l~h~niv~l~g~~~~~-----~~~~ 575 (792)
+...++||+|+||+||+|.. ..+++.||||++++... ...+.+.+|++++++++|||||++++++... ...+
T Consensus 20 Y~i~~~LG~G~fg~Vy~a~~-~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~h~~iv~~~~~~~~~~~~~~~~~~ 98 (348)
T d2gfsa1 20 YQNLSPVGSGAYGSVCAAFD-TKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDV 98 (348)
T ss_dssp EEEEEECGGGTTSSEEEEEE-TTTTEEEEEEECSCTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSTTTCCCC
T ss_pred eEEEEEEecCCCeEEEEEEE-CCCCCEEEEEEECchhcChHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeccccccCceE
Confidence 34457899999999999964 45678999999975432 3346789999999999999999999998533 3457
Q ss_pred EEEEeccCCCccccccCCCCCchhHHHHHHHHHHHHHHHHhhccCCCeEecCCCCCcEEEcCCCCeEEeecCCCccccCC
Q 003836 576 LVYEFMSNGTVASFLFGDSKPNWKLRTEIAMGIAGGLFYLHEECCTQIIHCDIKPQNILLDDHYNARISDFGLAKLLTLD 655 (792)
Q Consensus 576 lV~E~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dikp~NILl~~~~~~kl~Dfg~a~~~~~~ 655 (792)
+++||+.+|+|.+++.. +.+++..+..++.||+.||+|||++ +|+||||||+|||++.++.+|++|||++.....
T Consensus 99 ~i~~~~~gg~L~~~~~~-~~l~e~~~~~i~~qil~aL~~LH~~---giiHrDiKp~NILi~~~~~~kl~dfg~a~~~~~- 173 (348)
T d2gfsa1 99 YLVTHLMGADLNNIVKC-QKLTDDHVQFLIYQILRGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLARHTDD- 173 (348)
T ss_dssp EEEEECCSEEHHHHHTT-CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEECCC----CCTG-
T ss_pred EEEEeecCCchhhhccc-ccccHHHHHHHHHHHHHHHHHHHhC---CCcccccCCccccccccccccccccchhcccCc-
Confidence 77888899999999855 4689999999999999999999999 999999999999999999999999999976432
Q ss_pred CCCccccccccCCcccccccccC-CCCcccceehHHHHHHHHHhcCcCCCcchhhhhhhhHHHHH-------HHhhcccc
Q 003836 656 QSHTNTAIRGTKGYVAPEWFRNM-PITVKVDVYSYGVLLLEIICLRRNIDNEISKVDKAILTDWA-------YDRYQERT 727 (792)
Q Consensus 656 ~~~~~~~~~gt~~y~aPE~~~~~-~~~~k~DV~S~Gv~l~el~tg~~p~~~~~~~~~~~~~~~~~-------~~~~~~~~ 727 (792)
......|++.|+|||.+.+. .++.++|||||||++|||++|+.||................ ........
T Consensus 174 ---~~~~~~g~~~y~apE~~~~~~~~~~~~DiwSlGv~l~~ll~g~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 250 (348)
T d2gfsa1 174 ---EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSES 250 (348)
T ss_dssp ---GGSSSCHHHHTSCHHHHTTCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHHHTTCCCHH
T ss_pred ---ccccccccccccCchhhcCCccCCcccchhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCChHHhhhccchh
Confidence 23345689999999987665 56899999999999999999999997653321111110000 00000000
Q ss_pred hhHhhhchhc-ccC-----CHHHHHHHHHHHHHccccCCCCCCCHHhHHHH--hccCc
Q 003836 728 LEALVENDLE-AMN-----NVTMLHRFVMVAFWCIQEDPSHRPTMRKVTQM--LEGVV 777 (792)
Q Consensus 728 ~~~~~~~~~~-~~~-----~~~~~~~l~~l~~~Cl~~~p~~RPs~~evl~~--L~~~~ 777 (792)
.......... ... ....+.++.+|+.+||+.||++|||++|+++. +.+..
T Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~elL~Hp~f~~~~ 308 (348)
T d2gfsa1 251 ARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYH 308 (348)
T ss_dssp HHHHHTTSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTTC
T ss_pred hhhhhhhcccCCCcchhhhcCCCCHHHHHHHHHHCcCChhhCcCHHHHhcCHhhCCCC
Confidence 0000000000 000 01234678899999999999999999999974 55443
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=1.7e-34 Score=313.18 Aligned_cols=276 Identities=20% Similarity=0.221 Sum_probs=195.3
Q ss_pred hhhhhhcCccccceEEEeeecCCCceEEEEEEcccccccchHHHHHHHHHhcccC-----------CCCcccccceecc-
Q 003836 503 RGFKEELGRGAFGTVYKGFVNMGSSNHVAVKKLNSVFQDSEKEFKAEVNGIGQTH-----------HKNLVRLLGYCDE- 570 (792)
Q Consensus 503 ~~~~~~lG~G~~g~Vy~g~~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~-----------h~niv~l~g~~~~- 570 (792)
|.+.++||+|+||+||+|+. ..+++.||||++++.. ...+.+.+|+.++++++ |+||+++++++..
T Consensus 15 Y~i~~~LG~G~fg~Vy~~~~-~~~g~~vAvKvi~~~~-~~~~~~~~Ei~~l~~l~~~~~~~~~~~~~~~iv~~~~~~~~~ 92 (362)
T d1q8ya_ 15 YILVRKLGWGHFSTVWLAKD-MVNNTHVAMKIVRGDK-VYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFNHK 92 (362)
T ss_dssp EEEEEEEEECSSEEEEEEEE-TTTTEEEEEEEECSCH-HHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEEEE
T ss_pred EEEEEEEeeCCCeEEEEEEE-CCCCCEEEEEEEeccc-cchHHHHHHHHHHHHhcchhhhhhhhcCcCceEEEEEEeeec
Confidence 55678999999999999974 3567899999997542 23467788998888875 5779999988854
Q ss_pred -CCceEEEEEeccCCCccccc---cCCCCCchhHHHHHHHHHHHHHHHHhhccCCCeEecCCCCCcEEEcCCCC------
Q 003836 571 -GQNRLLVYEFMSNGTVASFL---FGDSKPNWKLRTEIAMGIAGGLFYLHEECCTQIIHCDIKPQNILLDDHYN------ 640 (792)
Q Consensus 571 -~~~~~lV~E~~~~gsL~~~l---~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dikp~NILl~~~~~------ 640 (792)
....+++++++..+...... .....+++..+..++.||+.||+|||+. .+|+||||||+||||+.++.
T Consensus 93 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qil~al~~lh~~--~~IvHrDlKp~NIll~~~~~~~~~~~ 170 (362)
T d1q8ya_ 93 GPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRR--CGIIHTDIKPENVLMEIVDSPENLIQ 170 (362)
T ss_dssp ETTEEEEEEEECCCCEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHT--TCEECSCCSGGGEEEEEEETTTTEEE
T ss_pred cccceeeeeeecccccccccccccccccCCcHHHHHHHHHHHHHHHHHHhhh--cCcccccCChhHeeeeccCcccccce
Confidence 34566777777655433222 2335678899999999999999999983 28999999999999986653
Q ss_pred eEEeecCCCccccCCCCCccccccccCCcccccccccCCCCcccceehHHHHHHHHHhcCcCCCcchhhhh---hhhHHH
Q 003836 641 ARISDFGLAKLLTLDQSHTNTAIRGTKGYVAPEWFRNMPITVKVDVYSYGVLLLEIICLRRNIDNEISKVD---KAILTD 717 (792)
Q Consensus 641 ~kl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DV~S~Gv~l~el~tg~~p~~~~~~~~~---~~~~~~ 717 (792)
+|++|||.+...... .....||+.|+|||.+....++.++||||+||+++||++|+.||........ ...+..
T Consensus 171 ~kl~dfg~s~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~pF~~~~~~~~~~~~~~~~~ 246 (362)
T d1q8ya_ 171 IKIADLGNACWYDEH----YTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHIAQ 246 (362)
T ss_dssp EEECCCTTCEETTBC----CCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC---------CHHHHHHH
T ss_pred eeEeecccccccccc----cccccccccccChhhccccCCCccccccchHHHHHHHHHCCCCCCCCccccccchhHHHHH
Confidence 999999999865422 2345689999999999999999999999999999999999999965432111 000000
Q ss_pred HHHHh-------hcc-c---------------------chhHhhhchhcccCCHHHHHHHHHHHHHccccCCCCCCCHHh
Q 003836 718 WAYDR-------YQE-R---------------------TLEALVENDLEAMNNVTMLHRFVMVAFWCIQEDPSHRPTMRK 768 (792)
Q Consensus 718 ~~~~~-------~~~-~---------------------~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~e 768 (792)
..... ... . ....... .........+.++.+|+.+||+.||.+|||++|
T Consensus 247 ~~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~dll~~mL~~dP~~Rpta~e 324 (362)
T d1q8ya_ 247 IIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLT--EKYKFSKDEAKEISDFLSPMLQLDPRKRADAGG 324 (362)
T ss_dssp HHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHH--HTTCCCHHHHHHHHHHHGGGGCSSTTTCBCHHH
T ss_pred HHHHhCCCCHHHhhcccccccccccchhhhccccccCCchhhhcc--cccccCcccCHHHHHHHHHHCCCChhHCcCHHH
Confidence 00000 000 0 0000000 112234567889999999999999999999999
Q ss_pred HHHH--hccC---cCCCCCCCCCCC
Q 003836 769 VTQM--LEGV---VEVPIPPCPWTL 788 (792)
Q Consensus 769 vl~~--L~~~---~~~~~p~~P~~~ 788 (792)
+++. +++. -++..|+.|.+.
T Consensus 325 ~L~Hp~f~~~~~~~~~~~p~~~~~~ 349 (362)
T d1q8ya_ 325 LVNHPWLKDTLGMEEIRVPDRELYG 349 (362)
T ss_dssp HHTCGGGTTCTTCTTCCCTTSCTTC
T ss_pred HhcCcccCCCCCcccCCCCCcccCC
Confidence 9985 5433 345566655443
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Probab=99.83 E-value=2.4e-21 Score=188.66 Aligned_cols=162 Identities=12% Similarity=0.144 Sum_probs=118.7
Q ss_pred hhhhcCccccceEEEeeecCCCceEEEEEEcccccc------------------cchHHHHHHHHHhcccCCCCcccccc
Q 003836 505 FKEELGRGAFGTVYKGFVNMGSSNHVAVKKLNSVFQ------------------DSEKEFKAEVNGIGQTHHKNLVRLLG 566 (792)
Q Consensus 505 ~~~~lG~G~~g~Vy~g~~~~~~~~~vavK~~~~~~~------------------~~~~~~~~Ei~~l~~l~h~niv~l~g 566 (792)
+.++||+|+||+||+|... +++.||||+++.... .....+.+|...+.+++|.+++..++
T Consensus 4 vg~~IG~G~~g~Vy~a~~~--~g~~vAvKi~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~v~~~~~ 81 (191)
T d1zara2 4 IGKLMGEGKESAVFNCYSE--KFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQGLAVPKVYA 81 (191)
T ss_dssp EEEEEEECSSEEEEEEEET--TTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTTSSSCCEEE
T ss_pred hCCEeeeCcceEEEEEECC--CCCEEEEEEEecccchhhhhhhhhhhccHHHHHHHHHHHHHHHHHHHHccCCCcceEEE
Confidence 4578999999999999764 467899998653110 01234567888999999999998876
Q ss_pred eeccCCceEEEEEeccCCCccccccCCCCCchhHHHHHHHHHHHHHHHHhhccCCCeEecCCCCCcEEEcCCCCeEEeec
Q 003836 567 YCDEGQNRLLVYEFMSNGTVASFLFGDSKPNWKLRTEIAMGIAGGLFYLHEECCTQIIHCDIKPQNILLDDHYNARISDF 646 (792)
Q Consensus 567 ~~~~~~~~~lV~E~~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dikp~NILl~~~~~~kl~Df 646 (792)
+.. .+++|||+++..+.+ ++.....+++.|++++|+|||+. +|+||||||+|||++++ .++|+||
T Consensus 82 ~~~----~~lvme~~~~~~~~~-------l~~~~~~~i~~ql~~~l~~lH~~---giiHrDiKP~NILv~~~-~~~liDF 146 (191)
T d1zara2 82 WEG----NAVLMELIDAKELYR-------VRVENPDEVLDMILEEVAKFYHR---GIVHGDLSQYNVLVSEE-GIWIIDF 146 (191)
T ss_dssp EET----TEEEEECCCCEEGGG-------CCCSCHHHHHHHHHHHHHHHHHT---TEECSCCSTTSEEEETT-EEEECCC
T ss_pred ecC----CEEEEEeeccccccc-------hhhHHHHHHHHHHHHHHHHHhhC---CEEEccCChhheeeeCC-CEEEEEC
Confidence 642 379999999865544 34555678999999999999998 99999999999999976 4999999
Q ss_pred CCCccccCCCCCccccccccCCccc------ccccccCCCCcccceehHHHHH
Q 003836 647 GLAKLLTLDQSHTNTAIRGTKGYVA------PEWFRNMPITVKVDVYSYGVLL 693 (792)
Q Consensus 647 g~a~~~~~~~~~~~~~~~gt~~y~a------PE~~~~~~~~~k~DV~S~Gv~l 693 (792)
|.|+....+.... |.. .|.+ ...|+.++|+||..--+
T Consensus 147 G~a~~~~~~~~~~---------~l~rd~~~~~~~f-~r~y~~~~d~~s~~~~~ 189 (191)
T d1zara2 147 PQSVEVGEEGWRE---------ILERDVRNIITYF-SRTYRTEKDINSAIDRI 189 (191)
T ss_dssp TTCEETTSTTHHH---------HHHHHHHHHHHHH-HHHHCCCCCHHHHHHHH
T ss_pred CCcccCCCCCcHH---------HHHHHHHHHHHHH-cCCCCCcccHHHHHHHH
Confidence 9997654222111 111 1111 35678899999975443
|
| >d1xd5a_ b.78.1.1 (A:) Gastrodianin (antifungal protein) {Gastrodia elata [TaxId: 91201]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Gastrodianin (antifungal protein) species: Gastrodia elata [TaxId: 91201]
Probab=99.82 E-value=2.3e-20 Score=163.67 Aligned_cols=111 Identities=16% Similarity=0.345 Sum_probs=92.0
Q ss_pred cCcccCCcceeecCCCCceecCCCeEEEeeeecCCCCceEEEEEeecCCCCcEEEEecCCCCCCCCeeEEEEeCccEEEE
Q 003836 23 NGTISIGQQLTAAESTEPWLSPSKDFALGFHQLDSKDLFLPAIWYYKIPSKTIVWYASAVNPAPRGSKLRLTANRGLVLE 102 (792)
Q Consensus 23 ~~~i~~g~~l~~~~~~~~lvS~~g~F~lGF~~~~~~~~~~~gIW~~~~~~~tvvWvANr~~P~~~~~~l~~~~~G~Lvl~ 102 (792)
+|+|.|||.|.+++ .|+ +|.|+|+|+.+++ |.|+. ..++||.||++.|.. .+.+.|+.||+|+|.
T Consensus 1 tDtL~~gq~L~~g~---~l~--~g~~~l~~q~DGN-----Lvly~----~~~~vW~s~~~~~~~-~~~l~l~~dGnLvl~ 65 (112)
T d1xd5a_ 1 SDRLNSGHQLDTGG---SLA--EGGYLFIIQNDCN-----LVLYD----NNRAVWASGTNGKAS-GCVLKMQNDGNLVIY 65 (112)
T ss_dssp CCEEETTEEECTTC---EEE--ETTEEEEECTTSC-----EEEEE----TTEEEEECCCTTSCS-SEEEEECTTSCEEEE
T ss_pred CCEecCCCEecCCC---EEE--ECCEEEEEcCCCC-----EEEEc----CCcEEEEccCccCCC-CcEEEEeccccEEEE
Confidence 48999999998765 676 5999999998765 34544 368999999998853 478999999999999
Q ss_pred cCCCCEEEEeccCCC-cceeEEEecCCcEEEEecCCccccccccCCcc
Q 003836 103 DPEGREIWKSEISTG-QAAFGVLYDTGNFLIVNTNSERLWQSFDHPTD 149 (792)
Q Consensus 103 ~~~~~~vWst~~~~~-~~~~a~LldsGNlVl~~~~~~~lWQSFd~PtD 149 (792)
|. +.++|+++++.. +..+|+|+|+|||||++.++.++|||+.+|++
T Consensus 66 ~~-~~~~w~s~t~~~~~~~~l~L~ddGNlvly~~~~~~~W~S~t~~~n 112 (112)
T d1xd5a_ 66 SG-SRAIWASNTNRQNGNYYLILQRDRNVVIYDNSNNAIWATHTNVGN 112 (112)
T ss_dssp ET-TEEEEECCCCCSCCCCEEEECTTSCEEEECTTSCEEEECCCCCCC
T ss_pred ec-CCeEEEEeeccCCCceEEEEcCCCCEEEECCCCcEEecCCCccCC
Confidence 96 567888776544 45689999999999999999999999999985
|
| >d1kj1a_ b.78.1.1 (A:) Lectin (agglutinin) {Garlic (Allium sativum) [TaxId: 4682]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Lectin (agglutinin) species: Garlic (Allium sativum) [TaxId: 4682]
Probab=99.80 E-value=5.7e-20 Score=159.46 Aligned_cols=107 Identities=21% Similarity=0.338 Sum_probs=88.9
Q ss_pred cCcccCCcceeecCCCCceecCCCeEEEeeeecCCCCceEEEEEeecCCCCcEEEEecCCCCCCCCeeEEEEeCccEEEE
Q 003836 23 NGTISIGQQLTAAESTEPWLSPSKDFALGFHQLDSKDLFLPAIWYYKIPSKTIVWYASAVNPAPRGSKLRLTANRGLVLE 102 (792)
Q Consensus 23 ~~~i~~g~~l~~~~~~~~lvS~~g~F~lGF~~~~~~~~~~~gIW~~~~~~~tvvWvANr~~P~~~~~~l~~~~~G~Lvl~ 102 (792)
.|+|.+||.|.+++ .|. +|.|.|+|+..++ |.++. ..++||+||++.|....+.|.|+.||+|||.
T Consensus 1 ~~~L~~g~~L~~g~---~l~--~g~~~l~~q~dgn-----Lvl~~----~~~~vW~ant~~~~~~~~~l~l~~dGnLvl~ 66 (109)
T d1kj1a_ 1 RNLLTNGEGLYAGQ---SLD--VEPYHFIMQEDCN-----LVLYD----HSTSVWASNTGILGKKGCKAVLQSDGNFVVY 66 (109)
T ss_dssp CCEEETTCEEETTC---EEE--ETTEEEEECTTSC-----EEEEE----TTEEEEECCCCCTTCCCCEEEECTTSCEEEE
T ss_pred CCCccCCCEEeCCC---EEE--eCCEEEEecCCCe-----EEEEe----CCEEEEEeCCCCCCceeEEEEEcCCceEEEE
Confidence 37899999998765 564 5899999987654 23432 3689999999999988889999999999999
Q ss_pred cCCCCEEEEeccCC-CcceeEEEecCCcEEEEecCCccccccccC
Q 003836 103 DPEGREIWKSEIST-GQAAFGVLYDTGNFLIVNTNSERLWQSFDH 146 (792)
Q Consensus 103 ~~~~~~vWst~~~~-~~~~~a~LldsGNlVl~~~~~~~lWQSFd~ 146 (792)
|++|++||+|+++. .+..+|+|+|+|||||+++ .+|||+-|
T Consensus 67 ~~~g~~vW~s~t~~~~~~~~l~L~ddGNlvly~~---~~W~S~t~ 108 (109)
T d1kj1a_ 67 DAEGRSLWASHSVRGNGNYVLVLQEDGNVVIYGS---DIWSTGTY 108 (109)
T ss_dssp CSSSCEEEECCCCCCSSCCEEEECTTSCEEEECC---EEEECCCC
T ss_pred eCCCcEEEEEeeECCCCCEEEEEeCCCcEEEECC---CEecCCCc
Confidence 99999999999864 4456899999999999963 59999865
|
| >d1jpca_ b.78.1.1 (A:) Lectin (agglutinin) {Snowdrop (Galanthus nivalis) [TaxId: 4670]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Lectin (agglutinin) species: Snowdrop (Galanthus nivalis) [TaxId: 4670]
Probab=99.79 E-value=1.9e-19 Score=156.15 Aligned_cols=106 Identities=18% Similarity=0.320 Sum_probs=87.5
Q ss_pred cCcccCCcceeecCCCCceecCCCeEEEeeeecCCCCceEEEEEeecCCCCcEEEEecCCCCCCCCeeEEEEeCccEEEE
Q 003836 23 NGTISIGQQLTAAESTEPWLSPSKDFALGFHQLDSKDLFLPAIWYYKIPSKTIVWYASAVNPAPRGSKLRLTANRGLVLE 102 (792)
Q Consensus 23 ~~~i~~g~~l~~~~~~~~lvS~~g~F~lGF~~~~~~~~~~~gIW~~~~~~~tvvWvANr~~P~~~~~~l~~~~~G~Lvl~ 102 (792)
.|+|.+||.|.+++ .| .+|.|.|.|+.+|+ |.||. ..++||.||++.|. ..+.+.++.+|+|+|.
T Consensus 1 ~~~L~~g~~L~~G~---~l--~ng~~~l~~q~DGN-----Lvly~----~~~~vW~s~~~~~~-~~~~l~l~~~Gnlvl~ 65 (108)
T d1jpca_ 1 DNILYSGETLSTGE---FL--NYGSFVFIMQEDCN-----LVLYD----VDKPIWATNTGGLS-RSCFLSMQTDGNLVVY 65 (108)
T ss_dssp CCEEETTEEECTTC---EE--EETTEEEEECTTSC-----EEEEE----TTEEEEECCCTTSC-SSCEEEECTTSCEEEE
T ss_pred CCCccCCCEecCCC---EE--EcCCEEEEECCCCe-----EEEEe----CCceeeEeCCCCCC-CccEEEEeccceEEEE
Confidence 37899999998665 56 46999999998875 35654 35789999999884 3568999999999999
Q ss_pred cCCCCEEEEeccCCCc-ceeEEEecCCcEEEEecCCccccccccC
Q 003836 103 DPEGREIWKSEISTGQ-AAFGVLYDTGNFLIVNTNSERLWQSFDH 146 (792)
Q Consensus 103 ~~~~~~vWst~~~~~~-~~~a~LldsGNlVl~~~~~~~lWQSFd~ 146 (792)
|++|.+||+|++.... ..+|+|+|+|||||++. .+||||+|
T Consensus 66 ~~~g~~vWsS~t~~~~~~~~l~L~ddGNlVly~~---~~W~S~t~ 107 (108)
T d1jpca_ 66 NPSNKPIWASNTGGQNGNYVCILQKDRNVVIYGT---DRWATGTH 107 (108)
T ss_dssp CTTCCEEEECCCCCSCSCEEEEECTTSCEEEEEC---CCCCCCCC
T ss_pred CCCccceEEccccCCCCcEEEEEcCCCCEEEeCC---CcccCCCC
Confidence 9999999999976544 45789999999999963 59999988
|
| >d1dlpa2 b.78.1.1 (A:116-235) Fetuin-binding protein Scafet precursor {Bluebell (Scilla campanulata) [TaxId: 81759]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Fetuin-binding protein Scafet precursor species: Bluebell (Scilla campanulata) [TaxId: 81759]
Probab=99.73 E-value=2.6e-18 Score=151.30 Aligned_cols=101 Identities=21% Similarity=0.298 Sum_probs=86.9
Q ss_pred EEEeecCCCCcEEEEecCCCCCCCC-eeEEEEeCccEEEEcCCCCEEEEeccCCCc-ceeEEEecCCcEEEEecCCcccc
Q 003836 64 AIWYYKIPSKTIVWYASAVNPAPRG-SKLRLTANRGLVLEDPEGREIWKSEISTGQ-AAFGVLYDTGNFLIVNTNSERLW 141 (792)
Q Consensus 64 gIW~~~~~~~tvvWvANr~~P~~~~-~~l~~~~~G~Lvl~~~~~~~vWst~~~~~~-~~~a~LldsGNlVl~~~~~~~lW 141 (792)
-|||.++++++.+|++|++.|+..+ .+|.+..||||+|.+. +.++|++++...+ ..+|+|+|+|||||+|.++.+||
T Consensus 11 ~il~~~~~~~~~~~~l~~~q~l~~g~y~L~~q~DGNLvL~~~-~~~vW~s~t~~~~~~~~~~l~~~GnLvl~d~~~~~lW 89 (120)
T d1dlpa2 11 SILYSTQGNDNHPQTLHATQSLQLSPYRLSMETDCNLVLFDR-DDRVWSTNTAGKGTGCRAVLQPNGRMDVLTNQNIAVW 89 (120)
T ss_dssp EECCCC--CCCCCCEECSSCCCBCSSCEEEEETTTEEEEEBT-TBCCSCCCCCSSCSSCEEEEETTTEEEEEETTTEEEE
T ss_pred eEEEcCCCCCCcccEEcCCCeeEcCCEEEEEcCCCcEEEecC-CcEEEEEccccCCCcEEEEEeCCeeEEEEcCCCCEEE
Confidence 4999999999999999999999654 4899999999999985 6789999987554 46899999999999999999999
Q ss_pred ccccCCcccccCCCccccceEEeeeccCCCCCCCceeEeecCCCceeee
Q 003836 142 QSFDHPTDTLLPTQTMERGGVVSSRRKDTYFSRGRFQFRLLEDGNAVLN 190 (792)
Q Consensus 142 QSFd~PtDtlLpg~~l~~~~~L~S~~s~~~~s~G~~~~~~~~~g~~~~~ 190 (792)
|||. +.+.|.|.+.+++||++++|
T Consensus 90 ~S~t-------------------------~~~~~~~~l~Lq~DGnlvlY 113 (120)
T d1dlpa2 90 TSGN-------------------------SRSAGRYVFVLQPDRNLAIY 113 (120)
T ss_dssp ECCC-------------------------CCSSSCCEEEECSSSCEEEE
T ss_pred EeCC-------------------------CCCCCcEEEEECCCCcEEEe
Confidence 9983 23678899999999999986
|
| >d1dlpa1 b.78.1.1 (A:1-115) Fetuin-binding protein Scafet precursor {Bluebell (Scilla campanulata) [TaxId: 81759]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Fetuin-binding protein Scafet precursor species: Bluebell (Scilla campanulata) [TaxId: 81759]
Probab=99.65 E-value=2.4e-17 Score=143.46 Aligned_cols=110 Identities=18% Similarity=0.196 Sum_probs=93.6
Q ss_pred EEeecCCCCcEEEEecCCCCCCC-CeeEEEEeCccEEEEcCCCCEEEEeccCCCcceeEEEecCCcEEEEecCCcccccc
Q 003836 65 IWYYKIPSKTIVWYASAVNPAPR-GSKLRLTANRGLVLEDPEGREIWKSEISTGQAAFGVLYDTGNFLIVNTNSERLWQS 143 (792)
Q Consensus 65 IW~~~~~~~tvvWvANr~~P~~~-~~~l~~~~~G~Lvl~~~~~~~vWst~~~~~~~~~a~LldsGNlVl~~~~~~~lWQS 143 (792)
|||.-.++.+..|+.+.+.++.+ +.+|.+..||||||.+ ++.++|++++....+..|.|+|+|||||+|.++.+||||
T Consensus 3 ~~~~~~~~~~~~~tl~~~~~l~~g~~~l~~q~DGNLvL~~-~~~~vW~s~t~~~~~~~l~l~~dGNLvl~d~~~~~vWsS 81 (115)
T d1dlpa1 3 ILFGLSHEGSHPQTLHAAQSLELSSFRFTMQSDCNLVLFD-SDVRVWASNTAGATGCRAVLQSDGLLVILTAQNTIRWSS 81 (115)
T ss_dssp CCBCSSSSSCSCSCCCTTCEECSTTEEEEECTTSCEEEEE-SSSEEECCCCCSCSCCBCCBCSSSCBCCBCTTTCCSCCC
T ss_pred EEEecCCCCCCcceecCCCcEEcCCEEEEECCCCeEEEEc-CCeeEEEcccCCCCceEEEEeccCCEEEEccCCCEEEEc
Confidence 78877778888899999999965 4589999999999998 568999999887777899999999999999999999998
Q ss_pred ccCCcccccCCCccccceEEeeeccCCCCCCCceeEeecCCCceeeeeeccCCCcccccccccCCc
Q 003836 144 FDHPTDTLLPTQTMERGGVVSSRRKDTYFSRGRFQFRLLEDGNAVLNTINLESGFAYDAYFWSNTF 209 (792)
Q Consensus 144 Fd~PtDtlLpg~~l~~~~~L~S~~s~~~~s~G~~~~~~~~~g~~~~~~~~~~~~~~~~~y~~~~~~ 209 (792)
+. +.+.|.|.+.+++||++++|. .++|.+++.
T Consensus 82 ~t-------------------------~~~~g~y~l~Lq~DGNlvlY~---------~~~Wssgt~ 113 (115)
T d1dlpa1 82 GT-------------------------KGSIGNYVLVLQPDRTVTIYG---------PGLWDSGTS 113 (115)
T ss_dssp CC-------------------------CCCSSCCEEEECSSSCEEEEC---------SEEEECSCC
T ss_pred CC-------------------------CCCCCCEEEEECCCCcEEEeC---------CCeecCCCC
Confidence 73 346899999999999998851 358877654
|
| >d1b2pa_ b.78.1.1 (A:) Lectin (agglutinin) {Bluebell (Scilla campanulata) [TaxId: 81759]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Lectin (agglutinin) species: Bluebell (Scilla campanulata) [TaxId: 81759]
Probab=99.54 E-value=8.8e-15 Score=127.97 Aligned_cols=102 Identities=17% Similarity=0.261 Sum_probs=82.9
Q ss_pred CcccCCcceeecCCCCceecCCCeEEEeeeecCCCCceEEEEEeecCCCCcEEEEecCCCCCCCCeeEEEEeCccEEEEc
Q 003836 24 GTISIGQQLTAAESTEPWLSPSKDFALGFHQLDSKDLFLPAIWYYKIPSKTIVWYASAVNPAPRGSKLRLTANRGLVLED 103 (792)
Q Consensus 24 ~~i~~g~~l~~~~~~~~lvS~~g~F~lGF~~~~~~~~~~~gIW~~~~~~~tvvWvANr~~P~~~~~~l~~~~~G~Lvl~~ 103 (792)
.+|.++|+|. .++..|.|.|.|...|+- .+ |. ..++||.||+..|.. .+.|.|..||+|+|.|
T Consensus 15 ~~l~~~q~l~-------~~~~~~~y~l~mQ~DGNL-----VL-y~---~~~~vWssnt~~~~~-~~~l~l~~dGnLvL~d 77 (119)
T d1b2pa_ 15 QILHATESLE-------ILFGTHVYRFIMQTDCNL-----VL-YD---NNNPIWATNTGGLGN-GCRAVLQPDGVLVVIT 77 (119)
T ss_dssp CEEETTCEEE-------EEETTEEEEEEECTTSCE-----EE-EE---TTEEEEECCCTTSCS-SCEEEECTTSCEEEEC
T ss_pred CEEeCCCeEE-------EecCCceEEEEECCCCcE-----EE-EE---CCeEEEEecCCCCCc-ceEEEEEeCCCEEEEC
Confidence 5788888873 477899999999988762 22 43 367999999987743 4789999999999999
Q ss_pred CCCCEEEEeccCCC-cceeEEEecCCcEEEEecCCcccccccc
Q 003836 104 PEGREIWKSEISTG-QAAFGVLYDTGNFLIVNTNSERLWQSFD 145 (792)
Q Consensus 104 ~~~~~vWst~~~~~-~~~~a~LldsGNlVl~~~~~~~lWQSFd 145 (792)
++|.+||++++... +..+|+|+|+|||||++ ..+|||-.
T Consensus 78 ~~g~~vWsS~t~~~~~~~~l~Lq~DGNlvlYg---~~~W~S~T 117 (119)
T d1b2pa_ 78 NENVTVWQSPVAGKAGHYVLVLQPDRNVVIYG---DALWATQT 117 (119)
T ss_dssp TTCCEEEECSCCCCSSCEEEEECTTSCEEEEE---SEEEECCC
T ss_pred CCCcEEEECCCcCCCCceEEEEcCCCCEEEEC---CCEeccCC
Confidence 99999999998654 34579999999999995 47999964
|
| >d1dlpa1 b.78.1.1 (A:1-115) Fetuin-binding protein Scafet precursor {Bluebell (Scilla campanulata) [TaxId: 81759]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Fetuin-binding protein Scafet precursor species: Bluebell (Scilla campanulata) [TaxId: 81759]
Probab=99.30 E-value=5.8e-13 Score=115.34 Aligned_cols=98 Identities=19% Similarity=0.249 Sum_probs=76.5
Q ss_pred cCcccCCcceeecCCCCceecCCCeEEEeeeecCCCCceEEEEEeecCCCCcEEEEecCCCCCCCCeeEEEEeCccEEEE
Q 003836 23 NGTISIGQQLTAAESTEPWLSPSKDFALGFHQLDSKDLFLPAIWYYKIPSKTIVWYASAVNPAPRGSKLRLTANRGLVLE 102 (792)
Q Consensus 23 ~~~i~~g~~l~~~~~~~~lvS~~g~F~lGF~~~~~~~~~~~gIW~~~~~~~tvvWvANr~~P~~~~~~l~~~~~G~Lvl~ 102 (792)
..||.++|+| .+|.|.|.|..+|+ |.++. ...+||.+|...+ ..+.+.|.+||||||.
T Consensus 14 ~~tl~~~~~l-----------~~g~~~l~~q~DGN-----LvL~~----~~~~vW~s~t~~~--~~~~l~l~~dGNLvl~ 71 (115)
T d1dlpa1 14 PQTLHAAQSL-----------ELSSFRFTMQSDCN-----LVLFD----SDVRVWASNTAGA--TGCRAVLQSDGLLVIL 71 (115)
T ss_dssp CSCCCTTCEE-----------CSTTEEEEECTTSC-----EEEEE----SSSEEECCCCCSC--SCCBCCBCSSSCBCCB
T ss_pred cceecCCCcE-----------EcCCEEEEECCCCe-----EEEEc----CCeeEEEcccCCC--CceEEEEeccCCEEEE
Confidence 4567777766 35779999998775 34543 3578999997643 3578999999999999
Q ss_pred cCCCCEEEEeccCCC-cceeEEEecCCcEEEEecCCcccccccc
Q 003836 103 DPEGREIWKSEISTG-QAAFGVLYDTGNFLIVNTNSERLWQSFD 145 (792)
Q Consensus 103 ~~~~~~vWst~~~~~-~~~~a~LldsGNlVl~~~~~~~lWQSFd 145 (792)
|.++.+||++.+... +..+++|+++|||||++ ..+|+|-.
T Consensus 72 d~~~~~vWsS~t~~~~g~y~l~Lq~DGNlvlY~---~~~Wssgt 112 (115)
T d1dlpa1 72 TAQNTIRWSSGTKGSIGNYVLVLQPDRTVTIYG---PGLWDSGT 112 (115)
T ss_dssp CTTTCCSCCCCCCCCSSCCEEEECSSSCEEEEC---SEEEECSC
T ss_pred ccCCCEEEEcCCCCCCCCEEEEECCCCcEEEeC---CCeecCCC
Confidence 999999999998643 44579999999999994 47999853
|
| >d1dlpa2 b.78.1.1 (A:116-235) Fetuin-binding protein Scafet precursor {Bluebell (Scilla campanulata) [TaxId: 81759]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Fetuin-binding protein Scafet precursor species: Bluebell (Scilla campanulata) [TaxId: 81759]
Probab=99.16 E-value=3.2e-11 Score=105.32 Aligned_cols=111 Identities=23% Similarity=0.311 Sum_probs=79.4
Q ss_pred EEecCCcEEEEecCCccccccccCCcccccCCCccccceEEeeeccCCCCCCCceeEeecCCCceeeeeeccCCCccccc
Q 003836 123 VLYDTGNFLIVNTNSERLWQSFDHPTDTLLPTQTMERGGVVSSRRKDTYFSRGRFQFRLLEDGNAVLNTINLESGFAYDA 202 (792)
Q Consensus 123 ~LldsGNlVl~~~~~~~lWQSFd~PtDtlLpg~~l~~~~~L~S~~s~~~~s~G~~~~~~~~~g~~~~~~~~~~~~~~~~~ 202 (792)
+++|+||+|+.+. +|+|.|++||.++|.| ..|.|+|.++.||+++++. .. .+
T Consensus 4 v~~~~~n~il~~~------~~~~~~~~~l~~~q~l---------------~~g~y~L~~q~DGNLvL~~--~~-----~~ 55 (120)
T d1dlpa2 4 VVANNGNSILYST------QGNDNHPQTLHATQSL---------------QLSPYRLSMETDCNLVLFD--RD-----DR 55 (120)
T ss_dssp CCSSCCCEECCCC--------CCCCCCEECSSCCC---------------BCSSCEEEEETTTEEEEEB--TT-----BC
T ss_pred EEEeCCCeEEEcC------CCCCCcccEEcCCCee---------------EcCCEEEEEcCCCcEEEec--CC-----cE
Confidence 4555566555432 6779999999999998 4688999999999998853 22 45
Q ss_pred ccccCCcccccCCCcceeEEccCCcEEEEecccceeeeccccccccccEEEEEEecCCcEEEEe
Q 003836 203 YFWSNTFDTNRSNAGYRVVFNESGQLYVLRENKQRASLVPETVSAKENYLRATLNFDGVFIFYS 266 (792)
Q Consensus 203 y~~~~~~~~~~~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~r~~L~~dG~l~~y~ 266 (792)
+|++.+... +....+.+..+|.+.+++.++..+..+... .. ...++++|++||++++|.
T Consensus 56 vW~s~t~~~---~~~~~~~l~~~GnLvl~d~~~~~lW~S~t~-~~-~~~~~l~Lq~DGnlvlY~ 114 (120)
T d1dlpa2 56 VWSTNTAGK---GTGCRAVLQPNGRMDVLTNQNIAVWTSGNS-RS-AGRYVFVLQPDRNLAIYG 114 (120)
T ss_dssp CSCCCCCSS---CSSCEEEEETTTEEEEEETTTEEEEECCCC-CS-SSCCEEEECSSSCEEEEC
T ss_pred EEEEccccC---CCcEEEEEeCCeeEEEEcCCCCEEEEeCCC-CC-CCcEEEEECCCCcEEEeC
Confidence 787765422 334678899999999998887776655321 11 223589999999999994
|
| >d1b2pa_ b.78.1.1 (A:) Lectin (agglutinin) {Bluebell (Scilla campanulata) [TaxId: 81759]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Lectin (agglutinin) species: Bluebell (Scilla campanulata) [TaxId: 81759]
Probab=99.12 E-value=9.2e-11 Score=101.99 Aligned_cols=84 Identities=24% Similarity=0.381 Sum_probs=67.7
Q ss_pred eEEEEeCccEEEEcCCCCEEEEeccCCCc-ceeEEEecCCcEEEEecCCccccccccCCcccccCCCccccceEEeeecc
Q 003836 90 KLRLTANRGLVLEDPEGREIWKSEISTGQ-AAFGVLYDTGNFLIVNTNSERLWQSFDHPTDTLLPTQTMERGGVVSSRRK 168 (792)
Q Consensus 90 ~l~~~~~G~Lvl~~~~~~~vWst~~~~~~-~~~a~LldsGNlVl~~~~~~~lWQSFd~PtDtlLpg~~l~~~~~L~S~~s 168 (792)
.|.+..||||||.++ +.++|++++...+ .+.+.|.++|||||+|.++.++|+|.
T Consensus 33 ~l~mQ~DGNLVLy~~-~~~vWssnt~~~~~~~~l~l~~dGnLvL~d~~g~~vWsS~------------------------ 87 (119)
T d1b2pa_ 33 RFIMQTDCNLVLYDN-NNPIWATNTGGLGNGCRAVLQPDGVLVVITNENVTVWQSP------------------------ 87 (119)
T ss_dssp EEEECTTSCEEEEET-TEEEEECCCTTSCSSCEEEECTTSCEEEECTTCCEEEECS------------------------
T ss_pred EEEECCCCcEEEEEC-CeEEEEecCCCCCcceEEEEEeCCCEEEECCCCcEEEECC------------------------
Confidence 678889999999975 5789999987554 47899999999999999999999862
Q ss_pred CCCCCCCceeEeecCCCceeeeeeccCCCcccccccccCC
Q 003836 169 DTYFSRGRFQFRLLEDGNAVLNTINLESGFAYDAYFWSNT 208 (792)
Q Consensus 169 ~~~~s~G~~~~~~~~~g~~~~~~~~~~~~~~~~~y~~~~~ 208 (792)
+.-+.|.|.+.+++||++++|. .+.|.+++
T Consensus 88 -t~~~~~~~~l~Lq~DGNlvlYg---------~~~W~S~T 117 (119)
T d1b2pa_ 88 -VAGKAGHYVLVLQPDRNVVIYG---------DALWATQT 117 (119)
T ss_dssp -CCCCSSCEEEEECTTSCEEEEE---------SEEEECCC
T ss_pred -CcCCCCceEEEEcCCCCEEEEC---------CCEeccCC
Confidence 1124578999999999999862 24777655
|
| >d1jpca_ b.78.1.1 (A:) Lectin (agglutinin) {Snowdrop (Galanthus nivalis) [TaxId: 4670]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Lectin (agglutinin) species: Snowdrop (Galanthus nivalis) [TaxId: 4670]
Probab=99.06 E-value=3e-10 Score=97.26 Aligned_cols=77 Identities=23% Similarity=0.399 Sum_probs=64.1
Q ss_pred CeeEEEEeCccEEEEcCCCCEEEEeccCCCc-ceeEEEecCCcEEEEecCCccccccccCCcccccCCCccccceEEeee
Q 003836 88 GSKLRLTANRGLVLEDPEGREIWKSEISTGQ-AAFGVLYDTGNFLIVNTNSERLWQSFDHPTDTLLPTQTMERGGVVSSR 166 (792)
Q Consensus 88 ~~~l~~~~~G~Lvl~~~~~~~vWst~~~~~~-~~~a~LldsGNlVl~~~~~~~lWQSFd~PtDtlLpg~~l~~~~~L~S~ 166 (792)
.-.|.+..||||||.+ .+.+||++++...+ ...++|+++|||||++.++.++|+|
T Consensus 20 ~~~l~~q~DGNLvly~-~~~~vW~s~~~~~~~~~~l~l~~~Gnlvl~~~~g~~vWsS----------------------- 75 (108)
T d1jpca_ 20 SFVFIMQEDCNLVLYD-VDKPIWATNTGGLSRSCFLSMQTDGNLVVYNPSNKPIWAS----------------------- 75 (108)
T ss_dssp TEEEEECTTSCEEEEE-TTEEEEECCCTTSCSSCEEEECTTSCEEEECTTCCEEEEC-----------------------
T ss_pred CEEEEECCCCeEEEEe-CCceeeEeCCCCCCCccEEEEeccceEEEECCCccceEEc-----------------------
Confidence 3578899999999997 45899999987654 4679999999999999999999986
Q ss_pred ccCCCCCCCceeEeecCCCceeee
Q 003836 167 RKDTYFSRGRFQFRLLEDGNAVLN 190 (792)
Q Consensus 167 ~s~~~~s~G~~~~~~~~~g~~~~~ 190 (792)
.+....+.|.+.+++||++++|
T Consensus 76 --~t~~~~~~~~l~L~ddGNlVly 97 (108)
T d1jpca_ 76 --NTGGQNGNYVCILQKDRNVVIY 97 (108)
T ss_dssp --CCCCSCSCEEEEECTTSCEEEE
T ss_pred --cccCCCCcEEEEEcCCCCEEEe
Confidence 1122467888999999999986
|
| >d1kj1a_ b.78.1.1 (A:) Lectin (agglutinin) {Garlic (Allium sativum) [TaxId: 4682]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Lectin (agglutinin) species: Garlic (Allium sativum) [TaxId: 4682]
Probab=99.02 E-value=4.4e-10 Score=96.28 Aligned_cols=77 Identities=27% Similarity=0.498 Sum_probs=62.9
Q ss_pred CeeEEEEeCccEEEEcCCCCEEEEeccCCC--cceeEEEecCCcEEEEecCCccccccccCCcccccCCCccccceEEee
Q 003836 88 GSKLRLTANRGLVLEDPEGREIWKSEISTG--QAAFGVLYDTGNFLIVNTNSERLWQSFDHPTDTLLPTQTMERGGVVSS 165 (792)
Q Consensus 88 ~~~l~~~~~G~Lvl~~~~~~~vWst~~~~~--~~~~a~LldsGNlVl~~~~~~~lWQSFd~PtDtlLpg~~l~~~~~L~S 165 (792)
.-.|.|..||||||.. .+.+||++++... ....+.|.++|||||+|+++.++|+|=
T Consensus 20 ~~~l~~q~dgnLvl~~-~~~~vW~ant~~~~~~~~~l~l~~dGnLvl~~~~g~~vW~s~--------------------- 77 (109)
T d1kj1a_ 20 PYHFIMQEDCNLVLYD-HSTSVWASNTGILGKKGCKAVLQSDGNFVVYDAEGRSLWASH--------------------- 77 (109)
T ss_dssp TEEEEECTTSCEEEEE-TTEEEEECCCCCTTCCCCEEEECTTSCEEEECSSSCEEEECC---------------------
T ss_pred CEEEEecCCCeEEEEe-CCEEEEEeCCCCCCceeEEEEEcCCceEEEEeCCCcEEEEEe---------------------
Confidence 3578888999999987 5689999998643 346789999999999999999999871
Q ss_pred eccCCCCCCCceeEeecCCCceeee
Q 003836 166 RRKDTYFSRGRFQFRLLEDGNAVLN 190 (792)
Q Consensus 166 ~~s~~~~s~G~~~~~~~~~g~~~~~ 190 (792)
+....|.|.+.+++||++++|
T Consensus 78 ----t~~~~~~~~l~L~ddGNlvly 98 (109)
T d1kj1a_ 78 ----SVRGNGNYVLVLQEDGNVVIY 98 (109)
T ss_dssp ----CCCCSSCCEEEECTTSCEEEE
T ss_pred ----eECCCCCEEEEEeCCCcEEEE
Confidence 112457889999999999986
|
| >d1xd5a_ b.78.1.1 (A:) Gastrodianin (antifungal protein) {Gastrodia elata [TaxId: 91201]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Gastrodianin (antifungal protein) species: Gastrodia elata [TaxId: 91201]
Probab=98.97 E-value=1.3e-09 Score=94.06 Aligned_cols=97 Identities=21% Similarity=0.310 Sum_probs=72.9
Q ss_pred cccccCCCccccceEEeeeccCCCCCCCceeEeecCCCceeeeeeccCCCcccccccccCCcccccCCCcceeEEccCCc
Q 003836 148 TDTLLPTQTMERGGVVSSRRKDTYFSRGRFQFRLLEDGNAVLNTINLESGFAYDAYFWSNTFDTNRSNAGYRVVFNESGQ 227 (792)
Q Consensus 148 tDtlLpg~~l~~~~~L~S~~s~~~~s~G~~~~~~~~~g~~~~~~~~~~~~~~~~~y~~~~~~~~~~~~~~~~~~~~~~g~ 227 (792)
||||+|||.|..|+.|++ |.|+|.++.||+++++.. . .++|++.+... ..+..+.+..+|.
T Consensus 1 tDtL~~gq~L~~g~~l~~---------g~~~l~~q~DGNLvly~~--~-----~~vW~s~~~~~---~~~~~l~l~~dGn 61 (112)
T d1xd5a_ 1 SDRLNSGHQLDTGGSLAE---------GGYLFIIQNDCNLVLYDN--N-----RAVWASGTNGK---ASGCVLKMQNDGN 61 (112)
T ss_dssp CCEEETTEEECTTCEEEE---------TTEEEEECTTSCEEEEET--T-----EEEEECCCTTS---CSSEEEEECTTSC
T ss_pred CCEecCCCEecCCCEEEE---------CCEEEEEcCCCCEEEEcC--C-----cEEEEccCccC---CCCcEEEEecccc
Confidence 799999999999999964 999999999999998641 1 46887765432 3345788999999
Q ss_pred EEEEecccceeeeccccccccccEEEEEEecCCcEEEEe
Q 003836 228 LYVLRENKQRASLVPETVSAKENYLRATLNFDGVFIFYS 266 (792)
Q Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~~r~~L~~dG~l~~y~ 266 (792)
+.+++.++. +..+. + ......++++|+.||++++|.
T Consensus 62 Lvl~~~~~~-~w~s~-t-~~~~~~~~l~L~ddGNlvly~ 97 (112)
T d1xd5a_ 62 LVIYSGSRA-IWASN-T-NRQNGNYYLILQRDRNVVIYD 97 (112)
T ss_dssp EEEEETTEE-EEECC-C-CCSCCCCEEEECTTSCEEEEC
T ss_pred EEEEecCCe-EEEEe-e-ccCCCceEEEEcCCCCEEEEC
Confidence 998876443 33331 1 122344689999999999995
|
| >d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Type IIIa 3',5"-aminoglycoside phosphotransferase species: Enterococcus faecalis [TaxId: 1351]
Probab=98.16 E-value=2.5e-06 Score=85.08 Aligned_cols=132 Identities=14% Similarity=0.050 Sum_probs=93.2
Q ss_pred cccceEEEeeecCCCceEEEEEEcccccccchHHHHHHHHHhcccC-CCCcccccceeccCCceEEEEEeccCCCccccc
Q 003836 512 GAFGTVYKGFVNMGSSNHVAVKKLNSVFQDSEKEFKAEVNGIGQTH-HKNLVRLLGYCDEGQNRLLVYEFMSNGTVASFL 590 (792)
Q Consensus 512 G~~g~Vy~g~~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~-h~niv~l~g~~~~~~~~~lV~E~~~~gsL~~~l 590 (792)
++.+.||+... +++.+.+|+...........+.+|...++.+. +--+.+++.+..+++..++||+++++.++.+..
T Consensus 25 ~s~~~v~rv~~---~~~~~vlk~~~~~~~~~~~~~~~E~~~l~~l~~~vpvP~vl~~~~~~~~~~lv~~~l~G~~~~~~~ 101 (263)
T d1j7la_ 25 MSPAKVYKLVG---ENENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSNLLMSEADGVLCSEEY 101 (263)
T ss_dssp CSSSEEEEEEC---SSCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEECCSSEEHHHHT
T ss_pred CCCCcEEEEEe---CCCeEEEEEcCCCcccchhhHHHHHHHHHHHhccCCCCcEEEEEecCCceEEEEEecccccccccc
Confidence 33468998642 34567888877654444556788888877764 444677888888888899999999998876554
Q ss_pred cCCCCCchhHHHHHHHHHHHHHHHHhhcc---------------------------------------------------
Q 003836 591 FGDSKPNWKLRTEIAMGIAGGLFYLHEEC--------------------------------------------------- 619 (792)
Q Consensus 591 ~~~~~l~~~~~~~i~~~ia~gL~yLH~~~--------------------------------------------------- 619 (792)
.. .....+++.++++.++.||+..
T Consensus 102 ~~-----~~~~~~~~~~l~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 176 (263)
T d1j7la_ 102 ED-----EQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWEEDTPFKDPRELYDFLKT 176 (263)
T ss_dssp TT-----CSCHHHHHHHHHHHHHHHHTSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCCGGGGSTTCSCSSHHHHHHHHHH
T ss_pred cc-----cccHHHHHHHHHHHHHHHhccCccccccCcchhhhhhhHHHHHHHHhhhhhhhcccccccchHHHHHHHHHHh
Confidence 22 1223445566666666666431
Q ss_pred -----CCCeEecCCCCCcEEEcCCCCeEEeecCCCcc
Q 003836 620 -----CTQIIHCDIKPQNILLDDHYNARISDFGLAKL 651 (792)
Q Consensus 620 -----~~~ivH~dikp~NILl~~~~~~kl~Dfg~a~~ 651 (792)
...++|+|+.|.|||+++++..-|+||+.+..
T Consensus 177 ~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDwe~a~~ 213 (263)
T d1j7la_ 177 EKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSGR 213 (263)
T ss_dssp SCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCEE
T ss_pred cCCcCCcEEEEeeccCcceeecCCceEEEeechhccc
Confidence 02389999999999999877778999998864
|
| >d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]
Probab=97.50 E-value=0.00018 Score=70.58 Aligned_cols=130 Identities=16% Similarity=0.091 Sum_probs=83.7
Q ss_pred cCcccc-ceEEEeeecCCCceEEEEEEcccccccchHHHHHHHHHhcccCC--CCcccccceeccCCceEEEEEeccCCC
Q 003836 509 LGRGAF-GTVYKGFVNMGSSNHVAVKKLNSVFQDSEKEFKAEVNGIGQTHH--KNLVRLLGYCDEGQNRLLVYEFMSNGT 585 (792)
Q Consensus 509 lG~G~~-g~Vy~g~~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h--~niv~l~g~~~~~~~~~lV~E~~~~gs 585 (792)
+..|.. +.||+...+ .+..+.+|...... ...+..|...++.+.. ..+.+++.+..+++..++|||++++.+
T Consensus 18 ~~~G~s~~~v~r~~~~--~~~~~vlK~~~~~~---~~~l~~E~~~l~~L~~~gvpvP~v~~~~~~~~~~~~v~~~i~G~~ 92 (255)
T d1nd4a_ 18 QTIGCSDAAVFRLSAQ--GRPVLFVKTDLSGA---LNELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEVPGQD 92 (255)
T ss_dssp CSCTTSSCEEEEEECT--TSCCEEEEEECSCT---TSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECCSSEE
T ss_pred cCCcccCCeEEEEEeC--CCCEEEEEeCCccC---HhHHHHHHHHHHHHHhcCCCCCceeeecccccceEEEEEeeeccc
Confidence 444443 678987543 34457888765432 3356778887777643 335677888888888999999999877
Q ss_pred ccccccCCCCCchhHHHHHHHHHHHHHHHHhh------------------------------------------------
Q 003836 586 VASFLFGDSKPNWKLRTEIAMGIAGGLFYLHE------------------------------------------------ 617 (792)
Q Consensus 586 L~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~------------------------------------------------ 617 (792)
+.+.... ..+++.++++.|+-||+
T Consensus 93 ~~~~~~~--------~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 164 (255)
T d1nd4a_ 93 LLSSHLA--------PAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQGLAPAELFAR 164 (255)
T ss_dssp TTTSCCC--------HHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTTCCHHHHHHH
T ss_pred ccccccc--------HHHHHHHHHHHHHHHccCChhhCCCcccchhhHHHHHHHHHHhhhccccccchhhhhHHHHHHHH
Confidence 6543210 11122233333333332
Q ss_pred ---cc----CCCeEecCCCCCcEEEcCCCCeEEeecCCCcc
Q 003836 618 ---EC----CTQIIHCDIKPQNILLDDHYNARISDFGLAKL 651 (792)
Q Consensus 618 ---~~----~~~ivH~dikp~NILl~~~~~~kl~Dfg~a~~ 651 (792)
.. ...++|+|+.|.|||++++..+-|+||+.+..
T Consensus 165 l~~~~~~~~~~~liHgD~~~~Nvl~~~~~~~~iID~~~~~~ 205 (255)
T d1nd4a_ 165 LKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLGV 205 (255)
T ss_dssp HHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCEE
T ss_pred HHHhCCccCCceEEeCCCCCcceEEeCCceEEEEEchhccc
Confidence 11 12489999999999999887778999998753
|
| >d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Methylthioribose kinase MtnK species: Bacillus subtilis [TaxId: 1423]
Probab=97.09 E-value=0.00028 Score=74.18 Aligned_cols=77 Identities=14% Similarity=0.204 Sum_probs=46.9
Q ss_pred hhcCccccceEEEeeecCCCceEEEEEEcccc-------cccchHHHHHHHHHhcccC-C--CCcccccceeccCCceEE
Q 003836 507 EELGRGAFGTVYKGFVNMGSSNHVAVKKLNSV-------FQDSEKEFKAEVNGIGQTH-H--KNLVRLLGYCDEGQNRLL 576 (792)
Q Consensus 507 ~~lG~G~~g~Vy~g~~~~~~~~~vavK~~~~~-------~~~~~~~~~~Ei~~l~~l~-h--~niv~l~g~~~~~~~~~l 576 (792)
+.||.|....||+..... +++.++||.-... ......+...|.+.|+.+. + ..+++++.+ +++..++
T Consensus 32 ~eig~G~~N~vfrV~~~~-~~~svivKqa~p~~r~~g~~~~~~~~R~~~E~~~L~~~~~~~p~~vP~v~~~--d~~~~~l 108 (392)
T d2pula1 32 QEIGDGNLNYVFHIYDQE-HDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEMAVT 108 (392)
T ss_dssp EECCSSSSEEEEEEEC-----CEEEEEEECCGGGC--CCCCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTTTEE
T ss_pred EEeCCCceEeEEEEEeCC-CCeEEEEecCCchhcccCCCCCCCHHHHHHHHHHHHHhhhhCCCCcceEEEE--cCCCCEE
Confidence 468999999999986543 3467888864321 1112344566777777652 2 335555544 3445689
Q ss_pred EEEeccCCCc
Q 003836 577 VYEFMSNGTV 586 (792)
Q Consensus 577 V~E~~~~gsL 586 (792)
|||++++..+
T Consensus 109 vmE~L~~~~~ 118 (392)
T d2pula1 109 VMEDLSHLKI 118 (392)
T ss_dssp EECCCTTSEE
T ss_pred EEeccCCccc
Confidence 9999987543
|
| >d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: RdoA species: Escherichia coli [TaxId: 562]
Probab=96.57 E-value=0.0029 Score=64.26 Aligned_cols=132 Identities=12% Similarity=0.056 Sum_probs=76.2
Q ss_pred ceEEEeeecCCCceEEEEEEcccccccchHHHHHHHHHhcccCCCCcc--cccc-----eeccCCceEEEEEeccCCCcc
Q 003836 515 GTVYKGFVNMGSSNHVAVKKLNSVFQDSEKEFKAEVNGIGQTHHKNLV--RLLG-----YCDEGQNRLLVYEFMSNGTVA 587 (792)
Q Consensus 515 g~Vy~g~~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h~niv--~l~g-----~~~~~~~~~lV~E~~~~gsL~ 587 (792)
-.||+...+ +++.+++|+.+.. ....+++..|+..+..|...++. ..+. ........+.++++++|..+.
T Consensus 36 N~vy~v~~~--dg~~~VlK~~rp~-~~s~~~i~~E~~~l~~L~~~gipv~~p~~~~g~~~~~~~~~~~~l~~~~~G~~~~ 112 (325)
T d1zyla1 36 NRVYQFQDE--DRRRFVVKFYRPE-RWTADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSVGGRQFE 112 (325)
T ss_dssp SEEEEECCT--TCCCEEEEEECTT-TSCHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECCCCEECC
T ss_pred ceeEEEEcC--CCCEEEEEEeCCC-CCCHHHHHHHHHHHHHHHhcCCCCCCceecCCCeeeeeeeEEEEEEeecCCcCCC
Confidence 579998765 3567999987643 23457788899888887543332 1211 223445678899999875543
Q ss_pred cc----c----------c----CC-----CCCch-------------------hHHHHHHHHHHHHHHHHhh----ccCC
Q 003836 588 SF----L----------F----GD-----SKPNW-------------------KLRTEIAMGIAGGLFYLHE----ECCT 621 (792)
Q Consensus 588 ~~----l----------~----~~-----~~l~~-------------------~~~~~i~~~ia~gL~yLH~----~~~~ 621 (792)
.. + + .. ...++ ..+..+...+.+.++.+.. ....
T Consensus 113 ~~~~~~~~~lG~~LA~lH~~~~~~~~~~r~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~~~~~~~p~ 192 (325)
T d1zyla1 113 ADNIDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDATLIPSGLKAAFLKATDELIAAVTAHWREDFTV 192 (325)
T ss_dssp SSCHHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCSSSCTTTHHHHHHHHHHHHHHHHHHCCSCSCC
T ss_pred CCCHHHHHHHHHHHHHHHhhcccCCccccCCCCHHHHhhhhHHHHHHcCcCCHHHHHHHHHHHHHHHHHHHHhccccCCc
Confidence 21 0 0 00 01111 1111122222223333322 2245
Q ss_pred CeEecCCCCCcEEEcCCCCeEEeecCCCcc
Q 003836 622 QIIHCDIKPQNILLDDHYNARISDFGLAKL 651 (792)
Q Consensus 622 ~ivH~dikp~NILl~~~~~~kl~Dfg~a~~ 651 (792)
++||+|+++.|||++++ ..++||+-+..
T Consensus 193 ~liHgDlh~~NvL~~~~--~~~IDFdd~~~ 220 (325)
T d1zyla1 193 LRLHGDCHAGNILWRDG--PMFVDLDDARN 220 (325)
T ss_dssp EECCSSCSGGGEEESSS--EEECCCTTCCE
T ss_pred eeecCCCCcccEEEeCC--ceEEechhccc
Confidence 79999999999999754 56899998864
|
| >d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Choline kinase domain: Choline kinase species: Caenorhabditis elegans [TaxId: 6239]
Probab=95.67 E-value=0.013 Score=60.99 Aligned_cols=75 Identities=13% Similarity=0.169 Sum_probs=50.2
Q ss_pred hhcCccccceEEEeeecCC------CceEEEEEEcccccccchHHHHHHHHHhcccCCCCc-ccccceeccCCceEEEEE
Q 003836 507 EELGRGAFGTVYKGFVNMG------SSNHVAVKKLNSVFQDSEKEFKAEVNGIGQTHHKNL-VRLLGYCDEGQNRLLVYE 579 (792)
Q Consensus 507 ~~lG~G~~g~Vy~g~~~~~------~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h~ni-v~l~g~~~~~~~~~lV~E 579 (792)
+.|+.|-.-.+|+...... ..+.|.+++... ........+|..+++.+.-.++ .++++++.+ .+|+|
T Consensus 48 ~~l~GGltN~~y~v~~~~~~~~~~~~~~~vllRi~g~--~~~~idr~~E~~i~~~ls~~gl~Pkll~~~~~----g~I~e 121 (395)
T d1nw1a_ 48 SRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFN--PETESHLVAESVIFTLLSERHLGPKLYGIFSG----GRLEE 121 (395)
T ss_dssp EEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECS--CCCHHHHHHHHHHHHHHHHTTSSSCEEEEETT----EEEEC
T ss_pred EEcCCccccceEEEEeCCCCccccCCCCcEEEEecCC--cchhhHHHHHHHHHHHHHhCCCCCeEEEEcCC----ceEEE
Confidence 4577788889999876532 123566666543 2334566789999888854454 577777754 68999
Q ss_pred eccCCCcc
Q 003836 580 FMSNGTVA 587 (792)
Q Consensus 580 ~~~~gsL~ 587 (792)
|+++..|.
T Consensus 122 fi~g~~l~ 129 (395)
T d1nw1a_ 122 YIPSRPLS 129 (395)
T ss_dssp CCCEEECC
T ss_pred EeccccCC
Confidence 99876554
|
| >d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Homoserine kinase ThrB species: Agrobacterium tumefaciens [TaxId: 358]
Probab=94.26 E-value=0.038 Score=55.13 Aligned_cols=152 Identities=13% Similarity=0.027 Sum_probs=78.5
Q ss_pred CHHHHHHHHhhhh-------hhcCccccceEEEeeecCCCceEEEEEEcccccccchHHHHHHHHHhcccCCCCc--ccc
Q 003836 494 TYKELVEVTRGFK-------EELGRGAFGTVYKGFVNMGSSNHVAVKKLNSVFQDSEKEFKAEVNGIGQTHHKNL--VRL 564 (792)
Q Consensus 494 ~~~el~~~~~~~~-------~~lG~G~~g~Vy~g~~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~h~ni--v~l 564 (792)
+.+|+.....++. +.|..|.--+.|+.+.+. ..+++|+..... ..+++..|++++..+.+.++ ...
T Consensus 4 s~~el~~~l~~Y~lg~~~~~~~i~~G~~N~ny~v~t~~---g~yVLri~~~~~--~~~~l~~~~~~l~~L~~~g~pvp~p 78 (316)
T d2ppqa1 4 TEDELRNFLTQYDVGSLTSYKGIAEGVENSNFLLHTTK---DPLILTLYEKRV--EKNDLPFFLGLMQHLAAKGLSCPLP 78 (316)
T ss_dssp CHHHHHHHHTTBCCCCEEEEEEECC---EEEEEEEESS---CCEEEEEECC-----CCHHHHHHHHHHHHHHTTCCCCCB
T ss_pred CHHHHHHHHHhCCCCCceEeecCCCCcccCeEEEEECC---CcEEEEEcCCCC--CHHHHHHHHHHHHhhhhcccccccc
Confidence 4455555544431 235667778889876543 258999876532 23455667777777644332 222
Q ss_pred cce------eccCCceEEEEEeccCCCcccccc------------------C--CC----CC-----------------c
Q 003836 565 LGY------CDEGQNRLLVYEFMSNGTVASFLF------------------G--DS----KP-----------------N 597 (792)
Q Consensus 565 ~g~------~~~~~~~~lV~E~~~~gsL~~~l~------------------~--~~----~l-----------------~ 597 (792)
+.. .........++.+..+......-. . .. .. .
T Consensus 79 i~~~~g~~~~~~~~~~~~~~~~~~g~~~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 158 (316)
T d2ppqa1 79 LPRKDGELLGELSGRPAALISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEV 158 (316)
T ss_dssp CCBTTCCSCEEETTEEEEEEECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGT
T ss_pred ceecCCCcceeeecccceeeeecccccccccchhHHHHHHHHHHhhhhhhhhcccccccccchhhcchhhhHHHHhhhhc
Confidence 111 122344567777777644332110 0 00 00 0
Q ss_pred hhHHHHHHHHHHHHHHHHhh-ccCCCeEecCCCCCcEEEcCCCCeEEeecCCCc
Q 003836 598 WKLRTEIAMGIAGGLFYLHE-ECCTQIIHCDIKPQNILLDDHYNARISDFGLAK 650 (792)
Q Consensus 598 ~~~~~~i~~~ia~gL~yLH~-~~~~~ivH~dikp~NILl~~~~~~kl~Dfg~a~ 650 (792)
.......+..+...+.-.+. ..+.++||+|+.+.||+++++...-|.||+.+.
T Consensus 159 ~~~~~~~l~~~~~~~~~~~~~~L~~giIHgDl~~dNvl~~~~~v~gvIDF~~~~ 212 (316)
T d2ppqa1 159 EKGLREEIRPEIDYLAAHWPKDLPAGVIHADLFQDNVFFLGDELSGLIDFYFAC 212 (316)
T ss_dssp STTHHHHHHHHHHHHHHHCCCSSCEEEECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred chhHHHHHHHHHHhhhccCccccccccccCCcchhhhhcccccceeEecccccc
Confidence 00111112222222222221 123479999999999999998777899999885
|
| >d1emoa2 g.3.11.1 (A:2167-2205) Fibrillin-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Small proteins fold: Knottins (small inhibitors, toxins, lectins) superfamily: EGF/Laminin family: EGF-type module domain: Fibrillin-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=92.52 E-value=0.03 Score=34.51 Aligned_cols=27 Identities=30% Similarity=0.607 Sum_probs=20.0
Q ss_pred cCCCCCCcccccCCCCCCceecCCCCccC
Q 003836 300 SGICGFNSICSISGAKRPICQCPKGFSLL 328 (792)
Q Consensus 300 ~g~CG~~g~C~~~~~~~~~C~Cl~GF~~~ 328 (792)
-..|| ||.|++. .....|.|-+||+|.
T Consensus 7 gnpCG-nGTCtNv-iGgFec~C~~GFepg 33 (39)
T d1emoa2 7 GNPCG-NGTCKNV-IGGFECTCEEGFEPG 33 (39)
T ss_dssp TCSSS-SSCEEEC-SSSEEECCSSSSCCC
T ss_pred CCccC-Cceeeec-ccceEEeecCCcCCC
Confidence 35687 6788753 345789999999974
|
| >d2vj3a1 g.3.11.1 (A:411-452) Neurogenic locus notch homolog protein 1, Notch1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Small proteins fold: Knottins (small inhibitors, toxins, lectins) superfamily: EGF/Laminin family: EGF-type module domain: Neurogenic locus notch homolog protein 1, Notch1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=88.34 E-value=0.094 Score=34.67 Aligned_cols=26 Identities=23% Similarity=0.577 Sum_probs=21.5
Q ss_pred cCCCCCCcccccCCCCCCceecCCCCc
Q 003836 300 SGICGFNSICSISGAKRPICQCPKGFS 326 (792)
Q Consensus 300 ~g~CG~~g~C~~~~~~~~~C~Cl~GF~ 326 (792)
...|..+|.|... ..+..|.|++||+
T Consensus 10 ~~pC~n~g~C~n~-~g~y~C~C~~G~~ 35 (42)
T d2vj3a1 10 ANPCEHAGKCINT-LGSFECQCLQGYT 35 (42)
T ss_dssp SCSSSTTCEEEEC-SSSEEEECCTTEE
T ss_pred CCCCCCCcEeECC-CCCEEeECCCCCc
Confidence 4569999999864 4568999999997
|
| >d1lmja2 g.3.11.1 (A:47-88) Fibrillin-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Small proteins fold: Knottins (small inhibitors, toxins, lectins) superfamily: EGF/Laminin family: EGF-type module domain: Fibrillin-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=86.64 E-value=0.076 Score=35.13 Aligned_cols=27 Identities=26% Similarity=0.700 Sum_probs=21.0
Q ss_pred cCCCCCCcccccCCCCCCceecCCCCccC
Q 003836 300 SGICGFNSICSISGAKRPICQCPKGFSLL 328 (792)
Q Consensus 300 ~g~CG~~g~C~~~~~~~~~C~Cl~GF~~~ 328 (792)
.+.|. ++.|.++ .++..|.|++||.+.
T Consensus 9 ~~~C~-~~~C~Nt-~Gsy~C~C~~Gy~l~ 35 (42)
T d1lmja2 9 PLLCR-GGVCHNT-EGSYRCECPPGHQLS 35 (42)
T ss_dssp SSTTT-TSEEEEE-TTEEEEESCTTSCCC
T ss_pred CCCCC-CCEeECC-CCCeEEeCCCCCeEC
Confidence 46785 7899864 357899999999863
|
| >d1xkba1 g.3.11.1 (A:48-86) Factor X, N-terminal module {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Small proteins fold: Knottins (small inhibitors, toxins, lectins) superfamily: EGF/Laminin family: EGF-type module domain: Factor X, N-terminal module species: Human (Homo sapiens) [TaxId: 9606]
Probab=86.46 E-value=0.19 Score=32.52 Aligned_cols=26 Identities=23% Similarity=0.565 Sum_probs=21.1
Q ss_pred cCCCCCCcccccCCCCCCceecCCCCc
Q 003836 300 SGICGFNSICSISGAKRPICQCPKGFS 326 (792)
Q Consensus 300 ~g~CG~~g~C~~~~~~~~~C~Cl~GF~ 326 (792)
..-|...|.|... ..+..|.|++||+
T Consensus 5 ~~PC~ngg~C~~~-~~~y~C~C~~G~~ 30 (39)
T d1xkba1 5 TSPCQNQGKCKDG-LGEYTCTCLEGFE 30 (39)
T ss_dssp TCCCCSSCEECCC-SSSCCEECCTTEE
T ss_pred CCCCCCCcEEECC-CCCEEEECCCCCC
Confidence 4668999999863 3568999999997
|
| >d1emoa1 g.3.11.1 (A:2124-2166) Fibrillin-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Small proteins fold: Knottins (small inhibitors, toxins, lectins) superfamily: EGF/Laminin family: EGF-type module domain: Fibrillin-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=86.18 E-value=0.18 Score=33.42 Aligned_cols=26 Identities=23% Similarity=0.427 Sum_probs=20.6
Q ss_pred CCCCCCcccccCCCCCCceecCCCCcc
Q 003836 301 GICGFNSICSISGAKRPICQCPKGFSL 327 (792)
Q Consensus 301 g~CG~~g~C~~~~~~~~~C~Cl~GF~~ 327 (792)
+.|+.++.|.++ .++..|.|++||+.
T Consensus 11 ~~~~~~~~C~Nt-~Gsy~C~C~~Gy~~ 36 (43)
T d1emoa1 11 PDVCKHGQCINT-DGSYRCECPFGYIL 36 (43)
T ss_dssp TTSCSSSCCCCC-SSCCCCCCCTTEEE
T ss_pred cCCCCCCEeECC-CCCeEeECCCCccc
Confidence 446678999874 46789999999985
|
| >d2vj3a2 g.3.11.1 (A:453-491) Neurogenic locus notch homolog protein 1, Notch1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Small proteins fold: Knottins (small inhibitors, toxins, lectins) superfamily: EGF/Laminin family: EGF-type module domain: Neurogenic locus notch homolog protein 1, Notch1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=85.42 E-value=0.16 Score=32.80 Aligned_cols=26 Identities=23% Similarity=0.497 Sum_probs=21.2
Q ss_pred cCCCCCCcccccCCCCCCceecCCCCc
Q 003836 300 SGICGFNSICSISGAKRPICQCPKGFS 326 (792)
Q Consensus 300 ~g~CG~~g~C~~~~~~~~~C~Cl~GF~ 326 (792)
..-|...|.|... ..+..|.|++||.
T Consensus 6 ~~PC~n~g~C~~~-~~~y~C~C~~G~~ 31 (39)
T d2vj3a2 6 SNPCQNDATCLDQ-IGEFQCICMPGYE 31 (39)
T ss_dssp TCCCCSSCEEEEC-SSCEEEECCTTEE
T ss_pred CCCCCCCCEEECC-CCCEEEeCCCCCc
Confidence 4669999999863 4578999999997
|
| >d1q4ga2 g.3.11.1 (A:32-73) Prostaglandin H2 synthase-1, EGF-like module {Sheep (Ovis aries) [TaxId: 9940]} | Back information, alignment and structure |
|---|
class: Small proteins fold: Knottins (small inhibitors, toxins, lectins) superfamily: EGF/Laminin family: EGF-type module domain: Prostaglandin H2 synthase-1, EGF-like module species: Sheep (Ovis aries) [TaxId: 9940]
Probab=84.95 E-value=0.13 Score=33.89 Aligned_cols=33 Identities=36% Similarity=0.765 Sum_probs=24.3
Q ss_pred CccccccccccCCCCcCCCCCCcccccCCCCCCceecCC-CCc
Q 003836 285 PENICINNDIRKGLGSGICGFNSICSISGAKRPICQCPK-GFS 326 (792)
Q Consensus 285 p~~~C~~~~~~~~~~~g~CG~~g~C~~~~~~~~~C~Cl~-GF~ 326 (792)
|-|.|. ..-|...|.|......+..|.|++ ||.
T Consensus 1 Pid~C~---------~nPC~ngG~C~~~~~~~y~C~C~~~G~~ 34 (42)
T d1q4ga2 1 PVNPCC---------YYPCQHQGICVRFGLDRYQCDCTRTGYS 34 (42)
T ss_dssp CCCGGG---------GCCCCTTCEEEEETTTEEEEECTTSSEE
T ss_pred CCccCc---------CCCCCCCCEeeeCCCCCEEEECCCCCcC
Confidence 456676 467999999964333468999986 896
|
| >d1uzka2 g.3.11.1 (A:1605-1647) Fibrillin-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Small proteins fold: Knottins (small inhibitors, toxins, lectins) superfamily: EGF/Laminin family: EGF-type module domain: Fibrillin-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=82.56 E-value=0.19 Score=33.26 Aligned_cols=27 Identities=30% Similarity=0.754 Sum_probs=20.9
Q ss_pred cCCCCCCcccccCCCCCCceecCCCCccC
Q 003836 300 SGICGFNSICSISGAKRPICQCPKGFSLL 328 (792)
Q Consensus 300 ~g~CG~~g~C~~~~~~~~~C~Cl~GF~~~ 328 (792)
.+.|. ++.|.++ .++..|.|++||.+.
T Consensus 10 ~~~c~-~~~C~Nt-~Gsy~C~C~~Gy~l~ 36 (43)
T d1uzka2 10 PGLCQ-GGKCINT-FGSFQCRCPTGYYLN 36 (43)
T ss_dssp GGGGB-TSEEEEC-SSCEEEECCTTCCBC
T ss_pred CCCcC-CCEEECC-CCCeEeECCCCCeEC
Confidence 45675 6899874 467899999999864
|
| >d1gl4a2 g.3.11.5 (A:359-398) EGF-like domain of nidogen-1 {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Small proteins fold: Knottins (small inhibitors, toxins, lectins) superfamily: EGF/Laminin family: EGF-like domain of nidogen-1 domain: EGF-like domain of nidogen-1 species: Mouse (Mus musculus) [TaxId: 10090]
Probab=81.76 E-value=0.19 Score=32.66 Aligned_cols=25 Identities=20% Similarity=0.531 Sum_probs=20.9
Q ss_pred CCCCCCcccccCCCCCCceecCCCCc
Q 003836 301 GICGFNSICSISGAKRPICQCPKGFS 326 (792)
Q Consensus 301 g~CG~~g~C~~~~~~~~~C~Cl~GF~ 326 (792)
..|.+++.|..+ ..+..|.|.+||.
T Consensus 7 ~~C~~~A~C~Nt-~Gsy~C~C~~Gy~ 31 (40)
T d1gl4a2 7 HQCSVHAECRDY-ATGFCCRCVANYT 31 (40)
T ss_dssp GGSCTTEEEEEC-SSCEEEEECTTEE
T ss_pred CCCCCCCEeecC-CCCeEeECCCCCc
Confidence 459999999875 4578999999997
|
| >d2vj3a3 g.3.11.1 (A:492-526) Neurogenic locus notch homolog protein 1, Notch1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Small proteins fold: Knottins (small inhibitors, toxins, lectins) superfamily: EGF/Laminin family: EGF-type module domain: Neurogenic locus notch homolog protein 1, Notch1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=81.57 E-value=0.3 Score=30.62 Aligned_cols=26 Identities=35% Similarity=0.727 Sum_probs=21.0
Q ss_pred cCCCCCCcccccCCCCCCceecCCCCc
Q 003836 300 SGICGFNSICSISGAKRPICQCPKGFS 326 (792)
Q Consensus 300 ~g~CG~~g~C~~~~~~~~~C~Cl~GF~ 326 (792)
..-|-..|.|... ..+..|.|++||.
T Consensus 5 ~~PC~ngg~C~~~-~~~y~C~C~~g~~ 30 (35)
T d2vj3a3 5 SSPCLHNGRCLDK-INEFQCECPTGFT 30 (35)
T ss_dssp TCCSTTTCEEEEC-SSCEEEECCTTEE
T ss_pred CCCCCCCcEEECC-CCCeEEECCCCCC
Confidence 4669999999764 3468999999997
|
| >d1edmb_ g.3.11.1 (B:) Factor IX (IXa) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Small proteins fold: Knottins (small inhibitors, toxins, lectins) superfamily: EGF/Laminin family: EGF-type module domain: Factor IX (IXa) species: Human (Homo sapiens) [TaxId: 9606]
Probab=81.37 E-value=0.25 Score=31.87 Aligned_cols=26 Identities=31% Similarity=0.561 Sum_probs=21.1
Q ss_pred cCCCCCCcccccCCCCCCceecCCCCc
Q 003836 300 SGICGFNSICSISGAKRPICQCPKGFS 326 (792)
Q Consensus 300 ~g~CG~~g~C~~~~~~~~~C~Cl~GF~ 326 (792)
..-|-..|.|... ..+..|.|++||+
T Consensus 8 ~~PC~ngg~C~~~-~~~y~C~C~~g~~ 33 (39)
T d1edmb_ 8 SNPCLNGGSCKDD-INSYECWCPFGFE 33 (39)
T ss_dssp TCCCCTTCEEEEE-TTEEEEECCTTCC
T ss_pred CCCCCCCcEEEcC-CCCEEEECCCCCC
Confidence 4669999999763 3568999999997
|